<SEC-DOCUMENT>0001601485-26-000027.txt : 20260312
<SEC-HEADER>0001601485-26-000027.hdr.sgml : 20260312
<ACCEPTANCE-DATETIME>20260312162452
ACCESSION NUMBER:		0001601485-26-000027
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		137
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260312
DATE AS OF CHANGE:		20260312

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elicio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001601485
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				113430072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39990
		FILM NUMBER:		26748140

	BUSINESS ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(857) 209-0050

	MAIL ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Angion Biomedica Corp.
		DATE OF NAME CHANGE:	20140228
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>angn-20251231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:b764f3f1-1aa2-42b0-ba71-263b5668ebc9,g:54ff377e-34d5-4517-b79e-9773ed1b9e6a,d:8f3bd7775f224765952a5c19fa601c7c-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:angn="http://www.angn.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>angn-20251231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-36">Nasdaq</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-37">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-38">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-39">0001601485</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-40">False</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="angn-20251231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="agreement"><xbrli:measure>angn:agreement</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="entity"><xbrli:measure>angn:entity</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:RegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:A2024RegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:JulySharesAndJulyCommonWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-31</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">angn:GKCCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">angn:EmployeeBenefitPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyAndJayVenkatesanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:A2024ATMProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-03-11</xbrli:startDate><xbrli:endDate>2026-03-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8f3bd7775f224765952a5c19fa601c7c_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December&#160;31</ix:nonNumeric>, 2025</ix:nonNumeric></span></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;to </span></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-39990</ix:nonNumeric></span></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">Elicio Therapeutics, Inc.</ix:nonNumeric></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">11-3430072</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">451 D Street, 5th Floor</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Boston</ix:nonNumeric>,  <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">Massachusetts</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">02210</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">857</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">209-0050</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.737%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, par value $0.01</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">ELTX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to section 12(g) of the Act: None. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  &#9744; <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> No &#9744;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-(&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> No &#9744;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-24">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-25">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-26">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the Registrant included in the filing reflect the correction of an error to previously issued financial statements.  <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-28">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the Registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes &#9744; No <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-29">&#9746;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the voting stock and non-voting common stock held by non-affiliates of the registrant, based on the closing price of a share of the registrant&#8217;s common stock on June 30, 2025, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, as reported by the Nasdaq Capital Market on such date, was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="dei:EntityPublicFloat" scale="6" id="f-30">81.8</ix:nonFraction>&#160;million. Shares of common stock held by each executive officer and director and by each entity affiliated with an executive officer or director have been excluded from this computation. The determination of affiliate status for this purpose is not necessarily a conclusive determination for other purposes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the issuer&#8217;s common stock outstanding as of March&#160;10, 2026, was <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-31">18,396,074</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-32" escape="true"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the registrant&#8217;s definitive proxy statement relating to the 2026 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;) is filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, then portions of the Proxy Statement will be incorporated by reference into Part III of this Annual Report on Form 10-K. If the Proxy Statement is not filed within such 120-day period, then the registrant will file an amendment to this Annual Report (the &#8220;Form 10-K/A&#8221;) within such 120-day period that will contain the information required to be included or incorporated by reference into Part III of this Annual Report.</span></ix:nonNumeric><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:33.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.575%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Auditor Name: <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-33">Baker Tilly US, LLP</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Auditor Location:  <ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-34">Tewksbury, Massachusetts</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PCAOB ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-35">23</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_13"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:92.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_16">Forward-Looking Statements</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_16">3</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_19">Part I</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_22">Item 1. Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_25">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_25">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_28">Item 1B. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_28">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_31">Item 1C. Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_31">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_34">Item 2. Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_34">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_37">Item 3. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_37">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_40">Item 4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_40">94</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_43">Part II</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_46">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_46">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_49">Item 6. [Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_49">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_52">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_52">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_76">Item 7A. Quantitative and Qualitative Disclosures </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_76">A</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_76">bout Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_76">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_79">Item 8. Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_79">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_169">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_169">132</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_172">Item 9A. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_172">132</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_175">Item 9B. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_175">133</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_178">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_178">133</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_181">Part III</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_184">Item 10. Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_184">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_187">Item 11. Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_187">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_190">Item 12. Security Ownership of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_190">Certain </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_190">Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_190">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_193">Item 13. Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_193">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_196">Item 14. Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_196">134</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_199">Part IV</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_202">Item 15. Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_202">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_205">Item 16. Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_205">137</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_208">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_208">138</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This Annual Report on Form 10-K, including the sections titled &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Annual Report on Form 10-K other than statements of historical fact, including statements concerning our business strategy and plans, future operating results and financial position, as well as our objectives and expectations for our future operations, are forward-looking statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In some cases, you can identify forward-looking statements by terminology such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;positioned,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our financial condition, including our ability to obtain the funding necessary to advance the development of ELI-002 7P and any other current or future product candidates, our ability to continue as a going concern and our cash runway;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the ability of our clinical trials to demonstrate safety and efficacy of our product candidates, and other positive results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to utilize our platform to develop a pipeline of product candidates to address unmet needs in oncology and other disease areas;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the timing, progress and results of clinical trials for ELI-002 7P, and other current or future product candidates we may develop, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the studies or trials will become available, and the timing, progress and results of our research and development programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the timing, scope and likelihood of regulatory filings and approvals, including timing of Investigational New Drug applications and U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval of ELI-002 7P and any current or future product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the timing, scope or likelihood of foreign regulatory filings and approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to develop and advance our current product candidates and programs into, and successfully complete, clinical studies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our manufacturing, commercialization, marketing capabilities, strategy and associated timelines;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the need to hire additional personnel and our ability to attract and retain such personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the size of the market opportunity for our product candidates, including estimates of the number of patients who suffer from the diseases we are targeting;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">expectations regarding the approval and use of our product candidates in combination with other drugs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">expectations regarding potential for accelerated approval or other expedited regulatory designation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our competitive position and the success of competing therapies that are or may become available;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our anticipated research and development activities and projected expenditures;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">existing regulations and regulatory developments in the United States, Europe and other jurisdictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the extent to which global economic and political developments, including the ongoing conflict between Ukraine and Russia, the conflicts in the Middle East, including the conflict between Israel and Palestine and the conflict between Israel and Iran, geopolitical tensions with China, and other geopolitical events, as well as the macroeconomic conditions, including tariffs, inflation, volatility in interest rates, potential for economic slowdown or recession and potential government shutdowns, will affect our business operations, clinical trials, or financial condition;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our expectations regarding other macroeconomic trends;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our intellectual property position, including the scope of protection we are able to establish and maintain for intellectual property rights covering ELI-002 7P, other current or future product candidates we may develop, including the extensions of existing patent terms where available, the validity of intellectual property rights held by third parties, and our ability not to infringe, misappropriate or otherwise violate any third-party intellectual property rights;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our continued reliance on third parties to conduct additional clinical trials of our product candidates, and for the manufacture of our product candidates for clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to have manufactured sufficient supplies of drug product for clinical testing and commercialization;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to obtain, and negotiate favorable terms of, any collaboration, licensing or other arrangements that may be necessary or desirable to develop, manufacture or commercialize our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our projected financial performance;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our anticipated use of proceeds from potential financing activities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our planned operating expenses and capital expenditure requirements; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the potential impact of anticipated funding pressures and the expected effect from U.S. export controls and tariffs; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the impact of laws and regulations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this Annual Report on Form 10-K.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in the &#8220;Risk Factors&#8221; section in Part I, Item 1A of this Annual Report on Form 10-K. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s beliefs and are based on assumptions as of the date of this Annual Report on Form 10-K. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. In addition, statements such as &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Annual Report on Form 10-K. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into or review of all relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely on these statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This Annual Report on Form 10-K also contains estimates, projections and other information concerning our industry, our business and the markets for certain drugs, including data regarding the estimated size of those markets, their projected growth rates and the incidence of certain medical conditions. Information that is based on estimates, forecasts, projections or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by third parties, industry, medical and general publications, government data and similar sources. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In this Annual Report on Form 10-K, unless the context indicates otherwise, the terms &#8220;Company&#8221;, &#8220;Elicio&#8221;, &#8220;we,&#8221; &#8220;us&#8221;, and &#8220;our,&#8221; refer to Elicio Therapeutics, Inc. and our wholly-owned subsidiaries.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Trademarks</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This Annual Report on Form 10-K includes trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included in this Annual Report on Form 10-K are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Part I</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_22"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Business</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mutant Kirsten rat sarcoma viral oncogene homolog (&#8220;mKRAS&#8221;) - positive pancreatic cancer, colorectal cancer (&#8220;CRC&#8221;), lung cancer and other mKRAS positive cancers. We intend to build on recent clinical successes in the personalized cancer immunotherapy space to develop effective, off-the-shelf immunotherapies. Our proprietary Amphiphile (&#8220;AMP&#8221;) technology aims to enhance the education, activation and amplification of cancer-specific T cells relative to conventional immunotherapy strategies, with the goal of promoting durable cancer immunosurveillance in patients. Recent advances have identified T cell responses as a key component of effective cancer immunotherapy and we believe our AMP technology can generate robust T cell responses in patients that can potentially translate to meaningful clinical benefit. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe the therapeutic utility of currently approved and development stage cancer immunotherapies is limited in many cases due to their inability to sufficiently localize to lymph nodes and adequately engage with the critical immune cells responsible for stimulating adaptive immunity.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP technology is specifically intended to localize payloads to lymph nodes leading to the generation of a robust T cell response that we believe is critical to generate an anticancer immune response.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our lead programs focus on our cancer immunotherapy product candidates, which target biologically validated driver tumor mutations using common and well-characterized neoantigens. This strategy results in an &#8220;off-the-shelf&#8221; therapeutic option allowing patients to receive treatment without delays due to manufacturing timelines and without the increased costs associated with personalized immunotherapy approaches.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our clinical pipeline includes the lymph node targeted cancer immunotherapy ELI-002 7P, currently being evaluated in a Phase 2 study, designed to stimulate an immune response against mKRAS pancreatic ductal adenocarcinoma (&#8220;PDAC&#8221;), the most common form of pancreatic cancer. The ELI-002 7P formulation is designed to provide broad immune responses targeting seven Kirsten rat sarcoma viral oncogene homolog (&#8220;KRAS&#8221;) mutations that are observed in approximately 88% of PDAC patients and 25% of all solid tumors, thereby increasing the potential patient population for ELI-002 7P beyond PDAC alone. ELI-002 2P (2-peptide formulation) has been studied previously in the Phase 1 (AMPLIFY-201) trial in patients with high relapse risk mKRAS-driven solid tumors, following surgery and chemotherapy. ELI-002 2P and ELI-002 7P also have been studied in patients with mKRAS-positive CRC in Phase 1 studies. The AMPLIFY-201 Phase 1 data for PDAC and CRC was presented at the ESMO Immuno-Oncology Congress 2024 and published in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature Medicine</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (Wainberg et al, 2025) and included a 16.3-month median recurrence-free survival and 28.9-month median overall survival for the full study population. In the future, we plan to expand ELI-002 7P to other indications including mKRAS positive lung cancer and other mKRAS positive cancers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our preclinical pipeline includes the lymph node targeted immunotherapies ELI-007, currently being evaluated in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-(&#8220;BRAF&#8221;) driven cancers, and ELI-008, currently being evaluated in preclinical studies for use in the treatment of mutated tumor protein p53 (&#8220;TP53&#8221;)- expressing cancers. We believe that each of our immunotherapy product candidates, if approved, has the potential to reduce the risk of recurrence of tumors carrying specific oncogenic driver mutations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Our Strategy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are focused on mobilizing the immune response to treat cancer through the development and commercialization of lymph node targeted immunotherapies. Key elements of our strategy are to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:13.8pt">Continue advancing ELI-002 7P in an ongoing randomized Phase 2 trial in PDAC</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. We are developing our first product candidate, ELI-002, for the treatment of patients with solid tumors expressing mKRAS. By targeting immunotherapy to the lymph nodes and generating a robust and differentiated T cell response, we believe ELI-002 could improve the long-term prognosis and quality of life for patients suffering from solid tumors. We are currently evaluating ELI-002 7P in AMPLIFY-7P, a randomized Phase 2 trial to evaluate the efficacy and safety in patients with PDAC. In December 2024, we announced that we completed enrollment in our AMPLIFY-7P trial. We will continue to follow patients for up to 36 months. In August 2025, we announced that following the Independent Data Monitoring Committee&#8217;s (&#8220;IDMC&#8221;) pre-specified interim review of unblinded safety and efficacy data in our Phase 2 AMPLIFY-7P study in mKRAS-driven PDAC, the IDMC recommended that the trial continue to the final event-driven disease-free survival (&#8220;DFS&#8221;) analysis without modifications. In addition, the IDMC confirmed the favorable safety profile of ELI-002 7P as of such date. We anticipate the final DFS analysis to occur in the first half of 2026, depending on the rate of event accrual. To determine how long patients live without their cancer returning, the study is comparing events (cancer detected on an imaging scan or death) in the AMPLIFY-7P versus observation groups once the pre-specified total number of events are observed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:13.8pt">Expand ELI-002 7P clinical development for the treatment of other KRAS driven cancers.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our ongoing Phase 2 trial is in adjuvant stage PDAC, but our Phase 1 trials also included patients with CRC and the preliminary safety, immunogenicity and efficacy data were encouraging in both PDAC and CRC patients.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to CRC, our platform may be applicable to patients with lung cancer, bile duct and other gastrointestinal cancers driven by KRAS mutations, and there is also unmet need in neoadjuvant stage and metastatic pancreatic cancer.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are evaluating opportunities to advance ELI-002 in clinical trials for CRC and other indications including in collaboration with other organizations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:13.8pt">Advance development of our internal pipeline, including ELI-007 and ELI-008, for additional oncology targets.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> We have two preclinical programs that employ our AMP technology targeting other key tumor driver mutations, BRAF and TP53.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ELI-007, for mutant BRAF-driven cancers, and ELI-008, for mutant TP53-expressing cancers, are AMP immunotherapies targeting biologically validated neoantigens expressed in high proportions of solid tumors.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have received grants to fund the preclinical development of ELI-007 and ELI-008. We intend to continue to seek collaboration opportunities to advance the development of ELI-007 and ELI-008 into Phase 1 trials.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:13.8pt">Realize the full value of the AMP technology through collaborations. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have published several preclinical proof-of-concept applications where our AMP technology has demonstrated meaningful improvements when applied to </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">prophylactic </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">vaccines, CAR-T and TCR-T cell therapies, and therapies for auto-immune disease. We will look to establish collaborations to </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">capitalize on the potential of the technology in these applications including additional pipeline adjuvants such as ELI-004 (Amph-CpG-7909). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Overview of Immune System and Cancer Immunotherapy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The immune system is a large network of organs, tissues, white blood cells, proteins and chemicals working together to protect and repair the body from infections, injuries and cellular changes associated with disease.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">One component of the immune system is the adaptive immune response which is responsible for mounting highly specific responses to substances deemed to be foreign.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The adaptive immune response is carried out by white blood cells including B lymphocytes (&#8220;B cells&#8221;) and T lymphocytes (&#8220;T cells&#8221;). B cells are involved in the humoral immune response, differentiating into antibody-secreting plasma cells upon activation and recognition of a foreign-specific molecular structure known as an antigen. T cells participate primarily in the cell-mediated immune response and are capable of specific antigen-directed recognition and elimination of aberrant cells arising from pathogenic infection or genetic transformation.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">T cells can be further segregated into distinct cell types, with the primary types being CD8+ T cells, which are also referred to as cytotoxic lymphocytes (&#8220;CTLs&#8221;), and CD4+ &#8220;helper&#8221; T cells. CD8+ T cells specifically recognize and eliminate cells infected with viruses, other pathogens, or cancer-associated mutations. In contrast, CD4+ T cells, which can also exhibit cytotoxic activity, primarily participate in the immune response by directing the activity of other cells, in particular B cells and CD8+ T cells.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The lymphatic system plays a major role in the production, differentiation, and proliferation of both B cells and T cells, and lymph nodes serve a critical role in lymphocytes&#8217; activation and acquisition of essential functionality. The lymph nodes act as the &#8220;school house&#8221; of the adaptive immune response, playing an essential role in the generation of B cells and T cells possessing the specificity and functionality required for effective disease modification.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Specifically, signaling delivered between immune cells residing in the lymph nodes is critical for the generation of a T cell response with the magnitude, potency, persistence, functionality, specificity, and memory capacity required for an effective cell-mediated immune response.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As cancer is the result of genetic transformation of normal cells resulting in uncontrolled growth, the immune system doesn&#8217;t always recognize cancer cells as foreign.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, cancer cells can adopt mechanisms to evade immune system recognition or defenses rendering the adaptive immune response ineffective.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">However, immune cells, referred to as tumor-infiltrating lymphocytes (&#8220;TILs&#8221;), are sometimes found in and around tumors and patients with TILs often have a better prognosis than patients without TILs - supporting the rationale for development of drugs such as checkpoint antibodies that target immune cells found in and around tumors rather than directly targeting cancer cells.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the last 15 years, immunotherapy has become a therapeutic mainstay for treating certain cancers.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Several approaches to cancer immunotherapy have been attempted, all with the goal of eliciting or enhancing an immune response to identify and attack tumor cells.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe that cancer immunotherapies hold the potential to eliminate cancer cells as cancer cells often contain tumor-specific antigens, or neoantigens, not present in normal cells; cancer immunotherapies could facilitate the immune system recognition and response to these neoantigens.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, because an adaptive immune response includes a mechanism to create life-long T cells, cancer immunotherapies may prevent relapse of cancer long after initial treatment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">While general neoantigen-specific immune activity has been demonstrated by previous antigen-specific cancer immunotherapy efforts, reduction in tumor loads has not been frequently observed resulting in only two FDA-approved antigen-specific cancer immunotherapies. Researchers investigating this lack of historical antigen-specific cancer immunotherapy efficacy have suggested a key reason is the limited generation of tumor-specific T cells as well as impaired </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">fitness of the elicited anti-tumor T cells. We believe our technology is differentiated from prior antigen-specific cancer immunotherapy approaches because it engages the lymph nodes and has been observed to produce higher levels of T cell response while engaging additional immunology mechanism. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe improved delivery of immunotherapies to the lymph nodes is required to generate the robust and multifunctional adaptive immune response, specifically T cell responses, needed for therapeutic efficacy. Our AMP technology is designed to deliver immunotherapeutic payloads of interest to lymph nodes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Our Approach</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fundamental underpinning of our innovative approach is delivering immunotherapeutic payloads to lymph nodes.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP technology is designed to rapidly deliver peptides, proteins, nucleic acids and small molecules to lymph nodes through reversible interactions with endogenous albumin.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP technology has been flexibly designed to be manufactured with various peptide lengths and sequences optimizing the localization of the AMP-modified molecules to lymph nodes and the subsequent cellular processing required to generate robust T cell response.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">AMP Technology: Lymph node targeting via albumin hitchhiking </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:112%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our proprietary AMP technology, and combined expertise in immunology and materials science, allows us to develop AMP immunotherapies capable of generating robust and differentiated immune responses.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP immunotherapies utilize modular conjugation chemistry, potentially allowing for application to multiple therapeutic modalities, including peptides, proteins, nucleic acids, and small molecules as illustrated in the figure below:</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">AMP construction: A molecular conjugation approach for</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">delivery of immune therapeutics to lymph nodes</span></div><div style="margin-top:6pt"><img src="angn-20251231_g1.jpg" alt="amp.jpg" style="height:276px;margin-bottom:5pt;vertical-align:text-bottom;width:684px" id="i-1"/></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">AMP molecules are multifunctional constructs with lipid tails linked to a therapeutic payload designed to accumulate in the lymph nodes through the body&#8217;s existing surveillance mechanisms.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">AMP molecules are designed to interact with endogenous albumin, an abundant protein that drains from the tissues through lymphatic capillaries and accumulates in lymph nodes where forei</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">gn substances are collected for risk-assessment by sentinel immune cells. AMP molecules use their lipid tails to target the lymph nodes by hitchhiking on endogenous albumin after subcutaneous injection resulting in precise delivery to immune cells responsible for coordinating protective immune responses. </span><span style="color:#1f1f1f;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Albumin hitchhiking is a well-established method for targeting molecules to lymph nodes. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP technology preferentially delivers immuno-modulatory cargo to lymph nodes - potentially enhancing the magnitude, functionality, and durability of the immune response. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe this lymph node-targeting technology has the potential to be broadly applicable to address significant unmet medical needs.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#1f1f1f;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">AMP Facilitated Albumin Hitchhiking</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><img src="angn-20251231_g2.jpg" alt="AMP technology.jpg" style="height:249px;margin-bottom:5pt;vertical-align:text-bottom;width:660px" id="i-2"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Targeting Common Validated Tumor Neoantigens</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe a critical strategic benefit of our approach is training the immune system to recognize common neoantigens to generate an effective T cell-mediated anti-tumor response.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Common neoantigens represent an elite class of tumor-specific antigens derived from recurrently mutated driver genes shared across certain types of cancer.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Neoantigens are newly formed antigens generated by tumor cells as a result of various tumor-specific alterations, such as genomic mutation or dysregulated protein synthesis. Neoantigens are recognized as non-self and can readily trigger an immune response.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our most advanced clinical product candidate, ELI-002 7P, is a cancer immunotherapy that targets the tumor driver gene KRAS, which is mutated in more than 25% of all solid tumors.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our preclinical cancer immunotherapy candidates, ELI-007 and ELI-008, target two other key neoantigens TP53, the most commonly mutated cancer driver gene, and BRAF, a cancer driver gene found frequently in melanoma, thyroid, and colon cancers. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">      </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Utilizing robust adjuvants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to utilizing well-known neoantigens, our product candidates incorporate robust adjuvants which utilize the AMP technology to promote localization to the lymph nodes and enhanced delivery to immune cells potentially resulting in higher,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">more robust immune responses with potentially fewer side effects.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Adjuvants are any substance included in an immunotherapy intended to activate immune cells to elicit a stronger immune response.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our current product candidates utilize a modified form of the synthetic oligonucleotide adjuvant, soluble CpG 7909, intended to mimic bacterial DNA that has been extensively studied and incorporated into FDA-approved products.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In previous clinical studies conducted by third parties, CpG-containing oligonucleotides have been shown to be both well tolerated and to exert immune-stimulatory effects. Our AMP-modification is designed to concentrate and retain the CpG adjuvant in the lymphatic system potentially allowing more effective delivery to immune cells and/or reduced side effects. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The result of our approach is the development of cancer immunotherapies intended to target common tumor neoantigens found in a significant portion of patients with cancer. Our AMP immunotherapies are manufactured through traditional pharmaceutical methods resulting in an &#8220;off-the-shelf&#8221; drug product. &#8201;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Our Product Candidates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">ELI-002: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">AMP Immunotherapy for mKRAS-driven Cancers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ELI-002 is a multivalent lymph node&#8211;targeted AMP peptide immunotherapy being developed to target seven KRAS driver mutations that are present in 25% of all solid tumor cancers including 88% of PDAC, 36% of CRC, and 25% of non-small cell lung cancer (&#8220;NSCLC&#8221;). Other cancers with significant proportions of KRAS mutations include bile duct and ovarian cancers. The KRAS protein relays signals from outside of the cell membrane to the cell nucleus influencing expression of downstream genes involved in the regulation of cell growth, cell differentiation, and cell death (also referred to as apoptosis). Mutations to the KRAS gene result in expression of overactive KRAS protein, driving aberrant signaling and unregulated cell growth, which are hallmarks of cancer.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Targeting mKRAS using immunotherapy presents several potential advantages. KRAS mutations are categorized as truncal mutations serving as a genetic driver of malignant changes where each tumor cell must maintain the expression of the mKRAS protein to remain viable. Such uniform expression across every transformed cell in a particular tumor holds the promise that immunological approaches may enable complete tumor eradication. mKRAS proteins are neoantigens, found exclusively in tumor cells, potentially limiting immunotherapy activity to the targeted tumor cells limiting side effects. ELI-002 is chemically synthesized with traditional manufacturing methods that allow the drug product to be readily available as an &#8220;off-</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">the-shelf&#8221; treatment providing potential cost and time-to-treatment advantages compared to personalized vaccine or cell-therapy treatments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8201;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">AMPLIFY-201: Our First-in-human Phase 1 trial (NCT04853017)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In October 2021, we initiated dosing of the 2-peptide version of ELI-002 (&#8220;ELI-002 2P&#8221;), covering KRAS G12D and G12R mutations, in a Phase 1 dose escalation study intended to evaluate safety and tolerability, as well as provide immunologic and anti-tumor proof of concept in patients with high relapse risk mKRAS-driven solid tumors, following surgery and chemotherapy. In April 2023, we completed enrollment of 25 patients with PDAC or CRC. In August 2024, we ended the disease-free survival follow-up for this study. Results published in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature Medicine</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> in January 2024 from a September 6, 2023 data cutoff, and long term follow up results presented at the ESMO Immuno-Oncology meeting in December 2024 from a September 24, 2024 data cutoff and published in Nature Medicine in August 2025 demonstrated (results from both timepoints presented below unless otherwise indicated):</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">ELI-002 2P was generally well-tolerated with no dose limiting toxicities or serious adverse events</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Selection of a recommended Phase 2 dose of 10.0 mg Amph-CpG-7909</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">84% of patients generated mKRAS-specific T cell responses with a 58x average fold-change compared to baseline (September 6, 2023 data cutoff)</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">59% of patient responses included both CD4+ and CD8+ T cells (September 6, 2023 data cutoff)</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">84% of patients had a decline in their tumor biomarker from baseline (September 6, 2023 data cutoff)</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">100% of the above-median T cell response group (12.75X) achieved tumor biomarker responses to ELI-002; in the below-median group 67% (8/12) responded to ELI-002 (September 6, 2023 data cutoff)</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">At a median follow-up of 19.7 months (September 24, 2024 data cutoff)  </span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">The median relapse-free survival was 16.3 months for the full 25 patient cohort; the median relapse-free survival for the 20 PDAC subgroup was 15.31 months (September 24, 2024 data cutoff)</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">The median RFS was not reached for the above median T cell responders compared to 4.01 months among the below median T cell responders (HR 0.12, 95% CI 0.022-0.615, P=0.0002); 10 of the 17 of the above median T cell group were free from relapse or death; 88% reduction in risk of progression or death in the above median T cell responders to ELI-002 (September 24, 2024 data cutoff)</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">The median overall survival was 28.9 months for the full 25 patient cohort; the median overall survival for the 20 PDAC subgroup was also 28.9 months (September 24, 2024 data cutoff)</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">The median OS was not reached for the above median T cell responders compared to 15.98 months among the below median T cell responders (HR 0.23, 95% CI 0.063-0.854, P=0.00099): 10 of the 13 of the above median T cell group were free from relapse or death; 77% reduction in risk of death in the above median T cell responders to ELI-002 (September 24, 2024 data cutoff)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2025, we announced the publication of ELI-002 updated AMPLIFY-201 Phase 1 follow-up data in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature Medicine</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> for minimal residual disease (&#8220;MRD&#8221;) positive, adjuvant-stage patients. The extended median follow-up of 19.7 months showed median overall survival (&#8220;OS&#8221;) increased from 16.33 to 28.94 months. In addition, the data demonstrated 77% reduction in the risk of death and 88% reduction in the risk of relapse, associated with T cell responses above the threshold for anti-tumor efficacy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to ELI-002 2P, we evaluated a 7-peptide version of ELI-002 (&#8220;ELI-002 7P&#8221;), covering seven of the most common KRAS mutations (G12D, G12R, G12V, G12C, G12A, G12S, and G13D), thereby increasing the eligible patient population for ELI-002 and potentially reducing the chance of tumor bypass resistance mechanisms.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">AMPLIFY-7P Phase 1/2 clinical trial (NCT05726864)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This trial is to assess the safety and efficacy of ELI-002 7P as adjuvant monotherapy treatment in patients with solid tumors carrying mKRAS. In April 2023, we initiated dosing of the Phase 1A portion of the trial enrolling 14 patients through October 2023 who were evaluated for safety and efficacy of two ELI-002 AMP-peptide total dose levels (1.4mg and 4.9mg) in combination with the 10.0 mg Phase 2 dose of Amph-CpG-7909. In September 2023, the IDMC reviewed the available Phase 1A data and determined enrollment for the Phase 2 portion of the study could be opened. Preliminary results from the Phase 1A trial were presented at the SITC Annual Meeting in November 2024 from a September 24, 2024 data cutoff, which demonstrated:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">ELI-002 7P administered as a monotherapy was well tolerated and generated a ~100x mKRAS-specific expanded T cell response relative to baseline levels at the 4.9 mg Phase 2 dose level</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">ELI-002 7P generated a mKRAS-specific T cell response in 100% of patients including responses targeting all mKRAS mutations enrolled (G12D, V, R and G13D) at the 4.9 mg Phase 2 dose level</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">mKRAS-specific T cells were polyfunctional with 85.7% (6/7) of evaluable patients having both CD8+ and CD4+ responses at the 4.9 mg Phase 2 dose level</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Tumor biomarker reductions were observed in 71% (5/7) of evaluable patients at the 4.9 mg Phase 2 dose level</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">ELI-002 7P was shown to induce antigen-spreading with increased T cell responses targeting non-immunizing, personalized tumor neoantigens in 100% (6/6) of evaluable patients at the 4.9 mg Phase 2 dose level</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Recommend Phase 2 dose was selected as 4.9 mg of AMP-peptides and 10.0 mg Amph-CpG-7909 adjuvant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2024, we announced the first patient had been dosed in the randomized Phase 2 portion of the AMPLIFY-7P trial of ELI-002 7P as an adjuvant monotherapy treatment for patients with KRAS-mutated PDAC. The Phase 2 portion of the trial utilized DFS as the primary endpoint. Patients were randomized in a 2:1 ratio to receive ELI-002 7P (10.0 mg AMP-CpG and 4.9 mg AMP-peptides 7P) or the current standard of care (observation), respectively. Crossover was permitted for patients randomized to the observation arm upon confirmed radiographic relapse via iRECIST. In December 2024, we announced completed enrollment and will continue to follow patients for up to 36 months. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2025, we announced that following the IDMC pre-specified interim review of unblinded safety and efficacy data in our Phase 2 AMPLIFY-7P study in mKRAS-driven PDAC, the IDMC recommended that the trial continue to the final analysis without modifications. In addition, the IDMC confirmed the favorable safety profile of ELI-002 7P as of that date. To determine how long patients live without their cancer returning, the study will compare events (cancer detected on an imaging scan or death) in the AMPLIFY-7P versus observation groups once the pre-specified total number of events are observed.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2025, we announced ELI-002 7P achieved robust mKRAS-specific T cell responses in 99% of evaluable patients in the ongoing Phase 2 AMPLIFY-7P trial. Specifically, robust mKRAS-specific T cell responses were observed with an average of 145.3x increase over baseline (median 44.3x; range 2.13-1310x), consistent with prior ELI-002 Phase 1 trial results. In addition, T cell responses included both mKRAS-specific CD4+ and CD8+ T cells in 85% of patients.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Phase 2 Amplify-7P Immunogenicity Data</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:55.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.106%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ELI-002 7P (1.4mg &amp; 4.9mg)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ELI-002 7P (4.9 mg)</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Phase 1 (n=12)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Phase 2 (N=90)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Patients</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">MRD+ only</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">MRD+ &amp; MRD-</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">mKRAS T Cell Response</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">T cell Response Rate (%, n)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100% (12/12)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99% (89/90)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Average Fold Change&#170;</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71.1x</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">145.3x</span></td></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Median Fold Change&#170; (range)</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18.5x</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">44.3x</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4.2x to 351x)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2.13x to 1310x)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Threshold Above Which Clinical Activity was Correlated</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9.5x</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:100%;position:relative;top:-3.48pt;vertical-align:baseline">c</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TBD</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(% of Patients Above Threshold)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(75% above 9.5x)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(80% above 9.5xc)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Including CD4 + CD8 T cells</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:100%;position:relative;top:-3.48pt;vertical-align:baseline">b</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75.0%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Including Response to 7 mKRAS Antigens&#170;</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50.0%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">67.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Including Response to Patient Tumor Antigen&#170;</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">83.3%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87.6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Overall Antigen Response Rate</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:100%;position:relative;top:-3.48pt;vertical-align:baseline">d</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66.7% (56/84)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85.7% (540/630)</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ELI-002 2P: Data cutoff 24-Sept-24; ELI-002 7P Phase 1: Data cutoff 24-Sept-24; ELI-002 7P Phase 2: 22-Aug-25</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">a</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Responses shown are best overall responses vs baseline for assessable patients at any timepoint during the assessment period, measured among T cell Responders; TBD = To be Determined; MRD = Minimal Residual Disease </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">b</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Measured among evaluable patients with samples assessable by Ex Vivo Intracellular Cytokine Staining assay </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">c</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> McNeil L.K., et al. 1473&#8197;AMPLIFY-7P phase 1a: lymph node-targeted amphiphile therapeutic cancer vaccine in patients with high relapse risk KRAS mutated pancreatic ductal adenocarcinoma and colorectal cancer. Journal for ImmunoTherapy of Cancer. 2024;12. https://doi.org/10.1136/jitc-2024-SITC2024.1473 </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">d</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Overall Antigen Response Rate calculated as the percentage of positive mKRAS-specific T cell responses among all evaluated patients against all vaccine antigens </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In October 2025, we announced robust T cell responses across diverse HLA backgrounds in the ongoing Phase 2 AMPLIFY-7P trial. Specifically, ELI-002 7P demonstrated robust mKRAS-specific T cell responses across a broad range of HLA types, highlighting its potential for use among a diverse patient population. Patients treated with ELI-002 7P presented a diverse HLA repertoire including 1,132 unique types identified among 1,398 total HLA backgrounds in assessed patients. Induction of mKRAS-specific T cell responses suggest that ELI-002 7P may address a broad patient population with high unmet need for PDAC. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Diverse HLA Representation Present in ELI-002 7P Treated Patients in AMPLIFY-7P Phase 2</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"><tr><td style="width:1.0%"/><td style="width:28.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Number of Unique HLA Types</span></td></tr><tr style="height:18pt"><td colspan="3" rowspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HLA Class I</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HLA-A</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">116</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HLA-B</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">158</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HLA-C</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">118</span></td></tr><tr style="height:18pt"><td colspan="3" rowspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HLA-Class II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HLA-DR</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">292</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HLA-DP</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">180</span></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HLA-DQ</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">268</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Unique HLA Types</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1132</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total HLA Types</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1398</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2025, we presented additional data on T cell responses and HLA backgrounds from the ongoing Phase 2 AMPLIFY-7P trial at Society for Immunotherapy of Cancer (&#8220;SITC&#8221;) 2025 Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2025, we announced that in the ongoing Phase 2 AMPLIFY-7P study evaluating ELI-002 7P in patients with PDAC, fewer disease progressions and deaths than projected were observed as of November 6, 2025. Based on the protocol specified 2:1 randomization, with twice as many patients in the ELI-002 7P treatment arm compared to the observation arm, Elicio believes the lower-than-projected number of disease progressions and deaths may reflect a favorable impact on DFS. The event-driven primary DFS analysis is anticipated to occur in the first half of 2026, depending on event accrual.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In December 2025, we announced antigen spreading data to patient-specific neoantigens beyond mKRAS from our ongoing Phase 2 AMPLIFY-7P trial. A subset of Phase 2 patients were evaluated to assess the ability of ELI-002 7P to broaden immune responses to personalized tumor neoantigens not present in the targeted immunotherapy. Antigen spreading (also known as epitope spreading) refers to the expansion of the immune response from the initial target antigen(s) to new secondary tumor-specific antigens. This process can occur during treatment with immunotherapy as tumor cells are killed, releasing tumor antigens which can subsequently be targeted by the immune response. The broader multi-targeted immunity which results from antigen spreading may limit the potential for tumors to evade immune responses, leading to more durable responses. 87% (13/15) of evaluated patients demonstrated induction of T cell responses to tumor neoantigens beyond mKRAS following ELI-002 7P therapy. The induction of non-mKRAS antigen-specific T cell responses supports the potential for ELI-002 7P to generate a broader, more adaptable, and personalized anti-tumor response.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Phase 2 AMPLIFY-7P Antigen Spreading Data</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.644%"/><td style="width:0.1%"/></tr><tr style="height:39pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ELI-002 2P</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ELI-002 7P (1.4 &amp; 4.9 mg)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">ELI-002 7P (4.9 mg)</span></td></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Phase 1 (n=25)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Phase 1 (n=12)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Phase 2 (n=90)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Patients</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">MRD+ only</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">MRD+ only</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">MRD- &amp; MRD+</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">mKRAS T cell Response</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">T cell response rate (%, n)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">84% (21/25)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100% (7/7)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99% (89/90)</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Antigen spreading T cell Response</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Patients tested for antigen spreading (n)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Median number of non-mKRAS antigens tested per patient (range)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 (6 to 10)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 (1 to 10)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10 (5 to 12)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">T cell response rate (%, n)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">67% (6/9)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">70% (7/10)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87% (13/15)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Median fold change over baseline</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.4x</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.7x</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.6x</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Responses to both CD4 + CD8 T cells</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33.30%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Phase 1 ELI-002 7P in combination with chemotherapy and a checkpoint inhibitor (&#8220;CPI&#8221;) in the neoadjuvant setting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2025, we announced an Investigator-Initiated Phase 1 Trial (&#8220;IIT&#8221;) to be conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in PDAC. The multi-center IIT will evaluate mFOLFIRINOX in combination with ELI-002 7P, with or without anti&#8211;PD-1 antibody. The study is designed to enroll 20 patients across two cohorts (10 per arm). Due to low immune infiltration, PDAC is often refractory to standard immunotherapy. ELI-002 7P has shown to generate robust T-cell responses in our prior Phase 1 trials and our ongoing Phase 2 trial. ELI-002 7P may be able to change "cold" PDAC tumors into "hot" tumors, making them susceptible to checkpoint inhibitors. The trial intends to examine the combination of mFOLFIRINOX and ELI-002 7P (with/without anti-PD-1) to measure safety, efficacy, and immune response mechanism. The trial is expected to commence in the first half of 2026.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">ELI-007:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> AMP Immunotherapy for mutant BRAF-driven Cancers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ELI-007 is a multivalent lymph node&#8211;targeted AMP peptide immunotherapy developed to target 95% of the BRAF gene mutations found in solid tumors. The BRAF gene is part of an intracellular signaling pathway that drives cell growth and division. BRAF mutations can lead to uncontrolled cell growth and are present in multiple types of cancer, including 40% in melanoma, 9% in CRC, and 2% in lung cancer. High levels of BRAF protein expression in these tumors suggest susceptibility to T cells targeting the mutated protein. We received funding for the initial development of ELI-007 through three grants from the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">At the November 2023 SITC annual meeting, we presented preclinical data demonstrating ELI-007&#8217;s generation of robust mutant BRAF-specific polyfunctional T cell responses in a murine model. We are currently evaluating opportunities to advance ELI-007 through partnerships, collaborations or additional grants.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">   </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">ELI-008:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> AMP Immunotherapy for mutant TP53-expressing Cancers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ELI-008 is a multivalent lymph node&#8211;targeted AMP peptide immunotherapy developed to target TP53 hotspot mutations. TP53 is a tumor-suppressing protein that controls DNA replication processes where mutated TP53 protein contributes to uncontrolled cell growth and tumor progression. We designed ELI-008 to target ~30% of the TP53 hotspot mutations found in solid tumor cancers including melanoma, CRC, and NSCLC. We received funding for the initial development of ELI-008 through three grants from the GI Research Foundation.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">At the November 2023 SITC annual meeting, we presented preclinical data demonstrating ELI-008&#8217;s generation of robust mutant TP53-specific polyfunctional T cell responses in a murine model. We are currently evaluating opportunities to advance ELI-008 through partnerships, collaborations or additional grants.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">   </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">   </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">AMP Platform Potential Expansion</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP platform has broad potential applications for the treatment or prevention of cancer and other diseases. These other applications include immune cell therapy AMP-lifiers for CAR T cell therapeutics and TCR T cell therapeutics. We intend to advance additional applications of the AMP platform via out-licensing, co-development, or other partnership arrangements.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">TCR T Cell Therapy Preclinical Data</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2024, data from preclinical studies was published in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Cancer Immunology Research </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">demonstrating our AMP immunotherapy in combination with TCR-T cell therapy led to complete eradication and durable responses against established murine solid tumors refractory to TCR-T cell monotherapy. Our AMP immunotherapy led to enhanced lymph node delivery and correlated with pro-inflammatory lymph node transcriptional reprogramming and increased antigen-presenting cell maturation, resulting in TCR-T cell expansion and functional enhancement. Addition of AMP immunotherapy enhanced the infiltration and function of TCR-T cells in the tumor microenvironment and led to antigen spreading against diverse tumor targets. We are currently evaluating opportunities to advance our AMP immunotherapy application to TCR-T cell therapy through partnerships or collaborations.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">     </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">    </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">CAR T Cell Targeting Preclinical Data</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP platform has the potential to be utilized as a mechanism to expand and functionally enhance CAR-T cells in vivo targeting blood and solid tumors. Preclinical results demonstrating this strategy were published in </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Science</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> in 2019, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Cell</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> in 2023, and </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature Biomedical Engineering</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> in 2025, highlighting the potential for AMP-conjugated CAR-binding ligands to expand and enhance the functional qualities of CAR-T cells in vivo, resulting in improved anti-tumor activity.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">AMP immunotherapies were found to specifically enhance aspects of CAR-T cell metabolism, polyfunctionality, and solid tumor infiltration, contributing to eradication of model tumors refractory to CAR-T monotherapy. Further, combination of CAR-T with AMP immunotherapy elicited antigen spreading T cell responses promoting improved activity against tumors with heterogenous expression of the CAR-targeted tumor antigen.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This strategy has further been applied to develop AMP-ligands for combination with commercial FMC63-based anti-CD19 CAR-T products. We are currently evaluating opportunities to advance our AMP immunotherapy application to CAR-T cell therapy for oncology and other indications, through partnerships or collaborations.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">     </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">AMP-ImmunoModulator (&#8220;AIM&#8221;) Preclinical Data</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2025, data from preclinical studies was presented at the SITC Annual Meeting which demonstrates that intratumoral AIM administration of Amph-CpG-7909 controls tumor growth and eradicates syngeneic solid tumors with subsequent durable protection against tumor rechallenge. AIM Therapy is designed to be an off-the-shelf therapy with the potential to treat various tumors in an antigen-agnostic manner. In the presented preclinical studies, tumor growth inhibition was critically dependent on CD8+ T cell responses and complete tumor eradication was further dependent on the development of systemic immunity induced in the lymph nodes. We are currently evaluating opportunities to advance our AIM Therapy application through partnerships or collaborations. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Licensing, Collaboration and Partnership Agreements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MIT License Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On January 27, 2016, we entered into an Exclusive Patent License Agreement with Massachusetts Institute of Technology (&#8220;MIT&#8221;), which has been amended from time to time (the &#8220;MIT License Agreement&#8221;). Pursuant to the MIT License Agreement, we were granted an exclusive, worldwide license, with the right to sublicense, under certain patents and patent applications owned by MIT related to the AMP technology (the &#8220;MIT patent rights&#8221;) for the treatment of diseases, disorders and/or conditions in humans and animals and for diagnostic applications for human and veterinary use. The MIT patent rights cover vaccine product candidates in our current lead programs that are being developed for the treatment of certain mutant KRAS-driven cancers, mutant b-raf murine sarcoma viral oncogene homolog B1 (&#8220;BRAF&#8221;)-driven cancers, and mutated tumor protein p53 (&#8220;TP53&#8221;)-expressing cancers, and vaccine product candidates targeting certain other proteins that are drivers of disease, as well as programs using CpG as an adjuvant for immune activation in conjunction with an immunostimulatory agent. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The MIT License Agreement established annual license payment obligations and intellectual property cost reimbursement obligations for which we are responsible, specific product categories (including immunotherapeutic products and adjuvant products) for which we are required to invest specified minimum amounts of research funding and the timing of such investment, specified development and commercialization milestone obligations, and payments due with respect to the achievement of these milestones. On October 21, 2016, the MIT License Agreement was amended to update language around patent rights and MIT procedures. On February 22, 2018, the MIT License Agreement was amended to extend certain diligence dates. On each of January 31, 2019, June 23, 2020 and January 7, 2021, the MIT License Agreement was amended to add certain patent applications owned by MIT and include an additional fee, updates to patent application fees and to annual license maintenance fees. The amendments on June 23, 2020 and January 7, 2021 also adjusted milestones and diligence requirements under the MIT License Agreement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of the MIT License Agreement, we are obligated to use commercially reasonable diligent efforts to develop products covered by the MIT patent rights, to introduce such products into the commercial market, and thereafter to make such products reasonably available to the public. In addition, we are obligated to achieve specified development and commercial launch objectives in accordance with a specified timeline as well as to expend specified resources in the development and commercialization of immunotherapeutic products and adjuvant products. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are obligated to pay an annual license maintenance fee, which can be credited against royalties paid to MIT during the same calendar year. Such annual license maintenance fee is subject to increase in the event of a &#8220;change in ownership&#8221; as defined in the MIT License Agreement. We are also obligated to make milestone payments upon the occurrence of specific development and commercialization achievements during the term of the MIT License Agreement, including those relating to the making of certain regulatory filings, the initiation of certain clinical trials and the achievement of certain sales thresholds. The achievement of each milestone triggers the payment of a set dollar amount to MIT by us. These milestone payments could, in the aggregate, reach a maximum of approximately $26.2 million if all milestone events are achieved for all product categories.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are also obligated to make royalty payments based on net sales by us, our affiliates, and our sublicensees equal to (i) a fractional to low single digit percentage of net sales of products that are covered by the MIT patent rights and (ii) a fractional percentage of net sales of products that could not have been identified, selected, or determined to have biological activity but for the use or modification of products that are covered by the MIT patent rights. These royalty rates are subject to an upward </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">adjustment if we or a sublicensee commence an action against MIT to declare or render invalid or unenforceable any of the licensed patent rights; and the amount of royalties payable to MIT are subject to a downward adjustment if we are required to secure certain patent licenses from third parties to avoid infringement by the practice of the licensed patent rights. These royalties are payable (1) until the expiration of the last to expire of the MIT patent rights with respect to products that are covered by the MIT patent rights and (2) for 12 years following the first commercial sale of products that could not have been identified, selected, or determined to have biological activity but for the use or modification of products that are covered by the MIT patent rights.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are also obligated to pay a percentage of any revenue that we, our affiliates, or our sublicensees receive for the provision of services using products covered by the MIT patent rights or services that utilize a process that are covered by the MIT patent rights (a &#8220;licensed process&#8221;). We are also obligated to pay a percentage of any payments we or our affiliates receive from sublicenses, with certain exceptions. We are also required to share a portion of any funds we or a sublicensee receives in respect of the sale of a regulatory voucher if one is granted by any regulatory authority based upon the regulatory approval of a product or process subject to the MIT License Agreement for the treatment of a neglected disease.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">MIT controls the prosecution and maintenance of the MIT patent rights, and we are required to pay all costs and fees associated with patent prosecution and maintenance of the MIT patent rights.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The term of the MIT License Agreement will continue in effect until the expiration or abandonment of all issued patents and filed patent applications within the MIT patent rights, unless earlier terminated. MIT may terminate the MIT License Agreement upon our uncured material breach of the MIT License Agreement or upon the occurrence of certain events, including if we or a sublicensee commence an action against MIT to declare or render invalid or unenforceable any of the licensed patent rights, or if we cease to carry on our business related to the MIT License Agreement. We may terminate the MIT License Agreement without cause upon six months&#8217; prior written notice to MIT and upon payment of all amounts due MIT through the date such termination takes effect.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Intellectual Property</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Intellectual property is of vital importance in our field and in biotechnology generally. We seek to protect and enhance proprietary technology, inventions, and improvements that are commercially important to the development of our business by seeking, maintaining, and defending patent rights, whether developed internally or licensed from third parties. We will also seek to rely on regulatory protection afforded through inclusion in expedited development and review, data exclusivity, market exclusivity and patent term extensions where available.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have sought patent protection in the United States and internationally related to the AMP platform technology as well as the mKRAS, universal adjuvant, mutant serine/threonine-protein kinase BRAF, and mutant TP53 programs. We have issued patents in Australia, China, Europe, Hong Kong, Israel, Japan, Malaysia, Macau, Mexico, New Zealand, Nigeria, Russia, Saudi Arabia, Singapore, South Korea, Ukraine, and the United States covering clinical product candidates but the patent portfolio owned by us currently largely comprises pending applications. Such applications may not result in issued patents and, even if patents do issue, such patents may not be in a form or scope that will provide us with meaningful protection for our product candidates. We also rely on trade secrets that may be important to the development of our business. Trade secrets are difficult to protect and provide us with only limited protection, as trade secrets do not protect against independent development of a technology by third parties.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expect to file additional patent applications in support of current and new clinical candidates as well as new platform and core technologies. Our commercial success will depend in part on obtaining and maintaining patent protection and trade secret protection of current and future product candidates and the methods used to develop and manufacture them, as well as successfully defending any such patents against third-party challenges and operating without infringing on the proprietary rights of others. Our ability to stop third parties from making, using, selling, offering to sell or importing our product candidates will depend on the extent to which we have rights under valid and enforceable patents or trade secrets that cover these activities. We cannot be sure that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications filed by us in the future, nor can we be sure that any patents that may be granted in the future will be commercially useful in protecting our product candidates, discovery programs and processes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The terms of individual patents depend upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, including the United States, the patent term is 20 years from the earliest date of filing a non-provisional patent application. In the United States, a patent term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) in examining and granting a patent or may be shortened if a patent is terminally disclaimed over an earlier to expire patent. In the United States, the term of a patent that covers an FDA-approved drug may also be eligible for extension, which permits patent term restoration to account for the patent term lost during the FDA regulatory review process. The Hatch-Waxman Act permits a patent term extension of up to five years beyond the expiration of the patent. The length of the patent term extension is related to the length of time the subject drug candidate is under regulatory review. Patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent applicable to an approved drug may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar provisions to extend the term of a patent that covers an approved drug are available in Europe and other </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">foreign jurisdictions. In the future, if and when our products receive FDA approval, we expect to apply for patent term extensions on patents covering those products. We plan to seek patent term extensions to any issued patent we may obtain in any jurisdiction where such patent term extensions are available, however there is no guarantee that the applicable authorities, including the FDA in the United States, will agree with our assessment that such extensions should be granted, and if granted, the length of such extensions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In some instances, we have submitted and expect to submit patent applications directly to the USPTO as provisional patent applications. Corresponding non-provisional patent applications must be filed not later than 12 months after the provisional application&#8217;s filing date. While we intend to timely file non-provisional patent applications relating to our provisional patent applications, we cannot predict whether any such non-provisional patent applications will result in the issuance of patents that provide us with any competitive advantage.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We file U.S. non-provisional applications and Patent Cooperation Treaty (&#8220;PCT&#8221;) applications that claim the benefit of the priority date of earlier filed provisional applications, when applicable. The PCT system allows a single application to be filed within 12 months of the original priority date of the patent application, and to designate all of the PCT member states in which national patent applications can later be pursued based on the international patent application filed under the PCT. A PCT searching authority performs a patentability search and issues a non-binding patentability opinion which can be used to evaluate the chances of success for the national applications in foreign countries prior to having to incur the filing fees. Although a PCT application does not issue as a patent, it allows the applicant to seek protection in any of the PCT member states through national-phase applications. At the end of the period of two and a half years from the first priority date of the patent application, separate patent applications can be pursued in any of the PCT member states either by direct national filing or, in some cases by filing through a regional patent organization, such as the European Patent Office. The PCT system delays expenses, allows a limited evaluation of the chances of success for national/regional patent applications and enables substantial savings where applications are abandoned within the first two and a half years of filing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For all patent applications, we determine claiming strategy on a case-by-case basis. Advice of counsel and our business model and needs are always considered. We seek to file patents containing claims for protection of all useful applications of our proprietary technologies and any products, as well as all new applications and/or uses that we discover for existing technologies and products, assuming these are strategically valuable. We continuously reassess the number and type of patent applications, as well as the pending and issued patent claims to pursue maximum coverage and value for our processes, and compositions, given existing patent office rules and regulations. Further, claims may be modified during patent prosecution to meet our intellectual property and business needs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We recognize that the ability to obtain patent protection and the degree of such protection depends on a number of factors, including, at least, the extent of the prior art, the novelty and non-obviousness of the invention, and the ability to satisfy the enablement requirement of the patent laws. In addition, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted or further altered even after patent issuance. Consequently, we may not obtain or maintain adequate patent protection for any of our future product candidates or for our technology platform. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. Any patents that we hold may be challenged, circumvented or invalidated by third parties.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to patent protection, we also rely on trade secrets, know how, other proprietary information and continuing technological innovation to develop and maintain our competitive position. We seek to protect and maintain the confidentiality of proprietary information to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection. Although we take steps to protect our proprietary information and trade secrets, including through contractual means with our employees and consultants, third parties may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets or disclose our technology. Thus, we may not be able to meaningfully protect our trade secrets. It is our policy to require our employees, consultants, outside scientific collaborators, contract research organizations, contract manufacturing organizations, sponsored researchers, advisors, and other third parties to execute confidentiality agreements no later than the commencement of employment, consulting, or service relationships with us. These agreements provide that all confidential information concerning our business or financial affairs developed or made known to the individual during the course of the individual&#8217;s relationship with us is to be kept confidential and not disclosed to third parties except in specific circumstances. Our agreements with employees also provide that all inventions conceived by the employee in the course of employment with us or from the employee&#8217;s use of our confidential information are our exclusive property. In the case of consultants and other third-party service providers, the agreements provide us with certain rights to all inventions arising from the services provided to us by those individuals or entities. However, we cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technologies and processes. Additionally, such confidentiality agreements and invention assignment agreements can be breached and we may not have adequate remedies for any such breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our consultants, contractors or collaborators use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting trade secrets, know-how and inventions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The patent positions of biotechnology companies are generally uncertain and involve complex legal, scientific and factual questions. Our commercial success will also depend in part on not infringing upon the proprietary rights of third parties. Third-party patents could require us to alter our development or commercial strategies, or our products or processes, obtain licenses or cease certain activities. Our breach of any license agreements or our failure to obtain a license to proprietary rights required to develop or commercialize our future products may have a material adverse impact on us. If third parties prepare and file patent applications in the United States that also claim technology to which we have rights, we may have to participate in derivation proceedings in the USPTO to determine priority of invention. For more information, see &#8220;Risk Factors&#8212;Risks Related to Our Intellectual Property.&#8221;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">When available to expand market exclusivity, our strategy is to obtain, or license additional intellectual property related to current or contemplated development platforms, core elements of technology and/or product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Company-owned Intellectual Property</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We own the following patent families and applications:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have two issued U.S. patents and pending U.S. and Canadian patent applications titled &#8220;ALK polypeptides and methods of use thereof&#8221;, which are related to our products in development for tumor indications where rearranged ALK is a driver of disease.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a patent family titled &#8220;Compounds including a mutant KRAS sequence and a lipid and uses thereof&#8221; with granted patents in Australia, China, Hong Kong, Israel, Japan, Macau, Mexico, Malaysia, New Zealand, Russia, Saudi Arabia, Singapore, South Korea, and the United States and pending applications in the United States, the United Arab Emirates, Brazil, Canada, China, Europe, Hong Kong, India, Japan, South Korea, Mexico, Nigeria, Thailand, Ukraine, and South Africa. This patent family relates to our products in development for tumor indications where mutant KRAS is a driver of disease.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a patent family titled &#8220;CpG amphiphiles and uses thereof&#8221; with granted patents in Australia, Europe, Israel, Malaysia, Mexico, New Zealand, Nigeria, Russia, Saudi Arabia, Singapore, Ukraine, and the United States and pending applications in the United States, the United Arab Emirates, Brazil, Canada, China, Hong Kong, India, Japan, South Korea, Thailand, and South Africa. This patent family relates to our products in development for tumor indications where expression of human papillomavirus protein(s) is a driver of disease.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a patent family titled &#8220;Compositions and methods for inducing an immune response against coronavirus&#8221; with pending applications in the United States, Europe, South Korea, and Mexico. This patent family relates to the use of our AMP technology, including products in development, in methods of inducing an immune response against coronavirus.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a patent family titled &#8220;Uses of amphiphiles in immune cell therapy and compositions therefor&#8221; with pending applications in the United States, Australia, Canada, Europe, Hong Kong, Japan, and New Zealand. This application relates to the use of our AMP technology, including products in development, in immune cell therapy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a patent family titled &#8220;Compositions containing polynucleotide amphiphiles and methods of use thereof&#8221; with pending applications in the United States, Australia, Canada, Europe, Hong Kong, Japan, and New Zealand.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This application relates to aspects of our AMP technology platform.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a patent family titled &#8220;Compositions containing polynucleotide and polypeptide amphiphiles and methods of use thereof&#8221; with pending applications in the United States, Australia, Canada, China, Europe, Japan, South Korea, and New Zealand. This patent family relates to aspects of our AMP technology platform.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a patent family titled &#8220;Compositions containing mutant P53 peptide amphiphiles and methods of use thereof&#8221; with pending applications in the United States, Australia, Brazil, Canada, China, Europe, Japan, South Korea, Mexico, New Zealand, and Russia. This patent family relates to aspects of our AMP technology platform.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a pending U.S. provisional application titled &#8220;Combination therapies for treating mutant KRAS expressing cancers.&#8221; This application relates to treatments using ELI-002.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have sole ownership of the above patents and patent applications. For these patents and for any patents granted on the pending applications, we anticipate that patent expiration would occur between 2037 and 2046 without taking into consideration patent term adjustments or extensions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a pending U.S. application titled &#8220;Uses of amphiphiles in immune cell therapy and compositions therefor.&#8221; This application relates to aspects of our AMP technology platform in connection with immune cell therapy.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This application is co-owned with the University of Pennsylvania. If we are granted patents on this pending application, it is anticipated that patent expiration would occur in 2043 without taking into consideration patent term adjustments or extensions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have a patent family titled &#8220;Compositions containing BRAF peptide amphiphiles and methods of use thereof&#8221; with pending applications in the United States, Australia, Brazil, Canada, China, Europe, Japan, South Korea, Mexico, New Zealand, and Russia. This patent family relates to aspects of our AMP technology platform. This patent family is co-owned with Cornell University. If we are granted patents on pending applications in this patent family, it is anticipated that patent expiration would occur in 2044 without taking into consideration patent term adjustments or extensions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Licensed Intellectual Property</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have an exclusive license from MIT for six patent families related to aspects of our AMP technology platform:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;Immunostimulatory compositions and methods of use thereof&#8221;, which contains four patents granted in the United States, patents granted in Europe, Hong Kong, and Japan, as well as pending applications in the United States, Europe, Hong Kong, and Japan. This patent family relates to aspects of our AMP platform technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;Albumin binding peptide conjugates and methods thereof,&#8221; which contains two patents granted in the United States, as well as pending applications in China, Hong Kong, Japan, and Europe. This patent family relates to certain additional aspects of our AMP platform technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;Chimeric antigen receptor-targeting ligands and uses thereof&#8221; with a patent granted in the United States as well as a pending application in the United States. This patent family relates to further aspects of our AMP platform technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;Compositions for chimeric antigen receptor T cell therapy and uses thereof&#8221; which contains patents granted in Australia, Japan, Mexico, and Russia, as well as pending applications in the United States, Canada, China, Europe, Hong Kong, Japan, South Korea, Mexico, and New Zealand. This patent family relates to the use of our AMP platform technology in connection with CAR T therapy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;Uses of amphiphiles in immune cell therapy and compositions therefor&#8221; which contains a patent granted in the United States as well as pending applications in Europe, Hong Kong, and Japan. This patent family relates to use of our AMP platform technology in connection with immune cell therapy; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">&#8220;Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof&#8221; with a pending application in the United States. This patent family relates to methods of identifying further ligands for use in our AMP platform technology.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For these patents and for any patents granted on the pending applications, we anticipate patent expiration to occur between 2033 and 2041, without taking into consideration patent term adjustments or extensions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also have an exclusive license from Dr. Roberto Chiarle for a patent family titled &#8220;Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination,&#8221; which contains two granted U.S. patents. This patent family relates to ALK antigen sequences that may be used in connection with our AMP platform technology. We anticipate patent expiration to occur in 2028 and 2031 without taking into consideration patent term extension.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Manufacturing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We do not own or operate facilities for clinical drug manufacturing, storage, distribution or quality testing. Currently, all of our clinical manufacturing is outsourced to third-party contract manufacturing organizations. We currently obtain our supplies from these manufacturers on a purchase order basis and do not have long-term committed supply arrangements with respect to our product candidates and other materials. Our product candidates are manufactured using reliable and reproducible synthetic processes from readily available starting materials and are based on chemistry that is amenable to scale up. We expect to continue to develop product candidates that can be produced cost effectively at contract manufacturing facilities. See "Risk Factors &#8212; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">We rely on CMOs to manufacture our nonclinical and clinical pharmaceutical supplies and expect to continue to rely on CMOs to produce commercial supplies of any approved product candidate, and our dependence on CMOs could adversely impact our business.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Competition</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The biotechnology and pharmaceutical industries are characterized by rapid evolution of technologies, fierce competition, and strong defense of intellectual property. While we believe our technology, expertise, scientific knowledge, and intellectual property estate provide competitive advantages, we face potential competition from many different sources, including major pharmaceutical, specialty pharmaceutical, biotechnology companies, academic institutions, governmental agencies, and public and private research institutions that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization. In addition, many small biotechnology companies have formed collaborations with large, established companies to (i) obtain support for their research, development and commercialization of products or (ii) combine several treatment approaches to develop longer lasting or more efficacious treatments that may directly compete with our current or future product candidates. We anticipate that we will continue to face increasing competition as new therapies and combinations thereof, technologies, and data emerge within the field of immunotherapy and, furthermore, within the treatment of cancer.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the current standard of care treatments for patients, numerous commercial and academic preclinical studies and clinical trials are being undertaken by many parties to assess novel technologies and product candidates in the field of immunotherapy. In the treatment of mKRAS associated cancers there are two approved therapies for NSCLC, Amgen Inc.&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Amgen&#8221;) LUMAKRAS and Mirati Therapeutics, Inc.&#8217;s, a wholly owned subsidiary of Bristol Myers Squibb Co. (&#8220;Mirati&#8221;), KRAZATI, both of which are for a single KRAS mutation. Other companies who are developing clinical stage personalized cancer immunotherapy, vaccine therapies or mKRAS-targeted therapies include AstraZeneca Plc (&#8220;AstraZeneca&#8221;), BioNTech SE (&#8220;BioNTech&#8221;), BridgeBio Oncology Therapeutics (&#8220;BridgeBio&#8221;), Boehringer Ingelheim (&#8220;Boehringer&#8221;), Bristol Myers Squibb Co. (&#8220;Bristol Myers&#8221;), Circio Holding ASA (&#8220;Circio&#8221;), D3 Bio, Inc. (&#8220;D3 Bio&#8221;), Eli Lilly &amp; Co., Inc. (&#8220;Eli Lilly&#8221;), Erasca, Inc. (&#8220;Erasca&#8221;), Geneos Therapeutics, Inc. (&#8220;Geneos&#8221;), Gilead Sciences, Inc. (&#8220;Gilead&#8221;), Incyte Corporation (&#8220;Incyte&#8221;), Jacobio Pharma (&#8220;Jacobio&#8221;), Jiangsu Hengrui Pharmaceuticals Co., Ltd. (&#8220;Jiangsu&#8221;), Merck &amp; Co. (&#8220;Merck&#8221;), Moderna, Inc. (&#8220;Moderna&#8221;), Roche Holding Ltd. (&#8221;Roche&#8221;)/Genentech, Inc. (&#8220;Genentech&#8221;), Revolution Medicines, Inc. (&#8220;Revolution Medicines&#8221;), and Verastem, Inc. (&#8220;Verastem&#8221;), among others.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Many of our competitors, either alone or in combination with their respective strategic partners, have significantly greater financial resources and expertise in research and development, manufacturing, the regulatory approval process, and marketing than we do. Mergers and acquisition activity in the pharmaceutical, biopharmaceutical, and biotechnology sector is likely to result in greater resource concentration among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through sizeable collaborative arrangements with established companies. These competitors also compete with us in the recruiting and retaining of qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, better tolerated, or of greater convenience or economic benefit than any products we may develop. Our competitors also may be in a position to obtain FDA or other regulatory approval for their products more rapidly, resulting in a stronger or dominant market position before we are able to enter the market. The key competitive factors affecting the success of all of our programs are likely to be product safety, efficacy, convenience and treatment cost.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Government Regulation and Product Approval</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Governmental authorities in the United States, at the federal, state, and local level, and in other countries, extensively regulate, among other things, the research, development, testing, approval, manufacturing, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, import, and export of biopharmaceutical products. In addition, sponsors of biopharmaceutical products participating in Medicaid, Medicare, and other government health care programs are required to comply with mandatory price reporting, discount, and rebate requirements. We, along with our third-party contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates. The processes for obtaining regulatory approvals in the United States and in foreign countries, along with compliance with applicable statutes and regulations, requires the expenditure of substantial time and financial resources.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">FDA Regulation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the United States, the FDA regulates biologics under the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;), the Public Health Services Act (&#8220;PHSA&#8221;), and their implementing regulations. The FDA further has issued a growing body of guidance documents, which, while not binding, provide the agency&#8217;s current interpretation of its statutes and regulations. Failure to comply with the applicable U.S. requirements may subject an applicant to administrative or judicial sanctions, such as FDA refusal to approve pending biologics license applications (&#8220;BLAs&#8221;) or the FDA&#8217;s issuance of warning letters, or the imposition of fines, civil penalties, product recalls, product seizures, total or partial suspension of production or distribution, injunctions and/or criminal prosecution brought by the FDA and the U.S. Department of Justice (&#8220;DOJ&#8221;) or other governmental entities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The process required by the FDA before product candidates may be marketed in the United States generally involves the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">completion of preclinical (or non-clinical) laboratory tests and formulation studies in compliance with the FDA&#8217;s good laboratory practice (&#8220;GLP&#8221;) regulations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">submission to the FDA of an Investigational New Drug application (&#8220;IND&#8221;) which must become effective before human clinical trials may begin at United States clinical trial sites;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">approval by an institutional review board (&#8220;IRB&#8221;) for each clinical site before each site can be activated for trial participation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">performance of adequate and well-controlled human clinical trials to establish the product candidate&#8217;s safety, purity, potency, and efficacy for its intended use, performed in accordance with good clinical practice (&#8220;GCP&#8221;) as well as IND regulations and other clinical-trial related regulations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">development of manufacturing processes and controls to ensure the product candidate&#8217;s identity, strength, quality, purity, and potency in compliance with current good manufacturing practice (&#8220;cGMP&#8221;) regulations;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">submission to the FDA of a BLA;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">satisfactory completion of an FDA pre-license (or pre-approval) inspection of the manufacturing facility or facilities at which the proposed product is produced to assess compliance with cGMP regulations and to assure that the facilities, methods and controls are adequate to preserve the product&#8217;s continued identity, strength, quality and purity for a drug and safety, purity and potency for a biologic;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">review of the product by an FDA advisory committee where appropriate or applicable, as determined by the FDA in its sole discretion; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">FDA review and approval of the BLA to permit commercial marketing for particular indications for use.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Preclinical Studies and IND Submission</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The testing and approval process of product candidates requires substantial time, effort, and financial resources. Satisfaction of FDA pre-market approval requirements typically takes many years and the actual time required may vary substantially based upon the type, complexity, and novelty of the product or target indication. Preclinical studies include laboratory evaluation of chemistry, pharmacology, toxicity, and product formulation, and may involve </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> testing or </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> animal studies to assess the potential for toxicity, adverse events, and other safety characteristics of the product candidate, and in some cases to establish a rationale for therapeutic use. Such studies must generally be conducted in accordance with FDA GLP regulations. The Consolidated Appropriations Act for 2023, signed into law on December 29, 2022, (P.L. 117-328) amended the FDCA and the PHSA to specify that non-clinical testing for drugs and biologics may, but is not required to, include </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> animal studies. According to the amended language, a sponsor may fulfill non-clinical testing requirements by completing various </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> assays (e.g., cell-based assays, organ chips, or microphysiological systems), </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in silico</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> studies (i.e., computer modeling), other human or nonhuman biology-based tests (e.g., bioprinting), or </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> animal studies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Prior to commencing the first clinical trial at a U.S. investigational site with a product candidate, an IND sponsor must submit the results of the non-clinical tests, together with manufacturing information, analytical data, any available clinical data or relevant scientific literature (including data from clinical trials conducted outside of the United States), and proposed clinical study protocols among other things, to the FDA as part of an IND. An IND is a request from a clinical study sponsor to obtain authorization from the FDA to administer an investigational drug or biological product to humans in accordance with a specific clinical trial protocol. Some long-term non-clinical testing to further establish the safety profile of the product candidate, as well as manufacturing process development and product quality evaluation, may continue after the IND is submitted.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">An IND goes into effect upon notification by the FDA or automatically 30 days after receipt by the FDA, unless the FDA, within the 30&#8211;day-time period, notifies the sponsor of safety concerns or questions related to one or more proposed clinical trials and places the trial on a clinical hold. In such a case, the IND sponsor and the FDA must resolve all outstanding concerns or questions posed by the FDA before the clinical trial can begin. Clinical holds also may be imposed by the FDA at any time before or during clinical trials due to safety concerns or non-compliance with applicable regulations. As a result, submission of an IND may not result in FDA authorization to commence a clinical trial. A separate submission to an existing IND must also be made for each successive clinical trial conducted during product development.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Clinical Trials</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with federal regulations and GCP requirements, which include the requirement that all research subjects provide their informed consent in writing before their participation in any clinical trial, as well as review and approval of the trial by an IRB. Investigators must also provide certain information to the clinical trial sponsors to allow the sponsors to make certain financial disclosures to the FDA. Clinical trials are conducted under protocols detailing, among other things, the objectives of the trial, the trial procedures, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A statistical analysis plan will be prepared for analysis of the data collected. A protocol for each clinical trial, and any subsequent protocol amendments, must be submitted to the FDA as part of the IND. In addition, an IRB for each site participating in the clinical trial must review and approve the protocol (initial and amendments) for any clinical trial, informed consent forms, and communications and documents provided to trial subjects before a trial commences and for the duration of the trial at that site. An IRB considers, among other things, whether the risks to individuals participating in the trials are minimized and are reasonable in relation to anticipated benefits, and whether the planned human subject protections are adequate. The IRB must continue to oversee the clinical trial while it is being conducted. If a product candidate is being investigated for multiple intended indications, separate INDs may also be required. Status reports summarizing the progress of the clinical trials must be submitted at least annually to the FDA and more frequently if suspected unexpected serious adverse reactions occur, findings from other studies suggest a significant risk to humans exposed to the investigational product, findings from animal or </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> testing suggest a significant risk for human subjects, or other significant safety information is found.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA may order the temporary, or permanent, discontinuation of a clinical trial at any time, or impose other sanctions on various grounds, including if the agency believes that the clinical trial either is not being conducted in accordance with regulatory requirements or presents an unacceptable risk to the clinical trial subjects. An IRB may also require performance of the clinical trial at the site to be halted, either temporarily or permanently, for failure to comply with the IRB&#8217;s requirements or if the trial poses unexpected serious harm to subjects. The FDA or an IRB may also impose conditions on the conduct of a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">clinical trial. Clinical trial sponsors may also choose to discontinue clinical trials as a result of risks to subjects, a lack of favorable results, or changing business priorities. Some clinical trials also include oversight by an independent group of qualified experts organized by the trial sponsor, known as a data monitoring committee (&#8220;DMC&#8221;) which provides authorization for whether a trial may move forward at designated check points based on review of certain data from the trial, to which the DMC has access, and may recommend halting the trial if it determines that there is an unacceptable safety risk for subjects or on other grounds, such as no demonstration of efficacy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Sponsors of clinical trials of certain FDA-regulated products generally must register and disclose certain clinical trial information to a public registry maintained by the National Institutes of Health (&#8220;NIH&#8221;). In particular, information related to the investigational product, patient population, phase of investigation, trial site locations and other aspects of the clinical trial is made public as part of the registration of the clinical trial. Competitors may use this publicly available information to gain knowledge regarding the progress of development programs. Although sponsors are also obligated to disclose the results of their clinical trials after completion, disclosure of the results may be delayed in some cases for up to two years after the date of completion of the primary endpoint of the trial. Failure to timely register a covered clinical study or to submit study results as provided for in the law can give rise to civil monetary penalties and also prevent the non-compliant party from receiving future grant funds from the federal government. The U.S. Department of Health and Human Services&#8217; Final Rule and NIH&#8217;s complementary policy on ClinicalTrials.gov registration and reporting requirements became effective in 2017, and the government has brought enforcement actions against non-compliant clinical trial sponsors. Sponsors or distributors of investigational products for the diagnosis, monitoring, or treatment of one or more serious diseases or conditions must also have a publicly available policy on evaluating and responding to requests for expanded access requests.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The manufacture of investigational biologics for the conduct of human clinical trials is subject to cGMP requirements. Investigational biologics and their therapeutic substances that are imported into the United States are also subject to regulation by the FDA. Further, the export of investigational products outside of the United States is subject to regulatory requirements of the receiving country as well as U.S. export requirements under the FDCA.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In general, for purposes of BLA approval, human clinical trials are typically conducted in three sequential phases, which may overlap or be combined.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">Phase 1</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;The product candidate is initially administered to healthy human volunteers and tested for safety, dosage tolerance, structure-activity relationships, mechanism of action, absorption, metabolism, distribution, and excretion. In the case of some products for severe or life-threatening diseases, such as cancer, especially when the product may be too inherently toxic to administer ethically to healthy volunteers, the initial human testing is often conducted in patients with the target disease or condition. If possible, Phase 1 trials may also be used to gain an initial indication of product effectiveness.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">Phase 2</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;Studies are conducted in limited subject populations with a specified disease or condition to evaluate preliminary efficacy, identify optimal dosages, dosage tolerance and schedule, possible adverse effects and safety risks, and expanded evidence of safety. Multiple Phase 2 clinical trials may be conducted by the sponsor to obtain information prior to beginning larger and more extensive clinical trials.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">Phase 3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;Clinical trials are undertaken with larger subject populations, generally at geographically dispersed clinical trial sites, to generate sufficient data to provide statistically significant evidence of clinical efficacy and safety of the product candidate, to establish the overall risk-benefit profile of the product candidate, and to provide adequate information for the labeling of the product candidate. Typically, two adequate, well-controlled trials are required by the FDA for biological product approval. Under some limited circumstances, however, the FDA may approve a BLA based upon a single clinical trial plus confirmatory evidence from a post-market trial or, alternatively, a single large, robust, well-controlled multicenter trial without confirmatory evidence.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additional kinds of data may also help to support a BLA, such as patient experience and real-world data. For appropriate indications sought through supplemental BLAs, data summaries may provide marketing application support. For genetically targeted products and variant protein targeted products intended to address an unmet medical need in one or more patient subgroups with a serious or life threatening rare disease or condition, the FDA may allow a sponsor to rely upon data and information previously developed by the sponsor or for which the sponsor has a right of reference, that was submitted previously to support an approved application for a product that incorporates or utilizes the same or similar genetically targeted technology or a product that is the same or utilizes the same variant protein targeted therapeutic agent as the product that is the subject of the application.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA may also require, or companies may voluntarily conduct, additional clinical trials for the same indication after a product is approved. These post-approval trials, generally referred to as Phase 4 clinical trials, are used to gain additional experience from the treatment of patients in the intended therapeutic indication. In certain instances, the FDA may mandate the performance of Phase 4 trials as a condition of approval of a BLA. The results of Phase 4 studies can confirm or refute the effectiveness of a product candidate and can provide important safety information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Concurrent with clinical trials, companies usually complete additional non-clinical studies and must also develop additional information about the chemistry and physical characteristics of the product candidate as well as finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">be capable of consistently producing quality batches of the product candidate and, among other things, manufacturers must develop methods for testing the identity, strength, quality, potency, and purity of the final product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the Consolidated Appropriations Act for 2023, Congress amended the FDCA to require sponsors of a Phase 3 clinical trial, or other &#8220;pivotal study&#8221; of a new medical product to support marketing authorization, to submit a diversity action plan for such clinical trial. The action plan must include the sponsor&#8217;s diversity goals for enrollment, as well as a rationale for the goals and a description of how the sponsor will meet them. A sponsor must submit a diversity action plan to FDA by the time the sponsor submits the trial protocol to the agency for review. The FDA may grant a waiver for some or all of the requirements for a diversity action plan. If the FDA objects to a sponsor&#8217;s diversity action plan and requires the sponsor to amend the plan or take other actions, it may delay trial initiation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Marketing Application Submission, Review by the FDA, and Marketing Approval</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Assuming successful completion of the required clinical and preclinical testing in accordance with all applicable regulatory requirements, the results of product development, including chemistry, manufacture, and controls information, non-clinical studies, and clinical trial results, including negative or ambiguous results as well as positive findings, are all submitted to the FDA, along with the proposed commercial product labeling, as part of a BLA requesting approval to market the product for one or more indications. A BLA must contain sufficient evidence of the biological product candidate&#8217;s safety, purity, potency and efficacy for its proposed indication or indications. Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a product&#8217;s use or from a number of alternative sources. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. The testing and approval processes require substantial time and effort and there can be no assurance that the FDA will accept the BLA for filing and, even if filed, that any approval will be granted on a timely basis, if at all.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the Prescription Drug User Fee Act, as amended (&#8220;PDUFA&#8221;), each BLA submission is subject to a substantial application user fee, and the sponsor of an approved BLA is also subject to an annual program fee. The FDA adjusts the PDUFA user fees on an annual basis. The application user fee must be paid at the time of the first submission of the application, even if the application is being submitted on a rolling basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Product candidates that are designated as orphan products are also not subject to application user fees, unless the application also includes a non-orphan indication.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, under the Pediatric Research Equity Act (&#8220;PREA&#8221;), a BLA or supplement to a BLA for a new active ingredient, indication, dosage form, dosage regimen, or route of administration, must contain data that are adequate to assess the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements. A sponsor who is planning to submit a marketing application for a product that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration must submit an initial Pediatric Study Plan (&#8220;PSP&#8221;) within 60 days of an end-of-Phase 2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase 3 or Phase 2/3 clinical trial. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including trial objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit amendments to an agreed upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early-phase clinical trials or other clinical development programs. Orphan products are exempt from the PREA requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA Reauthorization Act of 2017 introduced a provision regarding required pediatric studies. Under this statute, for product candidates intended for the treatment of adult cancer which are directed at molecular targets that the FDA determines to be substantially relevant to the growth or progression of pediatric cancer, original application sponsors must submit, with the marketing application, reports from molecularly targeted pediatric cancer investigations designed to yield clinically meaningful pediatric study data, gathered using appropriate formulations for each applicable age group, to inform potential pediatric labeling. The FDA may, on its own initiative or at the request of the applicant, grant deferrals or waivers of some or all of this data, as above. Unlike PREA, orphan products are not exempt from this requirement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA also may require submission of a risk evaluation and mitigation strategy (&#8220;REMS&#8221;) if it determines that a REMS is necessary to ensure that the benefits of the product candidate outweigh the risks and to assure safe use of the biological product. The REMS plan could include medication guides, physician communication plans, assessment plans and/or elements to assure safe and effective use, such as restricted distribution methods, patient registries, or other risk minimization tools. The FDA determines the requirement for a REMS, as well as the specific REMS provisions, on a case-by-case basis. If the FDA concludes a REMS is needed, the sponsor of the BLA must submit a proposed REMS. The FDA will not approve a BLA without a REMS, if required. An assessment of the REMS must also be conducted at set intervals. Following product </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">approval, a REMS may also be required by the FDA if new safety information is discovered and the FDA determines that a REMS is necessary to ensure that the benefits of the product outweigh the risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Once the FDA receives a marketing application for a biologic, it has 60 days to review the BLA to determine if it is substantially complete to permit a substantive review, before it accepts the application for filing. The FDA may request additional information rather than accept an application for filing. In this event, the application must be resubmitted with the additional information. The resubmitted application is also subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the goals and policies agreed to by the FDA under PDUFA, the FDA has set the review goal of completing its review of 90% of BLAs within 10 months of the filing date for a standard application and within six months of the filing date for an application with priority review. For all original BLAs, the 10 and six-month time periods run from the filing date; for all other submissions, including resubmissions, efficacy supplements and other supplements, the FDA&#8217;s stated review time periods, ranging from two to 10 months, run from the submission date. This review goal is referred to as the PDUFA date. The PDUFA date is only a goal, and it is not uncommon for FDA review of a BLA to extend beyond the PDUFA date. The review process and the PDUFA date may also be extended if the FDA requests, or the sponsor otherwise provides, substantial additional information or clarification regarding the submission.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA may also refer certain applications to an advisory committee. Before approving a product candidate for which no active ingredient has previously been approved by the FDA, the FDA must either refer that product candidate to an external advisory committee or provide in an action letter a summary of the reasons why the FDA did not refer the product candidate to an advisory committee. The FDA may also refer other product candidates to an advisory committee if FDA believes that the advisory committee&#8217;s expertise would be beneficial. An advisory committee is typically a panel that includes clinicians and other experts, who review, evaluate, and make a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making product approval decisions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA reviews a BLA to determine, among other things, whether a product candidate meets the agency&#8217;s approval standards, such as whether the application includes sufficient evidence that the product candidate is safe and effective for the proposed indications, and whether the manufacturing methods and controls are adequate to assure and preserve the product&#8217;s identity, strength, quality, potency, and purity. As part of its review, the FDA likely will re-analyze the clinical trial data, which could result in extensive discussions between the FDA and the applicant during the review process. Before approving a marketing application, the FDA typically will inspect the facility or facilities where the product is manufactured, referred to as a pre-license (or pre-approval) inspection. The FDA will not approve an application unless it determines that the manufacturing processes and facilities, including contract manufacturers and subcontractors, are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a marketing application the FDA may inspect one or more clinical trial sites to assure compliance with applicable IND trial requirements and GCP. To assure cGMP and GCP compliance, an applicant must incur significant expenditure of time, money and effort in the areas of training, record keeping, production, and quality control.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">After evaluating the marketing application and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a Complete Response Letter (&#8220;CRL&#8221;). A CRL indicates that the review cycle of the application is complete and the application will not be approved in its present form, and it describes all of the specific deficiencies that the FDA identified. A CRL generally contains a statement of specific conditions that must be met in order to secure final approval of the marketing application and may require additional clinical or non-clinical testing for the FDA to reconsider the application. The deficiencies identified may be minor, for example, requiring labeling changes; or major, for example, requiring additional Phase 3 clinical trials. In September 2025, the FDA began publishing CRLs soon after issuing them to the respective sponsors, breaking with long standing agency tradition of publishing CRLs with approval documentation after the product is approved. If a CRL is issued, the applicant may either: resubmit the marketing application, addressing all of the deficiencies identified in the letter; withdraw the application; or request an opportunity for a hearing. The FDA&#8217;s goal is to review 90% of application resubmissions in either two or six months of the resubmission date, depending on the type of information included. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#8217;s satisfaction, the FDA may issue an approval letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if the FDA approves a product, it may limit the approved indications or populations for use of the product; require that contraindications, warnings, or precautions be included in the product labeling, including a boxed warning; require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a product&#8217;s safety and efficacy after approval; require testing and surveillance programs to monitor the product after commercialization; or impose other conditions, including distribution restrictions or other risk management mechanisms under a REMS which can materially affect the potential market and profitability of the product. The FDA also may not approve label statements that are necessary for successful commercialization and marketing or may prevent or limit further marketing of a product based on the results of post-marketing trials or surveillance programs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements and FDA review and approval. The FDA may also withdraw the product approval if compliance with regulatory standards is not maintained or if problems occur after the product reaches the marketplace. Further, should new safety information arise, additional testing, product labeling, or FDA notification may be required.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Patent Term Restoration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Depending upon the timing, duration and specifics of FDA approval of our biological product candidates, some of our U.S. patents may be eligible for limited patent term extension. These patent term extensions permit a patent restoration term of up to five years as compensation for any patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&#8217;s approval date. The patent term restoration period is generally one-half the time between the effective date of an IND, and the submission date of a BLA, plus the time between the submission date of a BLA and the approval of that application. Only one patent applicable to an approved biological product is eligible for the extension, and the extension must be applied for prior to expiration of the patent. The USPTO in consultation with the FDA, reviews and approves the application for any patent term extension or restoration.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Biosimilars and Exclusivity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Biologics Price Competition and Innovation Act of 2009 (&#8220;BPCIA&#8221;) created an abbreviated approval pathway for biological products shown to be biosimilar to or interchangeable with an FDA-licensed reference biological product. To date, a number of biosimilars have been licensed under the BPCIA, and numerous biosimilars have been approved in Europe. The FDA has issued several guidance documents outlining an approach for the review and approval of biosimilars.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Biosimilarity, which requires no clinically meaningful differences between the biological product and the reference product in terms of safety, purity, and potency, can be demonstrated through analytical studies, animal studies, and for some biosimiliar products, clinical trials. There must be no difference between the reference product and a biosimilar in mechanism of action, conditions of use, route of administration, dosage form, and strength. A biosimilar product may be deemed interchangeable with the reference product if it meets the higher hurdle of demonstrating that it can be expected to produce the same clinical results as the reference product in any given patient and, for products administered multiple times to an individual, the biologic and the reference biologic may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic without such alternation or switching. Upon licensure by the FDA, an interchangeable biosimilar may be substituted for the reference product without the intervention of the health care provider who prescribed the reference product. The FDA approved the first interchangeable biosimilars, including an interchangeable monoclonal antibody biosimilar, in 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A reference biologic is granted 12 years of data exclusivity from the time of first licensure of the product, and the first approved interchangeable biological product will be granted an exclusivity period of up to one year after it is first commercially marketed. However, certain changes and supplements to an approved BLA, and subsequent applications filed by the same sponsor, manufacturer, licensor, predecessor in interest, or other related entity do not qualify for the 12-year exclusivity period. As part of the Consolidated Appropriations Act for 2023, Congress amended the PHSA in order to permit multiple interchangeable products approved on the same day to receive and benefit from the one-year exclusivity period. If pediatric studies are performed and accepted by the FDA as responsive to a written request, the 12-year exclusivity period will be extended for an additional six months. In addition, the FDA will not accept an application for a biosimilar or interchangeable product based on the reference biological product until four years after the date of first licensure of the reference product. &#8220;First licensure&#8221; typically means the initial date the particular product at issue was licensed in the United States. Date of first licensure does not include the date of licensure of (and a new period of exclusivity is not available for) a supplement for the reference product for a subsequent application filed by the same sponsor or manufacturer of the reference product (or licensor, predecessor in interest or other related entity) for a change (not including a modification to the structure of the biological product) that results in a new indication, route of administration, dosing schedule, dosage form, delivery system, delivery device, or strength, or for a modification to the structure of the biological product that does not result in a change in safety, purity or potency. Therefore, one must determine whether a new product includes a modification to the structure of a previously licensed product that results in a change in safety, purity or potency to assess whether the licensure of the new product is a first licensure that triggers its own period of exclusivity. Whether a subsequent application, if approved, warrants exclusivity as the &#8220;first licensure&#8221; of a biological product is determined on a case-by-case basis with data submitted by the sponsor.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition, aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of litigation. As a result, the ultimate impact and implementation of the BPCIA is subject to significant uncertainty.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Pediatric Exclusivity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Pediatric exclusivity is a type of non-patent marketing exclusivity in the United States and, if granted, provides for the attachment of an additional six months of marketing protection to the term of any existing regulatory exclusivity or listed patents. This six-month exclusivity may be granted if a sponsor submits pediatric data that fairly respond to a written request from the FDA for such data. The data do not need to show the product to be effective in the pediatric population studied; rather, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">if the clinical trial is deemed to fairly respond to the FDA&#8217;s request, the additional protection is granted. If reports of requested pediatric studies are submitted to and accepted by the FDA within the statutory time limits, whatever statutory or regulatory periods of exclusivity or patent protection cover the product are extended by six months. This is not a patent term extension, but it effectively extends the regulatory period during which the FDA cannot approve another application. The issuance of a written request does not require the sponsor to undertake the described studies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Orphan Product Designation and Exclusivity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Orphan Drug Act provides incentives for the development of products for rare diseases or conditions. Specifically, sponsors may apply for and receive Orphan Drug Designation (&#8220;ODD&#8221;) if a product candidate is intended to treat a rare disease or condition, which is generally a disease or condition affecting less than 200,000 individuals in the United States, or affecting more than 200,000 in the United States and for which there is no reasonable expectation that the cost of developing and making the product available in the United States will be recovered from United States sales. Additionally, sponsors must present a plausible hypothesis for clinical superiority to obtain ODD if there is a product already approved by the FDA that that is considered by the FDA to be the same as the already approved product and is intended for the same indication. This hypothesis for clinical superiority must be demonstrated to obtain orphan exclusivity. Orphan drug designation must be requested before submitting a marketing application for the product candidate and does not convey any advantage in or shorten the duration of the regulatory review and approval process. If granted, ODD entitles the applicant to financial incentives such as opportunities for grant funding towards clinical study costs, tax advantages, and certain user-fee waivers. After the FDA grants ODD, the identity of the therapeutic agent and its potential orphan use will be disclosed publicly by the FDA; the posting will also indicate whether the drug or biologic is no longer designated as an orphan product. More than one product candidate may receive an orphan designation for the same indication.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If a product candidate receives FDA approval for the indication for which it has ODD, the product is generally entitled to orphan exclusivity, which means the FDA may not approve any other application to market a product containing the same active moiety for the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity. A product is clinically superior if it is safer, more effective or makes a major contribution to patient care. Thus, orphan drug exclusivity could block the approval of one of our potential products for seven years if a competitor obtains approval of the same product, as defined by the FDA, for the same orphan indication and we are not able to show the clinical superiority of our product candidate. In addition, the FDA will not recognize orphan drug exclusivity if a sponsor fails to demonstrate upon approval that the product is clinically superior to a previously approved product containing the same active moiety for the same orphan condition, regardless of whether or not the previously approved product was designated an orphan drug or had orphan drug exclusivity. A product that has received ODD may not receive orphan exclusivity if it is approved for a use that is broader than the indication for which it received the designation. Orphan exclusivity does not prevent the FDA from approving a different drug or biological product for the same disease or condition, or the same product for a different disease or condition. In addition, orphan drug exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA&#8217;s approach to determining the scope of orphan drug exclusivity has been challenged in court, but at this time, the agency continues to apply its long-standing interpretation of the governing regulations and has stated that it does not plan to change any orphan drug implementing regulations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Fast Track, Breakthrough Therapy and Priority Review Designations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA is authorized to designate certain products for expedited development or review if they are intended for the treatment of serious or life-threatening diseases or conditions, and demonstrate the potential to address unmet medical needs or present a significant improvement over existing therapy. These programs include fast track designation, breakthrough therapy designation, and priority review designation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To be eligible for a fast track designation, the FDA must determine, based on the request of a sponsor, that a product candidate is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address an unmet medical need by providing a therapy where none exists or a therapy that may be potentially superior to existing therapy based on efficacy or safety factors. Fast track designation provides opportunities for more frequent interactions with the FDA review team to expedite development and review of the product. In addition, the FDA may initiate review of sections of a marketing application before the application is complete. This &#8220;rolling review&#8221; is available if the applicant provides and the FDA approves a schedule for the submission of the application sections and the sponsor pays any required user fees upon submission of the first section of the application. In some cases, a product with fast track designation may be eligible for accelerated approval or priority review if the relevant criteria are met. The FDA may rescind, or the sponsor may forfeit, fast track designation if the designation is no longer supported by data emerging from the clinical trial process.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the provisions of the Food and Drug Administration Safety and Innovation Act (&#8220;FDASIA&#8221;) enacted in 2012, a sponsor may request designation of a product candidate as a &#8220;breakthrough therapy.&#8221; A breakthrough therapy is defined as a drug or biologic that is intended, alone or in combination with one or more other drug or biologic, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">observed early in clinical development. Products designated as breakthrough therapies are eligible for the same benefits described above for fast track designation, as well as intensive guidance on an efficient development program beginning as early as Phase 1 trials, and a commitment from the FDA to involve senior managers and experienced review staff in a proactive collaborative and cross-disciplinary review. Drugs or biologics designated as breakthrough therapies are also eligible for accelerated approval of their respective marketing applications.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA may grant priority review designation to product candidates that are intended to treat serious conditions and, if approved, would provide significant improvements in the safety or effectiveness over existing therapies. The FDA determines at the time that the marketing application is submitted, on a case-by-case basis, whether the proposed drug or biologic represents a significant improvement in treatment, prevention or diagnosis of disease when compared with other available therapies. Significant improvement may be illustrated by evidence of increased effectiveness in the treatment of a condition, elimination or substantial reduction of a treatment-limiting reaction, documented enhancement of patient compliance that may lead to improvement in serious outcomes, or evidence of safety and effectiveness in a new subpopulation. A priority review designation is intended to direct overall attention and resources to the evaluation of such applications, and to shorten the FDA&#8217;s goal for taking action on a marketing application from 10 months to six months for an original application from the date of filing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In 2025, the FDA created a new voucher program called the Commissioner&#8217;s National Priority Voucher (&#8220;CNPV&#8221;) with the goal of radically expediting the drug and biological product review and approval process. The agency may award a CNPV to a company or a specific product candidate that demonstrates alignment with certain national health priorities. The FDA aims to take action on a marketing application for which a CNPV is used within one to two months after the filing date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. Furthermore, none of these programs changes the standards for approval and may not ultimately expedite the development or approval process.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accelerated Approval</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, products studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may receive accelerated approval from the FDA and may be approved on the basis of adequate and well-controlled clinical trials establishing that the drug product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit. The FDA may also grant accelerated approval for such a drug or biologic when the product has an effect on an intermediate clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality (&#8220;IMM&#8221;) and that is reasonably likely to predict an effect on IMM or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA will require that a sponsor of a drug receiving accelerated approval perform post-marketing clinical trials to verify and describe the predicted effect on IMM or other clinical endpoint, and the product may be subject to expedited withdrawal procedures. Drugs and biologics granted accelerated approval must meet the same statutory standards for safety and effectiveness as those granted traditional approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. Surrogate endpoints can often be measured more easily or more rapidly than clinical endpoints. An intermediate clinical endpoint is a measurement of a therapeutic effect that is considered reasonably likely to predict the clinical benefit of a drug or biologic, such as an effect on IMM. The FDA has limited experience with accelerated approvals based on intermediate clinical endpoints, but has indicated that such endpoints generally may support accelerated approval when the therapeutic effect measured by the endpoint is not itself a clinical benefit and basis for traditional approval, if there is a basis for concluding that the therapeutic effect is reasonably likely to predict the ultimate long-term clinical benefit of a drug or biologic.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accelerated approval pathway is most often used in settings in which the course of a disease is long and an extended period of time is required to measure the intended clinical benefit of a drug or biologic, even if the effect on the surrogate or intermediate clinical endpoint occurs rapidly. For example, accelerated approval has been used extensively in the development and approval of drugs and biologics for treatment of a variety of cancers in which the goal of therapy is generally to improve survival or decrease morbidity and the duration of the typical disease course requires lengthy and sometimes large clinical trials to demonstrate a clinical or survival benefit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accelerated approval pathway is usually contingent on a sponsor&#8217;s agreement to conduct, in a diligent manner, post-approval confirmatory studies to verify and describe the drug&#8217;s clinical benefit. As a result, a product candidate approved on this basis is subject to rigorous post-marketing compliance requirements, including the completion of Phase 4 or post-approval clinical trials to establish the effect on the clinical endpoint. Failure to conduct required post-approval studies, or to confirm the predicted clinical benefit of the product during post-marketing studies, would allow the FDA to withdraw approval of the drug or biologic. As part of the Consolidated Appropriations Act for 2023, Congress provided the FDA additional statutory authority to mitigate potential risks to patients from continued marketing of ineffective drugs or biologics previously being considered for accelerated approval. Under the act&#8217;s amendments to the FDCA, the FDA may require the sponsor of a product granted accelerated approval to have a confirmatory trial underway prior to approval. The sponsor must also submit progress reports on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">a confirmatory trial every six months until the trial is complete, and such reports are published on the FDA&#8217;s website. The amendments also give the FDA the option of using expedited procedures to withdraw product approval if the sponsor&#8217;s confirmatory trial fails to verify the claimed clinical benefits of the product.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">All promotional materials for product candidates being considered and approved under the accelerated approval program are subject to prior review by the FDA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Post-approval Requirements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any products manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, monitoring and record-keeping requirements, reporting of adverse experiences with the product, periodic reporting requirements, providing the FDA with updated safety and efficacy information, product sampling and distribution requirements, as well as advertising and promotion requirements, which include, among others, standards for direct-to-consumer advertising, restrictions on promoting products for uses or in patient populations that are not described in the product&#8217;s approved uses (known as off-label uses), limitations on industry-sponsored scientific and educational activities, and requirements for promotional activities involving the Internet.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">After approval, most changes to the approved product, such as adding new indications or other labeling claims are subject to prior FDA review and approval of a new BLA or a supplement, which may require the applicant to develop additional data or conduct additional non-clinical studies and clinical trials. The FDA may also place other conditions on approvals, including the requirement for a REMS, to assure the safe use of the product. A REMS could include medication guides, physician communication plans or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. Any of these limitations on approval or marketing could restrict the commercial promotion, distribution, prescription or dispensing of products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, quality control and manufacturing procedures must continue to conform to applicable manufacturing requirements after approval to ensure the quality and long-term stability of the product. The cGMP regulations include requirements relating to organization of personnel, buildings and facilities, equipment, control of components and drug product containers and closures, production and process controls, packaging and labeling controls, holding and distribution, laboratory controls, records and reports and returned or salvaged products. The manufacturing facilities for our product candidates must meet cGMP requirements and satisfy the FDA or comparable foreign regulatory authorities before any product is approved and our commercial products can be manufactured. We rely, and expect to continue to rely, on third parties for the production of clinical and commercial quantities of our products in accordance with cGMP regulations. These third-party manufacturers must comply with cGMP regulations that require, among other things, quality control and quality assurance, the maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers, including third-party manufacturers, and other entities involved in the manufacture and distribution of approved biologics are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other laws. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control, facilities, equipment and personnel to maintain cGMP compliance. Future inspections by the FDA and other regulatory agencies may identify compliance issues at the facilities of our contract manufacturers that may disrupt production or distribution or require substantial resources to correct. In addition, the discovery of conditions that violate these rules, including failure to conform to cGMP regulations, could result in enforcement actions, and the discovery of problems with a product after approval may result in restrictions on a product, manufacturer, or holder of an approved BLA, including, among other things, voluntary recall and regulatory sanctions as described further below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA also strictly regulates marketing, labeling, advertising, and promotion of products that are placed on the market. A company can make only those claims relating to a product that are approved by the FDA. Physicians, in their independent professional medical judgment, may prescribe legally available products for unapproved indications that are not described in the product&#8217;s labeling and that differ from those tested and approved by the FDA. Biopharmaceutical companies, however, are required to promote their products only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability, including, but not limited to, criminal and civil penalties under the FDCA and False Claims Act, exclusion from participation in federal health care programs, mandatory compliance programs under corporate integrity agreements, suspension and debarment from government contracts, and refusal of orders under existing government contracts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, the Drug Supply Chain Security Act (&#8220;DSCSA&#8221;) was enacted with the aim of building an electronic system to identify and trace certain prescription drugs distributed in the United States, including most biological products. The DSCSA imposes phased-in and resource-intensive obligations on biopharmaceutical manufacturers, wholesale distributors, and dispensers related to product tracking and tracing over a 10-year period which culminated in November 2023. Among the requirements of this legislation, manufacturers are required to provide certain information regarding the products to wholesale distributors and dispensers to which product ownership is transferred, label products with a product identifier, and keep certain records regarding the product. A manufacturer must also verify that purchasers of the manufacturer&#8217;s products are appropriately licensed. Further, under this legislation, manufacturers have product investigation, quarantine, disposition, and notification responsibilities related to counterfeit, diverted, stolen, and intentionally adulterated products that would result in serious adverse </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">health consequences of death to humans, as well as products that are the subject of fraudulent transactions or which are otherwise unfit for distribution such that they would be reasonably likely to result in serious health consequences or death. After an additional one-year stabilization period to give entities subject to the DSCSA additional time to finalize interoperable tracking systems and to ensure supply chain continuity, the applicable requirements under the DSCSA became fully enforceable as of November 27, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">FDA&#8217;s post-market requirements are continuously evolving and additional requirements may apply. For instance, in March 2020, the U.S. Congress passed the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;), which includes various provisions regarding FDA drug shortage reporting requirements, as well as provisions regarding supply chain security, such as risk management plan requirements, and the promotion of supply chain redundancy and domestic manufacturing. Any changes of law may require that we modify how we conduct our business and may require additional expenditure to ensure that we are in compliance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in significant regulatory actions. Such actions may include refusal to approve pending applications, product license or approval suspension or revocation, imposition of a clinical hold or termination of clinical trials, warning letters, untitled letters, modification of promotional materials or labeling, provision of corrective information, imposition of post-market requirements including the need for additional testing, imposition of distribution or other restrictions under a REMS, product recalls, product seizures or detentions, refusal to allow imports or exports, total or partial suspension of production or distribution, FDA debarment, injunctions, fines, consent decrees, corporate integrity agreements, suspension and debarment from government contracts, and refusal of orders under existing government contracts, exclusion from participation in federal and state health care programs, restitution, disgorgement, or civil or criminal penalties, including fines and imprisonment, and adverse publicity, among other adverse consequences.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Additional Controls for Biologics</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To help reduce the increased risk of the introduction of adventitious agents, the PHSA emphasizes the importance of manufacturing controls for products whose attributes cannot be precisely defined. The PHSA also provides authority to the FDA to immediately suspend licenses in situations where there exists a danger to public health, to prepare or procure products in the event of shortages and critical public health needs, and to authorize the creation and enforcement of regulations to prevent the introduction or spread of communicable diseases in the United States and between states.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">After a BLA is approved, the product may also be subject to official lot release as a condition of approval. As part of the manufacturing process, the manufacturer is required to perform certain tests on each lot of the product before it is released for distribution. If the product is subject to official release by the FDA, the manufacturer submits samples of each lot of product to the FDA together with a release protocol showing the results of all of the manufacturer&#8217;s tests performed on the lot. The FDA may also perform certain confirmatory tests on lots of some products before releasing the lots for distribution by the manufacturer.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the FDA conducts laboratory research related to the regulatory standards on the safety, purity, potency, and effectiveness of biological products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Although we currently do not have any products on the market, our business activities and current and future arrangements with investigators, health care professionals, consultants, third-party payors and customers may be subject to regulation and enforcement by numerous federal and state regulatory and law enforcement authorities in the United States in addition to the FDA, including potentially the DOJ, the Department of Health and Human Services and its various divisions, the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) and the Health Resources and Services Administration, the Department of Veterans Affairs, the Department of Defense, and state and local governments. Our business activities must comply with numerous health care laws, including but not limited to, anti-kickback and false claims laws and regulations as well as data privacy and security laws and regulations, which are described below, as well as state and federal consumer protection and unfair competition laws.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The federal Anti-Kickback Statute, which regulates, among other things, marketing practices, educational programs, pricing policies, and relationships with health care providers or other entities, prohibits, among other things, any person or entity, from knowingly and willfully offering, paying, soliciting, or receiving any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or in return for purchasing, leasing, ordering, or arranging for or recommending the purchase, lease, or order, or the referral to another for the furnishing or arranging for the furnishing of any item or service reimbursable under Medicare, Medicaid, or other federal health care programs, in whole or in part. The term &#8220;remuneration&#8221; has been interpreted broadly to include anything of value. The Anti-Kickback Statute has been interpreted to apply to arrangements between biopharmaceutical industry members on one hand and prescribers, purchasers, formulary managers, and beneficiaries on the other. There are certain statutory exceptions and regulatory safe harbors protecting some common activities from prosecution. The exceptions and safe harbors are drawn narrowly, and practices that involve remuneration that may be alleged to be intended to induce prescribing, purchases, or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">regulatory safe harbor does not make the conduct per se illegal under the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. Several courts have interpreted the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal health care covered business, including purchases of products paid by federal health care programs, the statute has been violated. The Patient Protection and Affordable Care Act (&#8221;ACA&#8221;) of 2010, as amended, also modified the intent requirement under the Anti-Kickback Statute to a stricter standard, such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the ACA also provided that a violation of the federal Anti-Kickback Statute is grounds for the government or a whistleblower to assert that a claim for payment of items or services resulting from such violation constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The federal civil False Claims Act (&#8220;FCA&#8221;) prohibits, among other things, any person or entity from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment to, or approval by, the federal government, knowingly making, using, or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government, or avoiding, decreasing, or concealing an obligation to pay money to the federal government. A claim includes &#8220;any request or demand&#8221; for money or property presented to the U.S. government. The FCA has been used to assert liability on the basis of kickbacks and other improper referrals, improperly reported government pricing metrics such as Best Price or Average Manufacturer Price, improper use of Medicare provider or supplier numbers when detailing a provider of services, improper promotion of off-label uses, and allegations as to misrepresentations with respect to products, contract requirements, and services rendered. Intent to deceive is not required to establish liability under the FCA. Actions under the FCA may be brought by the government or may be brought by private individuals on behalf of the government, called &#8220;qui tam&#8221; actions. If the government decides to intervene in a qui tam action and prevails in the lawsuit, the individual will share in the proceeds from any fines or settlement funds. If the government declines to intervene, the individual may pursue the case alone. The FCA provides for treble damages and a civil penalty for each false claim, such as an invoice or pharmacy claim for reimbursement, which can aggregate into millions of dollars. For these reasons, since 2004, FCA lawsuits against biopharmaceutical companies have increased significantly in volume and breadth, leading to several substantial civil and criminal settlements regarding certain sales practices and promoting off label uses. FCA liability may further be imposed for known Medicare or Medicaid overpayments, for example, overpayments caused by understated rebate amounts that are not refunded within 60 days of discovering the overpayment, even if the overpayment was not caused by a false or fraudulent act. In addition, conviction or civil judgment for violating the FCA may result in exclusion from federal health care programs, and suspension and debarment from government contracts, and refusal of orders under existing government contracts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The government may further prosecute conduct constituting a false claim under the criminal False Claims Act. The criminal False Claims Act prohibits the making or presenting of a claim to the government knowing such claim to be false, fictitious, or fraudulent and, unlike the False Claims Act, requires proof of intent to submit a false claim.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The civil monetary penalties statute is another potential statute under which biopharmaceutical companies may be subject to enforcement. Among other things, the civil monetary penalties statute imposes fines against any person who is determined to have knowingly presented, or caused to be presented, claims to a federal health care program that the person knows, or should know, is for an item or service that was not provided as claimed or is false or fraudulent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) also created federal criminal statutes that prohibit, among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any of the money or property owned by, or under the custody or control of, a health care benefit program, regardless of whether the payor is public or private, in connection with the delivery or payment for health care benefits, knowingly and willfully embezzling or stealing from a health care benefit program, willfully obstructing a criminal investigation of a health care offense and knowingly and willfully falsifying, concealing, or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, health care benefits, items, or services relating to health care matters. Additionally, the ACA amended the intent requirement of certain of these criminal statutes under HIPAA so that a person or entity no longer needs to have actual knowledge of the statute, or the specific intent to violate it, to have committed a violation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the federal Physician Payments Sunshine Act and its implementing regulations, manufacturers of biologics for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program (with certain exceptions) must make annual reports to CMS regarding payments and other transfers of value made to or at the request of covered recipients, such as, but not limited to, physicians, certain advanced non-physician health care providers, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family. Certain payments for clinical trials are included within the ambit of this law. CMS makes the reported information publicly available.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Further, we may be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (the &#8220;HITECH Act&#8221;) and its implementing regulations impose requirements on covered entities relating to the privacy, security, and transmission of individually identifiable health information, known as protected health information. Among other things, the HITECH Act, through its implementing regulations, makes HIPAA&#8217;s security standards and certain privacy standards directly applicable to business associates, defined as a person or organization, other than a member of a covered entity&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">workforce, that creates, receives, maintains, or transmits protected health information on behalf of a covered entity for a function or activity regulated by HIPAA. The HITECH Act also strengthened the civil and criminal penalties that may be imposed against covered entities, business associates, and individuals, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. We are not a covered entity or a business associate under HIPAA, however, we are indirectly affected by HIPAA because the protected health information held by investigators conducting our clinical trials is subject to HIPAA and can only be used for our research consistent with HIPAA requirements imposed on those investigators.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, numerous federal and state laws and regulations, including state data breach notification laws, and federal and state consumer protection laws govern the collection, use, disclosure, and protection of health-related and other personal information. For example, California enacted the California Consumer Privacy Act (&#8220;CCPA&#8221;), which took effect on January 1, 2020, and in 2020, California voters passed the California Privacy Rights Act (the &#8220;CPRA&#8221;), which became effective as of January 1, 2023, and significantly amends the CCPA and imposes additional data protection obligations on companies doing business in California, in addition to establishing a new regulatory agency, the California Privacy Protection Agency.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Many states have also adopted fraud and abuse laws similar to each of the above federal laws, which may be broader in scope and apply to items or services reimbursed by any third-party payor, including commercial insurers. Certain state laws also regulate sponsors&#8217; use of prescriber-identifiable data. Certain states also require implementation of commercial compliance programs and compliance with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government, or otherwise restrict payments or the provision of other items of value that may be made to health care providers and other potential referral sources; impose restrictions on marketing practices; or require sponsors to track and report information related to payments, gifts, and other items of value to physicians and other health care providers. Furthermore, to distribute products commercially, we must comply with state laws requiring the registration of manufacturers and wholesale distributors of drug and biological products in a state, including, in certain states, manufacturers and distributors who ship products into the state even if such manufacturers or distributors have no place of business within the state. Recently, states have enacted or are considering legislation intended to make drug prices more transparent and deter significant price increases, typically as consumer protection laws. These laws may affect our future sales, marketing, and other promotional activities by imposing administrative and compliance burdens.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If our operations are found to be in violation of any of the laws or regulations described above or any other laws that apply to us, we may be subject to penalties or other enforcement actions, including criminal and significant civil monetary penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government health care programs, corporate integrity agreements, suspension and debarment from government contracts and non-procurement transactions such as grants, and refusal of orders under existing government contracts, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that any of our products are sold in a foreign country, we may be subject to similar foreign laws and regulations, which may include, for instance, applicable post-marketing requirements, including safety surveillance, anti-fraud and abuse laws, and implementation of corporate compliance programs and reporting of payments or transfers of value to health care professionals.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Coverage and Reimbursement Generally</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The commercial success of our product candidates and our ability to commercialize any approved product candidates successfully will depend in part on the extent to which governmental payor programs at the federal and state levels, including Medicare and Medicaid, private health insurers, and other third-party payors provide coverage for and establish adequate reimbursement levels for our product candidates. Government authorities, private health insurers, and other organizations generally decide which therapeutics they will pay for and establish reimbursement levels for health care. A growing trend in recent years is the containment of health care costs. Accordingly, governmental payors are increasingly trying to control therapeutic prices through reimbursement restrictions, rebates, mandatory discounts, and formulary restrictions, among other strategies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Medicare is a federal health care program administered by the federal government that covers individuals aged 65 and over as well as individuals with certain disabilities. Drugs and biologics may be covered under one or more sections of Medicare depending on the nature of the product and the conditions associated with and site of administration. For example, under Part D, Medicare beneficiaries may enroll in prescription drug plans offered by private entities which provide coverage for outpatient prescription drugs. Part D plans include both stand-alone prescription drug benefit plans and prescription drug coverage as a supplement to Medicare Advantage plans. Unlike Medicare Parts A and B, Part D coverage is not standardized. Part D prescription drug plan sponsors are not required to pay for all covered Part D drugs, and each drug plan can develop its own drug formulary that identifies which drugs it will cover and at what tier or level.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Medicare Part B covers most injectable drugs and biologics given in an in-patient setting and some products administered by a licensed medical provider in hospital outpatient departments and doctors&#8217; offices. Medicare Part B is administered by Medicare Administrative Contractors, which generally have the responsibility of making coverage decisions. Subject to certain </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">payment adjustments and limits, Medicare generally pays for a Part B-covered drug or biologic based on a percentage of manufacturer-reported Average Sales Price, which is regularly updated. We believe that our product candidates, which are intended to be administered by a health care professional in a clinical environment, will be subject to the Medicare Part B rules.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the United States, the European Union, and other markets for our product candidates, government authorities and third-party payors are increasingly attempting to limit or regulate the price of medical products and services, particularly for new and innovative products and therapies, which often has resulted in average selling prices lower than they would otherwise be and sometimes at or below the provider&#8217;s acquisition cost. In the United States, it is also common for government and private health plans to use coverage determinations to leverage rebates from sponsors in order to reduce the plans&#8217; net costs. These restrictions and limitations influence the purchase of health care services and products and lower the realization on sponsors&#8217; sales of prescription therapeutics. Third-party payors are developing increasingly sophisticated methods of controlling health care costs. Third-party payors may limit coverage to specific therapeutic products on an approved list, or formulary, which might not include all of the FDA-approved products for a particular indication or might impose high copayment amounts to influence patient choice. Third-party payors also control costs by requiring prior authorization or imposing other dispensing restrictions before covering certain products and by broadening therapeutic classes to increase competition. Third-party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical products and services, in addition to their safety and efficacy. Absent clinical differentiators, third-party payors may treat products as therapeutically equivalent and base formulary decisions on net cost. To lower the prescription cost, sponsors frequently rebate a portion of the prescription price to the third-party payors. Recently, purchasers and third-party payors have begun to focus on value of new therapeutics and have sought agreements in which price is based on achievement of performance metrics.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Federal programs also impose price controls through mandatory ceiling prices on purchases by federal agencies and federally funded hospitals and clinics and mandatory rebates on retail pharmacy prescriptions covered by such programs. By example, payment or reimbursement of prescription therapeutics by Medicaid or Medicare requires sponsors to submit certified pricing information to CMS. The Medicaid Drug Rebate statute and state statutes require sponsors to calculate and report price points, which are used to determine mandatory rebate payments or negotiate supplemental rebate payments on both the state and federal level and Medicaid payment rates for certain therapeutics. For therapeutics paid under Medicare Part B, sponsors must also calculate and report their Average Sales Price, which is used to determine the Medicare Part B payment rate. Furthermore, as a condition of receiving Medicare Part B reimbursement for eligible drugs or biologicals, the manufacturer is required to participate in other government health care programs, including the Medicaid Drug Rebate Program and the 340B Drug Pricing Program. The Medicaid Drug Rebate Program requires biopharmaceutical manufacturers to enter into and have in effect a national rebate agreement with the Secretary of Department of Health &amp; Human Services (&#8220;DHHS&#8221;) as a condition for states to receive federal matching funds for the manufacturer&#8217;s outpatient therapeutic products furnished to Medicaid patients. Under the 340B Drug Pricing Program, the manufacturer must extend discounts to entities that participate in the program. In addition, therapeutics covered by certain government payor programs are subject to an additional inflation penalty which can substantially increase rebate payments. Certain states have also enacted laws requiring manufacturers to report certain pricing information, including drug price increases. States laws may also limit the amount that prices may be increased or require negotiation of supplemental rebates for new drugs entering the market at price points determined to be high. Refusal to negotiate supplemental rebates can negatively affect market access and provider reimbursement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Private payors often rely on the lead of the governmental payors in rendering coverage and reimbursement determinations. Therefore, achieving favorable CMS coverage and reimbursement is usually a significant gating issue for successful introduction of a new product. In addition, government programs as a condition of participation mandate fixed discounts or rebates from sponsors regardless of formulary position or utilization and may utilize mechanisms such as formulary placement to attain further price reductions, which can greatly reduce realization on the sale. Furthermore, recent U.S. federal actions include initiatives incorporating &#8220;most favored nation&#8221; (international reference pricing) concepts for certain prescription drugs, as well as agency testing of new payment models that could tie Medicare reimbursement or manufacturer rebates to prices in specified reference countries.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Further, the increased emphasis on managed health care in the United States and on country and regional pricing and reimbursement controls in the European Union will put additional pressure on product pricing, reimbursement, and utilization, which may adversely affect our future product sales and results of operations. These pressures can arise from rules and practices of managed care groups, competition within therapeutic classes, laws, regulations and judicial decisions related to governmental health benefit programs, health care reform, biopharmaceutical coverage and reimbursement policies, and pricing in general. Patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated health care costs. Sales of our product candidates will therefore depend substantially, both domestically and abroad, on the extent to which the costs of our products will be paid by health maintenance, managed care, pharmacy benefit and similar health care management organizations, or reimbursed by government health administration authorities, private health insurers, and other third-party payors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, in some foreign countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. Some countries provide that drug products may be marketed only after a reimbursement price has been agreed upon. Some countries may require the completion of additional studies that compare the cost-effectiveness of our product candidate to currently available therapies (so called health technology assessment (&#8220;HTA&#8221;)) in order to obtain reimbursement or pricing approval. For example, the European </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Union provides options for its member states to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. A member state may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. Other member states allow companies to fix their own prices for drug products but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our products that may be approved for commercialization in such countries. Historically, products launched in the European Union do not follow price structures of the United States, and prices generally tend to be significantly lower in the European Union.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As a result of the above, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain marketing approvals in the United States and in other jurisdictions. Our product candidates may not be considered medically necessary or cost-effective, or the rebate percentages required to secure coverage may not yield an adequate margin over cost. Additionally, companies are increasingly finding it necessary to establish bridge programs to assist patient access to new therapies during protracted initial coverage determination periods.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, a payor&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved or that significant price concessions will not be required to avoid restrictive conditions. High health plan co-payment requirements may result in patients refusing prescriptions or seeking alternative therapies. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in therapeutic development. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. Legislative proposals to reform health care or reduce costs under government insurance programs may result in lower reimbursement for our products and product candidates or exclusion of our products and product candidates from coverage. The cost containment measures that health care payors and providers are instituting and any health care reform could significantly reduce our revenues from the sale of any products for which we may obtain approval. We cannot provide any assurances that we will be able to obtain and maintain third-party coverage or adequate reimbursement for our product candidates in whole or in part.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Health Care Reform Measures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the United States and some foreign jurisdictions, there have been, and continue to be, legislative and regulatory changes and proposed changes regarding the health care system that could prevent or delay marketing approval of product and therapeutic candidates, restrict or regulate post-approval activities, and affect the ability to profitably sell therapeutic products that obtain marketing approval. The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product and therapeutic candidates. In addition, future legislative and regulatory proposals may materially impact the ability of the FDA and other regulatory agencies to operate as they have historically operated. We cannot be sure whether additional legislative changes will be enacted, or whether any of the FDA&#8217;s regulations, guidances or interpretations will be changed, or what the impact of such changes on the FDA and its scientific review staff, if any, may be. For example, negotiations on the next FDA user fee reauthorization package began in mid-2025, and the resulting agreement is expected to be sent to Congress in early 2027 for purposes of initiating the legislative process. Reauthorization of the prescription drug user fee program must be finalized by Congress by the end of September 2027 in order to avoid a disruption in FDA&#8217;s review goals for BLAs and other activities supported by user fees assessed against industry. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we otherwise may have obtained and we may not achieve or sustain profitability, which would adversely affect our business, prospects, financial condition and results of operations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in health care systems with the stated goals of containing health care costs, improving quality and/or expanding access. For example, the ACA has had a significant impact on the health care industry in the United States. The ACA expanded coverage for the uninsured while at the same time containing overall health care costs. With regard to biopharmaceutical products, the ACA, among other things, addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increased the minimum Medicaid rebates owed by such manufacturers under the rebate program and extended the program to individuals enrolled in Medicaid managed care organizations; established annual fees on manufacturers of certain branded prescription drugs; and created a new Medicare Part D coverage gap discount program. Additionally, the CREATES Act, which became law on December 20, 2019, was enacted to address the concern articulated by both the FDA and industry stakeholders that some brand manufacturers had improperly restricted the distribution of their products, including by invoking the existence of a REMS for certain products, to deny generic product developers access to samples of the brand products. Because generic product developers need such samples to conduct certain comparative testing required by the FDA, some attributed the inability to timely obtain samples as a cause of delay in the entry of generic products. To remedy this concern, the CREATES Act establishes a private cause of action that permits a generic product developer to sue the brand manufacturer to compel it to furnish the necessary samples on &#8220;commercially reasonable, market-based terms.&#8221; Although lawsuits have been filed under the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">CREATES Act since its enactment, those lawsuits have settled privately; therefore, to date no federal court has reviewed or opined on the statutory language and there continues to be uncertainty regarding the scope and application of the law.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Legislative and regulatory changes under the ACA are possible, but it is unknown what form any such changes or any law would take and how or whether it may affect the biopharmaceutical industry as a whole or our business in the future. We expect that changes or additions to the ACA, the Medicare and Medicaid programs, and changes stemming from other health care reform measures, especially with regard to health care access, financing or other legislation in individual states, could have a material adverse effect on the health care industry in the United States. Moreover, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2022, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) was signed into law. Among other things, the IRA has multiple provisions that may impact the prices of drug products that are both sold into the Medicare program and throughout the United States. For example, a manufacturer of a drug or biological product covered by Medicare Parts B or D must pay a rebate to the federal government if the drug product&#8217;s price increases faster than the rate of inflation. This calculation is made on a product-by-product basis and the amount of the rebate owed to the federal government is directly dependent on the volume of a drug or biological product that is paid for by Medicare Parts B or D. Additionally, CMS will negotiate drug prices annually for a select number of single-source Part D drugs without generic or biosimilar competition. CMS will also negotiate drug prices for a select number of Part B drugs starting for payment year 2028. If a drug product is selected by CMS for negotiation, it is expected that the revenue generated from such drug will decrease. CMS has begun to implement these new authorities, announcing the first round of negotiated &#8220;maximum fair&#8221; prices for the first 10 drug products in August 2024, which will become applicable for payment year 2026. The second round of negotiated prices for 15 drug products was announced in November 2025. However, the IRA&#8217;s impact on the pharmaceutical industry in the United States remains uncertain, in part because multiple large pharmaceutical companies and other stakeholders (e.g., the U.S. Chamber of Commerce) have initiated federal lawsuits against CMS arguing the program is unconstitutional for a variety of reasons, among other complaints. Those lawsuits are currently ongoing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Separately, the Trump Administration announced the creation of a government website called TrumpRx, which will allow consumers to purchase certain drugs at reduced prices as negotiated between the drug manufacturers and the administration. As of December 2025, the Trump Administration secured deals with five major drug manufacturers to offer certain drugs at most-favored-nation prices.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Individual states in the United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. For example, in recent years, several states have formed prescription drug affordability boards (&#8220;PDABs&#8221;). Much like the IRA&#8217;s drug price negotiation program, these PDABs have attempted to implement upper payment limits (&#8220;UPLs&#8221;) on drugs sold in their respective states in both public and commercial health plans. For example, in August 2023, Colorado&#8217;s PDAB announced a list of five prescription drugs that would undergo an affordability review. The effects of these efforts remain uncertain pending the outcomes of several federal lawsuits challenging state authority to regulate prescription drug payment limits. Furthermore, in December 2020, the U.S. Supreme Court held unanimously that federal law does not preempt the states&#8217; ability to regulate pharmaceutical benefit managers (&#8220;PBMs&#8221;) and other members of the health care and pharmaceutical supply chain, an important decision that may lead to further and more aggressive efforts by states in this area. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In mid-2022, the Federal Trade Commission launched sweeping investigations into the practices of the PBM industry, and published interim reports with its findings in mid-2024 and January 2025, that appear to be contributing to additional federal and state legislative and regulatory proposals, as well as enforcement action and private litigation, targeting PBM operations, pharmacy networks, and financial arrangements. In February 2026, President Trump signed into law several PBM regulatory reforms as part of a federal budget package, including but not limited to requirements for PBMs to pass back 100% of rebates and fees to commercial health plan sponsors; to provide extensive informational disclosures related to patients&#8217; coverage and benefits; and to accept only bona fide service fees from drug companies when providing services under Medicare Part D. The Department of Labor (&#8220;DOL&#8221;) also issued a proposed rule in January 2026 that would mandate specific PBM fee disclosures to self-insured plan fiduciaries under the Employment Retirement Income Security Act (&#8220;ERISA&#8221;). If finalized as proposed, the DOL rule would also allow plan fiduciaries to audit those PBM disclosures to confirm accuracy. Additional proposals and legislative changes aimed at PBMs and their business practices are likely to continue to be introduced and considered in Congress and by executive agencies. Significant efforts to change the PBM industry as it currently exists in the United States may affect the entire pharmaceutical supply chain and the business of other stakeholders, including biopharmaceutical developers like us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad. We expect that additional state and federal health care </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for health care products and services, including any future drug products for which we secure marketing approval.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The Foreign Corrupt Practices Act</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) prohibits any U.S. individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party, or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. Activities that violate the FCPA, even if they occur wholly outside the United States, can result in criminal and civil fines, imprisonment, disgorgement, oversight, and suspension and debarment from government contracts, and refusal of orders under existing government contracts. However, in February 2025, President Trump issued an executive order directing the DOJ to pause enforcement of the FCPA and to issue new enforcement guidelines that take into consideration U.S. national security and the competitiveness of U.S. companies abroad. It is unclear how this presidential directive may affect the biopharmaceutical industry as a whole or our business in particular.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">European Union Drug Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the European Union (&#8220;European Union&#8221; or the &#8220;EU&#8221;), our product candidates and products, should they receive marketing authorization in the EU, will be subject to extensive regulatory requirements. As in the United States, medicinal products can be marketed only if a marketing authorization from the competent regulatory agencies has been obtained. Similar to the United States, the various phases of preclinical and clinical research in the European Union are subject to significant regulatory controls. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In April 2014, the Clinical Trials Regulation, (EU) No 536/2014, was adopted and it became effective on January 31, 2022. The Clinical Trials Regulation will be directly applicable in all of the European Union Member States (&#8220;EU Member States&#8221;), repealing the current Clinical Trials Directive 2001/20/EC. The extent to which ongoing clinical trials will be governed by the Clinical Trials Regulation will depend on when the clinical trial is initiated or on the duration of an ongoing trial. As of January 2023, all new clinical trials must comply with the Clinical Trials Regulation. In addition, any clinical trial that was already under way as of January 1, 2023 and continues for more than three years from the day on which the Clinical Trials Regulation becomes applicable (i.e., January 31, 2025), the Clinical Trials Regulation will at that time begin to apply to the clinical trial.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Clinical Trials Regulation aims to simplify and streamline the approval of clinical trials in the European Union. The main characteristics of the regulation include: a streamlined application procedure via a single entry point, the &#8220;EU portal&#8221; or Clinical Trial Information System (&#8220;CTIS&#8221;); a single set of documents to be prepared and submitted for the application as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure for the assessment of applications for clinical trials, which is divided in two parts. Part I is assessed by the competent authorities of all EU Member States in which an application for authorization of a clinical trial has been submitted (Member States concerned). Part II is assessed separately by each EU Member State concerned. Strict deadlines have been established for the assessment of clinical trial applications. The role of the relevant ethics committees in the assessment procedure will continue to be governed by the national law of the concerned EU Member State.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To obtain a marketing authorization of a medicinal product in the European Union, we may submit marketing authorization applications (&#8220;MAA&#8221;) either under the so-called centralized or national authorization procedures. Before granting the marketing authorization under any such procedures, described below, the European Medicines Agency (&#8220;EMA&#8221;) or the competent authorities of the individual member states assess the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Centralized procedure</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The centralized procedure provides for the grant of a single marketing authorization following a favorable opinion by the EMA that is valid in all EU Member States, as well as Iceland, Liechtenstein and Norway. The centralized procedure is compulsory for medicines produced by specified biotechnological processes, products designated as orphan medicinal products, advanced-therapy medicines (such as gene-therapy, somatic cell-therapy or tissue-engineered medicines) and products with a new active substance indicated for the treatment of specified diseases, such as HIV/AIDS, cancer, diabetes, neurodegenerative disorders or autoimmune diseases and other immune dysfunctions and viral diseases. The centralized procedure is optional for products that represent a significant therapeutic, scientific or technical innovation, or whose authorization would be in the interest of public health. Under the centralized procedure the maximum timeframe for the evaluation of an MAA by the EMA is 210 days, excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;). Accelerated assessment might be granted by the CHMP in exceptional cases, when a medicinal product is expected to be of a major public health interest, particularly from the point of view of therapeutic innovation. The timeframe for the evaluation of an MAA under the accelerated assessment procedure is 150 days, excluding stop-clocks.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">National authorization procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There are also two other possible routes to authorize medicinal products in several EU countries, which are available for investigational medicinal products that fall outside the scope of the centralized procedure:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Decentralized procedure. Using the decentralized procedure, an applicant may apply for simultaneous authorization in more than one EU Member State of medicinal products that have not yet been authorized in any EU Member State and that do not fall within the mandatory scope of the centralized procedure.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Mutual recognition procedure. In the mutual recognition procedure, a medicine is first authorized in one EU Member State, in accordance with the national procedures of that country. Following this, further marketing authorizations may be sought from other EU Member States in a procedure whereby the countries concerned agree to recognize the validity of the original, national marketing authorization</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Only products for which marketing authorizations have been granted may be promoted in the European Union. A marketing authorization is valid for five years in principle and the marketing authorization may be renewed after the initial five-year period on the basis of a re-evaluation of the risk-benefit balance by the EMA or by the competent authority of the authorizing member state. To this end, the marketing authorization holder must provide the EMA, or the applicable competent authority, with a consolidated version of the file in respect of quality, safety and efficacy, including all variations introduced since the marketing authorization was granted, at least six months before the marketing authorization ceases to be valid. Once renewed, the marketing authorization is valid for an unlimited period, unless the European Commission, or the applicable competent authority, decides, on justified grounds relating to pharmacovigilance, to proceed with one additional five-year renewal. Any marketing authorization which is not followed by the actual placing of the drug on the market in the European Union (in case of centralized procedure) or on the market in the authorizing member state within three years after authorization ceases to be valid (the so-called sunset clause).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In April 2023, the European Commission issued a proposal to revise and replace the existing general pharmaceutical legislation, which was subsequently finalized and adopted in December 2025. The revisions will significantly change several aspects of drug development and approval in the EU.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">European Data Collection</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The collection, use, disclosure, transfer or other processing of personal data, including personal health data, in the EU is governed by the General Data Protection Regulation (&#8220;GDPR&#8221;). The GDPR applies to any company established in the European Economic Area (&#8220;EEA&#8221;) and to companies established outside the EEA that process personal data in connection with the offering of goods or services to data subjects in the EEA or the monitoring of the behavior of data subjects in the EEA. The GDPR establishes stringent requirements applicable to the processing of personal data, including strict requirements relating to the validity of consent of data subjects, expanded disclosures about how personal data is used, requirements to conduct data protection impact assessments for &#8220;high risk&#8221; processing, limitations on retention of personal data, special provisions affording greater protection to and requiring additional compliance measures for &#8220;special categories of personal data&#8221; including health and genetic information of data subjects, mandatory data breach notification (in certain circumstances), &#8220;privacy by design&#8221; requirements, and direct obligations on service providers acting as processors. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The GDPR also prohibits the international transfer of personal data from the EEA to &#8220;non-adequate&#8221; countries outside of the EEA unless a valid data transfer mechanism has been put in place to safeguard the personal data, such as the Standard Contractual Clauses or certification under the newly-adopted Data Privacy Framework. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The GDPR also enhances enforcement authority and imposes large penalties for non-compliance, including the potential for fines of up to &#8364;20 million or 4% of annual global turnover</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">of the infringer, whichever is greater.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, the GDPR confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">United Kingdom Regulation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of January 1, 2021, EU law no longer directly applies in the United Kingdom (&#8220;United Kingdom&#8221; or the &#8220;UK&#8221;). The United Kingdom has adopted existing EU medicines regulation as standalone UK legislation with some amendments to reflect procedural and other requirements with respect to marketing authorizations and other regulatory provisions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In order to market medicines in the United Kingdom, manufacturers must hold a UK authorization. On January 1, 2021, all EU marketing authorizations were converted to UK marketing authorizations subject to a manufacturer opt-out. UK medicines legislation is subject to future regulatory change under the Medicines and Medical Devices Act 2021, which sets out a framework for the adoption of medicines regulation. Guidance issued by the Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;) states that the United Kingdom will have the power to take into account marketing authorizations made under the EU decentralized and mutual recognition procedures. In addition, the MHRA&#8217;s guidance has been updated to refer to UK-specific licensing procedures including routes of evaluation for novel and biotechnological products. In some cases, medicinal products may be eligible for submission through the International Recognition Procedure, which was launched by </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">MHRA in January 2024 to provide an expedited authorization pathway for products that have received positive marketing authorization decisions from trusted partner agencies, such as the EMA or the FDA. In Northern Ireland, however, marketing applications granted by the European Commission continue to apply.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Different rules apply in Northern Ireland following implementation of the Northern Ireland Protocol, under which European Union central marketing applications continue to apply there. However, in March 2023, the United Kingdom government and the European Commission reached agreement on a regulatory framework to replace the Northern Ireland Protocol, referred to as the Windsor Framework. The Windsor Framework became effective as of January 1, 2025 and requires changes to the system that was previously in effect under the Northern Ireland Protocol, including the regulation of pharmaceutical products in the United Kingdom. Specifically, the MHRA will be responsible for approving all medicines intended to be marketed in the United Kingdom (including Northern Ireland), while the EMA will no longer be involved in approving medicines intended for sale in Northern Ireland.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Trade and Cooperation Agreement between the EU and the United Kingdom contains an Annex in relation to medicinal products with the objective of facilitating availability of medicines, promotion of public health and consumer protection in respect of medicinal products. The Annex provides for mutual recognition of cGMP inspections and certificates, meaning that manufacturing facilities do not need to undergo duplicate inspections for the two markets. The Annex establishes a Working Group on Medicinal Products to deal with matters under the Trade and Cooperation Agreement, facilitate co-operation and for the carrying out of technical discussions. It is expected that further bilateral discussions will continue with respect to regulatory areas not the subject of the Trade and Cooperation Agreement, including pharmacovigilance. The Trade and Cooperation Agreement also does not include reciprocal arrangements for the recognition of batch testing certification. However, the United Kingdom has listed approved countries, including the EEA which will enable UK importers and wholesales to recognize certain certification and regulatory standards. The European Commission has not adopted such recognition procedures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Relatedly, following the United Kingdom&#8217;s withdrawal from the EU, the GDPR&#8217;s requirements have been implemented in the United Kingdom (referred to as the &#8220;UK GDPR&#8221;). The UK GDPR sits alongside the amended UK Data Protection Act 2018 which implements certain derogations in the EU GDPR into United Kingdom law. Under the UK GDPR, companies not established in the United Kingdom but who process personal data in relation to the offering of goods or services to individuals in the United Kingdom, or to monitor their behavior will be subject to the UK GDPR &#8211; the requirements of which are (at this time) largely aligned with those under the EU GDPR and as such, may lead to similar compliance and operational costs with potential fines of up to &#163;17.5 million or 4% of global turnover. In June</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2021, the European Commission issued a decision, valid for four years from its entry into force, that the United Kingdom ensures an adequate level of protection for personal data transferred under the EU GDPR from the EU to the United Kingdom. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Rest of the World Regulation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For other countries outside of the EU and the United States, such as countries in Eastern Europe, Latin America, Asia, as well as Australia, the requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement, and data privacy vary from country to country. Additionally, clinical trials to support applications for marketing authorization in such jurisdictions must be conducted in accordance with GCP requirements and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Human Capital</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, we had 33 employees, all of whom were full-time, 9 of whom have Ph.D. or M.D. degrees, and 25 of whom are engaged in research and development and manufacturing activities. We do not have any employees represented by a labor union or covered under a collective bargaining agreement. We consider our relationship with our employees to be good.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Talent Acquisition and Retention</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are committed to advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic, colorectal cancer, lung cancer and other mKRAS positive cancers. To that end, we recognize that our industry is specialized and dynamic, and a significant aspect of our success is our continued ability to execute our human capital strategy of attracting, engaging, developing, motivating and retaining highly skilled talent. We offer competitive compensation packages including base salary, annual incentive bonuses, and long-term equity incentive awards. We also are committed to our employees&#8217; health, safety, and wellness and offer comprehensive and robust employee benefits, such as life, disability, and health insurance, health savings accounts, paid time off, and a 401(k) plan. We also provide flexible work arrangements consisting of remote, hybrid, and onsite work. We believe that our non-lab-based employees can be highly productive working remotely and we are building a culture that closely connects all employees, regardless of location, based on open and frequent communication, transparency, and employing people with a desire to participate in company events, frequent video face-to-face discussions, and other activities designed to eliminate &#8220;remoteness&#8221; from working remotely. We pride ourselves on our strong </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">company culture and initiatives aligned with our mission, vision, and values. We also support our local community in their efforts to bridge the opportunity gap for underserved communities. In addition, we strive to provide a collegial atmosphere where teamwork and collaboration are emphasized and valued. We use internal and external resources to recruit highly-skilled candidates for open positions. It is our express intent to be an employer of choice in our industry by providing market-competitive compensation and benefits packages, which we believe allows us to attract and retain superior talent. We are an equal opportunity employer and cultivate a highly collaborative and entrepreneurial culture. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Training and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe in encouraging employees to become lifelong learners by providing ongoing learning and leadership training opportunities. We strive to provide real-time recognition of employee performance. In addition, we have formal mid-year and annual review processes to determine individual contributions that may lead to pay and equity adjustments and promotions. The mid-year and annual review processes also help us identify areas where training and development may be needed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Corporate Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) was incorporated in Delaware as Vedantra Pharmaceuticals Inc. in August 2011. In 2023, the Company completed a reverse merger transaction with Angion Biomedica Corp. (&#8220;Angion&#8221;), a clinical-stage biotechnology company, Arkham Merger Sub, Inc., a wholly owned subsidiary of Angion (&#8220;Merger Sub&#8221;), and Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;), pursuant to which Merger Sub merged with and into Former Elicio, with Former Elicio surviving the merger as a wholly owned subsidiary of Angion (the &#8220;Merger&#8221;). On June 1, 2023, the Company completed the Merger in accordance with the terms and conditions of the Merger Agreement and Angion changed its name from &#8220;Angion Biomedica Corp.&#8221; to &#8220;Elicio Therapeutics, Inc.&#8221; </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our principal executive office is located at 451 D Street, Suite 501, Boston, MA 02210.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Available Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We file electronically with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The SEC maintains an Internet site that contains reports, proxy information and information statements, and other information regarding issuers that file electronically with the SEC. The address of that website is http://www.sec.gov.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We maintain a public website at https://www.elicio.com and use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Our website includes an Investors section through which we make available, free of charge, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, Proxy Statements and Forms 3, 4 and 5 filed on behalf of directors and executive officers, as well as any amendments to those reports filed or furnished pursuant to the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The members of our board of directors are reflected on the signature page of this Annual Report on Form 10-K. We also make available on our website the charters for our board of directors&#8217; Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, as well as our Code of Business Conduct and Ethics, and other related materials. The information on our website is not part of this Annual Report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Investing in our securities involves a high degree of risk. You should carefully consider the risk factors set forth below as updated by our subsequent filings under the Exchange Act, before deciding whether to purchase our securities. The risks and uncertainties we describe below are not the only ones we face. Additional risks and uncertainties not presently known to us could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment in our securities, and the occurrence of any of these risks might cause you to lose all or part of your investment.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Summary Risk Factors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to a number of risks that if realized could affect our business, financial condition, results of operations and cash flows. As a clinical stage biopharmaceutical company, certain elements of risk are inherent to our business. Accordingly, we encounter risks as part of the normal course of our business. Some of the more significant challenges and risks include the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We will require substantial additional capital to finance our operations, and a failure to obtain this necessary capital when needed, on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our research and development programs, commercialization efforts or cease operations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our recurring losses from operations have raised substantial doubt regarding our ability to continue as a going concern.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We may be unsuccessful in raising the capital necessary to address our going concern issues, or if we are successful, it may be on terms that are highly dilutive to existing stockholders.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We have a history of operating losses that are expected to continue for the foreseeable future, and we are unable to predict the extent of future losses, or whether we will generate significant revenues or achieve or sustain profitability.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We have never generated revenue from product sales and may never become profitable.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We have a limited operating history and we expect a number of factors to cause our operating results to fluctuate on a quarterly and annual basis, which may make it difficult to predict our future performance.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We are obligated to develop and maintain proper and effective internal control over financial reporting. In the future, we may not complete our execution of our internal control over financial reporting in a timely manner, or these internal controls may not be determined to be effective, which may result in material misstatements in our consolidated financial statements and may adversely affect investor confidence in our company and, as a result, the value of our common stock.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our product candidates are at an early stage of development and may not be successfully developed or commercialized.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The FDA or comparable foreign regulatory authorities may disagree with our regulatory plans and we may fail to obtain regulatory approval of our product candidates.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We may not be successful in our efforts to use and expand our discovery engine to build a pipeline of product candidates.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Relative to companies that are more established than we are or that have a larger footprint than we do, we have relatively limited experience as a company in completing preclinical studies to enable the filing of INDs, submitting INDs or commencing, enrolling and conducting clinical trials.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our ELI-002 clinical trials are designed to require, as part of screening to determine whether patients meet inclusion criteria, the use of an investigational in vitro diagnostic device. If we are not able to successfully collaborate or partner with a third-party company for the development and authorization of such a device, we may not be able to receive marketing authorization for ELI-002.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">If we </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">encounter</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Any product candidate we advance into clinical trials may cause unacceptable adverse events or have other properties that may delay or prevent our regulatory approval or commercialization or limit our commercial potential.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We may form or seek strategic partnerships or enter into additional licensing arrangements in the future, and we may not realize the benefits of such alliances or licensing arrangements. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We rely on contract manufacturing organizations (&#8220;CMOs&#8221;) to manufacture our nonclinical and clinical pharmaceutical supplies and expect to continue to rely on CMOs to produce commercial supplies of any approved product candidate, and our dependence on CMOs could adversely impact our business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We rely on third parties to conduct some of our nonclinical studies and all of our clinical trials. If these third parties do not meet our deadlines or otherwise conduct the trials as required, our development programs could be delayed or unsuccessful and we may not be able to obtain regulatory approval for or commercialize our product candidates when expected or at all. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We face significant competition in an environment of rapid technological change, and there is a possibility that our competitors may achieve regulatory approval before us or develop therapies that are safer or more advanced or effective than ours, which may harm our financial condition and our ability to successfully market or commercialize any product candidates we may develop.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our technologies are novel, and any product candidates we develop may be complex and difficult to manufacture on a clinical or commercial scale. We could experience delays in satisfying regulatory authorities or we could experience production problems that result in delays in our development or commercialization programs, limit the supply of our product candidates we may develop, or otherwise harm our business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our success will depend upon intellectual property and proprietary technologies, and we may be unable to protect our intellectual property. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We are substantially dependent on patents and patent applications under which we license rights from MIT, and if such licensed patent rights lack legal effect or if a dispute arises under such license agreement and our licensed rights are narrowed or this license is terminated, that could cause significant impairment to our ability to develop and commercialize certain of our product candidates.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Even if we receive regulatory approval of our product candidates, we will remain subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Health care and other reform legislation may increase the difficulty and cost for us and any collaborators we may have to obtain marketing approval of and commercialize our product candidates and affect the prices we, or they, may obtain.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our internal information technology systems, or those of our vendors, collaborators or other contractors or consultants, may fail or suffer cybersecurity incidents, loss of data, and other disruptions, which could result in a material disruption of our product development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Unstable market and economic conditions may have serious adverse consequences on our business, financial condition and stock price.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We will continue to incur costs and demands upon management as a result of complying with the laws, rules and regulations affecting public companies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The above list is not exhaustive, and we face additional challenges and risks. Please carefully consider all of the information in this Annual Report on Form 10-K including matters set forth in this &#8220;Risk Factors&#8221; section.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Operating History, Financial Position and Capital Requirements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We will require substantial additional capital to finance our operations, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our research and development programs, commercialization efforts or cease operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our operations have consumed substantial amounts of cash. During the years ended December&#160;31, 2025 and 2024, we incurred research and development expenses of $24.9&#160;million and $33.7&#160;million, respectively, and net losses of $39.6&#160;million and $51.9&#160;million, respectively. We will require substantial additional funds to support our continued research and development activities, including the anticipated costs of nonclinical studies and clinical trials, regulatory approvals and potential commercialization. Additionally, our estimates on future financial needs may be based on assumptions that prove to be wrong, and we may spend our available financial resources much faster than we expect.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Until such time, if ever, that we can generate sufficient product revenue and achieve profitability, we expect to seek to finance future cash needs through the sale of common stock in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. We currently have no other commitments or agreements relating to any of these </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">types of transactions, other than the Note Purchase Agreement, dated June 3, 2025, between us and GKCC, LLC (&#8220;GKCC&#8221;) and the related Senior Secured Promissory Note due June 3, 2028 held by GKCC, our Capital on Demand</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Sales Agreement with JonesTrading Institutional Services LLC and obligations related to the exercise of previously issued warrants, and cannot be certain that additional funding will be available to us on acceptable terms, or at all. To the extent that we raise additional capital through the sale of equity, convertible debt or other securities convertible into equity, the ownership interest of our stockholders will be diluted, and the terms of these new securities may include liquidation or other preferences that adversely affect rights of our stockholders. Additional debt financing, if available at all, would likely involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, completing acquisitions or declaring or paying dividends.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Furthermore, the impact of macroeconomic factors, including fluctuating inflation, the potential imposition of new tariffs or increases in existing tariffs and geopolitical instability and tensions, could make the terms of any available financing less attractive to us and more dilutive to our existing stockholders. If we are unable to raise additional capital, we will have to delay, curtail or eliminate one or more of our research and development programs or cease operations. In addition, securing additional financing would require a substantial amount of time and attention from our management and may divert a disproportionate amount of their attention away from day-to-day activities, which may adversely affect our management&#8217;s ability to oversee the development of our product candidates and the advancement of our AMP platform.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our recurring losses from operations have raised substantial doubt regarding our ability to continue as a going concern.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe there is substantial doubt about our ability to continue as a going concern as of the date of this Annual Report on Form 10-K. Our independent registered public accounting firm has included an explanatory paragraph relating to our ability to continue as a going concern in its report on our audited consolidated financial statements for the year ended December&#160;31, 2025 included in this Annual Report on Form 10-K. This going concern opinion could materially limit our ability to raise additional funds through the issuance of new debt or equity securities or otherwise. Future reports on our financial statements may include an explanatory paragraph with respect to our ability to continue as a going concern. We have incurred significant losses since our inception and have never been profitable, and it is possible we will never achieve profitability. We have devoted a majority of our resources to developing ELI-002, but this product candidate cannot be marketed or commercialized until regulatory approvals have been obtained. Meaningful revenues will likely not be available unless ELI-002 or any of our current or future product candidates are approved by the FDA or comparable regulatory agencies in other countries and successfully marketed, either by us or a partner, an outcome which may not occur. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe that our cash on hand will enable us to fund our operations into the third quarter of 2026 based on our current plan. This period could be shortened if there are any significant increases in planned or actual spending on development programs or more rapid progress of development programs than anticipated. There is no assurance that financing will be available when needed to allow us to continue as a going concern. If we are unable to obtain additional capital and continue as a going concern, we might have to further scale back our operations or liquidate our assets and cease operations entirely, and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial statements. Our lack of capital resources and our conclusion that we may be unable to continue as a going concern may materially adversely affect our share price and our ability to raise new capital or to enter into critical contractual relations with third parties.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may be unsuccessful in raising the capital necessary to address our going concern issues, or if we are successful, it may be on terms that are highly dilutive to existing stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Historically, we have funded our operations by raising capital from external sources and from the Merger (as defined below). However, we are currently facing significant challenges to our ability to raise capital through the sale of common stock, including the following factors:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">in general, it is difficult for development stage companies to raise capital under current market conditions, especially those with early-stage programs like ours;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the perception that we may be unable to continue as a going concern may impede our ability to attract further equity investment; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our common stock has limited trading volume, which limits the demand for our common stock.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Given these factors, there can be no assurances we will be successful at raising sufficient capital to address our going concern issues. Even if we are successful in raising capital, it may be on terms that are very highly dilutive to existing stockholders. In addition, if we are unable to raise additional capital, we may have to delay, curtail or eliminate one or more of our research and development programs or cease operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We have a history of operating losses that are expected to continue for the foreseeable future, and we are unable to predict the extent of future losses, or whether we will generate significant revenues or achieve or sustain profitability.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are focused on product development and we have not generated any revenues to date. Additionally, we expect to continue to incur operating losses for the foreseeable future. These operating losses have adversely affected and are likely to continue to adversely affect our working capital, total assets and stockholders&#8217; deficit.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Since we are a clinical-stage biotechnology company, our prospects must be considered in light of the uncertainties, risks, expenses, and difficulties frequently encountered by companies in their early stages of operations. Specifically, we have generated net losses each year since our inception, including $39.6&#160;million and $51.9&#160;million for the years ended December&#160;31, 2025 and 2024, respectively. We expect to make substantial expenditures and incur increasing operating costs in the future and our accumulated deficit is expected to increase significantly as we expand development and clinical trial activities for our product candidates and expand the capabilities of our AMP platform. Because of the risks and uncertainties associated with product development, we are unable to predict the extent of any future losses, whether we will ever generate significant revenues or if we will ever achieve or sustain profitability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe that our cash on hand will enable us to fund our operations through the into the third quarter of 2026 based on our current plan. We are dependent on obtaining, and are continuing to pursue, necessary funding from outside sources, including obtaining additional funding from the issuance of securities in order to continue our operations. Without adequate funding, we may not be able to meet our financial obligations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have not demonstrated an ability to perform the functions necessary for the successful commercialization of any products. The successful commercialization of any of our products will require us to perform a variety of functions, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">continuing to undertake preclinical and clinical development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">engaging in the development of product candidate formulations and manufacturing processes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">interacting with the applicable regulatory authorities and pursuing other required steps for regulatory approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">engaging with payors and other pricing and reimbursement authorities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">submitting marketing applications to and receiving approval from the applicable regulatory authorities; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">manufacturing the applicable products and product candidates in accordance with regulatory requirements and, if ultimately approved, conducting sales and marketing activities in accordance with health care, FDA and similar foreign regulatory authority laws and regulations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We have never generated revenue from product sales and may never become profitable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have no products approved for commercialization and have never generated any product revenue. Our ability to generate product sales and achieve profitability depends on our ability, alone or with collaborative partners, to successfully complete the development of, and obtain the regulatory approvals necessary to commercialize our current and future product candidates. We do not anticipate generating product sales for the next several years, if ever.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our product candidates will require additional clinical, manufacturing, and nonclinical development, regulatory approval, commercial manufacturing arrangements, establishment of a commercial organization, significant marketing efforts, and further investment before they generate any product sales. We cannot guarantee that we will meet our timelines for our development programs, which may be delayed or may not be completed for a number of reasons. Our ability to generate future revenues from product sales depends heavily on our, or our collaborators&#8217;, ability to successfully:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">complete research and obtain favorable results from nonclinical and clinical development of our current and future product candidates, including addressing any clinical holds that may be placed on our development activities in the future by regulatory authorities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">seek and obtain regulatory and marketing approvals for any of our product candidates for which we complete clinical trials, as well as their manufacturing facilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">seek and maintain grants that may be necessary for continuing operations; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">launch and commercialize any of our product candidates for which we obtain regulatory and marketing approval by establishing a sales force, marketing, and distribution infrastructure or, alternatively, collaborating with a commercialization partner;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">qualify for coverage and establish adequate reimbursement by government and third-party payors for any of our product candidates for which we obtain regulatory and marketing approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">develop, maintain, and enhance a sustainable, scalable, reproducible, and transferable manufacturing process for the product candidates we may develop;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">establish and maintain supply and manufacturing capabilities or capacities internally or with third parties that can provide adequate, in both amount and quality, products, and services to support clinical development and the market demand for any of our product candidates for which we obtain regulatory and marketing approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">obtain market acceptance of current or any future product candidates as viable treatment options and effectively compete with other therapies to establish market share;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">maintain a continued acceptable safety and efficacy profile of our product candidates following launch;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">address competing technological and market developments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">implement internal systems and infrastructure, as needed;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">negotiate favorable terms in any collaboration, licensing, or other arrangements into which we may enter and perform our obligations in such collaborations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">maintain, protect, enforce, defend, and expand our portfolio of intellectual property rights, including patents, trade secrets, and know-how;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">avoid and defend against third-party interference, infringement, and other intellectual property claims; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">attract, hire, and retain qualified personnel.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if one or more of our current and future product candidates are approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate. Our expenses could increase beyond our expectations if we are required by the FDA or other regulatory authorities to perform clinical and other studies in addition to those that we currently anticipate. If we are required to conduct additional clinical trials or other testing of our product candidates that we develop beyond those that we currently expect, if we are unable to successfully complete clinical trials of our product candidates or other testing, if the results of these trials or tests are not positive or are only modestly positive, or if there are safety concerns, we may be delayed in obtaining marketing approval for our product candidates, not obtain marketing approval at all, or obtain more limited approvals. Even if we are able to generate revenues from the sale of any approved product candidates, we may not become profitable and may need to obtain additional funding to continue operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease our value and could impair our ability to raise capital, maintain our research and development efforts, expand our AMP platform and our business or continue our operations. A decline in our value also could cause our stockholders to lose all or part of their investment.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We have a limited operating history and we expect a number of factors to cause our operating results to fluctuate on a quarterly and annual basis, which may make it difficult to predict our future performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are a clinical stage biopharmaceutical company with a limited operating history. Our operations to date have been primarily limited to organizing and staffing our company, acquiring, developing and securing our proprietary technology, and preclinical and clinical development of our product candidates. While we completed our Phase 1 trial of ELI-002 and shared final data in August 2025 and completed enrollment in our AMPLIFY-7P Phase 2 portion of the trial in December 2024, we have not yet successfully completed any other clinical trials for our product candidates, manufactured our product candidates at commercial scale or conducted sales and marketing activities that will be necessary to successfully commercialize our product candidates, if approved. Consequently, any predictions made about our future success or viability may not be as accurate as they could be if we had a longer operating history or commercialized products. Our financial condition has varied significantly in the past and will continue to fluctuate from quarter-to-quarter or year-to-year due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations include other factors described elsewhere herein and also include, among other things:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to obtain additional funding to develop our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to conduct and complete nonclinical studies and clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">delays in the commencement, enrollment and timing of clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the success of our nonclinical studies and clinical trials through all phases of development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">any delays in regulatory review and approval of product candidates in clinical development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to obtain and maintain regulatory approval for our product candidates in the United States and foreign jurisdictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">potential toxicity and/or side effects of our product candidates that could delay or prevent commercialization, limit the indications for any approved products, require the establishment of risk evaluation and mitigation </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">strategies (&#8220;REMS&#8221;), cause an approved drug to be taken off the market or an inability to establish efficacy needed for approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to establish or maintain partnerships, collaborations, licensing or other arrangements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">market acceptance of our product candidates, if approved;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">competition from existing products, new products or new therapeutic approaches that may emerge;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability of patients or health care providers to obtain coverage of or sufficient reimbursement for our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to leverage our proprietary AMP technology platform to discover and develop additional product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to manufacture clinical supplies of required quality to supply our clinical trials; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability and our licensors&#8217; abilities to successfully obtain, maintain, defend and enforce intellectual property rights important to our business; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">potential product liability claims.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accordingly, the results of any quarterly or annual periods should not be relied upon as indications of future operating performance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are obligated to develop and maintain proper and effective internal control over financial reporting. In the future, we may not complete our execution of our internal control over financial reporting in a timely manner, or these internal controls may not be determined to be effective, which may result in material misstatements in our consolidated financial statements and may adversely affect investor confidence in our company and, as a result, the value of our common stock.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are required, pursuant to Section 404 (&#8220;Section 404&#8221;) of the Sarbanes-Oxley Act of 2002, as amended (the &#8220;Sarbanes-Oxley Act&#8221;), to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. Complying with Section 404 requires a rigorous compliance program as well as adequate time and resources. We may not be able to complete our internal control evaluation, testing and any required remediation in a timely fashion. If we fail to maintain the adequacy of our internal control over financial reporting, as such standards are modified, supplemented or amended from time to time, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act and the related rules and regulations of the SEC. If we cannot favorably assess the effectiveness of our internal control over financial reporting, investor confidence in the reliability of our financial reports may be adversely affected, which could have a material adverse effect on our stock price.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, if we identify one or more material weaknesses in our internal control over financial reporting, we will not be able to assert that our internal controls are effective. For example, in our 2024 Form 10-K, we identified material weaknesses in our internal control over financial reporting related to our control environment. More specifically, we determined that we had not maintained adequate formal accounting policies, processes and controls related to complex transactions as a result of a lack of finance and accounting staff with the appropriate U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) technical expertise needed to identify, evaluate and account for complex and non-routine transactions. We also determined that we had insufficient financial reporting and close controls to ensure that incurred expenses were accrued at period end. Even though we remediated these material weaknesses in the year ended December 31, 2025, if other material weaknesses are identified in the future or we are not able to comply with the requirements of Section 404 in a timely manner, our reported financial results could be materially misstated, which could result in investors losing confidence in our reported financial information and may lead to a decline in the stock price. Failure to comply with Section 404 of the Sarbanes-Oxley Act could potentially subject us to sanctions or investigations by the SEC, the Financial Industry Regulatory Authority or other regulatory authorities, as well as increase the risk of liability arising from litigation based on securities laws.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We hold a portion of our cash and cash equivalents that we use to meet our working capital and operating expense needs in deposit accounts that could be adversely affected if the financial institutions holding such funds fail. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We hold a portion of our cash and cash equivalents that we use to meet our working capital and operating expense needs in deposit accounts. The balance held in these accounts may exceed the Federal Deposit Insurance Corporation standard deposit insurance limit of $250,000. If a financial institution in which we hold such funds fails or is subject to significant adverse conditions in the financial or credit markets, we could be subject to a risk of loss of all or a portion of such uninsured funds or be subject to a delay in accessing all or a portion of such uninsured funds. Any loss or lack of access to these funds could adversely impact our short-term liquidity and ability to meet our operating expense obligations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Changes in interpretation or application of U.S. GAAP may adversely affect our operating results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We prepare our consolidated financial statements to conform to U.S. GAAP. These principles are subject to interpretation by the Financial Accounting Standards Board (&#8220;FASB&#8221;), the American Institute of Certified Public Accountants, the SEC and various other regulatory and accounting bodies. A change in interpretations of, or our application of, these principles can have a significant effect on our reported results and may even affect our reporting of transactions completed before a change is announced. In addition, when we are required to adopt new accounting standards, our methods of accounting for certain items may change, which could cause our results of operations to fluctuate from period to period and make it more difficult to compare our financial results to prior periods.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Significant political, trade, regulatory developments, and other circumstances beyond our control, including as a result of recently announced tariffs, could have a material adverse effect on our financial condition or results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Changes in United States trade policy, including to existing or potential future tariffs, could have a material adverse impact on our business, financial condition, and results of operations. The imposition of new tariffs or increases in existing tariffs on goods imported from or expected to be imported from countries where we or our suppliers operate could result in higher costs for and delayed shipments of materials or components essential to our operations. For example, in April 2025, the United States imposed broad tariffs on imports from virtually all countries, with particularly high tariffs on imports from China. While the U.S. Supreme Court issued a ruling against the validity of such tariffs in February 2026, the Trump administration has announced the imposition of a new 15% baseline tariff under other legal authority, and there is ongoing uncertainty in connection with tariff policies. In response to tariffs, some countries have implemented retaliatory tariffs on U.S. goods, while others seek to negotiate agreements regarding U.S.-imposed tariffs. Historically, tariffs have led to decreased trade and political tensions and, to date, the outcome of the negotiations between the United States and the various countries is not yet clear. Political tensions as a result of trade policies could reduce trade volume, investment, technological exchange and other economic activities between major international economies, resulting in a material adverse effect on global economic conditions and the stability of global financial markets. Any changes in political, trade, regulatory, and economic conditions, including U.S. trade policies, could have a material adverse effect on our financial condition or results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to the Development of our Product Candidates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our product candidates are at an early stage of clinical development and may not be successfully developed or commercialized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In April 2023, we completed enrollment of the AMPLIFY-201 trial for ELI-002 2P targeting Kirsten rat sarcoma viral oncogene homolog (&#8220;KRAS&#8221;) gene mutations, which product candidate also includes ELI-004, our universal AMP-modified CpG adjuvant. In October 2023, we completed enrollment of the AMPLIFY-7P Phase 1 portion of the trial for ELI-002 7P and initiated enrollment of the AMPLIFY-7P Phase 2 portion of the trial in January 2024. In December 2024, we completed enrollment in our AMPLIFY-7P Phase 2 portion of the ELI-002 trial and in August 2025, we announced the positive recommendation by the IDMC to continue our AMPLIFY-7P Phase 2 study without modifications to final analysis. We also have an Expanded Access Program for our ELI-002 7P program that is ongoing. All of our other product candidates are in preclinical development and will require substantial further capital expenditures, development, testing, and regulatory approval prior to commercialization. With the limited data on ELI-002, we may not be able to effectively design and execute clinical studies that ultimately support marketing approval. In addition, we have not initiated or submitted for any marketing authorization to any health authorities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The time required to obtain approval from the FDA and comparable foreign authorities is unpredictable but typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of regulatory authorities. The outcome of studies is also inherently uncertain. Of the large number of drugs in development, only a small percentage successfully complete the regulatory approval process and are commercialized. The results of nonclinical studies, interim or top-line study results, and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. Failure can occur at any time during the clinical trial process. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy despite having progressed through nonclinical studies and initial clinical trials. Nonclinical and early clinical studies may also reveal unfavorable product candidate characteristics, including safety concerns. A number of companies have suffered significant setbacks in advanced clinical trials, notwithstanding promising results in earlier trials. In some instances, there can be significant variability in results between different clinical trials of the same product candidate due to numerous factors, including, among other things, differences in trial procedures set forth in protocols, differences in the type of the patient populations, changes in and adherence to the clinical trial protocols, the rate of dropout among clinical trial participants, and evolving standards of treatment from newly approved drugs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accordingly, even if we are able to obtain the requisite financing to fund our development programs, we cannot assure you that our product candidates will be successfully developed or commercialized. Our failure to develop, manufacture or receive regulatory approval for or successfully commercialize any of our product candidates could result in the failure of our business and a loss of all of our stockholders&#8217; investment.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our product candidates are in various stages of development and we will not be able to commercialize our product candidates if our nonclinical and clinical studies do not produce successful results and/or our clinical trials do not </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">demonstrate the safety and efficacy of our product candidates; early results and early understanding of product candidate potential may not be predictive of later success. Any product candidates currently in clinical development or that we advance into clinical development are subject to extensive regulation, which can be costly and time-consuming, and we may experience unanticipated delays or be unable to receive the required approvals to commercialize our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Product candidates are susceptible to the risks of failure inherent at any stage of product development, including the occurrence of unexpected or unacceptable adverse events or the failure to demonstrate efficacy in clinical trials. Clinical development is expensive and can take many years to complete, and its outcome is inherently uncertain. The results of nonclinical studies, preliminary clinical trial results, and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. Our product candidates may not perform as we expect, may ultimately have a different than expected impact or no impact at all, may have a different mechanism of action than we initially understand or than we expect in humans, and may not ultimately prove to be safe or effective.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The nonclinical and clinical development, manufacturing, packaging, labeling, storage, record-keeping, advertising, promotion, post-approval monitoring and reporting, import, export, marketing and distribution, among other activities, of our product candidates are subject to extensive regulation by the FDA and by comparable health authorities in foreign markets. We are not permitted to market or promote our product candidates in the United States until we receive approval from the FDA of a BLA, or in any jurisdictions outside of the United States until we receive similar authorization from analogous foreign authorities, and we may never receive such regulatory approvals for any of our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Some of our product candidates have only been tested in a nonclinical setting and while those studies have been subject to certain regulatory requirements in order to support product development and regulatory progression, as such product candidates progress they will require clinical trials (which are subject to much more extensive requirements, including GCP standards), as well as additional manufacturing development, including becoming subject to cGMP regulations as such product candidates progress from nonclinical to clinical settings, before we will be able to submit marketing applications to the applicable regulatory authorities. Even if our product candidates are approved, they may be subject to limitations on the indicated uses and populations for which they may be marketed. They may also be subject to other conditions of approval, may contain significant safety warnings, including boxed warnings, contraindications, and precautions, may not be approved with label statements necessary or desirable for successful commercialization, or may be subject to requirements for costly post-market testing and surveillance, or other requirements, including the submission of a REMS to monitor the safety or efficacy of the products. If we do not receive regulatory authority approval for, and successfully commercialize our product candidates, we will not be able to generate revenue from these product candidates in the foreseeable future, or at all. Any significant delays in obtaining approval for and commercializing our product candidates could have a material adverse impact on our business and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The process of product candidate development and obtaining marketing approval is expensive, often takes many years and can vary substantially based upon the type, complexity and novelty of the products involved and the conditions that they are intended to treat. The number and nature of nonclinical studies and clinical trials that will be required for regulatory approval also varies depending on the product candidate, the disease or condition that the product candidate is designed to address and the regulations applicable to any particular product candidate. We have not previously submitted a marketing application to the FDA, or a similar marketing application to any comparable foreign authorities, for any product candidate, and we cannot be certain that our product candidates will be successful in clinical trials or receive regulatory approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to significant clinical testing requirements, our ability to obtain marketing approval for our product candidates depends on obtaining the final results of required nonclinical testing, including characterization of the manufactured components of our product candidates and validation of our manufacturing processes. Regulatory authorities may determine that our product manufacturing processes, testing procedures or facilities are insufficient to justify approval. Approval policies or regulations, or the type and amount of data necessary to gain approval, may change and may vary among jurisdictions. Moreover, regulatory authorities have substantial discretion in the biopharmaceutical approval process, including the ability to refuse to accept an application and to delay, limit or deny approval of a product candidate for many reasons, such as a determination that our data is insufficient for approval, that additional nonclinical studies, clinical trials or other data or development work is necessary, or that our manufacturing processes, controls, or facilities are insufficient. Despite the time and expense invested in the development of product candidates, regulatory approval is never guaranteed.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our product candidates may fail at any stage of preclinical or clinical development, and may also reveal unfavorable product candidate characteristics, including safety concerns or the failure to demonstrate efficacy in initial clinical trials. Further, our product candidates may not receive regulatory approval even if they are successful in clinical trials. Although we have completed preclinical validation, including toxicology testing, for our lead product candidate ELI-002 and anticipate completing the preclinical development necessary to file additional IND applications for other product candidates in the future, we may experience numerous unforeseen events before, during, or as a result of clinical trials that could delay or prevent our ability to commence or complete development, commence or complete clinical trials, receive marketing approval or commercialize our product candidates, including:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be unable to generate sufficient nonclinical, toxicology, or other in vivo or in vitro data to support the initiation of clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulators or IRBs or Independent Ethics Committees (&#8220;IECs&#8221;) may not authorize us or our investigators to commence or continue a clinical trial, conduct a clinical trial at a prospective trial site, or amend trial protocols, or may require that we modify or amend our clinical trial protocols;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we, regulators, the IDMC, IRBs, or IECs may recommend or require the suspension or termination of clinical research for various reasons, including non-compliance with regulatory requirements or a finding that participants are being exposed to unacceptable health risks, undesirable side effects, or a failure of the product candidate to demonstrate any benefit to patients, or other unexpected characteristics (alone or in combination with other products) of the product candidate, or due to findings of undesirable effects caused by a chemically or mechanistically similar therapeutic or therapeutic candidate;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">new information may emerge regarding our product candidates or technology platform that result in continued development of some or all of our product candidates being deemed undesirable;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may have delays identifying, recruiting and training suitable clinical investigators or investigators may withdraw from our studies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may experience delays in reaching, or fail to reach, agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites or contract research organizations (&#8220;CROs&#8221;). Contractual terms can be subject to extensive negotiation, may be subject to modification from time to time and may vary significantly among different CROs and trial sites;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may have delays in adding new clinical trial sites, or we may experience a withdrawal of clinical trial sites;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">potential delays in patient enrollment for clinical trials due to public health emergencies, pandemics, natural disasters, staffing shortages, or other events, which may affect our ability to initiate, conduct ongoing clinical trials, and delay initiation of planned and future clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the number of patients required for clinical trials of our product candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate, or participants may drop out of these clinical trials or be lost to follow-up at a higher rate than we anticipate for a number of reasons, such as adverse events, lack of treatment effectiveness, fatigue with the clinical trial process or personal issues;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patients may elect to participate in alternative clinical trials sponsored by our competitors with product candidates that treat the same indications as our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patients who enroll in our studies may misrepresent their eligibility or may otherwise not comply with clinical trial protocols, resulting in the need to increase the enrollment size for those studies, or extend the duration of those studies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">there may be flaws in our study design, which may not become apparent until a study is well advanced;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our contractors may fail to comply with regulatory requirements or clinical trial protocols, or meet their contractual obligations to us in a timely manner, or at all, or we may be required to engage in additional clinical trial site monitoring;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulatory authorities or IRBs or IECs may disagree with the design, including endpoints, scope, or implementation of our clinical trials, or regulatory authorities may disagree with the study patient population, against our intended indications or our interpretation of data from nonclinical studies or clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulatory authorities may disagree with the formulation for our product candidates, or our product candidate dose or dosing schedule;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be unable to demonstrate to the satisfaction of regulatory authorities that a product candidate is safe, pure, and potent for any indication;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulatory authorities may not accept, or we or our clinical trials may not meet, the criteria required to submit clinical data from trials which are conducted outside of their jurisdictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the results of clinical trials may be negative or inconclusive, may not meet the level of statistical significance required for, or may not otherwise be sufficient to support marketing approval, and we may decide, or regulatory authorities may require us, to conduct additional clinical trials, analyses, reports, or nonclinical studies, or abandon product development programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our product candidates may have undesirable or unintended side effects, toxicities, or other properties or characteristics that preclude marketing approval or prevent or limit commercial use;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks or otherwise provide an advantage over current standard of care (&#8220;SOC&#8221;) or current or future competitive therapies in development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the SOC for the indications we are investigating may change, which changes could impact the meaningfulness of our resulting study data or require the initiation of new studies or which may necessitate changes to our ongoing or planned studies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulatory authorities may require us to amend our studies, perform additional or unanticipated clinical trials or nonclinical studies or manufacturing development work to obtain approval or initiate clinical trials, or we may decide to do so or abandon product development programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulatory authorities may find that we or our third-party manufacturers do not satisfy regulatory requirements and standards for the facilities and operations used in the manufacture of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the cost of clinical trials of our product candidates may be greater than we anticipate, or we may have insufficient funds for a clinical trial or to pay the substantial user fees required by the FDA or other regulatory authorities upon the filing of a marketing application;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be insufficient or inadequate;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may experience manufacturing failures or adverse shipping events that prevent adequate or timely supply of product candidates or other materials for our ongoing studies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulatory authorities may take longer than we anticipate to make a decision on our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be unable to demonstrate the efficacy and safety of our product candidates to the FDA or other regulatory authorities, due to inaccurate or inconsistent potency assessments, potentially resulting in regulatory delays, additional testing requirements, or even rejection of our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in regulatory guidelines of the FDA or other regulatory authorities may necessitate modifications to any future biological potency assays we may develop, requiring additional validation studies and potential delays in the development or commercialization of our product candidates; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in or the enactment of the approval policies, statutes, or regulations of the applicable regulatory authorities may significantly change in a manner rendering our nonclinical or clinical data insufficient for approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, our clinical trials, to date, have been open-label trials. Our Phase 2 study of AMPLIFY-7P is an open-label, randomized study, where both the patient and investigator know whether the patient is receiving our product candidate or is under observation, which may introduce study bias. Most typically, open-label clinical trials test only the product candidate and sometimes do so at different dose levels. Open-label clinical trials are subject to various limitations that may exaggerate any therapeutic effect as patients in open-label clinical trials are aware when or if they are receiving treatment. In addition, open-label clinical trials may be subject to an &#8220;investigator bias&#8221; where those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received product candidate and may interpret the information of the treated group more favorably given this knowledge. Positive results observed in open-label trials may not be replicated in later clinical trials. Additionally, as patients become aware that they are not receiving our product candidate as part of the trial, they may elect to withdraw from our study and enroll in clinical trials sponsored by our competitors, which may extend our study timeline.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and may receive cash or equity compensation in connection with such services. While we take steps to assess for conflicts of interest, it remains possible that these relationships and any related compensation could result in perceived or actual conflicts of interest, or a regulatory authority may conclude that the financial relationship may have affected the interpretation of the trial, the integrity of the data generated at the applicable clinical trial site may be questioned and the utility of the clinical trial itself may be jeopardized, which could result in the delay or rejection of the marketing application we submit. Any such delay or rejection could prevent or delay us from commercializing our current or future product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Furthermore, we expect to rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials and data analysis from such trials. Although we expect to enter into agreements governing our CROs&#8217; committed activities, we have limited influence over their actual performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A clinical trial may be suspended or terminated by us, our partners, the IRBs of the institutions in which such trials are being conducted, the IDMC for such trial or by the FDA or other regulatory authorities due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">therapeutic biologic, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. If we experience delays in the completion of, or termination of, any clinical trial of any of our current or potential future product candidates, the commercial prospects of such product candidate will be harmed, and our ability to generate product revenue from such product candidates will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow our product development and approval process and jeopardize our ability to commence product sales and generate revenue, and we may not have the financial resources to continue development of the product candidate that is affected or any of our other product candidates. We may also lose, or be unable to enter into, collaborative arrangements for the affected product candidate and for other product candidates that we are developing. Any of these occurrences may materially and adversely affect our business, financial condition, results of operations and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our potential future product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the PREA, a BLA or supplement to a BLA for certain biological products must include data to assess the safety and effectiveness of the biological product in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective, unless the sponsor receives a deferral or waiver from the FDA. A deferral may be granted for several reasons, including a finding that the product candidate is ready for approval for use in adults before pediatric studies are complete or that additional safety or effectiveness data needs to be collected before the pediatric studies begin. The FDA may issue a PREA Non-Compliance letter to any sponsor that fails to submit the required pediatric assessments, to seek or obtain a deferral or deferral extension, or to request approval for a required pediatric formulation. Similarly, the European Union, under Regulation (EC) No 1901/2006, requires that sponsors either conduct clinical trials in a pediatric population in accordance with a Pediatric Investigation Plan approved by the Pediatric Committee of the EMA or obtain a waiver or deferral from the conduct of these studies from the Pediatric Committee. For any of our product candidates for which we are seeking regulatory approval in the United States or the European Union, we cannot guarantee that we will be able to obtain a waiver or deferral or, alternatively, complete any required pediatric studies or other requirements in a timely manner, or at all, which could result in associated reputational harm and subject us to enforcement action.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Preliminary results from our nonclinical studies and clinical trials that we announce or publish from time to time may change as more patient data becomes available and as the data undergoes audit and verification procedures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may publish interim, topline, or preliminary results from our nonclinical studies and clinical trials. Preliminary and interim results from our clinical trials are not necessarily predictive of final results and are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary, interim and topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, preliminary, interim and topline data should be viewed with caution until the final data are available. Material adverse changes in the final data compared to the preliminary, interim or topline data could significantly harm our business prospects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or therapeutic product, if any, and us in general. In addition, the information we choose to publicly disclose regarding a particular nonclinical study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is the material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular therapeutic product, if any, product candidate or our business. If the preliminary, interim and topline data that we report differs from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The FDA or comparable foreign regulatory authorities may disagree with our regulatory plans and we may fail to obtain regulatory approval of our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA standard for approval of a biologic generally requires adequate, well-controlled clinical trials which convincingly demonstrate the product candidate&#8217;s safety and effectiveness. Such clinical trials typically involve hundreds of patients, have significant costs and take years to complete. In certain cases, the agency may determine that confirmatory post-market evidence is also needed to establish effectiveness and support full approval for the target indication. Product candidates studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may be eligible for accelerated approval and may be approved on the basis of adequate and well-controlled clinical trials establishing that the product candidate has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity or prevalence of the condition and the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">availability or lack of alternative treatments. As a condition of accelerated approval, the FDA usually requires a sponsor of a drug or biologic receiving accelerated approval to perform post-marketing studies to verify and describe the predicted effect on irreversible morbidity or mortality or other clinical endpoint, and the drug or biologic may be subject to withdrawal procedures by the FDA that are more accelerated than those available for regular approvals.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our clinical trial results may not support either accelerated or regular approval. The results of nonclinical studies and clinical trials may not be predictive of the results of later-stage clinical trials, and product candidates in later stages of clinical trials may fail to show the desired safety and efficacy despite having progressed through nonclinical studies and initial clinical trials. In addition, our product candidates could fail to receive regulatory approval for many reasons, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the population studied in the clinical program may not be sufficiently broad or representative to assure safety in the full population for which we seek approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be unable to demonstrate that the clinical and other benefits of our product candidates outweigh their safety risks;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be unable to demonstrate that our product candidates&#8217; risk-benefit ratios for their proposed indications are acceptable;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from nonclinical studies or clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the data collected from clinical trials of our product candidates may not be sufficient to satisfy the FDA or comparable foreign regulatory authorities or to support the submission of a BLA or other comparable submission in foreign jurisdictions or to obtain regulatory approval in the United States or elsewhere;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the FDA or comparable foreign regulatory authorities may fail to approve the manufacturing processes, our own manufacturing facilities, or a third-party manufacturer&#8217;s facilities with which we contract for clinical and commercial supplies; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the FDA or comparable foreign regulatory authorities may fail to approve our analytical testing methods, particularly with respect to bioassay potency testing; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may fail to develop a potency assay for ELI-002 that is satisfactory for the FDA or comparable foreign regulatory authorities; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Failure to obtain regulatory approval to market any of our product candidates would significantly harm our business, results of operations, and prospects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may not be successful in our efforts to use and expand our discovery engine to build a pipeline of product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A key element of our strategy is to use and expand our discovery engine to build a pipeline of product candidates based upon our AMP platform and progress these product candidates through preclinical and clinical development for the treatment of various diseases. Although our research efforts to date suggest that complex amphiphilic molecules can deliver conventional immunomodulatory payloads including peptides, proteins and nucleic acids directly and preferentially to lymph nodes, this hypothesis may prove incorrect, or we may not be able to identify a product candidate that is safe or effective as a treatment for various cancers or for other diseases. We also may not be able to identify an amphiphile product candidate that we can demonstrate to be safe or effective, and we may not be able to develop any other product candidates. Our scientific research that forms the basis of our efforts to discover product candidates based on our AMP platform is ongoing. Further, the scientific evidence to support the feasibility of developing viable product candidates based on our AMP platform is both preliminary and limited. Our discovery engine may not be proven to be superior to competing technologies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if we are successful in building our pipeline of product candidates, the potential product candidates that we identify may not be suitable for clinical development or generate acceptable clinical data, including as a result of being shown to have unacceptable toxicity or other characteristics that indicate that they are unlikely to be products that will receive marketing approval from the FDA or other regulatory authorities or achieve market acceptance. Investment in biopharmaceutical product development involves significant risk that any potential product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval, and become commercially viable. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We cannot provide you any assurance that we will be able to successfully advance any of these additional product candidates through the development process and we cannot predict whether the application of our AMP platform will result in the development of product candidates that make it through to marketing approval. Our research programs may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development or commercialization for many reasons, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our AMP platform may not be successful in identifying additional product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may not be able or willing to assemble sufficient resources to acquire or discover additional product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our product candidates may not succeed in nonclinical or clinical testing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">a product candidate may upon further study demonstrate harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">competitors may develop alternatives that render our product candidates obsolete or less attractive;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">product candidates we develop may nevertheless be covered by third parties&#8217; patents or other exclusive rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the market for a product candidate may change during our program so that the continued development of that product candidate is no longer reasonable;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may not be able to reliably or cost effectively manufacture or supply a product candidate; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">a product candidate may not be accepted as safe and effective by patients, the medical community or third-party payors, if applicable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If any of these events occur, we may be forced to abandon our development efforts for a program or programs, or we may not be able to identify, discover, develop, or commercialize additional product candidates, which would have a material adverse effect on our business and could potentially cause us to cease operations. Even if we receive FDA approval to market additional product candidates, whether for the treatment of cancers or other diseases, we cannot assure you that any such product candidates will be successfully commercialized, widely accepted in the marketplace or more effective than other commercially available alternatives.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Relative to companies that are more established than we are or that have a larger footprint than we do, we have relatively limited experience as a company in completing preclinical studies to enable the filing of INDs, submitting INDs or commencing, enrolling and conducting clinical trials.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our experience as a company in completing IND-enabling preclinical studies comes from our work in commencing clinical development of our product candidate, ELI-002. To date, we have relatively limited experience as a company in commencing, enrolling and conducting clinical trials. In part because of this, we cannot be certain that our planned clinical trials will begin, enroll or be completed on time, if at all. Additionally, even if the applicable regulatory authorities agree with the design and implementation of the clinical trials set forth in our INDs upon initial IND submission, we cannot guarantee that those regulatory authorities will not change their requirements in the future. These considerations apply to the INDs we have already submitted to the FDA, additional INDs that we may submit in the future and also to new clinical trials we may submit to existing or new INDs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our ELI-002 clinical trials are designed to require, as part of screening to determine whether patients meet inclusion criteria, the use of an investigational in vitro diagnostic device. If we are not able to successfully collaborate or partner with a third-party company for the development and authorization of such a device, we may not be able to receive marketing authorization for ELI-002.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The clinical trials for ELI-002 (AMPLIFY-201 and AMPLIFY-7P) employ an investigational in vitro diagnostic device (&#8220;IVD&#8221;), that identifies gene mutations in KRAS from tumor biopsies that are targeted by the ELI-002 product candidate and are an inclusion requirement for patient enrollment. Based on our Phase 2 study design, we must account for and address the investigational status of this device from a regulatory perspective through the course of clinical development (for example, through the compliance with any applicable investigational device exemption requirements). An IVD used to select patients who may be appropriate to receive our commercial product will be considered a companion diagnostic device. Companion diagnostic devices are subject to regulation by the FDA and comparable foreign regulatory authorities as medical devices and we anticipate that separate regulatory marketing authorization will be required for the device prior to commercialization of ELI-002. We plan to collaborate with appropriate companion diagnostic device developers to seek marketing authorization from the FDA&#8217;s Center for Devices and Radiological Health. If our companion diagnostic device partner experiences any delays in development or is not able to successfully develop and obtain marketing authorization for its companion diagnostic device, or does not comply with the FDA&#8217;s medical device or comparable foreign regulatory authorities&#8217; regulations:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the development and commercialization of ELI-002 may also be delayed because in most circumstances, the FDA expects the companion diagnostic and its corresponding therapeutic product to be approved contemporaneously by the FDA;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">ELI-002 may not receive marketing approval if its safe and effective use depends on a companion diagnostic, and none is commercially available; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may not realize the full commercial potential of ELI-002 if it receives marketing approval and, among other reasons, we are unable to appropriately identify patients or types of tumors with the specific genetic alterations targeted by ELI-002.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if ELI-002 and any associated companion diagnostic devices are approved for marketing, the need for a companion diagnostic device for the safe and effective use of ELI-002 may slow or limit adoption of ELI-002. Although we believe genetic testing is becoming more prevalent in the diagnosis and treatment of cancer, ELI-002 may be perceived negatively compared to alternative treatments that do not require the use of companion diagnostic devices, either due to the additional cost of the companion diagnostic device or the need to complete additional procedures to identify relevant biomarkers prior to administering our product candidates. If any of these events were to occur, our business and growth prospects would be harmed, possibly materially.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On November 25, 2025, the FDA issued a proposed rule to reclassify certain nucleic acid-based test systems indicated for use with a corresponding approved oncology therapeutic product from Class III (PMA) to Class II, subject to 510(k) premarket notification with special controls. This change, if finalized in 2026, will decrease the regulatory burden on industry because manufacturers of these kinds of IVDs will no longer have to submit a PMA and receive FDA approval before marketing the test.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may seek designations under FDA programs designed to facilitate and potentially expedite product candidate development, such as fast track or breakthrough therapy designation. Our product candidates may not receive any such designations or if they do receive such designations it may not lead to faster development or regulatory review or approval and it does not increase the likelihood that our product candidates will receive marketing approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We may seek designations under the FDA&#8217;s expedited programs for serious conditions, such as fast track or breakthrough therapy designation, which are intended to facilitate and expedite the development or regulatory review or approval process for product candidates. Descriptions of the fast track and breakthrough therapy designations are included under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Description of Our Business&#8212;Government Regulation and Product Approval&#8212;Fast Track, Breakthrough Therapy and Priority Review Designations</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">.&#8221;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The granting of fast track or breakthrough therapy designation to an investigational product is entirely within the FDA&#8217;s discretion. Accordingly, even if we believe one of our product candidates meets the criteria for a designation, the FDA may disagree and instead determine not to grant such designation. In any event, the receipt of a fast track or breakthrough therapy designation for a product candidate may not result in a faster development process, review, or approval compared to product candidates considered for approval under conventional FDA procedures and does not assure ultimate marketing approval by the FDA. In addition, the FDA may later decide that the product candidate no longer meets the designation conditions, in which case any granted designations may be revoked, or the agency may decide that the time period for review or approval of the product candidate will not be shortened.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we are unable to obtain approval via the accelerated approval pathway, we may be required to conduct additional nonclinical studies or clinical trials. Even if we receive accelerated approval from the FDA, the FDA may seek to withdraw accelerated approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We may seek an accelerated approval development pathway for our product candidates. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Description of Our Business&#8212;Government Regulation and Product Approval&#8212;Accelerated Approval</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; for a description of the accelerated approval pathway.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we choose to pursue accelerated approval, we intend to seek feedback from the FDA or will otherwise evaluate our ability to seek and receive such accelerated approval. After our evaluation of the feedback from the FDA or other factors, we may decide not to pursue or submit a BLA for accelerated approval or any other form of expedited development, review or approval. Furthermore, if we submit an application for accelerated approval, there can be no assurance that such application will be accepted or that approval will be granted on a timely basis, or at all. The FDA also could require us to conduct further studies or trials prior to considering our application or granting approval of any type, and may require us to have a confirmatory trial to verify the clinical benefit of the product underway and partially or fully enrolled before granting approval. We might not be able to fulfill the FDA&#8217;s requirements in a timely manner, which would cause delays, or approval might not be granted because our submission is deemed incomplete by the FDA.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if we receive accelerated approval from the FDA, we will be subject to rigorous post-marketing requirements, including the completion of confirmatory post-market clinical trials, submission to the FDA of periodic progress reports on confirmatory trials, and submission to the FDA of all promotional materials prior to their dissemination. The FDA could seek to withdraw accelerated approval for multiple reasons, including if we fail to conduct any required post-market </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">study with due diligence; a post-market study does not confirm the predicted clinical benefit; other evidence shows that the product is not safe or effective under the conditions of use; or we disseminate promotional materials that are found by the FDA to be false and misleading. Under the Consolidated Appropriations Act for 2023, the FDA may use expedited procedures to withdraw any product for which we receive accelerated approval if our confirmatory trials fail to verify the purported clinical benefits.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A failure to obtain accelerated approval or any other form of expedited development, review or approval for a product candidate that we may choose to develop would delay our commercialization of such product candidate, could increase the cost of development of such product candidate and could harm our competitive position in the marketplace.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we apply for orphan drug designation from the FDA, there is no guarantee that we will be able to obtain or maintain this designation, receive this designation for any of our other product candidates, or receive or maintain any corresponding benefits, including periods of exclusivity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, defined as a disease or condition with a patient population of fewer than 200,000 in the United States, or a patient population greater than 200,000 in the United States when there is no reasonable expectation that the cost of developing and making available the drug or biologic in the United States will be recovered from sales in the United States for that drug or biologic. Orphan drug designation for a biologic must be requested before submitting a BLA. In the United States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages, and user-fee waivers. After the FDA grants orphan drug designation, the generic identity of the drug and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If a biologic that has orphan drug designation subsequently receives the first FDA approval for a particular active ingredient for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including a BLA, to market the same biologic for the same indication for seven years, except in limited circumstances such as a showing of clinical superiority to the product with orphan drug exclusivity or if FDA finds that the holder of the orphan drug exclusivity has not shown that it can assure the availability of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the product was designated. As a result, even if one of our product candidates receives orphan exclusivity, the FDA can still approve other drugs or biologics that have a different active ingredient for use in treating the same indication or disease. Furthermore, the FDA can waive orphan exclusivity if we are unable to manufacture sufficient supply of our product.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We may seek orphan drug designation for some or all of our product candidates in specific orphan indications for which there is a medically plausible basis for their use, but exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan designated indication and may be lost if the FDA later determines that the request for designation was materially defective or if we are unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. In addition, although we intend to seek orphan drug designation for other product candidates, we may never receive such designations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Because we have limited financial and managerial resources, we focus on research programs and product candidates that we identify for specific indications. As a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Any future product candidates for which we intend to seek approval as biological products may face competition sooner than anticipated.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if we are successful in achieving regulatory approval to commercialize a product candidate ahead of our competitors, our product candidates may face competition from biosimilar products. In the United States, our amphiphile product candidates are expected to be regulated by the FDA as biological products, and we intend to seek approval for these product candidates pursuant to the BLA pathway. The enactment of the BPCIA created an abbreviated pathway for the approval of biosimilar and interchangeable biological products based on a previously licensed reference product. Under the BPCIA, an application for a biosimilar biological product cannot be approved by the FDA until 12 years after the original reference biological product was approved under a BLA. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. While </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">it is uncertain when such processes intended to implement BPCIA may be fully adopted by the FDA, any such processes could have a material adverse effect on the future commercial prospects for our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe that any of our product candidates approved as a biological product under a BLA should qualify for the 12-year period of exclusivity available to reference biological products. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider our product candidates to be reference biological products pursuant to its interpretation of the exclusivity provisions of the BPCIA for competing products, potentially creating the opportunity for generic follow-on biosimilar competition sooner than anticipated. Moreover, the extent to which a biosimilar product, once approved, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing including whether a future competitor seeks an interchangeability designation for a biosimilar of one of our products. Under the BPCIA as well as state pharmacy laws, only interchangeable biosimilar products are considered substitutable for the reference biological product without the intervention of the health care provider who prescribed the original biological product. However, as with all prescribing decisions made in the context of a patient-provider relationship and a patient&#8217;s specific medical needs, health care providers are not restricted from prescribing biosimilar products in an off-label manner. In addition, a competitor could decide to forego the abbreviated approval pathway available for biosimilar products and to submit a full BLA for product licensure after completing its own nonclinical studies and clinical trials. In such a situation, any exclusivity for which our products candidates may be eligible under the BPCIA would not prevent the competitor from marketing a product similar or identical to our biological product as soon as it is approved.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In Europe, the European Commission has granted marketing authorizations for multiple biosimilar products pursuant to a set of general and product class-specific guidelines for biosimilar approvals. In addition, companies may be developing biosimilar products in other countries that could compete with our products, if approved.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If competitors are able to obtain marketing approval for biosimilars referencing our product candidates, our future products may become subject to competition from such biosimilars, whether or not they are designated as interchangeable, with the attendant competitive pressure and potential adverse consequences. Such competitive products may be able to immediately compete with us in each indication for which our product candidates may have received approval.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We may experience difficulties in patient enrollment in our clinical trials for a variety of reasons. The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of subjects who remain in the trial until its conclusion. We may not be able to initiate or continue conducting clinical trials for our product candidates if we are unable to locate and enroll a sufficient number of eligible subjects to participate in these trials. The enrollment of patients depends on many factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the number of clinical trials for other product candidates in the same therapeutic area that are currently in clinical development, and our ability to compete with such trials for subjects and clinical trial sites;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the severity of the disease under investigation and the existence of current treatments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the perceived risks and benefits of the product candidate, including the potential advantages or disadvantages of the product candidate being studied in relation to other available therapies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the subject eligibility criteria defined in the protocol, as well as our ability to compensate subjects, as applicable, for their time and effort;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the size and nature of the patient population;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the proximity and availability of clinical trial sites for prospective subjects;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the design of the trial, including factors such as frequency of required assessments, length of the study and ongoing monitoring requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">subjects&#8217; and investigators&#8217; ability to comply with the specific instructions related to the trial protocol, proper documentation, and use of the product candidate;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to recruit clinical trial investigators with the appropriate competencies and experience;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patient referral practices of physicians and the effectiveness of publicity created by clinical trials sites regarding the trial;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability to adequately monitor subjects during and after treatment and compensate them, as applicable, for their time and effort;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability of our clinical study sites, CROs, and other applicable third parties to facilitate timely enrollment;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability of clinical trial sites to enroll subjects that meet all inclusion criteria and any patient exclusion criteria, avoiding erroneous enrollment;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability of our clinical trial sites to appropriately obtain and maintain subject informed consents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability of clinical trial sites to enroll patients due to public health emergencies or pandemics, natural disasters, staffing shortages, or other events; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the risk that subjects enrolled in clinical trials will drop out of the trials before completion of the study or not return for post-treatment follow-up, especially subjects in control groups, due to reasons such as, adverse events, lack of treatment effectiveness, fatigue with the clinical trial process or personal issues; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patients may elect to participate in alternative clinical trials sponsored by our competitors with product candidates that treat the same indications as our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, our ongoing or future clinical trials may involve therapeutic methodologies with limited precedent in published data to guide our trial design and planning, which could result in the need for additional feedback from, and submissions to, regulatory authorities to obtain authorization for such studies or delays in our current or future study readouts if our planning estimates are incorrect. Our clinical trials also compete with other clinical trials for product candidates that are in the same therapeutic areas as our product candidates, and this competition will reduce the number and types of patients available to us, because some patients who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. Because the number of qualified clinical investigators is limited, we may conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials at such clinical trial sites. Moreover, because our product candidates represent a departure from more commonly used methods for cancer treatment, potential patients and their doctors may be inclined to use conventional therapies, such as chemotherapy, rather than enroll patients in any of our future clinical trials.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our inability to enroll a sufficient number of subjects for our clinical trials would result in significant delays and could require us to abandon one or more clinical trials altogether. Moreover, a significant number of withdrawn subjects would compromise the quality of our data. Enrollment delays in our clinical trials may result in increased development costs for our product candidates, or the inability to complete development of our product candidates, which could cause our value to decline, limit our ability to obtain additional financing, and materially impair our ability to generate revenues.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Any product candidate we advance into clinical trials may cause unacceptable adverse events or have other properties that may delay or prevent our regulatory approval or commercialization or limit our commercial potential.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As with most biological products, use of our product candidates could be associated with side effects or adverse events, which can vary in severity from minor reactions to death and in frequency from infrequent to prevalent. Undesirable side effects caused by any current or future product candidate could cause regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other regulatory authorities. We initiated dosing of the AMPLIFY-201 trial of our 2-peptide formulation of ELI-002 in October 2021, and our 7-peptide formulation of ELI-002, in the Phase 1 of the AMPLIFY-7P trial, began dosing in April 2023. We initiated enrollment of the Phase 2 of the AMPLIFY-7P trial in January 2024, completed the enrollment in December 2024, and have an ongoing Expanded Access Program for ELI-002 7P. We have not yet initiated clinical trials for any other product candidates. The AMPLIFY-201 trial through August 2024, when we stopped the disease-free survival follow up for this study, as well as the AMPLIFY-7P trial to date, have shown ELI-002 to induce mild to moderate side effects, such as fatigue, malaise, injection site reactions and myalgia. If we initiate future clinical trials for any other current or future product candidates or continue to advance the AMPLIFY-7P study, it is likely that there will be new or additional side effects associated with the use of our product candidates. Results of our clinical trials could reveal a high and unacceptable severity and prevalence of these side effects. In such an event, our trials could be suspended or terminated, and the FDA or other regulatory authorities could place a clinical hold or order us to cease further development of or deny approval of a product candidate for any or all targeted indications. Such side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may materially and adversely affect our business and financial condition and impair our ability to generate revenues.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Further, clinical trials by their nature utilize a sample of the potential patient population. With a limited number of patients and limited duration of exposure, rare and severe side effects of a product candidate may only be uncovered when a significantly larger number of patients are exposed to the product candidate or when patients are exposed for a longer period of time.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If one or more of our product candidates receives marketing approval, and we or others later identify undesirable side effects caused by such products, including during any long-term follow-up observation period recommended or required for patients who receive treatment using our products, a number of potentially significant negative consequences could result, including:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulatory authorities may withdraw or limit their approvals of such products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulatory authorities may require the addition of labeling statements, specific warnings or contraindications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be required to create a REMS plan, which could include a medication guide outlining the risks of such side effects for distribution to patients, a communication plan for health care providers, and/or other elements to assure safe use;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be required to change the way such products are distributed or administered, or change the labeling of the products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the FDA or a comparable foreign regulatory authority may require us to conduct additional clinical trials or costly post-marketing testing and surveillance to monitor the safety and efficacy of the products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may decide to recall such products from the marketplace after they are approved;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we could be sued and held liable for harm caused to individuals exposed to or taking our products; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our reputation may suffer.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, adverse side effects caused by any therapeutics that may be similar in nature to our product candidates could delay or prevent regulatory approval of our product candidates, limit the commercial profile of an approved label for our product candidates, or result in significant negative consequences for our product candidates following marketing approval. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any of these events could prevent us from achieving or maintaining market acceptance of the affected product candidates and could substantially increase the costs of commercializing our product candidates, if approved, and significantly impact our ability to successfully commercialize our product candidates and generate revenues. Additionally, we may choose or need to abandon development of our product candidates, modify our development plans, limit development to certain uses or subpopulations in which the adverse side effects or other undesirable characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. The occurrence of any of these types of events would have an adverse effect on our business, financial condition, results or operations, and prospects. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may form or seek strategic partnerships or enter into additional licensing arrangements in the future, and we may not realize the benefits of such alliances or licensing arrangements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may form or seek strategic partnerships or collaborations or enter into additional licensing arrangements with third parties that we believe will complement or augment our development and commercialization efforts with respect to our product candidates and any future product candidates that we may develop. Any such relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing stockholders or disrupt our management and business. These relationships also may result in a delay in the development of our product candidates if we become dependent upon the other party and such other party does not prioritize the development of our product candidates relative to our other development activities. Additionally, any collaborations, or licensing arrangements would be subject to the same product candidate development and compliance risks and obligations as we would be if we were to develop the product candidate on our own. Should any third party with which we enter into any of these arrangements not comply with the applicable regulatory requirements, we or they may be subject to regulatory enforcement action and we or they may be delayed or prevented from obtaining marketing approval for the applicable product candidate. Any collaborations, or licensing arrangements may pose a number of risks, including the following: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">any third party with which we enter into any of these arrangements often have significant discretion in determining the efforts and resources that they will apply to the arrangement and may not commit sufficient resources to the development, marketing or commercialization of the product or products that are subject to the arrangement; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">third parties may not perform their obligations as expected or may breach or terminate their agreements with us or otherwise fail to conduct their collaborative or licensing activities successfully and in a timely manner;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">any such collaboration, partnership, or licensing arrangement may significantly limit our share of potential future profits from the associated program, and may require us to relinquish potentially valuable rights to our current product candidates, potential products or proprietary technologies or grant licenses on terms that are not favorable to us;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">third parties may cease to devote resources to the development or commercialization of our product candidates if the partners view our product candidates as competitive with their own products or product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">disagreements with third parties, including disagreements over proprietary rights, contract interpretation or the course of development, might cause delays or termination of the development or commercialization of product candidates, and might result in legal proceedings, which would be time consuming, distracting and expensive;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">third parties may be impacted by changes in their strategic focus or available funding, or business combinations involving them, which could cause them to divert resources away from the arrangement;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">third parties may infringe the intellectual property rights of other third parties, which may expose us to litigation and potential liability;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the collaborations, partnerships, or licensing arrangements may not result in us achieving revenues sufficient to justify such transactions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">by entering into certain collaborations, partnerships, or licensing arrangements, we may forego opportunities to collaborate with other third parties who do not wish to be associated with our existing third-party strategic partners; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">such arrangements may be terminated and, if terminated, may result in a need for us to raise additional capital to pursue further development or commercialization of the applicable product candidate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or other alternative arrangement for our product candidates because they may be deemed to be at too early of a stage of development for collaborative effort, and third parties may not view our product candidates as having the requisite potential to demonstrate safety and efficacy. If we license products or acquire businesses, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture. Any licensed products or acquired businesses may also subject us to the risk of regulatory enforcement should the product or business not be compliant with applicable regulatory requirements. We cannot be certain that, following a strategic transaction or licensing arrangement, we will achieve the revenue or specific net income that justifies such a transaction.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We rely on CMOs to manufacture our nonclinical and clinical pharmaceutical supplies and expect to continue to rely on CMOs to produce commercial supplies of any approved product candidate, and our dependence on CMOs could adversely impact our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We rely on CMOs for the manufacture of nonclinical and clinical supplies of our product candidates and plan to continue to do so for commercial supplies should we receive marketing approval for any of our product candidates. This reliance also results in our reduced control over the manufacture of our product candidates and the protection of our trade secrets and know-how from misappropriation or inadvertent disclosure, which may adversely affect our future business prospects. Nevertheless, as the developer of the product candidates and sponsor of clinical trials involving such product candidates, we continue to have regulatory obligations to maintain oversight of the CMOs to ensure compliance with, among other things, contractual obligations, specifications, and cGMP regulations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In complying with the manufacturing regulations of the FDA and other comparable foreign regulatory authorities, we and our third-party suppliers must spend significant time, money and effort in the areas of design and development, testing, including but not limited to, several complex release tests, such as tests for biological potency, production, record-keeping and quality control to assure that the products meet applicable specifications and other regulatory requirements. Although our agreements with our CMOs require them to perform according to certain cGMP requirements, such as those relating to quality control, quality assurance and qualified personnel, we cannot control the conduct of our CMOs to implement and maintain these standards. If our CMOs do not successfully carry out their contractual duties, meet expected deadlines or manufacture our product candidates in accordance with regulatory requirements, if there are disagreements between us and such parties, or if such parties are unable to support the commercialization of any of our product candidates for which we obtain marketing approval, we may not be able to produce, or may be delayed in producing sufficient product to meet our supply requirements. Any delays in obtaining adequate supplies on adequate terms with respect to our product candidates and components, due to manufacturing issues, global trade policies, or for other reasons, may delay the development, approval, or commercialization of our product candidates. In particular, any issues that occur during the storage of our product candidates at a CMO facility; shipment of manufactured product candidates to other CMOs for further processing, or to clinical trial sites or commercial distributors, if the products receive marketing authorization; or other logistical issues, may result in significant loss of product candidate supplies or delayed delivery to clinical trial sites or patients, which may have a material adverse effect on our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We may not succeed in our efforts to establish manufacturing relationships on commercially reasonable terms. Our product candidates may compete with other products and product candidates for access to manufacturing facilities, of which there are a limited number that operate under cGMP conditions and that are both capable of manufacturing our product candidates and willing to do so. Even if we do establish such collaborations or arrangements, our CMOs may breach, terminate, or not renew these agreements. These facilities may also be affected by general economic conditions, including but not limited to political unrest, global trade wars, natural disasters, such as floods or fires, acts of war, terrorism, or disease outbreaks, or such facilities could face manufacturing issues, such as contamination or adverse regulatory findings following a regulatory inspection. CMOs may also be subject to power failures and/or other utility failures or experience the breakdown, failure, substandard performance or improper installation or operation of equipment in the manufacturing process. Further, our CMOs may be temporarily unable to manufacture our product candidates due </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">to government restrictions, requirements, or limitations. While we have identified several potential alternative vendors who could manufacture some or all of our product candidates, if our CMOs cease to manufacture our product candidates for any reason, we would experience delays in obtaining sufficient quantities of our product for us to meet commercial demand if we receive marketing approval or in advancing our development programs, and we would experience significant additional costs and delays to our operations as we select and qualify replacement suppliers. We could also incur added costs and delays in transferring any necessary technology and processes. The terms of a new arrangement may also be less favorable than any prior arrangements, if we are able to negotiate a new arrangement at all. The addition of a new or alternative CMO may also require further comparability testing and FDA approval and may have a material adverse effect on our business. Any failures in comparability testing would delay our ability to use the product candidate supplies manufactured by the new or alternative CMO for either clinical development or commercial distribution, if we receive marketing approval. We or our CMOs may also encounter shortages in the raw materials or substances necessary to produce our product candidates in the quantities and at the quality needed for our nonclinical studies and clinical trials or, if any of our product candidates are approved for commercialization, to produce our products on a commercial scale, meet an increase in demand, or compete effectively. Such shortages may occur for a variety of reasons, including capacity constraints, delays or disruptions in the market, and shortages caused by the purchase of such materials by our competitors or others. Our or our third-party manufacturers&#8217; failure to obtain the raw materials or substances necessary to manufacture sufficient quantities of our product candidates may have a material adverse effect on our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, any problems or delays we experience in preparing for commercial-scale manufacturing of a product candidate or component, including manufacturing validation, may result in a delay in a future marketing approval, if any, or commercial launch of any of our product candidates, should they receive regulatory approval, or may impair our ability to manufacture commercial quantities or manufacture such quantities at an acceptable cost, which could result in the delay, prevention, or impairment of commercialization of our product candidates, if approved, and could adversely affect our business. Furthermore, if the future manufacturers of the commercial supplies of our products, if approved, fail to deliver the required commercial quantities of our product candidates on a timely basis and at commercially reasonable prices, we would likely be unable to meet demand for our products and we could lose potential revenues. The manufacture of biological products requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. Manufacturers of biologics often encounter difficulties in production, particularly in scaling up initial production. These problems include difficulties with production costs and yields, quality control, including stability of the product candidate and quality assurance testing, shortages of qualified personnel, and compliance with strictly enforced federal, state, and foreign regulations. If our manufacturers were to encounter any of these difficulties and were unable to perform as agreed, our ability to provide our product candidates for use in nonclinical studies or our current and planned clinical trials, or, if any of our product candidates are approved, our ability to produce our product for commercial use, could be jeopardized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, all manufacturers of our product candidates used in clinical trials and of our products for commercial supply, should any of our product candidates receive regulatory approval, must comply with cGMP regulations promulgated by the FDA and equivalent foreign regulatory authorities that are applicable to both finished products and their active components used both for clinical and commercial supply. Regulatory authorities enforce these requirements through facility inspections. CMO facilities must be satisfactory to the FDA and equivalent foreign regulatory authorities as determined by inspections that will be conducted after we submit our marketing applications to the appropriate agencies and prior to product approval and commercialization. Our CMOs will also be subject to continuing, periodic regulatory authority inspections should our product candidates receive marketing approval. Further, we, in cooperation with our CMOs, must supply all necessary chemistry, manufacturing, and control documentation to the FDA and equivalent foreign regulatory authorities in support of a marketing application on a timely basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The cGMP requirements include quality control, quality assurance, and the maintenance of records and documentation. Manufacturers of our product candidates may be unable to comply with our specifications, cGMP or with other applicable regulatory requirements. Poor control of production processes can lead to the introduction of adventitious agents or other contaminants, or to inadvertent changes in the properties or stability of a product candidate that may not be detectable in final product testing. If our CMOs cannot successfully manufacture material that conforms to our specifications and the applicable regulatory requirements, they may not be able to secure or maintain regulatory acceptance of their manufacturing facilities for the purpose of producing our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Deviations from manufacturing requirements may also require reporting and remedial measures that may be costly and/or time-consuming for us or a third party to implement and that may include the temporary or permanent suspension of a clinical trial or commercial sales, if any of our product candidates receives regulatory approval, or the temporary or permanent closure of a facility. Any such remedial measure could materially harm our business. Any delay in obtaining products or product candidates that comply with the applicable regulatory requirements may result in delays to nonclinical studies and clinical trials, or potential product approvals or commercialization. Any such delay may also require that we conduct additional studies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">While we are ultimately responsible for the manufacture and regulatory compliance of our products and product candidates, we have limited control over our CMOs&#8217; compliance with these regulations and standards other than through our contractual arrangements. If the FDA or a comparable foreign regulatory authority does not find these facilities </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">satisfactory for the manufacture of our products, if approved, or product candidates, or if such authorities find such facilities to be noncompliant in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain and maintain regulatory approval for or market our product candidates, if approved. Any new manufacturers may need to either obtain or develop the necessary manufacturing know-how, and obtain the necessary equipment and materials, which may take substantial time and investment. We must also receive FDA or other relevant comparable regulatory authority approval for the use of any new manufacturers for commercial supply.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our failure, or the failure of our CMOs, to comply with applicable regulatory requirements may result in regulatory enforcement actions against our CMOs or us, including fines and civil and criminal penalties, suspension of or restrictions on production, injunctions, delay, withdrawal or denial of product approval or supplements to approved products, clinical holds or termination of clinical studies, warning or untitled letters, regulatory authority communications warning the public about safety issues with a product, refusal to permit the import or export of a product, product seizure, detention, or recall, operating restrictions, civil penalties, criminal prosecution, corporate integrity agreements, or consent decrees and equivalent foreign sanctions. Depending on the severity of any potential regulatory action, supplies of our product candidates or products, if approved, could be interrupted or limited, which could have a material adverse effect on our business. Further, we currently rely on certain foreign or foreign-owned third-party vendors to manufacture certain materials we have used or are using in our clinical trials of our product candidates or to provide services in connection with our clinical trials or discovery activities. Our engagement with these foreign and foreign-owned vendors may be subject to new U.S. legislation or investigations, sanctions, tariffs, trade restrictions and other foreign regulatory requirements, which could cause us to need to identify alternate service providers, increase the cost or reduce the supply of materials available to us, delay the procurement or supply of these materials, delay or impact clinical trials, have an adverse effect on our ability to secure significant commitments from governments to purchase our potential products, if approved, any of which could adversely affect our financial condition and business prospects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In particular, a portion of the manufacturing for our product candidates takes place in China through third-party manufacturers. A significant disruption in the operation of those manufacturers, a trade war or political unrest in China, or a change in the regulatory framework in the United States or China, could materially adversely affect our business, financial condition and results of operations. The National Defense Authorization Act for Fiscal Year 2026 includes a section title, &#8220;Prohibition on Contracting with Certain Biotechnology Providers,&#8221; aimed at discouraging federal contracting with certain biotechnology companies for biotechnology equipment or services in China and other countries of concern. The statute prohibits federal executive agencies from procuring any biotechnology equipment or service from a biotechnology company of concern or contracting with any such company or any entity that procures or uses equipment or services from a biotechnology company of concern. Such prohibitions may limit our ability to obtain federal government grants for research involving our products, if approved, or product candidates manufactured in China or to enter contracts to sell any such products, if approved, to the federal government. If we are required to change manufacturers because of such legislation, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable laws and regulations. We anticipate that the complexity of the manufacturing process for our biological product candidates may impact the amount of time it may take to secure a replacement manufacturer and such delays could negatively affect our ability to develop product candidates in a timely manner or within budget, which could materially adversely affect our business, financial condition and results of operations. Additionally, there may be increased competition to find CMOs in regions outside of China, which may cause us to face challenges finding available CMOs or CMOs that can manufacture our product candidates in a timely manner or within budget. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The demand for glucagon-like peptide-1 (&#8220;GLP-1&#8221;) agonists and other drugs or product candidates containing peptide active pharmaceutical ingredient (&#8220;API&#8221;) increased substantially starting in 2024 and throughout 2025. As ELI-002 and our other product candidates use similar peptide API manufacturing methods to GLP-1 drugs, the manufacturers that we utilize may face capacity challenges, which may impact their ability to accept our production orders or the amount of time it takes to manufacture ELI-002 and/or our other product candidates. Any scheduling delays or interruptions in manufacturing could negatively affect our ability to produce adequate supplies of our product candidates. Additionally, with the increased demand, manufacturers may increase the cost of their services. These potential delays and additional costs could materially affect our business, financial conditions and results of operations.   </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We rely on third parties to conduct some of our nonclinical studies and all of our clinical trials. If these third parties do not meet our deadlines or otherwise conduct the trials as required, our development programs could be delayed or unsuccessful and we may not be able to obtain regulatory approval for or commercialize our product candidates when expected or at all.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We do not have the ability to conduct all aspects of our clinical trials ourselves and do not currently plan to independently conduct clinical trials. We use third parties, such as CROs, to conduct, supervise, and monitor our past trials, such as the AMPLIFY-201 trial, and our current trials, such as the AMPLIFY-7P trial, and will rely upon such CROs, as well as central laboratories, medical institutions, investigators and consultants, to conduct current trials and any future clinical trials that we may conduct in accordance with our protocols and applicable laws and regulations. In addition, we occasionally use third parties to conduct our nonclinical studies. Our CROs, investigators and other service </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">providers play a significant role in the conduct of these trials and the subsequent collection and analysis of data from such trials.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our service providers are not our employees and, except for remedies available to us under our agreements with such third parties, we will have less control over the timing, quality and other aspects of such nonclinical studies and clinical trials than we would have if we were to conduct them on our own. If these third parties do not successfully carry out their contractual duties to us, meet our expected timelines or conduct our nonclinical studies or clinical trials in accordance with regulatory requirements or our stated protocols, if they need to be replaced or if the quality or accuracy of the data they obtain is compromised due to their failure to adhere to our protocols or applicable regulatory requirements or for other reasons, our trials may need to be repeated, extended, delayed or terminated. Further, we may not be able to obtain, or may be delayed in obtaining, marketing approvals for our product candidates, we may fail or be delayed in our efforts to successfully commercialize our product candidates, if approved. Such failures may also subject us or our third-party service providers to regulatory enforcement actions. As a result, our results of operations and the commercial prospects for our product candidates could be harmed, our costs could increase and our ability to generate revenues could be delayed. To the extent we are unable to successfully identify and manage the performance of service providers in the future, our business may be materially and adversely affected. Our third-party service providers may also have relationships with other entities, some of which may be our competitors, for whom they may also be conducting trials or other therapeutic development activities that could harm our competitive position. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Agreements with third parties conducting or otherwise assisting with our nonclinical studies or clinical trials might terminate for a variety of reasons, including a failure to perform by such parties. If any of our relationships with these third parties terminate, we may not be able to enter into arrangements with suitable alternative providers or do so on commercially reasonable terms. Switching or adding third parties involves additional cost and requires our management&#8217;s time and focus. There is also a natural transition period when a new third party commences work. As a result, if we need to enter into alternative arrangements, we may need to delay our product development activities and our business could be adversely affected. Although we carefully manage our relationships with our third parties, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition and prospects, and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our reliance on third parties for development activities will reduce our control over these activities. Nevertheless, we are responsible for ensuring that each of our studies is conducted in accordance with the applicable protocol, legal, regulatory, and scientific standards and our reliance on third parties does not relieve us of our oversight and regulatory responsibilities. For example, we will remain responsible for ensuring that each of our trials is conducted in accordance with the general investigational plan and protocol for that trial. We must also ensure that our nonclinical studies are conducted in accordance with GLP requirements, as appropriate. Moreover, the FDA and comparable foreign regulatory authorities require us to comply with established GCP standards for conducting, recording, and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity, and confidentiality of trial participants are protected. In addition, our clinical trials must be conducted with product candidates that were produced under cGMP conditions. Regulatory authorities enforce these requirements through periodic inspections of trial sponsors, clinical and nonclinical investigators, manufacturers, and trial sites. If we or any of our third-party service providers fail to comply with applicable regulatory requirements, we or they may be subject to enforcement or other legal actions, the data generated in our trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional studies, which may significantly delay our clinical development plans and the regulatory approval process. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that we, our third-party service providers, or clinical trial sites are in substantial compliance with the applicable regulatory requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we will be required to report certain financial interests of our third-party investigators if these relationships exceed certain financial thresholds or meet other criteria. The FDA or comparable foreign regulatory authorities may question the integrity of the data from those clinical trials conducted by investigators who may have conflicts of interest. We are also required to register certain clinical trials and post the results of certain completed clinical trials on a government-sponsored database, www.clinicaltrials.gov, within specified timeframes. Failure to do so can result in enforcement actions and adverse publicity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We rely on other third parties to store and distribute our product candidates for nonclinical studies and clinical trials that we conduct.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also rely on other third parties to store and distribute our product candidates for the nonclinical studies and clinical trials that we are conducting or plan to conduct. Any performance failure, or failure to comply with applicable regulations, on the part of our distributors could delay development, our clinical trials, the regulatory approval process, or potential commercialization of our product candidates, producing additional losses and depriving us of potential product revenue. Any issues that occur during the storage of our product candidates at a third-party facility; shipment of manufactured product candidates to third-party facilities for further processing, clinical trial sites or commercial distributors, if the products receive marketing authorization; or other logistical issues, may result in significant loss of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">product candidate supplies or delayed delivery to clinical trial sites or patients, which may have a material adverse effect on our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may incur substantial product liability or indemnification claims relating to the clinical testing of our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials, and claims could be brought against us if the use or misuse of one of our product candidates causes, or merely appears to have caused, personal injury or death. We will face an even greater risk of product liability if we receive marketing approval for and commercialize any of our product candidates. Product liability claims might be brought against us by consumers, healthcare providers, pharmaceutical companies or others selling or otherwise coming into contact with our product candidates and approved products, if any. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. Product liability claims might be brought against us by consumers, health care providers or others using, administering or selling our products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There is a risk that our future product candidates may induce adverse events. Patients with the diseases targeted by our product candidates may already be in severe or advanced stages of disease and have both known and unknown significant preexisting and potentially life-threatening health risks. During the course of treatment, patients may suffer adverse events, including death, for reasons that may be related to our product candidates. Such events could subject us to costly litigation, require us to pay substantial amounts of money to injured patients, delay, negatively impact or end our opportunity to receive or maintain regulatory approval to market our products, or require us to suspend or abandon our commercialization efforts. Even in a circumstance in which an adverse event is unrelated to our product candidates, the investigation into the circumstance may be time-consuming or inconclusive. These investigations may delay our regulatory approval process or impact and limit the type of regulatory approvals our product candidates receive or maintain. As a result of these factors, a product liability claim, even if successfully defended, could have a material adverse effect on our business, financial condition or results of operations. Any claims against us, regardless of their merit, could severely harm our financial condition, strain our management and other resources or destroy the prospects for commercialization of the product which is the subject of any such claim. For instance, product liability claims may result in:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">loss of revenue from decreased demand for our products and/or product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">impairment of our business reputation or financial stability;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">incurred costs and time of related litigation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">substantial monetary awards to patients or other claimants, and loss of revenue;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">diversion of management attention;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">withdrawal of clinical trial participants and potential termination of clinical trial sites or entire clinical study or programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the inability to commercialize our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">significant negative media attention;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">decrease in our stock price;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">initiation of investigations, and enforcement actions by regulators; and/or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">product recalls, withdrawals, revocation of approvals, or labeling, marketing or promotional restrictions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we cannot successfully defend ourselves against these claims, we will incur substantial liabilities or be required to limit development or commercialization of our products or product candidates. Although we maintain product liability and clinical trial insurance coverage, it may be inadequate to cover all liabilities that we may incur. We anticipate that we will need to increase our insurance coverage as we continue clinical development of our product candidates and if we successfully commercialize any product. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Business, Industry and Future Commercialization</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If any product candidate that we successfully develop does not achieve broad market acceptance among physicians, patients, health care payors and the medical community, the revenues that we generate from sales will be limited.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even if our product candidates receive regulatory approval, they may not gain market acceptance among physicians, patients, health care payors and the medical community. Market acceptance of our products by the medical community, patients, and third-party payors will depend on a number of factors, some of which are beyond our control, including:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the efficacy of our products and the prevalence and severity of any adverse events;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">any potential advantages or disadvantages when compared to alternative treatments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">interactions of our products with other medicines patients are taking and any restrictions on the use of our products together with other medications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the clinical indications for which the products are approved and the approved claims that we may make for the products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">limitations or warnings contained in the product&#8217;s FDA-approved labeling, including potential limitations or warnings for such products that may be more restrictive than other competitive products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in the standard of care for the targeted indications for such product candidates, which could reduce the marketing impact of any claims that we could make following approval, if obtained;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the safety, efficacy, and other potential advantages over alternative treatments, such as relative convenience and ease of administration of such products, and the availability of alternative treatments already used or that may later be approved;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">cost of treatment versus economic and clinical benefit in relation to alternative treatments or therapies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the availability of formulary coverage and adequate coverage or reimbursement by third parties, such as insurance companies and other health care payors, and by U.S. and international government health care programs, including Medicaid and Medicare;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the price concessions required by third-party payors and government health care programs to obtain coverage and payment;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the extent and strength of our marketing and distribution of such products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">distribution and use restrictions imposed by the FDA and equivalent foreign regulatory authorities with respect to such products or to which we agree, for instance, as part of a REMS or voluntary risk management plan;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timing of market introduction of such products, as well as competitive products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to offer such products for sale at competitive prices;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to offer programs to facilitate market acceptance and insurance coverage from public and private insurance companies, provide patient payment assistance, and transition patient coverage;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the extent and strength of our third-party manufacturer and supplier support;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the approval of other new products, including biosimilar products that may be priced at a substantially lower price than we expect to offer our product candidates for, if approved;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">adverse publicity about the product or favorable publicity about competitive products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">support from patient advocacy groups;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the success of any efforts to educate the medical community and third-party payors regarding our products, which efforts may require significant resources and may not be successful; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">potential product liability claims.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If any product candidate is approved but does not achieve an adequate level of acceptance by physicians, hospitals, health care payors and patients, we may not generate sufficient revenue from these products and may not become or remain profitable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our ability to negotiate, secure and maintain third-party coverage and reimbursement for our product candidates may be affected by political, economic and regulatory developments in the United States, the European Union and other jurisdictions. Governments continue to impose cost containment measures, and third-party payors are increasingly challenging prices charged for medicines and examining their cost effectiveness, in addition to their safety and efficacy. These and other similar developments could significantly limit the degree of market acceptance of any drug or biologic candidate of ours that receives marketing approval in the future. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell and market any product candidates we may develop, we may not be successful in commercializing those product candidates if and when they are approved.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We do not have a sales or marketing infrastructure and we have limited experience in the sale, marketing, or distribution of pharmaceutical products. To achieve commercial success for any approved medicine for which we retain </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">sales and marketing responsibilities, we must either develop a sales and marketing organization or outsource these functions to third parties. In the future, we may choose to build a focused sales, marketing, and commercial support infrastructure to sell, or participate in sales activities with our collaborators for, some of our current and future product candidates if and when they are approved.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There are risks involved with both establishing and managing our own commercial capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force or reimbursement specialists is expensive and time-consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing and other commercialization capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our commercialization personnel.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Factors that may inhibit our efforts to commercialize product candidates on our own include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our inability to recruit and retain adequate numbers of effective sales, marketing, reimbursement, customer service, medical affairs, and other support personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the inability of sales personnel to obtain access to physicians to discuss our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement, and other acceptance by payors, and to secure adequate coverage;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">reduced realization on government sales from mandatory discounts, rebates and fees, and from price concessions to private health plans and pharmacy benefit managers necessitated by competition for access to managed formularies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the clinical indications for which the products are approved and the claims that we may make for the products, as well as any limitations on use or warnings;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the costs associated with training sales and marketing personnel on legal and regulatory compliance matters and monitoring their actions, and any liability for sales or marketing personnel who fail to comply with the applicable legal and regulatory requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">restricted or closed distribution channels that make it difficult to distribute our products to different segments of the patient population;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the lack of complementary medicines to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">unforeseen costs and expenses associated with creating an independent commercialization organization.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we enter into arrangements with third parties to perform sales, marketing, commercial support, and distribution services, our product revenues or the profitability of these product revenues to us may be lower than if we were to market and sell any product we may develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to commercialize our products or may be unable to do so on terms that are favorable to us, and we may also face competition in our search for third parties to assist us with the sales and marketing efforts for our product candidates. We may have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we do not establish commercialization capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing any products we may develop.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We face significant competition in an environment of rapid technological change, and there is a possibility that our competitors may achieve regulatory approval before us or develop therapies that are safer or more advanced or effective than ours, which may harm our financial condition and our ability to successfully market or commercialize any product candidates we may develop.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The development and commercialization of new therapeutic biologics is highly competitive. Moreover, the immunotherapy field is characterized by rapidly changing technologies, significant competition, and a strong emphasis on intellectual property. We will likely face competition with respect to any product candidates that we may seek to develop or commercialize in the future from numerous pharmaceutical and biotechnology organizations, as well as from academic institutions, government agencies and other public and private research organizations for our current and future product candidates. Our commercial success may be reduced or eliminated and our business, financial condition, results of operations, and prospects may be harmed if our competitors develop products that are safer, more effective or less costly than ours.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A number of well-resourced pharmaceutical and biotechnology companies are developing products to inhibit RAS mutated cancers. These products, as well as marketing campaigns by competitors and clinical trial results with competitive products, could significantly diminish our ability to market and sell ELI-002 for RAS mutated cancers, if approved. For </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">example, Amgen, Mirati, and Revolution Medicines, among others, have developed small molecule therapies for the treatment of KRAS mutated cancer including G12C, G12D, and pan KRAS inhibitors. Other companies in the immunotherapy and cancer vaccine sector include AstraZeneca, BioNTech, BridgeBio, Boehringer, Bristol Myers, Circio, D3 Bio, Eli Lilly, Erasca, Geneos, Gilead, Incyte, Jacobio, Jiangsu, Merck, Moderna, Roche/Genentech, Revolution Medicines, and Verastem, among others. While many of these programs are in preclinical stages or Phase 1 clinical trials, Amgen and Mirati have products that are approved by the FDA for the treatment of adult patients with KRAS G12C mutated locally advanced or metastatic NSCLC, who have received at least one prior systemic therapy. Revolution Medicines is in a Phase 3 trial for its pan KRAS inhibitor for pancreatic ductal adenocarcinoma (RMC-6236) with a trial readout anticipated in the first half of 2026. Moderna and Merck are in a combined Phase 3 trial of their personalized cancer vaccine targeting melanoma (mRNA-4157) and BioNTech and Roche/Genentech are in Phase 2 trials of their personalized cancer vaccine targeting pancreatic cancer, colorectal cancer, and bladder cancer (BNT122, RO7198457). ELI-002 may compete with existing and new therapies that may be approved in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Many of our current or potential competitors, either alone or with their collaboration partners, may have significantly greater financial resources and expertise in research and development, manufacturing, nonclinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient enrollment for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize product candidates that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than the product candidates we may develop or that would render any of our product candidates obsolete or non-competitive. Our competitors also may obtain FDA or other regulatory approval for their product candidates more rapidly than we may obtain approval for our product candidates, which could result in our competitors establishing a strong market position before we are able to enter the market.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our commercial opportunity may also be reduced or limited if we or our partners are unable to scale up the manufacture of our product candidates to meet clinical or commercial requirements. ELI-002 is comprised of eight APIs, including peptides and nucleotides with a lipid modification. The compositions we seek to develop may exhibit poor pharmaceutical properties, and formulation, purification and stable storage, along with manufacturing, could be challenging.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we could face litigation with respect to the validity and/or scope of patents relating to our competitors&#8217; products. The availability of competitive products could limit the demand and the price we are able to charge for our products. Further, intellectual property protection for the amphiphile components of our product candidates is dynamic and rapidly evolving. The scope of intellectual property protection for our AMP platform may be limited, and its commercial opportunity may be reduced or limited if our competitors are able to acquire or develop the same or similar technologies.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Corporate and academic collaborators may take actions to delay, prevent, or undermine the success of our products.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our operating and financial strategy for the development, clinical testing, manufacture, and commercialization of product candidates is heavily dependent on us entering into collaborations with corporations, academic institutions, licensors, licensees, and other parties and we may not be successful in establishing such collaborations. Some of our existing collaborations are, and future collaborations may be, terminable at the sole discretion of the collaborator. Replacement collaborators might not be available on attractive terms, or at all. The activities of any collaborator will not be within our control and may not be within our power to influence. Any collaborators may not perform their obligations to our satisfaction, or at all, we may not derive any revenue or profits from such collaborations, and any collaborators may ultimately compete with us. If any collaboration is not pursued, we may require substantially greater capital to undertake development and marketing of our proposed products and may not be able to develop and market such products effectively, if at all. In addition, a lack of development and marketing collaborations may lead to significant delays in introducing proposed products into certain markets and/or reduced sales of proposed products in such markets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we expect that changing policies of and actions by the U.S. government may adversely affect the ability of certain of our current, or potential, collaborators to maintain or retain our product candidates. In particular, upon taking office in January 2025, the Trump Administration implemented a freeze that prevented the NIH from reviewing and awarding grants, or paying out funds under already awarded grants, including for research or other projects. Furthermore, in August 2025, the U.S. Supreme Court ruled that the NIH may continue to pause payments on almost $800 million in grant awards as lawsuits challenging the NIH freeze proceed in lower courts. In December 2025, the NIH agreed as part of settlements with grantees who sued the administration, as well as with state attorneys general in a separate case, to review grant applications that were frozen, denied or withdrawn due to Trump Administration directives. Funding for certain research projects funded by NIH grants has been restored, although the agency has reportedly awarded and disbursed far less grant money compared with prior years. If the U.S. government takes any other actions to limit funds </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">available for life science or healthcare research or other projects, it may affect certain of our current, or potential, collaborators and may have a material and adverse impact on our business, financial condition and results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Data provided by collaborators and others upon which we rely that has not been independently verified could turn out to be false, misleading, or incomplete.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We rely on third-party vendors, scientists and collaborators to provide us with significant data and other information related to our projects, clinical trials and our business. If such third parties provide inaccurate, misleading or incomplete data, our business, prospects and results of operations could be materially adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Even if we are able to commercialize any product candidates, such products may become subject to unfavorable pricing regulations, reimbursement practices, or health care reform initiatives, which would harm our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The regulations that govern pricing and reimbursement for new medicines vary widely from country to country, and current and future legislation may change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals or receiving approvals at all. Outside the United States, some countries require approval of the sale price of a medicine before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product candidate in a particular country, but then be subject to price regulations that delay or might even prevent our commercial launch of the product candidate, possibly for lengthy time periods, and negatively impact the revenues we are able to generate from the sale of the product candidate in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates we may develop, even if any such product candidate obtains marketing approval. See the sections entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business --- Government Regulations and Product Approval -- Coverage and Reimbursement Generally</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business --- Government Regulations and Product Approval -- Health Care Reform Measures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; in this Annual Report on Form 10-K.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our ability to commercialize any product candidates successfully also will depend in part on the extent to which reimbursement for these product candidates and related treatments will be available from government authorities or health care programs, private health plans, and other organizations. Even if we succeed in bringing one or more products to the market, these products may not be considered medically necessary and/or cost-effective, and the amount reimbursed for any products may be insufficient to allow us to sell our products on a competitive basis. In addition, reduction in Medicaid or other healthcare reimbursements may impact our future potential domestic customers, which may eventually have an adverse impact on us. At this time, we are unable to determine the cost effectiveness or the likely level or method of reimbursement for our product candidates. Government authorities and third-party payors, such as private health plans, decide which medications they will pay for and establish reimbursement levels. A primary trend in the U.S. health care industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Increasingly, third-party payors are challenging the prices charged for medical products and requiring that biopharmaceutical companies provide them with predetermined discounts from list prices. Novel medical products, if covered at all, may be subject to enhanced utilization management controls designed to ensure that the products are used only when medically necessary. Such utilization management controls may discourage the prescription or use of a medical product by increasing the administrative burden associated with its prescription or creating coverage uncertainties for prescribers and patients. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, that the level of reimbursement will be adequate. Reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. If reimbursement is not available or is available only to limited levels, we may not be able to successfully commercialize any product candidate for which we obtain marketing approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We currently expect that any drugs we develop may need to be administered under the supervision of a physician on an outpatient basis. Under currently applicable U.S. law, certain therapeutic products that are not usually self-administered (such as most injectable drugs and biologics) may be eligible for coverage under the Medicare Part B program if:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">they are incident to a physician&#8217;s services;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">they are reasonable and necessary for the diagnosis or treatment of the illness or injury for which they are administered according to accepted standards of medical practice; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">they have been approved by the FDA and meet other requirements of the statute.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There may be significant delays in obtaining reimbursement for newly approved product candidates, and coverage may be more limited than the purposes for which the product candidate is approved by the FDA or other regulatory authorities. Patients who are prescribed medications for the treatment of their conditions, and their prescribing physicians, generally rely on third-party payors to pay all or part of the costs associated with their prescription medications. Patients are unlikely to use our products unless coverage is provided and payment is adequate to cover all or a significant portion of the cost of our products. Therefore, coverage and adequate payment is critical to new product acceptance. Coverage decisions may depend upon clinical and economic standards that disfavor new products when more established or lower cost therapeutic alternatives are already available or subsequently become available. Moreover, eligibility for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">reimbursement does not imply that any product candidate will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale, and distribution. Interim reimbursement levels for new product candidates, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the product candidate and reimbursement in the clinical setting in which it is used may be based on reimbursement levels already set for lower cost therapies or medicines and may be incorporated into existing payments for other services. Net prices for product candidates may be reduced by mandatory discounts or rebates required by government health care programs or private payors and by any future relaxation of laws that presently restrict imports of medicines from countries where they may be sold at lower prices than in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates. However, no uniform policy requirement for coverage and reimbursement for drug products exists among third-party payors in the United States. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Our inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any approved product candidates we may develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize medicines, and our overall financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe that the efforts of governments and third-party payors to contain or reduce the cost of health care and legislative and regulatory proposals to broaden the availability of health care will continue to affect the business and financial condition of pharmaceutical and biopharmaceutical companies. A number of legislative and regulatory changes in the health care system in the United States and other major health care markets have been proposed and/or adopted in recent years, and such efforts have expanded substantially in recent years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In particular, in March 2010, the ACA was signed into law. This legislation changed the system of health care insurance and benefits and was intended to broaden access to health care coverage, enhance remedies against fraud and abuse, add transparency requirements for the health care and health insurance industries, impose taxes and fees on the health care industry, impose health policy reforms, and control costs. This law also contains provisions that affect companies in the pharmaceutical industry and other health care related industries by imposing additional costs and changes to business practices. Since its enactment, there have been judicial and congressional challenges to certain aspects of the ACA. The uncertainty around the future of the ACA, and in particular the impact to reimbursement levels, may lead to uncertainty or delay in the purchasing decisions of our customers, which may in turn negatively impact our product sales. We continue to evaluate the effect that the ACA has or any potential changes to the ACA could have on our business. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">More recently, in August 2022, the IRA was signed into the law. If a drug or biological product is selected by CMS for negotiation, it is expected that the revenue generated from such product will decrease. Additional state and federal health care reform measures are expected to be adopted in the future, any of which could limit the amounts that federal and state governments will pay for health care products and services, which could result in reduced demand for certain biopharmaceutical products or additional pricing pressures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If the market opportunities for any of our product candidates are smaller than we believe they are, our potential revenues may be adversely affected, and our business may suffer. In addition, our estimates of the prevalence of our target populations may be inaccurate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We focus certain research and product development pipelines and our product candidates on lymph node-directed immunotherapies for cancer. ELI-002 is a KRAS therapeutic immunotherapy in clinical development for the potential treatment of several cancer types with KRAS mutations. ELI-002 targets six position 12 and one position 13 KRAS mutations, cumulatively present in approximately 25% of solid tumors. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">While we believe that the cancer types to be included in our early-stage clinical trials have a large KRAS mutation positive patient population in the United States, our understanding of both the number of patients who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with our product candidates, is based on estimates. These estimates may prove to be incorrect and new studies may reduce the estimated incidence or prevalence of these diseases. By example, because some of the cancer indications that we may target are rare, certain estimates are based upon studies with small patient populations. Moreover, because our product candidates, such as ELI-002, target specific positions on a mutation, not all patients with the overarching mutation (i.e., KRAS) will be treatment candidates. As a result, the number of patients in the United States may turn out to be lower than expected, may not be otherwise eligible for treatment with ELI-002, or patients may become increasingly difficult to identify and access for clinical trials, all of which could adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we or any CMOs and suppliers we engage fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We and any CMOs and suppliers we engage are subject to numerous federal, state, and local environmental, health, and safety laws, regulations, and permitting requirements, including those governing laboratory procedures; the generation, handling, use, storage, treatment, and disposal of hazardous and regulated materials and wastes; the emission and discharge of hazardous materials into the ground, air, and water; and employee health and safety. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste. We generally contract with third parties for the disposal of these materials and wastes. Although we believe that the safety procedures utilized by us and such third parties for handling and disposing of these materials and wastes generally comply with the standards prescribed by applicable laws and regulations, we cannot guarantee that this is the case or eliminate the risk of accidental contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. Under certain environmental laws, we could be held responsible for costs relating to any contamination at our current or past facilities and at third-party facilities. We also could incur significant costs associated with civil or criminal fines and penalties.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Compliance with applicable environmental laws and regulations may be expensive, and current or future environmental laws and regulations may impair our research and product development efforts. In addition, we cannot entirely eliminate the risk of accidental injury or contamination from these materials or wastes. Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not carry specific biological or hazardous waste insurance coverage, and our property, casualty, and general liability insurance policies (which provide for adequate and reasonable amounts of coverage for a company in our industry and at our size and stage) specifically exclude coverage for damages and fines arising from biological or hazardous waste exposure or contamination. Accordingly, in the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount exceeding our resources, and our clinical trials or regulatory approvals could be suspended, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we may incur substantial costs in order to comply with current or future environmental, health, and safety laws, regulations, and permitting requirements. These current or future laws, regulations, and permitting requirements may impair our research, development, or production efforts. Failure to comply with these laws, regulations, and permitting requirements also may result in substantial fines, penalties, or other sanctions or business disruptions, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any CMOs and suppliers we engage will also be subject to these and other environmental, health, and safety laws and regulations. Liabilities they incur pursuant to these laws and regulations could result in significant costs or an interruption in operations, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our technologies are novel, and any product candidates we develop may be complex and difficult to manufacture on a clinical or commercial scale. We could experience delays in satisfying regulatory authorities or we could experience production problems that result in delays in our development or commercialization programs, limit the supply of our product candidates we may develop, or otherwise harm our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP platform is novel, and the manufacture of products on the basis of our platform is untested at a large scale. Any current and future product candidates will likely require processing steps that are more complex than those required for most chemical pharmaceuticals. Problems with the manufacturing process, even minor deviations from the normal process, could result in product defects or manufacturing failures that result in lot failures, product recalls, product liability claims, insufficient inventory, or potentially delay progression of our regulatory filings. Even if we successfully develop product candidates, we may encounter problems achieving adequate quantities and quality of clinical-grade materials that meet FDA or other comparable applicable foreign standards or specifications with consistent and acceptable production yields and costs. If we or our CMOs are unable to scale our manufacturing at the same levels of quality and efficiency, we may not be able to supply the required number of doses for our current or planned clinical trials or for commercial supply, if any of our product candidates receive regulatory approval, and our business could be harmed.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As product candidates proceed through nonclinical studies to clinical trials towards potential approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods and formulation, are tested and then altered along the way in an effort to optimize processes and results. We have updated ELI-002, with two peptides (ELI-002 2P), to a new version of ELI-002, with seven peptides (ELI-002 7P), as part of our product development activities, and, may continue to update ELI-002 in the future if needed and subject to receipt of additional funding. Any such changes could cause any product candidates we may develop to perform differently and affect the results of clinical trials conducted with the materials manufactured using altered processes. Such changes may also require a new IND to be filed, additional testing, FDA notification, and FDA authorization. This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidates and jeopardize our ability to commence sales and generate revenue. For instance, the FDA may require that we conduct a comparability study that evaluates the potential </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">differences in the product candidate resulting from the change. Delays in designing and completing such a study to the satisfaction of the FDA could delay or preclude our development and commercialization plans, and the regulatory approval of our product candidates. Any of the foregoing could limit our future revenues and growth. Any changes would also require that we devote time and resources to manufacturing development and would also likely require additional testing and regulatory actions on our part, which may delay the development of our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the FDA and other regulatory authorities may require us to submit samples of any lot of any approved product together with the protocols showing the results of applicable tests at any time. Under some circumstances, a regulatory authority may require that we do not distribute a lot until the agency authorizes its release. Slight deviations in the manufacturing process, including those affecting quality attributes and stability, may result in unacceptable changes in the product that could result in lot failures or product recalls. Lot failures or product recalls could cause us to delay clinical trials or product launches, which could be costly to us and otherwise harm our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We also may encounter problems hiring and retaining the experienced scientific, quality control, and manufacturing personnel needed to manage our manufacturing process, which could result in delays in our production or difficulties in maintaining compliance with applicable regulatory requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The manufacture of biopharmaceutical products is complex and requires significant expertise, including the development of advanced manufacturing techniques and process controls. For example, given the aseptic controls required for the manufacture of our product candidates, if contaminants are discovered in our supply of product candidates or in the manufacturing facilities, such manufacturing facilities or areas within said facilities may need to be closed for an extended period of time to investigate and remedy the contamination. Any such contamination could materially harm our ability to produce product candidates on schedule and could delay our development programs and results of operations and cause reputational damage. We cannot assure that any such issues relating to the manufacture of ELI-002 or any other product candidate will not occur in the future or that significant delays would not occur as a result of any such issue.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ELI-002 drug substances and drug products are supplied by multiple manufacturers at present. Any problems in our manufacturing process or the facilities with which we contract to make, store, test, release, or ship our product candidates or any problems caused by it, our vendors or other factors not in our control could result in the loss of usable product or prevent or delay the delivery of product candidates to patients in our clinical trials, including the AMPLIFY-7P trial. Any such loss or delay could materially delay our development timelines and harm our business, financial condition and results of operations. Such losses or delays could also make us a less attractive collaborator for potential partners, including larger pharmaceutical companies and academic research institutions, which could limit our access to additional attractive development programs. Problems with third-party manufacturing processes or facilities also could restrict our ability to ensure sufficient clinical material for any clinical trials we may be conducting or plan to conduct and meet market demand for any product candidates we may develop, obtain regulatory approval for, and commercialize.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our insurance policies are expensive and protect us only from some business risks, which will leave us exposed to significant uninsured liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We carry insurance for most categories of risk that our business may encounter; however, we may not have adequate levels of coverage. The insurance policies that we currently maintain include general liability, property, workers&#8217; compensation, products liability and directors&#8217; and officers&#8217; insurance, along with an umbrella policy. We may not be able to maintain existing insurance at current or adequate levels of coverage. Any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our cash position and results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Business interruptions could adversely affect future operations, revenues, and financial conditions, and may increase our costs and expenses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our operations, and those of our directors, advisors, contractors, consultants, CROs, and collaborators, could be adversely affected by earthquakes, floods, hurricanes, typhoons, extreme weather conditions, fires, water shortages, power failures, business systems failures, medical epidemics and other natural and man-made disaster or business interruptions. Our phones, electronic devices and computer systems and those of our directors, advisors, contractors, consultants, CROs, and collaborators are vulnerable to damages, theft and accidental loss, negligence, unauthorized access, terrorism, war, electronic and telecommunications failures, and other natural and man-made disasters. Operating as a company where a portion of our employees have worked and are working remotely results in our employees conducting business outside of our headquarters. These locations may be subject to additional security risks and other risk factors. If such an event as described above were to occur in the future, it may cause interruptions in our operations, delay research and development programs, clinical trials, regulatory activities, manufacturing and quality assurance activities, future sales and marketing activities, hiring, training of employees and persons within associated third parties, and other business activities. For example, the loss of clinical trial data from current or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Likewise, we will rely on third parties to manufacture our product candidates and conduct clinical trials, and similar events as those described in the prior paragraph relating to their business systems, equipment and facilities could also have a material adverse effect on our business. To the extent that any disruption or security breach were to result in a loss of, or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the further development and commercialization of our product candidates could be delayed or altogether terminated.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Indemnity provisions in various agreements potentially expose us to substantial liability for intellectual property infringement, data protection, and other losses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our agreements with third parties may include indemnification provisions under which we agree to indemnify them for losses suffered or incurred as a result of claims of intellectual property infringement or other liabilities relating to or arising from our contractual obligations. Large indemnity payments could harm our business, financial condition, results of operations and growth prospects. Although we normally contractually limit our liability with respect to such obligations, we may still incur substantial liability. Any dispute with a third party with respect to such obligations could have adverse effects on our relationship with that third party and relationships with other existing or new partners, harming our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Intellectual Property</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our success will depend upon intellectual property and proprietary technologies, and we may be unable to protect our intellectual property.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our success will depend, in large part, on obtaining and maintaining patent protection and trade secret protection for our product candidates and their formulations and uses, as well as successfully defending these patents against third-party challenges. If we or our licensors fail to appropriately prosecute and maintain patent protection for our product candidates, our ability to develop and commercialize these product candidates may be adversely affected and we may not be able to prevent competitors from making, importing, using and selling competing products. This failure to properly protect the intellectual property rights relating to these product candidates could have a material adverse effect on our financial condition and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have sought patent protection in the United States and internationally related to the AMP platform technology as well as the mKRAS-driven cancer, universal adjuvant, mutant serine/threonine-protein kinase BRAF-driven cancer and mutant TP53-expressing cancer programs. We have issued patents in Australia, China, Europe, Hong Kong, Israel, Japan, Malaysia, Macau, Mexico, New Zealand, Nigeria, Russia, Saudi Arabia, Singapore, South Korea, Ukraine, and the United States, covering clinical product candidates but the patent portfolio owned by us currently largely comprises pending applications. The patent application process is subject to numerous risks and uncertainties, and there can be no assurance that we or our partners will be successful in protecting our product candidates by obtaining and defending patents. These risks and uncertainties include the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">pending patent applications may not result in any patents being issued;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patents that may be issued may be challenged, invalidated, modified, revoked, circumvented, found to be unenforceable, or otherwise may not provide barriers to entry or any competitive advantage;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">because of the extensive time required for development, testing and regulatory review of a potential product, it is possible that before a potential product can be commercialized, any related patent may expire, or remain in existence for only a short period following commercialization, reducing or eliminating any advantage of the patent;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our competitors, many of which have substantially greater resources than us or our partners do, and many of which have made significant investments in competing technologies, may seek, or may already have sought and/or have obtained, patents that will limit, interfere with, or eliminate our ability to make, use, and sell our potential products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">others may design around our patent claims to produce competitive technologies, products or uses which fall outside of the scope of our patents or other intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">others may identify prior art or other bases which could render unpatentable our patent applications or invalidate our patents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">there may be significant pressure on the U.S. government and other international governmental bodies to limit the scope of patent protection both inside and outside the United States for disease treatments that prove successful as a matter of public policy regarding worldwide health concerns;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">countries other than the United States may have patent laws less favorable to patentees than those upheld by United States courts, allowing foreign competitors a better opportunity to create, develop, and market competing products; and/or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which could be expensive, time-consuming and unsuccessful.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The pending application directed to the mutant BRAF-driven cancer program is co-owned by Cornell University. Cornell University has the right to make decisions, including decisions on patent prosecution and licensing, independent of us. These decisions may be detrimental to us, including to our ability to commercialize a mutant BRAF-driven cancer product.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to patents, we also rely on trade secrets and proprietary know-how. Although we have taken steps to protect our trade secrets and unpatented know-how, including entering into confidentiality agreements with third parties, and confidential information and inventions agreements with employees, consultants and advisors, third parties may still obtain this information or come upon this same or similar information independently. We may become subject to claims that we, our employees, consultants, advisors or independent contractors that we may engage to assist us in developing our product candidates have wrongfully or inadvertently disclosed to us or used trade secrets or other proprietary information of their former employers or their other clients.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may be forced to litigate to enforce or defend our intellectual property rights, and/or the intellectual property rights of our licensors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We may be forced to litigate to enforce or defend our intellectual property rights against infringement by competitors, and to protect our trade secrets against unauthorized use. In so doing, we may place our intellectual property at risk of being invalidated, rendered unenforceable, or limited or narrowed in scope such that we may no longer be able to adequately prevent the manufacture, importation, use, and sale of competitive products. Further, an adverse result in any litigation or another proceeding before a government agency such as the USPTO, may place pending applications at risk of non-issuance. Further, interference proceedings, derivation proceedings, entitlement proceedings, ex parte reexamination, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> review, post-grant review, and opposition proceedings provoked by third parties or brought by the USPTO or any foreign patent authority may be used to challenge the inventorship, ownership, claim scope, or validity of our patents or patent applications. Additionally, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential and proprietary information or trade secrets could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace. We are not currently involved in any patent litigation or another proceeding before a government agency other than normal patent prosecution.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We have rights in some intellectual property that have been discovered through United States government funded programs and thus are subject to federal regulations such as &#8220;march-in&#8221; rights, certain reporting requirements, and a preference for U.S. industry.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have rights in some intellectual property that have been discovered through U.S. government funded programs and thus are subject to federal regulations such as &#8220;march-in&#8221; rights, certain reporting requirements, and a preference for U.S. industry. Compliance with such regulations may limit our exclusive rights, subject us to expenditure of resources with respect to reporting requirements, and limit our ability to contract with non-U.S. manufacturers. Some of the intellectual property rights in-licensed to us have been generated through the use of U.S. government funding and are therefore subject to certain federal regulations. For example, all of the intellectual property rights licensed to us under the MIT License Agreement with MIT have been generated using U.S. government funds. As a result, the U.S. government has certain rights to intellectual property embodied in our current or future products pursuant to the Bayh-Dole Act of 1980. These U.S. government rights in certain inventions developed under government-funded programs include a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right to require us to grant exclusive, partially exclusive, or non-exclusive licenses to any of these inventions to a third party if the government determines that: (i) adequate steps have not been taken to commercialize the invention; (ii) government action is necessary to meet public health or safety needs; or (iii) government action is necessary to meet requirements for public use under federal regulations (also referred to as &#8220;march-in rights&#8221;). The U.S. government also has the right to take title to these inventions if we fail, or the applicable licensor fails, to disclose the invention to the government, elect title, and file an application to register the intellectual property within specified time limits. In addition, the U.S. government may acquire title to these inventions in any country in which a patent application is not filed within specified time limits.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Historically, the U.S. Government has enacted its march-in rights; however, on August 8, 2025, the U.S. Department of Commerce sent a letter to Harvard University and notified it of a potential march-in. The letter stated that it was initiating a process to investigate the following alleged Bayh-Dole Act violations: failures to comply with the requirements for timely disclosure of inventions and election of title; failures to comply with Bayh-Dole&#8217;s preference for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">U.S. industry; and failures to take effective steps to achieve practical application of subject inventions. To the best of our knowledge, MIT has complied with all requirements of the Bayh-Dole Act and would be cleared if such an investigation were to be initiated.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Intellectual property generated under U.S. government funded programs is also subject to certain reporting requirements, compliance with which may require us, or the applicable licensor, to expend substantial resources. In addition, the U.S. government requires that any products embodying the subject invention or produced through the use of the subject invention be manufactured substantially in the U.S. This requirement can be waived if the owner of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that, under the circumstances, domestic manufacture is not commercially feasible. This preference for U.S. manufacturing may limit our ability to license the applicable patent rights on an exclusive basis under certain circumstances. To the best of our knowledge, MIT has complied with all reporting requirements of the Bayh-Dole Act.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we enter into future arrangements involving government funding, and we make inventions as a result of such funding, our intellectual property rights to such discoveries may be subject to the applicable provisions of the Bayh-Dole Act. To the extent any of our current or future intellectual property is generated through the use of U.S. government funding, the provisions of the Bayh-Dole Act may similarly apply. Any exercise by the government of certain of its rights could harm our competitive position, business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are substantially dependent on patents and patent applications under which we license rights from MIT, and if such licensed patent rights lack legal effect or if a dispute arises under such license agreement and our licensed rights are narrowed or this license is terminated, that could cause significant impairment to our ability to develop and commercialize certain of our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our business is substantially dependent upon technology which we license from MIT. Pursuant to the MIT License Agreement, we have an exclusive, worldwide license, with the right to sublicense, certain patents and patent applications owned by MIT related to the &#8220;Amphiphile&#8221; (&#8220;AMP&#8221;) technology (the &#8220;MIT patent rights&#8221;) for the treatment of diseases, disorders, and/or conditions in humans and animals and for diagnostic applications for human and veterinary use. The MIT patent rights cover immunotherapy product candidates in our current lead programs that are being developed for the treatment of certain mutant KRAS-driven cancers (the &#8220;ELI-002&#8221; program), mutant B-RAF murine sarcoma viral oncogene homolog B1 (&#8220;BRAF&#8221;)-driven cancers, and mutated tumor protein p53 (&#8220;TP53&#8221;)-expressing cancers, and cover immunotherapy product candidates targeting certain other proteins that are drivers of disease, as well as programs using CpG as an adjuvant for immune activation in conjunction with an immunostimulatory agent. Therefore, our ability to develop and commercialize several of our product candidates, including ELI-002, is substantially dependent on the legal effectiveness of the MIT patent rights licensed under the MIT License Agreement and continuation of that agreement. MIT has the right to control the preparation, filing, and prosecution of the patent applications and to maintain the patents which we license from MIT under the MIT License Agreement. Therefore, we cannot be certain that these patents and patent applications will be prosecuted, maintained and enforced in a manner consistent with the best interests of our business. If MIT fails to maintain such patents, or loses rights to those patents or patent applications, the rights we have licensed may be reduced or eliminated and our right to develop and commercialize any of our products that are the subject of such licensed patent rights could be adversely affected, and we may not be able to prevent competitors from making, importing, using or selling competing products. MIT also has the right to control defense of any claims asserting the invalidity of the patents in the licensed patent rights and, even if we are permitted to pursue such defense, we cannot ensure the cooperation of MIT. We cannot be certain that MIT will allocate sufficient resources or prioritize their or our enforcement of such patent rights or their defense of such claims to protect our interests in the licensed patent rights. Even if we are not a party to these legal actions, an adverse outcome could harm our business because it might prevent us from continuing to license intellectual property rights that we may need to operate our business. In addition, although we have the right to control enforcement of the licensed patents, we may be adversely affected or prejudiced by actions or inactions of MIT and their counsel that took place prior to or after us assuming control of such enforcement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The MIT License Agreement is complex, and certain provisions in the agreement may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow or eliminate what we believe to be the scope of our rights to the licensed patent rights or increase what we believe to be our financial or other obligations under the MIT License Agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Currently, there are no disputes and no disagreements in interpretations between the Company and MIT with respect to the terms of the MIT License Agreement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we or our partners are sued for infringing on the intellectual property rights of third parties, it could be costly and time-consuming, and an unfavorable outcome in any such litigation could have a material adverse effect on our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our success also depends upon our ability and the ability of any of our future collaborators to develop, manufacture, market and sell our product candidates without infringing on the proprietary rights of third parties. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing products, some of which may have issued claims or pending claims that overlap with the subject matter of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">our intellectual property or our product candidates. Because patent applications can take many years to issue, there may be currently pending applications, including those unknown to us, which may later result in issued patents that our product candidates or proprietary technologies may infringe upon. Similarly, there may be issued patents relevant to our product candidates of which we are not aware.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, third parties may sue us for infringing their patents. Even if we are successful in defending any claims of infringement, the defense of such claims may be costly and present a time-consuming distraction. In the event of a successful claim of infringement against us, we may be required to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">pay substantial damages;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">stop using certain technologies and methods;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">stop certain research and development efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">develop non-infringing products or methods; and/or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">obtain one or more licenses from third parties.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If required, we cannot assure you that we will be able to obtain such licenses on acceptable terms, or at all. If we are sued for infringement, we could encounter substantial delays in the development, manufacture and commercialization of our product candidates. Any litigation, whether to enforce our patent rights or to defend against allegations that we infringed third-party rights, could be costly, time-consuming, and may distract management from other important tasks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As is commonplace in the biotechnology and pharmaceutical industry, we employ individuals who were previously employed at other biotechnology or pharmaceutical companies, including our competitors or potential competitors. To the extent that our employees are involved in endeavors which are similar to those that they were involved in at their former employers, we may be subject to claims that such employees have inadvertently or otherwise used or disclosed the alleged trade secrets or other proprietary information of such former employers and/or that we have inadvertently or otherwise used the alleged trade secrets or other proprietary information. Litigation may be necessary to defend against such claims, which could result in substantial costs, be a distraction to management and ultimately have a material adverse effect on us, even if we are successful in defending such claims.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are not currently involved in, nor have we been threatened with an intellectual property litigation suit.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The biotechnology and pharmaceutical industries have experienced substantial litigation and other proceedings concerning intellectual property rights, and third parties may initiate legal proceedings alleging that we are infringing, misappropriating, or otherwise violating their intellectual property rights, the outcome of which could be uncertain and may prevent, delay or otherwise interfere with our product discovery and development efforts.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our commercial success depends upon our ability and the ability of our collaborators and licensors to develop, manufacture, market, and sell ELI-002 and other AMP immunotherapies. The biotechnology and pharmaceutical industries are characterized by extensive litigation regarding patents and other intellectual property rights as well as administrative proceedings for challenging patents, including interference, derivation,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> inter partes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> review, post grant review, and reexamination proceedings before the USPTO or oppositions and other comparable proceedings in foreign jurisdictions. We may be subject to and may in the future become party to, or threatened with, adversarial proceedings or litigation concerning intellectual property rights with respect to our AMP platform and any product candidates we may develop, including interference proceedings, post-grant review,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> inter partes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> review, and derivation proceedings before the USPTO and similar proceedings in foreign jurisdictions such as oppositions before the European Patent Office (&#8220;EPO&#8221;). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our AMP platform and product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to industry participants, including us, which patents cover various types of therapies, products or their methods of use or manufacture. As with many technology-based products, there may be third-party patent applications that, if issued, may be construed to cover components of our AMP platform and product candidates. There may also be third-party patents or pending patents of which we are currently unaware having potentially grantable claims covering our technologies, compositions, methods of manufacture, or methods of use.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Because of the large number of patents issued and patent applications filed in our fields, third parties may allege they have patent rights encompassing our product candidates, technologies, or methods. Third parties may assert that we are employing their proprietary technology without authorization and may file patent infringement claims or lawsuits against us, and if we are found to be infringing any such third-party patents, we may be required to pay damages, cease commercialization of the infringing technology, and/or obtain a license from such third party, which may not be available on commercially reasonable terms or at all.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our ability to commercialize our product candidates in the United States and abroad may be adversely affected if we cannot successfully defend infringement claims or obtain a license on commercially reasonable terms to relevant third-party patents that cover our product candidates. Even if we believe third-party intellectual property claims are without merit, there can be no assurance that a court would find in our favor on questions of infringement, validity, enforceability, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">or priority. A court of competent jurisdiction could hold that these third-party patents are valid and enforceable and have been infringed by us, which could materially and adversely affect our ability to commercialize ELI-002 or any other product candidates or technologies covered by the asserted third-party patents. In order to successfully challenge the validity of any such third-party&#8217;s U.S. patent in federal court, we would need to overcome a presumption of validity. As this burden is a high one requiring us to present clear and convincing evidence as to the invalidity of any such third-party&#8217;s U.S. patent claims, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such third-party&#8217;s U.S. patent. If we are found to be infringing on a third party&#8217;s intellectual property rights, and we are unsuccessful in demonstrating that any such patents are invalid or unenforceable, we could be required to obtain a license from such third party to continue developing, manufacturing, and marketing any of our product candidates and our technologies. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain such a license, it could be non-exclusive, thereby giving our competitors and other third parties access to the same technologies as us. The license, if available, could require us to make substantial licensing and royalty payments. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, we may be unable to commercialize our AMP platform or product candidates or such commercialization efforts may be significantly delayed, which could in turn significantly harm our business. We also could be forced, including by court order, to cease developing, manufacturing, and commercializing the allegedly infringing technology or product candidates. In addition, we could be found liable for significant monetary damages, including treble damages and attorneys&#8217; fees, if we are found to have willfully infringed on a third-party&#8217;s patent or another of its intellectual property right. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The defense of third-party claims of infringement, misappropriation, or violation of intellectual property rights often involves substantial litigation expense and could be a substantial diversion of management and employee time and resources from our business. Some third parties may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations or could otherwise have a material adverse effect on our business, financial condition, results of operations, and prospects. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, this could have a substantial adverse effect on the price of our common stock.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are not currently involved in, nor have we been threatened with an intellectual property litigation suit or another proceeding before a government agency other than normal patent prosecution.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Periodic maintenance fees, renewal fees, annuity fees, and various other government fees on patents and patent applications are due to be paid to the USPTO and foreign patent agencies outside of the United States over the lifetime of our owned or licensed patents and patent applications. For our in-licensed rights under patents and patent applications, we generally rely on our licensor, MIT, to pay these fees due to the USPTO or to non-U.S. patent agencies; however, we reimburse MIT for these fees as required by the MIT License Agreement. For our owned patent applications, we rely on our outside patent counsel in the United States and foreign countries to monitor these deadlines and to pay these fees when so instructed.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The USPTO and foreign patent agencies require compliance with several procedural, documentary, fee payment, and other similar provisions, such as the requirement to disclose known prior art, during the patent application process. We depend on our licensors to take the necessary action to comply with these requirements with respect to intellectual property under which we license rights, and for our owned patent applications, we engage counsel and other professionals to help us comply with these requirements. While certain inadvertent lapses can be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which non-compliance can result in a partial or complete loss of patent rights in the relevant jurisdiction. Were a non-compliance event to occur resulting in a partial or complete loss of patent rights, our competitors might be able to enter the market with similar or identical products or technology, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. To the best of our knowledge, we have and MIT has complied with all various procedural, document submission, fee payment, and other requirements imposed by government patent agencies.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Changes in patent law in the United States and in non-U.S. jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our technologies and product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As is the case with other biotechnology and pharmaceutical companies, our success is heavily dependent on intellectual property, and particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve both technological and legal complexity, and are therefore costly, time-consuming and inherently uncertain.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Changes in either the patent laws or interpretation of the patent laws could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of our issued patents. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could weaken our ability to obtain new patents or to enforce our existing patents and patents that we obtain in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the Leahy-Smith America Invents Act (&#8220;AIA&#8221;), the United States adopted a &#8220;first-inventor-to-file&#8221; system for deciding which party should be granted a patent when two or more patent applications are filed by different parties claiming the same invention. A third party that filed or files a patent application with the USPTO after March 16, 2013 but before we filed an application could therefore have been granted a patent covering an invention of ours even if we had made the invention before it was made by the third party. Since patent applications in the United States and most other countries are confidential for at least 18 months after filing, we cannot be certain that we were the first to file any patent application related to our product candidates. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The AIA also provides a process known as </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> review, which has been used by many third parties to challenge and invalidate patents. The</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> inter partes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> review process is not limited to patents filed after the AIA was enacted and would therefore be available to a third party seeking to invalidate any of our U.S. patents, even those issued or filed before March 16, 2013. Because of a lower evidentiary standard in USPTO proceedings, where </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> reviews are conducted, compared to the evidentiary standard in U.S. federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a U.S. federal court action. Accordingly, a third party may attempt to use the USPTO procedures, e.g., an </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> review, to invalidate our patent claims that would not have been invalidated if first challenged by the third party in a U.S. federal court action.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Patents have a limited lifespan. The terms of individual patents depend upon the legal term for patents in the countries in which they are granted. In most countries, including the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest non-provisional filing date in the applicable country. However, the actual protection afforded by a patent varies from country to country, and depends upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent. Various extensions including patent term extension (&#8220;PTE&#8221;) and patent term adjustment (&#8220;PTA&#8221;) may be available, but the lives of such extensions, and the protections they afford, are limited. Although we will likely seek patent term extensions in the U.S. and in one or more foreign jurisdictions where available, we cannot provide any assurances that any such patent term extensions will be granted and, if so, for how long. Even if patents covering our product candidates are obtained, once the patent life has expired, we may be open to competition from competitive products, including biosimilars and generics. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting our product candidates might expire before or shortly after we or our partners commercialize those candidates. As a result, our owned and licensed patent portfolio may not provide us with sufficient future rights to exclude others from commercializing products similar or identical to ours.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may not be able to obtain PTE under the Drug Price Competition and Patent Term Restoration Act of 1984 in the United States and equivalent extension in other countries and, as a result, our product candidates, if approved, may not have patent protection for a sufficient period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the United States, the Drug Price Competition and Patent Term Restoration Act of 1984 permits one PTE of up to five years beyond the normal expiration of one patent per product, which if related to a method of treatment patent, is limited to the approved indication. PTE compensates for patent term lost during the FDA regulatory approval process that occurs after the grant of a patent covering, for example, the product, its use, or a method for manufacturing it. The length of the PTE is typically calculated as one-half of the clinical trial period plus the entire period of time during the review of the BLA by the FDA. There is also a limit on the remaining patent term including PTE to a term that is no greater than fourteen years from the date of drug approval. Therefore, if we select and are granted a PTE on a recently filed and issued patent, we may not receive the full benefit of a possible PTE, if at all. We might also not be granted a PTE at all, because of, for example, our failure to apply within the applicable period, failure to apply prior to the expiration of relevant patents or other failure to satisfy any of the numerous applicable requirements. In addition, the regulatory review period of an FDA-approved product may not serve as the basis for a PTE if the active ingredient of such product was subject to regulatory review and approval in an earlier product approved by the FDA. Moreover, the applicable authorities, including the FDA and the USPTO in the United States and any equivalent regulatory authority in other countries, may not agree with our assessment of whether extensions of this nature are available and may refuse to grant extensions to our patents or may grant more limited extensions than we request. If this occurs, our competitors may be able to obtain approval of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">competing products following our patent&#8217;s normal expiration by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case if we were accorded PTE. If this were to occur, it could have an adverse effect on our ability to generate product revenue.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In Europe, supplementary protection certificates are available to extend a patent term up to five years to compensate for patent term lost during regulatory review, and this period can be extended to five and a half years if data from clinical trials is obtained in accordance with an agreed Pediatric Investigation Plan. Although all countries in Europe must provide supplementary protection certificates, there is no unified legislation among European countries and, as a result, drug developers must apply for supplementary protection certificates on a country-by-country basis. As a result, we may need to expend significant resources to apply for and receive these certificates in all relevant countries and may receive them in some, but not all, countries, if at all.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Weakening patent laws and enforcement by courts in the United States and foreign countries may impact our ability to protect our markets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The U.S. Supreme Court has issued opinions in patent cases in the last few years that many consider may weaken patent protection in the United States, either by narrowing the scope of patent protection available in certain circumstances, holding that certain kinds of innovations are not patentable or generally otherwise making it easier to invalidate patents in court. Additionally, there have been recent proposals for additional changes to the patent laws of the United States and other countries that, if adopted, could impact our ability to obtain patent protection for our proprietary technology or our ability to enforce patents protecting our proprietary technology. Depending on future actions by the U.S. Congress, the U.S. courts, the USPTO and the relevant law-making bodies in other countries, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The laws of some foreign jurisdictions do not protect intellectual property rights to the same extent as in the United States and many companies have encountered significant difficulties in protecting and defending such rights in foreign jurisdictions. If we encounter such difficulties in protecting or are otherwise precluded from effectively protecting our intellectual property rights in foreign jurisdictions, our business prospects could be substantially harmed. For example, we could become a party to foreign opposition proceedings, such as at the EPO, or patent litigation and other proceedings in a foreign court. If so, uncertainties resulting from the initiation and continuation of such proceedings could have an adverse effect on our ability to compete in the marketplace. The cost of foreign adversarial proceedings can also be substantial, and in many foreign jurisdictions, the losing party must pay the attorney fees of the winning party.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position could be harmed.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to seeking patents for our technologies and product candidates, we also rely on trade secret protection, as well as confidentiality agreements, non-disclosure agreements and invention assignment agreements with our employees, consultants and third parties to protect our know-how and other confidential and proprietary information, especially where we do not believe patent protection is appropriate or obtainable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">It is our policy to require our employees, corporate collaborators, outside scientific collaborators, CROs, CMOs, consultants, advisors, and other third parties to execute confidentiality agreements no later than the commencement of employment, consulting, or service relationships with us. These agreements generally provide that all confidential information concerning our business or financial affairs developed by or made known to an individual or entity during the course of that party&#8217;s relationship with us is to be kept confidential and not disclosed to third parties, except in certain specified circumstances. In the case of employees, the agreements provide that all inventions conceived by the individual, and that are related to our current or planned business or research and development or made during normal working hours, on our premises or using our equipment or proprietary information, are our exclusive property. In the case of consultants and other third-party service providers, the agreements provide us with certain rights to all inventions arising from the services provided to us by those individuals or entities. However, we cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technologies and processes. Additionally, the assignment of intellectual property rights may not be self-executing, or assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. We may not be able to obtain adequate remedies for any breaches of such agreements. Ultimately, enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive, and time-consuming, and the outcome is unpredictable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to contractual measures, we try to protect the confidential nature of our proprietary information through other appropriate precautions, such as physical and technological security measures. However, trade secrets and know-how can be difficult to protect. These measures may not, for example, in the case of misappropriation of a trade secret by an employee or third party with authorized access, provide adequate protection for our proprietary information. Our security measures may not prevent an employee or consultant from misappropriating our trade secrets and providing them to a competitor, and any recourse we might take against this type of misconduct may not provide an adequate remedy to protect our interests fully. In addition, our trade secrets may be independently developed by others in a manner that could </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">prevent us from receiving legal recourse. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any of that information was independently developed by a competitor, our competitive position could be harmed. To the best of our knowledge, no employee, corporate collaborator, outside scientific collaborator, CRO, CMO, consultant, advisor, or another third party has misappropriated any of our confidential or proprietary information, such as our trade secrets. In addition, courts inside and outside the United States are sometimes less willing or unwilling to protect trade secrets. If we choose to go to court to stop a third party from using any of our trade secrets, we may incur substantial costs. Even if we are successful, these types of lawsuits may consume significant amounts of our time and other resources. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Third parties may assert that our employees, consultants, or advisors have wrongfully used or disclosed confidential information or misappropriated trade secrets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As is common in the biotechnology and pharmaceutical industries, we employ individuals that are currently or were previously employed at universities, research institutions or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants, and advisors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these individuals have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s current or former employer. We may then be involved in litigation proceedings to defend against these claims. If we fail in defending against any such claims, in addition to potentially paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and, if securities analysts or investors perceive these results to be negative, that perception could have a substantial adverse effect on the price of our common stock. Ultimately, any such litigation could substantially increase our operating losses and reduce our resources available for development activities, and we may not have sufficient financial or other resources to adequately engage in such litigation. For example, some of our competitors may be able to sustain the costs of such litigation more effectively than we can because of their substantially greater financial resources. In any case, uncertainties resulting from the initiation and continuation of intellectual property litigation or other intellectual property related proceedings could adversely affect our ability to compete in the marketplace. To the best of our knowledge, no employee, consultant, or advisor has disclosed any third party&#8217;s confidential or proprietary information, such as their trade secrets, to us.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Any trademarks we may obtain may be infringed or successfully challenged, resulting in harm to our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expect to rely on trademarks as one means to distinguish any of our product candidates that are approved for marketing from the products of our competitors. However, our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversions of resources and could adversely affect our business, financial condition, results of operations and growth prospects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, any proprietary name we propose to use with any product candidate in the United States must be approved by the FDA, regardless of whether we have registered it or applied to register it as a trademark. The FDA typically conducts a review of proposed product names, including an evaluation of the potential for confusion with other product names. If the FDA objects to any of our proposed proprietary product names, we may be required to expend significant additional resources in an effort to identify an alternate proprietary product name that would qualify under applicable trademark laws, not infringe the existing rights of third parties, and be acceptable to the FDA.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Intellectual property rights do not necessarily address all potential threats.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">any of our current and future product candidates, if approved, may eventually become commercially available in generic or biosimilar product forms;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">others may be able to make immunotherapies that are similar to any of our current and future product candidates or utilize lymph node targeting technology but that are not covered by the claims of the patents that we license or may own in the future;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we, or our licensors or current or future collaborators, might not have been the first to make the inventions covered by the issued patents or pending patent applications that we license or may own in the future, potentially resulting in the invalidation of such patents or refusal of such applications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we, or our licensors or current or future collaborators, might not have been the first to file patent applications covering certain of our or their inventions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we, or our licensors or current or future collaborators, may fail to meet the obligations to the U.S. government regarding any in-licensed patents and patent applications funded by U.S. government grants, leading to the loss or unenforceability of patent rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing on our owned or licensed intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">it is possible that our pending, owned or in-licensed patent applications or those that we may own or license in the future will not lead to issued patents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">it is possible that there are prior public disclosures that could invalidate our owned or in-licensed patents, or parts of our owned or in-licensed patents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">it is possible that there are unpublished applications or patent applications maintained in secrecy that may later issue with claims covering our product candidates or technology similar to ours;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">it is possible that our owned or in-licensed patents or patent applications omit individual(s) that should be listed as inventor(s) or include individual(s) that should not be listed as inventor(s), which may cause these patents or patents issuing from these patent applications to be held invalid or unenforceable;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">issued patents that we hold rights to may be held invalid, unenforceable, or narrowed in scope, including as a result of legal challenges by our competitors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the claims of our owned or in-licensed issued patents or patent applications, if and when issued, may not cover our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the laws of foreign countries may not protect our proprietary rights or the proprietary rights of our licensors or current or future collaborators to the same extent as the laws of the United States;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the inventors of our owned or in-licensed patents or patent applications may become involved with competitors, develop products or processes that design around our patents, or become hostile to us or the patents or patent applications on which they are named as inventors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in major commercial markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we have engaged in scientific collaborations in the past and we intend to continue to do so in the future, and our collaborators may develop adjacent or competing products that are outside the scope of our patents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may not develop additional proprietary technologies that are patentable;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">any product candidates we develop may be covered by third-party patents or other exclusive rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the patents of others may prohibit or otherwise harm our business; and/or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may choose not to file a patent, or we may choose not to extend patent coverage in a particular region, in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Regulatory and Compliance Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The FDA regulatory approval process is lengthy, time-consuming, and inherently unpredictable, and we may experience significant delays in the clinical development and regulatory approval, if any, of our product candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The research, testing, manufacturing, labeling, approval, selling, import, export, adverse event reporting, record keeping, advertising, promotion, and distribution of drug products, including biologics, are subject to extensive regulation by the FDA and other regulatory authorities in the United States. As such, the amount of time required to obtain approval by the FDA is unpredictable but typically takes many years following the commencement of clinical trials and depends </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">upon numerous factors, including the substantial discretion of the FDA. We are not permitted to market any biological product in the United States until we receive a biologics license from the FDA. We have not previously submitted a BLA to the FDA, or similar approval filings to comparable foreign authorities. A BLA must include extensive nonclinical and clinical data and supporting information to establish that the product candidate is safe, pure, potent, and effective for each desired indication. The BLA must also include significant information regarding the chemistry, manufacturing, and controls for the product, and the manufacturing facilities must complete a successful pre-license inspection. The FDA may also require a panel of experts, referred to as an Advisory Committee, to deliberate on the adequacy of the safety and efficacy data to support licensure. The opinion of the Advisory Committee, although not binding, may have a significant impact on our ability to obtain licensure of the product candidates based on the completed clinical trials. Accordingly, the regulatory approval pathway for our product candidates may be uncertain, complex, expensive, and lengthy, and approval may not be obtained.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Even if we receive regulatory approval of our product candidates, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If our product candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies, and submission of safety, efficacy, and other post-market information, including both federal and state requirements in the United States and requirements of comparable foreign regulatory authorities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Manufacturers and manufacturers&#8217; facilities must comply with extensive FDA, and comparable foreign regulatory authority, requirements, including ensuring that quality control and manufacturing procedures conform to cGMP regulations. As such, we and our CMOs will be subject to continual review and inspections to assess compliance with cGMP and adherence to commitments made in any BLA, other marketing applications, and previous responses to inspection observations. Accordingly, we and others with whom we work must continue to expend time, money, and effort in all areas of regulatory compliance, including manufacturing, production, and quality control.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any regulatory approvals that we receive for our product candidates may be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical trials, and surveillance to monitor the safety and efficacy of the product candidate. The FDA may also require a REMS program as a condition of approval of our product candidates, which could entail requirements for long-term patient follow-up, a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. Comparable foreign regulatory authorities may also have programs similar to REMS and may require that our product candidates become subject to such programs as a condition of approval in the applicable jurisdictions. In addition, if the FDA or a comparable foreign regulatory authority approves our product candidates, we will have to comply with requirements including submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with cGMP and GCP regulations for any clinical trials that we conduct post-approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FDA strictly regulates marketing, labeling, advertising, and promotion of products that are placed on the market. Drugs and biologics may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Later discovery of previously unknown problems with our product candidates, including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements may result in revisions to the approved labeling to add new safety information; imposition of post-market studies; clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">fines, restitution, disgorgement of profits or revenues, warning letters or other enforcement-related letters or clinical holds on post-approval clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">refusal of the FDA to approve pending BLAs or supplements to approved BLAs, or suspension or revocation of product approvals or suspension of any ongoing clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">product seizure or detention, recalls or refusal to permit the import or export of products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">consent decrees, corporate integrity agreements, debarment, or exclusion from federal health care programs; or mandated modification of promotional materials and labeling and the issuance of corrective information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The policies of the FDA and of other regulatory authorities may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. In addition, the U.S. Supreme Court&#8217;s June 2024 decision to overturn established case law giving deference to regulatory agencies&#8217; interpretations of ambiguous statutory language has introduced uncertainty regarding the extent to which the FDA&#8217;s regulations, policies and decisions may become subject to increasing legal challenges, delays, and/or changes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Additional regulatory burdens and other risks and uncertainties in foreign markets may limit our growth.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our future growth may depend, in part, on our ability to develop and commercialize product candidates in foreign markets for which we may rely on strategic partnership with third parties. We will not be permitted to market or promote any product candidate before we receive regulatory approval from the applicable regulatory authority in a foreign market, and we may never receive such regulatory approval. To obtain separate regulatory approval in foreign countries, we generally must comply with numerous and varying regulatory requirements of such countries regarding safety and efficacy and governing, among other things, clinical trials and commercial sales, pricing and distribution of a product candidate, and we cannot predict success in these jurisdictions. In particular, the European Commission issued a proposal in April 2023 for a new Directive and a new Regulation, which will revise and replace the existing general pharmaceutical legislation. If adopted and implemented as currently proposed, these revisions will significantly change several aspects of drug development and approval in the EU. If we obtain approval of any of our potential future product candidates and ultimately commercialize any such product candidate in foreign markets, we would be subject to risks and uncertainties, including the burden of complying with complex and changing foreign regulatory, tax, accounting and legal requirements and the reduced protection of intellectual property rights in some foreign countries.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, but a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and promotion of the product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from those in the United States, including additional nonclinical studies or clinical trials as trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we fail to comply with the regulatory requirements in international markets and/or to receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our relationships with health care providers, physicians, and third-party payors will be subject to applicable anti-kickback, fraud and abuse, anti-bribery and other health care laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm, and diminished profits and future earnings.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Physicians, other health care providers and third-party payors will play a primary role in the recommendation and prescription of ELI-002 or any other product candidates for which we obtain marketing approval. Our future arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other health care laws and regulations that may constrain the business or financial arrangements and relationships through which we market, sell and distribute our product candidates for which we obtain marketing approval. Violations of the fraud and abuse laws are punishable by criminal and civil sanctions, including, in some instances, exclusion from participation in federal and state health care programs, including Medicare and Medicaid. Restrictions under applicable domestic and foreign health care laws and regulations include but are not limited to the following: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase order or recommendation of a good or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs; a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">federal civil and criminal false claims laws and civil monetary penalties laws, including the federal False Claims Act, which impose criminal and civil penalties against individuals or entities for knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false or fraudulent or making a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">false statement to avoid, decrease or conceal an obligation to pay money to the federal government; actions may be brought by the government or a whistleblower and may include an assertion that a claim for payment by federal health care programs for items and services which results from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">HIPAA, which imposes criminal and civil liability for executing a scheme to defraud any health care benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for health care benefits, items or services; similar to the U.S. federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the federal transparency requirements, sometimes referred to as the &#8220;Sunshine Act,&#8221; enacted as part of the ACA, which require, among other things, manufacturers of drugs, devices, biologics and medical supplies that are reimbursed under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program to report annually to the CMS information related to payments and other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain advanced non-physician health care practitioners (such as physician assistants and nurse practitioners) and teaching hospitals, as well as physician ownership and investment interests, including such ownership and investment interests held by a physician&#8217;s immediate family members;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">analogous state and foreign laws and regulations relating to health care fraud and abuse, such as state anti-kickback and false claims laws, that may apply to sales or marketing arrangements and claims involving health care items or services reimbursed by non-governmental third-party payors, including private insurers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">analogous state and foreign laws that require pharmaceutical companies to track, report and disclose to the government and/or the public information related to payments, gifts, and other transfers of value or remuneration to physicians and other health care providers, marketing activities or expenditures, or product pricing or transparency information, or that require pharmaceutical companies to implement compliance programs that meet certain standards or to restrict or limit interactions between pharmaceutical manufacturers and members of the health care industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">U.S. federal laws that require pharmaceutical manufacturers to report certain calculated product prices to the government or provide certain discounts or rebates to government authorities or private entities, often as a condition of reimbursement under federal health care programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">HIPAA, which imposes obligations on certain covered entity health care providers, health plans, and health care clearinghouses as well as their business associates that perform certain services involving the use or disclosure of protected health information, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of protected health information; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">state and foreign laws which govern the privacy and security of health information and personal data in certain circumstances, including state security breach notification laws, state health information privacy laws and federal and state consumer protection laws, many of which differ from each other in significant ways or conflict with each other and often are not preempted by HIPAA, thus complicating compliance efforts; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">See also the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business --- Government Regulations and Product Approval -- Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business &#8211;Government Regulations and Product Approval-- Health Care Reform Measures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; in this Annual Report on Form 10-K. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge under one or more of such laws. In addition, recent health care reform legislation has strengthened these laws. For example, the ACA, among other things, amends the intent requirement of the federal Anti-Kickback and criminal health care fraud statutes. As a result of such amendment, a person or entity no longer needs to have actual knowledge of these statutes or specific intent to violate them in order to have committed a violation. Moreover, the ACA provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Efforts to ensure that our business arrangements with third parties will comply with applicable health care laws and regulations will involve substantial costs. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply with multiple jurisdictions with different compliance or reporting requirements increases the possibility that a health care company may run afoul of one or more of the requirements. If our operations are found to be in violation of any applicable laws or any other government regulations that apply to us, we may be subject to penalties, including criminal and significant civil monetary penalties, damages, fines, individual imprisonment, disgorgement, contractual damages, reputational harm, exclusion from participation in government health care programs, integrity obligations, injunctions, recall or seizure of products, total or partial suspension of production, denial or withdrawal of pre-marketing product approvals, private qui tam actions brought by individual whistleblowers in the name </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">of the government, refusal to allow us to enter into supply contracts, including government contracts, additional reporting requirements and oversight if subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We intend to develop and implement a comprehensive corporate compliance program prior to the commercialization of our product candidates. Although effective compliance programs can mitigate the risk of investigation and prosecution for violations of these laws, these risks cannot be entirely eliminated. Any action against us for an alleged or suspected violation could cause us to incur significant legal expenses and could divert our management&#8217;s attention from the operation of our business, even if our defense is successful. In addition, achieving and sustaining compliance with applicable laws and regulations may be costly to us in terms of money, time and resources. Moreover, federal, state or foreign laws or regulations are subject to change, and while we, our collaborators, manufacturers and/or service providers currently may be compliant, that could change due to changes in interpretation, prevailing industry standards or other reasons.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Health care and other reform legislation may increase the difficulty and cost for us and any collaborators we may have to obtain marketing approval of and commercialize our product candidates and affect the prices we, or they, may obtain.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">All aspects of our business, including research and development, manufacturing, marketing, pricing, sales, litigation, and intellectual property rights, are subject to extensive legislation and regulation. Changes in applicable U.S. federal and state laws and agency regulation, as well as foreign laws and regulations, could have a materially negative impact on our business. In the United States and in some other jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the health care system that could prevent or delay marketing approval of our product candidates or any of our potential future product candidates, restrict or regulate post-approval activities, or affect our ability to profitably sell any product candidates for which we obtain marketing approval. Increased scrutiny of the FDA&#8217;s approval process by the executive and legislative branches of the U.S. government may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing testing and other requirements. We cannot be sure whether additional legislative changes will be enacted, or whether any of the FDA&#8217;s regulations, guidances or interpretations will be changed, or what the impact of such changes on the agency and its scientific review staff, if any, may be. Congress also must reauthorize the FDA&#8217;s user fee programs every five years and often makes changes to those programs in addition to policy or procedural changes that may be negotiated between the FDA and industry stakeholders as part of this periodic reauthorization process. Reauthorization of the prescription drug user fee program must be finalized by Congress by the end of September 2027 to avoid a disruption in FDA&#8217;s activities supported by industry user fees.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in health care systems with the stated goals of containing health care costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a focus of these efforts and has been significantly affected by major legislative initiatives. In March 2010, Congress passed the ACA, which substantially changed the way health care is financed by both the government and private insurers, and significantly impacts the U.S. pharmaceutical industry.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Aspects of the ACA have been the subject of judicial and Congressional challenges, and as a result certain sections of the ACA have not been fully implemented or have been effectively repealed. Following several years of litigation, the U.S. Supreme Court upheld the ACA in June 2021 when it dismissed a legal challenge to the law&#8217;s constitutionality. Further legislative and regulatory changes under the ACA remain possible, although it is unknown what form any such changes or any law would take, and how or whether it may affect the pharmaceutical industry as a whole or our business in the future. We expect that changes or additions to the ACA, the Medicare and Medicaid programs, and changes stemming from other health care reform measures, especially with regard to health care access, financing or other legislation in individual states, could have a material adverse effect on the health care industry in the United States.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the DSCSA enacted in 2013 imposed obligations on manufacturers of pharmaceutical products related to product tracking and tracing, and the applicable requirements under the law became fully enforceable as of November 27, 2024. As another example, on December 20, 2019, a piece of bipartisan legislation called the CREATES Act, which establishes a private cause of action that permits a generic or biosimilar product developer to sue the brand manufacturer to compel it to furnish the necessary samples on &#8220;commercially reasonable, market-based terms,&#8221; was signed into law as part of the Further Consolidated Appropriations Act for 2020 (P.L. 116-94). Although lawsuits have been filed under the CREATES Act since its enactment, those lawsuits have settled privately; therefore to date no federal court has reviewed or opined on the statutory language and there continues to be uncertainty regarding the scope and application of the law. Other legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products. We are unsure whether additional legislative changes will be enacted, or whether the current regulations, guidances or interpretations will be changed, or whether such changes will have any impact on our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, there has been heightened governmental scrutiny in the United States of pharmaceutical pricing practices considering the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. For example, state legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In December 2020, the U.S. Supreme Court held unanimously that federal law does not preempt the states&#8217; ability to regulate PBMs and other members of the health care and pharmaceutical supply chain, an important decision that may lead to further and more aggressive efforts by states in this area.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FTC in mid-2022 also launched sweeping investigations into the practices of the PBM industry, and published interim reports with its findings in mid-2024 and January 2025, that appear to be contributing to additional federal and state legislative and regulatory proposals, as well as enforcement action and private litigation, targeting PBM operations, pharmacy networks, and financial arrangements. In February 2026, several PBM regulatory reforms became law as part of a federal budget package, including but not limited to requirements for PBMs to pass back 100% of rebates and fees to commercial health plan sponsors; to provide extensive informational disclosures related to patients&#8217; coverage and benefits; and to accept only bona fide service fees from drug companies when providing services under Medicare Part D. The DOL also issued a proposed rule in January 2026 that would mandate specific PBM fee disclosures to self-insured plan fiduciaries under ERISA and would allow plan fiduciaries to audit those PBM disclosures to confirm accuracy. Significant efforts to change the PBM industry as it currently exists in the United States may affect the entire pharmaceutical supply chain and the business of other stakeholders, including biopharmaceutical product developers like us. Further, in September 2023, the FTC issued a policy statement articulating its view that certain &#8220;improper&#8221; patent listings by drug developers in the FDA&#8217;s Orange Book represent an unfair trade practice and indicated that industry should be prepared for potential enforcement actions based on its analysis. The FTC followed that action in November 2023 by publicly calling out over 100 &#8220;improper&#8221; patent listings made by ten large pharmaceutical companies and initiating an FDA administrative process with respect to those patents. Initial federal court decisions appear to support the FTC&#8217;s policy challenging such patent listing practices, allowing the FTC to continue pressuring companies to comply, which has led some companies to remove patent listings deemed &#8220;improper&#8221; from the Orange Book. Accordingly, regulatory and government interest in biopharmaceutical industry business practices continues to expand and pose a risk of uncertainty.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2022, the IRA was signed into law. The IRA includes multiple provisions that may impact the prices of drug products throughout the United States. Under the IRA, a manufacturer of a drug or biological product covered by Medicare Parts B or D must pay a rebate to the federal government if the product&#8217;s price increases faster than the rate of inflation. This calculation is made on a product-by-product basis and the amount of the rebate owed to the federal government is directly dependent on the volume of a drug or biological product that is paid for by Medicare Parts B or D. CMS will negotiate drug prices annually for a select number of single source Part D drugs without generic or biosimilar competition, and starting in payment year 2028, CMS will begin negotiating drug prices for a select number of Part B drugs. If a drug product is selected by CMS for negotiation, it is expected that the revenue generated from such drug will decrease. CMS has begun to implement these new authorities announcing the first round of negotiated prices for the first 10 drug products in August 2024, which will become applicable for payment year 2026. The second round of negotiated prices for 15 drug products was announced in November 2025. Ultimately, the IRA&#8217;s impact on the biopharmaceutical industry in the United States remains uncertain, in part because of multiple ongoing lawsuits against CMS brought by large pharmaceutical companies and other stakeholders (e.g., the U.S. Chamber of Commerce).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any additional federal or state health care reform measures could limit the amounts that third-party payers will pay for future health care products and services, and, in turn, could significantly reduce the projected value of certain development projects and reduce our profitability.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our employees, principal investigators, consultants, and commercial partners may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are exposed to the risk of fraud or other misconduct by our employees, consultants, and commercial partners, and, our principal investigators. Misconduct by these parties could include intentional failures to comply with FDA regulations or the regulations applicable in the European Union and other jurisdictions, provide accurate information to the FDA or other regulatory authorities, comply with health care fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately, or disclose unauthorized activities to us. In particular, sales, marketing, and business arrangements in the health care industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs, and other business arrangements. Such misconduct also could involve the improper use of information obtained in the course of clinical trials or interactions with the FDA or other regulatory authorities, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">risks or losses or in protecting us from government investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, financial condition, results of operations, and prospects, including the imposition of significant fines or other sanctions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Laws and regulations governing any international operations we may have in the future may preclude us from developing, manufacturing and selling certain product candidates outside of the United States and require us to develop and implement costly compliance programs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We will be subject to numerous laws and regulations in each jurisdiction outside the United States in which we operate in the future. The creation, implementation and maintenance of international business practices compliance programs is costly and such programs are difficult to enforce, particularly where reliance on third parties is required.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The FCPA prohibits any U.S. individual or business from paying, offering, authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. The anti-bribery provisions of the FCPA are enforced primarily by the DOJ. The SEC is involved with enforcement of the books and records provisions of the FCPA. However, in February 2025, President Trump issued an executive order directing the DOJ to pause enforcement of the FCPA and to issue new enforcement guidelines that take into consideration U.S. national security and the competitiveness of U.S. companies abroad. It is unclear how this presidential directive may affect the biopharmaceutical industry as a whole or our business in particular.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Similarly, the U.K. Bribery Act 2010 has extra-territorial effect for companies and individuals having a connection with the United Kingdom. The U.K. Bribery Act prohibits inducements both to public officials and private individuals and organizations. Compliance with the FCPA and the U.K. Bribery Act is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Various laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If we expand our business outside of the United States, we will be required to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States, which could limit our growth potential and increase our development costs. The failure to comply with laws governing international business practices may result in substantial penalties, including suspension or debarment from government contracting. Violations of the FCPA can result in significant civil and criminal penalties. Indictment alone under the FCPA can lead to suspension of the right to do business with the U.S. government until the pending claims are resolved. A conviction under the FCPA can result in long-term disqualification as a government contractor. The termination of a government contract or relationship as a result of our failure to satisfy any of our obligations under laws governing international business practices could have a negative impact on our operations and harm our reputation and ability to procure government contracts. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#8217;s accounting provisions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are subject to, and may in the future become subject to, U.S. federal and state, and foreign, stringent privacy laws, information security laws, regulations, policies and contractual obligations related to data privacy, artificial intelligence, and security and changes in such laws, regulations, policies and contractual obligations could adversely affect our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We and our current and potential collaborators may be subject to federal, state and foreign data protection laws and regulations (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, laws and regulations that address privacy and data security). In the United States, numerous federal and state laws and regulations, including federal health information privacy laws (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, HIPAA as amended by the HITECH Act), state data breach notification laws, state health information privacy laws and federal and state consumer protection laws (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, Section 5 of the Federal Trade Commission Act), that govern the collection, use, disclosure and protection of health-related and other personal information could apply to our operations or the operations of our collaborators. In addition, we may obtain health information from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and security requirements under HIPAA, as amended by HITECH, or other privacy and data security laws. Depending on the facts and circumstances, we could be subject to criminal penalties if we knowingly obtain, use, or disclose protected health information maintained by a HIPAA-covered entity in a manner that is not authorized or permitted by HIPAA. However, determining whether protected health information has been handled in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">compliance with applicable privacy standards and our contractual obligations can be complex and may be subject to changing interpretation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we are unable to properly protect the privacy and security of protected health information or other personal, sensitive, or confidential information in our possession, we could be found to have breached our contracts. Further, if we fail to comply with applicable privacy laws, including applicable HIPAA privacy and security standards, we could face significant administrative, civil and criminal penalties. Enforcement activity can also result in financial liability and reputational harm, and responses to such enforcement activity can consume significant internal and outside resources. Furthermore, state attorneys general are authorized to enforce HIPAA and to bring civil actions seeking either injunctions or damages in response to violations that threaten the privacy of state residents. In addition to the risks associated with enforcement activities and potential contractual liabilities, our ongoing efforts to comply with evolving privacy and data security laws and regulations at the federal and state level may be costly and require ongoing modifications to our policies, procedures and systems.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Many state laws govern the privacy and security of health information and personal data in specified circumstances, many of which differ from each other in significant ways, are often not pre-empted by HIPAA, and may have a more prohibitive effect than HIPAA, thus complicating compliance efforts. For example, the California Confidentiality of Medical Information Act (&#8220;CMIA&#8221;) imposes restrictive requirements regulating the use and disclosure of health information and other personally identifiable information. In addition to fines and penalties imposed upon violators, some of these state laws also afford private rights of action to individuals who believe their personal information has been misused. California&#8217;s patient privacy laws, for example, provide for penalties of up to $250,000 and permit injured parties to sue for damages. In addition to the CMIA, in 2018, California enacted the CCPA which creates new individual privacy rights for California consumers (as defined in the law) and places increased privacy and security obligations on certain entities handling personal data of consumers or households. The CCPA requires covered companies to provide new disclosure to consumers about such companies&#8217; data collection, use and sharing practices, provide such consumers new ways to opt-out of certain sales or transfers of personal information, and provide consumers with additional causes of action. While there is currently an exception for protected health information that is subject to HIPAA and clinical trial regulations, as currently written, the CCPA may impact our business activities. In addition, the CPRA was recently enacted to strengthen elements of the CCPA and became effective on January 1, 2023. A number of other states have either enacted their own omnibus privacy laws or continued to deliberate and introduce similar privacy law proposals. These privacy laws may impact our business activities and exemplify the vulnerability of our business to the evolving regulatory environment related to personal data.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Numerous other federal and state laws, including consumer protection laws and regulations, govern the collection, dissemination, use, access to, confidentiality and security of patient health information. For example, Washington state recently enacted the &#8220;My Health My Data&#8221; Act which regulates a broad category called &#8220;consumer health data,&#8221; defined as &#8220;personal information that is linked or reasonably linkable to a consumer and that identifies a consumer&#8217;s past, present, or future physical or mental health.&#8221; Notably, the &#8220;My Health My Data&#8221; Act contains a private right of action, which is expected to increase litigation. In addition, Congress and some states are considering new laws and regulations that further protect the privacy and security of medical records or medical information. With the recent increase in publicity regarding data breaches resulting in improper dissemination of consumer information, all 50 states have passed laws regulating the actions that a business must take if it experiences a data breach, as defined by state law, including prompt disclosure within a specified amount of time to affected individuals. In addition to data breach notification laws, some states have enacted statutes and rules requiring businesses to reasonably protect certain types of personal information they hold or to otherwise comply with certain specified data security requirements for personal information. Congress has also been considering similar federal legislation relating to data privacy and data protection.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the European Union, we may be subject to the GDPR which went into effect in May 2018 and which imposes obligations on companies that operate in our industry with respect to the processing of personal data and the cross-border transfer of such data. The GDPR applies to any company established in the EEA (which includes the European Union Member States plus Iceland, Liechtenstein, and Norway) and to companies established outside the EEA that process personal data in connection with the offering of goods or services to data subjects in the EEA or the monitoring of the behavior of data subjects in the EEA. The GDPR establishes stringent requirements applicable to the processing of personal data, including strict requirements relating to the validity of consent of data subjects, expanded disclosures about how personal data is used, requirements to conduct data protection impact assessments for &#8220;high risk&#8221; processing, limitations on retention of personal data, special provisions affording greater protection to and requiring additional compliance measures for &#8220;special categories of personal data&#8221; including health and genetic information of data subjects, mandatory data breach notification (in certain circumstances), &#8220;privacy by design&#8221; requirements, and direct obligations on service providers acting as processors. The GDPR also prohibits the international transfer of personal data from the EEA to countries outside of the EEA unless made to a country deemed to have adequate data privacy laws by the European Commission or a data transfer mechanism has been put in place. If we or our partners&#8217; or service providers&#8217; privacy or data security measures fail to comply with the GDPR requirements, we may be subject to litigation, regulatory investigations, enforcement notices requiring us to change the way we use personal data and/or fines of up to 20 million Euros or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher, as well as </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">compensation claims by affected individuals, negative publicity, reputational harm and a potential loss of business and goodwill.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The GDPR may also impose additional compliance obligations relating to the transfer of data between us and our affiliates, collaborators, or other business partners. For example, on July 16, 2020, the Court of Justice of the European Union (&#8220;CJEU&#8221;), issued a landmark opinion in the case </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Maximilian Schrems vs. Facebook</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (Case C-311/18), called </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Schrems II.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> This decision (a) called into question commonly relied upon data transfer mechanisms as between the European Union Member States and the United States (such as the Standard Contractual Clauses) and (b) invalidated the European Union-U.S. Privacy Shield on which many companies had relied as an acceptable mechanism for transferring such data from the European Union to the United States. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 10, 2023, the European Commission adopted an adequacy decision for a new mechanism for transferring data from the EU to the United States &#8211; the EU-US Data Privacy Framework (the &#8220;Framework&#8221;). The Framework provides EU individuals with several new rights, including the right to obtain access to their data, or obtain correction or deletion of incorrect or unlawfully handled data. The adequacy decision followed the signing of an executive order introducing new binding safeguards to address the points raised in the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Schrems II</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> decision. Notably, the new obligations were geared to ensure that data can be accessed by US intelligence agencies only to the extent necessary and proportionate and to establish an independent and impartial redress mechanism to handle complaints from Europeans concerning the collection of their data for national security purposes. The Commission will continually review developments in the US along with its adequacy decision. Adequacy decisions can be adapted or even withdrawn in the event of developments affecting the level of protection in the applicable jurisdiction. Future actions of EU data protection authorities are difficult to predict. Some patients or other service providers may respond to these evolving laws and regulations by asking us to make certain privacy or data-related contractual commitments that we are unable or unwilling to make. This could lead to the loss of current or prospective patients or other business relationships.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Relatedly, following the United Kingdom&#8217;s withdrawal from the European Union (i.e., Brexit), the European Union GDPR has been implemented in the United Kingdom (as the &#8220;UK GDPR&#8221;). The UK GDPR sits alongside the UK Data Protection Act 2018 which implements certain derogations in the European Union GDPR into United Kingdom law. Under the UK GDPR, companies not established in the UK but who process personal data in relation to the offering of goods or services to individuals in the UK, or to monitor their behavior will be subject to the UK GDPR &#8211; the requirements of which are (at this time) largely aligned with those under the EU GDPR and as such, may lead to similar compliance and operational costs with potential fines of up to &#163;17.5 million or 4% of global turnover.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Inadequate funding for the FDA, the SEC and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent our product candidates from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business rely, which could negatively impact our business. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Future legislative and regulatory proposals may materially impact the ability of the FDA and other regulatory agencies to operate as they have historically operated. We cannot be sure whether additional legislative changes or executive orders will be enacted, or whether any of the FDA&#8217;s regulations, guidances or interpretations will be changed, or what the impact of such changes on the agency and its scientific review staff, if any, may be. For example, the FDA has experienced significant and rapid fluctuations in leadership and scientific review personnel, which may be key contributing factors in multiple reported delays in agency decision making on marketing applications and agency requests for additional data that are inconsistent with prior regulatory feedback. In addition, the next FDA user fee reauthorization package entered stakeholder negotiations in mid-2025, and any agreement must be sent to Congress in early 2027 for purposes of initiating the legislative process. Reauthorization of the prescription drug user fee program would need to be finalized by Congress by the end of September 2027 in order to avoid a disruption in FDA&#8217;s review goals for BLAs and other activities supported by user fees assessed against industry.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, disruptions at the FDA and other agencies may slow the time necessary for new drugs and biologic products to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, political disputes in Congress may result in a shutdown of the U.S. government, and in such cases certain regulatory agencies, such as the FDA and the SEC, would have to furlough employees and cease critical activities. If a prolonged government shutdown or slowdown occurs, it could significantly affect the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, in our operations as a public company, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Employee and Operations Matters, Managing Growth and Information Technology</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our future success depends on our ability to retain our key executives and to attract, retain, and motivate qualified personnel.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are highly dependent on the principal members of our senior management and scientific teams. Such principal members are employed &#8220;at will,&#8221; meaning we or they may terminate the employment relationship at any time. The loss of the services of any of these persons could impede the achievement of our research, development, and commercialization objectives.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Recruiting and retaining qualified scientific, clinical, manufacturing, business development, general and administrative and sales and marketing personnel will also be critical to our success. We may not be able to attract and retain these personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors, including our scientific co-founder, may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. In addition, inflation has had, and we expect that it will continue to have, an impact on the costs that we incur to attract and retain qualified personnel, and may make it more difficult for us to attract and retain such personnel. The inability to recruit, or loss of services of certain executives, key employees, consultants, or advisors, may impede the progress of our research, development, and commercialization objectives and have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we are unable to hire additional qualified personnel, our ability to grow our business may be harmed.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Over time we will need to hire additional qualified personnel with expertise in drug development, product registration, clinical, preclinical and nonclinical research, quality compliance, government regulation, formulation and manufacturing, financial matters and sales and marketing. We compete for qualified individuals with numerous biopharmaceutical companies, universities and other research institutions. There is currently a shortage of highly qualified personnel in our industry, which is likely to continue. As a result, competition for personnel is intense and the turnover rate can be high. Attracting and retaining qualified personnel will be critical to our success. We may not be able to attract and retain personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for individuals with similar skill sets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, failure to succeed in development and commercialization of our product candidates may make it more challenging to recruit and retain qualified personnel. The inability to recruit and retain qualified personnel may impede the progress of our research, development and commercialization objectives and would negatively impact our ability to succeed in our product development strategy.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We expect to expand our development, regulatory, and future sales and marketing capabilities, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, we had 33 full-time employees and, in connection with the growth and advancement of our pipeline and becoming a public company, we expect to continue to increase the number of our employees and the scope of our operations, particularly in the areas of product development, regulatory affairs, and sales and marketing. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational, and financial systems, expand our facilities, and continue to recruit and train additional qualified personnel. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expected expansion of our operations or recruit and train additional qualified personnel. Moreover, the expected physical expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As a growing biotechnology company, we are actively pursuing new platforms and product candidates in many therapeutic areas and across a wide range of diseases. Successfully developing product candidates for and fully understanding the regulatory and manufacturing pathways to all of these therapeutic areas and disease states requires a significant depth of talent, resources and corporate processes in order to allow simultaneous execution across multiple areas. Due to our limited resources, we may not be able to effectively manage this simultaneous execution and the expansion of our operations or recruit and train additional qualified personnel. This may result in weaknesses in our infrastructure, give rise to operational mistakes, legal or regulatory compliance failures, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The physical expansion of our operations may lead to significant costs and may divert financial resources from other projects, such as the development of our product candidates. If our management is unable to effectively manage our expected development and expansion, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced, and we may not be able to implement our business strategy. Our future financial performance and our ability to compete effectively and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">commercialize our product candidates, if approved, will depend in part on our ability to effectively manage our future development and expansion.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our internal information technology systems, or those of our vendors, collaborators or other contractors or consultants, may fail or suffer cybersecurity incidents, loss of data, and other disruptions, which could result in a material disruption of our product development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the ordinary course of our business, we collect and store sensitive data, intellectual property, and proprietary business information. This data encompasses a wide variety of business-critical information including research and development information, clinical trial information, personal information, commercial information, and business and financial information. We face risks relative to protecting this critical information, including loss of access, unauthorized access or disclosure, unauthorized modification, and inadequate monitoring of our controls over these risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Despite the implementation of security measures, our internal information technology (&#8220;IT&#8221;) systems and those of our current and any future third-party vendors, collaborators and other contractors or consultants are vulnerable to risks and damages from a variety of sources, including, interruption, failure, damage, cybersecurity incidents, or data theft from computer viruses, computer hackers, malicious code, employee theft or misuse, malware, including ransomware, social engineering (including phishing attacks), denial-of-service attacks, sophisticated nation-state and nation-state-supported actors, unauthorized access, cyber-attacks, phishing schemes, breaches, interruptions due to employee error or malfeasance, damage from natural disasters, terrorism, war and telecommunication, network, and electrical failures. As use of digital technologies has increased, cybersecurity incidents, including deliberate attacks and attempts to gain unauthorized access to IT systems and networks, have increased in frequency and sophistication. These threats pose a risk to the security of our IT systems and networks and the confidentiality, availability, and integrity of our data. There can be no assurance that we will be successful in detecting or preventing cybersecurity incidents, or successfully mitigating their effects.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any such disruption or security incident could cause interruptions in our operations, and result in a disruption of our development programs and our business operations. For example, the loss of clinical trial data from future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. If we were to experience a significant cybersecurity incident that impacts our IT systems or data, the costs associated with the investigation, remediation and potential notification of the cybersecurity incident to counterparties, regulatory authorities, and data subjects could be material. In addition, our remediation efforts may not be successful. Cybersecurity incidents could also lead to significant business disruption, including transaction errors, supply chain or manufacturing interruptions, processing inefficiencies, data loss or the loss of or damage to intellectual property or other proprietary information. In addition, our remote workforce could increase our cybersecurity risk, create data accessibility concerns, and make us more susceptible to communication disruption. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that any disruption or cybersecurity incident were to result in a loss of, or damage to, our or our third-party vendors&#8217;, collaborators&#8217; or other contractors&#8217; or consultants&#8217; data or applications, or inappropriate disclosure of confidential, proprietary, or other critical or sensitive information or data, we could incur liability including litigation exposure, penalties and fines, we could become the subject of regulatory actions or investigations, our competitive position could be harmed and the further development and commercialization of our product candidates could be delayed. For example, any such event that leads to unauthorized access, use or disclosure of personal information, including personal information regarding our patients, to the extent we have such information, or our employees, could harm our reputation, require us to comply with federal and/or state data breach notification laws and foreign law equivalents, and potential contractual obligations, and otherwise subject us to liability under laws and regulations that protect the privacy and security of personal information. In the event we are subject to any mandatory disclosures of a data security breach, such disclosure will be costly, could lead to negative publicity, and may cause the third parties that we work with or may work with in the future to lose confidence in the effectiveness of our data security measures. Despite our implementation of security and other protective measures, sustained or repeated IT system failures that interrupt our ability to generate and maintain data could adversely affect our ability to operate our business. Any of the above could have a material adverse effect on our business, financial condition, reputation, competitive advantage, results of operations or prospects. While we maintain cyber-liability insurance (covering security and privacy matters), such insurance may not be adequate to cover any losses experienced as a result of a cybersecurity incident.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information, including personal information, and as a result we may be exposed to reputational harm and liability.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We may use and integrate artificial intelligence into our business processes. Use of this rapidly evolving technology will require the application of significant resources to design, develop, test, and maintain such systems to help ensure that artificial intelligence is implemented in accordance with applicable law and in a socially responsible manner. If we enable or use solutions that draw controversy due to perceived or actual negative societal impact, we may experience brand or reputational harm, competitive harm, or legal liability.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A growing number of legislators and regulators in the U.S. and globally are adopting laws and regulations and have focused enforcement efforts on the adoption of artificial intelligence, and use of such technologies in compliance with ethical standards and societal expectations. These developments may increase our compliance burden and costs in connection with use of artificial intelligence and lead to legal liability if we fail to meet evolving legal standards or if use of such technologies results in harm or other causes of action we did not predict. The scope of requirements depends on legal and risk determinations that rely on novel legal provisions that have not yet been interpreted by courts or regulators, and non-compliance can lead to significant fines.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we develop or use artificial intelligence systems governed by rapidly developing laws or regulations, we will need to meet higher standards of data quality, transparency, monitoring, and human oversight, and we would need to adhere to specific and potentially burdensome and costly ethical, accountability, and administrative requirements, with the potential for significant enforcement or litigation in the event of any perceived non-compliance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our vendors may in turn incorporate artificial intelligence tools into their offerings, and the providers of these artificial intelligence tools may not meet existing or rapidly evolving regulatory or industry standards, including with respect to privacy and data security. Further, global threat actors are using increasingly sophisticated methods, including artificial intelligence, to engage in the theft and misuse of confidential information and proprietary information. Any of these effects could damage our reputation, result in the loss of valuable property and information, cause us to breach applicable laws and regulations, and adversely impact our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our business, operations and clinical development timelines and plans are subject to risks arising from epidemic or pandemic diseases.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The COVID-19 worldwide pandemic presented substantial public health and economic challenges and affected our employees, patients, physicians and other healthcare providers, CMOs, communities and business operations, as well as the U.S. and global economies and financial markets. To date we have not experienced material disruptions in our business operations due to COVID-19. Measures taken by the governmental authorities to respond to any future epidemic or pandemic disease outbreaks could disrupt the supply chain and the manufacture or shipment of drug substances and finished drug products for clinical products for use in our clinical trials and research and nonclinical studies and, delay, limit or prevent our employees and CROs from continuing research and development activities, impede our clinical trial initiation and recruitment and the ability of patients to continue in clinical trials, including due to measures taken that may limit social interaction or prevent reopening of high-transmission settings, impede testing, monitoring, data collection and analysis and other related activities, any of which could delay our nonclinical studies and clinical trials, and increase our development costs, and have a material adverse effect on our business, financial condition and results of operations. Any future epidemic or pandemic disease outbreak could also potentially further affect the business of the FDA, the EMA or other regulatory authorities, which could result in delays in meetings related to our planned clinical trials, including those for marketing approval of our product candidates. Any future epidemic disease outbreak may have an adverse impact on global economic conditions which could have an adverse effect on our business and financial condition, including impairing our ability to raise capital when needed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">General Risk Factors</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Unstable market and economic conditions may have serious adverse consequences on our business, financial condition and stock price.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The global credit and financial markets have periodically experienced extreme volatility and disruptions, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability. The financial markets and the global economy may also be adversely affected by the current or anticipated impact of military conflict, including the conflicts in the Middle East, in Venezuela, and between Russia and Ukraine, geopolitical tensions with China, terrorism or other geopolitical events, including the imposition of tariffs. Sanctions imposed by the United States and other countries in response to such conflicts, including the ones in the Middle East and in Ukraine, may also adversely impact the financial markets and the global economy, and any economic countermeasures by the affected countries or others could exacerbate market and economic instability. Additionally, the imposition of substantial tariffs by the United States on imports from various countries, including China, Canada, and Mexico, and the possible countermeasures by these countries could increase costs, disrupt the global supply chain, and create additional operational challenges. The uncertainty surrounding future trade relationships and the potential for increased market volatility and currency exchange rate fluctuations along with tariffs and trade regulations could have an adverse effect on our business. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay, limit, reduce, or terminate our product development or future commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves, or on less favorable terms than we would otherwise choose. In </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">addition, one or more of our current service providers, manufacturers and other partners may not survive an economic downturn, which could directly affect our ability to attain our clinical development goals on schedule and on budget.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Uncertainty about global economic conditions could result in increased costs related to the manufacture of our product candidates and, if our product candidates are approved and made available for sale, customers may postpone purchases of our product candidates in response to tighter credit, unemployment, negative financial news and/or declines in income or asset values and other macroeconomic factors, which could have a material adverse effect on demand for our product candidates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Inflation could adversely affect our business and results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Inflation has the potential to negatively impact our liquidity, business, financial condition and results of operations by increasing our overall cost structure. The presence of inflation in the economy has led to, and may continue to lead to, higher interest rates, increased capital costs, supply shortages, and rising labor, manufacturing, shipping and other costs, along with weaker exchange rates and other similar effects. In addition, fluctuations in inflation, geopolitical and broader macroeconomic developments and global supply chain disruptions have caused, and may in the future cause, uncertainty in the interest rate environment, which may make it more difficult, costly or dilutive for us to secure additional financing. As a result, we have experienced, and may continue to experience, higher costs. While we may implement measures to mitigate inflation&#8217;s impact, if these measures prove ineffective, our business, financial condition, results of operations and liquidity could be significantly harmed. Even if these measures are successful, there may be a delay between the implementation of these actions and their effect on our operations, compared to when the inflationary costs are incurred.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We have broad discretion in the use of our financial resources and may not use them effectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our management has broad discretion in the application of our financial resources. Because of the number and variability of factors that determine our use of our financial resources, their ultimate use may vary substantially from their currently intended use. Our management may not apply our financial resources in ways that ultimately increase the value of any investment in our securities or enhance stockholder value. The failure by our management to apply these funds effectively could harm our business. We have invested and may in the future invest our cash in interest-bearing securities. These investments may not yield a favorable return to our stockholders. If we do not invest or apply our cash in ways that enhance stockholder value, we may fail to achieve expected financial results, which may result in a decline in the price of our shares of common stock, and, therefore, may negatively impact our ability to raise capital, invest in or expand our business, acquire additional licenses, commercialize our product candidates, or continue our operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">U.S. federal income tax reform could adversely affect our business and financial condition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The rules dealing with U.S. federal, state, and local income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service (&#8220;IRS&#8221;) and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many such changes have been made and changes are likely to continue to occur in the future. For example, on March 27, 2020, President Trump signed into law the CARES Act which included certain changes in tax law intended to stimulate the U.S. economy in light of the COVID-19 outbreak, including temporary beneficial changes to the treatment of net operating losses (&#8220;NOLs&#8221;), interest deductibility limitations and payroll tax matters. Additionally, on December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act of 2017 (&#8220;TCJA&#8221;), which significantly reformed the Internal Revenue Code (the &#8220;Code&#8221;). The TCJA included significant changes to corporate and individual taxation, some of which could adversely impact an investment in our common stock. Under the TCJA, in general, NOLs generated in taxable years beginning after December 31, 2017 may offset no more than 80 percent of such year&#8217;s taxable income and there is no ability for such NOLs to be carried back to a prior taxable year. The CARES Act modifies the TCJA with respect to the TCJA&#8217;s limitation on the deduction of NOLs and provides that NOLs arising in taxable years beginning after December 31, 2017 and before January 1, 2021, may be carried back to each of the five taxable years preceding the tax year of such loss, but NOLs arising in taxable years beginning after December 31, 2020 may not be carried back. In addition, the CARES Act eliminates the limitation on the deduction of NOLs to 80 percent of current year taxable income for taxable years beginning before January 1, 2021. As a result of such limitation, we may be required to pay federal income tax in some future year notwithstanding that we had a net loss for all years in the aggregate. In addition, on July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;). The OBBBA includes a broad range of tax reform provisions, including 100% bonus depreciation and domestic research cost expensing. Additionally, the OBBBA modifies certain key provisions from the TCJA and expands certain incentives from the IRA. Certain provisions of the OBBBA are effective in 2025 while others are effective for tax years beginning after 2025. While we continue to evaluate the impact of these legislative changes as additional guidance becomes available, uncertainty remains regarding the timing and interpretation by tax authorities in affected jurisdictions. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. We urge investors to consult with their legal and tax advisers regarding the implications of potential changes in tax laws on an investment in our common stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Changes in tax laws may materially adversely affect our business, prospects, financial condition and operating results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">New tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our business, prospects, financial condition and operating results. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the TCJA, the CARES Act, the IRA, and the OBBBA enacted many significant changes to the U.S. tax laws. Future guidance from the IRS and other tax authorities with respect to such legislation may affect us, and certain aspects of such legislation could be repealed or modified in future legislation. Such tax law changes could have a material adverse impact on us. In addition, it is uncertain if and to what extent various states will conform to newly enacted federal tax legislation. While it is too early to assess the overall impact of these changes, as these and other tax laws and related regulations are revised, enacted, and implemented, our financial condition, results of operations, and cash flows could be materially adversely impacted.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our ability to use NOL carryforwards and other tax attributes may be limited.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have incurred losses during our history, and we do not expect to become profitable in the near future and may never achieve profitability. To the extent that we continue to generate taxable losses, unused losses will carry forward to offset future taxable income, if any, until such unused losses expire, if at all. December&#160;31, 2025, we had U.S. federal NOL carryforwards and state NOL carryforwards of approximately $311.4&#160;million and $179.5&#160;million, respectively. Under current law, U.S. federal NOL carryforwards generated in taxable periods beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such NOL carryforwards is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to federal law. In addition, under Sections 382 and 383 of the Code, federal NOL carryforwards and other tax attributes may become subject to an annual limitation in the event of certain cumulative changes in ownership. An &#8220;ownership change&#8221; pursuant to Section 382 of the Code generally occurs if one or more stockholders or groups of stockholders who own at least 5% of a company&#8217;s stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Our ability to utilize our NOL carryforwards and other tax attributes to offset future taxable income or tax liabilities may be limited as a result of ownership changes or other transactions. Similar rules may apply under state tax laws. If we earn taxable income, such limitations could result in increased future income tax liability to us, and our future cash flows could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The market price of our common stock is expected to be volatile, and the market price of our common stock may drop.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The market price of our common stock could be subject to significant fluctuations. Market prices for securities of smaller biotechnology and other life sciences companies have historically been particularly volatile. Some of the factors that may cause the market price of our common stock to fluctuate include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to obtain regulatory approvals for our product candidates, and delays or failures to obtain such approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">failure of any of our product candidates, if approved, to achieve commercial success;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">failure by us to maintain our existing third-party license and supply agreements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">failure by us or our licensors to prosecute, maintain, or enforce our intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in laws or regulations applicable to our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">any inability to obtain adequate supply of our product candidates or the inability to do so at acceptable prices;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">adverse regulatory authority decisions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">adverse results, clinical holds, or delays in the clinical trials of our product candidates or any future clinical trials we may conduct, or changes in the development status of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">introduction of new products, services or technologies by our competitors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">failure to meet or exceed the financial and development projections we may provide to the public;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">failure to meet or exceed the financial and development projections of the investment community;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the perception of the pharmaceutical industry by the public, legislatures, regulators and the investment community;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">announcements of significant acquisitions, strategic collaborations, joint ventures or capital commitments by us or our competitors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">disputes or other developments relating to proprietary rights, including patents, litigation matters, and our ability to obtain patent protection for our technologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">additions or departures of key personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">significant lawsuits, including patent or stockholder litigation;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">if securities or industry analysts do not publish research or reports about our business, or if they issue an adverse or misleading opinion regarding our business and stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in the market valuations of similar companies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">general market or macroeconomic conditions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">sales of our common stock by us or our stockholders in the future;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">trading volume of our common stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">failure to maintain compliance with the listing requirements of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;);</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">announcements by commercial partners or competitors of new commercial products, clinical progress or the lack thereof, significant contracts, commercial relationships or capital commitments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">adverse publicity generally, including with respect to other products and potential products in such markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the introduction of technological innovations or new therapies that compete with our potential products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">changes in the structure of health care payment systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">disruptions in the financial markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the impact of political instability and military conflict, which has resulted in instability in the global financial markets and export control; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">period-to-period fluctuations in our financial results.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, the stock markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of our common stock.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In the past, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our profitability and reputation. Further, our director and officer liability insurance cost may increase as a result of litigation of this nature and our insurance deductible may be significant before our insurers are required to provide any coverage to us. Additionally, a decrease in our stock price may cause our common stock to no longer satisfy the continued listing standards of Nasdaq. If we are not able to maintain the requirements for listing on Nasdaq, we could be delisted, which could have a materially adverse effect on our ability to raise additional funds as well as the price and liquidity of our common stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We will continue to incur costs and demands upon management as a result of complying with the laws, rules and regulations affecting public companies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We will continue to incur significant legal, accounting and other expenses that we did not incur as a private company, including costs associated with public company reporting requirements. We will also incur costs associated with corporate governance requirements, including requirements under the laws, rules and regulations of the SEC as well as the Nasdaq rules. These laws, rules and regulations are expected to increase our legal and financial compliance costs and to make some activities more time consuming and costly. For example, some members of our management team have not previously managed and operated a public company. These executive officers and other personnel will need to devote substantial time to gaining expertise regarding operations as a public company and compliance with applicable laws and regulations. These laws, rules and regulations also may make it difficult and expensive for us to maintain directors&#8217; and officers&#8217; liability insurance. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our board of directors or as executive officers, which may adversely affect investor confidence and could cause our business or stock price to suffer.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may become involved in securities litigation that could divert management&#8217;s attention and harm our business, and insurance coverage may not be sufficient to cover all costs and damages.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We may be exposed to securities litigation even if no wrongdoing occurred. Litigation is usually expensive and diverts management&#8217;s attention and resources, which could adversely affect our business and cash resources. We may become involved in such litigation, and our stock price may fluctuate for many reasons, including as a result of public announcements regarding the progress of our development efforts or the development efforts of current or future collaboration partners or competitors, the addition or departure of our key personnel, variations in our quarterly operating results and changes in market valuations of biopharmaceutical and biotechnology companies. This risk is especially relevant to us because biopharmaceutical and biotechnology companies have experienced significant stock price volatility in recent years. When the market price of a stock has been volatile, as our stock price may be, holders of that stock have occasionally brought securities class action litigation against the company that issued the stock. If any of our stockholders were to bring a lawsuit of this type against us, even if the lawsuit is without merit, it could result in substantial costs for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">defending the lawsuit and diversion of the time, attention and resources of our board of directors and management, which could significantly harm our profitability and reputation. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us more difficult and may prevent attempts by our stockholders to replace or remove our management.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Provisions in our amended and restated certificate of incorporation and amended and restated bylaws may delay or prevent an acquisition or a change in management that our stockholders might consider favorable. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law (&#8220;DGCL&#8221;), which prohibits stockholders owning in excess of 15% of our outstanding voting stock from merging or combining with us. Although we believe these provisions collectively will provide for an opportunity to receive higher bids by requiring potential acquirors to negotiate with our board of directors, they would apply even if the offer may be considered beneficial by some stockholders. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove then current management by making it more difficult for stockholders to replace members of the board of directors, which is responsible for appointing the members of management.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees, and could make it more costly for stockholders to bring a claim against us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our amended and restated certificate of incorporation and amended and restated bylaws, provide, among other things, that the Court of Chancery of the State of Delaware (or, in the event that the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) generally will be the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a claim of breach of fiduciary duty, any action asserting a claim against us arising pursuant to the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws, or any action asserting a claim against us that is governed by the internal affairs doctrine; provided that, the exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction; and provided further that, if and only if the Court of Chancery of the State of Delaware dismisses any such action for lack of subject matter jurisdiction, such action may be brought in another state or federal court sitting in the State of Delaware.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated certificate of incorporation and the amended and restated bylaws further provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims, and investors cannot waive compliance with the federal laws and rules and regulations thereunder. While the Delaware courts have determined that such choice of forum provisions are facially valid and several state trial courts have enforced such provisions and required that suits asserting Securities Act claims be filed in federal court, there is no guarantee that courts of appeal will affirm the enforceability of such provisions and a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation and amended and restated bylaws. This may require significant additional costs associated with resolving such action in other jurisdictions and there is uncertainty that the provision would be enforced by a court in those other jurisdictions. If a court were to find either exclusive forum provision in our amended and restated certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with litigating Securities Act claims in state court, or both state and federal court, which could seriously harm our business, financial condition, results of operations, and prospects. This exclusive forum provision may make it more expensive for stockholders to bring a claim than if the stockholders were permitted to select another jurisdiction and may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees or stockholders, which may discourage such lawsuits against us and our directors, officers and other employees and stockholders. Alternatively, if a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We do not anticipate that we will pay any cash dividends in the foreseeable future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The current expectation is that we will retain our future earnings, if any, to fund the development and growth of our business. As a result, capital appreciation, if any, of our common stock will be our stockholders&#8217; sole source of gain, if any, for the foreseeable future.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our stockholders may experience future dilution as a result of future equity offerings.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the (i) &#8220;at-the-market&#8221; offering program entered into in June 2024 under which we may offer and sell, from time to time, up to $40 million of shares of common stock through JonesTrading Institutional Services LLC, as agent, (ii) January 2025 underwritten offering of 1,261,830 shares of our common stock and common warrants to purchase up to 1,261,830 shares of our common stock, and (iii) warrant to purchase an aggregate of 103,225 shares of our common stock we issued to GKCC in connection with the note purchase agreement we entered into with GKCC in June 2025 (the &#8220;Note Purchase Agreement&#8221;), we may offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock in order to raise additional capital in the future. We cannot assure our stockholders that we will be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price per share our stockholders paid for our shares. Investors purchasing shares or other securities in the future could have rights, preferences or privileges senior to those of our stockholders and our stockholders may experience dilution. Our stockholders may incur additional dilution upon the exercise of any outstanding stock options or warrants, the issuance of shares of restricted stock, the vesting of restricted stock units, or the issuance, vesting or exercise of other equity awards.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">An active trading market for our common stock may not develop and our stockholders may not be able to resell their shares of common stock for a profit, if at all.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">An active trading market for our shares of common stock may never develop or be sustained. If an active market for our common stock does not develop or is not sustained, it may be difficult for our stockholders to sell their shares at an attractive price or at all.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Future sales of a substantial number of shares by existing stockholders, or the perception that such sales could occur, could cause our stock price to decline.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market, the trading price of our common stock could decline. We are unable to predict the effect that sales may have on the prevailing market price of our common stock. In addition, shares of our common stock that are either subject to outstanding options or reserved for future issuance under our equity incentive plan will be eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our largest stockholder has significant influence over us, including influence over decisions that require the approval of stockholders, which could limit our stockholders&#8217; ability to influence the outcome of key transactions, including a change of control.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Yekaterina (Katie) Chudnovsky, a member of our board of directors, and GKCC, an entity controlled by Ms. Chudnovsky, together beneficially own 43.1% of our outstanding common stock as of March&#160;10, 2026, assuming the exercise of all warrants and vested options held by Ms. Chudnovsky and GKCC. Although we are not a &#8220;controlled company&#8221; within the meaning of the corporate governance standards of Nasdaq, Ms. Chudnovsky, through her control of GKCC, is able to significantly influence our decisions, including the election of directors and the approval of significant corporate transactions, such as mergers and related party transactions. Ms. Chudnovsky, through her control of GKCC, has the ability to delay or perhaps even block, by ownership of our stock, an unsolicited tender offer. This concentration of ownership could have the effect of delaying, deterring or preventing a change in control of our company that stockholders might view favorably. Additionally, our largest stockholder&#8217;s interests may not align with the interests of our other stockholders. Our largest stockholder may make investments in companies and may acquire and hold interests in businesses that compete directly or indirectly with us and our largest stockholder may also pursue acquisition opportunities that may be complementary to our business, and, as a result, those acquisition opportunities may not be available to us.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The terms of our note arrangement with GKCC, an entity controlled by a member of our board of directors, places certain restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our ability to operate our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On June 3, 2025, we entered into the Note Purchase Agreement with GKCC pursuant to which we issued to GKCC a 3.0% Senior Secured Promissory Note due June 3, 2028 (the &#8220;Note&#8221;) in the principal amount of $10.0 million. If we raise any additional debt through a financing, the terms of such additional debt could further restrict our operating and financial flexibility. These restrictions may include, among other things, limitations on borrowing and specific restrictions on the use of the proceeds of such additional debt financing, as well as prohibitions on our ability to incur further debt financing, create liens, pay dividends, redeem capital stock or make investments.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we default under the terms of the Note beyond the applicable grace period, if any, GKCC may declare all amounts outstanding under the Note to be immediately due and payable. If we are unable to repay the amounts due under the Note upon GKCC&#8217;s declaration, GKCC could proceed against the collateral granted to it to secure the obligations under the Note Purchase Agreement (including but not limited to taking control of our pledged assets and foreclosing on other collateral, including those of our subsidiaries, Elicio Operating Company, Inc. and Elicio Securities Corp.). The enforcement by GKCC upon its declaration to accelerate the obligations under the Note, as mentioned above, could </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">adversely affect our operations. Further, if we are liquidated, GKCC&#8217;s right to repayment, as well as the right to repayment of other lenders under any additional debt financing, would be senior to the rights of the holders of our common stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Although we do not expect to rely on the &#8220;controlled company&#8221; exemption, we may soon become a &#8220;controlled company&#8221; within the meaning of the Nasdaq listing standards, and we would qualify for exemptions from certain corporate governance requirements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A &#8220;controlled company,&#8221; as defined in the Nasdaq listing standards, is a company of which more than 50% of the voting power for the election of directors is held by an individual, a group or another company. Controlled companies are not required to comply with certain Nasdaq listing standards relating to corporate governance, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the requirement that a majority of a company&#8217;s board of directors consist of independent directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the requirement that a company&#8217;s nominating and corporate governance committee be composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the requirement that a company&#8217;s compensation committee be composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If our largest stockholder were to obtain a majority of the voting power for the election of our directors, we would meet the definition of a &#8220;controlled company.&#8221; As a result, these requirements would not apply to us as long as we remain a &#8220;controlled company.&#8221;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Although we may soon qualify as a &#8220;controlled company,&#8221; we currently do not, and we do not expect to, rely on this exemption and we currently comply with, and we expect to continue to comply with, all relevant corporate governance requirements under the Nasdaq listing standards. However, if we were to utilize some or all of these exemptions, our stockholders may not have the same protections afforded to stockholders of companies that are subject to all of the Nasdaq listing standards that relate to corporate governance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business or our market, our stock price and trading volume could decline.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The trading market for our common stock is influenced by the research and reports that equity research analysts publish about us and our business. Equity research analysts may elect not to provide research coverage of our common stock, and such lack of research coverage may adversely affect the market price of our common stock. In the event we do have equity research analyst coverage, we will not have any control over the analysts, or the content and opinions included in their reports. The price of our common stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of us or fails to publish reports on us regularly, demand for our common stock could decrease, which in turn could cause our stock price or trading volume to decline.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are expected to take advantage of reduced disclosure and governance requirements applicable to smaller reporting companies and emerging growth companies, which could result in our common stock being less attractive to investors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have a public float of less than $250 million and therefore qualify as a smaller reporting company under the rules of the SEC. As a smaller reporting company, we are able to take advantage of reduced disclosure requirements, such as simplified executive compensation disclosures and reduced financial statement disclosure requirements in our SEC filings. Decreased disclosures in our SEC filings due to our status as a smaller reporting company may make it harder for investors to analyze our results of operations and financial prospects. We cannot predict if investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. We may take advantage of the reporting exemptions applicable to a smaller reporting company until we are no longer a smaller reporting company, which status would end once we have a public float greater than $250 million. In that event, we could still be a smaller reporting company if our annual revenues were below $100 million and we have a public float of less than $700 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are an emerging growth company (&#8220;EGC&#8221;), as defined in the Jumpstart Our Business Startups Act of 2012, as amended. For as long as we continue to be an EGC, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not EGCs, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding nonbinding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved. We may remain an EGC or until the earlier of (a) December 31, 2026, (b) the last day of the fiscal year in which we have total annual gross revenue of at least $1.235 billion or more, (c) the date we are deemed to be a large accelerated filer, which requires the market value of our common stock that is held by non-affiliates to exceed $700.0 million as of the prior June 30th, and (d) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">None.</span></div><div><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_31"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1C. Cybersecurity</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-41" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-42" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We recognize the critical importance of protecting the confidentiality, integrity and availability of our business operations and systems. With this in mind, we have implemented and maintain ongoing cybersecurity risk management practices, in accordance with our risk profile and business size, under the oversight of our Audit Committee that are designed to identify, assess, and mitigate cybersecurity risk. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-43">Our cybersecurity program is informed by the National Institute of Standards and Technology Cybersecurity Framework, and other applicable industry standards.</ix:nonNumeric> We <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-44">engage <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-45">third-party</ix:nonNumeric></ix:nonNumeric> service providers and vendors to assist us in managing our cybersecurity programs and information technology systems.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Cybersecurity Risk Management and Strategy; Effect of Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To identify and assess material risks from cybersecurity threats, we maintain a cybersecurity program to develop and implement effective systems and prepare for information security risks. We consider risks from cybersecurity threats alongside other company risks as part of our overall risk assessment process. We employ a range of tools and services supported by our third-party service providers, including regular network and endpoint monitoring to inform our risk identification and assessment, as well as undertaking the following activities: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">monitor emerging data protection laws and implement changes to our processes that are designed to comply with such laws;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">through our policies, practices and contracts (as applicable), require employees, as well as third parties that provide services on our behalf, to treat confidential information and data with care;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">employ technical safeguards that are designed to protect our information systems from cybersecurity threats, including firewalls, device encryption, multi-factor authentication, advanced threat protection for emails, anti-virus and anti-malware functionality and access controls, which are evaluated and improved from time to time;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">employ multiple backup systems for our data stored on our servers or other information systems with backup data stored in secure, offsite locations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">perform annual phishing tests with employees in an effort to deter and detect cyber threats; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">hold and maintain third-party cyber-liability insurance coverage, covering security and privacy matters, commensurate with industry standards for a company of our size and stage.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We face risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-46">During the reporting period, we have not identified any risks from cybersecurity threats, including as a result of previous cyber security incidents, that we believe have materially affected, or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition.</ix:nonNumeric> For more information, see the section in our Risk Factors in this Annual Report on Form 10-K under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Our internal information technology systems, or those of our vendors, collaborators or other contractors or consultants, may fail or suffer cybersecurity incidents, loss of data, and other disruptions, which could result in a material disruption of our product development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; which disclosures are incorporated by reference herein.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Cybersecurity Governance; Management</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-48" continuedAt="f-48-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-47" continuedAt="f-47-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-49" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-50">board</ix:nonNumeric> of directors considers cybersecurity risks as part of its risk oversight function and has delegated the oversight of cybersecurity and other information technology risks to our Audit Committee.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-51" continuedAt="f-51-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-52" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-53" escape="true">Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-54">General Counsel</ix:nonNumeric> who manages our contracted third-party managed security service provider.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-55" escape="true">Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above.</ix:nonNumeric> Our legal, finance, and operations teams oversee and review any reports of cybersecurity risks or breaches provided by our third-party managed security service provider. Additionally, our legal, finance, and operations teams review and assess potential </span></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-51-1"><ix:continuation id="f-48-1"><ix:continuation id="f-47-1">improvements to our cybersecurity policies and procedures with input from third-party vendors and professional services firms, as appropriate. As discussed above, the General Counsel reports to the Audit Committee of our board of directors about cybersecurity related matters, periodically.</ix:continuation></ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_34"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2021, we entered into a lease agreement for approximately 13,424 square feet of office and laboratory space in Boston, Massachusetts, which serves as our corporate headquarters.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The lease commenced in February 2022. The lease term is for eight years and expires February 28, 2030 and does not contain an option to renew. The initial annual rent was $1,235,008 with a 3% annual increase. We believe substantially all of our property and equipment is in good condition and that we have sufficient capacity to meet our current operational needs. See Note 10 to our consolidated financial statements included in Item 8 of this Annual Report on Form 10-K for additional information.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_37"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may be subject to various legal proceedings, claims and administrative proceedings that arise in the ordinary course of our business activities or otherwise. Although the results of any litigation and claims cannot be predicted with certainty, as of the date of this report, we do not believe we are party to any claim, proceeding or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to us, including any costs associated with the indemnification of directors and officers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_40"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Not applicable.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Part II</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_46"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Market Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our common stock trades under the symbol &#8220;ELTX&#8221; on the Nasdaq Capital Market and has been publicly traded under this symbol since June 1, 2023, prior to which it was traded under the symbol &#8220;ANGN&#8221;.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Holders of Record </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;10, 2026 there were approximately 197 holders of record of shares of our common stock. This number does not reflect the beneficial holders of our common stock who hold shares in street name through brokerage accounts or other nominees. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Unregistered Sales of Equity Securities</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">None.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Repurchases of Equity Securities </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">None. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Dividend Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have never declared or paid cash dividends on our common stock. We intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination related to dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, capital requirements, business prospects and other factors the board of directors deems relevant, and subject to the restrictions contained in any future financing instruments.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_49"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. [Reserved]</span></div><div style="margin-top:4pt;text-indent:22.5pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_52"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and the related notes appearing elsewhere in this Annual Report on Form 10-K. In addition to the historical financial information, this discussion contains forward-looking statements that involve risks, assumptions and uncertainties, such as statements of our plans, objectives, expectations, intentions, forecasts and projections. Our actual results and the timing of selected events could differ materially from those discussed in these forward-looking statements as a result of several factors, including those set forth under the section of this Annual Report on Form 10-K titled "Risk Factors," which you should read carefully to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section titled "Forward-Looking Statements" at the beginning of this report.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_55"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Overview</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, CRC, lung cancer and other mKRAS positive cancers. We intend to build on recent clinical successes in the personalized cancer immunotherapy space to develop effective, off-the-shelf immunotherapies. Our proprietary AMP technology aims to enhance the education, activation and amplification of cancer-specific T cells relative to conventional immunotherapy strategies, with the goal of promoting durable cancer immunosurveillance in patients. Recent advances have identified T cell responses as a key component of effective cancer immunotherapy and we believe our AMP technology can generate robust T cell responses in patients that can potentially translate to meaningful clinical benefit. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We believe the therapeutic utility of currently approved and development stage cancer immunotherapies is limited in many cases due to their inability to sufficiently localize to lymph nodes and adequately engage with the critical immune cells responsible for stimulating adaptive immunity.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP technology is specifically intended to localize payloads to lymph nodes leading to the generation of a robust T cell response that we believe is critical to generate an anticancer immune response.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our lead programs focus on our cancer immunotherapy product candidates, which target biologically validated driver tumor mutations using common and well-characterized neoantigens. This strategy results in an &#8220;off-the-shelf&#8221; therapeutic option allowing patients to receive treatment without delays due to manufacturing timelines and without the increased costs associated with personalized immunotherapy approaches.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our clinical pipeline includes the lymph node targeted cancer immunotherapy ELI-002 7P, currently being evaluated in a Phase 2 study, designed to stimulate an immune response against mKRAS pancreatic ductal adenocarcinoma (&#8220;PDAC&#8221;), the most common form of pancreatic cancer. The ELI-002 7P formulation is designed to provide broad immune responses targeting seven KRAS mutations that are observed in approximately 88% of PDAC patients and 25% of all solid tumors, thereby increasing the potential patient population for ELI-002 7P beyond PDAC alone. In August 2025, we announced that following the Independent Data Monitoring Committee&#8217;s (&#8220;IDMC&#8221;) pre-specified interim review of unblinded safety and efficacy data in our Phase 2 AMPLIFY-7P study in mKRAS-driven PDAC, the IDMC recommended that the trial continue to the final analysis without modifications. In addition, the IDMC confirmed the favorable safety profile of ELI-002 7P as of such date. We anticipate the final disease-free survival analysis to occur in the first half of 2026. ELI-002 2P (2-peptide formulation) has been studied previously in the Phase 1 (AMPLIFY-201) trial in patients with high relapse risk mKRAS-driven solid tumors, following surgery and chemotherapy. ELI-002 2P and ELI-002 7P also have been studied in patients with mKRAS-positive CRC in Phase 1 studies. The AMPLIFY-201 Phase 1 data for PDAC and CRC was presented at the ESMO Immuno-Oncology Congress 2024 and published in Nature Medicine (Wainberg et al, 2025) and included a 16.3-month median recurrence-free survival and 28.9-month median overall survival for the full study population</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> In the future, we plan to expand ELI-002 7P to other indications including mKRAS positive lung cancer and other mKRAS positive cancers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our preclinical pipeline includes the lymph node targeted immunotherapies ELI-007, currently being evaluated in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-(&#8220;BRAF&#8221;) driven cancers, and ELI-008, currently being evaluated in preclinical studies for use in the treatment of mutated tumor protein p53 (&#8220;TP53&#8221;)- expressing cancers. We believe that each of our immunotherapy product candidates, if approved, has the potential to reduce the risk of recurrence of tumors carrying specific oncogenic driver mutations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our operations to date have been financed primarily by aggregate net proceeds of $219.7 million from the issuance of common stock, pre-funded warrants, convertible preferred stock, convertible notes, promissory notes, the exercise of stock options and common warrants, the private placement of our securities, at-the-market offerings, and proceeds from the Merger with Angion Biomedica Corp. (&#8220;Angion&#8221;). Since inception, we have had significant annual operating losses. Our net loss was $39.6 million and $51.9 million for the years ended December&#160;31, 2025 and 2024, respectively. As of December&#160;31, 2025, we had an accumulated deficit of $233.7 million and $18.6 million in cash and cash equivalents.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) was incorporated in Delaware as Vedantra Pharmaceuticals Inc. in August 2011. In 2023, the Company completed a reverse merger transaction with Angion, a clinical-stage biotechnology company, Arkham Merger Sub, Inc., a wholly owned subsidiary of Angion (&#8220;Merger Sub&#8221;), and Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;), pursuant to which Merger Sub merged with and into Former Elicio, with Former Elicio surviving the merger as a wholly owned subsidiary of Angion (the &#8220;Merger&#8221;). On June 1, 2023, the Company completed the Merger in accordance with the terms and conditions of the Merger Agreement and Angion changed its name from &#8220;Angion Biomedica Corp.&#8221; to &#8220;Elicio Therapeutics, Inc.&#8221; Following the Merger, Former Elicio and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established in August 2019 for the purpose of qualifying for research credits for studies conducted in Australia, became our wholly owned subsidiaries.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway. As of the filing date of this Annual Report on Form 10-K, we believe that our cash on hand will enable us to fund our operations into the third quarter of 2026 based on our current financial operating plan. This period could be shortened or lengthened if there are any significant increases or decreases in planned or actual spending on development programs or more rapid progress of development programs than anticipated. There is no assurance that financing will be available when needed to allow us to continue as a going concern. Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the consolidated financial statements, raise substantial doubt about our ability to continue as a going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will require additional financing to continue this development. We plan to address this condition through the sale of our common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If we are unable to obtain additional capital when and as needed to continue as a going concern, we might have to further reduce or scale back our operations and/or liquidate our assets, and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K have been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Our consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our accounts payable and accrued expenses. We expect to continue to incur net losses for the foreseeable future, and we expect our research and development expenses, general and administrative expenses, and capital expenditures will continue to increase. In particular, we expect our expenses to increase as we continue our development of, and seek regulatory approvals </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">for, our product candidates, as well as hire additional personnel, pay fees to outside consultants, attorneys and accountants, and incur other increased costs associated with being a public company. In addition, if and when we seek and obtain regulatory approval to commercialize any product candidate, we will also incur increased expenses in connection with commercialization and marketing of any such product. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending on the timing of our clinical trials and our expenditures on other research and development activities. We anticipate that our expenses will increase significantly in connection with our ongoing activities, as we:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">advance our lead product candidate, ELI-002 7P, to late-stage clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">advance our preclinical programs to clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expand our pipeline of product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">seek regulatory approval for our investigational medicines;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">maintain, expand, protect and defend our intellectual property portfolio;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">acquire or in-license technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expand our clinical, scientific, management and administrative teams; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">operate as a public company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of the filing date of this Annual Report on Form 10-K, we believe that our cash on hand will enable us to fund our operations into the third quarter of 2026 based on our current plan. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. To finance our operations beyond that point we will need to raise additional capital, which cannot be assured.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have not had any products approved for sale. We do not expect to generate any product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our product candidates. If we obtain regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. As a result, until such time, if ever, that we can generate substantial product revenue, we expect to finance our cash needs through equity offerings, debt financings or other capital sources, including collaborations, licenses or similar arrangements. However, we may be unable to raise additional funds or enter into such other arrangements when needed or on favorable terms, if at all. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies, including our research and development activities. If we are unable to raise capital, we will need to delay, reduce or terminate planned activities to reduce costs.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_58"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Components of Results of Operations</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following discussion summarizes the key factors our management believes are necessary for an understanding of our financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Expenses</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our operating expenses since inception have consisted primarily of research and development expenses and general and administrative costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses consist primarily of costs incurred for the development of our product candidates and our drug discovery efforts, which include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">personnel costs, which include salaries, benefits, and equity-based compensation expense;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expenses incurred under agreements with consultants and contract organizations that conduct research and development activities on our behalf;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">costs related to sponsored research service agreements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">costs related to production of preclinical and clinical materials, including fees paid to contract manufacturers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">laboratory and vendor expenses related to the execution of preclinical studies and planned clinical trials; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">laboratory supplies and equipment used for internal research and development activities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expense all research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and service providers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses are not currently tracked on a program-by-program basis. We use our personnel and infrastructure resources across multiple research and development programs directed toward identifying and developing </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">product candidates. Substantially all our research and development costs are incurred on the development of ELI-002 7P and our preclinical candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We expect our research and development expenses to increase substantially for the foreseeable future as we continue to invest in research and development activities related to developing our product candidates, including investments in conducting clinical trials, manufacturing and otherwise advancing our programs. The process of conducting the clinical research necessary to obtain regulatory approval is costly and time-consuming, and the successful development of our product candidates is highly uncertain. At this time, we cannot reasonably estimate the nature, timing and costs of the efforts that will be needed to complete the development of, or the period, if any, in which material net cash inflows may commence from ELI-002 7P or any of our preclinical candidates. This is due to the numerous risks and uncertainties associated with developing drugs, including the uncertainty of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the scope, rate of progress and expense of our research and development activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">clinical trials and early-stage results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the terms and timing of regulatory approvals; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability to market, commercialize and achieve market acceptance for ELI-002 7P, or any of our preclinical candidates that we or our future collaboration partners may develop in the future. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Any of these variables with respect to the development of ELI-002 7P, or any other of our preclinical candidates that we may develop could result in a significant change in the costs and timing associated with the development of such candidates. For example, if the FDA or other regulatory authority were to require us to conduct preclinical and clinical studies beyond those which we currently anticipate will be required for the completion of clinical development or if we experience significant delays in enrollment in any clinical trials, we could be required to expend significant additional financial resources and time on the completion of our clinical development programs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our general and administrative expenses consist primarily of personnel costs, including equity-based compensation, and other expenses for outside professional services, including marketing, legal, audit and accounting, facility-related costs not otherwise included in research and development expenses, and recruiting. We expect our general and administrative expenses to increase over the next several years to support our continued research and development activities, manufacturing activities, increased costs of expanding our operations and operating as a public company. These increases will likely include increases related to the hiring of additional personnel and legal, regulatory and other fees and services associated with maintaining compliance with the Nasdaq Marketplace Rules or the Nasdaq Listing Rules and SEC requirements, accounting and audit fees, director and officer insurance costs and investor relations costs associated with being a public company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the years ended December&#160;31, 2025 and 2024, other income and expense consisted primarily of interest income and expense, foreign exchange transaction gains and losses, gain on sale of equipment, grant income, gains and losses related to the re-measurement of our warrant liabilities, and a loss on issuance of the July 2024 Pre-Funded Warrants. </span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_61"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Years Ended December&#160;31, 2025 and 2024</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the periods indicated:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$ Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(In thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">24,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">33,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(8,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(26.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">11,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">37,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">44,986&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(7,272)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(37,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(44,986)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(16.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(6,912)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(73.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(39,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(51,898)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">12,327</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:1pt;text-indent:18pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development Expenses</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses decreased by $8.8&#160;million, or 26.0%, for the year ended December&#160;31, 2025 compared to the year ended December&#160;31, 2024. The net decrease in research and development expenses was primarily due to lower clinical costs as patients progressed into the observation phase the Phase 2 study of ELI-002 7P.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">General and administrative expenses increased by $1.5&#160;million, or 13.1%, for the year ended December&#160;31, 2025 compared to the year ended December&#160;31, 2024. The increase was primarily due to an increase in headcount for 2025. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Other Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other expense for the year ended December&#160;31, 2025 was $1.9&#160;million compared to other expense of</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">$6.9&#160;million for the year ended December&#160;31, 2024. The decrease of $5.1&#160;million was primarily due to the change in fair value associated with the outstanding liability-classified common warrants and the losses recognized from the March 2024 Offering and the July 2024 Public Offering.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_64"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Sources and Uses of Liquidity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Since inception, we have had significant operating losses. Our net loss was $39.6 million and $51.9 million for the years ended December&#160;31, 2025 and 2024, respectively. As of December&#160;31, 2025, we had an accumulated deficit of $233.7 million and $18.6 million in cash and cash equivalents. Our operations through December&#160;31, 2025 have been financed primarily by aggregate net proceeds of $219.7 million from the issuance of common stock, pre-funded warrants, convertible preferred stock, convertible notes, promissory notes, the exercise of stock options and common warrants, the private placement of our securities, at-the-market offerings, and proceeds from the Merger with Angion. Our sources of liquidity for the years ended December&#160;31, 2025 and 2024 are described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, we filed a registration statement on Form S-3 (the &#8220;Prior Shelf Registration St</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">atement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $100 million. Simultaneously, we entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $21 million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#8220;2022 ATM Program"). During the year ended December&#160;31, 2024, we issued and sold a total of 650,179 shares of common stock under the 2022 ATM Program for aggregate net proceeds of $5.4 million after deducting sales commissions. In May 2024, we terminated the 2022 ATM Program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, we filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, we entered into the Capital on Demand</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services, LLC, as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221; and, collectively with the 2022 ATM Program, the &#8220;ATM Programs&#8221;). During the year ended December&#160;31, 2025, we issued and sold 1,717,507 shares of common stock for net proceeds of $16.2 million</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">under the 2024 ATM Program. During the year ended December&#160;31, 2024, we issued and sold 53,795 shares of common stock for net proceeds of $0.3 million under the 2024 ATM Program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Private Placement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, we entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, LLC (&#8220;GKCC&#8221;), an entity controlled by a member of Elicio&#8217;s board of directors, providing for the issuance and sale by Elicio to GKCC of pre-funded warrants (the &#8220;March 2024 Pre-Funded Warrants&#8221;) to purchase up to 1,032,702 shares of common stock, at a purchase price per March 2024 Pre-Funded Warrant of $5.81 (the &#8220;March 2024 Offering&#8221;). Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds from the March 2024 Offering were $6.0&#160;million. Refer to Note 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Public Offerings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, we closed an underwritten public offering (the &#8220;July 2024 Public Offering&#8221;), consisting of (i) 500,000 shares of common stock (the &#8220;July 2024 Shares&#8221;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#8220;July 2024 Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock, (the &#8220;July 2024 Common Warrants&#8221;). Each July 2024 Pre-Funded Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable and will expire five years from the issuance date. The net proceeds from the July 2024 Public Offering were $10.9&#160;million after deducting commissions and other transaction costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The July 2024 Public Offering consisted of the July 2024 Shares or in lieu thereof, the July 2024 Pre-Funded Warrants, and accompanying July 2024 Common Warrants. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $5.00 per July Share and accompanying July 2024 Common Warrant, and each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $4.99 per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant, which represented the combined purchase price per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant less the $0.01 per share exercise price for each such July 2024 Pre-Funded Warrant. Refer to Notes 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, we entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which we agreed to issue and sell, in a registered direct offering by Elicio directly to the Investors (the &#8220;January 2025 Offering&#8221;): (i) an aggregate of 1,261,830 shares of common stock (the &#8220;January 2025 Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#8220;January 2025 Common Warrants&#8221;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire 5 years from the issuance date. The January 2025 Offering resulted in net proceeds of $9.2&#160;million after deducting the placement agent&#8217;s fees and related offering expenses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, we entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC pursuant to which we issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $20.0&#160;million (the &#8220;Convertible Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. We received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#8217;s common stock. In March 2025, we issued 3,500,573 shares of common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3 million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, we entered into a note purchase agreement (the &#8220;June 2025 Promissory Note Financing&#8221;) with GKCC pursuant to which we issued a Senior Secured Promissory Note due June 3, 2028 (the &#8220;June 2025 Promissory Note&#8221;) in the principal amount of $10.0 million. In connection with the June 2025 Promissory Note Financing, we issued to GKCC a warrant to purchase an aggregate of 103,225 shares of common stock (the &#8220;June 2025 Warrant&#8221;). The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. We received net proceeds of approximately $9.9&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, and to a lesser extent, general and administrative expenditures. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable and accrued expenses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the consolidated financial statements, raise substantial doubt about our ability to continue as a going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will require additional financing to continue this development. The consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K have been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. We plan to address this condition through the sale of our common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. However, there is no assurance that we will be successful in raising additional capital or that such additional funds will be available on acceptable terms, if at all. Should we be unable to raise this amount of capital our operating plans will be limited to the amount of capital that we can access. We may also consider steps to reduce our operating expenses. There can be no assurances that we will be successful in any of the foregoing.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Summary Statement of Cash Flows</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth a summary of our net cash flow activity for the years ended December&#160;31, 2025 and 2024 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net cash provided by (used in)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(36,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(37,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">36,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">42,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Effect of foreign currency on cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net (decrease) increase in cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(225)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5,191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Operating activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December&#160;31, 2025, net cash used in operating activities was $37.0&#160;million, which primarily consisted of a net loss of $39.6 million and a change in net operating assets and liabilities of $3.4 million partially offset by net non-cash charges of $6.1 million. The change in net operating assets and liabilities of $3.4 million was the result of a $1.2 million decrease in the deferred research obligation, a $1.1 million decrease in prepaid expenses and other current assets, a $0.2 million increase in other long-term prepaid assets, a $0.9 million decrease in the operating lease liability, and a net decrease in accounts payable and accrued expenses of $2.4 million. The $6.1 million of net non-cash charges were related to $1.9 million of change in the fair value of warrant liabilities, $2.7 million of stock-based compensation expense, $1.1 million related to amortization of the right-of-use (&#8220;ROU&#8221;) asset and debt discount, $0.1 million of non-cash interest expense, and $0.2 million of depreciation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December&#160;31, 2024, net cash used in operating activities was $37.1&#160;million, which primarily consisted of a net loss of $51.9&#160;million and a change in net operating assets and liabilities of $3.9 million partially offset by net non-cash charges of $10.9 million. The change in net operating assets and liabilities of $3.9 million was the result of a $0.5 million increase in the deferred research obligation, an $0.8 million decrease in prepaid expenses and other current assets, a $2.2 million decrease in other long-term prepaid assets, a $0.9 million decrease in the operating lease liability, and a net increase in accounts payable and accrued expenses of $1.3 million. The $10.9 million of net non-cash charges were related to $3.9 million of change in the fair value of warrant liabilities, $3.5 million loss on the issuance of the pre-funded warrants and common warrants from the March 2024 Offering and the July 2024 Public Offering, $1.5 million of stock-based compensation expense, $0.9 million related to amortization of the ROU asset, $0.5 million related to issuance costs for the pre-funded warrants and common warrants from the March 2024 Offering and the July 2024 Public Offering, $0.3 million of depreciation, $0.2 million of non-cash interest expense, and $0.1 million of amortization of debt discount.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Investing activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the years ended December&#160;31, 2025 and 2024, net cash provided by or used in investing activities was immaterial.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Financing activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December&#160;31, 2025, net cash provided by financing activities was $36.7 million as a result of net cash proceeds of $16.2 million from the issuance of shares of common stock under the 2024 ATM Program, $9.9 million from the June 2025 Promissory Note Financing, $9.2&#160;million from the January 2025 Offering, $1.3 million from the exercise of common warrants, and $0.1 million from the exercise of stock options. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December&#160;31, 2024, net cash provided by financing activities was $42.3 million comprised of $19.7 million of net proceeds from the issuance of the Convertible Note, $11.5 million of proceeds from the issuance of common warrants related to the July 2024 Public Offering, $6.0 million of proceeds from the issuance of common warrants related to the March 2024 Offering, net cash proceeds of $4.6 million from the issuance of shares of common stock under the ATM Programs, and $1.1 million from the issuance of shares of common stock related to the July 2024 Public Offering, offset by $0.5 million</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">of issuance costs for the pre-funded warrants and common warrants. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Future Cash Needs and Funding Requirements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on our current operating plan, as of the filing date of this Annual Report on Form 10-K, we believe our cash and cash equivalents will be sufficient to fund our planned operations into the third quarter of 2026. However, we have based our projections of operating capital requirements on assumptions that may prove to be incorrect and we may use all our available capital resources sooner than we expect. We are unable to estimate the exact amount of our operating capital requirements. The amount and timing of our future funding requirements will depend on many factors, including, but not limited to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the scope, progress, results and costs of researching and developing product candidates, and conducting preclinical studies and clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the outcome of any future clinical trials, for any existing or future product candidates;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">whether we are able to take advantage of any FDA expedited development and approval programs for any of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the outcome, costs and timing of seeking, obtaining and maintaining FDA and any foreign regulatory approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the costs associated with any delays we may encounter as a result of evolving regulatory requirements or adverse results with respect to any of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the number and characteristics of product candidates we pursue, including product candidates in preclinical development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the ability of our product candidates to progress through clinical development successfully;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">our need to expand our research and development activities, including to conduct additional clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">market acceptance of our product candidates, including physician adoption, market access, pricing and reimbursement;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the costs of acquiring, licensing or investing in businesses, products, product candidates and technologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">our ability to maintain, expand and defend the scope of our intellectual property portfolio, including the amount and timing of any payments potentially required to make, or that we may receive, in connection with the licensing, filing, prosecution, defense and enforcement of any patents or other intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">our need and ability to hire additional personnel, including management, clinical development, medical and commercial personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the effect of competing technology, market developments and government policy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the costs associated with being a public company, including our need to implement additional internal systems and infrastructure, including financial and reporting systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the costs associated with securing and establishing commercialization and manufacturing capabilities, as well as those associated with packaging, warehousing and distribution;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the economic and other terms, timing of and success of our existing licensing arrangements and any collaboration, licensing or other arrangements into which we may enter in the future and the timing and amount of payments thereunder; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.46pt">the timing, receipt and amount of sales and general commercial success of any future approved products, if any.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Until such time as we can generate significant revenue from sales of product candidates, if ever, we expect to finance our operations through the sale of our common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. Adequate funding may not be available to us on acceptable terms, or at all. To the extent we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be or could be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through additional collaborations, or other similar arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to and/or may reduce the value of our common stock. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_67"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements in this Annual Report on Form 10-K, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Research and Development Costs</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We incur, and expect to continue to incur, substantial expenses associated with manufacturing and clinical trials. Accounting for clinical trials relating to activities performed by contract research organizations (&#8220;CROs&#8221;) and other external vendors requires management to make significant estimates in regard to the timing and accounting for these expenses. We estimate costs of research and development activities conducted by service providers, which include the conduct of sponsored research, preclinical studies and contract manufacturing activities. The diverse nature of services being provided under CROs and other arrangements, the different compensation arrangements that exist for each type of service and the lack of timely information related to certain clinical activities complicates the estimation of accruals for services rendered by CROs and other vendors in connection with clinical trials. We record the estimated costs of research and development activities based upon the estimated amount of services provided but not yet invoiced and include these costs in the accrued expenses on the balance sheets and within research and development expense on the consolidated statements of operations and comprehensive loss. In estimating the duration of a clinical study, we evaluate the start-up, treatment and wrap-up periods, compensation arrangements and services rendered attributable to each clinical trial and fluctuations are regularly tested against payment plans and trial completion assumptions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We estimate these costs based on factors such as estimates of the work completed and budget provided and in accordance with agreements established with our collaboration partners and third-party service providers. We make significant judgments and estimates in determining the accrued liabilities balances in each reporting period. As actual costs become known, we adjust our accrued liabilities. We have not experienced any material differences between accrued costs and actual costs incurred since our inception.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our expenses related to clinical trials will be based on estimates of patient enrollment and related expenses at clinical investigator sites as well as estimates for the services received and efforts expended pursuant to contracts with multiple research institutions and CROs that may be used to conduct and manage clinical trials on our behalf. We will accrue expenses related to clinical trials based on contracted amounts applied to the level of patient enrollment and activity. If timelines or contracts are modified based upon changes in the clinical trial protocol or scope of work to be performed, we will modify our estimates of accrued expenses accordingly on a prospective basis.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_70"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">See Note 2, &#8220;Summary of Significant Accounting Policies&#8221; in the Notes to the Consolidated Financial Statements set forth in Item 8 of this Annual Report on Form 10-K for a full description of recent accounting standards.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_73"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are a smaller reporting company and an emerging growth company, as defined under the Jumpstart Our Business Startups (&#8220;JOBS&#8221;) Act. Under the JOBS Act, emerging growth companies can delay the adoption of new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. Other exemptions and reduced reporting requirements under the JOBS Act for emerging growth companies include presentation of only two years of audited financial statements in a registration statement for an initial public offering, an exemption from the requirement to provide an auditor's report on internal controls over financial reporting pursuant to Sarbanes-Oxley Act of 2002, as amended (&#8220;Sarbanes-Oxley&#8221;), an exemption from any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation, and less extensive disclosure about our executive compensation arrangements. We have elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that (i) we are no longer an emerging growth company or (ii) we affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our consolidated financial statements may not be comparable to companies that comply with new or revised accounting standards as of public company effective dates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We will remain an emerging growth company until the earliest of (i) December 31, 2026, (ii) the last day of our first fiscal year in which we have total annual gross revenue of $1.235 billion or more, (iii) the date on which we are deemed to be a "large accelerated filer," as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which means the market value of equity securities that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter and (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Even after we no longer qualify as an emerging growth company, we may still qualify as a "smaller reporting company" and/or &#8220;non-accelerated filer&#8221; which may allow us to take advantage of many of the same exemptions from disclosure requirements including not being required to comply for a period of time with the auditor attestation requirements of Section 404 of Sarbanes-Oxley, and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_76"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Financial Statements and Supplementary Data.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of Elicio Therapeutics, Inc., listed below are set forth in Item 8 of this Annual Report for the years ended December&#160;31, 2025 and 2024:</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:92.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_82">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> (Baker Tilly US, LLP, Tewksbury, Massachusetts, PCAOB ID: 23)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_82">105</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_85">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_85">106</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_91">Consolidated Statements of Operations and Comprehensive Loss </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_91">107</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_94">Consolidated Statements of Stockholders' Equity (Deficit)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_94">108</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_100">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_100">110</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_103">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_103">112</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To the Stockholders and the Board of Directors of Elicio Therapeutics, Inc.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Opinion on the Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) as of December 31, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity (deficit) and cash flows for the years then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2025 and 2024, and the consolidated results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Going Concern Uncertainty</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses and negative cash flows from operating activities since inception, and has an accumulated deficit as of December 31, 2025, that raises substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis for Opinion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">a reasonable basis for our opinion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-56">Baker Tilly US, LLP</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-57">Tewksbury, Massachusetts</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">March&#160;12, 2026</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We have served as the Company's auditor since 2019.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-58">18,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-59">17,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Restricted cash, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="3" id="f-60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">1,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="f-62">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">19,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">20,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-66">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-67">483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease, right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-68">4,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-69">5,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Restricted cash, noncurrent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-70">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-71">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other long-term prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="3" id="f-72">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="3" id="f-73">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-74">25,862</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-75">28,178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Liabilities, convertible preferred stock, and stockholders&#8217; equity (deficit)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="f-76">672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-77">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">6,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-79">8,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Deferred research obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="f-80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-83">901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">8,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">11,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:WarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-86">2,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:WarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-87">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-88">4,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-89">5,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Long-term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-90">9,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">20,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-92">24,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-93">39,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Commitments and contingencies&#8212;Note 9</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-94"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-95"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Stockholders' equity (deficit):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-96"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-97">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-98"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-99">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="3" id="f-100"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="3" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="3" id="f-102"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="3" id="f-103">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-104">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-106"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-107">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-108"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-109">300,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-110">17,814,762</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-111">11,043,837</ix:nonFraction> shares issued at December 31, 2025 and 2024, respectively; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-112">17,800,307</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-113">11,029,382</ix:nonFraction> shares outstanding as of December 31, 2025 and 2024, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-114">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-115">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-116"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-117">14,455</ix:nonFraction></ix:nonFraction> shares outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-118">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-119">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-120">235,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-121">183,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-122">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-123">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-124">233,672</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-125">194,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total stockholders' equity (deficit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-126">1,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-127">11,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total liabilities, convertible preferred stock, and stockholders&#8217; equity (deficit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-128">25,862</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-129">28,178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations and Comprehensive Loss </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-130">24,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-131">33,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-132">12,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-133">11,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-134">37,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-135">44,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-136">37,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-137">44,986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other (expense) income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-138">1,915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-139">3,886</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Loss on issuance of pre-funded warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-140">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-141">3,502</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Gain on sale of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="f-142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="f-143">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign exchange transaction gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-145">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Grant income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:GrantRevenueNonoperating" scale="3" id="f-146">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:GrantRevenueNonoperating" format="ixt:fixed-zero" scale="3" id="f-147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeOperatingAndNonoperating" scale="3" id="f-148">776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestIncomeOperatingAndNonoperating" scale="3" id="f-149">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-150">1,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-151">455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-152">1,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-153">6,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-155">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-156">39,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-157">51,898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Other comprehensive gain:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.6pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-158">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-159">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-160">39,523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-161">51,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net loss per common share, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-162"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-163">2.58</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-164"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-165">4.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted average common shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-166"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-167">15,312,751</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-168"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-169">12,202,996</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.594%"><tr><td style="width:1.0%"/><td style="width:20.913%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.336%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.893%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.745%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.114%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.967%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.589%"/><td style="width:0.1%"/></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Accumulated <br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total <br/>Stockholders' Equity (Deficit) </span></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Par Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-170">11,043,837</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-171">110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-172">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-173">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-174">183,004</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-175">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-176">194,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-177">11,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-178">32,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-179">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-180">149</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-181">0.5</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-182">1,717,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-183">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-184">16,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-185">16,244</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from January 2025 Offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-186">0.8</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-187">1,261,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-188">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-189">9,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-190">9,143</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from the exercise of July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="angn:StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-191">258,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" scale="3" id="f-192">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-193">3,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-194">3,421</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Conversion of Convertible Note into common stock, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-195">0.3</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-196">3,500,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-197">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-198">20,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-199">20,176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common warrants associated with June 2025 Promissory Note</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="f-200">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="f-201">641</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-202">2,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-203">2,697</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-204">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-205">48</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-206">39,571</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-207">39,571</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-208">17,814,762</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-209">178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-210">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-211">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-212">235,407</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-213">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-214">233,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-215">1,636</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' (Deficit) Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.769%"><tr><td style="width:1.0%"/><td style="width:23.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.704%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.439%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.497%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.413%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="45" style="padding:0 1pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Accumulated <br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total <br/>Stockholders'<br/>(Deficit) Equity</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Par Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-216">9,618,178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-217">96</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-218">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-219">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-220">153,827</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-221">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-222">142,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-223">11,373</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-224">0.1</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-225">703,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-226">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-227">5,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-228">5,635</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-229">9,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="f-230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-231">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-232">39</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Issuance of common stock upon settlement of restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-233">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="f-234">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-235">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-236">25</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Issuance of common stock from the July 2024 Public Offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-237">0.5</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-238">510,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-239">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-240">1,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-241">1,080</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from the exercise of July 2024 Pre-Funded Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="angn:StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-242">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" scale="3" id="f-243">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-244">1,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-245">1,016</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of liability-classified warrants to equity classified warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="angn:ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" format="ixt:num-dot-decimal" scale="3" id="f-246">19,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" format="ixt:num-dot-decimal" scale="3" id="f-247">19,944</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-248">1,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-249">1,452</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-250">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-251">22</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-252">51,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-253">51,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-254">11,043,837</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-255">110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-256">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-257">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-258">183,004</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-259">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-260">194,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-261">11,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_100"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-262">39,571</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-263">51,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Depreciation </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-264">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-265">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Amortization of right-of-use assets, operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-266">924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-267">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-268">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-269">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Non-cash interest expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:InterestExpenseNoncash" scale="3" id="f-270">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:InterestExpenseNoncash" scale="3" id="f-271">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Costs expensed upon the issuance of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:CostsExpensedUponTheIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:CostsExpensedUponTheIssuanceOfWarrants" scale="3" id="f-273">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-274">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-275">3,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Loss on issuance of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-277">3,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-278">2,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-279">1,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Gain on disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="f-280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-281">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-282">1,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-283">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other long-term prepaid assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-284">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-285">2,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-286">366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-287">3,331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-288">1,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-289">4,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Deferred research obligation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-290">1,169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="f-291">475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-292">901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-293">911</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net cash used in operating activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-294">36,952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-295">37,068</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Cash flows from investing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Purchases of property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-296">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-297">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-299">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net cash used in investing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-300">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-301">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Cash flows from financing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from the exercise of common stock warrants</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-302">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="f-303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from June 2025 Promissory Note, net of issuance costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-304">9,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="f-305">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock warrants from March 2024 Offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-307">5,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock warrants from July 2024 Public Offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" format="ixt:fixed-zero" scale="3" id="f-308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" format="ixt:num-dot-decimal" scale="3" id="f-309">11,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-310">16,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-311">4,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock from July 2024 Public Offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" format="ixt:fixed-zero" scale="3" id="f-312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" format="ixt:num-dot-decimal" scale="3" id="f-313">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Payment of warrant issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:PaymentOfWarrantIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:PaymentOfWarrantIssuanceCosts" scale="3" id="f-315">549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from issuance of Convertible Note, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:fixed-zero" scale="3" id="f-316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-317">19,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock and common warrants from January 2025 Offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="f-318">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="f-319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-320">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-321">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net cash provided by financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-322">36,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-323">42,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Effect of foreign currency on cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-324">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-325">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="f-326">225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-327">5,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Cash, cash equivalents and restricted cash at the beginning of the year</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-328">19,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-329">14,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Cash, cash equivalents and restricted cash at the end of the year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-330">19,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-331">19,492</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Components of cash, cash equivalents and restricted cash:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-332">18,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-333">17,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="f-334">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-335">1,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-336">19,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-337">19,492</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.786%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Supplemental disclosure of noncash investing and financing activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Fair value of pre-funded warrants at issuance date</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:FairValueOfPreFundedWarrants" format="ixt:fixed-zero" scale="3" id="f-338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:FairValueOfPreFundedWarrants" format="ixt:num-dot-decimal" scale="3" id="f-339">13,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Fair value of common warrants at issuance date</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:FairValueOfCommonStockWarrants" format="ixt:fixed-zero" scale="3" id="f-340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:FairValueOfCommonStockWarrants" format="ixt:num-dot-decimal" scale="3" id="f-341">6,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Fair value of common warrants upon settlement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:FairValueOfCommonStockWarrantsUponSettlement" format="ixt:num-dot-decimal" scale="3" id="f-342">2,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:FairValueOfCommonStockWarrantsUponSettlement" format="ixt:fixed-zero" scale="3" id="f-343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accretion of promissory note to face value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:AccretionOfPromissoryNoteToFaceValue" format="ixt:fixed-zero" scale="3" id="f-344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:AccretionOfPromissoryNoteToFaceValue" scale="3" id="f-345">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Fair value of common warrants issued with January 2025 Offering</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:WarrantIssuedStockIssuance" format="ixt:num-dot-decimal" scale="3" id="f-346">9,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:WarrantIssuedStockIssuance" format="ixt:fixed-zero" scale="3" id="f-347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Fair value of common warrants issued with June 2025 Promissory Note</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:WarrantIssuedDebtIssuance" scale="3" id="f-348">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:WarrantIssuedDebtIssuance" format="ixt:fixed-zero" scale="3" id="f-349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Non-cash vesting of restricted common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:VestingOfRestrictedCommonStockNoncash" format="ixt:fixed-zero" scale="3" id="f-350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:VestingOfRestrictedCommonStockNoncash" scale="3" id="f-351">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Conversion of related-party senior note and interest into common stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ConversionOfStockAmountIssued1" format="ixt:num-dot-decimal" scale="3" id="f-352">20,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ConversionOfStockAmountIssued1" format="ixt:fixed-zero" scale="3" id="f-353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:1pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_106"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 1&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-354" continuedAt="f-354-1" escape="true">Description of the Business and Financial Condition</ix:nonNumeric></span></div><ix:continuation id="f-354-1" continuedAt="f-354-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic, colorectal cancer, lung cancer and other mKRAS positive cancers. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#8220;ESC&#8221;), an investment company, Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;) and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#8220;Elicio&#8221; throughout these consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Liquidity and Going Concern</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has experienced net losses and negative cash flows from operating activities since inception. As of December&#160;31, 2025, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-355">233.7</ix:nonFraction>&#160;million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. Our sources of liquidity for the years ended December&#160;31, 2025 and 2024 are described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a registration statement on Form S-3 (the &#8220;Prior Shelf Registration St</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">atement&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;) that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-356">100</ix:nonFraction> million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-357">21</ix:nonFraction> million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#8220;2022 ATM Program"). During the year ended December&#160;31, 2024, the Company issued and sold a total of <ix:nonFraction unitRef="shares" contextRef="c-48" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-358">650,179</ix:nonFraction> shares of common stock under the 2022 ATM Program for aggregate net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-359">5.4</ix:nonFraction> million after deducting sales commissions. In May 2024, the Company terminated the 2022 ATM Program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, the Company filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-360">200</ix:nonFraction>&#160;million. Simultaneously, the Company entered into the Capital on Demand</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services, LLC, as agent, to provide for the issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-361">40</ix:nonFraction>&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221; and, collectively with the 2022 ATM Program, the &#8220;ATM Programs&#8221;). During the year ended December&#160;31, 2025, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-362">1,717,507</ix:nonFraction> shares of common stock for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-363">16.2</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">under the 2024 ATM Program. During the year ended December&#160;31, 2024, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-52" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-364">53,795</ix:nonFraction> shares of common stock for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-365">0.3</ix:nonFraction> million under the 2024 ATM Program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Private Placement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, LLC (&#8220;GKCC&#8221;), an entity controlled by a member of Elicio&#8217;s board of directors, providing for the issuance and sale by Elicio to GKCC of pre-funded warrants (the &#8220;March 2024 Pre-Funded Warrants&#8221;) to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-53" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-366">1,032,702</ix:nonFraction> shares of common stock, at a purchase price per March 2024 Pre-Funded Warrant of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-53" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-367">5.81</ix:nonFraction> (the &#8220;March 2024 Offering&#8221;). Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-53" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-368">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds from the March 2024 Offering were $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-369">6.0</ix:nonFraction>&#160;million. Refer to Note 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Public Offerings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed an underwritten public offering (the &#8220;July 2024 Public Offering&#8221;), consisting of (i) <ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-370">500,000</ix:nonFraction> shares of common stock (the &#8220;July 2024 Shares&#8221;), (ii) pre-funded warrants exercisable for <ix:nonFraction unitRef="shares" contextRef="c-56" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-371">1,800,000</ix:nonFraction> shares of common stock (the &#8220;July 2024 Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-57" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-372">2,300,000</ix:nonFraction> shares of common stock, (the &#8220;July 2024 Common Warrants&#8221;). Each July 2024 Pre-Funded Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-58" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-373">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-59" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-374">5.00</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-60" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-375">five years</ix:nonNumeric> from the issuance date. The net proceeds from the July 2024 Public Offering were $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-376">10.9</ix:nonFraction>&#160;million after deducting commissions and other transaction costs.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-354-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The July 2024 Public Offering consisted of the July 2024 Shares or in lieu thereof, the July 2024 Pre-Funded Warrants, and accompanying July 2024 Common Warrants. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-59" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-377">5.00</ix:nonFraction> per July Share and accompanying July 2024 Common Warrant. Each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-61" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-378">4.99</ix:nonFraction> per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant, which represented the combined purchase price per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant less the $<ix:nonFraction unitRef="usdPerShare" contextRef="c-56" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-379">0.01</ix:nonFraction> per share exercise price for each such July 2024 Pre-Funded Warrant. The July 2024 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-57" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-380">5.00</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-57" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-381">five years</ix:nonNumeric> from the issuance date. Refer to Notes 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by Elicio directly to the Investors (the &#8220;January 2025 Offering&#8221;): (i) an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-62" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-382">1,261,830</ix:nonFraction> shares of common stock (the &#8220;January 2025 Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-63" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-383">1,261,830</ix:nonFraction> shares of common stock (the &#8220;January 2025 Common Warrants&#8221;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-384">7.925</ix:nonFraction>. The January 2025 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-385">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-63" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-386">five years</ix:nonNumeric> from the issuance date. The January 2025 Offering resulted in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-387">9.2</ix:nonFraction>&#160;million after deducting the placement agent&#8217;s fees and related offering expenses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC pursuant to which the Company issued a <ix:nonFraction unitRef="number" contextRef="c-66" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-388">3</ix:nonFraction>% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-389">20.0</ix:nonFraction>&#160;million (the &#8220;Convertible Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to <ix:nonFraction unitRef="number" contextRef="c-66" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-390">3</ix:nonFraction>% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-391">19.7</ix:nonFraction>&#160;million from the Convertible Note Financing, after deducting debt issuance costs. In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#8217;s common stock. In March 2025, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-392">3,500,573</ix:nonFraction> shares of common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-393">20.0</ix:nonFraction>&#160;million plus $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="angn:AccruedInterestPremiumForConvertiblePreferredStock" scale="6" id="f-394">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into a note purchase agreement (the &#8220;June 2025 Promissory Note Financing&#8221;) with GKCC pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#8220;June 2025 Promissory Note&#8221;) in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-395">10.0</ix:nonFraction>&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-71" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-396">103,225</ix:nonFraction> shares of common stock (the &#8220;June 2025 Warrant&#8221;). The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-70" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-397">7.75</ix:nonFraction> per share, is immediately exercisable, and expires <ix:nonNumeric contextRef="c-70" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-398">five years</ix:nonNumeric> from the date of issuance. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-399">9.9</ix:nonFraction>&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-400">18.6</ix:nonFraction>&#160;million in cash and cash equivalents. The Company&#8217;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the consolidated financial statements, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of its common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it may need to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_109"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 2&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-401" continuedAt="f-401-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-401-1" continuedAt="f-401-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-402" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-403" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-404" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Segments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The Chief Executive Officer serves as the CODM. The Company operates as a single operating and reportable segment, reflecting the integrated nature of the Company&#8217;s business.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-405" continuedAt="f-405-1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-405-1">The Company&#8217;s management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. Significant estimates reflected in these consolidated financial statements include but are not limited to, the accrual of research and development expenses, the valuation of stock-based awards, the valuation of warrants, the valuation of embedded derivatives and convertible debt, and the operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liability.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-406" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Foreign Currency Translation and Transactions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Australian Dollar (&#8220;AUD&#8221;) is the functional currency for Elicio Pty. Accordingly, nonmonetary assets and liabilities originally acquired or assumed in other currencies are recorded in AUD at the date they were acquired or assumed. As part of the consolidation process, the Elicio Pty results are translated from AUD into the reporting currency of US Dollars using average rates for profit and loss transactions and applicable spot rates for period-end balances. The effect of translating the Company&#8217;s functional currency into the Company&#8217;s reporting currency is reported separately in Accumulated Other Comprehensive Loss.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-407" continuedAt="f-407-1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Concentrations of Credit Risk and Off-Balance Sheet Risk</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-407-1">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and restricted cash. At times, cash balances deposited at major financial institutions exceed the federally insured limit. The Company regularly monitors the financial condition of the institutions in which it has depository accounts and believes the risk of loss is minimal. The Company has not experienced any losses in such accounts.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-408" continuedAt="f-408-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents are comprised of deposits at major financial banking institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. As of December&#160;31, 2025 and 2024, the Company&#8217;s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Restricted Cash</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-408-1">Restricted cash consists of cash securing a collateral letter of credit issued in connection with the Company&#8217;s facility operating lease and unused funds received from the Company&#8217;s research grant.</ix:continuation> See Note 10 for further discussion. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-409" continuedAt="f-409-1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Fair Value Measurement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company follows the guidance prescribed by ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, which establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The standard provides a consistent definition of fair value that focuses on an exit price which is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a three-level hierarchy for fair value measurements based on the nature of inputs used in the valuation of an asset or liability as of the measurement date.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-401-2" continuedAt="f-401-3"><ix:continuation id="f-409-1"><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 1:&#160;&#160;&#160;&#160;Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at measurement. </span></div><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 2:&#160;&#160;&#160;&#160;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. </span></div><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 3:&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The carrying amounts of financial instruments reflected in the consolidated balance sheets for cash and cash equivalents, non-current restricted cash, accounts payable, and accrued expenses approximate their respective fair values because of the short-term maturity of those financial assets and liabilities.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-410" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of the asset. Upon sale or retirement, the cost and accumulated depreciation are eliminated from their respective accounts, and the resulting gain or loss is recorded in the consolidated statement of operations and comprehensive loss. Repair and maintenance expenditures are expensed as incurred. Construction in process is not depreciated until the asset is placed into service.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-411" continuedAt="f-411-1" escape="true"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:67.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Asset Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Estimated Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-73" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-412">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-74" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-413">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shorter of useful life or lease term</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-414" continuedAt="f-414-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Impairment of Long-Lived Assets</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-414-1">The Company evaluates its long-lived assets, which consist primarily of property and equipment, and ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset.</ix:continuation> During the years ended December&#160;31, 2025 and 2024, <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt-sec:numwordsen" scale="0" id="f-415"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt-sec:numwordsen" scale="0" id="f-416">no</ix:nonFraction></ix:nonFraction> impairments have occurred.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtPolicyTextBlock" id="f-417" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Debt Issuance Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These deferred costs will be amortized and recognized as additional interest expense over the term of the Company&#8217;s Convertible Note (as defined below) using the effective interest method. The Company will present debt issuance costs as a direct deduction from the Convertible Note (as defined below) liability on its financial statements. See Note 11 for further discussion of the Company&#8217;s accounting for its outstanding debt and related issuance costs.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-418" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for income taxes in accordance with ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. Deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates and laws in effect in the years in which the differences are expected to reverse. A valuation allowance is provided if, based upon the weighted available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company is required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, the position will be sustained upon examination. As of December&#160;31, 2025, there were no accruals for interest or penalties related to uncertain tax provisions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-419" continuedAt="f-419-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Research and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development costs are charged to expense as incurred and consist of expenses incurred in performing research and development activities, including salaries and benefits, materials and supplies, preclinical expenses, stock-based compensation expense, depreciation of equipment, contract services, and other outside expenses. The Company accrues for costs incurred by external service providers, based on estimates of services performed and costs. The Company expenses all </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-401-3" continuedAt="f-401-4"><ix:continuation id="f-419-1" continuedAt="f-419-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by the Company&#8217;s vendors and service providers. Based on the timing of payments to service providers, the Company may also record prepaid expenses for those service providers that will be recognized as expenses in future periods as the related services are rendered. Research and development costs may be offset by research grants and research and development refundable tax rebates received by Elicio Pty.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-420" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 842&#8221;) requires a lessee to recognize a ROU asset and corresponding lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the consolidated statements of operations and comprehensive loss as well as the reduction of the ROU asset. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on specific facts and circumstances, the existence of an identified asset(s), if any, and the Company&#8217;s control over the use of the identified asset(s), if applicable. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected lease term. When the interest rate implicit in lease contracts is not readily determinable, the Company will utilize its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has elected to combine lease and non-lease components as a single component. Operating leases are recognized on the consolidated balance sheet as ROU lease assets, current lease liabilities and non-current lease liabilities. Fixed rents are included in the calculation of the lease balances, while variable costs paid for certain operating and pass-through costs are excluded. Lease expense is recognized over the expected term on a straight-line basis.</span></div></ix:nonNumeric><ix:continuation id="f-419-2" continuedAt="f-419-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Grant Income</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><ix:continuation id="f-419-3" continuedAt="f-419-4"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Not-for-Profit Entities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, and that the grants are not within the scope of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue from Contracts with Customers</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-419-4">, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-421" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company issues stock-based awards to employees and non-employees, generally in the form of stock options. The Company accounts for stock-based awards in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, which requires all stock-based payments to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period. The Company has elected to account for option forfeitures as they occur. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses the Black-Scholes option-pricing model (&#8220;Black-Scholes&#8221;) to determine the fair value of options granted, which uses as inputs the fair value of the Company&#8217;s common stock, assumptions the Company makes for the volatility of its common stock, the expected term of its stock options, the risk-free interest rate for a period that approximates the expected term of its stock options and its expected dividend yield. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Compensation cost of awards that contain a performance condition is recognized when success is considered probable during the performance period. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the Merger, there was no public market for Former Elicio&#8217;s common stock. The estimated fair value of the Company&#8217;s common stock underlying Former Elicio&#8217;s stock-based awards was determined by Former Elicio&#8217;s board of directors as of the grant date of each option grant. To determine the fair value of Former Elicio&#8217;s common stock underlying option grants, Former Elicio&#8217;s board of directors considered, among other things, input from management and valuations of Former Elicio's common stock prepared by third-party valuation firms and performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants' Accounting and Valuation Guide, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Valuation of Privately-Held-Company Equity Securities Issued as Compensation</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. Following the Merger, the fair value of the Company&#8217;s common stock is based on the closing stock price on the date of grant as reported on the Nasdaq Capital Market.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-422" continuedAt="f-422-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Warrants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s common stock warrants are evaluated pursuant to ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 480&#8221;), and ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 815&#8221;). The Company classifies its freestanding warrants as (i) </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-401-4"><ix:continuation id="f-422-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">liabilities, if the warrant terms allow settlement of the warrant exercise in cash, or (ii) equity, if the warrant terms only allow settlement in shares of common stock. Please refer to Note 8 below for the application to the Company&#8217;s pre-funded and common warrants.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-423" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Net Loss Per Share</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic net loss per share of the Company&#8217;s common stock is computed by dividing net loss attributable to the Company&#8217;s common stockholders by the weighted average number of shares of the Company&#8217;s common stock and pre-funded warrants outstanding for the period. Pre-funded warrants are considered outstanding for the purposes of computing basic and diluted net loss per share because shares may be issued for little or no additional consideration and are fully vested and exercisable after the original issuance date of the pre-funded warrants. Diluted net loss per share excludes the potential impact of the Company&#8217;s common stock options, warrants and unvested shares of restricted stock because their effect would be anti-dilutive due to the Company's net loss. Since the Company had net losses for the years ended December&#160;31, 2025 and 2024, basic and diluted net loss per common share are the same.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-424" continuedAt="f-424-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other Comprehensive Gain (Loss)</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-424-1">Other comprehensive gain (loss) is defined as a change in equity during a period from foreign exchange transactions and other events and circumstances from non-owner sources.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-425" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Adopted Accounting Standards During the Period</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2023-09&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the new guidance, public business entities (&#8220;PBEs&#8221;) are required to disclose an annual tabular effective tax rate reconciliation using both reporting currency amounts and percentages, disaggregated into specified categories as well as the amount of income taxes paid, disaggregated by federal, state and foreign jurisdictions. ASU No. 2023-09 is effective for annual periods beginning after December 15, 2024 and may be applied prospectively or retrospectively. The Company adopted ASU No. 2023-09 on a prospective basis for the year ended December 31, 2025. The Company&#8217;s adoption of ASU No. 2023-09 did not have a material impact on its consolidated financial statements. The additional required disclosures have been included in Note 12.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB finalized ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2023-07&#8221;). ASU 2023-07 requires enhanced disclosures about reportable segments and the CODM. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-07 on January 1, 2024. There was no impact on the Company's reportable segments identified and additional required disclosures have been included in Note 16.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2024-04&#8221;). ASU 2024-04 clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact the adoption of ASU 2024-04 will have on its consolidated financial statements and related disclosures.</span></div></ix:nonNumeric></ix:continuation><div id="i8f3bd7775f224765952a5c19fa601c7c_121"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 3&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-426" continuedAt="f-426-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-427" continuedAt="f-427-1" escape="true"><ix:continuation id="f-426-1" continuedAt="f-426-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-426-2" continuedAt="f-426-3"><ix:continuation id="f-427-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-428">6,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-429">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-430">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-431">6,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-432">6,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-433">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-435">6,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-437">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="angn:WarrantsFairValueDisclosure" scale="3" id="f-438">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-439">2,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-440">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-441">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-442">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-443">2,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-444">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-447">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-448">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-450">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-451">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-453">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="angn:WarrantsFairValueDisclosure" scale="3" id="f-454">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-455">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-456">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-457">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-458">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-459">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">___________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div></ix:continuation><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash equivalents at December&#160;31, 2025 and 2024 were held in U.S. Treasury securities.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There were no transfers made among the three levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the warrants assumed in the Merger with Angion (the &#8220;Angion Warrants&#8221;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-460" continuedAt="f-460-1" escape="true">The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liabilities (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-460-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-461">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-462">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="3" id="f-463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="f-464">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-465">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-466">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk free interest rate, and the expected term.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-467" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrant liabilities was estimated using the following assumptions:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-86" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="f-468">76.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-87" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="f-469">76.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Contractual term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-77" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-470">2.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-80" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-471">3.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Volatility (annual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-88" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-472">67.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-473">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-474">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-91" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-475">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-92" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-476">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-477">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into the March Subscription Agreement with GKCC. The March 2024 Offering provided for the issuance and sale of the March 2024 Pre-Funded Warrants. The Company identified these warrants as liabilities and measured them at fair value on March 19, 2024, and subsequently remeasured the fair value of these warrant liabilities on a quarterly basis. The Company was able to calculate the fair value measurement based on directly observable inputs for the asset from active markets, therefore these warrants were classified as Level 2. At the Company&#8217;s annual </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-426-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">stockholder&#8217;s meeting in November 2024, the Company obtained stockholder approval (the &#8220;Stockholder Approval&#8221;) for GKCC, together with its affiliates, to exceed the <ix:nonFraction unitRef="number" contextRef="c-4" decimals="INF" name="angn:SaleOfStockBeneficialOwnershipLimitationPercentage" scale="-2" id="f-478">19.99</ix:nonFraction>% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;). As a result of the receipt of Stockholder Approval, the March 2024 Pre-Funded Warrants were classified as equity at December 31, 2024 and no longer needed quarterly fair value remeasurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed the July 2024 Public Offering, consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-94" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-479">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-95" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-480">5.00</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-95" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-481">five years</ix:nonNumeric> from the issuance date. Upon issuance, the Company identified the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Refer to Note 6 and 8 for further discussion. As a result of obtaining the Stockholder Approval in November 2024, the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants held by GKCC, together with its affiliates, met the equity classification requirements under ASC 815. As such, the Company remeasured the July 2024 Common Warrants held by that shareholder at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. The remaining liability classified July 2024 Pre-Funded Warrants were exercised in the fourth quarter of 2024, leaving no remaining liability classified July 2024 Pre-Funded Warrants outstanding as of December 31, 2024. The remaining July 2024 Common Warrants not held by GKCC and its affiliates remain liability classified as of December 31, 2024 and the fair value is remeasured in each reporting period. During the year ended December 31, 2025, there were no changes to the equity classification. The Company will re-assess the liability classification for the remaining July 2024 Common Warrants at each period end. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the consolidated statements of operations and comprehensive loss.</span></div></ix:continuation><div id="i8f3bd7775f224765952a5c19fa601c7c_124"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> Note 4&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-482" continuedAt="f-482-1" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="f-482-1" continuedAt="f-482-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prepaid and Other Current Assets</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="f-483" continuedAt="f-483-1" escape="true">Prepaid and other current assets consisted of the following (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-483-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:PrepaidResearchAndDevelopmentExpenses" scale="3" id="f-484">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:PrepaidResearchAndDevelopmentExpenses" format="ixt:num-dot-decimal" scale="3" id="f-485">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AdvancedProfessionalFees" scale="3" id="f-486">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:AdvancedProfessionalFees" scale="3" id="f-487">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-488">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-489">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:OtherPrepaidExpensesAndOtherAssetsCurrent" scale="3" id="f-490">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:OtherPrepaidExpensesAndOtherAssetsCurrent" scale="3" id="f-491">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="f-492">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-493">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><ix:continuation id="f-411-1"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-494">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-495">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-496">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-497">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-498">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-499">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-500">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-501">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-502">1,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-503">1,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-504">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-505">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense for the years ended December&#160;31, 2025 and 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-506">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-507">0.3</ix:nonFraction> million, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-482-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other long-term prepaid assets</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="6" id="f-508">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="6" id="f-509">0.6</ix:nonFraction> million as of December&#160;31, 2025 and December&#160;31, 2024, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Expenses</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-510" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued professional fees</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-511">818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-512">1,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-513">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-514">2,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued research and development</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-515">2,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-516">4,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AccruedInterest" scale="3" id="f-517">741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:AccruedInterest" format="ixt:fixed-zero" scale="3" id="f-518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AccruedOtherOperatingLiabilitiesCurrent" scale="3" id="f-519">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:AccruedOtherOperatingLiabilitiesCurrent" scale="3" id="f-520">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-521">6,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-522">8,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i8f3bd7775f224765952a5c19fa601c7c_127"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 5&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="f-523" continuedAt="f-523-1" escape="true">Research Grant</ix:nonNumeric></span></div><ix:continuation id="f-523-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-524">2.8</ix:nonFraction> million award, $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-525">2.3</ix:nonFraction>&#160;million was received in September 2022 and the remaining $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-526">0.5</ix:nonFraction>&#160;million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-527">0.5</ix:nonFraction>&#160;million payment was applied as a credit to the second grant agreement described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-528">3.1</ix:nonFraction> million, with such amount received net of the $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="angn:ResearchAndDevelopmentArrangementCredit" scale="6" id="f-529">0.5</ix:nonFraction>&#160;million credit, described above. During the year ended December&#160;31, 2024, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-530">2.2</ix:nonFraction> million in research and development expenses related to this project and completed the development efforts defined in the second grant agreement in the third quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-531">1.5</ix:nonFraction> million. During the years ended December&#160;31, 2025 and 2024, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-532">0.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-533">0.3</ix:nonFraction>&#160;million, respectively, in research and development expenses related to this project, all of which were reimbursed from available grant funds. The third grant agreement activities were completed in the second quarter of 2025. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The award money for the <ix:nonFraction unitRef="agreement" contextRef="c-4" decimals="INF" name="angn:NumberOfResearchGrantAgreements" format="ixt-sec:numwordsen" scale="0" id="f-534">three</ix:nonFraction> agreements was recorded as contra-expense to offset the research and development costs incurred. Following completion of the third grant agreement with GI Research Foundation, during 2025, the remaining $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="angn:GrantRevenueNonoperating" scale="6" id="f-535">0.4</ix:nonFraction>&#160;million of the grant funds were recognized as grant income, as there were no further conditions to be met.</span></div></ix:continuation><div id="i8f3bd7775f224765952a5c19fa601c7c_130"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 6&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-536" continuedAt="f-536-1" escape="true">Common Stock and Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="f-536-1" continuedAt="f-536-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-537">300,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-538">0.01</ix:nonFraction> per share, and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-539">10,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-540">0.01</ix:nonFraction> per share.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2024, the Company issued and sold a total of <ix:nonFraction unitRef="shares" contextRef="c-48" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-541">650,179</ix:nonFraction> shares of common stock under the 2022 ATM Program for aggregate net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-542">5.4</ix:nonFraction> million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2025, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-543">1,717,507</ix:nonFraction> shares of common stock for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-544">16.2</ix:nonFraction> million under the 2024 ATM Program. During the year ended December&#160;31, 2024, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-52" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-545">53,795</ix:nonFraction> shares of common stock for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-546">0.3</ix:nonFraction> million under the 2024 ATM Program.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company closed the March 2024 Offering, which resulted in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-547">6.0</ix:nonFraction>&#160;million. The March 2024 Offering providing for the issuance and sale by the Company to GKCC of the March 2024 Pre-Funded Warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-53" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-548">1,032,702</ix:nonFraction> shares of common stock, at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-53" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-549">5.81</ix:nonFraction>. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-53" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-550">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds to the Company from the March 2024 Offering were $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-551">6.0</ix:nonFraction>&#160;million. Refer to Note 8 for additional information.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-536-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offerings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed the July 2024 Public Offering, which resulted in gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="f-552">11.5</ix:nonFraction> million, with net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-553">10.9</ix:nonFraction>&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The July 2024 Public Offering consisted of (i) <ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-554">500,000</ix:nonFraction> July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants exercisable for <ix:nonFraction unitRef="shares" contextRef="c-56" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-555">1,800,000</ix:nonFraction> shares of common stock, and (iii) the July 2024 Common Warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-57" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-556">2,300,000</ix:nonFraction> shares of common stock. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-59" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-557">5.00</ix:nonFraction>. Each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-108" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-558">4.99</ix:nonFraction>, which represented the combined purchase price less the $<ix:nonFraction unitRef="usdPerShare" contextRef="c-109" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-559">0.01</ix:nonFraction> per share exercise price for each such July 2024 Pre-Funded Warrant. The July 2024 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-95" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-560">5.00</ix:nonFraction> per share, are immediately exercisable, and will expire <ix:nonNumeric contextRef="c-95" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-561">five years</ix:nonNumeric> from the issuance date. Refer to Notes 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell <ix:nonFraction unitRef="shares" contextRef="c-62" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-562">1,261,830</ix:nonFraction> January 2025 Shares and the January 2025 Common Warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-62" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-563">1,261,830</ix:nonFraction> shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-564">7.925</ix:nonFraction>. The January 2025 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-64" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-565">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-110" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-566">5</ix:nonNumeric> years from the issuance date. The January 2025 Offering resulted in gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="f-567">10.0</ix:nonFraction>&#160;million, with net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-568">9.2</ix:nonFraction>&#160;million to the Company after deducting the placement agent&#8217;s fees and related offering expenses. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. Refer to Note 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC pursuant to which the Company issued the <ix:nonFraction unitRef="number" contextRef="c-66" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-569">3</ix:nonFraction>% Convertible Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-570">20.0</ix:nonFraction> million. Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to <ix:nonFraction unitRef="number" contextRef="c-66" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-571">3</ix:nonFraction>% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-572">19.7</ix:nonFraction> million from the Convertible Note Financing, after deducting debt issuance costs. In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#8217;s common stock. In March 2025, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-573">3,500,573</ix:nonFraction> shares of common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-574">20.0</ix:nonFraction>&#160;million plus $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="angn:AccruedInterestPremiumForConvertiblePreferredStock" scale="6" id="f-575">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-576">10.0</ix:nonFraction>&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-70" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-577">103,225</ix:nonFraction> shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-70" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-578">7.75</ix:nonFraction> per share, is immediately exercisable, and expires <ix:nonNumeric contextRef="c-70" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-579">five years</ix:nonNumeric> from the date of issuance. Refer to Note 11 for additional information.</span></div></ix:continuation><div id="i8f3bd7775f224765952a5c19fa601c7c_133"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 7&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-580" continuedAt="f-580-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-580-1" continuedAt="f-580-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2012 Plan and 2022 Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As a result of the Merger, the Company assumed the Former Elicio 2012 Equity Incentive Plan and the Former Elicio 2022 Equity Incentive Plan (collectively, the &#8220;Former Elicio Plans&#8221;) and all stock options issued and outstanding under the Former Elicio Plans. Each outstanding and unexercised option to purchase Former Elicio&#8217;s common stock was adjusted with such Company stock options henceforth representing the right to purchase a number of shares of the Company&#8217;s common stock based on the exchange ratio established for the Merger. Any restriction on the exercise of any Former Elicio stock options assumed by the Company continued in full force and effect and the term, exercisability, vesting schedule, accelerated vesting provisions, and any other provisions of such Former Elicio stock options otherwise remained unchanged. As of December&#160;31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-113" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-581">177,671</ix:nonFraction> shares remain available for future grants under the Former Elicio 2022 Equity Incentive Plan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2015 Plan </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2019, Angion&#8217;s board of directors approved an Amended and Restated 2015 Equity Incentive Plan (the &#8220;2015 Plan&#8221;) permitting the granting of incentive stock options, non-statutory stock options, restricted stock and other stock-based awards. Following the effectiveness of the 2021 Incentive Award Plan (&#8220;2021 Plan&#8221;), Angion ceased making grants under the 2015 Plan. However, the 2015 Plan continues to govern the terms and conditions of the outstanding awards granted under it. Shares of common stock subject to awards granted under the 2015 Plan that cease to be subject to such awards by forfeiture or otherwise after the termination of the 2015 Plan will be available for issuance under the 2021 Plan.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-580-2" continuedAt="f-580-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2021 Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, Angion&#8217;s board of directors approved the 2021 Plan which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards to employees, directors, officers and consultants. The 2021 Plan provides that the number of shares reserved and available for issuance will automatically increase each January 1st by the lesser of <ix:nonFraction unitRef="number" contextRef="c-114" decimals="2" name="angn:CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" scale="-2" id="f-582">5</ix:nonFraction>% of the Company&#8217;s common stock outstanding on the immediately preceding December 31st, or such lesser number of shares as determined by the Company&#8217;s board of directors. The Company has a policy of issuing shares out of respective plan pools (to the extent available) to satisfy share option exercises and restricted stock vesting. As of December&#160;31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-115" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-583">460,025</ix:nonFraction> shares remain available for future grants under the 2021 Plan. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2024 Inducement Incentive Award Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In February 2024, the Company&#8217;s board of directors approved the Company&#8217;s 2024 Inducement Incentive Award Plan (the &#8220;2024 Inducement Plan&#8221;) which permits the granting of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock-based awards to employees as an inducement pursuant to Listing Rule 5635(c)(4) of the corporate governance rules of Nasdaq. The 2024 Inducement Plan originally provided for an overall share limit of <ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="angn:ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" format="ixt:num-dot-decimal" scale="0" id="f-584">500,000</ix:nonFraction> shares of the Company&#8217;s common stock. As of December&#160;31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-585">10,940</ix:nonFraction> shares remain available for future grants under the 2024 Inducement Plan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-586" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-587">1,890,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-588">15.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-589">6.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-590">920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-591">821,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-592">7.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-593">32,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-594">4.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-595">58,406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-596">6.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-597">2,621,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-598">13.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-599">6.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-600">5,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Options vested and exercisable</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-601">1,416,162</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-602">19.19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-603">5.2</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-604">3,127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. The weighted average grant date fair value per share for the stock option grants during the year ended December&#160;31, 2025 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-605">7.63</ix:nonFraction>. As of December&#160;31, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-606">5.3</ix:nonFraction> million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-607">2.8</ix:nonNumeric> years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-based Compensation Expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-608" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the consolidated statements of operations and comprehensive loss (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-609">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-610">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-611">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-612">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-613">2,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-614">1,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-580-3" continuedAt="f-580-4"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#8217;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-615" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-122" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-616">3.7</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-122" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-617">4.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-123" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-618">3.4</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-123" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-619">4.3</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-122" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-620">0.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-123" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-621">0.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-122" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-622">100.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-122" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-623">110.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-624">79.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-123" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-625">107.8</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-124" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-626">5.0</ix:nonNumeric> - <ix:nonNumeric contextRef="c-125" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-627">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-126" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-628">5.0</ix:nonNumeric>  - <ix:nonNumeric contextRef="c-127" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-629">6.1</ix:nonNumeric></span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the consolidated financial statements for the year ended December&#160;31, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Stock Purchase Plan</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-580-4">In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#8217;s initial public offering. The offering period and purchase period was determined by Angion&#8217;s board of directors. No offering periods or purchasing periods were active as of December&#160;31, 2025. As of December&#160;31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-128" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-630">275,309</ix:nonFraction> shares remained available for purchase under the ESPP, and <ix:nonFraction unitRef="shares" contextRef="c-128" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="0" id="f-631">no</ix:nonFraction> offerings w</ix:continuation>ere authorized.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_139"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 8&#8212;<ix:nonNumeric contextRef="c-1" name="angn:WarrantsAndRightsOutstandingTextBlock" id="f-632" continuedAt="f-632-1" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="f-632-1" continuedAt="f-632-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with ASC Topic 815, certain of the Company&#8217;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-633">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the March 2024 Pre-Funded Warrants were liability classified, with a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="angn:WarrantExercisedFairValue" scale="6" id="f-634">6.6</ix:nonFraction>&#160;million, as determined by the Black-Scholes option pricing model as of the grant date. The Company recorded the $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="6" id="f-635">0.6</ix:nonFraction>&#160;million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024. The Company subsequently remeasured the fair value of these warrant liabilities on a quarterly basis. As a result of the receipt of Stockholder Approval in November 2024, as discussed in Note 3, the March 2024 Pre-Funded Warrants were classified as equity at December 31, 2025 and 2024. During the year ended December 31, 2024, the Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-636">1.3</ix:nonFraction> million in fair value remeasurement of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 3 and 6, in July 2024, the Company closed its July 2024 Public Offering consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-632-2" continuedAt="f-632-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-94" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-637">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-95" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-638">5.00</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the July 2024 Pre-Funded Warrants and July 2024 Common Warrants were liability classified, with a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="angn:WarrantExercisedFairValue" scale="6" id="f-639">6.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="angn:WarrantExercisedFairValue" scale="6" id="f-640">6.5</ix:nonFraction>&#160;million, respectively, measured using the Black-Scholes option pricing model as of the grant date. The Company recorded the $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="6" id="f-641">2.9</ix:nonFraction>&#160;million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As a result of the receipt of Stockholder Approval in November 2024, certain July 2024 Pre-Funded Warrants and July 2024 Common Warrants held by GKCC and its affiliates were classified as equity. The remaining liability classified July 2024 Pre-Funded Warrants were exercised in the fourth quarter of 2024, leaving no remaining liability classified July 2024 Pre-Funded Warrants outstanding as of December 31, 2024. The remaining July 2024 Common Warrants not held by GKCC and its affiliates remain liability classified as of December 31, 2024 and the fair value is remeasured in each reporting period. During the year ended December 31, 2025, there were no changes to the equity classification. For the years ended December&#160;31, 2025 and 2024, the Company recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" id="f-642">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-643">2.4</ix:nonFraction> million in fair value remeasurement of the July 2024 Pre-Funded Warrants, respectively. For the years ended December&#160;31, 2025 and 2024, the Company recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-644">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-645">2.8</ix:nonFraction> million in fair value remeasurement of the July 2024 Common Warrants, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell <ix:nonFraction unitRef="shares" contextRef="c-62" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-646">1,261,830</ix:nonFraction> January 2025 Shares and the January 2025 Common Warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-62" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-647">1,261,830</ix:nonFraction> shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-140" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-648">7.925</ix:nonFraction>. The January 2025 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-140" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-649">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-141" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-650">five years</ix:nonNumeric> from the issuance date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-651">9.7</ix:nonFraction>&#160;million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-70" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-652">103,225</ix:nonFraction> shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-70" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-653">7.75</ix:nonFraction> per share, is immediately exercisable and expires <ix:nonNumeric contextRef="c-70" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-654">five years</ix:nonNumeric> from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-655">0.6</ix:nonFraction>&#160;million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="f-656" continuedAt="f-656-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables summarize information regarding the warrants outstanding and warrant activity at December&#160;31, 2025:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Number of Warrants Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-144" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-657">144,814</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-145" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-658">53.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-146" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-659">3.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Angion Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-147" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-660">3,950</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-148" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-661">76.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-149" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-662">2.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-150" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-663">1,032,702</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-664">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-152" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-665">1,600,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-153" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-666">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-154" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-667">441,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-155" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-668">5.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-156" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-669">3.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-157" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-670">1,600,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-158" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-671">5.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-159" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-672">3.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">January 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-160" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-673">1,261,830</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-674">7.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-162" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-675">4.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">June 2025 Common Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-676">103,225</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-164" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-677">7.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-165" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-678">4.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total Warrants Outstanding at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-679">6,188,021</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-166" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-680">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-681">3.7</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of December 31, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> During the fourth quarter of 2024, the Company reclassified the March 2024 Pre-Funded Warrants, the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants held by GKCC and its affiliates from liability to equity classification. </span></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-656-1"><ix:continuation id="f-632-3"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.174%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.131%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Warrants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-682">5,081,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-683">3.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-5" name="angn:ClassOfWarrantOrRightWeightedAverageLife" format="ixt-sec:duryear" id="f-684">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Issued</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-685">1,365,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" scale="0" id="f-686">7.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightExercisedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-687">258,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" scale="0" id="f-688">5.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding at December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-689">6,188,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-690">4.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-4" name="angn:ClassOfWarrantOrRightWeightedAverageLife" format="ixt-sec:duryear" id="f-691">3.7</ix:nonNumeric></span></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_142"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 9&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-692" continuedAt="f-692-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-692-1" continuedAt="f-692-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Legal Proceedings </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company may be exposed to litigation in connection with its products under development and operations. The Company&#8217;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2016, Former Elicio entered into a license agreement to license certain intellectual property rights from MIT, which agreement has been amended from time to time to add additional intellectual property rights to the Company&#8217;s license and to adjust fees and milestones and diligence requirements. The Company is required to pay certain license maintenance fees and certain milestone payments upon the occurrence of specific development and commercialization achievements during the term of the agreement, including those related to the making of certain regulatory filings, the initiation of certain clinical trials and the achievement of certain product sales thresholds, and royalty payments based on net sales on certain products over the term of the agreement, with royalty payments commencing in the calendar year of commercialization of such products. Royalty rates range from <ix:nonFraction unitRef="number" contextRef="c-167" decimals="4" name="angn:RoyaltyRatePercent" scale="-2" id="f-693">0.25</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-168" decimals="4" name="angn:RoyaltyRatePercent" scale="-2" id="f-694">2.00</ix:nonFraction>%, depending on whether commercial sales relate to a product that is covered by patents under which Elicio licenses rights from MIT or a product that could not have been identified, selected, or determined to have biological activity but for the use or modification of a product covered by the patents, and also on the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions in the agreement. During the year ended December&#160;31, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-695">0.4</ix:nonFraction>&#160;million. <ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="0" id="f-696">No</ix:nonFraction> such expenses were recorded during the year ended December&#160;31, 2025. <ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:fixed-zero" scale="0" id="f-697">No</ix:nonFraction> commercialization royalties have been achieved to date. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company would be required to pay a total of up to $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="angn:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" scale="6" id="f-698">26.2</ix:nonFraction>&#160;million if all remaining possible clinical development and commercial sales milestones are achieved. The clinical development milestone payments will be recorded when each milestone is achieved, and the commercial sales milestone payments and royalties will be recorded when the sales occur.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-692-2">For the years ended December&#160;31, 2025 and 2024, the Company recorded an annual license maintenance fee payment of $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="angn:CollaborativeArrangementFutureMinimumMaintenancePayments" scale="6" id="f-699">0.1</ix:nonFraction>&#160;million. Future annual license maintenance fee payments will continue to be $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="angn:CollaborativeArrangementFutureMinimumMaintenancePayments" scale="6" id="f-700">0.1</ix:nonFraction>&#160;million and are due until the termination of the agreement.</ix:continuation> </span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_145"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 10&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-701" continuedAt="f-701-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-701-1" continuedAt="f-701-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#8220;Boston Lease&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-702">11.1</ix:nonFraction>&#160;million in the aggregate. As a result, at the commencement of the Boston Lease, the Company recognized a ROU lease asset of $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-703">8.0</ix:nonFraction>&#160;million with a corresponding lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-704">8.0</ix:nonFraction>&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:ProceedsFromSecuredLinesOfCredit" scale="6" id="f-705">0.7</ix:nonFraction>&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the consolidated balance sheets as of December&#160;31, 2025 and 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately <ix:nonFraction unitRef="sqft" contextRef="c-177" decimals="0" name="us-gaap:AreaOfRealEstateProperty" format="ixt:num-dot-decimal" scale="0" id="f-706">6,157</ix:nonFraction> square feet for approximately $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="angn:LesseeOperatingLeaseAnnualRentExpense" scale="6" id="f-707">0.2</ix:nonFraction>&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-701-2" continuedAt="f-701-3"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Lease expense for all leases for the years ended December&#160;31, 2025 and 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-708">1.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-709">1.5</ix:nonFraction>&#160;million, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" id="f-710" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-711">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-712">1,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-713">4.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-714">5.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-715">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-716">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-717" continuedAt="f-717-1" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt"><ix:continuation id="f-717-1"><ix:continuation id="f-701-3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-718">1,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-719">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-720">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-721">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="f-722">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-723">6,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less present value discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-724">935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-725">5,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-726">1,011</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-727">4,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_148"></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 11&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-728" continuedAt="f-728-1" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="f-728-1" continuedAt="f-728-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC pursuant to which the Company issued the <ix:nonFraction unitRef="number" contextRef="c-66" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-729">3</ix:nonFraction>% Convertible Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-730">20.0</ix:nonFraction> million. Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to <ix:nonFraction unitRef="number" contextRef="c-66" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-731">3</ix:nonFraction>% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-732">19.7</ix:nonFraction> million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815, and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the years ended December&#160;31, 2025 and 2024, the Company recorded an <ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:fixed-zero" scale="0" id="f-733">immaterial</ix:nonFraction> amount and $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="f-734">0.1</ix:nonFraction> million of other expense related to the accretion of the discount of Convertible Note debt issuance costs, respectively. During the years ended December&#160;31, 2025 and 2024, the Company recorded accrued interest expense of $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-735">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-736">0.2</ix:nonFraction> million related to the interest due on the Convertible Note but not yet payable, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. In March 2025, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-737">3,500,573</ix:nonFraction> shares of its common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-738">20.0</ix:nonFraction> million plus $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="angn:AccruedInterestPremiumForConvertiblePreferredStock" scale="6" id="f-739">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-740">10.0</ix:nonFraction>&#160;million to GKCC. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus <ix:nonFraction unitRef="number" contextRef="c-72" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-741">5.00</ix:nonFraction>%, provided that the maximum interest rate shall not exceed <ix:nonFraction unitRef="number" contextRef="c-181" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-742">12.5</ix:nonFraction>% per annum, with an initial interest payment date of July 1, 2026. As of December&#160;31, 2025, the interest rate was <ix:nonFraction unitRef="number" contextRef="c-182" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-743">12.5</ix:nonFraction>% per annum. The first 24 months of the June 2025 Promissory Note is an interest only period, with payments towards the principal commencing on July 1, 2027 as shown in the below future principal payments table. The Company may prepay the June 2025 Promissory Note in full at any time, but the payment must include the principal, all accrued unpaid interest, and a prepayment fee in one aggregate payment. If the prepayment occurs during the first, second, or third year of the June 2025 Promissory Note, the prepayment fee will be equal to the outstanding principal balance prepaid multiplied by <ix:nonFraction unitRef="number" contextRef="c-183" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-744">3</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-184" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-745">2</ix:nonFraction>%, or <ix:nonFraction unitRef="number" contextRef="c-185" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-746">1</ix:nonFraction>%, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-728-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">respectively. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default. As of December&#160;31, 2025, the Company was in compliance with all covenants.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-70" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-747">103,225</ix:nonFraction> shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-70" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-748">7.75</ix:nonFraction> per share, is immediately exercisable and expires <ix:nonNumeric contextRef="c-70" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-749">five years</ix:nonNumeric> from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of <ix:nonFraction unitRef="number" contextRef="c-186" decimals="4" name="angn:ClassOfWarrantOrRightOwnershipPercentMaximum" scale="-2" id="f-750">49.99</ix:nonFraction>% of the number of shares of the Company&#8217;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrants, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-751">0.6</ix:nonFraction>&#160;million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-752">9.9</ix:nonFraction>&#160;million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of December&#160;31, 2025, the net carrying value of the June 2025 Promissory Note was $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-753">9.4</ix:nonFraction> million, which is net of the debt discount of $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="f-754">0.6</ix:nonFraction> million. During the year ended December&#160;31, 2025, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="f-755">0.2</ix:nonFraction> million in accretion of the debt discount and $<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="6" id="f-756">0.7</ix:nonFraction> million in accrued interest.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-757" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, the future principal payments for the June 2025 Promissory Note were as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2026</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="f-758">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-759">5,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="f-760">4,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Total principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-761">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:1pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_151"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Note 12&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-762" continuedAt="f-762-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-762-1" continuedAt="f-762-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-763" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Income (loss) before taxes related to the Company&#8217;s United States and foreign operations for the years ended December&#160;31, 2025 and 2024 consists of the following (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-764">39,476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-765">51,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="f-766">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="f-767">170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-768">39,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-769">51,898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company had no income tax expense or benefit due to operating losses incurred for the years ended December&#160;31, 2025 and 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Beginning with the year ended December 31, 2025, the Company adopted ASU 2023-09 on a prospective basis. See Note 2</span><span style="color:#000000;font-family:'MS Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">for additional details. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-770" continuedAt="f-770-1" escape="true">A reconciliation between the federal statutory income tax amount and rate to the Company's actual effective amount and rate pursuant to the disclosure requirements of ASU 2023-09 for the year ended December&#160;31, 2025 is as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-762-2" continuedAt="f-762-3"><ix:continuation id="f-770-1"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended Year Ended December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">US federal statutory income tax rate</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-771">8,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-772">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Domestic state and local taxes, net of federal effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="3" id="f-773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="-2" id="f-774">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign tax effects</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-775">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-776">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Tax credits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-777">1,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-778">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Nontaxable or nondeductible items:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Nondeductible stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="f-779">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-780">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" scale="3" id="f-781">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="angn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" scale="-2" id="f-782">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Other nontaxable and nondeductible items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="f-783">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="f-784">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-785">8,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-786">21.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes and effective income tax rate</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-788">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A reconciliation between the federal statutory income tax rate and the Company's effective income tax rate prior to the adoption of ASU 2023-09 for the year ended December 31, 2024 is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-789">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">State tax, net of federal benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-790">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" sign="-" name="angn:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="f-791">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Federal research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-792">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">State research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="angn:EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" scale="-2" id="f-793">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-794">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-795">19.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-796">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-797" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of the Company's net deferred tax assets at December&#160;31, 2025 and 2024 is as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-798">77,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-799">64,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-800">16,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-801">15,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Capitalized research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-802">13,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-803">17,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-804">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-805">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-806">3,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-807">2,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-808">1,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-809">1,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-810">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-811">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:DeferredTaxAssetsNetBeforeValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-812">110,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:DeferredTaxAssetsNetBeforeValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-813">100,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: Deferred tax asset valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-814">110,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-815">100,117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-816">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-817">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Net operating losses (&#8220;NOLs&#8221;) generated in tax years ended December 31, 2017 and prior can be carried forward 20 years under the Internal Revenue Code (&#8220;IRC&#8221;). Use of NOLs arising in tax years ended after December 31, 2017 are limited to 80% of taxable income in any one tax year, and are carried forward indefinitely. At December&#160;31, 2025, Elicio has federal NOLs of $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-818">311.4</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-819">19.1</ix:nonFraction> million will start to expire in 2032 and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-820">292.3</ix:nonFraction> million can be carried forward indefinitely, and state NOLs of $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-821">179.5</ix:nonFraction> million that will start to expire in 2032. At December&#160;31, 2025, Elicio has $<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-822">14.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-823">2.9</ix:nonFraction> million of federal and state research and development credit carryforwards, respectively, that start to expire in 2027. At December&#160;31, 2025, Elicio has $<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-824">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-825">0.2</ix:nonFraction> million of Australian NOLs and research and development credit carryforwards, respectively, that can be carried forward indefinitely.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As the Company has not yet achieved profitable operations, management believes the tax benefits as of December&#160;31, 2025 did not satisfy the realization criteria set forth in ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, and, therefore, has recorded a full valuation allowance for the entire deferred tax asset. The valuation allowance increased in 2025 by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-826">10.2</ix:nonFraction> million primarily due to current year operating losses and research and development credits generated.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-762-3" continuedAt="f-762-4"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ownership changes, as defined in the IRC, may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income pursuant to IRC Section 382 or similar provisions. Subsequent ownership changes could further affect the limitation in future years. The Company has not completed a study to assess whether a change in control has occurred or whether there have been multiple changes in control since the Company&#8217;s formation due to the significant complexity and cost associated with such study and because there could be additional changes in control in the future. As a result, the Company is not able to estimate the effect of the change in control, if any, on the Company&#8217;s ability to utilize NOL and research and development credit carryforwards in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company files tax returns in the United States, Australia, California, Connecticut, Florida, Massachusetts, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New York, North Carolina, Pennsylvania, Tennessee, and Utah. The federal and state tax returns for the periods ended December 31, 2022, 2023, and 2024 remain open to examination by the major taxing jurisdictions to which the Company is subject, as carryforward attributes generated in years past may still be adjusted upon examination by the Internal Revenue Service (&#8220;IRS&#8221;) or other authorities if they have or will be used in a future period. To its knowledge, the Company is not currently under examination by the IRS or any other jurisdictions for any tax years.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-827" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A reconciliation of the unrecognized tax benefits for the years ended December&#160;31, 2025 and 2024 is as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Gross unrecognized tax benefit, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-828">4,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-829">4,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Increase (decrease) recognized in the income statement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="f-830">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="f-831">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Gross unrecognized tax benefit, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-832">4,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-833">4,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-834">4.1</ix:nonFraction> million of unrecognized tax benefits related to prior research tax credits that may not be substantiated upon audit. If recognized, the Company anticipates that its effective tax rate would not be affected for the years ended December&#160;31, 2025 and 2024. The Company has elected to recognize interest and penalties related to income tax matters as a component of income tax expense, of which <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="f-835"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="f-836">no</ix:nonFraction></ix:nonFraction> interest or penalties were recorded for the years ended December&#160;31, 2025 and 2024.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-762-4">On July 4, 2025, H.R. 1 (the &#8220;Act&#8221;), commonly referred to as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act has multiple effective dates, with certain provisions effective in 2025 and others to be implemented through 2027. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The provisions impacting the Company have been reflected in the financial statements for the year ended December&#160;31, 2025, and did not have a material impact as the Company has a valuation allowance against its net deferred tax assets.</ix:continuation> </span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_154"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 13&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedContributionPlanTextBlock" id="f-837" continuedAt="f-837-1" escape="true">Employee Benefit Plan</ix:nonNumeric></span></div><ix:continuation id="f-837-1" continuedAt="f-837-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Benefit Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company provides a retirement savings plan through the Elicio Therapeutics, Inc. 401(k) Plan (the &#8220;Elicio Retirement Plan&#8221;), subject to certain limitations. As allowed under Section 401(k) of the IRC, the Elicio Retirement Plan allows tax deferred salary deductions for eligible employees. An employee&#8217;s interest in his or her salary deferral contributions is <ix:nonFraction unitRef="number" contextRef="c-195" decimals="INF" name="us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" scale="-2" id="f-838">100</ix:nonFraction>% vested when contributed.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-837-2">Pursuant to the Merger Agreement, the Company assumed the retirement savings plan sponsored by Angion (the &#8220;Angion Retirement Plan&#8221;). The Angion Retirement Plan is intended to qualify for favorable tax treatment under Section 401(a) of the IRC, and contains a cash or deferred feature that is intended to meet the requirements of Section 401(k) of the IRC. Currently, no employees are contributing under the Angion Retirement Plan.</ix:continuation> </span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_157"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 14&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-839" continuedAt="f-839-1" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="f-839-1" continuedAt="f-839-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-840" continuedAt="f-840-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the years ended December&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-839-2"><ix:continuation id="f-840-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Numerator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-841">39,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-842">51,898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares used in computing net loss per share, basic and diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-843"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-844">15,312,751</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-845"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-846">12,202,996</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-847"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-848">2.58</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-849"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-850">4.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-851" continuedAt="f-851-1" escape="true">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</ix:nonNumeric></span></div><ix:continuation id="f-851-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-196" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-852">2,621,203</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-197" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-853">1,890,932</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of common warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-198" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-854">3,555,319</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-199" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-855">2,448,764</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-856">6,176,522</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-857">4,339,696</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:3pt;text-indent:22.5pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_160"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 15&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-858" continuedAt="f-858-1" escape="true">Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="f-858-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement and Subscription Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-859">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the March 2024 Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="f-860">6.0</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">July 2024 Public Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As part of the July 2024 Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#8217;s board of directors, and Jay Venkatesan, a member of the Company&#8217;s board of directors, and trusts affiliated with Jay Venkatesan, purchased <ix:nonFraction unitRef="shares" contextRef="c-201" decimals="0" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-861">1,600,000</ix:nonFraction> July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants and <ix:nonFraction unitRef="shares" contextRef="c-202" decimals="0" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-862">200,000</ix:nonFraction> July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants, respectively, with such July 2024 Pre-Funded Warrants and July 2024 Common Warrants subject to the terms and conditions of the July 2024 Pre-Funded Warrants and July 2024 Common Warrants.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the July 2024 Public Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="f-863">10.9</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-864">20.0</ix:nonFraction> million. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-865">19.7</ix:nonFraction> million from the Convertible Note Financing, after deducting debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. The Company issued <ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-866">3,500,573</ix:nonFraction> shares of its common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-867">20.0</ix:nonFraction>&#160;million plus $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="angn:AccruedInterestPremiumForConvertiblePreferredStock" scale="6" id="f-868">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-869">10.0</ix:nonFraction>&#160;million. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-870">9.9</ix:nonFraction>&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-70" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-871">103,225</ix:nonFraction> shares of the Company&#8217;s common stock.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_163"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements (Continued)</span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 16&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-872" continuedAt="f-872-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="f-872-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has <ix:nonFraction unitRef="entity" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" id="f-873">one</ix:nonFraction> reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#8217;s CODM, its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the consolidated statements of cash flows. Other segment items include interest income, interest expense, grant income, and change in the fair value of warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the consolidated statements of cash flows. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-874" continuedAt="f-874-1" escape="true">The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-874-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Clinical trial expenses </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-875">9,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-876">15,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-877">8,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-878">8,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-879">1,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-880">4,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-881">5,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-882">5,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" sign="-" name="us-gaap:RecoveryOfDirectCosts" scale="3" id="f-883">754</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" sign="-" name="us-gaap:RecoveryOfDirectCosts" format="ixt:num-dot-decimal" scale="3" id="f-884">1,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-885">5,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-886">3,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-887">7,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-888">7,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Other segment items </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-889">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-890">6,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-891">39,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-892">51,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-893">25,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-894">28,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div id="i8f3bd7775f224765952a5c19fa601c7c_166"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 17&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-895" continuedAt="f-895-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-895-1" continuedAt="f-895-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has completed an evaluation of all subsequent events after the consolidated balance sheet date as of December&#160;31, 2025 through the date these consolidated financial statements were issued to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements as of December&#160;31, 2025, and events which occurred subsequently but were not recognized in the consolidated financial statements. Non-recognizable subsequent events are summarized below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2024 ATM Program</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-895-2">After the year ended December&#160;31, 2025 through March&#160;11, 2026, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-216" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-896">668,504</ix:nonFraction> shares of common stock for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-897">6.3</ix:nonFraction>&#160;million under the 2024 ATM Program.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_169"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_172"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Definition and Limitations of Disclosure Controls</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this Annual Report on Form 10-K, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluates these controls and procedures on an ongoing basis. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our management, with the participation of our President and Chief Executive Officer, our principal executive officer, and our Chief Strategy and Financial Officer, our principal accounting officer and principal financial officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December&#160;31, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Based on the evaluation of our disclosure controls and procedures, our President and Chief Executive Officer and Chief Strategy and Financial Officer, have concluded that our disclosure controls and procedures were effective as of December&#160;31, 2025.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)) under the Exchange Act) that occurred during the year ended December&#160;31, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting except as follows:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Remediation of Previously Identified Material Weaknesses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As previously disclosed in the Form 10-K for the fiscal year ending December 31, 2024, we identified control deficiencies in the design and operation of our internal control over financial reporting that constituted material weaknesses. The material weaknesses identified in our internal control over financial reporting related to (i) insufficient resources with knowledge and expertise in U.S. GAAP to properly evaluate certain complex transactions, including debt instruments and equity instruments; and (ii) insufficient financial reporting and close controls to ensure that incurred expenses are accrued at period end and deliverables from third party contractors are reviewed for accuracy.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Beginning in January 2024 and through June 30, 2025, we implemented a series of remediation measures designed to address the identified material weaknesses. These measures include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We engaged SEC compliance and technical accounting consultants to assist in evaluating complex debt and equity transactions for conformity with U.S. GAAP;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We hired additional finance and accounting personnel to augment existing accounting staff and to provide more resources for complex accounting matters and financial reporting; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We strengthened our financial reporting and close processes relating to incurred expenses by ensuring our data capture procedures are clearly defined. We implemented quarterly controls which require outreach to business owners and vendors to discuss the project status, as well as began reviewing the accruals on a project-level basis rather than vendor-level. Additional levels of review were put in place over the expense accrual reconciliations and fluctuation analysis controls to ensure expenses are recorded during the period incurred. Additionally, all responsible personnel, including supervisory personnel, have adequate training regarding the process and expectation, ensuring all clinical invoices are approved and tied to our tracker.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of June 30, 2025, management completed testing of the newly implemented and enhanced controls and concluded the material weaknesses have been fully remediated.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Management&#8217;s Report on Internal Control Over Financial Reporting </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is a process designed by, or under the supervision of, the Company&#8217;s principal executive and principal accounting and financial officer and effected by the Company&#8217;s board of directors, management and other personnel to provide reasonable assurance regarding the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our management assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2025. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;) in Internal Control-Integrated Framework (2013). Based on our assessment, management concluded our internal control over financial reporting was effective as of December&#160;31, 2025, based on the COSO criteria.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Inherent Limitation on the Effectiveness Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute assurances. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but there can be no assurance that such improvements will be sufficient to provide us with effective internal control over financial reporting in future periods.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_175"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. Other Information </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended December 31, 2025, no director or officer of the Company <ix:nonNumeric contextRef="c-217" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-898"><ix:nonNumeric contextRef="c-217" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-899">adopted</ix:nonNumeric></ix:nonNumeric>, modified or <ix:nonNumeric contextRef="c-217" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-900"><ix:nonNumeric contextRef="c-217" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-901">terminated</ix:nonNumeric></ix:nonNumeric> a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as each term is defined in Item 408(a) of Regulation S-K.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_178"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_181"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Part III</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_184"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2026 Annual Meeting of Stockholders. If such proxy statement is not filed within 120 days after the end of our fiscal year ended December 31, 2025, the information required by this item will be contained in the Form 10-K/A.</span></div><div><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_187"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. Executive Compensation</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2026 Annual Meeting of Stockholders. If such proxy statement is not filed within 120 days after the end of our fiscal year ended December 31, 2025, the information required by this item will be contained in the Form 10-K/A.</span></div><div style="padding-left:18pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_190"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2026 Annual Meeting of Stockholders. If such proxy statement is not filed within 120 days after the end of our fiscal year ended December 31, 2025, the information required by this item will be contained in the Form 10-K/A.</span></div><div style="padding-left:36pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_193"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-902">required by this Item is incorporated herein by reference</ix:nonNumeric> to the information that will be contained in our proxy statement related to the 2026 Annual Meeting of Stockholders. If such proxy statement is not filed within 120 days after the end of our fiscal year ended December 31, 2025, the information required by this item will be contained in the Form 10-K/A.</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_196"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. Principal Accountant Fees and Services</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2026 Annual Meeting of Stockholders. If such proxy statement is not filed within 120 days after the end of our fiscal year ended December 31, 2025, the information required by this item will be contained in the Form 10-K/A.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_199"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Part IV</span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_202"></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. Exhibits and Financial Statement Schedules</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.18pt">Financial Statements: See &#8220;Index to Consolidated Financial Statements&#8221; in Part II, Item 8 of this Annual Report on Form 10-K</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.57pt">Exhibits.</span></div><div style="padding-left:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.014%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:112%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Description</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Incorporated by</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Filed Herewith</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Form</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:115%">Date</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">2.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123001714/ny20006674x1_ex2-1.htm">Agreement and Plan of Merger and Reorganization, dated January 17, 2023, by and among Angion Biomedica Corp., Arkham Merger Sub, Inc. and Elicio Therapeutics, Inc</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/17/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">3.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000110465921016652/tm215755d1_ex3-1.htm">Amended and Restated Certificate of Incorporation</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2/9/2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">3.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123028077/brhc20053890_ex3-3.htm">Certificate of Amendment (Reverse Stock Split) to the Amended and Restated Certificate of Incorporation, dated June 1, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/2/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3.3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">3.3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123028077/brhc20053890_ex3-4.htm">Certificate of Amendment (Officer Exculpation) to the Amended and Restated Certificate, dated June 1, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/2/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3.4</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">3.4</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123028077/brhc20053890_ex3-5.htm">Certificate of Amendment (Name Change) to the Amended and Restated Certificate of Incorporation, dated June 1, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/2/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3.5</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">3.5</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000110465921016652/tm215755d1_ex3-2.htm">Amended and Restated Bylaws</a>.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2/9/2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Reference is made to exhibits 3.1 through 3.5.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000234/a2242860zex-4_2.htm">Form of Common Stock Certificate.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2/1/2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000107/a2242765zex-4_3.htm">Form of Warrant to Purchase Common Stock.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/15/2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.4</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000107/a2242765zex-4_6.htm">Amended and Restated Registration Rights Agreement, dated as of March 31, 2020, by and among Angion Biomedica Corp. and the investors party thereto.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/15/2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.6</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.5</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148522000022/angion-descriptionofsecuri.htm">Description of Registrant&#8217;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/30/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/d914999dex41.htm">Form of Common Warrant</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/30/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_ex4-1.htm">Form of Senior Secured Convertible Promissory Note due February 15, 2026.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8/12/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036124031811/ny20031755x4_ex4-1.htm">Form of Common Warrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/28/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036124031811/ny20031755x4_ex4-2.htm">Form of Pre-Funded Warrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/28/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148524000015/angn-20240318.htm">Form of Pre-Funded Warrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/18/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">orm of Senior Secured Promissory Note due June 3, 2028.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/4/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">4.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">orm of Warrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/4/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123014578/ny20006674x9_ex10-34.htm">Lease Between Elicio Therapeutics, Inc. and RREF II 451D, LLC dated July 21, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-4/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.34</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/d914999dex101.htm">Form of Securities Purchase Agreement, dated as of January 29, 2025, by and among Elicio Therapeutics, Inc. and the purchasers party thereto</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/30/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_ex10-1.htm">Securities Purchase Agreement, dated August 12, 2024, by and between the Company and GKCC, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8/12/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_ex10-2.htm">Security Agreement, dated August 12, 2024, by and between the Company and GKCC, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8/12/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_ex10-3.htm">IP Security Agreement, dated August 12, 2024, by and between the Company and GKCC, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8/12/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_ex10-4.htm">Subsidiary Guarantee, dated August 12, 2024, among Elicio Operating Company, Inc., Elicio Securities Corp. and GKCC, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8/12/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">ecurity Agreement</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">, dated June 3, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">5, by and between the Company and GKCC, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/4/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">I</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">P Security Agreement, dated June 3, 2025, by and between the Company and GKCC, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/4/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">ubsidiary Guarantee, dated June 3, 2025, among Elicio Operating Company,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm"> Inc., Elicio Securities Corp. and GKCC, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/4/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148524000015/angn-20240318.htm">Subscription Agreement, dated as of March 18, 2024, by and between Elicio Therapeutics, Inc. and GKCC, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/18/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148524000045/angn-20240630.htm">Capital on DemandTM Sales Agreement, dated as of June 3, 2024, by and between Elicio Therapeutics, Inc. and JonesTrading Institutional Services LLC</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/3/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">1.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123028077/brhc20053890_ex10-8.htm">Form of Indemnification Agreement between Elicio Therapeutics, Inc. and each of its directors and officers.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/2/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123028077/brhc20053890_ex10-13.htm">Information Rights Letter, dated May 30, 2023, by and between Clal Biotechnology Industries Ltd. and Elicio Therapeutics, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/2/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.14#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123014578/ny20006674x9_ex10-29.htm">Employment Agreement between Elicio Therapeutics, Inc. and Robert Connelly, dated as of November 15, 2018.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-4/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.29+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.15#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123014578/ny20006674x9_ex10-30.htm">Offer Letter between Elicio Therapeutics, Inc. and Dr. Christopher Haqq, dated as of September 29, 2019.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-4/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.30+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.16#</span></div><div style="text-align:right"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123014578/ny20006674x9_ex10-32.htm">Employment Letter, by and between Elicio Therapeutics, Inc. and Peter DeMuth, dated as of April 13, 2022.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-4/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.32+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.17#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148525000022/confidential-elicioemplo.htm">Employment Agreement, dated March 21, 2025, by and between Elicio Therapeutics, Inc. and Preetam Shah.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/24/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.1+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148523000086/eltxpipesubscriptionagmt.htm">Subscription Agreement, dated as of December 22, 2023, by and between the Company and GKCC, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">12/22/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.19#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123014578/ny20006674x9_ex10-27.htm">Elicio Therapeutics, Inc. 2012 Equity Incentive Plan, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-4/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.27+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.20#</span></div><div style="text-align:right"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123014578/ny20006674x9_ex10-28.htm">Elicio Therapeutics, Inc. 2022 Equity Incentive Plan, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-4/A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.28+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">10.21&#8224;</span></div><div style="text-align:right"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123014578/ny20006674x9_ex10-25.htm">Exclusive Patent License Agreement, dated January 22, 2016, by and between Elicio Therapeutics, Inc. and the Massachusetts Institute of Technology, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-4/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.25+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000114036123001714/ny20006674x1_ex10-1.htm">Note Purchase Agreement, dated January 17, 2023, by and between Elicio Therapeutics and Angion Biomedica Corp., and Form of Promissory Note.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/17/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">N</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001601485/000160148525000096/angn-20250604.htm">ote Purchase Agreement, dated June 3, 2025, by and between the Company and GKCC, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">6/4/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.24#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-arnonxemployeedir.htm">Amended and Restated Non-Employee Director Compensation Policy.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.25#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148524000023/elicio-executiveseveranc.htm">Executive Severance Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2/2/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.26#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000107/a2242765zex-10_5a.htm">Second Amended and Restated 2015 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/15/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.5(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.27#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000107/a2242765zex-10_5b.htm">Form of Incentive Stock Option Grant under 2015 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/15/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.5(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.28#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000107/a2242765zex-10_5c.htm">Form of Non-Qualified Stock Option Grant under 2015 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/15/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.5(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.29#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000107/a2242765zex-10_5d.htm">Form of Stock Option Exercise under 2015 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">1/15/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.5(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.30#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000234/a2242860zex-10_6a.htm">2021 Incentive Award Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2/1/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.6(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.31#</span></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000234/a2242860zex-10_6b.htm">Form of Stock Option Grant Notice and Stock Option Agreement under the 2021 Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2/1/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.6(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.32#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000234/a2242860zex-10_6c.htm">Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2021 Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2/1/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.6(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.33#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000104746921000234/a2242860zex-10_6d.htm">Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">2/1/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.6(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.34#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio2021employeestockp.htm">2021 Employee Stock Purchase Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio2021employeestockp.htm">, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.35#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148524000023/elicio-inducementincenti.htm">Elicio Therapeutics, Inc. 2024 Inducement Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.36#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148524000023/elicio-formofoptionagree.htm">Form of Stock Option Grant Notice and Stock Option Agreement under the 2024 Inducement Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.37#</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148524000023/elicio-formofinducements.htm">Form of Inducement Stock Option Grant Notice and Agreement.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/29/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10.21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">19.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-insidertradingcom.htm"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-903">2021 Insider Trading Compliance Policy, as amended</ix:nonNumeric></a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148525000049/exhibit2112024.htm">Subsidiaries of the registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">3/31/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">23.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-btconsent202510xk.htm">Consent of independent registered public accounting firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">24.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="eltx-powerofattorney2025.htm">Power of Attorney (reference is made to the signature page hereto).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">31.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit311202510x.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit312202510x.htm">Certification of Principal </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit312202510x.htm">Financial</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit312202510x.htm"> Officer </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit312202510x.htm">and P</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit312202510x.htm">rincipal Accounting Off</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit312202510x.htm">icer </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit312202510x.htm">Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">32.1&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit321202510x.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">32.2&#x5E;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit322202510x.htm">Certification of Principal </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit322202510x.htm">Financial</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit322202510x.htm"> Officer </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit322202510x.htm">and Principal Accounting Officer </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio-exhibit322202510x.htm">Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.821%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601485/000160148525000049/elicio_clawbackpolicynas.htm">Elicio Therapeutics, Inc. Clawback Policy (effective October 31, 2023).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">3/31/2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">101.INS</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Inline XBRL Instance Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">101.SCH</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Schema Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">101.CAL</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">101.DEF</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">101.LAB</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">101.PRE</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Cover Page Interactive Data File</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">__________________________________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">&#8224;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">       </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Portions of this exhibit have been omitted in accordance with Item 601(b)(10) of Regulation S-K.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">#</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">       </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">Indicates management contract or compensatory plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">&#x5E;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">      </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:112%">The certification that accompanies the Annual Report on Form 10-K pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, is not deemed &#8220;filed&#8221; by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div id="i8f3bd7775f224765952a5c19fa601c7c_205"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. Form 10-K Summary</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="i8f3bd7775f224765952a5c19fa601c7c_208"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">/s/ ROBERT CONNELLY</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">March&#160;12, 2026</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Robert Connelly</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">President and Chief Executive Officer </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Executive Officer)</span></div></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">/s/ PREETAM SHAH, PH.D., M.B.A.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">March&#160;12, 2026</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Preetam Shah, Ph.D., M.B.A.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chief Strategy and Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="padding-left:180pt;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Power of Attorney</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Robert Connelly and Preetam Shah, Ph.D., M.B.A., and each of them, with full power of substitution and resubstitution and full power to act without the other, as his respective true and lawful attorney-in-fact and agent for him in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K and to file the same, with all exhibits thereto and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them or his or their substitute or substitutes may lawfully do or cause to be done by virtue hereof. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed by the following persons in the capacities and on the dates indicated. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"/><td style="width:33.377%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.898%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Robert Connelly<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Chief Executive Officer, President and Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Robert Connelly</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Preetam Shah, Ph.D., M.B.A.<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Strategy and Financial Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Preetam Shah, Ph.D., M.B.A.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Julian Adams, Ph.D.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Julian Adams, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Carol Ashe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Carol Ashe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Allen Nissenson, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i8f3bd7775f224765952a5c19fa601c7c_13">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"/><td style="width:33.377%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.898%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Allen Nissenson, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Yekaterina (Katie) Chudnovsky</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Yekaterina (Katie) Chudnovsky</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Robert R. Ruffolo, Jr., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Robert R. Ruffolo, Jr., Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Karen Wilson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Karen Wilson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ Jay Venkatesan, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Jay Venkatesan, M.D.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>2
<FILENAME>elicio-arnonxemployeedir.htm
<DESCRIPTION>EX-10.24
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-arnonxemployeedir</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-arnonxemployeedir001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-arnonxemployeedir001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    ELICIO THERAPEUTICS, INC.    AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY    Non-employee members of the board of directors (the &#8220;Board&#8221;) of Elicio Therapeutics, Inc. (the  &#8220;Company&#8221;) shall be eligible to receive the compensation as set forth in this Non-Employee Director  Compensation Policy (this &#8220;Policy&#8221;), which was first adopted pursuant to the Board&#8217;s action on June 9,  2022, amended as of December 28, 2023, April 23, 2025 and further amended as of February 10, 2026 (the  &#8220;Effective Date&#8221;).  The compensation described in this Policy shall be paid or be made, as applicable,  automatically and without further action of the Board, to each member of the Board who is not an employee  of the Company or any parent or subsidiary of the Company (each, a &#8220;Non-Employee Director&#8221;) who may  be eligible to receive such compensation, unless such Non-Employee Director declines the receipt of such  compensation by written notice to the Company; provided, however, that Non-Employee Directors shall  not be eligible to receive cash or equity compensation under the Policy (but shall be entitle to receive  reimbursement pursuant to Section 3 below) if and while they are receiving other compensation (including  severance compensation) from the Company resulting from their former employment with the Company.   This Policy shall remain in effect until it is revised or rescinded by further action of the Board.  This Policy  may be amended, modified or terminated by the Board at any time, without advance notice, in its sole  discretion.  The terms and conditions of this Policy shall supersede any prior cash and/or equity  compensation arrangements for service as a member of the Board between the Company and any of its  Non-Employee Directors, including pursuant to this Policy as in effect prior to the Effective Date.    1. Cash Compensation.    (a) Annual Retainers.  Each Non-Employee Director shall be eligible to receive an  annual retainer of $40,000 for service on the Board.    (b) Additional Annual Retainers.  In addition, a Non-Employee Director shall receive  the following annual retainers:  (i) Non-Executive Chairman of the Board.  A Non-Employee Director  serving as the Non-Executive Chairman of the Board shall receive an additional annual retainer of $35,000  for such service.  (ii) Audit Committee.  A Non-Employee Director serving as Chairperson of  the Audit Committee shall receive an additional annual retainer of $15,000 for such service.  A Non- Employee Director serving as a member of the Audit Committee (other than the Chairperson) shall receive  an additional annual retainer of $7,500 for such service.  (iv) Compensation Committee.  A Non-Employee Director serving as  Chairperson of the Compensation Committee shall receive an additional annual retainer of $12,000 for such  service.  A Non-Employee Director serving as a member of the Compensation Committee (other than the  Chairperson) shall receive an additional annual retainer of $6,000 for such service.  (v)  Nominating and Corporate Governance Committee.  A Non-Employee  Director serving as Chairperson of the Nominating and Corporate Governance Committee shall receive an  additional annual retainer of $10,000 for such service.  A Non-Employee Director serving as a member of  the Nominating and Corporate Governance Committee (other than the Chairperson) shall receive an  additional annual retainer of $5,000 for such service.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-arnonxemployeedir002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-arnonxemployeedir002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2      (c) Payment of Retainers.  The annual retainers described in Sections 1(a) and 1(b)  shall be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company in arrears  not later than the fifteenth (15th) day following the end of each calendar quarter.  In the event a Non- Employee Director does not serve as a Non-Employee Director, or in the applicable positions described in  Section 1(b), for an entire calendar quarter, the retainer paid to such Non-Employee Director shall be  prorated for the portion of such calendar quarter actually served as a Non-Employee Director, or in such  position, as applicable.    2. Equity Compensation.  Non-Employee Directors shall be granted the equity awards  described below.  The awards described below shall be granted under and shall be subject to the terms and  provisions of the Company&#8217;s 2021 Equity Incentive Award Plan, as amended from time to time, or any  other applicable Company equity incentive plan then-maintained by the Company (in any case, the &#8220;Equity  Plan&#8221;) and shall be evidenced by the execution and delivery of award agreements in substantially the forms  approved by the Board from time to time.  All applicable terms of the Equity Plan apply to this Policy as if  fully set forth herein, and all grants of stock options hereby are subject in all respects to the terms of the  Equity Plan.     (a) Initial Awards.  Each Non-Employee Director who is initially elected or appointed  to the Board after the Effective Date shall automatically be granted, on the date of such initial election or  appointment, an option (an &#8220;Initial Award&#8221;) to purchase 15,800 shares of the Company&#8217;s common stock  (&#8220;Shares&#8221;).  No Non-Employee Director shall be granted more than one Initial Award.     (b) Subsequent Awards.  A Non-Employee Director who (i) has been serving on the  Board immediately prior to any annual meeting of the Company&#8217;s stockholders on or after the Effective  Date and (ii) will continue to serve as a Non-Employee Director immediately following such meeting, shall  be automatically granted, on the date of such annual meeting, an option (a &#8220;Subsequent Award&#8221;) to  purchase 7,900 Shares.        (c) Termination of Service of Employee Directors.  Members of the Board who are  employees of the Company or any parent or subsidiary of the Company who subsequently terminate their  service with the Company and any parent or subsidiary of the Company and remain on the Board will not  receive an Initial Award pursuant to Section 2(a) above, but to the extent that they are otherwise eligible,  will be eligible to receive, after termination from service with the Company and any parent or subsidiary  of the Company, Subsequent Awards as described in Section 2(b) above.    (d) Terms of Awards Granted to Non-Employee Directors    (i) Purchase Price.  The per Share exercise price of each option granted to a  Non-Employee Director shall equal the Fair Market Value (as defined in the Equity Plan) of a Share on the  date the option is granted.      (ii) Vesting.  Subject to Section 2(d)(iii) below, each Initial Award shall vest  and become exercisable in thirty-six (36) substantially equal installments on each monthly anniversary of  the date of grant, subject to the Non-Employee Director continuing to provide services to the Company  through each such vesting date.  Subject to Section 2(d)(iii) below, each Subsequent Award shall vest and  become exercisable in full on the earlier of the one-year anniversary of the date of grant and the next annual  meeting of the Company&#8217;s stockholders after the grant date, subject to the Non-Employee Director  continuing to provide services to the Company through such vesting date.    (iii) Accelerated Vesting.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-arnonxemployeedir003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-arnonxemployeedir003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3    (A) Termination Due to Death or Disability.  In the event that any Non- Employee Director incurs a Termination of Service (as defined in the Equity Plan) due to such Non- Employee Director&#8217;s death or Disability (as defined the Equity Plan), each of such Non-Employee  Director&#8217;s Initial Award and Subsequent Award(s), along with any other stock options or other equity-based  awards held by such Non-Employee Director, shall vest and, if applicable, become exercisable with respect  to one hundred percent (100%) of the Shares subject thereto upon such Termination of Service.    (B) Change in Control.  In the event that a Change in Control (as defined in  the Equity Plan) occurs, each Initial Award and Subsequent Award, along with any other stock options or  other equity-based awards held by any Non-Employee Director, shall vest and, if applicable, become  exercisable with respect to one hundred percent (100%) of the Shares subject thereto as of immediately  prior to such Change in Control.  (iv) Term.  The term of each stock option granted to a Non-Employee Director  shall be ten (10) years from the date the option is granted.   3. Reimbursements.  The Company shall reimburse each Non-Employee Director for all  reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee  Director in the performance of his or her duties to the Company in accordance with the Company&#8217;s  applicable expense reimbursement policies and procedures as in effect from time to time.   * * * * *  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.34
<SEQUENCE>3
<FILENAME>elicio2021employeestockp.htm
<DESCRIPTION>EX-10.34
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio2021employeestockp</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio2021employeestockp001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">1  ELICIO THERAPEUTICS, INC.  2021 EMPLOYEE STOCK PURCHASE PLAN  (Amended and Restated February 10, 2026)  ARTICLE I.  PURPOSE  The Plan&#8217;s purpose is to assist employees of the Company and its Designated  Subsidiaries in acquiring a stock ownership interest in the Company pursuant to a plan which is  intended to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Code, and to  help such employees provide for their future security and to encourage them to remain in the  employment of the Company and its Subsidiaries.  ARTICLE II.  DEFINITIONS  As used in the Plan, the following words and phrases have the meanings specified below,  unless the context clearly indicates otherwise:  2.1 &#8220;Administrator&#8221; means the Committee, or such individuals to which authority to  administer the Plan has been delegated under Section 7.1 hereof.  2.2 &#8220;Agent&#8221; means the brokerage firm, bank or other financial institution, entity or person(s),  if any, engaged, retained, appointed or authorized to act as the agent of the Company or an  Employee with regard to the Plan.  2.3 &#8220;Board&#8221; means the Board of Directors of the Company.  2.4 &#8220;Code&#8221; means the U.S. Internal Revenue Code of 1986, as amended, and all regulations,  guidance, compliance programs and other interpretative authority issued thereunder.  2.5 &#8220;Committee&#8221; means the Compensation Committee of the Board.  2.6 &#8220;Common Stock&#8221; means the common stock of the Company.  2.7 &#8220;Company&#8221; means Elicio Therapeutics, Inc., a Delaware corporation, or any successor.  2.8 &#8220;Compensation&#8221; of an Employee means the regular earnings or base salary paid to the  Employee from the Company on each Payday as compensation for services to the Company or  any Designated Subsidiary, before deduction for any salary deferral contributions made by the  Employee to any tax-qualified or nonqualified deferred compensation plan, including overtime,  shift differentials, vacation pay, salaried production schedule premiums, holiday pay, jury duty  pay, funeral leave pay, paid time off, military pay, and prior week adjustments, but excluding  bonuses, commissions, education or tuition reimbursements, imputed income arising under any  group insurance or benefit program, travel expenses, business and moving reimbursements,  including tax gross ups and taxable mileage allowance, income received in connection with any  stock options, restricted stock, restricted stock units or other compensatory equity awards and all  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2  contributions made by the Company or any Designated Subsidiary for the Employee&#8217;s benefit  under any employee benefit plan now or hereafter established.  Such Compensation shall be  calculated before deduction of any income or employment tax withholdings, but shall be  withheld from the Employee&#8217;s net income.  2.9 &#8220;Designated Subsidiary&#8221; means each Subsidiary that has been designated by the Board  or Committee from time to time in its sole discretion as eligible to participate in the Plan,  including any Subsidiary in existence on the Effective Date and any Subsidiary formed or  acquired following the Effective Date, in accordance with Section 7.2 hereof.  2.10 &#8220;Effective Date&#8221; means the date immediately prior to the date the Company&#8217;s registration  statement relating to its initial public offering becomes effective, provided that the Board has  adopted the Plan prior to or on such date, subject to approval of the Plan by the Company&#8217;s  stockholders in accordance with Section 7.7 hereof.  2.11 &#8220;Eligible Employee&#8221; means an Employee who:  (a) is customarily scheduled to work at least 20 hours per week;  (b) whose customary employment is more than five months in a calendar year; and  (c) after the granting of the Option would not be deemed for purposes of Section  423(b)(3) of the Code to possess five percent or more of the total combined voting power or  value of all classes of stock of the Company or any Subsidiary.  For purposes of clause (c), the rules of Section 424(d) of the Code with regard to the attribution  of stock ownership shall apply in determining the stock ownership of an individual, and stock  which an Employee may purchase under outstanding options shall be treated as stock owned by  the Employee.  Notwithstanding the foregoing, the Administrator may exclude from participation in the Plan as  an Eligible Employee:  (x) any Employee that is a &#8220;highly compensated employee&#8221; of the Company or any  Designated Subsidiary (within the meaning of Section 414(q) of the Code), or that is such a  &#8220;highly compensated employee&#8221; (A) with compensation above a specified level, (B) who is an  officer or (C) who is subject to the disclosure requirements of Section 16(a) of the Exchange Act;  or  (y) any Employee who is a citizen or resident of a foreign jurisdiction (without regard  to whether they are also a citizen of the United States or a resident alien (within the meaning of  Section 7701(b)(1)(A) of the Code)) if either (A) the grant of the Option is prohibited under the  laws of the jurisdiction governing such Employee, or (B) compliance with the laws of the foreign  jurisdiction would cause the Plan or the Option to violate the requirements of Section 423 of the  Code;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3  provided that any exclusion in clauses (x) or (y) shall be applied in an identical manner under  each Offering Period to all Employees of the Company and all Designated Subsidiaries, in  accordance with Treasury Regulation Section 1.423-2(e).  2.12 &#8220;Employee&#8221; means any person who renders services to the Company or a Designated  Subsidiary in the status of an employee within the meaning of Section 3401(c) of the Code.   &#8220;Employee&#8221; shall not include any director of the Company or a Designated Subsidiary who does  not render services to the Company or a Designated Subsidiary in the status of an employee  within the meaning of Section 3401(c) of the Code.  For purposes of the Plan, the employment  relationship shall be treated as continuing intact while the individual is on military leave, sick  leave or other leave of absence approved by the Company or a Designated Subsidiary and  meeting the requirements of Treasury Regulation Section 1.421-1(h)(2).  Where the period of  leave exceeds three months, or such other period specified in Treasury Regulation Section 1.421- 1(h)(2), and the individual&#8217;s right to reemployment is not guaranteed either by statute or by  contract, the employment relationship shall be deemed to have terminated on the first day  immediately following such three-month period, or such other period specified in Treasury  Regulation Section 1.421-1(h)(2).  2.13 &#8220;Enrollment Date&#8221; means the first date of each Offering Period.  2.14 &#8220;Exercise Date&#8221; means the last Trading Day of each Offering Period, except as provided  in Section 5.2 hereof.  2.15 &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended.  2.16 &#8220;Fair Market Value&#8221; means, as of any date, the value of Common Stock determined as  follows:  (a) If the Common Stock is (i) listed on any established securities exchange (such as  the New York Stock Exchange, the NASDAQ Global Market or the NASDAQ Global Select  Market), (ii) listed on any national market system or (iii) listed, quoted or traded on any  automated quotation system, its Fair Market Value shall be the closing sales price for a share of  Common Stock as quoted on such exchange or system for such date or, if there is no closing  sales price for a share of Common Stock on the date in question, the closing sales price for a  share of Common Stock on the last preceding date for which such quotation exists, as reported in  The Wall Street Journal or such other source as the Administrator deems reliable;  (b) If the Common Stock is not listed on an established securities exchange, national  market system or automated quotation system, but the Common Stock is regularly quoted by a  recognized securities dealer, its Fair Market Value shall be the mean of the high bid and low  asked prices for such date or, if there are no high bid and low asked prices for a share of  Common Stock on such date, the high bid and low asked prices for a share of Common Stock on  the last preceding date for which such information exists, as reported in The Wall Street Journal  or such other source as the Administrator deems reliable; or  (c) If the Common Stock is neither listed on an established securities exchange,  national market system or automated quotation system nor regularly quoted by a recognized  securities dealer, its Fair Market Value shall be established by the Administrator in good faith.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4  2.17 &#8220;Grant Date&#8221; means the first Trading Day of an Offering Period.  2.18 &#8220;New Exercise Date&#8221; has the meaning set forth in Section 5.2(b) hereof.  2.19 &#8220;Offering&#8221; means an offer under the Plan of an Option that may be exercised during an  Offering Period as further described in Section 4 hereof.  Unless otherwise specified by the  Administrator, each Offering to the Eligible Employees of the Company or a Designated  Subsidiary shall be deemed a separate Offering, even if the dates and other terms of the  applicable Offering Periods of each such Offering are identical and the provisions of the Plan  will separately apply to each Offering.  To the extent permitted by Treas. Reg. &sect; 1.423-2(a)(1),  the terms of each separate Offering need not be identical, provided that the terms of the Offering  thereunder together satisfy Treas. Reg. &sect; 1.423-2(a)(2) and (a)(3).  2.20 &#8220;Offering Period&#8221; means such period of time commencing on such date(s) as determined  by the Board or Committee, in its sole discretion, and with respect to which Options shall be  granted to Participants.  The duration and timing of Offering Periods may be established or  changed by the Board or Committee at any time, in its sole discretion.  Notwithstanding the  foregoing, in no event may an Offering Period exceed 27 months.  2.21 &#8220;Option&#8221; means the right to purchase shares of Common Stock pursuant to the Plan  during each Offering Period.  2.22 &#8220;Option Price&#8221; means the purchase price of a share of Common Stock hereunder as  provided in Section 4.2 hereof.  2.23 &#8220;Parent&#8221; means any entity that is a parent corporation of the Company within the  meaning of Section 424 of the Code.  2.24 &#8220;Participant&#8221; means any Eligible Employee who elects to participate in the Plan.  2.25 &#8220;Payday&#8221; means the regular and recurring established day for payment of Compensation  to an Employee of the Company or any Designated Subsidiary.  2.26 &#8220;Plan&#8221; means this 2021 Employee Stock Purchase Plan, as amended from time to time.  2.27 &#8220;Plan Account&#8221; means a bookkeeping account established and maintained by the  Company in the name of each Participant.  2.28 &#8220;Section 423 Option&#8221; has the meaning set forth in Section 3.1(b) hereof.  2.29 &#8220;Subsidiary&#8221; means any entity that is a subsidiary corporation of the Company within the  meaning of Section 424 of the Code.  In addition, with respect to any sub-plans adopted under  Section 7.1(d) hereof which are designed to be outside the scope of Section 423 of the Code,  Subsidiary shall include any corporate or noncorporate entity in which the Company has a direct  or indirect equity interest or significant business relationship.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5  2.30 &#8220;Trading Day&#8221; means a day on which the principal securities exchange on which the  Common Stock is listed is open for trading or, if the Common Stock is not listed on a securities  exchange, means a business day, as determined by the Administrator in good faith.  2.31 &#8220;Withdrawal Election&#8221; has the meaning set forth in Section 6.1(a) hereof.  ARTICLE III.  PARTICIPATION  3.1 Eligibility.  (a) Any Eligible Employee who is employed by the Company or a Designated  Subsidiary on a given Enrollment Date for an Offering Period shall be eligible to participate in  the Plan during such Offering Period, subject to the requirements of Articles IV and V hereof,  and the limitations imposed by Section 423(b) of the Code.  (b) No Eligible Employee shall be granted an Option under the Plan which permits  the Participant&#8217;s rights to purchase shares of Common Stock under the Plan, and to purchase  stock under all other employee stock purchase plans of the Company, any Parent or any  Subsidiary subject to Section 423 of the Code (any such Option or other option, a &#8220;Section 423  Option&#8221;), to accrue at a rate which exceeds $25,000 of fair market value of such stock  (determined at the time the Section 423 Option is granted) for each calendar year in which any  Section 423 Option granted to the Participant is outstanding at any time.  For purposes of the  limitation imposed by this subsection:  (i) the right to purchase stock under a Section 423 Option accrues when the  Section 423 Option (or any portion thereof) first becomes exercisable during the calendar year;  (ii) the right to purchase stock under a Section 423 Option accrues at the rate  provided in the Section 423 Option, but in no case may such rate exceed $25,000 of fair market  value of such stock (determined at the time such option is granted) for any one calendar year;  and  (iii) a right to purchase stock which has accrued under a Section 423 Option  may not be carried over to any other Section 423 Option; provided that Participants may carry  forward amounts so accrued that represent a fractional share of stock and were withheld but not  applied towards the purchase of Common Stock under an earlier Offering Period, and may apply  such amounts towards the purchase of additional shares of Common Stock under a subsequent  Offering Period.  The limitation under this Section 3.1(b) shall be applied in accordance with Section 423(b)(8) of  the Code.  3.2 Election to Participate; Payroll Deductions  (a) Except as provided in Section 3.3 hereof, an Eligible Employee may become a  Participant in the Plan only by means of payroll deduction.  Each individual who is an Eligible  Employee as of an Offering Period&#8217;s Enrollment Date may elect to participate in such Offering  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">6  Period and the Plan by delivering to the Company a payroll deduction authorization no later than  the period of time prior to the applicable Enrollment Date that is determined by the Company, in  its sole discretion.  (b) Subject to Section 3.1(b) hereof, payroll deductions (i) shall be equal to at least  1% of the Participant&#8217;s Compensation as of each Payday of the Offering Period following the  Enrollment Date, but not more than 15% of the Participant&#8217;s Compensation as of each Payday of  the Offering Period following the Enrollment Date; and (ii) may be expressed either as (A) a  whole number percentage, or (B) a fixed dollar amount.  Amounts deducted from a Participant&#8217;s  Compensation with respect to an Offering Period pursuant to this Section 3.2 shall be deducted  each Payday through payroll deduction and credited to the Participant&#8217;s Plan Account.  (c) Following at least one payroll deduction, a Participant may decrease (to as low as  zero) the amount deducted from such Participant&#8217;s Compensation only once during an Offering  Period upon ten calendar days&#8217; prior written notice to the Company.  A Participant may not  increase the amount deducted from such Participant&#8217;s Compensation during an Offering Period.  (d) Notwithstanding the foregoing, upon the termination of an Offering Period, each  Participant in such Offering Period shall automatically participate in the immediately following  Offering Period at the same payroll deduction percentage or fixed amount as in effect at the  termination of the prior Offering Period, unless such Participant delivers to the Company a  different election with respect to the successive Offering Period in accordance with Section  3.2(a) hereof, or unless such Participant becomes ineligible for participation in the Plan.  3.3 Leave of Absence.  During leaves of absence approved by the Company meeting the  requirements of Treasury Regulation Section 1.421-1(h)(2), a Participant may continue  participation in the Plan by making cash payments to the Company on his or her normal payday  equal to his or her authorized payroll deduction.  ARTICLE IV.  PURCHASE OF SHARES  4.1 Grant of Option.  The Company may make one or more Offerings under the Plan, which  may be successive or overlapping with one another, until the earlier of: (i) the date on which the  Shares available under the Plan have been sold or (ii) the date on which the Plan is suspended or  terminates.  The Administrator shall designate the terms and conditions of each Offering in  writing, including without limitation, the Offering Periods.  Each Participant shall be granted an  Option with respect to an Offering Period on the applicable Grant Date.  Subject to the  limitations of Section 3.1(b) hereof, the number of shares of Common Stock subject to a  Participant&#8217;s Option shall be determined by dividing (a) such Participant&#8217;s payroll deductions  accumulated prior to an Exercise Date and retained in the Participant&#8217;s Plan Account on such  Exercise Date by (b) the applicable Option Price; provided that in no event shall a Participant be  permitted to purchase during each Offering Period more than 5,000 shares of Common Stock  (subject to any adjustment pursuant to Section 5.2 hereof).  The Administrator may, for future  Offering Periods, increase or decrease, in its absolute discretion, the maximum number of shares  of Common Stock that a Participant may purchase during such future Offering Periods.  Each  Option shall expire on the Exercise Date for the applicable Offering Period immediately after the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">7  automatic exercise of the Option in accordance with Section 4.3 hereof, unless such Option  terminates earlier in accordance with Article 6 hereof.  4.2 Option Price.  The &#8220;Option Price&#8221; per share of Common Stock to be paid by a Participant  upon exercise of the Participant&#8217;s Option on an Exercise Date for an Offering Period shall be  equal to 85% of the lesser of the Fair Market Value of a share of Common Stock on (a) the  applicable Grant Date and (b) the applicable Exercise Date; provided that in no event shall the  Option Price per share of Common Stock be less than the par value per share of the Common  Stock.  4.3 Purchase of Shares.  (a) On the applicable Exercise Date for an Offering Period, each Participant shall  automatically and without any action on such Participant&#8217;s part be deemed to have exercised his  or her Option to purchase at the applicable per share Option Price the largest number of whole  shares of Common Stock which can be purchased with the amount in the Participant&#8217;s Plan  Account.  Any balance less than the per share Option Price that is remaining in the Participant&#8217;s  Plan Account (after exercise of such Participant&#8217;s Option) as of the Exercise Date shall be  carried forward to the next Offering Period, unless the Participant has elected to withdraw from  the Plan pursuant to Section 6.1 hereof or, pursuant to Section 6.2 hereof, such Participant has  ceased to be an Eligible Employee.  Any balance not carried forward to the next Offering Period  in accordance with the prior sentence promptly shall be refunded to the applicable Participant.   For the avoidance of doubt, in no event shall an amount greater than or equal to the per share  Option Price as of an Exercise Date be carried forward to the next Offering Period.  (b) As soon as practicable following the applicable Exercise Date, the number of  shares of Common Stock purchased by such Participant pursuant to Section 4.3(a) hereof shall  be delivered (either in share certificate or book entry form), in the Company&#8217;s sole discretion, to  either (i) the Participant or (ii) an account established in the Participant&#8217;s name at a stock  brokerage or other financial services firm designated by the Company.  If the Company is  required to obtain from any commission or agency authority to issue any such shares of Common  Stock, the Company shall seek to obtain such authority.  Inability of the Company to obtain from  any such commission or agency authority which counsel for the Company deems necessary for  the lawful issuance of any such shares shall relieve the Company from liability to any Participant  except to refund to the Participant such Participant&#8217;s Plan Account balance, without interest  thereon.  4.4 Transferability of Rights.  An Option granted under the Plan shall not be transferable,  other than by will or the applicable laws of descent and distribution, and is exercisable during the  Participant&#8217;s lifetime only by the Participant.  No option or interest or right to the Option shall be  available to pay off any debts, contracts or engagements of the Participant or his or her  successors in interest or shall be subject to disposition by pledge, encumbrance, assignment or  any other means whether such disposition be voluntary or involuntary or by operation of law by  judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including  bankruptcy), and any attempt at disposition of the Option shall have no effect.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">8  ARTICLE V.  PROVISIONS RELATING TO COMMON STOCK  5.1 Common Stock Reserved.  Subject to adjustment as provided in Section 5.2 hereof, the  maximum number of shares of Common Stock that shall be made available for sale under the  Plan shall be the sum of (a) 390,000 shares and (b) an annual increase on the first day of each  year beginning in 2022 and ending in 2031 equal to the lesser of (i) one percent of the shares  outstanding (on an as converted basis) on the last day of the immediately preceding fiscal year  and (ii) such number of shares as may be determined by the Board; provided, however, no more  than 8,000,000 shares may be issued under the Plan.  Shares made available for sale under the  Plan may be authorized but unissued shares, treasury shares of Common Stock, or reacquired  shares reserved for issuance under the Plan.  5.2 Adjustments Upon Changes in Capitalization, Dissolution, Liquidation, Merger or Asset  Sale.  (a) Changes in Capitalization.  Subject to any required action by the stockholders of  the Company, the number of shares of Common Stock which have been authorized for issuance  under the Plan but not yet placed under Option, as well as the price per share and the number of  shares of Common Stock covered by each Option under the Plan which has not yet been  exercised shall be proportionately adjusted for any increase or decrease in the number of issued  shares of Common Stock resulting from a stock split, reverse stock split, stock dividend,  combination or reclassification of the Common Stock, or any other increase or decrease in the  number of shares of Common Stock effected without receipt of consideration by the Company;  provided, however, that conversion of any convertible securities of the Company shall not be  deemed to have been &#8220;effected without receipt of consideration.&#8221;  Such adjustment shall be made  by the Administrator, whose determination in that respect shall be final, binding and conclusive.   Except as expressly provided herein, no issuance by the Company of shares of stock of any class,  or securities convertible into shares of stock of any class, shall affect, and no adjustment by  reason thereof shall be made with respect to, the number or price of shares of Common Stock  subject to an Option.  (b) Dissolution or Liquidation.  In the event of the proposed dissolution or liquidation  of the Company, the Offering Period then in progress shall be shortened by setting a new  Exercise Date (the &#8220;New Exercise Date&#8221;), and shall terminate immediately prior to the  consummation of such proposed dissolution or liquidation, unless provided otherwise by the  Administrator.  The New Exercise Date shall be before the date of the Company&#8217;s proposed  dissolution or liquidation.  The Administrator shall notify each Participant in writing, at least ten  business days prior to the New Exercise Date, that the Exercise Date for the Participant&#8217;s Option  has been changed to the New Exercise Date and that the Participant&#8217;s Option shall be exercised  automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn  from the Offering Period as provided in Section 6.1 hereof.  (c) Merger or Asset Sale.  In the event of a proposed sale of all or substantially all of  the assets of the Company, or the merger of the Company with or into another corporation, each  outstanding Option shall be assumed or an equivalent Option substituted by the successor  corporation or a Parent or Subsidiary of the successor corporation.  In the event that the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">9  successor corporation refuses to assume or substitute for the Option, any Offering Periods then in  progress shall be shortened by setting a New Exercise Date and any Offering Periods then in  progress shall end on the New Exercise Date.  The New Exercise Date shall be before the date of  the Company&#8217;s proposed sale or merger.  The Administrator shall notify each Participant in  writing, at least ten business days prior to the New Exercise Date, that the Exercise Date for the  Participant&#8217;s Option has been changed to the New Exercise Date and that the Participant&#8217;s  Option shall be exercised automatically on the New Exercise Date, unless prior to such date the  Participant has withdrawn from the Offering Period as provided in Section 6.1 hereof.  5.3 Insufficient Shares.  If the Administrator determines that, on a given Exercise Date, the  number of shares of Common Stock with respect to which Options are to be exercised may  exceed the number of shares of Common Stock remaining available for sale under the Plan on  such Exercise Date, the Administrator shall make a pro rata allocation of the shares of Common  Stock available for issuance on such Exercise Date in as uniform a manner as shall be practicable  and as it shall determine in its sole discretion to be equitable among all Participants exercising  Options to purchase Common Stock on such Exercise Date, and unless additional shares are  authorized for issuance under the Plan, no further Offering Periods shall take place and the Plan  shall terminate pursuant to Section 7.5 hereof.  If an Offering Period is so terminated, then the  balance of the amount credited to the Participant&#8217;s Plan Account which has not been applied to  the purchase of shares of Common Stock shall be paid to such Participant in one lump sum in  cash within 30 days after such Exercise Date, without any interest thereon.  5.4 Rights as Stockholders.  With respect to shares of Common Stock subject to an Option, a  Participant shall not be deemed to be a stockholder of the Company and shall not have any of the  rights or privileges of a stockholder. A Participant shall have the rights and privileges of a  stockholder of the Company when, but not until, shares of Common Stock have been deposited  in the designated brokerage account following exercise of his or her Option.  ARTICLE VI.  TERMINATION OF PARTICIPATION  6.1 Cessation of Contributions; Voluntary Withdrawal.  (a) A Participant may cease payroll deductions during an Offering Period and elect to  withdraw from the Plan by delivering written notice of such election to the Company in such  form and at such time prior to the Exercise Date for such Offering Period as may be established  by the Company (a &#8220;Withdrawal Election&#8221;).  A Participant electing to withdraw from the Plan  may elect to either (i) withdraw all of the funds then credited to the Participant&#8217;s Plan Account as  of the date on which the Withdrawal Election is received by the Company, in which case  amounts credited to such Plan Account shall be returned to the Participant in one lump-sum  payment in cash within 30 days after such election is received by the Company, without any  interest thereon, and the Participant shall cease to participate in the Plan and the Participant&#8217;s  Option for such Offering Period shall terminate; or (ii) exercise the Option for the maximum  number of whole shares of Common Stock on the applicable Exercise Date with any remaining  Plan Account balance returned to the Participant in one lump-sum payment in cash within 30  days after such Exercise Date, without any interest thereon, and after such exercise cease to  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">10  participate in the Plan.  Upon receipt of a Withdrawal Election, the Participant&#8217;s payroll  deduction authorization and his or her Option to purchase under the Plan shall terminate.  (b) A Participant&#8217;s withdrawal from the Plan shall not have any effect upon his or her  eligibility to participate in any similar plan which may hereafter be adopted by the Company or  in succeeding Offering Periods which commence after the termination of the Offering Period  from which the Participant withdraws.  (c) A Participant who ceases contributions to the Plan during any Offering Period  shall not be permitted to resume contributions to the Plan during that Offering Period.  6.2 Termination of Eligibility.  Upon a Participant&#8217;s ceasing to be an Eligible Employee, for  any reason, such Participant&#8217;s Option for the applicable Offering Period shall automatically  terminate, he or she shall be deemed to have elected to withdraw from the Plan, and such  Participant&#8217;s Plan Account shall be paid to such Participant or, in the case of his or her death, to  the person or persons entitled thereto pursuant to applicable law, within 30 days after such  cessation of being an Eligible Employee, without any interest thereon.  ARTICLE VII.  GENERAL PROVISIONS  7.1 Administration.  (a) The Plan shall be administered by the Committee, which shall be composed of  members of the Board.  The Committee may delegate administrative tasks under the Plan to the  services of an Agent or Employees to assist in the administration of the Plan, including  establishing and maintaining an individual securities account under the Plan for each Participant.  (b) It shall be the duty of the Administrator to conduct the general administration of  the Plan in accordance with the provisions of the Plan.  The Administrator shall have the power,  subject to, and within the limitations of, the express provisions of the Plan:  (i) To establish and terminate Offerings;  (ii) To determine when and how Options shall be granted and the provisions  and terms of each Offering (which need not be identical);  (iii) To select Designated Subsidiaries in accordance with Section 7.2 hereof;  and  (iv) To construe and interpret the Plan, the terms of any Offering and the terms  of the Options and to adopt such rules for the administration, interpretation, and application of  the Plan as are consistent therewith and to interpret, amend or revoke any such rules.  The  Administrator, in the exercise of this power, may correct any defect, omission or inconsistency in  the Plan, any Offering or any Option, in a manner and to the extent it shall deem necessary or  expedient to administer the Plan, subject to Section 423 of the Code.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">11  (c) The Administrator may adopt rules or procedures relating to the operation and  administration of the Plan to accommodate the specific requirements of local laws and  procedures.  Without limiting the generality of the foregoing, the Administrator is specifically  authorized to adopt rules and procedures regarding handling of participation elections, payroll  deductions, payment of interest, conversion of local currency, payroll tax, withholding  procedures and handling of stock certificates which vary with local requirements.  In its absolute  discretion, the Board may at any time and from time to time exercise any and all rights and  duties of the Administrator under the Plan.  (d) The Administrator may adopt sub-plans applicable to particular Designated  Subsidiaries or locations, which sub-plans may be designed to be outside the scope of Section  423 of the Code.  The rules of such sub-plans may take precedence over other provisions of this  Plan, with the exception of Section 5.1 hereof, but unless otherwise superseded by the terms of  such sub-plan, the provisions of this Plan shall govern the operation of such sub-plan.  (e) All expenses and liabilities incurred by the Administrator in connection with the  administration of the Plan shall be borne by the Company.  The Administrator may, with the  approval of the Committee, employ attorneys, consultants, accountants, appraisers, brokers or  other persons.  The Administrator, the Company and its officers and directors shall be entitled to  rely upon the advice, opinions or valuations of any such persons.  All actions taken and all  interpretations and determinations made by the Administrator in good faith shall be final and  binding upon all Participants, the Company and all other interested persons.  No member of the  Board or Administrator shall be personally liable for any action, determination or interpretation  made in good faith with respect to the Plan or the options, and all members of the Board or  Administrator shall be fully protected by the Company in respect to any such action,  determination, or interpretation.  7.2 Designation of Subsidiary Corporations.  The Board or Committee shall designate from  among the Subsidiaries, as determined from time to time, the Subsidiary or Subsidiaries that  shall constitute Designated Subsidiaries.  The Board or Committee may designate a Subsidiary,  or terminate the designation of a Subsidiary, without the approval of the stockholders of the  Company.  7.3 Reports.  Individual accounts shall be maintained for each Participant in the Plan.   Statements of Plan Accounts shall be given to Participants at least annually, which statements  shall set forth the amounts of payroll deductions, the Option Price, the number of shares  purchased and the remaining cash balance, if any.  7.4 No Right to Employment.  Nothing in the Plan shall be construed to give any person  (including any Participant) the right to remain in the employ of the Company, a Parent or a  Subsidiary or to affect the right of the Company, any Parent or any Subsidiary to terminate the  employment of any person (including any Participant) at any time, with or without cause, which  right is expressly reserved.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">12  7.5 Amendment and Termination of the Plan.  (a) The Board may, in its sole discretion, amend, suspend or terminate the Plan at any  time and from time to time; provided, however, that without approval of the Company&#8217;s  stockholders given within 12 months before or after action by the Board, the Plan may not be  amended to increase the maximum number of shares of Common Stock subject to the Plan or  change the designation or class of Eligible Employees; and provided, further that without  approval of the Company&#8217;s stockholders, the Plan may not be amended in any manner that would  cause the Plan to no longer be an &#8220;employee stock purchase plan&#8221; within the meaning of Section  423(b) of the Code.  (b) In the event the Administrator determines that the ongoing operation of the Plan  may result in unfavorable financial accounting consequences, the Administrator may, to the  extent permitted under Section 423 of the Code, in its discretion and, to the extent necessary or  desirable, modify or amend the Plan to reduce or eliminate such accounting consequence  including, but not limited to:  (i) altering the Option Price for any Offering Period including an Offering  Period underway at the time of the change in Option Price;  (ii) shortening any Offering Period so that the Offering Period ends on a new  Exercise Date, including an Offering Period underway at the time of the Administrator action;  and  (iii) allocating shares of Common Stock.  Such modifications or amendments shall not require stockholder approval or the consent of any  Participant.  (c) Upon termination of the Plan, the balance in each Participant&#8217;s Plan Account shall  be refunded as soon as practicable after such termination, without any interest thereon.  7.6 Use of Funds; No Interest Paid.  All funds received by the Company by reason of  purchase of shares of Common Stock under the Plan shall be included in the general funds of the  Company free of any trust or other restriction and may be used for any corporate purpose.  No  interest shall be paid to any Participant or credited under the Plan.  7.7 Term; Approval by Stockholders.  No Option may be granted during any period of  suspension of the Plan or after termination of the Plan.  The Plan shall be submitted for the  approval of the Company&#8217;s stockholders within 12 months after the date of the Board&#8217;s initial  adoption of the Plan.  Options may be granted prior to such stockholder approval; provided,  however, that such Options shall not be exercisable prior to the time when the Plan is approved  by the stockholders; provided, further that if such approval has not been obtained by the end of  the 12-month period, all Options previously granted under the Plan shall thereupon terminate and  be canceled and become null and void without being exercised.  7.8 Effect Upon Other Plans.  The adoption of the Plan shall not affect any other  compensation or incentive plans in effect for the Company, any Parent or any Subsidiary.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">13  Nothing in the Plan shall be construed to limit the right of the Company, any Parent or any  Subsidiary (a) to establish any other forms of incentives or compensation for Employees of the  Company or any Parent or any Subsidiary, or (b) to grant or assume Options otherwise than  under the Plan in connection with any proper corporate purpose, including, but not by way of  limitation, the grant or assumption of options in connection with the acquisition, by purchase,  lease, merger, consolidation or otherwise, of the business, stock or assets of any corporation,  firm or association.  7.9 Conformity to Securities Laws.  Notwithstanding any other provision of the Plan, the  Plan and the participation in the Plan by any individual who is then subject to Section 16 of the  Exchange Act shall be subject to any additional limitations set forth in any applicable exemption  rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the  Exchange Act) that are requirements for the application of such exemptive rule.  To the extent  permitted by applicable law, the Plan shall be deemed amended to the extent necessary to  conform to such applicable exemptive rule.  7.10 Notice of Disposition of Shares.  Each Participant shall give the Company prompt notice  of any disposition or other transfer of any shares of Common Stock, acquired pursuant to the  exercise of an Option, if such disposition or transfer is made (a) within two years after the  applicable Grant Date or (b) within one year after the transfer of such shares of Common Stock  to such Participant upon exercise of such Option.  The Company may direct that any certificates  evidencing shares acquired pursuant to the Plan refer to such requirement.  7.11 Tax Withholding.  To the extent any taxes or social insurance contributions must be  withheld in connection with the Plan, the Company or any Parent or any Subsidiary may require  satisfaction of such obligations by a broker assisted sale of the minimum number of shares  acquired under the Plan, with the proceeds remitted directly to the Company pursuant to a  mandatory &#8220;sell-to-cover&#8221; program instituted by the Company. By participating, each Participant  authorizes the Company, its designated broker and their agents to effect any required sell-to- cover and acknowledges that no shares will be issued, delivered or released until withholding is  satisfied. The Company or any Parent or Subsidiary may instead permit or require payroll  deduction, cash payment or share withholding, in each case subject to applicable law and, for  Section 423 Offerings, the equal rights and privileges requirement of Section 423. It is the  Company&#8217;s intention that Participants&#8217; tax obligations under the Plan shall be satisfied through a  mandatory sell-to-cover program, unless the Company determines an alternate procedure in its  discretion.  7.12 Governing Law.  The Plan and all rights and obligations thereunder shall be construed  and enforced in accordance with the laws of the State of Delaware, without regard to the conflict  of law rules thereof or of any other jurisdiction.  7.13 Notices.  All notices or other communications by a Participant to the Company under or  in connection with the Plan shall be deemed to have been duly given when received in the form  specified by the Company at the location, or by the person, designated by the Company for the  receipt thereof.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio2021employeestockp014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio2021employeestockp014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">14  7.14 Conditions To Issuance of Shares.  (a) Notwithstanding anything herein to the contrary, the Company shall not be  required to issue or deliver any certificates or make any book entries evidencing shares of  Common Stock pursuant to the exercise of an Option by a Participant, unless and until the Board  or the Committee has determined, with advice of counsel, that the issuance of such shares of  Common Stock is in compliance with all applicable laws, regulations of governmental  authorities and, if applicable, the requirements of any securities exchange or automated quotation  system on which the shares of Common Stock are listed or traded, and the shares of Common  Stock are covered by an effective registration statement or applicable exemption from  registration.  In addition to the terms and conditions provided herein, the Board or the Committee  may require that a Participant make such reasonable covenants, agreements, and representations  as the Board or the Committee, in its discretion, deems advisable in order to comply with any  such laws, regulations, or requirements.  (b) All certificates for shares of Common Stock delivered pursuant to the Plan and all  shares of Common Stock issued pursuant to book entry procedures are subject to any stop- transfer orders and other restrictions as the Committee deems necessary or advisable to comply  with federal, state, or foreign securities or other laws, rules and regulations and the rules of any  securities exchange or automated quotation system on which the shares of Common Stock are  listed, quoted, or traded.  The Committee may place legends on any certificate or book entry  evidencing shares of Common Stock to reference restrictions applicable to the shares of  Common Stock.  (c) The Committee shall have the right to require any Participant to comply with any  timing or other restrictions with respect to the settlement, distribution or exercise of any Option,  including a window-period limitation, as may be imposed in the sole discretion of the  Committee.  (d) Notwithstanding any other provision of the Plan, unless otherwise determined by  the Committee or required by any applicable law, rule or regulation, the Company may, in lieu of  delivering to any Participant certificates evidencing shares of Common Stock issued in  connection with any Option, record the issuance of shares of Common Stock in the books of the  Company (or, as applicable, its transfer agent or stock plan administrator).  7.15 Equal Rights and Privileges.  Except with respect to sub-plans designed to be outside the  scope of Section 423 of the Code, all Eligible Employees of the Company (or of any Designated  Subsidiary) granted Options pursuant to an Offering shall have equal rights and privileges under  this Plan to the extent required under Section 423 of the Code so that this Plan qualifies as an  &#8220;employee stock purchase plan&#8221; within the meaning of Section 423 of the Code. Any provision  of this Plan that is inconsistent with Section 423 of the Code shall, without further act or  amendment by the Company or the Board, be reformed to comply with the equal rights and  privileges requirement of Section 423 of the Code.  *     *     *     *     *  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>4
<FILENAME>elicio-insidertradingcom.htm
<DESCRIPTION>EX-19.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-insidertradingcom</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-insidertradingcom001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   ELICIO THERAPEUTICS, INC.  INSIDER TRADING COMPLIANCE POLICY  (Adopted January 5, 2021, Effective as of February 4, 2021)     (Amended by the Board of Directors on December 7, 2023, March 16, 2025, and February 10, 2026)     This Insider Trading Compliance Policy (this &#8220;Policy&#8221;) consists of six sections:  &#8226; Section I provides an overview;  &#8226; Section II sets forth Elicio Therapeutics, Inc.&#8217;s (the &#8220;Company&#8221;) policies  prohibiting insider trading;  &#8226; Section III explains insider trading;  &#8226; Section IV consists of procedures that have been put in place by the  Company to prevent insider trading;  &#8226; Section V sets forth additional transactions that are prohibited by this  Policy; and  &#8226; Section VI refers to the execution and return of a compliance certificate.  I. OVERVIEW  Preventing insider trading is necessary to comply with securities laws and to preserve the  reputation and integrity of the Company as well as that of all persons affiliated with the Company.  &#8220;Insider trading&#8221; occurs when any person purchases or sells a security (e.g., common stock) while  in possession of &#8220;inside information&#8221; relating to the security. As explained in Section III below,  &#8220;inside information&#8221; is information that is both &#8220;material&#8221; and &#8220;non-public.&#8221; Insider trading  violates several laws, including civil and criminal laws. The penalties for violating insider trading  laws include imprisonment, disgorgement of profits, civil fines, and criminal fines of up to $5  million for individuals and $25 million for entities. Insider trading is also prohibited by this Policy,  and violation of this Policy may result in Company-imposed sanctions, including removal or  dismissal for cause.  This Policy applies to all officers, directors, employees and consultants of the Company  and its subsidiaries (&#8220;Company Personnel&#8221;). The restrictions in this Policy also apply to any  Company Personnel&#8217;s (1) immediate family members who reside with them, (2) others living in  their household (whether or not related to them), (3) family members who do not live in their  household but whose transactions in the Company&#8217;s securities are directed by them or are subject  to their influence or control (e.g., parents or children who consult with them before they trade in  the Company&#8217;s securities) and (4) any entities that they influence or control, including any  corporations, limited liability companies, partnerships or trusts (each person or entity identified in  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   clauses (1) &#8211; (4), a &#8220;Related Person&#8221;). Securities and Exchange Commission (&#8220;SEC&#8221;) regulations  specifically provide that any material non-public information about the Company communicated  to any spouse, parent, child or sibling is considered to have been communicated under a duty of  trust or confidence; and that any trading in the Company&#8217;s securities by such family members  while they are aware of such information may, therefore, violate insider trading laws and  regulations. Company Personnel are expected to be responsible for the compliance of all Related  Persons with this Policy. This means that, to the extent such Related Persons of Company  Personnel intend to trade in the Company&#8217;s securities, the Related Persons need to comply with  the black-out periods and all other restrictions in this Policy. Furthermore, Company Personnel  should not participate in any investment club (i.e., groups of people who pool their money to make  investments) that may invest in the Company&#8217;s securities. Notwithstanding the foregoing, the pre- clearance policy, blackout periods and prohibited transactions of this Policy, do not apply to  venture capital entities or other institutional investors who have implemented procedures to ensure  compliance with the requirements of Rule 10b5-1(c)(2) under the Securities Exchange Act of  1934, as amended.  This Policy extends to all activities within and outside an individual&#8217;s Company duties. All  Company Personnel must review this Policy.  Questions regarding the Policy should be directed to the Company&#8217;s General Counsel (or  the Chief Financial Officer in the absence of a General Counsel), or such other person as the  Company&#8217;s Board of Directors (the &#8220;Board of Directors&#8221;) may designate from time to time (the  &#8220;Compliance Officer&#8221;).  II. STATEMENT OF POLICIES PROHIBITING INSIDER TRADING  No officer, director, employee or consultant, or any immediate family member or any  Related Person of any such person, shall purchase or sell any securities of the Company while in  possession of material, non-public information (subject to the specific exceptions noted below).  This Policy also applies with equal force to information relating to any other company,  including our customers or suppliers, obtained by Company Personnel during the course of their  service to or employment by the Company. Specifically, no Company Personnel who, in the  course of work on behalf of the Company, learns of material non-public information about a  company with which the Company does business may trade in the other company&#8217;s securities until  the information becomes public or is no longer material.  In addition, no Company Personnel shall directly or indirectly engage in any other action  to take advantage of, or pass on to others, communicate (or &#8220;tip&#8221;) material, non-public information  to anyone outside the Company (except in accordance with the Company&#8217;s policies regarding the  protection or authorized external disclosure of Company information) or to anyone within the  Company other than on a need-to-know basis.  III. EXPLANATION OF INSIDER TRADING  &#8220;Insider trading&#8221; refers to the purchase or sale of a security by someone who is in  possession of &#8220;material,&#8221; &#8220;non-public&#8221; information relating to the security.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   &#8220;Insider&#8221; refers to employees, officers, directors and consultants of the Company and  anyone else within the Company who has material, non-public information about the Company.  &#8220;Securities&#8221; includes stocks, bonds, notes, debentures, options, warrants and other  convertible securities, as well as derivative instruments.  &#8220;Purchase&#8221; and &#8220;sale&#8221; are defined broadly under the federal securities law. &#8220;Purchase&#8221;  includes not only the actual purchase of a security, but any contract to purchase or otherwise  acquire a security.  &#8220;Sale&#8221; includes not only the actual sale of a security, but any contract to sell or otherwise  dispose of a security.  These definitions extend to a broad range of transactions, including conventional cash-for- stock transactions, conversions, the exercise of stock options, and acquisitions and exercises of  warrants or puts, calls or other derivative securities.  It is generally understood that insider trading includes the following:  &#8226; trading by insiders while in possession of material, non-public information;  &#8226; trading by persons other than insiders while in possession of material, non-public  information, if the information either was given in breach of an insider&#8217;s duty to  keep it confidential or was misappropriated; and  &#8226; communicating or tipping material, non-public information to others, including  recommending the purchase or sale of a security while in possession of such  information.  A. What Information is Material?  The materiality of information depends upon the circumstances. Information is considered  &#8220;material&#8221; if there is a substantial likelihood that a reasonable investor would consider it important  in making a decision to buy, sell or hold a security, or if the information is likely to have a  significant effect on the market price of the security. Material information can be positive or  negative and can relate to virtually any aspect of a company&#8217;s business or to any type of security,  debt or equity.  Examples of material information include (but are not limited to) information about the  results of clinical trials; communications sent to or received from the U.S. Food and Drug  Administration; dividends; corporate earnings or earnings forecasts; mergers, acquisitions, tender  offers or dispositions; major new products or product developments; important business  developments such as major contract awards or cancellations; management or control changes;  significant borrowing or financing developments including pending public sales or offerings of  debt or equity securities; defaults on borrowings; bankruptcies; significant pending or threatened  litigation or the resolution of such litigation, or significant regulatory actions or developments, or  other items that require the filing of a Current Report on Form 8-K with the SEC. Moreover,  material information does not have to be related to a company&#8217;s business. For example, the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   contents of a forthcoming newspaper column that is expected to affect the market price of a  security can be material.  A good general rule of thumb: When in doubt, do not trade.  B. What is Non-public?  Information is &#8220;non-public&#8221; if it is not available to the general public. In order for  information to be considered public, it must be widely disseminated in a manner making it  generally available to investors through such media as Dow Jones, Business Wire, Reuters, The  Wall Street Journal, Associated Press, or United Press International (all of which generally are  accessible via a nationally recognized service such as Global News Wire, Business Wire, or PR  Newswire), a broadcast on widely available radio or television programs, publication in a widely  available newspaper, magazine or news web site, a Regulation FD-compliant conference call, or  public disclosure documents filed with the SEC that are available on the SEC&#8217;s web site.  The circulation of rumors, even if accurate and reported in the media, does not constitute  effective public dissemination. In addition, even after a public announcement, a reasonable period  of time must lapse in order for the market to react to the information. Generally, the Company  allows trading to begin at the beginning of the second trading day following the date of publication  to provide for a reasonable waiting period before such information is deemed to be public.  C. Who is an Insider?  &#8220;Insiders&#8221; include employees, officers, directors and consultants of a company and anyone  else within a company who has material, non-public information about a company. Insiders have  independent fiduciary duties to their company and its stockholders not to trade on material, non- public information relating to the company&#8217;s securities. All officers, directors, employees and  consultants of the Company should consider themselves insiders with respect to material, non- public information about the Company&#8217;s business, activities and securities. Officers, directors,  employees and consultants may not trade in the Company&#8217;s securities while in possession of  material, non-public information relating to the Company, nor may they tip such information to  anyone outside the Company (except in accordance with the Company&#8217;s policies regarding the  protection or authorized external disclosure of Company information) or to anyone within the  Company other than on a need-to-know basis.  The restrictions in this Policy also apply to any Company Personnel&#8217;s Related Persons, and  Company Personnel subject to this Policy are responsible for ensuring that such Related Persons  comply with this Policy.  D. Trading by Persons Other than Insiders  Insiders may be liable for communicating or tipping material, non-public information to a  third party (&#8220;tippee&#8221;), and insider trading violations are not limited to trading or tipping by insiders.  Persons other than insiders also can be liable for insider trading, including tippees who trade on  material, non-public information tipped to them or individuals who trade on material, non-public  information that has been misappropriated.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   Tippees inherit an insider&#8217;s duties and are liable for trading on material, non-public  information illegally tipped to them by an insider. Similarly, just as insiders are liable for the  insider trading of their tippees, so are tippees who pass the information along to others who trade.  In other words, a tippee&#8217;s liability for insider trading is no different from that of an insider. Tippees  can obtain material, non-public information by receiving overt tips from others or through, among  other things, conversations at social, business, or other gatherings.  E. Penalties for Engaging in Insider Trading  Penalties for trading on or tipping material, non-public information can extend significantly  beyond any profits made or losses avoided, both for individuals engaging in such unlawful conduct  and their employers. The SEC and Department of Justice have made the civil and criminal  prosecution of insider trading violations a top priority. Enforcement remedies available to the  government or private plaintiffs (e.g., the Company&#8217;s stockholders) under the federal securities  laws include:  &#8226; SEC administrative sanctions;  &#8226; securities industry self-regulatory organization sanctions;  &#8226; civil injunctions;  &#8226; damage awards to private plaintiffs;  &#8226; disgorgement of all profits;  &#8226; civil fines for the violator of up to three times the amount of profit gained or loss  avoided;  &#8226; criminal fines for individual violators of up to $5,000,000 ($25,000,000 for an  entity); and  &#8226; jail sentences of up to 20 years.  In addition, insider trading could result in serious sanctions by the Company, including  dismissal. Insider trading violations are not limited to violations of the federal securities laws.  Other federal and state civil or criminal laws, such as the laws prohibiting mail and wire fraud and  the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), also may be violated in  connection with insider trading.  Any of the above consequences, including an SEC investigation that does not result in  prosecution, can tarnish the Company&#8217;s or an individual&#8217;s reputation and irreparably damage a  career.  F. Size of Transaction and Reason for Transaction Do Not Matter  The size of the transaction or the amount of profit received does not have to be significant  to result in prosecution. The SEC has the ability to monitor even the smallest trades, and the SEC  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   performs routine market surveillance. Brokers and dealers are required by law to inform the SEC  of any possible violations by people who may have material, non-public information. The SEC  aggressively investigates and prosecutes even small insider trading violations.  G. Examples of Insider Trading  Examples of insider trading cases include actions brought against corporate officers,  directors, employees and consultants who traded in a company&#8217;s securities after learning of  significant confidential corporate developments; friends, business associates, family members and  other tippees of such officers, directors, employees and consultants who traded in the securities  after receiving such information; government employees who learned of such information in the  course of their employment; and other persons who misappropriated, and took advantage of,  confidential information from their employers.  The following are illustrations of insider trading violations. These illustrations are  hypothetical and, consequently, not intended to reflect on the actual activities or business of the  Company or any other entity.  Trading by Insider  An officer of X Corporation learns that earnings to be reported by X Corporation will  increase dramatically. Prior to the public announcement of such earnings, the officer  purchases X Corporation&#8217;s stock. The officer, an insider, is liable for all profits as well as  penalties of up to three times the amount of all profits. The officer also is subject to, among  other things, criminal prosecution, including up to $5,000,000 in additional fines and 20  years in jail. Depending upon the circumstances, X Corporation and the individual to whom  the officer reports also could be liable as controlling persons.  Trading by Tippee  An officer of X Corporation tells a friend that X Corporation is about to publicly announce  that it has concluded an agreement for a major acquisition. This tip causes the friend to  purchase X Corporation&#8217;s stock in advance of the announcement. The officer is jointly  liable with his friend for all of the friend&#8217;s profits, and each is liable for all civil penalties  of up to three times the amount of the friend&#8217;s profits. The officer and his friend are also  subject to criminal prosecution and other remedies and sanctions, as described above.  IV. STATEMENT OF PROCEDURES PREVENTING INSIDER TRADING  While it is never permissible to trade based on material non-public information, we  are implementing the following procedures to help prevent inadvertent violations of this  Policy and avoid even the appearance of an improper transaction (which could result, for  example, where Company Personnel engage in a trade while unaware of a pending major  development).  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   All Company Personnel are required to follow these procedures.  A. Black-Out Periods  &#8226; No officer, director, employee or consultant listed on Schedule I (as amended  from time to time by the Compliance Officer), or any Related Person of such  person shall purchase or sell any security of the Company during the period  beginning on the 15th day prior to the last trading day of any fiscal quarter of  the Company until the beginning of the second trading day after the public  release of the Company&#8217;s financial results for each fiscal quarter and, in the  case of the fourth quarter, financial results for the year end, whether or not  the Company or any Company Personnel or Related Person is in possession  of material, non-public information.  &#8226; Additionally, from time to time, the Company, through the Board of Directors, the  Company&#8217;s disclosure committee or the Compliance Officer, may recommend that  some or all Company Personnel, Related Persons or others suspend trading in the  Company&#8217;s securities because of developments that have not yet been disclosed to the  public. Individuals affected by such an event-specific blackout may be notified by the  Company that they are subject to the blackout (or the Compliance Officer may  determine in their discretion to rely instead on the pre-clearance requirement provided  for in Section IV.B of this Policy). All those affected should not trade in the  Company&#8217;s securities while the event-specific blackout is in effect, and in the event  that a press release is issued by the Company in connection with the event that resulted  in the event-specific blackout (or the event or circumstances go away), such  suspension shall continue until the beginning of the second trading day after the date  of public release (or the event or circumstances go away). Additionally, those subject  to the event-specific blackout should not disclose to others that we have suspended  trading, as the blackout itself is material non-public information. Events that may give  rise to event-specific blackouts may include consideration of major strategic  transactions (e.g., acquisitions, dispositions, joint ventures or financings), product  developments, interim earnings or sales releases, significant legal proceedings and  other circumstances that potentially implicate material non-public information.  These prohibitions do not apply to:  &#8226; purchases of the Company&#8217;s securities from the Company (e.g., Employee Stock  Purchase Plan or exercise of an option) or sales of the Company&#8217;s securities to the  Company, or the surrender to, or withholding by, the Company of the Company&#8217;s  securities (e.g., to cover withholding obligations upon the vesting or settlement of  equity-based awards). This Policy does apply, however, to any sale of stock as  part of a broker-assisted cashless exercise of an option, or any other market sale  of stock for the purpose of generating the cash needed to pay the exercise price  and/or taxes upon the exercise of an option or the vesting of restricted stock units;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   &#8226; bona fide gifts of the Company&#8217;s securities, unless the person making the gift (the  donor) has reason to believe that the recipient of the gift intends to sell the  Company&#8217;s securities while the donor is in possession of material non-public  information;  &#8226; Transactions in mutual funds and exchange traded funds that are invested in the  Company&#8217;s securities; or  &#8226; Notwithstanding the restrictions and prohibitions on trading in the Company&#8217;s  securities set forth in this Policy, persons subject to this Policy are permitted to  effect transactions in the Company&#8217;s securities pursuant to approved Rule 10b5-1  Plans, which may include transactions during the prohibited periods discussed  above. In order to comply with this policy, the Company must pre-approve any  such 10b5-1 Plan prior to its effectiveness in accordance with the Elicio  Therapeutics, Inc. Rule 10b5-1 Trading Plan Policy.  Exceptions to the black-out period policy may be approved only by the Compliance Officer  or, in their absence, the Chief Financial Officer.  . For purposes of clarity, the Company shall periodically review and update Schedule I.  B. Pre-Clearance of All Trades by All Executive Officers and Directors and Certain  Employees and Consultants  To provide assistance in preventing inadvertent violations of applicable securities laws and to  avoid the appearance of impropriety in connection with the purchase and sale of the Company&#8217;s  securities, all transactions in the Company&#8217;s securities (including without limitation,  acquisitions and dispositions of Company stock, broker-assisted &#8220;net&#8221; or &#8220;cashless&#8221; exercises  of stock options, and the sale of Company stock issued upon exercise of stock options) by all  officers, directors, employees and consultants listed on Schedule II (as amended from time to  time by the Compliance Officer) or any Related Person of such persons must be pre-cleared  by the Compliance Officer. As part of the pre-clearance process, the individual requesting pre- clearance must confirm that he or she is not in possession of material, non-public information. Pre- clearance does not relieve anyone of their responsibility under SEC rules.  For clarity, transactions in the Company&#8217;s securities pursuant to a Rule 10b5-1 plan, which  was approved in advance of entering into the plan in accordance with the Elicio Therapeutics, Inc.  Rule 10b5-1 Trading Plan Policy, are considered pre-cleared. For purposes of clarity, the Company  shall periodically review and update Schedule II.  C. Post-Termination Transactions  With the exception of the pre-clearance requirement under this Policy, the insider trading  laws continue to apply to transactions in the Company&#8217;s securities even after termination of service  to the Company. If an individual is in possession of material, non-public information when their  service terminates, that individual may not trade in the Company&#8217;s securities until that information  has become public or is no longer material, and it would be prudent for the individual, if they are  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   subject to a black-out period upon termination of service, to refrain from trading until those  restrictions no longer apply to Company Personnel.  D. Information Relating to the Company  1. Access to Information  Access to material, non-public information about the Company, including the Company&#8217;s  business, earnings or prospects, should be limited to officers, directors, employees and consultants  of the Company on a need-to-know basis. In addition, such information should not be  communicated to anyone outside the Company under any circumstances (except in accordance  with the Company&#8217;s policies regarding the protection or authorized external disclosure of  Company information) or to anyone within the Company on an other than need-to-know basis.  In communicating material, non-public information to employees of the Company, all  officers, directors, employees and consultants must take care to emphasize the need for  confidential treatment of such information and adherence to the Company&#8217;s policies with regard  to confidential information.  2. Inquiries From Third Parties  Inquiries from third parties, such as industry analysts or members of the media, about the  Company should be directed to the Compliance Officer, the Chief Financial Officer or head of  Investor Relations (if any).  E. Limitations on Access to Company Information  The following procedures are designed to maintain confidentiality with respect to the  Company&#8217;s business operations and activities.  All officers, directors, employees and consultants should take all steps and precautions  necessary to restrict access to, and secure, material, non-public information by, among other  things:  &#8226; maintaining the confidentiality of Company-related transactions;  &#8226; conducting their business and social activities so as not to risk inadvertent  disclosure of confidential information. Review of confidential documents in public  places should be conducted so as to prevent access by unauthorized persons;  &#8226; restricting access to documents and files (including computer files) containing  material, non-public information to individuals on a need-to-know basis (including  maintaining control over the distribution of documents and drafts of documents);  &#8226; promptly removing and cleaning up all confidential documents and other materials  from conference rooms following the conclusion of any meetings (including  erasing any whiteboards or other viewable information);  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   &#8226; disposing of all confidential documents and other papers, after there is no longer  any business or other legally required need, through shredders when appropriate;  &#8226; restricting access to areas likely to contain confidential documents or material, non- public information, including individual offices that may contain such information;  &#8226; safeguarding laptop computers, mobile devices, tablets, memory sticks, and other  items that contain confidential information, including complying with Company IT  policies to prevent unauthorized access to their devices and/or electronic  information they have access to; and  &#8226; avoiding the discussion of material, non-public information in places where the  information could be overheard by others such as in elevators, restrooms, hallways,  restaurants, airplanes or taxicabs.  Personnel involved with material, non-public information, to the extent feasible, should  conduct their business and activities in areas separate from other Company activities.  V. ADDITIONAL PROHIBITED TRANSACTIONS  The Company has determined that there is a heightened legal risk and/or the appearance of  improper or inappropriate conduct if the persons subject to this Policy engage in short-term or  speculative transactions involving the Company&#8217;s securities. Therefore, Company Personnel shall  comply with the following policies with respect to certain transactions in the Company securities:  A. Short Sales  Short sales of the Company&#8217;s securities evidence an expectation on the part of the seller  that the securities will decline in value, and therefore signal to the market that the seller may not  have confidence in the Company or its short-term prospects. In addition, short sales may reduce  the seller&#8217;s incentive to improve the Company&#8217;s performance. For these reasons, short sales of the  Company&#8217;s securities are prohibited by this Policy. In addition, as noted below, Section 16(c) of the  1934 Act absolutely prohibits Section 16 reporting persons from making short sales of the Company&#8217;s  equity securities, i.e., sales of shares that the insider does not own at the time of sale, or sales of owned  shares against which the insider does not deliver the shares within 20 days after the sale.  B. Publicly Traded Options  A transaction in options is, in effect, a bet on the short-term movement of the Company&#8217;s  stock and therefore may create the appearance that an officer, director, employee or consultant is  trading based on inside information. Transactions in options also may focus an officer&#8217;s, director&#8217;s,  employee&#8217;s or consultant&#8217;s attention on short-term performance at the expense of the Company&#8217;s  long-term objectives. Accordingly, transactions in puts, calls or other derivative securities involving  the Company&#8217;s equity securities, on an exchange or in any other organized market, are prohibited by  this Policy.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-insidertradingcom011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-insidertradingcom011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">US-DOCS\114338280.5   C. Hedging Transactions  Certain forms of hedging or monetization transactions, such as zero-cost collars and forward  sale contracts, allow an insider to lock in much of the value of their stock holdings, often in exchange  for all or part of the potential for upside appreciation in the stock. These transactions allow the insider  to continue to own the covered securities, but without the full risks and rewards of ownership. When  that occurs, the insider may no longer have the same objectives as the Company&#8217;s other stockholders.  Therefore, hedging transactions involving the Company&#8217;s equity securities, including but not limited  to zero-cost collars and forward sale contracts, are prohibited by this Policy.  D. Purchases of the Company&#8217;s Securities on Margin; Pledging the Company&#8217;s  Securities to Secure Margin or Other Loans  Purchasing on margin means borrowing from a brokerage firm, bank or other entity in  order to purchase the Company&#8217;s securities (other than in connection with a cashless exercise of  stock options under the Company&#8217;s equity plans). Margin purchases of the Company&#8217;s securities  are prohibited by this Policy. Pledging the Company&#8217;s securities as collateral to secure loans is  prohibited. This prohibition means, among other things, that Company Personnel cannot hold the  Company&#8217;s securities in a &#8220;margin account&#8221; (which would allow the holder to borrow against their  holdings to buy securities).  E. Trading on a Short-Term Basis  Any shares of Company securities purchased in the open market must be held for a minimum  of six months and ideally longer.  VI. EXECUTION AND RETURN OF CERTIFICATION OF COMPLIANCE  After reading this Policy, all Company Personnel should execute and return to the Compliance  Officer the Certification of Compliance form attached hereto as Attachment A.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>elicio-btconsent202510xk.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-btconsent202510xk</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-btconsent202510xk001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-btconsent202510xk001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">                    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM      We consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-264994,  333-278373, 333-279925, 333-283199, 333-291515, and 333-293861) and Form S-8 (No.333-252906,  333-264995, 333-270676, 333-274217, 333-278374, and 333-286242) of Elicio Therapeutics, Inc. (the  &#8220;Company&#8221;) of our report dated March 12, 2026, relating to the consolidated financial statements of the  Company (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the  Company&#8217;s ability to continue as going concern), appearing in the Annual Report on Form 10-K of the Company  for the year ended December 31, 2025, filed with the Securities and Exchange Commission.       /s/ Baker Tilly US, LLP    Tewksbury, Massachusetts  March 12, 2026      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>6
<FILENAME>eltx-powerofattorney2025.htm
<DESCRIPTION>EX-24.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>eltx-powerofattorney2025</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- eltx-powerofattorney2025001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="eltx-powerofattorney2025001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    SIGNATURES    Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused  this report to be signed on its behalf by the undersigned, thereunto duly authorized.        ELICIO THERAPEUTICS, INC.         By:  /s/ ROBERT CONNELLY  Date:  March 12, 2026    Robert Connelly   President and Chief Executive Officer   (Principal Executive Officer)               By:  /s/ PREETAM SHAH, PH.D., M.B.A.  Date:  March 12, 2026    Preetam Shah, Ph.D., M.B.A.  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal Accounting  Officer)    Power of Attorney    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and  appoints Robert Connelly and Preetam Shah, Ph.D., M.B.A., and each of them, with full power of substitution and resubstitution  and full power to act without the other, as his respective true and lawful attorney-in-fact and agent for him in any and all capacities,  to sign any and all amendments to this Annual Report on Form 10-K and to file the same, with all exhibits thereto and other  documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, and each of them, full power  and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully  for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and  agents or any of them or his or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed by the  following persons in the capacities and on the dates indicated.     Signature  Title  Date        /s/ Robert Connelly     Chief Executive Officer, President and  Director  March 12, 2026  Robert Connelly  (Principal Executive Officer)          /s/ Preetam Shah, Ph.D., M.B.A.     Chief Strategy and Financial Officer  March 12, 2026  Preetam Shah, Ph.D., M.B.A.    (Principal Financial Officer and Principal  Accounting Officer)          /s/ Julian Adams, Ph.D.  Director  March 12, 2026  Julian Adams, Ph.D.            /s/ Carol Ashe  Director  March 12, 2026  Carol Ashe            </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- eltx-powerofattorney2025002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="eltx-powerofattorney2025002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    /s/ Allen Nissenson, M.D.  Director  March 12, 2026  Allen Nissenson, M.D.                    /s/ Yekaterina (Katie) Chudnovsky  Director  March 12, 2026  Yekaterina (Katie) Chudnovsky            /s/ Robert R. Ruffolo, Jr., Ph.D.  Director  March 12, 2026  Robert R. Ruffolo, Jr., Ph.D.            /s/ Karen Wilson  Director  March 12, 2026  Karen Wilson            /s/ Jay Venkatesan, M.D.  Director  March 12, 2026  Jay Venkatesan, M.D.        </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>elicio-exhibit311202510x.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-exhibit311202510x</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-exhibit311202510x001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-exhibit311202510x001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 31.1  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL  FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY  ACT OF 2002  I, Robert Connelly, certify that:  1. I have reviewed this Annual Report on Form 10-K of Elicio Therapeutics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a  material fact or omit to state a material fact necessary to make the statements made, in light of  the circumstances under which such statements were made, not misleading with respect to the  period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information  included in this report, fairly present in all material respects the financial condition, results of  operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over  financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant  and have:  a. Designed such disclosure controls and procedures, or caused such  disclosure controls and procedures to be designed under my supervision, to ensure that material  information relating to the registrant, including its consolidated subsidiaries, is made known to  me by others within those entities, particularly during the period in which this report is being  prepared;  b. Designed such internal control over financial reporting, or caused such  internal control over financial reporting to be designed under my supervision, to provide  reasonable assurance regarding the reliability of financial reporting and the preparation of  financial statements for external purposes in accordance with generally accepted accounting  principles;  c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures and presented in this report our conclusions about the effectiveness of the disclosure  controls and procedures, as of the end of the period covered by this report based on such  evaluation; and  d. Disclosed in this report any change in the registrant&#8217;s internal control over  financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s  fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably  likely to materially affect, the registrant&#8217;s internal control over financial reporting; and  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-exhibit311202510x002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-exhibit311202510x002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5. I have disclosed, based on my most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board  of directors (or persons performing the equivalent functions):  a. All significant deficiencies and material weaknesses in the design or  operation of internal control over financial reporting which are reasonably likely to adversely  affect the registrant&#8217;s ability to record, process, summarize and report financial information; and  b. Any fraud, whether or not material, that involves management or other  employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  ELICIO THERAPEUTICS, INC.  By:  /s/ Robert Connelly   Robert Connelly  President and Chief Executive Officer  (Principal Executive Officer)    Date:  March 12, 2026      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>elicio-exhibit312202510x.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-exhibit312202510x</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-exhibit312202510x001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-exhibit312202510x001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 31.2  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL  FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY  ACT OF 2002  I, Preetam Shah, Ph.D., M.B.A., certify that:  1. I have reviewed this Annual Report on Form 10-K of Elicio Therapeutics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a  material fact or omit to state a material fact necessary to make the statements made, in light of  the circumstances under which such statements were made, not misleading with respect to the  period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information  included in this report, fairly present in all material respects the financial condition, results of  operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over  financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant  and have:  a. Designed such disclosure controls and procedures, or caused such  disclosure controls and procedures to be designed under my supervision, to ensure that material  information relating to the registrant, including its consolidated subsidiaries, is made known to  me by others within those entities, particularly during the period in which this report is being  prepared;  b. Designed such internal control over financial reporting, or caused such  internal control over financial reporting to be designed under my supervision, to provide  reasonable assurance regarding the reliability of financial reporting and the preparation of  financial statements for external purposes in accordance with generally accepted accounting  principles;  c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures and presented in this report our conclusions about the effectiveness of the disclosure  controls and procedures, as of the end of the period covered by this report based on such  evaluation; and  d. Disclosed in this report any change in the registrant&#8217;s internal control over  financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s  fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably  likely to materially affect, the registrant&#8217;s internal control over financial reporting; and  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio-exhibit312202510x002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-exhibit312202510x002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5. I have disclosed, based on my most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board  of directors (or persons performing the equivalent functions):  a. All significant deficiencies and material weaknesses in the design or  operation of internal control over financial reporting which are reasonably likely to adversely  affect the registrant&#8217;s ability to record, process, summarize and report financial information; and  b. Any fraud, whether or not material, that involves management or other  employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  ELICIO THERAPEUTICS, INC.  By:  /s/ Preetam Shah, Ph.D., M.B.A.   Preetam Shah, Ph.D., M.B.A.  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal  Accounting Officer)  Date:  March 12, 2026      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>elicio-exhibit321202510x.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-exhibit321202510x</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-exhibit321202510x001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-exhibit321202510x001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 32.1  CERTIFICATIONS PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (18 U.S.C. SECTION 1350)  The undersigned officer of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) certifies to such  officer&#8217;s knowledge, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes- Oxley Act of 2002, that:  1. The Annual Report on Form 10-K of the Company for the period ended December  31, 2025 (the &#8220;Annual Report&#8221;), as filed with the Securities and Exchange Commission, fully  complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,  and  2. The information contained in this Annual Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.    ELICIO THERAPEUTICS, INC.  By:  /s/ Robert Connelly   Robert Connelly  President and Chief Executive Officer  (Principal Executive Officer)  Date:  March 12, 2026    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>elicio-exhibit322202510x.htm
<DESCRIPTION>EX-32.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio-exhibit322202510x</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio-exhibit322202510x001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio-exhibit322202510x001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 32.1  CERTIFICATIONS PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (18 U.S.C. SECTION 1350)  The undersigned officer of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) certifies to such  officer&#8217;s knowledge, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes- Oxley Act of 2002, that:  1. The Annual Report on Form 10-K of the Company for the period ended December  31, 2025 (the &#8220;Annual Report&#8221;), as filed with the Securities and Exchange Commission, fully  complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,  and  2. The information contained in this Annual Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.    ELICIO THERAPEUTICS, INC.  By:  /s/ Preetam Shah, Ph.D., M.B.A.      Preetam Shah, Ph.D., M.B.A  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal  Accounting Officer)  Date:  March 12, 2026    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>angn-20251231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:b764f3f1-1aa2-42b0-ba71-263b5668ebc9,g:54ff377e-34d5-4517-b79e-9773ed1b9e6a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:angn="http://www.angn.com/20251231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.angn.com/20251231">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.angn.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.angn.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.angn.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>9952154 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" roleURI="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical">
        <link:definition>9952155 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.angn.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessandFinancialCondition" roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition">
        <link:definition>9952157 - Disclosure - Description of the Business and Financial Condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952158 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.angn.com/role/FairValueMeasurements">
        <link:definition>9952159 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.angn.com/role/BalanceSheetComponents">
        <link:definition>9952160 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchGrant" roleURI="http://www.angn.com/role/ResearchGrant">
        <link:definition>9952161 - Disclosure - Research Grant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandStockholdersEquity" roleURI="http://www.angn.com/role/CommonStockandStockholdersEquity">
        <link:definition>9952162 - Disclosure - Common Stock and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.angn.com/role/StockBasedCompensation">
        <link:definition>9952163 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://www.angn.com/role/Warrants">
        <link:definition>9952164 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.angn.com/role/CommitmentsandContingencies">
        <link:definition>9952165 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.angn.com/role/Leases">
        <link:definition>9952166 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.angn.com/role/Debt">
        <link:definition>9952167 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.angn.com/role/IncomeTaxes">
        <link:definition>9952168 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlan" roleURI="http://www.angn.com/role/EmployeeBenefitPlan">
        <link:definition>9952169 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.angn.com/role/NetLossPerShare">
        <link:definition>9952170 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.angn.com/role/RelatedPartyTransactions">
        <link:definition>9952171 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.angn.com/role/SegmentReporting">
        <link:definition>9952172 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.angn.com/role/SubsequentEvents">
        <link:definition>9952173 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.angn.com/role/FairValueMeasurementsTables">
        <link:definition>9955513 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.angn.com/role/BalanceSheetComponentsTables">
        <link:definition>9955514 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.angn.com/role/StockBasedCompensationTables">
        <link:definition>9955515 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsTables" roleURI="http://www.angn.com/role/WarrantsTables">
        <link:definition>9955516 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.angn.com/role/LeasesTables">
        <link:definition>9955517 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.angn.com/role/DebtTables">
        <link:definition>9955518 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.angn.com/role/IncomeTaxesTables">
        <link:definition>9955519 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.angn.com/role/NetLossPerShareTables">
        <link:definition>9955520 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.angn.com/role/SegmentReportingTables">
        <link:definition>9955521 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessandFinancialConditionDetails" roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails">
        <link:definition>9955522 - Disclosure - Description of the Business and Financial Condition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails">
        <link:definition>9955523 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9955524 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>9955525 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails">
        <link:definition>9955526 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails">
        <link:definition>9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955528 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails">
        <link:definition>9955529 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955530 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>9955531 - Disclosure - Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofAccruedExpensesDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails">
        <link:definition>9955532 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchGrantDetails" roleURI="http://www.angn.com/role/ResearchGrantDetails">
        <link:definition>9955533 - Disclosure - Research Grant (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandStockholdersEquityDetails" roleURI="http://www.angn.com/role/CommonStockandStockholdersEquityDetails">
        <link:definition>9955534 - Disclosure - Common Stock and Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955535 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofShareOptionActivityDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails">
        <link:definition>9955536 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails">
        <link:definition>9955537 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails">
        <link:definition>9955538 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsNarrativeDetails" roleURI="http://www.angn.com/role/WarrantsNarrativeDetails">
        <link:definition>9955539 - Disclosure - Warrants - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsScheduleofOutstandingWarrantsDetails" roleURI="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails">
        <link:definition>9955540 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsScheduleofWarrantsActivityDetails" roleURI="http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails">
        <link:definition>9955541 - Disclosure - Warrants - Schedule of Warrants Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955542 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.angn.com/role/LeasesNarrativeDetails">
        <link:definition>9955543 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" roleURI="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails">
        <link:definition>9955544 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>9955545 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>9955545 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.angn.com/role/DebtNarrativeDetails">
        <link:definition>9955546 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofFuturePrincipalPaymentsDetails" roleURI="http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails">
        <link:definition>9955547 - Disclosure - Debt - Schedule of Future Principal Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails" roleURI="http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails">
        <link:definition>9955548 - Disclosure - Income Taxes - Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>9955549 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955550 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" roleURI="http://www.angn.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails">
        <link:definition>9955551 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.angn.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9955552 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanDetails" roleURI="http://www.angn.com/role/EmployeeBenefitPlanDetails">
        <link:definition>9955553 - Disclosure - Employee Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" roleURI="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails">
        <link:definition>9955554 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails">
        <link:definition>9955555 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9955556 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.angn.com/role/SegmentReportingDetails">
        <link:definition>9955557 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.angn.com/role/SubsequentEventsDetails">
        <link:definition>9955558 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="angn_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_WarrantLiability" abstract="false" name="WarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_GainLossOnIssuanceOfWarrants" abstract="false" name="GainLossOnIssuanceOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_GrantRevenueNonoperating" abstract="false" name="GrantRevenueNonoperating" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JanuaryOfferingMember" abstract="true" name="JanuaryOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_July2024PublicOfferingMember" abstract="true" name="July2024PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ConversionOfConvertibleDebtMember" abstract="true" name="ConversionOfConvertibleDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" abstract="false" name="StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" abstract="false" name="ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_InterestExpenseNoncash" abstract="false" name="InterestExpenseNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_CostsExpensedUponTheIssuanceOfWarrants" abstract="false" name="CostsExpensedUponTheIssuanceOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" abstract="false" name="ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" abstract="false" name="ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_PaymentOfWarrantIssuanceCosts" abstract="false" name="PaymentOfWarrantIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_FairValueOfPreFundedWarrants" abstract="false" name="FairValueOfPreFundedWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_FairValueOfCommonStockWarrants" abstract="false" name="FairValueOfCommonStockWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_FairValueOfCommonStockWarrantsUponSettlement" abstract="false" name="FairValueOfCommonStockWarrantsUponSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccretionOfPromissoryNoteToFaceValue" abstract="false" name="AccretionOfPromissoryNoteToFaceValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantIssuedStockIssuance" abstract="false" name="WarrantIssuedStockIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantIssuedDebtIssuance" abstract="false" name="WarrantIssuedDebtIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_VestingOfRestrictedCommonStockNoncash" abstract="false" name="VestingOfRestrictedCommonStockNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantsAndRightsOutstandingAbstract" abstract="true" name="WarrantsAndRightsOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_WarrantsAndRightsOutstandingTextBlock" abstract="false" name="WarrantsAndRightsOutstandingTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" abstract="false" name="ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="angn_RegistrationStatementMember" abstract="true" name="RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreementMember" abstract="true" name="AtTheMarketEquityOfferingSalesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreement2022Member" abstract="true" name="AtTheMarketEquityOfferingSalesAgreement2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_A2024RegistrationStatementMember" abstract="true" name="A2024RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreement2024Member" abstract="true" name="AtTheMarketEquityOfferingSalesAgreement2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_MarchSubscriptionAgreementMember" abstract="true" name="MarchSubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPublicOfferingMember" abstract="true" name="JulyPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JanuaryPublicOfferingMember" abstract="true" name="JanuaryPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_March2024PreFundedWarrantsMember" abstract="true" name="March2024PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_PreFundedWarrantMember" abstract="true" name="PreFundedWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPreFundedWarrantsMember" abstract="true" name="JulyPreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyCommonWarrantsMember" abstract="true" name="JulyCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" abstract="true" name="JulyPreFundedWarrantsAndJulyCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JanuaryCommonWarrantsMember" abstract="true" name="JanuaryCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulySharesAndJulyCommonWarrantMember" abstract="true" name="JulySharesAndJulyCommonWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_SeniorSecuredConvertiblePromissoryNoteMember" abstract="true" name="SeniorSecuredConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_SaleOfStockAggregateInitialOfferingPrice" abstract="false" name="SaleOfStockAggregateInitialOfferingPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccruedInterestPremiumForConvertiblePreferredStock" abstract="false" name="AccruedInterestPremiumForConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantsFairValueDisclosure" abstract="false" name="WarrantsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantLiabilityMember" abstract="true" name="WarrantLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_MeasurementInputStrikePriceMember" abstract="true" name="MeasurementInputStrikePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_SaleOfStockBeneficialOwnershipLimitationPercentage" abstract="false" name="SaleOfStockBeneficialOwnershipLimitationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="angn_PrepaidResearchAndDevelopmentExpenses" abstract="false" name="PrepaidResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AdvancedProfessionalFees" abstract="false" name="AdvancedProfessionalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_OtherPrepaidExpensesAndOtherAssetsCurrent" abstract="false" name="OtherPrepaidExpensesAndOtherAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccruedResearchAndDevelopmentCurrent" abstract="false" name="AccruedResearchAndDevelopmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccruedInterest" abstract="false" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccruedOtherOperatingLiabilitiesCurrent" abstract="false" name="AccruedOtherOperatingLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementGrant" abstract="false" name="ResearchAndDevelopmentArrangementGrant" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementGrantReceived" abstract="false" name="ResearchAndDevelopmentArrangementGrantReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementCredit" abstract="false" name="ResearchAndDevelopmentArrangementCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_NumberOfResearchGrantAgreements" abstract="false" name="NumberOfResearchGrantAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="angn_A2021PlanMember" abstract="true" name="A2021PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_A2022PlanMember" abstract="true" name="A2022PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_A2024PlanMember" abstract="true" name="A2024PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="angn_January2025CommonWarrantsMember" abstract="true" name="January2025CommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_June2025WarrantsMember" abstract="true" name="June2025WarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_WarrantExercisedFairValue" abstract="false" name="WarrantExercisedFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ElicioWarrantsMember" abstract="true" name="ElicioWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AngionWarrantsMember" abstract="true" name="AngionWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyCommonWarrantOneMember" abstract="true" name="JulyCommonWarrantOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_June2025CommonWarrantsMember" abstract="true" name="June2025CommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" abstract="false" name="ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightRollForward" abstract="true" name="ClassOfWarrantOrRightRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightIssuedInPeriod" abstract="false" name="ClassOfWarrantOrRightIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightExercisedInPeriod" abstract="false" name="ClassOfWarrantOrRightExercisedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" abstract="true" name="ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" abstract="false" name="ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" abstract="false" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" abstract="true" name="ClassOfWarrantOrRightWeightedAverageLifeRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageLife" abstract="false" name="ClassOfWarrantOrRightWeightedAverageLife" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="angn_CommitmentAndContingenciesDisclosureTable" abstract="true" name="CommitmentAndContingenciesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="angn_UniversityMember" abstract="true" name="UniversityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_CommitmentAndContingenciesDisclosureLineItems" abstract="true" name="CommitmentAndContingenciesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_RoyaltyRatePercent" abstract="false" name="RoyaltyRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" abstract="false" name="CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_CollaborativeArrangementFutureMinimumMaintenancePayments" abstract="false" name="CollaborativeArrangementFutureMinimumMaintenancePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_BostonMassachusettsMember" abstract="true" name="BostonMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_NewtonMassachusettsMember" abstract="true" name="NewtonMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_LesseeOperatingLeaseAnnualRentExpense" abstract="false" name="LesseeOperatingLeaseAnnualRentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_GKCCMember" abstract="true" name="GKCCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightOwnershipPercentMaximum" abstract="false" name="ClassOfWarrantOrRightOwnershipPercentMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="angn_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_DeferredTaxAssetsNetBeforeValuationAllowance" abstract="false" name="DeferredTaxAssetsNetBeforeValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_EmployeeBenefitPlanMember" abstract="true" name="EmployeeBenefitPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_PurchaseOfWarrantsMember" abstract="true" name="PurchaseOfWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_YekaterinaChudnovskyMember" abstract="true" name="YekaterinaChudnovskyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" abstract="true" name="JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_YekaterinaChudnovskyAndJayVenkatesanMember" abstract="true" name="YekaterinaChudnovskyAndJayVenkatesanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ClinicalTrailMember" abstract="true" name="ClinicalTrailMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_EmployeeRelatedReasearchAndDevelopmentMember" abstract="true" name="EmployeeRelatedReasearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_TranslationalMedicineAndCMCMember" abstract="true" name="TranslationalMedicineAndCMCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_A2024ATMProgramMember" abstract="true" name="A2024ATMProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>angn-20251231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:b764f3f1-1aa2-42b0-ba71-263b5668ebc9,g:54ff377e-34d5-4517-b79e-9773ed1b9e6a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ae2d4f9d-65a1-42f4-af99-6e0b68b4e1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_17a99705-f6c2-45c4-8f15-e18f7d31db2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ae2d4f9d-65a1-42f4-af99-6e0b68b4e1aa" xlink:to="loc_us-gaap_PreferredStockValue_17a99705-f6c2-45c4-8f15-e18f7d31db2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_5b710ff7-2b4b-4616-b904-5143c4caec62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ae2d4f9d-65a1-42f4-af99-6e0b68b4e1aa" xlink:to="loc_us-gaap_TreasuryStockCommonValue_5b710ff7-2b4b-4616-b904-5143c4caec62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_cde37de5-2f78-47b3-9d34-f0d5c451549e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ae2d4f9d-65a1-42f4-af99-6e0b68b4e1aa" xlink:to="loc_us-gaap_CommonStockValue_cde37de5-2f78-47b3-9d34-f0d5c451549e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_07cc9ce2-da86-41f6-8627-7a5647c26ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ae2d4f9d-65a1-42f4-af99-6e0b68b4e1aa" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_07cc9ce2-da86-41f6-8627-7a5647c26ddc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_40616e48-b06f-4464-8a41-94511fe470b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ae2d4f9d-65a1-42f4-af99-6e0b68b4e1aa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_40616e48-b06f-4464-8a41-94511fe470b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3e347273-8b45-43ba-bac1-5b9fc85e900b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ae2d4f9d-65a1-42f4-af99-6e0b68b4e1aa" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3e347273-8b45-43ba-bac1-5b9fc85e900b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b2fea-b3b8-7a4c-800b-9fccf8452017" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019b2fea-b3b8-7d3f-bbd0-3c2a01e98a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b2fea-b3b8-7a4c-800b-9fccf8452017" xlink:to="loc_us-gaap_Liabilities_019b2fea-b3b8-7d3f-bbd0-3c2a01e98a3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019b2fea-b3b8-7737-af94-dd099f5e0490" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b2fea-b3b8-7a4c-800b-9fccf8452017" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019b2fea-b3b8-7737-af94-dd099f5e0490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019b2fea-b3b8-73be-817f-8e0d808a3465" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019b2fea-b3b8-7a4c-800b-9fccf8452017" xlink:to="loc_us-gaap_StockholdersEquity_019b2fea-b3b8-73be-817f-8e0d808a3465" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_04fbb008-9975-46ff-a697-0347c5741c96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_396496eb-be61-4a5e-ba53-6c4e223cf21c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_04fbb008-9975-46ff-a697-0347c5741c96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_396496eb-be61-4a5e-ba53-6c4e223cf21c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1264019-6534-4be7-b50a-4f05e1114b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_04fbb008-9975-46ff-a697-0347c5741c96" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c1264019-6534-4be7-b50a-4f05e1114b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d9623167-c463-4bf6-9130-dd86c710db6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_04fbb008-9975-46ff-a697-0347c5741c96" xlink:to="loc_us-gaap_AssetsCurrent_d9623167-c463-4bf6-9130-dd86c710db6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_bd9ce2ab-dfdd-4a3f-b17f-7b82143db821" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_04fbb008-9975-46ff-a697-0347c5741c96" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_bd9ce2ab-dfdd-4a3f-b17f-7b82143db821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_7732a072-1de5-4054-ab99-c4d07c16ad65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_04fbb008-9975-46ff-a697-0347c5741c96" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_7732a072-1de5-4054-ab99-c4d07c16ad65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_da30a78b-002d-45a7-85ed-de910dd6ece1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_15810bee-6789-407f-8e78-e16fbef95162" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_da30a78b-002d-45a7-85ed-de910dd6ece1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_15810bee-6789-407f-8e78-e16fbef95162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_004cbe09-699c-4374-86df-129d5ee3a1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_da30a78b-002d-45a7-85ed-de910dd6ece1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_004cbe09-699c-4374-86df-129d5ee3a1aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_d52af181-4ce9-49ba-a858-ff52d25ab7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_da30a78b-002d-45a7-85ed-de910dd6ece1" xlink:to="loc_us-gaap_RestrictedCashCurrent_d52af181-4ce9-49ba-a858-ff52d25ab7ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2b855310-3195-41a9-8cf0-ba35684e4ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb37237b-6912-464f-9fd2-cc6f63e45312" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2b855310-3195-41a9-8cf0-ba35684e4ab6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb37237b-6912-464f-9fd2-cc6f63e45312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4187725f-6f32-41f8-b9ae-b665ca988d29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2b855310-3195-41a9-8cf0-ba35684e4ab6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4187725f-6f32-41f8-b9ae-b665ca988d29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_de08eaec-54e2-4d03-8f5f-71fc7059ea43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2b855310-3195-41a9-8cf0-ba35684e4ab6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_de08eaec-54e2-4d03-8f5f-71fc7059ea43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_103cbf38-e16a-41b3-9548-30f780bc3465" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2b855310-3195-41a9-8cf0-ba35684e4ab6" xlink:to="loc_us-gaap_AccountsPayableCurrent_103cbf38-e16a-41b3-9548-30f780bc3465" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c28c20ad-233e-40a5-bc73-49ff933acc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_58808ccc-9c8e-42ae-bb75-b56b8057bb29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c28c20ad-233e-40a5-bc73-49ff933acc9f" xlink:to="loc_us-gaap_LiabilitiesCurrent_58808ccc-9c8e-42ae-bb75-b56b8057bb29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability_335e5f1a-1523-4577-addd-5bc38a09bfe2" xlink:href="angn-20251231.xsd#angn_WarrantLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c28c20ad-233e-40a5-bc73-49ff933acc9f" xlink:to="loc_angn_WarrantLiability_335e5f1a-1523-4577-addd-5bc38a09bfe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04adc1ff-d63c-4580-9d29-058f24e3788a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c28c20ad-233e-40a5-bc73-49ff933acc9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04adc1ff-d63c-4580-9d29-058f24e3788a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019cd7b1-f79a-79c3-935b-2455e44a3280" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c28c20ad-233e-40a5-bc73-49ff933acc9f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019cd7b1-f79a-79c3-935b-2455e44a3280" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_29b9e8de-ddad-4162-8b18-ec59130e8e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a094166b-ac10-45d7-ae40-b7d2fd885f56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29b9e8de-ddad-4162-8b18-ec59130e8e2f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a094166b-ac10-45d7-ae40-b7d2fd885f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_58be108c-821b-4af5-88ac-62cf1f2921d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29b9e8de-ddad-4162-8b18-ec59130e8e2f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_58be108c-821b-4af5-88ac-62cf1f2921d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5c1d0248-f527-47a9-935d-f4e2e436e041" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_36930dd3-eec1-4a43-9ff2-8b1a5476017c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5c1d0248-f527-47a9-935d-f4e2e436e041" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_36930dd3-eec1-4a43-9ff2-8b1a5476017c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_c52886c1-30c0-4307-ae3a-58f25b643cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5c1d0248-f527-47a9-935d-f4e2e436e041" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_c52886c1-30c0-4307-ae3a-58f25b643cd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_4b29919d-098a-4505-950e-756f003ab01e" xlink:href="angn-20251231.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5c1d0248-f527-47a9-935d-f4e2e436e041" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_4b29919d-098a-4505-950e-756f003ab01e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating_0c752c92-b5fa-433e-96ad-2c0d8d183593" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5c1d0248-f527-47a9-935d-f4e2e436e041" xlink:to="loc_us-gaap_InterestIncomeOperatingAndNonoperating_0c752c92-b5fa-433e-96ad-2c0d8d183593" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_f733ae18-8b68-45df-8d4d-f273b39a51e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5c1d0248-f527-47a9-935d-f4e2e436e041" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_f733ae18-8b68-45df-8d4d-f273b39a51e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_7b743c08-402d-40c7-9bcd-6ca187e69cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5c1d0248-f527-47a9-935d-f4e2e436e041" xlink:to="loc_us-gaap_InterestExpenseNonoperating_7b743c08-402d-40c7-9bcd-6ca187e69cf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating_019c0861-0c22-73a2-b251-7e24f5f7de94" xlink:href="angn-20251231.xsd#angn_GrantRevenueNonoperating"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5c1d0248-f527-47a9-935d-f4e2e436e041" xlink:to="loc_angn_GrantRevenueNonoperating_019c0861-0c22-73a2-b251-7e24f5f7de94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_44127eda-62c3-4dce-bd12-106a91cf8fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f220a540-94b3-406f-9cd4-e99158e5320c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_44127eda-62c3-4dce-bd12-106a91cf8fb7" xlink:to="loc_us-gaap_OperatingIncomeLoss_f220a540-94b3-406f-9cd4-e99158e5320c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_699975e6-f286-465b-8c3c-065293b0c445" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_44127eda-62c3-4dce-bd12-106a91cf8fb7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_699975e6-f286-465b-8c3c-065293b0c445" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f2397814-5cce-42f5-90c1-536c9cf909d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_44127eda-62c3-4dce-bd12-106a91cf8fb7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f2397814-5cce-42f5-90c1-536c9cf909d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_895e2cf1-06be-40ef-a3ac-aa6db34c90bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c21affc7-909c-41cc-9f6c-5a1dcf893f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_895e2cf1-06be-40ef-a3ac-aa6db34c90bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c21affc7-909c-41cc-9f6c-5a1dcf893f7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7e5eaa30-1c3e-4dfd-b4e9-d123a58cb67a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_895e2cf1-06be-40ef-a3ac-aa6db34c90bc" xlink:to="loc_us-gaap_NetIncomeLoss_7e5eaa30-1c3e-4dfd-b4e9-d123a58cb67a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d40cc225-dab7-4c57-92a2-b801d8e2e9db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_76048eb9-e8f5-470d-b71e-25d7d976fce5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d40cc225-dab7-4c57-92a2-b801d8e2e9db" xlink:to="loc_us-gaap_CostsAndExpenses_76048eb9-e8f5-470d-b71e-25d7d976fce5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b2a9e-fa54-78da-865c-956b34c5ca00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019b2a9e-fa54-7031-8577-b53b8fbaa4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b2a9e-fa54-78da-865c-956b34c5ca00" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019b2a9e-fa54-7031-8577-b53b8fbaa4f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_019b2a9e-fa54-71b2-a139-80e8061c27e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019b2a9e-fa54-78da-865c-956b34c5ca00" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_019b2a9e-fa54-71b2-a139-80e8061c27e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e642968-0c6c-41bc-af02-55123ba823d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe82517b-f5dc-4803-970e-4a1a20c81f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e642968-0c6c-41bc-af02-55123ba823d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe82517b-f5dc-4803-970e-4a1a20c81f4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1caccd86-db2d-426f-92da-c8408c85f2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e642968-0c6c-41bc-af02-55123ba823d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1caccd86-db2d-426f-92da-c8408c85f2d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0d933065-eb6e-4d88-90b7-40355b302304" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e642968-0c6c-41bc-af02-55123ba823d2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0d933065-eb6e-4d88-90b7-40355b302304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_404f93e7-f7c9-49bd-bd59-6f5aa6ea75d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e642968-0c6c-41bc-af02-55123ba823d2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_404f93e7-f7c9-49bd-bd59-6f5aa6ea75d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019b2a9d-f60f-7a01-b412-07ba6d364a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_NetIncomeLoss_019b2a9d-f60f-7a01-b412-07ba6d364a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019b2a9d-f60f-77df-be25-a9dff28861a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_Depreciation_019b2a9d-f60f-77df-be25-a9dff28861a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019b2a9d-f60f-75b0-95b2-24c8e24beab4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019b2a9d-f60f-75b0-95b2-24c8e24beab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019b2a9d-f60f-7a94-ba63-a364c097e051" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019b2a9d-f60f-7a94-ba63-a364c097e051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash_019b2a9d-f60f-79bf-9869-6b797c55e7c7" xlink:href="angn-20251231.xsd#angn_InterestExpenseNoncash"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_angn_InterestExpenseNoncash_019b2a9d-f60f-79bf-9869-6b797c55e7c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CostsExpensedUponTheIssuanceOfWarrants_019b2a9d-f60f-7561-aba0-3bdee23a3488" xlink:href="angn-20251231.xsd#angn_CostsExpensedUponTheIssuanceOfWarrants"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_angn_CostsExpensedUponTheIssuanceOfWarrants_019b2a9d-f60f-7561-aba0-3bdee23a3488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019b2a9d-f60f-71ad-8fa6-254fcdcd13c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019b2a9d-f60f-71ad-8fa6-254fcdcd13c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_019b2a9d-f60f-7d52-b34a-faa5fb9b50a5" xlink:href="angn-20251231.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_019b2a9d-f60f-7d52-b34a-faa5fb9b50a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019b2a9d-f60f-79ed-8b9a-a98c5b5ea885" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_ShareBasedCompensation_019b2a9d-f60f-79ed-8b9a-a98c5b5ea885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_019b2a9d-f60f-7277-8d59-e7f541f94884" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_019b2a9d-f60f-7277-8d59-e7f541f94884" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019b2a9d-f60f-73ec-8588-7dc5d3e13261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019b2a9d-f60f-73ec-8588-7dc5d3e13261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019b2a9d-f60f-7fbc-8875-beae8f84adfc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019b2a9d-f60f-7fbc-8875-beae8f84adfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019b2a9d-f60f-7da1-8b75-799f66bedf81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019b2a9d-f60f-7da1-8b75-799f66bedf81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019b2a9d-f60f-7298-ad49-393e1ee66530" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019b2a9d-f60f-7298-ad49-393e1ee66530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019b2a9d-f60f-758d-a20e-a6845710aadc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019b2a9d-f60f-758d-a20e-a6845710aadc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019b2a9d-f60f-76e7-a0a2-67163ad62f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019b2a9d-f60f-7237-9b7f-df786e3e19fa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019b2a9d-f60f-76e7-a0a2-67163ad62f3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_019b2a9f-882f-70bb-a310-b10579a29a52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_019b2a9f-882f-70bb-a310-b10579a29a52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_019b2a9f-882f-7ad7-a02f-881023f7238e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_019b2a9f-882f-7ad7-a02f-881023f7238e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_019b2a9f-882f-71c1-bb79-c2b99e3d0e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_019b2a9f-882f-71c1-bb79-c2b99e3d0e8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering_019b2a9f-882f-76f4-884a-e7f6b407ce0c" xlink:href="angn-20251231.xsd#angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering_019b2a9f-882f-76f4-884a-e7f6b407ce0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019b2a9f-882f-7198-84a3-81077c4d28cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019b2a9f-882f-7198-84a3-81077c4d28cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering_019b2a9f-882f-77f2-aa52-907a2ecd8f11" xlink:href="angn-20251231.xsd#angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering_019b2a9f-882f-77f2-aa52-907a2ecd8f11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PaymentOfWarrantIssuanceCosts_019b2a9f-882f-7ad5-9055-739707fcb655" xlink:href="angn-20251231.xsd#angn_PaymentOfWarrantIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_angn_PaymentOfWarrantIssuanceCosts_019b2a9f-882f-7ad5-9055-739707fcb655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_019b2a9f-882f-7e11-8eac-7ee49157de9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_019b2a9f-882f-7e11-8eac-7ee49157de9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019b2a9f-882f-73b5-9397-2b12357ae305" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019b2a9f-882f-73b5-9397-2b12357ae305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019b2a9f-882f-77b0-9e88-5e33be541f06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019b2a9f-882f-757e-a858-a64bc17b343d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019b2a9f-882f-77b0-9e88-5e33be541f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4f5784b-a274-448c-ad81-cced0f007ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_85d04954-0c17-41db-9bd1-71b170a6903d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4f5784b-a274-448c-ad81-cced0f007ee7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_85d04954-0c17-41db-9bd1-71b170a6903d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6712d58-31f4-4d10-87e4-45bdcd1c6de1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4f5784b-a274-448c-ad81-cced0f007ee7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6712d58-31f4-4d10-87e4-45bdcd1c6de1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_324341b0-bff0-4c59-982d-d199a77add0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_bc2632a6-7d32-4c88-8f75-863229326de0" xlink:href="angn-20251231.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_324341b0-bff0-4c59-982d-d199a77add0e" xlink:to="loc_angn_WarrantsFairValueDisclosure_bc2632a6-7d32-4c88-8f75-863229326de0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ddba6e50-928b-4676-a4a6-d8e31bc1a85f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_48589e7a-e642-44f1-b34f-8934b84aca6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ddba6e50-928b-4676-a4a6-d8e31bc1a85f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_48589e7a-e642-44f1-b34f-8934b84aca6a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c6c2e22c-508e-4b0c-b7e0-51168df8a8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_c95d75bf-6a13-4f6a-8add-a3d7b51bf8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c6c2e22c-508e-4b0c-b7e0-51168df8a8a8" xlink:to="loc_us-gaap_PrepaidInsurance_c95d75bf-6a13-4f6a-8add-a3d7b51bf8e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees_75d1dd5f-73dc-4f15-9b21-99338c8fda0c" xlink:href="angn-20251231.xsd#angn_AdvancedProfessionalFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c6c2e22c-508e-4b0c-b7e0-51168df8a8a8" xlink:to="loc_angn_AdvancedProfessionalFees_75d1dd5f-73dc-4f15-9b21-99338c8fda0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_5bb0307d-bc2c-4d38-8e09-1c15e49ed8e5" xlink:href="angn-20251231.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c6c2e22c-508e-4b0c-b7e0-51168df8a8a8" xlink:to="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_5bb0307d-bc2c-4d38-8e09-1c15e49ed8e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses_b37f0529-6b3e-4ba2-986a-b86520169803" xlink:href="angn-20251231.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c6c2e22c-508e-4b0c-b7e0-51168df8a8a8" xlink:to="loc_angn_PrepaidResearchAndDevelopmentExpenses_b37f0529-6b3e-4ba2-986a-b86520169803" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2cf5ddc7-fd4d-471a-acef-af0aadf6da9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d3eead2b-46ea-47f9-bb51-80a77e99417c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_2cf5ddc7-fd4d-471a-acef-af0aadf6da9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_d3eead2b-46ea-47f9-bb51-80a77e99417c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c98c9c6a-e53b-432f-800b-a5b7cb2cda14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_2cf5ddc7-fd4d-471a-acef-af0aadf6da9e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c98c9c6a-e53b-432f-800b-a5b7cb2cda14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9ae9634b-8ab1-40fc-bd6b-9072f32be6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_676e2ac5-c654-4cd4-ba17-25959f6f447e" xlink:href="angn-20251231.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9ae9634b-8ab1-40fc-bd6b-9072f32be6e7" xlink:to="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_676e2ac5-c654-4cd4-ba17-25959f6f447e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent_71a508d7-cca6-4cea-bb10-b1a767e38bda" xlink:href="angn-20251231.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9ae9634b-8ab1-40fc-bd6b-9072f32be6e7" xlink:to="loc_angn_AccruedResearchAndDevelopmentCurrent_71a508d7-cca6-4cea-bb10-b1a767e38bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_181b1c3e-246e-44c1-9611-f895e100f00a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9ae9634b-8ab1-40fc-bd6b-9072f32be6e7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_181b1c3e-246e-44c1-9611-f895e100f00a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterest_019cd8bb-416d-736c-b1e8-30342ae8a31b" xlink:href="angn-20251231.xsd#angn_AccruedInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9ae9634b-8ab1-40fc-bd6b-9072f32be6e7" xlink:to="loc_angn_AccruedInterest_019cd8bb-416d-736c-b1e8-30342ae8a31b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_3effdbc5-b004-4f66-bd8f-bcb23197cd09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9ae9634b-8ab1-40fc-bd6b-9072f32be6e7" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_3effdbc5-b004-4f66-bd8f-bcb23197cd09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d24cac1-9dbc-4638-87e6-c318e1141059" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9736f2cc-4864-4ac8-b4c4-bf0d0dd6de8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d24cac1-9dbc-4638-87e6-c318e1141059" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9736f2cc-4864-4ac8-b4c4-bf0d0dd6de8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_57bbd6b9-85ca-4b68-bcca-b038de48bbde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d24cac1-9dbc-4638-87e6-c318e1141059" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_57bbd6b9-85ca-4b68-bcca-b038de48bbde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a2ec67a0-7be4-436e-aeab-199dc25d5351" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d24cac1-9dbc-4638-87e6-c318e1141059" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a2ec67a0-7be4-436e-aeab-199dc25d5351" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_85b5e7c5-068d-429d-a65e-a581015c950c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d24cac1-9dbc-4638-87e6-c318e1141059" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_85b5e7c5-068d-429d-a65e-a581015c950c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cd9fd9a3-16ba-4d54-a7bd-ef0110724f31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d24cac1-9dbc-4638-87e6-c318e1141059" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cd9fd9a3-16ba-4d54-a7bd-ef0110724f31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d72310c3-9d37-4487-a7cb-8aac31170282" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_48d54583-2e82-42c3-8ed3-89ce6ce5ad28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_d72310c3-9d37-4487-a7cb-8aac31170282" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_48d54583-2e82-42c3-8ed3-89ce6ce5ad28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2d62d6b3-3466-40a5-bf9e-a44b98d565ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_d72310c3-9d37-4487-a7cb-8aac31170282" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2d62d6b3-3466-40a5-bf9e-a44b98d565ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="angn-20251231.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a9da53dd-b30a-41c7-830b-83ce7cc9ec8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7019e9ec-3a75-42be-83f7-9691ba79c99b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a9da53dd-b30a-41c7-830b-83ce7cc9ec8b" xlink:to="loc_us-gaap_OperatingLeaseLiability_7019e9ec-3a75-42be-83f7-9691ba79c99b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d2ab79e1-f668-4be8-9dd2-625d3823ca46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a9da53dd-b30a-41c7-830b-83ce7cc9ec8b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d2ab79e1-f668-4be8-9dd2-625d3823ca46" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#DebtScheduleofFuturePrincipalPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019cd82a-0d56-7c00-b739-8cfc816a4e61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019cd82a-0d56-73bf-891f-f51bd3766fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_019cd82a-0d56-7c00-b739-8cfc816a4e61" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019cd82a-0d56-73bf-891f-f51bd3766fd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019cd82a-0d56-7a67-a70d-e0601b08658a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_019cd82a-0d56-7c00-b739-8cfc816a4e61" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019cd82a-0d56-7a67-a70d-e0601b08658a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019cd8b0-e55f-7a68-8cc3-0d7a119f2e91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_019cd82a-0d56-7c00-b739-8cfc816a4e61" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019cd8b0-e55f-7a68-8cc3-0d7a119f2e91" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019cb8ea-0983-7689-ab51-8f27a57067b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019cb8ea-0983-783f-b0a7-9d4f1ae462a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019cb8ea-0983-7689-ab51-8f27a57067b8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019cb8ea-0983-783f-b0a7-9d4f1ae462a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_019cb8ea-0983-7f38-bf84-5b9fde78f793" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019cb8ea-0983-7689-ab51-8f27a57067b8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_019cb8ea-0983-7f38-bf84-5b9fde78f793" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7898cf9f-979a-4c63-93a8-a5b111b9ca55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7898cf9f-979a-4c63-93a8-a5b111b9ca55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_fee50e31-2bfb-425f-a002-af4408b4b0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_fee50e31-2bfb-425f-a002-af4408b4b0a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_a8566147-3d08-4cc6-b5f4-6cbde3f04b29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_a8566147-3d08-4cc6-b5f4-6cbde3f04b29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent_d6c57c5a-b531-4e90-8b4a-8bfacfc02e91" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent_d6c57c5a-b531-4e90-8b4a-8bfacfc02e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_9a357a15-8b3d-43b3-9352-9fa072dd1c96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_9a357a15-8b3d-43b3-9352-9fa072dd1c96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_689c3bfd-d8d2-42a5-963e-fd228c5d395b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_689c3bfd-d8d2-42a5-963e-fd228c5d395b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_947c3bdc-1341-42c2-ab20-2a3b35775694" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_947c3bdc-1341-42c2-ab20-2a3b35775694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019c9e3b-b5db-7dde-a26e-6c346ca6429e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_019c9e3b-b5db-7dde-a26e-6c346ca6429e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_019cd837-2cb8-7722-91eb-1fc203ca0261" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_019cd837-2cb8-7722-91eb-1fc203ca0261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent_019cd837-2cb8-7f92-9648-ca3c8a19dc83" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent_019cd837-2cb8-7f92-9648-ca3c8a19dc83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_019ce2db-cdc7-7120-ba00-3622b7673a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_89db32f4-ee0a-450e-a15d-5790f0209170" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_019ce2db-cdc7-7120-ba00-3622b7673a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c9e43-dfac-7bb2-8ee6-2783c4e27c33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c9e43-dfac-7bb2-8ee6-2783c4e27c33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019c9e43-dfac-70b0-a1f8-159f880317b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019c9e43-dfac-70b0-a1f8-159f880317b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c9e43-dfac-77ae-9e73-4d3cc8e53fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c9e43-dfac-77ae-9e73-4d3cc8e53fe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019cd834-f78f-7590-b7a8-83c906ac23ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019cd834-f78f-7590-b7a8-83c906ac23ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount_019cd834-f78f-7462-b815-78a734870608" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:to="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount_019cd834-f78f-7462-b815-78a734870608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019cd834-f78f-74ed-9f4f-8d7a88835f62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019cd834-f78f-74ed-9f4f-8d7a88835f62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019ce2db-9dfe-793b-a76b-34ed999bef4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019ce2db-9dfe-793b-a76b-34ed999bef4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019ce2db-9dfe-792a-a35b-203156bf53c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e43-dfac-746a-8721-dc78c5270c9c" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019ce2db-9dfe-792a-a35b-203156bf53c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_76d4974c-e892-479d-8aa8-a05dbfcc3244" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e6687f02-242f-41d8-95ff-4723db0bb4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_76d4974c-e892-479d-8aa8-a05dbfcc3244" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e6687f02-242f-41d8-95ff-4723db0bb4b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_26c8ddbf-472f-4af5-a52b-2200eb7b3095" xlink:href="angn-20251231.xsd#angn_DeferredTaxAssetsNetBeforeValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_76d4974c-e892-479d-8aa8-a05dbfcc3244" xlink:to="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_26c8ddbf-472f-4af5-a52b-2200eb7b3095" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_b884196b-d2bd-4fcc-ac30-4a4a5c4bc423" xlink:href="angn-20251231.xsd#angn_DeferredTaxAssetsNetBeforeValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b169b099-0173-436b-9e3d-3d0047b62489" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_b884196b-d2bd-4fcc-ac30-4a4a5c4bc423" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b169b099-0173-436b-9e3d-3d0047b62489" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7ba29d0b-f7b9-43ac-8b67-08f17f1026f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_b884196b-d2bd-4fcc-ac30-4a4a5c4bc423" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7ba29d0b-f7b9-43ac-8b67-08f17f1026f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_663c3a05-9353-4933-ba8f-dc3cc57d47ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_b884196b-d2bd-4fcc-ac30-4a4a5c4bc423" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_663c3a05-9353-4933-ba8f-dc3cc57d47ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_9d8efab1-94b4-42ef-bed3-64da8b1b2a19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_b884196b-d2bd-4fcc-ac30-4a4a5c4bc423" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_9d8efab1-94b4-42ef-bed3-64da8b1b2a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_7c3df791-a8be-4c36-94f9-1ddc01acd5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_b884196b-d2bd-4fcc-ac30-4a4a5c4bc423" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_7c3df791-a8be-4c36-94f9-1ddc01acd5e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8f80dc5f-94cf-4e38-b92b-dffed9efac84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_b884196b-d2bd-4fcc-ac30-4a4a5c4bc423" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8f80dc5f-94cf-4e38-b92b-dffed9efac84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_DeferredTaxAssetsOperatingLeaseLiability_b618b29b-8bd2-4424-9726-c58a5073fd13" xlink:href="angn-20251231.xsd#angn_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_b884196b-d2bd-4fcc-ac30-4a4a5c4bc423" xlink:to="loc_angn_DeferredTaxAssetsOperatingLeaseLiability_b618b29b-8bd2-4424-9726-c58a5073fd13" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>angn-20251231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:b764f3f1-1aa2-42b0-ba71-263b5668ebc9,g:54ff377e-34d5-4517-b79e-9773ed1b9e6a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c90c6a8b-d2da-441a-a8b5-1b0d0ad40d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c90c6a8b-d2da-441a-a8b5-1b0d0ad40d8c" xlink:to="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_08a615de-3661-4d10-82c2-32899c0d0152" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_08a615de-3661-4d10-82c2-32899c0d0152" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_08a615de-3661-4d10-82c2-32899c0d0152_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08a615de-3661-4d10-82c2-32899c0d0152" xlink:to="loc_us-gaap_EquityComponentDomain_08a615de-3661-4d10-82c2-32899c0d0152_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08a615de-3661-4d10-82c2-32899c0d0152" xlink:to="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c4703b0-0100-4e2c-b712-90f4b7e8e7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_CommonStockMember_8c4703b0-0100-4e2c-b712-90f4b7e8e7cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_9f5e2491-1168-409e-b180-15cfd46e2287" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_TreasuryStockCommonMember_9f5e2491-1168-409e-b180-15cfd46e2287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_21a903e4-3fc2-4e2e-8e92-d7453c0dd62b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_21a903e4-3fc2-4e2e-8e92-d7453c0dd62b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_257881cb-41e6-4941-8919-0f500576283f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_257881cb-41e6-4941-8919-0f500576283f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1dcefe0e-deec-49bc-ad93-74f1928b0584" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_RetainedEarningsMember_1dcefe0e-deec-49bc-ad93-74f1928b0584" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e526e961-0a3b-4f5b-8443-426e72b98209" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e526e961-0a3b-4f5b-8443-426e72b98209" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e526e961-0a3b-4f5b-8443-426e72b98209_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e526e961-0a3b-4f5b-8443-426e72b98209" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e526e961-0a3b-4f5b-8443-426e72b98209_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e526e961-0a3b-4f5b-8443-426e72b98209" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember_a0b3bdb1-01ec-40ca-9af4-c1af52fc8720" xlink:href="angn-20251231.xsd#angn_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:to="loc_angn_AtTheMarketOfferingMember_a0b3bdb1-01ec-40ca-9af4-c1af52fc8720" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryOfferingMember_019c0ce9-d791-71b0-9285-a6a4049fed2a" xlink:href="angn-20251231.xsd#angn_JanuaryOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:to="loc_angn_JanuaryOfferingMember_019c0ce9-d791-71b0-9285-a6a4049fed2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_d666888b-5b77-41eb-9bde-3db0c8c6a28a" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:to="loc_angn_July2024PublicOfferingMember_d666888b-5b77-41eb-9bde-3db0c8c6a28a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019c0871-e821-7839-bc0c-a0ec04241ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019c0871-e821-7839-bc0c-a0ec04241ec9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_019c0871-e821-7839-bc0c-a0ec04241ec9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019c0871-e821-7839-bc0c-a0ec04241ec9" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_019c0871-e821-7839-bc0c-a0ec04241ec9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_019c0871-e821-783b-95d7-811decca0d85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019c0871-e821-7839-bc0c-a0ec04241ec9" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_019c0871-e821-783b-95d7-811decca0d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember_019c0871-e821-790e-89b7-699a8e968f5c" xlink:href="angn-20251231.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_019c0871-e821-783b-95d7-811decca0d85" xlink:to="loc_angn_ConversionOfConvertibleDebtMember_019c0871-e821-790e-89b7-699a8e968f5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c90c6a8b-d2da-441a-a8b5-1b0d0ad40d8c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6675c073-bc09-45fc-aa88-54158f7aceef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6675c073-bc09-45fc-aa88-54158f7aceef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88463bf9-0f3a-4721-9c75-6637c80b49b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockholdersEquity_88463bf9-0f3a-4721-9c75-6637c80b49b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_345f6796-b8e3-441f-b04d-93c823f92831" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_TreasuryStockCommonShares_345f6796-b8e3-441f-b04d-93c823f92831" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5913f740-3f66-4008-8404-3d810ae724f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5913f740-3f66-4008-8404-3d810ae724f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1c14c33b-9448-4cf3-a2c6-abf4bf065f17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1c14c33b-9448-4cf3-a2c6-abf4bf065f17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3c0dbb86-6cdd-4b60-b633-b680f6ed0344" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3c0dbb86-6cdd-4b60-b633-b680f6ed0344" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4d6c18a6-9017-416e-9370-1e3bc9791e29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4d6c18a6-9017-416e-9370-1e3bc9791e29" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants_be919da2-c0a8-444c-a2ce-05d178654019" xlink:href="angn-20251231.xsd#angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants_be919da2-c0a8-444c-a2ce-05d178654019" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c3cf72f2-21cb-4e8f-91e9-cc3d5753c68e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c3cf72f2-21cb-4e8f-91e9-cc3d5753c68e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c0871-e821-7961-a38e-dbc51d6a0d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c0871-e821-7961-a38e-dbc51d6a0d4a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019c0874-db6c-7422-8a62-9f127530cbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019c0874-db6c-7422-8a62-9f127530cbb4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_019c0865-33ab-7554-9c7c-5d0f99bd285b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_019c0865-33ab-7554-9c7c-5d0f99bd285b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a4af1066-484e-4132-91f2-fe73f7f4f31b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a4af1066-484e-4132-91f2-fe73f7f4f31b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3acb45a9-26ce-49ce-8e02-cd55ea56389a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3acb45a9-26ce-49ce-8e02-cd55ea56389a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6439e876-ebf5-40b0-9f0f-9971d188973e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_NetIncomeLoss_6439e876-ebf5-40b0-9f0f-9971d188973e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c84bc67a-a8f1-4d56-8f8a-9dfa80c826e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c84bc67a-a8f1-4d56-8f8a-9dfa80c826e6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d336327b-cc0a-4c28-87f3-f1edd825e949" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d336327b-cc0a-4c28-87f3-f1edd825e949" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants_7baca339-358e-4b4a-839f-26a9847d7193" xlink:href="angn-20251231.xsd#angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants_7baca339-358e-4b4a-839f-26a9847d7193" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9a4741c8-d528-4477-9095-72166fbda930" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9cd14fb3-4112-4989-a50e-31d1decb46a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_e3fd67cb-6ad6-4d4c-a1c1-955177a0255a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_04e502cd-f6d3-4570-8a7e-87a6a6d6fe02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_41fe7e0c-2b5f-404e-a57f-1b189673e741" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_04e502cd-f6d3-4570-8a7e-87a6a6d6fe02" xlink:to="loc_us-gaap_StatementTable_41fe7e0c-2b5f-404e-a57f-1b189673e741" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b5a29d16-60ef-487d-ba47-823daa5345b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_41fe7e0c-2b5f-404e-a57f-1b189673e741" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b5a29d16-60ef-487d-ba47-823daa5345b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b5a29d16-60ef-487d-ba47-823daa5345b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b5a29d16-60ef-487d-ba47-823daa5345b0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b5a29d16-60ef-487d-ba47-823daa5345b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b5a29d16-60ef-487d-ba47-823daa5345b0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember_019c0ce2-41c8-7132-bb12-20d13c260fd4" xlink:href="angn-20251231.xsd#angn_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:to="loc_angn_AtTheMarketOfferingMember_019c0ce2-41c8-7132-bb12-20d13c260fd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryOfferingMember_019c0cee-ce2a-7e72-8215-8854fb98f96a" xlink:href="angn-20251231.xsd#angn_JanuaryOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:to="loc_angn_JanuaryOfferingMember_019c0cee-ce2a-7e72-8215-8854fb98f96a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_14299d84-d6eb-4160-894a-73797bc11190" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:to="loc_angn_July2024PublicOfferingMember_14299d84-d6eb-4160-894a-73797bc11190" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_dda74429-54a5-40cf-a265-f87b5d57b8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04e502cd-f6d3-4570-8a7e-87a6a6d6fe02" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_dda74429-54a5-40cf-a265-f87b5d57b8cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019c086b-8bdf-7248-81e3-07fd3f1dae76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04e502cd-f6d3-4570-8a7e-87a6a6d6fe02" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019c086b-8bdf-7248-81e3-07fd3f1dae76" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#DescriptionoftheBusinessandFinancialConditionDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd7e6-42fe-74a6-9907-b423647d3b12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd7e6-42fe-74a6-9907-b423647d3b12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-74a6-9907-b423647d3b12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd7e6-42fe-74a6-9907-b423647d3b12" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-74a6-9907-b423647d3b12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd7e6-42fe-74a6-9907-b423647d3b12" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember_019cd7e6-42fe-7382-b234-b0cb6cc35575" xlink:href="angn-20251231.xsd#angn_RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_RegistrationStatementMember_019cd7e6-42fe-7382-b234-b0cb6cc35575" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_019cd7e6-42fe-74df-8311-184652dcb03f" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_019cd7e6-42fe-74df-8311-184652dcb03f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_019cd7e6-42fe-76f5-a299-a96ca9f73e40" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_019cd7e6-42fe-76f5-a299-a96ca9f73e40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember_019cd7e6-42fe-77ce-9e68-5f81acf68e6a" xlink:href="angn-20251231.xsd#angn_A2024RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_A2024RegistrationStatementMember_019cd7e6-42fe-77ce-9e68-5f81acf68e6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_019cd7e6-42fe-7a89-aac5-f8efb90e9672" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_019cd7e6-42fe-7a89-aac5-f8efb90e9672" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019cd7e6-42fe-7111-be5a-bc71bc5cab63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_us-gaap_PrivatePlacementMember_019cd7e6-42fe-7111-be5a-bc71bc5cab63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_019cd7e6-42fe-7721-9e13-fce68a3d83fb" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_MarchSubscriptionAgreementMember_019cd7e6-42fe-7721-9e13-fce68a3d83fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_019cd7e6-42fe-7428-967b-b7aa521c1b16" xlink:href="angn-20251231.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_JulyPublicOfferingMember_019cd7e6-42fe-7428-967b-b7aa521c1b16" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_019cd7e6-42fe-7d67-8ac3-2c8f10edcd91" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_July2024PublicOfferingMember_019cd7e6-42fe-7d67-8ac3-2c8f10edcd91" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember_019cd7e6-9c17-7b31-8c3e-9101ecaab660" xlink:href="angn-20251231.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_JanuaryPublicOfferingMember_019cd7e6-9c17-7b31-8c3e-9101ecaab660" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cd7e6-42fe-7e25-8758-c765b20ea844" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cd7e6-42fe-7e25-8758-c765b20ea844" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd7e6-42fe-7e25-8758-c765b20ea844_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd7e6-42fe-7e25-8758-c765b20ea844" xlink:to="loc_us-gaap_EquityComponentDomain_019cd7e6-42fe-7e25-8758-c765b20ea844_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd7e6-42fe-786d-ab6d-0d751175c3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd7e6-42fe-7e25-8758-c765b20ea844" xlink:to="loc_us-gaap_EquityComponentDomain_019cd7e6-42fe-786d-ab6d-0d751175c3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019cd7e6-42fe-7472-80aa-dd5449b7a411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cd7e6-42fe-786d-ab6d-0d751175c3e0" xlink:to="loc_us-gaap_CommonStockMember_019cd7e6-42fe-7472-80aa-dd5449b7a411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd7e6-42fe-70cc-9b92-515421e9d54b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd7e6-42fe-70cc-9b92-515421e9d54b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-70cc-9b92-515421e9d54b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd7e6-42fe-70cc-9b92-515421e9d54b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-70cc-9b92-515421e9d54b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd7e6-42fe-70cc-9b92-515421e9d54b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019cd7e6-42fe-7b0b-ad2f-1369b817881b" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019cd7e6-42fe-7b0b-ad2f-1369b817881b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_019cd7e6-42fe-7646-b762-544bf9831750" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_PreFundedWarrantMember_019cd7e6-42fe-7646-b762-544bf9831750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_019cd7e6-42fe-7d3b-9c5b-cbb181113500" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_JulyPreFundedWarrantsMember_019cd7e6-42fe-7d3b-9c5b-cbb181113500" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_019cd7e6-42fe-7115-8eb5-07f82fd9eef5" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_JulyCommonWarrantsMember_019cd7e6-42fe-7115-8eb5-07f82fd9eef5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019cd7e6-9c17-7ca5-8d1b-177fcfaf41f6" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019cd7e6-9c17-7ca5-8d1b-177fcfaf41f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember_019cd7e6-9c17-7453-b1ed-37cf7bfe0f55" xlink:href="angn-20251231.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_JanuaryCommonWarrantsMember_019cd7e6-9c17-7453-b1ed-37cf7bfe0f55" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_019cd8a7-cc7d-7bf5-956a-556a80aae898" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_July2024PublicOfferingMember_019cd8a7-cc7d-7bf5-956a-556a80aae898" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cd7e6-42fe-7516-bb2c-c344a305655a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cd7e6-42fe-7516-bb2c-c344a305655a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7516-bb2c-c344a305655a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cd7e6-42fe-7516-bb2c-c344a305655a" xlink:to="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7516-bb2c-c344a305655a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7214-9a28-6e93b28ef27b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cd7e6-42fe-7516-bb2c-c344a305655a" xlink:to="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7214-9a28-6e93b28ef27b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019cd7e6-42fe-7baa-8e0a-2451a598ee34" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7214-9a28-6e93b28ef27b" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019cd7e6-42fe-7baa-8e0a-2451a598ee34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_019cd7e6-42fe-7791-b17f-0df08d6de60b" xlink:href="angn-20251231.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7214-9a28-6e93b28ef27b" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_019cd7e6-42fe-7791-b17f-0df08d6de60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019cd7e6-9c17-7d3d-b894-fad410504662" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_DebtInstrumentAxis_019cd7e6-9c17-7d3d-b894-fad410504662" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019cd7e6-9c17-7d3d-b894-fad410504662_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019cd7e6-9c17-7d3d-b894-fad410504662" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019cd7e6-9c17-7d3d-b894-fad410504662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019cd7e6-9c17-7729-8218-452850c38607" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019cd7e6-9c17-7d3d-b894-fad410504662" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019cd7e6-9c17-7729-8218-452850c38607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019cd7e6-9c17-7c37-aa8a-ea120fe53b4b" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019cd7e6-9c17-7729-8218-452850c38607" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019cd7e6-9c17-7c37-aa8a-ea120fe53b4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019cd7e6-9c17-7ead-8b71-12ce6c7a9760" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019cd7e6-9c17-7ead-8b71-12ce6c7a9760" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019cd7e6-9c17-7ead-8b71-12ce6c7a9760_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019cd7e6-9c17-7ead-8b71-12ce6c7a9760" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019cd7e6-9c17-7ead-8b71-12ce6c7a9760_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019cd7e6-9c17-75be-923f-a733ce193edb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019cd7e6-9c17-7ead-8b71-12ce6c7a9760" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019cd7e6-9c17-75be-923f-a733ce193edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019cd7e6-9c17-78d9-992a-cc130e809762" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019cd7e6-9c17-75be-923f-a733ce193edb" xlink:to="loc_us-gaap_ConvertibleDebtMember_019cd7e6-9c17-78d9-992a-cc130e809762" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cd7e6-42fe-77a9-ba2f-a49b3cbfda34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cd7e6-42fe-77a9-ba2f-a49b3cbfda34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice_019cd7e6-42fe-7e1f-b102-cb198dfa2b18" xlink:href="angn-20251231.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_angn_SaleOfStockAggregateInitialOfferingPrice_019cd7e6-42fe-7e1f-b102-cb198dfa2b18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cd7e6-42fe-750d-aaf1-1356bc225bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cd7e6-42fe-750d-aaf1-1356bc225bcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019cd7e6-42fe-75ae-92f1-0ae6d49f62eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019cd7e6-42fe-75ae-92f1-0ae6d49f62eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019cd7e6-42fe-781e-bfc2-1af23ca81e16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019cd7e6-42fe-781e-bfc2-1af23ca81e16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019cd7e6-9c17-782f-b8f6-8a7a3df6e219" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019cd7e6-9c17-782f-b8f6-8a7a3df6e219" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cd7e6-42fe-7d77-9b46-a58e4af2ea3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cd7e6-42fe-7d77-9b46-a58e4af2ea3f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cd7e6-42fe-789c-b752-0e55c090c5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cd7e6-42fe-789c-b752-0e55c090c5e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_019cd7e6-42fe-7a02-ae67-96ddf5749d19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_019cd7e6-42fe-7a02-ae67-96ddf5749d19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cd7e6-9c17-7a8f-8603-3b8a046c9c99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cd7e6-9c17-7a8f-8603-3b8a046c9c99" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cd7e6-9c17-7b3c-97b2-63ca2a4f5c78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cd7e6-9c17-7b3c-97b2-63ca2a4f5c78" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019cd7e6-9c17-725b-aa62-3ebe14128b53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019cd7e6-9c17-725b-aa62-3ebe14128b53" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019cd7e6-9c17-76ba-8a5c-e43f2625863b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019cd7e6-9c17-76ba-8a5c-e43f2625863b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019cd7e6-9c17-7018-849e-d4f016446c98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019cd7e6-9c17-7018-849e-d4f016446c98" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019cd7e6-9c17-7d0f-8842-00b20dbcf5cf" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019cd7e6-9c17-7d0f-8842-00b20dbcf5cf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019cd7e6-9c17-71f9-a4d7-76258e976f14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019cd7e6-9c17-71f9-a4d7-76258e976f14" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cd7e6-9c17-70a0-8177-31a6946d6e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cd7e6-9c17-70a0-8177-31a6946d6e7e" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_685d4f38-1b08-4d24-ac4a-9824c74c6355" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d967e80-d31a-4132-ae8d-e8adc773b484" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_685d4f38-1b08-4d24-ac4a-9824c74c6355" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d967e80-d31a-4132-ae8d-e8adc773b484" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dbb5ee63-f679-42d9-a899-6ac0348e3d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d967e80-d31a-4132-ae8d-e8adc773b484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dbb5ee63-f679-42d9-a899-6ac0348e3d1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dbb5ee63-f679-42d9-a899-6ac0348e3d1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dbb5ee63-f679-42d9-a899-6ac0348e3d1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dbb5ee63-f679-42d9-a899-6ac0348e3d1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9bb671f-14b1-4a05-b5b3-f4bc60bda642" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dbb5ee63-f679-42d9-a899-6ac0348e3d1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9bb671f-14b1-4a05-b5b3-f4bc60bda642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d77ce39f-15e4-4cf6-841c-512c3e1298cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9bb671f-14b1-4a05-b5b3-f4bc60bda642" xlink:to="loc_us-gaap_EquipmentMember_d77ce39f-15e4-4cf6-841c-512c3e1298cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c2a8a997-351e-4eb8-b97b-f442ed931543" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9bb671f-14b1-4a05-b5b3-f4bc60bda642" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c2a8a997-351e-4eb8-b97b-f442ed931543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d76909c3-4fcb-4b68-98ae-4411e8a1dd66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_685d4f38-1b08-4d24-ac4a-9824c74c6355" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d76909c3-4fcb-4b68-98ae-4411e8a1dd66" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b2614976-789b-40c3-bd71-d018bb57f8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0630972d-b029-4fc0-a7ab-913988444cde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b2614976-789b-40c3-bd71-d018bb57f8f6" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0630972d-b029-4fc0-a7ab-913988444cde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3bac354-5e15-4193-b316-57e3536f6c48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0630972d-b029-4fc0-a7ab-913988444cde" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3bac354-5e15-4193-b316-57e3536f6c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3bac354-5e15-4193-b316-57e3536f6c48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3bac354-5e15-4193-b316-57e3536f6c48" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b3bac354-5e15-4193-b316-57e3536f6c48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3bac354-5e15-4193-b316-57e3536f6c48" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d5fd3fbd-422c-44b5-95c4-d036e951773d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d5fd3fbd-422c-44b5-95c4-d036e951773d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_413373d4-b138-4d08-8402-a68642a59413" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_413373d4-b138-4d08-8402-a68642a59413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5d9eb60b-9fb6-4cd2-ad49-71da0bb9d4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5d9eb60b-9fb6-4cd2-ad49-71da0bb9d4ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1d3c5251-fb9c-4ac3-b909-9d00b26e85aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b2614976-789b-40c3-bd71-d018bb57f8f6" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1d3c5251-fb9c-4ac3-b909-9d00b26e85aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_560bdb58-699b-42a8-bf16-e1bbe95b10a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1d3c5251-fb9c-4ac3-b909-9d00b26e85aa" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_560bdb58-699b-42a8-bf16-e1bbe95b10a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e31d796b-d899-454f-8a4a-76ee5652109f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1d3c5251-fb9c-4ac3-b909-9d00b26e85aa" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e31d796b-d899-454f-8a4a-76ee5652109f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_19734484-2fcc-4268-82f0-c15f09e305aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b2614976-789b-40c3-bd71-d018bb57f8f6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_19734484-2fcc-4268-82f0-c15f09e305aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_c739c76b-6d09-4371-b923-c71d6834cc7e" xlink:href="angn-20251231.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_19734484-2fcc-4268-82f0-c15f09e305aa" xlink:to="loc_angn_WarrantsFairValueDisclosure_c739c76b-6d09-4371-b923-c71d6834cc7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1a5e2a17-39a5-4039-b2c1-381bcbe81086" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_19734484-2fcc-4268-82f0-c15f09e305aa" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1a5e2a17-39a5-4039-b2c1-381bcbe81086" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_96d62ad4-e1f3-4dc9-86ef-1e7a4c453585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bcce03c0-cee0-416f-918a-46ab059438f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_96d62ad4-e1f3-4dc9-86ef-1e7a4c453585" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bcce03c0-cee0-416f-918a-46ab059438f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_54ce3b6b-b5d9-4894-bacf-497989284ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bcce03c0-cee0-416f-918a-46ab059438f2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_54ce3b6b-b5d9-4894-bacf-497989284ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_54ce3b6b-b5d9-4894-bacf-497989284ab9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_54ce3b6b-b5d9-4894-bacf-497989284ab9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_54ce3b6b-b5d9-4894-bacf-497989284ab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c37c06b1-4010-46cc-8e11-d284f24a4cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_54ce3b6b-b5d9-4894-bacf-497989284ab9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c37c06b1-4010-46cc-8e11-d284f24a4cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember_ccc8c3a2-82d7-4870-ae14-6bb277b162d5" xlink:href="angn-20251231.xsd#angn_WarrantLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c37c06b1-4010-46cc-8e11-d284f24a4cb1" xlink:to="loc_angn_WarrantLiabilityMember_ccc8c3a2-82d7-4870-ae14-6bb277b162d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_96d62ad4-e1f3-4dc9-86ef-1e7a4c453585" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bf679bdc-981e-4c43-809f-299663b0e4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bf679bdc-981e-4c43-809f-299663b0e4a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_58f28ee8-bf75-433d-9cf0-091b81502ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_58f28ee8-bf75-433d-9cf0-091b81502ea7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_497e68ab-9e84-4138-a9f3-52d6e1e8b339" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_826faf64-c649-47b3-afca-2832682e4cde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_826faf64-c649-47b3-afca-2832682e4cde" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f9864b0-810e-4ca7-a2da-f093b10c3f55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f9864b0-810e-4ca7-a2da-f093b10c3f55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f9864b0-810e-4ca7-a2da-f093b10c3f55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f9864b0-810e-4ca7-a2da-f093b10c3f55" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f9864b0-810e-4ca7-a2da-f093b10c3f55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce746ef2-a681-4762-bae1-e0378d40f61f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f9864b0-810e-4ca7-a2da-f093b10c3f55" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce746ef2-a681-4762-bae1-e0378d40f61f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8e2b5e85-1432-4a2f-9c87-0fadf2f0aac8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce746ef2-a681-4762-bae1-e0378d40f61f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8e2b5e85-1432-4a2f-9c87-0fadf2f0aac8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember_4dbb7b80-0e4c-4489-ab16-a97c6cbab91f" xlink:href="angn-20251231.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:to="loc_angn_MeasurementInputStrikePriceMember_4dbb7b80-0e4c-4489-ab16-a97c6cbab91f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_ddb87e28-083b-4c6f-b05f-ea30780f0824" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_ddb87e28-083b-4c6f-b05f-ea30780f0824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_db47b817-e337-40c8-8977-e545f84b70ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_db47b817-e337-40c8-8977-e545f84b70ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_25e8b04d-fc81-455e-bab8-c3364ef9cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_25e8b04d-fc81-455e-bab8-c3364ef9cad6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fb6ad75a-8d84-4b32-8173-bbaa6f392171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_826faf64-c649-47b3-afca-2832682e4cde" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fb6ad75a-8d84-4b32-8173-bbaa6f392171" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_dd33db73-35e6-4b6b-8203-6b109e4a2407" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_826faf64-c649-47b3-afca-2832682e4cde" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_dd33db73-35e6-4b6b-8203-6b109e4a2407" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_580b57f1-c0cc-4886-a1bf-0675156207f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_580b57f1-c0cc-4886-a1bf-0675156207f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_580b57f1-c0cc-4886-a1bf-0675156207f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_580b57f1-c0cc-4886-a1bf-0675156207f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_580b57f1-c0cc-4886-a1bf-0675156207f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_524730d9-1def-452f-93dd-6c1be8d65a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_580b57f1-c0cc-4886-a1bf-0675156207f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_524730d9-1def-452f-93dd-6c1be8d65a5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_60f2f8a2-c433-4827-b4ee-3b6d46ee8668" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_524730d9-1def-452f-93dd-6c1be8d65a5e" xlink:to="loc_angn_PreFundedWarrantMember_60f2f8a2-c433-4827-b4ee-3b6d46ee8668" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a3fe4ea1-fd87-426a-9138-d7bbb54633ac" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_524730d9-1def-452f-93dd-6c1be8d65a5e" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a3fe4ea1-fd87-426a-9138-d7bbb54633ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_33b588dc-8542-41f7-9460-d264305cd5ee" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a3fe4ea1-fd87-426a-9138-d7bbb54633ac" xlink:to="loc_angn_JulyPreFundedWarrantsMember_33b588dc-8542-41f7-9460-d264305cd5ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_c49297e3-54f5-478e-9153-49d15e168dfd" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a3fe4ea1-fd87-426a-9138-d7bbb54633ac" xlink:to="loc_angn_JulyCommonWarrantsMember_c49297e3-54f5-478e-9153-49d15e168dfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5bac7516-b396-41cd-909c-a5d939094d25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5bac7516-b396-41cd-909c-a5d939094d25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5bac7516-b396-41cd-909c-a5d939094d25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5bac7516-b396-41cd-909c-a5d939094d25" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5bac7516-b396-41cd-909c-a5d939094d25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e6d56c79-fb82-439c-a878-d0c430ecfd97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5bac7516-b396-41cd-909c-a5d939094d25" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e6d56c79-fb82-439c-a878-d0c430ecfd97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_ca49d58b-5ffd-4912-a51a-e2302536bfa8" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e6d56c79-fb82-439c-a878-d0c430ecfd97" xlink:to="loc_angn_MarchSubscriptionAgreementMember_ca49d58b-5ffd-4912-a51a-e2302536bfa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_af97a6e6-e3c2-4711-b6f1-999a31dcb2be" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e6d56c79-fb82-439c-a878-d0c430ecfd97" xlink:to="loc_angn_July2024PublicOfferingMember_af97a6e6-e3c2-4711-b6f1-999a31dcb2be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_019cd885-71ae-7b85-b3e6-f6e66d66bacd" xlink:href="angn-20251231.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:to="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_019cd885-71ae-7b85-b3e6-f6e66d66bacd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b22dcac5-698f-4ea8-ad6b-87812c4c9785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b22dcac5-698f-4ea8-ad6b-87812c4c9785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_7c3f5c6e-60ca-46cd-9d82-3bea2fd7ba2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_7c3f5c6e-60ca-46cd-9d82-3bea2fd7ba2b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1c59cb14-d501-45fa-902e-5c99d942d2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1c59cb14-d501-45fa-902e-5c99d942d2ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9a318a8c-2c94-445e-bf9f-87a176435dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1c59cb14-d501-45fa-902e-5c99d942d2ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9a318a8c-2c94-445e-bf9f-87a176435dbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9a318a8c-2c94-445e-bf9f-87a176435dbe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9a318a8c-2c94-445e-bf9f-87a176435dbe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9a318a8c-2c94-445e-bf9f-87a176435dbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9a318a8c-2c94-445e-bf9f-87a176435dbe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_70326796-d676-4bf1-b493-26e44a188f17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:to="loc_us-gaap_EquipmentMember_70326796-d676-4bf1-b493-26e44a188f17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3084598a-6816-4eef-9ba1-ebe8506466a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3084598a-6816-4eef-9ba1-ebe8506466a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_eaae0cd3-bb4c-4248-babf-4bb7fd7b4224" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_eaae0cd3-bb4c-4248-babf-4bb7fd7b4224" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a9e97c84-00c2-4709-b54e-3cd6883d8d15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a9e97c84-00c2-4709-b54e-3cd6883d8d15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_61bc28ca-3e39-47b2-80c4-8c88b756ab06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_61bc28ca-3e39-47b2-80c4-8c88b756ab06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b1c3e32-7332-4e48-85dc-632cf75ef4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5b1c3e32-7332-4e48-85dc-632cf75ef4f0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrantDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#ResearchGrantDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/ResearchGrantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_7e6b3afd-8727-44a3-a0f3-f43cad74490b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_7e6b3afd-8727-44a3-a0f3-f43cad74490b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_d0a6c97c-a0a0-4af5-99be-aea7360f811d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_7e6b3afd-8727-44a3-a0f3-f43cad74490b" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_d0a6c97c-a0a0-4af5-99be-aea7360f811d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_d0a6c97c-a0a0-4af5-99be-aea7360f811d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_d0a6c97c-a0a0-4af5-99be-aea7360f811d" xlink:to="loc_us-gaap_ProjectMember_d0a6c97c-a0a0-4af5-99be-aea7360f811d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_d0a6c97c-a0a0-4af5-99be-aea7360f811d" xlink:to="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_0e52d2e7-9870-4da3-a0cd-a01b8a8184c7" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_0e52d2e7-9870-4da3-a0cd-a01b8a8184c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member_24054bf0-2b9b-4397-8aff-cec8ad5d3b32" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member_24054bf0-2b9b-4397-8aff-cec8ad5d3b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_5a677c3c-cce9-4edf-8782-fde727f3884b" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_5a677c3c-cce9-4edf-8782-fde727f3884b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_dec7072b-a40f-4c78-8008-70cab49ff78c" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_dec7072b-a40f-4c78-8008-70cab49ff78c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant_36dddef1-4182-4838-b9c3-62c1289ad3cc" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrant_36dddef1-4182-4838-b9c3-62c1289ad3cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_f803e046-15f0-4704-a7a6-3eac52f9dcbc" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_f803e046-15f0-4704-a7a6-3eac52f9dcbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit_a77530b4-2883-4f50-ba52-6eca0c97ce47" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_ResearchAndDevelopmentArrangementCredit_a77530b4-2883-4f50-ba52-6eca0c97ce47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_91b1e6e8-8af4-47b3-add1-042cae5da503" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_91b1e6e8-8af4-47b3-add1-042cae5da503" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements_ff7b0017-48de-4e52-85e0-bcac7bf92eb9" xlink:href="angn-20251231.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_NumberOfResearchGrantAgreements_ff7b0017-48de-4e52-85e0-bcac7bf92eb9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating_019b2b1b-3a56-7689-a32a-58fbd3892748" xlink:href="angn-20251231.xsd#angn_GrantRevenueNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_GrantRevenueNonoperating_019b2b1b-3a56-7689-a32a-58fbd3892748" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommonStockandStockholdersEquityDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#CommonStockandStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CommonStockandStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cd8a0-0704-71f7-8208-c62557982062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cd8a0-0704-71f7-8208-c62557982062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd8a0-0704-71f7-8208-c62557982062_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd8a0-0704-71f7-8208-c62557982062" xlink:to="loc_us-gaap_EquityComponentDomain_019cd8a0-0704-71f7-8208-c62557982062_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd8a0-0704-787f-aa34-17798bebee59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd8a0-0704-71f7-8208-c62557982062" xlink:to="loc_us-gaap_EquityComponentDomain_019cd8a0-0704-787f-aa34-17798bebee59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019cd8a0-0704-791e-950f-fcc731845a37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cd8a0-0704-787f-aa34-17798bebee59" xlink:to="loc_us-gaap_CommonStockMember_019cd8a0-0704-791e-950f-fcc731845a37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_019cd8a0-0704-7844-91c1-aabb63b4a0d7" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_019cd8a0-0704-7844-91c1-aabb63b4a0d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_019cd8a0-0704-7039-85fd-33ba8910ccfd" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_019cd8a0-0704-7039-85fd-33ba8910ccfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_019cd8a0-0704-705f-b687-29ca87fae821" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_MarchSubscriptionAgreementMember_019cd8a0-0704-705f-b687-29ca87fae821" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_019cd8a0-0704-7090-ae83-91cbbf316a17" xlink:href="angn-20251231.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_JulyPublicOfferingMember_019cd8a0-0704-7090-ae83-91cbbf316a17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019cd8a0-0704-7f57-8ebc-f09201ea1d02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_us-gaap_PrivatePlacementMember_019cd8a0-0704-7f57-8ebc-f09201ea1d02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_019cd8a0-4ec0-7f94-93e2-ef6762131f73" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_July2024PublicOfferingMember_019cd8a0-4ec0-7f94-93e2-ef6762131f73" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember_019cd8a0-4ec0-7fd3-bec1-fc9f6ff6909f" xlink:href="angn-20251231.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_JanuaryPublicOfferingMember_019cd8a0-4ec0-7fd3-bec1-fc9f6ff6909f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd8a0-0704-792d-bbc5-ae0e8a016cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd8a0-0704-792d-bbc5-ae0e8a016cc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-792d-bbc5-ae0e8a016cc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd8a0-0704-792d-bbc5-ae0e8a016cc7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-792d-bbc5-ae0e8a016cc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd8a0-0704-792d-bbc5-ae0e8a016cc7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_019cd8a0-0704-7e9c-81a6-143cca99f7dd" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_PreFundedWarrantMember_019cd8a0-0704-7e9c-81a6-143cca99f7dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019cd8a0-0704-751b-bf28-e05f0053f3b8" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019cd8a0-0704-751b-bf28-e05f0053f3b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_019cd8a0-4ec0-77e6-9f86-af5c4a9dde73" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_JulyPreFundedWarrantsMember_019cd8a0-4ec0-77e6-9f86-af5c4a9dde73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_019cd8a0-4ec0-7cca-9472-e7ee72f52e21" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_JulyCommonWarrantsMember_019cd8a0-4ec0-7cca-9472-e7ee72f52e21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019cd8a0-4ec0-7104-beb6-6ca958c9d0ec" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019cd8a0-4ec0-7104-beb6-6ca958c9d0ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember_019cd8a0-4ec0-7ca5-934d-c610c0b2146e" xlink:href="angn-20251231.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_JanuaryCommonWarrantsMember_019cd8a0-4ec0-7ca5-934d-c610c0b2146e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cd8a0-0704-73f1-82b5-7dced9bec19b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cd8a0-0704-73f1-82b5-7dced9bec19b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-73f1-82b5-7dced9bec19b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cd8a0-0704-73f1-82b5-7dced9bec19b" xlink:to="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-73f1-82b5-7dced9bec19b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-7688-b07c-c10f21b69b66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cd8a0-0704-73f1-82b5-7dced9bec19b" xlink:to="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-7688-b07c-c10f21b69b66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019cd8a0-0704-730d-998b-f2072112ede2" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-7688-b07c-c10f21b69b66" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019cd8a0-0704-730d-998b-f2072112ede2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_019cd8a0-4ec0-7610-8b16-01e8039ee824" xlink:href="angn-20251231.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-7688-b07c-c10f21b69b66" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_019cd8a0-4ec0-7610-8b16-01e8039ee824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_DebtInstrumentAxis_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019cd8a0-4ec0-79e0-a8d6-274894d7c0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019cd8a0-4ec0-79e0-a8d6-274894d7c0a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019cd8a0-4ec0-7ac1-abf2-7029ecb8cf1b" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019cd8a0-4ec0-79e0-a8d6-274894d7c0a8" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019cd8a0-4ec0-7ac1-abf2-7029ecb8cf1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019cd8a0-4ec0-7c7d-9ba0-03b5ca38ed62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019cd8a0-4ec0-7c7d-9ba0-03b5ca38ed62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019cd8a0-4ec0-7bde-a1b8-8210f9ac22fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019cd8a0-4ec0-7c7d-9ba0-03b5ca38ed62" xlink:to="loc_us-gaap_ConvertibleDebtMember_019cd8a0-4ec0-7bde-a1b8-8210f9ac22fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019cd8a0-0704-7147-ac4b-740edcde1b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019cd8a0-0704-7147-ac4b-740edcde1b3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019cd8a0-0704-78ff-a527-b7275706d027" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019cd8a0-0704-78ff-a527-b7275706d027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019cd8a0-0704-75f5-b4c2-5f616889bb36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019cd8a0-0704-75f5-b4c2-5f616889bb36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019cd8a0-0704-7866-9ab6-c677913dc272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019cd8a0-0704-7866-9ab6-c677913dc272" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cd8a0-0704-7a64-b5e4-01bc08949c39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cd8a0-0704-7a64-b5e4-01bc08949c39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019cd8a0-0704-7278-a268-0ce29a828bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019cd8a0-0704-7278-a268-0ce29a828bcc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019cd8a0-0704-731c-bd85-692c5c92384c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019cd8a0-0704-731c-bd85-692c5c92384c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019cd8a0-0704-70bb-ac56-8e5054a588e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019cd8a0-0704-70bb-ac56-8e5054a588e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cd8a0-0704-78a7-9091-16d031669171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cd8a0-0704-78a7-9091-16d031669171" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_019cd8a0-4ec0-700b-bd6d-ea6c636c6095" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_019cd8a0-4ec0-700b-bd6d-ea6c636c6095" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cd8a0-4ec0-7cd8-9262-a5177dfcb486" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cd8a0-4ec0-7cd8-9262-a5177dfcb486" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_019cd8a0-4ec0-7091-95d8-7de82bb6874a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_019cd8a0-4ec0-7091-95d8-7de82bb6874a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cd8a0-4ec0-7c8c-a122-8219e64311f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cd8a0-4ec0-7c8c-a122-8219e64311f1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cd8a0-4ec0-7cd1-8ea0-b64548becd17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cd8a0-4ec0-7cd1-8ea0-b64548becd17" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019cd8a0-4ec0-70ac-a0c3-3ecff9aa3218" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019cd8a0-4ec0-70ac-a0c3-3ecff9aa3218" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019cd8a0-4ec0-745a-a3e7-4c8b94598869" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019cd8a0-4ec0-745a-a3e7-4c8b94598869" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019cd8a0-4ec0-7645-8221-73512cbc55e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019cd8a0-4ec0-7645-8221-73512cbc55e0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019cd8a0-4ec0-7263-b4bd-97a741abc7b8" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019cd8a0-4ec0-7263-b4bd-97a741abc7b8" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1626948f-5f35-48ca-acaa-cdf36027f47d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:to="loc_us-gaap_PlanNameAxis_1626948f-5f35-48ca-acaa-cdf36027f47d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1626948f-5f35-48ca-acaa-cdf36027f47d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1626948f-5f35-48ca-acaa-cdf36027f47d" xlink:to="loc_us-gaap_PlanNameDomain_1626948f-5f35-48ca-acaa-cdf36027f47d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1626948f-5f35-48ca-acaa-cdf36027f47d" xlink:to="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2021PlanMember_cc06d0e0-77f8-4876-a82e-a957e7c65258" xlink:href="angn-20251231.xsd#angn_A2021PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:to="loc_angn_A2021PlanMember_cc06d0e0-77f8-4876-a82e-a957e7c65258" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2022PlanMember_c353f0e8-a1c0-4260-b3d2-4d2119ae2700" xlink:href="angn-20251231.xsd#angn_A2022PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:to="loc_angn_A2022PlanMember_c353f0e8-a1c0-4260-b3d2-4d2119ae2700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024PlanMember_93c18b4a-c800-48c1-ba13-f8d287c61b46" xlink:href="angn-20251231.xsd#angn_A2024PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:to="loc_angn_A2024PlanMember_93c18b4a-c800-48c1-ba13-f8d287c61b46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6597b533-534e-4a19-b534-f1ea5c25a79b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:to="loc_us-gaap_AwardTypeAxis_6597b533-534e-4a19-b534-f1ea5c25a79b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6597b533-534e-4a19-b534-f1ea5c25a79b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6597b533-534e-4a19-b534-f1ea5c25a79b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6597b533-534e-4a19-b534-f1ea5c25a79b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_92a1d810-eba2-4778-9774-930135dd3a66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6597b533-534e-4a19-b534-f1ea5c25a79b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_92a1d810-eba2-4778-9774-930135dd3a66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_0b527fb2-c9e4-4acd-aeee-3708bdd7c1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_92a1d810-eba2-4778-9774-930135dd3a66" xlink:to="loc_us-gaap_EmployeeStockMember_0b527fb2-c9e4-4acd-aeee-3708bdd7c1a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019c64f0-1b45-79c1-aa7b-a558f4a46ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019c64f0-1b45-79c1-aa7b-a558f4a46ff5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019c64f0-1b45-79c1-aa7b-a558f4a46ff5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019c64f0-1b45-79c1-aa7b-a558f4a46ff5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019c64f0-1b45-79c1-aa7b-a558f4a46ff5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019c64f0-1b45-7b58-93ad-2e98d9cf549f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019c64f0-1b45-79c1-aa7b-a558f4a46ff5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019c64f0-1b45-7b58-93ad-2e98d9cf549f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019c64f0-4977-766d-ae3a-166d91b89d99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019c64f0-1b45-7b58-93ad-2e98d9cf549f" xlink:to="loc_us-gaap_SubsequentEventMember_019c64f0-4977-766d-ae3a-166d91b89d99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding_019b2b69-a710-7f64-bffa-1733f73d3ab5" xlink:href="angn-20251231.xsd#angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding_019b2b69-a710-7f64-bffa-1733f73d3ab5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5936c74e-bc3c-42b2-88d3-4c8629190ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5936c74e-bc3c-42b2-88d3-4c8629190ac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit_35ae6969-a4ae-46af-a26d-080c7fa0ad44" xlink:href="angn-20251231.xsd#angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit_35ae6969-a4ae-46af-a26d-080c7fa0ad44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c6de8694-56e2-48b9-896c-1d461ce8dd83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c6de8694-56e2-48b9-896c-1d461ce8dd83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9efba91c-7179-4ea9-a0ca-47379dabd726" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9efba91c-7179-4ea9-a0ca-47379dabd726" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_098e62da-e19f-4de3-ba03-5f3324587011" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_098e62da-e19f-4de3-ba03-5f3324587011" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a8b7979c-0b83-47ae-855e-9cc861223920" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a8b7979c-0b83-47ae-855e-9cc861223920" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_01c7bb06-a21a-4d3e-991d-c7341a272660" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3c330838-c036-461b-89c5-2e5442d454e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_01c7bb06-a21a-4d3e-991d-c7341a272660" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3c330838-c036-461b-89c5-2e5442d454e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_044bab42-fe58-4915-9925-ac7eba0752d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3c330838-c036-461b-89c5-2e5442d454e0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_044bab42-fe58-4915-9925-ac7eba0752d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_044bab42-fe58-4915-9925-ac7eba0752d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_044bab42-fe58-4915-9925-ac7eba0752d4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_044bab42-fe58-4915-9925-ac7eba0752d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_18d65403-75cd-4a43-9d83-a46051e33391" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_044bab42-fe58-4915-9925-ac7eba0752d4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_18d65403-75cd-4a43-9d83-a46051e33391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b3adf9d-8d0a-4b99-b450-d8a8c0cfd829" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_18d65403-75cd-4a43-9d83-a46051e33391" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b3adf9d-8d0a-4b99-b450-d8a8c0cfd829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_e169890d-b041-413f-8df9-0412041f493a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_18d65403-75cd-4a43-9d83-a46051e33391" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_e169890d-b041-413f-8df9-0412041f493a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4de6f672-7c0f-45a8-8049-2832dbdf71ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_01c7bb06-a21a-4d3e-991d-c7341a272660" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4de6f672-7c0f-45a8-8049-2832dbdf71ef" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cdc7b470-90b3-412f-b74a-2940da777087" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:to="loc_us-gaap_AwardTypeAxis_cdc7b470-90b3-412f-b74a-2940da777087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cdc7b470-90b3-412f-b74a-2940da777087_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_cdc7b470-90b3-412f-b74a-2940da777087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cdc7b470-90b3-412f-b74a-2940da777087_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9b53cf0-c613-4d76-a1e6-1819504ff542" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_cdc7b470-90b3-412f-b74a-2940da777087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9b53cf0-c613-4d76-a1e6-1819504ff542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_21e42109-1f23-4bb4-b341-5726bf610517" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9b53cf0-c613-4d76-a1e6-1819504ff542" xlink:to="loc_us-gaap_EmployeeStockOptionMember_21e42109-1f23-4bb4-b341-5726bf610517" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b2ba8-3cf4-7617-908a-664b4443ad77" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:to="loc_srt_RangeAxis_019b2ba8-3cf4-7617-908a-664b4443ad77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2ba8-3cf4-7617-908a-664b4443ad77_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019b2ba8-3cf4-7617-908a-664b4443ad77" xlink:to="loc_srt_RangeMember_019b2ba8-3cf4-7617-908a-664b4443ad77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2ba8-3cf4-7ad5-9157-1b7e681ad21b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019b2ba8-3cf4-7617-908a-664b4443ad77" xlink:to="loc_srt_RangeMember_019b2ba8-3cf4-7ad5-9157-1b7e681ad21b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019b2ba8-3cf4-77fd-a70c-ae1e38af268e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019b2ba8-3cf4-7ad5-9157-1b7e681ad21b" xlink:to="loc_srt_MinimumMember_019b2ba8-3cf4-77fd-a70c-ae1e38af268e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019b2ba8-83bd-7ba9-ad98-d6b18b677066" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019b2ba8-3cf4-7ad5-9157-1b7e681ad21b" xlink:to="loc_srt_MaximumMember_019b2ba8-83bd-7ba9-ad98-d6b18b677066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019b2b99-46c7-701c-8ce1-255b2573eefc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019b2b99-46c7-701c-8ce1-255b2573eefc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019b2ba4-f8e5-790c-bc7d-3cf75fd6c780" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019b2ba4-f8e5-790c-bc7d-3cf75fd6c780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12ecd7ad-a747-44ae-9546-2ab0f2ec87f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12ecd7ad-a747-44ae-9546-2ab0f2ec87f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019b2b9b-7cd5-74a6-9899-03f222fc8f62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019b2b9b-7cd5-74a6-9899-03f222fc8f62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019b2ba7-03bf-74b6-84d3-c1e2d1e3137e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019b2ba7-03bf-74b6-84d3-c1e2d1e3137e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b2b9c-0352-76ba-9a60-a534bc2eee84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b2b9c-0352-76ba-9a60-a534bc2eee84" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#WarrantsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1c0cd651-57f9-4276-abe0-78dfd167f5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1c0cd651-57f9-4276-abe0-78dfd167f5b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1c0cd651-57f9-4276-abe0-78dfd167f5b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1c0cd651-57f9-4276-abe0-78dfd167f5b5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1c0cd651-57f9-4276-abe0-78dfd167f5b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1c0cd651-57f9-4276-abe0-78dfd167f5b5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_0f056d7c-183d-422c-96ce-ae77d6656edb" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_PreFundedWarrantMember_0f056d7c-183d-422c-96ce-ae77d6656edb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_338f40c2-3e86-4ba8-86ef-47572a0062e7" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_JulyCommonWarrantsMember_338f40c2-3e86-4ba8-86ef-47572a0062e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_438e42de-bb7e-49ad-b1ae-866f7eafadf6" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_438e42de-bb7e-49ad-b1ae-866f7eafadf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember_019b2bca-d6b3-739b-a5b1-c006a2648a7d" xlink:href="angn-20251231.xsd#angn_January2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_January2025CommonWarrantsMember_019b2bca-d6b3-739b-a5b1-c006a2648a7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember_019b2bcd-3cef-78dc-9560-269affc72ce6" xlink:href="angn-20251231.xsd#angn_June2025WarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_June2025WarrantsMember_019b2bcd-3cef-78dc-9560-269affc72ce6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019b3052-7d37-7193-a463-0902dfe6c9d4" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019b3052-7d37-7193-a463-0902dfe6c9d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1aef2d38-72cf-4590-ae5a-55f35b76c17a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1aef2d38-72cf-4590-ae5a-55f35b76c17a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1aef2d38-72cf-4590-ae5a-55f35b76c17a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1aef2d38-72cf-4590-ae5a-55f35b76c17a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1aef2d38-72cf-4590-ae5a-55f35b76c17a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d882fac8-0a74-4771-bcea-d5220fa316a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1aef2d38-72cf-4590-ae5a-55f35b76c17a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d882fac8-0a74-4771-bcea-d5220fa316a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_a4696400-ad92-458b-bdee-b2a09ba8df30" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d882fac8-0a74-4771-bcea-d5220fa316a6" xlink:to="loc_angn_MarchSubscriptionAgreementMember_a4696400-ad92-458b-bdee-b2a09ba8df30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_d9b3a58b-7c08-4335-9c9a-159b2cb565f3" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d882fac8-0a74-4771-bcea-d5220fa316a6" xlink:to="loc_angn_July2024PublicOfferingMember_d9b3a58b-7c08-4335-9c9a-159b2cb565f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019b2bc8-bf19-7cee-94f3-e441808c0830" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019b2bc8-bf19-7cee-94f3-e441808c0830" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2bc8-bf19-7cee-94f3-e441808c0830_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2bc8-bf19-7cee-94f3-e441808c0830" xlink:to="loc_us-gaap_EquityComponentDomain_019b2bc8-bf19-7cee-94f3-e441808c0830_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2bc8-bf19-70bb-89be-e955f7ead12c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2bc8-bf19-7cee-94f3-e441808c0830" xlink:to="loc_us-gaap_EquityComponentDomain_019b2bc8-bf19-70bb-89be-e955f7ead12c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019b2bc8-bf19-7020-8cb6-69e3681b532c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019b2bc8-bf19-70bb-89be-e955f7ead12c" xlink:to="loc_us-gaap_CommonStockMember_019b2bc8-bf19-7020-8cb6-69e3681b532c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019b2bcb-619f-76ca-965f-7de27cac2c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_DebtInstrumentAxis_019b2bcb-619f-76ca-965f-7de27cac2c4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019b2bcb-619f-76ca-965f-7de27cac2c4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019b2bcb-619f-76ca-965f-7de27cac2c4d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019b2bcb-619f-76ca-965f-7de27cac2c4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019b2bcb-619f-77e6-a0db-9457f09c82b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019b2bcb-619f-76ca-965f-7de27cac2c4d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019b2bcb-619f-77e6-a0db-9457f09c82b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019b2bcb-619f-7cb8-a6ff-965f088499ea" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019b2bcb-619f-77e6-a0db-9457f09c82b9" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019b2bcb-619f-7cb8-a6ff-965f088499ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_480e1f02-644f-4334-a769-2d42e5ca0058" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_480e1f02-644f-4334-a769-2d42e5ca0058" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantExercisedFairValue_019b3024-6678-7fdd-9405-4cea580b513e" xlink:href="angn-20251231.xsd#angn_WarrantExercisedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_angn_WarrantExercisedFairValue_019b3024-6678-7fdd-9405-4cea580b513e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_c6e3e70f-816c-44ee-9e3c-45bc6808fa53" xlink:href="angn-20251231.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_c6e3e70f-816c-44ee-9e3c-45bc6808fa53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_c1f9f12e-bb38-4ad4-a4e6-cbca2623fac7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_c1f9f12e-bb38-4ad4-a4e6-cbca2623fac7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019b2bc9-35e5-76b0-90a6-fc995dcddfef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019b2bc9-35e5-76b0-90a6-fc995dcddfef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019b2bca-5754-7ce6-87b9-fffa6d4c8ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019b2bca-5754-7ce6-87b9-fffa6d4c8ddb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019b2bca-d6b3-7602-a7e2-7caeec5d54a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019b2bca-d6b3-7602-a7e2-7caeec5d54a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2bcb-619f-7531-90fb-b423619fce65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2bcb-619f-7531-90fb-b423619fce65" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#WarrantsScheduleofOutstandingWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2a7f-6cd7-7129-bf31-8127e468794a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2a7f-6cd7-7129-bf31-8127e468794a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-7129-bf31-8127e468794a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2a7f-6cd7-7129-bf31-8127e468794a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-7129-bf31-8127e468794a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2a7f-6cd7-7129-bf31-8127e468794a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ElicioWarrantsMember_019b2a7f-6cd7-7a28-b4d8-554756678ac1" xlink:href="angn-20251231.xsd#angn_ElicioWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_ElicioWarrantsMember_019b2a7f-6cd7-7a28-b4d8-554756678ac1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionWarrantsMember_019b2a7f-6cd7-705b-ab39-182fac12f798" xlink:href="angn-20251231.xsd#angn_AngionWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_AngionWarrantsMember_019b2a7f-6cd7-705b-ab39-182fac12f798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019b2a7f-6cd7-700a-b4b3-3940b9714186" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019b2a7f-6cd7-700a-b4b3-3940b9714186" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_019b2a7f-6cd7-714d-9d03-bc12011a3871" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_PreFundedWarrantMember_019b2a7f-6cd7-714d-9d03-bc12011a3871" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_019b2a7f-6cd7-7c29-9ad5-4383700190b9" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_JulyCommonWarrantsMember_019b2a7f-6cd7-7c29-9ad5-4383700190b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantOneMember_019c0d06-aae2-7775-82cd-868b9aafcf3a" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_JulyCommonWarrantOneMember_019c0d06-aae2-7775-82cd-868b9aafcf3a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember_019b2a7f-6cd7-706d-97bc-30d0553f83dd" xlink:href="angn-20251231.xsd#angn_January2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_January2025CommonWarrantsMember_019b2a7f-6cd7-706d-97bc-30d0553f83dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025CommonWarrantsMember_019b2a7f-6cd7-7017-b1ac-d154f071e9c3" xlink:href="angn-20251231.xsd#angn_June2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_June2025CommonWarrantsMember_019b2a7f-6cd7-7017-b1ac-d154f071e9c3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b2a7f-6cd7-7d6b-9561-11d81f23b92b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:to="loc_srt_RangeAxis_019b2a7f-6cd7-7d6b-9561-11d81f23b92b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2a7f-6cd7-7d6b-9561-11d81f23b92b_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019b2a7f-6cd7-7d6b-9561-11d81f23b92b" xlink:to="loc_srt_RangeMember_019b2a7f-6cd7-7d6b-9561-11d81f23b92b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2a7f-6cd7-729c-b72f-93c1490f0a96" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019b2a7f-6cd7-7d6b-9561-11d81f23b92b" xlink:to="loc_srt_RangeMember_019b2a7f-6cd7-729c-b72f-93c1490f0a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_019b2a7f-6cd7-745b-9fe9-21ec9cd70518" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019b2a7f-6cd7-729c-b72f-93c1490f0a96" xlink:to="loc_srt_WeightedAverageMember_019b2a7f-6cd7-745b-9fe9-21ec9cd70518" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019b2a7f-6cd7-7057-b648-5f46e2c65d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019b2a7f-6cd7-7057-b648-5f46e2c65d3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2a7f-6cd7-7132-9e4e-241ac5aadabc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2a7f-6cd7-7132-9e4e-241ac5aadabc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019b2a7f-6cd7-7177-8565-16079ab39e18" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019b2a7f-6cd7-7177-8565-16079ab39e18" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:href="angn-20251231.xsd#angn_CommitmentAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:href="angn-20251231.xsd#angn_CommitmentAndContingenciesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019b2f0d-b302-7aa7-a464-9861abca13ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019b2f0d-b302-7aa7-a464-9861abca13ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f0d-b302-7aa7-a464-9861abca13ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019b2f0d-b302-7aa7-a464-9861abca13ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f0d-b302-7aa7-a464-9861abca13ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f12-740a-735a-b11b-7e7e340dfcff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019b2f0d-b302-7aa7-a464-9861abca13ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f12-740a-735a-b11b-7e7e340dfcff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019b2f0d-b302-7ada-9557-9a06c160233c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f12-740a-735a-b11b-7e7e340dfcff" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019b2f0d-b302-7ada-9557-9a06c160233c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019b2f12-740a-7b31-827f-211888dd75e9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:to="loc_srt_CounterpartyNameAxis_019b2f12-740a-7b31-827f-211888dd75e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b2f12-740a-7b31-827f-211888dd75e9_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019b2f12-740a-7b31-827f-211888dd75e9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b2f12-740a-7b31-827f-211888dd75e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b2f12-740a-7ed5-bb07-67e9a86a642c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019b2f12-740a-7b31-827f-211888dd75e9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b2f12-740a-7ed5-bb07-67e9a86a642c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_UniversityMember_019b2f12-740a-7fc6-8928-6590d8541df0" xlink:href="angn-20251231.xsd#angn_UniversityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b2f12-740a-7ed5-bb07-67e9a86a642c" xlink:to="loc_angn_UniversityMember_019b2f12-740a-7fc6-8928-6590d8541df0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b2f16-06e7-7231-b477-5f06c3decf57" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:to="loc_srt_RangeAxis_019b2f16-06e7-7231-b477-5f06c3decf57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2f16-06e7-7231-b477-5f06c3decf57_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019b2f16-06e7-7231-b477-5f06c3decf57" xlink:to="loc_srt_RangeMember_019b2f16-06e7-7231-b477-5f06c3decf57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2f16-06e7-733c-b1ee-2f56c92a9e42" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019b2f16-06e7-7231-b477-5f06c3decf57" xlink:to="loc_srt_RangeMember_019b2f16-06e7-733c-b1ee-2f56c92a9e42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019b2f16-06e7-7213-b8eb-eecc7b756902" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019b2f16-06e7-733c-b1ee-2f56c92a9e42" xlink:to="loc_srt_MinimumMember_019b2f16-06e7-7213-b8eb-eecc7b756902" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019b2f16-06e7-7fa6-92ee-0528933980d1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019b2f16-06e7-733c-b1ee-2f56c92a9e42" xlink:to="loc_srt_MaximumMember_019b2f16-06e7-7fa6-92ee-0528933980d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RoyaltyRatePercent_019b2f06-dbca-7e9f-a076-f74dda9a9fcb" xlink:href="angn-20251231.xsd#angn_RoyaltyRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_angn_RoyaltyRatePercent_019b2f06-dbca-7e9f-a076-f74dda9a9fcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019b2f09-5334-7a30-a2bf-aadcf21f6b57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019b2f09-5334-7a30-a2bf-aadcf21f6b57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_019b2f0d-b302-7a75-8c0d-c5df94958ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_us-gaap_RoyaltyExpense_019b2f0d-b302-7a75-8c0d-c5df94958ee4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019b2f14-ca1b-7f85-8475-4ddc3e26a830" xlink:href="angn-20251231.xsd#angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019b2f14-ca1b-7f85-8475-4ddc3e26a830" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_019b302f-5148-7e49-80d0-92612f059113" xlink:href="angn-20251231.xsd#angn_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_019b302f-5148-7e49-80d0-92612f059113" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f91c3c86-848a-49c4-999a-a36665a1c0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f91c3c86-848a-49c4-999a-a36665a1c0e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a4428d25-0780-4d58-b549-3700d5bd40f9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f91c3c86-848a-49c4-999a-a36665a1c0e3" xlink:to="loc_srt_StatementGeographicalAxis_a4428d25-0780-4d58-b549-3700d5bd40f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a4428d25-0780-4d58-b549-3700d5bd40f9_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a4428d25-0780-4d58-b549-3700d5bd40f9" xlink:to="loc_srt_SegmentGeographicalDomain_a4428d25-0780-4d58-b549-3700d5bd40f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4cb95143-f6d6-425a-81bb-6d37768f0118" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a4428d25-0780-4d58-b549-3700d5bd40f9" xlink:to="loc_srt_SegmentGeographicalDomain_4cb95143-f6d6-425a-81bb-6d37768f0118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember_b9850992-9ce7-4e05-865a-0b20f671fa8a" xlink:href="angn-20251231.xsd#angn_BostonMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4cb95143-f6d6-425a-81bb-6d37768f0118" xlink:to="loc_angn_BostonMassachusettsMember_b9850992-9ce7-4e05-865a-0b20f671fa8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember_ea09fe90-c60b-4c1e-a4ae-3ce90b3c013a" xlink:href="angn-20251231.xsd#angn_NewtonMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4cb95143-f6d6-425a-81bb-6d37768f0118" xlink:to="loc_angn_NewtonMassachusettsMember_ea09fe90-c60b-4c1e-a4ae-3ce90b3c013a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_49b388ca-4763-4f16-bf60-d8995dcb8271" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_OperatingLeaseExpense_49b388ca-4763-4f16-bf60-d8995dcb8271" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1777bd19-ddff-49cb-b1dd-e061ed4bd65e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1777bd19-ddff-49cb-b1dd-e061ed4bd65e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ce8c3f49-ed73-46da-9d7a-788a84492ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ce8c3f49-ed73-46da-9d7a-788a84492ef0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_7a6db478-9bf6-4fbf-9563-6e23a9af7eba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_7a6db478-9bf6-4fbf-9563-6e23a9af7eba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_45f78437-ff38-4a5d-99e0-e1fe93243506" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_45f78437-ff38-4a5d-99e0-e1fe93243506" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense_e412ae8f-f4e1-4206-9e56-f282d2509e98" xlink:href="angn-20251231.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_angn_LesseeOperatingLeaseAnnualRentExpense_e412ae8f-f4e1-4206-9e56-f282d2509e98" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_134e48eb-e1b5-4637-9ab1-86e059a7519a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_134e48eb-e1b5-4637-9ab1-86e059a7519a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_134e48eb-e1b5-4637-9ab1-86e059a7519a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_134e48eb-e1b5-4637-9ab1-86e059a7519a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_134e48eb-e1b5-4637-9ab1-86e059a7519a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a82bc9ac-32b1-4dd1-a666-4d74ac4fb2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_134e48eb-e1b5-4637-9ab1-86e059a7519a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a82bc9ac-32b1-4dd1-a666-4d74ac4fb2a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7e2111b6-d6e5-48b6-9524-0bb1d51746db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a82bc9ac-32b1-4dd1-a666-4d74ac4fb2a1" xlink:to="loc_us-gaap_ConvertibleDebtMember_7e2111b6-d6e5-48b6-9524-0bb1d51746db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_DebtInstrumentAxis_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_84eb5728-1fc9-49d2-a1a4-252fd84b8370" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_84eb5728-1fc9-49d2-a1a4-252fd84b8370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_f09d3050-a55f-422a-a2ff-a81e2aa7263c" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_84eb5728-1fc9-49d2-a1a4-252fd84b8370" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_f09d3050-a55f-422a-a2ff-a81e2aa7263c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2f30-5f80-72bb-b0df-595899c1de76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2f30-5f80-72bb-b0df-595899c1de76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-72bb-b0df-595899c1de76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2f30-5f80-72bb-b0df-595899c1de76" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-72bb-b0df-595899c1de76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-777c-94a5-6a90d00e25b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2f30-5f80-72bb-b0df-595899c1de76" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-777c-94a5-6a90d00e25b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_019b2f30-5f80-7c64-9942-0bab09b8245b" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-777c-94a5-6a90d00e25b3" xlink:to="loc_angn_PreFundedWarrantMember_019b2f30-5f80-7c64-9942-0bab09b8245b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember_019b2f3c-916e-7a91-9cb6-85f274bf8cc8" xlink:href="angn-20251231.xsd#angn_June2025WarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-777c-94a5-6a90d00e25b3" xlink:to="loc_angn_June2025WarrantsMember_019b2f3c-916e-7a91-9cb6-85f274bf8cc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019b2f30-5f80-7449-8158-ff4e86c43d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019b2f30-5f80-7449-8158-ff4e86c43d7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2f30-5f80-7449-8158-ff4e86c43d7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2f30-5f80-7449-8158-ff4e86c43d7a" xlink:to="loc_us-gaap_EquityComponentDomain_019b2f30-5f80-7449-8158-ff4e86c43d7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2f30-5f80-70f8-ab5e-c8c0d945fb86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2f30-5f80-7449-8158-ff4e86c43d7a" xlink:to="loc_us-gaap_EquityComponentDomain_019b2f30-5f80-70f8-ab5e-c8c0d945fb86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019b2f30-5f80-74b2-a145-58e5efd131d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019b2f30-5f80-70f8-ab5e-c8c0d945fb86" xlink:to="loc_us-gaap_CommonStockMember_019b2f30-5f80-74b2-a145-58e5efd131d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b2f38-8769-710d-8456-20aa57c54ad5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_srt_RangeAxis_019b2f38-8769-710d-8456-20aa57c54ad5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2f38-8769-710d-8456-20aa57c54ad5_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019b2f38-8769-710d-8456-20aa57c54ad5" xlink:to="loc_srt_RangeMember_019b2f38-8769-710d-8456-20aa57c54ad5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2f38-8769-726f-9013-c304ae93af97" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019b2f38-8769-710d-8456-20aa57c54ad5" xlink:to="loc_srt_RangeMember_019b2f38-8769-726f-9013-c304ae93af97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019b2f38-8769-78dc-9cb9-064d0e554a78" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019b2f38-8769-726f-9013-c304ae93af97" xlink:to="loc_srt_MaximumMember_019b2f38-8769-78dc-9cb9-064d0e554a78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019b2f3b-c470-7ea7-8ef2-87e2d1a79626" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_dei_LegalEntityAxis_019b2f3b-c470-7ea7-8ef2-87e2d1a79626" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019b2f3b-c470-7ea7-8ef2-87e2d1a79626_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019b2f3b-c470-7ea7-8ef2-87e2d1a79626" xlink:to="loc_dei_EntityDomain_019b2f3b-c470-7ea7-8ef2-87e2d1a79626_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019b2f3b-c470-7244-9d57-cf1caf5fe853" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019b2f3b-c470-7ea7-8ef2-87e2d1a79626" xlink:to="loc_dei_EntityDomain_019b2f3b-c470-7244-9d57-cf1caf5fe853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GKCCMember_019b2f3b-c470-71b9-b619-0d67edd06d23" xlink:href="angn-20251231.xsd#angn_GKCCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019b2f3b-c470-7244-9d57-cf1caf5fe853" xlink:to="loc_angn_GKCCMember_019b2f3b-c470-71b9-b619-0d67edd06d23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019cd80e-9929-7736-beeb-ee8239a7a03d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019cd80e-9929-7736-beeb-ee8239a7a03d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7736-beeb-ee8239a7a03d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019cd80e-9929-7736-beeb-ee8239a7a03d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7736-beeb-ee8239a7a03d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019cd80e-9929-7736-beeb-ee8239a7a03d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019cd80e-cda1-731e-a1c7-710eab8ac93b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019cd80e-cda1-731e-a1c7-710eab8ac93b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019cd80e-f0da-795d-8470-8de3f5a29cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019cd80e-f0da-795d-8470-8de3f5a29cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019cd80f-12f9-746d-bf19-c17672abf655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019cd80f-12f9-746d-bf19-c17672abf655" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ecce5d16-108f-47b9-a73f-f5bbc0e7f443" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ecce5d16-108f-47b9-a73f-f5bbc0e7f443" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_675caffa-d66a-4b28-ae78-4d8be9663a48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_675caffa-d66a-4b28-ae78-4d8be9663a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_936300bd-0c6b-450e-b646-8a5e520e53fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_936300bd-0c6b-450e-b646-8a5e520e53fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a3941b8-5956-4adc-abb7-ed5337d41190" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a3941b8-5956-4adc-abb7-ed5337d41190" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_cf417baa-eaf6-4499-8d9f-25b208640bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_InterestExpenseDebt_cf417baa-eaf6-4499-8d9f-25b208640bc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2f30-5f80-76a7-b182-a8f7c8dbf885" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2f30-5f80-76a7-b182-a8f7c8dbf885" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019b2f31-f14c-7734-be17-cd2dbdf0f0ba" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019b2f31-f14c-7734-be17-cd2dbdf0f0ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b2f36-5c09-747a-92a5-e739a10045c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b2f36-5c09-747a-92a5-e739a10045c2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019cd80d-3809-7417-aee4-ee38ec301362" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019cd80d-3809-7417-aee4-ee38ec301362" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2f3a-3d11-70e3-91b1-31e5050f3c22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2f3a-3d11-70e3-91b1-31e5050f3c22" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019b2f3a-eacc-7750-bcdd-3c47857dd915" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019b2f3a-eacc-7750-bcdd-3c47857dd915" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_019b2f3b-c470-7e46-b093-d2510a22cecf" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_019b2f3b-c470-7e46-b093-d2510a22cecf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019b2f3c-916e-78a6-9434-b719a80b65c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019b2f3c-916e-78a6-9434-b719a80b65c9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b2f3d-3f4e-7318-a886-9bbf61d1fd51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b2f3d-3f4e-7318-a886-9bbf61d1fd51" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019b2f3d-f995-7883-8648-f7782bfd51c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019b2f3d-f995-7883-8648-f7782bfd51c4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019b2f3e-a6e7-7ce7-93b3-de7ba504d98a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019b2f3e-a6e7-7ce7-93b3-de7ba504d98a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019cd81d-1874-7738-af8e-8f85938f2566" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019cd81d-1874-7738-af8e-8f85938f2566" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_a996fe30-8b5f-4c03-8352-bd031b41642e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_a996fe30-8b5f-4c03-8352-bd031b41642e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a996fe30-8b5f-4c03-8352-bd031b41642e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a996fe30-8b5f-4c03-8352-bd031b41642e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a996fe30-8b5f-4c03-8352-bd031b41642e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9a4b729d-b302-4153-9ec1-7ed78f7663d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a996fe30-8b5f-4c03-8352-bd031b41642e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9a4b729d-b302-4153-9ec1-7ed78f7663d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_27998280-d98b-4c4e-b380-648ff0f5a2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9a4b729d-b302-4153-9ec1-7ed78f7663d3" xlink:to="loc_us-gaap_DomesticCountryMember_27998280-d98b-4c4e-b380-648ff0f5a2a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f7808843-65d5-457e-bf6a-562d4a610ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9a4b729d-b302-4153-9ec1-7ed78f7663d3" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f7808843-65d5-457e-bf6a-562d4a610ca3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_77e7264a-f22b-46fb-a576-8c2535af599b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_us-gaap_TaxPeriodAxis_77e7264a-f22b-46fb-a576-8c2535af599b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_77e7264a-f22b-46fb-a576-8c2535af599b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_77e7264a-f22b-46fb-a576-8c2535af599b" xlink:to="loc_us-gaap_TaxPeriodDomain_77e7264a-f22b-46fb-a576-8c2535af599b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_ac734331-4cd0-44cd-9158-76099e416abd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_77e7264a-f22b-46fb-a576-8c2535af599b" xlink:to="loc_us-gaap_TaxPeriodDomain_ac734331-4cd0-44cd-9158-76099e416abd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2017Member_9414d2ad-432e-42e0-ac2b-28b59f18b389" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxYear2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_ac734331-4cd0-44cd-9158-76099e416abd" xlink:to="loc_us-gaap_TaxYear2017Member_9414d2ad-432e-42e0-ac2b-28b59f18b389" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_d2abbc43-1293-4023-919e-dc55e711283a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_d2abbc43-1293-4023-919e-dc55e711283a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_d2abbc43-1293-4023-919e-dc55e711283a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_d2abbc43-1293-4023-919e-dc55e711283a" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_d2abbc43-1293-4023-919e-dc55e711283a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_d0fc6f14-447f-42fb-8d1d-48dcb6da6e30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_d2abbc43-1293-4023-919e-dc55e711283a" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_d0fc6f14-447f-42fb-8d1d-48dcb6da6e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_fd7ed7d3-c6de-4d25-a746-cb42ffac3299" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_d0fc6f14-447f-42fb-8d1d-48dcb6da6e30" xlink:to="loc_us-gaap_ResearchMember_fd7ed7d3-c6de-4d25-a746-cb42ffac3299" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019cd86c-0fb0-76b0-b6c2-d26a343799d3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_srt_StatementGeographicalAxis_019cd86c-0fb0-76b0-b6c2-d26a343799d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019cd86c-0fb0-76b0-b6c2-d26a343799d3_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_019cd86c-0fb0-76b0-b6c2-d26a343799d3" xlink:to="loc_srt_SegmentGeographicalDomain_019cd86c-0fb0-76b0-b6c2-d26a343799d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019cd86c-0fb0-7925-b548-9601b0dd4d97" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_019cd86c-0fb0-76b0-b6c2-d26a343799d3" xlink:to="loc_srt_SegmentGeographicalDomain_019cd86c-0fb0-7925-b548-9601b0dd4d97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_019cd86c-2c57-7466-a6a4-de381267531c" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_019cd86c-0fb0-7925-b548-9601b0dd4d97" xlink:to="loc_country_AU_019cd86c-2c57-7466-a6a4-de381267531c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_98ff6804-b33a-4349-a6aa-d9e12c5923c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_98ff6804-b33a-4349-a6aa-d9e12c5923c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ddbb581a-a6c0-4ba8-bcdd-bdcf1465a940" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ddbb581a-a6c0-4ba8-bcdd-bdcf1465a940" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_32ddc802-9991-4c91-b4bf-ceb5732dc123" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_32ddc802-9991-4c91-b4bf-ceb5732dc123" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e03e9e44-b67b-4f7e-ae52-5b2ac7ec8cab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e03e9e44-b67b-4f7e-ae52-5b2ac7ec8cab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8a25585e-64e7-4899-bc7b-7bd649732599" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8a25585e-64e7-4899-bc7b-7bd649732599" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acbe1d3c-e00e-4db2-bca1-074f1bde5816" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acbe1d3c-e00e-4db2-bca1-074f1bde5816" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#EmployeeBenefitPlanDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_0c89c5be-7cbb-45e3-988d-a1a33b8996bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable_a52948ba-e398-47d1-838f-2d65a31e2503" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_0c89c5be-7cbb-45e3-988d-a1a33b8996bc" xlink:to="loc_us-gaap_DefinedContributionPlanTable_a52948ba-e398-47d1-838f-2d65a31e2503" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_35dedf01-2c13-4a93-ae4c-22d206a041de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedContributionPlanTable_a52948ba-e398-47d1-838f-2d65a31e2503" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_35dedf01-2c13-4a93-ae4c-22d206a041de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_35dedf01-2c13-4a93-ae4c-22d206a041de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_35dedf01-2c13-4a93-ae4c-22d206a041de" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_35dedf01-2c13-4a93-ae4c-22d206a041de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_03bc2ffa-b0e9-4288-b543-b11eb22245f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_35dedf01-2c13-4a93-ae4c-22d206a041de" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_03bc2ffa-b0e9-4288-b543-b11eb22245f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeBenefitPlanMember_896a3faa-975e-443b-8878-a0c345bf1f5a" xlink:href="angn-20251231.xsd#angn_EmployeeBenefitPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_03bc2ffa-b0e9-4288-b543-b11eb22245f5" xlink:to="loc_angn_EmployeeBenefitPlanMember_896a3faa-975e-443b-8878-a0c345bf1f5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_1c499e79-3df1-413a-a7ef-aa7fcbab4e61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_0c89c5be-7cbb-45e3-988d-a1a33b8996bc" xlink:to="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_1c499e79-3df1-413a-a7ef-aa7fcbab4e61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_41e637d3-5f98-41c7-ae92-e276a1e18c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_17707a84-63c2-482f-b6bb-f3325a052650" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_41e637d3-5f98-41c7-ae92-e276a1e18c6d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_17707a84-63c2-482f-b6bb-f3325a052650" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a57c1559-9d86-403f-a2b1-f48fb89d426b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_17707a84-63c2-482f-b6bb-f3325a052650" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a57c1559-9d86-403f-a2b1-f48fb89d426b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a57c1559-9d86-403f-a2b1-f48fb89d426b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a57c1559-9d86-403f-a2b1-f48fb89d426b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a57c1559-9d86-403f-a2b1-f48fb89d426b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8a7458f-e091-45e1-9810-c3c0cc8d53f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a57c1559-9d86-403f-a2b1-f48fb89d426b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8a7458f-e091-45e1-9810-c3c0cc8d53f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4b77b764-37e0-40bd-8052-6238e5e77b95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8a7458f-e091-45e1-9810-c3c0cc8d53f2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4b77b764-37e0-40bd-8052-6238e5e77b95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_000b31c3-d04c-4d2b-936f-13d14a7cf75d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8a7458f-e091-45e1-9810-c3c0cc8d53f2" xlink:to="loc_us-gaap_WarrantMember_000b31c3-d04c-4d2b-936f-13d14a7cf75d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_df35f2f6-cad6-44f1-aa11-9ba546ab6eac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_41e637d3-5f98-41c7-ae92-e276a1e18c6d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_df35f2f6-cad6-44f1-aa11-9ba546ab6eac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1dc75d7e-9557-46c3-945f-df9a2242497f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1dc75d7e-9557-46c3-945f-df9a2242497f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1dc75d7e-9557-46c3-945f-df9a2242497f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1dc75d7e-9557-46c3-945f-df9a2242497f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_1dc75d7e-9557-46c3-945f-df9a2242497f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_f61fe431-ee33-4ccb-896a-1b5213c6aa10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1dc75d7e-9557-46c3-945f-df9a2242497f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_f61fe431-ee33-4ccb-896a-1b5213c6aa10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember_9cb22112-d8df-462f-bdcd-58b5b4d0a890" xlink:href="angn-20251231.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f61fe431-ee33-4ccb-896a-1b5213c6aa10" xlink:to="loc_angn_PurchaseOfWarrantsMember_9cb22112-d8df-462f-bdcd-58b5b4d0a890" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_cf81fb09-5b14-4632-8804-907b071d0e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_cf81fb09-5b14-4632-8804-907b071d0e0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf81fb09-5b14-4632-8804-907b071d0e0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_cf81fb09-5b14-4632-8804-907b071d0e0e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cf81fb09-5b14-4632-8804-907b071d0e0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cd4ea65d-4839-4012-bb39-ec7b7a59f273" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_cf81fb09-5b14-4632-8804-907b071d0e0e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cd4ea65d-4839-4012-bb39-ec7b7a59f273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_f6691b0e-64b3-4941-b619-6890952e79ee" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cd4ea65d-4839-4012-bb39-ec7b7a59f273" xlink:to="loc_angn_MarchSubscriptionAgreementMember_f6691b0e-64b3-4941-b619-6890952e79ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_9e1c7a7a-160f-4a27-8e0b-8783b5d42a3e" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cd4ea65d-4839-4012-bb39-ec7b7a59f273" xlink:to="loc_angn_July2024PublicOfferingMember_9e1c7a7a-160f-4a27-8e0b-8783b5d42a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_fa9d79ad-6991-4f23-8969-b87e028abc29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_fa9d79ad-6991-4f23-8969-b87e028abc29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fa9d79ad-6991-4f23-8969-b87e028abc29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_fa9d79ad-6991-4f23-8969-b87e028abc29" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fa9d79ad-6991-4f23-8969-b87e028abc29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_151f8827-7b7a-495e-9172-3ebad455eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_fa9d79ad-6991-4f23-8969-b87e028abc29" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_151f8827-7b7a-495e-9172-3ebad455eedc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_ffb95e6f-fc32-4a31-bf6d-3e383b3a0fb4" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_151f8827-7b7a-495e-9172-3ebad455eedc" xlink:to="loc_angn_PreFundedWarrantMember_ffb95e6f-fc32-4a31-bf6d-3e383b3a0fb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_b1265634-d720-4943-8b20-c3f827868a43" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_151f8827-7b7a-495e-9172-3ebad455eedc" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_b1265634-d720-4943-8b20-c3f827868a43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b5fd79f7-d401-4070-b68a-8a1650db5d6a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_srt_CounterpartyNameAxis_b5fd79f7-d401-4070-b68a-8a1650db5d6a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b5fd79f7-d401-4070-b68a-8a1650db5d6a_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b5fd79f7-d401-4070-b68a-8a1650db5d6a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b5fd79f7-d401-4070-b68a-8a1650db5d6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b5fd79f7-d401-4070-b68a-8a1650db5d6a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember_6ff4e0af-02c8-416f-b2c7-f477f6588a7c" xlink:href="angn-20251231.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:to="loc_angn_YekaterinaChudnovskyMember_6ff4e0af-02c8-416f-b2c7-f477f6588a7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_73c0bbe1-1105-4d38-bd51-4cc5b0d7181a" xlink:href="angn-20251231.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:to="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_73c0bbe1-1105-4d38-bd51-4cc5b0d7181a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember_019b2fa7-b65f-7ec7-8415-019619ec024e" xlink:href="angn-20251231.xsd#angn_YekaterinaChudnovskyAndJayVenkatesanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:to="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember_019b2fa7-b65f-7ec7-8415-019619ec024e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_65341858-d798-44a5-bc8b-c9c4814c8db8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_DebtInstrumentAxis_65341858-d798-44a5-bc8b-c9c4814c8db8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_65341858-d798-44a5-bc8b-c9c4814c8db8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_65341858-d798-44a5-bc8b-c9c4814c8db8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_65341858-d798-44a5-bc8b-c9c4814c8db8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6b43d207-a895-4161-9794-66427e95e124" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_65341858-d798-44a5-bc8b-c9c4814c8db8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6b43d207-a895-4161-9794-66427e95e124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_6601587a-f5d3-43ff-840d-1e8c592ce356" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6b43d207-a895-4161-9794-66427e95e124" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_6601587a-f5d3-43ff-840d-1e8c592ce356" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8c038510-a598-44ed-8c9a-590a305cf0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8c038510-a598-44ed-8c9a-590a305cf0fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8c038510-a598-44ed-8c9a-590a305cf0fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8c038510-a598-44ed-8c9a-590a305cf0fe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8c038510-a598-44ed-8c9a-590a305cf0fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c65be90a-c20e-4c0c-9b86-f7d8e87c2865" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8c038510-a598-44ed-8c9a-590a305cf0fe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c65be90a-c20e-4c0c-9b86-f7d8e87c2865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ec4edaad-48c9-43ab-b9c7-787b31b7bb09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c65be90a-c20e-4c0c-9b86-f7d8e87c2865" xlink:to="loc_us-gaap_ConvertibleDebtMember_ec4edaad-48c9-43ab-b9c7-787b31b7bb09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019b2faa-7254-7d44-b454-8a2b0b645caa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019b2faa-7254-7d44-b454-8a2b0b645caa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2faa-7254-7d44-b454-8a2b0b645caa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2faa-7254-7d44-b454-8a2b0b645caa" xlink:to="loc_us-gaap_EquityComponentDomain_019b2faa-7254-7d44-b454-8a2b0b645caa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2faa-7254-7934-9620-9be643efe874" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2faa-7254-7d44-b454-8a2b0b645caa" xlink:to="loc_us-gaap_EquityComponentDomain_019b2faa-7254-7934-9620-9be643efe874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019b2faa-7254-775e-8b27-2f1ecd7aa73e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019b2faa-7254-7934-9620-9be643efe874" xlink:to="loc_us-gaap_CommonStockMember_019b2faa-7254-775e-8b27-2f1ecd7aa73e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8b9e90aa-1ce5-491f-bee3-966cecf4c215" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8b9e90aa-1ce5-491f-bee3-966cecf4c215" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_9a4bd66f-68d2-4cac-97dd-bdcd1ade80ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_9a4bd66f-68d2-4cac-97dd-bdcd1ade80ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_4c8850bc-3c50-4857-9f1f-f5ac5cabc971" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_4c8850bc-3c50-4857-9f1f-f5ac5cabc971" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f1add452-2e43-4985-8736-a81283da32e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f1add452-2e43-4985-8736-a81283da32e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_895a92e0-9996-4bbe-8dbc-994a35a04892" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_895a92e0-9996-4bbe-8dbc-994a35a04892" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2faa-7254-7ac9-8c94-6a560de1c1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2faa-7254-7ac9-8c94-6a560de1c1d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019b2fac-3e2e-7d36-86e0-86b48e14cbce" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019b2fac-3e2e-7d36-86e0-86b48e14cbce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b2fad-1e8b-7cdf-a871-653153a0ef86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b2fad-1e8b-7cdf-a871-653153a0ef86" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:to="loc_srt_ProductOrServiceAxis_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0" xlink:to="loc_srt_ProductsAndServicesDomain_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0" xlink:to="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember_3bb91440-8c8f-4c1c-9646-372fd5d87450" xlink:href="angn-20251231.xsd#angn_ClinicalTrailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:to="loc_angn_ClinicalTrailMember_3bb91440-8c8f-4c1c-9646-372fd5d87450" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_21f3e1b9-091c-4694-bc10-47e4ec42a2ec" xlink:href="angn-20251231.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:to="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_21f3e1b9-091c-4694-bc10-47e4ec42a2ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember_68e5fa73-fa65-45d1-816d-3bda069c0b52" xlink:href="angn-20251231.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:to="loc_angn_TranslationalMedicineAndCMCMember_68e5fa73-fa65-45d1-816d-3bda069c0b52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember_a9f9417a-2329-46a3-9fe3-59b31fa55882" xlink:href="angn-20251231.xsd#angn_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:to="loc_angn_OtherMember_a9f9417a-2329-46a3-9fe3-59b31fa55882" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_951f50bc-6fe6-4eea-bcfc-c70137381a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_951f50bc-6fe6-4eea-bcfc-c70137381a1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_951f50bc-6fe6-4eea-bcfc-c70137381a1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_951f50bc-6fe6-4eea-bcfc-c70137381a1b" xlink:to="loc_us-gaap_SegmentDomain_951f50bc-6fe6-4eea-bcfc-c70137381a1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b0a90918-f76e-404c-9c3a-51b3937d15af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_951f50bc-6fe6-4eea-bcfc-c70137381a1b" xlink:to="loc_us-gaap_SegmentDomain_b0a90918-f76e-404c-9c3a-51b3937d15af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember_682969ff-46d1-467b-87fa-47edd7575a85" xlink:href="angn-20251231.xsd#angn_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b0a90918-f76e-404c-9c3a-51b3937d15af" xlink:to="loc_angn_ReportableSegmentMember_682969ff-46d1-467b-87fa-47edd7575a85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b2a2a249-2473-4f18-bf18-613c9dbddc41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b2a2a249-2473-4f18-bf18-613c9dbddc41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_edd0662d-12e8-4427-8e9a-e6e9bee8d344" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_edd0662d-12e8-4427-8e9a-e6e9bee8d344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3ce38ba1-83cd-4f8b-bef7-137a0e1c81a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3ce38ba1-83cd-4f8b-bef7-137a0e1c81a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_312af5da-7dbe-4769-af5b-83a6f66fd94e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_312af5da-7dbe-4769-af5b-83a6f66fd94e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_dc8c36a2-9a7b-47fa-a362-69194ae2234b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_dc8c36a2-9a7b-47fa-a362-69194ae2234b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4dd921f8-e968-4849-9063-0c9644b83261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_NetIncomeLoss_4dd921f8-e968-4849-9063-0c9644b83261" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_40ecc0c8-ddfa-4eb5-954e-f6e31c3b220a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_Assets_40ecc0c8-ddfa-4eb5-954e-f6e31c3b220a" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_bd16dc04-2c69-456c-8d99-dfaa2a855464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_bd16dc04-2c69-456c-8d99-dfaa2a855464" xlink:to="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5fd120e0-63c2-4724-ab03-ff3b474e9977" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5fd120e0-63c2-4724-ab03-ff3b474e9977" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5fd120e0-63c2-4724-ab03-ff3b474e9977_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5fd120e0-63c2-4724-ab03-ff3b474e9977" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5fd120e0-63c2-4724-ab03-ff3b474e9977_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f37fdd48-7f26-4371-a5d3-f83d21bf88cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5fd120e0-63c2-4724-ab03-ff3b474e9977" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f37fdd48-7f26-4371-a5d3-f83d21bf88cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a0f71230-5019-4583-9f0b-c2e1533874c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f37fdd48-7f26-4371-a5d3-f83d21bf88cf" xlink:to="loc_us-gaap_SubsequentEventMember_a0f71230-5019-4583-9f0b-c2e1533874c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9e6b-6783-7f41-9ad3-ec85d3665753" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9e6b-6783-7f41-9ad3-ec85d3665753" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9e6b-6783-7f41-9ad3-ec85d3665753_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9e6b-6783-7f41-9ad3-ec85d3665753" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9e6b-6783-7f41-9ad3-ec85d3665753_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9e6b-6783-7007-9c9f-cf1f57b5045e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9e6b-6783-7f41-9ad3-ec85d3665753" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9e6b-6783-7007-9c9f-cf1f57b5045e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024ATMProgramMember_019c9e6b-b016-7083-9cd2-f834b7b3cc75" xlink:href="angn-20251231.xsd#angn_A2024ATMProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9e6b-6783-7007-9c9f-cf1f57b5045e" xlink:to="loc_angn_A2024ATMProgramMember_019c9e6b-b016-7083-9cd2-f834b7b3cc75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cd82b-527d-7ce2-9863-1a78f3168371" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cd82b-527d-7ce2-9863-1a78f3168371" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd82b-527d-7ce2-9863-1a78f3168371_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd82b-527d-7ce2-9863-1a78f3168371" xlink:to="loc_us-gaap_EquityComponentDomain_019cd82b-527d-7ce2-9863-1a78f3168371_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd82b-527d-71a7-9178-8738b94768dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd82b-527d-7ce2-9863-1a78f3168371" xlink:to="loc_us-gaap_EquityComponentDomain_019cd82b-527d-71a7-9178-8738b94768dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019cd82b-7180-70b5-809f-9d57977568cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019cd82b-527d-71a7-9178-8738b94768dc" xlink:to="loc_us-gaap_CommonStockMember_019cd82b-7180-70b5-809f-9d57977568cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019c9e4f-2f67-70b3-8529-2f0731862586" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_bd16dc04-2c69-456c-8d99-dfaa2a855464" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019c9e4f-2f67-70b3-8529-2f0731862586" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1ef858c-561f-438b-aa9b-679c653dedad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_bd16dc04-2c69-456c-8d99-dfaa2a855464" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1ef858c-561f-438b-aa9b-679c653dedad" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>angn-20251231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:b764f3f1-1aa2-42b0-ba71-263b5668ebc9,g:54ff377e-34d5-4517-b79e-9773ed1b9e6a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0b5b5154-8e9e-4a94-a7b6-5b0c16f2d505_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_bd709477-68b8-4220-93be-6aaf2ff58930_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant award</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementGrant" xlink:to="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c0e27f4f-5f4f-4024-affb-29ebd93f7d12_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_e4c69b29-2695-4e74-b66d-6975f00f9514_terseLabel_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other prepaid expenses and other current assets</link:label>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_label_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Prepaid Expenses And Other Assets, Current</link:label>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_documentation_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Prepaid Expenses And Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:href="angn-20251231.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:to="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_8c1ad82c-809b-4b31-9157-c0a310c611a5_terseLabel_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_label_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPreFundedWarrantsMember" xlink:to="lab_angn_JulyPreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_e5dd2999-dd43-48a1-8208-d784b1e8d089_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_2141769c-03e1-4776-9f02-e509a7250717_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_June2025WarrantsMember_019b2bcd-3cef-78ab-aefa-2ce64140f511_terseLabel_en-US" xlink:label="lab_angn_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">June 2025 Warrants</link:label>
    <link:label id="lab_angn_June2025WarrantsMember_label_en-US" xlink:label="lab_angn_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">June 2025 Warrants [Member]</link:label>
    <link:label id="lab_angn_June2025WarrantsMember_documentation_en-US" xlink:label="lab_angn_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">June 2025 Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember" xlink:href="angn-20251231.xsd#angn_June2025WarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_June2025WarrantsMember" xlink:to="lab_angn_June2025WarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e4ec2063-cdf0-4248-bd1e-e641a9717d67_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4ccedd59-6b7f-4dee-a828-5dcc4bdead2a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_f2657f0a-a716-4a28-bd71-9564321431e7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_cda3c7ce-2ecb-47d7-897e-ab04e6b5d2e4_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_cf621a1d-3efd-4675-b637-dc9e9a924f10_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightRollForward" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_8d15a15b-0c96-4e27-b362-142252092b51_periodStartLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_2aac28ac-a504-4c70-b531-bd66696d5792_periodEndLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Weighted Average Life</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Weighted Average Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b879b718-5b89-4bdc-a288-b87cf3233341_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Adopted Accounting Standards During the Period and Recently Issued Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_8c71772c-e049-43c5-90d9-297967095652_terseLabel_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of research grant agreements</link:label>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_label_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Research Grant Agreements</link:label>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_documentation_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Research Grant Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements" xlink:href="angn-20251231.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_NumberOfResearchGrantAgreements" xlink:to="lab_angn_NumberOfResearchGrantAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6f554284-1d67-45fb-a845-c1c3b2d9f870_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019cd837-4ca7-77dd-8531-26eedc43a244_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_019b2a7f-6cd7-75c8-8bc6-6bcfcf5446f4_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_d58ba5c2-b790-4bb3-aee0-ae70272a7d74_periodStartLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_2f647178-5c42-4593-b42b-c7968a97bd89_periodEndLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_0e0e551e-a419-4812-a84b-ac5b49aaa9a1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per common share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3c13ae6b-9bfc-47c3-ba9f-42e90b9bf106_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_69d1b3a5-4ee9-4a49-9211-d08de2825f67_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_98f91a88-4e1c-43a7-97c9-b4fd0a68df64_terseLabel_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants</link:label>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_label_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants [Member]</link:label>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_documentation_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember" xlink:href="angn-20251231.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PurchaseOfWarrantsMember" xlink:to="lab_angn_PurchaseOfWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ce147286-8476-4b3c-a667-45a2b2265ecc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_8087b409-4a67-4062-ba51-ede275cb3e94_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7396-b278-fad465c2a72f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_61bd49b1-5cf7-4494-91ee-0569894f1cba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9dbb171e-32b4-43ea-9526-8e2f8e8f36c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d642a111-efdb-4c74-94a9-9b5eda50d452_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon settlement of restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_019cd80e-9929-7331-991b-b05e5070a644_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_1e15f1b0-70dd-4db1-b765-e73b5762f993_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of office space (in sqft)</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_7cef7c96-010d-46cd-beef-99489521a0fd_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-77d8-b7a4-877b6b663286_terseLabel_en-US" xlink:label="lab_angn_CommitmentAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitment and Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_angn_CommitmentAndContingenciesDisclosureLineItems_label_en-US" xlink:label="lab_angn_CommitmentAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitment and Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_angn_CommitmentAndContingenciesDisclosureLineItems_documentation_en-US" xlink:label="lab_angn_CommitmentAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitment and Contingencies Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentAndContingenciesDisclosureLineItems" xlink:href="angn-20251231.xsd#angn_CommitmentAndContingenciesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems" xlink:to="lab_angn_CommitmentAndContingenciesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_5ae93b2a-380c-45e8-aba3-2ce06851d6c3_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_02952a41-a6b8-4e83-8157-8f7ca2050ddf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9ee0240b-db20-4cc3-88e6-874b9526e724_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_2abd21a8-af8d-4e8f-a684-973521da4603_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_d6ca4f17-ddd6-4117-accb-8ed160db4247_terseLabel_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional fees and other general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_67700350-15d7-4187-959e-cc022da242b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_3ec3a075-cd70-4f54-aa0f-a42f1fe4f2c3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development and Grant Income</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74be-b346-62720ab928f8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_28debca4-0ac0-4083-8698-5135e2945de7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3a964bd8-1d67-432d-b374-cd6b20f34ded_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2aa1015f-b856-45b4-aa16-a7d4e4656e82_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_1a093f48-b3df-435d-be62-5a465e55b6a6_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_015721ba-4be6-4452-b533-7fdc7da7d2bd_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AdvancedProfessionalFees_5bcef5c3-ec13-4aa5-8442-99e7737770c0_terseLabel_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advanced professional fees</link:label>
    <link:label id="lab_angn_AdvancedProfessionalFees_label_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Professional Fees</link:label>
    <link:label id="lab_angn_AdvancedProfessionalFees_documentation_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Advanced Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees" xlink:href="angn-20251231.xsd#angn_AdvancedProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AdvancedProfessionalFees" xlink:to="lab_angn_AdvancedProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ec0d9dc4-e06a-48e7-b3c2-67f43c6a8745_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_2b45865a-0201-4353-8600-9a518d523806_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_41b7491b-3f21-44e8-89d1-6cf9bb40ea1f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_6d8347b0-9772-481d-bf7b-6fa8dee0b411_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_01246c67-3e63-4025-a16d-a80a302fbd15_terseLabel_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Share And July Common Warrant</link:label>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_label_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Shares And July Common Warrant [Member]</link:label>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_documentation_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Shares And July Common Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember" xlink:href="angn-20251231.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulySharesAndJulyCommonWarrantMember" xlink:to="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_f208b115-dd5b-4261-89ea-c209f3d9672d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_fb9504c2-0f91-4c33-aa09-5226a8b78a04_terseLabel_en-US" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from the exercise of July 2024 Common Warrants</link:label>
    <link:label id="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_label_en-US" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5c9eded5-141b-443c-9043-9ac7b50f2f5c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_afb14f1f-deec-430e-bb32-6fe612837200_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_32f4e533-05f2-4821-9fba-26267eb33ca1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (unvested) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_47d5fef6-434f-43f2-8231-fdf8f80ae1b4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities, convertible preferred stock, and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_70b8ced3-8eae-4da8-bebb-499e715a43ae_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation and Transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_04bda92d-ba11-4b09-96ea-6207ccaef646_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de8026a2-bdc7-47e4-9cb1-f3c0b49e80d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_8fb2bbfb-97bc-46f5-9382-ef97260e34c7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentrations of Credit Risk and Off-Balance Sheet Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02963edc-e2c3-456f-9c3d-34a1d502fb4d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, convertible preferred stock, and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_a323c833-bfc9-4300-93fe-a0931627e830_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e6ad5c4f-6642-4157-a93c-e495f2a480e6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_1e399b9d-d956-4799-86aa-ea978358443d_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_843717ca-2176-4af2-ac59-14e6928aa6f8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_e6addc0d-86db-43c2-b7ba-89fcd8f95451_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_e9f49d17-676b-49b9-9668-93d67512a508_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cf6ff501-fab5-4cd8-b94d-ceb7def0e943_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_55be6740-336d-4aa0-92bf-fee2ffb1f8fe_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_34819b76-699a-4c01-ad3c-bda066fd16ba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d47142d7-4ba7-4913-91a8-8c955665e81c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_e74df918-127e-41b2-9d37-513bd1e73ec8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_DeferredTaxAssetsOperatingLeaseLiability_72a5a986-b9f9-4e9f-963e-cc9d73dc5a1b_terseLabel_en-US" xlink:label="lab_angn_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_angn_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_angn_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_angn_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_angn_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="angn-20251231.xsd#angn_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_angn_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_c81caa37-adb2-42f2-b6e2-746ae694357e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_5ddc0372-71a7-4595-bacf-f2e978af9b5c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingAbstract_label_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding [Abstract]</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingAbstract_documentation_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract" xlink:href="angn-20251231.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract" xlink:to="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_125702f3-6def-48fa-9a16-bf7a11a134d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019cd80e-cda1-7966-8c45-b19bc00817d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First year</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-747b-9af0-395b08620a35_terseLabel_en-US" xlink:label="lab_angn_CommitmentAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitment and Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_angn_CommitmentAndContingenciesDisclosureTable_label_en-US" xlink:label="lab_angn_CommitmentAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitment and Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_angn_CommitmentAndContingenciesDisclosureTable_documentation_en-US" xlink:label="lab_angn_CommitmentAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitment and Contingencies Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentAndContingenciesDisclosureTable" xlink:href="angn-20251231.xsd#angn_CommitmentAndContingenciesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureTable" xlink:to="lab_angn_CommitmentAndContingenciesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019cb8ea-0983-715f-aaa7-07d4d0abae3f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a62f753a-a4f7-4b3d-98a5-3f5c16eae93b_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f1fa90f8-7de7-4bef-a89e-57564c5a7585_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_90749576-dd1f-4ae1-9546-7f0daff8489f_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Sept. 2022</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2022 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_7cf3c07d-ce7e-4175-919b-61da505531f6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-739c-aff7-a82b62b1bd03_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_30cb0e33-ceaf-4205-9888-3380821e88ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_213d2c22-7936-4232-b9e0-13a33e21147f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_73f34bc9-f732-44a5-9bde-d800f3b70e1c_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant award received</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant Received</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:to="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_38fc2da3-7b6d-48f2-bb51-06afdcc6830c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_49fadd88-2784-44b5-927e-71ddef8ef08b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_019c9e48-8c7c-7183-9b7d-ebebb8ecbb87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019c9e4a-b41e-794d-92ae-b6a1e50f6623_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c3f82ff8-7136-4a3e-9e20-41ebb1cf0b13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering_006699e0-079e-4345-ae0a-860600322b56_terseLabel_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock from July 2024 Public Offering</link:label>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering_label_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance of Common Stock From July Public Offering</link:label>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering_documentation_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance of Common Stock From July Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" xlink:href="angn-20251231.xsd#angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" xlink:to="lab_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_bc3e6608-890a-406b-95b7-f03f5e061de1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_03d86a38-46bd-44f7-8d9a-64360a83ac58_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: operating lease liability, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d1e00c6b-1d10-4dc5-8374-26ea56d8c5ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_38302a2e-2e03-40c3-aa1b-dafafae17362_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_db976f0a-9a91-4a8b-a175-8118b4cd5c16_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyCommonWarrantsMember_370d20cf-81a2-4f75-9a28-160c3cdaedb9_terseLabel_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Common Warrants</link:label>
    <link:label id="lab_angn_JulyCommonWarrantsMember_019b2a7f-6cd7-7695-aacb-361f9ef3f73c_verboseLabel_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Common Warrants</link:label>
    <link:label id="lab_angn_JulyCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyCommonWarrantsMember" xlink:to="lab_angn_JulyCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_d4f2d630-de4d-46fe-850a-71d0d998e860_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_fbac27d3-ba22-415a-aada-adf50b4bbd88_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f5f2707d-1e4e-4565-acff-f6b8c8ffe2aa_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit_301a31c3-6b44-46e8-ba1d-e4bc09b82756_terseLabel_en-US" xlink:label="lab_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Share Limit</link:label>
    <link:label id="lab_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit_label_en-US" xlink:label="lab_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Share Limit</link:label>
    <link:label id="lab_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit_documentation_en-US" xlink:label="lab_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Share Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" xlink:href="angn-20251231.xsd#angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" xlink:to="lab_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_ee5c1fc2-b777-4b5b-a7a9-bcda539de8bd_terseLabel_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_label_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Other Operating Liabilities, Current</link:label>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_documentation_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Other Operating Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:href="angn-20251231.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:to="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_019cd82a-0d56-77ca-932a-34fae0360024_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total principal amount</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_6f2150f9-5ebd-45cb-997e-de7769aab3ff_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5ded0ada-2b1f-4529-9f28-ccbf9a87bd7e_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_bfa75234-d289-4ea6-a8e2-d104e65a22db_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3de33844-6641-4ea6-8552-3d9910623021_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7f14aa65-fb43-47ea-a953-729f101cdd60_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_56b1798e-6cfd-467c-8ab1-8d9229f8671b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_a5cf5355-b373-4664-8dc8-f024aabdf963_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_e0d0cbe9-80b0-4840-bec8-39e3007edfef_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_534d4b9e-2299-4a0d-b4a9-265db60a8a12_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c85d9ce8-1186-4578-a8f1-962f635b8aac_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_0ca8e07b-4933-4216-920c-421779f15b03_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8e1f32d2-7e59-4fec-805a-c8a14d871ffe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_bd198fa8-9b2f-4779-b5d5-65c89560a4d1_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets (liabilities):</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9f24860d-e1bd-4cf6-8237-d22121f73a39_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_019cd837-4ca7-7d29-9c4b-5891fc322bb2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount_019cb8dd-97d0-78fe-8ee4-912997da0189_terseLabel_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrants</link:label>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount_label_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Amount</link:label>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount_documentation_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" xlink:to="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_ede51f32-04d3-429e-9952-baa963d5e3e1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ed2fa80a-a6e9-42f7-bbd8-080c984f3b77_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of foreign currency on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_NewtonMassachusettsMember_a49c1671-6ce1-4c8a-b1b5-cd9b1c05d062_terseLabel_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Newton, Massachusetts</link:label>
    <link:label id="lab_angn_NewtonMassachusettsMember_label_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Newton, Massachusetts [Member]</link:label>
    <link:label id="lab_angn_NewtonMassachusettsMember_documentation_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Newton, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember" xlink:href="angn-20251231.xsd#angn_NewtonMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_NewtonMassachusettsMember" xlink:to="lab_angn_NewtonMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3ad13932-5092-497f-b167-055b8cc7b4af_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_87560faa-7bc1-4999-b0ba-1684235d31bb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccretionOfPromissoryNoteToFaceValue_bbf5fa22-7fb1-4c5b-b7e8-093ab3a789c6_terseLabel_en-US" xlink:label="lab_angn_AccretionOfPromissoryNoteToFaceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accretion of promissory note to face value</link:label>
    <link:label id="lab_angn_AccretionOfPromissoryNoteToFaceValue_label_en-US" xlink:label="lab_angn_AccretionOfPromissoryNoteToFaceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accretion Of Promissory Note To Face Value</link:label>
    <link:label id="lab_angn_AccretionOfPromissoryNoteToFaceValue_documentation_en-US" xlink:label="lab_angn_AccretionOfPromissoryNoteToFaceValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accretion Of Promissory Note To Face Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccretionOfPromissoryNoteToFaceValue" xlink:href="angn-20251231.xsd#angn_AccretionOfPromissoryNoteToFaceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccretionOfPromissoryNoteToFaceValue" xlink:to="lab_angn_AccretionOfPromissoryNoteToFaceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_eee1a54b-efd7-4c8c-8c82-ed28088be154_terseLabel_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average strike price</link:label>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_label_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Strike Price [Member]</link:label>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_documentation_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember" xlink:href="angn-20251231.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_MeasurementInputStrikePriceMember" xlink:to="lab_angn_MeasurementInputStrikePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_50aaf2e4-374e-405a-aa1f-ce785b22cbca_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019cd8af-697c-79ce-a47e-94178a13e568_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_f507b01e-e328-4656-9ce0-11d788be3a7b_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon the exercise of common warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f952af46-2d24-4cb1-96db-c0009665f061_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of long lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_cef912ba-0a0c-4ff0-9c76-e52c155fcae9_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cee6f987-16a1-49ea-b941-7f5aa271fafa_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a454784-5e0c-47b3-aaf4-ab0e4ef5c455_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_d23dc66c-1af3-429e-ac95-ac6ad9726eab_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants_646a60ba-31bd-4d52-9da7-02224bb7ea00_terseLabel_en-US" xlink:label="lab_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from the exercise of July 2024 Common Warrants (in shares)</link:label>
    <link:label id="lab_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants_label_en-US" xlink:label="lab_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Share, Preferred Stock and Warrants</link:label>
    <link:label id="lab_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants_documentation_en-US" xlink:label="lab_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Share, Preferred Stock and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" xlink:href="angn-20251231.xsd#angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" xlink:to="lab_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3ce84c18-27b2-4f68-94af-e601e7ecb62e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_a80ddd52-30a4-44a1-94ef-992fd0bcb987_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019c9e3d-8c14-7c16-bcd8-c378e4a48dde_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic state and local taxes, net of federal effect</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_a233372b-b73b-4670-898a-8ec35a83fb95_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding_8e678f1b-836e-4708-a6fa-245d5a4e562f_terseLabel_en-US" xlink:label="lab_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of outstanding stock</link:label>
    <link:label id="lab_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding_label_en-US" xlink:label="lab_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Increase, Percentage Of Common Stock Outstanding</link:label>
    <link:label id="lab_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding_documentation_en-US" xlink:label="lab_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Increase, Percentage Of Common Stock Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" xlink:href="angn-20251231.xsd#angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" xlink:to="lab_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_2532f2b7-a021-4455-b8eb-a2577b2728aa_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of equipment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a35b8ebf-9b76-4f5e-a118-dca688d17c52_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_59c31d77-a94e-4efb-97c3-7f44c6eedaf5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_da0384e8-8933-4900-b46e-850237118794_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_5976adf7-aa6a-4aa8-a849-29630b076c60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_20396d16-fd0e-4e2f-929b-cbb03a5b8a4e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_1b4e8e33-a7fa-431d-a65e-c32abc51cd9d_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on fair value of warrants</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a54a52c8-a16b-4d67-b89b-8962a6659e1a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a37df182-b01b-4dff-b353-0e722be8f1c9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_A2024ATMProgramMember_019c9e6b-b016-7b4d-9f38-e57778c27980_terseLabel_en-US" xlink:label="lab_angn_A2024ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 ATM Program</link:label>
    <link:label id="lab_angn_A2024ATMProgramMember_label_en-US" xlink:label="lab_angn_A2024ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 ATM Program [Member]</link:label>
    <link:label id="lab_angn_A2024ATMProgramMember_documentation_en-US" xlink:label="lab_angn_A2024ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 ATM Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024ATMProgramMember" xlink:href="angn-20251231.xsd#angn_A2024ATMProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_A2024ATMProgramMember" xlink:to="lab_angn_A2024ATMProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_787e6adc-babf-4904-b533-d5df450580ac_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of Convertible Note, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_acd7c380-80c7-45fb-b780-6647f887dbf4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance increase</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_c5e05d27-07a0-41ab-b939-94f6a65de1b2_terseLabel_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of pre-funded warrants at issuance date</link:label>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_label_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of Pre Funded Warrants</link:label>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_documentation_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of Pre Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfPreFundedWarrants" xlink:href="angn-20251231.xsd#angn_FairValueOfPreFundedWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_FairValueOfPreFundedWarrants" xlink:to="lab_angn_FairValueOfPreFundedWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_35b6f1a8-bc96-429c-b585-2de59f6fa82a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_343ad217-a53c-49fa-ae64-ac1235c4620c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c9e41-8397-7a99-8dbb-3ff7c36dbfec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_06f47134-653b-4265-8ed7-8ec0e3f7dba0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0e6d6789-8d61-431d-9a96-ec3760178dd5_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dda7b1cb-439e-49a5-a71a-34063292a0d0_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7251b75c-fc50-4795-b6f4-ab3884c7fc4a_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_d5d68e8f-d038-4016-b9f1-b4ad4faee789_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperatingAndNonoperating_3d7c7b4f-3a6c-428e-b0b9-d2b0e227ddc4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperatingAndNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Operating and Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:to="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_01423a66-77c7-476e-a58a-2ac2a637abb5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ffa97fe5-2555-4aad-af00-28d14ed24c0b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_02aac569-a059-445f-9591-57789957fe2d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de00c2a0-1d93-4718-ac19-d07895a82850_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49da808d-ed43-40b9-9360-7f6fed20a158_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2d87aa07-10c8-4aa1-976f-5d0c5813677b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_968e2630-82ca-481a-a2e6-e3783ee335f3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes and effective income tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2e997b03-2f12-4e45-89ed-a6d16d787169_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b2f36-5c09-7768-9ed6-e454ef67ab38_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_0956e585-1abf-402f-8994-6711a9073d86_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Issued In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_d16d2d92-d794-4b05-889d-8f006a721332_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxYear2017Member_fd3a5efc-a046-4987-b8cc-9aa17d8a08ab_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2017</link:label>
    <link:label id="lab_us-gaap_TaxYear2017Member_label_en-US" xlink:label="lab_us-gaap_TaxYear2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Year 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2017Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxYear2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2017Member" xlink:to="lab_us-gaap_TaxYear2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_767fcfde-c254-40b0-9b6b-a5d74e9828a5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_2a3a1318-e8aa-4163-9202-1d05c6a5ce69_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield (per share)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_2ea92c4e-4a8e-4553-81f7-f55e620e9d09_terseLabel_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</link:label>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_label_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member]</link:label>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_documentation_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:href="angn-20251231.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:to="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_1b8fa3f2-2200-48fe-811f-8d84427c5684_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_c76e3a4a-cdd0-445e-94d4-c60032de30ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_d2169731-56ff-467a-a7ee-ddee0130274f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_RegistrationStatementMember_eaeba19e-8b14-43cb-b7d1-c788c4d2bf3c_terseLabel_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registration Statement</link:label>
    <link:label id="lab_angn_RegistrationStatementMember_label_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Registration Statement [Member]</link:label>
    <link:label id="lab_angn_RegistrationStatementMember_documentation_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember" xlink:href="angn-20251231.xsd#angn_RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_RegistrationStatementMember" xlink:to="lab_angn_RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountIssued1_4ae82a5a-f99f-4302-b28f-64e8aa5020f4_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of related-party senior note and interest into common stock</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Amount Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountIssued1" xlink:to="lab_us-gaap_ConversionOfStockAmountIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_0665a106-060d-407f-8630-117200da3981_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_July2024PublicOfferingMember_cf21e206-db96-4d7d-89dc-a0662cf4fcc8_terseLabel_en-US" xlink:label="lab_angn_July2024PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Public Offering</link:label>
    <link:label id="lab_angn_July2024PublicOfferingMember_019c3719-3fdf-7359-8f59-d23cc5165ea3_verboseLabel_en-US" xlink:label="lab_angn_July2024PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">July Public Offering 2024</link:label>
    <link:label id="lab_angn_July2024PublicOfferingMember_019c9e6f-bfc0-7c5d-974c-426d2612bd3d_netLabel_en-US" xlink:label="lab_angn_July2024PublicOfferingMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">July 2024 Public Offering</link:label>
    <link:label id="lab_angn_July2024PublicOfferingMember_label_en-US" xlink:label="lab_angn_July2024PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July 2024 Public Offering [Member]</link:label>
    <link:label id="lab_angn_July2024PublicOfferingMember_documentation_en-US" xlink:label="lab_angn_July2024PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_July2024PublicOfferingMember" xlink:to="lab_angn_July2024PublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PreFundedWarrantMember_954eab10-3ef0-41a0-81a9-11eb3545cb2f_terseLabel_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:label id="lab_angn_PreFundedWarrantMember_019b2a7f-6cd7-763c-a7c2-43d09ac9da31_verboseLabel_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_PreFundedWarrantMember_label_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant [Member]</link:label>
    <link:label id="lab_angn_PreFundedWarrantMember_documentation_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PreFundedWarrantMember" xlink:to="lab_angn_PreFundedWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_9d129872-b3b0-49d8-ac92-aaafb06d33e5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (expense) income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_dbdea454-1c2c-4391-b40a-10990d7edf10_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets, operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_GrantRevenueNonoperating_019b2b1b-3a56-7b17-9aed-9a7bc6299e93_terseLabel_en-US" xlink:label="lab_angn_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant income</link:label>
    <link:label id="lab_angn_GrantRevenueNonoperating_label_en-US" xlink:label="lab_angn_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant Revenue, Nonoperating</link:label>
    <link:label id="lab_angn_GrantRevenueNonoperating_documentation_en-US" xlink:label="lab_angn_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of grant revenue, non operating.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating" xlink:href="angn-20251231.xsd#angn_GrantRevenueNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_GrantRevenueNonoperating" xlink:to="lab_angn_GrantRevenueNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_721a836e-1630-438a-b30c-4bd2abee5768_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_19704535-4883-4ae8-9de7-e809ce8033f0_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedInterest_019cd8ba-af60-75d9-b81b-9ee66dc7554b_terseLabel_en-US" xlink:label="lab_angn_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_angn_AccruedInterest_label_en-US" xlink:label="lab_angn_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_angn_AccruedInterest_documentation_en-US" xlink:label="lab_angn_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterest" xlink:href="angn-20251231.xsd#angn_AccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedInterest" xlink:to="lab_angn_AccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_019cd80d-3809-7eb9-a192-be95bcf954f9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, prepayment fee prepaid (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JanuaryOfferingMember_019c0ce9-d791-7bc0-8a58-77399b5c8a69_terseLabel_en-US" xlink:label="lab_angn_JanuaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January Offering</link:label>
    <link:label id="lab_angn_JanuaryOfferingMember_label_en-US" xlink:label="lab_angn_JanuaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Offering [Member]</link:label>
    <link:label id="lab_angn_JanuaryOfferingMember_documentation_en-US" xlink:label="lab_angn_JanuaryOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryOfferingMember" xlink:href="angn-20251231.xsd#angn_JanuaryOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JanuaryOfferingMember" xlink:to="lab_angn_JanuaryOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_aa09a628-23b9-4994-9274-5ceba9d41a3b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_757f6fed-ada5-4bd5-82d0-cb4df97da9e0_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_45fcab6a-d9fc-49b1-9ae0-f0afba60632d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_0767b99c-3739-4a2b-bca2-df6000e0184b_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Credit</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementCredit" xlink:to="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9308cdb1-c0fb-4c04-91d4-fff513d55d63_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_9f00f57f-229a-4094-95de-bccd81e49797_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_faa447db-2b95-4073-9e6a-cb5d1c72879e_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee related general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_RoyaltyRatePercent_019b2f06-dbca-705d-90c2-c24e79020f23_terseLabel_en-US" xlink:label="lab_angn_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty rates (as a percent)</link:label>
    <link:label id="lab_angn_RoyaltyRatePercent_label_en-US" xlink:label="lab_angn_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Rate, Percent</link:label>
    <link:label id="lab_angn_RoyaltyRatePercent_documentation_en-US" xlink:label="lab_angn_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RoyaltyRatePercent" xlink:href="angn-20251231.xsd#angn_RoyaltyRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_RoyaltyRatePercent" xlink:to="lab_angn_RoyaltyRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f2665e3c-c323-4fb3-8268-e232448da20b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation related to unvested stock option awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6004edc-2d1f-48d1-9c15-131a5c398635_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering_c2b588b1-c5e1-405a-af4e-60a9dcdfc1d2_terseLabel_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock warrants from July 2024 Public Offering</link:label>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering_label_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance of Common Stock Warrants From July Public Offering</link:label>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering_documentation_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance of Common Stock Warrants From July Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" xlink:href="angn-20251231.xsd#angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" xlink:to="lab_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_DeferredTaxAssetsNetBeforeValuationAllowance_bc6750a8-e60b-4ccb-82ba-7e865b89ac39_totalLabel_en-US" xlink:label="lab_angn_DeferredTaxAssetsNetBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_angn_DeferredTaxAssetsNetBeforeValuationAllowance_label_en-US" xlink:label="lab_angn_DeferredTaxAssetsNetBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net, Before Valuation Allowance</link:label>
    <link:label id="lab_angn_DeferredTaxAssetsNetBeforeValuationAllowance_documentation_en-US" xlink:label="lab_angn_DeferredTaxAssetsNetBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net, Before Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance" xlink:href="angn-20251231.xsd#angn_DeferredTaxAssetsNetBeforeValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance" xlink:to="lab_angn_DeferredTaxAssetsNetBeforeValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_3cc98585-7207-4d9e-9a97-8972ef3bf71b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employers matching contribution annual vesting (in percentage)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:to="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent_b1dc9e7e-898a-4b6b-b203-161b00be6efd_terseLabel_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State research and development credits</link:label>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent_label_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, State Research And Development, Percent</link:label>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent_documentation_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, State Research And Development, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" xlink:to="lab_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_8b4a0cda-1830-4fc7-80b6-cc7a8838c922_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, useful life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_12063367-68ad-496b-98e3-4a09d75e3232_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_786b64d1-9dc9-4269-a7d9-557d2e82c3f8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a9c10f3c-09cc-4925-b222-b9759b4a59fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_aae076ae-8d0a-4272-8f4e-53afb9f871ba_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_059562fe-6673-42ed-b10e-70c5678f0449_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_a2af76e0-424c-4ae5-b3f8-81c08e55cf3d_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019cd80f-12f9-7802-adeb-dc4f2d62ee90_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Three Year</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_FairValueOfCommonStockWarrantsUponSettlement_019c084f-ae23-7b7c-9fd2-210467faa09f_terseLabel_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants upon settlement</link:label>
    <link:label id="lab_angn_FairValueOfCommonStockWarrantsUponSettlement_label_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants Upon Settlement</link:label>
    <link:label id="lab_angn_FairValueOfCommonStockWarrantsUponSettlement_documentation_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants Upon Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:href="angn-20251231.xsd#angn_FairValueOfCommonStockWarrantsUponSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:to="lab_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_c1dd66f9-ba5f-424c-8f17-b789f0662017_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8d6d370e-473c-4da6-b07e-982c27ffbc03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_39c090b6-5b88-4fe7-844a-2fc32f71acac_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_9bd81969-e71d-4ad7-9e39-8ede21a5bb61_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_f4a30224-7ccb-4766-b51a-42d331c560b7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_9c049284-b458-4130-8754-5f4bfdbff49a_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_296148b5-2112-4021-bc41-d5cc1df9cf64_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_c44456f2-b1c2-497c-bfed-929f0e7bca5a_terseLabel_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_label_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky [Member]</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_documentation_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember" xlink:href="angn-20251231.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_YekaterinaChudnovskyMember" xlink:to="lab_angn_YekaterinaChudnovskyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_c4814a63-dfee-4fa7-80b7-b36c172a03b1_terseLabel_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on issuance of pre-funded warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_6861fe12-f909-43d3-875b-2ffed3bbf9b8_negatedLabel_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on issuance of warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_d36e267e-f1e1-4f74-8a75-6eeb202fa4f9_negatedTerseLabel_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on issuance of pre-funded warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_label_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain Loss On Issuance Of Warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_documentation_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain Loss On Issuance Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants" xlink:href="angn-20251231.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_GainLossOnIssuanceOfWarrants" xlink:to="lab_angn_GainLossOnIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_c95c01dd-12b6-4e02-9e8d-1dfef7c95f9d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_bc099055-cfde-428b-82d4-e3370003e16f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_402b7a9a-fff5-4e82-9cfd-43c4359230eb_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_d1348bda-430c-4770-90fe-e7dbb9b91897_verboseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019b2f3e-a6e7-71c1-b039-50eaa5e0a57b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantIssuedStockIssuance_019c0851-2e7f-763d-9a02-8f965e085635_terseLabel_en-US" xlink:label="lab_angn_WarrantIssuedStockIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants issued with January 2025 Offering</link:label>
    <link:label id="lab_angn_WarrantIssuedStockIssuance_label_en-US" xlink:label="lab_angn_WarrantIssuedStockIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Issued, Stock Issuance</link:label>
    <link:label id="lab_angn_WarrantIssuedStockIssuance_documentation_en-US" xlink:label="lab_angn_WarrantIssuedStockIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Warrants Issued With January 2025 Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantIssuedStockIssuance" xlink:href="angn-20251231.xsd#angn_WarrantIssuedStockIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantIssuedStockIssuance" xlink:to="lab_angn_WarrantIssuedStockIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_28d9ccdb-3a4e-4b80-8b7a-4164ef66186e_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_35044899-27d7-4dc5-bfe8-2b7fe0f6fb0a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantExercisedFairValue_019b3024-6678-7695-8114-761de1968e57_terseLabel_en-US" xlink:label="lab_angn_WarrantExercisedFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants at issuance date</link:label>
    <link:label id="lab_angn_WarrantExercisedFairValue_label_en-US" xlink:label="lab_angn_WarrantExercisedFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Exercised, Fair Value</link:label>
    <link:label id="lab_angn_WarrantExercisedFairValue_documentation_en-US" xlink:label="lab_angn_WarrantExercisedFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Exercised, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantExercisedFairValue" xlink:href="angn-20251231.xsd#angn_WarrantExercisedFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantExercisedFairValue" xlink:to="lab_angn_WarrantExercisedFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5bc3b978-0a14-43d7-a78e-6c899ac30e7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_34f3e636-cbc5-4403-845e-07ea5e7ef03a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e59624b2-91af-4980-9625-3d968e615ff6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_e89f2a62-ac0e-4279-9e3d-4ca677e1bf05_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_93a41590-6ebb-42fd-8a70-367b279a2127_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-772b-b5f2-61413f7d1357_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_d252ee79-fdcf-4830-afd9-d12fd8c0809e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_b90bf832-d318-4bcd-80fe-7e785de07086_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_c2c000b9-bc24-4933-985e-d5f77445299f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_6626e358-100e-4e5c-9e72-d98febe9b862_terseLabel_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases</link:label>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases [Table Text Block]</link:label>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_documentation_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:href="angn-20251231.xsd#angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:to="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_480e75c5-d0f4-4767-ad31-b7c966d40f88_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc662dc7-0f27-4efc-818c-1c498b876dcb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyCommonWarrantOneMember_019c0d06-aae2-779d-b422-10881df7aee8_terseLabel_en-US" xlink:label="lab_angn_JulyCommonWarrantOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Common Warrants One</link:label>
    <link:label id="lab_angn_JulyCommonWarrantOneMember_label_en-US" xlink:label="lab_angn_JulyCommonWarrantOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Common Warrant One [Member]</link:label>
    <link:label id="lab_angn_JulyCommonWarrantOneMember_documentation_en-US" xlink:label="lab_angn_JulyCommonWarrantOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Common Warrant One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantOneMember" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyCommonWarrantOneMember" xlink:to="lab_angn_JulyCommonWarrantOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3ac9619b-5d8e-483c-8649-d178343024cc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_fd63e989-6ac3-43e7-b288-bf961ece72a4_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProjectMember_b8f0957c-0dcf-45a5-bdbb-7bdd4ffd0303_terseLabel_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project [Domain]</link:label>
    <link:label id="lab_us-gaap_ProjectMember_label_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProjectMember" xlink:to="lab_us-gaap_ProjectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_473aba94-ba02-43e6-ad0a-3eac06131873_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term prepaid assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense Other, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_65de5b5e-f116-45cd-ae24-59ff397f54f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7b46a1f3-c37a-4381-a13b-9a6ae1a65199_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_272e4654-2792-4402-ad01-6eb46c63b923_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_984c7137-2830-41dd-93ad-bf0ec62bed4d_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_0c233430-5c8a-433c-aec8-27dfc9eb1dcf_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_7509e6fb-74ae-4458-b554-b12375344709_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_5b650f6e-3504-4535-8e94-9a8ef1b55299_terseLabel_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee related research and development expenses</link:label>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_label_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Related Reasearch and Development [Member]</link:label>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Related Reasearch and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:href="angn-20251231.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:to="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3778a00a-e6f9-495e-81cd-568788bb7a22_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61387d7a-240a-4105-b8c0-1f576b6a76ec_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea05c522-66b7-425c-bf9c-96c1938d3b7b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_a59b5fe8-947c-41d7-a587-190f133314e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Deferred tax asset valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_InterestExpenseNoncash_51fccfad-81a4-413d-be8e-64a1175211f6_terseLabel_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_angn_InterestExpenseNoncash_label_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Noncash</link:label>
    <link:label id="lab_angn_InterestExpenseNoncash_documentation_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash" xlink:href="angn-20251231.xsd#angn_InterestExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_InterestExpenseNoncash" xlink:to="lab_angn_InterestExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c6ee6e2a-6acf-4f8e-ae7e-51f2dc480bea_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable, total intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019cb8da-74f0-7c18-a683-a026ee711f18_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nondeductible stock based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_019c898d-e83c-7ac6-a1d0-4862e1c1087a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_6aaba236-735f-433c-a391-dda0c9618433_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_6a2cdcd7-c5b1-4a11-9108-21cd20f9d40a_terseLabel_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_label_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding [Text Block]</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_documentation_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingTextBlock" xlink:href="angn-20251231.xsd#angn_WarrantsAndRightsOutstandingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsAndRightsOutstandingTextBlock" xlink:to="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_078010d8-52c9-46a1-b60e-76a7bcd36598_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_870fb8b7-a954-4234-9bb7-9b07dc343e52_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_33819adf-2861-4e27-8398-07c826bb4960_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a012107b-e4e8-45b5-abb4-79dcedda034f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_019b2b37-f6c4-7958-be73-4c1d56a45e33_terseLabel_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January Common Warrants</link:label>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember" xlink:href="angn-20251231.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JanuaryCommonWarrantsMember" xlink:to="lab_angn_JanuaryCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_019b2a7f-6cd7-7fa3-9589-8dc0f497e416_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_8b27b3a0-ea8a-42c8-80d0-34e58df30214_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_1283b111-55d9-489d-acfa-f8f011e82b2e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility (annual)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2dc43ba0-8243-4026-9ee3-2ac5ee6e28a4_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecoveryOfDirectCosts_e8459077-6d3d-4568-8aa8-6ebe56673e64_terseLabel_en-US" xlink:label="lab_us-gaap_RecoveryOfDirectCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract and grant reimbursements</link:label>
    <link:label id="lab_us-gaap_RecoveryOfDirectCosts_label_en-US" xlink:label="lab_us-gaap_RecoveryOfDirectCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Direct Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecoveryOfDirectCosts" xlink:to="lab_us-gaap_RecoveryOfDirectCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_019cd820-5ee4-7c02-a281-6f5f34cefa7d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Principal Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_fa42b9f2-636c-470e-99a7-d9ce7d771094_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_bbfa14a4-75de-4703-99a8-29d86cf94a0e_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7fc24d48-485a-4053-a676-3fd003d9a5ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CostsExpensedUponTheIssuanceOfWarrants_f3314c5a-a065-41f4-b293-71ff6340ca42_terseLabel_en-US" xlink:label="lab_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs expensed upon the issuance of warrants</link:label>
    <link:label id="lab_angn_CostsExpensedUponTheIssuanceOfWarrants_label_en-US" xlink:label="lab_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Expensed Upon The Issuance Of Warrants</link:label>
    <link:label id="lab_angn_CostsExpensedUponTheIssuanceOfWarrants_documentation_en-US" xlink:label="lab_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Costs Expensed Upon The Issuance Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:href="angn-20251231.xsd#angn_CostsExpensedUponTheIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:to="lab_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_1d27fcdf-2b58-4cf0-b9eb-070b10140c6a_negatedTerseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Exercised In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Exercised In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightExercisedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8449981f-e887-4340-b059-a95a77b2cebd_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_03727a23-5116-459d-9c28-98e056b503c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, end of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019c9e3c-ab95-7501-9ca8-7131ff1b52fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign tax effects</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AngionWarrantsMember_019b2a7f-6cd7-7995-b424-6953c4821323_terseLabel_en-US" xlink:label="lab_angn_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Angion Warrants</link:label>
    <link:label id="lab_angn_AngionWarrantsMember_label_en-US" xlink:label="lab_angn_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Angion Warrants [Member]</link:label>
    <link:label id="lab_angn_AngionWarrantsMember_documentation_en-US" xlink:label="lab_angn_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Angion Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionWarrantsMember" xlink:href="angn-20251231.xsd#angn_AngionWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AngionWarrantsMember" xlink:to="lab_angn_AngionWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60a36219-a260-4f27-96d8-42e5a43bf6d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_33222829-c7f2-4633-a6ad-a5e75b6a1944_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_9be3f28e-ea32-4079-8edb-a6d0a9f15c9f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred research obligation</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7ccd952d-25c7-411a-906e-a0b0f72e8a8a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c589535c-bfdb-4ed7-81a6-e02f96d64932_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4484d82a-f68c-4d73-ac81-865aa89127e3_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercise price of equity-classified broker warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2a7f-6cd7-7070-91c8-f564c5cd7f2e_netLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9cb044cb-0517-4f50-9ea1-2238dec9738c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_490f5cd3-37ba-4ee8-96dd-200e26eb285f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_738f53ad-7866-4c67-a5fc-3930ad0c8931_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c5ba06ed-7b71-4dd8-9f53-177a73a6651e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e70fa2a4-da97-4835-9ea1-2b099fa26d26_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_06a4e8de-8590-4c54-bb6e-258d55cf0869_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b7620017-5e09-4c8f-9c14-bd5b1465b918_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f12-740a-7678-abd0-abca463fc6ca_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fca44e63-fd59-4ea4-a937-8d67ffce18e7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statutory federal income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_ee33ea4a-a0fa-46ca-b9a2-baba9ae6cf38_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e00dd315-e739-47a8-92f0-965643db8b5f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_56bf1631-ca68-417c-97c2-b43c73eb2e7e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_019cd7af-9ce3-7690-8e9b-f486356b89bd_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_019b2f3d-f995-742f-9fa0-9be24597a557_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net carrying value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_ef247a8e-74fa-4bee-98dd-8bf0a191a5bb_terseLabel_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note</link:label>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_label_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note [Member]</link:label>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_documentation_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:to="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_be0d7c48-cc45-42fa-9387-c3cb777c8a29_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5b6c244c-518f-4494-b8e9-21094e6834d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_1af1b260-365c-49e8-a996-bb390fbe8b4f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_37fe316a-2217-4e83-af68-b7ba8eecb73e_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember_019b2fa7-b65f-7d57-bf5a-bc5cd3186151_terseLabel_en-US" xlink:label="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky And Jay Venkatesan</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember_label_en-US" xlink:label="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky And Jay Venkatesan [Member]</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember_documentation_en-US" xlink:label="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky And Jay Venkatesan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:href="angn-20251231.xsd#angn_YekaterinaChudnovskyAndJayVenkatesanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:to="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d7105efa-f734-48f6-a9d3-13724363c24b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_7f3a677d-0cd9-4462-8831-1f355e3161ea_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c201a508-304c-44d8-ab5c-4e36f7921e96_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_def3847d-4401-4b03-9292-232dd4d16236_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_83b8c911-4d42-4872-9fa6-416ffbedd057_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e3d67cc4-592c-44c1-9ec4-e0bbba4c73ea_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, noncurrent portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_e429782d-7b3b-4d01-b4c5-d22e504161ca_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b6833860-6ba9-4388-bb9f-3bb4a5b80609_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Convertible note into common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_019cd836-3ed0-7888-9723-8a1ff043412a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) recognized in the income statement</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_019b2f0d-b302-7499-989e-b57c5ac2e9d1_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantLiability_f3892f33-a78a-4177-9183-b7b078765631_terseLabel_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_angn_WarrantLiability_label_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_angn_WarrantLiability_documentation_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability" xlink:href="angn-20251231.xsd#angn_WarrantLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantLiability" xlink:to="lab_angn_WarrantLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_263f4aa0-202a-4f86-a8bc-4367d2a82748_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_d29bed8f-d1b8-41b2-9e66-7f1f97e6ff55_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other long-term prepaid assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_019cd8b2-eb66-7c18-b380-0fbbb9792480_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the exercise of common stock warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_685607e9-94d3-4ff4-8714-b7a81af367da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPublicOfferingMember_019cd7e6-42fe-7724-b687-2aeb70dbb812_terseLabel_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Public Offering</link:label>
    <link:label id="lab_angn_JulyPublicOfferingMember_label_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Public Offering [Member]</link:label>
    <link:label id="lab_angn_JulyPublicOfferingMember_documentation_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember" xlink:href="angn-20251231.xsd#angn_JulyPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPublicOfferingMember" xlink:to="lab_angn_JulyPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_94c23a50-3b3c-4cdd-803b-a7dea930552d_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_8d184377-3f17-44e5-a75b-101ef8ceb7b8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019cd80e-f0da-7530-9c3a-c0d0cbb631ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Second year</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_74c8a805-9c1b-49de-bdbc-9416b7b926c6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_0cb82ca3-4e48-42e4-9d1e-ac64554b2d36_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_87bf3fea-2f64-43f2-882e-3d6a2c724161_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_b04051c5-8590-4bd1-9074-26438d7efe39_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantLiabilityMember_9221bcec-ae3e-410f-ac87-28e6933ede34_terseLabel_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_angn_WarrantLiabilityMember_label_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability [Member]</link:label>
    <link:label id="lab_angn_WarrantLiabilityMember_documentation_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember" xlink:href="angn-20251231.xsd#angn_WarrantLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantLiabilityMember" xlink:to="lab_angn_WarrantLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantIssuedDebtIssuance_019c0852-5887-73d8-8045-05966bc41de5_terseLabel_en-US" xlink:label="lab_angn_WarrantIssuedDebtIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants issued with June 2025 Promissory Note</link:label>
    <link:label id="lab_angn_WarrantIssuedDebtIssuance_label_en-US" xlink:label="lab_angn_WarrantIssuedDebtIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Issued, Debt Issuance</link:label>
    <link:label id="lab_angn_WarrantIssuedDebtIssuance_documentation_en-US" xlink:label="lab_angn_WarrantIssuedDebtIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Issued, Debt Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantIssuedDebtIssuance" xlink:href="angn-20251231.xsd#angn_WarrantIssuedDebtIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantIssuedDebtIssuance" xlink:to="lab_angn_WarrantIssuedDebtIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_32ee024e-2459-48a3-8ea8-3b520167a0f1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_57f22914-d194-4af7-a6e4-91f93b66feca_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSecuredLinesOfCredit_7272ee33-2c05-4a5d-aa0e-4fa8416fe948_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSecuredLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Secured Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_019b2f0d-b302-7ef6-b5e2-6c1c3b3a522e_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90354cc5-c3a3-44dd-9293-c02daa0bb6d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, total intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_6696c7fd-1e3a-4f74-9d5c-0c5a272d3b5c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_472aef19-6ad1-47f5-9569-485c0f42ef03_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">ROU asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_d0a619ee-e41a-4821-87a7-00b9dedc5b68_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_A2024RegistrationStatementMember_0a2c0c9f-e302-4d9f-b472-9ced9ee1f6cf_terseLabel_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Registration Statement</link:label>
    <link:label id="lab_angn_A2024RegistrationStatementMember_label_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Registration Statement [Member]</link:label>
    <link:label id="lab_angn_A2024RegistrationStatementMember_documentation_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember" xlink:href="angn-20251231.xsd#angn_A2024RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_A2024RegistrationStatementMember" xlink:to="lab_angn_A2024RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_d83dd5d6-7566-4bd1-bea8-f2467c38a15d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_EmployeeBenefitPlanMember_235bab90-047e-45d9-ad4f-444fe5e4a068_terseLabel_en-US" xlink:label="lab_angn_EmployeeBenefitPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:label id="lab_angn_EmployeeBenefitPlanMember_label_en-US" xlink:label="lab_angn_EmployeeBenefitPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Benefit Plan [Member]</link:label>
    <link:label id="lab_angn_EmployeeBenefitPlanMember_documentation_en-US" xlink:label="lab_angn_EmployeeBenefitPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeBenefitPlanMember" xlink:href="angn-20251231.xsd#angn_EmployeeBenefitPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_EmployeeBenefitPlanMember" xlink:to="lab_angn_EmployeeBenefitPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5f5919e4-86b4-449d-896c-75aed1e86676_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b8147f04-1a72-47c0-9b66-ed80848b06a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_4c645e35-ab13-42c7-94a2-dccae19b4a21_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ReportableSegmentMember_6ddb78df-39a1-46fa-948d-53e1d821ea22_terseLabel_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_angn_ReportableSegmentMember_label_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_angn_ReportableSegmentMember_documentation_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember" xlink:href="angn-20251231.xsd#angn_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ReportableSegmentMember" xlink:to="lab_angn_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_25b90b89-3d3c-4137-ba32-aa2ff0bb8eae_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_5fd1e87a-ccc2-4c9f-9bcb-bca98a9a6f5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_8854fe0a-5a07-4ef7-95b5-94b87d57660e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e3f25bdf-f52a-4b61-bb0a-f8bcbb44e801_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_f05a22fb-fb51-4d8c-a0ce-1a4ec10e5020_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_019c9e3b-1084-76ed-bbbf-02479a4e20b6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign tax effects</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_255bc475-e17f-425b-aef5-ccae71c8c95c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_49555d63-42e7-48ab-898c-2678ffc4944d_terseLabel_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chemistry, manufacturing and controls expenses</link:label>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_label_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Translational Medicine and CMC [Member]</link:label>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_documentation_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Translational Medicine and CMC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember" xlink:href="angn-20251231.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_TranslationalMedicineAndCMCMember" xlink:to="lab_angn_TranslationalMedicineAndCMCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_AU_019cd86c-2c57-707d-8568-67e04cf390d3_terseLabel_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AUSTRALIA</link:label>
    <link:label id="lab_country_AU_label_en-US" xlink:label="lab_country_AU" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AUSTRALIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AU" xlink:to="lab_country_AU" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c15df578-b498-476e-ba34-8564f35a1e90_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_c6b2acca-695c-455e-84ee-be3eeb27a1ae_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_f4fdb752-1c6a-431d-9eb1-f15632936328_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_b4ff6604-3b10-41e1-b7df-4522aa476fd0_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3f121878-3e4e-4244-b748-676e2064b987_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Convertible Note into common stock, net of issuance costs of $0.3 million</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a632ff23-96d9-441e-b085-fdd1da39a988_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_39db9a18-33c8-4b68-b3c6-fa5fc3775ea5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosureLineItems_c9e93f8a-77c0-4b45-bc47-aa27b49b1649_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019cd828-d2b9-770e-9ed7-62575f33278c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_7417fa46-3db9-408f-b1ce-3ebb7ce04055_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Life (years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Life [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_d5dbe342-13a5-4b4d-b867-8abecbc8d1f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_23a2f4ff-b667-441d-9d08-3405f8498f08_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_74af8b0f-01bc-467c-bc58-6af2953b29ea_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4dc42ffc-ad98-4a98-b02d-7139df8a650b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_019c9e4a-b41e-79b4-acff-b99845352a95_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_UniversityMember_019b2f12-740a-7bb4-a412-7e0fd2c77ec4_terseLabel_en-US" xlink:label="lab_angn_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">University</link:label>
    <link:label id="lab_angn_UniversityMember_label_en-US" xlink:label="lab_angn_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">University [Member]</link:label>
    <link:label id="lab_angn_UniversityMember_documentation_en-US" xlink:label="lab_angn_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">University</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_UniversityMember" xlink:href="angn-20251231.xsd#angn_UniversityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_UniversityMember" xlink:to="lab_angn_UniversityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_66be2e85-aaf8-4890-b5dc-393650ff327c_terseLabel_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March Subscription Agreement</link:label>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_label_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">March Subscription Agreement [Member]</link:label>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_documentation_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">March Subscription Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_MarchSubscriptionAgreementMember" xlink:to="lab_angn_MarchSubscriptionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fe4ec40a-4b99-48d0-8fea-ea5376b81c84_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019cd834-027f-7ab1-befb-c0467b8b7859_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other nontaxable and nondeductible items</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_53e7f513-0cff-45e1-a60f-495124cfe8d4_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_83f93753-0613-4fa0-b7ff-cc990b637c13_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares of common stock to purchase (up to) (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c44430d9-fe1f-4eba-9cd7-e14fa62be0d3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_3a293e20-b083-45a0-9633-796825fa5cb9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_89aaed3f-c894-49fb-9b06-b5159bfcb69f_terseLabel_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_label_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_documentation_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:to="lab_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0bee4fcb-f5ed-45df-9a5c-3317dab0788f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_b8383f93-f10e-4546-96ab-d27299329f57_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.01 par value; 10,000,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_542a8307-2e0a-4ca4-910b-a9f8a26556be_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanTable_96e0df2f-6f83-474b-9028-68cc14a39564_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanTable_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanTable" xlink:to="lab_us-gaap_DefinedContributionPlanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_019cd81d-1874-734f-a4ec-e898351ee1bb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_fe545811-50f6-40ef-8a4b-4fa0b029ca65_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_ccb3f255-7ba4-4bb3-83a2-7efc63a1eadb_terseLabel_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, aggregate offering price</link:label>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_label_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Initial Offering Price</link:label>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_documentation_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Initial Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:href="angn-20251231.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:to="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_96dd5b77-6c48-41a5-8c09-df8d6f4005f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_86771712-98f7-4057-9a31-fd30a2d3953c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.01 par value; 300,000,000 shares authorized; 17,814,762 and 11,043,837 shares issued at December 31, 2025 and 2024, respectively; 17,800,307 and 11,029,382 shares outstanding as of December 31, 2025 and 2024, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_b06e5132-1805-4638-a1a5-875d885f15fb_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_a609ce01-c6b4-4faf-9cca-3e487429ade4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_05e13568-77c5-4cb9-b9dc-cca5813314e7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_85854866-4292-48be-857a-8fd31b3e84bd_terseLabel_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid research and development contract services</link:label>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expenses</link:label>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses" xlink:href="angn-20251231.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PrepaidResearchAndDevelopmentExpenses" xlink:to="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_afc8164e-a953-4334-ad50-5e3222a3a775_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0ce93fad-4fab-42ce-bb10-93af75cd2539_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in computing net loss per share, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_bc6ad733-2236-4687-bd3d-4aafca26233b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_fe016529-590d-497a-b995-eec7ae64a593_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies&#8212;Note 9</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_673d1947-d2f5-4625-98d0-979b0dadd243_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_FairValueOfCommonStockWarrants_2cb4d146-80d7-49ab-a828-6331bbc22196_terseLabel_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants at issuance date</link:label>
    <link:label id="lab_angn_FairValueOfCommonStockWarrants_label_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants</link:label>
    <link:label id="lab_angn_FairValueOfCommonStockWarrants_documentation_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrants" xlink:href="angn-20251231.xsd#angn_FairValueOfCommonStockWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_FairValueOfCommonStockWarrants" xlink:to="lab_angn_FairValueOfCommonStockWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d9039881-8000-4645-830b-66e0318a831b_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_fd67be26-0b21-4a59-b7c5-3ba08d6f64f4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ac27ff50-620f-4577-8f4e-376a835dab50_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_4e4a5ff3-1065-46b4-b160-4e0fe2ff4276_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_d5cf66d4-6d31-47a1-b5d8-4e5c6087bb6d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a0e11a53-8bd5-4551-948e-f856f4ebfe59_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_6cdcfd0c-4f44-4f29-b623-47ea3e8e62b7_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_67ceef8a-3d8d-4351-89fe-8580bd67f268_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_c200cc87-c4d9-44b4-acb2-bf3cc24e048e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b9e62319-9bc5-4c9d-a64c-b16ba741653f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_d2b5fe5d-2eab-46d1-97e6-dd32fd168c67_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_019cd830-6e0d-73b8-a7c9-317ce1031bc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8c436763-3130-434f-a6b0-de08a9abd08c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_baea0c5b-ccf7-4878-9b79-a4ceac1d8521_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanTextBlock_4273ed0d-102c-4c96-87e6-f2e91c976eb3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketOfferingMember_a206c57d-86d4-4bdd-a2dc-62ff6aa0e944_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-the-Market Offering</link:label>
    <link:label id="lab_angn_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_angn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-the-Market Offering [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_angn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-the-Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember" xlink:href="angn-20251231.xsd#angn_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketOfferingMember" xlink:to="lab_angn_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_870726dc-7743-400e-8b5e-6cf873164ff2_terseLabel_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:to="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4080bd7b-1c71-4bbc-81aa-e31f4753c7d8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_1620a9d8-e9c3-49d3-8a5c-7d7747a35cf8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_79744989-7f3c-431b-b150-1e9f58f3e827_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_20820ceb-1195-4793-9af3-3c070b934f20_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_61ac4c99-e683-428a-8c27-7e2eef71d7cb_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_d2f009fb-b144-41a7-a1ee-80c2bd25eaef_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019b2f0d-b302-7c49-9f66-1de460e76e02_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b0642916-79b0-49b7-8e0a-ed083b413edf_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3cdfd338-7f28-4cbf-b0b1-530a57d73ea4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7ef461e6-6c90-4904-be84-084196dc28d4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_26e38974-8602-4aa1-9e8a-8ed9e897cc75_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_742f49b6-e614-4253-8690-f3f3f8751897_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of cash, cash equivalents and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019b2a7f-6cd7-7c31-a0b5-9492f71889da_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Life (years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a13af92d-b8ed-4ed6-a908-5a3f0841e5f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_January2025CommonWarrantsMember_019b2a7f-6cd7-7f88-af24-36dd812e8908_terseLabel_en-US" xlink:label="lab_angn_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants</link:label>
    <link:label id="lab_angn_January2025CommonWarrantsMember_label_en-US" xlink:label="lab_angn_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants [Member]</link:label>
    <link:label id="lab_angn_January2025CommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember" xlink:href="angn-20251231.xsd#angn_January2025CommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_January2025CommonWarrantsMember" xlink:to="lab_angn_January2025CommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PaymentOfWarrantIssuanceCosts_fa6074d4-972e-448e-86b4-1f8175ab7dd8_negatedTerseLabel_en-US" xlink:label="lab_angn_PaymentOfWarrantIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of warrant issuance costs</link:label>
    <link:label id="lab_angn_PaymentOfWarrantIssuanceCosts_label_en-US" xlink:label="lab_angn_PaymentOfWarrantIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Of Warrant Issuance Costs</link:label>
    <link:label id="lab_angn_PaymentOfWarrantIssuanceCosts_documentation_en-US" xlink:label="lab_angn_PaymentOfWarrantIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment Of Warrant Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PaymentOfWarrantIssuanceCosts" xlink:href="angn-20251231.xsd#angn_PaymentOfWarrantIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PaymentOfWarrantIssuanceCosts" xlink:to="lab_angn_PaymentOfWarrantIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent_019cb8e5-e751-706b-bc75-d563214ccaad_terseLabel_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrants</link:label>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent_label_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Percent</link:label>
    <link:label id="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent_documentation_en-US" xlink:label="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" xlink:to="lab_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_019cd7e6-42fe-7c90-80fd-fe918ac0d35a_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_c7926711-68e6-4355-b2ec-614798f96a07_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive gain:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_cf7ed956-9f15-4bcc-ab6c-bc39de0483c6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from June 2025 Promissory Note, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_47c3ef0e-c392-450e-83f0-85d1b26df2cb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_54e15f14-6b9d-4175-9e0f-fb6095a414f5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized research and development</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_1926b48e-d1b4-4426-af06-50ec21c01349_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued (in dollars per share)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_863a5265-5e00-4cac-9f59-f55d03b38e8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option Activity, Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_ab40f916-d4bc-48bb-b4fd-e90158c36f04_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_9ad73aa5-8594-422b-a17c-d12005ff7d85_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_894b4fc1-a072-42e5-8abc-5e6df4e86f62_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_802267b8-ab95-4b90-8931-3db90430f877_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_11b3fb79-3d3f-4243-a3ef-2c67849fffae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1bd2136b-d24d-4b7f-85d5-ea1f6391cf2b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_c2ea7b61-cd0e-47c0-b5db-64e4a681c886_terseLabel_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_label_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants, Fair Value Disclosure</link:label>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_documentation_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure" xlink:href="angn-20251231.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsFairValueDisclosure" xlink:to="lab_angn_WarrantsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3f5fd07b-7c3b-4a51-a254-fbcc1b0e1423_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange transaction gain</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_019b3432-a08d-7f3c-8b22-2e22262bd7b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_a6420ff2-3f16-4175-bc17-9c86f96a8b0f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_24f68413-6180-4cc6-adf3-3fe054057f87_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per common share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_baa951ac-ac4d-4070-a82f-ee29468feff9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4578ea0a-af21-494e-9fde-08467fca1193_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_2aea9ca4-0152-4384-9120-c5be1e28062a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_b4145347-a6d0-4d1b-a2fc-cee9d9bbc9ae_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a78e5d3b-8ba5-4c16-b058-c910796063b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ElicioWarrantsMember_019b2a7f-6cd7-7184-8df3-a28ea4ec6c00_terseLabel_en-US" xlink:label="lab_angn_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elicio Warrants</link:label>
    <link:label id="lab_angn_ElicioWarrantsMember_label_en-US" xlink:label="lab_angn_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Elicio Warrants [Member]</link:label>
    <link:label id="lab_angn_ElicioWarrantsMember_documentation_en-US" xlink:label="lab_angn_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Elicio Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ElicioWarrantsMember" xlink:href="angn-20251231.xsd#angn_ElicioWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ElicioWarrantsMember" xlink:to="lab_angn_ElicioWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4c16815-6db9-4584-9c37-2551ca1a776c_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares sold in offering (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019c9e50-4dac-786e-9d38-b46b1402e330_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issued of common stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_GKCCMember_019b2f3b-c470-73b4-84ff-cb2a8880b3c5_terseLabel_en-US" xlink:label="lab_angn_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GKCC</link:label>
    <link:label id="lab_angn_GKCCMember_label_en-US" xlink:label="lab_angn_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GKCC [Member]</link:label>
    <link:label id="lab_angn_GKCCMember_documentation_en-US" xlink:label="lab_angn_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GKCC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GKCCMember" xlink:href="angn-20251231.xsd#angn_GKCCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_GKCCMember" xlink:to="lab_angn_GKCCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_b07a3afa-3fb6-404d-a387-a0a7979e9b5a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_c622a5fa-940f-4fdb-83ea-e2e5abdf4ae3_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_cc3125b1-cd5d-4e3d-94e4-001838dbe700_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_A2022PlanMember_6785da48-be75-4ab8-a9e2-ebc0e2be64cd_terseLabel_en-US" xlink:label="lab_angn_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Plan</link:label>
    <link:label id="lab_angn_A2022PlanMember_label_en-US" xlink:label="lab_angn_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Plan [Member]</link:label>
    <link:label id="lab_angn_A2022PlanMember_documentation_en-US" xlink:label="lab_angn_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2022PlanMember" xlink:href="angn-20251231.xsd#angn_A2022PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_A2022PlanMember" xlink:to="lab_angn_A2022PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_877de68e-8b42-4822-a034-e83b1c32857e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_3521204f-69bd-4b86-8b39-f40abf3dfb4b_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_March2024PreFundedWarrantsMember_019b2a7f-6cd7-7d0f-8b9c-0794cf59ceaf_terseLabel_en-US" xlink:label="lab_angn_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_March2024PreFundedWarrantsMember_label_en-US" xlink:label="lab_angn_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_angn_March2024PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_angn_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_March2024PreFundedWarrantsMember" xlink:to="lab_angn_March2024PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_052a2be9-97ef-4d0d-b3ee-4a35ac4a6c85_terseLabel_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, beneficial ownership limitation, percentage</link:label>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_label_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Beneficial Ownership Limitation, Percentage</link:label>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_documentation_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Beneficial Ownership Limitation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:href="angn-20251231.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:to="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_636b03de-1579-4c88-b550-6431c93f2221_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ba3bf6bc-7625-4a8e-b605-37deb0683fbe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c1e1c82f-d46f-45ed-a041-48df10519480_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred research obligation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2d74d267-bac4-4614-989c-b299925ef183_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_d78be500-ef28-4e1c-9d7a-6e85d9ee64a7_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019b2f14-ca1b-7a6e-815f-6af820d68d4d_terseLabel_en-US" xlink:label="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate sales milestone payments per product</link:label>
    <link:label id="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_label_en-US" xlink:label="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</link:label>
    <link:label id="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_documentation_en-US" xlink:label="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:href="angn-20251231.xsd#angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:to="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9961d0b9-f701-4014-88c5-37eba2ca3c55_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less present value discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_ffe6084e-6ab8-4d01-8b53-3694307be709_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_019cd832-9a95-772b-ac8b-c3f8c8a7d9b5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other nontaxable and nondeductible items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3b98cf13-f20c-4fef-85be-c73b387f37df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_33a0e7bb-d5eb-45b0-a784-e824f94d151f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_A2021PlanMember_f5636a1e-4013-479e-b4a6-d227bd5accb5_terseLabel_en-US" xlink:label="lab_angn_A2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021 Plan</link:label>
    <link:label id="lab_angn_A2021PlanMember_label_en-US" xlink:label="lab_angn_A2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Plan [Member]</link:label>
    <link:label id="lab_angn_A2021PlanMember_documentation_en-US" xlink:label="lab_angn_A2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2021 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2021PlanMember" xlink:href="angn-20251231.xsd#angn_A2021PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_A2021PlanMember" xlink:to="lab_angn_A2021PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_761f0053-aaea-4b95-afb5-91e9f3ca5271_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_5439f64c-54b2-4043-929b-9c346c0b0a98_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_4fa7c630-0d54-4a24-96b3-850c9350b901_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0620e073-dc97-4a9b-b529-3f83c4bdc733_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_53252215-8ca2-4abb-a150-222b4c7756a3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_019b2b37-f6c4-70d2-95fa-2bde53626663_terseLabel_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January Public Offering</link:label>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_label_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Public Offering [Member]</link:label>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_documentation_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember" xlink:href="angn-20251231.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JanuaryPublicOfferingMember" xlink:to="lab_angn_JanuaryPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClinicalTrailMember_5c5d7c23-8901-40fc-a6d5-f22169e3fdad_terseLabel_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical trial expenses</link:label>
    <link:label id="lab_angn_ClinicalTrailMember_label_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Trail [Member]</link:label>
    <link:label id="lab_angn_ClinicalTrailMember_documentation_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Trail</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember" xlink:href="angn-20251231.xsd#angn_ClinicalTrailMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClinicalTrailMember" xlink:to="lab_angn_ClinicalTrailMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_562eae51-a825-43d0-b96a-22e8f99cff9f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2691399e-d832-48cd-b885-2cc8ddf47dfa_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_eefe3fac-ae3f-46bb-b3d0-49b0cd480085_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_e2b15e6f-0330-4b62-ad9c-6a07ceb3a52e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_6bc4102b-0be4-47ea-a616-b9292ad508d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_bc856c66-e43d-4ae6-946e-a9d625bff1ce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other nontaxable and nondeductible items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_54974f20-adb9-4844-b2db-b9cf0b069693_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_186605b1-d70e-4ce2-9b25-07b3dd699c71_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_119e9bc7-b31b-479d-a040-4bfd020a7916_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_96d02e8f-a49b-4038-b270-ae963d67f412_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_581e8669-619d-4099-8d8d-02fe228cc8d4_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share of shares issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_d0bbf959-588d-4e75-aafb-7c83792b1408_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_d4625060-65a2-4d8f-aa99-bb5af84073e6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock and common warrants from January 2025 Offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3ba88271-22f9-4198-b0aa-fe1bd7f10630_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_019b2f3b-c470-732d-9fea-6d35801017f4_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership maximum (as a percent)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Ownership Percent Maximum</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Ownership Percent Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:to="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_76e6da6c-3d36-4a2a-940f-4ee62fbe60dd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019b2aaa-c2d2-704b-8bb6-adae06fd9842_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c9e3d-5ec0-724a-b0e4-ac9ff1f7c392_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US federal statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_a0181d9b-1505-4312-a2b0-d654f10a3387_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_7f211661-89c6-433d-ab88-d68f35b09eb3_terseLabel_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued research and development</link:label>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_label_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_documentation_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent" xlink:href="angn-20251231.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedResearchAndDevelopmentCurrent" xlink:to="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_03f9b6c3-d44e-4fd3-93ef-103626a841cc_terseLabel_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_label_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Interest Premium For Convertible Preferred Stock</link:label>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_documentation_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Interest Premium For Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:to="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019cb8e3-749c-7190-98b1-baf1efa7747d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nondeductible stock based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_ef0e566a-c31e-4e61-9c3e-0e76f983b73c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic state and local taxes, net of federal effect</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b3037-2f88-74a7-a050-2f0a29650db3_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_9091caa1-a25e-482b-827d-1503e467ec46_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c6e1e493-32df-4621-aaf9-66e974c4b061_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_June2025CommonWarrantsMember_019b2a7f-6cd7-7f41-aa40-d62f4b0b002e_terseLabel_en-US" xlink:label="lab_angn_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants</link:label>
    <link:label id="lab_angn_June2025CommonWarrantsMember_label_en-US" xlink:label="lab_angn_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants [Member]</link:label>
    <link:label id="lab_angn_June2025CommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025CommonWarrantsMember" xlink:href="angn-20251231.xsd#angn_June2025CommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_June2025CommonWarrantsMember" xlink:to="lab_angn_June2025CommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9a3a3c80-5f4e-4054-a1fc-180dae5b7e2b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_2d6fbf0a-3d28-404a-a7fe-3f481e7ee0c7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_fb27d2e4-518d-42e8-b362-d173bef4ad5a_terseLabel_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, payment per year</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_label_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Annual Rent Expense</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_documentation_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Annual Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:href="angn-20251231.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:to="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_17265645-b0d4-4fa7-8f79-fb5464d1bd39_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4558dd14-721a-4f5a-b5a5-623fce616d44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e093d84a-7053-497b-a047-6e2da5ec4e7a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e556389-42d8-48ee-9a24-3eeef2a9861a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d13db626-7843-4020-8aa6-b838f53c07fc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_OtherMember_ed274294-d8a8-46a8-a1e8-caaaa1e868cf_terseLabel_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other research and development expenses</link:label>
    <link:label id="lab_angn_OtherMember_label_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_angn_OtherMember_documentation_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember" xlink:href="angn-20251231.xsd#angn_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_OtherMember" xlink:to="lab_angn_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_019c0865-33ab-7245-ace8-514cbf51def2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common warrants associated with June 2025 Promissory Note</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_6143261d-eb44-438a-891c-5d31bd67701b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ca860d0c-10ce-4a26-80e8-0f54960bc0ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ae8d2c2c-83d6-44a5-8c95-6aed4fa2798d_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the Business and Financial Condition</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_f9fb873c-7d7e-4d67-be88-f2bf47ff9408_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Gross unrecognized tax benefit, beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_1f1815d6-fc0c-41dc-a16b-2bb3ece0754a_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Gross unrecognized tax benefit, end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_8472dcee-cf59-4af5-9f05-f02e95bb5a75_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member_087d5c52-5dcc-462e-b149-5d96440ba949_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF July 2023</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) July 2023 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) July 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_83ac874d-576f-4f59-8350-2ee09c3b5d5b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_7ce94c15-97f1-4233-b755-b2bafc0b996a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_70fd80e5-abfe-44ec-90ca-a8ab2d644c8c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_29bbe975-8b8e-4542-ae8d-1205c0d1894b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_7bb937fa-c187-4c62-b53c-16337f50ba8b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019cd829-10b8-776e-8a6f-7b8c887c0543_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5a64018-308f-4f01-925f-84c3ab039c46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_3971fecf-702e-4079-bcf7-0945f4617fee_terseLabel_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Convertible Debt</link:label>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_label_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Debt [Member]</link:label>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_documentation_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember" xlink:href="angn-20251231.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ConversionOfConvertibleDebtMember" xlink:to="lab_angn_ConversionOfConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_bfcedd01-75e5-40bd-808b-8f4a8dd61b21_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 14,455 shares outstanding</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_b1352bad-7e9f-4b15-81ae-0eccfaeee379_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f3b7b3ad-2c5e-4931-87d3-34cb9b82e6af_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AuditInformationAbstract_label_en-US" xlink:label="lab_angn_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_angn_AuditInformationAbstract_documentation_en-US" xlink:label="lab_angn_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AuditInformationAbstract" xlink:href="angn-20251231.xsd#angn_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AuditInformationAbstract" xlink:to="lab_angn_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1a72bd64-3ae7-478a-8c95-f9bf6fb1c08e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate&#8212;operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_931c1759-0bf5-4214-89fe-ebec888c37e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_8f4c8b73-edac-4987-943f-f355f33f8ac7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Outstanding Warrants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_675d1675-694a-42e0-b7fe-eb0ccaaf61b5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_2f51db61-a551-45c0-b331-96b13383fb1a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_606643a8-11f4-4102-a61c-b95daf3174dd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon settlement of restricted stock units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_db672f22-69df-4b74-a3c5-3b893c4bab5f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_40d86a5c-0551-4df9-b434-00f95fe7383f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in computing net loss per share, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a69bb3a6-8934-4ffa-aaa5-fa48a86d3cc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_019b2bca-d6b3-72f2-9d32-24b261ad3818_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_62ca6f0f-9738-4e54-a87e-65c1e1c70249_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Net Loss Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_9055df30-2545-41ab-860d-fd0b4cee76b0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4eeb74b7-7e16-44ca-be5b-e9315352f3c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_46a47caa-514f-4bf5-800b-3d00500049da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants_d91c6211-0251-4f2c-aec6-1f0a8263c7b8_terseLabel_en-US" xlink:label="lab_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of liability-classified warrants to equity classified warrants</link:label>
    <link:label id="lab_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants_label_en-US" xlink:label="lab_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclass Liability-Classified Warrants to Equity Classified Warrants</link:label>
    <link:label id="lab_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants_documentation_en-US" xlink:label="lab_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclass Liability-Classified Warrants to Equity Classified Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" xlink:href="angn-20251231.xsd#angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" xlink:to="lab_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_019c086b-8bdf-749c-93b1-e4c9baf97f13_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_935e931c-892f-4d03-a5f1-60fb9528b4d1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_05a59685-b19d-4a49-bbcd-ddee6f5a0a06_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022 [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_019b302f-5148-79e8-a2de-a28d3846496f_terseLabel_en-US" xlink:label="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future minimum annual maintenance payments</link:label>
    <link:label id="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_label_en-US" xlink:label="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Future Minimum Maintenance Payments</link:label>
    <link:label id="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_documentation_en-US" xlink:label="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Future Minimum Maintenance Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:href="angn-20251231.xsd#angn_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:to="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11f26a49-5ebb-45aa-8a5e-67b63beb6951_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_af097723-8588-4577-b79d-0533ea5c19de_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_A2024PlanMember_f6aaedd6-3bba-4e1f-bc3d-388f329810d7_terseLabel_en-US" xlink:label="lab_angn_A2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Plan</link:label>
    <link:label id="lab_angn_A2024PlanMember_label_en-US" xlink:label="lab_angn_A2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Plan [Member]</link:label>
    <link:label id="lab_angn_A2024PlanMember_documentation_en-US" xlink:label="lab_angn_A2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024PlanMember" xlink:href="angn-20251231.xsd#angn_A2024PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_A2024PlanMember" xlink:to="lab_angn_A2024PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dfb16573-715a-4338-9c0f-94210e690154_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_aab62824-f114-4fbe-9eea-15ce9e7ebb30_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_03b947ce-1b21-4f8d-8af8-aa6277416450_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_abf5028d-9c2a-400b-be86-1ea0001a5d05_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term&#8212;operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6ddb41eb-ebf0-416e-b9be-dcbdf384be33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_89901479-8b04-47f1-a224-2dedc1690849_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_c8582ef2-d516-41f7-976f-6237aa1d58d5_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_6e6e2bde-9496-43b9-b5eb-b7fa00ad194f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_492501e0-c243-451f-94cf-74233e8c4b8b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_923d505d-7c84-4586-975e-ee4ffc36f6f4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_4b585d3c-ccf9-4014-9d85-a0259f19514e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock warrants from March 2024 Offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1f98be25-5dd1-46cb-9dda-6b4e5b714688_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c1114c9c-17d0-48d4-b834-25d7356cda63_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (unvested) (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_c3157ad3-5318-4b19-b541-7532bafecb2c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_95945960-1edc-45ca-95eb-f411f7a80507_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_BostonMassachusettsMember_1a6d2c3b-a6cd-4472-9ed9-1eda5e91cf2b_terseLabel_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts</link:label>
    <link:label id="lab_angn_BostonMassachusettsMember_label_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts [Member]</link:label>
    <link:label id="lab_angn_BostonMassachusettsMember_documentation_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember" xlink:href="angn-20251231.xsd#angn_BostonMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_BostonMassachusettsMember" xlink:to="lab_angn_BostonMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_3dc8012f-8e8d-43ed-9724-a7445574fc53_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024 [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_VestingOfRestrictedCommonStockNoncash_cdc3cb78-9fb5-45cf-bdf3-8eb0d0b451a6_terseLabel_en-US" xlink:label="lab_angn_VestingOfRestrictedCommonStockNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash vesting of restricted common stock</link:label>
    <link:label id="lab_angn_VestingOfRestrictedCommonStockNoncash_label_en-US" xlink:label="lab_angn_VestingOfRestrictedCommonStockNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Of Restricted Common Stock, Noncash</link:label>
    <link:label id="lab_angn_VestingOfRestrictedCommonStockNoncash_documentation_en-US" xlink:label="lab_angn_VestingOfRestrictedCommonStockNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Of Restricted Common Stock, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_VestingOfRestrictedCommonStockNoncash" xlink:href="angn-20251231.xsd#angn_VestingOfRestrictedCommonStockNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_VestingOfRestrictedCommonStockNoncash" xlink:to="lab_angn_VestingOfRestrictedCommonStockNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_716e7ef3-adc2-4f55-98ce-6454bc49520c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b1a2bcaf-8559-4e32-b8f7-a5643f029c7f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e7315f91-4999-4eeb-a250-0880f273d8da_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_32ae086e-cd52-4c5c-a923-41e602df7330_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_103f6ecc-753e-44cb-9379-1bd08dacd1ad_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_73b264e2-e24a-440c-84db-3f38a9bd6726_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_d3e6595f-66c3-417d-957a-5ce41839fdea_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1424c931-d4ee-4825-adce-8d9b23fe58d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_54d39a95-d3e6-4bba-b307-da12e11dd210_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_f9eb9d5c-edac-4a45-9424-bca8b45949ca_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_dddc9172-3d3a-4b6b-af27-7ca6b48d04b1_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_887130d4-18bf-4d88-821f-822e8ac3e21e_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7a8e-8cae-7c05f52ba3d2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0044064a-cdcc-4d74-bc46-24d1e2ace1a7_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_83f2b609-c043-4ec1-a41b-39cb901c6102_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>angn-20251231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:b764f3f1-1aa2-42b0-ba71-263b5668ebc9,g:54ff377e-34d5-4517-b79e-9773ed1b9e6a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.angn.com/role/Cover" xlink:type="simple" xlink:href="angn-20251231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d767013a-5830-4155-8df6-d40ce11cfd92" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_DocumentType_d767013a-5830-4155-8df6-d40ce11cfd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_b060024e-ed83-4520-961c-8bfe1cf89d3e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_DocumentAnnualReport_b060024e-ed83-4520-961c-8bfe1cf89d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b613422a-fc0a-42d9-9fa2-24117919d2f4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_DocumentPeriodEndDate_b613422a-fc0a-42d9-9fa2-24117919d2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6541b861-19b4-482b-869f-7cdcdab41c63" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_CurrentFiscalYearEndDate_6541b861-19b4-482b-869f-7cdcdab41c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8cc6d34f-cd0a-483e-a9f8-84e824401e59" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_DocumentTransitionReport_8cc6d34f-cd0a-483e-a9f8-84e824401e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_384b8c4a-4367-4127-9557-2f7fe8c18850" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityFileNumber_384b8c4a-4367-4127-9557-2f7fe8c18850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cc1d49c0-d488-421f-9e54-109444d50219" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityRegistrantName_cc1d49c0-d488-421f-9e54-109444d50219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6515d6d5-a18e-49df-adf4-df2403dd016c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6515d6d5-a18e-49df-adf4-df2403dd016c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f8e3723c-bc98-4406-9061-6e2ee68de983" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityTaxIdentificationNumber_f8e3723c-bc98-4406-9061-6e2ee68de983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2a13be23-fcf5-4303-87e6-190234c84886" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityAddressAddressLine1_2a13be23-fcf5-4303-87e6-190234c84886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_726f8c47-8793-4305-a138-17648823c478" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityAddressCityOrTown_726f8c47-8793-4305-a138-17648823c478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9b0baa44-3e3d-4d28-abe9-4b87470a4518" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityAddressStateOrProvince_9b0baa44-3e3d-4d28-abe9-4b87470a4518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a1271d81-388a-400b-b777-ec04d5600451" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityAddressPostalZipCode_a1271d81-388a-400b-b777-ec04d5600451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a72ce764-7e2b-42fd-9cfd-caca9a1cf934" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_CityAreaCode_a72ce764-7e2b-42fd-9cfd-caca9a1cf934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ee3f1e72-524a-4127-abe4-3a248340dff8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_LocalPhoneNumber_ee3f1e72-524a-4127-abe4-3a248340dff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ed24dbfc-83e7-47d7-a353-a1b82fa0dda6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_Security12bTitle_ed24dbfc-83e7-47d7-a353-a1b82fa0dda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3f8d51a9-0903-4e73-a22e-e8f48874ea67" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_TradingSymbol_3f8d51a9-0903-4e73-a22e-e8f48874ea67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_db493910-c076-4510-9c4c-098f789dfc9a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_SecurityExchangeName_db493910-c076-4510-9c4c-098f789dfc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_2b031141-299d-43e5-ba65-4616d4aac985" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_2b031141-299d-43e5-ba65-4616d4aac985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_f212cfa8-6d1c-440e-b788-6759c2261463" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityVoluntaryFilers_f212cfa8-6d1c-440e-b788-6759c2261463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e3775cc6-bcc1-4f7e-86cd-97639ec89f64" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityCurrentReportingStatus_e3775cc6-bcc1-4f7e-86cd-97639ec89f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0eafd044-a39b-43bb-aa6a-a44977b3018b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityInteractiveDataCurrent_0eafd044-a39b-43bb-aa6a-a44977b3018b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a532252c-31ad-4c70-9ee3-1f07da761da2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityFilerCategory_a532252c-31ad-4c70-9ee3-1f07da761da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b4dc536d-fdfd-4f00-aa52-d7e75ab314e8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntitySmallBusiness_b4dc536d-fdfd-4f00-aa52-d7e75ab314e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d50b69a9-a340-4f73-ae91-cd772e06341f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityEmergingGrowthCompany_d50b69a9-a340-4f73-ae91-cd772e06341f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_1e031e3d-222d-42f4-bf1b-41947d34bc34" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityExTransitionPeriod_1e031e3d-222d-42f4-bf1b-41947d34bc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_c2154da8-e60c-404c-b723-5884ec4b7cd9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_IcfrAuditorAttestationFlag_c2154da8-e60c-404c-b723-5884ec4b7cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_cba1c718-0cae-42ee-a0a4-01195dafed2d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_cba1c718-0cae-42ee-a0a4-01195dafed2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f76c7585-f5a6-428e-8b2a-d4a02ed816b3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityShellCompany_f76c7585-f5a6-428e-8b2a-d4a02ed816b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_c0d642c3-09a4-495c-bbbe-e012170937a2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityPublicFloat_c0d642c3-09a4-495c-bbbe-e012170937a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e02c9b57-55e9-47c3-a5b9-6a7493b98d5a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e02c9b57-55e9-47c3-a5b9-6a7493b98d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_f56e6e3b-6aca-49c2-a35d-b2238565f81b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_f56e6e3b-6aca-49c2-a35d-b2238565f81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_765e3eff-23ec-446b-97f4-93f2194bf6a5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_DocumentFiscalYearFocus_765e3eff-23ec-446b-97f4-93f2194bf6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_aad2e533-df1e-4184-b1c7-900bd8cbc479" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_DocumentFiscalPeriodFocus_aad2e533-df1e-4184-b1c7-900bd8cbc479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bf4040a6-7650-4b11-8d65-e46f86426edc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_EntityCentralIndexKey_bf4040a6-7650-4b11-8d65-e46f86426edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_547cad75-dca6-47c5-ad4b-9cb10ea4da30" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ce3fb2d9-ff52-4e2a-b789-1d23a63bb753" xlink:to="loc_dei_AmendmentFlag_547cad75-dca6-47c5-ad4b-9cb10ea4da30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/AuditInformation" xlink:type="simple" xlink:href="angn-20251231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_AuditInformationAbstract_fb92e65c-d577-4c95-ae52-fb08de41c349" xlink:href="angn-20251231.xsd#angn_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_6b44142e-6bd8-451f-97d8-411ea4d693ed" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_AuditInformationAbstract_fb92e65c-d577-4c95-ae52-fb08de41c349" xlink:to="loc_dei_AuditorName_6b44142e-6bd8-451f-97d8-411ea4d693ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c02c7046-93a1-4f82-81e7-ab25d55f6bd0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_AuditInformationAbstract_fb92e65c-d577-4c95-ae52-fb08de41c349" xlink:to="loc_dei_AuditorLocation_c02c7046-93a1-4f82-81e7-ab25d55f6bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_23aaa812-4d47-4282-91e9-f629c1334a60" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_AuditInformationAbstract_fb92e65c-d577-4c95-ae52-fb08de41c349" xlink:to="loc_dei_AuditorFirmId_23aaa812-4d47-4282-91e9-f629c1334a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b4e8e1c4-ce34-4f9e-82f9-4ec91d76cdc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c2e8b489-5591-4915-9e34-2625f98307e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b4e8e1c4-ce34-4f9e-82f9-4ec91d76cdc7" xlink:to="loc_us-gaap_AssetsAbstract_c2e8b489-5591-4915-9e34-2625f98307e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4af48590-6120-467f-af8e-95b5f66458cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2e8b489-5591-4915-9e34-2625f98307e6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4af48590-6120-467f-af8e-95b5f66458cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6b55597d-571a-4179-9e12-c52671ffa7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4af48590-6120-467f-af8e-95b5f66458cc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6b55597d-571a-4179-9e12-c52671ffa7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_34851fe2-79de-464a-b2a7-86945e69612d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4af48590-6120-467f-af8e-95b5f66458cc" xlink:to="loc_us-gaap_RestrictedCashCurrent_34851fe2-79de-464a-b2a7-86945e69612d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1464d9c9-a47e-4dbf-ba4e-235df2a49344" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4af48590-6120-467f-af8e-95b5f66458cc" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1464d9c9-a47e-4dbf-ba4e-235df2a49344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9c794ac7-e14b-499b-b1cd-fed73d60ecf4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4af48590-6120-467f-af8e-95b5f66458cc" xlink:to="loc_us-gaap_AssetsCurrent_9c794ac7-e14b-499b-b1cd-fed73d60ecf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a1db34c8-68e7-4100-95a8-79e42cfb7d93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2e8b489-5591-4915-9e34-2625f98307e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a1db34c8-68e7-4100-95a8-79e42cfb7d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d0a6b2eb-e8bb-430a-8121-7eb3dd90eade" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2e8b489-5591-4915-9e34-2625f98307e6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d0a6b2eb-e8bb-430a-8121-7eb3dd90eade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_441267c8-913f-4330-a2b3-cd980d594e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2e8b489-5591-4915-9e34-2625f98307e6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_441267c8-913f-4330-a2b3-cd980d594e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_dcdd7a1a-2d2e-479b-bc13-b148c088f585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2e8b489-5591-4915-9e34-2625f98307e6" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_dcdd7a1a-2d2e-479b-bc13-b148c088f585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e1213cdc-6834-47cf-918d-826d365a8876" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c2e8b489-5591-4915-9e34-2625f98307e6" xlink:to="loc_us-gaap_Assets_e1213cdc-6834-47cf-918d-826d365a8876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b4e8e1c4-ce34-4f9e-82f9-4ec91d76cdc7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4db5463a-c390-498a-b046-4729d608a967" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_4db5463a-c390-498a-b046-4729d608a967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b6a22a5c-a6e9-49d0-a375-014eb4c6d87f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4db5463a-c390-498a-b046-4729d608a967" xlink:to="loc_us-gaap_AccountsPayableCurrent_b6a22a5c-a6e9-49d0-a375-014eb4c6d87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6d8bc16e-6cf6-4e28-ad29-39bd06a9ee3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4db5463a-c390-498a-b046-4729d608a967" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6d8bc16e-6cf6-4e28-ad29-39bd06a9ee3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_00ce3cfc-60d1-492a-9855-9a703c111b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4db5463a-c390-498a-b046-4729d608a967" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_00ce3cfc-60d1-492a-9855-9a703c111b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c021d709-b786-4347-ad7d-ee7f93a4947a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4db5463a-c390-498a-b046-4729d608a967" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c021d709-b786-4347-ad7d-ee7f93a4947a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bc458cfc-cb91-49fd-bca3-6176c548fc6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4db5463a-c390-498a-b046-4729d608a967" xlink:to="loc_us-gaap_LiabilitiesCurrent_bc458cfc-cb91-49fd-bca3-6176c548fc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability_05aa6e72-4a4f-4b64-8c2e-90501f5b735c" xlink:href="angn-20251231.xsd#angn_WarrantLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:to="loc_angn_WarrantLiability_05aa6e72-4a4f-4b64-8c2e-90501f5b735c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dd053610-a4c8-402b-9d04-881b0436e8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dd053610-a4c8-402b-9d04-881b0436e8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019cd7af-3e86-78cc-97ba-0ad4cab26cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019cd7af-3e86-78cc-97ba-0ad4cab26cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4f67441d-e2f5-4ef7-adfe-bc620312e712" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:to="loc_us-gaap_Liabilities_4f67441d-e2f5-4ef7-adfe-bc620312e712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9441b64b-6277-4d22-bd1b-a0468ed7a2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9441b64b-6277-4d22-bd1b-a0468ed7a2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:to="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f96fd0fa-34b4-49c0-8403-b8a9aca3868c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:to="loc_us-gaap_PreferredStockValue_f96fd0fa-34b4-49c0-8403-b8a9aca3868c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_42b88ed0-45ac-465c-ba54-21fbcb834332" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:to="loc_us-gaap_CommonStockValue_42b88ed0-45ac-465c-ba54-21fbcb834332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_6fe457e2-74d5-4701-89f4-b34ad931dc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:to="loc_us-gaap_TreasuryStockCommonValue_6fe457e2-74d5-4701-89f4-b34ad931dc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_39b7402e-1e99-44a8-a920-3aeb00fd8c41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:to="loc_us-gaap_AdditionalPaidInCapital_39b7402e-1e99-44a8-a920-3aeb00fd8c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_672bfe3d-a80d-4f57-bd55-9703032cb5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_672bfe3d-a80d-4f57-bd55-9703032cb5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_88996983-0184-4fc3-9c71-0d5380b50bba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_88996983-0184-4fc3-9c71-0d5380b50bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ba613337-2c43-44d9-af96-5211471b1e28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd304ee8-e3fd-476d-a660-08499f2059ee" xlink:to="loc_us-gaap_StockholdersEquity_ba613337-2c43-44d9-af96-5211471b1e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cf61e27f-bb0b-4b77-979c-41c4a45ec6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_61d2c596-6b69-4e47-9dcf-a103da53bd38" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_cf61e27f-bb0b-4b77-979c-41c4a45ec6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c863f827-dc82-494d-9ac8-5bcbb97f7b28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_c863f827-dc82-494d-9ac8-5bcbb97f7b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2829f1be-a025-4024-84ef-18c1d2e77861" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2829f1be-a025-4024-84ef-18c1d2e77861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_986efc2b-8e1e-4ef7-9e43-ed709b2f0493" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_PreferredStockSharesIssued_986efc2b-8e1e-4ef7-9e43-ed709b2f0493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_88447c8f-9d2d-49c4-98ec-b6727eb43b50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_88447c8f-9d2d-49c4-98ec-b6727eb43b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2e72c4e3-ca91-4f5e-89c4-19e97652c446" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2e72c4e3-ca91-4f5e-89c4-19e97652c446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ad8abdef-543e-4bd9-a3be-285a4d6b16e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ad8abdef-543e-4bd9-a3be-285a4d6b16e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d0ec6e4f-f3e1-40be-9104-d30aaf0b9c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_CommonStockSharesIssued_d0ec6e4f-f3e1-40be-9104-d30aaf0b9c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5cf4a786-6d93-42be-ac7f-d2661270bcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5cf4a786-6d93-42be-ac7f-d2661270bcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6ef6cc7c-b8c2-4938-bad2-a62f94a3185e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9c39c250-d354-436d-8364-11d675da2aac" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6ef6cc7c-b8c2-4938-bad2-a62f94a3185e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_6768815d-edbb-4e9a-b922-a58ce80cbd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_6768815d-edbb-4e9a-b922-a58ce80cbd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_98e6a830-ba46-496b-92f3-7beb25a794ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6768815d-edbb-4e9a-b922-a58ce80cbd8f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_98e6a830-ba46-496b-92f3-7beb25a794ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_12acb875-92f6-42d1-825f-390cddc7da0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6768815d-edbb-4e9a-b922-a58ce80cbd8f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_12acb875-92f6-42d1-825f-390cddc7da0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d6ab1bef-cffd-423b-bacc-b4edebf992f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6768815d-edbb-4e9a-b922-a58ce80cbd8f" xlink:to="loc_us-gaap_CostsAndExpenses_d6ab1bef-cffd-423b-bacc-b4edebf992f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f794d6df-9a6e-4ca3-844d-c037563b9459" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_OperatingIncomeLoss_f794d6df-9a6e-4ca3-844d-c037563b9459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_8d62da2d-8f1f-45bd-9d1d-5da8066b9771" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_8d62da2d-8f1f-45bd-9d1d-5da8066b9771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_4652c171-729e-4709-8d69-ceac1e679ec2" xlink:href="angn-20251231.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_4652c171-729e-4709-8d69-ceac1e679ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_123eaadd-2f40-47ae-9a4b-3a62cf12e377" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_123eaadd-2f40-47ae-9a4b-3a62cf12e377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e1fe2c65-e377-43ef-9695-532a7b40b2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e1fe2c65-e377-43ef-9695-532a7b40b2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating_019c085f-fd25-71e1-9d65-a65ffb38d90c" xlink:href="angn-20251231.xsd#angn_GrantRevenueNonoperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_angn_GrantRevenueNonoperating_019c085f-fd25-71e1-9d65-a65ffb38d90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating_935bf0f3-5af2-4582-9182-30159c894714" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_us-gaap_InterestIncomeOperatingAndNonoperating_935bf0f3-5af2-4582-9182-30159c894714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_f95fb224-4a79-48d7-b7f3-60ac8889957c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_us-gaap_InterestExpenseNonoperating_f95fb224-4a79-48d7-b7f3-60ac8889957c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1b82f300-4c6a-4ce2-8480-5f9dfad82474" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1b82f300-4c6a-4ce2-8480-5f9dfad82474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6a5bf242-561a-4fbd-9aa4-3c517f060fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_04ae3060-94d7-4bd5-ad95-71fd9c135b97" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6a5bf242-561a-4fbd-9aa4-3c517f060fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4267d4b9-f238-44e8-87e0-a174abd16038" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_NetIncomeLoss_4267d4b9-f238-44e8-87e0-a174abd16038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_f240ed39-9b89-47ff-bd04-32a696e00820" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_f240ed39-9b89-47ff-bd04-32a696e00820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2ebace44-42b1-40bc-9dcb-bb2a505b58ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_f240ed39-9b89-47ff-bd04-32a696e00820" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2ebace44-42b1-40bc-9dcb-bb2a505b58ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7267f0f0-e18e-4a75-8b72-0d1981a103d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7267f0f0-e18e-4a75-8b72-0d1981a103d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_038b1db9-e79e-4206-8c52-9d76e0dde9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_EarningsPerShareBasic_038b1db9-e79e-4206-8c52-9d76e0dde9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0794b996-1599-4cf7-93b8-f49768589be1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0794b996-1599-4cf7-93b8-f49768589be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dd372401-9c57-4ada-a3ba-85984a0a4c09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dd372401-9c57-4ada-a3ba-85984a0a4c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f6436091-97cf-438d-b9c6-22a0295db6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23a482fe-22db-43c0-b70f-bb97c75f944f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f6436091-97cf-438d-b9c6-22a0295db6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_901c95fa-3a6d-46ea-915b-167ecde4a85c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_901c95fa-3a6d-46ea-915b-167ecde4a85c" xlink:to="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_08a615de-3661-4d10-82c2-32899c0d0152" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_08a615de-3661-4d10-82c2-32899c0d0152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08a615de-3661-4d10-82c2-32899c0d0152" xlink:to="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c4703b0-0100-4e2c-b712-90f4b7e8e7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_CommonStockMember_8c4703b0-0100-4e2c-b712-90f4b7e8e7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_9f5e2491-1168-409e-b180-15cfd46e2287" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_TreasuryStockCommonMember_9f5e2491-1168-409e-b180-15cfd46e2287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_21a903e4-3fc2-4e2e-8e92-d7453c0dd62b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_21a903e4-3fc2-4e2e-8e92-d7453c0dd62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_257881cb-41e6-4941-8919-0f500576283f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_257881cb-41e6-4941-8919-0f500576283f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1dcefe0e-deec-49bc-ad93-74f1928b0584" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c16119a-4543-4007-860a-d048ea366115" xlink:to="loc_us-gaap_RetainedEarningsMember_1dcefe0e-deec-49bc-ad93-74f1928b0584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e526e961-0a3b-4f5b-8443-426e72b98209" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e526e961-0a3b-4f5b-8443-426e72b98209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e526e961-0a3b-4f5b-8443-426e72b98209" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember_a0b3bdb1-01ec-40ca-9af4-c1af52fc8720" xlink:href="angn-20251231.xsd#angn_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:to="loc_angn_AtTheMarketOfferingMember_a0b3bdb1-01ec-40ca-9af4-c1af52fc8720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryOfferingMember_019c0ce9-d791-71b0-9285-a6a4049fed2a" xlink:href="angn-20251231.xsd#angn_JanuaryOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:to="loc_angn_JanuaryOfferingMember_019c0ce9-d791-71b0-9285-a6a4049fed2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_d666888b-5b77-41eb-9bde-3db0c8c6a28a" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86396157-6a13-4d23-ac16-fc5e5914e2b8" xlink:to="loc_angn_July2024PublicOfferingMember_d666888b-5b77-41eb-9bde-3db0c8c6a28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019c0871-e821-7839-bc0c-a0ec04241ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019c0871-e821-7839-bc0c-a0ec04241ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_019c0871-e821-783b-95d7-811decca0d85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_019c0871-e821-7839-bc0c-a0ec04241ec9" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_019c0871-e821-783b-95d7-811decca0d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember_019c0871-e821-790e-89b7-699a8e968f5c" xlink:href="angn-20251231.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_019c0871-e821-783b-95d7-811decca0d85" xlink:to="loc_angn_ConversionOfConvertibleDebtMember_019c0871-e821-790e-89b7-699a8e968f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c90c6a8b-d2da-441a-a8b5-1b0d0ad40d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8c150d81-fc70-4a74-8842-ca6c559ae827" xlink:to="loc_us-gaap_StatementLineItems_c90c6a8b-d2da-441a-a8b5-1b0d0ad40d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c90c6a8b-d2da-441a-a8b5-1b0d0ad40d8c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6675c073-bc09-45fc-aa88-54158f7aceef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6675c073-bc09-45fc-aa88-54158f7aceef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88463bf9-0f3a-4721-9c75-6637c80b49b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockholdersEquity_88463bf9-0f3a-4721-9c75-6637c80b49b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_345f6796-b8e3-441f-b04d-93c823f92831" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_TreasuryStockCommonShares_345f6796-b8e3-441f-b04d-93c823f92831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5913f740-3f66-4008-8404-3d810ae724f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5913f740-3f66-4008-8404-3d810ae724f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1c14c33b-9448-4cf3-a2c6-abf4bf065f17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1c14c33b-9448-4cf3-a2c6-abf4bf065f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3c0dbb86-6cdd-4b60-b633-b680f6ed0344" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3c0dbb86-6cdd-4b60-b633-b680f6ed0344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4d6c18a6-9017-416e-9370-1e3bc9791e29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4d6c18a6-9017-416e-9370-1e3bc9791e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants_be919da2-c0a8-444c-a2ce-05d178654019" xlink:href="angn-20251231.xsd#angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants_be919da2-c0a8-444c-a2ce-05d178654019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c3cf72f2-21cb-4e8f-91e9-cc3d5753c68e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c3cf72f2-21cb-4e8f-91e9-cc3d5753c68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c0871-e821-7961-a38e-dbc51d6a0d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c0871-e821-7961-a38e-dbc51d6a0d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019c0874-db6c-7422-8a62-9f127530cbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_019c0874-db6c-7422-8a62-9f127530cbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_019c0865-33ab-7554-9c7c-5d0f99bd285b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_019c0865-33ab-7554-9c7c-5d0f99bd285b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a4af1066-484e-4132-91f2-fe73f7f4f31b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a4af1066-484e-4132-91f2-fe73f7f4f31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3acb45a9-26ce-49ce-8e02-cd55ea56389a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3acb45a9-26ce-49ce-8e02-cd55ea56389a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6439e876-ebf5-40b0-9f0f-9971d188973e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_NetIncomeLoss_6439e876-ebf5-40b0-9f0f-9971d188973e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c84bc67a-a8f1-4d56-8f8a-9dfa80c826e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c84bc67a-a8f1-4d56-8f8a-9dfa80c826e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d336327b-cc0a-4c28-87f3-f1edd825e949" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d336327b-cc0a-4c28-87f3-f1edd825e949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants_7baca339-358e-4b4a-839f-26a9847d7193" xlink:href="angn-20251231.xsd#angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants_7baca339-358e-4b4a-839f-26a9847d7193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9a4741c8-d528-4477-9095-72166fbda930" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9a4741c8-d528-4477-9095-72166fbda930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9cd14fb3-4112-4989-a50e-31d1decb46a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_StockholdersEquity_9cd14fb3-4112-4989-a50e-31d1decb46a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_e3fd67cb-6ad6-4d4c-a1c1-955177a0255a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f3221eff-ac01-4cf6-a9b4-76f3c6524b42" xlink:to="loc_us-gaap_TreasuryStockCommonShares_e3fd67cb-6ad6-4d4c-a1c1-955177a0255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9695eef1-8595-4f89-a1f8-b4fd4087dc51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_41fe7e0c-2b5f-404e-a57f-1b189673e741" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9695eef1-8595-4f89-a1f8-b4fd4087dc51" xlink:to="loc_us-gaap_StatementTable_41fe7e0c-2b5f-404e-a57f-1b189673e741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b5a29d16-60ef-487d-ba47-823daa5345b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_41fe7e0c-2b5f-404e-a57f-1b189673e741" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b5a29d16-60ef-487d-ba47-823daa5345b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b5a29d16-60ef-487d-ba47-823daa5345b0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember_019c0ce2-41c8-7132-bb12-20d13c260fd4" xlink:href="angn-20251231.xsd#angn_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:to="loc_angn_AtTheMarketOfferingMember_019c0ce2-41c8-7132-bb12-20d13c260fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryOfferingMember_019c0cee-ce2a-7e72-8215-8854fb98f96a" xlink:href="angn-20251231.xsd#angn_JanuaryOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:to="loc_angn_JanuaryOfferingMember_019c0cee-ce2a-7e72-8215-8854fb98f96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_14299d84-d6eb-4160-894a-73797bc11190" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89fe72bf-bfda-4694-bc7c-4670ebaa6104" xlink:to="loc_angn_July2024PublicOfferingMember_14299d84-d6eb-4160-894a-73797bc11190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_04e502cd-f6d3-4570-8a7e-87a6a6d6fe02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_41fe7e0c-2b5f-404e-a57f-1b189673e741" xlink:to="loc_us-gaap_StatementLineItems_04e502cd-f6d3-4570-8a7e-87a6a6d6fe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_dda74429-54a5-40cf-a265-f87b5d57b8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04e502cd-f6d3-4570-8a7e-87a6a6d6fe02" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_dda74429-54a5-40cf-a265-f87b5d57b8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019c086b-8bdf-7248-81e3-07fd3f1dae76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04e502cd-f6d3-4570-8a7e-87a6a6d6fe02" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019c086b-8bdf-7248-81e3-07fd3f1dae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="angn-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bde75c8b-b63f-4285-8448-8b17703c7c15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bde75c8b-b63f-4285-8448-8b17703c7c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6c3bf7cc-39f3-487d-a5c5-87974a43f8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bde75c8b-b63f-4285-8448-8b17703c7c15" xlink:to="loc_us-gaap_NetIncomeLoss_6c3bf7cc-39f3-487d-a5c5-87974a43f8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bde75c8b-b63f-4285-8448-8b17703c7c15" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d0f32d02-aeae-42a4-bb1a-a399f6665f65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_us-gaap_Depreciation_d0f32d02-aeae-42a4-bb1a-a399f6665f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_40291e64-59e4-4d80-a543-969867077ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_40291e64-59e4-4d80-a543-969867077ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_d5ef450f-0412-429f-b842-599b09d5e353" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_d5ef450f-0412-429f-b842-599b09d5e353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash_922e9a26-6928-4582-80f8-5c195e869fb6" xlink:href="angn-20251231.xsd#angn_InterestExpenseNoncash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_angn_InterestExpenseNoncash_922e9a26-6928-4582-80f8-5c195e869fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CostsExpensedUponTheIssuanceOfWarrants_c399533b-e5cc-44ac-9ead-a15459e834bd" xlink:href="angn-20251231.xsd#angn_CostsExpensedUponTheIssuanceOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_angn_CostsExpensedUponTheIssuanceOfWarrants_c399533b-e5cc-44ac-9ead-a15459e834bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_aad6be96-bcd0-44ed-b21a-daf1da110b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_aad6be96-bcd0-44ed-b21a-daf1da110b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_0ea62f36-4eb8-4d2c-981b-0982ce83576e" xlink:href="angn-20251231.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_0ea62f36-4eb8-4d2c-981b-0982ce83576e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_898a2894-28f5-47d0-ad91-0ddc57937886" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_us-gaap_ShareBasedCompensation_898a2894-28f5-47d0-ad91-0ddc57937886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5d2ff698-d1f4-4970-a0dd-ca747feb751d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5d2ff698-d1f4-4970-a0dd-ca747feb751d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ea3fb6f-b97d-405b-b2e2-9717c57d028a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01cef18f-0b37-4a8b-a9ae-98635515a919" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ea3fb6f-b97d-405b-b2e2-9717c57d028a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f508f0fd-0d67-4d77-ab8d-ccabe28081d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ea3fb6f-b97d-405b-b2e2-9717c57d028a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f508f0fd-0d67-4d77-ab8d-ccabe28081d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_fa26a194-8624-444f-b08c-4aedce70c8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ea3fb6f-b97d-405b-b2e2-9717c57d028a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_fa26a194-8624-444f-b08c-4aedce70c8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b9f146a8-a87c-4030-9c6c-1bc852df96ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ea3fb6f-b97d-405b-b2e2-9717c57d028a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b9f146a8-a87c-4030-9c6c-1bc852df96ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7406aa26-b2ab-442e-b56f-5213e69c06e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ea3fb6f-b97d-405b-b2e2-9717c57d028a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7406aa26-b2ab-442e-b56f-5213e69c06e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_48ee83a1-517e-4788-9eb0-c158815db2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ea3fb6f-b97d-405b-b2e2-9717c57d028a" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_48ee83a1-517e-4788-9eb0-c158815db2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_58595205-4b33-4238-b114-37cf4532cfda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ea3fb6f-b97d-405b-b2e2-9717c57d028a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_58595205-4b33-4238-b114-37cf4532cfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef3e0f5c-b8c7-454a-97dd-7ab251237b59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bde75c8b-b63f-4285-8448-8b17703c7c15" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ef3e0f5c-b8c7-454a-97dd-7ab251237b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_33302b16-40b7-41f2-9ad0-3c0ef8cca403" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_33302b16-40b7-41f2-9ad0-3c0ef8cca403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08afba90-09d7-4a62-89b5-fd686f32f935" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_33302b16-40b7-41f2-9ad0-3c0ef8cca403" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08afba90-09d7-4a62-89b5-fd686f32f935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e26e1e57-0704-49ea-a0d7-8bc9eb75017e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_33302b16-40b7-41f2-9ad0-3c0ef8cca403" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e26e1e57-0704-49ea-a0d7-8bc9eb75017e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_87279991-9a57-4b44-b3b0-af2eb3ed487e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_33302b16-40b7-41f2-9ad0-3c0ef8cca403" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_87279991-9a57-4b44-b3b0-af2eb3ed487e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_c0634600-9fa5-4b2c-9479-57334e884f22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_c0634600-9fa5-4b2c-9479-57334e884f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_ffb741af-bcda-49aa-81df-af5a0465973d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_ffb741af-bcda-49aa-81df-af5a0465973d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ace4cc9d-661d-4c4c-af95-a349e03d10a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_ace4cc9d-661d-4c4c-af95-a349e03d10a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering_8d933c54-0266-40e2-848a-5b5f5211ebc3" xlink:href="angn-20251231.xsd#angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering_8d933c54-0266-40e2-848a-5b5f5211ebc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6664226e-a72c-425b-8803-90c02812c2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6664226e-a72c-425b-8803-90c02812c2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering_70e59c73-8094-4080-9f20-a58dedb32fab" xlink:href="angn-20251231.xsd#angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering_70e59c73-8094-4080-9f20-a58dedb32fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PaymentOfWarrantIssuanceCosts_550c4905-3319-4104-8f5a-8ba2ca024acb" xlink:href="angn-20251231.xsd#angn_PaymentOfWarrantIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_angn_PaymentOfWarrantIssuanceCosts_550c4905-3319-4104-8f5a-8ba2ca024acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d04dc0b4-3131-4b7a-864f-d52e0a7aedb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d04dc0b4-3131-4b7a-864f-d52e0a7aedb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_bfb2b79a-8d76-4194-815b-00d164f5fde6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_bfb2b79a-8d76-4194-815b-00d164f5fde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_569bcaca-35fd-4a36-802f-e30202d6c8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_569bcaca-35fd-4a36-802f-e30202d6c8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f213c54d-7f0b-4128-b1ae-8240f5b42cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_787b6f3f-64cc-429d-abd0-9c859bba98b2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f213c54d-7f0b-4128-b1ae-8240f5b42cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3ff0beb-f789-41b6-bb50-6c6c8de15263" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3ff0beb-f789-41b6-bb50-6c6c8de15263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6cb97fff-c25d-43aa-9c0a-72aa710fcc65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6cb97fff-c25d-43aa-9c0a-72aa710fcc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c3144c9-a273-4f77-9b51-bca981e0d0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c3144c9-a273-4f77-9b51-bca981e0d0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_58e03a7d-bcca-4788-bf73-74e1834495c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_58e03a7d-bcca-4788-bf73-74e1834495c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_63a1cd1e-8ccd-4789-bbc2-425f76345571" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_63a1cd1e-8ccd-4789-bbc2-425f76345571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6a8e5bb-3438-4ac2-baff-9879ac4454b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_63a1cd1e-8ccd-4789-bbc2-425f76345571" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6a8e5bb-3438-4ac2-baff-9879ac4454b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_2159c743-d9a0-4f85-976f-27e76f6a5301" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_63a1cd1e-8ccd-4789-bbc2-425f76345571" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_2159c743-d9a0-4f85-976f-27e76f6a5301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dbc81a7a-2db7-45b5-94c1-22635918734e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_63a1cd1e-8ccd-4789-bbc2-425f76345571" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dbc81a7a-2db7-45b5-94c1-22635918734e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fb5f712b-4bda-4064-abb3-9ce7e51c1da0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfPreFundedWarrants_f7a6bbe5-3adf-46be-b96d-332eea96d108" xlink:href="angn-20251231.xsd#angn_FairValueOfPreFundedWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:to="loc_angn_FairValueOfPreFundedWarrants_f7a6bbe5-3adf-46be-b96d-332eea96d108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrants_8308dd60-9cf0-47e3-a90f-df9fcb5e1c40" xlink:href="angn-20251231.xsd#angn_FairValueOfCommonStockWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:to="loc_angn_FairValueOfCommonStockWarrants_8308dd60-9cf0-47e3-a90f-df9fcb5e1c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrantsUponSettlement_019c084f-ae23-7291-8ca7-9a2fd197af6d" xlink:href="angn-20251231.xsd#angn_FairValueOfCommonStockWarrantsUponSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:to="loc_angn_FairValueOfCommonStockWarrantsUponSettlement_019c084f-ae23-7291-8ca7-9a2fd197af6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccretionOfPromissoryNoteToFaceValue_e1faa450-71d3-4e21-990b-eaeb6eb96ba4" xlink:href="angn-20251231.xsd#angn_AccretionOfPromissoryNoteToFaceValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:to="loc_angn_AccretionOfPromissoryNoteToFaceValue_e1faa450-71d3-4e21-990b-eaeb6eb96ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantIssuedStockIssuance_019c0851-2e7f-7fdd-a8ff-de64e96efe16" xlink:href="angn-20251231.xsd#angn_WarrantIssuedStockIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:to="loc_angn_WarrantIssuedStockIssuance_019c0851-2e7f-7fdd-a8ff-de64e96efe16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantIssuedDebtIssuance_019c0852-5887-7152-9591-b75fed92524d" xlink:href="angn-20251231.xsd#angn_WarrantIssuedDebtIssuance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:to="loc_angn_WarrantIssuedDebtIssuance_019c0852-5887-7152-9591-b75fed92524d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_VestingOfRestrictedCommonStockNoncash_bdcdbb61-50dd-47e8-befe-4c56d214e846" xlink:href="angn-20251231.xsd#angn_VestingOfRestrictedCommonStockNoncash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:to="loc_angn_VestingOfRestrictedCommonStockNoncash_bdcdbb61-50dd-47e8-befe-4c56d214e846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1_8b478021-a81e-4571-8c18-4ab2cf386b76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0fb739ac-129f-45d3-bb6d-cc4139c29098" xlink:to="loc_us-gaap_ConversionOfStockAmountIssued1_8b478021-a81e-4571-8c18-4ab2cf386b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition" xlink:type="simple" xlink:href="angn-20251231.xsd#DescriptionoftheBusinessandFinancialCondition"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4411ae0b-b00b-430e-b8a4-61580c93c921" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_986f2fd8-467f-45e9-a2e7-d631ec5b56d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4411ae0b-b00b-430e-b8a4-61580c93c921" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_986f2fd8-467f-45e9-a2e7-d631ec5b56d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="angn-20251231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6179ce03-4f7c-410b-977f-47662d8e66d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_19b706f4-7b50-4aea-a3b8-040383477529" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6179ce03-4f7c-410b-977f-47662d8e66d2" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_19b706f4-7b50-4aea-a3b8-040383477529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_130e0fd5-e453-440c-9371-6786fc0048bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_a0f4a5df-a79f-4d21-ba10-1939b963f5af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_130e0fd5-e453-440c-9371-6786fc0048bf" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_a0f4a5df-a79f-4d21-ba10-1939b963f5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_830eb59a-ba6e-4bf5-8ae6-7670337348c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_bb1ff4b7-88eb-4993-8c1e-97136ce8e5be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_830eb59a-ba6e-4bf5-8ae6-7670337348c7" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_bb1ff4b7-88eb-4993-8c1e-97136ce8e5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrant" xlink:type="simple" xlink:href="angn-20251231.xsd#ResearchGrant"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ResearchGrant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_a5ee2089-caf5-4542-8810-6e44861694c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_bb8015fe-8fba-41d6-8ef6-9aeb163aa3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_a5ee2089-caf5-4542-8810-6e44861694c1" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_bb8015fe-8fba-41d6-8ef6-9aeb163aa3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommonStockandStockholdersEquity" xlink:type="simple" xlink:href="angn-20251231.xsd#CommonStockandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommonStockandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b4c07510-9587-4f0e-b64e-8fb4b06210b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_77b8080b-aab1-4750-92f0-495415bfbc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b4c07510-9587-4f0e-b64e-8fb4b06210b2" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_77b8080b-aab1-4750-92f0-495415bfbc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_27256097-5e00-4c4c-a504-d88655373f97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bf58c42a-e659-4208-b868-cf58a25d94f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_27256097-5e00-4c4c-a504-d88655373f97" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bf58c42a-e659-4208-b868-cf58a25d94f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Warrants" xlink:type="simple" xlink:href="angn-20251231.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_20444a1f-4215-421e-b177-6113087be760" xlink:href="angn-20251231.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingTextBlock_f93148dc-2680-44e6-b181-09a39d7f2414" xlink:href="angn-20251231.xsd#angn_WarrantsAndRightsOutstandingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_20444a1f-4215-421e-b177-6113087be760" xlink:to="loc_angn_WarrantsAndRightsOutstandingTextBlock_f93148dc-2680-44e6-b181-09a39d7f2414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="angn-20251231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_54f82203-047b-40f2-9bd9-c9973a7e4caa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_85602895-f5f9-4a34-8f17-980afe5dda9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_54f82203-047b-40f2-9bd9-c9973a7e4caa" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_85602895-f5f9-4a34-8f17-980afe5dda9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Leases" xlink:type="simple" xlink:href="angn-20251231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cd316599-734a-49ae-aee4-cee25d5412b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_e1ac784d-6c57-48b3-a4ff-813cbe7f268c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cd316599-734a-49ae-aee4-cee25d5412b2" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_e1ac784d-6c57-48b3-a4ff-813cbe7f268c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Debt" xlink:type="simple" xlink:href="angn-20251231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f5fa8418-3f51-461b-8cb2-4bcb17844d73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_71fd6992-db8d-4e44-aa4e-985872f0623e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f5fa8418-3f51-461b-8cb2-4bcb17844d73" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_71fd6992-db8d-4e44-aa4e-985872f0623e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxes" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f6099826-4e40-4a2c-b50b-e4ec0a9e4989" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_e2f1b6ca-f7e1-4f4e-8c68-5e99095bff04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f6099826-4e40-4a2c-b50b-e4ec0a9e4989" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_e2f1b6ca-f7e1-4f4e-8c68-5e99095bff04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="angn-20251231.xsd#EmployeeBenefitPlan"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/EmployeeBenefitPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ef72b018-422f-4443-b103-67c9e9c9c520" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock_9730f25f-37bc-4e87-a347-87272abe9fde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ef72b018-422f-4443-b103-67c9e9c9c520" xlink:to="loc_us-gaap_DefinedContributionPlanTextBlock_9730f25f-37bc-4e87-a347-87272abe9fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShare" xlink:type="simple" xlink:href="angn-20251231.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4fd9db80-cac3-42c4-8fe9-08456a4b893e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0f18c1a3-e073-4d8b-aaa3-de31ed8fd8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4fd9db80-cac3-42c4-8fe9-08456a4b893e" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0f18c1a3-e073-4d8b-aaa3-de31ed8fd8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="angn-20251231.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0d725873-c81d-4662-beef-4d9e54ed2a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0a4f9a58-aca3-4ccc-a02a-284f7889588c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0d725873-c81d-4662-beef-4d9e54ed2a0e" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0a4f9a58-aca3-4ccc-a02a-284f7889588c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReporting" xlink:type="simple" xlink:href="angn-20251231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b4f93d36-16e4-4980-8bea-87e370a3f405" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b89ad368-46a3-4cf8-ba3c-e62a2b843882" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b4f93d36-16e4-4980-8bea-87e370a3f405" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b89ad368-46a3-4cf8-ba3c-e62a2b843882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SubsequentEvents" xlink:type="simple" xlink:href="angn-20251231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_965f08a6-cc91-43d3-82e2-f987610c6eab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_56754893-131b-450a-8e19-2474637bff08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_965f08a6-cc91-43d3-82e2-f987610c6eab" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_56754893-131b-450a-8e19-2474637bff08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="angn-20251231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6cfb6fe9-ea64-4f2a-839c-482fc57297bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6cfb6fe9-ea64-4f2a-839c-482fc57297bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_848cbcbc-dbf7-4e2c-ab98-49b216cf06e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_848cbcbc-dbf7-4e2c-ab98-49b216cf06e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9f975e7b-a714-4e7b-857b-4130e07b7f69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9f975e7b-a714-4e7b-857b-4130e07b7f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_87246b86-7df3-411e-af37-362d12128d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_UseOfEstimates_87246b86-7df3-411e-af37-362d12128d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b7827706-2d04-469e-a95a-b878b372078e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b7827706-2d04-469e-a95a-b878b372078e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_0bb54b2b-345f-4936-8cd2-d58c3ee29a16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_0bb54b2b-345f-4936-8cd2-d58c3ee29a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_581c4484-0476-4e00-b5df-dc56394b33ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_581c4484-0476-4e00-b5df-dc56394b33ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_db40329b-6e11-4a32-9224-4558241f1945" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_db40329b-6e11-4a32-9224-4558241f1945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_60011ca0-6f48-4dc8-b4a9-8936c066a91e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_60011ca0-6f48-4dc8-b4a9-8936c066a91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_c48ddbe4-ec88-4517-ae62-563c9310e32d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_c48ddbe4-ec88-4517-ae62-563c9310e32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_25acb800-c014-41f3-ad08-650b56b0dd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_DebtPolicyTextBlock_25acb800-c014-41f3-ad08-650b56b0dd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_9921475e-09d0-4806-bd4f-e02caa0ec19e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_9921475e-09d0-4806-bd4f-e02caa0ec19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_e899af27-4f35-40a0-8ca0-f20118e67bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_e899af27-4f35-40a0-8ca0-f20118e67bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_7649005c-64fb-4dac-aff2-14018b1bb5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_7649005c-64fb-4dac-aff2-14018b1bb5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d13514e4-781f-4c79-b21f-5bc0578ab03f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d13514e4-781f-4c79-b21f-5bc0578ab03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_019c898d-e83c-7292-9ba4-785f8edc52e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_019c898d-e83c-7292-9ba4-785f8edc52e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_c420a02b-e2a0-46ee-93b5-057e8dbb8eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_c420a02b-e2a0-46ee-93b5-057e8dbb8eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8d4fbf3d-2f8d-4e8c-bb29-4e026ceb9a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8d4fbf3d-2f8d-4e8c-bb29-4e026ceb9a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9c6b4c84-97d1-4e9c-b6c4-9f955058bc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f85b23f-a414-4f44-abf9-28ce45b31b07" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9c6b4c84-97d1-4e9c-b6c4-9f955058bc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="angn-20251231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d28ac18a-c89d-416a-ae1f-3a6d3eb09bed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7267f054-735b-4725-a92e-241288dcb6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d28ac18a-c89d-416a-ae1f-3a6d3eb09bed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7267f054-735b-4725-a92e-241288dcb6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f6b42de1-119b-4f6e-ae38-aefda81e8fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_078ce0f6-924d-440d-bb1f-bfd1cfe3c560" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f6b42de1-119b-4f6e-ae38-aefda81e8fe1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_078ce0f6-924d-440d-bb1f-bfd1cfe3c560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d349a735-b46c-4d4d-896c-aa4739c10c13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f6b42de1-119b-4f6e-ae38-aefda81e8fe1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d349a735-b46c-4d4d-896c-aa4739c10c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ea3b1a1b-94c7-48ee-8dff-1f7d6a2c5cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f6b42de1-119b-4f6e-ae38-aefda81e8fe1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ea3b1a1b-94c7-48ee-8dff-1f7d6a2c5cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41f24a74-0a70-48ad-ac5a-607b6669546d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_38104cde-6417-4d57-9771-f5e171973cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41f24a74-0a70-48ad-ac5a-607b6669546d" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_38104cde-6417-4d57-9771-f5e171973cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_92784d18-3f8f-4fdf-bdae-5400edcfab3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41f24a74-0a70-48ad-ac5a-607b6669546d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_92784d18-3f8f-4fdf-bdae-5400edcfab3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_e78b1835-af0e-4b2b-97a6-478fa2ea5fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41f24a74-0a70-48ad-ac5a-607b6669546d" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_e78b1835-af0e-4b2b-97a6-478fa2ea5fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aa56c94b-e159-4035-a74f-11384cff045a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0469b79c-8300-487a-b2af-e8aea7c90ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aa56c94b-e159-4035-a74f-11384cff045a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0469b79c-8300-487a-b2af-e8aea7c90ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_66a0440e-5c88-45b1-b2b1-09ca31ac42ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aa56c94b-e159-4035-a74f-11384cff045a" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_66a0440e-5c88-45b1-b2b1-09ca31ac42ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_be8be4ac-c7a0-4db9-ad00-35455edd7957" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_aa56c94b-e159-4035-a74f-11384cff045a" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_be8be4ac-c7a0-4db9-ad00-35455edd7957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsTables" xlink:type="simple" xlink:href="angn-20251231.xsd#WarrantsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_97d246ff-f84d-41a7-b9dd-949c704081bf" xlink:href="angn-20251231.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_d8e21d36-9ba1-4bf8-8886-382a33f1bde0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_97d246ff-f84d-41a7-b9dd-949c704081bf" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_d8e21d36-9ba1-4bf8-8886-382a33f1bde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesTables" xlink:type="simple" xlink:href="angn-20251231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_da700db9-8214-4c79-abbc-82b211602ead" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_adfccb49-0f95-413f-b87f-4a95cc413458" xlink:href="angn-20251231.xsd#angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_da700db9-8214-4c79-abbc-82b211602ead" xlink:to="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_adfccb49-0f95-413f-b87f-4a95cc413458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ce10d475-69ca-49e6-92d1-6ab605c1701e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_da700db9-8214-4c79-abbc-82b211602ead" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ce10d475-69ca-49e6-92d1-6ab605c1701e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtTables" xlink:type="simple" xlink:href="angn-20251231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019cd820-5ee4-75a0-becf-b1ba8dfa9d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_019cd820-5ee4-718c-8368-f2da04a35337" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019cd820-5ee4-75a0-becf-b1ba8dfa9d1c" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_019cd820-5ee4-718c-8368-f2da04a35337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dd5ed9c4-0162-4e6b-9e5a-ddbe8e0595f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_019c9e48-8c7c-7af6-b839-c65ce910920d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd5ed9c4-0162-4e6b-9e5a-ddbe8e0595f1" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_019c9e48-8c7c-7af6-b839-c65ce910920d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e9d29be8-3e65-4bb0-ac9c-c322f6b598e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd5ed9c4-0162-4e6b-9e5a-ddbe8e0595f1" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e9d29be8-3e65-4bb0-ac9c-c322f6b598e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e168fa7f-7706-4402-8eb0-8c1c0e567df2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd5ed9c4-0162-4e6b-9e5a-ddbe8e0595f1" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e168fa7f-7706-4402-8eb0-8c1c0e567df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_019cd830-6e0d-7d38-a925-c8b14e3506e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd5ed9c4-0162-4e6b-9e5a-ddbe8e0595f1" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_019cd830-6e0d-7d38-a925-c8b14e3506e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="angn-20251231.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_70da760b-ddfd-45ce-bdfd-20638daa9434" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_db7b1321-9a70-41a1-a22b-2e922e80e2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70da760b-ddfd-45ce-bdfd-20638daa9434" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_db7b1321-9a70-41a1-a22b-2e922e80e2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b7edd290-364c-4c33-b8fb-42047e5f93a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70da760b-ddfd-45ce-bdfd-20638daa9434" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b7edd290-364c-4c33-b8fb-42047e5f93a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="angn-20251231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_68bfc7f9-cc9a-45aa-bb84-54600f227423" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7c38dbfc-8b45-486d-8ae0-49270142bb54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_68bfc7f9-cc9a-45aa-bb84-54600f227423" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7c38dbfc-8b45-486d-8ae0-49270142bb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#DescriptionoftheBusinessandFinancialConditionDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_11657db3-bad4-4ecc-aa0a-a244d80bca2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_11657db3-bad4-4ecc-aa0a-a244d80bca2a" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd7e6-42fe-74a6-9907-b423647d3b12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd7e6-42fe-74a6-9907-b423647d3b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd7e6-42fe-74a6-9907-b423647d3b12" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember_019cd7e6-42fe-7382-b234-b0cb6cc35575" xlink:href="angn-20251231.xsd#angn_RegistrationStatementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_RegistrationStatementMember_019cd7e6-42fe-7382-b234-b0cb6cc35575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_019cd7e6-42fe-74df-8311-184652dcb03f" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_019cd7e6-42fe-74df-8311-184652dcb03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_019cd7e6-42fe-76f5-a299-a96ca9f73e40" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_019cd7e6-42fe-76f5-a299-a96ca9f73e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember_019cd7e6-42fe-77ce-9e68-5f81acf68e6a" xlink:href="angn-20251231.xsd#angn_A2024RegistrationStatementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_A2024RegistrationStatementMember_019cd7e6-42fe-77ce-9e68-5f81acf68e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_019cd7e6-42fe-7a89-aac5-f8efb90e9672" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_019cd7e6-42fe-7a89-aac5-f8efb90e9672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019cd7e6-42fe-7111-be5a-bc71bc5cab63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_us-gaap_PrivatePlacementMember_019cd7e6-42fe-7111-be5a-bc71bc5cab63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_019cd7e6-42fe-7721-9e13-fce68a3d83fb" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_MarchSubscriptionAgreementMember_019cd7e6-42fe-7721-9e13-fce68a3d83fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_019cd7e6-42fe-7428-967b-b7aa521c1b16" xlink:href="angn-20251231.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_JulyPublicOfferingMember_019cd7e6-42fe-7428-967b-b7aa521c1b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_019cd7e6-42fe-7d67-8ac3-2c8f10edcd91" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_July2024PublicOfferingMember_019cd7e6-42fe-7d67-8ac3-2c8f10edcd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember_019cd7e6-9c17-7b31-8c3e-9101ecaab660" xlink:href="angn-20251231.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd7e6-42fe-70e4-b934-6ad9ce0ca35c" xlink:to="loc_angn_JanuaryPublicOfferingMember_019cd7e6-9c17-7b31-8c3e-9101ecaab660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cd7e6-42fe-7e25-8758-c765b20ea844" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cd7e6-42fe-7e25-8758-c765b20ea844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd7e6-42fe-786d-ab6d-0d751175c3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd7e6-42fe-7e25-8758-c765b20ea844" xlink:to="loc_us-gaap_EquityComponentDomain_019cd7e6-42fe-786d-ab6d-0d751175c3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019cd7e6-42fe-7472-80aa-dd5449b7a411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cd7e6-42fe-786d-ab6d-0d751175c3e0" xlink:to="loc_us-gaap_CommonStockMember_019cd7e6-42fe-7472-80aa-dd5449b7a411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd7e6-42fe-70cc-9b92-515421e9d54b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd7e6-42fe-70cc-9b92-515421e9d54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd7e6-42fe-70cc-9b92-515421e9d54b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019cd7e6-42fe-7b0b-ad2f-1369b817881b" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019cd7e6-42fe-7b0b-ad2f-1369b817881b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_019cd7e6-42fe-7646-b762-544bf9831750" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_PreFundedWarrantMember_019cd7e6-42fe-7646-b762-544bf9831750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_019cd7e6-42fe-7d3b-9c5b-cbb181113500" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_JulyPreFundedWarrantsMember_019cd7e6-42fe-7d3b-9c5b-cbb181113500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_019cd7e6-42fe-7115-8eb5-07f82fd9eef5" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_JulyCommonWarrantsMember_019cd7e6-42fe-7115-8eb5-07f82fd9eef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019cd7e6-9c17-7ca5-8d1b-177fcfaf41f6" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019cd7e6-9c17-7ca5-8d1b-177fcfaf41f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember_019cd7e6-9c17-7453-b1ed-37cf7bfe0f55" xlink:href="angn-20251231.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_JanuaryCommonWarrantsMember_019cd7e6-9c17-7453-b1ed-37cf7bfe0f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_019cd8a7-cc7d-7bf5-956a-556a80aae898" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd7e6-42fe-7530-b10f-9faea1841f3d" xlink:to="loc_angn_July2024PublicOfferingMember_019cd8a7-cc7d-7bf5-956a-556a80aae898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cd7e6-42fe-7516-bb2c-c344a305655a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cd7e6-42fe-7516-bb2c-c344a305655a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7214-9a28-6e93b28ef27b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cd7e6-42fe-7516-bb2c-c344a305655a" xlink:to="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7214-9a28-6e93b28ef27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019cd7e6-42fe-7baa-8e0a-2451a598ee34" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7214-9a28-6e93b28ef27b" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019cd7e6-42fe-7baa-8e0a-2451a598ee34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_019cd7e6-42fe-7791-b17f-0df08d6de60b" xlink:href="angn-20251231.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cd7e6-42fe-7214-9a28-6e93b28ef27b" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_019cd7e6-42fe-7791-b17f-0df08d6de60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019cd7e6-9c17-7d3d-b894-fad410504662" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_DebtInstrumentAxis_019cd7e6-9c17-7d3d-b894-fad410504662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019cd7e6-9c17-7729-8218-452850c38607" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019cd7e6-9c17-7d3d-b894-fad410504662" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019cd7e6-9c17-7729-8218-452850c38607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019cd7e6-9c17-7c37-aa8a-ea120fe53b4b" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019cd7e6-9c17-7729-8218-452850c38607" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019cd7e6-9c17-7c37-aa8a-ea120fe53b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019cd7e6-9c17-7ead-8b71-12ce6c7a9760" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019cd7e6-9c17-7ead-8b71-12ce6c7a9760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019cd7e6-9c17-75be-923f-a733ce193edb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019cd7e6-9c17-7ead-8b71-12ce6c7a9760" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019cd7e6-9c17-75be-923f-a733ce193edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019cd7e6-9c17-78d9-992a-cc130e809762" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019cd7e6-9c17-75be-923f-a733ce193edb" xlink:to="loc_us-gaap_ConvertibleDebtMember_019cd7e6-9c17-78d9-992a-cc130e809762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019cd7e6-42fe-7e29-b49d-cfb84fb476cb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cd7e6-42fe-77a9-ba2f-a49b3cbfda34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019cd7e6-42fe-77a9-ba2f-a49b3cbfda34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice_019cd7e6-42fe-7e1f-b102-cb198dfa2b18" xlink:href="angn-20251231.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_angn_SaleOfStockAggregateInitialOfferingPrice_019cd7e6-42fe-7e1f-b102-cb198dfa2b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cd7e6-42fe-750d-aaf1-1356bc225bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cd7e6-42fe-750d-aaf1-1356bc225bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019cd7e6-42fe-75ae-92f1-0ae6d49f62eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019cd7e6-42fe-75ae-92f1-0ae6d49f62eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019cd7e6-42fe-781e-bfc2-1af23ca81e16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019cd7e6-42fe-781e-bfc2-1af23ca81e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019cd7e6-9c17-782f-b8f6-8a7a3df6e219" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019cd7e6-9c17-782f-b8f6-8a7a3df6e219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cd7e6-42fe-7d77-9b46-a58e4af2ea3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cd7e6-42fe-7d77-9b46-a58e4af2ea3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cd7e6-42fe-789c-b752-0e55c090c5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cd7e6-42fe-789c-b752-0e55c090c5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_019cd7e6-42fe-7a02-ae67-96ddf5749d19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_019cd7e6-42fe-7a02-ae67-96ddf5749d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cd7e6-9c17-7a8f-8603-3b8a046c9c99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cd7e6-9c17-7a8f-8603-3b8a046c9c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cd7e6-9c17-7b3c-97b2-63ca2a4f5c78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cd7e6-9c17-7b3c-97b2-63ca2a4f5c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019cd7e6-9c17-725b-aa62-3ebe14128b53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019cd7e6-9c17-725b-aa62-3ebe14128b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019cd7e6-9c17-76ba-8a5c-e43f2625863b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019cd7e6-9c17-76ba-8a5c-e43f2625863b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019cd7e6-9c17-7018-849e-d4f016446c98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019cd7e6-9c17-7018-849e-d4f016446c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019cd7e6-9c17-7d0f-8842-00b20dbcf5cf" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019cd7e6-9c17-7d0f-8842-00b20dbcf5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019cd7e6-9c17-71f9-a4d7-76258e976f14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019cd7e6-9c17-71f9-a4d7-76258e976f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cd7e6-9c17-70a0-8177-31a6946d6e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019cd7e6-42fe-7f84-8495-64722053dd9a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019cd7e6-9c17-70a0-8177-31a6946d6e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1199ca54-e73a-4e3f-8457-19ddd50694c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d967e80-d31a-4132-ae8d-e8adc773b484" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1199ca54-e73a-4e3f-8457-19ddd50694c4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d967e80-d31a-4132-ae8d-e8adc773b484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dbb5ee63-f679-42d9-a899-6ac0348e3d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d967e80-d31a-4132-ae8d-e8adc773b484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dbb5ee63-f679-42d9-a899-6ac0348e3d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9bb671f-14b1-4a05-b5b3-f4bc60bda642" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dbb5ee63-f679-42d9-a899-6ac0348e3d1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9bb671f-14b1-4a05-b5b3-f4bc60bda642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d77ce39f-15e4-4cf6-841c-512c3e1298cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9bb671f-14b1-4a05-b5b3-f4bc60bda642" xlink:to="loc_us-gaap_EquipmentMember_d77ce39f-15e4-4cf6-841c-512c3e1298cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c2a8a997-351e-4eb8-b97b-f442ed931543" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a9bb671f-14b1-4a05-b5b3-f4bc60bda642" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c2a8a997-351e-4eb8-b97b-f442ed931543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_685d4f38-1b08-4d24-ac4a-9824c74c6355" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d967e80-d31a-4132-ae8d-e8adc773b484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_685d4f38-1b08-4d24-ac4a-9824c74c6355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d76909c3-4fcb-4b68-98ae-4411e8a1dd66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_685d4f38-1b08-4d24-ac4a-9824c74c6355" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d76909c3-4fcb-4b68-98ae-4411e8a1dd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_26d02756-6421-4318-a8ce-bb3b317aedae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_fb1348d2-3037-4ac5-a85f-4c496ba057e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_26d02756-6421-4318-a8ce-bb3b317aedae" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_fb1348d2-3037-4ac5-a85f-4c496ba057e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_74832940-70aa-44a8-8b5d-31fdc0f7ae5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0630972d-b029-4fc0-a7ab-913988444cde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_74832940-70aa-44a8-8b5d-31fdc0f7ae5d" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0630972d-b029-4fc0-a7ab-913988444cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3bac354-5e15-4193-b316-57e3536f6c48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0630972d-b029-4fc0-a7ab-913988444cde" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3bac354-5e15-4193-b316-57e3536f6c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b3bac354-5e15-4193-b316-57e3536f6c48" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d5fd3fbd-422c-44b5-95c4-d036e951773d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d5fd3fbd-422c-44b5-95c4-d036e951773d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_413373d4-b138-4d08-8402-a68642a59413" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_413373d4-b138-4d08-8402-a68642a59413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5d9eb60b-9fb6-4cd2-ad49-71da0bb9d4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2dd403d-a705-4c3a-a272-c5d469f61fc6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5d9eb60b-9fb6-4cd2-ad49-71da0bb9d4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b2614976-789b-40c3-bd71-d018bb57f8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0630972d-b029-4fc0-a7ab-913988444cde" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b2614976-789b-40c3-bd71-d018bb57f8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1d3c5251-fb9c-4ac3-b909-9d00b26e85aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b2614976-789b-40c3-bd71-d018bb57f8f6" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1d3c5251-fb9c-4ac3-b909-9d00b26e85aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_560bdb58-699b-42a8-bf16-e1bbe95b10a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1d3c5251-fb9c-4ac3-b909-9d00b26e85aa" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_560bdb58-699b-42a8-bf16-e1bbe95b10a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e31d796b-d899-454f-8a4a-76ee5652109f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1d3c5251-fb9c-4ac3-b909-9d00b26e85aa" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e31d796b-d899-454f-8a4a-76ee5652109f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_19734484-2fcc-4268-82f0-c15f09e305aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b2614976-789b-40c3-bd71-d018bb57f8f6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_19734484-2fcc-4268-82f0-c15f09e305aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_c739c76b-6d09-4371-b923-c71d6834cc7e" xlink:href="angn-20251231.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_19734484-2fcc-4268-82f0-c15f09e305aa" xlink:to="loc_angn_WarrantsFairValueDisclosure_c739c76b-6d09-4371-b923-c71d6834cc7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1a5e2a17-39a5-4039-b2c1-381bcbe81086" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_19734484-2fcc-4268-82f0-c15f09e305aa" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1a5e2a17-39a5-4039-b2c1-381bcbe81086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ce5cd408-bfcc-4741-8d48-d54817fc5bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bcce03c0-cee0-416f-918a-46ab059438f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ce5cd408-bfcc-4741-8d48-d54817fc5bdc" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bcce03c0-cee0-416f-918a-46ab059438f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_54ce3b6b-b5d9-4894-bacf-497989284ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bcce03c0-cee0-416f-918a-46ab059438f2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_54ce3b6b-b5d9-4894-bacf-497989284ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c37c06b1-4010-46cc-8e11-d284f24a4cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_54ce3b6b-b5d9-4894-bacf-497989284ab9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c37c06b1-4010-46cc-8e11-d284f24a4cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember_ccc8c3a2-82d7-4870-ae14-6bb277b162d5" xlink:href="angn-20251231.xsd#angn_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c37c06b1-4010-46cc-8e11-d284f24a4cb1" xlink:to="loc_angn_WarrantLiabilityMember_ccc8c3a2-82d7-4870-ae14-6bb277b162d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_96d62ad4-e1f3-4dc9-86ef-1e7a4c453585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_bcce03c0-cee0-416f-918a-46ab059438f2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_96d62ad4-e1f3-4dc9-86ef-1e7a4c453585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_96d62ad4-e1f3-4dc9-86ef-1e7a4c453585" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bf679bdc-981e-4c43-809f-299663b0e4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bf679bdc-981e-4c43-809f-299663b0e4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_58f28ee8-bf75-433d-9cf0-091b81502ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_58f28ee8-bf75-433d-9cf0-091b81502ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_497e68ab-9e84-4138-a9f3-52d6e1e8b339" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0c11ca2d-2f0b-4028-9613-1a24b89212f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_497e68ab-9e84-4138-a9f3-52d6e1e8b339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f8d44fb1-7dae-4350-bc67-056965f662cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f8d44fb1-7dae-4350-bc67-056965f662cc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f9864b0-810e-4ca7-a2da-f093b10c3f55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f9864b0-810e-4ca7-a2da-f093b10c3f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce746ef2-a681-4762-bae1-e0378d40f61f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0f9864b0-810e-4ca7-a2da-f093b10c3f55" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce746ef2-a681-4762-bae1-e0378d40f61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8e2b5e85-1432-4a2f-9c87-0fadf2f0aac8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce746ef2-a681-4762-bae1-e0378d40f61f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8e2b5e85-1432-4a2f-9c87-0fadf2f0aac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_e3b9d19d-d99a-43b0-9b7c-fcece9f33f5e" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember_4dbb7b80-0e4c-4489-ab16-a97c6cbab91f" xlink:href="angn-20251231.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:to="loc_angn_MeasurementInputStrikePriceMember_4dbb7b80-0e4c-4489-ab16-a97c6cbab91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_ddb87e28-083b-4c6f-b05f-ea30780f0824" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_ddb87e28-083b-4c6f-b05f-ea30780f0824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_db47b817-e337-40c8-8977-e545f84b70ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_db47b817-e337-40c8-8977-e545f84b70ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_25e8b04d-fc81-455e-bab8-c3364ef9cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_42cafc0a-3f87-4877-aafa-5c132c0419ec" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_25e8b04d-fc81-455e-bab8-c3364ef9cad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_826faf64-c649-47b3-afca-2832682e4cde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_20523fbc-7d16-4474-87e7-5519f746f8e5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_826faf64-c649-47b3-afca-2832682e4cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fb6ad75a-8d84-4b32-8173-bbaa6f392171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_826faf64-c649-47b3-afca-2832682e4cde" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_fb6ad75a-8d84-4b32-8173-bbaa6f392171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_dd33db73-35e6-4b6b-8203-6b109e4a2407" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_826faf64-c649-47b3-afca-2832682e4cde" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_dd33db73-35e6-4b6b-8203-6b109e4a2407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_292b0f93-c3ff-47c4-96f5-2820e8082678" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_292b0f93-c3ff-47c4-96f5-2820e8082678" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_580b57f1-c0cc-4886-a1bf-0675156207f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_580b57f1-c0cc-4886-a1bf-0675156207f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_524730d9-1def-452f-93dd-6c1be8d65a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_580b57f1-c0cc-4886-a1bf-0675156207f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_524730d9-1def-452f-93dd-6c1be8d65a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_60f2f8a2-c433-4827-b4ee-3b6d46ee8668" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_524730d9-1def-452f-93dd-6c1be8d65a5e" xlink:to="loc_angn_PreFundedWarrantMember_60f2f8a2-c433-4827-b4ee-3b6d46ee8668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a3fe4ea1-fd87-426a-9138-d7bbb54633ac" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_524730d9-1def-452f-93dd-6c1be8d65a5e" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a3fe4ea1-fd87-426a-9138-d7bbb54633ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_33b588dc-8542-41f7-9460-d264305cd5ee" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a3fe4ea1-fd87-426a-9138-d7bbb54633ac" xlink:to="loc_angn_JulyPreFundedWarrantsMember_33b588dc-8542-41f7-9460-d264305cd5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_c49297e3-54f5-478e-9153-49d15e168dfd" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a3fe4ea1-fd87-426a-9138-d7bbb54633ac" xlink:to="loc_angn_JulyCommonWarrantsMember_c49297e3-54f5-478e-9153-49d15e168dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5bac7516-b396-41cd-909c-a5d939094d25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5bac7516-b396-41cd-909c-a5d939094d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e6d56c79-fb82-439c-a878-d0c430ecfd97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5bac7516-b396-41cd-909c-a5d939094d25" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e6d56c79-fb82-439c-a878-d0c430ecfd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_ca49d58b-5ffd-4912-a51a-e2302536bfa8" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e6d56c79-fb82-439c-a878-d0c430ecfd97" xlink:to="loc_angn_MarchSubscriptionAgreementMember_ca49d58b-5ffd-4912-a51a-e2302536bfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_af97a6e6-e3c2-4711-b6f1-999a31dcb2be" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e6d56c79-fb82-439c-a878-d0c430ecfd97" xlink:to="loc_angn_July2024PublicOfferingMember_af97a6e6-e3c2-4711-b6f1-999a31dcb2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e32240a9-0000-43ee-b332-ae1bcc9a3d95" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_019cd885-71ae-7b85-b3e6-f6e66d66bacd" xlink:href="angn-20251231.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:to="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_019cd885-71ae-7b85-b3e6-f6e66d66bacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b22dcac5-698f-4ea8-ad6b-87812c4c9785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b22dcac5-698f-4ea8-ad6b-87812c4c9785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_7c3f5c6e-60ca-46cd-9d82-3bea2fd7ba2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e559c5b1-aa7d-4a1b-988b-c09396d912be" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_7c3f5c6e-60ca-46cd-9d82-3bea2fd7ba2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1c61f8-734f-4d0c-8779-56ba430606a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses_de97e71c-d8b7-4674-86d1-62bd35033897" xlink:href="angn-20251231.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1c61f8-734f-4d0c-8779-56ba430606a1" xlink:to="loc_angn_PrepaidResearchAndDevelopmentExpenses_de97e71c-d8b7-4674-86d1-62bd35033897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees_23c10ac1-8a3f-4984-baaa-f8240603e7ec" xlink:href="angn-20251231.xsd#angn_AdvancedProfessionalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1c61f8-734f-4d0c-8779-56ba430606a1" xlink:to="loc_angn_AdvancedProfessionalFees_23c10ac1-8a3f-4984-baaa-f8240603e7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_7f2749d6-347b-4540-8d0f-527c8b15f596" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1c61f8-734f-4d0c-8779-56ba430606a1" xlink:to="loc_us-gaap_PrepaidInsurance_7f2749d6-347b-4540-8d0f-527c8b15f596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_9f3d2379-53e0-4ccd-9bd4-34e99b09f24a" xlink:href="angn-20251231.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1c61f8-734f-4d0c-8779-56ba430606a1" xlink:to="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_9f3d2379-53e0-4ccd-9bd4-34e99b09f24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a575996e-d0ed-4e9a-ae3d-5ea3279b6b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8d1c61f8-734f-4d0c-8779-56ba430606a1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a575996e-d0ed-4e9a-ae3d-5ea3279b6b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c370b522-696d-4f87-b0d0-d12006432062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1c59cb14-d501-45fa-902e-5c99d942d2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c370b522-696d-4f87-b0d0-d12006432062" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1c59cb14-d501-45fa-902e-5c99d942d2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9a318a8c-2c94-445e-bf9f-87a176435dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1c59cb14-d501-45fa-902e-5c99d942d2ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9a318a8c-2c94-445e-bf9f-87a176435dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9a318a8c-2c94-445e-bf9f-87a176435dbe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_70326796-d676-4bf1-b493-26e44a188f17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:to="loc_us-gaap_EquipmentMember_70326796-d676-4bf1-b493-26e44a188f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3084598a-6816-4eef-9ba1-ebe8506466a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3084598a-6816-4eef-9ba1-ebe8506466a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_eaae0cd3-bb4c-4248-babf-4bb7fd7b4224" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3af39b77-6a7d-4b09-ae80-c399decdf50e" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_eaae0cd3-bb4c-4248-babf-4bb7fd7b4224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1c59cb14-d501-45fa-902e-5c99d942d2ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a9e97c84-00c2-4709-b54e-3cd6883d8d15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a9e97c84-00c2-4709-b54e-3cd6883d8d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_61bc28ca-3e39-47b2-80c4-8c88b756ab06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_61bc28ca-3e39-47b2-80c4-8c88b756ab06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b1c3e32-7332-4e48-85dc-632cf75ef4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_29b62d6f-24f2-48c7-ab1d-f396a956a12b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5b1c3e32-7332-4e48-85dc-632cf75ef4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ce2d246-6e1b-4c56-8498-339df992924c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a70e839e-f6b1-4e9c-bc68-a680ac62fa92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ce2d246-6e1b-4c56-8498-339df992924c" xlink:to="loc_us-gaap_Depreciation_a70e839e-f6b1-4e9c-bc68-a680ac62fa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_36c0c0ce-e59e-42e6-977c-8121080af7df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ce2d246-6e1b-4c56-8498-339df992924c" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_36c0c0ce-e59e-42e6-977c-8121080af7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14741a2f-1727-40f4-a5d9-d753ecb7fc64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_7639b36f-6fd9-41f0-8081-302e55078bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14741a2f-1727-40f4-a5d9-d753ecb7fc64" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_7639b36f-6fd9-41f0-8081-302e55078bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d3c49399-6d55-4fe8-8bd3-b27cf328c0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14741a2f-1727-40f4-a5d9-d753ecb7fc64" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d3c49399-6d55-4fe8-8bd3-b27cf328c0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent_f4193035-f706-4d4f-bdd6-ab7090cf847f" xlink:href="angn-20251231.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14741a2f-1727-40f4-a5d9-d753ecb7fc64" xlink:to="loc_angn_AccruedResearchAndDevelopmentCurrent_f4193035-f706-4d4f-bdd6-ab7090cf847f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterest_019cd8ba-af60-7681-afb9-040a917c518e" xlink:href="angn-20251231.xsd#angn_AccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14741a2f-1727-40f4-a5d9-d753ecb7fc64" xlink:to="loc_angn_AccruedInterest_019cd8ba-af60-7681-afb9-040a917c518e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_cd15f87f-30dc-4317-9b85-db77f501e41b" xlink:href="angn-20251231.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14741a2f-1727-40f4-a5d9-d753ecb7fc64" xlink:to="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_cd15f87f-30dc-4317-9b85-db77f501e41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6898debd-f772-4450-8a72-b629b72b91c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_14741a2f-1727-40f4-a5d9-d753ecb7fc64" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6898debd-f772-4450-8a72-b629b72b91c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrantDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#ResearchGrantDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ResearchGrantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_6d7bd7fb-8259-467e-9c1f-43bd36bbd407" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_7e6b3afd-8727-44a3-a0f3-f43cad74490b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_6d7bd7fb-8259-467e-9c1f-43bd36bbd407" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_7e6b3afd-8727-44a3-a0f3-f43cad74490b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_d0a6c97c-a0a0-4af5-99be-aea7360f811d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_7e6b3afd-8727-44a3-a0f3-f43cad74490b" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_d0a6c97c-a0a0-4af5-99be-aea7360f811d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_d0a6c97c-a0a0-4af5-99be-aea7360f811d" xlink:to="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_0e52d2e7-9870-4da3-a0cd-a01b8a8184c7" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_0e52d2e7-9870-4da3-a0cd-a01b8a8184c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member_24054bf0-2b9b-4397-8aff-cec8ad5d3b32" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member_24054bf0-2b9b-4397-8aff-cec8ad5d3b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_5a677c3c-cce9-4edf-8782-fde727f3884b" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_5a677c3c-cce9-4edf-8782-fde727f3884b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_dec7072b-a40f-4c78-8008-70cab49ff78c" xlink:href="angn-20251231.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_195d6754-bc31-4bc4-8218-ef5ad58420f3" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_dec7072b-a40f-4c78-8008-70cab49ff78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_7e6b3afd-8727-44a3-a0f3-f43cad74490b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant_36dddef1-4182-4838-b9c3-62c1289ad3cc" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrant_36dddef1-4182-4838-b9c3-62c1289ad3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_f803e046-15f0-4704-a7a6-3eac52f9dcbc" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_f803e046-15f0-4704-a7a6-3eac52f9dcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit_a77530b4-2883-4f50-ba52-6eca0c97ce47" xlink:href="angn-20251231.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_ResearchAndDevelopmentArrangementCredit_a77530b4-2883-4f50-ba52-6eca0c97ce47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_91b1e6e8-8af4-47b3-add1-042cae5da503" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_91b1e6e8-8af4-47b3-add1-042cae5da503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements_ff7b0017-48de-4e52-85e0-bcac7bf92eb9" xlink:href="angn-20251231.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_NumberOfResearchGrantAgreements_ff7b0017-48de-4e52-85e0-bcac7bf92eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating_019b2b1b-3a56-7689-a32a-58fbd3892748" xlink:href="angn-20251231.xsd#angn_GrantRevenueNonoperating"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d4e346fc-1860-4125-bce4-2b64f12561f4" xlink:to="loc_angn_GrantRevenueNonoperating_019b2b1b-3a56-7689-a32a-58fbd3892748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommonStockandStockholdersEquityDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#CommonStockandStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommonStockandStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_da28c4a5-aede-4e77-abc8-86f679287496" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_da28c4a5-aede-4e77-abc8-86f679287496" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cd8a0-0704-71f7-8208-c62557982062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cd8a0-0704-71f7-8208-c62557982062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd8a0-0704-787f-aa34-17798bebee59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd8a0-0704-71f7-8208-c62557982062" xlink:to="loc_us-gaap_EquityComponentDomain_019cd8a0-0704-787f-aa34-17798bebee59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019cd8a0-0704-791e-950f-fcc731845a37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cd8a0-0704-787f-aa34-17798bebee59" xlink:to="loc_us-gaap_CommonStockMember_019cd8a0-0704-791e-950f-fcc731845a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019cd8a0-0704-7cb5-8f31-5c77b8e9d7a3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_019cd8a0-0704-7844-91c1-aabb63b4a0d7" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_019cd8a0-0704-7844-91c1-aabb63b4a0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_019cd8a0-0704-7039-85fd-33ba8910ccfd" xlink:href="angn-20251231.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_019cd8a0-0704-7039-85fd-33ba8910ccfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_019cd8a0-0704-705f-b687-29ca87fae821" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_MarchSubscriptionAgreementMember_019cd8a0-0704-705f-b687-29ca87fae821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_019cd8a0-0704-7090-ae83-91cbbf316a17" xlink:href="angn-20251231.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_JulyPublicOfferingMember_019cd8a0-0704-7090-ae83-91cbbf316a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019cd8a0-0704-7f57-8ebc-f09201ea1d02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_us-gaap_PrivatePlacementMember_019cd8a0-0704-7f57-8ebc-f09201ea1d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_019cd8a0-4ec0-7f94-93e2-ef6762131f73" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_July2024PublicOfferingMember_019cd8a0-4ec0-7f94-93e2-ef6762131f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember_019cd8a0-4ec0-7fd3-bec1-fc9f6ff6909f" xlink:href="angn-20251231.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019cd8a0-0704-7c29-a66d-16881abae5f5" xlink:to="loc_angn_JanuaryPublicOfferingMember_019cd8a0-4ec0-7fd3-bec1-fc9f6ff6909f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd8a0-0704-792d-bbc5-ae0e8a016cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd8a0-0704-792d-bbc5-ae0e8a016cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019cd8a0-0704-792d-bbc5-ae0e8a016cc7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_019cd8a0-0704-7e9c-81a6-143cca99f7dd" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_PreFundedWarrantMember_019cd8a0-0704-7e9c-81a6-143cca99f7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019cd8a0-0704-751b-bf28-e05f0053f3b8" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019cd8a0-0704-751b-bf28-e05f0053f3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_019cd8a0-4ec0-77e6-9f86-af5c4a9dde73" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_JulyPreFundedWarrantsMember_019cd8a0-4ec0-77e6-9f86-af5c4a9dde73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_019cd8a0-4ec0-7cca-9472-e7ee72f52e21" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_JulyCommonWarrantsMember_019cd8a0-4ec0-7cca-9472-e7ee72f52e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019cd8a0-4ec0-7104-beb6-6ca958c9d0ec" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_019cd8a0-4ec0-7104-beb6-6ca958c9d0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember_019cd8a0-4ec0-7ca5-934d-c610c0b2146e" xlink:href="angn-20251231.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019cd8a0-0704-75c6-afe7-76249b768507" xlink:to="loc_angn_JanuaryCommonWarrantsMember_019cd8a0-4ec0-7ca5-934d-c610c0b2146e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019cd8a0-0704-73f1-82b5-7dced9bec19b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019cd8a0-0704-73f1-82b5-7dced9bec19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-7688-b07c-c10f21b69b66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019cd8a0-0704-73f1-82b5-7dced9bec19b" xlink:to="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-7688-b07c-c10f21b69b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019cd8a0-0704-730d-998b-f2072112ede2" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-7688-b07c-c10f21b69b66" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019cd8a0-0704-730d-998b-f2072112ede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_019cd8a0-4ec0-7610-8b16-01e8039ee824" xlink:href="angn-20251231.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019cd8a0-0704-7688-b07c-c10f21b69b66" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_019cd8a0-4ec0-7610-8b16-01e8039ee824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_DebtInstrumentAxis_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019cd8a0-4ec0-79e0-a8d6-274894d7c0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019cd8a0-4ec0-7e30-9b71-c44f53c4cf3a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019cd8a0-4ec0-79e0-a8d6-274894d7c0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019cd8a0-4ec0-7ac1-abf2-7029ecb8cf1b" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019cd8a0-4ec0-79e0-a8d6-274894d7c0a8" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019cd8a0-4ec0-7ac1-abf2-7029ecb8cf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019cd8a0-4ec0-7c7d-9ba0-03b5ca38ed62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019cd8a0-4ec0-7a8b-bbd3-171af5144dc7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019cd8a0-4ec0-7c7d-9ba0-03b5ca38ed62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_019cd8a0-4ec0-7bde-a1b8-8210f9ac22fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019cd8a0-4ec0-7c7d-9ba0-03b5ca38ed62" xlink:to="loc_us-gaap_ConvertibleDebtMember_019cd8a0-4ec0-7bde-a1b8-8210f9ac22fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019cd8a0-0704-7d03-bb8e-c27b9ea22215" xlink:to="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019cd8a0-0704-7147-ac4b-740edcde1b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019cd8a0-0704-7147-ac4b-740edcde1b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019cd8a0-0704-78ff-a527-b7275706d027" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019cd8a0-0704-78ff-a527-b7275706d027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019cd8a0-0704-75f5-b4c2-5f616889bb36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019cd8a0-0704-75f5-b4c2-5f616889bb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019cd8a0-0704-7866-9ab6-c677913dc272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019cd8a0-0704-7866-9ab6-c677913dc272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cd8a0-0704-7a64-b5e4-01bc08949c39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019cd8a0-0704-7a64-b5e4-01bc08949c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019cd8a0-0704-7278-a268-0ce29a828bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019cd8a0-0704-7278-a268-0ce29a828bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019cd8a0-0704-731c-bd85-692c5c92384c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019cd8a0-0704-731c-bd85-692c5c92384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019cd8a0-0704-70bb-ac56-8e5054a588e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019cd8a0-0704-70bb-ac56-8e5054a588e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cd8a0-0704-78a7-9091-16d031669171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019cd8a0-0704-78a7-9091-16d031669171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_019cd8a0-4ec0-700b-bd6d-ea6c636c6095" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_019cd8a0-4ec0-700b-bd6d-ea6c636c6095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cd8a0-4ec0-7cd8-9262-a5177dfcb486" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019cd8a0-4ec0-7cd8-9262-a5177dfcb486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_019cd8a0-4ec0-7091-95d8-7de82bb6874a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_019cd8a0-4ec0-7091-95d8-7de82bb6874a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cd8a0-4ec0-7c8c-a122-8219e64311f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019cd8a0-4ec0-7c8c-a122-8219e64311f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cd8a0-4ec0-7cd1-8ea0-b64548becd17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019cd8a0-4ec0-7cd1-8ea0-b64548becd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019cd8a0-4ec0-70ac-a0c3-3ecff9aa3218" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019cd8a0-4ec0-70ac-a0c3-3ecff9aa3218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019cd8a0-4ec0-745a-a3e7-4c8b94598869" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019cd8a0-4ec0-745a-a3e7-4c8b94598869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019cd8a0-4ec0-7645-8221-73512cbc55e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019cd8a0-4ec0-7645-8221-73512cbc55e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019cd8a0-4ec0-7263-b4bd-97a741abc7b8" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019cd8a0-0704-79d8-8b81-98989dbcaf55" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019cd8a0-4ec0-7263-b4bd-97a741abc7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d28b5fb3-40b0-498a-b7e2-60e1ff4cd8df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d28b5fb3-40b0-498a-b7e2-60e1ff4cd8df" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1626948f-5f35-48ca-acaa-cdf36027f47d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:to="loc_us-gaap_PlanNameAxis_1626948f-5f35-48ca-acaa-cdf36027f47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1626948f-5f35-48ca-acaa-cdf36027f47d" xlink:to="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2021PlanMember_cc06d0e0-77f8-4876-a82e-a957e7c65258" xlink:href="angn-20251231.xsd#angn_A2021PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:to="loc_angn_A2021PlanMember_cc06d0e0-77f8-4876-a82e-a957e7c65258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2022PlanMember_c353f0e8-a1c0-4260-b3d2-4d2119ae2700" xlink:href="angn-20251231.xsd#angn_A2022PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:to="loc_angn_A2022PlanMember_c353f0e8-a1c0-4260-b3d2-4d2119ae2700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024PlanMember_93c18b4a-c800-48c1-ba13-f8d287c61b46" xlink:href="angn-20251231.xsd#angn_A2024PlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_77fb0703-9c93-435f-b7fb-02e3075624d2" xlink:to="loc_angn_A2024PlanMember_93c18b4a-c800-48c1-ba13-f8d287c61b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6597b533-534e-4a19-b534-f1ea5c25a79b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:to="loc_us-gaap_AwardTypeAxis_6597b533-534e-4a19-b534-f1ea5c25a79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_92a1d810-eba2-4778-9774-930135dd3a66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6597b533-534e-4a19-b534-f1ea5c25a79b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_92a1d810-eba2-4778-9774-930135dd3a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_0b527fb2-c9e4-4acd-aeee-3708bdd7c1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_92a1d810-eba2-4778-9774-930135dd3a66" xlink:to="loc_us-gaap_EmployeeStockMember_0b527fb2-c9e4-4acd-aeee-3708bdd7c1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019c64f0-1b45-79c1-aa7b-a558f4a46ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019c64f0-1b45-79c1-aa7b-a558f4a46ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019c64f0-1b45-7b58-93ad-2e98d9cf549f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019c64f0-1b45-79c1-aa7b-a558f4a46ff5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019c64f0-1b45-7b58-93ad-2e98d9cf549f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019c64f0-4977-766d-ae3a-166d91b89d99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019c64f0-1b45-7b58-93ad-2e98d9cf549f" xlink:to="loc_us-gaap_SubsequentEventMember_019c64f0-4977-766d-ae3a-166d91b89d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_90fe8a9a-edd4-4d75-9531-b03dd0dcec23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding_019b2b69-a710-7f64-bffa-1733f73d3ab5" xlink:href="angn-20251231.xsd#angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding_019b2b69-a710-7f64-bffa-1733f73d3ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5936c74e-bc3c-42b2-88d3-4c8629190ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5936c74e-bc3c-42b2-88d3-4c8629190ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit_35ae6969-a4ae-46af-a26d-080c7fa0ad44" xlink:href="angn-20251231.xsd#angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit_35ae6969-a4ae-46af-a26d-080c7fa0ad44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c6de8694-56e2-48b9-896c-1d461ce8dd83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c6de8694-56e2-48b9-896c-1d461ce8dd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9efba91c-7179-4ea9-a0ca-47379dabd726" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9efba91c-7179-4ea9-a0ca-47379dabd726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_098e62da-e19f-4de3-ba03-5f3324587011" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_098e62da-e19f-4de3-ba03-5f3324587011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a8b7979c-0b83-47ae-855e-9cc861223920" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19f3efe5-6e0a-4a0e-832a-c498d8b9fe8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a8b7979c-0b83-47ae-855e-9cc861223920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensationScheduleofShareOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c168e3d-1656-43c6-a0f6-d97ba84dcd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de352932-00a5-44c2-ab1d-cfb6b1ab6918" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c168e3d-1656-43c6-a0f6-d97ba84dcd2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de352932-00a5-44c2-ab1d-cfb6b1ab6918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f6f2cec8-953d-4daf-b52d-016be9d3be46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de352932-00a5-44c2-ab1d-cfb6b1ab6918" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f6f2cec8-953d-4daf-b52d-016be9d3be46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fa252244-ac4a-4ab8-9ece-6033fd6b3353" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de352932-00a5-44c2-ab1d-cfb6b1ab6918" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fa252244-ac4a-4ab8-9ece-6033fd6b3353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_444a5289-bf4b-43a8-b42c-c24945747822" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de352932-00a5-44c2-ab1d-cfb6b1ab6918" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_444a5289-bf4b-43a8-b42c-c24945747822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b0ac2d65-c807-495b-a439-487c0ed26200" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de352932-00a5-44c2-ab1d-cfb6b1ab6918" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b0ac2d65-c807-495b-a439-487c0ed26200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d6c994f1-ffc5-4fed-a7bd-065bc6269c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de352932-00a5-44c2-ab1d-cfb6b1ab6918" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d6c994f1-ffc5-4fed-a7bd-065bc6269c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b0d0f2e1-69a3-4994-9970-3cdb574eddb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c168e3d-1656-43c6-a0f6-d97ba84dcd2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b0d0f2e1-69a3-4994-9970-3cdb574eddb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a119beb3-0994-485f-83af-cb59954a8163" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c168e3d-1656-43c6-a0f6-d97ba84dcd2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a119beb3-0994-485f-83af-cb59954a8163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e3d0e1a4-cbe1-46e1-a554-2f8dd9467520" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a119beb3-0994-485f-83af-cb59954a8163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e3d0e1a4-cbe1-46e1-a554-2f8dd9467520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6863d2e4-e6cd-4dc4-9011-46131ae70381" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a119beb3-0994-485f-83af-cb59954a8163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6863d2e4-e6cd-4dc4-9011-46131ae70381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_81cc48d9-c2c0-4cb9-9fee-d7cbfac0be3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a119beb3-0994-485f-83af-cb59954a8163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_81cc48d9-c2c0-4cb9-9fee-d7cbfac0be3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5d5a0a2e-2a70-4975-9327-ade5625d88fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a119beb3-0994-485f-83af-cb59954a8163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5d5a0a2e-2a70-4975-9327-ade5625d88fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3875db90-4fb7-40a3-8545-194900c50003" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a119beb3-0994-485f-83af-cb59954a8163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3875db90-4fb7-40a3-8545-194900c50003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cbf0ccde-978b-47f8-996c-b723b73c0208" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c168e3d-1656-43c6-a0f6-d97ba84dcd2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cbf0ccde-978b-47f8-996c-b723b73c0208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5ea6c1d9-6403-42f6-b4d8-ea3c8f694d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c168e3d-1656-43c6-a0f6-d97ba84dcd2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5ea6c1d9-6403-42f6-b4d8-ea3c8f694d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a66b0b8b-1397-4b82-93ff-681ca3e196e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5ea6c1d9-6403-42f6-b4d8-ea3c8f694d8e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a66b0b8b-1397-4b82-93ff-681ca3e196e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c59284e0-05ce-4a6d-b649-3a47699a3ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5ea6c1d9-6403-42f6-b4d8-ea3c8f694d8e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c59284e0-05ce-4a6d-b649-3a47699a3ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ca297577-b5ca-43b3-92a0-92347736ceda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5ea6c1d9-6403-42f6-b4d8-ea3c8f694d8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ca297577-b5ca-43b3-92a0-92347736ceda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c640f071-af32-4338-b6de-bddd7bec3792" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5ea6c1d9-6403-42f6-b4d8-ea3c8f694d8e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c640f071-af32-4338-b6de-bddd7bec3792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_643671ae-4c7e-488a-899a-bd046c5528f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3c330838-c036-461b-89c5-2e5442d454e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_643671ae-4c7e-488a-899a-bd046c5528f0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3c330838-c036-461b-89c5-2e5442d454e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_044bab42-fe58-4915-9925-ac7eba0752d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3c330838-c036-461b-89c5-2e5442d454e0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_044bab42-fe58-4915-9925-ac7eba0752d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_18d65403-75cd-4a43-9d83-a46051e33391" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_044bab42-fe58-4915-9925-ac7eba0752d4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_18d65403-75cd-4a43-9d83-a46051e33391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b3adf9d-8d0a-4b99-b450-d8a8c0cfd829" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_18d65403-75cd-4a43-9d83-a46051e33391" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b3adf9d-8d0a-4b99-b450-d8a8c0cfd829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_e169890d-b041-413f-8df9-0412041f493a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_18d65403-75cd-4a43-9d83-a46051e33391" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_e169890d-b041-413f-8df9-0412041f493a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_01c7bb06-a21a-4d3e-991d-c7341a272660" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3c330838-c036-461b-89c5-2e5442d454e0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_01c7bb06-a21a-4d3e-991d-c7341a272660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4de6f672-7c0f-45a8-8049-2832dbdf71ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_01c7bb06-a21a-4d3e-991d-c7341a272660" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4de6f672-7c0f-45a8-8049-2832dbdf71ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_65b91328-d9a3-4bc3-baa4-c3bdeef4f4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_65b91328-d9a3-4bc3-baa4-c3bdeef4f4f0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cdc7b470-90b3-412f-b74a-2940da777087" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:to="loc_us-gaap_AwardTypeAxis_cdc7b470-90b3-412f-b74a-2940da777087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9b53cf0-c613-4d76-a1e6-1819504ff542" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cdc7b470-90b3-412f-b74a-2940da777087" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9b53cf0-c613-4d76-a1e6-1819504ff542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_21e42109-1f23-4bb4-b341-5726bf610517" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9b53cf0-c613-4d76-a1e6-1819504ff542" xlink:to="loc_us-gaap_EmployeeStockOptionMember_21e42109-1f23-4bb4-b341-5726bf610517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b2ba8-3cf4-7617-908a-664b4443ad77" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:to="loc_srt_RangeAxis_019b2ba8-3cf4-7617-908a-664b4443ad77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2ba8-3cf4-7ad5-9157-1b7e681ad21b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019b2ba8-3cf4-7617-908a-664b4443ad77" xlink:to="loc_srt_RangeMember_019b2ba8-3cf4-7ad5-9157-1b7e681ad21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019b2ba8-3cf4-77fd-a70c-ae1e38af268e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019b2ba8-3cf4-7ad5-9157-1b7e681ad21b" xlink:to="loc_srt_MinimumMember_019b2ba8-3cf4-77fd-a70c-ae1e38af268e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019b2ba8-83bd-7ba9-ad98-d6b18b677066" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019b2ba8-3cf4-7ad5-9157-1b7e681ad21b" xlink:to="loc_srt_MaximumMember_019b2ba8-83bd-7ba9-ad98-d6b18b677066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_77b63db1-a3a5-4f60-91a4-ca34b9cff34f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019b2b99-46c7-701c-8ce1-255b2573eefc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019b2b99-46c7-701c-8ce1-255b2573eefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019b2ba4-f8e5-790c-bc7d-3cf75fd6c780" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019b2ba4-f8e5-790c-bc7d-3cf75fd6c780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12ecd7ad-a747-44ae-9546-2ab0f2ec87f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12ecd7ad-a747-44ae-9546-2ab0f2ec87f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019b2b9b-7cd5-74a6-9899-03f222fc8f62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019b2b9b-7cd5-74a6-9899-03f222fc8f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019b2ba7-03bf-74b6-84d3-c1e2d1e3137e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019b2ba7-03bf-74b6-84d3-c1e2d1e3137e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b2b9c-0352-76ba-9a60-a534bc2eee84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfb34cc5-fe5d-45a9-bbb0-30cf90fb050d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019b2b9c-0352-76ba-9a60-a534bc2eee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#WarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_4b42953a-35ab-495a-8f9b-56656f650f03" xlink:href="angn-20251231.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_4b42953a-35ab-495a-8f9b-56656f650f03" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1c0cd651-57f9-4276-abe0-78dfd167f5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1c0cd651-57f9-4276-abe0-78dfd167f5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1c0cd651-57f9-4276-abe0-78dfd167f5b5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_0f056d7c-183d-422c-96ce-ae77d6656edb" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_PreFundedWarrantMember_0f056d7c-183d-422c-96ce-ae77d6656edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_338f40c2-3e86-4ba8-86ef-47572a0062e7" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_JulyCommonWarrantsMember_338f40c2-3e86-4ba8-86ef-47572a0062e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_438e42de-bb7e-49ad-b1ae-866f7eafadf6" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_438e42de-bb7e-49ad-b1ae-866f7eafadf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember_019b2bca-d6b3-739b-a5b1-c006a2648a7d" xlink:href="angn-20251231.xsd#angn_January2025CommonWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_January2025CommonWarrantsMember_019b2bca-d6b3-739b-a5b1-c006a2648a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember_019b2bcd-3cef-78dc-9560-269affc72ce6" xlink:href="angn-20251231.xsd#angn_June2025WarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_June2025WarrantsMember_019b2bcd-3cef-78dc-9560-269affc72ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019b3052-7d37-7193-a463-0902dfe6c9d4" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_cf6bfb8b-4c3f-4933-9edd-c7057e8b8194" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019b3052-7d37-7193-a463-0902dfe6c9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1aef2d38-72cf-4590-ae5a-55f35b76c17a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1aef2d38-72cf-4590-ae5a-55f35b76c17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d882fac8-0a74-4771-bcea-d5220fa316a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1aef2d38-72cf-4590-ae5a-55f35b76c17a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d882fac8-0a74-4771-bcea-d5220fa316a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_a4696400-ad92-458b-bdee-b2a09ba8df30" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d882fac8-0a74-4771-bcea-d5220fa316a6" xlink:to="loc_angn_MarchSubscriptionAgreementMember_a4696400-ad92-458b-bdee-b2a09ba8df30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_d9b3a58b-7c08-4335-9c9a-159b2cb565f3" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d882fac8-0a74-4771-bcea-d5220fa316a6" xlink:to="loc_angn_July2024PublicOfferingMember_d9b3a58b-7c08-4335-9c9a-159b2cb565f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019b2bc8-bf19-7cee-94f3-e441808c0830" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019b2bc8-bf19-7cee-94f3-e441808c0830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2bc8-bf19-70bb-89be-e955f7ead12c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2bc8-bf19-7cee-94f3-e441808c0830" xlink:to="loc_us-gaap_EquityComponentDomain_019b2bc8-bf19-70bb-89be-e955f7ead12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019b2bc8-bf19-7020-8cb6-69e3681b532c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019b2bc8-bf19-70bb-89be-e955f7ead12c" xlink:to="loc_us-gaap_CommonStockMember_019b2bc8-bf19-7020-8cb6-69e3681b532c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019b2bcb-619f-76ca-965f-7de27cac2c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_DebtInstrumentAxis_019b2bcb-619f-76ca-965f-7de27cac2c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019b2bcb-619f-77e6-a0db-9457f09c82b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019b2bcb-619f-76ca-965f-7de27cac2c4d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019b2bcb-619f-77e6-a0db-9457f09c82b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019b2bcb-619f-7cb8-a6ff-965f088499ea" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019b2bcb-619f-77e6-a0db-9457f09c82b9" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_019b2bcb-619f-7cb8-a6ff-965f088499ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1755133d-46fe-4cbf-8f5e-ba06a25a5235" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_480e1f02-644f-4334-a769-2d42e5ca0058" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_480e1f02-644f-4334-a769-2d42e5ca0058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantExercisedFairValue_019b3024-6678-7fdd-9405-4cea580b513e" xlink:href="angn-20251231.xsd#angn_WarrantExercisedFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_angn_WarrantExercisedFairValue_019b3024-6678-7fdd-9405-4cea580b513e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_c6e3e70f-816c-44ee-9e3c-45bc6808fa53" xlink:href="angn-20251231.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_c6e3e70f-816c-44ee-9e3c-45bc6808fa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_c1f9f12e-bb38-4ad4-a4e6-cbca2623fac7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_c1f9f12e-bb38-4ad4-a4e6-cbca2623fac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019b2bc9-35e5-76b0-90a6-fc995dcddfef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019b2bc9-35e5-76b0-90a6-fc995dcddfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019b2bca-5754-7ce6-87b9-fffa6d4c8ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019b2bca-5754-7ce6-87b9-fffa6d4c8ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019b2bca-d6b3-7602-a7e2-7caeec5d54a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019b2bca-d6b3-7602-a7e2-7caeec5d54a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2bcb-619f-7531-90fb-b423619fce65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_d5144339-5429-45b0-bd89-b208c0b2a5bb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2bcb-619f-7531-90fb-b423619fce65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#WarrantsScheduleofOutstandingWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_019b2a7f-6cd7-7348-93e0-715cf17415f6" xlink:href="angn-20251231.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_019b2a7f-6cd7-7348-93e0-715cf17415f6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2a7f-6cd7-7129-bf31-8127e468794a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2a7f-6cd7-7129-bf31-8127e468794a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2a7f-6cd7-7129-bf31-8127e468794a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ElicioWarrantsMember_019b2a7f-6cd7-7a28-b4d8-554756678ac1" xlink:href="angn-20251231.xsd#angn_ElicioWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_ElicioWarrantsMember_019b2a7f-6cd7-7a28-b4d8-554756678ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionWarrantsMember_019b2a7f-6cd7-705b-ab39-182fac12f798" xlink:href="angn-20251231.xsd#angn_AngionWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_AngionWarrantsMember_019b2a7f-6cd7-705b-ab39-182fac12f798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_019b2a7f-6cd7-700a-b4b3-3940b9714186" xlink:href="angn-20251231.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_March2024PreFundedWarrantsMember_019b2a7f-6cd7-700a-b4b3-3940b9714186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_019b2a7f-6cd7-714d-9d03-bc12011a3871" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_PreFundedWarrantMember_019b2a7f-6cd7-714d-9d03-bc12011a3871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_019b2a7f-6cd7-7c29-9ad5-4383700190b9" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_JulyCommonWarrantsMember_019b2a7f-6cd7-7c29-9ad5-4383700190b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantOneMember_019c0d06-aae2-7775-82cd-868b9aafcf3a" xlink:href="angn-20251231.xsd#angn_JulyCommonWarrantOneMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_JulyCommonWarrantOneMember_019c0d06-aae2-7775-82cd-868b9aafcf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember_019b2a7f-6cd7-706d-97bc-30d0553f83dd" xlink:href="angn-20251231.xsd#angn_January2025CommonWarrantsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_January2025CommonWarrantsMember_019b2a7f-6cd7-706d-97bc-30d0553f83dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025CommonWarrantsMember_019b2a7f-6cd7-7017-b1ac-d154f071e9c3" xlink:href="angn-20251231.xsd#angn_June2025CommonWarrantsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2a7f-6cd7-749d-ae81-3bcb460b90c4" xlink:to="loc_angn_June2025CommonWarrantsMember_019b2a7f-6cd7-7017-b1ac-d154f071e9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b2a7f-6cd7-7d6b-9561-11d81f23b92b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:to="loc_srt_RangeAxis_019b2a7f-6cd7-7d6b-9561-11d81f23b92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2a7f-6cd7-729c-b72f-93c1490f0a96" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019b2a7f-6cd7-7d6b-9561-11d81f23b92b" xlink:to="loc_srt_RangeMember_019b2a7f-6cd7-729c-b72f-93c1490f0a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_019b2a7f-6cd7-745b-9fe9-21ec9cd70518" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019b2a7f-6cd7-729c-b72f-93c1490f0a96" xlink:to="loc_srt_WeightedAverageMember_019b2a7f-6cd7-745b-9fe9-21ec9cd70518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019b2a7f-6cd7-7c6c-926d-2be4852c936d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019b2a7f-6cd7-7057-b648-5f46e2c65d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019b2a7f-6cd7-7057-b648-5f46e2c65d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2a7f-6cd7-7132-9e4e-241ac5aadabc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2a7f-6cd7-7132-9e4e-241ac5aadabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019b2a7f-6cd7-7177-8565-16079ab39e18" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019b2a7f-6cd7-7c3d-ac58-78e68e010fe8" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_019b2a7f-6cd7-7177-8565-16079ab39e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#WarrantsScheduleofWarrantsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_379e95b0-125a-4219-8698-edea268e2429" xlink:href="angn-20251231.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightRollForward_b279bffe-bf9c-4c6e-af7d-743eeac3c412" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_379e95b0-125a-4219-8698-edea268e2429" xlink:to="loc_angn_ClassOfWarrantOrRightRollForward_b279bffe-bf9c-4c6e-af7d-743eeac3c412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8e0fc370-47dc-449f-b877-0f7a7d621719" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_b279bffe-bf9c-4c6e-af7d-743eeac3c412" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8e0fc370-47dc-449f-b877-0f7a7d621719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_ee2445cd-08e9-4825-9a49-a17485f7dc03" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_b279bffe-bf9c-4c6e-af7d-743eeac3c412" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_ee2445cd-08e9-4825-9a49-a17485f7dc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightExercisedInPeriod_d5791d4c-ba2b-4721-8662-9e9cd8cb5b78" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightExercisedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_b279bffe-bf9c-4c6e-af7d-743eeac3c412" xlink:to="loc_angn_ClassOfWarrantOrRightExercisedInPeriod_d5791d4c-ba2b-4721-8662-9e9cd8cb5b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d87fd84c-e7ea-4bb4-b20c-4f6adbad371f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_b279bffe-bf9c-4c6e-af7d-743eeac3c412" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_d87fd84c-e7ea-4bb4-b20c-4f6adbad371f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_e7047d74-f3b7-46a4-879e-257d17ba0540" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_379e95b0-125a-4219-8698-edea268e2429" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_e7047d74-f3b7-46a4-879e-257d17ba0540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_778d942c-8ed0-45d1-a4bf-9c53aa31c001" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_e7047d74-f3b7-46a4-879e-257d17ba0540" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_778d942c-8ed0-45d1-a4bf-9c53aa31c001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_532631b4-726e-4df3-bf90-9fa7f6ed17f6" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_e7047d74-f3b7-46a4-879e-257d17ba0540" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_532631b4-726e-4df3-bf90-9fa7f6ed17f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_d054359c-9b96-4b44-94df-f25b99b20350" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_e7047d74-f3b7-46a4-879e-257d17ba0540" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_d054359c-9b96-4b44-94df-f25b99b20350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9aed4977-3907-4a9f-b083-dac0656c320c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_e7047d74-f3b7-46a4-879e-257d17ba0540" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9aed4977-3907-4a9f-b083-dac0656c320c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_3e496428-ce05-4ec2-b089-c68c487d2f75" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_379e95b0-125a-4219-8698-edea268e2429" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_3e496428-ce05-4ec2-b089-c68c487d2f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_e54e1ae2-b29d-49c4-8cb4-028ec54a7a67" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_3e496428-ce05-4ec2-b089-c68c487d2f75" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_e54e1ae2-b29d-49c4-8cb4-028ec54a7a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_a85657da-dfe5-4f73-995a-85bd26411932" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_3e496428-ce05-4ec2-b089-c68c487d2f75" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_a85657da-dfe5-4f73-995a-85bd26411932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fa779489-cb2c-41e5-ab90-dfddc68e3835" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:href="angn-20251231.xsd#angn_CommitmentAndContingenciesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fa779489-cb2c-41e5-ab90-dfddc68e3835" xlink:to="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019b2f0d-b302-7aa7-a464-9861abca13ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019b2f0d-b302-7aa7-a464-9861abca13ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f12-740a-735a-b11b-7e7e340dfcff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019b2f0d-b302-7aa7-a464-9861abca13ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f12-740a-735a-b11b-7e7e340dfcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019b2f0d-b302-7ada-9557-9a06c160233c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019b2f12-740a-735a-b11b-7e7e340dfcff" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019b2f0d-b302-7ada-9557-9a06c160233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019b2f12-740a-7b31-827f-211888dd75e9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:to="loc_srt_CounterpartyNameAxis_019b2f12-740a-7b31-827f-211888dd75e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b2f12-740a-7ed5-bb07-67e9a86a642c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019b2f12-740a-7b31-827f-211888dd75e9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b2f12-740a-7ed5-bb07-67e9a86a642c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_UniversityMember_019b2f12-740a-7fc6-8928-6590d8541df0" xlink:href="angn-20251231.xsd#angn_UniversityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019b2f12-740a-7ed5-bb07-67e9a86a642c" xlink:to="loc_angn_UniversityMember_019b2f12-740a-7fc6-8928-6590d8541df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b2f16-06e7-7231-b477-5f06c3decf57" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:to="loc_srt_RangeAxis_019b2f16-06e7-7231-b477-5f06c3decf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2f16-06e7-733c-b1ee-2f56c92a9e42" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019b2f16-06e7-7231-b477-5f06c3decf57" xlink:to="loc_srt_RangeMember_019b2f16-06e7-733c-b1ee-2f56c92a9e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019b2f16-06e7-7213-b8eb-eecc7b756902" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019b2f16-06e7-733c-b1ee-2f56c92a9e42" xlink:to="loc_srt_MinimumMember_019b2f16-06e7-7213-b8eb-eecc7b756902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019b2f16-06e7-7fa6-92ee-0528933980d1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019b2f16-06e7-733c-b1ee-2f56c92a9e42" xlink:to="loc_srt_MaximumMember_019b2f16-06e7-7fa6-92ee-0528933980d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:href="angn-20251231.xsd#angn_CommitmentAndContingenciesDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureTable_019b2f0d-b302-7b54-843b-fb702e31da09" xlink:to="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RoyaltyRatePercent_019b2f06-dbca-7e9f-a076-f74dda9a9fcb" xlink:href="angn-20251231.xsd#angn_RoyaltyRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_angn_RoyaltyRatePercent_019b2f06-dbca-7e9f-a076-f74dda9a9fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019b2f09-5334-7a30-a2bf-aadcf21f6b57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019b2f09-5334-7a30-a2bf-aadcf21f6b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_019b2f0d-b302-7a75-8c0d-c5df94958ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_us-gaap_RoyaltyExpense_019b2f0d-b302-7a75-8c0d-c5df94958ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019b2f14-ca1b-7f85-8475-4ddc3e26a830" xlink:href="angn-20251231.xsd#angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_019b2f14-ca1b-7f85-8475-4ddc3e26a830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_019b302f-5148-7e49-80d0-92612f059113" xlink:href="angn-20251231.xsd#angn_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentAndContingenciesDisclosureLineItems_019b2f0d-b302-7226-b385-8c44564c8e06" xlink:to="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_019b302f-5148-7e49-80d0-92612f059113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_95378948-7516-451d-a28d-23bd4cdc7c39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f91c3c86-848a-49c4-999a-a36665a1c0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_95378948-7516-451d-a28d-23bd4cdc7c39" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f91c3c86-848a-49c4-999a-a36665a1c0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a4428d25-0780-4d58-b549-3700d5bd40f9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f91c3c86-848a-49c4-999a-a36665a1c0e3" xlink:to="loc_srt_StatementGeographicalAxis_a4428d25-0780-4d58-b549-3700d5bd40f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4cb95143-f6d6-425a-81bb-6d37768f0118" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a4428d25-0780-4d58-b549-3700d5bd40f9" xlink:to="loc_srt_SegmentGeographicalDomain_4cb95143-f6d6-425a-81bb-6d37768f0118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember_b9850992-9ce7-4e05-865a-0b20f671fa8a" xlink:href="angn-20251231.xsd#angn_BostonMassachusettsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4cb95143-f6d6-425a-81bb-6d37768f0118" xlink:to="loc_angn_BostonMassachusettsMember_b9850992-9ce7-4e05-865a-0b20f671fa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember_ea09fe90-c60b-4c1e-a4ae-3ce90b3c013a" xlink:href="angn-20251231.xsd#angn_NewtonMassachusettsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4cb95143-f6d6-425a-81bb-6d37768f0118" xlink:to="loc_angn_NewtonMassachusettsMember_ea09fe90-c60b-4c1e-a4ae-3ce90b3c013a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f91c3c86-848a-49c4-999a-a36665a1c0e3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_49b388ca-4763-4f16-bf60-d8995dcb8271" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_OperatingLeaseExpense_49b388ca-4763-4f16-bf60-d8995dcb8271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1777bd19-ddff-49cb-b1dd-e061ed4bd65e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1777bd19-ddff-49cb-b1dd-e061ed4bd65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ce8c3f49-ed73-46da-9d7a-788a84492ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ce8c3f49-ed73-46da-9d7a-788a84492ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_7a6db478-9bf6-4fbf-9563-6e23a9af7eba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_7a6db478-9bf6-4fbf-9563-6e23a9af7eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_45f78437-ff38-4a5d-99e0-e1fe93243506" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_45f78437-ff38-4a5d-99e0-e1fe93243506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense_e412ae8f-f4e1-4206-9e56-f282d2509e98" xlink:href="angn-20251231.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a0b19249-23d3-4f72-825f-8ccae77544d8" xlink:to="loc_angn_LesseeOperatingLeaseAnnualRentExpense_e412ae8f-f4e1-4206-9e56-f282d2509e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b5cc8e17-a0ed-4a5f-82ea-b6cc3980d08e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f5b26944-859c-4d31-a8fb-35ef9c0ab2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5cc8e17-a0ed-4a5f-82ea-b6cc3980d08e" xlink:to="loc_us-gaap_OperatingLeasePayments_f5b26944-859c-4d31-a8fb-35ef9c0ab2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4dae1ac9-7fdb-488c-9fb7-7a3329a9cf20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5cc8e17-a0ed-4a5f-82ea-b6cc3980d08e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4dae1ac9-7fdb-488c-9fb7-7a3329a9cf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2eb50532-ff61-449f-baf3-6ee00b4ff57d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5cc8e17-a0ed-4a5f-82ea-b6cc3980d08e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2eb50532-ff61-449f-baf3-6ee00b4ff57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4450df17-1c38-43e2-85b3-f00e4826d708" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4450df17-1c38-43e2-85b3-f00e4826d708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3710217b-8f5d-4001-8973-bc64f9564157" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3710217b-8f5d-4001-8973-bc64f9564157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_de82a007-98b1-498a-bc8b-1ac178238576" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_de82a007-98b1-498a-bc8b-1ac178238576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b8d7cd39-35bd-4cc3-9e40-c1320f68e330" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b8d7cd39-35bd-4cc3-9e40-c1320f68e330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4a705e97-54ae-434c-a870-402f1b1d83fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4a705e97-54ae-434c-a870-402f1b1d83fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_749a4a04-b550-4a6c-8103-a99a267a480a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_749a4a04-b550-4a6c-8103-a99a267a480a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_de90d8d6-b13c-46d1-9e53-da4d5384c015" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_de90d8d6-b13c-46d1-9e53-da4d5384c015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_908e03ac-23b4-40fb-a7f8-fecd97ecc96a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_OperatingLeaseLiability_908e03ac-23b4-40fb-a7f8-fecd97ecc96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_13b09911-a68a-4395-b0ca-47c9d3744c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_13b09911-a68a-4395-b0ca-47c9d3744c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2f71e516-e13a-4f00-b8f7-c9b7b58568dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb16fcd0-5f00-482c-8703-ffb9783c16c9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2f71e516-e13a-4f00-b8f7-c9b7b58568dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_680f195c-226b-44a0-9f10-914cf16ffe03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_680f195c-226b-44a0-9f10-914cf16ffe03" xlink:to="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_134e48eb-e1b5-4637-9ab1-86e059a7519a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_134e48eb-e1b5-4637-9ab1-86e059a7519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a82bc9ac-32b1-4dd1-a666-4d74ac4fb2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_134e48eb-e1b5-4637-9ab1-86e059a7519a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a82bc9ac-32b1-4dd1-a666-4d74ac4fb2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_7e2111b6-d6e5-48b6-9524-0bb1d51746db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a82bc9ac-32b1-4dd1-a666-4d74ac4fb2a1" xlink:to="loc_us-gaap_ConvertibleDebtMember_7e2111b6-d6e5-48b6-9524-0bb1d51746db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_DebtInstrumentAxis_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_84eb5728-1fc9-49d2-a1a4-252fd84b8370" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_72e26abf-67fe-4c6d-a6fc-fe2a2029e79a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_84eb5728-1fc9-49d2-a1a4-252fd84b8370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_f09d3050-a55f-422a-a2ff-a81e2aa7263c" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_84eb5728-1fc9-49d2-a1a4-252fd84b8370" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_f09d3050-a55f-422a-a2ff-a81e2aa7263c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2f30-5f80-72bb-b0df-595899c1de76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2f30-5f80-72bb-b0df-595899c1de76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-777c-94a5-6a90d00e25b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019b2f30-5f80-72bb-b0df-595899c1de76" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-777c-94a5-6a90d00e25b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_019b2f30-5f80-7c64-9942-0bab09b8245b" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-777c-94a5-6a90d00e25b3" xlink:to="loc_angn_PreFundedWarrantMember_019b2f30-5f80-7c64-9942-0bab09b8245b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember_019b2f3c-916e-7a91-9cb6-85f274bf8cc8" xlink:href="angn-20251231.xsd#angn_June2025WarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019b2f30-5f80-777c-94a5-6a90d00e25b3" xlink:to="loc_angn_June2025WarrantsMember_019b2f3c-916e-7a91-9cb6-85f274bf8cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019b2f30-5f80-7449-8158-ff4e86c43d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019b2f30-5f80-7449-8158-ff4e86c43d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2f30-5f80-70f8-ab5e-c8c0d945fb86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2f30-5f80-7449-8158-ff4e86c43d7a" xlink:to="loc_us-gaap_EquityComponentDomain_019b2f30-5f80-70f8-ab5e-c8c0d945fb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019b2f30-5f80-74b2-a145-58e5efd131d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019b2f30-5f80-70f8-ab5e-c8c0d945fb86" xlink:to="loc_us-gaap_CommonStockMember_019b2f30-5f80-74b2-a145-58e5efd131d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019b2f38-8769-710d-8456-20aa57c54ad5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_srt_RangeAxis_019b2f38-8769-710d-8456-20aa57c54ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019b2f38-8769-726f-9013-c304ae93af97" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019b2f38-8769-710d-8456-20aa57c54ad5" xlink:to="loc_srt_RangeMember_019b2f38-8769-726f-9013-c304ae93af97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019b2f38-8769-78dc-9cb9-064d0e554a78" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019b2f38-8769-726f-9013-c304ae93af97" xlink:to="loc_srt_MaximumMember_019b2f38-8769-78dc-9cb9-064d0e554a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019b2f3b-c470-7ea7-8ef2-87e2d1a79626" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_dei_LegalEntityAxis_019b2f3b-c470-7ea7-8ef2-87e2d1a79626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019b2f3b-c470-7244-9d57-cf1caf5fe853" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019b2f3b-c470-7ea7-8ef2-87e2d1a79626" xlink:to="loc_dei_EntityDomain_019b2f3b-c470-7244-9d57-cf1caf5fe853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GKCCMember_019b2f3b-c470-71b9-b619-0d67edd06d23" xlink:href="angn-20251231.xsd#angn_GKCCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019b2f3b-c470-7244-9d57-cf1caf5fe853" xlink:to="loc_angn_GKCCMember_019b2f3b-c470-71b9-b619-0d67edd06d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019cd80e-9929-7736-beeb-ee8239a7a03d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019cd80e-9929-7736-beeb-ee8239a7a03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_019cd80e-9929-7736-beeb-ee8239a7a03d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019cd80e-cda1-731e-a1c7-710eab8ac93b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_019cd80e-cda1-731e-a1c7-710eab8ac93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019cd80e-f0da-795d-8470-8de3f5a29cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_019cd80e-f0da-795d-8470-8de3f5a29cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019cd80f-12f9-746d-bf19-c17672abf655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_019cd80e-9929-7615-88df-5a8bb2083d1d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_019cd80f-12f9-746d-bf19-c17672abf655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ce794c2-db75-4d46-a539-8db37711fedf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ecce5d16-108f-47b9-a73f-f5bbc0e7f443" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ecce5d16-108f-47b9-a73f-f5bbc0e7f443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_675caffa-d66a-4b28-ae78-4d8be9663a48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_675caffa-d66a-4b28-ae78-4d8be9663a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_936300bd-0c6b-450e-b646-8a5e520e53fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_936300bd-0c6b-450e-b646-8a5e520e53fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a3941b8-5956-4adc-abb7-ed5337d41190" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a3941b8-5956-4adc-abb7-ed5337d41190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_cf417baa-eaf6-4499-8d9f-25b208640bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_InterestExpenseDebt_cf417baa-eaf6-4499-8d9f-25b208640bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2f30-5f80-76a7-b182-a8f7c8dbf885" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2f30-5f80-76a7-b182-a8f7c8dbf885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019b2f31-f14c-7734-be17-cd2dbdf0f0ba" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019b2f31-f14c-7734-be17-cd2dbdf0f0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b2f36-5c09-747a-92a5-e739a10045c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_019b2f36-5c09-747a-92a5-e739a10045c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019cd80d-3809-7417-aee4-ee38ec301362" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019cd80d-3809-7417-aee4-ee38ec301362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2f3a-3d11-70e3-91b1-31e5050f3c22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019b2f3a-3d11-70e3-91b1-31e5050f3c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019b2f3a-eacc-7750-bcdd-3c47857dd915" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019b2f3a-eacc-7750-bcdd-3c47857dd915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_019b2f3b-c470-7e46-b093-d2510a22cecf" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_019b2f3b-c470-7e46-b093-d2510a22cecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019b2f3c-916e-78a6-9434-b719a80b65c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019b2f3c-916e-78a6-9434-b719a80b65c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b2f3d-3f4e-7318-a886-9bbf61d1fd51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b2f3d-3f4e-7318-a886-9bbf61d1fd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019b2f3d-f995-7883-8648-f7782bfd51c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019b2f3d-f995-7883-8648-f7782bfd51c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019b2f3e-a6e7-7ce7-93b3-de7ba504d98a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019b2f3e-a6e7-7ce7-93b3-de7ba504d98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019cd81d-1874-7738-af8e-8f85938f2566" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a199651a-de31-4ccb-a5a2-96c6f6ff71e0" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_019cd81d-1874-7738-af8e-8f85938f2566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#DebtScheduleofFuturePrincipalPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019cd821-43f6-7572-9762-d72c30d05093" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019cd828-d2b9-7c60-b83e-9ba060576908" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019cd821-43f6-7572-9762-d72c30d05093" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019cd828-d2b9-7c60-b83e-9ba060576908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019cd829-10b8-7dc5-9eba-90efd066f9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019cd821-43f6-7572-9762-d72c30d05093" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019cd829-10b8-7dc5-9eba-90efd066f9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019cd8af-697c-7903-a391-78bd9f83985c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019cd821-43f6-7572-9762-d72c30d05093" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019cd8af-697c-7903-a391-78bd9f83985c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019cd829-b06c-7623-bcb3-4b18ed6f5081" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019cd821-43f6-7572-9762-d72c30d05093" xlink:to="loc_us-gaap_LongTermDebt_019cd829-b06c-7623-bcb3-4b18ed6f5081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019c9e48-26b3-74a3-a777-fdfcd2ac388c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019c9e4a-b41e-7ebc-ac94-a574792533d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019c9e48-26b3-74a3-a777-fdfcd2ac388c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_019c9e4a-b41e-7ebc-ac94-a574792533d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_019c9e4a-b41e-7397-86c9-3d6be6685ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019c9e48-26b3-74a3-a777-fdfcd2ac388c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_019c9e4a-b41e-7397-86c9-3d6be6685ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9e4a-b41e-7b17-b406-9a6ab2063070" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019c9e48-26b3-74a3-a777-fdfcd2ac388c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9e4a-b41e-7b17-b406-9a6ab2063070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8851ead1-9020-4218-99cb-3ec193f365c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8851ead1-9020-4218-99cb-3ec193f365c4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c9e3d-5ec0-7d0d-9551-e3d49757ab60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c9e3d-5ec0-7d0d-9551-e3d49757ab60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019ce2d7-44d7-7aba-affc-03d9c5774b09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_019ce2d7-44d7-7aba-affc-03d9c5774b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019ce2d7-44d7-7513-b0b8-c32f11e1684d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_019ce2d7-44d7-7513-b0b8-c32f11e1684d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019c9e3f-43a9-70c0-ab22-f8916252c773" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019c9e3f-43a9-70c0-ab22-f8916252c773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019cb8da-74f0-7423-9b17-85ff695cd90a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_019cb8da-74f0-7423-9b17-85ff695cd90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount_019cb8dd-97d0-7d11-9198-b71533e310d6" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount_019cb8dd-97d0-7d11-9198-b71533e310d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019cd834-027f-79ae-83b8-5d20d10dbb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_019cd834-027f-79ae-83b8-5d20d10dbb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c9e41-8397-73d9-9c2f-3d557c511331" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c9e41-8397-73d9-9c2f-3d557c511331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e41-d7c3-7d34-ac00-920ef0934733" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_019c9e42-6fd6-70f2-96e2-31ea899d69b8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019c9e41-d7c3-7d34-ac00-920ef0934733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8851ead1-9020-4218-99cb-3ec193f365c4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_55bdaa47-325d-49c4-8edb-afb68679a274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_55bdaa47-325d-49c4-8edb-afb68679a274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_019cd831-692e-7417-ac70-7c3e8c202cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_019cd831-692e-7417-ac70-7c3e8c202cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_019ce2d7-44d7-7b89-b749-631c1a3eb702" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_019ce2d7-44d7-7b89-b749-631c1a3eb702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019cb8e3-749c-7994-a044-e3bbdaaae621" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019cb8e3-749c-7994-a044-e3bbdaaae621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent_019cb8e5-e751-720e-b154-f5fa17ea122d" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent_019cb8e5-e751-720e-b154-f5fa17ea122d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_019cd832-9a95-73a5-8585-0944dcb54342" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_019cd832-9a95-73a5-8585-0944dcb54342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2af538ec-98c7-4696-ade9-92da500a11a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2af538ec-98c7-4696-ade9-92da500a11a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2c0c5e27-a750-47b3-ae8d-49e71b7dd307" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2c0c5e27-a750-47b3-ae8d-49e71b7dd307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_6e4e2c59-6ef6-4a2e-a47b-99aaddb12416" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_6e4e2c59-6ef6-4a2e-a47b-99aaddb12416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_1610764c-5ef4-4341-9dfe-10cb1240bed0" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_1610764c-5ef4-4341-9dfe-10cb1240bed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent_719afcba-d4d3-4253-8757-bbc1c3b54071" xlink:href="angn-20251231.xsd#angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent_719afcba-d4d3-4253-8757-bbc1c3b54071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_81f91cf4-eb81-4f02-bdc6-c8512d1ebb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_019c9e43-048a-74a2-a747-c51c8ca82c43" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_81f91cf4-eb81-4f02-bdc6-c8512d1ebb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4d135cae-f09b-4553-9312-03881ba0fc17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4d135cae-f09b-4553-9312-03881ba0fc17" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ec3dbade-9012-42c6-90e3-9346f125c0df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ec3dbade-9012-42c6-90e3-9346f125c0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ac160bdd-dc82-4419-9bb3-aacbf69eae7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ac160bdd-dc82-4419-9bb3-aacbf69eae7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_69c8f194-1e95-419d-a053-a3fd21fd186c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_69c8f194-1e95-419d-a053-a3fd21fd186c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_DeferredTaxAssetsOperatingLeaseLiability_c0e98e5e-2bc7-490c-80ad-cef4c4b00ba0" xlink:href="angn-20251231.xsd#angn_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:to="loc_angn_DeferredTaxAssetsOperatingLeaseLiability_c0e98e5e-2bc7-490c-80ad-cef4c4b00ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_5c39f13a-54f5-4f0c-b4ac-421c17e3e71a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_5c39f13a-54f5-4f0c-b4ac-421c17e3e71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_5535739e-9d5f-4aed-90c4-c5a19c8e3f62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_5535739e-9d5f-4aed-90c4-c5a19c8e3f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_801ea05d-2a62-42fb-9d90-634e622978d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_801ea05d-2a62-42fb-9d90-634e622978d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_6a08bf9f-bf19-4622-973d-bc19d16766ae" xlink:href="angn-20251231.xsd#angn_DeferredTaxAssetsNetBeforeValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_aa38114c-21c2-4010-9138-52f6a74dbfe1" xlink:to="loc_angn_DeferredTaxAssetsNetBeforeValuationAllowance_6a08bf9f-bf19-4622-973d-bc19d16766ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7b78005a-99ac-4b82-abc4-aa7fa4c80294" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4d135cae-f09b-4553-9312-03881ba0fc17" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7b78005a-99ac-4b82-abc4-aa7fa4c80294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_27f34612-71db-4e9c-bc23-e70effc09f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4d135cae-f09b-4553-9312-03881ba0fc17" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_27f34612-71db-4e9c-bc23-e70effc09f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019cd831-5d9c-7728-bdf0-6356f6a92b10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019cd832-ee0c-773d-bd15-4b2253afcd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019cd831-5d9c-7728-bdf0-6356f6a92b10" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019cd832-ee0c-773d-bd15-4b2253afcd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_019cd836-3ed0-7323-9d6d-7ec8a34b4986" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019cd831-5d9c-7728-bdf0-6356f6a92b10" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_019cd836-3ed0-7323-9d6d-7ec8a34b4986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_019cd833-d1fc-7573-abbb-b59e5d871488" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019cd831-5d9c-7728-bdf0-6356f6a92b10" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_019cd833-d1fc-7573-abbb-b59e5d871488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f6df9ecf-04ef-4a3b-b071-78a377b25b87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f6df9ecf-04ef-4a3b-b071-78a377b25b87" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_a996fe30-8b5f-4c03-8352-bd031b41642e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_a996fe30-8b5f-4c03-8352-bd031b41642e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9a4b729d-b302-4153-9ec1-7ed78f7663d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a996fe30-8b5f-4c03-8352-bd031b41642e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9a4b729d-b302-4153-9ec1-7ed78f7663d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_27998280-d98b-4c4e-b380-648ff0f5a2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9a4b729d-b302-4153-9ec1-7ed78f7663d3" xlink:to="loc_us-gaap_DomesticCountryMember_27998280-d98b-4c4e-b380-648ff0f5a2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f7808843-65d5-457e-bf6a-562d4a610ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_9a4b729d-b302-4153-9ec1-7ed78f7663d3" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f7808843-65d5-457e-bf6a-562d4a610ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_77e7264a-f22b-46fb-a576-8c2535af599b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_us-gaap_TaxPeriodAxis_77e7264a-f22b-46fb-a576-8c2535af599b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_ac734331-4cd0-44cd-9158-76099e416abd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_77e7264a-f22b-46fb-a576-8c2535af599b" xlink:to="loc_us-gaap_TaxPeriodDomain_ac734331-4cd0-44cd-9158-76099e416abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2017Member_9414d2ad-432e-42e0-ac2b-28b59f18b389" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxYear2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_ac734331-4cd0-44cd-9158-76099e416abd" xlink:to="loc_us-gaap_TaxYear2017Member_9414d2ad-432e-42e0-ac2b-28b59f18b389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_d2abbc43-1293-4023-919e-dc55e711283a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_d2abbc43-1293-4023-919e-dc55e711283a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_d0fc6f14-447f-42fb-8d1d-48dcb6da6e30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_d2abbc43-1293-4023-919e-dc55e711283a" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_d0fc6f14-447f-42fb-8d1d-48dcb6da6e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_fd7ed7d3-c6de-4d25-a746-cb42ffac3299" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_d0fc6f14-447f-42fb-8d1d-48dcb6da6e30" xlink:to="loc_us-gaap_ResearchMember_fd7ed7d3-c6de-4d25-a746-cb42ffac3299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019cd86c-0fb0-76b0-b6c2-d26a343799d3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_srt_StatementGeographicalAxis_019cd86c-0fb0-76b0-b6c2-d26a343799d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019cd86c-0fb0-7925-b548-9601b0dd4d97" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_019cd86c-0fb0-76b0-b6c2-d26a343799d3" xlink:to="loc_srt_SegmentGeographicalDomain_019cd86c-0fb0-7925-b548-9601b0dd4d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_AU_019cd86c-2c57-7466-a6a4-de381267531c" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_019cd86c-0fb0-7925-b548-9601b0dd4d97" xlink:to="loc_country_AU_019cd86c-2c57-7466-a6a4-de381267531c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7c551901-4ec0-488c-8e3e-da1a673988ea" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_98ff6804-b33a-4349-a6aa-d9e12c5923c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_98ff6804-b33a-4349-a6aa-d9e12c5923c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ddbb581a-a6c0-4ba8-bcdd-bdcf1465a940" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ddbb581a-a6c0-4ba8-bcdd-bdcf1465a940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_32ddc802-9991-4c91-b4bf-ceb5732dc123" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_32ddc802-9991-4c91-b4bf-ceb5732dc123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e03e9e44-b67b-4f7e-ae52-5b2ac7ec8cab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e03e9e44-b67b-4f7e-ae52-5b2ac7ec8cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8a25585e-64e7-4899-bc7b-7bd649732599" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8a25585e-64e7-4899-bc7b-7bd649732599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acbe1d3c-e00e-4db2-bca1-074f1bde5816" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4522eefc-b24f-4fe8-b4c7-1393ed897464" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acbe1d3c-e00e-4db2-bca1-074f1bde5816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#EmployeeBenefitPlanDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e8d04116-a3d8-48bf-a162-dacbb4c4da27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable_a52948ba-e398-47d1-838f-2d65a31e2503" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e8d04116-a3d8-48bf-a162-dacbb4c4da27" xlink:to="loc_us-gaap_DefinedContributionPlanTable_a52948ba-e398-47d1-838f-2d65a31e2503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_35dedf01-2c13-4a93-ae4c-22d206a041de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_a52948ba-e398-47d1-838f-2d65a31e2503" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_35dedf01-2c13-4a93-ae4c-22d206a041de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_03bc2ffa-b0e9-4288-b543-b11eb22245f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_35dedf01-2c13-4a93-ae4c-22d206a041de" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_03bc2ffa-b0e9-4288-b543-b11eb22245f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeBenefitPlanMember_896a3faa-975e-443b-8878-a0c345bf1f5a" xlink:href="angn-20251231.xsd#angn_EmployeeBenefitPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_03bc2ffa-b0e9-4288-b543-b11eb22245f5" xlink:to="loc_angn_EmployeeBenefitPlanMember_896a3faa-975e-443b-8878-a0c345bf1f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_0c89c5be-7cbb-45e3-988d-a1a33b8996bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_a52948ba-e398-47d1-838f-2d65a31e2503" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_0c89c5be-7cbb-45e3-988d-a1a33b8996bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_1c499e79-3df1-413a-a7ef-aa7fcbab4e61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_0c89c5be-7cbb-45e3-988d-a1a33b8996bc" xlink:to="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_1c499e79-3df1-413a-a7ef-aa7fcbab4e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cbd9ce24-b561-43f1-a9ac-0af27ded0634" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_95e78384-8724-4320-9437-d85929f6f8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cbd9ce24-b561-43f1-a9ac-0af27ded0634" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_95e78384-8724-4320-9437-d85929f6f8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d53cef4a-4d03-4803-85c8-ba93d953acf0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_95e78384-8724-4320-9437-d85929f6f8d5" xlink:to="loc_us-gaap_NetIncomeLoss_d53cef4a-4d03-4803-85c8-ba93d953acf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e2ff8afb-39a3-4103-8451-581bff5c2e75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cbd9ce24-b561-43f1-a9ac-0af27ded0634" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e2ff8afb-39a3-4103-8451-581bff5c2e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e6706744-2b67-4719-9bd9-1d6715f23ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e2ff8afb-39a3-4103-8451-581bff5c2e75" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e6706744-2b67-4719-9bd9-1d6715f23ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_78de95a9-e7fe-4424-af2a-927925101429" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e2ff8afb-39a3-4103-8451-581bff5c2e75" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_78de95a9-e7fe-4424-af2a-927925101429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_63dc7468-2f32-4b52-9495-22b878a03840" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e2ff8afb-39a3-4103-8451-581bff5c2e75" xlink:to="loc_us-gaap_EarningsPerShareBasic_63dc7468-2f32-4b52-9495-22b878a03840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e454c890-8241-4f75-bc69-77c92a530c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e2ff8afb-39a3-4103-8451-581bff5c2e75" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e454c890-8241-4f75-bc69-77c92a530c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5f5f22e6-2c44-4fdf-93ad-2788f0c59d01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_17707a84-63c2-482f-b6bb-f3325a052650" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f5f22e6-2c44-4fdf-93ad-2788f0c59d01" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_17707a84-63c2-482f-b6bb-f3325a052650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a57c1559-9d86-403f-a2b1-f48fb89d426b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_17707a84-63c2-482f-b6bb-f3325a052650" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a57c1559-9d86-403f-a2b1-f48fb89d426b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8a7458f-e091-45e1-9810-c3c0cc8d53f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a57c1559-9d86-403f-a2b1-f48fb89d426b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8a7458f-e091-45e1-9810-c3c0cc8d53f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4b77b764-37e0-40bd-8052-6238e5e77b95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8a7458f-e091-45e1-9810-c3c0cc8d53f2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4b77b764-37e0-40bd-8052-6238e5e77b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_000b31c3-d04c-4d2b-936f-13d14a7cf75d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8a7458f-e091-45e1-9810-c3c0cc8d53f2" xlink:to="loc_us-gaap_WarrantMember_000b31c3-d04c-4d2b-936f-13d14a7cf75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_41e637d3-5f98-41c7-ae92-e276a1e18c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_17707a84-63c2-482f-b6bb-f3325a052650" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_41e637d3-5f98-41c7-ae92-e276a1e18c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_df35f2f6-cad6-44f1-aa11-9ba546ab6eac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_41e637d3-5f98-41c7-ae92-e276a1e18c6d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_df35f2f6-cad6-44f1-aa11-9ba546ab6eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_d38813b6-e94b-4b02-842e-31baa5087449" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_d38813b6-e94b-4b02-842e-31baa5087449" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1dc75d7e-9557-46c3-945f-df9a2242497f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1dc75d7e-9557-46c3-945f-df9a2242497f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_f61fe431-ee33-4ccb-896a-1b5213c6aa10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1dc75d7e-9557-46c3-945f-df9a2242497f" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_f61fe431-ee33-4ccb-896a-1b5213c6aa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember_9cb22112-d8df-462f-bdcd-58b5b4d0a890" xlink:href="angn-20251231.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f61fe431-ee33-4ccb-896a-1b5213c6aa10" xlink:to="loc_angn_PurchaseOfWarrantsMember_9cb22112-d8df-462f-bdcd-58b5b4d0a890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_cf81fb09-5b14-4632-8804-907b071d0e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_cf81fb09-5b14-4632-8804-907b071d0e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cd4ea65d-4839-4012-bb39-ec7b7a59f273" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_cf81fb09-5b14-4632-8804-907b071d0e0e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cd4ea65d-4839-4012-bb39-ec7b7a59f273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_f6691b0e-64b3-4941-b619-6890952e79ee" xlink:href="angn-20251231.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cd4ea65d-4839-4012-bb39-ec7b7a59f273" xlink:to="loc_angn_MarchSubscriptionAgreementMember_f6691b0e-64b3-4941-b619-6890952e79ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_July2024PublicOfferingMember_9e1c7a7a-160f-4a27-8e0b-8783b5d42a3e" xlink:href="angn-20251231.xsd#angn_July2024PublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cd4ea65d-4839-4012-bb39-ec7b7a59f273" xlink:to="loc_angn_July2024PublicOfferingMember_9e1c7a7a-160f-4a27-8e0b-8783b5d42a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_fa9d79ad-6991-4f23-8969-b87e028abc29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_fa9d79ad-6991-4f23-8969-b87e028abc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_151f8827-7b7a-495e-9172-3ebad455eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_fa9d79ad-6991-4f23-8969-b87e028abc29" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_151f8827-7b7a-495e-9172-3ebad455eedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_ffb95e6f-fc32-4a31-bf6d-3e383b3a0fb4" xlink:href="angn-20251231.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_151f8827-7b7a-495e-9172-3ebad455eedc" xlink:to="loc_angn_PreFundedWarrantMember_ffb95e6f-fc32-4a31-bf6d-3e383b3a0fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_b1265634-d720-4943-8b20-c3f827868a43" xlink:href="angn-20251231.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_151f8827-7b7a-495e-9172-3ebad455eedc" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_b1265634-d720-4943-8b20-c3f827868a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b5fd79f7-d401-4070-b68a-8a1650db5d6a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_srt_CounterpartyNameAxis_b5fd79f7-d401-4070-b68a-8a1650db5d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b5fd79f7-d401-4070-b68a-8a1650db5d6a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember_6ff4e0af-02c8-416f-b2c7-f477f6588a7c" xlink:href="angn-20251231.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:to="loc_angn_YekaterinaChudnovskyMember_6ff4e0af-02c8-416f-b2c7-f477f6588a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_73c0bbe1-1105-4d38-bd51-4cc5b0d7181a" xlink:href="angn-20251231.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:to="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_73c0bbe1-1105-4d38-bd51-4cc5b0d7181a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember_019b2fa7-b65f-7ec7-8415-019619ec024e" xlink:href="angn-20251231.xsd#angn_YekaterinaChudnovskyAndJayVenkatesanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5946a28-308a-4fef-ac70-fb5d6945304c" xlink:to="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember_019b2fa7-b65f-7ec7-8415-019619ec024e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_65341858-d798-44a5-bc8b-c9c4814c8db8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_DebtInstrumentAxis_65341858-d798-44a5-bc8b-c9c4814c8db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6b43d207-a895-4161-9794-66427e95e124" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_65341858-d798-44a5-bc8b-c9c4814c8db8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6b43d207-a895-4161-9794-66427e95e124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_6601587a-f5d3-43ff-840d-1e8c592ce356" xlink:href="angn-20251231.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6b43d207-a895-4161-9794-66427e95e124" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_6601587a-f5d3-43ff-840d-1e8c592ce356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8c038510-a598-44ed-8c9a-590a305cf0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8c038510-a598-44ed-8c9a-590a305cf0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c65be90a-c20e-4c0c-9b86-f7d8e87c2865" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8c038510-a598-44ed-8c9a-590a305cf0fe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c65be90a-c20e-4c0c-9b86-f7d8e87c2865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ec4edaad-48c9-43ab-b9c7-787b31b7bb09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c65be90a-c20e-4c0c-9b86-f7d8e87c2865" xlink:to="loc_us-gaap_ConvertibleDebtMember_ec4edaad-48c9-43ab-b9c7-787b31b7bb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019b2faa-7254-7d44-b454-8a2b0b645caa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019b2faa-7254-7d44-b454-8a2b0b645caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019b2faa-7254-7934-9620-9be643efe874" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019b2faa-7254-7d44-b454-8a2b0b645caa" xlink:to="loc_us-gaap_EquityComponentDomain_019b2faa-7254-7934-9620-9be643efe874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019b2faa-7254-775e-8b27-2f1ecd7aa73e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019b2faa-7254-7934-9620-9be643efe874" xlink:to="loc_us-gaap_CommonStockMember_019b2faa-7254-775e-8b27-2f1ecd7aa73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8d2290e6-f991-4dc8-b4c0-3533d0debc66" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8b9e90aa-1ce5-491f-bee3-966cecf4c215" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8b9e90aa-1ce5-491f-bee3-966cecf4c215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_9a4bd66f-68d2-4cac-97dd-bdcd1ade80ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_9a4bd66f-68d2-4cac-97dd-bdcd1ade80ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_4c8850bc-3c50-4857-9f1f-f5ac5cabc971" xlink:href="angn-20251231.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_4c8850bc-3c50-4857-9f1f-f5ac5cabc971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f1add452-2e43-4985-8736-a81283da32e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f1add452-2e43-4985-8736-a81283da32e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_895a92e0-9996-4bbe-8dbc-994a35a04892" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_895a92e0-9996-4bbe-8dbc-994a35a04892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2faa-7254-7ac9-8c94-6a560de1c1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019b2faa-7254-7ac9-8c94-6a560de1c1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019b2fac-3e2e-7d36-86e0-86b48e14cbce" xlink:href="angn-20251231.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_019b2fac-3e2e-7d36-86e0-86b48e14cbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b2fad-1e8b-7cdf-a871-653153a0ef86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4ee6bf04-d9f5-4fe3-b44c-f3b8d549e12a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_019b2fad-1e8b-7cdf-a871-653153a0ef86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_053db3fc-11e8-4ae2-b51d-b0e02d1ec65d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_fc7ff48f-1544-4eab-8016-7fbf48b2c160" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_053db3fc-11e8-4ae2-b51d-b0e02d1ec65d" xlink:to="loc_us-gaap_NumberOfReportableSegments_fc7ff48f-1544-4eab-8016-7fbf48b2c160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_053db3fc-11e8-4ae2-b51d-b0e02d1ec65d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:to="loc_srt_ProductOrServiceAxis_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_19057e55-86a0-4a8d-b53e-3a0dfa2a31f0" xlink:to="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember_3bb91440-8c8f-4c1c-9646-372fd5d87450" xlink:href="angn-20251231.xsd#angn_ClinicalTrailMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:to="loc_angn_ClinicalTrailMember_3bb91440-8c8f-4c1c-9646-372fd5d87450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_21f3e1b9-091c-4694-bc10-47e4ec42a2ec" xlink:href="angn-20251231.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:to="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_21f3e1b9-091c-4694-bc10-47e4ec42a2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember_68e5fa73-fa65-45d1-816d-3bda069c0b52" xlink:href="angn-20251231.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:to="loc_angn_TranslationalMedicineAndCMCMember_68e5fa73-fa65-45d1-816d-3bda069c0b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember_a9f9417a-2329-46a3-9fe3-59b31fa55882" xlink:href="angn-20251231.xsd#angn_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a9ec562-4652-414b-b2a2-555d6c130a56" xlink:to="loc_angn_OtherMember_a9f9417a-2329-46a3-9fe3-59b31fa55882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_951f50bc-6fe6-4eea-bcfc-c70137381a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_951f50bc-6fe6-4eea-bcfc-c70137381a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b0a90918-f76e-404c-9c3a-51b3937d15af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_951f50bc-6fe6-4eea-bcfc-c70137381a1b" xlink:to="loc_us-gaap_SegmentDomain_b0a90918-f76e-404c-9c3a-51b3937d15af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember_682969ff-46d1-467b-87fa-47edd7575a85" xlink:href="angn-20251231.xsd#angn_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b0a90918-f76e-404c-9c3a-51b3937d15af" xlink:to="loc_angn_ReportableSegmentMember_682969ff-46d1-467b-87fa-47edd7575a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e5316449-064a-4075-a044-586a41276072" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b2a2a249-2473-4f18-bf18-613c9dbddc41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b2a2a249-2473-4f18-bf18-613c9dbddc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_edd0662d-12e8-4427-8e9a-e6e9bee8d344" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_edd0662d-12e8-4427-8e9a-e6e9bee8d344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3ce38ba1-83cd-4f8b-bef7-137a0e1c81a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3ce38ba1-83cd-4f8b-bef7-137a0e1c81a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_312af5da-7dbe-4769-af5b-83a6f66fd94e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_312af5da-7dbe-4769-af5b-83a6f66fd94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_dc8c36a2-9a7b-47fa-a362-69194ae2234b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_dc8c36a2-9a7b-47fa-a362-69194ae2234b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4dd921f8-e968-4849-9063-0c9644b83261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_NetIncomeLoss_4dd921f8-e968-4849-9063-0c9644b83261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_40ecc0c8-ddfa-4eb5-954e-f6e31c3b220a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3876ce3-68e9-454b-954f-b637263c1578" xlink:to="loc_us-gaap_Assets_40ecc0c8-ddfa-4eb5-954e-f6e31c3b220a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="angn-20251231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_7ba8f892-85ba-43bb-9dde-152ed6a35a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_7ba8f892-85ba-43bb-9dde-152ed6a35a7b" xlink:to="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5fd120e0-63c2-4724-ab03-ff3b474e9977" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5fd120e0-63c2-4724-ab03-ff3b474e9977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f37fdd48-7f26-4371-a5d3-f83d21bf88cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5fd120e0-63c2-4724-ab03-ff3b474e9977" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f37fdd48-7f26-4371-a5d3-f83d21bf88cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a0f71230-5019-4583-9f0b-c2e1533874c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f37fdd48-7f26-4371-a5d3-f83d21bf88cf" xlink:to="loc_us-gaap_SubsequentEventMember_a0f71230-5019-4583-9f0b-c2e1533874c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9e6b-6783-7f41-9ad3-ec85d3665753" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9e6b-6783-7f41-9ad3-ec85d3665753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9e6b-6783-7007-9c9f-cf1f57b5045e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9e6b-6783-7f41-9ad3-ec85d3665753" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9e6b-6783-7007-9c9f-cf1f57b5045e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024ATMProgramMember_019c9e6b-b016-7083-9cd2-f834b7b3cc75" xlink:href="angn-20251231.xsd#angn_A2024ATMProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9e6b-6783-7007-9c9f-cf1f57b5045e" xlink:to="loc_angn_A2024ATMProgramMember_019c9e6b-b016-7083-9cd2-f834b7b3cc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019cd82b-527d-7ce2-9863-1a78f3168371" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019cd82b-527d-7ce2-9863-1a78f3168371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019cd82b-527d-71a7-9178-8738b94768dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019cd82b-527d-7ce2-9863-1a78f3168371" xlink:to="loc_us-gaap_EquityComponentDomain_019cd82b-527d-71a7-9178-8738b94768dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019cd82b-7180-70b5-809f-9d57977568cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019cd82b-527d-71a7-9178-8738b94768dc" xlink:to="loc_us-gaap_CommonStockMember_019cd82b-7180-70b5-809f-9d57977568cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_bd16dc04-2c69-456c-8d99-dfaa2a855464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_26f14027-6a46-4b67-ade8-6e1483abe740" xlink:to="loc_us-gaap_SubsequentEventLineItems_bd16dc04-2c69-456c-8d99-dfaa2a855464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019c9e4f-2f67-70b3-8529-2f0731862586" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_bd16dc04-2c69-456c-8d99-dfaa2a855464" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019c9e4f-2f67-70b3-8529-2f0731862586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1ef858c-561f-438b-aa9b-679c653dedad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_bd16dc04-2c69-456c-8d99-dfaa2a855464" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1ef858c-561f-438b-aa9b-679c653dedad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>angn-20251231_g1.jpg
<TEXT>
begin 644 angn-20251231_g1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'X!. # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,<8:555@2Q/\*]O>O(S#+89A9WLT?H&2\1O+\4Z.$I+DE]_J<#^P9\(=4O\
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MA1114#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ORI*K,<GT KUG187M=(L8)!B2.!$8>A"@&JTY?,G6Y=HHHJ2@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $KR_X=_%
MR\\9?%;Q[X2GL(+>W\.20I%<1L2\V]0?F!X&/:O4*\7^%/P]USPW\</B?XAO
M[58=+UJ6!K*8."9 J 'CMS5*UG<EWNK'M-%%%24%%%% !1110 4444 %%%%
M!1110 4C'M2TR:188S([!$499F.  .I)H \-MH?!/Q _::GNX_[0;Q?X2LQ"
MY S:['R1D_WOF->Z+TKQ3]G_ .&MSX9\3_$+Q9>ZC8ZG/XFU(312Z=.)8O(3
M(C&1_%AN:]KJY6OH3$6BBBH*"BBB@ HHHH **** "BBB@ HHI* %HINZE'-
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M,8\HQ@KCZ4O:AR'S_P#L>_$;Q-X\TCQ'!KGDZE9Z9>?9K+7H;3[,M^@&-VW
M)^IKZ)J*"".WC2.*-8HU& J   ?2I:RE+F=T:15E8****D84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOQ/?%FO-<OOFFE9CDA?[HKUGH**6H;;W*"D8;A2T4@$Q2T44 %%%% #2N?\
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M_?0H^V0?\]X_^^Q7S[YS_P!XU!>:A%86LES=7*6]O&I9Y96"JH]R:E9Y%Z*
M6/HG[9;_ //>/_OL4?;+?_GO'_WV*^3_  9\6?"GQ"FNH/#^NVNI3V[%)(XG
M&X>X'<>]=;N/K^E.6=*+M*FPL?0?VRW_ .>\?_?8H^VV_P#SWC_[[%?/FX^H
M-)N;'7 _E4_VY'^0+'T)]LM_^>\?_?8H^VV__/>/_OL5\D0_&3P;<>+F\,IX
MBLFUE1@VPE'7TSTS[5V>X]NE5+.N7XJ;0'T)]MM_^>\?_?8H^VV__/>/_OL5
M\^;R><BD\QO85/\ ;L?Y /H3[9;_ //>/_OL4GVVW_Y[Q?\ ?8KY3\:_%+PM
M\.U@/B+6K?3'G8+''*WS-GOCKCWKH=/U2WU2QAN[.=+JUF4/'+$P96![@BK>
M=65_9L=CZ,^V6_\ SWC_ .^Q1]MM_P#GO'_WV*^>_,(ZG]*-YQP>:S_MV/\
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MK)'I_B%5RJJ?W5T!U9,]#ZKUK*^#'AW5=-_:&^+^HWFGW%M87LUL;:XE3"3
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M[*J=.*^;S7#\[C5EJD-'D4</Q#_:8E=KG[1X$^'K'Y8%RM[?)ZG^Z#77ZO\
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M\?O&=W=S&9+V*^AN(50CRQ),2.?H:]'\;^+]!_9+\-ZG9:3?#5?$^K/FWMF
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MT7^.=@,_0=ZM:'\59_%&F0ZCI6M1ZA8S#*30,&4U\[^%?V<KSQ9K:^*?BQJ
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MKC4KF"TM0P4RW#A4R3@#)]ZN1LLBJR$,I&01TKYY_;P4_P##/&H<G_D)6/\
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MX*\RJP_$'%>NZ',]SH]A-*Q>22!&9CW)4$FJL^6XM+E^BBBI&%%%% !1110
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M&,M*BCW85EZEXPT724#7>J6L /3=*.::C)[(F52$=9,V::S!02>E>7:S\?\
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ME@>XB#-&P.003Z&MC%$K/8%<6N)^+WC:Z\!^"YM1L;9;F\DFCM8?,'[N-G.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'SO^WA_P F[W^,_P#(2L>G_7=:]V\._P#(!TW_ *]H_P#T
M$4NM:/INNV+6FJ6EO?6;,&,-T@="P.0<'C(-78E2-%5  BC 5>@'I5<WNV%;
M6Y)1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_?7\Z7SD_OK^=?/_ -LG'_+>0?\  S1]MN/^>\O_ '\-?.?VXOY!GT!YT?\
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MG_[;<_\ />7_ +^&C[;<_P#/>7_OX:/[<7\@6/H#SH_[Z_G1YT?]]?SKY_\
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M\%44?ZNX+S^\/]=LT\ON/O;_ (;]\$_] O5/^_0_QI/^&_?!/_0+U3_OT/\
M&O@JBC_5W!>?WA_KMFGE]Q]Z_P##?O@G_H%ZI_WZ'^-'_#?O@G_H%ZI_WZ'^
M-?!5%'^KN"\_O#_7;-/+[C[V_P"&_/!7_0+U3_OT/\:7_AOOP5_T"]4Q_P!<
MQ_C7P1BE[>]'^KN"\_O#_7;-/+[C]#/#/[</@/7]4ALKB.]TSSF")-<1_)N)
MQR0>!7T)!<)<1I)&ZO&X#*RG((/>OQL?/EOSVK];_ADQ?X?^'F)RQL8>O^Z*
M^5SG+*6 Y94GHS]!X5S[$9PZD,0E>/8ZFBBBOF#]""BBB@ HHHH **** "BB
MB@ HHHH *X7XM?\ (%M/^O@?^@FNZKA?BUSHMI_UW_\ 937GX_\ W:?H,\P:
MEI*6OS<84444#"BBB@ HHHH *3COUJUI5B^IZE;6J#)D< _3J37;>)OL^M:)
M?):1*LFERA<J.2N.37?0PCK4Y5$]A'"_8Y]L;""3;(<1G:<.?0>M1R0O#(R2
M(R.IP588(KO(0/[)\(X''V@&FZMX6LM7UN_CCU'_ (F!+.+?;\OK@GUKI>7M
MPO!ZZ <'[4O/89K6O- -GX=BU$R,97E,31D# Q_^JM-?!*R:M;V0N6_?6PGW
M%1]['3Z5R_4ZS=K?TQ'*T*K2N%12S'HJCFNN7P;I\U@]U'JQ,<#;+DE.GT]:
M6/PU_9NM:1/8WADMKIOW<K("5/TK3ZA537-L,Y%E*L58%6'!4C!H'IWKL+CP
MS'?S:K>WE\81;S[)&V#!&,YQZUEZ]X;&G?8I+*9[VWNE)C.WYLCJ,5-3!58)
MRMH!BPP2W#,L<;2E1N(09( ZD^U,KK/ MF\6JZA%<*;?=9N,RC&!QS]*@O/"
M]J-&DO\ 3[YKL0L%E#+C'N*J."G*G&: YR2-XV =&0]<,,<4E=IJV@RZMXHM
MK&>[+$VN\2; ,8&<$>E9]YX5M3I-Q>6&H&[>W8+*NT 9/'%$L#5UY=@.<CC>
M9U1$9W8X"J,DTYK69/,#Q.I3A\J?E^M=KI/A>ST?5M/6?42NHDK)Y.SY>>V?
M6GWUO.W_  E$B7'E1K)EH]@.>/7M6JP$N2\GJ!P6*7\:[!?!=A UBESJ;1/=
M(&C54!.3V^E4E\)+;-J+W]RT-O9N$+1IN9R>F!6'U&OIH!SG'I1D?2MOQ+H=
MKH;6WV>YDG::,28=0,*>A^M7K6-?^%=W#[1O%U]['; J%A9<\H2>J5QG,K&\
MB,RJS*OWF X'UIF<5T&F6\\G@_5I5FVQ+(FZ/:/FR?7M6@W@FQANK6&YU1HY
M+I%,*A!DD]CZ#-6L%4FE*'8#D?+?87VL4!P6QP*6*&2:18XXVDD8X"J,DUT_
M]E7.F^']8@,X58[A8FC"@[O?-:&A>&+32-8T@W&H%;]\3+;[?E(P>,^M:QP$
MY2BOO$<.RM&Y1U*.O!4]125I>)/^0]??]=3_ #K-KSZL/9S<>PPHHHK( HHH
MH **** &M7M7@/\ Y%>R^A_F:\5:O:O ?_(KV?T/\S7T61_QI>A/0Z"BBBOM
MA'D'[4WQ,UKX1_".Z\1: \":E'>VL"FXB\Q-LDJJW&?0UZCHUU)>:793R8\R
M6%)&(XY*@G%>9?M0?#'6/BY\)+KP[H9A_M&2\MIU^T/M7;'*&;GUP*].TFU>
MRTNR@DP9(H4C;;TR% -7IR^9.MR[1114%'(_%C_DG/B#_KSD_P#037Y\1_=%
M?H/\6CM^''B _P#3G)_Z":_/E?NBOQ3CW_>*7H?K7!7\&KZH;WHI:2ORH_20
MHHHH **** "BBB@ HHHH 5<UUD?PK\6S6*WB:#=O;N@D5T0G<I&00*Y/L:^N
MM1AU&TUCP3JO_"1PZ3H=KIT#7=O-<!!)\G7;WSQ7U>2Y71S"-255M<MMO/J?
M,9QFE7+Y4XTDGS7W\O3N?),D;0R-'(ICD4X96&"#Z&K_ (?T"[\4:M;Z78HK
M75PVU-QP#7NNOZ7X/:SU[XA7U@^KV<]X8;2UC;8C <%S]?Z5)HG@O2++QEX!
M\5Z# ]CIVJNRO9R/N,<F">#Z8!KKCP[+VR7.FKK1;\K=KG)/B&/L6U!J5GJ]
MN9*]CP#5],FT75+O3[H 7%K*T,B@\;AUJB*]V\3>"],\76/CVXM(&'B/3=5D
M=F#9+Q%O3T[5H:=\*?"\?C+2/#=_:.T\6C27FH,CG<9=H/'TYK*?#M>56U-K
ME;T?S_,TAQ#0C23J)\R6J^5[^A\]KZ4<5] 6>@_#?6/ =]XDBT2^M[71IO+D
MC\X%[KL 3VSD5#>?"WPWXN\2^";C1[>73-,UV%YI;8MDJ$Z@'MFD^&Z]E[.<
M97[?F-<14$_WD)17=]TK_D>"^PZ^].53)(B#[SMM ]2>U?0GB[X5Z++X1URY
M&B+X;N=..;21;M9#<(#SN&>IK.\?>'? _@/0],B72;FXU;5+6-HY%DPL+$CY
M^>Y-*7#M:BVYS7*BH<0T:J2IP?,]+?J>0^(_"NJ>$KF*VU6W-K+(@D1=P;*G
MITK(W8Z5](:]\+=-UKXE*+V2YFT;3](6\N$>4L['G"@GH#@UY#X^UKPKK"VS
M>'M%GT>:-BLJM(&5U[$>]89AD[PD74<DET75F^ S?ZVXTU%M]6MD8"^'-2DT
M-]8%I(=-63RS<*/E#>E26WA75+SP[=:Y#;%]-M7$<LVX?*QZ#%>HV/R_LP7Q
MSG_B8_\ LRUB^']'BN/@9XBU!I)A+'J%O&%20A""P!RO0FM8Y3!RC%=8<WSL
M92S6<8RDU:T^7Y7/,1R!V]JV])\'ZCKFA:KJ]LBFSTU0]P6." >.*]WF\$_#
M[0?%/A_P_=Z-<W5[KT";)A+^[@)&,X]2:K_#?P,;S1/B9X6LI@H:9;6.68@
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MK\D9O]6_TK];OA=_R3KPY_UXP_\ H(KXGB?X*?J?K?A__%K^B.IHHHKX _:
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M*_0"BC^W\=_,ON#_ %,RC^1_>?G_ /\ # GC_P#Z"^B?]_)/_B*/^&!/'_\
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MON.RCPGDN(@ITXNWJ? '_# OC_\ Z"^B?]_)/_B*/^&!?'__ $%]$_[^2?\
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MOT HH_M_'?S+[@_U-RC^1_>?G_\ \,">/_\ H+Z)_P!_)/\ XBC_ (8$\?\
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M2NRQ-S?HKSR^^.GA6QL;.Z\ZZN([V[ELK5+>W9WGEC.'50.O/\JQQ^TUX+:
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MK0'BS7?ACI/PZN]6U<:EX?U)X[*_N)XEC^SM)$#"Q('0$$9]Z7*%SW&BO/\
MX0^*-:\:Z=K6MZB$CTZXU*:/28E4?\>L9"!R>N6=7//8"N_'2IV*%HHHI %%
M%% !1110 4444 %%%% !1110!YY\0/\ D?? O_7U+_Z!7H5>>_$#_D?? O\
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M^'=.GU0'=]I>!2Q/J>Q/N>:Z95V\#IZ42ES#2L+1114#"BBB@ HHHH ****
M$K*\-?\ (-;_ *[2?^AFM6LKPU_R#6_Z[2?^AFLG\: UJ***U X#XV?">U^-
M'@&?PO>7LFGPRW$-P9X5!8&-PX&#ZXKM=/M18V=O; [A#&L88]\#&:\W_:.^
M*=]\&?A?=>)M.M8;RZBNK> 13YVD22!2>/8UZ/I=RU]IMI<N,--$DA4=!D _
MUJM>7R%I<MT445(SEOBA_P B!KO_ %ZO_*M?PW_R+^G?]>\?_H(K(^*'_(@:
M[_UZO_*M?PW_ ,B_IW_7O'_Z"*X5_O3_ ,*_-G2_X"]7^2-*BBBNXY@HHHH
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MS12*'4GC@C(JKOEL397N3T445)1RWQ0_Y$#7?^O5_P"5:_AO_D7]._Z]X_\
MT$5D?%#_ )$#7?\ KU?^5:_AO_D7]._Z]X__ $$5PK_>G_A7YLZ7_ 7J_P D
M:5%%%=QS!1110 4R1A&"QZ 9I]0W49E@D0<;D('XBIDVHMH:WU/$8K&Z^.WB
M74FOKN>S\(Z=<&WBM8)-ANI%^\6(["KGCGX4_#CPOX?^TWD']B;2%BNK5V$Q
M;MC'+&N>\(Z%-XB\.:EX8@OWT7Q-H.HRW%LZL06RQ968=P<XKI?!_P /=?\
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MQ C#4;*3:6"3$\,NX[0?:L+X+^'1J4G@>]GUO0=.\1VUVTM['#%*-1N)#O\
M,BE).#D^O' I<J'<^O:6D7O2UF4%%%% !1110 4444 >>?$#_D?? O\ U]2_
M^@5Z%7GOQ _Y'WP+_P!?4O\ Z!7H0K@P_P#%J^OZ'35^"'I^HM%%%=YS"$XK
MQ?X4_#O7O#?QQ^*'B+4+18-)UJ6![&82*QD"H >!R/QKVAJY;PW\2M"\5>*]
M?\.:?<22:KH;(M]&T14(6&1ACP>/2J3=G83.JHHHJ1F'XY_Y$W6_^O.7_P!
M-<_\"_\ DDGA7_KPC_E70>./^1-UK_KSE_\ 0#6!\#/^22^%?^O"/^5;+^&_
M4Y'_ !UZ,[NBBBL3K"BBB@ HHHH **** "BBB@ I/6EHH ^6;C1]%\)_&#QO
MX4\96ZIX<\;LM[:7DQQ&TX&&3=_"PZ@^U=+\/_V<8/#OB"WU?Q3XBD\3V6C@
MIH<-V^4M(NH+9X9AT!]*]>\;^ ="^(FBR:5KUA'?VCG(#\,C>JGJ#[BO)?\
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M]N*BL?AW8V^K^*KNX8WD/B *MQ;2+\H4)L*_B*ZZBE<9XUH/[,^C>'?A_?\
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M!R:@&EV:W9NA:0BY/6;RQO\ SZU:HH C6&-&9E0*S=6 Y-"V\<;LZHJNWWF
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MBN6_X6AX6_Z#5M_WU1_PM#PM_P!!JV_[ZH^L4OYD'LJG\K.IHKEO^%H>%O\
MH-6W_?5'_"T/"W_0:MO^^J/K%+^9![*I_*SJ:*Y;_A:'A;_H-6W_ 'U1_P +
M0\+?]!JV_P"^J/K%+^9![*I_*SJ:*Y;_ (6AX6_Z#5M_WU1_PM#PM_T&K;_O
MJCZQ2_F0>RJ?RLZFBN6_X6AX6_Z#5M_WU1_PM#PM_P!!JV_[ZH^L4OYD'LJG
M\K.IHKEO^%H>%O\ H-6W_?5'_"T/"W_0:MO^^J/K%+^9![*I_*SJ:*Y;_A:'
MA;_H-6W_ 'U1_P +0\+?]!JV_P"^J/K%+^9![*I_*SJ:*Y;_ (6AX6_Z#5M_
MWU1_PM#PM_T&K;_OJCZQ2_F0>RJ?RLZFBN6_X6AX6_Z#5M_WU1_PM#PM_P!!
MJV_[ZH^L4OYD'LJG\K.IHKEO^%H>%O\ H-6W_?5'_"T/"W_0:MO^^J/K%+^9
M![*I_*SJ:*Y;_A:'A;_H-6W_ 'U1_P +0\+?]!JV_P"^J/K%+^9![*I_*SJ:
M*Y;_ (6AX6_Z#5M_WU1_PM#PM_T&K;_OJCZQ2_F0>RJ?RLZFBN6_X6AX6_Z#
M5M_WU1_PM#PM_P!!FV_[ZH^L4OYD'LJG\K.IIK''4X%<I/\ %'PS'"TBZFD^
MWG9 I=S] .36/-J6O?$)9+;3K:;0M%;Y9+ZX&VXF7TC3JN?4UG+%0VA[S\BX
MT9;RT7F3:.R>+/B%<ZNC&2QTF)K.W9?NM(Q'F$?3"C\#7?+TJAH>AVGAW3(+
M"QA$-O"NU5'4^Y/<GUJ_5T*;IQ][=ZLBI)2>FR%HHHKI,@HHHH **** (;F$
M7$$D3#Y74J?H1BO-/@WJCZ4-6\&WX,6IZ+<MY:MP)K5V+12+[8.T^X->HUPW
MQ!^'T_B*YL]:T6]_LGQ-I^?L]X%RDBGK%*/XD/Z=:VA)6<)=3FK1DFJD=T=Q
MFEKRS2_C,^D7?]F>--&N_#U^AV"Z6,RV4_&=R2KP![-@UKGXY>!ER#XBM ?]
MZDZ4UT".(IR6]CO**X/_ (7IX%_Z&.S_ .^J7_A>?@7_ *&2S_[[I>SGV+]M
M3_F1W=%<)_PO+P+_ -#'9_\ ?='_  O+P+_T,=G_ -]T_9S[![:G_,CNZ*X3
M_A>7@7_H8[/_ +[H_P"%Y>!?^ACL_P#ONCV<^P>VI_S([NBN$_X7EX%_Z&.S
M_P"^Z/\ A>7@7_H8[/\ [[H]G/L'MJ?\R.[I*X7_ (7EX%_Z&.S_ .^Z3_A>
M?@7_ *&2S_[ZI>SGV#VU/^9')_%/X3:[_P )?#X]\"7D=IXG@A\FYLY^(+^(
M=$;T;T-<U'\:/BDLTFGV_P (YHM8<9:4W*"#/]XOT/YUZC_PO/P+_P!#)9_]
M]TG_  O/P+_T,=G_ -]UV1J3Y5&<+V/*GAZ;FYTJO+??^NAS_P */A/JVE^)
M+[QKXTO(=2\77R>4JP9\FRA_YYQY_#)KURN$_P"%Y>!?^ACL_P#ONE_X7EX%
M_P"ACL_^^ZPJ>UJ2YI([:'L,/#DA([%M-M6\P&UA(E?S'S&/F8=&/J>.M2?9
M8O,,GE)O9=A;:,D>A/I7%?\ "\O O_0QV?\ WW1_PO+P+_T,=G_WW6?LY]CH
M]M3_ )D=E'8V\7E;((T\H$1E4 V ]0OI^%#:?;%94^S1%)FW2+Y8PY]2._XU
MQG_"\O O_0R6?_?=+_PO+P+_ -#'9_\ ?='LY]@]M2_F1UUWHNGZ@T375C;7
M+0_ZMIH5<I_NY''X5(MC;QK%LMHE$/\ JPJ ;,]=OI^%<;_PO+P+_P!#'9_]
M]TG_  O+P+_T,EG_ -]T>SGV%[:E_,CM&L;<B8>1&?._UOR#]YQCYO7CUJ&R
MT:PTN-X[*QMK2)_OI!"J!OJ .:Y'_A>?@7_H8[/_ +[I?^%Y>!?^ACL_^^Z/
M9S[#]M3_ )D=DUC;[8E^S1;83F(;!\A]1Z?A1_9]J?/_ -%B_?\ ^M_=C]Y_
MO>OXUQO_  O+P+_T,EG_ -]T?\+R\"_]#'9_]]T>SGV#VU/^9'7Z?I%CI,;1
MV-E;V4;'<5MXEC!/J0!4<.A:;:S--#IUK%*S;VDC@4,6_O$@=:Y3_A>7@7_H
M8[/_ +[I/^%Y^!?^ACL_^^Z/9S[![:G_ #(ZR;0=-N+IKB73K26X==K3/ I=
MAZ$XR15@V<#2-)Y$?F,NQF*#)7T)[CD\5QG_  O+P+_T,=G_ -]T?\+R\"_]
M#'9_]]T>SGV8O;4OYD=;9Z+I^GG=:6%M:MSS#"J'GKT%$>BV$8N0EC;(+GF<
M+"H$I]7X^;\:Y+_A>7@7_H8[/_ONC_A>7@7_ *&.S_[[H]G4[![:E_,CK+71
M;"QM7MK:PMK>VD^_#%"JHWU &#3[G2;*]M4M;BSMY[5<;89(E9!CI\I&*Y#_
M (7EX%_Z&.S_ .^Z/^%Y>!?^ACL_^^Z/9S[![:E_,CM;:UALXEB@A2")!A8X
MU"J![ =*FKA/^%Y>!?\ H8[/_ONC_A>7@7_H8[/_ +[H]G/L/VU/^9'=T5PG
M_"\O O\ T,=G_P!]TG_"\_ O_0R6?_?=+V<^PO;TOYD=Y2$_G7"#XY>!F8!?
M$5HQ/0!LUBWWQ<O_ !5=-IO@71KC4KAB4?5+V)H;.#_:RV/,Z\!>M-4IOH3+
M$4XK1W$^*5U/XL\5>'?!5AB1)+E-0U9L ^5;1G<H/H6D"8]LUZLHVJ .E<;\
M/?AXO@NWNKFZO)-5UW4)/.OM1F^](W95_NH.@%=G1-K2,=D%&,M9SW84445D
M=(4444 %%%% !1110 4444 %%%% !1110 E-:%)!AE##W%/HI 0_9(/^>,?_
M 'R*/LD/_/)/^^14U%+E78"'[+!_SQC_ .^11]D@_P">,?\ WR*FHHY5V A^
MRP?\\8_^^11]E@_YXQ_]\BIJ*.5=@(OLL/\ SQ3_ +Y%)]E@_P">,?\ WR*F
MHHY5V A^R0?\\8_^^11]E@_YXQ_]\BIJ*.5=@(?LL'_/&/\ [Y%+]EA_YXI_
MWR*EHHY5V A^R0?\\8_^^11]D@_YXQ_]\BIJ*.5=@(?LL'_/&/\ [Y%+]EA_
MYXI_WR*EHHY5V B^RP_\\4_[Y%)]D@_YXQ_]\BIJ*.5=@(?LD'_/&/\ [Y%'
MV6#_ )XQ_P#?(J:BCE78"+[+#_SQ3_OD4?98?^>*?]\BI:*.5=@(?LD'_/&/
M_OD4?9(/^>,?_?(J:BCE78"'[+!_SQC_ .^12_98?^>*?]\BI:*.5=@(OLL/
M_/%/^^12?9(/^>,?_?(J:BCE78"'[)!_SQC_ .^11]E@_P">,?\ WR*FHHY5
MV B^RP_\\4_[Y%'V6'_GBG_?(J6BCE78"'[)!_SQC_[Y%'V2#_GC'_WR*FHH
MY5V A^RP?\\8_P#OD4?9(/\ GC'_ -\BIJ*.5 0_8X!_RR3_ +Y%2;0N   /
M:G44[) )2T44P"BBB@ HHHH **** "BBB@".2!)5(=5<?[0S5;^Q['O9P'_M
MF/\ "KM%0XQ>Z'=E/^Q['_GS@_[]K_A1_8]C_P ^<'_?M?\ "KE%'LX]A\S[
ME/\ L>Q_Y\X/^_8_PH_L>Q_Y\X/^_:_X5<HH]G'L',^Y3_L>Q_Y\X/\ OVO^
M%']CV/\ SYP?]^U_PJY11R1[!S/N4_['L?\ GS@_[]K_ (4?V/8_\^<'_?L?
MX5<HH]G'L',^Y3_L>Q_Y\X/^_:_X4?V/8_\ /G!_W['^%7**.2/8.9]RG_8]
MC_SYP?\ ?M?\*3^Q['_GS@_[]C_"KM%'LX]@YGW*?]CV/_/G!_W[7_"C^Q['
M_GS@_P"_:_X5<HH]G'L',^Y3_L>Q_P"?.#_OVO\ A1_8]C_SYP?]^U_PJY11
MR1[!S/N4_P"Q['_GS@_[]C_"C^Q['_GS@_[]K_A5RBCV<>P<S[E/^Q['_GS@
M_P"_8_PH_L>Q_P"?.#_OVO\ A5RBCDCV#F?<I?V/8_\ /G!_W['^%+_8]C_S
MYP?]^U_PJY11[./8.9]RG_8]C_SYP?\ ?L?X4?V/8_\ /G!_W[7_  JY11[.
M/8.9]RG_ &/8_P#/G!_W[7_"C^Q['_GS@_[]C_"KE%')'L',^Y3_ +'L?^?.
M#_OVO^%']CV/_/G!_P!^U_PJY11[./8.9]RG_8]C_P ^<'_?M?\ "C^Q['_G
MS@_[]C_"KE%')'L',^Y3_L>Q_P"?.#_OVO\ A2?V/8_\^<'_ '['^%7:*/9Q
M[!S/N4_['L?^?.#_ +]K_A1_8]C_ ,^<'_?M?\*N44>SCV#F?<I_V/8_\^<'
M_?M?\*/['L?^?.#_ +]K_A5RBCDCV#F?<JQZ7:1-N2VA1O54 JPJ[1BG44U%
M1V0KM[A1115""BBB@ HHHH **** "DI:* (I;>.92LB+(G]UE!%4_P#A'=+)
MR=.M2?\ KBO^%:-%.[)Y8O=&=_PCNE_] ZU_[\K_ (4?\([I7_0.M?\ ORO^
M%:-%/F?<.6/8S?\ A&]*_P"@=:_]^5_PI?\ A'-*_P"@;:_]^5_PK1HHYGW%
MRQ[&=_PCFE?] VU_[\K_ (4?\(YI7_0-M?\ ORO^%:-%',^X^6/8SO\ A'-*
M_P"@;:_]^5_PH_X1S2O^@;:_]^5_PK1HHYGW#ECV,[_A'-*_Z!UK_P!^5_PH
M_P"$=TK_ *!UK_WY7_"M&BCF?<.6/8SO^$=TK_H'6O\ WY7_  H_X1W2_P#H
M'6O_ 'Y7_"M&BCF?<.6/8SO^$=TO_H'6O_?E?\*3_A&]*_Z!UK_WY7_"M*BC
MF?<.6/8SO^$<TK_H&VO_ 'Y7_"C_ (1S2O\ H&VO_?E?\*T:*.9]PY8]C._X
M1S2O^@;:_P#?E?\ "C_A'-*_Z!MK_P!^5_PK1HHYGW#ECV,[_A'-*_Z!MK_W
MY7_"C_A'-*_Z!MK_ -^5_P *T:*.9]PY8]C._P"$<TK_ *!MK_WY7_"C_A'-
M*_Z!MK_WY7_"M&BCF?<.6/8SO^$<TK_H&VO_ 'Y7_"C_ (1S2O\ H&VO_?E?
M\*T:*.9]PY8]C._X1S2O^@;:_P#?E?\ "C_A'-*_Z!MK_P!^5_PK1HHYGW#E
MCV,[_A'-*_Z!MK_WY7_"C_A'-*_Z!MK_ -^5_P *T:*.9]PY8]C._P"$<TK_
M *!MK_WY7_"C_A'-*_Z!MK_WY7_"M&BCF?<.6/8SO^$<TK_H&VO_ 'Y7_"C_
M (1S2O\ H&VO_?E?\*T:*.9]PY8]C._X1S2O^@;:_P#?E?\ "C_A'-*_Z!MK
M_P!^5_PK1HHYGW#ECV,W_A'-*_Z!MK_WY7_"E_X1W2_^@=:_]^5_PK1HHYGW
M%R1[&>OA_3$;<NGVH/M"O^%6TA6-=J(JJ.@48J6BE=O<?*ELA*6DI:104444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>angn-20251231_g2.jpg
<TEXT>
begin 644 angn-20251231_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &]!)D# 2(  A$! Q$!_\0
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MR/G?^(@8G_GQ'[V?J_\ \+D\ ?\ 0\^&_P#P;V__ ,71_P +D\ ?]#SX;_\
M!O;_ /Q=?E!11_JU2_Y^/[D'_$0,3_SXC][/U?\ ^%R> /\ H>?#?_@WM_\
MXNC_ (7)X _Z'GPW_P"#>W_^+K\H**/]6J7_ #\?W(/^(@8G_GQ'[V?J_P#\
M+D\ ?]#SX;_\&]O_ /%T?\+D\ ?]#SX;_P#!O;__ !=?E!11_JU2_P"?C^Y!
M_P 1 Q/_ #XC][/U?_X7)X _Z'GPW_X-[?\ ^+H_X7)X _Z'GPW_ .#>W_\
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MR> /^AY\-_\ @WM__BZ_*"BG_JU2_P"?C^Y"_P"(@8G_ )\1^]GZO_\ "Y/
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M .+H_P"%R> /^AY\-_\ @WM__BZ_*"BC_5JE_P _']R#_B(&)_Y\1^]GZO\
M_"Y/ '_0\^&__!O;_P#Q='_"Y/ '_0\^&_\ P;V__P 77Y044?ZM4O\ GX_N
M0?\ $0,3_P ^(_>S]7_^%R> /^AY\-_^#>W_ /BZ/^%R> /^AY\-_P#@WM__
M (NOR@HH_P!6J7_/Q_<@_P"(@8G_ )\1^]GZO_\ "Y/ '_0\^&__  ;V_P#\
M71_PN3P!_P!#SX;_ /!O;_\ Q=?E!11_JU2_Y^/[D'_$0,3_ ,^(_>S]7_\
MA<G@#_H>?#?_ (-[?_XNC_A<G@#_ *'GPW_X-[?_ .+K\H**/]6J7_/Q_<@_
MXB!B?^?$?O9^K_\ PN3P!_T//AO_ ,&]O_\ %T?\+D\ ?]#SX;_\&]O_ /%U
M^4%%'^K5+_GX_N0?\1 Q/_/B/WL_5_\ X7)X _Z'GPW_ .#>W_\ BZ/^%R>
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M^>Q_[Y_^O1_8*_\ /8_]\_\ UZUJ* ,G^P5_Y['_ +Y_^O1_8*_\]C_WS_\
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M'C_QKZPHH_MC'?\ /U_<O\@_U5R;_H'7WR_S/D__ (=\^'_^AMU+_P !X_\
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MW+_(/]5LF_Z!U]\O\SY:_P"'?/A__H;=2_\  >/_ !H_X=\^'_\ H;=2_P#
M>/\ QKZPHH_MC'?\_7]R_P @_P!5<F_Z!U]\O\SY/_X=\^'_ /H;=2_\!X_\
M:/\ AWSX?_Z&W4O_  'C_P :^L*;'(DJDHRN 2"5.>1P11_;&._Y^O[E_D'^
MJN3?] Z^^7^9\H_\.^?#_P#T-NI?^ \?^-'_  [Y\/\ _0VZE_X#Q_XU]85!
M;W]M=37$,%Q%-+;N(YHXW#-$Q 8*P'0X(.#V(H_MC'_\_']R_P @_P!5<F_Z
M!U]\O\SY6_X=\^'_ /H;=2_\!X_\:/\ AWSX?_Z&W4O_  'C_P :^L**/[8Q
MW_/U_<O\@_U5R;_H'7WR_P SY/\ ^'?/A_\ Z&W4O_ >/_&C_AWSX?\ ^AMU
M+_P'C_QKZPI&8*"2< <DFE_;&._Y^_E_D'^JN3?] Z^^7^9\H?\ #OGP_P#]
M#;J7_@/'_C1_P[Y\/_\ 0VZE_P" \?\ C7U397UMJ5I%=6EQ%=6TR[XYH7#H
MZGN&'!%3T_[8Q_\ S\?W+_(/]5LF_P"@=??+_,^3_P#AWSX?_P"AMU+_ ,!X
M_P#&C_AWSX?_ .AMU+_P'C_QKZPHH_MC'?\ /U_<O\@_U5R;_H'7WR_S/D__
M (=\^'_^AMU+_P !X_\ &C_AWSX?_P"AMU+_ ,!X_P#&OK"BC^V,=_S]?W+_
M "#_ %5R;_H'7WR_S/D__AWSX?\ ^AMU+_P'C_QH_P"'?/A__H;=2_\  >/_
M !KZPHH_MC'?\_7]R_R#_57)O^@=??+_ #/D_P#X=\^'_P#H;=2_\!X_\:[;
MX?\ [&/P_P#!-]%?W<=UXDO(B&0:FRF%6'<1* #]&W"O>J*SJ9IC:D>651V^
M[\C>CPWE-":J0PZNN]W^;8BJ%4*HP!P *6BBO*/I HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ JMJ&I6VE6KW-W,L$*]6;^0]35FO&?'.O2>(M<DA1S]B
MM6,<:@\,1U;KSD]/;'O0!MZE\6IGFVZ98IY8/^LN226'^Z",?F:JK\4M:SDV
MMECTV/\ _%5@V>G;@.*O26*0PM)(0J*,DFE<>AMZ?\6IXY,:C8(R%O\ 66I(
M*K_NMG)_$5WNDZS9ZY:BXLYEFC/7'53Z$=C7B$+1:@K;!M<?PGT]:L>']8E\
M+:S%=(6\ACMGC'.Y._'J.HH ]THI%8,H93E2,@BEIB"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#YF^)/QB72/B]+JL?BZ&QTGPM?6>EW6@_;U3[<LX(
MN93#NRYB\V @X.#')[U?U7QGK?AG]I#5-0EU:\E\)1RZ;I%UI[SLUM;F[B8Q
M3JA.U3YR(I8=I*]1L_@WX;M_".J^'I[=K^#5&NGN[N["-<RM<,S2,7"CD;SC
M X 'I5%_@3H%QH?B+2[N\U.]CUVPM-/NIYYD\T"WC*12HP08D_B+$$;@#@=*
MWC.,8I6U7XWW_6WKY&4HRE)N^C_"VS_*_H<#X?\ &&M>*/VBM+U*/5;Q/"MX
MFJ:?9:<DS"VF6T$*M<%,[68RO* V/NH*Y7X0ZWK.N7?@RZT35_%VJ:W)JUT/
M$']H2WDVEK9"28?>FS"&XC""$YR#GO7OFC?"?1-!N?"4UDUS$/#-E-864>]2
MKI*J!VD^7+-^[!R".2<YS6KX'\&V7P_\,VNA:=)/-:6[2NCW+*TA,DC2-D@
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M_P 'EK_\<H_X7]\,/^BC^$O_  >6O_QRL;_A2OP\_P"A#\,_^">W_P#B*/\
MA2OP\_Z$/PS_ .">W_\ B* -G_A?WPP_Z*/X2_\ !Y:__'*/^%_?##_HH_A+
M_P 'EK_\<K&_X4K\//\ H0_#/_@GM_\ XBC_ (4K\//^A#\,_P#@GM__ (B@
M#9_X7]\,/^BC^$O_  >6O_QRC_A?WPP_Z*/X2_\ !Y:__'*QO^%*_#S_ *$/
MPS_X)[?_ .(H_P"%*_#S_H0_#/\ X)[?_P"(H V?^%_?##_HH_A+_P 'EK_\
M<H_X7]\,/^BC^$O_  >6O_QRL;_A2OP\_P"A#\,_^">W_P#B*/\ A2OP\_Z$
M/PS_ .">W_\ B* -G_A?WPP_Z*/X2_\ !Y:__'*/^%_?##_HH_A+_P 'EK_\
M<K&_X4K\//\ H0_#/_@GM_\ XBC_ (4K\//^A#\,_P#@GM__ (B@#9_X7]\,
M/^BC^$O_  >6O_QRC_A?WPP_Z*/X2_\ !Y:__'*QO^%*_#S_ *$/PS_X)[?_
M .(H_P"%*_#S_H0_#/\ X)[?_P"(H V?^%_?##_HH_A+_P 'EK_\<KYU_:?_
M &M+OPKXL\'V_P .O&VBWNF7._\ M-K&6UO53$B ;F^;9\I;N/TKW'_A2OP\
M_P"A#\,_^">W_P#B*^0OVV?!/A[PMX]^'UOHN@Z9I$%SYGGQ6%G' LO[V,?,
M%4!N">OK71ATI5$F8U6U"Z/M;_A?WPP_Z*/X2_\ !Y:__'*/^%_?##_HH_A+
M_P 'EK_\<K&_X4K\//\ H0_#/_@GM_\ XBC_ (4K\//^A#\,_P#@GM__ (BN
M<V-G_A?WPP_Z*/X2_P#!Y:__ !RC_A?WPP_Z*/X2_P#!Y:__ !RL;_A2OP\_
MZ$/PS_X)[?\ ^(H_X4K\//\ H0_#/_@GM_\ XB@#9_X7]\,/^BC^$O\ P>6O
M_P <I?\ A?OPQ/ ^(_A(G_L.6O\ \<K%_P"%*_#S_H0_#/\ X)[?_P"(I/\
MA2GP\_Z$+PQ_X)[?_P"(H ](T77M,\26*7NDZC::I9O]VXLIUFC/T9215^OG
MC7OV3OA]<7CZMX5TU_AKXGQF+7O!3#3)PW_31(P(IUSU25'4^E:_PC^+7B33
M_&S?##XG?96\7"W>\T;Q!91>1:>(K2,J'=8\GRKF/<OFP@D8(=/E.% /<***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **@ENTBNH(#]^;<
M5^BCG^8IFI7AT^T>YV;XX_FD Z[>Y'TZ_A0!:HID4J3Q))&P>-P&5EZ$'H:?
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45PWQC^+%A
M\'?!QUBYL[C5]1NKF+3M)T6S(^TZG?2G;#;Q9X!8Y)8\*JLQX4UYKIO[-NI?
M%2)=7^.6N7'B:]N!Y@\'Z5=S6F@:<".(_*C96NW7)!EG+ Y^5%&!0![?)XHT
M:&1DDU>Q1U."K7* @_3--_X2S0_^@SI__@5'_C7FT7['OP+AC5%^#W@8A1@;
MO#]JQ_$E,FG_ /#(7P,_Z([X%_\ "=M/_C= 'HW_  EFA_\ 09T__P "H_\
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M.G_^!4?^-'_"6:'_ -!G3_\ P*C_ ,:\Y_X9"^!G_1'? O\ X3MI_P#&Z/\
MAD+X&?\ 1'? O_A.VG_QNN4W/1O^$LT/_H,Z?_X%1_XT?\)9H?\ T&=/_P#
MJ/\ QKSG_AD+X&?]$=\"_P#A.VG_ ,;H_P"&0O@9_P!$=\"_^$[:?_&Z /1O
M^$LT/_H,Z?\ ^!4?^-'_  EFA_\ 09T__P "H_\ &O.?^&0O@9_T1WP+_P"$
M[:?_ !NC_AD+X&?]$=\"_P#A.VG_ ,;H ]&_X2S0_P#H,Z?_ .!4?^-'_"6:
M'_T&=/\ _ J/_&O.?^&0O@9_T1WP+_X3MI_\;H_X9"^!G_1'? O_ (3MI_\
M&Z /1O\ A+-#_P"@SI__ (%1_P"-'_"6:'_T&=/_ / J/_&O./\ AD/X&?\
M1'O G_A.VG_QNE_X9"^!G_1'? O_ (3MI_\ &Z /1QXLT1C@:QIY/_7TG^-:
MBL&4,I!4C((Z&O(S^R#\#",?\*=\"_\ A.VG_P ;K O_ -DW3/!BMJ7P;UF\
M^%FNQ?.EG9RR7&B79'_+.YT]V\O:>1NB\MUSD-QB@#WRBO,_@C\7KCXE6.L:
M3K^EKX<\>^&[A;+7]$$GF)%(R[HYX7ZO;S+\\;D XW*?F5J],H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW5EVB4L2,<GC'/&>.M:^SAB(OV:LT<WMJN FO;RNG^?8[_XC>.-:\:?%+1_
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M\D(LO^P[K_\ Z>;VO:J\5_8[_P"2$67_ &'=?_\ 3S>U[50 5\K?MF7VA_\
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M ";K\4_^Q5U7_P!)):]&KSG]I+_DW7XI_P#8JZK_ .DDM 'H/PM_Y)CX0_[
M]G_Z)2NHKE_A;_R3'PA_V![/_P!$I744 %%%% !1110 4444 %%%% !1110
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MBBB@ HHHH \+\,JK?MJ_$'(Y'@C06'_@9J@_K7?>-_&9T3]U#_K#7G_AD_\
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MH5Z+?71L=0BG[(X)^G?]*YX+F31Z%:7(U(["BD#!@"#D&EK$Z0HHHH ****
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M)&7A(GRO&._4G/&![UE^/[6P\">,OA7J%S U_9KYNAI;*%*+(\(9)>>I A<
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MW4K?3MK7+^3&W'FL/D!]SV_&@"U134D610Z,&5AD,IR#3J "BBN2^(?Q"L?
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MWPOX?TWP]8J /L^FVJ0*<=SM R?<\UOT4#"BBLO6?$FGZ'9WD]Q<Q;[6,R/
M)%\P\$A0">K8P/6GOH@;25V:E>:_M%>,&\'_  AUXVMO]OUO5HO[%T?3U^]>
M7]U^YMX@.^7<$^BJQ[5>E^,&EK:V<L5CJ$[2LJS(MNP,''S$DX#8/'RYSVK#
M\!VJ_&[]HZ7761I?"'PY@$-AYB%4NM:NH@TDH!'/V>V=4!/1KE^ZU<J<Z>LH
MM&%.O2JW5.2?HSW7X8^#A\._AKX3\*"?[2-"TBTTOS\8\SR84CW?CMS^->0>
M*OC[XK\=>+-5\+_![3])N8='G-IJ_C/7A))IMM<#&^VMH8F5KJ9,_/AT1#P6
M+947/VDOB!K-Y?Z5\)_!-Z]AXO\ $\#SWVK0GYM#TE6"3W8])7)\J'_;);I&
M:W/!?@W1_A[X5TOPWX?LH].T?38%M[:WC'"J.Y/4L3DECR223DFLS8X63Q?\
M>OAMC4;^3PW\6M&C.^[L-+TU]&U54_B-ONN)892!R$<QEN0&SBH-:^'?A3]I
M+13\5?A#JZ^%OB''NMWOS T N)XN'T_5[4@%L'Y3N'F1\,C8P&];KQGXC:/J
M?P;\7R_&#P58RW95%7QAX=L_^8S8H/\ CXC3H;N 99#U= T9/*X![:HL?"'X
MLS^)H;HW%C)X=\6Z)<FPUO0KA@TEC<J 2A(X>-U(=)!PZ,".X'KOB_XX:#X)
MT/2;N[@O]1U+5KL6%AHNDV_VB]N[C8SLD:9'"HK.68A0HR2*\\^)WPC7XO-H
MGQ<^$OB+3].\3W&G1A+R:!I].U^P8;XHKA%96RI;='(#N3<RD$' YSX#^ [O
MPGX^?Q?XWUD>)_%]XC6@N%B,-EI<+'_56D!8^6.FZ1B7?G)QQ3.A_O8WMJCT
MWPSK^I?$KXJZ/JY\*Z]X<TG1=+O(W;7K1;=GN9Y( JH [;L)%)EAP,@9YKUF
M>>.UA>6:18HD!9G<X"@=237BMAXO\5_&+XA>,=.\)^*K3P[X3\+7<6ER:A9V
M$=[/?7IB62=%DD)C18MZ(5",=P;)&,5W&F_#/]Y'+K_B/5_%+HP<17[Q1V^X
M=#Y,*(IQ_M9I'*=3I>H?VI";F-"MLW^J9A@N/[V.P/:KM)TX%+0 4444 %%%
M% !115>^NA96DLQ_A''N>WZT]]!-V5V>%>#Y_/\ VW/B/CD+X)T-!^%YJ6?U
MS77?%31RP6Y4?6N#^&K%OVS/B&Q.2?!.ADG_ +?=2KW;Q%HZZQI[PD<XXKII
MS]E43."O3^L4''JSYK\-Z@FA^++;2[E7N=.U#=Y%NSEE,N4*Q<_=5F P> .:
MV=<DLO$4>H:09&EM[+355FF'EP6#2R;MC;OF<CR1A![ ]12^+?!)MY-MU!O5
M'WQR#(:-AT96'*GW%<)_9][H%Y;7UQJUU/:17D(,,;,N8RVTLXSB5QNX)':N
MC$8?GO4AL>=A,8HQ6'KIWV]1GPC\93Z!XAGMK5C!%J$2)OFC8KYB#<C..IRI
M8$#H6'I77:UHK^$O$FGS&8.VJ /=VI0*896#NK;N^0K#!YX%;>F6.GV[/>6R
MZ;/>//+YMBT17C>51F R<L 6]BYKF-0N$\1>,[Z&VNKN32+4P^5;L_[M95R2
M"1]XJ?<@?6N;"J7M%;^NYKB*4:&%E&;OV/H_PA<+<:/"5&.*C\8N5TQL'%-\
M$6KVNBQ!^N*/&4+2::VVN'&_!.Q[V7Z^SYO(\)CFFC\>78@U"XTRXDMX422W
M*[6 9F.\%2>,=ATR.IJUX\\.:!J7PQU/Q!K6FQ76J1S/$AN"QDC#W  1N>H4
M@D?7KC-9>I32Z'\0+;4)KB.U@DM)88)9(R^)R %&,$;LXP3G'S<<\Y'Q/\1/
MKGA6:X6WOK&SOI52W_M!XE5I3&V^X* [NN%&?]H^E<.#M+#(ZLT;ISJ-=OT(
M?A;X+TUO!$_B/Q+))%#IEUY;QQ0+*K +G&S!X!D4\>E>G>))K.\TV"QUV2&V
M6U!DM56=1%/MC)[896VYX'0_AF#X'V=MIOP\TQKV[CE@F:>&6&<!]\A(4%R>
MI*Q],<YKBKBSC\3^(-3L+:S:V\/V]R2BK(R-= @,H;DD1@L6'/.5XP*WE4A1
MI<\MCDP%&=6,(0_X;J=/X'\22ZM<3W,=NUK9M-FT5BQ;R>BY+<DY!Y/;'7J>
M^\>6,M_HD4P!.!S63X/\+NTD>$"HN/NK@ #@ #L *]0FTR.XL3;NN1C%<V5R
ME&I*K:R9Z.<4X5J2HWN[;GRUKENRM:WAMEO5LI?.>SD!*R@*1T'4C((]Q75:
M9%8ZUH*[+:WOFN94,%P#EV@9MHC.X80X_AQCCUKI_$GPXN(YY)+==R'G%<#-
M\.YD81PB\MG4;5:&X<;5#;@H&<8R2<8Q7UM:G'$VG!ZGPF%K5,"G2JP;7D;>
ME^&_#_A-M42#5O[/A2\_>2D;G4)A@&*X50&SPPQWKC;72]3\93'5]0O]3E\^
M,Q) ETRH83SSMP1N/S$#'4 ]*Z?0/@_YURJ"*:.%G$DT;.629A]UG4Y!([5[
M=H'A"TTJT1#&K-CTKGC&GA]9:L[/WF+BHT4X1/ _#OPKMA?(\&F@2@@B67+L
MN/0L3C\*]]\(>'AH=B%/WSUK9AL8(#E(U4^PJQ657$.HN5*R.K#8)4)<\G>1
MX5^T!_R63]GG_L:K[_TR:A7>>(/XJX/]H#_DLG[//_8U7W_IDU"N\\0?Q5-'
M<UQ7PG0^%+_^T-$@8G+Q?NF^HZ?IBMBN ^'FI>7J=Y8,>)%\U![C@_H1^5=_
M45H\DVB\+4]I23^04445B=84444 >%?%+XL^$?@QXR-M>SWT&H:G']L0:3$L
MDD;9VD2H2%97/(!R0=Y&,@UZ9\//%E]XRT,7][HMYI"L1Y)O8A"\Z8^_Y6XM
M'_NL?3!-9N@_!OP_I?B^^\67L/\ ;/B>[E\PZA>@-Y Z*D*](U4  $?-ZDUW
M=<.'IUHMRJ/3HET]7W]/Q/<QN(P<J4*5"+<TE>;>[_NKMZ[[V3"N1^)7PH\*
M?%[1H-*\7:2NL6%O,+F.%II(ML@4J&S&RGHQ[XYKKJ*[6D]SQ$VMCY _X)^_
M!?P;9_#/3O',6C_\57'JFLVBZD]U,[")+ZXA5-K.5P(U5>G:MOXL:/!\=OVN
M-)^%GB9YY_ 6B^%&\2W>BQSO%%JEU)=>1$)]I!DCC"LP0G!9N0:]@^ GPC'P
M/^','A0:K_;0COKZ]^UFW\C/VBZEGV[-S?=\W;G/.W.!G%<]\8/@3J_BWQ]X
M?^(G@;Q1%X/\>Z/:2Z=]HO+#[;9:A92,':VN(@Z,0' 965P5.>O9W]ZFY:I;
M_P#@+7X2:?RNM0_Y^<NC;=O3FO\ C'3YV=D<#\6/$7A/]A_PGI.G^"(-+\,G
MQAK<=G;+KU[.=&TLB)GEN#'ORB!$_P!7&4W,5Y')KR7XI?M(7'QE_9H_: \-
M7NJ^'/$USX=TZRFB\1>$EE2POH9Y!@>7))(T<J-&P9?,8'*D8KWGQ-^SUX_\
M>:/I6I^(?B59'Q_H6L1ZUH>H:=H AT[3V6)XGMS;M,TDL<B2.'+2[NFW;C!T
MO%WP7\??%WX.^-/!GC[QKH;7/B"".WMKCP_H$MO!8*K!F)26ZD:4L0.KJ!CB
MC6TN9W?3TM&WW._^;5AQ:C*#CHE:_KS._P!ZM_E>YA_#[_D]KQ[_ -B+H?\
MZ47=><_M;6NCZQ^U9\.-.\1^"O$'Q#T8^%M3F.A>'SF7S1<6X68J9HAA02,[
MOXAQ7T=X?^#XT'XV:]\0O[6\\ZIH5CHO]G?9MOE?9Y)7\WS-YSN\W&W:,;>I
MSQS/Q;^!7BOQA\6O#7Q!\&^.K'PAK&CZ5=:0T>H: =4BFBGDCD)P+F':08AZ
M]:.M/R<[_/GM^:]#.-U&:ZM0_!0O^3]3C_%'Q:L_V4_AWX"URU\%W'AGX0R/
M+!K=I>QR/JFAR3$M!(RB60,C2DHXRQ!D0@]JB\0?M$?%/3? _P *;Z'PEH,'
MB?XA:Y)96VDZC--&FGVLD$TUNTSJ23*J(C2!1S\RJ <&NN\3?LYZO\6(_"%G
M\4O%MCXPT31GN+J_T>ST0V-MJURP*V[RJ;B3"0HS83G<^&)& *\=^+'P-\8>
M"]#_ &?O!.B^,[R]NM'\92C2_$+Z6)9-.M%L[DV\=PA=A*J+MB+DIN7 ^4\T
M]W[VMY1M_A<DFO7L^W5/0K9>[TC*_JDVGZ=_.VF[/1/#/QP^(EKKGQ-\#^+G
M\$V?C+POI]IK%EKNZXLM%FL[@N/,G5WD>,QF-P?GPW'*\FN:^%?[7FK^)/$W
MQ#\/7&O^!_'KZ!X7?Q)9:YX,6:.T)4NK6TR/-+\P94(97Y5N@-:.M?L;ZU\0
MO#/Q'G\;>-[74/'/C)=/C_M+3M),-A80V4HEMX$MGE=I(R^XN&D^;<1QC-='
MHO[-_BG4?&'B7Q9XQ\:Z;?ZOK?A*3PF+/1=#-I9V43.762,-.[M@LQ(9N2>"
MH %9RYN5VWL_OY7R_._*GYW=[.Q<>6ZOM=?=>/-\K<UO+I<X_P %_M(?%=_^
M%->)O%NC>$X/!OQ'N+?3X[#2OM+:A833VSS0RM*[^6ZMY9S&$!0,!O8@FNC^
M"?Q\\5_%3XK>(]&O]5\'Z+!H^IWMC<>"I[:X3Q!#!$S+#=&1IMDB285_EAVA
M7&')KHY/V; _@7X+>&_^$B(_X5O?Z??"Y^Q?\A#[+;/!MV^9^ZW;]V<OC&,'
MK68/V??&7B;XQ^$_&'C7Q?H6K6?A&YN;G2CI7A\V6HS^;&\8BN;@SNIC57/R
MQHH<@$XZ5O+E]I*WPWDE_AM&S];\V_X:&"YO9J_Q65_7WKKT^'7\]3S'X8_'
M+5-(^#_PS\-_#GPKH&D>*?&GB#6K.QMKI[A]-L8K:YN'N;F0;S+(2%!V!QEI
M."H&*Z/5/VF_'WPYT7XRZ-XRTSP]>^-/ OAY/$EA>:/'/%I^I6LBR!=T4DC/
M&RR1,K#S#G(((K2C_8]O_#_@'P-9^&O&JZ?XT\%ZQJ&KZ5KEQI?F6\@O)9FF
MMIK?S<M&R2["5D!R@88Z59E_91UCQ9X7^*DGC3QG;ZGXW^(&D+HD^JZ?I1@L
M],M41Q'%!;M,S, TCN2TF6)[8K!\W)*V]G_Z3I;Y]_/^Z="Y?:)O:_\ [>[W
M_P"W?QMYC/"7QM^*&G?%;X=:-X[TSPM'H/Q L[J;3H=#^T&[TN:&!9Q'/+(Q
M2<-&2-R(F&'<<GZ2KR_6_@B-8\:?"?Q!_;)A_P"$#2Z46_V7=]N\ZT%O][>/
M+QC=T;/3CK7J%;SY;M0VN[>E]#GI\UES;V5_7J%%%%9F@4444 %%%% !7'^-
M/%#V;G3[1MLVW,LBGE,]%'H<<_0CUX["O&[J\_M2ZEO-Q99V,B[CG )R!] *
M3 JR/';0O+*ZQ11J6=W.%50,DD]ABO,=6UI_&VCWFMZA>3Z'\/+:,R PEH[K
M55'\61\R0L>%5</)D<@$ [?CJ)O%WB+2_!BDBQFC.H:OMXW6J,%2$^TLG!]5
MC<=ZR]*\3:'\8/'BZ;H]_!J&@>%2ES=K#]R6\+,L*=.4C".^1P6V8^[0=E.'
M*N>W_ 7^;Z&3\'_#\H^)/B'4;G3+71C:Z79VUKI=K L8LHI'ED\IV4?.^U8F
M8]BQ X&2SQHS6MO\4@J?\>VIZ5J8^JK:G/\ Y J?X+_$>+QC\8OBMIJ6$EF;
M&\@4-,_SN(T\@_)C@9B+9S_&*P/CEK6IZ#X;^+][IFEMJ+LVGV3XR1$I@4O(
M0.3M$B_F#T%/J=7+4>(4)*S?+^/*>H_"Z,VK>+=-;C[%K]T57T6;9<C]9S7<
M>57FWP@OK[4O$?B.YU&%+:]U"PTG5+B&-64)++:E' #<@ PXP>>.:9K7Q,M+
M3]HCPWX,COKAI9]*NI)[.)&,8D)1XF<] =D<O/;</[U+J<DJ<IU&ET5W]UV:
MGQJ5G^&NK6<9_>:B8=- ]?M$R0G])#7#7!::UU,;.+[X@VT?'I#);@'_ ,EQ
M^5=W\7EEDM_"EM %:2?Q!:D*X."8EDG&<<]80>/2O&/A)XLUOQE\/-.U;6](
M.G7"^/$D<JK(KF67YB%;D!7EV<^GKFFMC>C&7LN=='^>WXH] ^/'AZ>_NO!5
M_91V<M_!JK6R1ZA LL$JRP2'RW!!P&>.,;ARN<CIBJWAV:Y\/Z,NN^%+:YFT
M*-WCU3PG,=TVGR(<2BVYX93G,7W6&"F,C,?[3WQ(C^'MOX)22PDOOM>NV\N(
M9 )%6%U=@JX^8L#MZCK6OX\\1Z3\'?&EEXBU*^BT[0_$#?8=0\S.%N40M#/@
M#/*JT;'T\LGA:.@XQG*G!6O>]O.V_P#P/^"=UI.JV?B#2[74M/N$N[*ZC$L,
MT?1E/^>AY%;WA3XLZ9IOBFS\)ZA>*EU<J?LIDX&X#/E[CQD@' KS708XO"/Q
M"_LZW=3X?\2I)?V00Y2*[4!ID3'\,B'S0/59#WKQ']KBXET74%U&WR);9UF7
M:2.1SU'2A+4BAAE6J^S3W6A]I>!U/C3Q#>>,YANLMK6.B(W06X;]Y./>5E&#
M_<1/4UWU9WAV>VNO#^F36<2P6<EK$\,2#"HA0%5 ] ,5HT'GA1110 4444 %
M%%% 'SE^QW_R0BR_[#NO_P#IYO:]JKQ7]CO_ )(19?\ 8=U__P!/-[7M5 !7
MS-^TCJ<]C\2M%N+<1QW-C:)/;SB)3(CF1^=Q&2/E'!XZ^IKZ7D;RXV;D[1G@
M$G\J^6OVEFW^/[4]?^)='S_VTDKXSBVI.GECE!V?-'8^PX4BI9DE)7]V1]16
MLAFMHI&^\R!C^(J6L;PWXFT?7H##INJV.HS6R*L\=K<)*T1QT8*3M/!ZULU]
MDKI*Y\?=2;<=@HHHI@?GKXVL;[]HC]K*^\,:KJK:?90:A<:?!N_Y8P6^_*QJ
M>-S["?JV>V*^[/ _@?1OASX9L]!T*T6TT^V'"]6=C]YW;^)B>I_I@5\F?M@_
M G^P=:;XC^'-3BT^]N)T:>Q\\13/<9 $MOR"S$X)4<YR1G) ZSP5\?OB/H?@
M&TU+Q5X?LIH=/B+WL]Q.T5Y<PC^,1JI57"]0WWB.B]:][,*U.IAZ+A42CI'E
M;L^;]3\_RMK+\=BHXR#=1MRY[-KDZ+3;;].B/J6HKJ8PPEE&Y^BCU-2TC+N9
M3_=_G7@GZ"C$A\*VUQ=?;-25;ZZ["4;D3V Z5N !0 !@444 %<-\5_ ?B'X@
MZ*=-T+QYJ?@0."LMUI%K!).X/8/*K;/JF&]Z[FB@1^<6J?\ !&O2[K5I-5M?
MB_KD6IO.;DWESIJ33&4MN\PN)5);=SNSG/-?H'X+TO5]#\)Z3IVO:POB'6+6
MV2&ZU5+7[-]K=1@RF+<P4MC) ;&2<8' VJ* *VI:A#I.GW5[<-MM[>)II&'9
M5!)_05\Q?L\^-H[CXO>,=5U311:3^)WMKC1XH=CG[-Y:N1M!R"0Z2,V &Y.3
MM 'U#=VL=]:S6\HW12H48>Q&#7SS\-=%\.? 'XT:WIVK7AAAU.QMTT.^U(A4
M6)2^^U20\9!VD!SN8 8R%P #TJV\3>)?'OC?6-*TNYAT31]*<127)B\R>9\G
M. >%'&.1[\U@>,+;5/A_X]T2#PTLE_J6O1S^=#N2)6:-0QE/8\GGCOGO63XK
M\??\*K\1:OXDTR^T#5-&OR));-M12&Y63U0X;S,]=N,\''H<3P+JWQ8^*WB1
M?&UQX:TGPW#;PR6VD:?K%W*)<,Q\QY%1<JQV(,'H-W!R" #L;7PWJ?PY\)^-
M_B!XRDCO?$EU9YDBLE,BV\,:G;#'T+$L221UR,#UR_AWX1USXB>.+;Q)XV'V
M&/22W]BZ#;.6CM 4PTLS8 >4AMO'RC;QWK=UC1?'_CZT70O%6FZ3HOA^1E:\
MDM=0>YDNE5@?*"F-0JG^(DG.",$&O2O#LWV6TO)KT1VH^T%59V ^3@+G/2@#
MFOBKXV3P_J/A;0EM7O)M;OUMA$IP-@Y8D^@4$_AS@<UW,CVVG01P"-8H.(PN
M,( >@JKKD-M:Q'5#8"^N[5<Q*%!?/HF> >>O'7K3[;4!J%JUW 1+;J6!1E.<
MJ2#^HH \A\6>'=#^$WCS1M1LS)!9>*;LZ7)IZ29CAG*/*LL*'[OW&W $#!W8
MX)K"^)6K>,M#O-(\)>%M5M;W6=;FDC6>2$EK.#:<S28/13Z#G'KUI?M+?%(:
MC#X0M? R+K?B,ZLL2/&"T=HLD<L6Z3T);H"/X">U=I\#/@K)\,-/N-0US4V\
M1>,=1&;_ %:1<'D@^7'Z(,#CC.U<C(S0 WX=?L^Z7X/FT[4]9U75/%GB*T&]
M;[5KMY4BE.[+Q1D[4.'9<@9(/Y>K444 %><_M)?\FZ_%/_L5=5_])):]&KSG
M]I+_ )-U^*?_ &*NJ_\ I)+0!Z#\+?\ DF/A#_L#V?\ Z)2NHKE_A;_R3'PA
M_P!@>S_]$I744 %%%% !1110 4444 1SF41GR0C/Z.2!^E84_BA+.^M['6+%
M[);Q_(AG8B2WE<]$+=F/8,!GI70UE>*/#=KXNT&[TJ\:6.&X48E@;;)$P(97
M0]F5@&!]10!Q?Q \,S^$?#^H^)?"'VBTU338VO3IEO(QMKY$^9XC"<J"RA@"
MH!!(KIO#/Q&\,>,;.QN-'U[3[X7L*S0QPW2-(RD9^Z#G/J.U>=>/?"WQ4\.^
M#]<U;0/B)<:MJ>G6,UU9Z7+H-J_VV6.-F2%BH#9<@+E<'YJP]$\(_ ?]HCP+
M=ZQ::+X6EOFA\W4+[2+>&WU72+K;EB9$43V]Q&P/)VN"M 'K_CKQI;>"])>X
MD9&N7!\F-C@<=6;T4=Z^4O _@S4/VRO$CZ]KK2CX.6=R2D;95O%EQ&V.?2Q1
MEQCI,5Q]P?-YMH^H>*_C9\8?#'P,^)&H7OV4QW5S?Z[_ *D^)M*M53R8(W4_
M+)(7_P!(5>0(Y,$"0&OL3XT?%2S^!?@W2-*\.:/#J/BC5&&D^%O#%J!$D\JI
MQD+_ *NWA0!Y'X"(N.I4%G1)^S7(M^O^1TWC7XL> ?A+'80>+/%WA_P@EQB.
MTBU74(;,2 <81789 XZ<"NMM[B*\MXIX)4G@E4/'+&P974C(8$<$$=Z^</AS
M\"].\.QW^L>+&@\:>/-;7=K?B#4;=7:<D8,$2L"(K91\J1+@ #G)))L?LNW3
M?#OQ9XV^#LTC_P!GZ&T6M>&%D8MMTBZ+#[.I.3MM[B.:,9/"-$*1@?1=?+W[
M.+>=:?$NY'W9_B#XAVGU"7TD7\XS7U#7RW^RFWVCX475Z?OWWB?Q%=,?7=K-
MY@_D!0"/8:***"BOJ%[#IUG-<W$L<,,2[FDE<*H^I/2O!;K4O^$GU!?$=]:+
M%<72+]GME;(C0*.2>Y]\9Y [#'LGCRSDOO!NL01N(W>V;YC&9,8&20HY)P.,
M=\5X!<7WEVNEO"RK'Y/E%5.561<;E_7]*]S*X1;E-[H^4SVI4484U\+-.Z\0
M7%J?W8@\PXR/+/0=NM4K/Q--;ZJ+BP^U6,V^.2XAM;EHS<*K;B 1VXZXX)SC
MUSI9MS;W.2:SFO%AU2WD+* I/S$\ %2&)]L9KW)VFN66Q\K2O3DIPT:.T_9J
M\86/BC6O%'BC7;J.3QYXKNQ<W2JX9+2U0%;2QC/98HSSD#<[R-WKNOB=\;M/
M^&6K6ME>0;S.H8.S[1R?H?S-?%GA?7?^$-\;:;XD5FBLYM0G!*$E)%5@00,>
MI;H.0 :]$_:+^*WA?XL>&+9[6W5-6M)T\J0D[\,P4@<#L6KPJ>'HU(_6J<'*
MFN9/79Q;3U^6A]#5Q^*I2_L^O5C#$2<'!V^*,TFM.^MG\[7/L?PYX@M/%&D0
M:C9/OAE'XJ>X-:=?.G[+'Q"TW3_ .DZ-J=WY6K7+%EB;^Z3A?IT KZ+KS\50
M>'JRATZ>A[^68U8["PJW7-972Z,\B^%^I_\ #.?Q87P%<GROASXSNY;GPQ*W
M$>E:HV9)]-]%CF^>:$<8;S4'517*_M.^'Y?$?[0'A?P-J&I7VC^#-9TB\UB:
M'3YWM7U:YBDB1K0S(0P14E,C(A!8,,\ UZC\:/AX/BE\,];\/QRFTU&6(3Z;
M>H=KVE]$PDMIU/8I*B-^!'>N9\3:7??M:?LK>#O&VA+'8?$73H(M<TIF&T0Z
MM K175F_?RY&$]NX]&SU45R'KPER2\CVGX/V.BZ'X#T[1M!TVTT>PTU/LZ65
ME$(XTQSD*/[W4GN2:[:OF3X'?%N'Q)X=T#Q5IX>&QU:VCEEM9?O1Y^_&WHZ-
MN4^ZFOINF56AR.ZV84444C **** "BBB@ KD_%6J>;=I91GY8SND_P![L/P'
M\ZU_$6N1Z'8&3(,[_+$GJ?7Z"N!M9&FE+NQ9V;)8]2:ZJ-/[;/-Q59+]TM^I
MPWPS_P"3ROB#_P!B1H?_ *6:E7T97SG\,_\ D\KX@_\ 8D:'_P"EFI5]&5C/
MXCLH_ C"\5Z/'J&FR_NP7QP<5\]>)-'EFCFMM[6\@=723;G:RL&4X[\@5]0L
MH92",@US>K>!K'4Y"Y0*QKJP^(5-.,]F>;CL'*NU4INS1\[LFMS3>8=76,M]
M^.&R14<9!VD'.5SS@GJ3]*[CX=^ V9;90FVWA4 9'7'?ZUZ#;?#2QAE#$9'I
M756.GPZ?"(XE"@>E:2Q%.$6J*M<PIX*O5FI8F5TB6U@6V@2-1@*,4R^MUN;=
MT89&*L4V0;D8>U>9+WD[GT$?=M8\(\?>';748KFSN6DCBSO$D+E'0@Y!5AR#
M]*\\\-_#ZS\5:7?6"I/*9+B1UVSD;$B"'S=[@YRW! 'S8)YQ7KWCC299+B9<
ME QR&^AS7F<$>K>%X[$&W@OX;$(L?DN]O,RC((R,ASR#CY>5'X?.X6<*-64:
MCMV1]%BZ,L5AX\L>;OW.HT>UTS1?#]K]NGC&BQLP92P+QR#Y@KLPP"1W7&,G
MGFJG@^&._P#%7B&>V@@MK6:[CQ#;2B2,.(EW%2.,<CIZ5GW%GJ_BP10WA:VT
MGSEE:UD7<\NWA2^6(!(ZC!],UZ;X'\)BW9&CB$40.[ &,GN:VQ%:.(:H4M48
MX;#O!P=6III9(]!TBR2TLXPJX.*OTU%V*!Z5QOC_ .+6A_#6XMDUJ+4!%-$T
MWVBULI)XD"LJX8J#@DN,?_JKUW*%&%Y.R1Y=.E5Q57DI1<I/HMSLV4-U&:@-
MA;LVXQ+GZ5!H>O:;XFTN'4M)OK?4K";/EW-K()(WP2#AAQP01]15^ME*ZNF<
M\H.+<9JS1&D$<?W4 _"I*:9%7JP%"NK=#FBXK#J*** /"OV@/^2R?L\_]C5?
M?^F34*[SQ!_%7!_M ?\ )9/V>?\ L:K[_P!,FH5WGB#^*NFCN<.*^$XJUU;^
MQ/$-E>$X2.4;_P#=/#?H37MM?/OB#^*O8/A]K/\ ;GA*PG+;I8T\F3UW+QS]
M1@_C75BH>[&?R/+RVM^\G1?K_G^AT=%%%>8?1!1110 4444 %%%>8?M(>+='
M\&_"?4+K6M3\0Z9;W-Q;64)\)N$U2XGEF18[>W8_=:1B$SE<!B=R]0F[#2NS
MT^BO@SPSXV\;>"YOVB/#SMXU\-VFE^ UU_2K'Q=X@35[^PN&CNE,L5RD\Q56
M,:G89"5920!FNA\+P>*/AWXL_9Q\2O\ $+Q7XCNO'F;3Q!9:QJ+36,XDTU[E
M&BMO]7"R.@ * $C.XL22:C[WII][<DOQBR9>[?RN_DE&3_"2_K4^J/BA\2-&
M^$/@75/%WB!ITTC351IVMX_,DPTBH,+GGYG%=0C"1%8=&&17YJ_$[1]:^*G[
M%WC'XOZW\0O$ZZWJ&JS+)H8U)O[(BMX]4%O'9"S/[M2JHIW@"3=SN()!^_/B
M9\0;'X4_"SQ!XPU(_P"AZ+ILEZZYY<HF50>[-A1[D5#DHTW.73_)/^O\K-WR
MN514X]6U]SM_7_#H=X6^+7A#QMXN\2^%]#UZUU+7_#<B1:M8PD[[1G!*ALC!
MZ'H3@C!P:ZZOS@^"_BA_A%\2/@SXEU'POXNT34_$BW6A>-=4US0I[.TN+S4)
MC=0.)G 5BMRS1KG^!^.E>Y?#SPWJG[0?Q$^*>O:WX_\ &'A]O#'BR70=)TOP
M]K+V5K:06T<3;Y( "DS2EV8F56&T@  5JHO1/=)W[:-)V[_%%KR?D9N2U:V=
MK>C3:OV^&7W'TK;^,-$O)-:CMM5M+N;16\O4H;:42R6C^6)-DB+EE;80P4C)
M!%)X-\8:3\0/"VF>(M"N7O-'U*$7%K/)!)"SQGH2DBJZ_1@#7R9^S[\.$\/?
M&;]H[6+?Q/XHFN-)UG9%!<ZQ+)!,7TR)]\R$XD=2V%8_="J!TK*^&?QF\1^
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MR(X5^[&/0>_O790P\JOO/1'E8S'PP_N1UG^7J;NH:Y/X@U%KJ?@$X2,'A%[
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MP_\ LP_#SP[#XE$>E7NH7?B;3?[(UO4-4U:[N[O4;;#C;+-)*6)Q(P# A@,
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MW+P:Q?P[;$_WI!^4C"MJL3P8NWP[;#_;E/\ Y$:MNJ.4**** "BBB@ HHHH
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M?[&?SYJ_3/*"BBB@ HHHH **** /G+]CO_DA%E_V'=?_ /3S>U[57BO['?\
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MAF*:W9X4 <>E>/4PU6BI2H2LNQ[-+%4ZW+"O&_F>%>$M06.W:RU.TNKQM/\
M-@G6)PYE8HHA<,?FSLW*03U /O4OB:^37)K#1+>[\Z-[HW3IYRRE"@!PQR65
MCD9' &" ,GB]JWP_%UJ<TQGNK83 +/% VU9@#D!OQST]:V?#G@6.TF46ML$.
M-N[: <$Y/('K6$L<YTO9QB^9G1'!0IU?:N2Y4[I'5^ K%_M D89 'WJ](K,T
M'2AIMHJX^;O6I7IX2BZ-)1>YY.+K>VJN2/"OV@/^2R?L\_\ 8U7W_IDU"N\\
M0?Q5P?[0'_)9/V>?^QJOO_3)J%=YX@_BKUJ.YXN*^$\U\0?Q5YKK_P#%7I7B
M#^*O-=?_ (J^FPW0_.\?U*'PQ\5?\(A\3]$O7?9;23?9I\GC9)\I)]@2&_X#
M7VY7YU:\<%B.#7W3\*?%@\;_  \T+6"^^:>W59S_ --4^23_ ,>4_G7-G%'2
M%9>G^7ZGH<*XKWJN$?\ B7Y/]#K*Q_%GANW\6Z#=:9<'8LHRD@&2CCE6_ _I
MFMBBODZU&GB*4J-57C)--=T]S]&IU)4IJI!V:U1\O?\ "*ZU\._%-C=WVFS3
MP6EPDOFVZEHY%5@>&QQ]#S26?@W6O'_B2\N;33YK:VNKEYFGN%*QQJS$]<<D
M9Z"O=O$7Q0\.^&;AK:ZOM]TO#0VZF1E]CC@'V)S3_#GQ,\/>*+A;>SO@MTW2
M"=3&[?3/!_ U^,+A7)7B?J/U]<O-?V=X\U]K<U[^5K7/O'G&/]E]8^K:VMS:
MVMWM_P $U?#/A^W\+Z'::9;<Q0)C<1R['EF/U))K4HHK]HHTH4*<:5)6C%))
M=DMCX*<Y5).<W=O5GC^G_LUZ=HNK:C?:3XT\8Z.NH7KW\]I8ZC%' TKMD_+Y
M.<=N3G ZU;\1_LW^%/%LWBJYU:;4;R]\0/$TEW)*GFV@C.46W.S"*/<-GOFO
M5:*]'ZY7NGSZK_@?Y(\?^R\%RN+IJS=[=+NZVV^T_O/FSQ!\"=6\4?'>:=M2
M\0:3I=OX<@M8/$5C<B.>292%978##%EW%A@#OQ793?LP^&H?"GAS1]+U'5=&
MN=!N'N[35;29?M)E?'F,Y*X.[ Z 8P.W%>PT5K+'UVHI2MR_\'_-^1S4\DP4
M95)RAS.=]^E[:+[EKOYGD4?[,OAI?"?B?0)=4URY@\13PW5]=7%TCW!DC(.Y
M6,?\1&3D'J<8KIM4^$>CZMXMT;Q%+<W\5]I.GRZ; L,JJACD0H6/R[MP!.""
M.>U=O16$L56EJY?TUR_EH=D<MPD$E&FM+?A+G7_DSOZGDFD?LYZ9:ZQ<ZGJ_
MB37_ !+>-I\VEV\VJ7*.UM!(I5MI"#+8)^9L]>E.U#]F_0)O#?A;3+'5-7TJ
M]\,AETW6+6=!=(&)+!CLVL#GIM'\\^LT5?US$73Y]O\ @_YO[V9K*<$HN/LE
MK?\ 'EZ[_9CZ65MCRJS_ &<_#L'@KQ)X?N+_ %6^F\1.LFIZO<3JUY.P((.X
MKM &.!M[FMZX^$>C7'B+P=K+7%Z+KPK;O;62"1-DBM&(R9!MR3@=BO-=O14/
M%5F[N7]6Y?RT]#2.782,>54U;3\)<W_I6OJ%%%%<IZ04444 %%%% !1110 4
M444 %%%% #)F"0NS<*%).?I7RK-IOA_Q=XJU[QMXJA@ETCPK<&UTN2Y!V6[0
M8:XN .[&7Y._^I'<U]+^*KP6>@W;;/-+KY0CS@G=P<?@2?PKY8\-Z-=7UGX!
M\(ZC$T<GER>)=;@DX)?S?,2)Q[W$VX@_\\"*1TT=+N]O\NOY6^9:^%=J)/BU
MJEW!X6M?"=D=$CGBLX55)G\^X?$LZ*H"2,+?[N6( &3G@?2%];FT\(6:-&2\
M$<";2>A^5#^0)_*O&O!I:^\=?$/55Q*(Y[;2X@3P?)MQ(1]-]RP_ U[=XP1I
M-!E"-M/FP'KC@2H2/R%!-:7-._DOR.;6I%KE_'7B2X\+Z+;7-I''+<7&HV5B
MBS9VCS[F.(L<$'@.3^%=,#69ERNW,2J:\-\57'_%^+34<?)8ZAI-@7[ R6VI
M#'YW*?\ ?0KM/C=\1KKX7?#?5->T^R34]5CV16=B^X^=*S  87YFP-S$#G"G
MIUKS[P1$WCS]F_5O$$[^=XIU1)]8N98 RR0:C#\T*JN-R^48HE"X/"_Q9R6E
MU.NC"48.H]G[OW_\ ]2^+&O7WAGP)?ZAIDHBOXY+=(25#;F>>--N#_>W;?QK
MJVKY[^!?C3Q'^T)INGZEXNM+;18]!N5FETJ%)$DO+D#=#.ZO]R( [E4$[G7.
M0% KZ")H:MH95J;HOV<MUN,>M_PBRR07C!<,LPC)]<*K9_\ '_TKSWPKXDN=
M<U+Q-9W4444FDZG]C0Q9^>,P0S(QSWQ-@_2O0?!K!K6_QVN<'_OW'36Y@TXN
MS/GCXUZ+-)K7@*'^P++Q&GG75E+I.I.!'/\ Z,TNW+*R[O\ 1\C<,949(ZUF
M:Q:>&[*WL/BIX:TV/3KVSFCM]758O*E-F"()X)4Z*T("MCMY([5WGQJ+6L>D
MZN0(_P"R_$MM,Q!Z1R3FV8_]\3DFN=\1:)';>--;T,A5TSQII4^8_P"%;R)!
M&YQZR1.I_P"V!-,[J<_<BO7Y]U]Q])Z*P?2;0J<CRU''L,5=KA/@G?7MU\-=
M#CU.![74X;2$7,4I^<2&-6<L.QW%A^%=W5'"U9V"BBB@04444 %%%% 'SE^Q
MW_R0BR_[#NO_ /IYO:]JKY"_9Q_:G^$?PW^%P\.^)_B#H>B:Y9ZYKGVBPN[D
M++%OU>\==P[95E;Z$5Z;_P -O_ 7_HJWAK_P,'^% 'I?Q-Y^&_BP#D_V3=_^
MB7KYPT7YK_3=O/\ Q1.J=/\ KE;U].:=XFT+Q-X3AUVSU&RU#P[>6GVI+Y9%
M>WEMV7._=TV[>N>W6OGGPG^T)^RQX%N[FXT;Q]X6M9IXOL[L^I/,!%G/EH'9
M@B9_A7 X'%"2]I"HW\%_G=6^5OF>9BL+.M43BU;2_P G?3O]Z-?X$L#XN\*8
M/_,J7'_HRQKZ'KYN^''QR_9FT/Q/#%X2\<^&H]9U)EL8(UU-Y"=[C;#&'8A%
M+;?E7 R!Q7N/CKXA>&OACX=FU[Q9K=EX?T:%UC>]OY1'&&8X5<GJ2>PK.G35
M&"IQ=[7\MVWY]S;"4IT8-5+7\M=DEV78Z"BO#_\ AM_X"_\ 15O#7_@8/\*Z
MCX>?M(?"_P"+&N/HW@_QUHOB'5DA:X-G8W(>3RU(#-M[@%A^=:':>5_&KPGX
M@O/%?C>QLM U+4/^$EM8(K&ZM+<R0!O($+"60<1;2,DOC@\9IOQF\(^(+KQ1
MXUTZRT#4M0_X22VMXK&ZM;<R6X;R!"WFR#B+:5R=^.#QFO8OB5\>?AY\';BQ
MM_&OC'2?#5Q?(TEM%J%P(WE52 6 ZX!(&:XO_AM_X"_]%6\-?^!@_P *.6#O
M=;M-^JY;?^DJ_P _EXU3+8SYO?>OZ\U__2W^';7W"BN3^'/Q9\&_%[2;C4_!
M?B33O$MA;S?9YI]/F$BQR;0VUO0X8'\:Y/Q=^UA\'? ?B*]T'Q!\1O#^E:S9
M.([FRN+M1)"Q .U@.AP1Q0>R>L45X?\ \-O_  %_Z*MX:_\  P?X5ZWI'BS1
MM>\,VWB+3M4M+S0KFV%Y#J,4JF!X2N[S _3;CG- &K17B!_;>^ JDC_A:WAG
M_P #!5O1_P!LCX(>(-6LM,T_XG^'+J_O)DM[>!+P;I)'8*JC/<D@?C0![)17
M/^.OB%X:^&/AV;7O%FMV7A_1H76-[V_E$<89CA5R>I)["O+_ /AM_P" O_15
MO#7_ (&#_"@#W"BO-_AY^TA\+_BQKCZ-X/\ '6B^(=62%K@V=C<AY/+4@,VW
MN 6'YU<^)7QY^'GP=N+&W\:^,=)\-7%\C26T6H7 C>55(!8#K@$@9H [RBO#
M_P#AM_X"_P#15O#7_@8/\*]$^'/Q9\&_%[2;C4_!?B33O$MA;S?9YI]/F$BQ
MR;0VUO0X8'\: .LHKR?Q=^UA\'? ?B*]T'Q!\1O#^E:S9.([FRN+M1)"Q .U
M@.AP1Q6/_P -O_ 7_HJWAK_P,'^% 'N%%96D>+-&U[PS;>(M.U2TO-"N;87D
M.HQ2J8'A*[O,#]-N.<UY*?VWO@*I(_X6MX9_\#!0![?17C>C_MD?!#Q!JUEI
MFG_$_P .75_>3);V\"7@W22.P55&>Y) _&O1/'7Q"\-?#'P[-KWBS6[+P_HT
M+K&][?RB.,,QPJY/4D]A0!T%%>'_ /#;_P !?^BK>&O_  ,'^%=1\//VD/A?
M\6-<?1O!_CK1?$.K)"UP;.QN0\GEJ0&;;W +#\Z /2*\Y_:2_P"3=?BG_P!B
MKJO_ *22U:^)7QY^'GP=N+&W\:^,=)\-7%\C26T6H7 C>55(!8#K@$@9KQ'X
M\_MC?!+Q%\#?B)I6F?$WP]>ZC?>'-1M;:VANP7EE>VD5$4=R6( ^M 'U+\+?
M^28^$/\ L#V?_HE*ZBN&^!OB+3/%?P;\%:IHU_;ZGIT^D6PCNK60.C%8U1@"
M.X964CL017<T %%%% !1110 4444 <?\6KC[/X!U+G!?RT'XR+_3->+_ +%5
MJ)KKXSZHPS/<>,EM=_\ TSATNP"C\"S_ )FO7OC0<>!+G'_/:/\ ]"KRO]A]
M?,\%_$&Y_P"?CQOJ9S_N+##_ .TJ?0Z'_!7J>W^.O /AWXF^&;OP]XJT:TUW
M1;H8EL[R,.I(Z,.ZL#R&4@@\@@U\^>+/V;_B#X+TFXM/A[XPD\5^&WQN\(^-
M;IVE10<[+74U5I5X  6X69>Q(%>K?&O]H#PM\#-/M7UN:2XU.^61[/2K-/,N
M)U0 R/C^%%W#<[8 R.>:\07_ (*"Z'J%O)'_ &#J&E321,89KD @''#87)89
M],UU4<-6K-.FOZ\CQ,7F&%PB:KRM9:Z-K7OT5_,\_P#MNN>9]F\0Z!?^&?$5
MHICN]-U(QLTB@_))%)&S1RJ1GYE;!QC@@BFR7=S*H>.UGV=,^4P&?J1BJ7AG
M]J\ZEJ6J1^-[*VU^V*++I=I/"TK,6(*D#;DYS@@8&0<]*X37#XHUZ[DG\/Z?
M>>'K)Y?-:VO+YKF/DX($<HD*#_95P/:O7K9A0P4$\75BDUH[[^BW]=-SYG#Y
M;B<RJ2C@*$Y-.S7+\/K*_+YK78Z*/X@VGA_QUHUI)&+KS+A#<97=$!NRD8)X
M;)4Y(X&W'K7VY!,)H(Y1PKJ&&?<5^<FK6MOX1\2Z-/J,5U<VOF"ZNK@?-)-.
M,A1S@  'A<]&.!7LWQT_:2T/Q!\/=._X0G7635(I5\^S='BN(E"Y(9& /0'G
M&/>N"G5CFN'IXN&D6Y:]DNZ5[/?3M8]64*F0XVO@*OO3BH/EVO*2UY6TKQU2
MN^M^B/I3Q%\2O"WA'Q)H&@:UKUCI>LZ\TB:79W4P1[MDV[E3/!/SJ,=R0!DU
MP3ZC_P ,[_'*'Q$#Y'P^^(%U#8:VO2+3=9($=K>^BI< +!(>!O$#$\FO(=>\
M&W7Q(\ ^#O&NI^&9?'=CIEI>:7KF@0$?;;K3KH0.\MH21_I$$MO#+& 03M8*
M0VVK_A/XJ^%_&/P_OOAK\1_$]MK7A;7;6>PT/QQ>L+>/580N#!<E]OV?4X,C
M?&X5F*B11R0.*M3=&I*F^CL>YA<1'%T(5XJRDD_O/O2L;4O!?A_6/$6EZ_?Z
M%IM]KFE+(NGZG<6D<ES:"0 .(I"-R;@ #M(S7GO[)OCS4?B5^SIX&U_5[E;[
M5);(VMS>H<B[D@D>W:<'N)#%YG''S\5ZW6)T'G'Q<_9[\#_'&ZT6Y\7Z==7L
MND">.V:TU*YLR8I@@FB<P2(7C?RHR5;(.P=L@^ ?M.?$SPY\)=2\(_!#1+Y/
MA9X8U'3I-0U'4-$L72862R>6++3UAC8_:)FW;G4%HT4D?,ZD?8U% 'R+X&\3
M:]#X=LO#?P8^"6J:?H=LFRWO_%2?\(_IL8/_ "TV2*UU*2<L3Y.6SDMDYKL+
M7]F_QSXZQ+\2_BC?):/RWA[P'$='M/='NBSW4@QW5XLY^[7T510,X;X:_ _P
M#\'X)(_!WA/3-"DF_P!?=P0AKJX[YEG;,DA]W8FNYHHH$<1\5_C3X+^"/A\:
MQXSUZWT>WD.RW@;,ES=R?\\X(5!>5_\ 90'U.!S7S+>^+?C)^V!YMKX>T^]^
M&'PSE)C>62;R=4U&//(EF0G[.A'!C@W2<\R+RM:W[:'[/?C3Q]\1/!?COP-H
M%KXGOM/T^ZT>]T^:\BM)4CDDCDBFC>3Y<*5D5AG=AQ@'D5W6F^./C_X8TRS:
M_P#@[X7U:QBB2-K'PYXN O(@% ^5)[6*%O\ =$BCWIG1'DC%2W?;M_F=+\&_
MV:_"OP?T^R2UMH;F[M5VPLL0CA@_ZYQC@'/\1R<Y/&:]<KPW2?VQOA]_;EEH
M'BS^V/AIXEO)5AM](\9:;)9-,Q( \N<;K>49.,I*U>XJP=0RD,I&01T-(SG*
M4W>0M%%1S3QV\9DED6)!U9V 'YF@S)**16#*"#D'D$4M !12,P4$DX Y)-<S
MX5^)WA'QUK&LZ5X<\2:7KVH:-Y0U&'3;I)S:&3?L60H2%8^6_P IY^7ITH Z
M5E612K ,K#!4C((KRWQM\.5TUGU+28\6_P!Z:V7_ )9_[2^WMV^G3U2BMJ56
M5)WB<N(PT,3#EG\GV/!M/[?6NDL/O+5WQAX3&E71OK1,6DC?.B](V/\ 0U2L
M/O+7IN:J1YD?.QI2HSY)'$?#/_D\KX@_]B1H?_I9J5?1E?.?PS_Y/*^(/_8D
M:'_Z6:E7T97E3^(^FH_ @HHHK,V*&O7#6NAZC,G#QVTCK]0I(KP3_@G[MD_9
M1\'S+UFDOG;ZB\F7^2BOH6ZMTN[>6"09CD0HWT(P:^7?^";6HM)^S/#H\Q_T
MKP_K>H:7<+_=D67S"#_W]'YT ?4]%%% !1110 4444 %%%% !2,H88(R*6B@
M"E)I-M(^XQKGZ5-#9PP_<0"IZ*A1BM4BN:35FPHHHJR3PK]H#_DLG[//_8U7
MW_IDU"N\\0?Q5P?[0'_)9/V>?^QJOO\ TR:A7>>(/XJZ:.YPXKX3S7Q!_%7F
MNO\ \5>E>(/XJ\UU_P#BKZ;#=#\[Q_4\WU_^*O??V+_&'VC3M?\ #$K_ #VT
MJWUNI/.Q_E<#V#*I_P"!UX%K_P#%5CX">-/^$)^-&@W,C^7:7LG]GW'.!ME^
M52?8/L;_ (#7JXJA]8PDX+>UU\CYG+<9]1S.E5;T;L_1Z?AO\C]#:XKXN>*)
MO"O@^66U<QW=RXMHI!U3()+#WP#^)%=K7 _&KP_/KO@MWMT,DUE*+G8HY*@$
M-^0;/X5^.Y]+$0RK$2POQJ+M;?SMYVV/Z*RU4Y8RDJWPW1YC\--'T6&ZTW4]
M8FCO[N]NA!::>K!B&W8,DH[ =@>O6H?B)I.C-<7FKZ'<1V4]M>-;W6GE@KI(
M&($D8_NG&>.G\N=\ ?\ (\:#_P!?L7_H8J#QC_R-VN?]?T__ *,:OYN>-I?V
M(J?L(_%:_P!KFY4^;FWO?IM;3?4_5?J\_P"T'+VCVO;I:^UOUWOKY'T;\+?$
M\OBKP?:W5RV^[B8P3-_>9<<_4@J?J3775Q'P>\/S^'_!-LERACGNG:Y:-NJ[
M@ H/OM4'\:[>OZ4R25>>68>6*^-PC>^^W7S[^9^49@J<<755'X;NQ\R3?M)>
M/(]-\7>)(?#FA7?A?PWJTFG7,?VF6.\95<+N7(*]&7]>*]3UC]H;P)X;LM(F
MUC6UT^74[..^BMC!)-(D3J&#.(U;8.>IP*\?^%/[/*^,+CQNWC#_ (22PTZ3
MQ)<31Z,T[VMG>Q[@RRM'M!<$]&!QP/2L_P >>$]0\'_&;Q9<WB^*=/\ #>MV
M-O;VESX7TV.[1HTB$;6\@9&V#C@#'\J_0I4,'6FJ*T:5].ND=+ZZW;>WEZ?E
M<,9FN&HO%2UC*7+[VMO>E[UO=LK)1UEN[^OT!XD^-G@?PC9V-WJOB.UMK:^M
M3>6L@#R">(8^9-H.?O#CJ?2J6H?M"?#[2]0T^QN/$4:W5]%#/"B6\SX24 QE
MRJ$1[@P.'P>17DFA_#-K'X@_!1;'0]:G\/:787C/+K-G^\M6;<Z"?:-L;;B,
M ^@[U7^+"ZSX:^+5]J7@#3_%%KXJO9[:&ZM#IOGZ1JD(51O,G1 JD@GL0>G)
MK&&"PTJD:=V[\SW2VDXJ^CMHKMZ_=JNNKF^84Z$Z[C%*+@K6;;O",Y6]Z*EJ
MVDM+][Z/UZQ^)36'CKQS;ZWKNAQ:!H<$$XBB65;FU#+DF=F&P@]@A)Z=ZQ/%
M'[5'@K3/ 6K>(]%OAK4ED\<*6<D4UL99),E%R\? *JYW8Q\M<3K/@Z:Z\??&
MN?Q!X:UR^T#4K+3T7^S+9C)<;57<;<D8=D/S8&?N].U<_IMGXY\6?![XEZ L
M.M:UH,%G#'H5QK.G_9KZ<*0SQ!>L@4# /<].N 0PN'E&,Y=%"^J2U4;]'KKY
M=[O4FIF>.A4G1IK=U;:.3NG+ETNK1T[2[62:9[EIO[0G@FZ^']GXMN]:AL]/
MG=;=EV2.RW&T,T*J$W.5SU5?>M"S^-W@>_\ ";^)8?$-N=%CN%M9+ED=3%*Q
M ".A4,IY'4#UZ5\]>,AK?BSPW\*/$]CH_BG3;#PWNL;];;3P;Z!Q#$OVB*%P
MVY,@C<1V/2JOBCP"VM?!_P 9W7AZP\9:UJ.L:O937']M:6(I;@HQW2111H"5
MPQW-CM6O]GX9M7;5Y6WO;WDM=.VM[_)[F*SS'Q32BI6I\U[-<S]FY76O\RY6
MDN[NM$?2/@OXU>"?B'JU]IGA[Q!;ZE>V:EYHU1T^4'!92R@.H)'*DCD5'X:^
M.7@;QAXD?0='\00WVIKOQ&D4@1]@R^R0J$? Y^5CQ7F'CCX>:K??'*%M&TF:
MTLIO!5SIRWT-N4MXYB)%1"X&T$97 SG&*SO@[K6I7'PRM_AB_@K7-(\0VNGW
MMK)J5U9>5:02,DFV02GJ7+ <#N>2*Y982@Z3JTVWHG:ZT^*[>FJ5EHM==ST*
M>:8V.(CAZZBO>:ORRL](-16NC?,_>;:]W;>WK6A_'[P!XC\3)X?T[Q);W.J2
M2-%&@CD6.5QU5)2H1S[*QSVKT&OC#X6^#S=1^"?#?B2'Q_;ZGH>I1S)IL>DQ
M"PMI%D)\WS]@/ED').XDY/7BOL^N?'X:EAI*-)M[_P# :T6_S]6=V2YAB<PI
MRGB(J-K:+1JZU35WJN^E_P"5!1117EGT84444 %%%% !1110 4444 <CX\NA
M_H=L"AY,K+_$#C"GZ'+_ )5X]X/;[=\1O'6INRF.U:TTJ-ST58X?/?G_ 'KD
MY_W:]'\771G\272$+^X"1 CKC:&Y_%S7R=\4-:U;_A6^N:)X>NI+?Q#XL\57
MEM \+^6PB2Y6W;+#D E8H^/[_IFEN=>'INH^7:]E^OZ'NWP+7SO".GZK*F)-
M>U"34W# \I<7!9!_W[9!^%>T^+9$72EB?/[V5%&/4'>/_0:\X^"?AF\\/^&?
M"VC7TBSW>FZ?#'<MYI?+1QA25) )&[';I7<>,;H&:VMPWW09&7;Z\*<_@WYT
MNYA4:<VUW//?B7H5YXB\&7D&FA3JMN\-_9*YPK7$$J31J3V#-&%/UJUX5^(&
MB^++&PFL[Z%+F[1F%C-(JW*,IQ(C1D[@R,"K#'!%<1H?A6P^*&I:]J_B5'U2
MWM]4N-/L-/EE<6UO' YB9O+!"L[.KL6;)P5 P!7-3?LJV.@_%:W\>^#-5BT"
M_MX&1=.NK,W5NTA0H6R9 R@J2#CD=0>U+39G1&-*SA4E9KRZ]O\ @V/1_$2C
M5/BWX/LY#NALK&_U/9V\T&""-OP6>;\ZY[X.^/-%\2_$;XJ:9H]QY\=GJT,L
MFV-@@D-ND4N"1@_O('Z>F>^:XR\^)7BVS_:<\$Z!J_AFTL#=:;=6TM];W,DT
M$Z-MEW1$QKM93;CY6S]\\]#7L'ACX8^&/!OB/6]=T72H[#4]:</?31NV)6!)
MSM)VCEB3@#DT;+4TG%4J:4]W'2UK?%U*=XHTWXUZ7+&=HU;0[F*<#H[6\T+1
M$^X%Q-^==!KWC#1?#<=P^IZK:61M[=KJ2.690XB'5PN<D9XX'7BO$/&WQ*\3
M6O[4NC^&]*\-0ZREOHDSP2-</ J&8H6DF?8P50;?:  <[NN>*L:Y^S$?B-\3
M-*\;>.M7M;Z:SA$1T?3;1H8"%+% 92^]MI8G) )P.@XHMW#V,%RNM*R:OW;W
MM_3/1_A78WD>B:AK.HP26E_K]_)JCVTHP\$;!4AC;_:$,<61V.17J?A"<-]L
MA"XVE)"<=2V1U[GY1^E>">-?!6D_"_0V\4>%;9M&N]-EBDG@MI7$-W!YBK)'
M)&3M;*$X;&0P!!Z@^V>%KH0ZL(FDVB9"H7'WF'S#GV ?\Z.IRU+/WULSC?C1
MH;>)O#?BW2(!^_FM76#:,8F\H.A^N_!K@O%.NKK?A'P!XOAP@74=/NRW]V.Y
M'D./IBXY^E>T>.K-OM1*D(+B$@,KX;<."?; *\U\1^ 1X@\&?#3XC^ ?%-ZU
MQJFAK_:EDS3&9%BC\J9E1B <*3$W_;3ZU21TX>'M(O75-:>3T?Z'VYX)NA#J
MLL)**)H^_P!YF4Y 'X%S7<UY9H]X;76M/E4*29T0;O\ ;.P_CAC7J=". ***
M*8!1110 4444 ?)O[*OPQ\'>)/@S!J&K>$]#U2_FUS7A)=7FG0RROC6+Q1EV
M4DX  '/0 5ZM)\#?A[)T\$>'4/\ LZ3;_P!4KCOV._\ DA%E_P!AW7__ $\W
MM>U4 8:>'WL+*.TL#!#:1((H[98PD:(!@* . ,<8Q7!77P:\,6V2?A[X=E']
MZ+2K9OTV9KUFB@#Q2+PEX.T*^AN(_!>AZ?>0N)(I5TF&*2-@<AE.P$$'N*V=
M8US3O$6GR6&JV=KJ=C)@O:WD2RQ-@Y&58$'! /X5ZA)$DR%)$61#U5AD5AW_
M (&T/4,F2PCC8_Q0$QG_ ,=P* /)_P#A#_A__P!"3X:_\%-O_P#$5I:#;>%_
M"MV]UHOA_2-'N73RVFL+&*!V7(.TLB@D9 X]JZ#4O@[;S9-CJEQ;'^[,HD'Z
M;37):I\*?%5EEK5K74%[+'+L;\FP/UH TO$+>'O%S0'7=%TS6C!D1'4+2.?R
M\XSMW@XS@=/05D?\(?\ #_\ Z$GPU_X*;?\ ^(KD-8M_$6@[C?Z1>VZ+UD,)
M9/\ OH9'ZU@_\)M_M_K0![9H.H:/X5LVM-%TVQT>U9_,:"PMT@0L0 6*H ,X
M Y]JR]6T?P=KVH2W^I^%]#U&^FP9+J[TZ&65\  99E)/  Y]*\G_ .$V_P!O
M]:/^$V_V_P!: /3?^$/^'_\ T)/AK_P4V_\ \1756OBBVL;**SMHXK>TB011
MV\2!8T0# 4*.  .,5X1_PFW^W^M'_";?[?ZT >F_\(A\/_\ H2?#?_@IM_\
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MMU"XDBGATR!'C8'(96"Y!![BNAU/5;+Q592:=J-A;ZO:2X+VEU L\;X((RC
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M'#F5G'W7M:\=':VENUM#Z1T_3[72;"WL;&VALK*VC6&"VMXQ''$BC"JJ@84
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M-0\E+97N''L<[1^1->D:#^RUX7T[:VH7FH:M)_$KRB*,_@@##_OJO9:,XZT
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MS1SXC#T\52E1K*\9;H^"9[/]I+PDL?@RS&J26EFH@M[JR56B:,?=VSXR%P.
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M,KM.,?=6/&7/L!7+<]*RM8\#^&UU-?:/?3*7;3QJ-TFG2NY8M;B5@G)/(Q@
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M_L6?!6>ZDN+7P'9Z'+(=S?\ "/W-QI0SZ@6LD8'X"D8.W0]MKF_$OQ*\(^#
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M1-V-H@_\?D_QKS3Q/XP?1;FTTW3K)M6UV\#-!9K)Y:JBXW2RO@[(QD#."22
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M\3A9]$F7[5X=U;<RM:Q[E40F9<-$R%T5'!&Y65<Y'+W1M&]2A&,NC=N_1O\
MK_@GN#252^PVB:E)J"V\8OI(E@:XV_.8U)(7/H"Q./>O&/'GPW^):ZEHMWX2
M\?W$MM9SKOT_5-J!X]V6WRHO[P8XPRDX/4FO1O"_B_\ M][NRO+-]+UJQ*BZ
ML9'#[0V=LB./OQM@X; Z$$ @BE8YI4N6*E&2?>W3U._\&2#_ (2O3@0"2TF.
M.G[IZ[CQ]!'-X9N7?;NB9'1F[-N"_G@D?C7 ^",OXNTS_9:0_P#D)Q_6NO\
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M1J0U5MI0?PR7Y/S/(OV@/^2R?L\_]C5??^F34*[SQ!_%7!_M ?\ )9/V>?\
ML:K[_P!,FH5WGB#^*L*.YW8KX3S7Q!_%7FNO_P 5>E>(/XJY/0O#_P#PE'C#
M3--*[HYIU,O_ %S7YG_\=!KZ.A)0CS/9'Y_BX2J34([O0]^^$?AS_A&/A_I5
MJR[9Y8_M,WKO?YL'W ('X5V-(..!P*6OEJDW4FYOJ?I%&E&A3C2CM%6"N?\
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M6UC.GWEO)J%K<X(>&4L@W 'KAV5P0>,D'@BO)-8V26[1,?O<>E>I_ &^,WQ
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M\UVN?7%8?C;QAIW@#POJ&OZL9%T^Q0/*84WO@L%&!WY(KY;\+?$GQ7\4-/\
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M6=,N(1>6B2$(%2.'(,;%7#G:RY&".3D;'C+P9HGC6U6QUNTCNK7=YOSL5,9
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M&Y<X(X!;C.<U[+X*U -&8B>16/>> _"7Q^\*Z-J6I:?)::C9[)(9H',4]I,
MIQD?> ..&R#@'%4O"5U)9WWDRN'FAD:"5E& 71BK$>V0:\;$1]AB(5EL]&>S
M0E[?#2I/=:H]4KSS]HS_ )-[^)__ &*^J?\ I)+7H,;;HU/M7GG[2#%?V=_B
MDPZCPKJA_P#)26O97<\62T:/C[1_^018_P#7!/\ T$5;KZH^'W[.?@O5? 7A
MJ]N+:Z,]SIEM-(5N6 +-$I/'U-;_ /PS'X&_Y];S_P "FK[3^V,-V?W?\$_)
MO]5<?WC][_R/CBBOL?\ X9C\#?\ /K>?^!34?\,Q^!O^?6\_\"FH_MC#=G]W
M_!#_ %5Q_>/WO_(^.**^Q_\ AF/P-_SZWG_@4U'_  S'X&_Y];S_ ,"FH_MC
M#=G]W_!#_57']X_>_P#(^.**]@_:&^&FA_#F?0DT6*:(7:S&7S92^=I3&,]/
MO&O'Z]6C6CB*:J0V9\UB\+4P5>6'J_$NWFKA6IX;\-:EXMU:'3=)M'N[N4\(
MG0#NS'H /4UN?#GX7ZQ\2M4^SZ?'Y5G&1]HOI ?+B']6]%'Z#FOL7X?_  YT
M?X<Z2+/2X<RN 9[N0 RS-ZD^GH!P/S-<&-S"&%7+'67;_,]K*<DJYB_:3]VG
MW[^G^9R_PH^!.E?#^T%S?+'JFMRH5DG=<QQ C!2,'MV+'D^PXKD/CA\$-(\2
M:'<Z?J=C]OT*Y8,.2LEK*#E'1Q\R.IP5=2"".OK] 4R:&.XA>*5%DC<;65AD
M$>E?%U:TZTW.H[L_8,'1I8&FJ5&-H]OZZGRU\)?C=J_@+6K#X:?%F[&LZ?J;
M?8?#_C2Z5=FH$C"V-^/NK<D<*_W9O9\AI-:^&?B?]F.Z?4? &GWWB_X6NY>[
M\%VY,NH:'DY,FFY.98.YM2<KUB/\%=1\;OA+H-YX2UBVUZ&"X\)7,+?;#>.%
M2W0<[F8_="D9#Y!4@'((YI_L;_%74O%'PCTNT\47TU[<V]Q<6>E:U>_+)J^G
MQRLEK=/_ +<D04Y/W^&_BQ61VS@OBAL=!X ^)'AKXHZ"NL^%]7M]7L=YC<Q$
MK)!(/O1RQL T;CNC@,.XJ'QK\,/#WQ ,+:S8I<O$058@'I]?Q_.KOQ._9FT#
MQQKTGBSP_?WG@#X@;0H\3:"%5[@#[J7D##R[N/I\L@+ #Y67K7G-]\4O&OP7
M_<?%_P ,@Z+'P/'?A2*2ZTPK_>NK?F:S/3)(DC!/^L%5"<J<N:#LSCJTJ=>#
MIU8II]&;'Q=LX_"'P@U.VT:R1(XHML<*#\1]<D 5\K?"/X=Q?&/6KZV>5)[7
M1;(6MI;2D%7(7:S$>I.>3[5]KQW.A?$GPF)K"_M=9T74(LQ7EC,LT4B]F1U)
M!Y]*X;X4_ #3/A7X@U'4[.;<;K.(UR /P)_05VT:E-?O9OWX\UKZZRMK]R:^
M9XV,P]><EAZ2_=3<%*SM[L>9V]&W%_\ ;NIR'[-OP-U#P'=:I=>(;>*:X:3]
MU(R]2,8//H/YUI?M<>'],C^%][XG>QAGU73;BS\B23<  ]W%&<[2#]UST(_+
MBO=*\=_:V7[1\$+ZQ7F34-7T:P0=RTVJ6L?'_?6?PK&6(G*:G'2R25NB2L=U
M/ 484I4IKFYFY-O=MN]_O./\=Z)J?AG7&M-2A_TZ)2)2HPLL8)V3)Z@\C Y&
M,=C7*RZU#QY;J?7YNE>Z_MC:/;P:?\/?$)3R%@\7:;I^I741*,]C<M);&)V'
M.SS9XF]B 1BDN/@G9-?Q-;:K=VVG*5+V6 VXA@3\_7! QW[\UZU/,HN/[Q:G
M@5LEJ*;=%KE/(_!?@V_\;:PT<"+%;*,7#R@@+&W4G_:(R%'KST%?4%K;QV=M
M%;PKLBB0(BYSA0, ?E4.FZ7::/:K;65O':P+R$C7 SZGU/N>:-4U2RT/3;G4
M-1NX+"PM8VFGNKF01Q1(HR69B<  =S7E8C$/$2N]D?08+!QP<++5O=EJO$XK
M=_VKO'D6CV(\SX0>&=06;6=2ZQ^(=0@<,EC#V>WBD4-,_(=D$8R YIMC%K_[
M7$PM=(?4?"WP8_Y?-= :VO\ Q.O_ #PL\X>&T(^_<'#2 [8\ EZ] ^,7Q>\/
M_LS^"=&\)>$-$M;OQ3=VYL_"W@_3U$:'8,"20+CRK:/@O(<<<#+$"N0]#?1'
MD?QJUC_A9'[6L-C ?.TWX>Z&8GP.!J6H,KLH]2EM#']//KZY\+Z2-!\/:?8
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MN-)NB/A/K7[G.R[6,?-U!,/S=.VX\>U</7HVAV+O\*=3& /,=IAQ_"I7)_\
M'34G ><UX]X3!LM,^&FK-\AN+J\MY<=Q<K+-_P"AQI7L->26*#_A3?P\N?XH
M;C1Y!]7EB0_I(::.JCJFN[2^],ZOPWF#XC^,H<G;)'8W6.V6CDC)_*$?E785
MR.BL&^*'BG'\.G:<#_WU=&NO'N<#Z9H,JGQ?)?DCW[PC;I;^%]+2-=JFW1\$
M8.6&XY]\DUKU';VZ6MO%#&-L<:A%'H ,"I*1D%%%% !1110 4444 %%%% 'S
ME^QW_P D(LO^P[K_ /Z>;VO:J\5_8[_Y(19?]AW7_P#T\WM>U4 %5[VSCOH&
MCD&015BBGL)I-69XOXM\,RZ1=/(B9A;K7 QZKXU\)KK%GX<FLKK2M5R_E7C%
M'M9CDNZD Y!S]TXZ=17TSJFEPZI;M'(H.17DWB;PA-I$K21KNB)Z5ZU.I#$1
M]G4W/F:]"K@:CKT-CGO"?BW4)O$TM_;6D/\ PE$UFMGK>@B01_;+>)I%2[M-
MQPQ^=<J2,@J">!7J7P/OHY_A\J6\N;*&>:"VCE!22%4<H8I%/W65E8$?2O(+
MS2-.U9HAJ5DEY'&?E9AAX_H1R/Y5YKXON=2^$_BK4/\ A'/$DNA>$=;@\^6Q
MO&#V_P!JVLC*LLBOY;$*C<D!B<;E)W5R5L-*EJMCTL)CX8E*+TD?0WPQ^(%M
MX-MM6TCQ6ZZ9J,=[/<27-RPCCD5I#A@Q/3&W'U'>O.=!UE_&W[7RZU8VUP?#
MD>AR?9IWC\N.XN(I AG"MC<%$SHK 9.7P2 :Z30/VA/AGXF^%NG7?C&^T^UU
M&UM0EY9:E%MF\R,?.8XR-SJ2NX; 000:X[PGJ>@?%"ZG\;IXK70=4DA^SZ19
MV-RL+V-D,E4DC!^8R9WD$<97&",UQGJG<?%KQ7;2>,_#>C^)M4M]!\-I=BX9
M[^X17U.=,>7"BYR(PS!B3C)4#IG.EKGA/P3XV\76T7BS2--E<VIDMY+R- TG
MSD??ZD  <9QS[5XM\(?!^C?$C_A-=<\0W-OXA\2?Z3HUOJ6P+'(F,$98%L;A
MC[Q '3!S7<? ?QKH'BKP[<^&_&C6]SX@\/L;9[>_B'F[%^7S$R,LC8SD>M59
MQU(YHSO'<Z+1?#]MXLT7Q?X7@4VR:)K"MITND *]LIA22*12>&/[UCD<<LIY
M!-6=5\.7WC*_^R^(-3OM/TO3;4/=32P;?-<<;@3E!TS\O//!'%6?!_B'0/A3
MX^\7VNMRV^A6NL7$=]IMU.1%;S6Z6\*;58X52K9&SW#=7-6+CXX)XP\4?\(W
MH6EWEQ9W*LJZK-;&*VDVCG8TFTN,]T5A[\5)9/#J/B2%K'1M!U"VNDCB5YI]
M0F;,$9X0;%7+D@=V7\:\<TLQ:QXNU?5K3*:59O)86BNFV2203,\\S>I>1VQ[
M#W)/L[>'M9\*RVVC64UN;S6I9I9=1D!<Q$(<*%/4  8^GUSXW\,]/N8M)?0;
ME -2TNZDL[QD8L'F4Y+ DDG.[J><YSSFNW"I<[D^B/(S.4O8J$?M.QZ?I/B>
M5=+\G?@*.3FJ5U>/Y,MS-)Y%O&I=Y'[*.2?:F2:;_9J*K#A6!;Z5P\>A7_Q8
M\5:O!>:G+9^%=#NXH;C1HT4G4?E5SN?J$R0, _PL#7QLU/'XF5WH?=4>3+L'
M#2[,3QOXVTCQY8V_A/PUKC#4M9N!!+=V\32&.W7YIF!&.=@91SPQ&0>A]@;X
M=Z-\'_"-BOA*RBLKJZEM[-9YUW! Y +L/7W]Z;\0-8?X>Z]K^J6VGV2FTT"/
M^R9#"#Y;^8492!R%4F,\=0<=JV[;X"V>IZ9%<ZKXH\1WFI2 2SW4&KSQH[\'
M*H&VHOH%X'48/->[0H1P\>6)XE>O/$2YIGE/QR^'\_@&UM+ZSOY);;6M3@@U
M?[/;?Z0$; 8Q%>F0NW&WJ<\\@\3YEM9WUEK:Z;:VNLW=O%8Z1IT8W1Z;9[R%
M:1AD_>E)9N26<J,DDGV7^S=$\/ZI::5X;\,77B/6K[-P_P!NOY7CB2-MOF2/
M*7&XDGW)ZFBWA\/7'B+4=%UKP7=>'-:U%(;R[C7,L-SY4@:)XIU^4E73=M^4
MY.2,DU<Z<:D7%Z)N[_O>3?;OY::79XE7!\TU*F[=_P [K^K7=]6D=S\$O!J^
M![/7K0S/>W+W@EN+^50)+A_+7)..@'9>@'UKJ]'UV;4[[5H4\F46TNU3$=P7
MCE6;^]ZC'&17*:#J7]I:EXBGL]933X/)\KRID ,<F,>:0W0#('H:XKX=^,M2
M\#:3<Z-%HU[KNKW$^X3P@_9GG8'=(TW39QR1DCICFM3T(0C3BH05DCW6&/=-
M]IWXB*8*8Z$'DU\_BR\/?$+7/B5K5KH*ZUIYEMX/](AS%>R11;9'CSUXVIN'
M]P8K&^*GC?XIZ3H9\'Z6=!N]=U<L@N$N6+06[9,LBK\I 3.U6;)8]JP/!VD_
M%W2D^R7/BW0]%TN,+'%;Z9IWF%(QQ@$D#...V#W-<]3$4J6DY6.NGAZM76$;
MG5>+M!U;3_!4=Y\/O%5U'J6GS)+%H<MPLT5PH(+V_P"\RP^4G'/4#U-:&O\
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M5_\ 226OIEHK'S#U=ST'X6_\DQ\(?]@>S_\ 1*5U%<O\+?\ DF/A#_L#V?\
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MPDMLGO Z#_9/2N\T+]LB'PLRV7Q@\+W?P_G'RC7[/?J.A3GU^THN^#/)Q.B
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M JA*7*YPKQ'^-3VQWX.""*^O_P!GWX,^)/ OP],VLV<EI>ZC-]I-E*,/%'M
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MW_IE&(X[>)O]IFE _NFO4_A/\(/#OP;\/S:9H,5Q+-=SM=ZCJFHSFXOM2N6
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M)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,C=17ZYEN8T,TPZQ%!^JZI]F?E68X"MEM=T*R]'T:[EK^UIO^>:?K2?VM/\
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MM?0/[)OBQTU75?#$[DVUU%]K@!/"R+@,!]5(/_ *^?J]+_9Q:0?&/0=F<$7
M?'IY$G7\<5U9#7GA\SH2AUDE\GH_S.7/*,:^6UXSZ1;^:U7Y'UR1M)!ZTE27
M'_'Q+_O'^=1U_1I_/85Y'\9I?#^GZYI^JMXYMO WBZQLY39W%VZ>5<P,P+Q/
M')@2J64<*0P."*]<J.:WBN-OFQ)+M.Y=Z@X/J/>FM'=!TLSP'1/BFUOXKT?7
MO&$R^&SK'@])$M9F9(Y+D3L62)3R9"K(0@R^& YKD=.F\/WUK\%Y/&U^T&E2
M^';SSYKRY>&)W+6^U9GR/E)_O$ L%'7 KZMDACE9"Z*Y0[E+ ':?4>E++$DT
M;1R(LB,,%6&0?PK;VB3NE_7O?_)?@9<CZOM_[;_\C^)\JZ#?Z?<6O@NU\8:C
M)%\.9+C6/L%QJ5V\4$ZK,!9"60L,CRO,*;CS@=>*ZJ;QMX?\'^+-9"ZRUKH=
M]X2MO[$$\\CFZ*O<*1#O):1_FCX&6(*]J]^DMXIH_+DC22/^XR@CCIQ2M#'(
MR,R*S(<JQ )7Z>E3*?,N5^?XWU?GKN5&/*[^GRU3LO+38^:]-TW0&\3_  3U
M?Q'+'"UUX65%N[RZ:(2W2I:M$NXL 7)+\=6]ZS]%\2VFI?%SPKJ6DQ:?I%U=
M:_=V=Y:1:A//J31JDX;[6C':BED5E0]/EVGBOJ22&.;;YD:OM;<NX X/J/>A
M88XW=U15=^68#!;Z^M:>VU3MW_%W_P" 0Z=TU?>WX*W_  3YF\,Z/'8Z'X'\
M5)/>-KUSXPDL9;N2ZD8M;-<W$9AVEMH3 'RXZ\]:I^!_M6K>,K2ZU+Q)H.D^
M+8?$<HNH;F]F759HA.P^S"$MM,318V@#;C##G)KZHJ/[-%Y_G^4GG8V^9M&[
M'IFIC5MT_K33TT_'[ZE#F_KU_P _P^[Y5COM-N-/CO!J4A^,G_"3>4UK]K?[
M6%^V8,9AW<6_V;G[NS'.<UI^./'5OH?A[XI:%=:PUOXAE\0QR65CYK?:# PM
MF#HHY\O ?+#Y1SDU]+_9XO.,WEIYV-OF;1NQZ9]*7R8_.\W8OFXV[\?-CTSZ
M41J*-KK^O=V\O=_$4H<U[/\ KWO\_P #PCPSJ&F:/\>+BV6[TWQ1>ZM>796\
MM;QSJ&E;$^:"XAR1Y(V[5;C!*_*2<U[U4:V\23/*L:+*X 9PHW''3)J2LW*Z
MBNRL6E9M]PKFM0T^^\,ZI+KV@Q><TF#J&EJ<+=J/XT["4#H?XNA[&NEHKEK4
M8UHV>C6SZI]U_6NST.FC6E1E=:I[KHUV?]:;K4TO#_B"Q\3:5#J&GS>=;2>V
M&5AP58=58'@@]*\8_:T\62:9X5TW0X6VG4Y6DFP?^6<>T[?Q9E/_  &NC:2;
M2?B191^&QYUW?,'UFQSB!8,$"X8_P29P!W<=>F:\K_:^63_A+-"8Y\HV3!?3
M/F'/\Q7R&?8RI'*:\?M)J+:V=VKV^6C71Z>;^LR/!TY9I0E]EIR2>^B=K_/5
M/JM?(\"JQI^GW.K7T%G9P/<W4[B..&,99F/0 57JWI,=[-J=K'IOG&_>0+ +
M<D2%R<#;CG-?A].*E.,6F[OIO\O,_:IMJ+:=O78Z#Q1\*_%7@O3X[[6='EL[
M1V"B;>CJ">@.UCM_'%<I7M7CS41\//A;'X"FNO[0UR\G%YJ.&WI:<JPC!_O9
M5<_CZBO%:]#,L/1PM?V5%O1*Z;3:E;6-TDG;;8\[+L16Q5%U*MMW9I-)KH[-
MMJ_KYDEO<26EQ%/"[131L'1U."K Y!'XU]Y>&=?_ .$N\':)KF LEY;*TH7H
M'QA@/^!!J^":^S?@*LB_!70?,R,R3E,^GG25]EP36G'%U:/V7&_S32_5GR/&
M=&,L)3K=5*WR:?\ D=M1117[(?D(4444 %%%% !1110 5\__ !+TO6/BIX\\
M1Z9I>BVVL:;H^E-I/F7&H&U$%Y<*LC2)^[?<R(L/IC)]:^@**<7RN_\ 7;\K
M@]OZ]3YPLO%4_C.\\'ZA>+LU./PKK=I?Q]TNHC!'*#_P-2?H16#\*VT);CX7
MQ^#M0ENM?FTN9/$$"74DDBQ"TX$Z,?DVS>6$R!Q]WBOJVF+#&DCR*BK(^-S
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M/O1NO9A^O4<&JE<7XD>72?&&F7'AT>9XFNV5)[%>(KJU!PSSG^ (,[9.N?E
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M'C>SBTW3EB=V6RNUD"2NI).W]Q(7^L5=5^T9X<TL?"FQ2\0M8Z7J&G%I9)6
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M8"XOG4^5 ON>Y]%')^G-?9?A_P /6'@OP[9Z#I:XM;9<-(?O2OU9F]23S_\
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MJ>G3_9KVV;?%+M5MI]<,"#^(KTCXR? V_P#A_>3:AID4E]X<D.Y)E&YK?/\
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M0;7AF 96'H0>U:=%)JZLRN:SNCRG7_V:_!.ORO*EC<:1*_).GS;5S[*P91^
M%9-E^R;X0M9@\UYJUXH_Y9O-&JGZ[4!_6O;**\2>1Y;4GSRH1OZ?IL>Q'.LQ
MA'DC7E;U_7<Y?PUX#T;P1;F+0-&M[$L-K3_>E;ZN<L?Q-:#V%U(Q9AN)[EJV
M**]>G2A1BH4DHI=$K(\NI6G6DYU'S-]6VV8G]G7/_/,?]]"D_L^Z_P">0_[[
M%;E%:6\S.Z[&%]@N_P#GB/\ OL4TV-[VMP?^V@K?HI6?<?,NQSQL[_M:@_\
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M_P".5W5%+V<OYW^'^0_;0_Y]K_R;_P"2.#.H>(>WA*\/_;Y;?_'*:=2\1?\
M0GWI_P"WRU_^.5WU%3[*?_/Q_P#DO_R)7MH?\^H_^3?_ "1Y^=4\2?\ 0FWQ
M_P"WVU_^.T[3/"VH^*-2COO$EI]AL+5PUKH[2+)OD'_+68J2IP?NJ"0.IYZ=
I]14/#\W\2;DNSM;\$BEB>6_LX*+[J]_E=L****[#B"BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>elicio-arnonxemployeedir001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-arnonxemployeedir001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O#5
M\3)I_P 5/%]EK>MZ@NE6-N'M+8ZE+'F0[,*I# DG<>.>OM7N5>26/A/68OB9
MXJUF_P##\]QI&KVWV=$CG@+_ , R07 'W3W]* -?QM:ZAX9^%VO2P:SJ#W%N
MYFM;EKE_-16=<*6SSC)'.>,=ZW/AU-/=_#_1;RZN)[BYN+5)999I6=F8CDY)
M_2L?Q59>)_%'@/Q#8/HY@NKR0165K]HB.V(;#O=MV,D[^ 3C ^M)HR^*=$^'
M%EHEIX>G_M>WM!;K*US (D;&-^0Y)QUQCGI0!D:YJ&H1?M"Z!HL>I7R:9=V+
M3S6J7+A&<+.0<9X^XO XXJ33M=OO'WQ.UK2%OKJST'0OW;Q6DK0O<S;BI+.N
M&"Y5N 1T%3ZOX9UVY^.&B>*(-->32K&S:VED\Z,,S%9AD*6SC]XOOUXI;3PE
MJ_@[XD:IXBT>R.IZ3K(+75K%*B30RD[MR[RJL,EN,@_-[<@'6P^'[BUUDR1Z
MG?/I;VCQ-:RW3N4D+(0ZN3OZ!ARW';&37E?P^\;ZCIWPF\2^*=5O+K4KNRNV
MAA%S.SCE8P@QG&-S\GKBO7[:]U*X\V:72I+:!4^2!Y$:>1O^ L44?\".<]L<
M^9^ OAQJ</PXU_PGXDM&M#J-PTR2I*D@7*IM/RMG(9,X_6@#;\):;J?B/X=P
MZM?ZWJ7]LZC"UPD\-T\:0$YV!8U(3 &,@@YYS5CX1^-;KQOX.^U:@%^WVLQM
MYW48$F "'P.!D'GW!J/PY!XJ\,^!%\/MHC7>HV<;P6MU#<1""09.QFW,'7&1
MD;2>..M:/PU\$#P'X3337F6:[ED,]S(GW2Y &%SS@  ?F>,T <M\68]2\,^"
M;_6;/6]32_EOU*,EY(J11LQPBH#MQC';.<UT]KI$T6A?VFFJZDR3:1F2*2]E
M?$NU6$BDME3]X'!QT]ZJ?%WP]JWBGP4VD:/9FXN9)XY,F1$50IR<EB/TKH8H
M;Q?!26ILI?M@L1#]GWIG?LV]=VWK[T >2^#/& N?@WK5UJOB:4ZZ$N6@,NH,
MLP*IF/:-WK^?O5S3]6U27]G";7WU74&U;9)(+K[5)O!6<H._3:,8Z5H^#O"7
MB'1/@]K/AJ\TMQJ5PERD2I/$5;S$V@[MW&#U_K3++PAXBM_@-+X1?2F_M8J\
M843Q;#NF+YW;NF#]<T 3>"KF+Q/HFBQVWB'47UR&W@O;UUU&5U/[P9CD0L5^
M8!N,#''K5?Q+JLUI\>-)TFXUF\M=%N=.:>XB^WR11[\38.0PV\JO ('%:V@V
M'B+0O!^FV=KX:E&N062V+7+W, B1<YW9#EFV\D#'J.]5]>\):KJOQFT[7I-'
M^T:'#8/97&^6+Y]RR@G:6R5_>#WZ\4 .^&^N:OJ/C#Q/9+>SZEX:MI,6-[,=
M_P V>463^,=><GH/7E?B3XZO_"NO:#+;HW]D07BKJDJ\C]XK!4^H7<^/]RD\
M$^&_$O@#6]4TF"T?4?"LK&>Q=9XQ+ QYV89AP>A]P#W-6-8\$S^)/ >IPZC;
MWT>KWH>=K872E!<=4Q\VTJN%7D@X6@#5^)UY/:?#;5M1L+R:"XAA62&>WF9"
M#N7G(/(P:\[TKQ-K0U3X?IH>KW>IW&HP*VMVLDYN%1?DS(V2?+."YX(^Z./7
M?&A^+[WX)7'A?4-*8ZPL*VL1%Q$5= P*L6W<848/T]Z[7P-I]WI/@K2=.O[4
MV]W:VR0RJ65LE1C(*D@B@#RZ7Q,FF?%OQ;9:WK=^FC6-D)K:V.HRQYE*Q$*I
M# DG<V!SU]J[/Q=9W_ASX9^(I(=8U"2:'=<6EP]RYEB!VX4MG) .[KGC'>L2
MW\)ZROQ4\4:Y?>'Y[C1M7LOLBI'/!O/$8)(9P /D/?TKJM1TW6O%_A7Q%INH
MVJZ6;M&@LHWE60A0H(=RA(R6SD#. !0!E^';B[O/@>NHSW]Z]_)IDMP;DW+^
M9Y@5B"&SQC XZ5;\7Z5<6'AG7=8BU;4T:UTIC:1I>RJ(W1&;S#AOF8DC[V>E
M4/#&G>([;X>Q>$+W0I;:X6W>S:]-Q"T&QLC>,.7)VGA=O7N.M=7XSLKO4?!>
ML:=86S3W-W9RV\2!E7EE(!)8@8YH Y+X9VE]KO@OPWKUUK.IR71:<W8DO)&2
MX3,L8!4G (^4@C'W:QOAYXCNXM2^(=[J^HWUW::'<.8(Y;AW$<2F8D $X)P@
MY/I79_#/2-2\.?#[3](U2R:&\M!(&02(X?,C,-I#8Z$=<5S7@3P5JMEJ/CB'
M7M->&P\03.T;+-&W[MC+D-M8D'$@]: )_APVH>/-'E\4:]J-\/M,[I:65I=R
M6\,$:G'2,J6;.>6)I/'-UX@\&^%9+I+R_P!1LCJ\;W,J/B>.QV+N0, -OS+C
M<.><YR2:F\!:1XB^'^FW'AZYTF75K!)VDL[RREB!VMSM=)'4@YR>,CGVKIM0
MF\2;=/GATV"93</]KM%G&1 4( W-@,^[:<<#MG'S4 97@K6]'\1WW]H^'M=N
M;BQ6V9)]/NIW>2&0LI5L.2PX##J5].]=Q7F5EX(FT_QU>>*= T5=*"Z;)$MG
M+(BK=7+<KE48A$X7/(Y[=SUG@K5]7UKPW'=:Y9PVNH+-+#*D#9C)1RN5.3QQ
MZGI0!P^AW^H3_M!>(-$EU*_?3+6P$\-JUU(41R(<GK_MMQTYK)NO$OB+X>>,
M!JVIWMYJ'@_4+N:U(ED:4V925U&"<GHN?<9'4"NBT?PWKMI\;M;\4S:7(NEW
MMF+>)Q-$6# 1<E=W3]V?S%=-;:*FN>&]2T?7M*>.WN;BX8I(Z-N1Y6=6!5C@
MC(/L10!A:SXJB\)^%_$_B*VN);]4N(ULEEN7EC_>0PE=N3]W<Y;CMQZ5:\&:
M)=ZKX4L=8UK6M5GU348%N3)%>/$D(<;E5(U(3 !'53D]>.*R-)^%<J?#76_!
MFH7>Y9KQY+.ZZG: AC8CM@K@CV..QK9\(2>)M!\-66AZGX>FN+FQB%O'=6US
M#Y$J+PA.YPZ\8!^4]/PH ZC0[2]L='@MM0NVO+J/<)+ANLGS'#$=N,<#@=*T
M*YRYNO%D?B#1H(=/L)=+EC<ZE<"0AH7QP$!()&<<X.?]FNCH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!/4<T :%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY)V]"<Y-)'X.\.Q26LB:1;;K1E>WRN?*9>A4'ICVH B\>?\ )//$G_8+N?\
MT6U>46ES;V_[)RBX9?WL<L4:GJSFZ;:!ZGO^%>WW^GVNJ6<EG>PK-;2#$D3$
M[7'H1W'M6;9^#O#FGF$VNBV4?D,6A'E B)O50?NGW% 'A_CBPO=,^"W@.TU!
M62Y2\0LC]5!#E5/H0I Q[5U7QB$C>//AN(G5)#JA",R[@#YD&"1D9^F17INL
M>&]&\0>6-7TZ"]$1S&LXW!3Z@= ?>H[[PKH>I3VT]]IT5S-:X\B28EVBZ'*D
MG@\#IZ4 >7>#9GN/C9JH\983Q/!#Y>G>4-EN\&#DQ@\Y()/)/!;N*S'T[4M5
M^-OC^STJ]-I=2:7A6"!M_P L/R<],],CD5[1>^&]&U*^M;Z\TZ">\M0!!<.N
M9(\'(PW7K5;_ (0SPX;^6_\ [)M_MDO^LN.?,?ZMG)Z#\J .%^.7F:I\/-1@
MTLF5K"\ADOUCYPNTG!QW&8V/H,&N^\+7UG=^#M)O+62,6C643*P(PH"#(/IC
M!!],5:TW1-+T>UFMM.L8+:"9S)*D:8#L0 2?4D 50@\%^'+5V,&D6T:,V\PH
M"(BWKY>=N?PH H^/F@?X6Z\]ML,#:9(8S']TKLXQ[8Q65\+H9;CX*Z5#;MLG
M>TF6-O[K%W /YUV^H:;9ZK9/9W\"SVTG#Q/G:P]".X]C3-+TBPT6S6STVU2U
MME)*PQ\(N>3@=!R>U 'F7[/H^R^#=4TV=#%?6FIR+<0N,,A*(!D?\!(_ UC>
M#H)KKQE\4-8ML_V6ZW$ D'W9) 6/![X /_?0]:]=N_#6CWM[)>36*"ZE79+-
M$S1O(OHY4@L/8YJ=-$TR+2/[*AL88=/VE/L\2[$VGJ,#'![^M 'S3:3ZS;_
M_30^)/"T]^R:H+:/%S&HE!!#$D8)'H.<#O7TEX=73$\-Z:NC.KZ8MLBVK*<@
MQA1CGUQ4=IX7T.PTN?2[72[:+3[@$2VJK^[;/7*].:M:7I&GZ)9"STRTCM;8
M$L(HAA03UP.U 'DWPB$FF_$?QYIFJ?+JDMRLZ[^LD>^0[A[?.A_$5W'Q&M9-
M5\#:_IVG%9-3^PEA$G,A0G)&.OS!6 ]<5M:GX;T;6;B&YO\ 3X9KF'B*?&V5
M!Z!QA@/;-6K#3;+3(FBLK9(58[G*CESZL>I/N: .+^$5]:#X1:1-YJ)%;12B
M<DX\LJ[%L^GK^-<1\'[*Z@^'FH7DJ-'9WFM6SVJL,9 FB!8>V>/^ UZU/X0\
M/W#W#2:7#BY;=<1IE8YF]70$*Y^H-7;K1M.O;&.QN+.)K2,J4@ VHNW[N ..
M,#'IB@#R#P]HU]X=^*7B#P5;P,=#U=5U!6'W8H=WSKCT;)B_(U=^#_\ R/WQ
M*_["O_M6>O6?L=OO$GE#S!'Y7F?Q[/3=UK.L?"NAZ7/<3V&G16LUSGSY(24:
M7KRQ!Y/)Z^M 'BWPR\*-XR\'>(M)N=2DMM,EUEFN(X(AYDNW8P&\D@#('\/;
MK6K\3=/CL/'7PQTW3S]FB@N!! 0-WEA7A"]>N,#K7K&D>'-'T#S?[)T^&R$I
MS(L(VACZD="?>F:GX6T/6KR*[U+3(+NXA_U4DHW&/_=_N]!TH J^'5ETBSM-
M)U6\%SJLLMU()-H#2)YS-OP/NC#)P.A(%>>>*O!%Y=Z!I'C+PL3#XCTR%7Q&
M.;F,9^4CNP&1CN,KZ5Z=;>&-%L[R6\MM.BBNI8C"\ZYWE"0=N[.<9 JYI^FV
M>E6BVEC L%NIRL:$[5^@[4 >8V\>E?$7X5Z5%K9:Q?6=0G:W:-O]3<>9,XQG
MKPK#'?..O-,\&R^,/"7CVU\'^(+U-8T^YMI);.].3)$J=02>0.@(.>2N#7I-
MQX>T>ZLTL[C3+66VCF:X2)X@561BQ+@>N78Y]Z+?0-,MFF>.VS+-'Y4DKR,\
MA3^[O8E@OMG% 'E'Q0TF\\4:#?Z]9:?=F?39A+I]W&\>P0Q9WD#?NY;>V0O(
M1*])\$^)(O%W@_3=93;YDT0$RC^"4<./S!Q[$5HP:)IUMI)TN"U6.P*E?(4D
M*%/4 9X'MTJ/2?#VD:#;2V^DV$-E#*=SQP#8"<8S@=_>@#S+X1_\E(^)G_83
M'_HV>CQ'_P G.>$_^P8__H-Q7I6F^&-%T>]FO-.TZ&VN9R3-+$"#*>3EO[W)
M)Y]:2X\+Z)=:NFK3Z=%)J,?W+HY\Q!SPK9R!R>!ZT >9^ H)M,^.WC6UU'*W
M-VIN+8O_ !PE\C:>X *C_@)]*76H)M3_ &F=%;3\G^SM.#7KKTC!\WAOJ'0?
M\"KU+4=#TS5989KVSCEG@),,W*R1YZ[7&&7\#2Z?HFFZ5'.MC9QP&=MTSI]^
M5O5F^\Q]R<T >:^+O 4OB30AKFA.;?Q+IE_>26LJ'!E"W,IV$^N>F>_'0FNB
M^%VNW7B7PS<ZM?6_V>[FO&6>+!&'1$1N#TY4G';.*ZS3]+LM*A>&Q@6"-W+L
MBDX+$Y)QZDDD^M2V]I;VAF-O"D7G2&638,;G.,L?<X% 'DGQ+69_C#X"6WD2
M*4M)M=TW@'(ZC(S^=/\ &/PY.E?#WQA=:?/<W^M:H4N;N9@ 759 [*BKT&-W
M'.:](OO#&BZGJ4.HWNG0SWL./*G?)>/'3:<_+^%:P&!B@#A/!&HV*_!;3;PR
M(+6#2B)CG@%%(?/X@UY%IVGWME^R[K4EVKI'=7T<UNK?\\_,A7(]B5;^?>O>
MY/!OAV3S5;2;?RIG\R6!<B&1O[S1@[&/N15W4M"TO6+%;'4;&&XM%QB!Q^[X
MZ?+TXQQZ4 8_AO4;?2OAEH=[=/MABTJV)]6)C4 #W)( ]S7#R?\ )T,7_8*_
M]E->ACP7X<5($&CVQ2W96A0J2L97H5'08J8^%]$.L_VP=.B_M/\ Y^^?-],;
MLYQCC'3% 'F'PG$FF_$_QYINJ?+J<]P)TW]9(]\AW#VPZ'\:]@\VW:\,0>,W
M*1[BN1O5">OJ 2OXX]JHZIX<T?69X;C4-/AFN(?]5/C;(GL'&& _&K-AIEEI
MD31V5LD(<[G*CYG/JQ/+'W- 'C,>E_V#\>KOPU8S>7I'B*W^UW=N!P,;V*CT
M!*,#_LN1Z&O<0 !@<"L>7PMHDVKKJ\FG1-J2_=NR3YJCD8#9R!@D8]ZV* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***X#QUI.IS:_I.H>')5M]9
M@CGG4'A+L)L'E2=B"&(!/0XZ4 =_17"VNM:9XP;PSJ4=N$G74)(+FWF7]Y!(
MMO,6B<>S 'GT!J]>>-TMM,O=9AL'N-'L9V@N+A)/G^1MKNB8^95.<G(/RG /
M&0#K**Y2Y\93_P!MW>E:;HLU]-!91WL;BX1$EC<L 0><?=..Y],<ULZ#K5OK
M^@6&KVP9(;R%9E5_O+D=#[CI0!I45RNN>-K?29-1C@AANI-.0/<Q-=+'(<KO
MVQJ0=[;2#C@<@ D]&CQK)=ZNNG:7HUQ=2RZ;'J,#22I$KHYP <Y*_B,Y[8YH
M ZRBN)L_B%]LL]#U'^Q;F+3=4N$M!.\J;HIF)4#8.2NY2N[CZ8IEY\0KFWCU
MJ:W\,WUQ#HUP8KQA-&I5 BN749^8X;.T=AR1TH [G(R!GDT5P;7-I??$_P .
M:I:E3#=Z)<S+)TW(6A*D_@:O/XZABTNTUQ[)AH-U.L*W@D^9 S;%D9,<(6QS
MDG!!('8 ZZBN=MO%(DU?7-.N[5;232HEG+R3?++$P)#CCA?E()[$5!<>,?)2
M"$VMO%J3V:WDEK=7BP^6K$A5W$'+DJPQC P<D<9 .IHKD8/']C?V&GS64<:7
M%[;-<B&^G%MY:AMI#$@_-NR!@'."<@5L>&]>@\2Z%;ZI!#+ LNX-%*,,C*2I
M!]>1U[C!H UJ*X^]\;W,%UX@M[70)[A]$5))BUPB!T9"^5Z\X' []\=YK/QI
M]JU;1;=]*GAL]:A:2QNGD4EB(_,PR#E<KD@Y[=!0!U5%<:/B%9-<Z<T4,<UC
M?W0M8I8;A7E5B2%=X@,A"1USD9&0*@NOB));Z9J^I?V!<FTTB^:UO&,Z!E5=
MN74#.X_/G&>@Z]J .YH!!&0<BN6_X2$WVM7'A[4=(DMA<6+W4#/*KB:,$*P8
M#[I^9>.>#UKE? _BZ;1?!GA&"^T:Y33+N.*T34?-0@2MPNY =P4GC<>_;I0!
MZG17&ZC\0K*Q+SI%'<645W]DF:.X4S*P?8SB+&60-D$Y!X) (Y,T7C*ZN-<U
M#3K?P_=/'IURD-W.9HP(T:/?O S\W!'RC)_E0!UE%8'A_P 1MX@CM;J"TC^P
M75N9XKB*X$@4Y7]VXP-K_-TR?NGGBKFL:U%I'V.(QF:ZOIQ;VT(.-[X+$D]E
M"J23SP.A.!0!IT@8%BH(R.HSTKFX_%$TTVL:;]A6'6-.B68P--F.6-@=KH^W
MD<$'*@@C'O63\.=,AO?#NB>(;RR1=5:Q -XLI+W D 9C)@#))YYSCM0!W= (
M/0YKE'UK4IOB-+X?:T@;3ETT7#$R_,X>3:21M[;2,9[YSV',> _$;Z'X/\/6
MTNERFPN[^:R%V)5^61[B79\G4KG@GCGL: /4J*X[5_B#9Z6+N9(8[FVLK@6]
MR$N%$^<@,4BQEPI//(/!P#CGJKJ.*ZL9HY%62*2,@J>A!% $X((R#D45Y7X&
M\73:+X*\)07VCW*:9=QQ6JZCYJ$"5CA=R [@I/&X]^W2NJO?&BV]AJ6J6VGO
M=:7IDSPW4R2@/\G^L9$Q\RKSG)!^4X!XR =517*ZSXT&F6E[>V^GO<V%G9)>
MR7+R>4DJ/DA8B00[84G&1U49YIM_XTGAUB+2]-T*YU"XGTXW\&)HXPZAE&,L
M>/O=^^!WS0!UA.!DT=:\Z\>:VVL> O%4=GIPGMK*&6">5Y@I694RVQ<'=L)&
M3D<@XSBNZTO_ )!%E_UP3_T$4 6Z1F"C+$ >I-<E<^.H;?1VU\632: EP8'O
M%D^< /Y9E$>.8PPZYSCG&*S]7,VL?$R'1;W3[>\THZ1))Y,LN5(:5%,F-OW@
M,@>Q.",T =]1D9QGGTK(O;RP\(^&UD99/LEG&D,488N[G(1$!8Y+$D#D]^37
M*QR79^,EO+=:<D$QT"=OW,PD$G[Z+ R0N&'3TY'- 'H ((R""/:EK@-,\86&
ME^$-'O-.\/3Q6NH:D]DEK%(N8I&F=23D\Y8,>..>H'-:<GC*:$"UN=.@M-6$
M)N)+.ZOXT"IO94PX!#%MI(&.,<D<9 .LHKE]-\:0ZY;Z?_9-F\EW>VK7?D7+
M>3Y**VP[S@X.[(& <X)Z5G3^+]7GU3PG%;:.]JFJ-<&>"]8Q2J8XW^0C:<#(
M#!N^!ZT =S17+7OC,6]CJFI6NGO=Z9I<SPW<R2@/E,>843'S!><Y(^Z<9[Q7
M?C:;^VAIFDZ'<:G*]@FH0O'/'&DL3-MR"QX_'!/IW !UU%<]IOB@ZM?F.SM$
MEMH[R:SG=9P9('CWY+QX^524P.<G<IQS3_&FO/X:\(ZAJL**]Q$@2!6Z&1V"
M)GVW,,^U &]29&<9Y]*XW7+[4?"X\.:?IT,=P;^_6WN;B:7:\C;&8D_*>6V'
M)[= /3$BU6?P[XN\>WUKI#7:P+:7,Z1S+&$40%G()ZMU. .>>G< ].HKF;OQ
ME:)]GCL_L\EQ/9K?*EU<K;CRF^[R0?F.#@8Q\IR1QG3\/:W!XCT"TU:VBEBB
MN4)\N9=KH02""/8@T :=%<9=:)XM:RU2*"^TEI9+\7%HTT<F'AW$^7/@\X!
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MR"-A]: .F) QD@9X%+7 IKOVGP]X*N]>T@75Q?W-J89DE&V*9HMPE(X(/W^
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M:;)//9V%O;R3'?,\,(5I#ZG R30!S4?A"XM/$.A/;"W;2=,TJ332'E82L&"
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M;V=C?V]V[37MI,P:[MOFVQR)M )P4R23C;D'M6IX]T2X\0^"M1T^T -V56:
M$XW21N'5?Q*X_&MFPU&#41<& 2C[/.]N_F1,GS*<'&0,CT(X-6Z .3UVRNO$
M]EX>U31S;F2SODO?*NG:,,NQT9"0I*L-_3'4$&JDOAC6I+KQG*18$:Y:QPVY
M\YQM983&2PV' YSP3Z5VJ1I&6*(JEVW-@8W'U/OP*=0!Y^GAGQ1H]UI&IZ.^
MF2W46EQ:;?VES*ZQ2"/)61'"Y!!9NJ]#7;V"7<=E&M]*DMT<F1HUPN2<X7O@
M=!GGCFK-% !7GDOA7Q*WQ.N/%WE:5.B6/V.Q@DNY%,7<LQ$1]7X'][K7H=%
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M\ (M;:[N?,BM@1C"# /0D#). 2!UK?N[6"^LY[2ZB66WGC:.6-NC*1@@_@:
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M+LYH=?B>_OMNN#%W\T?38$^7Y./E '?\^:Q$T:YA^)=JEO/JD-K;:$+1;U8
M59A+G8S&,IG;@]!T^HH QYM:U#6O#?ATZMY;:A9>+(;&>2)=JRM%*R[P.V>/
MQS70KK.K:['XHGTR_P#L3:/=26EM%Y2.LKQQJY,FX$X9FQ\I7@9ZUJ3^"].F
MTW3K&.>Z@BL+P7R-&REI)PQ;>Y93DEF)/3.:=/X0LWU#4+NWO+VS_M) M[%;
ML@2<@;=QRI*MMX)4@_CS0!@6OBS4)Y_"6N3SM!HFMPB*:WV+B"Y9<Q_-C=M8
MAEZ]=OKBIW\1:D!I$233R-KEU.]LR+$'CMD5F0+N 4LRA3\V< GN*L>([*#5
M+5/!,6@W9L9(H?\ 21&%MH8E<<!]V=X"\ #J5[9K6\0^%M/\1Z?;VEP9[9K6
M19;6XM)/+EMW48!0]N.,8Q0!SC:YXETI;;3M34O/?ZF;>SN%,/G>1Y;298#$
M?F?(5'8YSCC!W_#9U]9]2AUKY[=95:RED,8F:,CD2"/Y<A@<$=15>[\"Z;J&
M@_V9>W>H7$GG+<+?R7'^DI*OW75P,*0.  ,=>.36IHNBIHUNZ?;;R^GD(\RY
MO9=\CXZ#(   YX  Y)ZDT <S\8/^26ZQ]8/_ $?'4_Q6@M)OAGKCW>T>3!YL
M+G@I*I&P@]CNP/QK:\3>'+;Q5HLNDWMQ<Q6LI4R"W*@MM8,.2I[@=*@N/"=K
MJ,MNVKWM[JD=NXDC@N601;QT9DC50Q'^UF@#$TC6-=?Q)H.FW=RJK=>'C=31
MM"-RW ,0))ZGEFXXK)TWQ+XCA\#KXIOM5CN TCV8M1:HJ[VN_)20MD?=';@$
M8YSDGN+CP]#<>)8==^UW4=U#;/:HJ%-@1B">"I.<J#U[54M?!6EV_A.?PS,U
MQ>:;/OW)<,NX;V+G!4#^(DCT- &'JVN^)?"UMK&IW:-<:7%9![<WIA$J7&\+
M@B+ ,>&!)ZC!K4U.U\06EOJ,G]O&2R;39"K^7&L\=PN3NCPFW85SP<D$<&I;
M'P/86^F76GW][J6KPW$!MB=1N/,*1'JJX QT'/7@<\"I-&\'6FD6KV\FH:GJ
M,9A-NGVZXW^5$>"JX ]!R<G@<T <SX=U>\MM%\!Z%'?S>;J]AY[W+JA>*..!
M&*)\N"26'+!CC=[$0:YXL\0:5I7C"RCO$:]T-[:2WO'@7,L4V,*R@;=P^89
MP>.*Z:+P)IT.E:79)>ZAYNE.&L;PRJ9H %V[1\NTKM^4@J01UR>:EO\ P5I^
MI:1J.GW-S>$ZE(LEY<JR"64K@*,[<  *   .GN<@&II5KJ-K'<#4=2%\\DQ>
M,B!8A$A ^0 'D YY///MFM"F1(8XE1I&D91@NV,M[G  _(4^@ HHHH ****
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M'5KXB2/S[9QY+2XS!:>4"CQD_=^8.V1_%]* /1R0.IH!!&1R*\CTBRDU;7?
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M<\=Q;2KNCEB8,K#U!'6IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1(8P5C(Z%1C@CVJSU&#7'P:GJ5OXMU3PM'=^9*=/COK&XN &,2LYC<-C&[!
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MQ!_JI9(E9X_]TD9'X5Q?BWQ2';0/[)O;N..;7+:U>6*(B&X4RA73>5Y'!Z$
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MA)9VH$N8I8T4N9^,D+M!^4\YXSSFJ6H^.+[28/$MM<6%O)J6C6@O5 D9(KF
M@G<."5(*D%>>>_/%O4/">H:E;:?=W&K(==L+L7<-PL!$(.W:T0CW9"%>#\V<
M\Y[4S4_!MQJUIK\D]W FHZQ9BQ,BQ$I!" W &<L<NQSD=N..0",^*=>77=-T
MUM,L/^)K9R3VC_:&_=LFPL)/EZ8<$;<\\>]5/^$^U--&M9SI-M)>'7#HUS&M
MP0H<2%=R$KR#COC&>]:Y\-7S:]H&IM>V^-*M9;=HQ"W[W>%!(.[Y<;!QSU-<
MCXDT:Y\.Z;81RZC:M-?>+H;Z-S$56,R2%B""WS >N1QZ4 ;?_">7NDWFLV'B
M/3H(;NQMH[R V<K2)<1N_EJ 2H(._"GCOTJQ)XLUJVN-1CDT8S10:>]Y#=>3
M-!%O7K"Y=.N.01U]!4NI>"8_$!U>?5K@?:-0LTLHS; @6\:,74J3]YMYW9XZ
M 8XR5MM \2S:->6>L:_;7<LEJ]M"\5H8U^88,D@W'<V.PP.O7L 5]*\8:K<Z
MAX96^TZTBM-?M3+$8IF:2-Q$)3N!&,$9Q@\58\/>+Y/$%R?LWV1A&\J75F&*
MW-J5)"AU)YSCK@ 9[]:9;^$+Z"3PBQU"W(\/Q&(_N&_?@Q>5G[WR\<]^:;_P
MA5Q=ZK8:E?WD O[."6'[=:1&.:<.A0;SD_=SGO\ , 1CH0!NG^,;^;7M*TN\
MM;2.?4;::4P1R%GLY(PI\N0C()PW.,8(Z5AP>)]7C^%NIZYJMII^J>7=SJT,
MN0A47+)C!#9 PN!Z#KFM72? ^K6%SX9EFUFT<:''+ %BLBGG1NJJ227/SG:"
M3TY/%)-X!OW\%ZKX975[<6]W<22P2&U.Z)7E,I#?/\QR< C''K0!N3:Y=7?B
M"^T72$MS<6%O'-<27&[;NDW;(P!SR%)+=LC@YXPH?B#=W]OX>DL=*BWZG=S6
M4\4]P5-O-&KEEX4Y&4/S>G:M=_#E];>*)?$&FW=O'<7ELEO?031L8Y"F=DBD
M'((R1CD$'MUJE'X&>T/A\6=]&!IEY+>S-)"2;B64.'/#?*,R,1UQP.U &GX6
MUV\UAM5M=1MX(;W3;PVLGD.6C<;%=6&1D<../:I];UPZ=?:7IMM&DE_J<K1P
M"0D*BHI=W;'4 #H.I(''41:!H-SI&JZY>3744RZG="Y")&5,9"*F,DG/"CTJ
M+Q/X;N-9NM*U+3KU+/5-*F:6WDDC\R-E==KHZ@@X8=P<B@#E=*U=_#OB'QU>
M7L$33_;;&%([<$+*\D:(F!@D9+ GJ1SU[Z\_C/4].76&O=&GE@LK074-W':S
M11R?-M9&#KD,OWCC.5R>,8J*X\ 7FI?\)&VHZO$'U=K>:-[6W*-;30JH1U)<
MYY4<?J,UJ6FD^*?[/E_M#Q!:R7X"K!)#9E(@ RL2Z;_F+;<<$  G'6@" >,=
MFDF_22QU&&XG@MK":SDPD\LK;=K<G9M)YZ\>_%-UOQ)X@\/Z/KU[<Z3:S)IT
M"SV]PLQ2.<$'<NWYF#*1]#GJ*I77PVAO(-8=+B/3;N_EM[B(V,>([>>$DK*%
M/5B3STR ._-7;_PQKVM^%=2TS5M:M7N[V VXD@M62*)3U;9O)9CZD@#' '.0
M"#5==UBT@TR;5=$TN2"[U:U@@_?EVB60C#D%,;U.>AX[$UE0W&MZ?XS\<R^'
M]-LKEXY+662.>8Q[\6X.U-JGYCSR<#ZYXZ?7?#M]K.F:/;B]MXI;"\@NW<PL
MRR&(Y"@;N ?J<5&WAO4[?7=;O]/U&WC36%B$OF0%G@9(]FY"& ;CG! P?7I0
M!3M_'@UFVL?[(@(FN=/2_;S8)9A&&)54(C!.2RN,]MO0YJ73O%][J[:3IZZ6
MVGZM>6LEU<P7JM_HL:.$)*\%MS$;>G&3[&";P+=:7=:7>>$]3CT^:RLET]X[
MJ$S13PJ<KN *G<"2<@\Y-6+SPEJ0UC3-<L-73^UK6%[:Y>Z@+1W,3MO*[58%
M<-RN#QP#F@"O\,UD6P\0K-%%%*->NPZ1'* Y7./:M3Q3JITV^\/1MI]M=1WF
MII;B28_- Y5R'48ZX4C.1C-/\*^'[O0$U075]#=&^OY;T>7 8]A<\CECD<?A
M[TOB70;G7)]&D@NHH!IU^EZ0\9?S"JLNW@C'WCSS0!@:CXVUVVC\4RV^DV!C
M\/N#+YERV98_*$AVX7[V#WX'OV[FVG6ZM(;A 0LJ*X!ZX(S7(W/@R^N;;Q=#
M_:-NH\0C&?(;]P/*$7][YN!GMS74Z=;R6>F6MM,ZO)#$L;.BX#8&,@9.* .)
MDO\ 5=0UOQSI]XUM)86=I&D<04_*&A=P>>"23R?8>E0^#O$&I:?IG@;3+FRM
MA8:GIR10RI*3*KQP!\L,8P0#P#QQ6Y/X5OO[<U^^M=1@2#6+=(WBDMRS(Z1F
M,$,&'RX.<8SD=15>U\&WUO'X03^T;=AX>0H3Y#?OQY1B_O?+P<]^: *L7C$:
M?I'B+4)M,MK3[#K'V.9X<NN#Y0,\A"@G ?)XZ*!GO74:%J,NIV<EP\MG/"9,
M6]Q9ONCFCVJ=PY.#DL,9/2L>P\,:MIJZNUOJ=KYNH:G]O^:W8J%(56B8;N05
M7&>.N<5=\,>&8O#AU)X1#$M_<_:#;6Z[883M52%'OMR3QR>E &!\4EB,?A)I
M8?-4>([7*[-Q(P^1COGTK/A=_"GB+Q5XN.GS6'AT6<86U*B,W5R"!O6/^'.0
MN2!DG-=5XL\.7?B*31S;WD-LNFZC%?\ [R$N9&CSA>&& =W7FM#Q!H=OXE\.
MWFC7Q(BNXMC-'U4]0P^A /X4 9DGB&^TWQ#I6EZQ;6WEZLKK!+;L2(I57<8V
M!Z@C.&&,D=!7(6>I#0?A[XJO5TVUOH8->NPUM<'"%3< =,$'!(...G6NQM_#
MM_<WVD7>MWMO<RZ2KF PQ%/-D9=GF/DG'RD_*.YSGH*R9_ =_/X/UO0CJEL&
MU._DO//%NV(]\@D*[=W/(QG(H V;W7;^?4]4TW1+>":YTVW267SV($DCABD2
MXQ@D+RQX&1P><0+XEU*'Q+HNGZCIT5G;ZI:M(C-)N>.X50S0''RYP20V>=IX
MJ&]\+ZS'XGDU[0]7MK.>]@C@OX;BU,T<A3.V10&4A@"1R<53\7)INJVUKX23
M4YFU^.6WN('0GSXL-\T^<8'R[\]N<=Q0!U.AW]QJ=B]W,D:Q/-(+<IGYX@Q"
MN<_W@,CV(K*\0>*ETC7+32C-:6LMU TL$UZ2L4S@@"(,. W.<G/; -=';V\5
MI;16T"".&)!'&@Z*H& /RK"\1:!<ZZMQ;2&QGTZXM_*>VNX"X1\MB12#U /3
MV'(H YR9M3_X6F);"SM%U&7PXC2"=RJ(WGG.2H)//']:T]/\87FJ^'-#U2&T
M@M([]7-S<7$@,5H5R,=06W,,#I_2I-+\(W>DZ]::A#J*316NCQZ6B31DNVP[
MA(S;NI/48_&L[3? >JZ5:^'$M]9M6ET<W"GS;1FCE64YW;=X(=>0#GH3ZT 9
M^L:X/%'@KPSJ\MLD,Q\06L94'<%9+GRR5) .#MS^-;>G(B?%_7"JA=VD6C-@
M8R?,EYJK%X!U&'PW9Z0-8@<6FK#44D:U.2!,90A ;J2W)&!CMWK>M=!NH/&M
M[K[W4+17-I%:^0(B&78S,&W9YR7/&/2@#+^*Z(_PPUS<@;;"&&1G!WKS2R>+
M]2TCQ(FG^(=/M;>TNK::YM+BUG:3'E+N=) 5'S;><CCM6WXHT)?$WAF_T9K@
MVXNX]GFA=VPY!!QD9Z52D\-2ZO?PWFORV\[06LMM%#;(R(/- 61R22<E1@#L
M">N> "GIWBS4[S4])!T>9]/U)"S21VTRFS.W<N]F4*P/3(Q@^HYKH-<OYM*T
M&_U&"!)Y+6W>81NY0-M4G&0#CIZ5A>&?#>OZ(EO87OB!+S2;(;;9!;;)V4#"
MK(^[!"C'0 G R<9!U/%[I'X+UQG957^SY^6.!_JVH YVT\:ZREWX<EU32;6'
M2]>5(X98)R\D4S1[U#@@##8.,$X[U.GC*]BUS2;*]M+>$ZC=RVQM1)NGMMH=
MD=R"0=P3..,;AR<&HO#&C3ZSX=\(7-_=6\EIIUO#<P) IS)+Y.U2Q)XVAFX'
M4X/&,5!9> -7M8-%A;7;9UTG4'NXG-F=\P<.&\P[^7^?J,#U!H L1^,(].B\
M475QI=O#-8ZA':JEN_-W(ZQA"S;1R2ZC.#@#OBH8TOE^,E@;Y+3>VASD26X(
MS^]BRI!ZX['OGH*FO/A_+J5IXDM[K4E3^UKN.\ADAA(:VEC"!#RQW?<4]N]7
M++PYKC>*K#7M3U2QDEMK*2T>*WM&42!F5L@ES@Y0?RQWH V/$>N0>&] NM5N
M$:1(  L:G!=V8*JY[99@,^]9DGB'4--\2Z?HVI6UJS:G#*UG- [*HEC7<T;Y
M!.,<AAUP?E%:/B;0+?Q1X=O-'NG>..Y4 2)]Y&!#*P^C '\*HQ:!J%UJ>FZE
MJ]W:SW6F12+;>3$45I'4*TC9)[ C:.FX\GC !7\&^(M;\36=MJ=SIUE:Z=-'
M*,I<,\HD24H!C:!M(!YSG(Z<U5^)0(LO#TL<*RSIKUD8P3C)\SIGMFMCP?H-
MQX9\.0:3<74=T87D998XS'D.[/R"3T+$=:?XHT&37[&TC@N4M[BSO8;V%GCW
MJ7C;<%8 @X/L: ,$^.KW1[S5['Q'IT$5U96BWMN;*5I$N(V?8%&Y00V_"].^
M:T]*U_5+CQ&=-N],E^RO;>='>QVTT<:.#@Q-YBCG'((Z\\"H=0\%1Z\NJRZS
M< W5_9K9*ULI46\:L7&W/);>=V3Z*,<<W/#VE^(;0J=>UR'4/)39%Y%MY.__
M &Y/F.YO88 R>O& !WC/7KGPSX3OM9M;6*YDM4#F.20H",@9R <]>G'UK.D\
M1>($\5G0?[.T_P VXLFN[64W#[4"N%82?+R?F!^7Z>]:?B_0IO$WA:^T:&Y2
MV:[0(9GC+[1D'H",]/6H9- OI/&-IKYN[8""P>S, B;YB[*Q;=NXY0<8H S]
M.\7W^I>'=/OA96]M)+=36M[-)+F"T\IG4OR06#,@ ''WN3QS'8>/&O='M'%K
M%_:5WJ<NF11ASY;/&S;I,XR%VH6QUZ#WJO:> ]5L8=+,&LVIFL-1N;T"2T9H
MI/.+$@KO!W+O.TYIG_"N[Y+(^5K<8U"WU>35;&<VO",Y8LDB[OF!#$'&.U %
M2SU5_#OC'QUJ.HPPLT-M8$"V! F+>8J\<D$L0.]=/I.OZI<^(GTV\TR7[*UM
MY\=\EM-%&K9P8F\Q1\W<$=1G@5ES^ [S59_$$FKZG RZS:P0.MK;LAA>+)1U
M8N>A.<'KCMTK0L=,\4VFF7)U/Q#;W-U%;/':RPV150V.))%W'>W X&!UZYX
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M?6-2M+=-)MKJ.&&0(89&\S(! SQM'N<<G'%;_AW7+N?X96&NW(-Q=_V6MS(
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MEE>1<[#E<CG!Z8S48&IIXC\*0#7M2,6LZ?,;M3(",I'&P*<?(?F()'..^>:
M.QUS7[?0!8-<03R+>7D5FC1 $(\C!5+9(XY[9K6KR"\N+Z[\-I97%_/,]CXS
MBLH+F4AY0BS+M))'S$;NI]*N:QK&L>"=3\06L6IW6HVBZ0NH0O>D2-:RF7RS
MR!RN"6P1_": /4Z*X6>SUVSDN[V/6%AT^;39-L0O&N7,P&Y98RZ +QG(''<
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M707@G^T7-O)<1RX'E[4*@C.<Y^8=JX.>+6]2A\;2)XGU*VDTB[=K+RV157;
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M632SEEA07"%I"IPP49YP00<=,56LO$^DZAKU[HUM>PR7=F%$J"09W')*@=R
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MFLS)ID2JL43RNQCV_=VN3N!&."#Q1IOA72M*U-M2MTN6O7A6!YY[J65G0$D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLA$P^Z8R1*1Z;I=P^B+5;5KPZ7\4].O-3D6+29=+DM[>>4XCCN3(&8$GA2R
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MU'4-7EOD#N;.W:%(UM5;&1E1ES@8#'L3ZUK3K(\#K$ZI(5(5F7< ?<9&?SH
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M \MTNPTR_P!)^&\FAI;'5K9[>6YDMP-Z0" ^=YA'(!.!SU)%58M8L9Y/"T\
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MU\,:2VI7D-Q+ LB1MY"!BI=@H)!(XR151?%L1Q$^EW\-X[R".UG$<;NB;<R
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M2&T-I907,LLT1D)>;<44#(X 7)/?(QB@#JJJ0ZE9W&I76GQ7"O=VJH\T0SE
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MY48/A5)V@@YQN]JT-2\2WUBKR(L4J76IKIU@%B.<@'S&;+#=@I( /ESM'/-
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M4 7=0U_1])GBAU'4[2TEE_U:3S*A?Z ]:DL-8TS5&D73]1M+IH_OB"97*?4
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M76M6MB;RR@G6W#B4)YA,@C9EX/RACC/?!QQ@D GB\%Z-%J6O7:VX":Y"L5[
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M)J+6LFER/+ JPA@S,NT[LGD8],4Z/PM%-KMOK.J7D^H7EJ&%JL@5(K<G@LB
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M;:=&)^>-"&PP..G517<^&;*UT_0+>WLM.?3K;+O':N260,Q/S9)P3G)';.*
M.2U_QT]]X'U?5="GGLYK&[6 /);XW 3+&V0ZX&<MQU'&<=*['3_$6D:K=W5K
M97T4T]J TJ#(PISAAGJIP>1D5YG?VM\/AUXJT<Z5J+W;:S+*B+9R,)$:Z$BE
M2!\P*Y.1G&.<<9V/$.GWNK^,=7BL(+J/[9X6DLX;AH'2,3,[%5+D8!P?PH Z
M^/Q1HTMPT"7H\T0FX53&X\R,=73(^=?=<U)%XCTF?2(=5ANQ)8SNL<4R(Q#L
MS;5 XR<MP/>N3\*2V>KWNE33^'-8MM6TZ-EEDU S!+4E-K"-G8J^XX V]N3C
M I= T>\L/%UYH.Q3H5A-_:EH0?NF;<!#CT5Q*X_X!0!V]]?6NFVCW5Y.L,"8
M!=O4G  ]220 !R2:SG\5Z'#87E]-J,<,%D^RY,RM&T38! 96 8$@@CCGM5/Q
MS/<6_AY9+?33?8NX/,"V_GM"GF F58P"69,9 ]1GG%<#JEM>RZ?\1H8M-UF8
MZC;V[6CRVDA:<^2%X 7KG^' QW Z4 >EP>*M$NDG:WU!)O(F$#K$K,QD*[@J
MJ!ECCGY<\ ^E7-,U6QUBT^U:?<+/$':-B,@JRG!5@>5([@\UQGBO[1;OX8UN
M#3M1N=-M!)'=V]DLD<\:R(H5PBX;Y2N".N&KH/"EO8I9W5UI^F7-A#>7!G/V
MK>)9F( ,C*Y+*3C'/)QGO0 ]O&'AY=2&G?VM;F[-PMMY2DD^:1D+P.M6(?$>
MDSZC%81WB_:)@QA!5@LVW[VQB-KX[[2<5S6BVEQ-XI\=A+>YMFO7A^S7,MNZ
M*^+=4RK$8.&STK'\*P17UCI&DWWA[6+?7-*18S+=&;[/;NB;/-C<ML((Z!?7
M'3)H [U?$>D/J$5B+U//F=HXLJP21U^\JOC:S#!R <C!]*&\1Z2FH16+WBK-
M-*88R58(\@ZH'QM+#!^7.>#Q7'>"+J0:/H_AW4_#=V-6T@B-I9[4^1'LR/.2
M4C!++G&WDEO3)K/\,VJ?9[/PYKGA_6)]6T^[WK-(TQM&*N66X5]VP<'..N<C
M% '8P^(M+LEUJ_NO$"W-G;7(23]V-ED=J_(64<C/.3_>Q6N^JV4;VR/,5-RA
MDBW(PRH&23QQ@'OBN3\/Z:NH:GXXL[^RN%L]0O,#SH'198S B,5+  \AAQ4_
M@6TU:"PSKL;B?3$;38'(),T:-S,._P X$?\ WQ[T 7=-\2Z19Z':75YXDAO(
MKJZDA@NY L?FMYC (  !\OW<^V36CI_B/1]4@O)K2_B>.S)%R6RGE<9RV[&!
MCG/3%>:6MI=KX&\.VTFEZAYL/B;[1+$;*7<D7VJ1]Y&WA=K Y]ZTM6M1/J/Q
M'^UV5_\ 8[K3( CQP,GFE(I P1F&TD96@#MH/$^BW%]%9)?HMU,@DBAE5HVD
M0]&4,!N'N.*OWM];:?");J41JS!%X)+L>BJ!RQ/H.:\_\.:G:7OBK3+K4Y+^
M'4H; V$"3:5/:QR,<,Q+.,9.P87/KUSQL>,8+V'7O"^M0P37-CIUW+]KBA0N
MRK)$8Q(%')VDG. 3@F@"]JOC32=-\,ZCK:2O<16 998DC;S%D ^XRD90]/O
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M=-N8+2'P[!:J4@DDC1DD<F-7Q\Q"D?6@#JSKVF&TM;F.Z$T5W'YL!@1I3(F
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHK'\0^((/#UM:2S^4/M5RMLCS2^7&K,&(+O@[1\I'3J0.] &Q17.7/BDV,%
MHE[;06U]=S2QQ12W6(BJ9)D\S;]TC!'RY^8#'7&2_P 0WCT5M2;2,);ZBMA>
M,;C]W$&95697V?/%\PYP#[4 =S16%J?B6/27U&2YA'V*QAC=YEDY:1SA8P"
M ?N\EOXU]>,EO'C17&I6\FFI,]I8-?QR65T)HI57[R%RJ[7'7'.1S0!V=%<E
M9>+=6O-/M;W_ (1F9(;W[/\ 97^T!U(D4LS2;5)C50.I!SN'3D"K)\1%C\-W
M^K+IAG:QU(:=/'!<JR%BZ*'5\#<#YB]@>M ';T5RB^-5M+_6+76[ Z=_9UDN
MH;Q,)1) 2PSP!A@4(V\^Q-6D\17D%THU/1Y+2R:S>[^UI+YB1!<$I+\HVM@Y
MX+ X//% '0T5R-AXX2\UG3+,V:&#4HV:&:WN!,T1"[@LRA<(2.F"PR,>];FM
M:Q%HUM [1F6:YN$MK>(''F2.>!GL, DGL >O2@#2HKF)_%LVFPZB=6TF:VDM
MIH8(/+??'>/+@((W(7)W'#9''O4B>)IX=?;0[_3A%?26K75IY,_F1W"J<,H9
ME7# D<$=#G- '1T5P=I\1;FYTW0-3/AZ46&LR"")ENE,BRL&*C:0!M.TC<2,
M>G<R7GQ FTW2?$=Q>Z(RWFA&,S6\5T'5T=0RL'*CMU&,C'>@#H+SP]%>^)-/
MUQ[RY2>PCDCBB39Y9$F-V<J3SM'?M6Q7))XUDMO$J:3K6D2:;%<V\MQ9W+SK
M()5C&7# #Y&"\XR>.]1VGCQ+K4=,@2Q22WU-&:"2WN1(\9V[E$R8 3<.,[B
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M]TBB.,QB3S ,?-@$94<_RH ZZBN/LO'D5WJ>E0"S1K74U)AF@N/->$[=RB9
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M;>6 J\I<,4V=FR%8]>-ISC% %9M$U.7QKI>MN+1;>UL);65!,Q8L[(V1\@!
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M-N0(7X^5SY>%ZCKCK6EI6NV.M2W\=FTI:QN#;3B2)D(<*&( 8 XPPYH Q8=
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M(TD C90NYE*G((.<J2/QH Y:P\37B^+8]+UFYO-/NS=3F*"2!#;7T #^6(9
MN=P&PD%@<@\= &Z+JOB?7K+0M?L9E%I=RJ]W;S/%Y(@8D$)A=^]>,9/)!SV
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M:/XGTY;_ %.2]LK[2)[R2$PH@B>(1GY-HS@ASPQ/UK9N/!>GW2ZZLMU>%=;
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MDBJ+?8A#!8_FR6R A&!P6]L@&WX?-\^C0SZC-))<3YFVR*JF)6.5C.T 952
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M""WFT+2S.JY76;(*V<%<S*#@]1QGI0!VJNCYV,K;3@X.<'TH66-RP1U8J<,
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M47OXXH38+:ES/&)?M+E0(B?FVX!^;'0'C-<KX!AM[+5_&%A9I'#:0:M^Z@B
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M *AN+2VNU5;FWBF"G($B!L?G4U5-2U.UTJU%Q=.55G6-%52S2.QPJJ!R230
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MMQ<FX@?2E#7MNT#&6)2,AMJYRI'.X9'!YX- &O)I]E+O\RSMWWL&;=$IW$#
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M0&!/Y8WX]-W6N)U+Q#)>^-O!@LI-1@L[V6X;#*4BN8Q [ XZ]<$!L'H<5WU
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M-\*]%OCJMZ;LZTL,DWG'?(AO2FUCU(V\8]*]8H *B>V@DE662&-Y%4JKLH)
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M\GRQLQZ;>F*PI/&VF0+JWVB&\ADTF%)[V-X?FC1@Q##!(884GY2:O_\ "0V
MU6RTXF43WMNUS;_NR5=% +<^HW+Q[T 75L+-+06BVD"VPZ0B,!/7[N,4V73;
M">U6UELK:2W4Y6)XE* ^H&,5QTGC"RTCPS)J.FG4]2675C:9N@Q:*1I@K+AL
M$*I)"KUZ#WKH[7Q)9W>O/HHBNHKY+<7126+:/+)P"#T//''0T :X 50J@  8
M ':EJGINI0ZK:?:8$E6/S'C'F+M)*L5)'J,@\]^W%7* "BBB@ HHHH ****
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MH6D]S&"@,21@AB?FP?P)S7<T4 <-_9^I+XD\:W7]FW!@U"R@BM7!3]ZR)(K
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M@#BM1U+Q1J_A;49]/\.R6%\(%6*"\:)I)&W#=MP2N N[&[J2. !SD1:3J/\
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M^PUW7$T'QSJ-[]BOUTZ[ND6W=&12L<2';U;Y=H/&.23SS5BT^'VI6UOI%O\
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MM/TB6Y6Y-E L"RK%Y>Y5&!D9/.!ZU6UOPX^H:SIFM6-TMKJ6G[T5GCWQRQ.
M&1@"#V!!!X([T <OX@\2ZAJ'@;QK9,L-KJFD0RPW)3<5>-HBRNG.5+*>AS@@
M]>M=?H%@L=A:7=Q!:&^-K'%Y\,6UC&!D+DDG ],XK*O?!;WFA^(;7[?&E_KV
M1=77V<E578(PJIN' 4#&2><GOBNDT^WEM-/M[>>5)9(HU0NB% V!C."3C\Z
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M<%RNX[GZ>@'8<FG77A*?4?!4.A7NI W4(B,-[!#Y9B>(J495)."-H[]ST'%
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M%% !1144=S!+/+!'/&\L.!+&K@LF1D;AVR.>: ):*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  0""
M",@]144-M!;[O(@CBW==B!<_E4M% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ@)(P1SC'(]:Y?5O%<?_  D'A"]L-8#:)J)N?."*I24)"Q7MNSNXV@]1C&:
M.YHJAI&LZ?KMD;S3;CSH1(T;$HR,KJ<%65@"I'H16!X[O_$&E6^GWGA]O/N#
M<A'L'1=MP@1W90V-P8A,#!Z]J .NHKDG\2QZ_P"&--UG0]0E@CGO+>&0!$++
MOE5'1@P.&&3^/J*V+_Q%I6E-*EY=L#;H'G98G<0J>C2%5(0<$Y;''/2@#5HK
M'O?%6AZ?=Q6MQJ$8N)83/%&BLYD08Y7:#GJ, <G/%7-*U6QUO38M0TZX6XM9
M<[) ".A(((."""""#SQ0!<HKC?%.IZE:>-/"^FVNIRVMIJ;W*7 2.(D>7%O4
MJ64XYZ]:TX;Q=*;4KR^\0&ZTZUC7S3.D8:W<#<>8T7(*LIQR1^- &_17/)XX
M\-R3Q0KJ:[YH?/AS$X$J<?<)7#-R/E&6[8IZ^-/#K:6NI'4XTM6N/LNZ1&0K
M+G&QE(#*<D=0.M &]16!:>*-)\00ZC;:/J@-W:H?,VH5>/(^5@KKR/0X(-4O
M"/B+S? .@:CK%VTEW>VZ$D1EGFD().U$&2< G ' !/04 =916'+XPT&#27U.
M2_VVD<WV>5S$^8I,XV.NW<AR0,,!U'J*T)-4LX;V"TDD9)YHFF16C8#8N-Q)
MQ@8W+G..H]: +E%95IXDTF^U!;&&Z/VEXO.C22)X_-C_ +R%@ XY'*YZBDMO
M$ND7>H0V$5W_ *1.C20!XG19U'4QL0%<#@_*3QSTH UJ*J:H95TJ[>"9H95B
M9DD4*2I R.&!'Z5QGAN;Q3K?@#3]<MM=WZK<6XF$%S;1?9W;^[\BJP!Z9W'%
M '?45Q&E>-++Q)X>\/ZD^HR:1/=WJQ-;*H<RRJ65H#D'Y2><\' '(K:;QGX>
M75/[,_M)#>"X6U,2HQQ(PRJD@8&?7I0!NT5DQ>)M(FU&"P2[_?W&[[/NB=4G
MV_>\MR-KXZ_*32?\)/HXOH;,WF)9Y6AB8QOY<DBYW(LF-I88/ .<@CM0!KT5
MSFC>,].U:VU2Z836EM87$D+R7,+QC"8!)+  '=GY>O3(J]!XCTJ>6YB%T8YK
M:,32Q3Q/$ZQGHVUP"5XQD#&>* -6BL;1_%FAZ_<>1I=^MS)Y N/E1@#&3@')
M '7MUJ]>ZE:Z>8EN'??*2(XXXVD=L#)PJ@G '?% %NBN(UGQ/Y'B;PG<6VIN
MFCWWVKSXS& )-D1*]5WYW<8'4XXK>@\5Z)<Z2-3BO@UJ9OLX/EN'\W=M\O81
MNWYXVXS0!LT5QOBWQ()/A_K^IZ#J,D-UI\<@+"+#Q2* 2K)(N1P1U'<$5)=:
MEJ$/CSPU9K>2?8[VQN9)H"JX+H(]K9QG^,]\4 ==169XCEN+?PSJEQ:W#6]Q
M#:R21RJJDJRJ2.&!!Z>E8?A+QKI.IV&BZ=/JB2ZS<6$4KJRD>:_E@OM;&UB#
MG(!R.>* .OHK)D\3:1%?0V<EWMDFF-O$YB<1O*,YC$F-A;((VYSD$=16M0 4
M5D0^)=(NK^&PBO"+BY1FM]T3JLP7J8W8;7P.?E)XYZ5RNFZ]*W@S6)]9\136
M30:O<6B7XB0NJI-M4!0N"2!C[O>@#T&BLZ_UW3M,E,5U.1*L)G9(XGD98QP7
M(4$A?<^]9EUXATF^_L:6T\0>3'<WBB'R5#"[^4_N^0< YSD8Z=: .DHKS_3?
M'%GH^K>)+?Q'K1\NVU,0V[21?ZN,Q1D;MBX5=S'YFQ]:U;C4[Q?B5I5C%>L^
MG76F3SF !2I=7C"L& ST8]\4 =7162OB;2&U&"Q%WB:X9D@+1.(Y67[RI(1M
M8C!X!)X/I5Z^O(M.L)[R<2&*!#(XCC+M@>B@$F@"Q17/Z1XML-3\-Z?K$HEM
MUO%39$\+[V=EW;4&,OQGE01P?0UIZ;JUCJ\4LEC.)/)D,4JE2CQN.JLK %3[
M$#K0!=HK.U77M+T/[/\ VG>1VWVF3RHMX/S-UQP/:JB^+]#DTR/4(KN26VD1
MI 8K:5V"*Q5F9 I90"",D#I0!N45F2>(=*CM;:X6[$T=S$9H/LT;3-)& "7"
MH"2HR.<8Y'K35\1Z3)I]K?07?VBWND+P&VC:9I%'4A4!8X[\<=#0!JT5S=UX
M@TF_CT.XM/$'D17EV!!Y*AOM9 8&(Y!*\]>A!7M6C:^(=,O)=0B@G=Y-/.+I
M?)<&,XSC!'/'/&>* -.BLFX\2Z5:V<=U)/*8GA^T#9;R.PB_OLJJ65?<@"M"
MUNK>^M(;JUF2:WF0/'(ARKJ1D$&@":BLB^\4:-IMQ+!=WGEM T:S,(W9(2_W
M [@%4SD?>(ZCUJ*_\8:#IEW<VEUJ 6YMHQ++"D3R.JG/.%!)Z'ITQS0!N45!
M9WEOJ%E!>6DR36TZ"2*1#D,I&014] !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%,\V,2B(NOF%2P3/) X)QZ<C\Z 'T444 %%%% !13$ECD=T21&:,[7"G)
M4XS@^G!%/H **** "N"\*0W6G6_CBS%LMQ>KJUU=16[])EE17C!]CG;^!KO:
MK-8P&_6^ *7 3RV=3C>G)"MZ@$DCTR<=3D \UT)+^7Q/X/OWTG5HUCT^XM[D
M26AABMI"(L(J<!$7:0#CD <L170:);R3?%+Q1J"@_9X[:TLRW9I K.P_ .O_
M 'U76PW$%Y"SVMS'(N2N^)PV#^HS45E#9V:O9VQ0.I\R1=V7)8D[F[Y)SR:
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M4#:'0O$5CHFAW<,=Q8322%;"2$23-&(T5$*@L2!R0.,#UKMZ* /.8+:Y%_\
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M9+,_\(^NV4[V_?#R3%\OR\<'//T]ZHWW@77I](UO1[:^TY+*^U/^T89)$<R
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M+V:X\WD7+0.8HRW]['WN>^#VKO)/#UUI^OW>K:&;9&O;2.VGBG)"JT>1'(,
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M1],:Y5;Q(/M#1,"/W60"^3P1DXS5>Q\1:5JEP+6SO0TTD/GQ HR^9'G'F(6
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M^&[.&WEGUFU"7$!N(2K[M\8&2PQGBIT\3:/)Y)CO-Z3&)4D2-V3=(%,:E@,
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M2'P,]?:J^NVFI>(+CQU_9%A? ZAIMD+9YK62%9_++F1,N!@E3MP<9SZ5W_\
MPB&F_P#/SK/_ (.;O_X[1_PB&F_\_.L_^#F[_P#CM '-/JO]M^.?"&HVVE:K
M%!#;WB7'G6$L?D,RQ@*V5'<$9''O6-+8W[^ M<"Z9J'F+XF-Z(3:2"1X?M:O
MN52,L-H)XS7??\(AIO\ S\ZS_P"#F[_^.T?\(AIO_/SK/_@YN_\ X[0!AWJ7
M-_\ $BTN;>VOH(I=!N(%N6M9 L<CR(R!FQA3A2<'D8P<'BL*'3K[4OAOHOA5
MK"ZMM;L;JVC<M P2'R906F$F-I!1200>2V.M=S_PB&F_\_.L_P#@YN__ ([1
M_P (AIO_ #\ZS_X.;O\ ^.T <7J%K<R6?Q/5--OV>_3;:XLI?WY^S*@V?+\W
MS@CCZT:J][<I=6/]CZC'YWAU(X)K>Q?S+J3:X,4DA7,84D$*2N=QY.0#VG_"
M(:;_ ,_.L_\ @YN__CM'_"(:;_S\ZS_X.;O_ ..T <E8+=/J/PVD;3M01;2Q
MFCN"]I(!"Q@5!O./ERP(YQ79>)[ZXL]'=+2*Z:ZN66WC>WMWE,.\A3(=H. H
M);GTQ47_  B&F_\ /SK/_@YN_P#X[1_PB&F_\_.L_P#@YN__ ([0!R?B[0+O
M0;30-;TF75-1N=$N(TALX[9'9K=@$D0".,'[N#DG'R^M:@D:;XJVVI"ROOLG
M]A/'Y[64H4.9E;:25X;:#QUK8_X1#3?^?G6?_!S=_P#QVC_A$--_Y^=9_P#!
MS=__ !V@#S[2;2\C\-^!X)=*U%9+/79IYT:QES%&6GVLPV\#YTY]_:I]=TS4
M+_3OB5#;:=>L]U+!+; VSJ)PD48;82 &.48<=:[K_A$--_Y^=9_\'-W_ /':
M/^$0TW_GYUG_ ,'-W_\ ': .6N;^?4/'$FK66BW]Q;-X<GAB6YLWB2:7S PC
M;< 5S@CY@,]LU3T%KJ3Q9X4OVT[55B72Y[>;?8/#%;2?NCY:I@;%7:0">N
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MK6_M/$]U?^'S?)<R7\"W>EW%JSVMXO[L>=&Y&$*J!E@<9CY'KU7_  B&F_\
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MG0AA&3G&W'-;\4ES/\3M/U.?3;R&)M D1V-L[+%(TL;B,L%QNV@\9[8KN:*
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M/)GDMG5)-D9#;7(P<'T-=E10!ROC2QAOUTU&FU*RN(YFDMM1L(V<VT@4CYP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J$VAZ1<7RWT^EV4MXN"
MMP]NC2#'3YB,U?HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HILCI%&TDC!44%F8G  '>N6_
MM]K[P;/KKZO!HMM=)NLKBX12(8\_([!B-S,.=ON!U!) .KHK$U'6'T?4],%T
MZO8ZC*+57Q@Q3E24^JMM(]0Q'8\;= !1110 4444 %%8'C&\U;3O#=S?:+)
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MO#WADZEIDL*S+<0Q%9HMZD22*A[@Y&[/6JWB;7->\&Z>NLW3VFIZ3"ZB]2.
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M ]*YS1+2WUOP#\/[338@=0M+JUN79(RI@1,F5V.. PX&?O%AC->MW<+7-G-
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M#@\XYV$],&O8** (H!#Y0>!4"/\ -E!@'CK_ "J6BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
MO7-<@T.&T:;9ON[E;6'S)-B;V!(W-V&%/8\X'>M2L;Q+ITFJZ?%:?V=9ZA:O
M,/M=M=' >+:WW3@_,&V$=.AY% %>Y\4I8V]N+ZV6TO;F>2&*&>=44[,Y<N>
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MWEVTB!^"%:VD;!&<9_PHM_"WB.%-#MI4TZYL[31TL9(99VV0W"@#SU&SY\@
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MB:1")-W5=H.1CU(YJIIT?C.YTZ:WUN'2DDC@:,-:S,WVIR,!CE?W:]\#)SZ
M8.AX.TR\T3PAI6E7XA%S9VZ0.87+*VT8R"0#S]* ([SQ.R7&IQ:=I\E^=+53
M=[) I!*[]B _>?;@X.!R!G/3GO$OB)M6C\(2:5"+O2]6O49@SA1.OE2,(V!'
M3*@G/=<5I6^B:QH?B+7;O38[:ZL]799PLTQC-O.$V'/RG<A 4\<C&,&J(\%W
MVF:?X-T[3/L\\&A3B:>2:4HTG[MU;: IZER>3[4 :6JZ!<Z;X$U+3O"D9M;N
M16D@A$Q 5F;<R(Q/R9&X#& ,\8K)^'MWH^J//-8>;INI6SW$=[ICDH\9>7<I
M=#P2H& V#U(SVKM=3_M Z>QTSR?M@9&59V(1@&!920#C*[AG!QFN3TWP[J$_
MB2#7I[*"RGLUO45?,R]P992RAR!PB]1U.6S@=P"C]GTG2/BKI%K9WU[:W<UO
M.;I;EIBE^<#: 7^5F!RV5Z8Q["KXT)C\2F\\4:/J)\.1F.&#4++471;?/5I8
MD(."QQNYP ./7J&TS5-?N='N-:L;2R.FW/VK$%P9B\@1E !*KA?FR>_ &.].
MU*RUS7;;4]%O[*PATVZW0BZCN&9V@;@_NRG#XR,[L \\XP0#7UB_&DZ!?Z@J
M!A:6LDX7L=BEL?I7G:W5QH_A/P7XD$SOJ.H7=J+^4G)N$N1\RMZA2P*C^':
M,"NRO);VY\0MH,MG:R:)<V#B1UD/G(WW2&7& I!P.<YSZ'&1:^$-0ETWP[HN
MH/ ;#0[B.83JY+7(A!$(VX^7JI;D\K@9SD &$UY<:MX,\7^*3,Z:C97=T;"4
M'FWCM_N*OH&VG</XMQSD5I:'?+XX\5:JE^C?8K+3K(PP!B LEQ&96D'^T!M
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M/7#'.\6VW)8* =XR!M.1TY[4 =!IOB#3]5O;FRMI)1<VRH\D4T#Q,%?.U@&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ P,YQ1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %97B/0H/$NA7.D75Q<0V]RN
MV1H"H8KG.,L#C\JU:* ,*]\+PW=_8:DM]=0ZG9(T27<>S=)&W5'!7:R\ ]!@
MC(Q5:Z\$V%SI\-J+N\B,>H+J3S1E-\UP&W!WRI'4#@ #  Z"NFHH 3'RX))X
MQGUK L?"=M:W&G3W-[=7[Z= \%JUSLRJL &R54;CA0.?Y\UT%% '&VGPZLK2
M'2H%U?57@TFY\^RC:2/$0PPV<)\PPQY;)]QSFQ;>!+&SUBZO+74-1AL[J<W,
M^FI,!;/*3DMC&X GDJ&P>XQQ7544 <Q/X'L[BVU^W?4+_P O73F[P8^/D"?)
M\G'R@#G-;8TY/['_ +-::5XS 8#(2 Y&W;G@ 9Q[5<HH YT^#[&YE:75)Y]2
M<V3V&ZY" F%\%P=BKDG:.?;C&3F'1_!,6CVS6XUO5[N)(C%;+=3*XME(Q\GR
M\G' +9P.!U.>HHH S- T2'P[H=KI%M//-;VJ".)IRI8*.@)4 '\JCT3P[8^'
M=(?3=,WP0M))(&&"REV)XR,8 P!D=%%:]% '''X<Z8/#VE:5#?ZC"^DR&2QO
MHY$$\).<C(7!!S@@CD5:U#P/8:GHT-C<WNH&ZAN!=1ZDLP%RLP&-X8# XXQC
M&.U=/10!@Q>&#'I@M?[:U5K@SQS2WIF7SI=I!V$A<!"!C: !R>Y).]110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M37L<F5V,JLJ%>N0<L.V/>J%EXULK_1]/O8+6X\_4+F2UMK1MHD9XV</DYP%
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M25LLF^C+B02,YR >GS8Z]10!4M_'NL3>$O#.I_V43+J]]#"S"1,!78MA1GN
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MKBPBBG+39%Q\JMYK $@N3GYC\W)S75UFZ!;W%IX?T^TNXA'/;V\<+J&##*J
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M[6&^^<=/?-947BSQ,GA6VUV>[LF%KJ@T^Y@2V(^TK]I\DONW?(>00 ,9'?.
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M:[*9;D@1Y0E0I"?+P,*!SFFWG@*"\N-2D.KZA$FIV*V=[''Y8$P5656Y4E2
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M59HH YS4_"$.I:[-JBZE>VK7-E]BN8H2FV:,%B/O*2I&YN5(ZU!I_@B'3I]
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MRQ:OI>IW?B#4;RYTZ&6&(R)$ ROMSNPG)^4<]34?_"!6O_"/3Z1_:5[B2_\
M[12XPF^*;S?-R/EP1N[$&MO3+V_EMKI]7L(]/>"5E!6X$D<D8 (D#8! Y/!
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M-)$DX3]UN))5=JCC))Q5[6-+.KVT4'VN6W6.>*?,2J2S1NKJ#N!XW*,UH44
M8_B#PWI_B73X;748]Y@F2>&48#1R*<AA_(^Q-17/AE&\0R:Y87TUC>3P""Y\
MM59)E7[I*L#\RY.#Z'!!K=JIJ,U[!;*]A:)=3&5%:-YO+ 0L S9P>@R<=\4
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M;^T :*0H0&G13T//!/6NC_L'1P;0_P!E6.;,8MC]G3]P/]CCY?PJ:_TRPU6
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MOM$MJF&_>QI@_,#@9P<!B<4 6Y/&&@PZ9+J,NHI%:Q7'V:1I$9627(&QE(W
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M=MX-B33[RRN]+O(KF\\ZW:,0+'$RN@8C#[F( VDY'/2L:\L;Z3X?>*;5-+U
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MM+U6>R :X#JT>Q2"0WS 94@'##CCK3(_%6BR7$L!O#'+'!]I*S1/&6BZ;UW
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MV@@EEW9& <Y]$OUOK#Q/XN\S2KZ8ZOI< MGMH&DC+I'*KJ7'"D%AUQGMD\4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH   ,X'7K1110!$EM#'<27"I^^D #.22<#H.>@Y/ ]3
MZU+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 445C_ -M376F7E[I-B;\0ED@42K']I=20
MP4G@+D$;CUP>V"0#8HI%)*@D8)'(]*I:EJ<>E"&6Y4K:O((WGSQ$S$!2P_ND
MG&>Q(SQD@ O4444 %%%% !15+5M6LM#TJXU+49Q#:6Z[G<C/L  .22<  =2:
MR;KQ+?6.CS:M<^'[Q;2.(RF-9$,ZJ!G+)G ]\,2/2@#HZ*** "BBB@ HHHH
M**** "BH;JZ@LK9KBYE6*),99NG)P/S) J)[B[&K16RV):S:%G>[\U0$<$ )
MLZG().>@Q0!;HHHH **** "BL)?$GV[4[RPT>S:^:R?R[J<R".&.3&?+W<EG
M (R ,#/)!JWI.KG5'O8WLKBSFLYQ"\<^W+'8K[E*D@K\W7V- &E1110 4444
M %%5+VXN[=[46MB;H2SB.8B54\F,@YDY^]@@# YYJ1;VV::XB$Z;[8 S#/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOM*L=2:!KRV29K=_,A+9^1_[P]#[TW5=%TW7+9;;5+*&[@5MPCF7<N>QQZT
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M .VOO$^AZ;=R6EYJEM%<QQ><\)?+A,@9P.>XP.IJ3_A(-)-A:7J7L<MO>?\
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M;N5^0(2/E.TG<>>@JW9F:76_AU+]BOE2WT^>.=GM9 (F:*-0'R/ER5.,XZ4
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M=C&WRSZ_>^7KQ6Y!!/X7UGQ?FUN)DU/;=V'E1,_FR>5L:/('#!E!YQPV>QP
M=1H6OV^N>%K+74!C@N;99RIY*<98<=<'(_"N:\/^([G7X!KQUQ+.QM[JX6YL
MY8%\LPJ[HA#D!@_RJ<[B.2,=*W/!NCOX9\$:5I=R09;2U43;>1OZMC'7DFN
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MACP0P!Z8KKJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5"#;@ XVJ.N:V:YS3?%0U72M O;2U1SJQSY?G?ZE0I9B3MYVXVD<?,0*S_\
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M<\X].>LN[.UO[9K>\MH;B!_O13('5OJ#Q3K>WAM($@MX8X84&$CC4*JCT '
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M,-M"'G8/NCW\M\F!G?VSTKH+S4(K&:TBDCG9KJ;R4,43.%.TG+$#Y1QU-6Z
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MWZ62G4I89+MR6D$ (C3_ &5SR0/4]3D\=!<HHH **** "BBB@ HHHH ****
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M'\_6K+> ].;1)M)-[?\ V::\^W/\Z;O-\SS,YV=-X!Q_3BK4VD/J?BO3]2N
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M<1Q012*@=%6-0P*D#<Q)P3T]ZCLM7\1)J&B>'-8N8H-0NA=2RW5N$+/'%MV
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MUC4+S3?B!IEY)/)#8V.ZW-RB+*%DMV8AM@ QD9&1GG!KKO"?_(FZ'_V#X/\
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M09R,^A%)I/B;5;_4/ SR7.V+6M+FN+N%8UV^8L<; J<9'+GC..E=%_PBUO\
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M,RK(53)3&U0!M))''4\YIEMX*T^+5#J5S=7]]<O9&QE:ZFW"6(DDAE  []
M/;.20!-(36Y9=(U%]9BN+&ZM=]U \2@%V4,AA*@$#[W#$\8[\UPOA*^U;1_!
M_@B[AU(FTO-0^PRV7DIL*.\OS;L;MP(!X('MZ]UH7@FQ\/@+:7^IR11*RVL5
MQ<^8EH#Q^[4C' X!;) R.A.8X? FG0:/I6EQWE\+;2[H7=M\Z%A("2,G;R 6
M;CW^E &CXHNM3L_#\]QI%O)<7:-&?+BVF1H]X\S8&X+[-V >^.O2N3A\:F?3
M(#I^I7%W+?:NE@JW,*0W%GF+<T;J5"[\HV"01\PZXKN-3TY=4LQ;M<3VY$B2
MK+ P5U96##&01U'((P1Q6-?>!M(U.QO[>^^T3RWTR7$MUO"3"1 %1E*@!2H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@AB0 <XP,XS7L,UE:W$+PRV\;1N,,I4<BLG37\/6&I-X;T^WAM[B"#[3]F2
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MN^(1V_E")"!\G4[L'/)YYK*U#P38ZGI.JV5U>79DU4I]LND*"1PH 51\NU5
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M#%Y@CBE<!F"RD@_N^"2,9) % '4UA1:],_CBX\//:(L<=@EZDZRDEPTA3!7
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M:Q.0.YZ]:U_!GVC3/$<.D:IIMHM[_9Q>WU/3V_<WL*L@+.O59,E3GD'<>>E
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M)X[UK4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ@3?:R@2.$WX4[<-E>01U[9S5K3?&&AZMI]U>VMX?+M)/*N$EB>.2)^ %*,
MV22 !CDG YH OR:/IDUY]LETZT>Z)4F9H5+Y7I\V,\8X]*2YT;2[R_AOKK3;
M.>\@_P!5<2P*TD?^ZQ&1^%9LOC70K>#49;FYF@_LU5>ZCEMI%DC1AD-MVY*G
M'4#%.MO&&C7C,EM+/+)Y@C5!;29D.S?E,K\R[>=PX]^1D U(],L(;V2]BL;9
M+N08>=8E$C?5L9-3F&(SB<QIYP4H)-HW!2<D9],@?E6;_P )%IIM;6=996^U
M,R01"!_-<KG<-F-PQ@YR!CO567QIH$&D'5);XI:+<?99&,+@Q2[@NQUQE#DC
M[P'44 :3Z/IDMQ+<2:=:/-,NR61H%+.OHQQDCV-,&A:0H@"Z58@6YS"!;I^Z
M/^SQQ^%5;+7]-U^>^TZRN;F*[ME4N'@>%U#9VNH=1N4X.#@@XI/#&MOK-E=)
M<!1>V%U)970084NA^\!V#*58#MG':@#F$\"7D[SPZII?A?4?-DD9M3GM";AM
MS$Y9"N"1G PX' KNX;2*&PCLR#+$D0BQ+\Q90,?-GKD=:2^OK?3K1KFZDV1*
M57(!)+,P50 .222  .I-<?XV\1.GA:>]TR]NK*6SU"U@N-T7EG#R1[E.]>FU
MP<C\Z .G@T#1K98U@TFPB$2ND82V1=BM]X# X![^M366E:=IQ8V-A;6I8 'R
M8E3('0<"L^U\6Z+='4@+IX3IL8ENA<P/"4C()#_.!E2%/(XXJ2R\0:=J]S)8
M6MQ/%=_9UN%62!HW\ILA9%#K@C(]\'J* +MUIMA>SP3W=E;7$MNVZ&26)6:(
M^JDC@_2GVEE:V$ @L[:&WA!+".&,(N2<DX'J:\SL]<UF7X=>$-1?5;@W5SK$
M$%S)\N9T:Y*E6XX&!CC%>IT 9YT+1RDZ'2K$I<'=,OV=,2'U;CG\:>NCZ8D\
M,ZZ=9K- NV&00*&C'HIQP/I6;JGC30]'U"6PO+F9;J*)9FBCM99#L+;0PVJ<
MC/<=,'-37?BK2+*X2*XN'16N!;>?Y+F$2DX"&3&T'/'7KQUXH MP:)I5K?3W
MUOIEG%=W (FGC@57D!Z[F R?QIG_  C^B_9C;?V18>07\PQ?9DVEO[V,8S[U
M6O\ Q7HVF22"[NF2.*5()IA$[10NV-JNX&U2=R]3QD9QD4NI^*=)T<S&]GD2
M.!E6XE6%WC@+8QO8 A>H//0$$X!H O)I6G1W?VM+"U6YV;/.$*A]OINQG'M3
M;+1],TUW>PTZTM6?[Q@A5"W.><#UK,.K:>GBF\3^T[UYX+!99+%86:-4W'$J
M@+EF/(^4GITJS:^)])O=(L]5MKB26RO)%CMY%MY"78G ^7;D#(/)&* +*Z-I
M::HVJ+IMFNH,-INA HE(Z8WXS^M26FF6&GM*UE96ULTIW2&&)4+GU.!S5"Z\
M5:197,<-Q<.BO<"U$_DN81*3C89,;0<\=>O'7BMF@"O>6-IJ-N;>]M8+F$D$
MQS1AUR.AP:8=*TYK#[ UA:FS_P"?<PJ8_7[N,5GZAXMT;2Y[F*ZN67[(8Q<N
ML3LD'F?<WL!A<Y'T!!. :9?^,=%TW4+FPGFN&O+:$3R00VDLC["2-P"J=PX.
M2,XQSB@#9M[:"T@6"V@CAA486.- JCZ 5+5;3[^UU33[>_LIEFM;B,212+T9
M2,@U9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M N8)/,#?/\W'R\_IUXK.\'V$T-KI6A:MX/F&HZ4Z+_:$JJUKB/@3(^[.XKT
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MBMB1(!YB_.N.<I]_C^[7":CIGB ^$]2TUSJ&K6ZZG9O83SVY%S)$DD;R>8,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>elicio-arnonxemployeedir002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-arnonxemployeedir002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N:TC5_[:US6K@RE-/TFX-E&-V TJH&E=O7&X*,]-I/?CI:X3P_H
MS1_\)OX=N',;7U]/=QR#O%<H,,/HP<?5: -NW\66%[>:?:?9;Q(M5C=K*X>,
M>7.JKN.,$LN5Y&X+D4S0-5D.OZSX>N9&DET\Q2P2N<L\$BDKD]RK!ESW 4GD
MFJ/@]O%5M86&C:MI$-LEA$L,E\MRKK<JB[5*(/F!. 3NQCG\':)9O<_$;Q)K
M0'^C+#;Z?&W9W0%Y,?0N%^H([4 =?1110 4444 -D02QLC%@&&#M8J?P(Y%>
M'0:_J%K\.(-6L->O;CQ.-2>&"TDNVG-T!<%/+,3$C&SG( /&<U[A-)Y4+2;2
MVT9V@@$_F0/UKCOAQ87&B>%EL=4MX[:ZCN)WYFC?*O(SC!5CV89H T-0\:Z?
MIDEZ)[>[:*PDABO9XT4I \FW:#E@Q^^I)4'&?KB[;^(;>X\2W6@_9KF.[MX%
MN"TBJ$>-C@,IW9/((Z<=\5PGB[2O$&N0>)+-K**\$DD3Z9,;V-(DC4H2H0G(
MDR&^8CD'&X  5K^,K*:^N="U#3[N*RU9I3928D#$P2J?-&1U*!=X/3*>] &H
M?'%@)=*B-CJ)DU02FU580V\("3R&QR!QST()P.:JM\1],CTRYOY-.U9(;*X:
MWO\ -NN;-@0"7^;!'(/R%N#FC5["3_A+?"<]A;(VGZ9YZRLDL:B-7BV( "P)
MQ[#I7/WNBZK<>$?'.G)8XN-8OI9K0&XAPR.D:@D[^/N'\Q0!VVK>)[72A=$6
MUU=_8X1/<BV"'R4.2"=S#)P"<+DX'3D9IGQWIDE]#9V-M?W\UQ8#4(/LT&1+
M$2 ,%B!GGO@=LYP*YVZL=3T_Q9=:G#X>LM9LM4AAWQS7$*2V<J)L.2V05( ^
MZ3R#QZZ=M9WMMX^M=3>UA-I%HILV>WEC5!*9%?:JE@=N 0#CT^M #[OQZLEE
MX;O-)T^YNK?6;KR0QV(T> Q9"&8?/E&'IP>>F>R!RH)!7(R0>U>66&AZQ9^%
MO"T9L4:[TG6)+J>W^U1 M&YFY5MV./-7C/8UZ3,\%U92023QH98RC;)!QD8.
M#0!C_P#":Z8$L[EHKE=.O9Q;V^H%5\EW)(7^+< Q! 8J >.>1G$OY[CQ!X^U
M'P]=0:G#8PZ?$T<EM<+$8W>1QYV5?/1%V\$C!R.><^#P_J=UX!LO!5]!&@M9
MX8WU!9XS$\$4H<,HW;PQ50N"HP2><5OV<-U'\2M2U1[;;83V$-M'/YT9RR.[
M$[=V['SCMVH TO%*R6O@?5FBN;A9K;3Y7CG64K)O2,D-E<<Y&?2N L=9NS;^
M!V\/ZQ=:CJMV;8ZO:M=-<H(&CS+)(&)\H@],;><C!Z5Z!XIW7OA35K.S59[F
MYM)8(T65%^9D*C)8@ 9-<A!H.IZ9I7AO6=+@BCU[3;*&QOK-[B,+>P*JJR[@
M2,J1N5C]#UH [+5?$=OI;W""UNKR2VA%Q<);!"8HSG!.YER3M;@9/'3I65!X
MV&H>*=)L--LI;G3[_3FOEND9 "N^-0<%@0!N.[(STP#S6/J-KJ5KXOGUJ#P]
M:ZO9ZG;Q)+;3W$"36DL>0#EB5*D$9P2<C\[[6&H6OC/1-5BMK.2!-.FL[A8)
ME1+=GDC<$ X+*-I' R?09H U+3QIIUY=V$207:PZA-+!:73HHCE>/=N'WMP^
MXV,J,X^E9Z^+-%T>R\3ZMLU5X[&\VWB.&<A]B?ZM2?E7!7T&37.V^F>)+B\\
M.W^HZ=%+J5AJ,DEY<O?1D2(R2*&C&3MC&Y?EP#_LDY-/U71-6N] \>6<5B/.
MUBZ\RSS<P@,OEQID_/Q]PGGU% ':6?BRQNM:FTJ2WN[2:.V-VCW481)80=I=
M3G( )&0P!YZ5%'XST]M0L+22WO(1J,;R6,SHNRX"KN(4!BP.WD!@I/UXK&U7
M2[K6/%R3M"8+&;0KC3Y)C-$3&\K*1P'R<!3T[XJ+PC%JMG%9V6I^&]+M9;!
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M[<J&)Q\X'3L:M:)%K<MJ_P!O\(66F7,,#(\L$L+FY<KC]WC&U3U^8C'3!Z@
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MPBC8;@3EADE06PN3CMR,\Y)HVLZ3XLU=X?#5EK>GZI.MS%<2RQHUJ^Q497W
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MUM+RQ6739+<O]K2W: PR@_<(9VW CD$8QCFEU?7KM-?.B:< MPEF+IY6MFG
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M18+O5(IQ!'&VZ(M!(RC>6(;@D$X'/2M?XE>8-(T8PJC2C7+$H'. 6\T8R<'
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M;$H\=S'@21R(0RN.,9! -<I8P75G\5[*'5-6_M"X.AS1O*8EB&XS1D*%7H2
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MO)KLQ77#&9RUNGR%5525QC^X,>@SU/-=K$)%B02NKR ?,RKM!/KC)Q^=/HH
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MBBB@ HHHH **** "BBB@ HHHH *X[XD&9-$TYX+JYMI/[6LX]\$K(2K3*I!
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MQBT<&/,<2C[P.[+$X!W8^;'&A/&ME\1_%>HVR.]W!HD%Q$OF-AY,S  C.#T
MQ767?A#P[?7%U<7>C6<TUTH2=Y(P3(!P,^^!UZU;70=)748-073K9;NWA\B&
M81@,D?91Z 9/YGUH XKP[9R:G%X<\00^)E,=S"4N(XQ(6O2Z9*L?,.UU()R
M"N".!4_PQT[S_#UGK=S?:A<7A:[@)GNW=2@N7 RI."1MZGGD\],=)8>$?#VE
M:A<7^GZ/:6MW< B2:&/:Q!ZX(Z9]L5=TS2;#1K7[+IUJEM;[BWEQ\*"3DD#M
MD\T <M\5+:*X\'QF4,=FH69&'*XS<(#T/H352ZT>TU#XJO82R7 MAX>52L5R
MZ,W^D,,%P=WZ_6NWU#3K/5K"6QU"VCN;64 /%*N5;!R/U /X56C\.Z3#>"[B
MLHXK@0?9Q)&2I$7]P8/"]\>O/6@#S_PYJ,FJ^&_!=M=WES>7T\-PWV9Y=J7*
MQG9OF?D_*,8X)).<<9%&QNKV]\'^"FEU.]$LFOR6<DD=T^9(@\X"DY^;A%P3
MSQUKT7_A#O#IMK2V.CVA@LW9[>,ID1%OO;1V![CH:<OA'P_&D:1Z3;1K%<&Z
M01KMVRG^,8Z-SU[4 8W@U6LO$_BW28Y[B2RM+J!H$GF:4Q^9 K, S$G&[)QG
MO4?Q0MHKCP_IQE#'9J]EC#E<9F4'H?0GZ5U5KI%A8WUU>VULL=S=$&>4$YE(
MX&[UP.!Z"GZCIMEJ]C)9:A:Q7-M)C=%*N0<'(_(@&@#AKG1[74OBA>V,LER+
M9?#\*XBN71CB:4#+J=QQ]?KFLC0=<OM4TSP/I^H:@JQZAILSM)<[B+F="BJK
M$,I)VESR>3S@D"O1T\.Z3%=M=16,<<YA%N9(R5/E#HG!^Z/3I5>X\'^';K18
M]'GTBUDTZ)M\5NR96,^J_P!WJ>F.I]: &>$K"?2]*FL;C6#JA@N9%24J08E.
M"(B2S%MN<9)]NU8GCVQ@N=>\'-+YF7U81G;*Z\>3*>Q&#GOUKL;&QM-,LHK*
MQMXK>VA7;'%$H55'L!4%_HNG:I/;SWMJLTMLV^!F)S$W]Y<'@^XYH YK3XV;
MXF:_I[7%R]H=+M6$37#D(2TH)7GY<A1TQ7"KI=I_PI.VG(E+G5DY,[X'_$P*
M\#.!P3_/K7KRZ)IR:A-J"VP6\GC$4LX9@[H.@)ST';TJ!/"^AQZ/+I"Z9!_9
MLO+VI&8R<[L[>@.><COS0!R=XCZSXNU?PU_:*VB6UC";-)'D+X;?OE0B1265
M@!DYQ@=,G-:WDNM3UZ'PS?:[%<[-'BD@N'1T^V,7=9)5VR+\P"I@Y/4D=:['
M4O!WAS6([5-0T6RN%M!M@#Q#]V/0>WMTJ36/"V@Z_%;Q:KI-K=I;_P"I$D8_
M=^P]!P..G% '$1V%R?$OA#2[SQ!>ZDDEA?1W-Q%-)"MR8VC"D@,<$9(+ Y/K
MS6/-%]J\+:;;74UQ.EAXS^QP-).Y98EN2H!;.20. 3R.U>JMH.EM=VMW]BC6
M>TC\JW=,J84QC:N.@P!P/2H#X5T(Z?/8-IENUI/+Y\L3#*M)G._G^+/.>M '
M'76DVVH^/_$5M)+<K!'H=KM$-R\9)#38)92&./<X]<\5U'@.]N-1\ Z#>7<K
M2W$MC$TDC')=MHR2?4U=7P[I"7$UPEC&DLT0@D="5+1C@)P?NCL.@JWI^GVF
ME64=E8P+!;1#$<2?=0>@'84 <G:R22_&?4%FSB'1(1 #_=:5BY'XJH_ 5)XB
M_P"2E>"_]V__ /12UMWVD%];M-:M-JWD$;6\BMP)H6()4GL0P# _4?Q9%BYT
M;3[S4+?4+BV62[ML^1*2=T>>NWGC/?U[T 8_B?P=I'B:5;FXFN+74[:+%O>V
MURT<EN"2<@ XZ^HYQ3?#MF?$/A/2+S7X5GO_ +*R-*,IO5^">,<.%5L?3T%:
M=WX:T6_U,:E=Z;;S7@01F5UR64'(##HP^N:U>@P* *5KI-C9/*\$&UI8TB?+
M%MRH,*.3V!-<Q\)Y99?AII'FL6V"6*,GO&LKJG_CH%=3J45U<6,L%G(L4LH*
M><?^60(Y8#N1V'K1IFFVNCZ7:Z=91^7;6L2Q1+Z*!@?C0!R\]T-5^)L^@WSN
M+2WTM+F" .5$SO(RLYP1G: H'IDGK7+^%7A3PMX;TL7%S+--JFH".T\W:MT$
MDFSYK]=JY#'J2<<'MZ3J?A_2-9FMYM1T^"XEMR3#(Z_,F>H!ZX/<=#54^#/#
M1M(K7^P[$013&=$$(&)#U;ZF@#A+.WU75?AY?36EW<R:CHVK7,EM&EU(1+'%
M,?W#'.74J"HS[5V/A>_A\2W$_B6UDE-C/%'#:*78*P W.^W.-VYBAXS^[]ZD
MNM+N]%CV^$M)TJ)[NX9[MI6,0&0?GPJG<<]N/PSFM;2M.ATC2K73X/\ 5V\8
M0'&-V.I/N3D_C0!B?$2".?X=>(O,W?)IUPZ[7*\B-L9P>1['BL*&01:[X1\/
MNTR:9=Z=+<%3,Y\^953"$DY("EFV].G'%=W?V%KJEG)9WL"SVTHQ)$_W7'H1
MW'M5:;P_I5Q8V]E+9(T%LP:!23F$C@%&SE<#C@CB@#S'Q!+>1>#?'NE232SV
M&GWUNEG)*Y=E5S$[1[CR0I; SR <=JZG5)9(/BM;RPQ^;*GAVZ9(_P"\PFC(
M'XUTL_A_2;G2VTR:PADL6;>\##*NV<Y;^\<\Y.>>:>-%TX:E%J/V53>Q1^2D
MY)+JG]W.>GM0!YL+Z[?X<>'O%EC>3RZW+<VQF(E8BY:24))"RYQM!8@#'R[1
MC%3ZY!=V^N>(?#,-Y>"?7(8[K1Y/M4@,,@^64*V<A4.),#L2*[ZW\.Z1:WAN
MH+"&.4R&;Y1\HD/5PO0,<G+ 9.35U[2WDNX;MX4:XA5DCD(^9 V-P![9VC\J
M .-\)7H\6V,&I/\ :8!;60LY8TF="MS_ ,M@<'DKA0&Z_,U<QIDMW>^$OAK)
M+J-^)+NZ,5PZ73@RJ8I6.[GDY4<]1V(KU:/3[2&VEMXH$CBE=WD5/EW,Y+,>
M.Y))_&J,?A;0XH;.&/384BLG+VJ+D"!O5!GY3UZ>M '!22:EIV@>/]/TJ^F3
M[!>1_9#-<L7C1XXG=%=B2"<L%YX+#%='H^F7+>-Y]1MUO[;15L8U2WFED13<
MDMN(B)P?DV@DC!/(R<FI_$7A5+G2+Z/2+&P:XO9HY+R.ZW!+M%8$JS8."0,!
ML''\J7AGP=#INJQ:C#H%EH31A@R6=X\IGR"-K#:JA1G/<Y Z=P#3^(4"3_#K
MQ&L@)"Z;<. &(Y6-B.GN!7+7&GV\FL_#NT62=8GM[DN4G8-S;*2-V=PS[$>U
M>DSP17-O)!/&DL,JE'1QE64C!!'<$5F0>%M#MFLF@TV"(V((M2@QY.>NW'3/
M0^O>@#SN'6+G2=%FL#J$D5@GBR333<7$COY-O@LJE]P;;NVKG=T/6NV\-:5-
MI&J:M$VLK=P3&*:*R6-@MID$':6=CAB,XX P<=:OCPSHGV*]LCIMNUM?.9+F
M)UW+,YZLP/5N!SUX'I4VCZ'I?A^R^QZ38P6=ON+%(EQD^I]3TZ^E &#XVU.2
MSO?#UDUTEI9W]ZT,\TF=A(C8HC$,IPS =QG&.A(KF==TR\T73X[9/$=Q,&\0
M612.W9X_LJ22*&BR7;<O\05NF>F"*](U/2K#6K"2QU.SAN[63[T4RAE/H?K[
MU2C\):!%ID&FQZ5;)96\@FBA5<*L@.0_^][]: . UC4[WPC)X^72I[IDM;"T
MN8%FF><PR2&17<%R3T ;'3Y:U;G3[&T^(O@F:QEDD2:UO?WC3M)YH\M"'R2<
MDYY;OQZ"NS70M,6\N;O[%$UQ=1^5/(WS&5.FUL]1R>#ZU2LO!GAO3I[:>UT:
MTCEM2Q@?R\F+/7;GIT[=.W6@"SXDO;K3?"^K7UE'YEU;6<LL*8SEU0D<=^17
M$22S6FE^!M;TJ\N)KG4+JV@NRTS.+J.6,F0L"<97!8'^'! P.*]+K,L?#ND:
M;.);.PAA92Q0*/EC+?>V+T3/?:!F@#E_"VGV\7Q'\92)YNZ*:TVYF<CYK<9R
M">>O?IVK6\?:K/HO@V\OK>4PE'A228 DQ1M*BN_'/"ECQTK6M=%TZRO[B^MK
M58KJY(,\JD[I2!@;N><#IGI5N>"*Y@D@GB26&12CQNH964\$$'J* //-3MDT
M&UU?5'\5O;Z?=:62(;&-F*-N $\9:1L,=X7C )(.>,UG7^JZKX=U3Q4+)# T
M'AZ.\AM?/,XCE#2#><\;L $@9!QU/6N\L?!OAO3=.N]/L]%LH;2\&+B(1#$H
M]&SU'/ [5+9^%]"T^YCN;32;2&>.'R%D6(;A'DG;G\3^= &1IUEIH?3]6L-8
MN72ZL&40F<R)=\!O-;.?F'/S<?>QZ"N*\,0MIOA_X::A;W5V)KN5;6=3<.8W
MB:&0[=F=O!4$<9R,]:])TWPCX?T<70TW2+6T^U K,84VEAZ9'0>PXIZ>%]$C
M@LX$TZ)8K)]]J@R! WJ@S\IZ]/6@#3N'>*VEDC3?(J%E3^\0.!7!>$C;:WX?
M\-^))-9N4U!VS=%)21<2L"'A9#D;5;H /E"YXZUZ#6/9^%=!T_6)M6L](M(-
M0F)+SI& Q)ZGV)[XZT <!9:@YU3PAJ-C>W$MK?ZE<QM>3SGS+R,I*?FC'RA%
M*C;W  X6B[U6?1K7QU=PS&!?[?MHYIP#^YB=;=7;@@\*3R"".N17=1^"_#,3
M*R:'8J5G^TKB$?+)S\P].IXZ<U;BT#281>A+"'%]DW:LNX3Y&#O!X;CCF@#A
M?$&EW&E:%XGO;;Q$WE3:+)<0VEHTB".1 2)E?S&(SD @8#=><&GP^=HOBOPY
M-:W%[.VH:-<R7,4MP\@F>-8F0A2<*<L1\H'6NMLO!OAS3M,N=-L]'M8;.Z_U
M\2)@2^S>H]CQ5I- TM+JTN5LT\^S0QVTF23$IZJO/ Z<>U 'F$C1:QX(\%>(
M)KF2?4+K6[&2XE\UL%VF^9-N<;5/ ';;]:M>(M0D O\ 4].O+B1[;Q#;VYNI
M)RAB/F1(\$:#@H 6SG&23P>M=P?!'AAII)6T.R9I)A.P,0*F3KNV],^O'/>G
MW'@WPW=2W4L^B6,CW3*TY:$?.0003[Y ^N* .;T_3%U7XD>)8[B_U$P6;V%Q
M;Q)>R!%<J['@'[I(^[TY/%=9XEU"XTGPMJVHVL?F7%K9RS1*1G+*A(X^HJ6T
MT33;&_GOK6SCANIU599$X+A>%!]0!P/3M5X@,"" 0>"#0!YI,84D\ 7UIJ%Q
M+)J-THN)?M+'[4I@=B6&<'# <8PO08Z5FZE?7,'P[\9R"_NDEL]>DCMY/M+A
MXE\V,!5;.0,$\=,&NDU'P1:V.KZ%<>'=%M;>*UU W=V8MJ$KY;IA1]7SC@5O
MW7@_P[>W-W<W.C6DLMWC[0SQY\S&.H]>!]>] '$>/+QC!XPGL;RY>ZTRTA8N
MTYB6Q?:77R@O+.V03G Q@9/2KUWIXUWXD?8+F_U%+2;04N&BM[R2-?,\[&X;
M3\O0=, XYS757/A'P[>7$L]QHME)++"('8PCYHP, ?@.!Z#BI[;P]I%G?17M
MM80PW,4(@CD08*QC^ ?[/?'3/- 'F<<X\.:!X]U&RDDAEBUTQ&3S';RXG^SB
M1\9Y(5F.[K[UL:KI4UAI^NZA:^(R;>XT.:6*TM&D4>8@RMPK^:Q!Y ..&XSF
MNV70=(6[O;L:;:^?>KLNG,0)F7&,-ZC &?7 JI8^#?#FF6%W8V.CVMO;78Q<
M1QI@2CT;U')XZ<F@"IX.T^WT_0;+4'O+J2?4+2V,S75TSJ7V#&T,<*3GH,9X
MKIZS7T#2I=/M;"2QA>TM)$D@A896-D.5*^F.U:5 !7D,321^!?BC-#/-!-#J
M]])')#*T;*RQH1RI!KUT@,I!S@C'!Q60OA30DMKRV7381!>L7NHQG;.QZEQG
MYB?4T <O80OIGC_P^D-W>.NI:3.]TLUP\BR.AB*MM)PI&YA\H P<5U?B>!+C
MPKJT4@)1K.7(#$9^4^E2)H.EI>6MVMFGVBU3RX)"26C3NJG/ ]JT'171D=0R
ML,%2,@B@#R:&RA;PY\+H$DF032PM(4F;<";)\X.<K^&,=L42ZM<>']/\2645
M]-%I]MX@MK;SYY7D-K;RK$7^8MN"Y8C.01N."#7H,/A/0+:.UC@TJVB2T<R6
MXC7;Y3G@LN.AQQGTXJ9?#ND*M\O]GP,M_P#\?:NNX3\8^<'KQZT 97A_29=+
MUZ^<:TEQ;7<*2I81HVR$CCS%+.V WIP"02.]1^/-5ETRRTE1<K:VUWJ45M<W
M#9VHA5R,D$$ LJJ3D<$ULZ+X>TCP[:O;:/IT%E$[;G6)<;CZD]35J_T^SU6Q
MELK^VBN;68;9(I5#*P]P: .'N_"5_)I7B33K/Q%*UQ,D=S8V]NTD7V*3:< -
MYC'8Y7E>@YP.:;%XCFUGPG?>+--25);#2)%B@W-@76S<X9>C;"%49[EQ79Z/
MH>E^'['[%I-C!9V^XL4B7&3ZGU/3D^E6;:SMK*!H;:".*)G>0HBX!9F+,?Q)
M)_&@#B-%TP7=WHNL6WB4-9WEJ\<D$/FYO=R;@Q8RG:Z$$[@,]1Q7-:";F'PO
M\/=;_M&_DO[O44MKAY;IV62)UERI4G:>5!SC.1G->D:;X0\/://<SZ;H]I:2
MW0*RO FPD'J 1T'L,4]?"VAI:6EJFFPK;V<GFVT0R%A?^\@S\IY/(]3ZT <[
MX!LK:WUSQ@\>\.-:D0 RL008HF/!."<]^M:_C.YA@TNSBENKF%KF_@@CCMR%
M:X8MGRBQQM5@#DYZ9Z]#K0:/IMKJ=SJ4%E!'>W( FG5 '<# Y/X#\AZ4NJ:3
MI^M61L]2M(KJW+!_+E7(##D$>A'K0!R_@6>Y&K^*K"9P([74%$,"S-*L(:%&
M95+ '&2>,  D\5L^*@&T>$, 0=1L00>_^E15;L-"TG2KF>YL-.MK::<*LKQ1
MA2P48 ./0 5-?Z;9ZG"L-[ )HU<.$8G&X$$'Z@@$>A% 'EOB"VN/A[%?V$$3
MR^%=8W+;JHS_ &=<L?N>T;GIZ']>G67^W/B)KFBZDTHMK2QMWM(5E9 X<OYD
MHVD$D$*H/;'&,FNNN+.WN[1K2YA6:!@ R2#<#CIG-5K_ $33=2N(KB[M$>>%
M2L<P)5U4]5W @X/<=#0!YCI]UJFI6W@I+_4;XL^JWED\T=PZ&ZAC28*S8."3
MM'S=>X.>:WO#=WJ6E#Q19:;9W&JK8ZOY5M;2WF&CC:*-R \A/ +'@GO77S:#
MI4[63/8PYL?^/7:-H@XQ\@'W>...U266D6&G3W,]I;)#+=/OG=<YD;U;U/O0
M NEW-[=Z?'-?Z>;"Y8G=;F99=O/'S+P<CFKE%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\0]
M8O\ P]X(U'6--E5+JT174.@96RR@@CZ$]#745Q?Q7CEN?AKK%I;6\]Q<SQJD
M44$32,QWJ> H/84 ;*Q:K#>66=8CE#DM)!) JET YVD=""5/_P"NFOXT\-)C
M.MV6#/\ 9]PD! DX&"1P.2!GIGBLRU;P[::E8W.EZ+(FH./LRF'3I(0$<J6+
ML4   7/)[8')KCM2MIIOAWX_MX]/NVN+O5YI((Q:2;IE+1E64;<L/E/(]* /
M2X/$^AW-Q=P0ZK:M):)YDX\P (F<;LGC&>,CBH;3QEX;O]0M["UUJSENKA/,
MAB609=<9X]\<XZXYK OR'^)5M<16\_V7^P)X?-$#A QD1E4MC . 3@US.AVD
M6N_#OP%8Z? _VVTNK6Z9Q"5\A$):1R<8PPR!_>+#K0!V_A_6;N77/%D&IWD;
M6NF72+$[*L:QQF%9#D^VX\DUKV_B#2KIYHXKQ3)#%YSQE2KB/^^%(R5]QQ7G
M.L:=JFI6WQ"ATZTN&GFO;6>&-HF074<:1;U4D8;.QEXZ].]='(/^$B\=>&=8
MTV.=(+&WN3=R2PM%Q(JJD3;@,MN^;';;SC(R ='%XBTB?28]5BOHI+"1PB7"
M9*,Q;: #WRW'UXHNO$&DV-TMM=7T44C2+%\V=H=ONJ6Z*QR, D$Y%<EHND7E
MCXPN_#HC']A6TXUBW(/"F0MB''8"4/(/]T5DQP6OVO7/#7B/1-8O)[K49KBU
M$33_ &:[C>3S(R60[$V\ YQC:* /1+_Q!I.F3>5>WT4#;E5BV=J%ONAFZ+GM
MDC-7;A7>WD6*4Q.5^5P <'Z'BO,98[:'6?$6A>)-&UF]74;PSVAMO/:"ZC95
M 0E&"JRE<$M@  '.*]*9DL].RZE4BC *IN<C Z#N?YT <3X3U+Q9XD\!6.O0
M:E8_VA<1LXMYK3]R2&8!<JP89QUYQGH:M:9XSMO$7AK2M0_M)-#NIK]+:6WE
M"R,\JOM> 9Z[N/F'(!!K+^'NKMH/PPTJSGTO59-2@B=39K8RARQ=B!DJ%&<C
MDD"LS_A&[_P_X+T.&]@DEU&X\20:G>1VT;2B',P9_N@\*H&3TZT >AS>+?#]
MOJ!L)=8M%NQ,EN8O,!82/]U3[G'^<U.OB#26U&/3Q?1?:9698U.0)&7[RJW1
MF'.0#D8KF]#B,GQ%\82&WE03QV8@GDMV"N41@VUB,'!(Z&L#PC#:3V>BZ%K&
MA:P==TB9"?.:?[.CQ\>>KY\L@C) [DXQCF@#T-_$&DQWZ63WT2SR2^2@.=K2
M8SY8;IOQ_#G/M5+1_%^EZS)JPAE\N/39WADDE!12$52SY(& "Q'X9Z5RG@^Z
M$.F6GA;6M!NY]8T^]:0-+:,T+'S687*RD;1PQ.<[LY ZUGW^GZK/X?\ '&EV
M=A=M>MK1OTC,+*EQ #"VU7(VL6",, D\8/6@#TBVU_2KN2:.*]C$D,8ED23,
M;+&>CX;'R_[73WJ+3/%.A:S=BUTW5;:ZG,)G"1/N)CW;=WTS_,>M<].RZ[XX
M\.ZY8)<):Z?:737DCP/&=LBJ$B((!+;@6V]MO/49F^%MN;;X?:9#+:R6UQ$)
M5DCFA:-U)D8\A@#SD&@#I-1U6ST\".XNA%-(C,BA"[8'5MH!.!D9/09&:Y[P
M5XE:_P# =AJ^L7T<DUQ+-&)54#S2)G50JJ.3A1@ $G%5)KN;0_BC>7>HVUW)
M8:AI\,-G<PV[S+&Z,Y:,A 2I;<&Z8.*Y?P[#?Z=IG@K4I;"]2QTZ[OX[V$VS
MAHO.9_+EVXR5 /)&<!_K0!ZG;:UIEW8RWL-["UM"S+,Y;;Y3+U#9Y4CT.#4<
M'B+2+F.[>.^C'V/'VA7RC19Z;E8 C/;CGM7G>M:1JEQ<>*-=TNTN9[.6\TZX
M2UCW1O=BW(,I0<')& ".I3C/%7I(?#NNZ7J6I0Z3KR)/##;W%VXN%N%Q*I78
MKY+&,_.2 0,8&<G !WUEJ=IJ)F6VE+-"P65&1E9"1D @@$<$'\:I7_BO0=,G
MG@O-6M8IK= \L9?+(#TR!SV/'MFLGP4^L+/JMMJ5RNHV\+QBUU3R/*>Y4J<J
MXZ$IP-PX.?4&J_"?%G4;N6VF\@:'%")OL[E"PED9E#8P3@@X% '3OK6G)96U
MY]KC>"Z -NT?S^=D9&P#);CGCL*S-6\::/I?A\:PMPMS;O,L$?DY;,A8+M.!
M\N"><].G7BN"\)Q7^D6_@;4KVTNUL+;3[BQN5:!]UI*S*5=EQD A=N[&!QV-
M3:SH]Z=#\7:E;6ERUG>ZS9W=O;I"Q=DC>'S90F,\E6/3)"Y[B@#U6*>*:W6=
M'!B9=P8\<?C5.TUS3;Z4Q6]TK.(O.P5*YC_O@D#*^XXI;N>*ZT*XF-M-+#);
MN3"49'==I^7!Y!(['GFO,_[+UV;2-5T'2;R?5--ET:5;.6]@,5Q:.2H%LSD#
M=N&>O(V\\8R >BQ>)M$FEFC74H%:&+SW$C;/W7_/0%L93_:&1[U3_P"$\\*E
M2PURS*K&DA8/P%<X4D^Y_F/6N=TF[TC6I$U--#UJ'4K.TE29K\7'^C;EPT:[
MR0Y)QPH/ SQP#8\*Z!!J_P 'K'0[VVDMVETX6TRR0F-XWQUP0#D-\WUYH [-
MM0M4NXK1I=L\L9E1"""4&,G\,C/U'K5:SU_2K^]^QVU[')<>7YJQ\@NF<;US
M]Y?<9%<?9V'B'7_A]J[7\+0:Y-I\FFQ*QQED5D+Y[;WW'/H%-/\ "T^E:YJ.
MF7?]A:Q!JVGQ.DK7YN%6T++M95+G:^2  !GCGC% ':7VI6>G"+[5,$:9MD2
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MVQU2UN+V%=SPH^6 Z$^^#P<=.]/7Q#I+WL=F+Z+SI':./.0LCK]Y%;HS#!R
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M:2)^[E!=2,YY&8VP>F.3B@#M**IZ7<W=YIL,]]8-87+9WVS2K(4P2/O+P<@
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MGI97UJ\S*,H<HZ/M.>I!! X.:H/X(U&&WTO[,UF\Z:^^MWQ>5E4L^_*)A3G
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M%Q<6OF,6=54#:_S$E<D=><]*6\\,^(!J7BZ73;VUMEUJ&-K>YWL)895A$>,
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M1HF4",G:"&(P>0>F>AH GT]+Q+*,:A+')='+2&($("3G:N><#ID\G&:M444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5RWCG5-4TFPTN72KB*&2?5+:U?S(MX99) I'7CK]?3%=3
M7&_$>VN+W2-+@MH;R1QJUK*[6L+2-&B2 L_ .,#GG]: ,B]UOQ-H6I^(M)N-
M5CO6BT635K&[:U1&B*$J8V5>",X()[>M31:WKUG9^'C=ZNL\WB*2WCC(M406
M@\HO(5/\3-@ ;A@$YQCBNDF\*VEY#J)N;N[FN-1M?LDUR^P2+#@_(H"A5'S,
M>F<GV&%N?"5A>>'['2)IKEEL&C>TN0RB:%X^$8$#&0..1R.N: .9UGQ'KFBW
M'BG2A>B:6RT<ZM8WDD*%E W@QN% 4_,G!QT/.:MK=:_;:;IEU=^(HF749(28
MUM%$J*8BS)" K;V+;3\PX4,>.VS<>$K2\L]4ANKN[FGU.W%M<W3%!(8@"-@P
MNU1\S=!U8FDO/"%I>6FCQ&^OXI])8-:W43H)1\I0@_+M(*G!XH X;4M8U?5O
M!Q^T7]S!-:^)X[!G58U>2,7" >8 "N0",[< D=QQ71WNJ:Y?ZGK6CZ1<72W.
MEPQ*DRK;GS)73>&E#C[O080#^+GIBX?A_I7]F7]@+K41'>7HORYN-SQ3!@X9
M"0?X@#SG-.U#P+97NK1:I#J>K6-\(5@FFL[G8UR@Z"3(.3UY&",_2@"KIVLZ
MOK>OR:+-<#3;BPTZ">\-J$DW3R[N%+AAL7:>V26'/')\*0Z_#C31(P9Q)<AF
M P"?M$G.*T+GP98OJUKJEC=7NFW<%N+4O:2+B6$=$<.K X['K[U=\.>'[7PQ
MHZ:992W$D".[J9WWL"S%CS@=R: .;N[:=_C-9%=0N47^Q9I BK'@ 31 IRI.
M#U/?T(K/E\7:O+\.W\=6MU^[CE>7^SFC3RV@68QE2V-X?:,YSC/;%=E)X>AD
M\41>(/M=TMU';FU6,%/+\LL&(QMSR5'.<U2C\#Z;%%<6B3W0TNXN/M,FG;E\
M@ON#''R[@I89*AL>V"10!F6]YXAU;QSK.G6^LK:65DME<1I]C1F*OO+1DGU"
MXSU'&,<YM?$]YXOAKKLMM=36TB6K'?$0"1T*Y(/!![8/O6O9^'X++Q%?ZW'=
M7+7%\D<<T;%?+PF=F %R,;CW[\U9UG2;77M&O-*O0QMKN)HI-APV#W!]: .+
MU*TO#\1/#EM#J4J3G2;S-T\2,X&^'H  N>PR"/8U'I7B_5KC2='L9Y&FU&[U
M*[L9+F%(U9E@,GS*K?(&(5?;K@=*Z:+PG!%JMAJ;:EJ,MU96[V\;RNC;E<@L
M6^3J2J],8QQ5&7X=Z3-HATQ[J_PMZU_!<K*J36\[,6+(RJ,<L>"#UH T?#1U
MY5OH=<*N$GS:2L4\UX2./,"?*&!R,C@BLC5;S7[KX@'0+#5TL;6323=AQ:K(
MZ.)0F1NX/X\8SQG!'1Z/H\>CVK1"ZN[R5SNDN;N3?)(>@R<  #T  _,US%]8
MW=S\6H;F)M1M8$T9H/M4-OF,R&4-L+,A7IS^'7M0!F:)XSUB^DT?0+Z5(]4F
MU*]L;F]BC #"U!)9%((#-E1R"!\W'3#->\5Z_I&G>,[&.]5[O1H8+JUO7@4L
M\<N?E=0 NX%2,@<C'%=9-X+TJ33K*VC-Q!-97#74%Y$X\Y9F)+N200Q8LVX$
M$'/3I27W@NPU+2=3L;JYNW;5"OVRY#()90H 5?N[0 !T '?N22 <YXAM-<@U
MSPPEUXCN)%N]7.$@MXXUC7R'(7D'=@J<;O7G) -3ZCXOU'0M1\:R7,BW5MI%
MC;7%K#Y87YG$F0Q')R57)_(5TNK>&[?6(-.2XN[M)M/G6>&YB=5DWA2IS\N,
M$,0>/RJ,>$M/;4=6NYY+BX75;=+:Z@F93&T:@@ <9Z,W.>] &1>ZKK&AZGX;
M,VH?;K75Y?LDRM"@\J5HRZO'M .W*D$,3QCGUP8?$GB9/#L&N3:ND@AUPV$E
ML+5%6:(W7D\GJ"!@@C'3G-=II_A.VL38;[V]O%TY2MDMRR-Y&5VY!"@L0N5!
M;)P3ZFJG_"!6']AG2/M^H?9C>_;L[H]WF^9YG79TW\X_I0!OZI?)I>DWFH2(
M72U@>=E7J0JEB!^5<1)XCUFQ\/>&?$LEX+F'4YK9+NR\I B+<8P8R!NRI8#D
MG(STKOVC62$Q2@2(R[6# '<.^17/:?X+L-/AL[5;F\FL+&;S[2SF=6CA89VX
M.W<0N3@,QQQZ# !D^'[6<?%3Q8[:A<NJ0V1*%8\."LN%.%S@=L$'US6UXOU+
M4=)TRWNK"VNIXEN5%Y]CC62=(=K99%8$,0VS(P>"<58LO#T-CXAU#6H[NZ>X
MOUC6:-RGEX0$(  H(QN/?GO5K4],_M'[*RWES:R6TWG(]N5R3M9<$,"",,>,
M>GI0!QL7BFXFC\*W.G:X-0M-1U22UE<PJI:/;(ZJPV@JZ[5!Z=#QS3+GQ?J6
MG3^([=YTE,&KVFGV<DL:@1"=8\LV,9"[V/X 5NW'@?3I]/CMTN;RWN([\ZDM
MY"R"7[0<Y?E2O(8C&W&.U1-\/M&FMM:M[J2\NH]89'N1--DAT50KJ0!AOE!^
MOMQ0!F^,[75[3P;XO6\U)+S3WTJ1K82(JSHX1@X.U54K]TCC/)J32;_5]/\
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M/E:$E77&W RY3&.=I//%5M.UOQ-KUEINN:4&^S379\^WF,(@^S!V4X/^L$@
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MZ)+C2[!-0LKQX$+%&# HX "Y#*<''0\CBNTT&#5([=Y]2U,7IN-DD:+;K&(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:)PP#*<,IQW!X(H FHHHH ***J#5=.-R]L+^U,Z EXO.7<H'7(SD4 6Z***
M"BBB@ HHHH **** "BBH6N[9+N.T>XB6YD4ND)<!V48R0.I R,GWH FHHHH
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M?OGC Z"G^'_"-II?AG3=)U&&SU%["$0I.]L.5'LV<?G0!SFI,@^-MO(FG/J
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MO&8QY8P, C/7U +444?_  N6]'EKA_#\.\8^]_I$@Y]:=\*P%^'&F*   ]P
M!V_?R5H1>'[Z/QE)X@>^@??IJ6)B\@CE79]^=W<L>,=.]2^$-!G\,^&[?29[
MJ.Z,+2$2I&4R&=GZ$GINQUH I?$M$D^&OB+>JMBQE89&<$*<&J5KXIU32M9T
MG3M;T^UAT_4;=S:7-O.SM&T<>\K*"H&2H)R,C(QSUKI/$.CKX@\.ZCI#S&%;
MVW>$R!<E-PQG'>LV+PU<7EYIUSK<]O/_ &="\<$5O&R*S.NQG;))^[D =MQY
M/& "C8>,=2OKG1KB'2)IM,U3&6CMI@]JK+N1W8KL93QG&,9X+#FNSKC_  UX
M5US0%@TV3Q MSH=H?]&B^S;;C8/NQO)NP57CH 3C' XKL* .1U;Q==6]SXDC
ML;:!_P"P+5+F99V(,^Y&?:I'W1M7[Q!Y.,<55F\7Z]+=:%:66D6'VC6+":[B
M\V[?;&4"D!OW8.,.O0=>.!S6!KUW#=^--7)U[P_8O&L5J;36[<AI$ W97]XF
M^,LYZ@\CZ5T]GI.K:OJ^@>(KR:UMY+&"XA>W2!\2B0@;U+$% 0BL 02-V#0!
M6UCQIJFAQO/?V-G"(;FW@-MYQ:2=9"BM+&1T56<@9'.T\C.*EOO%6NC6?$6G
M6&FV#'2;:*Y62:X;$BN'." O!^3&.@]3TJMJG@+5+^'7K:+6[=+?4[Z*^0RV
MA>5'1HR$+;QE!Y8P, C/7UTE\+:@NKZ_?G4;=FU:SBM=OV<CRRBL-WWN<[R<
M<=N: ,UO$VJZIX@\%O8F"&PU>QEO'ADW%LB-#@D=0!)Q[C/I4[^-K^98;[3=
M)FO;!KTVS1Q6TQD\L.4:8.%V8!!.WT[@\!]KX+OK-/";0ZI )]!MGM&9K8D3
M1LB*2!O^5OD'<CGIVHTOPCK.C7UQ:V.OHGA^>X>X%JUMF>'>Q9HTDW8"DD\X
M)&>.>: ,?QSK-SK_ ,/_ !=)8P6K6%D)K0F;)>1D&)'4]%VG('7.T].*]#L/
M^0?;?]<E_D*XB\\ ZG_9_B/2-/U>VBTG6GEF,<]LSR6\DGWPK!@"I//(X_6N
MXLH9;:Q@@FE662.,(SHFP,0,9 R<?F: .9\::EJUA?>&X=-E@CCO=36";S <
ML-CN!D=!\G/K^=<Z;_4]%\5>/[[2[.RE:VBM+F832,BL%@+$+@').#R<?C78
M^)] N-<&E2VEY':W.G7R7D;2PF1&PK*5(#*>CGOVK.D\(7[W/BF4ZE ?[=MT
M@&;<YAVQF/<?F^;()...: '2^,'NWMK?3(/](FTZ/4"9()9519,[%(C!.25;
M)[8Z'-;7AW4[G6= M-0O-.GTZYF4^;:3J0\; D$<@''&0<<@BN9;P5K%E-I%
M_HNMV]MJ5GIZ:=<>=:F2"YB3[I*[@58')X/?%=A86\UK91PW%RUS,,F29AC<
MQ.3@=AD\#L,"@"CX@UQ=$M;9O+,D]W<K;0(%9LN03DA020%5C@#G&/>L)?&E
M]:+?1:CI,HFCNH+6QE\J2"*]:8X7&\97:<[NN ,C/2M?Q7X=;Q)I<4,%Z]C>
MVMPEW:72J&\J5,X)4_>&"01Z&LK4/".L:YH+0ZMKD?\ :J317%K<6MMLBMY(
MFW*P0L=Q))SD\C&,8H ?-XDU>S\0WNCW$%D[PZ4VI1S1EP&P^W85.<=#SGN.
M!26OC&YN$\&RFTB6/Q!'F0;SF%O(,O']X<8[5D6D-W+\4Y++6K^UGNYO#C1R
M?98_*4 S] I9CG'/)_ 5;T[P/K-LOAB.XUJT>/P^Y$ 2S8>;'Y9C&[+_ 'MI
MZC 'H: ,_7/$^I1>#O&]UI]G9:=>Z=>M;M+$2QDRD?[S.%R^'&">F!UQ72W&
MO:EIOB?1],U""T%IJ2R*MU&S<3*-PCP?[RY(.?X2,50N? EQ>:-XKTZ?4H@-
M=N#<*Z0$>0VU% .6^8?(/3O47BQK;5=.@\*W6IHWB=VAN;<VD3(T3"3B902=
MJJ V<D\ ^HH ZG1;^?4K>>YE2-8?M$D=N4S\Z*Q7<<^I!QCM@]ZEU>[NK#2+
MJZLK)KVYBC+16RN%,C=AD]*GM+6&QLH+2W39#!&L<:^BJ, ?D*S?%.BR>(O#
M-]I,5VUH]R@43!=V,$'!&1D'&".X)H Q;7Q;J%W?ZWIEI%8WUY8V<=W;R0.P
MBGW;@8SUP04(R"1ST&,5#:^/'N;GPB=EJ+7Q!"Q,FYMT,JKNV8]SE<^HK0TK
MPWJ=GXKEUV[U*UE,]C':RP06IC4%&8C:2YP/FZ')SW XK.F^&]LVCZK8PWTL
M,ES?"\LYE'-EB3S55/H[2'_@?M0!I2:_J7V6WN%M[2.VN+J6/[9*^(H(5W;9
M&!()WE0  ?X@<]JQQ\0+^3P[INHP:9;RS7&L?V5*AG95#>:8]RY7H<9YQC/>
MMK6?#-S=76@W&DWD-H-(=MD$\!EB=2FP<!E.Y1T.>Y]:QD\ :E'IT-F-9MW6
M'7/[71GM#D_O#)L.'ZDL>1CZ4 :EOKFL7&IIH$]OI\>JK;-=73*[RPQQERD8
M PI);!)Z8P>O KE/"GB1?#?@JR-Y]GLDN]9O8)+B7+06I\V4\D8X)&T$X'.?
M:NMU+PU?MXM@\1Z/?P6UT;7['=0W$)DCFC#;E(PRD,"3WY!Q532?".J:3I(L
M#J%C>0O=7$T\$]H1',DK%BA^8\@G.<'TQWH Z;2KFXN]-BGNE@65RW^H?>C+
MN(5E/<%<'\:NUC>%O#\?AC0H],BDW(LLD@"@A(][EMB DX5<X'/:MF@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCJY8#;@D_P )Z@5P>H_VMIWPP@U]/$6J/>W4.G.X>1=B[GC5MHVY&X.<\Y.
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MVT9!?(.Y>,8Z8S0!ZG17F>E:YK'C!UL7?[+<_P!BVEV%2[>V;S)E8M(-JDL
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M(P!3)8!E!VM@DD9!P>E3W6JZ=8SQP7=_:V\TI CCEF5&<DX& 3SS5HD $DX
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M\\8#;2<]@:SO ]]J-S<:Q!J7V*ZFMY8Q_:EB,1W@*<$C) =0 #@XY%=?1TH
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M<@*RLOIND&!_US4TWPG>^'?$6JZ-?6=SJ$VJ:=;O$UN\0B^Q*RX9) $4=0
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M%6#QONPRDL ?NGW/;-<MI=I?ZSX>\;Z':V1(O]9OH!=,Z^7&'(#,PSNR!D@
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M8L;VZTVUF,$MU $*[PVP@ L&(#_*2!C/T.+O_"36_P#:FK:<+.[-SIL"7$@
M3$B/NQL.[_8/7%>;Z_I^O^'OAEK6@7=A#)IUO/YEOJ*W S)&]R' ,>,[P6P>
MWN>_7W^E:U;>,]5O[&PCNK75--BMO,,ZIY$D9D^\#R00XQCN.<=: )9/$>CZ
MK+X1O&M]0_XF<GFV#*VQ48Q,V)0&P?ESQ\W-06GCJX$'B>\O-$OC:Z/=O%B
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MY\MMP^\@).5[^AQ4-KX5\06NB:=8'2X1]D\2'4<07"%?(\UWX!QV8 #V.<4
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M )'8 U+_ ,?6EE-K42Z1JMPVC!6O#%&F%0IOW@EQD;><=?;K746UQ%>6L-S
MV^&9%D1O52,@_E7#W.A:O)<>/62P8KK-LD5F?-3YB(/*^;GY1GGZ>_%:-GX,
ML+[3-)DU:"\CO[2SA@98K^:-04']V-PIYSSCD=?2@!EY\0;2TCUB0:1JLR:/
M+LO6CCC_ ':[0Y?EQD;2#@9/M5ZT\76MSKMMI;65[;_;('N+.XF11'<JFW=M
MPQ8$!@<,HXKG[KP_K,UAX^A73SNUO<+/,J8.8%B^;YN.1GZ>_%69='UF37/"
M5W%9%%TVQN()W>1#L>2-%7@-\P!0DX[$4 :FG>-++4;S3(%M+R&/54EDL9I5
M4+*(QD\!BRY'(R!QZ'BLRW\7:-HVAZWJ\=EJGD0:L\%VCGS'$Q**2H+G"990
M /P%96E^'O$_]L>%M3U#2X#>V#SKJ-R]X'>8O&5WCCA,\A>V<8 YI+SPQKL_
MA+Q/IR:<?M.HZU]MMP9H\>5YD;\G=P<1GCW'O@ ZA?&,;76J67]DW\5[96GV
MQ()A&IN(B2 RG<0.5((;!'IVJMHGC*2]\.Z!=76FW7V_5XP8H8]F'/E^8S [
ML*N,_>(/M3;C1]2N_'=WJ/V1H[*XT3[")'D3*R[V?D DXPV,^OMS638:1XKM
M/#_A33I--B>UL(_LVH6:7@7SPL85'+8P4R"2G.01D'I0!IZEXIT;4_#%EJ%S
M;:E]FEU*.VV1-LDBG68( Y5AP''."01ZU;O_ !O;V>HZM81Z1JEW<:9"D\ZP
M1I@QL&.Y2S@' 4\=3V!YQR\?A3Q!#X+.C_V9 )4UT7J+#<+M,0N?-XSC'' '
M7U K<.DZJ/$_BF_&GN8-1T^&WMSYL>6=%D!R-W ^<?D: -9O%E@]K836:27;
MW]J+N")&1&,6 =Q+LH'W@,9SGZ'$%CXWTO5=/TVYT]+BXEU!I%AM0JK(#'Q)
MNR0%"G@G/<8SD5RMKX:\1Z+;^&M0MM(MM1GL])32[[3YIT4D+@B2-SE>H/7L
M?RT[W1_$%OKVA^)+73K:6:WBFM[O38)539'(5(,;MA2RE1G.,]L4 3?#FXEN
M3XI,HNUV:Y*BQW4A=XP(HOESD\ YQ@D>E9D'B)_#OB[QJ[6.KZE;P36TA6W_
M 'OD(8 S'YV'&23M7)]L5O\ @W3-5TZZ\0RZE:1VZW^IO>0A9@YVLB+@X''W
M/UJLNFZSIOB;Q/=6^G+=1:N(6MI1,JI&R1",B4$A@,C/RAN* -*W\9:==ZMI
M5C;PW,B:K:FZL[L!1#(@ )&2V[< 1QMS^M:>FZFFIBY:.":-()W@WR;<2,AP
MQ7!/ ((YQR#7&:UX8.C?#_1K#3KM/[7T5[<V$SC_ %DVX(5('.U]S*1[^U=M
MI=@FF:9;62,7$*!2[=7;NQ]R<D^YH \^U[Q)?:WX+\=J]G=V/]F&>&":.=5(
M*1(V"4?.26)QC;CC)KI=&\5037]MH]Q9WMK,UB+F&:X50D\:[0Q7#$C!8<,
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M4)IE#2*=\4D:K@X)PWRG]*E^'NGW=KX<CN=0NA=W,X"1W&,;[>/Y83^*_/\
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M(>.J'(]:ZZPO-*T'2+OQ9-JNHC2+NWBEBBO;F6;8,M@H')8%PR?+UZ?2N?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWS9P5"M'VZL>>*PK*XU27XKZM;/?(UE!I]O(D!A/RAFDR =W7*@DD'/ P,4
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M95L_.1D!NF>HQ6/!XTUF3P=I&KLME]HN-9&GSJ(6VF,W30Y7Y\JV!GDD9[4
M=EK&DZ?K-@;;4X?.M01(R&1E&5.03M(S@@'ZBI=,OK/4M,MKW3Y_/M)HPT4N
M2=R^N3S^=<CI-SK4OC?QC&=0@>.T%NL$<EN2$!B+J.'' +'/<^U1Z+XSOM6T
MSPC;@6\6HZY;27,L@C)2)(U!;:N>I+*!D\<GG&" =[17G&K>-];TS2O%$&VR
M;5-"GMQYK1-Y<\,Q&PXW95@"<\D9'3GC>TW5]8C\=7.@ZG):31/IZWT#V\+1
MF/\ >%"ARQW=CNX[\4 =317,^)-6U*PODAMIK:"$VDLJL8S--),I&%$:G.P
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M(+J6R<R6[2KGRV.,D?D/R%>?W_B+7M1\,Z8S7=O;WD7B>/3+IXH3LFV7.T$
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M/:=J29Q*HW$'!ZCJ.E4++QCXE?0]&UNY?33;W&K_ -G3V\<#AF4W#0AU8O\
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M)QQC(R<'-:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(93U!#'H0?>MFN?\1>)7T"^TJV%@UR=3N/LL3+*%VR8)^;(Z8!Y&?I0!7OO
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M=-<QK+)*KN@4Y=RY!Q[L?PJI'X4,E_I=S?WQNSI<KRVK&$+*"RLNUGSRH#=
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MM@#A1EC@=ABM2L31M8U'4[B,SZ/]GL9[5+F"Z6X#@[L?NW7 *O@YXW#WK;H
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MI&G:6LRV%C;VPG<R2B*,+YC'JQQU)]: .(N46QO?!-_H<LD@U*8072^86%W
MT+.9'R?F9=H.X\\XSS4-C$]CKNL^"96F?[9=)>VLK.Q86C\R#=G(V,C(#G@N
ME=S8:#I.ER>98Z?;V[8(!C0#:"<D+_=!/) Q5PVL!NUNS"GVA8S&)=OS!"02
MN?3(!_"@#S:[0>(]7\5:7=:S;Z7<6$R+;,Z,)+6'RD998R)% ^;<2<>Q.,"K
M.GSIK_B3Q)IVKW#7!T^QMA:ALQ91XMSSJN?E8N<9ZK@#CG/8:AX:T/5K^"_U
M#2+*ZN[?'E330JS+@Y')'8\T^_\ #VC:K>0WE_IEI<W,*[8Y98@S >F?3VH
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MWQ,\'RW$:G,5\&8L1PJ*1^7)KDM6M53PQ\0-7CFN([VPUN26V>.9D$;A83G
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M:1!)7F0Q1!"KO]Y@1@@GN: *_@R^MM1\*V=S:174,1,B&*Z.9(V61E9&/?#
MC/?%<4(5G\!_$J*XDFG6WO+_ ,KSIF<KMMU(&2<X'I7IUM;06=NEO;0I##&,
M)'&H55'L!5 >'-%6VN[<:7:"&\8O<Q^4-LS'J7'\1^M $7A2UAM?"NEK FU7
MM8G/).247)YK9J&TM+>QMDMK2%(8(QM2.,851Z =A4U !1110 4444 %%%%
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M &2399R+E9CM/R$=P>F._2N*T!ISX_L-2:SU=K:70F@,\]BT2I()58H$VC8
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M:W\30VC%+AGRGE$#)W!@"..:P_'L4LS^&1%:W-P(=;MYY?)MWDV1J'RS;0<
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MUQ?@G2[^TU*YTN\^>P\/2O;:?(6W&19 KKGT:.-@GT8UL^.9KF#PM,]MIO\
M:#"6'=%Y'G%%\Q29!'_&5'S >H% %MO%6B)9WUU+?I#%8D"Z\]6C:'(R-RL
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\QR!@$N<Y/<USMU;W[6WB">SM+B6*V\60:E+;I$VZXMD6+<4&/G^9<\9SMH
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M6]R4G43!L@,4BZN%)YY!X. <4 =A144]S#;VDEU*X6".,R,_HH&2?RKEX?'
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ME*Y) )[^E8>DV'B?3/"FF:.EGI0N+2VBMOM)O'8(54*9 IBY.,D#(],UU]%
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MT=Q#O\N1=R[T9#CZ, 1^-5M8UC3] TF?5-4N!;V5N 9)2I;;D@#@ D\D#@4
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M%'D>8<E%VD8W9.">AK9\(Z/J&C#61?K;C[;J<U[%Y,I?"2$8#948(Q[UTE%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K$\37MS965H;:]AM/-NXXY'92\C(<Y6)=K;I#@8&#QD]
MJVZR-?\ #MMX@CLQ-<W5K-97*W-O/:N%=' (_B!!!#$$$'K0!PUQXM\0Q^%-
M:N8[D+=Z=KR6"/<0)O>)FAP'"_*&Q*>0.P[U<O-8\3:%XAU'2KG5(;U)](FU
M"SG-HJ&WDB(#(5!^9?F&"3GZU#XP\(IIOA?4X],.K7<^IZE;74D:[IBK++%O
M==J\?*F<G/3CTKHM4T6.+2]6U-I+R_U";3GMHV>(%PA!(1411C+$$\9Z9X P
M <Y:Z]XHLH/!FLWNIPWEEK9M[:YM!;*GEO+%N616'.<@Y!XYX ITWBW5Y_A]
M<>.+.Z 2&:20:<T:>6T"2E"I;&\.54MD'&>,8K7\'^'0?#7AF74I;Z2;3K6(
MQVMV@003"/83MVAB5!91DG@_C5Q? ^FQQW=JD]VNEW=Q]IFT[<GDERP8X^7<
M%+#)4-CKQ@D$ JC6=4F\<7^FQW2):?V+'>VZM ,QNSLN3SD\+TSWK"T7Q)XB
M>P\$:M>:FD\6M2"WN;46R(HW1.X<,.=P*?3!Z=Z[*7PU!)XAN=:%[>)=3V8L
MRJE-BQ@EA@%2<@L3DD]:I0>!;&WT[0[&._OQ#HLHEM,M'G(!4;CLY&&8?C0!
MR$5_K.E>%?B!JUMK,[W5EJ5SY9N(XW'R1Q8. HYP /3':MR2]\11^,--TK^V
MU,&JZ?+.3]D3-L\93F/UR'_BW=,^U:=SX$TZYM]<MOMNH1VVLNTES"DJ[0S!
M0Y7*G!8*,YSCMC)JX?#$+:SIVJM?WIN+"W>WB!,>TJV-VX;.2=J^G2@#E--\
M7ZM+86&G3R-/J$^KW>G-=1)&CND&\[@K80.0JCTZG':EU;5O&.C:-(]Q<11O
M_:UM#;331QO)+;RR*I$BI\H()(R.H]#6Q+\.]*GTB;3Y+O4"7OFU&*Y654FM
M[AB27C95&.2>"".:GG\$6EUI,=A<ZIJ<[+<1W+W4LJ--(\9#)DE<!00.  .O
MJ<@&#J&IZY;R>,](GUB20VFDK?6MU'"D<D199,H,#&,QC!/(SUSS74^#8I(O
M!FC>9<2SEK*%@T@4%08UX&T#@>_/O37\)V<VJZEJ$]S=2OJ-F+*XC9D"&,;L
M 84$'YFYSWJFOA2>Q70+?3]7U81:;)\QDN%V21 *-DB@#=\JX7 &,ECSU -;
MQ)=W-CX=OKFSN;2UN(X\I/>$B)#G&3C]!W.!7'MXEUF*3Q?:Q7<Q&G:7'?6<
MU[;(L@)60D%5"\$QC&X C)R*[+7]#M/$>B7&E7K2K!/M)>%]KHRL&5E/8@@'
M\*QW\"64D^H7$NJ:K)/J%D+*YD:9/WB#<-V-N V'8<#'.<9YH R]*UK78]<\
M)"]U)+JWURPD>6#[.J")TB1PRD<G.2#DX] .E;WC+7I?#V@_:H%0W$UQ#:Q,
MXRJ-(X3<WL 2<=\8I(_"%K'=:%<"^OBVBQ-%; F/#*RA#O\ DY^4 <8Z>M:6
MM:-9>(-(N-+U&(R6TX 8 X((.0P(Z$$ @^U '-7NJZOHWBVVT9KXW=OJ5C/+
M;S30IO@FB )SL"AE(8=1G(ZUS]EXD\5P^'_"7B:ZU.&ZM=2FM[:[L1:J@ F.
MT2*XYW D''3GIQSVIT.*Q$FHW-U>ZC>0VCV\4LRJSJAP2%6-!DL0N3@DX%8/
M@+PT6\&>'%U5[_S-/1)%LKJ,1K%,H(!QM#';DXR2._88 *&E7.JV6C?$+48M
M7GDN;._NC%]HCC=08X(F4X"CL N,XQVSS6KIWB&_UC5M'T07;VTLNA1ZI<W,
M:(7=F*H H92H&=Q/'IC%:C>#+(C74CO+^*+6MYN8DD78K.H1V0%3@D*!SG';
M%'_"'6:'29H+R\@O=,@^S0W<93S&AP!L<%2K#@?P\$9'- '*2>+O$)TZ.!;F
M".^M/$T>C7$YMP5N(V9</C/RDJPR!WSC%='X:U#5#XJ\1:)J-]]M2Q%M-!,T
M2QL!*KDJ0H (!3@]>><U/<^"]/N+&VM1<W<7DWXU)I49-\UP&W;W)4@\]@ .
M@Z "KMCX?@L?$&HZREU<O<7Z1I,CE-F(\A, *",;F[]Z ,7Q+=/+\0/!^DDG
M[-(UU>2+V=HHP$_(ON^H%4O&GB#5])CUZXL=04-I]DEQ;VUO$LA4C<6-P67"
MJ< *%8$C)&:Z#Q!H\EW?Z1K%HF^]TJ=G6/('FQ.I21 3QG&",]U XSFJ6H^!
MM-UFXU6ZDO-2ACUFW6*\MXI0B/A-JM@KN# <8S@XY!H ISZEKNH>.4T>UU1;
M*TGT87H*6RN\;^8%X+9!_$8Z\=QJ^!=8N]>\%Z=J-^R-=R*Z2LB[0S([)NQV
MSMS^-.M?"=O::S#JD>HW[7,5C]A4NZ,#'G=DY3[V[GT[8QQ5OP[H-OX:T:+2
M[2>XFMXF=D,Y4L-S%B,J!W)H S[OP/I=X-85[C4$757CDE6.Z91$Z'<'B_N-
MN )(ZXKA_B;$-9\6>"/ T;/+$]P+NZ#L68Q1C ))ZDJ).3WKUVN87P/8_P#"
M;#Q8]]?R:DL7DJ':,QK'_="[.!U[YY/- '(Z]XYURV\;>);+3[F!=,T32OM$
MS20!@DQ4, 3P3QT7(R?8&J][XI\1W/@KP1;3R6S:QXBN52=7MD=&MR=Q;81C
M(4H>G<UUT_PXT6YT[Q#922WI77IQ/>2B4!\A@P53MX48Z$'@FI9O &D3:IH=
M^9;U7T:)XK=!-\K!AAMV1D\>A'Y4 <7+K6IS^//%FJ-JQ71O"MJRPPK"NPRM
M&20/5A@KD_08S5C1O%FLKH/A330+9?$/B5WNY94@5$@@Y=I-HX+;,8SU.<YQ
MBNA;X8Z,^E:_IQN]1\G7+AKBX/G+N1F96.WY>F5'WL\9]3F6Y^&^BW-_I%XT
M]^DNF6[6T>R?;YL;#!#\<CD\# YQC'% '#7WCO5KSX:>,=4ENEGMY+QM*T@I
M&%:52=F_(ZDAL\=U. *]2\*Z,OAWPII>D*!FTMDC<CN^/F/XMD_C7-Q?"C0H
M?#>FZ&MYJ?V;3[U;V)S,N\N"Q /RXQECT /O7:26V;(VT,TL'R;%DC(+IQC(
MW C/U!H XOQ]KY_L76+"U>\CC@LIGN+JWMY7 8(2(@ZJ0AZ%F)&![G*\;I6M
MZIX3_9JT[5](EACN+<$GS8MX(>Y9>.>#\V>_2O4)/"UM+X2D\.&\O!:RPM#+
M,&3SI%;.[<VW!)R<G&3G.<\U6MO ND0>$+;PO(9[G2X)$=4G926"R"0*Q &5
MW#\J .4NOB!JVI:IXCTW2E2UEMM+AN-.:6,.9Y7/! ]&+*JCZ'OBH]=^(>IV
M\/B.>WN(+>#PY;QQ32[ PNKY\#RQGH@.0<<Y[X%=W'X5TF/Q7+XD\C=J4D"P
M!V.1&JY^Z.Q.>3_]?/-ZA\(O#VI-JQENM31=3O!>RHDXV)(#DE5*D<Y/)R>P
M(H S+KQ1XKBU?P=HD-Q;G5=1L'NK]'A 56V_+TZ*&)SCDA..31+XSUNSN+C2
M+^^MDN-#TLWVM7\,8(:4C,<,888&<@DXYZ#!KM+;PGIUKXI_X2$/<27PLA8K
MYLFY5C#;N.,[B>22>YK%UCX6Z%K6I:U?7%QJ,;ZQ%''<I#.%3*8 8+CK@=\C
MDX% %3X5>'_*\"Z5J%^&>]O)I-4DST:27.USZG9C\_IC6\9Z=':_#[Q ]NS)
M.EO+?"8GY_.C&]7SZ@HN/0 "NATS3H=)TRWL+=I&B@0(ID;<Q ]3_D>F*SO%
M5A/K6B3Z) &47Z^3--CB*$\.<^I7( ]2.P- %W1KU]4\/Z??./+DNK6.8X_A
M+(#W^M><Z)KE_HOA629M0GN;K4/$<FFQR7*H1$6N&3S#A1D[0>,XR   .*]1
M@ACMK>."% D4:A$4=  , 5S9\!:0^FZCI\DMY):WMRUV(S-C[/*7W[HB "IW
M<C.?RR* &6^JZCIWC]/#]W<M>VEY8-=P32(BR1.C!64[  5(8$'&0<CFE\;:
MIJVF?V$-*N88&O=4BLY?-AW@JX8^O^S^/J*U;#0HK34#J,]U<7M\81;BXN-@
M98\YV@(J@9/).,G ]!6#\0[:XO$\.Q6T5ZQBUJ">22T@:0PHH?+G"D#!(ZC\
M#0!S^L>)/$_AV/Q9IUQJBW5QI^G)J=C>BV1#M9F4QNH&T\J<$<XKJ)M5U(>/
M-/TN.Z M;O29K@HT:G;(K1@,#P<?.>,U=E\):?>6FK17SSW;ZK"(+F>4J',8
M!"JNT *!N)&!U))S5:T\%06NIV>IOJ^JW%[:6SVJ332H24;!Y 0#C:.W/?-
M'*Z9XG\1Q^"++Q-?:M!,UXRV26YM%5(Y7N?+68L#G"KGY>AX[\G7\76NL6OA
M+Q<MWJ27FG/H\QMQ(BK.CB-@X.Q54K]W'?.:U8/ ^DQ^#9/"L[W-UIC!@!,Z
M[URV_(90.0W(--3P3;G0[W2[K5]6O1>0&VDN;J=7E6(C!13MVC/<XR>,G@8
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M3V>I6NI7NH7$,]\+NU-Q.'EMF4AE*,!A0&&57D  9ZD4 </?ZEJO]B>-5UN
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!Y#Q*T>!T&TC%6:* *K:;8/I_P#9[V5LUEMV?9C$ICV^FW&,4?V;8?V>-/\
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MG:I<BY2VA6<1^4)0@#!,YVYZXSSCI4U% !1110 4444 %%%% !1110 4444
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MH **H+K>FOK!TC[7&-1"&3[.V5<H#C< >H]Q3YM4LX-0AL)92MU."T4>QCO
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT;MS@G/2(5ZI9W<%_907EM()(+B-98W'1E89!_(U3L=&CL?#L6C+/)+%'!Y
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M&>VGEDV$2I\O R".@.",]Z[?4K(ZCI\UH+B:V,@&)H2 Z$'(*Y!&>.XK!O?
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M]NM"U&ZM[J%].6^A:.#RC$?,*%.IR.AR>:K_ ! DOHV\-I9WSVR3ZU;PRJJ
M[P=S#.>P*@X[ULQ^'E3Q4/$#7UP]Q]C%D8B$$93=NSTSG=[T_P 0Z!%X@M;2
M*2ZGM9;2ZCNX)H-NY)$SCA@01@D8(H XJ8ZO!XR\<S:9?0V\]OIUC*TLD'F;
MRL<Q QD  X.?TK3MO%FH:W_9%K9Q2PW%WHT6IS-;K&S*9,!542,!@'=GJ>G3
MK6J/"$:WVLW8U.\\S5K:.VFR$.U45E4K\O7#MUSUJC-\/;?[+HWV'6-1L;_2
M;86D%]"4WO" !L=2NUAP#TZ\T ;GAN?6;C0;=]?M([74QN69(F#*<$@,,$XR
M,'&>,UK55TZQ33K*.V6668KDM+,VYY&)R68^I/I@=@ *M4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5A>+_$1\*>&[K6C:?:HK4*9(Q)L;!8+QP0>3[5NUQ'Q?\ ^24Z]_USC_\
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M=JR@LTZ\EF4C&3T+8/7%<?I\-K!\%O#$UL1%/]MLC(87*ELW 4[@#SQD<^E
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M[;VE%NH+-_>/')]^M<GX0G\4>(_A]8:Y'X@;^U+F)I!'/;1&W+!B I"JK@'
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M9S%]F3:9/[^,8W>_6F1ZY8:DPM+.[F6:>)Y(95@8*RK@%D9EV,!N'J.17.>
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MS5(RH.%/WMHR0#UP*Y!;22;Q!XBENM$UR^T[4-'@C+3Q%7FPTF\ <;6PPPH
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MSVWVI;9@(I'>-E&67 ("D\^G-+KNB:E8^!O$=M)J^J:W/>6,D,$4L",RN48
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M1;_>=9,;6W!<#:3G?['%[6/"MW?>*M4TY(V70O$%JLM]*IQY4L7RD#W<&/\
M!&KO\CU%(TB(RJSJK-PH)QGZ4 <9X;MM73P?=W.O0/\ VH;8V91%+,Z1!D4X
M R2[%WX[.*P])LKV&V^&:2Z=?*VG1NMWFU?]P?LYC&[CCYB!^O2O400>AS10
M!Y/?V4O_  CGC,3V&HH\VO1W5GLMR'<Y@".BMC?AD)VCD@=L@UO>%[^TO/%U
M[?746IP:K>VT<2K=:9+:1F.+)PNXD,V7)/S9QC X)KIM9T6S\0V44,\L\?DS
M":&>UF*/'(N0&!'U(P<CGI1INB)82":6^O;^<*566\D#%0>H 4!1TZXS[T <
MKXUT^>;6)+W2Y-5L=8@L!Y%S;6S3V]V-SGR)4VE3@\\XQOSVI$;4M/\ 'D>H
M7NDW3F^T*"W/V.$R1I<([LZ%AP@^<8+$#WKOZ* /(- BUKP[I7@K5Y]#U*:"
MRL9[&]M8X"T\!=D99!'U(RF#W K?UN.6[E\+7%MH=S:PIK?VN2)+4[DC\N0&
M20*"%8LP..O//.<>@44 <CX6AGB\8>+YI;6XBAN;N&2"22%D60+ B,5)'/S*
M14$4<T7Q$\1W;V=W]FETNWBCE%LY5V0R%E4@<GYEZ5VM% 'E-A87\/@_X=6K
MZ;?+/I]]$]VGV63,*K%(K%N.!EE_.I-)LI(6N?#6M^&-3OKA;^6:"Z)=K.96
ME:19&;=M4KNR1C.1QDFO4J* /+8+*2&]UKP]K7AC4]2%WJ$US:S(7:SFCDD\
MQ?,.[:A4GG(_A&,G%;EA'=:?XV\7M-I]X8+U+>6"=(2T;*D&QAD=6W#&WKSG
M&.:[;(SC//I10!Y3H]A?P:+\-H9M-OEDT^5OM:FU?]S^Y=,MQQ\S#^=)JEC)
M)HGCQ;BQU!1=:I#/:;("K2$"$(R!@ ^'3[O4XP.HKU>LW6]$M=>L5M;IYX_+
ME6:*6WE,<D<B]&4CN/?B@#D-$U>U?Q-?:Q>VNL#59; 0Q0R:3+;+(D6Z0K'N
M)#2$L3C=T QT)KL=%U:+7-'@U&*WN(%EW PW,>R2-E8JRLO8@@BH;#0([,[Y
M]0O[^4*566ZF!* ]=NP* ??&?>M"-+>R@2)!'#$HPJYP* /._"]I?Z1JME_9
MRZH-!DMI9+C3M0M7+:<^ 0L+E06!/&T9X&:S]+T^_@\%?#VTDTR_6XL-2CDN
MH_LLF85"R@EN.F77\Z]8,B*<,Z@\<$^IP/UIU 'D=ZFK7C6,DN@ZG'<6?B59
MY;>VM=D"0B1OWBXQYI8$,S\X)/W1UW8X;I=?\?S-8WHCN[:!;=OLSD3%8"C!
M3CDAB!Q_*N_HH P?!,4MOX&T*VN(989X+""&6.5"C*ZH 00?<&MZBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+_3X[>]FN>LN!*)6=R@# $D!B.,YXK7\#Z//HWA2R@O)99KV1%DN))A\Y;:
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M2"+S,,NT#:0#@YSQR!5JX\.ZAJ>HOJU\+..]CT^6RMH8I6:-3)C>[,5!_A
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=I;26ZO([A/*97+'.64[AG@GC(H [>BN+E\2^(K*74]^D/?VT&GO=6\T-I)
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M?\(3X3_Z%C1?_ "+_P")JD]Q%X>U+2_"NBQ0PR7IN;H&1"T<$8;>V%!&<M(
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MQP<#W!XQ<'@N_M=<OKK2O$=Q8Z?J,OG7ED+=7)D( 9HW)S&6QSP>>1VQV%%
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M-V011G *J 0 .!QCL/2@#R^827_A;1(;R[N[@V?C 64<KW+^88UN&5=S Y)
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MYN2%SU'%3P3:A;^)M:TTS7MK;MX?2Z2)[UY9$D#NN_<2=CD 9"DCC.37:_\
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M2P3(8Y(W&5=2,$$>A%8UKX*\.V4MO+;:7%'+;1M%#*&;>BG&1NSGL,>F.,4
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MZTRSTN.&SNUV3QJ[9D7^Z6SG;R>,XY/K5H>&]*6XL)Q;-YNGH4M&,SYB4C!
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M[EXE\TR1 D;2"IY[$'MG&0>WNO#.CWE[->3V0,UPJI<;795G4=!(H(5P.GS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ JG?ZKI^E)$^H7L%JLL@BC,T@7>Y. HSU-7*XSXEH)?#U
MC$87F_XFEH[(L9<[%F4N2 #P%!S0!N1^*-#FL%OH=4MI;9F=%DC?>&*_>QCK
MCO5AM:TQ;&"]%] UM<8\B1'#"7C/R8^]P">/2N-\2W,6B>-[+5+ZVOSH=Q8-
M;_:+ 2GR)O,WDN(OFPX(YP>5%9ZFU\'ZSX?U2#2+^W\,_9;JW"^7+,]J\DBN
M)'0Y=0^T\=1G!QTH ]!77-+?38M02_@DM)CB*5'#"0\\+CJ>#P.>#5"_URPN
MM.L+FQ\165K'<7<:1S';()_G :)03]X_=XY'I7(ZS)!I=WX>UJ#1K^V\.H]V
MLZ6D<D<L1EV%9VC3#@$J^1U ;D9.*CUBTTV+PU8S:-IU[#;7/B.UOCYRRM)+
M^\0R3%7RR#@]0.F>] 'HD&L:=<WUU907L,MU: &XA1\O%GIN';/;UJ*37])B
ML8KUK^'[/*"T;JV[>!U(QU [FN8\26.I67C"QU31HW8:O =+O&C_ .61P7BG
M/^X/,'X@55\0O#X:\9:?=7MMJ T!M,%E%-8^:WV:17SAA%\VUEVC//*B@#O;
M6ZM[ZUBNK2>.>WE4/'+&P97!Z$$=:J2:_I,5\+*34(%N#*(=A;_EH1D)GIN(
MY"]?:J_A6QL=.\/6]OIEA-8V0+O#!,SEPK,3DAR67.<[3R,XXZ5YOKMU)<+>
MHNGWMJ]IXF@FDM+>Q=E=%F3_ $AGVG<6 R IZ=CC- 'H]WXO\.6+3K=:W81-
M;N(Y@TZ_NV/0'T/\JV58,H92"I&01WKS"Z5);[XFR?9I,W5C$D):%LR_Z,5*
MKQ\Q#8! [UW/A5B?".C[@P9;*%6# @A@@!!!Y!!!H P]"\1W;Z_XJAUB_M8]
M/T::.-)&01#:T8<EV)QQG':MZR\3:'J-\EE9ZK:3W3PB=8HY06*$ Y ^A!_$
M5PEFX-[\3&,<NRZ -N3$V)@+?9\G'S?-QQFC3T$4_P +@L#I]FM)$GQ$1Y)-
MMMP_'RY?CGO0!TEQXNT_1-"U75[K6X-3MXKQHHA;JH\MCMVP97.2">6/KSTK
M2_M2WN=?L(K;7;7:\$CFP"JSSCC#@YRH7![8.?:O.KVWGG\!^/(X+6X>1]>:
MY1%A;=)$)(6WJ,9885CD>AKI[^Z2[^)/AB]@BG,/V"\!=H67!8Q[ V0-I;:<
M XH Z>#7])NKY;.#4('N'+A$#??*<.%/1BO?&<=ZRO".JZAJ5UXBAU"=)38Z
MJ]M"4C" 1B.-@,?5CR37!Z7=O<:AX)NQI]]:I;7URDUC%82+%9%HI $SMRQ)
M(RV2._R@UV'@8D:GXNW(Z^;K+RQET*[T,4:[ESU&5(R/2@#J=0OH=-TZYOI\
M^5!&TC #)( S@#N3T K"\#^([GQ%HDSZC MMJMG<RVE[;J>(Y%/&/4%2IS1X
MA?\ M36-/T&.>:W!;[9/,D61^[(*)E@5W%RK8/9#ZU@11S^$_BIO>>ZO++7[
M4?:I?(&(;B+A&8HH50RDK]1S0!UQ\4Z"MG)>'5[,6T4WD23&4;4D_N$]F]JM
MRZMI\$K1S7L$3I";A@[A=L0ZN<]%]ZX'6?#%[>Z_K_AR"-X](U^);]KE1Q;S
M(-K@?[3,L+?]]&G^?JMQ\--4UG6-#-YJ<UJMO)8.A;<L?RL2HY(+F63 Y*D"
M@#M(?$.CS17,BZC;JEJH><R/L\I3R&;=C /8]#4=MXIT"\2=[?6+*1;>))YB
MLPQ&CC*L?0$5P45SYGBO7;HG4+F"[\.HL=S+9/&KL&ER -@P.0 #R<]Z;+;W
M%K\,/!=W;6$SIITUC+J=O% ?-\N-3ORF,DJY#8]LT =1H_B.?4OB%JNEQWD<
MUA;V$,R1K%M:.1G<$-GG.%!YQP1Q6_?ZWI6E2Q1:AJ-K:R2AF19I50L%!9B
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MCYI7T,G0;T1:U;^99N)(R6?R_,V$9X&,_,?3M0!V"(D4:QQJJ(H"JJC  '0
M4ZL7PYX@_MZ._22SDL[NPNFM;B!W#[6"A@0PX((8&F:GXD%EJTFE6ML+J^CL
M_MA@,PC:1,L (P1\S94\< <9/- &[17+:SXVM=*:ZC2*.:>SMUN+B%[E(F (
M)"H&^\^!G' Y'/-5G\?B>\M[72=#OM0DNM-&I0;7CCWQEE&/F;@C=SG'(P,Y
MH [*BN:M?%RS2:_%/8/;3Z* TT;R EU*;U9<=B!Q[@CM49U*S;QSI]O>:3)!
MJ;:9+,ETTH*1Q[DWQ\'DY*Y)';@T =-+'YL31EF4,,$H<$?0]J2W@BM;>.W@
M0)%&H1%'0 =!7/V?BMKV32YH=)NGTW4V*V]W&-VT8)5Y% ^1& X.>XR!FJ1^
M(NF?:]/"JDEE?W0M(IHIU9PY)"LT8Y"$CAO<9 S0!V-%9OB#5FT+0KS5%LY+
MM;2,RO#$0&* 98C/7 YQ6?#XLBE\0Z7I/V; U*R-Y;W E!1U 7*@=2?F!],<
M^U '145QU_KME=2^&YM0T:5_M6I%+*42@K&X5]LG!!(90Q'!X(S@UC:SK>H:
MWX>^(=I>6:Q6^FP3Q0LDN2I6W#@G &22V?;ISUH ]*HKCO#?B9EET/1+K3+B
MV%WIHEM+AW4B;RU3>-H.5X8$9ZCT/%7?'>N7OAWPE=:CI\"2SJT<8+M@)O<)
MNZ<D%AQ0!TE%>>W=Q=VOQ8@N(=,DGO)?#\N;9)E R)X^K$@ 8'6MBV\=Z?=:
M%I>H*@AEU(R)%!<RK&$:,D2;FZ *1C(SG(P.: .JHK$\,>)K;Q-97,T,312V
MMR]K/&6# .N.58<,I!!!%<^+I_$_Q-U31+EW_LK1+6%GM@Q"W$THW OC[RJH
MP%/&3GTH [NBN?ETS3O#UY+KRS&SL+6RE$\"L1"!E6WA.@("$<#G-1+XN$5[
MI45_ITMI#JW%G*7#?/MW".0?P,1G&"1P1F@#I:*X>7XC+#IEWJ;:%?"QL;]K
M&\D,D>Z(AQ&6"@DM\Q' [=S6@OC!X]5O].N]&NX+BVLC?Q)YD;&>$-M.,-A6
M![$]^M '445Q-E\1$N)-"EN=$O;33M;"):WLC(5\UUW*A4'<,\@$CDCTYJZW
MC-(KZQCGTV>&UOM0?3X)9&VN9%W?,8R,["4.#D]N!F@#J:*XB\^(GV2UUF[_
M +!OFM]&NC!>/YD8V*%5BX&[YN'S@=ASCI6VOB,'Q<N@26CQF2T-W!<LXV3*
M" 0HZ[@2,CT.: -RBJ&CZDVK6 O/(,*-(ZQY;=O56(#CV;&1[$5BZQXS31VO
M)IM-G^PV=U#:S3LVPLTFW!C4CYU&]<G([X!Q0!U-%<I?>,YK?5M7TVUT*\NK
MC3+>.X<B6-%=&W'()/\ L'CJ3V'6K,/BVVU"+2%TV!KBYU6T^V0Q.WE^7#A2
M6<\XY95X!R3Z D '15CZMH!U>^MY9=3O(K.-2LUC$5$5P,@_/QG''(!&1QT)
MSS_PR+'3=?W0O 1KMV#$[;BF"/ESWQTK5U[Q4VBG4"NFS3Q:?9B\N96;RU*9
M;Y4)&&?"DXX[<\T ='17+S^,O^)Q9Z98Z1=W<M[8&^MW#HBLH*C!)/'WQDG\
M,U67Q_$^AZ3JPTR=;>^O/L,N^11]DE\PQ_.?[NX$9'MZT =C15"#4C<:U>6"
MP'9:QHS3[N"S9.S'J  3[,OKQFZYXI.CZUIVDQZ5=WESJ$<K0>4R!28P"02S
M#'4<G ^IXH Z&BN2T[QTFHZ=*ZZ1>QZE#?KIT]BP!:&4]&9ER/+P<[_2HKGX
M@V]IH&K:G)IL[MI5Z+*YBA=7 <E &5N,K\Z]L^U '945R\GC!K9TMK[3OL%]
M,\OD0WEU&BO$FW,A<$@ EP,<G/; )JC!\2+6ZM-+F@TJ]E>^O9+ HC1GRYD#
M$KG=@@[<@CC!R2* .VHK@=;\>WL'@[Q#>VNF-;:II,PMIH9I581E@I60$9##
M#@X]>*[FW>62!7GA\F0_>0-NQ^- $M%<I=>.;>VTN76Q92R:'#<&"6\1QD;7
M\MI G>,-D$YSP2 1S3IO&,Q\1W>BV6@WEY-:K!(\B2QJICE)&\$MT&W..IYX
MXH ZFBL[7=9MM TF34;H@1(\<>2P4!G=47)/ &6&3V&367J'BN72K!KN]TMU
M1;V&TS%,&5Q*4"R(<#*Y?!Z'@T =+17&^*-9BO++Q5H$ELZ2VND-=B4/\K*R
MN%QCD$%#5/PSXN:RLO"^E:AI%W:VU]9PPV=\[(R2R"(':0"2N0#C/7VH [ZN
M:@\*W5G>7+V/B/4K>TN9WN'MML,@5W.6VNZ%@">V3CMBI-(\4?VT(;BSLC+8
MS-*BS1S!F1DS\KKQM)QP,GWQTK,T+Q+I-KX9AN+#3)K7[7J4UK!9%P7DN#*X
M;)R0!E78\X !QZ4 =?;6T5G:Q6T"[8HE"JN<X ]SUJ6O-M/N6@\:>/)K[3)"
M(]/M&EMXI0_FKMF)*,2O!'KCH:WM+UZ*+0?#\.CZ1((;O3A<01NY6*WB5%(5
MY,'GYE ]<&@#JZ1EW(5R5R,9'45QP^(5O-IOA^]M-)O;A=;9HX%4H"CJK$JV
M6ZY0C/3OFKNE^*I[S7XM&O\ 1Y]-NY++[8HFF1@5W!64;<Y()&?8@T =!;6T
M-G;K! FV-<G&2223DDD\DDDDD]2:EJAHVI'5M-2]\@PI(S>6"V[>@) <'T;&
M1[$5?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP:1NBY P/QQTK0H XBVT?Q7H>NZI%I1TV?2-2NFNUEN9&66SD?&_Y0")!D9
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M %2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>O>VRM)&V';=P<IR/G;WYY)XJ>6T@\(SZKKB)J^I2:E/&T]O;PK*P8 ("JJ
M<!0,\GIF@ T77CXCN]-N--NW;3S8"YN RKEG<X12<<$;9-P&,$#UKIZYSPSH
M$>DZ%>+';/93:A/-=R11,-T32$D*#R 5&T>F0<<5=\-:?>:7H-O9W]Y<7D\9
M?]]<N'E*EB5#L."P4@$^W?K0!Q-^GB+P1?:MJ>G6L>O^&;VXENKNT0@7-LY/
M[TIV=<@_+U[<<FM:Q\0>;KWA6UTBY)T34]+FF1&0;E$8CV8.,@X<Y!STK5/A
M9TCO(;;7-2@M[R6666)3&P4R,6;860E>I[^_7FF77@NQ?^Q387-UICZ/&T-J
MUJ5)$3*%9"'5@00HYZY&<T <7J>J:EK&BZ4T]Q&UU;^,1:12M&,;8Y'52RKC
M/ YQC/M6L^N>*M)U/7M#D=-8O(-/34+&6*!8W*,Y1D*@X+#:2OKWK6C^'^G1
M:8]E'?:@/^)D=4BE,BL\,^XMD94@C)/#9S5]O"\$B7DDE]=F_N_*#WP*"51&
MVY%7Y=H .3C'.3G.: .9B\=*^DS7.GZC+?22WMM8I!<P+%<6DDC;6$B809ZD
M9P">,]ZFOM?\2>'(-3GOH#+:.T$6G2W9B$@ED<1D2"(X* L&R,' (]#6M>^!
MM+U2WU1-1>>YFU)8EFN,K&Z^5DQE=H !4DG/OZ<4S_A!+*YT*[TK5M2U+51=
M((S<7<P,D84[EV%0 I# '.,D@9S@4 0F[U>T\>6>AR:M)/:W6FSW!9H8PZ2(
M\:C:0N,?,>"#]361I_BW6;GPEX)U62X3S]4U".UNU$2[71O,S@=0?D'0^M36
MFD76E?$O2/-NM6U*./2[B%[VZB+*&9XRJED0(#A6YZGN>E7X/AS8P6UA:+JV
MJ_9=.O1>64/F1[8""QVCY,LN6/WLD 8!'.0"F^O>)M7@O+[0('9K349+9+>3
MR1!+'%)L?>Q;S Q 8@C ' P>IJZGKGB;S?&_V;5;>!-"1)[<"T#%QY'F[&R3
MQV)Z^F.^Z? 5BFMW>H6VI:G;6][+YUYI\,P%O.YZL1C(W?Q8(SWJ>;P9:S/X
MA9M0OA_;J".Z ,?R@)Y?R?)Q\O'.?SH PX;N^U/XCZ!-]OGA@N-!DNS;($*
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M "IC\K(;!RI8G*@YW=JAD\&V$]QX@DN+F[F378A%=Q,RA0H38-F%!'RG')-
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MY8T9)1M"]6;&W&0.>XK=N_ MCJ.A?V=?7^HW-P)DN%U%Y@+B.5/NLI  7'.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ4YP2.V1@]#0!:HKA/"EP?'$^K:Q?R2M8PWTEG8V:R,L:I'@&1@"-S,<]<X
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MXR$L=S%LU&-1%<2[V3]RA.#D\$Y(YZ$=.E '<45S$GB2]7XACP^-/<VBZ?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;&ZMGOXXWC*N75U)."/F((_$9KM/['TS_H'6?_?A?\*/['TS_H'6?_?A?\*
M/-+&QMF\-?V3KUOHU_:RZC=7$D46I1F2,/(SHZ,2N&!;'!'!/(Z5U?A&\MM(
M\.PV6I>(;6YEC>3RVFO$D=8BY,:LV?F8+@$^HKH/['TS_H'6?_?A?\*/['TS
M_H'6?_?A?\* .(T0P>#M5U1-/O;"_P!$U"Y:\2&.]B2:UE;[Z@,P5D. 1R"/
M0]:SYK7[3;>/;K[;ID<WB&!(;6W-]&6CVP&+,A!VCDYX)XKT?^Q],_Z!UG_W
MX7_"C^Q],_Z!UG_WX7_"@#BM3OIY-'\.0VM[ILD5LRKJ5BVHI'YRB,J!O!.5
M#88C^(<'TK 73YXM$NK!9M%7=XC34XE@U&/:(1*LA !QCA<#^E>J?V/IG_0.
ML_\ OPO^%']CZ9_T#K/_ +\+_A0!PE\D5_KOBJ87^G16^K:0EC!(][&<2*L@
MRP!.!^\'KT-47;4+2+PYJ]I+H<U]IUD;"ZTZ34DQ-$0GS+)C"L&3/3H:])_L
M?3/^@=9_]^%_PH_L?3/^@=9_]^%_PH X'5)KJ74= \1P7>BM?:?),)M,2_0+
MY,JJI"R' +KM!R0 <D= *T/"UXMGK_B._P!1O-*MX=1N8IH0FH)(PVQ(A!'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRVU];31P_P"L>.96"<9Y(/'%<Y\2A>?\(3<M:123(DT+W448RSVXD4R@#O\
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M/ZA_T-NM?]^[3_XQ4.J^,[32M9DT@:;JMY>QVHNO+M+?S"\>[;D9(S@_R]<
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M\NXOV9AQCJ1D^M&BZK(GB75?#ES(TDEHD=S;2.<L\$F1@GN596&>I&W.3DD
MZ*BBB@ HHHH **Q/%VG:AJ?AF^ATF]GL]2$3/:RPR%3Y@&0#V(/3GUK#LM>_
MMSX7V=W933QWM]"EK&?-;S([DG8<G.?E;)/LI[4 =O16--J4.B0I81QWVHW,
M%OYKI&1)+L&1O8L0,D@X&<G!P..(+?QCIE_:VL^F"?4%N;4WB+;J-PB!P6(8
MCG/&!DY!XH Z"BN63Q<\_C&UT:'3KEK>;3?MQGPO1G4+QNS@9;/&<XP*K6?B
M[0]*T.\U+SM4EM?[5DMI#<([M',9 I4 _<0,< '&* .RHK"L?%NG7EUJ5M(E
MS9RZ?$)YA>1&/]T<XD&?X?E;T(QR!44/C/3I;[3+1K>^C?5(_-LF: D3)P2W
MRYVX#*3NQ@'ZT =%113)C((9#$H:0*=@8X!/;- #Z*\M\+:RGB&U@LWUS4;#
MQA;31MJ%E=3LF_:X,BK$?DV%<X* $#&3USW!\3V8NM9MO)N3/I$:2W*!1RCA
MBI4YP>$8^OXT ;5%>>ZEXD4>,/"VJ6DFHSV&HZ7<7"VD =S+Q$4/ECC=ASR>
MG<U>U#Q?H.K>$)-1>?5+>V2\2VF6!'BN()A(HV/C[O)4')P0?>@#M**Q=6\3
M6FD+=L]O=7*V40FNS;(&\A""<MDC/ )PN3CG'(RRX\6Z='!YUJL]^HM%OG^R
M*&V0,"5<Y(Z@' ')P<#B@#=HKDX_&B7GBG2M-L+*>XLK_3FODNE"@%2T84@$
M@@ .2<C/3 /-7?&7B&3PQX<FU**SDN7$D<2A<80NX0,V2.,L.G_UP ;]%9$_
MB"**=;5+*[GOO(^T/:1*ADCCS@%LL%Y(( SDX. <&K.D:O9:[I<&I:?-YMM,
M"5;!!!!P00>00000>A% %ZBO-[SQ#;1>.]2TCQ/J5_I)D9/['F2X:"W>/8,D
M,#M9]^[(?(Z #UZVVO)='TK3+&]DFU'5'AQB+;OG* ;WY(4#D9)(&6 [@4 ;
M=%<_:>,=*O[&"XM3-+-/</:I:!,3><F=Z%20 5P223CWY%9FH^/X8[&RFT^P
MNIY)M732YXV55:"0. ZMEL$XSC!(Y!SB@#LZ*YV#5-.?QC=0M-?PWL6FI+-#
M,Q6W2+>?F )V[LY!89X&,T^'Q?ITL^G*\=S!!J9Q8W,L8$=P<;@ <Y4D<@,%
MSVH WZ*Y*?XBZ-;PWT[0:B8+"[^RW<HM6"P-\OS-G'R_,/?OC'-=5)O\I_*V
M^9M.S=TSVS[4 /HK@;K3]8T#Q9X?DM=?U'4#J%P\-]:W;AHS&(V8R(H $>T@
M#CCY@/KMZ-JQUS6M8N!*4L-+N391J&P'D5097;U +;0.@VD]Q@ Z.BO/?$7B
M,WVH^#Y]..HPVEWJR*LX;9#=1%'.,!LD$A2-P&0,CBMDZ\NA^*+S2;Z9C:&P
M;4K>5SDHJ'$J9[@?*P[\D= * .IHKAY=9AD^&L_B/79]0@@O[87#"Q9A);Q-
MRBIM^Z0I&6[DG/& ->XO]/7QCIED\VH"^:SF>*-2P@=!LW%NS,.,=2,F@#H:
M*Y/3)H=6T75Y="O-0%U#?S[6O&8[+A>J;6_Y99XV\8&<8.#6OX:UR'Q+X:T_
M6(%*)=PB0H3DHW1E_ @C\* -6BO,]$\9P>'4\0_VLVK7-M;ZY/&;KRWG2UB^
M0+O<]%'H,X].:[+4O$]EIT=Q(L-S>):P"XN#:JK^5&02&.2,\ G"Y.!G'2@#
M:HKBFU+[9\1_#TUC?S2:=?:3<3A%E;RI,&+8^WIG#'G&>:U&\9Z6BV\[K<+I
M]Q<?9HK\H/(:3<5 SG< 6! 8C:3WY% '0T5SL_C+3[=-;:2VO<Z+@WBB,%E4
MKN#*,_,-HSD?T-:$&M07$^GQ1PSDWUNUQ&V%*J@V\L0?]M>F>OUH TJ**Y_4
MO&&FZ4LDUREQ]AAN!;3WJ(###(2%PQSG&2 2 0"<$C!H Z"BN>O/&>F64]PL
MB7#06MW'9W%RB QPS/MVJ>=W\:9(! W=>M2:MXLT_2!>O+'<SQ:>JO>R0(&%
ML",C=D@DXYPH) P2.10!NT5Y_)K[:9\1M4<-J5]:-H]O<QVMN&E )DDW,JDX
M7A1Z9^M=KI>I6NL:5:ZE92>9:W42RQ-C&5(R..U %NBN$TB^GB^(OC"*XN[V
M6RTZ"TD@M_,>0)YB,7PO).2HXYQVK2T[Q]I&IRZ2L,-\D.J@_9+B6W*Q.X4M
MLW?WL GTXQG/% '4T5PU_P"++/1M*\7:MI\>I7EQI\O[^"X8A(Y/+7&P,1M3
M&"<=<G&:TIM7LYM>\-PW8U.UO[GSFMX 2L3XC);S-I*MP,@9)!(- '3T5SR^
M,],>[@B"7'D3WSZ?%=;!Y37"[LIUW=589QC(ZU2\-37!\=>,;:2ZGE@@FM?)
MCEE+B/=#N8*#T!))P* .NHJIJ=_'I>F7-]*"R01E]J]7/91[DX ]S7+^ M8U
M2X?6-#\02*^LZ;=%G9>CPR_O(R/89*^VT4 =G17,S^.--MK#6;R6VO5CT>41
M7B^4"R<!MP&>5P0<CL?8XT;GQ!9V9S<I+'$MF][++@,D42\DL03S],YYQG!H
M U:*P+/Q;8W=TUJ;>\@G^Q"_CCDB#&6 G&Y0A;OC@X/(XJI8?$#1]0T\ZC'%
M?QV'D+.ES+:L(Y-S; BG^)]V!M'/- '545P]AJ=U<_%R:V==0MH?[$\TVMQ)
ME-_G ;U"L5Z<<<\&NIU#5H;"XM;8QR3W5T6$,$6W<P498_,0, 8[]Z +]%<#
MK6NL/%_@^]@?44MKE;U9;-0V9"D?R@Q@XW YZ].^,5MP>-=*N-(2_5;E6>]_
ML\6KQ[9A<[MOED9P#WSG&.<T ='17">+_$":E\./$]SITUY97FFK+%( YBEA
ME4 XRIY&&!R"00:GO)[F/XA^%(UNK@0W.GW;2P^:WENR"+:2N<9&X\^] ':4
M5E>(-?M?#6EMJ-]'.UJCJKM$H;9N( )Y'&2!GM4ESK-M9W30W"O&J6S74LS;
M?+BC7J6.>/ZX/H: -&BN?'C#3H]0^Q7L=S82-:O=Q&ZC"B6).79<$X(&"5.&
M [4R\\71VNDWE\-+OF\BR-\B$(/.C SD-N(]R#R!VZ9 .CHK,\/:E-J_A^QO
MY[=X)9X$D96 Y)4$D8)XYX[UIT %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !156?4[&
MVO;:RGO(([JZ)$$#. \F 2=J]3@ T:AJ=CI-H;K4;R"UMP0#)-($7)Z#)[^U
M %JBBB@ HHHH **** "BBB@ HHHH **** "BBJUA?VFJ64=Y87,5S;29V2Q,
M&5L$@X(]P10!9HHJK/J=C:WMM93WD$=U<DB"%I 'DP"3M7J< &@"U15:_P!0
ML]+LY+R_NH;6VC&7EF<(H_$U81U=%=2"K#(([B@"CK=@=5T#4=.5@K7=K+ &
M/8LI7/ZUQ+V=_K/P+72;*S>74CIBV#6^]4*31@1N"6( PRGO7HM4;*;39KZ^
M%E+"]S'($NUC?)5]H(W ?Q;2.>N /2@#G;FPU.?QSX:U%=,F%I:65Q%<2&2+
M]VT@CP,;\G[ASC/:C3;1[OXJ:UJZC_1[73X-.#=FDW-*P_ ,GYUUY&01Z^E1
MV]O#:PB&",(@).!W).23ZDDDD]R: ):*JPZG8W%_/80WD$EW H::%) 7C!Z;
M@.F<=Z6YO[2SGMH;FYBBENG\N!'8 R-@G ]3@&@"S1110 5Q&A>$KO2O'&JW
M!=/[":4W]G#G[MU*I24^P #>W[VNJU'1M+UA(TU/3;.]6,DH+F!9 I/7&X'%
M9_\ PA/A3_H6-&_\ (O_ (F@#G_$6EZE:>-O[;M_#T.OV%W9I:S0%HA+ Z,[
M*Z^9@%2'((SVS46N>&Y-0AM1_8LUC>6ULSV=YHTR1-:RLS$Q'YEW+]W/&TG<
M>,UN7'AGP1:3VT%QH.@Q2W3F.!'LH@9& )POR\G )JS_ ,(3X4_Z%C1O_ "+
M_P")H Q+/3O$%KXQT;5+VU6\9M#6QO9X9$58YPZNS$$@E3AL;0><< <C%G\/
MZ_)X1U>R71I_M-SXC.H11^?#S";E9<YWX!VJ>.N:[7_A"?"G_0L:-_X 1?\
MQ-1-X2\&K*T;>'M"#HGF,ILHLJOJ?EX'7\C0!BZI:7$?BGQ#JU_II&D3:"MJ
M7FGC5'93(S(<,6 (<#./6LWP[]LL+OP^VO>']:C:PA%C:W,LEN\4#2;4R1&V
MXYPJY(.!U[FNBL_#G@#7+:;^S](\.7L0)CD:U@A?:?3*C@U7T_X?> ?#NI1/
M!I-A%>2MF$7,IE;((Y19&."#CD4 =/IEW>7<4[7NGO8ND[QHC2J_F(#A9,KT
MW#G!Y%6;CS/LTOD_ZW8=GUQQ1#/%<1[X9%D3)&5.>0<$?4&I* /-O$V@W_B_
M1K".?P[+9>)(7A9-2$D6VU8,"[!U;<5P&PN.I' ZB[J.FZS:^*?$\UKI,EY;
MZUIT,4,Z2QJL4D:R*5?<0W.\8(!_P[RJM_J=CI<*RW]Y!;1NX16FD"[F/  S
MU)]* .#TW1M:TUO ][-I,S_V5I<EC>0Q2QL\;E(@&'S %<QGH<\CBJGB71+F
MP\$>(KVYC\NXU;6+6Z^S@AC$OGP(JDC@L0N3C(R<9.,UZC69/X?TVZU8:G/
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M7TJ[XM\2#PU;V,\K+!:SW'DSWDL321VPVL0S!2#@L N<@#/-1Q::VI^/!KK
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M>8S AB<Y'3!XXY-4/#-GINK>*=1\7Z:)C:W<$<,3.C1K*X'SRA6 /($:9Q_
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M=B.HZ7XK\4Z9IM_<2?\ $GCO+87UPTJQW!,JYRY.U254D=..@H ] H) &2<
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ME&1DY ]Z -"BN=\":Q=Z_P"!])U6_96NKJ'S)"B[1G)Z"NBH **** "BBB@
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M Y)4LK8']VNPHH \MO[G0ETJ]U[2-+O+R*\O;+[3?7<<[*I1^)?+;#,(QCH
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MD4?CSQO(_P L<EC:@,1\KE4E# 'N1N4''J*RF^3]G'R'C;SAHXMS$5(82D!
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M"8O^!?O2/^N@%>BT4 >9K+X5\2VFH:I%::W,XTN6UO)9!.LD,3<F(!N&?.2
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M1T(<J@=E(!R/E.03UQ5;4?#>HZO?:KK$D$$%Y/H[Z7:VYFR!O)9F=@..=N
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M*H!*''4 @C\Q0!,"#T.:*\O\)Z]?V_A'P58F^DDO->+9N)54F%51I'(XY8D
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M*ZFA&Y"AVLCA=H;G!! '4YS0!W=1W$\=K;O/*6$:#<Q52Q ^@!-<'I&OZ_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9Y+B5VQEY'8LQP  .3T I^IZ<=12WV7EQ:203"9)(-N20",$,"""&.1BKU%
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M((W9^\&SGFI+WP+;W&M_VM::QJVGW4L20W;6DZC[4JC"E\J?F XW#!Q7544
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8! &'/)/"XJCH_B#5-)TGQ)J%W=K?3?V^]A C1!?G:2.)#]X#: 1\O'3KWH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL37?$1T
M=HX;?2K_ %2[=2_D62*2B#^)BQ  [ 9R<' X. #;HK'\->)+#Q5I U&P$R*)
M&AEAG39)#(OWD=>Q%;% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 55O[R#3;9[J8$GA55%R\C?PHH[DD\#WJU7/:_X2B\07]M>2ZOJ]F]LI6);
M&Y$2@GJW3.2.,YZ?4T /\*:&^BZ;<M<!1>ZA=RW]TJ'*K)(<[0>X4!5SWQGO
M6]63H6@1:##.JWVH7TDSAFFO[@S28 P%!/11R<>I-:U !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>elicio-arnonxemployeedir003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-arnonxemployeedir003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<VKW,2R6LL6[#*S\%2&Y YR*[S372#3H8YC:0R!<M%;L B$G.U>F0.F<#/7
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MC@88W9&[<0N1DJIQSZ'$6H>.+"QU5]-BL=3OKI;5;M5LK?S-\3-MW+R,C/\
MG.!7.Q:/JFGZ'XI\.);QW4.J37,EG>^?&$1;@'(E!;=E2Q/ .15_2-)GTGQQ
M:RI'OTRVT&+35NC-'RZ.3DKNW8QWQU_.@#N:X"""2_\ BMK>G3W^I?8H=/@G
MCACOIHU1V9@Q&UAZ#CI7=?:8/^>T?_?0KB(4U"R^).KZU_9<L]C<V4-M$T5Q
M!DLA8DD-(,#YO_K4 &G:QJ.@_$"X\+7]W/J-E<6!O["610TT>UMKQ$@#?Z@G
MGL2:T/#_ (BTE/#>B?V8NH7,=^)!9Q3R!IW"EBQ9G;MCN<\BJVF:3=3>,+KQ
M=K!@2X6T^QV-C#,KF*+=N8LQP"['TX XR:P]-\-NW@30=#UO16F:U$ID>VO(
MDFM9-V4DC<..Q(.#^'J =FWBJWW64,=C?27EXDLD=HJ(LBK$0KEMS!1@D#KW
M^M<QK'B6"]U;P-KFG2W\EE>37&;>'?F4>1)A3&#@L&'4]/7'--M+7Q1;KH5M
MJ;#5K)(9TNE-W&C[R_[EICG]X!'PP7.6R<-@51T30]9TO1?!K3V$33:'=7!G
MMX;J,NZ.DBAE)(7^,'!(./?B@#?O_&FB:GX0UV>[AU:U2P!AO[94,5U!D9!^
M4\9'(8''O3]0EDC^)?AA8KBY%O/I]VSPF9BC;1%M)7.-PW'GKS63KGA^]U#1
MO&EW#"GV_7HHX(+3SXP42--JEVW;<DEB<$X&!S6K<V]Y/XU\-:DMKBUL[*XB
MN&,\64:01X&-V3C8<XSU'6@"I<^+K;2/"NM:KH]GJ-R\>K-;2K=2?ZJ9G1"0
M';(0%@ H[]@,FND@\2PR>(X]"FL;RVO)+4W2^<(]A0$*<%7.2"0"!_+FN)N-
M!U:Y\&>*;%;1$N[O6CJ%K&]S%^]C\Z.0#(8@'"'KW(K9\:0W-[IVD:M8306.
MO6EV@M@[A\"4B-T;'!&UMQQQE.N!F@#J],U*/5;>2>*&:-$FDA'FA?F*,5)&
M">,@X/M5VLB/S=*MM*L-*L1>6BLMO-+]H53!&%/SG/WSD 8'/.:UZ "N'O);
MA?C%868O+P6;Z1+<O;K</Y;2+(J@[0<=">.E=Q7'76FZFWQ4LM933I'TZ+3)
M+1YA)&/G:0,#M+9Q@>E #A\1=*,)N#9:F+6.^-A/<-;@)!+O"?/ELXW$#@''
M<#BNOKS"X\-Z]+X&UW3%TF3[7>:XU]"AFBP8C<K-DG?@':I&/7\Z].4ED!*E
M21DJ<9'MQ0!S4GB*XE\=OX:_LVX^SBP%P]PLB#.Y]H(^8$ 88<?-GM@9/.>!
M?%T=EX7T2UU)-2F:\O)K5;^4%T\TSR;$9V.XD@ 9 ([$BMZXT_4[?XDKK,%C
M]HL9M*%H[K*JF-UE9^03DY#<8[]<#FN;M?#>O0^"?#FFOI,GVNQUM+V=!-%@
M1"X>3(._!.UAQZYH ZW5O&>FZ/'<7%Q%<O8VLRP75Y&JF.!B0/F!8,0"PR54
MXS[''1 @@$'(-><VVB:WI.NZM:+X:T_5+._O)+NVU&:2,?9_,.6612-S!6R1
MMSD<<=O15&U0/08H Q-7\46FD"\)MKJZ%C$)KO[,$/DH03D[F&3@$X7)QVY&
M6V?BW3[_ %NUTNWCG9KNR%_;W&U1%+#QRISG/S#C&>?2N>U#1]8TWQKJ6H6_
MARTU[3]56)B9)8XWM940(<[QRA !XR1SQ5_Q+X=U2[L]#O-):W@UG395 9%V
MQB.0>7, /[H!W ?[ [T :P\2V[0Q,EK=--/-+%!;C9OE\LD,P^;:%&.I([>H
MSFCXAZ,;.VN/*OLS:@=-:$0;GAN!G*. 2,\=B<]LU3\5>';Z&Y\/ZCHNEV^J
M1Z2DEM)IT[JOFPN$&59^ RE%//7FHM4TG5[VTT"2'0(K5H-9BOIK6WDB'DQ*
MC*=QR SDG/'&.,\9(!:U3Q_';^&?$.H6NF7@OM&&)K.Y"(R$KN5C\Q!0@@\$
MG':NJL+B2ZL89Y;>2!W7)CD*DC_ODD?K7!:OX9UG4_\ A8$4=D8QK%O$ED[R
MIB1DBV$'#$KD],_I7=:7)<R:9;M=VAM9]@#0F0.4^I7C\LT 8_B'Q)<Z/X@T
M'38--FNAJ4TJNZ,@P$B=]HW,.<@'GC /?BN:L?%*>&]7\9RWT>J7EG::A&S,
MF9A;1&&,DDLW"@DG"Y/MBN@\4Z;J4^O>&M4T^T%V-.NI6FB\U4.V2%H]V6XP
M"PSWQT!K!OO#^MW&F>/[=-+D\S6F/V/]]%ALP+'S\W'*D\]ORH Z?5?%UCI<
MMS']GNKLVEF+ZX-LJD1PG.&.YAG[K' R>.G3-:7Q;(WB[2=*M-/FGM+ZQ>\%
MRK( 5R@! + X&_)XSTP#S6%K.D>)=2CO;"32C<6,^C""T1KI$2WN-C!_,7)W
MG)7:1D#';)-6-/T?7;76/">H/I:D6NDOI]W&+A,P,?*PQ/\ $/D/W<T =]7.
M/XTTY+M(C!=^0VH?V8+H(OE_:.FW[V[[WRYVXSWKHZ\OU+0_%6HRI+=:0+J[
ML]?BO(K@W:!&M5ERJQ*3\A"XW9 )(SEJ .CO?B#IMDVK@Z?JDPTAPMZT5N,1
M*5#;^2,J 0?7T!K33Q-9OXCM]$$-QYUS:F[AG*KY4D8QG!SDD%AQC/.>G-<K
M=Z%K<]M\04&EOOUJ,)9_OH\,?LXBY^;@;AGGM[\58\2Z7??\(KH%Y9[;37],
MEMUMA+A@6?$3QMM)RI!).#_"#VH Z_3=2CU2&:6*&:-(IY(,R!?G*,58C!/&
M01^%8?CZUOI_#F[2M0GL-1^TV\=O/'*RJK/,B?.HX9?FZ$&N@TZQBTW3;:RA
M),<$8C#-U; ZGW/4^YK/\30W=QIL,5G9R7,@O+68JCHN%CG21OO$=E./>@#E
MX_%$NO\ @O5H+SSM-\0Z6/+O;>&9HVCD'1U(.2C#D'I]<5U-SK<%C=OIUM:W
M=_=6\ FEBMRK-&A)"EB[#).UL#))P:Y_QQX+GUQX-8T9_LNL1*(91D 7-N2-
MT3]LCJI[$?B+(TW5-%\>ZIK-M92:A8:M;0K(L,B+)!+$& X=E!4ANH.0>W>@
M"PWCS1C#HTUN+NZCU<NMJT$!;+*K$JWHWRD8['KCK6CH'B"V\0073P07-O+:
M7#6UQ;W*!9(Y  <'!(/# @@GK7&V/A#5-);PFJ6GG_9-1NKZ]:*1 L7G+(-J
M[B"<&0#@=B?:M'2O#%Q=W7B:+58+VTMK[4Q=V\EO>>4[*(D3[T3[ARIX/M0!
MV]%4]+TV'2=/CLK>2XDC0DAKB=YG.3GEF))Z^M7* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JW^
MI6&EV_VC4+VVLX,X\RXE6-?S) JU7$_%W_DE6O\ _7%/_1BT ='!XBT.ZN8[
M:WUG3IIY21'%'=(S.<9X .3P":TZP8+F_N]2L;>[T7RK98VF%PTROMD7:% Q
MTR&;GVQ7)WGC7Q+;>'O$&LA-*\O1-2DMGA\J0FXC4H#@[_D;#$YPV?08Y /2
MJ*X_^W=>M?%D^C78TZ03:9)?VK11NOE,CJI1R6.\?,#N 7H>*Q+/QOXF72?#
M&OW]MIC:3J\L%O/# KB6%I>%D#%L%=W5<9'J: /0+/5;#49KF*RO(;A[5_+G
M$3AO+;&=IQW]JMUYJFO)X9U'X@ZH8A*T>H6J1QDX#2/!$B@GL-S#)],UOSZY
MJ^F>*M.T2]>SE&K03&TN8H&4131KN*NI<[E*G(((/!'O0!U=%<3I'BK5M1T6
M.*5;*+Q NIMI]Q (G,<95BS$#?DCR@7!S@Y [TRZ\6:[=17EWH.G"\2TOFM?
MLA@;=.L;[)")=P53D,0"#P/?@ [FBN(U#Q5KEP-4D\/V"W3:==?9A;/ Q-PR
M[=X\S< A^8@<'[N3UP.UB<R1([(R%E!*MU7V- &9<>)] M+M[2YUS3(;E/O0
MR7<:NOU!.15^UN[:^MUN+2XAN(6^[)$X=3]".*XRQ_Y+;J__ &!+?_T:]4?+
M.B?&P6>D!(H=7TI[B[@ _=B9&PLI4="?NGU^M '>Z?J-GJUC'>V%S'<VLF=D
ML9RK8)!Q^((JU7G%MXTUR;PEX6U&"VTU9]6U$V4T91PB9:0 K@_],^<YSFM)
MM?\ $/VBYT=?L;ZM96J33RP6DDD+O(S^6H7>"HVIR23UXZ4 =K17(6'B/6=6
MN[;2A:0Z7J@TY;V[2Y4S")F<HJ*%89R58YSP,<9/&?=ZAXG?Q/X,M[R6TL)K
MJ.Z>ZM40RIYB)C.X,,C#<#L3SNH [^BN%N/&&J3>&M6\2Z;':/8:;/,OV61&
M\R>*%B)&WAL*3M8@;3T&>O"MXE\0:IXH;3-$_LQ+=],M]2AENXY"=LCD%6"M
MUPO![>] '<U5L]1L]0-R+2YCF-M,UO-L.?+D4 E3[C(_.K5>=7?C36K3PGXF
MU..WT[[5I>KFS5=CA)$S$NX_-G=^\SGIQTH ]%HKB9_%NHZ%KFL6NMK:2VUI
MI)U6-K1&5E5696C.YCN/ PWR_05IV5SXGGN+&5UTYK*[M6DD=$8-:R8!4<M^
M\4Y(XV],\9Q0!T=11VT,4\LT<8627!D(XW$# )]\<9] /2N&L/&VJ7?AKP;J
MS0V:MK5XEM<QA&P@97.4.[C[G?/6IK#Q!XIU#4=;$,&F/;:1?20-$J2>;<((
M5=0IS@-N8#)!!ST&.0#N*B^SP_:?M/E@S;=@<\D+UP/3MTZX'I7+^#_%+>)6
M+I?64RI"/M%LD+0SVLV>4=&8G'7!QV/)K>UNZO+'1+RZL((9KN*(M$DT@C0G
M_:8\ #J?I0!?J"\O;73K5[J]N8;:VCQOFGD"(N3@9)X') _&N;\.^);G4O$^
MIZ1/)!<16UM!<PW,,#Q!PY<$88G<,ID,#@@_C737%M#=1".>-9$#K(%;IN5@
MRG\" ?PH R3XR\+#=GQ+HXV\G_3HN/\ QZMI'61%=&#*PR&!R"/6N&T&-)?B
MOXWCD571[6P5E89!!23(-/OO$.K#^UK3PU9I*VCLMLD$D#2>>XC5RN\, @PX
M4$YYY/% '67^E:=JBHNH6%K=JA)07$*R!2?3(.*H_P#"(^&O^A>TG_P"C_\
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M3N+ \GC&.: -?_A$?#7_ $+VD_\ @%'_ /$TR7PMX6@B>6;0='CC099WLX@
M/4G%2>&;[5=0T9)=:T\65\LCHZ+]UP#PZC)(!&#@G(Z5D:]>O<_$#PWH1/\
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M%H]K'IL<DEND;Q,TDJQR!&?=N 4E@2!M/ YZ\ '=_P#"(^&O^A>TG_P"C_\
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MHOB#5;/6EM);6VTA]6C:UC96148AHSN8[CTPP"_04 ;?_"(^&O\ H7M)_P#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRV>U?9"")XVVY&#G:<H.1GO6?I$6E^*/&2>*K"*Y$5M:&W\R:%X1++N.#M<
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M)SP.:[RFR,ZQLR)O8#A<XS^- %/2K&:PL_+NKZ2]N7;?+<2*%WM@#A1PH
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M@ZY'YFO1AX2\/#3X+ :-9?9()O/BA\H;5D_O >O)'TXI[>&-%=;Y6L(RM_\
M\?8).)^WS\_-QQSVH NZ=,]QIEI/(<O)"CL?<J":YKQ/?RCQCX6T:5WCTZ_:
MY,Q5BHE=(P4C)'8Y8X[[0/45U-O;Q6EM';P)LBC4*BYSM Z"H=1TNQU:W6"_
MMHYXU<2(&'*..C*>H(]1S0!Y5XEGU&PT;Q[IT%]>)9:=)9RV,JW#AX6EVF2+
M=G)49!"G( ?'I7J&E:1!H\=PD$UU+Y\QF<W-PTIW$ '!8G XS@<<FHYO#ND7
M.F2:;/8126<C^9+$^2)&]7_O'@<G/05HQ1K#$L: A5& "2>/J: .5^)__),?
M$7_7D],\57UG8?"J]>]9=DNF&!$/61WCVJ@'<DD5TNI:79:Q9/9ZA;I<6S_?
MB?.UOJ._XU5M_#.B6L\,T.F6PE@_U+LFXQ?[I.=OX4 <-H=KJ.CZG\-]/NY[
ME)O[+N([FW,K;-R11[05SC*[B,XIVE:E<Z3KEG!KZ2@SBXEM-9M;@R07B;&D
MQ(A^ZZIR."/E(''%=_<:1876I6VHSVRO>6P(@F).Z,'KM],]_7O4-IX=TFQ=
M6M[&--@8(I)98PWWMJDX7/? &>] ' :%=SQ>)O!CP7-PUIJ5C<N\L]P6DO0$
M1EDD3[JG)R,$D XXZ5BVVGS6GPNB\1:=?7T6L6NHS?942Y?RWW7K)Y1BSM8-
MD]LY/7'%>H6G@WPW8R6TEKHEE$]JYD@98AF-CU(]/Z58M_#>CVEV;FWT^&.3
MS#, HPHD/5POW0QR?F SR: .?TV24?$?Q7 ;B=X5L+21(I)694+>;G:"<+G
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M[VB-O#8=6W3)M=<D-@9YQ@=,G,-_IJ3>)/A\EYJ$FHRLMS')>([Q>?MMVPX
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MBU*0DM<I& Q)ZGV)[GJ<U'=>"_#5[<W-Q<Z+9RR73!I]T?$C Y#$=">.O4T
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M^_MA)<3P^(+<#35EE=UBNP=IB&2=JMO5^,8VMZ5V,/AW2+>]:[AL(4F:4S'
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M<=LN>3Z]:Y2P>>'P?X2TEM-U(WFEZ]&;Q!92$1 22G.=N&&"#E<\5M&%8?\
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MG5@O6(D 8EZ849![&J2>)%U6]N= U#3A!/+I9O@GF^9B,G:4<8!5P2..1[T
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MRPYZ#)'!]J .NI 01D$'Z5S]GXDN[J[TY6T2Z6SU&!IH+A&W^6 H8"88 C+
M\?,>>*Q](\5Z38>'8+BUTY-.2\U:>S6&>8(@GWR%F=QD+DHW3/) [T =S2$@
M=3BL)]>ODCLXSHTHN[F>6+:9#Y,2QACO>0*<*P4;>.=P''-<;XAU^#Q#I'A/
M6K>R<SQ>(D@\E65FW(9%95;(!!*C!X'0G% 'J% ((!!R#WK@M1\2?VYH/BS1
M-3TF33]1L].DF:"219%DC9&V2(R\'E?P(JQI/B2#2_#'AS3T-LU[+I,,X6YN
M1 @140<L0>23@  ]#TQ0!VM!S@X.#ZUD>'-?B\2Z#%J=M!)"7+*T,W!1U)!!
M(ZC(X(ZC!K D^((AT!M5FTSREAU/^S;J-[@ V[[PFYCC[N2#QV(//8 W?#^@
M)X=AOD2\EN%NKN6\<RA1M>0[FQ@#C-;-<OXFUJ&'1_$*7FDF^TZRLRURJ2@>
M8"A9DP<8PN">>C+CVIG7[]?%7A_1[*P@33;O37N2IFPP"^6,?=Z*'_'VQR =
MH"#G!Z5CZ5X?73;^YO9=1OK^>5F\MKN0-Y",VXH@ &%R!ZGY1SP*X3PWXA;P
MMIFLR?V5))ID?B2Z@FG215$ ><(NU3RP!*YZ8'3/.._\2:T/#OAV^U=K62Y2
MTB:5HHV"D@#)Y- &I17*_P#"921)%]NTO[ ]W(%L?M-U&JS+LWEV(R4 Z$$$
MY(XYXKV_Q"LYK13) EO='43IN)9P(#)L+AA+C!1@O!QDD@8% '945RM_XPN=
M-;2H9]!NFNM1N9K9(XY4(#)O(Y.,A@F0< 8/.*@L_B!;F#5$U2PETW4=-N(K
M>:TDE5MS2D"(J_"E6SU.,8.>E '8T5Q\?Q LHY-4BO8 DE@D<BM:3">.X$C;
M55'POS;B%((&"1SCFIM3\3:MI]IK._0BEQ8V!O893*6MY0 <J9-HPXQDKCIC
MF@#JJ*R?#%Y>:AX9TV[OT1;B:VCD8J^[=E =W08SGI6M0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M).]H?]NO$\VNBRAF8!4M[-V=$QG+%F ))STQ@8'6M.65(49VR=JEL*I9B!Z
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M_)GC/6MC3M1@U2V>>W$P197B/FQ-&=RL5/# '&1UJW0!S'BKPM)KU_I-Y;7
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M;I 6@<LK;1C/*@_ABN2F\&^)YC$TC:5/<6^MKJ*WDLLGF7$0=BJ-\GR;5;
M)'';J?2:* /-M)M]4OK[Q_I]E':E;K4##Y\LA'ELUO&"VT Y !R!GD\<=:?8
MV4^A_$RWTW2X([B*T\+P6X$TQC.U9G53D*?3GZ_A7=6>E:=I\TTUE8VUO+.V
MZ5XHE4R'U8@<GZT#2M.74CJ0L;87Q78;D1+YA7TW8SCVH XU_!.HV^DZ);VK
MVDEQ;:U_:]ZTDC(K,S.S*F%/]_ SCA?>GZIX)OM:O_%PN9;>&TUJUMX8)(Y&
M:2)X@V&9=H&,L#P>WO7=T4 <A'9>-M0T"\M-1O--L;[[(\,$]D[MOE*X$K94
M; /09Y.<\8JCI/A36[?Q#9:C-!I-K"NDR6$\5O*[D,75MX)4;B2O.<$9ZM7>
MUG:QK=CH-M%<:A(\<4LR0JRQ,_SNP50< XR2.3@4 <II?A#5#X<T#P_J8M$M
M-(FAE>:&5G:X\DY0!2HVY.">3TP,YR&WO@G5-27Q:DEQ;6IU6Y@NK*:)V=H9
M(539N!4#[T8/!/6N^K*U+Q'IFE7+6]W+,)5A\]UBMI9=D>2-S%%.!\IZ^E &
M7;2^,8])N[K5/[#@O(;=A!''+(8))/[\C$ JO'09ZG)Z8V]'N+N]T2SN+Z!;
M>[EA5I8USA6(YQGG'UY]:IZ;XLT;5Y;:.SN)G-TADMV>UEC250,Y5F4 \<\&
MMJ@#@-*\&:HOA71O#&I?9!9:;/%))<0RLS7"Q/O0!2HVY(7/)P 0,YR+&FZ%
MXKT/4K^QT^XTU]#O+N2ZCGF+BXM?,8LZJH&U_F)*Y(Z\YZ5V]% '$6>@>)]$
MUS5H])GTY](U2Z:\\RX9Q-:2.!YFU0,.,C(!(]ZL6^@:QHFNZY<Z6+2YM-79
M9]MQ*R-!.$"$\*=RD 'L01BNDO\ 48--CA><2D33I OE1,YW.<#.T' ]2>!5
MN@#AM-\%7>B:GX4%DUO)8:+93VTC22,LDC2;,L%"D=5)QGO[53NO!FNW'@WQ
M%HX_LX7&IZH][$QN'V(C2K)ACY><C;C@=Z]%I"0" 2 3P/>@#BY-&\5:7XIO
M]2T1M+EL]6\N2ZM[R1U-O,J!-Z%5^8%5&0<<CM6[KFA?V[X3O-$N+IM]S;&%
MK@+@[L</CZ\XJ[:ZC!=WEY:Q"426CJDI>)E4DJ&&TD8;@]JMT <OHR^-5MBN
ML_V0TMO$5C-M*^+I\8#.2O[M>Y !.?0#!IV/AG6=)\36VL64MLYO8=NMQRSN
M!-(.5DC&TX*Y*\X^7 [9KM** .(T+0O%>@3RZ/;W&FR:";AY8+ER_P!IAC=R
MYCV8VL<D@,3QUP>E6--\+7A3Q;:ZG]G6UUR>1T,$K,Z(\2Q$$%0,X7/!/6NO
MK&F\4:5#J45DTLI>6X^R+*L+-&)L9\LN!@-C_#KQ0!F>%K#Q;I]K::=K$NFO
M:V$?E)/;LYDN@J[4WJ5PG&"<$Y(]*H:?X5U6V\-/I5]8Z3?PSZE/<7-O+*S)
M)#(SO@$Q\.K,G;^$\BNJO]<L-.NH[6=Y7N70R"&W@DF?8#C<5120,\9/&>*E
MTS5;+6+3[583B:#>R;@"/F4X(P><@\4 </;>"]<TRTTFVM)K6YL+2]N)7TR\
MN7,:PN,1('VDMY?) (QD^P--@\%:]!HMO;F33I+BRU]M5A57=5F0N[%2=IV'
MY_1L8ZG/'HU% ''WGAG4-0?7]3E%LFHZCIO]G6\/FDQQ1_.<L^W))9R3A>
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MG"G:K\8(7&>V*W]2\#:;J>FV=M)<W\5S9RF>#4(KC%RLAX9MY!SD<$$8Q@8
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MMI%:-E+5&4O"@ 615Z(?]G.,CN!CH35/6O#D&LW$-R;B:VNH89;=9H=N?+E
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MH **** "BBB@ HHHH **** "BBB@ HJO?7D6GZ?<WLY(AMXFED([*H)/Z"N
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M@>:VB'E*W3>S!5S[98&FZ9X6M_[&@^WSW-QJ<D0,U_Y[+-YA')1@?D&>BC
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M;"DS9P#M/)3(QN_3'-68/$R7=]/!:6<EQ#;WGV*>5'7,4G&2R]0O.,]?;'-
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M5_$/A;38LLME>C4[A^NQ(T94S[L[@#UPWH:Z^F)#'&[ND:J\AR[ <L>G/K0
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MEOK)KHJEPDKNT9+!3D*6Y4C!]\5Z310!YE!X/\0P:1;61M++_1_$G]J#RIR
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M"=.,@'\<=^ZHH X;PGI?BS0K>U\/W,.GOIEBP2'4UF/FR0*?E0Q;>&QA2=V
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MRYDEOXXHI8I-I0",$+CC.?F/4G.: )?$6J/I&AW%U"I>Y($=N@0N6E8[5&T
MD\D$X&< UPW@J2#PSXZOO#D)O/[/U2!;ZS>[MY(F:= %G'[Q06+85SCWKN[_
M $@W^J:?>M>W$:V+F1($";'8J5RV5)Z,0,$=:I^(/"T.OW^E7K7]W:3Z9,9X
M'MMF=Q&"#N4Y!'!'>@# U37]<L=2\3:8+N,7<-I'>:./(!\X,2GEL.Y\S:G;
M[RU=T;Q%=Z[IUA?V%S&R?V6;JX6<!5,S9"*Q ^4!DDW8Z;16U>^'K'4-<TS5
M[@,UUIPD$1!P&W@9W#O@J"/0C-5K7P=I5IHNL:3$DBVNK23R7 #8(\T$,%]
M,\>E &%HGB35;GQ-8Z6]Y'<I>Z2]V9S;XC6=60'RB-I>+Y^,YS@8:LW3O%_B
M-/!%IXGO[RRE-Z!:P6BVQ4+.\_EK(S[L[0,DK@=.N>3T5CX'6RU#3;\Z[J<U
MS86KV<;R>5AHCMP" @Z%0<]3W)'%.B\!::O@<^$Y[F[N+$9*2NRK+&=^\%65
M0,AN0<?G0!FQ6]W;_&.S6YO3=@Z#,59HU5E/G19'RX&.F.,]>370^([ZZLAI
MZP745M%/<^7/(1OF*[6($*8.YR0.QP,G''%6P\(O;:]:ZU=:YJ%[>6]JUH#*
ML2JZ,P8Y"H.<J#GK_*K>N^'(];N]-O%OKJRN].E:2":WV$_,I5E(=6!!!]*
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M2E#M)5E*G'IP:Y[3_ R6.H:5?-K>IW$^FVSVL1D,0#1';A6 0=-@YZGN2.*
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MY8+GKMC &2>3DYQ@MUSQ9KFACQ3IHG@ENM-TT:G974L.=\9W JZJ0-P93@C
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M:)H8/*$:$#"8W'.#GGZ5?IL:LD:JSEV P7( )]^.*=0 4444 %%%% !1110
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MQT1-:V5G%]B=\R*D<?[IL]>%&3^9H ]!JI++?+J=M%%;1/9,CF>9I</&PQM
M7'.>>XQBK*.DL:R1LKHP#*RG((/0@UQVL*$^+'AE@S?O;&]#KO.#M\K''3N:
M +[>(M0N]1O(-'TR.\BT^]CM+O?<>6^2JLS(",$*''!(S@@=!GI*X3P!IUA;
MZYXODM[2WCDBUAXD9(P"J>3$=HQT&<\5M>.;NTL?!6J37TUW#;>4$=[1PDHW
M,% 5CP,D@9/0$T =#17D-RT=OJ7CFQ22TMD.@).MM82E424+-TQC+85<D 9
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M4U/6;""&]MYKN:U>*T,\DJPN3#&<@/G:1G(.!R?E/'!K(7Q?96$GAC3D>]U
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M+F$>B<?*/I61/X^\-6WVDR:BP6UN/L]PPMY2(7X^^0N%7YA\QP/>ICXIM_\
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MH5,0 Z#;C%3VEG;6%K':V=O%;V\8PD4*!$4>P' JCI=U/J4\U^'(T]AY=J@
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M^/2M.AL7LHK"U2TDSO@6%0C9ZY7&#5#Q5?6EAH;R7FJSZ7&TD:BZ@3<ZG>,
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M5"V35[#2[HQZ->,DOBF>XD86>^:*W=F99HE8=>@R 2 QXKU.B@#QZ\TO4_\
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MW3[*+3=.MK*#/E01K&N3DD 8R?4U9HHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!
M<V5K>!1=6T,X4Y7S8PV/IFIZ* $ "@   #@ 4M%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 57EL;2:X2XEM8))D^Y(\8++]#U%6** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUGR7)(1B,Y&XC /!."<D<BK^E:]I>N?:!IUVL[6SA)EVE60D9&00#R.0>AH
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M98?(<2^5SAU0@%E..HX]Z -VBL33O$]A>Z#8:I(7A^V(A2$QN79V3<55<9?
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M\-:F%CED=K6152*-G9B5(  4$FM.B@#CO":RVWPGT^WGM;J*X@TP0R0/;N)
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M=SYI09 .2HR".^.]>KT4 >6:M8IXG\-ZO?>']!U2+4VM8T,FJ>:DDP259/(
MD))!"L">F2 "<G&[)?IXLT759[+P]>V]Y)I<UL9KVT,$NYE.(5+#+#))./ES
MCUX[:B@#S"Q-];R^!=9?3]0%A8V#V%Y&]JXDMY&CC D\O&XKN0J3CCKT.:I^
M(]'O)=&\9WT%A>26^KZA9-:VJ6SL[B(Q>9)L R =K=0,A<]Q7K=% #8V5XU=
M00&&1E2#^(/(IU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>\OY$UB=([F6]9<LMRK*ZDCOM**OT6GW.D^-=8\,ZA9ZAJ6F65_);F&!]/\
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M\!-N"<9P=PZ]..0#H[#7]6O/'NKZ<MO:R:=:V=O-%LG.]O,\P[L%<$G:!C(
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MG/4CGI1%XJ-WK5YI]C:PSM974=O<H;G;,@;:3((]IR@W]<C.#3O%NBW^MII
ML3; V6I07LGGR,NY8SG:,*>3FLO5_!]YK.LV]_-#807=I?)-;ZG!(RW"P!@3
M$RA0&R-R\MC#9QQR =%XBUR#PYH5SJMRCR1P[5")U9F8(H]LLP&>U99\5WD?
MB*[T2;1\W-O9"^W0W(9'C)8#!95.=RD=/0TGQ#FA7P;=6TLMI&;UX[6,W@S%
MN=P/F/\ ",9.[MC(R<"L?1O[6M]4FMY[+1)[F^MC']IM=3FGD544[?,\Q21'
MDD9!/S-T.2: +NE^-=4U71[/5(O"]Q]EO4@-LRW(?+2-M.\!<HBCYB^#QVJ.
MZ^(BVOA_7]1_LT3RZ+<B":*"Z#(^0I#*^!Q\XR,9!!J-?".NP_#S1=!BN+'[
M5ITD'G(TC^1=Q1GF-CMR W&1@CC'(-4]0\#:_>:9XKM%GTM1K<D,D>#(HB*I
M&I!X/ V8'KG/R]* .AC\47[Z_>:+-HZV]VEB;ZT,ET&65 VTA]JG802.F[KU
MK+\/^-;E_!^A7VJK:"^U89A!N"B'Y2[%B5^0 #&!NZCUK5;0]2F\=1ZY(+1+
M7^RVL7196+AF</N'R $#&.H]?:N?MO!'B.Q\,^'X;2_TZ/6- <BU8AS#/$5*
MLLG&1N!'0'!'?/ !K6GCV*XM&#V#)J)U :=#;K+NCGD(W!TDVC,>T%BV,C:>
M,X!I^%1,/BAXO,]G#:RM;6)80R;U?_6_-G:IY[Y'4?C4^L>&_$6LV.G7\MYI
M\6NZ?>K=V\:!_LP 4J8R2-Q#!CEL9Z<<5)8Z+XEM_$&NZXW]DQW%_8PQ00B2
M21$EC#[=S;5)4E^2 #[4 =C14-K]H^QP?;/*^T^6OG>5G9OQ\VW/.,YQFIJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ II1"X<JI<
M@-CD ]?Y"G44 %%%% #41(P0BJH))( QR>2:BN+*TNI(9+BUAF>!M\321AC&
MWJI/0^XJ>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** $(# @@$'@@U6L]-L=.61;&RMK42-N<01*FX^IP.35JB@ HHHH
M**** "BBB@".>"&Z@>"XBCFB<8:.10RL/<'K4%CIFGZ7$T6GV-M:1L<E;>%8
MP3] !5NB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK^ZW1,YS_>Y ZT =K16/X2OKC5/!VB:A>2>9<W5A!-*^T#<[("3@<#D]JV*
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MSND4<K,"DB *=Y0 J-V.N<@G@ EL_'=GJ.G:%<6L*I-K*R-;QW4PB4&/AEW
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M*\NK=I7$2Q*,&)3L)?()R2!U/:@#6?Q1'!I5YJ]W;&'3(2!!,9!NN02%4JI
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M \L@C.<D5+J-WK/ANUN]:N=2BU#2[?39)Y(7C5)#.HW#RRJCY" >&)(XY/-
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MUB/5HM4U6POQ"L$\UE.(S<H.@D&W!(YY !'Y5T<#RFUB>Y$:3% 9 C94-CD
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M/X2M7U._OK6\O+)]10)>QV[(%FP-H8[E)5L<94@_C@UOY!) (R.HHR,XR,T
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M!OBA&  L6I,R#<?E/E0_U)KHKKP_I ^*EG:BRB-O?://)=Q'E;EEECVM(/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#.')VMQ@A3MX&,=*P_B+X>U+4RE_86ZN(+<QN(6=KB7<Z_($SY97^(E@QXX
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M?5K 2K!-N&R9=KHRDJRL.Q!!%:E !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 55U%+Z2PF339X(+LJ?+DGB,B*?=01_.K59.HZ++?:C#>PZUJ=B
MT2%#%;.GER#.<LCHPS[C!H P_AI<7+>&9]/O;.&VO-+O9K.X,!)29P0QD&>?
MFWY/N3TZ5V55=/TZVTNT%O:H53<SLS,69W8Y9F)Y))).:M4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>elicio-btconsent202510xk001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-btconsent202510xk001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M '645BCQ=X?(TP_VM; :H2+$EL>>00/E_$@?C5R76-/@U>WTF6[C2_N$:2&
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MIS2:E;!=2<1V;!]PG8XP%(X/45+=:UIMEJ=GIMS>117M[N^S0L?FEVC)Q]*
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M46%W;N<<6]VOF(GX, !^?]VO>O#7P\T7PR;V:"2\N[^^0I<7][-YL[J>V[&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!117,^+M4OM&GT&\MYMEF^IQVUZA4$-'*"BDDC(PY3IB@#IJ*\]O?%6JP_$V
M&W2=1X>BN(M+GCV*<W4L3R*V[&1C]TN,X^:KMKXM-MJ'BG4M2NF&CV-Y%86D
M21;F:4(-X4 ;F9G<*!S]WZT =K16'H_BFSUB_ET\VU[8W\<8F-K?0^6[1DXW
MKR01GC@\'KBI-<\266A26L$T5S<WEV6%O:6D7F2R;1EB!T  (R20.: -BBN6
M_P"$_P!%.FQW*K>/<27+6:V"VY-SYZC+)L[$#DG.,8.:4^/M%CT?4=1NA=VG
M]F,BWMM<0E9H=Y 4E>X.<@@D8SZ4 =117-6'CC3+S4'LIK>_T^46[749O[8P
MB6)<;G7/ID9!P>>E)I7CC3M6OK.V6SU*V6^4O93W-J4CN0%W?*>WR\C=C(H
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M)&>#U- '8T5P>O?$(6^BV%]I=E>.\NJQ6-S#):GS(3O4.A7(PY!PO4'-:O\
MPG6F'7I=&2TU%[FW9!=,ML3';!T#JTC=%&&_,'TH Z>BN3M?B%I5W<6(^QZG
M%::A*L-I?36I6"9F^Z <Y&[L2!FL5?'5S=V?B@W)O-+33M2CMX;I;,-M0M"-
MI#'!9BYSZ*P/:@#T:BN9U/QQIVG:A=6:6FHWSV2AKQ[*U,J6P(R-Y]<<X&3C
MM1>>.]'MI[&"W6[U":_M?M5HEE 93-'D<CTZYYP* .FHK,T'7K+Q'IQO;+S5
M597AEBGC*212*<,C*>A%<5K>OW,WCF_T6]\5CPQ;6\4360\N(&\W+EGWR@C
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MU&KMI:V:C5_LOV9IHU47(!4R;ALZ]]V,>]4;KPQ:FTT6SL%6SM=,NDGCCC+
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M]'%YGS1X1M/)W==OFMN_]IY_"L95OY?$EC!I\T4$4GBW4A#-*F^.-O)^\%R
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MJ-]%!<Z;LC,#JW^L\H!0RB,<[L]N>M3:1X3UK0_&>N:S_:&JZE%]BA%NL\\
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M#91'LBE_OD?><\GH,"NMU;2+W4O'>@73PYTO3H;B<N6&#<,%1!MSGA2YSC%
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M7$,3.0 ?FP6 XP<=16S;>&?^$@\-P:)<:-J'A:ST^>*>W6VNH)#*R[CSC>"
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MJX4@"!1,V22?O,!QGC->F4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M10> #& 3CKN/K0!O66O6=]?1V:>8DTMHEY$)%QYD3'&1[@XR.VX>M:04 D@
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M:Z[<SC>205SDXX.1QQ3[W3_^$2O?"]YIFKZC=2W]_%9W0N;QYTNT=&)DVL2
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M4+M(<,I<YX'4#:?6NR\!W.I7/A*V.JSQSW4;R1&5)TF+JKD+N9"06  !]P:
M.EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA'18X8Y/XR6(SCG@<\'TJI%\0XY+>'5&T6^C\/33+%'JC,FT[FV*YCSO$9;
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M2[M8C<1.MP$(!4,&PK98=>.>M %_5/!VA:Q-#/=V;^?#%Y*S03R0OY?]PLC
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MO>161TY=1-T\7[M8R,[203\X')49XK2LKN*_L+>\MR3#<1++&2,$JPR./H:
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M75W+:C>,,LD*HN3VY!KM:P)?&&E1V\,Z---'+J8TH%$Z3[RASG'RA@1G\LT
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MWEOVMA=2JX #. 2VT'.WWR>E=]\/EOK9M;L+EX%M[:[46]JE\;IK0% 6C+D
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M$!1E0*0/[^[OGVJ[)-+XAFT6QN[2;Q!J4>CQW%Q#%?BWLOG.!,6'+LVTXP"
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MVP;:LCN1QNXP ">?:LOXFV/]HZGH=KIM]'%JUY(^FS1*W[QK.9"96P.<*$#
M]/SJSXH\"K=:_I^KVNB:;J]O;V7V!].O&"!4#;D>-BI (R00>H- &I#XU>ZT
MAYK70[V;4XKW[!-IZ$$Q2XSEI!\HCVD'?TY'<XJJ_C^2RM=?&J:,]K?:-:K=
MO!'<K*LL;;L%7 &#E2""!6-+X&U=?#\$4&FZ5 C:D;JZT>QE-O%-!M*K&TJ@
M%V!PQ) !QCL*K'X>ZJT'BA;72M)TR+5M)6UM[6UER(Y S??;:,D[LEL>W.,D
M ]!\/ZK?ZQ9/=7NCR::C,# LLRR-)&0"&(7[IY^Z>16'=^/)U;4[C3]!GOM+
MTN5XKJ[6X1&+)_K/+C/+[>>XR00,UU]NABMHHVQN5 IQ["O++GX=7-I=:O%;
M>&- U7[==2W%MJ-ZV'M_,.2LB;"7"DG&#R,#B@#IY_&\\^L_V9H6BR:I(;&&
M_27[0L,9BDW8R6'!X&!@YSVQ3(_B E[I.C3:;I4]SJ.K-*D-B\BQF,Q$B4N_
M("J1C(SG(P.:M:)X;N=)\57%[^X%F=*M;*,1+L^:(OG"=%7## S6#8>#]=T6
MTT34+2.UN-2TRXOO,M7F*)-#<2E\!\'##Y#R,=10 S2_&5Q8:EXRU#6;:]A^
MS7%I##IQD$A$CQA0D?.W#L00>.N3CFM^U\920:C]A\0Z6=)E>VDNH7^TK/'(
MD8!D&Y0,,H(.,=.A-<Y>^!M<\16GB2758]/@NM0N;2ZM(-YEB4P@ 1R' R#C
M!('<XJ73? ANKV<S^&-$T&T>RFMG^QD33R-(NTD.%7:H4GW.: (M8\7ZSJ,?
MA>X31[W3=/U#6+3R;D7*EI(F;.V1%Y4,O.,D=CBM_P"*-S<VGP[U.:TN9[:<
M- JRP2%'4&>,'##D<$C\:QSH?C&[LO#FD75IIL=MH][:RS7:7))N8X2 "J;?
ME.!DY/7@5T?C[1;WQ#X+O]+TX1&[E:)HQ*^U3ME1SDX..%- '.>*-#NO!F@7
M'B/1M=UEYM.Q/);7M\]Q#<1@C>A5\X.,X(Y!K<N_&-S)JL^G:%HKZG+:PQRW
M3-<I L?F#<B MG<Y7G' &1D\UFZOIGC#QA8G1M4LM+TG2IW7[9)!>/<321@@
ME$&Q0N<8)/8]*IZWX$8>+-2U>+PUI&O0:@D6([V01/;2(@3@E6!0@*<=010!
MLCQ]#?6VD_V)ILU_?:G')+':NZP^2L9VR&1CG;AOEX!R>E$GCB:*TMHGT&\3
M6KF[>TBTZ1@NYD7<SB0_*8PO.\?3&:S;3PEK/AY]#U33+72Y[VTM9K6\LH/]
M&A=9'$F8C@X*L.X^89Z&H=;\'Z]XABT_5=8MM+U"]L[R65-)F/[@6\BA?*\S
M;RXVAMQ&,Y'2@#3N?B$FG:1K-QJ>DS6]_I B>XLUE63>DC;5=''##KV!R,4A
M\<:PNL+H[^$;A=1G@^TVL9O(]K1@X8R-_ 02!@;N2*QG\!7]QX:U^"VT71='
MFO\ R$MK6TQE520,QDE"C<3@X &![YKKYM&NI/B#9ZV/+^R1:9-:M\WS;VDC
M8<>F%- '(ZCXTOM0N_"%]I]A>":2_N[6YTQ)P-TJ1NA5FSM*JPW9]!G&>*W?
M^$_AL['5FUC39[+4-+,0ELT=93+YIQ%Y;# ;<>.V"#G%8R>$?$FG3:9>6,=E
M-/9:Q?WS12S%5DBFW[5!"G#$-Z<&EU3P)JOBFTUV]U1+*UU&_P#LPM;7>9HH
ME@8NJR-@;MY+9P. 1UH W[3Q?=)J::=K6BMIMS<6\D]KMN5G241@%TRH&UP"
M#C&,9P>*D\'^*+SQ78IJ+:'-8:?-"DEO-+.C&7/4;1R #T)ZC!K T3P=<1ZP
MMZ/"N@Z''#;2Q_Z,1+++*Z[<A@J[% )]2<UU7@_2KC0_!VD:7=[/M%I:1PR;
M#E=P&#@T <]XWMUL5O\ 6M7UW5X;-(A'86VEF5#%(%8LS^7]\DCJ_P H P>M
M6%N_%%]\.M,GLKNP74I[-7N[XMYBQ_)DM&%^5VSTY"]^1Q5S46\7V.LWDFG6
M]GJNGW*)]GBGG$!M' PV2$.]#PWJ.1TQ4OAKPY+X?\#0:$TR33QPR!G4;5+N
M68@#LH+$#V% "^ KB>[^'^@7-S-)-/+81/))(Q9G8J,DD\DUL:DEY+IEU'I\
ML<-ZT3+!+(N51R/E)'< \XKF[--3\'_#33;=+:&YU&QM[>W:'>=KME4(4@9)
MY...3BNAU=M072+LZ2D+ZAY3?9Q,V$WXX+>W>@#A7M+CP[XL\-Z?I^N:IJ&I
MW+EM3@N;IIHVMPAW2E3Q'\^T+MQG..:RVN-4N_ -_P"/TUC4$U&*6>ZM[=;A
MA;+#%*RB(Q?=(*)R2,Y.<UL^#M*\4:'.!>Z%823W<@;4=4;4S)/*?7;Y0X'9
M 0 *@E\)^(T\/7O@RWAL_P"QKF>39J)N")(K:20NR&/;RXW,H.<<@\4 :6N:
M<LZZAX@UWQ%?6.D);H]I'97;V_D#;EF;;C>Y8\ Y'08KFK[5-?N]&\$VNI_V
M\MS=037%^-)#1W#A4 C#$8"D[PQ!(&0:UM:T3Q5=^+Q>'1].U+1[$)_9MI-J
M!A1' YE=?+;<^>%SPHZ<\UNW<GC%6T[4;:ULG(C=+[23<@*23\KQS%,Y&.00
M 0?44 .\#76GW.D7"V-[JUP\5RR7$>K2,]Q;R #*-NZ#&",<<U=\77U[IOA#
M5KW3X_,NH;61T^<+MPI^;)].N.^,5@6MKK7ANPUKQ!/;6LVL:K>PNUG%(QCC
M3Y(E0-C+,%YS@ GVYKJ-?LI=2\.:I80;?.N;26&/<<#<R$#/MDT >:Z%<R:?
MI-M#*VKQ:C=>'KF^WRZH\Z,=L?[S!Z,201C&W)]:W](\77D>B>'-,LK"75M7
MFT>WO+@R7(B5$* ;WD;)+,V<#!)P2<4/X0U-I=.8&#%OX;FTM_G_ .6S"/&.
M/N_(>:R;CX>7$,NBW\NB:7KCV^CP:==6=W)MV/&.)(W*D=V!! XP: .A_P"%
M@0RZ9;-:Z9<2ZO<7KZ>--+JK).@)<,_*A0HW;AG@CUJOX4U?4]1\?^)8-1MK
MBR-O:V8%H\_F1HQ\W+(1P0PV\X!XP1Q5*V\%:KIMAI>HV%EI%OJMA?S78L+8
M&*!HY$\MH]X&2X7;\Y'4=,5L^&],UU?%FM:YK-O:VR7UO;10003&4QB,R9#-
M@9/S@\>N.V2 6M0\7VVEW^MVUY;O'_9>GKJ ?</W\9WYV^A#)C\15.T\<V^I
M:=H4L-E,LNL+.3%O :W$2MYA8XZA@%^I%0^-O"%YXAU;2+FQDBCB5OL^HAS@
MR6IDCD*CU.8P/HQJ'0O!=]IOBS7]0GEB:RE61=,C4\QB9O,FR.WS@8QV% &9
MH_B;59]9\$6UA!=2:7?:9),_VJ[5Y'QY8W.Q&6*!L_[6[VJ#PKXYU33O!MG?
M:EI%Y=::EW)!/J<ETI<;KAD#!#EF4$JN<@\' P*TM*\*:[HQ\$2QP6MP^E64
MEC?(9RFT2>7ET.T[L;#QQGBG_P#"&ZI_PJ;_ (1K,'V_SM_W_DQ]J\WKC^[[
M=: .C\::A>Z5X)UJ_P!.7-W;V<LD9W ;"%)W\@@[>N.^,5QD'B/Q"OBCP\%T
MZXNKFZT%W>R%X!'O$D>)78\#Y>^"?FQZUWOB/39-8\,:KID+JDMY9S6Z,_0,
MZ%03[<USN@:%K2>(-(U34K:VMOLNC/I\L<4_F?/YB%2#M'!5,^V<<]: ')\0
M8FT-;EM*N!JC:@VF#31(I8W*YRN_[NT ;MW3%:6B>)9=0U:YT?4M.;3M3@A6
MX$7G+,DD3$KO5QC."""" 1QZUR>I?#R]OK.[DD@L+J=/$$VJ06MRQ,5Q"ZA2
MCG!VDC)!P<$"MGP?X9DTO6+S4G\/Z/HD3PK#%;V0#RGG+,\@4<' PH],T 5O
MB#-=0ZEI)O&U=/#6V7[:^D[_ #!)\NSS#'\XCQN^[WQGM4/A?6='TVTUG5K#
MQ4^I^'+:W$S07$KRW%HZYW#+_/M8 85NX.*WM?M?$L&LVNK:!)!=1)"T%SIE
MU,8DD!.1(C $*XZ<C!!KG;CP3JGBJYUR_P!;@L])EU#2SIT4%K*9C][?YDC;
M5#$$   =,\T ;-EXSNS?:;%J^@S:9;ZH_EVDS7"2'>5+*DBC[C$ XZ\C&:BA
M\=7=VOV^R\.7EUH?VDVXO8I%:1L/L,BP@;B@;/.<X&<5CZ'X*NH=7TN67PGX
M<TO[$XDN+RWQ*\[ 8'E+L'EY/.2<CI5S2]&\7Z#I,?AK3%L8[.*X/DZLTV7C
M@,A<@PE""^"5ZX[T ;:^+X6T+Q'JGV1]NB37,3Q[QF7R5W$@]LU2;QO=SZ]!
MI&F:!/>S/9P7LC_:$C2**0D$DGJ1@<#KSZ5CW_AOQ5%8>*]$TZUT^6SUN:XG
MCO9;DJ8A*@#(8]IR<@X.<<Y/3%;V@^'K[3?$\NH3^5Y#:1:68VMD^9&7W<8Z
M?,,&@#EU\4:HH\+#1H+N:VN]7O(9A=7BL\NPS?(6(X7*[AZ!0M;-OXOM].M=
M0\BVO[V]FUV>PM[62X#&24<G:QP(XP 3[ =ZHQ>$=>T[2-!>U@M+F]TS6+J]
M:!YRBR1RM-C#;3@@2 XQZU#J/P[O;RTN)9+:PNYXM?N-3AM+IB8;B&0;2C'!
MVMCD'!P0* -N7X@)IMIJYUO2Y;*^TRV6Z:WCF6431,2JLCC QN&#D#'TK3T+
M7]1U*\-O?Z&]FK0^?#<PW"W$$@SC;O4##<YQW&<&N;TWPAJ5O;ZS<6.A>'M$
MFN+98+6V2(3!N<MYSA1E6X&T XZ\T_PIX2O=-\5?VI%H]IX?L?LSQS65I>-,
MES(2I#[=H5 H!P0,G- '4ZYK%[ITMI;:=HUQJ5S<EL;6\N*(* 29)""%SD8&
M"3SZ5S[?$98-'N[JZT:X6]L]2CTZ>SBE60[WV[2C=&!##T].*D\:>'M1UC5]
M+N8[.+5=,@259],ENC KNV-LG (;&",'UXK!L? &L6]K>0BTTRT2;7++48X+
M1R(HHHRFY1\HY&WK@;CSQF@#HHO'+6EWJ-KXATF32I;*P.HY$ZSK) #@D%<8
M8' V^_6L>_\ $VN7FO>#TN-'N])MKR_WJPNE<2Q^3(=DH7&UONG:<C@\Y%:G
MB;P;/XCUZ^D>5(K*ZT*73MX.665I P..X&/6JK:;XPU;4_#9U.QTZVM])NQ-
M<2171D-P1$Z;D7:-H^;H3GGVY +/Q4O9+#P49H[RYLU^VVR236TC(ZQF50V"
MO/3/2LKP_-X/N->LX].\3^(KJ[W[HX;B[NS&Y )PP<;2, \&ND\>:-J&N^&Q
M:Z6D+W<=W;W"I-)L5A'(KD$X..GI3;34O&DEY EWX;TN&V:11+(FJ,[(N>2%
M\H9(';(H J/\08DOY-'.FS?V\MZ+5-/\P9="-PG#8_U6S+9QQC'6I+SQI>?;
M-372/#USJEKI;^5=SQSJA+A0S)$AYD901D<<\#-9<OA/Q%)KC>,!/"-?2X$<
M5GYI\C["#@PEL?>.2^['#8'2K*Z5XJT&ZUR#0K:QN(-5NGO(+F>X*-:2R* V
MY-IW@$;A@^QH I6_B36U\=^)(M,TF\U2,6UE,D$MP($MPT;$C#]'8]L?PG)&
M*VXO&<VIZ3I%YH>AW=^^I0M, ["&. +@$22$$ Y. !DG!["IM T+4--\3:WJ
M%[.DZWL%FBRC 9WBC978J!A<DYP*X^'P)K=KI7ARUO+&UU>SL;66&XTUKQH8
M_-:3<LN<8?"Y&".,\4 ;Q^(R1Z'+>S:-<B[M]472IK*.5'82MMQL;HP.Y<=.
MO:K,/CDVESJ=MXATJ32I;"Q_M XG6=9(,D$@KCY@1C;[BN>TWP#K%I82VQMM
M-ME;Q';:JD-HQ$4<*>7N1?E'(V$=!GKQFM7QCX8&HZCK.HW]PMOI,GAZ2SEF
M +/&PD+[MH&2 !G\* )XO'&HQW^C0:EX8N;*/5YQ%;2FY1]N49OW@'W6P/N\
M]^>*CD^(C"SGUB+0YY/#D$K1OJ G0,55MK2+%U* @\YS@$XKGI]6UK6-?\#V
MMV^CR(M[Y^[3[HS-.%@DS+@J-B8/0YY8>G,4/PRN;"SDT>#PQX=N_P!\WDZS
M=89UB9RWSQ;<LX!P/FP>.E 'I/B+61H?A;4M911+]DM9)T7/#D*2!]"<5RMC
MX*N]3T"#4;SQ)K*Z_<0"8745XZ10R,,A5B!V; 3C!'(KLM0TJVU+1+G2;A?]
M%N+=K=PO'RLNTX].*X^VB^(.FZ*F@P6>DW$D40MX=8>Z90$ PKM#L)+@8X#8
M)H TKGQ'J>G7&GZ%'8+J_B![07%R(I!!"B@[2Y9@<;FR  ">OI52;XBQ0Z5#
M/_8]VU^=4&DS:>'7S(IRI8#=G:5.!ALXPV>QIA\.:YH&KZ?J^F.NM3)IBZ=>
M+>W!CDFVL764.0W.6;(/8CGBJD7@O6)6MM0NVM?M\_B&/5KN.-R4AB6,QA%)
M'S$#;S@9)- %I?'>L/=:CIZ>$9VU/3E66YB%['Y8B9<J5DQRQPWRX_A/-3'Q
M^UW-I%OHVBSW\^JZ=_:$*F98@B94$.3G&-W49YP/>K]KH5Y#XJ\3ZDWE^1J5
MM;108;G=&L@;([??%9/A3PCJ>C:CX>GNC!LL-!.GS;'R?-+QMQQR,*>: (HO
MB7</I@U5_#5U%IL-T+.^F>X3=!+Y@C;:HY=0Q )X^G!J6[\86NA7_B%_)O)Y
MDU*VLTBFN@(C))$A7:6XB3!R>O.3WJ*;P;JDGP_U?1%,'VN[U22[C^?Y=C70
ME&3CKM'YU)?>%]8-QXFGM[;3+N/4;^WG%I>C='<0I$B.C9!V,2N0<'H* +MQ
MXVN-+T/4M0UG0KBS>S:)559EDBG\Q@JE)>!C)&XG&VHK_P 2WK^&M>;5M%O+
M!;;3GN5GL[L.LJ;6SY<R@;7&/3C(/-8^E^#-:L;/6VT_3]-TVWNTA6#19YVN
MK9BK$R%LC";P=N%! P#5>#P%J9M/$:V6F6FA6VH:3+9QZ;#>M+').V<2G@*F
M!\O [F@#I6\6W37::7H>C3:I<V]I%/=-)=+$L0<912Y!W.0">F/4BH6^(D4U
MOHQT[2+J[NM4EG@6U+K&\,T/WU<G@8(.3Z#(SQ4<.B^(?#FM7.HZ396FHQZA
M:V\=Q!+<F%HIHDV!E;:05(QD=>*AT?P3J>G:EX=O)YK>6:WN[Z]U!HR0OF7"
MGB,$9(!('..F?:@#H?#?B.36Y=1M+O3GT_4=.F6*XMVE$@&Y0ZLKCJ"#Z"MZ
MN4ATK6=,UKQ9JME#:SRZ@]N]G%+*5#;(E1MY ^7D'UKJAG:,\''.* %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH K?V?9?VA_:'V2W^V^7Y7VCRQYFSKMW8SCVJS110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %! (((R#110!0L=#TC2YI)M/TNR
MM)9?]8]O;I&S_4@#-7Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %8GB307UZ/2U2X6'[%J4%\<KG>(VSM]L^M;=% ''6_@
M06_B;7-5%[F&_BD6WMRG%L\JJ)GSGG<8T/Y^M9\7P_U#3Y=!N;&]TZ>XTW2D
MTUEO[1I(_E(/FH P*MQ@^H[UZ#10!P=E\/[RW@C2XU=+B5?$ UIY?(V;OEPR
M8!XYSCT'%:FI>'M6B\1SZ[X?O[2WN+NW2WNX;R!I(WV%BCC:RD,-S#T(/:NH
MHH Y72/"-SIVN:=J=SJ\M_+;6$UK+).#OE>259"V<_*HVD!>PP.U:'A[0GT1
M]89IUE_M#49;T87&P.%&WWQMZ^];5% &+XGT)_$.EPV:3K"8[RWN=Q7=D1R*
M^/QVXK%\7^$]:\0ZWIUY::G81V=B-ZV=Y:M-&TV3B1@'7) QC.<')KM** .8
ME3Q;:Z*!)>6-UJ+7D0#6UHR)Y)90X(9S@@;CNS^%:VOV=_J&@WEGI=\+&]FC
M*17)3=Y6>I R.<9QZ'%:-% '%>%/#/B/PW':6)U'1CI<1)EB@L)$ED)'+%S(
M<L3@DD'-5E\!:D-/7PX=6MCX76Y$P@^SG[08Q)Y@@+[MNW=WQG'%=]10!P-U
MX0\4'QE>>(;;6=*:20>7:K>6+RFUB_NIB0 9ZDXR?I6C>>'-;?4+#7;/4K)-
M=AM3:7)DMF-O<QEMV-H;<I##(.3U(KK:* ,/PQH$FA6=V;FZ%W?WUT]W=S*F
MQ6D8 85<G"@*H')Z5N444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>elicio-exhibit311202510x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-exhibit311202510x001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8,R\@G(<D@#Y2.%SSUK&\5Z=HGQ+ATC5?#-M+!XA6^B\R0P&*6% ?F,W;Y<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS6T=C.\B 8Y*A,XY'/N*M6OBW1;VPOKVWN97@L'*77^C2AHB!N(*%=W YZ4
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M8VL,)CAA;.=YRS%FSCG( P..*JZO\/;K5/B/I_C$:S%%+81B**V^QEE*?/\
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MB64;](P"B@J/<.Q_X$:]DO-/MKY[5[B,,]K,)X6[HX!&1^!(_&N6U[P!'?\
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MWJ'CWP[I>M6^CW=W<)J%PH>"!;*9VE!S@KM0@]#T]*GB\8Z-->7%H&O4N;>
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M=;"=TAW*& 9E0@'# XSWKR3PQKNK>#]33X:^)=[E;^T;2[G!(=/M,;;0?[I
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M!&> >A/0FGZ[XWT#PU?VMCJUW-;W%V=MN@M97\TY PI52"<L./>O'5U;Q?\
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MGN1[&@#TMF5%+,0J@9))P *YM/'F@36EQ>6\]S<V-LQ6:[M[262%<=?G52&
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M-SU4E21CC?@C/!KH/VD/^1(TO_L)+_Z+>@#V"VN([NW2>(2!'&5\R-D;'N&
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M3P16A5'2=.&F:>EN9#+,29)YB,&61CEF/U/;L,#H*O4 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRZLT]Z^YPJC 4'T&2?QH Z>BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0B5Y3 A.=C2CK&'^Z7_V<Y]J -6BL6]\7>'M/FNH;K6+2.6U ,Z>8"T><X!
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MQTI&4,I5@"#U![T 9$FL6^IPS6VC7<5U.T3XF@<.D)VG:68< YQQU[XP#7F
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ.1@AA].: .GHKE/"7B5_$A2YMM3TZ_L3!F7[/$T4L$V1\CJSD@8W=ATKJZ
M,Q?$&DOK#:0M]&=14;C;<^8%Z;L>GOTK3K@(<_\ "^KW:!N_X1Q,9_Z[FLZ?
MQQXJC\+:YKPAT@1Z+J,UO-#LD)G2-PIVG=\AQDY.[/H,<@'J%%<U+KE]J7B"
M]T;1WMH9+*UBGFFN8FD!:7=L0*&7LI).>X '<:NAW&IW6BVLVLV4=EJ+)^_@
MCD#JC9(X(['K[9H T**S[/\ M?\ M34?MILO[/W)]A\G=YN-OS^9GC[W3';K
M6A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6'XPT6Y\1
M>%=0T:UEBB>\B,1EER0@/4X'4_E6Y10!D75MK7_",_9M.N+2VU98T1)9$,D0
M((R<<'D _0GO6LN=HW$$XY(%+10 4444 %%%% !7*6WAS4H?B+=^)GFM#;W%
MFMGY +;U56W!MV,$]>,?C75T4 <[XWT"Z\3^&)](M)H8&FDB8RR@D*$D5^@Z
MY*X_&JU]X;U*^\80:W]H@@C339;%EC9BX,A#%U.!R".!_*NKHH \YL? ?B"W
MM?#$,FK::#H,Y,92U?\ >H49"S?-RYW9[#.22:Z+6O"46K>*M(UL3F)K,-'<
M1J/^/B/(=%/LLBJWYUTE% '(^)/#&KW'B*S\1^'-2M[34X8#:31W<1>&XA+;
M@K;2""&)((]:Z#2;:\M;(#4;M;J\D8O+(B%$!/9%).%  '4^IY-7J* .;TG0
M;^P\::[K4LMLUOJB0*(EW;X_*5E!SC!SN/ICWK'TGP?XCT&>?2].UVU7PW+,
M\J1R0,;JW5V+-'&X8*!DG#$$C/2N\HH YOQ3X2B\276D7'GF"2QN"79?^6L#
MJ5EB/LPP#]*7Q9H%[KQT;[)+;Q#3]2BOV\W/S^7GY!CIG=U[8Z&NCHH XFX\
M+>(M.\47^J^&M7L;>VU0J]Y:WUNTJI(%"^9'M9>2 .#QQ^6CXC\)MKN@V-BN
MH317EG<0SQ7I/[P,IP[?5E+CTR?2NEHH YBV\&6MGXU&O6S^5 +-(/LBC"^8
M@*I)]1&S)]#5"X\+>(M.\4W^J>&M7LH+75&5[RUOK=I520*%\R/:PY( R"<<
M?EVU% '&7?A+5+7Q/9^(=$U&$W:V8L;V._4LMR@.X/E>5<'/;';BKWA#P[J'
MA\:Q]NO;:Y^WZC+? 0PLFPOC(Y8^@X[>IKI:* .:O?#U^WCNW\1V5Y;HGV V
M-Q#+&6)7S/,!4@\'/'.<=<&L*7P)JLW@SQ'H+7=F'UF]FNA,-V(A*^XKC'.,
M8!R,Y]N?0J* .6F\/ZE<>+]$UMY;18]/M9;>2(%B7,FW)!QQC:.._M51_!][
MJ.IZ+>ZJUB;O2KCSEU"W#">9 & C;(X!R,G)SCH,\=I10!B^(M.U#5([2WM7
MMEMDN8YKE)MV951@P08Z D#)YX&,<U4\=>&I_%GAE],M9HK:Y\Z.:&Y?),#H
MP8,H'4\$=NIKI:* .3N= UF^\2>&]8N9['?I4<ZS*FX><95"DKQ\N,9QSUQG
MO63?^!-6O=&\6Z?]KLD_M^Y$X?YCY PH(QCYN$'IUKT*B@#EKKP_J5WXLT#6
MFDM$33()HI(@6)D\T*"0<<8VCCO[5S][\/=<G\-:WX<@U6QCTZ]O'NH':!C*
MN^42%6YQ@'/3D\=*])HH XB]\(:W<:YK%Y'JUEY.K6"6DWF6S%X2JL/W7SX"
MG<202>?6HU\&:PND>$+-[VRD?0)8Y&8(RB4)&8PHZXX.=WKV%=W10!#="=K6
M1;81F8KA?,)"Y]\"N&TSX<LGPUA\(ZG<Q/):DO:WUN"KQ2[V=9 #T*ENQY&>
MF:[^B@#A]4\*>(M5T[2+E]7M(/$>D2%[>]CB)BF#+M=9$/0,,9P?IBLOXA6N
ML0_"G6YM;O[::^E:V&+6-D@B G3 56)).2223SP.,5Z95:^TZQU.$0W]E;W<
M0.0D\2R+GZ$4 8DGA^ZU;7M/U+6?LNW3HY5@@@+,'>1=K.Q8# VY 7G[QY-8
MUKX%U"V\)S^#C?0/H3LR1SD-]H2!FW&+'W2>2H?/ /W:[N.*.&)8HD6.-1A5
M48 'H!3J .8MO#EY;>/7UU'M5LCIR:>MNN[<JJY8-G&.^,?K3M+\.WVF>,-:
MU1+R!K#5'BF:$Q'S%=(PF-V<;> >F>U=+10!S?B3PU/JFJZ/K6G7$<&J:5(Y
MB\U28Y8W&UXVQR,C&#S@CH:I7WA&[U&+Q#=S2VRZIJ]C_9ZXW&.VAVL, XRQ
MRY8G SP.,9/8T4 <7)X4U1_^$1_?V8.@X+\M^_\ W1CXX^7@Y[\\>]=#XAL;
MG5/#]_IUJT22W=O)!OESA ZE=V!UQGIQ6G10!C>%=*N="\,:=I-U)#(]E EN
M)(LX<*  <'H>.G-9=IX:U30M:UFYT2YM#::M+]IDAN0V;><C#2+C[X. 2IQR
M.M=;10!P\?@2;39/"4>E3P"UT R,1/G?.TB%6/ POWBW?DUJ3Z#?O\0(?$4<
MEM]GBT]K+R6+!CN</NSC Y4#'ZUTE% ' -X'U5_!_B70VNK,/K-Y/<B8;L1"
M5LD8QSC'!R,Y[8Y[>QBEAL+>*?9YL<:JQ0DJ2!CC-6** .:ET&_?X@P>(EDM
MOLT5@UB826WD,ZN7SC&?EQC]:DNM!N;?Q/+K^DO +BYM1:W4,^0C[3E'R,G<
MN6&.X/48KH:* ,'0_">GZ1H<6G3117S"1YY9IXE/F2NQ9WP<XR3T[# JAXH\
M*W>KW6@'36LK6WTB^2]$;*1O*Y&P!1A1R>>?I76T4 </K'@W4_\ A,+;Q+X;
MO+33+MH]FH)(K/'>#C 91CD<_-UY]JZ][?[;ISVU]'&1-&8YD0DJ01@@'@]*
MLT4 <';^!M0/A)/!][>V\^B1NJB?#"=X%<.(BOW0> N\'I_#GFM:XT#4)/']
MKXACDM1;063V7D$MO8,ZL6SC QM''ZUTU% %#6[2XU#1+VRM3$LMS"\(:4G:
MNY2,\=<9Z5SVB:)XHT'PK9Z+:W6DL]I;B".X>.0]!@,5S^F:["B@#EI?#5^?
M%VAZNMU%)#IMG):N)2WF3;]N7)Q@'Y0<=\GI6:_@";4--\5Z?J5U$L.N70NH
MWM\[K=P%V]?O8**>U=W10!S6@Z?XIA"-X@U2QNVMT*PK:0M%YK8QOE))YQV
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MKANN2>,G))KL:* .7U/P_JTWC2TU_3[^UC1+)K.6"YB:0("^XO'@CYC@ Y[
M5Q6J>'M2\+>&/!6CO?6MQ/!XEB\B01%5PWG,-W.2?FYQCZ>OKM5+S2M.U%XW
MOK"UNFB.8S/"KE#ZC(XH YV[\'#7KW5+W7#&'O=..F)%;,6$,1)9CN(&YBV#
MT &T=>32>&M$\5Z?]GM-:UVSO+"S&(6@MV2>< 87S6+$8'7 ') R>N>N  &
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5DCV[A_%CMG^E ':G5-/$,,QOK;RISMA?SEVR'T4YY/TJ0WEJ+G[,;F'S_\
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MB=:00QI;V^J[HHE4!8R5A)VCMWZ4 >S_ -H67EI)]LM]CABK>:N&"C)P<\X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYDD/FKO1/[Q7.0/>O-],U7P_#?\ C7P]XMFMK:2>^9A%<OY?GVC1JL0CZ$X
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MW>M:787"6]YJ5I;S/C;'+.J,<G X)[G@5YR7B>;X37#LAF>,#S#C<P^R'O\
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M$>%G52 %V +NVXW8]5S764 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPRPR,]* .[&E:<$*#3[4(Q!*^2N"1T[>YITVF6%Q%%%-8VTL<)W1H\2L$/J
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M+==NO$FFZ39Z5;6WV_2C?#[:SK) X* JZ@#IN(P.I[B@#MZ*\LUGQ=KM_P"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6UI!<Q2WGF''F;N'52.?E[=.>3TJOH_Q#N=7T_1K7['#;:]?WL]C+$^6B@>
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M5.,$<_-G\* .FHKC;O7==TF]M=.U%[*2ZU*XD-JUI;22>3 B!FW+G+MD@ C
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M,[4CD_UC%CR6; '08 [YK=O--L=0V?;;*VN=ARGG1*^T^V1Q5E5"*%4 *!@
M#@"@#B;?P5?R>'+'PSJ>H07.D6<D1#B,B:>*)@T<;\X&"J@D=0.@SFM32?#]
M[I_C'7=:EN;=X-4$ \E4(:/RE*CG.#G// KHZ* ..L_#NK:!#XE>SUBUBBO[
MB:]MFDMB3!+(!G<=V&4$< #O^%;_ (?DU&70+)]6V_;S&/.*ILW'L=O\)(P2
M.Q.*TJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J>J:BFF
M6+7#(TLA(2&%/O2R'A4'N3WZ 9)X!JY7)ZU:^*V\2I>Z;9Z1=6<$.VW6[NI(
MVC<YWMA8V!)& #G@9_O&@"QX#UV\\2^#;+5M02%+J9YE=80=@V3.@ S[**Z2
MO-?A3J4VF_#2.[UN2PLM-AEF\JX,Y'6XD#;]P 7YC@8)S[=*])!! (.0>A%
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MTRSG$%UJ-I!,<?NY9E5N>G!/?M2W.K:=9VBW=U?VL-LQPLLDRJA^A)QV/Y4
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MFVL;:&>7_62QQ*K/]2!DUG:GJ\EOJ>FZ);.C:C>JSLY7B*) -\F/J54#U;N
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MTOQ=HVL:W?Z597T$MQ9,$<"49=L98*.^WC)'?([4 7/^$?T4Q0Q'2+#RX/\
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M\(27R6,ERB[9,9V')^]CMUJIJ?B[1M)UVPT>[OK>.[NPSA7E"A$ )W-GIDX
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M .> <8ZUWUM8VEDK"TM88 W+"*,+GZXIEMIMA92326ME;023',K11*ID/JQ
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MDQ1YX]SFNL&DZ:'C<:?:AHO]6?)7*=^..*DM]/LK-V>VM(('?[S11A2?K@4
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M"EDT^REN5N9+.W>X7!$K1*6&.G.,T 2P00VMO';V\210Q*$CCC4*J*!@  =
M!4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M))]1^)M_I<&IPW6F1Z6EPL<:K^[E,A4@GKG !P?7I6[KUP(18(NN0Z5))>1
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M)+V:V>31+A1);7+12(Q?@@J0<]3@\<=* -SPCXJOM0UGQ)HNK_9FFT29%-[
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MXP22>M 'JTNMZ5!>"SEU&U2Y+K$(FE 8NV,+C^\<CCKS5^O*[RXN]%U.YO\
M3+RVUC0[C6U2\TN<8N+6Y,P7=$PZ_. VTCISTR:]4H Y;POK6IZCXA\3:?J,
MENZZ;=110^1&4&UHP_.223SZ]NU4O%5WXNTAHM6L;RTF@^V10#21;9:9'D"9
M$F<[\'=T  SUQDL\&SQ2>._'2I*C'[;;G"L#_P L%'\P15/Q^NB^)= GN-+U
M</KNGR$:?]BO#YBW0. FP-C)/!R.A]!0!W%_J^G:6%^WWUO;;P642R!20.I
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M8'@CUKR7PXOV?]FR]-R"L;Z=?-&&_N,TA3\\C'UKT3PE#/;^#=#@N@1<1Z?
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M&2>!VZU[='(DT22QG<CJ&4^H/2@!U%%% !1110 4444 %%%% !1110 4444
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M?G2"TMA=&Z%O$+@C:90@WD>F>M344 5Q8V@NOM0M8!<#/[WRQOYZ\]:L444
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MIJFMVMM.]Q?20WIMU'[PVJR(0F.Q\I22/5FKT4*JH$"@*!C '&*4    8 H
MX/P[>^$_$?B.SUG1[^YU+4(K9D,ID;%O$W.V08 !)QA3SU(Z&NIT#4-(U/2(
M[K0WA>P9W"&&/8NX,0W&!_%GZUH1PQPAA'&B!CD[5 R?6E1%C7:BA5] ,"@!
MU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445P/
MB;QIJ_AZ#4;V:&QBBM+N..&RDR\UU 613*&5_D&6.,J?N\]: .^HHHH ****
M "BBB@!LDB11M(YVHHR3Z5AQ^-O"TJLZ>(=,**=K-]J0 'T)S@5O5P'PF1'\
M+:JCJK(VL7@*D9!&_I0!WD,T5Q"DT,B21.-RNC AAZ@CK3Z\AT76H_ GB;QW
MI<$;2:38M;7%I;*3MBEGP/+7 .%+N. .,<"NLM_$FNQ:\;6?3)+ZQ>T>9;F#
M3Y[;RY4&?+82$YW#H1CGC% '953TS5;'6;5KK3[A9X5D>(NH(PZDJPY]"#7-
M>$_%5SXG2&ZM;S3+J!K5FN(8D:.6UN,KMC<%B<<N,[1]WWJA;^/;R/X?SZ]=
M65L+L:@]DL<6X1*WG^4&8GG'<^OMF@#T"BN0CU[74\=R>&WCT^=1IXOUN KQ
M<%BFTC+<[AG.>GN*P+7Q[XDD\):5XGGL]+6RFOA:W,">89"K3F+<AS@8XX(.
M>3QTH ].HZ#)KC-5\5Z@]WK-KHD2M-I>(]KV$]P+B4H'V!H\!!AE&3GDGC Y
MDM?%=_JVHZ;I-M9C3]1GT_\ M"\2]C9OLR[M@3:"I+%L\Y& N>^* .ATS6=.
MUI+E]-NX[E+:8V\K1G(60 $KGOP1TJ]7"?#+[0/^$M%WY7V@>(;CS#$"%)V1
M\@'D ]<9-6M=\7RV'B=]"CNK"PN6M%FLVOXVV7DA+ HK!E"XVKZD[^G'(!V-
M%<Q%K^I?\)Y'X?FCMA%+I!OPX1MZ2"14*GYL$?,3VK+T_P =7ESI<0E@MO[2
MN=9FTF *&$?[MFS(P))P%0G&>3@9&<T =AJ6IV.CV$M]J-S';6L0R\LAP!4\
M$\=S;Q3PMOBE0.C>H(R#7#>*Y]>/@OQK:ZO:VQMHM.D:TO;?Y!.#$VX&,LQ4
MJ1C.<'-&D:_K.G:GX3TN]AL3I^K6;)#Y6_S87CA#_,Q.&! /  P>YZD [VJ$
MFM:;%K,.D/>1C4)D:2.WSEBHZGV_&JOBC7T\.:*U[Y7G3O+';V\);;YDLC!5
M!/89.2?0&N5ODU1/BYX7&H2V<P^P7IC:")HN<1[@06;CI@^YXXH [?3]5L=5
M^U?8;A9OLEPUM/M!&R5<;E.?3(JY7 Q>.;Z'PQXBU2\L[=7TO5WL3Y".ZK&&
MC4RL.K;0[,0,9 QQUJX_C&2TT&YU;[1I^J6TDD,.GRV1*+-)(P0*WS-MPQ&?
M;MGB@#KY98X(7EF=8XT&YF8X 'J:K:7JECK6G1:AIUPMQ:39\N5,X;!*G&?<
M&J%C-XBC\0/::A;VD^FM;"5+ZW4Q%)=V#$49V)XY## [5Q'@?7SHWPQ\)VEN
MB/?:G=26MN),[5_>R,SMCDA5!X&,G R,Y !ZE17'2>*]1TKQ#?:)J5K%=W"Z
M<^HV,EHC)]H"9#1%26(?.,$$@@]J;X?\4W?B&Q-]I^HZ3=V_V-I'\J%E>WG&
MW$<B&3.,;O3[M '9T5P,?CC4I?"7A'6Q;V@;6;VVM;B+:V$$K$$H=W&,=\U/
M'X@\4ZAXNUO1=/M=(2/3)+5C)<-(=\<@+,./XL#CC QWSP =O17GTOCG5[G3
MH-9T?37OK-[G9]BCL)S*\.\J9%F^YG W;<8QQG-=AKVLV_A[0+[5[H,T-G"T
MK*O5L#@#W)X_&@#1HKG(+WQ+#J5@U[:V,NF7$#O=2P91K)@H902S'S >1D*.
MF?:L.?QMJH\%#QI;VUK)I()E-D483FWW[=XDW;=V/FV[<=L]Z ._HKBG\3:[
M?>,9M#TF/31 VEQW]O<S[VX=RHW*,9Z=!CKG/&#@ZAXKUO6O!GA?48);:QGN
M]<AL[R-8F=699RORG<"$)CR1U(.,CG(!ZG17#ZAK_BL>+Y?#>FP:.\XTH7J7
M%QYBH6\S8<J"2 <'@9QG.3C!LP>(-9UL:TVB+8 Z5.UH5G1W^T3H@9U!#+L7
M+!02&YR<=J .@O=:TW3[ZSLKN\CBNKQ]EO$3\TAQG@#Z=:OUYCJ'B"#Q5#\.
MM;MHVCCNM5W>6QR4812JRY[X8$9]JV4\87%YXGO=&MKC3[>]M+R.+[!=1LLT
MUN2F^5&W 'Y2Q "G[O/6@#M:*J:I<75II5W<65H;RZBB9X;<.%\UP.%R>!DU
MRNE>+-0N/%L>A3R:==M-IK78DM59%BE1E5HV.YPP^;J.1CI0!VM,EECAB>65
MU2- 69F. !ZFO,X_'OB7_A#XO$\UGI2VD-^;:Z@7S"[I]H\G*'.%(XZYSSTZ
M5U7]N7^J^(M4TG1VM(O[+2,3S7,;2!Y9%+! %9< +@DY/WL8XH V=*U6QUO3
MHM0TVY2YM)2PCE3.&VL5.,^X-7*XCX0[C\,-)W@*VZXR > ?M$E1R>(O%VH>
M(/$>CZ/9Z.LNE& QR7+R$2"1"X4@8Y/ SP!COG@ [NBO-[?XB:MJFF^%+K3M
M.M$;69Y;6>.X=LPRH'W8Q_""F?7'&,ULV>NZ[<ZO'X=E;3(M7@L_M=]<1QR2
M0+N<K&J*65B2!DDGC'?/ !U]%<':_$">2SDL[BTA378]7&CF,,?),A^82COL
MV MCKQC/>M"]\0ZUX=M]:N];L[>:QLXHY+2ZMOW?GLWR^64+,5(8@9Z8/2@#
MK*H:KK6FZ)!'-J5Y';))(L2%SRS$X  ')ZUSD'B?5[;7X8+^S,^DR6TDLM['
MI\]N+1D&[#^9D,I .",<CI7->,=5U77OAW8:R5M(M/O;ZSE2W\MO-2(SH48O
MNP6/&1M&-W7CD ]7HKF;+7=0N_&6NZ"1:JME;03V\PC;/[S=PXW<XV]L5SL/
MC_6[GPIX1U>"PL#+K=\MI*C,X"$F3!7VQ'R3GKT- 'I%%<7_ ,)'K<%ZFB7I
MLDU=;8W4\UI97%S"$,C+& BD,"0I)).!CC.>*1\?WUII.D3:[9IH<MW<RVT]
MS=P2&",H,J<$J0'XP6(Q@YS0!Z#15#1I[NYTN*:^:V:9F?Y[4_NW3>=C+R>J
M[3U/6F>(-:M_#OA^^UB[#-#9PM*RKU;'0#W)P/QH TJ*XR^\3ZOH+Z%=:M'9
M26&J7$=K(+=&5[66093YBQ#KGY2<+Z^U1Z5X@\4ZQXAU2R@MM(BMM,U)+>=I
M&D+/"45CLQ_& >X [>] ';T5B^(M<.C1V$,,:27FHW:6=N'/RAF!)9L<X"JQ
MQWP!QG-49-1\6646MB32+:_:VB633I;=Q"+IB.496=BI4]\\CI0!U%%<;I/B
MF^O?%]SX?-SIUT1IPO8KRVA8(K>9L9"-YW<X.0P[BL^'QYJDWP_T#Q(+>S66
M_O(K>>':Q4!YC'E3NX(Z\YH ]"HKBKSQA<'Q1J.A6MQI]M?VIC^S6E[&P:]1
ME5BT;[@.I90 #RO/7AVJ^*]1>ZUFVT2)7FTLB/:]A/<"XEV!]@:/ 3AE&3GD
MGC Y .S)P,GI5'2]9T[6DN)--NX[E+:=K>5HSD+( "5SWP&'2N?M?%5_JVI:
M=I-K9KI^HS:>-0O%O8V?[,I;8$V@J2Q;=SD8"YQS5+X8_:-GBP7?E?:!XBN?
M,,0(4G9%R >0#Z4 =W17&:YXOFLO$L^A07-A97GV19K(7\;;;V0[@45PR@8(
M4=S\W3CF['KVH'Q\WAV1+80MI/V]) C;E?S-FT_-@COQB@#IJJ:GJECHVGRW
M^HW4=M:Q#+R2' %<?IOCJ\N]%LVD@MO[3O=6FTR *&$8\MGS(1DG 5"<9Y.!
MD9R&>+9]=;P3XUM=7M;;[-#I[FTO;?Y!.#&Q8&,LQ4J1C.><T =U!-'<V\<\
M+;HI%#HWJ",@U)7!Z3K^LZ?JWA72[V&Q.GZM9LL/E;_-A:.(/\S$X8$9Z 8/
M<]3WE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%9ZZYI
MKZ\VAK=*=26 W+0!3D1Y"[LXQU([YI^EZM9:U:-=6$WG0K*\);8R_.C%6&"
M>"#0!=HHJ&ZNH+&TENKF01P1*6=ST % $U%5=-U*TUC3;?4;";SK2X0212;2
M-RGH<'!JU0 4444 %%%% !1110 4444 %>;ZKX!U^^TSQ-ID>J6'V?5KW[;%
M-+$YF!W(PC8YQM78 ",\=A7I%% &7!%KBZQ&]Q<V3Z;]DQ(B1,LAN-WW@22
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M2AC&Y+LQ5UX(4ABIP>P/M7::EKFFZ1/907UTL,M[,MO;J5),DC=!P./QK0H
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MBX/)0+\OODG':KUQX9UCQ)X<U#3O%-_:B2[@\E%TU'6.(Y#!_G.6;<%/8 #
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MA,A*'=Q@C&"#5B'P4L^N:EJUVEK:S7^G-83I9 [9=QR96R!ENPXX&>3VS(/
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MO;?ZMN>"O)X(P1R>M9-QHNJM%;PR7%IJ=LT,B7MO?(0D[LP8,,;@H'("X/!
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M+3S/96TT$D$%NX1@^WH2V0?EZG/8;>YSY/ &J2?#_4?#!O[0/>7C7/V@1MA
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M&B;@6+,2!UX7IS4UMX9U.VUSQ-J/VJU?^V8HHT4JP,1CC* D]\YSQCTK,L/
MVM:6GA=K75;(S:+;26C":!GCD1@!YBJ&!5QC'7D=Q0!CZKXJUK6OA[8WT5Q!
M9W!UN.QN=D#8E"W 3(!;* X!*GGJ,BO4HUN%M0LLD4EP%Y=4*H6_W<D@?B:X
M)?AYJ2^%+O2/[7MVF.J_VE:RFW("L)O-PX#<Y/'&,5WL"W*6BB>2.6Y"_,RJ
M40M[#)('XD_6@#S.3QSXI3P+<>*2FD^787LD,]L(I,S(L_EG:V[Y#CU#9]NE
M=)%KFN67CNRT;4S82VNI6LT\'V:-U>!HRN59BQW@ANN%Y["LM_ .IR?#S4?"
MYO[0/>7+S_:1&V$#R^:1MSSSQUK;OO#VHWWB_1];:XMHTL;::!XE#%F\T+E@
M>V-HQQ0!B_\ "9:S9ZGH<6H+8K)J&H-97-A$I=K0$.8R958J6PH)! SG@#%0
M:;KVI:7K/CS4]4OHKBRTEU/E+;E6*" .JH=^%Y8]0<DYR*+;X?:]!H^A:>=;
ML"-&U$7<,GV-MTP^?)D^?EOG/3'?).:USX*EEU7Q,+B]B?2=>0>= (B)5;RO
M+.'SC'&[IG/Z@#+?7_$9UG2XQ9"[L;Q&%RR6,T'V-]N5.YSAU)X/ /?VJ#PO
MKGB[Q#YMR3HT5K;7UU:3+Y<F]_+)5&7YN/F R#U&>G%6_#F@>*M,2"SU77[6
M]T^R&(/*MVCFFP,*)6W$8''09..2>0;?A30-0\.Z;J-O-/;7$EQ>37D;(K*%
M,C%BIZ\ GK0!DZ-XLUK5O .BZWY5A#->3E;R=VVPVL0=P7 9@6^ZH SU;/M5
M5_$=SKW@;QW;W?E.^G175NDT<31B5#!N5BK$D'YOH>HI;3P!J]AX8\.Z=;ZI
M:&ZT2\:X0R0L89PQ?AESD$;S@YZC\K<7@K5H[7Q; ^JVDHU]6P?L[)Y3O$(V
M/WCP,<#\S0!T'A'_ )$O0O\ L'6__HM:V:SM!L)M+T#3].N'CDDM+=("\8(#
M;5"YP>F<=*T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "J6K:K::)I<^HWS.MM  7*1LY&2
M!PJ@D\D5=KF/B#K>H^'/!6H:OIAM_M%L%;$\9=2"P4]",'G/?ITH Z<'(!'>
MFR2)%&TDCJB("S,QP !U)-<AJVLZ\GCZST"PFL(K:[T^6X$DL#.\;*RC/# -
M][@?+UZG&#@ZAK6KZU\)O%WVN>W2]TYKZQGEBA(6=8U(R%W?(2".YQS0!VVG
M^*=)U/5!IMO-+]J:W%U&LL#QB6+.-Z%@ PR1T]:V:X6VUB]T^#PGH:S6[W^J
MPDI<&# @@CB5F^7<=S?= Y YSCC!CNO%FLZ9>^)=&F:TDO\ 3M-.IV5RT)VS
M18.5= PPP9<9!P<YP.E '?45YEJ'B7QEI_P_'BIKG2&2:TLY8[?[,^Y6D95;
M+;\?Q@]..F.YU;C5O%%KXW@T(W>F/'J-E+<0R?9G'V5D901C?^\X;U7GGCH0
M#N**X+3/$^OW/AK6"W]GOJ.EZJ^GRW3_ +F'RE9-TQ4MQA&)V[NHJ*/Q1JMZ
MGC/3X+U-^EVD=Q:7QM2C$/&[<J< X*'# 8.0<'N =KJ>K6FD6\4]V[K'+,D"
M%(V?+N<+PH.!GOTJ[7F=KK>N:'\,_"%['=6LYNFT^"3S8&W".4(#@[^6Y/)'
M.>@KHQK-]K7B?6=&TRYBM%TF.$2S/#YA>612P&,@!0H&>Y)ZC'(!U-%>9GQ_
MK=UH6CW-O!8PWSZ\NBZA#(K%1(&(8HV> <#J#][VYZ#P_K&L'QCK'A_5Y[6Y
M-M!#=03V\!A^60L"I4LW0KP<T =917)>+=:UK3-;\.V6EO9"/4[E[>0W$3,5
M(C9@P(8<#'3'..HS55=<UT7[:!-<1MJ5I:)/=7=I9&16:1W$8"%N  F3DG.>
M,4 =+JNO:=HLMC%?S-&]]<):VX$;,'D8X"Y P/QQT-:5>8:[?:OJ/ASP9/KN
MGBQU+_A)+19H1]TD.P#+R< C!P3QFM+QAXGUK0H]<N8YK2%;"!)[*W\LS/=*
M%S(T@4Y1<_*#P.,Y/2@#O<U2M-5M+Z_OK*!G,]BZI.&C90"R[A@D8;@]LUQE
MW>ZK>_$WP\L-^L-I/I4UR+=H=P4YCSD[ADD' /;TY-2_\)1K@/CF/?8F70E5
M[4^0VU@8?-PPWY)[9!'T[4 =W17GMEXG\11S>#;N_FL)++7D2.2WB@97B=H3
M('#EN<D'(VC ..>M&J>,=6&E^+]2LFMH#X?N##':SQEO."HK%G.01NW$+C'3
MOF@#T*C-4M+EO+C2+::[,8NI(@[;(BBJ3R!M+$C' /-><:+XFU+P_P"%/%6N
M:C=K?O!K%Q;11M'L+R^8L298$X7[HQC@#K0!ZI0<8YZ5Q^H:YJWASQ#H5MJ4
MT%Y8ZM,;1GCA\MH)]N5QR<H<$8/(ZY-,^*UQ>VGPVU>>QNS;2+&JNP7)9&8*
M5![9!Z__ *Z -9+KP]HWB&WTJ&WM[74]15W18;7;YH0;F)<+CCW/<5NUYYXE
MCU)?B!X&C2YMGO3'J($SPD(/W:<[ V3@=MPSZBEM/&VIV>E:K#J(@N=3L]93
M289882J2F39M<IN)R Y)4'G;C(SF@#T*BN6T74?$+^)Y[*^M))M):V$L-\\'
MDLDN[!B9=QR,<@@#T.:C\7ZWK.E:OX>M-+:S":E=FVD^T1,Q7Y&8,"&' QTQ
MSZB@#K:*X@:WKJW_ /PC\]Q&^I6UH+BZN[.R+J2[N(PJ%N.$RV2<YXQ42^+-
M?BTKP[!JNG)IVJ:G?FRGD89CC #$.HR>7"C:">"3UQ@@'<RRK#"\KY"(I9L
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MMM5\41^(K&%[)[S3;B*3[3)]F\@VL@&5VDL=RL<C!Y'!S5?P?XNF\27-NO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3Z5J7BO6/$^M6:ZEI\-KI.HQ1LHM"3-$45F3EOE.#][GGL ,&30_ NIZ"_\
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MQ'X<\RX0:%J#?99?W0W13E<QC=_=8@CIP>_-;.B7=W?W.IW,DP>Q%TT-HNP
M[4PKDGO^\#@>R@]ZYWQE<Z7?:))X,NKQ)M=NK=/LT,*,K;]V$E YVA67<>>
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M0V<94_;D,9(.",@ ?-D8JW>^(]'TV25+S4(8?)*B9V)V0EON[V^ZF>,;B.M
M&D8T,9C*+L(P5QQCZ4V."&&(111(D8Z(J@#\JR7\7^'(VB!US3R98VE3;<*V
MY%X+<'IGCZ\58L?$&DZEI+:I::A;RV*;@\X?"H5Z@YZ$>] &@J(@PBA1[#%-
MEMX9]OG0QR;#E=Z@[3ZC-4]/US3-4GN(+.[5Y[?'G0L"CH#T)5@" >QQ@UR7
MB;Q8IUKPM%H^L-LN]52":)$&RXBPQ8JQ7Y@"%!*G'/- '>TBJ%4*H 4#  '
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M\4=2TZ+499]/BTR.86\D00P2F0@@C:&Z!3\WKZ&@#M4C2/.Q%7/)VC&>,?R
MIDUM!<8\Z&.3!R-Z X/XU0MO$FCW>H1V$%_$US*I>).1YJCJ4)X<#OM)K4H
M9)#%,H66-' (8!E!P1T-*J(F=JJN3DX&,GUIU% $<=O!%$8HX8TC)SL50!GZ
M4>1#C'E)C_=%244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P_Q?DC3X6ZTL
MCJI=(U0$_>/F*<#U/%=Q10!Y_?7FGR_&309/M%L^-'N"C;U/+.FW!]2-V/;-
M<?=W$$GPU\:F"1'CA\3O,WEG=MC^TQ-NX_AP"<^QKW#%&!Z4 >8:WXATS3?'
M]OJNJWMQ!H.HZ8L-IJ$+NL0E21RRDKV8%2#T.!5'58O#NG0^"X]-3R--?Q!]
MIC^TR,2ZE'S( YR%+D8[=#W%>N,JNNUE##T(S2T <!K#V$7QA\,QEK="EA=X
M7*C:S%"/H3\WUYKEH=;T[3]#\22R16MS$?&)(DERT5J&:,BX8*02JD$]0">]
M>T4A (P0,4 >7^'=3LD\<>-F?4C<+/96DJ7$JA1(BQR L" %VC( /3IR:Z#X
M52QR?#'0 CJQ2V". <[6!.0?0UV.!Z44 >7V6O:1HWB+Q?H/BW"/J5X;BW$T
M3.+RW>-$5$P#N(V[=HYYX[U:MKI-"^)L<NI1KIVFWFBPP:>92%CA9&):#/0-
M@@X[X]J]%*J2"5!(Z$CI0R*Z[74,/0C- 'B.LV\=KX*\2SR-&FF:AXEBGL4<
MC;(GFQ[W4'JI(8^F!GH:[(W=H?C=;".>$E_#S(-KCD^>K*/RR0/2N]HQ0!X0
MFH:>WP&TK3YIXO/MKZ"*YADX*$7665@>X4$D=AR>#7<^*IUTSQQX1UJ78NAJ
MUQ'-<+CRXI94 CD<],'!7<>F?>N^P/2D(# @@$'J#0!YLR1MXG\;ZW:SQC2)
M=)CADF5AY<MPJOD@]"54J"?4XKHOAQ+'+\./#OENK[+"%&VG.&" $'W%=.%"
MJ%   Z 4M 'F_A[4+/2M2\;:7XEFBAFGU&6[07! ^T6CHJILS]\ +MP,X/%9
MT>@:OI_P:T"\DCD_MWP^%U"&-_O[%+%H3WYB)7'J *]8**Q!902O0D=*7J,&
M@#SKQ-%?W?PVO]8M[6XDN;R>#4)+9.)3;I(A$8QT/E(,CU+>M/T?4_!NNZFN
MNZ7=W%Y=V]DZ2W4TTNVVB/)1]QV@D]CSP3VKT*D5%4$*H&3DX'>@#B/A&+5O
MAEH30B$R1P,CE -RMN)8'T.<&H_B!>VMOX@\%I-<11L-8#D,X!"^5(N3[9(&
M?>N\HH X*2]M%^.$)-S"/^*==22XZ^>K ?D"?IS7$27-@/@3K&R:W$C:N[#:
MPW$_; 0?^^1GZ"O=,48% 'DGBO6["YN_'&GQ21V5PVE*1Y2;YM3!@8JP)!'E
MJ#M.T9ZDL!3K#4-.N_%'PS<3POMTF<98CAO*B Z]R0P'K@UZQ@9S@9Z4N!Z4
M >(W-TPTCQ9<V ^UPV7BV._NK> AFEMT,3.0!U&5S_P$^E>AZ5K_ (7UZ_GU
MG2F@N&6S\NXU$(56-,Y$;,0.>2<=L<XR*ZND551=JJ /0"@#Q?P]K=AIWPX\
M BX%M&#<O'_:,_*6#@2<D9P'(.T;N!G)SBGVM_:IX0^*=NUV\DC2W3JTZ;&<
M/;*%)&  6/08&>U>RD C! I<#TH R/"LT<WA'1Y(I%=/L4(W*<CA #7&^#!!
M?KX\2PEMVOWUFY>!U(+ F)0C@^F[=@_6O2:* /(O"E]X6UO2?#VCWHOWU_2I
M( =,>297MYXL*9,= @&3Z8XZ\5)I5QHBZ?\ $BTU%K;S)M4NE:%L>9*IC4*%
M'5CNS@#N>.:]7V@$L%7>1U]:YSPOX=N]$NM9ENY;:8:AJ$E\GEJ08BX4;>>O
M"CGCZ4 <5X;2]\)^)O"__"1OY%L_AM+&.:9L)#<AP[1LQX!*A1[[,"LKQ/"D
M/@WXB7R2(-*U'4;=K(9^69PT?FNGJ"P/(Z[2:]N95=2K*&4]01D4N!0!P'Q
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M'4BIDU#0;?5?%'ASQC/>P37E_+-##OEVWMO)C8$"?>( "X'/ ]./7 BJQ8*
M6ZD#K054L&*@D="1TH S5MIH?"XM=/C>WG2R\NWCD?<T;!,*"QSD@XYKQZYU
M_2I/@G8:2\Z1:M87%K'=V4G$\4B7";V9>HSR=W?=ZFO=*;L3<6VKDXR<=<=*
M /*[K6=&TSQMXCL_%-W=6EIJHBFL9A)(L5S#Y*HT8V]P0>.^ZI+^QMM.ET[_
M (1O61X>U*RTP&WM=3.Z&XM2[$)('.X$$9SG*AL?3U%E5L;E!P<C(Z&D9%?&
MY0V#GD9H \N?5DN]:^%US=V\6FS.D[-:D[?)!MRJ@ \@$X S["LK5=2T>UG\
M;^&+G7=.M(]4O2SO?LZ2PL\:!RJ[2'4 #:=R\CTP3[17(6GA[Q+I\UQ!!K.F
MW-C/<23[[VP:2=-[$E<K(JMC. 2!@ #H* ,>^N=+;XD^!1!>V]S"EA="*7S%
M?<"L81L^IP<'OS7-2W1_L7Q9<V.^YAL_%JWUS#:/EWMU\HLRX]QG/^R?2O8=
M,TZ'2M/BLX/N1Y.2 ,L268X& ,DDX  YXJW0!Y1J3:)XFT;7M4\&37>HZP^C
MR6QNQ+*VU"0PB^;C>?F('48[9&8-3\3Z!JFF?#]K"Z@S;ZM;++ OW[;$3J5=
M>JX(QSUQQP*]=550850H] ,4@1 <A%!SG.._K0!@^.H);KP!XAA@C:2633IP
MB*,ECY9X ]:X4>(=)U#6_AI+9WL<\<(E25X\LJ.;4KM)Z!LD#'49&>M>M4T(
MBXVJ!CI@4 >-FYT]_ 7Q3(FMB\NI7FWYERX,:;,>OS9Q[YQ6G9:Y;:1X]TJ_
MU>[CATN]\/Q06-[(X$(E#;I$+] QX//7 %>IX%(RJPPR@C.<$4 >'K?!?#VM
MWUHD\UI9>,GO;R.V#!_LV1\Z@<\'#?\  ?:NAN;OPEJ6C>)==T6YEO)9-%FM
MY[Z2:0I@J2D?S\%LYX'(Z'&1GT\  8  H5%1=JJ%'H!B@#G? 8M&\"Z#);"$
M_P#$N@1FC ZA!D''<$G(]<UBRW-FOQSC\R: .GAYE^9AE6\\''L=N3]*[VB@
M#PZ>>P/P8\<K%+;Y?5+O:%89;,V4QZY R/IQ79^,BVGQ:-XXTQ#=/IN$N4@(
M8W%I)@.!ZE3M8?0UWV*Y^]T75=1UX/<:K%_82F.06"VX#M(AW#=)G[NX XQS
MC'3.0"YX?L9K'1XEN@/MDQ:XNB#G]ZYW, ?0$[1[ 5P'B^:33M8U_4]#UBW^
MUQ1QKJ6A7P#1WR^6-OE_Q!BK;1CJ1CZ^ITTHK,&*@D="1TH \].KVNE?%R6Y
MU5Q9?;]"@$"2]9)!*Y:-<?><;A\HYYZ5QMG=61^&7@LW31^3#XI'GB5?E0&:
M<_-GM@@_2O=2JD@D D="1TKG/%7A^[UUM&%I-;PKIVHQ7Q$BD[]F1L&.F=W7
M]* .-\2Z9/K?BWQ#>^&RLC-X9EM)I;=@5EG9LQID<%]H/N 5]15GPYJWA#Q/
M<:)/ ][-K&GC<+:664&P.W$F\'@*,8YX/ %>EHH1 H55'HO2E"*I)"@%NI Z
MT <#\+387.DZP8OL\D@UN]<E<$X:0X/XKT/<57\)V%W8ZY=^#Y87_LO1[LW]
MM*?NM#)EH8O?:Y<Y_P"F0KT>C SG'- 'F;7.F-X[^(4=[*'MCI%N)TB8;V18
MY?, ]P#^&14GA.^OM-\1P:9-K%GKVCC3WFM=4&T36L89/DE8?*0>,'@G8?0U
MZ1BD5%7.U0,G)P.IH \/T:X:#X:>"-20^9INFZR\NHB/GRD,LH5V [*6#?B#
M787#6]]\3/[;L+J!]/MM$DBOKJ.0&(EGS&A8<$CYF]ACU%>@XI%147:JA5'8
M# H \1L[FQA^$GP]_?6Z-'K5FS_, 5(E.\GTP#S]:]:L?$FD:EK5]H]I>K)?
MV(5KB$*05##(()&#U'3.,UJX%5(]/B34I;]F9YW01J3C")G.!]3C)/H/04 <
MAX]N8;#Q+X+O[N00VD.HR+),_"H6@<+D]LGBJOA_4[;2?&'B^V\03QVS7DZ7
M=M)='8L]L8PH"[NNW&".Q->B4C(K$%E!P<C(Z&@#D?AAIUWI?P_TZUO$DC8&
M5XHI 0T<32,R*<\CY2..W3M6!H]WH4'B/XB0ZM):JLER@E24@-)$8%! !Y;G
M/ [GWKTZN:\/>';O2M<UR_NY;:5-3N5N55%.8B$"8R>O Z\4 >?:-;'1[KX4
MZ?K+QQW<$-X7CG8;HMT>8P0>A' 'N,5TUK=Q:!\5]8&JR16EG?V%L--FE(2,
M+%N\R($\ Y;=M].:] I&17&'4,.N",T >8:-X3EUCP#XGL$)AAOM5NKO1VZ>
M4H8-$Z^BEU+#V/O71>#-2GUO2O\ A)M4A-I+) L&R7Y?+$?^L//3,F_ZJBUU
MU   P!Q0!X7H]^+'X=^ ]2=M^D:?JTKZCY8W"',DHC=P.@4L#^(]JV=4OH==
M\<>)8] NXKBXO/"OE6TMNVY9)-\F K#@GH,Y_E7K1 (((!![4*JK]U0.,<#M
M0!YAX8U/PEXF;0!&;Z;6]/*D64DDP:R<+M<L#P%&".>#P.IKU"D"J&+!0"W4
M@=:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H:KK>F:';I/J
M=[%:QR.(T,A^\Q.  .IJ_7"_%IX1X)\N8H=]]:G8W.X"9"W'<  D^U '06OB
MW0KZTEN;34$N(H[@VI\I&9FE R450,L<<\ \<T^+Q3HD^EOJ4>H1FU2;R')!
M#++D#RRA&X/D@;<9Y'%<GX[O8=*\0>'->NUN7T!%N(KJXLG<>2T@39(3&<E?
ME(S[UG:E?>'=.T/^V-&TQI+&^U>V:74[M9I41\G-R%<Y(7  ;@%CW Y /0+;
MQ%I-U;WL\=XJI8DBZ$JM&T'&?G5@"..>1S4EIK>GWLUQ#%*ZRV\:R2I/"\11
M&SAB' X.UN?8UYA;3:5/K/Q M]3GU"XL;R&R9KCRF61H_+VF12% X)!&!SC@
M&F7L7B74= \4^'K34X?$"MI2O::K H$K#>?]'D*\,Q7=COSSUH ],M/$VCWM
M[#:0W@\ZX0R0!XV03J.IC+ !QCG*D\<U2N/'WA:VCGDEUJWV6\QAE9-S!&&,
MYP#P,C)Z#/6N7U>\M?&%IX-71)%-];ZG;W4L:</:1(K>:)!U3^[@XR2!6<EQ
M9MH'Q4_>PEIIKC9R,R VZJN/7YL@8[T >E7VO:;I[Q)/<$R2QM*D<,;2NR#&
M7VH"=HR.>G(KEO%OB,1#PEJVG:ULTN\U...9T91%+"4=B2Q&1C;Z@=<BLBQU
MRTBU/PS:2'[&9= CVZC%!YDTYRH-LAP0""NXC!/3&*P-'EC7X;> 99DD6#3=
M<4WCR1,%@ ,W+$C  )7GH,B@#U*S\3:3XET[4!H>KAYK=2LC1+B2%L'!VNOM
MP2,&L_P1KK2_#C1-4U>\:2XN(%W2,"SRN2>  ,L3Z 5G)';W?Q#U3Q)921?V
M7'HGV6>[1AY<TQDW##=&VJ,$CIN ]JY*PNO[-\ _#_5[A+J32=.\R+4?LC.)
M+<NA57.PA@%).?9O>@#U[2]:T_6HI9-/N1+Y,ABE0J4>)QU5E8!E/L14>H^(
M-,TF;R;NX*RB(SM''$\K+&#@N0@)"Y[GBLCP>/#UU<:EJWA^&X>*],?G7TLD
MS"Y=00,>8<G:"!D<'..QQC^(M5@3QS=Z;*C6,LFDCR[F&W+SWOS-^Y0X.%7J
M0!N^;.1CD [%]=TU;:UN%N?.CNTWV_V=&E,JX!W*$!)&".<8Y'K31XATMK2V
MNH[AI8[K=Y(BB=WDV_>(106P.YQQ7EFBBSO?!/@OR=>FT+6;6QF6UO'3$)*^
M6)(G#X# Y7_ODXZ5H//+K.C^';N_U-?#7B%1>/:WD*C[-)B10^Y7X*R?*X!]
M,B@#T"/Q-H\KV"I>C.H,RVI*,!*RYR 2,9&T\>U))XHT6$:B9M0BB_LW;]L\
MT%/)W E<Y'<#(]:\[N]6NFTCP3KVN6\-G';:Q+]KGA4B'!$JB8=PCG#9/][W
MIESJ5K<7OQ3E5G$=SIL/D,\;*)/]%91C([DC'KD8ZT =]!XW\-7(N##J\#^0
MD3R8#9 DX0#CDD\8&3GC&:LIXHT5K2^N6OTBCL#B[\]6B:$XR-RL 1D<CCGM
M7&7VIV>F_"WPO<BTMIX0UA$\[Q>8ED0!F9E'.4(Z<8)YK(COK9-1^)0:ZN)Q
M=:7"\,]Q$5\X>1(N1A0,9( P!GC&: /1;/QCX>U#4+6PM=4BDN;J+S8$ 8>8
MNW=P2,9 .2N<CN*EOO%&C:9,\=Y?+%Y;K'+(48QQ,V-JNX&U"<CAB.H]:\]:
MYM$TKX5[98E,4D/F8(&P?9F5L^GS'!SWI^@ZUI=A#K?A'Q18R3ZE)J5Q*EI)
M;-*-0223>C+P0>PYZ;1G&. #T/4_$&F:.'^VW!3RT\V39$\GEIS\[[0=J\'D
MX'!]*O0W,%Q:QW4,T<EO(@D25&!5E(R"#Z8KS"^U+3-#\=:_:^+?MMK::JL,
MEE-#+.(95$01XOW1Z@@\$<Y]QGT#P]:6FG>'K.VLK.2QLXH_W4$K,6C3)(W;
MB2#CG!Z=.U %2V\;>&KR_@L;;5[>6YGF>"-$R=SH,L,XQZ_7!QTJQ#XHT:?4
M8+&.]'GW 8V^Y&5)]O7RW(VOC_9)KB?"47]H^&/'=KILD?VZXU343 RD Y<8
MC<'T/8]*K^%;_P +:_!H5C+9:D_B#3&B+6,\MR/L<J !G.3L"@ X]>!C)Q0!
MWM[XJT33VF^UZ@D202"*:4JWE1.<$*[XVJ>1P2.H]11<^*M%M41WOED5H#<C
MR(VFQ$#@R'8#A<_Q'CBO*;_4="CM?%GA*^UR"QM;[5Y)7DNXI5FB!96?:-NU
M@2#M;<.""0:Z36=<L;CQ3=VD3?9UN-&1K:\MH?-EU%3N(1' (VKG)P,G=G(
MH [&[\5Z!8I9/<:M:HM\GF6QWY\U=N[<,=L#.:2+Q7HMWIUI>VM\9H;T.;;R
M(GD>0*<,50*6X/7CCO7F&F7UF^@?"M9)%'V:<"42J5V$0LN>>P8@9Z9]Q737
MVIQ>'/BXUWK+_9M,O=+2WLKIQB))%D+/&3T4G(//7 H JZ'XBCO/ _B.ZU;Q
M3<6MNFKW%O!J>561(U9=FT;<9QV"]S7:WOBC1-+O%L;S4X8[KR?.\ICERHP,
MX ZG(P.ISQ7D]W=02_"CX@QH'!EUJZ,2M$RE]TJE=H(Y/!XZ\&NOO;RRE^+/
MAJ59X70:5<@.&! +%-O/J0&Q^- '66GB71KW0WUJ#486TY-V^=B5"%3@@@X(
M.>,'FFP>)]&N-3&FK?)'?D BUF5HI2",@A' )'7G':O+I#9W'@+QUNNFC$?B
M.2YB>)#)C][$4<J.3&6')'8$C)%='X:UW0?$/Q .K1ZY8OJ3:=]ABLH&?YE#
M^8S9=5)/H . "><\ '3^*O%-KX6M;.6XCED>[NXK6-4C9AEW )) ., D^^,"
ML"X\2_V?\30MWJDRZ/)H1NDMY$P!)YRKE5"AB<9X.3UJ?XGGRM!TJZ8-Y%KK
M-E/.X4GRXUE&6..PJHNH64_QH@N1,@C_ .$=8*\GRX8SAL<]#MR<=<<]* .N
MMO$.DWFBQ:Q;WT4MA+_JYER=QSMV@=2V>-N,YXQFGZ9KFG:PUPEC<;Y;9PD\
M3HT<D3$9 9& 89'3(YKQ^UN6MO"-GJ2QW%QI^F^)KJ>]BM&82) YE59!L(;
MWAN.U>@^$7\-:EJ5[K7AZ.YG^T1I'<:A+),1*5^Z@\T\E1U(Z9 ]< &OJOBK
M0M$N1;:EJ<%O.8VE$;$EMB]3@?Y/:FR^+=#BT^*^-[OMI8!<AXHGDQ$>CL%4
ME5Z\M@<'TKG?$D]L/BSX-$LD>8X+T'<1\C,B!<^A."!ZUDZEJ.EZ!\0-=@\4
M&^MK#5(X&L+B&2=8G58PCQ$1'KD$@$?Q>XR ;VO:M<?\)?X*;3M3=M.U&:82
M1Q%3',H@9U;.,GMWQTXK5T_4=.?7M=>/7FN3;K$;FU=U\JRPK<@XXW8).2>G
M:N/OH]-TK6OAU:V=NUA9PW%RT=O,[%HHVB<*6W$E<DC@]"<=J;)?PV_BGXFS
M+:)J/^@6I%F.?M.V&0.GOU .,XS0!W5GXCTK5;@65G>L+B6#SX@T3(7C/'F)
MO7#CD<C(Y%<=X-\>Z;:Z+'!XC\0(=0DO[F%7N#R0)F5-Q4;5X'&<#CBLO2M4
MM;GQYX-O(KR6ZBETVXA4Q6K)#&Q$>(T 7@#G.22,<FH+,V<OPN\1^&Y8EDUF
MXNKU(].*XG:1Y6,3;#SCE6W= !G/% 'H[W=D_C2&U76Y!>)9NQTQ""I7<O[U
MAC((R .>]<YH&KRMH?C,ZUKTT,5IJMS:QWTA56MXPB;2N!C(R2..M0VX%A\4
M_#UI<W"//!X>>WE?=UDWQ\?4[2<5EV-W;'P7\3E\Z,F2^U!HQN'SAH552/4$
MC QU- '63^,=/T>?PUIAFNKTZE%N6Z,#L7C6$MYAVKRS$+P!_$3@5MV&OZ9J
M=Y>6=G<F6XLB!<QB-@8B>@.1U/8=Z\]DO(+23X6ZE*Q^QP0212RJI8([6NU5
M. >2PQCUK2\5P:GHGBZTUC1(F9M=B_LNY4#_ %<V"8)R.^T;@?:@#N-/U&UU
M2T6[LY#) Q(5]A7)!P>H'>J=_P")]'TV25+N]$8@*B=Q&S)"3C'F. 53.0?F
M(ZBKUA90Z=I]O96Z[8;>-8D!_NJ,"O-M%O;?2]&\8Z#X@8)J$MY=RK%(/FO8
MI1\C1C^/(^7 R00!0!T/C7Q0-(DT2RAEE0ZE?1Q2RQ1,Q6$AF;:0"-QVXXYP
M21V-;&BVLVE:?<R7&JW5_;.[7$!N(R9(8B =G3<V.>HW<X[5Y[=PRZ'H'PST
M[59U6]M;Z!IU9N8U$3KS[ D+GI7K!DC$7FEU$87=OSQCUSZ4 >9VNMOXHLM5
MU)_$M[H?V'4)T$B1D1+;1MLP0XV[CR<GY@3Z#%=9:^)=#TS2]&ANM>28W=LK
M6\]PV'N5";O,/ QD#.2!7'^&;ZT/P\\9#[1'S>ZDX!89*N6VD#T.1CUS5."Y
MM#8_"=7EB_<JOF!B/W9%L5^;TPV!SWH ]&LO%6AZAIMWJ-OJ4)M+-F6YD?,?
MDD#)W!@".*?;>)-)NY;B)+ORY;:(32QSQO"RQGH^' .W@\]*\UU/4[:SO_B;
M.+&'4T)LF%LR[TD C568@<L$/+8_NXXJ_I&JV9^+"WK:E->6]QX? 6\D@*1L
M1.6.TA0 H'?G'<DT =?;^.O#%U+8QP:Q YOGV6Y ;:[9("YQ@$X. <9[9J[J
M?B/2M',@O;K9Y2"27;&[^4AZ,^T'8O!Y; X/I7D5G-;1?!+PM&7C26/5H'9.
MC+MNBS$CJ,+R?:NBM=?TW0/%OBK2O$Z/Y6KSK<6<C6[3)>0M$J>6NT'=C;C;
MWS0!V%UJ.G3>)=$B37FCGECEDAL875DO$*9W-P>% W Y'XU/)XJT6*\%J]\H
M<W M-_EMY?G'_EGYF-H?_9SG/%<GJTMM!X_^'L:P1V210W:_9N!]G5H5"(<<
M#I@#U&!7)ZYK%M>Z#=D(]C):^(HWFTV"V($0%PN9I6VDEF^]G('. "1F@#T&
M"^OU^+MSICWTTE@=$2Z2W;:%20S,A(P 3PHZYZFM_5=<TO0T@?4[Z&U6>588
MO,.-[DX 'Y_A7)V]Y;S?&R1TD&'\/1H-WRG=Y[-MP>0VT@XZXI?BI) N@Z4D
M[)M.L6C%6YRBR L<>@'6@#H;7Q;H=[8F\M+\7$7GM;@0QN[M(O+*J ;F('/
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M)/KSUH ]'\3:_9V&F:C NH26]Y%;-(9((C(8,@[6<[65 <=6P.M+X&O+G4?
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MMQJ,\L-LCW!2_BD<NA0(=I/(&.,8]CCU01"'1A$(_+"6^T1[MVW"XQD]<>M
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M/B-G"3Q,KNINHVS@@9.T$D=AU H ]:@\9>'KI6-MJ23E;@VNR%&=VE"[BJJ
M2WR\Y (QS5/6_'>DZ7X3EUZWD:[A#^2@CC8_O=VW:XQE,-P<X].I JAXNUBR
ML=<\,DK##!<O-LU<1"3[.?+ "H<$!G!P"<C /![<-,_F?"WQO;1I=/)#X@:=
MA)"X?R_M,3[B"!SM!8CMZ4 >H7.J:=<Z_H<:ZW-;7$IF:*P"[?M8V'.]67<
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M4;JVOG9-.&;M&MI5DA&,[C&5W8P"<XJX?$VD#^RLW38U8*;)O)?;+N7<!G&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\R]NXK6\4>9#JVL:QX=O[BTUD"(3Z3=0EX=57RD*@(1G=AMA*\C;SCK7JM%
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MTZ_6YU[X?:B(K]EB6XBGCCL)(H+1V@VB%$"@  Y&>>!RV*]CHH \?8A_A_\
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M#DD].,9.=>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M & ?%VO6MMXFTUH)+[4-#N[<//:P@R26LN&WA/NF14W< 8R <=JAU3QC<?\
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M5-;\&Z?KVL7]U'J6E6UHLMJ) JSB;H4;8JKL)*\]1DU!JVLZUX9;P]?W-_\
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M6QP"W/&.U1VFKZQXGTKQ#J6F:F]D]A>3VMG"L4;(QA'63<I)W-GH1@$8YYH
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MHY;BY!2'9M#+;N0V&4Y."1SD8/ !YK-6VU*;QUX__L[5GT^2*"R?S4A1W9A
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M"[,H2>&QCD[AP./7I*Q[WQ%:V'B32]#E@N#<:D)3#*JCRQY:[F!.<YQCMWH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *YSQ=K4^E+I%I;2"&;5-1CLA.0#Y08,S$ \;L*0
M,Y&2.#C%='6-XG\-67BO1_[/O7FBVR+-!/ VV2"5>5=3V(_K0!SWB/4]9\#:
M%XBUF74$U"RCAC:PAG7]Y%(Q"'<0!N3<RGUZCBG:W?:KX5U7PW-_:<]_::E>
MIIUW%,J??D!VRIM4;<%3D<C!_&M.#P=#-H][8:YJ-WK1O(?(EENMJD1]@H0
M+SSGJ2 2>!AUEX3\IM,&H:G<:C'I9W6:S(H(;:5#N0/G8*2 >.I.,\T <3/J
M?B:7PUXVU%?$ES'+H6H7(M0D$7SK'&C!7^7E>3TP<DDD\ :5P;K4OB;X7N/[
M0NH%N-'FG,4978AS$2 "IZYY/7@<BMH>!(AI'B#33JET8M<FDGN6V)N5I%"L
M$XX& !SFIY/!L;WNB7JZI>17.E6[6HDC" SQ,%RK94X^Z.5P>O3L <_HUWKU
MYJ/B*ZNO$5R+31-5<"!+>+]]"L2L8V.WWX(P>N<\8KW7B'7$^&,'CN'46:Y"
M+>26)5?(:$O@Q=-P(4_>SG(]#BNQT/PRFB7>K3B]FN1J=P;F:.5%VJY 4[<
M<8 &#GI6=;> ;2VTIM#%_<OH!F\U=/<*0HW[_+WXSY>[G'7MG'% %.*4S_&4
M31K@OX85E#<=;@D9JMX1\37&H:U::9JU]?6.O11.;W2[R)52<X_UD#!>5!!P
M >G7.,UTLGAA)/%K^(3>SB9['[ 8 J[!'NW>F<Y[YJ*S\)B*\TBYOM1FOWTA
M'6S>6-5?+)L)=@/F.WCL.<G)P: )?%=U<VFGVK6^HQ6*O>1),[*6D>,GE(E
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MGL*\X\ :(->\"SZ?=:C(;":^N&N+,(H8J9F8+NZA&&">Y!." : +<E[K^O\
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MS X:4-;*J\D#YF/1>OL* /1_"\\MSX1T6>>1I)I;"!W=SEF8QJ22>Y)J._\
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M=V)+2_9%M2BDM,S=%5<9SP>,<8.<8- &O161IOB;2]6U&YTZUEE^VVIQ/!)
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M[AH3=RB&']TS!G/.,@$#@'KZ5!;>+M*O+""ZMC=2^?YGEP+:R><=C;7.PC<
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MC@?G)51MYSSD8P<\Y!KSR)I;30/B5IDUG>BZN+F]GA MG*R))"JIM;&&+'@
M$GVKTVQLXK"T2WAW%5+,68Y9F8EF8GU)))^M6* /+Y"VWX8D03_Z+M^T8@?]
MR/LQ3Y^/E^;CFJ.EFSLTU+PIXDT#5+V^:]G>!525[>^225I%;(.Q>6YW8 QD
M\YKUZB@"I=LEMI,I<;52$C"@MCCH.YKS*RTW4KOX 65E86DQU&UCAD:S=6B=
MVBF61DP<$$A3CUR*]8HH X/P_=Z#XDOH[VRT/4EN8H'CGGOXY4:W##!B4N?F
M8GLN1P23TSQVAZOH9T/PUINKZA>6EEI%VMY L^ESHWR[O*627&P!0W+#@X[#
MK[)J%E'J6FW5C*\B1W,3PLT3;74,""5/8\]:Y^R\+:G%:+I]]XEN+S35C\KR
M#:Q1N\>,;6<#D8X. #[T 8KLH^(OBJ:6RGN+5]%BC"B-@LY7S"T:MC!."!QZ
MU%X1M[W2O$EI8:5J-UJ?AR2SD8)?1'SM-(V[8]Y .&Z;&Y&WVKT@# P.E% '
MB47G+\%-*TB33[\7ME?0+/"UG)D%;G<V!M^8!1DD9'(KN?%FJ-;^(/#RFUG%
MA.)M^HVUF9Y8CM7;&I"L4W]R!DXP,=1VE% 'B$D<Z_#;7-._L_45N/\ A(S*
ML4EO(SLGVI7SG!W84$D@GZ\UV[2!_C-:7*)*;<Z#)#YPB;9O,R.%W8QG:"<5
MW%% '$?"EI(/!%MI=Q:W4%U923).LT#1@,9G( ) #<$'(R.157QI9QR^(3=V
M.J7VBZY;6*F"\2,O!=*6<^2ZX*L01G'WOGX!KT&B@#,\/SWDWAK39]3M4L[Q
MK6-IX$&!$VT94#MCT[5Y@Z2O\+?'ELMK<F>ZU.]:"+[.^^4.^4*KC)!'<>E>
MQ44 >>ZG*)?&W@">..9HH8KKS9!"VV+?"%7<<?+EACFL?2DN+'X8:WX-U&TN
M)-:5;RWBB\EC]K,K.T<B-C!!+C)S\N#G%>M44 >4:KHTNF1VWV/5KW3/$NF:
M1;PBX6)I;?40BG]TRD8=MP/ ^8;P<&M*":^M_B'X>U+4M-GA:Z\/&V=+>!G2
M*X,D;F,D A0,'DD# ZUZ+10!QOQ6CDG^&FLVT$,LT\T:I'%%&79SO4X  ST!
MJEXZ>:-O#7B&WLKR^TRQFD^UPV@<2K')'M$@48;Y3U'H3[UW]% 'E6MVL6J>
M&[O6_"NAW;/'>V=Y(9HY$FU 0/N*A7^8A1C!/7! Z"MC4;Z+QYX9UF/0M.N8
M[F?3);?[5=6K6[;R.(06 )&<YQE1^-=[10!YQX:U+2-=GTPR>'M3BUBQ^:?[
M=',$LF"X<AW.TYQ@!>3D9  ..=NHII/@UXJLTM+HW4^J7#Q0?9W\QPUP&4A<
M9(*C.?:O::* .%EF,'Q?M;\V]T]I>:&+:&:.W=E,@GW$,0,+A3GYL5K>/R3\
M/]>B1)))9K&:**.-"[.[(0  .3S7244 >:>)9#-X*\&B*&X=XM2TZ25%@<M&
ML94N6&,C;WS4'BN&6'6M8U;PY>7EIK:>6LEA)"9;;5U\M=H"D8)P=F5/&WG'
M6O4J* /-H]7E\+>.]?&NZ;>R6>M"":UFMK5[A2RQ!'A.P'!R..,$'WJQ>7\D
M'BO2[*?1[C3;*33#Y<EC:%I6;?Q;&1 ?+ 4!B 0,_P 0 Y]!HH \4LUN$^#G
MAFR>PODN;75H/-B:UDW*$N"S'&,D <YZ>]>K^(K6XU/PKJMI8/BYN;*6.!LX
M^=D(4Y[<D5J44 >-WNOPZCX,\):;]@OK2]L=6TV"ZAGM7C6%T=5(W$!3G'&"
M3CTK=:Z.C^/_ !BES:WC-JMK;-9>5;NZS;(G1AN VJ0<9W$=<UU/BCP[)XCM
M[&%+T6HM+R*\!\GS-S1MN4?>&!GK_2MU<[1N(+8Y(&!0!Y%H6H7%AX=\!VES
MIM];0?9)(I[Q-/=YX7"J!&OR%D#_ -X#D#@CJ,Z2.=?AIK.G'3M1$X\1F412
M6TC.R?:E?(.#NPH))!/UYKV^B@#B/';,+SPEJ:0W$UI;:JLDS00O*41HG4,5
M4$XR0.G>L*:[M]&\8:]!XBTK5IK+6)$N;.:VBFD60&)$:%UC/##;C!'3VQ7J
ME% 'G,5O'9?$;PLD.FR6=K!I4\(B6-F2W9V0I&6 *@X![_TKK_%5C-J?A#6K
M"VR9[FQGAC [LR$#]36O10!YM<1S:O\ L\I#8PO-.^AQQK%&N6+*@#*!ZY4C
M%.U&^34/$WP_O(;>\^SPO.TCR6LB^6&MR@+ C*@L<#.,_3FNZL=,BTV2X^RD
MI!,YE,'\*.QRQ7TR221TR2>,G-V@#R#5+'4=1/Q!73;2>6=KZRN[>,HR"Y6$
M1EPC8&>4(X[XKI_#%]H>OZM;ZCI^B:C'=V\3++<ZA%*C6X/6,%_O,3U"Y& 2
M3TSW%% '$?$,DW7A/;#+*(=<@GD\N)GV1A7!=L X )')JCXMG.B>/K36]0LM
M0N-#N=.^QO-9"1C;RK(7#,L9SM8-COR*]%HH \N\0P:;9^&-)U+3]*O-.1-<
MCO+;;:O(Y;:=TDL7W\, W'WN5)QSC0\*:QH5WK^OZDFH2R:I?Q1O+ ]E-;A(
MHEVC:'&7.6.2/4<"NE\0>'YM8GL+NTU6XTZ]L7=H9(U61#N&U@Z,,-QTZ$9.
M#S4VFZ1<V]PMUJ6IR:A=HA2-C$L21@XSM5>YP.23TXQDY /-]#TZTN?ACX3L
M-3.IZ7=P-(8KV!'CDL9ANP7XX4AB#NX.1ZYJ2^?79O">CW.KQ/>'3O$\,C7=
MM:,&N+9&(\\QJ,\Y[#G&1G->M44 <):SB?XR-=BWN$ADT%(5DD@95#^<S;"2
M,!MI!QUKDO&%Q=:IH'C&R;3+^&\BOP8;2TLG6.:)7CQ<.ZKB1F /4G&!QQFO
M:** .#BN5E^,"W_DW"6S>'_+$LD#JH?S]^TDCAMO.#S[5R<,-PG@"RD^Q7F+
M+Q6MY-&+9]ZP_:6;>$QDC:0>!7M%% $=O,+BWCF5)$5UW 2*5;'N#R/H>:\P
MT.&YTW7M)D\.7-V^FWETYO=$O8B3I^58M)&S %%!R,=&W<=:]3HH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *Y[QQK<_A[P;JNI6J.US#;2&%ECWA'VG#-[ ^M=#7+_ !&2
M6;X>ZY;003W$\]H\444$32,S$8  4$T 4=':PTPV6L/>:P+B^MUM183.[BYE
MP'\Q4;)W8!RP(7&<],UK_P#"9:0-/U.[=IT_LK/VZ!H3YMN,;LLO4C'((R".
ME<SJ:7D&K>"?$<=K=S:?80RVU[$MN_FP^;&H$GEXW8!7!XR!46IZ'=ZYJ/C7
M5K""407VA'3[970H;F;:YW -@X&54$]><=* .R?Q-IB7>D6[/*&U=2UFWE-M
MDPF_!/8[>>:SH_B#H<]Y):VXU">:.Z:SD6.QE.R0+NPWR_+GH,XR0<< FN2B
MOY=0N_AW)!I6K>7I[-'=L]C(GE-]G*$$$ X#'[P^7WKH/ (ECU/Q;YMK=0>?
MK,EQ"T]L\8DC*(H92P&1E30!SOB+Q=/XC^#VHZW;B^TV:.?]VR,\7R"Z\L L
M#AOE&&'(R:[W3_%>F:EKDNCPFYCNTA\]!/;O&LT>=I="P&X9(&1Z^E>8R07Z
M_ [4- .DZI_:4%TR&(64AW$W?F?+@?,-G.1D>]=C>-)-\6=$NX[6\-LNESQ/
M/]ED"*SLA56;;@$@'K0!H_$'7KCPYX'U74;-9/M20-Y+K'N$;'@,>PQGOQ6(
M]MHMEK&BWUQJ?B.UDO+B**&T>6;RIIP#AGW ]1G() 8#H<5I_%"*:Y^'&LVE
MM;7%S<7$/EQ16\+2,S$CLH-4?&,CWG_"&2V]I?2K#K$%Q+LM)28HPC@LPVY7
M!8=: .DN?$UC;3S1[+F5()TMYI8HBR1RMMPI(Y_C7) P,\D4W5?%>F:1]L,Y
MGD6Q027C01%Q;J1G+X]N<#)QSC%<1KUG=P:WJ&K>&6U*SUHW:)/ITD#O::D,
MJN_D;1\O5P>-ISZU:LM1N?"GBKQ)IVJ:+J5[:ZM>?;+.>UM3.DH:-4:)B.%(
MV@?-@8ST% '5W7B[2K=E2)Y;QS9B_*VL>\BW/20^Q[ <G!P*P/&&J)>6_@O5
M-+OY_LUYK5HH:&5D2:%PS89>,C@<$56U:YU"3Q%-IUWI%[!!)I*"W.FV[$3R
M_-F)YE'RJG& 2H.23U K$@CO#\/OAY;MI>I+-8ZI:-<1FSDW1I&K!G( R%!(
MY.,]N* /7I)$BC:21U1$!9F8X  ZDFN?/C725FT]'6\2/495ALIVMF$<[-TP
M<<<9()QD#(S4GC73;O6? ^LZ?IY_TJYLY$B&<;B1]WVST_&N%U/Q"-;MO R?
MV7J-C-!KMJD\=U:M$(W$4@*@MC=WY7/ YQD"@#O%\6:6]OJ\P-Q_Q*&*WJ>2
MVZ/"[NG\0V\\9I6\5Z88]--N9KF74K?[5:P0QDN\6T,7P<8&&7KCDXZUQ%T]
MQINI?$*PDTW4)9M3C\ZS,-J[QRJ;8(?G V@@@@@D'TR>*73KV^MH?!UC=Z5J
MEO9#15BEGM[*3SQ<*$7R&8#=$AP3GY<D#D &@#K9?'GA^'1-/UA[J7[%J$P@
M@D$#XWEMNUN/D(((.['0UFS_ !%MCK&BV5IINI,M]<3Q2-+92(RB*-B0%(!)
MR%[<#.<5Q5G;WT/PY\/V$FCZJMQ9^(UFFC-G([+&MR[EN <@*0<]#G@GFNU\
M7B:'Q=X,U=+.[N+2UN+D3&WMWD9/,@*IE5&0">,]N] &UJOBS3-(2YEN!<O!
M9X^US0P,ZV^0#\Y'L02!D@$$X!%5-1\?:#IMXUH\EU-<"T^VJEO:R2>9$2 &
M0@88<YR,@ '.,5R$9BT;Q%K^F>(?"^HZC%J5X]U9SV]L9XYDD S$V#A2I!'S
M<8]N3KV-O):?%6Q(TV:WM8_#HLP8K=S!%)YJMY8?;MX4?I0!VMQ=P)I<EW(9
MEM_*WDI&Y<*1V4#=G\,US.G>*_#NB^%M!D6^OI+&^*P6=Q<I)(\A).-[D<'@
M]<' X%=/J#B+3KERKL!$W"(68\=@.3^%>3VEO>1?#WX>6KZ;J(N++5;:2YB^
MQ2[H53?N9AMX W#GWH ](T7Q-I^NW=]:6HN8KJR*^=!=6[PNH8$JVU@#@X./
MI5+Q)XL_L'6]#TU;*XG.HSLC/'$6"JJ,Q QU;(''IDGMFAI(E_X6SK]P;6Z6
MWFL+:..=[=UC=D+[@&(P2-P[T>-TGA\0^$=36TNKBVL[^3SS;0-*R!X65254
M$XR0,XH S;3Q$FA^/_&7VN74KFWC@LI8K:-9+AHP4D9RJ<[5Z$]!T'H*[%?$
M>FRZ=8WMM(]TFH()+1(4+/*N-V0.P ZDX Z'FN5TQY8_'GC6ZFLKZ."XM+01
M.UI(1(4C<.%(&&(+ <9]LURFFVU]HWA_P3JU[H6HWEE96,UAJ%JEN_GVY=D8
M2",X)&4P<=J /6-$UZP\06LL]A(Y\B9H)XI$*/#(OWD93R"*CU/Q'8Z7+-$Z
MSSRV\/VB>.WC+F*/GYF],X.!U.#@'!JMX5CL6M;F\T_17TR"YEW@30^5+.<<
MNRGD>@SSQGN*YN34+KPG\1==GO\ 2M1N],UI+=[:XLK9I]CQQ[&C8+DC/4=N
M3[T =/\ \)=I,L>GFSEDO7U"!KFVCMDW,\0QEN<8 R!S@Y..M.M_%>E7FDV&
MHV<LEQ'J#F.UC1"'D<!BRX.,$;&SG&-IKG-1OKR+Q'HMM<:->6>FRV,GSZ?;
M%Y%D+C;;L\8)B7: 200-P^]@&N<T+2X;CX>Z/I&LZ?KFGS6^H7)2\@BD26SE
M\R5E<$ G:5;!;E?FZ]< 'I:>([![#[61.F9S;+"\+"5I02"@7J3P?; )SCFE
MTCQ#8:U/>VUN98[NQ<)=6TZ%)(B1E<CN".01D&O-[N'Q,-#TO5-2LY];31]8
ME+"*W\N>\M#&8Q-Y?!+C<>.X&>AS7:^$VTR]GN]3TS0IM/CF5$:XNK<PRW!&
M>-K?-M48Y/7/'2@#8O\ 6;6PN8;1A+->3JSQVT";G95QN;T &1R2!D@=36)J
MWC.U'@?5M<TDR32VD4Z;/);=#,BD[9%(RN"!G/\ 6J.II=:-\4[?7IX)Y=)N
M]+^P-+#&TGV:59-X+!02%8'&<=>M9%UI5U'X=^(NI):76S7!(ME:K;N9'Q!L
MW; -PWMGJ!P 3UH Z+PAIZ7$-CKJW>K+-+8I'<0W,C^7.Y"MYNUL\]0"N!@X
MJ[J'C71M->\\^28P6,J0WEQ'$6CMW;& Q_X$N< XSSBK?AARWA?2U:.6-TM(
MD=)8VC96" $$, :\R\9MJ>KZ-XUTZ32-46[6;_0[>SM'6&>(;,3,Z@"1S@_*
M2<8&%X)H ]%O_&&DZ=K3:/*;M]0%N;E8(;61V=,A?DP/F.3VSC!SC%7=#URQ
M\1:5'J.GR,\#EEPZ%&1E)#*RGD$$$8KDXYI)OBS9ZC]AOX[0Z \)E>TD"JYF
M5PI., [03@\CH<'BK/PUCFATC5DGM;FW9M7NYE6X@>(LCR%E8;@,@B@#6U3Q
M?I6E37T<QGD_LZ)9KYH(BXMD;)!?'L"<#)P,XQ1?>,=&T_4+*QFFG:XO86FM
MEBMI'$J@ _*0/F/(X&3S7%^+I=0O[CQII<FEZD"^G%=/%E;.$O"86RTDJCYB
MK':$+ 8X 8FIK1IYO$WP]G_L[48X[73;B*=I+.0")FCC50QQ\N2K=<4 =(WC
M_08_#5UKTLEU':6DS6]RK6LGF0R@@%'7&5/(Z\<CFK=IXNTN]UJ328OM0NQ
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M@VW/OC'XUB:LTGC3_A$Q:6=Y;7%GJ<-_=^?;O%]F6-6W(2P&26(4 9SUZ#-
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M+QC+"1B/DZ'KSZXXJ9?&FEYL))$N8K+4)!%9WTD>(9F/W0#G(W=BP /8G(H
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M Y(&&YR<%AG:#C/.*2.^TB7X@O;*]Y_:R:9O*MO6#R/,'(!^4MN/WAG@$9H
MZ.BN;LO&^DWUQIRQ+<K;ZF[QV-TT8\JX9,D@<Y'"DC<!G'%9WA=I%^)'C: S
MSR11FQ,:2RLX3=$Q(7<3@9YP.* .UHK$USQ5IOA^]L;2]%R9KYF2 16[.&8
MG&0,9..!U.1Q4</BRVN;*&:VT_4I9Y83.;/[/LGC0,5RZL1C)!P,Y;!QG!H
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M/Y4TJ%R4R1AN&'&>>E5]+2\E\>>&M4&E:ZT3:=/!<7%Y R%)6,9^93@1@8/
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M/UJC<6=_XC^&FE^$Y-,O;35HFM;><R6[K' (77=*),;&!5#C:23N ]<>IT4
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2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>elicio-exhibit311202510x002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-exhibit311202510x002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7>'RSYB 71<DKC(PO.?0T >S75U!8VDMU<R".&)2SN1G %<_'\0?"\OV$C5
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MJMM;YBN,YQQG."#T(KH*XCX2 1_#;2X&1HYHO-$D;J59297/(/(R"#^-=O0
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M_?VL44I:>W*;(Y(SC=YBL V< A1V)SVS5R'Q+IT]W;V\9G87$SP0S"!_*D=
MQ8!\8XV-R>#CC- &O15/5-4L]&T^2^OYA#;QX#,02<D@  #DDD@ #KFJ$7BO
M2Y!J0+7$<VFHLEW ]NXDC1@2&VXRP(!Y&>AH VZ*Q?\ A+-&^SZ1<?:7\C6&
M1+*3R'VR,XW*"<?*2 3SCI5'Q7XAL[?1M9MHKB[6YM;5FEELXW8VQ*DJ691\
MIZ'U Y.!S0!U%%<#HNJ6<GAOP$-4U748]0N8()(1&[XNI##R)6P0PZG!/45L
M:3XOAU3Q7K.C"UN8ETXQIYDD#@,S*S,2<85<;<9QGG&>* -Z_@GN=/N(+6[:
MTN)(V6.X5 YB8CAMIX..N#5'0='ETFVD-YJ$FHW\Y#7%W)&J&0@  !5X50!T
M'J3U)J"/QAHTD]FGVB1([Y_+M+AX76&=NP5R,$G!Q_>[9JO-X\\/P:G/IS7,
M[74$\5O+&MI*2CR?=S\OW>GS=.1SS0!TM%9$'B73KF[MK>(SL+J5X8)O(?RI
M'0,6 ?&.B-R>N.,U;U35+/1K![V_F$4"%5W8+$LQ 4 #DDD@ "@"Y16)'XLT
METU,O+-$^F*KWD4D#AXE89#;<9((!.1GH?2JUEX\\/ZA=:;!;W,Q_M)-UI*U
MM(L4AV[M@<KMW8_ASD=.O% '245R/C/Q':V_AS7H+:YO%NK2U<O/9QN?L\FP
MLFYU'RG[I/H""< YK5\)323^"]#GGD>6633K=W=R69F,:DDGJ2: -FBO.[_Q
M@WB#P?XS:S74+";3%ND@E$;Q,#%$IR6Q@-O)^7(.,<=:UO#'B_3+FVT/29;F
M=M0N;%'C>6&0).RQ@N%D(VNPZG!/>@#KJ*PK_P 7Z-ICDW4\J0+.+>2Z$+F&
M.0G&UI -HY.">@/!P:V9YXK:WDGGD6.&)2[NQP%4#))/IB@"2BL.Q\6Z3J%W
M;VL,DZRW5N;JV$ENZ?:(AC+)D<]1QUY'%1OXVT&/0+G7&NI1I]M,T$\GV:3,
M;JVU@5V[A@\9Q0!T%%9NH:U9V<Z6;M-)=2QM(L-M$TD@0<%\ <#)QD]3P,FO
M/=!URSF^&FHW6MZYJT5HVJSQI>Q/+YZJ)OW8W $J#@+R!UQQ0!ZI17-3^+HH
M?'D/AK[)=$M9-<O,+=V&=Z*H! ^[RV6Z#CGK6[?7UMIMG)=WDRPP1C+.WUP!
M[DD@ #DDXH L45CV?B?2[R^NK'SGM[NUA$\T-S&T3+$>C_,!E>.O;OBF6_BS
M2+B\L[82S1-? FS>:!XTN,#/R,P )QR!U(Y&10!MT5S%S\0/#ULNH$SW4ATY
M]EVL5E,YAXR2P"Y"@<[NGO4\/C70I]2LK**ZD8WW_'K/Y#^1,VW=M67&TMCM
MGVZ\4 =!17,W/C[P_;-J*F:ZD?3F"W:16<KM%QNW$!<[0.=W3WJ6+QOH$]_8
M6L5W(XO\"UN!!)Y$K%=P42XVEL=LY[=>* .AHKEX]9TFWU_Q#/%>ZG<W=E;Q
M-=6021DB #;3&A &6P<D$@X'2LG_ (65&/!^CZR=.N_-U*Y@A""VDV)YC@$Y
MQ\V%)QC.3T]@#OJ*R;OQ%8V<8+)=R2&'SS#%:R/(D?\ >9 ,KT/!Y.#C.#21
M^)M)GTZSOK2Y-W#>J7MA;HTC2@=2% R,=\XP>#@T :]%9^C:WI^OV37>G3F2
M-)&AD5D*/'(IPR,I *L/0U'?^(+'3[F2V?SYKB.(3216T#2M&ASAF"@XS@X'
M4X. <&@#4HKB?&OC**R^'LFM:)<-,+H1K;7,$3.JAY%0MD#"D!C@-W&.O%;.
MAZ;%:3W6HVU]JKVMTJXM+YI&\IER"RB3YQN].G&1UH W:*\XU/QB_B#P/XQF
MLQJ&GS:8+I(95C>)@8D')?& V[/RYSC&1UK=\.^+M+NETG2&N)S?SV2R1O+#
M($G*H"^R0C:Y&<G!- '545A7OB_1M.D N9Y$@\\6S77DN8$ESC:T@&T<\9S@
M'@D&M:\O(-/LIKNY9E@A4N[*A8@#J< $G\* )Z*YO3_'GA[4U9[:\D,2VHN_
M->WD5#&2!PQ&"<D#:.<\8SD5=L?$VFWVJ3Z8KRP7T,0G:"YA:)C$3C>-P&5S
MQD=#UQ0!KT5SC^.=!C6TD>XG$-Z2+286TC)<$==A"G/J/4<C(HLM4TC_ (2;
M7G35+LW%I!$U[!.76"V4!B&0, !D DD9S@4 ='16*OBBP8.!#?;UMFNE0VD@
M:2,$#*Y')^8<=1GD"L;2OB-I-QX6T_6]3\ZQCO9%C3?;2; SL0HW8P>,9;..
MM '9T5ST'C71KI8A ]T\TTTL,5N;6197:, OA& . ".3QR!UXI)?''AZ'1+;
M6)+XK8W,WD)(87XDW;=K#'R$-D'=CI0!T5%8%KXQTB]GO[> W;7-E$)I(&M)
M$D>,YPR*R@N"01D<5EV&LR^._A^]W:/J6G3W*;D>U39*HWY4(S_*20 "0<<G
MD4 =G16!#K2Z/IUM9ZM/+=:C;64<M\]M TF."#(0HX!97P,9.#@<5LQR)>6:
MR1NPCFC#*PX.".#[&@":BO+_  9X^TS2?#446OZI=O,;^YA:ZG225(_W[A!)
M+@JO&, D<8[5WU]KME87(M6\Z>Y\KSC#;0M*XCSC<0H.!G./7!QG% &E16+_
M ,)9HK:39ZG%>K-;7L@AMC$I9I9#GY N,[N#D$<8.<8J"7QMH4&BWVJS7,L=
MM82F"[#6\F^&08^5E R.HYZ<CF@#H:*P(?&>ASPW<J7,H2UDCB8M;R#S&D^X
M(QC]YN[;<YK"T;5I;WXN:G:I<7XMH])CD-K<AE6.4RD$JIXY7;R/SZT =Y11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5RWQ'#/\ #O78(HY99I[1XHHXHR[.Q&   ":Z
MFB@#SKQ5+]HT'P488;B3RM7L9I52!R8T0'<S#&5 SSFK>ES+#\4?%%U+',MN
M]C:JDIA;8Y3?N"G&"1N' KNJ* /'/#=Y=:5X/\"V=SIUY!$#<1W=VE@\EQ:-
MSM11M+)OW8W =!QC.13N8K@?#?QCIRZ;J8N)-?:6**2WD9W0SQL"#@EOE4DD
M$].>HS[?10!Y_K*/??$VQ:V\Y4DT.YMQ<B)MB2.R% 6Q@'@G%5O!&MC^P=(\
M+W_A^\76M+\N"2*:T;RH_+^7SQ*1MQMY!!R2<#KFO2:* /+I;B[MM3^)EU::
M0]_)*ENUM;SV[&.Z"P!& !&' .<@=>G>DTFX$GQ'T/4HX]7N+:;1YH&NKBSD
MC7S-\9QMV@1@ 'L![DUZE10!Q/PVWK:^(5DAFB,FN7<R"6)D+1N^589 R".]
M-N"1\:+.8PS&$:+)!YPA8H)#,K!2V, X!/6NXHH \K:>VT3Q3XBTSQ)I&JW5
MOJET;FSFM8II8KA'C5#$0AQD;<<CH>>,596:TT7XIZ(DUNMA GAMXEB4%DM_
MWR84D< #&,].@[BO2ZP)/#LS^-XO$@OE'EV;60M_(X*%PY.[=][(';&.U 'G
M5WH.IP+<^)+.RN&LAXICU7[&D9\R2W5=C2!.I))+ 8R0 :ZJ18]8^(NE^(+(
MR?V?IVG3I<7/EL!(7*[8QD98C#,0.G'<UW5% 'F'A>RNIO@#<Z8EI<+??V=>
M0_9GA9)-[>9@;2 <G(Q]:CU:Z-[X)\$>3:7V;;4]/:56M) R+&!O8J1D*.F>
MGI7J=% '"Z;,L7Q6\174D<RV[Z=;(DQA;8Y0N6 ;&"1D<"N/L!_9WPO\%SW%
MO?P7^G:D64"SDD,1S*6\R(#<5*9Z<\@],U[56%K_ (>GU>[L;ZRU:YTV]LM_
ME21HLB,' #!T88/08/!'- ',>&M?T&/4/$NMI=W5SJ5S&MU<VRV$L+"*%-BB
M-'&7//)!ZL.G%=MH^JVVN:3;ZE:"00SKD+*A1U()!5@>A!!!'M56QT6YB8W&
MH:K->WGEM$DPC2(1*Q!;8H'4[5Y.3QVK2M;6&SMH[>W39%&,*N<_F3R3[GK0
M!Y;<:7J-_8_$?P_;VUU'?W]R\]LS0LL<D9BC Q(1M^8J5QG//H#5_4W/C'2/
M"EI96UQ!?VNHVMU<QR0LC68B!,F[(&#_  @=\\9&:])HH Y_QS:SWW@+7[6U
MB>:>73YDCC099V*'  [FN1O;P7S_  ]FBM;T1VUR#,7M)%\L" KN8%<J-QQD
MX_+FO3J* /(M:T_4=3U#XC1:;:SO/,VGSVP*,BW/DA2ZJV "?EV\'J:Z3PQ?
MZ)X@U:UO[+0=1BO;:-A+/J$4J&UR,&,,_P!YB>R\8!)(XSW-% '$?$C<T/AL
M+#--Y6O6D\@BA:3;&C$LQV@X ]:I^,9GT?QKIFO7EE?7>B26+V<SV0D9K9RX
M=794.2IQC\![5Z'10!Y=XA@TR+P?;ZEI^DWNGH-<@OK=EMG>1I,@&:6+[Y!&
MX8^\?E/&>-'PIK.A7OBO5=3_ +0E;5+RWC4P26,ULJ11 _=$@^<Y8DD>W''/
M2^(= DUIK&>VU.YTZ\L93+!-$JNN2I4AD8$,,$CU&>#4FG:/=03I=:IJDFHW
M,8(B)A2)(\]2%7N1QDD\=,9.0#SC0M/M+GX6>'=/U9-4L)X[Z8I=01O'+8R[
MIF60_+PI!QDC'SBG:A_;\_@N.35%DU#^SO$5M(M[!:E7NK:-T/G&-1DXY&0.
M0N1D<GURB@#@X[@7'QCM;T6UTMN^@M"LLENZJ)#.K!22/E8J"<'!]>:Y7QI/
M=ZIH?C;3VTS4(;M+@&WM;.S=8[B,;,3O(HQ(Q /!/ 4#&1FO9J* ."CN1-\7
M;6_$%TEJWA]XO-DMW4!S.K!22.&V@G!Y]JY4V]R?AS?E;*\+0>)S>-&+=]_D
M_:@^\+C)&WG@5[/10!%;7"W5M'.B2*D@W*)$*-CME3R/H>?6O,=)@N=.U_39
M_#=Q>&QO+YOM^AWL)86>[<7FC9@"BYSCLV[CKBO4Z* .8\?7ES8^%WFMM/%Y
MBXA$@^S^>84WC=*(\'<5^\/< ]JY73(I+CQIXG6WM]4ECU'1X5M[F[@D42L!
M*"26 "\D +A?88KU&B@#QF"_:X\)?#RSCT[4S/I>I6B7J_891Y)2)U8$;<GU
M^7.!UQD9TK*]FT./QQH>JVE[]KOKJZO+*1+:21+F*5,* R@C*X (.,?A7JE%
M 'DL/FC0/A?&UG>(]G-#]I5[60&$+ R$ME>!N(&3Q5^:QO;CQ/\ $/2HH;F&
MXUBTB%E/Y+>4?]&*$^9C:,-QUS7I=% 'E-TDOB7X9Z+X:AM+FWUN%[.&6%X6
M4VC0LN^0G& NU6P<\Y &2:W_  P2/B5XTD,,R)<-9F&1X6590D.UMK$8.#QQ
M7;T4 >6:)!<Z;KVE2^'+B\;3KR[8WVAWL)/V'(8M+&S %%!R .C;^.M=7X^O
M;FP\-K-;V'VL?:X!*?L_GFWCWC=,L>#N9>HXX.#VKJ** /*+1S%XD\:2K;ZM
M)!?:1"8)[FVES,0DH/4<$E@ N!UX&*81(O@[X9PFVN?-L[VT:Y3[.^Z$)"ZL
M7&/E ) YKUJB@#R2VO)]&T'QSX=U2SO?[1N9KZYM72UDD2ZCE0E65E!&1T(/
M3^7?>"RW_"$:$DD,T,D=A!&\<T31LK*@!!# 'J*W:* /*$,UMX8^).E2V5Z+
MJXN[^:$"U<K(LL8$>UL88L>@&3Q5J8L;KX9LL%QBU4_:"('_ '.;8I\_'R_-
MQSBO3:* /(=)^R6EO?\ A+Q'X>U.]O\ [7,T"B.5[>^1Y6D1]P.Q1EN2V,8S
MUS7I>NR3VOAC47M;%+V>.TD,=H1N69@IPF.X/3'>M.B@#R73;EKGQAX(U%;?
M5I4^R7,,[O8R110R,D>(U3:%11@C.,8'+'%9FIM/#\._&WAW^S]0?4WU.YF2
M)+1R&C>8,CAL;2"#P <^U>VT4 ><QZB^A_$R\U+4;6]_LS5]/MTM+E;61_*>
M/=F)E"EE)W%L$5S5PEQ+\'_$EHNGWXN9=:DDBA-I(&=3=J^5&WD;02<=,5[7
M10!PUY*UM\7-.U$VUU):76B/:Q2Q0.Z^:9U;:Q POR\Y; JU\2+749_#5O=:
M9;/=S:=?V]\UK'RTZ1N&*@=SWQ[5U]% 'GVLW2^/O">M1:!IUS%<3Z<\/VJZ
MM6MW9L@B$%@"0?FR1\HR.>:JZD[>,-"\*V5G;7$&H6VH6MQ<QR0LC60B!,FX
MD#!ZJ/7/'&:]+HH \TLV*S?$EF@N MRY,&8'_?#[.$^3CYOFXXS5*7S!X.^&
M47V:Y\VSN[)KE!;ONA"0LKEQCY0"0.:]8HH \WL7*:S\1Y&AN!'<>686,#XF
M MPAV<?-\W'&:S&$J^ OAO ;:Z\ZTU"Q:XC^SONA5$8.6&,J 2.37K=% ' 6
M222_$;QELAFVW.GVT4,AB8)(RK(& 8C!(W#O7.)]H?X0^%T&GZ@)-)OK%KR-
MK20.@CD&_"XRV/4 C]<>Q44 >8:EJ":-X\N]3U;3=6DT?5[2#[-<VT4Q,+Q[
M@8W1/F&[=D9&>?KBOJ-O%X:U+0-83P]?0>'1:W%K);6:OYEGYDBR+(R(=WS;
M>1V)YYQ7J]% &!X4BT_[%<W>F:7+86UW.9@9D9)+@D#,C*WS#)XYY.,]ZP;"
M:7PW\1O$LNJI,MGJRV\]G="-F0^6FQHB0#A@>0.^>*[VB@#QS4M'O-,^#>HV
MCVESY]_JOVNWLTA9Y(XC=I(%*@$C"#<1VSCK7L$4J3Q++&VY&&0<8I]% 'DG
M[^#P;\1])DL;X7<]YJ$L*BU<B191^[VG&&W9Z#/0YQ6C<,S:Y\-9%@N"EM'*
M)V$#XAS;;!OX^7YN.<5Z510!X_HHM+>QNO"'B/P[J=[J:7,OE(8Y7MKU6D+I
M)N!V*.1DG&,9Z\5ZCK3"+0;\D,1]G< *I8D[2  !R:OT4 >5K8:E<_ O1X;"
MRGDOM/2TFDLBK122&&17>/!P0?EX]>,5KZ+/X?\ $DTM[9:%J2R+9R0W%S>1
M2I)&K#F%2Y^9CS]W@8Z\BN]JGJNG1:OI-WIL[RQQ74+0NT3;7 88.#V/- 'D
M.@:SHLNE>%++6=0O+:WT>5+B!9M+GC.X*5C$DN-F%#<D8#8!X%=)E!XW\=R7
M.GW-S:2Z7 @C$3@7.Q)=\:-C!/S <>M=!:>&=4$ L]3\27%_8!=A@-K%&TB=
M-KLHR1C@XQFNFH \W\+6VH:?KG]F:=J5SJWAY]/D:,WL1$U@^5"Q&0@$@C^$
M\C9[<\]$\I^$GA;3GT_4%NK'4;07$36<@9?+ER_&WD #)(XYZYKVFB@#B_%&
MIO!XIT*)[6X2PFAFSJ%K:--,K';B(,JDQAAR2.3M&",9KA8X[B/X<?V>VG:B
MEQ#XE$ACDMI&;8+K>3G!W +R6&1[U[=10!PK$S?&)YTBE,#^'_($WE-Y9D\X
MMMW8QG:<XS4OPJ>2/X?:983VMU;W-E%Y,Z7$#1X<,V0-P&>W(XYKM:* /.O&
MEHK:_<7^F:C?Z/KUM9*89TB:2WO5RY$+)@AF!SP/F^<'!KM]$DNYM!T^2_MD
MM;Q[:-IX$^[$Y4;E'L#D5>HH \CLH9'^&&M^%'L;AM9N9[R*.T>!AS)*Q23)
M&-@#!MV<<>O%:^CPS^#_ !YJ']JF5[#4-/LX[>]$;,BO A1HV(!VDY+#/7)[
MUZ+10!Y';PW_ (=TV.>73YX[+5/$MQ>><MF9IM/@<'8RQ[249L=<?*'(QFL^
M^BG'A3XD6,>GZJ9+NX$EL)K>5GE#1Q@8)!))P3CJ .<5[910!Y]XS:Z6T\):
M[:6MQ=:?IMZD]W!#$QD6,QE-^S&3LR>,9I=*OX]1^+UQ?VUO>&RFT.*)+A[2
M5$+"9VQEE&./7KBO0** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JIJ.I6FDV9NKR7
MRX@RH, LS,Q 55 Y))(  JW7&_$2PU"XL-'U#3[>6Z.E:K!?36T0R\L2Y#!1
MW8!L@>U &U:>);&ZU"YTXI<0:A;P^>UI-%B1H^@9<9##/'!.#P<5R'AV5O&E
M]JL]U<:O:7-CK,JVTL+/$J11%5$1'W3NYW*1DY/H*T'@_MWXB:1KUG'<)8Z;
M8SK--) \?FM)M"Q@, 3C#,>..!UI?ASYL<?B))[6[MVFUN[N8OM%L\6^-V!5
MAN R#0!T^HZO:Z9);0R^9)<W3%8+>)=SR$#)P.P ZDX XYY%<!H6L6S0_$"7
M4KS54TV&Y\MBQE::V3R1O"]67!W'(X'7IS6EXE:[T7XCZ-XBDM+JZT@V,MC,
MUM"TS6SLZL'**"<':!D#M6*AN9]/^)I73-24:@CFT#64@,VZV" *,9SGMU'?
M% '7'Q=H>BV6AVLDUZ_V^V!L]T$DKRJL>[E@#ER,<9W$D<<U93Q=836,-S;V
M]_.TD'VDVZ6S><D>2,LIQCD' ZG!QG%<@5G%[\,W-A?[;*%Q='['+^X)MO+&
M_P"7Y?FXY^O2I==8Z#\0KS4=4T2^U+2=3M84BGLX&F:WECW HRKR P;.?7\:
M .NA\6:1=Z=I][97#7B:B";1($)>7'WL XQCN3@ \'FL75_B+8VWA^/4M-@N
M+IFU!-.DC\H@V\N\*ZN.Q&>!W)&..:Q+J.?PMKGA_P 0V?ANXAT5;6XM)[*S
M@WR6@DD5UD,:]SM&['3W[W?&#7.K>#$O[31;N*--5M;OR!;D3R1K(A>0QCYL
M]>,9P,GT !UL_B"UAEAMQ#=2WDT1G6TCB/FB,'!9@<;1GCDC)Z9JA/X\\/0:
M)!K#W<GV.:<6P<0/F.7=M*N,?(0>N[%8J2W.E_$J;7;JTO#I.K:;'%'-]G=C
M;R1L2$=0"4#!B1D#G@X-<YJFBWUOX=U6Z6PO6_M3Q/%J$-M';.[K"LB9=E )
M4D*6P<'&._% 'H5KXPT^]PEO;W[7#2RQK;/:M%*WE[=[!7Q\HWKS_M =>*UM
M.U"#5+".\MQ((I,X$B%&&"0<J>0<@\&N4\:6%EJUYI/FR:K8721S2VFK6,;Y
MMF^3Y'P",.#T;&=A'6M?P9+J\WA6T?74 U#+AV$7E&0!VVN4_A++AB/4]NE
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M6\E@>XC41,0Z+C<01U(R..M>96^F:C=_L]W>DQZ;>KJ,?F.;66W>.0C[49,
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M(?MI9KJW2V:#R@%5$)*X.<YRQS_*MVBB@ HHHH **** "BBB@ HHHH ****
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M9 W!@<'@@=L=SU-CJ6J7/Q#U[19K\BSBL()K<1Q(&A9RX)R0<GY1UR/:H4\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;DGMM(((SUH Z_0O$5KK\FI);0W$3:?=FTF$Z!27"JQ(Y/'S#KBM>N*\!?\
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M9+U5N(T18)4D5?EV@'9ANA)/'4T =N3@$UD:!XBM?$4=^]K#<1?8;R2RE6=
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MP9-]H%Y+#>6=W=SF)$1O/C6YD+I\RG!VYQCOB@#UNFO(D2AI'5%)"@L<<DX
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MO^DO'/<P320BV-NW+*N/G#*,8)YR#GTH Z_3?$5KJFNZMI$4-Q'<:7Y7G&5
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M]2U_^UKJ_F9CI\FG/"J*JM$^"W/4'(ZYXKI&8*I9B H&23VI(Y$EC62-@R.
MRL#P0>AH XNT^'8MAH._Q#J<IT1B+0D1#$10IL.$Y^7C=U],5<7P6L3:O#;Z
MK=16&KSO<7=N%3=O< /L?&5#  =R.Q%7=6\3)IUS<6EK876I7EM;BZFM[7;O
M6,D@8W$98[6PHY./IFUH>KOK5B]TVFWM@!(42.\C".ZC&'QDX!SWYX- %&[\
M)P3ZSH5_;W+VJ:*CI:V\:+LVNFP@YYQM  QC%8^=*\;^+=,O+>UN6&A33&6>
M:W>(>9PJQC<!NY&_C."B^M=S10 5RUOX+6WL/$-H-4G*ZY+)+.QC3,;2*$;9
MQ_= QG-=310!RG_"$KL\.)_:D^-  %O^[3]YA/+^?CGY>.,>M1VOP^T^#2M7
MT:2YGFT;4G=S8,%"6Y8Y_=$#*C/('(!&:Z+5;^33;+[1%87-\WF(GDVP!?#,
M 6Y(X&<GV%7: .9T#PG<Z-M-UXBU'53"A2T%YLQ ,8S\H!=L<;F)XSC&356T
M&F_#3P];V=W=WUU;373K$RVK2OOD9G((C7H23CCVK7U?Q'!H^JZ3I\UM<.VI
MSF"*5 NQ&"EOFR<] >@-:TKF.)W",Y520B]6]A[T <_X(\/P^'?#H@BM?LK7
M,TEU) 3DQ%VR$_X"NU?^ U:\2^'8O$EA;V[W4UK+;745W!/"%+))&<J<,"#]
M"*O:9>/J&F6]W+9SV;S(':WN !)&3V8 GFK= '.2^$PFNIK=AJ4]MJ)MA;7,
MC(LBW2#D%UX^8'H1CKC&.*T]&T:VT.P-K;%VWRO/-+(07EE=BS.V,#))[<=A
MQ6;!XNBN[NT%IIE_<V%U<26R7\**T:NA926 .X)E6&XC&1Z$$]%0!QVH?#Z"
M_N=?*ZO?V]IKD>+JUCV;=^S9N#%2PX XS@X].*=-X$476E:A9ZS>VVJZ?;?9
M#>!48W$.<[)%*[2,\C &*Z^B@#!\-^&$\-OJ;)J-U=G4+M[N43A  [  D;5'
M8#V] *D\.^%].\,Z;<6%BA\B>XEG97Y WG.T?[(& !Z"MJB@#C-$^'R:%<+#
M;Z[J;Z+'+YT.E.RF*-L[@-V-Q4'D+G'KFM31?#(T:^UBY%_-/_:DYN)4=% 1
M]H7Y<#I@#@YZ5IWNH"VTZ[NK>"2]>V5CY%OAG=@,[!SU]JL02F:WBE:)XBZ!
MC&^-R9&<''<4 <]:>$0EUI$VH:A)?MI"LMHTL2J^6382[#[QV\< >IR<51TC
MX>QZ)=&*TUS4AH@E,R:064Q*V=VW=C=LSSMS@]\\Y[.B@#F3IEOX8U37_%=Q
M>W,B7<4;W,*P[@JQ*0NP*-W0G/7\*K^%K"QO_$.J^+[6UEA744BAA::-HVD1
M5&Z3:P!7<=HY'(C![UUU% !1110 45C:SXC@T34-)LY[:XD.IW(MHI8PNQ'(
M)^;)ST4] :V: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "L'Q;=3VNF6QAU)+ />0I*^PM)(
MA;YHX@ 29&' P/7ZUO5B^)/#<'B2VM$DNKFTGL[I+NVN+8J'CD4$ X8$$8)&
M"* .?\,W^H:CJGBW1[FYOHH;&:#[,9F0SQ+)$'*EAD$9Z9R<'GVXE;%Q^S*9
M_M]W@V&[RMR[!\Y&/NYQSZ]J]+T_P=%INJ:MJ,&K:DUQJ:1B=I'1@&5=H<#;
MC..WW1V XQ6'P_LQX$_X0_\ M/4/[-V>7OS'YNS=NVYV8Z^V: *]_?7UOKND
M^&K:XNIA/9S7<LC3+'*X4HH0-MX'S$G SP.>M4#J?B;1(-/T?5KR/SM2UG[+
M;7897ECM2K. WRA?,^7:#COGJ*WM>\%6VO0:<TNI7UOJ6G$FUU&W=4F3(PP.
M!M(( R,4V^\!Z?J?AW^RKZ\OYYO/6Z&H-*!<+.O"R*P&%('  &,=J ,3QKIF
MJV'@OQAYNN3RV#V1ELXMV)HMJ'S%9^K(3CWY(SBNQ\/0&W\/V*-/+,3 C;I2
M"1E1QP!Q6=%X.@?0M0TW4M2O]2?4(#;SW-RZ^8$(( 4* JXR3TY/7-:VCZ:=
M(TN&R-Y<WAB4+YUP5WD  #[H ' '0>YR230!P&B6LJZC\17>^NY1'.R[9'!#
M9ME//';. !@ 50T*XU31?#7PYOH=6N'@OGMK&:R*H(?+>%B"!C=N!4'.[UZ#
MBNX/@VW74M:O(-2OX!JZ_OX$9-@?9LWKE2<[1T)([XSC%?\ X0.U_LC0=-&J
M7XAT2:.>U/[K<60%5W?)R "1VH Q9+[Q+XHMM;GT.X>VN[/4);2T(G58D,3!
M2)$*DMNP2<]B,8[][$+BXTR/SI!!<R1#>\!#!'(Y*[@01GID5S%Q\/K5M?N]
M4L=8U735OF#WMK:3A(KANA;H2I/<J0?I75^0$M?(@/D*J;$* ?(,8& 1CB@#
MRG2-<UZT^&,?C:]UZXNIQ;21_9I(T$)=I]BR-@ Y7J><8XX[]996GBBU\3VL
MWGL^D20NEU%=W*NYD RCQ[5&,G((X&.0.*MZ7X*TW3O!S^%I9;B^TQT>,K<E
M=VUR21E0.Y)!ZBJVD>$V\+VKW U36-:-G"_V*UNIE.S"G"K@#+$?*"V< X&,
MF@#DH-?UW4M"T"XM]6N8?$-WJOV;4;*,(QACWL)!Y3*0FQ0#N(^I.:Z>&_U2
M/XH7NE?VA)/:KHB744,JJ%64RLN<JH/\(ZYZFN0T1+A=,A@TCQ5XHAU14W?V
M;/IVY8Y3R48O$/EW$Y9G]\UZ"?"L<OB*;79KZY^U7%A]ADB79Y0CR6X^7=G<
M2<YH YKPKK\VHZM!I&JWNJ:;KZVKB\L;L +.^!^^@;!4@$' 7C!Z'&:YRPN=
M4TCX#W&KZ?K-[%>+<2D,Q1QS>,C?>4GD,23G.>]>DV?A6.&^TR[O-0NK^72X
MWCM'G"!EWJ%9F*J-QVC'XG@GFLM_AO8OX9O?#PU;4UTVYF,HC#Q_N09/,*H2
MG3=SDY/;- ":C;:EI%S9Q7'B>YN(KV]9GM_+47$@\LXB@V+PNX;B3C"CEAR3
MR]YXDU]/AEXIO(]2NK>]TG5Y+2"1UC:3RA)& KD @D!R,@YX'-=[K/A5-8NM
M)O3J=]:W^F,YANH/+W,'4*X964J00!VK+E^&NGRZ/K.E'5=4%KJUU]KG'FHQ
M5\JQVDJ>I1>N3QQCG(!&)=5T[XD6NE2ZU=75KJ>FSS.DBH!#(C* T>%X&&(P
M<^^:A^%=H[^"Y6EO;N;S;R[0[Y>1^_D!8,/FW'J3GK70R^&8YO$UCKTFH7;7
M-G ]NB8C",K8+;AMSDD#H12^'?#,'AI+F*UO+N6WFFDFC@F92D)=BS!< $C)
M/WB3^N0#!\6:I-X8N['S+;4(O#,=LR23Z8NYK64$;6D YV!<^HSG(/%=3H$Z
MW7A[3IEOUU /;1G[6O2<[1E_;)YQ45[HTUQJ9O[?4[FU=H! \2JCQNH)()#*
M?F&XX.>_(-6-%TBTT'1K32K%66VM8Q'&&.3CU/N3DT >>:GKVK6,EE>0ZK-=
MR/X@CM)I(% M!"\NSR<-C<P&,LN<,""W:IHM*O=7^)/C:"TUJZTLB&P)DM40
MN6\M]N2P/RCG(&"?4=],_#*Q&G?V<FLZLEG%?"^M85DCQ;2"3S/E^3+#)/#;
ML9]:UF\)K%K=WJMAJM[9SWL,<-T$V.)!&"$8;U)# $\]#GD4 <5;^*?$%UX7
M\*7<]^T=XWB%-+OC$B!+I5D=2>F1G8.A ZUT$8+?&J]4,5)\.Q ,,9'^D/SS
M6C>>"-.N=-T?3[>>YL[;2KI+N!8"I+2(207+JQ.2Q)]2>:M+X:C7Q9+XB%_=
M?:I+069B^3RQ&&+# VYSDD]: /-=9O=2U3X1:K/?:I=2W%OK9M_,!5"Z"[6,
M!@H Q@]!@9KK_$%QJ/AGQ%X?OI-5NY=#GF^Q7D<FS"2/_JI"0H.-WRGG'(JR
M/A]IY\*ZCX?DO[^2VOKDW32LR"2.0R"3*D*!]X X(-5O$[07VGR^!I(-2U"\
MOK<#[5+ 3& S<RM( $!3&[ QT  Z"@#<\/2W%\VH:C)<RR6MQ<LMG$V-J1)\
MF1QD[F#,/8K7.3VLLGQPA_TZ[5!H32B-7&T?OT!4#' .!GN?6NXM+6&QLX+2
MW0)!!&L<:#^%5& /R%9-[X9@O/$]IKZWEW;W4$!MG6%E"S1%@^UL@G[PSE2#
M0!Q\&MZOKOPWU#QG9ZG-;7D7VFYMK< &%(X78")UQ\VY4Y)YRW!  %=WH]^V
MM^'+#40&MVO;2.< 8)C+H&[C'&>XK&7P)9Q0:C8V]]>0:3J,C27-@A79E_OA
M6V[E5NX![G&*Z80K';B&'$2JFQ-@'R#&!@=.* /*])UG7K;P!=^,KW7;J[DL
M!>J+1XXQ%,5D9$+X4'(('0@8 &!SGH8H_$UEK%AJ*W+2Z3Y+_P!H1W-PCF3Y
M<H\051M.>H!P0>E:VC^#[#2?#ESH+S7%]87)E,B76W.)"2XRJKP2Q^E5O#O@
M>+P_)$#K6JW]K; BTM;R8-' ,8XP 6P"0,DX!XH SM"?6O$?AS0_$MMK?V>:
MXE6YNH7 : VY)W0A>Q Q\V<Y!R>U)I]]J7BVT\2W5KJ=Q8S6%_/96*1;=L9B
M ^9P0=^YLD@\8P!@\U<TCX>V6B79%IJFIC2A,9X]),H^SQOG=QQNVYYVYQGK
MFK;>#H8M1U.ZT_4;RPCU0[KR"'85=\8+KN4E&(ZD=>O7F@#C[;Q+K?B:3P'-
M#J<^FIK=M=?:XX8T(#1Q_>3<I(.<D9) XXXK<T>>^U/Q-JGAR?6+PQZ%:VT;
MSH526YFE4OYC$#H   !P23G-:TG@RQ_M'0KNUN+FT31(WCM+>'9Y85E",&W*
M2?E '6DOO!\4_B;_ (2"PU.]TR^DB$%R;;85N$'3<KJPR.S#F@#+^$BNG@"!
M))#(ZWEV&<@#<?M$F3@5U.MO/'H5_);7#V\Z6[O'*BJ2K!20<,"#T[BN4E\#
MW&E>&K?2M#UO5X94O3=1R+*@&YBS$2':,QY8DKR3C%=3X@D2+P[J3NP4?9I!
MSW)4@#ZYH \R;5/$^G>"?#/C,^(+BZ:7[(M[8/$@BECE*J<8&X/E@<YZ]@.*
MW=.77-7\<^);%O$E[#::7=VCPI'%%\RM&':-OE^Z<D>O3).*/ OA]-1\">&E
MU"]N)X+.*&;['(JJ$F09"OP&(5N0#Z#.:Z;2_#46E^(-6UB.^NI9M3:-IXI-
MFP%%VKMPH(XXZF@#C(==UC6?AA=>-[/4YK>]C6>[@ML PK%$[#RF7'.53ENN
M3P0.*U-*UVX\9:S<V27,^G00:9:702%@LC27"LV2<9P@ &.A).<\5?3P'90V
MU_IT%]=Q:/?RM+/IZE=F6.756V[E1NZ@]SC&:=K/@:UU+6K?6+'4;[1]0BA^
MS--8,J^;#G(1E92#CMQQ^ H S)-1UV"_T+PQ=WBW=]+9SW%W=6S" S&-E4*I
M(.W[Q)Q@_+Q@9J">;QIHWAV7[7'-J(AU(,5LY%:[:P(/'  ,@.!QR1GH>:VM
M9\!Z?JUEIT<=W?65[IKL]K?V\W[]6;[Y+'.[<>6SUJPGA7RK*UC36-1^V07/
MVIKUV1Y)GV,F'!7;MVMC: ,8&,'F@#FAXBN;SPB^J>';J_UFV74@+F% %O(8
M HWQ $ [PWXE3USS71>"M8L];TNZN['5)[Z#[2RJMPNV6VPJYB<$ Y!SU[$<
MGK0GA"&'?/;ZC=07TM]]OEN8P@,DGEF/:5*E=FTXQC/?.>:I:OX1E71=132]
M2U&WU6_NENI+JU=8F>0*%4'C"QX49[G'<GD ZVX,HMI3 %,P0^7O^[NQQGVS
M7GOA37Y-3U6+2M3O=5T[7([1Q>:?>  3/\O[Z%L;2HPV IQ@].,UW\]M]IL)
M+69R?-B,;NHP>1@D5CVGA=(M1TZ^O;^YOY]-B>*U><(&4. &9BJC<V!C/3KQ
MGF@#B+;Q+K<WPK\*ZTVI3?;[C48(;B4*O[U'N"C C&/N^F*V4_M?5?B!XDT4
MZ_?6]E#:6TL(@6,/$7WY"L5Z<=P3P.?61?AE9KI4>E#6M5&GV]VMU:0*\8%N
M0^_ .S+#)_BW8'2MNV\,):>(M0UN/4KPW5]#'!(K",JH3.T@;.HR>I/6@#SZ
MWU[Q"_P[\/\ BV;7+AKO[9#!+;K&BPS(9_*;<-N2Q'.01CL!71DZMJ?Q%UW1
M3KU[;V,=A;SQ"!8P\;.S@A6*GCY>X)]ZMK\.[)?"%KX975-1%E;3B='S%YF1
M)Y@!.S&-W/2M.#PPEOXDO-=74KPW5W;I;NI$>P*N=I V9R"2>O>@#SV+7/$1
M^&>D^+9=>N&O(;R.!X%CC6&=/M/DMO&W)8CG((QV ZG=\8ZIJ5I_PD\UKJL[
M2V%@+BT@L0!]D949B\Y;Y3N(&%))VCA>]:0^'=D/!T?A@:IJ/V&.?SP^8O,S
MYGFXSLQC?ST]J?>^ +2]O-9F;5=2BBUF 17UO$Z!)2(_+#_=RIQV! /<$<4
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MI1QMVLI '8=,C% '%:WXCU_3=%\>:8FJ3BYT%89[2^"(7:*5=P1\K@E<$;@
M3P:WEN=6TKX@Z!:RZQ<7EMK%I<-/!*J!(WC5&4Q@ $?>(P2?<D\UJ7W@BQU'
M1-6TZXN[O?JS!KV[78)9<  #[NT     ?J238F\*QW&N:/JTNI7C7&E1R1PK
MB,*X< -N^3J0!TQ0!?TNPNK'[9]JU*:^\^Y>:+S55?(0XQ&,=0,=3SS6)K\]
MR_B."R349Q"]D[K8V'%PTFX 2LQX5 ,CYB 2>_2KGAK2[_3KC56NM0OKNVN+
MHRVZWKAGC!ZA<?=3H O;&>,TFH>$X;WQ-'KT6HWUG<_9OLDR6[J%GBW%@IRI
M(.2>5(//6@#AX?$GB#4/!7@+4EU9X+K4M1BM+LK$A653YF21C@_(.A Y/%6Y
MO$VH^$;KQO'<WUQJD.EV=O>6OVK;O#R!P5)4+\NY0>G S6U:_#BQM-(T?3(M
M6U/R-)O!>6VYHR0XW8!RGW1N;WYZU?E\%V%SJNL7UW<7-RNKVRVMU;2;/+,:
M@A0,*&!&X\YH Y;Q%8W,-_X!N[C5+F[DEU6(S!R-CN8G.Y0!\N.0 .,'G)&:
M]-KBHOAVBP:3;S>(M7GATFX6>R5S%F/:I4*3LRPP<<YX&.*[6@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM=1_8)_(#2VTB!B%#,22,+UX!P2!GO0!T=%9>J>(](T6[M;74;Z.WFNR1"C
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MN_NI;RR<PNPN86B5552 <E0N".WYU?\ !/B;3]&\$^#M-OQ=07%] EM$'MG
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M?XOP1B%8%C\-QVRKG<L;B;/E!^Y"XXZD<UZ%10 4444 %%%% !1110 4444
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MJ5R0V.&*<#<.N3W!IGCFUO[34=#\2:1:-=7UE<&UD@7CS89\(03Z!]C>V":
M-BU\7:->Z))K%O/-)8I+Y+.+67._=MP%V[C\W' ZURUIXGCT3QWXQ74[Z_FL
MX8K*6" 1R3&(,DC.5C4$JO3)QQQD]*9X?\/:EI'C&[T.3S)]&DDBUDW+]&GP
M5=#[F55EP.F/>I]/E6+Q_P".YI4D6&6UM%CD:)MLA2.0.%.,,02 0/6@#K6\
M1:6-.LKY+H2PWX4VGE(SM/E=PVJ!D\ D\< '.,4_2M<T_6?M LYF,MM)Y5Q#
M(C1R1-C.&5@",CD'H>U>5^'XKW2M/^'>LW%M<_8-/M9[.^3RFWVKR !79<9
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MB8G B1 H& >-W)]2 <5Z7XQAL;CPK>0:E;W$]G*8TE6V#&109%&]=H)RIPW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)8,I99Y(GB4@9R?G XX/-9MKX\T&^$LEE+=W=K$Q5[NWL9I( 1U^=5(./49
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?PQ6U=_\>4__ %S;^5><ZO\ #^?2M(\,Z;X7UC4;)M-N,K%'DK<;G4N\I&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(>3$&!!=F.68].,8&.O)H D\3^(?%\?AJ.]^SZ=8V]U=620M',[RE)74,K#
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M9-'_ / Z+_XJ@#:HJK8ZE8ZI 9]/O;>[A#;3);RK(H;TR"1GD?G5J@ HHHH
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M^\/_ 'P*/L=M_P ^\/\ WP*FHH A^QVW_/O#_P!\"C[';?\ /O#_ -\"IJ*
M(?L=M_S[P_\ ? H^QVW_ #[P_P#? J:B@"'[';?\^\/_ 'P*/L=M_P ^\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHP!'!]ZM,RHA9CA5&2?04 +1532]4LM:TR#4=.G$]I.NZ*0 C<,XZ'![5;H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQF,%LD?,01P, <]> -C3?#FJ:3KGB"[@NK22SU27[2D3HP=9/+"$%N1M^7/
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M\D:O QNK=&8LT<; A<9)PQR1GI0!(FO^*M0\7ZYHNGP:0D>F/:OYEQYA+1R
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MM;OS.9?L\;7"(D75U53DEMR8!/&XYSC! .SJ"6\MX+B&"60)).2(@P(#D#.
M>F<9..N ?0UY[JOC#Q7I'A#6]0GT^!9]/N8TMYY[=XTNX7=5#!"V58;N<G''
MO6QK]GK<_@GQ$-6GLC/'%)<V#V:,IA*+O0DL3EE=>HQG';I0!V-%9/AC56UW
MPKI.JNH5[NTCF<#H&902/SS6M0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>elicio-exhibit312202510x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-exhibit312202510x001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8,R\@G(<D@#Y2.%SSUK&\5Z=HGQ+ATC5?#-M+!XA6^B\R0P&*6% ?F,W;Y<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-_=K'/<MM@@16DEE/^RB@L?P% &I1638^)=)U#4I--ANBE_&N]K6>)X9=O\
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ME?LH6Z^P86VC"D!43S.Q+'))Y/(- 'CMF8OAQ\0[KPQ<7DA\&:M=;6?!VJP
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M]IWB:SBC@1XXKHZ63,H9BQP3-MSSZ>E=AIUF-.TRTLE<NMO"D(8]6VJ!G]*
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M-OD\ M'*&Q^"I6G\'-0UJV\&Z#;6MA&=,GU25+F[$V64;6(79CH6 &<GZ<T
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M !1110 4444 %%%% !1110 5R7Q \$_\)[HL6E2ZB;.W299R4AWLS ,!R6
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MRJK _,05(7IBFZ!X#OO!_P!HMO#>NK#I<TAE%E?6AN!"QZ[&#H0.!P<UV]%
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M?2-8C2X@N(]LFU=O/9ER3@@\CDUSGB'X>C7O 6G^$CJA@MK6*&-IA!N=_+4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !4_ +^>?2I?$OP[77=.TK3++6[W1[#3%400V> =RC"L6ZY Z?4FK_@WP?\
M\(E;W:2:Q?:K/<NK-/>ON<*HP%!]!DG\: .GHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !534=3L=(LGO-1O(+2V3[TLSA5'XGO[5
M;KD?BBB/\,O$.Y0V+-R,CH: .L1UDC5T.58 @^HIU5]/_P"0;:_]<4_D*L4
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M>A&0&4^Y [9R+<>N>+E\5VOARY&BK<RZ4]V]Q''*R+(LBIPI8$C!Z9'7KQR
M=U17F#^-O%:^#=5UOR=($FAW4UO>1[)"+KRGPQ3YOW?'3.[GTKTR&4301RJ"
M ZAAGW&: *PU;3VU8Z4M[ VH"(S&V5P9%0$#<1U RPZ^M)?ZO8:68Q>7*QM)
MDHF"S,!]XA1DX'<]!WKE941?C=:,J@%O#TV2!U_TA*9H4TE[\8?%IG.?L%G9
M6]N#_"CJTC8^K?R% ';03Q7,$<\$J2PR*'21&#*RGD$$=15'4=?TK2)X(=0O
MHK:2X8)"LF1YC'^%?4^PYKB?A_XATW1]!U>WU74[2QM+37;VTLS=3K$"BON"
MJ6(SC<:C^)6J0SQ^"]3TS;J<?]MQR0BUD5A.0C_*K9QR1CK0!W=WKVEV-Y;6
M=U>1PW-T"8(G!#2XZ[1CG'?TK1KC? >HV7B:U?Q"\PFU9LP7$3KM:PP>8 IY
M7!ZGJQYZ8 ZR[NHK&SGNYVVPP1M)(WHJC)/Y"@":J6HZM9:5&K7<K N&*I'$
MTKL%&20B L0!UP.*XR\\:ZQ8^#+/QI+#:-I4OES3V:QMYT5O(P"L)-V&8!E)
M&T \CC&2E_\ VG+\9=,$-[:B/^QYWB#VS-M0RQ;A_K!EC@?-Q]#0!U\.OZ5<
M:&FM0WL;Z:Z>8+E<E=HZD^F,'.>F.:J?\)IX;^R_:O[8MOL^W=YV[Y,>N>F*
MF\011P^$=6CBC2-!93X55  ^1NU<;X,U&_7X9^&[0:!-/;3P6UM+*\D93RG9
M49MH;=C!/;ZT =R^MZ;'K<.C-=I_:,T;2I  22@ZGI@=1UI]CJUCJ5Q>P6DX
MEELIO(N%VD;'P#CD<\$=*Y;5@!\7O# ';3;T?K'4,?CJ[L]-\5WFI6UNS:1J
M"V=O' 2HE+",)N)SU:0 G' [4 =Y5+2]6L=:LS=Z?.)X!(\6\*5^9&*L,$ \
M$&LVWD\40ZV+>ZBL+G3Y+4O]IA4Q&*<'A"I=BRD<Y&,8-<]I_CV]D\(V5]=6
M]J-3O]6;2[>.,,(@_FL@8Y). JECZXQQF@#T"L_4M=TO1Y8(M0OH;:2<,8DD
M;!<+C=@>V1^=8L?B#4=.\;6GAW5OLTR:C;2365U;Q-'\T>-\;*6;L000?;'>
MNE-O$;I;DQ@S*AC5^X4D$C\2!^5 &+#XV\,7#1K#K=FYDD$*8DX+DX"Y]<\8
MJ_I>MZ;K1NQIUVEQ]DF,$Q0'"R  D9(YX(Z5QOPJMX;KP;?PSQB2-M7NR5/J
M)<C]0#61:ZCKFCP_$+5-(^P!;'5)KF5;I'<RA88R4&TC;P/O'/T[T >LT5R$
M_BZ6ZO;2PL 8)IM.34'D:SENMBR'"+MCQW#9)(Z#@YXR9_&?BF#1]!FGT>VM
M;V^U9=-GBN%=0V=Q$B G(4A>^2,]\4 >BT5Q\NI>*;%K6WU271[;?'*TE_'&
M[QO)O BB2(N'+%22>O0@>M8Z>/\ 6KKPEX3UBUL;'SM9OUL9HI&<!6)D&5/8
M?NSUR1GH<4 >D45Y[_PG.K>'M8UK3?%4%E(;/3&U2VGL%9%EB4[2A#$X;=@=
M:OV^O^(FUW3;<V0N;&\1Q/*FG3P_8G"Y4EG.)%)XXVGOWQ0!V=%><R^.]93X
M:7OB416'VRTO7MVC\I_+=5N/*R!OR#@YZFKK7.LO\8VL5OX/L4>C"X2%K<G
M:;:PR''S'8/FQ@#C;W(!UFGZM8ZJ;L64XE-I<-:S_*1LE7&Y>1SC(Y'%7:X*
MU\=7L6AZ[=WUM;-=6>M-I5K%#N59&)C5"Q.3U?)/H.E:UQJ'BC2Y]1>XL;74
M;&'3GN8);53$[3KG]SL+,3D8(8?3F@#IZ*Y3PEXE?Q(4N;;4].O[$P9E^SQ-
M%+!-D?(ZLY(&-W8=*ZN@#,7Q!I+ZPVD+?1G45&XVW/F!>F['I[]*TZX"'/\
MPOJ]V@;O^$<3&?\ KN:SI_''BJ/PMKFO"'2!'HNHS6\T.R0F=(W"G:=WR'&3
MD[L^@QR >H45S4NN7VI>(+W1M'>VADLK6*>::YB:0%I=VQ H9>RDDY[@ =QJ
MZ'<:G=:+:S:S91V6HLG[^".0.J-DC@CL>OMF@#0HK/L_[7_M34?MILO[/W)]
MA\G=YN-OS^9GC[W3';K6A0 4444 %%%% !1110 4444 %%%% !1110 4444
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M!CIG=U[8Z&NCHH XFX\+>(M.\47^J^&M7L;>VU0J]Y:WUNTJI(%"^9'M9>2
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MS&<;E/4?,1UY!KT*B@#G;?0KN\\1V>NZP;87%C;R06T-L695,F-[EF .2%
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MXK?HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS*T,*H7/J2!S^-$FDZ;-?K?RZ?:/>*-JW#0J9 /0-C-+)JNG17@LY+^U2Z)
M$+3*')/0;<YYS6?IGBO1]7U>_P!-L[V"6>R<1R!9 =S8RP [XXR?7([4 6!X
M=T-8)H%T;3Q#.VZ:,6J;9#ZL,8)^M96H:3J]W>+HT%MI=MX7,:"39N$Q ;+1
M! -H5@ "?0GO6W;:QI=X91:ZE9SF%=TGE3JVP>IP>!5+0?%.D^)+>XGTV\AE
MCAE>,E9 20IQOQ_=)!P>XYH VJI'1],:^:^;3K0WC+M:X,"^85]"V,XIUEJF
MGZD)#87UM=>6</Y$ROM/H<'BI+J\M;&'SKRYAMXL@;YI BY],F@"@/"_A]8%
M@&A:8(E?S%C%I'M#?W@,=?>K4>D:9%?F_CTZT2\*[?M"PJ),>F[&<5/;75O>
MVZ7%K/%/ XRDD3AE;Z$<&HKC4["T:1;F^MH6CC\UQ)*JE4SC<<G@9(&?>@"&
MVT+2;.\:\MM,LX;ER6::.!58D]3D#.3W]:N/!#++%+)$C21$F-F4$H2,$@]N
M"154ZWI2K:L=3L@+LXMB;A?WW^YS\WX4^]U73M-*"^O[6U+_ '?/F5-WTR:
M)XX(8I)9(XD1YFWR,J@%VP%R?4X 'T JM:Z1IEBTS6FG6ENT^?.,4"H9/][
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M800A?'S;<\XSG&: )Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;C6_B9!<WME>-+IL#_NU 1V6"7)5<G[N!DY.,5MZ%X,T37OA-IUJ;*VCGO\
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M&DD1M)=RN 1PI/>O+Q:6=UX2^%'GPPR%Y[>-MR@[E^SOE3ZC.,CI7K\\$-U
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M'S)/\17<5372=.2\-XFGVJW1.3,(5#D_[V,U<H **** "BBB@ HHHH ****
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M0QCS< =R@;-=:-4\->(S#J/AR:WN]:339DM&MI/FMD9<@.H.%^8* &&<].]
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MVYQ\KL<*F,C<W4D#G&/6LGP5XO2]T2#^WM7LEU*>]N+>%'=(FE"2LBA$SSP
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MD:FHH @%C:+9_8Q:P"UQM\D1C9CTV]*&L[5IHIFMH3+$NV-R@W(/0'L*GHH
MK_8+/[,EO]D@\B,ADB\L;5(Y! Z"BXL+*[FBFN;2":6$YB>2,,R'U!(X_"K%
M% %=[&SDN/M#VL#3?\]&C!;\^M,&E:<$9!86H5L%E$*X..F>*MT4 59M,L+B
MU6UGL;:6W4Y6)XE9 ?4 C%.FL+.XV>=:02;!A-\8.T>@R.*L44 5TL;.*9IH
M[6!)6SN=8P&.>N34<FDZ=+;I;R:?:O F=L30J57/)P,8%7** &QQ1PQ+%$BI
M&@PJJ, #T H:-&969%+)RI(Y';BG44 -6-$9V5%4N=S$#&XX R?7@ ?A4/V"
MS^W?;?LD'VO&WS_+'F8]-V,XJQ10!7CL;2&<SQ6L$<K9S(L8#'/7F@V%D;T7
MIM(#=@;1.8QY@'INQG%6** &2PQ3Q-%-&DD;=4=00?P-5SI6G%%0V%J57.U3
M"N!GKCBK=% %==/LEF,RVEN)6SEQ&-QSUYQ21:?90"(0V=O&(<^5LB4;,]=N
M!QGOBK-% %232M.EGDGDL+5YI !)(T*EG Y )QD]!^5/NK"ROU1;RT@N%0[D
M$T8<*?49'%6** ,[4-'M]3NK*6X2-EM)!*@\L%MP((PW4#(!('4@<XR#<GMX
M+J/R[B&.5,YVR*&&?H:EHH JC3+ .CBQM@T>-A\I<KCICCBE;3K%[U;UK*W:
M[48$YB4R ?[V,U9HH C>WADFCF>&-I8L^6[*"4SUP>U)/;6]T@2X@BF0'(61
M P!_&I:* *O]FV D2065MO3&QO*7*XZ8..*0:5IP5E%A:A6^\/)7!^O%6Z*
M*4ND:9/&D<VG6DD:?<5X%(7Z CCJ:EEL+.=D::T@D9!A2\8)4>V>E6** *\U
MA97%U%<S6D$EQ%_JY7C!=/H2,BG/9VTEPMP]O"TZJ4$C("P4]1GKCVJ:B@"M
M+IUC-9K9RV5O):KC$#Q*4&.GRXQ1_9UCY;Q_8[?8Y!=?*7#$# R,<X  _"K-
M% %0:7IX*$6-KE/N'R5^7G/'''-9?B#P\]]HT]OHYM+&[D9"7:W!250P9HW
MP2K8P<'H36_10!QUCX6NKB\MKC5=*\/6;6TJS*^G1%I&93D?.RJ4&>H&<CC/
M-=C110!'Y$/EB/RDV!MP7:,;L[LX]<\_6FW%G:W847-M#-M^[YB!L?3-344
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M$Y."/?BO5+6VBMH0L5O#!N^9DB4!=W?L,_7%*MM;I.\Z01K,XP\@0!F'N>]
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M><G ))+,0N3T^5>.,D Z     8 [5X6^H61_9WOK%KF'[3;W+)/"6&Z,F^)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&>];FD:_JS>-+WP[J]O9*ZV27]O):,Q&PN4*MNZD$=1C/H* .IHHHH ****
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M6169/N.CA2<@$C!7D>E=!I6K6&MZ=%J&FW*7-K+G9(G0X.",'D$$$8-7* .
MOO =\^A_9[6:T-[<ZTNL7DDC,J%PX;8F 3C"JN3Z9[XK9CT/4?\ A8C>(G^R
MBU;3%L#&LC%P1(9-WW<=\8_'VKIJ* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N:\?:[?>&
M?!M_K&GPVTTUL%.RXR5(+!>@QGKZBNEKGO&^@W7BCPC?:+:30PR7853++DA
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M]H\_&W'7/R]??VK9OO#FI7OC*WUL3V\$2:;+8LJ.QD4R$,74X X*\#OUXZ4
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M<9)PQR1GI7<RF01,8E5I,?*'; )]S@T >3^%]0U32O@K+K>-/O7M/M=U#'/
MP*NL\I9BVX[B><8"]>IKIK_Q/KD6N>&-.L[>P*ZS:RR,\N_]VZ1JV<#M\W3J
M<8R,Y$%EX+U6V^%]WX0>YLVFFCFB6Y!8*!*[,25QU&['7GVJZ_AG5)-<\*Z@
M9+,+HL$L,J!FS*9$5"0<<8VYYSG./>@"MIWBGQ!<Z+KZ&QLKG6=*O_L?[HF.
M%U.P^:0S9 "N21N_AX/-+I_B^_NM3\0Z=&]A>MI]G'=VMU$CQQRA@V01N;."
MO53@YJG>^ ]8N['Q#$E]9PR:GJ46H1C#.GR;/W4@P-RD(,X_*KL?A;7E\1:I
MK$M]ISMJ&G):O"D+J$==^,')^4;\YZG'04 9]CXU\1-IOA'6+RWTP6&MSPVL
ML,2OYJ/(K%7#%L8R/NX/'?TU9/$&O:K::Q=^'+>SF&G7;VD=M< [KIXR!)A]
MP$?)8#(/W<GKBJ0\%:LOA?PKI"W%D7T*[@N6D+-B81 @ #'RYW=><8[U+;>$
M_$>BZYJ;:%J]C#I&J7+7<T=S TDMM*_WS$00#GK\W ]#SD TGU_4$^(-CH<E
MM;):7.G276[):575D!7/3'S>^<5CS>--8L;_ $=+^*PC>_U3[#-IZ M-;(Q?
MRW:17*Y(4-@J,AN.AK8F\.WI\<:?K<<T/V6TL7LMCNQE;<5._.,9&T?7UKFX
M/A_XBBT72--.KZ<W]E:JM_%,UNY>?#.293N^]\YZ=?6@#5T+_DK7B_\ Z\[#
M^4M;6MZW+9ZMI.C68B^W:DTI228%DBCC7<[$ @L>5 &1USGBJVEZ!?V7C;6-
M;EEMWM]0A@B"*6WIY08 GC!SN/';WJ/Q?X9O=9N-*U71[Z.SUC2I7>W>9"T3
MJXVNC@<X( Y'I0!6O/$VMZ'82KK%C:F\GU.+3],DB;;'<^:0%=EW,4Q\V1GG
M;QUJ9_$.J:7XPLM U(6DXU.WEDL;F&-H@)8QEXW4LW&""&!]L=ZAU;PCJGB+
MP_Y>K:I"FL1W,5W:S6L1$-M+$<IM5B2PY;))R<]L 5=30]0O]>L-;U868N=-
M@ECM8+=V*&20 ,[,5!'"X P<9/)H Y6#QYXF;P=8^*)[;2ELS??9KJ!%D+LI
MN##N0[L*1QP0<\GCI75#7+_5O$6JZ3H[VD(TM(UGFN8FDWRNNX( K+@!<9//
MWL8XK '@+5Q\.4\+?:K'S5O/M/VCY]N//\_&W'K\O7WK33PSK6F>,+_6]&N[
M%8=62/[=:W2NPCE1=H>,KC/'4'&?4=@#E/"NO:AX?^$/ABYM8+5S/J7V682[
MCM$ETZDKC'(SWKI(KK6I/B]>67V^W-E!I<4T<#6[<!Y&!&0_WCL'S8(Q@;>.
M:,'@#68/ FE>'C?V,DMEJ"WAEV.H(68R[.^<DXSQ@=C70/X>U%?'@\16UU;)
M#-8):7,$B,S?([."C9 YW$<CCK0!C6_CVZM_#FN7]_:VQNK/67TJVA@)597W
M(B9)SW8DGT'2M*Y\0ZKHGBG2M)U3['<P:LLB6]Q!$T7E3HN[8X+-E6'0CH1T
M[UF_\*]N+WP[X@TJ_O(8WU'5'U2VN+?)-O(65E&"!G!4<\9!/2M@:%J6IZMI
M.I:V;+S=*61H8[9F*RS,NW>Q8#: ,X7GDYR<4 <M+X\\3Q>$=0\1M:Z2+?3-
M0DM[B +(6F1)A&=AW84X.<G.?0=_4*\[E\!ZM-X"UKPX;JR$NI7DER)P7Q&'
ME\PC;CG&,=>_MST27.OCQE! TED^E-:9FAC5C)#(/XB_3!X &,GD]C0!%XU\
M0:EX>MM*ETZWMIS=ZE!9NL[,.)&QQCH?<]/0U4?Q#K=G?V^BZ@UB-4FCFN3-
M9VD\\:0*RJG[L'=N);GG VGKD5>\8:#?>(+;3(K*6WB-GJ$%\6F+?-Y3;@H
M'?U[>AJMXG\-:M?ZOINOZ!?V]EK%E&\+)<(7@GB?!*-C!X(!!% &7)XZU33M
M CN]<L!IK#5#8RWLEM)Y(BVDK<>62&"L0JX)X)Y/&#:U'Q3JVG:;I-ZLNEWD
M-[K$%D)8%8I+!*P ="'.&'/7(R*TSIOB(V-NTUY8W=TTY>]@=&2WDC*%?*0?
M,5 .#DYR0>.<#!;X<S0>&I[/39[6TNO[835[6 !FMX'0J1&.AV_*<D <G@4
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M)SQC&/>I[7P-J5KX3N/!HO;=]#D9DCN#N^T1V[-N,6W&TGDJ'R, _=XK4O\
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M)&*,Y;=P258@8X&,YSQKZAXO;2=1L-'EOK72UFTV*6SNKV%FAN)CD&,ON 7
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M<\XQ4L>M>+-1\8:]HUA)I$46F/:,LDT,A+QR LRD!OO8'7IQTYR #N:*\_\
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M"DX49Y.<\5O7=C:7\/DWEK!<Q9SLFC#C/K@U)##%;PK##&D<2#"HB@ #V H
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M--;4]/2[^R/?6RW/_/$RJ'Z9^[G/3FN*N;&STWXM^&Q8V\-OYVF7BR>4H7S
M#&1G'7G)YKEH+6UUOPI)X8?4--FE777G_M"6ZB^=1<%V8H3OWXW)@K@]<X-
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MU=;7 ^#9+)?B3X\BM9(/FGM'VQL.3Y/S' _VLY]Z[Z@ HHHH **** "BBB@
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M86K63=;8PJ8SSN^[C'7GZU; P,#I5"#7-)NKB*WM]4LIIY0QCCCN%9G"G#$
M')P00?3%+::SI=_=26MGJ5I<7$8W/%#.KLHSC) .1S0!>HJE#K&F7%W]D@U&
MTEN<D>2DRE^.O .>.]0^(-:@\/Z--J,Z&3852.)3AI9&(5$'N6(% &G16?\
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M#/-/%I]K'-,")9$A4-(#UW'&3^-1PZ[I%S=PVD&JV,MS/&)8H4N$9Y$(SN4
MY(QSD52TOQ=HVL:W?Z597T$MQ9,$<"49=L98*.^WC)'?([4 7/\ A']%,4,1
MTBP\N#_5)]F3$?.?E&..?2I[[3;'4X5AO[*WNHE8,J3Q*X!]0".M1V^LZ7=W
MDEG;:E9S748+/#'.K.H!P25!R.:8OB#17E2)=7L&D?>547*9;9]_ SSCOZ4
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MH=)$8,K*>001U!I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS3XKG[3'8VR3Y)\U8E#9/4YQFEATZQMKJ6Z@L[>*XF_ULJ1*KO\ [Q R?QH
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M#Z1HT_@O6[F2PLI98=0U$+*\2L8QN88!/W1M].QKT:'2]/MYIYH+&UBEN/\
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MTN.2".2.Z^V0O+@[SA1M9<$#J#ZB@#KO'6J:CH?@S5-4TM[=;FT@:4>?&7!
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M3MK^VEL"I?[2DJF/:.IW9QQ@YKEK7Q/+??%&/2K/5(+G2VTJ2X:&)5)242(
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M.U+XJ^#Y8I[:YB-G>M&P8,I/[O!'KT."/2N4ENS9^'?$]Q;LYLK+QGY]XML
MS);@QLS!<$'#?-TQP: /8+#6--U5IEL+ZWN6A(658I Q0GID#IFB]UG3--EC
MBOM1M;:2169$FF5"P4%F(!/0 $D]L5S'AMO#>J>*9=;TC5Y=6O7LA#/<)(IC
M2/<"JN%4 /G.,\X!JKXW6S?Q[X$6Z$)S>7'$F.?W+8Z_[6/QQ0!U3^)-$CTZ
M'4'U:S%G.I>*;SEVNHZD'/('?TJS)J=A%91WCWD MI=OER^8-K[ON[3WSVQU
MKSR_U#3_  W\2+NTU74#HFG7>G0KI\JK&D!",_F1Y92%.7!QQGOVJI?1Z'X9
MT[P5=Z;?B#3;._G-LFH3;(YHW1]S[SPN,DIGKN'8YH ]"?7=*O+"Z-IKEC&R
M1-F83(WD'IN8$\8/8]^*6RU.UL]"T^:^UF"Z\V%-MZ=J"Y.W.]0..1EL#M7%
MZ;%I4NA>.-6AU/2[LZBLL[Q6EPDRVZ^3M 9A_$VW)[9]<9JI8027GA+P$^D:
MY#IVNPZ3NM!.H>"X41Q"6-QUS]WIR,'TH [+4_'&@Z9)I2MJ-M(-2F,<+K,N
MS:,[G+=-HVD>YXJ[/XI\/VSND^MZ?&R,BN&N4&TOG:#SP3@X^AKSB;6UN;/P
M)JNHVUOI:1ZW<)<$2?N ^V92RL?X6;)'UK9T>#2M0^+?BH2PVMP6L;%E61%;
M/WR3@_\  #^5 '9MKVD)?BQ;4[1;II/*$1E7<7QG9C^]CG'6H[SQ-H6GFX%Y
MK%A ;;;YXDN%4Q[LXW<\9P<?2O(]9UO2[KP^TMK<6VGQ0^)DDDL-^Z96%R-\
MTQ8DKD\@# &0,GI77Z3_ &;<_%WQ'*1;2 Z7:,&8 \'?NZ^H(S^% '1:QXST
M71AI7G7T##4Y52W82C:4/)DW=-H'?OQ6\CI+&LD;!D8!E93D$'N*\1T:\M[?
MX>?#.ZGN(X[:#6"LDKN L8Q.!DG@=NM>W1R)-$DL9W(ZAE/J#TH =1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !3)88IU"RQI(H.<.H(S3ZKWE]:Z=;&XO+B."$$+OD; R3@ >
MI)( '>@!396A4*;6$JO0&,8%'V*U+,WV:'<W4^6,FJ2^)-%:PN+XZG:I;6SE
M)Y)) @B;^Z^<;3TX--M/$^A7VI+IUKJUI->M'YJP)*"Q7&<X^A!Q0!?^Q6FP
M)]EAV*V\+Y8P&]?K[TK6ELX8-;PMN;>V4!RWK]:Y;Q[XGATCPMK+66KQVFIV
MMLTB$!7*OM)56R" 6[ \G/%=#I,LMUH5C-)(3-+;1LSX&=Q4$G\Z + L[975
MQ;PAUQA@@R,=*$M+:.Y>Y2WB6=QAY0@#,/<]37#^$?&=O'974/B/7;?[8=7N
M;2W,[)&SJDFQ1@ #MC/K76ZCKVE:2Y2^OH8&$9E96/*IG&]L=%SW/% %M;2V
M1F9;>)68$,0@!(/7-"6EM&$"6\2B,%4"H!M!Z@>@-5)M?TFWNK2UEU&V6>\&
MZVC,@S,/5/[WX5-_:=B+JXM3=1">WC$LR%L&-#G#'T'!Y]CZ4 3Q6\$&?)AC
MCSUV*!G\J0VMN9O.,$1ESG>4&[\ZIV&NZ5J=U+:V=]#-<1*'>)6^8*>C8/)4
M^O2IM-U.QUBR6\TZ[BNK9F91+$VY20<$9^HH EFM+:XECEFMXI)(CF-G0$H?
M4$]*YJ\\-7=[\0(=;GAL9M.33VLFAE8LYS('WX*XXVXQGWS75T4 -$48B\H(
MHC V[,<8],>E10V5I;P&""UABA;DQI&%4_@.*GHH CB@AA4K%$D:GJ$4 &F&
MRM#&D9MH2B?=7RQA?H.U3T4 0?8K7<6^S0[CU/EC)K \1:!J-W-I]QHTNGQB
MU=VDLKR F"<LH4,=O(91G!P?O&NFHH YW1/#\EKJ(U2^M]+@O%A:!4TZ#8H5
MBI.YCRW*#' QSUS6CJ^D1:K% 2_E7-K,)[:<#)CD&1G'<$$J1W!/3K6C10!"
ML".T<T\,1N%7&\+G;GJ 3SBF2:=8S0I#+9V\D2<*C1*57Z#%6:* $50JA5 "
M@8 ':H9;*TGF$TUK#)*%*!WC!;:>HR>WM4]% $,UI;7%O]GGMXI8>/W;H&7C
MIP>*5[6WD14>")D08560$+]*EHH @-E:G;FVA.WA?W8X^E'V*T^;_18?F^]^
M['/?FIZ* ('LK22V-N]K"T!ZQ-&"I_#I3S!"T'D&)##MV^65&W'ICIBI** (
M8;2VML>1;Q184(/+0+A1D@<=N3Q[TZ6W@GQYT,<F.F]0<?G4E% $'V*UW%OL
MT.X]3Y8R:DBAB@4K#$D8)R0B@?RI]% %=K&S=BS6L!8G))C!)-*+.U$9C%M"
M$)R5V#!/TJ>B@")K6W=U=H(F=<;6* D8Z8I/LEM]J^U?9XOM&W;YNP;\>F>N
M*FHH @-E:EF8VT.6^\?+'/UH^Q6NU%^S0[4;>H\L?*WJ/0^]3T4 0-9VK AK
M:$@L6(*#ECU/UJ&[TZ.:UG2WV6MR\3)'<)&I:(E<!A]/Z5=HH X.V\'ZO/IR
MZ5JT/AR6V$7DO=QVC-/(N,9VMP'(YSD\\X-=H]C:2>3YMM%(8,>49$#%/<$]
M#5BB@!KQI*A21%=#U5AD&D2&*.,QI$BQGJJJ /RI]% $45K;PDF*"*,D8)1
M,BDM[6WM$*6T$4*$[BL:!03Z\5-10 R.*.%2L4:H"2Q"C&2>IIAL[9I/,:VA
M,F<[B@SGZU-10!&]O#)(LDD,;.OW6902/H:9]AM-\C_98-TI#2-Y8RY'0GU(
M[5/10!$;: S><8(S+_?V#=^=(+2V%T;H6\0N"-IE"#>1Z9ZU-10!7%C:"Z^U
M"U@%P,_O?+&_GKSUJQ110!#':V\+[XK>)&Z95 #21V5I#</<1VL*3O\ ?D6,
M!F^IZFIZ* (W@ADE25XD:2/.QV4$KGK@]J6.*.% D2*B#D*HP*?10 R6&*=0
MLL22*#D!U!&::UK;M;FW:"(P$8,90;3^'2I:* &10Q01+%#&D<:\*B* !] *
MS;'1H].NKP0;#8WDC3O;LN0DK?>*^S'DCUR>]:M% %&[L"UG+;V)CLVF&QYH
MT 9%[E?]KTSP,YYQ@RZ?86VEZ?;V%E$L5M;QB.)%_A4# JS10!"UK;O([O!$
MSR)L=B@)9?0^H]J#9VQ<.;>$L, -L&1BIJ* (4M+:-75+>)5<88!  P]_6D@
MLK6UV_9[:&':NT>7&%P,YQQVS4]% #71)$*.JLIZJPR#38[>&%2L4,<8;J%4
M#-244 0V]I;6B%+:WBA4G)6- H)]>*);.UGF2::VADE0$*[H"R@]<$]*FHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH*DL6SSD8"Y[XH Z'3-9T[6DN7TV[CN4MIC;RM&<A9  2N>_!'2KU<)\,OM
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MGZM9LL/E;_-A:.(/\S$X8$9Z 8/<]3WE !1110 4444 %%%% !1110 4444
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M++;0+&&/N% J[0!Q%SX9\3:?XIO-8\-ZCIT4.J"-KZTOXWD1)%4+YD94@DX
MX.,X_)]]X3U>V\36'B+1M0@EOX[/[#>I?!@ES'NW[@5SM8,21QC'' %=)J>N
M:;H\MG%?W2PR7LZV]NI4DR2,<!>!_/BM"@#F/"'A[4M!FUN2_N[6?^T=0>]5
M8(V786"C&23_ '1Q^IJ/Q/X<O?$,>H6%Q;Z9>:;=0A8ENBP>VEP09%PISU!
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MLVXQ[<;2W)4/N'7.WC%==<ZYIMGK%EI,]TJ7U[O^SP[22^U2S<@8& #UK0H
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MHP(96'T8 _A65I6@>()[-[/Q5JUI?VP@:W"6L#1&8,I4O*2QR=I/  '.>>,
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M@I.Q_E((89(Z_P#UP#/E\>7UG8^'WU^W3P\^H1RBXFNH6DCAF0@*AY&T."S
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MOB:\DL(2=+59K.\GM9(8[J,CD&,MN#*>.N#76Z$^NRB>;6&L/)E"/:I:JX9
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M7SA@?NY3.,9/'(JW%XJU^RA\86=S%#J5_H?E/ ]M;LGFI*F_F/<22O/ /.*
M._HK@%\?6]MX6UGQ)#JEKK&FVEO&T(C3RI5F)93'(/X<DQXX'4]<5=U/7=9\
M-:EH!U*:VN[+5;I+&810F-H)W!V%#DY0D$$'GH<]J -ZR\1:9J,^I0VL[O)I
MK!+I?*<%"1NQR.>.>,U9TS4;;5],M]0LV=K>X021ET*$@^H(!%<5HDEQ!XJ^
M(LMHT2W$<]N\9E0LN1;*>0""1^-.TWQI?ZAH7@^(>0NK^(49S(4/EQ(B;Y&"
MYY., #/4Y/3! .FL-1T2Z\1ZG9V:1_VK;+&;QA;E&PV=F6(&[[I[FMBO---;
M6+'Q]XYDB\B_U"+3K1K8-B%9#ME*ASG YX)X'TK2TCQ/J%UXO30_MUM=Q7&E
M->)=);D*DRNJD*<[9$^;L>V,T =SG-%>6^%/$>IZ9\/8-0N[I;ZZOM4DM( T
M)SYKW+J6;#?,,9(48Z 9[UK3^+-:\//K-WJ]E+<:+:6!NH;LP"!_-!QY)&3G
M.00V!COF@#?UJY\/6^JZ9%JUO;O?74ODV;26OF'?R<!MI"]">HK=KS3Q*NL-
MJO@.YU&ZMY!-JT;R0Q0[1'(8G("MDY7&0<\D@'CI7:^)]3NM&\-WVH65JUS<
M0)N6-4+G&0"=HY; R<<9Q0!K4A(4$GH.:X"3Q?<S>#M>U_1=:L-2MK.T$]N_
MDX974.725 P(Z+CA>O0]3H3^(]2BU_P;; VYMM:CE-RIC.Y66#S 5.>.>Q!H
M W]'US3]>AN)M.F:6.WN'MI2T;(5D7&Y<, >,UHUY'I,_BBRTKQCJ&@S:<J6
M>NW\[6]S"SM<;2"5W!ALX''!R?2MBY^(:O+I#2W<>BVFJ:9'=VEU=0EX7G?.
M8G?("[1M/49W=1CD [>YU6TM-3L=.F9Q<WWF>0!&S [!ELL!A>#W(SVI=5U2
MST73)]1OY3%:P*7D<(S[5'4X4$USMUKNL6?BSPEIDK6AM]4AG-T%0EA)'$&^
M5MV-I)].W7FL+Q!K.H^)_A[XMU&RN((-/@BN[:*)HMQF2-2KLS9X)(;;CI@9
MSG  .X_M_3_.TJ+S)"VJJ7M<1,0P";SDXPO'KBM.N$M-;U'3[[P#I<)MS8:G
M9LLP:,^8#';;QALXP3CMVZ\U7U_Q?K6B-<7,LEH&AU2.W6P1#+FV=U0.[J?W
M;MN+ ' [8- 'H=4K75;2\U.^T^%G-Q8E!.&C90-Z[EPQ&&X]"<5R5WJ_BN\\
M;:KH&EW6EP);6D%U#+/;.Q^9V!5@'Y/R]1C'ISD))XUO=+O/&YU);>:WT%('
MMUA0H7\R,MAB2><D#/XXH [NBN.MM5\41^(K&%[)[S3;B*3[3)]F\@VL@&5V
MDL=RL<C!Y'!S5?P?XNF\27-NO]H6PN41O[2TN6 Q3VLF. H)R5!R"<'/!R.E
M '<U2.JVBZVND%G^V-;FY"^6VWRPVW.[&W.3TSFKM<Q_;>HK\31H#FW.GOI+
M7J;8R) XE5,%LD$8)Z =: .GHKA/"7C"X\1WL$37]O%>QEQJ6D30F.>V(!QM
MR<LH. 3@YR#QTK3\?:WJ7AWPPVIZ8;8RI<0QLLZ%@5>14X((P?FZD'Z4 =11
M7#R:KXIA\<#P\UYIC)>V#W<,_P!E<?9BCA2NW?\ O.&')*\\^QBTSQ1KUWX7
MU"1SI_V_3M7?3KF[D/E0K$D@#3[6;J%.=N[K^5 '>UFW^O:=IFHV%A=S,ES?
MR&.V01L0[ $D9 P. >IKCX?B!)IT/C"74#]JM]"2&6"40F%YQ*F55@?]H8#
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M'5P  PZE17044 <W-X=OIO&UGXB^VVX6WLGM#;^0V6W,K%MV[CE1@8Z5A/\
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MGIR3G [3_A'+P>-F\2?VC#N.G?8/L_V4XQOW[MV_^]VQT_.L7_A7EU_P@?\
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MT_2-<TFPFG@O)4>:S9(EC%LQZJ^_=O P>>"<\"N]M[9+:SBME+.D:!,R'<6
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M=1X)N;]TN;:74-+U+3X53[->:=;>3'DEMR !F4XPIRI_BP: .MHHHH ****
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MH(KA DT22*#G#J",_C4E% #8XTAC$<:*B#HJC %.HHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7 Z3XS@TS7/$MMXEU
MZVB@MM02"S-R4B^4Q*Q QC."W4UWU>::5)H<'B?X@QZW]D59;B,ND^W=)"8%
M' /)!.0,=_>@#TE'26-9(W5T8!E93D$'H0:=7$> [A?#G@SPMH6MS^1JMU"Z
MV]O+G>0N7V^Q5"HP?3%=O0 4444 %%%% #9%+QLJR-&2,!UQD>XR"*\_\&7W
MB;Q-HE]>2:^L5Q#?3VL8^Q1LF(VP"P&"<^Q%>@NZQH7=@J@9))P!7E_PO\1:
M)8>%]4:[U>Q@ U:[?$EPH.TOD$#.3GMZT ='X0\6W&K7&L:3K4$%IK&C2!+K
MRF/E.C#*2KGD*0,X/3\:W;'7M)U*YDMK/4+>:>) [QHXW!#T;'=3Z]*\EOM.
MU?4[#QWXQM[&ZCBU#[,EG;E"LLUM"R>8^T\@.JG (SC/%=%:7W@WQ%=KK5GJ
M5YJES!I\PD9)#N@@9#N#C  )/ !YSR. 30!V]MK^D7<YA@U&W>3RC-M#CF,$
M N/5>1\PXYJKH>H6R:%->S>(8-3MDEE9KXE$C50Q^7*_+A>F?:N0\*75_I7B
M'2M*DU&SU_1Y;"5K#4D 6>VA79\LN."IP@#<$D<US]N]G-\%M3?[?% MOK,D
MJO\ >3<+O<BOCHAXR>P.><4 >K)XET-YVM_[6LTN%&6ADF"2 8W9VM@XQSG'
M2HH_%_AR::SABUS3WDO"5ME6X4^:0Q7Y>>>00/4CBN8\/ZCHVN>/;CQ!'K>C
MO.-,6T6SM;Q96(5R[2,2!TS@<=,Y/.*XNVFT^+X#Z5(DELCC6(WW!E!W"]//
MUV?I[4 >RZEKNE:1_P A'4+>V^7<?,<#:N<;CZ#/<\5)=ZI8V4$4MQ=Q1I,<
M1'=DR'&?E Y;CGCM7FUSJ^D67C/Q3IGBG5)M/@U'RY;5V<+%<VYA5"JM@\@A
MN,_Q'%.LKJP\,?$#0X[QI+'0FT$VVER7S$!)/-W,K,WW6*!.N#@ =>* .B^'
M^N76N0^()+C4%OXK;5Y;>VF55 \D(A4#: #U/-=%?ZUIFEL5OKZ&W(3S&\QL
M;4_O-_=7W/%<A\,[NSN+KQ@MK-$X;7YY0(V'*LD>&'L2#SWJKXQ-Q::]JFIZ
M'K-I%J%OIZ?;]*U  PWD WE2#G*GEQD<<\X[@'=IK&FR7S627UNUVL/GF 2#
M>(^/GV]=O(Y]Z;#K6EW&GR:A#J-K)9QL5>=95**0<$%LX!!XK@TUBTLOB3H6
MJZH4TJ"]\,%(UNG"!)/-C<Q9.,L!VZ\5R]KJT=GX?@U,EY-.T_QA<3ZBBJ=T
M4;.^QW7J K%3R.H'I0!Z/XG\1H_@C7[_ $#58UO-.MI)"R!7:-U4L RL.,^X
MZ5>T'Q+IFH1VFG_VK:S:M]DCEFMUD7S,E022H]S^&:Y7Q/J7AK4?!OC/5=&>
MWF>YTQH[F_B;Y)6$;!$W="P!Z#ID9ZBJ\L]C#XA^%ODRVZ+Y-P!L90,&U_JV
M/QH [[7[B.VT*\>75HM)S$RK>R%<0L1PWS<''H:B_M_2;"*T@O=:M//D@\U6
MEE5&E4+EI-O88!.>@K.^([QI\-_$9E95!T^8#<<98H<#ZYKE[F>PG\5_##?+
M;R#[)<,N64\_9TVG\QQ[B@#K=2\<:#8^$[KQ'%?P7=C & :!]V^0?P#'?/Y=
M>E:(U[3/[.BOFOH!!+PK!P0S8R5&.IX/ ]*\HU62*;PM\6(;5TD(NS)LC(/_
M "RCW-@>X.3[&MG6_$>GVOBKP[K%SJ<D7A^XT^6UCU"V;,4<Y9&^9L$ $+C/
MJ#Z&@#N_^$FT+[):W?\ ;%C]GNY!%;R>>N)7)QM7GDYXQVJ&'QEX9N!&8=?T
MU_,+A-MRG.P$N>O0 $D]*\X\0P^&K?PUI\NFS>9I][XIMKF2>XDREPQ<>8Z9
MXV=0<<<&N@\5IIL7Q%\"1E;1%:YO)2N% +&$X;ZEL<^N* .PL_$.C:AI<NIV
MFJ6DUC"6$MPLHV1E>NX]L>].M-7L-6^T0:??QO/$!O"$;XMP^4E3Z]1D8->6
M7VJZ98K\2'N+:&^M1J-H6@\PA 66(;VV\[0W)Q_=Q6MH.JV;_%Z]D.L07OVC
M1(BD\858W*RN6V8X*@=\MCD$\4 ='\.=5O\ 6O ]G?ZG<?:+QY;A7EV!=VV>
M11P  .% K;U'6]+TG_D(7T%O\I<B1\84=6/HH]3Q7*_"&:*;X<V0BD1]MQ=;
MMK XS<2$9_ @_C6:NO:5HGC_ ,6Z?XJGBMHM22![22YXCGMQ%L:-3[,6^7N6
M- '?W.K:?:6\4\]Y"L<W^J.[/F<9^7'WN.>.U02>(]$BTI-4DU:R6P<X6X,Z
M[&/3 .>3GC'6N(MIK?1?B3HCRP&PT.?0C:::)OE6*42!BAS]UFC"G!YXQU%<
MUXFA2#P=\1KM'C&D7FI6[6?(V22!HO.9/4%\\CNI]* /7+;Q'HMY>7=I;:K9
MRW%FI:XC2928@.I/H!W]*RM*\?\ A[4]&GU5M2MK6UBFDC+3RA#A7*@D'!&[
M;D#K63>36,7QA\/);RVZ!M(N8U6-@,KNC*@8[<$@?6N)N;^R'P$\1Z>]Q%]L
M@NKA98"PW1L;LD!AV)'('?!QTH ]AB\1Z+/'>21:K9NEG)Y5RRS*1$_]UO0Y
MXQZ\5);:E9ZQ;W"Z;J$;21GRW:,AFA;'\2GH>^"*XOQDUOINH>$-6@C@70HM
M0#7DL*C8N8BD,C$<;5)ZG@<59ME27XO7>K64\?\ 9Z:*L5],CCRS-YN4!/3<
M$!/L"/44 :/PYU:^UWP!I6IZE/Y]Y<([2R;0NXB1AT  ' %;6H:WIFE';?WT
M%N=F\AWP0G]X^B^YXKEO@_+')\+-$\MU;:DBMM.<'S&X-0:)?Q:;\0_&%KKD
MT4#W7D7%J]PP5);98]I"D\$*<Y'JQ]: .ON=>TBT:T6XU.TB-YC[,'F4>=GI
MLY^;KVJ<ZA9B]:R-U$+I8_-:$N-P3^]CT]Z\NTWPSJ-Q\'$6W5TOK"[DU+1U
M<'<BI*SQ+@_WER,>CBM+5I;_ ,1_#'6_$%C:S"ZU2T1H+?'S_9DP=GON!E;W
MW@4 =K;>(]%O)Y8;?5+5Y(H_.=1*,B/^_P"Z_P"T.*99>*-!U*[AM;+6+*YN
M)T:2*.*96+JK%6(P>0""/P-<EH6I>$/$NN:3K%AJES?ZA:0R%0TF/LD;)A_-
M   &0!@]^1W-/^$$6GR> [.:!+9YTN+K<Z!2RYF?OU&5"_@!0!K^-_%*>&[&
MRC2YBAN;V]@ME9R,QH[@/)@]=JYZ\9QFJ^DO/#XH59?',5_:RQO+;Z<T</FE
M"!\S.N"54@X.!UY)JM\3[JWM[/PWYT\<?_%063?.P' DR3] *;J]S:_\+B\,
MCSX=S:;=C[XR<F/'YX./QH Z!_&?AF,1EM?TX"28P(?M*X9QC(!SVR/SJYJ&
MN:7I3!;^^A@;89-KMR$'5B.RCN>E>0W$FGM\+/B2ZO;%GUB]^8%<M^\!3Z\\
MC]*W]4US39?$5Y:"X@LKJ30H_P#2V.^6^0[RL<(.5.#G) 8G=@8QF@#OI]?T
M>U:V6?5+.,W2[X TZCS5P6W+SR, G/2ETS7-*UJTDNM,U&VNX(F*220R!@A'
M4$]O6O)-,O--NM#^$Z//;R".;8X<@@%8&&.?1L#Z\=:D\0--<7'Q4@TK$]Q_
MH$C00MEI$"+YH '7*A@?RH ]5M/$&CWT\D-MJ5M+)''YS*L@SY?]\>J_[0XJ
MGH^J6<&A27MSXCM]2MA<2 7I**@RY C!7@XR%'<FL_1_$'A+Q/JMEJ>E-!>7
ML5LP\Y!\UK$W)5^RY( P>>N. :X32=8TRP\ 6<DR6LJ'Q1(L=Q,Y\FS?SW9)
MGVD< #@$@'(YQ0!Z?>:Q!?\ A_5+C1]1C,]M%("\8#&&15SAE/0].".],\%7
M]UJO@C1-0O93+=7-E%++(0!N8J"3@<5PNBZE9#7_ (C@ZFESYEO!,LS;5$B_
M9L%Q@ ;<X /0\<G.3UWPWDCE^&WATQNKA;"%3M.<$* 1]: -&7Q9X>AN?LTF
MMV"S"9;<I]H7/F-T3K][CI4S^(-(BU%+"34K9;J1_+2,R %G_N#_ &O]GK7'
M^&$TZ[^)GCI2+6:4363*"%8C;".1]&'YBN:\.76@:KX9M/#OB*^OO[>LKK$N
ME[RLK7*N6#I@9().[=G R23B@#TR\\8^&M/$IN]>TZ(12"*3=<+\KGG:>>N.
M<5H7&J6%K:Q74UW"L$V/*?>"),C(VX^]D<\5Y_I!T)?'/Q#CU;[$$+6_FB?:
M/W)MUW=>WK^%87A&._\ #5WX";7M\-@=.NK>)Y^!!-))OC#D_=8Q!5&?<4 >
MJGQ'HJZ4VJ-JMFM@A*M<-,H16'522>#[=:R-6^(?AS2X&9=3M;F9;F*U:**4
M$H[L!\V/N@#))/H1UKA/$D2)IWQ1OX)(QI-U!"D3!AY<ERL>)"G8G.T''4@]
MQ6WXT73[;P!HM];K;QVJ7^G22SQ@!1&LBC)8=@/RH ZU]2M;CQ%IXM_$4"J8
M)'.G(48W .,29^\ N#TX.:63QGX9B5&?7]."O,8%;[2N#(,97.>V1GTS7-ZI
MJ%C<?%GPC+#<PNLEA>[6##Y@?+VD>H.#CU[5R<TFGM\-/B:ZO;%GU:]^8%<M
MRI3Z\YQ^E 'L-YJ5EIYC%U<)&TF=B'EGP,G ')P.OI2:?J^FZO&TFFZA:WB+
MC<UO,L@7/3.#Q7GNJZYI^B>-/#^LS:K9KY^B/ R7<_E1E-Z,&23!!8MP1Z#.
M>!G0\*:IX<\(>!_M=SX@T^6TDO9#)<6TGF11RRN6$:D<X&>X'KQ0!WU9J^(-
M':^2R&I6QN7<QHGF#YG'50>A8=P.14NK+=3:)?+I[@7;VT@MV!Z.5.TY^N*\
MGN)8-8^!FFZ38L%UZ$VUM#;9Q/%>1R*&.WJ",,Q/H2>E 'IMUXL\/64\L%SK
M=A%+#(D4B-<*"COG:IYX)VGCV-:TDD<,3RRNJ1H"S.QP% ZDGL*\_P!$33KK
MXN^+HIQ:SS?9+$!6"L20'+<>Q"9].*T?B@;I/!$T]O#)/';W-O/=0QC+20)*
MK.,=Q@<^V: .ALM<TK499HK2_MYI(5#R(KC*J>C8_NGL>E,M/$6CW\YAM=2M
MI9/*\X*KC+1_WU_O+[C(KEKSQ#X1UBTU37=.MX]9FBT>5+A[8G/D8W>2Q_A+
M'/'48)KF]-UC3Y_&O@*XBU2UEA>PN84BMA^Z@)CBVPJ>6+#H0Q)X!PN<4 >F
M-XDT-=-.I-J]D+$.8S<F=?+# XV[LXSGC%27^N:7I;,M]?06Y5/,?S&QL3GY
MF_NC@\GCBO&=2U2QM_A'XOTB6ZC748]5N"]KG,BC[4&#%>H7!'S=.>M=-XKN
M&CU+6-:\/:W9/+'8H=1TF]PT-[ %8JR,#E20S+D<$]?< ]!U#6M-TJ-9+^]A
M@5E+C>W\(ZMCT&1D]!FGRZMI\-C%>R7L M9MOE2AP5DW?=VD?>SVQUKS:7Q!
M::=XYN)?$EW<Z+:ZKIEJ]D\C!8P%#>9"S$$!@SYQQU^E0Q/I7A7Q%X+9/.M?
M"JP7<5I-=L=L<SME69F^Z&7.W/9CTYH ZGP;KUSK'B7Q5;OJ2WUE9W$"6K*J
M@(&CW,O '(8D<\\5TU]JMAII47EU%"6!8!CSM'5OH,C)Z#-<7X(O["Z^('CG
M['<P2+)<6LB>4P(<>0H+#'49[U)XNBN/^$GCN]#UZWT[7;:PW&VO@#;W<!<G
M!Y!4AEY8=,CUH ZV+6]*GN;:WBU&V>>ZB\^",2C=+'C.Y1W&"#D4ZVUC3+NW
MN;BWU"VEAM69)Y%E!6)E&2&/\) .3FO-AK=LNM?#C6]0ABT:SDT^ZCVS/LCA
M8QQ[5W'  (4XSU%8MSJ._1/&%S9AKF&V\4Q7MW;H#ODM5\DL=O4J=N?H#0!Z
MI=:[9W^E:FND:I#]LMK=I/DPS1_*2K%3V..#C!K+\%^+[+4M T&WU#6+637+
MRRCF>$R*)'8KN)VCVYQCI4+ZUX5UM=2UG29K:ZN1I4D4U_&?ECC^\L;'H"22
M<=>#G'%<=!/8P?#_ .%K)+;QL-4L]Q#*",QN'S^)YH ]GHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBL7Q7=VUGX>N7N=<&B*V M[E=R'(/RAL@DXQC'>@#:H
MK*O?$NB:9=M9WNJVL-RD7G-$\@WA,@9([9) 'KGBLS5_'FB:;X4'B""Z2\M9
M'$4!AR0[EMN#Q\N#UST^O% '445G3Z]IEM:Q7,MT!'*&:,*C,S!?O$*!NP.Y
MQQ4#^+/#T=M9W#ZS8B&]!-L_G+B4#.2/88.3VQS0!L45S\/CGPM<11R1:]8N
MLD;2KB49*J=I..HYXYZFK=OXDT6ZT7^V(-2MWT_.WSPWR[L[=OKG/&.N: -6
MBLC^U[75=/U!=,ORES;*5DVIB2!]N1N1QQQSR.:H_#_4;O5_ .BZA?SM/=W%
ML'ED8 %F)//'% '2T5F:CXATG279;Z^CA**'DSDB-2<!G('R G/+8'%2WFL6
M%@L1GN5!F4M$B NSJ.255020,C) P,T 7J*R9/$^APZ9;ZB^K68L[E@D,WFC
M$C$XPOJ<\8IMKXJT*^>]CM-4MYWLEWSK$VXJOJ .HX[9H V**Y71_B!H.J:#
M!JTM[%:0SRF.-9VVLV7*H #U) !P,XS6E;>*M"O+*2\MM4MYX(YS;%XVW9E'
M\  Y9N>@SF@#8J-[>&25)7AC:1/N.R@E?H>U8]YK$&H^&M4N='U$":WBD'F1
M@%X9%4G#*P.#[,*;X)O;G4O VA7UY*9KFXL89)9&ZLQ4$F@#<:-&=79%+)]T
MD<CZ4ZLS4/$.DZ7(Z7M]'$8U#2D@D1*>A<@80'U; IT^O:5:W]I8S7L2W5X,
MVT?),PZY7'7CGCH* -&BJ9U6Q6YN;=[E$DM8Q+.'^41H<X8D\ <'GV/I56#Q
M-HMQ)<QKJ,*/;1B69928RD9Z.0V/E_VNGO0!K45CZ;XKT'6+U;/3M5MKFY:'
M[0L<;Y)CSC=],D?F*R?&GBE=$N=&TY+CR)-0O4BED"Y:.'#,Q'!&3MQ^)- '
M6D!@00"#V--6&)3E8T!]0HKD=";['XCN(+GQLVI8MGGCT^5(U:& LI#NP&21
MG&3C(/3C-:2^-_##M;*FN63?:I#%"5D!#MN*X!Z=00#T)'% &_4<=O#"'$<,
M:!SE@J@;CZGUK/U'Q'I&E2R1WM]'$T2"27@D1(3@,Y .Q20>6P.#27GB71-/
MN4M[O5;2&9XS,J-*,E ,[OI[]Z -".V@B+F.&-#(<N54#=]?6L?Q)HM[JEA!
M'I5Y#9SP7*7&V6'S(IMN?DD4$';G!X/4"K=CX@TC4M)?5;34;>2P3=OGWX5-
MOWMV>F/>F0>(M(N_M21ZA%&]J@><2_NVB4]'(<#"GL>AH SM/\/WDM_;7VLQ
MZ0LMJS/$MA;%26*E"6=B21ACP /J:Z+R(<8\I,?[HK$TC5K"R\+V%S/KW]I1
M2'RX[YP-URQ8X"JH^8\$  <XJKXDUY;CP#KNJ:%J>R:RMIV$L2J6CEC4DHRN
M#@\#((SS0!TKV\,I0R0QN8SE-R@[3ZCTHE@BG39-$DBYSM=01G\:IZ%/)<^'
M=,N)W+RRVD3NY[DH"35.+QEX;GO(K2'6K*2>6X:VC1)0VZ4 $J,=\$?GCK0!
MM*BH"$4+DDG QD^M,DMH)G5Y88W9#E2R D'U%9Z^)-&?48[ :A#]HE++$IR!
M(R_>"MT8CN 21BJ5SX]\)VB[I_$&GJOG&WW><"/, !(R/3<,GH,T ;\D,4I0
MR1HY0[E+*#M/J/0THBC"% BA#G*XX.>M5;S5;&Q2)KBX4>=_JE0%VDXR=JKD
MMQSP*J2^*=!AT==6DU:T6P9MHG,HVELXV_[V>,=: --+>&.$1)%&L2]$"@ ?
MA2^3%Q^Z3CI\HXKE-1^(WAVSEMX8+^*[FEOULF$.6$;'EBQ [+DCU/3OB^NI
MV,GBH[/$*933S(^FY7:J[@?.;C<O! Y(&#0!O,JN,,H8>A&:;Y,7'[I..GRC
MBL./QOX8E>T6/7+)S=R&.#;)D2-N*X!Z<L"!ZD<9K0O]:T[3)/+N[E4D$9F*
M!2S+&.KD*"0H_O'B@"X(HUSMC49X.!UI'@ADA\EXD:+&-C*"N/I5?3M5T[6+
M<W&F7]K>PAMIDMI5D4-@'&5)YP1^=95CXOT[4/%FI:!$S>?8I%N8J0&=]Y*C
MCL$'/O[4 ;QAB*JIC0JHPHVC %!BC8@F-21T)'2LU?$FC/>QV@U"+S99#%%G
M(61QU17^ZS#!R <\&I->>>+P]J,MK</;SQVTCQRHJDJP4D<,"#T[B@"]Y,6&
M'E)AA@C:.10(8AC$:#"[1A1T]/I7'>#?&VE7^BZ#87VMVTFNW5A#))$T@#NY
M0,?;=SG'7VKH-1\1Z/I,ICO[^* J5#LV=L>[[N]NB9[;B,T :2HB#"*JY]!B
MFR013,C21(Y0[D+*#M/J/2I 01D'(K@?B#XL2QT,'2-8:"\2^A@/E(&60F55
M>/<5(W $D@'<,&@#NY88KB,QS1I(AZJZ@@_@:#%&4"%%*KT&.!5#4]?TO1\_
M;[Q(=J>8^06V)G&YL [5X/)P.*=<ZYIMHD3RW:%98_-0Q@R9CX^?Y0?EY'S=
M.>M %T0Q @B-,CH=HXH,,1SF-.3D_*.3ZUAW.J6%UK.@^1XA6%K@/-#9QE3]
MN0QD@X(R !\V1BK=[XCT?39)4O-0AA\DJ)G8G9"6^[O;[J9XQN(ZT :1C0QF
M,HNPC!7'&/I38X(88A%%$B1CHBJ /RK)?Q?X<C:('7-/)EC:5-MPK;D7@MP>
MF>/KQ5BQ\0:3J6DMJEIJ%O+8IN#SA\*A7J#GH1[T :"HB#"*%'L,4V6WAGV^
M=#')L.5WJ#M/J,U3T_7-,U2>X@L[M7GM\>="P*.@/0E6 (!['&#7)>)O%BG6
MO"T6CZPVR[U5()HD0;+B+#%BK%?F (4$J<<\T =[2*H50J@!0,  < 57U#4+
M32K*2\OIU@MHQEY6SM0>I/8>]0MK>F)=V5JUY$L]ZA>U0G'G +N)7UP.?I0!
M;2W@BW^7#&GF'+[5 W'U/K3E1$SL15SZ#%8,OCKPM!&TDFO6(C6<V[.)00)!
MC()'IN7)Z#/6M2_U2RT\1BYN-CS9$2*I=WP,G:H!)P.3@<4 6FC1\;T5L>HS
M2>3%D'RTR.AVBN+\!^(GO](U^^U'5A=6UKK%Q##=2[5'DKMV?= '?TZFN@C\
M4Z')!>3'4[>)++'VKSCY1AR,C<&P1GMGKVH T_(AQCRDQ_NBE\F(,K>6FY00
MIVC(!]*S=,\2Z+K5S);:;J5O=31Q),Z1MDJCC*G\:2\\3Z'87DUG=:K:QW,,
M7G20F0%U3(&2!SR2 !U.>* -+R(0%'E)A1@#:.*<L<:MN5%!/<"L(^./# M[
M.X.N67DWA @?S.&YV\^G((YQR,5?&N:8VM'1Q>1G453S#;<[PG]['I[]* +D
M<$,(8111H')+!5 W$]S08(2C(8HRC=5*C!J&UU&TO9;F*VF$CVTGE3  _(^,
MX/O@@_0CUJO?Z_I>F/(EY=K$8U#R':Q$8/0N0,+G!QG&: +_ )49+$HN6 !X
MZXZ4Y45!A5"CT Q5)=9T][ZYL5NE-W;1B2:  [U0]&QC)!]JJCQ9X?-I:77]
ML68@O)#';.90!*P)4A?7!!SZ8H UEBC5MRHH;U IOD0^?Y_E)YV-OF;1NQZ9
MK-T;Q-HGB$7']D:G;7GV=MLHB?)3TS['!P>AI;?Q-HMU>BSBU&$SM&944DJ)
M$'5D)X<#N5R* ,O1/#=U9^*->U6_2REBU*:*:)5)9H2D83NHZ@9R,8]ZZ:6*
M.:-HY8UD1NJL,@_A6"/'7A9I(XTUVR=Y/,V!)-VX)]\C'88//L?0U>3Q#I,F
MDQZK'>QO82,%2X4$JQ)P,''.3Q]>* - 0Q"-8Q&@1> NT8'X4ICC,9C**4/!
M7''Y5BV-]:2^(]7\O7UN?(BB\ZQRFVS^]R2.06P<@GC%6;?Q%I-S(R1WJ!EA
M,Y\P%!Y0P-X+ 97D?-TH T#%&6W%%+>I'-)Y$.,>4F/]T5BZ%J-E!X5@O9=?
M74K4%_\ B92E5$G[P@#Y0 <'Y1CK@5;M_$.DW,=TZ7\*BTP;D2GRVA!&075L
M%01W/6@#(U70=<;7WU'3+O39K>6!(6L]1MV98MI)W1LIXW9Y!'.!SP,3P>%8
MVL;R*\-L);_:+K[);B)"H! 502<'D_,23SQCC$UOXS\-W=U9VL&LVDDUX,VZ
MJ_\ K/I[G' []JW: $5510J@!0, #L*8+>%9VG$,8F88,@4;B/3-8>O^+M/\
M/ZII6GW3-YVH2E%PI(10K,6) ]L8Z\^QJ[?>(=*TTD7=XD96,2OP6\M#T=\
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M9)E8>7+<*KY(/0E5*@GU.*Z+X<2QR_#CP[Y;J^RPA1MISA@@!!]Q73A0JA0
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M@\)ZBCP1V$>O6TLMPF/+5/+D4,2.,?=&?I0=0LF^-<$GVF)0WAQOOMM(S.K
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M&:,#J$&0<=P2<CUS6++<V:_'./S)H Z>'F7YF&5;SP<>QVY/TKO:* /#IY[
M_!CQRL4MOE]4N]H5AELS93'KD#(^G%=GXR+:?%HWCC3$-T^FX2Y2 AC<6DF
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M#)EH8O?:Y<Y_Z9"O1Z,#.<<T >9M<Z8WCOXA1WLH>V.D6XG2)AO9%CE\P#W
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M\5/WL):::XV<C,@-NJKCU^;(&.] 'I5]KVFZ>\23W!,DL;2I'#&TKL@QE]J
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M(W!]#V/2J_A6_P#"VOP:%8RV6I/X@TQHBUC/+<C['*@ 9SD[ H ./7@8R<4
M=[>^*M$T]IOM>H)$D$@BFE*MY43G!"N^-JGD<$CJ/447/BK1;5$=[Y9%: W(
M\B-IL1 X,AV X7/\1XXKRF_U'0H[7Q9X2OM<@L;6^U>25Y+N*59H@65GVC;M
M8$@[6W#@@D&NDUG7+&X\4W=I$WV=;C1D:VO+:'S9=14[B$1P"-JYR<#)W9R
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M%KK-E/.X4GRXUE&6..PJHNH64_QH@N1,@C_X1U@KR?+AC.&QST.W)QUQSTH
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MF:AI6G?%7QG_ &E<6T&^UL0IG8 ,HC?< 3U[<=Z .R?Q%I*V5G=K>I+#>_\
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M((Y(C),VTB+E?FC);!/0CO0!VE%8%[XTT&PU"ZL)KQVO+6,22P16\DC[3G&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYOV:V0R2&*-G( Y)P/Y]* +]%0VES'>V4%U%GRYXUD3<,'##(S^=34 %%%%
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M;3LQ;(&2",L1CT/XUT&@Z/J&G*\NKZU+JUZRA!,T"0JBCLJ+P,GDG))P/04
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M'AN?#X,<%PMNI\R,Q^605)(SM[^O:@#?U.VEBCN=3M(C=:C!:2+:1.<+NQG
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M87#YW;NN0.V,=N]5+3PA,;W1+K5=22^ET8,+>86WERN2A3+MN.1@DX &3@T
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MGB;0[?5[%95MIRX03+M;Y7*'(R<<J:G&I ZVVF?9+O(MQ<?:?*_<'YMNS?\
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MO.+GQ#KO@WQ9-:ZSJ1U?3+C3+B_B;[.D3PO"-S(-HY4@\9R>GXMU+Q'KFD>
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M0WEAJ&HW6BVTT2#2[_R$>U>0CYA*Q5MIW<<X&.:TSJ.H>(/$7B'2=/U)]/\
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M#7_"21ZIJ<.KK(^FY1[":X,7G\CYT<1?*0#T/7'6NEH **** "BBB@ HHHH
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MWD-RB PQ[<?*S9X)SQQV- '-7O@$W,WB!8-;NK:QUQ&-Q:I$A D:/86#'G!
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M*21@GCYA6O0!R?\ PAMPUUX?N9M;EFFT8LT;20+^]+)Y9R!C V],=^2339O
M-I?'Q(FHW3W%OKQ1IXU0)Y3(H5"AR<8V@\YY ^E==3&EC601EAYC*65,\D#&
M2!^(_,4 <]X>\,WVDNCZGXBO=8,"[+87"(@B'3)VC+MCC<Q/!/J:E\5^%8/%
M%K:@W=Q8WUE,)[2\MR-\+XQWX((X([U8\/\ B*V\1PWTEM!<0_8[R2RE6=0K
M>8F-V ">.:M3Z@T&JV=B+*[D6Y61C<QH#%#M X<YX)SQQS@T 9">%[MM U"P
MO-;N+R]OX3!/>RPH"$((PB+A5QN8]^22<U5O?!,E]X/T_P ./JS)!9&#9,L
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MBSM;A$ BXP-S ;G(' R<#TX&)+3P@XN-%EU+43?'1LFT<P!)"2A3+L"=W!Z
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M\7:U/I2Z1:6T@AFU348[(3D ^4&#,Q /&["D#.1DC@XQ71UC>)_#5EXKT?\
ML^]>:+;(LT$\#;9()5Y5U/8C^M '/>(]3UGP-H7B+69=034+*.&-K"&=?WD4
MC$(=Q &Y-S*?7J.*=K=]JOA75?#<W]ISW]IJ5ZFG7<4RI]^0';*FU1MP5.1R
M,'\:TX/!T,VCWMAKFHW>M&\A\B66ZVJ1'V"A  O/.>I(!)X&'67A/RFTP:AJ
M=QJ,>EG=9K,B@AMI4.Y ^=@I(!XZDXSS0!Q,^I^)I?#7C;45\27,<NA:A<BU
M"01?.L<:,%?Y>5Y/3!R223P!I7!NM2^)OA>X_M"Z@6XT>:<Q1E=B',1( *GK
MGD]>!R*VAX$B&D>(--.J71BUR:2>Y;8FY6D4*P3C@8 '.:GD\&QO>Z)>KJEY
M%<Z5;M:B2,(#/$P7*ME3C[HY7!Z].P!S^C7>O7FH^(KJZ\17(M-$U5P($MXO
MWT*Q*QC8[??@C!ZYSQBO=>(=<3X8P>.X=19KD(MY)8E5\AH2^#%TW A3][.<
MCT.*['0_#*:)=ZM.+V:Y&IW!N9HY47:KD!3MP!Q@ 8.>E9UMX!M+;2FT,7]R
M^@&;S5T]PI"C?O\ +WXSY>[G'7MG'% %.*4S_&431K@OX85E#<=;@D9JMX1\
M37&H:U::9JU]?6.O11.;W2[R)52<X_UD#!>5!!P >G7.,UTLGAA)/%K^(3>S
MB9['[ 8 J[!'NW>F<Y[YJ*S\)B*\TBYOM1FOWTA'6S>6-5?+)L)=@/F.WCL.
M<G)P: )?%=U<VFGVK6^HQ6*O>1),[*6D>,GE(E ;,C< #![UQK>(M<30?'Z)
M?74,VBCS;*2>.-I44P"3:W!!&>F><'GFNT\2^&X_$<-C_IMQ97-C=+=6UQ!M
M)1P".0P(((8\$5DO\/H'7Q K:SJ+#78ECNMWEG^#86'R\$@?09X XP 9UMJ.
MMV/B3P:9]9FNX-;@D6YMGB18T98/,5DP-P.0<Y)SGM63K>H7OBWX2^)-?_M&
M>")TNE@M8PNQ88V9-K C)9@I).>,C&,<]I)X/62[\/7+:G<[]#5A!A$Q)E-A
MW\?W>.,>M9DWPVA^QZQIMGK5_::3JID>6Q18V1'?[Q0LI*@]=H- '4Z6I;0;
M)5<HQM4 8 $CY1SS7EJZIXQF^&]SXLB\2N;K39KA_LS6T8BN(XYF!#\9SM'&
MW&,#OS7JUE;II>EPV[W+R1VT04S3E02JCJQ  Z>PKSCP!H@U[P+/I]UJ,AL)
MKZX:XLPBABIF9@N[J$88)[D$X(!H MR7NOZ_XV?2[+7[C3;2XT.'4(PD$;M"
M[2$8&5Y&!SGWQBKNFW^J^*X/$DMIJT]C+IM]-I]HL:(5WQ*N7D!4[MS$\< +
MC&#S6['X92+Q@WB);V82M:"R^SA%\L1ABP[9SDGG-5_^$06VU34[S3-3N;!-
M4.Z\AC564R8P9$R/D<CJ>0>N,T <[X;\:WGC&3P]9[VT]KS2Y;^Z:$#<[)((
MMB%@< G<WK@#GK5V\U'7]"ATK1KR_%[>:CJ4L$5U"J)(MNJ-(H.X!?,PH7.,
M<YZU<U3X?Z?=0:/_ &7=7.CW>CIY5E<VA!98R,%&# A@<=^_U.9-3\"V6K>'
MTTZ[O[YKJ.X%VFI"0"X6<# D! P.., 8QQ0!A:GKGB?PCI.N7=\1-:M) FDM
M=.C2QO(P1A)LP"JD[AWQP33M8TZXL_B?X(\W5+JZ#I? ^<$R'$(RPPHQG/3I
MP, <UMMX&MK[P_?:5KNI7NK->HJ2W,Y574*<KL"@!<'GH<GKGI4<'@B?^U-%
MU&^\2:E>7&D^8(&=(EW!U"D-A.>!R>I]J .9N?$NNQ_##Q7JBZK*+_2]2NH;
M>?RH\[(Y0J@C;M/'MFM75IM>OOB%'H5GK\UC:7&BO=9C@C9HY!(JY7(]^^>"
M<8)!%B]^&\%Y9ZWI_P#;6H1:9JT[W,EH@3"2N07(;;NP2,[2<>QK6B\*B/Q1
M:Z\=4NY+BWL_L6QUCVO&6#$MA1\V0#D8^E '-MJ'B37H-<BTBZNEO--N6LK:
M5#"L;2QHI+2JP).YB<@<!<8&>:;X@\3:IH]S;GQ!)>:78SZ?%MU#3XQ-!;WA
MW>9YF5)VYV;<C'7\-B\\!J_B.YUC3-<U/26OMOVZ"T9=DY QN^8':V.-PY_&
MKUWX7,HN8;;49;>RN;1;22U,:R($4%<KNY#8.,G(X''% &U9/YMA;R><D^Z)
M6\U#E7R!\P/<'K61XKNKFTTZU:WU&*Q5[R))I&4M(\9/S)$H#9D;@ 8/>JL.
M@W6G^(]'_LR_O(M)L;(6LEDQ!@,:JP0\\F3.SGL%.>HS<\2^&X_$<-C_ *;<
M65S8W2W=M<0;24< CD,"""&/!% '*6.N^));3QI9V2W-S>:9-%]ACN!&)PCQ
MJY7(^4D L5SD] ?2MCP5X@M==N=0:UU.\E\I8DDT^_B$=Q9R?/NW# )#?+W/
M(//:G1>!$@N]7NHM<U-9]3:"61\QY22+;AQ\O4[!Q]WDC%:NGZ EIK5SK-Q/
M]HU"X@2W:01A%$:$D# [Y8Y)/IC % &;JFL7%SX]L?"\%P]K&UA)?SRQ@;W
M<(J*2#CDDD]>!TYK#&I:G=6WCGPW?7TSOI$(D@O55 \D,L3.J/\ +MR,$$@#
M(]#S75:SX9AU75+#5H;F6SU2PW"&XC ;<C##(ZGAE/X$'D$4Q?"T*Z?JT/VN
M;[7JV?M=YM7>WR; %&, !> ,<>Y)) *OPYMWA^'V@L]U-.)-/MV59 N(QY:_
M*NT#CZY/O67I-O<-\8O$1;4;LQQV-HXB)0K@F3Y/N\*.O&#R<DUU>@:0-!T.
MSTI+F2XAM(EAB>4 -L48 .  >!5.3PNG_"5S>(+?4+JWFGMT@F@388Y-A)0G
M(R,;CP",]^^0#S/1KK5]$^%^G:[9:M+$EOJK1FR6)/*EC>]9&#D@L3\QP01C
MCC/-=A?:GK.N:QXATW2I+NW?3"D$#6[Q*/-:(2!W#Y)&6 QTP#U)XF'P[MQX
M.7PS_:UY]C6Y^TB3;'YF[S?-QG;C&_GI[5-J?@47?B ZYIVN:CI-]/$D5XUI
MLVW*J, LK @,!P#VH WM#?4GT.S.LI"NI>4!<B!LIO'!(]N]<+::MXK\1Z!9
M>(-#:599;@R"&62$6S0!RIC(P7!VC[W7=GH.!Z'9VD5C9Q6L.[RXUV@LQ9CZ
MDD\DD\DGJ37)V7P[@T[4;@V6M:E!H]Q,9Y=)5U\DL3E@#C<J$]5!&>G3B@#-
M:;7]2\3>---3Q%=6MOIT=O):F*&+>A>)GQDJ<KD<\9.!R.<IHWBW4?$">#]-
M:X-O<:GIK7][/$H#,$ &U,@@;F.2<< <8SD=)%X4$&KZ[J4>I7 EUA(TF4HA
M6,(I5=G'H3US68/AS;0Z;H<-GJMY;7VB I97R!"XC(P4=<;64CV_K0!7\#6\
MMKXW\<PS7,ERRW=K^]D #$& $ X ' P,]\5I:AJ]Q>?$&W\+0W$EK$NF-J$\
MD6-\G[P1J@)!P/O$XYZ>^;>A>%AHFLZKJAU2\NY]3:-IUF$87*(%! 51@X'T
M]J?J_AF+4M8L=9M[J6RU2R5HXYXU#!XV^]&ZG[R]^Q!Y!H Y&;4]3O="\?>'
M[^^F>;187,=XB(K30R0,ZJXVXR!P2 ,\=*ZCP';O!X%T/?=33[]/MV E"_(/
M*7Y1M X^N3[TYO"<!TC5[/[7,+C5]QO+S:OF/N39P,8 "@ #'&.YR:T=$TO^
MQ=%M-,6XDN([2)(8WD #;%4*,XP"<#K0!R6@6]PWQ;\6LVHW;)%!8D1,4*D,
MLIV_=R%!)(P1U.<UR/AV[U;1/AAX:UFTU:5(EU(0/9")/*DBDNF1MQ(+;N<@
M@@#CCN?3/^$76/Q3=Z];:C=6\MW!'%/ H0QR&/<$8Y&>-QX! />LM/AW;IX0
ML_#:ZK>?9+2Y%S')MC\PL)/, )VXQN/I0!5O-3US7[_Q%9Z1+=6\NFRBVMF@
M>$*)?*5]\@?)();&.F!Z].NTEM1ET2U.J"*+43"!<>0=R"3&&*^V:Y_4/ @N
M/$4FMZ;KNHZ3=W2)'>BT*;;D*, E64@-CC(KJ+>"#3[&.",[(($P"[9P .I)
MZ^I)H \I6_\ &%YX(UKQ!!XFD2YT>[NS'";6+9/'"YRLGRYY5<#;C\:W;;Q'
MJ7BJ^FM+(7EJL6FVMR1:/$KB2="^29.H4   =\YSQ6=X&T?^WO#>N6$NIR+8
M76JW9N+9%4,T;2$X#=0KKUZY!."*Z76? L-_K-OK&EZK>Z+J$4 MFDLMNV6$
M=%9&!!QV/;\!0!@3WOC*.^\%Z;J.JI9WU^UU!?\ V:.-U8I$S*ZDKPV,''W<
M]B!@Z4=QK.D^//#NBW.MS7UO-I]P\YDAC0R.A3#':,_Q=,XK3G\&PR7^AW<>
MHW:/I#2219VN97D!#M(2,DG)Z8ZU;O/#B7?BNPU\WLR2V44D,<*JNQE?&[/&
M<\#OVH XZ+Q!K6L_#2[\;V.I207$8N+J"T*(81#$[#RW&,DE4.3D')XP.*T]
M*\1W'B_Q";&">?3[2#2[:]D6+:)'DG&Y1D@X55';J3SP,&Y'X#MH+/4-+MM0
MN8=%OY'DFL%"X7?]]$?&51N<CW."*FO_  9%+X@@US2]0N-)O8[<6LIMT1DF
MA!R%96!&1V/:@#-^%221>'-2CEE,TJZS>J\A !<B4Y.!P,]>*L?;M0\1^(?$
MFE6>I2Z?_9210PF$*299(]_F/N!RHR %Z'#9SQC5\,>&8_#%I=V\5]=72W-U
M)=-Y^WY6=B3C:H_7/X50U7P0MYXD;7M-UF_TB]GC6&[-IL*W"+]W(=2 P' ;
ML* *B:KJUQXJTKPG>7RQW*Z2U_?W-HH'G.'$85-P.T9W$\9X'3FLU=1\3WMO
MXR\/6>IR?VOHC1R6-Z(HRTZ21F1(W!7:3P5) '8_7I;WP?:RW>EW]C<S66H:
M:C10W"X<R1M]Y) WWP3SGKGG-:&D:+!I+WDXD>>\O9?.N;B0 -(P4*!@<!0H
M  ]NYR2 86B:^_B.WT*\L;V=;?[%]LO0 A+$_*(V^7@[UD^[C_5D=ZQM.U/Q
M9X@T71_$.DM(&N)5GF@FEA%LUN2=R  ;PP'1NN0<\<#L= \-6'AM;];%6"WM
MT]TX;^$L<[5]%!S@>YK$TOX=P:/>.EGK6IIHK3&;^R-Z^2&)R5!QN"9YV@X/
M?(R* *6F-X@U;QIXCLCXCN(+32KVV:-$MXB71HP[1L=O0Y(R.??BJMAJOBSQ
M'H6F>(M&:17GF$S0320BV:WW$&/&-X8 ?>ZY![<#KM)\-KI.O:OJRWT\TFJ.
MCS1.JA5*+M7;@9Z#')-9&G_#N#2[^86>M:E%HTLQG;2 Z^1N)R0#C<$)ZJ#@
M]^.* *9U"]\56?B^2+49[*#3)Y]/MXH0O+1Q@N[Y!W9+8QP,#U.:V/AQ_P D
MV\.?]@^'_P!!%0S>!475]4O=.U>]T^'503>VL2HR2/C&\;E)5B.N.M;/AW1(
M_#F@6>D0W,]S%:1B-'GV[MHZ#Y0!0!YSI>GZY<V_C>ZT?7I=-EM=<NI8HT@1
MUE<1H<2%@3M. ,#&.2<\ :$?BG5FB\&>)[B\DAT;542"_M51-D4TB_NW#%=P
M0OP>>ZUT(\%K%+JZ6VJW<%EJ\S3W=NJH3O8!7V/C*A@ #UQV(JEXK?2KG3'\
M!6]C.T]U9I';QQVS^3"F=JOOQM&S;NZ_P@=2* -S0)[J^EU&_DNI)+.6Y:.S
MB95 2-/D+ @ G<X<C)/&VN<N;>XD^-ULHU&[2,:&\HB4H5'[^,%0"IP#@9/7
M@<UVUE9PZ?8V]E;)L@MXUBC7T51@?H*R;_PQ'>>*+37XK^ZM;J"W:U=8MNV:
M(L&VMD$CY@.1@^] 'FRRZMIWA7QWK6FZO-9R:?KUY.D,<2,LI#)D2;@201Q@
M;?Q[=I?:OJ*?$#PK:QWC+8:E:7,LUML7&Y$0J=V-W\9[]J<? $#:!KNCMJMV
M8-9N9+FX?8FY6DQN"_+@#@=0<5>?PH)=<T759-2N#-I,+PQ)L0+(' #%N,Y(
M4=,=* .<TWQ-=-XKBTC6KV]TO53>R[+>>-?LU]!EM@A?;U *'J#D$'-;OQ%U
M"_TGP#J^HZ9>/:7=M#YB2*BMWZ88$=Z</""R_8(K[49KRUL+L7EO')&H99 2
M5!<#E5W<#&> "2*T/$N@Q^)O#]WHT]Q+;P72[)'B W;?09! H YB]O-:T:]T
MNRDU>XOI==N/E CBC-LJ0L[K&2,?,0 -V2!GJ>:S/$5]XR\/^$/%5X]\\,5L
ML<VF3R>5).H. Z/@;2 3P>OJ:Z[7O"%MXBT.TL+N\NH[FS=9K:_@(2:*1> X
MP,=.HQBN6\>:,^D?"O7TNM4NM4U"ZA2/SKG:'?##:B(H  &2>!GDDT 6KZ\\
M0^&O&>@/<ZR^HZ;K,KVT]L\"(()-A96BVC..",$GCN3TIIX@UK5/AC<>.;+4
MGAN46:[BLRB&#R8W8>4PQDDJIRV<[CQ@<5UMCHD=Y=Z;JMUJ+:C]CC;[&=JJ
MJEAM+G;]Y\9&> ,GCFJ,7@*UM[&^TF"_N8]#O96DET\!<+N.71'QE4;G(]S@
MB@#%?4M=\0^,K;3[#7+C3+*_\/+J**L$;M"[2*!@E>>",YSWQC.18\(6MU'\
M1O&*SZK>7/V>2S4B39A]T&[D!> "QP%P/K71#PQ&GB^/Q#'>3))'9_85ME1/
M*\K=NQTSG(ZYI;7PS%9^+-0UZ"^NE-^(_M%K\OENZ)L5NF[[O;.,\T 87Q&2
M:6_\');S"&5M;0+(4W;#Y,O..]4HM2\0Z%XCUSP]/KD5XO\ 8[:G8W^HHB"V
M8,4*RE  5SALXZ5UWB'P]%KZ6+&ZFM;FPN5NK::(*=L@!'(8$$88\52O?!5E
MJMEJT6IW$US<ZI;BVFN1A&2-<E5C &% )+=\D\YH Q=$UO4AXZL-,-Y>75C=
MZ0]P7NXU0/*CH-Z<!@IW'@@#H0*@\,^*I[C5K>PUJ]OK#78(Y'O=,NHE$=QA
M3\\#!>5!' !Z9SG&:V[;P08M:T[5[C7M2NKRSMGMBS^6HEC8J<$*HQRH.1R>
MYJ>S\(K%/H\E]J,U^='5A9M+&JODIL)=@/F.WCH/4Y.#0!SNG:EXMUW2-$\0
M:8T@-S(D]Q!-+"+8V[?>10!O#*,8;KD'/I2W.H7OBOPYXRNTU&>T@L9+JQMX
M8@N/W289GR"6W$GCC QC!YK3TGX>0:+=M'::UJ:Z+YIF72"Z^2K$YV@XW;,\
M[<X/?/-/F\ QK>ZQ)I^L7MA::P':]M(E1D:1EPSJ64E2>^.OMQ0!H>!/^2>^
M&O\ L%6O_HI:YJWUG6/$7@[6?$MAJ<MI/;37)L[<(AC"0D@+(",DOM.3GC=Q
MC%=IH6DIH.A66E17$UQ%:0K#&\VW=M4  ': . /2L8>!X8/[5M[+4;FUTW59
M'ENK-%4@,XPYC8C*;N_7VQ0!@6_B#6?$/B'PPMMJ<VGV>L:,]Y+"D4;&)QLY
M1F4\_,>N1[5N^ =2U"^T[5K;4;MKR73=5N+%+AU57D1""I;: ,X;' [5;;PG
M;KXATW5K>YEMQIUJUI!;(B^6(SC(Z9_A&.>U3>'?#B>'CJ1CO)KC[?>27LGF
MJHVR/C=C '' X- ',^,?$=WHNMSQ:C=7^EZ5-:HMCJEM$LD,,Y+!O.^4D?P8
MR,8SWYK0M=4OY/B7)I U%I=.DT)+Q%4(0LAE*;E8+DC [DBM+4_#<FHR:DO]
MJ31VFHP^3<6QC1U V[2R9'#$<9.1P..*K3^"H1J^GZCIFI7>FR6ED-/*PA&$
MEN""J'>IP01]X<T <SH_B[5KC0M#M;B^9KW4]9N;$WC1H&2*)I#P -NXA HX
M[YJYXQL=6L/ WC1+W4Q>6$EBSV*R*/.B&P[PQ  8;L$=^>:M_P#"LM-/AG^Q
M3J.H?N[UK^UN0ZB6UF+%MR'&>K'[V>M79?!9O/#FH:7J&MW]Y-J$7DW%Y($#
M^7S\JJ%VJ.3VSSR: ,>SNM7TCQ7X1M7U:6ZL]8M)EEMGB18XC'$KJ8\#<.X.
M2<UZ%7.2>$EEU/0+]]2N#+HJ.D(")B0.FQM_']T=L5T= !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>;\4"3_Q\#]UD?ZT?9@GR_WOFXXSS0!WMUXATRT-JK7#2R7<9E@CMXFF>1
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M Z>H>ZCGADBDB4C(8HRAB".X&*?HWBO1?$%R]OIEYY\B01W!'E.H\M_ND$@
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M*KN; *Y8D8P!GKGM6YJ7BC3-*CEDN&N"L$8FN#%;22>0A&<OM!V\<X/..<4
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M0"<!6.2!@"H-:\>6>FV6FW%O;7<_VW4DL/\ CUD'EGS-K[AC.0 V!C)/0$4
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MC+P72EG/DNN"K$$9Q][Y^ :]!HH S/#\]Y-X:TV?4[5+.\:UC:>!!@1-M&5
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M8FM9-RA+@LQQC) '.>GO7J_B*UN-3\*ZK:6#XN;FREC@;./G9"%.>W)%:E%
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M@>,;)M,OX;R*_!AM+2R=8YHE>/%P[JN)&8 ]2<8''&:]HHH X.*Y67XP+?\
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MD<!BRX.,$;&SG&-IKG-1OKR+Q'HUM<:->6>FRV,GSZ?;%Y%D+C;;L\8)B7:
M200"1][ -<YH6EPW'P]T?2-9T_7-/FM]0N2EY!%(DMG+YDK*^0"=I5L%N5^;
MKUP >EIXCL'L/M9$Z9G-LL+PL)6E!(*!>I/!]L G..:72/$-AK4][;6YECN[
M%PEU;3H4DB)&5R.X(Y!&0:\WNX?$PT/2]5U*SGUM-'UB4N(H/+GO+0QF,3>7
MP2XW'CN!GH<UVOA1M,O)[O4],T*;3XYE1&N+FW,,MP1GC:WS;5&.3UR<=* -
MB_UFUL+F&T82S7DZL\=M FYV5<;F] !D<D@9('4UB:MXSM1X'U;7-):2:6TB
MG79Y+;H9D4G;(I&5P0,Y_K5'4TNM&^*=OKL\$\NDW>E_8&EAC:3[-*LF\%@H
M)"L#C.,9ZUD76E74?ASXBZDEI=[-<$BV5JMNYD?$&S=L W#<V>H' !/6@#HO
M"&GI<0V.NK=ZLLTMBD5Q#<R/Y<[D*WF[6SSU *X&#BKNH>-='TU[SSY)C!8R
MI#>7$<1:.W=L8#'_ ($N< XSSBK?AA]WA?2P8Y8W2UB1TEC:-E8( 00P!KS+
MQFVIZOHWC33I-(U1;M9O]#M[.T=89XALQ,SJ )7.#\I)Q@87@F@#T6_\8:3I
MVM-H\INWU 6YN5@AM9'9TR%^3 ^8Y/;.,'.,5=T/7+'Q%I4>HZ=(SP.67#H4
M9&4D,K*>0001BN3CFDF^+-GJ/V&_CM#H#PF5[20*KF97"DXP#M!.#R.AP>*L
M_#6.:'2-6CGM;FW9M7NYE6X@>(LCR%E8;@,@B@#6U3Q?I6E37T<QGD_LZ)9K
MYH(BXMD;)!?'L"<#)P,XQ1?>,=&T_4+.QFFG:XO86FMEBMY'$J@ _*0/F/(X
M&3S7%^+I=0O[CQII<FEZD"VG%=/%E;.$O"83EI)5'S%6.T(6QC@!B:FM&GF\
M3?#Z?^SM0CCMM-N(IVDLY (F:.-5#''RY*MUQ0!TC>/]!C\-76O2R74=I:3-
M;W*M:R>9#*" 4=<94\CKQR.:MVGB[2[W6I-)B^U"[6 W$0DMW1;B,'!:,L '
M&2.GKD<<UYKK%M>3^"?B):Q:9J3SWVK&6UC%E+F9#Y0W*-O(^1N?:NOU)WN/
MBGX:NXK6\:V2QNDDF^RR!$9]FT,VW )VGK0!JGQQHB^'!KYEG_L[SC TGD-E
M'#^7@KC(^;CI4VJ>+-,TJXO(9?/F>Q@%S>""(O\ 9XCG#-^"L<#)P,XKR^[6
M]A^%VM>&AH^J2:G#J;.T:6;E60W@D5E;&&!!Z*2>^, FM_Q+=7VHZEXGT]]*
MU-8IM+ T_P"QVCK]L8Q-GS9  05)P$8@<G@D@4 :OBB],OB+P/=V-[/]FO+T
M@B*9A'-&87925S@]CR*Z[5-3M='TRXU&]9UMK=#)*R1M(54#).%!->;_ .DR
M:=\,S_9NHK]C>/[2#9R9B MRA+ #Y1N..<>O3FNX\8AW\%ZW%'%++++83QQQ
MQ1L[,S(0  H)/)% %:Q\<Z+J$4DL+70B6*&59'M9%642\($./G8GC SS2MXW
MT:)=3^U-<VLVF1":Z@EMW,B1D9#@*#N7@\C('?%<MJUEJ,_PN\+SV>F7-S-I
M+6=Q<Z>T;1RRI''LD0*0#N&21_N\9HOIM*U/P?XHU33/#US8'^Q+F*2ZO;8P
MRO\ NR1& W) P23TSC&>< '1V?Q!\/WNJV.GI-<QO?INM)9;9TBG.,E4<C:6
M'L>O'6K=_P"+M+T\7<DAN)+:R?9>7$,+/';M@$AB/0$$XSCOBN.:#_A*/#?@
M2QL8)_.L[BRO)Y'@9!;I$F6RQ &3PH ZYR.!FG:*+G0M#\4>'=4L+R:ZFNKN
M6U,=N\BWL<V2N& (SDD$$C'?CF@#K-3\;:)I-Y;6DTMQ+/=0-<6ZV]L\OG(H
M!.PJ,,<$<#/KP*H:9XW@USQ3+H\-A>K;?88K@2R6[H6\W.,CJH '4XYSZ<\]
MIFD7FA>(_A_8W,%U,=.TNXM[F>.W=XHY&6/:"X& ,J0.>U;<*W%C\7M0FDLK
MMH+[3+>.&>.!FCW([[@S@;5P"#R1GMDX% &EH.KR+XBU;PW=RM+-8B.>WE<Y
M:2WD!QGU*L&7/<;2><TGB7Q7_8.L:)IRV5Q.VHW#(SQQ%@BJC,<8ZL<#CTR?
M3.9I]N]S\:-9OXP?(M-(@LY#V,C.TF/J%Q^8]:D\<)/%KOA+4DM+JXMK/47,
MYMH&E9 T3J"54$XR1SB@#,M?$*:)\0?%YNY=3N;=+:REBM8UDN&C!60N509V
MKTST'0>@KK#XLTE[72YK:5[HZJA>RBA3+S*%W$X., #KG&.G6N<TN22+X@^,
M;N:ROHX+BSM%B=K20JY1) X4@$,06 X)]LUSWAVXU'3/#?@BPN]*U."U6":*
M[GAL)&N(9!C;'PI:-6SRP'.!R.30!UNM_$"RL_"(US3H9[H27(M OE,#%)Y@
MC82 \C!XQW.,=<UUD,JW=J) DL:R*?E=2CC\.H->.C3]1_X5GKEFNCZFL]OK
MYNO*>!FD>/[4KY7J9,*,DC.?4U[#;72W-FET(YHT==P66,H^/=3R/H1GU /%
M 'G'A#QE9:)HEZNL75_,J:S<V[73I).L*^<4022<A1T')[BNSU3Q5INE7-S;
MR">:6TM_M5TMO$7\B+G#-_WR>!D\'BO,[JUO9?@]XJL4TS43>7&J3R0P?8I=
M\BM<!U8+MR1M&<UN^(KR\U#6M>L'TS4UMYM+7[ UG:.OVQBCY$LH *[20 C%
M1R<@Y H [1_$5@5LC;&2[:]@-S ENFXO"-N7YQ@?.ON<\5=T^_@U/3X+VVW^
M3,N]-Z%6Q[@\@^QKS"#3H-1\,>$XK@:WHFJ66EJEOJ<%O(IA=517CD7'*DC@
M-C=M..O/>>#YM6G\*:?+KD2Q:DR'S@L>S/S'#%?X25P2.Q)Z4 4)_B)H$-OJ
M$X^WRIITQAN_+L9282 "S,-N0H!ZGK@XSBK4/C31KC5[+3HY)RU\";6X-NX@
MG(7<520C!..>/YUQ]NEQ_8?Q*C-A?A[V>Y:V4V<N9PT"HI0;?FRP(XIUREP=
M/^&H%C?EK.6%KD"SES"!;E#O^7Y?F('- '72^-=&AG*M),8%O1I[W2Q$Q+<$
MXV$_4@9Q@'C-0P>+?/\ '=WX=%C<A+:VCD,QB.&9V(S[* O4]3GTY\_UZ74M
M4T6_6XT;5DOK77(Y3:6UG(L"PK<*?,&T8F9A\Q/S'))P!74A+I?B;J4C65]'
M%JFCP103K Q1'#/N#,/E4J&!P3],G% &^_C'2(KFSCD>=(+V;[/;7;1$02R\
MX4/[X.#T/8FJZ^/M#?4I-/B^W2W$5VMI*J64I\N1AD;OE^5>>IX/;.#7&^$5
MM_[,TWPUJ_@V\.MZ<8XB\UL6MOW? G$I^7&!GCG/ KHO!OF1^*_&4DMK=PI<
M7R2PR2VTB+(@B525) !Y!Z4 6M(\0^'['0]5U2&_O7LTU&5)FNQ(SK.6 ,:*
MPW ;B %Q6K9ZU9:Y/J&EK]IM[RU51<0N#'(BN"58,#T.#R#VKSRTN-4TWPCX
MBDM]'O'>3Q)+.1)8,SK;O*I\Z.-E^<@#(X.",GI6KX:9K3XB:]>?8=8^Q76G
MVSQ7-U;RDOL\S<3N&0<D83 //"@4 84-_?R_!'PQJ+:C>_;&O;<23"X<-*&N
M=K!SGY@1ZUZ;%XCL)O$LOA]?/&H10_:&1H6"^7G&X,>",\<=Z\O@M+Z/X'^'
M=/;3-1%[!>VYEM_L<OF($N-[$KMS@+SFNN\>V][:MI'BO181+J5A,L!A<[/M
M$,Y"&,^^XHPST(- '5Z=JEOJ8N#;B7%O,T#ET*@NIPP&>H!XR*S-3\9:3I4M
M^D[3NNG*C7TD,1=;8.,J6QSTYXS@<FM+1].&E:1;66\R-&G[R0]9'/+N?=F)
M)^M>:^,)-1U*/QMIDFE:D)3;8L([*U<1W2^5S(\JC#L#E=A/0 !2: .B\:^(
M7M=1\.:= MT;?4+P"=[=&/F1"-VV*R\Y)"YQSCV-85LJ#QO-X4DGU^727L7N
MHXY'E#PR22A1AQAO+0*=I)."Q]!BWJ\TT]S\/YET_4=MO<"6<?8Y"85\EDR^
M%.WDC@\UH1NY^,LEU]EO/LK:(EL+@VLGE^;YY;;OVXS@@]: +\/B;2M L+.U
MNKV^N+:.1;(ZI<(71I0=N'D QG<,%L8SP3G-7-5\6Z7I O&G,\D=B%:\DAB+
MK; C(WD>Q!P,D @D8(KS[P_!#::>_A+7O"%Y>ZI#.ZQRO;,]K=*7+)*9/NJ!
MD9SR,<9/%:NFZC<^%O$7B32-5T/4KV#4[][VRFM;4S1SK(J@QL>BE=N/FP,=
M<"@#??QG$?&UGH4%K<303V!O/M,<196!= A4C^'#$D].GO5N^\9:1IS![EYU
MM/M'V5KT1$P)+G;M+]OF^4GH#P2#6'<+=V7Q0T>_GTZX,,VBO9EK6%I(XYO-
M1MI8#"C ."V!Q7.:'!#9V=QX2U[PC>W^HQW$HAE:V:2UNT:0NDC2?=4#(SGI
MCUXH ]!UK7;*);ZP_P!,EFA@\RX^Q*Q:W0@X8E>0>"0!EL#.*H?#*YGO/AMH
M5S=3R3SR6^YY97+,QW'DD\FL72[JY\->+_%5GJ=A?R)JEP+NQNH+5YDE'EA?
M+)4':5V@?-@8YZ4G@C7E\-> /"=AJ>EZK%-<$6C'[&P$#%L R9QM4EEP??V-
M 'H5S<P6=K+=7,J100H9))'.%50,DD^F*R+?Q7ILVH6EE(+FVEO4+V9N(6C%
MP ,G:3WQSM.#CM57XA:->^(/ .L:7IQ_TN>$>4N<;RK!MN??&/QK$U9I/&A\
M)BTL[RVN+/4H;^[\^W>+[,L:MN0E@,DL0H SGKT&: -NU\>:)>ZE]@MC>R3+
M>&R?%E*!'*!GYR5^4=@3C.#V!-2^,KW2[/0P=7NKZVMGGB42V>\/OWC:"R#Y
M03@<X!S65X!$L>I^+?-M;J#S]9DN(FGMGC$D91%#*6 R,J:=\4HI[CP5);VU
MK<W,SW5LRQV\#RMA9D9CA0>@!- &[J7B.RTV6ZC=+B8VD(GN?L\1?R4.<$@<
MG.UN!D\=*TS,H@,V&*!=WRJ6.,9X Y)]A7G/C"S^T:M?:IH\^JZ7KT%JGD2Q
M6SR0:BNTLL3H5*L021CJ,@_3O[&6X_LBVFOXA%<^0K3QQ@L$?:"P&,YP<T 8
M.G?$'P_JAC:VFN?(=)G-Q):R)$@B)#[W(PIXS@X.,>HJ[;^*]-FU>'2Y1<6M
MU<1--;"ZA:,3HOWBI/< @D'! [5PVBZ-J6I_!35-%@M;BVU)VNBD5S"T)8M,
M[J/F X88&??FM'0M0LM:EM[JV\%WMOJ]E'(SF_MFC%NY0@JCMU+' X[<G'2@
M#H[+QIH]_=:?#"\X34M_V&=XB([C8"6VGZ D9QD#C-6/^$FL3<+&B7+Q-=&S
M%PD1,?G!MI7/;!!&2,9&,YXKS2UFO;NX\$:C+I.L_:+6\<7L(L9(HK5C$ZB-
M(\!0H)QO (Q]YJTOL=W9>)5O_#3:E;R7.KE=2T:Z@=K>1?-(>X0L,)D#?N!P
M>!UX(!VM_P"+=+T\7CR?:)(+%MMY/!"SI;G )W$>@()QG /.*;?>,M%L+^RL
MY)YI)KZ%IK80V[R"9  ?D*@AC@C@9/(KE-$-QH&G^*M"U6QO)I[B\NKFU:.W
M>1;R.;D , 1NR2""1CZ<U6TK1K[0M<^'=A<P7,S:=I]S%=31P.\<3NB;5+@8
MZ@@<]J .RM_&VB7&A7.L&>6&WMIS:SQS0LLL<V0OEE,9W$LO'N*K:IKUKJNA
M^([&WDO+/4=/M&>6,EHI8LHS(P93R#CJ#VP:X[[3J>GZ?XOFM='O)3/X@28%
M[!W86Y$0::-&7#LNTD<'! .,"K%E:W,WBCQ<+;3]7>+4M&B6VGNXI!YK!90<
ME\;22P 4X//W0* -3P?X[TE=#\+Z9?7%V+R[LH(TN9X)/*FF\M<H)2-K/GWZ
M\=>*?I>HOIWC_P <-<3WL]G:V]E,L.YYO+!20ML7G'K@5D)92^(/ /A3PY#9
MW<=]:/9&Z,]L\7V3R-I<DL ,_*5&.N[CC)K>T!95^*/BV9[6Z2"XALUAF>W=
M8Y"BN'VL1@XW#O0!M1>*M,G\/6NNPF>2QNF1866%BSEV"K\O7EB!^-;8Y%>=
M^&]$O=/\7WF@%5.@Z;.=3LR#]TS!@L6/1&\YA]4/I7HE !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !117%?%EI(OAGK$\,\\$L2(R/#*T9^^H(.TC(P3P>* .UHKG-2O=)7Q
MKH5G<M>C4VCN&M%3>L+#8-^[^%B !CJ03VKG_">KIHZ^+I+N6[N4C\0O;P1E
MVFE.4BVHNXDGKT';/I0!Z'167=:Y':M'"+.ZGO'B,WV2%5,BH#@L<L%'/ YY
M[9P:XWQ3KUIKNC^%-7TB\N!#+K]I"P5WCR/,(=)$R,D$=".U 'HU%8]IXCL[
MSQ'>:$D5PE[:1K+()$VJ48X5E.?F!P>GXXJWI>J1:M;27$$4R(DTD/[U0-S(
MQ5L8)R-P(SWQ0!=HKEM*\6R:CXPUS1WL)X(--$*^<X7&65G+,<\*1MQ^N,U.
MOC32\V,LBW,5CJ$@BM+Z2/$,S'[H!SD;NQ8 'L3D4 =%15;4+Z'3-/GOKCS/
M)@0R/Y<;.V!UPJ@DUS:?$70V32YF2_CM=35?LUT]JWE,Y7<(\CJQ'89YXZT
M=;17/67C32KK^U1,+JQ?2HQ-=)>0F-EB()$@'=<*??CI3K'Q;8WU_%8_9[N"
MXGM#>VR31C]_%QRN">>1\IP>>E &_6%XB\.MK\VE2?;3;C3KQ+V,"+=OD4$
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M8132+$&90YZM@$^AP>36MJGC/3-)BFN;A+DV%O,(+B^CC#0POD+ACG. 2 2
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M]*]%H **** "BBB@ HHHH *JZC:R7VFW-K#=S6DDL91;B'&^,D?>&>,BK5%
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MF.:I7%E?^(OACIOA&33+VTU>(VMM.9+=UC@$+INE$F-C JAQM))W >M>IT4
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M&/?.I*NBAL[@HS@=LY]COK.'4=/N;*X#&"XB:*0*Q4E6&#@CD<&N?L?!\UK
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MCI@<\5W-% 'G7AO2;R_\(^,]*:"ZL9]0O]0,#W$#QY2;.QQD#(Y^M4;BSO\
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MD7%G=V_VC6Y[F$SV[QB2)E0!@6 SRI]Z[2B@#QZ*RU-?@1J7AUM&U)=2A2:
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M6N?$'BKP5J-OH.LQ):SW!NUGLGC\@O"5 )8 $9/4<>]>DT44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>elicio-exhibit312202510x002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-exhibit312202510x002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7>'RSYB 71<DKC(PO.?0T >S75U!8VDMU<R".&)2SN1G %<_'\0?"\OV$C5
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MJMM;YBN,YQQG."#T(KH*XCX2 1_#;2X&1HYHO-$D;J59297/(/(R"#^-=O0
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M_?VL44I:>W*;(Y(SC=YBL V< A1V)SVS5R'Q+IT]W;V\9G87$SP0S"!_*D=
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MMF^3Y'P",.#T;&=A'6M?P9+J\WA6T?74 U#+AV$7E&0!VVN4_A++AB/4]NE
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M6\E@>XC41,0Z+C<01U(R..M>96^F:C=_L]W>DQZ;>KJ,?F.;66W>.0C[49,
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M(?MI9KJW2V:#R@%5$)*X.<YRQS_*MVBB@ HHHH **** "BBB@ HHHH ****
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M9 W!@<'@@=L=SU-CJ6J7/Q#U[19K\BSBL()K<1Q(&A9RX)R0<GY1UR/:H4\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;DGMM(((SUH Z_0O$5KK\FI);0W$3:?=FTF$Z!27"JQ(Y/'S#KBM>N*\!?\
M(8\:_P#8=?\ ]%1U=O\ 5+B]\=1>&8;J2TB333?RR1;?,DS)Y:J"0< 88G S
M]WISD ZBBN#N-4U[2)/#OAS4-3BFU#5+V:)K^*,!A!&I<<$;?,(VKG&.2<5'
M<ZQK&E>*-8\.G499HVT=M4L;MXT,D!5MC(W&&&<$$C/)'- 'H%-$B-(T8=2Z
M@%E!Y /3/Y&O+['6O$,&D^ ]<N-;EN?[8GM[6ZM&AC6)A)$S;QA=P8%<YSCV
M XJ32$U"#5?B'<PZU>B:UGS&7$;C(MU89!3MT &!CM0!Z=03@$UY9%KWB#2_
M >E>)+K6VNKC5K>SMHX)+=!'!+*5!ER "<*22#P3Z# &_?:CJ7ASQMH%@]]-
M?Z=K'FP.MPJ;X943>'4JHX(R"#P.HQ0!NZ!XBM?$4=^]K#<1?8KR2RE6=0I\
MQ -V ">/FK7KBOAU][Q=_P!C)=_R2K5UJ]SJ/C]O#,-U+:06^G"]FDA"^9(S
M/L506!PH )..22.>#D ZNBO,GUCQ5>>'O%FG6>HN-;\/W)$%RD,9^UQ;1(JL
MI4KO*Y'R@<X-=!:>(1JR66JV%Y,=-ATS[=<H A,I8?(I.W@_+)G&,$#UH ZV
MBO/--OO%VKV/A_7;!I2ETT4U[#.\(MS;N,L(\?.&7(P2<G!S3_#S^(M9\1ZW
M'+XCF2VTK5Q&L2VT7[Z+RU8QL<<#YN".>O7C !W%]?6VF:?<7UY*L-M;QM++
M(W15 R36"OC'.KV^FMX>UQ9)S&4E^SJT0C;/SLZL0H!&"#R,CBJ'Q9B>3X9:
MXR7$L02W)94VXD&1P<@\?3!]ZC\07>JZ&/"26VK7#QWFK0VMP)8XB9(V1FQD
M*,?='3'6@#N:*\],VOZGXM\7Z5'XAN+2VL(;:6V,,$6]"Z.V,E2"N1SD9.!R
M.<IIGB'4]8\-^$;ZXU)8/M]LSW4-LF;FYD"C;Y:[2 N<LQX XY H ]#HKR9O
M%/B*3X?6]^FI-%?0Z[_9\DCPQDRQ_:/+PX QG'7;CZUL2:[J?ACQ;K=K>ZC/
MJEE!H+:NJS1QHT;H[!D4HH^4@#KDCUH ]!JE9:B;VZOH#97=O]EE$8DGCVI-
M\H.Z,YY7G&?4&N=TF+Q!?6WA_6H];1XKF)9K^WDC7RG21 0(L#(*D@#)Y'7-
M9MIK6MM;>.HSK%LDVFW7EV=S?*J10*8E;+;1T&X]0: /0';8C-@G S@#)-97
MAWQ!:^)M,:_LXIXHEGD@*SJ%;<C%3P">XKF]!UJ_/Q"DT9KJ]GTZ32%O8S>Q
M*C^8)=A9< ,%(/1@.1P *E^%W_(K7?\ V%;W_P!'M0!VM%<#JDGB#4/B/=:!
M9>(9;"T;1UNT9+>-VBD,Q3C(Y&!WSWQC.1!)J?B7Q!;:VVAS7,=W87LEG:E3
M (2\6 ?-#?,=QSG&, C'/) /1:*\\DN?$VI>.SH9UIM.BDT..]D6WAC<PRF0
MJP1F!R..ISQG&,Y&;IGC77!9V^A7]TK:K_PD+Z,^H+$HW1HN\R!<;0Y4A0,8
MR<X- 'JM(2%4LQ  &23VKB'U+5=+\<OX<;4)I[2_TU[JUN)$0RVTB'#+T 92
M"",@D'CI7)32>(M8^"]SXCOO$UT3/H\C/;0PQHI;<?FW!=W(!! QU[4 >K7N
MIBT-CY=I=7:7<ZPA[9 ZQ @GS'.>$XZ\]15^N!U6\U31+3P6EMJL[QWFHP6M
MPLD<9,D;1LV,A1C&T#BH'N/$&H^)/&FG1^(KBU@TV.WDM3%!%N0O$SXR5(*Y
MZ\9.!R.<@'HM%>=0^+=3N]!\"W-S*+6WUC U"]10 C>42J@D87>XQG\!C-:G
M@N]U:^U37Q=ZC)>:=:7AM[*1HT D7 ).Y0-Q4DKGIQZ@T =C17(>)M0U'1O%
M?AVX^WRIHM[.UC<P!$PLK*?*;)7< 6&#SCD?CA:/XFU2X_X2729=4N)-0%TB
MZ3.\40)@E.V.10%PP!#DD@Y49XH [2#Q%:S^*KCP\(;A;N"U6Z9W0!&0MM&T
MYR>0>W:K>J:B=,LQ<"RN[PF1(_*M(][C<P&[&1P,Y)[ 5P]Q87=U\7KJT@U6
MXM7_ .$=A#W,:(93^_DY&5*@D]?E^F*H'Q5K\OPHTO6?[1*:@-12TN)5B3]\
MHNC"201@$J,\8YH ]4K'O_$5KI_B+2M$EAN#<:GYGDR*@\L>6A9LG/H.P/6L
MEK^]U_Q5K^BVNH2Z>FE00!6A52SRRJS!SN!^50%  ZG=G/%8>MP:NWB?X>V]
M]?P?VKF]2>ZMX\KN\C!95/&?J, ]L<4 >E45R/@K4-1EO_$>DZA?27QTR_$4
M-Q*JK(T;1JX#;0 2"3S@5)K]S??\)#!9Q:G)# ]F[):V*AKIY=P <[E*K&!W
M) W'!S0!U5%>51^*?$6H>"O FIQ:F(+K5=0BM+LB!"L@(DRV".#^[!P,#DUL
M"ZUF#7AX5;4[^_E@L3>2W<*P132;Y65!\PV@*%[#DD=!P0#O:*P_"?\ ;RZ&
ML?B,Q-J$<C)YD97]XF?E9@O ;'4#CBN;M7\1:OX[\2Z9'XCFM;339;*6%4MH
MF)5U+,AR/NGD9Z].>"" >@45YK;ZOXK\1Z##KV@F99WNF:."5X1:M"LI4HW5
M\[5^]UW>@XH\::]K.E6GB6]M-58SZ>L<MK;V<:LD"!5+?:"RXW,2?E!SMP0!
MUH ]*HK@/%7B>YT?5(7U&:_T[1)[)#%J5G"LL<%P2V?.!5B!C9CC'7.>UJVU
MJZUCQ7#X>BU(I#;Z1'>S75KM)N7<[058@C9@%N!R6'88(!VM%>3:GXL\16WA
M7Q#"-1*:EH>JPV@NQ"G^D0R2(%+#& VU^=N.@Z5T5M>ZQIGQ&?1Y]7>^M;K2
M9+U5N(T18)4D5?EV@'9ANA)/'4T =N3@$UD:!XBM?$4=^]K#<1?8;R2RE6=
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MP9-]H%Y+#>6=W=SF)$1O/C6YD+I\RG!VYQCOB@#UNFO(D2AI'5%)"@L<<DX
M_$D#\:YO3=7/B#6;*XTR_D.EQV"W$P"H1,\N/+!.,@A5<D C[RUE_$R.=XO#
M(AOKFV5]?LXV6$J V7R"<@Y((! /&>H/% '=45QUMJ%YK/C#6/#Z:E<VT.CV
MMN'EC$?FSRRJS;R2N,  <  $DYXP*G\!Z[?ZUI5_%JA5[[2]1GTZ:9%VB8QD
M8<#MD$9 [YH ZJ@\#->=>,]:U?3H_$MQ::LXDL+5)[.WLHU;R $W,UP67'S'
MHN<[1D#-:2:]=ZWXLLM"BN'LXQI*ZE<O"!O=G8*J D'"CYB2.?NC/7(!N:!X
MBM?$2Z@UK#<1?8;Q[*59T"GS$"DX )X^85KUY'I$&OV_A#QT^BZI,-6M-=NI
M4E\J,F?:D9*LI4C) /0#G'TKK[7Q"-62RU6PO)CIL.F?;KA $)E+#Y%)V\'Y
M9,XQ@@>M '6T5YYIM]XNU:Q\/Z[8-*4NFBFO89WA%N;=QEA'CYPRY&"3DX.:
M=H#^(]8\0ZXDGB*5+?2M7$:0BVC_ 'T?EJQC8XX'S=1SUZ\8 /0:*\X\,^+)
M[G4X++6+Z^L=<MX9)+[2KN%56?"GYX&"_,H(X ;IR<XS2Z=J7BW7-*T/7],,
MO^DO'/<P320BV-NW+*N/G#*,8)YR#GTH Z_3?$5KJFNZMI$4-Q'<:7Y7G&5
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M]2U_^UKJ_F9CI\FG/"J*JM$^"W/4'(ZYXKI&8*I9B H&23VI(Y$EC62-@R.
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MYGFXSLQC?ST]J?>^ +2]O-9F;5=2BBUF 17UO$Z!)2(_+#_=RIQV! /<$<4
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MI1QMVLI '8=,C% '%:WXCU_3=%\>:8FJ3BYT%89[2^"(7:*5=P1\K@E<$;@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM=1_8)_(#2VTB!B%#,22,+UX!P2!GO0!T=%9>J>(](T6[M;74;Z.WFNR1"C
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MN_NI;RR<PNPN86B5552 <E0N".WYU?\ !/B;3]&\$^#M-OQ=07%] EM$'MG
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M?XOP1B%8%C\-QVRKG<L;B;/E!^Y"XXZD<UZ%10 4444 %%%% !1110 4444
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MJ5R0V.&*<#<.N3W!IGCFUO[34=#\2:1:-=7UE<&UD@7CS89\(03Z!]C>V":
M-BU\7:->Z))K%O/-)8I+Y+.+67._=MP%V[C\W' ZURUIXGCT3QWXQ74[Z_FL
MX8K*6" 1R3&(,DC.5C4$JO3)QQQD]*9X?\/:EI'C&[T.3S)]&DDBUDW+]&GP
M5=#[F55EP.F/>I]/E6+Q_P".YI4D6&6UM%CD:)MLA2.0.%.,,02 0/6@#K6\
M1:6-.LKY+H2PWX4VGE(SM/E=PVJ!D\ D\< '.,4_2M<T_6?M LYF,MM)Y5Q#
M(C1R1-C.&5@",CD'H>U>5^'XKW2M/^'>LW%M<_8-/M9[.^3RFWVKR !79<9
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MB8G B1 H& >-W)]2 <5Z7XQAL;CPK>0:E;W$]G*8TE6V#&109%&]=H)RIPW
M_AH +KQ!IDVG:JD\]Y9K:V^ZY?R)(Y(4<-AU^7)^Z3D9QBBPUG2['PWHTJW]
MQ<P7<,26<DVZ2>ZW)E21C)8J-Q...2<5Q]@^K6VE>*M/N=1?6],CTW%GJ3P_
MOG9E<>0S ?O&'!R.?F]3@4;F:+3O!?PZU"1;N&[TY8H\BTDE$9%L5D22-1NY
M (&!P>>@H [D>.?#_D:A*UY*@TX,;Q6MI08=O4,-OOGZ<].:=8^-="U'4[33
M[>ZD,]Y$9;8O;R*DP W,$<C:Q Z@'(_"N'%_HM_X7\>36%_+=ZOJEI+++;_8
MY82/W/E1JB.-S=@2.I/;@5;G?-U\,V6*7%L#YY$3?N0;8I\_'R_-QSCF@#J=
M)U32CJ'B">UU#4;QX9T%U Z22"W;: %B3;G!')QGKFN%M=3M=?\  D'BC6O$
M?B'1R/,:\DLS,D;(SL%1!M*_+A1N09&.3DUT?A:=+?Q=XXN)EDCADNH9(W:-
M@)%6%5)4X^;# CBN5BCF/[-LNG?9KC[<+9HOLIA;S=YE) V8STYZ=* /5+K6
M++3S!!(\TL\L9>.&*-I9'5<9;:H)P,CD\9('4U3B\8:'<:;87UM>?:(K]S':
MK%&S/*XR64)C((VG.0,8YQ7*ZAJS>&_']KKUY;7<VB7^DI:"Y@MWE^SRJ[-A
ME4%@&#>G4>U2ZSJ@M9?#CPZ)+I^FW-S.QNHM/WSVH*_*0@4F-I23DXSCK@G@
M Z&;QOX?M]!FUJ6]9+*"8V\S&!]T<H;:49<94YP.1W'K4MIXOT:^U.XTZ":9
MKJ& W&PVTB^;&#@O'E?W@SQE<Y[5Y7>1S#X;^.M.6PU+SYM<:6&.6WD9Y$:6
M)@02"6.%)/4C'..*[>^E67XMZ#<1+(T TRXC:58VV!F9"JEL8!(!X- &OX.\
M51^+=(-_';3P?OI5"R0LHVK(RK\Q&"<*,@$X/%.U?QMH.AZA+87UU(EW';FZ
M:)+>1R8P0"1M4YZ]N@!)X!K'^%K/;^%3I<]M<PW5G=W(F66!D +3NRX) #9!
M!XS1<,!\:K.4QR&(:))!YOEL4$AF1@N[& 2H)QF@#=N?%ND6T<DAEGE6*%9Y
MC#;22>3&PR"^U3MXYP><<XQ6%XQU-VD\'7VEZE*+6\UFWB8V\N(YXG5VYQ]X
M':*K:#='PUXF\66FMI,J7UZ;^TG\IG6XC9%7RU(!RR[0-O7G@5S\6CWN@^"_
MA_IUY#-]HM];CNIHU0N;>(F5OFQG 4.H)Z"@#TC5?%&EZ,+@W<DVRV4-<O#;
MO*L"GG+E0=O'/TYZ<UJPSQ7%O'<0R+)#(@='0Y#*1D$'N,5Y<]Q::+XJ\1:9
MXETW5I[;5;DW-G-:I/)%<H\:H8BL9QN&W'(Y!YXQ7I&DV\=GHUG;QVBV<<4*
MJML&R(0!]W/MTH YVQ\3^'M*T;6M8;6+ZXL8-0E%S)<K(YMY,+F)%VY"#(P,
M8!)YK4L?%NC:CK(TJWN)#=M$9HP\#HDR# )C<@*X&1]TFO-;M9)/AQ\1;=+>
MX::ZU>Z>WC$#[IE<IM91C+ X/(]*Z;4I5F^(?@>>))&ABM;Q9)%B;;&72,(&
M.,*25( /I0!O^,O$Z>$] ?46MY9W,B11JD;, SL%!;'09/X]!R:P-6U[[%\2
M-$F>]OTT^YTZY=K0QR#<ZL@7$.-Q;D\8)]*O?%&WGN/ -X+>"6=XY[:4I$A=
MMJ3HS$ <G !/X52N[R.\^*7AR^CBN!;#3KI3)) Z!2S)M#9'RDA20#@T =-8
M^*='U'16U>WNC]D20POOC9760-MV%"-V_<0-N,DD8ZT_3?$6G:K?75A;R2)>
MVH5IK>>%HI%5NC88#*GU'%>6R6^H/H.NW=G8W=P;/Q>^I/:Q*\<EQ;< F/H3
MU)!']VNV\*7&A:OJLFKZ1IEZK_9_)EOKU)4?[P(B'F<L!R3C@'')S0!LZOXI
MTC0KRTM-1N6BGN]WD((7??M4L0-H/.!TZDD #FHH_%^D3:=!>P/<SI-"9UCA
MM9'D$8)!8H%RHR".1S@XS6)XP8#QUX*D,<CQP75P\KK&S+&&A95+$# !8@<U
MFZ]=)X=^(MW?:S::G)I&I6<$<-W9><PADC+Y1UB.>=^1P?YT =DGBC1YM.L+
MZWO%N(=1.VS\E2S3'!)"J!G@ YSTP<XJE+XMT'4=+U95U"YA2TCD2\>."5)+
M8@8;^'(89SQGUZ5R.MIIOA^#PAJ5EIEUI<=K>7#01+:R3*D4B-N\R-<L&<8(
M_NDG/0BI=-OM$NO#?C26PU"2[U*_CFN;B$VDL+*6CV(J1N-Q' &><D]N!0!V
M-AK.FVNB:.L-U=WJW5HKVK,C2SSQA5/F-@9SAE)) Y8=R!6?JGCRRLY="6V@
MNYX]5N&B61;60[%4,6^7&[=E<;<9ZDCBN9^PVEYX5\%Q37]_HNJ6VEXM]2B0
M@6\BI$KQ2@C&&_NMC.PTVXN=8?3/ ^K:W92"6VU64W3VMJYRI654E,:@L-^5
M/3JW;- '7W?C[P[97MS9S7<PN;8Q":);64LGF'"D@+T]3T&1GJ*L'QCHBW20
MFZ?:]W]A6<0OY1N,X\O?C;G/'7&>,YXK#T"0-\5O$TS0S(D]G9K$[Q, Q0/O
M4-C!(R,@'^5<=JE]/J&CPR3:;J%M=6?B.*6>PMK&18;>,7&2_P J_O6888G+
M$EC@"@#TF\\<:#97M_927$[W=BJM/!#:RR.H;." JDD8!)(X'&3S575O'EA9
M0Z!-9I->0:S.B0SPP.ZA""Q/ SNP#A>OMQ6=I-PB?$SQ5=RQRQP2V%H$>2)@
M&*A]Z@XP2-PR!7*Z7'/9_#_X=SS6=V%T[5 ;M%MG9X01*,L@&[&67MW% 'HM
MQ9ZE)XPL-4M]2NX]-%LPN;210L)&&*G!^829*_0*<XS@W++Q'IVH7-O!;M.3
M<Q&:W=K=U25!C+*Q&"/F'?G.>E7IY%?39)6A9U,)8Q,,$C'W2/7M7G/A&&ZT
MKQ!I5IHM_<W_ (=G@D9[.^B)FTK"Y50Y (!)V[&YP.,X)H Z_P 8WFFV?AZ1
MM4U*]TZW>2-?M%D6$BMO& "H.,G /UQ3[_Q?HNFZNVE7%Q+]O6 W MX[>21W
M3('RA5.XY/09/!]#6-\5U>7X>WL$,4LTTDUOLCBC+LV)T8X !/ !/X5%),A^
M,EK=@.;;^P7C\_RVV!S,K!=V,9V@G% %K5?B%IEKX:LM:T]9KV&]NX[6,I _
MR,9 C;QC*D<\=2> *VKOQ'86<89Q=.YB\\PQ6LCR+'_>9 NY1P>H&<'&<5Y:
M8I_^$!O76TNC]G\5_;'00/O\C[2&WA<9(V\\"MC4M2AT?QY=:GJ]EJ[:-J]I
M +:ZMDG'DO'N!1TC^8;MVX9'?ZX .NF\=>'(8=-E.HAX]35GM&CB=Q* "2!@
M=>"-O7/&,U##\0O#=P\,<5W<---;&ZCA%G-YCH&"_*NW).3T&3P3T%<Q>6MG
M8:OX"2QTB73[&"\N9?LXB8^0CQN%9^#LW,0<'H3[&M>Z<)\9[2=DD$*:'+"T
MOEG8',R,%+8QG:"<4 ;D'C#0[C0X-8BO"UI/,+>+]TWF-*6V^7LQNW9!&,?I
M5>^URUU?PYKPTZ[N(+JQBD24;6BE@D";APPSR,$'H1T-<#97\^F>'+AO[.E,
M;^*YGDG:R,KVD+R,RW"(5//0!L$#=WZ5>TI_(U'XB#[/J7EW4$4D$ES!)F4?
M9@N<D=2W 7KVP,8 !VO@>XFN_ 7A^YN9I)IY=.@>221BS.Q0$DD\DFGZGXNT
M;2/M!N[EUBM65+F9(7>. MC =E!"GYA] 03@&H/ &5^'^@1.CI+#80Q2(ZE6
M1U0 @@\@@UR>BZLN@7WB'PWK^CWMU-=ZE/=6@2S::.]BE.Y1NP5!'0[B ,=>
M* .\O=?L+*<0,TL\YB\_RK:%IG$?3<0H. ><>N#C-4Y_&OAVWTS3]2?4D^Q:
MA*L-O,J,59V.,$@?+SG.[&,'/2N?LI9O#GQ*UJZU>,Q6.KVEJ;6X52T4;Q*5
M:'<!P<L6&<9^M<U-I-UIWAZR>2VN%2\\9IJ<-OY+%H;;SLY90,J,#<<]-W/-
M 'HEMXST>\34_L[7;S:<@DGMS:2I+M()4JC*"P.#@CBL_3/B)I,WA;3=:U-I
M;%+YD1!);R!=SGY1NVX(Z?-G'6J!#3_%366BCD9)M!C@2380CR!Y"5#8P3A@
M<9KEQ,S_  E\)V+65\+BRO[);B)[20,OER9DX*Y(4#DCCGK0!Z5;>,-&N[59
MX)IVWW#VT<1MI%E>11E@$*[C@<DXP!UJCK>O6VK>!_$-QI-]/#<V-K.'V!HI
MH)40L P8 J> ?<=*H>)3/I_C_P .>(G2271TMY[2:2-2XMVDVE9"!R%.T GH
M.]9=]8R32_$/7;>.7[%J&F+:V^V,YN95A<%E7&2,LJ@]^<4 =OX5FEN/!^B3
M32/)+)80.[NQ+,QC4DDGJ2:CO_%FCZ:;DW$\OE6C!+F:.!WC@) .'900.""?
M0$$XH\''_BB]#4JRNEA CJRE65@@!!!Y!!%<7HLKZ-H/BOP]K-O.U]+=7<L"
MB)F^W1S9*E"!AB<X([=Z .YE\2Z5#K5EI#7#_;+V,R6RK"[)*H&20X&W@8[]
MQ4CZ]IT;7PDF=/L+*DY:)P S %5!QAB=RX"Y/S#U%<-J/AS4]&^&GAVZB1I]
M<\,I%<A$Y+JJXFB![@H6''7:*M>*]+U1? ]O=PV<UU?0ZA#JE[:0,1)* ^YX
MU(Y)48 QSA!0!TB>,-%+7\<L\T$UA$)[B&>WD218ST<*5RR^XS2Z)XNT;Q#<
M"'3+B29C;I= F!U4QMT(8@ GL0#D'(/(-<K#=Z#J^GZMJ^E:5J'G#2Y;>2\O
M(IA(,C*PJ),EN<D[<@''K71?#_Y?A]H$3(\<D-C#%)&Z%&1U0!@0>0<T 9_C
M'Q$UCK_A[1A]M2&^N7^U-;PREFC6)F"HR#.2P7.TY '8&D\/KIND^([^T'B/
M6[^ZBM?.-I>M(ZP0ER5QE<LV25R26P,'I3/&$H3QWX+DV2M';W-P\SI&S+$K
M0LH+$# !) YI(I5C^,E]<LL@M_[#CB\XQML+K*[%=V,9"D'% &A;_$3PS=I8
MR07TCPWTWD0S_9I?+\S<5"L^W"DD<!B#T/0U<U+Q?HNDRWB75Q)BR"&[>.!W
M6W#_ '=Y4$#(Y]AR>*\RA25?@CI%F;6Y%W'JB.T'D/YB@7A<DKC(&WG/I5SQ
MA>3:G;>.-/\ L%Y#,;<&UBL[-L7J^4/WTDJK\^/NA20 !C!- 'H5_P"+M%TW
M4X].N;I_MDL)GCBC@>0R(,?=V@[CR.!D^U/LO%>C7^AOK$-YBSCD,3F2-D=)
M VTH4(W;MV!MQDDC'6N1M[D3^/\ PG=""Y2%-&FC=Y('0(S&/:&R/E)VG .#
M7//#J(T76+^QL;FX;3_&3:J]JL3![BV!'* CYO48_NT >EIXHTB[_M*V-S/!
M/91![F)X7CEC1APX4C)'N,U7TG7M&L?#6BF'4KR^BO$"64DX>6XNL G)&,DX
M!)) P.N*@M=?TW7;34-2L-/G6(6C))>3VC0NYYQ&H90SXR<XX!(QG)QQVCW\
M^F>$? -M/8W$,0CDBNKU+%I9[-PF BC:2A?)!..F?7( .D\9>((M2^&&NZGH
MFHW$$MK'(OF1;HI8I4.&1@0&4@]>E=A9.3IMN[L23"I8GDG@5Y"$F7X:_$+3
MQ8ZBL\VHW301S02%Y ^W9@D98G!/&3ZUZWI<J2:1:2*?E\E>HQCCN#TH Q[/
MQYX>O]0CL;6\EDG>X>UP+:0!9$&65B5PO0]<9P<=*L)XOT9[ZTM/M$B->Y^R
MRR0.L5Q@9(1R-K<<CGD<C-<IX4M)[[P[XYL(%D@N;W5+]H&DC9-PD7"."1R/
M<>E5/"=WI6JP:-IE[X>U4:]IK1>;#=K/Y5L\> 90[$H!@$KCDY Z<T =)<?$
MSPG:QR22:C)Y<4YMYG6UE(A<$ [R%^49.,G )!QT-;MWKMA:/!&9'FFN(S+%
M%;1M*[H,98!0?EY'/3D#O7FVD7MFWAKX@Z9)$TUU<ZQJ,<5LL9+3L_RJ%XYY
MZ^G4X%6=#L+WP5XKTE]9WM8R>'[?3_M8!9()XCDHQ'W0<D@G@XQ0!V,WC?P]
M!HD>L2:@!8O+Y'F>4^5DW;=K#&4(/!W 8K*O?B1I<=SI\%E#>W!N=0-D[_8I
M0(RJ[FP-N6)&, 9ZY[5QVMZ7<1>&/$MX+:X\C5O$$%U:VZPL7:-)(]\FP#(#
M;6/(Z 'O77>.W*WOA'4UAGFM+;55DF>"%I2BM$ZABJ@G&2!T[T :L.IZ4_B^
M\":E?F]AL$:6Q99!#''N)$@0K]\DXXR>,8J&W^(GAF[6PD@OI'AOIO(AG^S2
MB/S-Q4*S[<*Q(X#$'H>AK-M[A1\8+V\>.:.W.A11^8\3!0XE=BN<8W!2#BN0
M@25/@EHUF;6Y%W'JD;O!Y#^8H%V7)*XR!MYSZ4 >JW_B/3=-N)X)I)'EMX/M
M$Z0PM(8H^?F;:#CH<#J<' XJ?2=7L=<L%OM.G\^V?[LFQE#< Y&0,CGK7GFN
M:O::#X]UJ99[BW74M.MUFD?3YKF-F&\(Z&,<84G(.,D]L&N@\,ZOH&C>$]!L
M=*FN[ZS:5=/BE2!RRR8.3(, IT.<@8R.U '8T444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% &;X@TM]<\/W^E)<"W%Y \#RF/?M5E*G R.<&I='L9-,T:SL))EG:VA
M2$2*FS<%  .,GG ]:NT4 %%%% &%I/A^YLM4GU#4=9N=3E)D6V6:-$6VC=@2
MH"@9/"C)[#C'.=VBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "L'7?#UUJ>HV6I:?K$^G7MHCQJ1&LL;H^TL&1N_RCD$&MZB@#+TW2I[:;[5
MJ&H/?WNPQK*8EC5%)!(55Z9(4G))X%:E%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!@:WX=N]1U6TU73M9GTZ]MXG@&(EFB=&
M*D@HW?*KR"#Q5S3-*FM93=7U^]_>E/+\UHUC5%SG:JKT!."<DDX'/ K3HH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#G:=I .."1FEH
MH P/#'AV;PZ-3$E\ET+^^EOFQ!Y>QY""P'S'(XX[_6M^BB@ HHHH **** .8
MD\,:I!K-]?:5XCGM(KZ433V\ULDZAPH7*$X*\*..1Q6YI]@FGP,@EDFED<R3
M328W2.0!DX '0 8    %6Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)8,I99Y(GB4@9R?G XX/-9MKX\T&^$LEE+=W=K$Q5[NWL9I( 1U^=5(./49
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /#O%TEU#^TMX?DLK9+FY73R4A>7RPYV3\;L''Y5ZCX5>6]T:PU3
M4X1%JTT+),">5.\DI[A3FL/5?AY=:C\0[3QE%K<<-W9Q^5# ;(NFW##YOW@)
M.'/3%;5KH6KIKQU6]UR*XV6SP06T=GY<43,RDOC>2Q^7')[F@#SCX#_\AGQS
M_P!?Z?\ H4M=C\6Y$;X6^(D5U+) FY0>1EUQFJWA+X<ZCX-NM5N-.\06\K:G
M*)9A<:>6"L"Q^7$HQ]X]<U:OO =]J?A;6M'O=?\ .FU>Y\ZXNC:8*KA $10^
M  (P._7UYH \N\3:C>V'[,GAZ.T9D2[D2"X9?^>>9&Q]"5 _3O7MWA"UMK/P
M9HL%FJK;K8P[-O?* Y_'.?QK+T_P#9Q^ $\':K,NH6"1^6KB+RG W%@?O'Y@
M>A'I3="\+>(/#NEQ:1:>)89M.@&R W.G[YXD[*'$@4X[$H?I0!R'QVL+;3?A
M6EM:1".'^TUD"#H"YD=L?BQKG_B]<3OH/P]TQV9=-N0C7 SPQ"Q 9^@9OSKT
MOQIX!;QAX8M]!?5Y8((Y5F>:2+SI9&&[DG< ,[CP!],#BK&L> [#Q'X-M_#V
MM2>=]F1!#=0)Y;QLJ[0P!+<XZ]CF@"/XHV\$OPN\012(OEI9LRC' *X*X_$"
MJ/P7O+R^^%>D27C,[)YD4;MU,:NRK^0&/PJUJW@W5_$.@QZ%K'B))-/.P7#6
MUGY4]PJD$!G+L!D@9(7GVZ5U>GZ?:Z5IUO86,*PVMO&(XHUZ*HZ4 >4_M!6\
M5K\,;2&",1QKJ4>%';Y)*]-TBWA;2]+N6C4S1V:HC]PK*I(_$JOY5A?$+P.W
MC[1H=*DU(65O'.LY*P>8S, P'.X #YO2NALK2[L]&AL_M4+W$42QK-Y!"G Q
MDIN_K0!XI\!+C58=%UP:?IUM=(;X;FENS$0=O0 (V:O_ +/&38^)BP /VY<@
M'..#78^ OA[/X"L[^VM-82Z6[D$N9K3!1\8[/R/;]:3P+\/9_ D.I1VNL)="
M^D$I,MIC8XSZ/R.>GZT >7_""_U>RLM373K-9+>;7K6.ZN/-PT,;2 '"X^8'
MH>>,UZ#\9+>WM/@]KD-LJH@EB=E4]&>X1V_,L3^-3>#_ (<:CX)@OX=,\06\
MHO91+(;G3BQ5AGE<2CU[YZ5:U;X?W>M>";OP[>:^TLE]<&XNKU[4;W.]64*H
M8!0-JCOP.U 'E&NZH_B3PAX'^'\ML-,-W!:S)J-XP,3J(RHV;<\DG'..< ]<
MU[IJU]'X6\*!O/3?!%';0/<.%#2'"(6)[9()/89-<WJ_PMM-=\!Z=X;OK[,V
MFJBV=_%!M>,* .1N.<@<\CL>U;-MX<UE)M%:\U^.[73 <[[(AIV*E-['S/O!
M21D#N3@T >7?#O4XO"/Q>U?PQ_:J:AI^KG[1;70E5P\V"W)'&3EP?4J*T/C*
M[I\0OAT\<9D=;\E4! +'S8>,GBNO\<?#L^,=7TG4XM6_LVZTQM\,L5OO<G(8
M9)8# *Y QW-'BKX?W7BK7="U:?68X)=&D$T*)9DJ[[E8ELR=,H.!V[T 4O#G
M@G5A\4]6\;ZJ(+-;F(0064,GF-@*B[G; '1,X&>3[<^=_"J_U>QDU\:;9K+#
M-K]G%=3>;M:&-I\,0N/FR"0>>,YKZ&99C;[5DC$VW[Y0E<^NW.<>V?QK@?"7
MPXU'P8VIG3O$%O*=1E$LOVC3BVUAG!7$H_O=\]!0 OQ9M[>U^$7B&&V147Y7
M95/1WG5V/XEB?QJS\/./@[I!_P"H<?Y&M&+P<MSX6U/1=<U"74SJ3N]S<;!$
MV6P!M R!M"KCZ"L[0O!&L:-X?7PX_B2.;1T5HUVV.RY$1)RGF>85'4C.S/IC
MC !T/AVWB&A:5<&,>?\ 8(8]_?;M!Q^=>4_L^V\5WX<\36T\:R0RWFR1&Z,I
M3!!_"O9VB:.T\FT,<150L>Y"RKCIP",_G7'_  ]^'[> 8;Z"/5?ML-W*)6#V
M^QE;&."&/'X4 <9XP_Y.5\(?]>0_G/46G3R:M^U!?)J62-.M66RC?HGR)R![
MAW;\:[76/A[/JWQ"T_Q?_;"13V"".&W^R;E*@L?F.\$GYSR,=N*L^(O %OK'
MB*R\2Z??2:7KUH-JW4<8=)%P1MD0D;A@D=0<'Z8 .GO+"VOQ"+B,/Y$R3QGN
MKJ<@C]1]":\3U ^-OA;K>K:QI%NFN>%;^ZDO947YC$6.6)(Y4CINY7 &>:]<
MM-.U=[F&;5=7BF6$[EALK8VZ.<=7R[EL>@('J#6=I_AK6M)L;FRM-?BD@GEE
MD47=EYC0^8Q8A"'7Y1NX# _EQ0!:\$ZSI>O^$;'4='B:&RE#%86ZQ-N.Y?P.
M?PQ6U=_\>4__ %S;^5><ZO\ #^?2M(\,Z;X7UC4;)M-N,K%'DK<;G4N\I&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,FC_ /@=%_\ %4 ;5%8O_"8^%_\ H9-'_P# Z+_XJC_A,?"__0R:/_X'1?\
MQ5 &U16+_P )CX7_ .ADT?\ \#HO_BJ/^$Q\+_\ 0R:/_P"!T7_Q5 &U16+_
M ,)CX7_Z&31__ Z+_P"*H_X3'PO_ -#)H_\ X'1?_%4 ;5%8O_"8^%_^ADT?
M_P #HO\ XJC_ (3'PO\ ]#)H_P#X'1?_ !5 &U156QU*QU2 SZ?>V]W"&VF2
MWE610WID$C/(_.K5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0!W+A$4)AAD(223QD8#<XCM/'%[=V&CPSZ5<:;J]_'-)+!/:2R^0L1"LWEJ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BHKBY@M+>2XN9HX8(U
MW/)(P55'J2> *S$\5:$^S_B90H)"!&9<H)2>FPL!N_#- &Q0<X..O:J%EK>F
MZCJ%]86=W'-<V)07*)G]V6SM!/3/!IVH:M8Z6UHM[<"$WEPMM ""=\C D+P.
M.AZ\4 8'A?P]JFC^(_$6HWC6;0ZM<K.JPR,6BVKMP<J >W/%3>(M"U'4_$?A
M[4;,VHBTN>2:19I&5I-Z%,#"G& <YKIJKWM];:?");F38K,$4!2S.QZ*JC)8
M^P&: .4UOPYX@@\6_P#"1^%[RP2:XMUMKVTU /Y4JJ24<%.0PW$>E,UOPKX@
MN9-(UG3=6M1XAT\RAVN(V%M.DF-\9 )95&!MZGCGGFNGTG6=/UVR-WIMRL\(
M=HV(!4HZ]592 5(]" :J?\)?X>$FTZO:C+%%=GPCL."JMT8^P)- &-K?AK7O
M$/@^XL[Z^LAJTD\,Z")7%M&8W5P@S\Q!VG+=>>F !1/X=\1R>*TU@7FFNLNG
M_9)4E1S]F;<6+1#OD$ Y*YV@^U=G10!YQIW@;7K+1?"-C)<:;*V@W7G,59U$
MBA64*/E//S$YX],=ZWK'0M5LO&'B#6L6;Q:E#!'%'YS!E,08#=\G?=VZ8[UU
M-% '/>!]"N_#/@^PT6]>"26T4IYD+$JXW$@\@8Z]*2.W\2V%_J+P#3KVTN)_
M-@CGG>%H!M4$$A'# D$]!C)ZUT5% 'G;_#V]M_"UIIEE-9FX_MA=6N2Q:.,,
M)-_EQJ <+P%&?3/?%:.I>%M7O_%.IZI%=6]HEYHITR-XY&,L+[F82#Y0."W3
M(Z9S79T4 >>V'@_Q'!>^$[J6?1H_[#AFMWB@23#JZ*I8$X^8[<XP,9)R:9-X
M&UJ;P/XET%I;!9M8OI[I)1*Y6,2N'((V9)&,>^>U>BT4 <VMWK\7BVQLV_LY
M],>T/VB.,NTT4@S\^[ &P_*H! )R?0TGCW0+WQ3X/OM#L7MXI+M54RSLP" ,
M&Z '/3':NEJA!K>FW6KW.DP7<<E];())H5R2BDX&3T_"@">R6XCL(4N%B6=4
M"L(W++D#L2 ?TKA7\$ZS)X1\5:,TE@)=;O9[F.02N5B$I&0?DY(Q^.>U=EJF
MN:7HJQMJ=]!:+*P1&F;:&8] #Z^U1VWB31;R^CLK?4K:2ZD!9(0_S,!R2!WQ
M0!%;0Z[#>62$Z>-/CLRD\8+F0SC&TJV,;,9ZC-8/A[P_XD\/W>O3(FE3?VKJ
M$EZNZXD'D[@!M(\OYL8]175:9JUCK%O)<:?<">*.5X&8 C#H<,.1V(J[0!RV
MA^%)](NM6UF>]CO?$.I+A[AXRD48482-$!)"#C/.3UIM]=^*[*#P\OF:3+=R
M3)'J42K)^\4E0QA] H+,2W8?A75T4 5-4AN+C2[J"U$1FEB9%\UBJ@D8R2 3
M^E<GJ_@/_A(-,\.QWTJ076E,J2/;N2)H2FR6/) .'&,UV]4M2U:QT>"*:_N!
M!'+,D",03F1SA1P.YH Y^\\.ZI-\1K#Q%$;,6=K9O:&(R,'8,V=WW<#&!Q^M
M6[^Q\0:AH^OV,[Z:WVL20V)4NOEQ,FW,G!RP))XX]ZZ*J%WK>FV.IV6FW-W'
M'>WI(MX3DM)@$GIT& >30!R<'AOQ/'X!A\*+)I,"K9"Q>]WR2G9MVDB,JHSC
M/5L5LZ9H=_X=T_0-(T::V.F62F.\-R&,LB[>"F. 2W)SQZ5T59$_BG0[:65)
M=2@7R6V3."2D3>CN/E4_4B@"+1],OXM2U6^U6.T:6[E7RC"[/LB5<+&=RCH=
MS9]7/2LO2O#6JZ1X^UC6+=K)=)U18S+;"1MZR(,>8/EQDCJ/QS76B6,Q>:)%
M,97=OSQCKG/I6-%XPT"6XEMQJ*++'"L^V1'3?&Q"JZ;@-ZDD %<Y) [T 7-&
M75EL,:V]F]YYC\VBL$V;CM^]SG&,UH5A:?XR\/ZIJYTFTU -J(W[K5XGCD7;
MC=N5E!7J.O7MFMV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#SKQI,VH_$WP7X=N.=-E:>]FC/W9
MGB0F,'U (SBNYU/3+75[![.[C#Q,58>JLI!5A[@@$?2LCQ7X5_X2$Z?>VMW]
MBU?3)O.LKK9O"DC#(RY&48<$9%6+>+Q%=(L6HMI]LG'F263NSR#T&X#9GURQ
M],'D ''1RZS!X_\ 'TNB_85GCAL9"]XK.IQ"Y"[5(//KGCT-:+^-K^;0_!FJ
MV]I:K%KEU;P7"R%B8O,4D[.G3:1D^O2KUOX<U.W\0^*-3#V;+K$4,<<9=@8O
M+0H"3MYSNS[8QSUK-C\$:M%X:\)Z2+BR+Z#>17+2$L!,(PP"@8^7(;KSC'>@
M"SJ?BS5)FUI="A6272Y# L3V$\_VJ545V4.A"I]X*,YYY/'7,\176KZCXD\
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MNNV2V[>=$SR6Y$93:AR!L));ZD\5)_PB>L$^$&DNK&1]!R9<!T$N8C'A>N,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !116=K^I?V-X<U/5 H8V=K+.%/<JI;'Z4 .NM9T
M^S2Z>>XVI:KNN'",RQ#&?F(&!QS[ @]#5.Q\8>'M2GMX+35[9Y;D9@4MM,P_
MV,XW?AFL'2X6C^"YEE<R7%UH\EW/(W5Y)8C(Y/XL:Y*'1M5\7?##P5I-AILL
M'DFUN6U*62,+"J+RR ,6+'/ P/?% 'LU4K'5K+4KB]@M92\EE-Y%P"C+M? ;
M&2.>".1D5R<.M>*]2\8Z[H]D^DQ0Z7+:-YDL4A+QR*69>&^]COTXZ<Y$#^+]
M<30O&UWML#<Z#/(L'[I]CHD2R?,-V<G/K0!Z!17"VOB37X?$'A>'4#I\EEKT
M,G[N&)E>!UA\P'>6PP.",;1CCKU,UMKWB+7=%&NZ!%92V[7C1Q64P*M+"DIC
M9C)NPK':S 8X&!R: .G35K*369=(64F^B@6X>/8V C$@'=C'4'C.:NURL>NZ
MM)X]U301]C$$&G1W=N_EMG<SLN'^;D?+VQ7(KX]\71> ].\;SP:4^F94WMI'
M&_FF,R;"Z,6P"./EP>.<]@ >L5G7&N:;::U9Z/-<A;^]#M!#L8[PHW-SC P/
M4UR?B[Q7K.@PZU=QM8PQV,*364#H9GO%QF1F"ME%!^4$@8(R2<XIVN3"Y^(O
MP_N NWS8[Y\>F8%- '97U_;:99R7EY)Y5O$"TDFTD(!R2<#@>]92^-/#S6\=
MP-23R)=NR4QN$;=P,-C'.14WBS_D3=<_[!\__HMJY/P->:A/X+\)Z;+H9;3;
MBS2*>X>5&78(&(^4'(R0!SZT =O#JUE<:O=:7%*3>6L:23)L8!5?.T[L8/0]
M#5VN/C\0ZQ)XI\3Z4!9;-.LX;BT;RVY+AR0_S<_='3%8EAXR\2-I'A#7+S^S
M39ZS<PVDUM%"X=3*&Q('+8X('R[3QW- 'I9 (P>16=::!HUA=M=V>D6%M<MG
M=-#;(CG/JP&:X_Q;XQUGP[:ZO?-]BC%C-']GLBIE>X@)4-(S*V8\EF R ,KW
MS6AJ&M>(&^()\.6$FG102:6;U)YH7=HV$H3D!@&^F5Z]>,$ ZBWT^RM)YY[:
MTMX9KAMTTD<85I3ZL0,D_6GW5S%96<]U<,5A@C:21@"<*HR3@<G@=JX;2_'.
MH7>@:8D\5J-9O-4ETO<JMY(:-GW2;<YQM3.W/)(&16K<W_BC3-/\137,=A)'
M90>?I]UM($V$+,KH&R"",9!&0?:@#HK&]@U&PM[ZU<O;W$:RQ,5*Y5AD'!Y'
M![U6UK7--\.Z<^H:K<BWM4(!?8S<DX' !/6N?B\0ZM<>'_#%_NL[:'4;1)KZ
M[DQB)VB5E2.,L"Q9B0.N .G-<MXD\07/B3X(Z[=7J1K<079M7,:,BOY=RJAM
MK<KD <'H: /6JS;S7],L;MK26X9[E5#O#!$\SHIZ%E0$J#ZFKT[M'!)(J[F5
M20OJ0.E<%\&7-Y\/X]8G?S+_ %.ZGN+N4_>9_,91GZ!1@=J .XL-1L]4M%NK
M&YBN(&)&^-L@$<$'T([@\BLZX\6Z):ZA#93WNR2:<VZ.8G\HRCK'YF-F[KQG
M/!'6N0LGN;'XX:[IFG2+%!?Z.E](&0LB7"N(PY4$<E>O(S6-I$6J/\$->G-[
M:%0FI28:U8OD/-N(;S."3T../>@#O)?'_AJ&]M[26_=)KGRS;AK:4"8.P560
M[<,I)'(R.:Z:O.Y-6U?P]X*\*W2/I\[3S65HQ:V92D,NQ<#YS\WOT/''%;,V
MM:OJVI:]8Z$]K%)I(6,&XC+^?.R;PO##:@!4$\G)/3'(!U=%<?/XFU(W]GH[
MP"RU-M.6]O/+MVNQ$S':$4*1GYE?DGH!ZY&3<^+_ !9:Z-H<MSIEI:WUWK":
M;-'/&ZK(K9VRI\V5! Z')'/I0!Z-15#1TU:/3PNM36DUX';+VD;(A7)V\,20
M<8SS7&ZCXQUG2[RR-U]B5Y]92QDL$4R-% [[4D:16(5R,-@@<'&.,T >@T5P
MSZWXHOO%?B31+"72X%TZ"WF@FE@=S^\#G:RAQD_*!G(QCH<\,TSQS=:UI?A.
M.WB@@U/7HGE=F4M' D:YD8#()). HSWR<XY .KL=<TW4M3O].M+D275@4%S'
ML8>67!*\D8.0#TIFK>(M)T-X$U.\6V,[;(MZMAV_N@@8)]NM<KX.2[C^)?CA
M+V6*:4+88DC0H&7RWQD9.#CKS^72F?%%VCG\&.L;2LOB.V(1,9;Y7X&2!^9H
M ['3-<TO6#,-.OX+EX3ME1'^:,^C+U'XU9OKR#3K"XO;IREO;QM+*P4MA5&2
M<#D\#M7!KHVMS_$;4?%T=D-,MXM)^QQ)<LK-=2!MV]EC8X4#CDYX%1Z=XF\7
MW?@&3Q;(VCK!_9$EVEOY,A;S4!;D[OND \=1QUYH ]!M+J&]LX+NW8M#/&LD
M;$$95AD'!Y'![U-7"7/BG7OM/@N&T6P_XGL#-.94?Y'$'F9&#TSVZG&,C.1#
M%XXU+3++Q#!JJ6MUJ.F7\-E \"-%'.9PGE[@2Q7!?GD\"@#T&J6DZM9:WIT=
M_I\IEMI"RJY1D)*L5/# 'J#6=;'Q/%K<MO<&QN-.>TWQW:QF-HY]V-A3<2RD
M<YR.F,UR,?CO7Y/A_H6NI!I[7E]J@LIHRKJFTW#1C:<G!PHY.?7% 'IE%<-:
M^(_$FG>,V\/ZU#879N[*2[T^6S5HLNGWHFW,?4?-_CQ'IOB[5?\ A)O#VEWT
MEE.VJ03&ZCMXSBTGC0.460,5?&2I'7(!XSB@#K-,US3=9EO(]/N1,UE-Y$^$
M8;'P#CD#/!'2M&N)\#_\C-XW_P"PN/\ T3'7;4 %%%% !1110 4444 %%%%
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M-=),UL08PTHD.0&^8DC'& *]$JCJNK6FC:<]]>&3R$95)BC:0Y9@HX4$]2*
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M5BNQ]K#1K(L\"DYVA6(4L,=S@YKJJ ,G7O$ND^&+1+O6+IK6V9P@E,+NH)Z
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M7T2C9H4<YEF'\4DJ!1$#WPI+'TROK7,^%@+WX;>-IKSYI+F]U(W&[_=*X_
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M/7.#Q74T4 84&@3S:S8ZKJUY%=W5C"\=L(8#$JE\!W(+-EB% Z@ $^M;M%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>elicio-exhibit321202510x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-exhibit321202510x001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O'YM=U@_'6Z\-2:]=V^BI:?:-H9!L/E!C\Q4G&<
MGFO8*\'U2ST[4/VA+NXU:Q%UHDEGY+RR6[20EO* QNP1D'C/8^] 'IVARW%A
M:WFLW6K7NH:+<6L%W:^=$'EB!#%QB-<L,%#T)Z^E3Z3X[\.Z[#;3:7>374=S
M,T$31VDW+J 6!^3Y0 1R<#WJGX?\0:? J:-:&9]/TC3XUFO98'1688557(^8
MX5B<9ZC%>>>#I/\ A$/BE,8K)U\/^(8C<6[*A863,Q(5^/W>=HRO;Y ?NT :
MUCX_FT;XH>+[+6]3N9-(L(5D@A6 R-'D*S$!%W8&3DG@#J:V?'?BFTF\&:7J
MFE^+#HUM>74;17Z6<DRR+ALQD!3M)QG!Q]TCUKC9(Y!X\^*4QAE\JZTB2*W?
MRSB5_+"[5./F.>,"L/6K6ZD_9W\+:>EK<->Q:FS26ZQ,9$ :8DE<9 PR_P#?
M0]: /0-9\6ZAHWQOLM)DOKIM(FTTW#VD4)E+2?.!M55+'[HX'O6SK7C/2M8^
M'>J:KH^OM8)&#"UZ+:1WM9,CAXPNX=<9QQG-<YJ[?9_C_I6MRJZZ4FD!'O2I
M\E"WF[0S]!GMDUS$6B:A%\//B/JCVTZ0ZW?%]/@,9#R()20P3&>0WIT7/2@#
MN-3^(L7AK0O"-N9[C5KO5C;+]M6TD"RQDJ'D"@9+D'A!\V2,CH#Z)!<+=6B7
M$*N!(FY%FC:)O;<K ,OT(S7A>NVMTOAKX2WXM;AK?39X!>,D+,8,>5G<H&1]
MQNW:O<)K]8=*DU#R+AT2$S>2D9\U@!G:$Z[CZ=<\4 >6Z]<^+]"^(_AF&'Q0
MM^=4N"MSIAB2..*($%BHZX )P3\V5[]*U/B;;>,(M*U'7-)\2KIEKIL7FQVD
M4()G"@%F=ST/4!<$<#UXP/%>G:)\2X=(U7PS;2P>(5OHO,D,!BEA0'YC-V^7
M (.3R  3FM'XE^,K9=3B\.3Z/K%_IJE9=0^PVQ82D$%8=QP-N<%B/0+W. #M
M_!.JWVN>"=(U34HQ'>7-LLD@ P"3T;';(P?QKD/BAXD\0^'];\,0:?J$4-EJ
M.H)#*B0?O"H9,@N2>#D] #[UI-\0VL_#^A:@?#.I!-4NC;QVT<?SVZ!BJEQV
M) R!Z=^*YWXS[I];\&K!'),;74A-<")"_E)N0Y; X_&@#UZBFQR)+&LD;JZ,
M,JRG((IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$MO&;0R;F#*WS'S!D94=,4 :_AF:ZU:&34-:LA:ZA;WEQ#'$7W>4F0H4-W!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/HWB&PEO=(ODNX8F*R>6K;T;T*$;@?;%8L7Q0\)3P7L\5_=/%8MMNG73K@K
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MX8J#SCD@9([XK0TW4K35]/BO[&99K68$QR+T8 D9'MQ7B^K1>-_AIXAUC7]
MBCUOPUJ%U)>7, ^8Q,2=^<?,I'(W#(P!D<5UNF_%;P78^%M+U"6:73X+_P U
MHX/(>0HX?]XOR @89N/8B@#MM8UK3= TY[_5;R*TM4.#)(>I[ #J3[#FL\^,
M]%BGM(;N6XL6O#MMFO;62!96[*&90 WL<'VKR+QUKD'BCXI_#TP3--H4[13P
M[T*K)(9RK94@?W%'/K[UVGQVABD^%.HO( 7BF@>(GLWF*./P+4 =/XE\<>'O
M"#0#7;V2T$^?+;[-*ZMCJ-RJ1GVZU:OO$VEZ;;V,]S)<".^D6.VV6DKEV8$@
M85202 3SCI7&PZ/!XV^!NGP^(YA&[Z>DWVN7K$ZK\LI/TY/J"?6N;^#>O32:
MJWA;Q,TJZQH\6S3XIQMQ$?O8!YW[2H!/.SICYL@'I>J^.O#^BZM::5J%W/#?
M7A46\/V.9C*2<  A",YXKH X,0DPV"-V"IS^77/M7C'Q2_Y+)\/?^OE/_1RU
M[.\B1[=[JNYMJY.,GT% ',V_Q#\-WFJ7>F6MQ>3WUH2+B"+3KAWCP<'($?K4
MX\<: =#O-9^TW L;*8P7+FRF#0N "0R%-PP",G&.:\7TZ^UC3OB7\2[G1+1+
MBZ2&8\S;#&-XRZC!W$=<9&<5[]]@LG2]A:&-A>?-<H>?,R@3D>ZJ!^% %70O
M$FE>)=*_M32+AKFS)8"3R77)'7 8 G\JFTG6++6[5KFQ:5X5D:/=) \664D'
M <#."",CTKQ/P?\ VKX'^(.L?#BUE8VVHMY]A<;AFW4C+/\ [WE@C_>1>Q)K
MW6TM(+&SAM+:,1P0H(XT'90,"@"+4=3LM(M1=7]PD$)D2(._3<[!5'YD5;KR
M'XS>1XATC4=*35;>VETF%;M8&G56N)CR%P3DXCW$#N9%]*UM \;W.N_!*[UZ
MU<MJMGI\R2D<D3QH?F_'AOQH Z>?QKHL>KRZ3!+/?7\',\-C;O.8?]\J"%/L
M3FD;QUX>2&XD-Y+_ *-)%#-&+64R))(2$0QA=VXXZ8]/6N,_9_AA'PZDNE^:
MYN+Z5KB0\LS# &3],'\?>O2#I5B=0DOC;H;B3R]SXZE-VT_4;VY^GI0!A+\1
M?#;ZQ)HZW%\VI1IO>T&F7)E5< Y*^7GH1^=;NDZM9:YID6HZ?*TMK*6",T;(
M<JQ4@JP!&"".1VKR/3?^3J-7_P"O!?\ T3%7LL%O%;1F.&-40NSD+_>9BS'\
M22?QH RK_P 4Z3I^K1Z3)</+J4B;UM+>)I9 O]Y@H.T>YP*?I7B32M9N[FSL
M[K_3+4@3VLL;12QYZ$HP!Q[]#ZUY/\#Y9M0\9^.=1U$EM2-PB.7^\H+R97V'
MRJ,>PI?&LTUA^T?X4ET\E9KFVCCN G\<9>16SZ_*/_'1Z4 >C?\ "P/#G]O3
MZ&MS=OJD W26L>GW#NHP#G 3I@CGW%:>D>(M-UR6[AL9)S+:,J3QSVTD#(2,
MC*R*IY%>.K/J%M^TOXCETRQCO;M=/79!)/Y0;]S#_%@UZ[X8,MUH&FZG>1!=
M1NK& W38P2P7."/8LWYT 9OB+XD^%/"NIQZ=J^JK#=N QC6-Y"@/0MM!Q^-;
M%_XATK3=-M]0N+M/LURR);M'ES.S_<5 N2Q/;%<I\3]+M;WPC<Z+9V$,VJZS
M.J6R;1N,F06E)Z@*H)+=@ .X%<?XRT]]!\1_";0$E:2VM+I4+]I'1HES_/Z9
MH ];TWQ!IFJVMU<6UTNVTD:*Y64&-H'7[P<-@KC\L<U5TOQCHFL7D%K:73&6
MYB::V\R)HQ<1@X+1E@-P'MVYZ<UX7K-[>6VI_%^.U+"-XXM^/>0*?_'6>K]U
M+-;7_P %7MR0YA1#C^ZWE!OT)H ]3U'XH>#M*\0_V'>:S''?!PCC8Q2-CV9P
M-H/X\=\5U]>9?$_PS:^(['2?">FVD*WMQ=BY:14'^C0#/F2L?<D#G[Q/M7I,
M$:0V\449RB(%4DYX XH DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** ,GQ'HK>(-&;3UO9K)C-%*MQ  70QR*XQGC.5K+U'PE<^()-.3
M7M1@N[2PN5NTBAM/*:6100I=B[<<DD*!GZ<5U5% '":A\/+B\^(EOXSBUM8;
MVVC\J*$VFZ/;M9?F^<$G#GN*V['0=0CU]]4U/6!>+]F:WBM4MA%%&&969L;B
M23M Y-=!10!P^C_#^?PGJ%[+X5UA+*QO'\V33[NU^T1(_JF'1EXXQD]O05U6
MFV,]H)9+N^EO+F8@NY&Q% Z*B#A1R?4GN3Q5ZB@#AX_A]+'\29/&O]KJ;J2/
MRFM_LOR;-@7KOSG !SZ]JL_$'P-_PGVD0:7-J1L[>*<3DI!O9F 8#DL !ACV
MKKZ* .6U[P-8>*/"UOHNL2&22V"F&[MU\MXW48#+DGMU'0_E576?!>I^)M'B
MT;7?$"S::&0W M;/R9;D*<@.Y=@!D G:HR1VKLZ* ,.ZT"0#1XM+N8+"UTN0
M/%#]GW@@1M'MSN&!M<^^<<TSQ;X1T_Q?ID5K?+ME@E6:WG49:)P<Y'L>A'?\
MC6_10 'IQUKG)O"4>IZ[:ZMK=T;Y[)M]G;+'Y<$+_P!_;DEG]R2!V KHZ* .
M8UGP>+[Q-;^(]/O%LM5BM7M'D>'S4DB;U7<O(/(.?J#67<?"G0IOA]!X11YH
MX;=_.BNACS%FY/F>ASDC'H<>E=W10!R^D>#A9^*KCQ-J-XM[JTMLEJKI#Y4<
M<8QG"[FY)&2<^PQ5[Q3X6TSQAH4NDZK$SP.0RNAP\;CHRGL>3^9%;5% '%W_
M (,U?5_#:>'=1\2>9II58YI(;/9<S1KCY6D+E><#)"<_G4OB/P#::UX'3PE8
MSKINFJ$7"0[V 1@PP2PYR,DG.:Z^J7]K61U&:P68-/!&))\#Y85/3>W0$]0.
MN.>E %?PWH[Z!X?L=)>Y6Y%E"L$<HBV$HH &1D\\5J-G:=I .."1FL/2?&.@
MZ]K%WI>E:A'>7%H@><PY9%R<8W="?IFH;WQQHME<:E"9)Y_[+4/?O;PM(ML#
MS\Q'? )(&2,'- &7X=^'TGA_QKJOB5=7$\NJ%O/A-MM498-\IWY'3OFE\=?#
MX^-[S2YI-5^QKILAEA5+?>68[?O$L./E'0"NPL[NWO[*&\M)DFMYT$D4B'(9
M2,@BN?M/'>B7WBB;PW UT=6@&Z6 V[#8..2Q&,?,._>@#-\<_#Z7QR=,^U:N
M+7^SY#*GE6N=SG')R_3CI^M)XX^'LOCG^S/M6L"U_L]S*GDVN=SG')R_3CI7
M3KK5L^N/HXBN?M21"8DPG9L)(!W=.H(QUI^KZS8Z'9"ZOY2B-(L4:JI9Y)&.
M%15'+,3V% &5/H&LWVH6,U[KR&UMIUG>UMK/RQ.R_=W,78X!P<#T%7_$>BGQ
M!HLFG+>S63-+%*MQ"!O0QR*X*YXSE:9;>);*?5(=,EBN[6_F1I(X+B J61>K
M!N5.,CH<C(S6M)(D,;22.J1H"S,QP% ZDF@#E]2\)7/B!M/BU[48+NSL;E+I
M8H;3RFED0';O8NPQSR% S[#BM/3=)O+/6M1U"YOX[D7FP+&+?88E0$*H;<<C
MECTZL3[5GV7CS2-4$LNF0ZC?V<3%7O+:S=XLCJ%.,OC_ &0:V-'UFQU[3DU#
M39O.M79T63:5R58J>#SU!H Y.Q^'4FF_$2\\7V>L"&2\RL]FMK^Z=2!G^/.<
MJ&SZ^W%/T3X?/H_CK5/%)U99Y=24I/;M:X0*2I^4[\C[HZY[UVLTT5M!)//(
ML<4:EW=S@*H&22>PQ7/#QQI/V*&_DCOHK"X*BWNWM7$<NXX7!QD!LC!8 '(H
M R?#7PY'@_Q!J=_H>K-#87Y+-ITL&^.-NQ4A@1@D_@<>AJGH?PQOO#RZX-/\
M3&,ZR^^X?[$"R'YN4._ ^^>H/:NAUGQWHF@ZY:Z-?M=)?7>/L\:6SOYN3@;2
MH(ZU;L?%%A?ZT=(6*]@O1 ;@)<VDD09 0I(+  \L.GK0!@Z9\-K7P_X7CT+0
M[YK>)KE+FZEGB\U[DJ5.UL%0%.T @=N.Y)O>.O!<?CKPZFD75VMN!*LOG+#N
M8,.ZY;CJ1SG@U:U#QGI%AK(T9'GO=5V[VM+*$RNB^KXX0<C[Q'45'+XYT2W^
MUI</=036=N;FX@EM9%D1-P4'&/FR3QMSG!]* &0>&M5@TS1+,ZY'*VENK":2
MSRTP5&0!OG_NL<D<DX/UG\7>$=/\8Z.MC?C;)%(LMO.H^:*0=Q['H1W'X&J4
MWQ'T&VUBUTB==1CU&Z3S(+9["4.Z\\@;?]D_E4EU\0-"LM$N=7NC>0V=K<&V
MN&DM)%:*3Y>&4C(SN7G&.: *7C[X?'QVVGB75391V,AEC$=OO)8XZDMTX]*T
MKC0-9O[^QEO=?C-K;3K.]M;67EB=EY7<Q=C@$ X'H*O6GB33+OP\->\_R-,:
M/SA<7"^6-F,AN>@K-/C_ $1-*35Y!?1Z2Y 6_>T<1$$X#'C<%)_B( YZT &G
M^'-8TB&\@L=?1H;FXFN MW9^;Y!D=F(0AUX&[HV>?RK0\,>&K#PIX?MM'L Q
M@AR2\F"SL3EF/N2:9KGBS2?#VB)K-]-(VFL%/VFWC,J -C:25SP<C!Z<T^S\
M3Z5J/AL>(+"9KK3S&9-\*%F '7Y>N1@Y&,T 4_%_@K3O&%K:BY>6VO;*436=
MY!@20."#D9X(R!D>PJAKG@B[\606EEXDUB.XTZ"42O;6=J8/M##IO8NW'LN/
MY8ZNPO8]1L8;R%9%BF0.@D0HV#T)!Y%9-_XS\/Z;K=IHL^I1'4[N411VT?SO
MD_WL?='UQ0 :GH-U?7>G""_AM].LG5_L/V7<LI484,=PX4X( '! )S@5@>*_
MAHOB/Q=8>)+75VTN_LE4))!;AF<@Y&XEL'N.G0X.:Z#Q/XOT?PC:+<:K/(N\
M$I'#$TCL!U.!T R,DX'-2:5XKT;6O#9\06-XLFFJCN\I!4H%&6W \@C% '.^
M)OAY<>)?$VC:[+K:V]SI)5H5CM,JS!@V6R_0D=/2MA] U>[UO3M0OM=CDAL6
M>1+2&S\M'=D9 S$NQ. QXS6?X>^*?A3Q3K$>E:1>S3W<BLP4VTB@ #)))&!5
M]O'6@)>FW-TWEK>?8&NMA\D7.,^47Z;OTSQG/% &)I'PYO-$\7:OXCM-=B-U
MJF[SHI;'=& 6W< 2 \8[FNET+1;S3;K4+O4-6?4;F\=3N,(B6)%!"HJ@GCDG
M\35Z'5+2;4I].$FV\A4.T+C#%#P'7^\N>,CH>#S5R@#AI_A[--\2(?&G]L*+
MN&/REM_LO[O;L*\_/G.&)S7;N&*,$(#XX)&0#]*=10!CZ%I%WI-A<07-_'>3
M3323&<V^PEG8GYAN.0,@#IP *YWP1\.?^$)O=2:WU7[18Z@Q>2R:V"HAYQM^
M8X&#C!SD8]*[JB@#AM%^']QX2O+QO"NLK9Z?=R>:]A>6IN(XWZ90AT9>,#!)
MZ#TKJ]-L9[-97NKZ6\N)2"[L-JKCHJ(.%'YGU)J]10!P]M\/I;?XD7'C3^UU
M:ZGC\I[?[+A-FU5X._.<*.?TKN*** .1/@9+#Q=<^)= O1I]Y>)MO89(?-@G
M[[BH92K9[@^O')R_2O!$-MXLG\5:I=G4=9D3RHI/*\N*WCQC;&F21WR22>3Z
MFNKHH X>S^'LMI\2+KQI_:ZO=74?E26_V7";-JKP=^0<(.>?I7<  # & .U%
M% 'GGB3X;ZMX@\1RZQ%XVU/36*>5%%9J8Q''UVY# G)Y)/4_05H7'P]M[CP_
MHED^H3/J&C7"W=MJ$J[V:4-N8N"?F#'J,Y]Z[.B@#D]-\!:=;6NOK?M]MN-?
M=FOY GEA@00%09.T $XY)R<YJKH_PZAL-1T2ZO=0-ZFA6[6^G1^3LV!N-SG<
M=[!0 ,!1QG&:[:B@#S+4_A7K.I:W>ZHOC_5[26[8%TM5,2!1]U0 _0 \?CZF
MO1;"S33].M;*,DI;Q)$I/4A0 /Y58HH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(5MPX(..,'KY;S3Y?C98RBYMG'_"/N8WWJ1DS*1@^ZY/TSVJ]IOAOQ-IUO\
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M27^MZK%?R1^8EFD5N(EA1B"<\G<V HSV /J: -V&&.W@C@A0)%&H1$4<*H&
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M<X YP/Q)P,=ZGKB?B4EW'IVB:C#%)-::=J]O=WL<:EF\E2<M@<G:2&Q[9[4
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MT11EAP3G>V.P&>XKA+;5+6+X3:%H[-(=1T[5X%O+<1,6@*W1)W<<<=/7MWH
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M\06-SJ?AW4;"SG$%S<6[QQ2-T5BI S[5QF@7$.O>-;6\?37T;Q%IL#Q:M;G
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M ,^!D"%@PY]"0".QX-<QI.HPZ+HO@35]4^U_V+%I<MC<SVSR*;29BA!?RR&
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M'M92%*[9$.&7D#./4<5?H **** "BBB@ HHHH **** "BBB@ H(!&",BBB@
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MSPQ8:/-<QW+6<0A69(RFY1TR"3S^-;5% !1110 4444 %%%% !1110 4444
M%8&J^&$U6;4!+=R?9=1MX[>YMW!=0JEN8^<(Q#$$X/0$8(K?HH **** "BBB
M@ HHHH **** "BBB@ HHHH , ]11110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %<7\3/#]]KGA^SGTR+SK_2K^'4(8,X\XQDY0'U()Q[BNTHH
M YB\\:::VC22V#O<ZB\1$.G*A^T^81PK1_>3GJ2 !U)Q7+67A*#2_AGI/@&]
M,;ZE>AB7!.+=RQD:0$=T/"_WB!VR1ZA10!YUX=UG'@C6=$U$+%J>E13V\[@'
M;=<'$RD_>+DY/?<3GJ*Y^.=M+\,?#W6+F"^DTJPLGM=1^R-(LELSQQ@.P0AL
M H0?3/O7LM% '$Z9HOASQ+H.MQZ?8W":?JZ[9;N?S=]P^"-X$OS?+QANY'MF
MF^ #JVHQM>Z]'MO--1M)5LY$K1OB64'T<K&/JAKI-=L-3U&RBBTG66TJ=9E=
MIEMTFWH,Y3:W SD<^U6M-L(M+T^&SA+LD8Y=SEG8G+,Q[DDDGW)H P?&%U#=
M_8O#9NC ^J2;)I% S'" 6;J"/FP$ /7<>N*Y?QI:S^%?$?AWQ8-2O=0EAG^Q
M7,+Q1EVM7!W$")%)VG#<YYQ7J%% 'F]QX@@\,_$B_P!1U43-H^LV-NMG?10O
M,BM'OS$=@)!.\MTHUUH+&^\"ZA%I<FGZ9;WT^88K8CR5>)PF4494L2#C&03@
M\UZ110!@>,["]UCP-K%CIVY;RYLY$B4_*22OW?;/3\:X[49XO%OACPI8::K)
MJEO?6DLT!0K)8^5_K"XZI@ @9QG(QG->H44 <)I5S"?C#K_[P;7T^UB1C]UG
M5GW*#T)&X9%='XE\1VOAG23>W*2R$L$CBBC9R['V4$@#J3@X'J< [%% '!:+
MJ>B^([?5-)LY;RYU#4[>1KV[>QEA0978 #(H^4 @*HR<9)YR:Y^XL[G5OA)I
M_@7RF36B\%A<P8YA2*4%I6_V-B9#=#N ')Q7KM% '!:8(_"'C7Q3+J!,=GJ?
MDWEI)M)\QE0I)&/5\@$*.2&X[UG:%J/_  KOX?Z=;:I')'JNH2RSF,022B R
M.6)<("<*"!CN>..2/3J* .,T#Q1X?M]%U&:P_M":WL4:[O;J6SD1I7;)8X90
M68X)P!@  <# KI]*U2UUK2[?4;)V>VN$WH64J?H0>00<C%694,D3(LC1EA@.
MF,CW&013+2UAL;6.VMTV11C"C))^I)Y)[DGK0!YK:W*V*_$BQN4FCGFGGGC#
M1-M9&MU52&Q@Y(P!G)-5?.A3P[\+5# /;SV_GC',0%NRMN_NX8@'/>O6J* /
M$_$VI?;_  ]X@B-I<V=S;:VCM86UFP7:MQ'^_D8+\[. 3G..F 2,UV%K=+!\
M7[J:2&Y6/4-'MQ;,8'PQ61RP/'RD @D'&*[RB@#.TC5[/68;F2R$H6WN9+:3
MS(FC^=#AL CD>]:-%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %4-7UK3=!T^2_U6\BM;6,?-)(?T ZD^PJ_7)?$\9^&/B+/_/D]
M '5QR++$DB'*. RGU!IU5]/_ .0;:_\ 7%/Y"K% !1110 4444 %<Y=>._#M
MD)6N+V5(XIS;O)]DF*"0-M*[@FTG<".#UKHZ\^^+44</@>%(D"+_ &I:G ]3
M,"3^9- &[=>._#]E9WMU/<W$:64:R3JUE,KHK$A3M* X)!&>E=%&ZRQK(OW6
M 8?0UQ_Q2AC_ .%;>(9M@\P6++N[XR#BHK;5];TSQAH6F7US:SV.K6<SI%%
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M4;@X*LY4*ISZFNCCD26-9(W5T8!E93D$'H0:\+LM;FLO!'B'2?L $6KZ]>V
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M, CS/EX)]>:[0\#-9>B^(+#Q EZ]@TI%G=/:3>;$T9$B@$C# '^(=J .<O?
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M"S8+$L20.XP!CU)PXOA[>0^"]%\.KK,&-+NX[E9S9G,FQ]ZJ5\SCGJ<UWM%
M$4JSM;LL,D:S8X=T+*#],@_K6!X'\,3^#_#4.BR7\=[' SM'(L!B/S.SG(W-
MGECZ5M:AJ%KI=FUU=R^7$I5<XR69B%50!R220 /4UD:?XRT_4-=;14M=1BOD
M+"5);5@L6 &&Y^5P0>.>: (I?#%S:^++KQ!HU[#;RWT*17L%Q"9(Y2G".,,I
M# ''<$>G6J%UX 9M*TRSL]22&2UU4:O//+;;S<3[RYR Z[02Q]<  5T.D^(+
M#6[G4+>S,QDT^803B2)H\/@' # 'H1S6I0!SVK>';K4O%&A:RE_#$-*\[]R;
M<MYID38WS;QC Z<&J</A"^AF\42_VI;DZ[SC[(?W!\L1_P#/3YOE'MS^5;.N
M>(+#P]!;RWYF"W$Z6\9CB9QO<@ $@87D]216I0!E^&])DT'PWIVDRW"W!LK=
M+=95CV;E4  XR><#UJCK'AV[U/Q5HFLQ7\,*Z49BL+6Y<R>8FPY;>,8'3BNB
MHH Q-4T!KK6['6[*=+?4;2-X-TD9=)8GP2C $'@@,#G@COFGZ#H$.B6]UF3[
M1=7MR]W=3E-OF2-Z#G"@  #)P!U)R:MV.IPW]S>P117"-9S>2YEB9%8[0<J3
M]X<]15?4/$6GZ9J.F6-P\OG:E)Y=L4B9D8X)Y;&T<#US0!G>-/"T_BO1XM.@
MOXK%$N(YRS6YE)*-N ^\N.153Q3X)N=>U#2]7L-5CTK6K!O^/Z*U+F1.\97>
M 5]CG]378T4 06B726J+>3133@?,\41C4_12S8_,UR-OX%N;'2-3\/V6J)'H
M-^\A\EH"9K=)/]9&C[L8.3@E21GO707GB+3['6M,TF9I?M6I%_LVV)BC;5+'
MY\;>@Z9STK5H Y?4?"<UQK?AV^L+V"TM]#618;9K8ON#1^7C=O& %Z<5T%_:
M)J&G7-E(Q5+B)HF*]0&!!Q^=6*0D*"20 .230!PP\":F?#WAW2I-=@?^Q+NW
MN(I/L) =81A%(\STZG/T J[<^"O[0U_6KZ_O(Y;/5K!;&6V2 JRH-V"'W'GY
MCV]*MMXXT);=;IIKD6;L%CNS:2^3(2<#:^W!R> <X/8FNBH Y+PWX7U[23;V
M^I^)VU+3[,8MHOLHC=@!A?,?)W8'L,D FMGQ%X?L/%&AW.D:BC-;S@?,APR,
M#D,I[$'FM2B@#G=/TWQ/;6Z6ESKUG<1(-HNOL1%PR^_SE-WOMQ_LU%>>$Y$\
M1V>OZ1>+;7T-K]BF6X0RI<0YW -\P(8'D-D^^:Z>HKJX6TM)KEU=DB1I&6-2
MS$ 9P .2?:@#CM4\ /J/AO5-.34HXKS5;Q+N\NS;%@65E*JJ;QA0$4#)/&>Y
MK3N/#E[<>,M.\0'4(!]DM9+8P"V/SARI8[M_'*C'!_&MJROHK_3[:\C62..X
MC61%F0HX##(!4\@^U1IJ<,FLRZ6(K@310+.9#"PB(8D !^A/'2@#S/QOX?G\
M._#GQ.9]2AF.IZM#>@K!Y?E.\\61RQR %![=Z[6;PU/JNJ6^HZM>QR/:V\L-
MJ+6,QA&E4*\F2Q.[:, =LGKGC?GM;>Z4"X@BE Y D0-C\Z>B)&BHBJJ*,!5&
M !0!P-G\/=5MK7PY _B.)AH,V;<I8!=\>PIALN?GP?O=/535Y?!5Z+#Q5:G5
MH#_PD#R.S?9#^XWQB,X_>?-\H'IS7944 >>^(TTL>$8O 5SJ$=QKC6<4=I'$
MA1RZD+'*!D[0I7<3G@*>U=QIMA%I>F6UC!GRK>-8U+<DX&,GU)ZFI_*C\X2^
M6OF!=N_'./3/I3Z .<UKPY>:GXHT368=0A@72C,5A>V+^89$V'+;QC Z<5#%
MX6O=+\0:IJ>B:A!;QZIMDN;>XMS(JS 8\Q,,N,CJ#U(ZBM73/$%AJVI:E86I
MF\_3G2.X$D3)AF&X8W $\<YZ<U:U#4+;2[":]NV=;>%"\C)&TA50,DX4$XP/
M2@#E3X"^S1^&8-,U!((-#F:<":W,C3NP8,6(9<9WL>G4_A7:5SJ^.-"?3!J:
M/?M8F/S1<#3+DILQG=GR\8QSFNBH X&7X=WC^$-9\-)KD:V5_/))$39Y:%9)
M/,8$[QN.> >.,\'C&S<^&;V[\4Z+K4NHV_\ Q+8)86A%J?WOF!0QSO\ E^Z,
M<'\:Z6L_6M9L_#^D7&J7YE6UMU+R&.)I"!]%!_/I0!RVB>!M6T&0Z=:^)7_X
M1L2EX[$VP\V-2<F(2YSLS[9P< CK6OX^95^'?B4L0!_9=R.3W,35NVTZ75K#
M<1Y\N5 ZY'.",BEF@AN(_+GB25,YVNH8?D: .-T/0;C6=!\+3:E>P3V=A%!=
MPQPPE3)(L>$+G<?NY)P!R0#QTIMGX&U;2M2O(M*\2O;:#>3O/)8FV#21,YRX
MBDS\H)SV..W/-=K%#%!&(X8TC0=%10 /P%/H YVP\-W-EXTU'7C?PO#>V\4!
MMA;D%!'G:=^\Y/S'/%4?^$$6ZE\4IJ=XES:>(-IDBC@,;0E4" ABQR0 #TZC
M\*["B@#E+?PI?7$6CV^MZG#?0:3,D\/EVYC>:1%*QM(2Q'&<X &2 >.E9K^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK=:B)8O$!D:3RX-AA+1^7P2QS@ =>],;P7J$L/AU9M=26319A*C-9@"0A/+
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M7IUY_*L=/AK=QZ/::6GB646MAJ2ZA9@VB%D(D,F'.<ORQYXZ\@T #ZIXHO\
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M,T+&- BSA?,*E]N?]40^,_GFFZKJ_B#3-)\+W1U A]2UBWAN$E@3<(96)$?
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M^+]=T2TOY=/ATB* -)#&C/)+*I?)WJPV@ < <DGF@#I-0U"UTK3Y[^]F$-M
MA>1SV ^G7Z52TW7XM1U.[TYK*]M+JU5'9+F( ,C9PRLI*D<'OD8Y%>:>)=;U
M#Q'\']8>^G:"^TW41I]V(%41SNEQ&N[# D#!!P".<]1Q7K=K#);VZQ2W4MRX
MSF64*&/UVJ!^E %;5M7M-&TJ\U&Z,C06B&280H790!D\#VYJ>PO8M2TZUOH
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MG;D?-Z=>F15O4=4U+1;#0--EU%;G4M5NUMGO3&H5!M9W9%  Z+A<YY()STH
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M^T_Q)JL^LO>0^0\KQ)"$3K\BJ, YP<\DD#L *?:^%9V;2AJ^J'48]*?S+4&
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MH 84WP[)"&)7#$# /K7$)\.I(_"=GX=&NS/:V=Q'- SVZDJL;[T7C&>>I/7
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MC'/OTQ45GX,DCL=,TW4-4:^TW2Y4EMHGA"R,8_\ 5B1\X8+QT5<D#.>_5T4
M<M'X0FCG\2RC4P6UT 2YM_\ 58C\L;?FY^7U[\^U:^@:4=#T"PTKS_/6S@2!
M)"FTLJ@ 9&3S@5I44 8&K>'9=3\2:/K*WRPMI1E,47D[@_F)L;<=P[=,8_&K
M.H6&L3ZG%<V&MBUMECV26LEHLJL<_>#9# ]NI''2M:B@#D=>\%QW?@ZXTNP<
M_;A<"_BGF(S)=!_,W,0,?,>#@8 / X%2:CHQ\4SZ+K5I?W&F7^FO(0K1*Y7>
MH62-T;C..A_$9!KJJ* .5TK1!X,AUBY6_N]0-_=O=1VS(@9IG RHP!DDJ/0
M>@!-6_!F@/X:\+VNG3.LEUEIKEUZ-*[%WQ[9.![ 5OT4 <T/"LUCKVHZIHVI
M?8O[3"F[A> 2J9 ,"1/F&UL=<Y![BJ[^!8(1X=CTZ\-K!H3M)"C1>89692K%
MSD==S'C')S76T4 %8$_AV6;QG;>(A?*K06K6@M_)R"C,&.3N^]E1ST]JWZ*
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MVW;G'?-:E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M Z*BL7P==SW_ ()T&\NI6EN)]/@EED;J[-&I)/U)K:H **** "BBB@ HHHH
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M0@]#4FH"&\\::]KUC<1/I2>'&M;BXC<&*6<NQ4;APS!?3IN [UZ70  ,#@4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %9^KZ[IF@VR7&J7D=M$[B-6?)RQ.  !]:T*X;XL-&?!7
ME. Q>]M3LQN+!9D+<=P "30!O6OB[0[ZUDN+2^\]([AK4B.)V=I0-Q55 W-Q
MSP#QSTJ2V\4:-=Z<U]!>;X4G^S,HC?S%ESCRS'C>'_V<9KE?'=XNF:_X<\07
M*7<VA1)<0W4UD[YA\P(4D/EG)7Y"#]?<53N[3PI?Z')=6?\ :&G6E_J,4D>K
MJ\JO]H56(F_>9.T8V[CP<GL,T =E-XOT*VLY+NYOQ;Q1W M7\Z)XV$I"D+M8
M!LX9>W>C2?&&@:YJ=QIVFZE%/>0+O>(*RDKG&Y<@!E]UR.:\S\07NIR_#?78
M=9EM]02UU6S2/4[>':M\GF0DL5'!8?=..,C':NDUNU7Q+X\T6]T&>-VL;"\6
MYNX6RB^8@6)"P[[B6QU !/>@#JAXJT4W]O9&\VRW+F.!VB<13..JI(1L8\'@
M'M1?^*M%TR21+R]\M8I%BEE\IVBB=L85Y "J$Y'WB.H]17GGA.[T#4M*T3P_
MJ>EZHWB'2WA5K"=[C;#+%A?.!SY:J!EA]< <@&QH&LV.F0ZUX1\2Z;-<ZC)J
M-Q-%;/:-*NH))(71@<%>XR6("XYQC@ [&#Q?:W'C2[\.K!<B2V@21Y3;2;2S
M$X&<8"X7[QX.>#P:O6GB+2[ZZ@M[>>1GN%9X&,$BI*HZLCE=K#D<@]QZURL4
MZV'Q9U<7<$H^VZ3;"$+&S+)M:3> P&.,CKBLSPB]QIFN:+8Z-JAU;P[<12,+
M6Y0&YTD!,@%NH7.$VMR,\9H ]2KFSXMMI?&<_AE(KM)H[42M.+9R S-A<':1
M@8/S'Y<\9X-7O#WB33?%&G/?:7+(\*2M"_F1M&RL,'!# 'H0?H17--<IIWQE
MN9+I9$CN]%A2%_+8JS+,Y89 P, @G/0<T 5/!?C6RM-$$6OZS))>2:G<6R2S
M*S=)F5 S*-J9Q@9P/2NSU3Q!INC[_MDT@,<?FR"*!Y3&G/S,$4[5X/)P.#Z&
MO(YY(V^"&O0IS</JTCK&!\[9NPX(7J?E&?H*W;_5=-T7Q[K1\1F_73-8C@DL
M+NV><Q2 1A&B/E'KD9''.[W&0#TVUNH+VTBNK69)K>9 \<D;95U(R"#Z5Y_)
MK+^*/$WB+2%U/5-+6P2!;.>""6,1N4,CO)E0".@P_! XZYKL?#EG:V'A^SMK
M&Q>PM$4^3;2$EHU))&<\@\YP>F<=JY?PO>6W_"R/&[F9 DCVAC8G"N$@PQ4]
M#@@YQTH OZ1XCT+2?"T5]/XEEO[1[EXUO;K)9W+D;0 HX!X&!BM;3?%&BZMJ
M%S865\LES;H))$*,OR$X#J6 #+G^)<BO)WDB;X+7-N>96ULL(MOS%?MH?.WK
MC9S]*ZS4KV)/BPMS#&MV!X;G18T((E<RJZQYZ98 X'I0!U-GXLT2_O+:UM[W
M=)=J[6Q:)U2<+]XQN0%? Y^4GCGI5.?X@^%;>*XEDU>,QV\Y@F9(W<1N,9W8
M4X'S#YNGO7GNGZI!=:C\/=047 2*66.:V@LG2"R9H&40J O)!XY)/&> :MB:
M!O"/Q20,IDN+N[,([RAH%52O]X%@0,=Z /3KW6+&P\D33,SS*6BC@C:9W48R
M0J D@9'.,<CUK&U+Q!H6HZ;HUW%XBDM8+N^B%K):M@W+[\>41M)P3PP(&.^*
MY"WUR/PSXFT76=4$O]BWOA^"S2\2-I%@G1BQ1@H)&<_F,=N+?BV6Q_X1_P -
MO8V L+1O$5K<1Q"'RB8Q+N>4I@%0<ECGL03@G% '9ZEXJT;29;B.\NRK6R*]
MP4A>18%;[ID*J0@.#][''/2L?Q#?W</CWP9':W\PLKV2Y$T",/+E"P,RDX&3
MSSUQTKE?%^I)=OXZTWR);2?[ /*2UM2SZB/).)'<*<JOW0 1C!R3G N37T$V
MM?#*8,RHD<Q<NA78#;; 3D< MP">O:@#TNXN(;2WDN+B5(H(E+R2.P554<DD
MGH*SK'Q'I>HZBVGP7#B\6(3^1-"\3M&3C>H<#<N>,C(K(^)5I?WG@2^738&N
M+B)X9_LZ=9ECE5V0>N0IX[]*H/K6F>.=+OW\.6SOJ;Z;/;B]EMFB:V++Q'O9
M1SNQP#@8)],@'11^*]$ENK>!;W!NG,=O(T3K%,X_A20C8QX/ )SCBJUWXZ\-
M6,M]%/JB>98E1<I'&\C1Y!.<*"2,#)(X'?&:X2Z=/$7PGT?PW9HT7B"!K.W^
MRE=LMI)$Z!Y&7JJA58[NA!&.M:UC<6R>-OB))))&J26]J%=N ^V!E8 ]\$@'
M'?B@#MY=<TV&PM;TW2O!=[?LQB4R&;<-PV*H);CG@= 37%:%XA6ZU?QX;S6[
MM-,M&A6*>8>6UJ&A)?"E1M(8GJN>!G-<WHE\^BVWP[UB_67^R+;3I;.XD"%A
M:3L% +@<KG&W/:M2VU"VGU7XGSQ^9Y%Q;0M%(865)/\ 1=O!(P221CUR,9S0
M!TDWC"PT.Q\+VL<U]J2:HL:0WC022-)'Y9;S&*KRQ '&,\YQ@5IVM]I]SXQN
M8H=9N)+M+)/,TT_ZN)=QQ)C;PYSCKVZ5P9F6V\,_"Z^E63[/9O"ERZQLWE-]
MF9,, "0=W'UK4N2]]\4]7CLY?*GG\-+!#(V5VS>9(0/]X!@2.HH ZW_A*]$^
MTPPF]QY\Q@BE,3B&20$C8LN-A;((P#U!%0WGC7P[87=Y:SZDOVBS56GBCC>1
MU!SCA02>ASC.,<XKSR0C6?@M;^$HHC%XCB2"S^PL,312QR+F0CJ%PI??TQWK
MI-*N+>#XL^)))YHPHTVU3S7( )4OO&>G&1D=J .VL+^UU2P@OK&=)[6=!)%*
MAX93T-9MYXLT2PGFBN;W9Y$J0S2")VCBD;&U7D VJ3D<$CJ/45A_"0X^&.CQ
M$%9(DD1T889#YC'!';@C\ZXGQGJ(O_#WC:R%M/9W4-\"+&VM&_?JK1_Z3(X7
MYMP''(& .IH ]1OO%VA:=J,NG76H(M[%#Y[0*C.^S.. H.3D]!SUXX-30>)-
M'NM!36X;^-]-D^Y, >3NV[<8SNW<;<9SQC-<K%?6L_QEBNPX6$^'2HDD4IAO
M/W;3G&#MYP><<UQUK--:>&=*U)(I9M/TSQ3<75]%$A9DA9Y-DNT<E1N#<?6@
M#MM*UV6_^+5[8PWUX]BFCK*;6>)HA%*9<?=95/W<<G/7K73ZMXATG0FMEU.^
MBMC<R".(/GYF_#I]3Q7'Z9JUEJ?QD>\L6>>VET!(TG2%]C,)V/WL8Z=_8CJ*
ML_$F2%9?"2R%2$U^VF<$9VHJOESZ*"1ST&: -ZV\7Z'>:?%?6MW)<0RF01K#
M;R/(VPX?]V%WX!X)QW'J*FA\3:/<Z=:W]M>"XM[MBL!@C:1I&&<@(H+9&#D8
MXP<XKCO%=_!H'Q!M-6UA;Y="NM-%JMW:/*%@F61G^?RCG#!AZ\K4%YIGAY],
MTW^S9[WPWYMW-=Z?J1+#$A4!FD67HKY/#8S@=-V* .U'BK1C'92&[95O;@VM
MN7@D7=,&*E#E?E;*L,''0U,-5LM1N[_2;:\DCO[:,&8+&5>(-G:PW+@YP<'D
M<5YMJ-_J<OA+P_J>M0Q;=-\3(]Q=VL1$<T*LZ_:0HZ*Q;.>ASD<&MC1-5M9_
MB?XCO5\U;273+4QSO"RHP7S,G)' Y&,XSVS0!!X=\=2:9\-?"U_JAN[V]U2>
M.W,@B>3):4@EBH/(7.!U)  'IV=YXGTFPB>2YFF58H1/+BUE8PQG."X"G9T/
MWL=#Z5Y;8DP_!WP/,Z2;=/U>UENP$):%5E;)8 9&,C\Q6QXKD7^T]3UG0=7>
MPU9+5/-TZ\BW0:I'LRJ^6P!W_,5^7D< @9H ]2!R,BL8^*]$6YBA:]QYTQMX
MIC$XA>7)&P2XV%L@C&>H(ZU9<7E_X=8!?LE]/:'"Y_U,C)TS[$_I7EAQJOP4
MC\(K"8_$4216?V!AB5)DD7]YC^[@;]_3'>@#J]>\0B?QU9^&6DU""U>RFGF>
MUAF61I-R*FUE7.T;F)(XS@$]JZ:PC;1-!C35-4:Z^RQDS7MSM0LHR=S8X&!W
M]LUREQ<10_&32UDG4E-$EA>0]/,,J$*3T#$ G%7_ (FV&H:CX!OX=,A>>X1H
MIC GWID2169!ZD@'COT[T ;%KXETF\O?L27+1W)B,RQW$+PEXQU9=X&X#N1G
M%9DWQ(\(0!&DUR (\IAW[7*JP./F(&%&>,G X//!K(U6XMO%WB7P?>:',)FL
MKE[JXE3K;Q&,AD?^ZS$JNT\\'C@USNFW.FS_  _\<:0XCEOKK4]1CBM ,RS2
M,Y$>U>K?-CD=,>U 'J.HZYI^E@?:99"QC,NR"%YF"#JQ5 2%]^E4IO&OAN"*
MPD?5[?9?HTEJ5);S5 ))&!Z _CQUXK@4E3P3XCMX_%3:@ME<Z/96T5_;23;%
MFA5E>-O*.<DMN&1W]S5BY@TG3=8\ 0V%BUAI\5[=3)!-NS&CQN%=@W*;F((!
MZ$]CD  [1/&_AZ2RBNX;]IH9;<W0,-O+(PA!(+LJJ2JY!&2!T/I4&K^-]/TR
MYT**)9KI-7?]U-! \B>7L+[@5!R3@8 YYST%8/B/4H_^$QU/3)();-WTH"&>
MVM2\U_DO^[#A3A5)Z#!^;.0!6!I]TD/A?X87TL=PMM8S"*X<P/\ (QMV4<8R
M1NXR.,T >C6-]I]SXOOH[?6;B:ZCM8_-T\G]W",G#XQPQS@\]NE2KXKT1[FW
M@%[C[3*88)6B<12N,_*DA&QCP> ><&N/N1)J'Q%\3P6,OE7-UX>2"W=OEQ-F
M3C/J-RDCJ*R+AEU_X.Z=X6M4:'Q%"+2T^QE=LUO+%(@:0CJJ@*S;NF#UYH ]
M O/&_ARQN+ZWGU-//L0IN(HXWD9-V2.%!)X4DXSCOBKI\0:8;.SNH[GSHKU=
M]MY$;2M*N,Y"J"<8QDXXS7):7<VL7Q-\9RS2QJALK10[\!MJR;P#WQD9':N9
MT*VM+GP#X,B?6;C0M7MK>?[-?#&R%P5#12JW!# J=IQG;^8!Z[8:A;:I9)>6
M<AD@<L%8J5Y!*G@@$8((JEJ'B;2=+DG2[N6!MU#W!CA>18%/(,A52$&.?FQQ
MSTJGX(O=1O\ PO!/JMO#%=^;*K- A5)P)& E4'H'^][YSWKF_#U]!H&J^,-,
M\1'RY+O49;VW,HXN[>1%"K'_ 'R NW:.>@Q0!J^-O%0TG3])6SEE(U.^MH//
MMX7D A=OF*,H(W%00 .><@5K:-:-I=K>7+:EJ%Y93-Y\$5U&[RP+CE!D>8W/
M(!&1TKSA[&YT#X<_#_3=48K>6^L6DTL;<M%'YC-\WH%! )Z#%>PHZR(KHP96
M&0RG((H \P\0^-IM<^%.H:]H\]]ITT,X",(FC)3[3Y0^9EQDJ,D*<@G!KN=/
M\4:-JFJSZ997RRWD,?FM'L9=R9QN4D .N>,J2*\FDG1?@'J&CO',M_;W31RP
M-"P(8WI?:,CYCM^;C/'6NMUN1+OXH:8+*X0-+HEU"DR-\JN[(4&1]"1]* .J
M'BK1?M]O9&\VRW,AB@=HG$4KCJJ2$;&/!X!SQ1XL\10>%/"VH:W<(72UCW!
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MA_&FMP36IU,PXB2-I&BBX2-<*"2"S,__ &TH [:BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV' ]!Q0!0U.>+P%X[N[S[/YEEK]L1 G7;>QYQ$O]T2@CCNPKM] TE=$T.UL
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M&T+_ ,&TW_R-0!T-%<]]J\8_] ;0O_!M-_\ (U'VKQC_ - ;0O\ P;3?_(U
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#/UR]GTW0[V_MHXY)+:!YA'(2 VU2<9'3..M<7)
M\1=1T[PCI7BK4](MO[(O1$9C;7+-+;K)T8J4 8<@'!'7O77>*/\ D4M:_P"O
M&?\ ]%M7D5M;O:^$_ M[XAGEOO!YMX!<0$*JVL^!Y4C[0"\>>"&/!Y.>E 'N
M61C.>/6L+QGK=WX=\(:CK%C#!--:0F4),Q"D#Z=?IQ]:Q?$5V+GXC^&=(O55
M]*N;>YF6-^8YYU VAAT;:I8@>ISV%<EXBADTVQ^)FD6@VZ-%80SQ0C[D$LB$
MNJ#L#@-@<#/O0!Z_:S&>TAE; 9XU8@=LC-2Y&<9&?2O,-1\/VFA>(_!FJ:''
M)#J5[=K;WFV1F-S 8F9VDR3NV[0<GID>U9^EV*>+_"4NIWFL6=AJEI?227-V
MEH3=VDJ2MA-_F=-H"A=N-I  H ]?R/6JEAJEIJ<EZEI*)39W!MIBO($@56(S
M[;@#[Y':O/['PUI.M?$_QC!J-L;B&)=.G2-I7 $FV1MW!ZY'ZGU-7/AKI^GV
MMWXKD@L[:&5->NH49(E5ECQ&=@('W>^.E '1^(_$L>ARV%E#;F[U34I3#9VH
M?;O(&69FP=J*.2<'Z&H;[4?$6E6\-Q-96-Y&T\4<PMW=&@1G"LW.=X )/\/3
MI7->*\Z;\8O"&KWAV:=+!/8K*WW8YV!*@GL6S@?2O0[BXBMHO,F<(F0O/<DX
M  [DDXQ0!(2!C)Z]*6O.-#M;/Q9<>-8M?ACDN[?4Y;5#*/FM[=47RF0G[F>7
MR,<\USVDK<Z\?A;<:V99+JZCO$F9I&!EC$+["V#SN7!/KN.>M 'M&01G/%)D
M'O7B^I6-M8^$_BCI5K'Y-C92B6V@C)58F:!&.T#H,\XZ5O?V9::/\0?!%Q81
M>3-J%I=1WD@8EK@+"C+O)^]@],]* /2LC.,C/I7-V?B#4+CQQJ^@O;VPBM+.
M*X@<,VYRY8?,<<?=[ _C7":/8IXN\()K%WK%G8ZI:7CRW-VEH3=VTR2'Y"_F
M9P1A0N,%2 !75Z;_ ,ECU[_L$VG_ *')0!I^"-?NO$OAF/4KV&&&=IYXF2'.
MT;)60=>>BUT5>2:)X:'BCX.2VL2I]OBO+R:SD8#Y95N)"!]#C:?8UT?A/4K;
MQK>VGB$6BQI86@MU1DP8[E\&9>?[@55!_P!IJ .XHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA\/Z5!HKZ/'8Q_V:Z&,VK9:/:>J@'H/85?2:*1V1)$9D.&"L"5^M!FB4@&1
M2VT L.OI]: ,I_"VBOID&G-8(;6W<20)N;,+#H4.<H1_LD59BT738K">Q%G$
M]M<9,Z2CS/.)&"7+9+$C R<]*MS2K#$79T3L"YP,]JY_P5KU[X@TB[N;]($G
M@O[BUQ "%Q&Y4'DD]J -'3?#^EZ2ZO9VH1T3RT9G9S&G]U2Q.U>!P,#@55?P
M7X:D\0#77T6T.IA@_P!HV<[AT;'0M[XS4&I>)9CXGC\-:/#%/J/D?:;B68D1
M6L6< L!RS$]%&/4D"I'O?$%GJEA9SP65S;W32*;N%7C\IA&S*#&2W!*_>W>V
M.10!H6^AZ;::K<:I!;!+ZY $TP=MT@'0-SR!V].U%KH6EV.IW6I6MA!%>W?,
M\R+AGZ=?R&?7 K)\$^(;KQ!X?6]U$6T5T;JX@V0Y"GRY&48!))X6MACJ7]N1
MA9+,:8;=MR$-YYEW#!';9C.>^<4 2ZAIUEJME)9:A:PW5M(,/%,@93^!JGI_
MAS2M+D1[6V8-'Q&99GE\OM\N\G;QQQBM+S8_-\KS$\S&=F><>N*YO4]=U"?Q
M'<>']%>SBO8+ 7AENXV=&9G*HF%8$?=.3SCCB@#2O/#6CW]\][<62-<21B*5
MU9D\Y!_#(%(#K[-D5)<Z#IEW>6=W/:*UQ9 BV<,5\G(P=N#QD<''4<5F^(-9
MU70_ MQK4EO:?;[2T\^>WRS1E@N656X/7.#BH[;4/$MSHMIJ<4>F2">*.8P
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M;G9?F)P!]WH!^)JOXCO/&<2WEWH4.E+:V:EA%>J[276T9;!4@(.H&<Y(SP*
M.NHK,\.ZPGB#PYIVL)"T*WENDWEL<E=PSC/?ZU:OYKBWL99+2W^T7 &(HBVT
M,QX&3V&3R>PS0!9HKA[77O%.D^,M+T;Q#'IES:ZLLOV:XL$=##)&N\JX8G(Q
MT/%+)XMU.]LO$.K:5';-8:)-)#Y,B,7NVB4-+A@P"#JJ\'D9/!Q0!V]%<O=:
MGKVN6-E<^%#I\5O<6J70NM01W#!QE455(YQU)/&1P>U?P_XV%QX.O]:\011V
M$NES36U^(R60/$<$IW(/&!ZG'- '845C:'=:OJ5O'J%_%%90S+OBLMI:5%/3
MS'SC=CDJ!QTR:V: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[W1R=>MM<L]H
MO(X3;3(W FA)W8SV96Y!]V'?(L1:#I$&HMJ,.EV<=\_WKE8%$C?5L9-:%% %
M/4-(TW5EC74;"UO%B;?&+B)9 K>HR.#3;O1M+OY+=[S3K6X>W.86EA5C&?5<
MCC\*O44 9O\ PC^C"6ZE&E67F78Q<MY"YF'HYQ\WXTR;PSH5QI*Z5-H]B^GJ
M=RVQMU\M3ZA<8!^E:M% &=+H&C3Z9%IDNE64EA%CR[9H%,:XZ87&!7-W/A>2
M[^),6J3Z7#)I,6E?8HR67<DGF;MRKV&W(XYYZ8KM:* ,^YT'2+S3$TRYTNSF
ML$(*6TD"F-<=,+C IH\.Z*OVC&D6(^TQK%/BW3]ZBC"JW'(   !K2HH @L[*
MUTZU2ULK:&VMTX2*% BK] .!6?-X5\/7%T]U-H6FR7$GWY7M4+M]21DUKT4
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M@ABSEIW*#:B#JQ)P,"N!\*:>/"ND>!=&U)%AUTK>7,+W4A6&V#<ON7(WOM<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
+%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>elicio-exhibit322202510x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-exhibit322202510x001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$MO&;0R;F#*WS'S!D94=,4 :_AF:ZU:&34-:LA:ZA;WEQ#'$7W>4F0H4-W!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/HWB&PEO=(ODNX8F*R>6K;T;T*$;@?;%8L7Q0\)3P7L\5_=/%8MMNG73K@K
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MX8J#SCD@9([XK0TW4K35]/BO[&99K68$QR+T8 D9'MQ7B^K1>-_AIXAUC7]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(5MPX(..,'KY;S3Y?C98RBYMG'_"/N8WWJ1DS*1@^ZY/TSVJ]IOAOQ-IUO\
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M27^MZK%?R1^8EFD5N(EA1B"<\G<V HSV /J: -V&&.W@C@A0)%&H1$4<*H&
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M<X YP/Q)P,=ZGKB?B4EW'IVB:C#%)-::=J]O=WL<:EF\E2<M@<G:2&Q[9[4
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MT11EAP3G>V.P&>XKA+;5+6+X3:%H[-(=1T[5X%O+<1,6@*W1)W<<<=/7MWH
M]7O_ !OX9TRYN+:\UFVCFMF1)DR24+DA0<#V/T[XJY_PD6E_:TM?M#&1YC C
M"%RC2#.4#XVEAM;(!XP?0URNBSV<_P 7_$AW1LTEA:*FX<DKO+*,]QE<CMQF
ML:RGETO7[-O#^J)J.EWNK,ESHET TUD[.QDEC(^8*#EL'C!SGF@#O_\ A*=%
M_LV]U#[:/LMC*T-T_EO^Y=0"P88R,9&<]*DN_$6E60A\VY+--";A$BB>5S$,
M9?:@)"\CDC'->77VHVVG^'?B=HUPSKJ4]U=W$5N(V+/$\*;7''W>#STK7CUR
MT77M%M)%>P,VA1[+Y;5FGN?FP;=,J<8(W$8).1C'4@':S>+- M[:PN)=6M5A
MO\?97,G$H(SD>WOT%0KXTT&72M2U&WO#<0Z:";E(HG,B<9'R8SR.AQCWKRS2
M;NU;X?\ PV@E8*]MK4?G+*I79M\W).1T!*\] 3722NEQXR^(<%NRR2SZ/ D:
M(<F1UCE! ]2,J#]10!W'AK7(O$7A^RU..-XS<0I(R,C+M9E#$ D#(&>HXJG8
M^+[*_P#%^I>'XXYQ+8I%ND,+@,[[R1G&, *.3P<G&<5%\/+ZWO? .AB!RWD6
M,$,F4(PZQJ&7D<X/!KG]TL?Q$\:V,3O!?ZEIMJ+!MC?,RQRJ6! P K$9- '8
M#Q1HINX;;[<H:>4PPR%&$4D@SE%D(V,V01@'/!K7KQR:2+6_@M9>%[8>5XCA
M6VM!9'B>">.107*]5 "EMW3'>O8@"% )R?6@#D])U/5)/B3KNE75XLME;V5O
M-;Q+$$$9<N#SU)^4=3^59]_XG"^+]<TG4M7FT@6EM'-IZHJ#[0I3+2#<IWL'
M^78/3H<T[2;JW;XQZ^JS1DMIUJBX8?,RM(6 ]2,C([5G^(=,T_Q'XAUNT\37
M1T]K01-HMQYGE-$-H9I8VXW-Y@P1V"J.,Y(!W/AZXU"[\.Z=<ZM;BWU"6W1[
MB(#&QR!D8[?3M7->'M1U:Y^)GBC2KG5IYK#38[5K>!HHAS*A9LLJ G!''/YU
MN>$)M5N/".ERZVI&I- OG[EVDGL2.Q(P2.Q)KEX;J#PQ\6=?N]7E2SLM9M;5
MK6ZF.V(O$I5D+G@-SG!/(H Z2X>^'CBQMDU*=+*2RGG>V"1[2Z/$HY*[L8D;
M//I5;Q_KUSX;\*R:A;%HP)XHYKA8_,-O$S@/)M[D G /&<=:DL;RWUSQ:FH:
M=(+BQL[*2 W,?,;R2/&VU&Z-@1<D9 W#O3+OQAI,NC+?1*]WI[7IL+D&W<E>
M2K':1D@$<\8QF@!NF+>7%YI>H:5XCDU719B_GA_*?/R':P=5! W<$>I'3!JY
MXQ\2P>$/"M]K<\9E%N@V1 X,CL0JK^)(_#-<'9:/I6C_ !$TF?P%?*UM>N_]
MK6%I-YELD04XD(!(C.[  []N,UM>/+5/B!X(UW2]#D,M_I]R$V,A0&:(ABF6
M !R#@'IDCF@#<T_2=;FTZ*XU'7KF/4I$#NEO'&(86(SL52I)4=,DDGU';3T-
M=131K9-6=9+]5*SR(,*[ D;@.P/4?6LC2/'FA:E8Q/->QV=_M FT^X.RXCD[
MIY9^8G/ P#GM6E)K]G;WFF65V);>[U,R"VA:-B3L&X[B!A3MP>3[4 :4I=87
M,:AI I*@G )[5QG@;7KGQ'Y-VNJ),L=KY>I64J@307>1T '"8W@<G.%([FND
M\06-SJ?AW4;"SG$%S<6[QQ2-T5BI S[5QF@7$.O>-;6\?37T;Q%IL#Q:M;G
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M ,^!D"%@PY]"0".QX-<QI.HPZ+HO@35]4^U_V+%I<MC<SVSR*;29BA!?RR&
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M'M92%*[9$.&7D#./4<5?H **** "BBB@ HHHH **** "BBB@ H(!&",BBB@
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MSPQ8:/-<QW+6<0A69(RFY1TR"3S^-;5% !1110 4444 %%%% !1110 4444
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M 8?0UQ_Q2AC_ .%;>(9M@\P6++N[XR#BHK;5];TSQAH6F7US:SV.K6<SI%%
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M4;@X*LY4*ISZFNCCD26-9(W5T8!E93D$'H0:\+LM;FLO!'B'2?L $6KZ]>V
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M, CS/EX)]>:[0\#-9>B^(+#Q EZ]@TI%G=/:3>;$T9$B@$C# '^(=J .<O?
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M"S8+$L20.XP!CU)PXOA[>0^"]%\.KK,&-+NX[E9S9G,FQ]ZJ5\SCGJ<UWM%
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M\*["B@#E+?PI?7$6CV^MZG#?0:3,D\/EVYC>:1%*QM(2Q'&<X &2 >.E9K^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK=:B)8O$!D:3RX-AA+1^7P2QS@ =>],;P7J$L/AU9M=26319A*C-9@"0A/+
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M7IUY_*L=/AK=QZ/::6GB646MAJ2ZA9@VB%D(D,F'.<ORQYXZ\@T #ZIXHO\
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M,T+&- BSA?,*E]N?]40^,_GFFZKJ_B#3-)\+W1U A]2UBWAN$E@3<(96)$?
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M^+]=T2TOY=/ATB* -)#&C/)+*I?)WJPV@ < <DGF@#I-0U"UTK3Y[^]F$-M
MA>1SV ^G7Z52TW7XM1U.[TYK*]M+JU5'9+F( ,C9PRLI*D<'OD8Y%>:>)=;U
M#Q'\']8>^G:"^TW41I]V(%41SNEQ&N[# D#!!P".<]1Q7K=K#);VZQ2W4MRX
MSF64*&/UVJ!^E %;5M7M-&TJ\U&Z,C06B&280H790!D\#VYJ>PO8M2TZUOH
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MG;D?-Z=>F15O4=4U+1;#0--EU%;G4M5NUMGO3&H5!M9W9%  Z+A<YY()STH
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M^T_Q)JL^LO>0^0\KQ)"$3K\BJ, YP<\DD#L *?:^%9V;2AJ^J'48]*?S+4&
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MH 84WP[)"&)7#$# /K7$)\.I(_"=GX=&NS/:V=Q'- SVZDJL;[T7C&>>I/7
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MC'/OTQ45GX,DCL=,TW4-4:^TW2Y4EMHGA"R,8_\ 5B1\X8+QT5<D#.>_5T4
M<M'X0FCG\2RC4P6UT 2YM_\ 58C\L;?FY^7U[\^U:^@:4=#T"PTKS_/6S@2!
M)"FTLJ@ 9&3S@5I44 8&K>'9=3\2:/K*WRPMI1E,47D[@_F)L;<=P[=,8_&K
M.H6&L3ZG%<V&MBUMECV26LEHLJL<_>#9# ]NI''2M:B@#D=>\%QW?@ZXTNP<
M_;A<"_BGF(S)=!_,W,0,?,>#@8 / X%2:CHQ\4SZ+K5I?W&F7^FO(0K1*Y7>
MH62-T;C..A_$9!KJJ* .5TK1!X,AUBY6_N]0-_=O=1VS(@9IG RHP!DDJ/0
M>@!-6_!F@/X:\+VNG3.LEUEIKEUZ-*[%WQ[9.![ 5OT4 <T/"LUCKVHZIHVI
M?8O[3"F[A> 2J9 ,"1/F&UL=<Y![BJ[^!8(1X=CTZ\-K!H3M)"C1>89692K%
MSD==S'C')S76T4 %8$_AV6;QG;>(A?*K06K6@M_)R"C,&.3N^]E1ST]JWZ*
M,6\TK6)M8:ZM?$,EM9O&$:T^RQOM(_B1CR#]0P]JS/$?A59- TU-*BS<Z/>Q
M7]M&6YF9&)=2Q[N&?D_Q')KK:* .6UCP['XEN]*U_3-1ET[4['<(9Q%NRC</
M')&V,].G!!HTO0O^$8U#6M:NM5N+V34FCDDB$*C+J@4! HR2<8 _F>:ZFB@#
MG?!>A3:'HDOVL 7]_=37]V%.0LLK;BH/?:-JY[XHN/"[Q^*)?$&DWPL[RY@6
M"[CDA\V*<+]QB RD,.@.>G:NBHH Y'4O <%YX.F\.07TEO'<S_:+FY,8>260
MR"4MV )8>G3@8KJX1*L2B9U>0#YF1=H/X9./SI]% '(/X&81^)((-7FCM-=:
M1Y(#"K")Y$".P/!/ X'0>]2-X.E?_A&LZF/^)#CRO]'_ -;\GE_-\W]WT[\^
MU=710!Q4/@">QU:]DTSQ'?66D7\S3W6FI&C NWW]DA&Z,-WV\\\$<8ZZYMEG
ML9K4'8LD9C! ^Z",=*GHH Y*?PAJ%WH'_"/W6OO/I31""4O;#[3)&."ID#;>
M1QG9GWSS3=8\#O<:U;:QH.LSZ'?PVXM':&)98Y81]U61N,CL:Z^B@#D-7\"+
MJ$.ESVFL7=GK.FN\D.I;5D=R_P#K-ZD!6#>G '08'%3:CX,.J^&)]+O-7N9;
MZ:6.X.H%%#+*C*R$( %"C:/E^O<DUU-% '*6OA&]A\3KXAFUZ:>_%@;)@;=%
MC8;]^=HZ#.. <^_-3:'X3?0_!1\-Q:CYL8CDCCG>'#*'))R <$_,<=.W6NEH
MH XX^!"/#_A[38M6EBGT*5)+6Z6%22%4IAE.0<J3S5\>%<^+)=<FO?.673QI
MSV[PC#1ABV2<_>))SQC':NBHH XS0/ ESH,D5HGB6^N-"MY/,M]-DC3Y,'*J
M9<;F4'D+QT&<C@VG\(27;Z>FI:D+NWT^]%[;YMPLJN"2JE]Q^49[*"0 ">N>
MIHH I:O8R:GI%W81SB#[3$T32%-Y56!!P,CGFL'3/"VKZ1X<M]%LO$0C@MX1
M!%+]B4R* , Y+8S^%=710!@GPS'+,RW,J7-BME]CAM9HMP0$89B<_,6'!]AQ
MC)SC-\.Q-X.M- N=;NI'T^9)M.OU0+-;,F=O<A@ <<]OP-=O10!RDWA"]OO#
MFHZ=J>OS7MW?P&VENWMT0)&000D:X"DY)).23CT #Y/"4TM_X<NVU)=^AJZQ
M@6_$NY/+.[YN/E]._/M7444 < OPSD328=+C\1WBV=IJ*W]FGD1DQ,)#)AB1
ME^2<9]>0:V[3PO<6>OZSJT>IAI=3ABA99+?(01J0I&&&3\QSZGTKI** /*=>
MTR'PMH7AKPU/KT]A9VS2.NIR6:O!A5(6.56!4DER03@?)ZX-:>B:=)XATZ^T
M6\UN#7O#UU:LAGM[%;81/D;0C)\K<;CP/E*CUKT.B@#E_#OA;4=(>'^TO$MY
MJ\5J-MI'-$B>7QC+,O+M@D9)[GC-:6H:1<7VM:;?"^5(+%VD%L8=P=V4KN)S
MU"L0/3)ZUK44 <YXO\*GQ5!IZ+?M8R6-VEY%/'$&=9%SC!)P!R<C'/%4]4\%
MW=SX@CU_2]>FTK5&@%O=R0VZR1W* Y&4?(##L>:Z^B@#F-1\'+=G1);;5+FV
MN])F>5+@JLC2&12LFX$8RVXG., ]NU;M_IUMJFEW&FWJ>=;7$30RJQ^\I&#S
MZ^]6J* .4L_!LB6>EZ?J.J-?:?I4J2VL;0A9&*#$?FODA]O!X"Y(&<U;MO#D
MUOXRO/$7]H!C=6Z6S6_D8"HA)7!W9SR>??I7044 -<,48(0KX^4L,@'W'&:Q
M/"_AU_#5C=6OVT7*SW,MUN,6PJ\C%F'4Y&3Q6[10!C#P^MSK,&JZI<?:[BUS
M]EC";(H"1@L%R27(XW$G Z8R<MN-+UJ74[F6+Q T5C.H"VWV1"\/&"4D]3U^
M8-BMNB@"MIVGVVE:;;:?91"*VMXQ'&@.<*!Z]_K6-!X<_LJT\1/::A/%/JL\
MEUYR1!VMW:-5!5?XL;0<=ZZ*B@#+\.0ZE;^'[2+5KAKB]12'E=0K,-QVE@.-
MVW;G'?-:E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M Z*BL7P==SW_ ()T&\NI6EN)]/@EED;J[-&I)/U)K:H **** "BBB@ HHHH
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M0@]#4FH"&\\::]KUC<1/I2>'&M;BXC<&*6<NQ4;APS!?3IN [UZ70  ,#@4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'BK1?M]O9&\VRW,AB@=HG$4KCJJ2$;&/!X!SQ1XL\10>%/"VH:W<(72UCW!
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MA_&FMP36IU,PXB2-I&BBX2-<*"2"S,__ &TH [:BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>FBWN8)(/L]C9[(]0C9"<29=MVW!.2/4'K7,>'H=%L_A+9K<0M%)?:HUL$M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%8/B7Q,
MF@?8+6&W-WJFI3>196H?;O;&69FP=J*.2<'Z5#J%YXFTJP^V-%IU^ R^;%"C
MQ-$A8!F!+-OVC)QA<X_"@#I**YC1O$-Y=^+O$VE7XM8[;2_LWDNF06$JLQW$
MG&> .,5LZD=1#69T^2S1/M*_:?M(;F'G(3'\><8SQUH BOO#VE:EJ%O?WEH)
M;NV),$I=@T1/4I@_+G';K5J^L+;4K*6RO(O-MI5*21DD!U/4''4'TJ9Y8XRH
M>1%+G"ACC)]!6)X@UYM,OM(TVW\L7>J7#0QO*-RQ!49V8@$9X7 &1R?:@"]_
M8>F'13H[643Z;Y?E?9I!O39V7!SP.WI4&B^%M"\.V<UII.EV]K!.<RJJY\SM
M\Q.21UX/K3;*]U2PT.\N_$*VIEM3*^^R#;9(5&0VUB2K$9^7)^M8=MXD\17G
MA:V\26EOI=S:W,:3"T1G#PQMCDR9(=E!R5VKT(S0!LZ+X.\.^'+J>YT?2+6S
MGF&'>)><9S@>@]A@<4C^"_#<EG>6C:+:&"\E\Z=-F-[YSGV.<GC'4^M7CK-B
M-=71A,IOC;M<F,$?*@95!/IDMQ]#5SS8]X3>NXD@#/.1UH QE\'>'8WF>/2+
M9'F@^SR,B[2\?]TD>N3GUSSFI&\*Z*]M96S6(,-@P:T3S'Q 1T*<\$=L=*U4
MFBD9E21&9#A@K E?K5/3-9L=8%TUC,LR6T[6[NI!!=0-V/7!./J#0 D&B:=;
M:M/JD-L%OIU"RS[V+.HZ \\@=AV[4NI:)INKM"VH6<5P\&3"[CYHB<9*GJIX
M'(YJXDL<N[RY$?:<-M.<'T-"RQM(T:R(77[R@\CZB@"A9Z!IEA]H:WMV$MPH
M6:9Y7>5P.@,C$M@9.!GC-51X/T :9#I@TV,6,$GFQ6X=MB/G.X#. <\_4D]Z
MVPRDX# D>] 8,,@@CVH P[GP;X<O+NZN[G1[6:>[C\J>1UR9%QMY]\<9Z^]3
M0^%]%MKNWNK>P2&>VB\F%XV93''_ '1@\ ]2.YYK4,T2RB(R()&&0A89(^E*
M\D<>=[JN!N.3C ]: .9U7P+HM_H5WI46GP+%=S>?)O9B!*<YEQGE^?;/<UT@
MA46X@R^T+LSN(;&,=1SGWI^Y=N[<-N,YSQBN9T[Q#>7?CW4M$<6K64%E%=02
M19+-O9E.XYQ_#V% &KI6@:7H8F&F6BVRS.9)%1CAW/5B,XW''7K3I]#TZXU:
M+5);;=?0J4CGWL&13U P> >X[UC>./$=_P"&+"QN[**VF%S>PV;),&&WS#@,
M"#V],?C6A%+X@BU.UCN8]/FLY"PF>#>KQ?*2IP2002,?B* &/X/T"33[RPDT
MR)[2]E$US$S,1+)D'>W/+9 R>IQ4M_X8T;4[^*^O;%9KJ(%8I6=MT8/4+S\O
MX58TQ]06TF;5I;(RK-)M:UW!!'GY0V[^+&,]LU=61&9E5U++]X \CZT 4=/T
M/2]+FEFL;""&:7_63*@\Q_\ >;J?Q-077AS2IAJT@TVWDFU6(1WF\E1<!5*J
M&(S@ '' K46:)I&C61#(OWE##(^HH::)/O2(O(7E@.3T'UH HZ#I$6@Z):Z9
M 08X%(&!@#))P!DX S@#)P,4^TTBQL;JYN;>$I-<G,[&1F\PX !.3R< #/H,
M5<DD2)"\CJB#JS' %4M4;4?LT+:7)9K)Y\?F-=;BIBS\VW;_ !8Z=LT 0WOA
MO1M1TF+2KK3X9-.B552UY$8 Q@;1P<8&/2I&T+3'O+"\>T5[G3U=;65V+-$'
M&&P2>XXJ\\T43*LDB(7.%#,!D^U<[KVO7^E^*O#>G01V[6FISRQ3,X8R+MC9
MQMYQV'7- %@>#M 6ZN+H:<HN+@YGE$C[I3_M'.3^-6H_#VCPZ-/I$.FVT6GS
MJRRV\<857###9QU)]>M6-3U*UT?2[K4;Z416MM&TLKGLH&?Q/M6'IVI^)-:T
M>+5[2WL+6*XC$UO970=I'0C*[Y%.$)&#@*V,]Z --/#NDQ7%E/'9JDMC$(;5
ME=AY48 &U>>F ,COCFG:QH&E:_%%%JME'=QQ/O1)"=JM_>QG&?>LBR\=:?>>
M"K_Q&(9(_P"STF%W:.1YD4L0):,]L\<'W!K-O/%'B#2X].N[E=+FL]5-M!;^
M6KH\%Q,ZC##<=Z!26R-I^7'&<T =S'&L4:QKG:H &6)./J>33JYS36\6KKKQ
MZG+HKZ4-_ER0+(D\O *_*20,?,#R<\=*Z RQB41&11(1D(3R1]* 'T4QY8XV
M57D12YPH9L;C[4KRQQ_?=5P"?F..!U- #J*** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEADL)HU9!A'\LMO [-D=?KZFL>:QLQX4^*\ MH1#'<SR(@0;586ZD$#L<\T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "D(# @@$'@@TM% &#I?ARWL-+DT.>W@NM(4M
M]GBF4-L0DGRV4C! R0#Z8!Z9.K8Z=9:7;"VT^T@M8!TB@C"*/P'%6:* *-OH
MVF6E_-?VVG6L-Y-_K9XX55Y/]Y@,G\:A_P"$:T+R[F/^QK#9='-POV9,3'U?
MCYOQK4HH S3X>T4M:L=)L2UH,6Q^SKF$?[''R_A2-X=T5]9&L-I-D=2'2[,"
M^8.WWL9SCC-:=% &=)I5A!=S:I!I=N^I,A4S)&BRN/0N>WU-<Y\/O"":!X6T
MRVU/2[5-4LPP:50KY8D_.I]<'&>#VZ5VE% &9<>'-#N[V>]N-(L9;J>(PRS2
M6ZL\B$8*DD9(QQ]*7_A']&\VTD_LFQ\RS79;-]G7,*^B''RCZ5I44 07EE:Z
MA;/;7MM%<0/PT4R!E;Z@\&FV.G66EVPMK"T@M8%Z101A%'X#BK-<CXD\:KH'
MBO0]*:#=;7DHBN[CM 9 PA'_  )D;\%- &ZV@:.]S<7+:59&XN5VSRF!=TJ^
MC'&2/K49\,Z";:"V.BZ>;>W??#%]F3;&WJHQ@'W%:A(4$D@ <DFJ]GJ%EJ"N
MUE>6]RJ':QAE5PI]#@\4 4IO"^@7%Q=7$VBZ?)-=)Y=Q(]LA:5?1CCD<#\A4
MJZ!HZ7:7::59+<I$(5E6!0RQ@8"@XR%]NE6(-1L;FYEMK>]MY9XO]9%'*K,G
MU .12'4K%;X6+7MN+LC(@,J^81_NYS0!7C\.Z+%87%A'I%BEG<',T"VZA)#Z
MLN,'\:+;P]HUGI3Z5;:59Q:>^=]LD"B-L]<KC!_&K?VZT+RH+J#?",RKY@R@
M]3Z?C2"_LS!'.+N Q2.$23S!M9B<  ]SGC% %*7PSH,]M:VTVBZ?)!:-NMXF
MMD*Q'_9&,#\*63PUH4MO<6\FC:>\-S+Y\\;6R%99/[[#')]S5C^UM-^SW-Q]
MOM3#:Y^T2"92L6.NXYX_&L<:^FO^%%U/0M5L[0RE&6>Y =47<.&7(P2N<9/>
M@#H8HHX8EBB14C0855& !Z"J5[H>E:C.)[S3[>:8+L$K(-^W^[GKCVZ59GOK
M2V9EGNH(F6,RL)) I" X+'/;)'/O2I=VTEH+I+B)K8KO$RN"A7USTQ[T -AL
M+.WLA906L,5J%VB%(PJ >FT<52C\,Z%%8R6,>C:>EG*<R0+;((V/NN,&KMM?
M6EZI:UNH)U!QF*0,,^G%8_BOQ.OARULTB@^U:CJ%RMI96V[:'D;NQ[*!R30!
M=D\.:)-9PV<ND6+VT#!HH6MU*1D="HQ@'Z4FH^&]$U>:WFU'2+*[DM_]2\\"
MN4'H,CI[5CZYJ7B'PUHTNM7$EEJ-O:KYMW;0VS1.(Q]YHV+MRHR<,.<=11KO
MC6RM+'0Y+&[M_P#B=7$,<,LC#]W$ZEC(03Z*0,\9(STQ0!NZKHFE:Y;+;:KI
MUK>PJ=RI<1!PI]1GI3)_#^BW-O;6\^DV,L-KC[/&]NI6''3:,?+^%<A'XCU9
M?$7_  C-QKNF>=+#-=0:A$BD^6"BQ(R$[=Y+,3CJ%&,9R.C\-'7 MTFO:CIE
MU=*4'E6"%1#\O.[)R<GGD"@#= "@ # ' %9#>%/#KFY+:%II-U()9\VJ'S7!
MR"W')SSS5^WU&QO)I8;:]MYY8N)$BE5F3Z@'BD74K%[YK%;VV:\49-N)5,@'
MKMSF@" :#HXN;BY&EV0GN5VSR^0NZ4>C'&2/K4;^&="DTG^RGT>P.G;MPM?L
MZ^6&]0N, ^]6I=0LMYM_M]O'.S^2H\Q=PDQD#![XYQ5+1=9-_<ZAIURJ)J.G
M2+'<*GW65AN21?0,.W8AADXR0"Q8:#I&ES--I^EV=K*RA&>&%48J.@R!T]J6
M_P!$TK598I=0TVTNY(CF-IX5<H?49'%7Z* (I;6WGM6M988Y+=EV-$R@J5],
M>E5$T'2(M+;3(]+LDT]L[K58%$1SU^7&*T** ,S_ (1W1,VA_LBQS9C%L?LZ
M_N1Z)Q\OX5)!H>DVTMS+!IEG')=#%PR0*#,/1^/F_&K]% &9IOAW1='MYK?3
M=*L[2&<YE2"%4#_7 YKF_%_A!;G0]/TO0M&LTMX]2@NYH$5(HRB/N88Z$D<=
M,>M=O10!2L]*T^SBD%O8PP^>!YJA!E^,88]\#BJMMX5\/V8MQ;:'IT/V>4S0
M^7;(OEN>K+@<'W]JUZ* *5GI&FZ=///9:?:VTTYS-)#$J-(?5B!S^-7:** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@!DTT=O#)-,ZQQ1J7=V. H R2:\XU#PSJ_C#P?JK^
M;91G6B+R 21/YL0 !@&[=@$*JYXZEO4UZ+<VMO>V[V]U!%/ _#1RH&5OJ#P:
M;%96MO:"TAMH8[8*5$*1@)@]MHXQ0!Y=J?C!];^$>DZU-N,27UM%KD:C)5$D
M F# =B0./[K>]:OBB72IM,\0ZQX7N$GUV3164RV4V\")>5.%. W+;3U^4XZ5
MVEKHFDV44T5II=E;QS#;*D5NB"0>C #G\:?IVDZ;H\#0:9I]K90LVXQVT*QJ
M3ZX4#F@#DM)N/">L1^&]1TF2WEU"VM733XH)?FC5H\.)%!Z# !W#@X[D5RD)
MBU+]GZZEGW?VQ \KRMTG2_$QQ[ARQ4#O@@5ZM8Z)I6ESS3:?IEG:2SG,KP0*
MC2'_ &B!S2?V)I7]HG4/[,L_MI()N/(7S"1P#NQG- '%6%Q]B^+#R:K-#!._
MAF!I6=@H9UF?><^U<=:16%Y\-/"8989&3Q4J=MR*UW)D>HR,5[3=Z3IM_<V]
MS>:?:W$]L=T$LT*NT1]5)&1^%1'P_HK0) VD6!AC<R)&;9"JL>K 8X/O0!Q,
M=C:67Q,\16=G:PP02^'X9'ABC"JS!Y #M'&<8%<U=#3Y_P!G;2V46SSP)8L2
M-I:-C.@SZ@XW#\Z]@CTK3HKTWL>GVJ79&TSK"HD(]-V,U%_PC^BFT-I_9%A]
MF+F0P_9DV;SU;;C&?>@#C[O2]/NOCA&+BSMY=_AYI'5XP0S"X4 D=R!Z_P!*
MYB!%B^%\\<=S!;P67B=_+MY7"1S(MWD09Z*#[\#'.!DUZU_8VE_:A=?V;9_:
M%38)?(7>%QC&<9QCM6#XB\+R2Z=!!H&GZ.L2W(GNK&XA"0WB@'"L54X()##@
M\J,\4 4M!TVSU/XA:EXI1;(;[.*WBC62*64.-VZ0E"P7@A.#R!SVJK\2[:6U
MUGPCXE96:QTG4#]L(&?*CD 7S#[+CD^]:6@^$TM]6M]4D\.Z)HDUN&VKIAW-
M+N4KAV$:#;SG;@\@'(Q@]@RAU*L 5(P01P10!S7CS4;>U\!:L=PE>\M)+:UC
M3YC/)(I5%4#[Q)(Z=JXZ[T0Z'H7PRTR^2-KJ#48(I<@'GR9"5SW )Q7HUIX?
MT:PN!<6>DV-O,H(62*W16&>N"!Q4MYI.FZA+'+>Z?:W,D7^K>:%7*?0D<4 <
MA-;VP^-MFGDQ?\B_*P7:.OGI@US&I?:+"R^*_P#8T9BF22!@MN-I"F%#(1CH
M<%SGUKU0Z-I9O5O#IMF;I0 L_D+O '3#8S3[;2]/L[B6XM;"U@FF_P!;)%"J
ML_\ O$#)_&@#E(;CPOJLFF:IX?EMYM3CT^6/3TMI/]7&4SAT!X4$*/F'#$#K
M7,>&E\/>(O"_AB6Y\17*ZE87$3BT1H5N%NQPZD;-Y#,6+9/(Y)[UZ?I^BZ5I
M+3-INF6=FTQW2FW@6,N?4X S21:'I,&IR:G#I=E'?R9#W20*)6SURV,F@#A_
M!>@Z//XH\722:;:/)::V'MRT0/DL(D(*?W3DDY']*N:>'/QOUEHL^2-%MQ-C
MIYGF-MS[[<UUUOI5AI[S3V&G6D$\H)=HHEC,AZ_,0,]:@TC1UT^>^O9F62_O
MY1+<2 <<#:B+_LJHQ[G)[T :E%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[ ;M4MP,GJ=W2N&TG3;W3/$^J?#];=_[%N+@:G#+CY8[1B3)#^,@"8_NNQH
MWO 'BS5O%5UKLNH106MO97?DP0+&1($*A@78L?FP1D #G-=99ZQIFH2/'9:C
M:7+QC<ZPSJY4>I / KS'3+VQM+'XJ3WT4ES:1WTOGPPOM=T,0! (Z=QGMSZ5
M)I][9R?$GPWOO].DBFT26!8;=@8T4M'LBW$DN<>N,]<"@#TF'6=+N;B.W@U*
MSEFE#&.-)U9G"G#8 .3@@@^E$6K:?>3S6EEJ5G+>(I)C2579.V2H.<9^E>4Z
M%I<?_"G=;OM(LH#K$+ZBMO/%&#+'F1P0C=5.SH!76Z#J/@W7V\,WNG26\]_:
MV[+9Q02_/;(T8#AT!X   ^8=<8Y(H E\$^+/[0T*%M=U.R749[VXMXD++$9=
MDK( B$Y/ 'J:[*O"Y;:S7X(ZK?K%"+E-99UGVC>I%\,$-U'!/YGUKW2@#E['
M7=2E^(NHZ#<I;"S@L([J$Q@[SN=E^8G_ '>P[]ZA\23>,U6]O=$DTN"VLU+1
MP7<+.]UM&6RP8!!U X/3)(S5>S93\:M47(S_ &';\?\ ;:3_ !%3>)_$VB27
M$WAN?7;"Q>1,7LDUTD;1Q-U1<D'>PX_V0<]=H(!N>&]8'B#PUINKB$P?;+=)
MO+)SM+#.,]_K5N_EN8;&5[.!9[G&(HV;:I8\#<>P[GVS6;:^(?#L%CIB6VHV
M<=K=M]FL ' 64K\NV/U'&!CCICJ*U+R\MM/LYKR\GC@MH4+R2R-A54=R: .-
MMM9\4Z-XTTK1]>ET^_L]76;R9K.!H6MY(TWE2"S94C@'KFAO%6J:A8>(M8TK
M[/\ 8M%FEAC@D0DW9A4&7YL_*#RJX'49.0<4[2_$?AS6?$$&J2:UI\MVZFVT
MZRBN4DDC5R"S%5).]L#/]U5YQ\U8>B,/#W@'QQIUW\MS9W=Z0A^]()5W1$#O
MOW #U/% '57%_KOB'3[&Z\+W%E9VMS:I="ZO(3*6WC*H%##&!]XDGJ, \U5T
M#QN7\%ZAK7B2.*SFTJ>:VO?)R49XFVDIGDY. !Z\54T[5[7P1X*\/Z!?ZC8V
M>KM8H@6[G5%B(4;G;)&0I. !RQ&!W(QO%\.CW?PR^S:%>)J6G:?J$$VHRV[^
M9YB^8'E9F7@M\V]L=/:@#OM"GU?4+>._U(1V:RC>EBBY:-2.!(YZMCD@  =.
M>M;->?3:3;:?\4?#MQX=BA@ANK2Y;4TM0!')"%7RG8#C.]L!NIY]#7H- !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
=HHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>elicio-insidertradingcom001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?3KE7E!Z%5,>3^%6)/'7AZ'2KS4Y;R:.TLIO(N7>SF4PO\IPRE-P^\O)&.:
M.BHK-TK7M-UO25U6PN"]BREEGDC:)2HZGYP..#S69;>/- OEEELYKJZM8F*O
M=V]E-) ".O[Q4*G'<@X% '2T5BMXMT0:7:ZBE\)K:\E,5J84:1IW!(PBJ"6^
MZ>@Z#/2IK#Q#INHW[V$,LBWL<?FO;S0O'(JY R0P'!)X/0\XZ4 :E%%<_?\
MC?P_IFO0:'>7DL>ISX\FW^RS,9 20"I"D$9!Y![4 =!17.W7CGPY8>((-"O-
M1^S:E.0(H9H)$WYX&&*[3DC'7KQ6E=ZU96.H6EA<-,+B[)$*I;R.&(&3\RJ0
M,#GDB@#0HK&UGQ5HV@W-O:WUWB\N?]1:PQM--)]$0%B/?&*+7Q3I-WJ,.G+-
M-%?S LEM<6\D,A4 DMM<#CCKTSQ0!LT444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'Q]_Y)=<?]?4/\Z]/
MKEO'O@Y_'/A_^QSJ LH&E61W$'F,2O0#Y@!^M &-X'GO]2L;>PUBP2#3;;2-
M.GM3YV]9"-S>8>!M(*)QVQUYKF/B-_R7CP)_P#_T8:[=_".N/X<M="'B2"*T
MA@CMG>'3MLLL2@#:6,A R!@D#O5;Q-\/+CQ#XTTOQ*FM):S:9M^SP_8]ZG#%
MOF.\9Z]L4 =RTB(4#NJESM4$XW'!.!^ /Y5XM\-F9?C3\065=S!Y"!ZGS37I
M!T'6;G7K#4;[7(9(;'S&CM(+(QHTC(R!F)D8G 8\>]9/AGX>S>'/&>K^(_[8
M2X?569IX#:[ N6W?*=YQ^.: .,_9^F;59/%.MWS>;JMS=()I&^\ 03CV&<\?
M[(]*]C:PMFU./43&/M20M )!UV,RL0?Q4?KZUR$/P^?1/%%[KOA;5$TYK_F\
MLY[;S[>1LD[@ RE3DD\'N>W%='::?J41EN+K5%GNW38@6 I!&,]H]Q))[DL3
MZ8H \/\ A3>76G_#7X@7EB6%U 99(F7JK")B"/IU_"NS^ $,2?#03+@RSWDS
MS-W+<#G\ *VO 'P[_P"$&@U&W_M-=0M[Y_,D22UV$'!'7<1CGIBI-"\#77A!
MKZ#PSJL-OIUW*9A9WEJ9Q Y&"4974XX'!ST'- '#> YIK/\ :#\8Z=:$BPF1
MYID7[HD#(0WUR[#\37M#6\+727)C!FC1HU?N%8J2/Q*K^5<[X1\$V7A1K^Z$
M\E[JFHRF:\O9@ TC$DX '"KDGC_ZU=+()#&PB95?'RLR[@#[C(S^= 'BWP)B
M2>Z\<12H'C>]564C@@F0$5'\4 ]O\8? 2VD*N\9011L^T'$G +8./K@UW'@/
MX?2>![O5)EU9;U-2E$LJM;>658;ONG>>/F/44WQ-\/9O$?C/2/$?]L);OI3*
MT$'V3>&PV[YCO&?PQ0!P7Q$GU";XO> #J%E#:L+N/8(K@R[AYR=3M7%6?B>\
MT?QN\$/;Q"68!2D;/M#'S#QG!Q79^*/A[/XF\6:+K[ZPEO)I+K)#$MH6#L&#
M?,=_0D=L4WQ)\/+KQ#XQTGQ)_;<=O<:6%\F(6996(;=\W[P$Y)[8H V?"DMS
MJ6EVVJ:Q:K;ZL)KR#87W&-?M#?(#_$,1IS_LYKQWP[XF;PE\0/B5J_\ 9=S?
MQ07#&1;<J"@\UN3DYQZD XZU[''H6L2:[;:C?:Y#+#;+)Y5G!9>5'YC#&]B7
M8D@%N,]S6/X;^'3:!XHUS69=4BO5UIF-U;/:;5^9B< [SQ\Q'(/% &-\#-$^
MR>&K[7?ML$YUJ?S_ ";<G9;X+?(<X^;+$'Z#K7+?%[4S<7=MXHTS6+;[3H&H
M"&"R$Z[B 1YDFS.?]8 A']U<]#7>^&?AQ=^#9=6CT'Q"T-C?LSQVL]KYHMF/
M1E.\9(''/7 STK?/AHR^"&\-SW$,JM:?9&F,!P5V[=Q7?G=WSGKS0!2UC6+;
MQ!\)=4U:T.8+O1IY5&>5S$V0?<'(/TKR+PUX7UKQS\%M%T"PMH(+87\D\M]<
M2C"@.XPJ#))^;OCI[YKTS0/AW>Z!X%U#PHGB 7%K=)+'')+9_-"LBD.  _/4
MD>A)ZUL>!/"3^"O#D>BB_%Y!$[-&Y@\MAN))!^8@\GVH \Q^*%N^G?$;X;6U
MN#</;R1QIYC;3(5DC R><9QUKU#PO+=:G:?VCK5HMMJ<5U<PI'YF[RD\S 4-
MW!5%.>^,UD^+OA[/XI\4Z/KHUE+2327$EO%]DW@L&#?,=XSR!TQ6PFA:Q-K]
MCJ%_K<,EM:%W6SMK+RE=V0IN9B[$X#'CI0!YQ\/?^2^^.?\ <;_T8E>DI;PW
M?B_6H)XQ)$^G6:LK="/,N.#6--\/[BS\=7/BSP]JT=C=7D?EW=O<VOGQ2].1
MAU*GY0>O7ZUT^E:7)8O<W-U<_:KZZ93-,$V+A1A55<G:HYX))R2<\T >4?$'
M_DOW@?\ W%_]&/76?%RWAA^%OB66.,*\R1O(P_B(>-03^  _"I/$/P^GU[QU
MI7BC^V$@DTS:(8/LFY6 8GYCO&>O;%;7C'PY+XL\+W6A_;5M$NE599?)WG 8
M-\HW#'([YH \7\6:E>V'[-/AN&U9DCO&C@N&7^Y^\;;^)4?RKV_PI:VUEX1T
M>WLU5;=+.+9MZ$; <_CU_&LBR\ V0^'Z>#M6F6_LHX_+618O*<8.0WWC\P/?
M]*-"\,>(O#^EPZ1;>);>:P@7RX'N-/+3QQCHN\2!3@< E?P- &%\0?!6J36^
MBWG@R>.VU71IKBYM[4L )!*P+[<\=3C!XPQ'I47P^^($GB/Q/)I'B316TSQ1
M:6S+G:566/*EA@\@\ CJ,9(-=;>>&;Q]1TJ^L-;G@GT^&:(^?'YPN?,*$^9R
M.,IG"XY(Q@#%5V\'M<:Y=^(-1U%?[3:P:QMYK6'RA;1G)+ %F)?)SDG\* .L
MKQ;QQ_R<9X,_Z]E_]#EKO/AUI.JZ+X;EM-4U&ZU#%U(;:>[!64P\ 9!)(R0Q
M )S@CITJGKGP]GUKQ_IGBS^V$AFTY0D-O]DW*5!8_,=X)/S'IB@#-^(7@*W\
M=ZAJ4"E8M3M;"VDLIS_"WF7&5/\ LM@9], ]JQ_ASXWO=<U73/#?B".2+Q!I
M$LJ3>8.94$3+N/\ M X!]<@]S7IMOIE]%XCN=3DOX7@G@C@^SK;%2H0N0=^\
M\YD.>.PZ54G\'Z?)XVM/%<0\F_BA>"7:.)T(P-WN/7TX], 'F7PIN)-9^+OC
M;4]2RVH0N8(@_6./S&7:/3 11_\ KKV6>PMKF\M;N6(&XM2QB?NNY=K#Z$?R
M%<G>_#\1>,'\5>'M2_LO4YD*72/!YT%R./O)N4@\#D,.GUSO6VFZFTK3ZEJW
MFR^6R1I:0F"),_Q;2S%F],G ]* ->BN>\&^'+SPOH1T^]UNZUB4S/)]IN<[@
M#CY1DDX&,]>I-=#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445R'Q-
MUS4?#/@6^UO2YUCN;0QX62,.CAI%4Y!Y[]C0!U]%><2:WXINOA/IWB#3;R*3
M6[E('$+P)Y<C2NJ! .,?>X.?K[1>!OB--XQ\+:C;SR+I_B;38W\^+RQR5SAP
MC=LC##J#Z9% 'IE%>;^(_'$_AZ3PEIU]J26BZNK/=ZH\2XB 4'"C&T99@,G(
M4<G/6NHTXZRVIR12ZA%>:5):B2UO8HU$F_=R&(^0\8(( !R>.,T =!17E_PQ
M\6Z]XPU+Q);ZG?(J:9.L$/V>!5+9+C<<@_W!5+P%XK\8^,_^$CC74[*&YTN<
M16X>SRDA^?[^&!'W1T/>@#UVBO.O"'Q#F\9>%-9D,8T[7-*5A<1( ZA@&*L
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MXD8=&5 #2RVT$Y!E@CD(X!= : .07QKHFB>!+&[.HV<LXLHEA@2=2TLA0!4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"T@^GR<5U]W9VU_:R6MY;PW-O(,/%,@=&'N#P:?%%'!"D,,:1Q( J(BX"@=
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M%J3/<PF4#]Y)@!01U]2>/0]J[>.?$1\&G6GBLX9M)U-K'6XUA:0!$<*\D7S
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M3E>3GH>#FMBV\5>(8(+33M4L8[?5+W5&LK2X>/:DL(4OYQ3<2#M4C;G[V.U
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MU!9DB VF."22./)'8NN6([;\'D4 >HZ?X@TO5)A#9W.]VC\U T;)YD><;TW
M;UY'S+D<CU%4)O'?A>#7!HTNLVZ7QD\H(=VWS/[F_&W=VQG-8GC8_P!G^)O
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M;Y64J5#*>C>O:N@HH YBR\-ZC9>+-4UP:C;R&]MHK<1M;D%?+W88D-SG<<@
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M,K\_W<.>"<YQD^O<T4 <:_@V_:'PHG]IVP_L J<_9F_?XC,?]_Y>#GOS5)_
M.J6MAXATC2]9MXM&UCSW\F>U+R6[RJ0P1@X&TDYY!Q^M=_10!0T:PFTO0[+3
MY;A+B2V@2'S5CV!MHP#MR<=/6L;PWX8O=#U_7=2GU"WN$U:=9VC2W*&(A=H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:5_'>&2Y>2WV0B/RH3C;&<'YB.?F[YH T**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J:G:2W^F7-I#,L+3QM
M'YC1[]H(P3C(YYJW10!B>%]!E\,^&+715O%N!:1^7#*T.TXYQN&[GKVQ6 ?A
MY*? \GA<ZP/)>Z^TF?[+\P/G>=C&_'WOT_.NZHH Y[_A'+AO&D7B-]00NE@;
M$P+;X!4L'+9W<'</R_.JUKX0F-[HEUJNI1WTVC!OL\RVWERN2A3YVW'(P2<
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M# 5PC;R2P(QT))S]35;P_HEMX=T:+3;542)'=PL:[44NQ8A1V )P!_.M2B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB._&J&,[;F78T9?'>+;M"Y] #[U;.LP:=;6<&H/*;][<2/!#$\TG &YMJ G
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M\N[:'*[=P'5<Y'0\\58U#Q;H^F&\-S</Y=B5%W+'"[I;E@"-Y4''!!/H""<
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M5LUN=N^4P^80%8-P-R]UK;B$@B43.KR ?,R+M!/L,G'YFGT4 %%%% !1110
M4444 5K6RBM'GD4L\L[[Y)'.2V!@#T     _F2:LT44 %%%% !1110 4=:**
M *.EZ7'I%NUI;.19JV882/\ 4@G)53_=]!VZ=, 7J** "BBB@ K-U32IM2:(
MQ:MJ%AL!R+0QC?GUWHW3VQUK2HH Y[_A&+O_ *&O7O\ ON#_ .-4?\(Q=_\
M0UZ]_P!]P?\ QJNAHH Y[_A&+O\ Z&O7O^^X/_C5'_",7?\ T->O?]]P?_&J
MZ&B@#A?$?P^O]=L8K5/&&J(J3),?M$44H)1@RX"JF""/4UKIX7O0BA_%FN%\
M<D-  3]/*XKHZ* .>_X1B[_Z&O7O^^X/_C5'_",7?_0UZ]_WW!_\:KH:* .,
MN_ ^IWMZ!<>,]8?3,*QM#'#N,BMN!W[.F0/EV]NN.*Z'2]*FTYI&EU?4+_>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !117CGBWX]6WAKQC/HL6C/=V]I((
M[F?SMC;OXMBXYQ[D9]NM 'L=%0VES%>V<%W VZ&>-9$.,95AD?H:FH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@?K7-_#Z^OKK3]8M+Z\EO&TW5[FRBGFP9'C0@KN(QD_-C/M6_KG_ "+^I?\
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M# E2 2I(ZCJ* %HKR%#XFU#P=XDUB/Q7?QWFC7][]F4)&$D6%C\L@V_-D+C
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M@B\B!(O,DDVC&^1LL?J:X;Q?!)<_$GP5#%<R6S/'J \V, LH\M,XR" ??!H
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M?S&:5)I+UY@;@R(RE7W8P,;1@8Q@=*FE\*03ZUI&JRZEJ#W.EI(L6YD(?S
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M:2B:UN[239+ _JIP>O<$5NT4 <W+X)TV\\/SZ3J$][?&=EDDO)YLS[UQM96
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M@\R57!1L;MV5R<X'TQQBH/L]KX"M;R\@M]:U,:E?F::*VA6=Q*XY?:H7"_*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG.<$8&,=J -.BJ=MJVFWMPUO:ZA:3S*"QCBF5F !P3@'/6KE !1110 4444
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MQ;P:58_:D.5G^SIO'T;&: ."NM;6W^(<0\0ZB^BI>Z-";5G\H1A]S&:,M(I
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M:5IS3&9M/M3*8O)+F%<^7C&S./N^W2@Z1IK-"S:?:%H%"Q$PKF,#H%XX'TH
MN5P&C/9#XI^-+6[:#=<16'EQ2XS(!%)NP#U]Z[^JTNGV4\[3S6=O)*T?E&1X
M@6*?W<D=/:@#R#0K;P[8? &+5M0TJ*Z!MGAE>,[)&#S[=IE'S*N=N?0#IVK:
MT^[M+GXOS1W>H:==BX\/*C+!M\IB)R=@!)W$#GGL>@%>B1:9I\-K):Q6-M';
MR9$D2Q*$?/7(Q@TU=(TQ%15TZT54C,2@0* J'DJ..![=* /&-,M+.#X/>!KU
M(84N?[8LV\\* ^?/(/S=>G'TKH?$,U]H=YK>L6+VNLZ&][$=4TR4;9[>8"-0
MT3#J<",A3[8KT,Z'I!A6$Z79&)6+*GV=-H)ZD#'7BG?V-I?VM;O^S;/[2I!$
MWD+O!'3G&: /)_&VI:=<Z3\0H;62WLY5"1W2SONFNI%C7:44G"( !C .<$\8
MS6U9>)-/M?B*C:O?6Z6EWHD(TZYFD B8AF\Y0QXW$[<^RCVKT"32]/FGEGEL
M+5YIH_*DD:%2SI_=)QDCV-)=:3IM[;Q6]WI]I<018\N*6%75,=, C H \YU*
M/0M*F\ #2@EOHL.ISB&220E"ICE.0S$Y4L3@YP1C'&*MS!U^*/B!](6,7DOA
ME)(=@ WRF23:3Z_P_I7H$]E:W4217%M#-&C!E22,,%(Z$ ]"*:NG6*7AO%L[
M<71ZSB)=Y_X%C- 'DMR8M2^ 6EG3S_Q.('MEM\?ZY+\2J']]Y8N3WP2:W],T
MS3KCXL^*EN;.UE/]GVC,&C!&YA)N.#W([UW":3IT5^U_'I]JEX_WKA85$A^K
M8S0=)TUII)CI]H9901(YA7<X/7)QS0!Y5X6MKZ^\ >")-'U>"TUNWAN7M(KM
M=\-R@;:\;8Y& 5P1R #7>^!=2.I^&A*^FKI\T=U<13P1MN02K*WF%#W4MN/Z
M=JU&T+1W@6!M*L3$K%EC-NFT$XR0,=>!^57888K>%(88TCB0;51% 51Z #I0
M!Q?Q4*)X6M)9"JQQZK9,[MP%7SER2>PJM=+8:E\9-*)$%S#_ &%,\?1E)$Z
M$=CWKN[BW@NX'@N88YH7&&CD4,K#W!X-0'2=-,ZSG3[4S*H42>2NX # &<9Q
MCB@#R;3;W3=.\,_9[B&-D7QE-#8[Y3'!;R"5F1GQ_"N"=O<XZ=0V:ZAFM?BU
M +ZWNY7M%E4PX ?_ $7YF503P#QG)]SFO6/[$TG[-);?V79>1*09(OLZ;7(Z
M$C&#4Z6-G&\CQVD"/*H21EC +J!@ ^H XQ0!0\+W5M=>&=->UFBE1;:)6,;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%&: "BBB@ HHHH **** "BBB@ HHHR#WZ4 %%%% !1110 4444
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M_#OBPE_[.^T_9-1CWGRU\SB.8KG&5;J<>E;'@.RO;%O$8O;*>V^U:U<7<'F
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M,0E3DY/.> !D9-3?$'2=2O;;2=2TNQBU&XTJ\%P]A*0!<1E&1U&>-V&R,^E
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M1!;K'L&>"P)EW9Z@GH!@<T =??>,K:SU^'1HM.U"[N[BT:[@\A%VRJ"!@%F
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% &-JGARWU76=,U26[NHI]-9WMUB*!067:Q(*
MG.5..M;-%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 445E>(]=A\-:'<ZO<VUQ/;VR[Y1;A2RKZX9
MAF@#5HJIIE\-3TVWO5@E@6>-9%27;N (R,[21W]:MT %%%% !1110 445EZS
MK]GHGV:.?S);J[D\JUM85W2SMC)"@D# '))( '4B@#4HK!;Q1'9W]I::M87.
MFF\?RK::9D:*23J(]RL=K'G . >Q-1GQ?;KXT7PN^G7R7CP&X29A'Y3Q@X+
M[\GGMC/M0!T5%96IZV--U+3['[!=W,E\[(C0;-J;1DEMS @ #K@]AU(%9MKX
MS%]K6J:3:Z%JDMUIC1K<@&!0-Z[EP3*,Y% '3T5S&I^-8-'\.WVM7VDZE%#8
MR^7<PXB,B?=P>'P0=ZG@FG#QK:0ZIIVGZEI]_IDNI';:/<K&8Y6QG9NC=@&]
MCC- '2T5SNH^+[?3/%6F^'Y].OC<:CO^S3J(_*?:,MR7!! [8SZ9J]K6MC11
M9YL;N[:[N%MXUMMF0Q!(SN9>, G(Z $F@#4HKGAXLA/C ^&?[-OOMHM?MF_]
MWY?E;MF[._/WN,8S4&G^,QJE]J5G9:#JDLNG3_9[CYK=0'QGC,HR,4 =117*
MZOXZMM#\-MKE]I.II;QSF">,+$9(6#[ 6^?&"<8()ZBK&K^+X-%U32+"YTV^
M9]5D\J"2/RR@?&=K$N,''Y]LT =%16;>ZP+/6+'3?L5S,]X'99(MFR,+C<6R
MP.!D= >HK2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAN1M!TRST6P\(:U;643%5:22U(0,Q)8XF)QDD\ FNOH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVD3(;FS1PL4V.$,BC .2,\\9&<4 =Y16)'KEM8Z98I/]HN+E[193%!$TTA4
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MDES%QG.-N2,<Y&>.: -ZBLJ/Q%ITUMI=Q&\S1:H0+0BWD^?*E@2-N5&T$Y;
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MSWZ"@#1HJEI&KV&NZ9#J6FW"W%I,"4D4$=#@@@\@@@@@\BKM !1110 4444
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M/?&@0,P&!D@@9KMZ* /+86EL])^).FS65Z+FYN;N>'%LY61)(%5"K 88DC&
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M;661I8X'4JY!/WF4\J3UP>>1G!R*V:** "BBB@ HHHH **** "BBB@ HHHH
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M2&.VMXER\K!2QQV  !))(%<W\/8]6NK%]1U[:;Z '3$=6W!UA9E:3ZNX.?\
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MWIN"_*>A.3]!@Y(JJWQ T9?#]GK82\:SN;C[-D0X:*7=LV2 GY3NXR>/?D4
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MVX8YS@-\I8 J#P30!T5%8ESXGM+>>Y1+:ZN([69+>XFA166*1@I"GD$\.I)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#3.RGD<Y# UR/C.+6M:T?QGILVBZJ]UYG^@1VL)%O+" F)"PP))#@Y!W$8
M&#7K]% '"0/<3?%:VU1M.U"*T.@- 9)+5\+(9E<*2 1G:,_IUXJOX5\/C5_
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M" 2=C9&._I67+X6UN\T7Q%X<TJ_U"ZT6XTT?8FU2-DEAGW9\D,X#,A4=_NY
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M=*7PYKT?B/21?)97EDV]HY+:\B\N6-AV8?3!_&M-(8XH%@B41QJH153@* ,
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M9SDE"",<=ZTK^"]\8:?X8LWTV\LKJRU"WO+XSPLBP>2"6"N>'+-@#:3P<G%
M'<WURUG8SW*6\EPT2%Q%&5#/CL-Q _,UY9KGB&Y\0_#;0M>NK>YLW?4[23Y9
M,(ZM,,@!&.X <?,,^U>K7$9EMI8U^\Z%1GW%>2QV.K_\*I\/:.^AZC'>V%[:
M^=&8<G$<NYV&,_* .#WSQF@#T#3?%MCJ&K7VF26UY8W-I"+EEO8Q&'A)(\Q>
M3\N0<YP1W%1KXSL!?Z9;3VM[;1:H=MC=3(HBG;&0!ABRDCD!E7/UKG]9TF[U
MGQ[JHBM[F*UOO#+Z<EVT+!%F9V."<=@P/Z=>*B\(F:6/3M-OO 1LM5L=BW%]
M+:Q"W&S ,D<@.68XXP.">3@4 =]J6HVVD:9<ZA>2>7;6T9DD;&< 513Q% C7
M@OK2ZT];2W%S))<[-GE_-R&1F'&TY'7IZU+XB19/#U]')IS:C&\15[11DS*>
M&4>^,UYU_P (CJT^E^(- T:\U%]!N=-_T2/5$=6M[G=D1(7 8Q[1SG(&1R>:
M .YB\6VAURTTB[L[VPN+V)Y;0W*(%G"C+ ;6)! .2& .*A/C?31)IS&"[%EJ
M5P+6TOMB^3+(<[0/FW -@X8J >N<$&L'1,Z_"MM+X&?1+](72YO)[2-$B8H5
M/DN#EB21R !C.3TR[P1J6O6.CZ=X7OO#=[#?:>J6SWC*OV0Q)P'5\Y8E1P ,
MYZX&< &Z/&M@=(UK4OLMZ(]&FDAO(]J;U**&8CYL$ $'@U'?^.],L+JPMOLF
MI7%Q?VK75M';VVXR*%#%1SRV".!T[D5R-[::M9Z=\0]&31-0N)M4DN+FTFBB
MS%(DD"KC=G[P*D;>IX^M:%M;W_\ PE7@>XETN^BCL],F@NF,)(A=TC"ABN1R
M4/3IWQ0!L66M:1?^,5>/3]4CUIM&$_ESHT8\@N"$VLP7?N..G&",UGZ7\1R?
M!=QXEU71[^*UBN)58PB-]B"5D' ?)Q@ G'7GIS5S[/<_\+B^W_9+G[%_8GV7
M[1Y3>7YOG;]N<?W><].V<U7\!Z7.GA*]\.ZSI5Q$BSW4<IF4".9))78;#GD%
M6ZT =3-K$<-WIMJ;:=Y+\,4V;"(PH!)8[N@R.1GDCU%:-<+\.],U*WAG_M65
M9_[++Z38R@Y+PQN<N?<X12/6*NJT?4I=4M))Y=.N[!EF>(172@,P4X##!/!Z
MB@";4[^'2M,N;^?)BMXVD8+U; Z#U)Z >IKB_ &JZO#K6N>&_$4P?4X9!?PL
M#\K0S?,57V1]R_E6QXC1M5U73-%DMKTV#2_:+J>%9%7*<QIO7!!+[6R#QLP>
MM<[XHT2?0?%OAWQ%H=GJE]<12M:WT8EEN"UJXY.78XVMR ",DT =9J'BBVL)
MK^-+.\O/[/C62[-L$/E @L 0S D[1G@&MRO,_%NE27^IZAJNC6^L:;XBAB06
M5U:POY5^-@*QS C;@,2IWXQQR<8'I%OYWV:+[0%$^P>9L^[NQSCVS0!SVH>-
M]-TR'[7<07?]EBX^S/J*JI@1]VSGYMV WR[@I&>])=>-]/LM8O\ 2[JUO8KJ
MSM3=D,J8FCS@&/YOF)/&/7CK7&^'["YTB&;PQJ?@;^T+N.>3[+J;6L;VTT;.
M65Y7/*D9Y')XXYK5\9:5?Z_/)JFGVLD-]X=82Z?YEL3]KDX++TY0A=HQ_%\W
M0*2 =#J?C*QT>?2[>^M-0CN-2W>3$MOO8,JEMIVDC=QC ).2*S7\5:?XI\.>
M)+2&+4+&^L+=Q<6MRI@GB)0E6^5NAQP0:RO$6KO<:_\ #_49M.O;>0W<YEM6
MA)EC)MV## ^]C.>,Y X]*LS:5<W6L>+/$*6=RD5UI:V%K$86$L[!6);81N R
MRJ,@=">F#0!;\+Z_!IG@3P=!,D]S>ZA8PQV\,6"\C"$.QRQ   !))-.UGQ5H
M&I>!-7O=1MM0.GV\DEI?6\:D31NAPRY1L#MR&QSUK&MFUS3_  OX'LO[+U(V
M45N(-52UC*W$3K$%11T(4MG+*1P!S@\Y3:1JR?#SQWI*Z#?Q3WNHW$EI%L#>
M8LFS: 03G !R>GN: .^O?%VG:5JECHYM;^6YNK=I;=(H"^\*!QDGD\CV'<CK
M3M.\9:9J.BSZD$N8/L]T;*6VGCQ,LX8*(]H)!8EEQ@D<BL:YBN9O'_A2^2QO
M/LMO87$<\IMW C9PFT'CC[I^G>N;GT+6;O1O$<EKI4LES%XF_M>WM+J(HMY"
M @V_,,<@-P>>!ZT >@6GBVPFU2^TR[BGTZ]L[<7<D5YL&8.GF!E9E*@C!YX[
MUR/BO6QJ>I^";BWM-2MX+C6(3%/(=L4T95CRH8D$_*1O4''XU)<:>?%_A?6;
M?2_";Z!/<:?);B6\M8X)7D."$&TD[.#DG Y&,\U4OKS5]9TWP;'_ ,(SJT5W
MINJV[WL;0!50)&ZL58D!ER<@CCU() (!ZB[B.-G(8A020H))^@'6N'TSQ=X;
MT/P5'JUG;ZBFER7LD05T9W61IBK%MS' WD]3^%=PS!$+D' &2 ,G\AUKR#^R
M]4_X5*=+_LF_^W?VQY_D?9VW>7]K\W=TQC9S^G6@#T/3/%=GJ6OW&BFTOK2\
MB@%RBW4.P31%MN].2<9XP0#STIGCJ35X?!6J2:$DKZBL0,:P_P"L*[AOV?[6
MW=CWQ6:8KB3XNVVHK9W7V+^Q'MC<&!@@D:97"DD<?*#_ "ZUT&OW=_8Z0]SI
MEF]Y=)+%BWCQN=#(H<#. #M+<F@#C_#%UX<\3S:=?^&-4NH9K27=>V$MU)O9
M=K*1+&S')#$'=ZCJ:Z+5O&%EI$%[<O:7MQ9V#A+RYMT5D@. 3D%@S8!!.T-C
M/L:Y;7-#MM=\7:!J^A:3>V.KV]\DM[>O:O;K]G .]'+ "0GA1MW?7%5[>UGT
M'Q#K>GZGX*FUN'4+Z2[LKV"VCE0K(<F.5G(V;3D9/;]0#MKKQ39Q,ZV<%QJ3
MQVRW<BV80[(FR58EF4?-@X .3CI6)<^/O/U7PM%I&GW%Y9:RDLXF38I94C)V
M ,PPP)4G..!@9SQGH=7\&^-K^\;0;K4-,U:UME']E1!_LTT2;-FTD80CD'H/
MSJYKL.KGQ-X-UI](GE6U:[6XAM=KM#YL8$8/..,8+9QGVH U=.U+1&\8>(1$
MEU#J%K! ;Z6<LL6S#["H)QP V2 ![FG+XUTX'39)[:\M[+4W6.SO9D412LPR
M@X8LNX=-RC-<Y=:'?:OXF\=6P@N+:+5M+AM+:Z>)A&SJDBMSCH"X^O.*AN+'
M4?$O@/1O#$^F7EGJ,$MJEV\D)$<*PLI:19/NMD+\H4D_,.F#@ Z&Z\?Z?;W6
MKVL6FZM=3Z3M-S'!;<A64MN&XCC SS@G/&>:Z+3=0MM6TRUU&S?S+:ZB6:)L
M8RK#(X_&N)M(+N+Q-X^N7L+P0WT4 M7^SN1,4@*,%X_O<?KTK<\ 6]Q9^ M$
ML[NWEM[FVM$AEBE0JRLHP1S_ #H P]25_P#A=6D6PN;I;:73)IY(%N'$;.K@
M!BF<9P?2DT"-I/BUXMM9+BZ>VM[:U:&![F0I&9$.\A2<#.*EU&"Z;XQ:3J*V
M-XUC!ILMM)<K Q19&8$#./;J..:30H[F#XI^*=1FL+V.RO+>U6WG:W?;(8T.
MX#C/?OU[4 -^&?F27/BUIKFZG-OKUS:P^?</)Y<2[=JC<3@#)J3XCS+97GA*
M\+W "ZW$CI$7;>NR0XV+]XY48X)I?AQ;7=G<>*5O+&ZMOMFN7-[;F:%E$D3[
M=K D>W0\^U6_'ME>7 \.WEK:372:?K$5U<) NYUB".I8+U;!8<#)]J +>D>-
M],U6ZU&TEAO--N]/C\Z>#4(A$PB_YZ#D@K[YX[TY/&%D=5T_3[FTO;0ZFK&R
MFG10D^!G PQ96QSA@I_'BN>UCPU=>+=8UO4H(Y;2&?09-)MFN(VC:5W8N6*D
M!E4?*.0"<MQCDKX3FDO&L;6[\!'3=3L\?:;R:TB$*E1@M$X.6+=L=,\GCD 7
MP7J-MHNF^,KN_NI%M+37[D%Y7:1@H6,!1G))Y  ZG(%=)%XIM_[8@TF[LKRQ
MO;F)I;6.X"8N HRP0JQ&X<9!(/>N F\.:QJOA/QA:6MG/#>R^('U.SCN(S&M
MRBM&RC)X^;8>#WQG%=+?03>+?$/A>]BL;VSBTR9[NY:Z@:)D8IM$0W ;B2>2
MN5PO7D9 +3_$+3(_#=WKSV6H"TL[IK6X4QIOB=6"G<N_@!B!^O3FMXZJHU6V
MT[[+<>;/ TY<;"L:@@$,=W7+ # .><=#CC+SP==7GBS6],DC/_",ZS$EY<D'
M&)PIC9!_O8CD)_V,=ZT/!%IK&F>&I;O78'EU.&+[*$CY>2*#<J8SU+G<WOO%
M '945E^'=:'B#18M0^QW-D[,Z26URNV2-U8JP/XBM2@ HHHH **** "BBB@
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M,%DSC;L7HA R=PP<GZU=\+:-)H'AZWTV2>6;RF<J993(R*7+*FX\G:"!GVH
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M3399Y)V@# -)(7*J6)5=QY;:"%SWV]J -:BLS6M;M]#@MI)XY99+JY2U@BB
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MO#$!0NY%P/0_4[%AXLM[SQ')H<UA?65R+<W4+72*JSQ!@I9<,2,$CA@#STH
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M4NK*/O[@NWGIN)]B:!X?;1M6UJ[6>X,%_.)5AFG,FU_F+,,_=#;@-HZ!!ZX
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M&$C7HH]^2?<D\D]ZEK-T+6K;Q#I$&J6<<R6TZAHC,NTLI&0<9/%:5 !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% &9XB223PUJD4,4DTLEK)&D<8RS,RD #\37!QZ;J::1\.(3
MI=YYFE/&;X"/_4A8#&<^OS'MGBO3Z0,&&001TXH \[:QNQXC\<7%QH%Q?6.H
MI9I%"Z#%RB+LE R1@C)QG%)H>BW^BC7+73FU2;PZ]ABTM;T,98ISN!CCW?-L
MQMZ\9/!/)KT:D!!S@@XX- 'E%MH^NZ5H_@#5X]*N9Y=!ADMK^P4 2[9(PA=
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MSGBN8AT37(OA19:(^A7:7MMJRR&)=IRBW1E+#!^[MZ9P3V%>PT4 (C!T5@"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI;.24LPC8-@,00.H(YQV- '2W7C5HK#Q)Y>ER_VEH4(EFMGD7:ZLA=6#YY7
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MN"7P>#G R?85R\>E^)[M?"]_?>';N75[#4_,U"XEN(B7!5QF/YN(QD<?+CC
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MTZ5XKF>-P&.PXD:-#]Y5YR<C[IQFH]0\=QP:G8V&G:3>:G)?V+7MH\#H$F4
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MYSUK5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(]1#IY#0%\B3&[<"%XVXZ@=CD;-]I&HQ>/\ PY=6FF3RZ9IME/;23B6(8+A
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M]X=LM*1@XMX]I8# +$DM@=ADG ]*U:** "BBB@ HHHH **** "BBB@ HHHH
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MK F'4-5FL5 <*T+/<2XR,8(&#T-=BWBQ(=;UO39[&7.E6:WI:$^89D8,0%7
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ME[P5<J.V01C(([U+9^-+N76]#LKW13:VVM0L]I/]I#MO6/S"KH!P",X.3TY
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MV.: .JHKA)/B'/'X-E\0?V(<V=X]IJ%N;G_CW9'V,P8(=Z@X).!Q73OJTO\
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M;&X,$\8O0MRQ5MKF.+:=V#GJ1G:<<8R =P2 ,DX JHPL-:TV2,FWO;*X5HW
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MM/%,@8H6C<, P.",CN#P14M</HWC#3H/"9U&'1TL&FU.2QAL82N9;@RE.H
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M].IK3H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLPD-N0#YA&"0 Q(P 3T[9Q77T4 4=92>71KR&VA,TTL+QH@8+DD$#)/05D>
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M;ES),RDDN<D]22<9)XZ#)K7H Y7Q)I6HWOB[POJ%I:^;;:;--+<-YBJ</$4
M4$\D$Y/M5.ST?5K?7_&=\]@3%JR1?9 )4R2D/EG=SQD\]^/?BNVHH \SL/#G
MB:QTWPC9RZ?;WEGIUJUO>V,ER%0RX 27."'48/!&1G.,XK7\(^&KRT\-:QHO
MB"UMA;7=W=,!'+N$D<K,3Q@;>#QW^E=K65KGAK1_$L5O%K%BEW';R^=$KL0
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M)TVE(PX.TYY)WC&<=#7IE% '*:7I6HP?$36]7FM-EC>6MO#$_F*3NCW9) /
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M?B=OWZ;-HNC-USUP<=.M7_%WA:\\2SW<@T?[/J<3(=)U>"X2.2W^1<B0@[B
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M)I5Y.3>R2M>)<_:"3M+,RXP>  , 8''2MC6?#&C>()()=2LA)/!GRIDD:*1
M>H#H0P'MFK.F:/8:/"T5C!Y8<@N[.SN^.FYV)9OQ- !K44UQH=_!;Q&6:6!X
MT3<!DLI Y/0<UQK^$]9N?A;I&CQF.SUS25MI+=G8/&9H,8R1_"<'\Z] HH Y
M"*3Q9J^B7ZZIH]M82-:201VT-VLQFD88#%L (H],D\^W.0_AO6_^$3\$:<+
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MFI-T7Q,\^[!!0# 7'.?6@#3HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWLX]'NS"SK*64H(U<N20,<'TXH Z:BH;6YCO+."ZA),4T:R(2,$J1D?SJ:@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR-_$Q^IR:QHXM4U_Q!"VJ:&MC8Z3=/-;2R3I*UR^THCJ!]T;68\\YV^AKJ:
M/,/&2V]]+XS:WWWMU8Z6#(UP^U-/81.Z^3@$^8W#$\#A>>U0R6W]M>)_ L=]
M=7;QW^B2O=(MRZB4B.(\X/&=QSC!/?BNXO?!OA[4=2N=0N],CEN;J(0W#%V"
MRJ!@;E!VD@="1D=C7,ZAX32+QMX7CL-)N4T;3+6XB,T$Q3RF<)MPP<.?ND$^
M] '':Y:SZ+X8^(6C6MW>#3-,NK-[ _:'S"9=C21YSRHW#@YZ^M=;?:,OAKXF
M>&;C2)KH'53<0ZC%).\@G58]XD(8G!![C'4"KWCWPV\OPZU/1M"TR2XN+QT<
MHK@M(WF*S,[NW)PO4DGH*Z73M%T^VE2]CMYQ<>5Y2M<S/*\:'!*@LQVC@9QU
MP/04 >=0H6^'GQ+822QO'JFIR(T4C(0RH".01W'2KQNY+W6?"F@W$UJMI<:'
MY\<=Y$9([B8>6,%=R[B%R0#GJ3C.".O3PAH<>GZA8K:2"UU%VDNX_M$I$S-]
MXGYNI[^O>FZGX+\/ZQI%KI>H:<L]I:8^SAI7WQ8X&UP=P[=^PH Y&;P[K.E:
M,FGZ;J5IKDEIJDEP-+NLQ1O"8\_9@69L[-X==QP.,]!71^ M0LM1T.X:SL[F
MP:&\EBN+*Y^];3<%D';;\P(QQ@CITJ^OA/1([&RLX;,PPV3F2W\F9XV1R""V
MY6#$G)R23G)S6A8:=::9 T-I%Y:N[2.2Q9G<]69B26)]2: .)\5:;8W7Q6\'
M-<6T4AE@O@Y9?O!40J#]"3^=5]&@@\86WC!]7)%[;:G<6D,A8A[.-%'EF,_P
M?WLCJ2>M=KJOA_2M;FM)M1LUGDLW+P,6(*$C##@C((X(/![BH;KPKHUY?W%[
M+:LL]R@CN#%/)&)U' $BJP#\<?,#QQTH I_#[4K_ %CP!HFH:GDWD]LK2,1@
MOU 8_4 '\:Y/QF+>]_X362VWWEU8Z<I>2=]J:>RQ,Z^1@%MYX8G@=.>U>GQQ
MI%&L<:*B( JJHP !T %8=[X,\/:CJ-W?W>F1RW%Y%Y-P2[!95 P-R@[20. <
M9'8T <M=SR7.O_"^>9R\LJ3.[GJS&TR36EX9_P"2G^.O^W#_ -$FME/!^A1'
M3#'9%#I@(L]D\@\K(P<8;DD<$G)(JU9Z#IUAJMYJEM Z7E[M^T2&9V\S:,+D
M$XX' XXH P/B1JEQIF@V BD>&"[U2VM;N9&*F.!W^<[ATR!MS_M53OK0:'\3
M?#UMI,0AL=6M[J._M8QB(B- R2;1P&RVTGOG%=IJ&GVFJV$UC?V\=Q:S+MDB
MD&5855T_0-.TR3S;>.4R^7Y(EGN))G5.NT,[$@>P/84 <=X T33'N_&"M90D
M+KD\(!7HFR,[?I7+V%A;P_LW7=W K07)MIW,L+LC,5F<#)!&1['BO5K#PUI6
MF&\-E#-";UVEN"MS+F1SU;EOO<#D<U7C\&Z#%X??04LF&E/]ZU^T2;.221][
M@$DDCO0!@-=PZA\0M/T#4PLEC_8:W4%O+RDTQ?:Q(/#%5 P#TR35"_2/0[SP
MSX7AU9I].N+NZCDDU#,JEU4-' V"NY1O( )ZJ!SC%==JW@S0-=M+.VU*P\]+
M/_CW<S.)(_I(&#=AW[5)?>$= U+0(]#N]+@DTV/!C@P1L([@@Y!Y/(.>3ZT
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MQ<A>@D<EF4>RYVCV K7HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKEO',MD-/TRVNVN&-SJ4
M$<-M$P5;J3)81R$@CRS@EO8=^A .IHKQRXA:'2?BK8,(X(K:%)XK>T=EBA<V
MNX[<8[@$\#)'2M&#3;72O%/P[O+-&CN;^"6*[EWDM.@MMP#9/(! (';M0!V_
MB_6+KP_X3U+5[."&>:S@:;RYG*J0!D]!S]./K6G83M=:=;7#@!I8D<@= 2 :
M\@F6T\3?![Q5K6I0QS:P'O/-=QF2V:-B$C4]5 4+P.N3GJ:]:T;_ ) >G_\
M7M'_ .@B@ OFU,7%D+!+5H3-B[,[,&$>#RF.K9QUXI8-3M+K4KO3X90]Q:+&
M9U'.S?DJ#[X7./0CUKD_',:CQ/X)F!8/_:VPX8X(\J0].G4"LO2],T^/QK\1
M)$6VL9HU@,5XL:AK<O;$LX/8Y)8^O- 'IE%>;^$'ETKQ5:Z/KFA06&KBPD2"
M^L2#;W\:LA9CP"'!"GGU/J*]'/W3SCWH 6BO*O#@DTK7M%TSQ!I5O.]R)18:
M[9D,E^&C8D3@C.XKELG()Z=ZQKGRT^!&ILQ420:M(L))^:,_;0,+Z?+D<=J
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ME^(>DQZ7J=\;FW5;"]%G*KN086\PH&DX^4$@GOP!W.!;O?%8;6K30]%ABO\
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M3^'H=,\36NB32V\UAAK:[1,?O%&,AE)!VGGGZ58U:V@LO!WA/Q#H( U1KBR
MGC/[R\67 =)#U?=DDYS@C/% 'JM%>2OH&G:EK'Q*BO87GC@\IXDDE8A'-MNW
M 9^]DY![=L9-,BA&KW'PIEO99Y7NK&43GSF'F?Z)GG![Y.?7)H ]=IDID$3F
M%4:0 [0[8!/N0#C\J\=GNV\+:/XZM=-8VFG6FKVJ@)DK;0RB+S2H!! PS=",
M9XQ79:1X=M].\5V^KVFJ644=Y:&,V6GVOEQ7('S"4@.PR,@;O0@9Y% %6P\;
M:Y?>!M'\0PZ-;3O=731W4*3[/+3S6C&S/WFX7CN3^6O%K>NOKFL6!TB )9HD
MUJZW&[[0AR-I_N,2IQGC^=9WPFC1_AGHY=%8H]PRDC.T^?(,C\"?SKM5C1"Q
M5%4N=S$#&3C&3^0H JZ5JEKK6EV^HV3E[>=-RDC!'8@CL0<@CL0:N5P7PRF\
MJP\21R.%MHO$=[%;;C@;2X( _P"!%J[V@#E_$&O:[I-KK-_!I5G)8:;;M-OF
MNG1YML>]MJA",=LYZ@U'I6O^(]2T[2]0_L?3Q:ZA;"92EXY:(M'O4./+Z=B0
M>I%7/'?_ "3WQ+_V"KK_ -%-1X+_ .2>^'O^P5;_ /HI: '>"]>F\3^#]-UJ
MXBCAFNXR[1QYVK\Q&!GZ5O5X7H^FVMI\-OA_K<*,NI#5+2(7&\[A&\S*R#GA
M2#TZ=^M=.]HOC'Q%XOT;4+FQ2XMI5B@2XMC)+;P&)2LD1WKM^8LV0.N,GH
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MNT<C%0O/? ![G/L,;EMI$/B#XC06^NQ2R_:/"T%Q=6S2L$:4RD-E0>G XZ9
MXXH [+QQX@O/#'AF75;*W@G:*6)&69B  \BID =?O>HKHZ\0NHI[+X2>*],:
M:66QT[7EM;%I&+$0K<0X7)ZA26'X>U=AXOBM_"WB[2?&K1HMH2;#4V(XC23'
MES>Q5@%)ZX;% '?U4U/4K31]+N=1OI1%:VT9DD<]@/Z]@/6LWPI9"'39-0>
M0W.IRM>2KMP5#<HI]U3:#[[CWK$^+UO#/\+M:,T,<ABC5T+J#L;>HR/0X)Y]
MZ .W!! /8TM>?WBVH^)&B>&Y;6"/13IL]Q#:B,"*6YWKD%>A*H6;'^UFK'@M
M)M/\8>+]&@+?V/:36\EI'GY86DCWR1KZ*#@[1P-WO0!W%%87C.[M++P;JT]_
M=W-I:K;,))[7_6IGCY/]K) 'UKD-(L_L7Q1@L?LEO86]SX>8R6MM)][;,BJS
ME0 7P2,@>V30!Z917A-GIMM;_"/0]>02?VI;:LODW+2,70&]*E1D\ @G([YY
MKL?$#VO@7QY#XF>#_B6ZK UK=;%R8[A07C8#U< J<=3B@#T6BLCPSI7]D:)%
M#)%&EU*6N+GRQQYKDLP'L"<#V K7H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/UC1--U^R%IJEI
M'=0+(LBJ^1M<=&!'(/N*T*R?$GB&R\+Z'/JM]O,46%6.,9>5R<*BCN2: *__
M  A7AO-X5TBW0WD2PW&P%?-0# 4X/3'7U[YJ<^&-(:33Y&M27TX8M&,SYA&,
M?+SQQQ]..E5EN/%7V WK6>FF;9O&G!W#=,[?.Z;O^ 8SW[UIZ9?&\T6ROKA1
M T]O'*ZG@(64$CGZT 9=WX&\,WUW>7-SI$+RWHQ<X+*LONR@X+?[6,^];=I:
M6]A:16MI"D-O$NU(XUPJCT J4L NXD =<TF]26 897J,]* *.HZ'IVJW%K<7
MMOYLMH_F0-YC+Y;?WA@C!]ZAG\,Z+<ZE<ZA-IT#W=S#Y$TI'+I@K@_\  21G
MK@XK5#J4WA@5QG(/&* RL2 P)7J >E &=8:#INFS)-;6["1(_)C:25Y#&G!V
MKN)VKP.!@<#T%:1&1@TT2(7*!U+#JH/(H+HO5U'..3WH R]/\,Z1I;V[6EH4
M^S K;JTKNL((P=BL2$R.. .*IS>!/"]R]ZTVC6[_ &Y_,N =VUVW!LXS@$D
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M7AQ+A='\->'+/[0,2-%J-QN(] WE9 YZ BN\W!U;RV4D9'7(!]ZY#Q!K^O\
MAWPE87US'IDNH-=0V]UY6_RAOD"90'GH>YZT :?A72KC1;![*33K"PMD;,,5
ME<R2J,DEOOJNWGGCKDUKWCW*6K_9(EDN",(';"@^K=\#VYJ>B@#GK/P;I,'A
MZST>[@6\BMYA=%Y1@O/N+F0X[EB3CISCI70TA8 X) I/,CVJV]=K<*<\'Z4
M5]1TVTU:QDLKZ+S;:4;9(]Q4..X.",CVZ4RUTBRL=+&FVT316:IL6-9&^5<8
MPISD#'85;=UC4L[!5'4DX%*2  21S0!B#P=H TRVTT:>!96LHF@@$KA8W!R&
M49X(/(]"3ZTS6/!7AOQ!>P7FJZ1;W=S"H5)9 =Q7T;!^8>QS6[YL>UFWKM7@
MG/ KG?%6O7VAWOA]+6*W>#4=3CLIC)N+*&#'*XP/X>_KTH Z-55$"(H55&
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MJ'4A;Q'2VLQ+Y\?FF[W;?*W?/C;_ !8Z=LU<9U7.Y@,#)R>U #J* <C(Z44
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M@DUW5EIEEIT<B6MNL8D.Z1N6:0XQEF/+''')Z5GZ9X.\.Z+>7%WIFC6EI<7
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MAZUW9VLHDL+L2&6)6W!88RN<CG&21Z<UZ#>:58:AIITZ[M8Y;(J$,##Y"HZ
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M-*MDLEA&PL<&U!)_<8Z;.>/3BKUQ9VUU);R3P)(]O)YL)89V/M*[A[X8C\:
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M&3")!O _W>M %*Q\,Z'IFFS:=9:1906<^?-@CA4+)_O#O^-(?"^@-#:PG1;
MQ6AW6Z&W7$)]4&/E/TJ^+VT(E(NH2(O]8?,'R?7TI);^SAM1=2W<$=N>DKR
M(?QZ4 6*H-HFEOJ+:BVG6IOF3RVN3$OF%/[N[KCVJR;RU%J;HW,(MP,F7>-@
M'3KTKF?&_B.ZTCP;)K>B7-G+LEA7<R^:KJ\JH=I# 9&[/?ITH V8_#NB0Z;-
MIT>DV*6,Y)EMU@41N?4KC!-6+#2['3$=;*UB@#X+E%Y;' R>IP/6I8KNVGFE
MAAN(I)83B1$<%D/N!T_&FB_LS>&S%W!]J SY'F#?CUV]: ,N/P;X9B#B/0=.
M57F$[#[,N#(,X;&.HR<>F:LCP]HXNVNAIEJ)FD$K,(P-SCHQ'0L.,$\C%9::
MWJ(^)TF@2- =/_LG[:FV,AP_FA,$Y.1@'H!UJ#Q]XHF\/Z#-<:9>6(OHI80\
M$WSN4>14)"A@1][.2"* -C4?#&A:O?PWVHZ/975U!CRYIH%9EQR.2/6K#Z+I
M<NI?VD^G6K7VSR_M)B7S-O\ =W=<>U6IQ,;>00.B3;3L:12R@^X!&?S%<SX%
M\3MK_A+2+W4KBU34KV-Y#"C!=V'8?*I.<8% &Q%X=T6"PN+&+2;)+.Y),\"P
M*$D)ZEEQ@GZU)9:/IVG1216EE#"LH"R;5Y< 8 )ZD 5.+VT/FXNH3Y/^L_>#
MY/KZ5GZIXFTG2?L N;R$-?SK#;@2#YR>I^@')/\ C0!)'X<T2'3)M,BTFQ2P
MFSYMLL"B-\^JXP:CL/"V@:7/%/8Z-8V\T2;(Y(X%#*/0'&:U&FB2'SFE18L;
MMY8!<>N:@.IV"HKF^M@KYVL95P<=<<T 6'19$9'4,C AE(R"/2LOP_I4FA6
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MO"'AR]O9[RZT.PFN;A=LTCP*3(.G/'/'&:UK>WAM8$@MX8X88QM2.-0JJ/0
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MKWPI8VX?4/"5\VHVLCINS O[V!0?[SAROT1J]M    & .@%,6"%)I)EB199
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M]&U*RALK[2;&YM8,>5#+;JR1XX&T$8'X5)=Z/IE_IPTZ\T^UGLE  MY85:,
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MW;B1D$';T!]:[#P[K4=_X?T26]NX/[0OK&&<Q[E5G9HPS$+Z9STKB/#WE?\
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MJKZ1XGTK6=&L]3@O(%AN@FQ7E4$,X!5#S][D<=:XLVMO:^./&]K:P111R:'
MYBB4 %@)1G [XQ6'<+IE]\,OATI^S3,FH:9%*002N1AE)'3..10!ZW_;&F&Q
M-[_:5G]D#%//\]?+W XQNSC.:S/%&LS6O@?5-:T6ZM7>WLY+B&7'FQML4GC!
M /3KG\ZYZ>"UT7XM:':"T@M-*GT^Y-HL<82,WK.I<X'&\QCZ\FL:]MWM=/\
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MT7Q$6PEO[+^PVT9K]9  H5A*J9,A8@C!/H.:Y>V-_:>*K[3_ "&CM?&<7VJ
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MK4*9%#;0;4YQGIT'Y5D:5K"V-M\.I=4U.2PTV71FBBN_DV)<XCQN+JRK\@8
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MBH(=,TZY^-6JK-9VTN=&@D*O&""YED!8CUQQGKB@#OH9HKB%)H9$DB=0R.C
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M;6#NJEQS\RJ&W<?UK%75M=LOB!H-F/$%OJ>@:J+EXV$,?F#RX\D%T 4C<>,
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M$^N!5BH+:]M+PRBUNH9S"^R012!MC>AQT/M4] !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<3\5V6
M/P,TKD+''?6;NQZ*!.F2?:NVIDT,5Q$T4T:21N,,CJ""/<&@#@KZ2PU/XO\
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M  X^&T GM[A%U+3(9D#!@#Y9#(WOZBO8JJ'2M.,:1FPM3&A)53"N%SUP,<4
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MGNBO0S.2SX]@3@>P%:=%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>63Q'<&DC0;H\CKN7*D>IYZ5O>$+@ZS9R^)7A>(ZKL:!)!\R6ZC$8/U)=_\
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M'^!FR03ZU8\3W4]A?>(-;T+4;6_ML1?VMH=X,>:#$FUHF'S*Q0J ,8)![C%
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M^/[7[#<M$&M&B@9IYOXHHV&" <C(P6&!S76ZAKNDZ2X74-1M;5B <32A< G
M)ST&>,FN(\87-HVG^ )?/A(.M695]PY7RWY!].16?)J>CP>)/%^A>+-6ET_[
M=/YD:R,J1W5J\2( K%221M(P#UZ<YH ]+OM4L=/B1KJ\A@\W(C+L/F.,\#O@
M<\5SOP]UJ\UW2=3N+R^2]\G5;FWAG15"M$C )C;P1CG/O7.Z3?67AWXBV]MJ
M4CV6GOH,,.DO?OMPJMET+-T?[I(/.%'M6G\*[FTFT_Q#':2Q,J:]>,%C(X4O
ME3CT(Z4 =$;^"/Q/<;_$-L(8;+,NFGRP8B&YF9L[@,$+@\=ZDA\5>'[BZM;6
M'6K"2>[&ZWC2X4M*.>5&>>A_*N7DFM$^-=XLDD*C_A&E\P,P[7#$Y_#%<9I[
M64'P=\!2JUO&XUFS<N" =PF(8D^N.OM0![E10#D9'2B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MD95=2K ,I&"",@BEHH CA@AMHA%!$D4:]$10H'X"FPVEM;M(T%O%$9#ERB!=
MQ]3CK4U% %:2W$5O+]C@@$Q4A0?D!/N0#_*L+P/X9?PSX9L-.O([22\M(S%]
MIA&2ZY)') (Z].:Z:B@"&>TMKDH9[>*4QG*&1 VT^HSTITEO#,0988W(X!90
M:DHH 8T,3RI*T:&1,[6*C*YZX/:D^SP>4L7DQ^6IR$VC /7I4E% $8@A$OFB
M*/S/[^T9_.FBTMEN3<BWB$[#!E"#<1Z9ZU-10!$;6W+%C!$6;J=@R:8]A9R1
M&*2T@>,]4:,$?E5BB@#/U'2+;4H(+:9$%O$ZOY80<[3D 'L..<=N*O/&DB%)
M$5E/4,,BG44 0FTMBH4V\1 Z#8.*7[+;[F;R(LMU.P<U+10!#]CMMH7[/#@'
M.-@I5MH%D$BPQAQT8*,_G4M% #%BC0,%C50Y)8 8W$]2:;!;P6L?EV\,<,><
M[8U"C/T%2T4 01V5K"VZ*VA1MQ?*Q@'<>I^M2R1QRKMD177T89%.HH A^R6Y
MVYMXOE^[\@X^E*UK;L9"T$1,@ <E!\X'3/K4M% $,]I;7007%O%*$.5\Q VT
M^HS3Y(8I@!+&C@= R@XI]% $7V:#<K>1'N7&T[!D8Z4J6\,1)CAC0G@[5 S4
ME% &!K>F:W=O;6FD7]G8Z8Z/'=@P$RA3T,1! 4XSR1QG.#TK;@@BMK>."% D
M42A$1>BJ!@ 5)10!%/;074?EW$,<R9SMD4,,^N#3I(HY8FBD17C88*,,@CZ4
M^B@")+6WCMQ;I!$L(Z1A %'X=*0V=L0 ;>$@=!L'%344 9.OZ4VHZ#J5G9Q6
MZ7-Y;20"23Y0N]2I)(!)ZYQWIGAG1O[%T*PM)X;47=O;1V\LT _UFQ0N<D \
MXS@]*V:* (C:V[&0M!$3)C>2@^;'3/K0;6W+ES!$6/4E!DU+10!#]CM=NW[-
M#C.<;!1+:6TX036\4@C.4#H#M/J,]*FHH AGL[6ZQ]HMH9L<CS$#8_.J]YI4
M%]>V=Q.%(M'\R-=@SN[9/7 ZX&.0/2KU% '-^.-!OO$GATZ98O;QN\\,K/.S
M  1R*^, '.=N*W;6VBMHL1VT,#/\SK" !N[\X&?KBIZ* (EM;=  L$2@/O&$
M PWK]?>ECMX86)CAC0G@E5 J2B@"(VMNP(,$1!;<04')]?K0+6W#AQ!$&'0A
M!D5+10!$MK;K<-<+!$)V&&D"#<1Z$]:$MH(R2D,:DC!VJ!D5+10!!%96L+2-
M%;0QM)]\K& 7^OK2_8[7;C[-#CKC8*FHH @:VB7+QV\)E4?)D <@<<XXKG?!
M?AB;P_ITD.H1V4MS]IFGCGARQ D=G*Y*@C&['O74T4 026=K-*DLMM"\B'*N
MR E3Z@]JGHHH A2TMH[A[A+>)9W&&D" ,WU/4TY;>%)#(L,:N>K!0#^=244
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MN7:")F/4E 2:3[':[0OV:' .<;!4U%      , =J*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2P)B=HX[9E<LA#'YBY&"R@],@<=>:V:* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>elicio-insidertradingcom002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK ]&P#MQWKF1-X@4^$/$.KVYFM]+U"\AO)+:W*B6.0&-+KRP,@'EC@=&ST-
M'H$?BS1GM=0N#=-&-._X_(Y8762 8R"R$;L$<@@8(Z57LO'/A_4+W3[6VO'9
M]0C\RU=K>18Y?EW;0Y7;N ZKG(Z$9KEM4MOMWB/Q/XBL]S::?#IL1(JG%S.2
M[#9_?P-JY'=L#H:I,P7PW\+T\N026D]J;A?+;,(6W9&+\?* Q .: -^YT+Q(
MVF^(88O$&J9FN5EL) L8E0YR47L(\[5YQT)Z'G0NM3NO#NLZ)%?W'G6VJL+2
M5CTCNMFY2OHK[6&WH#MQC)SU-<-\1X'OI_"-C "9W\06\P ZA(E=W;\ /UH
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M0LVSMO\ O>^<]ZZ.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSRM*XV#<-QY# 9Z <\"C6==MM7\&^)6T^YNK:[T^WG64#=#+!*L98?T((X-
M'645C>$99)_!>A332-)+)IUNSNYRS$QJ223U-5;OQQHMG?W]@6O);RQ17G@@
MLY7<*V<$ +R,#[PXZ<\T ='160OB?29-)L-2AN?.M]0VBT$:%GF)!("KC.<
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MN5+X]N<#) YZ55O_ !E%:>+M+T2.UN)4O+>2X-Q'"SJ5&W 7'7[P)/0#'KP
M=116#J7C#2-)\R2[DF6UAE$$]TL+-#"Y(&&<# Y(!/0$X.*FU/7+""6:P)NI
MIEA\V9;.-G>*,Y 8E>F<' ')P< XH V**X[X5WEQ?_#71[JZN9;F>192TTSE
MG?\ >OR2>3Q78T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5S'CBSL-0TFTM=1COA$]VNRZL=WFV;
MA6*S J"0 1C.,#=S73T4 >-Z[+K$/P_OH]7G?4(;;6[1;2^^S^7)=Q"2(Y*@
M?,0<KG^+;WKH]<TQ_%?C+3[S2]\<=EIEY%+=M&R*7F4)&@) R0=S$=N_)KI/
M%?AUO$^EQ6'VS[*B3QSEA%O)*,&4=1@9'/\ 2MM P10Y#/CYBHP"?8<XH \M
M\)2V5W9:/HNI>$M077=-:)9!<P/Y$31X'GK(?DZ E<<DG XYJ7PMJ5QHEA=^
M#]5T&^NM0BO)FMV^RE[>[1Y6D60R8VJ 6Y)Z8[GBO3Z* .(MRZ_&._N6M[D6
MYT6*$3^0_EEUE=BH;&"<$'K6=X8=X_#WC=9;2]C>?4[Z>%'M9%:6-P K*"N6
MS[5Z110!Y#:G4=#T7X>ZZVF7T]II=D]GJ-O';MYT!>-%W^61DX*<\=#6]X@U
MR:30H=3TW0;A+2?4X/-G;3RUPD?\5RL14G(PH4D9[XQC/H%% 'ENE>9;ZYX^
M86.K^1>6<#V\MQ;RLTH$#*>2,YW$#;U'H,<5YH[A?AQ\/;?[#?&>TU#3VN(A
M:2%XEB^^67;D >IKUJB@#A/'-KJ.GZMI/B?08T?4,_V;+&YP)8ICA"?]R3:W
MT+5V.F6$6EZ9;6$))CMXUC#-U; Y)]R>3[FLR+P[+_PD<FJW>KWEW"'\RUL9
M HBMWV[2PP,DX)QD\;CWYK=H \_.HVVG_&C4FN2Z*^AP .(V8 ^;)P2 <9[>
MN*YN;1[O3O#]A(;"["WGC%=52V2V=V@MO,R"RJ#M^4!L'INQUKT:#P[)#XTN
M?$1O@QN+5;4V_DX 16+*0V[KECD_I6]0!PVMBYTOXEZ3XBDAFETB73I+"5XX
MV?[,Y<2*[ #(#8"YQQCG%+H.@KJ&O^,]1N8'&E:WY,$<4B%#*J0['?:>0&+$
M ]]N>A%=Q10!PWP_L-6@MO)UJ-@^C!],M9&_Y;QAL^;]"@B ]U;UKE+K3=5U
M#P?XVBL+"Z:X/B(W\5O) \9NH5:)OEW ;L[#C'7'O7LE% 'F]WK4>O>/?!6H
MV5CJ?V:)+P3O)82IY+/&@ ;*\<\$]/>LCPW%;0:6OA+7O"U_=ZQ;2M&I>!WM
M;@;R4F\S[H7D$D\\< GBO7Z*  ]#7BL:78^!]CHK:7J8U"TNX$EA-E)G*W6]
ML?+\P"C.1QSUSQ7M5% 'G^HRW ^*9O[6PN+E!X<EBC)@<1R2F576,L1@$@=Z
MYVPN+BZU7P%J3:;JYDMY)DO(Q8210VKM RB)(\ *H;C=@C Y:O8J* .(\#>=
M9:UXKL+FSNXI9=9FNT=X&$;1.J;6#D;3G!X!)XJQXUO[FRU'0 MG.UE)<R"Y
MO;:T-Q-;?(=NP!6*[R=I8#(&>F<UU]% 'B%[;7:_#[QWIJ:3JWGW&M>?;QO;
M2R/(C-"00>2QPK$\G&.<9%=O?.TWQ9T&ZCM[EK==-N(VF%N^Q6=D*@MC ) /
M6NXIDJ&2%T61HV92 ZXRI]1GO0!YZNBWMG\0;K1H$4Z#JDB:S,,_ZJ2-@'3'
MH[B)OH'%>B$A5)/0#-8WA[0'T6*1[O4[K5+Z4*DEW<[0Q1<[5 4  #<Q]22<
MFMJ@#QV6&YD^%'C>T6POC<W6I7CP0_9)-\BR2Y0JNW)!'.:Z/5':?QYX$N(K
M:[:"&&[$T@MI-L6^)54.=ORY((YKOZ* /%KBZOM1TS0;FYTC58;VR\1137=E
M!8R)!:1B5_NJJXDR"&+#<<D],XK?>RO;CQ1X_P!-6UNX9=:LH19SF%O*_P"/
M9D),@^48; QG/I7I5% 'F/A6[T_4X]*LKSPGJ$.MZ>4,WVNW?RK9T&&D60_*
M<X.T+DG([9-:WP[9K>T\2&>WN8-^N7EROG6[H7C=\JR@@9!'I7<44 >/Z+=:
MAI/PT\.0MI=XFS591>2'3VDGLXVFE82)&5)R0RC=@X#'O4]FDT,/Q)A&G:L%
MO(=]LT]O*S3 VP48)R2Q;^'J.A QBO6:* ,/P;N7P3H<;QR1R16$$<D<L91E
M98U!!! (P16#IDAM_BAXINI;>Z6WDLK5$F-M)L<H)-P4XPQ&X=*[JB@#Q?PY
M9ZEI>A?#S5Y;"]^SZ1]JM]0MS;N)8?-!59-F-Q [D \'ZUMZO8RW^K>+_$%I
M!<&RFT Z?$%A?==38<Y5<98 %5SCG)QT->FT4 >72";^S_AD/L=[NLWB-R!:
MR9@ MRAW_+\OS$#FNQL?#VH6FM?;Y?$^J74&YV^Q2K%Y6"#@<(&P,\<]A704
MR42&)A$RI(1\K,NX ^XR,_G0!XOHZIKWP'7PY:V\LVHW;RPQ1F%L FY8^86Q
MC:HY+9QQCKQ75Q2/X?\ BA?27-K?317VEVT5M+#;/())(V<,I8#"GD'YB!@Y
M)KI/"7AX^%?#T&CB[-U% SE)&CV-\SESG!(/+'TK<H \8T>VO8/A[X#EFTV_
M0:9K'G7BFUDWQ1YF^?;C)7YUY /6NOBMC>^/=0\40Q2II\6CBQ$AB8&XD,A<
ME5QE@HP,XY)(&<5W%% 'C:V]TGP2\-6)L+_[9!=VOFV_V20R)LF#,2NW( '.
M:WGU2;PK\0];N=0TW4+G2];BMY+6XM+5YPKQIL,3*H)!/4<=S7HU% %32\_V
M9!FS6R!7*VP 'E+V4@< XQD#C.:XVU=H?B9XJN9+:Z%N^G6Z)+]FD*.R>9N"
MG&&(W#I7>T4 >-V\%U%\+/ MH]A?"YM-5M'N(?LDF^)4D)=F7;D  ]:ZM9&/
MQG-S]GNOLQT,6PG^SOY?F^?NV[\8S@YZUW-% 'DVE0W=A\+]9\%ZA8W4NLHM
MW;0J(&9;OS6=DE5\;=N7Y)/RX.<5I:58SZ5\1M!MIX[F9;3PT+&2Z$#F,S!X
MSC?C&2%)ZUZ/10!P6DR-!\0/'%S+;72P30V@BD-M)MEV1N&"G;\V"0.*YB&"
MZC^$G@NT:POQ=6NI6CSP_9)"\:I+N8LNW( '.:]DHH \@\8S7VK:=XWTY]+U
M%+C8#9PV=HXCNH]B_OGD4?.W!&TG@* %)K=\Z:+XB>']5;3]0^RW&BR6JL+5
MR5E,B,%<8^3(!/S8]\5Z%10!Y%J.C:EKVE_$K3["WN([B]NHY;4RPM&LZHD>
M0K, #DH5_'TK<U>1O&LGA(V-K=07%GJ45_=^= \9M41&WHQ8#YBQ"X'7KT&:
M]!HH \FV3MX-^)< L;WS;V]NVM8S:2;I@\2JI0;?F!(/2O1_#S%O#>F95T(M
M8U*R(58$* 00>0<UI44 >,>*)[_5- \16\NDZG'>V^KH\=I:63K"85GC/G$J
M,3,RC)Y8^@ &:ZJ&[_LWXFZEJ=[;7D-G?:7;+;RFVD8,RLY9#M!PV&'RGFN]
MHH \?A\/:MH(T+Q UC.;6'7;R_N+&)"\EO!< HC;!DDH.2!DC<?0UOW.ESZ]
MXSU?6M/CD^R-X?;3E=T*">9G9AC(&0HP,],MCL:]!HH \<@O9;GPS\.[2/2]
M5,NE7]JEZ#8RCR62%T;JN6YYRN0!U(R,]9X:\ZR^(7BZ">SNU%Y<03P3>0WE
M,@@52=^-OWAC&<Y[=<=O10!QWQ,M[B;PK#);V\UQ]GU"UN)$@C+OL252Q"CD
MX'/%5&N#<?%K3M0%I>I:_P!B2Q&5[6155VE1E4G'!*@G!Y'?!XKO** /%Q9Z
MD/#5Q?0:3?7(T_Q9<:C+9>2\<D]LQ<;HP0"QP^1CTKO/"DND:E?3ZKI6B7-H
M'B$<EW>0/%)*<Y" /\Q [GIG&,\XZRB@#AOB!HM_-J'A[Q-I=L]Y<Z'=-)):
MQ_?FA< 2!/5@ "!WYK<MO%5EJ$0&G0WDURPP()+66(J?]LLH" =\_ADX!W:*
M ."T^2?PW\1/$DVJ13_8M66WGM+J.%Y$S&FQHCM!PW<#N.E<T-%O=)\.^&TE
MLKO=)XK&I&WC@=S:V[.Y&X*#MP"I.>A:O8J* .'LI#'\6]9NWM[E;9M*@C68
MV[[&9'<L V,$@$=*XFW9]/\ A_X(6\M;J&2W\4!I(I+9UD ,D[ A2,G@@\"O
M;JP?$GAV3Q!)I3"]%L-.O8[Y!Y._?(@( /(^7YC[^] '*:S!=7?BO6/$VD:;
M]NCM?#\EFL<D1V7DS/O" $?.H YQU+8ZYQ1TV=Y/&_A35!:ZS-"=.N(9YYK*
M2-(Y"(_E"8 C48/0 ''5B*]7&<#/6B@#Q>>"Z?X*ZY8KI]^;R74Y'CM_L<OF
M,INPX(7;G&WG-=?X[AO+5M(\7:)")M0LI5MVA;Y/M$$Y";#GG(<HPSTP:[FL
M)_#LL_B1M4NM7O)[1662'3F"B&*15QNX&X]S@G&3GL, %_1].&E:1;66_P Q
MXT_>2'K)(3EW/NS$G\:XN_U&X\)?$J_U&^T^^N=)U:S@CCN+2W:?R98BWR,J
M@D [R1QU_''H5% 'G6H)=V'BSPQXC.E36^D)!<6LUO%#EK,2$,CLBYQG: V/
MN]ZSM=TRXNH?B%K5M;7+6^IZ;'9VL:0.7N9%C8%@F,XRP4''.#VYKU:B@#SB
M^,CZO\.95M;PI;>89V%K)^Y!MR@W_+\OS<<U0U%9WG^*82RO6^W6D:6N+20^
M>PMBA"?+\WS<<5ZM10!YI>&1I/ANRVEX1:N&N,6LG[D?9RGS_+\OS''-175E
M=ZAJWQ/M[>TN2VH:?%':,T#JLS+;NA"L1@_,0.M>H44 >41:BVH7GPZDM]-U
M0QV#-'=,UC*OE-]F*$$%<\,<$@;?>D"3MX0^)< LKWS;V\NVM4-I)F8/"JJ4
M&WY@6!'%>L44 >;2F5_$?PWE%I>&.VMYQ</]EDQ"6MP@#G;\N6&.:B\.ZE/H
M(U7PKJ^@W]Y=O?SS6K+:F2"\CED+JQDQM7!/.[IC\*].HH \H\6S7^H?\)KI
M<VF7Z3&QQ9)8VCA+S]SS(\JCYB#E0A;&!C#&KB2SP^)_!&J-IVH_9O[*FM6Q
M:.620B/:'&,IG:>6P/7%>ET4 >1Z:MMITNJ^&?$7AC4;^ZDOIY;9T@>2"]CD
MD,BDM]Q2"W.[ &*U]'N9O"OCWQ!#JEC=_9]4-O-8W%M;231L$C"&+*@[2".
M<<<UZ+10!Q?PGCF@^&^EVUS:W%M/%Y@>.>%HR,R,P(R.000<BNTHHH ****
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M <\DCUQQFI)GL-7\-:]>Z3X1O;&:32I[;S)]/,=Q*[+\L2J 689ZGIG&,\X
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MUF6XA,]N\8DC*( RE@,\J: .EU#5K;3I+>%Q)+<W)*P6\2Y>3 R<=  !U)(
MR.>16?;>,M&NM*EOTFD58KLV+PM&?-6X!"^5M[MDCID=^G-8?BY]0T3QKHGB
M:'3KO4-.BMIK*[CM(S)+"'*LL@0<D94 X[56\3)J>JV>B^(+'1[I(=.U9+Q[
M)HMMQ-#M*M)Y?7>-Q(4\X'J<4 =3;>*=/GN[RRE2YM[ZSB$\MK+"3(8ST=0N
M=XSQ\N>>#67%\2?#\MIIU[NO%L;]Q'%>/:L(5<DA59N@)Q_CBJS6YU7X@6_B
M2W@NDL+#2Y8'D>VD1IG=@0BH0&; !)XZD#KG'*06.H1?!WPKI[Z7J0O;;4+9
MIK?[%*7C5)]S$C;T YSW[4 >B6'B_3;_ %"\L!%?075K"+AH9[1T>2(D@.BX
MRPR,=,Y[5GQ_$KP]+8Z??AKQ=/OI/*CO&M6$*,6*@.W1<D?AWQ59FE3XOG43
M9WQLAH/D>>+.4IYGG;]N0O7;SC\.M<G!8ZA'\%-"TUM*U(7T-_"TEO\ 8I=Z
M!;G>21MZ;><T >BV/BZPU#5+K38K>^CO;>$7 AGMFB:6(G&] V,C/'8U&OC?
M1GT'3M;1YVT_4)E@AE$1X=GV ,.HRW&:S"LS_&*WO5M+S[(=#:W^T&VD$8D,
MRN%+8P#M!/Z=:XF"/48?AEH_A_\ L/5FU#3-5A-RHLWVA5N2^Y6QAP5YRN??
M% 'H]WXXTFUU+4--6'4+B]L$62:""S=F*MG!7CD<=>G(YR:K:SXA\/:AX=T?
M49[N]^PW]U;M:26@D4M(7&Q6*_=&>"&QT/>JFEM+#\2_$M]+8WR6LUC:K'*;
M23:[('W $+@D;ATZ]JY6WL=0C^#WA;3VTK4A>6VI6[S6_P!BE+QJD^]B1MSC
M;SGO0!Z7J?B2RTR2XB,=Q<RVL/VBX2V3<88^<,V2.NTX'4X.!4'_  F&E3"Q
M%@9K^6^M3>016R99H1C+G<0 ,L!@\YXQ7,F_O?"OQ URXN]'U.^TS6U@EMI[
M*V:8QND81HW4<KG&1GC]<6-0O-27Q1I=M=:-?0:;+I[$'382SB8OQ \B?ZM0
MH!R"JEN^!0!:U7Q_:Q:5X?U#2K>>]M]9O8K>.58^$!)W @X.["L /4>W.S?^
M)K2P24FVO)W@@%Q<1P1;F@0@D%AGKP?E&3QTKS/3;'4[;X<>#TET;4UDTC7D
MFNH?LS&18Q)-E@@^9@-Z\@=^,UK7K'1_'&JW>L>%]0U+3=92"6VEM[3[0T#K
M&$:*11G;G /IS]< ';?\)3I<MMI\ME(]Z=1C,MI%;#+2H "6YP% R,EB,$@=
M3BN>^&MX]Y+XK8RWCQQZW)'&MV[L\:B./Y/F)(P<\5G&"Y\+^-M(UO\ L&>'
M1)M*>P-O86YE-BYF\T;DC!X(P"5!&X?2M7P +E=3\6//87ELESJSW$+7$!C$
MB&- ",^ZGZ=Z .DO==L]/UG3M*N/-6XU$NML0F58HI9@3V.!GFJ$_C72+6#6
MI9S<H-&(%ZOV=F*97<"-H.1MYST]:S/&ZSVOB'PGK0M+JYM+"\F^T_98&F=!
M)"R!MB@DC)&<"N9O8]0NH/B<1HVIJ=2@C%F#:L3,?LP0 8!YSC([=\$&@#N;
M'QKI-_J]GIT:W<<E]"9;22:W9(YPH#,$8\$@'/IZ$U@_$7Q' _@?Q"MBVH;K
M2-XFO+,LJQ3 ?=+*03@D X! S@XP<17,=P^N_#J9;"_,=FDOVEOL<N(=UOL&
M_P"7Y?FXY^O2N?4:GIOPQ\2>#KS2-4EU5!=^1)#:/)'=K([.'60#;GYNA.>,
M8)XH ](CUN*RT^R@\FYO+LV:3&"V3>X3 &XY(')Z<Y.#C.#5-OB'X=^R:5=1
MW$\L6J,R6IBMG;<RYRIXX;*D;>N>U<G=>=HWB:TUC4O#=_J.E7^E6]LWDVIE
MFM)HBW#1CD*0YY]:M:E:>3>^#)+'P[<6-I#J<ES);V]FQ\B-HW4-($!"L202
M.HSST- '?:1J<6LZ7!J$$-Q#',#B.YB,4BX)!!4\CD5DW'C;2+:6;>9VM8+P
M6$UVL>8HIR0-A.<]6 ) P"<9KHZ\;\3'5]6T/7H+C1-7^WP:LCQ6]M:N(# L
MZ$2+MP)F91DGYF![ "@#V2O.?B9XDAD\ :\=/;4!]FS#]NM"R(DP8 J64@D9
M.T\%<\$Y%>AQ2&:!)-CQEU!VN,,N>Q]Z\7*:I9?!_6?!5UH^J2:S;K-'&T5I
M))'=*TI<2+(!MYW="<Y'2@#U*VU^T.L+H96;^T%LA>!2G#QY"Y#=,[CC%8>L
M_$*UMO#*:MIMK<W/F7ZV&#%M\M_,"-N!]#D#'4X[<U3N)Y].^(VE:U-IFHO9
MW.B&R!AM7D:.;S5<*X4'9D=S@>]<X-/U5OAO>QG1]06>#Q&;QH/()D>+[4')
M0#[W'IF@#TF+Q192>((=#:"[BOIK<W*)+#M!C!P3NZ<$@8ZU>L=4AU"XO884
ME!LYO)D9UPI; ;Y3WX(_/'7-<IXZBN)=%T[Q5IEO(NIZ1.+B&&8>6\T3G9)$
M0>F]2, \Y XSQ73Z%I\FF:/!;SL'N3F6X<='E<EG(]MQ./;% "ZAK%MI]S;V
MA66>\N S0VT*@NX7&YN2  ,CDD#D#J163<^,+27PMJNJZ:LTLU@LJ2P-$1)#
M*BD[74],<<],<C-9VLPWFD_$[3O$;6]Q<:7-IKZ=,8(FE-N_F"17*J"=K8VY
M XQS5 :7<I#\0=:6UNA%K,0CL[80.97V6Y3=Y8&X;F)Z@< $]: -#P/8KJ.F
MZ-XBDGU2.^?3XQ="64^5=LZ*Q<J<@X).",8SCI@5VU8/@D2)X(T.":">">WL
M((98IXFC976-01A@.XK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKF_&_B2?POH O;>RDN9))
MXH%*[<1EW"[CDCUX [XZ#)H Z2BN7U'QU8:9J$>G7&GZHU_):O=);16I=V52
M,J,'#-SG@GW(JSIWBVTU.748(;.^2YL(89YH)8@C[95++@%L9P#D$@CIUH W
MZ*Y^T\7Z?J&GZ5=V,5Q<G5(VEM8%55D9%^\3N8  9'?N*S=9\<268T$V>E7D
M@U._-JV]45H]A;<N"WWCL..V,G/0$ ZC4K-]0TVYM([N>T>:,HMQ;D"2,GNI
M/>J^B:/'HMD81<W%W/(WF3W5RP:29\ 98@ =   !P *T$8O&K%60D [6ZCV.
M*Q+[Q3:6<E\L5K>7HT\ WC6J*P@RN[!RP+';SA02 1QR* -VF3+(\+K%((W(
MP'*[L>^*YV]\=Z):'2-C7-TNK(SV;VT#.L@"EL9]3C&.N3SBMG2M075=+M[Y
M+>YMEF7<(;J(QRI[,IZ&@"CX5\/)X5\/6VC174ES!;;A&\B@-@L6P<<'DFMJ
ML35/%%IICWJ"WNKQK&'S[L6JJ?(0@D%MS#)P"=HR<#IR,@\4Z?/'8&P$U_+?
MV_VJWAMP S0\?.=Y4*/F Y(Y.* -NBN6N/B!H=MX<N=;D-UY%I/]FN8A ?-@
MEW!2CCHIR1R3CD8-6K+Q=8WNO2Z,+6^@NUMS<Q"X@\L7$8."R9/J1P<'F@#?
MH/(KRVSEB\73>)Y=:M=7A%AJ;);W%JVV2U2..,[%V,2&)+$X!!W=>!CJ-$UW
M1+#P9HUQIXNVLKH+#80R$O/,3G"\GK@$Y)P "20!0!T=K:0V41C@4@%B[$DE
MF8]22>2:R;GPX;GQ?9^(?MSK):P/;I (P5*.06R>N<J.:YC0=45/B7XNGNS=
MV=O;6%M)+'>RY$/^L+,/F90N,'Y3C]:Z-?&%BNK6NG75K?6<U[$\MF9XABX"
M#+!0I)# <[6 /M0!T-%<;'\3-$EL(+];;4A8R7/V5[EK4B.!]_EC>2>,MZ9(
MR,XS6QJ?B6UTZ:ZA2VNKV:T@^T7*6JJ3#&<X+;F R=IPHR3CI0!M45BQ^*+"
MZLK"XT]9K]K^ W%M# H#O&,98[RH4#<!R1R0.M58/&VFW6B+JEK;W]P@O!92
MP16Y::";=M*NHZ;2>3Z>M '24V2,2Q-&690PP2K$'\".E.KF]5\:Z;I4NIJ\
M-W/'I2HU_+ BE;<.,C(+ GY>3M!P* -^WMXK2WCMX(Q'%&-JJ.PJ6N>OO&6F
M6.LP:5Y5[<7=Q;&YA6"W9A(HQPIZ$\CV'<BBS\::1>>'I=9W3P0PSM;2PS1$
M3),&V>5L&<N6(  SG(H Z&BO/8+^6Y^--M&]OJ%IG1)7:"YDRA/FQ@,H5F0=
MP<<\<UWMU,UM:RS+#).R*6$4>-SX[#) S]2* ):*\DUWQ-<>(_A59:_+#=6#
MM?V[J5EVHR-<!<?*WS +P=PZ\XKO+#Q=I]]J]YICPWEG<VL NB+N$QB2')'F
M+WQD8.<$>E &_17-Z?XUTW4+O3($@NXEU6)Y;":5%"7"J-QQAB5.WG# <5'X
M1\4W/B.ZUE)M-N+6.SOY+5"^P@!%0$-AC\Q)8\#&,<T =115#6=8L]!TJ;4;
M]V2"(J#M7)9F8*J@>I) _&L^/Q=8F75(+BVO;:ZTR)9[BW>(._EL"59=A8,.
M#T/&.<4 ;]%<I9?$'2+Z31]EOJ$=OJV%M;J6WVQ-(5+",MG[V >F1D$9XK1T
MKQ+:ZOJ6J:?#;74=SIC*EPDRJO+#*X^;D$<@]/>@#:HJEI.IQ:QI=OJ$$4L<
M-PN^,2@!BIZ'@G@CD5AZGXJN;+QSIOA^+3+B6.XMI;AYDV<[2H  +#@;LG\,
M9YH ZFJ^H64.I:==6%QN\BYB:&38Q4[6!!P1R#@USMOX_P!+N]1ELK>SU21X
M;PV<[BS;9 VT-N<G[J\]3Z'MS4MAXWTS4+K2XHX;N.+50YL+B1%$=QL!)QAB
MR\ D;@,T -LO"-U;P+977B75+[357RQ:S+"-R8QM=U0.PQ[C/?-=/7!^/O$,
M$_@OQ+%91:A+]C@EBDN[1MB0S!,@$A@QP2-V 0._0XL6M]I(O_!5K>B].J26
M;-9LF\1']P"^\Y"MP. <D$]J .THKC[CXD:/!!J<RV>JS)I<QBO#'9G]T  2
MYSC"@'Z\' P*VKGQ%8PSV%O#YEW<ZA&TMM#!C<\:@$OEB !R.I'44 :U%8WA
M_P 36'B2.Y:Q2Z4VTIAF$\#)LD!(9,G@D$<X)[>M5?'-[I%CX4NI-<6\;3RR
M"3[)O#YWC;\RD;?FQR2!VH Z.BN?U#Q?I^G:\-$:WOYK]K8W*1P6[-O4$#"G
MH3S]!@Y(JYX?U^S\2:6+^R$R)YCQ213)LDBD0X96'8@B@#4HKF?&/B:?PW'I
M0M["6Y>_U&"TW)MP@9QD<D9)4,!VSU(K FU1M-^+<TI@U*83>'TF%C'F5PYG
M(.%W%5X49Y XZ\\@'HM%85EXNTS4=!LM6M?.DCO9##;P;,2O*"P*;3T(VMG)
MP I.<#-2Z-XCL]:N[^RCCGMK_3W5+JUN% >/<,J?E)!!'(()H V**Y/XB>)K
MGPQX8$VGA#J-[<QV5H7&5620\,1WP 3^ JY%X2MDL?+;4-3>]*8:_P#MDGFE
M\?>QG:.>=N-O;&* .@HK M]1.BV6E:-<^=J.L?8U+108+R!%57D)<@ ;B.21
MDGO56X^(&B6OANZUN3[5Y%G.;>YA$!,L$H(4HXZ*<D<DXY'- '4T5S#^.=.C
MUEM*DLM32Z:$S6RM:G_2E! /E]R1D9W8P.>G-1-\0]%B\-7>NSQWT,%G<FUN
M87MSYL,H(&U@,@?>7G..1S0!UE%<U8>-]+O_ !&-#,-]:W<D9EMC=VQB2Y0=
M3&3UQUYP<4EIXYTJ]FTWRXKI;74YG@LKQD7RIG7.0,-N&=K8W*,XH Z:BN1N
M?B+I-NNJE++59_[*DV7@BM#^[ 7<7.<84 YYY/. <5H/XNT]=7TG3ECN7;5H
MC+9SJ@\J10NX_,3P0O.,9]* -ZBL6[N8M:CUG1D2_B:&+RI9K=UC;+ID"-\\
M-@@\XQD9ZU6TZ9_#&A:1I=]-<W]_*3#"N\/+(0&?!9BH.U!RQQG'J<4 ='15
M/3-135+0SI!/!MD>)HYU"LK*Q4]"1U'4'FH]0U>'3[JUM/)EN+NZWF&"';N9
M4 +'+$# R._<4 :%%8R^)+62RM9TM[HSW4DD4-H4 F9D)#C!.!C:<DD#ISR*
MK6OC72+FQN[AC/!+:7(LY[26/]\LY("H%!(8MD8()!]>#0!T5%<Q+XYT^V75
MUN;2^@N-)A%Q=V[HA=82"?,!#%6& >ASQTJX_BBPCOM%M6CN,ZPA:TDV#:<)
MYA#<Y!VCTH VZ*Y6T\?:9?7\EI:V6K3-#>M93.EBY6%PH;+]PIS@<9R.E8DO
MBZPT+X>W>L>'K*^GB-])#_I#$F.5IMC,V]L[=QX'TX')H ]%HKE[[4]*E\5>
M&X+ZVU&#5)OM#6:'*HN(SOW[6V-\HX'.,CI4NJ^--.TB&>[GANWT^VF\BYOH
MD#10OD AN=Q ) )52 >#R#@ Z.BL.\\4VEJ]Z(K:ZNX[$*;J2V56$6Y0PR"P
M)^4@\ @ UN4 %%>8V7B*/PUXV\<>=;ZM?Q136KK%;1O<-$A@#,>3\JY).,_0
M<<=2/'.D2-H9MQ<7$&M<6=Q&@\MFP258DC:P /!'8@9((H Z6BJ,6J1S:S<Z
M8L,WF6\22O*0/+P^=HSG.?E;C';W&7:GJ=OI%BUW=$A Z1J%&2[NP55'N68#
MGCGF@"Y17.ZAXPM=*TW4;Z_T_4((]."-<*R(6"MT888AA]"?T.+DWB&TM]>T
M[2)8YUGU"*26V?:"C! "PSG((##J.] &M17-W/C?2[41321W)T^6[%DM^J P
M^;N*XZ[L;@5W!=N>]<O8:]'X=\:>.GFAU.^A@>UD$4 :=HD\C<Q^8X5<DG&?
MH.* /3**KV%];ZGIUM?VDGF6US$LT3XQN5AD'\C7(^/-9NK/4/#NF16EU+;W
MVH*EQY6W$R!';RN6'4J"1P".,\D4 =M17#VNM:+X/@U>WMH=4FM[(K>7T>Y9
M%T]9%W! "P.T %MJ[L9-;%[XRTRSU:STWR[R>YO+=KBW$%NS"10 >#W/(^G?
M% '045QI^).D_P!DW6H"PU9DLI7COHA:?/:%/O&3G& .>"3CFK>I:GHDOB;P
MS',;M[RY,LFGR0[Q"1Y1+%CD*?EZ Y/(XH Z>BO/]'OCI7C?Q_.XO+F"U6RE
M$*N964&)F;8&/U.!^ [5T<7BJRN/#UAK4$%S+;7[1K B*N]O,.%XW>_//'?&
M#@ W:*"<#-<?-\2-(BL=1O$L]5E@TVY>WO&2T/[G: 69@2/E&[Z\'C'- '84
M5SL'C33)];LM,$-XGV]6:SNI("L-QM7<0C'GISR ".A-)J?C73=)ADN[B&Z.
MFPS_ &>>_1%,,+[MI#<[L!OE)"D \9X- '1T5S5QXVT^+5=1TR"RU*[O;&-)
M)(K>U)+JV<%<X!'RGGITP235:+XCZ)-:Z;>Q17[Z??R)$EY]F(BCD<X"N3T.
M>#@$ ]30!I77AL7OB%-3N-4OWMD",NG;P+?S$.5<C&20<'KU /85N5YJFN+X
M?^)7BQGM]5OU-K9R);6J/<,O$A8J"<*.G&1[5UEGXOTK4M&L-2T^22[2_)2V
MBB7$DC#.Y<,0 5VG.2 ,=>E &]17)7'Q%T2TTC4+^Z2]A.G7"V]Y;M#F2!V(
M"[L$K@Y&&W8/K5N#QA:W$_V>/3M3%R\[0PP2V_E-.%4,73>0"F".21UQB@#H
MJ*IZ9J$>J6*W<<,T(+O&8YEVNK(Y1@1D]U-7* "BBB@ HHHH **** "BBB@
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MH*\<Y*GCK7.6&F:UI7AGX?:LNDWTS:"98[^P6$^<%D0H75#][;[=<_6O8**
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MV@M6"<P0#"1]]HQZ=,\9Z\4 9/CCQ!<>%_!VI:O:VC7,UO$2J@J A/ 9LGD
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M<C/4#O7.ZQX:OIO'@FM8@=)UFS$.K\_\\6!7Z[U9HS[9]*7P+H&JZ);7EM?
M,NFF2QTHN?O6^[>K$^^8U_[94 :%GX[TV]ETLI;7B6FJS/!97;JOERNN[C ;
M<N=K8RHZ=J;!X\L[O6)]-M=*U>>:WO$L[AH[7*PE@"';GA.>OZ5Q*VWB&^3P
MKJ%]X>U635;+51)J#.4"K\L@Q$N[ CY7D #IDDY-=9X2MKJ/Q)XO>XL[JWBO
M;U9K>62,J)$$2H2#V.1T.#0!=N?'&G6@M+B:WNUTV[N!;1:CM0PER2!GYMP4
MD$!MN.^<$&NGKRKPE87FE65OX8U'P,DU_9MY4>JFWB:UDC!^65G)W9Q_" 22
M.V>/5: ,[4]9M],FM+9DDGN[QV2WMH0-\FT;F/)   Y)) Z#J0*HVGBJWOX]
M3CM[*[_M'36"W.GN$65=PRIY;:5(Y!#<@'OQ67XIT_4+?QGX=\2VEM+>6MDL
M]M>00C=(J2@8D5?XL%1D#G'04VQTZ;_A*O$/BE[:YCM[FSBM;>$Q$2R[ 27*
M=1RP49 /!)P* ,_X=6,6OZ)HGB:^M+J+5DC>1[WS%47?F%LAMK$LHXP& Q@8
MXKT0D*"2< <DURGPUM;K3_A_I&GWUK/;7=K#Y<L4J%2#D]#T/X5U3DA&(&3@
MX'K0!AV'BF'4A926VG7K6U]&TEK<8CV2@+N'\>5)'0,![XP:IGQ]I@\)KXD^
MRWWV'[0;=QL3?&WF^5R-W3=QP37.^&=$N]-\1:7<Z%;ZGIFG7*R/J^DW2M]G
MMV*$@Q;N V_'W"1CTZ5BW.FZ['\--4\+1^'M0EO8=2,HD55$<L9NQ*&1L_-P
M?PP<XH ],U+Q+!87%U;PV=U?SV< N+F.U"9B0YQG<RC)VMA1D\>XKCM7UJTN
M_''@77+#[7<6][:7LB11ABTG[M-H"$X!^8\\=\G'-6#/K7ACQYJVH_V!J.I:
M;KD<$B&S"/);31IL*."P !&#NS@5:U*'4[GQYX.OY]/F"VL5Y]K:%"Z0&55"
M*6[],$CCC/ - '0^'?$=MXDM;F6"WN;:6UN'M;BWN5"R12+@D'!(/!!R"1S6
MQ7'>";:ZMM7\5O<V=Q!'=ZHUS;M+&5$D9C1<C/NIX/-=C0!Q=EXDT#3+;Q7J
MUM8Z@GV*Z+:B"A9G=8U)95+<#;C^Z*NV7CBQO-7TW3S8ZA;_ -IPM+9W$\06
M.;:N]E'S9! YY !QP37+2:?J+Z-\2(1IE[YFJ22FR7R6_?!H!&"/3YAWQQ5R
M>UO7U/X>RKI]X4T]7^V'R&_<YMS&,_\  O3/KTH @RGBWQKXHTG6]+N_L5K%
M:QPN9(E-EE'<R A\JS'!W+DX4 XZ5T,?C73;:QTZYD@ODTF[=(+?4I0IC<GA
M&;YMX#=F90#GG&161:Z7=W_BKQW%);7=K;:Q;006MT\+!6*P,C'VP3WQGM6=
M)I.JZW\+;7P1=:9<VVI1K;V<TK1_N4CB=3YRR?=8%4R /FR<8'6@#I[OQY9V
MVM7^DQ:5K%W=V/DF5+:UW_+(2 PYY48Y^O&><5Y?B1IT>GZI?1Z5J\T&EW+V
M]ZR6ZCR=@4LYRPRHW=LG@G&.:-%M[J'XG>)+N2SN4M+JVM8X+AHB$=HP^X9_
MX$.>_:L*+3]1_P"$/^(=H=,O1<:G>WDEG&8&S,LD2HA'ID@]<8[T =9#XTL)
MM<L---G?Q)J*LUE>21!8;@JNXA>=P^7D94 XXS4<GCO38Y _V:\-E_:/]F&\
M"KY8GW;<$;MV-WR[MN,^W-8=W:WLEW\/I$T^\*Z>2;O]PW[G,!CY_P"!>F>.
M>E8>LVOB/5M+E-]H&I3ZI:ZW'/E"OD"W6<%?)7=@DKU.,]<GH* .TLO%5Y=>
M/-7T-M*N%M;""%Q*IC.2^\[R-V<$*   3P<@5'H'B#P[9>&+S4K*&ZM;,:A+
M&\4V6DDN&DVE5!8G+.< ?RJ&PAU&Q^)FKWTNE71M-2L;79.FUDB,>_>K8/7Y
MA@ '-<Q'X<URY\%2_9["=-1L/$C:O#:S#R_M$8F+A03QRI_,<XH ] @\4VS:
MRVD7=G=V5^8#<0PS*C>>@Z["C,"1W7.?;'-8\/Q,TJ?3K34ET[55T^XN?LKW
M3P*$@?S#&-_S9P6'4 XR,X/%%Q:R^(?&GA_74L[RVM-&@N7D-Q T;N\J*@C"
MD9. &)(XZ8)KE?[(U;_A31T;^R;[^TO[1\W[/Y)W;/MGFYST^YSU]J /7ZQO
M$7B6S\,6MM<7L5R\=Q<1VZF"/?M9R ,^@R?KZ9K71Q(BN P##(# @_B#R*Y'
MXC6MW>Z+I\-G:3W,J:G:SLL*%MJ1R!F)_ ?C0!,OCFW;5KK23HVKKJ44(N(K
M8PINN(B2-Z'?M R,'>5QP.O%/@\=:5<Z!9ZK'%=?Z7=BQBM6C F^T;BIC()P
M""IR2<8'6J1BN/\ A;8U3['=_8/[#^S?:/(;;YOG;]O3/W?;VZUS=A'XCTOP
MT8X-*U%4E\0S37B0QXG^R2.S!H\]S\H.#N STZT =A)XYLH=,UF\DT_4 ^C2
M;+ZV5$:2,;0V\8;#+M.>#G':M$^(8/LVD31VUS*-595@5-A*@H7RWS8QM4G(
MS7,^#=,NK7Q/XL6YT2YM;"_DAEB:<JRNODJK*3N)+$YSU[Y-)X!T2]T^_O[2
MZE6:PT262QTMLY/EOMD.[U*@H@]-K"@#OJ0G"D@$D#H.]8V@Z^VM3:C#+IEW
M8364YB*7('[Q?X77!Z'%;5 'EVJ>)+SQ/\/?&[W.GW5D+$W<,3"50$,2@;24
M?);=DG@KVR:Z+P_XMM?,T/1)K*_@EN[(-:W$T0$5P4C!<*<[L@<\@9'3-<T=
M-U>#PCX^T9M'O3/?7E]-:NJADF$W^K"X.>YSQ@8YK2N+6]DU[X?7"Z?>&+3X
MYA=MY##R2UOY8S_P+TSZ]* -S4?'&G:9!]MGMKLZ4MS]FDU%%0PH^[82?FW;
M0WR[@I&:CF\>6<>M7VDP:5J]U=V,D*3+;VNX!9<X?K]T8R3[\9P<<EX?TZ\T
M5)O#6H>"%U"Y2>3[)JIMXGMY8V<LKRN3D$9Y&"3CBND\/V]U!\2/%=U+97,=
MK>1VBV\[1$)(8D8/@]L%AUZ]J +FH>.-.TV%;R>WN_[*^T_9FU%50PH^[9D_
M-NV[OEW!<9]N:Q-7NGUGXF_\(]J&CW-UI:Z2TGDL8MI9Y@GG??Z # /WADX'
M-97AW3KS1H9/#&H>!UOKJ*:06NJFWB>WEC9RRO*Y.00#R,$G'%='Y-T/B^VH
M&RNOL)T86?VGR3L\WSBVWZ8/7I[T 20>*-*\/Z &BAU*ZT73F^RR:D2)578=
MC,26WL%/!8*1P>PJQJGCJPTW5_[+CL-2OKMK(WL2V< D$T8('R'(R><^G'7.
M >6TO2]6TOX<ZOX'GTRYGO=MU;6=PJ$PW"3%BLC2=%QO.0V#QQFM'3-'NM(^
M(&B(+:ZFLK'P\--:\$1V&4.A&3[A2<]* -N_\9VMA8W5[_9^H3VUDBM>O$B9
MMLJ'(8,P)*JP)"@X^M;]I=07UG!>6L@EMYXUEBD7HRL,@CZ@UYLMG=:!XJUN
MWO\ P9)KMIJ=V;NSO(((I"I=0&CD+D; ".#Z&NNM]:DL-<TWP_/H\L*RV@*W
M5NH%LL@4DQ+W& I(X]/6@#H:Q3XEMT\6IX<>TNDNI+=KF.5@GE.@(!P=V202
M!C&>_3FMJN0\=Z3J5Q'I6M:'"LNL:5=J\4;' EBD^25">P((/_ : &>*M?T6
M3PMJ$FM:;J,FF0W:V\GE8&]UD4 JR.,*'P,DCG(]:W;[78;74AIL%M/>W_D_
M:&@M]@*1YP&8NR@9.0!G)P?0US7CO1;G_A6,NBZ=;SWMVS08$:9:1EF1W<]@
M3AF.>YIS07NC?$BXU_[)=7.DZK810N\,+/);2QD[0T8&[:0QY X/7% &;X_U
MNQ\1_"/5=1L)9T,$J1.C%HY(95F171U!ZC)!!R.:Z[4_$]OIVI2:='9W=[=Q
M6AO98K<)\D62H.79022#@#)XK@]:\,:F/A]XM$-A</?:[J?VN"SC7+HGF1XW
M8X!*H6//<#K6[K<FKWWB>6VDTF_NM'FTX?9!!B-#.2VX3Y*D #& >.O!- $V
MI^.V$GA632+">\M-<DW"52BG9Y;/M 9A\W ZX  /.:U=4\66^F0WTPL+V[CT
M] ]ZUN$/V?Y0Y!RPW$*0Q"YX(]17"Z=IFM6GACX?32:%?&31[DI=6ZA/- ,3
M)O W=,GN1ZU;-I=Z%XMUD:AX,EURRU6=;NUN;>&*5HG**K12;R-J@KP<XY_(
M ]'L;VWU*PM[ZSE$MM<1K+%(.C*PR#^1K+\8W>FV7A'4YM8M[B?3A PN([<'
M>4QS@@C'UR*T].A:#3K>)X(('6,!HH!B.,X^ZOL.E8GC^VN+[P%K5E:6\MQ<
MW-H\,442[BS,,#Z?4T ,N/%VG:3=:/I2V6H227]LTEHD46_*H@.W)/7!'MSD
MD#)I;/QQIMWH]S?M;W=O);7HL);2=5659RRJJ?>V\EUP=V,'.>M8TUO>2^+?
M UTNGWGD65I<)=.8& A9XT50?Q4CCIUZ50@TUI;?Q?!JGAZ\O+'4M7640F)@
MTD!6-3(O0Y4J6QP>.* .FUK7;!_#>NC6-+U&.TM8"MW#@;WC9"24*-TQGG(Q
M@U:CUVPL=/T:WM+>XEDO8%-G:(09/+5 26+-@!01DD]2!R37'+H^M6W@WQCI
M,4NIZCILUHT&CK>1L;G<\3!D.X!M@8J 6 []N:>;75M'USPKXCCTN\N[2+2/
M[,O;:&/,UNQVG>$/+#<N#CL,\T 2>#-6@L=2\<7MVMU;0Q:E&OE7!+R*QC0;
M1RV26.!@G.1BND_X3.SBU2YTR\L+ZTOH;4WB02(CF:('!*%&8$@]02#^'-</
M>:!KVLV_C0V^CSPRW&HVM_9+>! EQY0C/ED;CUV'KQZD<UT.DW(U"TN+F+P1
M-HKQVSK*TUK&LKN1@)%LY89ZL0!TXY. #8\.>,;;Q.T+V6FZG':SVHN8[N>
M+"W.-F[)^<>GL>:Z,]/6N8^'=M<V/@#1K&]MIK:ZM;=898I5VE6'\Q[BNGH
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M91U(12Q'Z5R'@?2X_$?ABT\0^(HTU#4-24W&)ANCMT).Q(E/" +CD<DY))H
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M61E8CCN,Y'YX .GHKSOX>:E;:-\/8WFWMNU.Z@AB4Y>1S<.%49(Y]R<  DG
MKIM'\4VVJZU?:-);S6FHV:+(\,I5@\;='5E)!'8]P: -Z@$$9!S7$_$?5+NR
MM=%M;>UGEAO=7M8)S&R 2(7R8N6!^;&/3!()YJ?36TS0-2O+#1-&N?MURBWU
MU8Q2(J6^?E'5MBEBIX7K@D\<T =?17(3_$72(M!M-82WOI8)[Q;%T2(>9;S%
MMI61<Y!!],^V<BM[1]3EU6TDFFTR\T]TE:+RKM5#$#^(;200?7- &C1G/2N
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MB 2LC+*@.& *,<,.X/X9H Z&BL[5]9MM'CM_.626:ZF$%O!$ 7ED()P,D#@
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M!P><>AXKB9/#GB%_@]J>@C1;@:E/>R21PF:'E6N?-!W;\?=]^M=+JFG:C?\
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MX&YD(&?Q-<+-IGB"Z\.>!K<^'[F.;2+ZUDND,\)*I%$R,WW\');@ DXZXZ4
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ML+R5)2CEX"&.Y2C$9^4@C/6M+3-9FO[F*.33WABFMOM,4ZRK)&RY'RY'\7S
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MVCP_:+BTD"R.\1&0R%"0V>G7@U>L_%1FULZ/<Z7/!>M8_;X4$B,)(]P4KG(
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MYK6LK@W=C;W+1-$9HED,;]4R,X/N* )Z*YS_ (2EI[Z]AL+$74=C>1V=SMG
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M4C0[<8^8DDGZG%6[7QY:/XDL]&NXH87OHI);:6&[29?D&YDDV_<8#GN#@X-
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MO"2?>4Y((/T((K4H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KEOB+INH:UX%U32M,M&N;N[B$:*'
M1 /F!R2Q''%=310!2T@3+I%HEQ;O;S)"JO&[*2I  /*DC]:X?0[/Q=X9FN]
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M!/?.0.M=5#I-WJ_CBR\175E+8PV%E)!%%,Z&1Y)""Q.QF 4 8ZY))].>LHH
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MN[> HYZ\G(].>CH) !). .I- '.^/-/O=7\#ZOING6QN+N[MVAC0.J\GN2Q
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M,T5Q"DT$J2Q.,JZ,&5AZ@CK0!D6VIZM?JL8T.ZTYSC?+=R0LJ#OM$;L6/ID
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M>0%DC+ ,P'4@=2!D?G4E '$:;HNJ^$?%5T-(L6N_#>I$SO;QRHK6-Q_$4#$
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MI<@$?,017<T4 <+K&C^(+C5O#GBA+6.6^TZ287&G12K_ *B90I5'; +K@'G
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M?"<MIIL:2W:7$$Z1N^P/Y<JN5R>F0#0!S^JO<VWQ9T>ZBTN*349M'N0T44H
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MXBD=BR;@3M;:V,GN/3FND?2+[4O%7_"27&GRV_V73GM+:T>2,RN[MEF)5BH
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M7ENDZJW50R@X/N,US;^.;BVN-):\TC[-;:GJ)L(4EF*W*G<RK(T14?*2O9N
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MN47&T>7(H)"@N%QCY@.>,T 6XOB"\%CX@N=4TU(%T6X^ROY-QO,\I*[ H*C
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MCD]L  >Y(!T,<L<J[HW5U]5.13JI:7I&G:)9"STNRAL[8,6$4*!5R>IP*NT
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MCF"ZB**K#<%# Y4$<?RKIHPZZ/,GBNYL%:]#1R0K)MA5"N#&I;!;C))P,Y/
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M#A'6)RV%_=YR<]QQ[U:\1^#]0\2R'[5:Z?%=PW:RV&K0S,)[:,.&(("#) W
M#.#D9P17>U4.J6(U==)-S']O: W @S\QC#;=WTSQ0!;KDCH&IZ3XWU#7])6V
MN;?588DO+:>4Q,LD8VHZL%8$;3@C ]>>E=;10!Y[JG@/49?A[JNAV,EFVHZM
M>/>W4TKLD:R/*)#MPI) "A1TZ9]J[Z S-"IG1$E(^94<LH^A(&?RJ2J1UC3O
M[8&D?;83J)B,WV8/EP@Q\Q'8<CK0!C>+]#U'5Y-$NM+-L;G3-06[\NY=D21=
MC*1N520?FST[5#8:)K5IXWU77)$L)(;NRAMT59W5MT>XY(V' );U.,=ZZRB@
M#S2W\#:_;^ ?#N@YTUKG2]1BNY'^T.$=4E,F!^[SDYQTXK1\6^$K_P 51WUM
M=6.G,2RMIFH"9EGLCM7)X3)PX9AAN<X..M=U10 R)#'"B,Y=E4 NW5O<UR?B
M+P_J^I>-_#6LV:V/V72&N"ZS3NKR>;&$X 0@8Z]>?:NOHH Q/%_AR/Q9X5O]
M%DF,'VE!LE SL=6#*??# 5F/H>L:]<:"^OQV<(TFX%VYMIFD^T3JA52 57:O
MS%NYS@>]==10!Q=CX;UJUD\8.ZV!.LR&2V N'^7,8CP_[OCIGC/I[UF-X*\0
MV>B>$KC39[!-=\/0FWV2.YM[F)D574MM# G:"..#7=66L:=J5S=6]C>PW$MH
MP2=8GW>6QZ X[^U7: ,2U:YCTV5_%-QI\;W9\HP(_P"Y52#\@+X+D\DG STQ
MQ6-\.M$;2/#4DJW+70F=ELI)NHM$9A;KG^[M.[_@==+JNBZ7KEO'!JMA;WL,
M<@E1)XPX5AT.#]3^=7@JA-@4!<8QCC% &'X2U#5]1T4RZW%9)>),\9>Q+&&1
M1T9-W..H^H)'%5_&_ANX\3:)##8W*6VHV5W%?6<D@)02QG(#8YP<D5TH  P!
M@"B@#AO[ \1:MXNT_6-5MM,M[>/3YK*Y@AN7D8B0J25)1?[O3MZGM5M_!>M+
MX'?P1<RVCZ:#Y*Z@)6\TVV_=M,>W&_'RYW8[^Q]#JGJ>JV&BV$E]J=Y#:6L?
MWI9G"@>WN?:@"U'&D,211J%1%"J!V Z5S-SHFIO\1;77XEM#90Z=)9E6F82%
MF=7SC81@;<=>]=,CK(BNIRK#(/J*=0!YK_PK_6)=%ND>>R@U*+7WUO3Y$D=X
MPQ8L$DRH.,$@D9ZY]JZ2'1+W4O%5AK^K0V]N^GVTD-O!#,9?GDV[W+%5[* !
MCN3[5TU% '+^ M"U3PSX<CT;46M'CM7<026[,3(K.S9;(&T_,!@9Z=:L^,](
MU'7/"UUI^E7,<%W(4(,I(1U# LC%>0K $''K6_10!Y^?#^N6^OZAKERFEP6D
MNB?8WM[9W8PE"[ +E0&'S=<#TQWK/\,:+J'B?X7>&-*NHK:'3?+MIII5E+/)
M'&0ZH%VC!)503G@9QGMZ5=6L-[:R6UPF^&1=KKDC</3CM4>G:;9Z191V5A L
M%M'PD2D[5'H!V'M0!PNB2ZI'\1/'HTZVM9]TUH 9IS'M?[,N,X4Y7]>.^>)7
M\"7UAHOA+3-,DM94T6_6]N))Y&C,K8??M 5L9:1CR>.E=?9:'ING7US>VEJL
M5S=$&>4,292.A;)Y([>E:% '">,]*L_$6MZ'#:7Z)J$=S)!<+"X9C:LA\]'Q
MR 0%&3T++ZUW0 4    < #M5&ST/2M.O[N^L]/MH+N\;=<31Q@/*?]H]_6K]
M '->--"O]<L-._LUK?[58:E!?(EPQ5)/+))4L 2,@]<&J<?A_6=*\8W7B&P%
MG<#5+:*/4+9Y6BVRQC".C;6R,$@@@>OM78T4 87A;0#H%A=B5T>[O[V:^NFC
MSM\R1LD+GG   R>N,\9K=HHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG?&NM:EX=\-7&L:=;PW
M'V3#SQ2!B?*R-S+@]5&3CN :Z*HYX(KJWEMYT$D,J%'1NC*1@@_A0!C3ZZT=
MY$\<UN^G1V#7UW,$)*I_ 5YZ-ASW^X?6L*#QEK$T^B7,6DR7-AJ;HDD<5G.L
MEFKC*NTA&QU'&X@#&>"15_POX-&B^%;C1+^Z:\$RO 9">1;X*1H/HF/Q)JGX
M8T'QEH\-KH]]JFFSZ/9;5AN(T<74L:_<1@?E7H 2,Y''4YH S9_'7B4:%XCU
M6+2],$>A7TT$R-,Y,L<84D*<#YL$G)XZ#'>KUYJVLW/Q*T6UL[JWCT^?2Y;I
M8I(F))W1@EL,,G!X],GKFHCX,UIO"WB[2F?3Q+KMY/<1.)GVQ"4 8;Y.2-O;
MKGM5]_#6LKXA\/ZO;S6*R65@]C=1R%V&UBAW(0!DY7H<=: *Q\::D/"OBO4S
M;VGVC0;RX@"X;9,L2JV>N5)W>IQ[T_4/%>O?VYI.E:9I^GO)J6G27<<EQ,X5
M74*<, .%^;MDGVJC?>"O$+67B[2K*YTP:?KLLUQ'+*7\V-Y$"E"H&-N5^]DG
MV]-*'PUK,?B?P]J<CV#Q:;8/9S;7=6<OMRRC:>FP=3SGM0!#=>+M8:'4(K*T
M@?4-,C1+B);6>=)[CRUD:-&0#:!N #'))/08R>FLM86;PW%K-[;36*FV^T3P
M3J0\.%RRD'G(P:YJX\.>*-*\5ZAJGAF]TPV6JE)+NUU%9/W4JJ%WQE.N0!D'
M'3KZ=6=.$^BOIU[,]P)H&AGD/!DW##'';.3QVH P;'7/$-]#HFIPZ9;S:9J9
M5I(D;;+:1.NY)&8MA^,94*,9X)Q6?J7C74]*NK5[RVLX4GU5;$6+L3<>2S[%
MGW!L8)YV[>AZU+X5T#Q=HMM::+>ZGITNCV)58+B)7%U+$I^1&!^5>@!(SD#'
M?-9$O@3Q.^COI_V[2I&CUA=2CN9!)YMSB7>!*<<$#CC=P .,4 :LOB7Q3>^(
M_$.BZ/IFE^=I:P/'+<W#[7$BLV"  =QP!Z#G)/%5(_B#<:AX;\,ZM%I<"_VC
MJL6GW44[DM;2%RK%1CG!4X.1U'%)HS:M'\4/&GV.*RG?R-/$GG2M$-WE/@C"
MMQUX^G-33^ [VW\.^'],T^:VDDT_58]3N9IV9/.<.SL% 5L9+'&>@ ZT 3Z=
MJ&MS?%'7K.2XMWL;2TMFC@$9!"L9#P=V-Q(Y)XX' Q3+7QIJ2:YH%CJ5O9Q2
M:LTB2V49/GV+!"ZASN(;(&#POXU=D\-ZLGC/4]6M+RVAM=2L8[>4D,9873?@
MH.A^]U)XQTK#L/!'B>WM_"R27.CJ^AW#,S(LC>>&1E,C$XRYW9([G)W4 :?A
M(8\?^//^ONU_])UK2UCQ'+!KG]BV.U;I;474DKVLMPJ*6*H-D>#R5;DD8QWS
MPW0-"U'3?%/B/4[HVI@U6:*6-8I&+)LC"8(*@<XSUXZ>]5/$7AW7O^$IM_$O
MAB[L4O!;?8[JVOP_DS1!BRG*@D,"3V[_ )@&<?'>O#3] DD\/+;76H:B=/FA
MNF>+# ,0R KG80N<GD9Z&I)?%6OBS\8V$R6$&JZ+:K<PSPJSQ.CQLX^4G.X;
M"/3IQ5O5O#FO:F?#\TMS8S7-AJ(O[DEGC0X5E\N,88@ -U)Y(SWX&\*:C<:[
MXLN9I+5+77+*.UC*.S/%L1TW$%0#G?GKQCO0!G1^(=6TCP!X3O+B&SOFO9+"
M!WD+ HL@0!L'.Y\DG.1SCBKT%_K<OQ9O]/\ M-L;&WTV*:.$QL,!Y&!YS]X[
M1SC&,<>M:X\)>(;KP7H.C2RZ8;G3+FUD+*\@1D@VX&=I)+;?0 9[UKMH.J1?
M$!O$%M+9_9;BPCM;B*3<74H[,"F!@@[L<XQUP>E &;8>.)$T'5KV[L((KFWU
MI]+B@MRS"23>J DXR<EB20N<#@$TYO&&L6%WJL=UH\U[;6NG/?07=O936Z2,
MN<PL),X;N""<CM50> =2N?#FNZ?<7EO:W=WJ[ZM97-NS/Y$A<.H(*C."N,]\
M]JV+*T\;3:=<G5+[2(K];=H[462R&(R'I)(6YXQ]T#N>O& "QX:UZ;7MES!>
MZ;J&FR0;UN+,%2DF1E&4L2.#GG!Z\#',FI:[*OB:T\.Z>(1?3VSWDDLREDAB
M5@H.T$%B6; &1T)]C0T7PD]CXQG\0FULM.:>S\B>WL9&9)Y"P;S&RJ@$8('!
M)W')J;6O#E[)XMT[Q/I$D'VVV@>TN+>X8HD\#'=C< 2K!N1P<T 8FH_$'4=.
MT'Q07T^U;6/#S)Y\9D812QN,I(O!/(_A)XP>:ZW19];G:YDU>VLH(6*M:BWD
M9VVD9(DR ,@^G%<OK/@:_P!4T3Q3MDM$U7Q#Y:2$NWE01QJ%10=N6( )S@9+
M=L5W%H)ULX5N5C68( XC8LN?8D _I0!R_P#PDNJ:I!K=UH4%I)#I-Q);"*X#
M%KJ2, N%8$!!D[02&R1V%8DWBO4=?UWP+<Z+<0PZ=JT=S.8IHV)WI$<AR&&0
M-Q&!W&>>*UK#PUK/A^]UV/1Y+&6PU6X>\07,CH]K,XP^ %(=20"!E?3WJ ^!
M+G2QX0&A7%MC0%FB878;$JRIM9_E_BS\V. <]10!DQ7FLZ?XO^(EUH\%D\D#
MVLSF[9@I"VH.T!><G!Y)X]^V^GC;[?;:(EE%Y5SJFGC4"6@DN!!'A>"L>"Q+
M/CJ!P3GH"R'PSK$6H^,+H_82-<1!"/.<>65B\KYOD[]>/I[UFKX)\1Z;8>&K
MS1KW3XM:T>R_L^5)R[6]U#A>"0 RG*@C ZT .G\>:_;:':W,V@+%=-K,>F2+
M/YD*RJS@++$&4':P/<\'UKL]';6&LG.M16270E8(+1V9"F?E)+ '/K7-:WX<
M\1ZUI&G)/<Z>]_#J<%_* SI"@B((C3@DYQRQ[DG'0#M5W; 6 #8Y .1GZT >
M?2>.-3MO"'BS6$TNQ6YT;4)K?RA*VQPBI\Q.W+'YO05I6_B;68?%ND:9J=G9
M)::O;RRVQ@=FDB:-58A\\'(;MT/<]:S)?!.MS>%O%VDF33Q+KM[+<Q/YSE8E
MD"@@_)R1M[=<]JUKKP_JUUXF\+ZH19+'I,,\<Z><Y+F1%7Y?D[;<\]<]J (O
M#OB^Y\27,9LY=/(6>6*\L6#+<V84.%+9;G+*H/RC[W&<5E>'==U\>'/%VJ7C
M65])8WUZBQ,&C!\G P#EL+M7@8SZGO5Y/!U_>Z[HFKZC%IT&I:=(6GU"SD;S
M;M-C+L9=@&#D$Y)QCCKPMGX4UJQTKQ5IJ3V$EOJMQ=SVS$NK*9^S\$ +D],Y
M]J ,_4->UN\'P^ELI;2UBU;;+-#Y;%=WV=G"\,/D'IUR!SQ6]8^(=2N=>\3:
M0Z6HDTF*"2&8(V'\Q&;#+N[;<<'_  K/E\(:RNC^#DMYK 7_ (?9 XD9S%*H
MA,1((7(.#G&/;-3R>&]>MO%NK:EI]QIS6VKVL,5RTX</$\:LH** 0P(;H6&/
M?N 8ESXJUS6=/\!7]H]K:)J]T#/"49@2$=@,Y'R_+TZDXY]>C7Q)/!XZO=(O
MK:TBM[;2%OS=(269=Y4@Y' &UCCGZUBVO@;7+/POX2LTNM/?4-!N1*=V\12)
ML92,XSGYLYP*V'\,WUUXXNM6O#:26%SI TR1$=@Y^=F+8VX .XC&>/6@"A=>
M.-1L_"-KXRDM+=M%E*22VRAO/B@=@JR;L[6/*DKM'4C=QDV9/$GB"\\6ZMH.
MF6>F VMK#<0W$\KE6#EOO  '/R]!TY.3T-*#P3J[>"QX+O;BSETE&6(7JR,)
MVMU<,$,>W:&P-N[=C'..U:]IH6IV?CC5=<1;)K6ZLXK:*+SF#*8RQ!/R8 .[
MMTQWH J:9XQU#6?"N@ZO;64%LM_N^V7$[9AL@@;<Q&5+ LN!R.O)]<+7_$<G
MB7X0>,))TA$MD]Q9,\.?+EV%2'4'D @CC)^M3Z;X&\1Z7HWA6VBN=,FDT2>=
MY8)7D\FX$A)5_NY#IN..#USD5))X&U]_"WBW1VO--D;6[R6XBD = GF;=VX<
M]-O &>O6@#O;0L--@* %O)7 )P"<>O:N!?Q[J=M\/+WQ#'I5B)[;47M9(%D8
M*/WXBW#CYCDYYVUWUFD\6G0I,D8G2,*RHY*Y ]< X_"N D\"ZY)\/]1\.^9I
MPN+O43>"7SGVJIG$V/N9SQM_'/M0!MVWB#6U\:/X?U"VL(C<6#WEI+ SOLVN
M%*29QN^\#D8JOI'B[4M1\-7\\T%I%K5K?MI[6@#%!+O"J"<Y((8-N[ YP<5=
MET/5)OB!8^("+-;:#3WM'C$S%\NRL2/DQ@%<>_MTHB\(^3X_N/$*7&+6>%&D
MM?6Y4,@E_P"_;%?U["@"KJ?BO4!<ZK9Z3%'+<Z6BK(&LYI5GF*!_+7R_N<%>
M26Y;IQDP-X[DDN]*LITAT.ZO['[2B:K&P#2[MI@!RN&!&<GG!&!3KSPYXGTS
MQ=?ZQX9O-,-MJ@C-Y:ZB),)(BA1)&4]5 R#CIU]+6L>'-0U2W;3[^WTW6=/D
MM51UO7:)EN,L6D7"-@$,, $$;>#0!G:AJ?B)O'/A2R,MK;)=64]Q/;E&8"54
M0,"0W(&\@?F<\8M/XLU2^T75M<T:WM);+39IHU@EW>9="+_6%7!PG(8+E6S@
M9QGB&/P9JUA<>$9[/4;>XET6TDL[A[L-F175!O7'<%.A/([TZR\)ZSHMGK>D
M:9-9/I>I2RS023NZR6AE'SKL"D2 $DCYE]#ZT 1S^.-4O]2T*VT"QLI8=:TZ
M2\MY;J5EV%0IPX X W8XSD^G6GCQAJ3ZM=:*6TNWUNTAA;[#*6_TMFC#,87)
M7*@EE'!.5YQFI8/!UUIOB+PS/IWV;^S-%L9++;+*PE<.%&[ 7&1LSUYSVIGB
MSPA?^*H[^SNH-->)Y%?3[YG9;BR^5<E0$Y(8,PPPSG!H ZG69K^WT:[GTN**
M:]BB9XHI<[9"!G;QTSTS7'#Q]<-!X-O%-E]CU\B.9BK;H)".@&[D;B$)/0D=
M<XKO479&JEBQ  W'J:X"3X:AM#\1Z<MV,7DSR:7U LLMYH XX_?9)QV"T 5_
MB3>W5[\//%)=839P7$$-NR*0SE98MY))QPQ*_536Y#XEU2T\9_V-K-O916T]
MC)>P2V[L3&(V 97R,'A@<C'2F>)?"=[J?P]?PW8S0&XD$?F7%PQ4,P=9'<A0
M<EF!/;[U27WAW4-0\:V&L3)9BSBL)K.>'SF+-YA4DCY ,#;CMG/:@#/N/'&H
MP^#XO&:V=N^C,PD>U ;[0MN7VB0-G:6QABFWIQNXKIO$$B3^$-5D0AHWL)F4
M]B#&:Y2V\$:O'X,D\%37-I)I&[RDO?,83_9R^[88]NW=C*[MV.^.,'L-7L9;
MGP]>:?9+$KRVS01"1BJ+E=HR0"<#/I0!P?ACQ#J^CZ#X$@N+2S.E:E;P6:E7
M8SH_D;E8_P .#M/'4>O:M+7_ !KJ>@K<7=S;6<,$.H);1V4K$SW$#.J>>K!L
M 98X!7MR>::?"&M?V+X-L0UAOT":&25C,^)1'&8\+\G&0<\].G/6J&H^!/$M
MYI&OZ:E]I;K?ZDM]#<S"0RN!*KK&^!@!0N 1GCC H Z;_A(+^W^(*>'[R.V2
MSN;-KFSG56W2LK -&><94$-[CTJL_BRYAM=/#I$UQJMQ*MF8X)'40("1*RJ2
MS94*0!C[XY')J;Q7X5N/$MCI96\6UU*RN4E^TQ KA&&R95ZD91FQ[@4GBSPQ
M>ZE%I-YH%U!8ZKI$IDM/.0F%E*[&C8#D*5QR.F* )_"^NZGJEUJEGJ>G20-9
M2J(KL6\D,5TC#(95DY!&,$9...>:8VNW8^(IT'[%:^4=*:\CGWG>Q$BIM/'R
MCD^O;Z5H:%#KBQ23Z]/9FZDP!#9!O)C ST+<DG/)XZ 8XR<Z70]2/Q%3Q%']
MD-HFF-8B-I6$A)D#[OND8XQC/O[4 <U)\0?$,?@RY\3G3--%M8WDD-U!YKEW
M19O+/EG& 1UR>O/ [[Z>(M:M?&=KHNHV=B(M0M9I[0P2ON1H]N5D)&#D,.0.
M/0UBR>!=;E^&^K>&3)IXN+ZZDF682OL57E\PY&S.1T_7VK>O=#U6]\;:%KA6
MS2"PMYXI8_.8LQE"Y*_)CC;WQG/:@#F3X_\ %3>$[CQ-%HFFM8V%Q,EY#]H<
MRND<A5C'QC@#.6Z\\# SIO<Q7OQ:T"\@.8I]!GD0D=5,D9'\ZQ?".F:KKOP]
MU31HC:165[?WL+W)D;S$C:9@X";<$XS@[AUZ<<]6?#5Y#XWTO5;46JZ;8Z<]
M@(VD;S,,5.0-N.-H&,\T 9;>/-2N+*RUC3-+EOM/N+@(;:*RG,WDEBOFB0#8
M?[VW'0_>J5_%/B2YU/Q186%AIB2:+Y91YI799 T?F8X Y(P.P'^U4?A_PMXL
M\.J="M=4TYO#B2,8)F1_MD,1)/EC^'C) 8GCKCH*O6GAW5[;6_%E^18LNLK&
M(%\YP4*1>7\WR=^O'3I[T 9\/CK5Y++POK,FG6<>DZW/!:F(2LT\;R@X;.-N
MT,,8ZXP>.@LZKXRU'9J\FAV7VHZ9,T/V<VD\C73J 7570;4/.T9#9(Z 55_X
M0O6E\(>%-'5]/,VB7EO<2.9GVRK#G 'R9!.?P]ZG3PWXKT3Q%J5QX>OM*.EZ
MI/\ :IH;])"]M,0 [1[<;@<9P2* )/\ A+-=O/%,.C6.EVL'VC2%U%&O7</$
M2X7;(@ ((R1M'?N*Q-5\7ZYJG@33;^W^S6-XVM1Z?>JH9U)6X"'8<@A3CG/.
M"1[UTT7A[5(/'D6N"2WFMHM)_L[][*PE=MX?><)CDC&/Q]JQ!X$UK_A#I=+\
M^P6]36/[4@;>[1L?.\W8WR@CTR : -J^\27R:G/H]H8?MUI;1S7$QLYIHR[[
MMJ!8^5SM)))XR, \XK:?XTO]4AT*R_LI].UK4DEDF@O$;%JD1PSE?E+9)7:.
M,YSGBF:CX<\4VWB5?$6@7FE_:[JV2WU&TO!((9-A)5T*Y8$;B.>HI=4\*Z\V
MJ:+XAL+^TFUNQ66.Y2X#1P7$<ARR C<4"G[O!Z<YH A\#?:_^$X\<B]\G[0+
MJU#&$$*P\@8(!)(R,'&3CU/6KNI^(]?7QL_AO2[#3V9M--[%<7,[A1^\"?,
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M51M4D#J06Z #. ..:K>%+Q_%NOW;RVKZ1KEI%!<QMN\Y=B.F%[8(;J3QZ=Z
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M9B&^[@YW'C]:Z9L[3M +8X!.!2T4 <5HG@N>$^)[?6ELKJQUVZ>X>*-FR@8
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M[FRCM"B%@X*%FW8(QR6/&>/4U'8>&;Z+Q!XIO;J6W^SZVL:JL18M%LB\OG(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4:A:BS-JQ-F4_?,^X?O <_= .,8ZFICJNG!XD-_:AY7,<:^<N7<<%1SR1Z4
M6Z*JW]_:V$&ZYO;:T+Y6-[APJ[OQ(S],UR/AW7=9U[P&NHRZE86=_P#;9(FN
M)(?W.Q)RN I;NHP.>IH [BBJXO[-KHVHNX#<CK")!O\ 7IUJAJUX\VE3G2]7
ML;6XCD0-/-B1(_F&X,,CDC(Z]Z ->BJU[?6MA!YEU=V]JI^57G<*N[\2,_3-
M<WX*\3RZMH\\^KWEF+@:C<6L13$:R!'VC:"23V[GK0!UM%0I=VTEP]O'<1--
M&,O&K@LOU'45';ZG87=Q);VU];33Q_?CCE5F7G'(!R.: +5%<CX=UO6-3?Q7
M!/+9FXTZ^>VM7\LI& (E92XR3C+<\UH^'=4OI/"\-]XB:RM[E2XEEA8K"RAR
MJNI?D*P (SZT ;M%0VUW;7D7FVMQ%/'G&^)PPS]17-S>([S4_%MUX<T,0(]A
M$DE_>3H76(ORD:H"-S$ G)( 'J>* .JHK#AEUZVUZUM;LVEUITT4A-S%$T;I
M(-NU6&XC!&[D>F,>NDNI6+7QLEO;8W8&3 )5\P?\!SF@"U156XU*QM/-^TWM
MM#Y*AI/,E5=@/ )R> :#J5@)H(3>VPEN%W0H95W2CU49Y'TH M455N=2L+,2
M&ZO;: 1 &0RRJNP'@$Y/&>U.GOK.VM1=3W4$5N<8EDD"H<].3QS0!8HJN+^S
M-FMX+N#[,V-LWF#8<\##9Q35U*P=KA4O;9C;?Z\"53Y7^]S\OXT 6J*JKJ5B
MUJURM[;FW4[6E$J[ ?0G..]6597171@RL,A@<@B@!:*X[7?%4EMXJ\/6&FZA
M82V]W>/;WD2X>1,1NPY#?+RO0C/'6NG&IV!MVN!?6Q@5MK2>:NT-Z9SC- %J
MBL:\\4:18ZU8Z3->PB[NT:1%,@&$ ^\?J< >O/I5BR:[.L:DLVH6L]N#'Y%M
M&F)+<;?FWG)SN/(X% &C156WU*PN[B6WMKVVFFA_UD<<JLR?4 Y%$6IV$]RU
MM#?6TEPA(:))5+ CJ" <T 6J**R_$6JOHN@W5[#"9[E5V6\ ZRS,=L:?BQ H
M U**Q?"/B"/Q3X4T[68P%-S$#(@_@D'#K^# BL*P\1:W<0>-%DFLS<:1.R6K
M"W.S:(E<;EW9)Y]?\* .WHK&\):E<:QX/T;4KLJ;F[LHII2HP-S*"<#MR:V:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX8\3Z-XU6)C"F=-U+RTW,89""C?\!D"_]]50^(&F+;?"J>6\AB^W/=V]U*Q
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M3TP"<G-<=XA6 ?$SP!,%C\QQ>C> ,L/L_'/<5BZ)J/AV_P!#\1Z!XNEB%_\
MVK.UW:RR%)ISYFZ$Q@$,W 0+M] * /38M3L+B\DM(;ZVDN8\[X4E4NF.N5!R
M*?;7EK>H[VMS#.J,48Q.&"L.H.._M7">+))?"/BFR\76EG)-#?1?V=?V\8RS
M.>;=N.^_Y"?1A73V!LO#.DZ=9ZA>P1W%S+Y>]V"_:+F0EFV^I9BQQ0!MT444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/XTY-+T^*V>VCL;9+>0Y>)85"M]1C!JW10!7M+"ST^-H[*T@MD8Y*PQA 3]
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M*BY)PHP,DY)_$DFG44 0W-K;WD7E75O%/'D-LE0,,CH<&HCI6G-,\QL+4RR
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MR@@8)!(SZ^U=+#HE[J7BNPU_58(+9M/MI(;>WBF,IWR8WL6VC@!< >Y)QTH
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MHNSSUEP1L."=O3)Z]>*W[O0];F\>)KT"V<<*Z1)8C,[%UD9U<-C9@@%<=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM$LK2\6$3V\"1,87+*=J@9!(![>E:%07E[;:=937EY/'!;0J7DED;"JH[DT
M<UX[\/:GXDL],M].-FGV34(;UVN)67=Y9)V@*IZ^OZ5U(,ODY*()=OW0YVY]
M,XZ>^/PIEI=V]_:17=I/'/;S*'CEC;<KJ>A!J:@#S;_A!=>_X5\_AW?IOVAM
M1^V>;YS[-OG^=C[F<_P_K[5M7_AW6+SQH=:BFM;:)M'DTX,DK&2-W8/Y@&P
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M7Q!<:FFJQ3H"T44D8VQIR 679D$XY+$X[5V#Z+ILFK)JKV437Z+L6X(^=5]
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MA^5V7JH/]X8)QUP">E:E<AXAT"#3OA_K<5EB*X2*6_CEC4)MN$&]64#A<%5
M]ASGG.WX;U4ZYX8TO564*UY:13LHZ LH)'YF@#4HHHH **** "BBB@ HHHH
M*:(HQ*TH11(P 9@.2!T!/XG\Z=10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4UHHW='9%9D)*L1DKVX]*=10 44
M44 %%%% %673+"?4(;^6RMI+V%2L5P\2F1 >H5L9 ^E6J** "BBB@ HHHH B
MN+>"[MWM[F&.:&08>.10RL/0@\&JFFZ#H^C%SI>E65B9/OFVMUCW?7:!FM"B
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ IL<<<*!(D5$&2%48'/)IU% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M758KMPO6&",-OD/H.0!ZDX%02V$.I?'6^BEGN8]N@1'-M<O"W^N/4H02.>E
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M7K*%[*5ONL\2A6C!_O8^;'I3OB5;MKVJ^%?#]E\]X-6BU";;R88(@VYV].6
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MW!?^ UYKK9NO$'PFTOQ'I]G.ZV>O2ZO):$?O#$+J8LN/4;N?H:](UG4K;4_
M=_JFF7S&)K&2XM[FWE*D$(2""#V/8_0T :FCW%W=Z+97%_ +>\D@1IX1T20@
M;E_ YJ[7-?#Z>>[\ Z)=W5Q-<7-S:)-++-(79F89/)_E72T %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !5:]T^RU*#R+^SM[J'.?+GB5U_(BK-% &;+X=T2>VBMIM&T^2"+_5Q/:H53
MZ C JPNFV"7<5VME;K<0QF&.41*&1"<E0<9 ]JM44 %%%% !1110 5S6N:%J
M6JWC,O\ 8$EM@!$O],:=UQ_M>:HZY(P!72T4 <I8Z+XDTN P6%UX:M8BQ8I#
MI$B D]20)^OO41\-ZX=0_M MX5-Z#G[1_8K^9G_>\[-=A10!R4NA>(9KZ.^E
MG\,27D8PEP^CR&11[-Y^127_ (?U_50@U&7PO>!#E!<:,\FWZ;ICBNNHH Y.
MYT+Q%>VBVEU/X8GME "PRZ/(R#'3"F?%+'HOB2&R^Q17/AI+3&/(72) F/3;
MY^*ZNB@#A!X(O NT6?@L#T_X1\__ !ZK;>'-<=K=G;PJQME"0$Z*Y\I0, +^
M^^48]*["B@#F7T[Q7)YF^_\ #S>: LF=*E.\#H#^_P">IJC'X4U:&VEMHD\(
MI;R\R1+H;!7^H\[!KM** .$_X0B\V[?L?@O'I_PCY_\ CU7FT'Q"]\M\\WAA
MKM1A;@Z/(9 /9O.S76T4 <U)8>+9C&9-1\/N8VWH6TN4[6QC(_?\'!/YU7O]
M!\0ZK&L>HS>&+Q%.56XT>20 ^P:8UUM% '-16'BVWB6*'4?#\<:C"HFER@ >
MP$]1WFD^)]0MS;WMYX;N8&()CFTF1U)^AGKJ:* .2L=!\0Z9YGV"?PS;&3!<
MPZ1(I?'J1/S3%\-ZXE^;]6\*K>DY-P-%<2'_ (%YV:["B@#GOLWC+_H+:%_X
M+9O_ (_5!/#>N1WYOT;PJMX>MP-%<2'_ (%YV:["B@#G?LWC+_H*Z#_X+)O_
M (_6;#X4U>WNEN8%\)QSJQ=9$T1P58]2#YW!]Z[2B@#D+_P]KVJ[?[1D\+7F
MS[OVC1GDV_3=,:AM?"6J6%TEU9Q>$+>X3.R6'0F1UR,'!$V1P37:T4 <?!X;
MURUO6O;=O"L-TWWIX]%=7/U839J._P#"FKZI<K<WX\)W5PHP)9M%=V ],F;.
M/:NTHH Y.;0O$5S8K93S^&);10 L$FCR-& .F%,^*K2>$M5FMH[:2+P@\$9S
M'$VA,53Z#SL"NUHH XJV\)ZK9W,=S:Q^$8+B/.R6+0V5ER,<$39'%)<>$-4N
MY6EN8_"4TC$LS2:([%B3DY)FYY)-=M10!SBVGC!%"KJF@JJC  TR4 #_ +_U
M2M_#>N6=XUY;-X5@NF^]-%HKJY^K";-=A10!R5_H'B#545-1F\+WBJ<JMQHT
MD@!]MTQHN-!\0WEDME<S>&)[52"L$NCR,@(Z84S8KK:* .3GT/Q%=62V5Q<>
M&9;5<;8)-'D9!CIA3/CBDL="\1:8'%A<>&;;S#E_)TB1-Y]3B?G\:ZVB@#CX
MO#>N07S7T+>%8[QNMPFBN)#_ ,"$V:%\-:VE\;Y3X4%XW6X&BOYA_P"!>=FN
MPHH XR+PKJ\+S/$OA*-IAB5ET-P7_P![]]S^-0)X*OHR"EIX,4@Y&W0".?\
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M+;VVHF4?+;R,2=Z==ZAB !P>.16M9>';[3_B#;ZC!;)_9,&BKIB$RCS 5DW
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M^(5UIFG)=RV^HB1;02>5OQ A(4A3SUP,<FM>YT;5KCQEX8U7[)&MMIUK/#<
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MO4K&PD@CO+R"W>XD$4*RR!3(Y. J@]3D]!5JO+M=UM_$GA[P?J5QITMA<_\
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MR IX)/(!ZE17#-XYU"W;7(I-*CN'TZQ-_#<1.Z03HH.Y"Q0[7&.G.<YXJ/\
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MDF-]K>3\G(QS\V/3GK0!Z/17'ZCXKU=/%P\/:7I%M<2RZ=]NAGFNRB8WA?G
M0D#D]-V<CIR1!I/CC4-6T:1DT)UUBVU(:;>6HDW1V[9YE+ <QA3G./;WH [>
MBN$/C^X71_%5S'9VEW<>'SEC#<D13H8]^Y3M."!D%>>1UJQ:^+]5_MW0K._T
MJV@M=;@=K:2.X+R(Z1B0B1=N ",XP3TH [.BN/T[QE<S6GB7^TK*"TO-#D96
M@29G\Q=FY'SM!P_;C/%=19O=2Z?#)=PQPW31@R1(Y94;'3.!G'KB@"Q3)98X
M(GEFD6.-!EG<X"CU)-<'<^/]2M?#'B+4Y-*M1>:'=FWGM#=$;T&W#AMG\08$
M#'/3K71Q:O+?7UC;V\5M/:W%E]JGF#GY%.-F!CD-EL9QPAH U;*]M=1M([NR
MN(KFVDSLEB<,K8..".#R#3/[2L?MTMC]K@^U11":2'S!O6,D@,1V'!YKRSP-
MXEU+P_\ #WPB[:; ^DW-PMD\IN")E:25E5PFW&T''\6?85W%IK!F^(6H:++I
MEO&\.GQSB[5]SRHSL I^48 (/&3UH W+'4+/4[;[1874-U!N*>9"X=20<$9'
M'!JS7F?@S7(/#W@,R,BL\^MW5K!&3M4NT[XR0#@  DX!X' -=+H'B>ZU+7[[
M2+NR \B)9X;R .89E)P5^8##@]LG(YH WKS4+/3UA:\NH;<32K#$97"[Y&^Z
MHSU)]*IV7AO1M.UF\U>TTZ"+4;S_ %]P!\[_ (]N@SCKBL_QAK)T8:*6TVWO
M8KO5+>U+3/@P,[8$BC:<D<]QCBJDWB?7)O%6K:!IND6;S6=O%/'-/=LJ.'+?
M>PA(/R]!D=>1W .PHK&\)Z^OBCPMI^M+ 8/M4>YHBV[8P)5AGOR#S6S0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7-^/-&U#Q%X-U'1M-6W^T7D?EAYY"BIR#GA23TKI** .(U;P
MIJMQ#HNLZ6;2T\2Z6BQ'=(QAN(> \3L%SM/4''!^M-U71O%4'B:W\3Z''I[7
M,UH+2_TZXG;RV56+(Z2!<Y&XCD=*[FB@#B_$&@^(=8T_0MS6,MY::M#J%R/-
M9(U5"3Y<?RDG@XR<9Y/&<#-USPEXEU*?Q9$G]G30ZO;>5:75Q,_F6R^7M,(4
M+C:6R<@CKD@GBO1J* .('AWQ!'KOAK5D73FELK"2RNXS,X5 VPAD.WY\;>AV
MY]1VKZ5H/C'PY>WNEZ7+IDVAW-S)<6]Q.[B:S$C%F78!A\$DCD>Y[5W]% '$
MVN@:_P"'_&&K7VE)9WNFZP4EE2YG:*2WF5=I885MZD#..#FM#X?Z)J/AOP5I
M^D:G]G^T6RLI,#EE(+%AU P><=^G6NFJK<:E96E[:6=Q=117-X66WB9L-*5&
M6VCO@<T <RV@ZP?BHGB416?]GC2SIY7SV\WF7?OQLQ[8S5WQIX?N_$.BQ1Z;
M=):ZE9W4=[9RR#*"5#P& _A()!^O>NCHH XZ6S\7ZUX:U6WU6'2[:YN+*6UA
MM[>=V0LZX,CN5R,=E /4Y)XQ/!I6L6W@O1]*:STZYEMHHK>]MII"T4\2Q[6
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M6VH6MA-=11W=V',$+-AI @RV!WP#0!!HRZK]D:76&MQ=RMN,-L2T<*X "AB
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MJ36K6MP/$EG#<6['<8I4FVLN>_(_(UUC>('B^(DNC7%E;1P1Z2;X7@<F0J)
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M0Q,Q8QA<;2>2 V>,YP>E %K5_&=ZC:Q_8UHMR^E.8VA:"9VN9 @=D1D!"G#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0,9]\U;BGAGC\R&5)$Z;D8$?F* )**CBGAN%W0RQR+ZHP(_2G,ZI]Y@OU.*
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MLY_LK1K<^6WE&4$H'QQNQSC.,U%823C3;0WTUN]T\:B1X,B-WQSLSSC.<>U
M%NBHQ<0M$TJRHT:YRRL"!CK7*>'-=USQ'!I6MVIT_P#L>\$C36[JRS0I\WEL
M&R0Q.!D$#KQTH Z^BHX9XKA-\,J2+G&Y&!&?PH$\+-M$L9;!. PS@'!/Y\4
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M40*-S;F P/4^U $E%,,L8 )=0",CGK3MZ[MNX;O3/- "T444 %%%% !1110
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M%(!'3!X[UU'B:&.X\+:K'+&DB&TE.UU!&0I(X^M&D^&-"T&:>;2=(L[*6?\
MUCP0A"WMQV]NE:C*&4JP!!&"#WH \?M);>T\,?#*U\J!-+O7@_M#8H"R2^1^
MZ$F.N7&>>I45T]C:MIWQCNX-.01:?=:.MQ>11C""<2[4? X#%0P]POM72Q>&
MM"ATF32HM(L4T^1BSVRP*(V/J5QC/ Y]A5JQTRRTQ'2RMHX0Y!<J.7(& 2>I
MXXYH H>+X(KGP9K<<\:R(;&8[6&1D(2#^=>=O86EYIGPF\^%7+QQ1,>A9/LA
M)4D=O;O7K%W:6]]:R6MW#'/;RKM>.1<JP]".XJA_PC6A[+1?[)L]MG_QZCR5
MQ!_N?W?PH Y#PSIMA;>+?'VD0V=NFFH]I(MH(P(E9H,L0G09(!_"N6TYHM-^
M$?@>18(HK&]U"UBU654 WP[WXD(ZJ6V@Y[''>O6U\/Z.L]W,NF6HEO!MN7$0
MW3#T<_Q?C2PZ!H]OI<FF0Z9:)I\@*O:K"OE$'J-N,4 <E>Z=':_%G3H;"WC6
MTU#3)QJENJCRW5"HC=EZ9RQ7/ID5R6@^&M%E^ MSJTFGP2:@FDWRK<.,NH#2
M$ 'V*C'I^)KUNTT/3+"&6*UL88TE4))A>64= 3U(&3@=J9%X<T6#2I-+ATJS
MCT^3.^U6%1&V>N5Z4 >;W6AZ9'-\-YX[.))KLB*YE48>=&M22KMU8<#@Y&..
ME-N!H^@7/Q-M98Y;/1HX;-F@T_$94R1%6V#HI8[<GIZUZ2WAO17%H&TJT(L_
M^/;,0_<?[G]W\*5O#FBO+>2-I5FSWJ[+IC"I,Z^C\?,/K0!PVEP1P_%M;2XB
MTZ**?PWB2UM^4 $Z!%8GASAB =HX.,5S45CI[?LTWCBVMO/\B61F"+ORMPX4
MD]>.0*];L_"^@Z?-:S6>CV,$MJK) \<"AHPW7!QQFD_X17P_]DN;3^Q;#[/=
M2>;<1?9UVROZL,<GZT <P\_VCXLV&FZBBO9#0S-9)(,HTWF 2$ \%@F/< GU
M-<7XBL1!X,\?V*Q@Z38ZM;G3QV@9GB:54_N@%L8'3)%>Q76A:5>VUO;W-A!)
M';', *<Q'IE#U7CTI)] T>YTQ=-GTRTEL5.X6[PJ8\YSG;TSGGZ\T <@NF66
MC_&+3%TZVBMA=:1<&X\M<><5D0AG_O-R>3SS79ZQ!%<Z+>PSQK)$\#AD89!X
M-,_L/2OM\-__ &?;?;(4V13F,;T7T#=0/:KEQ;PW5N\%Q&LL,@VNCC(8>A%
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M8V.A?#W6]'@6+6Y;JQC:XC)WW$;Q_O%<]678"?8# P*[WQ%X<MIM%UQM,TJ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8-N[[)NSCUSSGUYJK;:=8V.E_"N_M;:**\FEMTDN%4"1U:U;<&;J1P.#Z 4
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MA>"QZL>3R>>30!JW-W;647FW5Q%!'G&^5PHS]31]JMS(D8N(O,D&Y%WC+#U
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MNT+VUQ%,BL5+1N& (ZCCO7DT^C:8NC_#"=;.$37$UO%-*%PTJ/:MN5FZL#@
M@\8XZ4:JDNC7_P 38M"A%L4TVSF2*U79M)20.R@=&VCJ/04 >L07UI<RRQ07
M4$LD1Q(D<@8H?<#I0E]:22"-+J!G8,0HD!)"G#''L>#Z5P>F6'A?6=7T#5[+
M6UN76WDA@M;=8566%D^9)45<[5QT.,-QU-8?A'PSH=W\)Y+B58+&Z?[;;+J(
MC!>!6G=,9_N],C@8)]30!ZO;7UI>@FUNH)PO7RI V/RJ9W2-&>1E1%&69C@
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M$<BE W0C<I ]1B@#U-;NV=)'2XB98_OL'!"_7TI([RUFN&@CN87F50S1JX+
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M<21D;O[QY/)YK+L;(Z3JNH_#A;?_ $"]N!>6K!/E6R<EIT/T93&._P"]7TH
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M.D*B1_JP&3^-*^J:?%:QW4E_:I;R_P"KE:90C_0YP:>U]:(T*M=0*T_^I!D
M,G^[Z_A0!4L?#FAZ9)</8:/86KW(Q.8;=$,@]&P.1[4^'0='MK&6Q@TJQBLY
MO];;QVZ+&_U4#!_&GG6=+#PH=2LPT[F.(>>N9&!P57GD@\8%20ZA97-U-:P7
MEO+<0?ZV*.56>/\ W@#D?C0 VQTK3]-W_8;*WMMX ;RHPN0.@X[#L.U27=G:
MZA:R6MY;Q7%O(,/%,@=6'N#P:C_M33_M_P!@^W6OVW&?L_G+YF.OW<YIMQJ^
MF6@D-SJ-I"(F"R&2=5V,>@.3P3VH 2'1=+M[.6SBTZU2VF_UL0A7;)V^88Y_
M&IK*PL]-MA;6%I!:P Y$4$810?H!BL[5/%.D:/JFFZ=>7L,=Q?LPC5I -JJC
M,7.>B_+C/J16R#D9% %*]TC3=2DBEO;"VN)(@1&\L09DSUVD\C/?%,O-"TG4
M-.CTZ\TRSN+*,@I;RP*T:8Z84C Q7/Z;XHFB\7^*+#6K^RAL=.-H+9V A \U
M&8@EF.3P!U[=!732ZE80211S7MM&\H!C5Y5!<'H0">: .?\ %?AB*\\*:U9:
M+IEG'?ZC;&W,BJL>?EVC<P&<   #GH*T="T6TTO3[>1-+MK:]6 1R>4BYX'(
M##L2,_SK3%W;&Z-J+B(W 7<8=XW@>N.N*;?7]IIEC->WUQ';VL*EY)9&PJ@4
M <CX2\(BSFUB?6M)LVGNM5FOH)#MD(1VW*"<?>4Y/H,\&NJGTG3;J^AOKC3[
M26[A_P!5/)"K2)_NL1D?A7(ZKXSFGT[PIJ>B7-L;35=2M;>XC90[JDJ[BN0<
M*P P1C//:NRM-0LK]9&L[N"Y$;;',,@?:WH<'@^U $=MI&FV5Q/<6FG6D$T_
M^NDBA56D_P!X@9/XU!8^&]#TPW!L-'L+7[3Q/Y-NB>8/1L#D>U6+?5-/N[F6
MVMKZUFN(O]9%',K,G;D Y%6Z ,^+0='@T^33X=*L8[*7F2W2W01O]5 P:C;0
M-,33KJSM]-L4CN4V21M "CC& &'\0'I_*L71_$&H^+KJ_ET>6WM-(M+AK5+F
M2(RR7,B_>91N 5 > >2?:M;2I]9_M6_M=46V:"&.)[>X@1D$N[?NR"3@C:.,
MGJ#WP "WI&EP:+I-MIUL (8$VKA0H]3@#@#)/ X%-OM#TG4[A+B^TVTN9D4H
MLDT*LP4]5R1T]NE2VFIZ??R21V=];7+Q_?6&97*_4 \4R36=+AQYNI6:;I?)
M&Z=1F3CY.OWN1QUYH =?:7I^IVJVU]8V]S I!6.:(.JD=" >A%.M]/LK6T-I
M;VD$5LV<Q)& ISUR.ASW]:$U"REOI+&.\MWNXUW/ LJF11ZE<Y J.36=+A=$
MEU*S1GD,*AIU!9QC*CG[W(XZ\T 5V\,: ]E;V;:)IK6ML^^"$VJ;(F]57& ?
M<4]_#VB2PW$,FCZ>\5S+YTZ-;(5E?^\PQR?<U8O=3L--56OKZVM0_P!TSRJF
M[Z9-2/>6L7D^9<PIYQQ%N<#?QGY?7CGB@"M_86D?:H;K^RK'[1"NR*7[.F]%
M]%.,@>PH@T/2+:"Y@@TJQBBNL^?'';HJRYZ[@!\WXTY-9TN6S:[CU*S>V5]A
MF6=2@;TW9QGVJ1M1L5ABF:\MQ%,<1.95VN?13GG\* (=-T32M&M7M=,TVTLX
M')+QV\*HK'U( YJK;>$O#EFZO;:#ID++)YJF.U08?^\..O)_.MFB@!" P((!
M!X(/>J%CH.D:9,9K#2[.UD.<M# J'GD]!W-8"^(+[5_&6KZ!I]]9V+Z6D1*S
MP&62<NN[<!O7"#(''.>XXSKZ-J%[_8_GZ^;6UNEN)8F*,5C($C*A&XY^8!3^
M- %.SLM=O]=^U:Y%816=C-(UC';.SM(2"JR/D#:0A88&>6/3 STE5K;4;*]E
MFBM;RWGD@;;*D4JL8SZ, >#]:;%JFGS7KV45]:R7<8R\"3*9%^JYR* $U+2-
M-UB 0:G86UY$IW*EQ$KA3ZC(X/O2V&F6&EQ&*PLX+5&.66&,+N/J<=32R:GI
M\5ZEE)?6R7;_ '(&E42-]%SDU56::/7;PS:I:&R2V1A:;0)(3D[G9L_=(QV[
M4 21:#I$-^U_%I=FEVSEVF6!0Y8C!;..N._6G?V+I7VR:\_LRR^U3+MEF\A=
M\@]&;&2/K7&P>(]6\4)J,_A_7-,LVLK^6W$-R@D1X$(5I3@[LY)(/"XP#ZUV
M%I=K;:%:W.H:C:RX@0RWBD)%(2!\XYP 3R.>] $7_",Z!]B6R_L33?LBMO$'
MV1-@;UVXQGWKGK?PF9O'^K:GJ&DVDNFW%K!;V^_:Q3R]V?EQPIW8P/3D5UBZ
ME8O8?;EO;9K/&?M E4QXZ9W9Q6?J^KY\*ZEJ>BWEI-);V\LD<HQ-'N12<':P
M]/6@"W>Z)I6HVL-K?:99W-O 08HIH%=8R.!M!&!@>E1R^'-#F2X271M.D6X<
M23*]JA$C#HS9')'J:Y2Y\4:S'X<\"Z@DUONUBYLX;T&');S8]S%3G"]#V/7M
M7:PZA97%P]O#>6\D\>=\:2J67'!R <B@"O+HNG+,+V#2[ W\,96WF>!0R8'
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M8XU544855& !Z"G4U'26-9(V5T8 JRG((]0:=0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,^-;.
M6^L-/AM-4CT[41?))922IOC>95=@CCN" WOG&.:Z:J]Y86>HPB&]M(+F(-N"
M31AU!]<'OR: /)=4U^[31'?5K%=+>R\1P+KDMEB2%E,8(E7<#\N?))!!/'/)
MJ]K^F^';C1?&6JV.L-JUU<Z)(;@AX7A4HC>6Q\M0!)UP>N :]+CTZRBLFLX[
M.W2U8$- L2A"#URN,<U!#H.CV]@UA#I5C'9LVYK=+=!&3ZE0,9H X_\ X0G2
M]:^&*6UE9VT%]>:; Z72( YF1 T;,W4_-W/J:O>#=2;QC:PZ[>6I0Q6WV,Q2
M)C$QQ]HX/4;E5?\ @#>M=;;6MO9P+!:P100K]V.) JCZ <4);P1PM"D,:Q,6
M+(% !+$EB1[DDGUR: /%K6[32OAKILS+C2(?%+C4 @RJVXGD^\!_"&\O(KI/
M&,VD/H7B?5_#<@NM3GL8OMDUC-Y@,*L.#@E0QC+XXS@?GWT.D:;;6TMM!I]I
M%;S9\R*.%55_J ,'\:=8Z;8:7;?9M/LK:TM\D^5;Q+&N3U. ,4 <9H\?AG5_
M$NC:WIWB*;4+U+9XH8H6A $)7D2HB A0<8SC#$"N\(# @@$'@@U3L-'TS2VE
M;3].M+1ICF4V\"QESZG &:NT >'6]ZEM\&[-8F0PPZR3JL:8++:_;'+[@.=I
M^7/L3VKM]8A)^*GA.[TLKNEM;H7S1'A[8*IC+8[;R-ON378Q:=8P"X$-G;QB
MY8M.$B4>:3U+8'S$^],L-*T[2U9=/L+6T5_O"WA6,'ZX% %MMVT[<;L<9]:\
M=M&BU+X!:H+[/]LP-<-<Y_UR7XE8I[[RVS'?! %>QU2;1M+;4/[0;3;,WO!^
MT&!?,XZ?-C- 'GEOHUIJ/Q4M;?7+&UN+F3PLC7<<D:LKR^<%8D=">HS7IR(D
M4:QQJ%10%55&  .PJL=+T\WWVXV%K]L_Y^/)7S/^^L9JW0!Y9)<Z7>^)_&>A
M^)=<.FM<.NV.5H466T,*A=C2(>AWG@\$D]<TZUTC2T^(GA6WCC:Y@&@RA'O%
M!DE56C"%^!DXZ9''L:]$O=&TO4IX9[[3;.ZE@.8GG@5VC/\ LDCC\*=)I>GS
M7JWDMA:O=*,+.T*EQ_P+&: /(O[)TP_#WXF-]BMB;?4;]824!\H*BL O]T!B
M3@=ZUOL.G:A\2?"IO[>WG-SX?=F$JAO.<&,C<#][ R1G.,9[5Z$- T98I8ET
MFP$<IS(@MDPY]2,<US=]X2DN?'6FWXTS37T6TL9+7R'QD%F5@RQ[-N!M]>]
M'$:AIZ:9X%^*%O9*(]&6Y(M$7A%?8GFA!V <XP.,@CM76"[>/XMZ/#>G%G+H
M3#3RWW3<;P9 O^UL"_A]:[1]*TZ6Q6QDL+5[-<;;=H5,8QZ+C%-GTC3+JSCL
M[C3K26UC(*0R0JR(1T(4C H \]TWPM'KT7C_ $(@+HL]\!9$#Y89_+#2,GIM
MDQTXR"/6M+P;?W/BYX;O5[39-I$+V%S'(G#7A.V8CU 55Q[2L.U=-JT.K6>E
M0P^%[?3$F211Y5V&2)8^=V-@X/3';K4VDZ9_9^EBVG=9YI6>2YDVX$DCDLYQ
MSQDD <X  [4 >-2Z=IZ? ;6+I+:!9X=1E\N8* T>V\PNUNHP#V]3ZUVNH65M
MIGQ8\/KIMM!;O+I5XA$:!=^#&5!QUYR:[#_A']%%L;8:18>0S;C%]F3:6]<8
MQFI!H^F"XBN!IMGY\( CD\A=R = #C(H \I\-G0?$7A#1X=5\0W<>K6-VLDE
MBK0)<K>JYS@;-Y+,2>O()R>#5Z'2-+GU_P")XEL;5UC2+:&C!";K0%B/0D\D
MCO7I"Z-I::FVIIIMFM^PP;H0*)2/]_&?UIO]B:3NG;^R[+-P,3'[.G[SG/S<
M<_C0!YA93P*OPCNKV2)8_L<HDEF( _X\^,D^]>NJ0R@@Y!&0:I_V-I?V:*V_
MLVS\B%Q)%%Y"[4;^\HQ@'W%7: /.+'2]'U/XF>.5U>TL[A$@LCBY56"H86W'
MGIVR:Q]-T"_?X1Z7J-K$[ZEHES)?Z4)02[P+(Q6,]\/%P!_N^E>HWFC:7J%P
MEQ>Z;9W,T8PDDT"NRCV)&15#7H?$EQ-;VVBRZ?!9RHZ74\^\S19P T0'!(Y^
M]WQ0!7\)7,>O)<>*5C94U%42U#KAEMTSMS]7:1OHR^E7_%"!_"6LJ5W9L9L#
M&>=AK0M+6&QLH+2V0)!!&L<:#^%5& /R%3$ C!&0: /(+IK&\^'?PV@5X)4.
MHZ9',BL#SY1RK8[^HJ7689]/\0?$*'08A!.VA02)';+M.\"49 '\6.G?I7I/
M_"/Z+Y$4']D6'E1,6CC^S)M0GJ0,<&IHM+T^"\:\BL;6.Z88:9(5#GZMC- '
M":(/"NNZAX9U>P\0SW-W;1LMI:PM K(C)ATD1$#!5 [X ..Y&?12,J1G&1UJ
MG9Z-I>G7$UQ9:;9VT\YS+)# J-)_O$#)_&KM 'FWP@==&T.Z\(WS+#J^EW<H
MDA<X:2-FW+*H[J0>H]*T/B;J4S> =;73#)*UN(Q=&'G$1<>:H([[,Y'8'WKJ
MM0T/2=79&U+2[*\:/[AN(%D*_3(.*M0VT%M;K;P0QQ0*-JQH@50/0 <4 <+X
MDBAN?%7@:]T0Q-)),ZEH<;7LC$2^<=4^YCL"1W-<F^EZ:?AI\2'^QVQ:'5-0
M$3>6/W>T@J%],'IBO7K+1]+TTR&PTZTM3)P_D0*F[ZX'-1C0-&6&2$:38"*5
MMTB"V3:Y]2,<F@#A;NRL[3QE\.I+>WABDN([I9750#*#;;CN/\63SSWK#L=!
M\/7?@;X@M>65INM]3U!4D*#=!MY0)_=YQ@#K7K#:+I687&EV1>W&("8$S'WP
MIQ\O/I7-^$O"+:=-JT^LZ;ILEQ<ZI-?03)B5D5VW*N64$$>U '-VMXBW%O9:
MB\5MKD7AB%;^YOW)!1LY1(R0"V[.YCTX&#VR=*BL-2\/_"KSEM[EA,8)<X8X
M$#G8WMT^4U['-IMC<7D-Y/96TMU""(IGB5GC'^RQ&1^%0#0-&"0H-)L L'^I
M7[,F(^<_+QQSSQ0!Q>B:/I]]XP^(>AR6\8T^?[(KP(H"C? =Q [$X!SZC-,\
M%R7NHSVGA[5(F,OA61H[B1EPLSA=MLP]08V9CZ$*:Z_4M-FM+.[N_#FGZ4FL
MR8VR7$>Q7^89WL@W'C/XXJ70].N+&VFEOY(I-0NY3/<O""$W8"A5SSM554<]
M<9[T 6[34;*_>X2TNX9VMI3#.(W#&-QU5L=#STJS4%O9VMHTS6UM#"T\AEE,
M:!3(YZLV.IX')J>@#@_$'AKP]XYUF]C2XET_Q%H[I&M[:2[)XPT:NI..J_/C
MGT."*X_5+^^U?X5NWB*2"ZGTW7XK./454*)XTG13*I'3/S D?W:]<O-"TC47
M+WNE65RY.2TUNCDG '4CT 'X5A^-_#MWK7AJ#2=(MK-52Y@EV2OY<:I&ZMM
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MM1<R J\WDKO8'J"V,F@#SC0+>TG^'GCH/##(@U#5,Y4$8!8C^AJ"RU:'2O\
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M9)Y/K6[X#U0/+J.D:JB1>)[63-^2<FZ!^Y,A[H1C _AZ8'% ':U176=+>_\
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M.UG7RPQ=&1FX;/'W?3OUKG/%&IZ<VO>+;-)+>QNTT=$N9KA]SW2LLA1(4)P
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M[&:=<Z=8WLL4MU96\\D)S$\L2L4/J"1Q^%9\_B[PW;!3/KVFQAIC "UT@!D
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M2'U)=.74K0WC%@L E7>Q7[P [D=QVH GATZQM[N6[ALK>.YE_P!9,D2AW^K
M9--_LO3_ -[_ *#;?O7$DG[E?G<<ACQR1ZU&=;TI;T63:C;"Y9_+$1E&XO\
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M_6@# ^';J_PX\.%&# := #@YY" $5TU,CBCA39%&J+UPHP*?0 4444 %%%%
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M67\4)(H_AEXA\UT4-9NJ[CC+$< >]<_J<VEGQ;\- )+0H$N"GS+@#[.-N/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBMV5@RN-QRS;@">G P,<DWM!L/%(V?\ "2:E83"%"B+8Q.GFDC&^0L>N/X0
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M8"356ECN+2$$R6+JA=59PQ5C@8(PI[T ==IFM:;K0N3IMW'<K:S&WF:/D+(
M"5SWX(Z5?KR[PQK,EOKOBS1]+>V;6;G7II8XY\E$B"0AY& (..< #DD^F2.H
MU+Q%=P:U_8=M(@O([1;F>X%A-<(-S,J 1QG(SM8DENPZYX .IHK$\*:MJ.LZ
M#%=:MIDFG7P=HY865E!(. RAN=I&",_3M7.:MXTU?2+F%[J&QB635DL_L!R\
M_P!G=]BS%U<A<_> *].,YYH [J>>*V@>>>18XHP6=V. H]34&F:G9:SIT.H:
M?.MQ:3 F.500& )&1GW!K"_MS4=8U?6;#1FM(X]*VQ227,;/YLS+N*##+M !
M )YY/3CGC/"^OZCX;^%'@^^A6U_LUY4M[YY8V+0(\K*) 0P& 2 <^N: /6Z*
MY^^U75DN-9.FVD-ZEC;KY4 ^1Y;@J6V;RV  I0]/X_:LO2O%=_<^+FT%Y=.O
M"^F&\2>V5D5)%<(T9.Y@PRPY!XP1B@#M**\QM/'OB23PEI/B>XM-+6RGOA:W
M,">89"K3F+<AS@8XX(.>3QTK6T^[UF;XK:W:/>P/96UC;O'!Y!R%8R< [_O9
M'+$'/' Q0!W%%<%;>,]6BUO0++48K!9-4EDAN+*$$RV+!&=0SABK' P1@=<B
MDU+QOJ::1XIU6PALQ#H%RUN;>X5M\^Q59VW!AMSN^7@]/?@ [ZBN/E\57K7=
MKI:+'#?O8B]FD6SFN4168JBA$P<G#9)(QC'.>-3PGJVI:SH:W&K:;)I]ZDCQ
M21,C*K[3PZAN=K#!&>G3M0!N5!>7MO80>?<RB--P4<$EF)P% '))/  Y-<B?
M%.KZEHNL:UHD=D]KITTT<=O.C%[H0_?(<, F2&"_*W0$]<#'\2:M<^('\ :I
MIES#%9WU_'-''- SLKF&0_-AQD#.,<<\Y[4 =]I.M:=KEM)<:=<K.D4K0R#:
M5:.1>JLK %2/0BK]0V\"P(3LB$LAW3-%'L#O@ MCGT[D]N:QM6UZ:'Q'IWA^
MP\H7MY%)</+,I988DP,[006)9@ ,CN>V" ;]%>?7_CK5M.T_Q9;2VMF^KZ!$
MMP&^98;B%E+*X7)(/!!7/7O73>';G7KR.2ZU=-/2VFCBDM4M2Y=<KEA)GCKC
M&/>@#;HK@G\1^,-1UKQ)I>CV>CK+I,D0C:Y:1A*'CWA>,<G.,\ >^>)--\:W
MVN^'M"U:U@MK"TODE-Y=79W);2(=@C"[E+%G!QST'3F@#N:*\\A^(LP\&6.L
MWL<%KYNI/875UY3M#;A6=?,*Y# $HHP3P7Y/'-_4_%]SHWA^WU*\N+![6XOU
M@74K>-I+=(&4E964,3C(V_>P"?3J =/<Z1IE[=PW=UIUI/<P_P"JFE@5GC_W
M6(R/PJ[67H5Y<W]B\]Q/97,;2G[/<67^KFBP,,/F;G.0>>U9*:]JNMWNN0:"
M;)%TJ;[-FZC9_/G"AF7Y678HW!<\\Y...0#JJ*\[B^(>H:I:>$[O2K"U$>MS
M2V\T=R[;H9$5]PR!T#(>>X["MWPMKNIW^KZ]H^KI:&[TJ:)?.M%94D22,.OR
ML201R#S0!O6^G6-I<W%S;6=O#/<-NGECB56E/JQ R3]:LUQ$]WK+?&*"PCOH
M%L5T9[A86MR>#/&K<AQECM&&Z =CR:C?QCJUWX0O/%VEPV<NF6S3.EK(C>;/
M!$Q5V$@;"D[6(&T]O7@ [NBLT:[9'PR/$&]A8&S^V[L<^7LWYQZXKE;WQEJV
ME^&-,\5WD%F=(NC"UQ;QHPEMHIB C;]V'(W+D;1G/!XY .YFFCMX7FFD6.-!
MN9V. !ZU6TO5++6M.AU#3KA;BTFSY<J@X;!(.,^X-<IH5WK%Q\3_ !1;7%]
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M4J*K.H;<H0?-M!.>1GI3=>\1:WIPGD$%EI\45@+B,W?[XSW&"6A4(ZGY0.2
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M5E8J<>V0:W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP1M)(V"<*HR3@<G@5E6^D^'-9^S:['I.GW$EPBSQ7;VB^85(!4Y9=PXQUYH
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MCKQG/:K \*Z['X@M]2AO[$(=+73YDEC>0PE227BY'WN,@XZ#KBNVHH \[L_
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M(9BZDR+MC9QM.<#IW!IWA?P[>^'KG5D>^AGL;N^FO(8UA*NAE;<0S9(..0,
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MQ".F\\ KC(/0TNC>*K_7/#>@26\L,>JWDYBO$:$XA,>?/&W=D8(V@D]67UH
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M/M8 YZG8/F_2JS>+]:O/ 4WC;3C;&TB\R=+!XS^\MD<J<OG(<JI;@8' P>M
M'H=%5["]BU+3K6^@SY-S"DR9'.U@"/T-<IXJUW5]+FU-H;BVM8;:P-Q9KY?G
MR74H#%@R [EC7"@G ^]G/:@#LZ*X&7Q7KMW?>"DL?L$,7B"RDGD$L3,8F$*R
M<$,,CYNG!..O-,M]>\67.@^*+>VDL;C6]$NFCB?[,P2Z0(K@; W#$,1P>N*
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M1X_U;2;BSB2PUNZN7CGA:0S[8XR5R&&T8'7DDGMCGK;GQ1=7^JQZ9IPEA?\
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ML2\T[*%WL?11PH'  ]!U)R:N444 %%%% !1110 4444 %%%% !1110 4444
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MR31Q:'K 2*Y3RP6AFD3='\W]UC\I]#CGFNAT6[N[^\U2X>8-8I<F"U78 ?D
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M..*,MN; +,22<9.>@ QUS1'@/36N_$DLK.\6N*5>$_=AW(%D*^[%58GU4>E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH CEMX;@ 30QR = Z@X_.GHBQH$10J
M@8  P!2T4 %%%% #=B>8)-J[P,!L<X],TZBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MKG?'>J7VB>"]3U;3IECN;.$S('0.K8[$?X4 =%17G_B?Q!KFC^#="U.UOHS=
MWEQ:PS&2!2F)<9( QC&>.35SQ)J^KZ9XO\*Z5:WP%MJLLT=P7A5F'EINRIX
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M! [57\*ZGX@\0W7B&*75HX5TS59;&+9:*2R* 06R>O/:@#NZ*X+Q?KFO^'?
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MQEC*Q9BQ4$DD\DY]:TJJV$-W!:+'>W:W4X)S*L0C!';Y035J@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\E;V\BCMTBA<NL429.-Q +$LQ)X'8=LG2U76M-T.V6XU.\BMHF<(K2'[S$X
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MT <+I7ACQ=X?N;K2]+U'3#X>GN))HI)E?[3:"1BS(@'RM@DX)/4Y(/2N] P
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M!"EB,XZG+L2QY.?85+I5O>V]G_Q,;I+B\D8O*T:E8U/]U%))"@ =3SR>]7:
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MAW1-(G>;3='T^SE<89[>V2-C]2H%:5%% !1110 4444 %%%% !1110 4444
M%%%% !56RTRPTT2BQLK:U$KF2001*F]CU8X')]ZM44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
510 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>elicio-insidertradingcom003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0"/QK U>=/&B>$!ID4L=W:ZG!>W2-$R-9I&K>8CY'RDDA0.^>,@9H +G5_\
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M6*S&W=GA<,DH.THR;=RG) Y'<5)IGC/0-8UF72;*^W7L:>9Y;Q/'YB9QN0L
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M9CN/))KJZXSX4!T^&6B0RP3PRQ0E'2:)HR#N)Z,!D8(Y'%=G0 4444 %%%%
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MO&DZ @%HV8 .!D<CUR.*B\:>)AX3\/OJ(MI;B0R)$@1"RJSL%!;'09/U/04
M=#17GVK:W]B^)6ASM<:@MG<:;<LUGMD)=U9 N(<9+<GMFNGL/%>D:CHC:M#.
MZVR2F!UDB99$E#;?+*$;M^X@;<9.1B@#:HK)TSQ'8:IJ-UIT1FAO[55>6VN(
MC&X1NC#/53ZC-8?BW7[U/$FA>%-*G^S7>JM))/=!06@@C&6*@\;FZ D''/%
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MXD>&X[*6],]V;2&X-O/,+.7; P(4^8=OR#)QSBM&U\6Z3>:XFD1R3K<RQM+
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MC<0.@)!QW.#C.#53_A,M#-CIEZEX9+74YUMK66.)F5I6. K8'RG((^;&,'-
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M,X '0GFMZUM9]!OM4O+W5I9-&%M&\0NI ?LVPR&3YCR005.6)/'7@4 +XO\
M#LGBKP_+I"WJVB2O&[R>3YA^1U< #<.ZBMN,.(U$C*SX^8JNT$^PR<?G6/;^
M*=-GU*WL'-Q;W%U&9+5;F!H_/4#)V9') Y*G!QSBLZ;XC>'8;6\NO-O'AL;A
MK>Z9+*4^0RXW%QMRJC/4]<'&<&@#JZ*P(/&6C7&LV^EQS3>==*S6TK6[B&XV
MC+".0C:Y YX-9]S\3?#%K%<RO<W;1VMPUO<LEE,1 PQDR?+\HR<9/4@XS@T
M:.J^'[K5M8AFDUFXCTH1JLVF)$FR=@VX%G(W '@$#J!CN<[U8UWXHTRVFA@C
M>2[GFMC>)':QF1C ,?O..W(QZ]LU6F\<^'X+/2KMKUC;ZJ0+2187*R$@G&<<
M'@\'GVH Z*BN<A\<:+-8ZI=YO(QI9'VR*2SE66)2-P8QE=VTCG..@-71XCTX
MZ5I^I*TS6VH-&ML5@8L^_E?EQD CGG\: -:BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=G=I)*+:3;&7$>P,<84G:>M6_B?:W-WX#NUM;>:XD2>WE,<*%W*I,C-A1R<
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MMS;,B3%8I4.[&].C$;VQ]?I0!)<^(M-M=-@OY)7,-RXCM@D;,\['[H10,MD
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M* HX7J<\B@#O**\YO?%6OZ+IFAS>*XKC2H9895U&\L(DG6&8,!&6X<*C+N/
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MH-),7B*VPA\I"!\F 3G!SR>>:TJ "BBB@ HHHH **** "BBB@ HHHH ****
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M(!.<<[^I7\6EZ;<W\Z2M%;QF1Q$A9L 9.!6-)XUTV/2] U!H;OR=<D@BM<1
M[6E&5WG.!QUY/3O0!T=9NIV%[=7%I/8Z@+22W9BRM%YB2J1C:PR#[\$<@5I4
M4 <9-\/;=]#:R@O6MKIM5&KBXBA&Q;@,#Q&3C;P!C/XFKT_A25?$$&O:?J9@
MU,6WV6Y>:$21W4><C<@*X8'H01Z=*Z6B@#C[_P"'MC?Z ]C]LN(;YK\ZF-1C
MP)%NLY\P#I@#Y=OH .O-23^$+^_\.:CIVJ>();V[OX#;27;6R((XB""$C4@
MG.223GCL !JMXBLT\51^'3'<?;)+5KI7,>(]BD _-W.6'05KT <E:>"Y=/UZ
MSUBSU003I:):7:+;_)>*G"LXW<,!T(Y_#BI/^$0EN9-*&IZDMY%I=U]JMF^S
M;)MP!"JS[CE1GL 3M&3USU-4M,U'^T[>67['=VOES/#LNHO+9MIQN [J>H/<
M4 9OANVU>VN=6_M'49KVVDN2]HT\ B9%/50!U4< $\G!/0BM^BB@#G;CPU<I
MXHN->TW4UMI[JW2WN(YK?S4*H25*X92K#<>I(]JJ7/@&P;2M/M[.YFMK[3[H
MWMO?$!Y#,Q)=G' 8/DY''MC KJ6F0"3:=[1C+(G+#C.,>M0:7?\ ]J:9;WWV
M6ZM/.3=Y%W'Y<J>S+V- &._A:2XEU*]NKU)-4O;/[#]H2#:D,/)PB;B>2Q))
M8\X[#%43X&F_L;PUIHU50F@SQ30O]FYE,:E%#?-TPQSC]*[&B@#BY/ 4\-SK
M@TO7);+3]:,DEU:&W60+*ZX9T8GY<]Q@^V.,7-/\*WVE6%C9VFM"6"VL5LGB
MN[02)*J\*2%9<$#CJ<@G.:V]6U'^R=,FOOL=W>>5C]Q9Q>9*^2!\J]^N?H#5
MWM0!QL'AJ^T ^&M.T+4[F.QL2RW-NT*LDZ$Y9F?^$CG '=AV!KLJ*:\B11M)
M(ZHB@EF8X  [DT 8OBOPZWB?2%T[[9]E03QS%Q%O)*,'4=1W S4$WA9KGQ:-
M=N;R.0'3VT^2U^S_ "/&S!F.=V<DC\N/>NCHH XZU\!^1H<7AV?4VN= AE5X
M[9X?WI17WK$TF[E 0/X0<#&:OGPJO_"6W>MI?2+%?6T<%W9F-2LH3=M^8\@8
M8Y ZUT5% '%Z!X#N]!DCLT\2WL^@P2>9;Z;)$F4P<JIE^\4![<=,'(R#;E\(
M2WKV,>I:DMW;6%^+ZWS;;9E8,65?,W'Y1G'"@D #-=310!@>'[;5[?5=::_U
M&:\L99P]H)H!&8N6W(N.2@&P GJ03[G?HIJR(Y8(ZMM.UL'.#Z&@#F;SPC-_
MPEDGB+2-6?3KFYA6&]C, ECN%7[IP2-K < \_3KG*7X91#PQ%I7]MW@NK:^>
M_L[Y$17MY69F. !R#N.0>OM7>T4 <E/X*EU7PSJ.E:]KEUJ%Q?QK%)=B)(=B
MJ<J$11M'/)ZD^O Q?M_#\\VIV.HZS?I?7%@K"V$5OY**S#:SD;FR^..H R<#
MFMZB@#B=*^']QHUS):V7B.\C\.O*TO\ 9/E(0N3DH)3\P0G^$=L\\FKL?A&>
M.Z\2W U-2VN@"0&V_P!3B/RQM^;GY?7OS[5U-% ''#P*\=EX9CAUB6&Y\/J8
MH+A(%.^,Q^605)(SMQSZ]J?=^"IY=:UB]M-:FM;?6(4CO+<0*Y9E38&5SROR
MX!&.>Q%==10!QEMX#EM$\+K'K+N/#ZE83);J?,RGED'!&!MZ=_<U-KG@RXO?
M$::_HNNW&C:BT(M[ADA6:.>,'(#(W&X9.#76T4 8 T"]MVMS9ZL2$A>*=+R#
MSEN&9MQ=@&7#9STXPQ&,8QEQ>&;[0(?#FG:!J=Q#:64S&Y@\A3'<(S[G+-_!
MC+[0.[#L"1V=% !6/XF\.6OBC1S87,DD+)(D\%Q$1OAE0Y5USW!_0FMBB@#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=-AN0[2W]TEO&%1B%!Y9B0.P!P.I_/&!_P )2NE_$+5DU/6&72%TR"Y@CE4
M(SL^0H50QX7/.3UH [ZBJ"ZWICZ5!J<=Y%)9SA3#*AW>9GH% Y)/H.:73-8T
M_689)=/N5F6*0Q2@ JT;CJK*<%3[$4 7J*Q/%^OKX9\*ZCJN TL$#M"I4D-(
M%)4''09%9.AW1B2WURX\17,]G<6R126<T.=UR0&W1X ;ID;%!!ZCI0!V-%9E
MKXATB\TR?48=0A-I;LRSR,VSRF7J'!P5(]#@US-OXBEO?BQ;Z=;:C</8MI,L
M\EG)#Y>R02( V&4-R"<9R.N* .YHK)7Q-HS:C%8?;XQ/,S)#D$+*R_>5'(VL
M1@Y )/%5X_&OAJ6]CLXM:M)+B6Y-HB(^[=* "5!'&>1_+K0!O45D6WB?1;N]
MAM(+]'EN"X@.U@LQ3[PC<C:^,'.TGI61X9O[^?QOXOL+N]EN;>REM1;+(%'E
MAXMY V@=S]>!0!UU%17-S#9VTES<RI%#$I9W<X"@=R:J6NMZ?>/<QQ3E7MD6
M2=)HVB:-6SAB' (!VMS[4 :%%9=EXBTG4+\V-M>*UT(_-$3*R,\?3>NX#<ON
M,BF_\)-HWVZ*S^WQ^=+(T41(.R21>J*^-K,,'Y0<\&@#6HK)'B?1CI]Y??;D
M^S64C174FUOW+@ D.,97 (SGI45]XO\ #VFE%O-7M86> W*JS\F/ .['IR,>
MN>* -NBN;M-;TJ_\0_:;3Q&+A/[,$W]GQ$,@C+!A.<#<"00,9Z=JSX/&ND^(
M?!NH:@-5?1X,S1"[==C1 .R*XW#&3MSCKSCK0!VE%9TFJV6GV%J]Q=M)YD8\
MM@A>2; R6"*,GCDX'%,B\1:1/IUO?V]ZD]M<MLA: &0R,,Y554$DC!R,9&#G
MI0!J456L-0M=4M!=6<PEA+,FX CYE)5A@\@@@C\*YKQ[?W^FQ^'Y;&]EMQ-K
M5K;3H@7$L;OAE)(R.G8CO0!UU%9.H>)='TJ66*]ODB:%5>8[680JQPID(!"
MX."V*EDUW3(]5BTMKM?MLT9ECA"DET'5A@<CWH T:*R;?Q/HUU87E]!?*]K9
M,RW,H1L1%?O \=1W].]:<4BS1)*A)1U#+D$<'V- #Z*H:W<WEGH5]<Z?;FYO
M(H'>&$#)=P. !W^G>N>@\1ZG->>'D_L?6X[34(7\V22W0/!(.GGCH@QD\#DD
M>A! .PHKS"PU/Q+?+XTD3Q)+&^BW<D=JLMM 8RJIOQ)A Q],@BNC\(>-K;Q!
MH.A7%\4M-2U6%GCMB"!(4SO*$]1A=V,\ B@#K**QY/%6A0VM]<S:G;Q16+^7
M=-*=GE-C(4@\YQVIMOXMT"[%X;?5;:3[$46XPWW"_P!T>Y/0 =^.M &U17%>
M,/$J2^ _$%YH.JO!?:="6?;&%DB;&0&21<KD>P/H:V-'\3Z1J%Q%I<6I0S:D
MMNLDD0/S'  8@]#@]<=.] &[161_PD^BB]2T-^GFO.;93M;8TPZQA\;2_P#L
MYS[5)=>(-+L[AH)[K:Z.D3D1L51VQM5F PK'<N 3GD>M &G167J?B+2='+"_
MO%AV -(=K,(E)P"Y (0'U; XK.N(M=F\5B:RU?\ XD\U@W[G[(K+#)_!(LG\
M9)/W>F!SU% '2T5B>%(]8B\/Q)KEV;N\5W'VAH!"TB;CL9D'W25QQ^?.:VZ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SOXRSVZ>#K>&6559]1
MMB%W88J) 6([\#/-==INA:-;7C:K9P++=31A#>/*TSLG]T.Q)V^P.*=J>F7U
M],CVNNWNG(JX,=O% P8YZGS(V.?H:I?\(_K'_0Y:M_X#VG_QF@#RF?5;.W^#
MM_H<DI_M2TU8_:+4(2\0^W!@6&. 01@]\X%=M:W-A=?&N]_>02&308HU#8R3
MYKDKSWP5)'IBM_\ X1W5_P#H<-5Y_P"G:T_^,TO_  C^L?\ 0Y:M_P" ]I_\
M9H XK1M<T>P;Q'X4\5V[27T^ISS):20-)]OBD;=&4&,-V&.VT=,<:MC=6:?&
M746EDMXF30H$(+C"$2.64'V&"?;%;_\ PCVKYS_PF.JY]?LUI_\ &:7_ (1_
M6/\ H<M6_P# >T_^,T >:>'-;L=.\$^#(YQ;Q*=1NT_M&5=RV!WRD<= SJP"
M[N.<X-3:6^E7.E>*[#4-3O;,MXD\Z.^V&.2!R(S%*V5  ++W XST R/1/^$>
MUC_H<=6_\!K3_P",T?\ "/:Q_P!#CJW_ (#6G_QF@#S_ %"]\0S>&]66[$>K
MC2-3LKB6_P!,78;^!65V&%./,0!<[3QQZ5U?A:[\)Z_X@_MO07NKZ[6T,$M[
M)+,5CC+!A$=YQN)R<=1@YQD9U1X>U<# \8ZJ!Z"VM/\ XS5BPT;4;.\2:?Q)
MJ%Y$N=T$L%NJMD'J4B5NO/![4 ;5,E<QQ.X0N54G:O4^PI]% 'AT&N6%U9^!
M[R*06T,&L8DTZV@/EV.4E&QCMW%\GN>>2% K8BNK!K;XJMYUOF4R '<,N/LP
M4?7YLCZUZS@44 >0Z5K,.C:]X+U75;A8]%E\-)9173G]U!=91F#-T4E5 YQT
MQZUT'P[O+:YUSQG]G?<LFKF52%(#*8D&X''.2#]>M=Z0",$ CWI<8H *Q/%Z
M:?+X3U&+57E2QDCV320G#HI(&X>XSG\*VZJ:C:W%Y:F*VU">QDW ^= D;-CT
MPZL/TH \SCU;4["P\36>H&U\76-OI'FQWL"@/,A+ 03%<@G!9LCG&3WINDZO
M93_$;PS=QZE]KAGTB>)'B@*0JVZ,^7'@= ,YR21CDBNW'AW5QT\8ZJ/I;6G_
M ,9H_P"$>UC_ *''5?\ P&M/_C- 'FZ3RR>"?$%S8K)=I9^+9+ZX@M7_ 'DE
MNLZN2N#GH-P/^SFNS\+7?A/7O$']MZ"]S?7:V9@EO9)9BL<98,(CO.-Q.3CJ
M,'.,C.M_PC^L?]#EJW_@/:?_ !FK&GZ/J%E=K+/XCO[V( Y@FAMU5L]\I&I]
M^M &S4-W(8;.>40M,4C9O*4<O@?='UZ5-10!XC9:W874OP_O89Q%!%>.C6-M
M ?*L287 BS@L7SQR<GJ  :ZOP@UM=^)O'B6LL!NI+Y6B8$$\0J P]@V>>QS7
MH>!10!X[X4N_#6J:'HWAW5X-1;Q%IDD2MIDDLX9)XS@2C!VA>K9Z8)^E>Q4F
M!G.!GUI: /$AK5K:?"SQ?X=U>98O$,;7K36\H_>3EV9UD4?Q+@CD= .PK2DU
MNPT3Q/IVH:[/>6VC:AHMO#:WL;RQI'+&6+1MMP03N!Y]*]:*@G) STH(!&"
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M.?4=,U!X)U_0=0\.:#X=O;$R:_I311MI\L!\RWFC^4S$D84 9;=GOCJ<5Z>
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M)T2VALM#L;6VMI+6"*!$C@D8LT2@#"DDDY XZFLP^'M7)!/C'53CI_HUI_\
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M6FF6>AJ-'L9;.PEE>6))2^YPQR7(?YEW')P>V#QG%;M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%4]2U2STBV6XOIO*1Y%B0!2S.['"JJ@$L2>P% %RBLJS\1Z5>P7TL=T(UT]
MBMV)T:)H"%W?,' (&.<]"*;9>)M*O]3_ +-BGD2\,/VA(9X)(F>/.-R[P-PS
MZ4 :]%8$WC30H&@\RZE$5Q.MO!.+:4Q2R%MH59 NTY/H<<'T-6H_$>ERW&IV
M\<\C3Z8%-W&+>3=&&!*G&W+9 )^7- &K17+:EKVA:A9Z!=C7+JV@O;V%K)[7
M<OVIB2%C?Y?N-GD''3KQ4U]X\\-Z;?75E<Z@5N;5HUFC6"1RF\D+T4\9'7H.
M,]10!T=%8E[XMT73IMEU=/&@F%NT_DN84D)P%:0#:ISQR>#P:V)98X(7EE=4
MC12SNQP% Y))]* 'T5BV'BO1]3O+>TMKB3SKJ$W%L)8)(Q/&,99"R@,.0>.Q
M!Z5HWU_;:;;B>ZD*(75%"J69F8X"A1DDD]A0!9HK+A\0Z;-:7=SYSQQVDH@G
M$T+QLLA"D+M8 DD.N, YW#&:99>)M)OKB\MTN6BGLD$EQ%<Q/ T:$9#D.!\O
M'7I0!KT5B6_BS1[F^2S2>87$L)GA1[:1#-&.K1Y7Y_\ @.3WZ4T>,=!.BVFL
MB^)T^[E\F&<028+[]F#\N5^88YQ0!NT5SFJ^._#FBWES:7VH&.XMHUEEC6"1
MRJDX!^53GOTZ8YJ&'7=(MM1\2WT.IZA>O9QPO=V81W6VPAVB)=O5@"3@GL3@
M4 =!J$-S<:=<0V=W]DNI(V6*X\L2>4Q'#;3P<'L:I:#I$^EV\CWU^VH:C<$-
M<7;1+'O(& %5>%4 =/4D]ZR-,\?Z5<>']&U+4#<6CZGY:1(;.8JTK@$(K;,'
M.>".#@XKHFU.U358],+O]KDB,RH(F(V X)+8VCDCJ>] %NBBB@ HHHH ****
M "BBB@ HHHH **** .=USP[=:MXBT+5(;Z&!=*EDE$3P%S*70H1G<,<'T/-=
M%110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5-
M3@N[K3+B"PO?L5VZ%8KGRA)Y3=FVG@_0U6T/29=*M9/M=ZU]?3OYES=-&$\Q
ML!1A1PH   '\R2:U** *T-C%#>SWFYWGF"H6<CY4!)"C'8%B?7GD]*LT44 %
M%%% !1110 4444 8FOZ1JNK2VR66NR:;9@.MW%';H[SJP PKGF,CGD>OM6O!
M#';01P0H$BC4(B+T50, "I** "BBB@ HHHH **** "BBB@ HHHH **** "N=
M\.^';K1-5UN\GOH;A=4NOM)1("AC;:%QDL<C"CL*Z*B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "N3\?Z@^FZ9ILHLQ-$=1A66Y^S>>;)>3YRK@_,,  X."V>>AZRB@#Q2_L
M[_4%^(=KI=MJ,]Q<&QNK?[3"ZFY2-49QD@#+;2 O'H!CIU[Z[:>-]'O?["TZ
MX&J'3IX?M-S:-"UH[H0(][*,L6QD*2.,D],]Y10!XQ=^(;74/ GA72TM+RWO
MK#4]-M[JWFM7C$#HZJ06("\D<8)..W7'0_;4T;XB^+TNX;G=JEI:M9".!W$^
MR-U8 @8!!(SDC'7I73^*_#LWB2TLK>*^2T%M>17>YH#)N:-@RC[RX&1S6\NX
M*-Q!;') P": /&[9ROPU^',3P7"2VVK6;S(\#JR(F[<Y!'W1D?-TYZUUFB21
MGXN>)GP<2V=HD4FT[7*;]X5NA(R,@?TKN:* /'M)?3(;.^\(>)](U6ZU,7<Q
MCMQ]H:"_5I6D1P5.P#)&2< $9/.:]/UR22U\-:C)#8B^DCM)"MH1N$Q"'Y/?
M/3\:TJ* /(M-OEN?%O@34$6_F3[+<PRXL7CA@=HT B1 H"J"",\\#ECBNX\<
M6VGWFB0V^I27<$+W4>R[M"1):R#)64$ X (Y)X&>:Z6B@#Q^^_X267PU>&8M
MKD.CZQ;7*7EDGE2:C J@OC8?F=,@;E/)7U%6=6M=,\9>&==N?"FGW\NH2Z:;
M<WEV)E9AO5_LX\W[V<-G' XYYKU>B@#D/#WBG3/%5S8RVVDW O[=&$[7-FT9
ML<K\R!V4 DD 84\CD]*\[6[,/PFM= -I?-J>GZLGVJ!;60F,"\+YSC!R",8R
M3GV./<Z* .%LYHY/C/>3A7"/H<,22-&5&\2NQ3)'WL$$KU_*JEDK7'C+XBQQ
M([-<VMLD!VG$I6!U8*>AP2 <=#7HM% 'G6AZ5'XK^#5CHN)[>ZAL88DDEA:,
MPW,:@J1N /RNHR1[C/6M7P5>7NHZ-+XGUFV:"\N(5C,2C<4CB!!P!UW2&1AC
MJ"OI6QKVDZEJHM5L-=N-*1'/G^1"CM,A&, L#M([$5I6EK#8V<%I;H(X((UC
MC0?PJ!@#\A0!#I.IP:SI5MJ-JLJP7"!T$T91@/=3R*N444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5";N 7
M@M-^9]GF%0"=JYP"3T&2#C/7!QT-35B7/ABUN?$\>NFZOHYEMC;26\<Y6"9/
MFQO3N1O;![9H LW&OZ9:Z;'J$MP1;S.(X2L;,TS'H$4#<^>HP#D<CBF6'B/3
M-2U%M/@DF2]6(S-;SV\D3A,@;L.HXR1SWY]#7)ZK\/[RS\/:;;>'-:N?[3TJ
M[-Y9/J<OG!OE*F(\<)M.!@<?CFI/"WB\ZOXF&E^(=%ET?Q1;6KA8V.Z*>(LI
M9HW[C*@XYQSR>< '>UF:=K]AJFJ:EIUJ\IN=.9%N5>)DVEP2N-P&>!G(XY%<
M9#XKUFVU;P[%=W<$\NHWLEI?6\$6Z" [791'*!RR[0&!)[\"HTUI/#OBCXF:
MQ)&9!9PV4OE@XWD6YP,]LG H ](DD6*)Y'.$12S'T KF8OB)X5GT[3M0355-
MKJ-S]EMI#$XW2_W3Q\OU; Y%5K2\\6IXBTT/:RW.EW".+YI4AC%L^,JT>UR6
M4G(P<D=<UNC0+0V8M7,CQM<?:)MV,S/G=\W'3(' QP .G% &E)((HGD8,512
MQV@D\>@'6JVF:A#JVF6]_;K*L-P@=!-&4< ^JGD4NI27$6EW4EJ\:7"1,T;2
M(74$#/(!&?SKS[_A+O$,OA#P/J<,]F+C6;N"VNA) 2#O5VR,'@?)TQGW% 'I
M=(Q"J6.< 9X&:\]?QCJ?AR?QA%K,T6HKH]K#>6\D</DE_,#?NR,GC<HY]#71
M6L7B:+5]/DEO+6[TZ:%S>J4"&&3 *F+ R5)R"&)/?- %_1->L/$-K/<Z>\CQ
M0W#VSF2-HR'0X888 \'U%:5>16VL7_A[X>>+=7TZ5$N+;Q#=$!T#*P:X52"/
MHQZ5V>H:[>6'Q!L=,:9/[-N-.GNI%9!N1HRHR#Z88\4 :^O:_8>&M,;4=2>5
M+9652T<3/@L0!G .,D@9.!S6G7D/B_4M3\2?!Z?Q"UVL-M=R0R+9")2JP_:$
M"9;[V_A23G'48[UU>I:[JU_K6LZ7HPGCDTR.-1)#%$^^9TW@-O8?)@KTY//(
MQ0!V=%>=WWC/5-+BT3_A*$D\/I=6K?:+J.)9HX[H, $9OF"J1EOQQN&#7<:1
M)/-HUC+<SPW%P]O&TLT'^KD8J,LN/X2>1[4 7**\TGU_Q9/!XS>#4[& Z%*S
M0D6>[S56$2;""W [$\GGC&.=>U\576N:MHFD6KBSEO='75[F55#,B,5543=D
M9+,<D@\+TYR #LR0 22 !U)I:\C\6>)-9F\&>.='GNQ#J.B&-6NH(POVB"8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (RJ
MWWE!^HI0 !@# HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "C )!Q
MTHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@NUM_.<EL $L%5!ZD\GVQ[U=?Q#H\>HI8/J5LMU(_E)&7 +/_<!Z;O\ 9ZT
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M(8<&U=_[-38QF!*D2Y^\ !^!S0!N45FS^(='MKP6D^I6T<QD$6UI ,.>B$]
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MV4!G$C@; 3@%O[H/J<"EN]>TBPN(K>[U.T@FF1I(TDF52R*I8L 3T !.>G%
M&A1699^(M&U#2Y=3M-4M);"$L);A91LC*]=Q[8]Z=:ZM8:N+F#3[]&GB $@3
M&^+</E)4COU&1@T :-%<K\.-5O\ 6_ >G:AJ=Q]HO)6F\R7:%W;9G4<  #@
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M3-H7G-87%U).DLC%A,S8W.F?X2<X['!(X.:Z"6&*>,QS1I(AZJZ@@_@:>
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M?)MD\P #:H QSP> .M9TU[I^A>,(?%Z&+_A%-3O#"Y$N42[P4%V%Z8.&0_\
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MQGW&>,CH:\:U"]M1\-_B':/<O),^NF1?/38[JS0$$C &3ACC Z$XXKN-1O+
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M2 !R2>U8EEXITVXU6VT2:7[/K,MFEVUDZME%(Y&[&"0<\9SQTJ#Q_9W]_P"
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M70[=Y].:0!;I$F=I+<L.GRD'WP 1@FO3_#GB#3?$NBV^HZ7*K02(,Q]&B/\
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MNNL1?%E]/5IUGM8#%M0@R?Z)U ZG/;UXQ0!Z@VM:<M]9V37<8N+U"]M&>LP
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M/"7BC^T'UZ"Z<2:;YLRFXD\TNDD>TXP20V[@#DGCFM7QT(+K5YO$FDK#<?V
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M6:WE&4D0\,/45YG/I6D6=KH,?AK5Y?#=U%%=2:8]V2T4\3.A='60YPQVL!U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !2$ C! (]Z6L_5M;T[0XH9=1N/(2:011ML9@SGHO /)[#O0!?"J%V@
M+TP!Q0RJZ[64,/0C-9\>NZ;-K4FCI.QU"./S7A\IP53LV<8QVSFH?^$GTCR(
MI1<N1-*\$2+!(9)'3.\*@7<VW!S@<8- &O2*JJN%  '8"L5_%_A^/28=3?5(
M$LYI?)1VR"9-VTKMQD,#P01QWJLGQ \*2$!=<M23,\ '.2Z+N8=.F.<]#V-
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MR/6@#2"J&+!0">I ZT%5+!B!N'0XZ5!8WUMJ5E'>6<HEMY02C@$9YQW^E6*
M"BBB@!&4,I5@"#U!K"\9:%<>)?"=]HEK-%;M=Q^699%)"#(.0!UZ5O44 06<
M4D-I&LPC$P4!S'T)'>IZ** $(# @@$'J#0 %    '0"EHH *0(H;<%&[&,XY
MI:* *EKI\5K<W-SN9Y[@@N[8Z#.U1CL,G\R>]6R 1@C-%% !BBBB@!I12VXJ
M,],XIU%% "8'/ YXH9588900.>12T4 (RAAA@"/0BN=T30+W3?%6OZO//;O%
MJKPN(T!#1>6FP#)ZY SVQ71T4 ($5<;5 QTP*6BB@!%54&%4*/0#%+UHHH *
M3:N[=M&[&,XYI:* "D958$, 0>H(I:*    8' H(!QD=*** #&**** &A%!R
M%&2<YQWIU%% ";5W;MHW8QG'-+110 C*&4JP!!Z@TH&!@=*** $90RE6 (/4
M&EHHH 0HK$%E!(.1D=*&56&&4$=>12T4 (RJXPRAAZ$9I:** $95==K*&'H1
MFEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *Q/%^A_P#"2>%-1TH-MFFB)@?.-DJ_,C?@
MP!K;HH \A>\\0SOX?\>PV,JWMT@TJ6R9<82085V] +CG/]TCWKH/$-S:^'-5
M\*::ZBWB"31KJS0^9)"P11M7@@/)W)!S@\$GCOJ* /")KBW_ .%;Z[92^;Y@
M\4%REQ$P9D-TK9((&3M!)'8=<5W/C>XLO^$G\$.TL)C&HM,6R" IB8*Y/IDK
M@^N*[ZB@#@=>U2W@\?\ ]G2QM8M)I?[N\AMR\UWES^X0[3@#[Q &X[N,8YX[
M1+NV;PE\,(I&VM;:A^]$J%=F$D&3D= 2HSTS[U[?10!Y9=$76N_%.WML2RW&
MF0K$B<F1A;R*0OJ02 <=.*0S:9J_A;P@T&NSZ-J-O:8M-1V8C218XU>-PX"L
M#G&/52,YXKU2B@#F_ U_J&H^&4FU.W@CN5GF0R6ZE8[@"1OWR@]G^][YST-<
M]H&H6^@>(?&&G^(Y4@>\OVO;=Y^!=6[1JH5,_?*A=I4<\]*]%HH \8TJQET*
MU^&%AJY$<]O<7,KQS'F%'20QAL],;E7GN,=J]F "C   ]!2TV3>8V\LJ'Q\I
M89&?>@#Q'3CI^J_ FYT&#R9]5N9YXX;1<>:TQN6V-CK@#!+=  >>*ZN*]A\/
M?%6<:I,ZF\T6VBMW\MF^T2([AE7 .6Y!QUYKI?!GAZX\+>'(M(GO([ORI)'6
M5(C'G>[.006/=C704 >(:;.L7PK\%7$B2I%8^(HY;EFB;$2>=,=QXZ?,O(XY
MK:\5SB+4]7UC0-8%MJ0MX_M.D7T>Z+4X_+!4*APP<AMGR\Y ! S7JM% &):>
M*-/GUR/096:'6#:+=/;,C853U&[&"1Z5@_$.YGTF\\-:\\$L^F:;?L]\L2%S
M&CQ,@E*CDA2V?QKKVL8WU%+V1G>2-"D2DC;&#C<0/4X')S[8R<VJ /./$/B#
M1)_"^J:YI6C07UM/-:B>^DM&V2$. )&7 :01#!ST[9X.(O#NHVJ?$_69VOKB
MXAN-)MW2[GB*+(%:3+ A0H4<<]/<FO3** /$8YXE_9[T>$N!,MU &C/W@5N@
MQR.O"\_3FM[QA(L.L:IJVA:['::K':)Y^GW0$EOJD04E55>I8[BN5YY [YKU
M"B@#/!O+[PZ"L9L[V>TR$)_U,C)T_ G]*\JWQZG\$E\)"/9XCB2.S_L]N)EG
M648?'7;QOW],9.:]EHH \_TIX/\ A<6J1RRQRS?V-;P[SCYV5W+@>_W21]*U
M/B7I^H:I\.M9L]+1I+MXE*QKUD575F4>N5##'?-=910!YWK-Y:>,=0\&SZ#,
MLEQ;:BEW/L^];0"-O,60?P$DJNTX)/T-9,-Y#:^&_B=ILY>.[>[OYEC9",I)
M"H0@XQ\QX ZGM7K5% 'E3W-JG_"K"DL0\H#?@CY ;8J<^GS<<]^*HZ=<Z"+7
M5/"'BVUU*75#?3LMF'N-E^KS-(CH%.W!R.3C&,GO7L=% ' :$]K_ ,+<\1H3
M%O.GV<:#=NR5W[U!/4CY<_AFKOQ1@OIO MP;&"2Y\F>":>"(9:6%)%9U [\#
M./0&NRHH \SO?$>DZ[\2/!%[I=S]IA,-^K211,0I9(\!N.#GJ#TSSC-8WAJ?
M0;G0K?PEXCL]2F\16<VQM/:6XVS2*Y*RJ0=@4_>W< <GZ^RT4 <'X2EM9/B/
MXY*O$S23VA0\?.%@ .#WPV0?0U#X(M[+6+3QQIT^R6WN];NPZ _?B=$7</8X
M.#[5Z%10!P7P_CU26%;76(G\SP]OTV.1O^7A@?\ 6C_MD(P#_M/7%R:U;7VD
M>&+D1RV?V7Q)&T^EV]JPCL1YDF=^%R7).>O.XX KW&B@#@O#][!9?$WQE%<E
MX6NC:3Q%T8!HUMP&;.,  @@D]^*S/!VBP^)_@DVBLX260W(4]&AD\]WC;'48
M.UOI7J%% ' :,=9\4>"-2U*Y@>UUBYTZ2P@1_E*2(K*[>VZ7=^"+65X5U'PQ
MK\.A64MEJ3^(-,:(M8SR7(^Q2H &<Y.P* #CUX&,G%>J44 <UXY@TZY\/I!J
M5W<643W,7EWENVUK:4-E),]@& SGC!KA;V?Q'=^$M<AE,>MG2[^SG6^T]/+;
M4849'=?E.-ZA1G:?;J*]?HH \JN_[!\9Z/J]WX22^N]8;29K874TD_[H,,^3
MF0XW$YX'3!.1QG:\+>)] \31Z-%!I[2:O8Q[7BEM65M..S:^6*X7IM !R<CM
MG'=T4 >%7VHV]O\ ";Q'H#^;_:L&JR&6V6)BR*;Q65CQT((P>^>*[:&ZL[GX
MV-(&1@_AY(U+C'S>>S%.>C;2#CKBN_HH \\TYTF^(OCR*)E:26RM$C /WV6.
M0,!ZD$@'TS7,W-_;3?L^Z=:JS>?!]CAD1D92'29"Z\CD@ DXZ"O::* /,=7U
MC3] ^(E]=>(9;R'2M5L[?[#?6\LPBW)OW1L8CU.[<,^I]:;?:5HUK8^'X=&U
M"X\*7$$5U)IDTQ)C\LNI9)5D[/E6"D@C'J,5ZA10!Q_AGQ1M\/:)_;L"6>H:
ME/)!&EO"YCE<,QWCCY5<#>,_WJ["BB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5R_BGPQ>Z_JNAW=O?06R:5=B["20%S*P&,9## P3ZUU%% '-P>'+RV\;
MW>O0:A$MO?6\,5S;F EBT>[:5?=@ [N<@_AV?XN\/7/B2QLK:WO(K7[->PW9
M:2(R;C&P8+@,,9(ZUT-% '(^(O"E]XCM-4TV\N;*;3[[;Y8F@+26;;%4M&<X
M)R"PZ8)/7I6_?7,6BZ!<7+F9HK*V9R57?(0BYX'<\5?HH \;T*34-,TZSO\
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MGD8SFO0** .+O/!VJW&MZO>Q:S!%#J]BEK=(UJ7:,JK*#$2V%!W$D$'FHH?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCA2-QZ  #CI6';7,\%UX*O[&ZNYX;W4GADU&>4J]^CI(V6BY&S@;<D$8& *
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %8DGA/1Y-6O=4\B9+N]C"7#1W$B!\+M!VAL!MO&X
M#.._-;=% & ?!>A-X6'AMK1VTI<;(FGD)CP<C:Y;<,$9&#1:^"]"M-2;44M)
M)+I[?[-))/<22^:G/W]S'><,1DY...E;]% ')Q?#?PW#!;6ZP7AM[6X%S;0&
M^F*0.,XV#=\O))XK37PMI2ZE?ZBL=PMU?Q"*Y<74@WH 0!C=@8R<8QUK9HH
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M/,UU)#&^\(D18*I /5BN2.0!VS70Z'8W>G::+>\U.;4G#L4GF0*^PG*JV.I
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5<L>VY@<9ZUZ5110!X;)KEG?:/X9N5#60M?$L33Z5!;D)8CS),^8=N=Y)SU
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M026436I4K+9R0LHD=EZJH56PQX.1CJ*T[&XMD\:_$2221%22WM0KMP'VP,K
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M2<F#45\^%;:0M;'R74HP"\$'C'MGI7JU !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% &%XQ\/2^*O"]YHL=XEF+H!7E:'S< ,#P-R\\>M;,"RI
M BS.CR 89D4J"?8$G'YFI** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y[PWX<N="U#6KF:_BN5U.
M[-V42W,?EL55<9WMD84=A1J/ARZO?&6DZ\FH11QZ?%+$+<VQ8N)-N[Y]XQ]T
M8X_.NAHH **** *6L64NI:->6,,Z0/<PO%YCQEPH8$$[<C/7UJ#PYI,NA>'-
M/TF6Y2Y-E;I;K*L7E[E10H)&X\X'K6I10 4444 %%%% !1110!6M;&*UDGE4
MN\T[;I)'/)P, <<  = /<]22;-%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%0_:K?[9]C^T1?:O+\WR=XW[,XW;>N,\9H FHHHH **** "BBB@ HHHH
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M_F"1I.F>F#CKU]N:YE/"?B%?!EMI1T]/M46NC46_TA-OE>>9<9S][!QC'XT
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M.#VANO!6JVWA/3;"VACN+XZVFK7A60*BGS?,95)P3QA1QSC)Q0!NW/BS4O\
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MX7GGDY[<8_":QTC5O#GBS7+ZSLOM^G:PR7&Q9E22WG"[6#;B 4;@Y!)&.AH
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M(+U-(^TMJ.]6)B\P Q@[0=H;)Y(Z9Q7+6'A#Q+9>"_"5HUG:/?:%J2SO"+G
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MJSPPF0!Y%&,E1U(&1T]:\T\?:[<>(OA7K]_8V%O+I(#Q1RR2D22!'V&55VX
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M ?2I:Q_"NOQ^*/"]AK4<#0"ZCW&)FSL8$AAGO@@\UL4 %%%% !1110 4444
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M>*-?\'ZS:WUI96MW?6;VL%I%<%TC+*07>3:,]1P!P!U.>()?#^LR7_@F<6T
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MS/P_T6_\.^"[#2-22(7-MO#&%]ZL"[,"#@?WO2NFHHH **** "BBB@ HHHH
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ML?LS68T\^9]K$N[S2<?)Y>..N<Y[=*N>8F\IO7<.JYYH =16;X@OKG3- O\
M4+18GEM8'G"2YVN%4MC(Z9QUK/\ !/B@>+?#JW\EO]EO(Y7M[NUSDPRH<%?Y
M'\: .BHKB[7QK<:C\3;CPK:6L0M;:T-P]VY),A5PC*H''!)7/JIKLA(AD,8=
M=X&2N><?2@!U%4;/5[*_O[ZSM9A)+8NL<^TY"N1G;]0,9^M7%D1F95=2R_>
M/(^M #J*BF=S#(MN\7V@HWEAS\NX>N.<9QFH-/DNUTJW?5)+7[6(U-PUN2(M
M^.=N[G&?6@"Y17->._$%[X:\&WFM:;';32V^PXGR5(9PO8C/WL]:ENM7U"?7
M;W1]-CABGM;2.X$EU$[),7+ *"",8V<GG[W3B@#H**Q/"'B)?%?A2PUM;=K?
M[4C%HB<[65BK 'N,J<'TQ6W0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5SGBYY[JS@T.S6-[G4G*.DDA0?9UYE)(!(!
M&$R >9!71U1DT?3Y=5CU-[5&OHUV)/SN5>X!]/:@#@&>^\+?%:SU"^M[6UL/
M$D0L91;SM(HN8QF)CE%P2N4 YKTD7$)N&MQ+&9U4.8PPW!3P#CKC@U1U70-)
MUSR?[4L(+L0MNC$R[@C>H'8^]2PZ1I]OJ;ZE%:1+>O"MNT^/G:-3D*3Z4 7:
M*** "BBB@ KSSXD.?#NJ^'O&L<;NNG7!M;U8QDM;S#;^.&VX'J:]#J&ZM+>]
M@,%U"DT1*L4<9!(((_(@'\* /(;BSU/PAXLM?)5Q<^+K$V]PR<B*_P!VXR?1
M5D;'LM=/\1;*"#0?#5C$ICMTURPA148J54/@ $<CCN*[>:TM[B:WEFA1Y+=S
M)"S#)1BI4D?\!9A^-5]2T;3M86%=1M([E87$D8D&0CCHP]QV/:@#SV2'2_#/
MC;Q;%"K:=I9\/1W5P+(;&#!I5,B@<;\=_6J^F00V?CCP6L4%K:VUUI%RAA1@
MSR1!8RAF88#DY)Z8SNY->BMX=TA[V:]?3X7N9XC!+(XW&2,\%&SU7V/%5K3P
M=X;L6M'MM$L8FLW9[=EA&8V.,D'UX'Y"@#G/A796-MI6JO!;6\4_]KWL>Y(U
M5MBS'"\<X''';BE^('_(U^ _^PN?_19KK[+1=,TV[N[NRL+>WN+M]]Q)'&%:
M1O4FF:AX?TG5;J"YO[&*XGMSNA>0$F(^J^A]Q0!PMMX>TG5?B/XYM[^QBN(#
M:V3F*0;DW,DN6V]-WH>HR<=:PKR.+4/V?/#]S>Q1W$\9LT2650S*IN$4@$],
MJ #Z@5ZLOAW24N[J[6RC6XNE"7$H)W2J. &.>0*A;PEH#Z5%I;:5;'3XFWQV
MQ7]VIZY"].O- ',R1VO_  M>UT&XM($TJ+1FGL;7RP(6F,N)"%QC<%Q] 6]3
M7&^(;1H/!?CW3E!.E:?JMO\ V?SQ 7>)I$3T52V,=LD5[!>Z%IFH16Z7=HDO
MV9MT#L3OB/JKYW#\#3+CPYHUWI0TNXTVWDL-VXV[)\A;.<D=SGG)[\T <-XR
M\+:+I5[X7:QL5MWN_$4)G9'8-(3&^23G.3M&3W//6ETOPOH;_$KQ-I+:7;'3
M#96DYLM@\CS#YBE_+^[NP!SC-=U=Z!I=^MJMW91S"T8/;[\GRF'1E]"/7K0N
M@:6NH3WZV:+>7"[)IP2'=?0G/(_E0!YCX7N+:Y\%> K&Z\VZOI+BY^QV\DH6
M!_*,@S+D'(1<;0!G('OC*U"&!OA3XZ@F%M*+3Q!(( B )$/,@SY8).T?.W3^
M\?6O6&\&>&WT^"P;1;,VD$OFPPF,;8W/4J.V>^.M3+X6T%(+Z%-'LEBO_P#C
MZ00J!-Q@;J .6\1V-C:>/? 7V.W@A5+JZC"PJ%4#R')&!QU)/XU2T6VL_$^G
M>-AKL4;WT.I7,#/*!OMXD4>24)Y4 ?,",<Y/6NW_ .$9T3-B1IEN#8#_ $3:
MN/(]=N.A/<]Z==^&]&OKU[RYTZ&2XD0)*Y&/-4=%<#AP/1LT >7Z;;RZW?\
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M89\RQKN(V_P\@#ON/(J/3O%&BV,7BS4I-+.F+IUWB]?"EYWV*0V%X).5 &:
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MP4Y!R0>#@$<F2Z\=7/\ ;EYI.E^';O49[>VBNE*3QHLL;DC<"3@=.AY/IWH
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M[H)YVKG&0.F3C.,U85@RAE(*D9!'>H[>Y@NXS);3QS(&*%HW# ,#@C([@\4
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MQ>>+[B.UM=<T:&P^S*%N+I;I91=$# \M1RH)PQ+8QTP<Y'5LRHI9B H&22>
M*9!/#<P)-;RI+$XRLD;!E8>Q'6@#R>?PSXJ7X?7_ (4AT5'>/4?/ANC=QA)X
MS="8%1G((&<[L=.,GBNL@L-57XF7.MR:9(+)](CM ZRQG]XLC.0!N!Q\V <#
MGT'-=A47VFW^U?9?/C^T[/,\G>-^S.-V.N,\9H \OD\+^('^$>H^'AI+C49[
MUY40SQ;=K7/FY+;O[O'U_.M+Q?X;N?$DUU,-!N(=4AC4Z3JMK<QQ2POM^[(0
M^=H?.<!A@G'/7T.B@#BUTC7;3XA6.K_9X[R"31DL+FX$JIY<JR[V<J>2""<
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M]*]+HH Y!=.U/_A:DVL'3I/[-?25L1-YL?WQ*7SMW9VX;TSQTK#T[PUKVE^
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M<V]W")K:>.:(DKOC<,,@X(R/0@BC[3!]J%KY\?V@IYGE;QOVYQNQUQDCGWH
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MR^G0^O%+=V_BW6G\)R77AW[/<:7?++=LUY$4<"-D+)M).#G/(!' P>H](HH
M\]TBU\8>%]0U#2+/1[;4-+N;R6YL[]KM8Q;B5BS+(A^9L,2?EZ_RT].TS5(/
MB5J.IS6<AL9]/AMEN2\?S/&S$DJ&R =W'%=?10!Y[HUIXQ\+WE_HMIH]M?Z9
M/=RW%GJ#7:QBW65RY61/O-M9B?EZ^W:>QTS7_#7C;6;JVTXZKINLF*;S4GCC
M>WF5-AWAB,J<9RN2/0UW=% '*?#?2M3T/P+I^F:M:K;W5OY@9%E#\%V8<CC^
M*NKHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*6(&=HZG\Z\ZL_#FN0_#/Q!H;Z?B_OY+SR5$R;<3LQ4DYXQNY_3- &_X3TF
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M CP_JX-N+8C6[W,"D$1?O/NC'''3\*U+[Q9="+5IM'TAM3BTJ3R;@+,5DDD
M#,D2A6WE0PZD9/ J/P'I&K:/9ZO'JMM! USJES=Q"*?S,K(Y(SP,?YR!699:
M;XL\,>(]9CTK3K34M*U:[:]CFENO)-I*X <.,$LN0"-O]: -]O$DEUJC:7I5
MB)[R*U2ZG6ZE,"PJ^=B,0K'><'C' '7IG&F^)$*^'X-3ATFXDE_M-=+N[4R*
MKVT^\(03_%U!&.N1TJ5-$U?0O'%QKUM"VIVVI6<4%ZD;)'*LT0PLBAB%*D$Y
M&01[UCWW@O54T)UM[9)K^^\0IK-RBRJ%B42*VP$XR=J@=.3GM0!T-MXRECUC
M5=-U?27L9;&Q_M%/+G$WFP98$\ 88%<8Y^M6M&\17>KQVUQ'I\$EE<VC7,5Q
M:W?FC<"N(VRJ@,=WK_":R[O3-;/CV^UNTL (GT,V4#2R)_KP[.-RY^[R!GU]
MN:KZ#X5ETKQ8-8TW2I-&M);607]@DZ-%<3$KL,:JVT8PWS';U'')H ET/Q=I
ML/@FTU*TT=;'[7?26=KIT)4;YS,R8R  ,D,Q/89Z]\^">2V^--Q=:E9VUD4\
M./))+#+YBNHG7YB=JG(P1R.PJE#X*\0IX'TJ&*"&+6='U=]2AADF!CN 9';9
MN&<95\9(ZC\:U9=#UW7O&,FHW^E1V%A=:%)IDP:[5Y$+ODD!00?SQ[]J +$?
MQ&MVOM'4VUN]GJTBQ0O;WBRS1,PRGFQ ?*#TR&.#P:L:+XRU/7-2GM[;PW*M
MO::E+87=P]V@\K8H.\+CYN3C Z9')YQ6\*)XVL+6ST+5-/LEM[$+&=5CN0WG
MQ)@ "+&0Q  ))&.3UJ[X)TO4M*D\0#4+,P+?:M-?0'S%;*/MP#@\-\O/;WH
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M>3ST'/- &_165X:UR+Q+X:T_6886A2\A$@C8Y*'N,]^<\UJT %%%% !1110
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ME=0W"1R-$[1.&"NIPRG'<'M6>WBOP\MU]E;6]/%QN5!&;A-Q+': !GG)X^M
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MD'CD5Z+10!QC>&;RS\7^&;BR@5M+TBPDLBS2@/A@@4@=\!.?K7._\(AXIL/
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MZGI_BZ\6")=2UZWCM(8&E&V&-$(!=O4DDG&>PYZUVVE)/%I-I%<Q"*>.%4=
MVX @8.#W%26M]9WZ,]G=07"J=K&&0. ?0XI;J]M+&,27EU#;HS;0TT@0$^F3
MWH Y_P"(.C7_ (B\$:CH^FQQM=7055,K[%7#AB2>?2H/$.EZMJ7B/POJ-M9(
M8=-GDFN%>8!OGC*87U(SGM76HZR(KHP9&&593D$>M+0 #D=,5R?]CZO9_$6[
MUJV@MYK"\L(H)"TQ62-HV8X"XPV0WJ,?SZRB@#R\^#O$!^%LWAO[+;_;WO\
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M9H4.8W+Y&T<DD YK!N]*\3>)?"6L6.L_V?97-Y9R6T$%M(TB*S*1O=B >N.
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MRJX88SQD5SD?@OQ,GPVL?##)IAFLKJ%DE%R^)$CF\S<?DX)  QSCKGL-R_\
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M[AV!BW*GU(V\CCKS5+5-<UH>*O!MG81VD=IJ$$\[1,[+EDA!VD@'"C?P,')
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M4'</2J=GXMU6\TS77@TI+F]TW53IT<<+D*X_=_O&SR  Y)'/"_C0!UT\\-K
M\]Q*D4,8W/)(P55'J2>E9[>)-$33[6_;5;1;2[8);RF4 3,3@!?[W/I6/HGB
MA]7UG7M%F:TN#I\44BW5H?DE60-P5).""I'4_A7"1 'X">%..EY98_\  @4
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M;(Q"AF"]%4=ACL,CK0!T%%<K/XJGT[1VO+M;6Y,]Y':Z?):,QCN0ZJ0_&X@
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M\'1:6;G3'O++61J5L<R+'(!.9<.<$KG=C !QCJ<\>ET4 <-?:!XKL?%#>(-
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MPH[9Y.>.THH YCPY;>,%\B/Q'<:9Y=JNW?9%R]TV,!GW !1WP,Y..0!@\J/
MOBA/!L7AB.721;V5^MQ;W#22%ID$_FX==OR$9QP6S[=:]1HH Y;3M#U:W\?Z
MCKDXLOL=W9PVX$<S&13&6.<%,8.[UXQWJI;^%=3;4?&<ET]I'!KT:I"8I&=H
M\0^5\P*@>_!]O>NTHH XVVL8=/\ AY'X?\876FQ1BP^R,(ICAXTC"E@7 );
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M0RHX =' YP<#D=,?B #.M_&^I06=S'J6D2)?_P!HQV%B[0R6\-X9/NN XW*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1)JDWE@CRM\H!E]5WA0<\=16MXKMT\-Z'XIUK0M8,M[=V41GAL458XTWJAF
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MTP_9L;O.\P;,>N[I7GGB&#2O#'C'P[;(+?1M(O#<R&2.%%B-YB,(7W#:"4#
M'W-1OX=M8+&6#PUXB0WDFM+>0?:%5[5KGRV9H<(  "H+$#H<$<T >BKJ%DZ(
MZ7ENRN<*PE4ACQP.>>H_.GF>-WDABGB\]5^Z3N*^Y&<XZ5Y#K>H&\\$:B;[2
M(M+U"Q\0VGV](W#0^87B)D1NP92I/?DYZUU"7%J_QS(BEA9_^$>*MM89W?:
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MYD@7 )QGGMGBIZ\WN/#^CZK\9-3MK_3K:XAET.&1XI(P5=_.<;B.[8 &>HH
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M:RPPKNED2965!SRQ!P!P>OI5F*6.>))8G62-U#(Z'(8'H0>XH I3Z#I%S?\
MVZ?3+.2[^7,SPJ7.W[N3CG';TJ272=-GOX[^;3[62\C&$N'A4R*/9L9%.N=3
MT^RGC@NKZV@EEXCCEE56?Z GFEO-1L=.C62^O+>U1C@-/*J GZDT 55\.:&L
M-Q"NC:>(KD[IT%LFV4^K#'/XTY- T:.:WFCTFP66V7; ZVZ!HAZ*<?*/I5N2
M\M8HHY9+F%(Y658W9P Y;[H![D]O6H$U?3)$#QZC:,C%@&6=2"5Y;OVP<^E
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M5:36FGZ596MM/GS8H8%19,C!W #!XXYJOH7BC2?$0NFTV\AF6WF>(E9 =VW
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M39(9++1-/MWA+&)HK9%*$XS@@<9P/R%7+34[#4"PLKZVN2GWO)E5\?7!JU0
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MW-M;WEN]O=01SP2##Q2H&5AZ$'@U6CT72HM,;3(]-LTL&X-JL"B(]^4QC]*
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M=O\ #S6FTY7\Y+4X6'AMG&_;[[=U8>GOX5U+6-&\06/B&>^N;:UE$,%L801
M4RPD2- P5<# .,,0.IKT.J5CHVEZ9)-)I^FV=H\QS*T$"QES_M$#F@#R&UU+
M3=OP[NK2YL[73UOI#!;F;?+#&T<F3+(3U)ZC  /&3C-='X.\/Z)>>)/&/VC2
M[*<P:R&B$D*L(CY2'*@CY>2>G7\*[B/0='A4+%I-B@$WG@+;H,2_W^GWN>O6
MI(-(TRU:9K?3K2%I@1*8X%4R ]0V!S^- 'BT5A80? Z*_BMH$NHM74QSA1O3
M%_@8;J, GIZFNZ:WMO\ A>+#R8LS>'&\T;1^\_T@#YO7CCFNJ_X1_1?LWV;^
MR+#R-V[ROLR;<^N,8S4G]CZ7]H%Q_9MGYX38)/(7=MQC&<9QCC% 'BQT_3X?
M@=?7T5M ES#JQ,4X4;X\7X VGJ  3P/4^M=GJVH6VD_$Z\ENKBUN4N='2(VT
MUQ'$T/[QL#]X0"K\YQDC:,C!%=E_PC^B_9C;_P!D6'D%MQB^S)M+>N,8S7+:
MKX8U27Q!<W/]B^'=:TZ5(X[>'4,Q-:*HP57]VX*DDMT!YQV% &/IWA6;2/!W
MA>PT?6=-AURVEDN()-@>VNY-C!T8CEL(Q ;KA?RZKP)J3ZCHMUY^F)IUW;WT
M\-U#$^Z,S!LNR'NI+9^N14VC^$-,LM/DM[G2]-(FN#<FWBMQY$+E57$:D<<*
M"3@9))P,XK=M[:"T@6"VACAA3A8XU"J/H!0!Q=PD)^-UD&2,L= E;! R3YZ<
M_P ZP-*:WU+X7^,H-;"?VC%<7IO_ #/O+*,F)A]!LVG_ &1BO3'TG39+T7KZ
M?:-=CI.85+_]]8S23:-I=Q?+?3:;9R7BXVSO ID&.GS$9XH \RL]*2^\9>#(
MO$-G#/?3>'9/MB3H"9) (Q\X/WB.>O>IA)I"^+?%7AW6M572('A@CM86\F.*
M2S\D+M0R(>%;?P#P2>.M>DR:7I\UZM[)86KW:8VSM"I=<=,-C--OM&TO5)(I
M-0TVSNWA.8FN(%D*'V)'% 'G6E7^F>'O'.CV-Y?2C2/[!$>DW6H. &82'?\
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M/#H40AG.BVTB1VR[3NVR E0/XMOISTK5TB/PGXAO_#NJ6>O2WEQ!"\=M9Q&
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MP/<11F62) &EPO!8CECR>3ZUJU'!!#:P)!;Q1Q1(,+'&H55'L!TJ2@ HHHH
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MHZDX/->>Z;J-F_Q'\+-_:6GR1R:-- D5LX,<8)BV1;B27/UZ]<#-9=UYUIX
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M>$M7O["6.*ZM;26>-I(]XRB%NF1Z5L Y ([UA^- 3X$\0@#).F7. /\ KDU
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MD6MK<G4K3R+N406TOG+MFD)("J<X))!X'I6A0 U8T1W=456<Y<@8+'&.?7@
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MBHO[9TS^S(M2_M"U-C+CR[@2C8^3@8/0DGCBGVFJZ??VCW=I>V\UO&6621)
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MX7Z<<47^L:;I6/M]];VV5+ 2R!?E'4\]AW/04D^LZ7:QVSSZC:1I=$"W9YE
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M,.JV4@LPIN2LZGR0PR-_/RY]ZDM-4L=5CG73K^":2+Y7\M@QB8CC<.WKSUH
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M5PMP<]B8\,#_ 'L4:UJMKH'Q-V:OJ4FDZ==:7'%8W(V+"&1W+QEF4A3@H>W
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M+:1'5[>)ED.YP4!#'&,GUXH Y?P/J.IW4VMV>L6MHNH6=TJ3W=EGRKHF)<,
M>C!0H([<52^*0MCIOA\7/E;3K]D,28P1YG/7MC.:[>""&VA6&"*.*)>B1J%
M_ 42V\,^/.ACDQTWJ#C\Z .$B2Q_X7E<?+;[U\/QL.!D,)F&?KM./I7*Z)JV
MF6'@W0XYEM<?\))<K:W,\A$%DXDE*NVTC/RD@*2 =V>U>Q_8[;=N^SP[B,9V
M#/I2&QM#$8C:P&-B"5\L8)'3B@#R6QNK2?2/BG;B]2[=EFG!(7+J;4?. !C!
M/0]_4]:OVMT^GZ[\.KF^;9I3Z.;>*5CA([EHDQD] 2H*CZD5V'B+2-5U2.YL
M+)]/AT^_M)+>[>2-O.4LNT.I'#8!/!Q]:UX--M(-*@TWR5DM88EA6.10P*J
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M1Z9KH=4UW0]0^)O@6ZL-1LID>&]4/%*IX:--BGTSS@&O1XX8H4*11(BGDA5
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MUKV0V-H8S&;6 QD@E?+&"1T.*S/$FC7.JZ/-;Z;=165U))'(TCP[TE",#LD
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M:8R8@^S*%C !(P  ,8((QBM&J>EZ;!I-@MI;#"!F<G &69BS' X')/ X%7*
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MUK2?^$AUB$VTX@6T99< *8LB5_;,FX?1%KSRUN;!_@KX1CEFMRG]N0AE=AC
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MD+.@;IN((;W 'I7&ZU:I;^#O$UXVW^QKKQ-!/:Y&49/-C$CKVVEMW3@X)[T
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M[2B$+G@R?W >A;VZUHUY2+JXTC6UFT;4;?5M&O-=:*YTFX ^T6EP9CO>(CG
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MVF&&)I5E,:&11@.5&1^-95CJ=E9^'=-N)=3:\BEAC$5RRYDNB5R&"J,DD9.
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M*"1R J%P-H8[EX)SR*KV-W:W'BO4HH-<-S+%#&LNG*5*VQRWS<#(+>A/;Z4
M;/EIQ\B\>U9'B31[G5])^S6%ZMC<++'*KF+S$?8P;8ZY&5.,$ BFR^,/#UOL
M-QJ]M!'(S+'-,WEQ2,IPP61L*Q![ FF77C;PU9-=K/K5H&LRHG57W%"P) (&
M>RD^V.: *]GH.IW5W;W&N'2#]FD$L:V%HR,SCH2[,2!SG 'XXR#N:E#-<Z9=
M06_E^;+$R*9"0H)&,G -9.K:IITO]B,OB%;(75U%);B%E;[:I'$8R#E6R.1[
M<UD:SXC6Z\<P^%UOKBS@.GR3R36ZD2&7S$1%!VG &6/H3C/H0#:\(:%)X>\-
M:?IES]GDN+2!8#/$/]8JC@G(R/IS6TT4;OO:-"V"NXJ"<'J*YGPC,L5MJ*W'
MBW^WI;>4+<3,J1I 0@ROR\#ID\FM6R\1:3J%X;2VO4:X\KSEC960O'G&]=P&
MY?\ :&10!HO%')&8WC5HR,%2,C'TI0B! @50H& N.!67:>)]&OKN*VM[]'DG
M1I(,JRK,J_>,;$8<#N5)JG+X\\*PQF1]=L_+6<V[.'RH<8R"1P!\PYZ<]: .
M@\M,8V+^5(T4;NC/&K,ARI(R5^GI6#>^,-/LO%UIX>?>;B:W>=G$;%5 *A1D
M#DG=^&.>HK9O;ZTTVSEO+ZYBMK:(;GEE<*JCW)H L4PPQ-*LC1(9%^ZQ49'T
M-8EIXT\-7VJ0:;:ZS:2WD\8EBA#\NI7<,>^#G'7VJS?^)='TR<Q7M_'"0ZQN
M[ [(V;&T.^-J$Y& Q'44 :9C0L6**6(VDXZCTHV)Q\J\=..E8][XO\/:?<7-
MO=:M;)/;*&FC#;F0'ID#)SP>.O%6AKNEMI$6K+?0M83!3'.K9#[CA0OJ2> !
MSGB@"Z8HVE64QH9%& Y'('UH:&)I%D:)#(OW6*C(^AKAM&\2-=>/_$D$NKR'
M3+2R@E"7""+[*S%]P(*J1P ?FYZ5KZ7X@T;3?#VE-=>)8[U+IO)M[RX95:Z8
ML0,  9YXSCH/QH Z6F-#$\BR/&C.GW6*@E?H:S])\1:1KCW*:9J$-R]JP694
M/*9Y!Y['!P>AJN_C#P[$8O.U>U@2;/DRS-Y<<V#@[';"OC_9)H VBBDY*@GU
MQ2T5DP^)M&N+R&UCOXS+.6$!((28CJ(W(VN1_LDT :;PQ2,C21HS(<J64$J?
M;TIQ56^\H/U%84_C7PU;7CVDNM68G2=+=D$F2)'^ZIQW_EWQ5KQ'KUIX9T"[
MU>]#F&VC+[44LS'' &/7UZ#O0!I&-#U1?RI'BCD9&>-&9#E25R5/MZ5P>L^*
M)1K/@V\@U-K?3;V:5;R)E"QD+ SY)9=W!]\<5TD/B_P]/I-SJB:O;"RMG,<\
MKMM$;#^$@X(/MWH VMB[MVT9]<4FQ,YVKD^U8]KXMT"]^U_9M5MI/L>SS]K?
M<W_<'N3T '.>.M36WB31[NWO9X[^)4L?^/OS<Q-!QGYU8 KQSR* -+RTQC8O
MY5R<F@>(K?6+^>SU#2KJSO9A+LU"T9Y(/E"[5*L 5&. 0.IYYS6Q!XETFY:X
M2.Z/F6\0GDB>)TD$9Z,$(#$''! .:I^'?&6F>(/#O]M+)]GM]S9\T%<+O94Z
M]S@<#/)Q0!?TO1;;3K!K9DAE,DC2RD0A49V.3A.@'3 YZ<DG).F    , 5C+
MXLT$VU[</J<,*6) NA/F)H<C(W*P!&>W'/:BS\6:#J&IQZ=::I;RWDD?FI$I
MY9<9..Q(!Y'4=Z -:2*.9"DJ*Z'JK#(-.V+M"[1M'08XK+N_$NC6-VMM<W\<
M3M*(=S [!(>B%\;0QR."0>13M5UFPL0UO<7S6\S1&3,2&1XTZ>81M8*H/\3#
M% &D%"C   ]J6N4^&FIWNL_#W2M0U"Y:YNYA(9)F !?$K@=..@'2NKH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_#@D YXK1\4WEEHWQ'\)ZE>RQVNGFWO83<-\L8D<(0">@+8./6N_I" >H!H
M\-U6\@G^'/Q(P'^;7_.VO&RG87MP#@CV/'7BNTU**RUGXB^$;O1)()O[/CN'
MN9K8@K' T>U$8CCECP/9B.AK>\:^'KCQ1X7N=&MKB*V-PR%I9$+;=KJ_ !&<
ME<=>];T(<1+Y@02'EMG3- 'BL5Q,OPTOK:TAEN;K2M?>[O[*-"7,*79<J1[C
M#8[@'TKT'2?$7A?Q!?R:SI?DW#QV9CGU$QE!%'D,(F9@.<Y.WMCG&1GK*0
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M6I7_ (3?PWXD\1Z)ITVN+):)'=RS23/', P"J=QYV EFQR ,9YKU2D "C
M]!0!YAHNIVMQ\7;>X35&U!+KP^4BN%AVQNPG!*QX&-H&>YQSD\5S^G7QB^$7
MAQXX[J9-$U-9-6@MPZRQ1AY0>F#E25; Y& >!7N%% 'E.J7/A/4O"WBS6]"E
MFNI9]%FMIK^6:5E8E#LB'F'!;/IR. >HITMW8I??"PQW%NH17^ZX&T&U*_AE
MN/KQ7J8 48  'H*6@#QG3;GP]-INH^$/%J:B^KB]F+:?YLX%[NF:2-XPIQ@Y
M'/&,9.!S6_I.LVWA_P"(_BBT\03K:27_ -GDL))R=L\2Q[=B$_>(8GY>I+'B
MO1L#.<#/K00"02 2.E '#_!^6.3X8:0B9!C\U6!4C'[USW]B*[F@  8' HH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KC_BA>WVF_#S5;[3KZ:SN8%1EDAQGEU!&2#C@GI@UV%<3
M\7#GX8:S&.9)$C5$')8^8IP!WX!/X4 ;-_>6(\6:1:OK4T%[LF9-/C/RW(V\
MEQ@_=QD<CD]ZHZ7XVT[6EUU2UQ90:=.]NUQ+ \> J(6;++A3N<X!YX!QS6=K
M]W;2_$[P1+'-&\8BO275L@;XU"Y/;)! ]<53\.WD-C+X^L;K?%.VI7%UAXV
M\IH8PK;L8P2"!SS0!U6E:KIMEX5TVZ;5Y;VUE1(X+N<%I;EF^[P!EF/H!FI;
M?Q9H5S+=Q)J4*RV:L]S'+F-H57DEU8 J,<\]N:\T6XMK'X7> =0FG>&;3KF
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MO5_F;HNX*!D]QBL#Q/9M_P (U\2=3@R=.U6:V6Q51Q.Z*@D=!W!;/(Z[2>E
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MC(<JQ5@58 @@@CD=J +5%<[XF\60>'+O2;62VN99-1NA K1P/(J#!)/R@Y;
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MM;H2"*64JK>8JR ;>I^YA3GVKH=1UBQTM[:.ZE837+E((8XVDDD(&3M502<
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M;6+;[9JOC37[,EM.G\/_ &%70$K=3X<Y3^_@%5R.YP.AKU&B@#RN25!9?"\
M-FV:/S@$/[D?9BAW?W?F..>]>J444 >8^'[#2M7^*/C=]0L+:[AN#9BU>YMP
MZR!82K["PP<'&<5H^)[:70_%/@[55BE?1=-$]I<%%+>1YD85)& _A^7!/;/O
M7>T4 >6ZU:F[U#QQKUH2=.N=!^Q1N@)%U/M?E/[V 57([D@=#2^)F27X&:=;
MQ1LTIAT]!"L9+Y22(N-N,Y 5L^F*]1HH X2]GA?XP:-<*P:$:3.AE RH9G0J
M"W0$@$@5)\.'!/BD89=^OW4R!E(W1MMVL,]5.#@CBNWHH YWQM)J,7AMCIPF
MYGA6Z: $RK;&0"4H!SNV9Z<^G-<]H>AP:9XTN#X2N?)T.^L9'NXH,-!;W(*B
M-XQT#$%LJ/[O(Y%>AT4 <M'I^JZ-I^HW&K^)Y]3A-LRK'+:Q1;6QU&Q023TQ
M[UYGX9T.\\/^ =+\7^'2;?6+.V*:IITH*K>H&;Y67&1)C[IQSP*]UHH QO#?
MB6S\3:;'=VT<\$A4&2VN8C')$?0@CGZCBE\5Z&GB3PMJ.D,=K7$)$;_W)!RC
M?@P!_"MBB@#R)V\3SIX?\<)92IJT@&ES6;# $4B[0[#T$_S_ .Z1Z5N^.+2+
M3=,\'V,.]TM-;LV)VEB(TSND;';N2?6O0** .$L[E=.^+6NO=1S)'>Z?:-!*
M(F,;!/,WDN!M&,CJ17'1Y7X'6-KY4@NEU57,/EMY@ O2^=N,_<YSZ5[910 B
MLKHKHP96&00>"*X6TN!IOQ;UYKJ*=([RPM3!)Y3%&">9O)8# QD9R17=T4 >
M)QY7X'V-MY4@NEU57,/EMY@ O2^=N,_<YSZ5LW5_8Z+XVU^#Q'!JC:?K#13V
M-S:?:'BF7REC:(K$>OR\9'(/TKU.B@#.T*U@LM#L[:VL38P)&!':DY,2]0I]
M\=1S@]S61XAO])GU"30O$-BLNES6JR^?- 6A5]S J[XPAP 03CH>>E=110!Y
MIX$LD\/77B6*PN[A_",?EM8-<,S*LA!\Q8B>63)49Z$],G)K,^'D/ABW^&6F
M6^N6,,5_$KF7S+(^>K"5F4CY=V<8(_"O7J* /--76[LO&VA^/UT^Z;3YM/-E
M?0QQEYK:-F+QR% ,GJ-P&=OO7:6OB33]2:--*E%\S,-QB!VQCN6;&%X['D_R
MUZ* ,^PUBUU&^U"T@6<2V$HBF,D3*I)7=\I/WA@]JK>+)4B\(ZON/+V<R* ,
MEF*$  =R?2MFB@#S'6]+U5?$FC:[X8R1K%I_9>H.G_+(;=R3_P"\F&'/H!WJ
M:WCM;#XV6<5LACL;?PY]AC8*?+5Q."(]W3=M'2O2** /)=*9[+X9Z_X1U6"5
MM;7[9"D!0EKPRL[1R1_W@2XY[8YQBK^E6DFE_$/PQ9WCF6:S\-_8Y9L$KYVZ
M/C=TR0K'U_.O2Z* /*7N[#1O%'B32/%-GJSPZI=&XLY+<7#Q7<;QJABVQ'&X
M;=N".GMBKVG+_P (KX_6XOK4V&CWNCP6UHS'=':/$3F!GZ+PV03P<<$UZ110
M!YUHOA+^U_#GC&TND>&RUW49Y[174J44A0LN#R,NNX?0'O5CP]#K?B#P??76
MIQ-:ZQ+8OIL8<XPZ!D:3VW29/T5:[VB@#RKPI>Z+JUIHNEWVC:J=?TMHO,M;
MO[1Y=K)'@&8,Q,8& 2,'G(&.:V?A]<10+XNE=77.N75R/W9R\1"X=1CY@<'!
M'6N\I&!*D!BI(ZCJ* ,SP_K]CXETB/4]/,OD.2NV:,HZD'!!4]*U*KV=G#8P
M>3"#@LSLS'+.S')8GU)-6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S-<\0:;X<LEO-4G:&!I%C
M#B-F&YC@ X!QR>IP*TZXKXI+)+X,,,,$T\K7EJPCAB:1B%F1F.%!X !- &B/
M'6A?;[BP,EV+N*,2K ;*823H3C=$NW,@SW7/KTYJ:#QEH=QH2:PEVWV5YQ;!
M6B82>=NV>5LQNW[N,8_2L2XE#?&'3[M8YC;#198C.(6V!VE1E4MC ) )Q7,6
MM[=Z;H&K2)IEPZ2^+9)7E:Q:1[>W=\BXC1E.XC'! ."<X.,4 =Y=^-M,MM'U
MJ^2.ZEET=2;JT$+"5#MW#((Z$<[NF._%2Z9XHMKKP_IVH7"3)-=QIM@%O('D
MD*!B$4C)'4YZ8&<UP<5K<7%U\2K:VL=5<ZCID9M'N8),S_Z,Z]6'4L0 O!YZ
M #A;ZYFCTSP3KQTK5+G3-.MGM+^&.&2.:,O'&/,"<,0K(03]<9H [63Q[X=A
MTF?4IKR2*"WN/LLZO;R!X9<@;77&5Y(Y/'/6J=_XI\/ZI]@5]1U.T*ZO%;1>
M5#-#YT_!6-B5YC8-GG@@>U<QXIBT^\\ :I<:)H=Y$M]=VC@M;2>==%)D9G*$
M%MH4'!.,X/;&>@^(3F>W\+O!%/,JZ[:7#>5"S[8U)+.0!P!GO0!M:GXPT?29
M;U+F:4BP5&O'BA9UM@_*ER!QQS[#D\5DZY=3I\2O!JV][.+6[CO#+"DI\J3;
M$"I*C@XW'FN9\87-UJ,?C?37TV_BF-K_ *''9VCA;U?*_P!;)*H^8CE=I8#
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MP68CE,#[9"B.'"G&&P2!Q7*P17$?P>\'VC6=X+JVU*U::'[-)OC"3;F)7&0
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MS11VDKE58X#<+R/<<#\172UQ&G$CXQ:Q*89Q%)ID$23&%@C.KN64/C&0".]
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M?3=W(Q_=K?#^&M<TO4]0@\-ZE+;26?V:[FF@E2=T9U_=QALLQ7EOEX! P>>
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M+:UM7URU&G^(;N:2WS+/;&[\Y)(RK*-P.<?,01_NFK$OC'183&\EQ(MK)/\
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M%D:YF)6%# ';&>%&2365/#'XGTKP':Z='(T]C=6M[.YB9?L\<<9W!B1P6.%
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MV5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
.**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>elicio-insidertradingcom004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\,@RC%2N><=" :\CU6_TRQO_ !IH%S>W5C9ZK=?OFDTV>9E+Q()&1D4J01C
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MZI0!A7?C'0[&:=)[IPEO.MM/,L+M%#*V,*[@;0?F7OQD9QFL7Q5XB$7C'0]
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M;;[/&TC2XZX4#/&#GCCOBN1O=9'A?XDW>JZC!=2Z-J]A!';WEO;O,L4D9?\
M=D("1NWY'']<5-?E&D:MX=U^31+VWT!;>YM9H+)'1[02.CI(R1X(#;.1VSSS
M0!Z!H^MZ?KUF]UIT_FQQR-#(K(R/'(OWD96 *L/0BI[^_M=,LWN[R988$P"Q
MR>2<  #DDD@ #DDX%8_A*/3&M;N]TG3IK2VNYO-\V=762Y; S(5?YAGID\G&
M>F"<WXD6M_)I>D7]E!+<II>K6]]<V\*EGDA0G=M ZD9#8]J -VT\1Z;>WEQ9
M1R3)>6\0F>VEMW27RST95(!8=LKGGCKQ7(:%>R^-;_59#J6L6%Q8ZN\=L84F
MBB$,6P;'5AL);+$AOF&?0 5<E2/7OB/H>MZ8Y:RTZQN1=7(4A&\S:$CR>I&&
M8CM@9QD4OPXE4GQ.C*Z-+KUW/&)$*EXV*X<9'*GU% '97=U!8V<UW=3)#;PH
M9))'. B@9)/X5G:=XFTO4]0%A!+*MTUN+I(IH'B+Q$XWKN R,D>XSS4?C"XG
MM?!^K36VFIJ<R6S[;.1-ZS<="O\ $/;OTKB-(NEF^).@ZA%_:EU!/I$T'VF6
MS>-/,WQG:%V@(H /;'N30!ZE1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11534-2M],ACDN"V
M99!%$B+N:1ST4#UX)]@"3P* +=%9,?B+3VL[BY<S0K;SBVDCEA97\TA<*%QE
MB=RXQG.>,U%:^+-(N'U&*2=K2;34$EW%=H8FB0C(<YX*X!Y&10!MT5A0^+=,
MEU'^SR+J*[:W-U%#+;.K31 X+(",G'IU]J8OC30WT?3-66YD:QU.98+:80/A
MG9MJ@C&5R>.<4 =!17,WGCW0;+4KO3I)+MKNT:)9HX[.5BOF$A3PO*\?>Z<C
MGD537Q+I&EVGBO5[275+YK&4O=V\BR?NG6,';&K ;5P,D].] '945RUEXXT\
MZ?H;Z@EU!<ZJJ)$OV24*\I4,5!Q@#DXR>0/:MU=4MFUB32AYINHX5G8>6VT(
MQ(!W8QR5;C.>#0!<HJCJ&K6NFO!%*7>XN"1#!$A=Y,#)P!V ZDX R.>16;#X
MTT.?38[V*Y=EDNS8K"(F\W[0"<Q;,9##!Z\8YSCF@#H**YV7QOH<&BZAJL\T
M\<&G3&"[4V[EX7&#AE )[CGISUJ6Q\7Z1J&M)I,,DZW,L)FA,MNZ).@QN,;D
M /C(Z4 ;M%<7\4KB:R\%27MO>3VLD-U;?/%,8_E:9%8,0>1@GK6II7C/1=7U
MJ72+>6>.^2/S5BN;:2$RQYQO3>!N7W% '045@R^,-'ANK6*669(;N?[-!=&%
MO(DEY 0/C&20<'H<<$UHZOJUGH>EW&I7[NEK;H7D=(V<JHZG"@G% %VBN9'C
M[0/MEK;O-<QF[B,MM(]K($GP-Q6-MN';!Z#/H.:FM/&FB76G:G>M<2VL>EG%
MZEW"\3P\;AE&&>1R..: .@HK$MO%.GW-Y<60CNTO8;87?V:2W82/$3@,H[\C
M&.H/7%4/#/C:UUSPK'KES#-:QR2,%5H6^;,C+&J\?.QP 0N>30!U5%<Z?&VB
MQ1:FUS)<6\FF();N&6V?S(T(R'V@'*X!Y&0.^*R-:\;>&=1\-:D;B^U6ULHX
M8I)+NUMYHV"N<J4<+W(P2..U '<T5E7^OV.FWL=@WGSWK0-<"W@C,C^4I +G
MVR0/4GIFN5\8:U'J.@^%]8T;49Q;76LV2J\$C1B6-Y "K#C(XY!H [^BBB@#
ME+3PKJ^FW$Z:?XHGCL)IY)S#-:1RR(SL6;;(>V2<;@V*Z.RLXK"T2VAW%5))
M9CDLQ)+,3ZDDD^YJQ10 4444 %%%% !6+XKT%O$_AJ]T470M4NT\MY?*WD+W
MP,CFMJB@"&TBD@M(HII%DD1 K.J;0V.^,G'YU-110!S^C>'9]*\1:WJTE_'/
M_:KQN\0@*>640(,'<<\#GCK70444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7/WGAV>Z\9Z?X@6_C1;."2!;<P$[E<@L2V[K\
MHQQ^==!10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7/ZQX=GU3Q+HFL)?QP_V4TK)"8"_F&1-C9.
MX8XZ<=?6N@HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHE  ;JO)Y( KCK"*\C^%'@ZRDTS44N;/6;=IXC9R;D5)RS-C&=H!'/2O:J*
M,Z'6(IM<ETI;:[$D5NMP9VA(A8,2  _=N.E:-%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTH7H::)0R.!EC&RHFY#@X.,'J.* /1/$/B+3?"^E/J>K2R0V:,%>58FD"DG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML ;)(R2&& /QKN:* .1U#P7<ZCIEC;S:W+)=6]_%J,MU) I:66,C:-H(55&
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M?&GAN71);QK2&5T=Y$CW-\IR ,D8Y K*N/AX;GQ#X<UA]6(ET.!88D%O\LH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTN5EN+"017* $>6Q&0.1SQZ4 7J*** "BBB@ KB;75M6@^*%[X>U#47-E<6
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MN8M3MYX7L+F%([9?W,!*1;85/)+#H0Q)XSA<T >A>&O%NG>*4NWL),B"X>$
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M#3-3_9_.F6ZV\NJS7$B00QX\XW/VAMA ZYVXY_N^U 'LJ:UIDDUY"E]"TMD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS);5Q'<1.C1R1,1D!D8 C(Z<<U+JNK6.B:>]_J-PMO:H55I&!(!9@HZ>Y H
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M %%%% !102 "2< 51TO6=.UJ.XDTV[CN8[>9K>5H\X610"5SWQD=* +U%%%
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M#:MK4 @8Y(B@0(410<9.-S,3@9)Z#L 8MCKU[H?@3X=BV@MI(;\:?92F7)9
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M[B69HLA!&3\HRP );U)X[V_#>B>+]-CM[#5=9L+O3K( 0O#"Z7%P%&$$K$D
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M9P$;.W=U'6JDGBW5KS3O&]I;7EN)M&M%N+6^2V9=ZO$S_=+8R"APPX.0<'N
M=QJ>K66D102WTQB2>=+>,A&;,CG"C@'&3WZ5=KSI-=UO0? ?A"X66RN/MDUA
M:R%X7!6*4(./G.7'/S=.>E;HUO4-8\1:SI&D36UM_92Q+)-/"9?,FD4L%P&7
M"@8SW)/;'(!U%%>;?\+!U>[T/0KRTL[.*ZN=9&D7UO,6(24%@VQAT'R]P?O>
MU;WAW6]7E\5ZUH&L-9S2644%Q#/:Q-$&23=\I5F;D%>N>: .KHIKABC!" ^/
ME+#(!]QQFO+] \4ZGHW@K5]9U*YAOYCJTUK GE&,O,9_+7+;B O3@#@#J: /
M4J*Y*ZU_5-!\4Z-INJ/:W5GJY>&.>"%HFAG5=P!!9LJPSCN".<UUM &?I^N:
M;JE]?6=E<B:>Q94N5"D>66&0,D8/ [5H5YE;+XB;Q]X\'AZ33HIQ+9L6O4=P
MQ%N,* I&,_WLG'IZ7=*^(4NN:;H8@MS:WVH03S7 $#W'D>2XC<!5Y.7/!)P
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M^6XCF E1 ZKNRIQ(#R3TH ]+HKC8O$>KZ;XUDTG6FL7LY=-DU")[:)E:'RW
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M>6Q4B%D8$+GOL'?C-7;C0-0G\;V'B'S[98[:SDM6@PQ+;RK%@W;!4<8KI:*
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MI(@5RVT@[LC=QWKJ[72M.L9I)K.PM;>63[[PPJC-]2!S3[Z^M].LI[RZ<I!
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M0BW)\WS0H8AM_P N-HQP:YYOASJW]C_V4GB&'[/#J@U*U9[(M)N\WS,2MO\
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M28[J!D+J=N[*N5#< D9'OQ</C*?_ (3'PY:Q7D$FCZS9^:K>0=ZR%=T8+9P
MX5\#&<J12:-K/AW3;O5-0N;^6XO]4E5[EUT^=4PJA$105/ 4=SR23WP.<&D^
M%%\'OH,>L7R.MZ+JWNA93[[<+)F-5^7C:F5_$GO0!Z3H%U=W]@]Y<RQO%-,[
M6NR/;^YW$(3R<[@ V>.".*YCXS_\DFUOZ0?^CHZUX?&?ANW@CABGF2*-0B*M
ME/A0!@ ?)7+>)+VP\2W-S9W7B"7_ (1^Z2$2V7]ES;U:.0.2KA?XL8.<X[4
M=1=:W<W/C"/PS82I;NEA]NN+ADWD*7V(J@\9)R23G@ 8YR.7U3QYKMCX7\2D
M+9#6- O(K>5C$QCGCD90C@;OD8JV2/F&1[\6-4U+1I?%5IXETK57M]0AMVM)
MDFTZ=H[B$G<%.%!4AN01GTQ69JT&B:GX<UFQ&MO%?ZS=)<W=V=*G8?(4*JJ<
M8 " <D]SWH Z9->UC2_'(TK5Y[.>RN=.EO4,$#(T!C905R6.\8;K@<CH.E4[
M7Q-XFU"VT36-/L'N;2_DC:XM/LX416[C(=9"W+*",\8/. *KW6I:5>>,+'7)
MM7!BM[*2TDMO[*N/W@D(+'=V^Z.,&LWP])'H'EZ6GB^XE\.P/N@MFTF83JF<
MB(RX^[^&2..* -ZP\7SZAXFN-(:_@LM2M[]HVTRYAVM+;!B!)$Y(W$K\W&>X
MQWKNZ\NOKC2M8GLQJFK+.EEJ7VZWN%TNX6X11(76(-@C'12W<#IGFNRT(ZV-
M<UM=0O8[O3_-4V16W\HQ<MNCS_'M 3YO4D=L  P/C/D?##4"!D^?;8'_ &W2
MLCXFWUY/#H::OIS:5I$6IPSSZH)5F,!4G: J\KDG&[H/QK>^)EO;:OH']AW&
MJ#3Q<LDID^PRW!(1PP V$ <@=:Q?$-S8^+;&+3-;\0C^S/-22X@L]&N(VGVG
M(4NQ;"Y Z#/'6@#J8M:U!_B)=Z 9839C2EO8G$?SJ[2%,$YP1QGH*YZ#Q[J$
M?@C3]:U+;%')J4UK>WEM;,ZVT2/(HDV9/4H@).0-Q..@I-0U+3V\80:_I.M_
M96-E]@N(IM*GD!C#[PR8 PP)(YR/:JNA75OX?T6UL+7Q)YPANYIW672+C;,D
MA8F-L#KEL[L=NE &MKGBG5=.\ RZ]8:CIE\!=1K%<1Q[DEA>5$&,-PPW<YSR
M#P*N:AJ_B!_B'_PCMC<V$-M)I37B326[.\;"4)R-X#>WW>O.<8/)7-CH,GA'
M4M#L]7%G_:.H"_E*:3.8XB'1@D:8&!^[7OW/ Z#9.K:<?'$?B3^V1A=.-B;?
M^RKCG+ARV[ZCICI0 _2_'.HW&B:;!<1Q-J]UJ=QIS20Q$I^YWEI F>I5!QGJ
M<]!BI)_$OBC2M-UV:\TN6>"S>%K2\6WP\D+L!*6B#9+1@L>,!L=JYLZ=I7]A
M&V3Q--#J4&J2:I97T.DSKY,CDEE92#N4[B.HK;@UZ0Z;(UUXK9]69XBDJ:1.
ML"(CABGE]3N&03N[C&,4 7CXON#X4U/7-*OX-;M(C%Y$EM#F2-2P$I>,')95
M);&%R /<UL>%-:778;B[M=7M=4TX[/(FA0*ZG!W+(.S=#T'!Z=ZY""XTJTN]
M7U.PU9;#4M2DMG;R-+N#"/*;)W+@%BX+!CD<$>F3>T+4O#NDZYJVLM=;+G4A
M$)8K;3YTC&S=\Q^7ECN.3QT'N2 ;WC[0&\2>"=3TZ('[48O-MB.HF0[DQZ<@
M#\:\Z\2>)I]>\.^%_&&GQJ\^B1)J=]M'S ,XBDC'L=LQ/M'7I/\ PG'A_P#Y
M^KC_ , I_P#XBN6T,>#=&TW7+!;FXDM]7N)I94-C.-J2#'ECY.@RV/J: .IT
MN9-8\07NJ0.KV]O EI:R=02P$LC#U!S$/JAKD[OQKXA@^'OB;65>P-_I.ISV
MB_Z.WELB2*G WY!YSR36EX4UCPYX6\*V&BPW]Q+]EBVF4V,_SN>6;&SN2>*Y
MJ>UTZ?PCX@T%O$8']L7\EXTXT:X_=>8X=E"YYY'!S0!UEWK6OZ3?VFGWT]K/
M<:K.YM?LMLQ-O$D>YP06^=LX /'4DC^&M'PO?Z]<W.IVVM696&WE7['>&,1F
MXC89.4R<,IX)X!XP*YCQ-?:5K]GILUOKT]AK>FR^=;7L6FSE0Q&UE*%>58<$
M9_/O8@U#5+[P]J!LO$YDUXB,B==*=8T4-]R.)^I.2,Y)Y[ # !Z%7E-]KS^&
M_BAXPU0:9=WZ6^DVLCI;;<J!NY.X@X^@/ /%>GV9N#8VYO%1;HQKYP3[H?'S
M8]LYKSRROM-L_'>I^(9M:$D=]!';O:C2;@%53H=W.>ISQ0!-X,A3P;\/=7\0
M7-Q!=1W<D^LF.S8F)%90PC0D#L!S@<GVJ];:OXJ?5=**VK7%A>*1>'[-Y8M"
M5RKH2WSKG@@\]^.E86F+H&F6VKZ,FLRR>&M0\S;IS:9/OMA("'6.3'"Y)(&W
MBG>&M1.D"WL]2\83W^EV>!;QC2)HY7 ^Z)'P<A>.@&2!D]B 3S^-M<C^&.I^
M(0UG]OL;Z2WQY)\N15G$7(W9!P<]>M:#RZJ_QG%J-146<>BB=83#D*&G"L <
M]3L'S?I7)WEC9W'A_6O#\7B?R=+O[MKJ$?V/.TL9>42%6;H5!!Q@ GCG'!WY
M=3TUO&=IXBBUYD=;$6-U$=)G/FJ)-^4./D.<CG=Q[\T 21^+/$>J:79:[HE@
M]U!/.#]A^SX#6^XC<)2P^?'S=,=L=S9M-6\5ZIXPUW2K:[TN&WTFZM<LULY,
ML4B!V7[_  V#U]AP*Y[1_(T*633K'Q;<+X::5I$LSI,QFB5CDQ)+CA22><9
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M"TEU<;AEHY++Y<?[S;E/OS7HVA:K!XLU6SU>V.;.VL$D3OB:<!B#_M(B@?\
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MXAD&5WKV8<@XQS@CTKH;_6]1MO&OAK3HY8S::I;7+S(T8)5HT5@0>O5N1[4
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MG5=,DA2ZM;TRJ9HRZG%M!D8R.??GZ4 =_5*PU2WU&:]BA2=6LYS!(98F0%@
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M(ZN54D#\<5QT?B'7FU+P=';:A:W,.O6[S7!>UW"';&)"8]K*0ISM^8M@D=:
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MCJ>N3["75$T_6=%@COM;UIM:M[I+R#4DT*Y412IPH6/R\;,$_+GG).:]2HH
M\ST^\BC\81^(]0UB^GG&G_87A@\.7<2,-^_(RK$<X]>_2NEO/&&FS6DL5N^H
MQ2NI"N^BW;A?? 09_.NGK*U[Q#8^&[*.[U#SO*DE2%3%$7^9F"C)' Y(Y)%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXK6KRW3M/UZ_U_QS_8FMC3)H]25D_P!&27S'\A,!BV<+]!GW[46WB_7]?M_
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MQ9S1J8/LZR%2A(4OOVC.<CYN.!5+QIXAUK1[7Q'>6NJCS=/6.6TM;6)9$1,
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M(,J0W\2D<#'%1Z)KNLW.C:CH][J3GQ);:I]@\X11CY6.]) FW&WRLMR.=IH
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M5 S/)N4Y&YL8&. >YXY^S\9Z]KUIX(NK:YBL&U:>>VO8O(#KOC60%@3SC*9
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MX&+BXN%5?,&,;0J@!5 SP/4GDDUB+\.-''A?2]"9YGAT^Z2Y25CEW*GE6/\
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MC:4G ;J$=>O4D$X(H O:GKVI7MK)>6^HRP"31$O;:RL5#312LI8R2EEVA!P
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M4-5NUOIK@ZE<?:94D50%? 7Y<#., #!STJQXET./Q+X?N]'FN);>&[3RY'B
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M)A'N'7]YMVXXZYQ1#X2M3KD.M:E=W6IWUNI6V:Y*A+?/4HB*%!/]XY/O704
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MTAT)6%K!&JE3N38=Q(R>/?J<TZ'PCY%_K]XNIS^9K843YC3$>U-@*<?W?7-
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M*A#HV-Q; '/RC&,8Q59_A]:S:#KFD3ZE=O%J]X;Z20!%:*4LK97 QC*+P<T
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MS0DYV.IZ@'D8((-4=1\!VFH>'KO23?7,7VV[%Y=W*A#)-*&5@>1@ %%& .@
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M>,DU[#:0&VMDB,TLQ7_EI*06/UP!0!-17EVIZ]JME)97L&JSWDC^(8[2:6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N%^*X\WPK;6ZM()'U&U8>4,NJK*I9@,'H.<XP*[JB@#'LM#A&JIK-Q>27]V
M(/)@E<*%CC)!.T* ,MA<GV&,"N?7X8V*Z5'I7]LZJ-/M[M;JTMP\8%N0^_"G
M9EAD_P 6[ Z8KN** .>D\**NN7>KV6JWMG<WL4<5UY8C82B,$(WS*=K $\CC
MGI4=[X(TVZTG2M,@GNK*UTRYCNX%MV4EI$)8%BZMGDDGU)YKI:* ,,>&8/\
MA+&\1->W3W+6?V)H6\ORC%NW8QMSG)SG-9FB_#ZRT*Y"VNJ:H=+CE\Z#2WF!
MMXGSN&.-Q /(!.,\\UU]% &=KNB6/B/1;K2=2B,EI<IM< X(YR"#V((!'TK#
MM_ NW4='O[OQ#JU[<:3Y@MFF,0^5U"D-A!NX'4\^]=;10!S$/@J"WBU=(M6U
M)7U.[2\DD#1!HY592"GR8'W%&#D8I\_@O3=0&IMJS/?RZE;):3NX5/W2DE0
MH&#EB<]<X] *Z2B@#F] \(C0U'F:WJNHM%&8K9KV56\A>GR@* 6Z?,V3CCH3
MFM%\/-*3PJ?#\EU?36ZW!NH9G=!-!,7+[T95&"&)/(/7'2NMHH P4\+Q23S7
M5_>W%[>26C6:SR*BF*-OO;0J@ DX)//0=N*+3PQ'%J5A?WE_=7]QI\3Q6KW
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M_GH05DR1MR, 8QC P *Z6B@#E[?P5'!K5QJ[:SJ<M]<60LY9':/YE!)W;=F
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MC9PK#;6\8CBC7HJ@8 K#_P"$/AD-M%=:C=W5I:WOVZ&"8)\DH8LHW!0=JDY
MSV R1Q7244 <];^$+."^UZYDN[N?^VU"W44A3: $V#;M4$?+QU-9\_PYT^Y\
M-6&CRZGJ;/ISH]C?"55GMBHVJ%*J!@ 8Z<]^>:[&B@#FU\),N@W6G_V]JYN[
MK;YFI^>!<#:<@*0,*.HP!_$>Y)KHP, #)..YI:* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*M93M<&.*2+"B<,3Y84#+#ZX .1E5EB;PM\44',ES<W1@7;S,&@55*_W@6!
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MD-D;R.*&WD(=,X!+;< 9(SD\9YKH5\060L+:YE^T*UP/DA^RR^:Y R<1[=Y
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MQ(MOKDT$<DJ-)Y406,+NV+A$R3R<#.:[F_UFQT[8)GD=W0R+';PO,Y48RVU
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M8U%_MSW<:W>@W*>9%J!^10\0/()7!++D?+SC!K<TR==/^+/B9;J.:,7MK9O
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M- T31NY-U*5/R2M@Y4Y)()&<>U;MAXQ@O?%^LZ)]END73HX293;2$,S"1FY
MP%PJX)QN.<9XH Z>BN9T#6=$M_"SZE;ZO=W>GBXE'VF]+M(7,A&P @,?F.U5
MQGH!FK]KXETRZO+FR#S17EO$)GMIH'23RST=5(RPSQQGGCK0!KT5RUM\1/#-
MVEA)!>RO!?3>1#/]EE$?F;BH5GVX4DC@$@]#WKJ: "BJE_J5MIRQ>>SEY6V1
M11H7>0XS@*.3P"3V'>L63Q[X=BTI]2ENY4MHKG[)-FUE+0S9 V.H7*') Y S
MD4 =+15.35+6+4+:Q<RBXN8VDC7R7(VKC<2<87&Y>I'45G+XOT9KZSM3<2)]
MM)6TF>!UBG8#.$<C:21R.>>V: -VBN4E^(_AF&"YG:\G,5K<&VN76SE(@88R
M7^7Y%R0,G )SC.#75*P90RD%2,@CO0 M%8-KXRT2\NK.&&YD*WSO':3&%Q%.
MR9W!7(P>AQZXXS7-7VKCQ!XVU?0)KC6+2UM;&+R7LH[B)UF=GS(2HY "KMW9
M4\XSF@#T.BN0\(^,+;5/#L]W=M=11V4CP-/=0,C.(VV;F.-I=B,E5Y!.,5I)
MXPT<W%Y;2RSV]Q:0?:989[:1'\G.-ZJ5RRYXXS@]<4 ;M%8.B>,=%\17*P:9
M<2S,]L+I6,#JC1DXR&( )R<$9R/P-3ZGXFTS2KF2VG>5YXK<W4L<$+2M'$#C
M>P4' R#[G!QG% &O14%G>VVH6$%]:3+-;3QK+%(O1E(R#^5<S<_$OPK:1W$D
ME_,4MK@VUPR6DK>2XQG?A?E'S 9/!.<9P: .MKGH?#ES%XYN/$AOXF2:S6S^
MS"W((56+ []_7+'M5U?$6EOJUOIB7):ZN;<W, 6-BLL0QEE?&T]1W[UR'CSQ
M)#>^ M1U#1=3NH)-/U"*VF>/? RN)HU=&R <8?Z<T >AT5S^F^,M#UG5YM(M
M+N1;Y(_,$<L#Q&1.F]"Z@./<9_*N6T/5(X_ _BI]=UG48[6#5KVV-XDCM/#&
MK[5VL 2, <<8% 'I-%93:Q8V%I8H9IYWN(@;>-4:2:50H)8@#/0C)/&2/45-
MH^M:?K^G+?Z;<":!F9"=I4JRG!5E(!!![&@"_16#?^,M$TV6Z6YN9!'9R)%=
M3)"[1P.^-H=@,#[P^F1G%+?>,-%T[5Y-*GGF-^D'VC[/%;22.Z9 ^4*IW')Z
M#/0^AH W:*YQO'7AU-#LM9:_*V-Y,((I3$_^LW;=K#'R$'(.['2K6E>*=*UC
M4+NPM99ENK55>2*>W>%BASAU#@;E.#R.* -FBL)/&&BR36B?:9%CO9/*M;AX
M76&=^RK(1M).#CGYNV:FC\2Z7+/JD"32F;2@IO(_L\FZ,,"RD#;\V0"?ES0!
MKT5SLGCGP]%!I4[7Y$6JKNLV\B3$HP3_ '>#@=#R?2K&F^*]'U2SO[F&Y:)-
M/8K=BZB:!H,#=EE< @8YS0!M45CV?BC2[W5!IBR317CP?:(XKB!XC)'G&Y=P
M&?<=1Z5$GB_1GOK2U\^5#>Y%I*\#K%<$#.$<C:>.1SR.F: -VBN5E^(OAJ&U
MN;HW=PT%K<-;W+I9S,('7&=^%^49.,G ZXSBKUOXOT6ZUN'28KF0W,Z,]NS0
M.L4X49;RY"-KX')VDT ;E%85]XOT;39,75Q(D(G%N]SY+F%)"<;6D VCGCK@
M'@X-17GC?0[*_O;!Y[B2\LD5YH(;261PIS@@*IW#@Y(R!W- '156O;**_B6&
M<L80P9HP<"3!R W?&<<=^AR.*YO5O'NGV=GH%U8I->6^LW,<4,T4#NH0Y)/
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M/OAD!P4=,;E.<=0.H]: .AHK$L?%FCZCK3:1;SR_:_*,R"2!T65 <%HV8 .
M2.5)IEOXRT2YN;2&*YD*7DKP6LYA<132+G<JOC!/RMCUP<9H WJ*\STGQG9^
M'-8\6QZYJ5]-#;ZD!'F.2X\B+RD))V@[$R3Z"M3Q+J3R>(O!%UIVI3&ROKQE
M9893Y4\9A=@2!][H#0!W%%8FJ>+-(T?SVO)IA%;,JW,T<#O' 3C&]E!"\$'V
M!!. :U9;N"&S:[>3,"IO+H"V5ZY&,Y_"@":BN3@^)7A6XFL$CU%ME^P2WF:W
MD6)G/12Y7:&/H3GIZUIZKXHTO1A<&[DG*6JA[EX;=Y5@4\Y<J#CCGUQSTYH
MV:*YW4/'/A_3)XH)[UFEEMC=Q+# \GF1  [E*@AN"#QGCGI3-,U?1]4\6,]G
MJ=\]V^FQR_8W#I"(6;*R!64#><XSG.!CM0!TM%81\8:(LD&ZY=8+B;[/#=&%
MQ \F2-HDQMY((!S@G@&IM4URPM9)K&26Y:=8?-E6TB>1XHSD;CM!V]#CN<'
M.#0!KT5Q_P +;VYU+X;Z1=WEU+=7$JREYIG+,_[UP"2?;%=A0 4444 %%%%
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M[4Z_\-/#'AJV@G&J6[V8G62!D-D82ID9MP&TX5@/7/&:Z'1Y!#\5/%<\J2I
M]I:*DK1,$<H)-X#8P2,CI7<44 >*Z9'J6G_#GPEJ<6G7D_\ 8NK37%[9"%A*
M(F>8;PA )($@(^M>G:!JUEKDUQJ&GV$L4$BH&NY[9H'G89XPP#$*.YXYP.AK
M<HH \_U*[E\/?%<:KJ,%RVDWVEK:0W,4+2K#*LA8HP4$C<#G/<_2N7N1//\
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M#=@X#'UKV.B@#Q6YLKNX\%?$C3[?3M3:::\-Q"LT$A>2,I%@@MRQ.TG'48Y
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MO'-M& \;J"&! S@<@\8H T=)O8=(TFY-]K8U%8[D^7/O$DA5V_=H0@Y;)V@
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M%C%+"_E[U(9#T(P00:Y6YFN/^$&^&5R+JY666]TV.4K.P$JLF2'&<-R ><T
M>J45CWWB.UM+JYMHK>ZO9[2-9;E+6,.85.2,Y(R2 3M&6QVY%5CXTT=AHLD$
MDMQ;ZR^RSGB3,;-@G:2<;3@'@^A'48H Z&BL6S\3V=]?ZM8QPW*W&E &Y61
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M,''H1V(/%7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLS3QG:-B\#?&K$G)&#P!D5PT>DZ[!H$LUOH>H[]*\6MJC6DB_/<0;CPAR=[
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M^QR%HD25F9B-O3!'U[5['10!P+P--\2==GN+"\;3Y]$CMS(T#I'(RM(60.0
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MA/0 \X&3UQ6]10!P.A&Z\*^(O%%MJ-E>SV^H7IU"SN+>V>99 Z@&,[0=K+M
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M@(ML@,1*ET;*@D'CCG)&>J\#W=@]WJJK::K;:I>3&]N1J-F;<R9PH*#D;5
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MQTKH(O&FEVUEI\\B7PTNY=;>WU.4*8I&/"ECNW ,1PS* ?7D5D6FG75]XO\
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MI8;F+$951GDFMBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***S=8URQT.")[R1M\\@B@AC4O),Y
MZ*BCDG]!U.!0!I45A2^*$LY+5-0TK4K+[5.EO"TB(ZL[D  F-V"]?XL>V3Q6
M[0 4444 %%%% !116#9^*[6^\1:CH45G>+?6$:R3*ZH 5897:=W.?T[XH WJ
M*PO#GBJS\3PWLEE;7<8LKA[699T5&$JXW+C<>1D>U4[CQS:6]K9W#Z;J(BN]
M2&F(Y6/ E,AC)/S_ '=P;D9SCCM0!U-%%% !139',<3N$9RJD[5ZM[#WJMIE
MX^H:9;WDEG<6;S('-O< "2/V8 GF@"W1110 4444 %%85YXIM;+Q/9^'Y+.\
M:\O$:2 HJ%&5?O');C'O6[0 4452FOY(M7MK$6-U)'-&[M=*H\J(KC"L<YR<
M\<=J +M%9/B37H?#&@7>L7-O<3P6R;Y$@"EL>O) K3AD$T,<H! =0P!]Q0 ^
MBBL6_P#$MO92WT45I=7KV$:R72VH0F(,"1D,P). 3@9/YB@#:HJIIFI6FL:9
M;:C83":UN8Q)%(!C*GV[?2K= !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"YL_M#@!I%CD*J6P ,XQ5B#PC';^(K?6_P"U;^2Z@L38@2>659"P8D_)G)8
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M0Y+$8&,'@]N1Q0!TM%9]EK5EJ%W+:P-,+B)%D>.:WDB8*Q(!PZC()4_E6A0
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MXE(R&*E=Q4@$Y (P":LCQ)I3:+;ZNMP[6%RR+#*L$AWER%3"A<\D@#CG(]:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%O6K>KW-MXOUOP?=:++O>SO#=W,@&#;0^60R2?W68E5VGGKV!KT  *    .
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M>Z,G =-P&]<\;AD5<U/5K+2((YKV;RQ+*L,2JI9I)&^ZJJ 22?;T-<FTJ/\
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M\Y%;- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ!\/WTFF"":Y,6IL$MKAK6187<@D)O(VAC@\9S^-=+-*L$+RN'*H"Q"(6/X
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M[Q&1EMH;/'K71V\[:Q\2-5N;2TOOLMWX?2"&XEM)(T9]\AP2RC'![XS7H]%
M'C%M=3R^"O >G+I6J_:=)U6T%\AL91Y/EAPW;YO7*Y '7&1G<TK4YO#6M^(]
M$UC1-1O$U+4);VRD@M&FCN4E _=D]%*XP=V!CKQ7I=% '"W2W ^*F@3/93*D
M>E3Q2O%"[0QR,R$+OQC^$_E7(3W5]J.F>'KJYT?5H;VS\0Q2W=E!8R)!:()'
M^XJKB3.02PW')/(SBO::* .(\*F3_A8OC.9[2ZBCNGM&ADEMW19 D(5L,1@X
M;C@U1O=%O;7X@S:9:HIT7Q"HOKQ<_P"J>$J),#TE!C4_4UZ(1D$ D9[CM6)X
M?\/2:-YDUYJUYJM[(H3[3=;05C!)"@*  ,DDGJ?P  !N5XPLUYIWPP\3>$+_
M $[46UE/M?EF.TDD6[61V<2*Z@KSN[G/&.O%>ST4 >;/</IGC3PSK-S8Z@+.
M31)+(E+.5VCFW1L%9%4LN=IQD=JPY[+4;OX7^-;9-*OUNGUR:Y2!K=MSQ_:4
M?*=GX5OND]*]EHH X+7KHZAXS\#7\%E?FVCGN7D=K.0>6K0LBE_E^3)(X;!K
M"LA;Z9?ZUX>\1>&=2U"6YOYY[22*!Y8;R*5RZ@L#M4@G!W8 QUKUJB@#ROQ)
MI\UM?ZC?^'WOM,U^VABB^R) \MIJBB-=J;2N#C)3(.5 R<=:]1A:1H(VF0)*
M5!=0<@''(S3Z* /')=)U>]\">*M$M+"[&I0ZU-?+')"R)<1BX$BJKD8;<HR,
M9Z<XR,]/J6/%_B'PE=Z=#=1C3[E[NYDF@>(PKY97RSN ^8L0"H[ GI7>44 8
MGC&UGOO!.O6EM$TMQ-I\\<<:C)=C&P 'N37$W5Q)>Z;\/&BT_4@+.]A-P'L9
M08PL#(S,-N0 QQD]>HR.:]1HH \GUK2M2U?5?B-;6%K<":\MK(VCR0ND<[1*
M2RJY ![+U[UM>&M0TC7-1LKR+POJ%IJ%FKF:6_MY%-H2I#*C-]XDX&%[9)QP
M*[ZB@#Q>XM[M_@]KMD--U W4VLM+';_8I=[H;M9 P7;DC8"<U[+%(LT2R)G:
MPR-RE3^1Y%/HH \Z;4I_"?Q"U]]3TS4+G3M:$$MI<6EJ\X#)&(VB8*"0>,CM
MR:=,EWH_Q!TG7[G3I(-)N-(;3VCACWBQ?S/,7>$S@$84D< CKC%>AT4 >.^)
MM&O9O#7Q#U*VLKMX];EMULK9+=S))Y:JK/L R QW=1T7/<5U.L2-<?$OP?=P
MVUV]O%;7@EE%M)MC,BQ[ QVX7.T]:[FB@#Q3Q$)$\#_$UI+:YB6?4%FA,L#Q
MB1/W*[E+  C*GI78ZM"/$GB_PK=:=#,5TMYKFXF>)H_+5H]HCRP'S,Q&5Z@*
M<]L[_BWP]_PE7ARZT5KLVL5T ))%CW-@,&XY '('K6Q"LBPHLSJ\@&&95V@G
MZ9./SH \9:ZO=0T_PK>7&D:M%>6>O))>6<-A)'!9K^]&U$  ;J#O&X\G)&0*
MWK?SA>_$EVLKU5NU4V^;63]]BV"'9\OS?-QQFO2Z* /-)])N;GX.:'<P(]MK
M&A65O=P"=#&R2PQC>C!L'! 93VYKL?"\$XT@7UY$8KW47-Y/&3DQE@-J'_=0
M(O\ P&F:QX=EUG4X)9=7O(M/6/9/IT>T17'.?F)&['8@'D<=SG=H XWQ;?W%
MKXFT*%[.Z&GRK,);ZSM&FFC?"[8P54M&&YR1R<#D8)KA$M[R/P#/IYTG55GC
M\3B;RVM9'8Q_:=Y;(!W *,ELD>YKVVB@#S/Q+8WNK^.M7BL(;E3=^%);.&Y,
M#K'YS2$A-^, X.>M9EWJTFH^$/!]BNCZK'?:9JE@+VV^P2YA$7#'.W!'&1@G
MBO7Z* &EP(RYR !GH<_E7CIL;Z7X,ZM;)IU]]I35VN?LYMG61H_M@DW*I&3\
MG/%>R44 ><^*(H-6U6/4["ZUC0]7BL ]I?I:R%)U+O\ N9(RN#RH;8<-\XXX
MQ79^'9;^?PWILNJ6R6U^]M&9X$&!&^T9 ';Z=JTZ* /+;FUNK+Q%)J/AF34(
M+J?5ME_HMS S6]R/-VM<(6&$^4;]X..,=>"VXTK4;X?$;08;6[BN]3D,MK*T
M++#(A@0#]YC;R05QG//3@X]4HH \TU#S?%_ASPQIMO9W=MJ-M?6L]TDMN\?V
M/R>7)) '8A<'YLC'&<-T34I_#M_K_AS6-"U"\DN]2GNK-XK0RPW<<K;@"WW5
M(Z'<0!7IM% 'D7BK2=7U/X@75UIZ3Q7%II-O)'NMW-K<S12NY@8E<,"",>^#
MVK3\2:Q)XCT/PI>QZ3JD$RZW:3W-M)92[[=4)WEOE^Z/7H:]*HH \OUW2[[6
MO%GC"TLHKF,W^@1VMO.\+K$\H,F5WD8Z,!U[TZ^6;Q9X/\.:/#97=MJEO=VC
M7*2V[I]C\DCS&+$8Z A<'YLC'>O3J* /,;[3K_4_$GQ$M+2"YBEU#2X+>TF>
M%TCD=8Y P#D8ZL!U[U0O-7?4_#'@RU32-5CO=-U6Q^VVYT^7, B!#'.W!'&1
MC/%>NT4 >41-;Z1K^OZ1XB\.ZG?QZC>R75E-;V[RQ7$<@'[ML'"E>0=V!CK@
M==C3X'M?BO:8TZ:WMH_#B6@,<#F"*02AO+#XV\+[]J[^B@#RW4;6ZM-?N=4\
M,2:A;ZA)J2I>:/<0,]M>CS IF7(POR@,74X^7'7KZ?+(L,3R/NVJ,G:I8_D.
M33Z* /&+2VO(O@[X3LGT[4!=V^IV[S0?8Y?,C5+@LQ*[<@!><UU&B3R^&_&/
MBA=4AN3;:G.E]9720/(LJ[ IC^4'#+M "GDCI7?T4 >06VA:AX;\->"'NK*Z
M9;369+FXA@A:9K:.42E050$\;E!QT)KUV-M\:N59"P!VMU'L:=10!XU'INKS
M?#:?3;73;TZCI.M->RVSP,@N$6Y:0*A( ?*D,-N>@]1GJ[Q!XI\:^%=3TZ.X
M6#3!<3W$TL#Q;0\801_,!\Q)R1V"\XR,]U10!R/Q/LKK4/AOK-M96\EQ<-&C
M+%$I9FVR*QP!U. :SM5O/[1^(7@O4(++4/LL<=[OD>RE41[T4)NRORY(/7%=
M_10!YAXLGO;W4/&&E2:9J";],VV'V*U;%\3"V6DE4<[6.T(6 QGAB<56TRZN
M]$\0>%]>O=/U'^R9?#R:8["UD9[6=65B70 L V ,X[#M7K%% 'C,UGJE[I7B
MJ>QTF^DDB\1Q:I';2P/$;N%!'E5) Y^4G'7CIFNT\*W.CZQJG]J:;X?O;65+
M<Q27=];O%(N2#Y2[^6YR3C@8'K7944 <7X^M;X7/AS6;6WFNK?2M1$]U!"A=
MS&RE"ZJ.6*[LX'/)JI<VYU3QW+XCM8Y_L%KHDEJ\HA<&>1WW!%7&6P 2<#J0
M.N<=_10!X_#!=1_#;X?VS:??BXL]5LWN(OL<N^%48[V8;<@#/6O77E6.%I6W
M;5&XX4DX^@YI]% 'C$-M>)\#M&T]M.U 7L5_$SV_V.7S%"W6\DKMR!MYS74:
MC)<CXJ+?6UA<W"+X>FB1C XC>4R*ZQE\8!('>N_HH \<L;BYNM2\!ZD^F:OY
MMO-*EY$+"2*&U=H&41I'@ *&.-V#P/F:K4FEZI=Z'\0M"MK*Z34+K4Y;VV+P
MLL4L9$14"0X4[MA7 .?7%>LT4 <!X<U+1]:O[.^C\+ZC:7]DCM/+?6TBFTRI
M#*C-]YB<#"]LDXX%1>!UFM?@ZUK<6=W#<Q17:O!);2+)EI)"N%(R<AAT'>O1
M** /*M/O+W3?#/@&UGTV^AMA;&&]N8K!WN+5UC " ;2R;R2"P&<#@C.:RIK6
M]_X5?X\TQ-*U47,^JW+P1/;R.\BNZE<'DOP"203[GFO:J* ,$^)[.WUG2M'>
MVOA+?PEX9S;,(@0"=C,?NMA3P1V^E1^/4DE\ :_!##+---8311QPQL[.[(0
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M7D<1,2%5D5BS]%(+ XZGM0!O'QKI"+;3N9TT^ZF\B"_:/]P[DX W9R 2,!B
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MW1.APV1W )QQFDU7QSI&DZE_9\R7TMX;0W:Q06CN70$?=P/F//;I@YQBO/\
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M6'3-*O\ P"UKJ]@8UFO9K*/[."F 98Y>K,0.-O()]!FO2U!5 "Q8@8)/>EH
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M'D]<8KUNB@#&L_$*W7B:]T1].OK=[>,2QW$T>(KA?EW%#GG!8 U2^(5O/>>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM YYY.0,<U=2@O?&4GA</IMW82:?J$>H7IN(R@B,:-^[4]'W,PY7(P"2>@H
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MP/+I=U#J<C20222Q_N8T:8OYHD^ZP"G( .<XX[UN+;W^A?$F[NH])O;RTO\
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MLSP_K']O:+!J!M)[-Y"Z/;S@!XW1RC*<>A4UIT %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C>(_#
MEOXFL8;2ZN[JWBBG2<?9R@)=&#+G<K=",ULU1U35;?2;9)9PS-+*L,,28W22
M-T49('J<D@  D]* +J*515+%B!@L<9/OQQ2UR,OQ!L;5-;2[L+R.[T> 7-Q;
M+L=FA()\Q"&P1P<\@CTI/^$_MTO-,AFT;5(X]4B+V4WEH1,X3?L #;E..A8
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MCOQ4OPYY^&_AS_L'P_\ H(H Z>BL[5-8@TR6TMS')/=WCE+>WBQN<@;F.20
M !DDGT[D Y<7C:P-A>SW-M=VT]G>"Q>VD0%Y)F("+'@X;=N&#GZXH Z6BL"'
MQ3$=;;1;NQN;343;FY@B<HPN$'!V,&QN!Z@XZYZ<UCV_Q,L;C2[#51I&J)IE
MW<_96NG1 L#F0QC<-V2,CJH(&>N<B@#MZ*P+SQ3%;W.I0V]C<WATW9]K\EDR
MA90XPI8$_*03^F2"*E@\217'B#4M$2RNOM=C DYSLVRJY(7:=W7Y3UQ0!M$@
M=:*\R\6ZS9^*? _AW7;6&>**76;3RUFP'7$^PY )'\/J:Z%/$VH2?$B?P_\
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M!D G'J,'!%);W8\-6.AZ [2W^HR6YCCRX!D\I1O8LQ]QZGGZD '1453TR_\
M[2L$NC;36Q9G1H9P Z%6*D'!(ZCL34.JZS#I<ME T;2W-],8;>)6"[F"ESDD
M@  *: -*BL/_ (2:%+..6>RN8;F:Z:TBM'V>8\BY)P=VW&U2V<]!^%4K?QYI
M;+JZ7D<]I=Z4\:7%L^UV8R8\K85)#;R0!WSUQ0!U-%<T_B]8+V]L;K2+^&ZM
M;+[>(_D82Q X.U@VW<".5)'MFC_A-;'^S_#M]]DNS;Z])%%;MA/W;2*64.-W
M' /3- '2T9!Z5R:^.HYM;O-*MM"U:XGLKJ*WN3'&A$8D&1(?F^[@@^OM6+/X
MJL]'\%>+=:\/:+/%<VE_.MS'.RC-SA=\I^8_+DC@=<=!G- 'HV0._6BN/U35
MM/>Y\+C6M&O/M5Q> 6;LR8AFV-\S%7QRN[CG\*MZQXSM=)@U"X6RN;NVTTXO
M)8"G[O #-@,P+%003C]2"* .EHKG)?&-H_GG3;6?4A!9QWTGV<H#Y4@)3:&(
M+$A2<?3OQ70QN)(U< @, <&@!U%8EUXEAM/%5KH$EE=>?=P23P3_ ">4X3&Y
M02V=PR.,=\]*IV7C6VOM&U344TV^0Z==-:2VS^7YK2J0"J@/C.6&,D9R,4 =
M/D9QWH) ZUYK%>R:7\5?$,UMI5Y>3RZ7:R&V@*[L[I,Y9F"CMWY[9K3U3Q1X
M?UCPOH&K76G7=W8:A?6_V8 !3#.9,(7^88PV>F1QWH [?(SCO17#>4D?QS#J
M"#)X==FY/)^T(,_D!5Z?Q[I]M_9]Q+;7 TR_N%MH+\%"A=LA"5W;@C8X;'IG
M .: .KHR,X[T5RMMJ>E#QMKB0Z5=C5[:RA:XFX_?Q9;8$&['][J!0!U5%<59
M_$FQO;31K\:3J<>G:K.MO%>2(@1)6)"JPW;N2.H!'/6NUH **Y2_\<1VNMW^
MC6VB:K?7]G"DQC@C3#HV>5)8#''?!] :DL?'>D:GH6GZG9K<2MJ$QMH+3:%F
M,HSN0@G VA222<8'N,@'3U"EK#'<RW"I^^E #N222!T'/0<G@<<GUK!7QKI\
M+:O#J,4]C=:3;_:KB&4!BT."?,0J2&7@CU!X(%3-XHCMH+JXU"QN+2WM[)KX
MS%DD1HUY(!5CE@.WN,$T ;U%8D/B-,R/>V4UE;I:&\^TR.C1F,8SRK'D Y/;
MT)JI'XTM1K.FZ==V5U:'5%8V4LI0K(5&XJP5B4;'(!'MUXH Z:BL#3/%,>K?
M8)K:PN6L;\N+>[#(4.T,?F ;*YVG''UP>*--\4QZJ;&6VL+EK&^9U@NP4*':
M&.6 ;*YVG''UP>* -_(/0T5QNB^(?#UEIOB75(;.?3H;34I5O_.&6DN-J9(
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M\O;WZ 'H&A:Q'K^C6VJ06\\$%R@DB6;9N9",AOE9AR#ZYK#_ .$DU-OB9)H
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MUO>^*(]$2TF7SK(7UO=,R^7/$2!E><YY&00,5I:1JG]K17$JVSPQQ7$D"LS
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQS*6BD2102I*L",@X(_ UP]G%';_ !HUAX8 &?0X)'$8 ,C>:XSV&> ,FIM
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ME;<DB[R 1R01G/?FMG0O"^D>&Q<?V9;-&UPVZ1Y)6D8\DXRQ) !)X'')K8H
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MN;4721R6TT:[006P&4C&<=_U[;3A=BPB-\L2W+99TB.53))V@X&<# S@9QG
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M('8#<Q[#/4^U9M]X=L=0UNPU><S_ &RPWBV992JIO&&^4<'( '- ''ZIX?\
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M >V>W6N2C\)ZE>^)-5)T2/3-+U70OL#,MPC/"Y+Y+!?O-\P.02/]K/%>F44
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M)"6,$3;A$.R[L#<<=3ZYQQBKM%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8/BSQ-_PBNF07K6$
MUVDES%;D1L!L+L%!YY/7H ?PK>KA_BL9%\(V[1('D&J6952<!CYRX&>U %FR
M\:7;>)WT#5- GL+R6W:YL?\ 2$D%RJGE<CA7'<9/UZ9I:9\1WO/#X\1W>@SV
M>ABVEFDNVN$9E='V",)P26['UXZ<G0ETN]U3QCI^OW&GRVT6E6LR00.\9EFE
MEV@_=8J%"K@9/);MCG#T_P #ZC??!F3P?J*"ROMCA9-X=-_FF5#E3TS@'\:
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MF$73(76$N-Y4=2%ZXY'-3UYSJCWL'Q8T>XATVWDU&71KD-&D^$)$D>-TA4'
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M1*756"LK@*-K?,#P6'O0!TU%9FMZG<Z9!;&TT^6]GN;E+=53(6/=G+NP!VH
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ML50C:=N3G& .3Q6V+&/2O'7@N2VEN"VJ6ES'?>9.SB<+"KKD$X&#TP!CITH
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M=F\6(NSYV,9QNV[=WMTS_%WK5TN\.HZ197S1^4;F!)BA_AW*#C\,T 6Z***
M"BBB@ JO>V4&HV<MI<AVAE4JZI(R$@\$94@U8HH SM*T/3]$TM=,TZ*2"S12
MJ1^<[; >RDDD=>QK._X0;P]_8C:+]BE_LYI?.,'VN;!?=NS]_/WN?KS7144
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MK=RR31C&UP#RN?[ISC% &;>> O#.H3ZC-=:8LAU'_CZ7SI DAQC=M#;0W^T
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MV<0BB#,Y&22S,268D\DDDDD\DFJ5EX8TG3M9NM7M8)4OKO:+B4W,K>;M&%W
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MDUH444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYE# O&6^7/78,X3/^SBK-KX7T:RTR]TV"SVV=[O^T0M*[+(7R&)R3R<\D=:
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M36EU\4-,FLR6LKWPOYJ[ACS098]K,.YVFN6D F^'4T2R-Y8\8>7&4;[J?:P
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M:)IVOV#6.J6_VBU?&^$NRJV"",@$9Y /-6K6VBL[:.WA#".,;5#.SD#ZDDT
M>5V*1>(_AAK^NWY,>O02WLAN@<2V<D3,8T5NJ!55.!UR<]36A'=W=_XL^&=Y
MJ"[;R?3+N2=<8PYAB+<=N<\5V,OA31)KRXNGL1ON6#W"+(ZQSL.ADC!V.?=@
M:L76A:=>ZM::I<0,U[: BWE$KCRP?O8 ..>_KWH \QOM0O-!L/BA=:=+.)K>
MX@\M]Y=HPT2;F!.>@9B/3%=G;^'/#AU'3M2LIMD=U:O;B&%@8KY&7=NDXRY
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M=1@8/;%3#PYI8M[N%H)'%Y&(KAY)Y'DD09PI<L6V\GC..3ZF@#S?[,FH:/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%-:1%=49U#/G:I/)^E #J*:DD<F[8ZML;:VTY
MP?0^].H **** "BFI(DJ!XW5U/1E.0:=0 4444 %%%% !1110 4444 %%%%
M!12%E#!2P!/09I: "BFF1%D6,NH=LE5)Y..N!3J "BBB@ HHIJ2))NV.K;3M
M;:<X/H: '4444 %%%% !1110 44UY8XRH=U4NVU=QQN/H/>G4 %%-21)45XW
M5T89#*<@BG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;;ZU<"XU*.!5N)0<[GQSSW/OWH U:*** "BBB@ HHHH **** "BBB@ HHHH
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M3;O<(#DY[L.@K1FN;Y-7MK:/3_,LI(W::[\X#RF&-J[.K9R>1TQ0!=HHI#D
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M'VR^5%N-TF48("$&WH, G&* .(M[^X@T_P"(2W/B&ZLH[:^\J&]ES,UL&C3
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M ]/HKF_&DT4>F644E]<VQGOX8UBMA^\NSNSY .1M# ')R, '/%<3)/?PZ?\
M$VS,UQ:)I]NEQ:107CG[,S6Q<[7X(!(!*CC.>M 'K5%>6W*/H.@>'+N+4;TR
MZ]/96MY+<WC[ /*9OEY_=[B%4E<<>G6NH\/Z+?Z-XBOWEU&(V-W$KQ:<KN_D
MNN SJ6.0#D9 XS0!U5%>?W=A_:7Q<N]-N+W4/L$FAI.]M'>2(I<S,I(VD%>
M/ND9QSWKG]'U[4/^$8\(Z7<7MRT-[K-Q8SW32GS&BB>39&7ZY;:JYSG ([T
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M]1$5Q;SW,0BN1;7,D23J!@;U4@-@<<_2NCIDID$3F)%>0 [59MH)]S@X_(T
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MADLI"_VN5Y=K1 +\FU<?-D\'D8H N 84#).!WKFAX!\/+H=WHJVTXTZZ<M)
M+J7&"Q;:OS?*N23@8'-=-10!P&J:-+-\2]#D2+4A9V>GS0?:X]_R2,R[07_B
MX!SG(]:7Q_X>5?A[>Z1I-A<W,UW=0S.L8:225A,CN[-USM4\D]@!V%=]10!E
M6.B645RNH W,UR8?*CFN9&9XXS@[1NY7) SW.!DG K/;P%H#Z+?:0\-RUC?3
MFYN(C=R_O)"VXG.[(R0"0#CBNEHH Q9_#=D^JVVLA9Y=1LX6BMV>Y<#!ZJ1G
M!S@9)!KSO2O#6^W6&70O%FG:PQ9YOLFI&*U$K$LS(PE*A,DGH3CL3U]>HH H
M_P!G+=:&--U0K>"2W\BY+# FRN&.!TSS^=5-.\+Z;ILEL\?VF8VBE+7[3</*
M(%(QA-Q...,]<<9Q5?Q=XAN/#5A9W4-G'<K/>PVK[Y2A02.%W 8.[KTR*Z&@
M#DK)+KQ+XBM-1U'09M.CTAIA;FZ*%Y9&^7<FTG"[<]>I88^[75R()8FC+,H8
M8RK8(^A'2G44 <RG@+0(]$L]'2&Y6PL[@7-O$+N7Y) VX'.[/#$G!.,FK5QX
M1TFZU*ZU"=+A[FZLS8S,;A\-"<Y3&<#J3D<Y-:=E?VVHPO+:2K+&DKQ%EZ;D
M8JP_ @C\*LT 9%MX;L;:=)]]U-/% UO#+-<,[Q1MC(4DY!.U<GJ<#FJ/_"!>
M'CX83PZ;.1M-BD\V%&G<M"^2VY')W*<DG@]S72US]_XAN++QKI&@FSC,&HPS
MRBX\T[E,04D;<?[0YS^% "V/@W2+'5O[447<]\;86K37-W)*7CR3A@S$-R>_
MH*KZ-\/_  [H%\;K3K::(@LT41N9&BA+9R8T)VJ3D\@=^*Z>B@##LO"6D6&F
M:EIT$4_V74FE:Z1[AWWM("'().03GMBIK7PY8VUPMPS7-Q.D#6T<EQ.SM'&<
M9523GG R>IP.>*UJ* *.CZ3:Z%I-OIEB)!;6Z[8Q)(7;&<\D\GK5ZBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "N-^+'_)+/$'_ %[?^S"NRK/UK1-/\0Z;)IVIPO-:2?ZR)97C
M##.<':1D<4 <Y!X1DUJY\/:GK&H+/%I:)/:VL$'E)YNT8=R68L1VQ@5SEG9W
MOC3P[?ZD-9M].U*VU"?=>;7,MCY4IPGWP NP#*XP0<G)YKT^SLX;"TBM;<.(
M8E"H'D9R .@RQ)/YU@S^ /#-QK[ZW)IB_;9&#RE975)6'0O&#M8_44 <S;Z'
M#KOQ)\26=]>:@]M':V,Z1QWDJ!9#O.1AL@9'W>G/3IB&VNY](\3V4/B&Q=X[
MK4V.GZ]9R[TG+LVR&8=5P&V@<K\HQTS7>V_A[3;77+G6H8I5O[E0DTAN)"'4
M=!M+;<#)QQQFH;?PII%M+$R0S,D4YN8XI+B1XTE))+A&8@'))]B<CF@#A]/)
M\4>!O$FLWD\T.L07-X(YED*O9-$3Y:+@_*  I([Y.<YJ*R>Z\1>)O!DNIS7<
M;:EH,LUW!'</&CMB/G:#\N=V3C'H>*[N;PAHD]W>7+6LBF](-W%'.Z17!Z9=
M 0K<<'(Y'!S5B;P[IEQK5MJ\D$GVZVC,4,BSR*$0]5"AMN#@=NU 'GNDP:M+
MX4US2])G25[#Q'-!:VMY.V)X$*N;?><G!&[KV&#QFNG\!ZG:7T>K0Q:?=Z7>
MPW0^UZ=<G/V=S&H 0C@H0N1C Y/%:">"]"BAGCCM[A!/=_;G*WDP8S_\] =^
M0?I6EI^E6FF&=[=&\VX</-+(Y=Y&  !+$D\   =!0!S&O7K7/Q(T+P_=9&FS
MV=Q<F/.%N)5P C?W@JEFQTZ$]!7'>)8I(=)^).@,9)M)L;2&[LUD<M]G=T+%
M 3_""-P7H,UZIJVA:=K8MS?0EI+:3S8)HY&CDB;IE74@CWYY[TP>'=*&F7NG
MO:B2WO@PNO-=G:;<-I+,3N)P .O  QC% '#ZYIMN-6^'EG%YD,4D\Q;RY"&Y
MMFSALY&?;GTQ69<ZE<>%+#Q_:Z?<316EC>V8A+R-(;9)UC\TJ220!N8]>#7H
M">"]"C.FLMM-NTTEK5OM<V4)&"<[OF...<\<=*FC\*Z-'/J<WV,R-JBA;T33
M/(LP VC*L2.G' Z4 8%OX8EMM>BU"+6(8+*[M'@DL[/S$%R<%ED#>8<, /O#
MDCO57X4Z1#+X1T3Q!/<WL^HS631.\MR[*5+D_=)VY&.N,\GKFM_1? OA[P]'
M,FF6<D/G(8RQN969$/)5&+$H.GW<=!Z5IZ+HFG^'M,CT[3(6AM(L^7$97<+D
MYP"Q) ]J .1^)%C;76I>#7FBW,==BBSDCY3'(2/Q('Y57;1;/5?BOJ]C="8V
M@T2U4Q1S-&&'F2 9*D$X],X_2NUUG0M.\06L5OJ4!E2&99XBLC1M'(N<,K*0
M0>3T/>H(?"^DVVJ2ZE!!+'=RP"W9TN91^['10-V !VP.* //_#]^;_X?>#8+
M^^N[BZGO)8X[56!-\(FE 61C_ JJ&).<[>A) K,U&6\C^&_Q"@:>:W.GZFXM
MTM[I\0*5B.Q6X)3+-P1CGI7HW_" ^&_[*L]-6QE2VLIC/;!+N8/"Y))*N&W#
M.3D XYH?X?\ AB2WU"W.F8AU%@UTB3R*)",>C<9VC..I )S0!B-9KHOQ2\/K
M:3W1&IV%U]L$L[N)6C\LJQ!. 1N/0# X'%=7XF3?X7U4"26,BTE8/%(T;*0I
M((92"*1_#6ER:I8ZD\4[7EBACMY6NI3L4XR,;L'.!G.<XJ_>V<&HV,UG<JS0
M3(4D579"5/494@C\#0!Y65FN?#OPL9KV\1KDP13&.Y=?,4VS,<X/7(^]U'8B
MK=G97=OJ/Q \/Z-?M:(BVC67VB=V6*6:,[@&)+#<P X.03Q79?\ "&Z&+?2X
M!;3"+2R&LE%W-^Y(&!CYN>..<\<4LO@_1)[C4IY+:5I=3"+=M]JE_>A/N_Q<
M8[8QB@#D]$OHKEO$.F7FDW>@ZRNG*TMI%.1$R+OQ-"Z$=2V#C!X&<\UG:1JL
M\VC?#/1;J>3[)JMO))=N7(,QCB#+&S>C,<D=]N.A->B)X;TU!<EDGDDN81;R
MS2W,C2&,9P@<MN Y/0CK56?P1X?N- M=$DL6-C:,'ME\^3? PZ%'W;EQ[&@#
M@+^9O"FM?$F[TA3$\.FV4D07YA$2) 2H/0#EL=*Z6Q\/.NMZ1K-IK5O#93PO
M%+#;"3_B8*Z95BQD/SC!;?UZ\UNV/@_0["\NKN*T>2XNX1!<27$\DQE0#&&W
ML=W!/)]:AT/P)X<\.3R3:58- [JRC,\C^6&ZA S'9G_9Q0!Q/A30'U'P7>ZF
MFK7L.KQ2ZC;6EU/>2%(MTCH-PS@XX.XY.><\#&UX,U ?\)+/I>HZ+-HNMQV0
M9[=)-]M<1AP/-C8<9R0#GGD9)Q726GA+1;+1KO2(+606%V7,T+7$C;BWWL$L
M2,Y.<$5:L=#L;"[-W$LTESY0A$T\[RNL><[06)(&>3ZX&<XH RO&LMNMGIEO
M-<W*-<:A$D=M;XS>$9/E,20 AQECGH.^<'E-/>YBL?B7ITJK%!:H3#;1REXX
M=]KN8(2!@$\XP!DFN^UOP_IGB*UBM]3MS*D,JSQ,DC1O'(O1E92&!Y/0U2C\
M$>'H6U%HK HVHQ"*[*SR RJ!M_O<$CJ1R>Y- '("/5AX,\%7>G6$.KV]OI*&
MZTEY0CS*8H@)$SP63G@_W^.<5'8Z]::KJ'@O2K1[M=%OQ>R2171(D>2+.(9.
M<G:2V02<[1UKN$\)Z3%%I\<"7,/]GQ-!:M'=RJT<;;<KG=R/D7@YQ@8I9_">
MBW&F6VGO9;8+67SH&21EDBDR3O5P=P8DDDYR<G.<T 87ALW&F_$7Q!H4#R/I
M"6T%Y#&S%A;2.6#(N>BG:6V]!VQ4_C'4C!XA\*Z3/*T6GZE=R)<L&V[RL9,<
M9/HSXX[XQT)KH]/TJSTSSC;1MYD[!YI9':220@8!9F))P!@>G:HM=\/Z7XET
MUM/U>T6YMBP<*25*L.C*P((/N#0!RFMZ=I_A[1-<@77-0MH+R>!DMK<@M 7<
M*(X1QM$A5AU &2>.M9UFEQ#XL\6::8VL+5M'AN4M;6Y;$3_O!N4KC:Q"C.WC
MCJ:Z[_A"?#Q\/S:&]AYEC,P>4/*[2.XQAC(3OW# P<\8I(_ _AZ*[DNTLI/M
M,EO]FDF-S*7=.?O-NR6Y(W'YL'&<4 >>6%NUEX8^&^N1W=X=1NKVTMIY7N78
M/%)&^Y"I.W' [=1GKDU[&_W&^E8)\%Z"=/TZP^RS?9=-E6:TC%W,/)=?ND'=
MGC)QGIFM_'&* /![/2/L/P0TKQ5I]Y?0ZW8JCVSK<OL;,^WRO+SM*MG&,9)/
M>NQFBN/%WB?Q3H\]S;Q260ABMXY Y>!'B#>:FUAAM[-\W7@#-=38^#M#T[RE
MMK618(9?.AMFN)&AB?.=RQEBJG)R,#@\C%,UOP/X>\1:E#J.HV!>\B78)HIG
MB9D_NL4(W#V- %[P]%<6_A^R@NM1&I3PQ^7)>!=OG%>-V,GGCUYKFM)C6;XK
M^+HV+!6L+$$HQ4])>A'(^HKM((8K:".""-8X8U"(B# 50,  =A6=%X=TR'6+
MS5HHIEOKQ!'/*+F3YU'08W8&,G& ,9XH \Z\.W22_#'PS#>WU[)/<:K(BP(^
MY[XK/*?*=F/W,#+$GHN.<X-'5'N8O!GQ/T^4+%#:R+Y-NDIDCA#Q(Q5"0,#)
MSC ')KT0^ O#G]BV^D"QD6SMI_M,"K=2AH9,D[D?=N4Y)Z'O4D7@CPY"VHE=
M+C(U*,1W:L[,)0 !R"< G R1R3R230!RFH:2?#GBCPEJ.DW=Z;C4KH6E]#+<
MO(MQ&8F8N58D KMR-H 'TK.FU:XT30_B+?VTABD37$0RC.8T<0([#'HK$_A7
MH^G>'--TR:*:%)Y)88S%"]S<23-$AQE5+D[0<#..N!GI4=MX5T:T74ECLRR:
MFS->)-,\JS$C!)#$CIQQ0!C:9X>FT_Q3::K!JUM%9W-NT3V5NCE+HXW+)DN1
MN 'WL9(ZFM;QE;177@S64F7<JV4S@9(Y"-CI3/#W@K0/"TCOI%DT+LNP%YGE
MV+G.U=Y.T9QP,=!Z5K:AI]MJMA-8W:N]O.A215D9-RD8(RI!P10!YC:3+I^A
M?#?28]\%AK"1?;75V'F%;8,L9.> S8R!U QT)J[>Q3:7XTUS0[*6>/2;G0&O
M_*BE9!;3JY0&,@@H& S@8Y!]Z[!_">BRZ%#HLEHSV%N4,"-/(6A*?=*.6W*1
MC@@C%2Q^'--CM[N$QS.;Q!'<2O<2-+(H! 4N3N &3P"!R?4T <[\-=&@C\+Z
M-KC3W<U_=:7"DKS7+NI& 1\I.T$=,@9_$DE?B 7BOO"$L4\\9;7K>)U25E5T
M*N2&4'!Y4=174Z3I-GH>FPZ=I\;16D(VQQM(S[!Z L2<>U0ZMH&G:X]H^H0R
M2-9S"X@VSO'LD'1OE89(R>OK0!QD>C0:S\3?%&GWUQ>R61L;1_(%W(JAF\S)
M&&X''0<9YQTQE:-<:_J?PX\(ZA;PQZU)#%*UWIUQ/M>[C4E P)X9DX^]P2?7
M%>BIX;TR/5KO54BG6]NXQ'/*MU*-RCH,;L#&3C&,9JK:^"]#L;2QMK."XMH[
M'?\ 9O*O)08M^-P!W<@X'!R* .&U'4;2^\$^'+O2I=1MD3Q%!#)!/*Z21DW)
MWQ2#/S;2<#.> *W["2+Q-X^\4Z=J@,D6EK;PVUN6("!XR[2@#^(DX#=0%&,9
M-;UQX0T.ZT^WL9K1S;V]Q]J0+<2*?.W;O,9@P+-N).23S1?^$-%U'5XM5FMY
M4OXX_*\^"YDA:1/[KE&&\>QS0!YEX6OI;?P=X$T;[0D=KJ%W?1RO/DK*R22%
M(V(()W$],\D <@D&YXPT2\\/>!/%@&N.49K>YMK6V:2,68:0*P!WG*-@_*>!
M@\5W#> /##>&_P#A'VTM&TP2>:L1D<E'R3N5LY4Y)Z$=3ZT__A!?#O\ PC\N
MAM8NUA,X>9#<R[I6&,%WW;FZ#J>PH OZ1H5IHINFM7N7:ZE\V4SW#RY? !(W
M$XSC.!7)3:99S?'(.\67;0/-+!V!W"X4 \'L*[V&)8(4B0N508!=RQ_$DDG\
M:S;[PYI6HZO;:K<VQ:^MD,<<JRNGRDYVD @,,@'!S@\T <!X8TNS>Q\1ZSJ&
MJ:C$VDZOJ AN&NY&%O&HQDJ2=^!S\V3P*-),UCXP\$?9DFAMK^PN1+)+-F6]
M"1HRR3*. Q)W=2?F.<=*[RQ\+:/IUIJ%I;VK?9]0=WNXY9I)%E9QAR0S'D]\
M=:I6O@#PU9R:?)%I[F33B?LKR7,KF,$8VY9CE<=%/ ]* /-]2:+Q1\!]7\27
MQ9]4G$TCOO(:#;,5$0]%"@#;T/4\G-=E?[T^*GAE5GG$<^F71>+SFV$KY>"%
MS@'D\@5IW/P[\,737_F6$@BU!M]U;QW4J0R/W8QA@N[CKC-:'_"+Z1_:5EJ'
MV>475E$8;=Q<R#8AZC&[!S@9R.<4 >575CN\ >.-2:]U W>EZQ>&RE-Y(3#Y
M;+MQ\W)QQEL\5V>IS3S>-M(&I1276C3:3(WD11M+MN-R9=XU!.-IP&Q@$]B:
MVO\ A"= _LS4---I,;/4)FGNHC=S'S7;[Q)W9Y[^M<OXD\.I+XCB:^\,:EJ6
MF06:065QIMZ5FC.27$F9$8C[N.2!@^M &W\/=+U#2_#7_$UDO#<RS2,JW=R\
MKI%O/E AF(4[<9 QVSS76UY__P (&FI^%[O2YX+V*UGF26UMKV_>62T8 _O"
MRL3G)R$#$<#D9.._1=J*N2<#&3U- 'D\OFKX>^*2B\O<VLTKP/\ :I-\9%LK
M !MV<9[9Q5FWM/[+\1?#V\M[F[,^I0R17ADN'<3*+;> 5)P,, 1@"NR_X0W0
MS#JD)MIC'JI)O5-W+^^)&#GYN...,<<5(WA/1VDTMV@G+:6,69^U2_NN,?WN
M>..<\<4 <?H]O!XT\.:O?7^I3V6IV^ISJUW%)MDL!%)\J+GA5V*,CON)-:.Q
M)_C5*CKNC?PT@(8=0;EJUIO ?ANXUY]:DTT?;9&#RE976.5AT9XP=K$>X-:
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MG'M5^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.[BY@>(L^Y22/E"Y&  /P& #K]#\0W^KZCXDL7L[>*;2[@00A9699"8PX+'
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M6D )(/)^7&[K\O7- 'ME%>97_AG3=+^('A/2K,74=A-!J#20?:Y65N$;'+'
MRQZ=CCI63%H-C)X;^(-JXG:WTFYN6T^+SWVVI$"R H,\88Y'I^)R >QU5OM1
MM=-2%[J41B>>.WC!ZN[L%4#UZ_D":X*WEAURX\,6]SNU/49-!6YDL[E@+8*X
M0&=\@DOG*C /4].M<O;PQZI\.OAW-J"K=S#7TM_,F^<^7YLR[<GG&%4?@* /
M8F?4O[:C18;8Z68"7E+GS1+N& %QC;C/.>M7:X.2);/XQ6B6P?RQX>E*P"0[
M 5FC "J3A>..*YF-QJOP3G\6M,T?B*))KPWRG$T<R2-^[SU"X&S9TQVH ]BH
MKS.+3DUKXH+!JJ3E+CPU%/<6AG<)YAF(88STX''3CI6S\+9)'\#0Q22O(+>Z
MN8(S(Q8A$F=5&3UP !^% '4MJ-JNJQZ891]L>!K@1CKY:LJDGTY8?7GTIE@^
MI/->B_AMHXEG(M3"Y8O%@8+Y'#9SP*XR73+"3XYB62UA9_[!$^XJ,[Q< !OJ
M  ,US=ZC1^!_B>JW%R#;ZC,T3?:'W+B*,@;LY(YZ'B@#V2BO+-1T1-"U_P &
M:MI,UT+W4;I;2^#7#O\ :8FB9F9@3CY=N1C ''H*R8/#=GJG@KQE?7%W>B[T
MS4]0>RN#=R9MC$<J1\W/0 DY.._2@#VFBO+-+O+OQ3K=KI6N/9B9M M+I+6]
MMS(LCN&\YPH=?F!"C/)';'.2VCET_7?"7@[4-8;5=/(O&>:52HN9(_N1-DG<
M$R>"3DJ,]* .QT/Q!=ZGXG\1:1<VL,(TIX%1HY"_F"1-^3D#'&.,>O)K8O-1
MM;![5+B4(]U,((5[NY!.!^ )_"N,\%65MIWQ"\=6UI&(H5ELF6->BY@R0!V&
M2>.U)\0-/L[OQ1X*:YMHI2VIM$2Z@Y7R7.WZ9 /X4 =]17G^CQ6OB;Q;XMT[
M6($F33Y(+:UMWZ0PF/(=/[I8Y.X<\#G@5H_#*]U"^\$6S:E,]Q+#-- EQ(<M
M-&DC*K$]S@8SWQF@#HCJ4,E]=:?;/')?6\*2O$S;0 Y8+D@'&=A[&LWP5X@G
M\4>$K+6;BWCMY;@RAHHV+!=LC(.3UX6N>T#3+!?B_P"+IA:PB5(+&17VC(=E
MDW'ZFN*TZPAM/A/X;UZ$RKJ4&K((IA*WR*UXRLH&<;2"<C'.>: /=:*\VDM6
M\8^)/%NCW=U:1SVCQPVZ3V[226\31*5EB(==I+ECN SP,G  JN-,6;QSX5LK
MO5+C4XY-&N$FG\QT6ZV&,!BH8CGO@_-WR#0!ZC17BPT2S?P'X^#&X*Z+?WHT
MU?M#XM=D2R+LYXPQ//X5ZUHD\EUH&G7$S%I9;6)W8]R5!)H OT5YAI4,/BSP
MYXMO-4)74[>_NX8YMQ$ED(Q^[$9ZI@ -QC)))SFLRPAE\5:UX*;76N6;4M!G
M>\B$[H)<", X!&W(.3C&<T >Q52TQ]2>"8ZI#;12B=Q$+=RP,6?D)R!\Q'45
M+:V4-EIT-C '6"&)84!=BP4# ^8G.<=\YKQJ]1A\&?$Y%Q<A[?7)EC?SWW8%
MTJX)S\W''.: /;:YWQMX@N_"_AN35;6UAN#'+%&ZRR%<!Y%3( !SRPXR*YRX
MMH_#GQ1@;34F/VO1KF:XC:5G^T21NA5CDG+<D9]ZYC5(;/6?@9;^(Y]MQJL\
MUO/-=Y^<R-=(K(3_ '1D@+T&T<<4 >OE]2_MM4$-M_9?V<EI=Y\WSMW VXQM
MVYYSG-7:X:2)3\:UC9G>*;P](7B=RR$^>@X4G X]*Q=+A73;_7O $BDO=W:S
MV;L26:SERSG)YS'LD4'L=E 'HS/J7]M1HD-L=+,#%Y2Y\T2Y& %QC;C/.:RO
M''B"[\+>$KW6;2UAN7M@I*2R%1@L%SP#GKTX^M8LT2V7QCLUMQ)Y?_"/S$0!
MSL!66,#:N<#CC@5Q6J+:^(?@#>>)+Q5FU><F::Y/WT?[0%\L'J% ^7;TQV[T
M >XT5P\4:#XSWMOM'DS>'TDDB_A=C.REB.A. !FN9\/W%M/X&T&SN)[B:2?7
M+E;>T1QMNMDLI"2%L_NP &/7[HP#P* /2?$NJ7&B>&=2U6VMX[B2SMWG\N20
MH&"J6/(!]/\ ]56-'O7U+1+"^D54>YMHYF5>@+*"0/SKS.U,T/A#XGV+B..*
MV:Y$4$3%HX0UL&*ID# R3Q@#KP*O7MOJIT3PO>Z?I]KK4%MI2_:=(G<*SJR1
MXECR"I==I'/9B!UH ]+HK!\&7MAJ/A#3;G3!<+9M&5C6X_UB;6*E6]P01^%<
M;K5O;Z'XRUG3IH/,M?$M@#9IG&+M#L**?X<[T?(Z$$]J /3SG!P 3VR:Y_PC
MX@NO$,&JO=VL5O)8ZG/8[(G+@B/ SD@9R2>PKE/ S?VM:Z9H5["AN_#4TJ7Y
M"_>E0E(C[AP3)GN4%<Y>Z9;R>!/'^JDS"]L=<O9K65967R75U(90#@'WH ]O
MHK@8;E=>^),^D:O$DUI!H\-Q;6TJYCD9V(DDVG@D?*H/;G'4U9^'<EW&OB'3
M)999K/3=6EMK*25BS"+"MLR>2%+8R?IVH ZM]1M4U6+3#*/M<L+SK'WV*54G
M\W'Z^E6J\^N],L)_CA;R36L+.V@O*6*\[UG0!L^H'0UF>%]'TQH?%&L:C=7B
M-I.MW[07!N9";=%0 D#/S8'KGH/2@#U2L+QEKEUX;\):AK%I;17,EI$9/+ED
M* @=>@.?IQ]17":0ALO%G@&2TA-O;7UI<J\KR9GO4$*NLDX QN)PW5L9//:L
MR\^S>)_@AK_B#4(UDU=S<M+(Q^>W*2D+$IZJH0*-O0Y.>IH ]FMI3-:Q2D %
MT#$#W%2UYPS?V[XUGT"]DLO)BTBWEM;:\@,JR!BXDD4!U^8849Y([8YSU7A#
M3Y=(\-V^G3:NVK-:L\7VIT*DX8_*>3G;]W.>U &[17G^CQ6_BWQ)XQM-;B$L
MEG=):V\3];>$Q@JZ?W68EFW#G@<\"N6T^:_UG2/AW+JEW=O/)J4]J\RSNAGB
M190K'!ZD*/FZ]\T >TT5PO@JVCTOQKXSTBTW1V%O+:2PP;RRQM)#E\9Z9(S1
M\08!+K'@[]]<1^9K"PN(IF0%3'(2, ]>!SU'8T =U17F6D^&=+N/'GBS0I8I
M3I*P6DZV?GN(Q(ZN&;&>IVC\>>M4?#5ZFJ>"_ 5O?S3WU].)C%92./*NA&&7
M,Q(/RH-IZ$YQP>P!ZCJ6HVNDZ?-?7LHBMX5W.Q_( >Y. !ZFK5>&ZE L_P *
M/%4%VD;C3_$C16R9++ OVB(;4ST4!F ]C78ZBD-Q\0(/"Y%A#8+I7VBVM+FW
M,D4LAE8284,H+ !<=<98C'- 'H-4KI]274K%;6&V>Q8O]K>1R)$&WY-@ P<G
MKG'%>8ZKH3Z59^$]*DUVYOQ'XB6V,B.\>R)D=O*^\<[> &SD=,C%:M[HMGX>
M\>^!+'3?/BM=]_\ NFN)'7_5%NC$]V- 'HU<['XANF^(4OAN2UA6W731?).L
MA9FS)LP1@ =_7M7GWB"6)M+N=:TMGF:/Q%&!J<\F)MWGJC11@#/E*,KR1G!X
M.<UUP_Y+>W_8MC_TI- ':T4U'61=R,&7U!R*X#5=,M]1^,5O:W+3O;3:%*\L
M/GN$<B9!@@'IZ@=<<YH ]!HKQBTU.YT[PK8Z4)YETUO%\FER.9#E+42MB/=U
M ) 7.>A([UU$UB-*^*%AINF(8=,U339VO;6!C&B-&5VRJ%QM8[MI(QF@#OZ*
M\,TRS2#X7^#_ ! LMP=535($%PT[D[&N65EQG&T@G([]Z]3EU;Q -<^QKX89
M].,@0WXOXQA#U?9][CGCKQ0!T%%>-6WAJRU?PMXWN;JZO1<:=JU^UG.;N3-L
M8P"K#YN3P,DY.!6MX=N;J\\:^%;F_!6YOO"YEN@1CS)-T7+#N<$T =;XS\07
M?AK1HK^UM8;@-=0P.))"NT2.J9  YZ],BNA;<$)0 MC@$X!/UKQ2\_>?#GQ!
M$LC>6GBXQ1[6^X@NHP OH .E=1_8T7AGXJ:&FB-<);ZK;71U&!IWD5O+"E)3
MN)PVY@,]\_6@#8T+Q'K'B#PMJ-]:V-FFIP74]M% \S>46C<KRV,]O0?A751[
MS&ID"A\#<%.0#WQ7CDB9^"GC%Q)*CQZA?NK1R,AR)CZ$9'L>*ZA[J'4/B)8:
M!J@22Q_L,7-O;3#,<TI?:Q(/#%5 P#TR30!WM%8_AG3;;1M)_LVTOKB\BMI7
M0/</O9.<[,XY"YQ[8QVK8H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M![C'-:=% ", RE3G!&.#BL ^"?#[:5<:6UBQL;F;SYH#<2E7DSG<?FZYP?J
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MEO%)IBNEF47'DAQAL8]10!K4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
24444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>elicio-insidertradingcom005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\Z5;>W>8QQ\_,P0' X/7K@XZ&D;Q%I?V.TNH;@W27<9EMQ:QM*TJ  E@J@G
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M88PV0<-C.WBK>HW>J7GA?P5-J]J$OT\0133^1 R@QJ\@\XKCY0P*L<X^]VH
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M;($@;'H?2NAG7PKK>AZKJ$.DZFUE=+!!<WQ2=9W/FKM*!P7/EG#9 QQ@9YP
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M:2<''/..,UN5Y)X2GTN[TK2/#FK:!JC:_IC11M;3B<PQO%@"<.3Y87 R/K@
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MHZ'>ZQ;RS&RLC(L[O;NC(4^^-I /'?BMF"9;BWCF1759%# .I5@#Z@\@^QH
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M'1]6MM<TR+4+19EAD+ ">%HG!5BIRK $<@UCWWBU+3QQ9^'/L=TWG6CW#S+
MS#AE50N.WS')Z#CWP =-17F7AWQ?:>'U\5'6+S4)XK;79D$A26X^SP[(P-S
M'8@.<9]\=Z[R]UNTLF2,":YFDC,J0VL9D<H/XL#MS^/;- &C15'1]8L->TN'
M4M-N!/:S [7 (Y!P00>00000:O4 %%%% !1110 4444 %%%% !1110 4444
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MDH22*/RV1U3GYOO#CO\ 7$[1-X6\7>']970[BTT Z=/9?9[: R&Q=Y?,5G1
M2-P !QG!R*]0HH X;P+)))XD\82M9WD,5SJ"30O/;/&)%\I!D%@.<CIUJ[\3
M;*ZU'X;ZY:V<$D]P]O\ )%&NYFPP)  ZG /%=910!YY>74\7CO0O%?V6];19
MM.EL)&:V<-;,7#J[)C<JMMVY(XP,\8K2\*Z=+_PF'BK7Q')%9:E););K(A0R
M>5'M:3:>0"3@'OMST(KL:* .3^)UC=:E\-M=M+*"2>X>W^2*-=S-A@2 !U.
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M-O\ ^%L>(YC;W"P365JD<S0.L;LF_< Q&"1N'>NKU-Q'I5VY#,!"W"*6)X[
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MPWTB6MK'>7@6W(:UB<$J9%)!SA2<#)P,XK3N?$%C#]B2(R74U\ADMH;<9:1
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+=*$(R'4(6#*?52<=\4>'_%UEXE>/[#9ZBL$EJEU'<36Q2)U;^$-T+#N/YT
M=!17,QZCH_\ PG=_$B7YU:#3D:7Y9#&8=YQM7HS;L\@=NM5+;XE:)=VFG7L=
MOJ(L;Z?[,ETUL1''(7**'.>,D=LXR,XH U+#PX;'Q5J>O?;GD?4(XXY83& J
MB,$)M/7/S'.>OM1KWAPZY?Z3=?;GMSIEQ]IB58PP9\%?FSVPQX&/K3KSQ/:V
MDUZB6MW<K8LJW4D"J1"S*& (+ GY64G ( /UQ7CO=(D^(DMJJW@UF/3 S%MZ
MP^1YG& 3M+;CU [$9H Z.BO,?B-XBAU'P6UQI\>H>1]N@BAOX6V0N1.JL.&R
MRD!@"5VD]#R*[35/$EOIANE6TN[UK.(370M45C"A!()W,,G )VKDX[<C(!M4
M5REQ\0]#B?3T@6]O6U&U:ZM!:VS/YRJ 2%Z9;D<=N^*OZIXB^P>#9_$,>GW4
MHCM#="V=1'(!MW88,?EQW[\'K0!N45Q\/CRVM-%T*XU>TO8KG5!''&$M]P>1
MD#<;21@\X'WCZ59A\;V=P(HX=,U4WKVTETUD\ CFBB1RA9@[ <L. "2: .GH
MK#3Q;I<^D:9J-J\ERFJ8%E#&G[R8D$X .,8 ))) &.37):!J4?\ PF'Q!EO(
M]2CMH8;/S+>5GDDC!CD+! K-@'J-IQS0!Z35+5K ZII%WIXF,(N8FA:0*&*J
MPP<9[X-<U9>+?#^B>&O#?D)J'V'45CAL=T3RORI*ACSS@'C))["M/3/%^FZE
M_:JR)<V,FE ->1WL?EM&A4L'ZD;2 3^!H OZ%I?]B:%9:4)VGCLX4@CD90&*
M* JYQQG K0KF1XYTU;C2XI;34(_[50O8L;?>)P &X"DE?E(;# <?0XE\<7NE
M6'A"_FUM;MM.V 3?9 _F8R.A4@CG'.0* .AHK(NM=@L[H6,-K=7=PEN+AXH
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MC@A48 G<"<D>E1>#M)#^&?#6O/J.JO<FPBGNEDO9YUN"\'.8V8C.XAA@=N*
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MJ_'\14R1@]MP]*3P+X?U'1[N^LKU"-/TJ:6WTECU:&4B0GWV@J@/^RPKNJ*
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M1S]17">*X==UG1/$UI<Z'JLM]'J*M:);QXMS;K*A5UP0)'*@Y^\P/H*]AHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!5+5-5MM(M5GN2Q\R188HT&7ED8X5%'J3^ Y)P 35VN0^(.G:K=:?I6HZ/;_
M &N[TG48[[[)N"F= &5E4GC=AB1]* +$GCK3+5-9_M""[L9='B2:YBF16)1Q
M\I4H6#9Z=>O6K-MXJ@FU6YTN>POK:_@M%O!!(J,9(B2N5V,P)W#&#BL?5M<\
M2ZKX1U.\T70;RRN5B46\-ZB">1BPWE4R0-J[L;NI[8'.9I5O=VWQ&768]!U:
M/3YM$\AIKG#R^8)=QW_,6R1@ =?8"@#6L_B5I5[;:1>)8:FEAJDRV\-Y) HC
M21F*JK?-GDCJ 1S@G.<=;=W=O86<]Y=2K#;P(TDLC' 50,DG\*\GM=(U6'X4
M>%-*?2KW[?9:E;RW$ A)*)',78YZ$;2.AY_.N_\ &>BS>)O!6JZ3:R>7/=VY
M6)FR!NZ@'T!(P?K0 Q/&%F+O38;RRO;*/4SMLI[A5"2L1D)PQ*,1R P&>G7B
MN,T+Q-#X5NO&32:=J]_!#K,CR-;1F;R(_*C^9F9AP.> 20!TQ6G?6NH>+]*\
M-6$VF7=C=65];W=\9X]J0^2"2$?H^X\#;G@Y.*=IB:AHE]XOMY='O)Y=1OGN
M;+RX]T4RM$B@%_NIRISNQQZT 7;WQNY\1>&[/2[&:]L=6@EN5N(FC_>(J @*
M&88QN4G..F!GG%N\\=Z;9_:YFMKQ[&RO5L+F\15\N*4E1@@L&(!=02%/7O7-
M6_AG4O"]WX!6*SGU&/2K6YMKI[;'RR2(N#\Q'R[@PSVXK-\4V?B+6M$\1VEW
MH6HW%_'J*/9F,KY'V99HV4QC<-SE0V3@MR>0.* .YDO]'_X6(MJUI=_VS'I;
MR+-AO+,'F+E0,X+;B.W;K5 ?$W2CIHU+^SM5&GK=&UGN6MU"6[;_ "\OELXW
M?W<D=\4C)>/\5;357TZ\CLQHCV[R&(L$E:57"$KG)VJ>1D9XS7+3Z1JTGP@U
MS2%TF^_M"XU&26*W\D[F1KD2 YZ?=!/7VH ];GE$$#RE'<(I.V-=S'V KCHO
MB;I,NF:9JO\ 9^JKIFH2B%+QH!LC<L54, V[DCJH(YQG/%=>TZ_9#/LE*[-V
MWRSO^FW&<^U>3P:1JT?P>\/Z0VE7O]HVM] \UN(3N14N-['/3&WGK0!WMAXO
ML[S6;O2I[.^L+JVMOM8%W&JB6#.-Z[6/ (Y!P1Z5%I_C>PU"[TF%;2]A35XG
MEL)I539.$7<>C$J2O(W <>_%95_%J9^)<NJ:?83N@\/26T$LD3+&;@R!U1B<
M8&!R>G;.:P+&UUJYUCP3JUQH&K-=VCS+J4MP4!$CPE?E7=A8PV<8 &,8!- '
M4>'O&LFH1^(;K5+":QL],O98/,=HV"+&J94[6)+DECP".0 2:T%\7VRZVFD7
MFGW]G>30-<6R2HC?:%7[P38S?,/0X-<;)X<UJ]T'QSH*:?+%<7FJ2W]I<2[?
M)E!,;HN<Y))0@\8'>MSPU>?;)X;A_ KZ+/:HQN9I;6,'=M(VP%,L^2>N , ]
MS0 ZV\?Z7KVBR7*:1K4FES6<TKW ML)M4E63<&R&QDC'OSD'%S3/$6D6.@^&
MK?3+2[=-3ME_LZT!!D\M8P_S,S8&%QG+'\:R/"%E?6'P<.F7>GW4-_%:W$1M
MFB.\L[.5 QUSN'/;OBJEH->L/#_@BP;2M2:PAM/(U.*U7;.DJQJJ*3D$)G=D
MJ><#)QP0!WC[6[7Q'\(-=OK07,#VSF&2-V*/%*DH5E;:<'OW(.:])7[H^E>.
MS:)K(^&'C#14T&\BN;K4YI+6%55A(CRJPVX/0*.IP/3->BR^(S!X@TO2FTJ^
M\F_B)2]*8C20*S>6P/(;:C'IZ?@ 2^)/$MGX6TY+Z^BN7A>9(?W$>[:68*">
M1@9(J'3?%MI?Z[=:/+9WMC=06XNE%Y&J"6$MMWK@G !ZAL$9Z5G?$FTN[_PO
M':V5I/=3F]MI-D*%B%2568G\ :H:OI=UJ_Q"N72WNHK*[\-RZ?\ :_)8*DKR
M!@.>>%Y].W6@#8;QSIT=O97TMM>1:5>RK%!J+JODL6.$)^;<JL>C%0.G3(IM
MUXYM(=5U32X-*U6[O=-1))8H(!\RL&(*EF Z+WQG/&:Y632=5UKX66W@>ZTR
MYMM218+.:4QGR4CB=?WRR?=8%4R /FR<8[UNZ=%<VOQ$\4W\MC=BTN+2UC@E
M$+$2-&'W 8'^T/KVH ZC1M7M->T:TU6Q9FM;J(2QEA@X/8CU'2LK5?&=EI6O
M+HIL=1N;][9KF..V@W>8H(&%)(&>?H,')%<[X0\(SWGP]T&PU*YUO2;NPB>.
M2*UNGMR26S\V/O<8P?<^]%TR:+\5]"A(O;J.+09HC*0T\N!+'\S8RS=!D@$\
M_6@#5B^)&CR^'GUD6U^L4%V+*Z@>)5FMI2P4*ZEO5ATSUK7EUNSG\2-X8EAN
M5N)+-KH2 @(\88(<,K;@<L.PK@M8\*ZI=>&/%NH6]A*;G4]3@O8++@2&*%X^
MH[,P1FQUY //%;-J^I:A\4;'6AH>H6^GMH\EL9)U5"CF56&Y=W'"GCK[8YH
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MB\/_ &AM/O6F.D3[#++;M&4;(R5\P9+ 9/;OQ0!I:AXOT6_T/Q):ZG97\?\
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M_OK'QYJUO8W)DUJUAM+*V\LB238A&]E_AR20-V" O.,UZ-I#%M'LRT<D3"%
MR2*592!@@@T <]9^)+O4_'.M>'I=+N4L[." >:LB#F3S"7)#[@"% &,G@YQF
MN8^'_BZVT7P'H,-[:ZB\,]W+;-?; T4<CW$@4.Q;<<Y'(! SR:Z"T@OM+^)V
MNWLFFW4MEJ%G:^7<Q*&13$'#!N<Y^88 !)KDX=(U9/@]I>D-I-]_:,.I)+);
M^2=RH+HRDYZ?=.>OM0!VU]X\L[/6;[28M*U>\O+-8WDCM;7>2CD@,O(R!CG]
M,U->^,[*SM[^[6SO;FPT^1HKN[MT5DB*_?X+!F"Y^8J#CGT.*&DPW(^*.MWS
M65TEG=6-M%#</"RHSH7+#GD?>'6LC2+'5- \.>(O#%QIEU=2S3736$T4>Z*Y
M2;)&Y^B$%B&W8]LT =>GBBPEUZSTF))I'O;1KRVG3:8I8QC)!W9_B'456C\;
MZ4VBZGJDRW%O#IMV]E.DJ#>9E*KM4*2#DL .>]<Q'H6H>$M7\&S+8W>I6]AI
M<FG7#V:!V60A"&P2/E)4C/;O6;-IM\/ WC*WU+0[Q9+S7'N+6-9$#N7DCV-'
MSRRD9 Z-C )S0!WB>*+6X\0?\(Y<6&H6]]);^?M*J1Y1.W?O1C@ \=<@_@:X
MOP)XMMO#_@FP2]M-1DMGU&>WDO0FZ.%GN75-[,VX]1R <9YK2T/5X)?%R:CJ
MVE>(+?4I;7[#!/>:>(X=@S(5&QF^=BN>>NT 8Z'".D:M_P *;?1_[)OO[2.I
M>:+?R3NV?;/-SGI]SGK[4 >P5EZMKMOI-S86C133W=_(T=M!"!N<JI9CEB
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MW39&F< L6)).223R22223R2<U/0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/(ZD3K@'>N#P,DC!]*X+1==N8O%-CIGB)]2T_5FN9FCD:5GLM20J^U8^=JD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR#3I?.M(;AD*QN 5!R%#' 8X!) S[#$<?@?2OLNMVMT]S>6^M2&6[BG9<%R
M,KM4$'"KCTP*Z6B@#DK;P!9PW6DW,^L:S=R:2S&T,]RORAEVE3M4$C'&3SZF
MD;X=:0-;NM1@O-4MHKR3S;NPM[HI;7#GJ73&>>X! />NNHH QK3PW;V?B:]U
MV.[NFN;R-(I8V*>653.T !<C&3W[\YK9HHH P=.\*VVF^)-0UV.]O9+O4 BW
M*R,A1P@PG 48P/0_7-2IX;MX_%<GB(7=V;N2W%JT9*>7Y8)8#&W/!).<YK9H
MH XVZ^&FCW5KJ=HUYJB6FH7/VM[>.YPD4V\.608[L,X.1Z 5<D\$6/\ ;IUB
MTO\ 4K*[DB6&Z-O.,72J,+YFX$E@.-P(;WKIJ* .0@^'6EVVA:5I$-[J2VVF
M7:WEN3,K-YJL6!.5/ ))P,#FM&'PM!!K&JZI'J%\MSJ<:1SG,9 " A=HV<8!
M/Y\YK>HH \PUWP_!H,/A[1T_X21-(L%E>+4=-S)- Y 4(PC4G:0S_,5/89Y-
M=#X/M;R&YGE35-<O=+>,;?[:C"2>9GJ@**X7'7</3'>NNHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP,;=\3 6X0[./F^;CC-9)29? 'PX@-I=^=9ZC8O<QBVDW0JB,'+#&5 )')H
M[V]\9Z+I\ER)YY/*M)DM[JX2%FB@D;&%=@,#[RY],C.*@D\71KX]7PS]DNN+
M/[0TPMW()+JJX('W?O98\9QSUKS[QC/>:KH'C.Q;2]1BNX[L&WM;2S=8YH@T
M>)W=1B1F /!)Q@87C-=6T\B?%JUU%K*^%K?:&+>&06KX$GGEL/Q\GRG/S8_/
MB@#?N?&&C6D\*3S2I#+<?94NC"WD>;G&SS,8SD$9Z9&,YJO+X]T"+4YM.,]R
MUU!<1VTL:6DI*._W<_+P.1\W3D<UPGAI;2+28_".O^&M1NM9M93&JO%*UM<8
M<E)M^=@7H23SP< GBNI\+$CXC>-I6@G2.XEM&AE>%E64) %;:Q&#A@1Q0!=T
MK7] M--U[54U:\DM+?4)!=O>>8?(EPF8T5@"%&Y0% ZGBM.SURPU>[O-+C>X
M@O8(U>6&2-HI%1\[6!/4'!Y'0CM7GD-U>V'ACQS-;Z1+=22Z^\Z13V3.&A;R
MAYRHP^?;M9ACNN:T=!F$7Q0O+X1:O+9W.C1;+R[MI '*R.6)RHV=L+A?8<Y(
M!L_"Z[NK[X=:7<7ES-<W#F??-,Y=VQ,X&2?8"NBU?5[+0M+GU+4)&CM(%W2.
ML;/M'KA037!>"_$$'A#X5:5-JUEJ*;+B6*5%M'+P[I9'WNI (4+R373?$%7D
M^'VO0Q122S36,L4<<2%V=F4@  #)YH FL?&>BZAJUMIL$TPGNHC-;-);ND<Z
M@ ML<C:Q (S@FG7OC#1K 3R3SR_9K:7R+BZ6%FAA?(&&<# P2 3T!ZXKE;IF
M?Q!\.)5M[DQV\<WGL+=\0[K?8-_'RY;CG%4-)6XTWX>:_P"$-2L[F35@;R*%
M!"S"]$Q9DD1L8()?DY^7'.* .YO_ !AHVG:LNESSS->O ;A(8K:20R("!\FU
M3N//1<GKZ5<T37+#Q#IBZAITK20%F0AT*,CJ<,K*0""".AKAM*L+C1_'?ABU
MN5FE^P^'#9S7(B8Q^:#'QOQC)"D]:?X2TR^U'2M?M[?4-0T:5O$-W<I+';A6
MDB9CMP)%(*G.<@=J .OUGQ1I&@75I;:E<M#+=EA"/*=@Y4$D9 (S@=.IXP.:
MHVGC_P /7FF:E?QW,ZQZ9_Q^QR6LBRP#!.6C*[@, G..QKG/$T3Z'K?@1=0U
M"YU$Q:E.7N98E+D&%\9"*!@9ZXX R:BU71;C6]2\<:KIL#M!>:$=/@.TK]JG
MVN25SU !1<]"<XZ4 =O)XDTL76EV;3R++JR%K,B%\2 )O/S8PIV\X.*X;PSX
MYT[0+/6H]=U&^E$.N74 GDCEG$$8<*F]P"$'89(J"+4_[1U#X=2VUAJ;1V)>
M.Z9K&5?*;[,4P05SPQP2!@>M2V!:U\.>-=#N;"Z?4+[4;]K:U-NW[]9N(V#8
MV[3GELX'?% &[K%W,OQ.\(K;WTYL[RVO6DA24^5)L1"C;1P?OGFM'1]4T8WW
MB*Y@U2[<6\P-Z+QG6.U(0<(' VK@9...<US2Z;<:1XK^'5C*LTW]FZ;<6UQ.
MD3M&K&*)5RV,#)0XS69J&E:CK-I\2K/3[><7-W<0RVOF1,BSA$CW!20 <E"O
MXT >A6?BG2[W58M,5YHKN:$W$$<\#Q^=&.K+N SCTZ^U0^(+S3(=6T.WO;^^
MMKB6\'V6.W+JD[[6^20@8*XR<$CI53P_XHMO$]S:RPZ)>P74*'[2][:-$;4D
M<QJS#YB3CA>,#)QP#4\>;VUKP>4AGD$.KK-*T4+.(T\MUW,0#@98=: -"[\?
M:!9SZC;M+=23Z=M^U10V<KM&""V[ 7[H R6Z<CGFL[QIXM2TT#2)],EG>+5;
MRUC6XMXG;]Q(XW%6 X8KD ?>YXY%4K)C'XM^(<SV]P(KB&V$+FW?$NV JP0X
M^;#''&:Q9%F3X7^!+8V=X;BUO[!IX1:R%XEC;+EEQD >] '::?/8:!<SQQWN
MKWC7P^U16$RR326Z#AB PWJI/9CUX'I5F?QQX>M]%MM8>_\ ]!N91 DHB<@2
M%MNUN/D(/!W8Q6&)9=$^*%]JEZDK:5JVGPI;W:QLR121ELQM@?+G<6&>#TZU
MS&I:1=VGA;4K@V=T4U/Q2FH06R6[LZP"5,N4 RN0I;!'0CO0!WB?$'P\TT$+
M3W44L\\EO$DME,A9T7<P&5],8'4Y '--'Q"T!K:[E5KXRV;E;BV%C-Y\6!G<
MT>W<%P<[B,51\7.9/&/@J:.&>2**[FEEDCA9EC5H64%B!\N20.:JZ:YB\9^/
MYY(+A89XK;R7-N^V7; 5;:<?-@\<4 =5)XHTI;?398KAKC^TT+V20(7:=0NX
MD#L ,$DXQD=S6/K/Q T^R\+PZSI\<]VD]TMHH6!_W;F0(P<8RI!SQU)P!7):
M%>W6G>'O ME=:=>V]N+26*YNXK!Y+B"0  1#Y2T8?N0,G P1UJBMK>+\.-4M
MQI>I+):>)/M3QO [.8OM0;(ZE\+R2,_6@#T>?4]*N/%FBQ/>ZC!?R0S/;VFR
M2**9<#<9%*@$K@8!Y&>G-3WWB_1]/^T//-+]GM9?)N;E(7:*!^.&<# QD9[#
MOBL#5K@WGQ)\&WD5M=_9TM[W>[6S@1[U0)OR/E)VG@X/KBL?2!/I7@CQ)X4U
M2SN9-3,EXL"B%F%\LQ9D=& P<E\'GY<<XH [>_\ %^BZ=JD>FSW$K7DL!N(H
MHK>20R(,?<VJ=QY'"Y-6]#UVP\0Z<+[3I6>+>T3!XRCHZG#*RL 00>QKA=*T
MZYT7QGX/L[I9I38: ]I/<+$S1B7]WA=^,?PG'/:M?X=!T7Q,)(9XO-UZZGC\
MV)DWQL1M8;@,@X/(H VM4\6:3H_VHW4LI2S"F[DBA:1;<-R-Y4''!!QU (/2
MDOO%ND6#R(TTD[16HO)1;1-+Y<!SASM'0X..YP<"N0TS5&\,Z]XET36]'U"Z
M34M0DO+*2"T:>.Z215'ED@8!7;@[L#'M1KEU=S:UJVEW.E7=KOTA%M?[.M6;
M[6^U]R-,J\*A( 4E1R2>N* .LNO&>@V<NF1RWC$ZG&9;,I"[B90N[Y2!@G&,
M#J<@8YJUH?B'3_$,%Q+8/+FVF,$\4T+121. #AE8 C@@UYSH[2EOA86LKY!8
MVTL=R7M9%\H_9@@W<< MP">N,CCFNE\';QXR\9NT,\<<][#)"\D+(LBB%5)4
MD8/((XH Z#5/$>GZ09A/]HD-O'YTXMX'E,4?/S-M!P.#[\'CBH&\8Z&MYI5L
M+MF;5AFQ=(7:.;C/#@;0<=B:XW4)XM \>ZY_;VE:G<Z=J_DRV=S9Q2RKE8A&
MT3K'T.5R..<U>UO0K?7O#UAX2L]/?2&V?:X9!&V+#:<IM8<>:21D \#?STR
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MX8#<!G!!&1QQ5RJ6D:>NE:3;6*N9#"@#2'K(_5G/N6))]S5V@ HHHH ****
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M9&CFW ,H4C**"0 #@"@#M**P['Q;IE_KIT>/[3'=&$SQ&:W>-)XP0"T;$88
MD=/7(R.:KW7CG1;.W-W*]P; 7)M/MD4#21F8';L&W+'YOER!C/&<T =)15*\
MO;9-%FO)S<):F NY2*02*I'7:!O! [8R*YVQ\6>'M%\-^'R+J^>SOU2*REGC
MDD>3(R-S8^]@=#R>PH Z^BL?1/$UAKUQ?6ULMS%<V+JL\%U T4B!AE6VMS@C
M./I4E_KMM8W;VOE7%Q/'#]HECMX][1QDD!B.^2K8 R3@X% &I16-!XGTZXU6
MUTU/.%S=VGVR &,@/%QD@],_,.#3+;Q;I%SIMY?B:2.&TNFLYA)$P<3 A=@7
M&6)+  #.2>* -RBN,\0>([34O#OB?3X);RQU6PTZ2X,9+0RH/+8HZLIY&1V/
ML:3PGXPT]].\-Z3.]W]LN]/B\J>6!Q'.ZQ!G59",,P&2?QYS0!VE%9FLZ[9:
M$EK)?&58[FX2V1T0L!(YPH..F2>O2HW\2:?%K-UI,GV@7EM:_:W00,V8MVW<
MNT'=R",#GB@#7HKD[3XB^'[U=,DA>[-MJ4HAM[EK5Q$9"2%0OC 8XZ?GBJME
M</;_ !:UN*2[G^R+I$$_ERS,T<9,CAB 3A>%'2@#MJ*YZQ\9Z5J%WI\$0N%_
MM*-Y;"22(JERJC)*GMQSAL$BH6\>Z*FA7^LM]K%GI]PUM=,;9MT3J0&!7KP2
M.<=Z .GKG-2\-7D^NOK&EZ]<Z=<2PI!-&8DFB=4+%?E894@LW(/>M&76H(KF
MUMC#<M+<PO/&J1[OE3&[..GWE'U(KSRTUF#6+;6];U>;6[0:3J\S)/:[U$4$
M)4>65Z$$ [EP2<GTX /1M-TTV(DEFNI;N[F"B6XE"@L!G  4 !1DX '<]2<U
M?K(?Q)IT>HZ38LTHEU5&>T/EG:^U-Y!/8[>>:PO!<DW_  D_C.WDN;B:.#48
MUB$TS2;%,*M@;B<#)/% ':45F:AKEK87(M/+GN;ORC.;>V3>XC!QN/0 9X&3
MD\XS@U6@\7:/>:7IVH65PUU'J619QPH2\Q&=P"G&,8.2< 8YH W**YYO&VBQ
MZ5J6H2R7$:Z8Q6]A:W<RP'&?F0 G!'(;[I'.:+'QII%_J]IIL7VI);V$RVLD
MMNZ1SA0"P1B,,0#GB@#H:*\_^(OB2 ^!_$(L9-0#VD;1->6995BF ^Z64@GD
M@'&0,X.*Z+3?$%I]KL]$<S?V@VGK=J"AP\8VJ2&Z9R0,=: -ZL+_ (1Z>7Q(
M^IW>L7=Q:*RR6^G,J"*%PNW=D#<W4D G )SU PMMXMTBYTNXU%9I$A@NFLW5
MXF#^>&V^6%QEFW'  ZU1O_'FGV6GZW(+6[:^TB#SY[%H\2;2I96SDC:0#D@G
M&/7B@#JJ*S/#VIOK&@V5]+#)%)+"C.KH4RQ4$D ]N>*TZ "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *Y#XD6=U=^&(3:6LURT&H6MP\<*%WV)*K,0HY. .@YKKZ* . UG2I?&'B>U
MOM.6:WM[32[R W4T+Q>9).H5% 8 D+@L3C ) ZYQF^$7MKJUTG1]1\%7<6MZ
M<T2RRW%I^XC:/ \Y)3P3@$KCG)].:]1HH \[US1+V'Q\+>P53IGB6#;J:;L;
M#"5W.!_MQGRS[D&K=Y'=:'\4SK5Q;W$NDW^F+:":&)I/L\J.6 8*"0K GGIF
MMW0_#9TBXFNKG5;[5+I\HDMXRDQ1EMVQ0H  SC)ZG ] *W* /'M<T2_7PIXJ
MNXK"]<ZQK<%S;6L=L[2>6DD679 ,KG8S8(!QCOQ70:S;76H?$E7M8+R..;P[
M<6B79M9!''*[JR@MMP#@$^V/6O0:* /%Y[J]E^%.F^''T+5DU?3)[.&>W6QD
M92(IDRZN!M8$#/!)Y].:]%\;7=_!X+O;G2]/-[<[4*P-!YC;2Z[B(S]YE7)
M]171T4 >8Z<TD7Q%NM233]=DLKG05C6ZN;:4L\@E=CD$94X(PF%]EP<UF6]K
M?1?##P+9OIFI"ZLM5LY+B'[#*7B6.0EV8;<@ 'KW[5[#10!P/C/3]2M?$FE:
MUH)"76HJ=(N@3@['!9)<=S&0S>N,BNXL[6&QLH+.W0)!!&L4:CLJC 'Y"LFR
M\.&WUZXU6ZU6^OBSL]M;SLOEVNX8.P #MP"<X!/J<[3AC&P1@KD?*2,@'Z4
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M.NZ03;CN#8\OC^'"CT'(SZ310!P.B:#J&G>--2TKR"/#PN1J]N_;S9 08?3
MD#2>V%]:71GN/"_C'Q0FIVUV]MJ5PM[9W,-N\RR#8%:,[ <,NT8!ZCI7>T4
M>0C0-0T3P3X-L);&[>>+Q!%?30P0/+]FB,CN0VP$#:&&??.*W-*NKKPUX[\2
MQ:E87\L&K31W5C=6]J\ROB,(8V*@[",<;L#'.17H5% 'B.DV>I:9X/\  ^J7
M/A_4+NVTM+FWU"Q%NWG*LI!614."P&T?@?K6SKUB]YH=KKOAWPQ<6\5IJ]KJ
M$UL;?RKF]2+=N.P\G&X;<\G:>.F?5:* //(=1.I_%/3M6M=.U,V']C30F:2Q
MEC"N948*=R@CA3['MFNL\.>(;?Q+IAO8+6\M"LABDM[V'RI8V&#RON""/8BM
M<C((SCW%06MI#90^5 I"EB[$DDLQ.223R30!PNE3/HFO>,H[W3;Z1KZ[$]JD
M=J[K<H857 8 KU!!R1CJ<"LC0_#VJ>!M3\)WE[%-<V<.DR:=>&W1I?LLCR"4
M-A025S\FX#C SQ7K%% 'E&N^'M0U+2?B-JEE9W!76(8([2W,962;R8P&<(>>
M22!QD[<]Q6KJ-S+J/B[P)?PZ;J:VT!N3,[V,H\H-!L4O\ORY;CG'KTYKT*B@
M#BO!R3)XN\8R26EW#%<WL4L$DUN\:R*(E4E2P /(--U4RCXM:)<"SO7MH=/N
M(I)TM9&C5W9"H+A<<[3WKMZ* /-=$%UH&E^*= U.PO)[B>[NKBT>*W>1+R.;
M)7# $!LD@@D8Z].:KV6C7N@ZM\-K&XM[NX.F6MS'=SPV\DD<3/$%4%P" -V0
M/I7J5% %#6V*Z%?D)(Y-NX"1H79B5( "@$FO,X+>\C\(?#:W;3=2$UA>P/=)
M]BES"JQ.K%AMX&6%>MT4 >3^(=&U/6M4^(EG8VMVDFH:?:1VLKP.D<S1A]Z*
MY 4YR%Z]ZGU'6I=>N/!4\&B:O%)9ZBKWD3V$J_9SY3J025P1D]1D8ZXR*]1H
MH XKPS',/B)XTFEM+J."Z>T,,LMLZ)*$AVMM8@ X/%5O!VA:AI6LWFCW$)71
MM(N9)M,D/1Q,,A1_US#2K_P,>E=]10!Y;J&DZEJ^K?$NSM+:[ADU*RMXK2:6
M!XXYF6%E95<@ \G;U[U%?ZM/K.E>"HX]#U>*ZT_5K9KV!K"4>1LC=6YVX8=\
MKGCKBO5Z* /+KEKK3=2^(-C)IFHRRZI'YUFT-J[QRJ;8(?G V@@@Y!(/IDTN
MG7>H6L'@ZPN])U2"Q71EAFFMK-_/%PJHODLP&Z)#@G.5R0.0 :]0HH \6BM-
M03X/0:4VC:JMY!K 9H3:2,VT7AD)& 20%YW=#V)K=\7V+7&K:AJNC2:OIFOP
M6Z>1)%:R20:BNW<L3H5VD@DKS@C.?IZ910!S'BK3-3U_X=7^GHB1ZI<V0!C5
MOE\W )3/H2"/QK&\-W^G:Q>65P?!E[8:C9JS7$UW9%1;':0PC8\N2< !>HY/
MH?0** /&1:7W_"DDT[^RM3^W#4_,^S_89?,V_;?-SMVYQLYS_6MG7-3_ +&^
M(%]>V<&IH;O3(4GDBTR2[1CN?8=J$&-E&>&ZYZ#&3Z;7,S^%+E=:O-2TOQ#J
M&GF]97N8%2*6-F50H91(I*G  X...E ')V][::=H'A6PT"VU*;1;:>2VO;E+
M%WO+5@F0"FW<A<ORP7@'C&0:S#8.O@?QW97FD:Q&)-7:YMP4)D;<8?*968GS
M#N7) ))QCJ17K6GV$>GP,BR2322-OEFE(+RO@#<V !T &       *J^(-"B\
M06$=L]W=6DD,R7$,]LX5XY%^Z>001[$$4 <=H6M:;J'C:#4=1?48]5:S-C;+
M/I,UI$1GS&Y;=ESMX&>@P 36!?6E_-\+_'-G'I6IFZO-9N9;>'[#+OE1Y596
M4;<D$ G/:O2M/T*ZAFBFU36[O5'A.Z)98HHD1L$;L1J,G!/4D>@!K;H X?4F
MDN/B?X8O(K.]:VCLKI))OLD@2-GV;0QVX4G:>O3O7&07&G)I%QH&H0:W;Z(F
MK27 C72)9<(DY?:)TRI4LN<A<@$C)ZU[2Z"2-D;.&!!P<'\Q7+:9X.N]*MH[
M"#Q3JITJ)=D=JRP[E3LGF[-^,<9SD>M &SJ%U%<>&[FZMRT\4UJSQ&%"YD#+
M\NT $G.17FL%O>1^#?AO;MIFI":QO[=[J/[%+NA5(W5BPV\#+"O6888[>"."
M%%2*-0B(HP%4#  I] '%:$DR_%+Q3.]I=I;W%M9I%.]LZQR% ^X!B,'&X=ZI
M^-=.2ZU]KNSGU;2M:M;%6M=1LX'EBG!9_P!PZA2K8(!VGGY^*]!HH \UDFU3
M3_%'A'7-9TRY!;2)+6[%E;/,(;AO+;:50$@'! [<=:P_L.N'0M4O;71KXW-A
MXN?5A9R1%6N80W(0]&/4\$_=XSQ7LU% '#:GK7_"1>$=>GLM#U*)9-,FA5KB
MR=)Y9&0A45,;B 2<G&,D8)YQDR1W/V;X: :?J&;(I]J'V*7]QBW*'?\ +\OS
M''/\J]/HH X[XE6MS/X9MY[6VFN39ZC:W<D4"%W,:2@MM4<D@<X%9MM?277Q
M2GU==,U-=/DT!8HYWLI%#,)F;&W&X'&< @$XZ<C/H=% 'C=M:7T7PF\'63Z7
MJ0N[35+:2>#[#*7C5)BS,1MR !SGO72NU['\2M?O;73;J8-H<<=N9+9UBFF5
MI&\O>1CNO?O7?T4 >06$E[=:UX#U1]*UMI+<SQWP>S>*.WD: J$2/ 5$#<!@
M,8QEB0:W-0\,7D_C35M+6%_^$>U^!+F]D4X\N2/Y'0>[CRL^H#5Z'10!Q?P^
MLM6MM(,NO1L+NR0Z;$<$F2*%F'F =<OQ]0JFL#3;"^OO 'CW3H["]CN[V\U&
M6VCGMGB,JR?<*[@,YKU.B@#RU+Z;4M;^'US!I&K"&Q$T=T\ME(GE,;?9@A@#
M@,0-WW?0GG&[X-29/%OC&26TNX8[B^CEADFMWC611$JDJ6 !Y!KM:* //M1O
M;WPI\2;S5;C3+^]TG5K*&%9K*W:=H)8BWRLJ\@$.3GU_&FZE'?VGBGPQXF.E
M3QZ;%%<6UQ:PQ;Y+592"DA1,]=HW8SMSWKT.B@#RO7M*NKU/'VMVMG=M#J6E
MI96L2V[^9<R+&P+!,;L98*"1V)Z8)O7*SOKWPYF6QOS':1S?:6^QRXAW6^P;
M_E^7YN.?Y5Z-10!XPIU'3OA?XD\'7NE:G)J\8NA"\5G)(EVLCLXD60 K_%T)
M!XQC/%=!)--IGC7PYK5QIVHFSDT5[%C%:22/'-OC8*ZJ"5SM/)&*]'HH \92
MRUQ/#]S?V^BWS7&F^+IM4:R>(A[B NX/E]G.&R,$].,\5U^IW\OBWP=XA.FZ
M+>PF?3)H4:[MC#+/(4;:BJ>2!D\GC+<9YKMZ* ,3PA<FY\*:9NMKJW:*VCB9
M+F%HGW*@!^5N<9R.G...,&MNBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3TZUR&@:BEMJ'C^V:QO+IY-3DV1PVSR+*3"@V;@"%/3[Q Y^M1:5IVL>&O\
MA&O#][87]QIT.E%99M.0EFNBX)B>0$%(P.ARH)ZG H ZF7X@:#%H^DZKYER]
MIJLRP6[);L?G)(VMQP0588ZG!P#5!O'[S^(=%T^VT/5(X[[[0S_:8!&_[H8(
M"L0>I!SZ8QGG''Z;8ZI;^!/!FGS:)J<=QIWB!9[A/LK-LB$LI+\9X =?KGC-
M=EXFBNXO'WA35H=/N[JUABNX93;Q[C&TBILW?W0=I&3P.^* +-Q\0=)A&J^7
M::I<-I3[;M8;-LQC;N+8.. .>>O;-31>.M(GOM,@1;SR-3PMI>FW*P2N5W!
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M\4><98EP@R>!\W.#CH<9LWQ#T.'0H=7;[48'NQ92((#O@FW;2D@_A()Y_3-
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MYT41SD#=CABRDCD!@OY\4 =%16%8^*+?49;(V]G=M:WLCQV]WA#$Y4,<\-N
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M R<GMT. #6HK+\/Z_8^)=*74=/9_++M&Z2+M>-U.&1AV(-:E !1110 4444
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M!P&V[<X[YK*\43ZJGB72(4L+ZYT62.47!L,"3S?EV*[9!5,9Z$ G&3BNOHH
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M:PR6>IZ4XU&S6< .&3.48 G[ZY7&?XAFM.![OPWX0:[DT^XU#4#_ *1<6UH
MTDDLC9<+G&0I; _V5%3W_AFWU+7H-4N;[42D**/L(N2+5V5MRNT?=@<?D/2M
MN@!%.5!P1D=#VK@_&$5V_P 0O!]_!IU[<VNFO=-=20P,P021!5^O/IG%=[10
M!@1:N9=8W6^CWT:&$M<W4ULR95,[$4=6;+D].@/M7G]MI.JQ?"3PSI3Z5?"_
MM-2@EG@$#%D1)R['TQM(/'6O7Z* .*=+@_%ZWU$65V;'^Q7M#<>0VP2M,KA3
MQZ#KTK&TFPU31?!6O>$+G3+NXNG:Z2QF2(M%<I,6*LTGW4(+G<&(Z<9KTZB@
M#SK3-$N]$\:>%K?[/<SVNG:&VGRW:Q,8_,_=XY]#L/L.].M+C6?"/B_7X'T#
M4-4L-6NA>6EQ9*K;7**K))N8; -HP3QBO0Z* /-=9M=1TCQFNMW_ (8;7;"_
ML(8+A+.%9Y+6>,L?E5L90[SSQTY]YM3LKEK_ ,'36^@/90V^HR7,UO;0 BWC
M:-U!?9\NXE@2!G&3UQD^B44 <-I<5S;>.O&=[+8WBVUW#:BWD^SL1*8XW5PO
M'8L/KVKE+31-8T[P=X)OW\/RZ@^BI-!J&ER1#S"DF!N16X8J5!&.N?KCV2B@
M#S'Q-:3:O\/M3&E>$Y]/>\FMO*M1:JEQ+LE5F9U3(4  X!.>#ZBMJYBN)OBM
MI>HQV=T;)-*F@><P,%5W=&4'(XX4_3O7:44 <9\-;:_TSPT=)O\ 3KFUFM+F
MXR\H 23=,[@H0>1AAS4GQ/L[O4?A[JEA8VLUU=W"HL44*%BQ#J3]. >M=?10
M!PGCFSO;B7P_X@LM';5H=/DD^TZ<\8\QXI$"EE5NK*0#BL[Q':2ZQ\./$"Z5
MX3FTZ2^B2*"V^RK'<3,#DLZID*H[;CG@^HKTRB@#A]5CN;KQ[X.OHK&\:UM8
M;H7$OV=@(C(BA W'<@_3O7.WWA_6-2M/&0L]/D^T2:O!J-E%=1%([M8A&=OS
M<<E",'V[5ZU10!YN]DWB_P .:K:6'A!_#]S-82P&>\MHXG,C+@(A7DKG.6.!
MC'!SQ1O+G6=6T+P?:GPQJT5[I>JVCWB&)0BB-6#,K$X93U!''J1QGU:B@#SF
MYT2^U?Q/XZMQ;W%O#JVE0VEM<R1$1EU216Y] 7'UYQFG>$I)KG[!97G@/^SM
M4L]HN;V:UB$"E1@M$X.6+8XP.,\GCGT2B@#S'0]&O+'Q#I=]H%OJ>F174S-K
M&DW,;"UC!5B7C+<!M^W 0\YY  (KTZBB@#QVY@\1:G8:+=:CX?U635['7XKB
M[VA?*2)9&XA7< 5VE?FQSSN-=5XJT+5)O%&E:MHZ%'O(7TO4B#@I;L"XDS_>
M0AL>[ 5W%% ''>(VU*UU_1;2WTV]FT'R9$F&G !Q(-HC5CD%8\9Z$#(&3BN,
M;1]87X2:OH@T*^CO#JI>&$1AMZ?:A)E<'H%'4X![9KV2B@#B]4BN9_B;X;OX
MK.Z:SAL[F.6;R&VHTFS8#QQ]T_3OBN2OH/$6J:?IT^H>']4EU:QU^*XN @7R
M5A68D>0N[!&W&6QGKN/2O8:* .%T]KS1/'/BF]NM*OWBU,6LEHT$/FARD.UD
M)7(0[N/FP.^:Q'\,:CHGA7P7IOV2:>XM-<2_O!;1EU@0F5FY Y"F0#CDXR!7
MJM% 'F#VUQH/B[6X]0\'3:[8ZK<"ZM+NWMHY61F15:.3>1L *\$G'/Y>C:="
MUOIMM$\$%NR1J## ,1QG'W5]ATJS10!QFKVU_;_$_1]6BTZYNK0Z=/:,\(!$
M;LZ,"^2,+@'FL;2+'4]#\)^(/"ESIEW<W$LEU]AFCB+1723;BI9_NH06(;<1
M[9KTRB@#+\-:2VA>%]+TEY/->SM8X&<=&*J 2/:L#7[:_@^(WA[5H-.N;NU2
MUN;:1H #Y;N4*ELD8!VGFNSHH \P6QOSH7Q'@_LV]$NIRW#62FW;]\'@$:D<
M?WAWQZU7FL;_ $G4- UNX\,7&LV#:+#IUW:I;J\]K+&20P1NH.Y@<>F<],^K
MT4 97AZ,)IGF+I$>DI+(9$M%1490<<N%XW'&3CIP.U:M%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %9VMZU::!IIO;PN4WI$B1C+R.[!551ZDD#T]:T:Y+XCP"Y\(M"MI+=7#74
M'D)!(JRB02 AH]W!90"P!X.#GC- %RW\6V\GB2309["\MKV* 7+EPAC$1SA]
MP;ID%>G4?C5=_'5A%:66HS6EY%H]Y*L4.HL$\O+'",PW;E1CT8CN,XS7/63Q
M:SJU_'J>E>(+#5=6L'TV*\OK6-(E0*[;$\MB >6?GKCCTJ!]%UC6/A=;^!KS
M3)[>_18+.6X(!@$4;J?-5^ARB\+][)Y '- ';6GB:"[\4WOAXV5W#=VD*SEY
M0@22-B0&3#$D9!'08[TR/Q3;RVMM*EE=>==RR1VUNQC#RA,[G!W;0G&<DCJ/
M49RO&.@ZI/K.C:QH)V7T1>QN7STMI1@O[E&"N!ZYJKXST2\M;SPYJVDZ-'JM
MKI"RV\VFX4LT,BH 4#<$KL''>@"U/\2M*M='O[^>SOT?3[M;.\MPB%X78@*3
MAL%3N&"":DG\?P6EQ;07FA:U;-=7C6D'F6Z_O&"[@PPQ)!'3OD'.,5A^)K._
MUCP%>1Z?X6EL9;FYMFALECC68K'*KLTFT[5X!P,YX]\#8\7V]Y?:OX2N+2QN
M9HK341<W!6/_ %4?ENN2#SG+#@9- %F'QU:/9:[-<:9J-M<:( ]Y:2(AE"%-
MX9=KE2"H)Z]C4(^(5F)=)\W2=5BM]6C#6=P85*R.4W^7@,6!QP"1@]CCFL:]
MT[4GU7XB2)IEVR:II\4%DP3B9UA="!SQ\S#DX]:6XT_4FTWX>QKIEV7TN6%[
MU1'_ *D+ 8SGGGYCVSQ0!TFG^-+&Z761>VUUI<VCA7O(KL*2J,I96!1F!! /
M0YR,4+XQMTURVTB\TZ]M+J\A>:S$GEL)]@RR#:QPP'.#CZURNK^&M3US6/'E
MO%;36Z:I9VL=E<2KB.22(-D'N!D@9(Y&>M:OAF[O+N6!KKP.-&N;52;NX:*+
M:6VD8@*$LV3WP!C(Y)% #[?XF:=<:98:H-*U5--N[G[*UT\2!(',AC&\;LX)
M'500,\G/%6[7Q/?7'Q$O] .F3"TM;6*02AXSDNS?.?FR%^7  R>N0.*XU-$U
MD?!VUT4Z/>?VDFHB9K?:,A!=F7.<X^[[]>*ZJWM=1M?BE>:B--N);#4-.MXU
MN%*A8F1G+!P2"#AAC /\\ '775S!96DUU<RK%!"C222,<!5 R2?H*Y\>,[1)
M=+-Y8WMG:ZJZQV=U,$V.[#**P#%D+#ID>QP>*N>+-&D\0^$M5TB*412W=L\2
M.>@8CC/MGK[5R=U8:IXI\-:!HMWI=S97=I=6TM])* (XQ#RQ1@<-N(P-N?O<
MXQ0!M1^.H+C6KK2K;1=7GGM+N.UN&CA4K%O (D/S?<P0<]?:NBO[Q-/T^XO)
M(Y)$@C,C)$N6( R<"N7\*VMY;^,O%US<6-Q!;WUS#+;2R+A9%6)4/TY'?%='
MK7_("U#_ *]I/_030!RT'Q/TR4:1<2Z9JMOIVJE$@OYH5$(D<?*C'=D>F<8S
MWZFKA\=P-KE[I%OHNKW-S8W$,-QY4*D()!D.?F^[@@^OMP:Y'2K*X\5_";PO
MH,-E<1EEM'FGD3"111LKEPW1BP7  R?FYQ@UU'ANUO(/'_BZ\GL;B*UOGM6M
MIG7"R".+8WN.?7&: (=/\2Z+IND>)]8L-&U%4LM1E.HQJ%,CRJBEY &?&W&.
M 1TZ5T"^((9(-(FBM+F5=4P8@AC.Q2A?<WS=,#J,]AW%8?@K3[F&?Q4FH6$T
M,-]JTUS$)D&)861%!_':>#S3? ?A[4M%^T6NH_-;::\EGI;$Y9K=FW[C^&Q/
M;R_>@"W'X\L)&LI!9W@L;V_;3H+PJNQI@S+RN[<%+(P!QV[#FH]+\6W5WXQ\
M1:;=Z?+;V6EK"/.9X]J HSEW.[."-N  <8YQS7'7-CXFU*QT>YU+P]J$^LV.
MO17-U+YD>SRED; @!? 7:5[#IDDGFMU]#U2Y\3>-[.2PFCM?$%G$D-Z&4QQX
MMVC8-SNR&(X ]Z -M?&UDNHZ7;7-G=VT.JG;97,H39(V,A2 Q92PY&X#T.#Q
M717,XMK:2<QR2"-2VR,99O8"N \(#4O+L-,U#P1'8ZA9;%N-1:.(P,$_CC8'
M<6;' QQG)/&#Z!/_ ,>\G^Z?Y4 <1%\5-)DL],U%],U:'2K]UC74)(%$,3L<
M .=V1]0"!TSUPZR1(/C1JQ!8*VB02-EB1GS7!/MP!^5<KH-E<>*O@=I'AJ"R
MN%DNEB1YW3$4<2S!S)NZ'A>%'.2. .:ZT6FII\3]4U&"QE\B31DMH)Y%_=M,
MKNV#WQ\PYZ4 7;#QU8W]QI %G>16VL%Q8W,@3;(5!;D!BRY )&1]<'BJUIKV
MB66H>+[ZWTN^CN[ QOJ1QEIL194H"V,! /2N5M['Q#=W/A#4[SP]J4FIV5XQ
MU*:>2/)9HW7]V-^%B!.>,#I@$YK6^P:E_:'Q%E_LR[V:I"BV1V?ZXBW\H@<\
M?-ZXXYH VK'Q]9WEWHL;:9J-O;ZS&#:74T:"-G*;]A^;<#C/.,''!(YJ'1/%
ME[JNI>)(+K1[I+?3K@P($:-C@1JQ!P^2S;L\9 &.:QGT[4_['^'<(TN[,FE2
MP->KL_U(6 QG///S'MGBM30K;4M(\1^+EGTNY:WO+K[7!<IM*.IB5=H&=V[<
MI&,8]_4 QM:UZWL?@@M]X5LKRUL98%2W(=0]NC2A#DE\Y.XX()()[=:C\3VL
M.B:AHTNF^'[RR76=3M[>^MDDA6.95$C;"@DV[FVC)Z%>">HJ&31-9'P#MO#P
MTF[;5E2*,VP49!697)SG&-HZYKI?&D=YJ5SX5ELM.NYEM=7BO+C$>#%&JNI)
M!QSEAP,F@!;"]TKPP-8@TC1KXK;E;R^M87C(MF=-VU4+X' R0O'/&>E=I7FW
MB[0YM3U._P!1TNQU33_$4"(--U"S!"70V A)N=N Q(.\#C&">E>BV_G"VB%P
M5,VP>84Z;L<X]LT <SH^HGQ%XLUDDYL=&F6SA3LT^T-(Y]2-RJ/3#'O1=>/-
M.LTM;J:VN1I=U<BUCU ;#'O)*@D;MP0D$!L8[]"#5+P59OI?B/QGIDV0\VI?
MVC&?[T<Z#!'T9&'U%8?A/3]4T:SA\,7W@N*>ZM&,46L&.(V[Q _+(Q)W;@/X
M0"21U'8 ]+O[ZVTS3[F_O)1%;6T;2RN?X549)_(5S_\ PFUNM_I%G-I>HQR:
MO&9+([48.  S9PWRD*02/3Z&EUV^:\T3Q19WVBR_9+>U9$::542]#1DD*V<K
MS\N3W-<EH=Y]GOO#SZ]H?B9)-,C%K:W-S:Q>3"T@6,LYC8DD\+DC !YYYH ]
M4HK N=?U*#3M7N8_#E[++8S>5;P!T#7B_+\Z'/ Y)Y]/7BM73+]-4TFSU")'
M2.Z@294<890R@@'WYH YQ/$E[=?$*]\.-I<XLX;))#*KQ_-O8C>?F!"_*0 ,
MGKQTKE?!/BJW\,^#D^U:?J$ED-5N(9;Q%4QP;KAE7<68,1DC)4''?GBND-KJ
M-A\4[K4AIMQ/87FEQ0BXB*E8V21RP8$YZ,,8!S7*2:)K+_"#4=&&D7G]I2ZD
MTR0;1DH;H2@YSC[OOUH ]"U3Q+%I\MW#!8W-_+9Q":Y2W* QJ02!\[+EB 3@
M?CC(S>T;5[/7M'M=5T^7S+2ZC$D;$8./0CL0>#]*X._M;_1_'.I:I)X4DU[2
M]82%T:**-IK65$"%660C"D '.>*[[2HI(=,@2:U@M7P28(,;(LDG:,<'&<$C
MJ<F@#C;J_F\3?$^X\,O-+'I.DV:7%U%$Y0W,SXVJQ'.P*<X[GKD5OMX6M8-6
MTR]TTM9):RLTMO"Y2&93&Z<H/EW L"#C/%8>IZ/J6@?$)_%NF6,FH6=_:K:Z
MC;0E?-0J1LE0$@-P,%<Y[C-=-:ZG<:E(@@L+FW@ZR2W<?EG&.BKG=G/<C'UH
M S+KQS86NGS:K]CO)='@F,,NH1*IC7#;&?;NW% V02!V)&1S4EUXRMH/$/\
M8D&G7]Y>-9?;8O(5-DJ;@ORL6 ')ZG XZ\C/):;HVLZ=\-=2\"3:9/->;+BT
MM+H &":.5F*RE\_+MW\@\_+P#FM33]'NM)^(>FNMK<RZ=9>'AIWVO9D&0.I
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MM-4BUEA97EJ^D2M%<QW/EJV57=D8<C!'()(!KFYK#46D^'K#3+LC3.;WY/\
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M(_2I:* ,KP[H-MX9T2WTBSFGDM;<%8O/*EE&<XR ,]>]:M%% !1110 4444
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MDN8[UX?,B^T, 1$['A0 <\XSZC'/3VPUR=]$G-Y8_9OLY.HHJ%C*Y0;3$P.
MN[)]Q0!M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>*Z&B@#E;SPG<P>)YO$6@7\=E>W4:QWL$\)E@N@O"L0&4JX'&X'\*VK*TO\
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MD4P?PI(!AW'NP6,?\!/K7044 <5+X-UBR\27^H^'O$0T^TU*02WEI+:"8"3
M!DC)(VL0!U!&?7@5UT=L(;!;6.1\)$(U=VRW QDGN:GHH XUO!-Q?W^F7NKW
M\$MYI]M+ MY:VYBFF\R,QY8ECC )./[W/'0T;/X?:O;6_AJ)_$4!_L"0BW,=
M@%#QE"GS9<_/@_>Z>H->@44 <.? =ZWAOQ-H[:Q!_P 3R[FN6E%D?W/F@!E
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MX8TG2-3+Z;9Q>1=V\MN&,J ?ZPR?P8QP!U) Y&<=E10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M' QDY /3J*\LT&PO?$?AKP]XHBUVVM;L21W%S=JKL\Q)Q) _SX(+':%QQ@8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBDN)'C24DDN%9B <DGT!.1@U')X-T&6;4Y6LW#:H"+L)<2*LF1M8X#84D
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M.83V\(NY@(W!R"#OSP>1SQ2:GX$\.:QJRZI>V!:\""-Y$FD3S5'19 K ./\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!SMGX<O&UNUU36=3COYK'SUL_+MO)V+*5SN
M^8AB%4*" ."<Y-=%110 4444 %%%% !1110 57O;1+^TDM9'D2*0;9/+."RG
MJN>V1W&#Z$58HH 1$6-%1%"JHP !@ 4M%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%-=UC1G=@J*,EF. !0 ZBF0S
M17$*30R)+%(H9'1@RL#T((ZBGT %%%% !1110 4444 %%%% !1110 445%+<
MP0R11RS1QO*VV-78 N>N .YH EHHHH **** "BBB@ HJ*>Y@M55KB>.%7<(I
MD<*"Q. !GN3VJ6@ HHHH **** "BBHIKF"W\OSYHXO,<(F]@NYCT SU)]* )
M:**B:Y@6Y2V:>,7#J76(N-S*.I ZD#(Y]Z ):*** "BHH+F"Z5VMYXY51S&Q
MC<-M8<%3CH1Z5%#J>GW$L\4-];2R6_\ KD256,?^\ >/QH M457L[^SU&(RV
M5W!<QJVTO!(' /ID'K5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3!VG(.3P#G)/ K>.FZU+X\T?6I=-"V]MILMM-Y<Z-M=V5@!DC(&W!/')].:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "F"*,3&81H)2H4OM&X@=L^E/HH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD*I)Z<]JN:7>->Z-97LP17GMXY7V\*"R@G&>W- %RBC((R#Q2!E894@CU!H
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M;'&L4:QKNVJ,#<Q8_F>:PY_!/AFYGO9IM%M'DO3NN2R?ZPY!)(Z9) SZ]\T
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MFN;BS5I9T$<Q#LHE0=%< X9>O!R.3ZT 6;26UU32()402VEU K!95^\C+G#
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MW/%7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIHY9!&N=D2%V/X#FO*+:[T_5O 6G^*=?UGQ'I[F,->26;S(DYD;Y5  ("AL
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MR1W'&<*Q'4CD X)'3-;M>::AYWB_PYX8TV"RN[;4+:^M9[I);=X_L?D\N2Q
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MK@@Y(P"#TYJGI'A*X\%W_A"_='FAM--DTW4&B4OY3.?,#X')7?N4GMD$\9P
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MODA/N\(0=V-VX9SVK>M=0D\5^-]<TT7=S!IVD6]NB"VF:(R33*7+EE()VJ%
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M %51@ #L*=10 4444 %5ULX5O7O""T[+L#,<[5]%'8$C)]>,]!BQ10 4444
M%%%%  0",$9!JGINFQ:5;?9;9F%JI_=1'I$/[J_[/H.W0<8 N44 -1%C0(BA
M5'0*, 4ZBB@ JO<6<-V\+3 LL3B14S\I8<@D=\$9&>AYZ@8L44 %%%% !111
M0!7M;.&S$GE EY7\R1V.6=L 9)^@ ]@ !P*L444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7E5O$-&UW7=(USP=>:LE]?S7=E=068GBFCE.[RW8\(5)(^;C'Z
M^JT4 <'8P36GQ2,[:=/#:1^'XK7?!:R>0LBREC&C!<<*1C\NO%<Q;Z?J4?PZ
MTD'2=1\VP\2K>S6_V1Q+Y/VEWW*A&6^5@>,U['10!P]T;BX^*FA7PT^^6V73
M)XWE:V?;&[LA568# .%/?CO2>![2:)/$ND:EIETBRZK>3%IH2(I8I7RNUCPV
M03TSC!SCC/<UGZWIDNKZ7)9PZC=Z=(Y4BYM&"R+@@\$@CG&#0!R'@'2=1M+V
MZL;]A+:>'W>PTZ7=DR(^U\M[JAC3_OH5-=0/=?&>WN8U9HM-T1S,5&?FED^1
M/J0C''M76Z9IL.DZ>EI TCA2S-)*VYY'8DLS'N222:6RTZ&R$YC+--</YDTS
M'YY&QC)/L   . !0!3\.>((O$FE_;8K.]LF61HI+>]B\N6-A@X*^X(/XUQ/B
MMM4O[_Q;I<NDZF\<FF[=--E PCN6,3;C)(,9*L<!&.,= 2:]'M;2&RA\J!-J
M[BQR22S$Y))/))/<U-0!YCIZ7CZ]\/)GTO4HH[/3)X;EI+1P(F:*-5#''RY*
MMU_'%95_I.LW>E>*9+'3;QIHO$D>J16\D#Q_:X4$>0NX 'E2<>WN*]CHH \\
M?49=:^(_AC4[72=62SCL[J.:2XLI(O*9_+P&W 8Z=>A[$\UZ'110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>8_%7XJR^ )[&QL=/CN
MKRY0RLTS$(B X' Y))![\8H ].HKF? /B^/QOX3M]96V-M(S-'+%G(5U/.#W
M'0_C734 %%%% !1110 54AU2QN-2NM.ANHWO+54:>$'YHP^2I/UP:MUREIXB
MO)/%/BC3SI<+/IEM!-#Y#YDN=ZR$*20 #\H ';)YH ZNLP^(M&%K?73:G;+;
MV$K074C2!5AD7&58GN,BN=TWQ??MXHTK1;]+%IM0LY)WCMR=]G*@4F)^2&X;
M&>.G2J4^N3ZYX!\?"ZL[>VDL6OK/; Q8/M@!W$D#).[T':@#O;:XAN[6&YMW
M$D,R"2-QT92,@_E4M8_A/_D3=#_[!]O_ .BUK&T'Q?/X@U#9:26!$5W+!>6+
M;EN;5$WA7.6YR57^$ ;NIQ0!V-%<!=^/-2;3SJ^DZ7)?V2W)B^R16<[32QB0
MHTB2 ;,\%MN#P.H/ L/XH\1W7B#Q)I&G:?IJOI44$L4L\SD.)%=L,  <G:!C
MMSR>* .WHKS2]\5ZOK5MX#O]->"T@UB<--#(K,=PB=MI((^4$?4X'T.OJ?B[
M40VKQZ/;)<3:4?+>,VDTOVF4('9%9!A.& !.>3T &2 =I17#CQAK=WX@TO2[
M31X+=M0TMKT"]D=7A<%05==O&"Q&!G/'2DT_QW<RZ$'N[. :N=8?11%&Y\II
MU8C<">0FT%O7C% '<T5R=WXDU;0(=9GUO3XY+.SBCDM;NV^1;EG.WR]A9BK!
MB!GD'.:AA\5:Q#KR6=SI4UW9RVLDRW-K93Q"&1!GRW\P8.X=&XR>,<T =E17
M)^$_%$_B=;6[M[C3KFREMV>=;?<);2;*XB<%CG@OSA?N].:T->UXZ7>Z5IML
MB2:AJL[0P"0G:@52[NV.2 HZ=R0,CJ #<K,F\1:/;ZE%ITVH0)=2R>4B,<;I
M,9V9Z;L$';G//2LFQ\17[>*+_P +WT=LNI1V@O;2XC5A%/$6VDE225*MP1N.
M>M8_PRM[B_\ #LTNII9W,8U6ZF3=$2ZS"=_GR20,'.,<B@#T&BN=N->NX/'M
MIH'EPM;W5C+=++@[T9&5<'G!!W9[5SMU\0-4M?"VK:H-.M9IM.UEM,91(RAU
M$B1AP#GDE^A(^M 'HE%<9:^*=;L_&]GH&OZ=90Q:G%))83V<K/AHQN:-]P'.
MWG(P/Z+\0]0U73[70QIEQ#"+G6+6WF+J26#2 @ @C R.?4<4 =E17-#7-0O=
M>N]"T\V:W>GVT4UY/*C-&'DSL15# \A222>!C@YXF\(^)/\ A)=+N)9;;[+>
MV5U)97D ;<$FC.&P>X.00?>@"YJ?B+1=%FAAU35K&REF_P!6EQ.L9;Z FKL]
MW;VMJ]U<3Q16Z+N:61PJ@>I)XK"\1Z3H4>DZO>:EI\-T;F/$N^,.\AVA4C3O
MDG 4#^(^IKBS8WVDR_"[PIJ$ID^>26Z!.07@AWHN>X5CQ_N@T >GV=]::A!Y
M]G<Q7$6XJ6B<, 1U!QW]JL5PUC</:_&O5=/B)%O>:-#>RKV\U)#&#]2N!^ ]
M*T_$7B"_T+7=#B,5M_9.H7/V6:X<-OAD()08!QAB-N>Q]: .FHKE-2\5S:9)
MJDSPQ2VMO<065L$5M\MQ)M^4XS\J[UR0">HQD8-:+Q5KL6IZA9OHD]^D=BUW
M:W%O:2VZ2R#CR&\S.&/!!!Y':@#M**XS3/%M]-XL30+@:?<3RZ<UV&MF*B&5
M656A?EO[P^88Z?=K+L/'?B.X\*R^)IM(L!IUNER)DCF=I=T<A52HV\KQSWX)
MQT% 'H]%87AW5Y]8,LZ7>GWVG&.-K>[LL@,Q+;U92S8(PO?^+M6[0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<GXM\0ZIH>K^'[6R6S:+5;T6CF:-BT?!.X889X!X_6NLK@?B&0/$?@
M7G_F-+_Z U '<274$",9[B%#&H9RS!0 > 3D\ FI00P!!!!Y!%>;V>@Z1J/Q
M2\8Q7FG6T\36=FYCDC#*699 6*]-WOUY/J:V/A5*\WPO\/M(Y=A;;<DYX#$
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MS9YHXH^!O=@HY]S5/4I+UX[-]-NK.-3=()VN 6#Q9PRI@C#DX KS30H-8OO
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MG)S\_'-=%X#\/)I+ZWJ)M[:)M1U"6>%(MC-%$<80LN1U!;:"0-U '8D@ DG
M'4FHX+F"ZC\RWFCF3.-T;AAGZBN.^)6H#3M/T22Z;;I4FKP1ZBQ^Z(3N^_\
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M/&,Q[QN&?;K4U>66SW>A:UIOVVVM-8T*\U=VL-3@^6YM9Y7?Y9 ?O#+,N1T
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MII[M<$@N92X\XLW4L6W;O<5TME96C?&'Q!$;>%H[C1K=ID* B0F1P2P[\ 4
M=P+NV9XT%Q$7DSL4.,MCKCUQ2S75O;%!//%$9#A [A=Q]!GK7AVF:986_P (
M_!VK16T2Z@FK6VVZV_O /M)7:&Z[<$\=*ZS4P!XT\6VUPD.I)?:9!%%$9HU-
MM\KCRV#L,!B=^1GW[9 /2J*P?!FA_P#".>$=-TQO(:>*!//D@4!9),#<WO\
M4\FMZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPA=$DQ\K.I8 ^X!&?SKDO GBB^U_PO)K.M26%NJSRQ?N4:-5".5R2SGKCVH
MW+#PWH>ESI/8:196TR1^4LD4"JP3). <9QR?SJNG@SPQ'(SIX?TP,T@E/^BI
MR_KTZ\UJQ7MK/<2V\5S#)/#CS8TD!9,],CJ/QIL6HV,URUM%>V\DZ$AHDE4L
M".Q&<T 1PZ/IEOJ,FH0:?:QWLHQ)<)"HD<>A;&357_A%O#_V&2Q_L/3OLDDG
MFO!]E38S_P!XKC!/O4VDO=E;W[9?VMV5NI!$;=-OE1\;8WY.6 ZGCKTK!N/%
M$S_$'1=)L;ZQN=.O(+EI1#AW1XPI +!B/XNF!TH Z"\T32[^.WCN]/MYEMCF
M#=&,Q<8^4]N..*2XT'2+NQBL;C2[*6TA(,<$D"LB$>BD8%3_ -HV0OOL/VRW
M^UXSY'FKYF/7;G-#ZA91S>4]Y;K+O$>QI5!WGD+C/4^E %=M"TDWGVT:79&\
M$7E"9H5W[,?=W8SM]JC\/:#:^'=,-E:1Q11M*TI2&/8BECT5>P' _7J:TW=(
MHVDD=4102S,<  =R:R='\4:1K>E-J5I>P&U5W0R-(  %=DW'G@';D9Z@T 6[
M[2--U1X7O["UNF@;?$9XE<QMZKD<'W%1_P!@:.+FYN!I5EY]T-MQ)Y"[I1Z,
M<9;\:G;4]/2*:5[ZV6.%_+E<RJ C?W6.>#[&I8;F"XMUN()XY8&&1(CAE(]<
MCB@#.'A?05AMX4T>R2.V+& 1P*OE;L;MF!\N<#..N*EG\/Z-<V]M;SZ592PV
MI#01O I6(CH5&.#]*P8_%$US\1[32+2]L;G2YM/EN"8!N=9$=%P7#$=&Z8%;
M6FW,T%E=S:IJ=E.J7$F)8@(TB3/RHV2?F ZF@!U]X=T74[V"\OM*L[FY@&(I
M9859D'H"1TII\,Z$='.D?V/8_P!G'DVOD+Y9/KMQC/OUJ]%>VL]Q+;PW,,D\
M./-C20%DSTW <C\::VH62W?V1KRW%S_SQ,J[^F?NYS0!3_X1C03I4>E'1K Z
M?&=R6IMU,8/7.W&,^]:<<:0Q+'$BHBC"JHP /04X'(R.E01WMI+.T$=U"\RY
MW1K("PQUR.M $5]I.G:FT#7]A;736[^9"9XE?RV]5R.#3;31M+L+N>[L].M;
M>YG_ -=+%"JO)_O$#)_&J^H7<EQ;VLFEZK8P@7<:RO+B173/S1K@C#G( _E5
MV[U"RL AO+NWM@YPIFD";CZ#)YH SX_"/AN)2L>@Z8JF<7! M4 \T9P_3J,G
M!]S3[WPOH.HWYOKW1[&XNV3RS-) K.5QC!.*S?&NMZCHEII-QI\D 6XU.VM9
MA)&6)21PIVG( /U!K>N=2L;*2..[O;:!Y/N++*JEOH">: *I\-Z&1:C^Q[#%
MI_Q[#[.G[G_<X^7\*4>'=$#7;#2+$&\&+D_9U_?#_;X^;\:CO_$NEZ=K=EI%
MQ=Q)>78=UC9P-J*,[CGH"< >OX&IK-KLZSJ2S7UK-; 1&"WC3$D'RG=O.>=Q
M&1P.AH Y?Q'X4EDO-/6R\.:+J>B6T+QC3)\0^7(Q'[Q/D9>@QC ZFM'PIX8A
MT2XNKR+2;+2#<HB&SLI"Z?*2=S'"@MSC@<8ZG/&_#J-E<74EK#>6\EQ']^))
M5+I]0#D4D^IZ?;!S<7UM$$8(_F2JNUCT!R>"?2@"2[M+:^M9+6[@BN+>5=LD
M4J!E8>A!X-5M,T32]&LC9:9I]M:6S$EHH8@JL3U) ZU8NKZTLD5[NZ@MT8X5
MI9 @)]!FI8Y$FC62-U=&&593D$>H- %#3]!TC2I-^GZ;:VS8*@Q1!< G) QT
M&><#BH9_"V@75[<WMQHUA+=7,?ESS/ I:1<8PQQR,<?2KUWJ%EIZ*][=V]LK
M'"F:0("?;)J1[JWB6-I)XD64XC+.!O/7CUH IGP_HQGM9_[*LO.M!MMW^SKF
M$>B''R_A4%WX4\/7]]+>W>BV$]U,ACDFDMU+.I&,$XYXX^E77U73H[%;U[^U
M6T;A9VF41GZ-G%68Y$EC62-U=&&593D$>H- #+:VM[.W2WM8(X((QA(XD"JH
M] !P*K#1M+&J'5!IUJ-0*[3=>2OFX]-V,XJU)<00NB2S1QM(2$5F +8&3CUX
M!--M;NVO81-:7$5Q$20'B<.N1UY% %&[\-:'?ZI#J=YI%C/?0X\NXD@5G7'3
MDC/';TIUQX?T>[NY+NXTRUDN)-HDD:($R = W]X#MGI5FVU&QO&D6UO+>=HC
MB012JQ3ZX/%4M%\2:7X@>\73KJ*<6L[0,4<'<5"Y(]LMC/J* )K[0=(U.\MK
MN_TRTN;FU.8)9H59HS[$CCUJ$^%] :R^Q-HNGM:^9YODM;(5+_WL8Z^_6J_C
M74[[1?!NJZIIS0K<VEN\R^=&74[1G& 1_GL:>MS?W$6A3QW]I;K, US%*F6G
M!CSMCY&#GGOP* +TNC:9/>6MY+I]K)<V@VV\SPJ7B'HIQD?A5QE5T*, 588(
M/<56GU.PM1(;B^MH1&0KF255VD] <G@FG&^M!=K:&Z@^TNN]8?,&]E]0O7'O
M0!0_X17P]]B:R_L/3OLC/YA@^RIL+_WMN,9]ZL#1-*74([\:;:"\C3RTN/)7
MS%7T#8R![5"+J6UU749KS4[(:=%!&ZPD!7@^]N=V)^Z<<<#H:-&\0Z;KNC)J
MMG<QFU92^YF VKDX+>F0,\T :%Q;P7=M+;7,,<T$JE)(Y%#*ZG@@@]0:KV.C
MZ=IA9K*R@MRRA"8T .T=%^@[#H*FM+VUOX?.L[F&XBSC?#('7/ID5RU_XIE'
MCSP[I6GWUC<6%\;E;E8\/(C1Q[@-P; Y/3&>.M &W8^&-!TR[N+JPT>QMKBX
M!$TD,"JS@]02!T-2VFA:3I]M-;6>F6=O!.298H8519">NX <U?=UC1G=@JJ,
MEB< "LK0O$>F>([)[O3;J.:%)9(\JX.0CE=WT)4D'N* )4T#1H]*?2DTJR73
MG^]:K HB/.?NXQUYJ:QTRQTR-H[*UB@5SE_+4 L<8R3WXXYIUIJ%E?AS9WEO
M<!#A_)D#[3Z'!XJ>22.&-I)75$499F. ![F@#'B\'^&H%*Q:#IJ*TPN"HMDP
M9 " V,=1N./3)JPOA_1UO&NUTRT6=I/.9Q$ 6D_OGU;WZU9&H61MS<"\MS #
MM,GFKM!],YQ5:.2Z;Q!)_I]H]B;52EJJ_O0^XY<MGE2,#I0!I5FV_A_1[2Y%
MS;Z9:Q3!S(&2(##GJP_VCDY/4YJR-1LFO39+>6YNP,F 2KO _P!W.:P(-:U$
M_$RYT&5X&L%TI;V()&0X8RE,,23G[O8#K0!H/X3\.RM=-)H6FLUVX>X+6J'S
M6!R"W'////>IQH&CK=3W*Z59"XN%V32B!=TB^C'&2/K4\6I6,]T]K#>VTEQ'
MG?"DJEU^H!R*S].\2Z;K<VIVVFWL#S64K0,VX,-X16) !Y + 'W!% $K>&="
M?2#I+:/8?V<3N^R_9U$>?7;C /O4JZ'I*:.=(73+0::5VFT$*^41G.-N,=>:
M33)Y8M!MY]2U"TN)%B!FNX<)$Q[L.2 /QJU;WMI=6WVFWNH9H.?WL<@9>.O(
MXH J?\(_HWFVDO\ 9-CYEFNVV;R%S /1#CY1]*+CP_H]W?&]N-,M);H@!I7B
M!9@.F?7';/2K,>HV,T\<$5[;O+)&)4C652S(?X@,\CWH;4K%+O[(][;K<\?N
M3*H?GI\N<T 1S:/IESJ$6H3Z?:R7L0Q'</$ID0>S8R*K?\(OH'E31#1=/$<\
M@EE46Z8=QT8\<M[]:UJK2ZC90W<=I+>6\=S)]R%I5#M]%SDT %G86FGQM':6
M\<*NV]]BX+-TR3W. .3Z4M]86>IVCVE_:PW5N_WHID#J?P-87B;Q-'I.HZ1I
M4=S!#<ZE<&-I9&'[B-49RV">IV@#/&3WQ@Z6AIJT=BZZQ<VES,)6\J>V4J)(
MOX2P/1O7'%  =/32=+NAH5A:I=%"T<;?(LD@'R[V SZ#/I5;P_8ZB)+C5=:C
MMH]3ND2-HK9BZ0QIG:@8@$G<SL3C^+'.,EO_  DUC?7VJZ7IE];'4+%%W;_G
M42$,=NT$$X"\X/&?K5;P1XE_MWPIHUWJ-U;+J=];^<858*6Y.2JYSCB@#IZS
M9?#VBSW%W<2Z38O->($N9&MU+3*.SG'S#@<'TJS<ZC8V<L45U>6\$DIQ&DLJ
MJ7/L">:LT 99\-Z&4M4.CV!6T_X]A]G7$/\ N<?+^%%QX:T.[U>/5KC2+&74
M8L;+EX%,@QT.[&>.WI65X@\3)9^(M+T""]M[6>]2:26X<J3"J*"!@G&6+#&>
MP-:.FWUQ8V5K:^(]1TT:K(64>2_EK,-Q"E58YR1C(&><XH V*H:GH>E:TL:Z
MGI]M=^4=T9FC#%#ZJ>H_"IKZ^MK&#?<7EO:[OE1[APJ[NW4C/TS7/^!_$%UK
M7A1M3U::W$J7-Q&\D:^7&%CE90>2<# [F@#H+'3K+3(3#8VL-O&3N*Q(%R?4
M^I]ZK6OA_1[&[-U:Z9:0SEF??'$ 0S?>(]">Y'6K$6I6$UDUY%>VTEJN=TZ2
MJ4&.OS9Q0=2L%29S>VP2 @3,95Q&3T#<\?C0! - T=9[J<:59"6[&+AQ NZ8
M>CG'S?C41\,: UG!:'1=/-M _F0PFV39&WJHQ@'W%5?$^MRVG@G5-:T6YM)9
M+6UDN(Y"/-C;8I)'RL/3UK3T>YDO=$L+J8@RS6T<CD# R5!/\Z .4TWPF9?&
MWB34M6TB![/4/LXMF<HY"QQ[&5@#T) ..0<<UU%]H.D:FUJU_I=G<FU.;?SH
M%?RC_LY''0=/058NKZTL0AN[J"W#G"F60)N/H,]:)[^SM;07=Q=P16Q (FDD
M"H0>GS$XH HMX6\/O&T;Z)IS(TYN"IMD(,IZOT^][]:+O2+:W-SJFF:58-K0
M@9899$"%CCA6<#(7-:!NK<6OVHW$0M]N_P TN-FWUSTQ42ZIISVZ7"7]JT$A
MVI()E*L?0'.#0!G>'['41)<:KK4=M'J=TB1M%;,72&-,[4#$ GYF=B<?Q8YQ
MDRV?A^TM/$5[K4<$$=S=((W,484N!_$Y_B/ ^@'N:TA=6YN3;">(SJ,F(.-P
M'KCK40U&RDE6&.]MC,^X(@D!)*_>XSSCOZ4 /O+*UU"U>UO;>*XMY!AXI4#*
MP]"#P:I_\(YHFZT;^R+'-F,6Q^SK^X'HG'R_A6;_ ,)'#H&@Z;)KVK65S=W4
MZ6RS6^$29VDV_*,GA0>>?X36DTUS)KEHT.HV?V![=V-MMS)*V1AU;/W0,YX[
MT 20:'I-K-<RV^F6<4ET,7#I"H,P_P!LX^;\:CTWPYHFC03PZ9I-E9Q7'^N6
M"%4$GUP.>M6CJ-BM\+%KRW%VPR(#*OF$>NW.:)-2L8;I;66]MTN6QMA:50YS
MTP,YYH JKX<T1-*ETI-(L4T^7_66JP*(VYSRH&.O-+9^'=%T^>&>STFR@EAB
M\F)XX%5D3).T$#@98G\:TJY?P]K6HWWBSQ3I=\\#0Z9+;K 8HRGRR1;SNR3D
M\@?AT% %P>#/# EDE_X1_3-\L@E<_94^9NN3QZ\_6KG]@Z1]LEO/[+L_M4J>
M7)-Y"[W7^Z3C)'M4L&JZ==+*UO?VLRPC,ICF5MG^]@\?C0=5TX1K(;^U$;$A
M6,RX)'4 Y]Q0!4_X1;P_]BCLO[$T[[)$_F1P?9DV(W]X+C /O7(ZGX4O+KQ!
M?3ZAX3T+7K>=U^RW$\HBDMX@H C(,;< Y.0>_3H!WWVNV\[R?M$7FE=^S>-V
MWUQZ4RUU&QOMWV2\M[C;][R95?'UP: *'AK1(] T@6<4<4*&1I1! 28H=QSL
M3/.!^&22<#.!L444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>DZ=)OLM+LK9]I7,,"H<'J.!T- 'D$\YTOX?>*Q;)Y=@OBR6*[$(P$M3*@<
M#H,<'V)KJ=7DTT?%?PA/9/:;Y=.O%1HV7#+M3RQQVY;'XXKN+?1]+M(IXK;3
M;.&.XSYR1P*HDSUW #G\:@L_#6A:<\3V6BZ?;-"6,;0VR(4+8W$8'&<#/T%
M'F'AT:+XC\':6NJ^(;B#5K*\$LUJGDI<K>ASD %-Y+,3]0>M;?A?0-&NO'WC
M-I]-M)6MM1MI8 T0/E/Y*MN4?PG=R2.M=PNA:0FJG55TNR&HD8-V+=?-/;[^
M,]/>I+;2=.LKF6YM=/M8+B7_ %DL4*JS_4@9- %ME5U*LH92,$$9!KPJ2+3Y
M?V=;A66W-S#<,QZ;XS]N(!]1P2/H:]VK-?P]HDD4T3Z/I[1S2>;*C6R$2/\
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MC'&D,211(J1H JJHP% Z #M0!PVN7FGMX]GM0T$-_'HQ,]Q>OF);=I#\J1Y
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M6,J /+W9&!QG-='J;Z)HWCG3=.LX+'2[I;"XG6YE^2!(VD7>%C!"M(Q&23C
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M'=6EI+.AECWKE%+8QD>G_P!8TZPUJWC\-Z9?ZK>V]NUQ;1.TDTBQJSE QQG
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MPVT^HST-+)96DTPFEM87E&,.T8+#'3F@!]O;PVEO';VT,<,,:A4CC4*J@=
M. *X+XO2QQ>'=(,DBH/[:M#\QQT?)_2O0:@GLK6Z8-<6T,Q P#)&&Q^= '$2
MV]E+\=(_,B@>0>'BXW*"=WVC&?K@GFN3:2%/@'XKC1T$4=Y>QQJ",*/M!P!^
M?ZU[ -,L VX6-L&QC/E+G&,8Z>E)_9>G["GV"UV$Y*^2N,^O2@#C/&LT1NO
M;"1-KZU"5.X<CR9.1^8_.J*ZC9:=XV^(D5[<Q027%O:M#'(P#2C[.5^0=6YX
MXSS7H3:98,JJUC;%4^Z#$N!].*?)96DUPMQ+:PO,JE%D:,%@IZ@'KCVH \:T
M?6[?3=+^'=Y>:F]GI']F26K7<6QD@N2(\!RRL%RJL,XR,GH,U:\26'AV+PG)
M/I5T;ZVN_$5K-+<R.C122M*OF&,J ,8'.WC(/H:];DLK66T^R26T+VV ODM&
M"F!T&WI36T^R>&.%[.W:*(8C0Q J@]ACB@#@-0C:#XIZI;Z2(X;M_";>2D>%
MS()F"' ].*C\'ZOX3UOPOX5LY3#+K&GF)4LMY%Q!<(NV1V3(.!\S$G@_6O1$
ML+..83):0+*.CB,!AQCKCTI8[*TAN9+F*UA2XE_UDJQ@,_U/4T >0:;<Z%JW
MA[4O#GBG6KJ#4XM0F-QIP:-)9I?.+QM%\F]B<KC!/ITKHM$U:TL_B)XOL]?N
M(;>XD6W:V^U.%$EJ(\84G@@,6R!W)KO&L;1[Q;QK6!KI1M68Q@N!Z!NM+-96
MES-%-/:PRRPG,;O&&9#Z@GI^% '&?!Z>&7X7:.L,B/Y:R(X5@=I\Q^#Z'&*O
M?$._L-/\-1/J-LL\,E];1J9)&CCB?S 5DD8<[%(!/KC'>NIAABMX5A@B2*)!
MA410H ]@*)H8KB%H9XDEB889'4,I^H- 'D:7ME-XC^(:3:E:WK7&C0N'0*$D
M*Q3;BHR<A>!G)QW-+'%9VWASX3S0I#%(US; N@ )W6S;N?<XS[UZLUA9L"&M
M(""@0YC'*CD#Z#TIATO3RJJ;"U(7[H\E>/IQ0!Y9::O9CPK\1=/UJX@BU<W-
MZ98;A@KR(8\0E0>J[0H7'I7?^!YXKCP'X?>&5)%&G6ZDHP(!$:@CZ@\5K3:=
M8W$_GSV=O+-L*>8\2LVT]1DCIR>*L*JH@1%"JHP !@ 4 >?_ !3LKE8_#WB&
M"&2>'0]3CNKJ*-=S>3_$P Z[< _3/I771^(M'GT^.^@U*VFMY #&T4@<R$]
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MD&/.V]U7&U!W.37HXTZQ$@D%G;AP,!O*7.,8QG'IQ3!I.FJ01I]J".01"O\
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M/]G-JUTVFCL+8O\ )M_V2=Q'L0:M?$Y8F^&?B'S0A LI"N[LV.,>]=6 %
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MTG7='*N<,,X[^XJW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_*38W#+M&#]1216\$  AACCPH4;% P!T'';D_G4E% $2V\"2O*D,:R2??<*
M6^I[TY(HX\[(U7/7:,4^B@!KHDB[7567T89%)Y,>_?Y:;_[VT9I]% $9MX6+
MEH8R9  Y*CYL=,^M$D$,S(TL4;F,[D+*#M/J/2I** (_L\.Q4\J/8O1=HP*/
M(ASGRH\XQG:*DHH Y_Q'HFH:@EC)I%W:VTMK.9F@N8-\%Q\I7#@$'C.0>Q .
M.E,TK0+E=0AU'5(M+2Y@5EB73[<H!N&"6=CEN.V /7/&.CHH ;'&D4:QQHJ(
MHP%48 'TIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-6T\>'9IWEC,L3FZM5=BS)'@[3R3@GIG.#TJ7Q-X.OO$\5Q:7J:>4%RLMCJ
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MH=Q (PNW(QR?:@"EX?\ $&L:5;>"+*ZMK(Z7JEG';Q[&8S1NL =6)^Z0=IX
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MB<*&900PV ;@N<-SGCCG!;P=XNGT#1-'N;_2&31KZWGANMLF^:.$_*&7H&P
M#@G/J.^S9>'-7T#7=9N]'DLIK35I!<R17+O&8+C&&==JMN5L [3CIUH J6'Q
M#CUZQTAM,B:&XU"UDN9-]M)<_9Q&XC92D>"QWD@'(& 3Z PGQ]?V6BP7&MV'
M]DN=3:PEO+FVE%N$"LRSA6PP1B HR1@GD\<L;X>ZCH=OH5QX4U&WBU+2X9+>
M3[:A\F[21M[A]O*_/EABMU]-\126,'VJ;3+V:65C?6LBLENT13:(TR&/!P<D
M')SP,@  U=$NKN\L3-=O:2YD;RIK0YCEC_A<<GJ/<UD^,/$.H^'VT7[#:6UP
M+_4HK)_.D*E=^>1@?[)Y[>AJ7P;X9'A;3;NU3RXX[B\DNDMHF+1VRMC]VA(!
MQQGH.2>*9XNT*_UQM$-DULHT_4HK]_.=AO"9^484]=W7MCH: ,V+QK>:5>>)
M;;Q'%:@:/:1WJR66[$D;AOEPQ^\"N,]#GM3[WQ5JVB0:)J6JP6;:=J<T5O*D
M"L)+1Y1\A+$D2+G@G"^OM27O@NXU?7_$,^H-;C3M8T]+$K%(QDCV;L/RN,Y;
MIVQWHC\*ZOJ&DZ-H^N364EKID\4S3P,Q>[\K_5AD*@)DA2V&;."!C/  GA.]
MUJ\\:^*XKV\MY;>TNHH41864JIB#*%.XX^\<Y!R<].@Z77[ZXTOP_J&H6L44
MLUK;O,J2L55MJDX) /I65I'A_4=*\8:YJ(N;5M.U.2.?9M;S5=8PFWTQP#G\
M,=ZU=>L[C4O#^H6%KY8FNK>2%3*Q"KN4KDX!/&<T <G:^,=>BT'3]8U*ST];
M?58K5;**W,KR>=*,MO !RH&6 7)XQR>:=)XRUK3SKGVO1YKJ"RL3>6UY%936
MZ2D<-&RR9(8=>"<C/'%37?@R^O\ X>Z5H;7L5IJFE+;M:7<.71980 K$$#@X
M.1[]ZMVEEXSETZ>34M0TJ/41&$MDLTD\C.X$M)NY).,8 & 3USP 5H_%5[<>
M'=5UK3[_ $C4K.VL3<P3V\; ,ZAF>-UWDJ<!>^?F/'%.?Q;?*O@R806_E:]L
M69,-F(M"9,J<].,8(J&#P('U+7+UH;33!JVG&RFM[%RZ.[;LS-E5&[!P./7)
MYJE;^#_%#P>%([N]TE/[ E7'E+(WFHL1C#'./F((XX YY/0 $<,]W:>*/B=<
MV$D45U#%:21O(F]05M<\C(ST]:Z3P%+?7'@71;B_N(YY9K*&0.J$'!C4_,23
MEO4\?2JEMX6O_P"W/%MU<RVRVVNQQQIY;,SQ;(C'D@J <YSUXZ<]:TO"&EZC
MHGAFQTO4IK662SA2W1K8,%*(H4$[NYQDT 5_%^NW>A?V*UO:VTT=YJEO9RF8
MG*"1L;E ZGKWX]ZHR^(?$=UXPUCP_IUKIB&TM8;B&>X=V!WEA\P&,_=Z#&.3
MD]*O>,="O]>ATE+%K9#9:E!?.9W8;A$V=HP#U]>WO3+70]5MO'&JZ]BS:&\M
M(K=(O.8,IC+$$G9CG=^&.] %SP=K[^*/".G:S) ()+F,EXU.0K!BK8]L@UN5
MSO@;0;SPQX1L]&O9()9;7>/,A)*L&<MT(&/O8[]*Z*@ HHHH **** "BBB@
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M-.AN[99H8VC65/(W*VUB2#AO7'&1UKI;'1[;6O!FB6UVB/"MM;R,&0,3A <
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M<DY/OQ70T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5A^)=<?1X].@MUC:\U*]2S@,@)1"P+%F
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M9!4D]!T]ZUZ "BBB@ HHHH ***XZU\0:AKWB?7-*TZ_LK%])D6(0SP&624E
MWF$;UPF3@8YX)SR!0!V-%<W]KUF;PCYUW>V.D:H)F22:1-T*A9B. Q&0RC@D
M]\UL7.K:;92^5=ZA:028SLEF53CUP30!<HJF=6TU;$WK:A:"T!P9S,OE@^F[
M.*GMKF"\MTN+6>.>!QE)(G#*P]B.#0!+152\U33].*"^OK:UW_<\^94W?3)Y
MK'\9^*(?"^@_:Q+;_:9I(X;=97 !+NJEL9&0H;<<>G:@#HZ*Q-'_ +5#7TTV
MIVNIV#A7L)(T DZ'<K%?E(R!@CWS7,ZMKGC'1]0\-6-Q=Z(TVKSF"7;I\N("
M$W''[_YN>.U 'H-%9%A<ZC9BX7Q!=Z?S.J6LT*&!9 P&%*L[?-NR.#SQ5AM<
MTE+3[4VJ60MMYC\XW";-PZKG.,CTH OT57.H60@AG-W;B&=E6*0R#;(6^Z%.
M>2>V.M):ZC8WQE%G>6]QY+;)?)E5]C>C8/!]C0!9HJI:ZKIU](T=G?VMPZC+
M+#,KD#U(!I+75M.OIW@M-0M;B6,9>.&9791G'(!XYH N454DU33XKY+&2_M4
MNW^[ TRB1OHN<FJ%EXJTC4/$%]HMM>P/=V83S%$@Y9MQ*@=RH7)QTS0!M45E
MZ+/,NC^=?ZK:7S*\A:Z@4)'M#'C@D#:.#SU!JU::E8ZA$\EE>VUS&AP[0RJX
M4^A(/% %JBJ2:SI<DT$*:E9M+<9\E%G4M+@D':,\X(/3TJ[0 453M-6TZ_E>
M*SU"UN)(QETAF5RH]P#Q33K6E!XD.IV8>:0Q1+YZY=QP57GDCT% %ZBJE_J%
MII\&ZZOK6TWY$;W#A5W8]R,_3-87@#6[[Q!X7%]J,D4EQ]JN(BT2;5(25E&!
MD]@.YH ZBBN*N==\0O\ $N3PQ:7.F16W]E?VBLLMG)(X/F^7L.)5!]<_I5KP
M7XJN_$$^M:?J-O#%?Z1>&UF>W)\J7T9<\CIR"3CUH ZNBJB:KITM^UA'?VKW
MB@EK=9E,@^JYS2'5M.6^%B=0M1>$X%N9E\PG&?NYSTH N454N-5TZTN%M[F_
MM89V *QR3*K'/3 )S1>:II^G;/MU];6N_P"YY\RIN^F3S0!;HJ&6[MH#$)KB
M*,RMMCWN!O/H,]33+/4++48FEL;RWNHU8HS02AP&'4$@]?:@"S17->,/%$7A
MNTLD$]O'=7U[!:H97 \M7<!I",\A1D^F<9J73[Z;3(;B;7->TZ>QEEW6-TS+
M$S1D9(<\*2#G!7J* .@HJ"2]M(H(YI+J%(I2JQR-( KEON@'OGMZT6MY:WT1
MEM+F&XC5BA>*0. PZC([CTH GHKS_P 2:_XO\/V.E7,L^C;]0U.&R\@V,A\E
M96(!+>=\Q  SP 3736EQJFGS7CZ_>Z:;)$C:&YBB-N 26#JX>1NF%P<CK0!M
M452;6-,6*:5M1LQ'!)Y4KF=<1O\ W6.>#['FG#5-/-B+X7UL;,]+CSE\L\X^
M]G% %NBJT&H65U<SVUO>6\T\!Q-%'*K-&?\ : .1^--AU73KFZ:V@O[66X7(
M:))E9QCKD YH MT53BU;3I[UK.'4+62Z7.Z!)E+C'7*@YXI;C5-/L[F.VNK^
MU@GEP(XI9E5GSP, G)H MT5B_P#"5:0?$[>'Q>0F^2$2NGF ;22 J_[QY..N
M![BI](DN&%^;G4[6^"W<GEF! OD)P1&V"<L.YXZCB@#3HJI9ZII^H-(ME?6M
MR8_OB&97V_7!XIC:UI2O$C:G9AI9#%&#.N7<=5'/)]NM %ZBFN'*,(V"OC@L
M,@'Z9%<)X4USQ9XFT_4[D7FBP/::A/9(AL)2'\LXR3YW&?IQ[T =[17+^$O%
MDFO7.IZ5J-FMEK6E2B.[@5]Z,&&4D0X!*L.>>16[:ZKIU[/)!:7]K<31_?CB
MF5V7MR >* +=%9'B>ZU&P\.W]]IDEJEQ:P/.!<Q-(C;5+8PK*1G'7-9G@SQ=
M_P )9H\HDB%CK5F?)OK.0$F&3UQG)0]0<_CQ0!U5%8GAW4[NZ\/C4-6GM%;=
M)N>*,Q(JJ[+D[F;L,]:NIK.ER6$U]'J-H]I""99TF4HF.N6!P* +U%9?A_Q!
M8>)=*BU'3IDDAD&0 P+*,G&X=B0,X-<QK_C/4O#OQ TS3;J.T?0;T)')<"-E
MD@ED+K'D[B"I*8S@=: .[HKGO&WB&7PQX6N]0M84GO51A;0OG#N%+'.".%56
M8\]%-+X<UU[OP9I>MZU=64#WEM%.S*/*C0NH(7YF/KZ\T =!16)K'BS1M%T1
M=6GO[=[:1@D+1RJ1,Y. %.>>>OH 3VII\8:'_P )!;:,FI6KW,\#3C;,I  9
M5 SGJQ;@=\&@#=HJH^JZ='?K8/?VJWC?=MS,HD/?A<YI)-6TV*?R9-0M$E\Q
M8MC3*&WMT7&>I[#K0!<HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9WLZE0Q7<-W7);GDUU?@O3M(TZUU(:+?S7UM/>O.\K.C1^:P!<1E %VYZ@<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$\6:78>*SIR:='J&J7[W5G(]PQ6(,JKEOD^\ N0.1FN]HH XC3?"EW;>%_\
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MC).#P!D?F*K_ /"5>'<D?V_I?'!_TR/C]: ..?P?K\G@SQ=HYBLA<ZU?7%Q
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M<, D?6MP^(]:MM2L]&OK*PBU34)YOLHBG:2-+>-0QD?(!+9.W:,9/<"LC5?
MNJWGAW588'L?[4U;4X[^X,DKK'&(W0JBD(2V%C R0.23[5M>(O#VH7VLZ'XA
MTUK=-3TLNK02R$1312* Z;@N01C(.WKU% %*?QY+I:^(K74[)?[0T:!;G]P2
M8[B%^D@X)7!R&'.,<$U;'BXVNBZAK5Q+97VEP6\<MO=6#$B=V+ QX)."#L'7
M^+M3?^$>U;^TM6\01_8X]8NXH+>"%G9HHXHVW%6;;DELMG"\<8]:R'^&D=X/
M$*I'!HUMJUI'$;6RD+HLZL6$^,* <[1@#D G@F@#4MO%U_%XB@L;^QWV-Q;R
M3&]MX)E2V9!N*2%UQ@C.&XR1C%26?B/7-0M=&U6TTF.?2]3D4&-7Q-;PN"4F
M8DX(Q@E0,C/4T:-8>+[N#[)XJFTLVR1-$[6!<O=94KEMP 48.<#.3CH!@TO"
MF@^+]"M;;0;F]TV31K)@L-Y'O^TR0J<K&5QM4X^4G)XZ#/- $@\:7_\ PCOB
MS4#9VWGZ!<SQ;-[;9UCC5\^JDY]ZKW>O:W=>-/"<%LUM%9W]A-=M"V[E@B9R
M1U #\#\3VQ#>^$/$0M_&.F6+::;'7C-/'/-(XDC>2((4*!<8RH^;/ ['I5U_
M"^N1ZEX4U""33VGTJTEL[I79PI#J@WI@9)&S.#C.>HH DB\81V6I^,6U*Q@M
M8=#2&226!M[SJT9<9R!SC  ]>].N_%FHZ.-$O=6L[9=/U6:.W;R68O:22#*;
MB>'7/!(VX/8U7E\$W>IZEXS&I-;)8>((H8XS#*S21>7'L!(*@=<-U[8IP\,Z
MUJVE:)I.N_8O(TRXAFEN()69KKR?N?*5&W)P6Y/0@=<@ KW'C/Q$W_"4"STC
M3LZ"_P YENG(E01B3"X7[Q![X XZ]NSTC44U?1;#4XT*1WEO'<*IZJ'4,!^M
M<G'X7UM/^$TR-/\ ^)[DV^+A_D_="+Y_W?MGC/I[UIZ)8>(-)TWPUIFW33:V
MEJ+?4&WNSG9&%0Q< <D<[ATZ4 ;MW8VU\L:742RI'(LJJPR-R]#CV//U KAM
M#AB?XR>,$>-&0V-D"I4$?=:O0:Y'2?#^KV?Q#UK7YULOL6H00PJD<[F1/+!&
M2"@!SGUXH Q;BVN-,^+%E9Z):VY>+PRT,*S.4CC19U S@$D #& /RZUH6'CY
MKCPW9W5S:)%J=Q?R::8$9GC$L9?>P(&XJ%0MTST'O6A+H>J'XCIXAC6S-DFE
MM8[&F82%C('W8V$8XQU]_:N<7P#KR^'?+AO+&UUFTUF75;&57>2(EV8F.3*@
MX(<@XS0!TOASQ%?ZGJ^I:;?6#I]E"/#>QPR1PW",.P<9#*>",FLKQQ!KVG:_
MI'BG1].&KPV$4T-QIX.)-K[<R1>K#;CUQQW-=#H*>(75[CQ"UC',5"I;V+,T
M:^K%F ))XXQ@ =\TFHPZ['KL-[IOV2:S%N8YK:>5HRS;LAE8*P! SU'.>U &
M5X)UOPYXDN=3UC1"8KJ?RDO[62/RY8Y$W8+KZD'&>1\OL:Y3X;:W+I7PEB9-
M#O;M(FNCOC6,QG]\_7+;L#OQV/6NOTGP[>VWB?5_$\]O9PWM[!';I:PRDIM3
M)W2/MY8Y X7@ #FJ/@O0O%'A+PG!HK6>CW3PO*PE^WR(&WNS]/)/3=CK0!GZ
M^D=U\2O"G@XH%T6ULWO7MOX)C&"L2MZA2N<?G7=:MHUGK,%O'=1*QM[B.YA?
M',<B,&!![=,'V)%<WJWA'5;\Z)K<-];1^)]+W-YC*QMYA)_K(C_%LYPIZC'3
M-;=L^OWFQ+VUL]/0$&1H+IIV;'\*Y10 ?7DX[9Y  SQH ? OB$$9']FW/_HI
MJY?P[XCU73+;P5I]W86HTW5+..WAD28F9'6 ."PQMP0IX!./7M78>)+&YU3P
MSJ>G6?E>?=VLENAF<JJEU*Y) )XSGI7,OX5UMH?!2 :?G02IN/\ 2'_>8B,7
MR?N_?/./3WH 75O&^H:/(D]W96T$#:HMBEI+)BXEB+A//7G&,G.W'3O5JZ\7
M3OXBU31; V0O[#RRMG<L5ENE9 Y>,YQ@9(Q@Y*G..#7/W?@?Q3<:1J%AYVDR
MR2:LFH1WDLDGF7"K*'5)/E^7:!@8W#   '6M+Q3X/U+Q3#=6U[:Z8TN^-M/U
M..1DFLR%7<0 N>'#,!NYR <8S0!VFH/<1Z?</:>5]H6-C'YH)7..,XYQ7DMY
MJ&IZG\'O#^I:B8[B>?4;*92A^9R9P3G/ /Z5Z^\6^V:$L3N3:6/7IC-><1^"
M?$J_#_2O#CMI1DTZ[@D6032 .D4F_)^0X)X&,<8SDYP #<M_%U[9>(M5TO7[
M6UMUM-._M1)K65I!Y(9E8-N ^8%>W6J]MXTU*34=&)TMIK'4V"/Y$$N^S+#*
ML[%=K+V)&,>XJ6_\*7VJ^,KW4+L6JZ9>:(VE2HDS&4;G+%@-F,?,1U]_:F>%
M]*\:Z;#::3JM[I<FFV6U$NX-_P!HGC7[JLI&U>@!.3QQU.: .DUV^O-.TB:Y
MT^P>_N@56.!3C)9@N2?09R?8&N3F\3OJL/B[0IS9W#66FF5;FT;*2*Z."I4D
MX(*D=3U[5N>-='U'7?#<MCI=Q#%<&6-RLY(CF16!:-RN2%8#!Q]*Q8?">NS>
M(=7OKI],M[74]*6R:.W+L8&4. %R &'SYSQTQM'6@#'T'Q5K7ASPCX.GOM*M
M3H%Q:V=F9X[@F>(O&JK(R[=NTGL"2,^O%==HVMRWWC7Q%I,UA;0&P2V83QON
M:<2!R-W QC'3G&3S65:>$]6N_#>A>'=66RCL=+:W,LL$S2-<B#&P!2B[ 2JD
M\GI@=<C1TW1-5L?&WB'6F2R:WU&*W2!!.V\&)6'S?)@9W=B<8[T <;X=UJ7P
M]\"M(OX]/MKV-9O+>.=\!0UT5# 8.2"0<<?6NFN-3UP_%J+2H9;46"Z0UPL;
M!N<S(I8XZMQQV )]:RAX&UX?":W\);M-^V13JYF\]_+*K/YW_//.>,8Q[UT%
MUH6K'Q]9>(K5K+R3IQL;J.5VW(#()-R8'S=".=OK[4 5].\8WDNF^)6U&UM[
M?4=%F:(VT;,WF#:&C89P2),X KJH#=MIZ-.D*WACRRJ24#XZ9ZXSWKC+K2K'
M6_B3I^I:=?I)$EIOU*.!@Z2^7(#;[B/X@^\C_<([5W= 'FWAOQCJ5GX&N-:U
MDPW4TNHRVUO'$2IDE:X:-4YSM7IZX [UT+>([W2_%>FZ)K$-N4U1)#:7-MN
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M %%%% !6>VB::^L+JS6J'4%3RUN,G<$Z[<YZ>W2M"B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@"AI6B:7H=N\&E:?;643N7=((P@9CW..M7Z** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** $ "C   ]!2T44 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%8'BK5+W2H-,>R>)3<ZC;VDGFQEODD?:2,$8
M([4 ;]%8&OZGJFG2R'3X5NF73[BX2V$9+R2QE H!ST.\\8R<#!J/POK@UX27
M%MJEK?V011\D1BFAER=R2*3E>V 0#UZ]: .CHKFI]1U:7QM-HUK<VL5NNG)=
MJTEN9&WF1DP<../E!_K679>-[R^O[70OL\$.LM?W%G<.,M$BPHKM(HR"=RO'
M@$\%CG..0#N:*XC7/&EQX7O[O3KR-+R<VL=Q8LH\OS6:58=C]<8=T.X=B>..
M=VX_MZS@6>.2VOF5':6!8C&68(Q4(=QP"X4<YZ]: -JBN)T?Q3<ZKI[WUMJ-
MK<+;0[[ZV^SF*XMI%92Z%"Q(^7S ,CJ!R:W-1U.ZMO$>B641A-K>F82Y4ELH
MFX8.<8_"@#:HK&34[H^,Y=*;RC:"P6Y3"$.&+E3DYP1QZ"J5MKU]J'B>[L+9
M8$M!8+/;2N"2[%V7><$97C@=P,YY& #IJ*Y71=7U#4]-U<?VMI<CV=XT"7T<
M>4"!%8EH]_# EEY8 X#=.N:OC6:#PWHVJ:A=6L=G=O-'/J-K&9(E*DB([<G;
MOQSG.T_*<$Y !WE%<CJNI>*+7P];ZO$MA%-'#"\U@T;.T\K$!HU<-A>3A>&Y
M]J5O$]U_PF#Z'M1+D7">7;.A'FVA0%I@^<$AMPQ[8QSF@#K:*X_1_%ES?R:#
M<RK']DUTSB!%7#1; SIDYYRBMGWQBIM=U^\L?$NGZ>DRV%I,44W5Q8O-%,[-
M@1"0.HC; X+ @EAZ8(!U5%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>elicio-insidertradingcom006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;R,$E1R%)P37=Z=XITC5-7FTJUN'-Y%%YVR2!XP\><;T+ !USQE<BO*W,J_
M:[T1K.\&HV]T4D@-LX)8WI?"\?-\GS<9P.M=;JY-Y\4=.:U=@LFB7, N%4[$
M=V0H"W0'@D"@#I#XNT5;VUMFN77[7*8;>9H'$,L@S\BR8VDG!QSSCC-6O$5W
M>V'AO4[O38//OH+622WBQG>X4E1COSV[UYMX2FTRZTK2?#>KZ!JC:_IC11M;
M3B<PH\? G#D^6%P-P_( Y&?3-;OIM,T.^OK>W:XFMX'E2%%):0@9"@#J3TH
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MW(B8Q)<$@>66]<D#/0'@G-6K7Q'IUYK]YHD+3?;[1!)-&\#J IZ$,1@@^Q-
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M:7=Q]F@O3'^X>7) 7=UY((!(VGL:LZ9XELM6O=3L[:.X%QIK!+F.2/858C(
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M'FHT:*GF&%SE-J@@=1@D\8[\FQ-KNN)=_$.!=2YTBWBFL6\A/W68&D(QCGG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6/$CV=_>7*'S 4WW;>:P\K&.C< X'%=5>^,/#NGSW4%SJ]LDUH 9XPVYDSG
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M+;9(R E@KXVL0%;.#Q@U2\->+K#Q/-J*68D M+IX!OC92P0*"W(X^8D8ZX%
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M=#A5BS@ %97)!]P""?:N)M+BSB^!OA]1+"DJZO$Y7(# B[))(Z\+S]*]SHH
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M[P_WJ=XXDCC\!>(#(ZJ&TZX4;CC),; #ZD\5OT4 >3F[LGN?A1OG@8)$Q;+
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M#Q?3+R"U\)_"V^N)0MM:W!CGE/(B8PNH#>AS@5[,CB1%<9PP!&00?R/2G44
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M&PC@=XT"+C&5#;3@'ITJJMY'+X5^*0\N>,W$]PT0DA9-^ZW55 R.I(^[U]J
M.M7QI!I8\*Z==)=37.J6P=Y5@DDPJPEB<J#N8MC@9X))Q6Q>>+-$L)Y8KF^V
M>3(D4T@B=HX7;&U7<#:A.1P2.H]:XJ\NXK;4?AIJ<F\V<,,T4DL<;.%=K8*J
MD*"<E@1CUK!\9ZFFH>'?&]DMO-97,-X"+"WM3FX4-'_I,K!3G<!QR  !G)H
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MIMQ/Y3(51RI0*P7:&8G=P.<Y&.M=59^)=&U#1'UBWU")M/0L'F;*;"IP0P8
M@YXP1FN8U9[:'XN>&4S&B0:?=)C@",MLVCV) .![5Q\BW4VA:]<V$;W,=CXS
M_M*XMX1N::V5D)*K_$,C=QUVF@#UJQU_3=1OI;&"=A>1()&MYH7ADV'@,%<
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M 4 'KG'<Y% #W\4'6(?$6IOJ>KZ?_8VH,L M;65E,$2(65T*[6+$MG=RO!X
MKL])\4V>H>&K#5Y_,@^U1QGRC#)N,C(&VHNW<_4\J#D ^AKC-"D6]\-_$BUM
MCYL]Q?W[PQKRTBM"JJRCN"1@$5GS:I'!X<\!:V\5_+HVFV_V;46MA*CP,T"*
M'^7#$*P8$CU(Z\4 >A-XU\.1Z7-J4FJ1QVT$WD2^8C(\<F<;&0C<&Y'!'>KV
MDZ]I>N_:O[,NTN?LLODS%01M? ..1R,$'(X->8>+?^$>N?ASXCO]"MIVCU&6
MUW7,QF9KQTE4G:LGS$*O<#!Y_NUZY!)%+"DL#(\3@%60@@CVQ0!A^.;BZM/
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M&>$VLJR*""5(0J&8'!P0#FN"M=5B\3>&[S7-1\0ZYHOV>[N?,FM5F2-;=79
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MS,2<8 QMQG&[G&>*;H>NZ)9>$[.]BUJ[U"RFG>&"ZNMTDT\AD8; -H9CD$
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M1S,;VXD1("HGE2"21("V,>8RJ0O!!Y(P"#T-8MS>W0^+&DV\5_,]A<Z3/,8
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M/*?$H"[CAL8!V\X)!IB^)-,>[BMUEF8RSM;QR"WD,;2+G<H?;MR-K=^H([4
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MDCG"JH&22>P H 6**."%(8D"1QJ%15& H'  I]8^G^*-)U.^CLK>>07$MO\
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MM-RL$+2>3%S\S8''0\=>#Q4=WXRT*RGTZ&6\8OJ41FM/+@=Q,H7=\I P3C&
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MEMGE;#R&W<<_7IS4%_XXL;70M<OX[6ZDN=&4_:K,QXD1MNX9[;2.=P)&/RH
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M+E<>]03^<OQ#\1W7V&_-O+HD<,<JV<I5Y%:0E5(7DX8=*]"HH \C%M>)\./
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M:]EHH XEO-?XQ6MXMI>?9#H;P?:#:R",2&97"EMN =H)_P#KUQ6BP_\ "2?
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MH0I,E\)+3+,7*Q#;^[4D$Y)P1Z\UL?$K3KO5OAUK5E80/<74D \N)!EGPP)
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MXB Z >A5%://]YO>MO68)S\3_#%Q%9W+6MK:W<<LT=NYCC+A-@+ 8YVGZ=Z
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MR<'!QC-=?J-LVO\ CCPYJEO:W<=MHR7,T\TUM)$29(PBQJ& +'J3@$?+ZD4
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MBQ+L=IZ$^A.>*U=?:Z77=%\4/X8OM3TMK)[*YLS:A[B EE99!$>>H(/?'X4
M=9;>-=&N]'_M&*2;BZ-D;8QD3"Y!QY.S^]G\,<YQS6#H=]+<_&#68VCOK=5T
MF%FM[J0L%<R-DJ S+@C;]TXZ]\UG:Q874<>A>(]'\+RVMI8ZHUU/IL%NJ7$L
M;Q[#*8UZN,G"]<8SCD"]9WMS)\2=2UR/1=6-@VAQJCO:-&7=))&*!6P=QS@
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MCR[A[3$<OG<*5;.#@X!^HQG(H [*L;Q3X=B\5:!/H]Q=36UO.5\QH0NXA6#
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M*2268LS,3DL2>22223[U8HH **** "D=0Z,I) (QD'!_.EHH BMK:&T@6"!
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M,Q8G<6/?/OBK.IQ:C?>#_!L2Z-J*366I6,D\30Y=(X@-[D#. #T'4]A7IE%
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M<.!QZL/KVKMZ* .3^&=G=:=\/-'L+ZVFMKJVB,<L4J%2IW$_B,$<BL^R@O\
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MH Z&;QI:0Z?X<O6LKHQ:])!' 5VXB:5=RA^<],] >E=+7EEY_P B1\+?^O\
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M!.%VD\=2P[<$ ]'HKR_49_&.E:7X<MK_ %H1WLVO)8R20A'\VW8,RE_D'S@
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MS22. 2P7HH4#C&<\YH [ZBL3PG'KL.@QP>(IH)]1B=D:6$YWKGY2V  &P1G
MK;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHK$\4>(X_"^F1WTUG/<QO/' ?**C878*"<D<9(Z
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M4   *!T '<GDDFJX\1Q_\)H/#1LYUE-BUZ+ABNQE#JF!@DYRW<#I6W0!R[^
M=$?P_K&C>4ZVVJW#W,Q#?,KLP8;?0 @$#M5WQ#X8L_$7AM]!FFGM;)PBD6NT
M-M4@@#<I &5':MNB@#"?PQ')XGMM?;4KTW<%JUHJ_N]C(Q!)(V9R2 >#7+>(
MO#L7AWPS<6L,^N7%MJ.K+=W=S;*KRVA+^8TBK&F2-R@8P<9SCC!]&HH X'PP
M+R36+>33O$NM:KI_S?:EU*R$:*NT[=KF-"6W;>!GC.<<5WU%% '/ZCX4@O\
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MG1:78I:Q232X)9Y9WWR2,>2S'N3^788 Q5RBB@ HHHH **** "BBB@ HHHH
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M:R?:)C(&86[?.,_=)YX7 ]JWY/ VE7,NO->27-W'K@07D,S+M.Q=JE=J@J0
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M0;P/9W^JFQ27S8=,DNMUK"^<@JF,\'D D@'GK0!F>&-.5/BIXQ;[3=GR18L
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M[[?)=QL@>27RS'\P*[=NPXQM[ ]>:OZ3HMMI!NWB>26>\G,]Q-+C=(^ N?E
M P% P .GKDT 8>JZK-=_$/3_  OYTMO:MI\M_,T3E&F(<(J!AR ,LQP03@=L
MYQ$NK^=/'?AF]O+F>'2H5EM;HN1(8Y86<1LP^]M((R>2#S78:SX;M-8OK'4#
M-<6FH6+,;>[MBH=0PPRD,"K*>X(/X4U?#%JNG:E:BYN?.U/)N[O*>=)E=G7;
MM&%     [4 4/AQ:BW^'N@,)9G\W3K=R))"P7]VO"YZ#VK*URR$_QA\/DW-T
M@;3KIMJ3LH&UH^@' SGGUX]*Z[0](BT'1[72[>>>:WM8UBB,Y4LJ*, 9 &<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ JMJ&GVFJZ?/87]NEQ:SH4EBD
M&0PJS10!SUCX2CL+=;2/6=7DL$&U;26=64+V7?M\S'MOJ?4?#%C?ZC9:C$\U
MC?V:&*&YM"JL(SUC(8%67V(..V*VJ* .<OO!6EW^@3Z/*]RMO<S_ &FY=) )
M)Y-P;<S8]57ICH!T&*LR^&H)O$%IK<EY=F\M86@C.4"E&QN!&WN0#_+%;5%
M'F?CKPLFF^ ];M=-74[V?5;^*ZEB2,RL9/.C9V&Q<K\J_3CBNRMO#]I+<IJ%
MU/=7\WV=H(FNP 8XWQN 4*N"V!DD9XQFMJB@#CK?X:Z+;VVG6ZW6JM'IL_G6
M@:];]R,$;!CHN"1Z^]75\%V*VVMV_P!LOC'K3,UYET^8LNTX^7Y<KQQ7244
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MBB@ HHHH **** "BBB@ HIK.JE0S %CA03U.,X'X _E3J "BD=@B,Q!( R<
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M/,C1;/\ 79WKP?N\\=QZT 9=I<>,)-1TBZ@$\UC<(?MZW0MA''N7*O#Y;;\
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MJUN(;"74[R6RO8Q '&^-9 64GME,@?@377?\(K+9^(-0U;1]2^Q-J2K]LA>
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M<Z+J<-XT>E?;H[?48O+0@1R':K[B"0 Q4'!Z'M6/:^*[ZW\2>*M,NK^:X$$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLF[ X&=N>/6@#IJ*P?&.N2Z!X>:[@4&>2>&VC)QA6DD5-W) XW$\\<5DQ_\
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M64*-H(W'D<F@#T^BLW1[#4+".Y&H:M)J+2S&2-GA2/RE('R#;U .3D\\UI4
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MV%'!S6[13(I8YDWQ.KKDKE3D9!P1^!!% '-)X'L?.UY)KJXGT_6G:6XL7V[
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M%>-SA<8)/8]0.E;] &):^'XVU2?5KZX%Y>36WV57";$2'.2JC)^\>223G Z
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M86?%E:7&S;",8&650SX' R<#TX&.KJ*YF-O:S3+#),T:,XBC +.0,X&>YZ4
M<AI?P\CT>\DCL]<U&/0WE,W]D90Q DY*AL;@F?X0<'OG)J]#X1,%WXAN5U*4
MOK>/.S$N(R$V#9_P'USSS6]87+7NGV]T]M-;/-&LA@F #QDC.U@.XK.TOQ'!
MJNNZQI"6UQ#/I9B$QE"@/YBEE*X)XP.^.M &4W@5#H?A_2AJDXBT.>*>W?RU
MW.T8(0/V(P3G&,TR?P$5\07>J:7K^I:5'?L'OK6V*%)FQ@L-P)1B.I'/TKL:
M* .>B\*I;^*1KMO>/&ZV T^.W\L&-8@VX>^0??I6:OP\@7PP-%&JW0\N_&HP
M7(1-\4WF>9G&,$;B>"*[.J5M?R7&J7UFUC=0I:^7MN9% CGW#)V'.3MZ'('-
M %FWB:"WCB:9YF48,DF-SGU. !^0 K'U[PU#K5YIVH1W$EGJ6G2,]K<Q@$@,
M,.C*>&5AU'Y$5N5C>(_$=OX:M;:XN;:XFCN+F.V!A"G8SL%!;)'&3VS0 VV\
M.BW_ +3N?M;/J6I*JSW9C'"J-JJJ]  "< YY))S3_#&@KX9T"UT>.ZDN8+5-
MD3R* VW/0XX/7TJVU_(NM1Z>+&Z:-X&F-V%'DJ0P&PG.=QSGIT%7: *>JV)U
M/3)K-;F6V:0#;/#C?&0001G(SD=ZR1X3@N+^\O\ 4Y_M5U=6!TYW2,1#R222
M, G+$GKGL, <YLZ)XC@UR\U6VBMKB"33;G[-*)PHRVT-D8)XP11JWB.WTC5]
M)TZ:VN'?4YC#%*@78K!2WS9.>@[ T 85O\/&CAT..X\1ZC,-%E#V?R1+M14*
M!3\N#P<$G)XXQDU*/ "6^M7UWI^N:C8V&HRF>]TZ$IY<LA^\0Q!9-W?:0?<<
M8[&B@#GX?#)M_%-WKT-\ZRW-JEKY)B78B(25QWR"3WJ;PKX>3PKH$.CPW4MS
M#"SE'E4!OF8L0<<'EC5?4O%T-C/=I;:;?ZBMC)'%>&S17,)< CY<[FP&4G:#
M@'ZUT5 &;K^A67B70[K2-11FM;E=K;#AE(((8'L00"/I6%;>!6?2;O3]:\0:
MEJ\<]L]HC3E%,,;#!(VCYGQ_$V3^9SU]% ''6W@.2&_T2^F\0ZA/<Z3%)#$S
M)$ \;!1M("_[(R>I]>F+NC^$_P"QM%U+38M2FD6^FFG,CQKNC:4DOC'&,GC/
M3WK>N[C[+:2W'E22^6I;9'C<V.PR0,_C7--X]L!X6TGQ +*\:TU.:**(!4W1
MF1]JE_FX&?3- $7_  @:#0M TE=5G$.B7$5Q;OY:[G:,$*'[$8)SC&:NIX5:
M+7M8U=-2E$VJ0)!(GE+MC5 0I7OGYCUS71T4 <<O@&-/#NAZ*NJW @T:ZBN;
M=_+7<S1G*!NQ')Z 9KF=5NDD\9ZK)/XFU/P_="2.&*&2P6=)D11B2,O&PP2S
M<*?4GK@>KT4 <II6G:Y=VUC?7.LRB[MQ-&KRV807,3LI5I8N-K?(,8*GGD#)
M%5Y/"ESI-KHEGH.HWEL+:^:XN$15\NX5Y-TOF<8 P6VJ/4>F1TFK:O;:/;PR
M3[F>>=+>"),;I9&. HR0/4\GH#6=H_B:?5=7GTZ7P_JUBT ;S)[F)1#N!& K
MACNR&R".V: .@K!O?#*77BNV\0PZA<VUS%;&TDCC"E9H]X< Y!(^8=00<<5M
MQRQR[O+=7V,5;:<X(ZCZT^@#C'^'T4GAK6M#?5;@V^KW4EU/)Y:;U:1MSA>,
M 9 Z@XJ35? S7VJ6FL6&N7NEZM#;BVENK9$(N(P<@.C J2#T/_UL=?10!5TZ
MP33;&.U2267;DM+,VYY&)RS,?4DD^GI@52\1^';3Q-IBV=T\L313)<6]Q"0)
M()4.5=2<C(]_4UKT4 8MIH#1ZJ-6OKPWFHI;FVAD,01(D)!;"CNQ R<]AC%5
MM%\*R:)8ZI;0:I+)_:%S+=/))$NZ.20Y8KC QZ YKHZ* .-?X?Q/\/U\''5+
MC["JK&)A&OF[%;<!G&.H'..GYU/K7@MM3UBTUNRUF[TO6((/LTEU;(A$T6<[
M61@5//(]/RQI?\)'!_PEQ\.&UN1<_8C>B4A?+9 X3 .<YR>X'2E\/>(K?Q'#
M?206]Q!]CO9+*1)PH;>F-W0D8R?6@#,UGP)::KINGPIJ%]:ZAI\K3VVI1N#.
M)&^^6R,$-W& .PP.*9?^!CJGAN;2K[7+V>:XECDN+UT3S'\M@R*H VJH(Z =
MSW)-==10 V,.L:K(^]P,%L8R?7%.HHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *X?Q#/K$OQ$TG1K/6KBRLKVPN))5BBC+*4* %"5.#\W?('I7<5Y]
MXB5I_BWX=$-X]L\5C<JTB*&4,Q3:C9&/F .!P>.* .?O_$/B31_#?C"PFUB:
M:_T"\M1;7^Q TL4S(0KC&"0K$9QWKL[Z_OX_B?I^EQWTR65UI<\KQ *0LBL@
M5AD9SAC[>U6;GP3IM[X?U;2KJ6XD;57\V[NL@2M)QM88&!MVJ ,8 7OSF.W\
M%E-<LM:N=>U.YU"UMWMQ*_E .K$'E0F!C Z 'U)H X[3=<U^S\!7OC&\UVYN
MWTYKV,6;11B*8K(R(7PH.0<'@@8 &!R3V]GINKP:IIEZFO-<63PL+V&=0?.<
M@%'CP $YSP."/?FC2/!MAI?AR\T&6>XO["[:4R)<[,_O"2X!55ZEB?:H?#_@
MH:"(T_MS5;Z&V0I9174BLML", C"C<0"0"V<#@"@#SW3+C5=%^&$6OV6K7$/
MV35Y%%HJ)Y4J/>E&#Y!8D[CR",<<9Y/4^,=3U*U/B66UU6<RV.GBXM+>Q S:
ML$9F><L-IW$#"DDE0<+WK0/PZLSX0?PT=6U'[$]Q]I+_ +KS-WF>;C.S&-_/
M2I+SP#:WM]K%P=6U**/6;<0WT$3H$E(C\L/]W*G'8$ ]P1Q0!D:SXHO[*VT7
M4]3CU"/0[G34EN+S34W&VN& .Z10"=@'3@C.<@\5.FN7FI:GI>AV=\]XAT9+
MZ6[M9EB:Y)8(&#$<#()(&.6'8$'9L_"4FGQ6Z6FN7X$5FEDPE6.19$4G:Q!7
MAAN(&.,=0:I7GPWTR2TT=-,O;[2KK2(O)M;NTD'F>6>JOD$,">>G6@#*N;[Q
MAH?A^R?68;C4(H+V1;U],(:Y-MM)C8@ <@D;MN#@ ]S75>$-2MM6\.0WEKJS
M:I"\DI2Y==K[=[%488&&4$*>!TID?A<VZ6;6VKWZ75N79[B0K(UR7 #>;E>1
M\JX VXP,8 Q5[1-$MM"M)H+<L[7%Q)=3R/@%Y7.6.  !] .@H R?B!IMAJ_A
M*XL;P2&:5E%EY/\ K1<_\LRGOGZ<;LD#)K+^&FIRWD&IVNLEO^$ILYQ#J?F$
M98#_ %;)@#]V5Y&.Y8]3D])_8!?Q+'K4VIWDIBC:.*T<1^3&&QDJ N[=QC.<
MXR.AJC=>"X+CQI'XIAU2_M+Y8!;M'!Y8CDCSG#@H2W/?/&!C&* (OB;+=P?#
M3Q!)9%A,+-AE>H4\.?\ OG=6AX-2W3P3H2VFW[.+"#9MZ8V"MF2-)HGBE17C
M=2K*PR&!Z@BN9TSP<^A1FTT?7;^TTW<62S*QRK#DY(C9U) ]B2* (O$6J-I^
MO^'] L7^RG6KJ9IYXP-RK''O8#/ 9CM&?0D]>:R;O5M7TKQ)K_AU=1G>(:*V
MJV-TZHTEN58HR$E2&&0",@G&1GTZ35?"-AJME9PF6X@N;*<75M>1L#+'+W;+
M ALY.01@C\*#X6BE749;B^N);^_MA:RW>U R1#/R(-NT#+,>0>3[# !P-_>>
M)K+X40^+%\4WANY["S;R3#%Y:L[H&(^7.2&.>>O/ P!M7M[KGA3QWHZ7.LW&
MJ:9JZ7"S02Q(/(DCC,@,6T A< C!)]R3S4/C[1X]$^#4^@V]S<7(B6W@M]X!
ME95ECX 4#.%'IVKK;30X9]2M=7NK^349;>%H[1W"!45\;F 4 %F  )].@&3D
M XN37]:G^%H\=VVI2+?*AO#:_*;<Q!R#"5QG[O\ %G=GOCBK4UQK>O>.Y]*M
M?$%[IUE-HD-_&(XHB\+M(1@97IA1G.3[BMF#P#8VVG3:/'>W0T*68RG33LV+
MEMQC#8W",GG;GN1G!Q6C'X9BC\7R>(Q?77VA[469@PGE>6&+ ?=W9R3SF@#B
MO$VO:OI5AJNHV^K375S9:I#&IME'V:&$O&GE2Y #.=S$[<D$C[HK2M[69_C5
MJ/\ Q,+P(NCP2A ZE1F5QM (X7@'CG/>K%W\-+&ZLM5L/[8U2*QU&[^VFWC>
M/;#,7#EE)3)&Y?NDD>V<&M<^%(1XEAUV/4;Y+E+1;290ZE;A%8LI?*YSDD_*
M1GITXH XU/&&KZ9X4\0SS7K7-Y'XC?2[6XF1?W2%T16(4 ?*"3TY-;>I7FH^
M'/&7A^S34+FZT_6#+;2I/M9XI53<LB''?!!'3T%7(_ &F'1=:TF[N+J\M=7N
MGNYQ*4#)*Q!+(548P5!'7&*O6OAK9>VE[?ZE<ZA=64;QVLDRH/+W !GPJC+D
M#&3[X R<@'G4^L^)(OA]K'B,^(KMKK2=4FCBC\J(),B3A,2 +SE<CC:!Z5ZW
M-:0W,T$TJEF@8O&"QP&(QG'0GKC/3-<H_P .[.3PKJ/AY]5U$VFH7#7,S_NO
M,#,^]@#LP 6]JZ^)&CB1'D:1E&"[  M[G  H \\U3Q)<Z=XKFL-;NK_25FO8
MO[-O54&SFB^3,3'!VNV'!+<\\$#%=[J)NUTR[:P"->"%S '^Z9-IVY]LXK$O
M?!\6HPW=G=ZC=3:;=W(N9;1U0@$,&VJVW(4D D<GK@C-;>H6:ZCIMU9/))&E
MQ"\+/&<,H8$9!]>: .#\-:[_ &U<SZ;/J6KZ?JT5@XO--O0%E$F5_?1-MP5X
M8?+QR" *Q_#.L7FD?#7P9!#?3^?KEU%:F:3:WD*2[,4R/O$# W9Y.>U>@6WA
MI%U:VU.^O9KZ[M;=[:&2544A'(W$[0,L=HYZ=< 9-9<'PYTR+PM'H#WVH2V]
MO*LUE*\BB2S96+(8R% R"3R02<X/&!0!GZKXAO\ P=XKEM))YM0TR?2;B_BC
MF(,D,L W, V,E6&.N<'IQQ6CH\&MW]EX=UV/7<K<1I-?PR*#%*DB A8P!\I5
MB #G)'7-:MOX;A^W27VI7#ZC=O;&TWS(JJL1.64*H ^8XR>^!T'%9F@> H/#
M[QQ0ZSJD^G6[%[73YY5:* ]1CY=S 'H&) Z]0#0!R'AC5V?Q#K?AF&[ETZ:]
M\0WMPMX%'SJC)NBCR"I<CKGHO(R>GK<:>7&J;F? QN8Y)^M<9+\-=/GTV]LY
M-3U'=<ZD=46X4QK+!<$@EHV"?+TQWXS70QZ1.FK6M])J]_*(+=H&@9E$<Q)!
M\QE50-PZ<8H TRH)!(!(.1GM7!>#_P#DJ/Q"_P"NMA_Z(-=]7/Z/X4BT?Q#J
MVM1ZC>3SZHT;7,<HCV91=J[=J@C /K0!S=QI\U]\7M2M;?4)]/3^P;<&2U51
M(!YTF I8$#\ORJGHGB_5]0\,^$;:69I+_59[J&:="L;NL!D'!(P&;:N3CINQ
M@X([-?#*)XKN?$*:A=BZGM1:&/$9C5 2PP-N<@DGDUCGX9Z8?"UKH?\ :&HC
M[%<M=6=XKHL]O(S,Q*LJ@=6/!'?V% &CX7@\0VEYJD&L3++8^8CZ>9)0\Z(1
M\RN0 " PX/)P>35>^U:>^^(<7A>.XEMK>/3#J$SPG:\I,GEJH;J ,$G')..<
M9SK:'HAT:"3SM1O-1NY<>9=7; NP&<* H  &3P!W)YS4.K>&8-2UBRUF"YFL
MM4LU:..XA"G?&W6-U8$,N>?4'D&@#C+G4=2O?#7Q T#4+V:2318I/*NU"JTT
M+P,Z*_&"0."0!GBJ7B73Y$^!FFO_ &C>,/)T]MC%,89X1C[O0=1^N:[Q_"5J
M^B:KIWVNY635BYO;L;/-D++L/5=HPH   X ]>:K7_@B#4?!]OX:FU6_6S@$2
MB1/*$C+&5* G9C@J#TYH J:Q<ZEI7C7P=81:K=26EY)=)<QRA#YNV%G4DA0>
M#Z<<"J]E<:UXPTG5K_2]8;3[V#49;:S3:#%&L3A2)%QEBP!)STW#&,<[VH>&
M$U+6='U2;4KL3Z4SM"$$85RZ[6W#;_=..,5FM\/K2/6[V^L]6U.RM=0D\Z]L
M+>55AG<_>;IN7=WVD9]J *5UJ.L>(-8\0:;IL\T+::(H87MYDCQ(\0D$C!@=
MPRP '3"GKGBE=3^*YO$7A?1[S6VLI[_3[K[=]C2-E$L84;T)7@G=WR!V K>U
M7P);WWB#^V]/U;4='O9(EAN38NH6=%^[N5E(R!P#V%6F\'VO]N:3JD5]>1/I
M<3PPQ HRNKXWERREF)P"3G.>: -JQ@EM=/M[>>Z>ZFBC5'GD #2L!@L0. 3U
MXK(\674]K869AU)+%9+R))6V%I98R3F.( $EVX P.F3QUH@TR_C\<7.I+J%\
MVGR6OEO:2N/)60%=IC7J#@/N/^T.O:3Q)X:A\1Q66Z\N;.YL;E;JVN+8KN1P
M".C @@@G@B@#A9_$&N1>'/'Z1W]Y;2Z,PDLWF$;S1J80^QCA@1DG!ZX/6M2&
M\UC3O%_A%9M9N+N#6K>87-O*B"-&2$2*T8 R.<@Y)SFK\OP[LYDUY&U?5"NN
M(J7>7C/1 I893@D#Z#L!5^3PA%+J.@WKZG>F715=8!B/#[DV-O\ DY^7CC%
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MX8^G08&.=70?!9T155O$&K7XA0QV@NY$<6PQC(&T;FQQELX&0,9-%GX230O
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M[96$$>TOA0>I'3' K5U?4]6\.Z3X=UY-3GO1=7-O!?P2!2DJS8&Y !\A4D8
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MZL5SMP2 .>30!Z/17/\ @S4[/5_#ZW=CJ4VH0--(!).")(_F)\MP>05! Y]
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MG/$)9UG1$:,D?=PJKCUP>1D\UT- !1110 4444 %%%% !1110 4444 %%%%
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M\#KM1P0 A7J202<^U7: .9M?!<%MKJ:VVKZI/J*V9LVFEE0[E+;LE0NW.<<
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MA96=PMQ$=T6_<'WC)V<@-S6SJ6NQ6.I6NF0P27>HW2/(D$9 VQKC<[$G 7)
M]R1COBL/&&E#PY<:W(\D<-O(T$T++^]28-L,6T'[^[ &#@Y!S@YH I:EX!LK
M[7WUJVU35M,O)D6.[:PN!&+H*,#>-IY XR,&NFAM+>WLDLXXE%ND8C6,\C:!
MC'/7BLVPU^.ZU9])NK66RU!8!<K#*RMOB)QN4J2#@\$=LCJ"#5&/QM821PW@
M@G&DSW7V2+4#M\MI-Q0'&<A"PVAL8S[$&@!EGX$T^SL8M,6[O9='AG$\6G2L
MAB0AMZKG;O*AL$*6(X[CBKTOAF&7Q9'XC^W7BW<=L;58U,?E^66#$8V9Y('.
M<UM,RHI9F"JHR23@ 5S=IXTLKH:?<&VN(M.U*;R+*]DVA)7YV\9W*&P=I(Y]
MLC(!8L/#$.GZ_JFLQ:A?-<ZD(Q.KF,I\BE4VC9Q@'UY[YJ@GP]T<^%;KP[<2
MW=S97$S7&Z5U$D<C-OW(RJ,'<<]_RXJ[?>*8;:^OK2VLKF^?3HEFO?(V_N0P
M)"\D;G(!.T=OJ 9+KQ3I\5GID]JS7K:J0+&*#&9LKNSSC"A022>GUP* *]AX
M-L[?3KJSU&]O]9%U";>2349O,;RCU48  ]R!DD#)X&(= \#6_A_:(M9UB[CA
M4I:1WEP)%M01CY!MQD D MG X[FM;2-;@U=KN%4>"[LI?)N;>3&Z-L!AT)!!
M!!!'4'UR!-JMY=6-@T]GI\E_,'11!&ZH2"P!.6XX!)_"@"IX:\.V_A;2%TNT
MN;F>W1W=/M!4E2S%FY51W8GGUJO?^$;2^\2+KBWM_:W)MA:S);2A$GB!+ -P
M2,$GE2#[UT%% ''P_#K3;?0=*T>/4=3%MI=VEY;DRHS!T.4!RA&T$] ![YJ]
M?^$8-2&I0W&I7S66I,INK3,>QL*JD [-R@A!G!]2,5T5% &!/X4MCKLFLV%Y
M=:;>30K!<&VV%9E7[NY75AE>@(P<<=*T]*TNTT738;"RC*01 XR<DDDDL3W)
M)))]36?:^(UNO%]]X>-E-%):6R7/G.R[9%9B!M )]#UQ]*7Q!XC70+C28GLI
MIUU&^CLED1E"QL^<$Y.>@/0=NHH K?\ "&6GVK7;G^T-0$FM!!<$.@V%%VJ4
MPF5('UJ[9>'XK76#JT]U<7E_]F^RK-,$!6/=N( 15') )/MVJU!>74NK7=I)
MI\D5M"B-%=EU*S%L[@%'(VX'7UJ*^U22/2&OM+LVU1]P"0PR*I?Y]K$,W'')
M_"@"*^T(W>I27L6IWMJTMLMM)'%Y91E!8@X=#AOG;FLZX\"Z<R:*+"ZO=-DT
M>)H+62T==WE, &1MZL"#M'.,YYKJ** .3C^'NCKHVM:5)-?2VFKW#7-PLD^2
MKD@Y4XSG*KUSG'.:ENK.TT!H-;U6YU/59K4>1#(8!*T(<@,P2)!UP,M@G ]R
M#T]% '#:#X4AU/P]XELM9M6:RUG5KFZ2-P4?RV*A&P>5/R!AWZ5IZ1X)M--M
MIK>\U'4]826!K8#4Y_-V1,,,@  '( R3SQUJWX<\1KXA;55%G-:MIU\]DZRL
MI+,JJQ/RDC'S>IJ[K.K6F@Z-=ZK?.5MK6,R2%1DD#L!W)Z#ZT 8GAWP-9^')
M(O)U/5;NVML_9+6[N-\5MD$?*  3@$@;B< \5?T'PS:^'I;UK.YNVBNIY+CR
M)9 8XF=MS;  ."?7..V.:JQ>(-:.O1:;-X6NEB<JS7L<Z-"B$$Y).#N!&"H!
MZYR>,])0!BS>&;6;Q5'XA6YNX;H6XMI(XI (YD5BRAAC/!)Z$9Z'(K/A\!:;
M;V=QIL5U>+HT\QF?3-R>3DMN*@[=X0GDJ&QU[$BNJHH Y\:/=CQO_:T5]?BS
M^R&&6V>8&W+9&THG4-URWT SDX?K?A:VUK5-.U,WE[97MAO$4UHZJ2C@!E8,
MI!!P/?T-;M% '&M\-M+.DWNF+J&J+:WE]]N=?/5BLF\/@%E/&X \Y)[DUKOX
M9AD\30:^U_>_;(;4VJK^[V%"03D;,Y) /7]*VZ* .4'P_P!);1]3TRXGO+B'
M4+QKYWD=0\4Y(;?&RJ-IR >_\ZTK7PZD-\M_<W]W>WZ0&WAN9Q'NB0D%MH5
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M4K"0O;3KN4D8(.<$$=B"""/45=H **** "BBB@ HHHH **** "BBB@ HHHH
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M6-[:7#AHCYD98.BX^7;M/J3W)YST_P 18Y9_A[KEO!!-///:/%%%#$TC,Q'
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MDD$]: ,*W#CX[7IFS@^'X_(S_=\\[L?CC]*X/4%G;4M1D7/]G#Q]:>;_ '>
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MMMR,\GC)]J77[%SIW@'4Y=1N[FXN-9LGG:2=FCD9U9MP3.U<'IM X/>NNMO
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MVTTC3H-/L85AM8$V1H.<#ZGDGN2>2:M4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%<1XREN- U_1/$GVR[&E).+74;<7#B)5D^5)BN<?*Q /'(;VH
M [>BO.M6UF[LM'?6(+J58]9UB&T@,ERX2&W+!-RGD)OVLVX#@2#TJ:ZL=7T)
M];O9_$$.EZ7-IKE%ENI;QK:=?^6R>8 <8(RH[X]: ._HKSC1Y[Z'XA66FB74
MH;&[T225DN[EI'>170"7:S-L8ACQG/J 15#PKIVMZKX ;68/$.I/K(%[;VPN
M+L^2Q,SJFX'JP(X;MD=@!0!ZM5*>ZO8]6M+:+3S+9RI(9[OSE40$8VC:>6W9
M/3IBN3\%ZU#?:Y>V4\&JZ9JL5M&9]+OYWF50&/[V)V8AE)(!(]!4VLSW</Q3
M\,V\=[<K;75K>&6W$A$9**FT[>A/S'K0!V=%>-W U*3P;XZU(Z_JXN=(U6[^
MQ,MVRB,1JA4''WAVVG(]LDFO6;5WOM)@=W9'G@5F:,X()7G'I0 W2+J]O=,B
MN-1T\Z?=-NWVQF679AB!\R\'( /XU->RSV]A<36ML;JXCC9HH X3S6 R%W'@
M9/&37F?A_4KJ[^&GAA[W6KTW5SJ$BNJ,7N+\+++^Z#[@5X );( "XZ4MM?:H
M/#7Q$MVO;RW;3'E>T/VDR20?Z.) HD/. WOQT!Q0!U^I^*)])E\/0W.E2+)J
MUPELX\Y2+>1D+$$C[V-I''''6NCKS35I9)](^&4TTC22R:A:,[N<EB;9R23W
M->ET <WKOBQM$\0:5HXTJ>[GU0R"V:*1%&8U#-NW$8X^M \96UMK=KI&KV%W
MI=S>';:R3[&AG;^ZKHQ ;V;!]*Q?%_\ R5/X>_\ 76__ /1 JI\:QYWA&PL[
M?G5+C5+=;!5^]YN>H^@SS[T >DT5YU*VK>+K_P 4V=K<FWGL+G[):NFH2P-;
M_NE99"B*0^6+'YCR!CZP"WU;4?'NG:/?^(;PQR^'C+=&PG,:22K*BEDQ]W/J
M.>HX!- 'IE%>/V>OZUI%K<>'I]0FNUC\2II45]<SE9#"\9D"-* 3NX"[L9^;
MC'&-;6].U_1-$\5W7]L/;VC:9)<VEM'?232P2QJ2661P&"'C(['&,9H ]*K)
M\3:V?#GAR^UC[(]T+2)I6B1PI( R>3_]>N*MS>Z;XB\!W"ZMJ,YU:&2*]CGN
M&>.0"WWJ0GW5((Z@9/<G)K,U"X?Q9\)/%&OW5W=K<,+L1PQW#HD$<;,JQE =
MIRJY.02=WL, 'I4>I7L\NDM!IADM+R)I+BX\]1]F^4,HVGE]Q...F*U*\^DN
M+J#Q?X ABO;E+:ZLK@36ZR$1N4@4J2O<@L>M8$\>H7'AGX@7CZ]K FTB_N6L
MBEVR^68X4< XQE>VT\=>,G- 'L%%<%>:K>S:UX5.HS2Q:/>Z>\DSPNR W.U"
M-Y4@A<%L=LGGM5_X?6^JQZ5>S:I<7THDO95L_MCDO]F5B(V(;D$CUY(P: .N
MHK@;&>YD\3_$"Q>]O#;VT5LUNIN7S"6A9FV'.5R>>*Y_3KO5=3C^&D;ZYJ4?
M]IV=Q]K:.;!EVP;LD_WN3R>G4<@&@#UZBO&]1U[6?!$?C+3(=3N[RWLQ9R6=
MU>/YTEJ+AMC99NN.2,^E=1KGVKPSXH\,-IUY>RVVI7+6-W;SW#S!P4++(-Y.
MUEVDDCJ.M '>45XQ=-J?_"">,M6_M_5_M>CZO=BS87; ((W4 ,!]\8XPV1Z
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M3W-@J-&\$S0PZ>5528^&Q(QSN(VGA@"1Q0!V][XC-EXPTK0&L7(U"*:1+GS
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M1VGVO['$96B\S9D#KS@_RH @_P"$1T\7VCWBS7BR:1&T=IF<L%5@%;.[);(
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M^/4[U;,R^;M\HE6;.,'/"GTJ?Q3K4GASPU?ZQ':?:_L<32M%YFS( R><'^5
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M'(.XD_B>W%6+#P;I]AKD>LFZU&YU".V^R^=<W;-N3=NP1P#SVQCC.,\UT-%
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MPVTLS.@D!DZ GC.T=*N:#IRZCH_ACQ&FO7:3O''-=2&4LEX9% ,;*3M'SG@
M?+C Q711>'-/BU^XUL"8WMQ"()2TK%6C&<+MZ8&3V[UGZ-X!T#0+_P"U:?!<
M(%=I(K=KEV@@9LY*1D[5)R><<9XQ0!R-@FL^+_"W]NVNJQ:?J$=W+(;IKJ7%
MN(Y2#$\0PNW8,$'K]XY-78M)?6_B3XFL+G5M5CM((+*>**"]= CG>3CG@<?=
MZ<].!C>_X5[X=&O3:NEM/'+/)YT\$=PZP32==SQ@[6.>>1C-:=KX=L+37[O6
MXO/%]=HJ3L9F*LJYVC;G QDXP.] &-\49)X/AMK=S;7-Q;3PP;TE@E:-@<CN
M"..>E9.K0R:#J6B64&H7DBZ]=XNFN[UPI9(6(12.8P[8X7&<8X'%=KK>BV7B
M'29M+U%9'M)QB5$D*;AZ$CG%5=7\*Z3KVA)H^IP/<VJ;2A>1O,1E^ZP?.0P]
M: //_%^G:SX=\%>+)AKDL<9\BXLK:WNI"]IEPCC>3N*-SA>@YQ6GJ=G>>%OB
M#X=N+#4M2NX]6>>"^M;BX:59"L9<.JGA""/X0!C  %.\:^%(K#X8ZOI.C6M]
M>WEX(QEFDN)I2'4_,YR<  XY ';K77:?HMDES!J6ZZGGCB,<#7;,6A0XR &P
M03@9)^8XY- 'G:7UYJOP<E\:)J-S%KB1RWJS).VU&21OW6S.W9M7;M(YZ]>:
MO3VUQXC^(=K975_J=G;7OAK[5-;6]V\820RH/EY^4C(Z=<<Y!(/6+X*T6-KA
M$BF6SN9OM$UD)F^SO)D$L4Z<D D#Y3W%6V\.V#^)$U\^?_:"0?9PXF8+Y><E
M=N<8SSTH XG0-)2U\;>/A9W4T-Q!';>3<3W+LJNUL?G?)PV#SSG';%6/!VIO
M'XD@TG6K+4-+UR.R=6CDN&FMKX!DS,C$D%ACGC.'YSBNHN/".CW.JW^I20S"
MXOX/(N0L[JDB[2@)4'&X*2 <9%367AVSLKR"[+W%S/;Q-!;O<RF0Q(V-P!/K
MM7).3QUH SO%LL9N]$M&O+E7GNF*V%MPUZ%C8E2VX;47AB2<<8P<BN(>YO)?
MA;\1;6[D=A97=Y!"C3-+Y4?EHP0,W) +'&:]'UOPUIWB![*6]6=9[*0RV\UO
M.\,D9(P<,I!P1P:H#P#H"V6JV:6\ZV^JL6NT%S)AR0 <<\9P,D<G'- &#KL^
MJ646CWT>G7&K:/#IRK=V=E<%+B%CC$RJ"-_"D 9R.2.]1:9K4&M^(O#6AP7]
MS<:,^AM>+*TC(]W(K+& YSDD ,2,]3SG%=>?#-HLL$T-S?02P6XM5>.X;)B!
MR%;.0>O4C([&HYO!^C26VF0Q6[VK:7_QY36\A22'(P0&[@CJ#D'O0!D^#;F]
MM_%7BOP_+/-<6.FS0/9R3.7=%FCWF/<>2%/3.3@_2G7%V-7^)-SX>O99%M+;
M2TN8H$E:/SF=V5G)4@D* H Z DGKC'2Z;I5KI4<JVR-OGD,LTKL6>5R -S,>
MIP /8  8 K-\0>#M(\275K=WJ7$5Y:Y$-U:SO#*JGJNY2#@^E ',2276F:YX
M2\'W&LW5];3F[-Q=NY62<Q+N2)F!SQNYYR=HSU(JK?SWVF:EXVT.&[NVT^'1
MO[1M&\]]]I(5<;5?.X E=P&>,<<5VMWX3T>[TVSL6MFCCLI!+:R12,LD+C^(
M/G.3DY))SDYS5FUT&PMHKQ#&T[WHQ=2SL7>8;=N&/IC@ 8 R>.: .'DO;S[-
M\,K@7MUYEV8DN3Y[XG!MBQWC.&^89R:K7NLS^'M7^*6K6J![BUALWB!&0&^S
MX!(] 3G\*ZBV^'6@6R:>H6^D&G2^9:&6]E8PX! 53NR% /0<'C.<5HP^%M*A
MO]5O#%)+)JJA+U99"Z3*%V@%3P %XX[4 <1KVEV\$GP^OH[JYN)I=5@\R:2X
M9Q.6B=MY!.,^F.@) XKJ?B/_ ,DV\1_]@^;_ -!-10?#C0((K&$'4'@L)Q/:
M1/?S%8& ( 3YN ,UTM_86NIZ?<6%[")K6XC,4L;$X92,$<4 >;75A=>'+[P;
MJVG:IJ,LNH7<%C>6T]RTD4T;QDE@A^52NW(V@"F62:SXQ\,S:S:ZI%I^HQ7L
MS"Z:ZE_T81RD>6T0^7;L !!ZYW'FN[T_PQ8:=-;2AKFY>T0QVQNIVE\A2,$+
MGOCC)R<<9Q6>_P /?#K:]-JZVT\<T\@EN(8[AU@G<?Q/&#M8_48/>@#J 24!
M.,X[5XO92SVW[/WAVYMKJXMY8[B!=T,K)N#704@X/(()X->S2QB6)XRS*&&-
MR'!'T/:N=_X0/0QX:@\/".Y&EP2"2.$7+_*0VX?-G. W.,T 8/BQS=:CXA2W
MO+NZGM-*#"".9H(]/;:["0NIR9&P" %) 7D@&LN03>(-2^%SWEW<++>:5<R3
MS0R&.1RUO"6^8<C)SR,'G@BNVO/!.BWVJ7&H3Q7!GNH!;W(6YD1+A "!YBJ0
M&(!/6FIX'T6*RTNW@6ZA;2@19SI<OYL0("D;B3D$ #!R, #'% '$LEWI>F?$
MKPZ;VZO--LM-\ZT:ZE,KQ>;!(6CWGD@8!&>@/O5^WU"YN+GPAX>5D%O/H7VG
M8\[Q">15C 7*\G"ECMZ'J>E=D_AC3'T>^TQHY3!?[OM;^:WF3[AABSYSR./8
M8 P!5/4_ NA:MH]AIMU#.4T['V.9)V6:#  &V0'/0 ?@/2@!WA#3=1TBSO+'
M4-36^V73O -[.UO$V"L3,W+8SP3S@BN1\:SRO#XQN+&_O+FXL+-74QS-!'IK
M+&7PI4_.[<,>.F 2*]"TG2+31+!;.R5Q&"69Y)&D>1CU9F8DL?<FLB^\":#J
M-]J5U<03YU./R[R)+F1(YL+M#% <%@.AQQUZ\T <YK^H:M;_ -G:O<6%UJNC
MMI<9NXK"X,=Q:R-DF<("-P(XXY&TXQSGMO#]S;7?AS3;BSNGN[=[6,QSOG=(
M-H^8YYR>_O5*+PAIUMY?V6:_MREJMH3'=.2\2EB VXG)RS?-U&>"*V+*RMM-
ML8+*SA6&VMXQ'%&O15 P!0!Y_P"&T?Q?X,LO$DNM75CJ/VI[F::.4[8E21@8
M"F=H3: ,$>YR:LZ-N\97GBU+ZZNX)K+49+"U$$[QFV1$7;(H4CYBQ9LGKP.@
MQ6O!X \/VVMRZI!;SQO+-]HDMUN'%NTN<^88L[2V>>G7GK5NY\*:;<:I<ZBA
MN;:XNXQ'=FVG:,7"@8&\#N!QN&#CO0!YUIFK:MXCM_AO=7U_>P37[W<-W]GF
M:-9PD<@#$#C)VYR!D9XQQA-6@,?A;XG:(]S=S66G;9+59[F21H]T"N5W$DE=
MW."2*](G\*Z3/<Z5.(9(6TD$62PR%$A!7:<*.#\O'/:HQX/T??K+2132C64V
M7RR3,PE&W:.,_+A>.,4 <AJ]D\-UX!M+74-1MX;N5HYUCO)/G7[.S8Y8^G!'
M([8XJWI<"/XXNO"4]U?2Z=I>F1RP)-=.7G:1VW.S @MM^51GI]:WQX(T<#2^
M;TMIC;[5VNY&96QMR23\WR\<\8XZ5=U+PY8:EJ5OJ;>=!J%NACCNK>0H^P\E
M#V9<\X(.#R* /+M;O;^7X5>-]-O9Y;I-*U/[);7$S%G>(2Q,H9C]YEW8S]*[
M+Q#_ ,E6\%_]<-0_] CK8O/"&C7_ (>DT*:"3[!*_F3(LS!I7+;RS/G<26Y)
M)YJ:?PW876KZ?JLS7+WFGHR6\GGM\H8 -D9P<@#.?2@#A6ENULOBA&-1O\V6
MY[9_M3[X2+8. K9R!NYP.*2U2XTV_P#AYJ$>HZA)-J<8AO!-=.Z2J;8N/D)V
MC! (( /KDUV1\&Z25UA2+G&L#%]_I#_O?EV^OR_+QQCBG-X/TIAI /VK&D8^
MQ?Z0_P"[PNWU^;Y>.<\4 <1J[ZQ>6?C&W+:E_;\=]MTEK1I,+&50Q!2ORKU)
M?/KEN,5Z5I]J]MI<%M+)(\BQ@.[2L[%N_P QY/->9)HGG:IJ#ZAHGBRSU*XN
MY)6;2;YDMI 6PC*PD"@E0N=V.<_2O2-&@NK#0[:&_GDN+B*/YY&.]SZ D#YB
M!@9QR1G'- 'E$>F7NH> /$FL'Q!K$>H:3>WSV<@O7P@A=B%89P^0N/FSQTQ6
MYI^IZAXNUB33KP(C)H]G<_9S=26YWS*3(XV<D@[5Y^[CCK4O@KPPEWI>L0:M
M;ZC#%<ZK<W#VD^^..>-I"R$@CD$8R >>C"NDU_P3HOB.]MKZ\BGBO;9=D5S:
M3O!($/5=RD$CV]SZT <9<V&K6^I>!=)U'Q%=W4TDUW;7D]K</&)U2)R P!^\
M!\I;[V><YI_B*&[\+F59XM6U/PY%9+!]LM;UFN].<;BTC*""V0RG=U 7TZ]K
M+X0TB2?2I1%-$VE9-F(YV41DC#$\_,2"<ELYR?6I+WPU97UU=SO+=QF\B$-R
MD4[*DJ $8([<$C(P>>M '-V&I1>)O'5YI4MQ+)IEKI5M<6J1RM&+CS<DRG!!
M.!M ],GO7+7FHZP?"E[:2:I?!]*\4QZ=;W:S,'E@,J8#G^,@-CG.<<]Z],NO
M"NEW%Y9WD226=W9P_9X9[1S&RQ?\\SC@KP."#CMBH[OP=HUYI,.F20RK:Q3B
MY"I.ZLTN[=O9@<LV[G)/6@#FH8KC2/B-JNE6.I7*07.@?;<WER\RQW E9/,^
M<G:,8R!QQTIG@_4I(?$MMI.N66H:9KB64B%)+AIK:_ *$S(Q)!<;>XR _)-=
M5<>$],NM5FU.<7#W4UF;&1C.V&A/)7&<=3G/7-2V?ARRL[J"Y+W-Q+;1-!;M
M<3&0PHV-P4GG)VCDY/'6@#7HJAHNCVN@Z3!IEEYOV>'=L\V5I&Y8L<L>3R35
M^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<M:D1P/O\L;R3P"WIG&1G&: .RHK(O?$5M::E)IT5O<WEY%;_:98;95)2/)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%87BW4);'0VAMC+]LO7%K!Y*%W4MG<Z@<DJ@=_^ T 6]$U[3_$-G+=
M:;.)HHKB2W<CLZ,5/X=Q[$5I5Y=X6EMO"WQ+N=%M+6XM-(URW%Q9QSP-$$N(
ME"R*H8#.4 8GVK5E?6=2^(VL:&NOW=K8)IT-Q&((XM\;,[@A6*GCY>X)]Q0!
MWE%<Q\/-7O==\":9J&HRB6\<2)+(%"[RDC)NP.,G;FLO3[_5/%MMXEN;/5)[
M"73[^>QLDB"[5:(#YG!!W;F)R#P!C&#S0!UNJZM;:/:QS7)8F69((8TQNDD<
MX51G R3ZD <DUCQ>,HWG-E)I.HPZF9W@BLY416EVIO+H^[84P1SGJ0.M<3JV
MJW'B[PG\/]<DGGM);S6+59(H=NU7_> NNY2<Y!QDD8/0UK^(-.G/Q1\(1_VM
M? M:7H#CR]R[4B!(^3'S=^/IB@#J/#OB4^(3<?\ $EU73A!M&Z_@$8=B6#!>
M3G:5Y/3D8K=KSR;Q1J.BZUX_EN+E[RVT>RMKFT@=54(6CD8KE0"02!R<G K9
ML;36A)HVK#73/:/ 7U&&5%*S%D!0Q8 V8;MGD'G)YH ZJBO-M.U'Q9XAT/2/
M$6DRLCSRK/+#--&+9K<D[H\ ;@0/XLYR#GTJS8?V_J_CKQ+I_P#PDEU!::7=
M6;PHD$1+*T>]HR=OW3DCUZ<G'(!Z!17,>,==N-*.BV-I)Y,VK:C'9^?M!,2$
M%F(SQNPN!D'DYYQ5$7VHZ5\08?#LE]<7&GZI823P22;3+;2H0&PV.5(8'Y@<
M'VXH TYO%T"7GEV^G7]Y;I>BPFNK:-72&7@'<,[MH) + 8!H\2>,K'PK);#4
MK2]\JYE6&*>*-6C+GHI.[Y?QP*POA=:216FNRM>W,H&M7T?ER;-I(E^_PH.X
M_7'/2NF\66>E7_A?4+76EW6$L6R0 9;)/R[1W?=C:!SG% #]3UZ/2[JPMGLK
MR::]8I$D"JQ! R=WS#  ZGI[\BM7/RY/''.>U>;?#*\NX]2O]%\2M*?$MA#&
MB-.02]G@;"F..OWSDY;&2<#&_P#$V:[M_AIX@ELBPF%FPRO4*>&/_?.Z@"Y;
M>*[?45>;2M/O]1LT8H;NW5!$Q!P=I=U+@'/*@CCC-:&CZQ::[IXOK(R>29)(
MOWL9C8,CE&!5N1RIZ\U3\');Q^"="2TV_9Q80;-O0C8.:S?$.J-IVO\ A_0+
M!OLC:U=3M-.@!*K'&9&"YR S':,X[D]>: .MHKSR[U?6-*\1Z_X=&HSR1C1F
MU6QNG1&D@*L4:,DKAAD C(SC(S6-?7WBBR^%,/BU?%%TUW/86;>0;>+RU9W0
M,P^7.2'.>>O(P,  'KE%>>7M]KOA3QUI$=WK,VJ:9JZ7"S020HOV>2.,R Q[
M0#M(!&"3[DFJ<OB#6YOA<OCNVU%UO%0WALR%-N8@Y!A(QG[O\6<Y'7'% 'I]
M%><S7.N:[XZN-*L_$%WIUE-HL-_$$AB9X7:0C RO(PHSG)]"*J^)M?UC2;+5
M-0@U:6ZN+/5(8U%LB_9H82\:>5+N W2'<Q.TD@D?=% 'IIEC$HB+KYA4L$SR
M0, G'IR/SJKIVH/J NM]C=6GD7#P#[0@7S0O_+1,$Y0]C7'6]M._QJU$?VE>
M!%TB"41[E*C,KC: 5X7@'CG/>LU?&6K:3X,\47UQ=F[N[379=.M99D4!%+HB
ME@H PNXGW_&@#U"BN(U:]U/PSXI\/0KJ-S>V&K3-97$<X4LDFPLDJ$*,=#D=
M,= *Y:YUCQ*G@CQ1K@\1W7VC1-5N8H$$,065(Y H63Y>1C^[MZYYH ]@ID<L
M<REHW5U#%25.1D$@C\""/PJ-U-W8E1))"98_OQD;ER.HR#S7E7A+5K[2/A?X
M9:*\N9KG6+X6@:1D)B+22LQ4D?>;:1EL\D'VH ]2U*^33--N;Z2*66.WC:1D
MB +$ 9. 2*PI/&]C'H_A[4S:7A@UR6"&WPJ_NVFQMW_-QQZ9Z5FF#Q':Q>(T
MOY3)H\FGN]J+B57GBD"D,N5 RAZ\Y(KGIO\ DF?PR_[".E?RH ]:HKSKQ'XE
MNM)\27MIJ]Y?:1:3-&-*U&- UH<J-R2G!VL7W#)[8(QC)[?6II[?0K^:UN;:
MVG2W=HY[HXBC8*<,_P#L@\F@"]535-3M-&TNYU&^E\JUMT,DCXS@#T'<^U<3
MH>M:BOCK3---Y>W-C>:2\[O=QJHDE1D'F1C 90=QX( Z8%3?&"%Y/AKJ;K<2
MQ!/*RB;</F5!SD$\=>,4 =)INN/?:G=:?/I-_92P(L@>=%,<BMG&UU8C(P<C
M.:M-J#KK2:=]ANBC6YF^UA!Y*D,!L)SG<<YQCI7'^(#K5KXP\,Z+9^(;R.WU
M&.\$[M%"S@H@*L#L'/S'KQP.*DM+O5M+^(EEHUWK$]]:+H+W$@DB12\JRHN_
MY0#DC/&3U- '<T5YOIVH>+/$&B:/XBTJ5E>XD6>:&::/[,UN2=T8 &X$#HV<
MY!SZ5!-=>(;Q_':+XDO(%T=]]H8H8@1B 2!6)3!7)Z  GUH ]/K'T3Q%;Z[=
M:I;PV]Q#)IMS]FF$Z@9;:&R,$\8(KF=/\37OB#4_#6D&=K5KS1%U>\DAP&?.
MQ0BD_=&YF)(YP  1S3OA[!);:[XTAEN)+AEU8#S9 -S#R4QG  R!@9[XH [E
MIHTD$98>8REU3/S,!C) _$?F*RO#WB*V\1V]Y-;07$'V2\DLY$G #;TP&Z$\
M9-<S-;3R?'"(#4;M(QH1F$:LNT?Z0@*@%3@' SWXZURHFU73/!WC;7--U>>T
MDT_7KV:.&.-"DI$BY$FX$D$<8!'XT >T4QY8XR@=U4NVU03C<<9P/?@_E7%^
M(=0OVU"X2#4YD4:7Y\%G8 &9)<L3+(6&T(   "0"=W!KG9;R_P#$$GPPU"XU
M&YAGO@[S" JJ[_LS$N%*D9Y(YR "<8H ]3NIVMK9YEMY9R@SY<(!8_3) K%\
M.>+[#Q3I]Y>:=!=".TE:&19T6-_,49*[2<@C(ZXZUOJ,*!DG ZGO7C_C!8="
M\97.LVHN/^$<NI(K;Q,L.!'O)^5O7H0),=F ZL< 'IVAZU%K^FI?V]K=0V\@
MS$;A AD']X#)./?OU%,U/Q#9Z9?0:?MFNM1N%+Q6=LH:1E'5CD@*O;<Q SQ6
MG$T;PHT)4Q%04*=".V/:O//!SM-\7?'KWG_'U%]DC@#=5@V,?E]B<$^] '6P
M>(X)-6M]*N;*]L[V='DCCGC!#*N,D.A9#U'&<^U;-4]2DM[6T?4)XMYLT>9<
M?>&%.<?49KSR\\0:W!\,+;QW#J+O=!([R:R(7R'B9@#$!C(PIX;.<CGKB@#T
M^BO/))->UKQ[JVD6WB.[L+-+"VNX=D$1:-F9LKRO(^7G//3GKFA WBO6K'Q:
M]OXJN;>;2=3GBL]MO%APD:,JR?+RO.. .22<\  'J5%><^'_ !?>^+]3T73F
ME>Q$^AKJET8,!I'9Q&%4G.%!#-QSRO/7.5K?BGQ#8>%_&=FNIR+J'A^ZA6"]
M$2;IH92I4.-N-P5B"5 ['Z@'K=,EEC@B>65U2-%+,[' 4#J2:X[48-6TB>T2
MY\4330WEZ6>'R5$[+Y9Q# $7IN&XD\A0?FZD\;KNJ:IJOPI\5"\O;Q)--UDV
M<9)19&B$L0"2%>#@.0<=<#.: /6;O4'M;^QM5L;J=;IV5IXD!C@VKG,ASP#T
M'7FKM<9K-UJ>E>,O!UA%JMS):7DUS'<QRK'^]VPLZDD*#P?3 X%5++4M5\5:
M7XCU"RU2>QFL;VXM;&.-5**80 #("#NW'.0>@(Q@\D [ZBO+[3Q/K7B*^\#3
M6^HRZ?#K=E<O=0QQ(P5XT7YD+ GJ3C.1TX-=%X%O]0G?Q!IVH7LEZ=,U-[:&
MXF"B1H]B, VT $C<1G% '0R:@\>L0:>+&Z=)8GE-TJ#R8RI VL<Y#'/'':KM
M<C>:CJ$'Q4TO35O9#I]SIL\S6Q5=H=&0 YQNZ$]36/H/B6ZE\3VFDZY>7VF:
MT)YC):7"#[/>Q8?;Y# 8P,H>H/!SGK0!Z-63XEU^W\+Z!=:Q=6]Q/;VR[G6W
M4%L>O) JMXLNKBULK(P:BEBLE[&DQVEI98SG,<0 )+M@=NFX\=:\^UW5K^]\
M ?$6PO9+ATT]Q';_ &G;YJ(R(^UBO!P2<'K@\T >O1N)(D<# 8 C-.KSRZGU
M[PSXE\-S2:W+J&GZO.+.XM)84586*%E:+:,@#:<@EN.I/6JT.O:SK7PUO?&M
MEJ<EO=1BXNK>UVJ81%"[#RG7&265#DYSD\8 Q0!Z93)98X8VDE=41>2S' %<
M/H_B"^U7QU81"YFCT_4/#BZC]E8+^ZE:11D'&> <<G%<MJU_J>K_  Z,MYJM
MTTL'B46H=-B%XUN@BAL+@X S]>N: /9*9'+',I:-U=0Q4E3GD$@CZ@@C\*B%
MLXL3;&ZG+E"OGG;YGUZ8S^%>3^&-9O="^%F@RQ7\[W6L:J+!)9]KBW,ES(&D
M&1R<!C\Q/..W% 'L%%<7-J&HZ!\0M&TAKR:]TW68)]JSX+P2PJ&+!@!\K XP
M>AZ8Z4_Q[?ZMI\WAL:7J)M#>ZO%9S Q*ZLC*[9.1G@J.A% '8T5YE)?^(-"\
M2:[X?N-<N;Z!M$DU6RNY(XQ- Z-M*G"A2"2#T]JG.OZO_8'PZO\ ^T)/-U6:
MUBO1L3;,'@9V)&W@Y';% '7:)XBM]=N]4MH;>XADTVY^S3"=0,MM#9&">,$4
M:KXCMM(UC2=-GM[AY-3F,,,B*-BL%+'<2<] >@-<+IVDZOJFN>.1I6O3Z5+'
MJ0:,PQ(P>3R$QOW Y7V&._)Z5&FN7'B6T^&.KW<:I<7-\YE"C +"&121[$C/
MXT >DP:@\VK7=B;&ZC2W1&%RZ 12[L\(<Y)&.>.]7:\_G\3:AH_B'QU)<7,E
MW::3IT%W;6[*JA"4D8KE0"02HY.3BM73+37)CH6K)KOFV\T._4(9479+O0%?
M*P/DPQXYY!YR: -/P_XBMO$0U'[/;W$!L+U[*59U )=54DC!/'S"MBO,]"M-
M4O-(\?1:+?/9:D-?N6MI556^<1Q84A@1@]#6KH/B";Q1;>&VLKRXB;R6N-2&
M%W#9^[,3Y7@F7/3'$;4 =O16#XLNKBUTVV:WU&.P#WD22N5+221D_-'$ "3(
MW0<'O]:XN7Q#KD6B?$"*.^NX)-%59K*2=(VF0- )-K<$$9Z9YP>N: /4J*\\
M@OM:L/$_@[SM:N+J'6[>5;FWDC01HRP>8K)A<@Y!SDG.:QKC5/$K>$O&.K#Q
M)=+/H>IW*6P6&(!UCV$+)\O(QQ@;>I)SV /7**XR+6[G7O&1T)+F6SMX-+CO
M93 0'DDD;  )!PJ@=NI/H,'F;SQ7K]OX>U>%]0D%_HNN06/VI8T_TF&21,;Q
MMQNVO@X [&@#UFBN0EO]1_X6D='34)DL9M$>Y$85#Y<HF5 RDKGH>AR/:N.L
MM=\2#X?:#XJGU^XEN&U%()K?R8Q%-&UR8R&&W.<="" ,#CN0#V"BN+6\U+Q1
MJ?B>RLM4ETY]+=;6T\H+_K3&'\Q\@[AE@-O3"GN>(I-4UB]U]?#KSR-/:Z7%
M<74M@Z1&69V925WYPH*$X'=N>F* .YHK$\*+KJ:#%%XC>&34HV9'DB(^=<_*
MQ   ;&,@<5MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %95QHK7/B&T
MU9K^X'V6-XX[8*GE_-C<Q^7=N^4#.>!GU-:M,>:..2.-Y%5Y"0BD\L0"3C\
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M"K4,T=Q"DT,BR1N,JZG((]10!@1^$+3^V=<U"XN)KE-:A2"ZMI OE[%4J ,
M$<,>_>J_AWP0OA]H(SK>IWUE:<6=I=.I2 8P.0H+8!P-Q('8=ZT+[Q'#8>*-
M)T*2TN#+J2RM%.-OECRUW,#SG/([=^M;5 '&:9\.[;2+Z06>L:G'H[S&?^R!
M(OD!B<D#C<$SSMS@]\CBM?2_#::7XBU;65OKF675#&9HI FQ2B[5VX4$<>I-
M;E% &1XB\.V?B73DM+MI8FBF2XMYX6 D@E0Y5U)!&1[CO3;/0/)U-M5N[R2[
MU'[/]FCG=%41)G)"J!C)(!).<X'0<5LT4 8?AKPTGAJ&[BBO[FZ2ZNI+M_/"
M9$DARV-JCC/:I+[06O\ 7+'49=2NA%9OYD=D%3R2V,;FRNXD9..>.U;%% ',
MZYX-AUKQ)IFO+J5Y8WNG*RQ-:B,;E;JK[E.X>WN?6NB>%)8&AF594=2CJX!#
M C!R/>I*Q?%'B.'PKHKZI<6EQ<0HZ(PAVY4LP4$Y(XRPZ9^E %'2_!\N@QFS
MT?7;ZUTS<3'9ND<H@R<D1LRD@>QW8JQJWA&QU2SLX_.N(+JRN!=6UY&P,J2]
MV)((;/0@C!'T&.@HH Y]O"T<PU*:YO9I;_4+86DEWL0&.(9^1%Q@#+,><\GV
M '*^/M(CT/X,SZ%#=3W A2V@MRX'FLJRQ\ *!DA1GIVKL$\1POXQ?PV;2X2X
M6R^VB9MOENF\)@8).<D]0.E;5 &':Z'%<:E::Q=W[:C+;PM':,54(@?&Y\*,
M%B !GICH!DYS8/ -E;:;-HL=]<_V#+,93IQ"[5!;<8PV-PC)YV]>2,XK9\2:
M['X:\/W>L3VL]S#:H7=(-N['K\Q Q6C;S"XMHI@"!(@< ]LC- &/'X:CC\82
M>(Q?7'G/:+9FWVIY?EABP_ASG)/.:P[OX:6EU8ZM8?VSJ<5CJ%V;W[.C1[89
MBX<LI*Y(W#[I)'MGFNXHH Y\^%(AXFAUV/4KY+E;1;29 R%;A58LI?Y<@Y)^
MZ1GITXJK!X"TT:+K>DWEQ<7MIK%S)=7"R[05D<@DJ5 Q@@$=<$5U5% &!:>&
M"EU87.H:E<ZC-IZ,MHTRH-A9=I=MH&Y]N1GIR>.:SF^'UL_AO6=#?5;XVVK7
M,ES</B/>&D;<X4[< $^QKL** (K:%H+:*%I6E**%+L "V.YQQ7()\-=+'A-_
M#DM]J$MDLOFVC&15>S8,64QLJCD%CR<GMTKM** .:LO"4D&EWEM>:[J.H7-S
M ;?[7<%"\49ZA %VC/<D$D@9Z"H)/ D$F@:%H_\ :EZL.C3PSV[@1[V,7W W
MRX('L!FNLHH YO4O"*ZK'J=K=:G<OI^ILK7%JR(0,*JD(V,J#L&>O.2,&M/6
M]%M->T"[T:[WK:W4)A;RSAE![CW%:-% '*6G@@0:UIFK3Z[J=U>6$#6^Z0Q@
M2QDJ=K!5&.5'(P3W)K1\4^'(O%>@S:/<7=Q;6\Y4R-!MW':P8#+ XY K:IDL
MT<"!Y9%12RH"QQ\S$*!]22!^- &%>>%_MVO:/K$VJ77VG2Q*(E5(PK^8 &W#
M;W '3%2R>&XY/&$7B3[;<">.T-F( $\LQE@QSQG.0.<UMUB:MXC%A>26%G8S
MZA?Q6INWMH&4,(\[1]XC))!P.^#TH Q]+^'=MI%ZXL]8U--':8SC2/,7R Q.
M2!QNV9YVYP>^1Q5Q/!D2-XA8:G=YUW_CXRL?R?)L^3Y>/EXYS6_8W8OM/M[L
M0S0B>-9!%.FR1,C.&7L1W%6* ./D^']NL&AM9ZK>VFH:-"+:VO4"%VAP!LD4
MKM88'IUYK1\/^%X] O\ 5+Q=1O+N34IA-,)]F-X4+D;5&.!]/85OT4 85]X8
MBN_%%KK\=]=VMU#;FU=82NV:(L'VME21\PZ@@UF-\/K9_#NM:*^JWQM]7N9+
MFX?$>\-(<L%^7 !('8UV%% '*2>!HGU>74$U?48FN;-+.\CB*!;A%R%)^7*G
M!/*X_"H8?A[;0:1H5E%J^HI+HLF^UN@8RX!0H5(*%<;3CIGOZUV-% %6\M9;
MBP>V@O)K1RNT3QA6=?<;@1GZ@UFQ>&+>/PC)X=>XEF@DA>&2:54:1]V=S-Q@
ML<DDD<DYJ_'?3/K,U@;"X2&.%9%O#M\MR204'.<C&>G>KM &)X6\._\ "+:+
M%I4>I7E[;0#;";LH6C7^Z"JC(],]*AU?PG;ZAK4.MV=Y<:;J\4?D_:K;:?-C
MSG9(K AESSZCL:Z&B@#-M-*='$NH7LE_*%*KYB*J(#P<*HZD<9.3U P":Q+7
MP#9VNE_V*+ZZ?01-YJZ>X4JHW[_+WXW&/=SCKVSCBNMHH P[?PW';>+;OQ$+
M^X::Y@6WD@8)Y8122N/ESD$GG/>N.\(Z>^KW?C6W359K>WN]8FW1Q*N7B*(-
MZ,1D9Y&[D<<8/->FT4 <Y=>#K$WFEWVFRR:;>:9!]EMY( "I@P!Y3J?O+P".
MX/.:@U'P)9:GX>U+29;VZ0ZG.)[VZ39YLK KCJN !L4  < ?4UU+L51F"EB!
MG:.I]JJ:7>2ZAIEO=SV4]C+*NYK:?&^,^AP2* ,K6?"HUBYTB]_M2\M=0TMG
M,-U (]S!UVN&5E*G( [<5G'X<Z>^C:[I4FHZB]OK%P;F3=(I,4A*DLIV\G**
M><].,<YZ75+Z;3[19H+"XOG,J(8H-NX!F +<D<#.35HS1B=8#(HE92ZIGDJ"
M 3CT&1^= '/W/A/[7J.B7\^KWTEQI+.\;L(_WK.I5B_R^A(PN *C_P"$-B@O
M=5ET[4KJQM]58R7EO$$*F0C#.A()1F'4\^O!K:T^^FO6O!-87%H+>X:%#-M_
M?* ,2+@GY3GC//%7: .<?P=9C5M"OK6XFM4T6%X+2VB"^7L=0I#9!)X4=ZL:
M%X<CT*]U6ZCO;BX;4KC[3*LH3"O@+\NT#C '7/2MNB@#$N?#<=SXML_$)O;A
M9[6![=(%">648@MGC.<@=^U5;?P>BG2DO=1N+V'2IO/M%F1 RN%*KN8 $@!C
M@<=LYQ6SJFHII6G27DD$\X0JHB@7<[EF"@*"1DY(K _X3A#KIT3_ (1_6/[2
M%K]K,&(,^5NV[L^;C[W&,YH O^)/#47B);!_MMS975A<BYM[BWVEE;!!!# @
M@@G@BLS_ (5YI\D>OQ7.HZC<0ZXJBY1Y%X8*%WJ0O4[1[#H !Q5FU\:6UUK6
ME:9_9U_!)J4<\D;3JJA/*.'5@&)# \=,>];FI7<MCIMS=0VDUY)%&76WAQOD
M([#/&: ,RT\-[+RRN]1U"?49K!66U,J(@C)&TN0H&7V\9Z $X R:H)X#M8+7
M4=.M[^ZAT;4)'DGL%"[1O^^J-C<J-W'N<$5U,+F6".1HVC9E#%&QE21T..]/
MH YW4O"45WKECJUEJ-UIES:VYM#]E6,B2 D'80ZD#! P1TK/7X<V"^&;S1!J
M6H>5<7OVY)2R%X)?,\P%25Y&0/O9S77F:,3K 9%\UE+A,\E00"<>G(_.JNG7
MTUZ;OSK"XM/(N'A3SMO[Y1C$BX)^4YXSSQ0!/:PM;VT<3SRSLH^:67&YSW)P
M /P  ]!7*0_#G3$\,S^'Y;V^FL6F,UL&=0UHV\N#&P4'(8DY;/ITXKL:* ,6
MS\/^7JD&IZA>RZA>V\+0022(J"-6(W$*H'S-M7)]N,<YYOXFD2/X4A6Y:"1=
M>@E:1,%HD"2 N<@C:"1DGCFN^HH Q+?PY;F\O;Z^F:]N[VW%J\C *%AY^1 .
M@)8D\DDGKP ,.#X<1QV>CVLOB#598M'N$FL@?*'EJBE53A,-P>K9.!@8R:[>
MB@#FCX0$6HZK<V>K7EK%JK![N) ARVT+N1BN5)  [^V#3KSP;97#Z%]FGFLH
M=$</:00!=OW2F&W DC:2.O>NCHH YY/"5K_;NL:G/<S7"ZO MM<VL@7RS&H(
M &!GHS=^<U4\.^!T\/M#$-;U.]L+4_Z'97+J8X/3D*"V <#)('ID UUE,DFC
MB,8DD53(VQ 3C<V"<#WP#^5 '+16MC\/['5]4N+N_NH+Z]-U.JP"1EDDVJ2J
MHN=O ]>E2^#]&M[+^U=7BLWM)-8NVNC%(I5E3HN0>03\SD=C(15W3/$<.I^(
MM9T9;2XAFTL0F1Y=NV3S0Q4K@GC"]\'GI6U0!B>)?#<7B2WLE:\N+.XLKI;N
MVN+?;N2101T8$$88\$5D2_#RVE_M\-K.IL-<B6*[W-&<X386'R<$C\!V XQV
M54=8U:UT33);^\9A$A50%&6=F8*JCW+$#\: ,B3P>DMYH%TVIW?F:(K+;X6/
M#[DV$O\ +S\O'&*K?\(#;G0]=TEM5O3!K5Q)<7+8CW*TF-P7Y< ' ZYK9TK5
M[B_O+ZTNM)N[&6U*_/* 8YE8$@HXX.,<CJ*L+?3-K4E@;"X6%8%E%X=OE,Q8
MC8.<[AC/2@#'E\'Q_P!HZ?JEKJ%Q;ZG9VWV0W(5#Y\/79(N,'!Y!&,&DO/ ^
MG7OAJ^T=YK@->S_:YKL$"5I]P82=,9!50!C& !7344 <O:^#6@\0Q:]-KNH7
M&HI9FS:1Q$%=2V[E0F!R!@#'3G.351?AW:IX0M?#2ZM?_8[:X%PDF(_,+"3S
M "=F,;N>E=F3@$XS["L;P[XBA\1Q:@\5K/;&QO9+*1)]N[>F,GY21CGUH R[
M[P*D_B&76[#6M2TNZNHTCOOLC(%N0HP"0RG#8XR*76? =IJ%YI]_IVHWVD:A
M8P_9H[FT<%GA_N.&!##///?FNIEFCA"F614#,$7<<98G 'US3Z *>F:='I=B
MELDLT[ EGFG;=)*QZLQ]?IP.    *N444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %<#XBM&F^+?A@?;+N-7LKP[8Y<*NWR^@]\G/KQ7?5B:QX9MM8U
M?3=4:ZN[:ZT_S%C:V<+O20 ,C9!X.T<C!'8B@#SYX+X_\+*OK+5KNPDLKIKB
M+[-M&YTMD8;B0<KP!@8ZG.>,=%_:=WJI\/M+?S_Z9I(N7T^P)2>25@A\POD!
M8URPY(!)'7I6FO@FU6'7XO[3U KKA8W63%D;EV'9\G'R\=_SJ.+P%9P7NF7=
MOJNJ0SV-B-/WQR(#/;@Y"/\ )V]5VGWH X62^O\ Q#X'^'VH:A?W/VJ;7(H)
M7C<)OP\JAB ,%OD'/KFO8HD\J)(][/M4+N<Y)QW/O7(Q?#C3(/#EGHL6H:FD
M5E>B]M)O-4R02!F8!<KMQ\S=0<YYKKH8Q#"D09W"*%W.V6..Y/<T >?_ &O4
M;K6?B'IL^J7;6]I:V[6NUE1H=\+NP4J!CGOUQWK8^&MOY'P[T!C--)YEA ^)
M&R%^0<#T%7;7PI:6VLZSJ37=W,^L(D=S%(4V;44JNW"@C )'6I_#F@1>&M'A
MTR"\N[F&%0D1NG#%$'"J-H P![9]2: .:\8PRW'Q'\$0Q7+VS.NH#S8P"RCR
MESC.1GW(-4++5=4M]!\66$OB!HGTS5%MK?4+M?,D6)A&VW@?,_S,J\$Y(KL=
M1\-PZEXATO6I+V[CGTP2"".,IL/F *^X%23D =ZR;GX=:==VVK12ZCJ1.I7:
M7KR!XU:*9,;70A!C&T#!R* ,JQU37#X@\5:3I[72M%I<=SIT6HN':.9A( =Q
M).TE5.&/'H.E6_!GB"'5-9ELY)]4L]2@M?\ 2M)U(DNK;A^]1CPRGD<''(X&
M:O'P%:/?WU])JVK27-]8_8KB0SJ-PPP#X"@!AN. ,*.NW/-:=GX>CM]8CU:Y
MO+B]OHK8VL<LP0%8RP9N$4 DE1D^W&.<@%7QOKD^@^'TFMG6*:YNX+19F (A
M\R0*7P>. 21GC.,UGZV^H^#K;6-=CU.2[TZ'36=+"Y)=_M"Y.\/G(4C&5[=1
MBNBUW0[#Q)HMSI.I1&2TN%VN <$$'((/8@@$?2LW2?!UM86LT%]J.H:R)8&M
MB=2E$FV)OO(  !S@9)Y.!S0!SFKZCJGA_0?#OB*'4[B[>XGMH[^&1@T=PDV
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MEX\, RXP2 VTD+@\>F:ZNQ\&6]AJNHZFFJ:D]WJ$"03R22(V=H(#8VX!Y/;
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M(8D*>60^ V05).<#OVK.;P%9-I>NZ<VIZB8=;F>:[.8MVY@ VW]WP" !WZ4
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M'%,"8V"A%*IMRF<@,>I.<\YK-F^&NE2>'M*TE+_4H9-)8M87T4JK<09Z@,%
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M5+2=*M-%TR'3[*,I!$#C)R6))+,3W))))]35V@ HHHH **** "BBB@ HHHH
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M7OVT7ES"?+:X^SDJ K#D9/)(P?EXQF@#UBBO+]4U35]*F\;Z)#J=WY-CI/\
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M@XH [BBL;PQ'<_V,EU=R3F:\=KGRYG+&%')*1\]-JE0?<&MF@ HHHH ****
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MXXRI!KH-,OXM5TJSU&%76*Z@2=%D&&"LH8 CUYJU0!R^M> ]+UB^L[^*XO\
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M-+L3LX(D5G*C 'N#U_*KEYJ4@T>YO=)M?[3FBWK';QRJGF.K%67<W P01^%
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M'4=INXD?:DI-L7)8#KS^%17^L76E^*'A\0_VE:VUQJ<9T_5K6X=K4H'7$$J
MX0G!4Y'))/:NI_X0S3_+T2,7-Z%T7'V+]XOR87:,_+\WR\<]O>I)/"5E-YL<
MUS>2V<MU]L>SDD!B,F_S,]-P&X [0<9'3DY -N>%;B!X7+A7&"8W9&'T92"/
MJ#7BUK%-IGP&U?4]/U#4+6[CFNBLD=W)QBY8< D@<=2,$^M>UR*7C95=D)&
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MGM[=CGE(SP#R>N<9IY\!Z6VA:GHS7%ZUEJ4[W%TIE&7=SEL';D G!P/3C'-
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M;4" "98FR5R,$X & Q';CTBL*T\+VEI/9S27-Y>/81-':?:) 3"&&TX( ))
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MEUU"^M# +>2,V<YB.\6H()9>3C'3./4'C'<^#K^XU7P5H=_=OON;FQAEE?\
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MP2F52%+%2ARN>O'3OB@#G;/Q!K6CV]UX>GU"6[$7B./2X;ZYF*R&&2,R!6D
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MLVMK16 >5YI'8Y:21V+,['U))/IZ8%7J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBN,O[]]1^)\/ANXDECL(](:^V1R-'Y\AEV<E2"0H!X]6R>@H
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MCH<N>1SS4T-M>ZOJ^O\ AJ&[F==(AM[:WDFU&6*90T(83$H/G8L3R?[O;)R
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M-@L+9I3;P(L<0D?<54  #/4X [U<K \9^(IO"OAJ?5X;)+L0O&KHTOEX#NJ
MC@YP6''% $FI^%--U36H-7F-U%>11& O;W#Q>;%G=L?:1N7/.*X[Q5X1M-*T
M30=)T6RU![9-=@O)A 99#$@9B[@C[F"V<+CV%>F52TV?4)Q=?VA91VI2X=(
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M<YY'& >G2K2^#],0:P ]W_Q.,_;?WY_>97;Q_=^7CC'%;L3^9"CXQN4'%/H
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M:%=J(O8?4\DYY)/)-6:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRL0K?>SEOF)/4G)-1KX*T :?JE@]DTUKJDK37D4TSR"20XRWS,<'@<C'0>E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&5HVVM<1JPRI!Y4D?C7+>)!:6WQ6T.UN[^:UTV73IWE3[=)#&S*1M)PP&>:
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M8V0DAB&R>1UZU/X\AO?!>BGQ3H-]> 6#HUU87%T\T-S$6"D8<G8PR#E<=^M
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M8SV- '14444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7+?$:WN;[P!K%C9VT]S=75NT444,98LQ_E]374T4 9>@KYGAJP
MAF@DC9;6.*2*:,J00H!!!_\ U5R?@'PKJ6@ZEJ%I>\Z7IDTL6C9Z^5*5D8GU
MQPH/^^*] HH SY=2ECUVWTX:==/#+ TK7B@>5&00 A.<Y.?\]M"BB@ HHHH
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MW4>JL,'^52?\(5HOIJ/_ (-;K_XY1_PA6B^FH_\ @UNO_CE '.>%?!E_X?\
M$6I:7<2/=>'&LFBT]G.6B1WRT+'KQV]C^ E\$P:CX%TQO#.JV=W<65K*YL-0
MM8&G66)F+!75 65P2>HQZ&M[_A"M%]-1_P#!K=?_ !RC_A"M%]-1_P#!K=?_
M !R@#*\%Z;>Q>+O%^LSV<UO9ZG<6[6IF78[JD>UB5/S+SZ@5'\1[:\O9?"ZV
M5C=71L]<MKV<PQ%@D2;@QSZ\C@<UL_\ "%:+Z:C_ .#6Z_\ CE'_  A6B^FH
M_P#@UNO_ (Y0 +,S^.%E%K=^0=/\L3&W<)OW[MN2.#C\/QKG(O!=[H/Q%T^[
MT@_\4Y<W,MU<V@Z6MQY$B;U]%;?R/7'M71_\(5HOIJ/_ (-;K_XY1_PA6B^F
MH_\ @UNO_CE &=J$]OJUIJ.E>*?#EY=6HN)%MV6S:=9H\G:R[ 2C#ID[>@(/
M-<M>>&]:LO@-<^'6M;NYU"966VM0/,>.,S!D1F'&53KSCL.E=U_PA6B^FH_^
M#6Z_^.4?\(5HOIJ/_@UNO_CE '->+TO+X^"Y;33-0F%CJ,5U<JMLV8D5"#G(
M'.3T%6?&5KJOCG3!X<L+"YL]/NI$-]?W2B/9$K!BL:$[F8D#J />MS_A"M%]
M-1_\&MU_\<H_X0K1?34?_!K=?_'* .=UNUGM/B7X9O+72[Z73=-LKB"62&W9
ME3<H" >O3MFNEM=6,FJS&'2+V"W,1EN+F:V93(PPJJJ]6.,Y.. !Z\,_X0K1
M?34?_!K=?_'*/^$*T7TU'_P:W7_QR@#S_P .^#-2N?AY:".UFTOQ3I-W/=6,
MD\97EI&;8QZ%'4X(S7IGA_5KC5]*BGO--NM.O-H\ZVN$(V-WVMT8>X_'%4_^
M$*T7TU'_ ,&MU_\ '*/^$*T7TU'_ ,&MU_\ '* ,GXLV5YJGP_O=-TZRN+N\
MN)(3''#&6X65&.3T' /6MWQ%*UUX/U+R+>XDDN+.6.*)86WEF0@#;C(Y]>*@
M_P"$*T7TU'_P:W7_ ,<H_P"$*T7TU'_P:W7_ ,<H XBR\-:K9^#?#>NZ18RP
M>)M$M$@N+25#']KB 'F0MG@^JGGG].HU:\?Q''I6FOIFJP6=W*)+XM \9B5!
MN5"R]"7"\J2, \C-7_\ A"M%]-1_\&MU_P#'*/\ A"M%]-1_\&MU_P#'* .8
M\8Z!/HVL^'O$6@VNJ7]_9W7ESQ>?+<%[5P1(,NQ (X(Z9/TJ?Q";J;XD^%-6
M@TS49K*Q@NA<2):O\AE0!1@C)/'..E=!_P (5HOIJ/\ X-;K_P".4?\ "%:+
MZ:C_ .#6Z_\ CE &%XDTO4O'FI:58M836.@V5VEY=3W6%>Y9,[8T3)('/);'
MM3HX;I?C1<:J;"\&GG119"Y\AMAE$V_'3.,=^GO6W_PA6B^FH_\ @UNO_CE'
M_"%:+Z:C_P"#6Z_^.4 5M*TZWUG2=<TS5-/F^RW=Y.6CN(6021LV0PR/Q'<8
M[5@^&_!.IP6WB;P[KES)=:=-:165C=G[[6^)< _[:;\?@*Z?_A"M%]-1_P#!
MK=?_ !RC_A"M%]-1_P#!K=?_ !R@#(\'76I>&= M_#_B#3[PRZ>GD07=I;O<
M17$2\(1L!*D# (8#I4GPZTJ^TZ/Q'<WMI):KJ.MW%[;I)@.8GV[21_">#P>:
MT_\ A"M%]-1_\&MU_P#'*O:9H%AI$KRVGVK<Z[3YUY-,,>P=B!^% &G1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9(6:)@)(CAEXZ@]C7AOPY-W;? WQ#KD.IWR7D:W4B8F^59% 8/C^]D<YZ\T
M>]T5Y?X"M_%6M>&]'\477BF5G-E,/L,L8\F1OF".[#G@@$\>PQSGF(/%^O6F
MO^!3_;$MY)J-Y+::E-'(7L[D^8J_N@V!\H;EE 7/0G!H ]OO[Q=/T^XO&BDE
M6",R,D>-Q &3C) Z>]9WA;Q/I_B_0HM8TP3"UD9D7SD"ME3@\9-><C6=3\6>
M,_'-E)J=W9V.B6K16UO;L%5GPP9W&/GY4\'C!_&N7T#Q5>^%?@!I,FGN8KB]
MU1K3SP 3$K,Q9AGC.%P,^N: /H>N>\6>,=.\&VUI<ZI%<M#=3BW1X$#8<@D
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MVJ):"RAN)P@\F,9^Z%4#<<G).>O8<5AK\'=$7PM>^'?[3U4V-Y=B\ER\6_S
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M +B>Y<G=)/<-NDD;U)  [#@  8X%7*** "BBB@ HHHH **** "BBB@ HHHH
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M-3AC,UN]O(5+,O.SCKN&1]2*F\*>$K'P=I?]G:=<7DML&)C2YEWB,$EB%
M&23Z^];] 'FOP\UT^-]'T2Z%Y>!K"T9-0 N''F3D[%#<\Y"N_ME:X:P\?^(=
M,^$_BC4O[0N+F^BU<V5M/.WF&!"%Y&?09Q[FO;-"\-Z=X;LKJTTN,P1W-S+<
MN1C(=SDXXQ@< #T K#TWX8>'].T#5=$)N[JPU.3S;B.X=2=_'S*54$'@'\*
M.;M=;U'P_P#%+PQH*7UW=V.KZ4'N$NIVF(F"N?,4L25SMY XZ\5S?@2>^M?
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M8DDDD\UY7\0-1OXM9\2PIK$TPAT<W%I9V$TD4EBRC)EE965<$] <L<C  R2
M>O45X+XL\3ZZWP0\(ZU'J][;ZE/=)#+<03-&TBXD!W8(!^XIY_K70:)J&H:/
M\<->T7^TK^\T]=*%UY-S.9/W@$9RN?NYRW P.>G H [WQ=XHM_!WA^;6KRUN
M+BUA91(+?;N7<P4'#$9Y(K4TZ]CU/3+2_B5ECN84F17Z@,H(!]^:^=;V[O?%
M'P*\0^*-4U&]FOI=05?+^T-Y*1B2/$8CSM &<YQGWZY][\)_\B=H?_8/@_\
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M']V=NT<8P=WX 'KE%>4:[%XHT7POXVGEGNK331 MQI1^W%Y[=P!O&X,3M)Y
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MH@4FD1PV\ G:2?7;C/O7)^.KR[3Q9]D&JR26\FDS-%I5G+)%.L@R?/9E*@(
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MV1E)=B>"I'.#C@Y(B\-^*-4TSQEX^MS]M-EIUA]NMK&]G,K1,(PVW)9B,YY
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M&'BV^T^ZU;3M3L8H_-M);J4O9R D91R=VUL'Y3T((Z8J(:]K U#X3L-6O_\
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MW =K%L<[@<U8\1^)M>U&;X6WEIJ5UI\^M';=K#(PC<YB&2F=I^\Q ([@'(H
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M.2R7[:=8S&:)?M&6W\X.<=!N. ,#GI6E;^"]-MO&$OBE9KMM4EA\B1F<;63
M&-H&/X0>/2NCHH X.;X1^&I;+4+!9-1ATZ^G%Q)917.V%9 0=RKCC. ,'(QT
MQ@8[+3;"#2M-MM/MM_D6T:Q1^8Y9@H& "3R>*M44 <IJ?PZ\/ZOXDGUV[CNO
MM=Q;_9IUCN7C25,8PP4C/&..G XK0\-^%M-\+Z NBV F>R4M\EQ(9.&.2.>
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MLNJM8MMN[KS5BMXF_NASDLW!Z#\:U=*\0MJ.L7FE3Z9=65U:11ROYQ4HX<L
M492=P^0\\?2@"76?#>E:]I,6EW]JKV<4D4B1C@*8V!4#VXP?8D4SQ/X6TKQ?
MHSZ5J\!EMRP=2K;61AT93V/)_.MFB@#EU\"::?#=SHD][J=U#=1B*6>YN3),
MT8Z(&(X'L *J_P#"M-$SH)\Z^SH7_'A^]'[OY@>?E^;H!SV%=E10 5S-AX%T
MC2]7U74K%KNWFU-FDG1)SY?F$'+A3QGYFZY'/2NFHH X,_"/PTWAA/#I>_\
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MGN(;50\D<; -MSC(SP>HK(G\=A=#\.ZK:Z)J-Y%K4D:A8$W&W5QG<^/\]>:
M-3Q/X4TKQ?HITK6(6E@W!U=6VNCCHRGL>3^=5;?P58P:1]@-_JDS!XW%W-=L
M\X\MMR ,>@![ 8Y.>M=+10!SD7@C1UM-:@N%FNWUKB_GF8!Y0%V@?*% P.F
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MW4 ]3@]<>IK)^'UEJ-U\/])\:WNOZO=W=A;7DB6CW!:*8 R !P>6.1U)]!T
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M33H3!8BXEWBUC/4)^'&3DXXS4"_#O0DFUN9?M8?6T*7Y\\_O02<_3J1QC@T
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M;S'DR#O+]2W _#BET_X=>'=*UJWU>R@N8;V"W^SK(+J0[E[;LD[C]<C@>@H
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MHP>-Q'WO3)SR/K7<:>TN@?'N3P_8S7+Z3J.F^?/;S3O*J. ?GRQ)!.WG_>H
M]<HKY?A>[G^#OB769=3U)KZPUE8[5S>2?NANC!P-W7#'KGVQ79PSW6G_ !;\
M"R17UX[:OI?F7WFW#.)V,;G)4G YQ@  # P* /;:*\*TB;Q-XY_X2J>PN8(-
M;L]7 MKBXNWC^QQ(W"! A&T@.#_>/4'%3WD4NI_&CQ#IES>7:V7]AFX:WM[N
M1(S)LCY&".,G/;/?O0![)J.HVFDZ=<:A?3K!:VZ&261CPH%9]WXDM;"73&ND
M:*SU$K'#<D\+*PRJ./X<CH>1G@XXSX'?W=SJO[,D-S?7$UQ-;W_EQO)*Q.W?
M@ \\X!P,YQVKT+XB:;:V'P%O$MU= L-M,I:1G(?S(^06)(H ]4HK$\.ZU#?:
M3I45S>0?VI/I\-S);F0>9AD&6V]<9/6MN@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K.US0M-\2:1-I>K6JW-I,
M!N0DCD<@@CD$>HK1HH Y2S^'/ARSU>QU807<NH648C@N9KV5W51D8)+<C!(P
M>,<8I?\ A77AH>(I];2SEBNKEMUPD5PZ13MG.70':W/)!&#W%=510!1O]&L-
M4N;"XO+=99;"?[1;L?X'VE<_D?S /:L_Q/X.T3Q?;V\6L6IE:V??!+'(T<D3
M=]K*<]A^0]*WJ* .7U+X?>'=7TBVTN_M9Y[6WE\]0UW+N:3&-[/NW,V.,DGB
MK.H^#M(U.]^VRI/'>-:FSDN(9V1Y83U1R#\P]SSZ&M^B@#R7XJ>$I)=#\,:/
MX?T::2TL;Y9'AMHR5CB YR?4Y^IY-=UI/A'1],U*YU>VCN7O[R(1O<W,\DDH
MCP,("YRHX'OQSTKH** ./3X8>%(]#N]%6RG&G7<PN)X?M<N'D'0D[L]A^0]*
MM_\ "!Z!_:NEZF8+@WFEQ+#9R&ZD/EH 0!C=@\$CG.:Z6B@#E9?AUX:E\13:
MX+.6.[N#FX6*X=(YS_MH#AL]P>#W!JQ)X'T*7Q!=ZZ8)QJ5W UO-,MS(-T9
M&W ; & .@[5T5% '+P?#SPS;^%9_#2:>QTB9_,:!YW;#9!RK$Y!R >#5+Q#X
M,75M$L_"EK')%HWFQRWL\LQD=XT.1&"Q+%B57D\!1QV%=K10!AIX0T./Q4OB
M5+,+JBP"W60.0 F,?=SC..,XZ5N444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ<C!90>F0..O-;-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>elicio-insidertradingcom007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K:A?0Z9IUS?7
M+%8;>-I7(&3@#/'O5FN6\33)J>K:;X=6>>!99/M-Q-''D 1D,B;F4KN9]IP<
MY"-QS0!1^'_B#5;^?6M&\0JL>L6%SYI0'(\B8;XP#W"Y*_@*E^T7B_&)K'[=
M<FS?06G%N7_=K)YZKN"],X[FL/Q%;W'A/Q_H'B-+N_U$70;3]04PJS+ ?F1\
M1(.%;DD@GL*U?.1OC/'<#<;<^'S$)MIV;S.'"[NF=O./2@"Q\.[J[N;'75N[
MR>Z:WUR[@C>=RS!$8!5^@%-U77+W5/'T/A#3;EK2.&T-]J%U& 9-I8*D2$@A
M22<DXSCI@U'\-F_T?Q&&1T+Z[=S('0J6C9@589Z@]C5/5K6X\+_% >+&MI[C
M2-0L19WCP1F1K:16!5V5<G80,9 X[T =)+HM_:7^GS:;JEY]FCGS=VUQ-YHE
M0JPR&?+ @D' .#CI3[SQ=HM@9C<73K#!*(9[@0NT,+\#:\@&U>2 <GC/.*GM
M-?L]3DC33";M6/SRHI$<:]R6(QG_ &1SSV&2/.]*,MA\./$'A'5+:9]9!O(H
MHO*)-[YS.R2(<88$OR?X<'.,4 =_?>+-%T_51IEQ=/\ ;6@-PL,<$DC.@('R
M[5.X\C@9/M6>?B-X7&FKJ'V^4VV\I*PM92;<AMI\T!<Q\\?-BN>TRSFTCQYX
M5L[MFD>R\.M:3S[24\W,?!;ID[21GFLOEOAY\1X%BE\VZU*^>WC\IMTP<*$*
MC&6!(."/2@#T+4O&6@Z3J'V"[O2MV8#<+#'"\C.F0,KM!W')' R?RIMIXT\/
MWV@C6K?4%>R,PM\B-M_FDA1'LQNWY(^7&>:Y"/4;.T^(WA>XNI!'$?#LB>8X
M("-OC^\3]WH1SCGCO5"9+C1X-;UN'36;3]4\0P21NUH96MH@ 'NUCP3G<"5.
M.X;!'4 ]!'B_11::E<R7+PKIA'VU)8'5X,KN!*XS@KR" 1BH[+QMH.H:C9V%
MM=NTU[$9;8M;R*DP"[B%<KM9@.H!R._2O/F?9<?$M5AU-UO]+B-M+<6\FZ<_
M9W7C*CDL0 O'7@8'&C+(N/AB0DG^C;?/Q&W[D?9BGS\?+\W'..: .YTSQ-I.
ML17\EC/+(MA(T5R&MI4,;J,E<,H)('89J[8WMMJVFPWMJSM;7$8>-F1HR5/0
MX8 BN$\0:3?V?CCR=-0_8/%,/V>_VMCR7C^]*/0M#O7C^(*:]# 2&( !4C1>
M . H% 'E=C<ZQ=6WCJX/B:_M7T:]F2S=F1HXT1 X#!E.X=CGG'>NJ\+>+CJ7
M@K1=5U6)HKZ_A+?9X(F=I",Y94 )VD8/H-PYKG/!6D:5JVO>,1J>F0W FU=Y
MH/M5MD2QX&&7<,,N0:N>,Y#H7C#1]:N[.^FT(6<MC,UCYF;5BR,KE8R#M.W'
M'H/:@#H&\=^&TTVWU!]2"6\]S]D5FB<%9LX*.",H0>N[&*DM/&6C7\:O:2W,
MS%I%\I;27S!Y9 <E-NX %EYQW ZUP_B"+3/^$>TVXTG2KFWMKGQ%:WC;X9#)
M.JNIDG9&&X#W;KC/<5N^,[2TOM8L9HM8NM$U2&V=[34XAF%E)&8I 1M8'"D*
M3SCCI0!TI\1Z9]AL;M9W=+\9M42)VDE&,\(!NX')R..^*K/XST&/1;O5I+TI
M:63F.YW0N'A<=59,;@?J*XFSNM:MM;\(>)M>L3!;-83V5WY43!+61F!61EQE
M%<*N<CC.#BJWB+3YI['XCZS;1RM::I:06]HJQG-S(D9#,JXR1R #WP3TYH ]
M L_&.AW^JKIL%VYN9(3-%O@=4E08W%'("OC(SM)JD_Q&\+QP/.=0D,,=P;:6
M46LI6%P0O[P[?D&3C+8!Y]*Q;^>-O&?P^G0,88;>Z$L@0[8MT*JH8X^7)!'.
M.17.W"M)\*_'MND$QGN=5O'@B\IM\H>0%"JXR00,@CT]J /5=1URRTQMDQFD
ME$9E,5O \SA!_$50$@?SP<5RGB;6Q>R>"M3T7596L;_5XHF\B3"31E)"0PZG
ME1P?0\5DW^HP:'XVDU+5[?4I-&U6PMDM[RS\XB&2/?F-UCYYWY&1US[T_6;:
MSLK'P3%IVE2Z?:1:XMR+;RVS%%ME^=Q_!DL"<]-W/>@#TJZN8+*TFNKF5(H(
M4,DDCG"HH&22?3%95EXKTB_NQ:Q33).UM]K1)K>2,R0]-Z[@,CD=.>1Q2^++
MB>V\(ZM/;:<FI3+:N5LW3>LW'W2O\0]N_2N"TR]C?X@>'=34ZE<6TFDSQ/<R
MV;Q1J^Z,[0NT!%4 \XQQU)% '8Z?X^\-:G/#%::B7\U965S#(J 19W[F*@+C
M!."1QSW%7+7Q3I-WJD.FI-+'=SQF6!)[>2+SD'4H6 #8]!SCGI7 Z'IMYJGP
M7US2K&*2/499+S;%(AC9MTKLHYQPRX /O6KX:U/0_$FI:;<1:)JBZM9;C+]O
M6<?8"5PP#2':23@87DCDXQ0!U^M>(-+\.V\,^JW0MXII5A1BC$%F. #@''7J
M>*JVOB_1KVU,]M-/)^_>W$0M9/,9T + (5W$ $'.,<]:Q?BC\WARQC$;RM_:
MEI(4CC+G8LJEC@ \ =:J>-;@Z7XKT3Q!<VU]=:']EFM;B2Q,A:W+LC+(1&=Q
M4[,'_P#50!U-MXJT6[TA]4BO1]FCE,#[D9764';Y90C=OR0-N,G(P.:9#XNT
MB:]N;(/=)=VT'VF6"2SE5UCR!N"E<D9/;/0^AKA-76VL[;2/$NC:)>KI$&LB
M\O1Y4AFG5HV0W!C;YR 6[\G&<8YK1L-0@USXLW5Q9";R9?#*+&TT+1%_](?D
M*P!QSU([4 =6/%^AG3]+OQ>,;7594ALY1!)MD=SA0?E^7)_O8J"'4]*7Q9JN
MW5;U[NWM(S<63;S#"N6PZKM^\>0<$YP*\SM+TGX>^"M+%CJ!O-+UBS%[$+.3
M,.QVW9^7GCG"YXKL[*YCB^+>N74F]+<Z5;H)6C8*65G+*#CD@$<=: -;3_'W
MAK5"OV34=R&V>Z\UH72/RU.&)8@ $<<9SR.*O67B73+[56TM))HKX1>>(+BW
M>%GCSC<H<#(SP<=.]><Z1IVHW?[/5OI]A:R_VE;HKM:,K1R,4N/,*8X(+*#C
MUS6A'+I7C"PNY=!TO4DUE=/N(5N;\3(;-WC*A TAP6+$<+D  DGID L>-?%,
M,T.@-I.H7T:S:U:PB6&-TAN$,H#KOQAA@'H<$9ZC-=OK.J0Z)HUWJ<\<TD5M
M$TK)#&7<@#/ '\^@[\5Y1<ZS%>^ /">FII^H1ZCI>H:?'=VGV*4M"8F 8\+R
M.,C'4?C7J'B.&2\\)ZM#;QN\LUC,D:!3N9C&0!CUYH IZ3XML[WPOIVL7?F6
M[7<<0\HP2 O*Z!ML:E<OU."N1@$YX-:&F:[I^KS74%K,WVBT8+<02QM')$2,
MC*L <$=#T/:O-89KE=)^'6N1VMXUAHJ?9]0C-LZM&7MQ%YFTC)5#G) /4^]=
M-I=J=1^*-YXBLB3IHTF.R,H!"SS>:7RO][:N!G_:QV- $_Q \12Z#I-I';FX
M2:]O;>V,D4#OLC>10^"H(#;<@#KD\<BI=/N+'0;F<#4M7O!?C[1!83QS3RP*
MO#$!@9 I)'WN_ ZXJC\37_XE>C(J22.NLVDS+&A<A$D!9B .@'>H6N&T7XIW
M.JWY;^R=4TV**VO "T<3QLQ,;,/N[MQ8$\'ZT )X_P!?2]^%E_K6@:K-&$V;
M)[9RC ^:JLIXW*>2"."*N:W<W=O\4/"EO'>W"VMW!>F:W#XC8HB;21W/S'K7
M&ZWI5U;_  U\;3K;SA=8U8W-E;")M[(9(_F"8R-VUFQCI@UU6NSQS?$[P9<1
M;G@C@O=\JH2J;TC";CC R5.,^E &_?>+=&TXSFYN7$-M((KBX6!VBA<XX=P"
MJ]1G)XSSBIF\1Z6NN)HQGD-^\!N4C6"0AHQU8,%VGL.#U.*\_P!(=],\$^)O
M"VKV\SZJ9;P11^4S&^$Q9D>,X^;);!_NXYQ5S4]$U7P]X8\':G;0/>ZOH(AM
MIXHSDS12*L4B ]\':0?]G- '6VWB_1;S1[K58+F9[.UD:*9_LDH*NIP1M*[B
M0>#@5H:AJ4.G:3/J4L<[PPQ&5DCB9I" ,X"XSG^7?%<#H_A_5=*\:7&CR[Y]
M*OVBUFXN/X?M"\2(/3=((GQZ BN]UB*2?1+^&)2TDEM(JJ.Y*D 4 >?:UXLF
MU3PKX1UZ"ZN].6XU:Q%TF'A1HW(+*2P&]<=P<'FNVTKQ1I.LW%[;VEQ()K+:
M;B.X@>%D4@D-AP"5.#STKS4W(F^&_@.V%M=K+9:EIXN$>VD4IY1_>$@C.U>[
M=/>M+7K*YUCQEXNL[#<);WPVMM!)@A'ES)\@;IG##OQF@#MK?Q7H]SJ=MIZS
MR)/=HSVOFP/&MPH&28V8 -@<\'ISTJ2#Q+IES=V]O%),QN9'B@D^SOY<C(&+
M /C;T1N_..,UQGA?4=%\03:5&^A:H-;L2#+'>K.%LG PS!G.WG& !R<C@#.*
MF@QW&FZ[I#>';RXGTJ\N7-WHE[&6?3LJQ:1&(#(H.1@\-NXSF@#N+KQ=HME<
M1Q7%RZ(\_P!F%P8'\GS<XV&3&T'.1UZC'7BM+4=1M-)T^>_OI?)MH$+R2;2=
MJCJ< $UY/X?.GII)\'^(]#U2ZUF"=T6!A.UO=?O"R2A@=BKR"2<8P3UKT?QE
M_P B/X@_[!MQ_P"BVH J6?Q \,WVIV>GP:B3/>H'MB\,BI+QG:KE=I;!Y&<@
M\=>*=#X\\.7&H"QAOG>X-V;(JMO)\LN,[6.W"]>IX.#Z''&^5!XE\&> M.TT
M&2\M9["YDVH0;5(D!=F_NY' S]XL,9'-7_#=O-?V_P 0;.U+P75[?W!MI70J
M&#0JBNI(Y&X'D4 =6OB_1&FMD^U.L=W+Y-O<-"XAFDY^59"-I)P<<\]LU)JG
MBC2M'-P+N:3_ $6,2W)B@>40(>C.5!VC )Y[#/2O.[A)-?\ A#I_A**VF@U^
M(6MHUL\15[=XG0-*3CA-J%@W0Y !).*T;35T\+^+?$^EZ_I][/!JUT+JSFBL
MWN$NE:-4,7R@\C;C!XP?3J =K=>(],M88Y?-DN!) +A1:0O.3$>CX0'Y3V/?
M!QFD7Q/H\FGV-[!>"XAO_P#CT$"-(TW&3M4#/&#GCCOBN$O;M/#7C66[US3=
M0@TG4K"V2WDL/-9+62,,#"PA_P![CC'IWIBK#X4\6^'M771[FP\-O87%HD:Q
M._V21Y1('=1DIO 'T)P<8H N^&?%UM92>,=1U74[Y],L]25$>XBD8P+Y:Y4H
M%R@#$]A7:SZ_IMMJUMI<T[)>7,3S0H87PZ( 6(;&W@$<9SS7EM]#<ZOX?^)\
M-E8WK/=3+-;AK61/-411YVY R?E/'7VK:GUNVU;Q]X+U&T@O7LH[6]5YS:2*
MJ%DBZY7( Q@D\>_!P =/8>/?#>I7<-M::@7>8RA6,$BH#%G>&8J N ">2./P
MJU;^*](N=3@T]9Y8[BYC:6V$\#Q+.J\DHS !L#GCMSTKA=!TZ[U7X3^*-*LD
M>._N+B_\M)$,9;>[%.N.&&!GI5O0M4T/Q%)8R'0-4;6+%&::*^6<+9-MP^&?
M*\_= &2<\@ ' !V=EXDTV_N;:"W>9C=1F6W=K>14E08)97(P1R._(.1Q6M7E
M_A&*YTO7]'M-$O[B_P##MQ%(TEC>QDS:3A,J-Y&Y02=@5NW3/)KT#1=8M]=T
MR/4+6.XCB=F4+<1&-\JQ4Y4\]10!H4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <_/X=GF\;VWB,7
M\:B"T>T%MY!.49@Q.[=URH[5T%%% !1110!@Z-X?NK"_FOM2UFXU6X.]+<RQ
M)&+>-F#%0% R3A<D_P!T=*WJ** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *P%\.S+XY?Q*;Y"&L18_9O(Z('+@[MW7)/;&/SK?HH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L_7-.?6-"OM,C
MG6#[7 \#2&/?M5E*D@9'.#ZUH44 9^AZ<^CZ%8Z;).LYM($@601[-RJH4$C)
MYP/6M"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BJFG:I9:M;R3V-PD\4<TD#,O9T8
MJP_,?UJW0 4444 %%%% !116$_C#1EU>XTH27;W]N@>6"*PG=E4]#\J'@^M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***\WUOXL)X8\=1:!KFDBVL96"KJ:7!9!D C*E!C&1GG@'/- 'I
M%%9$VJ7J>([/3HK.WDM;FWDG^T_:"&4(4!&S80<^8,?-V-:^><4 %%%&><4
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M_*NP>A/)H [NBH+R\M]/LI[R[F6&V@0R2R.<!5 R2:J:%JCZUI<6I&U:W@N
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MCI^L64=W;%@X1B058=""""#[@T >6:)IUEI_[2&J6=G;QQ6PT<8@4?(N?+R
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M(SN'N2?UKT4> /"R^('UU=&@&HN^]Y 6"LV<[BF=I.><XZ\]:N-X6T-_$/\
M;YTZ+^U"H0W )!8#&,C."1@8)&1@>E 'S^NH7D_P<U7Q?/*Z^)%UT,M[TEC(
MV#8#U"@$_+TYZ5U?B&"75_C;X-M[EIK4W^D%[Q(',98^7-N4D<C@;<]0.AKT
MZ3P3X=EO'N7TU"SW(NWB\Q_):8?\M#%G86]R,U/=>%M&O?$%OKUQ9E]4MUVP
MW'FN&1>>  < <G(QSD^M %/1H?#O@JVT[PM!J"0R2;S:P7-P#+)EBQQGKR33
M_'>HWFD>!-;U#3R1=P6CO&P&2AQ][\.OX5#XA\'6.O\ B#1]4FM(1<:?,DHN
M]Q\P!&W!% XP6P23T&0.N1TLD:31/%*BO&ZE65AD,#U!'I0!Y'X TB\O;;PC
MXCL[JPM[4VCP:@!.SR:@S YWY4 NKACR3WYQ7GB:?;W'PN\>W\HD>XL-646C
M&1L0?O4'RC. <$C/I7O^B>!?#7ANYEN-(TM+663.2LCG;GKM!)"_\!Q4:?#W
MPLFFWFG+I0%G>R"6YA\^3;*X.06^;DYY_ >E 'EB(;#X@_#&_@EF^UZIIZM>
MS/*S-<%HP3N)//4\=N/05+IVBZ?K/Q1^(EAJ,?F6<5N'2(N0B,5!WA0<9!R0
M>V:]4/@CPZ;G3;DZ>3-IB+'9.9Y,P*.@7YNG].*X32? US?_ !0\5W^N:-<K
MI.I*$MYUN/++  !@3&X8!@.AX/>@#SW5-2O]3_9HL7U"225H=6$,4DAR6C4-
MCGOC)'X5Z'<,^N_'>/1-7B6?2K71_-M[:9<QLS!07VG@GEAGMBN[O?!7AS4-
M#M=%N=+B;3+4YAM59E13SS@$9/)Y/J?6I[[PMH^HR6LMQ;.9[6,Q0SQSR1RJ
MA&"OF*P8@^A- 'BF@:;JGCKX#Z@DLL\M_I5W*=-G+'S&1%5BF>I!!91]%]*Z
M[PUKI\0^"9/&-K9HM]I6BR6T/[O&;A4)? [K\J8]-S#UKK]0CU#PO8:39>%/
M#\%Q8).([BWCD6,Q0G.63<0"<]<G^>1H^'M%@T+0;?3HHHHPH9I%C'R;W8L^
M/;<QQ[8H \I^'FGZCK6B^%?$MI?6-O+;W,HU*Y>=FGO=\F&CD^4<]-H)/5<8
MK,\)1ZSXVT75=32\LK/7K/6C<R7]S,PEMT4#$>T+Q%C<,;L<'BO6](\!^&-"
MU234=,TB*VN78ME68JI/!*J3M4X)' '!Q0/ 7A<>('UT:1"NHN^]Y S!6;.=
MQ3.TG/.<=>>M &AXDN[K3_"^K7MDNZ[M[*:6%<9RZH2O'?D"O A>76F?#3P/
MXEL'=M?N]8<37(.9;D-)("CGJP.U1@U](=:P+7P3X=LKN"YM]-16MY6F@C,C
MF*%V^\R1D[%/N * /,KK18->_:"UO1[F:XCL)](#3Q02F/S,B/N/<@^^,'()
M!]?TC2[?1-'M-,M#(;>UB6*/S&W-M P,FJD?A;1HO$4GB!+,C59%V/<^:^67
M &TC.,<#C&.!6Q0!X9X,L(?B)::]<:OJ,UEK]AKGVG[3&0);>)1A8P3]U!AQ
MCID9-+<R2:]XK^)[:R@D.E:<R6"R<_9U",P=/[I.U6W#GFO3IO 'A:?Q VNR
M:- =1<[GERP#GU9 =K'W(JSJ?A'0]8NY;J]LMT\\/D3/'*\7G1_W'V$;Q[-F
M@#PW7=2U#6/AE\.K[49IOMLVH^0\X<K(\8<J"6'/(4'/<\UTOAJ :7\8/'VD
M:?<M867]G+*IW$K%(8XSYG)Z@NQS7INJ>$- UF"R@OM.22&QQ]EC5V18<8 V
MA2 ,8&/2DB\'Z%#JUYJJ6.+Z]C:*YF,SDRH0 5.6QC 'TP,4 >6_#=[G1O&,
M'A3Q-HL<.J):S"WOX #'?1-AF,G9S\N0W7J",DUPT<TG_"@-8E:5_.B\1;8W
M+'<HV1\ ]>F:^C].\+:-I5XEW:6C+/'#Y$323/)Y4><[$#,0@Z<+CI65+\,O
M!LQN_,T*!ENY?.E4N^TOZ@;L+_P'% '#^+R3\4/AB2<G8?Y+4?@32M-'QE\<
MO+;0J+25)(78?ZIB3EAGO7IESX.T&[OK"]N+)I+G3U"VDIGDW1 =,?-_^NI!
MX4T(:_+K@TV'^TIE"R3<_. ,<KG!..^,T ?/^HW@AL/#>I:9?R7SIX@:(:W(
MHBN+K)!92!DE!G&6//3:!BNUUS3[;4?VC+/3[E6:SN-)+S0J[*LIQ(/FP1GH
M/R%=LOPO\$I:_9E\.VBQ^<)^-P;>.GS9SCGIG'M6G)X1T.37$UHV6-22/R4N
M$F=61,$;1AL 8)X% 'A.ADWO[-/B6.Y+3+9W["W#DGRP#$>/^^F_.O9?AI86
M=E\/=":U@CB>XL()9B@P7<QKEC[U>T_P7X=TO1[S2+/2XH]/O,F>V+,R.2,$
MX8G!P!R/0>E7M&T33O#^GI8:7:K;VR=$#%O;J22>,#\* /--24-^TUI2L 0=
M&8$'O_K:Y;PQIVI:UX'\?:5IE\+>Z?5_*MQ))M5@'_U0/8,!MQTYQT->US>%
M-%G\0IK\EF3JJ+L6Y$SAE7!&T8; ')X]ZJV_@/PU:6EW:P:;LAO)5FG43R?/
M(K!E;.[.X$ Y'- 'D::E!K/PU\<V=_H(TK6;"WB%Y:HFV'>-VR1%_A)YR!QP
M".M0ZA=)H/PO\!1VL45O::I<VYU1]Q19D'.V1@#A2-V>.@[U[=;^&-'MK6_M
MULA(FH?\?AN':9IQMVX=G)) ' &>.U5/^$$\,'P\V@G2(6TQF#>0S,V".A#$
M[@1VP>* /,_'%MK_ (,\%>+)[6]MH+74)X'@M+*1C]B1R5D*G"X5R,< =353
M5-)TS2?B%\+QID$<4<L0=O+/#G:OSD=V.>6ZGOTKUZS\'Z!8:%-HL&F1?V?.
MNV6&0F3S!TY+$DX[<\=JHVWPX\)6D]E/%I"F6Q_X]I'FD=HO0 LQX&.!V[4
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M-Y;B*RAB63[?@#$+!B %/&2W [@\5VNO:)9^(]"O-'OU+6UW&8WQU'<,/<$
MCW%8L?A"UUKPY8:3XLT^WU!].*K'-D@2[1@2#!!!(QE3QG/48- 'FW@Y+Z;4
M/BAHEM=Q:4H.(%BE/DVDC>8"5.!M'0$@#ITXK4^%%]-:^);CPWK>AC3->L+#
M:7@4+%=0AE D('!?./F'WLG/2N^A\">%[>6_D@T6VB:_A\BY$8*AX\8VX!P.
M/3%7M-\.Z7I-Y+>6MN_VF2-8FFFF>5_+7D(&<DA03T'% '*_$^XMHD\/QSZC
M-$\FI1B/3HXE<:@<@>6^X@!>1DG(&>A.*XSP(\IC^*NF2+&EI;22&*TC;=%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M $]:\+\#Z?9>/M.UR77KZ6SUZPUTWLERCJLT**H"KN/W4&'&.@Q3U@O?&?Q
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M#WCS$#["Z[L9VYYQ0SHK*K,H+<*">M>$ZF;[PM\0I;W5[&'5_#^K:TDD&HQ
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MPP^N:W(9HKB,20RI+&>C(P8'\13([JWE,@CN(G,1Q(%<'9]?2@"4 *H   '
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MV/2+)8X(@3%;*Y"@GG SG:"?YFL"P\#VT&B:S%J-O:ZE?:S.;F^67(B=LY5
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MA.U<G)QGISS^-7:YSP'XEE\8>#+#79K9+:2Y\S,2,6"[9&7J?]VNCH ****
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M-5\/:/KDD#ZIIUO=M <Q&9=WEGU'H?>BX\.Z-=:K;ZI<:9:RW]NH6*Y>,%T
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M'D7:LSYS\Y'7OU[FI_#NGW,?VG5=2M(+;5;\1_:$A(8*$0*%W=^=Q]MV.<4
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M@#I=(\1Z?JVA6.JBXAACNX4E"22KE"RAMIYZC-:*7=M)-+"EQ$TL0!D17!*
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M']HV/D^=]LM_*W;=_FKMSZ9SUKR/X<Z=9S^//B7HKV\?]FR3I&;95 3:3("
M!P./2H?AI:75KJ.I?#O4;<RP:+J(O1,ZC:\6=T8^I?8X]MPH ]EN[J&RM);J
M=PD42%V8G' KR>Q^(_C+Q!X=.NZ#I6BR6[M*BV]S<^7)$RL N27 ;(W''R].
MOKZ?K<,5QH5_%-&DD9MWRKJ"#@$]#7SY86\"_LJZI,(8Q*UTNYPHW'%R@&3[
M G\Z /H*WU-(M,L9M5FM;2YN(TW1F9=OF$ E5)/S<^E69KVTM[7[5/=0Q6Y
M/FO(%3!Z<GBO$O$-EK=OIOAOQ+H$EK>RZ=X=@6^TJY4,'MF7+. >H.T@XY^4
M=>E)/XCM?^$S^&<]W ;+PU)IA\B*X;*1RLC1C)/!P/+ )[-GC- 'M_VNV^R_
M:OM$7V;;N\[>-F/7/3%9^I:PB>&M0U32[BUN3;6\DJ,&\R-BBEL$J?;'6O,?
M$VG^%?!OAK0=-LM3OI4BUM9;2%;M/+:;()65RI"QKN!/!(SWR367X*N=U_\
M%J+[1;NC1O(HMS^Z)*S9*#)XZ<_2@#U'X?>)[CQCX*L=<NK>*":X,@:.(DJ-
MKLHQGZ5OW5]:6*JUW=06ZN=JF:0(&/H,UP?P._Y))I'^_/\ ^CGK'TZ?[?\
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M;Z)8WVKW5M8M/"C-Y\@B7>5!(&X_7B@",>$O#@T\Z>-!TP61?S#;_94\LO\
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MK1LK&TTVT2TL;6&VMH_N10H$1?H!P*CBU;39Y+F.'4+21[7_ (^%2928?]\
M_+T/6FQZUI4L$L\>IV;PQ8\R19U*IGIDYXH 271-*GU6/59=-M'U")=L=TT*
MF11Z!L9'4_G54>$?#8CN8QH&F".Y(,Z_9$Q*0<@L,?-SSS6O'(DT:R1.KQN
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M=16L6I6<EQ,F^.)9U+NOJ!G)'!Y%+=ZQIFGS)#>ZC:6TKC*I-.J,PSC(!/-
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MMS;?%6/PW*VGC1Y-/^W"[.591@]6W;<<9SCH: .F3PCX;CAMH4T'3%BMI#+
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MO#\TEY))HFG.][_Q],ULA,W.?F..>0#SWHE\,:!,;0RZ)IS_ &,!;;=;(?(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGGNV\V1% :3][$/F/4\$CFNJU#1[L^,/B):PF'5)M6L4AC/GHIM&=2%1]Y&
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M#F0!;.,88_Q=.OO0!LUXYX'CLH/CAXW29+>-@T7D*X ()Q]WWY'2O8@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>E2:9)J2:E:-8QYWW(F7RUQURV<"I;#4['5(7EL;J*X1'*.8V!VL.JGT/L:
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M%VI.8P74>@;J!4[,%4LQ  &23VK"?QOX5CC21O$FD['D\I6%VA!?TZ]>1^=
M%T>']%".@TBP"R8W@6R8;'KQS4DNC:7/IXL)M-LY+('(MW@4Q@_[I&*=?ZK8
M:7"DU_>0VZ2,$0R.!O8] OJ?85GZEXNT+2_#DFOSZE ^G(#MEB<.)&_NKCJV
M1C% &O!;PVL"06\,<,,8VI'&H55'H .!4E8GA7Q+9^*O#]IJ=I- SRQ(\T44
MH<P.R@E&QT(SWK;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6")R,%DC"DCZB@#R#X;IHVO6G@W4(]?_ .)GI%N]NNG0JH8 KM?S!UV\9W'
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M3S9VK222&VA+RKMD8H,NOH3W% 'CWP&\/Z/?>!8=0NK"VN+V#4)'BFD0,\1
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^[G/M6JX8QL$(#X.TGL:^9EAN8O@?K&BW*N?$#>(@C6Q.9FF.PY ZDG!Y[T
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M$HRVZ4+O(]MI 'OF@#K$D20L$=6VMM;:<X/H?>G5PEIXLTS2] \5:U:>'[B
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MDHK"\*^*;3Q7IUQ<VT;12VMR]K<0LP;RY4Z@,.&'(((Z@UNT %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5YMX\^#FD^.=;CU=[^XL;G8L
M<WEH'$JCIP>AQQGZ<5Z310!0T71[30-%L])L%9;6TB$<88Y) [D^IZGZU?HH
MH *Y6'2&UOQ)J%YK>CRQPQ*L%@994(,?5VPCD@LQZ'LB]^*ZJFO(D2%Y'5$'
M5F. * .!T?0=2\._$35O[/TB9?#>J0QM)(LT8$5PN06"E]VTKU.,Y[5S[^'?
M%=O\+-0\"#0GN9H08[2^CN(EAGC\T."06#*V.,8QQUKUY)$D561U8,,@J<Y%
M.H X*.RU[0_'M[KD&CRW]CK-K EQ%!/&);66(%1]]E#*03R#U_7"?PSXD?X7
M:CHAT5OM\^JFYCC6XB(*&Y$N<E@!P,>OL*]:HH X^[T_5H_B78:[;Z:TUG+I
M36,Q,R*;=C*KY89Y& 1\N>?SKG[KP9K&MZ+XXTZ6V>P?5;];NQFDD1E;8(RH
M;:Q(RT?<=#^%>H44 <3>:?JGBRZ\-OJ&DRZ;_9EXM_<F22-@TB(P5(]K'(+-
MG)QP/7@8S>']>?P5XYT[^QYA=:O?W4UHAFA^9)0H4D[\#H<Y_6O3Z* //KC3
M_$5QJ]K%=:*UYI1TM(HH7N8UCMKD9#-*N3NXQ@@-C' Y-9=KX>\1Q^!O!.FR
M:)(+K2=3MY[E%N(CMBCW9.2P!)W< $^^.E>JTW>GF>7N7?C.W/./7% ')P:=
MJ0^*MSJ[:?*NG2:3':+<&2/'F+(SGY=V[&&QG'6J-KX>EA^)]]Y$R_V1(L6J
M3VV/NW9#QJ?3# %S_M(#7;W-O'=VLUM,"8ID:-PK%3@C!P1R/J*H:%X?T[PW
MI_V+38G2,G<S22-([G&,LS$D\ #V H @AUJ^;QC<:+/I+168MO/MKX3JPFP4
M#@H.5P7 &>N#6=\2=,U'6_ FHZ7I=F]U=W01442(@&'5B26([ UT@%I#>''D
MI=3C)Y >0+^I S^&:DBGAG#F&5)-CE&V,#M8=0<="/2@#D-:L]5OO&WA+5(=
M(N/LMC]J-T6EA!C\R,(O&_GD9.,\?E2)IFJ:!\0M7UFWL9=0T[68(1*('020
M31*5'#LH*LIZ@\'MCFNTHH \ONO!^L6VAVHM[!KB\N?$ZZW=11RQ@0)YNXKE
MF )"@#CJ<]JZ!+'4U^*,^M'3)_[/;1UM%E\R+F02L^,;\XP<9QU_.NMAFBN(
MA+#*DD9SAT8$'''44^@#D_AYIFHZ1X<FL]3LGM9_MMQ,%:1'RLDC..58]C3+
MG3=5M_BE%K-O8?:+"?2A922B95\EQ,7RP)R00>, \]<=:Z^B@#S"3P_KTGA'
MQY8#1YA<ZQ?3S6:F:'YTD15!)W\?=).:UK[3=7G\1>"+Q-)G\G3%F^UDRQ9C
M+P^6!C?SSSQGC\J[FB@#S'4/"6N:M)XW1+5K)]1N+6ZTZ>:2-E9X%3 8*Q(R
MR=QT/X5T_AR_\1:C+&=6\.1Z*(E/FDW"2F9\8PFWHO?).>@P>373T4 <IX\T
MO4=2T_29=,M#=S6&K6UZT D5&D1&.X*6(&<'N15*QT_6-"\;ZOK TR6\LM;A
M@>2.WEC,EK/&NS:=S*"I'<'@CTYKN** .<\%Z!-H&D72W6U;J^OI[^:-#E8V
ME?.P'O@8'US5/^SM5M/BA<:M%IYN-/O--BMS.LR+Y3H[L05)R<AN, \]<=:Z
M^B@#RFZ\->()_A]XSTI=&F%YJNJ7%Q:QF>'#1R.&!)WX& .1_.NCU.QU2\\<
M^%-3CTJ<6EC#<K<N9(LQF5%"C&_)P5.<9_&NSJ,SPK.L!E03,I98RPW$#J0.
MN.1^= 'F5UX3U_4+7Q9Y-G]CN[C5H=3TUYY(V20Q"/"L%8D9*'KZBNFTG4_$
MMW:S75WX5339+>!RML;J-WN9<<*K+PJY[GU'& :ZNFNBR1M&X#*P((/<&@#,
M\.:K<:WH5O?75BUC<N726V,@D\MT=D(##AAE3@CM6':6&K:9\1=>U%=,:XT_
M4K:VV3I,@V-$K@J5)!R=PQV]2*Z^.-(8UCB14C0!551@ #L!3J /)X/#/B&+
MX5:)H;:-,=0M-0CGEC$\. BW!E)#;\'Y3^=:WV7Q-X<\6:M-8^'UUG2]7E6Z
M4BYCBDM9MBHRONZJ=H.1G&.]>A44 5[6*4V$<5X(FE*8E$8^3)Z@>W:N)\*:
M=K/@*VET :3<:IH\<SR6%U:21[XT=BWER*[*<@D_,,@Y[5WU(2%!)( '))H
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M]6U"ZGM$,T.&27;M)._ QCD?SKLK+PWI6BR)<27=[,8S^Z.H:A+,L9_V0[$
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M*L942QA5;YB,@$<XR?0&NJC@BA>1XXU5I&W.P'+'U)[T-/$DJ1/*BR29V(6
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M>UE;P\3N@E\P2C[0O))53D=.1V% 'H$DL<*AI9$12<99@*(YHI@3%*C@==K
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M17"W4V]5+-*F,JI/][)/MZU-:Z+K=K/XJE;1[>YCU2_BFCMYY4*RP@(DBMU
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MTW/G<G;G...G6@#HM:\9_8[S4K33X[.:XTY%:6.YN3$9'*[Q&@"G)VD<GC+
M<\XIVOCV_P!4U;3]/T[0?GO],-_$;JX,6PAU4I(-A*X)/(W9XXYR&3:5XLT7
MQ;?ZOH5M87EEJZQ/<VEW<&)K>9$";E8*<J0!D8SQ5J/1-;3Q]8ZW<+!<0PZ7
M):32*^TM(\BOE5Q]T;<#)S]>X!B:EXYUF]\.:5<V5G;VETWB"+2[Z-IV.UUF
M"E48+RK8P21P">#6_-XNNSJNHZ5:6EE+J>GPQR26;715YMR;CY7R?,H!QG')
MXXZGGSX,\0?V#<1+!:?;(_$O]MPQFX.R1/-W["VWY6Q[$5<\4^%-1\41W27F
ME6:WZ[&TO4[>XV/9ML7.YL!B ^XC&=V>BT =7XHO[S2O"VJ:AIZ0M=6MK),@
MF)"_*I/.!STZ=_45Y]=W6HW!^&>H75K%/J$CDJ4FRTH-H3EF91MR221SCMGI
M7HNL:;+J7AB_TL3 S7-G);B5Q@;F0KN./<YKCH/#OB1D\%?:+*R4Z$V)Q'=%
MMRB'R@1E1R>6QV&!DT :5KXSU$VGB&*YT)I-6T:6.-K2QF,PG\Q59"K%0<8;
MGY> "?:HKGQI?QW/B#2X[:P;4M-T\7L;I<%XB/F!5OER&4KT[Y'2L[5/"WB>
MXN?&4^GF"V?5Y+5[8_:""RQ*JNC$#*[P",C/7M4L?A77)_$=[>-9:9865[H?
M]G>3!,6^SL&<@ ! &^\.>,>^.0#H_ ][J&H^"]'O-2\LSS6<,GF+*7,F8U.Y
MLJ,,23P,_6N-M=0U'1/%7Q"N=(TJWNA;RV\\BRS^2NU;96(7"L2QY[ >IKL_
M!ECJ>E^%-.TW58;>*>RMX[8""4R!@BA=Q) QG&<=O7TQ8?#^LQW_ (VG-K!M
MUI5%J!/R"L/E?/QQZ\9H OCQ9=7MMI]QIVG*MM=Z:-0:[O9#'!&#MVQE@#\Y
MW>V ,\UG0_$.6XTCPOJ\>DHNGZW,MM)))<D&UE8D $!#N!*D Y'..F:IZ3X9
M\3Z==>'?-MK"ZM;#28[)H9KDA;>X4\SJ-IW94 =B.F1DU-I/@?4'^$C>$M6^
MSQW21ND$L$A8*X<O')G P0V#@>G7G@ WM4\5#26U2:XMXS96(AC$JS?-)/(0
M!'M(P/O(<Y_C'H:KZ5XOEN_%/]B7%K RR6YGAN[*9I8L@X,;DJ-K=QZCTJ#4
M/"-]JGP];2);U8]:D*7;W8'RBZ#B3/\ N[AM'HH'I5_P]+XMNG1O$-KI]DL*
MX*V<QE-P_3=R!L7KQR2<<C'( WQ!XFO-'\1:)I-MI:W9U4S*DAN-FQHXR^"-
MIXZ<YZ9X)P#G0>/V@L-6&K:<D&I:=?1V MK>?S$GDEV^5M8JO!W#.1P 3[5=
M\0:/J5]XR\,:G:PQ/:Z9).\Y:7:Q\R,H-HQSC.3G%<YJ7@36-6F\2RYM[6>Z
MU"VU'393)O"R0JJ@2 #@'!Z9QGVY .CE\3W]CXCM="U"QMH[G4())-/FCG9H
MI)$&6C?*@J0,'.#D>AXJ'X;:QJNO>#K;4M5$)DG>5U>.0DG]Z^05(&T#  Y/
M [5(='U#7/$FB:QJEI'9+I*2LD*S"4R32*$)R!@(!G'<DC@8Y7X?Z+JOASPU
M'HVI1VH6T>189892YE5I&;<05&WA@,<]Z )[3Q)<R>-[SPY>6$5OY5L+NVG%
MP6^T1EMI(7:,%3P1D]15,>-C]ET_S8+2WN=1,SVHDN3Y9@0@"5FV@_-N4A0/
MXASUQ7\>Z0NL76B&POOLVK)>&W5XR"_D2(1.OM^[!8$]U7UJ;Q3X?U<:AHNM
M>%Q:_;-*22 V=PQ2.>!PH*;A]TC8I% &!JGCW6;O3[-;*RAM;A=?MM/N6,S%
M)5,@(:)]G*. 021D#(P:[S64:;PM?K=Q1;VLY/,13O4'8>A(&1^ KFM=T7Q/
MKVAV5Q/%8QZE:ZG;7T=BLY\H)$V2ADVY+'GG&.@QQD]9<6\][HTUM-Y<=Q/
MR-L)959E(X. 2!GK@9]!0!YOX:\7ZEX<\$^$I;[0U&@S6]M:M>K<@R1,RA5=
MH\8V$_[6?8=*W=7^('V.'4;C3[6VO(M.N&@E@-P5GF*D!_+0*<X.0,GDJ>G!
M-:T\*:O>>#M&\*:G;V\%K8M +JXCG\P3I"0RA!@$;BJYSC SC-/LM(\8>&];
MU2WTB+3;S1]1NY+R.6YF9'LWD.7!4 [USD@ CZB@"SJ'CY5BOWTJ&VG:QC5W
MBN9S#)*QC$GEHH4_-M9>O<X]320^.;_4-;L=-TW0PS7VE?VC"]U<&+9\RJ5D
M&TE<%CG&[G''<5QHWB[PYXFU"ZT-+#4]/U5DEF2\G,+P3A C/E5(*L%!( ^F
M.]Y-$UF/X@66M2K#<6\.DO92R!]C/*TBN65,<+\N.N: -/PEXA?Q)HSW4]H+
M2Z@N9;2XA$F]5DC8J<-@9'&>G>J5]KMQJDFMV&E6%O=QZ<GE7+7$I022E-WE
MKA3R 1DGC) ]2'>"-'U'1;/5(M1BB1KG4[B\C\J3>-DC;@#P.16;:Z#XAT#Q
M'K[:;;VE[I>M2_:@9;@Q/;3%=K9&T[E. 1CZ>] &+X0UA-.\&_#NUETJ"Z6]
M(BCN)&&ZW?:YW*"IYP",@CK756'BV;5K^ZAT^VM9DM-0-E<PFX(N(0K[3(4V
M].X&>G.>HKG--\(>(K30_!%E-;69DT.Y\VX*7)(9=C* N5'S?-TZ<=:NZCX0
MOM6UVSU-]/M['5[34?-&JVTP!EM1(3L=0 68IA<$$=\]J -)_%VH7.G-JVD:
M*=0TU+LV^(Y3Y\JK)Y;R(FW& P/!/(&>*RX[VST3XF^+M2N2(K:WT>VGF91V
M!E)/N>*70-"\7>&C<Z!9+I\NBO<22VM^\S"6VC=BQ7R]I#L"3@Y ]?2I=2\'
M7NL^)/$S7:1QZ9J^F1V*2I)F1&7<=Q7'3+>O:@"[<>,KO38M&OM4TR.#3-4E
MCA62.<O);/(,Q^8-H&#T)!X/KUJ73?%LVL7LR:?;6LT5M?O97,7V@BX@"N4,
MC)MZ$C(&>A!SU S?^$<UO6M T70M:@MXX]/G@DN;J*;<+A8>5V+@$%B%SG&.
M<9J.\\(WVI^(-/U9]/M[#5[34/,?5+68#S[4.?W;J "S,FU2",#DY[$ DU+X
MC+:V<NI65I!>V,%R8'BCG/VIU63RV=(PI! () SRHSQ5_4-?GU>+7;/2;&WN
MX-/0Q7#W$I022E-QC4;3R 5R3W./4C,T;1?&7AN>ZT33UTZ?1);B2:UO9966
M6T21BS*8\'>02<<@'N>P?:^'_$.@:YX@33;>TOM+UF5KI7FN#$]O,R[7R-IW
M*< C'_UZ -#X8Y_X5AX>P 3]B3&:QM%\:ZE::7XEU37(H)([35Y;.&.WF)8R
M QQI$BLH&"3G=GJ2<"ND\"Z3?Z%X*TO2M22!;JTA$3>3(74@=#D@<^WZURUS
MX"UF]TGQ+I+26D"7>JOJNGW8D9F$A97563;P 5()R>O H Z5O$UUIWB73M'U
MFRAA_M-7^R7%O,9$\Q!EHVRHP<<@]_056^(&L:MI%GH_]EB ?:M6M;:5I)&4
M[6D'RC . V,$]@3P<\.?1]3\0:WH6H:O9PV2Z2SSF-)O,\V9DVC:0.$&2<GD
MG' J?QQHE_K6E6(TU87NK+4;>^6.9RBR>6^XKN .,COB@#G%DU2W^*^KMIVF
MVDM_)HMLSH]P8X0WF29R^PL?0?+SWQ6I8_$*WU#0]$NTABMKO54E98KF?:D7
ME';(2P'.&P!@<Y[<XEL=*UJ'Q]?:]<VEOY%QIL5J%BGR0Z,S=P./FQGVS@=N
M:T[P5XJT71/#UUIXL?[9T9[I'MY)B8;J">0N5W8RK#Y<<=10!VGA3Q*_B**^
M6>S^S7%E<&!RC%XI1U#QN0,J1[<5T-9FBG6)+9[C6DMX+B0C;;6[F1(5';>0
M-S'G)P!T Z9.G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%<%)XQ\3W5WX@M=)\/64TVC3!'$EZ0)E*!\)A/OD'H< >I
MH [VJE]JEAIBQ&^O(+83.(X_.D"[W)P%7/4\]!7*Z)X^&NZGH$=M9H+36+"6
MZ1VD.^)HR%9",8/)(SGM7.^*_$$^N^%KEIK)$GTOQ3!9*L3[O-*2QG<"0,9W
M8Q^M 'JLDL<,32RNJ1H,L['  ]2:SSKNCOI<5_\ VG:_8;B00Q7"S ([EBH"
ML#R<@CBL+3_%.JIXP3P[X@TJVM7O('N+&>UN#*D@3&Y&W*I# $'IBN3\+ZRV
MA?"'PO*--MKV*;4!;L)GQY1>Z8*X&TY(/N,<4 >E:3H>G:''-'IT#0I/(9I%
M,KN&<]6^8GD]SWK1KF;OQ#J%S>:Q:Z%9P7,NDHOFB9R/.E*;Q$F.AVE?F/0L
M!@\UNZ=<RWNF6MU/:R6DTT2N]O(06B8C)4X[CI0 7FH66GQB2]N[>V0G ::0
M("?J35'4M'T+Q98VXO[:UU*TCD$T))#IN&1D8X/4^U<_\8 #\*-?R ?W*'_R
M(M37OB34M-US0M!L=+MIQ?V<DD4KW!0*8U7(8;3@?,.1D^U '8*JHH55"JHP
M !@ 5574[!M3.F+>0-?K&96MA(#($R!N*]0,D<^]<C9^/IO[(N3?6$2ZO#J_
M]C);Q3$QS3G!4AB,A=IW'(R #Q52(ZFOQK'VF&T:<>')#$T3LJR?Z0G#9!*X
M/?GCGVH [NPU"SU6S2\L+J&ZMG)"2PN&5L$@X(]""/PJ=W6-&=V"HHRS$X '
MK7GD'CJZMOAQIOB>WT6S@M)+EH[N!92JVL9G:/S!A?F /)X'4FNJOM5O4U"Y
MMK2UMKF.WLOM$ADE*?,20J9"GJ%8Y[8''- &I97UKJ5E%>65Q'<6TR[HY8F#
M*P]014=KJ=A>W5S;6EY!//:D">.*0,8B<X#8Z'@\&N3T;QD+S0O"\5CI]O!?
M:U"TD-LIQ%;QH,NQP.0,@ #&21TY(YN/7=1\,ZW\2=9ELK66XLQ8N\22%4D4
M1$ @X)!(P<'..F3UH ];HKG;OQ'/:^+="T<VL;0ZK!/*)0Y#1F)58C&,'.X=
MZR?^$WOK>_T2/4-/@MAJUXUJ+-Y<75N/GV2,O0AMG/3&X<F@#K;34["_FN(;
M.\@N)+9@DRQ2!C&Q[-CH?:K=>:V>KQ^'-;^).JM"9$M;BVD*+QG_ $=.3@'
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M!I 'DP"3M7J< '\JPK?Q1<:I<V-AIT$*WL^FQZC.TS$I"C\*O'+$G=Z8"Y]
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M<MN&T<DD=?6@#5HKS^7QQK[Z9XEO+;1+'_B0W,L<RR7C8D2.-7.TA/O$$]0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!'#"BQQH.BJ!@#\A63%:^'+7Q?,\4%E'XANK?S9&"CSGB!"YSUQD ?A[5MT
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MMM4FAEA$4K,R[(PF&!4#G&>":VM4U?3M$LFO-3O8+2V4X,DSA1GT&>I]JNT
M<7KFA^([/Q>/$?AE[&8W%LMK>V5Z[(KA22CJR@X8;B.G2KFN^'+[Q#X)NM,O
MKF+^U)5\Z*:(%4AG4[H]N><*0HSU/)[XKJ** .1UGPA=:EX(ATN"^6'5H)8[
MR.\*_+]J5_,+D>A<M],^U5[C3_&>N^%]5LM632+>XN;&6TBBMIG*.[KM\QV*
MY '90#U.3TKJ=.U?3M66=M.O8+I;>4PRM"X8*X )7(XS@BBXU?3K74K73I[V
M".]NL^1;LXWR8!)(7K@ 'F@#E)?#.MO)X*81V/\ Q(_^/G_2&^?]R8OD^3GK
MGG'I4NA>$)H$US3-<M--OM(O-2FOH5?,C-YCA@'1EP-O/<Y]L<]G10!RM]X7
MMK:UATW2_#^D2:+*9#>V#((@[$+M=0%(+#:1SCZ\"N-O-!O?"R^"=/B*3.FN
MS26]N\S%(8F20K$'(R=J\9QUKT^;5].@U2WTR6]@6_N0S0VQ<>8X ))"]<8!
MYJ/4-#TW5+JVN;VV\V:U;? Y=@8V_O+@\'WZT <EK?@2Z\42ZS?WDZ6-]=6L
M-M8^4V_[.(I/-5F.!DF3&0.@'4YJU'H_BGQ'H=YI7BMM-MH)K5[=CIS.YF9E
MV[SN V@9SMYR<<C&#VE% ''^&+/QG:V]K8:W)IAMK% @N+:1S)=A1A=P( 3L
M2><XQC!K-@\(Z]'X \2:$RZ?]KU2XNI(F%P^Q%G)/S'9G(SV'/M7H5% '$ZE
MX=UR]@\(JD5BKZ/<QSW -RV&"QE"$^3G[V><=*ALO#_BSP[KNK1Z))IDVCZI
M=O>![MG$EI(_W\*!AQGD#(^HKN&N(4G2!I%$T@)5,\D#J<>G3GW'K4E %:>T
M:;2Y+/S6+/"8O,?DDE<9-<19>$-7N?!VE>$]4CLX[&R:$7%Q#.SFX2)@RA5*
MC;N*KG)X&<9SD>@44 <#>^$_$,]_XVGM+JULVUN"".SGCF??$T:%?F^48W9Z
M@DBH8_!VM76MZ?<W=KI-G8#29M,N;6UE=O+5RI)0E0"3@\'&,]6KN]0U&RTJ
MRDO-0NH;6VC&7EF<*H_$U-#-'<01SPN'BD4.C#H01D&@#BO"ND^,]'LK30[Z
M?3)--T\*D5[$[^?/$GW$*$87@ $Y/'09YK%M? 'B#3I7UBP.G0:^FJSW*/Y[
MF*:VF?<\,OR9..W!P>1BO4J* .-MM"UG1_%^I:[8P6L\.L11?;+1[@J89HUV
MJR-L^92O!X![\]*S;CP)J-GHFF/ISVL^JVNM-K$Z2NT<4SOOWH&P2H < ''\
M/3FNZOM2L=,A$U_>06L;-M5II @)]!GJ?:F6>L:9J#^79ZA;7#X)V12JS #&
M> <\;A^8H XJ;P?K^HW?C&2[?3HEU_3H[:/RY';R76-U&<K\RY?KP3CH*Z[P
M[!J-KH-G;:HELEU#$L96V=G3"J!]X@$YQGIQG'.,G4HH X*'PKKB:-XULV2P
M\S79IY+<BX?""2(1_/\ )VQGC/I3Y_#&MR0>"T6.QW:&Z-<YN&^?;$8_D^3G
MKGG'I7=44 >77'@KQ7-I,]FQTF:==834%O))I/,NE67>JO\ )\FU>!C<,
M=:U/%FCV_B#7_#ZV]]&NH+)+;7RVY!\RT*9F1AG(&X(!GH7'K787^KZ=I;VR
M7U[!;O=2K# DC@-*Y. JCJ3DBJ-A:>'-+\1WEO8065OK-Y']LN5C4"65"V-[
M=\;B?Q- &WT&!7!VOAC7K+3?$>C1"R-OJ]Y<W"7IE;="DY^8&/;RR@G'S8/?
M%=Y10!Y_)X3U[PSKD-_X0-C/:/8P6-U97\C)D0@K'(KJ#R <$8_^MVNGQWD-
MA&M],DUV<M(T8*IDDG:N>=HZ#/.!S5NB@#SE_!NO2>#O%VCE=/%QK5]<7,#?
M:'VHLN.&^3.1CL.:T+?PYK&D>*5U^QCM9C=V,5KJ%HTY7#Q_<D1]O/&000/7
MVKMJ* //+SP)J0TI)[1[-]6;Q FN31R2,L3,#_J@P4G 7 W;>2"<#.*UX-$U
MD?$,^(9TLC;-I"V)5)FW>8)#)D KC;SCKGO[5L?\))H?VH6O]L6'GE_+"?:%
MSO\ [O7[WMUK1EEC@A>::1(XHU+.[G"J!U))Z"@#@[/PKKT/A3Q=I<L>G^?K
M5Q>30,MRY5!., -^[SQ[=:CD\+>*-+GT+6-%?3FU*STQ-,OK.XE?R9XUP0RN
M%R"&R>1W_/KK?Q+HMT+HQ:E;DVA43J6VM&6^[D'GGMZ]LTS3O%6@ZO?&QL-5
MMI[Q59F@5OWBA2 VY>HP2.#0!SFL>&O$EW=Z'XBAGL7UW3996>U+,MN\4JA6
MC5L%@0%!#$<DDX P!=\/:-K=KXTUS6]1BL8H-2AMU$4,[2-&8E8=2@!!W=>.
MG3O7744 <OKNBZE+XNT;Q!IZ6\XL89X);>64QEEDV_,K;2,C;T..O6ETW18-
M.N-:U+6Y;47&N2JLT9?]TL:Q[$B!;&X[=Q)P,DGCBNGK/U;0]+UZWCM]6L+>
M]ABD$J).@8!AG!P?J?SH YWX;:(=)\.F1KJ2Z29REI+)U%FC,(%^FTEA_OU<
M\9Z'J&LQ:--IGV9KG3=3BO?+N)&1)%4,I7<%8@_-Z'I72JH50J@!0,  < 4M
M '':=H6N6GBKQ%J\T=@Z:G;6\42I.X(:)6!R"G );U.,=ZP;+P/XHT31O#-S
MI<^G?VUHL$EI-#)(Y@NH'()&[:"I! (XZUZ?10!FZ,FK?96EUEK<7<C9\FV)
M,<*XX4,0"QZDG Z].*TJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KSOP+,VO>./&&LWOSSV-^VEVBMSY$4?7;Z;CR?7
M%>B5QI\,ZIH7BN_USPXUI+!JFUK[3[N1H@9%X$D;JK8)!Y!7!]: -G4[?3-*
MNKCQ5<J(Y+.QE2:55Y:(%7.?7&SCZGUK!N_&.I:5I&D:_J-I;#2=0DB66.,M
MYMFLN-C,Q.'&2 P 7&>,UMW.E7FO:9>V>L^3!;W5L]L;>UD,@ <8+%RJY/H,
M #GKQC C\(ZS?>&--\,:S)926%E)#YEU#(QDN8H6!13&5 0G:H8[CT..O !*
MWBCQ%=:WXFTO3].TU9=($+1R3SN5D#H7YP <G 'H.>35.#Q[JTVF>&=<;3+2
M/2=8N(+5X_.9IXWE^4,.-NT-VZD<\=!J66@:O:>)?%.J%;%H]62%8$\]P4,<
M93YOD[YSQG'O60O@G7(_ _AC0U;3C<:/>V]S)(9W"2+$VX ?)G)_3WH MR^*
M/%5[KOB'2-'TC3&GTDPE7N+E]L@="X'"@[CP.P'/)J33/&UUKV@:+JEE9QV<
M%Z)?MES=G,5BT?RE6&5+;FX'(XY]JHZ-)JJ?$SQS]@M[.4D6.1/.T>UO(XZ(
MV1^73\GP>!=5T8^&1I5U9W4>F>>;F*]W(DDLIW&90H/S EL ]CC(ZT ,;XB:
M@?!<6MPZ;:RS+JG]G3J)B%)\[R]Z<<YR#@D8SU-:UIXAUQO%E]X=O;33X[K^
MSQ?V<D,CNFW>4*29 .<XY Z=JP3X#\1CPS=Z2;G2Y&DUO^TDDW2(-OG>:01M
M;!.,8YQZFNB?2-0A^(!\3W#6,6GII)LY 9VW*?,\POR@&!C'7W]J *FE>,;_
M %/P@M_]GMH]9^W?8'LCN(CF$FPH3G/ ^<GT[5VB[MHW$%L<D# S7#Z-H]E=
M_$?4];TZ\6?3_*BD>.)@T1O"K*74C^(1%0?^NGY=S0!Q.AZAK5W\2/%-G<SV
MS6-FEJJ1A&!5621ACG&[)Y)ZX'I7+>"?$6K>'_AWX2F^Q6CZ3<7*V4A,C><#
M),RAP -H )Z<D^U=I;Z#J^G^-]:UFU>QDL]3A@W)*SK(KQ(R@# (P<@YZC'0
MUA0^!M=A^'VA>'0^G-<Z;?17+R^>X1U24R #Y,Y.<>WO0!H^*O&.I^'8-7O6
MM;2&UT_88([EL/J P&<QD'Y=N<=&Y!Z4ESJNLS?%+3+&VGMUTZ329+H1.C9/
M[R,$L0>3CIV&3US5'6?!7B/45\66R76F-#K:#R;B<R&6$! !#@#&P$$@@\9)
MVDFM0^'-<7Q/HFMI/IQDM]/>QO$;>  S*VZ/^\1MQSMSUXZ4 =B<X.,9[9KR
MG^T-9U/P%\1GU2>WF2&34+=1&C#:8X@H"Y) 7 ^N>:]7K@#X/UV+1_&&DPS:
M<]MK4]S-;N[NKH9U (?Y2 %YZ9S[4 +HGB+5M/NO"6EWME:+I^JV?EP/'(QE
MC>.$/\_&W! / Z'N:+SQYJ)T]M6TG2I=0LX[HP_98K.=YIHUD,;2(X&S.02%
MYX'4'@69?#.LR7O@V?%@!H:L+@>>_P"\S%Y7R_)^/./3WJMI/AGQ=X?N+K2=
M,U'3#X>FGDFAEF5_M5HKL69$ ^5L$G!)[Y(/2@#6L?$=Z?&]_H.HQVT$4=HM
MY9RKN!GC)PQ.3A2AP"/<'BM3P]?7>IZ+!?W:1(UQF2-8P1^[)^0D$]2N#CMG
M';-<QXTT[3_$FJ:+9V>HHNJ07;12B"0-(MLT9$Z.,Y4%<#)Z,5]:[I55%"J
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MI+IUI'I&NRPP*@F9IXGD0LK'C;MR",=<8/L+-MX:UF"]\83D6!&M[3;@3O\
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M R[1C&6)/WNG%9=WXI\5+K&AZ3%I&GVM[J=A-.R7,[.()8PN0Q3JN6[9)]J
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M2CJ5"SN3TZXQ4EMXOUN>XT2YCTM[FPU)T6:**PG5[-7&5<RM\CJ. V /49%
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MJZ2*ZNCB")LYD/?;ZX_2@#@[GP#KUSX5\3:0]]IIDUG4C>JX5U$0+(Q'?/\
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MP/K,O@OQ-H;36 EUF^GN5E$C[8A*P8@C;R1C\<]N_H,;K+&LB'*L P/J#3J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MILMVCD-YF]75<$YQCYO2NGKF[G0+Z7Q[:^(8Y;?R(+&2S\EMVYMS!MV>@P5
MQ0!R4OCOQ3%X0U+Q(T.DB#2]0DMYX!'(6GC241G:=WR''.3NSZ#OZC7GDW@'
M5)O >M^&VO;,2:G>27(N K8C#R>81M[X(QU[^W/H$7F>4GG!!)CY@AR,^V:
M..\<Z5X@>_T?Q#X;2"ZO=),P:PG;:MQ'(%#!6[,-O'U_ U- \=:%J U[69;*
MZTW6+"R4ZG87";952+>P(_O#YF&?<<#BNEU;3]6EUBPU'2[RWC6VAFCFMKA"
M5G#F,CY@?E(V'G!Z]*RQX..J:UJFK:Y]G\Z^TTZ7Y%H3M2 DEB7(!9B3UP,
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MZJJH]<4 4_ /B3_A*O!>GZFY'VDIY5RH_AF3Y7_,C/T(KSG_ )MJ_P"WD?\
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M9I%Y"MYA.Y6'0CD&NMKF/#NE^*[>2(>(M:L[R*V7$7V2!HWG.,;I220>">
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MX$B:2-"BMM&,X)..GK65XGT"]UN^T.>UFMXUTR^6\82YS(0K+M&.G#'GGZ4
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M,!44DG'N2223[ :5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTN8B\,Y7A7!4@HX'&>0?2NLJKJ.HVVE:?<7UV[+;VZ&25DC9RJCJ<*">Q[4
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M/7OCIUZ^'3;&VN'N(+*VBG?[TD<2JS?4@9-6J /.S\.M3'A^ZTD:W R2ZO\
MVDDCVARO[WS=IPPR2>XP,=JW)]'FL_&4GBZ\U"UBLX-+-I-&8R-J!_,:3?NX
MQCICI744CHLB,CJ&5A@J1D$>E '$>'['2=9\>:AXKTFY%Q9/;Q1;XVS#+<8(
M9U]66,JF?]IAU!KN*9##%;PK#!$D42#"HBA54>P%/H XZ;P?=ZE>Z1-JUS:3
M2Z5=BYAO(X2L[J,[8R23QR,G)W8Z#.:Z#5K;4+E+5M-NHH)(9Q)(LR%DF3:P
M*'!&,[@<\X('!K1HH X&?X9PS:3J,5O=KIM[<ZBFIVSV<>([.=%"J54]<X.[
MIG<>!5V7PCJ>O^';_3?%>KQW;74/DK]C@\E(N0P?!)W/N53D\#& !DYWM>U_
M3_#>EOJ6IR21VJ$*SI$SX).!G:#C)(&3QS6G0!S7A[1_$5H8O[?UV'4%MEV0
MB"V,1<XQOD.X[FQG@8'.>3C'.1?#G68_#5CX?77;1;+3;Z.YLV%F2Y5)#(!)
M\^#C./EV_6O2** .;TSP]?6/C/5==EO;>2+4(88F@2%E*>4&P=VXYSN.1BJ<
M'@VY/_"6I=7\31>(0P/E0D-!F+R^['=Q@]N:["B@#B+GP;J]WX;T'3)M6M#+
MI5W;W'FBU8*XAQM7&_(SCDY^@%/O?"6N6WBF[UOPYKD%B-15!?VUS;&:-G4;
M1(F&!#8XQT/>NGMM5MKK5+W3HQ+Y]D(S+NB95^<$KM8C#<#G'2KM ',7_AW4
M+F*2S:YM;_3I[-8)8-0B+YD!8F7(.,G<,K@?=&",5K:!I":#X?T_28YGF2S@
M2$22=6VC&?\ ZU23:K;0:O:Z8XF^T7,;R1E8F*83&<MC /(ZU=H Y@>"K)O$
M^L:K,YD@U.V6&2T(^0.5*._U9 B_@?6F:=X0DTOX?2>&H+WS)Y+9X&NYE+9+
M+MR1D9PN !GHHKJJ* .*;P9J!L/"5L-1MO\ BGWC;=Y#?O\ 9&8Q_%\O!SWY
MJ]8>&[^Q\0^)-5^VVS_VP(MD?DL/),:;!D[OFR.3TKIZ:[B.-G;.%!)V@D_@
M!R: . 7X=7L/@_0M-MM:6WU?0I#)9:A'!\ISD%70DY!!P>?\*ZO0K'5;6*2;
M6M1CO+V7 /D1>5%&HS@*I).>222>>.F*DT77;#Q!I@U'3I'DMB[QAFC9"2C%
M6^4@'J#VHT;7M/U^*ZET^1W2UN7M9=\31E9%QN&& /&?2@#-G\.7J^.3XBL]
M0ACCELEM)[>2 L6V.SJ5;<,9W8.0>.G/(PG^'VHR> K_ ,,'5;4&[O&N?M(M
MF^7=,)2-N_GD8SGI7H-% '%ZCX2UR/Q-)K_A_6K>QN;R&.+4(+BV,T,I085U
M&X$,!QUKJK*T-MIZ6TT[W3[3YDL@&9&/+' X&23P.!TINIZI::/IMQJ%Z[);
M6Z&25DC9RJCDG"@G'!J2QO(=1T^VOK<DP7,2S1DC!*L 1Q]#0!QV@>"]=T K
MI4'B-7\-QR%H;=K;_2$3.?*\W=]WMG&<<#';7USPG!K7B'1M7:9HI-/=A(J_
M\MXSA@C>P=4;\#ZUT5(2%4DD #DD]J .4\3>%=0U#6['7]!U5-.U:UB:W8S0
M^;%/"QSL=<@\'D$?_JCU3PEJNJ6>D+/K$,EW9ZG%J4TKVYVR,@P$10WR+CW)
MXSR2:U$\7Z++$T\5Q-):KG-W':RM!QU/FA=F!W.<#UK5LKVVU*Q@O;.59;:=
M!)%(O1E(R"* .='A6ZD\5:OJTUY";?4;%;(PI$0R!=V&W9P3\Q[59\+>'I]%
M\-V>D:E<VU^+.-8866VV (HP,@ELMCJ>![>O044 86J:1>7,Y2 V$NF26_DS
M6%U"2C')(88X'7!&.?48KB;G0Y?#?BGX<Z-I]U')):07ZJ]PIPXV(2, Y4<G
M'7&!UQ7J=59=-L9[E;F:RMI)TQME>)2PQZ$C- '+7_@&+6+#7?[0NRNH:N\4
MAN+==OV<PX\D)DY.TC)/&23TXQ+9^&-:U#2[JP\6:U%J,,UL]L$M;?R 0PP7
M;DY?'3& ,G@]NNHH Y'PUX;\1:3';66J>(8K[3[$!;98[;RY9 !A?-;<<A1C
M@ 9(!)[%-,\)ZCI^E^)+3^T+5Y-9NY[I7\A@(3*H4@C=\V,#TKKZ* .'NO!&
MH7/P\L/"O]I6RM:?9U^T_9V(9865E^7=P3M&>:FU/PGK"^*3XB\/ZO;V-W=0
M);W\-Q;F:*8+]UP P(89(Z]/QSTNGZK;:F]XMN)@;2X:VE\R)D^=0"=N1\PY
M'(XJ[0!6L+5[.RC@DN'N)%R7F? +L3DG X')/ X'2N1M_!%_!HFI>'CJ<!TB
M_GFDD=82)Q'*Q9XP=VWG)&[' /3/-=O10!S,OA>8>,=+UFVN((K2PLGLUM?*
M))5BO(;/&-HQQ7/0_#K6H=%TS2QX@M6BTK5%O[5VLB7DP[,?-._YC\YY&/?/
M;T>B@#B(_!NN:7X@U&ZT'7XK73]4E\^[@GM?-:.4@!I(CD %L=P0#V/2I=4\
M"KJ_B$7=W+!/IO\ 9;:8]I+&S.Z%E;?OW?>!48X]\YKLJ* .%;P-JEYX4L=+
MU+75GU#2[B.YT_41;D.CQGY?,4M\_!P>1D>_-;5KH-Q/XAAUW5Y;>2[M[9K:
MWBMT(2,,07;).23M [8 [YS704A( R3B@#SB'X=:U%X;T[0!KMH++2[Z.YLV
M%F2Y5)"X$GS\GG'R[?K726OAN]L_&U]KL.H1"WU""&.YMS 2Q:(,%*MNPH.X
MY!!^O>M<ZK;#6QI&)?M1M_M.?*;9LW;?OXQG/;.:NT <[XK\/77B$:2+:[AM
M_L&HPWY\R(OO,9)"\$8SGK5'Q'X0O/$UKJ.FW]S9RV%W*LD#O"3-9X50?+.<
M$DJ2#QC<>HXKL** ,[6].EU/P]?:9!,L3W5N]N))%+!0RE<XR,]?6N<'@W4%
M3PBHU&V_XIY<']PW[_\ =>5_>^7CGOS7:5'/,EM;RSR;MD:%VVJ6. ,G ')^
ME &#HOAZ[TSQ3K^KS7<,L>K/"_E)$5,7EH$'))SD#/0<U2UWPIJTGB=/$7AS
M5XM/OG@%M=17,'FPSH"2I(!!##)Y!_+G/2Z??P:EIUM?P;Q#<1K)'YB%&P1D
M9!Y!JMINOZ?JVH:C8VDDC3Z>ZQW*O$R;689 ^8#/'.1QS0!BZYX3U'5M'TRS
M&K1FXM+Z*_FN)H"WFNC;L!0PVKGC'.  .>M3ZQX>U'4_$V@ZQ'>6L0THS,86
MA9O-,B;#SN& !TX-=-69K?B#3O#]FEWJ,KI"\JPJR1,_SL=H!V@XY..<4 <Y
M)X0UW3_$E_J'AW7X;*RU.037=K<6OG;)< &2,[A@D <'C/KT"W_@W5+;Q%%K
MGAO68[2Y>U2TO([V$SI<*GW7.&4[QSSGGVYSVM% '*:IX3OKJ;0+RUU91?Z3
M/)*TUS!YBS>:I5_E#+C[QP <#@5;TQM<'BO4X[J]BNM)\M#;@0;&A?H5+?QD
M\D^G'KBN@HH YC4?#>I3>-+?Q!I^J0P 61LIH9[<RX7?OW1G<-K=!SD<#@XK
M#L?AYJ=EH'AW2O[9MI%T741>HQM2/, +X0_/U^<Y/TX]?0Z* .,OO K:KJWB
M2;4+N-K+6[..U:&.,AXA&&VL&)()RV>G855/@WQ+=0^'XK_7["3^Q;M)XY5L
MFW3*J,HW_O,9(/;'KS7>TF1G&>?2@#(\5:--XA\+ZAH\-PENUY"T)E="X4'@
MG (R?QK,D\+:A+KWAK4VOK;&C6\L+1B%OWWF*JD@[OEQL! Y[UU1('4XK-TW
M7]/U:_U"RLY)&GT]UCN5>)DVLPR!\P&>.<CCF@"AX:\/7>B:AK=S<7<,ZZG>
M&["QQ%3&2JKMR2<\*.>*;<>'+W_A.1XBL[^&)'L5LYX)("Q8*Y=2K;AC)8@Y
M!X]^G24A('4XH \_D^'VH2^!-4\--JML#?WCW/V@6S?)NE$A7;OYY&,YJY?>
M$M=A\3S:]H&MV]E/?Q1QZA!/:F:*1D&U9%&X$,!QC/-=K10!5M;+R-.6TGE>
MY.TB627K(3]XD#@9)/ X'05R/A[P;KV@>7I2>(UE\.P/N@@-M_I*IG(B,F<;
M>V<9QP,=NXHH YW6?"<&K^)M'UHS-%)8;EE1?^7B,D,JM[+(JM^!JKXE\*ZE
M?:]9^(= U5-.U6WA-M)YT/FQ7$).[8PR",'D$5U,TJP0O*^[:@+'8A8X]@ 2
M?PJEHNM6.OZ/;ZKITIDL[C)B=E*[@&*]#R.10!S^I^$]5U*WT;SM8BDNK'4D
MU&:5[<[974%0BJ&^1<''<\9.234O_")W,GB37M2GO83;ZM9)9F)(B&C"A@&W
M$X)^<]O2NKI&(52QS@#/ S0!B^%-'O= \.6>E7M[#=M:1)!&\4)B&Q %7(+'
M+8')SCVK;K-T77;#Q!;3W&G2/)%#.]NY>-HR)$X888 \'VK2H **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O+D;4YM2^)2W
M.I&>&V@\M8S$!\IM2P4<\ %C]>_6O4:X^Y\&7CZIXDN;36$AM]=A5987M-YC
M<1>5D-O&1CG&!R!SC((!@>']7US1=*^'PDN;633-3MH+,VJP$/'_ */N5_,S
MR?EY& .<>]6M2\6ZSI=W9O/<6[2RZVEC+8PQ^9'% [[5+2#[LN-K8)[_ ':T
MCX)O3IWA2T&KP >'WC=6^QG]_LC,8S^\^7Y3[\_E6=_PK?4ET>/2D\2*+:UU
M,:C:%K$,X;S3(1(V_P"?DGD;??/2@"UX3;4Y?B!XP6YU(SPVUQ!&L9B PIA#
M!1Z %C]>IZUJZ_J&HV^L6]M'>165E);.RRQH)KB6<$818L$E0N22!Z<BG:7X
M9N=+\5ZKJZ:IOMM2\IYK9K<;O,2,1YWYZ$#.-O7OC@LU#PQ?3^,HO$%AJXM2
M;+[#/"]N)<IO+[D)8;6R>I##@<<4 2^"-=NO$W@G3-7N4CCNKF$EP@.W<&*Y
M SG'&<9KCO\ A(_&]WX:UW6;2\TI6T6^NHS;FT;%TD+<C._Y. <=23W%=EX,
M\.2^$_#-OHTM_P#;5MRPCD\D1X4L6QC)YYZY_*N-\'Z;>ZYH?BW3X=2@BL;O
M6[^*4K#NE1&?#;6W8Y4\$CC.>>E %Q?$WB37_$5I8:-=V-G;W^@)JD+SVQD:
M)F=1@_-\W7';&3P<5)/XC\3ZE8:E<Z% TUS873VL4(@3RKEHFVR;F9PRY8-C
M&,#&<UMVWA*2R\86VM6MY#':6VF#3([+[.21$&# []_7@#ITJ@/!6KZ?KVH7
M6A>)6L--U*<W%U9M:K*5E;[[Q,3\I;W!&>QH IW?C.[7Q!/I-W=+H=^RPMI\
M%W$##=!D4N/,Z%PQ9, CD X;.*EN/%T__"776B3:@FEWR7<2V=M=0@17EN=F
MYED/5SEP ",$ 8/-7=:\%W&N:??Z1=W\$NE73H8DEMB\UJ%55.QR_4[202."
MQZ]*76?!MSKUI/IVH7\$VGR72W$1:V/GVX#!MJ/NZ\$;L< D<T 6?B#K.H^'
M_!&I:MI;P+<VL8<>=&7!&0#P",'GKS]*SKK6/$.EZG9Z;=W,%S-JTCO;_9+;
M#6T4: N/F;#MEE )QQDX[5M^,/#\GBGPO>Z+'>+:"[4(\S0^9A<@\#<O/'K5
M+Q)X3NM>M-+GAU8V&MZ9)YMM?0PY4$C:P,9)RK#J,_X4 <AXRO/$$_PT\56^
MN6;)'!-!]CNF54:XB,J'YE5CAE/!Z Y'%=5J6NZA=^(=1T72_.B:PMXI'FB@
M24F23<5!#, % 7GN<]1CF+5O!NJZ[X2O=)U'Q DE[>F/S;H6>$148,%2,.,<
MCDDDG)]@':MX/U6;Q%'X@T37DTW49+=;>]#6GFPW"J25.PL"&&3@Y/''KD K
M6VM^)YK321K4<.B2S6TOVA8@L\SW"L JQQC=E2N7.,D=,CK6;;_$*[;P9X;U
MO5"UE:WS2I?WUM;EUMV0E5."#M#$=2#CIWR-T^#M1A\1V6LVFOL)TLVL[HW%
ML)#*&D\PNG("-N/H1@ 8XJ+0/!NK>'-(L-.MM<AN(+7ST:*>S^2:.1]P! ?A
M@<\\Y!Q@4 ,'B>^EDTG3(+J.]N+V&XNFO;&-'!@20*A0%MN2'7.<XP>.>-?P
MG>:_<VEY'X@L_)F@N62WFPJ_:(?X7*ACM;L1[5SS?#)K.RTZ30]7.FZM87$\
M\5PEN&AVS-N>+RB?]7T &>,>M=?HUA>6-JW]HZ@;^]E;=+-Y8C7I@*B G:H^
MI.23GF@#EI?%&O0ZGXWMHX(KU]'@MY+&&"$AF\Q&8Y&XEB,#@$9QQC-:7@_Q
M##XA>YN++6XM2L5CC 5HA'/!+EMZR* ,?PXX'0]>M1_\(EJ4>M^(=4MM:CAF
MU86^S;:'-N8>%.=_S9&<C S5S2_#/V3Q/=>(;F2W-]<6J6SBUA,:, Q;>V6)
M9CP,]@,<T 0:AK6I6OQ%T;1U> Z?>VEQ*R^4?,#1[<?-G&/F]!^-9'AGQA<Z
MY?QV[7R1:I"9/[0T6XA$4D6%;;Y9/++G;D_-D'/'2MZ_\.7-[XSTO7UOXHX[
M"&6$6YMRQ<2;=QW[QC[HQQ6>/!=W=W.C7.JZE!<7>DJXAO(K8QS2DQE/G;>>
M/FR0.I /'0@%/PGXKN/$L\4(U9(=02)O[1TR>W$<UK+@8V \E <C)W9R.1TJ
ME#XUUJ7X::#XB,EN+RZOH[>=1%\C*UP8S@9R#@>M=!;>$KB37-'U?5;VVN;W
M2HGC2X@MC%)/N7;F0[CQC)P.YSQTK$'PVU)?#D7A]/$,:Z=:7JW5F!99=0)?
M,VN=_P V"<# 7WSTH LW_B+Q!J8UMO#T,AETVY:VMXO(1TN)$52PD9F!4$G:
M,8QC.3G N:?KVI^(==NM)A/]E2:=9V\MZ"JRNL\REA&,Y7:H')ZG(P1CF%_!
M>L67B&]U'0?$IT^WU%Q+>VSV:S RX ,D9)^5B!W!&?7@5,W@V\L/$YUO0-62
MU>XMH[:]ANX#.LXC&$?(=2' XSD@T 5_A*)1X%43%#+]NN]Y084MY[YP/3-<
MYI+>)[?3O&=_H%Y8PBSUV]F-O<6YD-R5VDJ6W#8,#C //<5W?@[PW-X6T9]/
MFOQ>AKB6=7\GR]N]RQ'4YY/7CZ5GQ>#K^U37+.UU>./3]8NI;F;-L3/$90 X
M1]VWH."5X]Z *.G>+]1NM>\-7-P\<6A^(+'S+=?+^>*ZVAO*9\\@KNQP"2*Z
M;P]>7>HVMQ>SS*]O-</]C 0+^Y!*JQ/?=@L#Z$>]<OXJA\/ZCIMOX$L;GR]4
MMGMOLL-N2);15*D2@]@J G/OCJ17=VUO%:6L-M @CAA01QH.BJ!@#\J /+2V
MIS6_Q0^UZD9XX(Y8@AB ^7[+D <\ 9Z=^IY-7=$U?7-(7P)!-<VLNFZK:I;&
MV2 AH2MOO5@^?F/R\\ <_C6O=>";R2Y\3FUUF.&UUZ,B2)[3>T3F+RB=V\9&
M.<8'..<9!>W@R]:/PJO]K0#^P-I!^QG]_B/R_P#GI\ORGWY_*@#+?Q1XGU72
M/[:\/6,ER!=,D5D8HQ'-"LI1LR%@0^ 6ST'3!ZE_QFOKFT^'-PD#O"MW/#;3
MR X*1NWS<^XX_&K%CX%U72;^[M],\2R6_A^[G>=[ VP:2(N<NL<N?E!)/;CM
MSS74ZWHMCXAT2ZTC48O,M+E-CJ#@CN"#V((!'N* +=M;0VEI%:V\:QP0H(XT
M4<*H& !^%<NU\;7Q19^"](9;..+3VO9)0@8I'Y@1$0'@<D\D' 7&.<BQI>D>
M)M.M([!]?M+JVB4)'<361^T;!P Q$FTMC^+;]0:;?^$G;7=.UW2[[[/J5G U
MK(UPAE6YA8[BKX(.=WS @]>QH Y75/'7B#3])U^VS9_VIH>H6UO)*83LN(9V
M4(P&[Y&PW/WAQP.>-B74O%$'CI?#YU&P>*]L'NXIOLA!MBCJI 7?\^0PZD<\
M^Q=JO@"34](U.W_M..._U2\ANKNZ-J6!\HH415WC"@(!R3U/K6I-X<O9O&EG
MXB.HP#[/9/:&W^RGY@S*Q;=OXY48&.GK0!R+^-?$D7AY'$EA+?6WB0:+/(T)
M59U\P*&&&^0D$9X;VK3BUWQ1I'C&70=3DL=2^VV$MWITL4)MP)4ZQ,"S?+R/
MFSFL+Q9X?N?#FA1K)JL$DFH^*[>^23[/L$+R2 D8+G<!C/;O78:CX.?79KVY
MU6^7[1/ITNGP&UC*"!)/ON,L26.%].!CU) ,G3?%.JMXFT32WOK>[_M.QFDF
M=;?]U#<1A2?*<8$B98@C)/'WJRH/&/BK_A!K+Q5/=Z>8X]0^SW%JEJ1YR&Y,
M)(8M\A Q@8/3))S@;MMX(UB._P##U]-XBA>?1H)+90E@%22-E5>F\D-\HR<X
M] M1?\*\O?\ A AX6_MN#:+K[3]H^Q'/^N\[&WS/[W&<]/SH T%US4-.^(<N
MD:K<PC3;JS:YT]Q&$R4/[U&;/)4$,.G!]JV/#EQ?7NB0WE](&DN2TL0\O84B
M8YC##^]MVY]R:Y;Q0-%\9ZA8^'4NUGU6QO4>Z%OE3!&%/FAO174[,9ZN/0UW
MP&!@8&.E 'F5]XS\16_@CQEJBS6/VW1M3EMH6^S'88U$>/EW\-\Y.23]*W(]
M8UVP\>Z9I>H7-I<6>JVD\J1Q0%#;O%M.-Q)W@ANI Y&<#I52Y^'MY<^'/$NC
MMK4 77;U[MY19',.[;E0/,Y^X.?K6Q<^&KVZ\4Z)K<FI6X.F0RQ&%;4_O?,"
MACG?\OW1C@_C0!+KFM3VVNZ-H5HRQ7&IF9S.R[O+CB4%L#H6)90,\#DX.,5D
M7NO>(-#-OINH&TENM1U46>GW07K 5W&21!@;@ 1@8!..U:7BSPK+X@DTV^L-
M1;3=7TR5I+2Z$8D ###HRDC*L,9Y[54U#P5=:QI4']HZTTFM6]U'>6]_' %2
M&1/NA8\_<Y;()R<GGI@ J:CXCUG1/$-WH<MQ!<&;3);[3[N6#E7C^_'(JE0P
MQ@@C'OFJ%CXI\2I8>"M8O+JREM=;EAMI[6.W*E3)&S"0/NZY7IC&#CG&3T4_
MA:ZU"[N=1OKZW;47L'L8&CMR(H$<Y=MI?+,<#N,  >I-$^!;W^PO"^F+K$ &
M@W$,Z2&S/[[RU*J"/,XX8YZT 94_B'Q;-:>,I8-0TZ$Z#,YB_P!#+>:JQ"38
M07^7/0G)//&,<ZB^++W5[JQL;&.:"2;28=2F>")963S<A5 <@8!5LGGMTZU*
MG@N]6U\50G5H#_;[.S'[&?W&Z,1G'[SYOE'MS^559O .I0-HU]I'B!;+5].L
M5T^2<VF^*Z@7H&C+<$'G(/>@ TGQ)XCO;O2] U2UCTW5YXIY[F8*K9AC955D
M7) 9RXZYQM;CD5G>*Y/%4.D:1#J%]!!(WB2VMUDMDS]H@,JF-G'\)R.5'!QZ
M<5L:IX&OKM],U.TU^2#Q#8,Y^W/ '28. '1H\@!<   'C'<\U8U3P?>ZKH<$
M%QK9;58;Z&_%XUL#'YD9!51$&&$P,8W9ZG))- $%QXEU#2/&]SIVH7$,NF6V
M@OJ3M'!MD+)(%;)W$'@$X&.M9]_XMUO3/ VG^-Y9(9+.40SW5@(^$@E( V/U
MWJ&7)/!P>!6T_A&XN/%9UF]U&&XADTMM,FMC:E?,1FW,VX/QD\8QT]^:IVW@
M2X3PY#X8O-42ZT*"1"J-;D3O$CAUB9]V" 0 2%!(&..M %*76_%5YJWC"RM=
M0T^W71Q$\$GV0L6#0F3:07_ MS[ 5U?AS5)O$'A#3-48+!/>V<<QVC(1V4$X
M![ FLR'PG>PZGXGO5U2 G7$1=AM#^XV1^6/^6GS<?3FM7PQH\GA[PUI^CR7*
MW/V.%85E6+R]RJ,#(R>?QH X*\\;Z_9>![Z_FN(/[9TK4WM+V!+;(DC5MQ*+
MG(_=?O,DXX;\.JO-7U";^TKG2;VW:UM-.$R-)#O5YF4N.A!QLVDC_;7Z5,/!
MUB?%FHZY(QD%_:I!+;,/D+ %6<^Y0JOT!]:9H_A$:'X(?P[:7I9VB>+[5,A<
MG<-H)&1G:NU0,]%% ')76K:UK$/PVO/[1$#:DPEG1(05:3[.S;B,]!S@=._/
M&!#K4/BGXB3Z3?6UM+;?9IB\MOYOF,MJ#MQD!0<<GFMW_A!;N/1/#%I!K$:7
M?A]U,-P;3*2*(S&0R;^N#UW=>U6+?P??07GB:Y.KPNVN(BG=9G]T5C\L'A_F
MXY[<_E0!KZ#J4^O^$=-U,%;>XOK*.;(7<(V= > >H!->4&74;GX$0WEY>F[E
MGU*-QYBA3N^WG)+#KD^W%>L^&M(DT#PWI^D27*W)LH$@658_+W*HP"1D\X'K
M7)_\*YOE\&GPRFOQ?9$NQ/ S6.611-YP4XD&X[N,\<=N] $ESXJU7PYXFU6T
MUFXM[VSAT635X_(@\IH_+?:T?WCD'(P34]GJOBQ]4T:86;W.GW@_TY6BCC6V
MRN5>-MY) /!!R2.>*MW_ (.?5?$\FJWM[#);3:5)I<UHMN1OC=@S$/OX.1Z=
M/SJ+PWX3US1?L]G?>*'O])L\"V@-JL<A ^X)) 3N"\= ,X&>.* +_B779M-O
M=)TVTC9KK4I70,J!BB(A=B 2 3T R<#.><8/-:CK/CJQT#Q!<BV4'3&6>TGG
M@3-W!C,BE%;Y70 \\ \<5TGB[PLWB2WLI+34)--U33Y_M%G>1H'\ML8(*G[R
MD'!'_P"JK6B:7J%K!*VM:F-2NY@%=E@$42J,X54R?4Y)))^@ H SY_$8*QZC
M:77FZ5;Z6VHW)" F12,QX/8D+(3_ +H]:R[76O%UU+HE[;633VE]M^V1/"BI
M;(ZY61&W[F"DC(/WATVUK^'/!ECX?\.76B;WN;:X>4-YG_/)LA8_HJ87\SQF
MJ'A[P=KFAI#I\OBE[O1K0C[+;/:A90%Y1'D!RRKQP ,X SCB@#G)/&/BR/P1
M>^)GN]/VZ;J,D$MLMJ?](19Q&?F+?)P>.O3D\\;NG-J<OQ?UJ%]2+6T-A;.D
M)B&%5FD^4<\<C)/4_@*CD^'EY+X&U/PRVM08O[M[DW LCE-TOF$;?,YY&,YZ
M5M1>&KR'QF_B"/5$47%I';W=N+;[YC+$%6+?*/F(((/U'6@#*\;OJ(\6>#H+
M343;PSWT@:,1A@6$+D,?7'IT[^F,5&UJ'Q/\1+C2;ZVMI;8VTQ>6#S3(RVH.
MW&0%!QR>>M=GXE\.3ZW=:1>6E^MG=Z9=&XC9X/-5@4*,I7<O9NN:HP>#[Z"[
M\37!U>%VUQ$4[K,_N2L?E@\/\W'/;G\J *\7B/4M2TWP[>^?#I]IJ6GBXE>)
M?-G:<JI6..,@EARQ. 3@=NM<RWB'6_$>C^ M0:]6TDO=4>&XCBA^1VC\T!B"
M<X_=YV^I]A71:?X#U+2KO0[FTU^-9-.TW^RY-UEN$D0((907^1_E'/(/'':H
M;7X<7EEH.D6$.OJ9])U%KVUFDLP5PQ<E&4,,D^8><CH.* -_QGJ>HZ'X)U/4
M["6#[99VS2AIHBRMM'/ (P?S^AK$?7?$5A)IL-Y<VUS+K;I]ECMK;#6RK$TD
MOWFQ(>  3CJ3C VUT7B30YM?\*WNBK>B%KN P/</#O.",$[05&?TK-USP=/K
M.@:7;KJIM-7TMTEM-0@AP%=5V\H6.5(X(S_A0!CW?B;Q5HMCJDNI:=<-86]U
M (=06!3+]G?_ %K-$I/S)ZXP0<XX()>>+KV+P[;ZOI>M6>IVLVKV]M%*L0^:
M"0QJP<#&V0,7].W%;L&A>(EMHYKCQ&DVIK,CF3['M@,:AAY?EAAUW$EMV<@>
M@K,N_ARESINKK%>16E]J%[#?J\%OB&&6+;MPF><E26.1DF@#3CUF^'Q+GT%Y
M(WL?[)6^0;,.KF4IC/<8'I7G6ER7\?PL^'RV=^UM'/K,,,JA V_,[L,^P*@X
M[UW]KX5U:/Q;_P )'<ZW!+=-IWV%XEL]L>=Y<%1OR!DC@DD\\C@"A!\/+FW\
M%:-H4>LQ_:-(ODO;:Z-I\I979@'3?R/F(X8=J '7FO:]?3:U9Z-YC7&E%;='
M6W1EN)_+5SOW,-JG<!@<CDY[5-I_B'5]<UJ'16C&DW=OIT=WJ( 61DE<D+&F
M<KCY6)//! XY--N/!>LVWB*?6-"\2_89+Y(QJ$4MFLR3.J[1(HR-C8'N*FN/
M!EY;>(K;7=#U<6UX+46EV+R SI=(#D,P#*0X))R#[4 5?A:LZZ1KJW+H\XU^
M^$C(NU6;S.2!DX&>U=U7.^$O#=QX:@U*.?41>?;;^:]R(?+V&1LD=3G]*Z*@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *I
M0:G#<:M>:<L5PLMJL;N[PE8V#YQM;HQ&.<=*NUQ=OK>M2^*O&&F&ZMO+TZUM
MYK/_ $?A"ZR$[OFRWW1W'TH [2BO+K#Q1XF&A^"]>NM1MY8=7NX+2YM%M@HQ
M*&^??G.X$ X&!V[9/J- "%@" 2 2<#)ZFLS3/$%AJ^I:E86IF\_3G2.X$D3)
MAF&X8W $\<YZ<US'BP7S_$?P;;P:G/;P3&\8QHJ%0R0\-R#DX8CGIVK( U=?
M%?Q&GTG48[&2W-M-O: 2EV6U!"X/ ''/4\\8[@'J+*&4JP!4C!!Z&HH+2VM=
MWV>WBBW=?+0+G\JXFU\7W^LQ>';6VAF2YU'21J=RUH(BZ#Y!A!*=N-SGDYX'
M3G(W?"<_B&73KE/$=J(;F&Y=()<IF>'^!V5&(5NQ'M0!OT5F>(M83P_X;U+5
MWC,BV=N\VP'&XJ,@?B>*YVVN?&!UG3&$%Q-IMU&RW[2BV06S%<J\.URQ&>,-
MNX[T =K17 Z5XBUA]/\ $.EWUX#K]C?"T@*Q*JE9,>1)MQ]T@Y;V5NF*LWNL
M:S?:QJVCZ4]V)=+AB4SP);DR3.F\%Q(0-N-O"@=^1B@#M:0D*I)( '))[5YX
M^N^,?[6\(:=>"STRZU2"Z%[!Y0E\N2) =P8.00<Y !X[D\BL?Q!K6N7'PW\<
MVEUJ;&[TBY:V%W#$L;31%4.&'0'#D$C% 'KG49%%<U>>*]%\*0VMKKVM!;B2
M/>C21'++_P  7'M6%XB\9O9ZS):2:H^CV]S:1OI-]);JUM<2L"2)'93MQ\O&
M5XR<\B@#T*BN%O\ 4?$MY\0;GP[8:K:6=L=*2]2?[)YCQDR,G0MAC\O7@8/3
MO6=I?CK69-&2POH4DUQ=;DT626W50KE$,AD56(7)48 )QDYQVH ]+HKSV\\2
M>)_#5GK5SJ=D\MDA@73;F[,*N9)'"%)!$V" 6!R . 1UKH[>T\26VME6U*"[
MTR2U.7GB DBN,\;50 %".Q.>.M %VRURSO-%?5F$UK:()"YNXC$4"$AB0W('
MRDY]*RU\<Z8=8MM+:UU-;FZV-"#9N5>-LXDR. O8YP1D9%<;J>K:IXA^ 6J:
ME?7@%T8KI9C%$JK(JRN@7'.!@#W]ZW]6U+6-!M_",<.H)-%?:E!:7'F0+O*,
MC-@$8 ^YCIGGK0!W-%<;_:>M>(W\1#0[Z.SDTNY-G;(\:LLTRHK,9202$)8*
M-N#P3DYP.LM#<&S@-VL:W)C7SEB)*!\?,%)YQG.* *.L^(+#038B^,P-[=1V
MD.R)F!D<X4$@87\36E)((HVD8,0H)(52Q_ #D_05Q/Q/\W^R] \DH)?[?L=A
M<$KN\SC..U+INJ>(-*\?Q^'M:OH-2M;^T>ZM;B.W$+1,C ,A )!7# @]: .E
MT'7;+Q)H\6J:<TC6LK.J&1"A.URAX/(Y4]:TJ\P\&WE[9?"73I;*XM;;.H3)
M/<7# >7$;N0.5!X+XX4'J3WZ5,/'E[I=KXQ:X+W:Z/);"S>YA\EW\]5VB0 +
M@!FZX!Q0!Z--*L$+RN'*H,D(A=OP !)^@JCH6MV7B/1;?5M.9VM+C<8V=2I(
M#%>AZ<@U3M;7Q%:Z]"9M0AO=*>W/G^;&J21S C'EA5^X1GAB2,=:X/X5ZO+J
M?A?2-"TV^^R26$;3WQ:,%G1Y)-JQAASZE^@Z<D_* >K"*,2F41J)"-I?')'I
MFGUR%KJNH^)-8U^RT[4#81Z3(MK&XB1S+-L#,SA@?E!(&%P>"<],8FF^.M4U
M2W\'W>$MWU"_EL-0MP@9-T:ODH3R,E/7H<>] 'I5(K!E#*05(R"#P17G>K:W
MK$J_$33TU%XETFRCFM)HXU$B;H'D89QCJ, XR![\UT_@J*6+P7HWG7+SEK*!
M@651M!C7Y> ,X]3S0!O56M;Z"],IMV,B1.8S(!\I8'# 'O@\''&>.H.,+XAZ
MQ/H'P_UO4K5BMQ%;$1..JLQ"AA]"V?PJIJ>I'PCX6\.Z;8*@GO)[73+=W&5C
M+#ER.^ K''<XH [&BN-DU?5M(\<V7AZXO!=VVJVLLEG<30KOAEBP65@FT,I!
M!'0YXS5?X?:AXE\0Z/IVNZGJMLUM*DZ26D=J%+,LK*K;\\8"D8QTQWYH [JJ
M>IZI:Z1IMUJ%VS_9[5#)*8XVD90!D\*">G-7*\JTX7TGAWXER7>ISW(CN;V'
M;(J<XMT / XP,# XH ]&MGL-=TVSU 6\<T%Q"LT/G1@D*X##@]."*O*H50J@
M!0, #H*\ST34];T>#P"DE]#+IVJ6T=J]H( /+Q;[U8/G)/R\]N>@JS-X@\5:
MUIEWJGANUGDDAO)(;:V86X@F2.4QMO9G#ACM8Y&,<#!ZD ]$HIL;,\2,Z%'*
M@LA(.T^F17.>(M<NK76M*T6QCF,]\DTSO (RZ1QA<[?,(7)+KUSP#QZ '1+%
M&CNZQJKOC<P&"V.F?6GUYU?ZAX\LO"&MW<D?E7>FRF:UDD2%FO+8<L&5"0K@
M;NF 3CBNACUP7MS;7ME>N^EQ:=]MN"$4F0.,Q\XX.%D)QZ+ZT =)17GUCK7C
M#4[70=:T^QFFM[YXI+NUD-NL,=O(,[HVW^9N4$=?O<\#I5"?7_%LVD^,[R+5
M[2%M!NIO)"V0/FK'$LFPY)P#D\\G)ZC&" >GE@" 2 2<#)ZTM><7=WJ&J>/?
M!DR:C-;0WNFSW)@15*HVR,YY')(<C)Z=L9.?1Z "BN8O=9N;SQPOABSN&M!'
MIYOKBX1%9SE]B(NX%1T))(/85R>K>-O$-CX6\4QK-;#5] O(H#.8,K<12,NQ
ML9PK;6YX(XZ<\ 'J=%9ND6NK6WVHZKJ4-Z9)=\(BM_*$*8'R=3NYSR>:A\5:
MZOAGPMJ6LM%YOV2$NL><;FZ*">PR10!L52TS4X=5AFDABN(Q#.\#">(QDLAP
M2 >J^A[UEV]MXF@U>R=M1MKO3Y8'^V+)&%,4N 4,04 E<Y!#,3CO7'7?C#Q'
M#\-/$&LI=VO]H:=JDUJK_9_E*+,L8P,\'G.3NH ]2HKB[C4->TW7=.T2[U6"
M:?6;B5XIH[4)]EABC#.J@DAFR0 6Z DD'&*J>)=2\5>&?"FK7\]_;RM;7D(L
MIA&I:6%Y$4B5=H 8;CRN.@H [^BN5NM6U&+XD6NBQ7"?8[G2YKG:\8.R1710
M01@D?,<C/XUQY\6>+$^'+>*VU*U,EG>O%);"U 6X07/E8+9RO&,8YXY)SP >
MM45QL.IZYIWQ#M-'OK^&]M-0L9KA$6W$7D/&RC"G))4AN^3Q5#PMXKN==U"&
MRN-5>SUB,2?VAI%U;K&\1VG#0_+EE!QSELC!..X!Z &#9P0<'!P>AI:\P\)W
M6MV_P_U;4(M6BENQJ-ROFZ@46.,"X*M(2 .0N2!TR ,8XK0LO$NJR:OXFTV&
M\:9+/3X[RSN+RTV."P?(90$W+E>#@=>] '?T5YE8^)O$J:7X)UJ[U&WF@UJ:
M"UN+1;8*/WD;,'#YSN!7IP.<8XR==-4U_P 26FN76@WL-K-I]])9VEO*BF.9
MHB YE)!;YCN VXP,=: .VHKC+W6M7U#7=1T;3UN89=/MH6EEM%@<^=(&(!\X
MCY %'09.3R,<YEWXNUO1].T*7Q;!-HD<\,JW]W:1I.D,X91&&(#A49=S=^<#
M(P: /1J*S]#GEN=$LYIKR"\D>(,;FWQY<O\ M+CC!JGXRUJY\.^#]4U>SMQ<
M7%K 72,@D9R!DXYP,Y/L#0!N45Q U;68?'&E:7!JL5[IUWI[7LTCVRLR!2H^
M4H5 5]W!(;D=ZS_^$IUN_P#AY/XYT^Z14C$MS'ISQ*8VMXW8%6;&_>54G(.
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M\&[Z5;7P7?\ ]M:AJLGB!GGO[!;.93:*$R-V& !R -Q^7.<]6/2NQHH XO\
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M-)@C[1(J!^>^%4+Q].W.:YC4O <%YX1E\/07TD$=Q<?:KFY,8>2:7S!*6/0
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MJ<KC(PI![X-5X8]%^'GABU\,:G>W6HI>+/%:6YMBS3 Y)B&Q<9._'S'G/IT
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M &D? &<* %&   !P!^-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ*\<[7&IK(T$J(#'A%W-EL^F.F>M;%>:ZU:78\8?#^WCU*8S-'?8N98T+J#
MO0!0N0.F0??/2HX/%NKZ58ZSI]S>27]U;Z[#I=K=2)&LFR7806 "H64,V"0
M3C/% 'IU%<MHJ^)8?$\ZW9GDT.2V#(;QX3-%.&Y \O@H5YYY!'I46K:Q>W7B
M^3P_9_;$6&P6[D>S,(D8N[*.9> !L)X')(],$ ZZBO-=4U'QEH?A"PUC5KTQ
M26%ZJZFD$<3>?:%\>9]T[7 ()"G'!K6\0^)+O2K+7=<MKDR6=FD-M!"50QF=
MV +YP"5'F(/O8R&_  [2BN+CC\6Q:XOESW0TJ6UD6=[TVYDAF RCQB/J#T(/
M'>N9T[Q!XE'A3P;XDN-<DF?4+ZWM;FU^SQK%(DKE2>%W!QP<@@<=/4 ]8$B&
M1HPZEU 8KGD YP<>^#^1IU<%X4@N?^%E>-#)J=Y+'!-:@12;"I#0[@/NY !8
MX (]\UIZAK%S>>/X/"UO<R6D:Z:VH3RQ!2[_ +P1J@+ @#[Q)QGITYH ZJBO
M)=;\6^(].T#Q?9)J/_$QT"\M5BO#"F9X9V3:'&-NX*Q!( [5Z1I%AJ-B+K^T
M-7?43++YD>Z!(_)7 ^0;>HSDC///?K0!I52BU$RZQ<:?]BNT$,22?:7CQ#)N
M)^56SRPQR.V17(:7>Z_XL\.C7M)U=+.=[UQ#:RHI@$,<I0J_REBQ52<@C!(Q
M@5*NJ:N_C?Q/I8U)A;V^FPW%J/*3]RS%\]OF^Z.N: .WHKRK3_$/B*T\ Z9X
MIO-<^T2ZC!!;+;/;(L44LLJJ)B1@G"DDCH?:NGU2U\0Z5'JMW%KSR:>NF2/&
M)8XS/'<KDAEP@4H5'((/(XQ0!UU%>>'Q%K']B?#R^^WL)-6EMHKY?*CVS!X&
M=C]W*G(_AQ51[_Q)>6OCAE\1SP-HMPYM3%;19(6%9 K94Y7)[8/OVH ].HKS
M=-;UZ%_!.LRZLTL6NR10W-@(46%!)"7!0XW@@CJ6.?0#BI+?Q1=?\)8='U?4
M+S2=2;4&%M#-"OV6]MMYVK&^T_-MQGD'=QT.  >A+(CLZJZLR'# ')4XS@^G
M!!_&G5YCX:_M.UL_'MW!K9^TP:I<I')J+)Y*LL4>V1R%R !@8!V@#I5[2=9U
M27QNNC+J-Y+97.BF[2:Z@16$JR*I=!M!VD-T88XXXH ] HKR+3_$/B8^"/"_
MBBXUUY9+G4(K>XM?L\:QRQR3%#GY=P;I@@@#'3N>FBO=9\5?\))_96JG3I]-
MO'L;- B,AD158O+E22"S$8'0#UH [>BN(FU?5]3UZ]T2*2YCEL+*W>:73O)&
MZ:4,2W[T_=&T8 ]3GM69>>(_$FA:;HTWBU+FVMO(E34+W2HUE$4P8"-W&UL(
M5R3@8W''3B@#TJBL[0+@W7A^PG.H1Z@7@4F[CP%F./O #@9].U><_P#"4>(+
MWPUIVH6^I20:Y<:P;*XTP11MY2>:RE I7(*H ^XGU)XZ 'J]%<98:AJ'B37?
M$&G0ZK/9)I#16L<D,<>Z24IN:1@RD8R0 HP.#ZC%WP%X@N_$GA6*\U"-$OHI
MI;:X\L85GC<J6'L<9H Z:BO,M2\1ZUI\]E<+JINI'U]+*=+:)3:) \FP1[BH
M)D P25)(;(/'%7+S5]8T_P 0>)](NM9N$+6"WVD2""(E!RK(!L^<B3: #DD,
M._- 'H-%<)X5U[4?$6D^'D-_/'?IYK:L"D>=T1V/&PVX7,A7&,':#SWK-?Q'
MK5G=^'I6U4WKWFLFQO/(C4V>QC)A(V*ABRA5Y!/(8$]J /3:J3:C!;ZA!9S;
MHWN ?)=A\LC $E0?[V!G!ZC.,X../37[[P_XNUW3]=U*>>T-E]OTPF*-3Y:Y
M$D8VJ-SAMN <Y!%0^-X]3L?A#<7=]=M+K%DD-YYY51LF216XV@# Y7IR/K0!
MZ#14-I/]JLX+C;M\V-7QZ9&:J:]J@T;1+J_$9EDC3$42@DRR,=J( .<LQ _&
M@!=/UNPU2]U&TM)Q)/ITP@N%'\+%0W]<?4$=JT"< FO(M-D@\(?$/2)XEO!:
M:Y +'4)KBSE@5[T$NDN7499R7&!ZUV=WJUSJ/CW_ (1JWNI+2&VT\7MQ)$%W
MR%GV*@+ X P22!DY'OD T] \0VGB*.^>TBN(OL5Y)9RK.@4^8@&[ R>/FH'B
M*T/BS_A'/*N!>?9#>;RF(R@8+P<\G)].U>;Z%K%YH&FZK9176^_U+QE+IRW;
MHN5W!2TA7&TMM4X&,9(XQQ6Y%97-M\:4C;4;BX#^'9#&\RH6C/GH#C"@$9YY
M'KVX !VFFZJE_IWVV6UN;!=[(8[U!&XPQ7)&>AQD>H(ITFHF/68-.^Q7;"6%
MY?M*QYA3:0-K-GACG@>QKRB]U+5M;^&6B7M[JUS]J;Q D$KQ*B"11=E%R-N.
M HP.F1R#797&I:EIWQ'TS2Y-2EGTZ32YYY(WB3<SHR#<2JCL3P,#VH [*BO,
MCXCUR]^&3^.K/4&CG57O%L2B& PJY!B/R[L[1][.=WMQ5N#4M:U[QM<:=;ZW
M/8Z=-HT%_$L<$1DB,C,, LI'89R#WQCK0!Z%67XBUZV\,Z%=:O>13R6]LNYU
M@3<V/ID?J:XW1O$>L:GX&\/7MWJL5O-->26]Y*D69K@(TB 0H%(+L44G X&X
MC%96J:QJ&J?"OQ]!J$DLC:?<SVL33*BR>6%1E#[."1N(R* /09_$]G;Z[I&D
M/#<_:-521X'"#8 B;VR<]<8Z9ZUM5P.L#/CWX>#./W-[S_V[K4=KX@U72+SQ
M3HVK:C-=ZA;A9]*8QQ(98I<)$%"J 6$IV$D$9(XH ]"IKR)& 7=5!(4;CC)/
M05#80W%OI]O#=7375PB 23LJJ9&[G"@ ?@*XOQ]%<2>(_!JPZC=6R2:F4*PE
M,9\IR&PRG)&,<Y'/3/- '2Z;XBM-3U[5M'ABN$N=+$1F,J;5;S Q7;SD\*>P
MZBM>O,HK+4+GQ_XZCLM7GL)([2P8SQ11M(S"*3&=P*@=<@#)[$5-H?C'4?$"
M>#].:?[-<:IISWMY<1(NX[ %VID$#<Q)/' '&,Y !Z/17F\WB+Q)8W/BG0K<
M3:G>::+:YM)DC3SY+>1AO7& ID50^WCGC(/=$\=1#PYJ>J:9JLU\1/;6J6UY
M$L<]E+(X1@ZX7IG<,GD@C.* /2:*Y32D\3P>*?WYN)-#EMSO^W/!YL<X/!3R
MNJD=0>AZ54\9>([C0-7MGOGU"ST![<AM0LH5D$,^[CS058A<=#C&2<Y[ ';5
MD>(?$5IX:LX+J\BN)(YIX[<>2F[#.P49R0 ,D5SMEK&I?\)EX=L/[8%[97NC
M//*T:1[)9$\L"1"%S@[B<9QSTKE]=U34M4\$ZREY>?:);/Q7'9V\DD:C$:3Q
M;00H4'&?J: /8:I:5J)U2Q^TFRN[/]XZ>5=Q^6_RL1G&3P<9![@BN02Z\0:%
MX_T_1[W6GU*PUJWG:)I+>-'M98@&.-H *D'H<_7US=(\8:Q)X5T9;BXDN=1U
M+5[BR,Z)&K*D;2GY0<)NQ&%&?7//< ].HKSK4-;\4>%K#6;F]S)9/);QZ9+>
MM&98GD=482"/AE4MN'?C!-;&HZ;K]J=0=?$$SZ:^G./G5!<1W Y#(RH %*YR
M#T/3% '5QR)*@>-U=#T93D&G5R7PRBE3X=:%)+=S7!ELHG EV_)\HX& "1]<
MGWKK: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9'\/WSRW$\L#QJC*"HC#, &W-M;C(Q'SU&=3QIIK^(]+'AR(-LO)(S=R#I%
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M#[JC:!T]3R:V:R?#7B"V\4:%!J]I#-#!,TBJDX <;'9#D D=5/>M:@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\NLKV70
M->^)&L/=W=R--,<RP2."LG^C!PIXR ">,8P*]1KGE\(62Z]JVI-<W+Q:JBK=
MV+%3#(1'Y>3QN^[QC..^.F #F=5U?6-"\*Z#XI74YKMII+;[?;.%\J5)L [
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MJ-LF<8Y ]:V-#T4Z/;N)K^[U"ZE(\VZNF!=L=    %&3@ =R>I-,\/>&]/\
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MH$L0Z*RL"#CL<<?@*75_ =CJ=OIGD7U]8W^F,S6U_!(#,"_W]Q8$-N/)SU-
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MVMFFJ:BDMI?-?VUVIB$T4C$EP#LQM)/((YH DMK^Y\0>,M?T-;ZYM+;1X;=
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MM5 .I!X].<YINF^"4TC1;/3;'6-0C%G=O=Q2L(RQ9]^Y6&S!4^8W&,],$8H
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M<&-5 QD,1COQU/-5O%'C.>\\$Z[/I=MKND7=G:-.D]UIYA!P0-H,BD$\]N:
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M3Q0![!6)XG\3VWA335U"]M;J:W,BQ$VX0E68X7(9AU)K5M93<6<$S  R1JY
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M 3!R1TXJAINJ:BGB;PG:+J&H3V^K65R+JYF.$N72-6$L2-S&,DXX4$$8!ZT
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M(DGWX?Y^.57:0O3DD@]N;&I>*;?P#X9U+4=7OTU"[UBVCG22**/="\VT*0J
M@%0#US\QSZ4 >L45PMSJL_AKXB7$>J7]R^D:AI[W%FKOE898N94 [Y4AAGT(
M%1O>:M#JFB>'))I6N+RTGOKK?=F-RP9 (ED ) 7>>F"=@YZY .^HKGO"=KKU
MC:WEKKMW#<E;EFM'64R2+ ?NK(=JY8<C..:Z&@ HHHH **** "BBB@ HHHH
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MJMU:VY/V2SNKC?%;9R/E  )P"0-Q.,\5U5% &/XC\.V_B:QAM+JZNH(XITN
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MGNIKF[36XTCO()V0H0B[5VX4$8'?/OUYKI*CFN(;?9YTBIYCB-,G[S'H![T
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MP#I::)I.EI<WZ1Z3,)K.9)@LL9P1MW!>1AB.1GGK74(@CC5%SA0 ,DD_F>M
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ML>TE/+,6[=C&W^]SG.?PXK,TGX>Z1HM^9K.YU%;,3&>/33=$VL<F<[EC]CR
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M4MQ"2$5D^Z^<9;<#]X].,=#'X&T^&[T>[AO+Z*YTJV^RP3(Z!FBX&Q_E^<#
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ME&MQQI=H74#]W_JRN%!!7M^N::GA&QTK48O$!NM8O;^RLWARUP9'G3(;:5&
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MC;^'1>I:N^0'$K XXY)"#DY/)YK%O-6U2+X3VOCJWU.X;54CCO98S*Q@E5G
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MS%RRD$A0% &<<G.>,<C/KWB";PPL#:O<Q7>G>*DT@W2!0;F+S% 9^.3AL'&
M<'.:]&O_  S:W>N1ZU!<W5CJ20F!KBU*YECSG:ZNK*0#R#C(]:K7G@C3+O2;
M731+=00V]V+W=$Z[Y)PV_P QV8$D[LG_ .M0!J:/I;:1:26[:C?7^^5I!)>R
M!W4'^$$ ?*.U-\0C46\.Z@NCNB:D8&%LSD >81\O)XZ^O>M%050 L6(&"QQD
M^_%5=3T^+5=-GL9I)8XYEVEX6VNO?(/8^] 'G^FZO:ZS9^(+"1M:TW48M-)N
M-+O;B0O$1N_>QR%B2IR!D'L.!GG*A%[IOPP\!R:;JM]:/=W>GPR[9=X*O@$8
M;.!_LC ]17H\'ANU2]FO;J>XOKJ6U^QF6XV B'.2H"*HY/).,]*RE^'NFIHN
MGZ4NH:I]FT^XCN+?,ZLR-&?W8R5/"]A^>: *=S82Z9J]AI)U[5]15X[B?[$)
MR+B3++AS*I3;&F2 ">21U. .1DN+O7OA_P"!KS4[RZDNCXCBMGD6=E+*MQ(@
M)VD98!%^;KGGO7I6I>$[+4M;M-8:ZOK>^MX3;F2VF\OSHB<E'P.F>>,'/>J$
M?P[T:'P_'HT4^H);PW@O;=Q<'?!*'+@H2,  L>W?G- &?/+J&M>)=;T"TFD2
M/2[>WCB(U*6WD#2(6\TLJL7[#YCCY3P<U#->:_IS^$+'Q!J$;6\IN(=3O;.1
MD1YD4^4&<!2H.&ST^9<=.NSJW@'3-4U*VU)+W5+#4((1 ;JQNS')-&/X9"<[
MOKU]ZP_%NG0VVJZ-:FW\0VNF6=M)Y6H:,9)9!*Y *R!0S'(&2Q4Y)Z]<@%:*
M37HO GC347U?4E2V:[.E2NRY,$:;D8$KN.3D;B<D $>IT;/5[C4M9\,Z!<7<
M\<-QHG]H3R)*R27$@V*%W@AAU9C@Y.!VSF71_#\^IZ7JNGW.JZ_/HU] (@=3
M"K<<[@^W*!E4J0/F&<YQCOH:EX"TS4]/TJWDNK^"YTI=MG?V\PCN(UP!C<!@
M@@ '(YQ0!I>'K"\TRRGM+S5FU)DN',4D@^>.,\K&QR2Q /WCR<BM>J6E:7!I
M%D+:!YI>2\DT\ADDE8]69CR3T^@  P *NT %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;&V\[4Y-&UUK8@W'E3WEJJ[M@DX_>#<N3QD+[G(!Z/JUU>66ESW&GZ>=0ND
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M=/GM[LWD,EM&R7)SF4;1\QSSD]>:B\2>:/#&J-#/+!*EK(Z2Q-AE(4D$'\*
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M]8V_:R)L9*@!2I ^4@#'%=#10!C1>&[=+B>ZENKJ>\EMOLOVF5EWI%G.U<*
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M&LODN+.2Z6Y\W^X5!7;C_:ZYK>H QG\-VLGB"UUN2XNGO;: VZ$N-I1L%@5
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MZ5IVWAC3K37CK47V@7IMUMBQG9E,2\A=I..#SGK[T >>2V,]Y9?$1I=7U?\
MXEDTCV>V_D7RF6W5P<@@D ]CD>U:L^H7UQJ'PTO'O;D-?H3=1I*5CE)M2^64
M<'GFNH7P=I2QZO&#=;=7)-Z/M#?O,C:?]WY>.,<4?\(=I7_$GYNO^).,6/\
MI#?N_EV\\_-\O'.>* .&EL9K^7XB)-JVK;=.?S+0)?2)Y+?9PX((() 8_=/R
M^U:)U74;JU^']S?23/IE]:;]0,6[+S&!60N%Y*9WD]LXS74KX0TM#JY4W0.K
M_P#'[_I#?O/EV\?W?EXXQQ7*>)?#T5I=Z)9?V1K5QHNG6CQ6]SI=RWVB!R5
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MD&\*D%LY(V\8/:@#V6BO/1ID>J_%/7M.O+F^>Q;3+>4VXO)%4,SN#C#9 XZ
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MK*\GGMS#</$(Y$MD8/\ *1DY ZYZ<8R<@'L55[N^MK%8FN95C$LJ0QYZL['
M _SZUPPG&N7VAPSRRW]Y+HBW$FGL_EP+OV_Z0[#G.054 $]2,<FN5A#:UX&^
M&EWJ4DMS<MK"0-*\K;BO[X=<]<*O/7B@#VNBH7MHVLS:YD6/9L!21E8#&.&!
MR#[YS7A\=I>1_!73/&<&K:FVOV866.1[MV60>?M,93.U@V>XR3WQQ0![M5>[
MOK:R$/VB58_/E6&,'J[MT _4_0&N+TID\6>*_%EEJWF[=/EAMK>!963R4:/=
MYBX(PS$D[NN  *X^)[C7M&\!SZRTES=1:])9?:2[*9HT$JAN#U.P9/4XH ]L
MHKSAX+CQ5K_BG1?M,4+:>8K>U5Y) ]NC0JRRKM8?,6+?-UX S5<V%S+XU\+:
M;?:W=WJR:3<I=2P7#Q)<-&47=@-\I.3DK@GUQ0!Z/?7UMIMC->W<JQ6\*EW=
MNPJ*[FU"/4+&.ULXIK21G%U,TVUH0%RI5<?-D\=L5X[J\ D^%/BVRFDFFATK
MQ";>S\V9F,<8GAPN2<G =@,YZUVNO0?V=X_\"P6LUS' \UXCP_:'*.! [#*D
MX)!)YZT =U7/CQ%<?\)ZWAIK*,1_V:;]+@3$EL2!-I7;QU/.3VK@?$MVZ:5J
MFL:9=7-S+;Z[$HU&24QF+]\B&")1G=&N2ISM!R3\U=2W_)<(_P#L6V_]*5H
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M)<76D7#S/YC*6(CB(Z'CEB>/6E@M=0\;V6O21ZI%97]KJD\$=QOD\RR$3X3
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MSPGS?*O)RHX/<&KR^#]%0:J%@N -5S]M_P!+E_>\;?[W'''&..*W:* .;O\
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M6.!T  Y-<'\.?"4=MX'T>UUBSO([JT8R/:7$C^6LH<LK!<[3V([ \]:]"HH
MQ[SPSIEYJIU,I/!>O%Y,DUM</"TB=E;:1G'8]1V(I+[PIHNH:79:;-9[+6QD
M26U6"1XC"R@@%60@C@GOWK9HH YK5O /AS6M0@OKJQ9;J&,0B6WGDA+1CHC;
M"-P^M76\+Z0VJV>IBW=+JRA,%L8YY$6.,XRH0,%QP.W85L44 <__ ,(3H']F
M:IIS6<CVFJ2F>[CDN97\R0D$ODL2IR!R,=!4K^$M'DN=,N7AN&FTS<;5S=RY
M0L,,3\WS$@G);).:VZ* .6N/AWX8NEOTEL)#'?3?:)HA=2A!+N#%U4-A&) R
M5P>W2M)/#&E1:W'K"0S+?1VWV59!<R8$6<[=N[;C//3KS6O10!S,EC#X,TVY
MGT'1+W4)+J[\Z>WBNBS,[GYI/WK8^N*N^&M*;3;&XFFMXH+R_N9+RY2/!"NY
MX&1U(4*">Y!/>MFB@#/UO1-/\1:5+IFJ1/-9RX\R-97CW8.<$J0<9[5 WAG2
MWU>TU5DN&O;2(PPRFZE.U#U!&[!S@9R#G%:]% '/KX+T-;'4[(6]Q]GU21I+
MQ#>3'S6888D[LC(X.,<5SM_X>V_$+P\MM:ZBFF:?I\UN+F-Y/W3L4V#?G)&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBCI0 4449&,YH ***.M !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH"V2*5EW0[K@JY(9CDD[L#.!GD@"MR.PGU3QQ!XD>TGM[2PL)+>)94VRS.[
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M1D-WP&W 9YP/I6?'!JWAOXD:WJ(TJZU'3-<CMV26UVEK>6)-FU@S#"D<YZ4
M4?AQK=KI7PUTII$F>6[O[F"VM@!YLCF>4A>3@8 )))P #S78:9XDM[_6;O1I
MK>:SU.UC69K>;:=\3' D0J2&7/'J#U%>=:5X;\16GAWPW?\ ]DSK>Z)JMS<2
M6;.FZ>"9WW%/FQN"MP#C//M7966F3ZE\0O\ A)VMIK:U@TS[#$LZ['E9I-['
M;U"@ #G&23V&2 7]=\56V@:EIEC/97L\FHR-'"UO&&&X*6P><YX],>I JO8^
M-]/FL]:GU"WN=+?1F O8;H*60%=RD;"P8$'C!Z\55\6V=[<^*/"=Q:V4\\%E
M>237,D8&(U,3(#R>>3T&:YO6O">K>(9_B#:Q6TMJ-4%F]A/+@)*T*+D'G(!9
M<<CH<T =F/%D4.K6&GZCI]YI\FH!OLCS["LC 9,9*L=KXYP>O8YXJKX/\37_
M (AO-<2[TV6VCL]1DM8R7C94"*GRG#9+$EFZ$<XSQ5'4+6_\8W'A@SZ7<Z>V
MG7R:A>&< !'1& C0@G?EF'(XP.N<"K'@RRU+2M8\36MWITT<-SJLU]#=%D,;
MHZH !@[MW!SQ@>M &SJ.OI9:O;Z3!9SWE_/ ]PL4950(T(!)9B!U8 #^0YK(
M;XBZ2-%T75DM-0DMM7G%O!LA!9),L"K#.<Y1A@9SBD\0?VR_B^QB;3+J_P##
M[VC!H[:15'VG<,>;EAF/9VY&2<@\5PB6NI:#X*\#6.H:3/!<V?B9080R$R F
M=LI@],,,9QGTZ$@'>6GQ"LII-7M[K2M3LK[2X/M4MG/&GF20_P!],,58>O/6
MH;?XE:?+-HS3Z7JEK8ZOY:VM_/$HA,CKE4.&R#VSC!(X)'-4M9TR?4-8U_Q,
MUO+;VL7AZ;3X?.78\Q):1FVGD*, #."23VP30L+&Y\5?#KP9I$5C<1");&XN
M)Y5VHD<2JV5;^(M@  9QNYQB@#0T>4:9\0_']Q#:W%SY<%C+Y$!#.Y\N0D*&
M(&>IQD5OVOC&SO?"]AKUM9W<L%])''# OE^:2[;1D;\<'KSP ?0U1T&SO8/B
M/XJOIK*>.SO8[1;>=@-LAC1@W?(Y8=1S5#PYX?N+#QQJEFLB-H5E.;^TB'6*
MXG4AD]@HWL!_TV% '3^*M8G\/^%M2U:WM#=2VEN\PBW!1\H)R23T'?'/I5"P
M\4L=-T:.XLKE]5U" /';@Q[G"HI>0D-M5,L.ISR!BKWB[3[C5?!NMZ?:('N;
MFQFBB4G&YV0@#)Z<UQUM8:U:ZOX7\2_V/=B.UT\Z9?69*&:-2%(E50Q!&]<$
M YQ@X[4 =-#XQM[C3M7FATZ_DO\ 26V76FI&&N V,KM )#!AR"#R/RKH89/.
M@CE*/&74-L<89<CH?>N+L[._TW5_%7BY-+N)Y+U($M; %5EE6),;CG@$EC@'
MG"],G%=I"[201N\;1LR@E&()4D=#CCB@!]%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 8VC^'+?1M1U*^AN[J67491-.)BA4N %!&%&. !6S110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5C:YX<M]?FT^2XNKJ(V%RMU
M (2H'FJ" QRISP2,=.:V:* *FI6":GI=Q82S2QQW$;1.\6 VTC!QD$=#Z4S1
MM+BT31[73+>6:2"UB6&(RD%@BC &0!G %7J* *NI6$>IZ;<V,LLT4<\9C9X)
M"CJ#W5AT-0Z-HUKH>GBTM3,XSN>6XE,LLK8 W.[<DX 'T '05H44 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M )."3GYLD]L<]'J7B+4].\6:!'*UJNA:L#$',+>9'<;=R(6W8PW...HQ5%O
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M<ML09.%&<#Z5DZWX/O/$,+V6I7-I+;"]%U;W'E$7%LH</L0YZ\8W<8!Q@XH
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MPCHNJ>']'33-0U--0B@RMM(8RLBQ_P *,23NP.,\5OT %%%% !1110 4444
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M!NM[F8[MRNYX7&%XRIY)ST%6KW7=2O-<OM&TXRQ26-K#)+-# DI,L@8J"&8
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M!)(JAL*Y",-W/!'H*V)-3UZPUC3M O-0LYKW5)IY8[F&V*""WC125"ECE]S
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MZM[A]5,\5[%#%F*VE2,N%CE'#8*E6!+'Z4 >AT5Y?/XH\7-X?\6ZG'?:;&=
MOYXU46C$3I&B-M.7^7@GG).3VQSZ-;7J3Z5#?N/+1X%F(Z[05S0!:HKSJ;Q=
MK;_#_P#X3FU>$VZYN#IK1C!M@^,;^HDV_-GIGC'>IWUWQ)K'C"ZT;2;^PM;5
MM+AOX+B6T9W0.S#!7?ACQUR /0T =\2!U.*I2:K;1:S!I3"7[3-"TR8B8IM4
M@'+8P#R.,UY9>^)M>USPUI N;F.RU"U\4PZ5?B"/*2NDH(89.=O"G'<^W%=H
M^LZK:_$/3M#FGMY+&?39;AB(2KF1&1<D[B,?,3@ ?C0!UE%>=GQ;K5]X!N/&
M^G20?9XO-GCT]XN)+>-V4[GZARJELC@<#!ZU87Q'KFL>,;;3-+N[.WT^]T-=
M2ADDMB\D>YU R-V&.#[ 9[XY .TNKZWLC%]I?RUE<1JY'R[CP 3T&3P,]3@=
M2*L5QWAR\N?&/@.^M]8$3W!>ZL)WB7:KE&9-X';. ?K5CX<:U<>(?A[HNI7;
M%KB2#9*YZNR,4+'W)7/XT =317GX\4:UJO@S4?%VDS0+#;/.]O92196:&%F5
MM[9R';8Q&, 9 P>M,D\4:_K?B#2;/0[JRM;35=$;487GMB[PME,9^;#?>QVQ
MG/.,$ ]#HK)U6ZU/3/"EU=00+?:I;VA=8XT($LH7LN<X)[9SVKGM$\43:WIV
MI7NAZK;:MY-H3';7"""6*Y&[Y91QM4X Z=CR>M ';,0JECG &>!FL[1==L/$
M%M/<:=(\D4,[V[EXVC(=.&&& /!]JY?1/$]]+XSLM'EO8[^VN],:Z:98-BK*
MC*"(W'#QG=[].M9'A[7'T'P[KDL,8DN;KQ9<V<"D9 >2?;DC(S@9.,C.,9&<
MT >HT5PSZQXPT^?6,:7+?V<6G-<V4TL2)(;@?\L2J-\P/!! ![<U=\'^(XO$
M4LLUEK4>H6B1*)(7A$5Q;S9.5=>,#TX['DT =917-ZQKDZ^*]+\-V4BPSW<,
MMS-.5W&.),#"@\;BS=3D  \&LJVUW5;FZ\4>&[NXC6_TR))H+V.+B:&121E<
MX##!4D<=P* -VW\7:/=:K::?%-*9+P.;60PL(I]F=X1\8. "?<<C-;,DJQ1L
M[9(52Q"J6./8#D_A7(?"V*=/ASH337"RHUG&8E$87RQCIG//UJOI+ZG+\6_$
M,4FI%K:"SM"D)B& K&0[1SQSR3U/X"@#JM$UNQ\1:3%JFFRM+:2LZH[(4)VL
M5/! (Y4]:T" 1@C(KQKPWJ^N>'OAII&KVMS:_8(]3>&6T: L\J27CHQWY^4@
MMP .W.<X'8:EK^LZAJ&N66AK(DNEE8HRL"2"68QB3#[F&%^91Q@]3GM0!U=K
MIMC8N[VEE;6[/]\Q1*A;ZX'-5;OQ%IEG?M8M-)->*H=X+:"2=XU/0L$4[0>V
M<9I^D7=_=:#:W6HV/V34&A#3VH8-LDQR 03QGI7&_!=S>^ _[7N&WW^I7D]Q
M=R'J7WE<'Z!1@=J .STW6].U:6XBLKD2RVQ43QE65HB<X#*0"IXZ'G\ZNS0Q
M7$+PSQI+$XPR.H96'H0>M<[XLU.W\)Z5?:]#;H]]<>1;*&.%D<N53=CL-YSW
MP,53O]:U;P[XGT2QO;F.]L=79[<2>2$:"<+N7 !Y1L$8/(QU- '7HB1HJ(H5
M%&%51@ >@IU>63^*_%O_  A_B+7$O=.5]$U&XA\H6A*W"1.!CE\ID9]3GO6Z
M=;UZR\9:#9W5S:2V6N0SE(4@*FU>- X^;=EP0<'('J,=* .U"J&+!0&/4XY-
M+7EO_"2>-[OPUKNM6EWI0.BWMU&UN;1O]*2$\C._Y. <=23W%;%YXHU&\M+:
M_M;F*PL[K2%O;55C$\\LS#=M,>"=BC;D@#[W44 =E=V-G?QB.\M8+A <A9HP
MX!^AJ:...&-8XD5(U&%51@ >PKSP>,-?OK;P+/:&QA_MY"+A)(6;8XA+Y!W?
M=R/N]3C&X9JQ9:OXIN4\6Z/%=VD^L:/)&;2X-MM2</$)%1DW<'J,@^AH [VL
MNQ\1Z3J6LZAI%I>+)?Z>5%S#M(*9Z=1@_AFL'2/$MSK^E^&);"Y43WRM->;H
MA\B1C$HQV(D*)^)ZXKH9[,6LU[JL,37%ZT&V-"0.%!(0<=SU)SV[   &C17$
M>"_%3>)+J/;JT<LD=LWV_3IH/)GM;C*8 7KL'SCG/;YC5_QIXC?PW%I\TS36
M^FS3E+R^BA\TVR[25)&#@%L#<00/QR #J*JQ:9807374-C;1W#YW2I$H<YZY
M(&:Y1O%%VEGH=K#=P:A<ZM/<>7>6:*RF"/<P95W8+;=@ZX!).#C!JMXH\2:1
M;W4&J6*[YM1M[+2KR9503><<9D16."G.<8W<8QUH [^BN1U*;Q1I-OKD[7=M
M/8V^GM<VMRT8$BS*"2C(."G .>#VYZU3;Q1JHL_ EV'AQK9A2[C\OC+P&0E3
MGCD>_% ':RVT$\D4DL$<DD1W1LZ E#Z@]JK:=JUKJD=S);^:%MKA[>3S8FC^
M=#@XW 9'N.*Y'2=3\6:SXCUFT34--AMM*U)(F_T1B9HBBL5'S_*>>N3D^@'.
M!XA\0ZYJ7PG\77,M['#<V6H3V)>VAVAXED6/ !)(R"><DT >G7NJVUA>6-K,
M)?,O9#%#LB9AN"ECN(&%&!U-7:Y'6-6UC1_$'A:P^U6\T&HW4D-RQM]KG$;.
M,'=@#@#IVZUGWOB3Q%J=OJ]SX=MW>6PO)+6"W,*-'<-$VUP[%@1DA@,8QP><
MT =]17GNL>,[NUUA]-N[I= NIK..33OM<0:">9E)='DZ JV%P"/7G(%=Y<K*
M]I*L$WDRE"%DVAMI]<'K0!,"#T.:*\J\*^)=2TSX:^')Y;M;J_UN]6U@::/B
M-Y)'+NV#EN QQQS@5U$>MZCI/CRT\.ZA,MW:ZE:R36EQY821)(\;T8#@C!!!
MP#VYZT =:2!U.*S(=?T^X\03Z''))]OMX1/)&T3* A. 0Q&#SGIGI7-?$:34
M(V\,)9WYMHY]<MH95$8;?DE@3[ H#CO5*>#5)?B[=P6-]!;W)\/0![J2#S,'
MSY.0F0,D^IX]Z /1:*\\TGQSJ.H>&O#GF1+_ &KJMQ<6\C01Y"B N'=5)')V
M# )P-V><8._X8O/$,M[JEKK5HPMH9$-C>,J(TZ,,D,BL<,IXSP#GI0!TE%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.AR00>,UU^E64]C9".ZO'O+IB7FG90F]CZ*.%    ]!W.28++Q!8:AKFH:/
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MJ-IJVGPW]C,LUK,-T<B]&&<9% '/W_A?4]2OO#][<:S 9]*G:=\61"S,RE2
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MC4+V4!2\<(AC11G 5,GU.23D\=@!4NA:]IWB72(M4TJX\^TE)"L5*G(."""
M0<BM*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<#))X' Z#BN>N?!\^HR62:IJ45U;V6H?;[<_9=LR$.75/,WD;1D#A02!CWH
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MG3-5NO-U?3Y%^Q;(E031R@" @8Y)<[3U -=S9QSQ6<,=U/Y\ZH!)+M"[F[D
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M5;*P-M=.UTLC":.(M%'L /SMT7.>/6DU75K71]+O-1N3(T%HADF$*%V4 9/
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M;</?+'C@<#.1Q5%?%NOZ7X/\92R2#4]0T*\>""=H0I="J,&=4 !VAR3C&0M
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M[ED:."TMQ<:==W<<#3<#YT=8SMX/0XZ=<T >C/&DBX=%8>C#-*JJBA44*HZ
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MH2/RVBD(7!0Y/38I&<\CO4FG>$=3AL)[?5/%5]J3&W>"UD>%(S!N4KO^7EW
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M0:%<R>9'9B.-O(RX<JKD9VY' [>IYSMW_A:XOX=1M9-8F>SU&$0W,4T*,<;
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M:-J4CR3V013LW_ZQ8WZHK<Y&#C)P15VY\+13>(M'U:&Z:!=)AD@@MDC&S8X
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M+E<_)\NUFCZ=F_&O1-/T(6^KRZQ>7!N]2D@6V\WRPBQQ EMJKSC).223GCL
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M:A!L$(;<.>N<]\_A3M(L=3M_$NLW$^HW5SITY0P0W"@"%QG<(^^W&WD]3^9
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MD1*YR?,*[<'!P<X/&* .AHKR]M?U>TNO#EP-5EOFO=9-E>31*/L<B-YF$CR
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M026IABB#(6A+XR5^[GVR<#GUZWP;JEQK?@O1M3NR#<W5G'+*5& 6*C)QVYH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5A;W$MO);22QJ[02XW1DC)4XXR.E ',ZIX$CO=?_ +;L=:U+2K^6)8;N2S9
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MO&GT^WDB6-40JZM@MD!<DG:.A'M7044 <5HJ:?XK\60^+K>PN84M;,VL,MS
MT32.S$GY6YP@R >A\QAVKLY(TFB>*1%>-U*LK#((/4&E9E12S$!0,DD\ 5B:
MCXGM].U;1+'[-/,NKR%(;B,KY:X0OSSGH.PQ[T 9]GX$M+338='-_=S:)!,)
MHK"7:0NUMZH6QN9 V" 3V )(XJ\WA>)?%-SKUOJ%Y;S74"0SPQE/+DV9V,<J
M3D;CP#@]\UO44 <8OPZM$\(VWAH:MJ'V.WN1<H^(O,W"3S "=F,;CGI4NI>
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M3TR>Y/&-BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<WM_(NJW*W<KEHPT4JXP\9"?*0% KJ+*W>TM(X'NIKID4+YT^W>WN=H S^%
M'FNG/_8/BCXC:MY]W/\ V:D,_E-+D2XM=V&XY]O2I-4U;5M(\ :-XSAU*XN+
MEA:S7L#-F&XCF*AD5.B8+C:5P>.<UU]AX4M;'5]7U$WEW<MJVW[7#/Y9C8*F
MP  ("!MXZ\]ZJV/@:QLK.UTXWM[/I5I,)K>QF9&CC*MN4;MN]E4\@%CT'7 H
M Q;6'6-8\?\ B?3CXDU"WM+![&:!(1&"-RLS)]W[IP1ZGC).*L_%^-G^&.KL
MLTT901G]VY7=F100<=1@]*W]/\-P:=XCU/6X[V[>?41&)XI"GEX0$)@!01@$
M]_K5C7]#M/$FA7>CWWF"VNDV.8VVL.000?4$ T <?XEL)/\ A87@FSBOKF-C
M%J ^T$AY0"B$X)&,]LX.*SK?Q-JND:+K=DU_+=36WB&/2[:[N6&^.*4Q\LV,
M$J';!(/;((&*[$^$87U;2-3FU74IKK2UD6)I'C._S  Y?Y.X Z8 QQBJ[> -
M)GL=<LKR:[N[?69OM%RDS(-LG&&0JH((VKCKTH 31[#Q%8^*97N+E#HD]MQ;
MS7;3RI.#]Y&*@[2O49X/2JOC.YU6+Q1X5L]/U:>RAO[F:&=8T1@0(F8'D9R,
M<9)&<$@XK6\/>%4T%B\FK:IJDP3RHY=0G$AB3C*K@ <X&2>3@<U@>/$:?Q;X
M-1)KB'R;V622>!-QA!B8 L2" "V!SUYH Q+W4-=\/MXUT1]:O;Q+'2?[4T^\
ME8>="<.-C$ !AN7(R.E;MQJNH)K?P_VWLP34HY!=IGY9L6Q<$CL=W/&*Z!?"
MMB\&K+>/+=RZM%Y-W-*0&:/:5"#: %4 G&!U)/)K,M?A]:P3:---K.KW4NCL
M?LK2RH,*5V;2%0 C;QG[Q[GI0!D^'[;6M;U[Q D_BC4XXM,UCRX5B6(;D\M#
MM;*8(^;@ #N3GMS:7_BC_A4T'C9?$UX]_9-)*;=U003QK.RLK@+DDCN",8
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MPJALJA)QGG'K69H<4SWUF="\3^*KSRY8Q+;ZG9E81%D;PS/"G.W.,'.<=LT
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M3"3;ZB74S8(PRME=I4@ $;<<>O-:>EZ-;Z7+=W"R23W=XXDN+F;&^0@!5'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ^XFNF,4D&T/<.RG=; G()P>2<9Z=L5@: U]I'@CX>:I;:K>@W-[:V4MMOQ
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M/M6CI^FFRT:+3I+Z\N]D9C-S/+F9\]RPQS[UXX+18?V=-4F66=WDFD!\V9G
MQ>D9 )X/J>_>@#W*BN"DGOM ^)%M;G4[Z]M;W2[BXF@GD#*)(V7!0 83(8C
MXJCI/_"3:_H6@^);'4;>"65H[F[:74)&ADA/WXO)V;%(Z @Y!7DDY- 'I=%9
M/B73[S5/#U[:Z=>36=\T3&VGAD*E9 /ESZC/4&N=\+ZR?%5CX?DBFN8GMK<S
M:@@F8,)%S'Y3\\Y=7;G_ )Y^AH [BBO,-.F\3>*O#-CXDTR_@M+IYS.SS:A)
MY(B5R&B>$)L "C&?O9&<U+J>N7.E^*)8/$#ZG8VT^HQ'3]4MY6:T,89?W$BJ
M<*3AE)8<[B<@"@#T9;B%[F2W613-&JNZ \JK$@$_7:WY56TJ\NKZP6>\T^6P
MF+.IMY75V #$ Y4XY !_&N+\-:<I^)OC@K=7BM&]IL/VAF WP$G@D@X). 00
M.U8"ZQK;_"+3-1&M7BWQU?R'GW M(IO#'AN,XV]ACTH ]@HKAM/>_P!*^)]W
MHZZG>7MK<:,+X1WDN_;,)=GR\ *"#T Q7.VNH:YJNB>''M]3U"/Q%/J?DZO!
M')_JHMSB7,; H@7:-K8].I/(!ZW16-XIU:3P]X0U358D\Z6SM'E0-_$P7C..
MV>M<AK%YJ.@^'O#?B.TU*[NII[BUCO8Y9B\=TDV VU#\J$%@5V@>G(H ZO5?
M$3V>H2:;I]BVH:C%:&\>W601_N]VT8)!RS$' Z<')'&=6PNC>Z?;W36\UN9H
MUD,,Z[9(\C.UAV(Z&N&M--B/QKU-O/N\KI,$V/M+XR9I.",_=_V>GM5_XGW=
M_8>#);O3K^>SN([FW4/%CY@\R(0>^,,>A% '945P-^M]I'B/2_#T6J7MZNJM
M<W;M>7AB;]VJ 1(Z)E5^8M@8Z=<9%0W%MXRT?1+N+SAJ@34$FCM8+UC=&S.2
MT0E8*2P(R#U(!&: /0+BXAM;>2>>18XHQN9V. !4E>.^)-0L->^&FH7-E?ZH
MPBU:V5K:[DD2:U8R0J8G!.3CDC)/)]1FN@UNUOW\?Z1H5OKVJ6MA=:;<M((I
M\N"I3#!B"=WS=3GVQ0!VHO+HZV]D=/E%H+<2B]WKL+[B/+VYSG'.>E7:\^2^
MO]#\>W]G)J5[?VEGX;6Z6*=P2TBNREN ,L0G)]2:L:#;W^M:#X;\2)XAFAN)
MQ'<WJLY:&9''S0B,MM3!(4,!GCG)- ':QW$,TDT<<BL\+!)%!Y4D!@#^!!_&
MI*\BTZ\?POH?Q#UJVFN'N+35IDB\Z=Y%!*1 ,P)()&<Y/.!CI71O;:_HNIPZ
MTM[&VDQVDS7MM+J,ERUP0A9&B#( K9!R%P".W% &_P"*?$:^&-+COI+*:YC>
M>. ^6R@(78*"<G.,D= :VZ\>\0"?6/A1I/B&ZU"YDO+RZL[B5%F;R</.G[L1
MYV@+D $#/R\DY.?5]2^U?V5>?87C2[\A_(>3[JOM.TGVSB@"U4<%Q#=1>;!(
MLD9)4,IR,@D']0:\[\-ZJFI7TVCZFVM:7K*:<ZW-A=W,A$QRO[Z&3=C P1E2
M/O<#BL;PWJ4VC_#/P1;VUS<1OK=Y#:33-*6\I"7+;,Y"EL8X]<]0* /8:*\[
MUC6K[P;XMEMX);B]TVXT>YOEM[B5I6AF@&[AV);:P(&">O3%:.BV5]?Z=X;\
M01^(9U>:*.:^61R\-T)$'R*A.V/#$8*C/8YH V/#GB-/$)U4+9S6K:??/9.L
MK*2S*JDGY21CYO4UMUX_HNK8\4Z[X>DGN-/CU+Q%<,M_&Q7<R)$?(1AT=AGD
M]L@9)X]<2!$MQ #(4"[<M(Q;_OHG.??- $E%>176LZJGP>\0ZBNIW@OK'4IX
MX+CSFWJJW 0 GN-O'.:Z&_2_OOBL^C_VUJ$&GR:']H,,$@3#^<%^4@9''?KZ
M$9H Z_5KRZL-.DN+/3Y=0G5E"V\3JC,"P!.6.. 2?PJRUQ"MRENTBB:1&=$S
MR54@$_@67\Q7DMQK6M+\&[J]&L7@O;#4C:"Y##S)46[$0WMC.=IZC!K?N;!)
M?CC;LT]T/^)$TNU;AU7(G08P#C![CH>] '?T5YKI>N7-OXJLM-\1OJ=AJ4EY
M*8+CS6>RU&,A]B)@[5(!4XP#E1R2:[K3M-DL+B_E?4+NZ%U.9E2=P5@& -B<
M<+QTH T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KCKSX;:->PZO;O=:DEKJDYN9K:.YVQK,6#%U&.I(!P<CVKL:*
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M,G!/&3@9Z"J%GX&TRRM8K!+B\?2H9Q/#ITCJT,;!MR@?+O*AN0I8C/:NFHH
MPXO#$$&N:EJ\5]>)=:C&D4V"A4*@(7:"O&,G\^<U8\/:#;>&=$M](LI9WM;<
M$1><P9E!.<9 &>2>M:E% & WA*R&MZEJT-U>P7&HHJW"Q2CRR538'VD$;MO'
M.1WQGFJ@\!:<NB:1I"WM^+72;A+FUPZ;E=#E,G9R!D\'UYS7544 <G??#[2[
MS7YM8AO=5L+BY"B[2QNS"EU@8'F #KCC((-=3'#'# D$<:K$BA%0#@*!@#'I
M3Z* .1TCX=Z1HFH>=976IK9B7SX],:[)M(Y,YW+'['D D@'!QP*MWW@S3]3T
M._TJ]N;N:*^N/M$TK,GF[P01A@O&-H [@# XKHZ* .7UGP+8:V=/GGO]3@U&
MP4I#J-M.([@J>JLP7!!]Q_,YDN?!5A<V^EPF[OT_LZY%W$XE#.\PS^\=F4EC
M\QZ\<].E=)10!SOB#P9I_B&_L]1>YOK'4;12D5Y83>5+L/5"<$%3Z$47W@W3
M[[3=/L6N+R.*QN5NXV24,[S*=P=V8$L<DD^N:Z*B@#G[[PE;:B=12XO[\VFI
M%3=VF]/+DPBH1RNY<A1G:1575O .F:IK:ZQ#>:EIE]Y8AEDTVY,/GH.BOP<X
M]1@^_ KJJ* (;6UALK2*UMTV0Q*$1<YP![GK7/#P-IB)?6T5Q>1:;?RF6YTY
M'7R)&;[W5=RANX5@#SQR:Z>B@#$U'PQ;:EK6F:JUU=0SZ9O^RK"4")O7:W!4
MYR..>G;%7=9TBSU[1KO2K]"]K=1F.0*<'![@]CWJ]10!R]MX%L;?4['4SJ6K
M37UG UND\MUN+H<'##&#@J#@  ]P:B_X5]IG_"+?\(Y]MU#^S_/^T8\Q-V[S
M/,^]LZ;^?_K<5UM% $9B5[<PR_O5*[7W@'>,8.1C'/TKG;'P/IUC;6]BMS>R
MZ9:S">WL)I%:*)@=RX.W>0IY 9B <>@KIJ* /.](TZXO/B3XQG%QJMA#<"T6
M*6.#8DX6+:V&=",@\9&#S717?@O2;G3M)LH1<6<>E2B6T>UEVNA (/)SG()S
MGDYZUT5% &+#X8M(?$DFN"XNFN)+5;-HW96C,0)(7&W/4DYSGGFJ5IX%TRSM
M5T^.XO&TE)Q<1Z:[J8$8-O 'R[]H;G:6(SVKIZ* ,2+PS!!K]_K45[>)=WT2
MPRX*%0JYV[05XQD_GSFIO#N@6OAC1(-(LI9WM8,B+SF#,H))QD 9Y)ZUJT4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[K]Y8^)=/T])EL+28HINKBQ>:*9V; B$@=1&V!P6!!+#TP0#JJ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
=HHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>elicio-insidertradingcom008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM
M=ZC96!C%Y>6]OYAVIYTJIO/H,GFK-?/7QK\ ^+=?\:Q:CIEE-J-C) D42Q,#
MY)'4$$\ GG/3F@#Z%HK"\&:;?Z/X,TC3M4E\V]M[98Y6W;L$=L]\# S[5NT
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MO[4)!M\UO.7$>>F[GC/;->8>*-)\/GPUXVU&QU5M5N+K3?-N<-"\*.JD1O\
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MY)X-6)-5TZ$XEO[5#YOD_-,H_><'9U^]R..O-<?KT-N/BYX/F2.,22VE\K.
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MD\ORY)"Q\Y=TBD;B/+],@#VKK_!.F:9I'AQ;+1[VXO-/CFD\F:5E8'+9(0J
M-@;(&!ZT ;-SJ%E9,BW5Y;P,_P!T2RA2WTR>>HJMJLESMLC9ZC:6@-W&)3.N
M[SH\\QKR,,>,'GZ5PFJ3P6_C/QA:3S6EY_:6G01)%-<QQFW.QU\M@[#Y6W;\
MKG&>G2JNK^'[/0/"OP]LU%I+/;:W8(US B@2,0=Q!'7) Y[X&: .JUGQ,/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\8^][]:F@U73KJ]DLK?4+66[C4/)!',K.BGH2H.0.122:OID-\MC+J-HEVY
M6!IU$A)Z +G- $.J+J\K&#3Q;)#+ ZM<.YWQ2' 5@N,, -QQD<@#CK1:^']+
MMO#]OH1LX9].@B2)89T#JP7&"P(P3D9SZ\U-=ZQIE@SK>ZC:6S)'YKB:=4*I
MD#<<G@9(&?4BJ$6M&W\2Q:/=NCK?0O<6$Z\>8%(WQGL2 RD$=0?522 :,^EZ
M?<W%M<7%C;2SVIS;R21*S1?[I(RO3M1'I6G16L]K'86J6]PS--$L*A)"WWBP
MQ@D]\]:MUQ\OB.YL/B1=:9J%_:PZ/'HXO0TBB,1L9MGS.3[>PYZ4 =+I^EZ?
MI-O]GTVQMK.'.?+MXEC7/K@ 5C^+](U/5K6S6PCT^YCAG\VXL=0!\JZ4*0%+
M '&"0PX(R!FMDZG8+8+?M?6PLV 9;@RKY9!Z$-G'-)#JFGW%DU[!?6TMHF=T
MZ3*T8QURP..* .8T/PA#%J4>HW'AW0]'>-'3RM.^<S!A@B1O+0%?]G!YP<\8
MKH1X?T461LAI%@+0MO,'V9-A;UVXQFK%GJ-CJ <V5Y;W(0X8PRJ^T^^#Q5F@
M"E)H^ERVL5K)IMF]O"P>*)H%*(PZ%1C (]133HFDM>F].F69NBP<S>0N\L.A
MW8SGWI8M:TJ>YCMX=3LY)Y2PCB2=2SE?O8 .3COZ4MMK&F7EW):6NHVD]S&,
MR0Q3JSH,XY4'(YH NU1@T72K6]>]M],LXKMR6:=(%5R3U)8#.32QZQI<U\;&
M+4K-[P$@VZSJ9!CK\N<\=Z635],BO!9R:C:)=%@H@:=0Y)Z#;G.3D4 (='TP
MW_V\Z=9F\_Y^/(7S/^^L9JU+%'/$\4J+)&ZE71QD,#U!'<55N]7TRPG2&\U&
MTMY7QL2:=49LG P">>:EN+^RM)4BN;N"&20,R))(%+!1EB 3S@ D^@% %8>'
M]& MP-(L +88@'V9/W0SGY>/EY]*E@TG3;6>:>WT^UAFG&)9(X55I/\ >('/
MXU)8ZA9:G;"YL+NWN[=B0)8)!(I(Z\@XJ9W2*-I)&5$4%F9C@ #J2: *>G:+
MI6D>;_9FFV=EYIW2?9H%CWGU.T#-7B 001D'M6)X?\5Z1XEM[B?3;R&6.&5T
M.) 20IQOQV4D'![CFK]EJVFZDTBV.H6MTT>-X@F5RN>F<'B@"O:^&M"L;O[7
M::+IT%SG=YL5LBMGUR!G-6;_ $K3]46-=0L;:[$;;D$\2OM/J,CBK=<<OB>:
MQ\?ZOI^K:C9V^DVUA!<1-(%B",[LOS.QY/R^WTH Z2?1]+NK>&WN--LYH(/]
M5') K+'_ +H(P/PI/[&TO[7]K_LVS^T[=GG>0N_;C&-V,XQVJ8WUHMD+TW4
MM"H?SS(-FT]#NZ8]ZP?$_B Q>!-7UKP_J%G-):6\DJ3)B=,H"2.#C/\ +TH
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M H'0 =A3Z9#-%<0I-#(DL3@,CHP96!Z$$=13Z "BBB@ HHHH **** "BBB@
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M10>(?&UO J)$FKAA&G 4F%,G'N:[FJUOI]E9R/);6=O [_?:*)5+?4@<U9H
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M+@09EV#H"&*CCH1CM6I=:M%IGBCPJVIZI)INFW&B>7;7?[ORQ/E"REG5E7*
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MPRNX \9'2K4TB10/))*L2*I)D8@!?<YK%\)6=A!X;TRXL[>W1IK*#?+$@!D
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M#K.GR7%TI>WB2Y0M*O/*C/(X/3T-:A( R>!7B%@EG!\)/A].@@CD_MFR8R#
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M=VT-Q%G.R5 Z_D:FK!@U2SBUK69I?$EM+;V\<7FVC-&JV)^8$LW7YL=&Z8H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MURVDSO!?VT,RLT>WJZD<.F#G(QQGBMS3?$T&I"[NHDC_ +*MXED_M!9<QO\
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M[[2].TY-4%M"CW:O(%3#C*QC(.YRO.#@8(R1FLOX1?\ )*]"P,#RI./^VCT
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MW;BH8DJ<9ZY]:]"HH XCPC+XPMM/L=$U718K<6"+#)J*W2.EQ&@P-B#YMS
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M_ QCD?SJ[<67B;0_$L6NZ7HG]IVU]80VM]8FXCCEADBW;7#$[2,,00#7H=%
M%/3#>M8(^H1Q0W+DLT,3;EB!/"[L#<0,9/<Y[5<HHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O.O"[IXR\:^)K_5$6XM
MM(O3IUA;2C='$4_UDFT\%V/\74#BO1:X:#0]6\)^+M5U32+(:EI6L.)[FT25
M8YH)QU=-Y"LK=2"0<T ;<FBZ3HNK2^)%6.RCALI4N=B[49<J^\@<9 0\XR0?
M85GR^-WL[32M3O\ 2S;Z1J<D<<5R)]SP^9_JS*FT!0>.0S8)&:O:A8WOB?1=
M1T^\@?3K6\M)+?8[*\N7&-QVDJ /0,<Y[8YYQO#VN:WX-TOPIJU@(/LLENMU
M>K,C1RQ0L"#& =^YMJC#*,9/H,@&G+XTOY-4U_3K#P[+<7.CB)F$ETD:R*Z%
MQ@X.#@<#GWQ5>'XAM-:Z!J0T29-(UB:&W2Y>=0\<LG"YC'5=W&<CUQC&9+#3
M-5M?%GC#47TV0V^I1VXM2LL>7,<90Y&[C).1[=<=*Q$\,:]'\/O".C_V8S7F
ME:A:SW"B:/;LB?<=IW<Y[?KB@#;N?'&I-JVMZ9I?A:YOKK23$9%-S'&'5T+
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M0"2#\N?I76T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &78^'=-TW5[[5;:.9;R^V_:7:XD<2;1A?E+$# X&!6I110 5#>6D%_9
M3V=TGF6]Q&T4J9(W*PP1D<C@U-10!G:)H6F>'=-73]*M5MK93G:&+$GIDL22
M3@ 9)Z 5HT44 %%%% !1110 4444 %%%% !1110 4QH8GD21XT:2/.QBH)7/
M7![4^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJF!MN4DAV$D\\;6W<8ZT =DKJ^=K!L'!P<X/I4=S<PV5I-=7,JQ00HTDDC'
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MOET;4=2GT>[:_C%C'- GV:\MMRY"R%2=Y&X8W#!( KT*@#F'\?:''=ZC;/\
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M/'6N4U_6-9U/X4>-9+K4Y!/8ZG<6:R0(L>^)'5-AX/!!.><^^* /72ZJ5!8
ML<+D]3C/'X _E3J\[U^TU!/'W@FU&NZALE6\8G;#]Y8N&QY>"<,5Y!XZ8.27
MW.M>)==@UJ;P\+E+BPO9+2VC5;<P2-$0&$N\[_F.?NXP,=>X!W[N(XV<AB%!
M)"@D_@!R:S?#^OV?B72AJ-@)A 99(AYR;&RC%3QVY!K"L=9U/Q!XFU#1Q</I
M9TNTMFNA (W<SS*6V@LK#:H'8<D]<#F#X2K(O@55E</*+Z[#L!@,?/?)QVH
M[=G5 "S!02!DG')X I:X7X@I=-K'A!(-1N;5)=76-TBV8/[MV#'<IR01P#Q[
M9QBS::EJ'B'Q!KVE6FJ36,>C^5;K+'%&SRRLFXN^Y2,#@8 '\7/3 !V-%<UX
M$\0W7B3PTMU?Q)'?03RVMR(_N&2-BI9?8X!KI: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEK_P (2:K"]EJ&I"XTYKX7
MJQM;CS8R)/,"+)NX7/'W<X)&1VZFB@#C9? MS!XAO=2T7Q'>Z5;ZBXEOK2*)
M'61\8+H6!\MB.I -.U#P*YUZ/6=!UJXT6Z-NEK<".))DGC3[N5?^(#@-S6_J
M>L0:9+:VYBEN+R[+"WMH=N^3:NYL;B%  [DCJ!U(K'C\=6<]EYMMI>JS72P/
M<2V @5;B)%<H2RLP!^8$ *23@XS0 NJ>#C=/HMS8:I/:7^DO(T=R\:S&42#$
MF\' );KGL>U9\WPZ,NE^(K%M<N63791).TD*$I\J@D8QR=H]AV%=C8W<>H6%
MO>0K(L4\:RH)$*, PR,@\@\]*GH YS7_  O+X@\,P:/-J/E;'B=YT@Y<QL&7
M@G Y49_I3[CPR\_BVT\11ZE+!<1VGV.>..-2LT>_?CG)7YL].<''O6\9$$BQ
MEU#L"P7/) QDX_$?F*=TH X]? %M/IGB+3M1O&N;;7+EKJ4)'Y;12$+@H<GI
ML4C.>1WJ33O".IPV$]OJGBF^U)C;O!;2/$D9@W*5W_+R[@'[Q/KZFNJ1TEC6
M2-E=& 964Y!!Z$&G4 <_:^&G_P"$@M=;U*\CNKVTMGMHI([?RBRL027^8[C\
MO&, 9;CGC5U2SDU#3+BTBNI+625-JSQ@%HSV89[BK=% '+R>"[;4;^\O=:DB
MNY[O3SILGDP^2#"3DY^9B6SCG/&.!4?ASPA?Z(T$5YXFOM4L;08L[::)%\OC
M WL!ND('3/'?&0,=910!@>&/#)\,P7-M'J$UQ:23R30PNB@0[W+L,@9;DGDU
M8\3:(?$?AV\T?[5]FCNXS%)((]S!3UQR.?>M>HGG14F9<R-$/F2/ELXSC'KC
M'YT <[?^$3>KHUR-0,.K:.3]FO$AX92H5E=,\JP'."/;%-N_!POK#7%GO@;_
M %J 6]S=+#@)$%*A(TSP &8\D\DDYX WM,OO[2TRWO?LMS:^<@?R+J/9+'GL
MR\X-6Z .:U/PC_:O@N#P_/J#H\ A\J[CB (:)E*,5)(/W1GUYZ4H\+W/_"46
M6NR:J99[6T>UVO ,.'8,Q.",'(&,< <<]:Z2B@#"\,^'6\.IJ2F\^TB^OI;Y
MLQ;-CR'+ <GCT[^YI?%?AT^*-'&G&\-JGG1S,ZQ[R2C!U')'<#-;E4M)U'^U
M=-BO?L5W9^86'D7D?ERKAB.5R<9QD>Q% &8/#EP/&)\1_P!H)YQL/L/D_9_D
MV[M^[[V<[OTX]ZD\*^'3X9TN6Q^V&Z1[B2X#&/809&+,.IXR3BMRFR2)%&TD
MCJB*,LS'  ]2: ,7Q-X<_P"$ABT_9>R6=Q87B7D$R('PR@C!4\$$,:@M?#-Q
M:>*+O75U/S)KBTCM"DD&0 F2K$AADY))Z ^@JY+XBM(?%-MX>:*X^UW%N]PD
MFS]WM4@'YL]?F'05KT </'\/&B\(:;X=35V\FPO%NXYC;C>S+(9 #\V,;B?P
MQ6EJ_A:YUF#5;*XU16T[4U59H'M@QC^15)B8M\I.W/(;!Y'OTU5K_4+32[":
M^O[B.WM85W22R'"J* )8(4M[>."(8CC4(HSG  P*Y\>%IAX\/BG^T1YAL_L/
MV?R/E\K?OZ[L[L]^GM3Y_%]K::;)J=UIVJ0:<D9D-R]L<;0,Y* EU'NRCWQ6
M_&ZRQK(IRK ,/H: ,GQ-X<M?$^D?8+F22%DE2>">(@/#*ARKKGN/Y$U%;>'Y
MCJ\&KZG>QWE_;6[P6S)!Y4<8;&YMNXDL=J@G.,#  R:W:* .+'@%O^$.U;PX
MVK$PZE/+-)-]G 9/,;<X W8Z]/3WJ75_!,]]?:;JUAK<VFZU8P?93=PP*ZS1
M=2CQL2",\CG@_ACKZ* .3U34=&\,:7%I&LW%U?W.J+*H5H&DDO7P R_(NT9!
M  X & .!4NB>''\/_#V+1+>ZFMKF.T*M<QKYSI*PY8#^+!/ ] !73T4 9?AV
M'4;?P_9Q:M.T]ZJ$22NH#,,G;N XW;<9QQG-<AXGF+?%SPM%;:A!;7*6=V/W
MBAQEO+PK+D'G!Q@@\5Z'5#6=5@T/2;C4KF*>6*!0S);Q&20Y('"CKUH PKSP
M%8:GH^JVE_<2R7>ISK<SWD7[MTD0 1F/KM"!0 ,GODG)I;3PGJ8TR[M]4\2W
M&IW,UL]K%/+;(@AC888A5QN8X'S,3T^N>BT^_M]4TVUU"T<O;7,2S1,002K#
M(X/3@U9H YVT\-W5CX7TS1[75FCDTWRUAN1"/F1!M"LN<$$<'!'X52NOA]I^
MI6NM+J$I-SJTD4LL]LGD^4\0Q&R#)PP/)))SD]N*Z^B@# M_#MQ)J5GJ6JZ@
ME[>6$3QVC+;^4B%P SLNXY8@8X(&"< 9K&?X>,_@J\\,MJ[?9[JY-RTPMQO!
M,OFD#YL?>'IT_.NXHH YG5?"]YJ]OJEG<:JC6.IQA)X&M0WE_(%+1$M\I.,\
MAL'!^O0VUO':6L-M""(H46- 3G  P*EJIJ=]_9FF7%[]EN;OR4+^1:Q[Y9,=
ME7C)H PM9\(RZY;ZGI]YJ0DTK4)5>2W>W#/$ %!$;[OESMSDJ<$G%.N?"<K>
M*I]:L=7FLA=V\=O>0)$K>:$)VE6/*'#$=_P/-=$LZ%(BW[MI?NH_#9QG&/7
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MUU2Y2+5I&F>W*H4CE90K..,GA1@$X'H: .<TGQ;J=]HW@.QENRM_X@C>2XO
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MYY8%E9'66+&Y&1PZD9X/*B@#D]:L[MOBAX=M8M3F28Z7>!KMHXVDQOCY VA
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M !@#% &;X/MYK7XF>-XIKN2Z(2P*R2A0VTQR8!V@ XZ9Q]>>:/C)G_A7-SM
M)^UVN 3C_ELE;FB^%6TGQ!J6M2ZM=7=SJ"1).KI&J'RP0I 5<CJ>A^N>M/\
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MFM41DN$'3<C@C(YP>U &QX;?67\/69\01PIJH0K<"!@4+ D9&/4 ''8FN?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT1V-U>MYB)Y-LH9\,P&[!(X&<GV%,T2WO;71;2+4KIKF^$8,\K8Y<C) P ,
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MALL?N_=P.G>N:&N7_BNQ^'>H3LMK?RZE<12R1H" Z1RHS*#QSM)&<@$]#C%
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M3 .0<\ '1>'=<M_$OA^SUFTCECM[M"Z+* & R1S@D=O6M2N,^$__ "2SP_\
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M[V[6S%-\SJ@;"X8CG( R: ,J/X= 6NDVLWB/5YK?2;I+BR5_*S'L!"J6V98
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MPU;485TQ'C@?,9+(V,JX*88<#MGWK4T;1K70[26"V+L9IY+F:1\;I)7;<S'
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MMC?PRJEQ$N,%=P7!!  .1VKH='TF/1[(P)<7-U(S;Y;BZDWRRM@#+'@= !@
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M5]3M+[4]K&SD#[#N( !7)W8QVQZYFT?4M03QQIFFI>:D;*^T>25WNR"9)49
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MM?"^C1:5937$EK$6,8G8,5W$L1D =R3S45AXE@O_ !1J.A+:7,4UC#'*\DH
M5PY.-N"3CY3UQ3;SQ((]5NM-T^QEO[JS@6>Z6-U7RU;.U1GJ[ $A>.!R1D9
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MRRNSR/%<LS,<EB;3))K;O? &C7UQJTDDE\D6JJ?M=M'<E8G<KM\S;TW8Q[9
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M3&#V+VK[&MR%VC;V(P2,$$4[_A&+$V6H0/)=--J"A;F[\XK.^!A<,N-N.P4
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MP[1S0))A) +=F&X#KR.]=%/X2TVXT.^TF0S^3J#,UY('_>3E@ 2S8[@ <8P
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M>8QEF0Y ;'5?45H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC4=,MX-T%HTLMK-&6^5H\;@"'ZXZUWOARW@MM&C%MI*:5"[,Z6BH$* GJP'
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MRA_U? /  !_A!K(CL[]?@K8:<=*U+[<FIK(UO]BEWA1>&0G&WILYS_6O9:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+\SZCJ%Q)9Q_97!F5XT52./53]* .WLO&>G7NMVNE""^@DO(6FM)9X"D=P%
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M4260AMPF?((QD81B!UX)(K*@M=1_X1?X<0OI&HQRZ;=0-=(ULQ,:I"R%B!G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %,FB6>%HG+!6&#L<J?S'(I]% #(88[>&.&&-8XHU"HBC 4#
M@ #TI]%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#%:00W$TZ)^^
MFQO<DDD#.!ST R< <<GU-344 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_JLSZ(66T+&,8B*;/+.$&?EXW?>]"*U]"\-#0;C59HM0N)SJ5RUU()53"2$
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MX/\ L?B&373K6H37TMHMK*9/+VOM)(;:% &-QX&!Z@F@#SJ/_DVVP_Z^8?\
MTN%>TRJSQ,BR-&Q& Z@$K[C.1^=<</AW:CP-%X3&JWOV&*42++B/S.)/, SM
MQC=STKKRZV]OOGF4*BY>1\*/<GL* /'DUCQ>?A9%XU7Q'))=63RR26C6\8BN
M(UG96#X&<X'!!   &,\UTTVL:QXDU'7++2GNK8V"11P&"2)2LKQ"0.X<$D?,
M!CI\IZYXS/AWH*ZW\-[2POKZ9K$W$SW%B453Q.[!&.-P1N&(ZG/7!Q73:MX&
MCO?$3:[INLZCH][-&L5T;-DVW"K]W<K*1N X!["@#"NKKQ9+XA\,:1=ZS]@N
M+_3[G[:+2.-U66,*-Z$KU.[H<@>E7K?4M4TCQ^VEWVK3WUE;^'?MCAXD4M*L
M@5G^4#D@=,GJ:V&\(0?V[I&J17UU&VEQ20PQ?*RN'QO+D@LQ. <YZ\U.?#4;
M>,3XC-Y.9C9_8C;E5\OR]V_TSG/?- '&7'B#7/\ A5\7CN#47^UJ@O'LB%^S
MM$7P8L8R,+_%G.1Z<5MZ?J]QXK\3ZS8PWMS86FF0VX58=H=Y94\S<Q(/"C:
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M?/M[-K7R512C1DAFXQNR2 >#6/I TWQ?XNM?%=K97,<=C:/;QS7,#0M([MR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBN'\;7^JV7B;PK:V&JW%I!J5XUO<)&D394)N&"R'!R* .XHKAI]9U3
M1/B/HN@_VD^J6FJ0S/+'-'&);3RUR'RBK\C'CYAU'![5W- !1110 4444 %%
M%>?1SZWJ'Q-UO0T\17UM9V]C#<0K%% =CN2#DM&21QTH ]!HKSWP9\0XKKPP
M;KQ->VL$\>I2::EPHVI=,I #J!G&=W/;CM73VOB[0[VR^UVEZ;B/SG@"Q0R.
M[2)]Y0@7<<#G@=.: -NBJ6E:O8:W8B\TZY2X@+%-RY!5@<%2#RI'<$9KG_%7
MB*\MM>T7PQI+I'J6JL[-<.H86T"#+N%/!8]%SQGK0!UM%<Y?Z/K%M;12:7K=
MY),DT32QW(C<31AP7'W1M)7.,8'MZ4M(O;YOB?XAL)KZ::SALK66&%\;8BQ?
M., >@ZY/O0!V%%8\'BG1KC4;>QCO/W]R&-OOB=4G Z^6Y 5^.?E)XYI%\5Z(
M]Y%:K?#?-.UM$_EOY3RC.463&PMP1@'.01VH V:*YZX\<^&;6^DLI=7@%Q'/
M';N@#,5D?[H.!^O09&<9%6/^$KT3[9':_;AODN#:H_EOY33#.8Q)C86X(QG.
M01UH V:*Y^\\<>&[&6^BGU6/S;';]I1$9VCR"1PH)/ )..G?%:$FN:;'86M[
M]J5X+L*;8Q R&;(W#8J@EN.>!T!- &A165;>)-(O--DU""]1K>*4P2$JP9)0
M<>64(W!\D#;C/(XYJ33-=TW6)+F*RN"TUJP2>&2-HY(B1D;D<!AD=#CF@#1H
MJE?ZM9::\27,K>;+GRXHHVED<#J0B L0,C)QQD5DZKXNL+;P;?\ B#3YA=QP
M02M'Y:,W[Q%)VN ,KR,'.,=\4 ='17(^$([G4(K#7!K.H2)-9(MW:7$;"-YB
MJMYB;@-O4C"_*<^U7O&6H:A8^'IHM'4-K%WFWL5/_/0J3N_X"JLW_ : .@HK
M#\'^($\4^$M.U=?E>>(><@_@E'RNOX,#7'VFJ:NW@GX@3-J]VUUIM_?+:W!V
M;T6.)650-N ,^@'4T >F45F>&YY;GPMI$\\C232V4+N[')9B@))_&N(\2-XD
MT ^%83XIOY)]2U.*SNR(;?: RL6V#RN.1QG- 'I5%<X;U/"8FEU[Q$\]G/)&
MEL]VJ!U<\%/W:+D9VG..YJ6W\:>'[N/?:Z@)R;A[94AB=W:1 &8*@7<< @Y
MQ@CF@#>HK,@\0Z3<Z*=8BOHCIZYW3'*A2#M((/(.>,$9SQ7+VFORWOQ=6P@O
M[PV7]C/,]G/"T023S4 ;:RJQR">3GOB@#NZ*QT\4Z,^H6]B+W$URS+;LT3K'
M,PZA)"-C'V!-2#Q%I;7D=J+AR\DS6Z,(7\MI%SE ^W:2-K9&>Q]#0!J45Q_Q
M-O;W3/!%Q?V%]-:30SVXW18&Y6F1""2,@88],5IZ?XS\/:K?75E8ZG'/=6T9
MDDB1&W%!_$@Q\X]US0!NT5CVWBG1KS09M<M[WS-,A#%[@1/M 7[QZ9('.2.F
M#Z5K1R++$DB[MKJ&&Y2IP?4'D?C0 ZBN#\;>,+WP]K>E-;H#I5M/'_;$G_/.
M.;=''^1!8_1?6MWQM/=6O@;6[NRNY;6YM[&:>.6+;D,J%AU!]* -^BO/M1U/
M4HE^'TL>HW"K?3Q1W48(Q,# S$L<9)R/7%=EKAF30[Z2WN)+>:.!W22,*2I"
MDCA@1^E %^BO/O#,FK:S\/--UB\\5W]O>WL"_O!%;[!*YVK\OE?WB!BNK;Q!
MIUMJUMHMU=;=4GCWI#Y3_O !EBIQ@@4 :U%9UOKVFW.DG5([G_0LX$KHR G.
M. 0"<G@8ZG@4RQ\1Z5J$EY'#=[9;(!KF*>-H7B4C(9E< A2.<XQ0!J45C6_B
MK1[FZ^RQ73FX,/VA(VMY%:6/^_&"OSCW7-(/%FAG2[+4Q?J;&]D$5O.(V*NY
M;:!G'&3QSB@#:HKF[?QC97'C"_T 1SJUE#&[RM X4LQ;C.,!0%^\>#G@\5!I
M_B70M+\/W.J3>(9[W3_MLJM>3JSB)BW^KRJ\*"<#\LT =715.34[6&YM+>1I
M%EN\^2IA?YL#)SQ\N!ZXJF?%.C"_@LFO=LMQ(887:)Q'+(.J+(1L9N#P#G@T
M ;%%8/C/Q-#X0\*7VMRQ^:;=0(X@<>8[$*H^F2,^V:KP:+KL^D)-<^(+F'6'
MC#DQ)'Y$;D9V",J<H#QR=Q'<4 =-17FDGQ,FD^%.H>(!;^3J]KYEI)$L;/''
M<J0I/0X7D,,^N,TW7-8FT"2PN+/6=7EMM7O+:T>&XMI6,67_ 'DB,RY#,H("
MCURHZ8 /3:*XO14MK3Q?Y'_"6ZE=R30//;Z3<Y/E1';DL6&XD'IN((#8K<N?
M%.BV=T+>>]"$SBV\PQN8A*>B&3&P-[$YH V**R=3\3:1HYD%]=&-8MIF=8G=
M(0>AD900@/\ M$56U+QMX;TB>2"]U>".6.W^TL@RY$60-WR@YZCWQST!H WZ
M*QV\4:.KH/M3,K21Q"1(9&C#R;=BEPNT$[EX)_B'K6G=74%E:RW5U,D-O"A>
M221L*B@9))]* ):*R+3Q-I%[<2V\=V4FB@%RT<\3PMY1XW@.!E<\9'%4X/'O
MA>Y:R$.KQ.+Z3RK=@C;6?<5"EL84D@X!QGMF@#HZ*RM5UK3[(R6LUY+#/Y)D
M;[/"TKQ)TWD!6"C@\L,<'TK'^&6HW>K?#O2+^_N7N;J99#),YR6_>,/Y 4 =
M;17G]C/K.H_$OQ%HS>(;^&QLK>WE@CBC@R#(#NR6C)(XXJ>S\1:KH7CV'POK
MMTE[;:A \^G7_EK')E!EXY N%) &=P ^G/ !W-%<I8>)-!TS1=4U6;Q(]U81
MWTHDGN#D0OQ^Y3"C*KG@#/7K6C;^+-"NUO#;Z@DOV.589@JL2';[JJ,?,3VV
MYSVH VJ*RK3Q+H][;7MQ%?(J6)*W0F5HF@.,_.K@%>.>1S4!\7:-B\7SYO.M
M(/M,MN;:59?+_O*A4,PSQD B@#<HKG=#\86&K>%K;7)B]K%,J';)&P^9_NJN
M1\Y.0!MSD]*NV_B72+A+QEO%C-D ;E)T:)X01D%E<!@#V..>U &K17.VOCSP
MQ?.4MM7BD86XN<!&YC+!01QR2S*-HYR1QS6K8:M9ZE+/%;/)YMN5$L<D+QLF
MX9&0P!Y% %VBLS4=?TW2IQ!=SL)O*:<Q10O*XC'!<J@)"Y[GBH)_%WA^UBL)
M9M6MECU!=UJV[(E7&[(]!@'DT ;5%96E>)-(UN"ZFL+U)$M'*7&]6C,1 S\P
M8 @8YSTKE-9\4"Y\:>#X-,U.Z6VO+B42P^2T<=Q&(F(8,RC>,XZ$CD>HH ]
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MUZS10!C>$9$D\&Z*48,!8PJ<'H0@!!]P>*Y;XF7$*:MX,5I%#1:Y#-(,_<C
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M1NG]O6DQ9&R!&N[<QQT4=ST%>@44 <)>W,#?&71F65"O]D3IN!R-S.A49]2
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MIRA9+F)8]NQ" <D'^'J<G%7OA"X/PQT>/9(C1K(K!XRO_+1B,9'(P1TKN**
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ML3N4"%W &=PYP<-\O08Y /0Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK.JALG[HR0.3CZ55TK4X-8TNWU"V6989UW()HS&X&<<J>1TH N4444 %%%%
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M!(R""1@XSU.,UQM_XLUK3;W3VFNH'FGUQ-/GLH8O,ABA=RBYE XEQM;!;O\
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M)YI9B"2&3!(C4;<D8^]]X5(/ UW_ &-XHTXZQ"1K\TLSO]C/[GS$", /,YX
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M-P(R6/)(/"^^1C1ZQJEVOC'PW>WC?:M)A62*^BC56FADC9E#+C:&&""0!GJ
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M'\I3Y<$,#@YW"@"&X\*/>>*QK=U>12(VG-ITMK]G(5XV8,QSOR"2/R_.L/\
MX5M??\(]#X?'B>8Z7:W$<UHK6BF6)4<.J,^?F QQP/Q'%=)X9\6Z7XM@O)M+
M,Q2TN6MI/-C*?.N.GMS]:W: &HI5%4L6(&"QQD^_%<M!X.FEN=%FU;4DO7T<
ML;>5;;RYG)0I\[[CD8.< #) )Z<]710!Y_;_  TN;?2-)TU?$MQ]GTB^6[L_
M]%CRH!;Y6/\ $?G/S<#V-;*>#E?7-?OKR[6YMM:MH[:XMC#MPB*RC#;NI#G/
M'TQ73T4 <AX<\&ZEH9@MKKQ1=ZCI5IC[):2P(A0#[H>0<N%[#@9 ]!6_KFC6
M?B'1+S2-00O:W49CD"G!'H0?4'!'N*NS2I!!)-(2$C4LQ SP!D\5B^'?%VD^
M)O#AUZRDDCL 7W/<+LV[/O$]L=\T 5K;PK<R-I(UG5%U&/2G$ML!;^6SR!2B
MO(=QW, 3T"C)SBI=+\.7&G>*]7UQM024:F(A)!]GV[!$I5=K;CZ\Y!_"EUWQ
MEI/AV?2XK]I@-4E$5J\<>Y68D8!]/O"N@H R?$VA1>)O#=_HL\SPQW<6PR(,
ME3G(.._(%9DOA2^N-:T#5+G61-/I(E^]:@"8R+M;.&&T #C]<UU-% '%S?#V
M&^M?$5KJ%^TL6M3K<L88O+>WD4*%9&W'IM4_YQ6EX>T#5=-<2:SXCGUF2)-D
M&^W2%4!ZDA?O-P!N)]?4YZ!W2.-G=@J*"69C@ #N:;!/%=6\5Q X>*5 Z..C
M*1D'\J *.OZ%8>)=%N-)U.(R6LXP=IPRD'(93V(."*S[#1_$-K;K9W'B1+FV
M4;1,;$+<E?>3?M)]]E=%7-V?CC1[W5=8TU#<)=:/&9+M'B/RJ.>,9W<>E !?
M>$P=?LM<TF\%CJ%M;&S8R1&:.>#.0CKN4D@\@AL^N:I:GX"34?#FI:8-0\NX
MU2Z6[O;OR-Q=U92 J[OE4;% &3P.Y.:VO#/B2P\6Z%!K&F>;]EF+!?-3:P*D
M@\?45KT <]<>'+JX\6Z?K[ZA$'L[9[?R1;'#AR"QSOX.5&/3WKA_'FA'PW\.
M/$_G:I'(=5U.&]'[H1E)&GBW!<L<@!0?P->D:[K5IX=T.[U>^\S[+:IOD\M=
MS8Z<#\:;::WINH:'9:N) EG>+&T+3+M)\P@(,'N2P'XT 4!X>.I:E;:IJ=_'
M>-;V\D5K]FB\I4\P ._WFRQ P#D  GCFL.U^'%W;V&A6A\2W#)HEP)+0K:1C
M";67:>N6PV-W3C[M=\  , 8%1W$\5K;RW%Q(L4,2%Y'<X"J!DDGTQ0!RB^"K
MA;/Q/;G54(U]G:4_9?\ 4[T$9V_/S\H[]_RK-\0G2HO"R?#VYNC>:O/IZ0VL
M20.I;'R)+D9"[2H8G/&TG%='K?B_2M OM&M+UIC)J\X@M3'&6!8XY8]A\P_/
MV-;V!G..?6@"KIMA%I>F6MA!DQ6\2QJ6.2<#&2>Y/4FJ^I6%]<W5I<V.H+:M
M!O#I)#YJ2JP'##<IXQD$'^H.E10!C^&_#UOX;L)[:!E8W%S)=2E$V)O<Y(5>
M=JC@ 9/3K6Q110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7.^,[_ %/3-%BNM-M;JY5+A/M:6:AI
MQ!SN,8/5NG'7&<8/-=%6?JVFRZBMJ8+Z6SFMIQ.CQJ&#?*RE6!ZJ0Q]#Z$4
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M0W$EK'"%.6&#EBP.>F??)I\?P^M+?Q#K^N_VI?>?K-LT%PL84;%*@ QX&0P
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M2/AKJ9GN;=M3MA/L1\>2613A...OO7I/Q.FO+?X:>()+ L)Q:,,KU"$@.?\
MOG=0 ZS\>6&KWMS;Z%I^H:PEJ_ES7-HD8A5NZAY'4,?]W-:NB^(+/7C>"T2X
M1[.;R)TGA,;(^T-C!]F'/0]LUR/P06W'PFT@P!=Q:8RXZ[_-;K^&/PQ2?%OQ
M%=^#_"OVK1@L&H:I>QVS7(4$IE3\W/&=J #_ .M0!Z)17F5KKE_I7Q>F\'->
M75SIEWI@GC,TI>2&0 Y(<\X(4\9X)&,5YS#XL\62?!^;Q4_B;4/M]KJP@C4;
M A3"Y##;\W7H>/:@#Z3HKR6VUG6]/^-&AZ3+K%U=V6K:2;FXAFV[$DQ(?W8
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M1*BLP8R* =V_:>H.,8%8WBCQ GA7XXW6KWD$UT;?0<LELARS8_\ '5SW/04
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M?TW4+;5M+M=1LW+VUU$LT3$8)5AD<=N#5JJ216VB:*L5M#LM;*WVQQ+V1%X
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M1K/5+59%@NX5FC$J[6 89&1ZUY[XIM/$WACPSXOU!-?EDL%BCFTP&1GGMV&
MX9F'*G/0D_A7/:OXR\0:5X<\%ZY?C4+G0IK!6U&:RD\N43,!AV([#J <*3D'
MM0![A17D=[XTNIM5\#:%8:A=7]GJ=NUQ<7=N5BGNPJMM4$E=A+*=V"#V'O4U
M[6/B!H'A.VNM2L;R2TL]4D^U&&X47$UE@&,L\9.WJ0Q'/RC/4F@#V>BN9\ Z
MQ:Z]X5AO[/4I[^&260K)<@"5!N)$;XXRH(&>X />NFH **** "BBB@ HHHH
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M-"6YU[69QH<F^PW/$/+ *E1]S!QM'7GMT&*T7^'>GOXFUG7SJ.H"\U:T>SN
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MLOA]HM1U*"YT)-EI=1-&)"N<A7.S# <C&.Y]:FD^&UBOBRX\0Z?JVJ:;<7@
MO(K2552X]SE3@GU&.^,&NUHH Y:3P)I[^-[3Q4MY>)>6EN+:*%2GE"( C;@K
MG^(\YS74USGC+QG8>!]+BU+4[:\EMI)1#NME1BK$$C(9AUP>F:Z)3N4$=",T
M <3J7PMT75->UC5IKW5(WU:W^SW4,-QLC8;0H.,9XP#@DCVQQ5FP\!PZ5I6G
M6%AK.HQI8P2VZF3RI!*DA4E74I@@;>, =3UR:ZZB@#D;+X?V6DZ58Z=I.H7E
MG#:6\MN5Q'(LZR,&8R*RD$Y!(QC&3VXJE+\*=$>S\.VL-W?V\6@2>;:")D^:
M0L'+ON0Y)89[#VKNZ* .2OO -GJ<T0O]0O+FSBU ZBEK((RJR[BV VW<$RQX
MS4R^!]/B\<7'BN"[O8+RYB6*YAC=?*F"[<9!7(^ZO0C..>IST]% '$Z)\,].
M\/:I=3Z9J>IP:=<R^=)I:RKY!?\ [YW8Z<9Y P<CBH[OX7:9->Z[-:ZGJ-C;
MZXA%]:V[H(Y&.?F&5)'+$D X.>>.*[JB@#(\,^'K;PKH%MHUG/<36UL"(VN"
MI8 G.,@#N36O110 UU+(RJY0D$!AC(]^:\\7X-Z&GA*X\-#4]5^P7%X+Q\O%
MO\S '7R^G _*O1:* .,USX<6&LWVE:FFI:A8ZMID0ABOK9D61T'9@5P>I[#J
M>W%3Z_X TWQ%I%C8W=W?B6RN!=17BR*9C*.K$E2#GTQ@8&, 8J]HOBNTUS7=
M:TF"TO(IM)E6.62:+:DA.>4.>>G?'&#6]0!%;P_9[>.(RR2E1@R2G+,?4_\
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MWUV^_M'4+?51YMQ$AS( V1QU)VX'J37=> -?M/%UWJVL17=_'-'<FW;3)Y6
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M. =WH$/@&S7PQ=:%<:MJ]W#<PBW>:YN \BQ?W%RNU1[XS[\#%*7X5:)+9Z%
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MH<.^ZM(-$97LHK5E"HPQ@G<I)^Z*(/A]I=OK.N:JMW?FXUJ%H+L,Z;=I&/E
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M 4D_*2,?,*XFRU/4O%/QEU/0]0O;RSM-*TU)([>SN6B!F81DN2I&_!<@ Y'
MXZTG[/'_ "3V]YS_ ,327_T7'0!ZU17DEUK&H>(/B=XLTB>]O+:QT?2BUM%;
MW#P_O2JMYI*D;CR<9XQCBN3UKQMX@U'X)>'];&IW=KJ?]J?8Y;FWE:,S( _)
M (!^ZOX@^M 'T/6/K_B.UT 64<L<D]W?3BWM+:+&Z5S[D@  <DD_T%<#X=O-
M1T[X\:SH!U6_N]/;35N/+NYS)MD_=_,N>%^\W P.>G K=^)'A"#QI:6-A%J3
M:?K-NSW5A,,]5VA@<<C[R\CD8SV- &_9Z^\VN+H]WIEU9W36[W*LQ5XG5613
MM=3R<N." ?S&=JO'?"'BSQ=H?BT>%/&]FEW=?9)9;*_C +2*J[B-PZ@A.N <
M@9SFE\!'7?'>AZ;XGB\1W%MJ$6JR->P^8S0O#D?N1'G:!MQ@XSR3G- '>:)X
MULM;\4ZOX>BM+J&\TK'G-*%V-GIM(8G\P*Z6OGRYMY9?'7Q5N(;^\M)+2Q,Z
M-:S&(EU3*Y8<X!'3.#WK1N/'.M#X;> 1)=SF;6+Q;>\N4DV2O$DFTJ'R-K,,
M?-D'@\T >Y5S.K^-K+1?%VD^';FSNS<:IG[/,@0Q\=<_-D?E7G_B[6/&'@OP
M=XGN"TL%M/=1+I3RW FFMD?/F G)Z8^7DXW>U4=8TU=.^)WPU"WEY<F6(N[7
M5P\Q+[1E@6)(SZ X] .: /=*YOQKXRL_ VC)JNH6EU<6S2B$_9@I9202,AF'
M'!KSI]7U4>/?B58?VK?_ &6RTEY[6/[4^('\M6W)S\O)/3Z=*YSQ/J%[JO[,
MFC7NH74UU=27QWS3.7=L23 9)Y/  _"@#Z*1Q)&KCHP!&:5B0I(&2!P/6O)]
M6UW4M4^*1\+1F\^QP:.98H;2Y\AI)F ^<MN4D*#P,]1G%=YX.378O"MC#XE9
M&U:-2D[HX8/@D*<CN5QGWS0!EZ'\0[37_%>I>';;2[^.\T[=]H:4QA!AMO!#
MDG)]J70_B%9Z]XOU#PU;Z9?17FG[OM#R^7Y:@,%X(<D]1VKAOAQ_R7;QW]7_
M /1@H^'G_)?/'/\ NM_Z,6@#V#4+^TTK3Y[^^G2"U@0O+*YX4"BPNVOK**Z-
MO+;B4;ECF #A>Q('0D<XZCOSQ7G/QGN9?LGAC3,D6U]K4"7 [,H.=I]LG/\
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M&XDFCBDDWF)&/"DC@G R<<9)QGK73UR\WC6V@^(5OX.DLYQ=7%L;F.<,ICV
M-U[@_*10!!+\-]$?Q/<:_;SZC97-W_Q]Q6ET8HKCUW@<\]\$?K5J;P1IDOB^
M#Q.)KJ/48(/L\6QE$:1X(VA=N,?,?SJ?PUXE?Q#)JB-I-]8?8;IK<&Z3:)L?
MQ+[?XBMZ@#AH_A1X?B\.W^@K/J']GW]PMS<(9ERS@@YSMR.0I_ 5ROQ#\.W
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M **** "BBB@ HHHH **** "BBB@ HHHH *\S^/$2O\+;V0M(&CFA("R,H.7
MY .&Z]\^M>F5FZ]H.G>)=%N-)U2#SK.<#>H8J<@@@@CH00#0!Y)XR-QX>T7X
M??V7J.I6XNKR!9P+^9O,5E3*G+'Y?;H.:OWHNM2^/MUH<NJZI'I<FE^<]K!>
MR1H6P.F#\O\ P''ZG/8WOPZT+4++2[2Y-[)'ICB2V+73%@XP Q)Y) 4 =@!T
MJV?!>EGQ4_B4/=#57A\@S"7C9C&-N,>_3K0!X'!JFL3? V;7I-=U4ZAI^JBW
MMI!=N-B?*<$ _,<L>6SC  P*]%U[Q'J%]\2O"WAZ0.]E<Z8;R2!)S +F5E?
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MQ6?\3?#]]X<^$6M6MUK$VHP2:DDMJ)@2UO$7&(]Q))Q4/BJQ^)OC+3DLM8\
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M+N0K$\2L7'UH ]@HKB_&DFJV^H6-]::=)K&F0PR"\T^VG,<XW%=LR $;R K
M#WX]MGPC>V6H^$].NM/NI[JU>+"2W!)E."00Y/)8$$'W% &W17FL.BGQ#X\\
M9Z7>:MJR6<"V;0QPWLB>6SQL200<@ Y.W[N3R#@8H^&]4O=6T#PO;ZKJ%U>7
MHFO(OLD9V_V@L3,@DD?(PJ<$YSN..": /6*@N;RWLQ$;B58_.E6&//\ $[=
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ML.E)/<3L6AMB5.TR'+ <E=V<@-UX% 'KU4M4N+^VM%?3K%+V<RHIB:81 (6
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M,K@A#G*CC/'<FLC2K/5M>^!5K<VNH7S:Q )KB&47,@>9DF<E&(.6W ;>?44
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M[@W&&^4;@#@8Y%:>K>'-.URSM;:_6=Q:3+/!*D[QR)(H(#!U(.<$CKWK6HH
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M-]V[*+NPF6Y.W&?I5^?PEI%S+=M+%.4O"IN8?M,GES;5"C<F[!X50>.0.<T
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MI_PNK6YO*/F#3+:;.]OOEY!GKSP /PKC([06GPGD\007%U'J-EK+M;ND[JJ
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M?:\CL2S88J"3US@#FN'@T%=6\)>,KV;5=42[TO5+\V,WVZ7_ $?RN5_B^;H
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MXDB6Y,:H V WRDY.2O)]<5HV5NFB_%>*QCN[K[##X9W;;BY>15*S*N[YB<'
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M1M DEQT;D@KG)Y]<\8]+LO#VGV,C2QBXDG,/D">>YDDD6/\ NJS,2HZ'C&2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M],5T-EX8@77=+U>WU>Q6RNH'@DM;6U8)J*LA92Q,C988+;L$GG)H [JBO+=
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M7GKVR<G'%=/)<2>(?&O]B7\UF8_[&@N8+>\MS*LS.7$C@!U&X809Y(YQC)R
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M3;,WRMG(&3G .* /3:*XOX<:'96WA?1M97SWO[O2K=)I9)W8,-@(&TG QG'
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MV:7_ (N\"Q7$URT5UHTYGC%PX63;'%C(!X^\<XQGOF@#U&N=N?$-U;^/-/\
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M$,&S@@X.#B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4.R%E_NMM(W#V.:O7'A[2[G4[+49;8_:K%2MJZRNHB!&" H(&"  >.<5IT4
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !102 ,G@44 %%%(2
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MVHVLEK=VT1CEB<@X.XG@@D$<UU5 !1110 4444 %%%% !1110 4444 %%%%
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M&P>@4$\=3GVH Z^BN,U3XCZ;I=LVH/%YFE1W/V:6Y29-RG?L+B/.2@;C/7N
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MQ@D[L8')]* .IWKOV;ANQG;GG'K61?\ ARWU#Q!IVLRW-TESIXD%NJ,H0!P
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MF:!;Z#/96FQ6\3V<XCC7)0G"L$'8'8#@=Z /3J*YFQ\9P27VL6>J6,^E2Z7
MMU+Y[HX: ACO!0D<;3D?SJO'X^M?[9TW3[BT:/\ M-6-FZ3QR$LJ[MC@'Y&(
MZ<D=LB@#KJ*XO3_B$-1@EO$\/:FFGV[7*W-R=A\EH0205#$L3MP-N1D@9ZXO
M6/B\W&K6>G7.ESV\]]8M?6H\Q6+JN,HW3:_S#CD>] %[6O#EMKEUI]Q<7-U$
MVGSBY@$+* ) " QRISP2,=.:V*\^;XJ1+HBZX?#FJ_V0D[0W5T?+_P!'Q(4R
M5#9;D9)7(&>I.16_J7BRWM;F2ULHX[RXBMUN'4W"1#8V=H!;JS;3@=/4C(R
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M\":/;7,DEI+J=I#+(9'M;;4)HX2Q.2=BL ,GKC KHX88K:".""-8XHU"HBC
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M5W4#^)RO&3GH,X ZY) UZ* ./\6^'=1U#7M&U/2)!%,OF6-\^<'[)(N6(/\
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M21+>10R&:5N7(/!(48'ID^M<3J%UO\.75E/&9_[!\7PVUFVW<Z0^:K*BD\\
ME?H *]&N]'N].\=?\)+8VKW<5U8_8[NWB9%<,K;HY!O(!'+*1GT/K7/77@C5
M4\*3M%%%-JUUKJ:U<0"4 <2AO*5CQD*H&3@9S0!T6E^,9;GQ0_A_5=%N-*O7
M@-Q:^9*DBW$8.#AE. PSRO/UKBK:VM(/'=M/XY\)F#4[Z]S8:LMV9H6D!S%$
M5! 0@!0,CG'UKLFTR_U;Q99^(9[![1=,LYHK6VGD3S)99=N2Q0L%4!0!R3DD
MXXY1X=5\5VUA!JVA/I*V]W%=S>;<1S9:)@ZK&4)R"P&2P7C/'/ !UM<+KT"1
M_%WPA,I??-;7X?+DCY4CQ@$X'WCT]:VW\%:!)KHUIK.0Z@)1-YGVJ4#>.AV[
MMO;IC%4-;T[4KGXA>&]3M]/DDLM/BNDGE$D8YE5 N 6!.-ISQ],T ='J>G0:
MMIMQI]T"UO<)Y<J@XW*>H_$<5YQ>^&=!C^,NDV*:)IRV;Z/,[0"U38S"0 ,5
MQ@G'>O4JXJ]TO59/BQIVMQZ;(VFV^GR6CS>;&#N9]P(4MG''U]J 'W.J6W@>
M[TCPYIFB7$\>HR7#6RPNBHC -*4&3P,GV !Z\8I\OC'4(K6X=_#LT,]G8"]O
M(KB<*$!W?NT< J[80GL.G/H[Q)IVI77C3PKJ%I823VNG2W#W$BR(NT21%!@,
MP)P3D^U9WB'2/$&H^(=8B?3(]1TVYL!%ISR7"I':2[6#ED/)8DC# '& ,C)H
M W!XMM[J+15TZ!KBZUBV%W;PN_EA(=H8O(<':!N4< DD_4CB]!NH=.A^)-S>
MZ&&MXKDM<Z?$4*L@MP7P3@%2,GU(/3/%2:=X?\3Z))X2UN+21<7&GZ4-)OM/
M2Y3S/+ 7$B,2$SN7)&>F.?2S'HGB&2T\?>9H_EMK:G[&GVF,L28!'AN<#!Z\
M^N,]2 :Y\80Z;%X5LK30[AH]8MLVT<#H%B"P[Q'R1T  [ #G/&*EM?'ELNDZ
M_>:M8RZ?+H3E;N#>)3C:&4J1@'<",=.:RQHNLB[\ 2?V7+MT:)EO?WT7R$P>
M5Q\WS<\\=O?BJM_IM]:1?$"ZOM*B-OJPC%FES,NR=O*6((=C%@6?&/J.0: .
MB/B^X@U_2M'N]%E6;5(C-;O#.CJJKC?OW;<%0P.%W9[9K%^-4$$GPWNII8D9
MXKBWV.R@E<S(#@]L@D5#HSZCIVKZ7<:[X7U5?(1;"WOI[^WN!;B0JOW4VD[B
M$!8@G\,UK_$[2-3U_P &S:5I-DUS<S31./WB(JA)%<Y+$=AVS0!@BVMX_BKH
M?_"&PK%I_D3#61:)MM=F/W8./EW[L].>G:I_"-_!X;TCQM=Q6,LL=OXAN EM
M:QY9BPB4  =!DCZ"O1H9&DA5WB>)B,F-R"5]C@D?K7FR:+XLM?#WBR/3[.2V
MOK[67O;<?:8U:6!B@9 ZL=CE589[9ZYZ '30^+9!JFK:7=:8PO\ 3K5+OR[>
M<2++&V?NLP7!!4Y! ]LUFV7Q$:ZM_#]]+H5S!INM2I;Q7+3(2DK@E1L')4X(
MW<?3&":%EH>LVOBS4=2@\.1VMC=Z.MNL4=S'O60,YPPZ%CN&3DCON)XJ!/#F
MO1^!_!.F?V5(;K2-0M9[I1-%@)%G<0=_.<\#^5 '2?$J"&?X;^(/-B1_+L97
M3<H.U@I((]"*X 6]LJ^ 6\'0K'K&ZW.H-9)M0VWECS?/V\=<8W<YSCFO2?&]
ME>ZIX*U;3M/M6N+J\M7@C0.J@%E(R2Q P*M^&8;FU\,:9:WELUO<6]K%#(C,
MK?,J '!4D$9% &;<^+9/)U6YTS3&O[729&BNG68([.@#.L2X.\J#SDKSD#-8
M.OWFGZUXD^'FM6.R6.YNY&BFVX8H8'.#W'/;UJSI&DZWX8D\1:?!IK:A::A=
MS7ME<)-&H1I1\T<H9@0 W.5#9!]>*JKX/U#18? EA96SWD.B2L]W,KHH^:-E
M) 9@3\S$X]* -FSU[28?%/BHRZ:+"?3;>"6]OGVYGCVN5/RY.%53UYYZ58A\
M3WLE[ID;Z%<);ZI&[VTROO\ +(7<!. N(]PZ8+<\5B7/A;4=6U_QM'<6SV]C
MK=A#:V]R71L,B.I)4-G&7!''8]*O^%+CQ@;:RTW6='@LA9HL<]\MTL@N0HP/
M+0<C=P3NQ@9QST )M.\:_;O#NL:I)IS6\VES2P36CS N73^'@8R<C;USD5T\
M#RO;QO-$(I64%HPV[:?3/>N(O/#TC_%%);6=5L+RW2[U.VQ]Z6!@(&]LD_CY
M-;\FLZA%XQATA]*_XE\]NTD=\)U)\Q?O*8^H !'S=,D#O0!-JFL3V6I6.G6E
M@]S<W@D=69BD,:H 27<*V"<@ 8YKGI/B/;KX6LM<72KJ1;B^%A)$CJ3%)YGE
MGG/S#(XP.>.E6?$]GK=QXCTE[>P&I:(J2+=6GGK&/-.-CN&X=1S\O/7."0*Y
M./PMXFA\&QZ2=%0S0>(!?*(KJ,JT0G,I(R1CC  Z^H% '7MXREMS%;:AIB:;
MJ,SR^3;WE[&J&)-O[PR+D $L   3GM@$U<\)^*K7Q787,\$9AFM+E[6XBWAP
MLB]=K#AE((((ZUE>*+#Q!;>(]*\4:!8I?2P6\EI=Z?),L321.58%6/RAE9?Q
MKH]&FU.YM&N-5M8[.:1LI:I()#$N!PS#@L3D\<#('.,D QK[QE)#:7VH6&D3
MZC86%S]FG>!LRNP8*YBC .\*3@Y*_=.,XJY/XBEEU2]TW2+$7MS81I)<B2;R
M54N"50'!RY S@X !&3S7-:)8^+O"U]J>C6FDP7NFW5Y+=6>H-=*BVXE;<5D3
M[S;22?EZ^W:]9Z5JWAOQMK6HP64NIZ=K"0R,89(UD@FC78<AV4%6&#D'@\8Q
MS0 K_$>R;2-%U*STZ\N8M4O18[!M5X)OF!1@3G<"I]O<"IH?'21#Q"NK:9/8
M3Z) MU+&)%E\R)E9E*D<9^4@CL>]<^W@W5K#2= A@L_M-Q'XA_MF^\J5 L88
MN2J[B,D!E'O@GBM233-;B\7^*-3AT<3P7FGPP6RS2Q[)GCWY5ANX#;L<CUS0
M!O6VLW=RLGFZ6DD)M1<0R6MRLR3@\;02%&>_IR.36/H/BG2H?!.@W.EZ7]F3
M4G\G3].C('S$L3ST  5F)[<]3C-7PWX8N- UZ^N]*T^\T_19K,[M*DG1@;DM
MG=& Y5!MR#R <CTK%LO"/B33O"'@V>"P5M8\.3N9+%YT N(W#*VUP2H.#QG'
M?\0"[IEZFF_%/Q3?ZE:0Z>D&CPS7#1OO1P&<F0' )X&.0#D?2MB'XA6IUO3=
M.FMX@-35OLK6]VDS!PN[9*HQL8CIR1GC-9-WX;UKQ)X@\02W>F-IUCJVB+8I
M)+.CO'("YY5"1U8=#C'?L-CPU?>-)(K>QUO0X+0VJ@3WL=VD@NMHP/+3JI8X
MSNQ@9_  BTSX@OJ%M)?R:#=6VDVSW*7E[+-'BW,.<Y4'+9VX^7(R>IYQ+;?$
M"T?Q!IFEW$,$8U-6-M)#=I,591NV2J/N-CI@L,\9K/T7PIJ-U\/_ !!X>U*W
M:QFOY[MHG9T<8E9F4_*3TR,BK^@7'C&_MHM,U[18;!8HS'<W\=VL@N !C,:#
ME<\$[N@SWZ '-?$C6O\ A(?AE>W]KI:3:6;B)8+QY!O^6=5\Q4QPA((!W9(.
M<8->BZ_JXT'0+[5FMI;E+.%IGCB*ABJ@DGYB!T%>9R^'?%T?PNN?!']B+<3V
MS)';7R74:Q3Q+,K@X)W*V!R",<=>Q[KQNSM\-_$32H$<Z5<ED#9P?*;C/>@#
M-A^(3KJ.C1ZAH-W9:?K)2.SOGD1E:5ERJ,HY7/8GKZ#G$UIXVN[_ %F\L+7P
MY>,MC?+:W<SSQJ(5*AO,Z\@ YP"3CTX%9MOIE]XGT'P;;RZ?):6VGR6M_-/)
M(C!S%'\JH%8D[F(.2!@ ]^*T/#>CZA%K'BTZA8RV]KJEUYL$GF1ME/+5",*Q
M(/&: ('^)FFQR:9,4A;3M2N%MX9H[I6E0M]QGBQE4/KDD9&0.E=P[K&C.[!5
M49))P *X'PE'XTT:QM/#-YI-L;:RVP1ZPMTNQX%Z8B^]OVC'/&>?KL_\(#X>
M2]N+Z&TECO)Q*&E^U2M@R*58[2Q7HQ[<4 ,A\82W":5>PZ-<RZ3J<XA@N8B6
M=0V=LCQA?EC.,[MW (R!6-X?N+'0_&7Q&NY1';6=M):SRE5P%'V8,QP._4^Y
M-2^#H?&.D:=9>&K[2K=8+#;"NK+<J4E@4\;8OO!RH"\X Z^QBD\*:CJU_P"/
MK>ZMGM+778XDM;@NC %(1'DA6)'S#/T]* -&V^(%I)X@TS2KB&%/[35C:R07
M:3%64;MDJK]QB.F"PSQFG6_CDO/HS7&E2VUGK%P]O:O))B564,09(RHVA@IQ
M@GJ,XS3?#U[XUN88;'6-&MK"2W3;-?"Z65;@@8!1!R,G!.[&!G')XY>'P[XL
MF@\-W-YH4<FK:?J@GOKN6]0O<C:XW*><(-P^7@CH%H ZJT\:WFH:Y>:;9^&[
MR3[#?):W4K3QJ(E90?,Z_, #G R<>G JK<_$[3+<6=WM@DTNZN1;+-'=J9DR
M2JR-%UV$CKG."#BK7A;3-2M/$7BF>^L)(+;4;I)H)#(C;E$:H00K$@_+GZ5F
M>$[;QGX>LH?"TNDV\MG:$Q6^L_:EV^1GC,7WBX'&.F<<XY(!<\4:V-6\/>)[
M2RTM-0M+&&6"ZDDD"@R"/<RHI!W%<@G)7G@$D5J^ _\ DGOAO_L%VW_HI:Y>
MWT;Q'H:>+-&@TDZA9:M-<W=G=I<1IY;3+\T<@8@\'H0#G/;MO>&EU[1]"\+:
M1-HZ%8[46]],+I?]&\N,!3C'S[B,<=* ,KXU012?"G697B1I(A$T;E<E"94!
M(/;BKEC:^%-0UVR@L=#^R7MLAO([C^S7M&7:57 +(NX'><@9_E4GQ.TC4O$/
M@+4=&TJT-Q=W815_>(BKMD5B26([ ],UU%L#/;Q2S6S0R[-I1RI9,XR,J2.P
MZ'L* .8N?'20Z)-XAATY[C089622Z24>845]C2K'CE 0>=P. 3BC4?'$T&O'
M1],T*YU*X;3O[0@:.:-$F3<%X)/'4\G';CG-8>G>&M>TWX?ZCX%^P><C+/:V
MFI>:GE>3*6.YQNWAE#'@*<X&#W&I8:!?:9\0K"Y@L97TFUT)=,6X,D>=RR!@
M=N[.,#KCKV[T ;'B?Q./"_AIM:N-.N)E0QB2*-ES&78*,\\\L!QFJ%OXUG/B
MF+0=0T*XTZ>\B>73I)YD9+G8,LIVYV,!SCGBJWQ=+#X8ZH4 +>9;8!.,G[1'
M5NXTN]U[Q?H6JW%A+8VVD+/(!,Z,\LLB! !L8_*!N))(R<8'6@"#_A8,?_"$
M1^*/[,D\@W/V:2$RC>A\[R<CC!^;GMQ4NI^-+RU\1WFA6'AR\O[VWM4NU"S1
MH)$9RN02<#H>O)].]<C/X9\5+\/[[PI#HJN\6H^?#=&ZC"3QFZ$H*C.00"<[
ML=.,GBNLM-/U4?$^YUB;3GCL9M*CM/-\V,@2+(SGC=G&&QG'4=* *D_Q#O/+
MUEK+PIJ%T=(G,5VOG1*54*&+#D[C@_=7/3G&0#K6_C*TU,:5'HT?VNYU.U-Y
M%&[^6L<(P"TAP2OS,%P >?H37->'+J_BUGQ[!9Z7+=O)J;"-UDC5 YA08?<P
M('0Y /&>/5=,\%:CX.U/PYJ.FQG4DL]+.EWT,;JCE2_F>9'O(!^?.02#C'6@
M#;'C^Q33=1EN[=K6]TZ[CLKFVED "22,%1M_3RSN!W8Z \9&*OS^)3IFGZA>
M:Q9BUCM#&%:.82+/OP%V,0O5B%YQS[<UA'PY>";Q'J]QHT=Z^MW%NLNF2O&3
M]FC4)R2=F_[S8SCH,]ZRE\ ZHOAW7M,TN6>QLVFM[G1K2]F$OV:6)@[#(+81
MF"@#)Q@F@#>C^(MA'J]UIU]'"CPV+WZ26=RMRDD:9+KD $. ,XQ@^M;&CZY<
MZI);,UC&MI=6IN8;F"X\U",J-I^48;YL]QP>36;8ZCXPU+3;IK[P[;Z=/%;2
M;87NTF%U-M(4#'"IGKDYZ=LUG^&/"LNC^+#?Z7I]SHNDSVS_ &S3I)T>)IRR
M[6C568+@;LG@=,#K@ Z74-=%MK%OHUG MSJ4\+W C:3RTCB4@%W;!(!) & <
MGZ$UB7/C":^\+>(I+*T:WU?24ECN;>60 PL$+!U8 [E(P0>,^U/UC1]2L_B!
M8^*M.MFO8C8MIUY;(ZK($W[U=-Q"G#<$$CCIFJC>'-0^Q>-=3%FW]H>((_*B
MM!(F8U2'RDW-G;DDDG!.,CK0!8\":1:S^'_#VLW6F0Q:C#IL4<5RLA9Y$=%+
M%L 9)/.#G!)YYJQ<>,W6S?4['2+B_P!+BN_LKS0,6E8A]C.D8!W(&R"<@\$@
M$<G2\)6UU8^$M)L;VV:WN;2SBMY$9E;YD0*2"I(QD5RGANP\7^%TN?#<&EP7
M&G_:99++53<J%BCD<OAXS\S,I8\#@],@<T 6;2."T^,^LRI$%W:'!+)Y:<N?
M-?G ZG 'Y5>LO&S7&H:';W6E26L>MQR/9EI<R+L7?B1"!L)7T+<\57FTO6_^
M%A:MJMK:&*&?1UL[:Z=T*B96=@2N<[?F';MTK L/#_B;[?X0U*?P^BWNG22C
M49Y;U'EG9XBAD+#.5R<@9R,X"@"@#I-,\;7NKW]S;V?AF]>.TU"2QN93/$/*
M*J#NQN^;)., \<<\XK!N?%K6/PREU;PWHL6GJ^H-;/$SA3$S7'EL^%!!8L?H
M,YR<8/0>"]/U/2YO$C7^G20B\U6:]M_WD;;T95 '#'#?+WXYZUS8\)Z_)\*[
M_1O[.V:E_:1O(H7GCQ(OVH38# D [>.<<T ==)XGN;7Q1IFAWVEB!M1BD>*X
M%P&3<@RR?=!+8Y^G?BM/3=3DU"\U&+[,$ALY_(682;A*VT$X&.,;L'W!':N=
M\<V=UJ7@Q;\1K9:S8S1WEBI<.5G#82,D<'?G80.,MWZU<O9-1\(^"A)86":I
M>6R^9<*TZPAR26FD+'@<EFQ[T :VOW]QI?A^_O[2!)Y[:!Y5CD?:K;03R<'T
MKS;6KVZU+PE\/=9U*S5[YM6L'#QD.\@:,L<<#;N/;..G->DZE!)J_AJ[MXU,
M4MY9NBK)QM+H0 ?IFN$;1/$<WA+P782:(R7&C7UG)<*MS$W[N%"K,#N R<Y
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M.HZ39>&I93IUW#!<RM=H@2.10WF 'K@'.T'/TXS5F^)ME$MC>1PVT^F7=RL
MDBO UP@8X61H0OW,C/WL@$''8 '0:9X5TS2IDFB-[/)'_JS>7TUP(^WRB1B%
M..,CG%:TMS!!)%'-/'&\S;(E=P"[8S@ ]3@$\5@:;XIDN]=US2;NRBLY=*1)
M"S7&X2HX)#CY1A>""><&J-[X@1[SPD=2\/(9]2G)@D>16^QN8V8$97.[:.<
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MJ.T1I;)I/,MY$#$>;$P.#DM@]#TSG%=Y0 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%>??$D2:/=:!XG6>X2TLK^.+48DF98W@D.W<R@X.UB,?6O0:S/$6C0^(?#FH
M:1/CR[N!HLG^$D<-^!P?PH X:]O8]&^..GQ_:+IK+4K(Q-&TSF&*Y)+(0,X#
M,J$8QWSWKH[58&U/Q!K<@N9+:/\ T1(HW=@PC!\QE3.-Q9F0D?\ /.N2F\(Z
M]<_"6&2="_BRWEAU*/\ O>="%5%^OEH!]2:[ZTL6TCPJMHV^>:.W/F&-2S2R
ML"78 =V8D_C0!R?_  EEOH_A'PDWAO2;M].U.ZAM8!)(I:-"2=IWODLP5@.<
M#N1P"QM1;3/BUJ$RV.HW,DNA0R_8X2)'#&5\CEMBX  ^\!QQG/.=#H^KV_PV
M\$1'2KM[K1]2MIKNU5/WBHF\,0"1N^\.AKHK1+L?%*[U6;3KR*TDT:*#S#$6
M E61G9/ESD@,.1P3P": .DT#7+/Q)H=KJUAYGV>X4E1(NUE()4JP[$$$?A6,
M_B:\D^(C^&AIEQ]E33Q<-,KQC=ND"A_O A1AAQ\V3TX!,?PSL[O3O!-O97UI
M-:W,<]PS1RI@X:9W4^_#"H[FWO[/XLKJBZ=<SV-QHZVGGQ %8W69G.[G(^4Y
M[YZ#F@#G/"7BRU\+^'M3>]M=2FLXM<NHI;M$WI;J9MJEV9@2.G3<1WKO]1U^
M.RN)K>WL;O4+B"$3S16@3,:'.W.]E&3M; !)XKSBYTC5IOA1XITM-*O?M]YJ
M4\UO 82"Z/.'4YZ#Y0>IX_*M/5+>YTKQQ=ZQ<>%)]>TG5K>$ PVR236LL8*[
M2CXPI!!SG@B@#O-$UFQ\0Z-:ZMILOFVERF^-B,'K@@CL000?I69J_C"STB"^
MN397MU::>VV\N+94*P' )R"P9L @G:#C/J"*T]%A:#28$:P@T\G<WV6$ +$"
MQ(7Y>,X(SCC.<5Y[#97.@>)=;L]0\%R:Y;ZC>O>65[!!%(!YF,QRER-@4YY/
M:@#K9_&VEV^L66GRQW"K?6S75K=ML$$J*N\X8MUQS@CWZ<U:_P"$EMDT>SU"
M>TNX#>NL=M:RHHFE=N54*&P"0">2, $G&#7.^*/#\_BFQCT1H/L']FP)<PW4
M5MF/[2%PJQ@@_(O<=2" /XJH:K-XEU?0?#?B)="N$UC1[L37FF,-IE4HR.8R
M>"<-D#/?'7J =5;^,M.D.K1W,5U9W&E-&MS!.@+?O!^[V["P;=G  .<\8J-O
M&ME;ZE=:=?6-_9WD%H;U89$1S-$#@E/+9@2#U!(/?IS6-XDCUKQIX-O#9:--
M921207%K:ZDJK)</'('*NH)"J=H R>3G.!@E-/G34=,OKF/P4^A-%92B:6ZM
MHXW+%#\D94Y*]26.!P.#G@ M0?$[1YCI,CV.J06.JE$M[^:W"P>8X^5&;=D'
MMG!&<\\&K.D^*[S4/%WB#3)=)N8[?3/*0,IC8Y9&?<0&S\P*X !Z<XR<<CIE
MG-XJ^$WA;0;>SN4D9;-YIY(BJ111LKEPYX8D+@ $GYN<8..FT>"^TOXB^*II
M]-NC9ZA]FFAND4-'M2':PZYW;AC !/- $GASQ!X>LO!%E?:9!=0Z?/<O!:V\
MN6FDE:9EVC+'DL&/)X'7 !QI6_BNTDU*[TR>TO+74;>#[3]EE16>6+.-Z;&8
M,,\=<@]:\^T_P]KD7@'PU+'IUP-0T/5WO9K!QM>6)I9"0N>"VR0$<^HZUU4E
MG+J_CFU\2):W<-EI^G2PCS8&22:20CY0A&["@'G&,L,9YH ?9_$G2KVWTB[2
MPU1+#5)EMX;N2!1&LK$A5;YL\D=0".<$@YQV+,J*69@JJ,DDX %>1VVD:K#\
M+/"6F/I5[]NL=3MI;B 0DF-(YB[-Z$8(Z'G\Z]/U:R.JZ'?6"R&(W=M)"'QR
MF]2,_AF@#&;QSIL=O97LMM>1:5>RK%!J+HODL6.$)^;>JL>C%0.G3(K&UR]E
MU/XEVWA^]TBXN]+_ ++FF: F+9(QD1/-(+CA1D#/S L<#O69)I.JZU\++7P/
M=:9<VVIQK;V<TK1GR4CB=3YRR?=8%4R #NR<8[UOS0W2_%RVOQ9736*:.]HU
MR(B4$K2JP&?H.O3WH U+Z1?!/@>XELX+F_CTRU=T228,[*H)^9V/0#ZG X!Z
M5QVO:K/>6/P_UF\@NX)Y-1@\Q <^:&@9B51&8')QC(SQT%=WXILI]2\(:U8V
MJ;[BYL)X8ESC<S1L /S-<1<0ZE=Z-X"4Z+J$3Z;>P/=(\66C1(61F(!/&YN!
MU.,XH ZO3O&>G7JZQ]I@NM-DTC#7D5XBAD1E+*XVLP((!Q@YXZ4^'Q9;'7[7
M1;RQO;"ZO(GEM/M*IMG"\L 59L, <D-@XKCM8\.ZGK>K^/[>"VFA&IV=HEE/
M+&5CEDA#%ER>@R0.>N3UK7\*W#:C=VK2>!/[%N[<'[5<3VT2*K;2,0LIW-D]
M\ 8S[4 =#XE\267A726U/4$N&MU=$8PQ[B"S!1GD #)'4UGV/CK3[OQ ^BRV
M.IV5X86GMQ=VVP72+U,?))/L0#[50^+C%?AO?LJER+BT(4=3_I,?%27MI)KW
MCC0-8CM+J&TT6*YDEDF@9&=Y4""-5(RV!DD@8X !.: )-,^(NEZI MW'8ZI%
M8;)VEO9K;$,/E$A@[ G!.,C@YZ=>*T(?%EL=>L]&O+&]L+F^B>6T-RJ;9P@R
MP&UB0P!SA@#BN0T?PYJ>H_!W4_#KVTMEJ,C7)C2X3:"6F:1.>F"" ?3-:/AJ
M1]6E@CF\#/H=Y"C"ZNY((HPC%2/W#J=S$D]<  9YZ9 .WN[N"QLYKNZE6*W@
M1I)9'. J@9)/X5B0>++2XU:PTN>QO[234H7ELY)D4+,J@%A\K%E.T@X8*?QX
MK&U?X?/+X6UO3[/6]8NKB]LVAC74;]YHPW!'!Z9(QGT)J]X9\0ZUJL=K;WWA
MN^TV>!,7TMRJB,L%QB(AB7R<'., 9[XR 97@2_@TC0?$,US)*T<7B"[AC!8N
M[$R!$09Y))( K<_X3?38+W4;+4H+K3;FPLS?R1W*J2]N,YD4HS @$8QUSVKB
M3X>UJ[\'ZVEOICF^B\1R:M;VEVFU;N+S0X7GCYESP>_7%;,=SJ%YH6IWWA[P
M3_8^HQV3I%]MM8HY))3C"(%/*C!.6P"=O'7 !T-CXOM;S4XM/DL;ZUN)[+[=
M LR(?-B! .W8S?,,C@X/-4-/^(VEZC;&\CT_5H[!$N'FO)+7$4/DYW!R"2"0
M,C@YZ=>*P=-M[]?'.A:U_86L+;G39H+F>[PTHD+(Q+#<2!P< #_=7%6_"T&N
MZ9\,-3MK33I(M:C>\DMX+F/ <O([IUX.01QZ\&@#H;#QA:7NHVUB]C?6LUW9
MF]MO.1")HQC.-C-AAN'!P>:S%^)NDMIJ:E_9VK#3_M1M9KEK=0ENWF>7E\MG
M&[^Z#C/.*P].MM1/C/PUK)T+6!&MA/#>3W>TR"1MARPW<+PV  /]E:HS:1JS
M_![5](72;W^T9]1DECM_).YD:Z$@.>GW>>OM0!Z+J7B2"PN;FVAL[N_N+2 7
M%Q':A"8D.<9W,HR=K8 R>.G2F0>*["]L=.N=.CN+U]0@-Q;P1*JN8QC+'>5"
M@%E')ZD8S7-//J_AGQ]JVJ)H>HZII6N16[HUG&#);RQILVNK%< C!R>GYU%X
MFL]6@U_1O$MQX<&L6XM)+2^T^%%ED@#.'5D#<.1C:<8_(\ '8^'O$5EXDL9K
MFS$L;03O;7$$RA9(94.&1@"1D<="1S6;J_CBRTG6YM'_ +,U6\OH[3[8(K2V
MWF1-VWY<D9.<^W'7) -_PV@_L^2=-%31XYI-\=KY:))MP!ND"$@,2#QDX&,\
M\#&-O=#XP+J'V.Y-C_8OV3[2(CL$OG;]N?\ =[].V: +VI>-+/3;*[O6L+^>
MSLL"\FA1,6YP"0P+!B5# G:#CZ@BK4GB6U:XCM]/@GU.=[=;K9:;/EB;[C%G
M95&[!P,Y.#Q@&N(@LKG0?$FMV6H>"I-<@U"^DO+*^@@BD&).3'*7(V!3GGGC
MM5ZUCU?PKX[O[A]#N+ZPU>UM41]-12MM+"A0H58C:ASD'H/SP ;$'Q TN?2M
M/U);6^%M>Z@-.0M&H*3%R@W#=D#<#R,UIIXCM6\0WFB&WNA=VMLMT?D!62-B
M5!7!))R#P0*\RTZRO[SX96=S:64MS+8>)FOI;:##.R1W3%@O3)Q^>*ZG36U"
M;XG7FM2Z+?V^GS:-%$LLB+D,LCM@J#G)!Z#)Z9QF@!=*\7^&]"\":9J5C9ZC
M'I%S=-!"A0R.C-,RDMEB0"V3U)QV[5MV_BN.XC4?V3JD-W)-)%#9SPK'+*$
M+2#+;=G(^8D=0.I KS^#2=6B^$^B:6VD7WV^VU=;B6W$)W+&+II2<]/ND=_:
MNC\<6-ZNN:'XCMM$.MV=K'-!=V(C5I=DFPAT1^K H,CKS]2 "[)\1]'ATF:_
MEM[]#;7HL+FW\D&2"8L% ;#;<<CD$@]LU/\ \)S;?VQ/I#:/JZZ@D'VB" P+
MFYCSMW(=V!@]=Y7'>N=\1V5SJ7@MO[-\+2Z>9]0M94M$MU68I'(K,\@0D*<
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MA]EGW#:D1?YMNW=D#(Z<G-6/BQ8WNK?#O4=,TZSGN[RY,0CBA3.=LJ,<GH.
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MZD \JX7Y=VTY[%U'Y^E9?Q"L;V[TK2IK*SFNVL=7M;R6&$ N8T?+;02,GVH
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M [LYRPZ@?6@#:HKF[+QII][I4U\+>ZC:._?3A;R!/,>=6VE5PQ7KGDD# ).
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MTG3M3'CS0]87P]J$-NVFRVUS-=S(THD+(=TAWDXX('Z "O2Z;(I>-E5VC)&
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MV">R\XR 3UKG_%^F^)-<L_%^G7.BW5Y)(O\ Q*I%E06ZQ;1T4MGS<AN2">0
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M\,>)IX-.G>]UO5H+J*T0KNCBCDC.6.<!B$9L9[@=<UZJS*BEG8*H&22< 4M
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M8^>,-N/3O7IE% 'F&GV&J^'M9U72Y_!RZQ#=WTUU8Z@GE; LK%BLQ;E=I)Y
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MQKOA6_C#:W#;V9G,>%E/,<WROG')]>00:OZSXTCTDZPZZ;<W%OHZ))>R*0N
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M;?97#QGS3'&588W9')XSB@!?#GB/1;?P7H4ND:=);V^H,8M/T]<;R<L3U.
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M=OY%O9F2+S78GEF((55'&!G/7CI0!NVGC!9_$=GI%SI5Y9_;X'FLIYBFV8(
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MB5@",1!3GDX.3C XYKE[GP[XAF^&7B/2%T2X^WWNK2W,$1EA^:-IUD!)WX'
M/'K0!Z/I&J7&I_:OM&DW>GB&79']IV_OEP"'&TG YZ'D5ITR)S+"CM&\189*
M/C*^QP2/UI] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"QE"^YI' (5?D/8]1Q6)XLUJV\4?"SQ=YMD(Y].\^UFB<B0+-& =R-W'((.
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MDT =7167X;UVW\3>';+6;5'CANH]X23[RG)!!^A!%:E !1110 4444 %%%%
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M,+QI+-&C2MMC5F +GK@>IJ2@#SO5=-U*'6_&VJ36$D=A=Z*(8IC)&<M&DF>
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MI .,\]CCD<]<=W10!Y9;^&?$$/PY\):.=(D-[IFHVT]R@GBP$BD+$@[\'(/
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M0  S'/7./5JKZ.?$7@?X:1K_ &&ES>VMS+)-"UTBCRGD>0LK#.6P0-O4D]Z
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MHHH **** "LS6?#^FZ^+4:C%+(+6=;B$)<21[9%^ZWR,,D>]:=% " ;5 &<
M8Y.:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@!D<,4._RHT3>Q=MJ@;F/4GWI]%% !1110 4444 4=8T>QU_2
MI],U.#S[.< 21[V3."".5((Y Z&I=/T^TTJPAL;&!8+:$82->@[GZDG))/))
MJS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !116!XJU2]TJ#3'LGB4W.HV]I)YL9;Y)'VDC!&".U &_16!K^
MIZIITLAT^%;IET^XN$MA&2\DL90* <]#O/&,G P:C\+ZX->$EQ;:I:W]D$4?
M)$8IH9<G<DBDY7M@$ ]>O6@#HZ*YJ?4=6E\;3:-:W-K%;KIR7:M);F1MYD9,
M'#CCY0?ZUEV7C>\OK^UT+[/!#K+7]Q9W#C+1(L**[2*,@G<KQX!/!8YSCD [
MFBN(USQI<>%[^[TZ\C2\G-K'<6+*/+\UFE6'8_7&'=#N'8GCCG=N/[>LX%GC
MDMKYE1VE@6(QEF",5"'<< N%'.>O6@#:HKB='\4W.JZ>]];:C:W"VT.^^MOL
MYBN+:164NA0L2/E\P#(Z@<FMS4=3NK;Q'HEE$83:WIF$N5);*)N&#G&/PH V
MJ*QDU.Z/C.72F\HV@L%N4PA#ABY4Y.<$<>@JE;:]?:AXGN["V6!+06"SVTK@
MDNQ=EWG!&5XX'<#.>1@ Z:BN5T75]0U/3=7']K:7(]G>- E]''E @16):/?P
MP)9>6 . W3KFKXUF@\-Z-JFH75K'9W;S1SZC:QF2)2I(B.W)V[\<YSM/RG!.
M0 =Y17(ZKJ7BBU\/6^KQ+8131PPO-8-&SM/*Q :-7#87DX7AN?:E;Q/=?\)@
M^A[42Y%PGEVSH1YMH4!:8/G!(;<,>V,<YH ZVBN/T?Q9<W\F@W,JQ_9-=,X@
M15PT6P,Z9.><HK9]\8J;7=?O+'Q+I^GI,MA:3%%-U<6+S13.S8$0D#J(VP."
MP()8>F" =51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>elicio-insidertradingcom009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_0+?6]7F?4;O<C3SI(RM(7;"M+C:&(QP3TQ[5UL-YILOCJ>WCU2\;48[ ;[
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MDD+RQ&..I)'&37#.V[PW\4(UCE+7<\YME$;9FW0*@*<?-E@1Q5]Y%;Q%\-)
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M63_EB<%XYS_N /\ H* -2_UW1+^309#JU_:_:+T?9%B22(73@,-C@KRAY/.
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MU,@G#%20,+\O.3@8JAX2GDM_#'C:2'3VNK@ZIJ%S%:21$?:5;)3 (^96Z>]
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M&M3T/Q+J>FW$6B:HNK6>XR_;UG'V E<, TAVDDX&%Y(Y.,4 >@T444 %%%%
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M:::REBCCAC9V=F4@   GK72T4 ><W1D?Q%\.9EM;LQVT<WGL+63$.ZWV#?\
M+\N6XYK/TF.ZTWX=Z]X/U&QNI=6'VR&!1 S"\$Q=DD5L;<$OR2?EQSBO5J*
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M+O3Y;M46XA,4<T;;!A2H894X)Z''M6QIVG+I\4FZ>6YN)6WS7$V-TC8 '"@
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MDVKR1\F#CI^5>@T4 >5>(H+23PQ:W&D>'[RVAN-<M;HH+20S3*CJ7E= "R\
M_>Y.,]Q6[XSL;/4]3TY_M>I:3?Q0226>K6B,5CR5S'(,8(;@[6QG:?Q[BB@#
MRRU;Q!;:IX/\3:[92%$M;FSOA! W[AG;*3&,#*A@J[N/ESSBH]?TRYNK?XA:
MU:VURUOJ>GQ6EK&D#E[F18V!8)C.,L%!QS@]N:]7HH \YO&=_$WP\G6UNS%;
M0W'GN+63$.ZW"#?\ORY;CFL66&YD^&_Q!MEL+XW%YJEX]M%]DDW3*Y78RC;D
M@X/->P44 >67MQ_8GBZ/5=4TG4KS1]2TRWA2>U@E9K:6(O\ (Z+\P!WYZ=?Q
MJ?7;2*WTSP>FG:'<6-M'K\5V;:*V9C#%B3+R!0=N=P)!Z9YZ&O3** ,^VU>*
MZUF]TQ;:[22T2-VFDA*Q.'!("-_$1CGTK0HHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *Q=9\5:7H%Y9VE^;D37C%+=8K627S& R0-BGG%;5<#X]_Y
M''P%_P!A1_\ T4: .DMO%FC7&J1Z8;B2WOY06BM[NWDMVD Z[-ZC=^&:VJ\Y
M^-L<:?#J:_4[+^RNH)K&1?OK+YBCY??:6_*O0K=I&MHFE7;(4!<>AQS0!)11
M10 4444 %8T7BG3)_$<N@(UQ_:448F>(VS@!"<!MV-N,^];->?VH<_'+6 C!
M7.@P[6(R ?-/;O0!Z!5#4M6M]-:WB=9)KFY9EM[>+!>4JI8XR0!@ G)('XD5
MYFOBCQ6G@ >*I=8B9K343#);+:(%N(_M7E$,>J\'C;CISG-;7BBTN9OBKX1$
M>IW, DAOB@1(SY6$CSC<ISGOG/MB@#L=%UBVU[3$O[5)XXV9D,=Q$8W1E)5E
M*GN"#6A7$V>JZOXIB\13Z7J1L3IM[+8VL8B1UD>)1EI=P)P6)&%*X'O6-;^,
MM=\1?\(/-IMU#I\6NQ7(N$-N)"CQQG)4D\C<"0/89R,B@#T^BO/X+CQ2/&Z^
M&9_$,;J-$%T]U'8HKF3S=A8*20#@?3D\=,8DOBCQ7%\.;[Q(VL0_:-'NY()(
MEM$VW@CFV$OG[N1_<QC\> #UND+*I4,P!8X4$]3UX_(UQGBK5=5L[W4%M]3%
MM'%IQGM8+2)9IGE&[+2JR$+&,*,Y7.3SGIA7-_J6O:M\-+YM2N+0ZC!+/+%;
MJFQ9/LI;< RGGYB.<X!XYYH ]$BU))M8N=-%O=*\$:2&9H2(G#9X5^A(QR.U
M7:X=_%%_I?BKQ9'?SK/IVE:9%?11)$%89$A89ZDG8/;VJEJ7B/7-&\&:1XQE
MOA<0S?9Y;ZQ\I!&L4Q4?NB!O#*77!+'//% 'HM%>?-?^)M1\3^+]+M];CM(=
M-BMY+9TM$9E+QLV/FR",@9SGIQBNE\&ZQ/K_ (-TC5KI5%Q=6J22A!@;L<X'
M;F@"!O'&C+J=]IP&H/=V 5KJ./3YY#$&&5)VH>HY&*UM)U?3]<TV+4-,NX[J
MTESLEC/!QP1Z@CT/->8W.N7WAWXA?$+5++2CJ/V>UL'DC6785 C;G&#D#DG'
M85K>'!;^ OA3?ZW#=Q:F91+JA>(%8G>0 A5'4+PH]>OTH ]$)"J2<X SP,UF
M:%X@LO$5M<W%B)@EO<R6K^=&4.].&X//7UQ6'9R^+8_$6FMLN+G2ID<7WVH6
MR"%L91XO+8L03P0V[C'-87AZZO;+PIXKGL+JTM9E\278,]TV$C0S*&;H06VD
MX!ZG'7I0!Z;5'4M5BTVRCNC!<W*/(D8%I$96^=@ V!_",Y)]*X9->U6[G\9Z
M4-1O1'9:?'=6=U);I%<)N1R1C8!C*<$J",GV-5(M2UC0?A)X6OK+4V9YAIZ/
MYT*,1')L4JI 'J>3D^] 'J5%<1=WWB"[^(]WX?MM7CM++^RDNT=+56>-C*4X
MW9!/R]3QUX[C+M?&NL-\/M%U"XDC%U<ZL--O+U8P%B03/&9MOW03M YX!;IC
MB@#TND9E099@H) R3CD\"N0T/4-9F\>:WI4U^+K3+".%T=H%#[Y%)*,RX&1@
M'IG##/K57X@K=MJWA!+?4;FVCFU=(W2()@_NW8,=RG)!7@'CVSC !W5%<?::
MGJ'B#Q!KNE6FJ2V,>CB* 31Q1L\TS)N+,&4C:.!@ ?Q<],6_ OB&Y\2>&ENK
MZ)([Z">6TN1']PR1L5)7/8\'\: -V[O(;.VGGE+%84\QUC0NVWG^$9)Z'\J@
MT35[77]%M-5LM_V:ZC$D?F+AL'U%<5I$=X_C_P =>;JEU+%;Q6P6)PFTJT+L
M%^[D!2QQ@CWS6'X8U'6]#\$^ ;R+44:QO+BWL);'R%V[)-PW[_O;@1G@@=L=
MR >P45P%WK?B/6TUU_#PN4GT^[>TMD1;<PR/&!N$OF'?R21\N,#!YKKGN;]?
M#;74EL(M1%H9&@4[@LNS)4$=<-Q0!!+XFL%U">QMEN+VYMR!.EI"9!"3SAF^
MZ#_LYS[5/I6MV&LFZ%E([-:R"*=)(FC9'VAL$, 0<$5R?P:"-\,-,N@_F3W3
MS3W$I.6DE,K;BQ[G@#\*U/%NJCPW!;364<:7^LZA;:>LK#*JSG&]AWPH/UP!
M0!U-%<9<:KJVB^.=,T*:_:\M-9MYS;33PIYEO-$H8YV!0RE3T(SGO7+0^*/%
M?_"N=(\6/J\+3&\6&:U^RH(YD:X,7)Z@@8QMQTYR>: /7**XB'4-?LO'LV@W
M&K1W<5UI3WL+O:JOV>19 A "D%E(;HQ)XZURH\5>,;?X;Z9X\DU6WFA38]YI
MPM% EB,FPD/U#<C&,#'KW /8:*\V\9^)M;T2S\0WUOJ2"73S'):V=M"LJ"+"
MD_:"5RA8EL ,#@ C-:-WJ&OW?Q&ET&UU6.TLGT=;U66V5WC8R[."V03QWXY/
M'< '<45Y;_PD_B5_AS;>(1?$S:;>R1:F(;=,W%O',4=U!!VL%&[CCKQTKM;*
M_FU/Q+,UI>%]+M[:/<JJI6260;AAL9X0J>O.]?>@#=HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKU8K^=LQ6)W2D,<$#+*<+DXYSVJM?74,G@3XD6\=S)<RKJZ7)+)AC'F ^80
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ2B@#GO[$U[_ *&RY_\  *#_ .)I/["US:5_X2JXVGJ/L4&/_0:Z*B@#G(]
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M ,)7<_\ @%!_\35_2["_LGD-[J\M^& "AX(X]G_?(&?QK2HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHJ&VN[>\C:2VF25%D>-F0Y 96*L/J""/PJ:@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **IZ=JUCJ\<\EA<+.L$[V\I4$;9$.&7GT-3W%Q#:6TEQ<2
MI%#&I9W<X"CU- $M%5=-U*SU?3H-0L)UGM9UW12J" P]>:M4 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO<LR^1/C!=2H.X'@E3CD=10!DQ?$/4-4M/"=WI5A:B/6YI;>:.Y=MT,B*^X
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M& )X&0VXY Z#UJ6P\+:]'XGT?6;J\TM!9V+V4MO;0.%"$J1LR?\ 9[X '8T
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M)'J: .XL%N5LHQ=RQ2S8Y>*,HI]."S']:\VL[O6;WPU\2&U&^@N(X)[VW"K
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M!?,)"(%#+D_*Q)SQQUSQSGB>YU2[T;P3-K=@ECJ)\1VHF@CD#JI!D&003P0
M?;.*NW7A+Q!:ZU8Z]H5]I\.H"Q2QOK>Z5W@G13E6!7#!AS_+ZW-<\,ZOJEGH
M2?;;>:YL-3CU&>64,@D9-WR(HSM7YL#DX '4Y- $UEK^I7?B?Q-HQ%HO]F0V
M\MO*(VY\U7.'&[G&T="*S=)\<WFKZ+X5$<-M'JVO)))@AC%"D8R[8SD_P@#(
MY;KQ5V;PWK,'C'4=7TV[LDMM5MH8;I9T9I(FC# %,<'(8]>AYYZ5B6?P\UG3
M=$\+-::G9?VWX?\ ,2)FB80312##QMSGZ,!^% !H<VIV?C?XA3R_9)KV&VL7
M0JK1QN!%(1D98CCW/2I_^$VUG_A&O!FHV]E8-)KDT4$J,S*J%T9OEZX'R]3G
MZ&KUEX8UV'6O$FJ7%UIS/K%M#$(8T<"-D1E!W'M\Q[<X'2JD?@K5XO#_ (1T
MT3V);0+J.=W+.!,$5E 'R_+D,?7I0!:LO%VI6=SXKM=;@MII="MDO%>Q5E$T
M;([[=K$D,-A&<\YJ >+==%QX3Q%ILT?B&,OA5=3;GR_-ZY.\;<C.!R,]\!=4
MM+KPW?>+O%5U<VT-K=V,<:;5,C0M&K*K$$ -DOT) 'KWK%T.#6O#RZ7*O_")
M7T*!+>(6DLWG%&(#>3N+*"?O$  ''..P!V_C6[OK#P3K5[IMPEO=6UE+,DC1
M[\;4)X&1SQP><>AZ5Q-^=2$?PU=Y+>YNVGS&=K1K@VIQNR6)/<D=?05Z)KVF
M?VUX>U+2O-\K[;:RV_F8SMWJ5SCOC-<J/"FO./"C7%SISOH<F]P@=1(/*\L
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MQX+(ZEOF&"#D$?X48?'6L3?#[P[XB\JQ%QJ%[#;W$7E.5VO,8\I\^00.><T
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M1<& /O\ */\ #G^'?Z?PYYKNZS5U[3F\1-H(F;^T5MS=&(QL!Y88+NW$8/)
MX/K0!CW'AK4X?&DFMZ3?6L$%W:1VMU%- 790C,5:/! SAB,'COSTK&@^'VJ0
M>!-'\._VI:.^GWJ7?G&!@"$E,@3&[GDXSQQVKT.B@#D&\+ZM8>,;S7]%O[2)
M=3CC34+:ZB9UWQC:LB%2#G'&#U_E=\$^'KOPMX;BTJZO(KHQRRR*\<13 =V<
M@Y)SRQYXKHJ* .1@\,ZQIVI:])IU_:+!K$WGEY8F\RV<H$.T X?A01G;@^M4
MKSP!<Z<VBW?A'48]/O=*M?L0%U&98KB D';( 0<[OFR.Y-=W10!0TBTO;2RQ
MJ-X+N\D;?+(B;$!P!M1<G"@ =SW)ZUD:=X?U#3_%7B'61<6SKJJPA(MK Q&)
M"HR>^<Y/3%:FM:]IWA^T2ZU*9HH7D6)66-G^9B !\H.,DCD\5I4 >?0> -2M
M_!?A_0%U"T+:1?1W?GF-L2B-RX7;GC.<9R>GO6XF@7Z^.YO$?GVQCDTY;$6^
M&R,.7#;OJ<8QTKI:* //6^'^IMX"N/#7]HVF^:^-W]H\IL >>)MNW/J,9STK
M<NO#M_)XVLO$5M>V\)6Q-E=0O$7RA</E#D8.1CD'Z5LVNJVE[J-]80M(;BQ9
M%G#1LH!==PP2,-QZ9Q5V@#A-(\&>(-"FFTS3]?@7PU),\B0O;DW,"L2S1QON
MP!DGYB"1GCFI5\(:OINLZW+HVI6B:=K3--<6]U"SM#,5VLZ%6&=W&0>E=M10
M!B>$=%N/#GA73M'N;J*YDLX1$)8XR@('3@D_G^@KGS\/'NM*\2Z+?:A&^F:O
M=RWD0CA*RPR.RODMNP=K*,  9[UTUMXDTJ[UF;2(+AVU" !I8/(D!C!Z$Y7
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M(9RO"N,$%'QW&0>XK2DT6;5+&[MM<GCN([F![=H;=#'&J,,-U));W/3L!SD
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M="T\^(K<IHE\+FV86'+KAP?,^?EOGZC ZY!SQZ*.E '/>.M7O]!\%ZIJVFM
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M;+GY\'KT]0:T[OP?=ZK<:>=5O+6X73]0^VV]RL!6X50Y98MVX\= 3W Z \T
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M#8[$DB8*.,N<-\O)Y'H!6;)\-M67P?>^$+;7[==$D<&U,MF7GA7S ^PMO 8
M@X.,_2@#HCK-YJ_BS4]#TVXCM4TN")KB9HO,9I90610"<!0JY/<[@!C&:X;0
M=;U;P[\(8]1M&M?M"ZO+%.'B9E(>[*';\PQ][/.:[&3PGJMKXLE\0Z1JUM#/
M>P1PZC#/:L\<Q08610'!5@.,9(Q6:/AWJ'_"#OX;.MP'=??;//-F3C]]YNW
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M".IH Z:BN#L]7\7W4VAW]O9R3V=]M-[%(D2QV\;KD21L'W';D9!R6'3%9/\
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MQ %H)D^ZV#UZD8]ZWJ* .3D\'3ZSX?O]-\4:LVIO>0^27B@$"Q '(**"?FW
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M>. !G '3BL#P=I]WKND^,+"#5((K&[UV_BEV0[Y51GPVUMV!E3P2#CKS7J)
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MUB9D9TW $#N,C/YUY;_PE/C"S\"Z)XWGU.UN+1_(^VZ>MJ%W1NX0L'Z[LD<
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MF>YAM(0<8#RR! 3D@<9)P2,XQD=:S;#_ (2UM?N;68W:Z1-:;HKRY%MYUO<
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M $$#)'X9X]:XO0M7O-,\)^ ='AOYC<:W!$//E1";>)( [!/E )X !;=U).:
M/3:*Y#3=7U&Q^(=QX7O;EKVVET\:A:7$B*LD8#['C;: ",D$' /8YJ]XEO+R
MVO=*CAU!+2UFDD$XB3?<S$)E%B7:V>>6.. .HYH Z&BO*)O%WB/_ (5[=ZA'
M?>7?66N'3S)+ A:2,7"QC<!\H;#<[1VXKH+6[UNW^(5SX>N=:DN+>ZTDWL4G
MV>-&MI!*$(3"X*X8'#;CQU- ';T5YWH_B'6;GP]<:/=ZBX\4P:I_9\DHBC'5
MMXD5-N-GD@OR.=IYK2L]1U#Q)KGB#3[35)["+27CM8WBCC9Y)2FYG?<I&,D
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MT2;MP*J 5(/0@X(].*X.5+EOV>M<N+C4+FZ:2>?(FV'!%X<MD*"2>IR3[8H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN<YRQ_ _C53P[X)N=!:"WE\2:A?Z7:'-I8SJ@$>/N[G W.%[ \# XX&.OHH
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MOG)/X8XQWKHJ* .0L_ J6^D6^A3ZG+<Z%;3++%:R1C?M1MZ1M)GYD# <8!X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:1K:2]N;>,C[8D;@F,''SE4!S['')R  =]9^(=)OKIK:"]0SK'YWEN"C&/\
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MRB;4M9^*MEH\Z-?SVUNL"QN-S,+;:0/?/RY[&@#T*W\2:/=7D5I#?Q--.&,
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MS0"/:57=CE3G*]><XK2^&&G7.F>![>"X1XD:>>6WBD!#1PM(Q0$'IP0<=LT
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MY'W0@&3SP1QU.*];H XV+7;[Q)XRU31=+NC8Z?HX1;NZC16EEF<$B--P*JH
MY."<\#'6M:WM-:L_$$ ;4GO=):WD#B:)!(DN4VG<H *XW]LY[G(QQ^C31>!?
MB%XDBUJ06NG:Y.EY97TIVQ%\'?&SGA6R> >HKK=2U(:UHVI6F@7*7%R]G,L=
MS!(&CCD*$(-XXW9(X'3J<<9 +2>)=&DO8K1=0B\V9S'$3D)*XZJCXVLPP<@$
MG@U#=^,/#MC)>1W&L6JR66T7"!]QC+9P"!W^5CCK@5YQ=30:]\&M(T'3F6/Q
M# ;.WCM.D]O<1.@=BO5< .Q)['/>NBT:[T]/BQXR>:>V7%G9*6=U'"K)O&3Z
M?+G\,T =*/&'AUKJRMEUBT::]"FW"R9$FX94 ],D= >33+_QKX9TQKI;S6[*
M)K1E6=?,!,;-G ('?Y6./:O*K.YLH?@7X4'G0)(FIVS,-P!4K<Y8GW"\GVKK
M=-OM(MOBOXQ?4+BSC$EC9;'G90&38^[!/4?=S^% ':R:]I4=E:WGVZ)X+O'V
M9HCYAGR,_(%R6X!/&> :@;Q7H,>EIJ3ZM:I9O)Y2R,^,OG!3'7=GC&,UYAH<
ML7A?2?"5K?Q)I\=S>7TMG?W2'-C"Q)1%!X#R*W&[@<\$\5FW=[9_\*T\7V<D
MY:7_ (2<MBX38[*;F)LD$#DJ"2,#C/ H ]BM/%.AWUQ>6]IJ=O/-9IYDZ1MD
MJO\ >]Q[C-/A\2:/<Z*VLPZA%)IJYS=+DI@'!.?0'O7*RW=G_P +KTX17$'S
M:#+&-KCG,R,H_+) ]*I6&F7FG>+KOP:D#'0[BX76(9!]V.+=ND@_[_!./[K-
M0!Z2CB1%=<[6 (R,<4ZLN#Q'I-SXCNO#\5XK:I:Q+--;[6!5#C!R1@_>'0]Q
M5V^E\G3[F7R6GV1,WE*,F3 )VCW/2@"A:^)M&O;R&TM[^-YIPQ@X(68+][RV
M(P^.^TG%<WI6HZK/J?CJSDU2=OL$L8M)"D>808 ^ -N#R>X-<98:WI]S>?#N
M]ANHTMX[B6,V5M$?*LBT#@0YP6+YP.3D]0 #72:-?V8\1_$AC=0A?,B;.\=!
M;!2?H",?6@#I_ =_=:IX#T2_O9FFNKBT2261L99B.3Q715R7PPECD^&GA\1N
MK;+-$;:<[6 Y!]#76T %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 445!>7EMI]J]U=S)# F-SN< 9.
M /J20 .Y- $]%9EIX@TR^EN88)V^T6J!YK>2%XY54]&V, Q![$#FN)T_7I?$
MLFJWPU?4M/?3=5=(D@M9&C:WC*J49-N&+$DG/S+GL!0!Z317DMKK(U[P99^)
MM0\8ZCH.]6:]\M"(R&8[$C#+C(P!E 21G/)S7IE_J]EIAC2YE<RNI9(HHFED
M95QE@B G R,G&!D>M %ZBLR/Q#I,VEVVI07J3VEUQ \ ,AE//"JH+,>#D 9&
M#Z&JI\9^'5TT:@^K0);&?[-E\JPES@H5(W!@2,@C(S0!NT5AVOC#0;Z)GL[_
M .U;9G@*P1/(Y= "V%522 &7D#'(YYK4L;ZVU.RCO+.42V\F=C@$9P<'KSU!
MH L445%<W4%E:RW5U,D,$2EY))&VJJCJ230!*1D8-(JA5"J  .@%<))XC:Y^
M*6D65KJ-T+*73[B6:TFA,*@KMVOAE#$'+<Y(X..]:5AXDT+3='U359_$IN[!
M+Z4/<3L"L+<?N4P!D+GC&>O6@#J555SM4#)R<#K2UC6_BS0KM;QK?48I?L<J
MPS! Q(=ONJ!CYB>VW.>U2V?B32+ZVO)XKY%2R)%T)@8F@(&?G5P"O'/(H U*
M*Q/^$MT;%X/M$OFVD'VF6!K:19?+[.J%0S#/&0"*@T+QAI^K^%[?7)6:UAF5
M6*RHPP6^ZHR/G)R!\N<GI0!T5(44DDJ,G@G%9=OXDTBX2\9;U8S9 &Y2=6B>
M$$9!97 (![''/:J=KXZ\,7KE+;5X)6%N+G"AN8RP4$<<DEE '7D<<B@#H:*I
M6&K6>I2SQ6TDAEMRHECDA>-DW#(R& /(J[0 C*K## $>A%*0#U%%9'_"4:,-
M0@LC>A9;B0Q0LT;B.5QU19"-C-P> <\&@#7P.>.M%<Y<>//"]K%<R2:Q"4MI
M3#,R*S[& !.=H/ R,GH,]:M1>+-!GU>'2HM3A>\G!,2KDK)@9(5\;20.< YH
M V:YK5]$UN37TU?1]5M8S]F%N]I?6QEBQN+;E*LI5CQGKG ]!27?Q"\)6*RM
M<:Y;*(IC!(5R^UQC(. >!N&3T&>M4_$>IW4?B[P9]AU&3[!?W$JRQ1E3',HA
M9U;.,GMWQ0!NZ1I,EE-<7EY+!-?W*HDKV\'E1[4W;0%R3QN;DDGGTP!JUDZA
MXETC2Y)DN[O9Y !G98W=8 >AD900G'/S$<<TZ7Q%I4&JV>F/=C[9>KOMHU1F
M\U<9)4@8( Y)SP* -2CK5!M:T]+B\@DN1&]D@DN"ZE5C4\@EB,<X/?L:BL?$
M.EZC>SV4%R1=P())()HGAD"'HVUP"5]QQ0!IX [4N!Z5D6OB?1[S48K"&\_T
MF=#) KQN@G4=3&S "0=\J3QS3[?Q%I=U=PVL-PS23EA"?)<)+M!+;'(VM@ ]
M": --55%"J  .P%+1534-4L]+CB>\F\OS9!%$H4LTCGD*JJ"6. 3@#H#0!;P
M,@XY%&,=*PY/&'A^'1YM6FU.**R@E,,KR!E9) <%"I&X-[8S4UCXGT74M6FT
MNSU".6]B3S&B (RF<%E)&&&>,@G% %O^SXCJG]H.S/,L9BC!QB-206QZDE5Z
M^G&.<VZ\^^)7BR.R\(:@VDZM/;WT$T<0E@B)0OYBAHS(5*AL$\ @@BO0: "D
M95;&Y0<'(R*&944LQ"J!DDG  K*M/$VCWU_%907@-Q-&98%>-T$Z#JT;, ''
MNI/'- &M16._BG18[E('OE4O-]G24HWE-+G&P28V;L@C&<Y&.M1WOC#P_I]Y
M<VESJ<*W-L@>6%0SNH/3A023P>!SP: (O&V@77BCPQ<:/:W$-N9VC+2RJ6VA
M'5^ .N=N.M;L*LL0WJBR'EPG3-4$\1:5-IEIJ,-VL]M>?\>S0HTAE."<*J@L
M2 "2,<8.>E1#Q3HWEVDAO-J7EP;6!GB=0TP8KY?(X;((P<=#0!K[%R3M&3R>
M.M#*K8W*#@Y&1TK/75+*_O;S2;>]>._MT#2JJ8>,-G:PW+@C@X/(XKA?#OCM
M]-^&?AO4M7DN;V^U*Y6W\SRV<DM.5))4<87H.^  * /2Z*Q[SQ3H]@,W%TZD
M0?:758)&:.+^^X"DHO!Y;'0^AHNO%>@V4MG%<:K;(][&9;<;\^8@7=N&.V._
M?M0!K[5W;L#=C&<<TM<O?>/=$M_">H>(;6=[RVLMR.D43[Q(!]QE(RO;D@
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ME% '&V>O:#XN%S?:';?:[K[!)"]X;9D:-3R(=S $DMSM'3&3U&>)L;MQX#\
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M6JPZ9?>'OM$,<44MXRG4I(?,^Q'RVP5&,!FSM!.0,DD&NRHH \)U"XB'P_\
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MJZ]KFCP:39ZGI^DP1V%WK,3MJ4EH0L;E3FZVX!)XVASQDYY&,^D44 >*75W
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M'#39M@HQE1R6Z+Q[# X /3+'QAH6HZK#IMK?;[J>(RPJ8G595 !.QB-K$9Y
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M@=P,>U;FG:RFA_$KQ!+JZ7,5MK,5K+IMPUNY#JD95HL 95@23M//)]:Y>RD
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M7DPEC3P7\,(^DEM?6AG7!S$%A=7+C^$ D D^M>JZA+'#IUS)*X5%C8DGITH
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MH *#G!QU[9HHH Y_PQX=N/#\VKO+?QW0U&^DOB%MS'Y;. "OWVR/E%=!110
M52U>UO+W2KBVT_4&T^[D7$=TL2R&,YZ[6X/I^-7:* ,[1=*.E631RW4EY=3.
M9;FZD4*TTA &<#@  * !T %:-%% !6+XMT&3Q/X8O=%2[6U%VGEO*8O,PO?
MW#FMJB@"&TBE@LX8II$DD1 K.B; V.X&3C\S4U%% !1110 4444 %%%% !11
M10 4444 %%%% !5;4+-=1TVZLFEEA6XA>(R0MM= P(RI[$9X-6:* .5LO#&L
MI8C3-0\1B[TP1>28DL5BD>/&-K.&(P1P<*#Z$5U0    P!110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<;\4()Y_!,I@@EG,-W:S.D*%VV+,C,0HY. ">/2NRHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.IB\>(S+;G2;KS"@."P7R\XSQFNCDC25=LBAER#@C/(.1^HK@[O_ )+QIO\
MV )?_1PH WK?QIHUW?Z79P27+2ZF9A;[K62,9BW>8&W@8(*D8//M6S?7:6%A
M<7DB2ND$;2,D2%W8 9PJCDGVKB/%\$H^(/@B.Q:*"5Y+\AV3<%)AR6QD9/)/
MUJ&#Q'K\'AOQLDM]!/J&@/*8;I[8 2((1*H9%(&>2,]/:@#OK6X6[LX+E%D1
M)HUD59$*L 1G!!Y!]JE=@B,YSA1DX!)_(=:\^O-?\0R3^!H+.^MHO[;MV-RS
MVVXAQ;[]PYQUYP .1UQ5[3-0UC4-?NO#<NKXFTFTA>]O8+=%>>:7<5 5@RJH
M5<GCDD=,<@'0Z%KUCXCT]K[3S*8!,\.98RC;D;:>#R.1WJI>>,M&L=:;1YI+
MPZ@L/GF"&PGE/EYQO&Q""N>,UB?"A95\(W"SNKS#5+P.RK@,WG-D@=N:I7\\
M]O\ 'B%[>T>Z?_A&6'EHZJ?^/GKEB!0!W&D:SIVO6 O=+NX[JW+%=Z'HPZJ0
M>01Z'FKU>:Z5HFN>%-+UG5);FPL;G6-86ZN%,F4M(&;#;"1AY<'CC!)'7O'<
M>+]<ATGQTMO=[I=#2.:TGO+3;(R/%OVL@VC((.#@<'D&@#TUF"C+$ 9QDFJ<
MNIQ1:Q;Z88;@RSQ/*LBPDQ*%(!!?H#SP*\W\3KXF.E:#>7GB$>3?ZMIH6WMK
M54\O<X)!8Y+C<%(X'(Z8XKIY]7U2Q^(>E:-)>)+I\^G33OF$!RZ%!DL/]X\
M"@#KJ*\ZM/$'BW6M*TK7]&LYYH[J99)+.3[.L!MB3]UMWF!P,')X)S\HJ6W\
M6W$WBR;1KS4GTO4TORL-C<P*L-W:AL!HG*Y9BO/WNN1CN #T"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MXVZ\*>)9=:N]1MO&1MC/\J1C3(G$2#HBEB3CN?4\UV5% &-'I.J1/H^-=F9+
M0-]M5X%)OB5QDG^##9;"\=N@K9HHH **** "BBB@"MJ%T+*PFN")"$7/[N!Y
MF].$3YF^@KRN'3K2+PEKGA]K_6&BU>XEN))O^$8O R&0@L ,8QQQZ>]>NT4
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M%Q#=IX=N\>9$05)0IR..1G_"GR7EK+XLTW79+G6G:RM7MC&WAR[S('(+$D(
M#E1C X]Z]$HH \GT>T@T2=[.SUKQ*OAPRF1=+/AVY)0$[C&)?+W!">P&<=^2
M:N7CV>J>3#J<^KW-I!J/V^$'PU>":,B0R*@DVD  _+G;G;Q7IE% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M921C';F@#J]0UK3-*(%_?06[%#(%=L':.K8_NC(R>@ITVKZ=;VT%Q)>0B&X
M,+AP1(,9RN.HQSQVYKBO$.K:?'X[O+!Y(=.O3I !NY/FEND+MB*%3\I(.23A
MB<X XS7.>'2NH^#/!+:/XBBT[7K:QF6V,P#P3 >7YL3@]_N=.1@^E 'KUI>6
MU_:I=6<\=Q;R<I+$P96YQP1UK,6^@'BBY!\00&.&S!DTWY,PD-DS,WWAD$#!
MX[U7\#ZE-JWA.VN[BQBLIFDE$D4)S&6$C!G0_P!UCEA[&L6.>U7XX7JF6$-_
MPCT>X%AU$[DY_#!^E '1Q^+O#LLUI#'KFGO)>$K;*MPI,I#%?EYYY!'N15C5
M-6L-/0Q7.I0V<KH65G8951U?![#U/'K7C=M)I\7P&TN5'MDD&L(^X%0=PO3S
M]=GZ>U=AI&MV>F_$GQ;;:]=0VTMT+>2R>X<*DUL(\80G@X8MD#N30!H^ O%0
MU'P7H=SK>J6YU/4#($\QDC:9A(X 51C/ Z#TKIX]7TV::\ACU"U:6R -T@E7
M, ()!<9^7@'KZ5XSHM[:0?#;X=W;W$26UEKN+B0L L )G WG^$<CKZBMJ34-
M"U+Q3\08[O4 NGW6F6@:>%QGR]D@9T/\07(.1D?6@#T&7Q3H<-I=W3:E!Y=I
M%YT^&RR(>AV]><<>O:JVE>--#U+1=.U%]1M+?[<L>R*2==P=@#LZ\L,C(KDK
M2ZUM9-=T35)[366&AR36VKVB[7DC.X+'*HR-Q))&.H!]ZQ[G4=)O?AQ\-XS=
M6LR1:EIL4P+@A2L9#*?IW';/- 'IMEXN\.:E/#!9:YIUQ-/GRHX[E69\'!P,
MY/0UH0ZA9W%Y/:0W4,ES;X\Z%7!://3<.HS7(^.],^P:;9^)M(M4%YH4[7GE
MPJ!YT+?Z]./[RDM]5%;GAB-Y-.DU2=&2XU.0W;*PP40@"-3Z$1A 1ZY]: +]
M_JMAI@C^VW<4!DSL5V^9L#)P.IP.OI4+>(-&2WLYVU6R$5ZRK:OYZXG). $Y
M^;\*YGQ'K&GV?Q TNTGDM]/NGT^9DU*X/\!=088@3M+D@')!P!P#FO/]/NM.
MF^&G@RTFFA<P^*426.7'R@W,QPP/3Y2"1Z$>M 'L^FZ_H^L+<-INIVEVMLVV
M8PS*PC/OCIWHLM>TK4YS;V.HVT\_E^:$1P24Z;P.ZY[CBO/=7O\ 3['QSXUD
ME@6\@'AV)I[2)\-,!Y@9>.1\I SU -5M,U>PE\?^#)TU6TFBDTRXAC2VQY41
MQ%MB4\DL!U!)/&<+F@#I?"WB@Q:?K]QXDUBW2*RUNXLHKBX*0J$7;M7L,]:Z
MR35-/A-H)+VW0WC;;;=(!YQQG"^IQSQ7!>#K#3_$>B^.=)N'CFM[K7;V.0*P
M) 8+AA_,'U%6? LVJ:M-'%K43BX\.*]@\C#B>XZ>:/\ MD$.?^FS4 =<FOZ3
M)=BU74;8SDL%3S!EBH);'KMP<XZ8YK.T/QKHNO07]Q;WL*PV<SQLSR!3M3 +
MD'HN20/_ *]<9X<N;K2=3\.V]C?6^N^&[Z>3[#O %WI[>6Y()!PR@%E)/(SC
MTS!I4VDW'@_Q5I.H:J;"1=?G9Y(V DMF-TOE2,#T7>5//4 ^AH ]0LM5L-2:
M5+.ZBF>' E13\T>>FX=1GWJ2\OK73X1-=W$<$98*&=L98] /4^U<EX,O]7?7
M-8TS6OL5Y=6D4!&J6:[5N4;>5#KT5QR<#LP]LQ>*KI].^(WA.^O6V:1MN8/-
M;A(KAU&PL>Q(!4'W/K0!U"^(-';3)-2_M2S%E$Q62<S*$1AU#$G@CT/-/T_7
M-*U6>>#3]1MKJ6W"F9(9 QCW#*Y Z9KS#Q#"@?XFZA;R1_V7/I*QLP(\N2Z$
M3 [3T+ ;0<=R.]>A^$X+%/#.ESV<5N/,LH09(E'S (,9(ZXR?S- %J[U_1["
MY>VN]4LX)XXC,\<DRJRH,#<03P.1S[U4;QEX:2TM;MM>TY;>[8K!(;A0)"#@
MXY['@^E<]J36A^-NC"1H?-71[C 8C(;S$Q^.-WZUR@.G?\*V^)Q0VN3J=^ 0
M5YX!0?F3CWZ4 >N:AJMAI48DOKN*W5LE=[8)QUP.^._I4+>(=%1+1VU:R"W@
MS;'SU_?#&<KSR,#J*\[DUZTTGQCIUSK.JRV.FW^AP)9WRL!%YBLQD0L00"0R
MGMT'M4%_9^']/B\#6^F?\@U]=:2$W+9\Q620EEW?P%CQV.01U% 'H(\9^&3I
M\M^->TXVL,GE22BX7:K]=O7KCFLCQ1X@GLM5\*7%EJD2:7?W92X("%)(O*=P
MV\]!\H.0:H:,VG?\+8\:M(UKG['9;BQ7IL</G\-N?PS7(:++:2> _A?+=O"U
MK%J)69Y2"B';*%#$\#G&,^U 'L.E:]I.NVTEQI6I6M[#&VUW@E#A3Z''2F6W
MB+1;N>6"WU2TDEBC\UU$HR(_[_NOOTKS3Q/IES=:QXTO_#,6^"31(X+C[-]V
M>Y$A9E&/O,(N#C^\!U-;6AZEX0\3ZSHVK66JW%_J%I%(41G -I&R8?S5 &!P
M!SWQCUH ZR#Q9X>NI$C@UO3Y&>)YE"W"G,:$AFZ] 5//L?2K=EJ^GZC++%9W
MD4TL05I(U;YD#9VDCJ <''KBO,?!]IH%U\%)#>R100E[J.>[@V^9 'N&&[/;
M V'Z 5T/A"]UF/Q1>Z1K$UEJCQV44T6L6J[3+%O8*DJC(#9+$8X(S0!VEW>6
MUC;F>[GC@B! +R,%&2< <]R:K0:YI5S9S7<.H6SV\#%9I!(,1$=F_NGV-<IX
MYN9-/\5>#=1NCMT:"]F6[<_<CD>(I"[>@!+#)X&:-/C5OBYJ^J64J?V9_9$,
M=[(K#8UR)&*Y/0L(^OH&'K0 SPGK5_XPAL]:L]?CB N9OM6F".-U\@.Z(.F]
M6PJG=G!R>,8%;VJ^+])T?Q!IVBW5S&ES>!W^=PHC15SDD]R< #W]JQ?A#<0S
M_#;3A%*CE9;C<%8'&9Y",_A3/%EY;:?\3/!EU>3)!!Y-_'YDAP-Q2/"_4XX'
M4]J %TCQ?'I^N>)X/$FN6T5M:7\<%HUP4B 5HE?:.F>6ZG-=A>:G8V$"3W5U
M%%&_W&9OO\9X]>.>*\R22PE?XKN[VS,592Q*D[?LH&,^F[]:JVFMV^DW/@J_
MU;49K/2;GP[';1WL9&R.XPC,KL00NX*.?5?8T >M65]::E9QWEC<Q7-M*,I+
M"X96^A%4KOQ-H5A)<1W>KV,,ELH>=7G4&,$X&X9XSVJAX+M-&M=*NGT)YI;&
MYNY)Q,[;EF=L;G3_ &<YZ<9!QQ6+;/9?\+NU0LT'F)HD/4C(/FOG]",^U '3
M'Q7X>$EE'_;=AOO@#:C[0O[X$X&WGG)X^O%6=1UO3-(4-J-_!; J6_>N!A1U
M8^@]^E>,[]/B_9[NVB>V1AJ>05*@@B^&/QV_I[5TE]K6F:=\0O$%IXCU633K
M34;>W>QF9E6&>$1[73<01D,6.,_Q4 >BW&JV%I:Q7,]Y"D,V!$^\$2$C(VX^
M]QSQ7$Z#XDGU/2_%\EUXF@@@MK][>SU)EB"0)Y2%3V5L%CUZUE64^F^%_&_A
MI)6EM/#AT>:WTR6]8A4F,NXY9ONEHPN,X.#CVK/-]ILWA+XK+#<VS*]Q<2H%
M<88- H##URV<'N: /5&U>PT^PLVO=2B8RQ@I*V 9\*"6"CVY..!FKMI=VU_:
M17=G<17%O*NZ.6)PRL/4$=:\Z.MZ9;ZSX5@>>VLKB31"T>J3/D%#Y8,,0)VE
MR0#D@X Z'-,^&_B?1-&^'>FQZAJ44!:_GM5\S((D:>0JIP/E..><8!'3(H ]
M.K,MO$&D7MVMG:ZG:RW#AC&B2 EPO#%?[V#UQTJUJ$RV^FW4SQ/,D<+NT2#+
M. "<#W/2O'=/UO2YM1^'%W;WUI%:(\R+9V[;DLPUNP6)G.6,F<+R1DCA: .M
M\,^-;>W_ +8@\3:_:)/'K=Q9VIN&CA+1IM"@ 8]>OO79WNIV6G(CWEU%")"0
M@9N7P,G ZGCGBO+]/71#X?\ B):ZFELUQ+JUX#"X!F<,!Y6U?O$EC\N._2IO
M#?V[P]XS\/V_B.3RA)X:BM+>65OE%PK RQ[CQO("GW"B@#T-_$&C)I\-^^JV
M2V<Y"Q7!G4(Y)Q@-G!.>*EDUC3(KV6RDO[9+J*$SR0M* ZQCJY7KMY'->0ZU
M:20^#/'5Y!G^QY-<@N+;;RI"RQ&:1?\ 9W!N1Q\IKITUO2[_ .,^FRVE_;SQ
M2:'-$DL<@9'?SD.U6'#' / H ZCPOXJTWQ9IK7NG3(RB21=F[Y@JR,BL1U&X
M+D9]:9JOB_2=(\0Z?HMU<QI=7@=_G<*(T49R2>Y. !6%\)+RV?P1%8I,C7=K
M<W0N(0<M$3<2$!AV)'/-'BN\MM/^)W@VYO)D@@\B_C\QS@%BL>%^IQP.IH -
M'\81Z?K7B>#Q)KEM%;VFH)!:-<%(@%,2MM'3/+=3FNPO=5L-.@2:[NX88W^X
M6;[W&>/7CGBO,DDL)1\6'9[9F(92Q*D[?LH&,^F[/XU5L-=MM)U'PG=ZOJ<U
MEI=WX:MX+>]1AY:W PTB,Q!"DC;Z?=]J /7+.\M=0M(KNRN(KBVE&Z.6)PRL
M/4$=:GKG?!=GI%EH;C0C,VGRW$DT<LC$B4M@LR9_A)SCL>2."#714 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 445SWC3Q0/"?A\WR0?:+N:5+:T@)P)9G.%!/IU)]A0!T-%<^ND^
M(!8&0^(W;4BF=IMHOLP?'3;MW[<_[>?>K,&K+8:/IS:S,(KZ:!#)&%W.T@4%
M\*HR<'.<#B@#7HK*D\3Z%#I,>J2:M9K8RG;'.91M=LXVCU.>,=:A'C#PZ9[N
M :S9^;:+OG7S1\JYQGWYP.,\G'6@#;HK&7Q9X?;2(]6&L68L)'\M)C* &?.-
MHSSNSVZT_3?%&A:QJ%S8:=JMI=7=M_K88I 67G!/N,\9% &M4;P0R-N>)&/J
MR@UG6_B71KN]BLX-0A>:8N(0"<2E/O!&Z.1SG!.,55N/''A>U21YM>L%2*7R
M783 A7XR#CTR,^F>: -K[-!DGR8\GK\HYH:UMWA:%H(FB;[R% 5/U%5'UW2X
M]5ATMKZ$7TZ;XH,_,Z_W@.X]ZG@U"TN;RXM(9U>XML>=&.J9&1GZB@##T?0;
M[3_&FNZQ*;7[+J26Z)'&[;X_*5E&?EP<[OPQWK?CM;>''EP1)M)8;4 P3U/X
MTR\O[;3XUDN90@=MB  LSM@G"J.2< G '8UR/B_Q%(NGZ%?Z+JI2"76[:SN-
MBJ5=&DVNK;AE2,$'&.X- '9?9H.?W,?/7Y1S2^1#LV>4FS.=NT8S5'2O$.D:
MY)<QZ7J-O=O;,%F$3Y*9Z9]C@X/0TV#Q'H]S>Q6D6H0M--N$(S@2E?O!&Z/C
MOM)Q0!?DMH)8/)DAC>(_P,@*_E1);031>5+!&\>,;&0$8],5277])9+YUOHB
M+ @7?/,'&?F'4<<_2N>\3ZW<I>^#[K2=3/V'4M2CAD$85DGB:-W!SC/\(Z$4
M =BB)&BHBJJ*,!5& !36@A=MSQ(S>I4$UD>(=<LM.L;N%M2%I=K;F4.BAS".
M<.P((5<C&6XZU!X#U"[U;P'HE_?3&:ZN+5))9" "S'J>.* -]88D8LD:*Q[A
M0#3?LT!N!<&"/SP,>9L&['IGK7&:KXD;0_B6D.I:N+?13HTERT<VQ4243(@(
M.-Q)!Z$GKQ73VFO:3?:0-6M=1MI=/(S]H60;.N.OKGC'K0!=,$)<N8D+'J2H
MS2?9H,8\B/'7&P55T[6M.U9YX[&[266W8+-%RKQDC(W*<$9[9'-6KBY@M+:2
MXN9HX8(E+/)(P55 ZDD]!0!(JA5"J  .@ IA@A8L3$AW$%LJ.3[UQ,?B9[GX
MIVNGVVJ.VG-I4MQ+:O&$$;AT ;E0V"">IQUQ6IIWB#2-/T6ZU"[\4V][9F\D
M"W4KHJH2W$2E>&V]!U)H Z'[-!D'R8^.GRCBC[-!S^XCYZ_(.:SH/$^AW,5S
M+!JEM*EM-]GE,;[MLG]S ZD]@,YJ6UU_2;W3YK^#4+=K6!F6:0OM$3+U#Y^Z
M1Z'% %[RHQ&8Q&OED8*XX/X4V*V@MP!#!'& NT;$ P.N..W-9$_B_0X+#4+Q
MKY2NGQ^9<QA&\Q 1D?(1NY[<8-+I7BC3]2\.6>LM,D,<\<9*DDE790VP<98\
MXXZT 5O&V@WOB/0X]/LGMXV%S#.SSLP&(W#X  /7&/:MZVMX[>+;';Q0%OF=
M8@ -W?L,_7%5+77M)O=/GO[?4+=K6W++/(7VB(K]X/G[I'<'%<O'XDDO/BI8
MZ;9ZG))82:;--+:-$$VN&0*W*AL$$XR2/2@#M%MX$ "PQ@!BP 4<,>_UIR0Q
M1DF.-$)[JH%0:CJ%MI6G7%_>2>7;P(7D8*20!Z <D^U9>B^+--U?PS;:XTZ6
M\$L:.PD;&QG (3W/(&!U/2@#:,$)4J8HR"VXC:.3Z_6DEMK>:'R98(I(NNQD
M!7\JKZ?J]AJIF%E=)*\#;)H^5>,GD!E."O'J*K^)-?L_#&@7>KWQ;R;="VU0
M27..%'U_3K0!H36T%Q'Y<\$<J=-KH&'Y&JNH:5;ZE%;P3*OD0R+)L"#DJ05&
M>PXYQUZ=,YY'6/%$BZ_X/NK;5!#I=]).+R,A1&0D#/DL1D8/OCBNKTWQ!I&K
MV,U]8:A;SVT+,LLJO@1E>2&STP.>>U &B0&!! (/!!J.&V@MRYA@CB+G+E$"
M[CZG'6J5AK^E:G>26EI>QR7,:"1H>5?8>C '!*GU'%)XBURU\-^'K[6;S)@M
M(C(RKU8] H]R2!^- %U;6W5BRP1 L_F$A!RW][Z^].DMX99(Y)(8WDC.49E!
M*_0]JYO1+?7]6T>WU/4-9FLKFZC$PM+6&(Q0!AE5)="S$ C)W#)SC%7M-OKK
M3M"CE\27,"W?GR1LZ+M63]XPCV+R>5VX')^M &L8(F?>T2%O[Q49I4BCBSY<
M:IGKM&,UG)XCT:33[B__ +3MEM;9BD\DCA!"PZJX."I]C@U!'XQ\.2W<5JFM
M6?G2P^>BF4#*;=Q.3Q]WG'7'- &PT4;2+(T:ETSM8CD9ZX-1R6=K+"(I+:%X
MAT1HP0/PK-MO%GA^\L+J^@UBS-K:-MN)6E"K$?\ :SC']:;:>,/#M_JD>F6N
MLV<M])&)$@60;F4C<,>^.<=<4 ;0 50J@ #@ =J88(2Q8Q1ECU)49-<AHFKW
M8\6^,[34M4/V'3VMC \P1! KQ%VY  ZGJ?05JZ3JMC9>&-/N+C71J,<N(X[U
M@-UTQ)QM51R>#P!VH V?LUOC'D1X]-@H>V@D:-GAC9HCF,L@)3Z>E9C^*M!B
MTE]4EU:UCLHY#$\LD@7;(#@H0>0W^SU]JELO$6C:CJD^FV>I6T][;KNDAC<%
ME&<$^^#P<=#Q0!>:V@:W^SM!&8,8\LH-N/3'2G"&)=V(D&[&["CG'3-9S>(]
M'2_CLFU"$3R2F% 3\K2#J@;H7_V<Y]J+[Q'H^F3^3>ZA# ^Y48N?E1F^Z&;H
MI.1C)&: +\%M!;*RP0QQ*QW$1H%R?7BC[-!M"^1'M'0;!@5+7&V&NWWBOQ/K
M%AIUVUCIFCRBVEN(D1I9Y^K*-X955>AXR2>HH T=:TG6=5U!+:._M(= EAV7
M<'D$S2<\JK9P%9<*>.F<=<CH>E<='K][H7CBS\-ZM<F\M]3@>6PO'14D#Q\O
M&X4!3Q@@@#T(/6LK_A))?$VJ:];V/B)M*.FSQI:.D0D1P$5W9U(^8')&,C
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M]15/6GN8?#][+!<M#<0V[R+*B*?F52>C C&17(^'I]?USP)I>K?\)--#J=]
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M(I0D:-+(Z-QABS<;AM &.^>RT;4;.V\+6=W/KBZC!M &H2;5\\EL# 7@DG@
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M,06-8\_?Q@C:,\FNA^%LT<WPR\/^6P;9:(C8[,.HKK6C1F#,BDCH2.E.
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MDE#Q7E-IJD8\'_#?4XYA+I.E211ZF5!*P.8?+5G]-C$Y],C->RTFT8Q@8]*
M.'LHEO\ XO3:MIDJ2V":,MO=S0L&C>8R[D7(X+!<GU (]16A\28WE^&OB)(T
M9V-C(0%&3P,UTZ(L:A44*HZ # %.H \OU;5])U#Q!\.)8KRVF@\^5@Q8;3_H
MY (S_M8&?48ZBLG5I9+F3XF1Z4?M,J7=C<&WMW!>2-%B,H7'J%8'WXKV4
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M=I=S9)\3O&TDTT 'V*S7>[  [4DWC/ME<_A7-:#':7/@'P4$\0/H>LV]K/\
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M G:QF9QP.IVJ37::9J5KK&EVVHV4ADM;F,2Q.5*DJ1D'!Y% %NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K/?2HQK*ZI;OY-PT8AGXRLT8)*@CU4DX/;<>N:T** "BB
MB@ HHHH R]=L]7O;**/1M633+A9E9Y7MA.&3G*[21C.0<^U6-.T]-+TR.S@=
MG* DRR<EW)+,[8QR6))QCDU<HH HZ;I<6G?:90QDNKJ3S;B=A@R-@ ?0   #
ML!W.2;U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(4FAD22)QN5T8%6'J".M/H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYMFGF#*I#(Q^S$X/8]N*[^#2=-MEF6WT^TB6<$2B.%5$@/7=@<_C3/[#TC$
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MA<:7936:'*6\ENC1J?92,"@#*\$Z;I6E:%);:+>3W=A]ID>.61E922<L(RH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@"C'HVEPWIO8M-LTNR<F=8%#G_@6,U/=V-IJ
M$/DWMK!<Q9SLFC#KGUP:GHH KR6%G- D$MI \,?W(VC!5?H,8%,_LO3_ #4E
M^PVWF( %?R5RN.F#BK=% ')>,_"DFL^%KG2M%M=/MYKB6%W>3]V,)(K_ ,*D
MG.W'XUT=C86UE$?(LK:U>3#2+;H "WU &?KBK5% %5-,L(P EC;*!+YP"Q*,
M2?WNGWO?K31I&F@.!I]H _WQY*_-]>.:N44 <UJNC:Q>7::;:/IEKX:EAVW4
M:Q,+ACN)95P0@5EX)QD9/M72@8&!THHH KW5C:7R!+RU@N$'19HPX'YU+%#%
M;PI%#&D<:#"HB@!1Z "GT4 5;G3;"\FCFNK*VGEBYC>6)69/H2.*DNK.VOH#
M!=V\-Q"2"8Y4#J<=.#4U% %?[!9XE'V2#$N/,'ECY\  9]<  ?A3(M+T^"V>
MVAL+6."0Y>)(5"L?< 8-6Z* *1TC3"JJ=.M"J?='D+@?3BI8["SAN&N(K2!)
MFSND6,!CGKD]:L44 5;?3;&T:9K:RMH6F.93'$JF0_[6!S^-);Z7I]F\CVMC
M;0/(,.T4*J6'O@<U;HH JVVF6%E*\MI8VT$C\,T42J6^I YJQ)&DL;1R(KHP
MPRL,@CT(IU% %$Z?%9:;/;Z596L!93MB51$A8C'.T''Y&L3P-X6_X1OPWI]G
M?6M@=1M8O):ZMQN+CUW%0?P]JZFB@"M<:=97<T4US9V\TL)S$\D2LR'U4D<?
MA2MI]D]T+IK2 W ((E,8W\=.<9JQ10!6?3K*66662SMWDF3RY7:)277^ZQQR
M/8T\VELSPNUO$6@_U3%!F/C'R^G'I4U% %>"PL[5V>WM((7?[S1QA2?KBFVN
MFV%D\CVEE;6[RG,C11*A?ZX'-6J* *0TC3 C(-.M K'++Y"X/UXI)-&TJ81B
M73+-Q&,)N@4[1G/'''4U>HH *JC3+!=V+&V&^02MB)>7'1CQU]^M6J* *?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !13(IHIT+PRI(H9D)1@0&4D,/J""
M#[BJPU?3FU-],6^MS?1Q&9[<2 NB9 W$=AR.M %RBJFGZI8:M#)-IUY!=Q1R
M&)I(7#J&'49'&1FK= !116=>:_I&G7<5K>:C;03RNJ(DD@!+-]T>Q/8'KVH
MT:*Q;_Q=X=TN9X;[6;*VD0,2)90OW?O#W([CK6RK*ZAE(96&00>"* %HHHH
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M7I0!9'B^^BLM*@U#2_[/UB_:93 Y,J1K%]Z3Y!E@<K@<?>ZCK65>_$'6-/\
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MNRY&R0'DJN,D@Y(VGK3O%_AW5K_4]'UW0+BVCU72VD"Q76X13Q2 !T8KD@\
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M^4#<1RK?=YQVV;C6[V^UZ^T;1A;+/8VT<\\URC.NZ3=Y<84,IY"DEL\<<'/
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M!W5%<'#XVU:X_L6_MM*ENM.U*6-9((K&<2VL<@RLID(V,!QN  QG@G&:[R@
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MWI:VEM);ZE).C3NQ,D92)G^48P,XQG/KQ0!TM0W5U!96[3W,JQ1*0"S'N3@
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M/&<X/2I7\-^*='\4:E?>&K[2SIVJR">YM]020F"7:%+Q[/O9 &02.G6NXHH
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M+PF*1F><QQ@QJ5*@*,X)Y;ICOFEO?!^O[_%UI87.FC3]?5Y \Q?S8I&A$97
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M5PD@$S28<]03O/0<8ZFO2:* .5N=!U:Y\;:+KCO9&&QM98)@'96<R;<E1M(
M&WH3SGM699>#-8TOPYJOA6SGLFT:\:9;>XD=A-:Q2YWILVD.1N;!W#KR*[VB
M@#D+?PK=Z?XRT[4;%;4:98:1_9D<3RL),;E(/W<<; .OO[5:\&Z%?Z!::G#?
MM;,;K49[U# [-@2MNVG*CIZ]_:NEHH Q?%NAMXE\)ZEHR3B![R$QK*R[@IZ\
MC\*H#0M2U:_T:YUM;*&/27,T<-K*T@EFV% Y+*NT %CCGDCGCGJ:* .#ET[3
M/$/Q(L-5TO4(KB&"T+:@MM(KQ2E'!MPQ!^\&WL/]RMVXO=:C\;6EI";&31Y;
M=C,@#?:(G&3O)^[L/RJ!U))]*T].TG3M'MV@TRPMK.%F+M';Q+&I8]20!UJY
M0 5YE<> _$TNCW6G"^TN3.KKJ45S*)/-GQ*'"RG'! &!C/  XQ7IM% '*:?H
M>L6?C35M<D^PRQWMI# J+*ZG='NY(VG )8\9./>L)/ NN)\-;#PN)=/-Q;7:
M3F;S7V,JS^;C&S.>WZ^U>D44 <C!X>U;1_%FIZUI7V*:'5DC:[M;B9X_+F1=
MH=&"-D$=00.F<]JSI/ =[;:;H%K8S6LDECJ_]K7<LS,GG2'>6"@*V!^\.,]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS)/9J)1E'3[A)QDXR>#Z\U7O/ASH-\NK1S?;1!JDGG7-NETZQ&4XS(%!QN)
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MJGVV$W3^;=6L-TZ6]R_]Z2,'#9[CH>X.36C)X7T^;7KC6)3.]Q<6OV.5&?\
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MGFQD@X<$X89'3I[5'H?@'1?#UX)K%K[R8W9X+26[=[>W8YR4C)P#R>><9.*
M.(T:T-A\,/&]Y97E];W%M=:F8I$NY"5\MF*GDGG@9;J>YK=LM5N-3\3>'?#U
MS<7"6K>'UU"1DF9'N)250 N"&X&YB,\DC/2MW_A!M(%KK%JC7B6^K-(US$MP
MVW]Y_K-H/"[N^.?I4T_A#3IH=+ DN8KG2EV6=W'(!-&N-I7.,,"  0P.<>M
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MZ4DNKZ9!%;2RZA:I'=,J6[M,H$Q; 4(<_-G(QB@"[15'3M:TO5S.--U&TO#
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MCGYNHSSR*](GLK6Z5%N+:&98SN021AMI]1GI4DD,4VWS8T?8P9=R@X(Z$>]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF'"MI:YWC@J8]P^HP<^E 'INI:K8:<HCNKZ.VDD1BF3EL#JV/09&3T'>N=\
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MS)%S(DH(A(ZACV([YJ_!-%<P1SPR+)%(H9'4Y# ]"*\NM+/5;/Q=<Z1<0/\
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M>)45$_O8VD;1SD\<YJQ)>Z=H7Q/T6XO#'I5C)X<>VMUN&"!6$L;"+)XW!>U
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M7T-=K=6]G?\ Q2\/ZCHQ@=+.RN?[0GMR"GE,JB)&8<?>RP'H": &:'KMW=^
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M1C()'M6KIU[8_P#"XM>DFFMT==)ME.]URN&<NN?;C/X5Z 54L&*@D=#CI2T
M>&^&KLV7ACX<:M)(#H^GW=Y'?,#E8'DWI$[_ -T#<>3TW#UKIK^S?5O%_BK4
MM'87%C-X<-I*\!W)-=$N5 (X9E3 /IN KTP@$8(XI H4 *  .@% 'C<7B#2[
MO1?AC';W:RM:7-O'<[ 3Y+BV92K8Z-GMU[]*MZ@]Q?:S\5+32)@^H2V=JL*1
M,-[D0,&"^_;CH2*]9"J.B@<YZ4M 'D&I>)]!U32/ !L+J'=;:M:K+ H^>VQ$
MZE77JN#QSUQQP*[WQ[%)<?#WQ#%#&\DCZ=.%1%)9CL/ %="$4'(4 YST[TM
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M",$<&D"JOW0!QC@4 >(6VNZ;)X ^'MFERK7%CJ]DEW&H)-NR[P0_'RGKP>2
M3T%;]EK^D:+XC\7:'XL^1M3O/M%MYT+.MY;O$B!$P#N(VXV]>>.]>H!5'11U
MST[T%5)!(!(Z''2@#SM[BUTKXJ:"T\/V"";0'MK>$KT?S8R(ACJP'8>E<_I]
MWX>FL-5\(^+CJ!U7[?.6L!),/MH>9I(WC"G!SD>G3)P*]EI-JE@V!N' ..:
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M8FEGTWP\-/TTZ#JUSH$LU[/=Z;J$K%XYI"JA]RRGE'R<#C.W(ZC/J+*K*58
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MF:6%I1&61HV0D$\<;@:J:;I6L^&O%.N7D%@=0L-89+G;!,BM;SA=K@[RN4.
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M!TFF>(SJ7B;4?#=_9VRW%M;1W!,,_G1NCDJ5;*@A@1T(Y!!K.^$:A?ACI*J
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M]ZSS\0TNF\,OI.F/>V^OK*89#,L9C9$9BK @]",$YXP<9Z%=*T?6O"^L:_\
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MCV$/D9VD\Y7)]JS9_!6H:?X?\*:98(EV^F:LFHWDI<1ASEV?:#W+2' ]!R:
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M!'/7.0>16[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&]BEE\N02Q#:DBG&""I((X]1GI78T4 ><W?@;5$T:WCM1:R7LWB%=<O=TI5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA=%E # 9(YP2.WK7/V=_=^*-<\26T>H7%E!I4JVD"P;03)L#-(V0=W) "GC
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MC$=RH#,%8@,,$_*>HKBO#":]K>KZV9_$UZL.EZW)!'&L,7[R,1H=K?+VW<8
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M3IM.76M5CLFO1?00J\>+>7S/,.TE,D9SPV0,],\UW%(Y*HS!2Q R%&,GVYH
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MPM!$SK&WF1MM^5QM&<;1@C!]ZZ6B@#-T/1+70;![6U+-YL\EQ*[XR\CL68X
M ')Z 8 K2HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR(H YO7KW5_".GFW_MAK@:GK%O:6<DB[I+**5L-N9L[\;7VEO;.>E6+RYO\
M0/'^B:5!?74VG:W!<(R3/YCV\L2!Q(C-D\@X(.1TXK4D\$Z;=^'[C2-1GO+_
M .TE7EN[F;,Y=?NL&  7:1P  .O')S:M?#B0WL5]=:A=WU[# T$$]P(\PJV-
MQ4*H&X[5R2#T],B@#S2+5-?C^&EOXI?Q#?R7EKJ?E^6=@CE0WGE$. O/RGV
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MYY%<7;Z[KMS\./ NHKK-S'>7^J6\%S)M4^:KR,#NR,]AP"!VKT71O#EEX?\
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M8[Q0"Q8[(W 8,Y&W Z9[\ '4^ )-:N/!FGW7B":XDU*X3S)5G1$*9Z !57'
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M^IZF@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:;(TEN(BH4,05)(*G/!(K8HH YT>#K,7&N3B]OM^M($NSN3H%V#;\O'R\?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK \5
M:I>Z5!ICV3Q*;G4;>TD\V,M\DC[21@C!':@#?HK U_4]4TZ60Z?"MTRZ?<7"
M6PC)>26,H% .>AWGC&3@8-1^%]<&O"2XMM4M;^R"*/DB,4T,N3N212<KVP"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM0U'_1[^ZM)+ F)VCCMF5RR$,?F+D8+*#TR!QUYK9HH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>elicio-insidertradingcom010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG(C*11(X!7=G)R><]_PKK/#UY-J/AK2KZX(,]S9PS2$# +,@)X^IKS^P8?\
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M&HZDT373SSQN8DVKA)708&3V4=ZZ&XN8+2!I[F>.&%?O22N%4?4FN.^$Y!\
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MG^[ TJAV^BYS5&?Q-I</B2/0&O(5U![=I]C./D 954$9ZL6X'?!KS:P,6I_
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M':37MM'<R_ZN%Y5#O]%)R:XO4%L;3XR:6TRV\,9T2<*7"J"PFCQCWQ7-V?\
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MZWNK>[5VMIXIE1RC&-PP5AU!QT(]*FJGIVE:?I$4D6G6-O:1RR&5T@C"!G(
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ML&AZ3;:C+J,&EV45[-D27*0*LCYZY8#)J2STK3M.>1[&PM;5Y3F1H(50N??
MYHN-4T^SD:.YO[6!UC,S++,JD(, L03]T9'/3FI;2[MK^UCNK.XBN+>0926%
MPZ,/4$<&@"M#HFDV^IR:E!IEG'?RY#W*0*)&SURP&35YT61&1U#(PPRD9!'I
M5.]U?3--=4O]1M+5G&5$\ZH2,XXR?6I+C4;&T95N;RWA9D9U$DJJ2H&21D]
M.2: *P\/:(+0V@T?3Q;%_,\D6R;-W][&,9YZU<M;.VL8/)M+>*"+).R) HR>
MIP*KQZSI4NFG4H]3LWL!G-TLZF+_ +[SC]:?!JNG75[/96]_:S7<'^N@CF5G
MC_WE!R/QH +K2]/O9XI[NPM;B:+_ %<DL*NR?0D9%);Z5IUK<37%O86L,\W$
MLD<*JS_[Q R?QIJ:UI4MS';1ZG9//([(D2SJ69E&6 &<D@=1VI8M7TR>^:QB
MU&TDNUSF!)U,@QU^7.>* $L=%TO2W=]/TVSM'?AF@@5"><\X'K5R2-)8VCD1
M71AAE89!'H15*[US2+ 2F\U2RMQ"5$OG7")L+9VALGC.#C/7!J674K&!86FO
M;:-9_P#5%Y5 DXS\N3SQSQ0 R'1M+M[*2RATVSBM)<^9 D"JCYZY4#!HMM'T
MRSM9+6VTZTAMY.)(HX557XQR ,'BJ7]H1WVJZ5-I^OV!LI4E)MT*2&[XX*.&
MZ*0V< U=.L:6M^+ ZE9B\+;1;F=?,)QG&W.<XYH B/AW1#;1VQT?3_(C8ND7
MV5-JMZ@8P#[UR5[X6U.77+^:[\/>&M>MKB4-;S7S>7);QA0!'CRG!48/0C.2
M<<UT=MXMT>[\37>@0WL#7MJB%U\T<LV[Y .[ +D@=,BKZ:QIDNH'3X]1M'O5
MSFV6=3(,=?ESF@#.TSPKIUIX?.D75C936KR-*UKY ,"%CG:B'( '_P!?C-7G
MT'1Y+&&Q?2;%K2'_ %4#6Z&-/]U<8%68+RUN99XK>YAED@?9,D<@8QMC.& Z
M'!S@U/0 U$2*-8XU5$4855& !Z 4ZBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *\1\8ZKIUQX4\9+936]D(]84302R;[
MBXG22(-(,GY$PO  /"YR.E>W53DTK3I9)Y)-/M7>X4+,S0J3*!T#''(^M '$
M0VVEW_QJFE6&UN$?P_'*K!596)G8;O0G'&?2LGP[H!\0?!S[)8E4OK*_N9]-
M<8_<S1W#M'CT';Z-7IQTK3C.9S86IF(VF3R5W$8QC..F.*R]4T_5[2.WB\*1
M:-9J\A^U&XA887'#($P"P/8\'U% &?X+U)O%0/BB6V>W\R!;2"*1<%-O,QY]
M9,K_ -L@:I?$.*VFUKP9'>)$]LVK[767&QLPR8!SP<GMWKLM-L(M+TVWL82S
M)!&$W-]YCW8^Y.2?<U)=6EM?6[6]W;Q7$#_>CE0.I^H/% 'E^JZ1%;^(_'1T
M:V2.PD\.-'=QP+A&O")-HP.-WEXS_O#UJ%M8TR2W^%FR_MF,31^81(#L_P!%
M9<-Z<\8/<'TKU:VM+:RMUM[6WB@A7[L<2!5'T XJ"#1M+M0@M]-LX0DAE3RX
M%7:YX+# X/O0!YT9K[0]4BFADM=;\-7FO,GED;;JPNFG(.TCAU#[N#S@^E.C
MM[3_ (2#XJ0F*'ROLULS)M&W/V9CDCZ\UZ)'I.FQ7AO(]/M$NB23,L*AR3U.
M[&>:#I&F%I6.G6FZ;B0^0N7YSSQSS0!Y7!:V=IX6^%-S!##%</>6BM*B@,VZ
MW?<">IR0,_A2P7&B:I%XLT#Q7K\MA.VISM-:NT*-+$6!A:,LA9OE" 8)/ ]J
M]1.C:44C0Z99E8^44P+A?IQQ3YM+T^XO8KV>QM9;J'_5SO"K.GT8C(H \U\0
MK?Z2-;U72YX=3L(K2%-:T?43MFV+""&1QT8H>A&"0V.:D\42WUO+KVO:5):W
MUB;2/^VM$OAL<1B+<&C<?=.QCP1C(.,FO19M)TVXNA=3:?:2W(((F>%6<$=.
M2,]A^5$VDZ;<W0NI]/M);@$$2O"K.".G)&>P_*@"*]GN[GPW<7&GHZ7DMFSV
MZ.,,LA0E01ZYQ7EMT8M3^ >E?V<?^)Q ]LEMC_7)?B50_N')WD]\$FO8ZJ)I
M6G17[7\=A:I>/]ZX6%1(?JV,T <)IVCZ5??%KQ1%>V%G<?Z#9.8Y(E8%B7);
M![Y"\]:TOBK)=1> +R2W1WB26%KM4&2;<2+Y@^FW.?;-=6FG6,5VUW'9VZ7+
M9S,L2ASGK\V,U8(!!!&0>H- '":^B7?CSP3?:.Z/*WGF62$@A[,QY.['5=VS
M';)&*Y7[5;#X3^/K3SX_M*7NI%HMPW*/-[CJ.H_.O6[+2]/TW?\ 8+"UM?,.
M7\B%4W'WP.:'TK3I?.\RPM7\Y@\NZ%3YC#H6XY/UH X*>UM+'QW\/#:0PPF6
MTO%8QJ 7'DHW..O//UK!T.70]>\(KI7B'7[J#5[6_9KC3T:%+C[6)2P,8*;V
M+$C!!/7&:]:&DZ:'B<:?:!H<"-O)7*?3CBE.EZ>=0&H&QMOMH&T7/DKYF.F-
MV,T <+X?TC2;OXG>-UGL+28Q2V#HKQ*VQO)W;@#T.0#GU%:_Q2('PP\19./]
M#;^E=+#IUC;W#7$-G;Q3OG=(D2JS9ZY(&:?<VMO>1>5=013QYSLE0,,_0T >
M=:GJ\.F_$#2!JFK/IFGW.BA+.Z/EB,S;\R*6D5@"5\OTS@50U"TT30?#^@SZ
M1JXDTZW\0"XB^V3HL-R2&+B-P @4'>RYP-RD#J*].GTG3;JS6SN-/M9K5#E8
M)(59!]%(Q6)XHT+4K_\ LPZ4FF2V]FS>9IU_&1!,"NU3E0=I7G'RD<^PH Y=
M$T:*'QYXJG:TO+:]MAOM;&X225(DA*-ET)VL_L>, YS5;3=1M/\ A8OA%QJ&
MGF-]'FACBMG!6)3Y6R/<22Y^N,XS@5U^A>%UM=1.I76E:-83F![?R=-C^5U8
MJ3O<JN[[HP-HQD]<\;T.E:=;B$06%K$(-WE!(57R]WWMN!QGOCK0!YA;NI^&
MWQ/(88_M'51U_P!BM77[*6/P3X=\4Z?%YFH:#!#=J%ZRP&,":/\ %"3]5%=P
MNCZ6L4D2Z;9B.0@N@@7#8Z9&.:R-8TK6KF6+3-,;3+/0)83'=XC<7"Y/(BVX
M497(R>A.>: )?"W^FVD^NLC*VJR">,,,%8 -L0]LJ-V.Q<USOB'3]/O/B_X=
MCN[6WF$NG7F])$!$F-F-P/WL#/6N_1%C1410J* %4#  ]*@DTZQENENI+.W>
MX7&V5HE+C'3!QF@#S$3Z-!XG\6>'=>U==&@E6);>%O)BADL_)5 J%T/"D/P"
M,$G ZU-I%_INA>/=.L;Z\DATU-!C32)M1<+N^<[^3@!RHCXX.T"O1KO2]/OY
M(I+RQMKF2$[HFFA5RA]5)''X4M[IUEJ"H+RRM[KRVWQB>-7"MZC(.#[T >,W
M;0-\,O&D\&S[,OBHRAD'RA/M$)W#VQS772:EIMW\:;$17=M,CZ%-%E7#*S&9
M#MST)QSCTK8\)^'K[2XM>AU>&RDAU+4I[Q4BD,@V28^1@R#T]\YK?@TK3K4(
M+>PM81'&8D\N%5VH3DJ,#@9[4 >,7\-I_P *3\6#9$$AUV?R\ #9_I:#Y?3C
MTKJ_&(T[PQK_ (8N5V:3H\MS,+JZMH8U5)S$%A9\J1TWC<1QGK7<_P!B:2(C
M%_9EEY;-N*?9TP3ZXQUJ:2QLYK(V4MK ]J5VF!HP4(]-O3% 'DOB1=(TS2+O
M4=)U*?4=,N];LI=<G5T>#R]W[S'EJ%YPF_'7(SU-;\]_I<OQIT6:WN[1VET:
M= \<BG?^\0J,@\\;B/QKNXK"S@LOL4-I!':!2OD)& F#U&T<8J*TTC3+ H;/
M3K2V* JAA@5-H/4# XS0!R/Q6@MYO#VF&>.-B-8LU!8#(!E7.#VR*I7EN;+X
MGZO!HT4<%R_A7=%'"H4&42N$.!W' KT"ZL;2^55N[6"X"G*B6,/@^V::FFV$
M=R+E+*V6<# E6)0P&,=<9Z4 >8>&9?#/B'1?";2:_<OJ6GRPF+3T:%)HIU&U
MU90@<I]XMD\@$DU3TR;0]<\,:AHGB77[FUU.'496N;!6A2=IA,71HLIO8GY<
M8)].E>M1:7I]O>RWL-C;1W<HQ).D*B1_JP&30VEZ>^H+J#V-LUZHPMP85,@'
MH&QF@#@=$U.T'BCQW9:]-#'>&10B73!=]GY6$QG@KDL3CC+'UJQ\,]>TFS^'
M'A6VN-2M8I[F+R(8VE +R \J!Z\CCW'K7;7&EZ?>7,5S<V-M/<0_ZJ66%69/
M]TD9'X53OO#NGWJ6$)M;:.WLI5FB18%RA5@RA#_ ,J,X'(XH K^.06^'_B,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***XWQU\2M$\ "V34DN)[FYR8X+=06VCJQR0 /YT =E161X9\
M2:=XLT*WUC2Y&:VFR,.N&1@<%6'8BM>@ HHHH **** "BBN33QU%-KEWI-MH
MFK3SV=U%;7+1Q(5B$@R)#\WW<$'U]N* .LHKE+KQ[IUHMG=2VUP-+N[D6T5^
M"ACWDD*2N[<$)& V/?H0:N#Q3%+<2K;6-S<6\-\+"6>(IA)2P4Y4MNV@L 3C
M\,<T ;]'2N,TWQC?7/B'Q-:W&CW0MM):-%\IHF/^KWDGYP<L", 9 P,X.:K2
M>.=-USPK>WEQX>UB30Y=,>YEE,2A9(L8= 0X.X#/IT.#TH [RBN>MM=L;73M
M%M-/M)I)+RT62TLT(W)"J+RQ8X 7<HSGJ1C-8>L?$&9=%LKO3-*N_-EUF+3+
MB.8(K0OYJJZX+88D9 (..<DC% '>YYQWHKE9M2TM_'>EP76DW<>LM83203.5
MVI'E=Z?*Y!;.WL?K5&7XFV4>F7NI?V+JQLK"[>UO9?+C MRK!2Q&_P"89/\
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M<<@T :%%<?H_BZZO/$GB2UO["2TL=)9%,S/&5C7R]Y=R&SR".@( '.#FK/\
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MN2!WXS39?$]^OQ*C\.IIDS6@TXW+2J\?S$RJH?E@0J_,/4YZ<"@#K**Y2_\
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M"NU2V?,X;)QGG&0.*Z5[?55^)MCK@T>Y-I<Z.;-R'CS;R><'_>?-TV_W=W/
MS7;4UY$CQO=5W' W'&3Z4 >7>&--U;0H/^$8N_!T5W-!*ZVVL%8C \18E7D)
M.[< ?N@$G';K71>'+2]@^('BV\GL+B*TOFM3;3N!MD\N+8W?(Y]1S78T4 >8
M16OBBPT/QI)I6G7,5_=ZN;JUW; TD#>6K%,G ;:KX!]JMZ)87UI\1I=63P_?
M6VG7&CI$9)I$>3S%D9CYGSLQ8@CNQZ9QV]$HH \W\-W^J>"/A=:&\\/WLUQ:
MW$QN;=&0-'$TLDADSG! 4C@=SBNN\6PSW?@[6;:U@DGN+BQFABB0<LS(5 YZ
M<GO6K/;0W2JL\8D56#A6Z9'3([XZ\]P#VJ6@#SB73M3,/P\ TN[)TLH;T;1^
MYQ 8SGGGYCVSQ1I&G:OX>T3Q%X<DTNXO#<3W,FGW$>#',DV2 [$_(5).<]NF
M:]&5E;.U@<'!P>AI: /.=.\-WVA^)?!ENEM/<6FDZ7-:7%V@&P2.$QWSC*GM
MQQ4WA[PW/?P^);35(M3T^.[UR6^@D@G:!WC*J%.Y#D=#P?:O0** *&CZ1#HE
M@+.">[G0,6WW=PTS\_[3$G%7Z** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M);K3I'DABG>!B\;(0Z'### '@^U &E112 @@$'(/0B@!:*** "BBB@ HHHH
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MB,$(S*<;ESV/\\UUU5M/T^STJPAL;"VCMK6%=L<42X51]*LT %%%% !1110
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MRRW*Y++PV#C(J:?P)?W^I:O>W^NAFU32_P"SIE@M?+"?>^9/F) &[H<GKSZ
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M.N,X./>@#J],UR_O_&NLZ/YZ?9(;&WNK9Q%AT,F[(/8@;1VKD+CQ!KFO^#_
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M^*)?[4@)UTYQ]D/[@^6(_P#GI\WRCVYH QX_%7B 0>#M:GFLOL.NS06\MC'
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M.7&F:JT']CV36+>=")3-$0HR#D;6^0<X(YZ4-X%6[N?%7]I7J7%IXA5!)%'
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M4M5T6298/*!4?OHPPZ]3@<]L4 =1HVO:?K\5U+I\DCI:W+VLN^)HRLBXW##
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MTVVN$N[2&YBW>7,BR+N4J<$9&0>0?8U1US7]/\.V2W>I221PO(L2LD3/\S$
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M;&)"8]K*=ISM^8M@XZ]* /0**PO%.N2:)9V2VZH;K4+Z&Q@,@)1'D/WF QD
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M ,]/E^4^_/Y5H>'EUM=1U@:G?B]LS<;K)_LPA,:DMF/_ &PHV_-W.[TK?HH
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M$*I)S@#/ S6;H>OV/B&VN+BP:4QP7#VS^;&8R'3AAAN1SZB@"A'X<NU\=?\
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M().><$=J,?P\O(O!&E>&EUJ#&GW:7*W!LCE]DGF!2OF<<\$YZ5WA8 @$@$G
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M..YNC=,+>PVRLBJQ7;+@-M &1Z@"KVJ>!Y;^'2[J/6YXM=TZ=KB+4GB5][.
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M+4(!_I&H7_BVZLA(B*/F+,S.%8@9PC8!.,D=>E=CJGA.XF\5P^)-'U4:??\
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MJVX]-H/(ZC\*L:#X8U2P2.+6O$4NLPP1F."-[98@ 1MRY!)=MI(R<#D\9YH
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M@J>6^N:SKCQ-XM_X17Q3K*ZK:(^A:E<1)&MF,3I$5^5LG*@@GISD]>U;EGX
MU"WE\-RS>)'DDT$/%!MLD0-$T?EX(R?FQCYN>G0=:D;P%</X;\1:,VKH4UNZ
MFN9)1:<Q&7&Y5&_D<#&?UH M#7;K6O%AT.RN&LH[>PCO+F9%5I"TA(1%W @
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MC-=W&@31ZHP;29VN=TT/F-<2,&#%B&4#.YC@#@GC@8H RKW7?$6L#76\.QW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_M[3CXA.ABX0WRP>>\88?(I( !]SDX'M]*O"ZMVE$0GB,A) 0.,DCKQ[=Z
M,MO"7AYM,ETPZ/9FQED\UX/*&POG.['K[]:FM?#FBV-S)<6NE6<,TL(@=TA4
M%HQT4\=/:KJ75O+.\$=Q$\T?WXU<%E^H[42W5O!)''-<11O(<(KN 6/L#UH
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M<4:A511T  Z"I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KSBSL;-O'OQ#@:VA,,UA9M+&4&UB4ER2.YKT>LXZ!HYN;
MFY.E61GNEVW$GD+NE'HQQEA]: /)+#3;&T\"?#34X+:*._?5+)&N@O[UE8,&
M4MUVD<8Z5UL=C9GXW79^R6Y<:#%,,QC_ %GVA_F^O3GK75'PSH)M8+8Z+IQM
M[=_,AB^S)MC;U48P#[BIET/24U(ZDNF68OB,&Y$"^81Z;L9H \KM!!JWP*U:
M_OP!KD#74]Q,>)HKU)&*<]0PP@ ]"!TK0BT.TUGXFV4.OZ?;S3W'A5'O(G08
M>7SE!+#N1SCTP/05Z"WA_1WU!M0;3+0W;,':8Q+N9AT8^I'8]14AT;2VU0:F
M=.M#J 7:+HPKYH'INQG% 'G>G>'=%F\6_$*TETRT>VBCM?+A:(%$)MCDA>@/
MOUK'M;"TA\ ?#C5D@C&HOJ>GHUWC,K*Q*E2_4KMXQG& !VKUD:!HRS74HTJR
M$EV,7+BW7,P]'./F_&HSX9T%K2"T.BZ<;:W??#";9-D;>JC& ?<4 >6>.;BR
MN?#'CVXL#%&8;M([B:Z?=*]P@CPL0XV*,#!R<G=@#K73.FGR?&JWGD2U8-X?
M9Q(P4@R"X0 Y_O#IZUUDWAC0+BYN;F;1=/DGN8_*GE>V0M(G3#''(X'Y"IVT
M/27FLIFTRS,EB-MJY@7, ]$./EZ#I0!Y-?27&D^$?B<VCQF%H]5&1;C:4C*Q
M>85QT^4N<]NM=+XCM;:'7/ U]X>CA226[%O_ *.H"RV31,S@@=5 52,]"17:
MVFC:7827$EGIUI;O<G,[10JIE/\ M8'/XTRPT'2-*<O8:;:VS%2N8H@N%)R0
M,=!GG XH \AFT/2F^'WQ(G-A;F6UU6^^SOL&8"H0C9_<Y],=!Z5ZM<W%Z/!<
MUS9YDO\ ^SFDAXR6E\O*_7G%2#PSH(M[BW&BZ>(+EM\\?V9-LK>K#&"?<UHV
M]O#:6Z6]M"D,,8VI'&H55'H .E 'GGA7_A%=9\,>$=1%PC:A;%#&8I<3-<LN
M)0X'S-D[F;/8$GBLK3DMM9^$_BJ?6%0:O#/>O=R-Q)#/&6:,@]1M CV^P&*]
M)L_#FB:?J<VI6>DV5O?3Y\RXB@57;/7) SSW]:67P_H\^H&_ETRT>[8J6F:)
M2S%?NDGN1V)Z4 <'HK7(^(/A>XU<+'J$_A9A<LX +2AXBP/N.2?QKG[J2!_@
MOX_^SM&8O[7O-GED;=IF7&,=L8KU[4]"TG6F@;5--M+PV[;X3<0J^P^V1QT'
MY5&_AO0I+:XMWT>P>&YE,T\;6Z%97)SN8$?,<D\F@#EY;Q)OC'!IVH[/(31O
M-T^.3[KRF0B1ESP7V@#U SZFCX7QVT$'BFWM!&D,?B*[")'C"KA,  =!74W_
M (<T75+:WM[[2;*YAMSF%)8%81_[HQQ^%36&D:;I7F_V?86UKYS;Y/(B5-Y]
M3@<T <-!H>DZY\4_%\.KV-O>1+9V)6.X4,HRL@+ 'C/OU&3@C-<MHUY)I>F>
M#[74+TP:"^H7\=M<W #IM4XMMQ;C!&_:3[$=!7KU]H&CZE=+<WNF6EQ.J[!)
M)$"VW^Z3W'MTJ:^TO3]3L&L+ZRM[FT8 &"6,,G'3@\<4 8/A#2=-TF]UK^S=
M3:[6YN%GFC39Y,,A'(0*, D8)'N#WK+T3R=6^('C.PUF".:2,6\<$4ZAA]D:
M/^$'L6W9QWZ]!79Z?IMCI-DEGIUI!:6R?=B@0(H]>!4-_H>E:I/'/?:=;7$T
M:E%DEC#,%/5<^A].E 'E=IH]]?\ PBMM01/M-_H-[)>:5)*-S200RG:N>I#(
M"!Z_+[5N:SJ,FI^ _$/C'28W$MS8^79R*N)%MUY9AW!RTASZ*IKT9(TCB6)$
M58U 5548 'H!Z4RWMH+6UCM;>%(K>)!&D2* JJ!@ #TQ0!P6F:9X;U76-!UB
MRUF&<_9Y((;:UCB59X63E)549*KCH>AXZFL#PIH.DK\'+[518P?;XK34XTN-
MOSHF^4;0>PP.G3D^IKTS3_#&@Z5)<2:?HUA:O<C$QAMU0R#T.!T]J?#X>T6W
MTZ73X=(L8[*;_66Z6Z"-_JH&#0!YK;:;9:>GPMO[2VBANY_+CEG5?GD5K0Y#
M-U(X'!Z8&*9:1:5XGT;Q#9:_K:6-]!J<[70*QK/"4E)B9&8;L! @4CTP*],/
MAS0RMJIT>P*VG_'L/LR8A_W./E_"DN/#>AW>KQZM<:192ZC%C9=/ ID7'3YL
M9X[>E 'FGBV6QN],\??9RGGV]A%'>SWYW.SB',:1)QLZYW9^\3A3UJW/INF:
MWXZ\'_;;>"[2ZT.<7&\!A,0(L!_[V"3UZ'Z5Z#<>'-$N[Z6^N=(L9KN6(PR3
MR6ZL[H1@J21DC''TXHC\.:'#/;3Q:/8)-:J$MY%MT#1*.RG&5'TH XSPU'IT
M_C/Q;I&H6]NHL8H+:TM95&V.R\H<(#_"3G./;/05H?"$H?A9H80@@1R#@Y_Y
M:O727_A[1M4O8+R_TJSNKF#B*6:%691Z D=*L:?IECI-HMKIUG!:6Z\B.",(
MN?7 [T >667A[0-7T;XAW&LVEO(8=7O=MQ*,M !$AW(3]TYYR.N!G.*EN;6\
MT?PMX/\ '%] S:GI5M$FI[TS(]M(H5RW<LF0W_?5>BR>'=&FOVOY-*LVNV(+
M2F%=S$="3CDCL3TK.UVTUW5;XZ3'!8KH-S"%NKAI6\[!)WQJF,?,O&<\9)[8
MH F\+6ZO:7&LO$$N-6E^U'Y<,(\!8@?I&JDCU+5@:.8M3^)/C"PUB".9XXK9
M+6*=0P-JR'=M![%\[L=\ ]!7>      #H!5&_P!$TO5)HYK_ $^VN)8@51Y(
MP64'J,^A[CH: /'[:W+^%/!R7RK/;P^+/LUG+. Q:U!E"#)ZKQQ[ 5U:Z9I>
MJ_%Z^AN;6VNK1=!MS'$ZAXL>;)@[>AXZ?I7;WFD:;J%@MA>Z?:W%FNW;!+"K
M1C;TPI&.*8N@Z0MX]XNEV0NG3RVF$"AV3&-I;&<>U 'D.BZD+'P7X"CO;L6V
MD-J%Y!--*H:-&5Y1 'W<8!'&> 0#VJWXTT'1[+P+XUFL[\7S7!M[F2-53R;>
M7<!N3:,*S 9;OT/>O4!X<T-=*DTM='L%T^0Y>U6W01L>N2N,9IJ>&-!321I*
MZ-8?V<&W?93;J8\^NW&,^] ',:]X72RGT^7PJ--LM6$[W8MKF,^5?$1[&WD<
M[P&R&Z\D]R:U? 6H17_AV0)I1TN:WO+B&YM-P98YO,+2;2."NYB16Q<:)I5U
M#;Q3Z?;/';?Z@&(?N?\ <_N_A5FUM+>RMUM[6".&%<[4C4*!DY/ ]^: /,KM
M[O0M7-U<VUIK7AV[UP,EU'\MU87)FV8(/WU#C9QSCCI@5&/LEO9_%:&;R8UW
MLVQL 9:U&TX]ST]37HT?A_1XKPW<>F6B7#2F8R+$ 3(>KG_:Y^]UIESX;T.]
MU!]0NM)LIKQXC"T[P*7*$8*YQG&"1].* //-%U2VAUSP-:ZK+$NG2^&D-F9B
M/+-UB,-UXW!.!_O$=Z?XDTS1;/0]!L-'=GL&\66^<2EE#,Q+JA!X4$D8'0@C
MKFN_NO#6A7VF1Z9<Z/8RV,1S';M;KL0^JKC _"I)O#^C7%M;6T^DV,D%J0;>
M)[=2L)'3:,87\* .3\/V5II7Q9\06>GVT-K;2:9:3-# @1"^Z1=VT<9Q5K7I
M[*7Q]IUF!&=2CTZ>8/=M_H\4)959MG\;DC&,KA=V3TKIHM'TR#47U"'3K6.]
M==K7"PJ)&'H6QDBFWVB:5J=S;W%_IMI=3VQW023PJ[1GU4D<=!^5 'E?A6"]
MU#X=>%UT;4K%=6L;NZFMK:[!:&X59)DV''*X4Y4CIC\1W7@+4([_ $*X THZ
M5<6][/#=6@8,B3;MSE"."I+9_$UJ?\(QH0A$(T>Q6-96G4+ HVR-U<8'#'UZ
MU?M;2WL;=;>U@CAA4DA(U"C).2?J3S0!P6DV-FWQ#^(%NUM"89K:R:6,H-K$
MQR9)'?-<EIFFV-M\./AUJD-M$E^VKV*&Z"_O"K2%67=UVXXQTKV :#I N;FY
M&EV0GNEVW$OD+NE'HQQEA]:B/AC0#:0VAT33OLT#^9%#]E39&W]Y1C /N* ,
MCXE7EQ8> M0N8#(%1HO/,8RPA,JB7 _W-WX9JIH^FZ))XLL=;T_7([BXELFA
M6&S6-8Y8>H9P@Z*< 'L2!7:M&CQ&)D5HRNTH1D$>F/2LW3?#>AZ-'<)IFD65
MFEQ_KA! J>9[' Y')XH \GTW4!I_PO\ "3W$X@TN36YDO92H9%4RS[-X/&W?
ML)SQP*ZZW\(:#J=UXAMTU,7HU>U074,*Q^3$<%4D 48#GDY[[<]JZV+P_HT&
MF2Z;#I-C'82Y\RV2W41OGKE0,&GZ7H^FZ':?9=*L+:RM]VXQV\80$^IQU- '
M$^!KB77K;3;#4;=1<>&=]O= IP;E<Q(5_P"V89C_ +ZFN9N;NQGTKPQJ.FM%
M#92^*D>)IWWW4I,SB1F;C:.2-N"=NW)'2O98;:"W>9X84C:9_,E*K@NV N3Z
MG"@?@*S#X2\.'S\Z#II^T2B:;-JG[QP<AFXY.>?QH X>W"6WB_XC7.F0VYU%
M+2VDL=JKN,IMG(V^I)].M9^H1P7'P7\.ZOHP4ZU"]F]K,G^M>Z:14E!/4EB9
M-P/7G->J?V3IW]J?VI]@MO[0$?E?:O*7S=G]W=C./:H;?P_H]K>M>6^F6D5R
MSF0R)$H.X\%O8GN>IH XC3/#FBZG\4_&4=[IMM.B+I\RHZ# DVN=^/[V1UZ]
M?4U5T][O0=:T9;ZVM-7T2[U.1M-U6#Y;BWFE\SY95/WOO."1Z<^E>BP:-I=M
MJ$NH0:=:17LW^MN$A42/]6 R:9:Z!H]E<">UTRTAE5BZM'$%VL>K#'0G)R>I
MS0!9M;^SOO-^QW<%QY,ABE\F0/L<=5;'0CT->?W7A[1]7^,FHVVH:?;W$$NA
M1221.@VN_G.-Q'=L #/45V.C>'[31KK4;FV@@ADOI?-D6",(O&>3ZL222W?/
ML*LC1M+75#J8TZT&H%=INA"OFD>F[&<4 >7V\&D^)+3Q7I>O:Q#87,.I3"97
M6-98HE;,+HS<@! N"/?UJQXECOM-&L:M%%!K^C&TACU:RNOW=W;A(@=Z,1C[
MK;RIQ\V<<YKT*[\-Z'?:I%J=WI%C/?PX\NXD@5G7'3DC/';TI]QH&CW5X]W/
MIEI)<2;?,D:(%I-OW=Q_BQCC/2@#C+>/3;GXQW$\MO;[)] MY5$T:@EFG<9P
M?XN0/TKGM#T:WM?ASXBUG2]/B.MV%SJ8L9T3,D W.N$],*3@#C/UKUBXTC3;
MN_AOKG3[6:[A4I%/)"K.BGJ Q&0.3^=+I^D:;I*2)INGVMFDC;G6WA6,,?4X
M')H \WU>"U;P5X)U7P^J+?+=V:VDD0^9PXQ*C$<D$;BV?[I)Z5<\/Q6>O+X\
MM?$$<;W*ZE-#-YP&Z.U"#R2,]%VY8'UR>M=M9^']'T^Y-S9Z9:6\Q+'?'$JD
M%OO$8Z9[XZTMYH&D:A=B[O-,M)[C;L,DD0+%>NTGN/8T >4Z3:RZG)\*YM=@
M$U[/;WB3-,OS2QB$E _=@5P2#UR<]35^S\/:-)J'Q'LWTVU:UMV5X(3&"D+/
M:AF9%Z*2>XP>*]+N='TR\O(+NZT^UGN;?_4S20JSQ_[I(R/PJ)?#VBJUTRZ1
M8@W8Q<D6Z?OA_M\?-^- 'GEA#K-YX8\&ZEHUQ97>IVVBCS-.O\[;J)EC#%6_
MA<%0,G^]SQUZWP?KND7'A?1O)2/3/M2O';V$\JAPR,5=$'&X*0>@Z8K3/AG0
MO+@C&D62+;@K"$@5?*!ZA<#Y0>X'6H=1\,:=J$^DL;.TC339%DMRL(WQ;2I"
MQG^ $JN<=0,=Z ,3XN?\DOUG/_3'_P!')5*XL]/T'XM:;)9V\=K'-HUTUR84
MP9=KHV6QRS=>3DUW.H:98:M;&VU&RM[R D'RKB(2+D=#@C%1?V'I/VV&]_LR
MS^U0KLBG\A=Z+Z!L9 ]J /)K6XLHS\.[VR>"VL9+Z4VXED#W+1M'(6>63(&2
M?O+@X/4FNR\.D?\ "T_&_/\ RQT__P!%O6]%X2\.0*%AT'38U$XN %M4 $HS
MA^GWADX/O5E=#TE+NYNDTRS6XN1MGE$"AY1Z,<9;\: /*]*T=]3^ 6CWEK"D
MFHZ46U"SRN3OBF9BO_ @",>XJ7^W#:>+K?QAIUDIL/$ML;"V'EX9[A5W0L_I
MO;S$^B@UZI8:98:5:_9=.LK>TM\D^5;Q*B9/7@#%*NG626]M;K:PB&U*FWC"
M#;%M&!M'; .* .)NK/3-+\2>'=#MDC-_:Z?/)')<G$"1_*))"@^_(3V!'!8D
MUSF@:"OB7X.1P6;02ZIIMY<76G, "$DCN'9 !SA6QMQTP?:O4]0T32M5FMYM
M1TVTNY+9MT+SPJYC/JI(XZ#\JS=0LM2TB*./PEI&DI]HG9[LRDP@%A_K,(OS
M'/7O_0 Y_3;ZT\9Z-J7BB8O86QTQ[.&<IA[?*%IW!Z\,0OUB/K4?ABYOM(\4
MP:3XBT^Q2[CTQ_LFK6)VQ7%NC)N#J?N$?*?3DXKM=/T>VLM"CTEU6X@$1CE\
MQ01-NSO+#I\Q))'N:;#H.E6<$T=IIMI&)(C"5$8"E/[AX^[[=/:@"Y:7=M?V
ML=U9W$5Q;R#*2PN'1AZ@C@U-69H&B6WA_2(]/M$C2)7=]L2;$!9BQ"KV )P!
MZ>O6M.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLEG+'I&LV8VL8556*RI[@+\P."<=S6G\1+I[6X\+F?C26UB);XG[HX/E[_\
M9W[3SQD"@#L+6^M+Z$S6EU!<1 D%XI Z@CW%)!J%E<RB*"\MY9"GF!(Y58E<
MXW8!Z9XS7#:C8*?BK<K!$C6=UH3G4XBH,;L'Q$S#INQN SV4^E2?";1],B\!
MZ#JD5E;B_>R\M[H(/,92V2I;J1D#CM@4 =/?>)=*T_7+/1[B[B2]NE9UC9P-
MJ*.ISTR< >O/H:NR:E817B6<E[;)=/C;"TJAVSZ+G)KC/$7V2'XL^&);KR$1
MK"]R\N "1Y?<^E<AXMU"PG\*>*)K"6"V2/7D$HGDWW$MPDL2LRY(\M0%X'/
M)XH ]C.H60G: WEN)E!+1^:NX #)R,^E4]4NI9]+6;2]4L;<F9!]HF DC*[A
MN7@CDC('/6N)\?VC7&HVVN>&U>;5K*V9KTVC@&:Q;(9-W/SG!*>ZL>PI/&TN
MBZC\,]&OM)CMS8"]L39E$ \M?.08']TXR"/8B@#T2[O[/3T5[V[@MD8X5II
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#:7=M?VL=U9W$5Q;RKNCEB<,KCU!'!I+N\M;"V>YO+F&W@09>69PBJ/<G@4
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M+,QP /4F@!U%0VMW;7ULES:7$5Q!(,I+$X96[<$<&IJ "BBB@ HHHH ****
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MWBFAG,GDSD96-P5'7! ([CIWK%T.2XT_Q1\1)M,L8[F>*XMWCMM_EB0_9E.
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M3^^0W(FP5"_*0,Y.3TP <Y'3MI>LV/CJXU^&R@NH;S3XK5XDN=K12(S-GYE
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M:#D _A4^G^']0/BWQ5=W]K&NG:U%!"A2;+J$C9&W#'&=W&":RX?".NR^ ?\
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M?E 8D<\A3R.E<HGA#Q<VEZ5#<6VF37]AK4=_/>/=-OO@K/@GY/EP& QSC&
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MZ[DE?L01C('3/4U6\#ZKK>J:GXE_M(VS16VJR6Z"-V^0+''A5!'3J2<]2>*
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M=X?DD7;YIVSA8A)G.,J2#CO0!V-5KG4+.SN+:"YNH89KIS' CN 96 R0H[G
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MY(46[<AB8HR.X"]>>6''>JM[XUU$WOAJWTS2()_[>LY+F!IKDIY96-7PP"G
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M\GN<8XS0!T&L:+I^OV#6.IP&XM6(9HO,90Q!R,[2,X(!Y]*O1QB*-8U+%5&
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ME7@#@9Y.>)I-$UGQ!/H+:]#:0#2;@7DAMYB_VB=4*J5!4;5RQ;GG@#WKKZ*
M/.SX/U]O"GC'2BFGB?7+RXG@87+[4655&&_=YR-O;.<U./#?B'2O$UCX@TR.
MQGDDTZ.PU"REN&1?D.5DCDV'IZ%>E=[10!YHW@;7[CPAXCTV5]/2\OM7;5+4
MK(Y3/FI($?Y1C[F,C/7VK1_X1S7M5\8KK&J0:?!:3Z/+IMQ;PW#NZ!W#$AB@
M#'Y?1<9[XR>ZHH X;PGH_C'1K2ST&^GTU]+L-J17T3/Y\T*GY$*$84X 4G)X
MZ<\UH>&=#U71-<U\S?9'T[4+][Z*178RY954H5Q@8V]<G/I74T4 <OXGT/4[
M[7O#NKZ7]E>72YYF>*YD9 R21E"00K<C.<8Y]15.U\/ZW!KWBZ_:.Q9-8BA2
MW N&!!CB,?SC9P#G/!.*[2B@#S2#P9XGTC2O"]YI4NG_ -M:+:-93P2R.8+J
M%MN1NV@J<J".*U/$N@^)O$G@:[TZ=M.74KN6)_+$KB&!$D1]H;:2Q.TY.!U]
M!7;T4 <HVC:N_P 1K7Q 8K,62:8UE(OVAC(&9U<D#9@@;<=16[K5@VJZ%J.G
M(XC:[MI( Y&0I92N?UJ]10!PUMX8U:_T/P_HFK0VD%II#V[RR0SF0W)@ V!0
M5&T$@$YYXQSG(KWOA;Q%'/XQM+!-/>RUY'DCGFF8/$[0^64*!<') P=PQG.#
MTKT&B@#A9/"^H77A[3]$UG2-*U2PAT^.WDC,Y5DF0;=Z,4R 1C)X([9YJ)?!
M^N6]OX*A%Q;WAT.0R7,T\[*TF49,+\IS@-U..@KOZ* .(A\-ZW'?>-)S%8E=
M;51;#[0WRD0B+Y_DX]>,^E9T?A#Q1I%IX9U#2)-..KZ3IPTVZMII7\FZA 7H
M^T%2"N1QW]N?2** .6N=/U^]TV%-3M-*OUGE8WU@['RA$5PJQEE.Y@P!RP&<
MGIQ67I7A"_T70#I45I97NF37\LLFF74Q=(K9E^6)&93DA@&P<#DC/>N]HH Y
MKP3X;?POI-U9%MEO+>23VUJ)#(MK&V,1ACUY!/U8]>IPM<\)^(]0OO%:1-IT
MUOK%GY%K<W$K^9:KY>TQ!0I&TMSD$=<D-TKT*B@#AK/PYKZ>(O#.HW$>G^7I
MFG26DXCN'R6<(,KE.0-G<C.:S9_ &M7NA:]:O-9VU[<:V=9T^5)&D5'!4JK@
MJ/[O.,]?;GTNB@#B$TGQ1J'C+0==O[/3+5+&WGAGBBNWD)\S9\R_(/[O3]:T
MO&NCZKK.F64>E-;NT%[%//:W+E([J)<YC8@'@D@]"..172T4 >;7?@'6=8D\
M717TUC;0:XEM)"]LSLT$L*J%&"!E05'/?T&>.E\/KXNE,?\ PD?]FPB!-I^P
MR,YN'QC<=P&U>IVC)SCD8P>DHH \Q_X0CQ&?A%<^##_9GGA?)@F$[[63S2^]
MODX.,#: ?7/8=3XOT"[\1^&TBMWBM=7MIH[NTEW%EBG0Y'.!D$9'3H:Z6B@#
MD_%?ABZU'X=W7AK2C"9I8%@62YD*CJ"78A223@GIR33=2T+6IO%/A_7+1;'=
M:6TUM=12S-A1)L^9"%^;!7H=N?4=NNHH X*;P3?ZI>^-H]0:WAL]?2)8'AE9
MY(C''L!92H'4!N#[5?T"'QQLBM]>DTM$MD(^T6CNSW3!2%+!@ @Z,>N2.@%=
M=10!PFF^$+S_ (2S2_$,]E9:;?P12+J4EC,2M^63 RNU>-WS9/(P!SU&KX^T
M/4/$G@Z]TC3?LXN+DQX:XD**H5U8]%)_AQT[UTU% '*2Z-J\GQ"L_$'DV8M(
MM->S=/M#;][.KY V8(&W'7O4G@K1-2T.VU:/45M@;O4[B]C\B5GPLC;L'*KR
M*Z>B@#@]9\,>(;W7O$,L+:?/9ZIIXM;:6YD<267R,K*JA2"&)R2"/?. *CL?
M"_B*&^\$W$\>F[="M)+>X"7#Y;?$L8*_)SC9GG'7';)] HH X>_T/Q1I/C*]
MUOPV=.N;75$C%Y:7TCQ^7(B[5D1E!XVX!&.WY276A>)?^$ITK5!-8:A##9O#
M+'<NT:P3L^XS1J%;/'R $@X&-W)-=I10!YYH7A37-+\(V&@:E8Z1J=E$\ZW-
MNSG$J.Y='&Y,;@3TZ8[YQCH?!7AZ7PQH+:<\G[K[3++! )#(+:)FRL08\D ?
MJ37144 <%XI\'W_B:2=9K.QCNX[A7TW5XIBL]J@*DY 7)(^; R0<C..M27&A
M^*M%\7:CJ?AQM-NK#5BDEQ;7TCQF"95";U*@Y! &1[5W-% 'G6H#4;3XJ^'@
MHCO;E='N?.+-Y6_]XF2O!QSC /;O3M2\%:U/8ZE>6TMI_:>HZI#>W5H\C""6
M"(!1;LX7)!4 D[<$DC&*[*70].FUB/5Y+?-_$NQ)_,;*KW4<XP>XZ&M&@#SQ
MO"GB1KWQ;/Y>E*FN:?%;QQI,X$+K&\>W.SD#?G=@=/NC/%O4/#>O3_#K2=&M
MWLTO[(6RSPF9O)NHXL!HRVW(5@.>/8\5W%% '!6WA37)-;\1W-R--M[76=-B
MM@D#NQ@9$= HRH!'SYW<=,;?2JWA'Q0GAOPS):S:;!KWAU5B@3S'>"XB\L1N
MKMM!!8 '@<>O<>CT4 9.AC6WADN-=%I%<28"VUHS.D0&>=S %F.>> !@>Y.7
MX@T75K_QCX;U6SCM&M=*>=I1+.R._F1[/E 0CC.>37544 <MHNBZI8^./$>K
M7,=I]BU,6XB\N9FD7RD*_,"H'.>QXK&L/"&MZ5X3U3P?;&TDTRY\^.TO'E(>
M"&8DLK)M^9EW-C!P>,XKT*B@#C;;PO?:=XUTR_LX[;^RK#1_[,17G82_>4@X
MV8P @'7O66W@W7W\$^*]&*:>+G6;VYN(6%RY1%E.<,?+SD8[#FO1J* *EE!(
M-)@MKN-!((1'(J,67I@X.!D?@*X:S\&ZW:^"+KP07M7TY]\$.H&4^8MN[$D-
M'MY< D#G'0^U>B44 <@?#FI6'CNVU?3%LVT\:4FG21S2,KQA)"X*@*0V0<<D
M8Z\]#A3>"/$$WP\\0>']NG+=ZE?2W,;_ &ERBK)*),$^7G(QCIS7IE% '"WV
MB>*M-\5RZ_X?&FS#4;>*+4+&\F=55XP0KHX4]C@@C_ZUB^T#7[GQ'X6U-GLI
M_P"RVN)+MFE:,L9D*XC7:>%SQDY( ^M=E10 V2-)8VCD4,C JRD<$'M7%>'-
M"U_P5!)H^GPVNIZ(LKO9F2Y,,UNK$L8V^4A@"3@Y!]J[>B@#DO$_AC4O$N@J
MCW<%OJEO=Q7UGMRT,,L9RH)P"P/.3@=>G&*>=&U'5_$>DZWJ=M;VSZ3#-Y%O
M%.9-\TJA22VT84 $#@D[LG&.>JHH \S?P1XA?X6WGA?;IPO9[MIED^TOY84W
M'G<GR\Y[=*Z*[T75KKQ]H^N"*T6TM+.:WE7SV+[I"IRHV8(&WN1G-=539$$D
M;(Q8!A@[6*G\".10!Y1X1TW5/$'PMN=#CBMXK6]NKN)KLRDLD1N'W_)MY;[P
M'..02>U;&I>$-=DU/7H[3^SY=/U#3%LK.2YE?S+$"(HR*H4@AB<D@CWS@"NR
MTK1M/T.U-KIML+> L7\M6)4$G)(!/&3R:OT <#8>%_$$6I>"[FX33MFAV<MM
M<!+A\MOC1 5RG.-F><=<=LG1\.:5=Z%?^(KG5VL8K;4]0-S$5G+8!14VMN51
MGY>V>M=;5'5M&TW7;+[%JME#>6VX/Y4R[EW#H: .7^'>@QZ5:ZA/#<M<6;7,
MD&G9Z1VJR,0H]1O9\'NH7MBM/QMI&J:UHD5OI4D'FQW<4TL%PY2.ZB5LM$Q
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "L+QAK.H>'O#=WJ^GV$=^UHAED@>4QDH/O$$ ]!
MD_A6[39(TEC:.10Z."K*PR"#U!H RK/6?M?A2'6MULJR6@NMV\^6%*[N6QG
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M7[/0M.*2F0);'4&5SL=D/)BVY)4XSQ[BM[3K)M)U6X^U:M/>R7VWR1<;=Z[
M=P 15 7D'..I]Q7-?!EE3X3Z6[L%57N26)P //DH Z/PMXILO%>F275K'+!-
M!,UO=6LXQ)!*OWE8?UJ+6=5URRDOI;+3+.2RM+;SC+<7+1M(P#%E4!#T '.>
MI]JYCX8H;WQ!XT\06X/]EZEJ*K:/C"R^6&#2+Z@D]?:NV\1?\BSJW_7G-_Z
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MA-W;G[P*AU61/XEPWZ$<@8I?"OB[4F\+ZU-XB@B.HZ+=26DSVWW+IU"[2O\
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M)0;6P!CKG-0KXX,/A70]3N;)6U#6Q%]AL(),EVD4, 6(&  <LV,#W[Z7C?\
MY$'Q'_V#+G_T4U>;^6]F_P 'M:G_ .0=!9K:RN?NQR2VZ*A/ID\9]J .]UCQ
M%JOABQ&J:S:6DFF(RBZ>S=B]L&(&[##YU!(SC! YP:I^(O'P\+Z[I,6H6T+:
M+J08KJ$,I/DX*@,Z[<;"70;L]ZL_$VXB@^&^NK)\S3VK6\2 9+R/\J*!W.2*
MSM/T%##X6T#685G \.7%M=1/R"0;0,/P/>@#I=;U2\T\Z>;.&WG6ZN4MR9)"
MNT-D[A@'/3IQ]:SX/$6HZOJVJV>C6]BRZ5*+>8W,S*TLI4,0 H.U1D#<<Y.>
M..>+M)=2\*>(-'\$ZF9KJQ-^DVC7[#):%0V87/\ >3(QZCTX%;6M>#8]<UB[
M\0^$]8ET;Q%!(;>XD3YHIV0#"RIT/&WGT(X- '8:%J-QJND17=W9_8[AGD22
MWW[_ "RKLN,]_N]:TJYGP%X@O?$GA:.\U*VC@OHII;:X$7^K9XW*EE]B1^>:
MZ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHI%=7!*L& )'!SR.M "T444 %%%% !1110 4444 %%%% !11
M10 44C.J*6=@JCJ2< 4M !1110 444A=0P4L S=!GDT +1110 4444 %%%%
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M<0^<A88('<$>HY!^E<;<VOB#0O&FIZE:>'/[:TW61#(R+-$DMI,B!"#O."I
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M-V4D$* >5)'7WK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>O2M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M &9>RWE])%(BJID#Y"AB"<%_3H/7BO2I)(X8VDE=411EF8X 'N:<"",@Y!H
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M#T! .< UJ:'/JEGXEMKC6_"]U!<72"QCU!]1BN2B@%PFU0I .TDD DD#/3@
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MK6ND7LEK>%KM P5" S(,'<><XX&.YZ#=E\420^,;#0Y+%5M]0MWGM;PS\2%
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M:S26;7EHRW*R&558*588 1N1W(]ZP/\ A:5T/#=OXD?PO<KHOFM'=W N4+P
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MC12QS1)+$ZR1NH974Y# ]"#W%.KF(_$JXT/3=/LHC?:A9"Z2 R;([>%57))
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MKJ;3D2P1.Q8J8MIW.,G!R!_*I(]+\7>'/$NJMHEKI^HZ3JMQ]KQ<W)A>TF8
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M*FS!B*L@3:?O,<Y!'OG %>AT4 <%9:!KJ:]X1OKFSMUCTK3Y;6Y$=QN.YU0
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MSUK5HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNP7.T;F).!D\=.3ZFKU%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%'7I0 4444 %%%% !1110 4444 %%%% !111G
MG% !111WQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !11WHH **** "BBB@ HH[XHZ4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 444=* "BBB@ HHHH **** "BBB@ HHZT4 %%%% !11
M10 4444 %%%% !111TH **** "BBB@ HHH[XH **.M% !1110 4444 %%%%
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M_G:$]?EW$<GFK&DV&H1_$'3-:3P]J,%H^DR6T\MU*CS"0R(VZ0[R3PI ZGV
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MJRM]0TR^DBC222'4K D3V<N5QM*G=\PSV(^49H Z73;X:EIT-V()K?S <Q3
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MR*^X@ABV /EZ'DD].#0!U=%<U;>-=/O]'T6^LHIII=9'^AVW"N2%+/NR< *
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M]J[7P]#/;>&],M[J!H+B&UCBDC9E)5E4 \J2#T]: .:L=9U#6_%'BO1=0TZ
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M,D;(%S&FXCDYSTZX'/7BLE?']Y)9ZN8_#-VU[H\C+>V_VB,*BA0X97_BRIR
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M\@X.#@<#G/?'>];^,(-1M=$.FVYGNM7MC=00R/L$<0"EF=@#C!95X!R3Z9(
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MM(DM;35[I[6W,DI$ZL-VTO$5& =IZ,<9'K5>X\?7RGQ"+3PW-,VAO_I&^Z1
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MZ_=^'[NP2WU>*V%W @GW17$1.W*OM!&&X(*\=LT ;;7]FEZED]W MTXW+ 9
M'8>H7.35BO./ -F?$6ESW>MZ=;3-#K-S=17!F+.LR3$+@;1@*  .>@ Q6OJ&
MNZS'\2]/T.WMK9K"33Y;EMTY5G(=%)/RG&W)P.^>HH ZR*XAG,@AFCD,;[)
MC [&P#@XZ'!''O4E>2Z'KLWA*Q\;7=EH9NK*SUZXEG\N58A'&$CSL&/F(&3C
M@>]=OJ7BZUM;FVM+9[1KJXMOM:B[NA;QB,G"DMACDG.  >ASCN ='16'X3\3
M6_BO1!J,$+P,LKPRPN0VR13@@,.&'0@CJ"*W* "BBB@ HHHH **** "BBB@
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MF?=#9QCC/K[<UR/A?2[_ ,5?!71O#OV!H;>Y2,37C2(4$*R[R5 .XL0N "H
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MMYHYH9%#I)&P974]""."*HZYH.G^(K#[#J<<DML65RB3/'DJ01DJ03@@'\*
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MT\.VD7A=M.M)M/MF,=MK/VH#;!G(S#C)<#@=!T].?0JANKRVL8#/=W$-O""
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M@LH/(STR* /++/PWXI+^%;NXT6V_M#3KMGO[B2]5I+DF-D,I;!.WYLXY(Z
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MC6MM<7EMIBZ;?Z=/.$$B*00R2 $ AL]>QZ=J +=G\1[>\TZPD>UCM+J[OI+
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M6UN5T^7RKB WH2X=EQO$:;3NVDD<D9*G'8GK#?B31QJ%K"TP> 31QD["P(R
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M-Q7=@@Y92&P1CMTS5G3O$6K-X]\46M\EI'I6F06[;A.V8T*R.7QL^9CQD9&
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MQ!BRVU!MV\[L-@Y'W3[9TZXWX?Z;?Z?X-2YN)Q?:A<1@QRR?)OB1=L )Z@%
MK'W=JZ;2I;^;2K:35+:*VOF0&>&)]ZHWH#WH X>TAC3X[ZM+';HTHT&)A@ $
MMYI[^IP!FE3XE7Q\.Q^('\.^7IB7IM;IC> O'^^\K<BA?GYQG)7VSUJ_;Z3J
MT/Q1OO$+6&=/FTY+--LR>9N5]V=N<8.?7-83^$?$#_"R\\.?8HQ?S7S7"GSU
M\O:;D3<GKG''3K0!Z'K&HMI.C7=^EI<7C6\1=;>W7=)(1T51ZUB67BYO^$FN
M=#U.VM[::#3QJ#2PW/FHJ;MK*^54J1P?<'M5SQ7::OJGA"_MM%F^QZI-"!$S
M/M*G()7<,X)&1D=,YKE(_"6KWGB,7,NE6&FZ;=:'+I<T4%SN: N^XMPH#$\_
MS)[4 4O&VK7.O>%-#U5=*A33[C5;.2VF>;,RH95*N4VX 8=@Q(R,]\=7J6N2
MZI_;FG:;IL%]%IZ>7=&>;8K2%-WEH-K9(!!).!D@>N.5D\.>,IO!&F^&9=-L
M7ETNYMO+O/MFU)XH7!4[=I*G:H!S^&>E:UEHGB/0->U\65C:WNFZU*;L,;KR
MVMIV0*X;*_,IP,$#/'2@#*\+:M!IW@3X>07.D17JWDL4$4\A7_1I"KD.H()S
M@-R,=>M;VB:[KU[XS\4V4]I:R6VGM#'%&ERP(#1EQ@%,$MN&3D8QWQSC6?A3
MQ#;>%_!&GRV4!GT2]CN+GR[@$%%5UP,@9;Y^G3CK70:=I.L:5XX\1ZBMK!/I
M^I^1,CK-B0-'%L*;2,9) .<XQ0!5T#QC9/X1\/3:=I$-I-J\KPV6FQ.$1-I<
ML20O"@*6)"]3T.:LS>-IK*ZUG3KW2PNJ:=9'4$ABN-T=S!SEE<J"""""".N,
M9KG=,\$:[8>%O"3I% -:\.7$C^2TP\NXCD+!U5AT)5A@D=1Z<UL:EX=U#5]2
MU?77L_)NIM&?2K.U:52WSDLSNP)4<E1@$\ GJ<4 /LO'=[-+X:EN]#%MI^O(
M@AG%T'>.5HO, *;?NG! .<^H'2NVKSUO#NM?V/X$M18J9-"DA:[_ 'RX(2$Q
MG9SSG.1G%=+H>JZK>ZMK-EJ5A!;I9S 6\L,WF"6-MV-W]U\ $CT=: *VO>)[
MW2I=1%OI0D@T^S%U)<7,Q@CD)W8CC;:P+?*<],9'K4*>-H;R;1K>QA@%QJNG
MB_@2\N/)#*=N$!"MN?YN0.@&>:H:YH/B&^\2ZNZVUG>V%W8""QDN)ROV%]K!
MR$VG)8D'(P> ,XJE%X4O;SPII&A>(_#EM?VMKIT4 ^SW"^=!,@V[E9MN,@ G
M!XP!\W- '>V-S<76DV]U/:-;W,D*R/;%LF-R,E,\=#QFN'_X65?CPZ^OOX<V
M:=;7K6MVQO1O0"7RMR*%^?!.2"5]L]:ZOPS8:AI'A73['4KEKV^MX DLN[<7
M([9.,]ADXSC-<-+X1\02_##5_#PLHQ?W=\]Q&3.OEA&G$O)ZY &.G7% '93>
M(+BXUJ_TG1[.&ZN=/BC>Y:>X,2*S@E$!"L22!D\8 (ZYXY;4?'E_J6G>&KO1
M+>*);[5UL;N&YE*212+N+1':I &4.6YXQQSQJVVD:MHGC35=;L[(W=EK44+3
MVXE19;>>-=H/)VE2.N#D$=#65-X'U2RT727LDMKG48-?.LW<1E*(Q??N5&([
M!P,D<[3ZXH VM6\;?8)K^VMHK"6[T^)7N(9[[RMSE=_EQ_(2QQCD@#YA[X?9
M>,TUQ]/MM)LO,NKNR^W2QW;F(6\1.T!\*Q+%L@ #^$G/3.;)IOB[0?%E_JFC
MV-AJ5GJZQ/<VTMT83;3H@0LK%3N0@#MGCMW=/H?B/2_&EOXELX[?4S<V(L]0
MM_-$)5@Q97C)&-HR5P><>IH ;\*PPT_Q()+9+9_^$@N]T"-E8S\N0#@9'O@5
MFV=UJ>E?$+QT=!T*/4)<V3M%]H6W7_4DGG!RQ[<8ZY([]'X'T?5]'77?[4M[
M:+[;JL][%Y,YD^5R.#\H]/UZ"HH=-UG1_&OB'5+;3X[VWU9+<Q%;@(8GBC*8
MD##[ISG*[C[4 ):?$33M1T?2+NV$44^IK*4BO9Q"L/E';)O;!Z,0  .<CH,D
M<QXR\1Q>*/ACKC36*0W>G7]O"VU_-C)^T18>*3 RK ]< ]15]O!&N>';30+_
M ,/R6UYJFFFX^UP3,8TNUG;?(%;G;A@-N>PY]#?\4:5XG\3>!;RRFLK:'4+N
M6!H[5+@-' D<B.=TA W,=IZ#'0=B2 ;UQK\TNO7.BZ3:PW-Y:0)/<-/.8DCW
MD[%R%8ECM)Z<#GVK"D^(V/#T.KQ:5\D>HC3=2CFN-AL9=X0DD*0R@D<\<$?A
M8&CZII/CJ\\1V-F;JTU6UBCO+7S566*6/(1ER=I&"01GW&:6P\$(WA77],U$
MQ^=KUS<75R(SN6)I>%"DXSM 7GN1F@"[!XID?QQ>^&I[2"%H+,7L<WVK)EC+
M%?N[/EP1SSW'6M31+^?5-'MKZXMEMFG3S%C60OA#RI)*CDC!QCBN&D\ ZO=Z
M=X?NKF\3^VXY"FJSJ?\ 6P21B.5![A50 ^HS75ZOJFJ:;K>C6UII\$VG74AA
MN)/-VR1G'R[5QR  2?8&@"K\0=-U35?"%Q;Z1&D]RLD4IM9&VK<HCAFB)]&
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ME,:JLF=B_*"23M;/H,=<T =952]U/3]-"&_OK:U#G"F>94W?3)YK/\->(?\
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MLFU32+ VMTEGK]M>P/9,C!VCD9MK CNI0N3[#/:NML+*'3=/MK&W!$-O&L2
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MBGGTF[AMHU>:6%D17;:,D8Y.#2SZKI]MJ%MI\U[!'>W.?(MVD DDP"20O4@
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M>H:09[BSU:"VTP6I>ZG8&VFW$F51M._Y2%S\I(7J,U5TWP;XDM/#?@W3IH;
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M>3N8#KZ8XQU.> "VOC^];X>V?BC^SX TMV+:6W\TX -QY.5;'X\BM.77+O\
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MAXCL[JPO+:QN654_LW5'E*7%JP107.U/[X9L!N<X..M=1K>DR:KX3U#1Q/\
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M+F>_FL6N+Q76WRB[@ZE@I*OQMSCOSQSV.E7%[<Z:LM]!%%<[Y 5B<LA =@K
MXZ,H#?C6#<Z9KU_9PQZO::3J4,_F?;K%V(B0$+L$993N(PQ).,ECTP,6_!GA
MZ7PQX>&FO)N59Y9(8A(76WC9B5B#'DA1@9QZT <S/X_U]="U[5X]$L?)T2_F
MM[E&NV)D2/;G9\G7DG)QV&#72-XCFU#77T?1T@,\-HEW/-<9*H)"?+3:.23@
MDG/ QUS7/-X-UY_"'B_2"-.$^MWMQ<0L+A]L:RXX;]WG(QVZ^U7K;PWK&D^)
MXM?L4M)6N;".TU"T>=E&Z/[DB/MYXR""!Q0!C:KXXU74M,TO[!%#8WB>(H=*
MU&!W+;9%<'"L ,HV!SCH<8KN]9UJ'P[X;NM8U/ 2T@\R41<Y/]U<^IX&?6N1
MO/ >H_V4LUI)9MJ[:^FN3)([+"S*?]4&"D@!<#=MY()P,XKI_$6@#Q1X1O=$
MOY%C:[@V/)$"0C\$$ ]0& /OB@#,O/%&I:+>:,-8L[9+75IEM4>!V)MIW&41
M\_?!P1N&,'M69<^/M4M/"WB+4I-.LQ?:'>&">T,S .GRX<-C^(,"!CGIUJ\W
MA_6M<@T&UU];-$TJZCNY9;>9G-S)$"$PI4;02=QR3TQWS5BX\'B?QU)K)E7^
MS[FV5;NT(R)IX]RQL?4!7;\57TH LRZ]>2R6_P#9L5I>1-IYO9',C(,''E@'
M!X?YL<?P&N>L?'^L3Z9X8UBYTBTBTW6;B*U8+<,9HWDR%8#;C;D8ZYYSQTK5
M\*^%+OPSX8N]/\]+NY)DCMVE<@+ "1"A;!. IST/+&L>/P7KT7@KPIHH&G&X
MT:^M[F5_M#A)%B8G"_N\Y.>XX]Z .TUR_O-.TMI["P>^N2Z1I"IP/F8*68_W
M5!R?85QNH>.-2.F>,K:R?3WOM$LA<QW<+%HG5D=C\N3AE*$8R1T^E=#XTT?4
M]<\/"UTN:!+A;B*5XIV817"*P+1.0"=K#@\<].]<_+X-UZ]O_$\D[Z9;P:WI
M*V82%G8P.J2* ,J,K\X.[CIC;WH ZKPQ+?2^%M/EO#$]PUK&P*LQW908+$\Y
M]:\OUS4M8U?X1^-)]6>WE\N_EA4Q[N#'.B@ 'HH"\<YKU/PU;:C9>'[.TU1;
M5;F")(B+9V=,*H7.6 ))QGH,9QSC)XB^\#>(YO"/B;P] ^EF+4K^6ZMYGFD#
M 22B3#@(<$8(XSG/;'(!T*>*-1M/%Z:1K%C:V]M<V<MW;S13%V01D;ED! &<
M,#QD=N>M4(_'E[-_8U[!I;7.G:G,B&.&*4S6\;C*2L=NTKTW =,]6JYJ?AW4
M]4\9:7JLT5FME!8SVMQ&+ABY\W;G;\F"!M[D9SVJGX7T3QGH=O;:#<WFF2Z-
M9D)#?+O^TM"I^6,IC:#@;=V>!ZGF@"U\0]4U73+#2/[+DAC^TZM:V\K/G)5I
M%X&.@.,$^F?6IDUR^'CX:'+IEC]H_L=KQ+I93EB)%3R\[,JN23W[5/XUT*^U
M[2+1-.:W%W9W]O>QK<,51S&X;:2 2,^N#54:+KG_  G\/B)X]/:%=):Q:-9W
M#;S(),CY#\HQCKGO@=* ,2+XBZTW@_3?%+Z):#3YKD07$2W),H!F,0*?+@X.
M.I&>>E;</BR_LO%-SI.NV=I;Q#3GU**:VF:3;&C!75\J.1D'(XK"7P/X@7X6
MVOA;_B6F\ANUF:7[0_EE1<>=_P \\Y[=/?VK:U/PQJ&J^-%U*X2T&FR:1+IL
MZ+.WF_O&!) V8P,8Z^_M0!!!XXOY;O195TLSV&J2+&RP12F6T#C*.YV[2O0-
MC 7/5NM;VOZ\-'?3K6*)9K[4KD6UM&S;5S@LS,?15!/'7@=\UA>%M)\:Z5!:
M:+J-WI<FEV.U([V'?]HFB3[J%"-JG  )R>/?FM'Q?X<NM:.E7^FS11ZGI-V+
MFW$Q(CD&,/&Q ) 8'J <4 ,M_$E^/$UUX9O+>V74A:"\LYE9A#/'NVMD<E6!
M[9.1S6/\++>34O NEW.IV]I<>7//<6\K#?(LIFDW/R.#R>1ZUM0:)?3^*7\2
MWD%O'=16/V.UM4G+* 6W,S/MZD@   X /K@+X!T/4?#7A&TT?4_LIFMS)^\M
MI&=6W2,_\2KC&[% %>;Q=/-X@U32-/%D;W3WC7['<.5FN$958R)[ ,1C!R5Y
M(R*J>)_&]_X<M=4U&:QMXK.PG2..*XDVRWJG;O>+M@;N!@YVGI3/%?@^_P#%
M!NH;BTL%F6='TS54E9;BT4;2<@+DD$,0 V#D9QC-9VN>"/$VIV'BW3UFTR5=
M7E\RWO9Y'\Y$&W; 5"X"C:<$$]3\O/ !J7$D=O\ &L3R$(B>&9&=CV N%--C
M\>7LQT:]@TMKC3M3F1#'#%*9K9'&4E8[=I7IN Z9ZM5IO#FKWGCA=9ODL#9R
M:.VG3I%,^_+2!R5!3! QCJ,]>.E5?"^B>,]$M[;0;F\TR71K,A(;Y-_VEX5/
MRQE,;0<#;NSP/4\T =W7-MK]]J.L:KINB0VK/I819I+EFVO*R[A&NWI@8RW.
M"<8/-3>&M0UF]EU2+6(;$?9[HQV\MDS%'CZ@'=_&.^.,G'4&LZ#0-5T+Q?J^
MJZ4EK=6>KB.2:WGF,30S(NW<I"ME6'7N".,T 9D?Q'N]0A\./IFD1,VK3S6L
MD<]P5:WGC5BRG"G*Y7[W7'\.:Z>75M0TOP=<:OJ]C&+ZUM9)YK:TD+J2@)PK
M$9Y ';C-<O!X$U+39O#+636<W]G7MQ?7KRRM&99)@P8( K<#?QD] /K7<:HE
M[)I=TNFO$E\8F$#39V!\<;L \9ZT 8%CXFO;S2[C4[.*TU>S%FUQ VG.2TDH
M_P"6.#G!Z<]>O Q4>E>++J?Q=%X>OH[-IIK W9-M(28'5E#1.#GGYASQTZ5C
M7'@'4)+G6K[2!;>'[G4--:U:.SF9HY)RP(E.%7;@ KD#/S$\8YLZ?X9\10>)
MM%U=K?1K:&STZ2RDM;>60A<LK J=@SDKZ#;G^*@#/\$Z[%H/@"Q0('GO-6N[
M:W0YVY\Z5B3@$X"JQX'H.^:OS?$*ZTV+51J>G>6EG+;K'J BD2VD25@I<[AE
M=F?F&3]:I0> O$$/@^RM8;NQMM;TS4Y-1LY5=Y(7+NY*/E00")"#@&NA2W\8
M7>G-+J$>C_:2R(;!'<P/%G]YN<J268< ;<#'?)H U]%OKN_2>2<VDMON4VUU
M:/NCG0J#N')QSD8R>G7FLYM?OM2U;5M/T.&U=]+V)*]RS 22LN[RUV], C+'
M/)Q@XJ'P?X4_X1N\UB:&&.RLKZ5)(=/AD+QP$+AF'  +$]!P,#\([;0-6T'Q
M9K&IZ4EK=66K[)98)YFB:&=5V[@0K95AC/<$<9H YOQ1XHG\3> =&U/3HD@B
MN=5M8;F"9CO21;A04.!@C<O)],5WD\MGH&F:AKM_!;03+!YU[-;IS((U..<
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M^N]R*<A3Y[Y />NYKF/ >A:EX=\/O8:FUJTGVJ:96MV8C$DC/SD#!^;WKIZ
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MS;M8VD%ILB$; JKB5N.?O9ZGO@=,4 =M2%0W4 \YYKG->UZ]T;Q'H-J8[?\
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M=VQR0JCH.I(&1U''6VJR:#\0O&6IZTT+)9Z1;2L]LA7S$!D(PI)PW;&3]>:
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MQJ]SKOAVSU&]TVXTVZE4^;:7"E6C8$@]0#@XR..A%:] !1110 4444 %%%%
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MZ[M[HNUO<1 Y&&4;@0<D<=_S[VB@"CI,.H0V6=4N(IKR1B\GDJ5C3MM0'G
MZGJ<GC.!RDO@Z_U+6='U._ATZ'4=.NO-;4K61O.N(@"!&R[!P00#ECT.!S@=
MS10!Y\?!FMMX7\7Z4S:>)==O)[B)Q.^V(2JJX;Y.2-O;KGM5D>&/$,?B"VU"
M.XTUHO[+6P=)B[FV8$Y>( #=NXR#M/ YXKN** /-].\$>(;+1_"%F\VER-H-
MP97*R2*)%VL@ ^4\X8G/'ICO6KKGAWQ##XL7Q'X7N[!9YK9;6]M-0WB*55)*
MN&0$AAN(],5V=% '+WNCZQ>6MM;WT>EZM;RQRC4+>ZW1QL[%2GEC:^ H##GG
MG.<U;\'Z _ACPS;:2\WF^2SE0&++&K.6"*3R0H(4$]<=NE;M% '+3>#TF\<R
M:XTJFRN+54N;0CB69-RH[>H".PQZA3VI_@SPO+X2T&2Q-Q]KE$C^4SL1B($B
M*/.,@!<=CR3UKIJ* /.8_ >L#X;KX>:XL5OX+X7D,@=VB8BX\[:WR@CKC@'U
MK9.A:U)XYL-?F_L\QP:?):2(DK@EG=6R!M/ V@=>>O'2NMHH \XN/ VN7'@C
MQ-H7F:<L^L:C-=QR><Y6-9) Y!^3)(QCWSVK=GT/5I_'&EZ\5LE@M;&2VDC\
M]RQ9RI)'R8P-OXY[5U5% '->#]"U#0O[:%\;4B_U.:_C\B1FVB3'RG*CD8Z]
MZH:A8>.9/$,M]:'PZUM'E;..Z,Y,2]"WR@#<>Y[#@=\]I10!RMWX=U.[ET'6
M)9[1]>TMI"^ R02K(N)(P<$@#C:2"?E&>IJWH.@2:?JFKZS>M&VHZK(AD6(D
MI%'&NU$4D G R2<#);I6_10!QTGAS6]+\<7^O:')8RVVJQ1+?6UX[H4>,;5D
M1E5L_+P5./KZ8EEX$\2V&AZ);)>:7/+INI37CVTGF+!.LC.PW'!.Y2^1Q@$>
MU>F44 <=X?TRZ\+7NO7FN:EIBV>I7WVA'!,?SLBKM.XX'W>!DYSVZ5'\.]!@
MTJTU"ZMIVFLI[J1-/!Z16JNQ55_V=[2$'NI7VKJM1TNPU>T-KJ5E;WEN6#>5
M<1AUR.AP:LHBQHJ(H5% "JHP /04 <1;>#K^X\0:)K>HPZ=;ZG8;OM5]92-O
MO04*[64HHP20W).,8'7C2\4:'JVI:OH6H:9-:,NG32/+:7A81R[EVJ^5!^9.
M2.._:NGHH \_@\&Z_#X9\7:2USILKZW<7,L4@WH$\]=K%N#C'8#/UJYJGA?6
M+[PSX<M8GL4U#1KNVN0'D<Q2^4I4C.W(SDGH:[2B@#AKKPYXJTWQ3<ZWX>O=
M*<:E%$NH6U\LBIYB+M$D97)''&#Z=?2U=>'=9E\5^&]5-Q:W":9%<)</([(\
MK3!<E5"D*%*\ D\<9XS77T4 9OB'2VUOPUJFE+((FO;26W$A&0I92H./QKEI
M?#'B*XM_"8G;2S+HMPLLH260!PL9CPI*G).2V3CTQWKNZ* .#OO MYJ]_P",
M!>S6\5IKT5ND3PR,TD#0KA6(*@'G!Z]L>]:GAVT\8H\*^)+[2WBMAA6L%??<
MG& TF[ 7@YP!R<<@#!ZBB@# \0:5=ZM*+=['3=1TF2$I/:7KE?GS\K*0C=LC
ML>A!XYYNP\#ZYHS^&397]G=QZ5;S020WI<JA=LAX\ Y*CY!G'R]QFO0Z* /-
M&\!>(/\ A +WPV;K37DEU$W4<N9$ 3S_ #N>#R>F!T]36KJGA[Q-;>*V\1>&
M[G35EO+>.#4+*^+F)BF=KHRC.0&(Y XKMJ* ,5+?Q! ^EHMU8SQ[W;4GE1U9
M@02HA )  8X^8G@#DFMJBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@#U0$$ @Y!Z$4M8OA"]LM0\':1<Z=%+%9-:1K#'+]]%4;0#[C&,UM4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %9FI>'='UB>*?4M-MKN6'_5M,@8I_NYZ?A6G10!G66@:/IMTU
MU9:9:07++M:9(E#D>A;KCVJ:UTNQL;J[NK6TBAGO'$EQ(BX,K 8!/KQ5NB@
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M6TTVVAM[K<9XEC&R7/!W#H<]_6J]IX0\.6+6CVNB6,36;,]NRP+F-FQD@^O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BD!!&00>W%+0 4444 %%%%
M!1110 4444 %%1Q3PSAC#*D@1BC%&!PPZ@X[CTJ2@ HHHH **CBGAG#F&5)
MC%&V,#M8=0<="/2I* "BBB@ HHHH **CBGAGW^5*DGEN4?8P.UAU!]#[5)0
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M\A_FSA>!ZFL^U\.>*G'AB[NM#@;4].OC)?W,MZK/<Y1U\S=@G9\PXZCH%P*
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MG=R3G@?GBMG2-,UGPMKOB VVFOJ&GZK=&_@:.:-&AF90'20.P^7(!!7=QVH
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M[MI3#,V ",@  <FN6\"^)[KPY\._#A?2-^E27;6DEU]H"M&TEPZJRQX.Y02
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MJL,ZN2H."1@] >,UP'C.WO+/6/#EW!I.G0W>HZO;)=M'=M^_,:RM&C'R^5&
M=V,Y &#@&M?39-+TWXC3Z>GARSLM0NM.;4+C4(F4E_G164':#C/.3C.,XR:
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M,J@3L&P[-E\;.6^7&W( '<YI+?QS.;[0H[W2#9PZU))' LDQ%Q$5#%3)$5&
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MX'!J[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"-/:TMKB(_;QO8RE005V<8+ CU'H>!IS^*]:MO%,>ARZ#!YMY;//8N+W@["
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M$M]M$B",2';A#\Q!Z$ >]31^.+QKGP[<2Z.D6D:ZR1V\QN<S([QEUW1A< $
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M*LDK>4KR-B/[W&!QR/3.*O:1KNC>'9/%L(T.TTBTT+RWF:T )G#H9 <!1SR
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M(6N1Z!K6LKH5G]GT:_EMKI#>,6=8V"L8_DY/)/S8^AKT6-UEC61?NL P^AH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7->-?#]]K^EVK:5=1VNJ:?=I>V<DH)C+J"-KXYVD,0<5TM4M4
MU?3M$LFO-3O8+2V4X,DSA1GT&>I]J .9O=-\6Z]X2UBSU--+M[N\LI+2&W@F
M<QJ74@R.Y7/T4#CGDYXCN?#>MS2>#'6.Q_XDAW7(-PWS?NC'\GR<]<\X]*[>
MB@#S3Q+HFIV&G_$C5KE;46FJ:;^Y$<S,Z^5 R?,"H'.<\$UHV6BZAXBTGPFM
M_#;V]GIIM[YFCE+M-(D>(P!M&T9;<<^F!GK78:CIUIJUC+97T/G6THVR1EB
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MG/!XJDGA#6[[P5:>#=6^QM8V[0Q27L<IW36\3JR@1E?E8A%4\D#DC/2O0:*
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MAL,./FSZKC%>G11+#$L2;MJC W,6/YGDU5EU?3H=4@TR2]@6_N%+16Q<>8P
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ML6MO,74DD-(" ,'@''/J.*T]2OM:M_%NDVUHMA)I<ZN+I&+?:%(!(=<?*$&
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MOD=1T) 7U&14OAOQA<>([V-;>>P^2XEBOM/9&2ZM%4.%)RWS?,%!^4#YN.E
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M X.X\':Q/;^-(O,L1_PD(Q$?,?\ <_NA%S\O/ SQ]/>K,OAG5I;_ ,(7.ZR
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M,@[3R3ACTSG!Z5KZ)H6HZ=XO\0ZM<-:FVU5H&1(W8O'Y:;.<J <]?;WKIJ*
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MXS@D"ID\+:UHWB^YUG1+RUFAU&"&*_AORVXO$NU9591R=O4'&?7T[2B@#FO
MWA^_\,^'!IM_<V\[K/+*K0(R@!Y&?!R>>6__ %U3MO#6K07WBZY+63?VWM,*
M^:_[HB(1_-\O/ SQ]/>NQHH X%O!NL?\(SX1TI9+'S-"NK>>1S(^)A$I4 ?+
MQG/X8[U3U'P%XBO-(\0:8FI::8M1U 7\4\L;F4XD1Q&YZ *$P",\8&!7I5%
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MF:W3&),C.57R=W7_ &?:N]JK%IEA!J$VH16-M'>S@++<+$HDD Z!FQD]!UH
MGAACMH(X(4"11J$1%Z*H& !3Z** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %5_L-I]N^W?98/M>SR_/\L>9M_N[NN/:K%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !116!XJU2]TJ#3'LGB4W.HV]I)YL9;Y)'VDC!&".U &_16!K^
MIZIITLAT^%;IET^XN$MA&2\DL90* <]#O/&,G P:C\+ZX->$EQ;:I:W]D$4?
M)$8IH9<G<DBDY7M@$ ]>O6@#HZ*YJ?4=6E\;3:-:W-K%;KIR7:M);F1MYD9,
M'#CCY0?ZUEV7C>\OK^UT+[/!#K+7]Q9W#C+1(L**[2*,@G<KQX!/!8YSCD [
MFBN(USQI<>%[^[TZ\C2\G-K'<6+*/+\UFE6'8_7&'=#N'8GCCG=N/[>LX%GC
MDMKYE1VE@6(QEF",5"'<< N%'.>O6@#:HKB='\4W.JZ>]];:C:W"VT.^^MOL
MYBN+:164NA0L2/E\P#(Z@<FMS4=3NK;Q'HEE$83:WIF$N5);*)N&#G&/PH V
MJ*QDU.Z/C.72F\HV@L%N4PA#ABY4Y.<$<>@JE;:]?:AXGN["V6!+06"SVTK@
MDNQ=EWG!&5XX'<#.>1@ Z:BN5T75]0U/3=7']K:7(]G>- E]''E @16):/?P
MP)9>6 . W3KFKXUF@\-Z-JFH75K'9W;S1SZC:QF2)2I(B.W)V[\<YSM/RG!.
M0 =Y17(ZKJ7BBU\/6^KQ+8131PPO-8-&SM/*Q :-7#87DX7AN?:E;Q/=?\)@
M^A[42Y%PGEVSH1YMH4!:8/G!(;<,>V,<YH ZVBN/T?Q9<W\F@W,JQ_9-=,X@
M15PT6P,Z9.><HK9]\8J;7=?O+'Q+I^GI,MA:3%%-U<6+S13.S8$0D#J(VP."
MP()8>F" =51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>elicio-insidertradingcom011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio-insidertradingcom011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M74,$URZ+//\ 9HYS _DM+DC9YF-N<@CKU!'7BN1TVULK#XVWGV"S2TLWT18
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M&%=EKDP^425(._YNIR".: ,_2_%,^KZ-K%]H&M6VH/!:@QP:@JP/;3C=N\X
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M# ]XD%UK4L,LDMM;[(XVB*E2$+'))7+$GG/:@#JVE.FZ7+/=SM/]GC:223:
M6 !/0<=*YC2;SQ-K&F:!KUI=6IAOF2:[L9% 2*V<9&Q@-QD4%>IP3G@5U%O:
MR?V<+:_F%V[(5E<QA ^>ORCH.<8R>.YZUROA[P/J&@>5IZ^)9Y] MY-]O8-;
MJ'0!MP1I<Y90>V!GIG'% %>+Q!K.O>'M:U[2+R.W%C//':6KQ*R3+#P?,)^;
M+$'&TC (ZU2;64\0^+OAKK$<9B6\M+Z;RR<["84R,]\&MJ'P7<6 UFUTO5EM
MM,U:5YI;=[;>\+R#$AB?< N>N"K '\JGD\'*FL^&[NQNH[:UT&&2""U,!?>K
MH$.6W#H%&..O7- '/:7<W]G<_$6XTPVJWD>H*T;7;[(E_<QY9CZ 9/X5?TOQ
M%J,_B[4=$AOS<P#2DOK:ZNK380Y=D/ ";T. 0?U-+>_#V6_L?$EM+K.S^VKF
M.Z#QVV#!(A3;U<AE^09!QGFK</A'5$\3'7Y?$ ENWT_[#*GV)1&V&+ @!L@9
M/3)/OCB@#G=*\1>,;CP#:^+9+F*[2:U4O8VMEF5<S -*IS\Q$>\[<8X'7DGK
M/"&MPZ]#=7=EK<>JV.4$3%%26)L'<LB@#!S@]!Q^9ATCPG?:)X*L] M-9"S6
M;(8;O[-U57W;63?R",J<$<&KNB^&TTO6M5U>22%[S4O*$WD0^5'B,$ [=Q)8
M[CDD^GIR 9'BK6=6T^ZU(0W\=K'!IYN+.*"(32S2C<6,BE25C&%&>.I^:J'_
M  E'B#4-1\$QVMQ9VT6O:=+<S VY<QNL2/D?-R,OP..G)/2M74/!=S=:_K&H
M6VMO;6^L6B6UW!]G5V^1652CD_+PQR,'J>G:'3O MW877A>9];6?^P+:2VC5
MK3;YJNBH>C\8"#'7G/7H #*@\;:MI^D:G:7LL%WJD.NIHUI<&+8CF385=U!_
MA#$D#&=O;.:GDMKRV^,FB"YOVO$;2;DH9(U5E.^/=]T $=,<9'/)J>Y^' OK
M+6X+K53YFHZ@NI0S00;'M9U"A67+'( 4<>YYJ[;>$]6;Q/IFO:GK\=Q<65M)
M;E(+(1+*KE22<NV#\O/Z8[@%+XNQSM\/[IHKEHE6>V#H%!WYN(@.3TQUJ\=5
MOKCQ>/"L6H.CV]A]MN;P1)YC%G*HB@@J,8))P>W3FKWC#P[+XJT"324OELTD
MDC=Y##YA^1U< #<,<J/6H;[PO<3>(K/Q%9:A%;:K%;FTG9K<O#<0D[MI3>""
M#R"&_.@#D=1\<>(;70-8B62T&JZ-JL-E+*83MN(I74(X&?D8JW/#=.*U]6OO
M$WABZTJ[U+6;>[TVXU1;>Z\NS$7DQ2#$?.3P'X)]&'0\U8U+P";_ $2\LDU)
M8KN_ODO[NZ-MNWNC*5"KN&U1L4 9/ ZY.:W]?T./Q%X9O=&O) !=0&,RHN-C
M]0X&>S $#/:@#D[3Q;>QZ]XKTRZO#,UE$LNF[854S DH0./F82_N_3/:K6MZ
MCKFFM)!+JT<;1:9YT36T"R37%P,[BT>T[8AA>>/O<M6A)X(T]]3\/WOF2>9H
MZ.G/)N 0#F0]R' ?_>YJ._\ !]S<^)=0U6UUI[6'4;-;2Z@^SK(2%W;2C$_+
M]XY&#U_( PV\5^(=0B\"26<]G;?V_"QN0UN7V/Y!?(^;H#R![#FM+2=1UK4M
M<OO#LNK*L^CVT)O+V"V56GFEW,N%;<%4*!GN2>",4RQ\ WEE%X63^W4E_P"$
M?W",O9_ZP%/+QPXP-OU.><]JO7?A*[3Q=+XBT75EL9[N%(;Z&:V\Z.<)]Q@-
MRE6 XSDCV]0"C\)1(/ BB9E:47UWO91@%O/?.!V%=Q6!X0\-R>%='?3WU!KT
M-/+,':()C>Y8C ]R?_K5OT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMAL8(P,=><@'HEK-;ZI8VMZD8:.:-9H_,49 8 CZ'FK5>>Z;K-_=+IV@Z?\
M;(OLVB6MS)+:" R%I 54?OCC: A)P"22.1CFM+K'CB"7PG8ZA-:V%[?W,]M=
M8A23>%C9ED&&(!P =H[CKCB@#TNF?NYXOX)(V'U!%8=[;ZI9^![N*YUB274H
MK20M?PPI$Q8 D$+RH.,#]>*Y#P[K-[8>&/ 6BQ7\K7.N6ZGSY40F"*. .X3Y
M<$G@ MNZDG- 'IJJJ*%50JCH , 5EW7B&QM/$5AH<HG^V7R2/#B(["$&6^;I
MW' SU%8VE:SJ-KX_O?"NH7!O(S8+J-I<LBJX3?Y;(^T!3AL$$ <=<U7\1?\
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MLEK"8T83#R]^]]P)(9LJ-I&,>M3P^(-:N)M%TB47"ZA=Z8=1NVM8HDECY0!
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M4/Y8#L"^/F*C )]ADX_.N8MO"$IN]$GU34EOGT;<;:46WERL2A3YWW'(P>@
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M:E:6+N;QH%&]T0G<4Z#)'2N'?6_%>EZ%X3\4SZT+RUOVM(;VP-LBKMF4#>K
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MFG:=-/J.C7T"1.74!M\1"C*<.!@G@@_79T?P)/IEM]BN/$NI7]A#&T=G;3A
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M50 DL> #@$XK+\/>,M5U;1_"5E<7/E7^KSWD<]VL:!@ENS@[5P5#MA>Q ^;
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M#MSR'^N1GV&IXQ\176B:W*NI3ZAIVC2VJK::G:1"2*WN"6#&88)_N8R,=?P
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M$@N;1E^\)HSO7'N<8_&O/=?\1S:]IV@^/K _N?#X@FNE09+&;"W$?_ 5V_\
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M12V5V GFQ/%]P_=VMZ<CD5-9^#1::U>ZN=:U"6\O+1;:9I/+PVW.&QMP#\W
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MU(V@^R"JUMX-L;+P,_A.TFGALGMWMVD7!DVOG=R01GYCVXKHZ* .8?P9$_\
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MXN(C+'$?)V_(78*"<D<9(Z9K:H *Y^P\':3IWAJ_T""'%C>M.TJ\9_>DY'X
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MY\7(F?X?W+K/-$4N+;B)]N[,R*0?48)XJU_PB+:=/X?@T6^U&VM]/E=Y8UF
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MFMM1B8W5IEL-$JD%B[C(7[QR3@\<=YJVF#5K'[-]JN+5A(DJS6Y4.K(P88W
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MK5-J2RL22Q&"V.FXC/.. 2!P37+:9]C\8>*['Q&NE7ELNEP2PQRWMNT+O(Y
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M(WWD8%2C*?0KP>1BJM_X'TW4=#N-*EN+Q8[JY%U=3(ZB6>4,K!F)7L57
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MC//3%:-% '.Z=X.L["+3X)+R]O+732&LK>Y9"D!484C:H+%1P-Q;'UYJM?>
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M>K[1=K]J9M^  ?O9Y.T9/7WQ6A)X6M)M3TG49+J[:XTI'2V)=< , K;AMYR
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*O/4\'MGFL:X\7Z9H/@OQ)KNCC4;_P"SWLXD2Y#DI<<97#X*1J2..,<XH ]
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MC;)! ;;U!&"1P._6M.\\6Z1I-_9Z7,UVUU<0&6"-;>20R*H'0@?,W(X&3ZT
M=!17/0>--)N?#=YKD8NS;V3O%<P_9V\Z.12 R%.N1D?@:WHW6>%77<%=01D%
M3@C\P: 'T5Y18BXN;OQZUQXAU2T32K@BTF^VOMMQY>[E6)##/8@^E,BUW6-9
M\)_#O6;^6>WOKS5X8KA8W:-)H_WF"R X.X(K=._'% 'K5%8FK>*M/T=;MYDN
M98K(!KR2WA,BVX(SEL>QR0,D @D8(J2?Q%I^;:&V:6]EO(/M$,=H-S-#Q^\S
MD +R,$D9)XR: ->BO._ 7B&WM/"6L:EJ-[<O;)K5S%$]R7>4J9 L:8;+%N0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEKY80,6!Z9SN)/6N1U[0XO"WAG3M'_M'5TL9-2:YDU&" 2&U.6D^=54@J7(
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MH96B! *[<,0@+<<9//N*1/AU8P:Q=W=IJNJ6MC>RF:ZTR&<"WE<_>.,9 ;N
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MFQOI+%TF*EBZ8R?E)&.?4]* *0\$6-SX?OM)U>\O=6%\@2>XNY 9"%.5"[0
MNT\C Z\G-2Z'X372$876KZEJS^48(WOI0WEQGJ!M Y.!ECD\=:Z*B@#CO^%=
M61\'#PPVKZJU@K(4)>/>BHP=$'R8P"!SC)[G&!6E>>%HKC7(-;MKZYL]3C@^
MS23Q!")X\YVNI4@X/((P1].*WZ* .7O? NGWFBIIGVN]A07HOY9HV3S)YP^_
M>Y92/O <  < =!BKJ>&HE\6CQ&;^\:[^QBR,1\ORS'NW= F<[N<YK;HH 1E#
M*58 @C!![URR_#W05\,6GA_R7-E;72W29.6WJ^[!/IC*?[IQ71WEW!864]Y=
M2".WMXVEE<]%51DG\A63I7B&XU+4(87T:\@MKBU%U;W9(:,J<?(Y'W'P0<<Y
M&>>* )/$7AR#Q)%91W%Y=6XL[N.\C^SE!F1#E<[E;@'M4<GA:!O$[:_%?WL%
MS);+;S1Q,FR4*25+ J3D$GH0#T((R#KR7,:2/$O[R=8_,\E2-Q'0=2!R1CDB
MLSPMXAB\4Z!#JT-O+;QRR2H(I2"R[)&0YQD=5H Q_P#A75B?"+>&O[5U/["U
MQ]H+9B\S=YGFXSY>,;^>E=>BE4568N0,%FQD^_'%.HH X>/X8V$6FVNGQZSJ
MZVEE>K>V40ECQ;.&+87Y/F&2?O;L=L<Y[1H8Y+=H)%WQ,NQE?YMPQ@@YZUDW
MOB6W@UC^Q[.VGU#4EC$LL%OMQ"AZ-(S$*N>PSD]A3K/7UN=9_LF?3[RTO/L[
M7&)E4HR!E7Y64D'ENG4=P,C(!E:#X!M/#\R);ZMJDVFP.9+;3IY@T,)SD8XW
M$ \@$D \]>:J?\*RL%TY=/36-72SAOA?6D*RQXMI ^_Y?DR1DGAMV.U=Q10!
MS5YX-@O[>\LKG4KV;3;R599K20HPXVG"L5W $J">2>I!&:FA\*Q6^NZMJ\6I
M7RW&IQ)%*O[HH@0$+M&S(QN/4GKS6_10!R"?#VQBT#1=&35-26VT>Z2ZMFS%
MO+H25#'R\$#)[4[4O 5M>^(9-;LM7U32KRX18[LV,JJMR%& 6!4_,!QD8KK:
M* ,";PNIE8VFI7=I"]FED]NH1T**6PWSJ3O^<\YY[@U&GA"&T2.'3M1N[.U2
MPCT_[.H1T,:;L'YU)W_.><X/<&NCHH J:7IMKHVE6FFV2%+6UB6&)2<D*HP,
MGO7-W7P_M)/$%UJUCJ^K:9]M(:]MK*<)'<$#&X\$J2."5(/T/-:TGB*.+Q7#
MH$EA?*TT!EBO##_H[D9)0/G[P SC%;- &,WANT>YNI)999(9[3[$ELZH8H(L
M<A!MSSQG).<#T%8[_#G39?"-KX=GU'4YHK*19;*Z>51<6K+]THZJ.F2!D'C\
M*[&B@#E6\$0W'AV_TF^UG5+M[^/RKB\ED0RF/GY%^7:HY/09Y/-6-7\'6.N>
M&[71KVYNV-HR26]XCJD\4B?==2H ##Z5T5% '-Q^$$.A:AIMWJ^I7<M_"8)[
MV9T,OED$;5^7:HPS=%[D]:DM_"[646F)9ZQ?1'3[7[(A81L)8_EQO&S!(VC!
M&._7-=!10!QUY\-](N-(TRSM;F]L+C3)'EM+ZUD"S(SDM)SC!#$G(QCTP*Z#
M1M(31[,P_:KF\F=M\US=/NDE; &3@ #@    #%2+>W#:U)8G3YEME@647A9?
M+9BQ!0#.<@#/3'--OM2:#2+F^L+5]1DAW!;>!E#2,K%64$\9!!_*@"EJ?AF"
M_P!<M=;M[J>QU2WB: 3P[3YD1.3&ZL"",\CN#WIC^$K-_#VI:0MS=(-3,C7E
MRI3S9FD&UB25*CC X P ,8K=1BR*Q4J2,E3U'M3J *6D::ND:3:Z<EQ-/';1
M+%&\VW=M4 #.T =!Z5=HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR]N90'1MFZ*(NH7:A;=SQT SCBJ%M<:\OA#QI?G6=0\FU-U_9,S",YBC3<K
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MZQ*A!"PLP(R.OIG(!P<'%<SJ%]KF@1>.-%;6KZ[33]-74M/O)9/WT)(;*,P
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M4DA:*Y2;:&"IT0@L"NW'3G-.5-4U3Q)XYT^3Q!J<4%B+=K;R'5&C+0E^"%Z
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MP_XCO[.74;74+."!)-+U8LSVCLY7S06)W*=ZG.2/D[9KT;5=.35M.DLI)IX
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M=RVPM6C)3R_+#%@,;<\$DYSWK*7X>:6GA>]\.I>ZD--NF;,?G*?+5F+E$RO
MR3ZGWH KWVI7VI>+H_#T+$1QZ4EZX6\:V>1G<IG>JEL+MZ#'+<YK-N9?%^AZ
M%IHU99M9CM;B47XTJ8_:6AQF)N A8KGY@N,_*?6N@UKP+8ZW)I]R^H:E::E8
M)Y<.H6<RQ3%#U5CMVD'TQ_,U:3PM# MB;74M1MYK02?OA*KO.7VEC(75MQ)4
M?3'&,"@!?!VHVFJ>&K>[LM2EU&!WE*SS9$@&]B$8'G*@A>?2MVL_1]'M=$LG
MMK7>1)-)/+(Y&Z21V+,QP ,DGL /05H4 %%%% !1110 4444 %%%% !1110
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M=X@-K+="6*[M'+VUW;R&.:$G@[6'8CJ#D'N*V** ,NRT7[-*DUUJ%[J$L?\
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MP !@5T%W=06-G-=W4JQ6\"-))(W15 R2?PK'O?$;67C#2M :Q8KJ$4TBW/F
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MFCC[L%QN(^F1^8K(\->(V\0MJZO8M:-IVH/8LK2!RY55;=QP/O=.>E %34_
M>E:EK[:TESJ-C>2HL=R;"[: 7*CH),=<#C(P?>K.I>$-.U"\TZ[CEN[&?3XS
M!"]E+Y1,1QF,\?=^4>XQP16_4-Q=06@C,\JIYLBQ)G^)CT H Y=_AUHK:'J.
MCK-?I9ZC=M=W""XSERX? R#M&0.G)QR36IK/ANWUZSLK:]N[O%I.ERCQLJLT
MB'*LWR]CSC@5M5SEEXHDUMYWT'3_ +99P2-$;R6<11RLIPPCX8M@\9P!GH30
M!9E\,64GB1->\VZ2]%NMN_ERE4E5267>HX)!)-4X_ FC#1=5TBY$]W9:I.]S
M<QSN#F5CEF4@ @Y /L1QBM+1=9_M@7H:RN;.6SN3;217&W=NV(^1M)!&'&#G
MFM2@#E[#P)I]CIMU9/?ZM>?:(#;^==WC2211G^&,_P  X'09X'H*TK+0(+34
MQJ4US<WEZL'V9)K@KE(\[BHVJHY(!).3P.:UJ* ,KQ#X?LO$NE_8+XS*@D2:
M.2"39)'(IRK*>Q!K+_X0'2C=WUTUSJ33WUJ+6XD:[;+@9PW^\-QQV'8"NIHH
M R;+0(+34_[2FN;F\O1!]F2:X*Y2/.XJ-JJ.2 23D\#FIM;T6P\0Z/<:5J<
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M:WEY]ME3[26_>;@W&X''S 'U/<FM?Q1KC>&_#5]K LVNQ:1&5HE<)D#KR?\
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M?2$:.T8R_=5@%;(Q\V5 '/IZ\U&_@S2VGOV1[N.WU&0RWMHDY$4[D ,2.HR
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M[8RVLC!VW2,7+@Y#[\[MP('.<\4MGX?M[2X:[:YNKB],/V=;J=PTB1YSM7C
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M;&[=C*H4KDY)^;!(SU /&*G;P?IS)HR&:[QH^/L7[W_5X7:,\?-\O'.>* .
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M!E_UA9=K8X^7*\<8XJ#4O &BZI9Z9!,;R*;3$\NTN[>X:.>),8V[UY(P .:
M+?A&RU33=%:QU?4DU"Y@F=5E#EV6,X95=CRS $<GJ,&MZJFF:;;:181V=HKB
M),G,CEW<DY+,Q)+$GDDU;H **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML/WET2V?(4Y&W> 03D8&<\9H Z.BO(;O7]5\.6OQ$,!>W%@+-[:'S3.+7SE
M=EW#MG=CH"#U%=E+I<.C7,>N:=J=TR"RD7[&TS2I>L%+JY+$_-A3R.2#0!UE
M%<!X;LUUWPQX9\3'7+J&]9H[BZG64E;@MP\#*3M"[CM  XP,<U1TZ27Q7X0\
M2ZO<7EU;ZG;W=W';O%.R&S\G_5J #CH 6R/FR<T >FT5YCH6KZAJGBGP7>74
MLT3ZEH4T]U"LC".1P(\-LS@'DD<=ZQM5NKU/AQXYDCU*_26R\0216\BW4FZ-
M/,A79G/W<,W!XYH ]GKG]=\3-IOA^XU;3-/?5UMI6CECAE5"H0D2'+<?+M/'
MM6#]C.E_%2TL8;R^DMM3TJX>Z2:ZD<.Z.@#C)^0X8CY< =@*C^%.E67_  @P
MW1%U:\N04D=G3"W#[<*20.@[4 =);^(;B;Q7_8\ND7$-O):?:;>]9U*RXV;E
MVCE2-ZCGWJ_J6JQZ>]K %\V[NY/*MX <%R 223V4 $D_S) -L01+.TXC43.H
M5GQ\Q Z#/IR?SKB9)7G^.D%O+DQ6WAUY80>@=[@*Q'OA5% '<KG:-V,XYQ2U
MY[KDZ>'?'S2WUS>-I.M:=*BQBXDQ'<Q?,1&-WRETZ8P<KQUJAX-GO+ZPMO">
MISW7]KZ7?R'4'^U.7>),.C;\Y(?S(EQT(#<4 =EX=\12ZWJ.MV<UD+5M+NQ;
M<2[_ #,H&W=!C[W2M*\N+^*^L8[6Q2>VE=A=3-,$,"A200N/FR<#%>77&F)>
M)\3;IKJ\AEM)WG@-O<O%LD6V5@WR$;CD#@Y'M6M/?7ESJ7PSO'N[@/?(3<HL
MK".4FU+Y9 <$Y.<XH ](K C\12MX\E\-/9!$73Q?+<B7.\&39MVXXYSW]*YK
M3(6\;V'B1Y]4NK+4+759K6&:&4J;)8F&S"Y Y R2>NX]@,)=6$&L?%U8)KBX
M:W?PRI8P2M$91]H/5DP0._!'Y<4 >BT5Q_PRNKFY\%QK=7$MP]O=7-NLLSEG
M*),RKDGDX  _"N=U%)M.U[Q1X;>]OB^KVT=UH[_;) T<C'RF16SE0LA5\#HI
M.1@4 >I45YWX/U.3Q!I^D"3[2+K1;>0:A$)WW&Z4F,(W/S9*2/@Y_@K'6\NM
M2^#3^-(]0N(]=2.2]%PDS85DD;,6S.W9@;=N,=^O- 'KE8'B_P 12^%]%748
M[(72^?%"ZF79MWN$!Z'/+#BL'2;JYNOB;-#.]Q'#=>'8+F2U,S[$E:5@Q S\
MIP .,=*Y::YGNO@7')<W$UQ(-75/,FD+L0M_@ L22<  ?A0![*Y8(Q5=S <#
M.,FL/PEXA?Q-HTE_):"T=+J:W,0DWX,;E<YP.N/2L:*Z'B#XD:WHU\\@M-+L
M[<P6ZR,@D:7<7D.",D851Z<]S3/A/$(/!\\(=W$>IWB[G;<QQ,PR3W/O0!W-
M8#^(Y4\=Q^&VL0$DT][U;GS>3M=5V[<<?>ZYK@?%M[/%HWB'5]-OKNZN+/5H
M@+XS&);4B2)#;QJ"=X&2&R #N/4BNHN?^2UZ?_V )_\ T?'0!K>%O$4OB)-6
M,UD+1]/U&6Q*B7S-VP+\V<#KNZ5OUX\VM76@^$/&UW:2-#(_BF6!IUZPH[1*
MS^Q )P?4BNDUJ&7P]XT\,+I<MQ]EU226SO;5IW=9%$982?,3AEP<L.2#S0!W
MM%>.7Z:E%I7B;PA;7NH2:[;WHN=+E^V2B1X'7S5!;=DJ DB'MG X)S7:>%=3
MM_%EQ:Z]:/*MI!91Q+&)FV^<X#.K+G#%!M&3W9J .HFO+>WN+:WEE59;ERD*
M'JY"ECCZ!2:Q]"\12ZOKNO:9-9"V;2IHXMPEW^9O3>#T&."..:Y[Q;IMM=?%
M+P691+F6.^5BDSH<+&I&-I&.2>G7O61/I4>HZ[\2WDN;R(P>3)%]GN'AVN+4
M$-\A!)!'0Y'M0!ZO17F5GKE_JY\$Z;<S(PU'13>2^;*T8N9@L?!*\G 9VQT/
M7M75^$=+O]&M[ZQO=46]47+26Z;F=K:-N1$68DL!VSS@_2@!^A>(I=7UW7M,
MFLA;-I4T<6X2[_,WIO!Z#'!''-;]>43Z5'J.N?$QY+F\B,'DR1?9[AX=KBT!
M#?(0201T.1[5:TG7+O7-3\%Z5J,\OV>\T'^T)R'*_:I]J#:Q&,@ LQ'0Y&>E
M '=^(=4DT3P]J&JQ6PN39P/.8C)LW!5+'G![#TJ;2+XZIHMAJ!C$9NK>.<H#
MG;N4-C/?K7G%S/>6MG\3/#[333Z=8Z<9K1IG+M$);=V:/<>2 1D#L#]*LV.H
M/=:CX'\-RR/'8S:*+N15<K]H=(T"H2.<#+,1WP,\4 =7H7B*75];UW39K(6S
M:5/'%N$N_P S>@<'H,<$<<UOUXY->OX3/Q$EL9I(PFHV,?G22%C"DBQJQW')
M 57./3 ]*ZR/P]?6FM&\751;:?=6;PR6<-U*QED ++*C,<JP Y(ZCK0!V]0/
M>6\=]%9-*HN98WE2/N54J&/X%E_.N'^%NF&;PKHWB"ZU#4;F^N+'RY//NG>-
M@7SG83C<,=>O)SG-)>:=;3?'"SD<2[VT.20E9G7E9XP.AZ>W0]Q0!Z!5>^N)
M+6PGN(81-)%&76,OMW8&<9P<5YI93S^)?AOK?B26]NK;689+R6*2.=E^R&%F
MV1A<XV[57((YR<YKMM*O[C5? MGJ-W&([FZTY)I4 QAFCR>/J: )O"^MGQ'X
M7T[63!]G-Y")?*W;MF>V<#/Y5KUX?;:=<:1\(O#OBO3-2U%-5M4M=D7VEC%,
MCR*AA,6=N"&[#.>I-=GI'_%8:SXMM]1GN8VL;W[%;)#.T9MT" B1=I'S,Q8[
MO8#I0!WM%>-6.I:KX@TOX>SZAJ%[%/=WMQ:W3P3M&+A$64!B <9(7[PYYR".
M*UIO#<:_$&R\-KJVL_V:V@S.ZG4)2Q;SD .[.01D=,<  Y&00#T^BO/M A7Q
M/J'BBQO[F\4Z;=#3[4+<NKPQK&NV4$$9=B6;<>3@=JP+?5]5F\"^%/&FH75R
M9-/O/)U'9*RQW%OYC0^8R X)!VOT]>U 'L%%>46FK3V7B7Q!IPEN6AUR$2:&
MTMR[C._R7"Y/"[B)!M_@.?IZ1)'#I.@R)]K>&&VMFS<S,9&0*O+L6SDCKS0!
M?HKRO29[JU\4^!3;S7AM=1M[E9[BXF;??A80ZRO'DA<GYASD X('2H=376]0
MT;Q/;QG43XF35BFGRVS2!5BW)L"NORJFPG<"1SDGDB@#UJJ6H7%_ UF+&Q2Z
M$EPJ7!:81^3$0=SC@[B./E[YKC=;MXY-9N=.AN[R^EMM)YM&N'1+8DMB=Y<E
MB[8PO!(VYX!S6/\ VC?W7@SX::C+?W9N;G4;.*X83,!,I1R=X!PV2H/- 'J]
M%>;)I8UCQYXUT^[U#4S9Q6UG)'"E[(@1F20D@AL@9&=H.WU!P,4;#4/$-_X"
M\'ZM';OK2I:NU_8BX\N>X& HD7^^5[@]2P[X- 'J%S>6]GY/VB54,TJPQ@]7
M<] /R/Y&I)98X(GEE=4C12S,QP% Y))KR2^.DZ[;^ ;NSFOY87UB6+_29I%F
MC^64M&WS9#*1MSG/RCFNU^(=K%)\-/$$3ARD>G3,OSMG*H2,G.3R!UZT 2ZK
MXJ-AJ'AV&"T%Q:ZS.(EN/,V^7E"X.W'.0/45TE>6ZMI\267PXMXI;B-9;V-F
M<3,SC-LV<,Q)'X=.V*K76JW?A*/XAV]A=7)M]/\ L<EMY\SS&W,R@2,&<DX'
MWL'/2@#UNJ6EW%_<VC/J5BEG.)741I,)04#$*V0!U&#CM7,66@7MOXCL=2AU
M6.#3[B!X9[5+F6479*ED=68\.,$[AR1GFN+GN;[_ (4S>W*ZG?K=0:R\27'V
ME]Y7[8$PQS\PVG&#D4 >T45FZ/HL&BI<I!<7DPN)C,QNKAI2&( (4L>!QG'N
M:TJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *ANK6WOK26UNX8Y[>92DD4B[E93U!!J:N?\8^(;CP
MQHT>H06<=RIN8H'#RE-HD<(&'!SRW3B@ LO!NF:?"+:";4#8J,+9O>R-$H_N
MX)SM_P!DG';%6M2\.:?JEY:7LJ20WMH"(+FWD,;HIZKD=5/H<BM:B@#!O/!^
MBWVAR://;RFREE\^95G=6EDW!MSN#N8Y /)[#TJ>3PWI\NMVNL/]H:^M8C#%
M(;A\!#C(VYP<X&<CM5:#Q#<2>/+KPY)9QI'%8+>I.LI8N&<I@K@;>A[GM1XP
M\0W'AG2(K^"SCN5:YA@</*4V"1PFX<'/7IQ0!S/CGPC!:^!M8L=%LKVXN=4O
M(KF:)'DE+OYJ,[<D[?E7VZ5U]GH5@LXOG%Q<S- 8%>\=F9(CR4 ;IG SD9.!
MDG%6A+J/]MF$VL/]F?9]PN/-_>>=NQLV8Z;><YJ[0!R<'PX\-6\%E"EM=&.R
MG\ZU5KV9O)//RKEN%Y.5'![YJZO@W1UM]6@"7/EZN6:]'VJ3]Z6&T]^,CCC'
M%;]% '&ZQ:SBQ7P5I^AW<NG7%D+?[?)(K0P1G*,"6.XLJ\@8.3CW(ZZW@BM;
M:*W@01PQ($1%Z*H& !^%257COK:74)[!)5:Y@C265!U57+!<_78WY4 5]1T>
MVU.>UN)7N(I[4L898)60KN&#G'## Z$$5)INEVFDVS06D957D:61F8LTCL<L
MS$\DDU<JGJUY-I^D7E[! D\EO"THB>38&VC.-V#CIZ4 9\?A/3(Y%)^T20I=
M&\6WDG9XUF+%MX!/]XD@= >0,U3NOA]X<N]>EUA[25;F<AKA(KATBN".AD0'
M:WXCGOFM3PWJK:[X9TO5GB$3WMK'.8U.0I90<9[]:U* .<UCP-H6MZNFJW4$
M\=ZJ>4\MM<R0&5/[K["-P^M3ZGX2TG59-.DDBFMY-.!6V>SG>!HT( * H0=I
M  Q[5N44 <NWP]\./I=_IOV6=;._N/M-S$EU(JN^0<X#<<A>F.@K1U7PWI^M
MVEI;7XN)8[29)XL7#J1(O*L2""2/>M>B@#(E\-:9-KT>MM'*+](1!YBSNH=
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MH;OM;F9O,GR-IW/G/W0!UX' P*JWG@G1;[3M-LY(KA?[,Q]BGCN'6:# QA9
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M5^UR920=&SNR< X / %=-10!C1^%]-BU34=2C^TK=ZBBQW+BY?YU4$* ,X&
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M5LM\K'[2V[8Q8!AEU50<'.,D^]=W>Z!8WVH&_D^TQW)A$#207,D6Z/).TA6
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M)+P6WB'P?)/.UO;S:B8KEEE:-7CV$X;!&1D4 >C45RNBKX>N?$4C:+=N\]G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA/'=M?7/B/P
MG/9Z==W<6GWYN+EH8\A$V$=\9//05W=% &%%J<USK4"VVC7<0D7%S=W$815C
M4,54<Y)+-QQC!:KNC:A<:G8&XN=-N-/D\QT\FX(W85B W!Z'&:T** .(^*=C
M?:IX26QTVQN+RY:[@EV1+G"HX9B2>!P/6K/Q%MKK6?ASJMGIUI/<75W"$BA6
M,AB=P/(.,< ]:ZZB@#CO$MSK#/X?:ST^_FTN21O[1BM<)<+\G[L<D$+NSN((
MX'7!YXK_ (1KQ%%IE^]GH,T4MAXJ&M06K.@%S" !L0@_>QD^F1P2:]FHH X"
MWFU#4/B98ZX-!U.#3UT>6W>2>-59',BMRN[/\)& "?;'-8']C:Q_PJA])_LB
M]_M ZO\ :!!Y?/E_:_-W9Z?=]^O%>O44 <3<03O\4HM4>RG.F?V%):O.\95
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 445@^+KZ:UT4VMH)6O;]Q:PB$9<;@2[K[J@=OJHH L^'_$6G>)K&:\
MTR;S88;F2V8_[2-@_@1@CV(K5KR_P[+'X6^*$VEQ6%Q8:3K]N);6*9 H6YA4
M!U7!/5,'ZBM 1ZIJWQ!\2Z.WB#4;>RAL[:6);<HC1L^_(5MO X^IP.<<$ ]
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M" 1(Z)D+EBW !XQG%5KD>,]$T>5;@/JL$6HB3R+.Y+7ALBK?)NPI9@P!R.2
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M25B  QN]"3T'/4ULVGB1F\#:MXWBNY+EQ;2SQV)<^7:LBG]T5X.X$?,3WS@
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MD]LUTWA[1H/#WAZPTBV_U5I"L>[^\0.6^I.3^-7KBXAM+:6YN)%CAB0O(['
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MX;<NQM_R<Y7CC'YU:\0^'K7Q)8P6US-<0-;W,=U!-;L%>.1#E6&01^8-:]%
M&!;>%(+7Q!+K4>HWYNY;1;1M[(R[%)(ZIG.23DGOZ<5EO\,]';PU::+]LU%5
MLKAKFSNTE5;BWD9BQ*LJCJ6/!!_05V=% &7HFB1Z+;/']LO+Z>0@RW5Y+OE?
M'09P  .P  Y/<DU3E\)VZZU>ZK87][IT]\BK=K;%-LQ485B'5L,!QD8KH**
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M'$JL5%[ 1\LJ$8Y[''0_B  =[16#X/$AT$237%Q<2&XG4O/*SG"S.JCD\8
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M<+K<;=A.<J8OIO DQVV+ZU;^+D<]SX,%K:VMU=3O>6[B.VMWE;:L@9CA0<8
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MQ&N,,J@L4(S\P'7KBNUL]9BU*9!8132P<F2=XGC11C@#<!N)/IP.<D< T?\
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MDTR33IY8(FD,#>8)%9E4$[3TSC [XK:_X1*/_H-Z[_X,'H_X1*/_ *#>N_\
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M,'H J^*;]]0\#^(!!97;1S6$T-N/L[^9-(T;# CQN S@9(YY[8)QM O-'L/
MFAK>:+J#W]C96Y,4>DS>:)D1> =G7<,9SCDY.*Z/_A$H_P#H-Z[_ .#!Z/\
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M &0.QI/'$9\>:/'X9TE)GBNYXFO+LQ,D=O"C!C\S  N2  HR?7 K>_X1*/\
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MXET[63J*P_=2>2-CT/3# D@].E=W_P (E'_T&]=_\&#T?\(E'_T&]=_\&#T
M)8>,;&_MUVV>I17I'S64EE(LJ-_=.5V_\"SM]ZYGQ87D^(_@JZNM.N9;>SCO
M#>M#:23QQ&2)0H)53GYA_P#JKI_^$2C_ .@WKO\ X,'H_P"$2C_Z#>N_^#!Z
M $TR^T]M=:#2M,N8C/'YEU.]E);Q@+PHRR@,YW=NRG/05T58UCX>2QO([D:I
MJTY3/[NXO&=#D8Y4]>M;- !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]F]N)+"^NTMFECFZ&-UCR&0]<X!ZC-0^ _$.J>)0\U[=^2^EK]CO[4"-C+=
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MCL<8[;^EZCK-I\1KG0-0U%;^VETP7\3&!8C"WF["@V]5Z'DD^] '8%E4J&8
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M" 1MC7)P/F8\D\GGH (+[P4M_P" X?"<FI2K;1110^>L:^84C*E1Z9^49.*
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MDB.5.UE7;TVC!!SR><<4 :WAB]74/#UM=IJB:I'*79+Q !YB[SMR   0, C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>elicio2021employeestockp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[5 GVB(-MRRC@-RO3^][<]?J>EZCJ&KVLD6KW5E810N)(K;8&ED)7:264X
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MM"#+/<+$(8HP6:3$J$[0.3QS0!BR?$&Y\+?!;3?$M]*]_JU]&JQ><>&E;)Y
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MHKG_  =XG_X2[0%U3^S;K3\RO'Y-R,,=O<>H_J#Z5T% !1110 4444 %%%%
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MACO+(ON4AEW<9Y (##V.* /:Z*\W^*7B:]MO!,EUX=OV@<6ZWS7,.,^2654
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MKQ7H%WKFI#3K%&:W1+@@Q_,HZ]\ GKFKOPP\;ZGJ$'BM=;O#?:=HDS>3J10
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MPSPAE^9,@#(Z'\?:N-^.FM:KX<\*6.I:/J-S97+7JP,T3\,A1VP1TSE1SUH
M]3HKR67Q#K6B?&/2/#5IJ5QJ6FZA:++<V\Y#O;DA\L' W#A0<$]_<4SPAJ^J
MWOQO\2:'=:K>S:980M);V[S'"G='C)ZD#<>"30!Z[117F/BCXB3Z%\5-"TME
M*:)-OM;F8CY6G;81S_L;H\G_ &V]* /3J*YKQW!?S^%YAI6H36&H&6*.">-R
M K/(J?,.X^;T^E<1\.O'&H:HU_X(\6RS6WB.TWJDV_8\RCG@C^(=>.&7GGF@
M#URBLGPOYC>%M*EFGEGFEM(I9)97+,S,@)/YGITK6H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M Q3.Y<<D_4XSGC'  /9:*\@T'XB:S8:3\0'UBX&I2>'+DQVTK1+&9,LZ*&"
M#&5'0=S6KX5\1>)M0U#P]))]LOM-U33S+>SM9")+.8KO7RVVC<ISMYW= <^H
M!Z51TKY]/Q!\:OX!UWQ NNQK)I6JK;(@LXOWJ$J"&..G/8 ]>>F.UUCQGJM_
MXV\)>%]-N?[._M2S^W7=S'&CN%V,P1-X*C[AY(/44 =IHOBO1O$-]J-EIETT
MMSISB.[C>"2,Q,2P .Y1GE6Z>E;->$^#-8D\+ZW\6=6N"+N:QF5R=NP2N&FQ
MD#IDXSBNF\->*_$MU-X=OYEN[_3-1LGFU%S9>5'9OMWH8VVC<O5>2W3.?4 [
MS7_$.F>&-,;4M7G>WLT8*THA>0*2<#.T$CD@5>M+J&^LX+NV??!/&LL;8(W*
MPR#@\]#7S]X@\0:YXT^"GB'Q'>ZCY=J]\D46G)"GEI$)8\?-C?OR>I.,#ISQ
M[?X3_P"1.T/_ +!\'_HM: -BBO%/&?CWQ7X>L]4O'O(K>^L]45(;&%8YX6M"
M/E,I"ED9L=V4GG"C%;WB[Q1K]I\0?">D:7J"6UKK$9,R20))M([C(SGGUQP*
M /3:Q=:\5Z-X>O;"TU2Z>WFOY!%;?N)&61R0-NY5(!R1U(KS?1/B/K5AX9\>
M7&JSIJ-QX>NV@MIFB6,R9<HNX( ,9 /'J:Y[Q5+J]]8_#+5M6U5KV34+^&X9
M&AC01%BC )L XP0/FR<CKVH ^@)95AB:1@Y51DA$+'\ .37*6GQ-\*7]E=7M
MI?74UK:'%Q+'IUP5B[_,?+X_&NNKYC\%>+9O"/@3Q?=+I$U[%->F RJP"1,R
MD N.N/P]!WH ^D-+U6PUK3HM0TV[BNK24926)L@^OX^U7*\;T";_ (57\")M
M6M;N#5)YV%S"R9\H/+M0 9P<#&3T.01Q6U8^(?%T=Q,+:WO-6M)=$-U#<7%G
MY(6]"DB,85<HW&.O7K0!Z53(YHI6D6.17,;;'"G.UL X/H<$?G7E/@#QO>>+
M+6YA;7KB/4[>PD%W9W-O$LD4X*XDBP@!0?,,-D@D9S6;\*KKQ$?A5JVM6%X;
M[4GFG>.WNRBQF4E29&<X.<9ZMCZ=: /:Z8)HFG> 2*94579 >54Y )'H=K?D
M:\G\/^.=7F^)FC:$^I-?6.I:5]HE\R*/$4X#[O*D1%#IE,9Y!YP:H> -0U"'
MQ=\1M6O]7NKB/2[@^=&43]^D8F"@\?+@+P%P* /:JH:SK-CH&ES:EJ4KQ6<(
MS)(L32;1ZD*"<>]>:^%_&?BG6[;PWK$45U>P:C=R1ZA:I9[8+6(N51DDV@G;
MCG+-GG@=L'4O$NL^-_ /CO56U$V^G6<C6MO8+"A5HQ@EG8C?N((Z, #V- 'M
MFF:E::QIEMJ-A+YUI<H)(I-I7<IZ'! (_&L6X\?>';7Q =!EN;K^U<;A:I8S
MNY&,Y&U#D8YR*A^&?_),_#O_ %XQ_P J\XUF6[A_:<M9+&U2YN%T\[(7E\L-
M^Y?^+!Q^5 'KFE>)-,UF^N[*T>X%U:*C317%I+ RAL[3B15R#M/3TK0O+N&Q
MLYKNX+"&%"[E4+$*!DG !)_"O/=;\77_ (:^%\WBN[L8UUYU^SM&W*QOYS *
M<=0F6^N/>DM]7\0RSZC9W(O;[1IM$:<7]Q9^1Y=QM.Y!A5RI'(X/U- ';Z#K
M^F>)M)CU32+G[39R,RK)L9,D'!X8 ]?:M*OG+PYKFO\ A'X(:9XCTO4P(8+]
MDDL'@0QRHTC Y8C=G/<$<=N]=SK_ (O\1GXF^&]%T:\CAL]8T\SF.X@5Q$Q2
M0[N@8XV@XSR1C(!H ]4HKR;Q'KOC'PC-X)L;W6X;NZU'4C;7TB6R*LL9D7&!
MMX.UL<8_K6AX;\4Z_??$/QGHCSI=0Z9&&L8G14^8C(#,H'&>,T >DT5XK%X_
M\26?B+P;;W=^DTNJ74MIJ=FJ1/!"X=5 BE1>2 ^2-[8X!K3O/$/B^^^+>M>$
M=)U:"WMTT\3P2SVR/Y#$(<C !;EL<YQG/.,$ ]7HKRK7_$/BGP7XH\)+K.L+
M<:-?[;:_D2WC4+< 8)SMR%)(;Z!NG&.^T"2[N8+J[N+MYX)KAS:JR*-D(.U<
M%0,YP6!/8B@!GB#Q;H/A: 2ZSJ<%KN^Y&QS(_P#NH.3^57-6UBPT/3GO]2N%
M@MT(7<022Q. H Y))Z <UY=^T1&G_"$Z9)L7?_:L8W8YQY<E2?&V:877@NW!
M/V>36$:0=BP*A?T9J /2=*U[3]9DNHK25OM%HXCN8)$*21,1D;E//(Y!Z&M*
MO(_#<TR_M*^+X$)\A]/B=QVW!(,'_P >;\Z]<H Y+6_B;X0\.ZVND:GJZ0WG
M&]!&S"//3>0"%_&MO4]>TW28;:2ZN!_I<BQ6R1J7:9ST" 9)]<],5Q?Q2T*V
MUCPY%X9TZR@;5=4NQ)"=@S%APTL['L ,@GON [XKG_$UNVG?%SX;:.CL]G96
MQCB+=V52I/UPBT >GVWBC1;K1;C5TOXUL;4NMQ))E#"R<,K@\J1Z$?SK/\,?
M$+PQXPN9[;1=2$]Q"NYHFC:-BN<;@& R.G3ID5PGPKC%[XV^(]G<Q+-9IK F
M5'&5$GFR\X]?E4_@*UO#_A^'4_B]JWC&UB2'3H(?L4+H,"ZF'$CCU P5SW(]
MJ .ZU#7]-TR[@L[BX)O)P3%;0HTDKCN=B@G;[G@>M30:I:SWSV(<I>)&)6@D
M4JVP_P 0_O#/!(R >*^?O#7B[7['0?$_Q*BCL;MWU-+>ZAN4?S%@^7:L;AL*
M!YBC&T],]J[?XCZ\+:R\"^,+#<CM?Q  ]6@GCW.A^H4?C0!ZM1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<*RCDL!C#'M5[Q-X3B\5:'!9:A<!;NVF2Y@NH8\>7*AX8*2>.Q&><]NW144
M<9_P@R0IXEU&?5)DU?6HMDU]:Q%# BIM41IEB, #/))/IQ5[P%IFI:1X1M;+
M5+NXNIXWDV27/^L\HN3'NY.#MQQGCIVKI:* /-]<^&.L:SXBN]83QWJMA).
M@BLU,:I&,[4X<9 R?Q)/>MF[\!6\]GX=,5XZZEH)4VUY*GF>8< /YBY!(;&3
MR#GO77T4 <;:^ CIWA[6+'3]6DMM1UBXDN+S44A&XLYRVQ<_*,$@<DC).<\U
MG>%/AE>>&]8LKRX\7ZKJ=M9JPALKACY2DJ5! W$# )QQ7H=% 'G<_P )[1K3
M6=*MM3>WT/6+I+JYLQ""Z,K!B(WS\H) ZJ< <5+XI\.KXFUOPWH5K#LTG1KA
M;R[<#Y%V+B*$'N3DY'9>3U&>_HH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 $ @@C(-,6*- 0L:*#U &,T^@\CKCWH B%O .D,?\ WR*<L,2-E(T4
M^H4"O(]/\2^*-3^(_BOPZOB!H+?2[9IK:0VL)Y&W ?Y>5^8],'WJI;?$WQ!K
M'P3U/Q3&R66JZ=<+!OCB5HILM&,[6!QPYZ'J/PH ]G6*-6++&H8]2!S2?9X
M<^3'GUVBN2\-:CJFJ_#"VU>XU*3^T;BR-P9EBC&QL$X"[<8^HKE_B7XJ\1>$
M_AYHNLZ=JSF]N)(HYC+!$RONC9R<;>.0.G:@#U9X8Y#EXT8^K*#3E147:BA1
MZ 8KROQEXOU_P+JOAJ5=0_M2RU27RIK6XAC60?=Y1D"_WNA!YQZU-\3O%&N^
M'/$_A2STK4F@M]7NC!.AAC?: \:Y4LI(/SGKGM0!Z1'96L,[316T*2M]YUC
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MU '2>1%E#Y293)0[1\N>N/2I*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXB/E*$8QCZ5ST>K7=SXAO/#>CS01'2;2%KBXNHC*2\@.Q0H9?X5R3GN !WH
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M4K"(.H)3<)% ;'!QQG'Z]ZWI_"[ZWK+:CKJP%5L9;&&V@8LH67'F,6(!)(
M&.!GDYXO[M#\23W5K-:P7KZ=/Y4BW-MN$<FT-\N\8/!'(K7551 B*%51@ #
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M%X@TI.U=RD9XZXSTJ]10!QFC>'/$VD>$K/P_;ZIIUO\ 9H! +Q+=Y' '<*6
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M@S4]7TX6YN;2+S LZ%E(^@(K$G\1>)]'\2Z''JO]G2Z7K;FWC%O&PDM)BNY
M23AP<')P/P[WOBF0/A?XAR<?Z(?YBIH-!N]5N=#O=6N+>2+3!YT$<"$>;*4V
MB1LGC +849Y.<\8H P;CQMK<7P\\1ZXOV$WVD7]Q;(#"WER)'($&5WY!/7K6
MAJVM^)G\;KX?TF73(DFTA[V.6XA=C&XD5><-\PY[8QG/.,&E?_#S5KG1_$>B
M0:S;1:7J]U+=IFU+2QO(P9E+;L%00>V?<5N1>&]17QK:>()=0MG$.G&P>);=
ME+@N'+@[CCE1QS]: ,H^+[X^)+G09[^RL-5AEA6"VN(&5+V,JA=XW+#))+@
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M^CO80LI5[B6XV1KMCCWL6V(.RC.!^=;E !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5+5M4M
MM%TN?4;OS?(A +^5$TC<D#A5!)ZU=KE_B%K6H^'?!&H:OI;P+<VRJP\Z,N""
MP4XP1@\Y[].E '4 Y /K02 "2< =2:XW5]7UX>/[+0;"ZLH;6[T^6X$DEN7>
M-E91G[P#?>X''7G.,'E==\0:[J/PQU9I[Y(KW3]9_LVXF@BVBY03HF<$G;D-
MR!Z8Z&@#URBN1OM:U(:\?#UM-*UQ!9+=3W4%NC,2[LJ *S8 ^0YZ]NE8]QXF
M\96FF^&OMMI965_?:J-/N8Y(]P=2'*R+M<[00O*\GW% 'HU9FHZ_I^E:AI]C
M=R2)<:A+Y5N!$Q#-@G!8# X!ZFN0_P"$TU#P])XPCUV6&^71((+J&6&'R3()
M5;$9&3C#*!GT-5O$D6K#7/ <^H7T4WFZF&EB2$*L<AA<_(<YVXR/FR>AR.E
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M!;X6+<C/^[;.>-I'S9SG/%-C\2:PUAXXS<0^=H<C_99/)^\!") '&>>3CC%
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MT+<YQS%XZ778OAQXR@U=[>>V2$?8KA!MDD0X)$BC@$'C(Z^E 'HR.)$5UZ,
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M@)F@CD)\R-'W8P<M@E21GO4'C :%JMA'X)M+H1ZM&]N;2"W)$MKM8%90>P5
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M[6WN@HN((I@O02(&Q^= &-%H,]SXAM-:U2YAGFLH9(K2."(HB&3&]SEB22%
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MH XF+P+>P^'_ !#HD>M1_8]5DN6B#6F6@$Y)?)W_ #D9./N^^>,3R^#+A9-
MU"TU&.+5]'M_LOG& F*XA*@%'3=D= 00W!]:Z^B@#C=2\#/J>C^(89-0C34=
M=")<W0MR52-5VJB)N[#/))Y)/L+5QX7O;G7_  [JCZE #H\<L9C%J?WWF*%8
MYW_+PHQUKJ*0L 0"0"> /6@!DUO#<*%GACE4'(#J& /XU@6OA.*Q\4ZIKMK)
M DMY;10Q1FW&(63=\W!&<[N0,=.M7]&\06&O-?K8F8FQN3:S>;$T9$@ )&&
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MO^$&;8 6^W6>,],_:$KMZP?%OAV3Q1HRZ<EZMHOGQ3,YA\PDHX<#&X8Y49H
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M$&O:%XB2_2R@66 R0()8G&=Z2IM'MC@'\N>ZU>SNK_3V@L[TV5QYD<B3^7O
MVN&P5R,@XP>>A-<_-X$M[Y/$+WTZ?:-<M5M9WM8?*50H8!MI9LMECR3V ^H
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MD66VF1=V1M4 J1G@@D$=2*PY?&&N+\*;OQ"+J/\ M"UOV@W>2NV1!<B+E?\
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MEKBPU!-1DGFMPQGE4$ 8#*%7!Q@=@.?6U!X<N[?Q?J'B!=1A+7=LEMY)MCA
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M<@^P:-KNS2E8F&UN[7SF@!.=J.&4X]-P;%6-8\(6^JVUB5O)X=1L;G[7;WV
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MJ2"\BY8[>2-@/I7J&_9#YDQ5,+ER3P/7GTKQ+X,WMJOC[Q^S7,(6:\\R(EP
MZB28EAZC!!S[T ;_ ,-_%>O>(?&OBK3=3U$RVND7!A@188U+C>ZY8A<YP@Z8
MKU&O#?A#?VL7Q#^(,IG0K+=-+$%.3(HEE)*C^+@CIZUZGX/\7:?XUT/^UM-B
MN8H!,T.VX0*V5QZ$@CD=Z -^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBO//C'XAUGPKX.35M%U![6X%RD1'E1N
MK*P;.0RGG@=* /0BH/4 T%0>H!^HKRGQ-XJ\3>"O#.B>*/[0.K6%R(1?6ES#
M&C+O3=NC>-5QSD8(/45%\4/&^KZ38>%]3\-ZM)!:ZNXRI@B<%&"D$;E)!PWK
M0!ZWL7^Z/RHV@C&!BN6MH-7_ .$C@:T\1W5]8VMPUOJ-M<PVXP3#O4JR1J1@
MM'Q[^U<>OB'Q'<?'&]\(_P#"0746EQVPF3RX+?>I\M6QN,9XR3VH ]9*@C!
MX]J H P ,5Y[JUWK^F^#_$.M6OB6>\M4LEN]-N6M[<,I ?<K )A@<(<X'7BJ
M'AO6_$NN?!7_ (2 Z[*NLR)-(DOD0[%*2,H7;Y>,$*,]_2@#U$*H.0H_*FRP
MQ3ILEC21?1U!%>6_#GX@:GJ]]?\ @_Q9*UGXFM68)*J(IF4<G QMW <CC!7G
ML33O&'B#Q#H/P>M_$%KKDYU/$+O*]O"0V\@$;=F !GC'/UH ]2"J%"A0%'
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M0:8UK!N/+X7"@>IZ5S'@34;.R_9]BCN;F**2-)T>-VPRLTSE01UR0017L5%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ (M('B**;P[;OF",VY%T(P<B(R;L;>V<9QP,=NGT;7-/\06DMUITK2PQ3/
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MCU72]0DO[*[6$E,R,S,CH3RIW$<'/2MK2_#FL0^-)O$>H:A9.9K!+1[>WMV
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M;=L#,V=V>^XC&/QKJ:* .&M_ U]_PBT7A*^U""XT2&1 '\LB>2!'#K$W.T=
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M1A)#$=C,A8F0)G^XAXSU]JW!X:U$^,+/Q!+JEO(\%B]FT7V4KOW,&+ [^.5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% #'ABE='DB1VC.Y"R@E3ZCTI]%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[:.XMIHYH)5#QR1L&5U/0@C@B@"6BL^/7=(FD>.+5;%WC4NZK<(2J@X)(SP
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MC:7,R#<T<,ZNRCID@'I5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *S=<UW3O#NF/J&IW,<$"D*I=PN]CT49(&3^7<X )K2J"YLK6]55NK:&=
M5.0)8PP!_&@#F/#&K:%>:K=3PZSI]_K5\HDF2SG680Q)PJ KT5=W4XRS$\9
M'1:?JEAJ^GI?Z==PW5H^[;-$P93@D'GV(-.MM-L;)R]K96T#,,%HHE4D>G I
MR6-G'9_8TM(%M>?W*Q@)R<GY>G7F@#D?A&P;X6:&5((\N3I_UT>NVJ"VL[6R
M0I:VT,"DY*Q(%!/X5/0 4444 %%%% &1K&KFVG@TNQ>)M7O Q@C<Y$:C[TK#
MKM7T[D@<9R/'_%FGW6F_%'X?:??7MK<R+=M.TD4+1N[LZ9=\NV2Q7C& ,8 P
M ![>;&S:[%VUK ;D=)C&-X[?>ZTR72M.GG,\UA:R3$@F1X5+?F10!XUK_C%(
M?B1XJO[Y]S^'-.,6E6;=Y74;I<?C@GT('7%8=W8HOP9\'>$-.>-[WQ#?*\C]
M0,G<QS_L[HP<?W2.HKZ"ETS3YI)Y);&VD>X01S,T2DR*.BL<<CV-.%C9@P$6
ML -N-L)$8_=CT7T_"@#YYO+:UA\0>/\ 7HP&T_1+ :8N1_Q\3L GS>H#CD=,
M;5Z<5-JT%K:?!KP1X52=%.M7B//,QPJKNWR')_NEU&1_=->__P!GV7DS0_8[
M?RICNE3REVN?5ACG\:66QLYV@::U@D:W.Z$O&#Y9]5ST/TH \BUR*W\0?&>R
MMD)@TOPQI1N+@JI5EW+]T=U.TI[C!Z&N4T?4;;2?@3XKUF)(X[C7+QXEAC7"
M1*[; @[ A?,..P*^HKZ*6TMDFEF2WB667B1P@!?ZGO4;Z9I\ED+)[&V:T!!$
M#1*4&#G[N,=>: /'O$&BFV\#Z#_PC6IQIK/A&S34?*/W)D8,)&&>N3&Y!Z$'
M_:!JKKLVG^(_$GP[TV;3X;&.Y#:W>PNO=R7V<\G<X<8[[AQ7M4^E:==2"2XL
M+6:0  -)"K$ =.2*D>RM)+N.[>UA:YB4K',T8+H#U ;J!0!Y#I?AZP\=?$_Q
MF;RW!T>SCBTP1QDIN*CE<KV#+GZA/2N:U7Q/:V\GQ NI>9]-@_L+2K/.?LT!
M)B9P#TR=IS]!WKZ%AMH+<N8((XC(Q=]B!=S>IQU-02:1IDPN!+IUHXN2&G#0
M*?-(Z%N/FQ[T >%76GZ6S_"_PB3;O;Q(;^[D*@A\$L5!_B#.)!@=<C&:U$UE
MQXA\>Z_?H0-#C_LC1[(+PK-E0$3U<A.1V8]A7LK6%FUS#<M:0&>%=L4IC&Z,
M>BGJ!]*3^SK$WOVTV5O]KP!Y_E+YG' ^;&: /")="U&ST3X:>!KDD:A+>2:A
M.IY-NJDN!^ =N.A*D5[3X?\ #.E>&+:XM])MC!'<3FXES(SEG( )RQ)["M)K
M:!KA+AH(S.@VK*4&Y1Z ]14M !7 BTLI/CE/OMX&?_A'T<@H#\WGL-WUQQFN
M^JJVFV#W#7#65LTS AI#$I8\8Y.,]* /%9K2QB^!'B*:*"!7BU*81R*HRFV[
M^4 ]L9X^OO73WNJV-M\1M>L-?UIM+@O+.W^QO*85BGA"L)%W2*1PY;C(SFO0
M!HVEB(Q#3;/RR=Q3R%P3ZXQ2W&DZ==Q0Q7.GVLT<)S$DD*L$_P!T$<?A0!YW
M:3Z#HFI^&=*T^?R/)TZY:TU+5)20+<R#*HN5#LV 03C" '!Z5S%F=/NOA9X<
M@=X)F@\3I&P;&45KMS@C^'*\XXXKW":SM;F2&2>VAE>%MT3/&&*'U7/0_2HG
MTG39$V/I]HR[R^UH5(W'J>G4]S0!P%_!IUM\1_$=NY%I92>%E:Y^S@*0H>0%
M@!W"]/PJSX7N-7TWQ58Z+K!LM41M.D?3M8M!M9H%:/*RKR.?D(8<''N:[?\
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MO4;2":1&=8Y9E5BJ@EFP3T !)/M7!^'KJT2+Q[IGB.2*.X.H7$TZSD#S+1T
MB89ZKM&T>F*Q='LY;>^^%%KKBH;Y+:\WI.!N4>4#&"#W VCV(H ]8TW5=/UF
MS%WIE[;WEL6*^;!('7(ZC([UE:];>*KN]B30M1L=/MDCS))<6YG:1R>@ 88
M Z]\^U8_@-X?^$F\;Q0NFT:L'V(1@$PIDX]R#^(KI/$FIOHWAV^OHEWSQQ[8
M$_ORL=L:_BY4?C0!F^"+S6K_ $^_EUB]M[LQWLMO;S00>4KI&=C'&3_&''7M
M3?B!K6J>'_##:EI<ENKQSPQOYT9<E7D5/EY !^;N#5VW;3?!/A&U34+R."TL
MH8XI+B0\%C@%C[LQS^-8?Q;ECC^'ET7D5<W-KC)QG_2(S_*@#N*XG_A*)-,^
M(&M6FL:M;P:1;V$%Q%YP2-8V=W!!8\D_+Z_A7:JP90RD$'H1WK@K06<OQIUK
MSO(=X]'MP-^"5^>3=].",_6@#LSJ=@NGIJ!O;?[&ZADG\P;&!Z$-T.>WK58>
M)-#.FMJ/]KV(LE<QF<SJ$#CJI.?O>W6O']$U5-+\$> -1N;N:WT:"ZO(KFY@
M 86[LTBQ,V00!RPSC@-6AXQA\.'X>^+]2TF_:_%[):M<7;2*T3RB11A"H"[@
MN-V/4=\T >IQ^(-'EAN98]4LWCM9?)G99U(CD_NMSP?:I+35]-OK%[ZUO[::
MU3<'F24%4*_>!/;'?/2N&\:S67A[6?#&I@_8-$\^5;J[M(DVQR-$$A=OE(QC
M<N<< UB^(HM+B\/ZCK'A^ZN-3LI=5L[K6+A&$D4T:-F0+M !P A; QCKT- '
MJ5GK6EZ@TRV>H6T[0@-(L<H)0'H2.P/K7'6GB*[\6ZIJ\&B>([:QFL+Y8;:$
M+',ES&JHSLP/S$$LP!4C&![U)J@CU'XG^$K_ $B>.7R[6Z:]EA8,#;,H\L,1
MV+D%?H2.AIO@2_M([_QS,]S$(XM;EDD;<,*HBCR3[<'\C0!WM%5M/O[75-/@
MO[&=9[6= \4J=&4]ZLT %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !3)H8KB(Q31))&>JNH(/X&GT4 ,6&)'9TC178 ,P4 D#IFHHK"SMV#0
MVD$9#%@4C Y/4\#J:L44 5Q8V@! M8 #U'ECFE^PVGR_Z+#\OW?W8X^E3T4
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M_"@"2BH+*\M]1LH+VTF6:VG0212)T92,@BIZ "BBB@ HHHH ***J7^J6.EI
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M=N5.,^G;O0!F'6M>\4?%74?#B1Z?_8>D1'[5&Q:19S(F%$@P V Q.S@9!Y)
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MJ-:O;;M\9/5)">"W&<#H,9ZB@# \:->)\1/!36$,,MUMU 1B9RJ ^4G+$ G
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MUQ<1EQM#*@15#+DY;)YX ]^ #2;PWH;R22-I%D6E;?)^X7#M_>88P3[FM0#
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MC&"#)_"ISR?]KCWH ]'HKA=+\>S:QH_A4V]O#%J>OB0@/EHX1$I,C8!!;D
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MGW()@NH7AD /.U@0?T-<IX9T#Q=I,5MI>HZU87.DV6!#+%"ZW4R+]Q'.=H'
MS@$D#'<UVE% 'G[>"=7?PGXIT9I[(2:W>SW*RAGQ")<9!&WDC'7C.>U4M<6_
MO/%6GZ?97VB1ZCI>GCS(;YI$P9#C=$Z%7/"$$=!D=<\>FU0U'0](U@H=3TJQ
MOC']S[3;I)M^FX'% '"II6N:[I%K80?V';2:+J,,\:V1=K*X4 DQL,9#*2&[
M\X/7H:KINI>&+/QCK6H:M8)'J\<2(PMCB*8HL*[@S%=F2.N>.3C&#Z+!!#:P
M)!;Q)%"@PD<:A54>@ Z4LL4<\3Q31I)&XVLCJ"&'H0>M 'F^AQZUH-_II:/P
MM=0.8[2/[#-,;A820#Y>\L-J_>*@@84GM5[2?"7B?09[C2M-UFR'AR:9Y8Q)
M"YNK978LR1D';U)PQSC.<5T$MOX:\&:?<ZJNGV.F6Z >=+:V@4D$@#(1<GDB
MMW(QGM0!Q<7A;6M(\3:O>Z+>6)T_6&$MQ!=J^Z";;M+IM^\".H./K532]+\3
M>$/#OA?1K6\TVX,$RPW<?E/NEB+#.PY_A!9BQ ' X['K]*US3=<6Z;3;D7"V
ML[6TQ"D;9  2O(&>&'3BM"@#+\2:=<:OX:U+3+9HTEO+:2W#RDA4WJ5SP#G&
M<XK"U+P?>:IX&TS2#?)::KI?D2VMW""ZK-$,*Q!QP1G(]^]=C10!RL&C>(]4
MT74;7Q)J%CYUU:26B)I\3B-0ZX+MO.6;IZ <^M94?A#Q)%;^%7&HZ8]QH:M$
M87B?R9$\L1J_7.\ $@\#YB..I[^B@#SQO >M-X4\4Z*VH6,AUJ\FN(Y?+=/+
M\T@L2,G/3@#\S6O+X>U2;Q5X?U=FLUCTRUE@DC#L2YD"@D';VV#COGM764C,
M$4LQ 4#))[4 >?2_#_4+S2M>MI;^&UN;W5O[7LKF#+&VF&W:""!N V=?<\5?
M?PSKWB/P_J&F>+=1LB+FV:W1=-C=5!.#YC;SRP(& , <]<\=)I&M:?KMK)=:
M;<BXACE:%G"D8=3AAR!TJ_0!Y^_A7Q;?1^'4U#4=)+Z->)-YR12,TZJC)DC(
M 8@\@'&><]CT.AW6MRZ[K<.HR6<UA%(ILI+9&!4$L&C<G@LH"DX_O?@-^B@#
MEM5T#5YO&MEKVGWEH(H[-[1X+N-G\O<P8R1X(^8X .<<#K7%:IX?U3PMX5\&
M:/)=VEQ/!XFB,#JC*I#&9QNYSGYL<#CWKT[5]<TW0;>.?4[I;>.618D)4MN=
MC@# ![D4^^TC3-3>)]0TZTNVA;=$9X5D*'U&1P?I0!S.K:'<.VN>(]2\A+D:
M/+900P.76./#.Q+$ EF..PP%[YK+\,Z'?>(OA[X1L[\VJ:;!!:73&)F,DP15
M9$*D +SMR<G..@SQZ#<VEM>6KVMU;Q3V[C:T4J!E8>A!X-5';2O#6DLXC@L-
M/@!+"*+9'&.I)"C 'O0!@67AG5] U+6SHL]FUCJT[7>VY+!K6=QAV4 $.IP#
MM)7ZU!)X&ELK3PE8Z3) +30)Q,?/8AICM93T! )W%L^O:MZP\6>']3N(;>SU
M>TEFG7=#'YF&E'JH/WA]*LV>N:;?ZK>Z9:W2R7EB$-S&%/[O=G;SC!SM/2@#
MGX?#.J0ZKXLO-]FPUM(UB7>P\HI%Y?S?+SD<\?3WJE%X*U>VTWP>MO>62WOA
M[,9,BNT<J-$8R<#!!QSC]:[VB@#AAX7\3Z/XBU"Z\.ZMIRZ=JDHN+F"^@=S#
M,0 SQ[2,YP#@G%33^%-7T[Q;'K^AWUO(\UFEG?0W^[]\$^[*&49W^HQ@^U=G
M10!S7@SP]J'AVRU&&_N[:X:ZU">[4P1LNWS&+8.2?_K>IZU#_P (YJ.E>,-1
MU[1GM9(]4BC6\M;EV0"2,;5D1E5OX>"N.>N:ZNB@#@KCP'=Q:5H]K8W%LTUK
MK(UB[FFW+Y\NYF90 #M!W8!R< #K7>#.!D 'OBEHH \T/@#Q'_8R::-5TUQ;
M:PNIPSR0N9)R)?,_>G/49QQG. ,C%;;^&M;MO%VHZKI][8B#5;6&&[\Z-M\;
MQ!@&C .""&/!/'OTKL** //+7P'K%GX4\+6$>H6+7^@W2SJS1/Y4B[64J><Y
MP_7CIT%;5CH.JV?C+5==9[.5;RTAMU3<RD-'N^8_*>"6/';WKJ:* /.=.^'F
MHZ;H'AE(;VU&L>'I96@EPWE3QR$[T88RN0<9&<8SWQ6O=^%;W4)M;U.X-JNJ
M:CIW]FPHKLT=O%\Q/S;06)9R3P.@'O77T4 <;>^%=2O/A:/"?G6JW7V%+(SY
M;9M50N_&,Y('3WZTW6/#&LZOJ6BR7+V$NG::BR&Q:1PLMP.%=CM.57J%QUY.
M:[2B@#B]?\,:_K(M-2@U&TLM;TZ[:>Q95:2$1L@1XGR 2&P22!WIFK^$=;\2
M^'&BU?5;:'6$GBNK1[.)O(MI(B2I"L26SDY/';CCGMZ* .,@\/\ B2Z\7Z3K
M^IW.E1FSM9;>6&V21M^\J<J6(Q]W\/>M/QGH%QXD\/&RM)XH+E+B&XB>524W
M1N' ;'.#C'%=!10!R,GAO5;;Q5#XFLI[.2]EM/LE_;2;HXI@&W*R, Q5E/'(
M.1Z5I^'-!_L5=0GED62]U&[:[N7084,0 %7/.%4 <]>3QG%;=% '$:IX1UJ[
MUWQ!<VVH68L]9L5M3]HB9Y;;:C+A,$#:2Q8^_8U3_P"$(\0V4/AW4=+U/3TU
MS2;(:?*)8G^SW,&!\IP=P(*YSZ]A7H=% ''ZWX7UC6?#UM'+J-LVK0:A#J 8
MQL+<-&P(C"Y+!<#U))R>]=+);W-QI4EM+<^7<R0LAGA7;L8C&Y1GC!Z<]JMT
M4 ><V'@;Q%;P^%5DU'2E.@RMCRX'_?(T;(7;GESG..!G)R>E:%]X/OM9U'3K
MG4A8"XT_4!=0ZC"6%QY0<LL)&WH00I.XC'.,UVU% &5XFT<^(/"^IZ0LPA:\
MMGA$A&0I(P#BN?E\,Z[<W7A:YN+C3FDT:1I)0F]1)F,QX7(/8YR>_&!7:T4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "JD6EZ?!>/>0V%K'=2??F2%0[?5@,FK=% !1110!!-9VMS+#+/;0RR0-
MNB>1 QC/JI/0_2IZ** "BBB@ HHHH **** "BBB@ HHHH HC1M+%]]N&FV8O
M,Y^T"!?,S_O8S5ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% 'EOA:UO[SX>>$&T;5+:VU>TENY+.&\4O#<*KR(R-CD85N".0 :[KP)J/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUF^I6=I!>6$5R8'BBG)NF4/Y;2)&%.0""<9R5YXZ4 =S+-%!$TLTB1QKU=V
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M5Q=EXNUW4]:U'3[+P["ZZ=?I:W$CWP4!&4-O7Y.2,\C^>>,X?$C4_P#A&O\
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M\NCW$=E#/I^J3)$OD3E[BW#C*/(@7 7INY^7/>@#NJ*\^G\?ZRNF^(KZ#P[
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M>C?*C# <CU'I5)O'][_9.@ZM%H\4EGKERMM;*;HJ\;/DQE_E(Y"G..AP.>M
M'=U7N;^SLY(8[JZ@A>=Q'$LD@4R,>BJ#U/L*Y^V\4W5QJ7B;3_[.A6?14B=3
M]H)6821EQD[,K@#'0US>OZJGB+1/AYKAM5@>[UNTE";MQ0,DAV[L#- 'IE%<
M;XE\:WGA^WU>];2E%CIAC&^YF,37>X!F\GY2#M!]>2".,4RYUS67^)VG:7:Q
MVQTV32Y+K:\S*S?O(P6;"GD9("^YR1TH ZZ"]M+J:XAM[F&66W8),B.&:-B,
M@,!T.#GFIZXFV\8V-@GB^^OM,BL%T>=5N'@8.]R?+4J2<#+'*J,^W-7+CQ3>
MZ3J>D6^M:=#;V^K2BWAF@G,GDSD96-P5'WL$!AW'3O0!U5%>?3_$#65TOQ#?
MP>'8&CT*[DAN0]]C>D:JS%,(<MAB<' QCDG@;%QXP5]9MM*L$M3=7%@E]"EW
M.8?/#$@(F <M\N3Z9'!YP =314%G-+<6-O--"899(U=XCU1B,E?PZ5/0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5C^)6UX:44\/0VTEZ[!2UQ-Y8C7N1\K9;TR,=SG&#L4
M4 <OX:3Q-!,EKJ&EZ78:=%&Q'V:[>>21R>Y95ZY8DG))^II6\-0^*M,LI?&.
MD6;:C!Y@$<$SLD89NQX)R%4GWKIZ* .(\'^ +/PQXEUS4HK.")+B919&.1F*
M1;%#*0?5@3WKMZK#4+-M2;3A=0F]6(3-;[QO$9. V.N,\9IM_J=AI<:27]Y!
M:I(X1#-(%W,> !GJ?:@"W1110 4444 <;\3/ Y\>>%?[.BN%M[R&43VTCYV[
MP",-CG!!/TXJYI-SXNN;:"VU+3+*PD50L]U'=>;NQU,:;>I_VCQGHW2NFHH
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MMO#;S))N>-X@V&9<=-Q!X/:NRBUS2KBSN[R'4;62ULRRW$R2JR1%1N8,1P,
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MP5']TYQGK[<[4NBZ_P"*?#NHZ=XF-E9"ZM6MTBL':0!CC]XQ8#H0,*/?).>
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MSM3>'O$%KXH\07=BNGRVNN6T*R2RRLC021QE.$ .X$$'[PQ0!GS^+=;U6X\
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M110!!>V5OJ-G+:74?F02J5D3<0&4]0<=CZ4W3]/M=+L8K*RB\JVB4+'&&)"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTZY4RKC!!P>X !]>^: /.[+3;73/^%8:G:(8[VZ2*"XFWDM+&UJ3M;)Y4$#
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M?)>UN1,Q9F,X3R\9QM.XC;CD\GJ<]6;-?&6N>,-(U"ZL8[JVG$4*W%L9);:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN:D^-6BQ^'[W6/[+U)H+:Z^R[0J%B>,L2&*A<G YYYQT. #TRC(%,BD$L*2
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MW,"NUN^#D'UXKOZ* /+K7PIKO@:Z\/:AH]E_;*6NE_V9?VT<JQN?G\SS(]Y
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M@8(.1CIWK4\1:5?^,?"NJZ6\+:='=6QCB$Y4N9,@AFVD@+D 8R2<GICGJ:*
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M;"YW^1<1F-_+<HV",'!'(J+1]&LM!TY+&PC98E.XL[EW=N[,S$DG@<GT [4
M)9WE]/JNHVUQIC6]I;F,6UT9E87.Y<MA1RNT\<]:T*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *S]8U3^R;(3+:3WD\CB.&VMP"\KD$X&2 . 222  #6A4<TL4
M$+SS.D<<:EV=S@* .23VXH YWPYXP76]4O=(O-,NM*U:S19)+6Y*MNC;HZ,I
M(89X^M:&OZV^B6D4D.FWFI7$LFR.VM%!<\$ECD@ #'4GN!WJEH^G&Z\1WOB>
MXC,4ES EG:1N,,MNA9LL.Q9F)QU "YP<BNCH Y?0/%\^LZY-I5SX>U'3)HK8
M7)-T8R"I;:/NL>I#?]\FNHKFO"G^GW.L:\>1?79B@/\ TPAS&OX%A(X_WZZ6
M@ HHHH *SI-:LX]:;2S*@N([<7$@9P-J$L!@=3]QNG0#GJ,Z-9\VAZ7<ZS!K
M$UC ^HP1M%%<LOSJASD9].3^9]: &Z?KEE?Z(-76>*.R*&4R-(N%0#.6.<#C
MDCMWK$TSQL_B**:Z\.Z-<W^GQ,4%Y)(L"3$=1$&Y;TR0HSWKA/C;:0>%?AA%
MI>@VD=C8WFHJ+A(!M4@JS8/U*K^6*]6T33[30_#MC86Y1+6TMT16S@8 ^\3[
M]2: &^'M9'B#18=26SN+-96<"&X $B[6*_, 2!RI[UJ5YQ-XDGU;XD:AH,,[
M6.@:!:FYU&2%C&TTC#<%W#!51DDXP25.>*X67QAXF?X)V4_VV^&KZGJWV73)
M5D(F>+/&3U;D,N3ZB@#Z!HKPB3Q!XCLO&7B5?[=O#I^A:*%N&,@9(YMJE0H/
M#2$Y7<V23N/3Y:DO=8\1VGP4\-1'5[T^(M;O(X[>X\YO-"R.6&3U(VE1_P "
M% 'N=%>-_P!O:CX4^)6N+)K.HZEH^DZ&)[N.YEW 38&P#C"LW'N<G.:H/K7B
M'4G\%6QUN\CUCQ)<?;;J.WF94@LN&554'"C8#SU.&R30![G17C6J>(=6N/B9
MXJDM-5O+?1-!TTF<I+E%E*9.U3E2_P!X $$ C.#C!HSZAXGM/V<X]>FUW4%U
M0.MP)O-RYC>8*JECR1M8$?7TH ]@\0:K-HFBSZA!IMSJ,D6/]'ML;V!(!//H
M.?PJC:^*Q=:]8Z<-+O4M[ZS%U!>NH\MB1N*'G(8 UGZ5;7&M>([G49=0GN-(
MGTV"*6Q<_N1.<.=H_P!W&[UWXYZ#K/LT(N1<^6OG!/+#]PN<X'IVSZX'H* )
M:*XKQ_+>0WGA7[)J-W:"XUF*VE$#[0Z,KD@CORHZY'M6;I^E33^.O$7AU]:U
MDZ8EK;72)]OD\Q'?>&VR9W@?*#@'&?;B@#T>BO)M"\3:M?>&? ]C/<M--JCW
M4<\TERT+3>26"J9%!8$X!)')VXSR:U+FUU;0])U>#4/$9M;:XN[<V213275S
M$KOAH5=MKG>054]5R>>,T >BT5YI97>HKK'C?33<7]I!!I\%S;1271EDMV9)
M,D,2V,[0< D#M6?8RZC9Z-\.M;_MG4IKK49[:UNDFN6:*6.2%B<IT)!4'=C/
MJ30!ZW4%[/):V<L\<)F:-2WEA@I;'H37G5YJ]UI?BAH/$(U*VM[C5$.GZM:W
M#M:LF\;8)4#80\%#D<DD^]>BWO\ QX7'_7)OY&@#F='\97>O>'H-;T[P[>2V
ML\;21KY\0=@"1C!;KD&K=QXJ$/B'P_I7V"4KK,4LB3LX CV1[R"O4GD#M7'_
M  WLM?N/A1H7V#5+:&+:&\O[*=Y03$LN_?@$C(SM[UM>(I$E^)G@1XW5USJ
MRIR.(0* .KL[J]GOKZ&YT\V\$+JMO.9E;[0I4$MM'*X/&#Z5=KRN]\1ZGX?M
M_B1=QWD]P^G30"U\]MXAWQ)DA>F 7)Q[5V%MH;6NKV-_:^(+S[+);M#+;S3M
M,MTQ&Y9%+,0K  GY1R/84 :^F75[=PS-?:>;%TG>.-#,LGF1@X5\CIN'..HJ
M[7D5OXCU.P\(/&VH7+R77BM]*-Y+(6>&$S%203TPJX'IG-=+<R7?A[XDZ!86
MES=3:=K,%RL]O<3O,(GB4,)%+DD9SM(SCH<9H Z75=4N+"6UAM=,GOYK@M\L
M3HNQ5&2S%B!CD#ZD5SMKX_N+R'5Y;;PU?RC29WM[I5FAW!T +;1N^;@]J[6N
M!^&W_(5\<?\ 8PS_ /H*4 =#I'B3^U?$FN:.;%[=M*\C,CR!O-$JLP( Z<#U
M[]JW:\P.F'4_'/Q"4WU]:B.WLF4V<[0MN$#X)9<'CTS@]P:;I/B/5-9L_!6G
M32AY-1TJ2ZG9KI[=KB1 @ WHI;HS,0,9QZ<$ ]1HKRGQ%;>(M \'7,<VORB5
M=7MS:F"Y>22&"255\N1V 9P,M@GJ.M;M_IHTC4M,T]==UB\^U7%Q<&P:X+2W
M'R 8$NY?+B0_-@G!+8]!0!W-%>-RZMK1^&UQ(-6O(;JS\1&R219R[>7]I"!6
M<_,X )&3U[UL:A)J7@KQU:?9]4U'4K'4M/O)IK:]G,NR6! X=/[H;(7 P.>G
M3 !Z917F^D6VOZOIOAKQ%;:I% 9##->R/J,LD=U&X^>/R2H1&R?EQ]TC%5/M
M]^/ _P 19/[1OO-TZ_O!:2_:7WPA(D90&SG )/&<4 >G274$5Q#!)*JRSY\M
M#U; R<?057M+J]FU"^AN-/-O;P,@M[@S*WV@%<L=HY7!XYZ]:\_DLTOOB)X,
MGGFNFEFT69Y&6ZD7) B.>&&,Y.<=>^:@U#Q'J?A\?$FZCO)[AM.>V%KY[;Q!
MYD2DD+TP"Y./:@#U2BN9BT5[+5+/4;/Q!<BW>V>)X+F9IDN7*[ED!9L*1@GY
M1R/0"N<\)ZM<1>(=.T?Q"FJ6&O""0'S;AYK34L %I(SG:",;MN!@''T /2:Y
MV\\5&S\8V7AO^SI7GO(7GCG$BB,(OWL]P?;!ZUT5<#J__);O#?\ V"[K^:T
M=]17DTT%_>VWQ#:37M74Z7*[V?E7;)Y;"W#C[N,C/\/3VSS6OIFN7&OZ]X?T
MB_N98XI_#T>IR"&5HFN)F*J1N4@X4;C@'^+GI0!Z%163X=T^XTK36L;G5I=3
M>&9P)IO]8BD[E1CDEB%(Y/)XK6H **Y?Q3-G5]$M?MUT#+)*QTZT)22\PG>0
M,NQ4)W')P>!Z UOAO>WMWHFI17T\LSV>K75K&993*RHCX52YY;'3)YH MZOX
MM?2O$^GZ"FD7%U<7\<DD#QRHJD(,MG<1C&:?#XQM4U^#1-4LKO2[ZY!-K]I"
M&.XQU".C$$CT.#[5B>(?^2R^#/\ KTOO_0%JI\8!Y]KX8M+7G59-<@:T"_>&
MW.YOH,C/X4 >DUA3>(_)\:VOAQK%_P#2+22Z6Y,@VX0J"H7K_%WQ^-<D/[<\
M91>(?[/O/LEY9ZE+:6TRZC+%]F\H@+F)5*N#]X[B<[L= ,7"TK_%3PT\\L4L
MS:%<&22'[CMNBR5]B>E '?45Y-+J=[ ?#>H66JWUZMUX@%M-J#3,D-U&[2 H
MD.XC:H  ; Y7(SG-:&ISW&D>*?$.DW.H:B8M5L%N=**W<@:.8'RVBC.>"7>-
M@/\ :QTH ])HKSOP;J-SKVGZ+I]Q<W:ZAI+2KJV+F3<98B8PKG.2'8[\'C"8
MZ5E7.IWL!T#4;+5;Z]%QXB2VEU S,D%Q$\CJ8DAW$%5 "[L#E<C.30!ZS17G
M5EI]WK/Q$\564^O:O%:V3V,T$4%T4"DJS$=/NG!!7H<\]!BE8MX@\6^&%UW3
M]1BL;Y;N207$FHRB.)8Y2#$\ 79MV+@Y.?XLT >I45A>,]9N- \%ZOJUJBO<
M6MJ\D8(R V."?4#K^%4;;2WM9]*UNUUZ]D@%LWGV\LS2K?EDW*P#-A&!!(VC
MH<<"@#JZ*\G.I:C??!\^-X-4NH]92-[X%9W\GY9#F$Q9V%=HV],Y&<YYJ[+!
M>^(OB%+ITNLZO86=SH$-X8;6Y,;12M*1\IQQC [<XYXR* /2Z*\ML='U'Q#?
M>,;*3Q/K4'V&^V6;Q793RV\E6!..J@G[O Z]^0SPKXIU'Q5=>%--U.::%+G1
MI+^X:)S$US(L@C4;EP0, N0",Y':@#U6BO']>U/6-/T/XAZ1%JE\$T98+BQN
MQ,?.194W&,N?F(4]"3G!ZUTFHZ<=)AL2WB+5Y)=2O86>U\TN]R5C8F*'!7RE
M)PS'( "]A0!W,TT=O!)/,ZQQ1J7=V. J@9)-4[N^ND?3S8V!O(;F4+-*)53R
M(RI._!Y;G P.>:\IU66[O/A[\1;&^ENC'I]R_P!GC>Z=VB4QHX0OG+*"3P<C
MMR!72:T)]*N/ J6=]?1PSZ@D4T1N7<2*8G;#;B21E1QG'M0!Z#17!Z1)-XRO
M?%:7-]>VDECJ#V%HMM</%Y"HBXDPI 8LQ)^;(P .F:YS3=<UKQ%;?#NZN=2O
M+674)+J"\6W?8LWEQR /C&,G;GVSD8P* /7Z*XKP3)<6WB+Q9HKWMU=6MA=P
MFV-U,TSH)(5<KO8DD9Z9-=K0 45Y;:7U]XB^&>J^*UU*]M=6B:[G@$=PRI;^
M2S;(S'G81M09W YW$^F!)M0\4^*]"BGU74]/M]4\-F[GM[2X,>R0F/E?[I&[
MKU[=": /4J*R=6(TSPI>9U1K3[/9L!J%P/,,9"8$C#^(CK[FN,TBYOK?QWHU
MBD^I)97VCRM)]KN&=IG0IB78S-Y9.X\9SSR!B@#TFBO%))]4A^&.H^(O[>U9
MM0TW59%MRUTVS:MT$VNHX<%3C#9QVQ78ZY=R>%_'^FZK=W]T-#U*-K.5);AS
M#;7/WD?:3@!@&7V.#WH [JBL7PO%/_9'VVYDN#+?2-=".>5G\E')*( Q.W"[
M00.^:XWQ3JUWHVNZC)K8U.+19WB%GJVGW#F.R.U04FC5A@%\DL0<A@.PP >F
M45Q6E337'Q(\4:<]Y=/9"SM)(XOM#XC9_,W%.?ES@=,=*YOPQXBO[_0OA_IM
M]J%R?[86Z>ZN3,PEE,62J;\Y&20>#G"X[T >LT5Y[KTMYX0L/LJZ[<30ZEK-
MM C3,6DL()6PP#L22/E8 GIGCI5GQ&+OP9IFOZW8ZM<2Q_V>7@T^Y=IO+E4X
M,H9V+8^9<KT[]Z .YHKB;+2M:BUW2M4M]3BBTYXF2ZBEU*6Z%WN7*,H=0%8'
MGY<9''05D^&-7NH?$&F:3XC&I66ME9"LS7#S6>I_*260[MJG^+;@8''I@ ],
MHKR_0=<NK'6;'3_$<>J6NM*LSI*+AY;/50$8YCYVJW1@N!CIZ57;4M1O/@^/
M'$&J72:RD;7V5G?R?ED.83%G85VC;TSD9SGF@#UBBO-);>]\1?$.?3I=9U>P
ML[C08+PPVMR8VBD:5A\IQQC:.W/?CBO2E&U0N2<#&3U- "T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8S%*F2,J?<=*PK7P'I5K?:=?"XU*2[L(FBAFEO'=BIQPV>"!M&!C'J#7444
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MAG%T?LSD0%H B[B 0,M_]?%8&NC6M5T>\%WH>KG4+76XY1#!;L(%@6=2&0#
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MGZC'\'-!TUM*U$7T&I122V_V.3>BK<F0DC'3;S0!Z3?^)[*QN[RU6*XNIK*
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M6[72&U<F)4A9&9@ <#<1UP>^,5<TY]0\.:QXOTR]TK4;A=4NI+ZQNK:V:5)
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MD.0#D@88CK7-P>,;77?AGJ.K^(M+OX=.;SUE6 @DQB5U 4HV00% ).T9[XH
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M+#NV[UYS@'@AL$9Z5"?&NG)<Z8DUO=PVFJ2"*RO9$7R9G(RH&&W#<!QN49H
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M .'T'0;NP\=ZCIBE#H%I-_:ML@/,<\P93'C^Z")' [;E-=3XJDU2+PKJ;Z)
MEQJ0MV^SQ. 0S?0\$XSP>M3:)HD&A6)MXI[JYD=M\US=RF2:9L ;F;N< #Z
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M/2=+;3=$U'P%Y&JV!CCEU"2UB-L1'@>:DG4L0,@ 9W'L,FO3J* .<\=^&/\
MA,/!NH:*LHBFF4-#(W19%(9<^V1@^Q-0Z-XHNWL(;?5]#U6WU9$"2Q):-)%(
MXX)25<Q[3U&6'O74T4 <+K-IJUGXVT'Q0UG)<6R6TUE>P6JF1[=7(97"CE\$
M -@9[@5D:[H5]>V?CW5[>RNB=9LXK.RM_*822E(R-Y3JN2V!NP<+D]17J-%
M'G]_#=2^(? -REA>F&R68W3?9W_<[H-@W<?WN/UZ5S_B>WN8M)^*5S-:7,4%
MY%"]O+)"RK($B5&P2.Q%>P5E^(M"A\2Z%=:1<W$\%O=+LE:#:&*]QE@0/RH
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M80B@L"0VX'##MWZUY_X3\7VWA/PYJ+76F:K<6,&L7:SW<$/F1VZ^<0"Q+;B
M,9V@X[UK;]7U;QEX.U1?#VHV]I:074=P9]BM&71!DC=TR/J<' ]:UCINK6_A
M'Q-X9;2+DWVH75Z('91Y!CG9MLAD!P  V2/O<8 - '7W7BJVBFN(K.UN-1:V
MM4NY1:E"1&^[;@,PW$A2<#^HS5N=1T>7QSHL$]C='59+2:2TN.1&L>%+@_-@
MG[O8_6N8UWPHHBB@M;;5;;6-*TZ*WTS5]/!!G*ICRI,'&-P&=^!ANHYK4EM-
M8D\<^$;V\M))&M=.FBO[B%/W2S2+'T]LJW3@<4 4OB/K\.I?#WQ&+.SO;BVM
MT>!KR%E5%E7@X^8,RJW!(!&<]<'&RE[I \5>&[2YLKEM6:PD:TN1D1JFU?,'
MWN3]WL?PKC5TWQ!IOPUU_P $R:%?7-THN%M+N$*T5Q'(Y<,6+##?,<KC-=))
M:ZC+XW\'WK:7=QP6EA/#<L5!$+NJ!02I(/W3R,@=Z -3_A/-/WV[_9+S[#<:
MB=,CO-J;#/N*XQNW!=P*YQU]N:9/X[MX]:U#2;?1=8N[NQ>%9EMX%;"RYPXR
MP^48Y[\].#CC+^R\2ZII]E-J/A_4+C5[+7HKF9PZ>5Y*3$@0*7QC9MR<#."6
M-=9X>M[V/XB^*+VXT^YAMKZ*T$$KK\K-&C!QGV+=>_:@#1TSQA9ZG8ZQ="SO
M+;^R)7BNHK@1JX9%W'&'(QCH20#6U8W1O;&"Z-O-;^<@?RI@ Z9[, 2 ?QKA
M]<T"Y;XB6_V)T%AKEOC5H3U*V[*5<#ON#"(^S5TUWKTEGXIL-'?2[IH+V-BM
M^N/*60!F\L]\[4)S]* .?^*X1?"5O<,9 8=1M"-A;H9D!X'7CMS6IIOC:RO?
M$$FB75AJ&F7@A-Q"+Z)46>(=60ACT[@X(].N(OB'IE]JOA0PZ?;-<SQ7=O<>
M4A 9ECE5FQD@9P#QFJ6J:-/XP\1V-^(+BRL[&QNH1)<1E))))T"8"GG"@$DG
MJ2,9YH T6\<V$=QI7GVMW#9:K*(;*]<)Y<CL,H,!MR[ATRH]\5SK!?%GCWQ)
MHVM:1<S6-O:VL<.YXA]EWB1FE!#Y#,0N"N3\HSBF^#X-1MK;3]#U'P/'!J%A
MLCDU0Q1&W=$P/,5L[BY X '4Y..:T+#3[N?QUXP::TNX+/5+6VM[>Z,9VL42
M17/J,;QC.,XH O)XUTRPTBSOFM[[^PV=;>/5)"K1]=BNWS;]I/&\CG.>AS3M
M1\=VUCK5[I$6CZO>WMI%',T=K K;T9B-RY89 Q_AFN6CT;6;SX5?\()=:9-'
MJ2(MD9]N;<Q*XQ,'Z8VC.W[V>,=ZW]+LKJV^*&HW)LKH6$FF06L5RR?*SQLQ
M(SUZ,.<8- %[5O'%AI%K<7TMI=RZ;:S^1<WL00I$P;:WRE@S!6."0#@YZX..
MD,T0@\\R*(@N_>3\NW&<Y],5YAI5AJ&@:AJ.BW?@H:L)KV:>QU)8XC$R2.7Q
M,S<KM+'/!)[#IGOM;TN35/"VHZ3'(D4MU926RNHPJLR%0<=AS0!P?C;7(]9L
M?"UY;V%\MI/KEF;>[8A8Y%,@Y*AMV& R"R_ED9Z[5_%]MI46H3K97=Y!IHS>
MR6^S$/RAB,,P+$*0Q !X/KQ7#W"^(;WP9X:T>3PQJ*:AI%_9?:0/+\MEA899
M&+ $$#/H.YZ9N+9W^@>*M9CN_!KZY9:I<_;+2ZACA=HF95#12;R-H!7@Y(Y[
M]@#L'\465S):VVFQ3:C-=V@O$2V*KB!ONN68J!GH.<GGT)'%^!_$EMH/A.ZN
MKFTOC!<>(;BV484O"7FVH'W-GC(!QGI5^*TU?PSX]?56TB2\T_4M.@MY!IR@
M_9)HL_*%)'[L[C@_GBL7^PM>D\":K&=$NDNH_$;:G';LR;YXA<!SMPQYP#UQ
MGMF@#T7_ (22T7Q-/H,L4\-Q#9?;C-)M\HQ;MN00V1SGJ!TJE'XULY+G2E-C
M?):ZLQ6RNV1=DIV[ER VY0P&02![XKF[O3M5\1>-KZY.D7ME8:AX;DT];B;8
M#$[2,067=D<'H,GIG&:T/!FI^(TTS3M U#PY<VEU81I!<7LC(;9D0 ;D(;<S
M, .,8&<D\8( [1_%T^L67BA]3T:[2SL+J>V*HT;'8B(&3Y7R7.6;C@ XW<5>
MTC7]&LO"OAX:9:W AOX433K$$-*5V;L$LV/E49)+?B21G'T>SU338?&UE/I-
MUB[OKF[MYDVLDJR(H15P<EL@YXP.YK-LM#UG3]+^'^KII]Q)-H4#VM_8X'F!
M9(PC.HSAMI4' ZCI0!UO_";6"6^LFXM+R&[T>/S;NS**91'M+!UPQ5E(!Y![
M8.#45CX\LKV^T:!M-U&WAUB/?9W4T:B-VV;RGWMP.,\D8..">M8NJZ+>:EJ'
MBGQ!%97*BZT,Z79P-'B2=SO)8J>5&651NQT)X&,QR6&HFQ^':#3;PMI;QF]'
ME?ZD" QG/K\Q[9XYH [K6[V;3M%O+RWMY+B6&)G5$*YR!U^8@8'7K7 ^%7TR
M#P[X<\4ZC8WD>LRP1P),KIOU&69<\A7^?G)&_&W&> *[W7MYT#4%BBDFD>WD
M1(XURS,5( 'XUYZ-"UG_ (0;P5/;V$YU'P[+!)<V#@*TBJFR0(2=I;!R.?UH
M [.#Q9;/J5[IEQ9W=MJ5K +G[*ZJS31$XWQE6(89X/((/6H/#7C2W\4_9Y++
M2M3CL[BW,\=Y/"%B.&VE,AC\W?'3@\\5GR6,VJ>-8_$HL[J&TL=,DMD62(K+
M/)(P) 0\X4#J<9+<=":M_#6SN]-^'VD:??VLMK=VL7E2Q2C!!R>G8C!'2@#3
MU'Q!%9:O#I,-I<7E_-;O<B&':,1J0"2SL!U8 #^G-93_ !#T@:+HFJI;W\EK
MK$ZV\!2#+)(21M89SG*MP,].*9K[:NWC&R@?3+R]T![-LK:.J@W._I+EA\FS
MMT))R#QCCM,T;6[;P5X,TV?0[R.?2]<6XN%"JP6)7E)<8/3YUP.IYP,4 =U;
M>-8;C^V8FT?5(KW2466:R9(S*\; E63#E6R >,YXQC-6(/%MI=>'=,UJWM+N
M:'4GC2")/+\SYSQD;\<=3SD '/0UFZ3:W:?%#7K^2SN$L[FSMHH9V3"NT9?<
M/4?>'7K5'PIH%SIWB[5+#>C:'I=PUS81C_EG+<*"R>VP%\#TFH [+5M4MM%T
MJXU&\8K! H+8ZDD@ #/&22!SQS6;<^*K?3K35+G4[*[LHM.MTN)6<*X=6W ;
M-C')RA&#CJ/K5GQ+$LWAZ[A?3/[3CD"I)9@#,J%@& R1R%)(Y'(K@X=*\3Z#
MI/B&'PI)J$^GBTB.FP:B/WD,VX^8D?F<E0G(W<;L8SS0!VMCXC@U#6Y="N+*
M[L[W[(+L),4P\3-MR&1C@@\$<'TS7*>!]9M?#_@:>:X$TH;6[BUAC3YGD=[@
MHB@DX].20/>ET>RO8?B/;ZQ'H&I06$VC&W>:Z=7E$@E#DR?,6S@8 Y/L!TI:
M?!XFTKP.\-II=\DS:[)-=Q1@"<V<DK,3$2<;B"!P<CGH<&@#KQXTLU@UUI[*
M]BN-$4/=V^U6?84WAE(8@@J#W'0UFS?$NT@T5]9DT#7/[-6WAN/M(@0(4D],
MN,X. ?SZ<UA0Z5J=O>>/#%X>O8;?5M.B6TR5<NXA="&PQ.\LPSU[DFNS\.Z<
M+GX?Z=I.IV;I_P 2Z.TNK>9<'B,(P_GR* +\VL)#J&G67V6XDEOD=U*;"L:J
M 26^;I\RC(SR13]7U>UT6S6XN=[&25888HQEY9&.%11ZD_0#DD@ FN6^'.F:
MA;6<[ZI.MRUBSZ792@YW6\,C#>?]HG /_7-:G^(.F:I=0:+J>DVQO)](U&.\
M>T5@&FC 96"YXW -D?C0!E65Z!\:+V:ZMKBP6/P]YDHN9%*X\\9<$,0!@8[?
M=KH%\:V2ZCI=M<V=Y;1:J=ME<RA-DK8R%(#%E)'(# >G!XKF;_3]3\3^,;^=
M-(U"RL;_ ,-2:<+BY5$\N1Y&(W+NSW^OM@YJ?PA]O*6&FW_@9+#4;+8MQJ#Q
M1>00G&^-@=S,V.!CC.2>.0"K$(/%OBGQ99^(-,NEL[-K=(IGEB4V"B'S"P97
M)5BQ)RF>P/ XZA?&MC%>Z5;7%G>V\&J?)8W4H4K*V,A2 Q92PY&X#/?!XK#L
M]'O=1U7Q_;36MS:0ZVJQVEQ)&0K#[/Y9;VP1WQFF>$?MXBL--U#P,ECJ-D$6
MXU!HHC 0G\<; [F9L< #@G)/'(!L6/C^VU*ZE@L]#UJ807DMG/(MNI6&2,9.
MX[N >@_#.,C->T^)NEW6CG6?[,U:+2A:O<&\>W'E_*^WR\AC\Y.,#I[\'#O
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M[,$,R_*1SG/%2:C9:U:^,M#\5R6+SQBTELK^VMOG>W5V#HRC^/! 5L<\9 H
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M"(8C(BJ.K<@$=>_;/-9WA/3M1T:SA\+W_@J.XN[1S%#JYBB:VDBS\LC,3NW
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M%% !1110 4444 %%%% !1110 445QWQ41?\ A6FN38Q+#;EXI!PR-D<@]0:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N6^(MC?:KX#U;3=.LY+J[NH?*CC0J.21R2Q  KJ:* .
M4CU#5(M#LH(?#%\]_#$B1F9H1'')MVEB1)G R<X!.,XJ#3+34;3XB>)-3ETV
MY^QW5K;1P3 I^\:,/N &[(^\,9 KL'=(T+NRJHZEC@"G4 >2P^'M>C^$6AZ(
M=&N3J-K?0RRPAX_E5+CS"<[L'Y??K6OINH/:?%?Q:PL+J=7L[ GR5#%6VR84
MC/?)YZ#')%>@I(DBED=6 )&5.>1P16+I^AV-MXEU+6+>^FEO;M4CNHS(A4!
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MBT?1/!^J#P\;V;3+)["_TR1XR[1MM(>,Y*Y!4<=>U>O4UW2)&>1E1%&69C@
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M3M2MIKF(/'\B1REF.=V#QTP:]6\Q/,$>]=Y&[;GG'KBAW2-"[LJHHR68X H
M\_L1XC\*>)]<BM] GU73=7N_MUM/#-&GDR,JATEW$8'RCD9X['H+VIV&K3>/
MO"=^UD\T-E;7*7ES$5"*\BH!@%MV,J>QQQ7:44 >47^C^((= \=Z!!H5S<2:
MI=W-W:W*R1B)TE5<+RV[<"",8_$#FM*.RUW0_&5EKZZ+=7=I>:3%8W5O"\9F
MM94)(."VUE.3T/O7HM% 'D=UH/B&Y^'WC731H5RMYJ>K3W%K&98OG1W4@YWX
M&-IZ^V,UU%S::C-\2-%U5=,N?L4&FS02RDI\CNR$ C=D_=.< UVE% 'DUUI-
M]%X+\5VM]HTQGU'7GN+&$S(CR"21"C(0QPXVE@#CISQFMK0+\GQ='=ZMH6O6
MVI7<'V*&\ODA,05=TFP>4< G!;)')'4<"NLUS0+#Q#91VU^LN(I1-#)#*T<D
M4@SAE92"",G\ZBTSP[;:;*LS7=_?3ID))>W+2E,\':#P#CC.,X[T 9/CG1M1
MOO[$U72HOM%UI%^MT;7<%,\>"KJI.!NP<C-+;Z9<:MX^MO$DEK-:6UGI[VT:
MS@+)*[L"3M!.%4#'/4GC@9/5M(BNJ,ZAGSM!/+?2G4 <3H'AB^TKQCJ@8*-!
M6X.H6*YY%Q,I60>P7#G'_37VK+@LM:\.>)M9MSX476['4KQKRTNT>(&)G W1
MR;^0H(R",\'H>@]*HH XJ'3M4A^)]EJ$FGN;*/0S8R7,.Q8Q,95? 7=NVX4]
MO2GZ=9ZGIGQ'\1WC:9-+8ZE%:O%<HZ;5\J-E92"=VXDC&!CW%=E10!Y)'X?U
MY?A1::,=%N?[0CU47#0[X^(_M1FSG?C[I]>M=5+::@WQ4MM7&FW']GKH[VK3
MY3 D:57 QNST!YQUKKT=)$#(RLIZ%3D4Z@#R0^&/$3^'KR:#2?\ 3[3Q+-J]
MO9W3IMNX6+#9D$@$JYZ]"*ZW3M2U3^S;S5(O!SV+PP'RK)FB6>YDZX!7(51C
MOR<]!@9ZZF2Q)/$T4B[D8889ZCTH IZ+J7]L:+::B;=[<W$8<PN02A[C(X/U
M'6K]-1$CC6.-55% "JHP !V%.H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R]<UN#1(+9Y0
M&DN[E+6!6<(ID;.,L>@P#Z^P)K4K!\6V*ZEI<5E/H@U>RFG"W5ON4,L>UOG7
M<R\AMO0YZXH Y3XDW)O_  '>2WNFFWN+'4[5%W8DS^]B.]"!R"&QZ]1CM736
M'BM[KQ+<Z%=:1=6=TEI]L@$CQMY\6[:?NMA6SC@GO7%WGA/Q#'X&U'1K2"^O
M8'U."73H+JXC,L%NCQNP9F;&,JVT9)QC..W3R6.J-\4;?6AI<_\ 9ZZ.]JTO
MF19$AD5P,;\]!C/K[<T 91UZ&/X5Z_JGAO27T\Q?;<Q[U5HI%W[I#@D9W#.
M368\TFAQ>#=2LO#\<.H7S0:=)<+< -)$4$F"!P2Q0\MR.?6KUEH6NQ?"_P 1
MZ/)H\RZA?27OD0^=#\PF9BIW;\#&X9YS]:N:SI.LW'AWP?);Z5+)=:1?6TUS
M:>=$'*I$R-M;=M."WK0!W+7"PVAN+DK B1[Y2S<( ,G)]O6O,O&NJG6[#PCJ
M*Z2R6<^N63VET[+Y@4N""5ZJ&'(Y/;(!KO\ 6M-DUSPQ?Z9(PMY;VSD@8@[A
M&SH1U[X)KSV:Q\67OA/PYHT_AJ5;S1[^S::47,/E31PD?,AW9Y !P0,4 =99
M:E82^.=<MK?1GCU:WLX6EN'*C[2A+;%!!.!P>3CZ<5R6@QOKVD:WJ>I:(+J\
ML]9N;FWG:<*\<D3X10P.<*HQCH0,=ZZ;3K#5(?B3K6K2Z9,MC<V,$,4OFQ'<
M\9<D8W9&=PQD#\*J^%=.UC3?#&O6UWH]Q'<W-[>7$$7G0L9%E8E1D/@'GG)'
M2@#'\)3:;;^$/#/B/5].4:ML$=I=>< ]S),K%RQR!@C<QWYQ@D<UN'XCV<4&
MO":PE>[T6$7,\-M-'*LD1!.]'R 0,<C@CT-8J^&?$<?PY\+QVVGJFM^'Y8YO
ML=Q*FRX"JR.@96(&58X)K6U-?$/B'P5KD#>&SI\]U8R6T%F9XFD=W4C<S A5
M4<=\GGCI0!=A\< V@NKS1[JR@G\A;%YY(P+II%)P.?EP 2=V..<=JJO\2;."
M#71-82O=Z-"+B:&VFCE62(C.]'R 0,<C (]#46NZ'KEWX/\ #L^G6:#6-&EA
MN/L-Q(N)ML9C>/<"5&0QP<T:LGB+Q'X(UR ^&O[/GNK)[:"S-Q$TCNPQN9@0
MJJ.W.3SP.,@&C:>-?/UO2]/N-'N[6/58'ELKB1T(D*('92H.5^4Y&<9]!6=H
MWBJ_U32O%<^KZ.TMI8W=S;F"&5&)2-5#1\D9R-S$Y[D#M1<Z7K$NN>!;I=)G
M\K2XY1>$RP_NBT/EC^/YN>>,\?E3-+TG6].L?&>GOI+R+?WEW=6DR3QXF$J@
M*H!8$$<YW8'IF@#3TOQ#:PZ!X8ATC29%75+96L[8';'!&L8?YWP< # Z$D_C
M7-^.]9M/%/P=U^Z^R&*6TE:WDBEPQBFCE56P1U]B.QJ>WTSQ-9Z%X,L'T>>X
ML;.U^SZI8QW,2LSK&JHQ._:\8(;*YYXR#TK-E\*^(_\ A7'BW08]"5+F^U*:
M:TCAN8MC(\H<$9(PH QS@^U '?WGB'R-7.D6=J+J^CM!>/$9A&3&6*C9G[S9
M4^@'&2,BM6SN/M=C;W)C:(S1K)Y;=5R,X/N*XGQ;H/\ PD=POVKP_?":&T5[
M'4;.>..XMI\ME"=XX^X>Z\FM*QU77=*N?#FC:KIYNVNK41W6J1SJ%6Y6-F*[
M.I!V$[AQR* -'Q7XA_X1;0)]8>QFNX+?!F6%@&52<;N>H&>?:IY-7*W]A:I;
M^;]JA>=I(Y 1&B[<GIR,LH&.N:NWEI!?V4]G<QB2">-HI$/1E88(_(UR?@O0
M-:T7P_/#J$T<FH0HUE92-R/L\180EO<YR?;'I0!-9>.$N;K1!-ID]O:ZTTBV
M4KL-^54M^\3JN0"1@GWQ3[_QHMM:7M_::7<WVGV%Q]FN)8#ERP8*_EIU<*3@
M].AQG%<?:Z'XGFF\)ZA=^'7;4["\9M1N9[R)GF+1NN]2"?W>3G;P1T"FM70K
M;Q9X5O-3T2WT5+ZQN+V6YLM1^THJ0K*Q8K*I^8[23]T'/MUH W=8\8'3'U<P
MZ7/<Q:1;)<WDA;R_E8%L1Y'SL%4DC@=!G-4M0\6:@?%OANPTZR$MAJ5M+=[S
M(%:0*BD#!Z ;P?<_3G*\2Z-XDU6\\3V4^E'4K6YL/*TF=KB-88&,1#[D)R)"
MYR&VGL,J*DCTGQ!#J'@?4AHQ=M.L9K2[@%S&&A+)&JL3G!&4.=N2/0]* ->Q
MU[1;;Q!XNGDTYM.GTY()-1NY-O[Y?+8HWRD\!1QWYZ5.WC$6L^DG4M-FL[35
MI%BM;AG5MLC#*)(H^X6'3!89X)%<_>^$M3UO4_'UM/:R6EKK=O;QVETTD;*6
MCC*Y(5BP&[';IFK%QI6L^)]&\/Z5J>ERV,MC=V]Q>SO)&T;>3S^[VL2=Y QD
M# )SR,$ LW/Q!DC773;^'-0G.B2%;L>9$N$"!RP.[!X.0!D^N.*ZVQOH=1TV
MVO[;<T%S"LT>1@E6 (_0UPL6C:TL7C\'2)P=7+&R_?0_O,P",?Q_+R,\XX_*
MNK\*6US8^$='L[VW:WN;:SB@EC9E;#*@4\J2",CUH YJ?XF,FGZE?P^&-5FM
M=+NY;>^<-$#"(\;FQN^;')PN< 9)%;,WBU)98H])LI+_ ,S3AJ0D+>7&83]T
M!B#ESS@<=.2*Y#PZ]_<:-X[TRSTN6XENM;U"**7>@B!?"_.2<@#.3P<CID\5
M=7P[K6FWVGZ.=..K:%;:1':VY,Z)%'<+PSRHQRV0!@@-CL,Y- &P_CVV.G^'
M=1AL)WL=<DCBBG9E40N_W5D';.",C/(^E;L6J-+K]QI:VS%;>!)GGWC:"Y8!
M<=<_*3],>M<;I'A>XG^#*>'=?@&G3P6A3>TJMY3)\RRY4D## 'KT%:WAP:S8
M>!FU6YL_M^OW</VR:W5Q%YLA0!4R>%PJJOU!H ZVN=M/%)U"4O96)GLUOGL9
M)DE&Z-U8HS,G9<CCG/(. #FM+0M2?6-#L]0DM6M9)XPS0,X?8>A&X<,/0CJ,
M&N&E\,7TWB>UUK3=*N=&U?\ M'_3IXID%M>6H<Y+J&.69,8X!#'GIF@#<O/'
M,=F)+F33+@:=%J0TV2X9@K>86";PA'*;CC.<]P"*IB"*+XYF1(U5Y/#I:1E&
M"Q%P!D^IQQ7.ZUH/BO5=,U&*[T)KS4X]62X@NVNHMC6RS*RI""WR?*.0=N<$
MDD\5T[Z?K+_$Q=8736CM3H9L_/,L;(LYD#XQNW%1TSB@">T\<QW$^C-+IEQ!
M9ZS,\-I,[#?N4,1O3JH8*<8)[9Q3;7QO/?ZO=Z?9^&]1E-E?+:73[X@(@5!W
M_>Y'/0$G'7' /*0Z'XIN%\,7MYX>>35M/U'S=0NIKR(O,"KKN0@G$8W#Y>,=
M IZUU?A*PU.PU_Q3<7NFS6\-]?"YMG:2-MZB-4QA6)!RO>@"+0_$VAVGA_5-
M1M],?38DU66VE@)0/+<EPI/!VY9CUS@8SG%6+3Q[IS:OJ&F:@([2>SLS?M(D
MZS1/ #AF##H01R"/IFN83PGXBG\)ZM%%9"TU2/Q!)K%C'<21LDP\S>JL58XR
M,@Y[X^M:]W9:[XT\+:KIM[H:>'S<6;PJ))TE9Y3C!RG1!CGN<]!CD S/%E_+
MJNI^!;Z31VMXYM9A>"X=U,@0HYVN!RI/!P">G.",5WGB'64\/:!>ZO+;37,5
MI$TKQP[=VT#)/S$"N%NX?%6KV'A*&X\,SPW6DZG!-=L;F'RW5(W4M&0^2#G/
M(!Y YZUU'Q#_ .2<>)/^P;/_ .@&@"C#\0%_M?2K6^T2_L;35@%L;V4H4DD*
MY"$ Y7/;<!GT%2:=XYDU34+FW@\/WXAM+][*[N)'B"P;5#;S\W(Y[9P/J!6>
MNFWOBC3?!\+Z?-:6^FS6^H3S2LA!,<9"HFUB3N+ Y., 'OQ5CPSH>H>1XOLM
M3L9K.'5M0N)H9#)&V8I$5/X6)!X)P?:@"S-X\M[?2K779K"9- N9%1;[>,HK
M-M61TZB,G&#DGD9 J]?:VEU?7^D6>F_VF]I$K7B,ZJ@#@E8QG[SD#..!@C)&
M17(KX=UV_P#AHG@6^TYHYD$=HU^LB& P(X(D7YMV=BXVE<[O;FM*PT_6_"_C
M;6YK?29=2TK6&BFBEAFC5K>14"%7#L/E. <C./0T 9?P[\0IHGP\\&6LMI(\
M>IS/:1R*P_=N7D8;@>V%/2NM_P"$QLH-0\06M]$]JFAPQSSS,P961U9@5QSG
M"],=>F:XG3_#7B.P\ >$$?1W>_T34Q<S6:3Q[Y(R9,E26VYQ(#@D=#5F^\*Z
MYXBOO&J7.G_8(=;L;:.VE>=&V21JQ"L%)/4C.,CK@GN =='XFN_[4M;&XT*[
MB:]MWGMG#!ERH!*2$<1M@CN1[UR]IXNDU3X5ZCK?B/0VN[,FX\V"&1&#1B9U
MV\D<*% SU.,@5T/AO4_%6H"WAUG0AIA@7%S,UPD@G8#'[L*20"?FR<8QCG.1
MR\'A[Q%%\)=9\+-HSF\/VF*!EN(ML_F2NX89;A0&&=V#[4 =FVO0PW&GZ5I]
MIYU[/:?:4M]X1(81@99L' R0HP#D^P)&3=_$:SL_#6J:L^FWAFTJX^S7MF"F
M^%R0 2<X*G<""N<@].M5CI&KZ;XOTGQ-!I\UQ$VE#3;ZS62/S8<-O5URVUN<
M@@'IR,UE^(/"&L7WAWQC<VVG.^H^(+FW:*T$L8,4<6P NQ8+DA6)P3U H ZZ
MS\5F?Q4-"N]*NK*2:V:YM9960B9%8!N%)*GD'![>G2K^MZW#HD-H90K2WERE
MK K.$4R,"1ECT&%/KZ $FL.\L=3N?B1HFK)I<XL;>QGAFE:2+Y&D*$#&_)QM
M.< _C6CXNL$U/2X;*XT0:Q933A;J#<H9(]K?.NYEY#;>AS@G% !+XF^QV;R7
M]A-!<_;%LH;=6#&XD8 KL/ VD$G)Q@*<XQBL'Q7JO]K>$?&.DZAI,EO<6.FR
M2AG'F0R Q,59'P,D$<\ @BL:3P=XEMO#Z-ITDUQ)I.LI?Z39ZA.&D:!4VM$S
MY(&=S[<G@8SC/'1:G)XC\1>#-<ADT&2REN;"6VM[)KB)Y'D=2-S-G:JC(QSG
MJ<=* (O#?BLVT?A?1KK2KJ"+4+%4M+MV3;(Z1!B"H.Y1@$@GKZ5+JWQ'TW2K
M:;4&B$VF6]S]FGG2=/,4A]C,L?5E#<$]>"0".:I2Z1K+W'@%QI$^-)!^V_OH
M?W>8#'_?^;DYXSQ^50:%9^*O#4EUX>3P_!?69N99++53.BI''(Y?$J'YB5+'
MIUZ<=: .GO==CO;N_P!*L=.&J?985:\4NJH XRL8S]YRO..!@C)&:Y'X=^(4
MT7X?>"K26UD=-3D>UCD5A^[?=(WS ]L*>E:=A8Z[X9\:Z[+%I4NIZ9K+QW$<
M\,L:M!*$"LL@=A\IP#E<X]#6%I_AOQ%I_@/P<KZ.[W^AZB+B>S2>/?)&?,!*
MDMMR-X."1T- '92ZU;ZU<>)O#]Q8D-IUNGF^80Z2K*C,N/\ OGG-8O@K7;;1
MOAEX3BD*M<W=JL<$;2! 2%+$ECP% ')]P "2!4FF6&NIXI\7:G<:+)'#J=I;
M+;J+B-F+1QN"I^;&?G'?'!Y/6L>#PWXFTWPGX-O+32EFU70$>&XTV::,?:(W
M4*VUP2N1@$9/^! .U\,^++7Q)+J5JD1AO=-F$5S%Y@D7D95E8<,I'3H>#D56
MU/QC)9>)9/#]KH5]>WXL_MD8C>-4D7?M^\6PHSGEL=. <BM'0)]2NX9+K4-*
M72P^!':F17D &<LS+QSG@#.,=><#F+VZEM?C:CQV<UT#X=PPA*[E_P!(ZX8C
M([<>M $P^)UB?#*:Q_9=_N6_&G75MA?,M9MP4AAG)ZC&T'/M6C_PE[Q"."]T
MJ2POYYI4@MKNXC4/&@4F4N"0%^91W.3T/6N5U+PEK7_"/7KV^F/-?ZGX@CU2
M2V2:,>1&KH0I9F +;4YP2,G'3FMSQ=I^MQZYHWB;1=-74)+2*6WNM.DD5'>*
M3:<JQ^7<I0=^: (S\3K!=!NM2_LZZ=[._6PNH8W1O*D+!0VX'YE.X8*@Y]*N
MGQI<+X@ET-_#M\M^;;[5:)YL1$\8;:26#83!(SD_F< YGBBQ\0^(/!C1)H/D
M74UY;RI9)/%NBCCD5R78L%+':> 3CCWK0FL=3?XH66LKI<_]GQZ3):O+YD7R
MR-(K@8WYZ*1G'7\Z *&L>,M*U'X<:GJFJ:#<7-K;3-:W^GL4)CD20*03NP0&
MVG(S]*Z1_$"0^+HO#IM'$LMF]W%,&&PJK*I4CJ#EA7!7OAGQ#<?#OQAI*:+,
M+W4]5FN;6,SPX:-Y%8$G?@8"G(KH]9M=7@\=:-XBM-'GO(/L$UG/!'+$LD+,
MR,K'<P4CY2#@G\: %N/B);VWAJ_UE]*NV2QU!M/GC1D)5PX3=G/*[F'0$^U6
M'\:3Q^(6T23P]?+>26YN;-?,C(G4,%;)W83&0>3T]\ \C<^&O$TO@7Q)I9T5
MC>7VNM>PK'<Q;6C,Z29RS#'"'&<'D<#MU5W8ZG-\2]*U=-+G^P0Z=-;RRF2+
MY7=D8#&_)QM(.!^= #[7Q[:3Z$]_-:26MS'J/]ER6LTBC9<;@NTN.-O(.[T[
M$\5O:9?7%X;I+JQ:TEMYO*P7#K(-JMN4\9'S8Y .0:X73]#U)-*\06FJ>%VO
M;34M=FNGMI)827MG PP^? 92H.,@^G/2;2K?7/!'A_6YK*PN]1T^*='TW3[R
M\1988=H\S,A) 0') )S@>] 'H+HDL;1R*KHP*LK#((/8BO)_!/B<>%O MJSZ
M1<OI::G/!-=QLBI!ON65<*3N8 E<X'&>YR!ZG!<FXL(KI89 9(A((C@,,C.W
MGC/:O+F\->(F^$=QH/\ 8LW]I/J!G6+SX<;/M0FSNWX^[Q]?SH [RY\0N=4O
M--TNQ:_NK&-)+E?-$:IO!*H">KD#..!C&2,BN.\8ZQIOBGP;H&LV:$C^V[0*
M)4Q)"XF"NA'8@@@UK66GZKX?\;ZWJD>FW%[IVMI#-B%X_,MIHTV%6#, 01CD
M$X(QTYK&N_!VKV?@RTL[:Q-U?3:ZNJW4<4J!8AYWF%079<X7 XZD4 =4=0TU
MOB4FGOI3KJBZ6TJ7[;<&'S%!08)/WCGD#I[UQ_Q*UM/$'PSO[VUTSS]-\^-(
M+UG7.5F53(J]=A(*@YR<],'-=)=:5J5S\38M2.GSKIIT:2R>X$D?RR-(K]-V
M[@ \XZUR,N@^+(_A5=>!SH$D]U;%([>]CN(A#/&)E<'EMRMCJ".W6@#O-8\5
MMIL^J1P:9-=+I=H+NZ<L(QL(8[4)'SMA&..!TYS3)?&<*:AX>A2QF:UUU UM
M=LZJBDIO"L.H8KT'<\5@:_IGB35]3UVWN=%-Y976G!-,W7,8BM9#&P?>I/+[
MB,, >PR!DU+J&B74_P '+:UU"/\ LW4M*L89H7+AS#/ @*ME<CDJ1QGAO7B@
M#L+/5&O-7U"Q6V81V116GW@AG90VT#KD @G_ 'A65J_B]M,\1Q:%!HU]>WD]
MJ]S#Y31A9-I (R6^7KR6P..,D@5H>&[&XL=$A%]M^WSDW%V5Z><YW,![#.T>
MRBN7UNXEM?C#H<D=I+<_\2BY#+$5W >9'S\Q&><>_- %VP^(5K?:+<W9TR]B
MO[:]73Y].909$G9@J@D<;>0=W3&:LQ^+Y'.O6W]DS/J.BJCS6T,H;S5=2ZF-
MCC)P#P0.17.WF@>)+>WUC6-.M9%NM6U:">XL8IUCF-G&H0H'SM61@,G#< X!
MS6AX2T?4M,\;^(+Q]#2PTW48;5H=LT9V&-6#*57^++9/;K\Q[@&O;>+([WP_
MHVK6EHTPU9XTAA64;EW GD]/E"DL.VT]<5T=<'X1\/2Z;XKUF%9E?1]/N7;3
MX0/]3).JR2K]%S\N.TC5T.CZW>W^M:OIU[I+V/V)T,$IG607,3%@KX'W3\A^
M4\\B@"IKE_IT'C+PU9W>DO/>7#S_ &*\.W; PB)?OG)48Z8YZ\5$/&T9T7Q#
MJ!TZ8'0IY(KF+S%R_EH'8H>_!XSBJWBI2WQ#\"X!.+B\)_\  =JQ;W1?$-M:
M>/-(MM%>Y36FGN+6[$\:QGS( FP@G<&RN!Q@YY('- '07WCK[->Z39VVB7UW
M<:I9O=VRQM& VU0Q7);@_,,DX'IGI5C2?%LE_P"(QHEWH]QI]V;%;T">13E"
M0"!MSDJQP?2L2WTG6U\2>"KJ31YEATW3I;:[<3Q$1NZ(HQ\^6&4.<#N.M7?B
M#I=W.-'U31[A+?6K6\6"W=AD.DWR2*1W !W^VR@#H]&U1M7M9;C[,T,:3R0H
M2X;S C%2PQV)!QZCFLK5M;2]_M?2[/3/[26RAQ>@NJJ"R[A&H/WGVX..!R.<
MUO6%E#IVGVUE;KMAMXEB0'^ZHP*XBQL->\-^)_$<<6D2ZCINLS_:X+B&:-3#
M(4"LD@=@0O P5SQV[4 5? 'B%-)\%>!M.EM7<:I$88Y4881E#-\P/; [5L:I
MXVFMK+Q:MKII:]\/PB1UDE 20-&9 P/7 4<C&>WO7-6'AWQ#IOA'P-(VC22W
MNA7)-S91SQ[V1D==RDL%)&X<9J\- U^_NOB"9M,%LNN621VC-.C#>+8Q[6P>
M#DC)Z<'!/4@&G!XRN[#1_#4NIZ9*3JIAM_M(F3:LCH""_H&.<8[\>E=)%JC2
MZ_<:6MLQ6"!)GGWC:"Y8!<=<_*3],>M<ZVC2ZU\+3I&MVITN2.R6/,DJL87C
M08ERI(&&7(P>@YQG T?!%M?)X:M[W5B&U74 MU=D#'S%0%&.V%51]0: .BHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***P?%?B9?"NFP7LEC/=)+<QVY$)'R%V"@G/)
MZ] #0!O45R5CXVD?Q-)H6KZ)=:7<M;M=6A:19A<1K]X#9G#C^[S]>F2R\:O/
MJ6AVMUI3VJ:Y%))9EI<R+L7?B5"HV$KZ%N>* .MHKE]+\8?;8O$!N[);&;1)
M&2>*2?.0$WA\A>$(Y!Z\'CBM_3[B>[TZWN;FV-K-+&': MN,>>=I..H[^] %
MFH(;VUN)I88;F&66(XD1) S(?<#I6-XYO;W3O!&M7>GJ//BLIG#^9L,>(V.\
M<')''''UKFM+N;714\(7UUH,"7M]#%I<-U#<994:,/\ ,-H!!V$]R#]30!Z+
M17+S>,?(O?$MJVF2O)H=O'<,(I5/G(ZLPQNQ@@(<_IFJECX]DN9_#S7&B3VM
MCKB*+>Y:96VR&/S I4<X(! ;VZ"@#LZ*XG6?B18Z5!>W<<4%S9V-P8+C;=JL
MY(;:YCB(^8*<CDJ3@X!&"9+SQS<C7+G2=*\/76HW$=G'>QE9XXUEC=L9!)XZ
M'@\GT[T =E3#-$)Q 9$$I4L(]PW%1P3CTY'YUR6H^.6TZ*>]FTF5--M]073Y
M)9)-DI8LJ[T0KAD#,!G=S@D"JSP11_'*"5(D627P_(795 +8G0#/KQ0!VTTT
M5O$TLTB1QJ,L[L  /<FGUPWQ@@BF^&&KM)$CM'Y3H64$J?-09'H>36QK/BJ#
M3=2.FPFT>^6 7#)=78MT"$D*-Q!RQ*M@8[')'&0#H:*Y'2_'<>NZ9H]SI6FS
MRRZD\J;)3L2W,8)?S' ;'3 P#G(JO-\0A'X-O/$4>DR2K874EM>P+,,QE'V,
MRMCYE'!SQQSB@#MJC,$)N!<&-3,%V!R.0O7 /^>E9TVL&+4+.W$43Q36[W,L
MPF^6)%V\].0=PQTS@^E<Z/B58"YTAFBA:PU6=8()8KM7F1G^X9(@,JK>N3C(
MR!0!V]%8WBK7U\+^&[S67LY;M+5-[1Q,JG'KDGI],GVK(B\<RIXDT_2]3T*Z
ML+?5 PL+N25&$K 9VLHY0D=,\^P.< '845R#>.6B?3II])EAL-0U(Z;#)))M
MF$FYE#-$5&$)4\[B<$''-7]-\2R7OBG5=!N+'[+/81),KM-D3QOG#*,=!@@^
MAXYH Z"BL[0]3DUC2(-0>V%NLXWQKOW[D_A;.!U'(]B*C\2:V/#GAZ]U=K26
MZ2TB,KQQ,H. ,DY)'^/M0!JT5QD/CV1-:TFTU'0;JQLM7PME>O*C!Y"NX*RC
ME,]L\GT'.))?'+0/933Z3+%87FI_V9%)))MF\S<4#F,K]PLIYW9P0<4 =6)X
MC.T E0S*H<Q[AN"G@''IP:)I8H8BTLJQ*2%W,P')X'7OFN;M]7T[_A/]3M)-
M*6VO;;3HYI=0<KF2'<V!QSM!#'G'TKDO'6K/K_AC0]3CTE/[/FU:T>UNGD'F
MJIE7#E-ORJPZ88G!&0.< '?Z)X>L] ^V?8WG(O+A[J82R;MTK?>;VSCITK2F
MGBMX_,FE2-,@;G8*,DX R?4\5!JES/9Z5=7-M"DT\43.D;OL5B!G!.#C\JX!
M?%#W'POTK6/$FB1ZC'=O;%E$BE=SNNUR&'RX8C &Z@#L=9\+Z5K]Y9W.HQ2R
MM:;MB"9U1@V,AU!PPX'!K6EBCGB:*5 \;##*>A'H:YN]\67$'BV3P[:Z+/<7
M0L?ML;F9$1QO"8SS@9SR>?8UCM\3)%\,OKY\.W0L[29H=1W3H&MV638VT?\
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M/I>KW">&9VNM&E=+^#[4@5%50^4?'SDJ<@8'3G'&0#MI)XHGC225$>0[45F
M+G&<#U. 35+5]/LM>T^[T>ZF)BFCVW$44FURC9&#W //Y5@ZAXATNYU'PA*^
MD&Z75'\VQNY-H^SEHB^<<G<5]./>J.@QI:?%#QRUO:AB;:PD,4053(Q67/7
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M%LOEOG8,D$[C@\8XQR1QD ZB2:*)D621$,C;4#,!N/H/4T^O+-2\0:9XFN_
M'B2WB$"OJ,JNTP >(+%)N4GT!7/IWKO](U.XU42SFQ\BSW$6\S29:=>SA=HP
MI[9/Z$&@#4HK'U/6;BUU6UTVST]KFXGADG,DCF*&-4P/F<*WS$L,#'KTK,LO
M'=G?^&=+U:"UE,^ISFUMK,L-S3!F5@6Z;1L8EO0=,\4 =1YT1G,/F)YH7=LW
M#=CUQZ4D,\5S$LL$J2QMT=&# ]NHKSW1VN(_C%KLDNEQP7']C0LT=O(&$Y\Q
M_F#$+DG@?,!]WTP:L:/XPT^Q\%^']0T[0EL].U"_%DEK&X4P,\S(&P!@C().
M#W[T =]4<T$-S'Y<\:R)D':XR"1TXK G\6Q6?B#4]+N[5T6PT[^TFF1]V^++
M#&W (;Y3Q3;3Q)?WUDMU;Z9;R0SV+7=M-'>;XV(VX1F"?*?FSQD<'K0!TM%>
M=:5X^U"V^'VCZ_JNF-<-?RQ1[K>48!E? )!&0!G  ST[5K#QEJ'_  D-QH+>
M')UU$6PN[9/M*%98MVTEVZ(0< CYNO&: .OHKD;/Q]97'AV'4I[<VES+>OI_
MV6:91MN%+!E+]-H"EMWH.A/%4S\2K>.U\0%]/\ZZT6$7$L=I<I+'+$1G>DAV
M],8(QD>AH [JBN2M/&DTNN:1876BSVL.KP/)9SM,K;F1 Y5E'*_+R"?Q K,T
M;QO?IIGBC5M;M(H[73=1FMU$4^[9L\M0G*C@DDEB>YXQ0!Z!6-J'A?2M5UJT
MU:\BEEN;50L:^<XC.&W L@.UB#R,CT]!4VF:C=WEU/#<V4<2)%'+%/!/YL4P
M?=]T[5Y&T9X_B%:9 (((R#VH 9'-%,7$4B.8VV/M8':W7!]#R/SK,F\.V<_B
M.#7GDN!>P1&&/$F$$9(++MQ@Y(!]:\Z\.Z[=>%;+Q=+I_AN>^L;77[N2<V\B
M1B&,!,[%/+$ $X ''>NVM/&-O?Z[IFGVUOYD&IZ>;^UN0_!0;>&7&0?F'K0!
MTM4M6TNVUK2KC3KSS/L\Z[7\N0HV,YX8<CI7$>(/'FH#P-KFI:;8I#=:?J)T
MV4R39",'1"Z?+SRXQG'K['O[9YY+=&N85AF/WD1]X'/K@9_*@"#2]+L]&T^.
MQL8C'!'G +%F8DY)9CDDD\DGFK$4$,!D,4:H9&+N5&"S'N?4UQ-[\3=.LXX+
MX);RZ7+<BW,L=VIG7+;?,,./N9'7.<<XJWJ'CEM+\07>C7>EM'<K;?:++]]D
M7Q+!0D?R_>R0"#TSZ<T :^G^&=.TZ_:\C^TRS%Y'C-Q</*(O,(+A Q.T' Z5
MJS316\32S2)'&O5W8 #\361=Z[);7.GZ<MHKZM>H\BVWG82-4QN9GV\ %E'"
MG)(XZD<5X_U'^WOA?JTUYI,ME=6-_% 4G3.'6>,;XV(&Y"#PP SDT >GUC0^
M%]*@\1SZ\(I6OYL9:29V1#MVY5"=JG'&0.F?4TS_ (2%AXS;PX;3]Z=/-]'-
MYORLH<)M(QD')]^*SK7QW;3Z"=0DLY$G;46TR&U5PS2SAR@ / QP3D] ": .
MJ\Z+SQ!YB>:5WB/<-VW.,X].120SQ7$?F0RI(F2NY&!&0<$9'H>*\]LFN%^-
MUS)<:9%;W!\/%B+>4.)_WXP=Q"\]N0.G7%2V7C73](\!)KECX=DM[1K][=K6
M%D&QS.8RQQZL<X /6@#T&BN;T[Q5+<^*9]!O]*EL)Q:?;8&>99!)%NV'.W[K
M D<9/7K69)\1%71],UJ+299],U.[%I:O',HE+,Q5&96PJJQ4\[N,C(ZX -[6
M?"^E:_>6=SJ,4LK6F[8@F=48-C(=0<,.!P<ULTU"61692A(R5.,CVXIU !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5P_Q69U\(V[1)OD&J695"<;CYRX&>U=Q6-XCT
MG2-7LH8=:E*6Z3HZ?Z2809 04Y!&3G&!ZT 8VH:/JNN>)K;6H[8Z=)IEA<Q6
M?VAD9GN)@ &(0L-BA?7))Z<<\]I_A[Q-_:/A#49]!B2[TZ24:C/+>H\L[O"4
M,I89)7)R!DD9Q@ 5ZDB[$5<DX&,DY)I: .$\0^'GN_B'IDUI.L<5_;,FJP8_
MUT,+JZ'Z[B$.>JN16_?ZQJ-GXJTS3ETH2Z;>JZM>B=0T<H5F"^7U(PO7IR*D
MT/POH_AQKEM+M/)>Y<O*[2,[,<DXRQ) R3P..36KY,7G^?Y:>=MV>9M&[;G.
M,^F: ,;QE9W>H^#=7T^QMFN+J[M);>- ZJ,NI4$EB!@9KG=8T;6I_#7A.6UT
MQI+[1;NWFFLVFC5I%2(HP5MVW/S9&2.E=]10!YU_8WB.75O&=]+I"(FL:;#!
M;HMTA8.L;K@]!U<9/08.-W=&T'6_[&\ VPTJ0RZ++ UX/.B^4)"8SM^;GDY'
MM^5>C44 >>Z59^,/#&I:EI5EH]KJ.EW5Y+=6E\]VL?V;S6+,LB'YF 8D_+U_
M'C3L],U2+XFW.JRV<C6$FEQ68N2\8W2([,3M#9 .[TZ]JZ^B@#R?7/#7BO5=
M+UNWN-'AO+]M22>TO7NT&ZV69'6.,'E,*N"#M!Y.2374?V=JS_$ZTUJ33BMF
MND-9R2+,A"RM(K\#()4 8SCKVKL** .5^(VE:AKO@74=+TRV-Q=W/EJB[U0#
M#JQ)+$=@:SM6L_$NE^,1XDT32%U*WOK..VO=/DN4AEC9&8HZL25/#D$9KNZ*
M .'UFT\4W=UH4\NGPWEEOF;4=-BN555+ >5DM@2*O.1W)S@X #O!GAR^L])\
M0Z5K>G6\5K>ZA=2HL<P=9(I2>  !@8..<'V%=M3)IHK>%YII$CBC4L[NP"J!
MR22>@H X_P (^%;^P\+W6FZW<>;</$UA'*IY%JFY8OQ(8M_P+!Z55\))XTTR
MSLO#NHZ1:K!8A(1JZ72E984P!B+&[>5 '. .OL>[CD2:))8G5XW4,KJ<A@>A
M![BG4 <A\4_^27^(?^O1OYBHYM+O_$E_X9EN=/>RMM*E%Y(\LB,9)!&514VL
M3C+$DG' ''/&]XAT_2M8TPZ5K$@%M>,(O*\\Q&8]=@(()Z9P/2M"VMTM;:.W
MC+E(U"J78L<#U)Y- 'E4GAOQ;=6&EO>Z+#<:O8ZW%>7%Z]XF;F)9&(\O^Z@4
MCY3C&. <UT'CC0KC4-7T"ZL+@6NH3R/I]QM))DM9$+2@'U7;N4]C]:[JL?3_
M  OH^EZS>ZM:6FV^O&+32M(SG)P3M!)"@D#(&,X'H* (=:U2^T.YT>"QTA;F
MPGG6VN)%G6,VRDJJ%4/+]3D#H%-5OB/_ ,DV\1_]@^;_ -!-=(T,3RQRO&C2
M1YV.5!*YZX/:JFL:1::[I<^FWZR/:SJ4E1)&3<IZ@E2#B@#DAI=_XFM?"27&
MGR6=MIDT-_++)(C>8Z1D(J!6)P2V26"\#U/&!<>&_%MY86AO-%AN=6L];CO)
M;Y[Q,W,*RE@(_P"XH7 VG&,< DFO4[*TBL+*&TA+^5"@1-[EC@=.3R:F9@JE
MF(  R2>U '#7/A[4M2\;:U/<6C0:?J&B#3OM"RHVU\N20,[L?/P<=N@K"ET7
MQC/X$TOPU+H*-<Z5<VH%TMY&(IXH74AE&=P.U1D$#\>E>IV]Q#=0+/;S1S0O
MRLD;!E;Z$5)0!7NH7NM.FA.U))8F3KD D8ZUYK)X=\22_";3O#K:.!?6DELF
MU;J,AEBD5BV20 "%X'7GG%>I44 <A_9^I_\ "T!KG]FR_8/[&^Q[_,CW>9YO
MF8QNZ8XSZ^W-<W-X7U^;X8>)="&E.M_J%]/- IGBV[))=X).[C Z^_3->I,R
MHI9B%4#)). !3+>XANK>.XMYHYH9%W))&P96'J"."* .%O+3Q1HOBZ77M'T9
M=3M-4M88KRQ>Z2&6"2/(5@Q)4C#8(!KM--^VFPC;4!$MTV6=(CE4R<A0<#.!
M@9P,XS@=*M44 <#I.C:YX:B\0Z3;Z:;^TO[J:ZL;E9HU6,RCE)0S!@%;NH;(
M/KQ4%SX2U#2M.\#Z7IUH][%HETDUS,)$3(",K8#,#G+YQZ=Z]%HH X_4K#5)
MOB1HVK1:;*]A:6<\$LGFQ@AI-I&%+9(&W!_3-:FDZQJ-YK^KZ;?:4+2.T*-;
M3K.L@GC8L Q ^X<H>#Z_GN4R.&*$N8HT0NQ=]J@;F/<^IH Y;7--U&Y^('AG
M4[>Q>2RL([I;B42(,&55"X!8$XV\\?G65!HNLI;>.U;2I0VL/(UF/.B^;="(
MQGYN.1GZ>_%>@U%<75O9Q>;<SQ01[@N^5PHR3@#)[DD"@#@!H6MBU^'\?]ER
M;M%V?;?WT7RX@,7R_-\W)S]/?BM72]/U.R\?^)M6ETV4V=[!;);NLD>7,2N#
MQNXSN&,_CBNOJ*"ZM[DRBWGBE,3F.3RW#;''53CH>1Q0!YC:^$_$$'PN\/:9
M_9P.IZ1J4-V]L9TQ*J3%R%;..A[XZ&M+6-*\2ZGK>I"YTF"\LKK3ECL0]VHC
MLIMK!]RD99B2,, <8QD FO0:* /---T'Q# _P]:XT<K_ &'!)%=[+F-L9@\H
M$<C)SR0,\=R>*V_B)IL]SI-CJ&FS)!K5A>Q/82.,AG=A&R'_ &65CGZ>U=A6
M./"^C_\ "2MXA-INU-D">:TC$# V@A2=H."1D#."?4T 7=,L(]+TNVL8262"
M,)N;JQ Y8^Y.2?<UQ-M=7-K\8/$)@T^>\5M,M-PA>-64YDQ]]E&#SW]*]!K%
MT_1]'_MV\UVRF:6]F_T>XD2Y9U^0GY"N=H*DGC&10!QJ>%?$&DV.EK#:I?07
M&IW-]K&GQ7"QAS+DHH9L!D0D97^+'2MCP3H.HZ8/$EIJNF6T%G?:C+<Q+'*'
M1HY$1=H4 <#:1SCZ5VE8_B72M&UC2?(UXJ+))%EW-<-"%8'@[@1_.@#G_ASH
M<^F6EX9[K[5!;326&G.>JVL<C8!/KN)4GN(UK<\+ZQJ.LV-R^JZ4--O+>Y:!
MX5G693@*P(8<'AL'T((K7MK6"RM8K6VB2*") D<:# 51P *=##%;Q+%#&D<:
M]$10 /P% 'GOB30_$>J:IXEMWTR&_L[RP\G2II;E52T8Q,KC8>=Y8Y# =,#(
M%.L]%UX:MX$N+C23&FD64T%WMN(VV%XD08Y&>4)./7C->AT4 >5W_@W7M3L/
M%"Q6HM;N?6(M5T\S2H4D,80!6VL2,[#^8K7:W\2:OXV\,ZU<>'S8P64%S%=+
M+>1N4:0(,C83D?+QWZY XSWM% '#_%DNO@5FC4.XOK,JI.,GSTP,U;GTR]U?
MQCI6NW&G36L&CV\_E12/&9)Y90JD#:Q4*%4]2,D^@S6UKF@6'B.R6SU))7@6
M19-D<S1Y92"I)4@\$ UHHNQ%0%CM&,L<D_4T <9X,TG5=&^'!TF]TYTOHA<
M1++&PDWR.RX(;'1AG..]8MEX2UVQT'P1>Q68.J^' \4UDTR?OXY$V/L;.W=@
M C)'?.*]/HH X6_T#4-3U;7/$#:?)%<3Z*=*M+1I(_,;)9F9R&*CYF4#YCP#
MZXK?\'VEWIW@[1]/OK<V]U:6<5O(A96^9$"D@J2,'%;=% '+>-=!U#5H]*O=
M%D2'5M.O%DAE?H(W^24'U&UMV.^T51TGP5+H_C>6YM6"Z"T,4XA)R?M:(8MW
MT,9R3W;![5VLDB11M)(ZI&@+,S' 4#J2:2&:*XA2:"1)8I%#(Z,&5@>001U%
M '!PVGBSPQXFU==,T:#5])U6Z-Y'(UXL#6LK* X<,"67*@_*":6_T_Q5H7BP
M:[I5A#K<5]916VH6PG6W998]VV1"W&WYB,=:[ZB@#SWQ9X<U7Q./#T6I:4ES
M#'=237\4,R!(XWC= BEBI8C<.<#H2,<"MGP;#X@TRVFT?689)X+20QV6HM(A
M:>$?=\P Y# <9QSWP:ZFB@#D/$5CK=QXMTZ6/3TU/0Q;.DEJTZQJEP6!61P?
MOJ%X P<$DXSBN3L?!WBG3_#.@2Q:?;_VGH&ISW"6OVE<744CON ;HIVN,9]\
MXKUNB@#BM)LM<F^)%QKUUI'V*QGTJ*V_>7*-(KK([8(0D=^QQTYZ@<OH>C:C
MJGP8\/'3;<3W=CJ2WZ6[.$\X1W3MM#'@$CH3Q7H^NZ=I=[';3ZI.]NMK*'BE
M2[>WVL1C&Y6&<YQ@UH6EI;V-I#:6L*0V\*!(XT& JC@ 4 <.MAXFE\:ZCKPT
M:&&.?0Q;0QRW*,1,KNRHP'!SD9YQSU/-,T'PC-IWB5[W2].GT/3;FSD6]L'G
M1X7G)78T:(S!<?-D_+QC Y-=Y;75O>0">UGBGB)($D3AE)!P>1Z$$5+0!Y4G
MAOQ*/AEHWA^31Q]KT^[MBVRZC(=(I=Y;)(P" ,#KG.<5TS:?J9^*$>MC3I?L
M T<V9?S(\^891)TW9Q@8SZ^W-=?10!Y5%X3\31:&US9V:0ZO8Z_/JMK!/,A2
MXBD+@QEE)VDJY'/?\ZW=63Q1XD\$ZW;7.A)87-W9O;060NHY6+L""[N,* .,
M $GK["NXHH X2XTC5Y=9\#W2Z7+Y>E)*+S,L64+0^6,?-\W//';WXJ/3=(U[
M2H/%5HVBV][!>ZG+>0B2="MS%*R;HRIZ':'SNXZ8S7?T4 >?:'X?U/PK/K=U
MH&EW$>G26JM::+=7:8^TY8L4(9EC4C:.O7/0 5V.AZC)J^AV6H36QMI+B)7:
M'>&VD^C#J/0]QBKLL4<\3131K)&PPR.,@CW%/    & .@H X"QTG7M*@\5:;
M'I?G'5K^XN;6[$\8A195"CS 2'!7&2 ISVIC>%]2\-ZOX5N=(L3JEMIFG2:=
M,HF2)QG81)\Q (RIR!R,\ UWJ75O)<R6R3Q-/$ TD0<%D!Z$CJ <''TJ6@#R
MR;PCXDNO WB_3)+&W2\O]8>_M5%P")%\V-\9QQD(<9QU&0*]+LY+B>SCDN[8
M6TSC+0^8'V>Q(X)QUQQ[GK3[:ZM[R 3VL\4\1) DB<,I(.#R/0@BI: /._"]
MEXR\.6J^%_[*MI["!V2UUDW2@+"6)&Z+&XN <8Z'CGN;/BK0-7\1"YOX()K3
M4M)</HA$D?SOP69OF^ZV-A4]%YY)P.[HH X#6++Q2^JZ#XML-'1]1MK>2UO]
M*>Y1=Z/M),<F=O#+GG&1CI4OB[3_ !'XC\ 7EH=-1=0NYH6CM$G0B!$D1B&<
MX!)VGIQR!VR>ZHH XO4['6K?X@6'B.PTDWD$FF/831&XCC:!C(L@9LG!'&#M
MR?8US2>#?%">'HY4M+==4TWQ#+JUO;FX&VY1G8E<]%)#<$_CBO6:BANK>X>5
M(9XI&B;9(J."4;&<''0T <79VNOW/Q&C\0W&AM:6?]CFT9)+J-I!)YN_&%)'
M;UQR.1R!A?\ "+^(?^%8OH?]DO\ ;SJOVK9Y\6WR_M/G9SNZXXQZ^W->K44
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M)4 *,#DDDDG&.<A?"VN7_P /H/ VI6J+'%Y5O)J*2J8WMXW4@JN=P<JH7!&
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M-O49A/%=>8T) R$D7:-K=B,G!!'IF#0+GQK<K'#KFFV-D;=")+B&Y$OVMMI
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M5/W:D*<M\XP .BD]L5))XKECN])TZ2R@MM4U""286]W<^6JE"H*!@IW-\W
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M;%9)$3;@J"&ZL"0I/IF'PE%XSLK*QT/5;&RBM[!5B;4HKG>;F-.%"Q[<J2
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M;7+&R@ XAEF5'G ]@=N,=-[CUH [JBBB@ HHHH **** "BBB@ HHHH ****
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M[1()KBTMH[F.6:\V(X<L/FPA*_=Z '\* .NJO'?6DUW-:174+W,(#2PK("Z
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MS9Z%<-;W ><I)(R*K2%1M( 4-QGK@].X!VE%5-.NY;W2H+MX%BDFC$@C$FX
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M;1)&+%3'@[R"QQR!ZGL/0:* ,[7=(BUWP_?Z1.[+'>6[P,XZKN&,_AUKDO\
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M6-]I<<SZI"8M7,42[BSB1(63"X#9"DX!YX/->NNBR(R.H9&&&5AD$>AK L_
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M#XAL= 86^J:[+'"EB_F0SRW30K$WJ,,!G&1ZU?DU73XKVVLI+VW6ZN@3! 9
M'E !)*KU(P"?PH P/#\OC63RDU^TTZ 6JG?+:3EVO&P0,*5 C'?KG('09KFQ
MX.\0#X6)X:^S6WV];[[06^T?N]OVGS^N,YQQTZUZ?10!Y_XN\*7OB@WBRZ3
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MM/\ NKF*9FWJ'Q\K;2,$CJ#71Z%I6NIX[U77+^SM+>UOK2"$(ER9'1H]W^R
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MM"EV=R2*@?$ORX"D9^[N(QWI;;QU+;6/B$ZW910WFBW$<,B6TI=)C*%,6TD
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M#LQ W'<J\ < 'DYXDET36?$$V@MKT%I -)N5O)#;S%_M$ZH54J"HVKEBW//
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ML%I#D*'F<*"3T SU/L*YJW\5ZHGB&PL[O3C)8WL;E[B"VF063J-V)&=<,IY
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M9G@>PTF;&R)6W*BPAPJ9.,G/.>I/:M"V\6:J-?TVTN=-,ME?(_F306TR_8G
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M_MR^_P#1IH [:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML#W#"M#QGX=O-?TZT?2[Q+35=/NDO+.6124WJ""K@<[2&(-=&JJB*B*%51@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !6?KFCP:_I%QI=W),EM<H8Y
M1$P!93U&2#C\.:T** *]C:"PL8;199)4A0(K2$%L#@9P!VJQ110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>elicio2021employeestockp002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7Q)'X?\ B7KR:A>W\MH-/MY8K6-9)]K%GW%(U!P, 9./J: /0U544*JA548
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M VBPH7:<%=WRJ!G[O)]!UQ0!!X>T*ZTI9)]3U>75M1E58WNI(4B^122JJB\
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MC/\ 9I]6M%62"5HPZM*%9748STP0?2BSU2VL_B[K\DRSA)=+LRK+ [8YDX(
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M8]9O].BB9O.2T95\]2,;6)!(^HY&3WP1LT4 1P016UO';P(L<,2!$11@*H&
M!^%2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9/B
M#0H_$%A';-=W5G)#.EQ#/;, R2+]TX(((]B"*UJ* ,33]"NX9HIM4UNZU1X6
MW1+)%%$B-@C=A%&3@GJ2/;-;=%% $%I9PV<;K"IR[EY'8Y9V/<D]3P![  #@
M"IZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4G<1SE2H'IWH ]>HKB+_ %75M8\0:]I&F27D!TQ(HT>U:$'S9(]X9_,ZCD
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M2Y(^P%9)0-V#$^ <  XZ9Q]>: .^HHHH **** "BBB@ HHHH **** "BBB@
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MPQ9VM]>VT&@2O-"$*DRLQ#%F)'7(SD#C)QVQQ>JQ:W?7NJ^*-+\1R:#JL0,
MT.[C\YI$AR$ #==^-PVJPRW4U[A10!Q;>&9_&6E>%-0\2F6UOM/:.]FLXL!'
MFP#A@<D8P> >Y%6K;P)I]OXNUCQ$UW=RSZI&L<L+. B@)LXP,].Q./Q QOZI
MJ=IHVEW.I7TOE6MM&9)'QG 'MW/M5/3=;FO=4N+"XTB_LGBC6599E4QR*W&
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M_>,94[AGKNSFNSHH P/^$86>:YN]0O9+F_FM&LUG"!!#&WWMBCH2<$DD]!T
MQ20>&6_M6RU.^U![R\L+>2"VE:)5(#XW,^/O-\H]!R>.:W1-&TKQ*ZM(@!9
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M0A"T\9.XJZ%=I&22. !^5="+^0ZV=/\ L%R(A;B;[9@>23NQY><YW=^G2KM
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MA R[EVEF*J-QV\?CR">:G\3^&;'Q7I(L+YIH]DJS03V[[)8)5^ZZ-V(R?SH
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M-4BD59B&X96 7:5.!Q@?J<[VD:6FD67D"YN+J5FWRW%R^Z25\ 98@ = !@
M  4 <ZM[J)^*UUI!U&?["VB"ZCBVI^ZD,Q3*_+SPO\6>IKCK?6?$:?#C3_%4
MOB&[ENH=2\IX3'&(YHS=F(AP%R3@]B ,# [GT9O#49\6R>(UO[M;I[/[%Y8"
M>6L>XL,#;G.XYSFLH?#NR'A!?#7]JZC]B6X^T!\Q>9N\SS<9V8QOYZ4 =-JD
M;3:5=QK-+"S1,!)$VUUXZ@]C[UY L,J_!'PK)]JEDDFOK!E\[#!#YPZ 8./J
M?QKV?RPT'E2$N"NUB>"W'/2N/3X<V:>&[30AK&J&SL[B.>#+1%D\MMR+]S&
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MV5U;'\11<Y'.1[UVNDWZZ_K\FHV-Y*^EP6L:(%<^7++(/,R1_LHR?]]G/(%
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MOXZA7P=N,X]Z /7Z*SM'TN;2K>>*;5+W4#),THDNV4L@./D&T ;1@XX[UHT
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M.<[FX&!S73T4 <O<>!K)]:O]3M-0U&P;44VWL%K(HBN#C&XAE)5L=U(-1IX
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M>X,F0FX[.0 3^?-,C\9W=S"8K7P_='5HK7[5<:=/*L;QKO9 H."&9BC%>@(
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M%2J#"@!HCC%3OX5BFTW5+2XU349WU-/+N+B1H_,\O:5V+A JK@MT7JQ-;]%
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M9R  6;&3[G'%.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M17J".XFU"X:65U'W1N[ 'D8Q@\]:?H/A"RT%&"WNHW[>684;4+DS&*/C*+T
M' [9.!SP* /.XC=:3^SYINHZ=J-[;7/E6C%DG8YW3(A SG:,,>%Q79&_DUSX
MBZEH$T]Q!9Z?812K'!,T+2O(3ERR$-A0  ,XR3G/&)?^%>:3_P (J?#8NM1_
MLXNK!#<;F55;>J D'"A@#QSZDUHWOA>UO-5MM62ZN[75((3;_;+<H'DC)R5<
M%2K#//W>#TQ0!YU>:[KW_"*W]L=6NTN=)\21Z:EVA :XA,B8WG')"O@XQGOF
MNITHWFE_%.ZT?^T[Z[LKC2%O2EW+YFR43%"5_N@@]!@5JWG@G2[S1H]+,EU%
M MT+QWC<;Y9MV_>[$')W<_IT&*M)X<MU\3KX@-W=->BU^QD$IL,6[=C 7^]S
MGK^'% &SCG/>N:\)_P"G2ZOKS<_VA=LD!_Z80_NTQ[$AW_X'70SQ^=!)$)'C
MWJ5WH<,N1U'O56UTJWLM#BTBV,D5M#;BWC*-AU4+M!!'?'?UH GO+JWL;9[N
MY8(D8Y;&3R>  .22<  <DXK&\,Z/)93:IJUW'Y=]J]P+B6/(/E(JA(T.."0J
MC/N3U&*KWG@:TOM-TRQDU?6T33EQ%)%>E9&;&-SL!DMC(]LFKN@^&;?09+B5
M+_4KV68*IDU"[:=E SPI/0<\XZ\4 <]XR@:Y^(?@>%)Y("[7P,D6-P'D<X)Z
M'WK$'B+4O#^D>*;,:A/<"RUJ"SMKF\FWO#'-Y6<N03\N]L$@XXZ]*[_4?#MM
MJ>N:9J\MS<I<Z;O-N(V4*-XVOD%3G(X_EBJ7_"#Z3)%K<-V9[N#6F#WD4[+M
M9@  5P 5( &,>@/6@#+;2?$5AJ5[<#4Q;:7-8NOV<ZA)<RK.N2)(VE3C@$$=
M.^*YVQO]4TOX::9XJEUW4+B]OK:UM7%S./(B\R5%,N"IPX4GYCGW!Z5VFD^!
M[+2+2:!-3U:Y:2$P)+>77G-!&>JQY&%' [9X'H*L6_@_2HO"'_"+S++=Z5Y7
MDB.X8$A.PR #P>0>H]: .<U+_A(?"1U37A<1-ID6F2O]@FOY;IFN$!970NH(
M&!R <8YQ575KW4=%\(>'O%-IJ5Y<W4DEH;R.29GCNDFVA@(R=J'+ KM QCO7
M4:'X*T_1(I(S=ZCJ2M$8%&I7)G$<1ZHH/ !P,\9.!18>"M.T^&SM1<7D]A8R
MB:TLYY%:.!AG;@[=Q"YX#,0./08 ,*+386^-]TQFN\C1(I^+J0#=]H?C&[[O
M^S]WVKT&L5/#5NGBF3Q"+N[^VR0"V92R^7Y0;<%QM]2><YYZU:TK28](2Z6.
MYNY_M-R]RQN9C(4+=57/11C@=J -"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME&CC(R' _B!_V<\\=:FM/%&GW=_-8%+J&\BMA=^1+ P=X2<!U SGGC Y![4
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MMY!(/2O6** /-[;S6\8^!IOL=Z(H-)FBFD:UD"Q.RQ@*Q*_*<JW7TJG"D_\
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M@OS!XLTWQ//HVJ7FA7.GFSD$5M()K9Q)O5VBX8*0<=.P]L^FT4 >8>)K6%O
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M[ENY;F[EMBEN\BWL<V2I5@,9R2"">._%1Z/I-YH7BCP+8W4-S*UAH\UM<3I
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M6P090#< 6!&2,=^G-6;[3+[6/$WCZSMH;F!]1TF"WMIY(76-Y D@90^-IY8
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MW6&69&=MF_&.Z]^]<_8?VC=:QX%U271M<::V:9+_ ,RU:-()&@*A4C.%1 W
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M+NXKVZFN;5X?*$<;+Y8W@;F9F XR, D]LU;&*Y1?B*7T^_7[9*[VV;.3]\#
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MGMA;SWQA?<59>N ,;=W).<#ID [2U\5:=-JEUIMP)K&\MK87<D5TH7]QG'F
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MJIN8# R0?ZUS<DNM6%MXUN+#1[Z1[C6(IH]UBS,T&(U>2)67#LNTD#GD X-
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MTI@0J&; SC)./U_.L31?%XN/".CZIJ5M-%=:A'"L4*A2UQ*Z!OW8#=.I^;&
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M=R6VL2"*V:.W9OF.>&]#\IX&2<< T =317,V_C>QN+?6&^P:E'<:0%>ZM)(
M)@C LKJ-V&! )ZYX/%6X_%%G-H>F:M#;W,L&I-&MNB!2Y\S[I(W8'')YX'7&
M#@ VZ*Y^VT2>W\:WNM+>WGV6>V$<EO+/NB+C;M9$_@P%;/J7/IS+I_B>VU*2
MQ,%G>?9K]6:UNF5/+D4 MGAB1D#(! /ZT ;=%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%FSP06''6O0J* /*YM-U+7OA99>"Y],N[758Q;6<SO"PBC2%TS*)<;6!5,@
MYR<8ZUW/C#1I_$'@[5M(MI!'/=6KQQL3@;B. ?8]#]:VZ* /.+VVOO%OAWPY
MI+Z9>V5]:WEM->F>!D2W$/+%7(VODC"[2?O9XP:U/"4-S%XP\7S36=U##=W<
M4MO)+"RK(JQ*A()'J#79T4 <A\0M*U'4-+TN\TR%KFXTG4X-0-JI :=$)W*,
M\9PV1]*AFMGUWQWHOB"&VO(++2;2Y\QY[9XWE>4* @1@&. &).,9( S7:T4
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M >3R^&M1T+X<>$]&^QW%S=VNK6]Y<1VT;2"%/.,KC(X^4-CWQQ7JR.)$5P&
M89&Y2#^1Y%.HH \?GTW5U^$WB7P\=%U WS75QY0$.5FWSEU*$=1M.<]!]:Z?
M4X;B[^(7A6\BL[W[+#9W4<TWV=P(FD5 H.1Q]T_3O7<T4 >3^$[*73M/MO"^
MJ^!//U.S;RDU)K.-K21 ?EF,AYR!SM^\2.V>/3=4D\K2KIO+DD/E, D2%V)(
MX  YJW10!P_PMT@:=X%TF&]TLVNIVT;1R^=;[) =S'[Q'(P1T-)=1:@GQ5N]
M0M;"=XQH'V:&5XF$33B5G"%L8Z$<]/?-=S10!Y#:1:S=WW@K5+G0=:>\M+F0
M:@98PJQNT++B--P"Q@G@@ 8QDDU>6SOCX=^(\']FWPEU*XN6LT-L^9@\"HI'
M'=@>OUKU"B@#+\-*Z>%]*CEBDBDCM(D>.1"K*P4 @@^XKA+&TU&V\)^*_#DF
MDWC:AJ%Y??9@8&\ETG8[',H&P* V2"<\=,X%>GT4 >?>*-!N]$\+>';_ $HI
M-J_ATP0P;SM%RC!87B)_VLC'N!79Z-IW]E:1;69?S)$7,LG_ #TD)W.__ F)
M/XU2E\,PS^)/[8GU#490NTI8O<?Z,CJ,!PF/O=^3C//4"MN@#BO*O=/^*]Y?
M-IUW+97FEPQ)<0Q[D1DD<L&/8X8$#J>V:Y.33-3;X-ZAI0TJ_P#[0DU)I4M_
MLS[BINQ*#TQC9S^G6O8:* /,M0BDT?QUJE_?^$[G7=*UA(9()K>S6:2WD1 A
M1U;!4$ ')QC\\=_HT'V;2+>(6$%@ "1:P* L())"_+QD9YQQG.*O44 >=^&;
M:\^'VHZMI5SI][<Z-=WCWEC>6<#3^7OQNBD1 6&".#@@Y[5I>,M/U#QGX'UC
M3=/@DMO/A7[.;A3&\KJP?&T\JIV[?FP>>@ R>RHH X'4X[KQFWA51IU[936&
MHQ:A>FY@:,0^6K90,1ARS$#Y<C&36=#9WW_"-?$:W.G7PEU&YNWLT-L^9@\"
MHI''=@>O3J:]/HH \WN;:\9/AWMT^^/V!T:[Q;/^Y @,9W<?WCC]>E5_#]]Y
M<?Q LEL+NZFFUBY6)(H&=)6:*-=A8#:O;.X@8/UKU ].N*Q- \-Q>'Y]3EAO
MKJX_M&Z:[F6?9@2, "5VJ,#"CCGI0!QVG:;K'AZ?P_X?N["^N]+M](6-I=/'
M#W6[YDD?(*H!TR0ISSGH,?2-.U:#P7X#L)]%U&*?3-96:Z4VY.R,>:"_&>/G
M7W/88KV2B@#C-%@N$^)WB:ZDL[E+6ZMK2.&9X6"2-&'W@$C'&X?7M5'P?H5W
MIWB;4-+<HVB:+</+IH!R5:=0VP^GEJS@>THKM=6T_P#M72[BQ%Y=69F7;]HM
M)/+EC]U;L:9I&DP:-8"UADGF)8O)/<2;Y97/5G;N>GT  & * +S9"$@9..GK
M7F7AC2+O3?$&DSZ!#JMAIET)'U32+V)Q!:L4)!B+#@[R!A200>P%>G44 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %4-6U>#2(K=IE>22YG6W@B3&Z21
MLD %B . 3R>U7ZYWQG8VFIZ3!97^DS:C937*B80 F2 !6(E7!SD,%Z<X)X/2
M@#-\4>-;O2?#-W?6NCW:W,-Y'9.LQC'EERF'^\0P_>#&,\]<#-;<WB%(KJWL
M5L+N34IH6G^Q(8]\<8.W<QW[ ,D ?,<_@<<%?:#XCD^'NL:=NO\ 5(H-1@ET
MW[6,74ENDD;L&S@D@A\;L$X]Q6U)#J-A\0H?%#:;>/IM_IHLYXT3S)K5U<NC
M,BDDJ03]W.#UH VK;QII-SH\NH S(T5U]BDM73$ZW&X*(MN<;B2.AQSG..:S
M->\06^K:'XHT>6UO;*_L]->=HY2%)4HQ5E>-B#R,8SU'2N=U+PEKC6VI>(M/
MM";]M>AU:#3W8*TD42[-I[!F!9L=N!UXKI;S5=3\0^$]9VZ!J%BDEA+#%!=(
MOGS3,I  56.%'3)QG/8#) '^$M:2+PYX8TR*TN;J=](MY9&AV%8%\M0#(688
MSSCJ3@^AKF]$\0P^%;OQO/)8:E>V]MJS22M;CS/)B$49+,789 YX!)]L4[P7
M8ZUX.FTR 6%_<Z5J-G$;V-D+2:?=)&B,>>61L8P,XV\<5(NGZB=%^(T/]FW@
MDU26=K)3"?WP: 1KCT^8=\4 =K/XCM$GLK>TCEOKJ\@-S##!MR8ACYR6( 7+
M*.3R3QWKEO%^NV7B/X7^*)+;[1!<6,,L4\$A,<L$JC.UMIP>QX)!]ZK:=IVI
MZ+XA\/>(&L+J6T.A1Z5>PI&6EM70A@VP<L,Y4[<^O2H]5\.ZA-H'C_4(K*?[
M1X@"I:687Y]J1"-68?PECN//08S@\4 =?%K<%A9Z/8+#-=7UU;*\=O!MW;%5
M=SDL0 HR!DGJ0!FN5\"ZM!8?\)C=W,=U"@UPQ)!,=\N]DC58QR<DL<#!(YZX
MYI\UOJND>+]"\2QZ7>7EB^CC3+J"&/,ULP8.'V'!(R,''IGTK&N/#_B#4;#Q
M--!HDJ3_ -NQ:K:6]X4"72HJ QGYCU"GKQTYH [D^-K*&^U"PO+&^M;ZRM/M
MIMG1':6#.-Z;&(.",$9!%5K/XAZ?>V,5\-,U6*SGA@D@GE@54F:5PBQJV[&_
M<P!S@=3G'-4K.5M2T?4I[;P7-HS?8982)K:-9Y9&& B!"25]2<=O?"66G%OA
M+I.D:MH-Q>!+>WM;RQ*8D 7:&9>1G;C<"#VXYH ZW3M4-_/=026-S:2VS*&6
M?;\VX9!4JQ!']<UE:I>Z0GCK0K2[M+IM4:*X:RG7(B50H\P'Y@"<;>QZ]JI^
M!M-U/2I]5M9+N_N=#5X_[-;40?/7Y3YBG< Q4':!N'K]2:_:W<WQ)\)WD5G<
M26EG'>+<3I&2L9E1 F?J5/3IWH 9-\2M.BLM3O%TG6)8-+N7M[UD@7]SM )<
MY897YN@R>"<8P:[&*5)X4EC8-&ZAE8=P>0:\P_LW4V\'_$*S_LR\%QJE[=26
M2&(YF62-54CTY!ZXQ7H6B"1?#^GH\3QRI;(K)(NTJP4 @CZB@#&@\>:=</IT
MBVMX+'4;QK*UO2J>7)*I88QNW@$HP!*]NW%3:KXRLM+BU&<6=Y=VVF$+>S6R
MH5A. 2.6!8@,"0H. ?7BN"EM?$FHV7AZ\U'P]J<NL6.N1SWS[DV! 9!B$;\!
M,%>0!TR23S6WI,VO>$M?UW3W\.WNI6NI7[W]E=6K)L4R ;DE+,-@4CKSQVH
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M/9S,>@MYEP7/KL8*X'L:I^&O"=WH7B^_M8TQX=B=;^R!.2+B1#&ZY]!M=O\
MMH#0!?@U?2XO$?BF6QTN]?5[.W@:\#,%$XVOY83<VT8 .3@=>]<EKFNW&O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU8Q,R,Z1PALJ 3A3+N;J.@-=5I>H1ZMI-IJ,,<L<5U"DR)* '"L 1D G!P:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAW4K>2XLX)[C[9>CRMEO%:?P0KN&97<<EAD#/:NS/@RTN= N])U34-0U-+J
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M#>@6_AC0;;1[.>XFMK8%8C.5+ 9SC*@9ZT <8B7[_'#5Q836T3_V-!N,\+2
MCS#T 9:O>*;G7]+^&>MW<^HBWU>W6>9)K10 4#G8 &W$#:1WR/6M5O!T?_"3
MW/B"'6M3@OKB%;=]GD%!&#D* T9[]^M)>^#(-3TW5+*^U;4[C^TD6*>9VB#B
M-<X10(PJCYB>F>>M '/WIUBT\7^%K>/Q#?>7K<%PETK!"J;(@X:(;?E/49.?
M?)K,U#5];TSPMX_M8=;O&ET296M+J38TH5HU?8Q*\@$GG&?>NYG\)P7&IZ+J
M$FHWQGT=76WP8\-O7:Q8;.<KQQBN8\<>&HM+\&^,+NVN+ZZN]9B!:%E5]T@
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MPBZNKR9VW2W-W)OED.,<G        %1ZYX>T_P 0QV<>H1EUM+I+J( _QKG
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M(YY% '245P7@_7_L.EZ_-K%_=7"0>(+FSA>17F? 951%503^ %=W&XDC5U#
M,,@,I4_B#R* '45A6OC#0[RZM((+MF^VNZ6LIA<13LF=P1R-IZ'OSCC-0:'X
MO@USQ!J^F1VMU%_9\JPAY+:10QV[B22,+U& <$]>] '245QOCRYO+.Z\*R6M
M[<0+-KEO;S1Q/M66-@Q(;'4?*.*VM5\4:5HWGF\FE"VX#7#Q6\DJP ]"Y4$+
MQSSVYZ4 ;%%8]YXITBR=4:X:9VMOM86VB>8^1_ST.P'Y?0]^V:D_X2+3&M+&
MYAN&N([Y/,MA;QM(TJ8!+ *"< $9)Z9 ZF@#4HKD]6\>6%B-%-O#=W":I=F!
M'6TE.P+NW9&W.[Y2 N,]\8%=+,\TEC(]H%$[1DPB92!NQ\NX=0,XSWH GHKS
MR]MM?\+^*/#TL7B*^U:'5+S[+>6EVJ;<%&<R1A5&P+M/'/:K5G?7_BS6/$Z6
MM_/9PZ5-]ALO); \\)N>1Q_%\Q "GC /&30!W-%8'@GQ"?%7@W3-::,1R7,6
M9$7H'4E6Q[;E-<MHOB^VT'4_%PUW5+R:"UU/;&6CDG\F+RD.2$4[$!)YP!0!
MZ116?=ZW868MM\QD>Z!:".!&E>50,DJJ@G !'/3D>M49/&>@1:'+K+WS"QAE
M\F:3R)"89 0I5U"[D.2!A@.HH WJ*SIM=TZWUE-)EG9+UX6G2,Q/AD7&XAL;
M3C(XSFLFV^(7A>[D1(=3R&$S;S!(J*(@3)N8KA< $\XX^HH Z>BLZRUNSO[Q
MK2(7"3K$)BDUM)%\A. 1N SS_P#7J+5_$^CZ#<VMOJ=ZMO+=;O)4HQW;02>0
M/0'ZT :U%8>C^,-!URUO;BROUV6)(NQ.C0M!QG+JX! P#R1V/I3H/%>D3Z@U
MAYTT-T(3<+%/;21-)&.K(&4;L>W- &U17/:1XW\/Z]=V]MIM\UQ)<1R21$02
M!2$;:WS%< @]CS@@]"*OW>OZ=9:U9:1<32)?7H8V\?DN1)M&6PP&W@<GF@#2
MHK&M?%6CWL.I307$I33&9+LM;2J8F49(P5!) YXS3KGQ+IMK DKM<OOA^T>7
M%:RO(L?]YD"[E'7J!T/I0!KT5E+XDTJ73K2_M[K[3!>+NMOLZ-(THQD[54$\
M=^..^*Y/QCXDCU'PE:ZGH.J7$8CU:WMI1$6B<$S*KQR*0&4\\@XZT >@T50B
MUBRGU:?3(GE>ZMPIE @?8F1D OC;G';.:-&UJP\0:8FHZ;,9K5V95<HR9*L5
M/# 'J#0!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KAKJ"2V^-^G
MWD@/D7FA2VL1[>8DRNP_[Y.?PKN:I:CID&I)#YA9)K>02P3)]Z)P",CZ@D$=
M""10!YOXNO);N[\;:4]C=V\K:;BU6SM&)U#,+?.\JKR%)VA<@=0<YP+'BJ0W
MGP%$$4,OG7%E:VL44D91VD9HT VD ]?\>E>F+N"C<06QR0, FJ=UID5[?6UQ
M<L9$M6\R&''RB3!&\^I )QV&2>N" "Q:Q-!:0PLVYDC52WJ0,9J6BB@ HHHH
M *\WWV__  FGQ!:[M9KFTETRW4QHC?Z0$CE$B(>Y^8#CN:](HH \[\')?Z=X
MECTVTU:36_#_ -B9XI[F/]_8MN4")GP"=P_A/(V=!CFUX[GN='\1>&/$9M;B
MYTRPDN([T6\9D:(2H%63:.2 0<^Q]Z[JB@#S;QE)%XA^&VOW>BZ3,(YG@F$@
MM6BENMDJ,[[" Q 5< D9.#CC!+CJ]OJOQ1TC4;.WO)K%M(N(A.;214+%T.#E
M<@<'D@#MFO1Z* /+?"27.F:YHMMH5]/?>'KE)'DTZ]CS-I.$)&'(W*,G9M;U
MXSR:R4M-3F^&=WIUI8WCW^EZV]Y<6A@93-&MT9-JDC#DKA@!GI[C/M%% '!:
M@\'B;QIX4U32I"]OI@N;BZN-I41(\841MD##$]5Z@*2<5R,ZL_P-\06:P3&Z
MEU"<I!Y3>8X:YWJ0N,G*\_05[710!P>KW,<OQ1\+7$ :6)+&[5G13M!<1[%+
M= 3@XS7'C46OM/\ "-X]A?V\UKKJ-<V%OI\D<-B,2C8JJOS')!W?,>3TSBO;
M** .&\&R(?''C5]K*)[J!XV9"!(JPJI*GH0&!'%<] V? ?Q,B"2>9<W]^T">
M6V90\2JA48^8$@@$5ZU10!Y_K>G2W_PSTK4].(75-&@AOK4M\OSQH-\;>@9=
MRD'\>E=)X5CF?23J5W$8KO4W^V2QMUC# !$/NJ!%/N#ZTW6O#]WK.H0EM:N(
M-*\LQW6G1Q(5N1G/+D;@"."!U'IDUO4 >?\ C2UBD\1"[L=9N=#URVL5:&ZV
M;[>Z0N_[EU(PQ!&<?>^?(!K*BUK4/#_B;1O$7B'2Y[:QO]"BM)OLUN\BV5PK
ME]I102JD$=NHQVKU6B@#S7Q1+;S6OA*6UTU[.W_X2&*Z$0MRC+%A]TKH!\F2
MV>>>1G!R!2UVQN]8\0_$"RTX,9[S2+>*W."%F=!)N0-T)Y //>O5Z* /-]#U
M#1O%,]E):Z3JL>N6B/N:_%QC3G9"&^:0E22<#"Y)ZD#''*SZ@5^",OA>XL+Z
M/7;!H89[06LC,2MRK;P0""&'(.>2:]RHH \_EU"/2_BS)?74-V+;4-&BBMG6
MUD;?(LKDI@+D-A@<'%<E;F5?@WHUK):W4=Q'K:R-$UNX;:+QI"PXY4*0<C(K
MVVB@#R_4KZUT+Q_K$NO6^J-I6KQ0265W9>>\>5CV-$PB/4GD<=S32(_"?B_P
M[JC:5<6/APZ;-91QK&TGV*1Y1("X&2NX  ^AX[5ZE10!PG@*<3>)/&,BP7*1
MSZBLT3RV[QJZ^4@R"P ZCIUI^M.UC\6-#O9;>X:WDTVXMEDBA:0>:7C8*2H.
M,@'DX'%=Q10!Y7H\C:7X.\3^&-8@F;5&FO/*C\LL;Y9BS(T?'S9+8/ICG%=Y
MX4TVYT?PCH^FWC[[FULXH93G/S*H!&>^.E;%% 'F-]X6O+SQ#XC\*B.2/0M:
M U)KA>D3D%70'^\9%C?Z;O6K.CV&OZ_\/=6;4(VM];N-/?3(MYP<QJR%\]M\
MA<Y]-M>BT4 >4WA/B?X=:#H%K!-!K<,UFDD#Q%7LVA9?,=N/E4!6P>^0!G-;
MOAF6,?$SQM(0RK,;,QR,A"R!(2&VMC!P>#CI7<T4 >):1/?:#K.H^)UCGN]/
M37KR.>Q,)+I%,XVW,*XR3V.,Y7..]>S+=)/8_:K4><K(60#C=[<]/2IZ* /%
M(=0-Y!X*OC8W\4EMJO\ I-E;Z?)'!8Y20>6J!1DY(YY/N <5V?A5VM/'WC"T
MGM[A)+F[BN(F,+;&C\A1NWXV]01USFNXHH XCXBM^]\*85V\O7K::3:I;9&H
M?<QQT49&2?6L![JQT?Q1XCTOQ/8ZM+;ZI=&XLY;47$D-U&\:H8BL9QN&W'(Z
M>V*]6HH \TNIUM->CT8Z1<:9 -%1+;[';-)).<M_HYF4':J<< CDYSCKD:1:
MVE]X&\'03WNI:%J=I:RBVU(1-&L$B[ R.&&"K9'7 .P@&O8J* /*+JZU>71/
M!FJ:U9MYEKKC&YEM;9L.F)56;RU!(#Y!Z?Q>]>G3WL-KI[WTXD2%(_,8;"6
MQG&T<D^PYJS10!YYIGC72M3UN&]FL]6?4)#]GL[8Z=,JVZN1G+LH4,< LV<
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MQB0QLD\1C=6&#@J?8@_0BM8\@C./>J]G9Q643)%N)=S)(['+.QZL3_D   8
M H L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0?!=WHNE;I]1OUF6-I#\\L\N=\KXZ %BQ/0 8'85UO2CO0!GZ%I,.A:!8:3
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M&.I^,-+9I+6Y@B@CDY"32 ?/(H(_N^6F?]EA74ZOI=KK>D7>EWJ%K:[B:*0
MX.",<'L:N*H50J@!0, #M2T <EX>\+:YI(AAU#Q3+J=K:+BTB>T6,CC"F5@<
MR8!]N>3SC%%OAY<MX"NO"IUJ/R[BX:<W'V,[AF7S2,>9_>[^GYUW=% '.77A
MVZG\6Z;XAEU*!?L-M) T(MB X?!8[B_'W1C@X]ZXSP'H\WB3X=3::^IPC2[F
M]NEGBCAS+L\]R4#[L ,.^W.&..Q'JK*KJ58 J1@@C(--CABA!$42)GKM4#-
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MZ9)_VL<53C^'US%X0T/P^FLQ[-)NXKI)C9G,GEOO52/,XYZG^5=U10!'()3
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M @ $Y/KZTM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+)(!&1Z@XM:P/#-]X?\ &&LZ7JKZI<3Z)+'<W7F(T0PA\M3M &_KCN!UQD9
M._C\3:%->?8X]9L&N?*\_P H7"[A'C=NQGICGZ<U/INM:7K-L]SIFH6MY C%
M'D@E5U5AU!(/%>;WT6G%?A:"EKM,@P,+@@VQS^;8_'%5-<\]]0^*D&E#S+CR
M+!S#"1N=1&?, '<E010!ZC9:YI.I7,EM9:E:W$\:AVCBE5F"GHV!V]^E<MX^
M\6C2M+0:1K-K%?K?00R1#8[,&D577!S@@-D\9'M6=:WOA_Q+=VFL:#K5QJ>N
M064XM$#(#;AHSQ*JJ,#=M #=\8[UR]UKFC3_  1T>W-W;I?6EU:+<P2N!-',
MLZ^:S*>0<[B2?7WH ]OFFCMX7FFD6.*-2SNYP% ZDGL*X30O$%[XMFDOM.\0
MVULMIJ4J26)6.1)+2-]I8_QAFQN#;L<]#7>+(CQ+*CJT;#<&!R"/7/I7BZR7
M%U\%O$O]EG[0ZZM<O+'"<L\/VG<X&/5,_4&@#UNSUS2M1G>"SU*UN)43S"D<
MJL=O]['I[]*BB\2Z%<745K#K%A)/-(T44:7"EG=1EE !Y(!&:Y+Q!+;:YXE\
M#WNA3Q32K</,9(2"!9F,^9NQT4G8.>Y%)\-K739Y/$\ZP6LD\7B.\9'"JS)R
M "#VX)Z>IH [B[U*QL'A2\O+>W:9MD2RR!3(WHH/4_2JEIXFT*^L[B[M-9L)
M[:V.)YH[A&2+_>.<#\:Y;XHI9E?";7JP^1_PD-LLAE V[2DF0<]O7M5&^TE&
M^(NOSZ/"@@;PV\-X(%&UKAF/E@@<;]@/OC'K0!WQUG2Q]CSJ5I_IN#:_OE_?
MY&1LY^;(]*KR>*- BG$$FMZ>LIF$&PW*9\P\[.OWO:O+(]=TF3P?\+XDU"V9
M[:^LEG D!\DB%U(?^Z<\8..A]#73>#[32[SQOXWWP6D[IJ,#J&16*XA7!'I\
MV>?6@#J_^$L\.F:VA&NZ:9+IBMNHNDS*0Q4A>>?F!'U&*MW^KZ=I84W]];VV
MX%AYL@7('4\]AW/:O&K2PT>]^!6JP""WDU W=RD*HH\W[1]H;RE&.=W*X]CZ
M5UWAVYGTWXE:Y::_,JW%SIUF;*25L+)'&A$P4GTD8DCWS0!W,NIV$-G'>27D
M"VTN/+E\P;7SR-I[Y]J;'K&FRZ>U_'?VS6:DJ9Q*I0$'!&[.,YX^O%>5Z+I4
MW_"/VD5KK/\ 9$_]NWL_AZ61 T30_,%C*GJK*7(QV.1[I>>(;V/3=%U36+<:
M=:Z?KUQ!JEQIXWQ&0HRK.NX'Y-['.0<'/>@#U.WUS2KNQFO;?4;62UA)6659
M5*QD=0Q['V-266IV.HF465W#<&(@2"-P2A/0,.Q^M>>75GX5O].UZ_L?$-QF
M_FLQ/J\<B/$EPLBB$C "9!V;O8C-;?@N_P!7DUG6M-UR*SFO[-8-VHV0*I=(
MP8KN7^%P!R/]H=L4 =5>ZC9:=&KWMU#;JYVJ9' W'K@>IQ6=JWB?3=-\+76O
M1WEM/:QP/+$ZS+MF95)"JV<$G&.*Y^]NVL/C-9/J+".QN='>"QD<X3S_ #0T
MB@]F*A3[A:PO*^R^&OBE<Q.JZ/<&X-H<X1I/L^)2O;!?CCN#0!U7A2YU+5UL
M=8'B&&]LI[-3=6:Q1D0W!"M\C)@@#)!5MQZ<U77Q!<ZOXZU?P]%JR:7)IR1&
M&$1(TESN3<7^?.4&0,+@\$D\BMSPC(DO@W1'C=74V$'*G(_U:US/B+2?"7CC
M5+_3]1E2SUG2758[J*817$8*+('4]U^8C!R 0>E '3Z/=W\&AM/XBFMHKB*6
M9995'E1;!(P1@&)P"NT\D]:MV&KZ=J<<LEC?6]PD+;93%(&\L^C>A^M>1_VU
MK47@;2K_ %F^GNM/TSQ"8I=3AC!:>T0,J7!!!! <@YP<[0>3S5SQ)'I=]X;\
M4:QX7O[C6;V>UA%]-#(K(\2.I*?( "_E[^!R!UZC(!Z3%XCT2<3F+5;.3R(_
M.EVS*=J?WNOW??I6&/%^F^(O!<^I:=XAM='#DA+N4QN8 '(4LC$#+*IX/K[4
M_2=9\)>)=9L=2TB2WOM02U9%D@;+6T+8)60 X7)  !YZXX!KSD7EE-^S'+;>
M?"\]M;JDL>X%HG^T< CL>.G6@#VB\U*RTV)'OKN& /PID<+N(&3@=_7BHI-=
MTB+3HM0?4[-;*8@17!G78Y/ "MG!_"N2:]^R?&*)[^15L[S1A'ITS'Y#()-T
MB ]-Q&T^X4>E<9KMM'!X(\:2YC&DS^(('L<D;3^^B\TI_LEMW3C@T >PV6N:
M5J5W<VECJ5I<W%L<3Q0S*[1G_: /%7ZX-OLMO\:]/C@\F/=X?E3:F!D"9"HP
M/;./QKO* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***BN+B&TMI;FXD6.&)"
M\CL<!5 R2: ):*XKPQXCUG5?$_BFWNX-L-E':R65G@*ZB1';#G^\V%R#PO3L
M2:6IWGC'PSJNBWMYJ]KJ5EJ-_%97%C'9B,0&0X#1ODLP7_:ZCT[ 'H5%<?XU
M/B:TTN_U72=8ALULHC)#:?95E^TD#.UB>06/R@+[<G.!?U3Q!<:?I>DHT"1Z
MQJDD=O% QRL<C+N<G'54 8GUP!D9H Z&BN&U/7Y] ^(%A;:CK>S1VTJ:>;[0
M(T42*Z*&+  \[NG3G@5T)U-=;T+^T?#>H6]R1EX61@\<I'\#'MGIQR#^1 -B
MLW5=(349;.ZC<0WUE(9+:;&=I(VLI'=6!P1]#U -8TGC6VN?"^DZIIJAY]8E
MCM[.*3^&5B0V_'9-KEL?W2.]:&J:?KEQ:QV^GZX+ HA+W;6R2R.W;Y3A0OKQ
MD^V.0#4DM8+GRGN;:&22,[E+*&V-Z@D?K5/4=)75;NT^U,IL[65;A80/]9*O
MW2WLIY [D ]L'&\.7WB'6/ EK?7)BBUC#LN$Q%<!68(2.H5U /'3((]*VO#^
MMVWB/0;/5K0,L5S'NV-U1@<,I]PP(/TH TJ*SM0U[2M*<I?7T,#*GF,';[B=
M-S?W5X/)P*Q?&WBR+P_H=O-;W4*SWMQ###(2& 1W56D'8X4DCMT[4 =716)H
MD5S;+>W<^O'4=-F(EM6EC56@4 [P77 89Y' Q[UR7B'QZNI_#?7M8\.:@UM=
M6)<1L$5F*J^S)5AP#R1QGI0!Z14+6EL[2LUO$S2@"0E 2X'0'UJAI_B+2-0O
MY--MM3MI[^! TT"2 NHZ$D>QX/H:<_B'1X]1CL'U&W6ZDD,2(7QN<?P ]-W^
MSU]J +KVEM(^^2WA=O[S(":?Y4?G&;RU\TKMWXYQZ9]*IZUJ]KH.B7NK7A(M
M[2%I7QU( Z#W/0?6L30!KVO:+;:Q>ZK+I\EY&)XK.UBB9(D894,71F9L$9(*
MCL * .C2SM8II9H[:%)9?]8ZH S_ %/>G16T$!/DPQQYZ[% S^596F7UY8:*
M9?$MS;1W*7$D9E1?+20&1O+VJ23DKMXR3GU-7K#5;#5(I)+&[BG6)RDFUN8V
M'56'53[&@"S+%',A26-9$/)5AD4PV=LSES;PEVSEB@R<UQ6O^+ ?$WA:VTC6
M4:&\OS%<0QJK":/8QW*Q&2 0!E3BNHO/$.CZ?=+;7>HV\,I=8\.^ &;[JD]
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M\MR4\Q8U?ET_O+_>'N,B@"W)96DML;>2UA> \^4T8*_ETJ955$"(H55&  ,
M"JE_JNGZ6L37][;VPF<1Q>=(%WL3@*N>IYZ"J^E>)-$UR>X@TO5;2\EMSB5(
M)0Q3\NWOTH T)[>&ZA:&XACFB;JDBA@?P-)#;PVD'E6L$42+]V-%"+^@XJC'
MXBT>;45L(]2MS=/NV1[_ +^W[P4]&([@9QWJ&+Q=X=GNXK6'6["2>:9K>-$G
M5B\B@$J,=2 1^= &9X3\+SZ1/JLVIP6$LMUJ<U_!)$2[1"0@[<LHQC'4=?2N
MI>*.1T=XU9D.4)&2I]O2J">(=(DU!+!=1MS<R,R(F_[[+]Y5/0L.X'(I+KQ#
MH]C>+:76HV\,S.(PKO@!ST4GH&/8'DT 7H[:")R\<$:.>K*@!--AL[6WEDE@
MMH8I)3F1TC"ES[D=:SKSQ9X?T^2ZCN]9L8GM<>>K3+F/.< CL3@\=>*J:QXV
MT;2(](=KN*5=5F1+=T;*%#R7W#C& ?J: -O[#: $"U@P>O[L<U-'&D2!(T5$
M'15& *(Y%EC61&#(P#*1T(-9T7B'1Y[Y+.+4;=KB0LL:A_\ 6%?O!3T8CN!G
M% &EL7?OVC=C&['.*%14&%4*,DX QR3DG\ZQI_%WAVVN7MYM;L$F29(&0SKE
M9'SM4\\$X/%7M3U73]&LFO-3O8+.V7@R3R!!GTYZGVH E2SM8[E[E+:%;AQA
MY50!F^IZFE>UMY9UGD@B>55*K(R L >H!]*S?^$K\/\ VN[M?[9L1/:(9)T,
MR@QJ#@D_0\'T/%6+'7=*U/3&U.RU&VFL4W;YUD&Q-OWMQ[8[YH LM9VK(B-;
M0E$&$4H,*/0>E+):6TTL<LMO$\D7^K=D!*?0]JJ6FO:5?2S16]_ \L*>9(A;
M:RIV?!YV^_2H+3Q9X?O[V"SM-9L9[BXWF&.*96,@3.XC'7&#^1]* -:...&-
M8XD5(U&%51@ >@%1?8K3YO\ 18?F^]^['/?FJ=KXAT>]OQ8VVHV\MRR%UC5^
M74=67^\!ZC-7[BXAM+>2XN9HX88UW/)(P55'J2>E #'LK62W:W>VA:!NL1C!
M4_ATJ1(8HH1#'&B1 ;0BJ H'IBJ5IKFEW[3I;7L3R6ZAIH\X:-3R"5/(!['H
M:X[2]=N_&.H:H-,\0BPEL-3,,$"1)(DT$83>7!&3N+-R",<8[Y ._CC2*-8X
MT5$4855& !]*B>SM9+E+F2VA>=.$E:,%E^AZBL?7/%VF:#K&E:9=S*L^H2.!
MDX$:*C,6)^J@ =\^QK"LO%J:7XP\60:]K<4>FV9L_LGG[$">9&S,!@ M^.3@
M4 =O<6T%W$8KF".:,G)21 P_(U(JA%"J % P !P!52?5;"WLXKN6[B%O, 8G
M#;A)D9&W'WLCGCM3M/U*RU:S6[T^ZBN;=B0)(F##(X(^H]* ));2VGFCFEMX
MI)8_N.Z E?H>U#6EL]K]E>WB:WQM\HH"F/3'3%8J^+]+?Q?)X<69?M44 D<D
MX&YFP$'J>"3Z<?A=?Q#H\=ZMF^HVZSM+Y(4OP9/[F>F[_9SGVH T%AB2 0)$
MBQ!=HC"@*!Z8]*BCL;2*W^SQVL"09SY:Q@+GZ=*QQXOTMO&$GAM9E^U1P"5R
M3@;F;"H/4]2?3C\+L/B/1[B^CLHM1MWN)&=(U#?ZQE^\JGHQ&#D#)&#F@"X;
M&T(4&U@^7I^['%.2V@CD,D<$:N>K*@!/XUR^@:EJ,_Q!\5:9=7C3VEG':/;1
MLBKY7F*Y89 !/('7/2NEO+VUL(/.NYTACW!07.,L>@'J3Z#F@!T%I;6K2-;V
M\41D.YS&@7<?4XZFF_8+,RO+]D@\R0@N_EC+$<@DXYQ4%MK>EW>GRW\%_;M:
M0EEEE\P!8BOW@V?ND=P<8IMKKVE7AN%@OX"UNH>96;:T:GHS X('OTH T&57
M4JP#*1@@C((J.*V@@),,$<9/4H@&?RK(3QEX:D>S1-<L&:\8I;XG4^:=Q7C\
M00/4CBI[37])UFXN[#3-7MY;N!?W@@D5VCSQG'(//U&: +T%E:6OF?9[:&+S
M#E_+C"[C[XZTZ*V@@),,,<9/78H&?RKA? ?CJRN_#.CQ:]KUH=;O&E 25T1Y
M,3.J_*, <  #OBND-];?\)9)'_PD$7[FQ+2Z7E/DPX/G,?O#@@8/'.: *?C#
M0+_7Y-$%H+3R]/U*.^D%P[#S @8;  IZ[NI].E=%;6T%I"(K>"*",<[(E"J#
M]!60OC/PT\EJB:[I[-=N8[?;.I\Q@Q7 ]>00/4CBKFI:YI>CC.H7L-O\N\[S
MT7^\?1?<\4 68[&TB.8[6!/G,GRQ@?.>"WUYZT"VB@#R6UM")B#C@)GV) -0
MW&K:?:VT-Q+=Q"*XQY+*V[S<C(V <MQSQGCFN:\ ZW=:W)XC:?4?M\%MJKP6
MTH50!$(T('R@#J3[T 6/!'A>7P[HR6VHPV,EY%-,Z7$.6.V21GQDJ",;L5TE
MS9VMXJK=6T,ZJ=RB5 P!]1FJQUK3%U<:2;Z :B4WBVWCS"O][;UQ[T[^V--V
MWC&^@5;)MMRS. (3C.&)Z<$'\10!8GM;>ZC\NX@BEC_NR(&'Y&E%O +?[.(8
MQ!MV^7M&W'ICIBJ-OK^E72730WT+&U7=.N<-&,9!93R 1TXYKGE\9Z5XA\$W
M.IVVO1Z*C%T6[D*[H0'95;:_&6"9QUYH ZQ;.U2V%LEM"MN.D00!?RZ4ZWMK
M>TB\JV@CAC!SLC0*,_050N?$6C:=,+6]U>TBN!#YK)+*JML&,L1V'(_.I+37
M=)OM(.K6NHVTFG@,S7(D&Q0.N3VQWS0!;N+:WNXC%<P131GDI(@8?D:5K>!H
M5A:&,Q+C"%1M&/:L^#Q'HUQ>K9)J=L+QL;;:20)*V1D$(V&((YSBK%_JNGZ7
MY/V^]M[8SR"*(2R!3(Y. J@]3R.E %F*&*%=L4:1KG.$4 5%<V%E>+MNK2"=
M=V[$L8;GUY'6J>D^)-$UV6XBTK5;2]DMSB58)0Q3ZX[>_2EC\0Z/+?)9)J-N
MUQ(S)&N__6,OWE4]&(YR!R,4 :)C0Q>447R\;=N.,>F*9;VT%I"(;:&.&(=$
MC4*!^ K/_P"$ET3%\?[4M<6'_'W^\'[C_?\ [OXU*NN:6]M:7*W\!@O&"6T@
M?Y9F/0*>^: +5O:6UJ'%O;Q0AVW,(T"[CZG'>@VEL4*&WB*EBY4H,%CU/U]Z
MI3^(='MK]+*;4;>.X>01*C/C,AY"9Z;O]GK4%SXN\.6EQ);W&MV$<T4J0R(9
MURKOG:IYX)P>/:@#3FLK6XMQ;S6T,L(Z1O&&4?@>*<]M!)&L;P1LB?=5D! ^
M@ITLL=O"\TTB1Q1J6=W8!5 ZDD]!5&TU[2K^:6&VOX'EB3S73=A@G]_!_A_V
MNE %L6ELL@D6WB#KC#!!D8]ZFK'M?%GAZ^O;>SM-9L9[FX+B&.*96,FS.[;C
MKC!_(^E;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %8'BG3-9U2&S32;FPB$
M,XEECO8GD27;RH(5E/#8;KU K?HH \O\)OKUI\2_%\^KWFD+!%#:/?O%"\8P
M(G*%"SG: ,[MV?;%68OB!X/UG6K>]GUJW<6TA73[-<M(\K?)YA4#[Q!*J.P8
MD\G"^C;1SP.>O'6D$<8.0B@_2@#C_%\GA#Q'8ZAHFJZE;FYM1DPI.5FBD(RI
M50<LW3 P<GBN>:VU:UUCX53:TSM<1)<073.<D3O;?*&/=OE8?7->H>3%YWG>
M4GFXQOVC=CZU4U;2H-8LA;SED9)%FAE3[T4BG*NON#^!Y!X- '(:[):6WQ>\
M/W%^T,4/]F7*12SD!?,WH0 3QNQGWQFIO =BL&L^*[^R01Z/>Z@KV8481R(U
M$LB]MI?/(ZXKL5A,MLL=XL4S8&_"?*3Z@'./IS]:BU&TEO;%[2*<VZRC9)(@
M^94(P=OH?0]NM 'BWAFWGBA^']_("+!]<U#R\]!YOF>5^9#$?6O6->U#PW(6
MT+7+ZTC-U"7-O//Y1D3H<'(]^]6+OP_I]UHD6DK%Y%M (_LWE<&!HR"C)Z%2
M!CZ<YJY';EXHOMBPS3I_&(\#/J <X_.@#F/AQIT^E>';FU,LTFGI?S?V:9B2
MPM<C9R>2,[B#W!!Z54^$L;KX*>4Y$,^H74L'_7,RMC'MP3^-=AJ-M->63VT,
MYM_-&QY5'S*IZ[?1O0]NN#3[*SM].L8+*TB6&V@C6.*->BJ!@"@#A- U"WTS
MQ?XTLO$,T,$MQ<+=1-<L%6:T,84;2>"%P01V)]ZY>6.31?@]X7MM4E\A_P"V
M+>2*.=MKK#]I+*"#SPF#[#Z5[/)#%*4,D:.4.5+*#M/J*<R*WWE!^HH 1'61
M Z,&4C(*G(->(SZC9I\$O%VG/<QK>0W=VLL);YD+7!*@CL2.@[X..AKW   8
M P*;Y:'/R+R<GCJ: //-1N;%/B9X*6TGME#:?>(GELN,%8]@X[<' ]C7/>&K
MOP]JGAJQ\.>(+F_.OV-R%DTLR,LAN5<D.N!T).[=G R237LGEID'8N1TXI/)
MC\[S?+3S<;=^T9QZ9H P/'FAS^)? VKZ1:D"XN("(LG +@AE&>V2 /QJAX/\
M8:1<>&+*&\O;>PU"S@2"\M+J0120R*H4@JV#C(X/<5V-1/;023+,\$;2K]UR
M@+#Z&@#@_%FI-%XH\&:U.LD6A0W5PD\DHVJCO'LAD8'[JY+ $XQN[9K"\6V>
MHW^K>-K_ ,,L989=!B@F:W.1+<!V)"D=6$/''/S =Z]=95=2KJ&4C!!&0:2.
M-(D"1HJ(.BJ, 4 >4ZOXF\.ZI+\/KC3KZT,<6H("BN-UNIA<;6'\'.!@XZ>U
M5+2]\/S0^(/"WB^[O(KY]1G9K+<P-XCREXFC &6R-H !SP*]?6"%&W)%&IW%
MLA0.3U/UI3#&TJRM&AD485RHR/H: &0)LLHX]K+MC"[6;<1QT)[GWKQ/3-0"
M_";P;+"_FVVCZI!)K$: DP1K(^=X_P!EMK$=1P>E>Y4@50" H /) '6@#AI%
MCU/XM:3J6D3QS0P:7,E_-"X9"C,IB0D<9SN8#T!-,^*)M4C\)O>^4+8>(K;S
M#+C:%V2YSGC%=U%#% FR*-(UZ[44 5SOBW0+[7I=$-J]LB:=J,=^_G%OWFP,
M-@P.,[NOMTH XSQ-I=UJ/BWQ-=^&,&1O#3VT[VYXDN&?*+D=9-@/N 5]14FI
MW5GXD\&^#8=$EC.I17MFT,49'F6WEC$NY>JA5# Y]AW%>HQ1)#&$CC2-1_"@
MP!0L,22/(D:*[_>8* 6^I[T >67=U<:/K%Q>Z+J-OJFF3ZTL=[HER!Y\-P9@
M"\)'/W@'VD8P,_0OKJXT?5[N_P!$U&WU/39M95+[0[D S17'FJN^$CG.X*X4
M\8&?IZEY$7FB7RD\P# ?:,X^M'D0^:)?*3S ,!]HR!]: /)EU'0H]3\5^'/&
M%]=6DUU?RRI 68+>6\@ CV8&6. %P.>!BI]>C?2I;V\T#58;:[L]+A2_T352
M'2Z@5#M^;.X/@LN0>3U]3ZFT,;R)(\:,Z?=8J"5^A[4CP12,K/$C,IRI902#
MZB@#R_7[JX6XN]<T?4K>QU--*A?4=#U, Q7$.UF"]F5AN=<COP<9Y](TNX:Z
MT>RN9+=K5I;=)&@?K$2H)4^XZ?A5AX(I&5I(D9E.5+*"0?45)0!YUX+U"Q9_
M'G^EVY4:Q.[?O!C9Y48S],@C/M6?H.CMXC^ FDP6$B_VC:VZW-FZD$QW,3%E
M'L<C;]&KU,1QCHB_E2JJJ,* !["@#SN:74O%?PVUO7;.VEAO]4TTQVL&,.J*
MA^4>[,TF#W!6F>'M3\(^*M1T*\L[N[N]6L@S16S2,&LLIMD$@P !QMYX)QBO
M1P JA5  '  [4U(8XV=DC16<Y8JH!8^_K0!P_P 63 OA*T:Z">0NJV9DWC@+
MYJYS[8S6=K^GG4O'\-UX9:+[5%H=W'<S6Y&W+@"W4D<9W9('HN:ZGQGH-[XB
MTRUM+.6WB,5Y#=,\Q//EN&"@ =\=>WO6_!$D,058HXL\LL8XSW[#- 'E7A:_
M\*^(-.\-V<UQ>R:UIDD.W36=EDM9HP%8E<#" 9SG@CCKQ5SP?'!?V_CT:<UL
M^HG6;MK=U*EE8QJ$8'M\Q;!^OO7I2PQ+(TBQH)&^\P49/U-*J*OW5 ^@H \T
M\%Z]X9UCPWX:TB>!9=<TSRH_L#H1-;3QC8\A'8#YFR>.?7BL>PO/#]UINL>%
M/%UU>IJ7]H3F33]S!KO=,9(VB &6SE<8/;L*]B6*-9&D6- [?>8#D_4T&&-I
M5E,:&11@.5&0/K0!Y_I4M@GQ?\0>;);AX])M5)D=2RX+[@2?;&?PKD='O;6W
M^''PXNYKF)+6UUO$TK. D0_?@;CT4<CK7M_EIDG8N3[4>6FW;L7&<XQ0!E>(
M5N[[PAJBZ2S"\GL91:L/E.]D.WKT.2*\YO9[77_A1X:T[271=:AFLHX+=3B6
MVGB91(2O5=H#DD]OK7KM,6&)96E6-!(W#.%&3]30!P/AS^SKKXK>-T;[+-+B
MPVJ=K'Y8SG'T(7/H0*L_%^2)/A7K@D=5W1(JACC)WK@#WKM@B@Y"@'UQ2LJL
M,, 1[B@#SW6Y=,;XJ>"!'):%1:7NP*5P!MCV8_7'XXKD]0F>32?&KZ>1<06W
MB:&[NX(#N+VZB(R' ZC*Y/\ NFO;?+3(.Q<CIQ0J*OW5 ^@H X+59;;6OB%X
M1U'1KN&=;:*YENYX'#*MLT8"AR.Q;& ?0GL:PO#5JNI?"CQ.FCK#+J1N-2$1
MAP7#,S@8(Y!*X _"O6(X(H5*Q1(BL<D*H )IZJJ_=4#Z"@#S3PYJ?A+Q3=Z!
M<6UU>7.KV(+1VA=@UD=NV3>, !1C;SP> .M:WQ/:YAT+2[V-'DLK+5[6ZU!$
M&[-NC98D=P#M)^GM79I#'&[ND:*SG+,% +?7UI] '!W9AU7XI^'M2T>YBFBM
MK"Y_M">!PR^4P7RE9AQRV6 ]B:/AK>6UQ-XN6&XBD8^(;IP$<$E2$P?I[UW,
M<,4*;(HTC4G.U5 %*J(IRJJ#["@#AO'%U;Z?XT\#WUY,D%I%>7*O-(=J*6MV
M"@GW/ K.L+G3I/'?Q%DDEMS_ *':+ER 0OD-N'/09QD?3->EE5;&X X.1D=Z
M3RTY^1>>O% 'B6C:S!I.D^ -3U.\GAT4Z3)9/=PM\MO<$QD;R <9"%?\FO2?
M!EOHD=KJ%UH#32VEY=M</<NY99Y2!N=,]NV1P2#Z5T;0Q/&8VC1D;JI4$'\*
M<JA5"J  !@ =J . DNX[3XQZA"\Z07%YH<*6@?\ Y:.)9/NCOC()]!STKF()
MH+WX$W'A^?\ Y#\(:V>R9OW_ -L\TLIQU)+$-GT)/K7LVU2P8@;AP#CFF^3%
MYWG>6GFXQOVC=CTS0!Y[:7:Z5\69(M2G!NIO#]LD8_BN)%D?<$'<]_8<]*Y*
M'7M*N;#P-=V]U;VEK#K(SIL(RMB"LORR,<MYA/J0#DX7C->X[5+!B!N' ..1
M31%&.D:CYMW3OZ_6@#A_#=U;O\6?&D:3QES#884,,\(^>/;(SZ9IOCC5%T#Q
M?X4UC4-RZ+"]S#<38)2"61%$;MCH/O+GMN-=V$4-N"@'UQ0Z)(A1U5D88*L,
M@T >7>++C3IO#ZZUX=MA+I::[:WVJSVZ$K=1HP,C#^^%(0DCC@^AK6OWM]3^
M)_AS5-)NH98+6QNCJ-Q#(&3R6"^4K,..7RP'^R37>*JJH55 4#  ' %,C@BA
M0I%$B(3DJJ@"@#PU9M._X9YA'F6N3J2DC*Y)^W?_ !'Z>U=Q/<V:_&K25BF@
M!;0ID 5AR/-0J/R!(%=YY<>,;%Q]*/+3.=BY'?% 'B-G;Z?J'P(;1(XX)=;D
MGECBM5QYZW/VAMI(^\"%P23T4>E=A'<00?&N&.>ZA,R>&MDA+@$L)P3^F3]*
M[T0Q"4RB-!(1@N%&2/K2E$)R57/KB@#PQKC3T^ NH/'+;+)_:Y;*LH.?MP(/
MUV?I[5T=[K6E:9X_\0VWB74IK&SU.""2QGW[89X1%M=-V",AMQQ_M>]>H>5'
MC&Q<?2D>&*0*'B1@ARNY0<'U% 'E=G<:;X4\<^'?/\VQ\.-HLMMILMZQ"QS&
M;<0S-]TM&%QNP<<>U;'PWO+.YU;QFMK-$X?6GF781\RM''\P]02#SWKO)(HY
MDV2QJZYSAAD4Y55,[5 R<G ZF@#B?B!')I,VD>,+:)Y)-(GV721KEI+67"R
M#N0=K >QK.\8V][IGA?0]0N(V:.'6K?4-85!NVH6+-G'54)0?1!Z5Z.0&!#
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MRF?COLQ1X!MKZ.X;0;Y)##X7FDMX)9/^6P<9A8>ZPL0?]\5Z&0"02 2.1[4
M $D  GD^] 'C.BW?A_4/#TWA;Q1=7W]MP7D@ETP2,KSR^:71X\#)W$@[L^I/
M'-=-H']G77Q;\:1R?9II?)L JMM8_*C;L#V(7/H0*[[R8S*)?+3S ,!]HSCT
MS2A%#;@H!]<4 <=\4DO&\$R26L4DT<%S!/=0QC+20)(&<8[\#)]@:IZO-:ZY
MX]\'ZCHMW#.+=;B:ZG@<,JVS1@ .1V+8P#W!/8UW]1QP10AA%$B!CDA5 R:
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MV#(ZAE([@]*=0 45GQZYILNNR:)'=*VHQP?:'A"G*QY"YSC'4^M:% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9]0U&/RWECA9885]$3))[\DY)/H * )=0U/4[26PMX)+2SL7LMWVN9?-9Y^
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MN8Y)SC :4EB#@'H!UP2>*F\8:!>>(K&QM[2X@@:VOH;PM*I;)C8,%P,=3WH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1LJCC)+G@GL#Q0!U6LZ]IV@00S:C,T233+!&1&S9=B HX!QDGO4_]EZ?]O\
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M&.%Q(8VDV%U<MP1D87!XY)/2N@422?&341!(L<C>'8=CLNX ^?)@D9&?ID4
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M'8A_F^;&T=,50TOQ3K&J>$O#.JRO96D>H(S7USC_ %9VG8L49.69FP,<]^*
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MF@#U"BH+..ZCM46\GCGG ^>2./RU)]ER<?F:GH **** "BBB@ HHHH ****
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M=ZD\8Z5T=% '->+/"\VO2Z7J&GWPL=6TJ<S6L[Q^8A##:Z.N1E6'!P<UF_\
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M*".![Y[:,7AO4+ZYT>;7KZWN_P"RG\V+R(2GG3;2@D?+'& 2<#N<YXQ73T4
M<-I7@C5]$N;FPT_Q L?AR>=Y_LAMLS1!SEHTDW<*23S@D9XYYINK?#U]9U/Q
M#=75]!MU2* 0;(&#VDD(;RY%;=RP+9[>E=7K>M67A[2)]4U%Y$M8%W2-'$TA
M ^B@G\>E6UN(WM%N5W&-D\P84DXQGH.2?:@"KH]OJ-KI<,&JWL5[=QJ%:XCA
M\KS,=RN3@^N./I5^L[0]<L?$6EKJ.FR/);,[QJSQE"2C%3P<$<@]:T: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAMUMB-X9@Q;=OXY48X/XT 6/$U[?6-C;26<]M;H]U&ES<3L!Y4)SDH#PSDX
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M98K<AH?+!VG=O^;[QR,#/M0!'HOB:_E\:1:.;P:C:SZ2UX)C!Y8\U752(V
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MB0)&BA551@ #H!3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)"* ,_A4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1_Z/YA:5,[<_,/EYZ=?>NDHH Q#I6L7%Y:R7NLPO;P/YA@@LS&)6 .W<2['
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M\# ('X5?HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=?TB]NS9V^I6KW:DAK;S )5P,G*'YAQSTJGXB\5Z;X:ET^&]F59;ZY6")2<
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MI)$X96^A'!KQW4KW2E'CCPO/KVDVZZGJ#.9=0N/*DA9TCW_(1\P7 VG(R1V
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MZSD#SK-T58RN?O*%7;@=,8H [F[US2;&YBMKO4K2">9&>..2959E4%BP!/0
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M9FG7$P/0KSR/<5YKH-VFBW7AS1M6>/3-67P\@DO9^970OQ;1*WREP0">&/0
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MUU,B;%9\!0%7)PH55 &3TYY)K3HH *BCMX(D9(X8T5CE@J@ GU-2T4 ,,4;
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MT4 ->-),;T5MIW#<,X/K36@B965HD*L<L"HP3[U)10 R**."-8XHUC1>BH,
M?A3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "N0^(6J6NDZ;I4UW;P-&VJ0*MU<*3'9-R
M1,P!'3&!D@9(S77T$ C!&10!XO)J-F(OBO$;]K@SV"/%+,H4R@VA4$84#!;
M&!SQC-:<MW81W?PK,<]NH56^ZZC -J5_#+<?6O5<#THQ0!A>-)X;?P1KC32I
M&IL)U!=@,DQM@#W-<-X5D\"6_@#P_>7]WI,%[9VUO<.ZRH)UE0 D8'S$D@@C
M&3FO5J,#TH X"ZOX9/B_X>,K+#*^C3[H78;D9FC(4^_!_(U@0'3]0\)?%"WD
MO&6%]1N9&>V'F.%\J/Y@H/(RI'H<'FO7JRO$>D3ZWHDUA;7[6,SLC+,L8<?*
MP;:RG[RG&",C()% '"Z!KFC>(_%V@7LOB#1_MUA926\=K:7#,UQ)(%W?>5<
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M1N1DR21M8 @Y[4 ='16+X1UA_$'@_2-6E $MU:I)(!TWX^;'MG-;5 !1110
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M[4O8X;JS-K/9(P\M^" _3((!/3_'(!<E\1Z1#=:?;/?1^=J#%;10"?-P"<C
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M$4VF71G\FZC+Q2Y0KR 0=PR2#V-=)10!S'A;PYJ.@ZEKD]W?V]S%J5V;L+'
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MK:F\;>'X(Y)I;]EMD8H;HV\GD%@<$"7;L)SQ@$\\=:WZ .6LO#^I67BCQ'K
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M"RU%[FX^T6ZL&"/]G?."">.XY/6@#T:H+N[@L;=I[F01Q@@9QDDDX  ')))
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MC;_V&^Z!A9[O,'DB0*06X'.">3Z8QSV_A_4GUCPYI>IR($>\M(KAD7HI= Q
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M!XA\/W^D7/$5W"T1;&2I(X8>X.#^%/TS6+35OM MO/5K=Q'*D]O)"RD@$<.
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M+:-DB1S)*4W,S[P?E!(  P>#SR,58_AY+%X+T[PTNL#R;&Z6Y2<VOS,5D\P
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M5@I?S ,'.<$YX JSX=\(:EH_D0:AXFNM5T^T&VUMI8$3:,8&]QS)@=,X'?'
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MA\17FJZ)XEN=*CU!@]]:I;I*LC@8+IOSL8@=<&NMBM88;)+-5S"D8B"L=V5
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M8&X\<=?3BKU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K"UG67BUK3-!LWVWM\'E>3 /D0(!N?!XR2549X
MR<\XP=VN%N(Y(/CG8W$N1#<^'Y8(2>AD6=68#WVD4 =3;:WID^J3:1!>+)?V
MR@RP<ET'8M]?7O6;K&N^7HMWK.DS?:%TLN;FW"\2*G^L3D<. #CW&#UK&\;K
M>>'M<TWQAI=HUS*!_9MY;IUFCD.(C]5E*_@YK:NK./1/A_?07$@?R;">2XE/
M'F.59I'/U8L?QH V[.[@U"QM[RVD$EO<1K+$X_B5AD'\C4]<S\.[6>S^'7A^
M"Y!$RV,9*MU7(R!^ (%=-0 4444 %9-SXFT:SNFM[B_CC=)%A<D'9'(V-J,^
M-JL<C )!Y'K6M7A_C'6;.[\->-+2(KI\]OJ:F33XHLR3[9(LW$A()VL ""-H
MX&22: /6+WQ5H.G7<UI=ZK:Q7,$?FRQ%\LJYP,@<Y)/ ZFFMXMT!+"QOSJD'
MV6_;9:R@DK*V<;5Q_%GC'7@^E<O%J&G7'QK%PMQ 5_X1P;'8@8/GD]^AV\_3
MGI69X5T>W\5?"K4M*@G19QJ%U);2(W,$HG9XG&.G.#[@^] 'I;ZC:1ZC#I[S
M 74T;21Q8.65>I_#(S]1ZBN7^)FK:GH7A==1TJ^>UG6ZAB.(T<,KN%.0RGGF
MG>!;R]\06S>(M4M6MKIXELUA8?<\LD2D>FZ7</HBUE_&B>V3P((9Y8PTE[;D
M(Q&6 D4MQW &<T =.UCJ-M?V83Q'=3$R;GMKF*#$L8X;!2-2",@YS[=Z9<>.
M/#%K'/)+K=F$@E\F5E?<%? )!QZ9&3T&>:RX[KP18:Q9WFDRZ6VI2?Z)#%82
M1EI!(RYR%[#:"3V -<W:7>GFT^*9,]M\\LO.Y?F'V8*/J-V1]: /08_%.A3:
MO%I46J6SWTJEHXE?._ R<'H3CG&<XYJI=^/?"EBKM<:_8H$F,#$2@X< $CCT
MR,^F>:X26\L8O#7PJVW%NI2YM2V' V_Z.P;/I\QP?<U;T>[T.'4OB+;ZK):K
MYMZPDCDQOEC,*C '5N<X [GWH Z+Q)JEY;^*_!ZV.H,+'4+F1)HD"%)E$+.I
MW8SV'0XK<O\ Q'I&ER21WM]'$8@#*2"5A!Z%R!A ?5L5YG:02Z'9_"NPU:58
M;R"5S*DK -&#"X4'/3&57Z\5JZ!J%GI<OC;2/$LL<-Q/J-Q=*LYQ]IMI% 39
MG[_ VX&<8 H [J;7]*@U.UTV2]C%Y=KNMX>291U)7'4 <D]J>VL:>EQ=P/=Q
MI):()+@/\HB4]"2> .#^1]*\X3P]K&G_  C\.WS1M_PD'AZ-;V)&^\4&=\!^
ML1VX]0*M>(8[^?X>3:_':7,DUU?6^J7%K'D2FV21"L8QT(C120.^Z@#NK#7M
M,U.ZGM;6[5KF !I874HZJ>C;6 .#Z]*CM?$FCWFH)8P7\;7,J&2)""/-4=2A
M(PX'JN:X*X;P_P"+M.U?4/",UWJ&LOHT]JMT993Y:L,K$=YQN+'@=1@GCO+X
M:U/PEXHN-": 7T^MZ>0PM)99@UBP7:^\$X &,<\'@4 =_JFLZ=HMND^I726T
M3N(U=\X+'H/J::FN::^L'2%NE.H"/S3;[3N"?WL8Z=L^O%5_%6AIXD\+:CI#
M':US"1&_]R0<HWX, ?PKS5M3U^6/0/'XL)OM4>W2;BQV@&4/\C,?3_2, #T
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MCFB+/:67RJPRS*) WXC(SZ9%'BJX?2OB)X7U:^;9HRQ7%L\[<);S.!M9SVW
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M1:SJ%Q9SP*C6MW&1ME'612P#*"/X0-OI63<>,XM9L?%5KILEW:7&EQR)'/\
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MBQ[*LH7)]&-9WA71M0TGQ-=^%IA)-I5G.NK17+CA_,! CP.!B4.__ 17I5%
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MZMIOC*YT.X5I;#6#'K-S*OW(Y4/[Z,>S.(>/[I-:GGP_\+RQYBY_X1_RNO\
M'Y^[;]<<XZXYKNJ* /#KFZB7X$:_I#B1;^&ZG22!HV!#-=E@O3DE3G [<UV>
MI7EFWQ9\,R0SPF+^S;I-R,-OS&,H,CCG!Q]*[ZB@#Q*^N()/A9\1(DD5GFUJ
MZ:) <F0,Z%2H[@X.".N#76ZE=V;_ !/\&O!-"8Q97:[D88&Y8]@X]<' ]J]
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M"MJ_O=!TG2K&_P!)TQHM.O\ 6UF;4[M)9?+D*'-R%DR02?E#'C/.",9]3HH
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M.>#6]J<JV'C_ ,!6]Y=H\]K9W<=S(6X#F*, L>VXJ<9ZUZ-10 4444 %%%%
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M>>!IVW/'-&1O&[NK*0<'H0<<' J^,_#C0^&= _LR!Y4\/7]I=K!&N7>*+Y6
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MWR!I@R%5ZD$#(([#VKK&ND@^+UG>LDSVU[H*V\$L<3.KR"?<5R!@8!R<XP*
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M''!%*L3,A=9W+ L!@8!!.>@H H^#_&MEI^DW,6OZO/)/_:]S;+-,CR;%$I1
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M6\C[9,[=K@*2ASQA@.>*U9-4M8M0MK%S*+BYC:6-?)8C:N-Q+8PN-R]2.HH
MN45A)XOT9[ZSM3/*AO25M)G@=8K@@9PCD;3QR.>>V:JQ_$#P[-=FUBNKB25;
MIK1@EG*=DJKN*M\O'MGJ0<9P: .GHKEK?XB^&;M+&6"]E>"^F\B&?[+*(O,W
M%0K/MPI)' )!Z'H:G&H:7_PF]S$-1OCJ$.G!I+'#^0(M_P#K N,%R3C().!B
M@#HJ*Y6#XB^&;B*SFBO9FM[N?[/'/]EE\M9-Q4*[;<(21P&QV/0UJW_B'3].
MN9;:5Y9)X8/M,L<$32-'%DC<P4''0X'4X. <&@#5JCJ>F1ZM$EM<MNM-P:6'
M'$N""%8_W<CD=^AXR"FD:S8:]8+?:9.9[9CA9-C*&X!R-P&1SUZ57N?$NFVM
MQ)$[3L(IDMY9(X'=(Y'V[5+ 8!^=?89&<4 6;K3(KV^MKBY;S([5O,AAQ\HD
MP1O/J0"<=ADGDX(O5D1^)=+FN-4MTEF,^EA#=Q_9Y-R!@2I V_-D GY<TD?B
M?29],L-0@N&FAU 9M%CB8O-QGY4QNZ#)R..^* -BBO._&WB:WO\ P8-3T;5+
MB VNJP6UQL9H61O.59(Y <$8!Y!]?2NKTOQ1I6KZI<Z;:RS"[MT$K136[Q%H
MR<!UW@;ER,9'% &S17$?%B_O=)^']]J>G7D]I>6[Q>7)$Y'#2HI!'0\$]:T&
MM;1;^RCL_$5V;II@ZPF[\T2HO+@KSQMSSZD4 =/17,W/C[P_:MJ*-/<R/IS!
M;I(K.5VBXW9("YV@<[NGO4L7C?0)[ZPM8KMW%_@6LX@D\B5BNX*)<;=V.V<]
MNO% '0T5RM]\1?#.GO>I->3L]BX2Y2.TE<Q<9R0%^Z 1\W3D<U0\4ZJ9[_P3
M?:7J4QL[[4T0^1*1'/&T;L,@=>@ZT =I<VT-Y:RVMS$DL$R&.2-QD,I&""/3
M%1Z?:-8V:6IG>9(QMC:3EPHZ!C_$1Z]3WR<DT-0\3Z9ILES',\\AM$$EUY$#
MRB!2,@OM!QQSCKCG&*;-XLT6&\TNU-TSOJHW6310NZ3#&>'4%>G/)Z4 ;54;
MK3([V_MKBY;S$M6\R&''RB3!&\^I )QV&2>3@ADNNZ=!>7EK-.T;V<"W%PSQ
ML$2-LX._&W^%N,YX-06?B?3+S56TL/-!>B'SUAN8'A+QYQO7<!D ]>X[XH V
M**PXO%VCRZA9V8GE1[X'[))) Z1W&!D['(P>.1SR.1FMR@ HK/O]9L]/N8[6
M0RRW4B-(EO!$TDA08!;"C@9(&3W..M9TWC?P]!H<>LO?_P"@22^2)!$YVR;M
MNUAC*'/!W8Q0!;\1:*VO:6+2._GL94FCGCGA ;#HP9<J>&&0,@U7LM%U1I8G
MUO64U!87$D<<-H(%+#HS?,Q)'48(&>U7-'URQUV*XEL&E9;>8P2>;"\9W  \
M!@"1@CGI6;8:H^O>*-4M8I'2PTAD@;RV*F:X9=S9(YP@*C'<DYZ"@#I**\V\
M-2S:AKWB^VU#7[^*'3[_ ,JV_P!+V^5&4![]<$]6S5_P-JFJ>*?#.I"[OI&:
MVU":VL=4B0)]IC0C9+M'RMSD'C:<4 =U16'X3U__ (2+04O)(UBNHI'MKJ)>
MB31L5<#VR,CV(J75/$NFZ0TZW#S.UO#Y]PL$+RF&/GYGV@X'!]S@XZ&@#7HK
M*?Q'IBP64L5P;G[='YMJENAD:5, E@ .@!')XY'J*IS>./#]OH$VM2WK+902
MF&8^0^^*0'!1TQN4Y('('4>M '0T5SA\<Z"NI2Z>UQ<+<K%YL:-:2C[0N<9B
M^7][R?X<Y[4G_">>'AX?FUM[R2.R@F-O,7MY \4H(!1TV[E.2.H[B@#I**Y_
M3_&FA:MK<FC6MX_VX1F1$DA>,2H."T;, ''N,^O2N8T'4DC\*>,FUO5]02TM
M]7O;?[6LCO-!$H4#:0"1M'3 XZT >CT5AKK^F6%KIMLL]S=2W-L);>-8VEFE
MC51EV &>XR3C)/K44OCCP[%I.G:H^H8LM1F6"VF\I]K.6VX;CY<$'.[&,'TH
M Z&N>\/^'+G1=8UJ_FOXK@:I<"X:-;<Q^6P4+@'><C"CMUJQI7BG2=8N;VVM
MII4GL@K3QW,#P,JMDA\. 2IP>:9;>+M'NM0L[))Y%DOD9[-I(71+D*,DHQ&&
MX(/N.1D4 ;E%85QXOT:UN(8YYY$CFN/LJ7)A?R#+G&SS,;<Y!'7&01G/%:6J
M:E:Z/IL^H7K.MM;H7E9(VD*J.IPH)P/I0!;HK#/B[1A-I,7GS[]73?8XM9<2
MC;NZ[<#Y>><<56\1Z]HPT76H;Z_O[*&T41W5S:Q2J\)90P*.%/."#D9QD9ZT
M =+17*WGC"WT[Q'HNA);WDPO+=YC/Y#R955&,8&2<L"3T'?K7/Z-XMMO#^J^
M,!K.H7\\%KJ0"$QR7'D1>4A).T'8@)/)P* /2JY[6?#ESJGB;0]8COXH%TII
M66%K<OYAD38<MO&..G'6MZ.:.:!)XG#Q.H=67D,",@CUKSW4?&+>(/!7C*6R
M&H:?-IBW202B)XF!BC!R6Q@-OS\N0<8XZT >BT5R?AOQ?I=U%HVDO<SMJ%Q9
M(Z/+#($G*H"^V0C:Y'4X)J_?>+]&TV3_ $J>1(!.+=[GR7,*2$XVM(!M'/&<
MX!X.#0!NT5'/%Y\#Q>8\>]2-\9PP^A[&N&\!>)$@^&7AZ^UF]FGNKTF)&?=+
M+/*7? '4DX!^@'H* .]HKGI?&^A0:+>:M-<S1VME.;>[S;2%X)!C(=0I(ZCG
M&.1S5MO$NF)K=KH[23K?741FAC-M)AD&,G=MVC&1G)XS0!K45D'Q+IHW@/.S
MK<FT6,6[[I)0"Q5 1\V "21P #SQ5O3M3MM5@>:V\S;'(T3B6)HV5EZ@A@#0
M!<HK+O\ Q!8:?<26[F>:>*(32Q6T#RM&ASAF"@XS@X'4X. <5SOC3QE%9^!5
MU71KAYA>M$EO<V\32*%>158Y (5L,< X.>.HQ0!VU%8>AZ;'9RW=_;WVJR6M
MV%9;2^:1O(9<ABHD^<;N.#Z<=:Y+5?&3^(/ ?B^XLAJ&G3::+E(9%C>)AY2C
MJ^,!MV?ESD#'O0!Z317+^'_%VEW9TS2#<S&_FLUDC:6&0)/M4;]DA&UR,\X)
MJW>>+]&T^55N9Y$A,_V8W/DN8%ESC:9,;0<\9S@'@G- &[14<\RV\#S.LC*@
MR1&A=C]% )/X5YQX:U6/Q!I:^)]0U?5-/DL[VXFE.9([9H%E9%B*L-C#:%S@
M;L^] 'I=%8]MXFTRXU'^SR\\%X83.D-Q;O$TD8ZLH8#=CN!R.XJEI_CWP[JE
MY#;6EY([2M*@<V\BHIB!+AF*@*0 3@X_44 =+16)!XMTB?4K6P\V:.:[1I+4
MS0/&MPJC)V,0 V!SCKCGI530]9T2/3M<U*'5[J:TM[Z9KN6^9@+9P%+1J& *
MHO&!ZDT =-16$OB_2/[2ATZ1[F&\FC$L4,EK(&="<;A\O3/7/3OBJ)^(_A@0
M&X^VS&W6X-M+,+279"X;;^\.W"#<<9;% '5T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QGQ7
MCEG^&FL6\$,LT\RHL<449=F/F*> !GH"?PKLZ* . UK4VF\9&T>SNX[2?2P;
M>ZL[1C)=N6;]TTH&45>#C*\G)(%8NG:9>7_P,TO[-:W$.KZ,B7=LDT+(WG0G
M=M (!.1N7T.:]9HH \MFT?6SXFM-12"98_%5N;;5(B?^/15^=,^C"'?'_O<]
MZT/&=E$_B#[5I^IWNB:W:V"FWNXXR\%RFY_W#K@JQ!&0.OS\ UZ%10!F>'I;
MVX\-:;+J-JMG>O:QF:!!@1/M&5 [8].U>;:9'<6WPFU7P5?V=P^NQI<VL</E
M,?M+2.S1RHV,%27!+9XP<XKURB@#SF_@DTSQ;\/+:8S3_P!G6UQ%=7"Q,R*3
M;J@+,!@;B#UKM=>@DN?#FIP0H7EEM)411U9BA %:-% 'D3W!N/ ?P\@6SOA)
M8ZCIXN5>TD4Q^4A$A(*YVJ?XNGO5K7=/N]9\4>-[.P2427VA16]O(494DD'F
M90.1C/S =>]>IT4 >=>&=1TCQ#=Z83X=U./6++YIOMT<P6R;;AB'<[3GH O)
MSR  <:'Q<_Y)9KW_ %R3_P!&+7:US^M>&YM=N98KO5)&T>98Q+I_DK@E'#Y#
M]1G !!SQTQ0!B:W<#1_BMIFJW<%R;*;29K-98+=Y<2^:CA2$!() .*XVX%P_
MPZURV?3K]9Y/$[3K"UJY9D^U*Y(P"&  .2"1Q7MM% '#_$-_.@\+O#'+,JZ[
M:7#>5$S[8U)+.<#@#(Y-8GBB&>WUO5]6\-75W;:TLD:3:9-"9+;5AL3!"D8S
MM.TLIXVG..M>IT4 >=Z7J$OAOXA>)8]9M;L)JSP7%C<16[S)(%C"&+*@X92.
MA^M<Q8).GPD\'6SV5ZD]OK,$DL36L@946X9R^,?=VD'/3FO:Z* /-HM7/A?Q
MQXC@UG3[Z>QUEXKBRN+>T>X67]TJ-$0H."-O /&#VJQJOFV/CCP;?OI=Q!:K
M9W5N8K: R"!V$>R,[ 0O (STX/.*]!HH \HU#2[[6[KXGV%@DJ3W\=N+5G1D
M6;; %958C!Y!4_6KVIR'QCI'A2TLK>XAO[74;6ZN8Y(61K,1 F3=D#!_A [Y
MXR*])HH \MC+?8/B<I@GS=O*;<&!_P!\#;!!LX^;YACBNW\'$_\ "%Z&K*Z.
MEA CJZE65@@!!!Y!!!K;HH \5O;K28X?%/AJ^NK^STR^U:660G2YYG +*TFR
M1 5VLRG!.2H/.>W407J:?\1VUV1VET'5]*ACM+Y%+QQLC$[&(^[N#%@3C)XZ
MUK:=X2U725-I9^*KQ=-WLZPR6T3RIN8L0)2.>2>2":Z:TM8;&TBM;==L42A%
M!.3@>I/4^] '!Z+X1_M70/&%M>QO!9Z]J$\UNCH59%( 67:>02R[@#SP*F\.
M6FN:YX/OIM6C:VUB6R?3(]YZ% R-)[;I,GW"K7>44 >6>$[K3=2M-&TG4/#>
MIC7=,>+S(KJ.7R;=X\ S*Y)0# )7')R ..:V? $JP7'B]IHY8A)KD]RC20LN
M^(I& RY'(RK=*[JB@#Q6&.9?@EI%F;2[%W'JB.T'V9_,4"[+DE<9 V\YKL%F
M7_A<LMWLE^R_\(^L7G^4WE[Q,SE=V,9VG.*[JB@#Q58YA\#H;+[)=_;!J@?[
M/]F?S /MOF9VXSC9SGTK<US6+;0?B#J-Y%)=0"^TR!99#I\MS$QRX1E\OD8&
M<@]<\8P:].KF)_"^I1:W>ZCI7B.XLUOG62XMY+=)TW*H4%"V"O"CC)'M0 [P
M$-'A\'6%GH=V]U9VB^1YDB,C[QRVY6 *G)S@CH17(ZY#<V>N:AJOAFYNX=4:
M]1+K1;B(O;ZARJ^8@(^4[<$NO V\XQFO2-.T]=/A=?-DGFE?S)IY<;I7P!DX
M  X &  , 5;H \Y-T='^('C!+FUO&.JVEJUEY5N[K-LB=6&X#:I!(^\1ZUSN
MB7%[X=TSP)KUSINH/IUIITMA>HMJYDMF?81)LQDJ=H&0.E>T44 >:>-+F/5/
M!+3Z?I-Q#'<ZI;3(HM&66<+*C/*R!=P& >6&2%SW%:8??\:(KE$E-NV@&$3"
M-MF\SA@N[&,[<G%=Q10!P7QC22Y^&VH6=O!-<7,[P^7##$TC-ME1CP >@!-:
M$NH^'H;JTN-/TQY-0\P16_DV$D9R_P IW-L 5.<DGT]<5UM% 'G%@^S7?B/*
M\,ZQW B,+&%L2@6X0[./F^;CC-91$B_#_P"'$!MKGSK34;%KB/R'W0JB,'+#
M&5 )&2?6O7** /-]$U73[#QSX^2]#$//;D((F?SA]G7Y%P/F;_9Z\UD6VC7G
MA_PO\.--O()OM%IJ?VBX5$9_(1A*?F(! "[U7->@:+X=FTG7M:U1[Y)_[5D2
M5XQ!L\LH@08.X\8 S[UOT >?:!<MX9\1>++/6HI]E]?-?VDPA:1;B-T5?+7
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M5LF]I(P 2P]%^8<G'4#J17!QI<>1\3 ;"_'VTN;8&SE_?YMPGR?+\WS#'%4
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MP!8 Y);&.V<UBZ)>P?V+\0=--K<7%Q<:Q?QQ01P,PF+JJA00,=>N3P.3@<T
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MG;_EM&C<RCV=1$/^V>>]<I)I&KZCX.\5QV-A=BZ3Q*^I0V\T#Q?:HED1QMW
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M6[7G'A6[L=8DTR&?P=>VNL61!GDO+5ECMF PS)(>#G'&WDYYX!KT>@ HHHH
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MG[PYH T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !6)KNOSZ4Z6]CH]YJUXR&0PVQ10B=-S,Y &3D =3
M@\<&MNJFH7T.G6S7$BLS'")&@R\K?PHH[D_XDX&30!1\,>)K+Q7I'V^SCFA*
M2M!/;W";9(95^\C#U''YULUA^%M$;1-.N//*?;;ZZEOKO8<J)9#D@>P "Y[[
M<]ZW* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KGM>\(6OB"_M
M[RXU'5K:2W0I&+*\: +GJ?E[GI70T4 9.A>'K;P_#.D%S?73S.'>:]N6GD.!
M@#<W.!SQ[GUK6HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>elicio2021employeestockp003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTK(& ZD%02#WQ70MK-KJWQ2T*_LHKJ>R;2KF,3_99 A8LAQRO XZGC/&<YH
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MF^M_9ZG<7VFPS3B>VPLS(CIY;$!AAR,$X(. 3UYK.\8&SO=$;1;B&.X;5O\
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MW=JISM::69L9)"J"Q]SVK0;QSX;338M0?4T2WEN?L@+QNK+-G!1E(RA!(SN
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MRQ16IMR2#)MW/OW]<+@<=":WZKWM];:=;&XNI-D>X*,*6+,3@* .223@ <T
M6**PH_&&B-'J;3736K:8H>\CN8VC>)2,AL$<@CH1G/UJ?3_$>GZCJ4FG1F:*
M]2!;CR+B%HV,3' <9'(SQ['KB@#6HK"3QAHKWEG;BY<"^D,5I.T3"*=Q_"CX
MP>AQV/;-<CX?\7VF@2^*_P"V]0OYXK;6I$5VCDN/L\.R/!8J#L3)/7 Z^] '
MI=%-1UDC61&#(PRK Y!'K7"^$=0G\?V][KEQ=W4&EFZ>"PM;69H<QH<>8[(0
MQ9CGC. !T[T =Y17#Z7XANM'\=:AX3U*>:\A6R&HV$[)OF,6=K1MM&7((.#C
M)'7)K'TG5V\065[KT]YKEO<Z?J<[HEM',(G@C?8L+)M*-D ;N-P.3QB@#U"B
MO.?"-\FH:)HWBN_U75H;IHO]*@(E\B[>7.U4C((."?E\L?G72/XXT**UU.>X
MN)H#IF#>12VT@DA!&0Q3&2I'((X]Z .BHKB=:\9>&M1\/:DLVJ:G9VL(A,MW
M:PS1NH<@H4<+R"1C(XYQGFMK4/%VCZ7JXTFYFF^WF SK!';2.SH"!\NU3N.3
MT&3U]* -RBL2V\7:)=>'SKD=YBQ#F)B\;*ZR!MNPH1NW;N-N,DTZU\4:7=ZR
M^CJ\\>I(H9K>2W<%5(R&)QMP<'G/48Z\4 ;-%<1\6+V]TKP'=:EIU[<6EW!+
M"$DA<CAI54@CH>">M5+W4=3\.?$SP]HMKJ5QJ%CJT4WVBUN2)'M]BY$JMC<
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M4D\D*1"./.=JJ@QR<9/? ]*I^/?$UQX;T>T33TC?5-3O(K"S$@RJR2'&YAW
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MRRB(2;BH5WVX0DC@-@]#T- '545A:GXOT?29;R.YFE/V%4>\>*%Y%MPWW2Y
M...?8<GBJNH^,8++Q;I>AI;7,HO())S/' [KM4# 7:#GE@2>@'UH Z>BL+4O
M%^CZ29&NYY4@AE$,URL#M#"YP '<# Y(!],\XJ;4]<L+:26Q>2Y><0^;(MI$
MTCQ1G(#G:#C.#CN<' .* ->BN/\ A9>W.H_#?2+N[NI;J>42EIIG+,_[UP"2
M?;%9-QXAMI?B-J>@^(-4N]+PL1TE4N&MXYE*Y9MXP'??D8;(XP!G- 'HU%<W
M;:E_PBNC6L7B/49YYIKQ[>.Z:$L9-\K>4&V#"DJ5'85;N]8L;J_O= 2YGBU%
M+0W!549"(R=H=7Q@\\<&@#9HKS7P)\0-*C\)^'+35]2N&O[R)8S<SQR-&\I)
MPAF(V[_;-=G=>)=.M)YHG,[B"5(9I(H'=(Y&V[58@<'YE]AD9Q0!KT5@6UYI
MLWCB\MXM0O6U&*R3S;-BX@1-YPZ@C!8DD9!/ KE_'WBB&71+&32KV_CW:I;P
MI<6ZND4W[T*Z[P,,,!N^#@XS0!Z/17/Q7NF2>.KBW74;W^T8K &2S8N+=8]_
M$@!&TL2<9!/ Q3K+QCHM_=V-O!/)_I^_['*T+K'<;!EMC$8/ )]QR,T ;U%<
MRGC[P]+?FRCN;AYUN_L;JMI*=DN,X;Y?E'H3P><=#1H&L:+'HE[?VNJ7EU:"
M^E5Y+O>SK*7P8D4@-@,0JJ![#- '345AP^+M'E?4(Y+A[:;3HQ-=17,31ND9
M&0^".5..HSZ=:MV.LVU_>2V:1W,5Q%&LK)/ T?R,2 02,'[IZ=,<XH T:**Y
MBTUK1;?6/$MTNIW\CV8A:^@E61H[4!#CRTV]P"QVYSP: .GHKF[+QYX?U"ZT
MV"WN9C_:2[K65K:18I#MW; Y7;NQ_#G(Z=>*Z2@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?6%__;UL)T*+:2.+C?*7$JN 00=W7/4?2O9=/E$VFVT@21 T2G;(A1AQT*D
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MVLA;&)L.WF964-C!3&&W9P,'O70:@KVGQ(\((XGF2SL+F&>Y$+% S+&%W-C
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MTR,]:P-/NI+G7O &I_8]4;R5N([I!8210VKM!M$21[0%4-D9YX'+<5[ NX(
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M;.Z,T6U(PH&<@!<CU)H 9+XOM=&L/"-KI]O?WEMJJQK%/(K2/Y7E%@6/5G(
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M+2\#P0),;EX<0N&)&U7[L,<BM&@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#T#PXVC/+/=:K>Z
MK=N-@N+QE+)'DD(H4  9/)ZG ] !N44 %%%% !5+6-+M];T>[TNZ:5;>ZB:*
M0Q/M8 C'!J[10!SEIX9OU40ZGXDO]2LUP/(EBA3>!T#LB!F'KR,]\CBNCHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJG?Z;!J*PF3<DL$GFP3)P\3X(R#]"00>""0:N44 (,X&3DU4ETZ&XU&"\G)D
M:WR8$/W8V(P6 _O8)&>P) QDYN44 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;V 7QLPQ,RQ^:X X122 6/;)!QZX/H: +%%5(M1AGTW[?"LDEN4WH50Y=>Q
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MVJ7"R:=,()_.C*?,5#< \XP1V% &M1110 4444 %%%% !1110 4444 %%%%
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M/TOPQHD\,5A#8-<W<1A4I$JA@N3C*J,*3C'& .2*XVW^)?C>[\#Z?>0W5O\
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M4D C:.2<9Q@ XJXU[Q6?"OB[5TUY8Y-"U*YCA1;./$J1[3L?(/&">F#DGD\
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MZ,?[6F\W3;O[:9I8@[W$V""7Q@ 88C  P, 8 % &9>W/B'PMK7AH:GX@DO\
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M& OF-D[MF3@ +R!G.*;<_#3S],U+34\07L=C=WWV^*(11GR93()#\Q&6&X<
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M<IUP ,?=QT%6].\4:C?6G@/2WNV2ZUNP-U=W:JN\A(58A01@%F8<XX .,<$
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MW1]S27$OE11KC+-@L>O'"JQ/TH R!X:DNM7L=0U;47OFT]F>UB$*QHKD;=[
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MO:ZK<V6KV4'V8W42(1/"3DHZ$$$9Y'H:ZFLGQ+KT/AG0+O6+FVN+B"U3?(D
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M' ;9W5 Z31$YVNIZX/((((JO=>"[6X\+ZEHBW<\8U-Y)+VZ"J9)6?[QZ8'&
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M 8'_  C3?\);_P )'_:$GVK[#]A\KRU\O9NWY]<[N>OM7):_H:>%_#%MI?\
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MN%/*L>Y!&>XJU?\ A6RUC1;W3=6DEO1>H%FE<A6X.5VX "[3R,#KR<\UNT4
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M<,]S<S6[)$JH-Q*O@!BWW,#^^W84 =!X9%X^BQW5]-,\UTS7"I+C,*.24CX
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M ,6XN_&.B^'+5M5BGU)+>_=;LZ:P:Z:TVDQL0 /F!*[MN"0/<UTW@[4[75]
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MW' XY SC!YK;TF_OM-^)-]X9DN)KK3Y--74;9IV+O ?,\MH]YY8$\C))'/-
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M037OMVW[-]@FW[O]PX_'.,>^*X/P=J.KW.D^%O#<N]6_L+[;(INFMWD7>$C
M=5+ *N#@8SD<X&" >M52U6]GT^Q-Q;:?/?R!T7R("H8@L 3\Q P <_A7#7#>
M,=%\.P+?B36%MM1<W,>FSG[4]GL)0;L(2ZL5)VX) '/)JIJ_B%I?AHVKZ!K]
MZX34HH]T@Q*@:=%:&3<-P*AL=CT.3GD ]1HKC-:U.5/'D6FZG>26&BR:8\L,
MR3&$27 ?# N".50@A<X.2><<<L]_XK@^'>A:A>ZUJ$6HW6KP1/YD4:[H6GVK
ME0@(!3:V,YYY]* /7**X&VN=0T?QYK.D-K<\UJVBKJ*2Z@RL+>7S'0MP  F
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M-LTZJ?0D #KZ5NA_$6@^,-1T"RUBXU)+S1IKVR;4"K-;W"L% +  ;"6'!'%
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MMDD$S$J2R%,X(/ '\Q7HE9FLZM-ID2"UTRZU*ZDR4M[8HIP.I+.0H'([Y.>
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M C Q@8P,8P,5KSP)IM[HESI;W5XD=U>?;KF6-D#S3;@P8_+@<JO  Z"NHHH
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MD!1. "<\@@5ZE10!D6FA0PW\VIO>7%S?S0"!;F4)NCCSG:@"A1R<G@Y.,\
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M,XN$7S$W!P_F#YMN<;^?_K4 0"XO3\7;G3?[1NOL<FA"=8=PVQR&;;N48QG
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MALXX+;4-'#R>>,EF$@B4X(.,?*,\G)XQU?A&TOK2QN%N;S4KFV:7=:G4]IN
MFT9W8 XSG /([^@ ,NTNY/$WC3Q-I5Q=7=O;Z2MO##';7#PMND0NTA*D$GH
M#Q\O3FN-UR^O==^#.HOJT\TEYINIBQ,Z.8Q<!+J--[*I )Q^H)&*],N_"]K/
MKAUJVNKJPU!X1!-+:LO[Y!R ZNK D=CC(]:@U#P7I6H>&4\/;KBWTX,'9()
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MW([J_7)[YSGKUI9_ NCWGAR71;XW=Y'*XE>ZN+AGN#(/NOYG4$8 &. .,8H
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MI5I+-);6R[(O.8,RKV&0!D?6@#E?$"ZA=_$S2])BUJ_M+&[TVXDEBMW"\JR
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MH/ _*LK1([BT\9^*]!74M0DLEM+:XA\^Y>5X7<.&VNQ) .T'';M7.37ES?\
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MI=):7;PQW2J, 2*I&[CCW[U9U+Q*]AXH\/Z0MD)(=7,P%SYN/+\N(R?=QSG
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MWD-T,8&,?_7_ !K2HH YG1/!&E^'H95M9M2N/W+0Q"YO'D,$9ZI%DX3H.G/
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MY;Y6/?D%EZKSV/M6YI&O1^);*V\06(F,%AIIE:!97VM<,N?+8 _,4"GKG_6
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M2\\#:)>:I>:ALNH)KZ/R[M;:ZDB2X&, NJD G'_U\T +\/O^2<^&O^P9;_\
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MMD,6B7-PTJVXQCY QZXX!.2!D X)I%\)Z8LN6-S)!]K-Z+:2=FB$Y<OO /\
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M$GS1$9P4ZILZ>V:UH-.77/B5JEGJ,M\+:71K:>2T%W(JK(SN"!AL@<=!@>U
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MAY3;6)WXYXR,=^U=&;>+7_$-EK$A4:=IF_[(Y/$\SC89!_L@$JI_B+$C@ D
MGU7Q*=+\3:)HYT^5QJDDB+<[U"(4C+GCDD\>@'O6]7%>+O\ D?/ G_7Y<_\
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MI+Q)-%/*8S.SJ'*HW1<*1R<Y)QQC)W=(DU*72X7U>WMX+\Y\V.WD+HO)Q@D
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M Y94)*YY.".!GC%=+H.I3:OI$=Y<V;6<QDEC>W9@Q0I(R8R.#]VM*@#FM4\
M^&]9UK^U[S3]UZ5"2/',\8F4=!(JD!Q]<\<=*T#X<TPZ_'KGDRC4(X?LZ2+/
M(%$><[-@;;C/.,5JD@ DG %9,VIW.H>'QJ'AQ;:\ED(,'GR%(W7?ACN )Z9(
M]>* '1>'M-@UZ?6TBE&H3QB*60SR$,@Z+M+;<#)[=ZJV?@[1+!HQ;VLBP13?
M:(K4SN8(Y,YW+&3M')R,# /(P:WJ* ,&]\':)?ZTVKRV\L=[)&(II(+B2(3H
M.BR!& <?7/ITJ]HFB:?X=TJ'3-+A,-I",(AD9\?BQ)K0J&[FD@M998H&GD1<
MK$K!2Q],G@4 95UX3TB[U"YOFAFBGNT$=UY%Q)$MPH&!O"D!N.,]<<=*DU+P
MQI&K1V$=W;/Y=A(DMJD,SQ+$Z?=("$#([>E,\):__P )1X6L-;^S?9OM:%Q#
MOW;!N(QG ST]*UIYXK6WEN)Y%CAB4N[L<!5 R2: 'HH1%4$D 8&22?S/6EKE
M= \9G7-&U?41IEQ&;&^DLX[;_EK*5"[<@XVL2P&#T[GK5>P\8:M%XJL]"\0Z
M"FG/J*2/93P78G1R@W,C?*NU@.?0T =E17/ZCXDDT_QAHNA'3V:/4Q,1=&0
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M5H96OK:,Q13-<2$JIZCEL'.!G/7O5)_ WAN2SO;-M,7[-?2F6XB65PKL3N/
M;@9YP,#/.* .?-C%HGQ7T5;)YE&HZ=<_:]\S/YS(8RK')ZC)Y]#CI6=X;GGT
MGQ%HNG>(-.7[7,TAL==LWW1:CE&/[WN'*_-SGD<8%=ZWAS2WU.TU)X97O+1#
M'!*UQ(2BGJ.6P<X&<]<<TS3_  MI&F-:FUMI +0$6R27$DBP9&#L5F(7C(X[
M$CO0!KJRN,JP89QD'-<- \6O_$SQ#I&L1+-:V%G;&SMI1E&$@8R2 =VSM7=V
MQQC)K<\*^&;;PQ:7D%I$L$5S=-<"!)&=8R54$ MR<[<GIR<=JM:AX>TS4[^&
M_N('6\A0QI<03/#($/52R$$KWP>* /)YGOY_"MM9W-[>%-/\9)IUK<"=@[VX
MF &XY^8CD9.?NUZYH^B6.@V;VFGI(D+RM,5>5I#N8Y."Q)Q[56N_"NBWNGVE
MA-9?Z+:2"6"*.5XPC@Y#?*1EL\Y/.236PJA5"C. ,<G)_.@#RYIYM&\2PC7M
M.6ZLKO5R;'7K-]S*S2$)!.O4*/N=UX'&1FHAM3PE\4(R2%MKNZ: ;O\ 5$6Z
M,NW^[@\C%=_#X6T>"<2I;2'%P;H1O<2-&)B2Q<(6*@Y)/3@\]:KWO@CP[J%]
M>WEUIP>:^C\NY_>N%E&W;DJ&V[L<!L9'K0!RVF7L>I^*?#^A:J5FLV\-Q7<,
M$W*7$Q(#%@>&*J,@'.,DU7\3:1;:9HOA;2;;4;NZAA\46\?F2RY>('>=@8#H
MH.!W'X5V&H^!O#>JZ=96%WI<;6]C_P >NQV1H?\ ==2&'0=^U3S^$]$N+.PL
MWL=MOI\@FM8XY701R#HXVD9;D\GGD^M '.^%[6+2/B7XETNRWI8FTM;D0M(S
M!9&+AF&2<$X&?7%3^);UIOB%X9T*Z'_$LNXKF9XV^Y<2HHVHWJ "6P>"<>E=
M';Z#IUMK,^KQ0N+^=!'+*9G.Y1T!!.,#MQQ3]5T73];ABCU"W\WR9!+"ZNR/
M$XZ,KJ0RGW!H \N\06QMH/B/H2IYFC0:4M[;PMREK,T;DJGH"5W = >F*O:O
MIUJMO\.;6%#!%+>(7\EBA)-LV>1R"?4<UZ#%H6F16-W9?90\-X&%SYK-(T^5
MVG>S$EOEXY/3BJ,?@O0(HK"..R=5T]]]KBXE!C;&,YW9)QQDYXXZ4 >?7EY-
MX3A^)%OI,DL%K9&RDA0,S_9_.0"5UR<CC+=>HKJ+'PPD/B#3]6MM:M8K2ZMW
M@>UL8'C6^!4LKEO-/S#&=_4CC/-='%X;TB&]U"\6TW3:BH2\,DCNLZ@8 96)
M! !(Z=.*IZ)X&\.>'&G?2=-%J\RE&99I"RJ3DA26)09Y^7'0>E ',_"?1+27
MPII.O3/<S:B%N81+)<.PV&=^-N<'IGD9R35CQE9+>_$3P;:R3W2070O4FCBN
M'0.JPY P#QU(R,'!ZUU^C:'IWA^P%CI<!@M58LL7F,X4DY.-Q.,DD\>M<QXL
MT>ZU7QQX4N%T^ZFL;%KEKF>&3R_++QA4((8-U':@#C;VXNO!3>--,TRZGBT:
MWDT]XV=VD^Q+.X68*<[L;<G@@C(.1UKK4\+"SU=]0AUFWAM;VP>)K'3X'A2X
M(&X2AA*<,/[PZ@XSS75Q:#ID5A=67V1)(+LL;E9B9#,2,$N6)+< #D] !VK/
MT?P-X<T""YATO3OLZW">7(5FD+;/[JL6RH]@10!PGA_0;1O@VVOM+>G5)- F
M5KC[7(#@ L. V!@@=O7.<G-RQOGN;SX=Z'>$G3KO1S.Z.?EN94A3"M_> !9L
M'@G![5W4'AG2+7P^V@PVS)IC(8S;B:3&P]5!W9 // ..:9-X5T:?2[/39+0F
MVLBK6N)G#P%>%*.#N7 XX/3B@#S7Q!J^I>#_ /A.K/2I9(].MX;.6WP219-.
MVR39Z#&7 Z ]*W-7T?3-.^(O@*;3H4C#O=J70Y\T?9R0S'^)O]H\G/6NVBT'
M3(K&ZLOLBR07>?M(F)E,^1@[V8DMP .3T %9=IX!\,V4ME)#IQ+V+$VIEN)9
M/)R,$+N8X&.W2@"7QG:W][X?-OI<UNEX9XF2*Y8B.XVL&,3$<X8*1^G2O-M?
MU&"Y^'/BV./3KS0=6LY[9KJR6;"1,S(H,90A61E!XQC.3CO7KNI:79ZO:K;W
ML;/&LBR+MD9"KJ<JP92""#Z&N1\?>&6G\!ZQIVBZ=-=WVH-$7S+O>3:Z'YGD
M;H%4@#/TH S]3TC_ (1?XC^'+K19+IGU3[3%J$,EP\@N D>\.=Q."&QR/4"J
M.@:=-XH\)Z+XG&OVEG?QS+<7%Y':,9BX;#P.WF\J2=NW&,8P.E>B:=HMA:S)
M?16\XN/*\M6N9GE>-#@E1N8[1D#('7 ]!5"#P'X8M=??6X-(A2_>3S2X9MN_
M^_LSMW>^,T <SIEK9^-;7Q6NJW4D%_::K-;I<(X66QCC(\LQD_<! W$CKELU
M=? ^+VCM'<3R1S:',QWR-AL/& VT\ D'G %;=]X&\-:EK?\ ;-WI,4E\<!Y-
MS 28Z;U!VOCC[P/2K\N@Z=-KD6LO YU"*,Q),)G&U#U7;G&#Z8H XWP;HNG#
MQCXU5;54\J]BCC:,E616MTR 0<CJ>E<]H>JW$'PZ\#6LUXL5MJ&HS075Q<[G
M5OFF*(_S D,X4'GG&#D9!]/L_#6E:?=7MS:PS13WIW7+BYE)D.,9.6ZX[]JK
MCP9X>_X1QO#S:;&^DL2?LTCLRJ2<Y4DY7DD\$<F@#A_$MO>^ ]!\1W=GK2+'
M>&V(M+:W,2:>KN(WE3+MMW GTY&1TK1U71]-TSXG^!9-/MTA$B7JL8SQ(! ,
M,?[S<GYCR>YKJM.\(:!I>CW&DVNFQ"RN01/'(3)YHQCYBQ)/'J>.U5K/P%X;
ML9[&:'3V,EAN^RM+<2R^2",$+N8X&!TZ#\: *GQ14GX::ZZR2QO';,ZM%(R'
M(^A&1['BL?6+&.\^(/@^WEEN?(N=.NO.B2X=5?:L>. >/O'.,9[Y%=UJNDV6
MMZ=+I^HPF:TE&)(][*&'H=I!(]JJGPSI1O[&^,$INK&,QVTAN9"8U/4?>YS@
M9SUQ0!S_ ,-U^S1>)=.C9_LMCK<\%M&SEO*CVHVT9[ L?SK7\>?\D]\2?]@R
MY_\ 1;5?TO0M.T:6[DL(7B>[E,TY,SOYCGJQW$\\#GVJ;4],M-8T^6POHVEM
M9E*R1B1D#J1@@[2"0?2@#&\*0K<?#;0XG+A7TFW!*.4/^J7H001^%><:7"NC
M_!:U\713W?\ :S6:6\MVT\C;(7N%#D+NQE5)((P>^<\UZ[::/96&DKI=JDD=
MFB>6D8F?*+C "MG( '3!XJ&P\.Z3IFBG1K6S4::59#;2,TB;6ZKAB>#D\=.:
M .630XM&U5?$">(+2RL)+&598;&U*).H0N)N9&!90,[L'(XSS6'I(-GXH\ 2
MV<;PVU_;W*O/))F>^3R X><#C).&'+$9[=*[C1O WAKP^ERFFZ5%$MPABD#N
MTF4/5!N)PI[@8%1VW@#PO9FR,.DH#8N7MBTKN8\C& 2Q^7_9/'M0!R-K--H_
MB6PB\0::MQ!=ZDYT_7[1]WFM(7V0SCJ.&VCJORKCIFJ<AV?#CXDC>1]EU2]^
MS_,?W.$0KM_NXSQCUKT>V\+:/:2Q/%;28BF,\<;W$CQI(<Y=49BH/).0.YJK
M=^!?#=_=7]S<Z:KO?KBY'FN$DXQNVAMH;'&X#/O0!R-_I<&L>.O#5G>2W3VM
MWH4QGB6Y=5DQY8'0\=>V,]\U-J*6?PX\86>J%91HE_9FS?<S2&&XC7<A&23F
M15*GN6 )Y-=C'X5T6&_LKZ*T:.XLHO)MV6:0"-.Z@;L8/?CGO6?>Q:GK^N#3
M;W0U@TBRNH[D7DDZ/]I*?,@5!RI#X))[*1WH TO#6F-I>B0Q3(JW4I:>Y"]!
M*YW,H_V03M'L!7":K!K$_P 7M;70KR*UU$>'8S"TL0=2WFM@'/3GO7J59,?A
MK2HM>?6TMY!J4B>6\_VB0EDSG:1NQMSVQB@#B/"U]:Z=\+=?U+1X9TUR%+F?
M48[IM\XOE0EM_ SR 1@ 8[=:L:-H0N3X;\36>O6L*E5\QX+9M]^'4 I*QE.Y
ML\Y()!!Z8KL4\.:3'K4^L1VGEW]PH6>2.1E$H P-Z@[6P/4&J.D>!/#.@:E)
MJ.EZ3%;W+%B"&8JA/7:I)5,]/E XXH X2\TW5=7T'7K-(KF3Q*=986FH1;@J
MQ^8N,3+PJ+'N4ID$$$8R:Z*"VBM/C"ME%O\ LS>'"6C=V<.1.JY;<3N..,G)
MQ6!9^#UGEE_M?P-??VO--)++>V6J"*U=V8G>-LJLHY_N$_4UW!\':;>V^E-J
M\;7M_I\ A%T975WX ;<5(W D9(;(- 'F]Y(9/@7XC!D9U35I43+9PHO%  ]@
M*ZSQ-%::GXEU&U53?W-OI.9+>X8+;V@8L1(."?-;'&!P%ZC(K=/@?PX=(N=*
M&F(MC<S&>:%9'42/NW9.#GKSCH*FNO"&@WVI1ZC=6"S7:0^1YCR.=\?7:XSA
MQ_O9H \WCABUC2?A5=ZB@NKB9Q')++\S./(<X)/7D _A6]---I7Q'\22V0DE
M:'PZEQ# TC.N\-)@*"> =H&!72CP1X;72+32ETQ%L[283P()'!1QQN#9W=#C
MKTXZ5=@\/:7;:R^KPVQ2^>(0&02OCRQT7;G;@=ACB@#S._)3X.:7XPTV9F\0
MQI;7/VM6S)<2O(JR1N?XE)9EVG@8  XK6AT.TUGXD>+[+4#<S6ILK-_(-S)M
M#,),GKV[#H/3I776OA'0[*826]D419OM"P><YA23.=ZQ$[ <\Y Z\]:F7PYI
M::G>:DD,JWEX@2XE6XD!=1T'WL#&3C'3/% &/\,;NXOOAKH5Q=3/-,;;:TCG
M+':Q49/?@"LO7/!QU;6[SQ#X0UJ32/$$+^1<D?-!<,J@A94^A7GTQQ79Z1H]
MAH.FQZ?IL!@M(\[(M[,%R<X&XG ]JIR^%-(EO+F[6*X@N+IMT\EK=RP&4XP-
MVQAG@8&>E ' ?\)EJ&L:'X>CU-+?3'GUJ73=28J6@:2-7PO##*NX7(W=B#D9
MR_Q%:W7@;2=;N8-:1+6]FM#):6D#0K81M((Y)$^=MNX9Z8Y&1TKO[CPMH=WX
M?_L&?3+=]+QC[.1P.<Y!ZYSSG.<\YJ/3O"&@:7H]QI-KIL0LKD$3QR$R>:,8
M^8L23QZGB@#-N/#.BV]]<W-O)LBO=.>%]/C(\B<*=WFE0.6&0-V>0P!ZUP+V
M<%M^SE8W5L&@G,5J[/#(R%B9D4[L'G@D8->H:#X1T+PS'(FD6"VXD 5BSM(=
MHZ+EB2%]AQ4 \"^&UT5]'73 NGNX=H%FD )!W ?>S@'D#H#T% &0TR:U\4]1
MT358EEL[33(IK6VE&4D+N0\FT\$C"J#VYQU-<9J#7P\(:K8R7EV8-+\416=C
M-Y[;O),L?R$Y^?;N(&[/Z5ZO?>'-,U&>UN+B&3[3:J5AN(YY(Y54]1O5@Q![
M@GFF77A71;S2XM-FLLV<4GG+$LKK^\SNW$@@LV[G)R<\]: .:TNRAT7XP7%C
M8F6.UNM$%U-&TK.'F$^T.=Q/S8.,UW<G^K;Z&LY?#^FIK:ZR(9#J"P_9Q,9Y
M"?+SG;@M@C//3KSUJ_/"EQ \,F_8XP=CE#^!!!'X4 <A\)O^26Z#_P!<&_\
M0VJ?Q5=:J;^PAM= N]5TP#SYOLTT2[W!&Q6WNORC[QQU(7MD'9T[P_IFE:.=
M(LK8QV!5D\@R.RA6SD#).!R>E6-+TRST;3+?3=/A\FTMD$<4>XMM4=LDDG\:
M .#^%VI7<\_BI;G2;BSB.M74[RRR1E4<[,QG:Q.X=2>GO71Q6\6L^(+7Q!<%
M4L[)'AT[?QYCR8#2_0@!5]02>XJ])X9T>33M0T]K,"UU&9I[N-9'7S7;&XD@
MYYP,@<5G:;\//"FDZC!?V6D)%=0$M%(99&VG!&<,Q'0F@"CXF_Y*=X%_[?\
M_P!$BM76M8\06%\L.E^%I-4@*!C.M]%#ALG*[6Y].?>KMYH&FZAJEIJ=S#(]
MY:;OL\@GD7R]PPV & Y'!XYK3H !THHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDK.D3-&GF.
M!\JYQD_6GT4 8'@[Q#+XH\/KJ<UH+1S/-"81)OV[)&3K@9^[Z56O_%-Q_P (
MYK6MZ5;P3VNGQ3F)I7(%PT0.\@@'Y0591_>(/08)Q/ LD\/PMU*6VS]H2;46
MBQUW"63'ZU#HZHO[.I\OH?#\Q/\ O&)B?US0!W6B7TFIZ#IU_*JK)=6L4SJG
M0%E!('MS4-AJ_GZK=Z3=*L=_;(LN%/RRQ,2%D7VR"".Q'<$$^>6FFVNEZE\-
M-0M$:.[O(O(N9=Y+3(;4MM;)Y (! Z#'&*U?%4MS;?%309+#)GDTF_60#NJA
M63/_  /% '3P^(/MD.H7EG;M<6=H[P)Y?+W,RG!"=@ WRY/4YZ 9./:^+==L
M_%6GZ-XCT2VM(]4#_8[BSNC,H=%W&-\JN#CN./Z+\*FC3X6:"^X;?LQ=V)[E
MF+$GZYJ[&EOK&O6>O7,B)968:/3@YQYLDF%,O/8CY4'?<3W% &C8ZOYNKW6D
M72K'?0(LRA3\LT+$@.OX@@CL?4$$ZM<+KS21?&+P@8,YFLKZ.?'>,*C#/MNQ
M7;Q31SQB2&1)$.0&1@1QP>10 ^BO*_&B66H?\)R]NGVJZL=-7SI;MAMLF$3.
M@MP!G<<AB<@9V]<8IUS:Q:KXK^'IO'EE^UZ7<&X!F;$N(8CS@_[1SZY.<YH
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MJ+6DL=GJ]BP:'4$ 5F,G\0DPH;)SDEL=>=/XHVZS:9H1+RHW]N6: QR,O#2
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M(;6&TULLN-@E10)B.Q5\ GKAL=J /4J*P?"EFJ:?-JC0"*XU68WD@VX(5O\
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M>9R50SN"N,X(XSR.I)[U<\;64.H>// ]I<AC#++>AU5RI8?9SQD$'!Z'U'%
M'>T5Y;IOA&SDU_QCX1MA(F@O;02Q1[BPL[APV3'D\'A6Q].QJSX1NO\ A)5T
MC2;ZTC2Z\-EQJ*;.!<)F./'LPW2<=U6@#TFBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM5BM0E\T8B:4.W*#HN,XVCL,8%6;^PM=4L9;*]A6:VE&'C;HPSG^E6"0HR2
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MUK7#J6*AAD=1GI5:^:[?3+AM+:V-X8F^SM/DQ;\<;MO.W/7% %#3_">A:5J
MU"STV)+P1"'[0Q+R;!GC<Q)[]>OY59UK0M+\1:>UAJ]E%>6K$-Y<@Z$="#U!
M]Q5NW:7[-#]I:+SR@W^7G:6QSMSSCK^%2*RNNY6#*>X.10!BQ^$= AT!M"CT
MR)-,8Y>W4L%<_P"T<Y;MU)Z"IKGPUHUXU@UU81SMI^?LK2$L8\X!&2<D<#@Y
MZ"M$W$*PO,98Q$@)9RPVJ!U)-5],U.UU?2[?4;-]UM<)YD;GC*GH: *0\*:*
ML-_$+,^7J!)O%\Y\3D\'=\W.1Q].*AU'P5X<U?3+33M0TJ&XM;,8MU=FS$/1
M6SN X'&<<#TK>1UD4,C!E/0@Y%<UJ?B&\L_''A_1H4M7LM2%SYKY)D1HD#8'
M.!U'K0!=F\*:'/:6-JVGQK;V#![6.-F186'1E"D88<\]>36R!@ 44U71QE&5
M@#C(.: ,C_A%-#^US7(L$5IY?.FC5V$4LF<[VC!V,V><D9SS5'78=8UJ_DT%
M]'A&A3+&9]0DN5.]0V7C$6,Y(&,YP 2>HQ72^8F0-ZY)( SUQUI6940N[!54
M9))P * %K)NO#6DWMU<7,]J6DN5"W $KJLR@8 =0=K#'&"".OK6)XA\9R6WA
M>QUW0Q;W%M<WL4&^;."CRB/<H!Y]1D^E=@&5B0&!(.#@]* ,ZXT#2;K5;;5)
M["%[ZU3RX9BO*KG./< \C/0\BLU? 'A18O+&A6GEB<7 7:2%<$G(&>!R>!Q[
M5T0="Y0,I8<E<\BHKV[BL+&XO)B1%!&TKXZX49/\J *D>@:3%K4NL)80KJ$J
M!'G"_,P P/;..,]<<=*S8O 'A6&-(TT2V\M)Q<(C995<9Q@$X Y)VCCVK.M-
M5\9:M9:3JFFQZ&-/U"WCN'6Y$BO;*VUMN02')4D9PO(]*[-G5/O,!QGDT 9Z
MZ!I*:T^L+80C4'C$;3A>2H&![=#C/7''2J6D^"?#6A:G+J6F:-:VMW)G,D:G
MC/7:.BY]@*W2Z!]A=0V,XSS5.UU:RO=2O;"WF$D]EL$X4Y",P)"_7 S^(H F
MOK&UU*RFLKZWCN+:9=LD4JAE8>XJK9:!ING!_LT,@=XQ$97G=Y @Z*'9BRJ.
MP! %:)(4$D@ =2:YO0_$%[J7C#Q'I%Q';"WTU;5K=X<DN)5=CN)./X1T'K0!
MK:1HNG:%:&TTRV%O;EB_EJS%03R2 2<9/-&J:)IVLK"+^U65H'WPR!BDD3>J
M.I#*?H15U9$?.QU;!P<'.#3LCUH QKR&;0-$G?P_HZWUUO#_ &8W B:9B0&9
MI'SEL<Y;DXQ2^'].FM(;J\O88HM0U"?[1<K$=P0[0JINP,[4503W.3WK8HH
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M27T,9CCN&3YT4]@>O<_3- 'C-QIEDOPDU;6Q O\ :=GK,KVUT>7A(O0/D/\
M#G)SCK7672Q>(?'GB?0M3N+!2EO MK#>6WF$P-'EVCRXP=Y;) SPOH*[#_A$
M?#_]FR:;_95O]AED\R2WP?+9LYR5Z$YY^M)JWA#P]KQMCJND6MXUL-L33)N9
M1Z9ZD>QH ?X6MDLO#%A:QZC)J,<$?EI=R?>E4$@'W&!P>XY[UYMIEG;^+O"=
MS>:AK%K8ZI:7\DES<);?Z9:S)*< .7S]T!0,?=. *]?CC2*-8XT5$0!551@
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MQN;!(S@<'%<_+_R03Q9_U^7O_I0:].M/"7A^QGMY[72+2&:WC:**1(P&13U
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MS0P>&I?#>@_VS%<:-+J%TC2W4.ZWCEV!HX<;@"H+/@$G# #JO$/C/P[9:/\
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MLK]X%MH[:&;SO*0$LQ+X&2S8X' "KSG- '0(B1QK'&JJB@!548  [ 4ZBB@
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M78=P[V@*QX#' &23D# /N#5N&>&YC\R"6.5,XW(P89^HKQ72[DV/PO\ !T#
M+I,WB!X;[^[Y7VF;:K?[!8+G/'8]:Z/Q&MYH?CZ>Y\.PA99O#]U/=01+\K21
M_P"I<J.-Q8[0>I ([4 =#XR\276A1:>=/DLWDEU&WMKB*7+.L<CA<@ C!Y[Y
MKJJ\:ODTFZ^%_@C4H?(EG.IZ>[W)P9&F9QYQ9NI8MNS]/:O7HKZTFNYK2*Z@
MDN8 #+"D@+Q@\C<.HSVS0!+)(D4;22.J(HR68X 'UI$FBDB$J2(T9&0ZL""/
M7-<5XHN6'Q&\(V-X =+G%RP5QE'N50; W;(&XKGN?45S&OZ>MO/\2[&"%#I
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M#TNHHKF"=&>&>.15.&*." ??%<?\4+V:Q\+6S@LMB^HVT>HL.,6ID'F9/H>
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MDO&N)T,BKM=45=H8<DL2>>@]\CD]=TS2+#2? 46DEIK6U\0P06\\C[VV9ER
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M'EJ " #N.WTK9\8"ZL;S7M9CMK+7M DCC74[0D+<6@2,'?$QX(VL'QZG([T
M>G>;'EAYB_+][GI]:/-C"!S(FUB #N&"2< ?G7!Z>]G_ ,+<UF5UBCAN-"MI
MF\P!=R^8^6;/MC.:XJPL[.[^%_@#?'&V/$BQ!EX(1KB;*@CD \?I0![>EU;R
M8V3Q-DX&UP<GI3PZ,Y4.I8=0#R*\[\7>&--\*VNF^*-#TFW@?0KEKB>&"(#?
M;OD3 #U .X>F#BNE\+117:7GB$1*'U63S(WVX/V=1MB]^5&_GNYH Z&BBB@
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M@TN&PD9KB..%86:7YC( N"6]2>]<WXH\7SZ1K>BZ;86\<WVK48;6\E?.V%9
MQ"C!^^0I/L,9'S"K.O3^+WGF7P[!I21P*#G4 Y-P^,[5VD!1T&XYYSP,9(!J
MV.A:5ID@>QL+>W94\M/+0#8O7:O]T<#@8'%5!X.\-!IV_L'3LW$HFFS;K\[@
MY!/'///UJ'PWXCG\3>";37;6S2*YN(F/V>:0A5=6*L"P!.,J<<=,4[P3KMQX
ME\&Z;K-W'%'/=QEV2(':OS$8&23T% %G4/"^@ZK=6]UJ&CV-U/; "&26!6*
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MBTT'D+MD).<L,<G/.36G10!E0^&-"@T<Z1%I%DNG$[FM1 OEL?4KC!/UI_\
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MZ_N!I-C;6::/=6YCNKMYB)8@3A@B 8)*\ YX)SVP>ACC2&)(HU"1HH5548
MZ 4ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUO9QKR(D8@NW^\VU1[!<=S45KX?BL[S48TBAFTS4I&GN+:5<A96 #D C!5\
MD'H<GG=P 8PUW0-<UBTU*XU>P^QV4A^PPFX4M-,PV>9MSGH2J#&3N)[K4'C@
M.?&G@/R,^?\ VC+TZ^7Y)W_ABNC@\)^&[6XCN+?P_I4,T;!DDCLXU96'0@@9
M!IRZ0;CQ$NL7FUI+:)X+.->1&K$%W/\ M-M4>P&.YH O6M]:7OG?9+J&?R)3
M#+Y4@;RY!U5L="/0U8JO:V%G8F<VEK#;^?*TTWE1A?,D/5FQU8XZFK% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKI;8M'=;H[EB0I",4'() (QWZT_3?B:]_P")O#VBG0IHGU>T-R9O/!$6$+$
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M '>,\@ CW(SQHQZ/JD/Q';6S")K(:.MAO,BB1Y!(7W;>!@YQ]>V*ZZB@#E_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ;I(7GNHV)[J(&('Y\UER:+9ZMXM^(T=WYK1Q0VC(B2L@#"V.&^4C)&.,]*
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MB;0+/6=/9C:W2;DWC# @D$$>H((_"N \.:=?ZIXA^(-I::DMC'-J(CD<0;Y
M#$ 2I+  X]0:LS:;;:%KOAKP1:20PZ2+"X>*.\0RK=3!UX8!EW'#.V.F3G'
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M;M_EEMN=W/3K@]14T/A[2K?7+C6HK0)J%P%$LH=L-@;0=N=N<<9QG'&:TZ*
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M6R%B?+B5AM49[#)KHSX=TPZG!J1@D-[!%Y,<QGD+*G=?O=#W]:DTO1-/T47
MT^ PBYE,TW[QFWR'JQR3R>Y[T <SXJ\):=XKUD26>HW&E>)--A1HKZV;#+&Y
M;:&&?F0E6XX[^IKE[GQ?XBM?"/B#3]<>%-0TB_M+:[U&V4A)()63,F!@AMA.
M<8QD8P:])O?#FE7^H'4)K9EO?+$7VF&9X9=@)(7>A!QDGC-26^@:5:Z9/IT=
MC$;2X+&>.0%_.+?>+ELEB>Y))H X?4M*F\-#4_$>CZG9)-)H\YBL+"TV17#(
MI99L;V!*\#=CD$#/-7]"T?0+S3_#'B"WNW2<P@>;$XW7S2)AEFX)D.06.>A!
M/&#6_H/@_P /^&!,-&TR&U\X8D()8D>F6)('MTIFD>"O#>@ZA+?Z7I%O:W,F
M<NF?ESUV@G"Y_P!D"@#@=$TK3X? 'C]H+6*WECOM52-X!Y;*B$E5!7!V@@<=
M*MV5V;B^^'>B7HW:9=:,9C&_*7$R0IM5AT; +-@]\'L*[?\ X1+0MVI,-.C4
MZEN^V%&9?-W?>S@\;N^.O?-/F\,:-/I=KILED#:V95K8>8X: KPI1P=RX' P
M1QQ0!YKKL$MA!\2-'M6E32+;34O+>)'95MIFC8LJ8/"G:&V]!Z<UI1:=;Z3X
MR\ 75F)$GU"WGBO)#(S&=1;AU#9/.& (].U=T_AO29-+N=.DM-]K=$FX5I'+
M3$C!WMG<W  Y)X %-/AG2&FT^9K9S)IP(M&,\F801@[?F[CCZ<=* +VH65GJ
M5A+9W\,<]K,-DD4HRK#/0_C7%:+X<C\(?$".RT%I(]&O[*6>YL"Y:.WE1D"N
MN?N[MS#'?:?3CL-7T?3]=TZ33]3MEN;60@M&Q(Y!R"".001U%+INDV.DQ-'9
M0>7NQN=F+N^.FYF)8X]S0!+<7UK:6DEU-,BPQ\,P.><XP,=3GC YSQ6/I%B%
MUFZUN_VQ:CJ"+%# S#=% F2J>[99F;'&3CG&23>!_#=QI;:9+I43637#730E
MVVF5CDL>>O/X=J=HG@OPYX<O'N](TF"TN'C\MI$R25R#CD^H'Y4 8OQ-C$MG
MX:C+,H?Q#9*2C%2,L>A'0^]<_>F3PGK_ (YCT!&A":#'?1Q*2P$_[P&0 YYP
M 3ZXYKTC5-$T[6A;C4(#,+:430CS&79(.C#!'(['M38] TV+5I=56W/VV:/R
MI)6E=BZ#HI!."/:@#C=*T"UN;CP]XCLM;M(8W3839VS(]^KK]V1O,)9A@MD@
MD$$]C6%H.EPVO@[Q'XCMXYYM8TF[U0V$C3.WEXWJ!MSAOQ!S^5>@Z1X'\,Z#
M?S7NEZ1!:W,H(9XRWR@]=HSA,_[.*OZ5H6FZ)%/%I]MY,<\AEE7S&8,YZMAB
M>3W/>@#B=&T.WNCX;\366MV<(VJ"UK:L'OPZ\QRL9#O.<G)!(()XP:QK41Z[
M\&M3\37;&/Q% +NZ:\!Q-;SQ.Y5 W50 JKMZ8/3FO0-(\$>&=!U.34=+T>WM
MKN3.73/RYZ[03A<_[(%3MX4T1KR>Z-B ]Q()9XUD<12N.C/&#L9N!R03P* .
M)U2RAU3QA\.KG5M.MVO+RVN6O$>('<XME.#D<X)./2O35:/)C0KE ,J#]T=N
M*SKWP_IFHZE;:C=6[/>6N[[/*)G4Q9&&VX(QD<'UJ6VT?3[35KW5(+94O;X(
M+F8$YD"#"Y[<#TH O4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445
MGZQI,6M6:V5Q+*MJS@SQQ.4,J@'Y"P((!."<=0,=": -"BN!\)Z(GA_X@ZW8
M:,TJ: MG"\ELTC.D-VQ8D)DG'R!6(_VE]J[FY@2ZMI()#($<8)CD9&_!E((_
M T 2T5Q?PJED?X6Z+*Y>:4Q2$EFRSGS'[GO]:YC0%LO^$YMO^$P\/ZAIOB2Z
ME>:UN7OWEM;AADA5VML!5< *1T YSU /6Z*** "BBN>NK'7CXSBO+>2Q;2&L
MS$_FAC-!*-QW1C[N&RF<]DH Z&BN(,^I>&?AAJ4_B>/3I;FSMY2?LVYDGP/E
M+;^2[-U]S7!_"^TT*;PAI>FZU:SWVL:U++(AEBD#1Q 'D2D8 "KN&T]6'K0!
M[G17&2^)M+\"W/A_PM?1WBQ3P^1!J$NSRF**,[CNW DXZCJ:M+XZL8M-O]1U
M'3]2TVUMIEAB-W;E&NRWW?*3[S9/08S].< '4T5RO_";V)?7;:ZL[BWFTBR6
M[NDE (",I8*2"1NP.0,CG@GG'G?PQ\567AC0]$LK^WO)]2\37SR>9&F4B+$*
MH+$_W=C8&<!LGJ,@'MU%<QK'CK3-(U"]L_*GNI-/MOM=^8 NVVB[;B2,L1R%
M&3@9K.OOB?IMCX6T77GTS43%K$HBM8<1A]Q)V[AOX! SD9[4 =Q17):7\0M)
MU7Q'J^CQQ74)TNW%S-<SQ[(RA .1SG&"",@9'-9O_"V-)_LRQU4:;J+:=J%X
M;.SE")NGD&1D(6!"D@@$]QR!0!W]%<QK7CG3='-S"8I[B[M;)KZYMX]H-O$!
MGYR2 ">@&23Z8YK8T35HM=T.QU:"*6*&\A69$E7#*&&1D4 7Z*Y_Q9X@ET32
M+EK&))]1%M+/'&Q^5$126D?_ &1^I('?(Y?X6:\(_A.GB'7K_ >6XN;FYF/_
M $U89_3  ]@* /2**Y)/'UHU\EHVF7ZS2Z>^HQ1LJAFA4XRV6 0MV!(Z<[3Q
M7,^'KJZ^*MO;:]<Z?/I\%EJ2S:9+Y^T")2 _"GYV)1E.X!0&XS@Y /4Z*P-#
M\-1:+KFMZA 71-3E65H3,T@W@L6D^;[I;<!M' "#Z!FH^+!8>)HM CTF]N;N
M:U>YB:,H$D"D @$L,=>2V!]<B@#HJ*X4_$E!H5YJH\/:FT>G320ZDF8P;5D.
M&Y+?/@<_+GCTK=O_ !/;6]Q':VB+=74EN+H(9EB C)PI+,>K$$ >QSB@#=HK
MD]/\>V&L:=I-QIEK<3SZG+)#' P"^4\8)<2-R%QCMG.1BHKCXAV=KX5O-=DT
MV]*V-XUC=0)L+12APAYW<KEAR,GGI0!V-%<W:>+XY/$<NC7NF7=A(+1KR"2<
MH1-$K!6.%)*D$C@\X/:IM'\2G6/L$T6GRK97\!GM[D2*R[0 0' /RL0>G/0\
MY&* -ZDW+N"Y&XC(&><5R_CGQ#?^'K'37L+3SGN]1M[5WWJ-BO( 0 >I89 [
M#.<\5@7-Q)9?&-;N#29YKR?PX2UM$R!BWVA?O,2%& .I/8 9X% 'I%%<O9>.
M-/O?#MKJODS127-RUFEI(5$@G4L&0G.WC8QSGH,^U6-!\66NMZKJ6E&%K?4-
M/V&6/S%D5D<95T9>"/R(/:@#H**\\^(UY)I6KZ-J>IZ9-J7A>%95OH8D\P12
M';LE=.CJ!N'/ SGKBM'PY<^&;2SU7Q-HVI0MH<ENCNL;DI;F,.6PG\'# [0!
MSGCF@#LJ*Y:#QQ:G7]/TF[M7MGU)':TD,J.&*C<4<*3L;'/<'US0/&L+1Z?>
M1:;=S:5?W0M8;R(!LL20KE!R(R1][Z'&#F@#J:*YI/&,3V_B&3^S[D2:$Q%Q
M'N3+@)YF4.<'Y3WQ5:X\>P1'P^L.D:A</KMJUS:+'Y?.(Q)L.6X;!')XYSGB
M@#K=R[PFX;B,@9YQ0S!5+,0 !DD]JXZTUNQOO&>GK<^';RUUN329)XY)RF4B
MWKNBX8\[B.H'ZUFV/BV;5O!7B34-?T.::PMY;J*:"&2-LQ1DJR<L"< $D]^<
M=J /1 01D'(-%<W'XBL;+3='MK.W DN[-9K:U,JH(XE5?O,3@ ;E7N23TX)%
M73_B#IVIV<#6\+K>RZ@^F_9975=EPBEF!<$C&%R",YR,#)H ZZBJ6F7\FH02
M/-9RVDD<K1-'*03D=P1P0>H]O2O/?$,>EQ?&?3UU"!'M9=&D>2,PEU>02X#%
M0#DXSSB@#T^BN4T5](B76=3\.V$DGELMO);0KY7F/&N_Y5; !Q+CG&<"G>'_
M !O;>)5L3I]C<-]H1WG#,H-IM;;B49X8D' &2<'TH ZFDW+NVY&[&<9YQ7,:
MAXUAL[6]OX--N[W3[&X^SW,]N 2'#!6V)U<*3@].AQG%<^UP^E_%[6I=/TJ:
M]N)M&MW\F JA9O,?)9G( X [Y]J /2**Y>T\;V>H:)HNH6-G<ROJ\IAMX" I
M1U#;][=%"[&YYZ<9JM<_$*TM/"^K:U+IEX?[)NGM+NW0H6212!D$L 5^9>1S
MSTH [&BN<M/%@F\3QZ'=:7>63W%N]Q:33[-LZJ0&X!)4_,#A@#CK@\52N_B%
M9VVDMK2:?<W&DK>&S%Q$R;F</Y>X*Q V;_ER2/7&.: .PHKG-0\6QV;S0PV3
MS7=O;K<7%NTT<;1A@2$R6P7X/ )'OR,Z6@ZW9>)-"M-8T]V:UNDWIN&".<$$
M>H((/TH T:*X[X@Q:EJ^DMX>T6X:#4+N*2<RJ<%$C (&>VZ0QK]"Q[5I>$/$
MD7B/P;8ZVY6-GA_TD'@1R+Q(#Z8(/X4 ;]%<Q%XR263291I=[_9VJR>7:W:J
M&SD$JSJ.55@,@GVR!4/A#Q)J6O:EK\5YI[0166HO;1GS$8(%CC^4X.2226]!
MG&>* .MHK+U/6XM/OK/3HXFN-0O-YA@4@?*@RSL3T49 [G)& :S(O%PO;'6D
MM[&9-6TKY;BRD90R$KN5P<X*D<@]\=,T =*)$,AC#J7 R5SR/PIU>?\ PZTJ
MUU/P]X?\07NG,FJQ6NY;XR#=<&0?.6VGYLDYPW0\BK'Q.C_XE.D3K+,CIK-F
MN$E958&500R@X;\10!W%%<5X[U VVK^%;&Z;9I-_J!BO&)PKD1L8XV/]UGQD
M=\8Z9JKICK8?%'6/#.GRF'3KC24OO+@( M9MYC.P=%R-K8QUYQS0!W]%>9V-
MGX?TSXO6EGHEZ;.Y%E,;^V:20_;"<;,;LAF7#L3G/3KSA?BU>7-]X*UV&SF>
M*TL8T^TRH<>;(77$0/H <M[E1_>% 'I=%%9VN:Q#H.D2ZA/%-,J,B".%=SNS
M,%4#ZEAR: -&BN;C\8VT5QK=MJ-K+:3:/;+=W #"16A*L=RD=?NL""!S5W3-
M:FO[F**33WACFMOM,4ZRK)&RY'&1_%\P/IZ$T :]%96K:V--N]/LH[66YN[^
M1XX47Y5&U2[%V_A&![DDC K#N?B'9VOA2]UU]-O2MA>-974";"T4JN$/.[!7
M)'(SUZ4 =C17*2>-7A\0?V-+H&I+=30-/9#,9^TJI ;^+"$9!^;''OQ3[#QQ
M8W6A76HW%M/:36MZ=/FM)"I<7&X ("#M.=R\YQ@Y) !H ZBBN17Q]:K?:G87
M%C,+ZPL_M_DP2QRB:#."R-N R#P0<>V:99?$"*[DT%Y-'OK:RUL*MM=RE-OF
M,F\(5#;N@(SC!(XXYH [&D5@RAE(*D9!'0UQ/B_7(]2\+^)[6TTV2_M[*WFA
MN90R@+((\D*"?F*9!/3'09(Q3O#WB"'3O!WABPC19[Z71X)A$TJQJJ"-!EF;
MIDG ZD\]@2 #M:3<N[;D;L9QGG%<I8>/]+U+1;>^MH9VN;B\:P2R^7S?M"YW
M(3G;@ %BV<8Y]JR/#;.WQ?\ $AEL39RG3K8R+N#!SN?Y@1U!&.H!X/% 'H=%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5C^);_5K#2B^B:5)J-Z[!%19$41@]7.]ESCT[G'3K6Q10!R?A:[UCSOL=QX
M6N=,M@K2RW5U=Q2O-(2.R$_,<DDG &,#MC9TO4;Z\T-+V^TB:RNSNW67FI(X
MPQ ^8$*<@ _C6G10!QO@"RU70?AM9V-WI<B:E9PR?Z,TJ?O&W,R@,"0,Y R>
MF:F>*\\62:1)>Z+<Z6EC=K>O]J>,L9$5@%38S<9;ECC@8QSQUE% !1110 44
M44 >=?&+3?$7B'PG_8?A_2Y;IKF9&N)!+&BB-3NQ\S D[@OY5>2?6K:VT;2=
M'\)W4$=N([<WM[+ %M8@ K,%61BS;0<#IGUKMZ* /*/'6D>*O''AE;J+05TW
M4-)O1<V=O)<)+)<%6QD$8"KCG!Y)';',_C:P\4:TWA#7(=!=QIM\+J[TM;A#
M(/N[3DG:2"'Z'N/?'J%% ' ?$"V\2^)OA]=:?IFCO!=W\L<1ADGCWQ0YRS.0
MVWMC"EN#^ S?^$)U*U^)7A@VFGJ?#NA:=Y4$SRK@2G(8E<[BV,'IU YKU&B@
M#P+4/"?CPZ!XVLX='+W.KZJ'-R)TW3P;N%4$\*!W)'!QCKCK=4\&:CK/BSP7
M:7&F"+PYHEL9)!YJD>8!A(R,Y.-B9XQR1FO4** /(M(L-6\.0^.=:U_3;<7>
MLW,D=I!-<*?M8P1#"NTD\Y(QU/'I6/X).C7.O>&_#GB31M<T_4M-5Y=-M+T#
M[,9!EV92%#-C!(W%@,=2>OLFLZ'8:];0PWT;-Y$RW$+HY1XI5^ZZL.01D_G4
M47AZS75;?5+EY[R^MD:.WFN&!\E6QNV@  $X )QG'&: /,]%\)ZM#XN\5+KO
MANXU*+4[\3P7!NU6U>-22@E7=DA01\NUOIQFO5KZ>>PTR26UL7O)HT_=VT!5
M"Y[ %B !^-7** //]<\+W&H^#-2NY;"\N?$FH63QM''=&,([*P5,"0)L0M[Y
MY)R2:Y"X\$>*&^!&E^'XM,8:E97OG7-D\R?OX_,=\!@Q!^\IY/\ "?:O;Z*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6::5HY_/>2RU-2K8"<[5(!5@N!C;CO0!Z71110 4444 %%%% !1110 4444
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M0,G 8D#C&,#&8_CID\-^&=8&ELR:Y<6T!03C_1S,1@DX^;'/8?A78T %%%%
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MI_9ZO=7EU#IS[[.&Y=66%MI4$$*&.%9@-Q(&>.@QOT4 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(+=G$BC'W3T)Y'3IWQ6:?B5HHTB;4A;:HT-M*T5ZHM&+694X;S>PQUX)..:
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M[+GS"Q52<*.GH/Q- 'HU%8L'BC3;O2M.O[(R72ZBNZTBB7]Y*,9/!( P.I)
M'3/(J"V\::-<:7>7S22P?8I_LMS;RQD2QS9 $>T9W$DC&W.<\4 =#17GUMJ$
MMS\:8(FBU"U']ARN]M<R93/FQ@,H#,G3(..>.:[/4M5@TS[,LBR2374ODV\,
M>-TC[2Q R0!A58Y)'2@"]16.OB.T-D;B2&YBD^TFT6W>/]Z\O]U0#@]SG.,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB+RV>S^-6F:C(/W%]HLUC
M&>WF)()<?BN3_P !/I7;U5O]/M]1A6.=3F-Q)%(IPT;CHRGL?Y@D'()% 'G?
MBS^U]2NO&&ERZ1J<D<FG%-,^QQ$13DPMN:1P1N8,<!&/0<*2:D\5+<7/P.33
M_L<\-]=6MK916TR;9#*S(@&.W<\]A7I*@A0"Q8@<D]ZJS:?#<7T%W/ND:WR8
M4;[L;$$%@/[V"1D] 3C&3D FMH?L]K##NW>6BIGUP,5+110 4444 %<%91W
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MBO3+R+3_  ;+H=^]C/ UW>V*P-"[QE0L;#YFY.21Q@>I KT:B@#Q^XN=3O/
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MV/UQM:_IUQ?:#9ZUX?\ "KV2V6KVVH/8BV6"YO$CSN)0=_F^4'GY3ZBO4:*
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M<<;*[, "0 3CGD]0,<U$\1T+Q;KMOK'@^ZUJRU6Y^U6EW;62W'WD56BDS]P
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M"N67)&,;@%YZY]*W/"URFIWMM+_P@K:+=6ZG[1<7-K'&%8J1MA8?,V2>N ,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"V<?+@ 9/7(Z5%8?$?3[^T:^72M6CTZ-+AI[R2W'EP^3G<&PQ.3MXP#U ZY
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[K3Y(-5%L;JWB\Q2ER@.#L?CD'J"!C.>16)X:\<W=YX(L];U+39C->77DP)
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MY<94,#R,;CP>F36M=^-8H+"_U2WTZXN]*T^5XKFYB9<C8<2,BDY95.<GCH<
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M$^YP"PZ8Q&3P?\:O_P#"86D&JZ_9WT1MH]%MX[F:X+[E:-PQ! QG("'C\LT
M6M6\+Z9K>I6=[?K/(]J"$B$[K&X)!PZ X89 X/XULURS^,6LYM(;5-,DL[+5
MI%AMI_-#E)&&425<?(6[8+#/!(JCH_BZ^?5_%<FKP16VFZ/+M+K+N\M%B#DD
M8Y)SGVZ<XR0#MZ9)+'#&TDKJB*,EF. /QKDK;Q_:/K^FZ7<P11_VFK&UDBND
MF*LHW;)57[C8]"PSQFN9^)&M#Q#\,[V_M=+6;2S<1+!>-(-_RSJOF*F.$)!
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M%]HNG^'+V_N[6WCN,)-&@DC=B-P)..QX/)].] '7T5G:[K-OX?T2YU2[!\F
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M05((Y^IH Z:BN,?Q^4M-$OO[%N)+/6W$=D8ID\PLP+('5BH7<H)&&/H:[.@
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MJ.HR:A97QF4JS$QNBE1EAADP<CZ9KH= U'Q5>[/[8\.1:9]G0F9DNHY3<MC
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M+AL8'EJO*@GYLL>,8YSD=5UHH Y3QOH6H:HNCZEI2K+?:1?)=I;NX43I@JZ
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MA$;Y8EN6RSI$<JF23M!P,X&!G SC.!FK51QW$$TDD<4T;O$=LBJP)0]<$=J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2[BW:95>VGW$,I[-C![@<CIV .ZHKC8?%NN2Z[J.@_\ "/6XU2WA2YB_T_\
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MK,ZEDC3"MEBHSV W+USQS&M:G;OXU\ ZY>VS:;YEO?23K=*$DB'DK\K_ $-
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M"&WCTVWU*UDF"WEK.5 >':V=N[C<&V$9QTZCK6S4%U>VMC&)+NYAMT)VAI9
M@)],F@#S2X\":M!X,U+1=,A9;:XU.&YLK*XN0WV2%&C=E+9/4JQ"C(&1SUK?
MO]'UJY\>_P!LVL*V\/\ 8LEBDKR*6CF9PZMM&<J,?GVKH?\ A(=%_P"@QI__
M ($I_C5F#4;&ZNY[2WO();BW"F:*.0,T><XW =,X/7TH \XT_P +>*(Y_"5U
M-IFGQW.E32&]D-X7>Z9XC&9F;9DG)S@Y/.. *W_#.@W]N_BF'4[416^KWTMS
M$R2AB$=%3:<=&^7/<<UV-% '!^%++QMH]I:>';V#3VL+';%'JJ3G?) OW5\K
M;P^T!<DX'7GON>-O#C>*_"=YI,4XM[B3;)!*1D+(C!ES[9&#]:UFU.P6[%HU
M];"Y)QY)E7?G_=SFD@U33[J<P6]]:S3#.8XYE9ACV!H YJ;2=5\2:CX?N-7L
M8[%=*G-W*%F$GFS!"JA,?P98MEL'@#'>I/#NEZI9>,_$VI7=F([75)8'@995
M8J(X@AW#MG&1C/6NDAO[.YGD@@NX)9H_OQI(&9?J!TJ=W6-&=V"JHR6)P *
M.9\:^%I?$MC92V-PEMJVFW*7EC-("4$B_P +@<[3T./;Z59M;_Q%=0B&?18K
M&X(P\YNEEB7W4#YF]@0OUJZ=?T==,&IMJMD+ L5%R9U\LD$J0&S@G((^HK1H
M XV/1-4T'QQJ>MV,']H66KP0K<Q>8J2Q31+M5AG"E2IYY!![&LB?P3JEMI>F
M);0Q3W9\1C7+[;*%1<N6*(3R2 5 R!G!/%=Y)K&EQ7PL9-2LTO#R+=IU$G_?
M.<U<1UD171@R,,JP.01ZT <G!IFIQ?$>_P!=:RS8S:;':IB5=Y='9N1G@'=C
MK7-6WA'Q##X-T/2FL8C<V&N#492+A=IB$[2X!_O8;&,8XZUZE10!R4>F:FGQ
M*N=>-E_H+Z4EFN)5WEUD9^F>ASCKU]JYNS\#Z[#X=TMUC@CU?2-7EU"&-ILQ
MSQR.Q:,L!\I*MC..H]Z]1HH Y"31;[4?$DGB.XLO(DATU[*UM#*I=F=MS,Q!
MV@< #D]SZ"L*/PIKT7@?PAI'V*,W6CZA;7%Q^_7:R1,2=I[DYXR!W_'TF66.
M")I9I$CC499W. ![DU#:ZA97V[[)>6]QM^]Y,H?'UP: (M9CO;C0;^+3G$5_
M);2+;LQP%D*G:21TP<5R/BO0M6\:Z#%HM]H]O:SF6-WU 7"ND&U@6:+@.6(!
M !"]>37>44 <A/H.ICXA76IQPV\NF7^FQV<[-,5>(J[$X7!W9#<<CG]<:U\)
M:['X F\"311-;X:VBU,2C;]F+YR4^]Y@4D8QC('S5Z110!P+:%XC\,>+KW4?
M#EE::CINIPP)-;7%T8&MY(DV*X;:V5*@9&,TWQ1X/O?$VK^'EU2UBO;&UBND
MOV#A,M,@ \L'GY2,@GD8'4UZ!5:\U&RT\1&]NX+?S7$<?FR!=[DX"C/4DGH*
M ,3P=#XAL=-;3M?"S-;,4M[T2!FGB!PAD'9\8SC(/K52]T34M.\?_P#"3:;"
M+RWNK(6=[:^8$<%6W)(A; /4@@D>O-=?10!YKJW@G59_#FL+;PPOJ>L:K%?R
MIYH"0I&Z%4W$<G:G4#JQ["MYM+U*3XF6VN_9-M@NE-9,6E7>':17S@'H-N.O
M6NLHH YCQSHVH:SI5A_9B12W-CJ5M?"*638)!&^2N[!P2*K1:9K'_"QTU^>Q
MC^R_V/\ 8F$4P)$OF^9QG&5[9.#GL!7844 >6P>#/$MOX;MGM%MH-;TW6)]1
MMDDDW13)(S[HV(Y!*N1_^O([G09M>NT>YURSMM/) 6.T@G\['JS/M')XP!T]
M3GC9JM;:C97L]Q!:W<$\MNP69(I QC)Z!@.AX[T <]XBTG4;[QAX7U&TMEDM
M=,EGDN"9 IQ)&4 4'J1G)Z5RNL>$O%>H:7KUH]G87-U<:BES;W\MT0\D"S(Z
M1 ;?D"A<=<>Q))KU2B@#SWQ7X5O_ !.+H7&CP)J2!#I6JVUP$>U?8N=S<.5#
M[CP#D'H*U$T36+3XB+K$:V]S9W&F16<\KR['1TD9BP4 YR&XY&#7756M-1LK
M]IUL[N"X,#^7*(I _EMC.TXZ'VH Y#XKF0>#X#$JM*-3L]BL< GSEP">PJ[-
MI5]JGBRQU^YLF@32[6:.VMS(ADEEEVAB2"5"A5P.<G)X&.=K6-"T[7[:.WU*
M%YH8Y!*J"9T&X'(/RD9((R/2M!%"(J#)"C R23^9Y- 'GNF>"M2F^#__  B-
M\R6=^D9"31OO0.)?,1LCG&0N>/6M/38O%FN6$NG^)K&QL(#;O!/):7'FFZ+*
M5RJE1Y:\YZDY [9KL** .&\(V?C/2[&RT#4;>P%GIX6,:G%<%FGA3[JB+;\I
M( !)/3.,FJ^C:5XR\-7-YHMA;Z?=:/-<RS6E_+.5>T61BS*T>T^802<8(SW(
M[>@T4 </::-K_AWQIK%[IUK!J.F:R8Y7\RX\I[:95VDGY3N4@ \<CT]<6S\'
M^([;P#X7T:2SMFN],U2*\FV7((\M)6<C) ^8[L8Y''6O4J* .2L],U2V^(.L
M:VUCFSNK*&"+$J[RT98G(SP#NXY[5R0T35M*\#^%_#,EC9SZU!?-<)";ORV9
M4+R%XI #M(W("2.Y'>O6JR]9\.Z1XACB35;&.X\EMT3DE7C)ZE64AE_ T 8'
MA2>^MM;NK75/#9TZ\OT-T]V+];HSE-B88@*5P&4 8QUZ=W>*-#U?_A*M&\3Z
M)%#=3V*26UQ9RR^7YT+XY5L8# C//6NATO1-.T6-UL+81%\;W9F=VQTRS$L<
M<]36A0!YG=>&_&$[>-+FT2UL;C5S:O:E+LEAY:*KH2%&W<H8;@>#T]:TM'T'
M6;?QY#K+:5I]AI[Z2+)H(;C<86$I?H$ 8G/L/<]^ZI&940N[!549))P * /+
MK/P5XHMO >D:=#]A@U;P_>"XLG,Q>.YP7R'X&T,KX[G/I7;Z#/X@O UQKEE;
M:=A=B6D$_GDGN[/M'X =.<D\8T[*_M-2MA<V-U#<P,2HEA<.I(." 1QP015B
M@#E/&FE:GJUSX>.GVJRKI^JQ7TY>4)\B*P*KGJWS>PXZU"NC:IH_CK4/$%A:
M_:[/5[>)+NV\U4EAEB&$89.TKM.",YSSS78TV26.%"\KJB# +,<#G@4 >;W?
M@G58=%MTM889KZ?Q$-<O )=L:?O-Q121D\!0#CG!/%>DJ25!*E21R#U%+5:\
MU&RT\1F]NX+<2N(X_-D"[V)P%&>I)/2@#FM0\)377CR'5XY$73;BV5-1@(_U
MSQ.&A/YL<^R@=Z/!7A>Y\*V%[#/)]I"2O%8JI&4M59FC3)[Y=N?IZ5UU% 'E
MP\(>(!\+(_#?V*+[>M_]H)^T+Y>S[3Y_7KG''3K70S:'?WGQ%;5I;3;IDNBM
MISGS5WAVDWDX';'&<]>V.:Z@7]H=0.GBZA-Z(O.-OO&\1YQNV]<9XS5B@#@O
M".F^,M"L;7PU=06#:=9,$CU59SO> '(7RMO#X^7).!UYQRV/P_K2Q>.E-DN=
M;+&T_?+QF$1?/Z<C/&>*[?[?:?VC_9_VJ'[;Y7G?9]X\SR\XW;>N,\9]:L4
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M/<^6UO+(N'5@0<C(&,?CUXZ7P7IM]H_@W2=,U&.%+JTMD@<0R%U.T 9R0/\
M/<UNT4 <&- UD:CXZG^Q+LUJ%$L_WRYRL/E?/Z<\\9X]^*A;PYK?]C>!;062
M&30I8'N_WZX(CB,9V>N<YYQ7H5% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !52]TRSU"6VD
MN[>.<VSF2(2*&"L5*YP>^"?SJW2'(!P,GL* /-?!FCZ=J.N^/[.[LK>6!]4\
MLHT8(VF,<#THMI-2T_XD>,!HEA;W,XLK%O\ 2)O*3A9.I"DECVXQUR1WV_"&
MA:MH^N^)+N_BME@U2]^U0^3,791MVX8%1SP.F:=9Z+J]IXU\1ZP8+9K;4+>"
M*!1.0V8@P^8;< '=V)Z4 1VWC^VO=$T"[ABCAN=9A::..>0A(E0#>20,G!(
MP.<]N:T?"GB2;Q!'?QW-D;:XLK@PLR$M%,O59(V(&0?TKD+/P3XGT?PYX6FT
MZ2P_MS04E@>&21C!=0R$;ANP"#PI''45WNB_VP]N\^M+;0W,A&VVMG+I$H[;
MB 68]S@#H!TR0#D/'T:Z'XJ\+^,54!+>Y_L^];'_ "PF^4,3Z*W/_ JH65Y'
MI'QQO'C@6*PUR(VGFCI)=P(KD^WRN5]V4UW/BO0H_$OA74]&DP/M<#(C'HK]
M5;\& /X5S&L_#^?4_ >D:.EXR:I97$-RUYN^8RELSOGWWR'ZXH T;*\EL?#N
MJ>)K339;^[U&;[1%;P#YY8_ECAYP>-BJQZXRU3Z1XG>_\5:CX<NXK1YK6V2X
M\VVEWH59BI1@1\K C\0>U2^+=&U#4/!UQI>@S1VMQMC6(,Q1616&8RPY *@K
MD>M9.E:#KMIXW.MO8Z7;6<FE)9_9;>=B861V8*OR $'=UP,>AQD@'%/&G_#-
M5P-BX6YDV\=/]//2O;:\R/@GQ ?A#/X3\NQ_M!YV</\ :&\O:;@S==F<XXZ5
MZ7&7:)3(@1R/F4'.#]>] 'CT&JV_A*VO?"?Q TDC3KZXF:/6A'YD-SYC%LR'
MJKC.,]L#H!FNGU'4]7T_Q9X/T?3)+2?3[BVG?<967SO+B4 D@$;</D 9R?3
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M>=VPC@-TQGCK7('X=7,?P]L='M[R)-6L;X:G!,V3$+@2,^T]]OS%<XSWQVH
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M2V-W#J$$<-[97DK1?-'G9(C 'L2",?GVDU[0M>U-?#3YM)[C3]26_NF,AC7
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M*** "BBB@ HHJI#J5I<:G=:?%*'N;5(WF0?P!]VT'W^4G'ICUH MT4ASM.T
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M>W-=%0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTER29381<GJ0%P#^6*Z>HK:VAL[6&UMXQ'!"BQQHO15 P /P%2T %%%% !7
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M[ZTVE6(QF= >GL30!W.1SR..OM2@@C(/'K7FL_AO2(_BY#8I9(MG>Z+++=P
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M*+&WM8_AKKD2$:K>S01W5V6)DF5[9BRNQY(R!@'@=L5ZM'/#,\B12QNT;;9
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M>C7ME;64^GPM:VK!X(0"J1L.A '&1V/:M15"J%&< 8Y.3^=-:6-#AY$4\=6
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M!V].U7VGB218WE19'^ZI8 GZ"JLQU$:S:B*2S&G&-_.1PWG,_&W9VQUSGVH
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M)K/2M.MK.W<EGCAC #'U/K^--T_P[H^E2B2PTZWMV4$)L3 C!Y(4?P@]P,4
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M6QA%^(_*%SM_>;/[N[KCVJM9>%/#^FZM+JMEH]E;W\N=]Q'"%8YZ\]L]\=:
M/+M1ELIM+TG5=+V);R>*XV2YN7#74SF<J_(QL3&5"G)*XSBM^ST#1]7^)WC"
M*\L;>ZMWL[*3RW4,A9EDR^.A;T/49..M=<_@SPS(;DOH.G-]JD$L^;=3YC Y
MR>/7FK2^'](2[N+M-.MUN+E=DTJIAI%Z ,>X]J ,'X5S27'PO\/R2NSO]E"[
MF.3@,0!^0 K)\/V]EXEN/'-MX@ABDN8]2DMSYP!:&U"+Y)7/W1C<P([Y-=WI
MVF6.D6:V>G6D5K;*25BA4*JYZX Z57O/#NCZA>&[N].MY;@IY;R,G+I_=;^\
MOL<B@#RHQRZK\/OAO>:[;QSW\VKVD3RSQAGDB)DV@D\D%0I/KUKV(6MN+3[(
M+>(6VSR_)V#9MQC;MZ8QVJK?Z'I>J&#[?86]S]G8/#YJ ^6PZ%?0CU%7U4(B
MHHPJC % 'AJ6UG#^SC=-%#!'/),1*R*%=@+\@9(Y.!P/2NKO;"'0OBC =$M(
MX)[G0KIY%C7'GR*Z%2_]YLD\GGGK77MX1\.O;W-NVB6!ANI?.GC\A=LKYSN8
M8Y.>:L_V%I?]H0ZA]@@-Y"GEQ3E<NB^@/4#VH \U\-V6E^(?#7AC6FUR"&^M
M9X9'D@A47+W!^62*1LEFW,3N!'/7I79?$C_DFOB/_L'R_P#H)K0MO"GA^SUJ
M36+;1[*+49,EKE(0')/4Y]3W/>K]_I]GJEF]I?VT=S;2??BE7<K?4=Z /.QI
MEEI7CGP!/8VT<$][:W4=U*@^><"!6&]NK8(SSFJUC;&'0OB?!8746FL+Z;9.
M6V+%^X0DY'3OR.E>A_\ ".Z.9K.8Z=;F6R&VU<IS"/1#_#^%9>N^&%_X1_58
M/#]CI\%[?@>=YJ;4N 2-X<@$Y9=PW8.,T <[IN@+K/B'PIJ<>DQ65OIMBPNE
M<QG>Y5/+50I.=C!FW''7U)QS=]I&GW?@;XDW]Q:QRW=MK%Z]O,XRT+*$(*'^
M$YZD8)P,]*Z?2O ]M)J-K=+X,T_P_-;S)*;FWNPS_*P)50@ (;&TYQP3P:Z\
M>%M!%K=6HTFT^SW;^9<1>6-LS=RP_B/N: +VG2--IEI*YW.\*,Q]25%>+Q>'
M=(N_@_K&L36X&JVMS>R6EVI/FQ2K._EJAZC+8&!U)]:]LM[>&TMX[>WC6.&-
M=J(HP%'H*SXO#6B0WK7D6EVJ3M)YQ98P 9/[^.F[_:QGWH X^&*5/BMH-Q<Q
M*-0E\.RFYP,%I \><_CFN2O#9:Y^SYJNKWT<,NL-)))=RN!YL=P)\;2>JX7"
M@?W<#I7LDFC:;+JJ:I)90M?QKL2Y*_.J^@/4#VJA<>"_#-W=7-U<:%82377,
M[-"#YA]3ZGW[T :LT\5OI\EQ*Y6*.(NS+U"@9)%>16!M8+_X=7MB(K>SGFG\
MEY7#74L30NQ>9Q@9)P2,'![YKV&*WA@MUMX88XX47:L:* H'H .,5CP>#/#-
MLD:0Z!IR+',+A MNORR#.&''49./2@#S.3P_I-QX8^)\LMA [VEY=O;%ESY#
M"W1@R#^$Y[C!X'I6[INH?VEX^\/Z?JY66 ^'$NK5)N5EN&($C<\%P@^H!;UK
MM1X8T-8;N$:5:B.\):Y3RQB8GJ7'\7XTEWX6T&_LK6SNM)M9;>T.;=&C'[G_
M '?3\* .:^&4%M:'Q=;6B)'#'XAN D:=%&R/@#L/:IM:_P"2N^%?^O"^_P#:
M==/INAZ5H[3-ING6MHTS;I#!$$+GWQ2S:-IMQJ<.I364,E]",17#+ET'H#V%
M 'E]A';ZY\(O$6HZJJKKD$E[+<3GB6WN(F8Q@-U7: @ ';CO5O4"="NO"'C7
M5[91-<V2Z=K1\H%LR1AE8C'42+M/LV*[^7PYHTU^]])IMLUS(5:1RG^L9?NE
MAT8CL3DBKUS:V]Y"(KF%)HPZR!7&1N5@RGZ@@'\* /*/#%@UM>7_ ("O]/@C
M$]W'J@C6,%%M'_>,GN%D7RL^C<=*]< "J%4  #  [5%]EM_MAO/)3[28_*\W
M'S;,YVY],\U-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !39)$AC:21U1%&69
MC@ >YIU<IX\N;"&RTB&]C>5[C5;=+6/S?+C:8$LOF'!^0;22,') H Z:"ZM[
MF'SH)XI8O[\;AE_,5CZ_K;6WA35M3T>YLYI[*UDN%W'S$)12V"%8==I'6N!L
MXHKR_P#B-I4NL6MH;B>U43P)B-)'B4$["QXW8#<\\YQ4T]]?IIGC73->TFUM
M=:706D>[L6S!=PA)51L'E6!+#!_D* /0-$U47GA_2KN\FA2XN[2*9ER%RS("
M<#ZFK[WEM'<I;27,*SR#*1,X#-]!U->:_#^]1]1T^Q\0V\0U-=-ADT:4C,;V
MIC3<(\]) 1\_<\8^4#&;91:3XG\/:U9Z_KOV'4(-3F>[4+&MQ$Z3$QLC$;ON
MA%7';@4 >LWMU';0X:ZM[>63Y8FG/RENW&1GZ UB^ M<O/$G@K3M7OQ$MU<B
M0R"%2$&)&48!)[ =ZP- N+?4O'_B^RUL1R3P101017('_'H8\L0#Q@L26QWQ
MGH*M?" H?A;HH1@0JRC@YQ^]>@#L9KVUMPQGN88@I ;?(%P3TSGUJ1YHHMOF
M2HFXX7<P&>,\?@":\RTOPSX?U?QWX_M=3T^UF@22U.R11MCWVX+.!T5B<G<.
M>O-<]HNFK>Z9\+EU>%;AWFNXM\R_-);A)#&K>JE0O!X(/O0!Z_)-=3:KI\EI
M?61TV2.0RQD;I)3@;3&P.,#G/!JXUY;)<K;-<0K<.,K$7 9A[#K7!7>CZ;HW
MQ2\'6^FV4%K&+&^0+$@7@!"!^;-^9K,\+S:!K_@AE\0S*NL6^IR2WBB39<BZ
M68E /XLXVJH'; '2@#U">\MK9XTGN88GD.$61PI8^@SUHGN[:U*"XN(HC(<(
M)'"[CZ#/6O,"-.U[6?&NB>(-6BLIVN-GESK&&^RF)?+9&<< '<>.C'/4U)JE
MGJ-DJ7^BR6^OVT&BPP7^FZG\LTUN-Y617Q@,PW9!&#M]<8 /4 RLH8,"I&00
M>,5QG_"0ZOKNHZO;^';G38WTRZ2W6*[!87/RJSG<IRHPV!@'E>>O'1:!=6^H
M>&],N[6.1+:>TBDB24?,$* @'WQ7G-G%)9:9\3;G1K:-=1M[N;[,T48WI_HZ
M?=QWZD =Z /4H[RVEN'MX[B%YX_OQJX++]1U%#W=M')Y;W$2ON";2X!W'H,>
MIKS'5X;63P-X)U3P^J+?+=V8M)(OO.'XE1B.2"-Q8'^Z2>E6_#GAW1KWXA^,
MS<Z;;2_9;^TF@#(,1/Y*MN4=B6Y)'6@#T>22.&-I)75(U&69C@ >YJ%+^SDC
M61+N!D8X#"0$$^F<^]8?C6RGU'2+:WL]0ALK[[9%):M<)NBEE3+A''H=I_$#
M'->>^(KYKOX>>*X-1T:'3=6L]2LY+X0L'A=V>#$J-V!0 D'D=^M 'L8FB,QA
M$J&4#)0,-P'TI@O+8W1M1<0FX W&+>-^/7'6N!U:Y0?%ZW:Q>%[P>'KD* 02
M7\Q"@-5?"#^&=<\%^&+J[N%;5+6YCE.V7;<&]R0X8?>.6+$@\$<G@4 ='X;\
M275YJ7B*VU>>SC73]0%K Z#RPP,:L,[F.6^;UKJZ\@N=)T[4++XJ3WEG#<2P
MR3&)I5#&,BU4@KG[IR!R.>!Z5Z1X5E>?PAHDTCEY)+"!F8G)),:DF@"AXY\0
MS>'O"VHWMA<V:ZC;V[3QPW'S;P.N%# _C6S'J-O%I]K/>W,$!FC4YD<("Q .
M!FO(6GM-8^!_BNZU-87U@3737PEQOCG60^6.>1A0@4>@Q707ESIUYK%Q!"8/
MM<7AU!<3WC[H4@;)PD>1EB1\S9 'R]>E '<:GK^G:3=Z?:W=S&D]_+Y4"%AE
ML*6)^@ Z^X]:N37MK;M$LUS#&TIQ&'D +GVSUKQ[3/LEWHGPIDN?(F(<PRM)
MANEN^%8G\.#6BATKQ!JGC+1M<U>"S=I]JI*L0_T0Q+Y;QLXX Y/' )SWH ]7
MJ$WEL+H6IN81<$9$6\;R/7'6J>DH8/#5G';3377EVB"*6Y^_+A1M+].3QFO+
M(A#J?P"N-0ES_;<!DF>?&)TOEF..>H?=@ >A Z4 >OS7=M;Y\^XBBPNX[W"X
M&<9Y[9.*FKR]= L-7^*TEOK>G6T[S>&H)+J)D&UY?.8%B.Y&, ]17HUK>V,\
MT]I:75O)+:$)-#%(K-"<<!@/N\>M $.HF^%SI_V2ZM(83/BY6=26D3:?E3D8
M;.*Q-5\0W,_BE_#6E7EI:W:V!NS/.OF#>7V)'MR.X8GOTQ5#QW!#_P )3X(N
M#&GGC5]@DP-VTQ2'&?3(%,CL[,_'"Z)MH"PT&*7_ %8SO^T/\WUZ<T =%>:Z
M/#WA=-3\1R6T,\<2^>(&)1I3QMCW8)R>F:H7_B&\MO'FBZ7'+:-I=]:W,SN%
M.\&(+_%NQCYO3M5'XNQ1/\-]0>5$;RY;<AF .W]_&"?;C-5=>L=.O/B9X1M#
M!;RV?V2_'D@ QDCR\@J.#SG@]Z .^AGAN(5FAECDB89#HP*D?44R"\M;J-I+
M>YAF13AFC<, ?<BO&Y+D:+X7\1Q1?Z/I%OXO$=RL2 K#:DQEAMZ;,D97H02.
M];^HZ+H4J^(=2M]6CU":[T.59K>$1&!E4921@@^_SA2>P..E 'HT5W;3,5BN
M(I"%#D*X.%/0_0^M%O=VUXA>UN(IU4[2T3A@#Z<5Y)<V6GZ'\)_#NLP6L<'V
MB'34U6\CCW.UL=A;?_>7. 0>W'3BNOT'3-'3QC+J]AK8O+JZL DL-MY?DLBL
M"LC!!][G )/(SZ4 =;<7,%I$9;F>.&,<%Y'"C\S2_:(/(6?SH_*;&)-PVG/3
MFN2\2W%FWC7P_:;5.IB&YE@:X?$$:;5#LR_QMC@ $<%N17G/EVEU\)1$SP2F
MV\2;8FC('EHUYC*8.5!&<8- 'N!O;4023FYA$49*O)Y@VJ1U!/:I(IHKB)98
M9$DC895T8$$>Q%><>(;?2O#/B[P[9QBVT?2+QKJ1G2%!";PB,(6!&T':& /O
M71>#=)TW2#JT>EZD][%-=F>0#9Y4,K#+*FT #L2.V?>@#HY;JW@W>=/%'M7>
MV]P,+ZG/;WIPFB,(F$B&(KNWAAMQZY]*\_ET?3+WXV7<=U8V\R/H,<KQR1AE
M=_/8;F4\$X Y-<KI%TUKX3\&6LW&BGQ!<6]R&^X )9?)1O\ 9W8Z\?** /:+
M>Y@NXA+;3QS1DXWQN&'YBN=\5:WJ.C:KX<BM3;FVU'45M)Q)&2X!5FRIS@?=
MQR#UK-@MGLOC-,-/41VESHXEOXT&$,HEVQN1_>(W#W"GTI/B-#%<WO@Z"9=T
M;Z[&K*3]X>5)Q]* .S6XCNK>5K.XAD894.&#JK#UP>WI5?3)KB/1+>74[NTE
MG6,&>X@^6)CW(R>!7"Z7IUA;^+_B#ID-I;QV#6=I(;98P(]QBDR=O3G _*LF
MT9HOA;\/+CSXO+ANK9WM9)%3[2 K?*"Q"Y7[X#$#Y>N<4 >E:QJ4D/AJ_P!1
MTN:VDDAMY)HG8>9&Q4$X.TC/3'6H?"^M?VOX<T>ZNIH/M]Y80W,D2$ Y9 20
MN<XR:Y&'0X5D\=^)/L]K&M_:D6ZJ8WDC"P$.Q9"0-[8. ?X<GDUCVNG65CHW
MPKU&UMHHKV:>VCDN%7]XZO;-N4MU(X''; % 'H'CG5[_ $#P9J>K::8/M-I"
M95$Z%U('48!'-:UE?0W4:)Y\37 C5Y(U8;ER,\CJ*YWXG_\ ),?$7_7D]<]J
M?A_3].\0^![[0;2*WU2:ZVW#P##3VQB+2M(?X^=O+9Y8>M '?:>;XW>H"\NK
M2:,3_P"CI I#1)M'RODG+9R>W!K#U;Q-<6_C3P[I=C<V4UG?S3Q72@;I$9(F
M<<AL#D=",\5P>H3SZ+X4^)TFD(86CU10?LXVE(V6(2,N.A"ECGMUKH-:CT5/
M&_PZN=-6T6%FN5@>' !B^SG:!CJ.F/K[T >CLRHI9B%4#)). !45O=VUW$9+
M:XBFC!P6C<, ?J*YSXA7.G6_A.1=3262">X@A6..7RP[F1=H9N0$R/F.#QFN
M4MEAD\<>-;.]DL)?/TF R0PKB,N%EX().6  YXZ=!0!Z:E[:R21QI<PM)(N]
M%$@)9?4#N/>J7B#4_P"S-(NI8;FUBO%A=X%N#D.RC.-N03^!KRJRTVQL_!7P
MQU.WMHH[^34K*-[E5_>,K1N&4MU((P,=, 5L:=/::M9_$>/65A>_ANKB)TGQ
ME+58QY.,]%^\P/J2: .Y\*:G<:UX0T?5+K9]HN[.*>38,+N903@>G-4/#NMZ
MCJ'BCQ/IEZ;<QZ9/"D!AC*Y5X]_S9)R><?A3OAXRO\./#>U@<:; #@]]@KBM
M5N=0M6^+$^E%Q>HML4,?WE'V==Q'N%R1]* /5(KRVGFDAAN89)8_OHC@LOU
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?EP3Q@=:Z>Y\3Z5:^([?0I;N%;Z:%IMA<#:H*@9]R6X'?!H UPJJ@4* H&
M. *I66BZ5IL\L]CIMI;32G,CPPJC.?4D#FI)=2L(+R.SEO;:.ZD^Y"\JAV^B
MYR:=>7UGI\/G7MU!;19QOFD"+GTR: *UIH&CV%T;FSTRT@G)8[XH54@M]XC
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M6E:??V-SIU[%<F98<.Z/&JD L&(_BZ8'2NNFFBMX7FFD2.)!EG=@ H]23TH
M@L=,L=,C:.QM(;=6.6$:!=QZ9/KQ3+W2--U*2&2_T^UNGA.Z)IX5<QGU4D<'
MZ5);ZC8W=LUS;7EO- F0TL<JLHQUR0<4D6I6$]PMO#>VTD[QB58TE4L4/1@
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MS(A2U0%6]1QP:U;FZM[.!I[J>*")>LDKA5'XFF1W]G+9?;([N![7!;SUD!3
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M>4LC0JDUFT*A2C2*> =YX/!.>N:[C0;S2=/L-)T2+4S),;13:QW<B_:)HE&
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MG:<7-CI]K;%_O^1"J;OK@<TVRT72M-E>2PTRSM9'SN:"!4+9.3D@>O- '#>
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MCIR>/>@#SJ%].U[Q9\/IA8[;*;1KB2.UG&[:NV+:#G[V/7V!K/MKC2]-\/\
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MXZ=^M<OI/B"QTWQ3X4FU.\ABTN?PVD5E<R.!$MP"OF+N/ 8J%'X8[T_Q%::
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MG3:Q!P.Y/%=KX(U'4+FYURRUC3[6WU6TND%U/9L3#<LT2[77/(.P*"#TX]:
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MGS8F9L1Q(2 3G.6YZ@8/8 U_&&MZAI;^&Y--N81;WVKV]I/F,.7C?).ULX'
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MA7'Z1<E?BSXIM-3VAYK2U;3Q)T>W"MY@7/;S"<_45QD,;Z?X0T&29PFE0>-
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M))^4?X"NJKB/#[HWQ9\8;6!S::>>O^S)_B*[>@ HHHH **** "BBB@ HHHH
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M=.N(49%32X^6W8SND*J2/]G'7G/%;0U[1S9S7@U6Q^RP.8YIOM";(W'56;.
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M&UM-PR//E5.,XSR>F>]27FJ:?IUNMQ>7MO;Q/]UY) H;C/'KQS0 TZ-I9@6
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M7374=G;I</G=*L2ASGKDXS5FBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ0?PQ5F.-(8UCB1411A548 'H!0!Y_H%EIEW\5?&Z36]I,Z+8,JNBM@B,DD
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MUFE:3!I,=P(50/<S&>8H@12Y4+PHZ#"J/PY).35BZL[6]C$=W;0SH#D+*@<
M^N#0!XI>V<-OX)N_.\H:5+XP5]/#XV"W,RYV?[!(<C'&.>E>V6UI:VB,MK;P
MPH[&1A$@4,QZL<=2?6B6TMIU59;>*14X4.@(7Z5*JJBA54*H&  , "@!:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,C8+;6_C7*@_F<8YJMH7B_4M,\-^)M<UR6&Z6TU6XMDCA4HSR*ZQ(BY) 4G
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M"VB>:0@=%4$G]!7(6WC#5Y-0T5O[)DGL-38+((;2</9;AE6=V&UU[$C;CW%
M';T5QVA>+KCQ!?E+.2P/E7<MO>6+;EN;54WA7;)YR57^$ ;NIQ6;X:USQ(UC
MXOOIH8M4GL]3N(8+2 %&=D6,*JDD@+C\<Y- '?SSPVL#SW$J10QC<\DC!54>
MI)Z5%I^H6FJV,5[87"7%K*"8Y8SE6&<9!_"N9TOQ3<77BVY\.7+V-RRZ=]L$
M]GD!"'V-&P+-R"0<Y_"N)\*^)]=\*_"S0-6;3+.;P_ BI=$3-]I5&D*^8%QM
MP">F23[=@#UB+5].GU672X;V"2^A3S)8$<%T7.,L!T_&G:?J=CJL#SV%U'<1
M)*T+-&<@.IPP^H-<G$3_ ,+JOFC"LQ\.PD G )\^3'-5K7QZ\'@V;6;RSM;+
M;JKV,C)N>& >;L,KXP2.I/3)(Z=: .SU35].T6T^U:G>P6D&0H>9PH)/0#U/
ML*NUYI\0+VZO_A1KTUP]G<0B>W^RW%F<I/%YD)##DX.XL.I^[6]!XFU.U\9'
M1M9M;.&WFL9+V"6WD9B@1@&5\@9.&!R/2@#K:KWM]::;9R7=]<Q6UM$,O+*X
M55'N37%Q>.-4N$T?4;729;K3M1F16ABLY_-MXG^[*7QL8 8+  8SP3UJ/Q#K
MM]KWA#Q=)I:6OV"RBNK-O.#%[ADC(D*D'"@$D#(;)'84 =W;7,-Y:0W5O()(
M)D62-UZ,I&01^!J6L3P=_P B/H'_ &#;?_T6M9.A>+I]?U I:26)$-Y+;WEB
MVY;FU1"X#G)YR57^$ ;NIQ0!V-%<!<^/-1?3UUC2M+DO['[28OLL-G.TTD0<
MH95<#9GC=MQT_B!X&I<>(=6OVUO_ (1ZUMISI#^28Y\[KJ8(':-2" F RC<<
M\D\ #) .KHKEX/$FH/XQLM$GLXH%N]*:_P ,<R0.&13&V#AL%NHQT_&L.Y^(
M&JV_A6^U5=-M99K/66TQT$K*& E6,.H/<D]"1CU- '<WVIV.F"W^VW4<'VF=
M;>'><;Y&^ZH]SBK=<3JOB#Q#I"Z5_:VEZ4WVW6XK)##.[^7&_P!U\,H^<88=
M1VI-.U'7;CXG^(+)I[5[.TM+9HH2K+@-YAZY/S$CDXZ <<4 =9I^IV6K6[3V
M%U'<1)(T3/&<@.IPP_ U;KA-,\<N?"HU"?3X8;N;59-.BMX-S(9!(R[C@9/"
MLQP,G'3FE;QKJNGC7?MVD37$6GV7VRWO(;2:".<#@H0X)5@>>"<C)[4 =U16
M#X=UF?62]Q'>:=?Z:T2/#=V60"Y)W(REFP0-O?OT&*;KGB$V&JV>D6P'VRYA
MDG,C023+%&A4$E$Y)+. .0.ISP 0#H**X3_A*_%$OA/4M0M] ']HZ;.\;V\T
M4L:W<:X/F0[@#R.<$'D8S6EI7BT:AH][XC+1?\(]#;&:*<1LLDH5=TAP3P 0
M1ZD@]@"0#J"0H))  Y)-5--U;3]8AEFTV\ANXHI3"[PN&4.,9&1QQD5AV6L>
M(KB;1KHZ9;R:=J2[YEB;$ED"NY"S$XDST. ,'UKB=-UW5_#>A>,M6L+*SFM+
M+Q#>2W"SR,KR+O7(0 8! YR?RH ]>HKEM=\0ZC92R&VBM+:RCLOM*7EZ<I/*
M2<0J P(.!DGGJ.#6:_CO49[+PA=6.EV[+X@P"LMP08F,9?'"]./O=<?PT =W
M17#P>.+RPM/%G]MV4!N?#RK*WV)FV3(\>],;N0>QJ4^*=:M_$'AW39;33YTU
MN!YED21X_(V*K..C;_E88/RY([9H [.BN!N_'FHMIYU?2=+DO[)+HQ?9(K.=
MII8Q(4:1' V9X+;<'@=0>!WP.0#ZT %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 44R65((7FE8+'&I9F/0 <DU#I^H6FJZ?;W]C,LUK<()
M(I%!PRGH>: +-%%% !7'ZO8-I_Q(TCQ)C_1I[.32KE^T99P\1/L6!7/JR^M=
MA6>=6TJYU:70S<P2WH@,LMK]XB/(7+#IC)'!H YBZ\.>)-+\9:AK7AJYTUK;
M55C^V6VH;QY<B+M$B%!S\O4''U]'^.-.NM1\%IX96X:XU#5'C@:4C'R[PTLA
M'90H;Z94=Q79JH10J@!0, #M31#&)C,(U\TJ%+XY(';/I0 L4:PQ)$@PB*%4
M>@%.HHH **HZIK.FZ+#'-J5Y%;)+(L49<\NQ.  .I/-7J "N1M?#^K0_$N\\
M2.++[%<6*68C69_,7:V[=C9CN>,_C7744 <OX;T/5=+\0^(+^\%F8-4N4G00
MS,S1[4"8(* '[H/6G^,-!O\ 6H]'FTV2V6ZTW48[T)<E@D@564KE02#AO3M7
M2T4 <I9Z'K-OXYOM>D^PR17&GQ6H5975MZ%FW8VG );IDX]ZYZU\ >(+#PKH
M,=E?6$.O:'<32V\A+O!,DK,71_E! (8#(ST]^/3** ,G0XM;$,D^O36ANI,
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M_6_^$8\8:6QT\2Z[=7$\3B=]L0E4+AODY(QGCKGM7?T4 <1!X5U?3==TW7K
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M]1AO7MW-UJ$]ZIA9C@2MN*G('3U[^U "-KE[J?B35-%T=[6&32XHFN)KF)I
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M.,WEO<,T069%VB1" W!'53^=4'\!W=K8^'[:QGMI&T_5#JEU+,60SRMOW
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVY8;EV DX<9.&('ISP<U)IWC"YU3Q#<Z7%=V-O>VM^T,NF7$3+.UN&QYJ,6
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M!E." ,9//H*W#(BQF0L @&XD]A7C-S_R0GQC_P!?][_Z45[+#_J8_P#='\J
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MAT5S?@K7;W7=+O?[22 7MA?SV$S6X*QR-&V-R@DD9!'&3724 %%%% !1110
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M\MQ)%=1,SV\TBX<H5(!!Z\]/?NMEX+U6S?P:6OK.4>'8GB;$;)YP:+R^.3C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\9]ZUJ* *UAI]MIEH+:UCV1AF8Y8LS,QRS,3R22223R:LT44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>elicio2021employeestockp004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@ HHHH **** "BBJFIZI9:-827VH7"P6T>-SL">2<  #DDG@
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M-6-)U:QUS3(=1TZ;S[2;)CDV,N[!(/# 'J#0!=HKGM<\<^'/#=T+;5=1$,N
MS!87D$8/0N54A ??%;+7]HMA]O-S%]D\OS?/WC84QD-GIC% %BBLF'Q)IT^O
M)HBF=;][4W8CD@=!Y08+G) '5AQU'?%7KR^M["-)+E_+B9PGF$?*I/3<>PSQ
MD\4 6***S-.U_3]5U+4=/M'D-QIS(ERKQ,FTL,C&X#/'.1QR* -.BBB@ HHH
MH ***PKSQ=I%C>I;S23%6NELS.D+-$D[8PC,!@$Y ] 3@D4 ;M%%% !1110
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M110 4444 %%%% !1110 4444   '048&<XYHHH **** "BBB@ HHHH ****
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M;JXC$L,*7"%Y$(R&4 Y(QSGTJ676M+@O!9RZC:)<EUC$33*&+MT7&>IR..M
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M+:4XPDTRJ>3@=3W/ H OT5ROC/Q9!X>73+47MO;W&H7L5N6DD4&&)B=TN#V
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M+:WESX.TUH]_V&._4W3*,[ 5(5C[ D_B16C\3=2%QX4M_!OAD)=ZEJRI!#%
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M;Y(C&S'IMZ4&QM""#:P$%!&<QC[HY"_0>E 'D<,=G;>!OA7-$L$<K:E9@NH
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MCMM+N[B6-Y8XX7=DC^\P"DD#W-.GL[6Y8-/;0RL!@&1 Q'YU,JJBA5 50,
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MWCL(?+C"J6(SW8Y8\G'&!@<YV7MH))TG>&-IHP0DC("RYZX/:@#Q?2Y-/O\
MPQ\*E=K><K=B&0,0V"(7RI^A*\?2NT\*F%/B=XZAA**,V+E%QU,+9./RKKSI
MMB51396Q5!A!Y2X4=>..*DCL[6&8RQ6T*2-G+J@!.?>@":BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6W?[0N)2#@[3GG!!SCIBN3&J6.D?&#56U"ZBMA=Z3;?9_,;'G$22 A/[QY'
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MF." &"XS[?6H=6;2-'L]'U;2GN)?#C>(Q>:C=,Q>-W9?]:/^F8?'(XW+QVH
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MQAO;6=);6:,2QRJ?E92,@Y],4 <_XK\/7FM2:&++[(D6FZA'>LLK$;PBLNP
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M0&7+[L$\8QC\*]%P/2N9M/#MW#XYU+79I+5[:\MXK<0@'<GEEB&R>#G=T[4
M>;RVJ:-\-+192+:SN/%"7-C%(=NVV-R"N >@VC=]#FNNT_4H]'^*7B,ZQ<10
M0:E;6LNFW$SA8WCC5@Z*QXR&8MCT.:] IK(C@!U5@#D9&: /+]%\(W.J?#;5
MK*(M;M)JEQ?Z&Q&TP 2;H&&>@)&?H_O5J%M7\7?#[7=<2TDMM4U#36M;:W/#
M)L1@P'H6D,F/4!*[#7K'6[[[*NCZO%IR!F%R7MA*SH1QLR1M(_'],'1LK.'3
M[&WLK9=L$$:QQC.<*!@4 ><^'=3\)>*;G1);1[Z?6[$%DM9))=UBVW:^\'@
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M$-S$+>VB/DVA, "P@X+%AP""2> <#->A?$">&#X>^(3-*D>_3KA%W-C<QC8
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MK1C0MN**21C)':G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX6M;@JQBMM4LYIF"D[$6926..PH Z.Z\0:;96\<T\T@#QF4(L$CN$'5BBJ6
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M4%LZ L9BWW0J@9)]L9X/H:;IWB32=5OI[&SN]]W 2)H&C9'CQ_>5@".H^N:
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M9KRRBO)FFN+M^(&R,QJ2!\J] .?J:O6OB32KN]DLDN'BNHXO/,-Q \+F/^^
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M)XGA!&02K '!'0XYJM9^./#FH7EA:VVI!Y+]-]J?*<))\N[ 8KMW8YVYS[4
M=#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA:6JRS)AKI "SH.V_KCVSBO,;34Q8>"]>F%BETK>*)9&,L!E$$3S@BXV=6
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MAB8'!4[@!GD<?CTK6KSWPMKOA^UC\2ZO!?7%Y>3/]OO($LI8G5 H50D;@,P
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M=V8_,=I7>W)RS8_B)]: *_AF/4;+QSJVFQZ[<:KI$-K&[_:Y5DEM[EF/R @
MXVC)!Z9%=C<^?]EF^S;/M&P^5YF=N['&<=LUQ&FZ-IUS\0[7Q#X?MA;6GV&6
M.^ECA,4=PS,AC ! W,,.2>W -:]CI>J:%+-J.J>*K_4K2*)BUO):1 #OD>6@
M8GCH.N: ,#4+/7O"_B3P]<0>(]0U1-2OQ:7EG=A"A4HS&2,*HV;=I./I^/0V
MNK/K/B_4-.@D9+/1UB$Y0X,T[C<%R/X57!([EN>!@\]IOC33]1UJ*^N--UEK
MYS]GLK=M-F5;=7(!+.RA0S8!9LX &!T):WX)@DL?&7C>TF!\Q]0CNU)_BCDC
M&TCVRK#\#0!MCQCHANH81=/MFNC913^2_E/."1Y8?&W.01UQD$=:ANM5DT7Q
MAI^GSRL]EK D$.\Y,,Z#=M!_NLN<#L5XX.!YQ>WT^H:3I4\VFZA;75GXDBEN
M=/MK"1(;2,3L2V%7]XS##$_,26. *['QK$^H>*? UM"K"4:BUVP(Y6..,EL^
MGWE'U(H U_#^K/XBU'4KU)&6PLKI[*V13@2,@Q)(WJ-Q*@=/ESU/%*PO=1'Q
M5U339K^6:Q72X;B*!E4+$S2,IQ@#/W>IR:K?"N"2Q\-7^FS@BXLM5NH9<]2=
M^X'\593]#2V<@/QDU*79)Y3:1# LIC;8TBRN64-C!(!'% &I>ZK)HGB[3K*>
M5GL=8,D<6\Y,-PHW8!_NNN[CL5XZ\=)7#>/('OO$G@FS@!,PU?[6<=HXHV+G
MZ<@?B*Z+1O$=CKEWJ-K;)<QS:?-Y,RSPF//) 9<]5)5L'V- &O1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 445SOC/Q/_P (IH8OEM9;B22:.! B%E4NP7<WMSTZDX%
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ME2E0Q;#=N%;&<9QQFH+KQCI%E+$)Y)DMI;C[*MYY+>1YN=NTOTZ@C/3/&<T
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MI5>X-FC?,%=L9PJD'!RP7!/&*L:AX\T#3KI+:2>XFFDM#>Q+;VTDGFQ<?,A
MPW7/&< $G&* -B+38EU234I29;HIY2,1Q%'G.U1VR0"3U) [  2V]E%;33S+
MN::=@9)'.2<=![ =@/<]22>>L-:T:Z\47DUO=ZFUXNG12RVSQ2B-8B2598RO
M+')' )XQ3;7XC>';R/3IH)[EK;4)A!!<FUD$7F%BJJSD85B1P#STSC- '5T5
MCW_B73]/N+JW;SII;. 7%TL$9<P1G.&;'KM) &20"<5:TC5[+7-/CO\ 3Y'E
MM9.4D:)X]XQG(# $CGKTH O4444 %%%% !1110 4444 %%%% !1110 4444
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M,Z"19V9@S 87"D'G'MDX%=O10!XQ=6UY+\'?%5BFG:@;NXU2>2&#['+O=6N
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MEY^88_7I4>GC4- \0>&-=N-,U&;3G\/1Z7<+#:2/+:3*5;+1@;L'&,@'I]*
M-#P)K4,,/BV[N[B\^SQ:X\4:73/)*I*1JL8!)8G<< #/)XKHAXTTQ)]1MKN.
M\M+O3[<74UM+ 6D,/_/10F[<N1CCIWQ7GL^F:S>Z;XEN;70[N22+Q''JL5K<
MPF,7D*J@*C/4D \>WKQ71036&J:3JM_IW@^\TZ7^S98&EN-.\JX=F'$2* 68
M9R3VSCKS@ Z30/%VG^))%%A#?>6]LERD\MLR1NK=@YX+#H0/?T-5;WQ9):^/
M;/PXFGW+I+9O<O,J @X9%&.>@W')^GO4W@-)8? >A6\\$]O/;V,,,L4\31LK
MJ@!&& /4=:S-7CNK3XJ:/J8L+NXM'TR>T,EO$7"2&1& <]%! /)P* -2]\9:
M78Q7-S(MR]A:3&"YO8HMT4+@X(/.X@$X) ('.2,&KMUK]G;WMM91![N\N86G
MB@M]I)B7&7R2 %R0,D\D\9K@=)MM0TGP%KW@^]TV]GU F[BM72W=X[M9BQ1_
M, VKR_.XC&.:;>03>#]9\+F*WU&YO;+1#97$]I9->(Z*4 5HU(9?F!8-GMCG
ML =II_C31=3TM]1M9+DP+*(,/:R(S2EMOEJ&4;FW#! SCO56\\=V-K8ZVWV*
M\^WZ1!]HGL'0+(4P2&!!*E>#R"<8]>*XN>SAN/!=L?#]C>ZA<Z5K"ZGJ%A>V
MK03W&_?OQ&P'7>2H&1\N.2*W/(M=?\-Z_-HWA.?39KC2Y[8275D+>>9V0[8P
M.I4'J3QDC&>: *>NZ[-=V'@/6IFO+1I]1@6XC5G5)0T+.<1J3N!.,<$]J[#3
M?%^EZBFJ%C/9OI>#>1WL1B:)2NX.0?X2 2#[5Q=R]W=Z'\/@ND:JC6%];M<J
M]C)NC5(61F( R &..>O4<<TW6M%U+6M9^(-K9VES&]_8VBVDLL#I%,\08LH8
M@#J0.O>@#MH_%M@=6BTRX@O+2ZN(6GMEG@(^T(HRVP#)W <E2 WM4&B>.=)\
M0W%M%IT5_(EQYNV9K1UC4QL0RLQ&%;C(!YY'3-8WAJ^L=5O+2Y_X0:YTR^LU
M9KB>ZT_9Y!VD,(6QER3@?*.5SGL#;^%T-Q:^"TM;NTNK6>.ZN6:.X@>(X>9W
M4C<!G(8=* .CO]7AL;NWLQ%+<7=PKO'!"%W%$QN;YB  -RCKW%4CXLL"FG"*
M*ZEN=1\S[-:B,+*PC^^2&("X[Y(Z@=:R?&^EV>JW^FQW"ZM:7,22R6NK::DC
M-:O\@VML!X8=CP=N*Q+>^\3I'X9BUZPOI(Y$N1=W=A:'SBV_$0?:-T(=<,Q&
M.< D8- &UK7Q MK;PG;ZUI=M<72W%VEH 8]IA<R"-@X/0@Y&.YQVYJ]-J6E3
M^,M&@G_M&'57MIGMX6#I$4P-^\?=8CCU(S7G\>F:JOPSO;/^Q-32>TU_[48&
MA+221BZWDH,DOA><C(/8FNLU%Y[SXE>%;^/3[];:.TNUED:U?;&9 FP,0,*3
MM/!Z=\4 =!!XFL[FYMTA@NG@N9WMX;I4!B=TW;AG.0/D89( ..,Y%<9+>'Q3
MXG\4Z;?V^LQP6*6ZVILR8Y+8^69&<8/WR<8ZY  ]JCT[3KRQ\1:??>'$U6SC
MN[X_VIH]W;O]F13N+S1LPPASR-I^;(&.HK;\,"9?B'XPGDL[V*"[DM3;S2VL
MB)+LAVMAB,<$8]^U &K8^+=-NO"46OV_VJ:P)"(QC_>.=_E_=ZYW<8ZY[5JZ
ME:2:EI<MK'<36CS*%,L3;9(P2,[2.C8SS7$:9H=Y9>/[[1HPI\/^:FMJH/\
MJYGW+Y6/[OF*91Z%?K7H= 'FL^G>7\6K/0UU+6?[.DT>2Y>+^U;GF42A0V[S
M,].V<>U;[Z]I_@TV&AW]UJ5[=7)G>V9HI)Y)%!9PF_'S, 0H&2>GUK,NDN#\
M;+*^%C?&S31WM6N1:R&,2F7<%W;<=!UZ>]6?$Z3M\1?!MQ'9W<L%JUWY\T5L
M[I%OBVKN8 @9/_UZ -4>+K.2Q2Y@LM0G<VPNI+=+?$L,9S@NK$8)VM@<DX.
M<41^,M(NH-,DT]Y+]]3C>:TBMU&Z1$^\3N("XR <D'/'6N5UE7T+X@ZA?ZGX
M;N]8TK58(?)GM+3[0UO)&"I1E'(#9!SZ_CB>X>ZT_4= LXO#EUI^B203EH]*
MMLR12,X*1.T?^J!'+%2!N_BP#D Z:V\7:7>Z19:C:-+,M[,;>WA";9'E7=N3
M#8 (V/G) ^4\UH:;J4>IQ2O'#/"T,IADCG3:RL,9^HY'(X/:O+M&TB.;P+;Z
M-KFB:W;B/6+AEG@BD$UHQ>5TF0KDD#(&[!7Y^IYKIO#NI:UH?AZY;68=2U<)
MJ(M[.:*TQ<30':%DD3@\$L"QZA<T =M(@EC9&+ ,,$JQ4_@1R*\5L=0>/X;:
M[JUQXEU.'5[:]NHK)VU"1V=D;$<8C9BKY.!]TGFO:I)!%&SL&(49(52Q_ #D
MUXYX>\'76I>$[N:WL[C2_$MEJUQ?:=<7-JT1.6RJL6 RC X(_P * /1]+UFX
MA\(Z5?Z]&8-0N((A+ B'<TS ?(%]<]NW.> 326_C#29#JJ7+R6,VE()+R&Z4
M*T2$9#\$AE(!Y4FN2\0WNJ>(_"^C:NGAR]-[I=]'<WVD3V[*TB['1Q'N&),;
MLC&?SXJ6[31]7\(>(;R'PA<V-M)I[QRF:V6TN;@@9"KGG QU/&2, X- '3+X
MRTT:G8Z?/!?P7-_&);17M6?S4XRWR;MN,C.[;C/.*Z&O+M$U6TN/$&@3ZZFM
M1WEA";.TDNM&EM8C)*%0EV)8%FP%'(&2?48]!TO5/[3-Z/L-[:_9;E[?-U%L
M\W;CYTY^9#G@]\4 8/CC67T1M*NI5N)=,69S?QVI;S5CV'$F%Y**Q&['J/I6
MQX9(/ANQ*ZM_:R&/*7O_ #V4DX/4]!@=<\<\UD>*DUG2]6M?$6D6_P#:"0P-
M;WFFYQ)+$2&WQ?[:X^[_ !#CKBK/@:WL8_#,=SINU;*^EDO(8D&%A61BVP#M
MCN.QS0!0^)EQ>V?ANWNK*_N;5UO[5&$+!?,5I54@G&<8)Z$5V=<9\38KBY\+
M16]K:75S,;ZVDV6\#RD*DR,Q.T'& #UKH=3U@:;:VMPMA?78N)XX0EM 6:/>
M?ON#@JH[GM0!@?$'5KV#PWJ]KI$[0W<.GS74UPG6WC5&(Q_ML00/0!CV&;,.
MF7/B#PMHD4NJ7MM UG')</:S&.:9BBX'F=0.6)Q@DXYQG.'XN\%:G)H?B:XL
M/$6K.U[!/*;".*%EE8QD"/[F\C "CG..E31ZAJ?A'P3I%E]FUK5;Z:%%,D=C
MYK6J[1G<$ 'R] #R3U[F@"3P9%J\%WXIT-]6NKNRL;E(K&^N3YLJ;X@[H6/W
MBA88SGW]*@T6(6/Q,>QTOQ)<7UJMBSZA9W=_]H:.7> A4$DJ?O9 X QTR*TM
M!U^&#2;L6WAS7[>WLH_-?[59E9KEV)+;%SF1B<DGU(]>*S:?:^(O&F@>(-.L
M+FU:Q$S7-S<6CVS2*\958B' +')ST(&T\\B@#MVW;3MQNQQGIFO-O$>C:OX>
MFTG6;#Q#JMSJDVHP03VTTY:WN5D;#J(ONH ,D8Z 'ZUU%MX;DT[5GU5_$>O7
M,:EY#92RH\."#P$6/<<9X .>!UKG(_%\EUJOV^Z\)>)Y)H2T=C#_ &:P2,'C
M>6) #,.I_A4X'5B0#??5&U;QQ-H,3LMKIMLEQ>;3@R22$^7&3_= 5F([Y4=,
M@NNO&^D6CW#.+AK2UO%L;B[2,&*&8E1M;G=U902 0">M9>@V\FG_ !;\5B<8
M_M.TLKJ ]BL:M&X'T)'YCUKE/%(UG5]"\26T^AZNU]#JB-;PVULP@:W6:,B1
M=N!*S*"3]Y@>P H [S7=3?PYKVD7)D8V&J7:V$\;'(25E)BD7TR5VD=#N!ZC
ME=+U1O$'BG5D1V%AH\JVJJIP);C:&=F]0H*@#IG<>>,97Q"BDU>T\+V,,4B3
MW6M6THC88=$C#2.Q';"K^M.\!P/I>M^-;"X!\W^V'OAQDM%,BLI'K]UA]010
M!F^+=&UC0[&W\0V/B'5)M;^V0(;5IR;:X\R15,0BZ!0&..^!DG/-=)X@U-_#
M>M:3>&1C8ZE=K87,9.0DC@^7(OIRNT^NX'M6$_C!KG5S>W?A/Q1*MH["QA33
M&V@X(\TDD?,02!G[H)[DU;^)%O-J>G>'=-1,75WK-L=BG.P)F1V^BJIYH Z_
M4=0M=)TVYU"^F$-K;1F660C.U0,D\=:S;+Q58W>HMI[P7=M=BT%ZD4L66DAS
MC<NTMGG V_>Y'%+XPFU&W\(:I+I-DE[?K ?*MW3>'/?Y?XN,G'?&*XW2O/7X
MD:?JZZ9KSV<NBR0/<WENX;S/-1CN4_<X!^4  _P@T ;T'Q*T"XM+*\C6_P#L
M=W<?9A<FT<1Q2;R@#L?NY8?AD9QFM?4M;M(KF?34AN[NX2'S9X[,?/%&<@$G
M(P3@X .XX.!7F:V6H#X)PZ9_96I?;UU+S#;_ &*7>%^V^;G&WILY_3K71:?<
MWGAWXA^()KW3=1GL=:^SSV=U;VKR@%(]AB<*,H?3=@=<D4 7_A/<RWGPTTFX
MFGEGD<SDRS.6=OWTF"2>3QZU=L]4;7/&>IV*.RV.BB)7"G'G7#C=S[(NWCU8
MYZ"J7PK@NK3X?:?:7ME<VEQ$\VZ.XC*-\TKL#@^S"HO!MM)IWC?QK9S AYKN
M&^C)_CCDCP"/8,C#\* -1/&^D/-;;1<?9;J]-A!>>6/*><$C8#G=U4@$C!(Z
MTRYU-]#\:Z=ITDC-8ZTLOE!CGR;B,!B ?[KJ3QV*\=37 7;:SJ6FZ1<WN@ZR
M-2LO$,4]U;PVK+!!$LS',2C D!!!+@,<DY(!%=;XMMY-2\<^"+:)&#PW$]]+
MZQQI&!SCU9U7\: -'PYJ<GB6YU/5$D*VMO=265BO5?W?RO*1QN);<!Z*HQC)
MSAFV.F_$G1K73O%%U<7,JS/J=E=WWF!XPGRL(R<(VXC 4#C/& :L?#-'T?PC
MJ.G3QR/<:7J-W')&BY=_G,BX'?<KJ1ZY%)J=M:^-+_P]?6.F7UK>6-_'=27-
MW8R6SQ1+DM&2X&[=PN%R._:@#6OM3?0?&.EVKR,UAK1DB"L<B&X4;@1Z!QN!
M'3(!'4YZ>N(\;6SZCXL\%64()DCU%[UR/X8XHSN)]LLH^I%=/IFJ?VE+?)]A
MO;7[)<M;[KF+8)L '?'S\R'/!]J -"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@8MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115'5M6
MM=&L&N[LR% 0JI%&TDDC'HJJH)8GT% %ZBL#P[XOTOQ+-=VUJ+FWO;0C[19W
MD#0S1@]"5/8^M7]9UJUT.S%Q=+/(7<1Q0V\32RRN03M55Y)P"?8 F@#0HK#\
M.^+-+\3QW7V)IXI[-_+NK:ZB,4L#'D;E/3///M26?BW2[V:U6,S+!>NT=G=.
MF(KEER2$/T!(R!N )&: -VBBB@ HHJL;Z 7YL@29EB$LF!Q&I) +'MDJV/H?
M2@"S15>SO(KZSCNX=WD2#<C,,;E[-]".:YZ?Q_HT=G=W]NEY>Z=9$BYO;2'?
M#'C[WS9&\#N4#8H ZFBJ,6LZ;/HJZS'>PG36A\\7.[";,9W$]JPD^(GA_P"S
MS7,\EQ:VL=HMZL]Q 562)F*J5[DDCA2 3D8% '5T5E:/K]MK4MY#%;W4$UHR
M++'<Q;"-RAQCJ#P1QU'?%:M !16+XB\4Z9X76P;4FF47UTMK#Y<9?YVZ9QT%
M;5 !1110 450UK5[;0=(N-4O!)]EMD+RF-=Q51U.._X5SUE\3/#5X^F!I[FV
M35"5L9;FV=(YR#C ;&,Y]<=1ZT =A1110 45BW?BG3++Q7I_AN9IO[1OXGFA
M C)3:H).6[?=/Y>XK:H **1CM4M@G S@#)KC=$^)_A[7]7ATZR6_WS2/%%-)
M:LL3.@W%=WK@'CV^E '9T5D>'?$EAXGL9KJP%PBPS-!)'<0F)T8 'E3SR&!'
ML:UZ "BBB@ HHHH **** "BBB@ HHJ.>400/*4=P@)VHN6/L!0!)169X=UVU
M\3:#:ZQ8I*MM<AC&)E"M@,5Y )]*TZ "BBB@ HHJE!J/GZM=V'V.[C^S)&_V
MB2/$,N[/"-GDC'/ID4 7:**K:C?1Z9IUQ?3)*\4$9D=8EW,0!DX% %FBJ.C:
MI!K>BV6JVRR+!>0)/&L@ 8*PR,@$\\^M7J "BJ.J:K;:3#"\^YGN)E@@B3&Z
M61LX49('0$\D  &HM%UE-:M[B065Y9R6\[02PW<01@PP>""58$$$%20: -.B
MJ&IZJFG:5/?QVMS?B(X\FR3S9'.[:0JYY(.<^F#5^@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHJE'J._69M.^QW:^5"LWVEH\0ODD;5;/+#&2,="* +M%
M%% !1110 4444 %%%% !11535-1BTG2[G4)TE>&VC:5UB3<VT#)P* +=%4])
MU*'6-'LM3MU=8+R!)XUD #!74,,X)YP:N4 %%9%_XBM-.\0:5HLT5P;C4S((
M'5/W8V(7;<V?0=L]:UZ "BFB1#(8PZ[U 8KGD YP<?@?RIU !154ZA =2^P)
MNDN @DD"#(B4YP6/;)! '4X/8$U8D8I$[JC2%02$7&6]AD@?G0 ZBJUC?V^I
M6JW-K)OC)*G((*L#AE8'D$$$$'H15F@ HHHH **9+)Y43R%6;:"=J#)/T%9W
MAW7K3Q/H5OK%BDR6UP7V+,H5_E<J<@$XY4T :E%-DD2*-I)'5$0%F9C@ #J2
M:=0 4444 %%%4KW4?L=W8V_V.[G^URF/S((]R0X4G=(<_*O&,^I% %VBBB@
MHHK(M_$5I<^)[KP^L5PMW;6ZW+LZ80HS%1M.<GD'MCB@#7HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]UDQ01E68%@H4[01SM'&.O:L&[^(?B8P^/=2M-35=,TF7[-92R6R, ^XK@8
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MJT@LO.10(S.J?>V@9 9\\\X&,UU=KI^N6>O)(^L?:]*>V*RQ7**)1.#PR%%
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M9:XN1()MN&?[.WS@ #;WX''3CUDM=4\22GQY;65R]]>V$Z)IZ2*BE08E;:,
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M<JHR< D#H/6LB;QG9PV'AV\:TNS%KTD$=N0JXC:5=RA^>.,],]*YJTU:_O=
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M3SM=6/V":V=4\IH<DXP%SG+'OWJEX>\!Q>'Y8HTUO5;O3K8[K2PN95:*'TZ
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M \7A2[GN;BSAC2.&8LJRQ[,;"&4 97 YQ]<UKZYJ\>@Z-=:I/;SS06L;2RB
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU$<ZH25+C;G(R>A /<5EZ/\ #O3M$O=UGJ6JC3EE\Z/2FN<VL;YW#"XS@'D
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MU="_M=7>!;@JF73[4(\'Y>!M/\.*]#T3PU#H5QJDUO?7DK:C<-<S"8QD+(0
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MR^:I7:RX7:,;%&,=N<DDT 4-<:YCU=K"/5;V98]-9X[.TD*SK)N/[^23(&T
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M(W!4LH))QE5&>2: -:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM+63[?)&L!B8 !XE0JX;&3NS][C&!7H-FTKV-N\[1/,T2F1H3E"V.2I],]*
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MQ6[JL,[NI%P"H)90#D8/'-7:\MO/%.J>'K3XC7OVJ:\?2Y819K/@B+?$IZ
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M+N QUQZYH [*BO&!?:W%\,F\3-XAU.2^L=49$5I1Y<B?:_+*NH'S J>_ P,
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MJNI:A;:3I=UJ-X^RVM8FFE8#.%49/\J ,2+P59KH=]ID^I:I=_;H3;W%U=7
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MNBRLX3Y4"( #P&/?IG.:/"^F1B^U;Q"VG/97&KRHQBE7;((T0*N\=F)W-CW
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MUS9*FV-2<+DLP&3@\#TH =<^#].NM U#2));D1:B[/>3AE\V=FP"2<8'  X
MP  ,57UCP)IVM1Z:TMYJ%O?:<NRWU"TF$4ZJ1@J6 P0?I_,U<\,>(SXDM;N9
MM,N]/:UN&MGBNMN[< "<;21QNQ]<UN4 4M+TR#2+%;6!YI "6>6>0R22,>K,
MQY)/_P!8<"LBY\%6$NOW.L6UYJ%C<7B!+Q+28(ER , N"#@@<94@^]=)10!R
M</P^TNWT;1M+BO-06WTBX6YMLS*S>8N<$Y4\#)X&!STJW=^$+2^6\AN;V]DL
M;R83SV;,AB9@0<?=W $J,@,/U-=#10!RVH> M,OO$$NM17FIV%S<*J7:V-T8
M4N@O W@<Y XR"#[U=/A:S_X2*SUJ.>YBFL[<VL,,901+$<97&W..!W[<5#X@
M\6PZ+I5IJ,%LU]!<7D=KOCD"JA:39DD\D9] >E=%0!RNJ^ M-U/7VUN*]U33
M;V5%CN6T^Z,(N5' #X'.!QD8/O5R\\(Z;=:AI=ZC7-K+IL30PBVE*!HFQE&]
M1\H]#[UO44 8$'A#3HKC6I)GGNDUK'VR&<J4?"[1@!01\O'7]>:33_"-I8_V
M>DEY>WL.G'-E#=.K+ =I4$84%B%) +$X!KH** .97P38K9:Y:?;K\Q:T[O>9
M9,DLNUMOR<94 5<M?#<-I/I,J7^H%=,@:WCB,V(Y5( 'F*  Q  P:VJ* "LV
M?1UGUVWU8WETLMO$\*1*4\O8Y4L""N3DHO?MQBM*B@#-U+0M/U6]TZ]NH0US
MI\WG6THX9"1@C/H0>1[#TJG-X4M3K5WJMG>7NGW-ZBI=_960+/M&%+!E;# <
M;EP?>MZB@#GKWP9I-U8:39PB>RCTF026;6DFQHR%*D9.<@@G.>3ZU=U#P]IV
MIW6E7-U"7ETN;SK8DYPVTKSGKU!^J@UJ44 9MAH.GZ;J^IZI;0[+K4FC:Y;^
M\47:N/P_4FJ-OX0T^%]<+S74Z:V"+R.5EVME-G&%!'R\5T%% '+#P)8BRTBU
M_M'4V729EGMF>968.J[5SE>@7C' _'FII?!EE-J&KWK7M^LVJI&EP4D5<"/[
MA3"Y4C)Y]ZZ.B@#$3PO9M<75S>S7%]<7-H;)Y9R@(A))*#8JCDG).,UF+\/-
M,CM=(BCU#54FTDD6ER+G]XB%0ICSC&W: ,8[?6NNHH X^3X;Z/)I6JZ8+K4E
MM=4N?M5PGVG=\^58X+ D9*J2>IQUQ6K)X9MYO$-GK<MY=O=VL#6Z E-C(V-P
M("\Y('Y<8K;HH XE_A?HS:5=:1'?:K%I,\HF%A'<@10L'#_)\NX#(Z9(YR #
M@C:/ABV_X2./75O+U;R.T-FOSJR^63N.<J23N .2<_AQ6Y10!R1^'VF'PO+X
M=-[J!T^6?[0P\Q-V[?YGWMG3?S_]:N>U^WW^,[R34)/%NG[;>&WM[S2$DD2Z
M4 L2XC1@K!G88VCIGOQZ=10!A>%+:_M=+E2]N[ZYC,Q:V?4 OV@1;5X?:!SN
MW$9&<$9YXIS^%[/_ (2.XUV&YO+>[N(4BE6*7$;[,[&*D')&XXSQ[5MT4 <D
MOP^TQ/#%KX>6]U 6%M.+B(;TW!@_F#YMG(W<_P#UJ?JG@'3M2UW^V8[_ %33
M[]XUBN9;"Z,/VE5X DP.?J,']*ZJB@"*VMX;.UBMK=!'#$@1$'8 8 J6BB@
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M]$U"YU:64WJIJR8NX(KIDB=MNW?M'&[&/;C.*LP>#["VU/3]0CN;WS["W-M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKSNWO;W3?BU'X:L]0NK[2KG36GN89YFE>S<$A6$A.X;N!@GOD=J=X&UZ'2_
MINM4N[B8MJMQ:Q&1FEEE<SLB(">23P.: /0J*Y\>,M*6TU>><74#:1_Q_0M
MS21 KN!PF<@KSD$BHK'QSH]_J.G6<0NT.I1>9:32VS)%-A=Y57/!8#GTX/-
M'2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR<  < <  >U '(O%//\ %JXN4M+O[-)X?%LMPUM(L9E\YFV[B,9VD&K/PO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<NIZ# )STXJMI_Q TF^UR#29+74["XN@QM&OK-H4N0.3L)[XYP<&@#JJ***
M"BBJIOX!J#60),J1":3'2-22%+'W*MC_ '30!:HJM9WL5]8QWD6X02+O1G&-
MR=F]@1SS7.S?$#25L+S4K2WOK_3+(D7-]:1!H4V_>()8%P.Y0,!0!U=%5=.U
M&TU;3K?4+"=)[2X0/%*G1@:M4 %%8WB3Q1IWA;0KC6+\RO;6[JD@MUWL&)
MQGCJ.M:T,JW$$<R9V2*&7<,'!&>0>E #Z*** "BH;NX%I:2W!C>01*7*IC)
MZXR0/UKBK?XN>%Y]+AU5S?P:9+<?9EO);4B(28S@D9(^N,4 =W12*RNH92&4
MC((.016+=>*=.L_%UCX9E6X^WWL#SQ%8B8]JYSENQ^4_Y(R ;=%%% !17)S?
M$'2X;'5KIK+53_9=P()X19MYAR2 ZKW3@\^QKJ+>>.ZMHKB%MT4J!T;U4C(-
M $E%%% !1110 4444 %%%5KN^BM(+B0AI7@C\UXHL%]O.,#/?!_(T 6:*SM
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M+LJXW,2Q"JHR!DD<D"DTG7[;5[F\M8X+J"YL]@GBN(MA0MD@9Z-P,Y!(YZT
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M9SK/')MC\PE7\P G;C&[VK4?PM%-XJ77YKV:27[";!H"B>4\18,<C&<DCUH
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M' P!R> .@Q6>WA*-?$&JZO;:G>6[ZG$B7$";#&61"BORN<A3TSC/)!H \_\
M#EUJVB>"/A_J$&K3&"[NK:QEL?+3R3%)N&>F[<" <[L>U=#/J7B+Q(NOG0YK
MBWN;"]DL[38\0B#QA<^8&!+;B3GT4C'.2=)?A_;IX>T31EU6\%OH]S'<V[[8
M][-&25#?+@@9/0"BZ\ QMXAN=7TW7-4TLWVTWT%HZA)R!C=R#L8CJ1S]#S0!
MTMH;N?28#=E(;UX%\TPD,J2%?FVD]0#G&:\F35_&#?"Y?&:>)'>ZL9)I'M6M
MHQ%<1I.ZL'P,YVC@@@  <9YKUY$M["S5%V0V\"!1DX"*!@<GL!7F?P\T%=<^
M'4%A>W\K6+W4SW%CL4$CSW8(3C(1AAB.IR><'% &]I.K7]_X^U33FO9Q8MI=
MO=PQ%4S"\C.#@[<] .N:YFW\2>([KP%X-U!=9=;V_P!96RN9##&1(AFD7D;1
MC 1>F,\UW%]X36Y\3KKMKJEY8S-;"UN8X FV>-6+*/F4E2"3RN#@]JR[?X<6
MUMH.D:1'K.H"#2[X7\!(C)\P,S 'Y?NY9N.O/6@!MO-J4/BNV\(SZY=3[;&7
M49;MDC2:53*$2,87 "Y)) R>.@R*RO%MKK-KX?\ #EKJ>I0WEZGB>T6*Y$>/
MD\P[-ZC + $9QC/ZUU'B/P=%KU]8:G!J-WINK6(98;VUV[BC?>1E8$,IZX-,
MOO!4-_I^G6LFJ7V^SOH]0-PQ1I)YD.5+DKC'L !@ # % &59ZAK&F^*O$NBR
M:U]J2'3([ZUN-15%6"1MZG<451LRH/3@9JOHVN:G'XQ\/V+7]W>6FHZ=-)/+
M<1JJ2RQA#YD0P&"G<>H (((SUK<O_ ]IJFJ:K>WE]=.-3L/[/GB4(JB/G!4X
MR&!8G.3]*BM/ @@U+1=0GU[4[FYTJ-X8V?RP'C8*-A 0?W1R/F/<], &/X?\
M3W,WB*UTO6[V^TW6TDE:>QN8U\B\C"O@P,%Y ^4\'. <YZTS3]3\5^(M"TKQ
M%I$CK)/,)I()I8A;-;[B&CQ@L"!_%G.0>W Z2V\((C:2+W49[Z+29/-M!*B!
MPVTH-S #< &.!QVSG%4=.^'=OI5]*+/6=3BT>28SG2 Z^1N)R0#C<$)Y*@X/
M?(XH UO&EW>:?X*UJ^L+EK:ZM;.6>*145L,B%APP([5QT^H>)=$?PCK<NN27
MUKJUQ;65Y8O BHGG+\KH0-P(/7).?8<5U?Q =5^'OB%21NDT^>-%[LS1L H]
M23VJCX<T)-0T3PY=7NH27L5A#'+;1%5 641[=SX'S,H+ =,=P3S0!G^&O^$@
MUO6=;\_Q+<I!I>M/ D:V\7[V(1H=C';_ +7!&.^<\8HV'B[5H/"S?:;XRWMS
MXE?1XKN2-!Y2&8J&V@!<A5..,9QG-=EH7AI=!N=5GBO[B<ZE<M=2+*J820@
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M5KZYE7^VKY#')LVDB7[_  H.X_7'/2MCQ!<W0U^QM$U&2*WDMY6^QV0S=32
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MEENEM8XW6.="@+1EESU)ZYXST/(U[[P&L_B&;6M.US4]*N;M%2^6S9-ESM&
MQ#*0K8XR*O?\(E GB/3M8AO;B(V%J;2*W 4H8SC.XD%B3M'.>U '/?;?$&LR
M:YINGWMW]JTDI9PW$;0IOF$*N99%8'(+-C XP..>EBTU37X_&^@:;J5TJFZT
MF:6\MH=K1B="B[D.-P')XS5W4_ J77B.77--UO4M(NKI%2\%FR;;@*, D,I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4,4C/51M '.!D]3@<\5T%% ''GX>63>$8O#3:MJK6,3QM&Q>,NJQL&1!\F,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>:O)!+.85PB1QLP+GA=Q'W5SC)/\\"N<\!V6J+>2:9JH9X?#+/8VDS'/VC<
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M=6F1I9UC/(3@;FQZGGUZ5Q^M>+IM3\*^$M=MKJ[TY+G5K$7*;6B1HY&!92S
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M76L:)9W9$L2QS7]T)E:4CH@\WEMO<]!D 9YP =;1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9'MRI=66-B77U4 9(/; Y[5R]O\ %3P;=6:7J:K(MF\WV<74EG,D(DQG:79
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M3C+2$8/! &1P>37-Z?XXU270_'GBF6:T^SZ9*]GIDPME!<H3C<>K EH^_<T
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M*!<NP,<@3'W#'ESGG"M7H$:E(U5G+L  6;&6]SCB@#GK#QQHFJ6K75A_:-S
MKLA>+3+AAN4X(XCZ@U/-XNTF$:,Q>=EUAUCLV$#@,6&X;B0-O /!Y]JX+X?W
M7B&W\ :HVCZ=97#K>WK1-+=LKE][=$$9!YZ#=S[5T/CI%CU'P2B(J*->CPJC
M '[J6@#JXM3BEUBXTP07(E@B25I6A(B8,2 %?H3QR*NUR5EK6J-\0M<TF:1)
MK.UL(;FWBCB"L"S.""<DD_*/0>U<Y'XK\0WGA[PMJUI?QBZUG41:7%FULKI
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M@+D\9)(Z8YYN;Q5XFN/!^LW5O*JZIX=U![>]$,*E;N%,%G4-G:VPYQZ@\<C
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MVWF#2;;))7((9]WZ;<^V*XK1M4BTWP+X)U.:XE31K/4;R.\FMCN-N7>58G(
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M,21")8D6-> @4 #\*?10 SR8N/W2<=/E'%/HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MXGXK'9X%DF;/EPWEI+(V/NHLZ$D^P%=M1UH \\_M>"T^*T>IWERBZ1J.D"&P
MO'.V+S%D+,@8\ L,,#_$ ,9J]X LY(;SQ1>Q<:9?:L\UF!]UQM4/(O\ LLP.
M#WQGO7:,BNNUU#+Z$9I: /+_ !3J]F?$7BK2R5TZ[.DJ ZQ[Y]1!20A4R"-B
MY(.!GD\@"L[3M0T^YF^$>9X6$5I(K;ST86H7O_MC&?48ZBO8,#.<<^M+@>E
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M%L$+WM[:0IIVI11?>N8Y, 'ZB7:1_O&H/%<,GA?3_"M]?FXDL+*\DEU6>UW
MK)+&X,WR\[0[M^#8KJYM%U6]\1&XO=5BDT6.2.:"P2W"L)%'&^3/S -\P&.H
M'IST! (P>10!Y)K::1=^'-9U[PG'>:@'N;*XO[B.61OM20R LB;CR50<D?3K
MG'1>&;SPEXA\11:UH<]SJ%]':&&2Z>64B&,D$1MNXW$\XZ\$UW"J%4*H  Z
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M=O;?#D@_W@*])Q7/Z+HNJP7[W^NZK%J%RBO%;>5;B%8HV8$\9.6.U>?1?J2
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M\2? SI<1'=IUV/O8/S+'M_/!QZX-<EJ&O:?>:+ITT<L>GK:^*(GGTR*/_CU
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^'#/XJ36TU2\A0VOV:>S1AY4P&_:3W!'F,>/;\0#4%];-9M=K*&MU!)D4$C
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M/'<-DD]AQSP =?17$VGB7Q'/H>GW%]IEOI<S7+PW]S=96*&-0=LBHS*QWG:
M,Y!/.<5E7'Q UF/P%KFLPP64EWI.IM8L7C=$E4.BAPA.5.) <$]J /2Z*Y&V
MU[6[7QTFAZHEC)!=V$EY;FU1@\;(R@HQ8X?AA\V%^E5_"'B^X\426TD=Y8$A
M6_M#3_*:.YLWQPI#-D@'*D[1D\CT !VU9_\ ;>F_VZ-$^UH=2,)G\@ DB,$
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MQ+&K*QXRQ(SZ"L!?B,Q\*>&-9O/(TV#5@1<7<D320V[ ' .",;F'!)P,<^M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV\,#SVUXLK1J 91Y"M\QZMSSSWYH [^34K&*Z%K)>VR7!Z1-*H<]^F<U9!#
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M;^Q]/^SAM_E?9DV;O7&,9I]UH>DWTMO+=Z797$EMCR'EMT<Q?[I(^7\*OT4
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MM-*. \D2L1^)%6NE 'F^CW7A37[WP[J]EKMQ>WMG$_V6TA,(>%"F'61$0$*
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ML,\!;:2-R@@@\$$<T =;53^U-/.J?V8+VW-_Y9E^S"0&0(,?,5Z@<CGWKFO
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MV[CM^]SG;C/O6A110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY^$'? 1B?P]\;M1M;P/<)<-#&9D!5)"HW*#U /44 <H?B#I:_#ZY\7JZ7%K
MFYHX&R0Y( C)/\664'L,U2LO%OB>XT31-7_L;3YK75I85VP73[K5)2,,V5P^
M ><8YK:U1-!O)F\&W5O$%U*TFF:! $!4,H)&/XLMG/\ LDUYY\-Y=3\&?$#5
M_A_<W9O=(M;<WEM,W6!3M.#Z AN1ZC(ZT >RUROQ"\72^"O"[:M!:1W<QF2&
M.%Y"F]F/; .3WQQT->(Q^)'MO 7BK6;1I#J/B;4S:6<:.<PP;FQC^[G+J!WQ
MGL<=EXATR/4_$GP^\"+<-/:V< U"]E20G>$7"MN!S\Q5^?\ :H ]AM6G:TA:
MY54N#&IE5#D!L<@>V:EKPOPOI=YJNA^/K/0]0>RL-4OVM]$9I6VNZ;VDV$G.
M&5<9] ?2JI\001?"#Q%?W&F#3]=A5-#N(8UV*9E/#J!T;#DGW0>U 'L?A74=
M:U326N->T<:5>"9T%N)1)E!T;(]>?RSWK,B\7W=Q\4)O"<-E";:VLA=7%UYA
M++G 5=N, \@]3Q7!SS_8+KP7\/7O1!8)9&^UB428\[9N+1$CL9%?<._2L"PU
M&TMOAW\0?%\<21-J]R;6QA'#)%G9&5 Z8W'I_P \^.E 'MWA;4M;U339IM>T
M<:5=+</&D(F$FZ,8PV1Z\C\,]ZVZ\4>8Z</ _P /FO?L]K):M?:Q*),&0+N9
MXBW7!=7#=^WK67I.JP1^!OB+XN#%(;N1[73H"V/*BSLC*K_"-SCIW3VH ]_J
MO?R7,6GW,EE"D]VL3-#$[[%=P/E!/8$XYKRG3_A^+;X?G5[R]U :@OA^6%8!
M.52(E?,! '.[<,GDY)/M3_AU91^)]#\%:E)-.\VD6LRSMYA*,K;HUC8="<#=
M[!1G[PH ZBV\5:_+;>';A]#@$=_.]O>A;G+1,&*JT8Q\ZD OG^Z,^]=G3?+C
MW*VQ=R#"G'0>@_(?E7$_%^)9/A=K3-N#1QHRD,1@[U';V)H [C(SC- ((R.1
M7FVL>'M,M_BEX?AAMRD>IV=XM^HD;_2@GELOF<_/R3UZ]#Q6";UO#GAKQ3:6
M<GV32[;Q-%;M@$I;6SF(R  $$+\Q& 1PQQB@#V8$'H<T @YP1Q7G=UI&G>'Y
M]4UM]<BL[2YTB42V^DVWE*RK_P O"@,PWC< &]Q5#2;9;#Q]X7C@MH;*WN]&
MG5HXG!DE11&4:5E !?DGC.#G!- 'J>1ZTI('4UX1<Z39Q_"CQ'JRQM]OT_6+
MAK.X,C%K<K<@#8<\<=?7O75>-X+RWU'5-4DTRVU[139K#>VP8+=6("LQDBSP
M<AMQQ@Y ]* /3:3()(R,BJ2:A:R:"NHK,R6;6HG$N,,L>W=G'KCFO+-,2&UU
MKX>7EC&(;:[:X"SRN#=7<30,^^<J ,DX;'S8/<'B@#V#(]:6O%YM!TZZ\-?$
MR:>%I9+*]NI;4O(Q\EUMT8,N3PV>_7MTK;UV,:;9^%/'SQB62SBA34V*Y+P2
MH%,A]61B&SZ$T >FTA('4XK \*VT4L-WKGDJDNK3&X4A<'R0 L7YJ Q]W-<Y
M?;=>^(VL:#J,E@4CL8&L[:^MC,'1M_F.@WK@YP">3P.F* /0ZKWM[;:?8SWM
MW,D5M ADDD8X"J.2:\MN-#@MM3^'NFRZK<:HD=S>6S73.R&5%BD^4X/;[N>X
M%4]1TZSL_#_Q4TB"VB73[,)-;6^W*0NULKDJ#T^;GCI0!ZI<7.H7-OIUQI*V
MIBFEC>X^U%@1 1D[-O\ 'TQGCK4T&J6ESJMWIL,H>ZM$C>=1SL$F[:#[_(3C
MT(]:\^\06%E::7\/VLX(X/\ B=68*PC:IW1L3D#@DD*<^U6-#T72+CXG^.$G
MTZS<;++&Z%>#)$^_''5N_K0!Z+37=(HVDD941069F.  .I)KRK0[98//^&EQ
M"':VOQ.'9<^;8%O-#D]SD"(GWKT37[6WG\,ZC;S01R0&UD'EN@*\*<<=.PH
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M*M,RX!?G/&<'/)J;P-X0T/6+?6)]1LOM4EMK=_# 9)7(C0L4*@9QT/?/;T&
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MR;_A)+5]6\.^/A9Q0Z<D2:;J;"/F.:1<YQV\M@JYZ_.1VK6\7Z0EAX$T^>2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI]G#=M:&\MKFQD9HI8PP5@0P!# D?YZR^)?%[:+K>BZ9:VPG>]OHK:XD8_+
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M*"<#KC)H S[;P1X9LVLVM]&M4>S):W< EHR0!P<Y[#'I@8Q4\>DP>'=,OY-
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MC[_^D8Y_# KHO^$2\/\ ]FC3?[(M/L*OY@MMG[L-G.=O3.>:L?V#I?\ :/\
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M:,-!F_2'$QR&8@@Y(7@>F6ZY&,7X3ZI+:_#GS]4MH[&QMI9V2X:<.),SR%N
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MD8B14P1@!1R?7MS5Z\U<_P!O6^B6>PW;PFYF9AD0P@[0<=V9N /9CVP<&?\
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MHG>Q1E!2*4VQ:0)Z ,W0="37H7A&VM[;PCI(MX8H@]G"[>6H7<QC7)..I]Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEMM0LKUY$M;RWG>(XD6*56*'WP>*/[1LC,L/VRW\UG9%3S5W%@,D 9Z@')%
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M-4T^VA'B!9(#9748'G&?SPH4-U/&1MZ#'M7=>'##J7BGQU8:Y'')/]H1?+F
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MHQP>,FO7!HNE+=170TRS%S$H6.80+O0#H <9 J*+PYH<*A8M&T^-1,+@!;5
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MX?[%'L2W.U<H>2<YR><'FL1?*/QQE7Y"W_".*<<9_P"/DUQUX9++P?\ $?\
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M26ZYZ;(\_P#?U*I:KHVGP?$3PA<:#:V\%PHG:Y:U4*&M?+QE]O4;RH4GN>*
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M=[-"]MIWV4VP2+9M$B,QR<G)X'/MT%;=MK.EWK2K:ZE9SM$N^013JQ1?4X/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5%<W,-G:RW-Q(L4$2%Y';HJ@9)J6N-\3:VT'B"WLKG1M9NM/@
M5;EFLK%YDFER=JDCC"XW8[G;Z'(!L^%_$4'BK08M6MH)H(9))45)AAQL=DY'
M;.W.*V:\]^#NI+>>#&MQ:WD)@NKAB\\!1'WSR'"D_>(Z'T/%>A4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!G:)HMGX?TQ=/L X@6220!
MVW'+N7;GZL:T:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>elicio2021employeestockp005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%OXIU0:/I, 1I\0F0S\#KY>/O;^,?PUZIK&J0Z-I-S?S980QLRHHRTC $A5
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MMW9XQGKQUXKA/"=WHNJ6.B:-J&C:LWB#2WA#VER;@QVTD6 9@Q)C"@ D<\Y
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MHZGX:OY1?M?(MYH%TF^*^.57S(@1E3MP2RY'R\XP: .]U3Q/I.C><;V>15@
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M-+Y"2&-P?,W;=I7&5(/!R!CO7GV@ZF=/\/\ @*TN;:6W3['+%+?I9F6>WD
M\E?E)0OWXR0,#U&<3M^&FIV#6UXLR>)=_ES0ON*?:@^>1\V%&2><=^M 'K.E
M^*-'UC4KG3[*Z+W=N@D>-XGC)0G ==P&Y<_Q+D57F\;>'[=(I);\K!-*T,,_
MD2&*60$@JK[=K'@]#S@XZ&L5I8I?C/#(K;H7\/M#YJ_=+F=6"[AQG;DXZXYK
MB-&UCP[_ &!H.B:GK$EE9Z3J NXA<6,Z2X1V,:2,5V+C(W,"1QCCK0!ZSJ7B
MC2=)21[N>79#&)9FBMY)1"AZ,Y13M'?G''/2M2">*YMXYX)$EAE4.DB'*LI&
M00>X(KRZ>]T_1?%_B*P\3VVJM:ZM,MQ93VWVAXKE&B2,Q%8CC<-N,$<@^F*]
M$TBTCM- M;6UM381I %BMRVXPC'"GW% %6?Q=HEM)MFO"D?G_9S<>2_D++G&
MTRXV YXY/7CKQ27WC#0M.U.;3;B]/VV*'SFMXX9)'*YQ\H53N/L,G@^AKSJR
M5S\&K[P9>VTG_"0Q1S68LV4EYI&D)25?[R'(8OT'))XK>TU/L'Q6A2ZFWFW\
M,QVTERWW6E67+#<>,X^;'7'- ';:3JUCKNEP:EIMPMQ:3@F.101G!P>#R"""
M"#Z55'B?23>ZC9B>4W.FH)+J,6TI,:GH?N_-G!(QG.*P/A8=OA*6(JR.NH73
M;&4J0K3.RG![$$$5'XJL]3T_QII6L:-"SR:E ^DW) R(\@O%,1W"$/GV.* .
MC@\3Z3<Z5::G!<226=Y(L=O(MO(?,9C@8&W.#ZXQ7':%XQM=#O/%0U_5[J6*
MVU=HXVDC>4PQ>7&>0BD(F2>2 *D\%:)?:3K5WX>FBD_LC0[A[C3Y7.=ZS+E%
MSWV;I@?]Y?2LD.C>&_BD@!+W4]R8%VG,P:W55*?W@6! QWH [K4;_3&\2Z#;
MR:Q<P7<IE>VM(&/EW8\LD[\ @A0-PY'-3:CXMT32FF^V7ACC@D6.>80NT4+-
MC =P"J'YEZD8R,]:XMYD;6/AB^21#!+YS8/[K-ML&_\ NY;Y>>_%1Z%J]MH[
M:YX4\1:5=75[-J5Q/;PFS::._CD?>I!P5[X.X@#')X. #3F\0_V-\4-4BO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-M(T4CF%U3>." Q&&Q[$T 8P\&PW/BVP\2:B]M)?6*2+";6U\D,7&"SDLQ;
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M2;[4&)R^Q<97G)R!Z'D8K<M/%7A_1]!T%9-3NI;>_B1+.XN4=WG&W(+MC[Q
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MMD$X]P*[.B@#GK#QEIM_;J8X;Y+PCYK&2TD69&_ND$8'/?.WOG%8<SW>B_%
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M^URRLH'GN9K1ECB3[S'T'O0!%I?CC1KG4;71M]U'>30;[<SVSQI=;5RWE.P
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MEU<066JA[C[-"TK(IB=0VU03C)';O4&ER21_$OQ+>S65]%;S6%JJ2-:R;69
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MX6>-RN&"L!O&,G;WQBIM(>3_ (6;8:I'9ZY-:3Z)) ;N\MI%S)YJ,<J0!&,
M\84'^$'/(!<G\8:;H'@;4=9T<:CJ$8OY(LW(=C',T@4YWX*H&; 'X4:UK'V/
MXC^&[DRZC';7-C>%[/$A+LNP+B$?Q<GH.E<[+I^H7/PG\3VT6F7YN6UJ2Z2!
MK5UDDB^U+(&52 6^4$\5TU]<O??$KPMJ$5CJ"VJ6=VKR/9R*$+[-F[Y?E)VG
M@X([XH ZG0=?L?$=@]W8&4+',\$L<T9CDBD4X9&4\@BM2O._#&I/H%CXRU"Y
MTO59$.N2W$4,5D_F31N(U#(I W#()^@)KT,'(!P1GUH 6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH CGA6X@DA<L$D4HVUB#@C'!'2N8TWP?>:=:Q:</%&IRZ5$@BCMFCA#",#
M0RA-V,<9!!]ZZNB@!L<:0Q)%&@2-%"JJC  '0"HI;.&>ZAN)07> DQ@GY58@
MC=CUP2,^Y]34]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5DZ]HUSK,5O';ZS?:9Y4N]VLRH,BX(*DL#6M10!!;6<-E8165LO
ME00QB*,*?NJ!@=:6UM8;*W$$";4!+<DDDDY))/)))))/7-344 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!C:]H<^MFU6/6;_3HHF;SDM&5?/4
MC&UB02/J.1D]\$:L$$5M;Q6\$:QPQ($1%& J@8 'X5)10 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '+0>$;VPN[EM-\3Z
ME:V=Q.]P]L8X9=KNQ9MC.A(!))P<UT5G9Q6%JEO &V+DY8Y+$DDL3W))))]3
M4]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !115+5=5M-%L&O+UW6,$*%C1G=V/ 554
M$L3Z 4 7:*PO#WB_2?$TEU!9//'=VA N+6Z@:&:+/0E6 .#ZUH:IJEMI%I]H
MN!,^6V)%!$TLDC?W51023P3] 3T% %VBL?P]XFTWQ-:SS:>\H:WE,,\,\312
MPN/X65N0:DT_Q#INJ:OJ&EVDS/=:>(S<*8V4+OSMP2.>%)XXH U**** "BBJ
MYO8!?&S#$S+&)7 '"*20"Q[9(./7!]#0!8HK-GURRMM!FUN0R?8(HC.TBQDD
MQ@9+@=2,<_2L1OB/X<3PHGB=IKD:.\GEK<&V?DY*],9QD$9QUH ZVBL:7Q/8
M1:;IU\T=V8M1=4ME6W8NQ8$KE0,C(!//0#G%&B^*=+U_4-5L=/ED>?2Y_L]T
M&C*A7YZ$]>5(_#Z4 ;-%8?B7Q;I/A2PAO-3DF$4\P@B\F)I"TASA>. >#U]*
MW* "BL3Q-XKTOPE90W>JO,L<\P@B$4+2%Y""0O'0G!ZXK;H **** "BBB@ H
MK$\3>+-+\)6<%UJKS*D\H@B$4+2%G(R%X'!.#UK:)PN<'Z4 +17*6/Q"T/4K
M^_L;%-0N;K3W\NZCBLI&,39(P<#U4_E3[CX@:!:>%G\1SRW4>G),8&9K60.'
M#;2"I&1\P(YQS0!U%%16TZW5K#<(KJLJ*X5QA@",X([&I: "B@D 9/ K%OO%
M.E:?XBTS0KB9Q?:DKM;*L9*L%&3EAP.AH VJ*** "BLC7O$NG>&ULWU)Y42Z
MG$".D3.%8]V('RCW-&G>)-.U36]2TBW>47FGE1,DD3("#T*DCYAVR* ->BLF
M?Q%96_B:TT!TN/MEU"\T;>6?+VIC/S'J>1TS6M0 4444 %%-9U3&Y@NXX&3C
M)]*R]/\ $5EJ6O:GH\"7"W6FB(SF2,JI\S<5VD\G[IYQCZT :U%%% !1110
M4444 %%%% !15+2=275M-BO5M;NU$A8>3=Q&.1<,5Y4],XR/8BKM !1110 4
M444 %%-5U<L%8-M.#@YP?2J>I:K;Z6L E#O-<R^3;P1XWRO@G:,D#HI.20 !
M0!>HK-T36H=<LY+B*WNK9HIF@EANHMCHZ]1W!^H)!]:TJ "BFLZ*RJS ,WW1
MGD_2LO0O$-EXA&H&S2=?L-VUG*)H]A\Q0I. ><?,.N* -:BBJ6GZDNH/>*+6
M[@^RW#0$W$102$ '>G]Y#G@^QH NT455U'4;32=/FO[Z80VT(R[D$XYP  .2
M22  .23B@"U16'#XILI-2L]/GMK^TNKTL+=+FV91)M4N?FY P%/!(/M6Y0 4
M44UG52H9@"QPH)ZG&<#\ ?RH =15*VU);G5+ZP%K=QFT$9,TD16*7>,_NV_B
MQC!]#5V@ HHHH **S[[6K.PNX;-V>6]G!:*VA4O(P'5L#HO^T<#WJ\C%D5BI
M0D9*MC(]CCB@!U%9?_"0Z;_PD:Z )F.HM UQY?EM@(" 3NQCJ>@-6KR_@L?*
M$A+2S/Y<,2#+R-C. /H"2>@ ).* +5%%51J$']I'3W+1W!3S(U<8$JC&2I[X
M) (ZC(XP02 6J*JZE?PZ5IMS?W"R-#;QF1Q$A=L 9. *;I.I0:SH]EJEL'$%
MY D\8D&&"L 1D>N#0!<HHHH **** "BJVHZA:Z5IUQ?WLPAMK="\CGL!_/Z5
M2TW7X]1U.[TY["^L[JV19&6YB 5T;.&5E)4]#QG(]* -:BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *8\4<C1O(BLT3
M;T)'W3@C(_ D?C3ZQ_$NC76O:4;"VU673@[ R211*Y=?[IW9&#W]1QT)H S=
M&T];_P ::CXJ1=L$EI'86I'_ "V169VE]P20JGN%ST(KIY0VPM&B/*H.P.<#
M/UP<?E6!HOA[5=.OA<:AXGO=3C6,I'!)!%$BDX^;]VHR0!@9XYI4T/7(='LK
M6+Q3.;NWE9Y;J:UC?[0I)(5EXP!D#*D'B@#%\"W=ROB7Q38:MIL5IK/VB.[F
ME@E+Q3Q.NV,J2 1@1X.1UR>Y FT#_DK'C+_KUT__ -!EKH]-TA+"YNKR69KB
M^N]OGSLH7(4$*J@=%&3@<GDY)S5/3O#DEAXKU373?"1M12*.6'R<!1&&";3G
M.?F.<YS[4 ;U%%% !6-<^&-.NO$L.O2"<7D=N;8A9F$<B'=PZ]&QN;'U^E;-
M% ' >*-%LO!_P?\ $5CI[W!M_LDVWSYC(5WC;@$] ,X KR#Q%<71_9YT**,M
M#IZ3I'R,&XE8R.3_ +BXQ[MG^[S]$>)=!@\3^'[G1KF5X[>Y*"5DZE0ZL0/3
M(&,]LU4UCP;I6LVVC64\*KI^E7"7$=HJC8Q1&5%/^R-V<=\4 4+)A#H4GB&]
M+06UC8,+)2O,42IS*0?XV X!Z+@<$L*\YOO%OBQO@W8:J=16'7->U#R8/(MT
M1F1B5 ! XX0G=R?F'->O^*-"7Q-X9O\ 16N9+5;R+RS-&,E1D'IWZ8^AKFKG
MX8P7%MX6A76+M/\ A'W#QMY:'S"%4 X/"D;!C@]R<DDT <AXDLIH_&'@#P-%
M)]O;2T-]*678KE,B(OCH!M.3R2#W)YO^'?B7J5OX'\3^*=>GBO;6TOWM].\J
M(1>=C 4 <\$D<DDCGDXKLH? UM'XIUG7VOKE[K4;,6:YQ_H\84#Y3U)) .3W
MK#D^$.GO\.T\(C5;P1QSB=+DJN58,3]T8&/F;WZ<\ 4 <[?+J_B/XA^"M$UF
M\$\T$?\ ;6H6R1JL=NPR408&< X7YB3SGO5_1/$7C;Q3JNN)HVH68L;'6!;B
M6XA48@1L,%P/F9@<Y/0*,8W9KI=*^'B:5XQN_$@UJ]GN;FU6!Q*JY8@#+,P'
M.2 =HP.@Z "M'PCX.L_"/AEM%@GEN$D>226:3 >1GZDX]L#\* //=;^)FL3>
M%]9\3Z3<1V]G'>KIVD0&)7-V^</(V1GIDJ!C[O.:V=:\6Z[X:\<>$=+O[R*:
MSO[5_MB);C?),L9^Z1ZN1@ #TJ"V^"MM;Z5I=@/$-\T>FW_VR'=$A"\YVA2,
M9SR2<Y],<5W$WA>PN?$NG:W<;IKC3K=H+82'=M+8RY)Y+8&,^YH X71O&WB/
MQ1I$5U8/!:78\2_8Y+5XPY^RJ 77/J%)8M['&.*H:Y\3-6E\,Z]XFTFYCM[&
MVO%T[2H3$KF\DR \C9&<8)*@8^[SGI7?>&O ^E^&&U*2V\R6?4+F6>620_=$
MC9VJ/X1C ]3@9Z#'(P?!.UM](T_3AXAOFBL-0^VP[HD(7OM"GC).,DYZ=* (
M/$"WFO\ Q'\"^&K^033:=!_:NI,J@*9%&%X' ^=3QZ/7IVL:E%HVBWVIS_ZJ
MT@>=O<*I./TKG['P+%9>/+SQ3_:=U))<V\=O]G;& $"CE^I!*@D=SUS5_P 7
M^&W\6>'Y]&.H/96]P )GBC#.P!!P"3@#CGB@#RSX46/BB+P?)K5E#:-)KVIB
M2YN9';SDB\S8S*N,$C+L,GOT]=[XH1QZSKGA'P9;JOE:CJ!O;I$'!B3+-G_>
MW.?J*W8_ FI6_AFV\/VOBN[M+&"(0@VUM&DC(.V_J"?48-6)/ 5L_CFR\2QW
M\\0L[);.*T10%" DC#=0.<$#KZX.* .:UCX@ZEJM_P"(-.\,[P^F#[+;^1")
M9KJ[.1P""JQ)@[F(_$=]:Q\2:WJ/B6S\)":&/4++3X[G6KR- <2$+B.,$$ D
MG))!&.@STET/X>2>'M4U22P\07D6FZC<M<RV:Q(&#'J!+]X#MQ@X[YYJ6?P#
M(GCBZ\3Z5KMUITU]$L5Y"D*2"0*  07!VG"CL?UH XOQE<^,;JV\*^$[_5(K
M?4M;N98[U;-0?]'#9R6P/X#R  #@UKZ?XKO8_'OB5+V_27P_X9L%,KBVC#&8
MH"V"!D?=<8'< 5T=[X$BO/&VF>)?[4ND>PM#:K#PQ8$MEMYY!(8@D<XZ$51L
M?AA8VUKXFMKG4KNYBU^6624$!3'OYZC[Q'8GCVY- ',7_P 0_$:>%="\3(4A
MEUC5D@M=*$:L&MCN'S,1N+G .00/F'%7M4\:ZXOQ.UG2;"\B72M)TTW-R9(%
M9(GV@Y8C!( .=H()(QD#)'2Z5X M+.;1)M0NC?MH=L+>P3R_+CCP /,*Y.9"
M .<XXX /-5A\-;3[!XK@;4KDS^(Y"]Q<;5#1KSA%']T9(^AH ;\.KS5/&'P]
ML=0\2R":6XF:4!$$8=%<[ P';(S[@#.><]E'90QWLUY@M/*JH68]%7.%'H,D
MG\?I5/P[HD7AS0;/28)Y9X[:)8Q)*1D@  <# ' [?J<DZE ' ^)XKF?XI^&(
MK6Y^S2M87H\[8'*#]WD@'C/IG(]CTJ#3=?UV3POK23:O:K=Z9K3:>VH7**A:
M$,F6"JNTR;7P!C!..*Z>^\.O>>+=.U\7NQK&&2%(/*R&63&[)SG/RC'I[UBS
M?#KSK*^A_MF:.>XU<:S%-'"O[FX&.@)(9>!P?SH JV'B+7Y;KQI86?GWT^G6
MT,^FK=PK'*S21N=K !>-R\ @'G!K0\&>)(-?O;GR-8NIS#$JSZ=?P)#<VLN3
MG<%1>",>HR/?AZ>!YH]2U?4!XAOOM.J6\44KB.,;7C!"NN!QC/ Z>N:TK'P[
MY/B)M>O;B.XU V@LP\4'E+Y>[<<C))8D#G.!C@#F@#!\<QW4GB[P9'#J=W:Q
MRWTJLD.S&1"Y#893D]N<CGIGFL^.TU*Y^(OC2/3]6>PE6RL29UA21RP23'#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<-\4?'$
MW@?P_;W5I#YUU+<)\NW(6)67S"?0'(3/JXKKK6[AU?28+RRN&$%U"LL4T8&=
MK#((R".A[B@"W17C/@/Q3XK\5^%_$>H7/B$P76F2.L)%K#Y9"H6^<;<]NQ%;
MW@GQ5XA^('@"WOH'CTW4!??9[BX2(,IC7!9E5LC)!V]^<]J /2**\DM?$/B6
MX^,]_P"#&\07 L+>U$R2BW@\TL8T;D^7C&6/:D^)7B/Q=X'\":=?KJZMJ9OW
MMI7^SQ;)8R961MNWY3M5. ?6@#URBO//'/CRX\%^'=*AMA_:&NZH5BM1,  6
MXRS!0. 6 P,=:V5T;Q5;Z0TJ^*'N=7\LL$FM81:E\?=VJH<+GC._/?GI0!U5
M%>1^/O%GB?PY?^";:VU%X'U@K%>H\$3;&!B!*Y7@Y=O45ZTBE(PK2,Y P7;&
M3[\ #]* '45Y'I_BG7[OXN>(?#-UK\UOI6FVC7*2I! '  C/S$H1@!SV["N_
M\-IJZ"\.IZ@;^WD=)+*9H4C;RF0':P4 9!SS]* -VBO,OC1XKUSP;H-AJ6B7
MWD22W7D.CQ(ZD;6;/(SGCUJ+XN>)]?\ !7A+3-1TG57^T27"P2F6")@X*,V<
M;>#E1TXH ]2HKRWXL^)]?\&>#=+U/2M5?[3+<)!*988F#@H[9QMX.5'3BO2=
M.$O]G6YFG>>4QJ6D<*"Q(]% 'Z4 6:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ*EM<Q3,]Y'(JQN&+*(I 6&.V>,UZ!<>.M)TF\\-:6ZW%Q)K($=O-;('C4@
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M!E)'"KCGIUKJ?"_C_0;SPY8_:]0BM-1CA2.XL)CMN%D  91']YN1Q@'-<?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ P,YQS1110 4444 %%%% !111
M0 48&<XYHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.Z@>T*[Q.L@*;?7=TQ[UR^F^)I]0^)-UI,%_9W>E+I:W<9MP"5D,I0AF!.<
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MLM4T_4O,^PW]K=>4<2>1,K[#[X/% %NBJ=KJVFWLC1VFH6MPZ#<RQ3*Y ]2
M:K:-<21Z$L^H:O:7S(9#)>PJ(XB Y]R!M'!YZ@T :M%5;?4]/NPQMKZVF"D@
MF.56P1R>AJ--9TN6>""/4K-YK@%H8UG4M(!G)49YQ@]/2@"]15.XU;3;.Y2V
MN=0M()WQLBEF56;/ P"<G-4;KQ5I%GXEM]!FO8$OIH6FV-(!L *@ Y[L6X'?
M!H VJ*IR:KIT-\EC+?VJ7C_<MVF42-]%SDU#K.J6^G6<@;4;.TNG1C!]I889
MO]W<"W..AH TJ*Y[P-J]WKW@C2-5OF5KJZMQ)(57:,DGH*Z&@ HHHH ****
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M0 "N/NG'W<5QNCV5G?\ Q?\ '2W%Q<1E([# @O)(,_N3G.QESVZ]/QKTT
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M5M D$$211(-J1QJ%51Z #I0!Y]XC5_#WCS[5;V@GA\369L)(BF4:[0'RB_\
MLE&<'V6H? D%TDZ^$KU7D7PM<O\ OG7 F1A_HQ]/N.Y/H46O2'BCD:-GC5FC
M;<A89*G!&1Z'!(_$T+%&DCR+&BO)C>P7!;' R>] 'CMQ86-SX.^*EQ-;02S)
MJ%YMD=02N(8R,'MSS]:W=)OI?^%E:*NHOF"X\.(;!W/RM-N!E /]\KM)]A7<
M#0M'6.2,:58A)3F11;IAS[C'-/FT?2[FSCLY]-LY;6,Y2!X%9%/J%(P* .5\
M 6TEKJOBV.#C2!JK?8U'W0Q4&4+_ +.\D<<9!]Z9J<4*?&C0)%1%EDTN[WL
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M_C0!Q7AN34[/Q/:Z!X@M[#4@^F2?8=5M5P)K=60,DJ<@=5((X].IKF-.$:?
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MX4S1R_##0/+D5]EL$;:<[6!.0?>NRJ*VM;>SMTM[6"*"!!A(XD"JH]@.!4M
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M&<A=V<#&02,^AKG=1TK3[+X+>+)HKK3;PW4EQ=EK.198X2[Y6,..NT'\R<4
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M7EOC/5-.FC^(5I#);V-REFJ7(E?=->.("4V*3A4 .,@$GD\8R;D?]G:EXY\
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MV%;7C&^O=,\':QJ&GS)#=6EI+.C/'O&44MC&?:N3U>6/[3\,CO7#7"D<]?\
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MT@&"ICD!4GT)P"*TM?MM-T;Q=XNOXM/,NC#PX%U.VM3Y8DG+G:"5Z-Y><GJ
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M.T8+%/[I/I[4S^S;'>C_ &*VWQ@!&\I<J!T XXQ3?[6T[^SDU'[=;&RD *7
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M-5U!=0NE9O\ 25A$9=<G;E1QG&,XP*T* "BBB@ HHHH **** "BBB@ HHHH
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MDU#0DB>">\M9[F\A.8YI!/%N8'H< #)''7N#7J$D,4L1BDC1XV&"C*""/3%
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MK^'M0TF>.5(M/N?[0EA<,IA;;Y(8CCE]Q'T)I?AK<P3R>+A%-'(?^$BNFPK
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M5C8(A;."P!/ Y&1GJ*[9;>%49%AC"-PRA1@_6D2UMX[<0)!$L(Z1J@"C\.E
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MEFC&EWL"<><7_P!0_P"$N%)]'KLM'TX:5I%M9;_,>-/WDAZR.>7<^[,2?QH
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M\Z *XY_?J5'Y9('I0!VU[>0:?937=R^R&)2S'&3] .Y[ #J:Y#PKK^O:I?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQJ$AC"1(3@  8 SSQ7(>&O#GB'PW_;'ERZ7.-2U*;4#N,B^69,?+TY V]>*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5R%N)03'!&K22N!U(106('KBJXOM!\1F339#:WK*N^6SN(LL@S@%XW&5Z\9
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M$=@3\PR 5'''..>* .WHKE(=:U/6=;UC2M+N;2!M)6*.2>6 N)9W3=@+N&U
M,=R22>1CFWX,\2-XI\.I?S6XMKJ.62WN80<A)48JV#Z<9'UH Z"BN!;6_&.I
MZ_XFTC26T>)])>'R9)XI&\S?'O"D!NIS@MVQT.>(=&\?ZAK)\%SI;V\,.MO<
M0W<+(Q>*2%')V-NQC<G0@\4 >B53FTC3;B_COIM/M)+R/_5W#PJ9$^C$9%<9
M?>,-;M;7QR8Q8-+X?"O;LT+@.IA\PAAOZ\XR"*E7Q'XBM+?37OFTQI-;EMX;
M!(HW'D%D9Y&DR?G "\ 8R>..M '7:IJMEHNFS:AJ$X@M85W22%2VT?0 FI[:
MXBN[6&YA;=%,BR(V,94C(/Y5Q'BIM>7P;XUM]52VDLDTV1K.[B&QI 8FWJR9
M."I[]P:CTG6];TS4_"&GW;6,FG:O:&-(XHV$D#1PAP2Y;#Y .?E&/>@#T"BO
M/M2\8ZSI=Y9FZ%DK3:REB]@BF1HX'?:DC2*Q"N1AL$#@XQQFK%YXPN!XKO\
M0DO+.POX9(Q9VUY"0+V,JI9D?< 6R64 ="O.<\ '<T5Q.I^*-5NKC6X-"0>=
MI;^2B-923BXF\M7*EE("#Y@OKG)Z=>ITB[N;[1[.ZO+-[.YEB5Y;9SDQ.1RN
M>^#0!=HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "L'QAX?D\3>')=-@N5MI_-BF
MBE=-ZAHW5QD9&0=N.O>MZB@#ECX=U63QAIVOSWUI(;6SDM7C6%EWEV#%AR<
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MF8;8TD#C(W<L< 'D"O0J* .-U;PKK1\3Q^)- U2UL[^6V6UO8+F!I8)E!RK
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M_A34H)_%<OVRU)UTY0>6W[@^6(^>?FX&>W-=A10!P[^"M2;P_P"%-,6^M =
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M_8OAX-JMN-8\/LHLKA+<B-HP@C9'7<2=RCD@CV'K=N_!4>NRZM=:X\;W&HV
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MJ$4>#%<)@(54D_*J@#!/KSDU;'AW7;S0]0M=7UV"YO;NU>U22.TV11*PPS;
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MAEOX6BO=): P" J4$:.0=^XY^\<\4 9!\6^*]/TCPQXEOI-.GTK4S:Q75K%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %5=0U&TTJQDO;Z=8;>/&YVR>IP
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M4A2WS$<*,#J:N$!@00"#P0:Y#6-4UC1M?\*6"WL4UOJ%U)#<EX ';$;.,$'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<$8X/8US]KX0NFM-(L=7U5+ZSTF5)H +;RY)&C!$9D;<0=N<\ 9(!]0>LHH
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ME7=M<JIMI8'CD!Z;"I!_2O'?!.O^)D\%^ +6VO88EU":XM&:>#>=B"0H<YZ
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M!.[/'3!QTJY9>'435KO5M1E2\O[FW6U+"+9&D().Q5)8X)))R3GCL* //=?
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MW5O$C+/$#D*\;94X/(/_ -;'3:;8+IMBEL)I9W&6DFF(+RL3DLV,#)/8  =
M  *MUCZUXBMM"NM+M[BWN'.I7:VD3QJ"JNV2-Q)&. >F>E %=/#^HV=W?3Z=
MKDD2WLS3/#<6ZRI&Q '[O!4CH.I(SSCFLZ[^'.F7'AJWTJ&[N[>YMKHWL.H1
ML!.MP22TAXP<DG(QC'I@5V--CD2:))8G5XW4,K*<A@>A!H Y:7P/'J?AV^TO
MQ!JMWJLMZJK)=.J1,@4Y38J *N#ST))ZY'%6=$\-7>GH3JVO7FLR"(PQ-.B1
MB-#UX4#<QP,LQ)X[9.>BIKRQQLBNZJ9&VH"<;C@G ]3@$_A0!Q9^'8/@8>%&
MUN[>S5HPDC1)O1$<.JC  Z@9)R3[5J7GA=I/$,'B"ROOLFJ+;_99V\K?%<1Y
MR R9!R#R"#D=.15K2_$=MJNMZOI,5O<13Z6T2S&50 WF*64K@G(P.^.M;% '
M)7W@.VN]#_LV.^EB:2_&HW-QL5GFG#A\GL!D 8 Z "KZ^'''C)?$CWQ,PL?L
M)@$0"%-^_/7.=WZ=N];U<]J/B^TTWQ!%H<ECJ$M]-"T\20Q*P= <$@[NWH>:
M .AK M_#/V(Z])9:C/!<:O/YYF"*Q@;8J?*",'A>_>K6A>(M,\1V\TNG3LS6
M\IAGBD0QR0R#JKJP!!K5H X[2O!6IZ;):H_C#5+BS@D#FV,,*"3!SAF5 QR>
M3SSSG.36A/X=U"]-];7^OW%QIEVS9MO(C1EC;K$) ,[<<=-V._>M^66.&)Y9
M75(T4LSL<!0.I)]*J7FH-:7MC;K8W4XNI&0RPH"D&%)W2'/ .,=^: +<<:11
MK'&H5% 5548  Z 5@_\ ",&RUF\U71;S[#/?$-=PO%YL,KC@/MRI#XX)! /<
M&N@JDVH,NM1Z=]ANBKP--]K"#R5(8#86SG<<YQCH* *&GZ'::-=WNM7MV;C4
M+A L][/A0D:]$4=$0=<=SR237#_#?0_[>^%FCV%[J ETU6+S68C <E92PC9L
M_=R <8!(XSBO5** ,#_A&?+\73^(+?4)X7N;>.&>V"J4DV%MA)(W#&X\ C-9
MD?P\LG\-7^B7=[//%=7CWR3JH22"9GW[D(XX;IQZ@YKLJ1F5$+LP55&22< "
M@#"M_#TQU*WU34K\7M_:0/#:OY C2/?C<^T'ECM )R!CH!DUC_\ "O%/@MO"
M_P#:TWV5KG[29O)7S,^;YN/3&_VZ<5VJLKH'5@RL,@CH15.TU!KK4+ZT-C=0
M+:LBB>5 (Y]RYS&<\@=#TYH M;9/(V[U\W;C?MXSZXST]LUR^E^#9]&T2TTZ
MRUJ93:WCW:2M"IW%]Y9''0J3(>F#TY[UU=% &1H>@0Z-+J-P'$EUJ-Q]IN75
M-BEMH7Y5YP,*.Y))))KA/%-U#+XYNQ<^)+KP^\$$4,'GV*3PW(Y<O&9$(!RP
M4X.25YZ"O4J* .%AT#5/$VDV:ZGK4D@L-32]M+O["(7N @!4NAZ#<7'09 !^
MNQJ?A9[[Q+9Z];:M<V-Y#;-:2^2B,LL3,&(PP.T[AG-= DL<C.J.K-&VUP#G
M:< X/H<$'\:=0!PT/PX2WT*RTB/6KHV]EJ0U"$R1HQ#"0R*O;(W,<YY/J.E;
M*^&,^*[G7I;UG:YLA920",!?+!+ @YSG+&MZ.1)HDEB=7C=0RLIR&!Z$&G4
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M4LTT\=Q<7CQIOD9&5E   55!4< >O<DGK** ,'_A'';QA#XC>^)FCLC9&$1
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M"C2)<HC0JL962<L/D4 X.3GH<8[XP:;K^@V_B&R@M;F66-(;J*Z4QD9+1L&
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M>_'% ' ^&[_Q))8?#W3%UB:SCU+3+@S?N4=@L:KY;*6&<[6'7(Z'!JOXCO\
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M#"U@C"E3N0HVXD$G()[CDYJWI'AQ-(UO5]46]GFDU21))HY%4*K*H4;< 'H
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M.[VW8Q[^U<E#KVLZW\-[[QI8ZG);W,7VBYM[78IA$4+L/+<$9)94.3D$$\8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6_M[BYM1HT+PVEM#L\H(RA2""I)X4#KVJ?0_#<.A7FIW,-[=3MJ-P;F99]F
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME@9?+ B=0QR.%W$8;I[T >E0>+]%NK"UO+:XFGCND>2%(K:5I653M9O+"[@
M>,D=<>HKFO$WB:":?P;K&EZTXTJ\U'RY3$^V.6/RW)W<9X*XP?3IFDU?5O\
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MK>(-+:%&LYS<&*)XL*)PQ/EA0!N'UP <C(!ZI>WMOI]I)=74HCAC&68@GO@
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MD-V2D,_V:2,PN)4FR (S&1OW9(XQ5S3M5M-4%Q]E:7=;R^3,LL+QLC[5;!#
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M*,#/3G Z&@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBN5^(>KWVA^$I;ZR$P5)H
MA<RP(&DAMRX$CJ#QD+GZ=>U '545Q^ABWU.YTS5O#GB&YOM()<7,$ET9@24.
MUB7RZD'&5SCD' Q6G?>+]&TU_P#2IY4@$XMWNA"Y@CD)QM:0# YX)Z \$@T
M;M%8VJ>*-+T<W(N9)F^R1":Z,$+2"!#D[GV@XX!..N!G&*SKGQO:)XITG2+>
M&>XAO[5KL7,4#NC)\NW:5'.=P)/0#'KP =517.Z1J6D/K'B&6#4[N22W>,WL
M=TS+%:D)QL# !05&XD<'K4]OXLTFXO;.U\V:)[U2UHT\#QK< #)V,P )QSCJ
M1R.* -NBN5N/B)X<MDOG:XNG%A+Y5WY=E,Q@( )9P%RJ@'[QX]*Z>&6.>&.:
M)U>*10R,IR&!&010 ^BO/_'VOZE#]CBTFX:"W@U2TAO)TZNSR+^Y4_[IRWU4
M=SCH-=\/W^NSE5U[4-,M4C B73W5':3G+.Q4D@< *,=\YR, '045Q?@Z?6_$
M/@.$:CJ+Q77GRP/?0(%>:-)&4.N00I8*.<'N1U!!X'-['J_B*T.M2ZMI%M/'
M':3SS++*C[,RH6'4 E0,^X[&@#M**Y+QUXDN]%BTG3=,*+J>LWJ6<$KKN6$'
M[\F.^T=!ZD4WQ#I=]HWAR[U72-5OVU*QA:X_TJX:6.XV#<R.A.T;@",H%P<8
MH Z^J,FEQ'5DU.%C%<^6(I2!D31@D@,/4$D@]LGL2*YZQ^)&@7&EZ1=7$TD$
MVIVIN(H!"[DX'S*"J_,0>,#DG''-1:A\2=(C\%:IXATSSKS[#NB>W\AU>.4=
M%D4@%!GJ3_/B@#K;R![JU>!)W@WC:TB?> [[3V/OVI;.TM]/LX;.TB6&W@01
MQQJ.%4# %<[J&L:5<WOAX75[J=G<3W.;:%(Y85G<*V5D!7E<9.#CH#5_4/%&
MF:;)=),\\GV-0]TT$#RBW4C.7*@XXYQUQSC% &S16%>>,="L)M-BFOLG4D+V
MC1Q.ZS*%+?*R@@G'0=3D8'-6-#\0Z=XAAN'L'EW6TQAGBGA>*2)P <,C $<$
M&@#5HKG=:U>0^(]*\.6DACGO5DN+B5?O16\>,X]"S%5SV&XCD"KMYKMCILYL
MS]HGN(H1*\-O"\SI'R S8!/.#C/)P<9P: -6BN?N/&WAZVTW3M1?45:SU&18
MK:9(W978GH2!\IX/!QT/I6CH^LVFNV'VVR\[RM[1D30O$P93@@JP!'(H OT5
M@-XRT1;E(C<2;'O/L*W A8Q&XSCR]^,9SQGIGC.:BN_'6A6=YJ%F\MU)=:>J
MM<00V<LCJ&!(( 7E<#)8<#(YY% '245@OXRT-?[((NI'35P/L+QP2,LN1D#<
M%P#CL<&M)=4M7U>32U,ANXH5G<>4VT(Q(4[L;>2K<9SP: ,6\\-ZJ-?NM6TG
MQ"UF;M8UGM[BU6XC^08&SE2O4\9(R2:V--T[[!'*TD[W-S._F3SNH4NV HX
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M^4)C=D8;(QQ@YZ&J4OCOP_;Z7J&H7%S-#'IT@BO(WMY/,@8]-R8R >QZ'UH
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M615X)P&!X['ZU[=10!S'A(Z3=S7VJ:3I5Q:QW(C#W5S&\<ERR@CH_P Q"@@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K37T$-Y
M#:%BUQ,"RQJ,G:.K'T R.3ZXZU9KB? ]W)JWB'QEJ4QS)'JATZ,'^".!!@#V
M+.[?4T =$FNP26FJ7(M;X+ITDD<BFW8-*47<3&/XP<\$=34D.L6LIL0XE@-]
M&)(!/&4+$KNV'/1P.=IYX/7!QQUIXCUZ3PMXWNWO+<WFCWEU';/]GP@2*)7
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M@6(F59 AV$*N8SN&"0?8F@#NZ*\\\,>,VU*8?;=4FBU"TM9)-4T>ZMUBDB<
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M[(?GSE2 .,>G.2:WM->]O/BUJ#KJER+<:3;3Q0LB%5#N_P N,9QP#G.??I@
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M\9!&#CTZUQ,'P[OET_0;*?Q++)%HEU'-:;+1%.Q%955N3EL,!N]!TYS7>T4
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M!.]E!.,!1DY()Q5O4O#%CJ?B32M<FW"YTX2*H7I(&Q@-ZA6 8>A&: ,:]O\
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M*^")+;P-9^%[#6[FTAMQM>X6%&>5=Q.TAN,'//'(XZ$T 2:/IJ:CXRU+Q2$
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M69CQECZ =!P,"NFLM$&H76EZK>ZDFH+8QL;/RHPB[F7:9&()W-MR 1@#)X]
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M(Y*/&4OB-+X"5[(60@:'*A Q<'.<YW'\N/>L=_AYYG@J^\,-JS_9KRX:=YA
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MUB/2+FW/BR_DU"6572^>"+,:KCY!&%VX/.>,G/7B@#,\.S>(= \6#PSK5_\
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MX ^7MR<]> *@T;X?1:'<&&UUK4?[$68SQ:22GE(V[=C=C=LSSMSCUSSGLJ*
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M1U' .>G4&N2\9Z59:):^#=*LKIK?R]=CN&F8JSY*REI7R,<LW)QCG'%>G44
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MYS@\C!YK7U29]/T*[FMK6:X>"W=H[> _.Y"\*ON>@J]10!X_H)NHK"WA\/\
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MG;27-PX2&-2SL>P%<W!\1O"ES=6%O%JH+7Y"V[F&0(['HN\KM#'^Z2#R/44
M=3163'XDTJ6;4X4GE,NEA3>1_9Y-T88$J<;<MD GY<U4E\<^'(8--G?41Y>I
MH9+,B)SYJA2W VYS@=#R>@Y- '0T5A0^+]&N;"VO+>>:=+F)IHDBMI'D**<,
MQ0+N !XR0.:YOQ'XE@EU'P7J^FZT_P#9%[>.LAB?$<J")S\PQDG(Q@]QC&:
M/0:*P[/QAH5[IVH7T=[Y<&G,5N_M$3PM"0,_,K@,..1QS4UCXDTS4+Z6RBFD
MCNHH1<-#<0/"WE$X#@.!E<@C(Z'KB@#6HK*L?$6FZC=0V]N\Y>>%IX2]O(BR
MQC;EE9E (^9>_<'I4*^+=%:^M;3[4ZM=N8[:5X76*=A_"DA&UCQQ@\]LT ;=
M%5[V]M].M'NKJ3RX4P"V"3DD   <DDD  <DD"L#7/&^GZ1H&K:DL-W+)IT8:
M2 VLBL"P.W.5&%..6Z"@#IZ*R(_$=B-.L[F=ID>Z^6*$VT@DD;&2%C*[B ,G
M.,8YSBG6?B/2+VPN[V*]18+-F6Z,P,30,O)#JP!7CGD4 :M%8D?B'3=5NI])
M@NKBWOS;^>L<D#PR&,G&]-ZC(SQD=*P/ 7B51\/O#<VKWES<7U^KJK>7)-)*
MP9B<[03P!U/ H [JBJNHZC:Z5IL^H7CNEM ADD=8V<JHZG"@G [\<5G'Q=HH
M?2D^TRYU9=UCBUE(F&,\';QQSSCCF@#;HK@_B7KC1>!]?_LO4+RUO].$1=X5
M:/:69>-Y&#E6_A.>171V7BO1M1U>;2[:[8W<47G;7A= \><%T9@ ZY[J2* -
MFBN;T+5]&32]6U"'6[B[LXKZ8SS7C'$#\;HER!A5R !SUQS2W?B*PU*TU73K
M.\N+;4H+-I_+>%X950@X=0ZC(R,9 X]C0!T=%<'X'\::=-X;\-6.H:C-)JE[
M:(!)+'(RRR[<E3+C:7Z\9S70>,I)X?!>MSVMS+;3PV,TL<L) 965"1@_44 ;
ME%<AX5\8:7=6&@Z7-?22:I<V$;AI(Y,3.L8+XD(VLPY) )(YS6G)XPT.*Z$#
MW;?\?8LO-$+F(3]/+,F-H;/'7KQUXH W**R;[Q)IFG2W"7$LQ^S;?/:*WDD6
M(L,@,54@'!!Y[$$\$5J22)#$\LCJD: LS,<!0.I)H =16+8>+-&U*\M;6WN9
M/-NX3/:^9!)&MQ&,99&90&'(/'8@]*2Y\7:):7"Q3W;*K7 M?.\ES")LXV&3
M&T'/'7@\=: -NBL;5/%.D:.;C[9<.!;*K7#1P/(L /0N5!"^O/;GI5;4O'/A
MS2KAK>ZU$"46OVP+'$\FZ+CYEV@[NH/';)Z T =%16-9^*]'OQ??9;F61K&.
M.6X3[-*&177<AVE<G(&>,U)'XDTJ?2K/4H+EIK:]&;;RHG9YN"?E0#<> 3TX
M YH U:*Q[;Q5HMWI-QJ<=\HM;:0Q3F1&1XI 0"C(0&#9(&W&3D8ZUS=IKDE[
M\84LH;N_%I_8KS/9W$;Q*K^:@#!6 SQGGGN/44 =Y16?J>MZ?H\EFE_,T1O)
MTMH#Y3L&D8X5<@$ GWQ4+^)=)BO[VQDNF2YLH1<3HT+C;&20&!QAAD'IGI0!
MK45S=IX]\-WT^GQ6^H,_]H'%K)Y$@C=B,A=Y7:&P/ND@^U+XE\065IIVIVJW
M=S'=06QDD>UA>0V^02I8JI"],\]N>G- '1T5R/A#75C^'_AVZU*YGGN[NRC;
MA6FEF;;EC@ L?<_G5QO'7AM-,AU!]35+:6Y^R O&ZLLV<%'4C*$$\[@,4 =%
M16=H^N:?K]K)<Z=*\D44S0.7B>,AUZC# 'N*J3^,-#M[EH9+M@$NA9O,(7,2
M3G&(VD V@\@=>"<'F@#<HIDS.D$C1IOD5253.-QQP*\O\-ZO<^,/"MQ+8>)K
MRW\6QH_VFS9E7RI 3^[\EA@)V##GN3G- 'J=%9^HZU9:8P2<S/*4,GE6\#S/
ML'5MJ D#WJ&/Q-H\^EV>I6]ZL]M>G%L859VF/.0J@;B1@Y&.,'.,&@#6HKD-
M:^(6EZ?X9N-7LA-=F*Y%FT:P/F*8L%VR+C*8)'7&> ,Y%7)]4TNY\4:)&=4O
M[>\DCG:"QV21)<#;\QD5E_AQD9QU[YH Z.BL6^\6:-IS3_:;IUBMG$=Q.L#O
M%"QQP[@%5ZC.3QD9QFDO_%NAZ;J,>GW5[B[EA,T<21.Y=!C[NT'<>1@#DYX%
M &W16=HNN:?X@T_[=IDYF@WM&VY&1D=3AE96 *D'L157Q)JEQ96+6VG;3J4\
M;F$L,B)5&6E8>BY''<E1WS0!MT5Q7AHZQXB^&^@.-6FMKBZMD>[O4"M,1CG9
MN! 8G')!P,]\89X5DURP\4>(/#MSJ<NJ6MI##/:7=VH,D9D#?NW*@;ONY[''
MUH [BBN%CM]8TOXA:5:P>(KK4H+J":74K6Z,>(E &QT"J-F7(&.<C/H:ZCQ!
MK,'A[P]?ZQ<J6BLX&E*CJV!PH^IP/QH TJ*Y#P_8ZEKWARTU;5=6O8;Z^A6X
M1+23RX[8.-RJJXPV 1DONR<]N*HZ!\0;>'3-7C\3W,<%WHM\;*YG2,[9N<1R
M!5!QN]/6@#O:*Y^P\;>']3U6XTRTOS)>0QF4Q>3(#(@ZM'E?W@_W<YK'MO&N
MF>(/!FJZA=SZAI%HC3PM<I#)')$BLR!E;:1OXS@9*]^E '<45E?VQI]AI^GA
M[F:8W,:BW&QI)IP%!W;5&3QR3CC/.*K2>,_#\.AW.LR7X2RM9#%<,T3AXG'5
M63&Y6]B* -ZBL6Q\6:+J.L?V5;7;->&(S(K0NJRH" 2C$!7 R/NDUM4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<-\/X7L=:\;64_$W]N277/>.5$9#], C\*[FJ,FEQ'5DU.%C%<^6(I2
M!D31@DA6'L22#VR>Q(H \XL9%_X1+XEIA]UQ>WSP+L.90\*JI0?Q L"!CK3[
MV5?[&^&0PV;>YMVF&PYB"V[(Q?\ N@,0#G'->I44 <-XQ@>\\>^![>$'S(KJ
MXNG(_AC2/!)]B64?C7<U1@TR*+4YM1D8RW<B"(.1@1Q@Y"*.PSR3U)]@ +U
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MY)8C/;&<5M>&?$FCM'>_9(]3GE6-[V_NY=/EB\Q@ . R@DX&%50<!<?7LZ*
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MLNQ\51^(K62[T[P[>->6]I(9%OK1H2C;<^0&8?,68 ';D8'/8'C["YFN=8\
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M(,06Q@8&/4]S2V6L7W@[P!HL%V-0U&_G@C6/9IS/]F78O#K&O1.F#@L>..2
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M-YT:R(4W[",G;G/T-=3XCOXM;^'OB>YT_2KF-+NR>.%FM&2:ZD*$9V8W$?=
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MMO;B/#S/'G?MR<8&UOF) XZ]*K3^/-"MO#T^MS2W"6EO<-:SC[.Y>&4-M*.
M/EY(&3QR.: .FHKGX_&.ERP2R;+Q"ET+2..2U='GD(RHC! W CG/3 ).!S6%
MX6U"2\^)_BJ(M?)%%;6A^S73L?*<^86V@D@ \'Y>* .]HK-U/7+33+JSLY!+
M->7A?[/;PJ"\@098\D  #')(ZBLR3QYH,6A0:P\\XM)KC[*#Y#Y27?L*OQ\F
M&XYP/K0!TM%<R/'>D'4;G3C#J*WT,8F2V:RD$DZ$XW1KC+#(Z\8[U9M/%^C7
MF@)K,<\BVS2_9PCQ,)?.W;/+V8SOW<8H W:*Q;;Q/97%[=V!BN8=0M8A.]G+
M'B1HSP'7G##/'!.#P>:@7QKHSZ/I6K+),UCJDR06THA;EW;:H8=1D]S0!T-%
M<S=^.]'M;[4[$1W\]WIJHUQ#!92,P# D$#'(PN=W3D<\U5U7QW;6X\-R:=;S
MWEOK<RB.>.,D"/86Z==QQT[<YZ<@'845B7/BBRMGN!Y-U*EJR)<O%%N$+L%8
M*W.<X92< @ \XK6N;F&SM9KJXD6."%&DD=NBJ!DD_@* ):*R;/Q!;7=TL#07
M5NSVYN4:>/:K1@@;LYP/O#@X([@553QEI+26&\W$5MJ#B.SNY(BL,['[H5NV
M>V0-W;- '0457OKVVTVPN+Z\F6&VMXVEED;HJ@9)K,T[Q18:CJ::<([F"ZEM
M1>0I/'M\V'(&Y2"1U(R#@C/2@#;HKGF\::.D]FK/,+:]N?LEM>>6?)EFY 0-
M[D$ XP<<&EU3QEI.D)=37#3M:V<BQ7=S%$6CMV.,!C_P(9P#C/.* .@HKF-2
M\?:)IFH7-A(+Z:ZMX5G>*WLY)"8V. RX'S+[CCWSQ5E/%VF26>KW0%SMTABM
MZAA.Z/"[SQW^4YXS0!O45DGQ%9-:6,]NL]RU]!]HMX88\R/'@'=@XP!N7DD<
MD#J:KVWC'1;O14U6&X=H6G^RB+RV$OGYV^5LQG?GM^/3F@#>J*YB>>UFACF>
M!Y$95E0 LA(P&&>,CKS7#:%J,MW\6]:@S?Q1)ID#-:W3L1'(9&R5&2N"-O*\
M?CFMGQ3XJ;P]>:-:I93SMJ-XL&]$W!!@L?JQ"G ^I^H!=\/Z$^C02-=:E<:G
M?3!1->7 4,RKG:H"@  9/'JQ/>MBO.H]=&D?$OQ 9CJ=S"=.M9H[.-9)V4DO
MNVISM' ST'YBNG3Q?I$VG:5>VLSW*ZL<6,42?/,0I8@ XQ@ YSC&* -ZBN,U
MWX@6ECX-O=<T^WN+B2WN#9O$T9!@FW!") >@!(Z=<C'7-=;!<">U6?RI8P03
MLD0AQCVH FHKF+#Q]HFI7ZVEK]M=OM,MJ\ALY%2*2,98.Q'R=#UQTJ=?&.E&
M^L;:3[3$NH9^Q3R0D1W! SA3ZD<C(&>V: .@HKC;CXH>&K>":X9K]K>WN&M[
MF9+&4K;LI )D^7Y!DXYYX/%7=2\=Z)IE_P#89&NY[DVAO$2VM7D\R+(Y0@8;
MKGC. #G&* .EHK OO&&FV%I-=M'>2V]M&LMT\5NS?9E90PWCJ"%() !(') !
MJ:;Q/IZ8^SB:]'V5;QC:IOVPMG:_7D':V ,DX/% &S163/XAM(HX##%<W4TT
M N4@MX]TGE_WB,@#KCDY)SC.*SC\0/#OV+2[Q;J5X-3D,5LR6[G+C.5/'##!
M&WKZ T =/17+-X[TYM'UN^@M;YI]'0M<V<EN8YA\NY3M;H"!G/H#6GX9U:37
M/#EAJ,L#PRSV\<CJR%069 Q*Y_AYX- &M17.WWC;1]/>\,S3M;6,Z6]W=)'N
MC@D;;A6/7^)<D @9YQ70NVQ&;!.!G &2: %HKRRWU:#7_P#A)-1U>;6[)-*U
M-_(N+19%^SQ0I&2I5002<L6!!X/L,=3!\0M"GM&N@;Q(/*ADCD>U=5F\TX14
M.,,V3C [Y]#0!U5%8]EXFTZ\DU.%V>TGTP*UY'<@(8592P8G)4J0"<@GH:@B
M\8:9)J%M8LEW%/=P/<6:RP%?M**,ML'7."#M.#STH WZ*X&W\9V&O_#W4]5U
M>#4;"QS/'(\$;[TC$CH,,F<, HR>@/?%=.VM65C;Z? GGW$]U%NMH%&^61%4
M$L<GC (RS$#)'.2* (/%/AU_$EG:6RWHM5M[N*[SY6\LT;;E'4<9'/\ 2MU=
MP4;B"V.2!@$_2N;G\>:%;>'KS6I9IQ;64IANHQ;N989 <%74#*]1R>.1SS5B
MR\6Z7?Z[_8\?VF.Y:$SPF:W:-)T! )C8C# 9'3UR,CF@#=HKG;;QMH]U/8K&
MT_V>_G>WM+LQ_NII%SE0>O\ "V"0 <<$UF^&Y)A\3/&5LUS<201QV+1QRS,Z
MQ[D<MM!)V@GG H [2BJ-_JL&GSV]NR2S7-SN\F"( LX498\D  9')/<>M<5X
MNUN.2;P?JMM<WMO;R:SY$T9,B;E590RM&.IW)P,$T =W:6<-DCK$&+2.9)'8
MY9V.!DGZ #V  & !60/#LH\;MXE^W+DV0L?L_D\>6'+YW;OO9/7&,=N]-L_&
MFC75KJUQ))/9C2>;U+N!HGB4KN#%2,X(Y'K4MEXJL+S4&L#%=07?V47J12PG
M=)#G&Y=N<\X&/O<CB@#<HKEM-^(6@:J(Y+9[L6[1S2&YDM72*,1$AP[D84\9
MP><8]15ZV\5:?/K,&DR)=6MW<Q--;+<PE!.B_>*^X!!*G# =J -NBJ>I:G::
M3:K/=R%5>18HU52S2.QPJJ!R23VJG9^);*\O+RQ$=Q%J%I&)I;.6/$I0]&4#
M(8$C&5)YX/- &Q17G/A1F\927&I7<^K6MY::O,T,D3M&GE1R;1"1]T@@?,,9
MSD]:[6^UJWLKQ;,13W%T8C.8;=-S+&#C<>1WX ')YP#B@#1HKD;WQQ''KGAV
MQM;&[F@U>![D2B$_ZL1[@ .N[+*3Z#]-*_\ %FG:>;UF6YGBL/\ C]FMX2ZV
M_ ;YL<D@$$A02 <G% &Y167/X@L(TLS [7<EZAEM8[8!VE0 $L.P7!')('('
M4BN-\5>(;;6M&\/:GI%[=(H\0VMK,JN\1SYH#QR)D9Y'0Y]NM 'HU%9]KK%O
M>ZE=64$<[M:MLEE\O]V&QG:&Z$\C('3OBDU/6[32IK.WF\R2ZO7,=M;Q+EY6
M"EFQG   !))(% &C17,S>/-"MO#TVMS2W"6D%P;6<?9W+Q2AMI1P!\IW$#)X
MY'-6M/\ %>FZEKDNCQ"ZBNTA^T(+BW>,319VET+ ;AD@?C0!N45YK\1O$L-S
MX0:;3)=051?0PQ7MN62*1A,JNN0?F7&X9(VDC@YKT.\NELK.:Z=)'2)"[+$A
M9B!UP!U^E $]%<V/'&CG3](OU^TM;:O(L5FZPG#NV=JG^Z3@]<5HSZ]8VMU>
MPW#21"RA6::5D.P*V=H![DX/ Y_,9 -.BL&+Q=IS:E-IT\=Y;7L=O]J6":W;
M?+%G!9 N=V#U Y'I533/B#H.K1">W>Z%H;5KK[5);.L.Q6VD;\8W=/EZ\^O%
M %K4O#LNH>*](UP7RQ_V8LR1P>3N#B4 /D[O]D8P./>M^L6S\3V%UK?]CO'<
MVM^T/VB**YB*&6/."RGH<=QP1W%2ZQX@LM#FL([T3 WUPMM R1EE,C?=4GMG
MW]* -6BLBT\1V5[K=_H\*7'VVP17G1HBH ;.T@G@YP>GISBLJZU[1-1O_#,L
MLVI0RW<S26"JDD:2G8WW_P"$C;D@$^AZ4 =917&P^*#KNI^)M&^R7MLFGHL2
MS*&C;<8RY;<IRN<KCO\ GBLSP'XSLH_"?A:RU"6]>YOH4A6[DA=HGF()V&4\
M%C@]^HQUH ]%HKS:R\1Q>'O&OC@7DFI7=O;O:21PQK)<F%##N<@<[5R2>P]*
M[1O$-@UI8W%LTEW]OB\ZUCMUW/*F =P!Q@ ,O)P.0.I H U:S-=TV\U6P2"Q
MU>XTN995?S[=$=B!U7# C!_I^%<9XX\0VVL_#:[U31[VZADMKV&!PCO#)%()
MT1XY%!'.&((/'.:[/4-9M;2[73PD]S>2Q-*+>V7+B,<%R<@*,\#)!)Z9Q0!9
MTZPATO3XK. N4C!^9SEG8G+,Q[DDDD^I-6JXCX67DE]X8O9GN+F=?[4NEC>Y
M=FDV"0A0=WS<#'!JA)KZ:!\3O$ N'U.[A_L^VECM($DN2I+2;BJ#.T<#/0?F
M* /1J*YV'QQH5S8:1?07#RVFJSK;6LJQD@RG/R-W4_*>OI4EUXLL+>;6+80W
M4MWI4"W$\"1?,R-G:5/0YVGOQWQ0!O5E:[I=[JMK#%8ZS=:5(DPD:6V1&9UP
M05.\$=_TJ'PCKLGB/PQ8:I+;R027$"2LK*0N64'Y?4<]:JW?CG2+74=1T\1W
M\]YIZ(\\$%G([8;)! QR,#[W3D<Y- &[864&FV$%G;@B&% B[CDGW)[D]2>Y
MJQ6,GBC2I=*T_4;>=IXM2Q]C2-"7F)!. OJ "3G &#G%4KOQOI\&BZU>QP7,
MESH\9>ZL3'MF3Y=PR#QM(&=P)&,XS0!TU%9?AS5'UGP_8W\L,D4LT".ZNA4%
MBH)*@]N>*U* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-N=MX%$UHXZI.AWQD>GS #\37044 >5SZ3XCNM2T;Q)';RP7NN1-8:G""?\
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M*W.,Y&>^..,&MVBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/UC6;31+6*:[+DSSI;0QH
M,M+*YPJ#MDGU('J:T*Y?QS=:I:Z98/IUG<7$9OHEO#:P^;-%!SN>-<'YLX&0
M"0"2/4 $C>-M*AT_6+JYCO(&T=L7L#0[Y(\KN!PA8$%3G(./7%06GQ"T6ZU>
MQTXQW\!OTW6=Q/:LD-P<9*HW<X_ ]B<C/$7MM=6FG?$]WTK4;:TO-/66WFN@
M2'"VQ4Y8L26SVY([XZ5N2VTGBG3O!%O:VEU&=/N;:_N)I[=XUB6*,_*&8 ,6
M8@?*3QD]* -*Y^)^@V]O>7 M]5E@L;EK>[DCL7(MRN,L^?NKS]>#Q4.M7*3_
M !'\"W-I=RO:WD=X^$F8Q2*(04;;G;_$><9YK%T*\!TGQ_IR6%W=7%QK-]'%
M'';LZ2ET50I<#:O/7<1@<U:BT2\T76_AS9&WN;A-)M)X;NXB@=XXV:%47+ =
M"P(]N^* .BTK5]"75_$]S#+=0RVCQMJ+W1=8TQ'D%5;H-HR< 9]ZMP>*[*37
M+;2+BVO+*ZO(FEM!<QA1<*O+;<$X(!!*M@X[5Q5[H6I:U<?$BSMK6X@?4A;F
MREGA9(YBD*J0&(QC<N/QSTK0T.2+Q (HQX(FT74HHG6:[NK%(UMV*%3Y+]7)
M)'(XQG/8$ J?$CQ'#?>")I].74?)%[#%%?P,4A=A.JN.&!9<!ADKM)Z'I7H]
MW<&ULYKA89)S&A8118W/CL,D#/U->.SC6/\ A3P\)2^'=5_MBPDMX66*U9HI
M52X1MZ2?=8%1V.1SD8!->QDF:U)V,C.GW7ZC(Z&@#E?#GC>+4O!MIKVHVTMK
M]J8+$FT-YK.Y")& 26/0<@>O2M*'Q3:RWUWITEI>0:E:P?:392(OF21=-R88
MJPSQP>#P:\ZL-)UQ?AWX3\O1[Y;SPW?Q3W-G)'M:=5+J_E@GYB V0>ASQDUU
MZ64FN_$33=?@@N8++3["6)I+B!X6EDD(P@5P&PH!).,9(]\ %H>/=*?1M)U9
M(+Q[359UM[9Q&O,C,54-\WRY(/7\<5?U+Q/I^D-J!OA-#!86RW,\Y4% K$A0
M,')8E3QCM[C/"S^!M3OH?$GAS#0:3%,]_I,H8K^_E&]5'^S'()#C_;'I6O*W
MB2+X97NJIIOF>([Z-+B6T,8<H3M7:$/5EC&=I_B!XYH Z&U\46EQJ=QILUK>
MVM]!;+=F"6(,SQ$D;EV%L\C&.N>U4-*^(6BZQ EU!'?1V+6\MP;V:V9($6-L
M,&?H#WQ_7BL#25G@^)<>K+I.N?8)]#\DW-W$S.9!-N.X$DJ<=%P/9<51L/#N
MK:G^S_+X>BM+BUU81./(N(S&21,9 OS8'S+QGISS0!HZ[K#7WCGP.T5OJ=K'
M<7,K+YQ*1SQ^2Q!*!B >0<, W/UQUD7B>UGGC$-M=R6TMTUHEVBJ8C*I*L/O
M;@ RL,D8R."<C/'ZAJM[X@UOP9?1>'M9A-I>.]XDUFT?D$PLN,M@$9/WAQ[Y
MXJ*'2[RU\2VVH^'(M5L);G4R-4TRX@<VDD>\[YU+#:K$ ,"IY) QUH [3QAK
MS^&/"FH:Q':/=/;1%UC7'7'!.3]T=^_I7)Z_JL@\2^!-2F6_MQ++<++;Y8^9
M_H[$?NU)!.3QQGFNE\?6%UJG@'7;&RA::YFLW6.->KG'0>]<[?275_KG@.\3
M2M3CBM))6N/,M'S$&@* L #CYCC!Y[].: .ET[QCI>H6&HW3BXL_[-D,5W#=
M1%)(FP"/E&<Y!&,9SFI;/Q1:7.N_V)/;W5EJ#0?:(HKE5'G1YP64JQ'!Z@D$
M>E<#JNAZMJTGC^.RL)Q-<W5E=60N(62.Y\E8RRY8 ')0CGU]*Z7PO=6>K7\-
MU!X)GT>>!")KB]L5A9"1C9&W5LGN.,#U- &WK_BC3?#;60U$SK]LG$$1C@9Q
MO() ) QG@\=3V!K.L?'VE7W]JQBUU""[TR/SKBSN;?RIO*QG>JL>5Q[Y]N16
M?\2YA;-X1F,<D@3Q#;DK&I9B-DG0#D_0<U'=:-<:]XQU76;:WFA@_L%],C:>
M)HFFE=BW"L =JC R1U;CI0!OGQ?IHMM"N=MQ]GUMHTM)-@QN=2ZAAG(X!/3M
M5:/Q[I<^K2Z;;VFJ3SP7:6DQCLG(B9AD,_\ =3GJ?Y#-<3 VIW'ASX?V:>'M
M7671[ZV6\$EJ4V;(70D9QE<\[NG(YR<5TOABUN'\0^-5EMKRVCOKI7MYI;=T
M5U\E4)4D#H0: -5_&VE1R6+,ER+*^NA9VU]L!ADF)("CG=@E2 VW:<=:Y72O
M$D/AK7_'#W2:G>06U[&Y$2O<&&+R59F)8\*,DXSZX'%6/ ^I:QIVB:?X4OO#
M5^FHZ?MMS=-#_HAC4\2B3//R]ASGTY(BBM[L?\+(SI]^/M^3:9M)/W_^CB/Y
M>.?F&/UZ4 =A/XHL$FL8+5)KZXOK<W5O#;!=S0@#+Y8J /F7J<G-,M?%^F7V
MDZ;J%EYUPNI.T=K"JA9'=0Q=<,0!MV/G) X^F>0T^;5K:/PEI]UI&J_V:FBI
M%,;2!EE%TH1?*D;AD3 )SD G&3@5GZ'HJS?#W1]$U[0]9MFM[VY(N;:-Q-:2
M>;(Z2)LRV,,!G!'/<<@ ]%3Q':-8K<-!<QR/<-:QVSH!*\HSE0,X/W2<YQ@$
MYQS2Z-XCL]:NK^RC2>WOK!U2ZM;A0)(]PRIX)!!'(()%>=W6G>*%T/2]2OK*
M;7QH^K3$02P!9[RS9#&',9',@R2 0"< UVWA5K2[>YU"R\,OHT4JJI:XM%MY
MYB,_>4<[1P!GKD]AD@&G?ZU!8WL-@D4UU?3(TJ6T 7?L7 +$L0JC) R2,DX&
M:Q-3\9P2>!]9UG2$GDN+&*='B:,![:9$)(D4GC! SUXZ9JKJ5O>Z/\4(/$#6
MMS<Z7=Z9]@D:WA:5K>19"ZDHH+;6R1D X/7%9<^C7B>'OB#J*V=UNUX2+9VB
MPL9&'D>6K% ,J6;)YQ@8SB@#:\&:5!/::;K^-1M[R2P2*X66;Y+HE5;S67)R
MV<X;@\GVJI8:A/XR\<ZY8O<SPZ-H;);^3!*T1N9V!+,[*0VU<8"YP<Y.:Z7P
ML6'A72HY(9H98K2*.2.:-D96" $$$#O7*6ME>>"/'>MWYL+N\T/7&2X,MI"T
MSVLX!#!D4%BK9SD XZ4 =+%H;:;KL-_;7]RM@EO+'-:S7#/&&)0AQN)QC:1U
MQSVYS"/&NE@6,TD=U%8:A((K2_DC AE9ONC.=RANQ8 'L>13M1>;Q/H>HZ?8
MQ7%M#=6<L/VFYA>$AW0J-J, W&<DD >F<\<;/8:AXA^%^G>#Y=,O;35HOLMK
M.TENPBA$+INE$N-C JA(VDD[@/6@#K+CQUIL-]JME%9ZG=76EA#<106C%L,"
MP(SC(P,Y[Y&,TR+X@Z)/_94D2WK6>IND5O>_9R(?,?[J%CW)XZ$ \$Y!K/TI
M9[;QYXUO);*]6VN8;002_99"LICC97"\<X) ]^V:YJ'3]1C^%7@[3VTO4/ME
MEJ-K)<0"TD+1K'+N<D8Z ?GVH [FX\<:=#J.J:?%9ZG=7FFJC30P6C%B&!(*
MYQD84\]#D8S4,7Q$T2>/2[B);U['4G2*&]%L1"LC\*C,>ASQP" >"15/2/.M
M_B+XLOI;*]6UN+:T$,IM9-LAC5]X7Y>2-P^O:N6@T[48O@]X8TQM+U#[=:ZA
M;O-;BTD+HJ3[V)&.FWGWH ](O?$=M:W5U:P6MW?3V<:R726B*QA5@2,Y(R2
M3M7+8[<C-.X\>:#!::1=)/-<6^K/LM)8('=6."<' X/!&W[V1C%9&D?:_#7C
M/Q(][9WTUCJTL=Y:7-O;23<A K1N%!*$8&,X!'?M6!:^'=1T32?!EM+8W3R0
MZU)?W,<,+2+:QOYN%)4$<;U!QWSVH ]"T+Q-9Z]<7]M##=6UW8.J7%O=1>6Z
M[AE6QD\$=/I7.?$;6GT2[T*XOQ>+X;,T@U.6T+!D.T>5O*8;9DMG'7 Z]#9\
M/PW$?Q+\6W,EI=1VUU'9K!,\#JDAC1P^&(QP6'U[9K7UK4Y['4[*"33;F\TR
MXAG%T\$!F\I@8]FY1DD$%Q@ GVQF@#.T;[+:K?Z[H^HW.K:/+:H8+=+HS[74
MN6"%VXR"O!/&.W2D\/>-H]0\'66NZE;2VQNRJQ1A0QE=V(1(P#ECT'./4\9K
M%\,>&8['QMK-[X?LKG3] NM/$;V\T+P))=EOO1QN 0 O&< 9;BL>QTO6U\ >
M$'CT>_6Z\-WL4MU9R1[7F4;E?RP3\Q ;(['/&30!Z/9>)K*ZU.ZTR=)K'4+:
M(3R6]T%4^4>/,!4E67/!(/!ZXJM%XSTR:\TVW:.ZBBU7<+"Y= ([@@9^7!W+
MD<C<!GM7.ZWH-QXR\137UDEQ:6Z:'<V*S7$#PL\LPP!M<!L*,DG&,D8SSBUX
M/UW5)],TW1KWPSJ-I?V,:0W4]Q!BW4(NTM&^?G+ <!<]>>!R 5?!VKII%CXD
M:Y:\N\>);BV@C#F:5ON!57<<G ]^ ">@->@"5S;^;Y$@?;GRB5W9].N,_CBO
M'=/L-<T36=5\4V6G:E,ZZW<B33GMGS<V<S)B2($<."N>V0,'M7L-M.MU;QSH
MLBJXR%EC*,/JI (H YX^.M)'A=/$7EW?]GM/Y#-Y8W1MYGE<KG.-_'&:?>^-
M-.M-;N=&6UU&YU"" 7!@M[5F+J3CY<X!Z'GIVSGBO.;BUU>+X8:CX870-5DU
M"WU,R$K;'RY$-X) R-T<%3VSCG.!796WGCXKWNHO8WL=H^BQ0B5K9ROF+([E
M<@$$X8=/H* -FW\8:1=>';+6H))7M[YQ%;1"/][)*25\L+_>!#9[#!).!FN:
MT74Q_P +4\1O<_;+2"#2X))8KV7*Q'<Y9A\S*%P ?E..O?-<WINFZUIOAOPG
MJBZ1?RMHNJ7<MW8B!A,8IGD =%(&XA7!P.>?K6GJ.GZAXH\2>*!::=J%M;ZG
MX?2UM[FZMVA4R R<$-@C[P&,9]L8- '9IXPL/[4LK"XM[VU>_C:2RDGBPMP%
M&XA<$D-CG:P4^U0Z1X[TS7+Z*UL+74Y \TL#3&S81Q/'G(=OX2<< \].F16'
MX7NHM0>QCN? 4VG:I9@&YN;BP18XF489HG'+ECP-OKSTYT/AO#<6VDZI%=6E
MU;2-JMU.JSP-'N1Y"RL,@9R#^% '0:KKEKI5Q96LB2S7=](T=M;P@;Y"JEFZ
MD  *"22165/X_P!%MO#=QKDPNTM[6Y:TN(_()>&4,$*MC@<D<YQR.:A\876I
M6^K:$D-E>S:7)+*+V:PB+SQ_)\@!'S(K$G++@\=1FN$N=,U4?#SQCI2:#JB7
M%SKC7%M$82YDC,T;@@@G.%4Y.<<=2: /3-/\66&H:_)HH@O;>[$'VB/[3 8U
MGC#;2R9Y(!(Z@'FM+4-1M]-@22<L3)((HHT&7D<]%4>O7V !)P 37*W:S3?%
M?1[Z.SO#:)I<\+SFV<(KNZ,H)(XX4_3O3OB+I]_/9:3J5AIW]J?V7?K<S6&
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M"R Q_?&TG.1Z'!]*W$G#6JW$B-"I3>RR8!08SSCTK@KC0KN#XCRV-KL_L36
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M-VQA@@9!'0^E3Z=9'3]+M[(3O+Y$0B61P-Q & 3@ 9K&O?&5KIUA)>7NGZA
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M\CDN<@'C=P<_2@#T2BN2T?Q;=ZCXG\0:?-I-U%;Z8\<89=C')3?D@-G+9&
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MAH9M'U"+^RH'CO-T)/E9MO*!.,]6[=<<D"O4Z* .#G34O#OQ.O\ 5FTR\O\
M2]7LX8A+:1^8UO+%D;67J%(8G/3-8FF:,UQX4N-.\0>&]2^SW&O7,^47][ K
M-(Z3)L);@X&1_>XR*]7HH Y;P+;:Q9Z9>VVJ7=U=V\=VRV$]ZNVX>#:N#(,
MYW;AD@$@9]*J207UC\6)M1_LZZFL;K28K<7$2@K&Z2NS!N<CY6!'!ST%=I10
M!X_/I6JR?"#6])72;[^T+C4I)8K?R&W,C7(D!]/N@GK[5IZA!/I'CG4]2N_"
M5QKVE:PD,D,D%JDLMM(B!"C*^"%( .>,?GCTVB@"CH\)M]*MXVLH+$X)^S0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQS6]HMWYSE=KJS%1MP2>H/7'3I5[5+VXL;9);;3YKYVF2,QPLH*JS %_F(X
MYH NT44A(52S$  9)/:@!:*Y.3QU"NBR:Y'HVIS:.JLZW<2QG>@_C";]^T^N
M.G) '-=90 445'//%:P23SR+'%&I9W8X"@=Z )**I75[<0:E8VT6GS3PW!<2
MW*,H6WVKD;@3D[CP,5=H **** "BL/7_ !&VB*?)T?4M3=$\V5+*-3Y:<\G<
MR@G@X R>.E7=%U>SU_1K35;!R]K=1B2,L,''H1V(/'X4 7Z*QO$'B6S\-Q6C
MW<-S(+JYCMD\F/< SL%!8\ #)]<UHW]];:;92WEW((X(AEFQGV  ')).  .2
M3B@"Q16 _B?R?$NE:)/IMS#-J,,LT<C,A51& 2IP2=WS#/;G@FM74+S^S[-[
MIH9)8X_FD$8RRKW8#OCK@<^F3P0"U14<$\5U;QW$$BRPRJ'CD0Y#*1D$'N,5
M)0 45B6/B..]\5:EH/V.>&6QACF:60KMD#E@-N">/E[X/M6W0 45C^*-?3PO
MX<O-9EM)[J*U3>\<)4-CU^8CC\S[5%>>)X[/Q#H6D/93EM7$ACG!78FR,N0>
M<YP!VQSUH W:*R?$VNIX9\/7FL2VDUU%:H9'CA*AL>OS$<?K[5I6\PN+:*8#
M D0. >V1F@"2BBB@ HHHH ***Q/$_B./PQIL=]+9SW,;SQP'RBHV%V"@G)Z9
M/8&@#;HJE)>W":S#9+I\SV\D+2->!EV1L" $(SG)SGIVJ[0 456U"[^P:=<7
MGD23^1&9#%%MW, ,\;B!^9JMX?UB/Q!X?L-7BB:*.\@698W.2H89P: -*BJ5
MI>W%QJ-];2Z?-!#;L@BN'92MP"N25 .1@\'-7: "BBB@ HHHH **** "BD)P
M"0"?8=ZQO#?B*/Q'!J$D=I-:FROI;)XYBI;?'C)^4D=3ZF@#:HHHH **** "
MBBB@ HHK.L-4>?21?:C9R:8VYE:&X=25PQ4'*DCG@CZT :-%8C>(XU\9Q^&V
MLYUEDLFO%N"5V,JLJX !SG+=P.G>MN@ HK&O?$*0:P=)L[&XO[Y(1/+' 441
M(20I9G8#)(. ,G@]!S4VBZU'K<-TZ6MU:O:W!MY8KE KJX56/0D$?,.0<'J.
M* -.BBB@ HJG<WWEV%Y/:1&]FME?]Q$PW.ZC.P$\ G@?C4]K*\]I#-+ \$DD
M:LT+D%HR1DJ<<9'3B@"6BBB@ HHK$L/%6G:EXEU+0[8NT^G1))/+@>7EBPV@
M]R-ISV!XZ@T ;=%<<?B-81:G9V]WI6K6EE?3""TU*> +!*Y^Z,YW*&[%@,_2
MKWB+Q<GAY)I/['U._AMD\RZELXU*P+C.3N89..<+G Y..* .CHK/_MO3QH4>
MM?:!]@DA2=)<'YE8 K@=23D #J2<50?Q/Y7B73-#GTVYAFU""6=)&9"JA,$J
M<$G=\PSVYX)H WZ*JZA>_P!GV;W30R2Q1_-*(QEE3NP'?'7 YQTR>"D^J6-O
MI1U22YC^Q",2^<IW*5(R",=<Y&,=<C% %NBL>ZU]+5["W>SG:_O]Y@M%*[]J
MC+,Q)"@ $9Y/) &:9#XE@FMK^06ER)M.E\N\ML R1?*&W  D,-K!A@Y(Z<\4
M ;=%1V]Q#=VT5S;RI+#*@>.1#E64C((/IBI* "BJ&LZO:Z%I,^HWA80P@9"C
M+,Q(55'N20!]:ATO5;R]O[VSO-(N;)[;85E8AXIU;/W''4C'(QQQZT :M%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M AX4.GW7W$9;<#][ Q@5TLWA.WN-3T?4)=1U!KC2O,,#-(AWF08<OE><CCC
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MSH I?$W_ ))EXB_Z\9/Y5@7*ZQX9UCPI?PZY>WMMJES'8W=E<;3&-\996C
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M/V*'Q=-;#/1HH6:2-#[;B/\ OD5ZS#81>'[*[ELX)[R]N9#)([',EQ*1@;F
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M) Q?RVSAE"YW#@CC)!'(K/\ %T3Z'X'O%T#18)60IBU@M5<!2Z[G$8&&*C+
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M>Z;'.RSL/.5TRP<9^;) /.:]0EB6:)HV+A6&"4<J?P(P17EES%=#P#\.K?\
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M".0Q'MFL[39-2\-Q^"=?FTC4IK&WT7^R[Z&.V<S6KXC._P O&X@E,$@=!]*
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M.7_&NAHH Y[_ (1&W_Z"^N_^#.7_ !H_X1&W_P"@OKO_ (,Y?\:Z&B@#GO\
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M% '/?\(C;_\ 07UW_P &<O\ C1_PB-O_ -!?7?\ P9R_XUT-% '/?\(C;_\
M07UW_P &<O\ C1_PB-O_ -!?7?\ P9R_XUT-% '/?\(C;_\ 07UW_P &<O\
MC1_PB-O_ -!?7?\ P9R_XUT-% '/?\(C;_\ 07UW_P &<O\ C1_PB-O_ -!?
M7?\ P9R_XUT-% '/?\(C;_\ 07UW_P &<O\ C1_PB-O_ -!?7?\ P9R_XUT-
M% '/?\(C;_\ 07UW_P &<O\ C1_PB-O_ -!?7?\ P9R_XUT-% '/?\(C;_\
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M<;F[ $@@9.3@XS@U)H^MV6NP3S6+2%8)C!()8FC97 !*E6 ((R.U &C1110
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M=2R[<\G@>G<4 ;%%5-+U!=5TRWOEMKFV6=-PANHO+E3V9>QJTQVJ3@G S@4
M+17.MXRL(K;19;BSU&V;5YUMX(I[8HZ.<X#YX7[I/7.*WIYEM[>29E=E12Q$
M:%F/T Y- $E%9N@:W:>)-#M=7L1)]ENE+1^8NUL D<C\*TJ "BL75_%.G:)J
M-E87@N?M%\S+;+%;M)YC 9(&T'D#UJ:SU^UO-16P$%[#.T33*+BU>-652H.&
M(P2"R\=>: -2BBB@ HHK)7Q#9/XJ;PZ%G%\MH;PEHR(_+W!>&/4Y/;T- &M1
M110 4444 %%%% !1110 4444 %%9.M^(;+0'T];Q)R;^[CLX3%&6 D<X7<>@
M'^>:UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KB;VZ>]^,VEZ8Y_<6&CS:@B]C*\@BS^"[A_P(UV
MU<OK6EO:^+]*\40(SK!!)8WJH,MY+D,K@=]KJ,CT8GM0!D^,-:UC3O\ A(9;
M;5?*-C8"YLK:SB65@55F9KC<A"J2H Y&0#C)I/'FH3S?"3^WH]L5];Q6NHPL
MO\$@9&X]L$CZ$U=O_ HU"^UZX@UNZ@M->MQ'=01HC D1^6&5B"0-O;OZU%K?
MAR6\\(V7@I+J6Z\SR8[NY=0I2W1@6)P, L$V*.ISGG!- '96\PN+6*< @2('
M /;(S4M(JA5"J  !@ =J6@ HHHH *\WC>_3XWZR;"WMIG_L>WW">=H@!O/0A
M&S7I%<K_ ,(E>1^+[SQ';ZR([FZMUMFB-J&144Y&/FSGWS0!82#Q!?>'+K=/
M#IFMM)*(Y8465  [>6#N7YEVX[ \GI6/X"\0ZEXGB>[O+PQ'3D%G>6@$3>9<
MKG?)E5R$(QMP>>?3G8E\.ZC/!?\ FZ[*UQ=A(_-6 *(HAG*( >-V3ELY^F!A
MJ>$UM?%R:]I]V+,&U2UN+2.$>7.B_=+<\%1P".@XY'% &5HU_P"(O%'A[3/$
M>EZG##]IN?,:RF1?)^S;RI7(4OYFT YSC=G@"H+K6?$>NIKK>'S=13Z?>26E
MJJ+;F%WC SYOF'?R21\N,#'4U<TKX?OHUS+;6>OWJ>'WF:;^R?+3:I)W%!)C
M<(R?X1C/KR<NN/ MQ'XBO-4T7Q'?:3%J#![ZUACCD65P,%U+@[&(ZD T 4)=
M0\5ZAXWCT(:G%I:RZ&E[*L=NDK02F0*P4G(;D8R>,9XZ$<UJ>M:[JG@^:RU/
M4I$U#2O$D&G3SVJ(BW2^;&5<J0<<,#@<9'.>E;LBB+XT06FFZA;VS0>'1"J2
MKYJG$_W"-P.[&#USQWK<O/ =K=>&Y]+6]FCN9[T:C)>A5+-<!P^_;TQ\H&/0
M 4 =3!&\,"1R3/.RC!DD"AF]SM 'Y 5YQ#XFUNVU+PUY^IK>-?ZA):7R00J;
M1<AR!%)M#$KM SENA!YKT.*V86(MIYY)V*%7E;"LV>IXP!^%<5;?#:2WT[1K
M+_A)+TQ:-=">SQ!$"B@,-IXY.&QN/ITH B_X2NY7Q=)HVI:E<:1?'4%%G#/
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MSVYTO"3ZE+.]O9>)K?6=+:!_WR::D*029&W:R$*^<ME>V!R.X!SMQJNI^(/
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MQS@BSXEE\3>'/ GB6[.MK)/;%I["<1(95BP,)("NTG.1D"@#NXW\R-7VLNX
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M#D8SP 0/7-9/AZ\UC1/"'P]OH=6D:UO9[:PEL3$@B\N1&^;.-^X%0<[L>PH
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M=D4%P2I(*D@G!Z9KMM,NKC4?$&I7$=X[:9;A+>*(!"C2XW.X;&2,,B]<9#4
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MW\265S<V]O/ +>ZEM'2<*&#QG#="1U]Z (_#_AP:!<:K*M[)<?VE=M>2JZ*
MLC  [<=L*.#FJ^N>$VUKQ#I6LC5)[6?2_,-LL4:%<R*%;=N!SP/:NDK"'BB"
MYNKJ#2[&\U0VCF*>2U\L(D@ZIND=0S#N%SCO@T /AT6\&I1WMWK-Q=&&-UAA
M:)%C1VXWX4 E@,CD]&/K6*?AY"? ]UX4.JW)L[F5I'E\M/,&Z3S& XQ][VZ5
MT>CZW8Z[;2364C$PR&&:*12DD,@ZHZGD$?\ UQQ64OC6T9[>=+"]?2IWF0:D
MB*T*&/=N+8.Y4^1L,1CCT(- ',^,)E'BJTAOM<U'1A;V6V*]6S66"Y9V^889
M&5678OH3NXX'-^WT/4/%7A;5-&U+7;F\TVZ"+%?-9+;S,O5E"X *\+AMO.3[
M&M_2_$W]IW]O NDZA#;W5J+JVNWC4Q2)QP2I.QL$'#8X]^*WJ .=O?"[W&JZ
M=J\&IRP:E90-;"3RE9)8V()#(>^5!R"*@O\ P/:7_AG4]&:[G5M5D,M[=X4R
MRL<>V!PJ@ #  _&MS5+^33K5)H["YO6:5(_+ME!8!F +')' SDU=H Y/6O!'
M]JWFGZI;:S>:;K-E#Y OK95S+&3G8Z,"I&>?K6_I>G+IEBMO]HFN9"2TMQ.0
M9)7/5FP /P     X%7:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC_BI_P DO\0_
M]>A_F*["LCQ+H$/B?0KG1[FZN+>WN5V2M;[=Q7.<993CI0!EZ4GB'[-H!>2P
M;3]BFY$:,'V>2VWDDC[VW-9D1U?5_'GB?1O^$AO;>R@MK66#R$B#Q%Q)D*VW
MID=P2<#GUVV\*SR:;'ITGB+56M%18VC"P+YB# VEA$#@@8."#4UOX82U\1:G
MK<.HW8N-0BCBD0B,H@0';M&W/&X]2: //K;7O$+^ /#7BR;7)VNI+R"WFMEC
MC6&9&F\IMPVYW$<Y!&#T K<*:[K?CKQ1HL?B6]LK2U@M98#!%%OC9PYP"5^[
MD<]S@#<.<Z*_#NR3PC9>&UU34196<ZSQ/^Z\S*OO4$[,8#<]*RM,AFN?BMXH
M-OJDUL6M+2-76-&68JK[\;A@LO'3IDY!H Q9M:U'7/ GAF75F5]0MO%-M:3R
MHNT2M'.5W >^/SS776M_=>)O%?B32UO[FRM])\F"(6Q"L9'0N9&)!SC@ =.#
MD'/%J[\"Z=<:+I>E07-W:V^G727D9B*%I)58MN<LISEB2>F2:L3>%8QX@FUN
MPU"YL+VYA6&[,2HRW 7[K,K*1N'0$=N,&@#B#XE\1W7@.'Q"UY,MQHFHO!JT
M=NBA;N"*3;(Z@@[3M^;C'1O;&_K7B:>SL_$'B*QN3/I^FV*K!%D&*6=EW[NF
M2 KQ]#W;N*NWMSI7@W2;/1(]-OKQ+L2I'%#;M-YSGEO,8# +ECR<#D] *LZ%
MX3L=,\#6_AF>!)+;[,8;A,DARP._GKC).._2@#+AC\3V6M6&H"Y>72?)D_M"
M.YN$<N=N4>(*HVG/4=,'I6;IEYXLUW1]#\1:=.$:X=+BZCFN$^SM;MRT84+E
M2HX!SG(Y)K>\.^"(_#\D0.MZKJ%M; BTMKR562 8QQ@ L0"0,YP#Q5?2?AW9
MZ->G['JVJ+I/G&=-),P^SHV=V!QNVYYVYQZYH W/$]Q<6GAG49[2_MK"X2$E
M+JZ&8XC_ 'B/_K'G'!KE=,U?55\<WFD6LMY);2:']MMTU( $S"0H&_O*K9&5
M;!&.@KK/$>@VOB?0+O1[UY4@N0 7A;:ZD,&4@^H(!K&_X02%]5_M.YUO5;B\
M>P>PF=WC EC8YY"H "#SQC/?/.0#,\&>(FU#6XM/U"[U*SUF&S;[;I>H*!YL
MF4_?1,!@KPX^4XPW05K^+-;N+'5/#VCVLI@?5[QHGN  2D:(78+GC<V H/;)
M[U<M?#*1ZI8:C>W]Q?W.GPO#;23*@90^ S,5 W,0H&>!UXSS4WB'PY:>([2"
M*X>6":UG6YM;F @202KT9<@CV((((- &!;7NHV/Q"N/"TM]<3V%WIAO;:9B#
M+;,K[&7=CD'((+9(/%0?":U>+PK),UW<2!KZ[7RW*[1B=^1@9R?K72V>@+;:
MA/J4]W-<ZE- +?[2ZJ/+C!)"JH& ,DDYSD^P #/#'AN+POISV-O>W5S"TKS#
M[1LR&=BS<JH[DT 9WB"XNF\11V<>HSB)K%W2QL.+@R[@!*S'Y50#@;B 2>_2
MN5A\2>(-0\'^ =175G@N=4OH[6[*PH5E!$F6(QP?D'0@<]*[6_\ "4-YXG77
M8M1OK.X:V%I.ENZA9X@Q8 Y4E3DGE2#[BLVU^'%E9Z3HNFQZOJ?DZ/="[MMS
M1D[ANP#\GW0&;\^M "^%KK48/&GB70KO4KC4+:T2UGMY+D)YB^:K[E)50",K
MD<<5E^+6<_&3P)'<9^Q;;MHP?NF81G'X],5UECX;BL?$^HZZM[=23W\<<<L3
M[/+ CSMQA0>-Q[]ZFUS0+'Q!:10WBNKP2K/;SQ-MD@D7HZ-V(_(]P: ,#XLK
M"_PMU_S\;1;@KG^^&4K_ ./8KG[VTOKGQ'\-&O;Z\BNYK:;SMI7*2"U!8C*G
MDG.<YKL[CPO_ &FUNNM:E<:C;02+*MLZ(D;NO*M(% W8/..%SVZ4_5?#,>JZ
M_I6L-J%W!-IAD,$<7E["77:V[<I)X]Z .::PD/QN4?VA>#_B0^9PR]/M ^3[
MOW?U]ZK0:CXK\3: -=T*;R;HW;F%)9T%MY22E#&Z;2>54Y/7=T('%=<?#,9\
M8#Q+_:%V+D6OV/R<1^5Y6_?C&W.<]\UE1?#JSM=6N[BSU;5+;3KR8SW.EQ3
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MH;.552XVC )R"5;'&5P?H>:O77A.TFUW3M6M[JZLYK&W-H$MV4+)"2#L;()
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MWJOB>_T'Q1XK8S/<V>GZ(E_#;.!@29DSR!G!VCO6M=> M/N=%EL5NKF&XDU
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M7!QD [BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LC5
M/#Z:GJ-O?#4M2LY8$*;;2Y*)(I.<,I!!^N,^]:]% %>RLK?3[5;>VCV1J2>2
M6+$G)))Y)))))Y)-6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>elicio2021employeestockp006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVJS11C!^7L>">@]:RWD:'X<^/])DM[E;UKZ_98S _P XD?*;3C#;@<C&>,T
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M!P1R#C!KRK2)A_PAOPTADAFC>SU)#.)867RPJ2 L<CA06 W=,]^*[+PZZ_\
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M3C\ZM5PGQ&N+VTN_"PLM0N[3[=K,-E<>1*5WQ,&)&.@/'7K4?C.?6?!&E?\
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M$8.BL 0",X(P?RK!\4WFFVPTJ+4=0O;(S:A"EN;4N/-EW86-RH(VG/(.,@4
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M%46&EMIMK([21V[J5?!/WF4\J3UP>>><'(K9HH \S9[,?&35+R_LII;(Z5%
MDS64DD9D#DD A2,X-/\ %4]I<_#WQ/IFB:9=+ (&V!;21/-FD8L5C0J"<=20
M,?-]:])HH \]U&42>-_ =PD4YA@MKL32"%]L6^) H8X^7)!'/I5?PQ8W6H^#
M?&NFVZS6MW>ZAJ)@::)H\B7/EN,@9!R.17I5% 'E%TDWB7X8Z/X9AM+FWUN%
M[."6%X64VK0NN^0G& NU6(.><@#)-;]@_E_%S7+AXYE@;2[=%F,3;&9&<L V
M,$@$<5W%% 'BL<<X^#%C9&SO/M::P)&@^S2>8%^VF3=MQG&SG-=C+*#\8[2Z
M$<IMO["DB,XB;8',RL%W8QG:"<5W-% 'BHM]030+G4(--OKE-/\ %MQJ$UI'
M&\<LMLY==\8X+</D8]*W-2DTC5O!_B?4=%T:^62YTN6V^TW$$HEG<J0L:J_S
M, >_3)&,\X].HH \TN&+:G\-9%@N"MLK^>1 _P"YS;%!OX^7YN.<5J>!3)9Z
MSXLT^XM;J*:36I[M&>!A&T3JFU@Y&TYP> <\5V]% 'G_ ,3'8WOA'RX+B;[-
MKD%U-Y,#R>7$H8%CM!P.11XZGN_&.A2>&-!L[IVOV1+B]FMWBAMH@P+'<X&Y
MCC 5<]>U>@44 >7ZSOM]2UGP^-/OHH(]&CAL7L[5BU^1&PQ),HX"' "D@<G.
M<XJK:236]C\+]0DL-0%O80O!<XM)"\;FUV#* ;L%N,XQWZ<UZU10!Y0D]MI'
MB#Q#I'B71=6N8]2O'N;.2WBEEBN8Y% \HA#M##!!SQCVKTW3(%M=*M+=;9+5
M8H400(<K$  -H/<#I^%6J* /%)DN5^!NK:$=/O\ ^T8;J5&A^R298F[+C;Q\
MWR\Y7( Z]JZ_5)V?XI:'>6UO--$FEW*;Q$P3>Q0HI;& 3M/6N\HH \6AO)[R
M+P7?OINIQSVNJ?Z7:0Z?)%!9920"-$"@$9(^;D^I&<5V7A8RV?CSQ?:SVMTC
M75W%<0R&!O+:/R5&=^-O4$8SG/;@UV]% '$_$3<TOA4)%-)Y6O6\\GE1,^R-
M0X9FP#@#(Y/K6%XC@N;76]4U;PS<WEOK'VB-+C29H6DMM4&$ 901P=IP74\;
M3G'6O4Z* ,7Q?87FJ^#-9L+ XO+FREBBYQEBI &>V>F?>O/+[6TU7P[X)@AT
MS4TN]/U>R^V6WV"7-OY:L&S\N"!UXSQ7KM% 'D\,UII6M^(-$\2Z)JUV+^^E
MN;-[>*66*[BEP1&0IVAAT.[ QUK8CB?2?BCI<CZ=/#:R^'ULHA;PM)''(LP/
ME[@, !>YP,"O0** /'_# LX](A\(^(/#NI7.M6DAC"21RM;3X8E9M^=@7H23
M[X!/%=1X8;;\2/&LK13)'.UH8I7A95D"0[6VL1@X/'%=Q10!Y R2O\-?B#;B
MUNO/NM3OGMXOL[[I5D(V%1C)!]16YJ$GF>+OAY.D,[10)<^<X@?$6ZWV+O./
MERW'->AT4 >23"5_#/Q/B6VNC)>7,YME^SOF8-"J H,?,"P(XK3N7+>(?AO*
ML-P8[>.?SV$#XAW6VP;^/ERW'.*](HH \?T 6<.F2>$/$7AW4KS5H9W5$:.5
M[:[!D+)+NSL5>023TQZ\5KZ9?2^'?$WB[3]7M;POJ5R;RQN([9Y4G0QA0@*@
MX*[0,''Y5Z310!R/PO62/X;:'#-!/!+#;A'CGB:-@1[,!Q[]*R=)NH]&UWQK
M#J-G<LUY>>?;0BW=OM<9A5<(0,-D@@C/'?%>B44 >8S>$]0T;X1:. R#7?#L
M:W\+%N ZY9XR?[I4LGITKM?#$$ZZ3]MNXC%>ZBYO)T/5"P&U#_NH$3_@-1ZO
MX>N-8U2"636+J+3!'LN--C1/+N/FS\S$;@#T(!Y QW.=V@#B->:2R^*7A^_>
MUNI+9K"YMO,@@:0"1FC*J=H.W(!Y.!QUKG0';PK\3HA;7/F7ES=-;)]G?,P:
M!44H,?-E@1Q7K-% 'DLMR=$UG0]8U/3]2GT:ZT."R>6U24O:SQDG#HF& .['
M3J*] \+6]E!I!;3]+?3;6:5I4AD4J[9QEV4\J6/.#SC&<'(&U10!YQI\<O@3
MQYX@GOK>X;1=<E2[AO(8FD6"8 ATD"@E<DY!QCWKI=4N7\2Z!JEAI'F?Z393
M1)=NK1HKLA5=N1\W)ZC@8ZYKHJ* /)[F.;Q'\+=)\+16=S;:Y$;2WDA>%E-J
MT+IOD)Q@+M1B#GG( R36SI4HA\>^.YY8IUAFAM/*D,+[9=D3*VTX^;!('%=_
M10!XW#'/'\)_ ]JUI=BYM=3LWGA^SOOB5)<N67&0 .<UOZ1JMCI_Q.\<F[9E
M61+%E(B9M^(#\HP#D\\+U/8&O1:P-*\.S:;XGUG6FOEE_M3RO,A$&T)Y:[5P
M=Q['G/Z4 <!HMM?>%=*\):9?:?<VUO*UY+)<V]H9YK3>Y9( 55C'N#88@9XP
M".M9[Q7"_#?6M._L[4EN!XD,JQ26TC.R?:E?.<'=A022"?KS7MU% '#L^_XR
MVMRD<QMSH3P^<(FV;S,K!=V,9V@G%4=/T:]L?'=YX>CC!\/R3IKBG/\ JV).
M8<=@9E60=OE(KT&ZB>>TFABG>"22-E69 "T9(P&&>,CKS69H&AR:/!(UWJ5Q
MJ=_-M$UY.JJS!>%4!0 %&3QZDGO0 MOXCL[CQ/=>'Q%=)>6\(F+R0E8I%^7.
MQ^C8WKGZU@?$D.UIX>$<,TICUVSG<11,Y6-'RS' . !WKKELHA?->'<\Y3RU
M9CG8O!(4=LD GN<#T&+% '#:?,L?Q8UZZ>.9;=M,MD68PML9E9RP#8P2 1P*
ME^%$<D'PXTNWGAF@GB,JO%-&R,N97(R" >A!_&NTHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *Y_QK>Z78^%+R76;F]MK$A1)-9;Q(OS#&&097)P,G YQWKH*XWXJ03W?P
MWU>TM;:XN;F=46.*WA:1F.]3T4'L#0!;OO%GV+QO8>'5L;IQ-:R7#S+$6'!4
M #U^\<GH./?%Y/$UC+<11QQW+Q2W+6L=PL1,32J2&7/;!5ADC&1@$US^JO-#
M\3- U9;&]FLY=-GMA)%;.VR1G1E#\?)D \M@5C6UE=V/B2UO?#;:E;K=ZH1J
M>C7<#FW"ESON(RPPG3>"#AL@>U 'I&H:A;:79/=W;E(E*KP"269@JJ .I)(
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MK-UGN'R,GRP-P4   L!T/;!(!U%OXPTNZ\\1B[W1S+!&K6SJ9V92P\K(^<$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBJU[?0:? );A\!F"(H&6=ST51W)H LT5D6/B.SO_$%]HL<5REY
M911RS>;'M7#YQ@]^AY''N:NWFH06$D N2T:3.(UE(^0.3A5)[$G@9XSQU(!
M+5%%% !1110 445C7/B:R@O[BSBAO+N:U -S]DMVD$.1D!L=3CG:,G!''(H
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M:4OAHOXOL]?CNQ']EM&M$MA"-IC8@GG/7*C';VH R/A[_P ??C+_ +&*X_\
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M-(1'&V,X"#[QP#N.3P.G< YSQ';:DM_X"NK[59+II=6B,L7E(L8D,3G*;5!
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M=,VHW:D3[#R)F&[(4')^N/0"KMIX*N8=<TG5[KQ#=W-U86[VQ_<QHLJ':<8
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MK2O:3)<*FZ.4+N612JC@X((Z>F*I^"K*>/Q[XS9]3NY1%>0!E<1XES;K@MA
M>.VW'3G- '?-+&B*[N$5B "W'). .>Y) K*MO$5K<^*+OP^L-PMW:VZW#NZ
M(R,Q4;3G)Y![=JYSXD13O<^$O)O[JV6378(66$K@Y5V#$%3D@J,9X]JJ26%W
M=_%K4;6WU6XLV_L&W#W,2(93^]DY&Y2HSW^7Z8H ]&HKS+1?&6KZAX9\)02N
M\FHZK-=133PB-798"X)4-\H9MJY]MV!G&.I\+IXBAN]4@UEC)9"17T^29T,^
MPCYE?9QP1P>I!YH FUCQ99:)JUCIES;7LES?[Q:K!%O$I098#!XP#WQ4^B^)
M=,UZ6[@LI7%U9N$N;::-HY82>FY6 .#V/0^M<IXX:=?B5\/VMXTDE$M]M21R
M@/[@=P#C\J8_A_6M*OO%?C":_P!+T_4KVV2*W#NS06R( -\CE1N;C/W<#IS0
M!Z+17!Z/J^HR^/;K0UO;]K&71UO(9+R%%D63S2A91M! ([,.HZ8KGK*7Q)K?
MPDN_$=[XGN@[:5>%H(((T#,I?:VX+D'Y<'&.#QC&2 >G7NJK:0V4L-K<WL=U
M/'$K6B!PBO\ \M&YX0=S[U?KS6:\U31/"/@5K359RMW?6%M.LD<9W12*,H"%
M&!QUZ\GDUK+>ZIXGU'Q-::=JCZ<^ER"UM=BJ<R^6'\R3<IRN6 P.RGN> #I[
MK43;:E8V8LKN879<&>*/,4&U<_O#GY<]!UR:NUQ5]J.MV7C#P583ZA&5OH[A
M;^*&-?+DEC@W;E)&X#<3QGL*Q()?%VM6?BQK7Q/);3:3J4T5H%M8B'"1HP1\
MK]WG'&#DDDG@4 >H45Y[8>(M1\0V.@7C7S6J7^EF9K*P4&Y>?*C>-P(6(<\D
M@9(!)K+A\5>(K_P1X&U1-2$-WJ6IQ6=V?(0K("9 21V^X/ND=30!ZM61KOB.
MR\/Z(=7N$N+BTRO-I$93AOXL#^'OFN,GO-8AN/&^A3ZY>7"6FF)>6MT5C2:(
MNDFY<JH&,H,<9&>O>M[P5IRW'PVT6VN[F>XAN-.MRRN57"F-?D!4 [>W.3R<
MF@#J894GACFB;='(H96]01D&GUQ7C+7[CP]J5G)=C4+;P\8'$M[81"3[/-D;
M3(-I(0+GH,9ZYKI="G-SH&G3&^COV>VC+7<>-LYVC+C'')YH KW/B2TBU232
M[6&XO[^)0\T%JH/D@]-[,0JD]@3D^E2:;K]IJ>H76GI'<PWEHD<D\,\10J'+
M!<'HWW#RI(]ZXWX..UQH.MW=SSJ$VM7)NRWW@XVC!^@QQ70^.-97PIX6U/Q%
M#!&]Y#"D2%NA+.%7=ZJ&?/Y^M '2T5Q&M7^J^%=9\..=2FO[/4[Q=.NHIT3(
MD=24D0JHVX*G(Y&/3K6#)J?B6?PQXVU >([B*;0K^Z%KLMX?G6*-'"/E3E>O
M3!Y))/  !ZK17GO]JZW:^(/!]U+JTDUOKH=+BS,*+%%^Y,BF/ W @CG+'/M6
M=#/XOU?2O%EQ;>)Y+>?1]3N8K51:Q$2"-$8(^5^[SCC!R23G@  ]3HKSG3/%
M^H^*I--M8([J!IM&AU"?[&T2N7D9EP#)_"-A/'7<,].8;[4/&FFZ;X7AU#48
MK?4+G65L;ADCC<31,KLK, .&PHR%('6@#TRBO/;;4?$MIJ7C31;6^DU6[L;2
M&YTYKE(U??(CY0[552-RC''?%&B^*?[5L]:?3]:E@OK6Q)>QUR,1/93 $[Y,
M*,ITR1D#'&,XH ]"JG?Z@MEIMU>1P37AMU8F"U4/(Y'\*C/+>U<3H^M:DWC6
MQTDZC>SV5[I$DYFGA1"9E9!YD7R@@'<>&7'0@5B:)<:KIGP=U[5[36KL7D$M
M](CRK')ADF?GE<DG'.2?;% 'K4,GG01R['CWJ&V.,,N1T(]:?7%1Z[>:GXIT
MOPXMW);!M&&IW,T87?*2RHJ@D$ 9W$X&>G3FN;UOQ7XAT[PWXVL5U)AJ/AZ:
M P7WDINEAF"LH<;=NX D$@#M0!ZS17%)=ZQI?Q(T[3;G5I+VSU.QGE:&2)%6
M&2,I@Q[1D+AB,,6/N:V/%=U=6FEP/;:A#8!KN))I74L[1EOF2)0K9D;HHP>M
M &[17G-CKWB.6/QM8V0N+JZTQH3IZ7*H)L21!RIQP2.2N[GD ^E:W@KQ#;:]
M=Z@;?5+R7RDB633M0B$=Q9R9?=N&T$ALKZC*GGM0!V%(S!5+,0 !DD]JY;5M
M9N)O'.F^&+>X>U2:SEO9YHP-[*K!51200,DDDXS@#&*QXM2U2Y?QIX9O;^9W
MTN%9K>^1$$CQ2QLP1_EVY&TC( R/0\T =%I_BVVU*_LH8-/U#[+?Q-+:WWE
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M"(?-CPOEG:02_F$L/RQC!H ].)P"0"?8=ZY0_$+2%?4PUKJ832Y#'>NMHSK
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M5#DY!R>,#BKR^(;X>*='GN=1FM]$U[2FFMXV6,?9KA5$A&XKG_5DD9)Y4_@
M=]5*'43-J]UI_P!BNT$$:/\ :7CQ#)NS\J-GDC'/'&17!>%O$.KZQH(TRYU*
MZ37DU3[/+*\,2NL/^M#[-N ##QR#\QK5M=1U:7QSXITIM3D^SVUC;S6O[I,P
ML^_/;YONCKF@#M:*\ET[7O$@\*^"_$=QKDLSZC?6]K<VI@C6*1)6*D\+NWC@
MY! XZ5L:QXAOQJWBZUEU-M+.EV<<VF@! )LQEC(=P.\;QLP.!CU.: /0JIW^
MI0:?8W5TX>46L9DDCA&Y\8ST_ U3\*R:E/X7TZXU=W-_/;I+.KQJAC9E!*X
M&,$X]:XK1;>Y%_\ $1Y=2O)UBG=-DI0A@;92,_+D8S@ $#':@#O]%U6#7-$L
MM5MDD2"\A2>-9  P5AD9P2,U>KR70;O5]$\-_#J[CU:1[6_:VL);$Q((@CPL
M0P.-^X%1SNP?0#BM:;5?$OB.UUF?0)+B&ZL[^6UM%#0^1F)MI$H;YCNP2>F
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MUL<;A76TR*6.9"\3JZAF4E3D94D$?@01^% &!=^%(9M8T+48KR6 :*LBV\0
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MF@E1 D;Q!&!C"@$#YB,$GW)/-66^'ED_A34/#K:IJ!L[^=YYGS%ORS[V .S
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MM[B))894*21N,JRD8((],5SFE^$)=$@%EIGB#4H--3_56K"*7R1_=1W0L%]
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M**>4#>\:[2N[  )^;&<=JRO&#7"_%CP(;6**6;R]0VI+(44_NEZD*V/RKJ=
M\.0^'I-2>&\N;C^T+M[R43[/ED8 ';M4<<#CFH=3\*1:IXGTS7GU&\BN=-$@
MMXX_+\L"1=KY!4DY ]: .:?P]JFA_P#"6^*[G5]/T_5=32-4D +P6D: *.2,
MNQ'^SUQQSBI])U"_N/'6HZ"+O4H;"72([N%KK;YT;F1D+KG) ( .UQP1T%=3
MXDT"U\3Z%<:3>231Q3;6\R%MKHRL&5@>>00*R!X9@T75I/%5SJFK7MU;V!AG
M!VMYZ*2X^1%'/H%P#Z$YR 8FB:WJMWH1\/7>HS_\)-!JGV&XG 4-L!\SS0,8
M"F$'''4@5?M+VZ\47_B>%-0N;2#2I?L-NL) /F",,TKY'S9+8 /&!TR:L^'+
M6SUKQ->>,8;">V^T6D=I"UQ$8I)%!+,Y4\CJJ@G^X>Q%3S>"H1XAO-7T_5+_
M $Y]04+?06Y0QSD# ;#*=K8XRN#^/- ')^$;F>/P#X&MTU!H8)K>3S;2W!^T
MW1 .T(1]U0>6.0!QD@=7VNH>*-7^'&JW-CJ-TFKZ5J%S'%E8R\\<4A_=O@$%
MBN1D=P.3WW;3X;V>GVVAI9ZSJD$VCI)%!<*T99HWQN1@4*D<<<9'K3X;;3/A
MQ97$F_6+R'4;]I!&D37)CDDRQP%&<$]SDYQS0!/I&LKXFU33KO2[V;^S([!;
MB901B1Y?]6K<=5"N2!CJM.\7:W<:??:!I5K*8'U>^\A[@ $QQJI9MN>-QP%'
MIDU/X+T&'0-":..T%I)=W$MY+ #_ *MI&)"?\!7:O''RU:\0^';/Q)90P73R
MPRV\ZW%M<0,!)!*O1E)!'X$$'- &!!>ZAI_Q#D\,27UQ/I]]IK7=O*Y!EMG5
MPC*&QRIR"-V<'VJO\*+5HO#MW*;NXD!U*\7RW(V@B=OFX&<GZUTUGH"V^H3:
MG/>376I2P"W%RZH/+C!)VJH&!R<G.<G'8 !GAGPW%X8L9;.WO;JYBDFDG/VC
M9D.[;FQM4=R: -NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "HYYXK:%YII%CC099F. *DKA?B
MS"9?!T;"::/;J%H,1R%0V9D'..O7\\'M0!OR^(XXO&-OX<:SG$L]J]TEP2OE
ME5*@@<YSENX'XUMUYYJ^GO)\5-#LHKZZA']CW0:=7!E(\R/HQ!P??&?3'49U
MAXGU:T\/'3WO9+BX_P"$GDT2.[N' D\H,2,MM/S$#;G'<&@#U2LW6=<L="MH
MI;QV+S2"&"&-=TDTAZ(B]S^@ZG K)T#3_$&G^(KT7EU$^CSPJ]O;R7;W$T4H
M.&PS*"4((ZDX/UK \3%Q\;?!7VG/V3[-=B#/W?.V'/X[=M '43>*H["XMH]7
MTZ[TR*ZD$45Q.8VC\P]$8H[;2>V>.V<U<U76HM-N+*S6,SWU\[I;0!@NXJI9
MB2>@ '7W%<W\7Q"?A5KOG8QY2;/]_P Q=N/?.*Q]2TZXG\9_#P7UU>1W<MG<
MB?;,5*NMNF['H2<Y]: .EA\9RW*+;PZ%?+JX@EG?3IBL;JB/L)#$X(8_=(X/
MM70:;>_VCIMM>&VN+8SQA_(N4V21Y'W67L17#KIP/QOE/VN[XT-)N)C_ ,_#
M?+_N^U5+*Y\4^*?#=OXBT>]@MKMKEI5,UZX@$2R%3$\00C[HP6^]GG(Z4 >F
MU2L;V>[N+V.;3Y[5+>;RXY)"I$ZX!WK@].<<^E<390:OK/C_ ,3V#^)-2@M-
M.ELI8(X?+'WD+LA^7[IY&.IXR3BJ4FJZRGAOXC2#6;OS]+N)C:383=&JP*X4
M#;@#)[ 'WS0!ZA17G%O<ZKI_B;P3(^LWETFLP2I=P3%3'E8/,4JH'RD$=<DG
MN35#5];UJ72?%)CO[JV\2VFIF'3+2)OOQ93R]L1X<,I)+$'&3T X /56)520
MI8@9P.IKCE^(UFT6K3_V)K'V;29WM[V81Q,(F7ECM$A8@ YR >*ZNSBE@LXH
MIIY)Y54!I)=NYC[[0!^0%>7>&[35]1_X6%I^F&RC^U:U<0M/<,Q,>Y%!(0#Y
MN#QDCF@#T_3[^UU33[>_L9UGM;A!)%(O1E/0U9KSJSLYM"O]'\!:?*[VUII3
M7+N;EK9YV\P+D,H) !+' QU'.!@T]6;Q=HV@:1;WNO!;MO$,%JLMNPD+VTCC
M:LI* E@.N, C&<YH ]$OKVXM;BRBAT^>Z2XF\N22,J! N"=[9/3C''K5VO/]
M7BU/P[JWA2UC\0:E=0W>K/'.+ED)="CL%)"@X!'':IM+N;SQC/XHQJ-U8R:?
MJ$FGV8MY"@B,:K^\8='W,3PV1@  =20#NJQ=&\1QZSJVL:<MG/;RZ7,D,GG%
M?G++N!&TGC!'Y]JXGPYXSU#Q=_PB>GW+O:/?64]W>O 2C2F)_+"J1RH8@L<8
M.  #C-:?@6V-GXT\<P&>6?;>V^'F;<V# I )[X!QD\\<Y- '6:OK$&CQ6QE5
MGFNKA;:WB7 ,DC9P,GH, DGT!Z]*;HNJ7&J0W!NM+NM/FMYVA:.< A\ $.C#
MAE.>OU':N3^(ED+C7?!K&XN8]^L)'B.4J!^ZE.X>C>_I5JQNI?$'B_Q#HDE[
M>06NC16T,0@G,<CO(A<RLPY8]  >."2#F@#;\2>(X_#=O9S36<]PEU=Q6@:(
MJ!&TC!06R0<<]@:!XCC_ .$S'AHV<ZS&Q:]%PQ7RV4.J8&#G.6[@=*\XOM:U
M#6? -FNJ.);RP\406$DX4*)_*N  ^!P,CKCN#74W<@A^-$,I!(3PW,Q ZG%P
ME '<45Y8=9U:]^$Y\=6VI3QZHJ/>B(.3;^6KG,)CZ$;1C=][/.:T9]7EL?%]
MM-J-]=PZ-K6DO-"AE(^S3Q@.X&.F4.1[J<4 >A52M[VXFU6]M)-/GAAMQ&8[
MIRNR?<"2% .?EQ@Y'>N \):KJ6K:+;:#J%W>QZ[;:D\=^[2D2B),2;N. K(T
M:<<9?(Y&:O6]]JC^)_'MD=6NO+L[6VDM#A,VY:.1CM&W'4#J": .^HKR:PU#
M6K;0? &O2:Y?7$VIW5M:74$C+Y3I+&Q)VXSN!4'=G.<]N!?UO6=0^U^,H+G4
M+FQOK*%'T6*%ROF@QDJRKTE+2 J00>F,"@#TJL[5=9ATS2M0OA')=?8(VDFA
M@*[QA=Q'S$#.T@]:;X>2_3P]8?VI-++?M CW!E"!ED(!9?D4# )(Z=J\[T>R
M\K1?B9*;J[D*7=[&!+,6!'V=.2#U/;Z<4 >E:/J*:QHEAJ<<;1I>6T=PJ,<E
M0ZA@#^=7:\JTF34=&M?AQ<Q:M=R0ZC##:3VCE?)V&VW+A0.""HYSD_I5M)_$
MWBW2M1U#1;Q+2^AU":&U9[QECB6*4KLDB"$-N5<G.3\W! P* /2)&*1LRHSD
M#(5<9/L,D"N8T?QJ->M9KG3?#^KS10SO;N2;=2)$.&&&F'>NE@9WMXGDV%V0
M%O+.5SCL>XKRSP%!X@E\)^(/[&O;&%SJM\(EGMF=M^[CYA( .<=N/>@#TW3;
MY-3TZ"\2&6$2KGRIE =#T*L 2 0>.M6JX;Q9=:E%XB\)6MEJUQ:1W=U)!<I$
M$(.(6;)R#\W'?(Z'!K#N]1UC3-+^(NGPZW?.=&CCN+.YE97E7?!YA4L5Y&1Q
MW'K0!ZK378K&S!&<@$A5QD^PSQ7G%Y=ZIH6G:'(VNWUQ-XCO+*T=YMFVU#*2
MYB&."P&.<^O)K46\O="^)5AHJ7-Q<Z7JEE+*L=Q(9&MY8B,D.V6VL& P2>>F
M.E #I/B':Q^ [KQ9_9=Z;>WEDC>W!3S%V2&/)^;&,CL3^-=D#D ^M>+3_P#)
MO/B+_KZN_P#TJ-=CJTFI3?$S3-*BUB\M["ZTN>62&'8,,K(,J=N0>>ISCG&*
M .YHKR$SZXW@?Q=='Q)J8F\/7MW%9R!EW.L0#KYIV_/UQSQBNB?6-0U[Q##H
M\9V(NCPWSK'=M;,[R,PR&52<+M'' RW.>* .\HKS#4'\6Z78^%+/4=> OI=9
M%E/):E6$L11V4OE!\X 'L>I!HG>^C_X6'H,VK7]S;6>GQW-O+++^]C+Q2%EW
M@ [<H./<B@#TN">*YMXYX)%DBE4.CJ<AE(R"*YZ?QE''XIE\.Q:+JEQ?QVXN
MCY7D!#$6VA@6E'?C'7VIW@*W%OX#T+$LLGF6%N_[QRVW,2\#T'M6)!_R7R[_
M .Q<3_TH- '0Z7XLT[4]6GT@K<6>JPIYCV5W'LD*=-RD$JZ^ZDUNUYMX[&?B
MAX ^Q_\ (0%Q.7V=?L^T;\^V,_K52]UK4K632+VVU2ZO7G\1)9SW49VVCPO*
MR>2J$X)48&]1U4_,3F@#U 3Q-</ )%,R*KLF>0K$@$_7:WY&I*\PMI6T;QI\
M1M7$UU,VG6MO<I$\S%7Q!(^TCTST':M+3;?Q/<R>']:MM0A^S3*CZ@)KUI([
MF.11@HGE[48$C&T@=CF@#O:*S]-TZ:QGOY)M1N;L7-P9D2;&(%( V)@?=&*Q
MO$$TLGB2QLA?7+1/:RO_ &=8L8YY&RH$AD!&U%!(Y(!)'4\4 =317D<.OZ_>
M_#SP9J']L7$5Y=:U%97$BJG[U//=/FXY.$&<$9YSFM&?7K_PAK?BZ*2_N]3M
MK+2(]2A2[8,RR$NI4$ 84E0<=NU '8Z_XCCT"XTJ*6SGF&HWL=DDD97;&[YQ
MNR<] >@/3M6U7EGB&SF-AX!U*?4KJYN+C6;)Y]\F8Y&=6;*IT3'(&W'!YSUK
MJOB3J-QI7PXUZ\M6*SK:,JLO5=V%R/<9S0!H2:\9=&N]2TVPGU".+(@2$J#<
MD'!V9/3/<]<'&1@FW<7UQ#J&GVZ:=<2Q7._S9U9=MMM7(W\Y.3P,9KDO&#W.
MA?!V:32+R6REL;"+R9(=N< *,<@XX],'WJQK5]?V_C[P9;Q7\ZVEZ+H7%L-N
MQRD.Y2>,]3ZXZ4 =-8ZG#>S7-MM:*ZM6"S0OU7/*L/52.A]B.""!=KA]6GDL
MOC'X<\HG&HZ==6\X]5C*R*3]"3^9J?XC7FH6&BZ?/IVH36DC:G:POY84AU>0
M*0<C./H10!V-%>>BVU-?B3<^'O\ A(=4:PNM)%\Y9T\Q)!+L(1MOR @\@#MQ
MBJ>D:SJ-QX/MXKS7)5D@UV6P>7:6N+V*.1P(U*X(<@#+#& "<CDT >G45YQI
M#:WK=KXRT:'4+ZSN;*Z"Z?)+*'E@+1*X5F!.Y<GN3P>O JWX=UR7Q19^'8H9
M[F"X@5Y=43S3N5H\QM$_^](<C/9#ZT =%XJ\1Q^%-!FU::SGN88F166$J"NY
M@H)R1QDCID^U;5<3\7,_\*QU?!P<P8_[_P =4[U]7\*>.]$']M7VIV&K^?'<
MVUSM/END9D#Q;5&T<$$=* /0J*\TTJ7Q3XAT'1/$NG7UO#+,Z7-SYM\Y@> D
M[XO*V;5(' (.<CDFNL\;:W-X=\'ZCJEOL$T*JJ,_W4+NJ!C[#=G\* -^BN.M
M-)\10>)+:4WJKH\\#Q7<$NH/-(TF,K)$2@VG@Y (&.0.*PM"O-3'C2?PEJ>M
M7$@MKA[RWO/-(>\BVK^X.!C*;LMCG@8')- 'IU%>=_9]7UWQ[XIT8^)=2M+.
MW@M)(1;>6KQLXD. VW[N1SW.!S@<X5KX@\27_A_PKY^L3PWC:\^DW<L*(!<*
MGF#?@CK\@]L]0: /8:*X ?VC#XD3PBFHW=\EOIQO6FN+TP3REY649=$R0@&.
M,?>&<]*K7,WB_0]"T[^UUFUB.VN91?C2IC]I:#&8F. A8KD;@N">#ZT >D45
MYM-K]P_AC1]5TF74M>T7SYVOC:N4O FYM@QD,=F0& ()P#TIT'B;[?!X9T[2
M-4>_@U66[<W$LS0RLD9+"(MM+*PW ' !PG!&<T >CUBS>(XX?%]KX=:SG$MS
M;27*7!*^60A ('.<_,.H'XUQ^H:AXF\*:9/;7M_"PU'5;:STV;SC/+:1S-AB
MY91NVX;:3GWSBK$NG"P^,FA[+JZFC?2;K"W$QDVD-'D@MD\\<9QQP!0!Z%45
MS*\%K-+'"\SHC,L2$!G(&0HSQD].:Y[QEK%UIHT:SM&"2:GJ"VAD+[-J['<@
M-@X+; H./XN.<&LIK/Q-I5IXD>;4Q%8M9M/IZBY-Q<6\BJ=WS2)RA..N2* .
MOM;_ ,VPL[B[A:RFN57_ $>9AO1R,[#C@D<]/2J.F^(X]2\2ZQH@LYX9M,6%
MG>0KB02!B"N">,+WP>>E<!<"?5H/A7=75]>&>Z56E=9BNYC:LQ?C^+.>?<^M
M7H],FU#XB^-8(M3O+$+96)\RU8+(3LDP=Q!X'7CK^A /2Z*\PT;Q5JVM:1X*
MLI) UQJMC-<7,GGF!IC$%&T.JD@G<6.W!^7J!FH_$1\7>'O!.JO<:V$DBU"
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M(@0Z*2. 6(&,Y'88+M:C\4:)X;L;>Z\0/]H_X2""&*2WF,CBVDD7:DK,H+,
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MQDI$KJR+T0@Y&1R>^3S6X/ M@?#][I%Q?ZI=+?(([FYN;GS9Y$&<)N(X7D\
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M:2WN+678Z[AAAG!X(X-&A>%]/\.SW\MB]T?MTYN)5FG:10Y !(SW.!DG)]Z
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M[V?E3[-A6 2#. ,KG^'@=<Y[=1;_  XTF"+2XGOM5G72YA)9B6[/[H!2H08
M^4 _7@9.!5U?!EDL6MQB]OMNM$F\^=.<KL.WY?E^7C_Z_- '(3(=:\7?#F^N
MYKD37NEW$LWE7$D8W>3&V0%("\L<XZ]\XJ>ZUNYTWQ4UIXA;4[)+C4U.GZG!
M,S6<L>\;8)%!VHQ *G(Y.3FNG?P3ILD6B(;B^5]&0Q6LJ3['\LJ%*,5 R"H
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M$MA%:7CSQ^3.ES#-;R;)(I4/RLI]>3^= '")J6JH/B)9+=ZA:)IUE%<V:RW
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M\;KY<B[=IZJ2I*\$J0?R&-B""*UMXK>! D42!$1>BJ!@ ?A0!)1110 4444
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M .28^'?^O-*Y>STC4/$'_"9Q2>)=9@>PU*1+)HKMD\HB)&&<=5R?N].O<YH
M]5HKRWP[KVJ:KK'P_N[JZN%?4]+NGNXA(PCE9%3:Y3.T'DG@=ZS]7U#4HO /
MQ"DBU;4(Y=/U=TM9!<N7C3;%\@8G(7YFXSWH ]BHK@M=TG6-%MHKO2Y]3UH2
M70N+ZQDORDDD8C*D0GC: Q5B@.#C'3BL>?7(KK0?#E[HVI:JH?Q/#:SQW4TB
MRQAI#O@E!8YQP.<\8H ]5HK@;C4)[3Q[XH@;5Y;2SBT2.Y629VDCMG+2 R!"
M<<;0<#&<50TFZOK;QGX7MH[G4?LFHZ9<><]W<,S7+(L9$WELS>63N)'.<'!
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>(1[LN,LQ<R8''4Y()X&: -7PLCS6=QJSR3'^TYFN(DDD9A'#TC"@GY<J Q
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M=L$\0_VZ//.H?9Q:F1IF(,6<[=N<=>>G6I=3T2TU::TENFN UI*)H1%.R .
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBN8UK57N/%NE^&+=V3[1#)>WCH<,($(4*#VW.P
M!/H#ZY !T]%8>H^);/2FNH(K2YNVL8!/<I:*I\B/!(SN91DA20HR<#ITK)\1
M>(H+'PY9>-M-F:2Q7R7G R!-;2,%)VGHR[@P/7@CN: .RHI 0P!!R#R"*6@
MHHHH ***\MEN]-M?BUKEGK.N36FGK8030Q3:M)!&)"3N*_.!T'04 >I45R^F
M7^EZ)H4=_#?7EW::I<(]C'-*\TC&15VQH78D@X+<G !/0#-7K+7[+5M0O-%E
MBNK/4(8P\EM,0DAC;@.C(Q!&>,J>#UP: -JBO%3),W[.MK=&ZN?M$=RN)!.X
M9LWVT[CGYN">N:]6OM=AM-0&G0V]Q>WQA\\V]N%W+'G&XEV51D\#G)P<=#0!
MJ45R\GC[1TT6VU9$NI;6:Z%FVR,!H)BVW9(&(V'=QSQ^8SH0^([:;Q//X?\
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M*PMQM#?-E@20I#$*"0"#CD4]_%%B_P!G73XY]2EGM1>)':!2?)/W7)9E !Z
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MLPT&<&0,C,, C!YR*X-/#NOOX#GTN/1G-_I>L/?Q17)3R;U1.T@13DY!5NX
MS@?36N--F\7^%M8M+#PH?#TMQ8O )+N&.*1Y3@A5V$G9P<DXSD8'6@"'Q7K
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MHP% Z "G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI/( '/9T4 >;:3IVI1?$#3-:C\.WUO:/I,EM/+<S1O,)#(C;I#O)/"D#DGV
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M9>.+5[76WU.SGTV?1I%2Z@D97/SJ&C*E3@[L@#WIUAXTMKGQ/'H%S;_9[N>
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M+$T$Q'&]6+@@'K@C(]ZI:QI&LV_B_0_%$-N+UH();.^M8& 81N=P:/<0&VD
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MH0X2$(>%8D<CN.E;TFG7GB?_ (1(2:?-9V^F3QW\\LS)RR1E51-I.<ELD\#
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MHCDD@W#S%1R0%8KQG([XYQ7+6>B:O:Z]XGNK?PVUM9ZGI<4<"+/%N$BK("K
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M8/I6A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9]NWS$#XSG&1F@"6BBCI0 45%;7,-Y:PW5M(LL$R"2-UZ,I&01^%2T %%%%
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MF5"Y )"C&3[<\4 .HK$\*>(1XHT)=3%HUKF:6(Q.X8@H[)R1Q_#6W0 4444
M%%%82^(]WCAO#+6,B$:>;X7)<;6'F!-H4<]2>3CITH W:*** "BBB@ HHHH
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M68O)FG:%YP5;YF))4'#8/'6NNMOA]H]I8:59P3WZ0Z5/]HM0;C<4?D _,#P
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M4DV]W VR6//4 ]"#W4@@^E,M/#UK!J:ZI<37%]J"(8X[BZ8$Q*>H15 5<]R
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M-2O;.+P[))Y=S/O+NDJ+O/3+D=_<^M=#+X2TY]3TF^C>XADTI&CM$C<!45@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR-*S(L*812JDX&XJ7R.S#TH L:QK:Z;>:=811+-?ZC*\=O&[[%^1"[,S '
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@*K?>&WH<XYR*SKWX>^'K[79=7>"XBN+C'VJ."Y>.*YQT\Q%(#?CU[YKJ:*
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M "NUU9I)/'E];:M'=W&EMI2M:):H\GER;F#DJF2KGC:QQT(!SFM?_A!/#_\
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MK+5+I)VO+'=]FD2YD3R]PPV K <C@\4T^%]+.JWFJ!+E;R\A$$\J74J[D'0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*K:AJ%KI=D]W>2K%"F 6/J2  /<D@#ZU9KA/BW:07/@Z)IHE<QZA:;"?X<S(
MI_0D?C0!W=%>?7L:7_CZ7PNS6<=G!I<<UK:7,+2)(6=Q(X =>1A0#R1SC&36
M/J6BW&FP>#-*N/$%WJ+)K36LEQ'(\6Z/9(WED;SDK@+NSD8Z@B@#UFBO,Y?#
M=CIWQ&T'1;>2]&G/I=V6@:]E8']XAQRV0/F/3J.#Q6'_ &1 W@'QV6FO#_8E
M]>KIH^U2#[*$177;SV)ZG/'% 'K=U)J*ZE8I:V\$EDY?[7(\A5XP%^38N/FR
M>#R,5=KSN\FFF\9_#BY>>8O=07)F7S6V.?LV<E<[<Y)YQ6!-I$%WHGQ)FGN+
MV1]/NKB2T+7<A\EUMU=6'S<D'USCMC)R >QU6O=0M=/6$W,JQ^?,D$0/5W8X
M '\_H":X1)(M=U#0K>X+:E?2:$L\MC.P6V0/MS.YP3OR"JX!/7IUKEK:-=8\
M!_#.ZU+-U<-K"0-+*Q9BG[X8S_P!?R% 'L!DU'^VQ$+>#^R_LY8S^8?,\[=]
MW;C&W;SG/6KM<$X:Q^+Y2V\YXU\-O(EOYK%-RS*!M4G X '%<V96O_@I_P )
MC'<NOB&.-KS[<K'S!*LAS'_N<%-G3':@#V&BO-8]-36OBA=6NI_:O(GT"">:
MT^TR!!(TK C / X' XXSBMGX6SS7'P]L//FDF:*6XA5Y&+-M2=U4$GKA0!^%
M '8UD^(M<B\/:2;V2,RNTT<$4><;Y)'"*">PR<D^@-<MI$<'BWQ'XPM-90R-
M9726MO$6(-O$8P5=/[K,2QW#G@<X KE+J2XUSX2^'+S6?])O$U>"W%P_WI8Q
M=; Q^JJ.>_7O0!ZKI-QK4EU?0:M96\4<3+]FN;>7*SJ1S\IY4J>#GKGBL[Q)
MXL&E>$M7UK2XH;XZ:721'E*+N7AAD Y()QCCH>17016D$%H+6*,) %*A!V!K
MQF'3[2T^"WC22"!(W%S?Q KV19C@?04 >SVTIGM8I2 "Z!B!VR,U+7G LH]%
M^(GA%[.2X#:G972WF^9F\[9&C*2"< @DXP!CITK,T6QNO%WA&S\1_P!NVNGZ
ME%<M//>+;.TT+*YW0L?,'R8^79C&,<4 >M45A>-%)\$:ZRR2QNEA/(CQ2,C*
MRH2""I!ZBO/)]);2-$\">)=-N[W^UKB>PM[@O<NXN8I4 9"I.W '(P!C&?>@
M#V"J6FR:C+'<'4K>"!Q<.L(AD+AH@?D8Y PQ'45P7ACP_::IXK\3O>3WTO\
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M@>:O-!CAU;X86>IP*]TL+V]SN/WF2T/!^A%:<VD6#?&RV4VR$?V"\N.?OB=
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M2*$:4;<(\<I?S1(A;)R!C@#CZ\FNAK@?!UG;:;\1?'4%L@B@4V+!,_*F8F)
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M:EIUM?VS%K>YB6:-B,95@"#^1JQ0!E_\([IG]MRZP(I1J$L/D/,MQ(,Q]=N
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M\A17D5)!P-N_ )!W$'IQGLJ ,S7/#VF>)+'[%JUNUQ:Y#&+SG16(.1D*1G!
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MYJN@+I=IX1TM]9N-06+Q"+8R*SQ[(RDC&+[QSMX&<Y'3(Q6E)IMC9^-[;P=
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MCU))8YI[V%P)9YR=KPR'!)4L<;/0#& *ZK0_!?ASPU=2W.CZ3!:32@AG4DD
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M_L\'6/L8N][[OLA;R]NX[?O<YVXS[YJY)&LL;1N,HP*L/4&O$%M8G^"&F9W
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MSL[%U3^[DGI[=ZT:* *>EZ38:+9"STVUCM;8,SB.,8&6.2?S-7*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0,&&5((/<4O2@ HI
M0P!!!![BEH **** "BBB@ HHHH **** "BBB@ HHHH **BCN8)I)(XIXW>,X
M=5<$J?<=JE)P,F@ HHIJ2)(&,;JVTE3M.<$=10 ZBBB@ HHHH **** "BBB@
M HHHH **** "BF)+'(7$<BN4;:VTYVGT/H:?0 4444 %%-21)-VQU;:=K;3G
M!]#[TZ@ HHHH **** "BBB@ HIKND:,\C*J*,EF. !21317$2RPR))&W*NC
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MCC>-V5B"% /*DCK6/'I+ZUXGOKO6M'=;>"-8+ RNC*5ZNV%8D%FQU'1%[\4
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MS6ZLQP,#)(]*Q[;QY&_B.ST>>U@:2^ADDM7L[U;CYD&XQR< (V.G)!]:SO\
MA9DX\,1^(V\.SKIBW)M[IS<KOBQ-Y6Y5 ^?G&1QUXS0!T'_"">$O^A;TK_P%
M3_"C_A!/"7_0MZ5_X"I_A45IXJN&\5KH6HZ2]B9[5[JUF,ZR>8J$!@P'W&&X
M'J1[UF2?$RQ0Z;<B*WETR_N%@CEBNU:=-QPKO#CA#_O$@$9':@#8_P"$$\)?
M]"WI7_@*G^%'_"">$O\ H6]*_P# 5/\ "LBX\?7R_P#"0BT\-33'0W_TC?=(
MFY-F\D<'G!X S[D<9;?>+-4N/$OA&'2K:!].U>VEO 99BCN!$&"MA3M $@/?
M)';'(!L_\()X2_Z%O2O_  %3_"C_ (03PE_T+>E?^ J?X5':^*I-0N[A=/L8
MKFWM=0^PW!6YQ-$P?:SF/;]T'G[V2.:UM:U>TT#1KO5;]RMM:QEW*C)/H .Y
M)P![F@#-_P"$$\)?]"WI7_@*G^%5[KPGX&L?+^UZ-H=OYC;4\V&--Q]!GJ:?
M)XJGT_5]+L=9TP6::HQCMIH[CS0)<9$<@VC:Q&<8W D$9KGM/BN?$'Q \8:9
MK&FVES8^19V\D;W!81QE';Y1L&22<GD8..3B@#I6\#>$%^]X<TD?6U3_  I/
M^$)\'?\ 0O:1_P" R?X5>O?#>D:DUE]NL8+F*R1E@AG0.BY &<'/( P#[FO/
M? GA/0=7@\:6UWI-FP7Q#=PQ.(%WPJ-FT(<?+CJ,=* .V_X03PE_T+>E?^ J
M?X4?\()X2_Z%O2O_  %3_"J$?C/4+KQ'J6CV/AJXG?3KF"*XD-S&@6.1=WF<
M]< @[0<]>G&:MY\3;"TA@OUBMYM+DN1;F2.\4W"@MM\SR<?<R/[V<8.* -G_
M (03PE_T+>E?^ J?X4?\()X2_P"A;TK_ ,!4_P *H:[XXDT.VU6^?2)&T[2Y
MHX9Y9)3&\F[:28E*X<#>/XAG!_&]?^)WAUNYTC3[2&ZOK:T6[:&2Y\II%8L
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M,KJVKW/@.PO= L%N]0F@C7RI91$(6QA]V>ZD$8]13?#,OB..XCM+SPY!IMD
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M&?D$;1\9(R<MG XQWSQ71ZOI6JCX@Z1KEC:Q7-M'936<^Z8(8MS(P?IR/E/
MYKK:* /-KKP9JNLVGCFRFB-D-9GCGLIVD5@&C5-NX*21\R _0_A71>'[[Q9>
M"+^W-'M].^SH?-,5TLQNGQCY !\BYYY.>@Z9-=/10!X[KNEZGHWPCUBWOK/R
M;B36DN8E,JL&62\1E&5)P><'^M=G?:1J6O>*-+U=K5M.&DV]SY'GLCL\\J!
M<(6&Q0">3DDCCBMW7-!T[Q'8?8=4BDEMMZN429X\E2""2A!." ?PK01!'&J
ML0HP"S$G\2>30!Y99^&_%1;PM=W.BVW]H:=>,]_<27JM)<DQNID+8)V_-G'4
M= H K230=:&F^/8#IKA]:DE:S_?1\AH1&-WS<<C/T]^*]"=U1"[L%51DDG
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MX PX].?KTREEXVN)-8T&QO\ 21:'6HI)($,Y,T.Q-^)8RHVY7/0G!&/>EO\
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MSIWA32;"\B$=S:6D5O(H8,-R(%)!'8XKE;3P_K]CI?B;1([2%AJU]=3P7WG
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M*HX'/S,1C'KVINCKK&C:CI<NK^$W"0*FGP7IU=;EK=9&5>$*J3D[<GEL#T%
M';Z[K4&A:;]KF1I&>6."&%/O2RNP5%&?4D<]ADUFGQ%JEI=ZE!J'A^XVVMD;
MR*:R9ITGQG,2DJO[SCA>X.>*/''A^[\1^'?L^G7"0:C;7$5Y:22?<$L;;E#>
MQY'XU1E7QMK7AW44E@M-#OVM'BMEBN?.+3'^,L%&P#& !D_-D]!0!8T[Q=/-
MXFMM"U#3XK:XN; WJ>5<&0QX(!1U*J5/S#USS2Z#XID\36]E=6MC;2Z9>%T>
M1+G>\&%)"RILP"<8(SP3CFL32_#NO0^*= U3^Q]/LK>VLIK:YB2[WLK,4)<G
M;\Q)4^OJ3S2Z;X3O4\3:7KZ:4ND:C&K_ -KM;3+Y-]E"  @/)WD-E@N/?@T
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M[FWENOWZX*QQLAV>I.[(SB@";3_%^K6]WXSO=5MH&L=&D("6\[,RJL0<!04
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MNBC*$VGEB<[ACL">* -:[\;3)J/AVULM'>Y77;9YX':=4V[8P^&&#_>&3]<
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M7$?SD+@#/&TX!/?M5OP_XBN==%G<QVEJVGW=LTZ75M=&4(P*?NV&P8;#'O\
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M(KFVE&8Y8G#*P]B.#4]<'IOCFSB\(>&;U+.STN/6',4*.^RWML!F )  YVX
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MN?\ "7B&?Q!9WXO+-+6]T^^DL;B..3S$+H =RL0"00P/(%=!0 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)3&IPV/DP2/ZBM;5/%K1>-;3PG8"V6_FM&O'ENF(14#;0JJ.7<X)QD8 )YH
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M3T^*YM8L>7 ^?+7 P,*..!Q45YX2T+4-,ATR\T]+BQ@QY5O*[,BX&!@$XX'
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MDM(YZLS')8^Y)-7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIK>Q^W2R/)Y4>S) 56VG+G:3C@>IKEM?U*PUK4OAWXAAC$<=S=F19)0 Z1M
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M%I[Z9HUO;S,'N2#)<..CS.2SL/8L3CVQ4%WX7TB^\0V^N7-LTM];H$C9I6V
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M^W7'F2QOOE5"JI'L8Y&YLY.. .YXC\-^'M0;2/%NFZG9R6::MJ%W-%(9$?\
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M?=V4T$>XX&YD*C/XFN,FTGQ#=:1X)BDT.2.72+R&2Y07,3%4CB,9.=P!))R
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M_P#2H6CUXCI+AQ,NT=QO!3O\AQ7>17$%PTBPS1R&)]D@1@=C=<''0\CBI"0
M23@#J30!R5[IVI-\3]/U>.PD?3X--EMGF$D8^=W5A\I;./E]*YFZ\,>()_A[
MXPTA=)D%[JFJ3W-LAGBP8Y)%8$G?@8 .1_.O4()X;F%9H)4EB;[KQL&4_0BI
M* ."U.R\1Z5XS@\3:1I!U&"[L$L[VP-Q'%+$RL65PQ.T_>((S4NO:?X@U.Z\
M+73Z<))+/4OMERD,R;8(]C*$!8J6(W#)QZ^PKM)KB"WV>?-'%O<(F]@NYCP
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M]<4&^(%O+:^'-0LK/SM+UR9;=+EYMA@E.<*Z[3SE2O!ZC'O3-+TK6/"WB'Q
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MWZ=Z .@MM0LKQ=UK>6\Z[MN8I0PSUQP>O!IUM>6MYYOV6YAG\IS')Y3AMC@
ME3CH<$<>XK@?#6O>%_%OB.SF2R.D>)=.5UFL+F'RYMA0J5[;E!(([C'09K*T
M77;SPKIOC:^L=%CNK*SU^YFN/]($.V,+'D(-IW,!S@[1[F@#TW5](L=>TJXT
MS4H//L[@!9(]Q7(!!'(((Y Z4_3M.L])L(K&P@2"VB&$C7H.Y^I)R23R2:QM
M2\27<$^RPTU98!8?;FN[J4PP8SA8P^UAO/7G&!@\YK*D^(3OH_AC4;/1I)X]
M>D6)%,X4Q.58X/'/W3SQZ^U '<45R#>,;N%H;"^LK#3]9:!KB6WNM1 BC3>5
M3$@4[BVTG 7@ Y[ U[/XBV][IVD2_9$L[K4;B6V\N\FV1QR1C)&_:=V>-O S
MGMTH [>BJ>EW-W=V"RWUF+2X\R1&A$F\#:[*"&P,@@!AP.#7,>(O'%SX?M=6
MOY-'QI^F2QQ.\\QB>XW!2QA!4A@ WKR01QB@#LZ*YVY\33VGC73M!FL(UM]0
M@DEM[PW!^9D +)LV?>P<_>Z?E23>([];>62WT9KG=J(L+<PRLRM\VUI9#L^1
M%(8$X;I[B@#H998X8GEE=8XT4L[N<!0.I)["JYU.P$-M,;ZV$5T5%N_FKMF+
M?="'/S9SQCK7+Q>,?MVG>*(IM,@N)M%RD\,=P)(KA#'OX8J.V001P1CFL3Q!
M/;:CX=^'.I06,-HLVK:?)%#&!B%&C8[%( X' Z#I0!Z;4'VRU^VBR^TP_:BA
MD$&\;]@(!;;UQDCGWKE?$?C:ZT"WU>];1\V&EM&KR7$YA:YW %O)!4AL ^O)
M!'&,UDZK/<V_Q?M;K2=-CO+N?P](0C2"%3^_3!=L$XQQP">GU !Z#=WEK86S
MW-Y<PV\"#+2S.$5?J3P*FKR?QCXC3Q5\(?%/VS339:CIK_9[JUD82>5*&4@J
MV.00>#QWKM=7\4Q:?J0TJ!K+[:+87#?;+KR(U4DJHSM8DDJW;@ D]@0#HZ*Q
M?"GB)/%&@0ZFMK+:.S-')!(<E'4X.#_$.X/<&J$/BVXEG\46W]FQB?0MAQ]I
M.V<-'Y@YV97CV/- '4T5Q/\ PGMQ(GA-K?1&E_X2& RH/M('DL(C)M.1R.G/
M'&3@]#);>/5ATS7Y];L/L5SHDRPSPP3><)"ZJ8]C$+DMN P0.: .KDO+6&YA
MMI;F%+B?/E1,X#28&3M'4X )XJ>O.-7;4)/BGX'DU#3;6V=A>D20S^8?]1RC
M$JO3U&0<GIWMWWQ+M[:U34;>WMKK3OM/D.(KO-T%W[#((0IRN1G&[.WGCI0!
MWE%<</&&L7/B;5=%T_PX+A]-EMQ+(UZJ QR@DL,KU YV]\'D<9F^)&L:EH/@
M/4]1TORA<1H%\QV(,88A=RX!RPSQG'KVP0#I'O+6.[BM)+F%;F4$QPLX#N!U
M('4XJ>O.?$+WL/Q(\&W/]FV[:B]MJ"F**?*MA8]N9"H. #D_*<<X![ZEEX]0
MZ'J%WJ=DEG>6.H_V;);BX#(TQ*A<2$#Y3O!R0,#/'% '95#-=VUNP6>XBB)&
M0'<+G\ZYS1?&!U+Q/<:'/;6_F+;"ZBN;.X\^%UW;2I;:NUP<<=QS6+\8(X'T
M'1&GB615URTR"F[C<<C'?([=Z .MU?1M*\3V"07V;BU219 (KAT&Y2"#E",X
M(!JW!+9ZA8E;6Z6>#F(R0S[CD<$;P<Y'US7G]CIIE^+J7F@Z?+:Z)_9[1ZHQ
MMFA@N)"3L 5@ S#(R0.G&:=X&U"71_ DC66FRWDKZW<6\<,0(5-UPR[F(!VH
MHY)P< 4 =QHFAZ?X=TR/3=+B>&TC)*1M*\FW)R<%B3U)K1KC4\<R?9_%(;3H
MI;OP^@DE2WN@T<RF,N,,5&" K @C@BF67CB^EO?#@O-$6VL==C'D3BZ#NDGE
M>9ADV_=(!P<Y]0.E '87-U;V=N]Q=3Q00(,O)*X55'N3P*P[KP;X?U+47U7[
M/+'<S@&2:SNY8/.&."WEL W'<YJI\3HHY?AIXA\R-7VV4C+N&<$#@CWJ'2O%
M%[;ZQH6B7^DK;V^I6;-9W"W(=RT2*6#IMPN0<C#'_  ZRTM+>QMDMK6%(H4^
MZBC '<_B3SFIJXR;QS<VD^EO>:1]FM=1U(Z="DTQ6Y!W,JR&(K]TE>S=&!YS
MBM"Q\33W'C#4_#]W816KVENEU#-]I+?:(V)&X#8, $8/)P?7K0!T=%<HWC,1
MVNF>?!:6UYJ2/-!'/=[8UA7'SLY3()W)A=N?F]B1;\)^)_\ A);:\+VGV:XL
MKEK>55D\R-\='C? W*1T.!0!LI>6LEW):)<PM<QJ&>%7!=0>A*]0#4]>:R3:
MAI_Q8\0-HFD17MU)I=JYC:=8$SODR6;!.3]/J16K8_$:ROM$LKHVZVE_<W4E
MFUI=SB,031@F0.^#P .H&3E1CG@ [6BN)M?B);&VU8WUM'%/I]Q#;@PS[X+@
MRD",I(0!C)^;(^7!S3H/'<C:K?Z:UA;SS061O8);*[\V&50<,A<J-CCKC!R.
M?:@#M**X2R^(%[<6_AJ_N="6WTS7)(X$E%V&DCE=2R_)MY4X(SD'V%=5K^L1
M>']!O=6G1GBM8C(RKWQ_+Z]J -&BN:/BO['IFH:KJ<-LNE6MHMU'>6=QYZ3
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M/&EIH$FGQ"*]M99K:[:X(\QX\;H]NS@\@YR>.?:@#H:@CO+66ZEM8[F%[B$
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M)T9CDAN"IW=0<C'0UBW'@;6M.L+#5-'GM9/$%MJ5QJ4T4A(@F,^1)$#C(&W
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MI3T216#J3[949]JS+C2=7\277A^36+&.S&DW(O9MDROYTRH541XZ+EBV6P>
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M3\IS\VWTY[;5_HVIS_$32];BBMS8VMG-;R;I2)"9"IR%VXP-OKWK&7PIKO\
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M#M=8XV0[/EY)W9YQTH M:M\0'M;>_O-.LX;V"QN6MY+<2L)YMC;7,:A2.#G
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M7]BW6K:=##I^JS1P!XIBSVTD@R@<%0"#T)!X/KUJC<>-]=)\3"ST&T=M!?\
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M5IL^T0JP+1;AE=P[9'(JU7&Q>,(K+5/&+:E8P6L.AQPR230-O>=6C+C.0.<
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M$-G+:,Q)5MWR29XW@!20/[PJ73/"/AW1KG[3INBV-K.,XDBA *YZX/;\*V0
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MD66,EP54X9L#) 4\$GIWQ0!E6^@:Q;^+/$VK!+%H=4MH88%^T.&4QJPRWR8
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M)%)21&&'C<#G!'<<@\U7UO0-4\76\.FZREG::2)4EN8;:=IGN=I#!"2B!5R
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M&5@X*;L[!TP0QZGCWH H0^-M6N!HNH6VDS76G:E+&KPQ6,XEMHI!E93(1L8
M8W  8SP3UKO*X7PSX=\8:%#;Z'-JNG3:%:,%@N%1Q=F)3E8R/N#C"[N>/?D=
M5IXU<7FH'46LS;&8?8A;A@XCP,^9GC=G/2@#0KR=]6O_ (=7NK6GB72'O_#&
MHWDUR-4MT\SRQ*<E)T]!G&?3@9Z#UBN5BLO%%MI]Y8/%I%_'-),8I)YI$V1N
M[$*Z;&#X#8ZKD#'O0!6@UR/2;KP9I&DM;W>CZE"T$4PSN5(H"RL#G!R% QCB
ML;Q;KMUJ?A+XAZ7=10C^RH!&DD8(\P/$'R02<$9Q5W_A K[1](\)0Z'<VTUW
MX?D=@+PLB3B1&63E0Q7[Q(X-(_@;6+V+QG%>ZA9*OB"-!&T,;$Q,(@G()Z<>
M_K[4 .@\3Z]HNI>'[;5].L1I&JE+2WFMY6:6&4IE!)D '=@_=Z<\G',T'C:2
MTM_%EUJ%A!'_ &1>+ J6[%C.S*FS)QU)=1TX]ZL/HU[=_P!B2^(GT^UM-'E6
M=1!.SB:8*41B65=@&XG'.21SQSC6GAL>)5^(6FS2/!%>ZDJQ3J.5=(HF##UP
MP'Y4 :T7BW4[37/L^I6$DFEM:27#7\-A/"MLR#<4?S!@@@'# C)&,<U8L=;\
M17T6B:G#IMO-INI[6DB1MLMI$Z[D=F+8?C&5"C&>"<4S2])\5WUG)9>++S3)
M+7R7A/\ 9ZN'N=RE2TA;A>"3@#K@Y&,&OX5T#Q;HMM::-?:GITVCV.U8+B%'
M%U+&OW$8'Y5Z $C.0,=\T '@6_UK4-4\3G4KJWECM]6DMU5(V4KMCCP%RQPN
M/QR2<T>*K_6H?'GA*PL+JWBM;I[EF22-CN9(6^\0PR,-P/7FK_AS0-2T/7-=
MD>>UDT[4;UKV/:&\T,RJI4]@!MZ\YSVI?$N@:CJ.O^']7TR:U2;2Y9MR7(;:
MR2Q["1M[CKCC/J* (E\0ZKJ[:VV@Q6;)I,[6NVX#$W,R*&=001L W!<D-SGC
M YU?#'B"V\4^&K'6[1&2*[CW;&ZHP)#*?H01^%8EAX<UGP]K&MRZ.]C/9:M.
M;PI<R/&UO<,,.P"JV]3@'&5QC&>];?AG08/#'ANQT6V<R1VL>W>PP78DEFQV
MRQ)Q[T <58WVM:A9?$)=1NK:6&VDN+=42-AM MU("Y8X'//J23[4>&?$.KZ/
MHO@2WN+2S.E:G;06:%78SH_D;E8_PX.T\=1Z]JU4\*ZU:S>+8K>>P>TUIGFB
M\PNKH[Q",AL @ 8SD9)Z<=:A/A'6O[(\&V8-AOT"6*25C,^)0D9C^7Y.,@YY
MZ=/>@ U'QOJ9M;^^T33FOH[*Z>W%HMG.\ESL?9(4D4;%.0V 0V<<D9P.X@E\
M^WCFV.F]0VUUPRY&<$=C7#V?AGQ9H.L:C#H>I:9_8FH73W6+N-VGM'D.7\L#
MY6&<D!B/YY[J-/+B1-S-M4#<QR3CN3ZT .HHHH **** "BBB@ HHHH ****
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M-Q=5W1]\$,",]/>MW2M>U@>.+KP[J\=BP-@M_;RV@<;5\PH4;<3N(..1CZ4
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M$9QRCHP92/3ICZ$CO0!<HKB_^$GU?5-,UK5=#CLFM],GF@C@G1BUT8OOX<,
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M+-%)@C<C#(.#R.#WH XT^#M9M[3P?-97-A_:'AZ!K4B;>8IHVB6,G(&0?D!
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M*]R%EW%=I!"MTPW4'.ZN9MO -]IUEX8M;2YMFBT:]DO&61GP=^_]TG!PJA\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<;\6/\ DEGB#_KV_P#9EKLJP/&F
M@W/B?PK?:);7$5N;Q C32*6V#(/ &,]/6@#E;_1M5\3:WX*N;?39K&WTAEN9
M[V=XP67:O[I K$G=CG.!BK&I^,M9TJ[M6NEL4,NL)9/8(ID=+=WV)(TBL0K$
M88 @<'&,\UVVF03VNF6UO<M&TL4:HS1YVM@8R >GTK@F^'FN?V-_9:ZY9F*#
M5AJ5O*]HS2.WF^9B4[_FZD<8)P.10!?DUOQ7>^,M:T+3#I$:6$=M-'+<1R'*
MR%MRG#=<+U'3'3G(J^%+W7W?QI<2ZA:W#VNIS1QK);LHRD46W&'X7'&,9SSG
MFMW2_#VH6/C35-<FNK>6&_MX83&J$,OE!L-G..=QX[5#I_A?4M,O/$9@O[9[
M35IWNHXWA.])714.YLX*C;G &?>@"EI/C*^U31_"486VCU378'G9RA,<*(H9
MR%SDG)4 9[Y[8+M;UWQ5H'@WQ!J5U;Z>;G3V9K27!V7$.!AB@;*MSC&>U5/^
M%>ZE!X=\-Q6.K0V^M^'MRVMUY1:*5&&UD=,YPP Z'M6IJWAG6=;\&ZGI=_JE
ML^H:C'Y4DL<++#"OHB;B3WY)R2?0 4 0:IXB\0)XIT?1M-33@NHV$MQYMPCD
MQLFSD@$9'S=.,^HJGIOB[Q)-8Z_IUS9V#:]HUU%#+*K>7;F&3#"8AF!&$W,5
MW=NO-1ZK'?P?$SPA%"UJUU%IEVKJ^X(X'E@X/5?7H>E6]3\!7=_8:A.FH0QZ
MQ?:C!?RN8BT#>3M$<++G+( HSZGGCI0 VR\8:E<7'BNSBDL[E])M8KJUN?)=
M$E#H[889Y&4.&4X(-5K+Q?XC%MX-U.^&FM8Z\T4$L$,3B2-Y(BX<.6QC*_=V
M\#N>M7E\(:U_:^O:C)JMD[ZO81VTD8MF4(ZJZ@CYC\H#DX.22.HII\%ZG_8?
MA+3A>VF= GAE+E&_?^6A0#'\.0>O- !X,N-7NO%GBT7NH0SPV]^L(06Y4A?*
M4J%.\@ 9Z8.3DYYJ_K$J>!_"MY?V5OO)N$EN76'<$#LJO)Y:8R$3G [+R>IJ
M;1_#M[I'BC6M06^A>PU.9;@P>2?,60($(W9QM^7/3/\ 75U>WU"XLU73+F*W
MN5E1PTJED90<LI (X(R/;.: */AG5GUFWGNX]2L=1L&9?LUS:#&1CY@XW'#
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M!^I>(-9\-ZAH1U8V=S9:I<I8R^1$R-;SN"4()8[D)!!S@]_:L[2O^1G^)?\
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MK7)WNHZE;2:7;17,%E8R61;S]GG323C;MC2+JPQN8X!Z=NM<G>^)-9\0^#?
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M'[Z(-W&6.!SV].M '=T5YX_BWQ'J6DKK6@6#W:?:F6.Q^S_+-"LA0GS2PP^
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M<5F?*@AN#D<MSGZ 5!;^+M9@UGP[;7TMI)+J5S+;7MK!'N2U8*S*JR@D%AM
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M .WMD?G7>44 <B_AK7]0\.:G8ZQKT%Q>7MH]HLD5ILBA1P0S; V68^I.!@8
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M2O#2ZQ;G^S[M+D7!M&^?9+Y@7;OXY.,YZ5W,\'VFSDMY3_K8RC%?<8.*FHH
MX%? .JCPIHNAOKELPTF[@GBD^Q$;EA.44CS.I[G/I@#J=*Y\'2:AXHU'4[Z[
MADL]0TO^S)K582K;,L20^[K\Q[5OZ7JD&K6TD]NDZHDSPD31-&=R-@X!'3(X
M-0MK]@OB1- +R_V@]NUR$,3!3&" 2&(P>2.A- &#X:\+>(-'%O9:AXF%]I5G
M@6\0M1',X'W%D?)R%XZ 9P,G&0=CQ5HT_B'PS?Z/!=1VQO(6A:5XC)M5A@X
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M>6!H5MV_>>9MW$-OX^Z,<&NEI"0!DD#MS0 M%5[Z]@TZQGO+DN(($+N4C9R
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M9(_.V_?"';GUVYSCVS^- '!>$=4\7:_X?BUN?5-.2,"[C: 61.YDD94;.\$
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MY I9L.3M !;IG.#TK5\-2>)!J6J6^LP2-8(R-874YA$S@CYU=8CMX/0X&0:
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MJ4<:1($C140=%48 IU<A;ZG?ZWXGUG0K74I;--&AMT>=(HVDFFD0MN(92H4
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MB\MFVG&X#NIQD'N*NT <Q_PAZWVK1:CK5Q!>SQ64MEF*V\GS4DP&\SYCNX'
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M9?[NW:NT<XVCKSFS:>'I/[;@UC5+Q;V\M;=K>V*0^4L88@NV-QR[8 )R!@8
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ML,[OXER0I SSS0!##X6N;?6O$.IIJ4>_68XT9#;<1>6A12/GYX)SGOZ=*O\
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MF:.1E!4[6"KNXXZ\=*Z^V\,3VWBB?7AJC2W$MDEF5EA!&U26#'!'S;B2>@[
M"LNW.D?#OPY:Z#J5U<7L=V\RV\:V;2/,6)=D(0$<ER!G'7V- &U87\VJ>))Y
M+2]+Z5;VT8**J%))G&_.[&[A"AZX.\>E1^);R\MKW2HX=02SM9I)!.(DWW,Q
M"918EVMGGECC@#J.:=X+\/IX8\)V&EJA5XX]TH+;B'/)&>X'W1[**37?##:O
MK6E:O;:G/87FGB1%:-%<.D@ 92&!&?E&#_.@#DK'QOJP\+11SRYU.Y\0MH<-
MQ+&H*#S"/,=5^4L%!X'!.*MQV=U:_&JW2349KH-X?F,;3HFY#Y\>?N*H(Z'I
MZ\],66^&5G)HM_ILNK7S^?J)U.VG^0/:3EMVY2!R<D]>W3%%SI</AW7]/\3^
M(O%$S2K#_9P8VR1Q/O;=\V%.T$J.21SW XH Q)?%7B"/X;:CK!U,F_L]9:U$
M@@CVO&+E8L%=O]TGISGO747&JZE#\3H-)CN2]C-I$MU]G9% $JR(H(8#=C!/
M4FLC0O"1UKX=ZGI5^TMLFHZA<W44B#YT4W!>)P#_ +JM[@UKP^#+@^(+?6[W
M7[NYO8[)[-R(8T1U8@GY0.!D \<Y[XXH R/"GB>YUK48=-OM7O+#6XX'^WZ7
M=6\<;!\<20'9\R@YQRV1@GWYS3]2UO1?@G?:W9:U<&\2[F(,\<<G)NV1CG;G
M)R2<YYZ 5Z#:>%'&HZ1>ZEJ'VZ;2(W2UD\@1R,7783(V3N./0*,G/-9<GPX5
M_"FH>'%UJZ&GW<[2HIB0F$&7S2JGC/S=SGC@ =: &7MQXBL_'UAHXU\O;:K9
MSR'-I'FU>,KS%QW#8^?=CKS5"S\8:O8Z'J=M=W!OKZW\0C1K>Y,:*[*Y0ABH
MVIN <XZ D#/>NKN?#<UUXHTS79-0 FL(9(5B6#"N),;R?FSGY1CT]ZS'^'EK
M=:7KNGWU]+-%J]X;YGC01O!-\N&C.3C&Q<9S^M %>:?QA8OK4IDG&F+IKSV]
MQ?+;M-#<+D[0L7#(1SSR#[5FV6N^(X+3P'JUUK'VF+6S!;W5I]FC5,R0%PX(
M&X-E>><<\ 5T5IX1U!=,N[;4O$MWJ=Q-;/:QSS0(HAC88;"KC<QP/F8GH/?,
M9\$.=+\-V(U0A- DCDMV\@9D,:%%#\]-I.<8H H^"8;H^,O&+3:I>3K#J"((
MY?+*D&%".B@C&<  @>H/6KGC'4M:L_$7AFRTN_CMHM1N98)@\ ?I$S \^F.@
MQTZXK3TWPR-,\2ZIJT&H3^5J+K++:%5V"0($W;L;N@'&>M<Y\09D'BWP5$E]
M':S+?R/O;!VCRF )!/W2?E[=>"#0!FW6O^)]#;QAH]YK!N[C3M*.JZ??_9XT
M?;AOD=0NT_,OIG&?PVY]=U5-5\"!;PB+5D<7D7EIM<BW,@(.,@[O0XK7_P"$
M2MKE-:?4IVN;G6+?[+<2HNP)#M*A$&3M W,>222?H!EVW@*X6;0)KOQ'>7$F
MBL?LY$,: J4V;2,')V]2<GTQ0!3\.W/BG6=3UIVUY1#I6LRVZVXM(\7$:QH1
M&S=5&6'(YZYSQA/"7B:XUO48=/O=7O++68K=OM^E7=O'&ZOQ^\A.SYD!W8Y;
M@@GWZ#1?"[Z0=;SJ#3#5KA[J0>4%\N1U"G;STPHX/IUIMKX5?^U-)U#4M0^W
M7&E1O';2^0(W;>NUC(03N./0*.<XZ8 .1C\6:\_PFTS7SJ)_M%K]8)7$,>)$
M-T8L$;<#Y?3%:7C'6]8TT>(IK75?+:QL5N+*VLXED*X5F9KC<A"@D8 W#(!Q
MDTY_AGNT.71!X@O$TP78NK:!8H\P'S?-(W8RW.<9X&>AP,6[[P!]KNM>==<O
M8K;6X!'>0!(SN<1^7O#%<CCJ!C\!Q0!3O-:UV[\3>%+2UU)+2VU?3YIYE6W5
MRC*B-E2W?YSC/'3(/2N;\0ZIK-Y\,?%UM>:M/)<:3JOV(7,:)&UQ$6BP' 7'
M20@[<9P.V0>XMO!DEOJ>@7S:O+,^C6SV\8DA7]ZKA0V[&,<*,8Z8YS5>7X?1
M7.C>(M,N=2E:/6[DW<CI$%,4ORD;>3P-B\'\Z .MMH)(+58I+J:X<9S-*$#G
MGOM4+Q].U>4Z9KE[X6\*^--;?4+F^FM];N+6*.ZV%"Y>.-'8JH/&1D @8& !
M7JEC!-;6<<5Q=274RCYYG55+GZ* !]*YD?#^QDMO$%C=7EQ/IFLSR7$EH0H$
M4CD%F5@,Y!4$9X'O0!!JVI:MX6\0>'EFU&74;#5+G[!.DT4:M'*RDHZ%%'&5
M((.>*V_%NA0>)?#%YI$]TUJMQL"3J>8Y X9"/7Y@O'?I5>U\,3&XTR75M3;4
M3I>6M=T(C)<KM\R3D[G"D@$;1R3C.,:.NZ3_ &WI+V/VN>T+212+/;XWH4D5
MP1D$=5'4&@#A-/\ $VO:)KFE:#X]TZ*4S7 CT[6K3_52S$%5#K_"Q!([=>F.
M:LSZUXFU^UU>X\/?:H[FSOI;6UC M_L[F)]K"7>?,^;#=,8!&.F3T$_AFYU.
M\T^36=3%Y;Z?<+=00QVPBW2J#M>0Y.<9)  49[50?P'+!K][?Z1XBU#3+349
M?.OK*!499'/WF1F!,9;N1S[CC  0:IJWB+7-9TF"];2IM,MK<,(520F>6,OD
MEE8;%X P.>>>E8^KP:X_C#P#;ZEK$D5Y(EV+G["$\KS4@/SJ'0\D,1R#C)P!
M6WJ/@8OKZ:UH>M76B730);7 @B21)HU^[E7! 8#@-Z5:U'P='=S:)<6VI75I
M<Z2\C1S@+(T@D7;)NW @LW7..O:@#)D\4W^E>)?&?VV?[3I^D:=#>00+&JE<
MK(S#(Y.=H&3574]?US1/".B^+9-1-U',ULU]9&)!'Y<Q4?NR%W J6&,L<]ZZ
M*/PE%_PD&L:G<W/VB'5;9+6>U>+Y?+4,  <YSACGUSVJK9>"!!IECHUUJ<MY
MH]A*DMO;R1 .0AS&COGYE4@8  /RC)(X(!D/>^)=0\0^,].AU\VD.EI!):M%
M:1EE+Q%\'<"",]<@G@8(YSU/@_5I]=\':/JMT%%Q=6D<LNT8&XKS@=N:JQ>%
M98-6\0:BFI?O-:2-)%, (BV(44KS_=)SGO\ E6AX;T7_ (1WP]9:.MP;B.TC
M$4<C)M8J.F<=Z .5\5:)XBT:[U+Q;X?UR6254$UQI=TBM#-'&OW%( 9#@$CW
M/O7;:=>+J.F6E\BLB7,*3*K=0& .#^=8S^'+^YGOHKWQ!<W.EW3LQLS#&I5&
MZQ^8!G9V]<=ZT;C3KB35=/NK?49;:UM5D62S1%\N?<H"[NXVXR,4 8?C32H=
M=T1/"-O$H^V&/S HXM[='#,_M]W:OJ3Z XZVN)'@G7DGNIHO'.HQ-=.7DVV=
MOGV )0D #@#/%=C'"8;5(8W)*($5Y"6/ P">YH \;TV_UK0?AQ<Z]8:IY45G
MK,VZS$",DZ-=E&#L06'WCC:1CWKL]0UC5M5U[7-)TIKZ!M,2)$DM%MSF5TW@
MOYQ^[RHP!V;GIA&^'F_P9=>&6U>3[-<W)N6F\@>8"9?-('.,;AZ=*L:IX)N+
MGQ ->TK7[K2-1EA6&\:WA1X[E5Z$H^0&'0'G H Q[K4_&/\ :W@_3+J]@TV[
MU."Z6^2*%)0KQQY#J3GUSCH.,YQ@V5U'7KK4-1T"&_OIKO2K:!)+VTAMD:::
M1"V]UD. N-O"C^]STQL3^$-^L:%J$6HR(='$OEK(@<S&48D:1L\D]>,<D_2H
M=:\%2WOB,:_H^N7>C:@\0@N6AC25)T'3<C@C<,\&@#/LM>\07.JZ#X;U0II^
MJS6,MYJ$EML?[C!%5,@J-Q.X\' &!ZB*+5=4NG\9>&;Z_E:;2X5F@OXXXU>2
M&2-F"L-NW<,%20!D=,&MJ\\&0R3Z3>V=]/;ZIIF_RKMP)#*'_P!8LJ\;@Q)/
M&,'IBK$?AD1VVL-]KSJ.K#%S=F(< )L4*N> JYP"3R23G- &%X-TO[7\'K&T
MN;J6XAO-(5-DJIB-6BQA=J@XY[DGWK3^'&K7&N?#O0]0NF+W$EL%D=NK%24+
M'W.W/XTBZ;<^&_ Z:#8S&]NTMOLECE-I)V[5+X)&%R"3QP/7&9]+\+2:/IOA
M^PL=4G@M=*CV31(B[;OY<?-GD?-EN/6@#HZH:PBC1=2<* S6TF2!R<*<5?JK
MJ5K)?:;<6D<PA::-HS)LW;01@D#(YH Y?X6HK_"[PZ'4-BV4C(S@@G!KB-$O
M]:T+X96.N66J>7!;ZJ\;V7D(4F1[QD;<Q!8'YN"I&,=#7IWAG0'\,^&K;18;
MSSTM8S'#+)%@@<D;@#SU[8K#_P"%>?\ %%CPQ_:\GV87/VGSO('F9\WS<=<8
MW^W3B@!+_6-9U?5]?TW1VO8'TS9#$]JMN0TK1B3,GFG.WY@,*!T;GD8ZC0Y-
M3ET.S?68(H-2,0^TQQ-N0/WP?0]?QKG]2\$7$_B)]=TGQ!=Z1?7,217WV>)'
MCN0HP#L<$*P' /.!^.>HM+1+&QCM868B-<!Y#N9CW9CW)/)/<F@#BO&D=AXD
MU"7P_?QWCV,%J[R&WLY9P+B12L>?+4X**6;![LA[4>!O%K2?#2>]U-9#>Z%%
M+!?QLI5]T"YR0><E0#R.I-=/H>D3:2+TSWOVN2[N&N'D:((VX@#'!Y  4#T
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M6)-5U_2=.TJXNM6>^EUV:V@AACMHD-J3&SR%"2 Q(7 W< \X/2KDGP^,J^)
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M'OP"<(0"PZL.#CFSJDWB_1]'\4W37DL5E!8/=6$LYADGBE1260X!!0\')Y%
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M_.KDKAE)Q@XR,]: .]HK@+J^UO1DTM)=7N+Z;7KF*)%$42?90(G=Q&2,'<5
M&[./<]722>+=,L/$+3ZA;VMF(DDTZ[U.1&>W/ D#[!A@.JY!.< YH [VBN!T
MS6M7_P"$SU32+:6[N(/['6]M%U%%1O-WLG8!@K8'# $$'@"J.B^-ML5[->WN
MH1:IIFES3W^C:A$J.TBA6\R,A1E?E<<'&&!P* /3**X/3I?%EW-H&J6TLDEK
M<!'U".XDA$+1NH.Z(+\P()X&>1UR>:[R@"E<:@T&JV=B+*[E6Y61C<QH#%#M
M .'.>"<\<<X-7:Y+6=2U&T^)'AK3XKUQ87\%VTUOL7!:-5*G.-W\9XSC@5R<
M^J>)I/"_C34U\27$<NA:C<K;!;>'#K&B,%D^7E<$],')))/  !ZS5"RU,78O
MFEM+FS2TG>$O=($$@4 ^8ASRASP>.AJ:PN&O--MKE@%::%9"!V) /]:\IUW4
M=5U#X9?$ 7>JW#O8:C/;12($0F%5CPAVJ./F.<8)H ]>!# $'(/((I:X+Q%J
M]]X932I+N759="\A_M=]:QH\D$GR["X5?]6!OY ZXSGOU7AZY%YX>L;A=134
MA)$#]L0 ";_:P  /I@8Z4 :=8]EXBM;[Q)J.AI!<)<V$<<DCR( C!\XVG.3]
MT]A7$Z_XAUG3%GOH=5>YEAUN.W*6T:FUC@:14$3E@,R8.3M)(;T%32:=?ZG\
M4_$L%CJ\VEG^SK,M-!$CN3F3 ^<$ >O&3ZB@#TBBO++3Q?XA/A6UNM0@NKI;
M#4KBQU>XTR(&5EBRJR*F/NYP6V\\<<<5H1>+&N8/"^GZ;KGVY=<O+@#4@BAU
MAC#2;-NT /C8G*^IQF@#OKJ<6MK+.8Y)!&I8I&,L<=@*I>'];MO$>@V>L6:2
MI;W:>9&LH 8#)'(!([>M<Y::IJ-AX\U#PO=7,E[:2Z7_ &C:S2@>9%A_+:-B
M -PS@@GGMDUR_A[4[_2OAO\ #E[&[>%;N_@M+B,*K+)&YD)!R"0?E'((H ]=
MIL<B31K)$ZNC#(93D&N#O-1U.;Q)XQTG^T[A+6WTJ*XM_+"*\+,)-VUMN?X1
MUR1VK-\/ZK>Z9X*\#:;;W-S--K$*#=F(-$B0%RJ$@#)( RV3C/?% 'J%!. 3
M7->&(_$4&H:I#J[F33]Z/I[S.C3JI'SJ^S@@'H>N#S4-WJMQJ7CX^&H+J2UM
M[;3Q>SO%C?*S/M502#A1@DXY)(YQG(!8M/&-O?Z/JVH6FF:E.=,NI+22U2(&
M:21-N[8N[G[WKV-=$IW*&P1D9P>HKQN"\U70?AQX^O;'4Y4O[/7;IA<^6A9^
M8P<@KC)![ <]*ZKQ;XCNM"U2VDU"34;309+0?\3&RB$@@N-QYE&TD+MVXXQD
MG(/8 [NBN*M-8N=7\16>@1ZJ?*CT:*_FN[7;NNF=M@*D@@+\I;@<[AV!!S];
MN/%>C:?X7MI]>C>^N=82RN9HH$VRQ-O92P(X8!5SC ZT >BTV21(E#2.J*6"
M@L<<DX _$D"N$%UK$&OKX5;4K^_D@L3>RW<0@BFDWRLJ#D;0%"]AR2.@X.+K
MD/B4Z;X0BU[4)(KX>(8K=FMF3$L>'9'<!<;Q@<=,\XH ]*.H,-;73?L5V5:W
M,_VL(/(!#;=A;/W^^,=*NUQ<FK:AI_Q+.G37\T^F)H$EZ86C3/F+*BEL@ DD
M9XZ9)K%G\1:XWPPC\=V^HM]J5/MC6)5#;M#OP8NF[(7^+.<CTXH ].HKS];S
M6=9\?7FE0ZY=6>G2:1!>QK%#%YD3.[#"EE/]T=0?;%;'P\U>^USP-I]]J4HF
MO"98I90H7>8Y7CW8' )"@T =16+K7B>RT1=->6.>>/4+R*SBD@ 90\C;5+'(
MP/SZ58\0+(WAW4A%<2V\@MI"LL) =2%)X)!Q7ELD,Z_"KX?L+R22274]+9#,
MJL(R2, !0"1]3GWH ]DHKSF7Q%J?A;6_%5M=ZA/JMO8Z0NJ0?:$165\N"F45
M1M)4=N*OV!\5OJFC7T,TLNGS+_Q,4NI(=C!E!5X@G((/;/(]^: .WHKDOB5J
M6HZ/X&O=1TN]:UNH'BPP16R&E5"#N![,>G-9UV^O6OQ"L]&7Q%<M:ZI8S3/F
M"+-N\;+S%\O&0V/FW_B>: .^HKS?3=;UD^%]=@FUR))],UMK!=0ND&]H R'@
M*N&E*N57"\G'%7O#NHZGJ7B3Q3H;WU]#!;16LMG+.D?GP^:KY[$$90$!AD9(
M- '=52M=0:YU.^LS97<(M/+Q<2H!%/N7/[LYYQT/3!KA_!.LZWJVLS:-JVK?
MZ;HC2+=F-8\:AN<A' V_*BA2#C!W<'&.91J^L_VK\0;7^U),:7!#)8MY4>82
MT#2$8VX//KGB@#T"BO+!JGB2'1O NKC7Y7EUE[:UN8)+>,Q?O82V\  -N!&?
MO8)[ <5?CU'6;#4_&6COK5U<BQTZ.^M+F6.+S8F99"5X0*1E 1\M 'HE%>=G
MQ#K']A_#R^^WN)=5FMHKY?+3;,'@9V/W>#D=L5";KQ#?W?CBW7Q'=6ZZ2ZM:
M-%!%N'[@2!3E2"N3Z9/K0!Z517F,>N:\FG^!O$$NKR2?VS<6UM=6(AC6#;+$
MS97C<&! .=V/8#BNU\77-W9>#]8O+&Y:VNK:SEGBD55;#(A8<,".U &S17FU
MIJ>NV=]X&N[C6IKJ+6XQ%=6SQ1K&";?S RX7<&R.<DYST XI/[?UH>#O'US_
M &I,;K1[VZ2SF\N/<BQQ*ZJ1MP1DGJ,^] 'I5%>?3ZGK=SXI\*6,6L2P6^IZ
M7+-<!(8R0ZI&=RDKP?G/7(]JREOO$DGACQ@__"372S>';FY6VF6"'?,(XQ(H
MERI!'./E"^^>P!WT_B*UM_%-IX?>"X^U74$D\<NP>7M3&1G.<\CM6Q7F-_)>
MZ[XT\%SPWAL+B\T6XE>:*-69-PB)VAL@'GJ0?I4,7BW7M$DU;P]?7AO[VVU6
MSLK:_,:([1W(W#(X7>H! )XR1D'N >J45P-TWB[3DUZ?[7-%IBZ8]Q:R7+0R
M3PW" D@!1@H1SSD@],5I^!X]7N=&T[6=3UN6\%]IMO(;9H45(W* E@0,DG/.
M>^>V  #JZ@O;RWT^QGO;N58K:WC:661NBJHR3^0KF9-5N=8\>7WAZ*[FL[;3
M[*.>1H-HDEDD)QR0<*H';J3SP,5R&M:MJ>L?"[QK8ZC=R&[T6:>T>XB1%%T@
M4%2PQ@$AAD+CD4 >A:9XB&HZH;%M+U&U)MA=133QKY4J$@<,K$!N1\IP?:MJ
ML_0X'M]&M4DNIKDF)3OF"Y VCCY5 Q^%<5)XFNK?Q<^DZS?7ND74FHJ+!GB4
MV=Y;[AB-7VG#E<YR0=Q'..* .MTCQ':ZSJ>K6$,%Q%-IDJ13><H4$LNX%>3Q
MC'7'6MBO*F@U%]?^)-QI^KSZ=);/#,C01HQ9UM5(#%P?EXY  )]:VH=;U#5=
M/\+7,FH>0NH::+B:ULUS<SRLB$;<@A8QN;)) !*Y/- '=T5Y-'XH\1W7@'PO
MJ":F8;ZYUU-/N':&,B5/M#1_, .#A1G:1WK>DNM8L=?M?"[:G?:A));3W\ER
MJPQ3%/,54C!("X&XDD#/3H,T =W17G=QJ'C+1?#:2:I;W-XL&I,L\EB$>Z:Q
MVDJQ4#;O#;0VT= <>M=)X/U6WUG16O;36#JEN\[^7,ZA70<?NW4 89>G(ST/
M>@#H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *I:OI%CKNE7&F:E;K/:7"[9(V_,$'L0<$'L1
M5VB@#FYO"]W=Z8=*O-?O)].9/+D78BS2Q]"CR <@C@D $^M/UWPE;:UH]EI4
M5Q)86EG+%+$ELB\&,@H.00 "!Q70USEQXNC2ZD2TTR^O[>"]%C<SVJ*XAD.,
MY7.XJNX;B!Q[X- $FK^&3J^J:/J$FI3Q2Z7(TL2QQIM=F4J2V0>,$C (ZU0U
M+P*+GQ'+KFF:YJ.D75TBI>BT*%;@*, D,I 8#C-;NL:W8:%:)<7TI422+%%&
MBEWFD;[J(HY9CZ"J-QXI6P2"34='U.SBGFC@21TC<;W8*N[RW;:,D<G _'B@
M!C>$81X@TK5H;VXB.FP/;Q0X5E9'QNW$@L2=H.<]:E?PV#XP;Q(M_,MP;(V(
MAV*8Q'NWYZ9SN]ZW:* .+/P[MSX-?PP=6O/L;W/V@R;(_,W>;YN,[<8W\]/:
ML'Q!.I\:WGVOQ!JVA3100P0.+(30W0 +%TW(R@[FQ@$'Y?ICU*B@#"\*'4SI
M<G]IWDM[^^/V>YFMA;R21;5P70 8.[<.@R #BHQX5 \;-XI_M&X-RUI]B\C8
MGE^3OWXZ9SGOFNAHH QO$_AJR\5:.=.O7FB D6:&>!]LD,BG*NA[$?UK,'@J
M2;0;_3M2U_4+^:]MVM7NI@@9(F&"J*%VC/<D$G ST&.LHH YO5?"$>K^"E\,
M7&H7*V_EQQ-.BH)&5"".V,_*,\4^^\+"XUNTUVVOI;75H(#;/.J*RSQ$YVNA
MZX/(P1@UJZKJEIHNF7&HWTOEVT"[G;!)ZX  ')))  [DUF)XH5;^QL[W1]3L
MI+Z0QV[3)&R,P4M@E';:<*>&P?UH IWW@'2]0T&?39IKD3S7G]H&^1@LPN<\
M2@@8!'  QC'%-C\$R/K2:O?:_?W5XMB]BQ\N)%:-CDY 7U /'.>^.*ZI9HVF
M>)74R( 64'D YQGZX/Y4^@#G8/"VV_TZ^O\ 49KVXTR&2*UE:-5<;U"LS$#Y
MFP,= .3P34GA+3]2TW1FM]2O[J^83.89KO'G>6<8WX[YR1Z @'I6]6,GB.!O
M&#>&S:W"7*V7VT3-M\MDWA,#!SG)/4#I0!&WAL'Q>_B-;^9;AK+[$(=BF,)N
MW@],YW<]:R/^%=V__"&_\(Q_:UY]C^T_:/,V1^9N\WS<9VXQOYZ>U=I44EPB
M,T8.^8(9!$I&Y@/3/OQ0!R^H^!OM/B%M<T_7+_2KZXB2&]:T"%;E5X!*NI 8
M#@$=!5J3PC"=>TC5(KVXB.E0R0PPX5E=7 WER06).T'.>M7/#/B&W\4:*NJ6
MT$T$32R1>7. '!1RAS@D=5/>M>@#D]7\#K>^(VUW3-:U#1[Z:-8KIK385N%7
M[NY7!&X#@'M4DO@J :W9:K8ZI?V4]O:&RD\ME?SXBV_YBZD[MQ)+#GDUTKS1
MQO&CNJM(=J GEC@G _ $_A3Z .2T?P.= TZQL].UN^464LKQ>:J.I60DF-A@
M97)SG.<XYXQ45[\.=,O-(-J+JZM[W[>^I)?VY"21W#=64 8 QQM]!Z\UV58O
MB?Q-:>%-+_M*^M[J2U#JC-;JK%2Q 7(+ \D@<4 2:%HLFD0R&ZU.ZU*\EP)+
MJYVAB!G"A5 "@9/0=2<U7U+PQ'=^(+;7K.[DLM4AA-NTJ*'6:$G.QU/4 \@@
M@@TEGXNL+C74T2YANM/U.6,RPV]W&%\Y1U*,I*MCN <^U;] ')ZAX#L[_P /
MW.DF^N8OM=V+VZN5"&2:4,K G(P!E5& .@ KJHU98U5WWL!@MC&3ZTZJMU?+
M#8W=Q!$]W);*Q,$&"[L%SL&3C<>/SH YN;P(BZIJMWIVL7MA!JP)O;6)49'<
MC!==RDJ2.N.OM5>?X;6K:/HMK:ZQJ-K?:*GEV>H1E!*J$ %& 4*RX X(_'KG
ML+29KFS@G>"2!I8U<Q28W1DC.TXXR.AJ#5K^73=/>ZAL+F^=651!; %SE@"1
MD@8&<GV% &#J'@.SU7P^NG7NHW\MXEPMVFI[P)UG485Q@;1@<8 QCWYHG\%-
M?>'+_2]1UR_O)K^,0SWDBQA_+&?E10NU1R>V3GD],=710!SFM>#[77O#=MI%
M[=W(DM622WO82$FBD3A7! P#CV[FJ=QX"34?#MYIFK:WJ-_<7(C_ --D**\6
MQ@Z;%4!1A@">"3W/3'7T4 <E_P (,'U>75+C7=2GNY].;3YV/EJ)%))!PJC;
M@MP!CWSSFVGA.*XO[:\U:[;49;6VEM8C)$J;DD #E\?>) QV')XYK?2:.1I%
M1U9HVV. <[3@'!]\$'\:?0!Q_A_P$N@2Q0IKVJ76E6[;[73IW4QQ'.1\P&Y@
MIZ G P.XK1\-:?J5A/JIO-1O+RVFNC);?:\;T!Z@8Z)T !]">];]% &'J'AQ
M=0\3Z5KC7LT<NFK*D4*JNQA( 'W9&>BCH1C%9H\"1?V-K^F'5+HPZY/)/<ML
M3<K2 !@G' P!US7744 5M/M#8Z=;VGG-+Y$:QB1@ 6 & 3CC-<VO@*T;1?$.
ME7%_=30:Y/)<3DA5:-W !*8'3Y1@'/2NMHH Y^+P]>V[VTT6O73SQ0&"1IXD
M=9@3D%E  !&.,8ZG.<U?T'1;3P[HEMI5D&^SVX.TMC))8LQ.,#DDG@8YK1HH
M X:?X9V\NG7NG+KFIQV,][]NBA7R\02^8)"02N6&1T8D<]SS6L_A5X]>EUBP
MU:YMKJ>VCMKC<B2"14SM;D<,,GGISTKHZQM"\1P:]=:K;Q6MQ;OIMU]EE$X7
M+-M#9&TGC!% $$/A9-/@T^/2;Z:S-F9"20)!<&0Y<RYY8EOFR"#G\JI2_#_3
M7TV.".>>&]BOVU*.]B"ATN&.6(&-NT]-N,8]^:ZVB@#$M_#PCN[S4)[QYM3N
M;=;8W)C4>7&"2%1>@&6).<Y/L !DCX?6R>#]-\/Q:G=I_9<Z7%E=[4,D3H25
M)&-K=2.1T-=C10!S%EX+BMM:O]4N-5OKN:_M%M;E9-@5P-W. HP?F. N![&J
M+_#>SE\*66ARZMJ+-I\B26%Z&1)K4H,)MVJ!P#@Y!)]>!CM&.U20"Q S@=36
M1X<\0P>);*YNH+:>W%O=2VKQSA=P>,X;[I(Z^] "Z%HDND12-=ZI=:G>2X$E
MS<[0=HSA0J@  9/;)).35/6?"2:CX@M-?LM1N=-U2WB-NTT"JPFA)SL=6!!&
M>0>QKHZCGE:&WEE6)Y61"PC3&YR!T&>YH XYOAS;OX?US1GUG4'@UFZ>YN78
M1[@S$$[?EXSM&?T K8N- NI;AY8]7E42V:VDT;PHZ. 6._!'#?.1Z>H-:FGW
M3WVG6UU):S6CS1J[03 !XR1]UL=Q5F@#C+OX<V0&D2Z-J-[I%[I5L+.&ZMRK
ML\/]QPP(89YZ=35R_P#!<5];:3$=3O%;3KQ;X3-L=YYAGYG)'3YCP,#& , "
MNGHH YCQ'X-CUS4[/5K75+S2M7M$,27=IMR\9.2CJP(9<\X/>C4/!<%_I%C:
M-J5\MU9WJ7Z7V4:5IER-S94J>"1C& , # Q73T4 8"^%T7Q7#K[7]P\T=C]@
M\IU4J\98,2>,[BP!S^E9]OX!M+;2I=#2_N#H#S&7^SV52%!;>8P^,^66[=><
M9Q77UC:5XC@U77M8TA+6XAGTHQ"5I=N'\Q2RE<$\8'?'6@")/#0C\67/B&._
MF$\]HMIY113&J*2RXXSD$GO6(W@V^T;PUI^D:'K>I1O;7IG1U"#>&=F992
M4RQ..IZ<UW-86K>)4TZZGL[2PN=2O+>V%U-;VVW<L9) QN(RQVMA1R<'VR ;
M-Q EU;2V\H)CE0HP'H1@UR"?#V-= TG2#K>H/#I=U%<VS.L>1Y1S&O"XP._<
M^O:NMM+E;RR@N5CEC6:-9 DJ%'4$9PRGH?44\S1B982ZB5E+A,\D @$X].1^
M= & _A&VN/$-]JUW<R7 OK'[!/:LJB-HN3C@9S\Q[]ZJ>'? QT"2&(Z_JE]I
MUJ?]$LKEE*0^F2 &;;V!.!Z9 (ZVB@#&\4^'H_%6@S:1/=36T$S(SO"%W?*P
M8 ;@1U4=JBG\-&X\3V&O2:A-]HLH'@6,(NQE?&XGC.3M'0\5O44 <5-\.;>:
MROX#JUZLMUJ@U9)U5 T-P,8*C;@KP.#FK=OX*>UU74M3BU_4A>:C;1P32$1?
M>0$!P-F 0&. ..^":NCQ1!<W=U;Z78WFJ&T<Q7$EKY82.0=4W2.H9AW"YQWQ
M5O1M<L==MY9+-V#P2&&>&1=LD,@ZJZGH?T/49% &5-X+MVU/1=1M;V>SN=*A
M,"M"J_OXSC*R9!R,C/U)/6C_ (0Y/MWB*[&IW(?78DBG&Q,1A4V#9QUVD]<T
M?\)K:EH;A+"]DTF62:+^THU#11F/<&9P#N5,HPW$8X]"";.E^)CJ=_;P#2-0
MAM[JU%U;7CHIB=..&()V-@@@'M^5 %%_ \;Z3X?T[^U+H1:%+%+;,$3<YC4J
MN_CD8)Z8JVGA.'_A(=4U::[FE_M*V6UGMRJA/+4$#&!G/S'OWKH:I:G?RZ?;
MQ2Q6%S>L\R1%+< LH8X+G)'RCJ: .4@^'(CL]%M9?$6IRQ:-<)-9?+$/+5%*
MJA^3#<'&2"<#C&3G3A\(+!/X@F74[@OK>//RB?NR$V#9Q_=XYS72T4 <DW@6
M)M&\/Z8-4NA%H<\4]LVQ-S-&"J!^.1@GIC-;VLZ8-9T2]TQYWACNX7@DDC +
M!6!!QGC.":OUA^)?%%KX6M[:>\M;N:.XG2W0VZJW[QONJ06!YQUZ4 4W\&(Z
M>'5.IW(_L+!MSL3]YA-GS\<_+QQBJM[\/HKMM?BCUF^M[#6][W-I&$VB5D"%
MPQ&[H =N<$CGCBM73_%FGWVMR:))'<V6J)%YPM;N,*SQYQN4@E6&?0FMV@#F
M8O!R0ZMHFH?VI=R/I%LUM"LBQX=& #;\*.<*.F.E1)X(C33O$-E_:ER4UV22
M2Y;8F4+H$;9QQ\H YS75U2TN_EU"VDEEL+FR99GC$=P &8*V PP3P>HH Q#X
M,6-M$N+;5+B*]T>W:UAF,:,)(B%!#KCGA5Y&.E+>^!-*U+0]0TZ]>>634)A<
M7%YN"S&48VNI PNT*  !@ =\G/3UC>)O$<'A?2UU"YM;B>(S1PGR0OREV"@G
M)'&2.F: ,ZU\&SII5Y:7_B'4=1GN;=K47-P$W11,,,% &,GC+').!6UH>EC0
M]#LM+2XDGCM(5@CDD #%% "YP .@K0HH P=0\,)<>(H=?L;R2QU)(#;2.J!T
MGBSD*ZGK@\@@@_457N_!5G=>%M0T);NXC34I'DO+D!3+,[G+'I@9X' X  %=
M-7.S>+X8_$TOA^/2]1GU".W%T5C$6TQ%MH8%I!WXQU]J -JPMGL[&&V>=IS$
M@02,H!8 8YQQFL&Y\(+?1O:7NHS7&GM??;A;O&NY7$GF!0^,A-W;KCC..*U=
M-U;^T)[FW>QN[.:WVEDN549#9P5*LP(X/?M6C0!S">#ECG\0S#4[C=KH N,H
MG[O";!LX_N\<Y]:JV_@".SGT:>SUJ_MY],LO[/$B+&3-;\$*P*D9&T<@ UV)
M. 3C-8WA[Q%!XBCU%H;:XMS87LEC(D^W<70*2?E)&/F]>U &#%\-K:#1K32X
MM9U 6]GJ0U&#<(V*.',BKDKR-S$G/)]<<5I>)?!\7B&>POH]1N]-U6P+>1?6
MA 8!OO*P((93CH?\:Z6B@#GD\,S0VUIY.M7OVV"<W$EU*%<W#%"A#K@#;C'"
MXQM&*N:'H5OH<=X8F+S7MT]W<R%0H:1@ 2 .@PH'X<DG)K5HH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *Y?QKKEQI$&CVMK)Y,VJZG#8>?@$Q*^2S#/&["D#/<Y[5U%97B
M#P_9>)=+-A?>8JB198I8FVR0R*<JZ'LP- '//>7^C?$*QT'[;<W&F:O93/'Y
MK;I+:6+&2KD9VD,.#G!Z>E5OAE9M#_PDLIO+F0+KU['LD8%3AQ\QX^]_G%=-
M9^'U@U$:G=WL][J"P&WCGE5%\I"03M55 R2 2>>@[<4WP[X:B\."^$%]=W*W
MMU)=RBXV<2.06(VJ,#CI0!R?B5V;XW>#(KG_ (]!:W3VX;[IGVG/XA<5Z'/%
M%/ T<ZJT1Y8-TXYK,\0^&]/\2VD,-Z)8Y;>436US ^R6"0=&1NQ_,'TIMKH=
MRNP:CK5YJ,:$$1RQQ1JQ'0ML4;OIT]J .?TV\U#Q@_B9H-3N+"33]0ET^R6$
M@"-HU7]XX(^?<Q/!XP!CG)K"T_Q5K?B-/A_>)J$M@-8^U1WD,4:%6:.-_G7(
M)'*D@$D=.#CGLV\(PQ:MJ%_IVHWFGG4@/MD4&PK(P&-XW*=KXX)'7TSS22>"
M]/\ M6@RVL]Q9QZ&&%I!#LV?,NP[MRDGY>.OOUH Y:U76[B[\9:,WB;4EBT=
MDDM9U$?G$O )-K-MY4'L #[TU-?US4K;X=7"ZK+;-K"%;Q8XT*NWD,VX97@Y
M&<=.G!Q76P^$88+[7;Q-3OO-UI5%QGR\)M38"GR<?+QSFJMOX"M+:'P_%'JF
MH;-!)^R9\KG*E?G^3GY21VH P;.+6KK5O&&A-XFU)8-+\F6VG C\_,D._:S[
M>5!'0 'GK1H_BW4=<A\#Z=/<-#-J]C)=7D\0"L_EH/E4_P .XG)(Y '&,UU,
M'A.*WU76]1CU*]$^L*BS@B/";%VKL&SC /?-4XOA_I]OH^C64%[>I/HK$V%[
ME/-B!&"I^7:RD<$$<B@#G=4US6]*/C;1DU.X)TW3/[3T^\*HTD:E&S&Q*D,-
MR\$C.._>K%M>ZS8:_P"")I=:NKJ/6H7CN[>54$8(M_,5D &0<CDDG.:Z2X\'
MVMWIVL6]Q>737&KQ>3>78V"1H]I4(HV[54 G''<GKS37\&P23:!*=3OMVA@B
MV_U?SY38=_R<_+QQB@"YXJT6R\1>&[O2;^9H(+K8@E1L,C[QL(]]VVN*L]<\
M3>%-:TK1?&D$.IV%S=+!8:W;C:PE.0BRIV8Y(S]>O)KOM;TB+7=*DT^>:>%'
M>-_,@?:ZE'5P0>QRHK/?PO\ ;+RRFU75;O4([&87$$,J1HOF@$*[;%&XC)QT
M&><4 <997LOA[5OB1K1N;NY.G.LJPR295S]G# 'CH">,8P*N:MJFK:#X:\/^
M)H]3GNWGFMEOX'P8YTFP#L4#Y""PVX[=<UTZ>$+%=;U;46GN7BU5 MW9,RF"
M0A/+SC&[[O&,X[XSC$%AX)M;.UL+&74+R[T[3I5EM+6<H5C*_<!8*&8)_"">
MPSG H R[6?5O%\'B.33]7ETZ[L-1EL;()@I&8MN6D7'S[CGKP 1@9Y.)XG\0
M_P#".?$N&_G"R%_#R0O<*"(HB]RH\U\9(0$YX]A[UU-QX M'\07>JV6JZIIP
MOB&OK6TF"17# 8W'@E21U*D'Z5:N/!MA<Z^^JR3SD/IYTTVA6,P>03G;MVYZ
M^] &KI%G)9:=%'+J$]_)M!:XF(RY]0%  'T_6N/T^UD;XSZVQOKLJFFVT@C,
M@V\O)\N,<+QT'?-=-X:\/KX9T>+2X=0O;RWA&V'[6RLT:]E!51D#MG..E13>
M%X)/%+>((;Z\M[F2V6WEBB9?+E522I(*DY!)Z$ ]#D9! /,--GU31OA@NOV6
MK7,)M-7D M$5/*D1KTHP?())(8\Y&.,#J3U7C#4M0MF\2R6VJW#2V.G"XM+>
MQP/LC*CL7G+?*=Q PI).T'"]ZT3\.K$^$I/#9U34OL4EQ]H+9B\S=YGFXSLQ
MC?STJ2\\ V=[?ZO<MJFI1)K%N(+Z"*1%28A-@?[N5.WL" >X(XH Y^Y-QJWC
M?P#=RWUU$]YI=Q-(L+A55O+B.0,8&=QS[5VWBFXN+3PQJ,]KJ%OITZ0DI=W(
MRD1_O$=_8<\XX-9G_""V@702NIZDD^BQO##.LB;Y(V4*RM\N,$*OW0",<'/-
M:WB+0;3Q-H-UH]ZTJ07 7+PMM=2K!E8'U! - ',Z#JMZOQ&GT?S+\Z=)I"7D
M:7^"^_S2A8?Q*"/X6Q@CH*C^,N?^%;7> "?M-MC/_79*V;+P;%:>(X->EU?4
M[J^CM/LDC32)MF3=N&X*H P?[N!ZYYS8\5^%[?Q=I!TR\O+NWMBZR-]F* L5
M(9>64]P#Q0!EW/A?4M9\<Z1X@U5[2VM]'CE^S6]M(TC2/(,%G8JN  !@ 'ZU
MS\>NZK;7OA>==5GOC?:H]I>7,8 LYU82$+$IY^7:,,HP<')->F+#_HWDS2--
ME=K,X +?7  _*N-@^&=C!8:99#6M8,&EW0N+)3*@\G&[Y!A.1\QY.2.Q% %/
M2XM<UKQAXDLW\37\%MI=_;F%(HX@61H@[(WR_=YQP,^N:RO#HOK#X:>+M0M=
M6O4NK:XU)XI'99,-&SD$[E.2=HR?Y5WND>&HM'UK5=4COKN:74W22>.79L#*
MH52N%!'  ZFJ$7@6SATW6].BU+44L]6:9I(@Z$0^=_K-F5[Y_BSCMCG(!FZ?
MKEWJFI>&M"EO)81<Z&-1N9D;;).WR*%#=N69CCG@=LYK^*I/$7AOX?W<S>('
MFN[>_C6*>.- Y@>9%"29!^8*Q^88/3\=;4/A_97MCHT<>I:A:WVCQ^5::A Z
M+,$P%*M\NU@0!D8_F<V-1\$VFI^&FT2?4=0,<LJ3SW.]&FF=65@6+*1U5>
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MX#0/"XR8E7^$KD -UR.<US+0Z@L7Q*U"QU>ZL)+&\DN8A;A/G=+=&&\L#E>
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M5N[K21(L#RM& 590NT@(!C Z_>.>3P, &;HEQK'B[PO:>)++6FLKJ6[:01.
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M;;3_ .RHKE5@6,/&S2,IVL5.!\HY()]Q659^*M:?X:^'M0N+IB9M3%GJ5\%
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MWPB#0>5*?-!7:Q<#YAWR!Q7)Z'\/;/0;E1;:MJKZ9%)YL&F2SAH(FSD8XW$
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M\9$!#A\*Q0MC(X!) SZT 4O$WB*YTCQ#?6^LW&H:783&-=,U2 ;K5#M&Y)L
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M;&,^F?QJOH.HWL?Q)N-)#:@FG2:.EXD-_+YCB3S2F\9)901_"2.1T%<?<?\
M)O6O_P#7[<_^EE 'M=%,ED$4+R$$A%+8'4XKS;2I/%7B+0=$\2Z??6T$LSI<
MW/FW[F!X23OB\KR]JX' (.<CDF@#TRBO,O$=YJ6@^-$T]M9N!I>NJD,<SS,3
MIDN[J/:3!"[OXAZ @Z7B7^TT\<>%='L]:O;6SOH+M9U0JS'RT4A@S G=\QY.
M<=0,T =G?7$MKI]Q<0VTEU+%&SI!&0&D(&0H)XR>E/M97GM(9I8'@DDC5FB<
M@M&2,E3CC(Z<5Y<+_7M*L/B#HCZW>3G1;1;RPOY-K3!7B=]C$C!P5ZXSSVXQ
M<O;O5[J_^'MM%K5[;1ZI;2"[\LKER+7?NR1G=G/)R <''% 'I5%>>P_VI=ZY
M?^%X]0NKA=*LH,3RW[6\\CR;SYA9$.[ "C'3KD'/'5>%X]9@\.6D.OW5M=:I
M$"D\UL24<AB >0.<8SQUS0!L45YY87M_XLT/Q)JD6I75E=V=[<V]B(9"J0>3
MPN].CEB,MN!X.!BL^TU[6/$>I^!)O[3NK&+6=/N9+J" *%W(B?,N02,ECUS@
M8Q@\T >IU&\\23I 7'G.K.D>>6"XR1]-R_F*Y/P!=WL@\0Z?>7L]XNFZM+;0
M37#;I/+V(P#-W(W'FJ%W9"7XWVA-S=J/[#DEVK.P4$3QC '3![CO0!TOASQ'
M'XCBU%X[2>U-C?26+I,5+%T"Y/RDC'/J>E;5>,,M_:^%/'^L6.KWEG/I^N7D
M\*0,%5F78?GR#N!Z8Z5UDNJ:CXA\2W6D0L8XK;3K>XVQWKVSL\N[+AE4DA=H
M '3).0>, '=US0\8H_B2]T&#1=3GO;.-)9=A@"[&^Z06E&:N>%8=:M_#UM;^
M(+NVN]3AW)-/;DE7P?E)R!\VW&>.M<A;)J#_ !K\0_8+BVA8:9:[C<0-*",G
MH ZX_6@#N-+U0ZD;I)+"[LI;:01O'<[,G*A@P*,P(Y]>H-:%<Y_9VK7OA:XL
M;[5C:ZN6F=+NT.P(/,?RVVDGY=NWY23]<\U@_#O6;O7XI[K4;N47FFQ):36:
M2L5=MN[[00>HD!RO; SR>@!Z#17F6ES>*?$OA[2/$VFWUO;SRRBYF,U^_D-#
MN.Z(Q>7M&!QG.[(R35K3+?5M7\<>)K6;Q'J<=KI=[:2011%!N!B#LC?+RIR1
M@8]R>* /0ZI0WMQ)J]S9OI\T=O%&CI=LR[)2V<J!G.1@=?6N+\/R:GXM\)Z9
MXGM]<ELKN:X-Q("Q:!8%=@T)CR%^Z,;C\V1G-3Q7NLGQUXNL+;4'D,6F0S6,
M<^WRX96$F.@'&0.3D^] '=45Y?IGC#['#J4ETNJV>MZ9I$UQ<Z3J+LZS.@!\
MV-LD%<J1\N!\W %:>FVOB>>?0-9M]1@^RRJC:@)K]Y$N8W48*)Y85&R1C:0.
MQS0!UFO:Q%X?T6ZU6>WN)X+6-I95@"E@@&2<,P!P!ZUBMXZ@AT6'6KO0]8MM
M+EB6;[4T<4@2-AD,RQR,P&#G[O'>I_B#_P DY\2?]@RX_P#19J;PMY(\ :*;
MC9Y/]EP>9O\ N[?*7.?;% &O9WEMJ%G#>6<Z3VTR!XY8SE64]"#3YYXK:WDN
M)Y%CAB0N[L<!5 R2?PKQOX>37,/P^T.'^T)[>SN-5N!;VL(;S[N ;BJ1D$%1
MNRQ;(  .2!2:[>W^I?"3QS%>W-X#INJ2V\ >;,@B!B(1V!^?&\CDG/')H ]I
MHKB=1N;S_A++3PM:RRO"-/>]D,E\\,DI\P*!YBJ6PO)P,=1S@8.OX1M=<LM*
MFM=?O(+NXBN7$,L<A=O)."@D)5<N <$XY&#0!8U3718W\.FVMLUYJ4\,EQ';
MAPG[M, DL>G+*!ZD^@)%K2;]M4TJWO7L[FR>9<M;W2;9(ST(85Q=[IRR_&RS
M)NKM=VB2R_),1C$T8P/]GVJ&SU#4?%'A'7M>@U.ZL[ZVN+I;)8I"$@$)(573
M[K[MN6W _>XQ@4 >CT5Y9!JNL>*M;\+J-7OM-M]8T.6YGAMMJ['&SYD)!(Y;
MJ<\=,=:]!NK-D\-R64EW<R,EKY;7._;*Y"XW;EQACC.1B@"EKWBJVT.QLKP6
M\MY!=7D=H)(&7:C.^P$Y.<9ST!Z5OUXJELT?P2\)ND\IDFOM/;,CEPA\X= >
M@]JZ2?5M0\*^+?$-N=0N]1M8?#YU98[MPQ65&<$+@#"D*.!QZ4 >C45P.F6W
MB>YD\/ZU;:C!]FF5'U 37[R)<QR*.4C\L*C D8VD#L<UT'B^YDMM!+1ZF-.9
MYXHS*$+NX+@&.,#DNPRHQSD_C0!O45Y>-6U:%OB!9Q7>H6::=I\5W9+/(LLL
M#-%(Q&YB^02@."3CG&*@FGU_1M+\&^)5U^^O#?RV=M>V4Q4PNDR@950,A@3G
M.22?RH ]7K$U3Q''I?B'1M(DLYW;5'D2.=2NQ"B%R#SG.!Z8YZUQ%K::_K\?
MC!%\5ZG;RZ;J4J61C** 1$C /A>5R<;1CJ2<GHVWUBY\07'PLU:\4+<W+SO+
M@8!;[.X) [ XS^- 'H]M>W$VJ7MI)I\T,%N(S%=.RE)]P).T Y&WH<^M7:\W
MN?$NI:'JOQ%N'NI;R/2K2VGM(9L;8RT3L1A0.,XSWP.M;^GZ9?+<Z+JT/B&9
M[=X#]NBG;>EV74%&09VQD-S\H (.* .IK$T3Q''K6I:Q8K9SVTFESK!)YQ4[
MR5# C:2,8([UPPUG4K:X\+W<.J7=\;W63:75X&*VMRC>9\L<9/ 7: &  .T\
MG-26.AWFM^*_'4=KKE_I;I>PF-K0JN7^SI@OD$D#^Z"._M@ [76/$<>CZQH^
MG26<\AU2<P1S*5V(P4MSSGH.PQ[UMUY+;:U>>(=,^&6J:@%^US:C()2HP&98
MY5W8]]N?QK4>;Q%XMC\0-I%VMK=6.H2V=I)]M>-86BQ]^,(0X8\G=G@\8H ]
M&K!C\41WMS=0Z1I]UJ:VDABGFA:-8UD'5 SL-S#OC('0D&KCM?OX:9MT3:DU
MF3N@.4,NSJI/;=TKE/@P8C\*M'$?WQYPESUW^:^<^] '5:+KUEKL,[6ID2:V
ME,-S;S+ME@D'\+#^1&0>Q-9(\;1,L-]'IMU+HDDDT9U&/#+%Y6X,[KU$>4;#
M>W09%<]I5N]Q\;O%L<$DL=JVFVPNFA8J1-QLY'0[,UD:!IJM^SS?3?:KP$Z?
M>OM$[;1M:;C'H>X[T >A:5XCGU.^MXSHUY#:7=J+JWO#AHRIQ\KX^X^""!SG
MGGBM^O.(+RZT_3/!>AV<TK?VM;F21IKID)$<"MY:N 2N<@\<X4X(S5+Q./%G
MAWP+XGGEUKRQ#)%-IQAN#-/%&SA621W0$C.=IZ]>>* /1]4O;BPM4EMM/FOG
M:5(S%"R@JK, 6^8C@#FKM>>>+[?5?#FBQW=OXCU.62XU>UWB0IM"O(JLBX7*
MJ>3@&IKI=2U#XI7VBG7-0@T]M'CN1' RH48RLIVMMR.%'/7WQQ0!WM%>5V7B
M36V^&6AWLUU-)G5A9ZC>@?O%M5G>,OD=#A4!8<C)/7FM_P -/J-QXVUSRM3N
M[GP_;I#]DW.LD;2LI,BB0@LV/E/WL G'L #8\4>*;?PI:6]U=V5Y<13SI;K]
MF"$AW.%!W.O4]Z;8>+K*[U\Z#<VUWIVJ>5Y\=O=JN98^[(R,RMCN,Y]JY_XO
M;O\ A%]-V %_[8L]H)P,[ZL7V@7Q\5CQIJTEN/[(L9EM+*U+-DE3N9G(&<C(
M  H [>BO.=*7Q3JVG>'/$-GJ%O'YYBGOO-OG:*:%QED6+R]J,,C;@]L$GK3O
M"UMJVLZQKLEUXEU01Z9KDD4,:&,!T$:?*XVX(^;@ #N>] ';Z9>W%]!+)<Z?
M-9,DSQJDS*2ZJ<!Q@G@]:NUY1:^*]6LO!K&74)I;NZ\3/I*WDH4M#&9BN[&-
MN0JG'&,D<5LZQJEWX.\::5#'<75WI6I6ETTMO/*TK1201^9O5FRPW#Y2,XZ4
M ='XH\1Q^%]*74)K.>YC,T<)\HJ-A=@H)R1QDCH#6W7CWB$W.M?"73O$5WJ%
MR]U>7-I<2QK*?)VO.F(PGW0%R.<;LKR3DUZ_(A>)D61HRP(#KC*^XR"/S% %
M32;VXU#3TN;K3YK"5F8&WF92R@,0#E21R #^-7:\A36]<?X0Z5J8UJZ%^VK"
M&2?Y295-XT>&XZ;>PQZ5N&VU*/XE2: /$.J&PO-)-Y)ND4NLBRA/W;;?D!#<
M@#MQB@#T*BO(;C6]<C^&M]*FLW0N]-UXZ>MR=I>:(7*QC><9)VMU&"<5NRV^
MIP_$I=#7Q#J9L;_2GNI0SJ71TD5?W9V_("&YP/ICJ #T&BO*K#Q-JUKH*Z:U
MZ]Q.?%$NB1W=Q)MD,2EF&Y]I^8A=N<9Y]:MZUJ'B7P-I'B/6)[BWET\6R-8V
MTMV]S)!,65"=SJ"8\N"02<8[9H Z_5?$<>E:]HVE26<[MJDKQQSJ5V(50L0>
M<YP/3'O5ZSO;BYOKZ"73YK>*W=5BG=E*W *@DK@Y !XYKA->TMK#QKX#D.H7
METS7<RRF>4N)&^SO\X!X7OPN!STXJ2WU74HI_B#%+KWD"P>,6MW=JI2U#0!L
M[0 , GTYXZT >B5'#/%<(7AD5U#,A*G(W*2K#\""/PK@-(O+T^/TT;S]433K
MO0VN"+N8F1I%D5?-7)+1Y#'Y>,>@K!\+:A<Z)\+-">UN9C<:KJALB\TYQ&&N
M)<D$AMI(!&<'DYH ]9O[O[!I]Q=^1)/Y,9D,<6W<P S@;B!^9JKX?UB/Q!X?
ML-7AB:*.\A698W.2H/8XKG+?3O$&GWNLF[NX6T:>P9H;:2\>XFBF PQ5G0'8
M0>A)P<8ZUS5L^HZ?\'O"NNV%S=+'IMO!->VT+D"XMACS!]0/FR.P- 'K5%<_
MI%U_;&OWNI6UW))IL44<$*K(3')(1O=P.AX9%'N&J#Q+/)_;6D6HOIQ'*)F?
M3[0E9[H@#:0X*[$7)))(!)49[4 ;VHZA;:3IMUJ%Y)Y=M;1-+*^,X51DUE6'
MB.6XU1+.\TFYLDGA6:VN796CES_RSR.D@&3MYX!.3BO/KZ[O=:^!&O2ZC=W#
MW%HUW"',F&=4D95#D<-Q@>^,UI:]I*KXA^'\7V[4"LD\H.;IN/\ 1V.1SU[9
M],CO0!Z;17G<LVN^*9O$EOI=U]FGTZZ-G9N+YXO)=8U8.Z!&$@9F/WLC P #
MDF*Y77]0\::5HUUXAN+7[5H4DMU_9[*$$RLBEHB5R.23DYXR!C- 'I-8&M>*
MK;1XM(F6WENX-3O8;.*:%EV(9#@,<G..O0'IVJ;6[5E\'7ULUU<,Z63J;@/L
MD8JGWMRXP3CG&.M>:R6K1?"WX>^5<3;YM2TM@TC;_+)Q]T'H!Z4 >QT5YI<:
MWJ/A/6_%\/VZZU*"ST=-3@2\<.4D_> @$ 84E0<=NV*T]/LO$O\ :6BZK!J,
M!L)$_P!/6:_>5;E74;6C4QA4;)R N <XH [BBBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JNHZ
M=9ZOIT^GZA;I<6DZ;)8G'##_ #W[5:HH YR3PBEQIPTR[UG5+G3=NQK621!O
M3^XSA Y7'!^;)'4FL+QO: ^(O!=M:K<V\-K>.S26D)(MT\IE4_=*J,X&",5Z
M!10!B+X6L&@U9+IYKN758O(NYY2 [Q[2H0;0 H 8XP.I)Y)JC)X$LY=&TO3'
MU/5&BTVXBN8)&E1G+QX$>24Q@ #@ 9[Y-=310!@W'A6W?79=:L[Z\T^^GA6&
MY>V*8N%7[I=75AN'8@ ]NE0W'@G3)K/1[2&:ZM8-)N!=6ZPLIS*,_,Q926)W
M-GUW&NDHH QK+PY!8^)+_7$N[I[F^1(YHW*>7M3.W "@C&3W[\U-?Z.;S4;>
M_BU&\LYX(WB'D%"KJQ4G<KJP/*C![<^M:=% '+KX%TV+^QOL]S>0#299)X!&
MR8:1]V]GRIR3N;I@<\ 5'>_#_2]1_M[[7=W\@UORC<C>B[6BQY;)A005VCUZ
M<YKK** .:M/!=K:Z]%K9U/59]02T^R-+-< ^8F[<"P"@9![  >H-5C\/=-;P
ME=>&FO\ 43I]U,9I/GCWY+[R =G0MS_]:NNHH 9$C1Q*C2O*RC!=\9;W. !^
M0KD]-^'6E:3J3SV=]JD=BTWG_P!E"Y_T029SD)C.,\XSCVKKZ* .>O\ P=8Z
MII6KZ??7-U/'JCAYG<IO3&-H0[> ,#'!QUZ\US.O:;+%XZ\$6T=[J;K917BR
M7WEAV3<B!-[;-GS8(Y'/UYKT>B@# D\(V4VE:M8R7-TSZL"+VZRGFR@KLQG;
MM "_*  ,?7FH3X,M3/H,W]HZ@'T-"EH0T?(*;#N^3GY>/_K\UTM% ',Z]X'L
M-=UB#6$OM1TS4HH_)-UITXB>2/.=C9!!&?:MVPL8=-L8K2WW^7&.KN69B3DL
MS'DDDDDGJ35FB@#FW\&60O-3FM+V^LH=4):]MK=T$<S$89N5+(Q'!*D9Z]>:
MFE\)6+:QI&HQ37%N=)A:"T@AV")48!6&"I/(51UXQQ6]10!C:)X<@T*YU*>"
M[NIFU"X-S.)RA'F$ $C:HQP ,>U)J'AFTU#Q#9ZV;B[M[RVA:#,$NU98V(8J
M_'(R >,5M44 <I_P@5@=&UG2FU#43;:Q/)<7>6CW%WQOVG9P#@?EQBDU3P!8
M:E<6%XFI:I9:E90"W6^LYUCEDB_N/\NTC\*ZRB@"KIUA#IEC%:6YD*1Y^:1R
M[N2<EF8\DDDDGU-8G_"&QIXCO->M]:U2"^NXUBE*>05V+]T -&0,>O6NEHH
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MSD%4QG@\@$D9YZUJ:)X:@T*?4YK>]O)6U&X:YF$Q0@2$ %EPHQP!QTXK;HH
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MO&OG9W4/%.QR7C95&TY_#\,U8M/!&GQZ1>:=J-WJ&L)>1>3++J-QYC^7_=!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LW5-$M=5GL[F1
MI(;RS<O;7,) >/(PPY!!!'!!!!X]!6E10!2TW2K;2TG\@,TMQ*9IYI#EY7(
MW,?H  !@    "KM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>elicio2021employeestockp007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFF19MX>7=C,A5_F7<<G!YQ@\9H QK36;OQ7XUUG2;:ZEM-)T79%,T!"R7,[
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MT2R0/$SQ]-Z;U ;'MFN2\ >-[)/".BPZWJLTNHW<\L/G3([AI#,X16D VJQ
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M $L !T&1DG &0.IJI-XWT"WT"XUN2\<65M(89SY#EX9 <%'3&Y3D@<@=1ZT
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M+XETW7IKR"R><3V3JL\-Q;O#(FX94E7 .".0: ->BF331V\$D\SA(HU+N['
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MD2255 9T3:"?8$G'YFI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8P2 1P*XC28[W2O!_@O5;C2]1FL],EO8=1MH8Y$GB65R4DVC#$# S[-7N%%
M'DWBN/3[_P"''B"YT/1+R/\ M![?#O;R^?>,LBDML8%\!>A/7GL 3M^/7FAN
M_#GB&*RN[_2[*647D5H'$JI(FT2!1@G:1R/0UWU% 'E6NV$>L>&+K5_"^B78
MV7UI>2^;&Z3:@(7R5VO\Q &,9ZD$#H,[=X$\4>./"NJ:8)3;Z8MS-<SM$R;1
M)&%6,[@/F)Y*]0%YQQGNJ* .#\%W0M]5\9S2P7*J^IO<Q9@<&6,1(,ID?-RI
M'%=AI6HQ:OI5MJ$,4\45Q&)%2>,HZ@^JGH:N44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&^ZP'&<'Z5-=^"H[O7-.O9+I)+6SM);,VLT/F>>D@&\NQ;DG'7'<]:ZJL/\
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M&@#,\4^''\10:?Y&H/8W5A>)>02B,2+N4$8921D$,>XK'D\ W,A\3%M?E?\
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MH:KXDBC74(Y'3>A7]Z@/RN0I(!(Z@=Q7*2S7</QTO&L[5;F3_A'8_D:7R_\
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M:1[9XXY@FUSC(&.FW!]2>WK>28]RXR1D9KBY/A\9?">L>'GU9C!JEU)<RRB
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MLUT81.DG1D(BX*]P<9[5%?\ @#3=0\/W.G37%R+FXN_M[7Z,%F6Y&,2+C@8
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MUZ\GOM8N]?\ AOX%U2^96NKC6;!I65<!F$I!.!TSC->GZA&\NG7,:3RP,T;
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MEH[;H2 6&.5)QT/?&#6%KMI<IKGP\@CU"5IFFN,7$J(S*#;-T  ' Z9!]\T
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M0PX(.#[<4 =K17C\>O\ B@?#&P\6-X@D:\BO1$\!MXA%.ANC$0XVYS@_PE<
M#C/-=3;W.L6'Q&71)]:GO+6^TN2Z'F11J8)4D5?DVJ/EPW1MW3J: .WHKQ]-
M?\4+\,+/Q8WB"5KR&]\MX#;Q"*=#=F(AQMSG!_A*X '&>:Z1]6U/P[X[DL[W
M59]1L)M(FOVCDBC4Q/$RY$>U1\I!(P<GCJ: .\HKS&\\1:Y;_#.U\=Q:BSSA
M([N:P*)Y#0NP!B'&X$*>&SG(YX.*T%N-;UCQ[K.CQ:_<V=BFGV]S#Y4$7F1%
MR_ +*?09R"?0B@#OJQKGQ);PZE/I]M9WE_<6RJUR+6-6$(894,6(R2.=HR<8
MXY%4OA]K-YK_ ($TK4M0=9+N6-EE=5"[RKLF[ X&=N?QK!US1/$VB^)=0\3>
M#9[>^%T4_M'1[AL"1T4 -&W\+;<<']>!0!V>EZW8ZQI*ZG;2,MJS.FZ9#&04
M<HV0V"/F4CFM&O(]?UZW\3_#JRO],-[I3#7(8;NTR R3&X4NKY!SAFW>G(R.
MPZM=1N]0\;7'AA-1N8H=/L$N)IU"":>21B!SMP H'8#)/H.0#L:H:UJT.A:-
M=ZI<QS206L32R+"NYMJC)(&1V%<!:^-=72)M#NYU.HKX@&C?VAY:C=&5,@DV
MXV^85&,8QD@X[5K>)+'5['PMXR%WJ@O--DTJ9K1)5'G1,(F#@D  KG!'?F@#
MK]/O8]2TVUOHE98[F%)D#]0& (S[\U9K@/ >K2>(K6T2VU":TM](M8;::RV*
M'F?RU(=MRDJA'W=I^;DY[5N>./$$WAOPS)>VP3[3)-%;0LXRJ-(X7<1Z $G'
M?% '1T5Q.IW^J>&_%V@6AU&>]T_6&DM95G5-\,H3<LBE5'!P00>/3%<M<:[X
MHB\!Z[XA_P"$AF-QH^J3Q1Q"WB"3(DP3;)\N?N_W=N/>@#U^JD.H07%]/:0;
MI&M\"9U^ZC$ A"?[V"#@= 1G&1E]W<_9M/GN@N[RHFDV^N!G%</X)N+M/@[%
MJ45W;1:C<VT]XUU=G$0F=G8O(?0$\^PH []R51F"EB!D*,9/MS5:PU"WU*W,
MUNQ(5S'(C##1N."K#L1_]?I7%:'KFH_\)Y9:6U[>75A=:0UR7NHE3=*CH"Z?
M*K!2&/! '0BK&G7,EI\9=9TU"?(O=)@OW7L)%<Q9^I7;_P!\B@#M7D2/;O=5
MW':N3C)]!63I_B*UU+Q#JNBQ0W"7.FK$TS2( K"3=MV\Y/W3V%<WX[AN)?%O
M@M(M1N[9)+^12L)7&1"YW893D]N<C!/%48[&^O/B/XSAL]6GL'6QL29X8T:0
ML$EQ]X$ >N!D]B* /2J*\UT?QEJFM:3X1MCYOVS5+"6ZN9+;RT=O+VKA=_RC
M);)QTQQCMU/A1?$,4-]!K["0)<$V<K,AE: ]!)L^7<.1D=: .AHHHH ****
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M:-87,*6I0)<2 >7/N7)V$')QT.0.:NT 8"^%XUL=7C%W)]MU;/VN\*+N/R;
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M4SZ9Q[5N:M?R:9IDUY%8W-\\>W%O:@&1\L!P"0.,YZ] :N$X4G!.!G ZF@#
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M&,8XJQ<>$@=9M-:M=2N(=6AMS;2W#(KBYC)W8D7 '#<C;C'3IQ7244 <I?\
M@#2M0\/SZ7--<B::[^WF^1@LPN<Y$H(& 1T Q@#BG#P?--H.H:?J&O7U]<7U
MNUM+=RH@9(B""J*H"KUY."2<9S@8ZFB@#DK?P-'9ZII>I6FJ7$%U8V8LG9(T
MQ=1#&T2C'.,<$8K;U_0['Q)HESI.HHS6UPN&VG#*0<AE/8@@$?2M*B@# M?#
M4@O;&]U+4I=0N=/C=+5Y(U386&TNP'WGQQG@<G@9K+?X>PR>%=5\/OJUT;;4
M[E[F:3RTWAG?>P7C&"1Z5V=% $4416V6*9_-(7:S%<;OPKC-+\)P_P#"&WW@
M/4?.6T E2WG0X+V[.60@]-RYVD'^Z#C!%=Q3$ECE:14=6,;;7 .=IP#@^^"/
MSH Y:V\&FUUO3]<N]?U"YNK*V>W=Y!&JRQDAL$!1@ KDD<GN<5/HFDR2^*=6
M\37,;(UU'':6B.,,L$>3N([%G8G'H%Z'(KI:QKCQ'!;>*[+P^]K<>?>0R31S
M87R\)C<.N<\CM0 WQ#X;CU^339Q>W%E<Z=<_:()H I(.TJ00P((()[5!;>%3
M::[JNK1:G.9M2ACAD5T5@@C!"$=\_,<YSFNBJ&[N/LMI+<>5)+Y:EO+CQN;'
M89(&?QH XQOAG:#P]H^FV^K7UO=Z,S&PU"+:)8PWWE/&&![C'.!^/3Z+I+:5
M:LL]]<7]U(=TUU<;=SGH!A0 H'8 8Z]R2<4^/K >%=)\0"QO&M-3FBBC4!-T
M9D?:I?YN!GTS764 %%8?B#Q1:>'M+34)(9KJ!KA;8M;[3L=GV?-DC@-P<9K<
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ K!\6W4]KIEL8=22P#WD*2OL+22(
M6^:.( $F1AP,#U^M;U8OB3PW!XDMK1)+JYM)[.Z2[MKBV*AXY%! .&!!&"1@
MB@#AY=?UN'2/B%#%>WEL^C1K/9-.(WFC#0>9M8_,",],Y(!ZU)<W?B+0KGPC
MK#Z[<7UOJ]S!97EG+&@C7S4RKQX&05(R<DYJSXJ\*V^B^&?&.I1ZA?W-UJNG
MM&\4SJPDE$112 %!W'T' [ <8U_#^APW>D:!?7NH37D=A DEO%*%"QR>7MW-
M@ EE!8#/3)R,\T <O"?%.KZ+XLNX?%5Y!<:/J=U':!88MKB)5(63Y>1CC QU
M).>@M)JTFN^)/A?JTT8CEO+2[F=1T#-;J3CVS2>#]*.L#QC:MJ5U!:WFM7)>
M"-5'F0L%&Y&*Y 89&X>G&#S7777A.TGUC1-0BN+BV_L9'CM;>$((PK*$((*D
M_= '!&* .3NO%FJ:"?B'<S73WJZ08#9I,J@)OB#8.T#(#-]<#K746^F:M::K
M8WD>OM/8M;NMW%= $328RCIC 3OD#C';O21^"[#[7K\UU/<7<>NJJW<$VS9A
M4V#;M4$?+QU]^M0:)X%@TF 6UQK&J:G:QQ-#;07DH*P(5*D#: 2=I*@G. <#
M% '-V.NZK!K/A$_VI<7R:E/-!>W 4"UN#Y;,#"#A@%*C#  $=S5;3-*U:_;Q
MS-I>OW.F36^M3R0K#&A5Y!%&?WFX$E>@P,=\YXQT=M\-[6VM]'A.N:Q(NCR[
M[/=)&/+3:5\OA!D8.,GYAV(J^?!D*7&JFVU2^M[75I3->6R%,,[*%8JQ7<N0
M #@_3!H Y2+69O$.H_"W5[F,)/=&YDD51@;OLS9(]B>:M-?>)_%%CJMWH5P]
MO=VVH36UIF=5A3RGVD2)M);< 2<\C<,8KI[SPE9W.H:'=0W$]HNB[A:00!!&
M 4V$$%2<;>."*SY?A[:?V]>:E8ZOJNGPW[^9>V5K.%BG?NW3*D]RI!/M0!MZ
MI-?KX4O9[=5_M$6+O&L1W#S=A(VGO\W2N<^$+6[_  LT1K9@<QN9#U)DWMNS
M[YS7;(BQQK&BA44 *H&  .U<[:>$(M(O+J?0[^XTZ*[D,LUHBH\!D/5U5AE2
M>^"![4 <M>^*-8NM*\>O"UO876A1LD=S:IEYF6,NI(?( QQCD\]1BKI35[+P
M]9ZE<^*YA_:#6?F)+$I*@CYXX JEB[Y &<G@GKR-9? =C_9.N637UZTFN$F^
MN<H'?*[2%&W:HQQP*EU'P;;ZEH6EZ:^HWT<NERQS6MY&4$JO&"JD_+M/!((V
M\T <J-=UI-,^(5O'>WMLVCQ+/9-.(WFBS;^9M8_,",CODX/7/2>UOM:L=8\#
MW$VM7-U'K431W=O(J",?Z/YBL@ R#D<DDYS6RWP_M&?76;5]48ZW L-V6D0Y
MPFPL/DX)7(]!G@#C%I_!D#OX?8ZG?9T,?Z-_J_G^39\_R<_+QQB@#&^'-M*F
MI>+I)+Z[GV:Y/%ME<,&PD6">,YQQZ8[4?$__ %W@O_L9[/\ ]GKHM)\,P:/K
M&IZA;7EV4U"<W$EJS+Y2RD ,PP-W(4<$D>U1^)?"D/B>33FGU"\M?[/NDO(!
M;^7_ *U,[6.Y&SC)XZ4 8OQC6U;X6:T;K;\JHT)/42;UVX]\_P!:HW]]K"V+
MI-J=S]LAT*.86ED )89]K%Y9F;Y<9  4GG#84XKII_"%KJ%]:W6L7U[JGV1Q
M+!!<E%B1QT?8BJ&([;LX[5%?>"K6]UV_U1=1U"V_M&V6VO;>!U"3JH(4DE2R
MD!B/E(_GD Y&XN+S7K[X77]Q?W,4U]$\LH@8*N\VC,6"XQGDCV!XQ6C+>^(?
M$R^(!HMQ+;W.GWKV=FRSHJ(\:KS(I4[MQ)SGC!& #DG63P!:1:7H-I'JNI)+
MHC9M;H.ADV[-A4@H5QMXX&>_7)*77P_MGU^?5M/UG5M+:["_;8;.<*EP5& Q
MR"0V."P(/X\T =-8/<OI=L][Y*W9A4S^4V4#X&[:>XSG'M7G%IKNK6^I^$W_
M +4GOAJ%Y+;7MPB@6D_R.P\H'! 4J,,HP<=37I(L[<6/V)8P+81>4(QP F,8
M_*N0MOAK:6]II-M_;FL/'I$_FV69(QY2X(V<(,C#8R<L.Q% &%/<Z_=V_CQA
MXEOH?[&E=[3RXX@?E@$@5ODY7/8 $\Y)K6T[Q'>>(M<T+1WN'MEFT&/5[MH#
MM:5G*J$!ZJH)8G'/W1G&<ZR^"K=(_$"#4[XC72QN<^7\N4V'9\G'RC'.:@D\
M 6H&C36>J7]IJ&DVXM(+V/RR[P@ >7(I7:PX].O- %+X:PO;77C"&2XDN&37
MI1YLF-S#RX\9P ,XI\=R]Y\:YK>4GRM/T0-"IZ!Y9?F8>^$4?A6WX>\+P^'9
M]2FBO[RY?4+@W,WV@H1YA !(VJ,9 'MZ 56U+2GL_&5GXGMXVD7[*UA>H@RW
MEE@Z. .NU@01UPQ/:@#FH=)OM7^(WCB"SUJZTHA+ ^9:HA8MY+;<E@?E'<#!
M/J*6/4KWQ/\  [5[C5F4W\-I=QR31C:'D@+A9!CIR@/'>NIE\+*-=OM8L-4O
M+*;4(XTNEB$;*^P$(R[E)5@">G'M5;6]"1?!Y\):+"88[J$VNX9(AA;B1V8]
M6(+8[LQ^I !I^&;Z;6/"&D7\[%9[NQAE=AU#,@)(_$UY=';R1_!WQQ))>W4^
M+J_CQ,X;I(1NSC)/'K7L5G:PV-E!9VZ;(((UBC7T51@#\A7+2?#VR?2M:TM=
M4U)+'5I9)9(5:/$1D;<X3*=SZYQVQDY ,ZWN-4T?QIX6M6U:XNK75[.<36\J
MH(XVBC1E,8 R.I')/N35.QU#Q7XF\/6/B+1IQ%/+.9?+FN%%N8 Y!B9-I((4
M?>ZY'4#@=7+X3BFU?1-2DU*],VCH\< Q&%<.H5M_R<Y '3%9UG\.K+3]3GEL
M]5U2'3+B8SRZ2DP^S,Y.3QC<%)ZJ#@].G% '0>()Y[7P]J,]M>6UE/';NT=S
M<_ZN)L<,WL*Y#1M4U$^/(-(6\U$V-UHK7.^[5=QE61%\U PRH(8_*P Z<5U^
MOZ):>(]!O-'OO,%M=Q^6YC;##N"#Z@@&L:#P=!8ZS9Z]=Z[J5Q=65JUN\L\D
M:K)&2&PP50  5!XQGN30!PB:GXL/PJC\:)XFN'O;%YI&MFAC$,\:7#JP<!<Y
MP.""    ,\UT*R:WX@\<:OI4?B&^L+$:=;742PQQ>9$SE_E#%>G SD$\8R*J
M?#OP^NL?#NUL=0O+DV9N9GN-/9%7_EN[*K97<$;Y6([YZX.*N6\4ES\8-;:V
MU"6TSIMO$K(BLLC!GW+\P(++D'CIGF@# N-8U/5_ >F)K$BS7^G^*H+"6=5"
MB8QW &_ Z9_I78SZK?6GQ4>R>\FDTT:%)>?9=JX61957(( )X]2>IJU=^!=.
MN=#L=)CNKNWAM+M;WS(RA>68/OWN64Y)8DG 'Y<5</AJ)O%L?B)KZZ-REF;+
MRL)Y9C+!CD;<YR <YH P=!?6_$?AW0_$MOK?V>:XE6YNH7 : VY)W0A>Q QA
MLYR#D]JR/%6O:MIECK.I6NJS7%Q9:G$B?95'V:WA+QKY,F[AW.YL[=Q!(^Z*
MZ'2/A[9Z)=D6FJ:F-*$QGCTHRC[/&^=W'&[:#SMSC/7-0WGPTL+NSU>Q_M?5
M(K'4KHWC6T<B!8IBX<LI*YY(^Z21[9P0 9]]IUSJGQ=U.VMM4N=.SH<!::U5
M/,/[Z3 !8$ >O&?<5A:CJNIZC\.+JUU><7-YI?B2'3VN@@7SQ'<1X<@< X//
MTKT&;PHO]N)K-IJM[;7WV1;.63"2":,$L"0RG#9).1CKTQ45_P"!M.O?#T6B
MI<W=M ER+MY(F4R2RA_,WNS*<DMR>/TXH S[[4-4UOQ-KNC6,D\*Z;#"J-;S
MK$PDD0N'.0<@< #IP<YXQT7AO^U_^$>LUUYK=]55"MR]N<HS D9' Z@ D8X.
M:R=8\#0:GK<6M6FKZEI>I"$033V3JOVB,= ZE2"1V./Y"NCL;*+3[**U@WE(
MQC<[%F8DY+,3R2222>Y- 'GNC#4C\7O'7]GR6J'R]/W_ &A&;_EB<8P1[UT5
MU8Z]>>#[B$ZJNG:Z!*XN8 OEAMS;<A@?D( '/('N*+?P9]D\0ZGK=MKNI17>
MI",7&%@*D1KM3 ,9Q@5._A036MQ#<:QJ,[7,Z2SRR>5F1%QB$@(%$?!R !G<
MV3R: ,/P3XDN=<T:\U^\N)5:S@\B730P.R2-,N[<9R^<CG&W!ZDXKZ9<>+-8
MT[P]X@L;E1]I,4]['-<+Y#P.,LJ(%RK+D;3G/')-=.GA6VA\6W/B&&[N8I;N
M!8+FV79Y,P7H6&W)89QG/3CI69HWP\L]#NP+75]5.E)+YT6E/,#;QMG<,<;M
MH/(7.,]<T 9&E3ZW=ZMXEN+GQ%?&UT/4RR0)%$/.B6)7,;?+TYP,8/4G)QC0
MT/\ MO7="\/>(X-<\J6Y:.YO8'4&!H7!)B5?X2N0 V<Y!SFMS1O#,.C7^JW2
M7MS<'4YO/GCG";0^ OR[5!Q@ 8)-9FB?#ZST&Y"VNJZFVE1R^=!I;S P1/G<
M,<;B >0I.,\\T 4+?4?$,FM^/["RO&NKFQB@_LR.8(!&[PLX'  /S$=?09-9
MUOXZBMM)UV_AGU%-0TS3C+-HVJ*1)%*.D@./F0D@$@XZ8 S75?\ "&6_VW7[
ML:G?K+K:(LY4QCRMB[5,>%R"!ZYJ7_A$K2YO)[O59GU&>:Q;3V,J*H,#'+ A
M0,DG&3[< <Y ,NRM_%$>NZ5>1W9DTR1&74%N;A7$F0-CQ!5&TY[#@@U)\5/^
M27^(?^O0_P Q4OAWP-%X>EA UK5KZTMLBTM;N8-';\8XP 6P"0,DX'2M7Q+H
M$/B?0KG2+FZN+>VN5V2FWVABN<XRRG'2@!D*6DG@N-+\(;-M/ GW_=V>7\V?
M;&:\V^'MWJ*?#KPA!/J$D,$TER/LL0/VJZC!;RUC(^ZH/).0  .0*[NX\%QW
M^F1Z9J6LZI>:<BJC6K-%$LJCH',:*Q''3.#WJ75?"%I?WND7EI=W.ESZ4KQV
M[66P 1L &0JRLN,*,<<8H \[UG4=2U?X3ZLU[>W8FL=<^QJQ95=XUN40+(5X
M8@-CC@D \UV%Y>W]QXJE\-6T]V\=IIZ7+R)<+%+(TCN =VWHH4= .6YS4O\
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M94.0K\;B%;!"GT&<BNJTWPU%IOB/5=:2^NI)M3\OSXI-GECRUVKMPH(P#ZT
M<;#KFKZU\,KSQM9ZG-;WL8N+J"VP#"L43L/*9<?-E4Y/7)X(&!5Z37K^'Q%X
M3UB:[GCT/7;<1/:MMV07+H'CYQGYAN7&<9Q6HG@.RAMM0T^WOKN'1]0E:6?3
MU*[,M]]5;;N56[@'N<8S6IK_ (;T[Q'H3:/>QE;4F-E$7RE"C C:>W3'TH Y
M#Q7J6KV7PVU3Q!9:M=02RSI-;<(0L#2JBJ,KGE#N]06QGBMF74Y]8\?W7AY+
MJ:VM+"Q2XE\EMKS22,0/FZA5 SQC);G@8.IXE\-VWB;P_+HL]Q/;6LNS=]FV
MAL*P8 ;E( RH[53U+P='>Z[:ZY;:I>V&JPP?9I+FW$9\^+.=KJRE3SR#CC\J
M .&\/:K>:'H$]E#.\MU?^+KFQ-PVU6.69BW3:&;9CIC+=*UM7UCQ+X)TGQ%J
MUVR3Z:ENCV$5S.)98IF8(02 ,QY8'DDC&.]:O_"M=)DT'4-)N+S4)H[R^;4!
M*TBB2"<MNWQL%&"/?/ZU;@\$6CZ->Z=K.H7^LB\B\B26]D!94[!=H 7G!SU)
M R>!@ P->TV>Q\<^ WEU.ZNV:ZG67SB"&?[._P X 'R]^!QTXK5^*RNWPQUU
MHYYH2EL6)B;:6'0J?8YY'>E@\ A9M'ENO$6KW3:1(7M#(8@0"NW#$)EN#C)Y
M^E=#KFCVOB#0[W2+PN+>[B,3F,X8 ]P?6@#B/$%G.OBOX?VT5_.)&>\Q<.%9
MU!MSG'&,XZ9!^AIMIJNKVNF>,].?Q $DTJ\CCMM1OU5FCCD1&P=J_,PW,%X.
M20,'I71GP:DE]HE[-K&I37&D%S"[F+]X778VX;/[O'&/7KS56]^'=A?Q:VD^
MHZ@3J\T5Q*RLBF*6/;L9,+QC:.N: ,RRU&_F\5:]HGVK4XK$Z1'=P&Y8":-B
MSJ65N64$*.&Y!["M'X5Q.GPWT25[B:8RVJ-B0@A>O X_GFKEGX,@MO$)UN;5
M=1N[M[,6D_G.@690202%48QN/"X'?&>:N>&/#D7A;2(],M[V[NK>(;81<LI,
M:9.%&U1P,GDY/OP, &2;W4?^%L2:3_:,PL)-#:Y2$*F(I?.";A\O/'][/>N-
M@UGQ&GPWLO%4OB&[EN[?4O*:$QQB.:,W9B(<!<DX/8@# P.Y]&D\-1OXM/B-
M;^[2Z^QFR$8V>6(RV[H5SG=SG-97_"N[+_A$/^$9_M74?L7VC[1OS%YF[S/-
MQG9C&_GI[4 =7=I)):2I%,\$A0[94 )4^H# C\Q7DVFZUXA'@WP9XEGUZZFG
MO=0M[:YMV1!%)'+(4;("YW=#G.!C@"O69(7DM&A\]U<IM\T!=P/KTQG\,5RJ
M?#VRC\-:3H*:IJ M=+N4N;=OW6_<C;E#'9@@'VH AT^]O?%NJ>)H8]2N=/73
M+K[#:BWP"KA 3*V0=V6; !XPO3)S6CX U^[\3>"[#4[^-4O&WQ3;!A6='9"P
M]CMS^-/;PG'%K=YJNG:E=V$]^BK>+"$992HPKX93M<#C(X/<&M;2M+M-%TNW
MTVQB\JUMT"1KG)QZD]R3R3W)H X5[[Q-XHM-8N=#N'M[NTU":UM/WZK$GE/M
M(D0J2V[!)STW#&*NW.J:EHOCO1I-3OV&DZM:/$8@R^5!>* _#8R590P&3U%6
M9OA]:G7[O4['6-5TZ._?S+VSM)PL4[=VZ94GN5(/TK7U_P ,:;XCTB+3+V+_
M $:&:*:-4XVE&! 'H",J?8F@#F[G6=3MHM"M5GG:;7KR5U+NJ-# $:1(U)&
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M&@B;.1CC<0#R 3@'GDUV% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 55U+4K/2-.GU
M#4+A+>T@7?)*YX4?Y[=ZM5YQ\8RXT+02^?L(UVU-[Z>5D_>]LX_'% '23^+?
MLFG_ -IW>B:G;Z:%WO<ND9,:?WVC#EPN.3QD=P.:WX)XKJWCN()$EAE4.DB'
M*LI&00>XJ/4! =-NA<[?L_DOYN[IMP<Y_"O%/!D^O1>#OAU9QZM=64=_<7,+
MJJH<Q 2,A^89S@<9R.AP: /<R0!DG K/O-3>*ULKBQLY=0CNIHTS RX2-_\
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M?[T8^<E>#]!WR3U=X=2O/BI-HW]M7T&GR:)]I\J$JI1_.V_*=N1P.O)ZX(H
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ML9'RJ0"AQ@'Y><DT:3K]Q%XJL]+\0RZEIVJO=RF)V<M9ZC$0^Q(R#M4@%#C
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M*J7$  "X#!<$8 !R.<5/=^!M*U'PY+HU_+>70ED$S7DL^;CS1C;('QPPP ,
M#'&*Z:B@#%T#PY'H2.6U+4=2N' 4W.H3^8X4=%&  !]!D]\X%<WXI@DNOB?X
M4,4MW MO!=B2X@BW+&SJFT,2I7YL$8/\\5WU% '/3^"](O-'U/3K])+M=3?S
M+N:5AYDC@ *<J !M"K@  #'UJ'2_!4.FV5Q ^M:Q?22PFW2XO+A97AC/54RN
MT9P,D@DX'I73T4 9N@:+#X=T2UTFVGGFM[9!'$9RI8*.@RH&<5%?:";S49;V
M/4[ZU::V6VECA\LHR@L0<.C8;YVY%:]% '-P>"M.M-2TB\M+B[@&DVQM;6!&
M0QB,@ @Y4DD[1SGM5.7X=:9-97ELVH:D&N=2&JB99$62&Y&/G0A,#H!@@BNP
MHH Y5? =BMWJMT-3U4SZI;+;73-.IWA05W8*XW89AZ#/ %6)?!>EW/@U/"UX
MUQ=:?'$D4;2,!(@3&PAE Y7 P<?7-=%10!A>'_#$>@[G;5-3U.<KY:SZC<>:
MR)_=7   .!DXR<#)X%2ZYX;M-<FL;F26>VOK"0RVMW;D"2(D88?,""I'!!!!
MK8HH Q[?P[!;Q:@RW5RUYJ&!<7K;/-8 ;5 ^7: !G "]R>I)I_AW08/#6B6^
MDVMQ<36ULNR+SRI95],JHSU[UJT4 8>M^%;'6KZUU'SKFRU.T!6"^M'"RJIZ
MJ<@JRGT8$5:LM(:"9)[S4+K4)D!$;W 10F1@D*BJ,XXR03R1G!-:5% '+0^
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M,]\FNGHH X_3?ASI>DZB\UG?ZI'8--YXTH7/^B*^<Y"8SC/.W./:KGQ #/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFGSW%QXA\!ZH=/UES#'<17F^QDBCMY&A"B-8\!44'(W 8P!EC@UWO_"(P_\
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MZ1L #)XP,\?2M.UE\7_VUI<L:W$^G3QL+[[6+95B)7*/%Y;;B,\%6)X[YYH
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M$*ZX*[6^8^H]J@O? MO-H.F:397CVT5C>I?>8\8D>:57W[F.1U8DG],5UE%
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M.>JDX)&>]:4'AIH/&<GB%;Q0'LULOLHAPHC5BPP<]<D^V.U;TDB11M)(ZHB
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MHX#*PP?IUKF_#W@W4-$\F"X\3WNHV%H,65K/"@$>!A=[#YI-HZ D#\ACKJ*
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M;>;"TOVE8\PIM(&UFSPQSP,=C0!=HHHH **** "BBB@ HHHH **** "BBB@
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ME>/?&0 ))#,S;MR$=,$ C\>M/_X09KS0K[3=<U[4-5:ZMFM1/($C,49Q]T*
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ME)MF62)G8_=^4Y4?=Q731>%HY=7?5-3N!>79LFL ZQ"(>4Q!;."<L2!SP!V
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MS8:[>:7J\4 MIKFV1"MQ&#D!T8%20>A_^MA^H^!H+HZ5=6>IW=IJNF,YBO\
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MI"ZC?Q2Z0P:POXG59X>,8R!@@C@C'-;^B:-_9%LZRW]UJ%U*09;JZ8%WQT&
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MPSG-4+?P#96VFRZ,E[=?V#),9?[-(4HH+;C&&QN\LMSMSZC..*ZFWF%Q;13
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M;"I6&590N5V@;5PW(]JT+[P%I^HZ=>VD]Y>A[ZZCN[J>,QJ\KIMV?P$ #8O
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M'-=U"_L]4T*>_O?[5;4HUM)Y& D^R2CS8Y .@(B63C'5<&N\\0>'[#Q-I?\
M9VI1E[?S8Y<*<'*,&'/OC!]B:3_A'M/_ .$G7Q"(L7ZVGV,-V\O=NZ>N>_H:
M .,CTR;4?B9XLMH=3O+%1I]EF2V8"0G$F/F(/U]3Z]0:47B36KWX?^ ]7.I3
M1W-[JEG;WFQ5 N$:0JV[C(SM[$=37<0^%X8/$&I:U%J%ZMUJ$212K^[**J9V
M[04[;CU)Z\YK.C^'NGQ>'M(T2/4=26UTJZ2[MCNBW[T8LNX[.0"3V^M %=+B
M\\5:SXIT^'4I[!M,9+6T\AMI21H@_FN!][YFP%/&%Z9-9NK6M[<>/_!EK<:F
M?M?]FWB7%W;(JEF B#%0<A<D'L<?RWM2\"6=]X@?6[;5-4TR\FC6*Z-C.(Q<
MJO W@J>0.,C!Q5M_"=FVN:7JL5S=0OID#6]O"A3RPC !@<J6.=HYSVH S_A_
M?7MQ:ZY97MY->'3=7GLX9YR#(T:A67<0!DC<1FE>]FUWQOJ^@M>3VEOIUG#(
MHMY#&\LDN_Y]PYPH50!TRQSGBM70?#D'A^74I(+NZG.H737<PG*$"1@ 2NU1
M@8 X]JI:[X)L]:UJ#68=0U#2]3BB\AKFPE"-+%G.QPRD$9Y'% &=/_:EG'X>
MTW4]>-[<XF6YBL4,<]\RCY2I4C8%SEB2HSCGG%<S)XAU]_AF+U=5N8;VVUS[
M"9"$+21_:1&%<@<D XRI&<=:[>Z\$6$]WI=W;WNH65SIR21I-!,"TJ.<N)"X
M;=D\D]<G.:I_\*VTP:/<:6FHZJMK-??;ROG*Q5]^\ %E/&[GG)/<F@"/3)=0
MTWXH3Z++JMW?6=QI/V[;=%28Y1-L.W:!A2#T]J9\3$DDC\*)%*89&\0VH60*
M&*';)S@\'\:WE\-0CQ4GB(WUXUVMI]CV$Q^68]VXY 3.=PSG/Z5+K_A^V\16
MMM#<33P26MREW;S0, \4J9VL,@@]3P010!P6IZYK/@/7-:M6U.YUBS_L274[
M;[;M:2&5'"[25 RAW ].,<>^]8V?B9-:TC4(KZ-M-D0C4$N+PRB?<HV/&-@"
M-GL, @]*VXO#%D7O9;]I-1N+VW^RSRW(7)AY_=@* %7DG@<D\D\5G^'? EIX
M<FB\K5M6O+:WS]DM+RYWQ6_&/E  )P"0,DX!XH A^)-]J.F^&8;K3+^2TG%]
M;1$JJD.KRJI!R,XY[$'WK-QK&@?$;3-)FUN^U+3==MK@LMP5#V\L0#%D*!=J
MD,!BK/Q70S^#TMHQ,TDE];$"!"SA5E4LPP#T SFNALM#@74X]8GO)[^[6 PP
M2S! (XV()VA5 RV%R>O Z#B@#SZW\0ZS+\)/#FLMJ5Q_:$NHPQ2S9 ,B-<E"
M&&,'Y>.E:[PZQK'Q$U_2%\2:C9V=O:VMQ$(!&"C,SY4$K]WY><\GCG P;?\
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M=U=33:O 9_,?*2.T3G<J]$QR %P,'G.,UW7B6SO[[P[?0Z5=RVFH>4S6TL9
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MBB$EN=MK!$943R'4G#MACN(!()ZC&*]&TG35TC2K;3HYYIXK:-8HWFV[MJ@
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MQ.RC,D@&<=6"?]LSZU@>,K5[WXC^#;:.[GM2\.H RP$!P-D>=I(.#[X^G/-
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M0G"D@$D=AWKSR676_%L_B:#3KK[+<6%VUG:.M_)#Y#+&I#M&J$2 LQ/S9&.
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M3H6A@.Y,%6 #;AMY)P/RXK>JKJ=Q=6FF7%Q961O;J-"T5L)!&96[+N/ ^IH
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M35)-4EN+B\OW@6V\^?8"L8);: BJ.IR>,UJT44 %%%% !1110 4444 %%%%
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MTB#3+:68P6\8BB,A#,J@8 SCG'OGWH XF\\>2W/PCM_$EK(+>YG\FWGDP/\
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MUIYS^6LID3D*3\I 8C(KG[G4M6_X5Y?W$>L7\<]OXE:UCE$[%O*^U*@4L>2
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M4-[-$V)Y.@8*=I8G^$'G'3KZU0D\)Z?+JFGZF\MW]KLH#;K(LY3S8\@[9 N
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MU_[;J$6HF#[,)(I@H6+=NV 8QC//K0!R_P 0QY_C_P  06?.HIJ#S';]Y;<
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MS1V!NW-K')G.Y8LXSGD9S@],8% &CXL75'\,WBZ*5_M#Y/*5I?+W_.NY _\
M"67*@]B17G^H:U:ZIX#\;Q(-5L[V#3B+G2]2D=WMVVO\R,Q.5;U']W/>O3=5
MTR'5]/>RGDFC1G1P\+E'5D<.I![<J*R[KP=I]_:ZE%>3W4\FI1+!=7#,JR/$
MN<)\J@ ?,W0 \]: .8MENM'\7^"1%J=_+%JMI/'=0S3EHCLA5T*I]U"#QP!Q
MUS6?<:G>P'P]J%EJM]>BY\0K;37YF9(+B)W=3&D.XC:H &[ Y7()R:[I_"=G
M)>Z/=O<WC3:0K+:$NO 9=K;AM^;*\<_SYK,3X9Z!'9PV:/J*VUO=B[MHEO7"
MV[ABW[L _*,D^_/6@"/3/^2QZ_\ ]@FT_P#0Y*/A/_R3NR_Z^+K_ -*)*VX?
M#5K;Z]=:U#<72WES MNYW@KL7.T $=LDY_/-2^'O#]IX:TM=-L'G-LKLZK,^
MXJ68LW.,\DD\^M '&W&C_P!M?%?7K5M0O[./^R;4LUE.87)WR8^<<C'H.O?-
M96C^)-;>WTKP_=W;7,AUF]TYKR2=H&N8[<$H#(H)!)P,CD[,9Y->@WGABUN=
M;;6(+F\LKZ2$6\LEM( )8P20K*P(XR<$ 'GK4.I>"-!U3P]#HDUHR6ENXE@:
M*0K)%("3O5^N[))).<Y.<T 1>%]-UC2[_58=0OXY[.5TFL[8W+W$EL""&!D<
M!BI(R,].1735EZ'H-KH-L\4$]W<RR$&6YO+AII9,=,LW8=@.!SZFM2@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'@%LX'4GI7-V$*CQT/!\EY?2Z=INEBZ19[IS)</)*1N=\@L$' '3GV&)_A?
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M7D#RQNN&4$X4X)&% 'M5+1+?6?$&@>'?$UMJ\-M.S1W-U<&\E=9U/$D+18V
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M++D@$8((SU'->07=_JMMX1GTI+S4;C7_  [J4LLY%[*KW-I&?-+/@Y96C9%
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MU,+-LCV [<84;@1SN.: /4J*\OM+J]\0>+?"SWEW?6\>I^'GN;JU@N7C3?\
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M%];Q>2KQS.@=-VX*Z@X8!N<'O53_ (0K1@]VJ1SI:7DOGW-DLQ$$LG!+%/?
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M/A;3K?6FU>%KE+QK46F_SV(\H<A<'(X)SGKGO6E;7MM>/<I;RK(;:7R9=O\
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M))8=4NC;&8RX,1V,WW<<_=]10!:L_#MC8Z[?:S"9_ME\$6X9IF*N%&%^7H,
MG&*J2>"]'>>^95GB@U!_,O+6.9EAN&/!++[]\8W=\UT-% &3+X<L)M>MM:/G
M+>6T)@B*2D(L9QE=O3!P.W:J:^"=(73-5T[_ $HVVJRO->(;AOWCN,,<]1D
M9QBNBHH @LK2.PL8+2$N8H4$:;VW':.!DGK4]%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY_,N[>.=UAN&[ET!VDGOQ\W?-69?#NFS:[#K31RB_AA,$<BSNH6,\E=H.W'
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M[RXNI3<I)<PB"<17+HLL8SA2H./XCR.>>M '+:==1W/Q.T[[)=2S:?=^&3.
M78)+^]0*^TG&=IZ]>:Q])O _A@VUUJ5\2WBB>WAMXW+O=*LC8@W,PPF!DDG&
M%QWP>\O_  AHVHW%A/);R0RV$9A@:UG> K&<9C.PC*\#@\<53/P]\,_8&LEL
M9(XC>&^4Q7,B-'/DG>A# IU(^7 H X>ZFOH?#?Q,M#-/:#3R);6.WNW(MRT"
MN0C?*=N>=O3D\5JQVK:5XS\#R6]W>LVJVUQ'>^;<NXF"P!U^4G"X(XV@=:Z9
MO /AMAJ0^Q2 :DBI=@7,H\T 8Y^;J0.3U/?-6V\*:2]UI=RT=P9M+4K9L;J7
M]V"-I_B^;(XYSQ0!S7PPTZUM?^$FDA1E9->O(5_>,0%#+@8)Q^/6D\5Z;:W7
MQ5\&-,C$RPWRN1(RY"QH1T/')/2NKT[PYI>E:E>ZA96[17%[(99_WKE"YQN8
M(3M4G R0!G HU?P[I>N7%E<7\#O-9.S0.DKQE=PPPRI&01P0>#0!R&CI_P )
MC#XN?4)YXKNTU.XLK9HYF1K1(U&QDP1@DY8GOG'(&*W_ (?ZM?:YX!T;4M2'
M^F3VX,C8QO() ;\0 ?QJS<^$M(N=0NKWRIH9KQ!'=_9[AXEN% P-X4@$XXSU
MQQG%;,,,5O!'!#&L<4:A$1!@*H&  .PH \YU+PEJ<.IWOB?X?ZN+>[GGD^V:
M=<#=;7<J,5?C^!LJ1G]14$/C"7Q/!X,00QV$&KBZ\ZWD9@C2PX7R\K@E2=Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?"/B&X\1V%]/<VL=M+:W\]F8XY"X_=MMSD@9S]!6)>P"R^*_AJ"&:Y,+:;=
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M[XZ_A69I6CZ1GP]X@L]1FB)@(+))D:AOCSF4G)<C!;/48/:@#L:*\>241_\
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M\':!XAM[:'5M.2[6U_U+R.V]/HX.[T[T ,\':8VB^'DTQM6?5!:R/&L[*00
M?N<DYV_=ZGICM7+1P7=Q\;-=2SO?LDG]C6_S^4)/XSV/>O0;*RMM.LX;.S@C
M@MH5"1Q1KA5'H!5&'PYI4&MR:S';,NHRKLDN/.<LR]E/."/;I0!R%[X<T;PM
MI.CZ)'+>7,U[JWV@Q/(O_$PG*LS>>2,;. 2 /X1@$US=U&\?@CXF63$0QV=R
M[PPVTC+'"3"C$+C'RY)XP!GM7J^L:#I?B"WB@U2S2X2&02QY)4HXZ,"""#]#
M5$^"/#6R]0:1 BWP5;E8RRB0   '!Z<#([XYS0!PGBSPIHMEX>T2^2R62ZO-
M5TW[1+.QD+_,%)^8D#()!QC/X5O75M!:?%_08[9?+B.DW0\I&(1=K1@87H.I
MZ"NIN_#VE7VBKH]W:">P4*%BD=CMVG*X;.1C QS35\-Z2FHVNH):!;JUC\J!
MUD8>6G=0,XP>_KWH X3PO;:9XL\$6NO:I=R6^KP7KSW5Y$P6>&5)3^YR02%V
MX78.H(XYJ_!;(WQ0\50%YO+DTBW9AYS @EI,X.<KT'3%=$G@GPTFOMKJZ1;C
M4F?S#,,X+_W]N=N[_:QGWJ>XT2RMKN]UBVLI)=3GA,;LDIW2#LOS,%P.V>!0
M!Y NBI!\&]!\6V,MS_PD=M]G:WN//8LY:8)Y6,XVD-TQR>O4YU_')M[K2/&^
MH6&ZXN+)T5[VX<!K25%0B.WP-PQG).1RQ^]S73_#[PBNE^$-'@U;398-0LAD
MPRW'F1K)D_.JJ[(#SU SR:VKSP3X;O[N]NKK2+>6:^7;<ELXDXQDC.-V.-PY
M]Z .8U#3K?5/BMI45V998;C0IFFB\U@CD21C! .,<\COWKE+RSMF^&^HV<D*
M2P:;XL-M:+*-_DQ"Z0;5)Z#!(^AKUF'PMHUO>V]Y!9>5<6T/D0NDCKLC[J #
MC!/)]3R>:C_X0_0#IE[IK:<KV=[+YUQ$\CL)),@[^3PV0#D<\"@#5MX[6UCC
MM;=(H44'9%& H !YP![FIZS(O#NDP:A:7\5C&MU:0-;P2 G*1L<D=><GN>>O
MK6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %<_P"-=>NO#'A2^UNU@AN#9H':&5BN
M\9 X(Z=?2N@KC/BQ_P DL\0?]>W_ +,M &E%?>(VBL;G['ITL$[Q^:L<KAT1
MB,L,C!QG)Z< UT!90P4D9/09ZUS>@Z%-;S:=J3ZO?7*+8F+R)V0J-WEG(VJ.
M1LQSGK7%:?#;>(OAMXGU/544:U!<7K2W!XEM)8BQC"MU4*H3 'OZF@#UDL%Z
MD#ZTCND<;2.RJBC+,QP /4FO)8=-3Q'XL\)#Q#;F6:^\-R-?1,Q42-^ZSN /
MJ<X]?I7I-[IUG'X9FTT6T;6<=J8EA<;UV*N #G.>@ZT 8>O>,9+;0='UC1DM
M[BTO[^"W+S9_U<D@7<H'7U&3Z<5UP(.<$''!KQ5+.SC^#'@\00Q127%]IS3-
M" CN3*!N)'.>O-;%Y#_PC'C;Q0GAZW6W9O#!O5AB7A[A7D"OCNW3GO0!ZD&4
ML5!&1U&>E+7F>A:3I^I6_A;Q):ZS90NA0![.V*RW9=0'BE8NQ<YR3D9!!/&#
M72^/9K%/#B07[W.RZO+>".*W<*9Y#(-L;$C 1L8;/\.: .F5E895@1Z@TM>:
M^'M-@N?''C71;ZWLUM)[:S,EG;C]TK,D@. <?-@#YL#H#BH?!T*7EG;>";^W
MCDF\/7C_ &O=&,21H=T#^Q?>K9[^6_K0!Z>64$ D GH">M4KPZF+VP^Q?8_L
MAD;[9YY;?LVG;Y>.,[L9SVK@=%M;/Q58^-?[=BC>^@U*XM]\@^>VB11Y10]5
M 'S C'.36;IT][J ^%.I:KO.HS-*)'<G+KY#E2?<C!S[T >E>(M1GTGP]J%_
M:I#)<6UM),B3,0K;5+8XY[4N@ZD^I^&=+U.Y$<<MW:0SR!>%#.@8@9/3)KSF
M$6?B3PG\0+O5H8I]2MKB]@Q* 7MXXT/E!<\J.-V1U))JSI2V&H+X/L#$MY?)
MX;CF^SW9!M8HF6-3*5()9\C: ,<;LD4 >H$@=32 @YP0<<'%>(6<:7OPN\ &
M:5WD7Q!%"'61@PC^T2J "#D#"@#TP/2M;4$;PKX@\<IX<@6UVZ!'>)%"N%$P
M,@\P+_>P,^^.: /60RDD @D=1GI1N7=MR-V,XSS7$Z+IGAJXA\,Z_I\VRY\@
MK T#@&\+Q_,)>,N1@L<G(()/>N7T"R@\5^#]/UNZUBSL]3M;H37%U%:G[7'<
M!R#&S%\G/W=NWD%0!TH ]?I RDD @D=1GI7-?$._U#2_A]KE[I987D5JQ1D^
M\@X#,/<*2?PKF]>LK331X)U;PU''%<3ZC;VY>$8-S;2(2X?'W_E&[)S@@F@#
MH=0UW5;K6]3T;0%LQ>Z=:Q7#F\5F25I"VV,;6&WA/O<_>''%=);-,]K"]S&L
M4[(ID16W!6QR >X![UP6@Z3IB_%WQ2ZZ?:!X;:RDC80KE'82;F''!/<]ZN?$
M74#:)X=M)G\O3K_5X;>]<G ,>&(1CV5F !]1D=Z -&'Q#>/\19/#S16WV(:7
M]NCE0DN6\W9@]@.#^G-=)N7<5R,CMFO+]2MTT+XF:U/H=G%%=CPG)/'%"@ :
M593M^4=^%%4=0AA'PBT#Q+HP4Z\GV.6*Z3_6SSR.B2H[=6W%F!!]/:@#U^N;
MUK7[[3?%_AO2HH;=K/5))DED8MYBE(F<;1T[#KFN:LH+2/Q3\2X)(H5M_(M7
M:-@ G-NQ)QTZ\Y]:P]/M(=2TOX36UT&DAEAF$BAR-P^S'()!S@]".XXH ]=N
M[VVL;&:]NITBMH4,DDK'Y54=3FG6ES'>V4%U%GRYXUD7<,'##(S^=>/:MH=K
MI$7Q'TC3[=?[$CT=;M;8C=';W11S\@/W3@*W'3CVKTKPP-.T_P -Z3! +6V\
MZWC(C3:GF.8P3P.IQSZT ;,_G?9Y/L^SSMA\OS,[=V.,XYQFH=.:].FVQU(V
MWVTQKY_V8GRM^.=N[G&>F:K>(X8[CPSJD4HRAM9,C./X2:\O%G#=>$?A290^
M7GMXF*N5)4V[DC(/L* /8@0W0@_2ER!C)ZUP?@VRMM)^(/C/3+"%+:QC%C,E
MO$-J([QON(7H,[1GZ4SQII]M>?$/P0LZ,RRRWB2 .1N40$X.#T_F"1WH [X$
M,,@@CU% 96S@@XX.#TKQ;4KB7PQH7Q#M=&5K2RM=1M@J6^5%O'*D7FE /N\$
M].G6NIURP@T?QAX.N_#T,5NUW</:W$=LH5)[;RRQ+ <-MP"#VS[T >@TBLK#
M*L".G!KD/B3J4FE^&[:7S5AM)-0MHKR5E)5(&<;BP!!VG@'D9!([U6L_"&EM
MKUZTE[9R6^JZ?Y<VFV=L(X)%##$V-S?-\V >_P"% '<TA90P!(!/09ZUYAX-
MB6]L[7P7?V\<DWAZ\?[7NC&'1.8&QZOO5L]_+?/6JMM90>,M.\1IJ6J6-G?6
MFISB:X>W_P!*LUCD)B9)"XVJ$ P0,?>ZDF@#UDL%ZD#C/)JGJ.K6>E1V[7<P
M3[3<1VT(SR\CL%  []<GV!-<##H>G:I\5=0M]0@%[!)H5M)(DX.V5C(XW,AX
MSP.".#]*YJUM;>]^&_@'[9#'<>7XC2U5IE#D1">5=F3_  X51CV% 'N%1R.Q
MC?R"C2@':&.!GWQ4$Z00:1*D,BVL$<#*KQ  1*%Z@#T]/:O/?"?VC1/%&E:/
MKFCVJ7S6<L5CJ^GD>5>Q@*S>8,9#X4-DY!)..M '5^!_$%SXF\(6.K7L<,-S
M<-*&CASM&R5T&,G/1170EE4@%@">@)ZUX58Z99P?"3PYKL<(&J0:NGE763O0
M&]92JGLI!.5'!SFMKQNMC?6?CRXM46:>SMD6>XO&!^S2+'N1+=0,CJ"6)'S'
M@&@#N-6U^^T_QOX>T9(;<V>IK<%Y&+&13%'NX[#)(]>]'A_7[[5/$GB32[R&
MWC72YX8XC$6)8/&'RQ/?D= *P;Z5I_&WPWE=][O;WA9B<Y/V=,U<\)_\E#\>
M?]?5G_Z3+0!VK,JC+$ #N31D 9R,5R'B;[%>>,-$T]HC=7X@N)HK6=@+8)\J
MM)(""689PH'JW0<UYZL:7'PFTZ-Y=_V;Q&L,1C<J$3[85 7G@8Z>E 'N(().
M"#CK[4$A022 !U)K@=*TZTT7XQW=GIL"VUO<Z$EQ-%'P))1.5WGU;!QGJ:TO
M&#64VL>'+"=)+B\GN9'M;-G"P2E(SN,N0<A0<@ 9W8_  ZS<-N[(VXSFC<,D
M9&1U'I7AFHQ*?A%X^MG:,K9ZU.L"0Y5(QOB)"#/"Y9N/>NKUCP[I5O\ %/P_
M#%:*D>I6=XM\H8_Z4$\ME\WGY^2?O9SWH ](!# $$$'N* RMG!!QP<&O%;B[
MD\/>$_%UI8%K;3(/$J6[B(E1;6S^49 N/NCYB..FXUU>L:=#I/Q"\*G1;:&"
M+4%N+>^MX4"QS0+'N#,HX.TXP?\ :QWH ] I"P'4@<9YKQ"[6WC^!&LJPB5H
M-7E6(' ,9%X.%]#MST[5U=WHNG:E\9[FWO;9;BWET!))(9"2DC>>1\R]#P!P
M>.!Z"@#N-2U:STFWAFO)@BS3QV\8SR\DC!5 ]>3^0)[5=KPZ.TMKCX:^&8KF
M&.=+;Q0MK%YRARD7VMEV9/\ #@ 8] *]M@BA@@2&V2..&,;42, *H'& !P*
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MLYH)[;2+6*:"(PQ2HF'53U ;K^/6@>$/#XTN+3!ID(L(I/-CMP3Y:MG.0N<
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MS@X(![9H Q!X.\.KIRZ>ND6RVBS?:!"JX7S,YW8'?T/;M6VJA$"C. ,#)S7
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MDG:#V+9R1WP#T%<;;VKW?ACP2NH;IUC\3M:6L[L=[VH\X*-W7'RC\ *]?OM
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M2WDMY)HUD]S+_K)FA!=_J>IIZ>&-"CM6M4TBS6!IA<-&L( ,HQAS_M# Y]J
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M&>B^PXH X;1--T349_#&OV.MVZR1J4@CLX51YPZ_-')@DMC!)ST()K<^)O\
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M(=3^TB,2*S$KN7864A<#C/3K7H&C:8-)T2UT[>9%@C"9).,>@R2<#H,D\ 4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ'N&XJ" 3CKC)'/O4E<(J6Z_&^.XB6,>=X;=VD4 ;_\ 2$P2>_%+)\3+&/\
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MN07(V8+?+C;D #OS53Q9H>K>-?#T>B7VBP6URTD;/J N%>.WVL"SQ?QEB 0
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MJ&2/:=P!8 Y*^P/6NT\/W'C&9(4U[3K.U^RH1));7/FM>N!@;5( C7//)SG
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MM9QAYY?] !N7;]WY:_*V2<9=>IR<4 =5K.G:;?6HDU2R%[!;Y<0-"9E)]?+
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M $L2QC?Z$8R<9_&NO\.VUQ9>&]-M+N+R[BWM8X9%#!AN50IP1U'% &G1110
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MIYR3"ZWN)-V-I3:.,9(.>W09Q0!TDU]:6]U;VLUS#'<7)801.X#2E1EMHZG
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M;RUDDFV&WDD'SJXP<J#R",GJ,=Z@M?!5[HVI^"TTY89K#0;>>&>2278\AE0
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M7]YG>S$[<8QAL=>U=A10!POA73?&VD6UIH%\=-?3;';''J4<C>=+"OW4\LC
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M155$5%&%48 ]!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=C^\2!B5+ <J-V1QR0#Q6EJV@ZAJEM'8ZK8Z;K5A) ?M$<[&(K.6)W1_*<*
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MX?>']4\,:!+IVJ?9&<W4LZO;2LX(=BV#N5<8S575O#>OW7BC5KNWDT^:RO\
M3Q:PO=.^^R.&#;%"D$-D$\@\#K@ @"7/CC4'_P"$2.FZ3!*OB*$R)YUR5,3>
M3Y@!PO3IDC)P#@=*KVFL>*IOB/IVFW\=A;K_ &.]S-;12NRAC,BL=V.3@<#'
M&3S3+'PEXCMX_ XE&F,?#Z,DX6X<;P8?*&WY.3CYN<>GO6W?Z%JA^(-CXAL6
MM&MQ8/8W"3NP9 9%<.H (8\8P2/K0!GVGC5+73O%%]>Z9#;MIFH_9/+MGW&Y
MD(C"$L0.6+J,D<#Z5M6^H>($UO[#=Z7;O;26IFCNX)"(XY0<>4^1GOD,!Z_+
M7,R^ M2U+2/%VGWLUM;?VQ?"]M)K>5G,+KLV;@57O&"<'N:Z#05\7.%?Q#_9
M<;01D*EC(Y%P^,;F+*-J]?E /)SVQ0!SL/CV[MO =KKL&A6JF74FLY+6*;:$
M)G,>Y?E 8D\\[>3FM.T\6ZO;>+QH&O:1;P/=VTES826<YE$FS[T;;E7YP.?2
MN4US0]4\.?"V#3KP69NAKD,T9BE9D/F76\ DJ",;L=#78WOA[4M:UV+5KIH;
M"6RL9[>Q$,AE9)9@ TI.!P HP.^23CI0!6L_&E]_;V@Z;J-G;0RZQ'*QM5D/
MGV3*F\+(#UR 1G"X/K5&?QYX@&D>(]1@T2P\O0;R6&=7NV_>)&JL=F$^]@D\
M@ <=><0Z=X/\40/X2DE71HWT2203^7+(YN-\11IB2HRY)W%3U/\ %Z61X1UT
M^&_&>FE=.$NNW-Q- PN'VQB5%3#?N^HVYXSG- $]SKNL77Q%T.TLFMUTVYTN
M2[$<A8,W,8RV.X#<#W.3Z=#'H5E8Z_?>($MXA=30>6Q@A"NX&"=Q_C;Y0!Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKP6-I ;]O])E8X@LHQNRY!8$CY0,9')_"LZ^\22^(_AGXY6X6 R:?'>6GFP
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N?\8Z!<>(]#6TM9XH;B*YANHS*I*,T;APIQR <8S7044 <VFBZA>^(
M+?7M2CM%NK&VDAL[6&9G16DQO=I"@/(4 #;P,]<\9.F> I6^%LG@O6)H2&C=
M!<6Q)Y,AD5L$#D$CCOBNZHH Y#_A'=8U==#B\0/9%-)N$NC);.S-=2HI5&(9
M1L&3N(RW( K$F^'NK/+J>H07%E;:R^JG4M/NTD<^3N5$>-QM^92J\COGVKTJ
MB@#B-6\.^)FUZS\2Z+=:;!JPM?L=[:W)=K:>,,6!# !@02<<=\?676/#>O:I
M%H+R7=E-=6&IIJ-PS%XT8JK+Y<:X;"X;J3VR1S72C5K$ZT='^T#^T!;_ &HP
M[3GRMVW=G&.O'7-7: .5U/0=:D\;VFNV%U9&!+)K1X;M7;R6+[C)&!U)& 02
M,@#FN/N=#U#0/!WAWP=<:CHS7[WS26_VA'6*1(RTG+Y#*V63!7G/'3)KUJL7
MQ//X=@TL'Q*EF]DTBJJ740D4N3@87!YY]* .3MM)U'4XM5\+:W:Z.D>J6LDD
MMWI=Q))*KC:JM+Y@R3R-I)/W,=.FWX;T[QC;M;P>(=3TV>VM!A)+.-Q+<X&
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MJ<J"#P-H')YZ\=*["B@#C]!L%\*6FL?\)!>Z9#;ZIJDUTA>?:I\WGRSO !.
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MP2#@CKR"*GH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,F_.,=3C'XY[4 <AH&M^+8/A3=:_;SV.H7D4UU,89K9PSJL\F_D2=<#*@ 8
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ML82LN_=&,'<  ^ ?;WHF^'EYJA\61ZMJ<#0Z\L!!MX"K0R1(H5AEN@9>G)(
MYH Z.TE\2Q:]%;WL-E<Z9);EVN;=3$T,H(^0JSL6!'0@#&.:\Z\'Z]K7A[X;
M^&+V..P;2I+T6DT3*YF(DN'7>K A1@G[N#GU'2N[T/3_ !9"BG7M3T^[:W0K
M"MK$\7G-C&^5B3SCLHQDYYXQA1> M6B^'^E^&A=V1EL;Q+DW'SX<+,90-N.,
MDXZ]LT =QJUY+I^CWM[!;/<RV]O)*D"?>E95)"CW.,5S&A>))/$NFSW-MJ6F
MW]BUDYD^SQ-'+!-@?(ZLY(XW=ATKJ-0BN[G2;J&TF6VO)(&6*7[PCD*G#>X!
MYKEX_"-R?$-QKYAT^TOY;![21;5FV7+L0?,D^4=,<#!//WN!0!S'A'7M:T+P
M7X%<QV#Z5?20:>T6US.#(&VR;L[<9'W=IX[^FWXK\9ZQX<MM5OGBL(H[*:,6
M]G(#)+=PDJ&DW*_[L99@,KU7GK0G@?58_"?A?15N;(OH=[!=&4EL3"(G"XQ\
MN<]><8[YX@U7P!KFH:?XITU-6LA:ZU<?:DDE@9ID;Y<1ELXV#8 ."<=J -'6
M-?\ $O\ PFS^'='ATL%]+:]AFN_,(5A($PVT]/IZY[8,-[XMUJ>WU4Z1!%+=
M:9(8#!]@GF%U,J*SJLBD!!EMHSGID\&M&'P_JP\=6WB&>XLW1---A)&@92Q+
MARXZXY&,9/'>J3>%O$FE>)=1O?#>KV,.GZI*)[JVO;=I##+@!I(]K#)( X/'
M% $=]XXGBU6VTV5[71;JZTZ.ZMDU2)BLTS;MT.X,H4J0H/4G=P..>UBE=;))
M;H+&XC#2XZ*<9-<QKGAF^U:SNM+G%CJ.FSVJ0H+\MYD,H!!E! .XG(.!M.1U
M&:W],TU=.T.STMI7N$M[9+<R2=9 JA<GW.* .-F\:ZO_ ,(1_P )K;06DFE@
MF8V)C83&W#[=PDW8#X&[&W';/>HM8FU"]^*'A::ROK5;>;3[J:W\RU9MJD19
MW8D&XGL>,>AJQ:^!=1M?"=QX.%[;OH<C,D=P=WVB.!FW&+;C:3R0'R, _=.*
MU+SPY>OXRT;5[0VB6>F6TMLL#%@S!PO.<8&-HXYS[4 0_$C4IO#?PUUN]TM1
M!/'%B,Q#;L,CA2PQW^8G/K6MX3TZVTGPEI5E:*HBCM8^1_$2H)8^I)))/O5[
M5-,M=9TJZTV^B\RUNHFBE3U4C'X'WKGM#TGQ1H&GPZ0EYIVH65NHBM[FXWI,
MD8X4.J@AR!QD%<XH =<WD7AR_P!(\,:-%%'/J4MS,AD4F.! 3+(=H(S\S@ 9
M'7VP<ZY\9:MI\GB?3+F"SDU32+$ZA;RJK)%<0[2>5R2K J5///7BM#6O"EW>
M7NC:O9WZ_P!L:5+(ZR3J?+G208DC('*@C&,9QCO45YX2N]03Q!>SR6RZIJUA
M_9Z!2QCMHMK#K@%SERQX&>!QC) ,T^+?$T)\*W,D&E26VO*D8A42*\4K0^8&
M+Y(*\'*[<CID]:GA\5:];CQ?97D>G37^AVZ7,,L2/'%*CQLX#*68@C81UYR*
MFF\)ZK)9^$81-9[M!>-W)9L3[(S'@<?+D'/?TI;CPIJDFK>++Q)K,)KEG':Q
MJ6;,.Q&0,>/FSO)QQTQGO0!GCQ?XFBMO">H2V^E26VO"*$P*)%>.62(NK;\D
M;<@Y7;D#N>M68_&U]HTOBJ'Q$MI*=#MXKM);*-HQ*DBL0FUF;#;EQG.#D=*?
M+X0U5](\(V2SV>[0)H978LV)_+C,8 X^7(.>^/>I+OP1+JNM>)I=0DA.GZW9
MQ6A2,GS(O+#8;)&"<MG'; ZT %_XFUC0?["O=52REL-3N(K69;>-E>UDD'R'
M<6(=<\'A3W]JSKCQ9XJDB\6O:0Z1'_8,K$>:LC^:BQ"3;PPP2#][I[=ZU(O"
MVJWUAHNFZY<VDUMI4\4_G0AM]VT0_=[E(PG."<%LD=JC3PGJBP^+T,UF3KY8
MQG<W[C,0CYX^;@9[>GO0!U&CZ@-6T2PU()Y8N[:.<)G.W>H;'ZU=K-\/6$^D
M^'--TVY:-Y;.VCMR\>=K;%"YYZ9QG%:5 !1110 4444 %%%% !1110 4444
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M.T=OJNK6]C=.IQ^Y8DL,]L[0/IFN]^RP?9/LGDQ_9]GE^5M&W9C&W'3&.,4
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M7+/QGHEA?-8R6.M0SM%'#$RO;-&@?!<L0X(.,[5Y[4 =E1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !65KVFWNI6ULNGWRV5S!<).LK1>8, '*E<C((.#R.":U:* .7G\.W^LZ
M[I.H:S+9B/2I&F@BM4;,DA7;N9FZ  YVCOC)XJA_P@#7%KXGTN]OTDTC6[B2
MZ\M(<2Q2.%YWY((4H"!CKU]*[>B@#E(O#.I7XT6+7KVVN8](F6X1H8V5KB5%
M*H[Y)VXR3@9R<<@#!HZ?X+UO1;^^M=*UZ*'0+VX>X:W>W+3P%SEUB?<  3G!
M(.,],\UW-% '"ZQ\/VUO6=:N[NXMS!J%I';PHJ,)+=XBQCE#Y^\"V>@JS=1>
M+]/TO1H$U>SN;Z*X1+EA:'-W'P#QD["!R6'Z=#V-% %74K)=2TJ\L'<HMS \
M)8#)4,I&?UKC3X)UE_#_ (:TV;5;)VT.[MYU=;9E$BPJ55<;CR0<D_D*[RLV
M]U[3]/U?3]+N976\U!F6V01,0Y52Q^;&T8 [F@# NO!+ZGKOB"ZU"XB>QUFQ
M2R>&-"'C"[L,&)P3\Q/3L*D\-Z!XGTXV]OK/B&&_L;,8@$5L8Y9L#"^:VXYP
M.P') )/KUM% &1XF\.67BK09])O]ZQR89)(SAXG!RKJ>Q!JK86?BN&W6TO-4
MTZ8*-OVU+9EE8>I3=M#>^2,]NU=#10!RUSX6N;;Q3!XAT>Z1;G[(+*ZANMS+
M<1@Y5MPY#@]\'(-9^I> 9[SPY?6$-] E[J.HIJ%W<O"2I=75@JKGA0$5>3ZG
MJ:[FB@#FI?#^H2^.+3Q%]IM@D%@]F;?8V6W,K%MV?51QCI7$^+O#][X?\ ZR
MDU[;R/J&O17R.D9 C:2XC)4@GD#'MFO6ZK7FGV6H(J7MG;W*J<JLT0< ^V10
M!A7'AJZU;5XM2U2YCCEM;2:VM%M,_NVE #R[CSNP  .W/)SQA6/@'7+:#PQ'
M)K=C_P 2"0B+R[(CS(S&4);+_?P>O3.20:[31M2L]6TF"\T]76T<%8U>%HB
MI*XVL 1R/2K] '$+X,U(:3XMLC?VO_%022N'$3?N/,C$9&,_-@#/;FJOB5--
M_P"$,C\%WFHV[ZZ;2%+.&%MLK2J0(I%7D@!E!)[ -VKM-6U6UT73GOKSS?(1
ME5O*B:1LLP4?*H)ZD5.;6W-T+HP1&X5=@F*#>%],]<>U $6EV$>E:7;6$1+)
M!&$W-U8CJQ]R<D^YK$\0^'K[7$U"SE>PN-,O8!&(+J(L;=\$&12#SU!QQR,Y
MYKIJ* .0LO"%WIWB;2]2@O8I+?3])&F+'*A,D@RIWELXSE!QCUK+_P"%?ZLF
MF>5%JUJMS'KK:S$6MV,3%B28W7=D@%L@@]A]:]#HH XF'P;JT=WXIN'U>UE.
MNP(A'V4J(W$7EY^\?E Z#KTR?5)O!>I2>'_">F+?VH;0+BWF\PQ-B?R4* 8S
M\N03GK7;T4 5-3M[JZTJZM[.Y^RW4D3+%/MW>6Y'#8XS@\XKEY/ D.J:M?ZC
MJJ6L<E[IKZ=<+9*5\X.03(Q/\0P .N/4\8[.B@#D/#?AWQ-I@M[/5_$4-]IM
MF L CMC'-* ,*)6W$$#C@#D@9/4&IH7@O7M 8Z3:>(8_^$:$C/% UN?M,2$Y
M,2R;L!>3SC.#QCJ.ZHH \_U/X=W&JWOB&\FOH([C498+BRFBC8/930IL1P<\
M\=>G<5VNF1W\6GPQZE/#/=JH$DL*%%<^NTDXSZ9JW10!Q7_"!-.OB>PO+Z.3
M1]<F>X,*PXECD954G?G& 4!'R]>_8V(?"VI7L&BVNNWUM=0:1.EPCPQ,KW,D
M:D1L^20N,Y(&<D#D#@];10!C^*/#UMXJ\.7FC7;O''<*,2)]Z-P0RL/H0#5"
M/P]J.H7NCW.OW5K.=*8RQ"WC*^=-M*B1LGY< D[1GDYSQBNGHH XJ#P9J5MI
M^M:/'J5N-,U:ZGG>40D3QK,<R(.=I."0&[9Z&K<OA*:#Q1I.K:3=PVL%E8'3
MGMY(2^8=RL-AW###:!DY'M6O?:_IVG:II^G7,SK=:@Q2V41,5<@%C\P&T<#N
M:TZ /.$^'>MQZ-9:8->M&BT_5EU*VD>S8O(1*9/WIW_,<L>F,^M=!#X=U&#Q
MI>^(!>6SK<6*6:Q-&01L)8,2#W+'(Q73T4 >?1?#_4HO FD^&AJ5J6T^\CN?
MM!@;#A)?, V[N.3C.:[;48+JZTFZM[6Y%K=RPLD<X&X1.1@-CO@\TS2]6M=7
MLFN[4R>2LCQDRQ-&<HQ4\, <9'6KU ')V_A R^))M=OA:174M@]C,+)"HGW$
M$N^>XQ@#G&3R>,8T'@'7ET7P_I<NN6/DZ%?0SVS)9MF1(PP&_P"?EL$#@@=>
MO&/1:* .(C\'Z[I7B#4KG0==M[73=5F^TW5O/:^8\4I&'>([@ 6Q_$"!Z&M!
M?#5Y#XWCUZ*ZA,$6F?V<L$BL7(WA]Y?/7(QTKIZS=/U[3]4U+4=/M)7:YTYD
M6Y1HF386!*_> SD#.1QR* *'@_P_=>&],N;.YN8;@RW<UT'C0ICS'+%<$GH3
MUK'U3P1JE[?^*#;ZQ!'9:_;"&19;8O+"1$8P%;<!MYS@CN<8)S767^JVNFRV
M4=QYNZ\G%O%LB9QO()&<#Y1P>3Q5V@#B9?!^L(WAF]M-4L_[2T:![9VFMF,4
ML;JJG"A\@C8".>>>E59/AW>W'AOQ1I,^LQ-_;5X;Q)1;8,3Y0\_-@C]V.,#'
M/)KKEU[3V\1G0!*_]HBW-T8S$P'EA@N0Q&#R<<'UK2H Y23PYJ]SXHT/6[K4
M+-WTZ&:*2-(&02>;MSM^8[0-HQG.:S)/AW->:5KMG>:C&DFH:I_:MM/!$0UK
M,-NW@GY@-@],Y/2N^HH YM-!O[W6=/U?6)K1[K38I5M8[=&">9( K2,2<]!@
M+VR>3QAOA3P[?^&_#UQILEW;7$C3S312+&R &1RY!&3T+>M=-10!P,/@"^@\
M":)H*:G;_;-'O8KNWN# 2CF-RP#)NS_$1P:7QF--\16]MX8_M:-O$<-U;R)]
MF8+- V0SR[<DJOEESSZ@9R17>U"MK;I=/=+!$MPZA7E" .P'0$]2* *-_8WZ
M:?9VNAW,%B()8@WF0^8I@7AD R,$C@&M2BLW4->T_2]1T^PNY72YU"0Q6ZB)
MB'8 DC<!@< ]30!E>.?#5YXKT6/3;6[@M0MQ'.TDD9?)1MP  (ZD4MUX?U"Z
M\9:5KYN;55LK:6!H C$OYFW)#9XQM'&*Z:L/_A+M'_M.UL//DWW4KP02^2_E
M22IG<@DQMW#![]B.HH YF;X?ZJ^G:A$FK6J3SZX-:B)@8Q[@5/E2+N^9?E!S
MQS5V/P5J,NI^)+F]U>!X]=L4MIUAM2IC94= 5RQ^7#DX.23CD=^UHH Y"T\)
M7TMAHFG:O=VLMGH[Q21BWC93</$,1E\D[0.I SD@<@<&:P\-ZA9:[XEU/[7:
MO_; C*1^6P\DI'Y8R<_-D<]JZDD#J:S=/U[3]3U34=.M)7:ZTXHMRC1,FPN"
M5^\!G(&<CCI0!R?_  @6HCP%H_AI=1M=^G7$,OV@PMB01OO4;=W!)X/-;$N@
M7<'C9O$L>HV\-O)8I;7<,D18X1F?*MN 7[Q!R#P/RZ:@@$8/(H X/3K71O$W
MQ#3Q+H]XMU;6UF$G>!]T4L^6$><<%D1I,^F]*[:[M8;VSGM+A \$\;1R*?XE
M88(_(U2NK[2/#EK#'(T-I'(^R&"&/YI&ZX2-1ECWP :9!XDTJXOH+$3R17D^
M?*M[BWDAD< $DA74$@ 'GIV[T <Y;^!KT^%X?"=]J$-SHD$B /Y9$\D*.'6)
MN=HZ %AU Z G-:DWA^_?Q_#XC2ZMA!%8M9?9S&VXJSARV[/7('&*Z6B@#'\5
M:$/$WA;4M%,_D?;(3&)=N[8>H.._(K)G\,ZS=ZWX;U2ZU&R>72/.,BI;LJRF
M1-A"_,=H YYSD^G2NNHH X2X^'TNHP^)X+[4$5-:N([J)[="KVLD84(02?FP
M4![=ZV?#VE^)+=UD\1:U;WQA79$MK;F$,?[\G)RV.PP!D]>,=%10!@^*_"]O
MXIT^&%YY+2\M)UN;.[B +P2KT8 ]1ZCO2VUKXEFA%OJ-]IZIC#SV<3K(X]@S
M$(3Z_-[>M;M% '+?\(S>Z;XLO]<T6YMU&I11I>6URK%2\8PDBL#D''!'?U%4
M)_ ,J:7HUG97L*O8ZJ-6N)I8B3<3;F9N ?E!+GUP .M=Q6;K>O:?X=L5O-2E
M>*!I%C#+$S_,Q  .T'&20,GB@#,@\/ZA!XVO_$(N;9DNK-+58-C KL+,&+9Y
MR6.1BN)UGP_?>%_#/@W1S>VTL\7B:)XIO*(4ES*^"N[/5L<&O6ZJW>FV%^R-
M>65M<,GW#-$KE?ID<4 <UJ7@V?7)-6O+^\6WO;W36TV!K8$K;1DEF.3@L2V,
M]. !ZDUK3P?KD>LZ!JEQJ]@9-+M9+1HH;,HCHP7&/G.#\G)Z>@KN    !@#M
M10!Y]+\/]2E\":OX:;4K4-J%Y)<_:! V$#R^81MW<\C&<U+XU.F>([>W\,C4
MHE\1175O+&EK)^^MFR"T@'4 1ESSZ@=2*[RHEM;=+I[I8(EN'4*\H0!V Z G
MJ10 MO;Q6EM%;0((X8D$:(.BJ!@#\JYV3PO<'QI=ZS'>0_8K^SCM;NUDA+,P
M0MC:VX  AB#D'V]NFHH X6V\!WL7A5O"$VHQ2Z#OPKF,BX\C?O\ *)SM_P!G
M?Z=L\UV-[86U_IMQI]Q&&M;B%H)$'&48;2/R-6:* .(M_!-^_ARR\,:EJ$%U
MH]G)$0XB(FFBC8-'&W.!@JH+#J!T&<U=3P[JVG^)=:U33+ZT":N(C(MQ"Q:!
MXTV!EPV&&.<''/>NJHH XN?P&;6R\-0Z)>I;R:'.TJ/=1&43;U99"P!7YB6+
M<'K5'4_A_JU];>*+&/7(!9ZXWFEI;4M,C[57;NW ;/E'&. 3C'6O0J* .4F\
M,ZG/XC\.ZM+?VKG289HI%$#+YQE502/F.T#:,#GW-4/^$(U(^'?%6E-J%KG7
MKF:X\P0M^X\U0I&,_-@*.>*[JB@"IIEM-9Z5:VLSH\L,2QLR A6P,9 /3I7.
M:9X8U33Y?$DC7EG(=9F:90(F'DDH$P>?F& /2NNK#OO%VCZ==K;W$\@S<K:-
M,D+M%',P&U&<# )R.O3(SB@#(3P&+GX:0^$-1O Q@B2.*[@0J59""CX)/((&
M1GG\:NIX?U'4-1TJ^URYM)I-*WO"MO&RK+,R[?,;)XP"<*,\G.>!7344 <$?
M FI/X.\1:"VHVN[6+N>Y\X0MB(2MN8;=W..QR*T[KPUJ-WX@\-:HUW:K_8Z2
MJ\8C8^=YB!"0<_+@#/>NJHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_$M[?6&F1S6+VL
M6;B-+BXN7"K!"6^=QD@%@.@]3WZ5L5S_ (L\.W'B&UT_['?K9W5A>QWL3R1>
M;&S)D;77(R.?4<@4 <TOC'6!I7C?R989)M C\^VGN;1D,J&#S<.F5YX(R, \
M'%36OB+Q#!K'A(WUS9RV>O0LKPQ0%6A<0^8&#[OFS@@C %32>!-1E?Q4SZ]&
MW_"0VRPRYLO]6PB\HD8?ICH.HXR3WMR>#[V27PK)_:EN#H(_Y]3^_P#W?E_W
M_E^4^_- %.R\4ZE9W'BK3]:FB:^TP":S$,.WSX'7]V0"3N8OE".F<#O78Z>M
MXFG6ZZA)')>",><T2[5+]\#TS7%NFA>-?'.E:EI=V+K^RDE%W) 3L.&4QQ/Z
MD2+O [;,]Q7>T <%X;\77&O:K'9OJ,5KJ44LJW^D7$&R6%0&V&,GEQG82>00
M<_+TJE<>--<B^&NOZZLEK]OTN_GMT_<G9(D<H097=U(YX-;<?@^ZN;_0[K5[
MZVNKC1Y"\5U%;F.:;Y"H5V+'CYLG'WB!TK+OOASJ-UHVOZ'#KL4.E:I=272+
M]DW2Q-(X=E+;L%00<# /3GU -R35[_5O$NI:)IES':'3K6*669HP[-)+N**
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MS'Y94H'!^[CG=USTSQ(G@*YDB\617FL^<OB&,*Y6V"F%O*$>X?-R/;TQR>M
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M*O\ OWZ -E<<'OP?QH 72/%^O:AX=?[4+"TO[#5VTW4[DMMC1$Y,D:L>6;*
M#GENG:J\GC76D\)>,;N"2!KK0IV6":XM60RQ[%<;DRN&^8C/3@<5IW'@"9;6
MPDL-56+4[?5'U26>:WWQ3S."&S&&&!@X7#9  YSS44_P^U">Q\4VK:\A37R&
M<M9C,3%%5CPXS]W@<8[[NM $L6N>(+3Q;X?LKZYLYK36[:9ECB@*M;/&BN#N
M+'>""0>!]!4=AXIU:&T\466J2P-K6F3!+9(H=JS)( +=@"3G>QVGG@\5IW'A
M:]GUOPWJ;ZE;C^Q8Y4*"U/[[S$"$YW_+P..M9=LFA>,O'FG^(-(NA=1:=;.E
MS-"3Y<CEAY2-ZE3O?V^4]Q0!V:RO9:7YU_,KO#%OGE1-JG RQ [#KQ7EWB[4
M=5\0?"N#7GN(HK6]N;6468BSLB-PFSY\YW_=)/3D@#O7K$T,=Q!)!*H:.12C
MJ>X(P17G;_#C6/\ A$G\*Q^(X?[)CFCDM&DLBT\:K*) C-O 8#'' /X<4 :>
MI^(=6O=3UO3]$61)=+"1JRVXE$LS1B3#9887#*..>O/%1IXHUF\N=/TF:QFT
M_4WTX7MZD4:S-$2Y0*H)Q@E6.3GC [Y$E]X.UF+Q--KF@>($T^:^CC34(9;0
M313,@VK(HW#:P''4TNL>"KZ6_P!-U?1-=DLM8LX&MY+B>$3+=1L=Q$BY'\66
M&,8SP.F #+NO$_C"QT71)+ZSM+2]N-;CTZ998SB:)F.V5<,=F0.0<GKTJY;Z
MCXJE\7ZIX9;4]/W):17L-Z+(YC5F92GE[\'E>"3P/7/%W4_"&HZG8Z5'-K:O
M=6>I1:C-/):Y$KIT55#@(N.._3N<DVXO#E[%XUN_$0U" B>R2S%O]F/RA69@
MV[?SRQXQTH YF'Q]?#P)HVM:BOV>.:[DMM2O+: R+;JC2)Y@7G 9D7D@@;CQ
MTKL_#E[)J.D+=/?VM_')(YAN;7&QX\_+T)YQP?<'I6)H?A'5_#^C6=A:ZS;2
MBWN)Y9!):,$G25F8H1OXP6R#[=.M:OA;PW#X9L;N"$Q_Z5=R7;I$FR.-GQ\J
M+DX4 #\<GC.* ,-]5\3:AXTU[0;.^T^UBM+:">"9K5G9=^_@C?@GY>O X^[S
MQ5TOQW>ZMH'A8B#9J&LQ2R2M!'OV"+ARBD]22N,DX!/7%;UOX<O;7Q=JVO)J
M$!^WV\4"P-;']WY>[:=V_G[QSP*P(_AK=VOAC0[*SU[[/J^AR2/9:@EMP5<G
M<CQECD$'!Y["@"1?%7B/3;5K75;%4N;G58K#3;N5 BS))D[W16."H5L@$9.,
M8S6AJ>L:YX5M-<U#4_L]]IEM;I+9RC$<K2D[3&X'&,E?F]#WIFI^";S7O#K6
MNK:X[ZL)X[F"^MX1&MM+&24*1Y/ RV<G)W'D<8G'A2^U;0[ZP\4ZL-1:[MS;
MYMH! D:GG<!DY?(!R>.!@#G(!#;ZEXJA\16L36,E[ID\$AN)'@6 V\JC*[?F
M.58_+@Y(X.:J^$?%T_B&:+;J$37D4#G4=)FA\F>WFXP%!YV Y&3GJ.>U7=$\
M->(K.%8-7\4'4(;>-DMMEJ(G)*E0TC!B6(!Z<<\G)Q0GA"ZN=9TW5M3O;:2_
MT^WEA2ZM[<Q/.73;E_F/ &3M'<YR.E %+P?XNF\1W,"_VE"+R.)O[2TF:#R9
MK:7 P%!Y* Y&><Y'(Z56MO%NLP:UX<M[V>VEDU*YEMKVV@CW16SA69524<%A
MMPP))]A6J/!EQ>:IIFHZM?02WFGV\L"W5K 899]Z;,N=QQ@$G']XYXZ5F6?P
M\U:VLO#ML_B*$KH5QOMRE@%WQ[67#9<Y?#?>Z>H- $NE:GXMUO7M:M(M0TRW
MM]+U)8&/V1B98C&K$#+_ "D;NO.3Z <IIOBG69-!UNUO9;8>)+&^^Q)&D.(V
M9R/(?;DG8P8$\] WI6UH>@S^']2U[4KK48)H=1G^ULJP&/R2$"_>+G(PH["L
MC2H-%\4^/D\4Z1<?:;:VLQ%)+$3Y4LQ+!/JR(S@^GF+Z4 =L$F^R[#,#/LQY
MNSC=CKMSZ]J\KT#6[CPMX2\9Z]>3)=Q6FLW@$'E;?,F,JJIW9. 6(&,<?A7K
M#;MIVD!L<$C(S7&6G@$-X=U_0]6OH[NUUBZFNG,4!B:)Y&#<99L[2,B@!=5U
MO6?#&J:#_:%Q!>6>JW2V$VR'88)W!*%,'E"000<GH<U!X9U7Q5KNJ:B9;W38
M[33-9FLY46U8--$JKC!WG:<D'OG)],'1A\+W]V='77-2@O4TF43PF.W,;32J
MI5'DRQY 8G ZGGVJQX7\.W7A^;6&GOXKI=1OY+["6YC,;. "N2QR/E'I0!T-
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !2,P52S$  9)/:EKB/BH]Y%X/5[2]DMLWMM'
M)Y8!\Q6F12#GMSVZ].F: .C?Q!8)XDBT M+]OD@:X53$P0HI )W$8/)'0FM2
MO/-7M]0/Q4T."WOE6Z.CW0-U)"&('F1\A!@9_3OST++#QKJJ>'S#=%+G51KT
MFB)/'&%$A4D^9L) SL!XR!G% 'H<4,4((BC2,,Q8A5 R3U/UK.U+Q!8:3J&G
M6-TTHGU";R;?;$Q4M@G!;&!P#U.:S- G\2C7[ZUU.VF?2?*62TN[CR5E#YPT
M;+&<$=P<#N#FJ'CO_D/>"?\ L-#_ -$R4 =M17G'C#Q5K6@VFNWZ7L(ET^6)
MK:RAB$J/"=F3.V,H6RV/F7H,9K:O]6U*P^(%CIMQ>;-)U2SE^S$1KNCN4P2"
MQ'39EAGN#U% '6UF:KKMII+B*1)[BX,3SBWMH_,D,:XW-CT&0/<G S7&^&O%
M>J:WX>D@>_QK8U06@80*J^6?W@D"$=#!E^>XI[6MZWQM95U.50-!#C]TAPOV
M@_)T]NO6@#N-,U&UU?3+;4;*3S+6YC$D3E2N5/L>156;Q!80>(K70I&E%]<Q
M/+&OE-L*KC)W8QW' -<3-XLUN/X?^+-5%VGVW1M1NK>"3R5PZ1,  PZ<@\XQ
M6AJ;F7XI>#I&^\VG7I/U(BH ['4;Z+3-.N;Z9)7BMXVD988R[D 9X4<DU+!,
MMQ;QS(&"R(' =2I (SR#R#[5B^--1OM'\&:MJ>FR11W5I;/.AECWCY03C&1_
MGL:P=:\7RZ2-#DU.ZGT_3+RS#RZE%;B15N#MVH^5(12"QZ<^HP: .\HK@-6\
M6SZ,FA_VMJ1M].NK/=+K%G LL+7'R[03A@J$%B#WXY&#5H:YJMOXE\&V+W]O
M=0ZK:3M=/$BE'>.)&#QL.Q+$]^,4 =K17!6_B+79;#Q<D5U9FXTO4!;V\]WB
M-$BVQLS.1@$@,Q[9P*73?$FIS:]X@TF&\,\=K817EI<WEIL8%MX(90$W+E<@
MX'XT =Y17E]AXI\3#0_!FO7=_:RPZO=06EQ:+;!>)0WSA\YW @'  ';G&3N+
MJFN^(X=?FT&\AM9M-O7LK6&5 R321A=YE)!(!)(&W& ,Y.> #M**XV[UO5]0
MUN^T:R$\$]A:PO-):)%)^^D#$#]Z1\@"]ADYZKCG<\,W.LW?AVSF\06266JE
M2+B&-PRA@2,@@D8( .,\9Q0!K54U#4K;3+=9KERH>18HU49:1V.%51W)_P#K
M]!7(0:[K/B'2-=U;2+Q+;^S[F>"TMVB5TG\GJ92?F^8@XVE<#'6L77M5G\4Z
M=\/=:MKE[2.^U.!O)"*WER>7+DY(YQR/3O0!Z#HNNV>NQ7+6RSQR6LYMYX9X
MBCQR  X(/7@@Y&0<UIU _GPV#;"LURD7RE_E#N!WQTR:X/3/%&JCQ+X:L)[^
M.\&JP3_:]D \B*:- _[F0 ;U!RIY;ZYH ]#HKRJX\3>+?^$7\5:PFIV2-H6I
M7$21BSXG2+;\IRWR@@GIDY/6NCO-=U*P\9:#]HN0NA:Q$8T7RUS%=;0RH7_N
ML-V.^1UQQ0!UTT$-S$8IXHY8SU610P/X&ECBCAC6.)%1%X"J, ?A63X>NKK4
M(KR]FG,EK+<N+-=@&(E.T'('.XAB#_=*^Y/,^)?%L^F^([O2KG43HI>!#I5S
M- IMKF0@[@[D'!!P,97CGG.* ._HKE8=6U!_B/?Z"USFR&E1WD1"+OC=I&0X
M..1A<C(-8>A^--3U'0?#D,TL0U/6+^ZMC<",!8XX6DRP7INVH .V3GG&" =I
MKNN6/AS1Y]5U%I5M8!EVCB:0C\%!Q]3Q5R-89BEVL:[V0 2%1NVGG&?2O/\
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M,!BM_)-M+&N\KU.Y2.YY_K2M?%6LP:SX:ANKV*Y?4KF6VOH88@;>%@C,!%*
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MT=;9;=$7J?D4G)) R2>PP!SF/Q%X=GUS4-&NHKY+8:9=BZ5&@,GF-M*X)W#
MPQKH** .!U+X<7-_9>)-/3Q#)#I^MSFZ:+[*K/%*=N?G+?,GRCY< \=?7<U_
MPG%XDT>QLK^[D:6UN([C[0BA68J<. !T#*67VSWQ714C,J(SNP55&22< "@#
M"@\*6=MXSN?$D;%9I[1+=H0,)E2?G_WMN%]@/>H_^$<NO^$Z/B4:C%M-D+'[
M-]F/^KW[\[M_WL^V/:NBI RL6"L"5.& /0XSS^!% '!WWPZN[JQ\1:7#KY@T
MO69Y+EH?L@9XY),%OGW<KD9Q@'W]=9_"UT_B/1-7;5%8Z7;R6_EM;<RAPH8D
MAA@_*,<<>]=/10!E>)='?Q!X<O\ 2$N1;"\A:!I3'OVJPP<#(YQ[U2&@:G'#
M;0IJEK) EDMI/!<61>*;'1MOF#!P<$9(/Y8Z*FNZQHSNP5%!+,3@ >M '*Z=
MX.N-%TRTTS3M2A:PBL_LLMM>VOG)*=S-NP'7'WB,<C''IBK_ ,*_-E9>&DT;
M53:76@B1(99X/.619!B0,NY<9ZC!XK9T_P 66.HZE;6<5O>(+RW-S:7#PXBN
M(QCE6!.."#AL'!%;M ' S_#>:>PUN!O$$WF:E?17Z2FW4^5*FP@D9PX^0<<"
MKT7@[44U^]UF37_,N+RP6TE0V:A,@MA@ V0HW'Y<YS_%CBNPJIJ>HP:3IESJ
M%R)/(MXS))Y<9=MH&3@#F@#DU\!7*>&O#NC+K$6W1+N&YCE-F<RF+.U2/,XZ
MG/\ 2GGP1J%GXAO]0T3Q)+IMGJ<@FO;06JR9DQAGC9C\A/?AN?PQU.EZA!J^
MDV>I6V\07<"3Q[QAMKJ&&1ZX-6@RL6"L"5.& /0]>?S% ''ZKX(NVUZ'6O#N
MNR:/>"V6UN UN+B.>-?N[E8CYAG[V:Z?3K,V%C';M<27$BY+S2XW2,3DL<<#
M))X' Z#BK5!( ))P!U)H Y*'P;<Z=-K,>DZLMKI^K2O/- ]MYC0RN,.T3;@%
MSUP0P!Y]J=J/@H3V_AVTTV\CLK30YXYX8FMS(7**5 )W#C#'/?/-:M]XCL+#
M6M+TF;SC<ZF7%NR1DH=JECENG0=.O2M:@"IJ5@NJ:/=Z=-(R+=6[P/)%P0&4
MJ2/0\\5R-GX"U&"?PW//XD,LFA*\4.RQ1%>)HPF"-QPV /FR1QT%=S63K_B/
M3?#%B+W59)8K8N$\Q('D 8G !V@XR>* .?/@*Y;PYXCT=M8B*ZY=37,DHM#F
M(RXW*!YG/08S^M5?%+:7JNEQ^!GOO.U[%NT8MXV1X2&!$X/(4* 6//MW%=/8
M>*=(U#5#I<<\L.H"/S1;75O)!(R?WE#J-P]QFMC:N_?M&[&,XYQ0!%:VL-E9
MP6EN@2""-8XT'1548 _(5SVN^%[O7(-6L9]2@;3-24*T$UIYC0?(%+1MO !X
MR,@X//UZ>JE_?QV&G75Z8YIUMD9VBMT\R1L#.%4=3[4 8%QX0N(_$MKK&DZL
M;(I8+I\\;VXF,D2L64J21M<9/)##VK)3X9&/PM9Z7'KL\=]I]Z][8WZ0KF!V
M9F(*Y^93N.03S7>02BXMXI@CH)$#A9%VL,C.".Q]JK:KJ2:39?:I+>ZN%\Q(
M]EK"9'^9@N<#L,Y)]* .=O\ P?J.K^%=2TK4M?\ M%YJ$8AEN_L@54C&?E2,
M,,=3R22<^@ %F?PO=W/B#P_JTFI0[M(BEC\M;4@3>8JJQSO^7A1CK^-=-10!
MGZM97EY%!]@OQ9SPS"7>T7F*X (*LNX9!SZURVH_#H:AI&O6BW\-M/K=Q%-<
MR0VF$7R]I 5-_!)7)))SDUW-% ',WGA:YO\ Q3::U-J4:^1926;0QVY4LLF"
MS!M_RG*C'!Q[UBVGPYO[:QT"U;Q,S+H=QYEJ5L47,>UEVMR<MAOO=/\ 9-=^
M&5BP5@2IPP!Z'KS^8I: .>T+PW/I&K:W>S7T=RFJSB=XA;E/+8*%P#N.1@#M
M63H?@/4-"D^P6WB:X;PXLADCTUK==Z*3N\OSLYV9[8SCC-=O10!R=]X/N-6\
MJ#4]2AN;2'4?M\'^BXGBQ)YBQB3>0 /NYVYV\>XW]6L[F^TV2WM+PV=P61DG
M";]I5@WW<C(.,$9Z&GZC?PZ7IUQ?W(D,-O&9'\N,NV ,G ')INE:E!K.D6>I
MVN_[/=PI/'O&&VL 1D>N#0!S5YX'>_?7;F6]MXK[5]/_ +/EE@M"J"/Y@6*[
MR6<[NI/  &/61_!UT[^%W.JQ Z"/E_T0_OOW?E\_/Q\OUY_*NEOKV+3K*:[G
M$GDPJ7<QH7( &2<#DU@6?Q \.7B6,BW<\,-^P2TFN+26&*9CT"NRA<GL,\T
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MXMGU\ZK'+)-8I9F-[7'"DL&R''.6.1@<>G6LNU71OA[X5M_#^O:I'<Q733K
MGV5@T^]F=TV@MDY<@=,Y KN:0JK$%E!*G()'2@#G_!&@#PUX1L-.(?S@@>7S
M'W,&/\)/?:,*/912^+?#D_B;3K>SBOTLUBNHKDL8/,+&-@RC[PP,CFN@HH Y
MVX\.7=QXQT_Q VHP@VEL]L8!:G#JY!8[M_!RHQP?QJ,^%[FR\3W^MZ-J,5H^
MHQHMY!/;F:-W0861<.I5L<'J#72JRNBNC!E89!!R"*R])\0V.M7NI6MH)Q)I
MTPAG\V(I\Q7=P#SC!':@#"F\!*NGZ%96.H"!-*OQJ!:6#S&N)OFW%B&7&2['
M@>F.E:%MX<N[7Q;J>O)J,):^MXX/):U.$$>[:<[^?O'/3/M715E>(?$-CX9T
MS^T-0$_D>8D>8HB_+,%&>PY(Y)% %?P?X>?PKX:MM&:\%VMN7V2^5Y9(9BW(
MW'NQJ.V\.7-KXPU/7UU"(_;;>.#R#;'Y F[:=V_GECG@9]JZ&B@#@H?AU=6_
MAK2],AUT)<Z9J)U"VN?LF5+%G8JZ;_F'[QNA&.*L?\( \S>)Q>:W//%K\*I,
MJP(AC81A-P/?@<#''<GK7:T4 <U:^%[F6323K.H0WJ:40]M'#;&$&0*45WR[
M9(4G&,#))],0VOA"ZMD\3#^U(F;7':0G[*1Y)*!./G^8;0/3G\JZNB@#C)?
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M)Z4 9UCJ/B+Q3H,FMZ'J$%O+]M>.WLYT7R6ACE*,)&VE]S!6;Y2,9 ]24O\
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M\D^U:O,+BYO%0 ^8I4IM7LJ[% 7)X'7)S0!T]O#)#:B*2ZEGD (,TBJ&/X*
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MN&WGG!ST%=;;>%]3_LN\@U/Q%+J-Y/;-:I<26R1K$C?>PBD98\<DGH/<&L?
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M_DX"JI+*0V[KECGBL%?AQ(G@P>&$UV4V4<Z20E[=2T:K+YJKP1D[NI/4#H*
M'#7M5T+QM?:?JNHB_L!HLFJ "W6,PF-PK*N.2I!_B)/'6J%]XGUVP^'EEXZ^
MV"5&6&ZN=-\M/*\B1@-J-C>'4,.2Q!(/'.!TTOA=[GQ:FO7%Y')_Q+VT^2V^
MS_(\;,&8YW'DD?EQ[U0M? 0@T-/#DVIM<>'XY5=+5X?WNQ7WK$TF[E 0/X0<
M<9H ?INK:C>>-?$VD/>O]EM;6VFMF$:!XC('+<[>?NC&0:X^35M7\0>%_AWJ
M5QJL\,]]J:)<"!$57.)"&P5/(V# Z>V<8[FZ\*3MXKN-;L=7ELQ>6Z6]Y L*
MOYH0G:58_<.&(Z'\#S6;;_#K[+X5T/1XM:N!-HUVMU;71A0\C<-I7TPYZDGW
MH [,I*+7RTF_>A,"5U!YQU(&!^6*\PB\7>))?AEX?UI+Z 7]UJB6UP[6XPZM
M<M'@#HHP .F??/->GB.1+81I+NE";1)(N<G'4@8S^&*XN+X>21>$=.\/+K'[
MJQO5O$F-M\S,)#(%(W8QN)_#'UH ;'?Z[!XOUCP[=ZR\Z/I"ZA;W,=O'&]NQ
M=D*J,$$< C=D^YK'\+:U?Z9\//",27-U=7>LNL2DB(M$-CR.5W;06.W WD\G
M/.,'LO\ A&9&\8R>();Y6,FGC3WMU@P-@8OD'=G.2?P_.L9?AK&?!]KH$FMW
MA;3Y5FTZ\1%22U9"=I&/O'#$'/4>E %34]3\9Z/H'BJZE+);VEK]ITZ[NT@:
M7(4ET=8SMZC@XZ=<U-+J_B#2K/3);O4A?3:[-;P6\,-K&AM,Q,\A5F8!R0N!
MNQ@\X(XK1F\':A?^&]1TW5?$4U]=W\!MGNWMD01Q'J$C4@ G/)).>/0 3ZQX
M.CUSPK9Z/=7TL=S9-');7UNNQXI8QA7 R><=?J>G8 RI+[QMIUIX@?[#<7D$
M4*2Z<\P@^T%NDB%8CM8@9*\#.,'-9=_XB_MWP%XLO-)\374JVVGEA&\2175K
M*JR%T<;!@'"C.,\-@]ZZBW\,:J-,F2^\37-WJ;[!'>_9TC$(5P^%C7CDKSDG
M/'88IL_@F'4)-:N-1N4>ZU:P_L^:2VA\E1'AOFP6;+?-U)Z #'J :?A:&2#P
MQIJRW,MP3;1L&D"@@;!Q\H P/SK7K.T+39](T>WL;B^>]>% GG-&J9     Z
M<#WYS6C0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !37D2*-I)'5$499F. !3J
MX?XK"?\ X0Y&@O+BW_T^U5A"5&\-,@P<@\<YQ^>1Q0!T,GB*SC\50^'6CN/M
MDULURK^7B/8I /S9Y/S#H#6O7GFKV=V_Q4T.UAU*:.8Z/=!KMHT:3'F1\@;0
MF?\ @)'M5:P\8:O!X?-K<SO=Z@/$4FB)=+'&KNJL2'VG";]H(';.#@]" >F4
M5P%Y<^,-,LO$MP\\R6$.G/=6-Q=B!IXID4ED(C^5E.,@GD<CTJM'K'B#3/#>
MC:K=ZP][+KGV*VB@6VB3[/)(NYW4G 8D9P&XW<]/EH ]'P,YP,TM>>:CKOB7
MPG:Z_JU]%-<Z/;V/G6OVUH?.6XR%V'RN"AR#D\C!%3ZQJNL^&/\ A'-1DU.3
M4+>_O(;*]@DBC"@RCB2,JH(PW8DY!]>: .\HKRZ?4_%%Q8>.9H_$3P'0YY&M
M?+M8OF"0K($;*GY?U]^U>A:)?/J>@:=?RJ%DNK6*9@O0%E!./SH OT444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "8&<X&:6B
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0@'J :6B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&)(8]R[]R@QERI4-M)XR&JAX>U/PIXJN=(ELDOIM>L 2MO/+/G3WV[7WACM
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M)(&>3CC-8WC#2M*T#X8^)8+"VAM4GLIRV/O2RLA&23RS$XZY-8YUZP@U3PG
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MZ'O0!P'@SQYI\6B6]OXC\00G4YKVXB0W#!68"9U7. %7@8'0<<5VFIZYIND
MF]N?+PAD8*C.50=7(4$A?]H\5Y59_8+CX3:_X=D2*369[J\CCT\@>>9GE8Q-
MLZ_W6W= !G.!5Q[ZS\*^,+RU\87=W;V][86B6MZDLJQ2F.,K)&2AZ[B6 /\
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445!>7MMI]H]U=S)#
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M>X;&Z[A<\ESM!Y 'IU.:T8+V^7XNW.G-?326)T5+E;=L;$<S%21@#L.^3UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*XKXDQ7BZ?HNHV\,L]MINKV]Y>Q1*68PJ3E@!R=I(;'MGM7:T4 <*5BU[XGZ
M-K&CSQSVEGITZ7=S"VY'WE?+CW#@G.YL=L<]17$"YB_X4%'I4B2+>6UW'%-
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M)'))Z#J<U;N(K6ZT?PG+;>('T+6+?21]FO3M,+#;&'AE#<'D#@X/!]*]2HH
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M=6*P(D,RMNWJHP#GUXY]Z\R6ZCM_!_Q,TR82)>/>:C*D;1L-RR(!&0<8.[/
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MK+5H;:2RNG!\O]TA5HBW0-D[@.^30!T$_C/P[;6%A?2ZK +34'"6TPR5<GW
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MTRZ\:I#'JMZ+\:<9/[-8.D7EEU_>LI48?)"\G.,C'6II?%VB02*LMXRQ-/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0!U5%<I:_$?PQ=V[7,=](+5;5KLW#VTBQ^6K!3\Q7!;)'R]>1Q6K8>(M/O\
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M6LVG@>-;@ 9.PL,$XYQP2.0,4 ;=%<U'X\T";4CI\4]R]RMV+)U6TE_=RD9
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MDE:2Q:1[>!YBPN$C9?F(&"#@X)S@XQ4L-M<7&H?$6WM;'59/[2TJ+[))<P2
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MW:23GTR:R]/C@CTGQMI&LZ3J4L,^LSSND5O)\T$CQA71@/F(Y8!<GY:]2HH
MX;P2NK6>M:AI\FI3:QHT=O$UKJ%S'B96);,+/@>9@<Y[;L'K2Z^MSI/Q+T?Q
M!-%-+I+6$MA-)&A<6SLX<.P'(5MH7/08YQ7<44 >0^)-+N9])^(VK6UM<M!K
M$5O!9Q+"Q>=HX\,X3&<$G ..=N>F#7JFF2I-I=K)&&"F)<!E*D<="#R*M44
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ JGJ.IV^F0Q//N+32K##&@RTCG.%'
MOP3SP ":N5S/C>RL=1TFUM-1MK^2"2[7%Q8!S+:.%8K,-@)&" ,XP-W- $US
MXPTVRLGN[N.[@CCNULY=\!S'*VW:"!V.]>1D<]:NC7;(^(FT(F1;Y;;[6%9#
MM:+<%W!NG4XQUKS?4K+Q)<?#[5[>Z^U:LMEJ=O+9W!MREQ=6Z/&S$I@%B,,,
MX^;;]*OW1N/$/Q!EN+2QU&"TO/#<UE%=S6CQJLC29&<@%>A^\ >..,$@'6+X
MSTAKJPB+S+#J,IAL[IHR(9W'\*M[X."0 W8FDU'QIH^EK--<O-]CMYQ;7%XD
M9,,,A(&UF^I ) (!.#BN>\%:W>-HVD>';WPWJ$.J::D=O,T]L1;QB,;?,64\
M'*CC;DY/IDU4\,:A?^'X+_PGJ/A_4+N[%[/):3+;%[>Y220R*[2?=7!;G/3'
M<\4 =IJOB:QTG[29([F<6D8ENC;1&3R$(SEOP!.!DXYQB@^)].D6 V?FWWGV
MPNU%JF\^2>C]N#V Y.#@<&N(N\:%XVUU-<\.7VJ6.K21SVEU:6K3C/E+&T3@
M?=^[QGC!J76]$MGFLOLL.H^&]4L]/#6=UIT#21*"S$V[JJE6QA3M[EN* .R/
MB6R9+8V\5S<O<6HO%BACRZPG&&()'KC'4\X!P:<WB2P\C3WA$T\VH0^?;6\:
M?O'3 )8@X"@!ADD@9('4BN&O[&[U6VTBZU/^T]"\30:6CIJ&GP.\>\D[H'50
M5(R%.P^O'N^P_M[3O%/A[Q+KMA*([G1/[/O5MH2_V2;>) S(H)"MC!P, ]<4
M =1/X\T&V\/W.M2SSBVM)C!<K]G<R0R@@;'7'RG)')P.1SS4L'C'3;J1HH(;
MYI_/-O%$ULT;3$)OW)OP"NWG=D#IZC/GWB?1+Z?P_P"/M2MK"]==;N+06=JE
MLYD<1; S[ ,KN(8\@<*#W%=CXRM-/UJ#2TNH]5@!=I;?4;&.19;*0+P3A<J"
M"0=PQZ^H .DTS48=5L_M4"2HOF/&5F0HRLC%6!!]U-8T>IZ0OC3446?46U&W
ML4:>#9*8A'N.&1,89B<\J#TI? [:T?#[)KCF:>.YECAN6A\E[B$-\DC)_"3S
M^A[UF0F6'XN:G>O:7@M/[&BA$XM9"C.LCL5#!<$X(Z4 6[3XC>'[V/3)H7NS
M:ZC*((+DVKB+S"2%1GQ@$D<#\\5U$\J06\DL@<HBDGRT9FQ[!023]*\>M;._
MB^#WA6P?2]1%Y;:G;R30?8I=\:I<%V)&W(&WG->PO,L<!F(<J%W85"6Q_N@9
MS[8H Y#2O%GAO1?!^BW45[?R:;>S?9[6XN5DE=V9R/G<CCG/WB.![5HVWC/3
M;LZI'%!?BZTZ(32VLMJT<KH<[616QD'!],=\5YY8V=_#\+/!5E)I>I+=6FLV
M\MQ#]BEWQ(DS,S,-N0 "#FNI,-Q/\4=8F2TNQ!/H4=O'.UNZQM('<E=Y&,X8
M=Z -3P[XQBU7PG8ZS=P36[W87RXA&29&;)54_O<=_8DX -++X]T2VL=5N;IK
MJW?2BHO;=[=C+%N&5)"Y^4CHP./>N"@MM33X>>$+E=!U"Y?P_,HO]/DMV221
M3&\;F-3@N5W C'!SP>#C2UV.SU;P'XDN=$\+WMK+>6?D*SV+)<7+]EV8+;5]
M3QSQTH [*U\9:5=K.T:W@$3QQIOM77[0T@)7RLCY\@'D<8&>G-+#XRTB2/4?
M->:VGTUD2ZMIXR)4+XV8 SNW9 !!(.:YWQA!>3:!X:UBSTNYU"+3+A)KFP$3
M+*\1B:-L(<$LN[(%,DBT+5_#^J7:>$+Z.QNEA@N"UH\5U./,4951\Y$8^;/J
M..E &[K/C*'2=$UB^.G7IN-,@$TEN\>"0P;:=P)!7Y3D@G&#WXK7T34&U31[
M6[>*2)Y(U9ED0IR0"2 >W->='3-??PMXQT6*ZO=9TXZ:5TZXNX2MPSE7S#D@
M&3''..K8]<=_X9NOM?ARP?[-<V^V!$*7,)B?(4 _*W(YR.1V],&@""_\6:;I
M_P!M9EN9H; XO9K>$NEOP&^;')P""0H) .3BHM1\;Z)IMQ9022W$TE] T]J+
M:W>43HJ[OD*C#'!' R>1VKF]"-SX<'BO2-5L+R=[J_N+RTDBMGE6[CF&0H90
M0&!X(.,<'IS6?H^AW_A_5OAS8W-M=3-IME=QW<T4#R1PO(J;5+@$=01U[4 >
ME6FIVUWI$6J O%;20B?,Z&-D7&?F!Y&!5&VUNTUB6.R6&^A^UVS7$,C*8Q)$
M"HW*P.5/SKP<-STJ_JA"Z1>DVQN@(')MP,F7Y3\OX]/QK@?"UI=Z%K]M%I-S
MJEQX9>TD>6TU"VD\S3V&W:B,R[CGD;.<;<^E $?P\\:VEMX)\.0:K/?2W%X[
M0?;)(G>,S-(^U7E/&X_7ZXKK-3\9Z3I4E^)S.\>G;/MTL419;;>,KN[G@@G:
M#@'G%>=VMG?Q?![PO8/I>I"]MM4@DF@^Q2[XU6X+LQ&W.-O.:L^,'U/5[/QK
MITFD:IYQB_T".TM76*X3RQ^\>0 ;WZC8QX  "DYH Z?79I4^)W@WR;J<07,5
M[YD2S-Y;[8E*G;G&1N/..]+X0DF_X33QK;/<W$T4%W;B)9I6D\L-"&(7<3@9
M)XJC=M/<^,O 5VNGZ@L,%O="=FM),0[XE5-Y ^7)!X/([XJ[X229/'/C.62U
MNHHKFY@>"26W=$E5851BK$ '!!% $'C#4?[(^('@^X>YO%MY/M@F@A9W64K#
M\@$2YW-D\8&>:V]*\:Z)JVGWUY%/+ +!]EW#<PM'+"W8,A&<GMC.>@YK,\71
MS6_C3PAJYMKB2QLI+M;F6"%I?*\R+:I(4$X)[XP.]<YXA\-ZKK+^*M>TRR<F
M=K$VMK*IC:\^S.'8E3@@'[JYY.WT(H [ZQ\36-[K4FCLEQ:Z@L(N%@N8]ADB
MSC>IY!&>#W'<5;U#58-/DMX7626XN6*PP1 %WP,MU(  '<D=NY%<QX6NM+UG
M4HK^R\*7>G3PQ%9;F_M#"\>?^6:$\MSUQQQZD5/XWTZQU1]-@O%U.W=6DDM]
M3TX/OLY  !DJ#A6!(YXX_$ &@?%VF(FG/*MU$NH7;64'F0,/WRLRE&'\)RC=
M>.*H^(M<M;[1_%.EVT]U!J&FV#3.4+1,FY'*,KCK]WL?K7*WR^(3X5\.7VKV
M]Q>OI?B%9I98+1A++:KYBB8Q 9!.X$@#.#FK CO=4\2>.9(-*U!(]2T:**T>
M:W:,2,(Y1CGH?F'!P>>0* -'PGX[TI=)\,Z5>2WB75W901Q7,]NXAGF\M<JL
MI&&;/OUXSFMC3=3T7_A)/$CQ7EV+FU2!K];HNL, "-M*!L  J"21P>#FN5%G
M-XA\&>$=!AL[N*[L9;*2[:>V>(6OD ;^6 !8D;0!G.[/3)IFH:5=:WKWQ0TR
MR(%S<V-E'%DX!;R9, GWZ?C0!VUOXLTZ;5[73)%N;:XO(VEM/M$)1;A5&6VD
M]P#G:<'':HI/&FCQ36H=YA;7=U]C@O/+/DR39(V!OJ",XVDCK7-^'KBR\026
MB'P?>:=JUNK":XN[0HMHQ4AC&Y^\2< ;>QR<8J+P/JE]8:%I_A+4/#E^-5TY
MA 9'MB;4JK<3"4_+C'/')/ H Z/0O%AUGQ-K6E_8;F&/3Y4A5WCQN)3<23VS
MD8'^.*=XI\5'P]>Z-:)93SMJ-XL!=$W!!@L?JQ"G ^I^N=X;6YL?B%XMAGL;
MM4O;B">"X\EO)9! JD[_ +N0PQC.?;&2'^/HKA;KPM?Q6ES<PV6KI+<"VA:5
MT0QNN[:H)(R1T'>@#;N_$EI:S2P)!=W,\$*SSPV\)=H4;."P]3@X498XZ5=T
MS4[+6=-M]1T^X2XM+A=\<J=&']#VQVKC-(EN?#OCGQ'/J=I>?8]7\B[M+B.W
M>7!6,(T3; =K# P.XZ5I_#S1;G0O"H@NXS#)/<SW0@/6%9)"RI]0",CU)H F
M\1Z_:1V&K64?VV2:VMB]Q)9!LVV5)4EE((..<+DXYQ@USWA[5+!_"/@(:O>Z
MC]NN1"UNT;28FEV'B1AP1C)PQYQ4.GSWGAW4_&6E:CIVH2MJ5W->V-S!:O+'
M,KQA0FY00I7:!\V!6?:07J^%/AK"^EZBLMC>0M=(;.0F%5B=2S87@98=: /0
MY_$UE!<2QB*YECAN4M99HHMR1RN5 4]_XUR<8&>36;?_ !#T*PN=1MF&H37&
MG%?M,4%C*[1@C=N(Q]T#G=TY')KF=9L;N#7;S5O#/]IV>L-?(EQITD#O::@N
MY5\SD;5^7DN",;3]:NZ/JEOIWQ+\>"XBN&#&R9?*MWEW8MQ\OR@\^@[_ )T
M=6OBG29M.T^]M;@W2:E_QYI NYY^"3@=L '.< 8YQ3(/%VD366H7#3/"VG.(
M[N"6,K+"Q^Z"O?=D8(R#G@FO/-$\.:MX/'@O4KFSGDM;1+N*]@@0RM:"X<NI
MVKDD#A6QG&*U;W2(K_5_%>N7>EWESH]_;6ME]G2%UEN K?/*J8W?*&&#C)VG
M'&#0!U=YK]C)I^K1WT6H6:VEL)+G]TV]8W# ,A3.?NMRO3':L:7Q?;:-I_A"
MUTZVO[RUU41K%/(I=_*\HL-Q)RSD ?J3VSE:?;ZQ8Z;XGTX7>HZQHPTW%C/=
M6SFY$C*X\G.T-)C@YQQNQZU"UO>6WAKX;73:;J##3)(4O(DM)&EA/V=D.4 W
M8#<9Q0!V-I?Z5<>.KJ".>_&J)8(98)/,6%8MYPP4_*6R2,C/3%*?&FCJ+:9W
MF6QNIO(@OC$?(>3. -W8$C 8@*>Q-<_<V=WJ/Q*U;9;WEM'=>'1:)<O;N$24
MNYQO VY 8'@UC-97VK_""'P3)IMW!K:)#8NCV[B-/+D7][YF-I3:N[(//0<\
M4 =M=^.-(M-3O]-$=_/?64:R2P06<CN5;."HQR..O3ISDUL:3JMGK>DVVIZ?
M+YMI<QB2)\$9!]CT/M7):8);7XH>(;J6UO?LK:?:QI.;60I(R;]P#;<$_,.G
M6I_A7;W%G\.-)M+NUN+:Y@619(KB%HV4^8QZ,!V(H Q+'Q3;^&O%WC5+^35+
MN""XMV2.*.6Z,$9@#,3UV)DD]AZ=*ZW_ (3/1FN-'BBFEF76%W6,L<1,<F!D
MC=T! YP<&L+3IWT+QSXPEOK&^,=_);RVABM7E6<+ JL%*@C.X8P2/7IS5%/!
M5[8_!ZSTYGCM]8TO=J-J^X;8)P[2A<],88H3TP30!WT6J03:O<Z:BR^?;QI)
M(Q3Y &SM^;UX/'M]*SM7\7Z3HFJ0Z9=M<F\GB:6***UDD,@7&0N!\QY' R?7
M%'A*.YDT4:I?0^3?:HWVR:/.?+W !$_X"@0'W!/>L#Q+>167Q7\*2S+(8_L5
MZI,<;/MSY?)"@G'O0!%XG\4V/B/X6^(K_1KR[MY[**174%[>>"51]UAP1].A
MKJ4UB&RT_3X62>YNYK82+! N^1E &YN> .1R2.2!U-<#K&C7<VA_$;5;:QNR
MNMK'%96RV[F24QQ;"^P#(#,3U'09[U/K'FZ9XAT77KO0[[4M'FTE;&=(+9WE
MM95;<&:/AL')!X[?3(!V5OXPT6[T2+58+AWAEF^S)&(V\TS9QY6S&=V0>.P&
M>G-<[H6K&3XH>)!-+>P6UOIUO(\%Y(VV%MSEB 25 P <J<5FZM9RV,GAOQ)I
M7ANXM],LM2FN+FPAM\3E)8O+\]HASN!R<?>P1G!SB=)$U3QMXFNY=,U)M*O-
M"CA$DEJ\(D \S<H+@;20W&<?ES0!TW_"<Z.KZ=Y@O434U+6$@M'<7(QG*A 6
M''/S <<U/JOB_2]'2XFN?M#6MK(([JZBA+QP,<<,1Z9&< XSSBO/- U73VB\
M*1ZZ=7@31U46WGZ/-"@<IY:>9+RI"@XR H)Y.!Q5FSCBTG5=;T/7_"5]J;7=
M_/<V=Q#:F:&YCE8N%=ONJ020=V * /5D=9$5T8,C#*L#D$>M5K_4;?38HWG+
M%I7$44:+N>1R"0JCN< GV ). ":S+37;>WUZ'PRVGW5O,EHLJ2K 1:G  *(_
M<CTQTK&^(EK>(^A:S;Z;-JEOIEVSW=E NZ1XGC9"RK_$5SG% &A-X^T.VTW5
M+RY:Z@.E.$O8&MV,L)897*J#P1T;.WWJS9>,-*O];CTF/[5'<30F>W::W9([
MA%QN,;$8;&1T['(R*XOQ!#:ZK\/O$UQH?A>\M9+ZV6%"UBR7%TX/]P MM48P
M3ZGL.=74A-<>//!-S%9WQ@@MKM9I1:2!8C)&@4,=ORDE3U].: -RX\::/:R0
MF5YA:2W7V-;P1DPF;)&S=]01NQMR,9J=/%.G2-K"*+CS=(V_;(_*.Y,KN!']
M[Y>>*XSP1J-_I&AVW@[4O#U_)JEC(8DF:V)M9%WDK-YI^4  Y_O9' S3YGN=
M+\5^.89--U"5M6@ADLG@MF>.0+;[&!<#:I!'1B/;.: .GD\<Z'&FC.9;@KK$
M?FV96VD/F+LW]AUQ_#UR1Q58?$/1FM[UU@U-I[%RMS:"RD,T0QNW,N.%P<@G
MK7)Z;#>1VOPO633-11M/1ENP;.3]S_HYC^;Y>/F..:U]/$T7BSQ_</97RPW4
M=O\ 9W-I)B;;!L;9\OS8;CB@!GB77K8>)_ NL6M]=-IMXUPY2%I&6=#;LR?N
MA]YLD8&,Y.*VH/B%H$^D:GJ+/=PKI9Q>V\MI(LT'&063&0"!UZ>]<;I5K>V&
MC?#6\N=.OTBTH2QWP^RR%X"T#("R8W8W$<@8JSXCTJZU"+QQKEM97?E7^DKI
M]I$MN_F7+A6R^S&X#+!02.Q/3!(!UD7CW1949E%X,R0Q0[[5U%R\H)01$C#Y
MP>0<#&<XYJ5O&NCQ:5JE_.;F%-*<QWL30,TD+ !N0N<C!!W#CWK%UN_OK3PG
MX:>VT^[:$S0)>/'9-)<6B!""RQE20V1C."0"<=JYJ6UO%TWXE6L6D:Q_Q,(E
M:S,L$DC39MPH )R22>W4=\=* /0+'QII%_J]IIL?VI);R$S6LDMNZ1SA0"P1
MB,,0#GBB]\::/8$R3O-]D6Y%I)>+&3"DQ.W:6^O!(! /!(.:YNZ6=_$'P[F6
MQOC':QS?:&^R28AW6^P;_E^7YN.:K>$=0U#0M,D\'ZCX?O[C4+>YE^SS_9BU
MM<(TC.LK2?=4 MDYYXXR>* .SU;Q3I^D+=O,ES-'9*'O'MX3(+=2,Y;'MR0,
MD#!(P16M;7,%[:0W5M*LL$R"2.1#D,I&01[$5YE($T/Q;K]GKOAF_P!4M-4N
M?M-G=6MJ;A7#1JC1/C[N-O?C!["NNM-;MM)U'1_#;Z3<V;W%MF(P0YM82%8^
M3O'&X!&XQT'O0!K:MK%GHMHMS>R%5>5(8U5=S22.<*BCN235&'Q9I4D&JR3/
M+:OI1 O8ITP\65W+P,[L@\8SFJ7CN\O[+1[*6QLI;A3?PK<O!;^?+;PY):5$
MP<L,#'!QG..*Y&SMD75_'*7F@:S=:9J$-F56:*5GGC";7P3EMPSD+]X>@QP
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M"-[@_;P?LER;=Q!.0N[:LA&"<<_AZT_5/&&E:0D\US]H-I;2B&YNXXBT4#'
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MBEXGE>UNU@GM;1(;B2W<1R&,/O <C!QN'?FNVH **** "BBB@ HHHH ****
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M-%P>6X4$G SD]*TO^$STU+;69+B*\MY-' :]@:'?)&I7>K#86!!7)R#V.<4
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M6U>-M1>[+K&F(\@J&^Z-HR2  >O- %S7O#AUFZL;VWU2\TZ^LM_DS6^UAAP
MP9'!5@<#MD>M6-,T>6SE^TWNI7&HW80QK-,J($4D$A510!D@9)R>!S52+Q=8
M->V%M<07=H-1'^A37$85)SC.T8)*L1R%<*3Z5GW'Q(T6"#4IEMM4ECTR<PWA
MCLV_<X )=LXPH!^O!P"!0!U]%,AFCN((YX7#Q2*'1AT8$9!KG[SQKI=E;SWC
MQW3Z;;S&">_CC#0Q.&VG/.X@'@L%(!SSP: .CHKA?%^N3+XI\,:0EK=7%A?2
MS/.L.TBY58695!W#(R02. <#K71:;H5OI6A2Z=!/?-;N7=1+<,7B#<[%<'<
M.@YR/6@#8HKS[P'XABT_X9>&)+Z2>YO+_,,* [I)Y"SGJQ Z DDD#CK6S-X\
MTJWT'4-7EAO%ATZX-M>Q^4#);N,9W '!'S+RI(P<^M '445BMXEM4\0V>B/;
MW*W=W ;B$E5V,@QN^;=U&1D=?PYJ[IVI1ZD+@Q0S(L$[0%I  &93AMN"<@'C
M/KGTH NT5YK#KR>'OB-XP,L6JWZ""RD2WMDDN60%9"Y )PJ]..!Z5T8\>Z+)
M::+=V_VBXM=8E$-I-'&-ID)(V,21M;@\'T- '3T5175(GUN32EAF,T<"SN^!
ML"L2%YSG)*MQCL:O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %<OXYNM3M-,L'TZSN+B,W\
M2WC6L/FS10<[GC7!^;.!D D DCU'444 >2-8WT<?Q)ABT35UCU2Q061EC:1I
M2;8QXSDDL6/U'?%:<\%TUU\.7&GWQ%B";H_9)/W.;<Q_-QQ\W'Z]*](HH \]
M\0Z%>+X]B2PV?8/$4'DZK'G! A(.\#ON0F(_[RUZ"1E2H..,<=JQ-$\-1Z-<
MSW4FI:AJ-S+N"RWTWF&)"V[8F  !G'N<#T&-R@#RC3=/U.S^%>H^!;K3+N35
MDCGLX)! YAG$C,4E\W&P ;LG)!&T\9Q6O;Z;>:#\0](D-G>7=HOAY=-^TPQ;
ME$B2J27/\/RC//7H,FO0** /(+BPU";X9^.;%-+U#[7?ZK=RVL)M) TJ22!D
M8#'0@'Z=ZT-1672/&;ZO>^&+O6=)U2Q@C#0V7G36DL>X;6C(R%(;KZUZ?10!
MYQJ-G)%JG@F2T\/RV-M;7LT\MM:6A*VT;QNJE_+!4,2P) Z$GKC->C,P1&8Y
MP!DX!)_(=:6B@#QV;3M2?X*:SI2Z5J/V^:^E>.W^R2;V5KKS 0,=-O/_ ->N
MHUJ&>_\ B/H%S#:WHM5T^[ADN!:R!8FD";,DC@_*>O3OBNZHH \I\(VYMM.L
M?#.K> V;5K K#]NDL4:U=4.%F\T]3M&<?>)_2GXICUS6-#\26MQH>K27T6IH
MUK';PD6YMUF0AUP0)7*@D_>8'L *]BHH X>V-PWQ8GU-]/OHK1]#CA\Q[9RH
MD$K.4R 1G:1T/MUKG-(T:*Y\"Z?I>MZ3K,+#4KJ5;BV@E2>S8R2/'*NT9P0V
M,X(YY]O6Z* .9\#)K46B3Q:U/+<M'=R):W,\7ERS0#&QI%X(;J.0"0 >]9_B
MO1]5_P"$MTC5M$4B2ZBDTN^D7K'"P+K+]496QZE@.]=M10!P7@[PW?:)K^H:
M;)"5T+3;AY]*))(/G@$J/^N?[Q?^VAK)%K>MX9^)-O\ V;?^;J-Q<M9H;23,
MP>!44K\O=@?YUZG10!Y1/!=:1JVAZW>>&;O5],FT6"PN(8[/S9[2:,DAO+89
MP=Q!QZ?3-_7K"4:/X=OM.\-26=O;:]%>R65K; 2I%M=2[1I_%D@D#) (ST->
MD44 </8FX'Q4U'4I;"^BM9-'AB$C6SE?,5W9DR 02 PZ$Y[9KCK#2=6L/!GA
M6_?P]=7W]D7EW]MTN2W/FM%,[X=$8?,0"I 'K]:]IHH \L\3VRZM\.M?;1?"
M-S827RPI'$+ 1W-PRN"2R*,A0.A;'?VSZ?!*L\"2JKJK $!T*,/J#R/QJ2B@
M#R_Q'I=Y_;>H:MX;BU73_$*W$:&(0.UGJ2?* 7R-@^7(W9!&T^QK1S>Z/\1?
M$DKZ5?W$6K6=M]EEMX2\9:-75E9^B'D'G'%=_10!XWH]IKN@Z!X$ULZ%J,RZ
M5;SVE_8I%FX59-N)%3J<%1D=:W_&T]_X@^']Z;;0[^)KBYMS!;M;$SN$E1F=
MU7.WA3@'GY?<"O1:* .*E2>7XN:??I9WALQHTL#3FV<(LC2(P4DC@X!^G3K1
M\0;34O,\/ZSI]G-?)I.HBXN+2 ;I'C*LA9%_B9=W ]Z[6B@#@-/NI[OXJ3:P
MNE:I'ITFAI")YK1X_G$SL1M(W9QVQGVP03C:-H\4WPPT?2-=T;5E(U&8NT$$
MJSV;%YG29=HW=U&0#]_GO7K%% 'CNM?VU9>"(DU>:ZOX[?Q':"RN)X=EQ<0"
M1,%UP"6SN4$@$X![BNAUW0Y_%_B@7=FEQ:P6^CW=H;F>!XB\LX"JH# ,0HRQ
M.,9('7..F\2^'(_$MI;6TMY/;);W,=T#"%R71MRYW \9%;2@A &;<0.3CK0!
MY7-8:CK_ ,*['P9+IEY:ZO&+:TF+P,(HA"Z;I1+C81M3(VDDDXQUJ77]+O%U
MN^U?PW%JNGZ^+I$>#R':SU) 5&Y\C8/ER-V01M/J#7J%% '&6<-P/B]J5V;2
MZ6UDTF&W2X:!Q&TBR.Q4-C'1A7()8:J/@'>^'6T74EU.&-[<1?9V)D<S%ODQ
MU7&#NZ<]:]BHH X*>.\TOXC6OB-K2\GTF^TE;)VBMW>2VD5RZ[HP-P4@D9QP
M>N*Y_7] U!_"WC&\@L+QY-;U.WFM;1(&:3RXWCR[*!E2VUFP<'&,\\5Z[10!
MQ5RLTOQ8TJ^2SO#:+I4T+3FV<(KNZ,JDD<'"GZ=ZG^(=E=W>D:9+:6LUS]CU
M:TNYHX5W/Y:/EB%ZL0.PYKKJ* /.]?T&Y\::U<7EE'-:V\>B75C'/<0O"TLL
MXP!M8!MJ@9)(ZMQGG#/"<J7HTVRO/ 4ECJ]EL%Q=W%BBPQLHP7CE_B)QQM]>
M>!FO1Z* *VH6%OJFFW6GW:;[>YB:&1?56&#_ #KD/!.CZRNAS0:X6CNK2%]*
MM9>[0H2!,/=_D^OE@]Z[BB@#R:WT[4YOA'+X%N-+NEUA(_L*DP.8&&_Y9A+C
M9MV_-USD8QG%=!'9W%K\5["06UW):0Z$;,W7D.4,GFJP!;&,X4GTKN:* /%K
MBUU:+X8:CX870=5DU"WU,R'9;'RW0W@D#(W1P5/;..2<"NRMO/'Q8O=1>QOD
MM'T6*$2M;.5\Q9'<KD @G##I].M=O10!X[::;JD/PY\.JVDZ@9]-\1+>7%N+
M9_-$7VB1MRJ1EOE=3Q6OXAFU?5-2\06,^BZK]FGTM1IRVT>U)7,;;O.=3C<K
M' 0G&,X!)%>ET4 >6V$5]]K^&4DFDZE$NG6DD5WOM7_<DVPC&[ .,L".>>YP
M*WOB%9WD$&F>)-(1'U;2KE1'&S;1<1RD1O$3[[E(]Q7:5AR>&HY_$G]L7&I:
MA,@VM'8/-_HT;J,!PF.O?DXSSU P 7M&T[^RM(MK(OYCQKF63O)(3N=S[LQ)
M_&N3L$N_#7Q \1W%[:7D^GZQY%Q;7-O;O/M=$V-&X0$J> 02,8[YKNJ* /(A
MX?U'2=#\-1O87;RGQ-_:L\$,+2?986,AP=H(X#+D#N3C.*]=!R ?6BB@#RF6
MSOG\-?$FW73-0\W4;F9K-/LDF9@T*HI7C^\#_.M.ZBN9-?\ A[.MA?&*SCF^
MTM]EDQ#NM]@W<<?-Q^O2O0Z* .#O?#VH1?$.7[)#G1-;A2746[1RP$?A^\4J
MI'<!CVJ2:&\T+XGW.LS6MU<:5J=A'!YUO"TQMY8V)"LJ L%8,3G&,]:[BB@#
MR/6_#NHK\/?&3Q6%T]SKFI_:K:SCA9I F^/!90/E)"%CGID \\5T.L27%C\2
M-'UX:;J%S82Z9-9EK:V9VCD,B.N]<94$ C)P!WQ7=T4 >-7%AJS^ /$%FVB:
MDEU/XD:YBB%N6+Q_:4<L-N> JGGH>V:[!TGD^+UG?K9W?V/^Q7MS<&V<()&E
M5PI)'!P#_+K7:T4 >2:3)X@T7X9Z?IL6AZBMQ9ZEY=Z5M0\BPF=V:2!3G>0"
MN" <;LCD<*+.]BNOB$(M$UA8=4TR);-Y8WD:5A!(F"22VXLPX/(SSBO6J* .
M;T338=4^'=AI.HVLJ1R:;':W$,T91E/EA6&".H.>?RK+^'=GJGV.2?6G66XL
M-VE6TJG/F10N09/JQ !_ZYBNDUW1WUNRCMX]4U#32DRR^;8RA'8#/RDD'Y3G
MI["KEC90:=8PV=LA6&% B@DDX]23R3W)/4T <MX_T[49QH6JZ?;R79TC4DNI
MK6,9>2+!5BH[L V0._-02VSZKX\@\20V]W'8V&ERP%I+62-YI'8$*$90Q"@$
M].I&,\X[BB@#D?AA;W-E\.M'LKRUN+6ZMXC'+%/$R,IW$]QSUZBH?$,5Q:?$
M3P_K+6=U+I\-I<V\LMO TQC=RA7*H"V#M/.,5VE% '&:'X=%]J'BW4-0M&CL
MM?>.);:5=K&%(O++,.JEB6.#R!C.#4'P[T_4XX9CJ\BS-I6_2;.8'/F11N<R
M?5L1J1ZQ5T^NZ0^M6"VL>J7^G,LJR>?8R!)#C^')!X/I5JPL8-,L8;.V4B*)
M<#<Q9CW))/)).22>I)H YCXA:;J-W9:/J&FP/=2:3JD-]):Q_>FC7(8*.[ -
MD#VJ)K-]?^(&EZ];P7,%GIUC/&\EQ \+2O(5 0*X#$  DG&,D#UQVM1SQO+
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MA^PVMS>::(H5:0J"7968;V(5<\+STYH ]+HHHH **** "BBB@ HHHH ****
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MF2A!')&3@,F&)(SQTX[U<TC54UBT>YCMIX8UFDA7SMOS[&*EAM)^7(.#WZT
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MXCV&3]<4 ==17--X*TXZ5]G$EP-0\O U3S6^T^9C[^_.>O.W[O;&.*YKPO\
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M=-;H/A'\08P7VP:KJ/E_.<C:^%YSDX [T >RTUU+QLJNR$C 9<97W&<BJNF
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MR848!F2.16;;D@$X!XS75T4 <3?V.HZ[XGL]>L;.2V_LJPN5M?M:>6T]Q*H
M4KU"KMY)QDGC/6N=LK'7KC5_!>KW/A[4VO;-YEU.>XDC+&1X2N5&[B,,2<#
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M/H>U '!3:!<Q_$V2&U=/['U%(]2OX.ZSPL%0CTWG83Z^4U6?B%:/JMQX6TJ
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MEO&QN'>*+<[8QLAV'+#/.XX&!CG/';44 >20Z)K,?PB\/:,VD7?]HVE]!)-
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MC=/])#SLP,9W= K9.<=.,UZ!10 BDLH)4J2,X/:EHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "L'7_$LFBW,%M;:)J>K32(79+&-3Y2@X!8LP R<X]=I
M]*WJAO+J&QLI[RX8)#!&TLC'LJC)/Y"@#&\,^)SXD^WAM)OM.DLIA#(EV$!W
M%0V!M8] R_G6_6!X-M)K?PW!<72%;R_9[ZX!ZJ\IW[?^ @A?^ UOT %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !5+5M,@UG2Y].NBXMYP%D"'!9
M<@E?H<8/L35VB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>elicio2021employeestockp008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6D<NQ/J2:Y_XA:[=>'_!>H76GH\FHO$Z6RH,D-M+%_\ @*JS?\!H ZBBN9\
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M9+I"P5@RGA>N<IMZ5G^)=5UWQ?X#T'7/!]]<V&I7Q(\A)?E?;'(SI@\;MT9
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M"L)&^?AMO&<=#QBO-_#OC233?B9XOB\0:_<+HVE;_L\<\QP#O  '=SC( .:
M/;**YS2=,U&XU:76KZ]NX890/L^F+<;HXA_><CJQ_N@[1TYZUT= !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  7&<Y[8KR_X3I/I'PAUFSU"SO+:Z$EPP@DMI [!HU"[5QDY/'%>ST4 >?\
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M)_$6N:4\O@_Q)8WQ2S=HK'4?LTABD0'&TOCIW4GMQV&?7J** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ=\E]%%:0WD$H@6(H'9E9,#J,KD9Y]S0!TNI:C::1IT]_?3"&U@7=(^"<#V
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M*L#@]#D8YQ0!PFIPV&H6^F7"7_B2/7=.G:XBU-O#]TQ9G 5PT8B V%0!M&,
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M,1P:R\5SX?5HH9UMP?,C:/RR"I) ;&.?7M767MW'86,]W,LC1PH781H7; ]
M.36"_CC2DT/1M7,=V;;5Y8H;;$.2&D("[^<+U]?SH O^)=!B\2^&K[19YY(8
M[N+RS*GWE[@^_(Z=ZQH?!E__ ,)!9ZU=^(I9[J&Q>RE"VJ1K(C,&X SMY7)Z
MD]B*ZF[NDLK.:YD61DB4NPC0NQ ] .3570]8MO$&B6FK68D%M=1B2,2##8/J
M* ,>U\)S-JNC:CJNH1WMSI,;I!,EMY4DA9=A,C;CGC/  &3FLKXLS1Q^'M*1
MKJ.WD?6;/8[$?+B09;!ZXZUWM-9$?&Y5;'J,T 846@SRZN=;NKZ">_6U-M:M
M';E8H58AF;;O)8L0O.X<  =\T=/\"6L'P^/@W4+DWMCY31"01^6X!;<#U(W
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M'/RC''YUC/\ #F.YT;6-/N]3D+7^I-JD5Q!%Y<EK<$@@J=QR!M'OR>?3N**
M.4@\*ZO)H]]:ZMXE?4;NYMGM$N&M%C2*-AAB$4C+'CDGL, <Y6Y\$PW_ (#M
M?"][>R-]DBB2WO(%\N2-HL>6XY/S# ^O/2NJJEJVJ6^BZ3=:E=+*;>VC:63R
MHR[;0,G@>U &%9^$;NXTV[L_$^N2ZX+BW:UYMTMU6-L;N%ZL<#YB>,<8YREI
MX.N/LFDV&J:J+^QTJ5);9#;[)':,8C\UMQ#;>O 7) )[YZ+3KZ+5-,M-0@#B
M&ZA2:,.,,%90PS[X-6: .>M?#EQ;>,[[Q"=01Q=P1V[6_P!GQM1"2N&W=?F.
M>/PIWA.#6;>QNTUC49-0/VIC;7$MN(',1"\%!TPVX#/.,5OU0U;5[71M*O-1
MN?,>"S0O,(4+LH W'@>W- &;<^&97\9+XCM=2>W<V:VDT'DAUD57+J<DY')(
M/J/3K6,_P\F?P1>>&&UA?)NKHW+3BU^9291*0!OQ]X?E^==CI][%J>F6M_ &
M$-S"DR!Q@A6 (S[X-6: ..U/P7?R^(CKVB^(9-)O[B%(;X):K+%<A?NML8_*
MPZ Y/'XYZFPM!8645L)9)2@^:64Y9V)R6/;)))XXYXJQ10 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %<G\1-5U31?"XO\ 2KI+>9;J"-BT0?<KRJA'/3[U=96'XJ\/
M?\)1H_\ 9K7C6L9FCF9UC#,2C!U')]5% '/27'B.+X@_\(__ ,) S6U[IKW@
MD-I&'MF615(CXQ@AA]_=C'>J^E^(=<G\)WOGZM;)=6&MOITU_-&%9X4E +*@
M4J92IPHQ@GM72R>')I/%]OXB-^HFALVL_)$'R%68,Q^]G.5'X>O6L9_AT6T^
M:!=:FCN#K!UJ&=(%_=3DG(VDD,G/0_F: #P]JFKZOJOBO13J-U%]A: V5U/;
MQB9!+'N^9=H! (X! .#SS4'@;7=:UZ^ELM2U 1W>BE[?48XQ$1=2ESM=<+E4
M"J>F"2<?PG.G;^#+JTU+6M0M_$5XMUJT422NT,9V.B[0ZX YP>!T'?-2OX.2
M/7]*UC3[L6,UC;&U=(H<K<QG!VODYP",CN"3R: ,9M>UT2_$&'^T$WZ/&DED
MWV=<1Y@\W&._/')-4SK/B>"U\$ZA_;:2?VV(;>XMY+1/+5G@+B08PVX$9(W8
M.>@%=$?!LAG\32_VGSKZ!)AY _= 1^6-GS?W?7///M39?!<DEAX;M/[4PN@O
M') WV?F4HA1=_P W]TG.,<^E &.-8UVQE\<:9-K$ES)I-E'>V=VT$2R*7C=M
MK +M(!3TS@U._B+5A:_#^Y%X<ZP8DO4\M-LFZ R$CC*G<.Q K97PBC:YKNH7
M%X98]9MEM9X!'M"HJLHVG.<X8Y_I69;_  ]N$@T&*Y\27DRZ),KVNV"-,(J%
M IX.3@X+'/3@#)) ,Q]3\3WD7C81Z_\ 9FT:9C;-%:1G($(D"MN!^7)Y[^XZ
M5(FO^((AX*UJ;4UDM]=EAAN+!;=%C3S(2X96QOR".[8/H*W8O!\L2^) -3S_
M &Z2TI,'^J)0)\OS?W1WSSS[5')X)D?3/#=B-4PF@RQ2P-]G&9#&A10_S=-I
M.<8_"@#2\97M[IO@S6=0T^=8+JTLY9XW:,/RBENAX[5S%MJ_B"TUSP<UUJ_V
MFVUV%TGM_LZ(L3"#S%="!NSD<Y)!SP!TKL=?THZYH%]I/GF!+R!X'D";B%8$
M' SUP:R)/"$LD_AN8ZGAM"!$6(/];E/+.[YO[OICGGVH YN7Q-KB?#_QEJ(U
M)OMNCZC=0VTWDQY*1D;0PVX/7DXS6G=ZGKL_CK2M(@U46UI>Z3)<OMMT9E=6
M0;@3GGYCC(Q[&G7OPZ-U;>(+"/7;F#3-9E>XDMEA0[)7 W$/U*G&=O'UQD'3
MC\*2Q>(M-UC^U'DDL;-K-4DA7]XC$$EBN.<J.@ ]C0!QIUOQ6?!?B;4/^$@V
MW/AV\N84<6D6;L188>:",#(./D"^N35[4?MVK?$O0WLKP:?/<>'Y7,PB$A0&
M2,G:&XS[D$>U; \"O_8/B'26U4F/7+B:XG?[.-T9E #A?FZ8 QG./>K+^$ID
MU#2M3M=4\K4-/LS9;WMP\4T1(/S)D$'*@Y#"@#F+3QGKNG0WVAZE*MYJMOK,
M.F17L42(94E7S%?:2$#[01CIDCKWTKFZ\8:=;^(IGDE&GQ:<]S97-ZL#31S*
M"2A6([64]02..16C?> =-U'0+S3KB>X^TW=T+V2_1@LPN!C:ZXX&T  #L!CW
MI8/"6H-H]]::GXCN=1NKJV>T%S+;H@AB88;:BX!8\?,2>@^E #O!8UR[TFQU
M?5=9%W'?:?;R"U%LB")RH+,&')SD9!XSG&!P&OJ]UJ_CB_\ #UK>RV,.GV<4
MTLL*(9)))"< ;U8!0%STR2?;G;T+3&T70K+2S<?:%M(4@20IM+*H &1GK@5G
M7_A@R>)H_$6FWOV+4?L_V:;?%YD4\6<@,N0<@]""/3D4 <+KNLZEKGPJ\96N
MH7+)>Z--/9S2P(JK=*H!4D$';D,,A<<CJ <5Z9HL$EMI-LDMW-=-Y:G?,$!
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ME%&X;3\OS'#$9/Y5;D\!O#>ZR^EZW<6-EK.][NT$*2#S67:SH3]TGOUS[<8
M,;P[K5X=%\(>'[(72L_AZ*\EDM?)\S 6-% \T[0,DD\$]/>NM\)MX@.F3Q^(
MT7[3%<ND$N4W30\;&<(=JMR00..*Q9_AR!INAI8:]>V>J:+#]GMM05$9C%@
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M,RE$*+O^;^Z3G&.:KR_#]XVUV#3=<N++3=:\U[FS$*2!99%PS(QY4'N/R([
M%#2-:O)+7P[X>LOM:$>'[>]EDM/)\PY"HH'FG: ,,3P3]WISF'4-7\;:9HFA
M+?7$%M?SZ[%8.YBC?SX')VNP4D*V!@A<=\$5JW7P\)M]%ET[7[VQU72;86D5
M^L:,9(< ;'3 5AQQ_6K5_P""Y+^QTV&36)VGL[^/47N98E9YYDZ9 P N.-H
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M5_,T]UIL:(59V^]L<C=&&[[>?0CC !V:%FC4LNUB 2N<X/I3J15"*%4 *!@
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M4G.-V\'!SNQ[5M>-/$&LZ18^)+^TU5GGT]XWMH+2-6B@CPN1.67&YB6^4,2
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MID=<E@ VWY1G)/>LK2=?U6/Q5X5LWU*>^M]4LYS=2R1*L,LL:(V^#Y5;;DD
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M %[6])U'Q7H7]HR2/::0=5T^\>-#)& &!C?Y=K?,O!QG&<YZT >CTC,%4LQ
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M&-Y9MTD@]N%4>N&/0@GIZQE\1P-XP/ALVUPMR+(WHF8+Y;)O"8&#G.3W Z4
M3ZOI][?QP?8=7GTZ2*3>6CB202#&-K!@>/IBBPTA;"2[NO/:?4+H*);F91R%
M!"J%7 "C)X'J><G-:5% &3:Z##'JYU>\E>\U'RS%'*X 6!#R5C4?=![GDGN<
M "JM[X5CGOM1N;2]GLCJ<2Q7RQ*I\S:"H921\K[3MSSP!QD UT%8WBGQ'!X4
M\/7.LW5M<7$%N 76W"E@"< \D<9(H HZAH5U;W/AV#0KRYL;33W"-:Q >1)
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MH+:,J"P0 L26(  R!]2* ,K4/!:7]EID#:K>"2QODU W#!7DGG7."Y(QCG&
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M:VEY#-L"3 !AGY5&.&( &!WY/-=910!RGA[P7+H(AB?Q!J-_:VBE;&WN=FV
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M1R^<J;@=N3QZY[UQAUGQ'%\.+CQ._B*[>[T_4WC6+RXQ',@NO+(D 7)^4]L
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M)(F ,,'5LXQUZ\F@#%^'5Q>)_;VDZI900:K9Z@TEW+;DF.Y:4!Q(,\C@@8[
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M%X[H9G",&51E=JJ".@ ZGN35WQ%X2M?$NGVD%U=W45W9RB:VO[=@DT4@_B!
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M@C5/+D_?C(DR"6!!(X(KM+S4]1UKQ3JFBV;W$,5C:P/FWG6)R\H8[R2#D *
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MKA>5^8]<L.Q%;">$=/37M1U7S;IO[2C5+JU:0&"7:FP$KC).WCKCOC/-;U%
M')Z!X L/#MQ&;?4]6GLX&+6UC<W6^"W)_NK@$XR<;B<=>O-.6SL_ =EJNII_
M:^H+>W?VF>&*%9G\QR%+*J*#C 'T KJJ* .<\):/%9#4]5%B;.XUB[:ZDA<8
M=5P%4,.Q(!<CLSL*R_BQ&]SX!N;6*.>6:6XM]J0(SN0LR,Q 4$\ $Y]JZJZN
M[N#4;&WAT^2XMYV<3W"R*HMP%R"0>6R>..E,US5/[$T.]U0VTMRMI"\S11%0
MQ502>I Z"@"K;:#"]]'JLU_=7ETD#0VT\PC'DJV"Q550#<<+DD'ICIQ46C^$
M-.TCPY/H/F7%YIT_F;X[HJ>)"2XRJC@EB?QK3TF_&JZ-8ZBL9C%W;QSA"<[=
MRAL9_&KE '+>'? MGX<EC,>J:M>P0 BUM[VY\R.V!&/D  [$@9S@' J+2/AY
MIFBWI>SOM373Q-Y\>EFX_P!%C?.[*KC. >0"2,\XK2L/$:WWBO5-!-E+#)80
MQ2F5V4B02;L8 )P/E[\^U;E '(W'P\TV37KK5+;4=5L1>L'O;2SNO+AN6[EA
MC()[E2,U:O/!EG/X@36[*]O=+O?)%O,;)D"SQC[JNK*PXZ C! [U8T+Q&NMZ
MGK-E]BEMGTNX6!_-927)0-D;20!@CO6Y0!QZ?#G3(_#D>A)J&IK:1W?VP'S5
M9O,#^8.2IXW<^_?-:B^&85\32:^+^]^VR6@LR,Q[/+!+#C9UW$G/].*W** /
M-O$'AR'P[X>TW2(&U^73/[1:ZFO++$D]H?F<,%1,D%S_ '6 _*M'PG!=_P!J
MK-9:YX@U'3#&PF_MFW\L;N-OE[HT<GKG@KCWQ7<44 8WB3PY;^)].2QNKJZ@
MA65)O]'*@LR,&7)93T(!IM]X9AU#6M)U6:_O!<Z7O,&TQA6+KM8L-G.1QQCV
MK;HH YT>$+9S"ES?WUU:PWOVZ*VF*%4EWEQ@A VT,<@9]!TXJF?AYIBZU>:A
M;WVIVL%])YMYI\%QMMKASU9EQGGO@C/>NNHH Y6_\ Z;?W^L7+7NHPQZQ"(K
MVV@G"Q2$)L#8VY!Q[X..0:D'@JS5]!<:CJ.[1 1;%I$8ME=A+Y0Y^7CC '8"
MNFHH H:UJL>B:5-J$MK=W*1;<Q6D)ED.2!PHZXSD^P-9/A32H8+C5M<%@UE/
MK-P)VBD7:ZHJA5W#LQPSD=M^#SFNEHH X]?AUI<.LW5[;7^J6UK>2F:ZTV&Y
MVVLSGJ67&>>X! /3IQ2W_P .M*OWUM7OM3BMM9^:ZM89PL?F;0/, VYW<#@D
MJ<<BNOHH YV#PA;0:YI^K#4=1>XL;8VL8DD1E="06W97))(!X(QCC XKHJ**
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHQ6%\+J27[0^H2^7$J2,#$\ 79MVC!R<_P 6<T >EWD[VME-/'"TSQH6$:D
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M)'9;2PR <MC(XS6M;>$[B7QNOBG5KZ*:X@M3:VEO;PE$B4DEF)+$LQR1V %
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M7#R\J(^1O)()SSZX%5-&&O\ B;PUHOB:TU*&TN&D6ZN)VU&5HG3)\R%H=NP
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M?PJT4US#G$A5B/SP #[@UP?VZ_'@/XC2?VC?>;IVHW@M)?M4F^$)$C*%;.<
MD\9QS0!ZI17F\_VV^\9^%;1]6U&.VO=&EDN(X;AD#LHCYXY!^8_,.?0BLJ'Q
M#J.D^&[W31J%RV?%G]B0WDTADE@MV923O;)) + $],CTH ] E\1F+QM;>'&L
M7Q/9R72W1D&/D905"]?XNIQ6[7F][:1:)\6;&XMVNI5&A74GE37#R\JZ="Y)
M&>,_3/7-1Z-%KVO:'X=\2VNJ0VTKM%<W<SZA*\<Z-_K(C"5"+R<#'W2.IZT
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M[%(T:&Z$P)E8YW*4QE<<<YYS0!G2^$K"XCO#<37<MS=F$RW?F[)?W3;HP"H
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M7YN!CC'YYH ZJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBR!D[V7G)QCU!SBN2N8I],\9ZEJDGA63Q%H^N)!<6T]M#')) XC5"K!R,*0
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M*ACDX;< =C8R/RJK>^.=.T^*&[GMKO\ LN6Y%J-1 0PARVT$C=OV[@1NVX_
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M1H/_ #QO/_!A<?\ Q='_  A&@_\ /&\_\&%Q_P#%UT-% '/?\(1H/_/&\_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG>*-&T-[*9FU3SMEP&78GEH7((SG/3MCGK6+X3EO+3QMXHT274+N\M+5;2>
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M]Q<2K'$@RSMT% $M%84OB/RO&MMX<:QD'GVDETMR7&TA2H*A>O\ %WQ^-;M
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MQ\QX*XYZ4^[6S\.32220:I?WVJ(T<EXEL9C\B_(K>6N$7DX 4#))/.374T4
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M7)V<@;CP?7G-6O$?@S3_ !+/9W<UQ>V>H6>?(OK&;RIE!ZKG!!!],?SKHJ*
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MB+4-;CN;I[F_1$G1RNPA,A, *",9/?OSFEUGP[:ZU=6%X\]S;7NGNSVUS;L
MT98;6&&!4@CCD&M>B@#GYTM?"&FWVJ+::CJ5Q-(CW+6\7G7,YX4':,#"CL
M #Q3?"FDQVK:IJYL#97.L77VF2%AAU4*%0-CHQ +$=BY%=%6=J.KQ65CJ,\*
M&ZFL8C)+!&P#?=W 9/ XYH ->T2S\1Z)=:1?AS:W*A7\MMK#!!!![$$ _A5#
M_A$K8ZKI6I/J&H276F)(D+22JV[S,;RV5YS@?3'&*OZ!JPUWP[IVK+"81>VT
M=P(BV[9N4'&>,]:T: .7/@+1Y;#6K&[:YN[;6)C<723,O^LX^92J@J1M7'TJ
MUX>\*6WA[++J.IZA-L\M)=1N3,T:<':O  ' SQDX&3P*WJI275XNLPVJ:>SV
M3PL[WGFJ C@@!-G4Y!)STXH BU#1Q?W]I>I?W=I/;))&K6[)AE?:6#*RL#]Q
M<<<5F3^!M)FTRQLD>Z@-E=F]BN(9=LOG,6+,3C'S;VR,8YXQQ72T4 8$OA.T
M&L/JME>7NGWDT*P7#V[J?/5>%WAU;+ =&X/O5?4_ 6B:CHUAIJI<68TY_,L[
MBTF*30/W8/SR>2<YR>3S73.2J,P4L0,A1C)]N:Q?"OB(>)](>_%H]H4N9;<Q
M.X8@QN5)R..U %.[\#Z??>'9-%N+W49(9Y%EN)WG#33LI4J6=@>A5>!@<583
MPG;0^(I]=M[Z]@OKB!8)S&8PDP7HS+LP6'K^'3BI]5UPV6I6NE6=NESJ5U%)
M-%%)+Y:;(\;BS8;'+*!P>OM5K1[ZXU+28+NZT^;3YY ?,M9B"T9!(QD<$<9!
M]"* , ?#[3!X73PZ+W4/[/2?[0HWINW>9YGWMG3?S_\ 6XJ_/X5MGUIM8M;V
M\L=0EA6"XFMRG^D*OW=ZLI7([$ $=.G%;U% '.WO@O2[O1;#24>YMK2RG6YB
M$#C<9%;<&8L"2=V6/J3SFDNO!ME/XA.N07M_97TL2PW+6DH072KT\P%2,CL1
M@CL:UM*NKV\L!-?Z>UA<%W4P-*LA #$*=R\<@ ^V:NT <<?AIH)\+6V@>9?B
M&TF-Q;7(N2)X)"2=R-VY)[8YJQ/X#T^[\-W.B75_J=Q'=E3<W,UP'GF"G*@N
M1P!CHH'?U.>IHH RKS1/M9L9/[2O8;BSW;)XF0,^1@AP5*D?A[]:ETC1[71K
M>:*VWLT\[W$\LA&Z61SEF. !GIT '%:%% &%<>%;5]<N-8L[R\T^\NHUBNFM
M63$X7[I8,K#<!P&&#CO46H>"]+O] L]$1[BTL+1TDCCMW )9#N4DL"2=W/N>
MN:Z*B@!L:E(U5I&D('+-C)_( 4ZBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA/BU;1S^
M#HF=I04U"TQLE9.LR YVD9X/?H>1S7=UFZ[H=EXCTB;3+]9#!(5;,;E&5E8,
MK CH00#0!QVKZ8DOQ4T.P2ZNX8O['N@72X;S2OF1\>826'U!S[UDV7B+4[#P
MXVG&^FG/_"52:,ES<W#"00AB0&EP2"<;-V,C/'.#7>+X4LTUJTU875Z;NT@:
MWC9IMWR,<MG(.22,Y//IBJI\ Z)+HVIZ5<I/<VFI7+7<ZS2<B9CDNI !4Y /
M'''3K0 W0-*UG3/$=Z]U?(=,N80T-B]Y)<R12*0&97D .T@C([''K6#XI+1_
M&KP3)='%F8+M("WW1.4/ZD;<5UOA_P ,6?AZ-_)N;^\F<!3/?W+3R!1T4%NB
MCT&*L:YH.F^(K 6>IV_FQJXDC96*/$XZ.C#!5AZB@"]/Y)@?S]GE8^??C;CW
MS7#:1)/XRNO%:SW][:26.HR6%HMM</%Y"HBXDPI 8LQ)^;(Q@=*Z6S\/K;F/
M[3J6HZ@L1#1I=RJRJ1T)VJ-Q'4;LX//6H9_"=C)JMWJ-M<7=E/?($O!:RA5N
M !@%@0<-CC<N&]Z . TW7M9\16WPZO+G4;NUEU&2ZAO$MWV+-Y<<@#D8QD[<
M^@SQT%7;/3KJXU3QMHCZ[K0LM,,4MIB^D\V-I(-YS)G>0".%)QSR#79S^$M,
MEN-'EB\ZV&C@BRC@8*D>5VGC!S\O'-$7A6TAOM7O([J\$^K*JW3;UYVKM7 V
M_+A>./Y\T <'!J6KZQ;_  T=]9O;=M4AE6\,#A?-Q;L=QX^]GOV/(Y%.^TZC
MX>OO&.@R>)KR+3X;."[M=0O";F6T,A*E,GEB2/E'7ICFKFM>&UTS6O VF:<F
MJFPTV:<FXAB>0VZF(JF7"D8W8&#GCKQ757?@S2-0TO4[&^6:Y_M,JUU.[XE<
MIC805 "[<#   'IR<@'/Z//>K\1KO1_,U&UL)]$2Y6"YNS-(DGFE-X+%MA([
M GH#UKF-.NM5C^'?A3Q*^NZI+J#ZE##()+EC')&]P4963HV0>IR1V(  KT2W
M\$Z=;:O'JR76I-J"6IM3<27;.SIG(W \$@\CC'M4*^ =)3P[9Z"L]Z-/LYQ/
M @E&5<-O'S8R<-D\T 9-[J;>#?'US-J=[>2Z/JMD\MJLL[NL$\0+/&JDX&]>
M1[@@5UGAVRN;'0[:.]FFENW'F3F69I"KMR5!8D[5S@>PK"OE/BK6[;2KG0KY
M+72;Y;I[V\B58YF13L,1!^;+$$G & 0>HK2\1:%)K%]H\\,]W!+8W2SAXI]B
M;05+*ZC[^5!4#MD_0@$7Q @2?X>>(5<R +I\[C9(R'*H2.01D9'3H>]<=J=B
ML>A_#>&">XC,M_;L9#,TC*3;/G:7)Q[#H/2O3;ZR@U+3[FQND\RWN8FAE3.-
MRL""/R-8"^!=-6UTJW%UJ!72Y1-:L]QO*N%V@DL#G"\8Z8[4 <A<ZYJ'A/\
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MK=/@C3CI^CV/VF]$&CR)+9 2+F-D!"DG;\V 2.<]:EF\'Z>^H7]W!-=VAU$
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MZ%#+IGPZ\!:S;7]\ETVHVULR"X81-#)*RLAC!VD$'J1G/>@#VZD;(4[0"V.
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MVC^(;W5=3NKV2"6)UFNF:-AYK<E3P6&.O7D^V #T.F32QV\$DTK!8XU+LQ[
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ME*WCRN2\^5V\MUZ<#& .V*RQXIU8:99:J^@*;"\>$(8KP/+&LK*%:1-@ 'S
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MR M;M<W9AEG3LRIL8 'MN89XSBM+P_K]CXDTL7]B7"AVBEBD7;)#(IPR..S
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M@6)KVX-S.1_'(0 3^@_6KU% '+67P\\/:?K+ZE:P7$1>;[0;5;E_L_FYSO\
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MC'+,,G(.0#QC! Q3M%\':3H=K-!"MQ=+-'Y+&]N'G/E?\\QO)PGL.#WK?HH
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M\_,W0<].O5C0!ZA17D]E8W/C3PW?ZFVN6VFZG;:A.7O/(9I[$Q2G"9\P +L
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MG.#@C!/!R*S;O1%\/?$WP^-+N+T0:S%=1:E$]U(_F;(]RRY)RK;B!D8ZC&*
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M7&OMKDFDQF_9@[N'<+(PZ,R [6/N0:T8/#^FVVN7&M10R+J%PH264SR$.HZ
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M1=+U0:G;6LAO_)$!N)KB25R@)."78YZ]3ST'0"MNB@#-UK0=-\0VBVFJ0//
MKAP@F>,;@<@G:1G!&1FF7_AW3-3-H]U#(TUF2;>X6>1)H\C!Q(&#8(ZC.#WJ
MU?ZE:::MN;J4(;B=+>)>[NQP /U/T!JW0!BW?A+1+[1GTBYLR]C))YLL?G2
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MDLB1_P!U6=B5'3H1T'I3M%T'3O#]HUKID+PP,YD*&9Y!N)R2-Q.,DY.*TJ*
M,K7/#FE>(H8(]3M?--O()89$D:.2)_574AE/T-06?@_0+&34)(M/5GU%!'=F
M9VE\Y0NW#;R<\=?7))Y-:-YJ5I836D-Q*%EO)O)@3N[8+<?0 FK= &!X?\%^
M'_"[R/I&GB!I%VDM*\A"YSM7>3M&>PP.!3-*\"^&M$U-]0T[2T@N&9F&V1RD
M9;@E$)VH2./E XXKHJYSQOX@N_#'AN35;2V@G,<L4;+*Y4 /(J9  Y^]TR*
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MJNI<NTC@L2HP.3T X KJK+1K&T:2>*&5;B>,))+-.\DNT=%WLQ( R> <9)-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFL?3(+7Q+X&\67VKHO\ :\%W>B2=N);1HLF((W5 JA2,>Y[F@#U8D#J:0$,
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M(]3W/>J6E^#?#FBZI+J6FZ-9VMY+D-+%'@\]<?W<^V*V99HH5#2R)&I. 68
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M +.1\A;.<D=SGG)[\]:TFFB658FE02,,JA89/T%$DT4.WS943<=J[F R?04
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MJY?MJ!GL&L)K-8#/_I7GABS1X/$>#][..OO1K-Z]AI=S-!) MRL3-"LY^5F
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MQ@,Z],$]Q[5#_P (GX?_ +.33O[&LOL4;^8EOY(\M6ZY"] <T <A'H.DZ_\
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MR;G1-<\.Z?JUE:7]O.)!I&O6?#RAHV<K,IYRRY)(."0#ZFO44C2.-8T&$48
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M%"ATE=/CN1$5!2*[,3%BHZ!B K''<@]ZTQIUCIOB_P"'$]G;1037,-RD\B*
MTP^R[OG/5OF /.>: /3Z@M[VTNU=K:ZAF"'#F.0-M/H<=*Y'XIW<]GX+,J;A
M:&[MUOBO46QD'F?@1P?8FH-;M5A^)7A&XTE(T-Q%<Q7@A VR6JQ@KNQU 8KC
MW:@"=?$.KZ_J&K0^';O38WTR\2V6*Z!87("JTAW*<J/FP, \KSUX["XNK>SA
M,US/%!$."\KA5'XFN(^'UI:QZWXR>.WA5X];=%*H 57RH^!Z#K5SQ-=6?_"9
M^';3:O\ :?EW,ML]Q)B"-=H#LR_QM@X !'!;D4 =7]IM_LXN//B\EL$2;QM.
M>G/2FK>VKF8+<PDPG$N) ?+/^UZ?C7AY2SN?A-<1E[>9K;Q+B%H\#RU:\ RF
M#E003C!KMK?2]/L?C&]G:65O!;7/AUFG@CC"I*1<  LHX)P2,GUH [L7EL83
M,+B$Q X+[QM!],U*"&4,I!!&01WKRS1;-K*]N?AI);DVD-V+V%RF5;3RQDVD
M]R)!Y1]F]J[CQC-?6O@G6IM+W"]CL96@,?W@P4X*^X[4 :L=[:S7$EO%<PO/
M']^-9 67ZCJ*&O;5;M;5KF$7+#*PF0;R/4#K7%Z$?"6J6GA74]/EA:]MX"MD
MD$N'RT>)%=0<G&"3NZ$>IYY>T\G5?@-JEW?#&MP-<S7$IXFCODE8KSU#9V >
MQ Z4 >O2W5O 6$T\495#(=[@84=3SV]Z:;VT6*.5KJ$1R#*,9!AAZ@]Z\XL]
M)@OOBK9C6+&WENI/"\<MW&\8*O,)@"67H2#Z^@]*HZ/X<_M_X17^G6B(+JQU
M&[DTW@'RI(IV9%'H#C;]#0!ZQ]HA$JQ>='YC#*IN&2/4"F1WMK+<R6T=S"\\
M?+Q+("R_4=17"VNKW'BCPIJ7BW3K=DNTTF2'3UV?,DWE[I-O_;0*GUB/K6?H
M%KX<URS\*:K!KVZYMMH@MX%B61F9<212 #<1U+9]"?>@#TB74;&#=YM[;Q[=
MP.Z51C:,MW[#D^@K'&N_V]X6;4O#VH6<+.08I[H;HU4/@E@"",J#CGN*Y+P)
MX:T2Z3Q'<2Z7:2S6OB"^6W9H@?)' VKZ#!Z"N;:#3Y/V;+-UCMFN(TMG+!5W
MJWVD+GU!QN'YT >D/XAO+;XCR:+=36B:6ND&^#E2C*WFA/F8MC&,]AUI?'GB
M"]T+P1=ZWH\EJ\D(C93*AD5E9U7C##^]G/(XK'U+3-/U7XT16VI6D%U#_P (
M\6$,ZAT)%P.JG@_C7(ZC9C3OA1X[M;7(TB+5BNGJ3E502Q;@G^R'W >X- 'M
M-S=VUG%YMU<101YQOE<*,^F34JL&4,I!4C((Z&O/-5OH#\49].U;4([.&72X
MS8>>B-')\[^< 7!&X_)D=2%%='X*TVQT?PQ!8:9?SWUC \BPSRL&R-QR%( !
M4'('TH V7OK2.Y%L]U MP0"(C( QSP..M++>VL$\<$US#'-+Q'&\@#/] >M>
M::C)>Z%J<]_+#:ZWX:N-:21W7Y;NPN?-5!_OJ'"@#K@XZ55B32O$:^+])\1:
MVEC<IJ4HF241+(L((,+HSC. H7!'3\>0#U:YO+6S0/=7,,",=H:5PH)].:=]
MHA\T1>='YA&0FX9(^E><Z9>Z>_CS6])\03A@VEVJV!U A6DMRA\X\XPQ<_-C
MG@?W>&2V^EZ?XL^&Z::Y_L^);Z"WFE?<67R<+\QZ@XR/48Q0!Z.+NV:)Y5N(
MC&GWW#C"_4]JHZK=3RZ=,-)U&PANHG3=)<?.B D$A@",$KG'U%>4:L+"\\,?
M%8(+>9%NO-CQA@&$*?,/?.>:V/'7A[1=/^&KWEIIMK%<RS6#O.L8WNPFC&XM
MU)PS<]3DT =^_B'38_$4>A&YC^WM;M<&/</E4,JC/N2W ]C4FG-?&YU 7EW:
M3H+C]PD"D-%'M&%?DY;.3VX(KD;B*R3XWQO/';KNT L&D &7^TJ >>_3WKEK
MB0Z1X7^(;V,9B@BUY/.6!!E8#Y'FX _V2V?;- 'L%O>VMYO^S7,,_EG:_E2!
MMI]#CI207UI<R/';W4$KID,L<@8KCKD"N#&G^';C4FUNU\3%Y9=)FA8V/E!?
ML^W/F,$&?E.,'L<"D\+2:CI'BG3=%UVQLIY_[.DCT[5[#Y5G@0QEED3^$_<.
M0<<\=: /0WD2*-I)'5$499F. ![FHHKRUGMOM,-S#)!_SU20%?S'%<=XZNG@
M\1^#8KG_ ) \VI,MUN^Z9?+/D!O;?SSW ]*9:V7D?&'4H;6)?[-NM&CFOX0H
M,9N/-*HQ'3<4#?4"@"QH6OZSXG%MJNEW.G+8&]EAGLYE/F>0CL@<,"?G)7."
M,8..V3OW/B#3;77K;19+F,7UQ$\RQEAE44@9/IDG ]<'TKF?A)!;IX#@EBBB
M61KJ[#.J@$@7$F 34>L162?&/1I;E+=5;2;EBT@'+!X\')[@4 :7A7Q+<W\N
MO1ZS<6<;66KO80,@\I74(A PS'+'<>]=-<W5O9P^;=3Q01 XWRN%&?J:\?NM
M*T^]\*?%*ZNK2&:>"_O#%)(H8QE8(V!7/W3D#D>@]!6J-41_&6D6NKZDMI#<
M^'X7LY)U1DDE)/G#+@C<1L^H% 'J"LKHKHP96&00<@BN7D\27>J>*KSP_H2V
MX;3T1K^]N%+I$S\K&J J68@$DY 'N>*F\$Z9I^C>'A8:7?S7ME%/)Y4LA4J,
MG)5"H V@Y''H1VKF?!9&A_$GQCI&H,(KG4;I=0LRYQ]HB8'.WUVG@B@#K;:Y
MUV#Q!#8WR6D]C+;22"[@1HR)%9 $*%FQD,QSGG'08YU4O;62Z>U2YA:X09:(
M2 NH]QU%9GB74+BWT/5(=,)?5EL)I;>-!DA@AVG\6P!ZGZ&O/=1C@N?A#X6U
M31-O]K12V1LY4_UC7#.JRJ3U).9-P/7!S0!ZK-?6EN)#/=01"/&\O(%VYZ9S
MTS2F[MA<);FXB$TB[DC+C<P]0.I%><6&AZ3>>.OB'#<Z?:RQ!+1O+>,%06@;
M<P'0$^O7DU@6EC:1?#CX=ZHD$8U!M5T]6NL?O2I?:5+]<;>,9Q@ =J /99[Z
MTM@YGNH(@F-QDD"[<],Y]:6XNK>T@\ZYGBAB'\<CA5_,UYOIGAO0-6^(GCVV
MU+3K2>%39MY<B#:F^#YG Z!CS\PYZ\UE>$+A4TGP/97;&34UCO9+":[D(A2W
M#%0[+_&WE[=H!'!)R* /7OM-O]G%QY\7DM@B3>-ISTYZ4U;VU<S!;F$F$XE
MD!\L_P"UZ?C7A[)9W/PGNHR]O,UMXEQ"T>!Y:M> 93!RH()Q@]*[:WTO3[#X
MR-9VEE;P6USX=9IX8XPJ2D7"@%E'!."1D^M '=B\MC"9A<0F('!?>-H/IFI0
MP90RD$$9!'>O+-%LVL;ZY^&DEN3:178O87*95M/9C)M)[D2#RC[-[5Z%X@B@
MD\,ZI%/=-9P-9RK)<)UA4H06'T'/X4 +<ZE'+I]V^F7EI)<Q1LRY;S%# ?Q!
M2#^HK-\&>(6UWPKHU[?36ZZA>VHG:)"%SZE5SG%<SHUQJ6GZW)HOB#3K(WZZ
M1+]DU2PXCN8$*@JZ=58$J?3DXKG-/TZRM? /PTU*"VBCOGU6R1KD*/,96W!E
M+=2".,=.!Z4 >R27UI#<I;2W4"3R?<B:0!F^@ZFL"ZUO48/B/I^B9MSI]U83
M7'$9\P.C*/O9QCYO05YYXWN[*X\*>.9]/>*'RM21)Y+I]\\EQ&8QB,9&Q5QQ
MUSAL "NROI8Y?C#H#QR*ZG2;O#*<@_/'0!H^#];U'6+CQ##J)MRVG:H]G$8(
MR@**B,"02>?F/>NCDGAB8+)+&A() 9@,@=3^%<;X (_M/QI_V'Y?_1455/$>
MF6%Y\7/#0N;2&42V%YYH= 1(%\O:&'\0&3@&@#O8;B&X@6:":.6)AE71@RGZ
M$4R"^M+J-Y+>Z@F1#AVCD#!3[D=*\8N)CI7A3Q#!;H(M(A\9"*\CC&$BLRT9
MD7 Z*2<$=,,:[+6+-8OBEX8ETV- MW:74>HI&!MDMU1=A<#@@.P /OB@#J=$
MU_3O$-F]UIMPDT*RR1!E8'.QBI(]B0<'N*R)?$%Y;?$@Z+<RVJ:7_9#7P<J5
M=6$JI\S%L8P3V'6LWX3+:1^$-L:PK<?;+L.% #X%P^,]\#(J+5--L-5^,]M;
M:C:P74'_  C[L(9U#HQ%PO53P?Q^O:@#O4GBD@$Z2HT)7<) P*D>N?2FVUW;
M7D7FVMQ%/'G&^)PPSZ9%>+,W_".Z5>PQ2M;^%4\6+'OQOCB@V_-P<CRQ-@>F
M0:] \.:9I-OXJU'4M/UDWMQ>V\9N8H3'Y(P<(Y"#AB,@'N ?2@#KZ*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KD];T.[UOQGH\UU813:-IZ2N0[J2\[@*K;3V4
M;N>N3TXKK*:[K&C.[!4499F. !ZF@"O'IEA%8R64=E;K:2AA)"(AL<-][<.A
MSWSUJPD:11+%&BI&H"JJC  '0 >E<C9^)YK[XE#2+6^LKK2FTIKI3;@,RR"5
M4P7#$'@],#K731ZG82WSV,=];/=H,M LJF11[KG(H 99Z/INGR>99Z?;6[X*
MAHHE4@$Y(&!P,\XJPUO URERT*&>-61)"HW*K8) /8':,_05%+J>GPWL=E+?
M6T=W)]R!Y5#M]%SDT7&IZ?:>;]IOK:'R5#2^9*J[ > 3D\ ^]  =-L6U)=2:
MS@-\L?E+<F,>8$SG:&ZXR3Q50^&=!,=U&=%T\I=R"6X7[,F)G!R&;CYCGGFK
M1U33Q-;PF_M1+<C= AF7=*/51GYA]*6\U.PT[R_MU];6WF'">?*J;CZ#)YH
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M$[HOM$*R;#WQD<59DL[::T-I);Q/;%=AA9 4*^F.F/:A;RU>:6%+F%I8AF1
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M#;&]MA<3KOBB\U=TB^JC.2/I0!E^'['53--JNO):1ZE/$D/E6K%HX8UR<!B
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MTE@%IJ-Z;>=6CRY'ELPPV< ?+Z?C0!M6^B:3:QW,=OI=E"EUGSUC@51+GKN
M'S?C2Z?HVF:2K#3K"VM0P"GR8@N0.@X[#L.U8ND:SJ5SX_\ $&CW4D+6EE;V
MTMN(XMI'F;\[B2<GY1Z?2D\5ZUJ.D:SX:BM98%M;_4!:W"O'EMNQFR&S@?=]
M/QH WK/2]/T^6XELK&VMI+E_,G>&)4,K?WF(')]S3+_1M,U5HFU#3[:Z>(YC
M::(,4]<$\BIK._L]1B,ME=P7,:L5+P2!P".V0>M-MM3L+RXE@M;ZVGFB_P!9
M'%*K,GU .10 K:?9/IYL&M(&LBGEFW,8\O;_ '=N,8]JCTO1],T2U-MI6GVU
ME 6W&.WB" GU('4U8GN(+5 ]Q-'$A8*&D8*"3P!SW-0#5],*W+#4;0K:G%P?
M/7$)_P!OGY?QH N457%_9FQ%\+N#[(5W"?S!Y>/7=G&*6TO;6_@\ZSN8;B+)
M&^&0.N1U&10!/17':KXJD3QKX;TS3=0L)[2]GFBNXX\/(I2)F'S!OEY'3&>.
MM=/)J>GPWJ64M];)=R?<@:51(WT7.30!:HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KAOB?>F
MQTW0WN#MTI]9MEU)C]T0Y)^?_8W!<_EWKN:CN+>&[MWM[F&.:&0;7CD4,K#T
M(/!H \VU:XB7XL74NE2VYU"7PK,(3&RY>7S08Q[GICVJIX:_X1KQ#HGA*X;Q
M#<G4+"6)HK.-H5F2<#$B,H3>5/S%LGD DGO7I%EH6D::Z/8Z796K1J40P6Z(
M54G) P.!FG0:+I=KJ$NH6^FV<5[+_K+B.!5D?ZL!DT >56#:'X@\-:OI/B3Q
M!<6>HPZG,]W:JT*3>:)BT;1[D+DD; N"?[HXXKH-,TK3KCXM^)$N+*WE!TZT
M=EEC5LL3("Q'3<1U/O[UVLFBZ7-J::E)IMF]^@PETT"F5?HV,BE.CZ8;F6Y.
MG6GGR@K)+Y"[G!Z@G&30!XQ:V5E%\"]%U!((A>1ZE"4N-H\Q=M[M&&Z\+Q]*
MZ6>[TVY\;>+M&\1:R=.^T1Q"!93"J36IB (5I$/1_,) /4D^M=]_PC^BFV%M
M_9&G_9PV\1?9DVAO7&,9IUYH>DZB8#>Z797)M_\ 4^=;J_E_[N1Q^% 'GNDS
MV>E_$'PYIDMU/)I,>@LND37S#,DOF8)!P 6\H+C@':?>M/X:/9K>^,8;1X=H
MU^=PD3#&"D?( [9S79:AI6G:M L.I6%K>1*VY4N(5D4'U (/-26NGV5AYGV.
MT@M_,;<_DQA-Q]3CK0!Q=V]K;_&VV>X:&,/H#A3(0-S_ &A< 9ZFN=TYH-2^
M"WB9-7"_VM!)>M>[O]8MT'9HSZY'[L+] !7JTUC9W%S!<SVL$L\!)AE>,,T>
M>NTGD?A4,FC:7+J OY--LWO1C%PT"F08Z?-C/% $?A[[=_PC6E_VGG[?]DB^
MT[NOF;!NS[YS7CL]E9+\%M8U(00_;(M8=TN-HWH1? ##=1P3T]3ZU[FRJZ,C
MJ&5A@@C((K._X1[11;-;?V/I_D,V\Q?9DVEO7&,9H \[\7WVGS2_$"WMWM[:
MYBTM([R2[?<TY\EVC2)"0%'S?>YRQZ=ZFU?;%X(\)^-+,K<7.A10RSLA#%[=
MHPDZY]0#N]MIKT)M%TI[@7#:99-,(O)$A@4L(\8V9QG;CC'2ITL;2.Q^PI:P
MK:;#'Y"Q@1[,8V[>F,=J //?%D\L'@2?7F65(;[4+:ZO3&F76R$B #:0?^68
M4E2",LV1@FM70[;P_=^,!K>FZ_+J5_-8>5((9(6B\D,"K.(T'S9.!GGJ.QQV
M31H\9C9%9"-I4C((],55T[2--TB)X]-T^ULHW;<ZVT*QACZD*!DT <?X_@MK
MKQ)X*@O(XY+>34Y%=).5;,+X!!ZY/;O7+^(]/ET?5/'4GAFW,-E_9$!NXK1=
MJB?>=^T#@-Y.2<?W@>]>N7MA9ZE;&WOK2"Z@)R8YXPZD_0\4ZUL[6QMQ;VEM
M#;PC.(XD"J,]>!0!Y] F@:MJ&G:YH7B&6^U6*QGCLH(&@ V&,\2HB A58+@'
M&&('>LKPS_PCGB'PUX6>X\0W0U*PGA=;-&A6=;H<.K+LWD$EBV3R,DGO7IUA
MHVEZ5)-)I^FV=H\QS*UO L9<^^!S1%HNE0:E)J,.FV<=](,/<I HD;ZL!DT
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MFGVD#QQ"%&BA52J9)VC X&23CIR:;;:-I=G>SWMKIMG!=3_ZZ>*!5>3_ 'F
MR?QH \CN]/L;CP#\3KJ:VADN(]6O=DKJ"R%0A&#VYYXKU[3IBVC6DSL6)MT=
MCU)^4&HAH&C"&6$:18"*4[I$%LF'/J1CFKL$$-M"D,$211(,*D:A54>@ Z4
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MQL-2)L+FZ>*Q>YE7]^[$G$>  5)W8P,'MP1764 %%%% !1110 4444 %%%%
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MCY1QM]^,4 ;OAGQ;IWBJ.ZDL6.V">2(!@0S!3MW8(XR<\5OUYKX)\2:1X?\
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M(5!+;'*[6Q@]">E &F !T&*  !@  >U>>^$?&MI::?=P^(M<#77]L7-K$\^
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M?:@MA!> W+QF6)'1D\U/[T98 .ONN14VJ:UINB112ZE>PVR2R"*/S&P78G
M'4]: +])M'H*P5\;>&WDNHUU> O:@-(G.<'@%1CYP>Q7-68?$VBW&BQ:Q#J$
M+V$K!(Y5R=[EMH4+C);=QMQG/:@#5VKZ#\J,#.<<^M4+#6].U*.Y>UNE(M7*
M7"NIC:%@,X=6 *\<\CI7(ZOXI%QXX\(6VEZI.+6\FF\Z#RBD<Z"%F5U9E!89
MQRI(Z4 =XL:*[.J*&;[Q Y/UIW6LF[\3Z-870M[J^6)C*(2Y1O+60]$:3&U6
M.1P2#R*OWEW!86<MW<OY<$*EY'P3M4=3QVH E2..-2J(J@G. ,<TNT>@_*L<
M^*]$$.GR_;AY>HG%FPC<B<GH%XY]?ISTI-8UG38K/4[6?53I[P6^Z6XQM-N'
M!"N"PVYX..O(/I0!L[%Y^4<]>.M&!G.!FN4N/&.GZ*_AK3FN+B];4XQLNC"Q
M+QK$6\P[5^\Q X _B)P *R[/Q9%H_C/Q=%KFLO\ V?:_9&MEE4?NP\;,V%1<
MD>IQP ,F@#OC&A<.44LO1B.108T9U=D4LO0D<BF6]Q#=VT5S;RI+!,@DCD0Y
M5U(R"#Z$5BCQOX9:^2R76;5[A[H6BHC;LS$ [,CC/(]N<4 ;]-$:"0R!%#G@
ML!R:R_\ A)]&_M"&Q-\HFG=HH2R,$E<=55R-K,,'@'/%/?Q#I<=VMLUR?,:8
M6X81.4,O]S?C;N]LY% &E@9S@9H(!&" 1[USEW\0/"=BLC7&O6:B.8P.58MM
M<8R#@'IN&3T&>:UKK6+"T@AFDN-ZSKNA$*-*TJXSE50$L,<Y H N(B1H$1%5
M1T4# H9$="C*K(1C:1D5G0^(=(N-(CU6&_ADLI#M25#G<V<;0.I;/&W&<\8K
M*UCQYH^E^&=3UF.5[@6&4D@6)Q(LN.$=2,IGCD@#'- '3@!0   !T I%C1%V
MHBJ,YP!BH;*\BOK-+F(ML8?Q(RG\B :Q/#_C'3_$%SJT<'F1II]R\!>6-D#!
M%0LQ)  Y8C!YP,T =%M'H/RI:RK3Q)I%]>Q6<%X#/,AD@5T9/.0=6C+ !Q[K
MFM6@!JQHC,RHJLW+$#!/UI<#.<#-<_J?B^QTWQ3I^@R+,9[J-Y6<1.515 QR
M!R22/H.N,BN=T7QC;Z1J7BB/Q'KA,5MJGDV[3@92/RT/1%&%!;KC'/)H ]"9
M0PPP!'H:-HYX'/6J5[K%C81QO/,3YJEHUAC:5W4<DA4!) R,D# R*DT[4K+5
M["*^T^YCN;64926-L@]OY\8H L[1Z#\JP-#T;5K>\>_U[5(=0O%1H;<PV_DI
M%&S GC)RQVKD_P"R/<E;OQOX:L7O([C6+</9%1<*I+F,D$C(4'L"3Z=\5=_M
M_2C<:? +V,OJ*[[/&2LXV[OE;&#\O/7I0!I4T(@<N%7>1@MCDBLJ3Q3HD,6H
M2S:E#"FGL%NS+E/))&0"".XY'K4">-?#;WB6HUBV$SPF90Q*AD R<,1@D#DC
M.1W% &[@9S@9H"*N,*!CI@=*X[Q%XHMM1\ >(=1\.ZNRW&GV\K&2)0'CD5"V
MUE=<C/T^AJWX>\9:)J)L=)&KP3:LUJCO%N^9V"@M@]&(YR <C!]* .E$:*Y=
M44,>"0.30(T5RZHH8C!8#DUEWGB?1K"Z%O=7RQ,91"7*-Y:R'HC28VJQR."0
M>15:_P#&WAG2[FXM[S6;6*:V9%F0MDH7)"@X[\'Z=Z -.RTZ*RDN95)>:YD\
MR5R ,G&  !T  _F3DDFK31HY!9%8J<@D9P:2::*W@DGGD2**-2[N[ *JCDDD
M]!6=:>(])O;LVD5V%N/*\X1RHT1>/^^N\#<ON,B@#3P,YP*"BD8*@@]L5A6G
MC7PW?7]O8VNL6TUS<2/'$B$G>R#+ 'IQ@_7!QTJ[J>OZ1HTL$6I:C;VLDY(B
M65P"V 23]  <GI0!H;1SP.>M&T>@_*L*Q\:>&]1T^\O[76+5[:R.+EV;9Y7^
M\&P1G!QZ]JH:CXR\,ZAH^H10>*(K(K:K*UU$V&A20?*R[A@GVZ_0T =;2!%&
M,*!C@8'2L^75;+3[2U,]T\AF0>5MC9Y9L#)(1!D\<G XIL/B#2;C28]4@OHI
M;.5ML<D>6+MG&T*.2V01MQG/:@#2VCT%  '0 51TO6=/UF*5["Y$ODR&*5"I
M5XG'565@"I]B*=?:M9::T:7,K>;("8XHXVDD<#J0B@L0,C)QQD4 6TC2,$(B
MJ"<X48YH5$0L5506.6('7ZUS7B#QC9:?X&OO$.G3QW:);R-;L@+JT@4X#8Z8
M(YSC&,4>&(+FXDBU9=<O+FUGM52:TN(L#S^"9%) *C!(V@;>>.E '0W-N;BV
MDB60Q%^"ZJ"1],@C/UHM+6&QLX+2V01P01K%&@_A51@#\A5*;Q#I<%W]FDN2
M'\Y;?<(G*"5B $+@;0QR.,YYKD;#Q=#HOBKQ?#K^M-]CM)[<6PF4$QJT(=L!
M%Z MR<>F30!Z!L7GY1R<].]&T>@K/N==TVT2U:2Z#_:U+VZPHTK2J!DLJH"2
M "#D#'(JL_BWP_'IUE?OJ]JMK>R"*VD+\2,3MP.^0>#Z=\4 ;#1HZ%&164]0
M1D&E"JN< #/7 ZUC6WBW0[VQ%Y:7ZW$)E>%?)C=W9U^\H0 L<=>!TYJ6'Q)I
M%SIL.H6]ZDUM-)Y49B5G9W&<H% W%A@Y&,C!]* -3 SG H  Z "JUAJ5IJD#
M36<OF(KM&V5*E6'!4@@$$>E0:AKNFZ7(8[JX(D6/S62.-Y&1/[[!02J\'DX'
M!H OI&D8(1%4$Y(48YI64,,, 1Z&N2\;>+XM%\%OJVFW"2O<"-;6:-?,0AW5
M=X(!' ;(SUQWK3T*RFBN+J\CUB[O-/N0IAM[I/FA89#$,0&P>.".,<=: -K
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M>BC)')XKG_$VDW/B+6O%.I^&P)HI?#ILFF@/RW5P7+;5(X8A!M)']X"O6**
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M*XM[K,"W.JB>RMY!M9(#=JZ@+U'R@MCL#7L\4L<\2RPR))&PRK(<@_0BGT4
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MENN0,G&*]RHH 165T5T8,K#((.012T44 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/#M)PZAAA@RD9!P>N.U98BTB'3/#/V?69TU;P]&(K:Z_LBXV2Q[ C(Z8SAE
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M",55E8L=O(''/?GGBG'JMA=ZGINHZUJC7-QIB/\ 9A!I%S&IE==ID8$'G&<
M8QD\GC$GA+5-+\-65[;3ZK-=BXO);L,FD7,6TR,6*\ALC)XH ?\ %_\ Y$N'
M_L)6G_HT5WU><^-[[2_%NC1Z=!J\]DJW$<YD?1[B4DHVX#&%[XJ5_$<MU+;I
M=^((Q:K*KS1VWA^ZC>55.=FYF8 $CGCD<4 2/XWN])G\<3:J(9K;0?):!8(R
MA</'O"G)/)) S^.*GU35?$6BZGX:2XO;65-5O5MKJ%;? B)1G_=MG./EQ\V<
M]>*PI8=!OKCQ6-1U6XFM?$*QJ\<6DW"- 438I#$')X!Z=16)J&M-9WO@Z+5O
M$+ZD+355VL-*EMV*")UW-D$NW('RXZ]#UH [%/%&L'1/&\QFMS<:%-,ML_D\
M.J0B0!QGGDXR,5-)XFU87_@90UL+?6T)NU\H[@P@,GRG=@#/;&>.M<[>K9RS
M>)H;+Q!-;Z?KR,TL3:+</)'*T7EG:^,;3@$C;GL".M6#)I^_PHW]NRDZ ".=
M$N?W_P"[\O\ X#\OUY_*@#0U/6-1\2^&?%]Q8745M9V NK**-HM_GF-#YC,<
M\ DD+C&,9.<XI=&U#4+7PKX0@CN8;.PETB(O.%$L[RB--D<<?);@L3@'@=NM
M8K):6<NOV^D^()8-*ULRRS6T^BW,C0RR+AVC8 8!ZX(..U+9):Z;>:%=VGB6
M82Z=IO\ 9DGF:'<,LD0*D,@_@?Y1SR#QQVH 2\\1ZUX@\$^#=3^UI:37FNPV
MURD4/RR%9V4'!.0,QAMOZUUSZYJ=I\0K31+B>V?3WTJ2[=EA*OYB.BDD[B,<
MDX 'XUQ<%AIUMX3L=&3Q'<M-IVIC4;2=]$G*@B1I-KJ -V=YR01VP!WVFU#3
MI/&5EK\NL32"WL6LGA.C7 ,@9@S-NQ@<J.,'CUH =)XOUN;P WCBS: VR;K@
M:<\?#6RN0<OG(DVC=GIGC'>K1U_7M5\:G1],O+*WL;C1H]1@FDM6=X]\A7D;
M\,<#V ST.*P+:#2K3P[=>%HM:N/^$>G=ML9TFY\^*%VW-$'QC') 8C(![\&M
M2._TJ#QJVOP:G(D(TU=.CM/['N?E57+@[L>IQC'2@#H? NN7GB'PI!>Z@(A>
M++-!,8AA6:.1DW =L[<X]ZZ2N!\)Z;=Q>'/[.T7Q -\.H&YEGDTMX]T;R,[Q
M[9#WR1N'2N^H X'XQ?\ (@M_U_6O_HY:O:[K&NP>.M(T33Y[*.VU"UN)"\L#
M.T;1[>>&&[[W3CZFK?C?PQ<>+M#&EPW\=DGG1S-(T!E)*,&  W+CD"EN_#E]
M>>+=(UY]0MU_L^"6$PBV/[SS-NXYW\?=&.#0!'X(UK4=6M-6M]4>&6[TS4YK
M%IXH]@E"A2&VY.#ANF>U9MU)J;_&:TM4U'9:+HTDRP&($#]]&&[]3@<]O2MK
MPQX=N= GUF2:^BN1J5^]]A(#'Y;,%!7ECD84>E-U#PW=7'C*R\0V>HI;/%:/
M9SQ/!YGF1EP_RG<-K97J0?I0!P%KJ6N:)X>\<:SI5S:1QV&OWD[PS0&0SX*9
M7.X;!CN 3GT[]C>>)+R_UN;2=,\Z$P645S)-' )F#2EMBX) P A)]<C&,56;
MP%>OX9\2Z,VL0?\ $\NYKEI19G]SYN-R@>9SC P<BGZAX+U;^U;+6M%UZ.PU
M2*T6SNB]KYD-S&IRN4+9!!)YS[4 ;OA:]UB_\/6T^O6 L=3^99H5(*D@D!AR
M< C!QGC-<S>^)O$.I6^K7/AVV>26PO)+:"W-N&2X,;;7#N6!7)#8QC'&<YX[
M33+.6QL4AN+I[NXR6EG<!2['DG X [ =@!7*#P7K.G:_J%UH/B3[!INI3FXN
MK1[592DK??>)B?E+>X(!['I0!*NOZM:^.M+T_4?*@TW5;%Y;>,Q_O([E "\3
M-G!PI)! YP:CF\3ZA#;Z4@82SZU=RBT9(,F.V56<-MS\S%54]L;NG&#I^)_"
M-MXDT>SL&GEMVM+B*:&=&)=0O##.<_,A9<^^>:;XK\*?\)#8V0L;Y],U#3IA
M/8W42!A$P!7!7H5(."/_ -5 '-ZMXE\8:-X8\3WDUM$G]G*DMA>7-N!]HC(^
M9617X93WZ'TK336M?LO&FCZ;?7-G-:ZQ:3R1I% 5-M)&JM]XM\X(;G@=.W2G
MZCX0UC6O">I:7JNOQS7NH1B%[A+3;'$@.<)&&ZG)R2?3T%6[GPS>W7B30-7?
M4;<?V3%+&8A:G]]YBJK'._Y?NC'!H S?AI)J5Q9:Q/?Z@;HC5KN++1!6)1]H
M.0>F !C'%:E]K=Q<^-(_#%C,MNZV!OKBX*!V"E]B*H/&2<DDYX XYR'^&/#=
MSX=GU-3J*W%E=WDUW%#Y&UHVD;<P9MQW8/3 '4YSQA-6\,S3^*+/Q)I=VEMJ
M,$#6DJRQEX[B G=M8 @@AN01^(- ',WVOZIJG@_QQI-W+##J>BPS1RS11';/
M$T+.C $_*Q7KR<$5U/@J*>/P;HQN)TF)LH3&5CV;%\M?EZG/UJK+X/D?0_$%
MLM]&-0UW?]KNS 2H#1^6 J;NBK@#)/.2>M;6A:?-I.AV6G3W$=PUK D(E2,H
M&"J%!P2>>/6@#E/#SZG-\2_&$=QJ/FV]L+15B,0&$:-V"@YXP6/KFN6\'ZOK
MF@_#OP5>Q7%HVFW%U#8RVAA)<K+(R[_,W<$'MC'N:[Z+PS>V?BW5]:L]3B2+
M4XXA+;R6V\B2-"BD-N'RX.2,9XZBLB+X>WD/@S0_#J:S!C2KR*Z6<V9_>>6^
M]5*^9QR>3F@!^H>(]<U%]=7P_$_FZ9.;:!/LXD2XE5%9@[%AM!+;1C&,9R<X
M'76$]W=Z/;3W%O\ 8[V6!6DA?Y_)D(Y4X/.#[\URT_@W6;3Q)>ZIX?\ $2Z?
M#J3*][:RV@F4R !3)'EAM8@=\CUSTKL+:!;2TB@5W=8D";Y&RS8'4GN: /+!
MXM\;2>!KCQ7%-I31Z?//Y]F+=A]HCCE96(;=\F%' P>F2><5KRZ_XFU?Q9-I
M.C7FGVT$FD0ZE;RSVK.R[W(VL-W)P.O&,]#67X(T>[\1?#V\TQK^!-,N[^[2
M;9$3*(S.VY V['S#OC@-T/!KL;;PQ/:^-WU^.\@6V.GI8+9K;D%41BRD/OZY
M)'3I0!G6VN:UXAM=>NM'N;> Z7=2V=O%)#O%Q)$HWESG(4L2!C! &<G.*RX?
M'&M:]/X0;1_L5M!KUK<2.+B)G:"2)1GD,-P!)P,#.!R,UN6_A.^TG4-9DT74
MX;>SU:5KB6&:W,A@G88=XR&'WL X/<?A7/ZKI,>@^-/AYH^CRQ0K:6]['$)Q
MOW 1IG=@@Y/)SZ\X/2@ 7Q]K&A0>(M-UM+6ZU;2Y[:*VGB0QQW N#B,LN3MP
M<[L'M@>M;UYK>J>'O%>B:??W$=[8ZNSP"00^6\$ZKN'0X*,,C!Y&.IIM]X M
MM8T[7(]4N2U[K#QO)<0+L\DQ >4$!)^[C/)Y)/3.!=A\.WMYJ>EW^NWMO=2Z
M8', MX#&'D9=ID;+'G&< < DGGC !C^&?%\^N:Q%9R:A%;:C%-*NH:/<0^7+
M$@#;3&3RPSLR>00<_+TJO'XK\2ZKI5EKNAV$EU#-< _8C H5[?>5R)"P(?'/
MIVQW.JG@^ZNK[0[K5[ZVNI]'D,D5U%;F.:7Y2H5F+'CG)_O$#I572/ VK:'/
M+I]CXD9/#;RM*MB;8&6)6.6C27/"DD\XR >,'F@!\VL:CXCC\3KIMU%:VVE/
M)9)OBWF:98PS[N>%^8* ,'@G/:KGPT_Y)IX<_P"O"/\ E5;_ (0S4;#6M9N=
M&U>&WL-9)DNK6>U,I24KM9XV##!/<$$9_*MKPGHDOAOPO8:/-=K=FSB$0E6+
MR\@=.,G^= ')ZQK&H^)O!WC"\L;J*WLK-+NSBB:+?YXC0B1F.<C)W!<8Q@$Y
MSBGZ=K6HZ;:_#BPMW@^Q:E:)%.K1DR?+;;QALX R!V_&IV\!ZE:)X@L=*UJ"
M#2-:,TDEO/:F1X)95(<QL' VGK@@X[597P7>K_PB?_$WA;_A'UP";0_O_P!W
MY?\ ?^7Y?KS^5 %6'Q?/<^*[G19-0BT_48;X)'I]U#M%S:[A\\;G[S%=QX/&
M,;>]$'B^>Z\57.C2:A%I^I0WX2/3[J':+FU##]Y&Y^\Q7)X/MCO5[4_!]UK7
MEV^IWUM/;0ZB+ZWE^SD7$($GF"-7W$?[.[ ^7C'>DU+P?=:T8H-3OK:>W@U'
M[=;RBW(N(0)/,$:ON(]%W8'R\8[T 00Z]K.OV&O:AHMQ;P+IMU-;6T$L.\7#
M1 ;BYR" S9 VXP.><XK)NM=C\37OPUUJ*(Q+>74LAC)SL/V=P1GO@@\UO6_A
M&^TJZUI='U.&WL=7E:XDAFMR[6\SC#O&0P'/7!'!_*B?P0(Y/"Z:9=QVMIH#
M$QQ20&0RY0IRP88X).<=: *D7B35WA\;QF:#S-$8_99/)ZCR1)AQGGDXXQ67
M<:GK.K:W\-[A=02W&I6DMS+$L.4\W[-N+8SD_?8 9X]ZV;SP7J+ZGXBDL=8B
MM['78O\ 2(GM=\B2"+R\H^[ !&,Y4GTQUH'@>^BMO"GV?68TN_#\;0),UIN6
M6-HA&?EW\-@ @Y(SV[4 (?%MYIWB/Q=%J30OIVC6,-Y$(8RKE661F!))R?E
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M7>M:>%(!JMN/^$?9&#?9#^_VQF,?\M/EX/OS0!V5%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%<]XMU^71(-,@M@GVO4[^*QA>096,ODER.^%!P.YQ0!T-8-]XOTK3[KR93.
MT8NELY)XH2\<4S8VHS#H?F7GH,C)%9AUC4]*\<VWAR[NS=6VJ6DLMG=-&JRP
MRQXW*P4!67!!!P/0YJC\,X+I3XEDEOGF0:[>(R&-1N8,OSY S^'2@#OBP! )
M ).![UF:;X@L-6U/4M/M6E-QISHEPLD3)M+#(QN SQSGIR*YCQ=_:#_$3P9;
MV^IRV\$SW9,:HI 98#AN1R<,1STS62!JZ^,/B)-I.H164D M9=[P"4L5MLA<
M$X XY/)^E 'J-%<'9^,;[6;?PY;6\4L=UJ6E?VE<O:K&60?(,()#MY9SR<X
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MNQMSQG;G!(ST(U(_#5Q#XSN/$,=_"!+8K9+;?9CA%5BRG=OY.6/8<>G6NBK
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM<K=I;FV9$F*Q2H=V-Z=&(W-CZ_2G:%H]]IJ/+JFL3:M?. IG>%(E51T"HO
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MGO;&TS]GA$"PX!).'8$EL9/<#US0!RR^)?&WB'Q-XKTSPW=V(33KF.""2XB
M6/!_>9(!RV>!GC"MWQ6O#XFU[Q:/$4GAAH8H-,D:SM&?;FZN0!N+%@0J+D8
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MVKNAUF:&X+10 &"2+;L(RQW#Y!D'K[5=L_!]Q#XH.O7>MSW4\EB+.>/R$19
M&+ C RH^8\=??M0!ROA;6K_3/AWX2C2YNKN[UF185+"(M$-KNY7=M!8[<#>3
MR<\XP>N\./XE75]2@U>*5],&Q[&YN#")LD?.CB([2 >AP..M9:_#6,^#K70)
M-:O"UA,LVG7:(J26K(3M(Q]X_,0<]1Z5T&@Z-?Z<KRZKK4VK7K*$\YX4A5%'
M947@9/)/).!Z"@#.U_5M2L/'/A2PM[A%L-1DN$N(O*!9MD+.OS'H,XZ8Z=:P
M'U7Q1>+XU6+7([9M%F)MFCLT.0(1(%.[/R\\]_<=*ZS6/#LFJ^(M%U9;X0G2
MGD=(O)W"0NA1LG</X3QCOZU2A\'SP_\ "2XU1"==):3_ $;_ %)*"/Y?FY^4
M=^_/M0!AIXB\01IX+UJ;4(GMM=EA@GL%MU")YL)<,K\MD$>N#Z"AM3\3WUWX
MTMXM<CM?['=3;/'9H3S")-IW9XR>>I]".^N_@F9]*\-6 U50N@RQ2PO]FYE,
M:%%#?-_=)SCOZ5/!X1N(+GQ).-30MKF/,!MN(2$\L;?FY^4=^_/M0!ST?B3Q
M"MEX*UZ;4(FM];GM[>XL$MU"*)8RVX-RVX$>N.>E6+G7/$^N6VKW/AU+E9[*
M^EM;:(+;F"4Q-M82EVW_ #$-]W;@$=>2=!O TQT/PYI8U90FA3PSPO\ 9N9#
M$I50WS=,$YQ^E-;P)=VNO7U]HWB6\TRSU&7SKVRBA1P\AX9T9LF,GN0#_+ !
M)9ZSJ/B#Q/J.CQW#Z7_95K;M<^2(Y',\REMN6#+M4#L.2>N!SQFCZKJV@_!U
M+ZQNXDN8]8DCE<PAMX>\*-@'@?>)[UW$_@QX/$W]N:'JCZ9-+;I;7<)A$T<Z
M)PAP2,,!P#SQVZYSQ\.6'@Y_#@UR9HGO?M9F>W4D'S?-P "/XNN<^V* )O%6
MJZK97FI+;ZF+9(=.,]I!:1+-,\HW$M*&4A8QA0#E<Y/.>F'<WVHZ[K/PSO3J
M5Q:'4K:6XEB@";%D^REMP#*<GYV'.< \8/-=)>>"IKK7-3U&/6I[=-5M$MKZ
M".%2'V*5#(6R4X8\<]>N>:@B\ R06'AJ*+7+A;K004@N/(0[HVC\LKMZ#Y<8
M)SSZT 4[K6_$FMIKC^'A=)/I]V]I;(JVYAE>,#<)?,;?R21\N,#!YIUV]S/\
M3?"3W<7V:[DTB[,L:,&\MSY60#R#@YYJW-X%NX/$-YJ6B>);S2H-08/?6J0I
M*LCXP70L#L8@<G!K0F\+9\3Z5K$-Z(H],MGM8[<Q%MR-MSEMV<_*,'^= &#9
M>(]7M+?Q1I.I7QFUNRG5+%A$B"5)L+;L %P<L<-UP0:[F&*XCL$B>Y\VY$>#
M.Z#YFQ]XJ,#KV%<7IYT/QOXTL/$VE&2>'3+:2%[DQO&LDC,-J88#=LP[>Q9:
M[J21(HVDD=411EF8X 'N: /(E\2>-6^&R^,TUBU=K*25IK'[&H6YC29D.6ZJ
M0!QCTYR36[-J7B76?&EYH^F:W%I]J=*@OH)#9+(T9=R,$$\Y"\G/T'>LOX>Z
M.?$OPTBTZ;5(GTN6ZG^T6T<0\S;]H=MF_=PK8!/RYPQP>F.V@\-R0>-)_$(O
MEQ-:)9FV$& $5BRD-NZY)[8QVH P'\7ZAI&J>.WU&5+JTT2VMY[:)(PGWXW8
MJ3R3D@#)HU37=;\/:3H&O3W_ -MM[R>"&^M3"BH@FP-T1 W#:Q'#%LCWYK83
MP=$^L>(KR]N5N;;788X+BV,.T*B(4&&W9Z,<^_3%16?@R1+#3-,U#53?:;I<
MJ2VT;0!9&,?^K$CY(8+P>%7)49SSD SM-N_%&L>,-?L%UR"WM=)OK?"K9*QE
MB:,.T?)^7@XW9)^G0S?%<W*>!Y)+:]GMB+NV1Q%M_>*TR*0<@\<YXQ[Y&16Q
MHWAR72?$&M:JU^L_]JR)))%Y.T1E$"+M.X]@,Y[^E3>*?#\?BCP]<:5)<O;>
M8T;I,BABC(ZNIP>#RHXH RFU2]N?&0\*PZC/%]FT_P"V7%X(XS+(6?:J@%=@
M  ))V^G3G,G@W7;[4;C6])U1DDO='O/LYN$3:)XV4,C$#@-@\@<4^X\)S-K-
MCKMKJK1ZS;V[6TT\D >.YB)W;70%<8;D8(QWS6GHFB1:,MVXD,UW>W!N;J=E
MQO<@#@=E   'H.I.30!R\L=Y)\;$B&J72P+H?GK"!&4&9U#*,KT;:,G[WN!7
M*PWVMZ+X/\8:YI>I);C3]>O)?LYMU<3_ +T;E=CR!@\;<'W/;T:]\,O<>+[;
MQ%;:C+;31VALY8A&K++'O#@9/W>1R1V].M9#_#^23PMKFA/JX,6L7<MU+*+;
M#(9&W,%^;&,@8STYZT 27NN:EJOB#4M(TLWL L;:%S+:+;LWF2AB-PF.-H"C
M@#))/(Q6[X9FUJ?P[9OXAM8K;5MI%Q'$P9<@D @@D<C!QVS6'J7@B\GUFWUO
M2O$$VE:J+=;:ZEBMUDCN47INC8D CL<FNHTZR&GV,=L)I9V7)>:4@O(Q.68X
MXR22<  #L * +5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)+*K/N)=6&U0!@8Y).:Y9O&/B.YT#32MY%;ZC;^)ET2]=8 R7 #X+8/0$8R
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M&#DG.>U;?Q(U74M$\!ZEJ>E70MKNW"%7,:OU=5(P<COZ4 =717 7=[XE\/\
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M:);74;K&JOM# -\JC& QP!]3FJC?#\OX/M/#CZW=O;VLD31RM$FY5B(,:
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MO)V\D&.9Y?O ID87@8 .>!R><Z.@:#;Z!;74<+;I+NZDNYW"A0TCXSA1T'
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M5DA)4[.0=O*CD<X]*Z*B@#C_ /A P=#\0:4VJ2F+7+B6XN'\E=R-( &"<],
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M45 0I7Y<Y&X]2>M0Z;X..C:5I-CI^L7D8TQ7CB9U1O,1L?+(-HR!@'C!X'-
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M6T%I!M.[<<\= ",#/)W8?"T,'BT>((KR=9!9+8BV"IY0B5BP XSG)ZYK.F\
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MD\E5+QDC@@Y&>1[4 4;#Q/X@\1IX"ECU22P_MJ&[2\2**,C=%&?G7<IP<@D
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MH9G\QHSYZ@X9LD^N#GGVXJGI>L^)+CX=M>Q&[U6[AU::.Y$3*L\MNDS!A'@
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MXI@&",2O)4$C<,'I^(!ZY17#+-J>D_$G1[*35[J\MM5LKAYH9@NR-X]A!C
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MO(C()!'HSE%/J"WI7/?#>Z_L?7==\'R0S6\,$IU#38IUVM]FE;E0/17R/QH
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M=SK7@G1=2O&#7-S9QR2L!C<Q49./<\T ;M%%% !1110 4444 %%%% !1110
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MR"R[#M^3CY0!W_.C_A"K7_BG_P#B9:A_Q(ABUYB^;Y-GS_)S\O'&/SYKIZ*
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M@)4G)R1@$\#\JWZ .:LO!L%CK=WJ\>JZF][=VZ03/)*A#%<X?&W&1N/&-O\
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MSG2>VG0/'*ARK*>A% &5K'A>WUO0[;3;J]NPUM+%/%=QE%E62,Y5ON[<_P#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAN.6:&"WBC02P-L<,I#;P><$L,_C5JPT*"SU2;5);B>[OY85MS//L!$:DL%
M15'5B>F?R% '-^+)-2?Q[X7TVUUB[L[74([P3I#M_@C4@C(Z_,>3G'! S7+:
MEJ.OZ)H_C_1AKM_-_8\,-U8WSLIG"R*28V;'.".O!]Q72>+[>6[^(_@XQ&^B
M2V%X9;FVA+"$O&@7<Q4KR01S6W=^"]/OM'U/3[BXNV.JL&O;G<OFS8  !.W
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MSO!&N66L7.IK;S:G#/#Y2SZ9J9<RVC?-SEB25;C!R>GX5T>K:8FKZ>UI)//
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MP@85B0#ZD<GOFNY'VK1?BCI]J-4OKBUU'3KB6XCN9RZ!XV3#JO1.&(PN![4
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MK<S'R&A>)^/+^[D;1ANOO0![#6%+XD\KQI;^'#8R9FLY+M;DNNTA64%0.O\
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MISG3GNUO[R.RC$<H4B5\[<YXQQUS4&H>-%T*>V'B#2[G3[6XD$2WN])8$<]
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M +,W;7$<EG.+B"6WE,;HV".H[$$@U!;^%K2UU>_U."ZO$N;Z)(93O4C8@(0
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MO&G&ZDG(E5AF16<9 P0"!QG!J]-X0T>\T_4K._MS>KJ14WCSMEY2H 7D8QM
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MV;U+:68M&LQ8ON //#$D+G:#SBJU]X#T2_N]4GE%VJZI&4NX([EUBD;;LWE
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MD @NDBN72.=0"!O52 V 2!FF6W@;1[0Z,83>*='5ELR;EFV97:<YZ_+A<'@
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M*Y?_ (0'1?\ A'!H&;O^S1-YXB^T-G?OWYW=?O?-UZUTR+L15+%L#&YNI^M
M#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>7<4$D<S(;+RO]6J@' Z G^]DYJEJ#OXBT[X::KJ:2+>7MU%Y^R1D!S!(<@
M@#/7(YYQ0!Z/HMYJEW!<#5M-6QGAG:-?+F$J3(,$2*< @'/0@$8K3IL<:Q1)
M&F=J*%&22<#W/)IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;?S.(,C&%RW QQC\\UU-% %/5=+M-;TRXTZ^1WM;A"DJ+(R;E/494@X-4/\
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MG&<GKUK1HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN 0RA@00>012U%;0BWM8H <B- F3WP,5+0 4444 %>5:GJ-[X6^*@U(W=P=
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M069'^Z^[&%VD_>YQ@UJ6D=ROQ;U&^:RNULI-,AM4N# VQI%D=B,X]&'/3WH
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M<!\S#<VWG"Y."/49\ZTBTE\5?!;0/#EM9W2SSK;AYGA98X8TD#M('QM/RKP
M2<MT'..FT6.^\*>)O$T=W87ES9ZE=_;[.XMH6EW,RA6B;'W""HP6P,=Q0!O)
MXLTVZATV33O,U ZE"\]LEN5!:-<;F^=E P648SG)Z<'#U\26\EI9R1VEVUS=
MF016>U1,=A(?.6"J!CDDXY ZD"N#M?!,-EX4\/:)K%GJ*7$"7%PFHZ7O:33Y
MG<-L4H"<$.1T(.SZ4RYT[Q-;6GAC7M8TAM?DLEN;:^M?)0SM#(X,<H0\;\(N
M1UY^I !VMMXXTBXTN[O6^T026EU]BGM)$'G+.2 L84$ABQ(Q@D'/7K6#9W<E
MQ\;@LEK?6A_L!V:&YD#*3Y\8#+M9E'IQCI537M,O[_0M/UC1/#'V$V&K0:A_
M9OE)%<7,:!@Q8*<!OFX!.>/4X%^SFOM2^*=GK*:)J<.GG1GMFEN81'L<S*V"
M"<]%/O\ AS0!UVIZO!IDEI"T<DUS>2F*W@BV[G8*6/+$  *I/)_6J$OBVTAM
M+:66TO$N+J\:QAM&11*THW9'WMN,*3G=C'U%5?&NFV.KV]C9ZCIU[<6S2EQ=
M60?SK.0#Y9%V?-ZC@'KTQFN9C/B_3]$TR"[34M1LEU61);B*/%\UGM(B9AP5
M);[Q&&V^A)H V/$.N6OB#X=^+6MUN[6XTZWNH9HW;RY(IDB+#E&((Y4\$@UI
M:/J\=EX:T"V6&:[O;C3XWCMX=N]E5$W,2Q  !91DD<D5QUKIFIV_AWXB6 T*
M_@.HF=K-2H?S/,MU15!!.3G.3R!W-.O]/O[!O"NNMX<FUBTM]+&GW]AY ::$
M_(0Z(WWB&4@X[4 =]X?\0V7B2RFN+,2HUO.]M<03+MDAE0_,C $C(XZ$CFFW
MGB*&WO[BQM;*[U"ZM8EEN(K0(3$K9V@[V4$G!(49/'3D9;X:1/L$D\>B)H\4
M\F]+;RDCD(P!ND"\!B<\9/&,\\# L8+WPSX_\0W=S9W=SINLB&>"XMH6F,<B
M)L:-U4$C/!!QCWH @\:>,1-\,WUGP^9YHKLQQK<PE4,(:5$8'<P8-RR\ X/7
M'6NDT+0[+3KBZU&TLKC3WO0OFV;R+L1ER-P16*AB.I!YXSSFN"U+PSJ=A\)[
MO34L+B;4=0U,7WV2!-YA4W*R;21P,(OKUSC->K12K-$LBAPK#(#H5/X@\B@#
MFD\=Z9)):,MO>?8KR^.GP7NQ?*><$KMQNW@%E8 E<9'TK.T^('XO>((#),8Y
M-)MV*F9N"7D!V\_+T'3%<M=P>(M3L-(N=0\/ZK)J]CK\5Q=;0HA2)96($"[@
M"-I7YL<\EC76V,=U'\4M7U&6QNTM)=,@A2;R6*ET9V900.>&'U[9H /A0S-\
M/K3>[N1<W8W.Q8G%Q(.2>36]>>((;?4)M/M;.ZU"\@A$TT-J$S&K9VY+LHR=
MIP,YXZ5C?#*UNK#P7%9WUI/:W,=S<,T<T94X>9W4^_#"J]O!>^'/B-KVHW%I
M=7.F:U%;O'/;0M,898D*%&506 (.0<8H O3_ !"T*'1],U5#=36NHW*VD9B@
M)*2DXVN.JD$'(Z\< UM:/JG]L6)NOL%]8D2-&8;V+RY/E.,XR>#U!SS7FLWA
MO4M.T/3#_9]S)/<>+!K,UO#&7-M"9"<$CC(7;D#N3C.*]94AE!&<$9Y&* ,.
MW\4V]W+!]GLKR6UGN9+:.[0(8RZ;@<_-N RC#)&,_456/CC3AH.KZN;6]\C2
M+B2WNX]B;T:, L0-V"!D=#7+V>C7=MXELM3\/6^IZ7/<WY.KZ=+&WV.2/)WS
M*3\H8X!&TYYY'6J5_8ZQ;>'_ (@:"FAZA/<:E=W-U:S1Q@Q21RHN,-GEL@C:
M!G..V2 #4U354L?BKINH10W]TMQH4KI;6X:1G/F1XPA.U3CJ>!ZFN@T_QYI&
MI:1]OA2Z647@L6LI8Q'.EP3CRV4G /?KCWK%$-_8^,/#VM7.EWRV::*]E-Y4
M7G/#*61@&5-QQA3R ?>JTOAM)K?7+S6=%N;BTUW5(Y&M803-;1)'M2;"G(?<
MH8@<@-CKQ0!K^*/&UQI'A/5-2MM(O!<V=PEJR3>6/+9]FU^&(9?WB],\\' R
M1K7'BB."]AT\:9?2:E+;/=&S3RMZ1*P7<27V<D@ !B>?K7":AH7B.;X=>)=)
M5[_5;=+F!]+-XN+J6)'C=PV[!."K ;@"<>F*WM1OM7O?%-B)]$U1M$GL25CA
M"J_VC?\ =G(8;5V $ G')SDC  -"3X@:*FD:+JBK>2VNL2K#;-';EB';/##U
M^5N!D\<9H3QQ!-:ZYY6E:@M]H\0EFLIU2.1U92RLIW%=I /?(P>,\5P^F:9J
M\'@;P/I\^BZA%<:9K237*>3NV1*TN7^7/'SCW/88KHGT^^NO&GC!TLKD0W^D
MQ6UM,\15))%60$9/^\.3P: !_$MCJ?@?P]J'B73;]?MLUFR>20 9F*E'RC\)
MN/1B#[5O:KXQL=+N-3A%I>79TNW6YOC;JF((V#$$[F4DX5CA<\#Z5Q=S:ZI<
M?"[PQIW]B:BEW8W%@LL+0Y;$)7S&P"?EX.,X)["KGBA-;U6]\4:=-H^H7-K-
MINW23;@+"[-$VXRG(RX<C"MG@<#/) +WB*XBN_&O@"^M9I&AN9IV7#L$=#;L
MRG;TSSUQFHM*N_[)\>>/[CR[NZBMXK&7R8V,CX\MRVP,?J< _3TJHMMJ+2?#
MB1])OXQIR,+L&$DPC[.8P6VYZMVZ@<D"MKP_;W,7Q(\6W4MG<QVUXEH+>9XF
M"2&-&5\'V)'7KVS0!J0^++.Y\.Z?K=O;74MOJ#QI!&@3S#O.%R-V/KSQSGH<
M:.KZM::'I%UJE_(8[6UC,DC 9( ] .IKB_"N@W6G>+]1TS<C:%I=PUW8*#S'
M)<+DICL$!DP/245TOC&75X?".HR:# )]3$8\F/:&)Y&[ /!(7) /4@4 %EXC
MMM1UB;1)K2\LKX6HNA'/M!>)CMW*R,V,'CJ"*\RF5S\!?$K>?<;X;R\V/YS[
MN)R!DYR1CUS70Z/;7<7Q*@U>/1-7CL)]%,#7%W\TGF"4.2^6)' X'7T&*RVT
MK5'^#?B/21I=Z-0N;NY,-N8&#.))BZD=L8_*@#UB#_CWB_W!_*N=N_'&FVEG
M-J+6]Y)I,$Q@FU"-%:%&#;6.-V\J&X+!2.#V%;]F_FV4+[73*#Y74JPX[@\B
MO,M,TO5M.^&6J>!;C3+J;4!'<VEK.(B89TE9BLID^ZN-^2&(/R\ T :_BW5Y
MY/&/AG2!IUQ>Z;=_:998XVB*786(%0-SC(!;)#8!(&,XKK-$T:VT'3%L+-IS
M;JS,BS2F0H&.=H)_A&< >E<?=Z9<Z;XK\"116UY<VNCVEQ!<W20,RKNA1$)P
M.<E3TSCO7H- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/#]S%:7LMKKK*EK.JH$1R"0CY8$-P>@.<<9H L_\(5HO_42_\&MU_P#'*/\
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MN#L]%UI/A;<> [C3)CJ"H]E%=!1]G>(OQ-OSP IR5/S9'2O4Z3<-Q7(R.2*
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M7B55!YYY!Z9KNZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "L_6=9MM$LTN+D.[2S);PQ1
M@%Y97.%1<D#)/J0  2>!6A7)^/=$U#5K#2[O2D$U[I.HPWZ6[.%$X3(9,G@$
MAC@F@"Y!XI5M;ET2ZL)K;4Q;_:88F=2MQ'G!*/G&0>H./Q'-4D\?V,GA?2/$
M"6-V;/4[A+=%^3?$SR; 6&[IGT)IHTRYUWQSI>OR64]E;:;:31J+C:'EDEV@
MC )X4*>3U)&,]:XV#1/$L7P_TCPV/#MRUSI6IPR22F:(),B3E]T9W<_+_>VX
M]Z .RL_%-_-X]UO29[!H[#3[:!_-#H<;O,)D;G."%  &3QDXS5[3?$[ZI%9S
MV^EW#6U[;-<VTRR(0P !"MS\K'/3D<')XK*BLM8L/B%K>HQ:4\UMJ5A;B*;S
M$V1O&'RKC=G)W#& 0?4=:H>&_#=SI?BFQOM&L+[1M/GBD;5M-FD5K=9"!M\H
M!B V[/*\8';H0"UX<\=W-UX*37=5TV</-=O!"D!5_,9KAHT0<\8^4%FQTS6J
MOC*)1KT5QIUTMWHD:2W,$;(^]&4NK(20#PK<'!XKDM.L/%^C_#Z/2+32;E+B
MTU%C<&*XC5[FV:=W?R6W?*2K#D[3UQSS4EMHNKVVJ^,Y8/#<UO:ZMIL*6RK-
M%G>L<BE6PWWR7!/)'4EO4 W['Q]#=SZ#YFD7]M9ZVB_9;N79L,ACWA" VX<9
M .,$CCCFJWC+7(M2\)^*+:TTZ6^M[*WF@N)E90J2B,DA03EBF03Z=LD8K.;1
M]9&@?#RV&D7)FT>:W:]4/'^["0&-C][GD]L\5!!IGB#1-(\7^'/[$N;Z+49+
MNXL+V"2/8PF4_+)N8$,"?0Y[4 :&DWVEPVWPZL[[3)9[V>Q7[#=C&R%A;9?/
MS9R5&.F.?:KMS\0UB36V@\/ZI.=%D*W@'E+M4('+ E\'@Y &3["LR+2=:6;X
M=%]'N%_LB)DOOWD1\HFW\H='Y^;GC/'Y4Z+2M8$/Q!4Z3<@ZJ7-D-\?[W, C
M'\7'([XXH ZB7Q59F71X+-&N;G5X3/:IG:/+"AB[$]!AE'0G)Z=<'ASQ1%XD
M-\L5A=VS6-PUK/Y^S E7[RC:Q)QD'. ""*XB[M]2L;?P.L&B7LNK:98,LZVD
MT(GA41I&RD.2C(S=^ORC'>NF\#SVZ+J%D-)U33KYIC>W7]H!-\[RDYD#(2I^
MYC QC XH S]3OY?$'Q4B\*/(Z:58Z>;^[B5BOVERP54;'5 #G'0GKFJ_CWR?
M 5G8>)M$@CLTAO(XKVV@4)%<0.<'*#C<#@AL9'/:M36- O;'QY:>,-*@-T3:
M&QO[16"N\6[<KIN(!8$#()&1TYJ+Q+I5WXZ.GZ6]C/9Z/%=)=7DUR K3!.1$
MB D\G&6.  .,T 3W?CPQ:IJ^F67AW5;Z\TL1M-'"(P&5U+!@2V.@&!]XD\#@
MXHWGQ!>]@\*7>@V<EQ9ZS=%&=F177:K$QX)X;*D$YQQP3FHM)OY;+XI>-]EA
M=70:.P(\@*<,(FPIR1C/KTXY(JC'X0U?0]#\)-#8M>W%AJLE[>6]M(@*"429
M"ERH(4N!UYQF@#J;;4=+?XA75L^ERV^KQZ6DDEY*5VM!YAPHPQZ-NZ@=*CE\
M>6<&F6VLS65RFA7$JQIJ!*[5#-M61ESD1DXP>O(R!5&?1M1U'XAZA<SV$T.G
MW>@C3S<JZ$+(79B ,[NC=<=162N@:Y??#!? EYILD5VBQV;7@93;F%'!$H.<
MGY!]W&=WH.: .GN?&;)KVHZ+9Z%J-Y?64*3;4,:K(K9P0Q? 'R]\'T%:WA[7
M+7Q)H%GK%D'6WNH]ZK(,,O."#[@@C\*Y_3K#4++XCZUJ+:;<FPET^W@@F#(=
M[1ER1C=G^(8) J?X:Z;?Z/X"T[3=3LY+6[M_,5XW96ZR,P(*DCH10!<;Q2KW
M=U':6$UU%9WD=E<21NN4D8KSM)SM&\9/7@X!QFN1LM0;0/B#X]FLM(N;XA+*
M9HK8JN (G+,2Q S[#))[=34FO>'+V]UJ;5=(TV\TKQ''=HL=]!(HM[R ,.9A
MNP0$R""-V0,9&!6C9V&J6_B[QK?/I=S]FU""W2T<-'^],<;*PQNR.6&,XH U
MD\86MW;:')IUK/=2:U"T]LG"!450S%VZ+C(&.>3^-<IX]UBS\4_!O5]0CMY(
MFAD$313 ;HI4G5&'!(]>0>AJ/2=.\3:;H7@_3;G1;R;3K:V>'4;.">)7\T "
M,L2X#1_>X!^H/ JG)X:\0CX5^(_#Z:"Z7<^HRO;1131[71IP^5.0 H4=\'VH
M Z77(8T^+WA&94 DDM+X.W<@+'C\LG\Z/B_#%)\,]4DD0,T30LAQRI\Y!D?@
M2/QJ?5;/4;OXA^%]3BTRX-G:6]TEQ*60>690@4$;LG[ISC-6_B%H][KW@74]
M-TZ(2W<HC,<98+NVR*Q&3P.%/6@!MIXUCD\3PZ%?Z3J&FS7:/)8RW039<A1E
M@-K':P'.UL''7'2H;CXA:;;?8;F2"3^R[VY6VBO5D0C<Q(5BF=P0D<-],@"F
MWFFW7BKQ'H=]+8W-A9Z8)I7^T;1(\CIL"*%)X ))/3IC/.,7PC9^(M&LK;PQ
M>>%8'>S/DQZSNC,+P@\.5^_OV\;<<D<D"@#O=8U6WT/1[O5+L2&"UB,CB)=S
M$#L!W-9EIXJC?6YM(O[*:RNH[$:@-S*ZM#NVGD=&!ZC\B:F\7#6CX3U$>'<?
MVL8O]'R0#G(S@G@';G&>,XKD-/TO5K?QU'K5IX:N+>VET1[5C<SQO)YWF!\R
MD.2Q(&,Y)/&<<X .JTSQ0NHI9W L)H[&\MFNH;K>K*$ !PV#E6(;..>AYR,4
M:9XG?58[*>WTR<VM];M<6TXD0J0 "%;!^5B#TY'!R<C%<MH?AR]TGQ!!?:#I
MU[I-E-;S-J6ESR*UN)BOR>4 Q&=W4KQ@=NE/\-^&[G3/%-C?:/87NBV$\4C:
MOILLBFW$A7Y?* 8C=N[KQ@=NA -A?B!9-X0LO$HL+S['<W MRGR;XV,OE D;
ML$;AV)XJ>Y\8-'XAOM"M=$U"ZOK6W2X"H8U616) (8M@#@]<'V-<*=#\2Q_#
ME?"T?AZY>YLM267SO.B$<\?VKS08SNS]T\[@H&#SGBNOL[74H_B9J6KR:7<I
M8S:7# DA:,YD1G8K@-G^(#/3- $*?$NTDT2QUM='U(:5/*L,]TP11;.S^7AE
M+;FPW!*@CW)R*U]7\5PZ;->06]J]Y-91"6Y1)43:""0HW$;F(&<>F,D9&>&/
MA[7_ /A33:!_8MS_ &F;[S?)\R+[OVOSL[M^/N^_6M6\M=:T/QMJ6IP^&3K>
MF:RL,FU'B66UF2,(5(<XVD '(/% '0VWC/3]2M])?24DO9M4A:XMX@0A6-<!
MF<G[H!(7N<G SS6)\,R#?^,<6CVG_$Z;,#X)0^5'GH2",^E-O=.UW2/&>D^)
MX=*^V0MI[Z?>V=DRAK<&3S%9 Q4. ?E/3.,XJ_X)L]4M=7\3SZAI<UG%?:C]
MI@:22-MR^6BX(5C@_+]/0F@#;O==6#5UTBSMGO-0,'VEHE<(L<>=H+,>F3D
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MKTG2/"NNZYI^@7L=O9ZE<?;H$V&4R@CS9,;\8SZ'H*Z@ZTIGTN**VDE.H(9
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MI-WI]FVH&*5DE\ZW7.71D)!(Q@BM33]=NKUHV.F$PSVINH);>X619!E?DR<
M-\P[X]">< &U')',@>-U=#T93D&CS$\SR]Z[R-VW/./7%<7X>\4:+:^!-+O]
M,TI[.WO;E[:RTY-H9I3*XV]<#)5F)S@#/I6?ISS+\:M2DETM;>X_L!&9(9%8
M3GSCA@QVY/1?FQ]WTP: /1(Y(Y4WQNKJ21N4Y''!IU<1X?\ $VF0^"M.O='T
M.:VAO;Y[6WLD ^60RNI9R,A5RK,3SCWXJQ+X\CM=*\0W,^ESFYT%]MW!#(K
MC8'#*Q*Y7:?0'VH Z^BN(O?']UI^E2:M=>&;Z+35,!6X>:, I+P'(SD*"1G/
M(R#CKCI9-5=-<M-,2V\PS0/.\JR#$2J5'(QSDMQZX;TH TJ*R]8UN'26LH#&
MTUY?3>1:P(0"[8+$DGHH4$D^@[G -*R\4&ZU74-%EL&@UBSB6<6QE!2>)C@.
MCX&1G@Y (/:@#=^T0BX%N9H_.(W"/<-V/7'7%25YO\/+&+Q+H-GJ^L:8KWL.
MH7-U#>F7YS)YTBXXP<  +@\84<<"MK4?$.JP_$?3]"@L4>REL9;AV\T N0R+
MG&. N3QWS[<@'6+(CE@KJQ0[6 .=IZX/YBG5Y/H.NGPC;>-KFVT2>YLK379Y
M9_L[)&L,?EQY(!(W$<G _3C/;ZAXLM+:XAM;4P374UL+M5FN%@01GA26.>6.
M< #L<XH Z&BL;PMXEL_%FA1:K9*Z(S-&\4F-T;J<,IQD'ZCJ,56'BDSWMW%8
MV/VJ*SO4LK@K,!(CL5!;9C[@W\G(/!P".: +>B^'K70I;^2UGN'-_<-=3B5@
M096P"PP!C@#CIQ6O7.0^*_.N_$5H+!Q<:((VE7S!ME#IY@VG']WU'7\Z;:>,
M(-1T_1);*U>2[UBW^TV]L[A=D8 +,[<X W*. 3DC ] #I:*YB#QG$^G^9<:;
M=V]\=0.FI9NN#+,.<HQP&3&6W^@/?BG#QA':)K/]KV$]BVE>69&^_%,)!\GE
M.0 Q)^7!Q@T =+17'Q?$&PCUJ73+^-(9!9O>QR07"SHZ(,NIV\AP.<<CT)J]
M9>*&N+=+V>Q\O3Y+%[Y+J*82KL7:=K8'#8;.!D<'!- '145@:9XE:_2WN9;-
M8=/N+-KV.[6X$B*@V_*^ ,-AL\9'RGDXJC)XZBM].T_6+K3Y8=#OY$2*\+@L
M@?B-Y$_A1N,')(R,@4 =;17(S^-KC_A(=2T:R\.:A=W.GF RE9(E!23/S@EN
M@ Z=3SP,&M_6-7MM#TR2^N]YC4JBH@RTCLP544=R6( ^M %^LC6?#MMK=UI]
MQ<SW,;Z?.+BW$3* L@!&XY!SP2,'CFJL?B=H-3N[+5].EL%M[(WQN@WF0&('
M# O@8<8R5].0355_&R6T6E7M_ILMMI>JR)%;W1D#%&<9C\U/X W8@G&1G% '
M5T5R'_";W,VO:CI-EX:U&YFTZXABN"LD2A5D&X.,M@C!!QG/7.,5G2_$\II-
MUJT?AC5)-.L;F2"]F#1Y@V-M8[=V7QU.W( []< 'H%%8+^)H[F_2PT>%;^Y:
MT6]8F7RXTB;[A+8)RV#@8['..,Y$_P 2+&+08=433;V0G4!IMS;@+OM9]P4J
MXSSUXVYSQTS0!VM%<Q'XIU!Y[6RD\.W5M?W4LRQQ3RKY8CC )=I$W  [@ ,$
MYSVYK%U?Q_=3>#['5M(L&62XU..PG6:1086\X1N!C(;." ?0Y]J ._,D:R+&
M74.P)52>2!UP/Q%.KE;C4[/_ (3G1+.]T1EU26UGDM[LLC")0%WJ"#DGE>PI
M+KQND.EWNLVVG2W6C6,KQSW,<@WD(=LCHG\2*0<G(/RG (Z@'5T5RMSXV1=>
MM=)L-+NKZ2[L#?6TT3H(Y4RH&"3P/FR2<>V<BM#PQXAC\2Z4]VMK+:S0W$EK
M<6\A!,4L;;67(X/U'K0!M445P/QGBC;X5ZS,R*985C:-\?,A,J D'MQQ0!WU
M%<M?^(H/#>H:'H=OHUQ+_:"2+;_9O+5 43<5P2,'IR<#G.>*N>&O$G]O_P!H
MPS6,MC>Z?<_9[BWD=7P=H8$,O!!!% &[35D1V95=6*'# '.T]>:Y/5O$.JVW
MQ"TG0[:R5[2>UFN';S0&<J5'IP!N_'\.>6T36SX3;QU<VFB375I::Q)/.+=D
MC6*,11EB,D9/4X'IVR,@'J]%<]?>+K."2U@M3#+<W-J+M%GN%@41'H2QSR3P
M  >ASC%3^%?$UGXLT1=2LT>,"1X98I,%HY%.&4D9!^HZ@B@"77?#UGXBMX(;
MV2[1(91*OV:Y>$DX(P2I!(P36C!!%:V\=O!&L<,2!$11@*H&  /3%<IKGCZS
MTA-2ECA2ZATQMMWBY1),@!F$:'[Y4$9Z>@R00+-OXQ@NO$>FZ7':OY&IV1O;
M2\+@)*@ )4#KNPP./3G- '345SMQXL@M+:6>Y@$:_;38VV9E N)!G)!. H&U
MLD_W&Z\9RC\2;.*WU\2V+R7>BPBXFBM9TE62(C.]'R 0,<@@$>AH [>BN3M/
M&IGUK2;"YT:ZM8M7A>2RN)'0B1E0.RE0<K\O()QGT%-\%>(=5UZZU[[?9)#'
M::G+:QE90P38J#;TR>[9]\4 ==31(C.R*ZEUQN4'D9Z9KD_$?B'5=.\9^'-)
MLK)9;>^-P\C&4*7\N,G;R. "P;/?&*YRPU*3PWXP^(,VGZ++>)#-;3R1P,D2
MJOV8,QRV,D\G R3[4 >HT5SJ^*UO%T@:58RW3ZI:&]B,A\N-(@%/SM@X8[P
M,'OTK U7Q]=7'A/0M8T6Q8+J6IPV<BS2*&B_?;'7N"259<],'- 'H--DD2*-
MI)'5$49+,< ?C48EG^Q^:;?$^S=Y.\?>Q]W=T_&O(-?UF\\4_ S4]4U:QB20
M7!:)PP?;B\V@+QD;5&W/?\: /9:*YNT\6&3Q0VB7VEW%@[VK7=M--(A$L:L
MV0"=I&0<'MZ=*SF^).FI-I4CQI_9VISK;V]PEPC.K/\ <+Q]55NQR2,C(% '
M:T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)^/=&U35-.T
MZ\T18Y-2TJ_COH8)'VK/M#*T>>V0QYKK** .&UO3-=\>>"]5TV]T\:(UQ"JV
M\,LZRN958.&8ID!<J!QD\DD=!3KS3]6\6-X;74M*ETYM-OH[^[>22-@TD:L
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M'R'E=P058]F%=910!Q.F:=JWA?Q3XAEBTV;4=.U:87D+P21AHI=H5T<.R\'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!65J6MI9:E9Z9# UQ?W:O)'$&"A43&YF8]!EE' ))/3J1JUP?CNQ;5]>T2RT
MBZ>R\2PK-=6EX#\D,2[0X<?QJQ*+M_'M@@'4Z/K4.L+=JL3PW%G<&VN87P2C
M@!N".""K*0?0]CD5IUQGPYO7FTO4+*]L6M-:L[QEU,%]_G3,H;S0W<,I! [
M #@"NSH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LW4=$MM1O+
M2^+RV][:;A#<PD!U5L;E.005.!P0>@/45I44 4M.TNWTT3M%O>:YD\V>:0Y>
M5\!<GMT      &!5VBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
@H **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>elicio2021employeestockp009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M369=15;&*0PR.8WW1R X*,F-RMG P0#R*N:3K^F:XUVNG7)F-I+Y4W[ME ;
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MEMUF@DC$ZCJ8V90'P.>">.>E:-]?6NFVCW5Y,L,"8RS>I.  .I))  '))Q7
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M-!U>"WD:UU%<&%E+#=%*&^5@2%(!.3CCI6%-J-]&_P //$.O61LU@DNDO##
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M%I:"\U"YC \P[B D2$@A<YR3C..F#S6[X<LYK72%ENTVWMV[75R/[LC\[?\
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MSGBO19)$AB>21U2- 69F.  .I- #J*PK'Q?H^H7=G;0S3!KZ%I[-I('1;E%
M)*$CG@@XZX.>E49?B/X9AM[B=KNX,-K<&VN76SE(@<8!,GR_(,G&6QDYQT-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR_-\W'%4M&NK^SLO!NGW>EZI#9+HXAFGMK*3SQ<*$'D,P7=$IQG(QD@<@ T
M:?CG7(-6^&T6N:-?7*1M=VX22)WB)S<+&ZL.#_>!!J]J$L\7Q>T6)+FX$$VF
M7+/!YK>665D ;9G&>3SBN*2UOT^"ITDZ1JBWL6J9,!M9&<@7GF$C )("<[NA
M[$FNRU R2_%C0;M+6[:V33;B-YQ;2;$9V0J&;& 2%/7I0 [XJS2VG@*ZO(+N
M>VEAGMR)(9FCX,R*P.",C!/!K4TSQIH^J:Z^C1-=0WPC,L<=U;/#Y\8ZM'N
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M;81C[HQQQTXKRB:WOT^%/B[0CI.I&_-Y=[$6SD(DWS%DV$#Y@0<Y&0,<XXR
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M12N3O(+8!P3C%=7IWC#2M0T_4+MOM%H-.E,5W#=1%)(FP"!MYSD$8QG.>.:
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M6,BC./09)^G(YO0?M?A76_%-IJ-A>W$%_?OJ-G/;VSS+,LB@&,E0=K*5 ^;
MQSTKOJ* /)M*\.:CX=A^'%A/:W,KZ=+<RWCPPM(D'FH^%+*".&<+^&>E;-@E
MQ%XJ\?7,EC?+#=QV_P!F?[))B;9!L;;\O.&X_P#K5Z!10!XY9-+I-O\ "J.]
ML[N*:U,\4T!MW\Q6%NP/R8R<=> >*U=8M-9%[XN\4Z-IDLLD]G;6EK!+;G?/
ML;,D@C8 G"MA01R5Z$8SV6K^&QJVNZ1JIOIH9-+=Y(8T52K%U*-NR,]">F*W
M* /-=)$\/Q,754TK7#83Z'Y1N;N%V8R"8L=P/*G'1<#V7%8]MI^HQ_!_PUIS
MZ5J(OK;4X9)K?[))O15N"[$C'3;S7L5% '!>-M/U&'7='UW06$=_=9TJ<-\I
M,4H)5\'O&PWXZXW5VUE:0Z?8V]G;)L@MXUBC7T51@#\A65:>&DM]?GU:?4M0
MO&=V>"WN)0T5J6&#Y:@#'&1SG )]3G<H \_\:Z5'?:XUU;?VQINL6MDIL]4T
M^"219<L^87"J58 @'!_O5V&A-J#^'].;5HTBU$VT9N4CQM63:-P&..N>E:%(
MX8HP5MK$<'&<&@#R'19&U#X:>)M#M[&ZN+V\OM0MX%%NYC9GE8!C)C: I.3D
MC&/IG?TK3;C2_B7IZ-;W<EK;>'$T\W?V=_+,JR XW8QRHSGI^-=+X9\.)X9L
M9[2*\FN8Y;B2XS,J@AG8LWW0.,FMN@#@=!-WX5U_Q1:ZC8WUQ;ZA?-J-G<6]
ML\RRAU ,9*@[64J!\V 1STKF[+2Y_!TGPQL+^.1YH)+YI8X4,I0R1NVT!<D[
M=^.,]#7L58>K>&QJOB#2-7-]-#)I;2-#&BJ58NNQMV1D\>F* .#\2^$M3\3?
M\)CJ>F020M>06D5I',AB-RT#!V)5L$ X"#.,XSTP:W-227QEJ?A6:WL+ZT.G
MWHOKMKJV>$PA48>7E@-Q+$#Y<C )],]Y10!Y?INF7ECXBT^^\.1ZK8I=WK?V
MKI%U _V5%.XO-&S#"G."-IYR!@8(JIH=G_9L%SX6UGP-)J5ZEQ+]GOFLDDM;
ME&D+H\DAX7&>0>>.,GBO6Z* /.=,>_\ #/B?Q397NEZA<0ZK<?;+&ZM;9I4?
M,84QL1PA&T ;L#'>MGX9075I\.M%M;VSN+2X@@$;Q3IL8$$]NOYUUM% 'E]Y
MIEY!XBDU7PU'JMAJ<FJ!+VPD@<V=['YFUILD;%.P;MP.<C&,D9S?%J:WK.A^
M*[*?0]6>]COU-G%;0,+=[=9(R) 1@2N0#G.Y@>@ %>Q44 </<"YN/BGHU^+"
M^2V&E31/*UNVV-W=&568 @'"GOQWKG/"]G]@T^/PIK'@62[U.UD,<=\]BCVD
MZ[B5E:4],#!(^]QQR<#UNB@#G_'.BW7B'P1J^DV3A;FYMRL63@%NH4GL#C'X
MUS>HQW7C'3?"]FNG7MG=V>H6]Y>?:+9XUM_*!+ ,0 Q)^4;2<YSTKT2B@#B_
M!4<\7B/Q<TUG=P)<ZB)X'FMW19$\M%R"0 >5-.^)4%Q=>';2&UM+FYE&HVLI
M2"%I"$2568G:#C !KLJ* .)99C\7XM0^QWGV+^PFMS<?99-GF&97"YQUV@G]
M.O%<@-(U<^&);N'1+FZDL/%$^I-I\]NR-=6[EQ\@8?,=KY ]O6O9:* /--26
MVU?P7XCGTCP?=:=+<Z;);(9=.\JYGD93A J@MM'J>,GCH:M^*8A/\+-/#V5^
M;B(V?E1Q18GBF5T 81M@L5.?E_BZ<9R/0*R/$'A^'Q!;VR/=W=G/:S"XM[BT
MD"O&X!7/(((PQ&"#UH XJRN+37]:U)KJ/5K/6]4TQM-MGO-+DM(@@#MA<ELM
MDLQRW1>.E,\([);;2](U'P%)!K.G-&LMW/8I]G4QX'G)+W8@9&W)R?3)KM]-
MT*6UF2XU#5[W59X\^4URL:+'D8)"QHHS@D9.3@G&,FMB@#B_ ,<\%YXJ%Q9W
M=N+G6IKJ$SV[QB2)D0!@6 SRIXZUTFBZH=8TR.]-A>6)=F7R+V+RY5VL1DKD
M\'&1[&M"B@ K@M2CN&^,FD7RV-ZUG#ILT$EPMLYC5V8$#=C';KTKO:* .,\5
MQ7$GCKP;/%:74L%I<7#SRQ0.ZQAH6122!@98US&JZ)JVJMX_2QL)_.N+RSN[
M-;B!DCNA"(RR@L #DH1_]:O6J* .*\+7-CJ^H0W=MX*GT>X@C(FN+VQ6!T)&
M-D9ZMD]2.,#U-:?C":1]-CTN*"\<:C*MO/+;0._DPD_O&)4'!*Y4=\L#V-=%
M10!YOX^\,S6&EZ=K6AIJ=YJVD7<<UI;AY)]Z9"O'CG:"O4\=,5+?75Y8?$/3
MO%7]EZE/I%YI/V"18K1VFM)/,\P%X@-V#TR >1]*]#HH \9U*RU2[\#_ !!M
M8]$U,3ZCJIFM(S:MNE4^5@@#G^!O;\>*[#5Q-<_$OPK?0V=ZUK#;7:RS?99
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M0S(X7<!C.U3_ "ZUR$^GZC)\&]=TU=*U$WT^I2R16_V23>ZM="0$#'3;S_\
M7KV.B@!L<@EC610P##(#*5/X@\C\:=110 4444 %%%% !1110 4444 %%%%
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MY%,9?<&YSGYA@ $F@#!\!>+[71/ ^E17\&HR12WT]N][Y>^.)WN7"!W)R<Y
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M,960J81'(5!^\5[ =><5>U#3I]4\3ZEXDAM+M+:/0GTZ)7MW26XD=RW$9&[
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M-WS>7@#/4<\$\UZO10!P_A6>ZOKFV%QX&71;JW!^U7,D403=@C$)4[FR>^
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M]%UBYNIK X5Y897?YDYP6"L"!GUKV*B@#A=)&HW?Q0NM8;1;^VT^?2(H%FN
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M^F7N?*MY>-@ASW)+9VDK@=>E>B444 %%%% !12 @YP0<<&EH **** "BBB@
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MC(P)'!P"#T'0XK#'A+5M,TCPS!'827$\7B ZM>K"Z;8$;S,J"2,XWJ.,YP:
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MUK'U7Q##I&KZ3I\]M.YU.8P12IMVJX4MALG/0'H#3+77+F7Q7=Z)/I,T$,4
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MSW 4+.KC/RX)/'N!U%<GK?A[4=4;Q?K,.GSB;4=(_LRRM25623Y6R[9.%&6
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MS%L"6ZM/M4X9@S 9&=H.*[S5/$T=A=7%I;6KWMU;0B>:-)43:ISM&6(RQVG
M'IR1D9X*Y\/:]-\*O$FC+HUR-0O=1FF@A+Q_,CSB0'.[ X'.36KJ-KK&D>-K
MS6H?#+:WINKP0B2)3$)K2:,%>CG!4@C.#U'Y@'9Z!KEEXET*TUC3G9K6Z3>F
MX88<X((]000?I6E5/2DGCTV$7-O#;3'+-!#C;'DDA<CJ0" 3W.35R@ HHHH
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MO*06BE1BK+D<'D=17,^*+V^D^(_AS3#IPN;(P74WDO(NV9@J#<0?[NYASZT
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M"[LJJ.I8X%.KRKX@ZR-?\$6NH6^EE].DU&V^RWC.-P'GJ/,V=0C $ YR<C(
M-==K7C.WTN6_B@A2ZDTZ,27*&Y2(C*[MJ!OO-MP<<#D<YXH Z>FJZ.6"LK%3
MA@#G!ZX/YUSEOXRLM432UT>(WEQJ5J;N*-F\L1PC +2'G;\Q"X ))]@2,7X7
M  >+0+/['C7Y\V_'[L^7'D#'&,^E '>F1%D6,NH=@2JD\D#K@4ZN9U'4-.C\
M?Z-8W&DO)J$EM</:WQVX10%WJ.<Y.5Z@?6LJ;XE>7I>JZDGAW46M=)O)+:]8
MR1 QA-NYA\WS'GH,\#KS0!VR6\,<\DR1J)9<;W[D#H,^@YX]SZU)D9QD9]*2
M.1)HDEC.4=0RGU!KQRPO]#M;Z_\ #GCZR^PZY<W$S0ZQ,N!<JS'8T4_5-H(
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M%M,T%Q;-#Y4D,B]0Z^OOSGUK%^+L(?X=7\V^57BD@*[)&4<S(IR <,,$]<T
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MWF2%%>-RI*D  \J2/UKS'4-!\6:CIZ&^T!KO5K36X[HW;746)8%FW*L(+?(
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MU%;RQ[8$*,H7+,NYAN&<#'7':N[HH Y'7].U*Z^('A74;:PDELK 70N9A)&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$7EF=90R@.N3@J(]HYZ"NYH **** "N>\0^*?^$?U'2;-]/EN#JEP+:%XY%
M5R,_-GH,=QGI70UP/Q#_ .1C\"_]AI?_ $!J .]&2HR,''(S2UY])9SZI\4=
M8TJ?5M42P.EP3B""[:,*S.X.TK@K]T=",]\CBLK2=3\1WOPX\.:A$ESK#0S3
MB^MH[DQ7%S$CR1JP8$%BN%)&?FXH ]6HKRN;6XKG1?"=YHVIZILE\2):SI<S
M2+*JLTC-!*"QSM^5><\ 5OZ>\T_Q,\2:9+=W;67V"UD6+[3(!&S&0,4P<IG
M^[B@"W'XPFN?+O;/26N=%-U+;2WB3@/%Y9*M(8R.8PRMR&SCG%0IXNUN[BTZ
M[TSPK)>V&HQ+-!.EZJ%$)',JLHVG:=P +9QCBN9\'Z5;O\'M3D,EYN87^0+R
M8#Y99<8 ; Z<^O?-17"3:7\%O#=Y87U];S,NFERMU(0P=HU9>2<+@GY1@>U
M'K=4KZZO;>XLDM-/-U'--LN)/.5/LZ8)WX/WN0!@<\URXG;Q)XW\1Z'<WES;
MQ:=;6ZV\=O.\))E5F:7*D%B#M [#'O5'6/[1TJX\"V[:]=7DG]I?9+J96\M;
MG:DF=Z@\D%1U)Y% 'H=%>:_\3KQDOB-;&[^R7EGJ,MG;3+J$L7V;R\!28E7:
MP/WCN)SNQT P]8;[4OB1!IMWK5ZUM-X<6XG2SN6CB>7S0I9"N"H/J"#[X)R
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MT^BO*_LMWJ#_ !!CFUO5PNGS;K3RKQXS$WV<.,%2. 3]W[OM2)<ZA!8_#[Q
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M1'WV@@$_F17EGB?4KRVTS5M6T[5+ZZFM=:B47:S-%# OFQH;=8]Q$F 2&.T
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M@& .@["KE%% !16!IGB*6_\ %NM:%)9"'^S8X)%F\W=YHDW8XQ\N-OJ>M;]
M!7&^*=+N-5UFRF;1-1NQITHGM9K>]BB59,?>VL03Z<\?G7944 <,EMJ<>OW&
MMIX;U07UQ +=W_M"WQL&2 %S@8))S5.QT2]TRQLK6P\.ZS;I8O(]NR:G;DH9
M#EP<DA@22<,"/TKT6LS7];@T#3/MDR&1GEC@BC!QODD<(HSV&2,GL,T <A=Z
M+->:,=-D\(ZDH-W]N^T1ZC LPN-V[S0P;AL_AC@#%.L-*N]-U:XU6W\+ZO\
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MKL;\J *FKZ'8Z]HSZ5JD9N;6387#]6*L&!X]P*;KWA_3/$ND2:7JEN)K9R&
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M%[S3Y+E_,N$L[EHXY6[L4SMW'U !- &;XYUAK Z+8VTQA74M8@L[R:)MKJK
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M)9_M*61F8P))NW;@F<#YOF"_=!Y S5E/#6GQ:U>ZO&;E+V]C6*:03M@JN=H
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MP27!N6A[%S)YF?\ OK]..E6-<T"P\16D=KJ*RO#'*LRK'*T?SJ<J<J0>",T
M<E'IULWQRNI#YP;^PX9N)W +>>XY .", ?+T]JXZ6"2S^&?B+7[:]O8;[3];
MN9+8Q7+HB'[4 <HI"MD$@[@>M>LW/AC3+K7+?69$G%_!!]G$J3NNY VX!@#A
ML-R,@\U1;P'H3:#>:(T=R=/O)C//$;J3YW+;B<YR,GD@&@#HY(Q+$T;%@&&"
M48J?P(Y'X5X[H\EYIWPED\8_VIJ=QJEM#=QH9KIW0 W#+N9#D,5QNR<GUR
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MZS?$5M<6O@_XA>'KB\N[RQTB>UEL9+B=F=!*%8QELY8+D8!SUS7=>(]-GO\
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M.=CA2 RYYP: /-+2^U+5/ WPXNI]5OUN;S4DMKB6.X93*F)?O<\GY!R>>]=
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M=32PL8Q>3"7RLM@\A0IR.FXY/05T.M>!-!UW4X=2N8)X;V*/RO.M+AX&>/\
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MREEC=&*LC*I(((Y!K"O)I1XI^'++/*#<PSK/B0@2@6V1N&><'GF@#T.D.<'
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MPG'(4$ YYSD&NPN7F\2^-M:T.XEMQ':V=NT$$Q<9$@8O*NUAR#@;NV!C&3D
M]!KC4\8ZM<>(];T6S\/Q3S:0D3RD7^WS1(I90@,?7 /4@>];/A6TN[#PU:65
M]JO]JW-N&ADO-NTR%6(YY/(Q@G/)!KC=+@U&X^+/CQ-.O8+1S!8 R2VQF(_=
M-@J-Z@$>^: -)_B/!=>&=(UW2;(SV]]J$5A,D[^7);L[A#E0#DCZCM7<UY?X
MA\,6?A'P/H&DV3R2HNOV<DDTIR\CM,"S'%.\9,ETWC*2UFGO+FQTY6)>4Q)I
MK"-G!B(Y,C<,< = "W:@#TZBO,;I9M3\3_#\7%[>A=0TRX>Z6.Y=%E(AC.<
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M6-"C.G1X^T3:?=F=H%_O,C1H2H[D9/M0!?T[PEH^EFV%O#,8[0YM8IKB26.
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MF9@59BJ$]2BD[4)Z?*!QQ4H\(:&(M0C^QN4U&0270-Q(?-<$$-][@\#D8Z4
M>=WGB232="\3 Z/+X>UV"WM?M,,)#P>292AGA*X[.^<8(VCN#76:7X<%AXHL
M=9M=9LXK:YMVB:SL[4I'><;ED)\QAN&,[L9(XSS70P^'],B6Z#6QG-U$(9VN
M9&G:2,9PA+DG;\S<=.3ZU4\/^"_#WA>6631]-2V>0;2WF.Y"YSM7<3M&><#
MX% '/_&?_DEVI_\ 76V_]'QUO>.=0L],\#:U<7SJ(39RQ[6_C9E*JH]220/Q
MJ]K>@:9XBLOL>JVYN+;<&,7FNJD@Y&0I&<$9YJ!/"NC"Y@N);1KF6 [H6NYY
M+CRCZKYC-M/N* //_#.F&'3/".@ZA%)>:G%I,DSZ9<D+;QHSKB27()W+G8
M3DGIR:R8XEU/X8>"9-0 NI8_$<=N'E)<A/M4B;<GG&U0/H*]9U/PQHVL:A;7
M]_9++=6RE8I-[*=IZJ<$;E/H<BJJ^!_#::/)I*:5$MC)-]H,:NPQ)NW!E8'*
MX.2,$8R<4 <U- FN^.-9\-S26,=O9V5N+.UN;=I!L8-ODC =<,#A=W)&!@CG
M/5>%+673/#=EI]SK!U6>#?";QUV-+M8C&,GE<;2<G.,U#J_@7PUKOV0ZAI4<
MCV:[('1WC=%_N[E()'L?4TW4O"&GWU]H4T5I%!_8[AK:2-V4Q*-OR*H^4AMH
M!ST&<=> "I\4;>&X^&?B 31K($LWD4,,X8#(/U%8.MZ;:C4_AY9PH889+B4L
M(6*'FV8GD<C/MS7HM[9VVHV,]E>0K-;3QF.6-^C*1@@UDQ^#=!B_L_R[)U.G
M$M:D7$N8R1@G.[DXXR<\<=* /.[J^F\*6'Q"M=,EEM[.RO+/R@&9_LZ3+'YK
M+SD<%CP1CMBNNTOPY_9_BFRUBUUBSBMKFW:)K*SM2D=WQN60GS&&X?WL<@XS
MS6[%X9T>&XU&<6>]]27;>>;(\BS@# #*Q(/''3IQ5?P_X,\/^%Y)9-&TY+9Y
M!M+>8[D+G.T;B=HSS@8% %KQ#J,NF:+/-;*KWCXAM8VZ/,YVH#[;B"?0 FO.
M-9MK[P5J_ACQ)+90V]E9 :7J,R7)D:2&4\2/\B])/F)[EJ],U'1;'59K66\C
MD=[63S82L[IL?&-V%(YP2.?4^M)K.B:=X@TY]/U2W-Q:.07B,C*&P<C.TC/(
M!_"@#F-4NUU'XJ6'AZ_"MIRZ3)>I _W+B;S F&'1MJ@D ^N>PKAM2LXK'P#\
M38K5YH5M]69HO+E92OR1<<'E><8/&*]3O?!VA:C:V,%S9NXL#FUE%Q(LL/\
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MM5M5DBN\_:?.8RM-D;?G9B2W'')Z<4 8,NDZ%I-TFO6FI26$+Z?(C"W8&.=
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MJFFWPCM+E[ART2+>^6%'.,;>#Z_@*]?'A_31K,VKB&07\T7DR3">0$IV7&[
M R2,=#S5+_A"?#YT1M%-B_\ 9K2>:UO]IEVEMV[/WO[W/UYZT <[<:5;:E\8
M+^RNVGELY="BE>W:=]C,9W4\9Z8 X''&<5QTEFL7P:N-9^T73:CI5^\=C<-<
M.6@5+O8%'.,;>#GJ/H,>O)X<TR/5FU58IOMS0"W:<W,I8Q]E^]TSS]>>M5#X
M)\/G19=&-BYTZ:3S9+<W,I5FSNR?F_O<_7F@#%@>+7_B7XBTC6(5FMK"SMOL
M=M*,HPD#&20#NV=J[NHQQC)KC99+^;PQ9VES>WC+I_C--.M;CSV#26ZS #<<
M_,1R,G/W:]6O/#6EWUU;W<T,HN[>,Q1W,5Q)'+L/52ZL&8=\$GGFFW7A;1;R
MPL[&6R'V:SE$T$<<CH$D!R'^4C+9R<GG))H YK0K.+1OBOJ^FV)DCLYM*@NW
MB:5G!E\QU+_,3R0!GUKO:S8M TV'6WUE(9/[0>(0M,9W.4'(7!;&,\].O-:5
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !6-XG\01^&])6[:(2RRSQ6T$;/L5I)&"KN;!VKS
MDG!X%;-8OBBRT?5-(_LK7(A)9W\JVX!.,.>5P>QR!@^N* (H]2UVVUFPLM0L
M+-[>[+C[7;3-^[94+;2C#OC@Y['@<5IV.IVFHRWD=K*)#9SFVF*\@2!58C/L
M&&??(KSS3H?$/@#Q5HVAS:F^M^'=4E>WMOM(S<VC!"P&[^)<#\!V'?%0CP[X
M'^(^IZ)9P6^HV^KW,,,L,2J\49\K=M(&0%!+8Z#&: /::*\XU^RM=&O?!FJ>
M&HTBENM1AM)##Q]JMI$9G+X^_@+NR<D')[U6T2UTKQ?X7U:]UNY>WU6UU.<W
M%Y&P6XLC%*2BHQ!**$"C ZY;N30!UNG^(+RZ\=:MH,]O EO9VL-Q%(C%F?>6
M'S9P!]WH/SKHZ\?\5:G<:9\0M>G$#OICZ?9)J<L0S+#;,TH9U7'/;/<#) [C
MU/2;;3K72[=-*C@2R*!HO)QM92.&SWR,<]Z +M%>->.&MKC0/&FJ:=F:>RO$
M5K^Y<>9;3)Y?[NWP,JHSU)'+-P>M=)XN6V\-^+="\9.L:VA8V&I2$<(L@_=R
MGT*L I/7#8H ]!J*Y,_V28VHC-QL;RA(2$+8XSCG&<9Q7!:I:V,&BZ:U[#*E
MYK.K1W LXMJ"X<Y9(9L@C8J@;O4J< DX.;I<)2W^)6FN(X8("'C@M798XF:V
M#-LQC'/7IDYX'2@#J=:\0ZQH<7AE;BUL7GU*^@LKPH[%8W=26,8QR/E."3Z<
M&NKKRF<Y\"?"LDY)U#3?_1#55\<BUO-*\<7]B#//9%%DO+EQNM)412([< ;A
MU!)R/F8XSS0!WH\07@^(H\./;P"T;2VOEF#$N6$BI@C@ <GU[4>.O$%YX7\'
MWVLV-O!/+;!3LF8A<%@N>.O7ID?6N9O=,L_$'Q4L;;4HS<6\GAIFDCWD+(?/
M3AL$9'/0\9 ]*YK4K>33OA7X_P!*BDEDTNPU#R+ R.6V)NB+1@GDA6)'YT >
MW9XS17 :K(-6^)4N@7SV)@_LN.:TMKZV,R2L7<2,J[U&X (.Y SC&3GH/!NF
M?V+X>CTP:J^IK:R/&L[J1M ;[F<G.W[O4XQCM0!%JFN7[Z_+H&C+:C4(K#[<
M7NU9HR"Y1$^4@C)#9;M@<'/&WI\MU-I]M)?6Z6]V\:M-"C[PCXY ;N >]<-#
MI.FGXVW[_P!G6C.NC0W*DPKD2^?)\_3[W ^;K6!:K%K?P8U+Q+=GR_$4(NKI
M[P<3P7$4CE4#=5 "JH7I@].: /8:;)O\I_*"F3!V[NF>V?:O+/['A\2_$.Q@
MUZ"1OMGA59;RV\UU4R&5 1@'C![#'(![5Z-J%I#_ &#<V@#"%;=D #D$ +QS
MG/ZT 2:8U^VF6[:JMLE^4'GK;,3&&[[2W./K5NO)M(M-4O?AIX+ETM+*^N+>
MW,[Z9?-A+Q-NT\G(#*6!!/&34T32ZUX9TU_#FG0QSV%_=-<>']3("R,&;S(P
M?N_(TF5[#CIB@#U.BO()[S3[S1?"4]CITNFR0>*TMY[:8#?;N6D:2($=4W$8
MQQC'I6E=W5EI_C7QY)/=2V=JFC0/-+:\21DB3+J/[_3'OB@#TVBO+-(M18_$
M'P[##:Q6-O>:+,KQ12?O)54Q[6E*@ OR>1G!)P37-OI=K#\(K[6D63^TK#5Y
M&M+DRL6AQ>!?ER>,@G/KWH ]WHK@$%EXD^(/BG0];1)EM[6W6R@E (6)T)DD
M0'^+><%NHPM49&@'B;P_X9.HQ76F'2Y?LLFJ1_:%NYED"G/S*'8*,@\\$D=<
MT >FT5SG@W1UT#3;S34U3[='%>.44(56V# -Y*Y)^5<\<\9QVK#TN*U\3^-O
M&%AKMM'<_8G@AMH)ER(H6CSN3/0LV26'/ YX% '?T5XG;"[U'PYX'_M*YN9G
M3Q$]E'<&9@\T"^<%)(/7Y0-W7CK78>#K.WTGXA>,-+L(Q!8HEE.ENI^1'='W
MD#MG:,_2@#O**XKQM::I+J>GWFF65CJXM89?/T>[8+YR,4_>1D@KO7;CGLY'
M>N=M+O3KW5OAM?:7!-;6\DU[#LG&)$VQ.#&Q[[6! ^E 'J]1SM*MO(8%1Y0I
MV*[%5)]R <?E7D&K:G+HD'Q+N-/D:%(;ZR1F@.#$CI&)67'0X9SD=#S7>V6A
MZ#9:_:ZMIDPMY+FS,26]JP$-P@PPD90/F(Z;\_Q8[B@"?P3KT_B?P?IVLW,,
M<,UTC,T<>=JX<CC/L*VYO-$+>0$,N/E#DA<^^*\.TG3;6T^&/@?7(49=335;
M:-;C>=P1KAE9!SPI!.1T/UKW6@#B_"OBG7_%GAB#6[72]-A6<R!8I;Q\@H[)
MR1'ZK766$TUSIUM/<P&WGDB5Y(2<^6Q )7/L>*\N^&FA7FJ_".UC@UR^M1,;
ME5BC$7EC]\_!)0O@]_FSR<8K:\>V4>I6FFZWH(2;Q!:7.^P55R+G83OC;IE,
M G=V(&#R,@'?T5Y;>:Q867PIM=4TB;R;>[O8!J5PZ8=-\P$_F!2"""2I (P#
M@8XK2?PQ;6-]J%]#J=K'%?:5(K:?I\!@BEV\B;ASR,A<C&00* /0**\6AM+3
M0/A!I'B6 3Q7ES:V=K?7JS/O6U:5-^.<# X! R,]:]$M?#N@VGB#[982&!KZ
MQ,1L[5@D,J!@?-VJ/O#<%W9Z-B@#8TEM3;3(CK"6B7V6\Q;1F:,?,<8+<],9
M]\U=KR'PY9:E??"/PTNF26DUW%>SRBSOF)CO0LD^8V/K@[@3D90$TC>(;8Z?
MIEJEE_85M-K[VFJVMVH>*&7R2RQ_*5#1LVP]0/PXH ]?KE?%/B?4="UC1+"S
ML+6Y_M6X-NC33M'Y;!=V3A6R,9H\,^'TT#7M5\G4862\6.8Z=;6_E0VYY7>J
M[FV[\'/3)!/:LOQ]_P CAX#_ .PH_P#Z+- &AJ7C"[\-W]E'XBTR*WL+R40)
MJ%K<&6..0]!(&52@/J,CUQ775YU\:)$NO S:#"HFU35KF&"R@7EF82*Q./0
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MG<CN>>M+K&@Z7K]O%!JEG'<QQ2"6/=D%''1@1@@U?$B,2%=3@X.#W]*7(]:
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MK5I%+$T?SVMOMFN'< 212MO);)SNR,Y!->@KH>F)K+ZNMG$-1=-C7('SLO\
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M-W%?;F7:P)"!/O9QCYL#!Z'H?2Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\4>(
M[3PKH<NIW:O)AECBAC^_-(QPJ+[D_P!36S7GOQ>L[B3P[I6IQ1O+#I&K6]_<
MH@R?*0D,<=\9S],T ;=[>^*M/TB35)(=-N&AC,TNG1(X?:!DJLQ8AF SCY "
M?3K6MHVMV&O:+9:K8S!K6\0/$6X/N"/48((]C2:GJ]C9>'KG5YIXS8I;F;S
MP*NN,C![YXQZYKQO1/"W]G:)\,K#6;8+/+=W/FQO\K!)$D<1MWP<C*^Y% 'M
M=QJEA:Z=-J$UW"EG I>2;>"J@=>:I27]UJ6E:;?Z//:11W$D,DOVL$YA;!91
MM/#D$ =LUYIJFA6FD7_Q%L-+M8X]'.@?:7MD4>5#=%),;5Z*=JAN/;VJ[K-I
MIZ^#? $MO!;+(FK:8=T:J"&8*3T[D8/OQ0!ZE-<06X4SS1Q!CM4NP7)]!FG,
MZ)C>RKD@#)QD^E<'HPAUCXA>,K#6K>*=XEMX[:&=0P^RM&<[0>Q;.['?&>@K
MC;:T:Z\+^"%OP9TC\3M:VL[D[WM1YP4;NN#M'U % 'ML4T4P8Q2I(%)4E6!P
M1U'UIL-S!< F">.4#KL<-_*O,5TJQM_$?Q"T>TFBT>QGT^T^:! L<+NDBE]H
MP!VSTS6OX2N[ZW\6W6DZ[H]I:ZRM@CK>V!_<7<"OM!VXRK MT/J>V* .KU'6
M[#2[RPM+J=4N+^4Q01Y&6(4L3] !U]QZU<EN8(-GFS1Q[SA-[ ;CZ#UKA_'-
MI:3^-/!#7-O!(&OID<R(#D>0Y .>V>U1>'4L]>\3^-;+68(;ATFCABCE4$"S
M,8V;/12=QX[F@#T*HI+F"'/FSQI@A?F<#D]!7*?"Z6^F^'FF-?RR2N/,2*60
MY9X1(PC)/?Y0,'TQ7,:5X4\.ZSK/C^WU2RMW@CO1M+CB - I+K_=.<G<.>*
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M-8\(Z/JEZT,=Q>6D<SA?E7<R@G )Z<UMUY#\.+N*1O#UAXCM8O._LN&30I&
M,3IY:^8!G_EL".?]G&,<Y['XGWE_8?#?6KG33(+A(5RT7WEC+J)"/0A"QSVZ
MT =3%<03.Z131R-&<.%8$J?0^E(US AP\\:G?Y?+@?-_=^OM7 >(K2UMM8\#
M7_AR*&.2:]6W_P!'4 2V31LS@X^\H"@C/0URLVA:5)X"^),[6%NTMIJM\;9B
M@_<%4C8%/[ASZ8S@>@H ]NJ(75N96B$\1D3[R!QE>,\CZ5#I<CS:192R,6=X
M$9F/<E1S7FV@FYT76/#UEJMG::IIUU+)_9.N6W$A+QNVV=3R2REB2."0">:
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MJTUS DPA:>-92,A"X#$=.E>;ZK8:9:7WPY&FEIH(+]H+>XE;>[Q"*3'S=U.
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ML4?RW#;6'8XZ'VKEO%'BB;3=5T*VTV\L9!=:K%97D)^>5%8,<C#?+]W'([T
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M3;70_B.^JQRRV;:TL;QQ2^66++"H!;^%<D9/IGKTK1L&AF^+6J6M]-ITPN=
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M.G6MO*R[2\42JQ7TR!G'M2S:-I=Q?K?3Z;9RWB#"W#P*T@^C$9H X^PMH/\
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M>23ZUW,&AZ3;7S7T&EV45VWWIX[=%D/U8#-2WVF:?JD:1ZA8VUVB-N5;B)9
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M#:ZHFG:@+Y'LI94WQO,JN0CCN" WOG&.: *OC7Q+<:?X4.K:#?6<NR[@AD8
M3 AY$4@$' .&SSFNGM]1LKR>>"VO+>>:W;;-'%*K-&?1@#P?K7DOB'4;F_\
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M=J /18=5TZXO9+*"_M9;N,$O DRLZ_50<BFC6-,,RPC4;3S69D5//7<6498
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ME8SZ,0>#]:?_ &E8#[/F]MO](_U'[U?WO^[SS^%>?SZ';V/Q2N/[$M(H(9=
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M:1#T;?D \$D]<T >E7=_9Z?!Y][=P6T.<>9-($7/U-9FK^+=&T9-/:YO[?\
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M]<&M#X2$'X9:4 <JCW"+SG $\@ _  4 6=9E\;B]NYM,ET"TTN$?(;^.5Y&
M&68[&  SG ]!FM3PE?ZCJGA33=0U9(4O;J$3.L"%5 ;E>"21\I&>>N:J^-&:
M?1HM'B8B76+A+'CJ(VRTI_")9/QQ6Q/?V&G/:6T]S!;O</Y-M&[A3(P'W5'<
MX'2@#D=;\5:E<>*V\/>&]3\/P7MNBF>+4V<O([#(6-5(/"X)Z_>'H:[2 3BU
MC%PT;7 0>8R*0I;') )R!GMFN*\:Z?X5\1^']4+/8R:C:[DBGMF4W$-TOW5!
M7YM^[ V]3TKK]*6[72+);\AKP01B<CO)M&[]<T <QX5\527 UE-?U&QCDM]:
MFL+8G$(=5";0 223R>Y/-=3>ZC9:;")K^\M[6(G >>547/U)KQ^ZL+&X\!?%
M"YEMH9)TU6]VR,H++M5",'MSS6U)K$-OX\MHM:UA].@N]#@^Q3OY7ER-N8S+
MND5@&.4/;( Z\4 >C/J%E''#(]W;JD_^J9I !)QGY>>>.>*B?6])CL$OWU.R
M6SD.$N&N%$;?1LX/0_E7EU]H6@65OX%L]/D:]TX:XT<4UR5;S$*2$JI  ,>[
MH,8/N,5J7\NF^'OB1#IMQ>)H6F2Z5C3VCCAC@\PRL9E^="H8Y0G&,X'M0!Z(
MU[:I9_;'N85M=H;SC( FT]#NZ8J./5-/FLFO8K^U>T7[TZS*4'U;.*\O2#3O
M#^I^"+;3[N>Y\+_VE=CSYV5H_/9#Y6TJ -N\N%XQGIV-='IEJT7Q>UYK0 :=
M+ID#WJC[GVK>P7/;=Y8!/L1GM0 >%]?U3Q;%8ZSI^J62VKSRB[TUE#,D(=U0
MAA\P<[03G@Y.,8Y[BO/_ (8ZAI^E_"/3-0O;JWMK6/S?,GE<*HS.X&2?<@?C
M7?@@@$'(/0B@#F_'NMZAX;\&:AK.FFW,]F@DV7$9=7&X#'# CK577O%C^'_#
M6FSW5S9_VC?RV\*D_(B^8RAGVEB=J@D]>PS47Q;('PK\0$D#_1P.?]]:H>.C
M$?"GA1V*8.KZ;@G'3>#0!U>A+J8-V]YJ=MJ-E(X:RGB0*^PCD/M^4X/0C\:N
M1:MIL]ZUE#J%I)=+G= DREQCKE0<\58E=+>W>0J=D:EB%'. ,\"O%[;5-,,/
MP\NK2ZL[33UU!V@MO.WRPQM')DRR$]2>HP "<9.,T >O7&M:5:AS<:G9PB.0
M1.9)U7:YY"G)X/M5[K7D::3I<D/Q3+V5JWE-)LS&#L_T4$X].>>.X]J]!\&R
M-+X'\/R,Q9FTVW8L3G),:\T 9NE^(;_Q7J6IIH\L-KIFG7!M#=21>8]Q,N-^
MP9 55R!DYSVQ3]-\430>*;OPSKA@2\BMA>V]U$"D=Q!G!)!)VLI!R,D$<\=*
MQ/A7"V@KKOA>^_=W]KJ,MPBMP9H),%)5]0<$'T/!IWV8Z]\:X=2M,/8Z+ISV
M]Q.O*F>0G]T#W(4Y/IQF@"2U\676OSZA=:9KNF6<6G:DUNUO<%62:W0JKN6S
MN!)8[2..@.<YJ;POXAU+Q/:Z?K]MJU@E@YD:^L) I,$66$9##D-\HSNX/.,8
MIOPZ$+6GBML1D#Q#? GC@;@:Y"QO/L'P.\(WA=X[!+Z$ZA+"@8I")7RQ!!!
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M)P*TCK6EBPCOSJ5G]CE($=QYZ^6Y)P &S@\\4 $6BZ5!'+'#IEE&DHQ(J0*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTT1F,:?:;"02ODK@D=\8]ZL""$0>0(D$.W;Y>T;<>F/2@#Q""*SC^!>GWJ)
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M4:!/I)U6/6K!M/5MC7/VA?+5O0MG /M5IM5TY+V*R>^MENID,D<)E4.Z@9)
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M-4GTRUU.TFOX!F6VCF5I$&<'*@YX/Y43:]I%O>BSFU*UCN"XC$;2@'>>0O\
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MMH&?,95S&=I*DJ>QQQV-4O"OB2*?P;X>N]9U*W2_U&TC<&5UC,SE06VCC/T
MJE)J_A76O[4UC29[:[NAI4D<]]"^5CBZK&YZ DDG!YX.:Y+X<:T-%'A^'7I8
M'M]2TV)-(O<X6$JBB2W(SA6)P=W\7 /0  'L$TT5O"\TTB1Q1J6=W8!5 ZDD
M]!7.Z]X@B?PMKEQHFJ0?;K"RDN/D"NT9",R[E/0':>HYJQXQBL+CPEJ$.I7<
MEI9RH$DN8R 8LL 'R>P)!/L#7#3ZCJUOI7C'2M=EL;Z:+06DCUBU&SSHRLH1
M)%SA7R6(QP0: .S\,^)]/U+3]*LY]6M9=:EL(9YK<2KYI)C5B=HZ=<]*TGU_
M2([X6+ZE:K<F00B,RC/F$9"?[V.=O6O. ]E;Q?"=H6@C.0 5('WK4[OS;&?>
ML;7=<TNZ\/73VUQ;Z>D'B5)); -F56%RN^:8L25!/(QM R!D]* /1%U/4Q\5
M)M&-YG3VT7[7'%Y2_))YVS.>IX'3/>G> =5U#5M'U"34KG[1/!J=U;+)L5/D
MC<JO &.@K.CO+:7XW I/&0_AL%?F'.;C/\N:?\+IHIM%UGRI$?&N7I^5@>#*
M2/TH DO?$TFC_$FXL]4U:"WT1=&%WB8)&J2&8)]X\G@=,]ZZF+5M.GTM=3BO
M[9[!EW"Y653&1G&=V<=>*XV^^PI\;('U#[.JMX?(A:? !<3G(7/?:3T[&N/9
M'T#2'U:(3P>&!XK:Z!MTR([8QE!*HP1Y8D^8<=@1VH ]BT_5M/U9)6T^]@N1
M$^R3RG!*-Z,.Q^M1WNNZ1ILQAOM3L[:41F4I-.JL$'5B">GO6!X5'AV]U_4=
M8T34)=2N+F&-+N[60-$=OW%^4 ;P,].0.N,BL[Q*MC_PMWPG]L6##V=X$\T#
M!<>65Z]^N* .OMM>TB[TDZK;ZG:2Z>N=URLRF,8ZY;.!2V^M:9>P7,EMJ-NR
MVW$["0?N3C/S _=XYYKRFZ.GZ(WC"]^Q0RZ#=:U9);;F*6\5P-OF3$J1\BR8
MSC@E<5L^&=1LG^)7BH2:K!>?:+"T<2C:J2!1)N*XX*KD#.3CH230!VFCWT-M
MX7M[N]UZWU&)4)?4SLC27YB,_+\H]./2L31/$<^I_$C5M-BU*.ZTV"PBFCC1
M%'E2,[!@2.<X X/K7!:/J*V'@'X:7US(/[$M[UOMS]4B?YQ$S^@#'.3T./:N
MOT;4M,NOC1JS6=Y:S>=H]OAHI%;S&61\X(ZD#% '2^(/%FE^'+G3K:^N(TFO
MYQ%&K,%"CDEV/8 #\3Q5V\UW2=.1'O-1M8%=/,4O*!E/[W^[[]*Y7XB7$-EJ
M?@Z[NI4@MHM:7S)I&"HF8I ,D\"H/#^HPV_Q!\70ZO-'$;M+>XLWG(59;41X
M^7/926R/5C0!W\<D<T22Q.KQN RNIR&!Z$'N*HSZYI5K=BTGU"VCG+K&$:0
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MDV[AV)R,9Z]JNQZ[:Z%XH\):AJUPD6C7'A\6UO=.?W45P2C-ENBY10,GT^M
M':ZMJ]E=:%!=67B:TT^*>9/*O0T<BR8<91=QP2<%>.1FK=]XDT/37G2^U>QM
MW@0/,LLZJ8U)P"1GC).!ZUY_XS;08_AQ)-H\<,-C+K%O-'*#A)F,Z%Y$)[?>
MY''!(XK2D736^.$OVL6Q+^'T:+S0O)\Y\D9[[<_AF@#L_P"VM+.F1ZD-1M38
MRX\NX$H*.2<  ]R3Q@=ZC'B+1?[-EU$ZK9K91.4DG:90B,.JL2>#['FO*=-E
ML?#^E0>;!;QZ==^*YY-'NKEBMO:1[2%DX(RIPX4$@'=G-5[J^LG\+?%. W\=
MR[2F9&;:"X,,8#@  8)Z$=>V>M 'KUOXBT6[U"6PM]6LI;R%/,D@2=2Z+ZD9
MX'(_.JOASQ;I7B@WG]G7$;_9IWAQO&Y@N 7V]0,D@>N/>N3NWL8/&_PW%NUO
M&K6MVH$9 !4P*0..V?UJ[\-+RV\OQ#8>>GVR/7+UY(,_.BF7@D=@<\>M '2:
MC<JNOZ3;KKL-H[-(6T\A"]X-AP!GY@%P6R/3FFW'B_PW:HSSZ]IL:K-Y!9KE
M !)@';UZ@$9';-<_XME@C^)7@+>\:OY]YU(!P;=@/UP*YI1I[:#\6G_T8L9;
MD9^7./LRX'_?6<>] 'KX((!!R#WK.GU[2+6\%I/J5K%<%Q'Y;R@'<>BGT)[#
MJ:@\)RB;P=HLBN'#6$!W YR=@KS?39[>;X.>)-&UDK_;4+7D=U _^MDN7=GB
M8#JQ8LFTCK@8Z4 >G7GB#1M/GE@O-5LK>:*(S21RSJK(F0-Q!/ RP&?>I8-8
MTVZTI=4@O[:2P9=PN5E!CQG&=W3KQ7GNEPF'XG>&X=6:%]3A\+XG9R"WG!XP
M3GU^]S]:YZ*_6P\*O>Q2R#2[#QE<27AM0&,,&]]KXP1M#,C=.P(H ]CT_5M.
MU996T^]@N?);9*(W!*-Z,.H/UK \3ZIJ6G^*O"EO:W?EVE]>/#<P^6IW@1,P
M^8\CD#I4?A;_ (1V^\0W^L:)J,NIW-Q D=U=+(&B^7[BG: -^,^X'7&1FMXX
MGBB\7^!A)*B'^TI#AF _Y8N/YD#\: .I&O:0T-W,-4LS%9G;<N)UQ"?1SGY?
MQI'\0:-$;8/JMDINHS-!F=?WD84L77GE=H)STQ7G<NIV.G:Q\3+.\NHH;FX1
M'@A=L/*IM ,HO5N0>G2JFG7&GW,WP@S+;2[;213EE.&%H!CZA@/Q% 'HA\9^
M&1IHU$Z_IHLS(81-]I3;O'5<YZ]\>G-7;G7-)LWB2YU.SA::,RQB2=5+H%+%
MAD\J "<],5Y]8#3CX@^*!/V;&V/<3MZ&V&[\"W7WK)T]["6/X0O>-;O%]FE0
MM*05W"W 4'/?<!@>N* /6=+UC3=<M/M>E7]O>V^XJ9+>0. 1V..]+?:MI^FE
M1>WD%N6!8>8X'RCJWT&1D]!FN0\*6$<'Q'\7WFG(J:9*+9&\O_5M<A6+[<<9
M *YQW/K3?%L=XGB@WN@:W:VFM6VG!I;&_ ,%W;[W(YR"I#!LL.F1GK0!U\6M
M:7-=0VL6HVKW$T7G11+*I=X\9W 9R1@CFH6\2Z&EC-?-K%@+6&0PR3?:%VI(
M.J$YX;D<=:\_36K1/$GP_P!8O8H]'LY](N45)W")$2L1";FQV'&>HKGM5O[&
MX^&_Q*43Q%FUQY%5CAL%H=IP>><''TH ]?'BC0#<WEM_;-AYUFI>Y3[0N85!
MP2W/ !X/I5O3=4L-9LEO--O(+NV8D"6!PZDCJ,CO7$:RNG?\+7\&*@M<"RO
M@&WH!&4Q^N/QQ5CX>2P-JWC2.&2,@:[(VU".,QQY/XD'\<T =%>7*CQ+IL"Z
M[#;MLE+Z:0A>Z&.&Y^90N">.N>:;-XO\-P('EU[344S&W#&Z3'F  E<YZC<N
M?3(KG_$<L"?%KP4&>-9##?@@D G,:8_D:Y,C3V\"?%5Q]F+G4;T;OER?W2%?
M_'LX]\T >S45GZ#*L_AW395<.&M8CN!SGY1WK0H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-N&!"R'=QUZ9ZXK+N/&.F:(OAVQN=0^V2ZDBA;HK@.@B+&5L# W8''^UQTH
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MB<R@;Y,XV ==V>W45:TK6=-URVDN-+O8+R&.5HG>%PP#CJ,_B/SH GN;*TO
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M]-D>.\O8XF0!I,YP@/3<1PN>V<9[4:EKNEZ.,ZA>Q087>V[)VKTW''1?<\4
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M&NKT6<.I6[7!0R(F[&]1U92>& [D9Q0!H200S$&6)'QTW*#BGJBHH5%"J.@
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M %.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7[I/LYU73YIU24@%(S"5B7\1AL>KFL.2_M+6Q^%6HSW,4=E$@22<L-B,;0J
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MQ3PEGT6WRJN,LPD?]0"/P-5OC-<6L?@ZVBN9HDWZE;':[ 942 M^ &<UZ)M
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MPLKV/AVY>>VG<?ZV.5<PCWV[I<^A5:JI-#=:Q\5X+:1)97MHPJ1L"6/V0J<
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M66&Y>2,'(]*OT@5020H!;J0.M+0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !2$A5+,0 .23VI:R?$VFWN
ML>';W3M/O([.XN$\L321[P%)^88R.HR/QH 32?%6@:[<O;Z3K%E>S1KO=+>8
M.57.,G';)%:]<-X-O[^TUZ\\.:YI6G6NJ0VZW,5WIT6R*[@W;<XZJP. 1[UO
M>(];CTN&"U2[M[>]O6*0/.X58P/O2'/4*"..Y*COF@#1MM2L[VYNK>VN8Y9K
M1Q'.B')C8@$ ^^"*M5YS\-VTVV\2^,+*QNX95^W1-'B8.T@\E-SYS\Q+$Y/J
M37HU !1110 5F:EXBT?1YXH-2U*WM99O]6LS[2_^[GK^%:=>>_$21H?%7@65
M89)F74Y,1QXW-^Z/ R0/UH [73M8TS5UD;3M0MKL1-MD\B4.4/HP'0_6BVU:
MQO-2OM/M[A7N[$H+F, YCWKN7M@Y'/%<'X.4^)OB)JGC2U3[%8K;'2VM7($[
MS(^6:51]TC@ $DXQTK9M?%EXFK>,H;ZUA,.@QQ2QBWR7E5HC(02>IP !@"@#
ML*H:=K>FZM-=PV%W'</9R>5/LR0C8SC/0\>E<>/%^O$>$IDCTV6+Q"N=@1P;
M<F/S!\VX[QC()P.1GV&3#?:WINK?$2^T9;#-I=+</]K5V$@6V5B@"D8) ^\3
M^![ 'JM%>=7^MZQJGBCP'+8WD%K::I:37?D20&3#" 'YB'7=Q(0!Q@\\\8T+
M?QA<W_B6\TBWN=/M[RTOEA;3KJ-EFEM\KNE1BX#?*6884].: .UHJEJ]S>6>
MCW=QI]G]LO(XF:&WWA/,?' R>!7,:3XNO9_%\FASR65\O]EF^6:RC9 '5PC1
M\NP;EAR#QT- ':5!>7EMI]I)=7EQ';V\8R\LK!54>Y-<GX0\77'BDVT\-YIT
MD9B8WMFD;1W%E+QA&#.20#N!.T9(R.O%SQWH>IZYH,2Z/-%'J-E=Q7MNLX_=
MRO&<A&]C_,"@#3LO$>CZA="TMM0A>Z(+" G;)CUV'!Q[XQ6I7GOA[QA::_XF
MM=/UW29M$\5V<<GEP3KN252/F\M_XE^4''^SP3@FJ6B^*M3T7P]XKUO5[J&^
M^S:O/:QQ)"8V>0.D48#;B%3H,8)'7)[@'I]%<E>>(=5T#Q#HMEJ_V.XL]6D-
MNDUM$T9@G"[E4AF;<K8(SQ@BH;7Q%XAUK1[?7="L[.YLI;LQI9R965X!(4:3
MS"X4'@MMVGCC)- '26>MZ;J&I7VGVEW'-=6.S[3&F3Y6_.T$],G:>/:B\UO3
M=/U"RT^ZNXX[N]8K;PG):0@$G 'L#R:X&/6AI?Q1\86MNT+:K?16$5C!*>))
M!%*23R/E Y)ZXZ9) -SQD-1CUKP/YC6L]]_:3\HK1QY\A_4L<4 >@T5P \>7
MFC6?BPZ_#:S7&@-%M:S5HTG$R@QC#%BIR<$Y-:-_XAU?P]J^AQ:P+*>RU6X%
MGOMHFC:WN&!*#EFWJ<$9PI&,^U &_I^M:;JT]Y!87<=Q)9R"*<)DA&(SC/0\
M>E%YK>FV&HV6GW5W''>7K%;>$Y+2$ D\#V!Y-<)8ZY;^&=2^)&LW2LT-I=PN
M47JY\A %'U) _&G>(1K)\7^ WU.2Q97OI&*6\3*8G\A_EW%CN'7G"].G.  >
MD45P%YXUUFXTZXU30K#[;%#=O"ED+&=GN$20QNRS#Y%.0Q P>!SR<":X\1>*
MKSQ=J>AZ1;:3']FM8+J*2\\S[KLP*L%[X7MT]Z .YHKBM.\87.JZ_=:;;W.G
MPW=I?M!-IL\;+<& -CS48N V5P_"XP<=>O:T (2 "3T%95MXFT2\CNY+;4[:
M5+/(N2CY\DCJ&]/QK6KSB.XA\'?%;5UN6$6F:[8'4%8]%F@&)0/JGS&@#N+#
M6],U2P:_L+Z&ZM%SF:%MR\=<$=:@_P"$GT7[)8W2ZC"]O?7"VMM*F6665LX4
M$#V//2O-O ^I7WA_0O$'A>6);;4K>:.73X1T1;O&Q1ZA)&.3]:[+7=1N/",'
MA?3]-M[9K*>_M],;S<ED0J<%<8&<+U/KTH ZJ66.")Y975(T&YF8X %5M*U6
MQUO38M1TVX6XM)=WERJ" VUBIQGW!KE-%NM9N/BGXEMIK^![.U@M-D/V<@A&
M$I !W\-GJQ!SQP,5RGA#7M:\._#?PY?116#Z4U\;6:-PYF*R7+KO5@0JX)^Z
M0<XZCI0![%1535)Y[72KNXM5C:>*)G1920I(&><<UP^G>-/$'_"*V7B34[;3
M!97UM MO!;B4R_:99%1<]1L^;.!EACO0!Z'17%IXFU^VU._AFTJ34+./3WNH
M+F"QFMLRIG]R5D)R6[$?3%)HGBV[US3)=1TZ^TG4(%LFD98T>)X)Q@A)%+L0
M,;NP^[0!VM%>7CQ]XHMO#&B>++VPTLZ)=F%;N*'S//B$A"^8"3MQDCY>3TYY
MXV-3\7:K,NL-H-NLSZ9.T"V[V$\QNI$ +*)$(5.3M&<\C)X- '<45REOXCU'
M6M2DTW3(8;&YM["&ZNOMT32&)Y@2D6T,O(VG<<^@QSQAZIJ?BJ;5_ T=R;;2
MKF\GG^U6AC\]1(D,F"65QN4CD+G@D9)QB@#T>BLSQ!->6WAK49[*>.&[AMGD
M25XMZAE4G.W(]/7\^E<?H'B/4+'P?X-LY9[>YU/6X8DMW>)@(T$(=WD^<ER
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M:?/;_9I%&0K&0D,&Z C'/6F>$/%UQXI-M-#=Z=(AC;[=9+&T=Q92<81@SDD
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MH#Z#<23]>/H* +=%<5<^,+E_%&HZ%;W.GVM_;21BWL[V-@]Y&RJQ>-]X'=@
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M^G:S- L$MS&2\:$E0P8J<9YQD4 ;U%%% !1110 4444 %%%% !1110 4444
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M=2>0I*X]:UAXPT'R#<'4%6TZB[>-UMS])2-A_ \UM1R)-$DL;;D=0RD=P>E
M'&Q>"9=.U3PFVFO MAH$$T.R5CYDWF(%)R!@$8S[D]J(/"NJQ#Q=F6S)UTEH
M\.W[DF(1\_+SP,]O3WKM** .&M/"&JV\_@MVFLBOAVW>!\,V9]T0BR./EP!G
MOZ>]6+?PQJL-UXMG,EF?[<P8QO;]R1$(^?EYX&>WI[UV-% '!6G@?4=.A\,7
MEI=6O]K:':_87#;O)NX-H!!.,H> P.#@^M3:IX)N]3TOQ,S36R:IK\20.WS&
M.WB1=JJ.,L>6).!DGH,5V]% ')7'AS5+C7_"VI&2S5=&CE25-[$RF2,(2IV\
M8QGGKTXZUL^(+"^U+2O(TV\2TNUFBE2:2,NHV2*Q!4$9! (ZCK6I10!R>H>'
MM2\1:GH\NL+806^E7:WJ?9G:22:100HRRC8N3DCYLX S54^!9KB;Q39W=W"^
MCZZYF*+&1-&YC5.N<8!4$<5VU% '&Q>%M5O[#1=-UVYM)K;2IXI_.@W;[MHA
M^[W*1A.<$X+9([57L_"7B/1-8U*/1-8LHM$U*Y>[=+B!GGMG?E_*((4Y/(W<
M#T/.>ZK.FUS3;?6[71I;D+J%TC/##M8[E498YQ@8]S0!RNM^ 7UWQ#?W=X8'
MLKC3$L8E\QA-$Z.724-CA@Q_^N>E=-X=M]8M-&@MM<NK>[O(E"-<P@CS<=RI
MZ'UQU]JU:SM:UW3?#U@;[5+D6]N&"[]K-R3@# !/4@4 <WXF\(7OBB"\L+[[
M ]O).LMG>'<+BR VYV<<G(.#N7KSG%6)O#>L6_C*_P!7TR]LTMM3MHH;I9XV
M:2-H]P#)@X.0W?H>>>E=;10!Y[8> M6T_P ,>%[-=0LI;[0+@S)F)EBE!5E*
M$Y)!PQ^;';I6I+816>I:EK&KWEHFK7U@UO!;I)Q'!&&8JN<%SEBS-@=N!CG8
M@\2Z1<2:G'%>!FTP@7?R-^Z)&1VYX';-) -"\6:=8ZH+:UU"V8>;:RSVX;;G
M^)=PRO3VH XC2?".JWW@'P5?:9>)IVNZ3:*\)N(RT;K(@WQR*.<$!?<8_+:U
M?PCK'B/PX8M4U>"+6H[B*[M9K.)A!;2QDE-JL23U;))R<^P%=I10!S-MH^OZ
MCI-];^(M0LC-<VKVJ)I\3K$@88+G<26;IZ 8]S5SPIIFH:-X;L=-U&XMII;2
M%+=&MT*KL10H)R223C)Z#VK:HH Y%O"%Q)XF\0W,MS ^DZ[;QQ74!C/FC;$8
M\*V< $'.<9[>]5(/!FIS^%[+PIJEW:SZ3:21 SIN$T\,3!DC9,84_*H+!CD
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M3_U]WO\ Z4FNXL_#&MQ^,(/$5UJEB\@TTV,L$-JR)]_>-A+$CGJ3GV [9Y\
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M4(P5QZ8KFHM3N9O$4_A;2)HH%TJRA>>XGC,K%GR$4#*]ER3[@#'6K=G;>*A
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MMP%#"-FW;<,N2..HQ[UK:#?7FI+?7,[0&T^U/'9^7&58QH=I9B6.<L&P0!P
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MM#KEE ";B/:L\D!CE* G@[@& R.AJW>7<-A9S7=PS+#"I=V5"Q '7@ D_A7
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M%W,>I..I]ZFKEO!'B"[UVWUA+PAGT_4I+-)?):)I$"JRED/(;#8/3IT%=30
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5S_C'P[<>*-$&FP7L=I^_BF,
MCPF7_5N' P&7NHKH** .=\3>';OQ#%HX2_@MWT^_AOF)MRXD:/.% WC .3ZU
MQ6NSQ:IXUU8CQ%H-E)9I':FTUNR1SC;O9H]SJ=C%@"><E?0"O5B0JEF(  R2
M>U0SV5I<R))<6L,KI]UI(PQ7Z$]* .+CTG6?%=GHEW<W^GQMI6H_:8Y;>U<Q
M7:JI564%P54AF'?.,C@BKY\'3RZSXGO)]0C,&NVB6K1) 0T(1'0$,6.3ASV'
M:NLJIJ>HVVD:;<:A>,ZVUO&9)&2-G(4#).%!- '/Z;X=UW3-(TJR_MBTN18P
M&VDCDLRL<\6U54$;R0PVYW<]2, &M#PKX<A\+Z3)8PLI$EQ+<E8TV1H78MM1
M<G:HZ 9K2TZ^@U33+34+8L8+J%)XRPP2K*&&1]#531_$%AKDE_'8M*S6-P;:
M<21-&0X )&& /0B@#*B\+WVE>(-5U+1+^"&'52LEQ;W$!D"3 8\Q"&'4=5/4
MCJ*J+X"-FWAA-,OXX8-"DDE"S0&1IWD5@Y)##&=S'IU/X5VE9^MZS9>'](N-
M4U!I%M;==TC1Q-(0/HH)_'I0!H5Y3X&T:[\1?#1]+DOH$TNZO+I9MD9\WR_M
M#[D#;L?-_>QP&Z=Z]0C>&]LT?:'AFC#;77.5([BLOP_J>C:BVH1:/ (OL=R;
M>X7[,8?W@ )&" 3PPYQ0!5M_#-Q;^.9/$"7D MVL$L!:"W(*HK%@=^[KDD=.
ME/TGP[<Z=XNUS6Y+Z*6/51 /(6 J8O*4J/FW'.03G@5T-% '/:1X3MM(\3:Q
MK,,K'^T&#K!_#"Q $A'NY1"?]T4S3_#E[I_BG7M;6_MW_M5(56$VY'E&)2JD
MG?\ -G<<\"NDIDTT5M!)//(L<4:EW=S@*H&22?3% '!1_#:XA\%:1HT6MF'4
MM&G,]CJ,5OC:V6R&0L=P(8@C//%/\0KJ>B>"-3N-<U\O>W2):BZM[;RX;4.V
MT-MR< ;B68GH.,8%='IWBC3M3U7^S8EN8[AK<740F@9!+"2!O4GMDC@X//2M
M*]NH+2SGGN-QBB0O($C,AV_[J@D]^U 'G?AR2\TW5;2+3M9\*:I#,R12P:99
MB*81?W\H[ *N<\C'8<D5I:/X'UC0YI-.L?$A3PTTK2)9&V!FB5CEHTESPI)/
M.,@'C!YKIO#]SI>HZ-;ZEI$$<=I=H)4*Q",L#T)%:E '(:QX/NM>A:RU*]MI
MK07PNX)?LY%Q;@2!]B/NQVV[N, XP:Z#6]'M-?T2\TF^4FVNXC$^TX(![CW!
MY'TJ_63<>)--@OY+!9)KFZB ,L5K;R3&+/3?L!"D]0#@F@#(M_"=_<6^C6FM
MZE#>6VDS)/$8X"CSO&"(VD)8CC.2!U(!X'!M6'AR]L_&FJ:^U_!)%?PQ0FW%
MN04$>[!W[SD_,<\5IZ9K6GZP;@6,_F-;.(YE*,C1OC.U@P!!P1P:T* .>\6>
M'KG7X=-:ROUL[K3[U+R)I8O-C<J"-K+D9'S>O%1:!X8O='\1ZUJMQJJW2ZH8
MI'B%L(]KH@3(.X_+@<#KZD]:Z:B@#$U;2;^_NY=D]G+I\]L()K&\MS(C')._
M(8=C@C'.!R,5B1^ 9;&/PJ-,U;R9-!BE@#SP>9YJ2* W&X;3QD=0/0UVU% '
M)6_A._TF_P!9;1=2A@L]6E:XEAF@+F"=AAW0AAG=P<'H1^%4[OX>M9_V'<>%
M]2_LR^TBW-I&\T7G)/">2LBY&>?FR.Y/MCN:* .0U;PAJ.K:7I]O+K2-=6^H
MQ:A-/):Y$CQD$*J!QL7@#J3QW))HTSPA?:+=:PFFZG;Q:7J!,D=BUJ2MM*PP
MS(=X^4G)VXQZ8KKZ* .%3P#>IX7\-Z*NKV__ !)+R&Z68VA_>^43M4CS.,YY
M.35^W\+7^D:SJUYHFHP00:J_GSP3P%Q%/C!D3##KQE3W'7M75UEZGX@L-(OM
M/L[MI5FU"806^V)BK/@G!;&!P#U.: ,&?P&(M-\,Z?I=ZEM;:%<K<J)H3(TS
M ,#DAEQG>Q/'4T@\':E8:YK%WHVKP6]CK!\RZM;BV,A24KM+QL&&"1U!!&?R
MKLZ* //$^'&HV>C>'UT[Q MOK.B1-!#=BUS'+$V-T;QEN1P.<UHZOX/U76=
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M:RE& 9>#NSG/! H \\\5ZO=:E\-[C4--\1I=VLFHV\<5Q;HH:2%I(E*2#'#
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MD!E(8'H0?:JMWX)\_P *ZSI$5^L=SK,DDM[=M!NW,XP=J[A@   #)P!SD\T
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MLEGI-Y#<V;&Q'F[8CE$=M^&QP,@#ISF@#T"BD (4 G)QU]:6@ HHHH ****
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M:IX7 W=SDYZ5EZEJGC/2-#\4W4VY+:SM#=:==W:0-+E5)>-UB;;U'#8Z=0:
M/1*CN)A;VTL[([B-"Y6-=S' S@ =3[5PC:OX@TVTTF2\U>&XEU^>UM[=1:J@
MLRR,\C Y^<D#C('..,<5K7"^)M+M?$$KZG;W%K';>=I\TT0,R,%)=750JD9
MP1SSSF@#H-/O4U'3K:]2*:))XUD$<\91U!&<,IZ'VJS7G,WC'4+3P=X3UC49
M+N.QO;19=3U"SMUD:!S&I4E=I 0DMDA>,#UJX/$UW*-!TVSOSJ4FI)<W'V^R
M$.YH8V 7:'(0-\ZYX.-K#&>0 =U17/>%)/$1BOX?$$! BN"+.X<QB2:$]-ZQ
MDJ&'0XP#QQ54:M=ZWXRU?0;.]DL(M*MX&DEB1&DDEE#,/OJPVA5';))Z\<@'
M27MY;:=8SWMY,L-M!&9)9&Z*H&2:SM-\16VHZI/IOV6]MKJ*)9PMQ#M#QL<!
ME8$CKVX([BO-_$VN:CX@^#OB@7TWDWVDW4NGW9@0!+DHZ?-@@D A@< ]<]J]
M7L8);>T2.:ZDNG'/F2*H)]L* /TH IZ-XAL==EU".R$X:PN#;3>;$8SO"@\
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M\[??V2'E W<#GT(KM:* .:?PK+:>);O7-&OTLIKZ)([R&6W\V.4H,(X 92K
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M;_N,1U.#6K)X;CGNL7,L=QIZ69M(+.6(L$R,,Q8M\Q(X.1TZ$9.=VB@#AO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO"DEY/X8L+B_O9+RYGA65Y9$1.2,X 10,?A6S0 4444 %%%% !1110 4444
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M2]2TN1LR%!&EPO=BW 9AZ]UP>>:S?%V@7&O>"_!_B/PRRS:OI4L$0,?)&YE
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MSMFO'M(U:\)\R0#:,C>22![5U-% ' O$OCFYUQ[74M/-AY3Z9LFMVF(3&9)
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M:WZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%PH)Q_%G/&*S-1U;6-4\3^ )K2\BM8-2MI[HP-"9%5Q;@Y)# MQ(0!QCKSV
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M!X0U+XPT%/$_A#5-'8#=<P,L9/\ #(.4/X, : );SQ-I&GW=I:7=WY-Q>?\
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M,(G$R@HI4LVT[CC.34.OQ:PGCGP(VHW5I-ONIRRPPE/+D^SOP"6.5^O/'OP
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS*Y8-CU4#&*P$M;*#PI!HD/BVVVV&HK>V1;3Y=K 2M+LF&?G&6[8Z#K7LE%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %8^KZR;/4-/TJU"-J&H,_E[AE8XT&7D8=P,@ =RP[9(V*X2<.OQVM&E
MSY+^'9%ASTWB=2V/?&V@#K[G5-/TYHX;W4;:"1P-HGF5&?MD XSSZ51UO6'T
M&:UN[DJ=,FF2VF;&# SG:CY[J6(4^F0>QK@?&-_I\Q^(5O;O;VMQ'IJQWCW3
M[GN&\EFC6)"0% W?>YR3T[U;\8W$5Y^S_-(DJS;M.ME#(V[,F8P!D=]V/QH
M]-HJ*U$HM(1,<RB-=Y_VL<_K4M !1110 5B>+=:GT'PU=WMG!]HOMNRT@ SY
MDI^Z,=QW/L#6W7*W9O=:\6XTZXM5BT5</Y\32 W$B^BLN"L9_P#(I]* -;PY
MK<'B3PYI^L6V/*NX5DVYSM;^)?J#D?A5/QOJ]_X?\'ZEJ^G&V,]G"90EQ&SJ
MV.WRLI'YUR_@%Y/#/BW7?!5Y+#@M_:FGB-2JF*0_.BJ22 KYP,GJ36W\4"!\
M,?$1)Q_H;B@#,G\8ZWH=SX8DU==/N['798[??:0/#);RR %>&=PZ\\],5VK:
MKIR7PL6O[5;PG MS,HD/&?NYSTKG-#\*Z=>6GA_5KV6YOIK.UC>T6>7,<+%!
M\RJ  3Z$Y(K@-<U33KCP[+<6$UM:6Z^*$D,,LF^X>87"AY"2?D'7"X.%QR,X
MH ]BN-5TZS=TN;^U@9-NX2S*I7<<+G)XR>GK6?IOBK2=9OM2L;"_MWFL7\IR
M) 06V@D@9Y S@GU!%<E:Z/HFK_%O7EN;&RO()=*M90KQJZ.2[_/CH3TYZ_G4
MGA8:>^N>.[*Y%L7DU-CY$@7+)Y"'[I[<&@#L=)N7A\/P7&I:I:7;I'F:]B C
MB?GJ.2 .W6DO+^.]T"[N=)U:RB/EL([TLLL43#N><''UKRC1=3CTKP9\,+G4
M'":()7%U(W^K278XA+]@ V3D\ @'M71>+K7PW/X(\<76E"&X>>V,]U,DGF1&
M81D#;R0'  )QC[P]: .]6^M[>W@%W?6WF-%OWEP@D &68 GIW]A3X-1LKFR^
MVP7EO+:8)\^.563 ZG<#BO.-0L--N_'/P^6[MK>59]-N0PD4$2[8XBH/][')
M .:R+J#2] E\<Q-:;O#\NIV$<%O')Y,*W1VF3+#A4#;"W';&.U 'KMKJ=A?0
MR36E];7$49P[Q2JZK]2#Q38M7TV:XAMXM0M))ID\R*-9E+2)_>49R1[BO-K6
M>VN/'?C*WO+RPNVN-'@++$ (W91+D!23DJ!ZG\*S;.RLK7P)\,+V"WACNGU2
MR5IU4!V#(X8%NI!P!CV'I0!Z=IWBG2-5UJ_TJSO89;BR94D"R Y8@D@#OM&,
M^A..U:DUS;V[1K//'$96V1AW"[V]!GJ:XCPE+:P_$/QM SQ).]Y;F.,D!B/L
MZG@=>QI/B+:6MQJ_@PSP1.S:VD9+*"2ACDROT)QD=* .M&NZ0;.6[&JV)MHG
MV23?:$V(WH6S@'VJQ-?V=O:+=SW<$5LP!$SR!4.>G)XYK@]'T;2I/BKXL@>P
MM6A%G9/Y1B4H&*R G;TR0 ,USWA34;*'PA\.H)MGV^1[HV=Q<RD00; ZL6 (
MWG:V%7(^HQ0!ZP=8TQ;2.[;4;06TIQ',9UV/]&S@U*U]:(\"-=0*T_\ J09
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MQ4I<AAMB7SYL$GL,$?G6KX@U%Y/%'CQM$N4>^/A^(0F!P6+*9-VW'5@/3H:
M/4HM6TV>>:"'4+22:$$RQI,I:,#J6 .1^-9%IXHL/$>BZE-HFK6D4D/FQ1W$
MC*ZHRY42%<C*YZ=B!65H=WX-UW_A&+[3Y+>:\MK=DLHH)?GA1H\2!T!Z #!W
M#@X[D5R^G_8)O@[XRMI/L[SQ/JKF)L%D(=RIQU&"1B@#U..\BM-)@N;^_MMO
MEIONBP2-R0/F&3@ GD<]ZD74;%K'[<MY;FSV[OM E7R\>N[.,5YW:7;P^+O
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ME=I5=X<;7LO+R<XZJ#LQVR1CK0!WM%%% !1110 4444 %%%% !1110 4444
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M_OV_D+Y;?5<8-"Z/IBZ<NGKIUH+%?NVP@7RQ_P !QBBWUC3+NWFN+;4;2:&
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M<2J[_4@9--_LG3<R'^S[7,GWSY*_-SGGCGF@#(\ 2&3X=^''+;B=-M\G.?\
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M4-HK26FGJ95507Q)$2">_5C^)K;U&/3Q\9/#JJEL"-)N @ 7C#)MQ_X]C\:
M.VT_4K'5K)+W3KN&[MI,[987#J<<'D5%J&MZ7I3!;_4+:V8H7Q+(%.T=6]@/
M7I7*?#62%G\71PNA5/$5T0J$8 (3^N:H>)=6TX>+->L#)!I]Z-'59)Y3NEO$
M/F%8X4)VX!)R<$DMC'&: .[GUK2K5[=)]2M(FN%+PAYE!D4 L67GD8!.>F*-
M-UG3-9M&NM,U"VO+=&*-+!*'56'4$CI7DVFW&G7NG_"57DMYMF8VW$-AEMB,
M?@V!['WIGB22<)\58M*^=Q)8O)% ?F,9C3SL >JA\_C0!V6H^+/-\?>%=/TG
M6+>:RO7N!=01;'+!869&W=<9'4<'%=G<W5O96TES=3QP01C+R2L%51[D]*\V
MU?7_  _J/CGX>WFGZA920"2Z"M'(O[M7MR%4_P!W)P,'N,5T7Q$U"QT[PQ'+
MJ%JD\+WMN@,KLD4+^8I660J0=JD D=\8[T :Y\2Z*-/O+[^TK9K>R&;EE?)B
MXSAAU!/8=^U'AW7[/Q+HEKJ=E(A2>)7:-7#&,L =K8Z$9Z5YYIU]!/XR\<Q)
MJ45]-=:1 8WB  F(CE!V =5&0,Y/H3FNL^&M]:WGP[T%;6XCF,%A!%+Y;;MC
MA!E3CH1W'44 ;MSKFE6=S]GN=0MH9LJNQY ""WW1]3V'>E76=+=KM5U&T9K/
M'VH"9<P9SC?S\N<'KZ5YSX@N+O1=0UO5]'O+;4]/-]$-5T.Y'[U9<1J&A8<[
MB!&0IXXXYXJ]!J5CI7Q+\:I?W45N]W9V36Z2-AI@$D4[!U8Y(&!DYH [DZOI
MHTZ/4/M]L;*3&RX$JE'STPV<'/M7+^-_$LMOX(EUGP[JL!,5S#$TD064'=,D
M;+SD C<?>N%\.:Y;:3HOPUU.]G4:+#;W%M//G,=O<LH"%_0XWC)Z;C6SXZF\
M/2_#G7;K1A ;:\U&VDFN8VS'<RF>+>5.<-@#DCC@]P: /1['7-)U.[N;2QU*
MTN;BV.)XH9E=HS_M 'BJ?B3Q1IWA>UMIK^94:YN8[>)"V-Q9@"?8*#DGV]Q7
M/,UK!\:]/C@,,>[P_*FU,#($R%1@>V<?C4OQ1D2#0M)N)7"0PZW922R,<*BB
M498GL/>@#<;4(+CQ#8_9_$-L(FMI'.GKY;&<'!$@;.X!>>G!S3I/%WAR)8VD
MU[35624PH3<IAG&,J#GDC(_.N9U"[LKCXN^&)H9H76;2[LAE8?."4P1Z@@''
MK7)2"P;X3?$5E%N<ZK?8(V\XD!3_ .M0!ZY;Z[I-UJLVEV^IVDM_",RVR3*9
M$'?*@Y%$NO:1!J"6$VI6D=V[B-86E 8N1D+C^]CMUKB-0>SA\=?#GR&@0-!>
M*-A RI@4@<=L_K7/:-=:%JOAF7PYXFU6\36+>]D\[2PRI++/YI=6B^7<VXD'
M(/?DXH ]CN+F"TMWN+F:.&%!EY)&"JH]23P*S[?Q/H-WJ$5A;ZS82WDT0FC@
M2X4NZ$;@P&<D$<_3FF^*T5_"&M*ZAA]@GX(S_P LVKS-]/T^_P#AW\/1I*6Y
MU9;BQ>!X -ZE5!G)(YP &+9[@9[4 >FOXHT".X%N^M:>)C,+<)]H3)E/1,9^
M][4S1+N.2VU"X;7K?4X%NY2)4"*MLG!\HE3@[1W///-<MX0MM,NO'?CC=#:3
M21ZA;NN55BN(5P1Z8;//K7)SR2GP%XP>P'G00>*Y9KN*'YBUN)49Q@=L#GV!
MH ]?L]<TK4))8[/4;6=XE#NJ2@E5/1B/3WZ5#;^)="N[N&TMM8L)KB<N(HH[
MA6:39][: ><8.?H:Y;6F@U?Q_P"#;[1[B*8QI<27,L+!E^R-&/O8_A+;<9[Y
MQT-,^%EMILVDZE<10VLD\6M7I6154LF9"!@]1E?TH Z7Q!XKTOPY/I\%]<1I
M-?7"PQ*SA0!_$Q/8  _C@5<O-=TG3XT>\U&U@5T\Q2\H&4_O?[OOTKEOB+<0
MV=[X/NKF5(;>+7(S)+(P54!BD&23P*@T#48H/B-XLBU66./[9%;7%D\Q"K+:
MB,@A<]E8MD>K&@#OHI8YHDEB=9(W 974Y# ]"#W%<Y'XNT[5=6U?1-.OX4OK
M)%7>2"3(0Q(53][:%&>W/M5'X6VEQ9>"DCD#"V-U</9*W5;<R$Q_@1R/8BJ&
MCW]I:?$GQW;W-S%%-,+22.-V +J+;E@.X&#D]J +W@7QC;:IX8T)=6U>T;7+
M^W\TPM(B22')Y"#'8=AVKI+_ %W2=*D6._U*UM7;'$TH7&3@$YZ GCFO(+ V
M4'PF^'DJF"-QK5FQ<8!W>8P8D^N.M:IU+1AK?C#0/%NL3:>;NZ:18I"BI=6S
MQJJ;&*DD@+MP#GCCG- 'K)^9" Q&1PP[>]<+X6U+7]?O_$4$VKB)-,U22SBV
M6J$LB@$%L]^>V*ZW1X(K30[""%)HX8K:-$6X.9%4*  Q_O8ZUYGX-C\/7VL>
M-_[2NX 6UN8 &\,64VJ.S#/.>: .^MM8@TO2K5M?UFP6:9W$4[NL*S*6.S:"
M>I3;P.]:<.HV5Q=SVD-W!)<P8\Z)) 7CSR-PZC/O7&:J= UGP(N@02K>12%=
M.T]UD ,LT:C$D;?[!4DL/[C=>AQ+6_OKCX?^+?#F[=XOLHIEN]C9DNRR_+,O
M<[DP /X< <<4 >C6WB#1[RZ>UMM4M)9T0R-&DRD[!U;KR/?I3+;Q+H5[=PVE
MKK%C/<3[S%%'<*S2;<AMH!YQ@Y^A]*XO0K_PEXHU'0-0M-7N+W4;1',-KN16
MM%9,2"15484 ;>>,XQUK(\/6*W?PF\22:-##)JJW&I""2%09%8NXPI'()7 &
M/:@#T^VUW2;R\-G;:E:RW.TMY22J6(!P2!W /7'2JFDZA +;5+N;Q#;:A;1W
M;GS5\M4M%PI\HLIP=N>IY^:N>\.:YX0\2Q^&Y;+R+C4[. B"",_O+(&/;)O4
M?=&!MYX)QCM6!IB:;=^&_&]M<:G_ &?$WBA]EW"5_<2>9#Y;G/&-X7.?>@#T
MZVUC3;Q)WM[ZWD6W&9BL@_=<9^;^[QSS26&M:9JDLT5AJ%M<R0X\Q(I S(#T
M)'H>Q[UY7K.I>(%T+Q#::G;PW5WIDUA-=7^F+C[7;"3<04.0'"@DCI@^F,]5
MX>G\,:YXIAUO2=8GU;4!9&%Y5==L4).X+(%48);H#SU]#0!8^(VM:IX?T&WO
M]*N4BE:\AMV$D0=2KMM)QUR,^M1^)M1\3>$])DUN.>VU>RM!OO+9X/*E\O\
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M$>0N\ #N1N'UK6URXL_$%CX#N/#\D37*ZC;RPB$C=%;A#YP('10ORD'O@=:
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M*:1JFI6_BBQTF.ZQ'HQU 1JC8(W2<KE@W.T<\8;G(  .Z2V@C8LD$:L1@E4
M)I8[>&'/E0QQYZ[5 S7*OXYTS2]6T;PU?ZE:W.OW6R*=8G"JC[,LQS]W<>%7
MJ2PX[UB:/XVG?QWXL?5-:M[?PUI#I:Q&<1QCSV^\-^,DJ588SW% 'H4%E:VR
M.EO;0Q*YRXCC"AC[XZT^*"&#/E11QYZ[% S4%UJ=A8VB7=U>00V[E0DCN '+
M?= ]2>P'6N"\.^-9M0\:>*KB[UJVC\*Z68X())?+1#*P!8^9QG!# <_Q#J:
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M >QZ&J\'C#PY<W5I:P:U923W@S;HLP)DZ]/K@X]>U &PD4<40BCC1(P,!%4
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M2,(&N3B=<")3@OGT'K0!K"UMUD,@@B#GJP09_.FBTABC4000QM&"(L1C"9]
M/Z52M_$>CW7VCRK^(FWC$LRG*LB'HY!YVG!YZ5&?%>@"SM;PZM:?9KM_+MY?
M,&V9LXVJ>Y]A0!!X?TK6(IVU#Q%>6EUJ/E^1']DB:.*./.3C<22S';D\#Y5X
MXR=^JRZA:-J#6 N$-VL8E,.?F"$X#8],USOC?Q2GAZ'3;=+E(+B_OX+8N<$Q
M1,WSN >,@ @9[D<&@#I4L[9+EKE+>%9W&&E" ,P]SUHFM;>Y:-I[>*5HSN0N
M@8J?49Z5RUCXBTO03?)JWC*TNXN+F$3E%E@A;  8KC<-QX) //>MN\\1Z-88
M-UJ-O&-@D+%LA4/1F(X53V)P* -2H?LMO]J^U?9XOM&-OF[!OQZ9ZXJI=Z]I
M%C/;P76IVD,MPI>%'F4%U +%AST !.>E43XW\+C3GOSKMC]E20Q-)YHX<<D8
MZYQS].: -C[%:?:1<_98?/7.)?+&X?CUJ3RH_-,OEKYA7:7QSCTSZ40S17,$
M<\$B212*'1T.592,@@CJ*Y&7QI9ZO;>)+32;WR;O3$=4E"@EG6/>2 P((!./
M?GV- '5QVEM$$$=O$@C)*!4 VD]2/2@V=L;H71MX3< 8$NP;P/3/6N7\'>+K
M#4=#T&TO=7MY=<N]/BF>$NHD=C&&8X'?G./3GI6W?>(M'TRX$%[J-O ^Y5.]
ML!2WW0QZ+GMG&: +[6\#R"1H8VD'1BH)'XTT6=LH8"WA ;A@$'/UJ1U+QLJN
MR$C 9<9'N,Y%>56?B3Q5)X,\2>(%UJ)YM&O;J);>>U3RY8X3T)4!@Q&>0>N.
M* /3X[&SA@,$5K D1.XQK& N?7%+]CM?E_T:'Y>GR#BN'B\3ZAJ/B/P'<0S2
M6]AK=G///9%5(!6%77YL;N"WK@X'%=6_B/1X[X6;ZC LYF%N 6X\T\B/=TW_
M .SG/M0!>:UMVN5N6MXC<*-JRE!N ] >M++:V\TL<LL$4DD1S&[H"4/L>U9=
MYXM\/:?)=1W>LV44EKCST,PS'G. 1V)P>.O%:=K=6]]:175I-'/;S('CEC8,
MKJ>A!'6@"2...&-8XD5(U&%51@ >PIU%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7#_%9
M4/A"%IE!MX]2M'F+#*K&)EW%O;'7-=Q00",$9!H X.2WM=3^*VC:EHQADCM-
M/G34+BW(*,K[?)C+#@G.Y@/09]*S])TZ[T[Q/<^"!;O_ &*MRNKV\N/E6W+%
MC!^$X''=2:]$F@=;":&P,5O,8V$+&/*HY'!*C&1GG'>LWP_I.H62RW>LWT5[
MJDZHDLL,7EQJB9VJJY/&68D]RQZ#  !H:DC2:5>(BEF:!P .I.TUXV=4TRY^
M$'@JW-U;R>3J.GQ3HS#"E7&]6SW ZCL",]17MU-\M,8V+CZ4 >7ZZSW?Q!\3
MVFDSQ_;[CPIL@6-QN:7?)MQ[X(_,4OAG4?"?B8>'=EQ>SZSIY4I8,[J]FZKM
M?<N  H (YX/ ZD"O4 B@Y"C/KBFK%&CLZQJKO]Y@,$_6@#C/BKH5]KO@IUTV
M(SWEE<17L< ZR[#RH]\$X'<BM;3?&WA[5-.CO(=4MEW ;H)) LR/_<9/O!L\
M8QGTKH*C^SP"?S_)C\[&/,VC=^= '!WVH/8?%C2M1U0-:Z9>:/):VKSX58K@
MRAV5CT5F15^N,5R/BB%8?"7Q,OHI$&D7UW ;/D;)90$\UD]<OQD=2I]*]LDC
MCE0I(BNAZJPR#2[%VA=HVCH,=* //=:FTQOBKX)$<EH0+2\";67 &V/9C]<?
MCBN/URYM)/!'Q.2.:)U&M1R;48'@M!EL#W!Y]17N.Q<YVCCVKGO&WAZY\3>%
M+O1K.2"![DIF64'"A75^@Z_=QVZT <_J]O8WWQ!\(WFAB&5K&&YDN'L\$+;&
M/"J=O&"Q 4?7'0UR$.O:7<V'@:[M[J"TMH=9 .FP#*V(*R_+(QRWF$^I&<G"
M\9KVVWB\N+)BBCD;YI!'T+=^<#-/$:#HBCG=T[^OUH \K@N-.:^^*CM+:DL@
M!)9<E?LH!'TW9'UJ62UEN/A+X4\1:7MFU30;&VNXMIR9%6)5FB)_VEW#'J!7
MI^Q/[J_E6#K>CZOJM[';PZE!;Z'+$8[RW%OF67)Y"OGY01\IXXY[G@ ?X6#W
M.G2:Q-&T<VJR?:MCC#)&0!$I]"$"Y']XM6$T<D/QUCEESY5QX=:.$GH66X!8
M#WPRFNY      '0"L_4])CU"6TND?R;VSD,EO/MSMR,,I'=6'!'T(P0" #S'
MQGJ]C,?B!IR/%IUVMD/,B"[I]0(@)#X.<1J./E&>"2PKTKPQ=0WGA;2YX)!)
M&UK'AQT.% /ZUI!%/S,B[RN"<=O3Z4\    8 H *\H^(&B:IXC^*_A*VTUO*
M%A#)>37)7(@4N!N]"V5X'K[ UZO2;5W%L#<1@G'./\F@#QNP\&SZA\:]8D@0
MP:'I]G#93-R3-NC1S&&[DY.X]<,>[9J[\4)X=0\<^"/#$HQ:FZ-_,@7AQ&/D
M0#N3AQCW%>KA54D@ $G)P.II#&A=7**77(#$<C- 'CFD:S9O\5/'GB>\((T6
MU-I!$1DA8P2[>V63@]]^!7#7.D.GPNT5;\[M0\5ZR)GE9,^3&S#+#J=S80\=
M1QZY^G!'&I8JB@N<L0.I]Z7:O' XZ<=* /%M?\0167Q;$=Y!+]B\/:(UUIUE
ML)#S; 2QQTPI89/39ZUS22,GP&BM8#YNI^*=8"RE1C<[R9P#]$4''0L1US7T
M:8T+ERBEB-N2.<>GTH6-%555%"K]T <#Z4 >-?$_2=/\(>%+6&QB%J^M74%C
MJFH1@AFA&XMGTSSP.PQT %3>#Y[+6_C;JUU%;F"#1]/BT^Q@,9!5,9W$?PC&
MX<X^\!UKU]T20 .BL 00&&>10L:*S,J*&;EB!R?K0!\UW^@ZY:_"[7+J)98K
M23Q$;BTMH@=T^9%C!(';*C:.YY["NL^)ZRZ5H%WJQB;3I?$U];6=XZCYX;55
M;[Q'\9P<^WR\XY]IV+M"[1@=!CI2.B2##HK#(.&&>: /$M(U;3I/BOKNL+;-
M%9>&M$%O96_ED,$5"^[&,J,;AS_>4=>*Z7X'P+_P@;:@[^9=ZE=RW=S)C@NS
M8QGOPH)]"?7->D".,,[!%!?[QQ][Z^M"(L:!$4*H&  , 4 >*_%S4].USQYX
M3\*3WMLEE'<_:=0,DJA%&<!6). =H<8/]X5V.A:CX-M/&5Y;^&VM[B[NK99+
MUK(AXH8XMV&+#(R2X&T?7M7<^6A/W%_*E"JO10/H* /GC2]?O8/A=XX\8Z<9
M/[4U6_),L8.;>(OM'/8@,_TRI]*ZC0],TQ=#M]<TG4(M8O="T:5M.M[./,4,
MS1DLTAR=TSMU!Q_N]Z]=6*-8S&L:A#GY0..>O%+'''"@2)%1!T51@"@#R;X:
MCPMXC\$:/:7LJ:CJJW;:C=(78RK<AF/F2X[8X&[@\#FN6T?7XHO OQ&\9*<W
MVI7+PQ +DPQD^7'D]C^\/'^S7T#'%'%N\N-$W'+;5 R?4TGD0^68_*3RVY*[
M1@_A0!X3/8F/0_AEX3WF/0[MS/?R'Y8YW7$A0GNI)?'KP1T%7GOKNTO?'WQ'
M*O!8-9_8-++#'GXVHL@']TN%(/?<:]IDBCE39)&CKG.&4$4X@$8(!'I0!\WO
MX:@T[3?AOX;NXB\]]/\ VC=MY>6"#YQ$OU#$'W SP!CZ1I-HR#@9'0^E+0!P
MWQ?1IOACJEM$"T\[V\4*CJTAGC"@>^:ZF#6+"36)=%6Z5M2@@6>6'!R$)P&S
MC'4>M)>Z4FHZA:373!X+.030P@<&4 @.Q[XR<#UYY(&-#8H<OM&XC!;'.* %
MKC[BY'B+QD;;3M4MX_[$3<X"B4F>0%>F1C:F1G_IH1VKL*0*H.0H!]<4 >8^
M&+R+PA\3=9\+WFH0/%JP&IVQ&$"S,2)$VY."V P'H*ZCXBSQ0?#GQ$9I4C#Z
M?.B[F W,4( 'N:Z;8I.2HSZXH*AA@@'ZT <7X+T#0[[PUX:U8Q_;+FVL8?*>
M6Y>987\M=VU68JA^@!%<'XKUO3[KPSXJAAEBT][?6T,NGHN99&6>+=<2DY(5
ML9!7:!@#)SBO<  HP !]*0QH2Q**2WWN.OUH \]AGTK4?C5/E[6<2^'HU56P
M=V9F)&#_ +)!^AJ7PY?V5E\1O&]I=7$4,TL]M,D;G!,8MUR_^Z,8)Z9P.XKO
MMJYSM&?7%&U22=HR1@G':@#P[0]372_AS\/M8E)ETC3[^7^T/+&X0[O-5'8#
MLI;/XCVKL=;U#PYJ'@WQGJFD?9W6ZTZ1;B_3A+B01.JJ&/#%1@<?W@.N:[_8
MA4KM7:>HQP:%C1(Q&J*J#@*!@#\* /*);C3SJ'PGFNI;<V_V:4;Y""@;[,N.
M3QG=C\<56UG[#IMWX^UM-/BO=$G%E%(@)\F2X#?.Y*]0FY2Q'<$=<UWFN>'K
MS4_%>@:I";46VEF<O%)G,OFIL(X&!CKWS[5T@C18_+5%" 8V@<8],4 >7Z5J
M]@WQ6O9I-9AO8[CP_&5N %6)\2N6V$<%0.^6QR">*Y^QN+"#X/> F$UO&R:S
M9NQW*"&$QW$^X'7VKW 1H,81>!@<=O2CRT_N+^5 '">'[VVM_BSXPM99D2>[
M6QDMXR?FE182"RCN >">@I?B)??V1J7AK5KQ[F/1K:ZE6\F@SF O&520X[ E
M@3_M>]=WM7=NP,XQG':AE5U*L RD8((R#0!Y3KQ\-MX!\;ZKHES)<+?V@$]Z
M\I:.>4*5"IG@D# ..N0.H.'7^MV>C^*]"U#5KZ:UT2\T1+>WOH7/EI.&W,K,
M,XW+MY_V?:O4UCC2,1JBA!T4#@4CQ1R1^7)&C(?X64$?E0!Y+>2Z1X9D\,:W
MIT=S_P (K'JES+<SOO==\L6U9\'D)N+<XQSD=1F[XUGT75/AOXOU#0(4E2XC
MC>>\@4[;AU9<X/\ %M4#)'')[@UZ>R*R%&4%2,%2."*141$"*JA ,!0. * /
M//%&L:9>^(_ 5U;WUO)"^H2,DJN-K+Y+C(/<9P,],U0MY].;6/BF[2VI)C12
MQ9>5^R@$?3=Q]:]2V)Q\J\<#CI1L3^ZO/M0!X^FJV.F:%\,=:FU*VB:VLS"5
MN7*PL&MU5\N =KJ0 !CG)'')KK_A\=,DCUN\L-7L+^6_U![R:.RF$B6^\ !<
M\'.%SD@9.?2K^NZ)K-QK%KJ>D7]FGDP- UG?6YDA8,02X*L"K< =^*M:-HLM
MG=2ZA>FS:^EC6(_8[?RHU0$G&"26.3U)], <Y .=U^\M].^+7ARXO)5ABETZ
MZAC9^ \A:,A!ZL>P')K%T>\M8/!_C/1/$$D::D+J\:>&4_/<++DQN@ZL&! 7
M'H!7JI4$@D D<CVIK0QM(LC1H77[K%1D?0T 8W@VTOK#P5HMIJ98WL-E$DVX
MY(8*.#[CI^%<-?Z!<W&N>)? \4;QZ=K>-4BN N5@!XE'U,J1D#T<GM7JM)@9
MS@9Z9H XSP'?7NL:6-;UF)K>YMX?L#"7C#1$B9_8,XQ_VS%<':W-N/@5IDRR
MQF&UUI9)F4Y$:?;F.6]!@@_0U[>%4 @ 8/;%)L3:5VK@]1CK0!Y\=1TR\^-.
MGSI=6TB?V!*8GW#J9EP5^JY((ZCGI7'0Z@EKX7M[Q'$FD6'C*6:_$/S".#S6
M*N0/X Q5ORKW/8N<[1GZ4FQ,$;5P>",=: /.8-<T6Z^,XN[?4;.6!_#I3SXY
M5*,1/G&X<$@9-8GAZYTFS_9W2]ETRWU%(;:1)H1U.Z;!W%?F 'RL>^%KV!(8
MHQA(D48VX50./2G;% (VC!ZC% 'F.BZK:7'QAAF&L1:@+KP_LCFA0")V$^2L
M>.H R>K$<Y/'&7-H&JSV&N^"K!'A&CW3:IIMP%X"M^\@B4GOYF\9]$QWKV$(
MBXVHHP,# Z#TI<#).!D]Z .;\&7<FN:7_P ))<0-!+J:1LD3]8XE7"K^+%V'
ML]9/Q+N[:W;PDLUQ%&?^$AM'P[@?*-^3]!ZUW0 50   . !VH*JW50?J* //
MY9--NOCBD<KVLQ;PZ456*MDF?.,>I4GCT-1>'+ZSTS6_&VF^(Y88)9KYKI?M
M!"B:S:-53;G[P4*5('0\5Z)L4'.T9^E(\,4C*SQHS(<J64$J?:@#QG2;:32[
M/X5V6M,J74<]R_EW! 9$,<AC!!Z8!0>Q %;VF3Z:/&_Q)=I;7_4VVYBR]/L^
M&_#. ?>O2BJDY*@GW%)L3^ZO/M0!R?POF2;X9>'RDBOMLT1L'."!C!^E<[9:
MC9V=[\2;*YN8XKEIGF$3MAO+-LH#X_NYXSTS@=Q7IX 48  'M044DDJ,GKQU
MH \=CNK"#P9\*BD]M&RWUKNPR@C,#A\_\"(S[GFGP7^@&?Q-X9\87EW!=3ZE
M/(+4LX%Y#(^Z(QA1ECC:N!S\HKU[RT_N+^5(T4;2+(T:EU^ZQ'(^AH AM%2U
MTV!6#0QQ0J")7R4 '1F[D>M>7_#G1]#\2Z1X@BO3]LC.NW4AMQ=OY;KO!4M&
M&VL._(.:]9(R,&D"JO10/H* .#\236MM\4? D'F0Q;$OE$>X+M!B4*,=NF!]
M*XK6]=TV[\/W#PSPZ>+;Q)')-IJ#+QD7(W33$Y*[CR,;5&<<U[B54G)4$^N*
M3RT^;Y%^8@GCK0!Y_I=YILOQ?\03--;?\@FUPSD @9<MUY'&W(^F:M?"":.7
MX7Z.(Y%?8)5(4YV_O7X]N,5VVQ<YVC/TI0H7H /I0 M%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !5'5-9TW18$FU*]AM8Y'$:&1L;F)P !U)^E7JX7XMR0)X&9)G0;[V
MUPK$?,!.A/'? !)]J -Q?&GAMY;N)=8MC):J&E7<<X)P"O\ >!/'RYYJS#XE
MT6XT5-8AU&!]/=MBS \%MVW:!UW;N-N,YXQ7*W5U8'XUZ9)Y]N<:',JMN7@F
M5"H!]2NXCVS7+6NMV&G^'=6F>.UFB_X3*0BXE&^.R#2;EN" >@QP<@9(YH ]
M0_X2G1?L-Y>-?*D-DVRZ,B,C0'&?G4C*\$'D58;7--6QM+TW/^C7;*L$FQL2
M%ONXX[]O6N%\'RV5[X\\;6<MQ+?17L5FP>>+'GQ^258\*!M[ XP1C&:D\%6>
MHQZG_P (YJ"2-:>%Y6%O</\ \O"NO^C_ (I&S@CUV^E 'H<TT5M!)//(D44:
MEG=V 50.I)/05FVFNZ;JUQ<6%G?%+R./>T90I*JG@.%=>1Z'!%9'Q)AO9? ]
MVUC!+<20RP3O!"2'EC25'=1CG.U3TK.\.:CX.U_7(=<T>6ZO+RWMF26ZGFFV
MVT9Y*/O.W)/;V)[4 6O &NS7'P\M-4UN_,LS33I)/* "Y$[HHP!UX   ] *Z
M&RU_2M0ANI;>]CVV9(N1)F-H"!GYU;!7CGD"O'],O/LGPS\+:F1/-I^FZQ<2
MZBMJS>9%&SSJ)#M^; WAOH16MKT6D:SX5U_6?!T%UJ4\JVS7=QYDKBZ2*16,
M2[S\Q"!LX'0X[XH ]$B\4Z-,\\:7G[V"'[0T1B=7,7]]5(RZ]LJ"*C\*>)[3
MQ9HD6IVBNB29(1E((7<0N<\9(&>*SM%\1>&O%NHQ:CHT2WEVELR277DE6MT.
M#Y;,1]XG^'V)^M+X17<,OPYTNT1C]HLXS%<(5(,;[VRISW]O<>HH V4\7V$G
MC*7PVOF?:(8%E=S&V-S-@*#CGH<GIV]:MR>)M&BNUMI+^-7:;[.'(/EF7_GG
MYF-N_MMSGVKEI;E;3XQ7\3R>3->Z)#':$J3O<2R9Q@<XR"?0<]*YB":&[^"%
MQX4N% \11*UHVGL?WYN?-RK!>I!.'W=,9.>#0![-63#XET:?48K".^0W$^[R
M000LVW[WEL1M?'?:32:C9W\G@^ZLH9MVI-8/$DH.,R^60&S_ +W->?>%-0\*
M:_:^'["6'4)-?TMXB=/EEG#6<L8"LY!.T*!GKP1@8R<4 =:OB32M+M?$6KMK
MLFI6UI+NEAC <6I"#]VNT<],\GC/..:Q]8\5S31^#=5M=0>TL[V]2.]A("IM
M,+2'+,N<# Y!Q65')'>67Q7@M76:67S3&D9W%_\ 10O '7Y@1]:;?:OIE]H_
MPU9+J%XX[^WWEN -L# GGL&(&>QXZT >CZ7XBTC6H+F;3[^&>.V8I.0=OED#
M/S XQQSFH[?Q/HMS=/;)J$:S)%Y^V4&/=%_?7<!N7_:&1[UYMK:S:AK'Q.M-
M*99KR6SLBD,;?--L1O,48ZG'RG'J!6WH&K^#/$FL:;JU@][<:C8QR,S7,\W^
M@*R$.)-YVCG"XY]1P,T =5IWC#P]J]Y!::?JUM<SSQO+$D;9+JK%6(_$'^?2
MFZ_K3V5[I>D6A U#5)FCB8C/E1HNZ23'? X'NR]LU@?" VK_  [L/*\HRQRW
M DVXW*3,YY[C(V_ABG:[%)%\7_"5R^?(EM+R!#V$FT-^94'\C0!N/<6@\5V=
MB-?D%TEH^[30RDRCY?WC<9!';D=:32M8D3Q)?>'+V3S+FWA2[MY2 #-;L2N3
MCC<K J?4%3W-8>JW-NOQGT!&FC#C3+E""PR"S(5'U.#@>U+-$\WQRMI(L[;;
M0&\]AT^>;Y0?^^6/X4 =7?ZUIVF7-I;7MRL,UV_EVZ,I_>-_=&!R?:FVVNZ;
M>7UY8V]SYEU9 &YB5&W19Y&1COV]>U8_Q!TN?4O"4\UB,ZCISIJ%F>_FQ'<!
M^(W+_P "KD)&UG_A(K#Q#9PSQ1^+H#9/%@ VF%W0RG_:$8D8YZ$XH [6;6=+
MU#5-!:V\0^2;AGD@M8\?Z:NP]01G:,$@C X^E4)/&5OK-OXEL],N)[:YTQ'1
M)Q%R76/>2 ZD8!..>O4=C5+Q6UE8>-O -LKQ0QP7$ZJFX#8GD,J_09P![UGV
M>H6MCJ'Q(LKJ40W$DK3JC@C,9ME ;/3!(QGUXZT ;O@SQAIU]H7AZRO=6BEU
MJ[L(I61C\TC^6&;GIN[XZX[5<\7^(K73=#U:.'4FM;^"U:0211[_ "6VDIO)
M5E7)'&[&>U<$EW91>"_A8%G@1HKZU,@# %/W+A\^GS$ ^YYJ:TUJUTS2_'^A
MZY,L&KSW-[<11S#FZA>/$;1_WQM&,#. * .OT3QAI=IX5T!];UB"._NM,BN7
M$KC>_P"Z#,Q'Y_4UHMXQ\/K:1W0U*-X'MQ=;XT9PL)Z2-M!V+P>6P.#Z&O/=
M-O;%]1^$PDEBS%I\RL).-C?9D49ST^8$#U(XJ[XGU2S77?%6D!5TVX_LA1'Y
M,&Z;41Y;X"\$;$S@X&>2<@"@#T!]?TI-0L[ WL9N;Q/,MHUR?.7&2RD#!&.<
MTRV\2:1>6][/;WBR16+,MTP1OW++RP;C@@=1U%>?S'=\*_"/B?3U>6Y\/PVU
MP0BG<\0C5)T'K\I;\5IT&G:O:>,);":&0VGBR$7=V,#;:O&P\V,X_O1,D>>Y
MYH ]/@GCN;>.>%MT4BAE;!&0>AYK-M?$^C7MY#:6]^CRW&_R/E8+/M^]Y;$;
M7QWVDU?O)/)L;B40M-LC9O*4<O@?='UZ5XS8ZW874_P^O8;A8X(KN2-K*V@/
ME61,+@0YP6+YX.3D]0 #0!VFF7^J3^(/'=C)JEPR6/D?9'*1Y@W0[S@;<'D]
MP:UO -_=:IX!T2_OIFGNI[57ED;JS'J:YO2;^T7QE\1V:ZA"XMCDN,86WVD_
M@>#[UL_"Z1)/AGH 1U8QVBHX!^ZPZ@^AH V]0\0Z5I3R)>78C:)!)+A&?RD/
M1G*@[%X/+8'!]*Q/&WBQ-#T:QDM+A?,U"ZMX(YD7>%C=U#.IP03M)Q[XX-9.
M@:C;:)XG\8V'B2>*WDN[W[7 ]R0JW%LT:J A/WMNW:0.F:YN2WET'X3^#;+5
M9/(N$UBVE$4S8>.+[07 (/(VH1GTZ4 >FZ+;RV,5[=R:S<7VGS$36Z7$?SVZ
M@?,-W5@3R,C(Z<UQWB/QTVK_  OUO6] O+FQN+1W$;"+#%5E\O)WKQD9/&"/
M:O2DD26-9(W5T89#*<@CZUX?<WULGP+\2Z6\FV^@N[E)(&!#*S7195^I!R!Z
M4 >N6/B71M1U272[348)KZ%-\D*GG;G!([$ \'&<&A_$NC1ZA%8O?(LTTIAC
M+ A'D'5 ^-I;@_+G/M7):K=VC_%+PJ+.ZMQNTV[C1D88&X1[!QZX.![5SOA:
MZ\-ZAH.F^&-=AU%_$>GRHCZ8\TX/GHW$HP=H7^+=T )_$ ]?NKJ&RMGN)V*Q
M(,L0I/Z#FO.O#?B<:MI>D>*+[Q'-8K)(PN[1X<V[J[,L<8./E(.W# DG!!SF
MO1;J>&UM99YY4BB126=VP /<UXU!(DW[-UD(CYC6A@DG1/F:-4N@S$@<C !/
MT% 'KCZWIL6IR:=+>1QW<<!N&CD^4B($ OD\;02!FLZ+QSX8G>R6+6K1S>N8
M[<JV0[;BN,]!DJ0,]<<9KF(M?TN_^,%C>VMVDMFV@S(MRH/EL?.1N&Z$  Y/
M3@^AKDX;FR3X#V*B6!9AJZN5# -D7Q;..OW,'Z>U 'L&JZQ86&ZWN+UH)FB,
MG[J,R/&G3S" K84'^)ABN<\ ^)'N?AYH^HZQ?/<7=VTJAPA=YB)'^ZJ#)PJ]
MAP!6=I6NVFB?$GQ/%KEREO\ VD+:;39Y3\EQ"L>W9&>A(8GY1R2QQFN;\,K9
M7GP[\)Q)KDFAZK!)=M97A4>6K^8V8W5L!@RL./;\" >Q6&H6NIV:W=E,)H&9
ME#@$<JQ5ASW!!'X5@V_BRSUC7]8\/VDT\%Q9(B^>(CGS&#,<;E*X "\G@Y-.
M\":C?ZEX;\W4;>WCN$N9HVEM01%<X<_ODS_"QR??KWK$TG4+73?BAXTBO9A
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MGJ#@@CJ"#P0>17)2:EJNG?%J#2KS5)WTG5+"22RB*1@).A&]<A<G"_,,G\Z
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M@GO+!+^02W$REUMF./W0*KPBY !YZXS6Z^K6<;V2N\@:].VW'DO\QQNP>..
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MDW'V+-N%$ES.!E\L0=JKD !<$]<]JVK2SU2PUQFFU.2ZT@VK$"<(&BD##JP
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M N$C1W,>03T4'(P,DCIWQ6Y;7,-Y:PW5M*LL$R"2.1#D,I&00?0B@"6BL/\
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MTV>)WLO$D2ZA>D<I;RQL/-C]U96CC]QS7J%% '""XMT^-MQ*\D:JN@+'O8@
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M![UO44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^">=I-21^,-#ENK>!+QC]IN&M8)O)<12RKG*+)C:3\K=^<$#I7,:A/%)X\\
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ML:E<:=973-=VZ"1XWA>,E"<!UW ;US_$N15Z_P!1M-,MA/>3"-"ZHO!9G8G
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M);IY$DC2JH!."%.YN1P,G)Z5<T/7]/\ $5D]UI\DC+%*T$J2Q-&\4B_>5E8
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M9'.#ZU'I&OZ?K;7<=I(XGLY/*N8)8S')$Q&1N4\X(Y!Z'M7/:[KE[?>.]/\
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M)=\$@(!5TV[EZCJ.XH Z:BJ$VL6EO-80R><)+]BL"B%CDA=QW8'R\9/.*OT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5PWQ7=8O"%O(RLRKJ=FQ55+$@3+P
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5S_C:]TNP\*7DNLW%[;V)"B26RWB
M1?F&,,G*Y.!DX'..]=!7'?%2WN+SX;ZO:6EK<7-S.J+'%;PM(S'>IZ*#V!H
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M 3U8#@,>I';..M<;8Z7;ZC\7/$4^HZ+)/93VEM'!-=6#-$S*#N 9EQW% #_
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M<RK&C@L?+QNR/3&:2\,]U\4M"O4LKY+<:9<1O*UL^V-G9"H9L8!PIX)X[XH
MV;CQIH]M)"97F%I-=?8TO!&3"9LD;-WU!&[&W(QFH8-7T:+Q3KSK<:BUY:6T
M+7D3)*T:)\VTQICDGG)4'/YUS/@C4;_2-#MO!^H^'K^35+"0Q),UL3:R+O)6
M;S3\H !S_>R.!FK\*3+\1/%MPUK=);S:9!''.]NZQNR"3< Y&#C<.] %ZW^)
MGANYETT++=K!J+*EO=O:NL#.W1#(1C=[=N^*O:CXUT?3'OC.T[0:?(D=[<1Q
M[H[=GQ@,>O1@3@'&><5Y[IT!\4?!7P]X>L[>X-[+]F&]H'58%20,TI<C&-H.
M,'G.!3_&G]JZOI'C739-'U3[4'_T*&SM7$,\0"?O6=0!(YP1M)., !>": /0
M[_QAI6G:W_8\OVN34/LQN5AAM9',B @?+@?,<GMG&#G&*R-6^(=G!X5M=:TR
MWN+E;F\2S"F(J87,@1@X/((Y&.YQVYJO'+-/\5-.U'[!J$=K_84D)E>TD"J[
M2HP4G& =JDX/(Z'!XKF)+'4&\":MMTO4#)%XI-_Y/V202/!]I#[T4C+?+SQ0
M![!!,)X$EV/&&&=LB[6'U':LBU\1V.IO:PQ1W?DWZM]FN0A$<JA2258'(X&1
MG!/45JV]P+FT2<12H'7<$E3:V.V5/(^AY]<5YGX9L[K2=;TE]!.J1:+<B22_
MT>_MY,:>=A.8V905^;Y=HSG)(XZ $G@GQE9Z1X8C35KC4)BVIW%NUV\<DR1$
MSLJ"24YQG@<GN,\$5V&J>+M,TJ>^AD%Q,VGP+<WOD1[_ +/&<X9OP5C@9.!G
M%>;RV=^WP5U33ETO4OMTFIM(EO\ 8I?,93>"0$#;G&SG-;'B>XO]2O\ Q5IS
MZ5J?E2Z8!IQL[5U6[8Q-DRR #E6.T(Q QG@DT :OB>\,OBCP-=65Y/\ 9KN[
M<%8YF$<R&!V4E<X/8Y(J7P]),/B?XPMVN;B2!(+%XXY96=8RRR%MH)^4$]A6
M&1=26WPT;^S-17[$R_:0;.3,(%N8\L /E^8XYQZ]*V]!29/BEXKG>UND@N(+
M-(9GMW6.0QJX<!B,'&X=Z .HU'5;;3! )RS2W#^7!#&NYY6P3A1] 23T &21
M6?:>+M(O+.[N%EDC:SN/LEQ!)&?-2;( 3:,Y))&,9!SQ6)XX_M#3/$?AOQ+;
M6%S?V6GM<0WD%JA>54E50)%4<G:5YQV-4?%9O]>\.0:OI>@7+1V>I0WILYHO
M*GO8U!5_D/(.&& >3MZ=,@'31^,]'#:G'=R2V,VF1">ZBNH]K)$1D.,9#+Q_
M"3SQUJ:P\46%_J9TXI<6UW]E%XD=Q'MWPDXW@Y(QDC(.",\BN0FO(KKP]K.L
M>&O!DRWJV)B']H6.R2<D@^6$/+J!DD="0 ,\XKZ<9C\1+#5(].URYM9]#E@:
M>\MG7=+YB,0RD 1C /&%!_A!SR =S8>)+/49[1(8;H1WD9FM9VBQ',@ .X'M
MD$$ X)':J[^,M)CN;*.1ITM[Z;[/:WC1'R)I.<*&]\'!(P>Q-<9X?TJ]LM4L
M;3P_/JD>A7MM-]JT[48'']EL4.WRW< CYCMVY/&2,CD1>$4@_LW3?#FK>"[K
M^VM.,<32S6I:V_=\"<2GY>@SQR3P/6@#O_%6O#PSX8O]8-M+<FUA9Q'&.I [
MGL/4^E,@\2VXTO3IKB.<7=Z L-L(B))7V[FVKZ 9.20 .IJ+QY97.H^ =>L[
M.%IKB:QE6.-!EG;:< #N:Y:9[U-;\'^)UT_4#IMM:R65W$ULXE@WJN)/*QNV
M[EVDXZ#/(YH [?2->L=:-U':LZW%I)Y5S;S(4DA;&0&![$<@C(/8U4U?Q?I.
MBZI#IEVUR;R:)I8HHK620R!<9"X'S'D<#)]<5F^'M.EF\>>(/$:QRPV5W!;V
MT/F1E#,R [GVD X&0H)'.#VQFEXEO(K'XL>%99ED,?V&]4F.-GV_ZODA03CW
MH U[/Q[H%[H-QJZ7,L<-M.+:>*6%EFCF)"B,H1G<20!]?K5F+Q;IK#5%F6Z@
MFTM%DNX'@9I$1@2K )NW @'[N>AS7#WMOJNGMXI\1Z?I<[P:IJ5F$C^R^9,D
M,0"R7"Q$9+9R5R.P;&*6S2:#Q-XOG33-::VO])A^SS7%O*[2%5D!Z\@Y8#9@
M$9^Z!0!K:O\ %+3;?PO>ZMIEG?W1CLENH6-JZQ,&X&7/'!(W8/'(ZBM74-6T
MJ?5_#B7KZG;7D\[FTB"21I(P1LB3'RD8R0"<]*YJZTV_O?V>1I<%A=?V@FE1
MPFU>!DDWH%W*%(!)X/U[5>U^YEU/7/!%[;Z=J7D17CRREK*0&)#$R@N,97YB
M!S@]^E '0ZIXPTK2$NY;@SO;V+*EY/#$72W)Q@,1WPP) R0",XJ*74M'D\;V
MD/VJ^.HC3Y)8XD\SR'A)4EL8VNW3&,G]*YG1M0O/#.K>(-"U/0-2OA?:E->6
M4UO;&6&X24YV,WW5*G@[L#%:5S'=?\+7T6X>SN/*CTF:&6:*W<PI(S(0N_&/
MX30!++\4O#,5M]J,E\;19S!-<"RE\N!@VW]X=OR<]CS[5KZCXLTW3KB:#$]S
M+;VOVR=;9-_E0\X<\\YP< 9)QTKSS1YUOOAOXKT2&SN;B^N[_4;>")8&*N[R
M,%;?C: "<DD\8^E7KN#4;2XNO#US8:C)##H<-O9SV%NV+R1496\R9<;=IQA2
MP!R<YR!0!TFI^.(+;5?#5M96T]W;ZR'E6>*,L#$(F<;1U+$[3CL,YK0U7Q;I
MND1W4LZW,D%GC[9-#"76VR ?GQSP""0,D @G&:X*P2^MM.^&5]+I&IB/38WM
M[I!:.9(V-ML!* ;@N[C) '?I@U+&(]&\1:]INO\ A34-3BU*\>ZL[BWM3.DJ
M2*,Q.0<*5((^;C'MR0#U".XBFM4N87$D+H)$=/F#*1D$8Z\5R%CXL\-Z+X9O
M]82[U&33UU"5)9+B.5V24N 5PPRBAB ,X KJM/A%II5K#]GCMA#"B^1",I'A
M0-JX[#H*\CN[2^D^%OBFS32]2-U<Z[)/##]BEWO&URKA@-O3:"<T >E:?XKT
MS4M<ET>(745VD/VA!/;O&)H\[2Z%@-PR0/QJ#QEXG;POI=O<):2W$EQ=16R[
M%R$WN%)/X$X'<X]ZR[OS9?BUH]Y':7AM5TJ>)I_LL@179T95+;< X4]:G^)5
MM<W'AB"2UM9[DVVHVMQ)'!&9'V)*I8A1R<#G H S;W6?L'Q6M)G?43;SZ%+(
M+)1(Y:03(!MB&<-C/0= 2>]=/8^+-)U#0H]7@ED^SR2F 1M$PE\T-M\O9UW9
M&,?CTYKGS++/\6;#4187Z6G]B2PF5[20*KM*C*I., E5)P>1T.#Q7*#3M5'A
MJ:]AT6]N3I_BFXU&2Q>!XWN+9RXR@8#<</D#VH ]0TKQ'8ZO?7MA&)H+^R*_
M:+6X3:Z!AE6]"I]037,?$22YAU;PG';7U[;)>ZLEK<+;W+QB2,JQ(X/MU'-:
M7A233-0NY]3TWP[/IRM$(WN;NU,$LISG: ?F*CU/&2,9YK)^)-L]]JGA*(:=
M=7D,&K)/<B.T>9$BVD$MA2,<CB@!FD7U]%\4-6\*)J%U?Z.-.6Y9I)BTEG*6
MV^7YH^;D?-@G/IWI_@#Q%'9?##P[<ZI<SW%W>NT$6XF26>4R/@9/4X!.2< #
MK7:6MGI^E6CM9645K"?WC);V^TD^NU1DG\,UY=H4VJZ/\./"%K)I.HQK'=NE
M^Z6#O<6JYD(9$*DC.0"P!P"<<F@#NY/'&BP:)J.JSM<QPZ;,T%Y&;=FDAD !
MP0H/&"/F^[SUJ2R\8Z5?ZU%I4?VI)YX3-;O-;ND=PJXW>6Q&&QD=.W(R*\XN
M;.^'A?XC6$6C:QOO9O,M!);R2-*&BC"X;DL>#GDXQS@\5T]_YTWC?P)<QV5Z
MT%O;W0GD^R2;8B\2*H<[?ER01S0!V.K:O9Z)8F\OI"D6]8U"J69W8A550.I)
M(%9P\8:6L&K/.+F"32%#7L+P,TD2E=P;"9R" 3D9'!STJOX[N[^RT&"6PLI+
MG_38!.8;?SY((MWS2HF#N9<#'!QUQQ7&)#<1ZEX_,6E:TT.HZ3$+62>WE=IB
M(I%/7)R68#;U&>@ X .UL?'6BZA?:;:Q&[7^TXO,M)I+9UBE.W>5#D8+ =O8
MCK6?XY\16P\)^(XK1[\RV=K*LEU9;@+>;RR5!=2#D$J3C. ?FP*Q)(KG^S/A
MHO\ 9]_OL7A-T!9RY@ MRAW_ "\?,0.:IPR7^C^$_&OAB_TO4I-0N&OYK6:&
MTDECNTF5BK!U! /.""1V')XH ]&\,R,_A'1Y9&9W:PA9F.26/EC)]S7%ZGXL
MF\1^ _&<T4%_I\FG?:HX)%+1,IB0=64_>W9./2NR\*>8/".CI+!-!+'90QO'
M,A1U94 ((/(Y%>?^3?0>#OB'I#Z5J)NKF[OY8-MH[+,LH_=["!\V<]LXQSCB
M@#K/#OB[3I_['T>1KH7=S9*\,LL#K'<%4!?8Y&&(ZG%7+_QEI.F_O+EIULA<
M?9GO1$3!'+NV[6;_ 'OE)Q@'@D&N8N$N'UOX<RK8WQ2TCE^TM]DDQ#NM]@W_
M "_+\W'-9.B6\5C:W/A37?!UWJ&H)<2^1.;4R6MVC2%T=I#\J@9&<\C'<\4
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M@VC7 M7 @;=#+NVE)!_ 03SG'MF@#J**SM'UB+6H)Y8K2]MA#.T)6\MVA9B
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MNHVP-D/)>5F58]P#-SEL <9))/XU)!XZT:31]4U*?[39II<GE7D-S"5EC;C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KDOB'X9NO$OA^ :<4&I:==Q7]H)#A7DC)^4GMD$CZXKK:* .8
MN_$\\^C2+8:/J9U:2(K':RVCH$D(Q\TA'EA0>K!B"!QFN*DT%/ L/PWTIO,N
M&M;V8S-!&7+.T3EB%') +'MG KURL/6?#::SJ^DZBU]/ ^F2M-"D:J59F4J=
MV021@D<8H Y/4]!O-:U#QGJ]I:3(EYH9TVU26,QO<2;7);:V"!EE4$CG![<U
M!J?VV]\%^#(TTC4UEL]2L'GB:T?>B1 >8Q4 D '(YY.. 17I]% '"::+OPUX
M\\1SWMI>3:?JYAN;6YM[9YMK*FQHW" E3P",C&.^>*YZ/P[J.D:)X4A>PNFE
M'B0ZG/%#"T@M86\W@E01QO7('<GTKURB@#C-$BN$^*/B:Z>TNDMKFVM$AG>!
MU1VC#[@&(QQN'U[4GQ&BN+BRT-+:SNKEHM9M+F06\#2;(T?+,<#L/QKM** .
M%=+O1?B9<:Y+:W=QI.J:?'!YL%N\C6\L;$A6106"L&)SCKUQ7-ZMH&HP^%]:
MN$T^\>75O$,6H16L4#.Z0K)&2S*!\I(0M@\\@=>*]>HH :CB2-74, PR-RE3
M^(/(KS&]TN\A\12:KX:BU73]4DU,)>6+P.;*]C\S:TQ)&Q3L&[<"#D8QDC/J
M%% 'E]U'J&GWWQ L/['U&=]5C,UG+!;EHI ;8(1OZ @@_+U/8&H+,:SX;N?"
M>OOH>I7-HFA)I5];00[Y[=QM8/Y8.2"5P?8?2O5Z* //?%KW^K:/H<\>C7L6
M-=M;KR%MV:5($<%GD"Y"GJ<=<$=\BKUG'.?B[?WOV2[6TDTB&!)VMW6,R+([
M%=Q&.C"NTHH XSQUX?O;Z^T'Q#I</VB^T.Z,OV8, 9X7 $BJ3QNP!C/%'BG4
M+CQ%X8O-%T6POC>ZC"UL6N;22".W1QM=W9U X4G@9).,#O79T4 >=ZSH[:--
MX"TVQM+RYMM)N5\V6*W=PL8A9-S%01DDCBKVH"<_%C1[Q;*]:TBTV>&2X6V<
MHKNR%06QCHI^G>NVHH \ITZW.C:AJVA:SX'FU=Y[Z>XL[U+-)89XY7+@2R-P
MA!8@Y[?AG>TVWN(/BO=S-8SQVIT:"U69+9UA\Q)&8JK8P!@C';M7<44 >=1P
MW2>(_B).;"^\J]MH%M7^RR8G*P,C!>.?F('Z]*H&TO1X1^'%M_9NH>?IUY:O
M=H+20F%4A=&+<=B1]:]4HH \BU.58-6\7Z6NG:\--U2XV7+66FFZ5B8E$C)(
MI^0L#@@AL8SQG ],T*ZL;O0K.730XLQ&(XE=&5D"?+M*MR""I!!YR*QX/!CV
M-U.VF^(]8L[2>9YY+1&AD0.[%FVF2-F4$DG@]ZZ.TM(;*U2W@4K&F<9))))R
M22>22222>230!P'AG2X[GXA>,+K4=&E-O=SV[V<UW8MM<)%M8J67CD>V:L^.
M[2ZM=>T'7X]$?6=/LUGM[RSAB$LBI)L(D1#]X@IS[&N\HH \O\3VHO\ P%>M
MI'A2XL#=WELZ6\=CLGF"2HS/(B#Y> <;N>/<"MOX@)/>VGAQK2SN[CRM;M+J
M016[L4B1LLS #(P.QYKM:* .$TT7?AKQYXCGO;2\FT_5S#<VMS;VSS;65-C1
MN$!*G@$9&,=\\5S5MX<UKPO'X6UPZ=<W,5GJ%]<7EA;+YDL$=SPI51]XH.H&
M>IQZU[!10!POAM[JX^)7B+43IFH0V5Y:6@AGN+<Q!B@?/#8(/S#C&?85/XVT
MJRU:_P!.CN8M6MIXHY9+75M,21GM7^4;3L!X8=B,';79T4 >7K'X@F?P%-K-
MI=3WEK>3R7<T5HV!&4D1'<*,*S J2.Q)SBFWQURSU#XAWNE:3<S7%R;-K,26
MC%9E2-4D*!AAF7YB >I ZBO4J* /-]&CN(OB:FJ)I6MBPGT3R3<WD;%C()2Q
MW G*G'1<#V7%8KZ;J3_ C4](&E:A_:,ES+LMOLK[V#7)D! QTV\Y_K7L5% #
M(I5FB210X5AD!T*D?4'D?C7D@T76Y?!6L:9!H]PU_8ZX^HQQ7"!8;M!<>8$5
MCPP9<^W&#BO7J* ."TVZLM3M;N^L_!5SI4D=G)')+<Z<(IRQ'$<84;F&<DGI
MP.N>,QK&^;]GW^R1IU[_ &B-,%K]E^S/YGF8QC;CI[]/>O4** .!U)+B;Q?X
M#NH[&^:"TCN?M#_99,0[X B[OEXRW'MWXK.DMKQH_B:!IU^3J,9%G_HDG[\_
M9A'\O'/S<?KTKT^B@#S06]W]L^&K_P!GW^VPA<79^RR?N";;RP&XX^;C]>G-
M5[MM<LKCQ_>:7I%W+/<W-J]J'M&/FQJB)(R!AAF7#$ ]2!P:]3HH \XT2WN1
M\39;Z+2M86QN]%2%;J]5LF02LQWECE3@CY>#Z "L"STO6HOAMX97_A';NXN?
M#MX'N]/N(@#<IB1'\L'[Y <$'H<\9->S44 <;I&HV<=EJ&NV'@V[L%BM^4-@
ML-W=,.=BH.2![]2>.G/2:-JD6M:1;:C##-"DZ;O*G7:Z'."K#L0015N6-9HF
MC8L%88)1BI_ CD?A20016T$<$$:QQ1J%1%& H'0"@#SW1([WPW!XIT;4--O;
MEKJ]N;NREAMWD2Z289"E@"%8'(.X@=^G-4],T"^\/ZO\.K&6WNK@:79W45Y/
M% [QQ/(B;1N QC((_#G%>I44 4]6M&U#1KZR1MK7%O)$&]"RD9_6N0\'N_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3N.1QR?7%)8VDOBKX:^#=&M[.Z1XQ8S3S2PLJ11Q*K%@Y&&+   *2?FYQ@X
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ME8:4]O975S?7^G#4/LMOLS''P#DNRC[QVCG)JIJOCX#2?#>HZ-8SW=MK5[%
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M[R?#\J6.H2+KJ;[79$IQ\A?:WS<' [9'OCF@#JZ*XY/'Z2KJ<4?A[6&U#3&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5ZJ,[5&>>#QTSUM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO([JVMA<>6-KI/&V1A7R%W9!!!(_&N<O_#VN7GPO\/6UG:^3K>B_8[A+6=U
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M*YZ\YQVJ>WL]>\.>)-8@_P"$536K'4[MKVVNHY8U,+N!OCDW\A01D$ \=CT
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M)"FYVYP !ZDD"N3\/ZAJOA;POX1TF[T"Y;<D=E>2B:/_ $5_E120"=X);L>
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MI'(&QD2*#AQP.#^/%;-%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 1/;PRS1321JTD6?+)YVD\$CWQQGW-2T44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5E:CK:6>I6VEV\#76HW,;RI"K!0L:X#.S'H,L!
MW))Z=2-6N0UK1=6A\=:?XHTF.&Z5;-["[M9)?+)C+[U=#@C(8<@]J -K0M>M
MM>M[AHHY(+BTG:VNK>7&^&1>H."01@@@C@@BM6O/_AO]HU#5O%GB&2-([;4=
M05+<1N61Q"GEEU.!D$YYQSBO0* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ JCJ6F)JD)@GN;E+9AMEAB<()!Z%@-P'T(J]10!%;V\%I;16UM"D
M,$2A(XXU"JJCH !T%2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>elicio2021employeestockp010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD\ 195V'^]+O/N E<Y%INH:C^SQ9V.F6[O?6\$+26FTJ[F.0.\9'7) /'?\
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M;NU+7$5U:0K/+!+;NK^6V<,%QEAP1QGD8H @\*^'9_#D.HQRWT=V+V^EO<K
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M6;,+.5FCF/ED*R!2P)VG&1SBO3:* /%A#JW]@ZK?VNDW[RZ?XP?57M&@8//
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M7,=L\J3QF,*$!4'!7:!@X_*O2:* .0^%RR1_#70X9H)X)H;<(\<\31L"">S
M9'OTK A+?:?B8Q@N +H#R"8'_??Z,$^3CYOFXXS7IU% 'E2^8-,^%RFWN=UH
MT7VD>0^8<6Y0[^/E^8XYIVH07-EK]SJ?ABXO(KV74U2]T.YA+P7?[P*9H\CY
M/E <N#CY>>E>IT4 <WX_TF]UWP%K.F:<?]+N+<K&,XWD$';GW (_&N=U64^,
M[3PE%8V]Q#>6NIV]Y=))"T9LUB5MZMD#!)^4#OG(R 37HU% '$>!"1X@\8%H
M9H_/U4S1-)"R"1/+1=RDCD9!Z4[XGJ\GANSCBAFF?^T[639%$SG:LJLQPH/
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MWG8JO\S;1WZ<X'0X["VN%NK2&X175945PLBE6 (S@@]#[5+10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>\O;>P@\ZX?:I8
M(H R68G 4 <DD]A5BN)OKM[WXQZ5I3G_ $>PTF;457L97<1 _@I;'^\: .@L
MO$5C?Z[>Z-$)UO;*))9EDB*@!\XP3][H>1D>]7;J_M[*6!+AC&L[^6DA'R[S
MT4GL3T&>IXZD \!-::M>_%7Q%#I.IQZ;*=,M"9VMQ,1\TF %) ^N<_U%G3]2
MO/%OPQUV#6$C74;7[78W#P\*98L@2+Z<[3]10!W]%8/@G5IM=\$Z+J=P<SW%
MI&TI]7QAC^)!-;U !1110 56U'4+72M-N=0O91%:VT;2RN?X5 R:LUR'C*:R
MU"ZL_#M\D\EE.#<7RPP22YC7A$.P$C<^#[B-A0!UD,L=Q#'-$X>.10Z,IR&!
M&015/6=:L= TR74=2D>*TA&9)%B>38/4A03BN0^%&J22>'[GP]=/(UYH,YM"
M949&>#K"Y5@" 5X&1_#6E\3_ /DF/B+_ *\GH O67C+0[^^MK*.ZEBN;I/,M
MH[JUEMS.N,Y3S%7=QSQFMZO-IO#^J^*QX)<VJ6-CI#P7LEP\H:24J@VHBKG
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MX'!Q]:T+'PA>66MZQJO]N22S:I;Q13*]LH4.BLH88(.,,<+GZDUU=% '$_\
M" 2KX0T7P^NKJ$TJYBN(YC:Y+^6VY 1O]>OK[5V,J2O;.B2(LI7 <ID ^N,_
MIFL_5=>@TR<6RV]S>WA@>X%K:JK2>4I 9L,0.K 8SDD\ \U9TO4[;6--@OK1
MF,4R!P'4JRY .&4\@X(XH Y./X?2Q>$=&\/IJZ^7I5W'<QS&U^9S&^]01OQU
M//MZ5HQ^%+K3]<U+4M&U1+0:GM:[@DMO-7S0,>9'\PVL1USN!KIZ* .1N/ =
MO'I_A^VTF^DL6T28RP2&,2E]RLK[@<#+;B<^IZ5T6H6<EYI%Q9)/L>:%HO-=
M-V,C!. 1DU5G\165MXEL] =+C[9=Q231MY9\O:F-WS'OR.F>M:U '&?\(+.-
M$\-:8-60)H,\4\3_ &7F4QJ54-\_'!.<?I52^^&T]YINN:8GB&>*PU2\-\(O
MLR,T4I=7.6)RRY48'!'J:[ZB@#G_ !'X5@\3Z';Z=?74N^">*=;E %?<AY(Q
MC&Y=R\=-U)XJ\*0^)=-MH([N73KNRF6XLKNW W02*,#CH1@D$=ZZ&LD^(K(>
M*E\.[+C[:UJUV&,9$>P,%.&/4Y8=,T -T+2;_3HY)=5UB35;Z0!3,85A55&<
M!47@<DDG))^@ %*_\+7%QXN37[/6);-VLQ97$0A63?&&+ J6^XV2><$>U=+1
M0!P=G\.I[+0] TM=<,D>BWHO(6DM1\Q&["G##C#G/4GVZ5I2V,'A?6];\8:E
MJB)9W$$23I]F;$2QY"D$$D_>.>/RKJ'=4 +L%!( )..2< ?G3B 001D'M0!Q
MWA'3-.N-=UKQ58(XM]3=!;E@55P%7?*JG&-[ 9]?+![BM[Q%H5GXFT"[T>^W
MBWN4VED.&0@@JP/J" ?PK3Z#Z5DZ%XAL_$*7SV:3J+*[>SE$T>P^8H4G /./
MF'7% %#0/#NLZ:0VK>)IM7>%"EMYELL2ID8W/M.7;'&2>Y[G--T+PM=Z'I.I
MV2:I',U[<37(D:UQY;RG+<;^1G.!6C'XBLI?%,OAU4N!>QVOVLEHR$,>[;P3
MUY]..#6M0!Q/_"O(Y/ ECX9FU24/ISI)8WT,?ERPR(25?&2"1DCMQ^=63X*F
MU70+[3?%&M3:P]W#Y/FK EN(ER&!55R-VX*<G/W1VKK::[K&,NP4$@9)QR3@
M#\S0!SOA[P[JNF-$VL>(Y]8^SKLMP]NL(08QN;&2[XXR3W/&3FI/"'AI_"FC
MC2QJ,EW:Q,WV=7B5#&A8M@D?>.6Z^PX'>U!XBLKCQ/<>'T2X%[!;"Y<O&50H
M6VC!/7D'IQQUK6H YK4O"]S<^+8?$&GZLUC/]D^Q7"?9UE$D6_>-I)^5@2><
M$<]*X?Q-H*^$?#'AS2O[:WL?$UO/%+,BKY>Z5G)QGD MDY/Y5Z[6=J^K:;H\
M$<NH2!?-<10QA"\DKGHJ* 2Q]@* ,[_A%H=0O[O4-9FBOI;FR-@%CB,<:0,<
MN -S'+'&3GH!C'.:5IX)ECTG3]%O]5^VZ1I\L<D$36^V5Q&<QI(^XAE4@=%&
M=HSWSJ'Q190SVMO>6U[92W4JPVZSVY D8]!N&5!ZG!(/!XK;H Y>'PI<PZKX
MCOUU.,MK:1JRFV.(=B;!CY^?EZ^_Y5I^&M&;P]X<L='-R+E;.(0I+Y>PLHX&
M1D\UJT4 <>O@FX&G>)[,ZJA77Y)'E;[+S%O0(=OS\_*!C/?\JE/@^X-WX8N#
MJB9T%&1!]F_UVZ/RR3\_'R^G?GVKJZ* .5O/!\^J&*'4M2CN;.#4O[0A!ML3
M1D2&14$F[[H)VYVYV\5LZ]HEGXDT*\T?4%9K6ZCV/M.".X(]P0"/<5HT4 <U
M;^%[N672GUG5$U :4WF6VVV\HM)M*"23YCN8 GIM&3G'3$WAGP[-X?EU9GOE
MN5U&^DOF @V;'? ('S'(^4>_O6_10!@^*/#LGB*+3D2]6U^Q7T5\"8?,WO&<
MJ/O# SU_I56?P>M[XCU+4[Z[2:WU#3QIT]J(2H,>6/#;NOS'M7444 <?X>\'
M:KH@AM;GQ3=:AIEH/]#M9;=%*8^YYCCYI O8<=!Z"M+PKX=E\-6=W;/?+=K<
M7<MWD0^65:1BS#[QR,GC^M;U% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/>+=;GT>#3(+
M57-QJ-\EFC(%+)E68D;R%W80@9XR1UZ'H:Q/%/AFU\5:/]@N)IK=XY5GM[F!
ML202K]UU/J.?S- &&I\2QP>)(=36:3238N]G-=&$3J^P[T81<%>X.,]CFL:T
MU74M(^'/P[?3[I84NI].M+A3&&+QN ",GIT[<\UU=GX8OTTN\@U+Q!<:E>W,
M#6XNIH$011D8(5$P,GJ2<DD#L,54D\#,_AS0-&&J%8]%N()X9/(&Z0P_<#<X
MQZXQGVH AU'7+^7Q3KNE-J)TF&PTV.YM9-B'SBV[?(=X.50JHP,=3GMC)/B/
MQ.G@[P?JMS=K#=:GJ=I%=1&V53Y4K<J,YQP.O7YJJ>(+N"?QOJ'VGQ3)H$\(
MBAABO+".:.<*N[S(C(I !+D84YRO/8#H%T'5?$^B:>NIZL2UCJ27EO=?8O*:
MX$>"A:,GY1DL.V0 >,T 9HL=5U#XG^+8=+U?^RY/L=B3.MNLS9Q)@ -QCKGC
M/H155/&7B&?PAHUY)<0P7Z:_'I5^8X05G FV,5S]W(]/4XQ782^&;F+Q)=ZW
MIVJ?9KB^@C@NDDMQ*A"9VLG(*L-QZDCVJM?>!;:;0M-TBSNWM8;&\2^\QD$C
MRRJ^_<QR.K$D_7C% %60$_&U0I ;_A&VP2,X_P!)%<IK^K:QJGPB\5S7>J3?
M:+/5)K0/"B1[XEF6/81CH03G')]<9%>A'PY*?&:^)/MP$HL?L/D>3\NS?OSG
M=G.X?3''O68/A_%)X5UO0+G4I9(=5N9+II5B"M'([ASCD@C<!@?7F@!GB&]U
M;PSK&@74NL7$^B37/V2_\V*'<K/GRG+*@PN["GIV]ZV]$N+N^OM4NWNG>P%R
M8+2(JH "?*[9 R?G#CDGA<]ZP/%5U8R:/-X*O[BXU+6M2M#Y2FV8;RS$"0E5
MV(%8;NO 7//?K],T^'2M+M;"WSY5O$L:ECDG QDGN3U)H XR^BNY?C381KJE
MY'#_ &++*(4\LHO[Z,$ %3PV!D]>."!4$7B#6]<\$:IXKTS43;/;O<26MF8D
M:)HX68;9,C=E@A.0PQD8Z<]-J/AG[;XIL=?AU">UGM[=[:1(U5A-$S!MO(^7
ME1R.?I6?'X&%K;ZKIUCJ<EOH^J2/)/:>4&:,R<2")\_(&]"&QDXQ0!N:)JG]
MN^&[#585\DWMJDZJPW;"Z@X]\9KS-==\:R_#NX\61:[ 9=.FN&>T-FFRYCCF
M92&;JIVCC;CISDG(]7ABMM.L8X8E2"UMXPBC.%1%& /H *\Q\ :1_P )'X!N
M-.EU1&TR>^N?M%O'&/,V&=CLWYX5A@_=SAC@C(P :>O^(=5^RZE>VFIM;*FD
MI>V5K:1++*&V,S-/N0A4X4#D9PW>F7>O^(+^_P# T5GJ,5DFNV4LMP%MU?8P
M@#Y7=GH6X'3@9SR#K7O@1;G5=9NK?5[JTMM8M5M[NUBC0@[4**58@E1M.,#]
M*2V\#RVT_AF7^V99&T")HH?,@7]Z&01D-@CC:!C'/<DT 9%A9:M#\6H+2]\0
MWEW)#H"RNXBB1';S]K#9M.T-M!.#GWQ@!D'C/5K'P]XEN+NXBN;NV\0'2[-W
MB")&K&)5+ =0N\L><GIFNKN_#/G^,+?Q%!J$]O,EK]DFB1%*S1[]X&2,KSU(
M[>E9H^'UI/HVOZ5J%X]S;:U=M>R%$$;0RMMY0Y/ **1G/3G- &G;6'B"VUN7
M=K"76E26F%^T1)YT5QNZKL55*%>QYR/2N'A\6>)9?AMX=U=-0A_M"[U=;2=W
MMUQ(C7+1@8'"C  X&??/-=IH?AW4M,7S-1\0W.K7,<9BMWN(418AZE5QN;@9
M8G/IC)SQ'BS0XO"?@30M$_M;(37+>2*=U574-,79L=#M+$],8ZT ;,.I^)=#
M\=?V'?ZI#JEMJ-A+=6<LT"P^1+'C*MLZIR.3D_U@TOQ'JX\3>%[*35'OH=5M
MK@7<@@00>;'&'W6[;%++DD9.X$8YSFNBF\*1:M+=W>JW@NIKJP>P1[=/*2*&
M3[Y098[FX^;)Z# '.<^S\ SP7/AZXG\17DTNB*\<'[F-0T3($VD8ZX ^;D^F
M* .<T/5[WP[X7\6ZN^H75[-%KL]I&EQY94N94B5SA5.1D<;@N!@ 5UFFGQ3#
MXIC6874VB2V[>:U]]G$D,PZ%/*ZJ1P0>A[TP?#^RDLM?TZZO;F?3-8GDN'M2
M%7RI)"&9E8#)(901G@>]6O#WAC4-)>-M3\1WNL"W79;+/&B"(8QDE1EVQQN8
M]"?6@"'Q]JNI:-I>GW.FW2P%]2MH)08PQ='D"D#/3@U1FN_$%_\ $35-!@UO
M['9IIT5S&T=JC/&S.R\%@0?NCJ#[ =:W?%/AT^);"WM#>&U6&ZCN=RQAB6C8
M,HY/3(Y_I4<7AR>'Q9=>(5U!3/<6B6AB,'R*JDLI'S9SECWZ?G0!%\/]:O?$
M'@?3M2U%D>\?S(Y71=H=DD9-V!TSMS^-<YXT\1:WH]KXCO+;5 )=/6.6UM;6
M%9$1,*6^T%E^4L2V &!Q@@5UOA/P]_PBV@1:0MVUU%"\C)(Z!6^=RY!P<'EC
M6'J/PZ%^GB*V77+R"PUQC+-;+&AVRE0I8,1G'RCY>.G7% ":AJ6NW/Q!L='M
M-46TL;O29+DA;='>-PZ#(+9Y^8]>/8UDQZSXKN_A_K%U9ZDTFK:)J-S TBV\
M>;R*%^<J5(#%<XVCJ!ZUU$/A2>+Q'8:TVK/--:636062!?WBL0Q8X(YRHQC
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MLAEDQNR<YS\HQZ>]93^ FDT+Q%I+:JWE:[<R7,[B 9C9P P7YNF%&,YQSUH
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MCQB4.0'S@!@=R\=\#=R.E &$VM:SXBTSP?)?7\]K?1>(&T^\%J$$<CQB3]X
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MMP*Y^]@D] .*GD\4:IX7G\;07=]+JD>DV<%W:/<HBN&D5@58HJ@KN4'H.,T
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M3<^'EAN%N[>V6Y9W0!&1F*C:<Y/(/;M7#:?XXU:ZM;+1+B98]6?79]'FODC
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MQ)J^LB^EEDU0QF:%D4*OEKM7;@9Z=<YS6[3))8X5#2NJ*6"@L<9). /J20*
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M,"K&F^$I+/Q0WB"YUJ\N[Q[-;216CC1&4,6SA5XY/8_G72T4 %%%% !1110
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MW*7<%U#L$@D4$ D%2IR&/&,4 8SZG?V'Q.>PDO[B?34\/O>?9V5.)%E52V0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYCO AT_'VM)T:%X 1N!97 (!'(.,&@#6HK(M/$VDWFH2V"7+Q7<4/GM#<P/
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ML45C7OBS0M.NK6VNM2B2:[C,L"@%O,4#.1@'MC ZG(QG-5_^$Y\.?V#-K9U
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MN0" IVKP7)(&%'.1@5O?\)EH M]0FEO_ "!IP!NTGA>*2($9!*,H;!'(('-
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M<VQ8R"0*&RV\8^Z,<?G70T >4V-Y!'XU\3SF:^GAN]$A,5U<P,HEV^9DCY0
M.0!P 2>,YJG')%'\/?AK$3MDMM3LVF3'S1!5<.6'\(!(R3ZU[%10!PWAB86O
MQ&\86LT<RR75Q;SPGRFVO&(%!;=C&,@CKUXJ_P#$+3;B^\*27=BN[4=+E34;
M3'4R1'=M_P"!+N7\:ZJB@#RN:PUK_A)[;4HH)TB\76YMKZ/./L@7YHR?1A!O
M7_>K9U9X(OBYX; VK'#IUU&3C"QEBFU<] 2 <"N[HH \4DBO)M"URZL(9;A;
M'QG_ &G-;Q*2T]LK*257^(9&X8Z[3787'D^(_B-X9U;1IEGM=/MKIKRXB^[M
MD552,G^]G+;>HQSC(KNZ* .)^(SW=BF@:U%;375GI>I+<7D,*EF$11T+A1UV
M[LUF^);F'Q5X.UJ_\+:;)/*PMY7N%@:"2]\J17,:D@.V%4C/JV!SG'I%% 'F
M]AJGAS7!+K&C:/J6I:C9V,V];W[1F/*']QF0D%F/&T9[GTSB:;J,5UXA^'NH
M)]K=$CN(I8XK)XX+1V@ $**%X .1R2>.3BO8Z* /*M+,^F:_IS^'=0>[TV]U
M!A=Z'=INDL2Q8O+&WWD4')YX.[@\BJ.DRZ0MA>^#_%&F:K<ZLMW-LM-UP8;X
M-*TB2+M.P#)!). ",FO8Z* /*?$GG:=K.L:GX;U%DU,31I>:%=+YD6I'8@!C
M!Y#%2!N7/W><<UW7C&PO-5\%:U8V&1>7%E+'$ <98J?ES[]/QK<HH X7PQXF
MTKQ)!I-O%I4PUBRBV2K<63(=.;9M?YV7 SC  .3GT!QS%AN'P;U'P;?P.?$4
M4<]I]C927GE:1F21/[RDLK;^@P23Q7L-% 'G6FJ+#XJVD5W.KO;^&$MI;AC\
MIE67+#<>^!NQUQS7,1$CX:P2B.0I9^*1=3*L9+1P_:BV_:!G&T@U[910!P"W
MEM<_&:SN5SY;Z"\:,Z%<.9E8*<CABN3@\X[46K+)\4?%2IR9=+MXTP.'=?,W
M*#W(R,CWKOZ* /&[>V36_@YHOA6U0G7%:WC: H5DLW24,\C@C* *&Y/7.!G-
M;37T6C^/O&T-Y'.LNIVML]DJ0LWGA861MI QP>N<8Z]*]*HH \;TZ4VOA7X8
M7L]O=)!93^7<$VTF8R8'49&,X)(&0,5O7(DO_B;KL5G*89[GPXMO#(P*[9M\
MAQG^\-P)'45Z-10!X],/[;^#-IX2BA>'Q%$MO9_8F4B6&6.109".R@*6W],=
M^:Z'2[BWA^)?C.6:5%0V5FHD?@,463> >AQD9 Z5Z!10!XUH=K:7/@'P;#+J
M]SH>K6MO/]FOU&%@<,H:.56XPP*G#8SM_/T/P1>:E?>%X)M6@ACN_-E5GA0H
MDX$C 2A3T#_>]\Y[UT5% 'F$T%W/XF^)&DVZS17^J6T1LG\M@K?Z+LW;\8 W
M#;G/6JUY(OB;X;:!H-DCQ:Y!-9QM;%"LEF\++YCL.JJ K8)ZY&.M>L44 9GB
M.&2X\+ZM!"C/+)93(B*,EF*$ "O,YK^WN? WPYC42!K34M/$XDB9=GEQ$.3D
M?=4X!;IGO7K]% 'E&O6EQJ_B7Q]8Z:V;F\T2&&#:<"5U$FY >A." ?3-:/AK
M5/#GB?4=+FATS5&UFRRTD=ZUS_Q+V*X?+2';S]T 9)].#CT:B@#C/BNP/PTU
MN 9:::#9%&HRSMN'  Y-:7AS1M$%G8:I:65L;K[,B"XVY=!M&5!/*^X&*Z&B
M@#R22_\ LEC\2;B+38]39KU)$M9(BZ3)Y<:%MO\ &JD$G']WJ*MZ3J-L/BG#
MJ!NKVZM9] *"]GMFC1F$P8@?* J@?A[DUZA10!XE:,D7P6\+6[ K<0ZK [Q;
M2'3;<EF)7J,*<D^A]Z]0\86MYJ?@C6;72VS=W%E*D&T_>)4X /OTS[UNT4 >
M07_B*PU7P]X%BM8+I;FQU>R%U:BTDWVQ1'5@P"\8_4#(JY/?Q:7KWQ$LKF.X
M%QJ$*36B+ [><GV;:2I Q@$$'/3O7J=% 'D6GSQ"7X4>:CI]EM9%F$L3+Y1^
MS!!NR. 6X!Z'M72:O-&GQ@T!F8!4TZZ1V[*S%"H)Z G!P/:NYHH \6N'CD^%
M?Q!A09EN-7O7AC"_-*'D!0J.I! R"/0^E;>NZY8:#XXTG7#=,OGZ,T#M)!*\
M+IYBLNUHU8APV<Y&,8Z$UZ=7-7_AW5CX@GU?2-?^QM<11Q307-H+B,A,[2OS
M*5^\W<@YZ4 5_AR='3PJMOH^J)J*QSR//*J&/$KL78;#RH^;@'M7,^+=0^T:
MEXTTIK6>TF.E@0"UM&+ZEF%N6D"GY4)VX!'?)(.!Z)IFFM8B66>X:ZO)R#-.
MR!=V!@ *.@'8<]3R:OT >565W!/KOPQDPZK!ITZ2&2-E\MC!&HSD<9((&>N.
M,UI>%;.RUF[\>:;=*)+6^U%\K_STC:%%++ZC(/([BO0ZS=<L=2U#3O(TK5FT
MNZWJPN!;K-\H/*[6XYH Y3P!#JUQ(T>M*3)H ?2X92?^/AL@F7\8Q$,^I?UJ
MS\3/#]]KOAVUFTR/SK_2[Z+4((<X\TQYRF?4@G'N!74:7IT>E:?':)(\I!9Y
M)9,;I'8EF<XXR6)/''/%7* .8N_&NF-HTDUBSW.HO&?*TU4/VGS".$:/[R\]
M20 .I.*X6_\ #[^#OA'X?T2Y</>1ZC;3S+'\W/GB1\8[*#C/M[U[#10!P?C*
M]MCXM\$R+,C1I?2R.ZG*HAA90Q(X )(&36/=7^G:+XT\16?BB+4Q9ZM(D]E<
M6QN&BN$,2QM$5B/WAMZ$<@_2O5** /-1%96/Q!\%P06?V*WM].NHT@8EOL^_
M9L1CSAB 1C/J!FM"2>&/XV>8[JL:^'S$TAX4/YX;:3TSMYQZ<UW5% 'B+NG_
M  HN\MU4_:3JI<0A3YA'VT.#MZ_<Y^E=#KNOV'AOXBW.HB[\L7NE1*[36\LD
M+8=]C(T:MT^;(. <C!ZUZ;7,7'AS68M>O=3TGQ$+9+W89K>ZLQ<*I5=HV'<I
M48'3)&23WH 3X>QZ/;^"=/LM$U(:A:6BF(SX*DOG<V5/*\MT/0$5SEW#8:A\
M=&%VJRVW]@?9]YR%\[[1G9N'\6T],YKOM-T\:?%+NF>>XGD\V>9P 9'VA<X'
M  55 'H!U/-7: ."\=Z6NC^&M)ET?2W^P:7J45U<V>G QN80'5B@3!R"P;CT
MK*U*X\.:KX3\4:MH=M>2R3Z1-:O?7/G[I6*G9"HEY8Y].G [UZE10!YGXM>.
M;X"/% -SOIL$4<:+EBXV?*%ZY&#QVP?2KD]X-*^*%OK5[(!HNH:.MK!>$_NH
MI5DWE6;HNX'()QDC':O0** /%]5TO4K>TU;Q!9VMQ+I3>*+;4VMHT)::WB $
MDBKW!<!O<+GI710ZU8ZO\6]'OM/::XM7T>>(3I;R;-QD0@$[>.AZ].E>C44
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M@MI4E:X%U'YMNMM&TK2I@'<H4'Y>1STY'J*?H^LV&O:<E_IMP)K=F*YVE2K
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M%(WJHY;:220.2.E #O&#7O@S0)/$6EWMY.+%D>ZM+J=I4N(BP#8+9*,,Y!7
MXY!J/Q#XLBFUWPOIT)OQI^J++<3O;03!Y(Q#N159!D\L"=IR,<\$TOC>]7Q9
MX7N/#N@$W=YJ6V%I%0^7;1[@7>1L87 !^7[Q)X%0:O;Q:7XX\!6L2RM;:=#=
M0R2B-BL:F!43>P&!G'>@"G%.R>+QX-N-4\03V*:?).L^)UG$CS;5S(H#%44$
M!B2O/).!CJ+;Q)I6B6EE87VJ7-SMD%D=1G@;9),#MPT@79NR".O4$$YK,$P'
MQJ>4I)Y/]A+;^=Y;;/-\\MLW8QNP<XS7+>'A8II7_"(>(M!U2ZUFWF=%A<3M
M;77SEDE# [%7D$DXQ@]3Q0!WT_CSP[;ZE-I[WDINH)XX)8UMI6*/)]W.%Z=/
MFZ<CGFJ]CXCT"PM?$&J?VQ?3VUM>-]K-PLCBV<(N41=N0H&#QD9)YJGX88?\
M+,\:R&.15G-GY4C1L%D"0[6VL1@X/!Q7-S;W\,?$^)8)S)=W,YME\ELS!H54
M%!CY@6!'% '?6/C+0]1U6WTVWN9#<7,1FMR\$B),H +;'(VL0",@$X_"B^\8
MZ)IR74MS=.+>TF$%Q<)"[QQ2''RLP!&>0/8D X-<K=2!O$'PWE2.4I;QS><P
MB;$6ZWV#?Q\N6XYQS7.WMWH\<'BGPS?WE[9:;?:M)+(7TR>5P"RM)L=%*89E
M.TGD \Y[ 'LD$\5[:)-$S&*5<J2"AQ]#@BO+;&YU:YL?'5T?$M_;/HU].EF[
M.C)&B(& 8,IW#/'/.*]0L[RUN]/AO+69);22,21R*<AD(R#^5><^"='TO5-;
M\8?VII,4_G:S)/ ;RUR)(\##+N'S#(- '1>%_%S:AX,T74]5A=-0O[?S/L]O
M"SL^.K*H!.T\'/0;@,\BK+>//#::9:ZB^H[;:YN?LJ,8G!67."CC&4(/7=BN
M>\8R'0O&NF:U>V=_-H36+V4KV'F9M7WAE9EC(.T@8_ >U9VOPZ>OA[29M*T>
MYMK:?Q';7K*T,ADF4,#).ZD%EZ?Q<D 'O0!TTGB?0-8O]%:/5=1MY6OI(X(4
MBEA$\BJP9) R\J!S@XY K6U#Q1I6F/=+/+,WV10UTT,#RB $9RY4'''/KCGI
MS6!XV??XD\&2(DCI%J1ED9(RP1#$ZAF(' R0,FJ?A^Y_X1O5?%VFZY#-_IFH
MRW]JXA9UNHI%4!$P#N9=NW;UZ<8H [.XUW3K>VM)_M E6]Q]E$"F1I\C=\@7
M.1CG/0#DUR_@35)M2\1^+U-Y>7%O!>Q)"EUN!B'E LH5@-OS9XQ7*:)IVI^!
M9O!-WK4%Q)80:=/9W#1HTOV.6602+N"Y.,83(XXK=\.ZQ#I^O>/-6EL]0^R>
M=#<(PLI 946!0=N0,G/;KWZ4 >CT5';S+<VT4Z!U65 X#J58 C/(/0^U24 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 <_I7AR?3?%.M:T]^DW]J>3OA$&WR_*4JN&W'L
M>>/RKH*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@!DL8EA>,LRAU*DJ<$9]#V-<MI?A/5M,LXM-7Q
M3=2:7"@BCB-K&)A&!@+YH'IQG;GWSS7644 1P0Q6UO'!"@2*)0B(.BJ!@"I*
M** "BBB@ HHHH **** "BBB@ HHHH *Y/3O">KZ2IM+/Q5=#3M[.L4EK$\R;
MF+$"4CGDGEE)KK** (;2UAL;.*UMUVQ1*$4$Y.!ZGN?>IJ** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKAOBI>7D7AFRTRQD,4NM:E!IAD#%=J2$[N1TR%(_&NYK)\1:#;^(])-E/(\3
MI(D\$\>-T,J'<CC/<$?B,B@##T[6+[1/%]EX2OK:R%G<6;2:?-91M&$$> T3
M*S-T!!!!_"NMDAA:6.>1%+Q9V,W\.1R1^%9-MH,C:W%K.IW4=S>V]NUO!Y4)
MB2,,078 LQW':O.> ,>N<Z^\,Z_?^&K;2Y?%1^T*[-<W9L$)N%W$JA3(4+C
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MYV_+PHQUQ[UB6^D6UOI&CZ8-=U\P:/?K=V9_X1BYR -WRN?+^9OG/S<#U!H
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M4GFB0AF)RXR./NGGG/2MRU\,WEKXKN]>&J1R27%G':&.2UZ!"2&)#C)RQS@
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MUNX:Z6\62\9[57%XI(W[CP(U"YQCL !DXKJ)UE>!U@D2.4C"NZ;@#[C(S^=
M'D_A#6KOP[\)O#DD=R)KC5+N*PM5EC&R!Y)G!8XP6 &3@GJ *ZJ?5]5T3QOI
MFA7%Y]LM=8MYC:SS0J'@FB4,0VS:&0J?0'(ZU%;_  [C7P%;>%KK4FE%FXEL
M[R*'RY(9%<NKXW$$@G';BM>'P]=2ZM:ZMJE]!=7]E!)#:&*V,4<9?&]RI=B6
M.T#J !GUS0!B^ =0\3>(=.LM9U'5;4VI>YBEM8[3:9"LK*K;L_+C;C'/'O7=
M5@^$/#LOA;0ETM[Y;M$EDD1Q#Y9&]RY!^8YY8_A6]0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 445B>*;N\L],ADL[RWLPUU$D\\W++$6^81C!#2'HH(.2>E &W17FH\4:V
MNE>/4CO'\W0XA/9SW=LJR[3!YNUE 4=1QD9P>1FI[76?$-KK'@V2[U5;FVUV
M%DGMA;H@C80>8'5@-V<CG)P<\ =* /0Z*X"U\1ZGI5[XITK6+Z2XOK15N--(
MCC0S0R?+&% 7!?S/D)/&2.*[6QANX=,@BN[H7%XL8$DY0 ,^.3M&!C/;TH M
M45YGI&O>)&T;6/$6H:S')9Z+=7Z2V:6B#[4D08*-_5""!TS[YSQJ6-WXOEU'
M1+R*.XGL+E0=0CN/LRQQJRY#PE&+\'LQ;(]^: .XHKS6Z\3ZW87FCR/J2W,E
MSK@L+J"WA5K2.)W9559-H8R* I/S'!W CI5B_P#%=S;>+;C1]1U*?1IWNXAI
MWFP(;6\A^3<OF%2=Y^<8W#!VX]P#T*BN-L]3U/Q3J7B*#3]3?3DTNY^Q0;(D
M??*$#,\F]3E<L  ,< \\\<_:^-M?UNP\%W5K/!8OJEU-:7L1@WKOC60$@DYQ
ME,@?K0!ZE17(^$M2U1_$/B70]3OOM_\ 9DT!AN6B6-V26/?M8* .#GG%==0
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M[; --:SPO#*@/0[' )'N.*UZX0>'=9G\>WGC"XCM+-H-+:RL[<S%M[9+;Y6
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MVR,@]#DX]ZFU3P>=0M-'MUU*13IM\E_YLL8D>>923EN0,$L<@ =L8 Q73T4
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M?04\,>'K31HKE[B&U79&\B@-MSG!QP>M '%P:=JNI_$7QS%I>MOI3A;$^;'
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M>R6=H$^S^27CQGS=YW'<2>F, C'/)DD>XD^*GAJ2\C2.Z;0[AID1MRJ^Z+<
M>XSFKESX#8>(KO5=)\0:CI*7[!KZVMMA29@,;EW [&(ZD<UHMX6C'B?3]:AN
MWB%A:M:16P0%/+;&<D\Y^4<^U '+6>L^*_$.A6'B#0Q<>9-/YGV>5K<6K0;R
M"F<^8&VC[W]X'H.!I17NM>*E\1G2=5.G3Z=>O8V:;$9"\:J2TN5)(8L1@8P
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M+HR:M=20A2[;R%6-=P.!DL2>O ''-6U\$8LO$=J=4E*:^SM<'RES&70(=G_
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M P&/X<#H<_6J-GX$AMM)AT.349[C0K>998K.1 6PK[UC9^K(& (&,\ $D<4
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MD52#D9QSV(/O68;O7_#?C^TTRXUM]1L-7L[B6-KR-%^S31 ,3E /W9!''ZT
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MQ)<SVT]E=+=VTT.W*2*" 2&!!&&/!%;%% &$GA:RE.H2:DS:A<:A;_9;B28
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MFM.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KA?BS"TG@Z-A//%MU"T!$3E0V9D'/KUS]
M<'M7=5E>(M M?$VBRZ7>231Q2,CB2!@KHR,&5E)!&00.H- '(ZOI\DOQ4T.S
MBO[F'_B3W0:=2#*1YD?1B" ??'3I@\C/L?%&K6GAXV#WKW%S_P )-)HD=W.P
M$AC#$@EMI&X@;<XZD&NS7PG"-?LM9;4]0>[M+=K9=[1D.K$%BWR9R2 >" ,8
M  XJB_P[TB;1-4TJZN+VX@U&\:^=W= \4[')>-E4;3D#U_G0!-H%EXAL/$-\
M+VYC?1YH5>W@ENFGFBE!PV&*@E""#R3@_6J'BR?5?^$Y\+:;9:Q<V5KJ"W:S
MI$B'[D0((ROWN3UR <''%;F@>&UT)6:35-1U2Y90GVC4)A(ZI_=7   [GC)P
M,DX&.;\91M<?$7P8(I[B#R#>&2X@3<(MT0"[B5*@,1CGK0!BOXEUSPI+XHT6
M?4I=0%G+9?8KZ[V^9&ER^P[VQ@[>2"1VZ8XKI8--\3VNN32?VAY&D3VC(T<E
MW]HFCN!R'C+QXP1G*GCN!6G+X-TJ[TW5K/4%DO?[6(-Y-,0'DP $QM "A<#&
M!QUZDFH=%\&1Z/"Z'7-8OG\HPP2WLZR-;H>NP;<9X')!/% '*>'AXJO_ (;V
MWB2VUJ]OM5N+ !;)VC2-CY@)*DCB3:& ).,D< 8%-N/'L-AX4\1ZKIMQ?I>V
MB6\3:;JJL9;&5W*;CNY*G<#U/W?PKL;'P=:Z=X1A\.6VH:@MM 4,,^]/.CVN
M'7!V8ZCN#Q3I/!VFWG]I-JADU"34;=;6X>8*N8ER54!  .6)SUSWX& #'URX
MU#PKKWAI[?4+N[M-3O!I]W#</OW,RDK*O]P@J<@?+@]!7,W%[K[^$/&FJ_\
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M^+'\1+>7?VE[46AARGE>4&+ 8VYZDG.:K^/\GX?Z_$JL\DUA-%&B*69W9"
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MMRX9R  !T '0#H!^9)H \WL;Z3PR/B/KB3W5S+87;-''+*65V\A"NX>@)'T
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MG4+;R[]Y*?+TSV;<!GC!YH RSI-QK'Q0\5V\&KWNFC[#8DR6>T2$XDQ\S X
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M;HXD '/0[>/>@#T_3KU=2TVVO5AEA$\8?RI@ Z9_A8 D9'0\U:KB/%MS??\
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M^NYY[;Q-'9^=YS*TB+=% 7VD98 #GU&>M 'M%%<)/->ZKXJU3P[;2RK!IMG
M4_XF,MO*6DWDR;U5F?&%')QG.0<\95PGBB#4? ^DZGXB?[7<R7=O?26# )*$
MB<J>5!WXQUX!YQ0!ZA17GL*ZC<Z_?>%H[^[N8]+L8"LTVHO;W$K2;R9"\:$O
M@!1Z>H.>(+VX\5:)HVB/K*S:U%;)-'JIT:9EF)R/+D &UFPH8,HQR<]J /19
M;B&!HEED5&E?RXP3]YL$X'O@$_A4E>3W?V+6]5^'=W:ZO>WUM<7%TJW'VB2-
MF BD/(!&''W2>O!'3BN^\6P"7P9K$9DE0"RE(:.1E;A"1\P.>U $.L>*[?2E
MT22.VDN[?5[N&UAGB==B^9RK')R1@$\#\JZ"O(;FS\KX=?#58;B=7FU'3&WN
MYD*$PG[H;( '8=/:K]SKFH^$M0\;PQWUU?PV&F0W]JMY)YACD8.",]=N5!QV
MYQB@#T^BN(M-,\1+J^E:C;ZI&FG21,MZLNH/<?:-R_(\:M&%1@W.%P"#C%<[
MH]YJUMX+U;Q9<:YJ5W<:3+J(BM7D'DRA&=5\Q<<X(!X(QCCW /6:*X:RL?$*
M:CHVL0:E%]@:/_3DEU"2<7:NHVLB% J-GD;< YQ6)'JVIZM\)IO'%OJ=S!JJ
M)->HBRGR%6-V_<F+.TC:N"2-V><T >J45YQ#<ZCKWQ M[1]5U&SL+SP['?-;
M0R!#&[2@$*0,CCOU]QFMKX<7]Y?^$5-_=274]O=W%MY\IR[K'*RJ6/<X YH
MZVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPENQ'IDBR6-R) )K=EZ%6 P>XP001US5L^%[5X-1$UU=376H0BWN+QRGFF,
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MU6:XEFDL+5':!9'<L=CLC1E>>I8 ]>*]>HH HV5M<2:';VNJLL]PULL=TP&
M[;</T[$YKF[?X:Z1;V^F0"_U=TTN;S;/=>']T,$;!@#Y<$C^][UV5% '-KX+
MLE@UR$7U]LULL;S+)R678=OR<?+Q_P#7YK8TO3H])TJUTZ&662*VB6&-I2"V
MU1@ D 9P *N44 <S:^#(;'5M2U.TUG5(;K4F1[IE:(ARHPO!C(&!QQ2WW@FQ
MU+0;[2+R^U":*_F$MS,TJ^9(1MP,[<!1M7@ =/<UTM% &)<>&8+K7=,UB:]O
M&N].C>.'E I#@!]P"\YP/3IQBO/;*S,UU=FXG\=:/JEQ=RS/962.UN&9R1L<
MHT>",<E@/H.*]=HH YNV\,R75UH6KZK?7+ZMIMN8\H4"$NH$FX;>2<#./3C%
M)_PA-@'U)([N^CL=3F:>\LED7RI7?[YR5W@-W"L!72T4 8MYX9L[S6]*U7SK
MB&72U=+6.$H(U#@*P(VG.0 /;'&*RW^'6D?VW=:E!=:G;1WDGFW=C;W12VN'
M[ET'7/?! />NNHH 9(A>)D61HR1@.@&5^F01^E<UI'@F+0K%[/3=;U:"W>1Y
M64-$WSL<L<F,D9-=110!SA\&6)FT:47E\)-)9Y(&\Q6+.^=[N2I+%MQS]:DB
M\*6T%_K-['?7HGU=56Y.4Q\J[5VC9QA>/_K\UOT4 >8ZUX=72=9\":5I[ZJ;
M/3II_P#28X3(;=#$0FY@A7&<#Y@>.M=D?"UFUEJL,EQ<O/JJ;+N[8KYKKMVA
M1\NU0%)   ZD]3FMRB@#FY/!6G2:7I%F)[M)='V_8+Q'430 +MP#MP05&"""
M".N:?/';>$K"_P!8^S:EJEU.R&X:"(2W$V,*N%4*,*#T  ')ZDYZ&B@#G/"N
MDQVSZIK)L#97.L7/VAXG&'50H5 P'1B 6([%R*J1_#K1X=9N;^WNM2MX+J4S
MW&G0W16UFD/5F3OGN,X/0C'%==10!RNI^ =,U'Q ^M17NJ:=>3JJ71T^[,(N
M57@!\=<#C(P?>IY?#SKXKTG4+*XO+>ULK<P/;K/BV>/:P5?+_OY*G=Z*!71T
M4 (0""" 0>H-<XG@30(_#EGH*VG^@6=REU$A.2'5]_)[@Y(/L<5TE% &1KWA
MVV\0I9+=7%S$+.Z2[B\AE'[U#E2<J<X].E1R>%[1_$;:ZES>0WCVZP2"*4!)
M I)4LN.2"3CMZ@UMT4 <E_PK[3!X6'AW[;J']GB?[0!YB;MWF>9][9TW\_\
MUN*OW'A6VDUHZQ;7MY9:@\ @GFMRG^D(.F]64J2.Q !'3IQ6]10!SM]X*TF\
MT"TTB,W%I%9SK<VTUO)B6.8$G?N(.6)9LY!SN-)9>"M,L]3O]0,]]<3W]NMO
M<F>X+"10",D#'/S'V&> *Z.B@#*\/Z#;^&])BTVUN+J:"%0D9N9=[*H& HZ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA)P1A20,\#OQBMJ\NM=O/B5=:!!K3VEB=(2[4Q6\;/&QE*?*6!'\/<'J>.X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5@ZSK+Q:WIF@V;[+R^#RO)@'R8$ W-@\9
M)*J,\9)/.,'>KA;B.2#XYV-Q+D0W/A^6"$GH9$G5F _X"10!TE_XCT?1W>&\
MOEC:"-7F)#/Y2'@-(0#L!P>6QG!JIXCUEO#\5MK33!]+,L<-VO!")(P595/L
MS+D="I)ZCGAO&&K6DMYX\TL8T^[&F?<CBW3:E^X;#9(/[M<[?E&1R2P'%6_%
M5Q%?_L_'[/F7SM/M88@%.7D+1J ,]?FH ]/HJ*UC>*TACD;=(D:JQ]2!S4M
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MC9U6)#)(%'5]H!X&1R1CUK"^&FJW>M>"8+Z]O6O9GN+A?M#;?G59G53\H Z
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M(T\ W:W$;PO"",@LC@-@CH<<]JAC\<^&9+FW@&K0J]S#YT)=65'4+N.&(VY
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M"X\KGD\XQQ0!Z317GUKXI71?'/BN+7-7E-E;0V;P1LN_R]RN7VJBY(X&3@\
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MC0QPI&,F5UAE!50.I!91@>HIKI:^(_"_@;3=*>.;4+&YLIYO+^]9K$H\TO\
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MM&4LLHZ'(') ZGV%;]% 'DMK>B[^(5E<6-_<7;7?AZ>"WNOLK1Q>:9$(5 %
M"CKWQCDYK&N-:LV^"EOH,J31:UI\UK#=630L94=+A-S$ =#UST.<=>*]SHH
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MY<M<&69I";ER!NEQ)\P!/&>^,]""<%;L:;\6->,MO-(]WI5N;:-8V/GE#)N
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXF78K0E5+ C*ACP,XS0!TU_XJT?3&N!=7+A+4A;F5()'C@) (WNJE5X(/)&
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MQ=@4/*\OP#VQUZT =71110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP/,(ZYZC=@]:]2HH \P76I$TGP2G]G7\-GY)@N;X:<[3VSK"H"("A9=Y+*6
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M2Y90<8)&X<#-<I:13Q?"3P3:/9W8N;75;5YH?LS[XE28LQ9<9  .<^]>ST4
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M]G$#^9YHC *[,9SG/:O3** /.]3D>#Q5X#U3[)>2VD=I=0R-#;.Y1WCC"JP
MRN2I'.!QSBL_4=,O=8UGXF6-E%,DVH6-M%:N\;(DS+$X958C!Y(4\]Z]4HH
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MT4K6Z*JLH&1EE(YXKT>RU>&^U/4+"."ZCDL619'EA*H^Y=PV-T;'?'2M"B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=+(W15R0,\$\D  $G@4 8T7A:YAU[7M534H]^KPQPF,VQQ$(U*J0=_/#'/\
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ML008QN;&2[8XR3W/&3FI?"'AI_"FC+I0U&2\MH2PMP\2H8T+%L''WC\W7V'
M[[]4K/4EO;R^MA:7<)M)!&9)HBJ2Y4-F,_Q#G&?6@#+N_#,LOC.+Q';:D]O(
M+,6<T/E!UE0.77D_=Y)SZCTZUC2_#R6;P;J_AQ]87RM3NGN9)A:X9"[[V &_
M'4<>WK7=52M-26[O[ZT%I=Q&S=4,LT16.7<N[,;?Q =#Z&@#G-5\%W]QKZ:]
MI'B&32=3>!;>\:.U66*Y5>A,;'AADX.373:?9BPL8[;SI)V7)>64@M(Q.68X
MXY))P  .V!5JFHZR(KHP9& *LIR"/44 >/\ VV"]\1:G>+XUL](OC>N$L-3T
MV*6XBV_(H0L5;!V[@%S][US747'A75M=&D^((]7?1O$=O T$EQ%;!DGA+9 >
M)SQGAL$Y4DCJ..YVJ6#;1N'?'-([K&,NP4$@9)QR3@#\Z .5U#P=<W]KI"2:
MR[W%CJ":C)<2P!C<2J" " 5"K@XP.P'/JMSX)CU#6=<O+^[6>UUBS2SFMEAV
M[47=M(;<>?F/./3I75T4 <GX?\*:OI BCOO%-QJ=M:*5LXIK9$V<%09&4[I"
M >Y'KUP1'9>!!!X(U+PO<ZDTUO>^<?.CB\MT\UBS?Q$'EC^'%=A03@$T <=:
M>"[^+7-'U>Z\12SW.GVSVS 6B(LJ-MXQSM^Z,\G/;;6GX8\.R^'4U)'O5NA?
M7TM\<0^7L>0Y8#YCD>G]:L:%XAL_$4=\]DDZBRNWLY1-'L/F( 3@'G'S#KBM
M:@#EK_PA-<^)[O6+769K5+ZS6TNH!"KEE7=M*,WW#\Q['K69%\-Y;72O#Z6F
MO2Q:KH09+6]-NI4QL K1M'D94@#OG.3FNFUOQ%9:#)IT=XEP3?W<=G"8H]P$
MCG W'H!_A1%XBLIO%$WAY4N!>PVHNF+1[4*%MHP3UYSTXX/- '/MX#NY6\32
M3Z\TDOB"W2"?_1%"Q@1F/*C.>A..>.,YZU:F\'W,R^&A_:D8.A$,A^RG]\0A
MCY^?CY3V[_E6MKWB*R\.Q6DEZEPRW5S':Q^5&6 =V"C<>@&3W_6M:@#EX_"E
MS%K'B+45U./=K44<3(;8XAV(44CY^>&.??TZ533P)/'H_AG3EU9-N@SI-$YM
M>92BE5#?/QPQSBNTHH Y@>%+E-<U_4TU.,-J]O' R&V)$01652#OY.&.?PZ4
MW2_"VH:-I.C6%EK*;=-@:W/FVNY)T.W&Y0XP1MZ@]ZZFB@#BG^'D":)965E?
MFTN+353JJ3) "@E)8E1'G 3#D 9XP.36G8>&KBS\77.O/J8F-Q:QVKQ-!@E4
M)(;<&^]ECGC'L*UM1U.WTO3[J\G+M':QF658E+N% S]T<]C1I.I0:SH]EJ=L
M'$%Y D\8D&&"L 1D>N#0!QES\-9Y]+U+2T\13QV5U?\ ]H0Q_9D9HI#*)"&8
MG+C(XZ>Y-;G_  B\R>+4U^'5I4D:R2TN(FA4^<$8LK9XV\DY '(Z8KHZ* .)
M7X=PS>']6TF^U!I1?:@^I1SQ1>6]O.S;\KR>A''MD<UK0>'KJ75;/5-5OX;R
M]L89([0QVQB1&< ,[+O8EB !P0,$\<UT%% '"M\/)F\#7'A<ZRODS71N3/\
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M0HI0Y/.#SG.?;I3+;P1=1:MI&J3^(KNXN]-@>W!,$:K(C;>" ./NC)SD^HH
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MY^[N .-H.,#..O7-X6DM?$5]K.CZB;*7441;R)X1+'(RC"R*,C:X'&>0>X-
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M2W&K^)V\)^,-67Q'.DVAZG<I;*MO%B1(]I"R?+R,9^[M.222>,=3'KEUKWC
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M0>7B-=S9.<YY'0=ZMV>H&[OKZU-E=P"T=4$TT>U)\J#F,Y^8#.#TYKE_$?\
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M!*LI!'()KSC6-5N/%GAKX>ZVUQ/9O>:O;!X8@FU'VR@NNY2<Y!QDD8[&O4S
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M2Q*2PHZ2(F=K,./F .,CCU!K4T/1K3P]HEII-B&%M:Q[$WG)/<D^Y))K0HH
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M,LJG&!QT&<XK1UOPU8:]?:3=W:MYNF7/VB$J<9.TC:?8G:2/]D5LT4 8>O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&QW] <;=QX&?>I/#EM]I^(WB/7+)PVEW%O;0^:ARD\R Y93T;:I5<CN2.QH
MZJ_U.TTU4-S(P:3.R..-I'?')PB@L<=\#BJT/B32+G38-0M[U9[:X<QPF%6=
MG<9RH0 L6&ULC&1@YZ5Q_C*_@T#Q[INK:U]LCT*:P>T^U6TDJBWF\P-\_ED$
M!@ /JH]*J76G>&GTBR?2KR]\/K<:E+=V&J%W.Z<QX:1A*?N.-RX; ;''WAD
MZ?6?'>EZ5IUE=QF:X%W?QV*!8'^5S(%?<,9!7G@\DC K1O/%.CV S<73*1!]
MI=5@D9HXO[[@*2B\'EL=#Z&O.=2U'4KGP7IU[K$<!.G^*+<S7MI&1%<0I(,W
M  Z YP2.,@U>\0:W:W>O>(+)4DL9)M(1H)(K5C/J0*O\H)4X1<X( !Y)R *
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M0=7T[7=%MM1TF0/8S*?*(0IC!((VD#&"",>U &C1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !6>^E1C61JEN_E7#QB&<8RLR DKD>JDG!_VB.>
MVA10!!>0RW%J\,-P;=G&TR*,LH[[?0^A.<>AI+&QMM-L(+*SB6*V@01QHO0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ=HMD6@78L$*DL F23G<2Q)ZD#@ 8IWAS0?$6GO"NM^)%U."U&V!8[7RF?C
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M!D[>>3G(Z$ ZNBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[8 R0%')/M7+)J>O6?CZ#1;V^MI[;4;":XB\NWV&VD1E& <G<,-W[CMTKG-
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MYXFCEC62-AAE<9!^HIMO;06D0BMH(X8QSLC0*/R%2T4 %%%% !1110 4444
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M!($E6+R]RHH49&X\\5@7?@O4X?$]YK'A_P 1OI::AM-];-:K.CNHP'3<1L;
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M_3=?DU&$&RMI+<P+;$"0/M+'=OXY48X/XUEQ> [J#PIK7AU-;'V/4&G\K=:
MF!9F+,#\WS'YC@\#V-=M10!Q>I>![R=]%U#3=;^P:UI=O]E^U+:[XYXL#*/&
M6Z<9^]P?PQ+J'@V_NSI%Y'KSC5M/NGN6N9K8/',SIL8&(,H4;>!@\>Y)-=?1
M0!Q"> KI-,\46/\ ;I>/7F=W:2T7,1D0(YX(R<#CH!W!I_B/1[BZ\$P>#HKA
M9KNZBBM9)DCV!(%(WR$9./E4@<\L0*[2C'.>] './:ZO;^+M/6ROB-%CM3%/
M8&V&U,!MKB7KNSL&WT!-='110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHY5*NS.%)STPN22>V*X>"ZTCP=K_ (1<RSP^%OL5U;V=S>,=L<S2!@S,>@9
M0I./E/IFI_%3Z#%X7M;_ $98H]-;Q-:W4]TC9BD8RJ9)0Q.-N>,CC(- 'IT<
ML5W;++;SJ\<BY26)@P(/0@\@UPWA74_$OB)O$ ;6+:$Z;JT]A#FR#!E3&&;Y
MADG/;%=U!<0W-NEQ!(LD+C<DBG*L/4'N/>O./AQK&EV;>-'N=1M(%_X2.[DS
M+.JC;\OS<GIP>: -[PKXKN]1UG5?#NMVT-OK6F;6<VY/E7$3<K(F>1VR"3C/
M7TW;/7-)U"[>TL]2M+BX1=[113*S;<XS@'IGC->3ZA9ZGXCO?'/B[2()UM9-
M)_L[3VVE6NP,-(Z#KC@A3WSQ71:+?>$_$VJ:%JEEK-S?ZA:Q2&"W1T5[9&3#
MB1452%X YXSC'6@#MX=;TJXNQ:PZE:R7!W8B692QV_>P,\X[^E5M%NU>UU"X
MDUZWU.%;J4B6,(JVR<'RB5.#M'4GGGFN%\+37FDZGX:TU;JUUWP[>1R?V7=@
M;;FS58R=LF.&7;\N?7&>PK,$=I<_#+XBP_;4M81KEX?,09 Q(A ('9B I]B:
M /4X?$.C7$PABU6R>4@$()UW$'H0,Y(/8]ZB_P"$J\/;[=/[<T[=<2&*$?:D
M_>.#@JO/)SQQWXKDM(NM)\3^/++6O[5T1I[;3FMA9VM['/)(S,&)P/X%P<=^
M3T[\?<I8I\$/%<\:VX<:O,1(N,@BZ&WGZ=* /9;_ %O2M*<)J&HVMJQ7?B:5
M5(7.-QR>!GOTK/U?QCHVBZMI>G7=[ DVH%BA>4*J(J,V\D\ $@*/4GCH:XWQ
M1J^F2:UXNLHYK>PNO[(19I9&W2WRF.0HD2D[=HR02 22V.,9JE::I8QI\)KZ
M6\A6UBM)8I9WD 17^R ;2W3.<C'KQUH ].O==TC3IDAO=3M+:1\;5EF52<\#
MJ>YZ>M/U'5+'38Q]LOK>U,@/EF9P,X') )YQU->71ZAHD]YXN\/>+=9FL)+B
M_DD-M(407-NX7RBA*%F.T!< Y&T8K3T;4K71?B7>VNL3-:1/H]HFE/?.%/E(
M#YJ[CQOW$$]SM]J .@^'FM7NO>&I;R_NTNI5OKB%9D155D20JN O&, 5!<>(
M9[[Q_=>&(]432FMK6.>(>6K27;/NSMWY&U0!D 9))Y&*J?"6>TD\+7L5K+$R
MQ:I=C9&1\@,K%>!T&,8J3Q)IGA/QKJMUH>L>7!JFGA'MYTE$<Z*RA@Z-Z YR
M.1P">HH VM/U2YTVRN6\4WUA;NETT44YQ!'(F%V$;F/)SR,GG(K3DU"T:\?3
M8[^V34#&7$!=3(%_O;,YQR*\?OKG5Y_@[XJM-1OFU6#3;](;742,FXA2:)BQ
M/\6WY@6YZ'GBNHFUK2[WXQ:')::A;3QOI5S&LD<@96<O&0H8<$X&<#F@"WX%
M\:07WAK3!KVMV7]L7<MPJ1R2)$\H6>1%VIQV4#WQW-=5>ZWI6FR&.^U&UMG"
MAB)I57 / )R> 2"!ZUX]:6&E7OP+N[/[/;RZN]U<1PQH%\_[5]H?RP/X@V-O
M_ ?:MOQ'_:.E2:YJFG:C9WY@M8DUW1KW@3 1#YXF'*DJ<#C!(/?B@#OVN-WB
MN.!=<@ 6T8OI05#(QW+^]SG<  <8QCFN=^(_BW^P_"NH2:5K-I;ZK;E L9V.
M^2RY7:>^TDXQTYJM).LGQCT^6-%BN9O#DK".3 8,94(#>_7\C7$7.LZ?-^SY
M?6%[<PKK4,A%[;3L!.+C[2&8E3R2>N?3Z4 >PR7&?%,$"ZY @%JY?2]J&20Y
M7$N<[@!TQC'-3IKVD27XL$U.T:[+,@A$R[BR_>4#/)'<=17(W%Q:2_&71IH)
M87\W1+@AHV!WCS$(P1UX!Q7%MKNDW.B^#KJTNK6QLHO$:.-/$FY[52TVYIG8
ME@Q))Q\H&['.,T >O2>)="AN/L\FLV"3><L'EFX0-YC=$QG[Q].M1Z-=++_:
M<K:[;ZE"ETV#&$ M%VJ?*8J>2.N3SS7*>%K32[SXD>.2]O:S,EQ9.@9%8J1
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M^F/:@#O:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBH+R]M=/MC<7EQ'!"" 7D; R3@
M#ZDD #O0!/166OB/16L;B^_M2U2VMG*3R22!!$P_A;.-IZ<&DM/$VAWVI+IU
MKJUI->M&)1 DH+E<9SCZ$&@#5HKD?'GB>'1_"^L-9ZO%::G:VS21D!7*OM)5
M2"" 6[ \GM70Z/-)<Z)83S-NEDMHW=CW)4$F@"[1110 4444 %%%% !1110
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MO]'>VTB6VL;@RQR$M &CF"MGRY ,$HW0X/0GZ5O44 <C8^&+JYO+>XUBPT&
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M"7$MI \R'*R-&"RGU!QD58HH A-I;&?SS;Q&;KYA0;OSICZ=923/,]G;M+(
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MBPRG(/RBK[V\$CEWAC9RNTL5!)7T^E2T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEQ0I?:J\UR[R*2D:H 7<J",DDJ,9'))SQRW0?$=U=>(]6\.ZI%"M_IZQS)-
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MQQDINR""""-WO[5E_":&>Y^'ND7%\UM<*#)+!^Y.^-S+)N8L6.2<GD =3UH
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MEXJT"ZT>_#>1.H^=#AHV!RK*?4$ U0-KXM;2?[.:ZTT3&/RCJ@+[\8QO$.W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"U8M;W4*31%A@E6 (X[<&@#F+'PKK&G+KSVVL6\=QJ>H)?QN+9L1$%,H1O\
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M)!&>]*WAG5]5\.:II_B#68[BYO[5[57MK?RXX58$9"DDLQ)!))[ #'.>KHH
MXZ2S\4:7;>';6WU>UF>&9([N)++ GA&Q3@EB4VKN8G/)('<+6OXMT%O$_A:_
MT9+MK1KE !,%W;2&#<CN#C!'<$UM44 <?:^%M;3Q;!XBN=8LWN!IQL988[,H
MA^?>"OSD@9ZYSWQCMGK\/=07X>6WA0:M;9@N1/\ :?LK<@3><!MW^O&<]*]
MHH Y>[\+7%]XPCUJXNK=K;^S7T^6U\ELNKL&8[MW'(QC'2J/ASPAK^A"#3)?
M$HN=!M&!MX3;;;C8IRL;29QM&!T&2!C@<5VU(2!U(% '$CP1J']B^*]..IVW
M_$_GFF+BV;]QYB!",;_FP%'IS0W@O4[35=)UK2M4MH=3M+!=.NA-;LT-S"IR
M#M# JP//4^E=O10!S?A/PY>>'GUAKK4(;O\ M&_DO<1P&/8S@ C[QR/E'T]3
M3;OPS=0^+SXDTBZABN)[86UY;SH6CF53E&!!!5AT[@CTZUTU% '#W_@":XT(
MV-MJ,,=U/JHU6[N9+<L))0X? 4,-J_*J]3P.YYKMTW;%WX+X^;'3-+3)95AA
M>5PQ5 20BEC^ &2?H* .>T#PW=:3J>O7-U=P7,.K7/V@Q)"4,9VA-N2QR,*.
MPK*\/^#-=T#9I4?B02>'(9-T-NUM_I"IG(B\W/W>V<9QP,=NIT36K'Q%H\&J
MZ;(TEG/N\MV0J3M8J>#R.0>M7V944LS!549))P * .>USPG;ZUXAT;5VF:*3
M3W;S%7_EO&<,$;V#JC?@?6FZUX9FN_$FG>(],NH[?4K.)[=UE0M'<0L<E&P0
M1@\@COV-6+'Q9I6H:I!I\#SB6Y@-S;,\#*EQ&,99&(P1R/P(/2MR@#B=6\!S
M:IH?B&W-_#'J.O,GVJY\@E$1%"HBKNSP!U)Y))]A9T_PG?:5XIEU:QU"WBMK
MR%5U"R%N2DTHX\U?F^1B, \'/?GFNMI 01D$$>HH X;0_!.MZ QTNT\1C_A&
MA(7BM6MO](C0G)B67/"\GG&<'C'6NB\5:&?$OA?4-&%T]J;N(QB91G;R#R.X
MXP1W!-;%% ''6OA76T\4V7B"YUFS>XAT][&6&*R*1LI=7&WYR1RHSG/'0#M0
M'P]U ?#^+PM_:]MF.[%S]I^RMS^_\[&W?_>XSGI7H%% ' ^+UT;Q=<V7AR._
M1]:M;V-Y5M7P]NFW]Z6[JK1EE^K**[U55$5$4*JC  & !6=;7E@^O7ME# R7
ML<<<D\OD%0ZMD+\^,,1@\9XK2H X_6_!]WXA@EL=2N[6:T-X+FWG,)^T6JAP
MVQ&SUX(W<8!Q@XHNO"6ICQ)K6H:?JMO!:ZS!&EU');EY$9$* QMN &01G(/2
MNPJEI.J6^M:='?VHF$,A8*)HFC;Y6*G*L 1R#0!Q0^'FI6FD>'#IVN10ZUH4
M1@ANC:GRIHF #(Z;LD<#G/X>FCK/A'5=;\.K8W6LPM>O=Q74UP;8[/W;*RHB
M!OE7Y1U)/)/>NQHH YQ?#UY_PGB>)'O(-@T[[ UN(3DC?OW!MWJ,8QTI?%GA
MZ[\0II2VUY#;?8-0BOLR0F3>8R2%X88!SUKHJ* .:\1^';_4]5T35]-O;>VO
M]+>7 N(3)%(DJA7! 93G@$<UF1^!M133/%EH^LPR'7RY+M:D&$O&(R>&YX'
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ME$QFO2XB*1,RC8NX[F PO'3/6KM %'2K.YLK()>WAO+MV+S3;-@9C_=7G:H
M  YZ<DG)J]29&2,C([4M !1110 4444 %%4KG5+>UU2RTZ03&>\$AB*Q,R#8
M 3N8#"]>,]:NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %1W%Q%:6TMS.XCAB0O([=%4#))
M_"I*R/$>DW>M::+&VO8K6-Y$,_F0&7S8PP)3AEP&Q@]>": /+9-6M]&\5Z%X
MT,TBRZG,UKJT;HZ^5#*1Y.<C \O:@/J<^M>C:[KD\'B'1O#]DZQ76I>;(\[+
MN\J*-06(!X+$D 9X')P<8JQXK\/_ /"4>%;W1))XXOM<>QI6A+A3D'<%W#D$
M CGMWK%O?!.I75OH-VNO(NO:+E8;\VOR3(RA662/?SN Y(8<],4 <_;W.JZ+
MKGQ/O8KN":]L[6UGCEE@X<);NP#*I'.!C(X[X[5?;Q#XIMY/"-R;VPEBUU5A
M>!K8@0NT.\2;@V6Y!R. >G'6KQ\#:E++XHFGUR%I?$%JEM+MLL+%MC,>5&_/
M1CP3Z<FK$W@V]E@\+QC5H =!96!^QD^>5C,?/[SY?E/OS^5 $&E:WKHO_%NC
MW5Y:W%UI,<,UM=&V*JPDC9MK(&[%2.#WK-_X2[Q#)X5\#ZC!+9>?K5S#;W(D
M@.,NC-D8;@?+TQGW%=!%X5O8==\1ZFNJ09UF&*+RS:']SY:LJG/F?-PQST[=
M*H)X"O(]!\,:6NLP8T&YCN$D-D?WVQ64 CS..&.?PH ?I&LZ]_;?BC1+R\M+
MBXTZ&&XM;K[,47$BL=K(&Y *>N>:S(_'5]%X#\,Z[J3206]_SJ-];6^_[,-K
M;3MP< L ,D''U.:Z&+PO>P^)=<UA-3@SJEO' (C:']UY88*<^9\WWCGIVZ5#
MHWA35-"T'1],M-8@D73HWA<2VAV7$;8P&7?P1CKD_3K0!S_B34-3O-#\)W%O
MKT$T5WK\,1GM$4I/&9&:,GGL$7(]0:T+O4?%MSXUO?#EAJFGP"'3(KN.XDLR
MQW&0J05W<YVGGC&>G>I'^'21Z!;V-C?QVES!JXU>.1;;,*R[B=@CW#"8.,;O
M>M2S\-7MOXTE\0RZI%,);%+)X?LNTD*Q8-N#XSEC_#C% '/>)?%FM:%!J-Z]
MU;^;:7\,4=C#%YJ-;,R+NE<<QNVYB 2.@X/6K'GWZ?%_4!+J;"RMM'CN!"8@
M513*VX#W.P$GK^0IE]\.+^[TO7-+C\1".QU*_-^BFS#/'(9%<AFW?,N5X& >
MG.!@[;>%;G_A+X]>75!\]BEE>0M; ^<JN7!!SA<EB",'CT/- '/S>+=</P^7
MQU;O"T 'VEM-:,;3;;\8W_>$FWG/3/&VI[G6_$VJ^,KG1M&U"PM;9])BU"WF
MFM"[+O<C:PW<Y Z\8ST/6K%MX!FMO#DWA8:HK>'I)#MA: ^>D1;<8A)NQC.1
MG;G!QZ$:D'AJX@\<2>(5OH1"]BMB+06Q&U%8L"'W]<D_P]* .B7.T;B"V.2!
MBN8\3:UJ6E^(_#-K:R0"TU&\:WN%:(E\"-F&&S@?=]/QJSHR:VOB/6?MNH?:
M],9D-HIMA%Y!^;=&&ZN -IW'N<>N&^(/#EQK6K:)>Q7\=NNEW)N1&UN9/,)4
MKC.\8&&/8T <Y-K?BJ[U+QE9VVHV%N-%\MX'^QEBX:'S-I!;CK@GGV KK_#6
MJOKGA;2M5E18Y+RTBG=%Z*S*"0/;)K(B\(WL6H>*+L:I 3KJH-IM#^XVQ^6/
M^6GS?+].?RK7\-:1)H'AO3](DN5N?L4"0+*L?E[E48!(R><#UH X/3&U*;3O
MB0]YJ37*13W4.UH@.ELF,8Z #C'X]:=H&K:YHVF?#\275K)IFIV\%FUJL!#1
M_P"C[E?S,\GY>1C'/XUO_P#"&7D4GB9+;6$CM=<9Y#$]KN,4CQB-CNW#<,#(
M''/<]V'P3>'3_"MH-7@ \/O&ZM]C/[_9&8QG]Y\ORD^O/Y4 4+CQ-XFU73;O
M5/#EG),T%Y)#;VACC\J=(Y#&VYRP96.UB", <#!ZUV>I:FFEZ#=ZK<1,$M;9
M[F2/(R JEB/KQBN7@\#ZKIFKWS:/XFDLM&OYVN)[$VRN\;MR_E2$_)GZ'':N
MONK&WO--FT^>/=:S0M Z9ZH1M(_(T <=9ZOXMGO=$NHK.2XL;W'VY&CC1;=6
M7(>-M^X@'J#G(]*K?\)!XCM_&-QX4NKJW%W<LEQIUWY*A#;#/F[ESS(,8P.N
M0<  UH>'/!^MZ((+&Y\427NCV9'V6V:U5),+]Q7D!RRKQP ,X';BDU;P-<ZM
MIN9-6CBUQ+Y;R'5([4[HBI^5%3?]T+\N,X())&230!+J.N:C=>(;[1---Q&U
MC;122SPPQR,9)-VT$.0 H"9..3GJ,<X\WB/QFB>$;>[M[+3;_5)Y;:\ADC\S
M:RHY#J0^,$ -MZ]MPK4U7P=JT^O0:_H^OIINJM;K;7A^R>9!<H"2#Y9;*D$G
M!R?2IK[PA>W5YH%RNL@RZ5.]R[SVV]KB1U*MG#J%&&. !QQZ4 0V&H:Y=ZS+
MX;FU.%;VPLDGN[Z&W \UY&8(%1B0 %7+=<DC&*KZGKGBG1]*\*MJ']GQ7U[J
ML-C?I"C.I5V;YD8GC(4<$'KUXJ[KGA"^NO$\7B+0=9&EZCY'V6X$EN)XIX@<
MC*Y&&!/!S[4[5_"-UJ=EHT"ZOB73]0CU"2:>W\QIY%)." RA0=QX'08 Z4 9
MNI^+IX/%=[HD^HKI-V'C_LU+F >1>H54M^\/\>XLH (Q@<'FI-0\0:YJ<^O0
MZ!'*)=+E^SPA88W6>81JY$A9@0IWA>,$8)R>@N:]X0NO$5IJ.FW^H6\NFWLJ
MR*CVI,MM@*"(WWXR2I(.."QZ]*@N_!>JV_B:[U?P[XB.F)J&PWMM):K.KNHV
MATR1M; ]\]Z .GTNYN[C1K6YU&U^QW;PJ]Q!N#>4^/F&1U .:X=O%NMWGP_E
M\<6$L/D1^9<)ISQC:]LCD$%_O"0JI;(X!XP>M=_:VRVEI%;J[R"- N^0Y9O<
MGN3U-<=;> IK/0;WPS;ZHJ^'KIWQ 8"9H8G.7B5]V-IR<$J2 3UZT 9VN376
MJ^/_  )>65^88+RVNYH T()C!A0\\\D@_A76>+Y+NV\%ZS/9736MS#92RI,B
M@E2J%N,]^.M5=1\+7%UXET+5;2^@MH-'CECBM3:E]PD0*<MO&,!1CC\ZV]5L
M$U72+W3I79([N"2!F7J RE21^= 'F.HI>KX.^&I-RDT[ZG8M$TB8" VSX!QR
M<?K[5TFD:SKO]M>*-$N[RUN+C3H8;BUN?LQ08D5CM9 W."GKWII\#ZG)I'AN
MQFUV!SHEU%<(_P!AP)!&A15P).."<G)Y]!Q6A%X7O8/$FN:PFIP9U2WC@$1M
M#^Z\L,%.?,^;[QST[=* .>C\=7T7@/PSKNI-)!;WXSJ-];6^_P"S JQ4[<'
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M<@C.,8P<<XR=^W\*7MOJGB:^75("VMA!M-H<0%8_+'_+3YN/IS^54CX#O/\
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MO!+;):G%P@N/*/S%ODX/'7IR3GCK)=5U/6M<U[2M(NH[-M)CC4.T8<RSR)O
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M'4%#6X>2)LIW)PQ^; Z#U!K:\":QJ&K:3?IJDR3W>GZE<6#3H@3S1&V Q4<
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MWKN551026QSCM@^E)H/B[1_$=I=3V5PZ&S8K=17,9BD@.,_.K8(X!YZ<'TH
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MM4\CJ/PJUIOA._\ L4]KXD\03:Y%) ]LJ-;K H1AM8MM)+,1QN)[GCDUU5%
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M9-%<31*67Y)2,A0 <?0=JV]3\"I?VVF2QZM=PZSITS7$.IE5=V=AA]ZX"E6
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ /2L?1_#EMHE[J%U;W%S))J$OG
MW E92&DP!N& ,< # X]JV** ,&Y\(:9=2W>_SEM;V59[NS1P(;B08^9AC/.U
M<@$!L<@\UO=*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>elicio2021employeestockp011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2TM&:34"0^4,@4X5"1QD?>))QQ61I]S]GT[X6ZA+;7BVUE$]O<-]ED)1S;;
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M=JZ_4=;L=+;9<-,TFPR>7! \SA!U8J@) ]Z\AN&DD^#OB2V-K=)<2:W(R0O
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M<J$ W%A@Y&,C!STKSK3GN_A[KF@W'B&.X?3W\/PZ<]U%$TPM[A&+%&"@G!!
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M)O$EN^G7VIWWA^^>PUFW@BBGT>=3-;ZFHB7:BJ1EFP=F5YXYQG- 'J<\T=O
M\TK;8T!9CZ"L#3_'GAG59%2SU1'#6[W6]HW1!$APS%F  QZ$YP0>AK<$^RQ$
M]T%@(C#2 MPAQR,^U>5:/I]]??L\KI^G02'48HBQML%')6?S"F.""R@X]<T
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MY) B+&S'&T'+9 X&2 23@5C^"-3T+4_$NNZA9ZJEQJ>H^5)+;""2(11Q+L7
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MD9+7"?\ +--N0"!N.,@]:FL?'.@ZA?:?:6]Q,6U&/S+21[:18Y?EW%5<C:6
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M7BN?WYC\O81Q\O/RX/%=S!>7K_%JTBDGN8[>?P\UP]F\A,<<GG1C.WID#C-
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M%/9ZC'?77F0LAM41&W1OD##%B%V]^3T&:V_'UY<V/A.>:UT\7S"6(.AM_/\
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MEA>KY+;[21U7#LF,@94 G''%+XI\/:IKJ>-]6T6"1XKRWLXX(]I7[886#R$
M\D;?E![\@5Z_10!YI?Z_!K_C'P/J%E9:D8H9KDW&ZQE!@+0E0K?+V8X.,@?2
ML#4+RYU'2K":?2]2M[NR\20S7%A;6$BPVT:W!)8!5Q*S##%OF)+'  KVJB@#
MSH0W3>/?%]M]GNX7UG3+9;.;R&V K'*K$N!M4J6'4Y],U0\)7&G7]EHVBZEX
M9U,:[ICPB2*ZCE,,#QX'GJY.P# )7')S@<<UZI10!RGQ+L[G4/AOKUK:023S
MO:G9'&NYFP0< #J<"L?4[Y-1\:^ [Z"VO/LT9NVD>2UD3RPT&U2P(RN6X&<9
M^G->AT4 >/:C8ZE?0^.SIUG<33#5K2^@A*/']J2(1%@C8&>4/3N!75^%[W1-
M>U:+4M.T34(KF&%DENM0BE1H0?\ ED"_WCGD[<@8Z\C/;44 <?XXL;'4)M+B
MN;F_TZY1I)+75+//^BR  8<X(VL"0=V <8[UR-[?ZFMAX*N/$"AYH?$3KY\5
MN4^T1A90LWE@97=][I[UZ]6!XA\.RZY?Z/=)?+;C3+H72(8-^]]I7!.X<88_
MXT <3XE\/WOB?6/%&I:(A\N70DL(WQM6ZG$AD(4GJ H5-W3+8SP:OZ->:5XJ
MEMFMM!U.VUBWBD#RW\<R_P!GLR%6VN_!).!A>2.3C%>C44 >:^!]:VZ!I/A7
M4- O!K6F%('BFM&,*;#@3B4C;C;R"#DG@=<UH^'9/)^(_C:XECFC@E%F8Y6B
M8+)LB(?:<8;!XXKN:* /(]-67_A0FKV!M;I;UHKU%MFMW$A,DLA3"D9.0PJ[
M<:A/X=\2^'O$5Q97D^C3:*-/F>"W>1K67<K[F0#< <;>G45Z?10!F:'/%=6+
M7,&GM8P32M)&CQ>4[@]79,94DY//.,9P>*YO1"1\6?$TC0S+'-:6B12M"P1V
M0/O ;&"1D=Z[>B@#R#2/LEK:WOA'Q'X>U.]U$7<QA3RY7MKU'E:1'W [%&2,
MEL8QGKQ6WI&I2^&O''B.PU.POG.IW$=S83P6SRI,OE*GE[@"%*[?XL#OD"O1
M*9,LC0NL+JDA&%9EW 'Z9&?SH \7T7?;?#/X<:H89I+2POQ)<M#$TAC0B5=Q
M503@$CIZUT>EW9D\7^.[QK*^BM[JSM3!)):2*)-L3@XXX/S+\IP>>E=;X2\/
MGPKX:M-$%W]JCM05CD,>PE22>1D\\UMT >/6RR1^#?AI#):70EL[^![E/LS[
MH0L;J2XQ\H!8<FMOQ5.=#^(,&LZE8ZA<Z)=Z<MH9[(2,;>5)&8;EC.=K!^O/
M(KT:B@#R_6[>TBT_PJVF:-<65J?$<-Z8O(?>(]KAI9%P2F20>><$9P<@:^GR
MB+XM:[<O',MNVF6Z+,86V,R,Y8!L8) (Z5W-% 'B.F0WVF^"?"&J2:7J$]MI
M5Y>#4+2&.1)T25Y-L@7AC@$'CLWUK6\4)IVI?#GQ/=Z%HMZC:A'#&)9+>7S[
MQU;^XPWD*.A/OV%>L44 <)J4HG^)_A2YBCF:!+*Z1Y1"VU"XCV!CC )VG@UA
M:/!:-X"U#0];T_54$>K2^<\,$B/"6N2T<J,%^;&0V5S@#)]_6** .-\"MK$=
MSJ]G?WQU6QMVB%CJ;Q!))U*DLC$</LX&X=<GOD"O?&?0_BL-8O4E.DWVEK:)
M<JA98)4D+;7Q]T,#D$\9XKNJ* /*[G3+B#P=\1+X6]PL6M23M8VPA;?)F+9N
M"8R-[9/3H :] \-R+)X9TS 8%;6)65U*LI"#((/(-:E% 'F&H:=>:MXH^(5C
M:+-%+J&E06]K,T;*DDBI(&4.1C^( \]Z9>^9XJ\#>'=$M[6YM]7@N;/SXI(6
M0V9A(\QR2, 84[3_ !9&.M>I44 >9:5JI\.:SXDT#7-'O[K^T-2EO+-H;-IX
M[N.7&$R 5!7&#NP /:G:]=W4VMZSI=SIEU;;](1;;^S[5F^V.5?*-,J\*A(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "LK7O$6F^&K2*ZU25XH995A5Q&S
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M,7"KRQ4GN 02IP<=JXC1=&U'5/@WK6BPVUS;:C+)>>7'<PO"6W2LZCY@.&!
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MW1(0-V<KD@9( -<5%:WZ?!:VTIM(U1;R#55+0FTD9\"\,A( !) 7G=T/8DT
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MA1:Q!-(;>20PJC1,)?-#;?+V8SNR",?CTYKGA/)/\6[+4A8WZ6AT*2'S7M)
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M59K19$D5Q(!M8J,I\PVG.!VK2O\ QCI6GZT^CR?:Y-06W^TB"&TD=G3<%^7
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M!\Y@N,N)"6//"D*N._7I0!U-%<Y_PFNE!;*>1;F/3[Z40VU^\8$$KGA1G.X
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M)SN.&."0" >"<@U#9^+);KQQJVAG3KI8+""%O." [B^\EL YVX4 <9)SQTH
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MAM7DBNUD=G#B0#;GYN03GCH3Q70,UYIGCG0M:FTC4I+6;0VL2(+8R-%-YB,
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MW6-G\YG*;B  =I]?UKC=#U&RBT/P];:U8^(8-,TB=;V OI+E(\;O+WSJ2'1
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M ME'=F!Q&)=TA(#8QP&!K.\(!)+72]&U+P%)#K.GF-);N:Q3[.ICP/.27NQ
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M-I)$&E$9&0Z[20RG!Y!.,<XK"\06VM76H^%_%4>ES :;=S--IR8:98)DV%B
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M)M+4N9$W;?EY&><^W'7. 8H_'^GSZK/IMOIFLS7%O/#!.L=F?W/F#*N_.54
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M]M0M-9O!""& CWX.2""1CV&>2 "0MCXWTVYTG5;^[AN=._LJ4Q7D%TJ^9&V
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M/&YC6-IMGJ0\;>']:_X1_54A&GS07<]TZ-+YA*'+_,3C@X ^@4"O3J* ./\
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MY_:%UJ,LL,!099&N!(#G.!\H/>O64E#P"7:X!7=M*D,/;'7-/R,@9&3SBEH
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M9C\VWECW;2 Y *D-SSU_74O]/O-8T>VT&\TA;>TU .;XP["EO%DD1]>7/ +
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MUF\U.5)&#@#\:ZC0-;\0:J(_[2\.S:5Y*$W)EE1_-?&-L04G(SSN..@'.<@
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M=@ABV /E[\\].":HQ?$F"?2-*UE-&OAI%]+' ]T[(ODR.VS!3.Y@&X)'X9H
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M: .EHKBK+XAK=)H%U)HMY;Z=K3I#!=.Z865U+*I4'=@X(W8Z^V#7:T %%%%
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M&"L2 64=1T-=+X<O_$6HRQG5?#4>C"%3YS&XCE\Y\8Q&%Z+WR>> .<DCJ**
M.+^)^E:IKGA%M-TFP>[N7N(9,"2- H1PQR68=AVKL8I&DA5VB>-B,F-B-P]N
M"1^M/HH \QATGQ;9>&/$4=AITT%Y=Z[)>I&+F-7FM7D4LJ.&(1RH(R<8['-2
MV.B:Q:>)M>O8/#?V:RU#2HXHD2XBW"1?,RK#=C>2PR<D=]Q/%>DT4 >8KH&O
M)X,\"Z=_8\QNM(OK6:[030_(D:L&(._!^\,8_2N^LKR_GU/4+>YTPVUK R"V
MN3,K?:05RQVCE=IXYZUH44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1;"2_N?#][]C%Y]DCE$L0,A\PQA@N[(4D9&>U=E7 _%__D2X?^PE:?\ HT4
M7M;\:WFA:3J=[=^'+I396XN IN(]LJYP<,"<8XSQGD5UL,GG01RXQO4-CTR*
MY/XI?\DP\0_]>;?S%9BI<Z+\0?#$<.HW\T6JV5R+J&>X9XV:-$965#\J'DCY
M0.* /0J*\MTEM?\ %?A;3O$EEJ,5E=F8W,EP^HRF,(KG?"\&W8% &WKD8SG.
M37J5 &)J7BG3M*\2:1H5PY%WJ?F>3Z+M&>?3/('J16W7DGB>SU'Q'H&I:W8Z
M/?/?BYCOM*O$:'8L<&?+P#('(8&1L;<_O.^*W=<\:F[\!Z%JNF3&W&N7=K:&
M=3S;"5L2'/JN&7/8T =#/XC,'C6T\.M8OBYM)+E;DR#'R%05"]?XNIQ6[7G<
M^E0V/QAT=()[O9+H]T,2W#RE2'C&5+DD$Y'Y9]:Y=Y=3C^$EQXC&NZL=3L-0
MD$$ANWVX%WLPZYPX*G'S9]!@4 >V52TZZO;H77VW3S9&.X>.',RR>=&/NR<?
M=S_=/(KD1%<:-\4M-LX=2U":WU+3[A[B.YN&D7S$9,.JGA#\Q&% 'M7,7U_J
M<?PO\>3KJ^H"YL-8NH[><7#>8B*R *&Z@8/04 >Q52TZZO;DW8O=/-F(KAHX
M"9ED\^,8Q)Q]W//RGD8KCVCNM'^)FA01:G?SQ:K971NH[BX9T+QA"K*A^5#\
MQ'R@"L[3)M?N?#7B^'3KR:[OK?Q#)% EQ=%6>%#$3"LG\&5W*",8)[=: /2K
MBXAM+:6YN)%CAB0R2.QP%4#))_"GJP=%=3E6&0:\<\0ZE8ZW\-?&2*-6M+NU
MBC:XTR_FDWVKXXP2QW1MR0.AQG'2M[7K.>'Q/X)TVTU74[:UO?M23HEXY+@0
M%NK$G/7!SQVP0* /1JAFNH+>6".654>X<QQ*>KMM+8'X*Q_"O/-6M'LWU'3+
M76=6U"2PT@;8_M3QM:M\Y$TLRL-SM@8&"?DZ8.:SMK:YJ'PKO[^>Y>YN[25I
MI([B2,L?LNXD;2,$D\D8)Z=* /6J*X+1VE\8WWBN*ZOKVU>POVL+1;>Y>(P*
MB+B3"D;F9B3EL\ #IFN;L-9UGQ)8_#RXN]2O+6;4)KJWO!;2F-9A&D@W8'<[
M<Y[9R,8% 'L-%4=-TP:;H\6G+>7EP(T*"XN9?,F;.>2W<\_I7D+RZFGPCF\1
MC7=6.IV&H2""0W;[<"[V;77.'!4X^;/H,#B@#VRBN#"3Z'\4=.M8]3OIK74-
M.N);F.ZN6D3?&R8=5/"<,1A0!CM6'!J%[;W?@^\M=3O[V.]U-[>>_EE9([Y&
M60_+ 6("C:,' Z<#!S0!ZQ17G,NJ3>#O&&L6=]<WEW;:G:_:M)2:Y=_WJ_*]
MNF3P2S(1CLWM7;Z+82Z9HUI9SW,MU/'&!+/+(SM(^/F.6)/7/':@"_45S*\-
MM)+'"TSHI*QJ0"Q],GBO*]1U*\@33=3L-4OKP2>)(X'O_.:.&2)YBAA2+<0R
MJ/EW8 RN02:W]/G?Q7XA\5075U=PQZ9,MG;16]P\7E_NPQE.TC+%CQG( 7W.
M0#HO"NO+XH\,6&M+;FW6[C+B(ON*C)'7 ]*V*\=\&ZI,/#_PW\/"66"UU*"Y
MDG>)RC2>4"5C##D9)R<$'Y<=":O:U>ZII%WXVT6VU&]^R6^B?VI9RF=FDMGP
MX*!SEL$KN )XY XH ]4J&*Z@GFGBBE5Y+=PDJC^!BH8 _@P/XUY?<Q:KH<?@
MKQ!;:YJ=S-J%S:6=[;7%P7AE29.2$Z*5QD$<]R2<DZ_PZT^"WUGQA(CW!9-;
MEC >YD<$>7&<D%B"?<\^] '?T5QOC:YU:RO=/O+:PN]2TJ&.7[;9V%P8[@$[
M=DJA2"^W##;G^+/;C%M]62XU7X>SZ3J]]<V%[)=QR-+,^9E6)R!(I."RL,9/
M.10!VGBG73X:\-7VL"S>[%I&9&B5PF0.O)_^O6G:S?:;2&?;M\V-7VYSC(SB
MO*?$%S<OHOQ5LY+JXEM[6.,01RRLXC#0!F"[B< DDXJ]=VE_X:U;PAJ=EK&I
M7 U*ZBL;RTN)R\3H\9;>J=$*[<_*!_/(!Z;17-6GB*?6+N73G\/:_IRLKC[9
M/%&B#'HP=CD]N*\S5];A^#VE^.(O$.K2:O:A)3%)<L89U,VTQLG1LYZG)S[8
M  /5+7Q&;CQG>^'6L7B-M:)="=I 1(K,5&%'3[IZG\*W:X(RB'XLZ[,TZVP3
MP]"QF<9$6))#N/L.OX5E:5>7UOXG\$+#>ZC+:ZE;W*W%S<SM_IVV'>LHB9F$
M8SR.AP<8Q0!ZE17C=PNH2>#?'>HG7M8%SI&J7?V)EO'7R_+5"H./O#MM.1Z#
M))K=\2ZKJ=G/;:I>6>H7FA2:;'Y[:7<,DUE*=Q:4HI!92".>=NP^IR >CT51
MT6X@N="L+BWNS=P26T;)<'.95VC#'///7FO-#J-Y _A;4+/5+Z]2[US[--J+
MS,D5W&YD^5(=Q&P;0 <#[N1G.: /6:*\RM='O?$GB;QIILWB+6;>*TN(1:_9
M[MD,3-"&SQV!/W>GKGC&3I&K:WXAC^';7>KWUO)J,=]%>?9Y=@F$2, WU(&<
M]LY&#@T >IZYJ;:-H5]J8MFN?LD#S&)6"E@H)/)]A52UUJ]O](T+4+/2C,FH
MK%)./M"K]EC=-Q;D?/@X&!@G.:X6/[?I2?$/PW+J%W?Z?:Z7]IM9+N4RR1>9
M%)N0N>2,KQGM4\L]U:^'OA@]O>7$*3S6<$T4<A5)$-N6PP'7E1UH ].HK@;(
M3^-)?%<+:K>6-W97[6-H;:9T^S!44K)M5@'+,6/S=1QTIFM/)=7T]O%K%WJ$
MT6C*WDVDIMTA8[C]I>1&'+8&U0&(P2!@DT =)JWB,Z7XET/2#8O(NJR2(+CS
M !&4C+].IZ>W6K^LZ@VDZ->:@MNUQ]FA:8Q*P4L%&3R>.U>8F:ZU^V^%DUW>
MSK<W2RF6XB(60DVK9(..">>>O/&#5M%OM&OO&WAQM1O+_38]'^V6[7DQED@9
MUD4IO/)!VY&>E 'H.A:F-:\/Z=JHB\D7MK'<>7NW;-ZAL9P,XSUQ6A7F&F:G
M='2_A_H,.T17NBB9E-T]OYK1Q180.@+=&9B!C.!SC(/6>$].U724O[34]02Z
M3[09;6/SVFDMXFZ(SL S $'!//Y4 ;INH%O$M#*OVAXVE$??:" 3^;"IJ\^^
MP0?\+QNI<W.X:#%/M6YD +"=QC ;&, ?+]WVYK(BU&_U?X03^-8M3NX-91)K
MU"EP_E)Y<C?NO+SL*[5VX(YZ]>: /6**HV$\FJ:':W$JO;R75LDC*IPT9902
M![C->.I_;0^#EMXSC\2:L=7L2\RB2Y)BD59V4HZ='R.YYZ#H * /<**\O\77
MMU):^++NTU"_ENK*P25(X)F@CTQUC+X)#?O'8_-C:>, D U+?_;M8\7>%K1]
M8U&VM]2T>>2Y2UG,>6"QX9<=#ECSUH ]%^U0?;/LGFK]H$?FF/N%SC/Y_P J
M@TRZO;J&9K[3S8ND[QQH9ED\R,'"OD=-PYQU%<+H6B06GQ7U: 75_*T&D6>)
MI;R1G<Y=<OSANF<$8SDXK,L_$.H6'A&99=1N6-QXJ?3&O)9"SPP&;:2&/3"C
M /;.: /6J*XS6=&ETFSU^ZM]<OE@ETR1X;-KB1FBEC4DRI(6+#JH('&>3UK'
M;4;_ /LCX9W7V^[\Z]DMX[H^>V)PUNS'>,X;+ ')YH Z[2/$9U3Q+KNC-8O;
MMI1@S(T@;S?-4L" .G '?OVK=KS>.X%IXM^)DYU%=.V6EF1>,F\0'R'P^WOC
MKCO2:/<7UOX^TJP6748[*]T:5W6[N6=Y71D EVLS>6QW'OGGD#% 'I-<_P"+
M/%(\*6EK<R6$UW'<W,=JHA=0PD<X7.[ Q[YKF_AS87.H62:Q>ZWJUQ-:WU[
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MM"[;]I.T'KC:  #CIBO3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBLO7]<@\/Z:+N:-Y7DFCMX(4(#2RNP5%!/ R3U/09H U**P8M<U*+6++3M1T
M80?;-^RXM[D2Q+M4MM8E58-QP,8Z\\5O4 %%8#>(I4\=Q>&VL@(Y+![Q;KS<
MYVNJ[=N/]KKFM^@ HJIJD][;:9<3:=9K>WB)F*W:41"1O3<1@590L8U++M<C
M)4'.#Z9H =7/ZUH\C:_IGB&SCWW5BLD$T0.#- ^-P'^TK!6'K@COFJVE^*-0
MUC3=?EM-'0W^EWLMG%:FZ $[(JG.\KA<[O3M731,[1(TB!'*@LH.=I[C/>@#
M"O?".F:AKJ:ZDE[9WS1"*62UG:$SQ]ED ZX]>"/7BJ4GA2+2?"$WA?01<1QW
MBR1&:65G$"R$^8_)X/S$A1U8^F2.MJE>7%_%?6,=K8K/;2NPN9C,$,"A200N
M/FR<# Z4 2V%C!IFG6UA:ILM[:)88E]%48 _(58HHH **** "L?Q%X:L?%%E
M'9ZB]Q]G2190D4FS+J<J21SP:V*S/$.JR:'X>U#58[7[2;.!YS%YFS<%!8\X
M/8>E !K&A6VNZ'-I%_).]K.NR7:X5G'H2!_+%5W\+V<NJ:7J4D]V]SIB-';,
M9!@*P ;(QSD #GTJ_I-\=3T:QOS'Y9NK>.8H#G;N4'&>_6KE '*6_P .]!M-
M:EU*W%Y$LTWVB2R2Z=;5Y<YWF('!.>?3VKH=1L4U+3Y[*66:..9"CM"^QMIZ
M@'M]15JB@"K:6"66F16$,LHCBC$4;D@LJ@8'.,<#VKGK7X=^'[7PS<^'?*GE
MTJX;>8)IBVQLYW(>JG//!Z_C6\U^LUM?'3PEU<VI:/RM^T&4*&"%NW4#/;/M
M4MC+<S6%O+>6XMKEXU:6%7WB-R.5W#K@\9H P;7P/IUMJ=IJ37NJ7%]:0M##
M//>.S!6QU'0]!U&#WS33X!T<^&9O#QDO#ILTIFDC\[DL7WGYL9^]SUKJ** ,
M:7PW:SZY9ZS+<737MG$T,3[Q@*V-P(Q@YP/RJ@_@/2)-&U327DO&L]4N&N;M
M#-S)(Q!8YQD9(' P./K7444 8LOAFTFUC3M5EN+M[O3XVC@<R# 5@ V1C!R
M.OI5:+P7IL%K?6\<]\HO;P7\KK.0WGA@V\$#CE5XZ<=*Z.B@#"E\):9=6>J6
M]Z);MM4C$5W-*P#R(H(4?*  !DXP!R2:B_X0S3OM&DW!N;]IM+W&VD>Y+L"P
MVL6)SNRO'/ '3%/TWQ'+?^+]9T*2R$(TZ*&59O-W>:)-V.,?+C;ZFM+4KB_M
MTMC86*W;/<(DP:81^5$3\T@R#N(_N]Z ,N^\&:1J&M7&J2_:DFNH!;W20W+Q
MQW"#(&]0>< D5"O@+14T[2;)#>JNE-NM95NW$B97:5W YVE>,#''3%=/6!>>
M(Y;3QKIOA\V0,=];S3+<^;T\O;D;<?[0YS0 LWA+3WU2YU&VENK&>[C6*Z^R
MR[!.JC"[A@X(' 9<-CO1<>$=+FFTAXQ-;+I'_'E';OL2+Y=O3'/R\<YK>HH
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M>ZG,GDAA@[1TR1QN.3CC-9]Y\/\ 0+^;4WFBN?+U/+75NMU(L+N0 7V [=V
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MW<I\UCUR2W? R1R<<YJ:?P9HUQ?V5\Z70N;2W^RI(EU(A>'.=CD$;USS@YH
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M6*X95EC&< CH/O'D8//6@#F=.NQ<?$^Q2UOKB?3KOPR;E5\U_+D)FC"R!2<
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M$'&,4Z*ZNO#VI>(O"4MW=S7>H,L^C33W#R.8YB(RH).<1-EC@YV\UU%K\/\
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M#A7.-W\.W/OBNJU&WB\1ZK9[RO\ 9>DW/VJ64GB6X0$*H/\ =0DLQ_O #LV
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M&\#ZX&[^'.<'I71Z_+'9:WX6\/6<L4>G7ZW#9F=W6=T1=BLV[+9#,>3R0.M
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MNRK95>1CH*WZY2P\1ZMK,D%]I.GVT^DF^DM)=\I2541BAF&>"-RGY>N,<\X
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MEM(XI'C6)UZ, I'(R>?<^M2V^@Z=:ZS<:O#"ZWUP@264S.=ZCH""<8'...*
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M6)/&!CGC Q0!P/B.QU'P1I/B;6=*U2 23:=OCTVUM3''$ZLJFX4%V (#<@
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M^D[B+F(R132I%%L1E#+GAF(!."0."0*[_P#X1;1_/U*;[-)YFIJ$O&^T29F
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M8R)+;1 <1NARK#W!H XGQ'I1T6U\#0K(ZS_VY;I<>7(P21F5V?*YP1N'&>@
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M#NF7%A964D4ODV3B2V*W$BO$P4J"'#;NC$=>AH \V;Q';G3+&UM[>70TN?$
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MHC9).,GYCV%<]X7T_0M8\,>%?$AO'34%,4DEY"X$MS.XVR1RG!+ N3E>V!T
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MMM%'+-;P/*J2.55MH)P2 ?2H/#.J2ZWX5TK59T2.6\M(KAT3.U2R@D#/;FN
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M&]"00'4\ GC#GUJM=W6GZAH'@*]TV"ZM8AXCCA^SSL0T1S-OC(S@X9< ^@%
M'K5%>?:/!:^*O%'C*SUZW2XDM+F.W@BE&?(@,8*LG]TL=S;ASG'H,<K8&[U?
M1?AW)JMQ<33-JD]MYWG,K30JLH5C@]2%'S=3USS0![717E=II0@U'XA^'M(N
MDTNW/V/[*"3Y44LL?/'8.P ./6MCP3>!/$6IZ;J&@1Z+K:VL+RQVI!MKB)6<
M++'@#'+$$'G@>E '>5'/,EO;R3RG$<:EV/H ,FN,UZY^U?$[0=$OT5M+FL;B
M=(I!E)[A2HPP/#;4W$ ^N>PK*LK)8M2\?Z"8$ET*VABGMK>10T<$CQ,SJ@/
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M100H9))'. J@9))KSBZT30=*T#1I?+NOMNKW%DCQI.<7TJ*2J2[LJ(^I; Z
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M[R3.R,A5GR>6&3R>>: /0**YGQO97]_I-I%IDEH;M;M)$M;S/E7@568Q-CU
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M#30(TCY)"S.JKD]> !^% ':T444 %%%% !1110 4444 %%%% !1110 4444
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MXDA<,5>)Q_$K*0RGW!%(NAZ<FG3V"V^+>X),P\QMTI/!+MG<Q(X))Y'%:%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW@9VYYQZT .HHHH **** "BBB@ HHIH="Y0,-X )7/('K^E #J*** "BBB@
MHHHH **** "BBB@ HIJ.DB[D8,O3*G(IU !1110 444C,J(7=@JJ,DDX % "
MT4 @C(Y%('4L5# LO49Y% "T44=* "BD5E=0RL&5AD$'((I: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y36M1:^\;Z5X60X@:VDU"]
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M>?[*95 BB5@I=W&0 20!@$DGV)&/>?$>QLO#FIZK)IUX9=+N!;7UH-F^!R0
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M<YY4-NQ\X[=C5KPM-XFECM-.U?PO!82VJA+C4!-&Z3!1C,:K\V6XZXQD]^*
M+[^-8_(MK^#3+JYTF>[%HMW#ACDL4\S8.?+W#&[KWQC!J'1_$NJW_C7Q'IDN
MFM]FTT0)&$E0GYD9\G)'+948S@8&>]9/@Z#Q9X;TZ/PG)HHDAM9&2WUC[0GE
M& L2&9,[MX!QMQ@D#) YK4TNPU73/B'XEO6TUY;#4UMI8KE)4P#'$4*%2=VX
MG&.,8/44 1^'?$VAVG@BQO\ 3M,ELK:[O)+:UL%V^8\QF==O7 )8,QYP!GGB
MM2#Q4/[;N-$O-/F@U..V^U0PHZNMS'G!,;$@9!X(;'Y<UQ%EX1\0Q^ ]"5=/
M:+5]$U=]06TDFCQ<(99&*!@Q )63@GN/QKJ#IUWJOC2S\22Z=<VT.G6,L44,
MI02S22$9X#$  +CDC)/H,T 5K+XE0WFGZ+JG]B7\6EZI<+;+=.R8CD=BJ@KG
M<1D<D# SWKK]2NY+'3;B[BM9+IX8RX@B(#/CG SQFO,K?PWX@A^%WAG16T:<
MZA8:C!-/$)H<*B3%R0=^#QTKU93E02""1T/:@#DAX]MFT_PW?I83-:Z](D4$
MGF)B*1@2JOSUP#TSR,4_Q+KUI'HOB)-0T:>]TZPAVW2HR8E!0,R@%AT4@GZC
M&:YB7X>:C-H_B#2RZI;VL\D_A[:>8G<K-GVVR#8#Z%^QK?U;1M4G^%^I:>+;
M[1K6HVDIFCC95'GR@Y&6(&U2=HYZ** ([[Q->V6O>$=+TS2Q]AU""27:)%!V
MI#D1C/0#<IS[8%8FG:HWAKQ9\0)[+1I[R.&>WGDCMRB!%%NK,<L1D]3@9)K4
MOM+UI=2\#ZI;Z3).=,AF@NX/.C5XS)$J Y+8(!7G!)QT!Z4V#2M834?'L[:1
M.$U5$^QXEB_>E8!&1]_CGGG''Y4 =MINH0:MI5IJ-J2;>[A2>(L,':RAAG\#
M7 2ZY?>)?#GCVVU+352WLC<V\8+JP39 I /<MDEL]LXSQ76>#+.[T[P5HMA?
M6[6]U:V44$L;,K89$"GE201QZUR\6CZY9VWCNP&D23)JDT]Q:3I-&%D\R%4"
MX+ @@CG.!CN: )O"?BO[%I'@[2;K2KN&"_L(8;:]8IL>180Q7;G< 0#@D<X]
M.:O:O\1-.TFVN+]H#-IMK<?9[B=)DWJ0^QF6/.656X/?@X!'-9+:+K7]G?#Z
M$:1.7T=XC>CS8OW86 QG'S_-R<\9XINC67B;PW=7VA+X:@U&TDNY9K'4S-&J
M1I(Y?$JGYLJ6/0'/0>M 'HZ.LB*Z,&5@"".A%.IJ*515)R0 "<8S3J "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBLS6]7.CVL$B6DUU-<7$=M%'&.-SG +'!VJ.I..* -.
MF/+'&R*\BJSG:@8X+'&<#UX!KFK?QM9I#X@;5(OL3Z"P%WMD\U"&0.I0X!.0
M<8P#GBN<U^>ZNOB%X#N;S1TM'>><I*)0[A?(8^6_ VGG. 6'7F@#TNBN&E^(
M=P--UR^M_#=W)'HMU)#=AIXU(6-59F')!.&)VCL.HR!5Z+QJ7UK1[672;B&P
MU@-]BO'D7YV";P&0<J"H."?Q H ZA)HI))(TD1GC(#J&!*Y&1D=N*?7%VWB.
MPM+WQC=0:!+%=Z88WO2AC$EUB+<K9SCA,=3GGIGBG6/CQ[FX\/&XT2XM;+7(
MU^S7+RJ<2&/S I4<X(! ;OCH!0!UZ31/))&DB,\9 =0P)7(R,CMQ4=W:07UN
M8+F,21D@XZ$$'(((Y!! ((Y!%<E;^)])T^^\97K:.]G-I7E/?2@*7N?W6Y3P
M<?=P!D]^<5>NO$>I0Z5J%U'I5O(8+'[9;R1W>^&8<\;MH.0!GIW&#0!TJC:H
M7).!C)ZFH6LX'O4NW3=-&I6,L<A >N!T!/KUKB++QS?6'A#PM?:GI4]S/JYM
MH%DMY5.YY(]P8@X()PW'3U(K6A\3ZK-+;V;>')K;498IIWBN+@"*-$8*,RJ&
M!+9! QTSG'< ZBF>=$)A#YB>:5WA-PW;>F<>E<!J?CR\O/#7AC5M$L@(M7U*
M"VD$T@5H_P!X0R< @Y*,N>P_3935+-_B'!87.C"+5/[):?[<65@(O,4&-2.2
M-QSSCITYH ZFBN/N/'L4&AKXC_L]W\/&78;M9,R!-^SS?+Q_J\]]V['.VIKG
MQC./$MSH-AH=Q>745FMW&_GQI'(C,5!W9.!P>O/MCF@#JJ*R/#&OP^)_#UKJ
M\$,D"S[@T4F-T;JQ5E..N"IYJO/XCFEO]1LM(T_[?+IH7[3F<1C>R[A&G!W/
MMP><#D<]< &_T&34-O=6]Y&9+:XBG0':6B<, ?3(KSOQEXJ.M_#FQU/1$+V6
MHW5O%*7?8Z@SJK1,N#U(93^/4&NTTO2+2QEN]2ATR*TO[X*;E8I,AR@(7T&<
M'K@>_2@#4DD2*-I)'5$499F. !ZDTJL&4,I!!&01WKR35M8U#Q/\+/&DVKV%
MNJVTMU'%MDWB-HCM  *CIC.[N3T%=;I/BJ6/5=&T2\TF>U2_M"]G<M(I\TQH
MI8%1RG!R,_H>* .OK(UKP[::[-82W<MPIL;A;F 1.%"RC(#'CG@D8/'/2N=U
M#XFZ980QWQ6"72VN?LS3)=*9E^;9YGE=2F>^<XYQ7:7%O#=6[P7$22PN,,DB
MAE8>X- $HZ>M,,L8F$)D7S2I8)GYB!U./3D?G7SQI-O8-\$M)DT6'_BL6F/V
M22Q3_22_VAOOE>=FS.=W&,5Z9! 8OC1:2RQQ+=R>&G-PT:XWN)XQGWH [ZBN
M1MO''FW&BFXTJ6VM-9F>"U>1\2JRAB/,C(&T,%.,$]1G%5;CXA7"0Z_);>&[
MR8:)*5NMT\:?(J!RPY.3@Y"C/3DC@4 =Q15>PO(=1T^VOK<DPW,2S1DC!VL
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M>N,\5Z7&Q>-6:-HR1RK8R/R)%1SW5O:A3<7$4(8X7S'"Y/MFI0RMG!!QUP:
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M:QQJ%10%50,  =!7E>N>%O%>J:7X@M)=-M;N\FU!9[2^DN@"UNLR.D2J1\F
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MLUVH9 CA"RC'SD$Y(X'H3SC1EUS6O^%IQ:)%!:G3UTLW7,[!FS*BEB-AY&"
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MC:#_ ,"%:U>?Z)X;O_#5_K.H>']+DM+*:S!AT:>Y78UV"267#,L:D8'7GT
MKKM U&?5]!L[^YMA;3S1[GB5]X!SCANZG&0>X(H \XT#6+_PT/&DFD^&VU"U
MM]=GEF$4Z0A$$<9.Q<'<P )Q@?7-=)<?$ RW6BPZ1HTVH#6;*2[M',ZQ!MB@
ME3G.W[P!)Z=LU%8:3KVCS>*;6#3DN/[6OI;JUNA.HBCWHJXD!^88VY^4-FHK
M3PE>Z+X@\')96S7&G:+8S6LTYD12S2*@W!2<]5)/UXS0!L6_B>_OYY[*RT>-
MM1L[>*6^@GO BPR2+N$0=58,V!R< <CGGCEO$>NZ=XFTSP5KEO%Y1'B*"-Q,
MH$D#+Y@=&/;!'TX!K>M](U7P]XWUK5;.R;4-.UE8I'2*5%DMYHUV]'(!1ACD
M'((Z5@7W@&^_X1W2--:QCOBVN'5=302*(]KE]\:[B"W#@#@9P3Q0!V*>)PFG
MZCJ]U;+!HMHC21W?FDM.BC)94VC@\@<\]1D$$YMOX]1O$%AI4UI;M_:$;M;O
M9WJW!5U7=LE  "$CH<D$\9[UFVOA76Y/#.M^"[W>VDO&T6EZ@\JM)'&1E4D7
M.3M. ".H':M;P[=^-9EAM]>TFTM1:K^^NH+H2F\(&!L3 V9."2Q]L<Y !2L/
MB'=WNESZP_ANXBTJT%W]JN/M*,T9@W<!.K;MN,C@$_C70Z/K-UJ<L1:SM_L<
MUOY\-W:W7G1MR!MSL7!YS_DUA>%=*US1O!6IV4FGQC43-=3V\<DJM'+YCLZJ
M2"<=0#G]:;X7\*/HWBR?4=.L)=&TJXM2MQIS3*T;W!8$.BJQ"@*&';.1Q0!T
M6KZZFFWNG:=#"+C4-1=UMX2^Q<(NYV9L'"@8Z G) Q6/)XY-K'K\%WI;IJ>B
MV_VJ6UCG#+-#M+!T<@9'!!R 0>,4_P 5:%J$_B'0/$>E(L]SI3RI+:LX3SH9
M5"MM)X## (S@'UK.U/PUJ.IS>)M9^Q-'>:CI/]EV=JTB;E7#$M(02HRS#@$X
M"^IP #=\-:]J.O1)=7&AO8V,UK#<6\[7"N9=XR5VCE<<<GJ".G2N@K)\,6US
M9>%]+L[R PW-M:Q02)N##<JA200>1Q6M0 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,VG@[Q+;>#]!TB2UM'FTS7%OV9+CAXEG>4]1PQW8 YZ<GM7J=% '!:MX2O\
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M*J0RCGI_3)<^-[O3]%TOQ#?:;%'HE^\09EE)FMDEQY;N,8(Y7(!XSQNJ6_\
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MK02'<R[ ,/@DXY'OZ4 6['5]=N/B=K.FLMJ;&ULX'CC\U@0'+_-]TY8X /0
M =:ATWQM##X;NKY])AM;EM9?3(;."08FN#)L!+;1U.23CH#UJ_%H>K67Q"O-
M9MUM9;"]LH89#)*PEC:(MT7;AMP;KD8]^AY\> =8N/"][9RRVEMJ4>N/K5A(
MLC21A_,+JK_*#W(.,]<^U '2?\)->V7BBWT#4[.W6>^MY)K">&4^7*R#+QMD
M94@$'/((].E8$/Q&U:3PQ9^))="MHM-:]^RW0^V%I$S.80R#9A@#C.2">>,<
MUN'1]1U?Q+I6NZE:0VK:3!,(+=)_,+S2J%8EMH 4*"!W.[) QSSG_"%>(?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"JNH:C9Z382WVH7,5M:Q &2:5MJKD@#)^I JU7->/=;E\.^#;_58K"WOA %+
MPW#X4@L!G&#G!(../K0!TH((R#D&BN4U7Q)J]MXTM?#UCIUI+]ILI+F.>:X9
M0"K*#N 7@?-VR3QTY-<UKGC/7+OX<ZC>P1VUEJ-GJ?\ 9EYL9F7(F6,F,\$9
M##D\CGOS0!WTGA_2)M=CUN33K=]3CC\M+ID!=5YX![=3S[UI5RVH>);JVU)=
M&06XU%;47,TGDRRQ(&8J@"J,\[6Y)&,=\UC_ /"?ZRVG:!-_PCOD7.I7YL)8
M;F1XRD@#$,N4Y0A<[NH'8T >@UGZKHFG:VD*:C;^>D,@EC4NRA7'1N".1V/:
MN4;Q3XL@UVPT&?1=+_M&[LYK@.EZYB4HX49^3(&"#QDDG''6J,WQ)U6T\*ZY
M=W.C6ZZOHEVEM>6PN#Y9#LH21#MR0=V<''3K0!Z0JA5"C. ,<G)_.EKD;CQ-
MJ^FSPV>J65G!=WUPZV7D/),JPJ@9G<!<D@D# ZDCD#FN;\2^,O$#>"/$31V?
MV&[L)HH?M9BD2.XBE8*'BW $-\V#UV^IXH ]2HKF]0U?6+.Y@MFALK=/L[S3
M:A.3]G5PP"1#D'<V<Y)XQT-<MJ'C/5]8\*>#M7TU(+-=5U6""XC=BQR';Y0P
MQ\I,9SW(./6@#T,ZE9#5%TPW40OFA,XM]WSF/.W=CTSQ5JN637KB/X@)HMW8
MV: :0UX;Q')8XD52N"!M7))ZGM6=/XYOD\(CQC#8PRZ)NWM!DBX^S[]OF@_=
MS_%LQT_BS0!W5%<9)XJUF\\5W>AZ386#A;".]@NI[APC*[$ L N1TZ#/U[55
MM_B*DWA;0-4NDM]-;5+A[:2:X):"V=-X.3QG+)@9(Z]>.0#O:*HZ1<7EU8"6
M^CA2;S' ,#%D= Q"N"?[RX/XUR_BGQCJ7AZ#5[TV=K%::<$,2W3[7O\ *AG\
MH@\;0<=&R0>E ';45R.H>*=53Q78:+I^FVLBWU@]W%--<,NTJ5'S +P/F[9S
MQTZU4L_'TQ\.S7%[8Q#5H]6;1EMXI3Y<MSOVC#$9"X.XDC( /6@#K?[6T\ZM
M_90O8#J'EF4VPD!D"# W%>H'(_.KE>>Q_P!H#XUV*Z@+9C_84Q22W#*&'G1Y
M!4DXP>^><]JZGQ#KPT5+&&*)9K[4+E;6UB9MJEB"2S'LJJ"3],=Z +BZGIMS
MJ;Z8EW;2WT*B5[<.&>,9P&([<FKM>;)?3Z5\6=8OM9, CM/#2S-+;J0'B69V
M+;23@_>&,GH#WP-.W\9:H^IZ0ITHS6>I?*Q@@FW6;$94R,5VLIZ$C&/>@#MJ
MSHM"TZ'69=7CMR+^5-DDWF,2R]E(SC [#H*XKP_XLU.ST7Q-J^MM!<1VFK36
MJ)#N!+ADB1%!SA2<>IY)K5MO%6L-X@_LQ]+6YCFM6FANXXIH8DD7K%(64XR.
MC#K_ ': .QHKS>U\>>)KGP0_BT:'IPT\:?)=;&O&$F]&/&-A&, XYYQVSBK\
MGB_7[?5M"MY=)L6AUN)_LP6Y8/'(L?F?O#MQM(S]W)&._< [6>>*VMY+B>18
MX8D+N[' 50,DD^F*;:7=O?V<-W:3)-;SH)(I$.5=2,@@UR-IXLU.2S\56U]I
MUD^I:$ 7CCF80SHT7F+R5)!QD$8/-5SXSU"'2?!DMII%HRZ['&NP3&,0LT.\
M*!M/RC'7L!T- '>45QEEXMU@CQ/9W6CQW.K:+Y;)!8R$K<B1-R %AD'J#Q]*
M?I_BJ^N?%5UX<8Z=-=KIWVR.>!CLC</L:-UR3D$@Y!&1V% '3ZAJ%GI5A+?7
M]S';6L(W22R-A5&<<GZFK"L&4,I!4C(([UY9IOBS6K?X+3>)M0M;+4GVR2M'
M*[*&!F<-D8((&1A>.!UKM+K7YI?$<7A_3EA%[]C^VS2S E(H]VU1M!!8DY[C
M &?04 =!17GE]\1KVS\,:S>?V5 =3T:]2TO+8SG;\S*JR(=OS!@P(!V]^>.=
MBU\2ZK%XS.A:KI]M&D]B][:O:RM(P",%9'R!\WS Y'':@#JZ*Y+PKXKG\3Q6
M=[:O836<Z,;B.)CYUD^,B-P3R>H)PO(X!!S5KQEXBN_#6G6=W:V45T)KV&U<
M/*5*B1PN0,8)Y[D4 ='17%KXE\2#Q9<^''TS3?M;60OK:9;E_*6/?L(D^7)(
M..@YSVI=,\8:IJGAJWO(M*C^W_V@^GW85RT-ML9E>8G@E %SC@\@9[T =G5.
M;5M/M]2M].FO8$OKG)AMS(/,< $DA>N  >:Y*V^(<,>C^(KR^2&;^QKA8 ]F
M^4NBX4Q[<DX)+!<9('K5/6#JQ^)O@0ZE'9X8WK*;<ME&\@Y0Y^\.GS<9]!0!
MZ+4-W>6UA:R75Y<16]O&,O+*X55'N3P*X:Z^(%Y]A75M-TQ[ZP^TF(VT-O,T
M[Q!RAE5@NWMNV^G<'@=3XH /A+601D&QG_\ 1;4 :%K=07UI#=VLJRV\Z+)%
M(IR'4C((]B#4U>6Z%XJUKPYX4\'S7VE6IT"YMK.S,\=P3/$SQJJR.NW;M)[
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MV2=<Y!(SA>1TK.G\?>(5T+7]6CT;3Q#H=_-;W"-=,3(D>W.P[>N"3DX[#!H
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M[M]_VBX1?NAE(VKT&XY.>G?-=G52ZU2QLKRSL[FY2*XO79+>-CS(RC<0/H*
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M<$G)]ACO7HUO,MQ;13H"%D0.,^A&:X(^"]9?PIXLTAI+ 2ZY>3W$;B5]L0E
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MW\<<5VT8,R1'*!N^#W%<_>:/K6I6D5MJMGHNI6DEOLN;.5G5!)GAD8HQZ9[
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MY/7T'?II_$%_9>/[+1+N.V33K^VDDM)PK;WE3&Z(\X!VG=GN!C%8$W@76I_
M.O\ ATRZ>L^J7LMRLHE<K&LDF\@C9DD8Q[^U7?',=MK>F6FE1ZC!;>)(;RWD
MM5MI@\L$N>6VG!V["Y.1T!H Z30M0NM3@N;F80_9_M,D=J8U(+QHQ7<<D]2#
MC';![U@>*O%6JZ%'K%RL-E;VVGVXFM_M1):_(4LZQ[6!7: !DAN3GI76V5I#
MI]C;V=LFR"WC6*-?15& /R%<1K'@[7KZ_P#%0@O=/-IKEF((Y+A7,MOB,IL
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M,,$?44ZD5=B!020!C).32T %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,=4'Q+\=_P!G+9OEK('[0[+L;R.&X!W#VX^M>B53MM(TVSNY;NUTZT@N9O\
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M0<8XV_C[5TU% 'FD7P_\11Z+IVFG5].<:;JZZC%.]NYDN")&<F4[OO?,>G7
MY%;\7A_6M,\3ZUJNG7%C*FKK#O\ M =3 \<>P, ,AP>N,K]:ZRB@#A[CP+-;
MZ7X9T_2YX?*T:_6^D>X)#3O\^[H.-QD8Y[>E#^%_$NE>)=1OO#>K:?%8:K()
M[JVOH'D\F7 5I(]I&20!P3CBNGL==TW4]2O]/L[D2W5@4%R@5AY9<$KR1@Y
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M<'.,_C4I\+>)M(\1W][X<U>PCL=4D$UU;WUNS^5-M"M)'M89) !P3CBNYHH
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MZS'.\H929$*0[Q@YQC)';M[US5A/J]UHGQ(:_OX;B.&>[@VBW*GY;9-NT[B
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M1";L==N[./;=^->9>&?%.IZ5\.XM3OKF&^N[[5)+2V5HBA,TERZ9=@Q&WO@
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M);R1XD\LB>6%'#I$W.T?=4%AU Z G-:DOA_4&^($7B-;FV\A+ V/V<HVXJ9
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M!W8Y9F)XSQP,5T&AV4^F:%8V%S)')+:P)"9(P0&VJ!G!Z9Q0!H4444 %%%%
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MF&/S%;=PNX#.<X##TKM+&]N[SQ%J<:R1G3K01PJ-GS&<C<_S9^Z%9.W4MZ4
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MZ&43P1R@8#J& ^HS0 ^BO.T\7:S:ZIH$5[+:O-J%^]G>6<$>^.V.'*A9AP7
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MGB"U2VD"61"Q;8S'N4>9GHQX)].>U69O!U]+!X5C&J6X.@LCY^RL?/*QF/\
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MC7V7)R3W)/88 [U_$_AV[UZ[T6:"_AMDTR^2]VO;F0R,H9=N0PP,,?6NBHH
MY:[\,ZE_PF U_3M4@MC/9I:7<<EL9,A6+!HSN&UOF(Y##V-9$7P[OHO MAX:
M&M0G[)>K=B=K0G.)3*%QO'\1QGT[5Z!10!S<WA^Z/C:W\3/J$"Q6]@UH\'D'
ME68.S;]_'*CMTK'L(M$\6^/[;Q+H]T+J"RM#'/+"Q\J64D^6#ZLBF0^VY*[O
M()*Y&1R13888K>,1PQ)%&.BHH4#\!0 \D $DX KRCP#H5SXD^$FF:9<WEO\
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M/XTL/$+W\ %K:/:M;BW/SARI)#;^.5&.#3O%WAVY\2V%G;6]]%:&WO(KO=)
M9=QC8,!@,N.1S70T4 <KXH\*7NL7NFZOI6J_V;K6GAE2?R?,CE1\;T=">0<
MCGBITT;78[6V<ZW%-?K<>;<M);$0S)L*^4J!OD49!!R3D9.<XKHZ* /)_%OA
MN/PUX9MTMIH()K_Q/:W6(XML,+LZC"IGH-H)Y&3GIV[23PM_:FK2ZCKDD-PS
M64EC'!"A5$CD_P!8<DDEFP!VP!WZUNW-C:7FW[5:P3[?N^;&&Q],U,JJBA5
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M.UN;F!;>\BG@,L<X7[C8#*0PZ9S@CC'>@#DI?'7B";P[:R0_8H=2M_$*Z)?
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M1PH+60#*,@23<R$\%3DC^]3V\"QS7?B-+B_:32]=^>>S$0#(YC"$B3/3@$#
MP0.3TIWA[POKFE"*+4?%,FIVUHI6TC>T6,@X(4RL#F3 /MZGG& #G]&UOQCJ
M7A*Z\0MJNG(MHM\K6YL21*8F<(V=X*_=QCGCJ3GB(^)_%FFZ+X6\37EY97.F
MZD;2*\LH[;:T8F48D5\\G)R1@#G'O6TF@/X3^&^NV-QJ$=S'Y%W,LGD^5M,@
M=B#\QSRQQ57PEH4VN>!O"/V_4()]/M+>UNDABAVL[H@**[;B"%/8 9*CIR"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\I(OLL'EIG:GEC"YZX':@#FO"&KZ!>W5VFGZO::GJER?M5[+;-O48PJKD=%
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MGT)/2N_&@ZZ)O.'B"V\W^_\ V6F[\]U(/#NMK=F[&NV@N2,&8:5'O(],[LT
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M* "BBB@ HHHH **** "BBB@ HHHH *KWM_:Z=;&XO)TAB!"[G.,L3@ >I)(
M Y-6*Y#XA:I::5INE37<$#(VJ0*MU<@F*S;DB9L$=,8&2!DC)H VE\2Z*UA<
MWIU.WCM[1BEP\K^7Y+==KAL%3R.#4,?C#PY)>+:+K5EY[PF=4,H&4"[B<GT7
MDCJ!S7F9U&R"_%:-M1-P9[!'CEE4*90;0J&& !@G ! YXQG.:O7EQIGV7X6
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M!"S?\M)//0[%]3CG% $?ACQG;V::S%XDUZ+S8M<N+.V>X*(3&I4*,*  .>N
M,FNRU'6+#2D#7MRL65+!<%F*CJ<#)P,C)Z#->0SW.GR?#3XF%9K9GEU>\P0R
MY?)79]><X_2M>ZU[3]'\:Q7>NZA<6NEZEI-LME?Q2L(MZ%R\99>YW@\T >GV
MEW;7]I%=V<\<]O*H:.6)@RL#W!'6N*M-?GUWQGKFB'79-)NM/E5+6SCBB+3)
ML#>:?,4E@22,+C  SUS6[X/L=+T_PW!!HL$T.FEG>!9F8EE9B=PW<@$DD>Q]
MZYCQ%:>#/&<U[;ZW/#IVJZ9,T<=V)A!/&!R'1CC<O/N <]Z .GTW59-.TZQ@
M\27L":G<3O K;?+69][!0@]U (&<XHUK687TS6K;3M26+4[&U>5@@5GB.TE2
M58$8./3FO.)+[5/^%>^$]1\07+RQV7B.!VOYE*E[97=4F?/0$$<GL0>]:7]I
M6>I^.O&'V&87 N- B$!C!(FP)>4/\0Y'(X- '1>#_&FE:AH^A6-YK=K+KMSI
M\$LD+2 2.[1ACQTSSG'7VK?FU_2[>\%K+>(LIE6#&#CS&QM3=C&XY'RYSS7F
M"PV.M_#3P5I>E-;RZQ!+9.BPD%[9DVF9V Y7 #9SW('4BK5[=3Z1K-U?:%J<
M&HV,^LJE]H-T 9HY_- ,D)'(.0'P>, GZ '>Z?=V]QXFU6.'75NVBCB633UV
M$6A^;DD<Y;'0^E<YXO\ %BQ7?AV+1]8VM<:U;VLT<:*4GB+X<!BO." #M/&2
M#63>2S7'C'XC6VDSH=3DT>!+=8W&\R".48'N"5^F167>^)-!OO!7@.*VNH%F
ML=6TY9[;.)+8Q_*^]>JX(/)ZT >F6=Y;3>)]22/7EN&AAC$FG*4(M3EOF)'(
M+>A]*FL_$FC7]RMO;:A"\KQF6,9($B#JR$\,H]1D5Q$FHV</Q#\:R^6E[LT.
M%FM8V&Z?:)2R >N"!^(K&TW6].G\3?#N\BU&![86US$(;9/W-J3 @6$'!8L,
M $,2> <#- 'I$?C3PS-<Q6\>NV#RRNZ(%F!W%!EN>G [T:#J-G'X;6]?Q FJ
M6HDD_P")@Y0*W[PC:-N <'Y1CKBN;^&DNFRP>)ID>U9D\07LI<%254MPV>PQ
MGGTS7'Z=?"V^%N@:C&TLNGZ=KTTVH"T8EXX3+, ^!S@%T;\C0!Z];>(M(N[>
M[GAU"$I9G%SN.PPG&?G!P5X]1S4UCJUCJ,LT5K/OE@VF6,J59-V=N5(!&<&O
M/+E?!.L:;K6J6FHWCP74,$%YJT<[D1GS%\KEN,J<,?0#GK5WP_XCNM%NM='B
M74+*^M-.M893KEK'CS(R7PDBKD;QDG"]F'K0!Z'65_PDFC?;DL_[0A\YYC;J
M,G:THZQAONE_]G.?:KMC?6VIV%O?6<RS6UQ&)(I%Z,I&0:\4O=>TV\T72)XI
MHM/CMO%$3S:7&G-H!<-N>9B"0QY;JJ_-@ XS0![#=:_I=E<-!<7B1NK*C9!(
M5FQM5B!@,<C )R<CUK2KR?7KR72]3UC5O#^IPWD;W<0U+P]>*-TLA"*&A_B5
MBNS QC(]L5W?C.+4+CP3K<6EAS?/92K"$^\6*G@>_I[T <_XJ\6*FI^&8M'U
MC'VK6(;:>*-%*3Q'=OPQ7G! !*GC.#74ZAXBT?2I?+OM0A@8%0Q<_*A;[NX]
M%SVSC->8ZCXFT#4?#?P_%E=VX>UU>R66 $;[;:CJRNO5<$8YZXI\>H:!'J/B
MCPYXPNKRWGN]0EEC@WR!;VWDQY>P+]XX 7 YX'X '?R>,-,3QBGAOS/]*^S>
M>S$' )=551QR3DGVQ[U<E\1Z/!?QV,NH0I<22^2@8X!D_N;NF[_9SGVKCH)K
M72/BUIL,VZU2;PW';6T<K%F9UG_U8/.Y@,9Z^M<YX>NO#VH>'HO"WB62_;Q!
M:7)633/-D5I9Q(661,<8).[=G R2>.: /3)_&?AJVN6MYM<L5F69;=E\X<2-
MT4^_\N],D\<>%XHUD?7K 1M,80XF!7>, C/3J0,]*YWPO)IUQ\3?'67MI9/-
MLF&2I.%A&2/HP_ BN4>YT]_A5\1MLUL3)JU^5PR_-E\ICUSV_2@#UBW\1Z-=
MZQ+I-OJ=M+?Q*6>!7!8 '!^N#U].]9]AKNE6MOK&H7'BBWN[**[(:1W01VAV
MK^Z##KCKW/-<UJ-Y8+XW^&_DW%L$\FZ V.N-I@  X[$C ]ZPY[VR;P=\5E6Y
M@.^]N"H#CYLPH!CURP(^HH ]/L_$^AZAJATVTU2VFO1'YGDH^6V]S^&>1VIT
M_B/1[6^2SGU"&.=Y!"H8X'F'HF[H&/\ =SFN%N;O3T\4_#'R9[94$%RHV.H
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MJ!\'<3/G !]5)/N#Z4OBF+4?#?B^WUC1;<N-=B&F7"*.$N "8)B/0?,I]@*
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MR0 >^0,DFM#4FT]?V=C+$;8%M"BBW+MR7V#Y<^NXGCUS0!Z'/JMEIMG ]W>
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MY+A5M;O1)H8)2#B5_,C(5?4D#(QU[5Z/0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2%0PPP!![&EJO>WUMI\ FN9-BE@B@*69F/1549))] * )]HR>!SUHVC
MT'Y5PWCKQ$X\'3:CH>IS6\EM?P6\VV/:<M*BLC!UW#A^V#72Z;XET;5[ZYLK
M#4(9[BV4-*BY!"GHPS]Y?<9% &I@ YP*18T1F9452QRQ QGZUE6?BC1K^\@M
M;:^5Y;E6:WRC*LX7[QC8C:^/]DFN;TJ_U2?5_'=G)JMRPL9(Q:2%4W0AH ^
M-NWJ>X- '=;5]!^5<UJ^B:W)KZ:KI&I6:K]F%N]G?VQDC W%BR%64J3QGKG
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ME+8Y;YN!D%NX)[4 ;>T>@HVKZ#\JX#QGXL16T%='U::-IM:MK:3RHOW5PAD
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MKVH [T    8 I,#.<#/2LR#Q'I%UI-OJEM?1W%G<MMADA!D,C<_*JJ"2W!X
MR,'TK-US7=(N/#5Q.?$#Z5%YPA-V@V2)(K E KKG/8C&>30!TNU?0?E1L4DD
MJ,D8/'452U#5;+3S'%<3NLTP8QQQ1M)(P'5@B@D@9&3C R,]:X#0_$27O@#6
M;O5O%<UI$-5N((-4!0.(UD&P*-N#D#& O<T >F8'' XZ4M9NHZ]INDR>5>7)
M$HB,QCCC:1EC'!<A 2%]SQ4-SXJT&SBLI+C5K1$OEWVS>8")5QNW#';'.>E
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MB1R#:_ED LIZC/;/J.?0B@":.1)8TDC8,C@,K#H0>AIU-1%C1410J* %4#
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MURQ-,B"-B"@(!.[&!R0.3W'K5NN+\'ZC=WVB7/BO7+=K:X:W$31!=Q1(0=Y
M']Z3S",=1LKI-#UNQ\1:/!JFG.SVTX.TNA1@02""#R"""* *G_"6Z+Y>IO\
M:GVZ6<7O^CR?N>,\C;Z<\=N>E6$\0:;):Z=<I-(T.HL%M6$$G[PD%A_#P-H)
MR<# )Z5R/B#3;ZT\>9T^!VM?$MG]BO'4<0O'_P M3[^4T@'J56E\ :=J-K/-
MI6H1O]F\.2RV=E*__+97PR-]5B*K_P "- %T^*M)T;0O$FN0:G>ZO#:74AEC
M"EQ!($4^4F%&$'!SR!DY-4-;\2RC6/!5^M_<VEC=SR+=P.C1(^(&;D,H8\XQ
MV/%8@1KWP?\ %&WM4:6:>]NI(D0$F13"@#*/X@2I&1UQ5_4-3L[_ %+X=SQ,
MQACG9G9XV4*/LY4,<@8&XXSZT =QIGB;1]7LKN\L[U3!9NR7)E5HC"5&3O#@
M%>.<D4EKXFTF[O4LX[B1;F6(S11RP21F9!U*;E&\#_9S7F.OV5[K#?$ZTTA3
M+<S/92Q1K_RW6-$\Q5_O?=*G'?CO71ZQ=6WC+5?!T^B2;YK34!>7# 8:VA$;
M!TD_N,Q*KM/)Y]#0!T[>+]"71[K5FO2+&TF:"XE\F3]TZG#!AMR,'@Y%5KCQ
MC:0>,K7P\(+IGFM&N6E6VD91\R*H! Y'S')Z# R>:\VU.\2U\#?$/0I([C^T
MY-2O)TMUA8DQ2.K*^<8VD=\^W7%=5)>);_$WP_?RQ7*VUSH<EM$WV=^93)&V
MTC&0< GG% '3^+O$D/A/PQ>ZS-#+,($)2.-"VYOX0<?=&>I/ KG==\0O;>,_
M"%P-0NK;3+H7@N+>6-HE8I%E<JRAB<G@=^,"M#XHVT]W\,]?AMXGEE:VR$1<
MDX8$X'T!K(U;4[/4?'?@&\@<M;C[8Q=XRH4-#M4G(& 3P">IZ4 =?IWB?1M5
MTNXU*TOD-I;.T<[R*T9B9>H96 *D9'4=Z=8>(M,U+4)M/MYW6]AC$KV\\#PR
M;"<!@KJ"5SQD<9KRZ_CN[JV\=MID,EU)%K5K?"WA8AKB*/RB^PCD_</([CUK
MK?"]]X8\0ZW%JVC6M_/>0V[12W=V9QY"DY\K,AP6)[#.,$YZ9 .KU#5K+2_(
M%W,5>X?RX8T1G>1L$D*J@DX ).!P!6>_C+P_'HYU634HTLQ,;=F=65EE!VE"
MA&X,#Q@C-9/C75$T[6_#BS0"&&::8'4Q;^:]H=F J<$*SYVY(/ /'IY[?RI'
M\,O'$$D5W\OB+SB+B!PS(UQ"03D<DC/'7VH ]7T_QKX<U34;FPL]5ADNK:,R
MR(0R_(/XE) #+[KD547XC^$6:T UN$K=N8X7V/L+;BN"V,+R#C)&>HXK-OXK
M?7_B1X7U#2'CGCTR&Z>[N(3E51T"I&2.Y8D[>H )KC---EJWP+N= @6.?5;J
M>>.&T _>-*;EBKXZX'!+= %//% 'IFI^.O#6CW5S;7VJQQ36H0S($=B@8X&=
MH/?\N]6K_P 4Z-ICSK=795;<@7$BPN\<!."/,=053@@_,1P0>]<OHGEP_%S4
MHY)%DD&C6T E(^^ZLY< ^O0D50T2[BT?3?%^A:^"M[->W<\4;J2;Z*890QC^
M,G[NT9(QB@#NY?$6E0ZQ:Z4]R?MMVADMT$3D2J!DD,!M( Z\\47'B+2K07IN
M+HQ+9,J3EXG 5FQM4''S$Y& N2<CUK@KS0-4T/X8^&=1,;RZWX:2.Y:->6:/
M&)H<_P#7,D?\ %:GB2:71O!$=[=Z<D\]W?PSW;2PF86A=P?,*C[WE*%4?[HH
M Z:'6;+6HM0M+"\FBNK8!9E,31RPEAE3MD7N.0<8-9GPVO[O5/AWHM]?7$EQ
M=30%I)9#EF.X]:YWPU>V\'Q"\4S//>2PW-A:21W5S"RB1563<V=H4#D < 'M
M6S\*#M^&6AQ,"LD4)21&&&1MQX([&@#?U#Q%I>ER2QW,[[X8Q+,L,$DIB0YP
MS[%.T<'DXZ'T-87C?Q:FE>%K>\TV9I#?S01P7$$32J$>10S!E!&=K';GJ>@-
M9^BWR>'?&WBR#7I!;K?W$=W9W$W"3Q>6%V*>[+MQMZ\\"N:N-/GT+X0:+8WJ
M/%,VKPW$=LRG?%#]I\P CJ-J$$^G2@#TO1+(V/VV]34M1N;&YVR0VUXKE[?
M(8+O'F$'@X/3''6N.U[QM)KGPU\2:GI$M_IT]B95BD$#1L0C;>69< DYX!W#
MVYKTJ.1)8UDC=71AD,IR#^->,33B/X3>--(>.9;Y;V\!B:%@27F)0 XP20<C
M&>,F@#TS2O%6CZA?1Z3#?"34! )2A1@'48!*L1M?!/.TG%23^*M%MKR*VFO"
MC2S_ &9)3$_E-+G&SS<;-V01C.<@CK7*ZA<V\GQ \!O!*AC6TNU9TY5=T<80
M$]LD$ 'J17/>&I=&ET2#PCXCTW5)_$%G+L-B[W)CG=7)652#L"=&W'&.3Z9
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ML4MY7FQ[$E('\*DG)[;J33DBN?B=J7B2TG3^QUTB*UEN P\J:;S&;(;HVU,
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M-@(&DP<@.V]ACCD*%KI** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZOX+S25M))+X-&$>*11D&(*.5/(PQ)'K5+2;WQ-K.EZ#K]G=6QAOF2:ZL9%
M2.V<$_(P&XR*-O4X)SP* .RHK@XM?UG7M UO7-(O$M_L%Q/%:6K1*R3"'@^8
M3\V6(.-I7 (ZT:5XQO-8\0^%S WEZ?K6ERW;P,H+1.FS@-C.,L>OI0!WE%>7
M:CXP\0VO@CQ;J,%W;FZTC5WLX7DMP=T0:,#(! W?.><$>U;R:EKUEX_@T6]U
M"">VU'3YKB+R[<(;:1&4<')W##=^X[=* .R#!LX(.#@XI:\J\,ZKK>F?#2[U
M<7%WJ4O]HS"4+"KR)']J99)% 'S,%R0.@QTP,5V7A'68==M;F\M-:BU6Q,@$
M$@14DC^4;DD  PV>>@X(X[T ='66_B"PC\20Z S2B_E@:X53$P0HI )W$8/4
M< FN<\5^*VT/Q%%97U]+I&GSVH-MJ)@#PM<%F!25B#M  4C[N<GD8JAJ:ZA<
M_$GPR(+N".\DT2XWW 3S%!W1991D \].W.>>A /1J@O+N*PLYKN??Y4*%WV1
MLYP.N%4$G\!7"Z9XDUVY\*ZB9KRQ6\T[67TZXOI@(E\E) &E"]-^UN%Z9QUZ
M58T;7[S4KOQ?I5S-)/!IT<;6\T\'DRLLL3,0RX7H0<':.#0!L'QIHRZ3H^I&
M2?[-J\L4-HP@8[FD.%#8&%_$BMJ\NXK"SFNY]_E0H7?9&SM@=<*H)/X"O)E_
MY)-\.?\ L)Z;_P"AUZMJ?_()O/\ K@__ *": &:1JMKKFD6NJ63,UK=1B6(L
MNTE3TX[5=KQO1]5\2^%_AEX:\0QWMI-I$,5O'<Z=]FPWE.P3>),Y+Y8'& /K
MCGI[W7O$>KIK<GAV*;SM.NGM;:,)"8IY(P-PE+L&&22!MQ@8.3G@ [VBJMI)
M=W&EP2SPK:WDD*L\3'>(I"O*G!^;!XX/..M>8'Q;XL3X='Q8VH69>SO6BEM1
M:X6X07/E8+9RO!&,>G).> #UFBN.@U37-/\ B%::/J%]!>6FH6,MPBI;^7Y#
MQLHP#DEE(;OSQ63%XJUJUU3PZEU>PW$NH7[V=];P1!K>$X<J(Y0!EEV@$%F[
M\"@#NK?5(;G5;W3DCN%FLQ&9'>)E1MX)&UCPW3G'2KM<3!KVMR>(?&NGFYM<
M:7;V\MD?LYPN])&.X;LL?E ZCITK(L?$_B5=*\%:W=W]M+!K,\%K<6BVP7'F
MHQ#A\YR"O3 '..V2 >F;AN*Y&0,D4M>>>'WU@>*?'4B:@;J6UF18(;@*L;'R
M R*2!E5!;M]3DU)H_B;4CXMT73);\7\&HZ?+--(( L:31["?)< !X_F(_BZ#
MYJ .RT_5(=2>\6&.X0VEPUN_G1,FY@ 25S]Y>>HXJ[7FD_BWQ#'X*\:ZB+JT
M^VZ-J$\$#_9OD\M%0@;=W7YCR2:TXM9UZP\9>'[2_O;>YL]:M9V,*6^S[.\:
M*^0V<MD$@Y^H Z4 =Q5:_OH-,L)[ZY+B"!#)(4C9R%'4[5!)_ 5P=OXB\5ZS
MI.G:_HEE-/'<3AFLG$"PM;%B.'+[Q(!SGIGC;5BZU;4/$^D^+9+&]%G:Z:]Q
M8Q1B)7\YXX\R-(2,[23M 4@\9R<X !V6EZE;ZQI-IJ5H6-M=PK-$6&"589&1
MVX-4=9\3Z?HGG"<7$S6\(N+A+:(R-#$21O8#MP??@\<&JGP]_P"2<^&_^P;;
M_P#HL5SND_:+/XG^,;JXU*0PVMI9RRCRE^=-LIV].,<].M 'H5O<17=M%<P/
MOAE02(V,94C(/Y5)7G%UXKUR'X>P>.HYHWC(6YETPQKL^SLV-JOC<) I!W$X
M)!^6K$^J^)]5\:ZCHNE:K96=LFGP7D$KV7F,N]V&T@MSD+UXQZ=P =_16+XK
MUQO#OANZU)(Q+*ACCC4]"[NJ+GD<98$\CZUE6=SXM@\1")K2:ZTF6U=FEN_(
MC:&<<J!Y;$E&Z<@D>IH Z^BO.],\4ZLOB7PQ8W%]'>#58[A;P1PCR(98X]^(
M9 !N (*GEOJ#5S3]5\1>)M A\0:)=6R"6\98K&=0(FMTE*-N;!;>0I;@@#@8
M/4@'26/B"PU'6M1TFW:4W>G",W"O$R ;\[<$@9^Z>1Q6I7FRPZK/\2/&RZ5?
MQ6,HL[%O.> 2G(23  )QCU//]1UG@O6I_$?@S2=7N41)[JW5Y @PN[H<>V10
M!'/XWT*VU.YTZ2:[-W:H))XTT^X?RT/1B50@#WZ5KZ=J5EJ]A%?:==175K*,
MI+$VY6K@+>YN;7XS^)'M;"6\D.EVV$CD1,'+8R6(X^F?I2:!HFL^!_"D4$MY
M96LE_JSW-ZRMN%M'(/\ 5P@CYWRJ@#!Y8X!H ]*I"P498@#U->8S>,M=C\%>
M,;R"XC-WHET\<$]S:[6>/8K#>GR@/\W7 ''W:3Q>OB:/1M.N+O7D\J[U>P"0
MVUJ$\M6=<J6))<;L'MG'/'% 'H<NJ0Q:Q;Z8T=P9IXGE5UB8Q@*0""_0'GI5
MVN2EU;5;/XB:3HDEW%-8W&GS3O\ N0LA="@R3G&/FZ #\:J:7JOB/Q+H%CXB
MT:ZME2XNLBQF4",VPD*G+8+>9@;L@XSQCN0#JXM4AEUBXTQ8[@301)*SM$PC
M(8D !^A/'2KM<?%K6LR>./$&C_:;806NGPW-KFW/R,Y<'=\V6^[V(KD_^$O\
M86O@'2/',][8S67[HWNGI:X+1N^PL'SG<"1@8Q]<<@'KE%>=^,O$^M:';Z_>
M17L*/IZQRV=I#$)A)'@%FN.,ID[@.5Z=ZO:AK&O3>/;'1;&]M;:SN]+DNMS6
MV]XV5T&>6PQ^;CH!GG.* .U9@JEF( '))[4M>0ZSKFMZG\.[G[3J/EW=CKZZ
M;/-!$J"Y5;A4!(YVY!!('7'ID5ZS!'+%;JDDQFE P9&4#<?7 XH KZ=JD.IF
M[$,=PGV6X>V?SHF3<RXR5S]Y>>".#5VO,KGQ=XBB\">,M3%U:?;M'U*>WA?[
M-\GEH$P N[K\Q.236O'J^NV'CC0["_O;>YL]8M9W$,=OL^SO$$;ALDL"&P<_
M7CI0!VK,%4LQ  &23VK,E\06$7B.WT%VE%_/"TZ+Y3!"BXR=Q&#U' )KG?BM
M)=P^!)Y+2\DMC]HMT?8!^\5YD0J2>WS=NO3IFJ6N6^H?\+.\-007RBZ.FW@-
MU+$#@;H^0@P">WIWYZ$ ]#HKSFQ\::K#H%S#=F.ZU2+7VT2*=(@@D.01(4R!
MG;GC(&0*WM"G\3+XBO+74;::31S LEM=W'DK*LF<-&PC.",<@X'<'- &CK?B
M;2O#IMAJ<TT7VJ588-EM++YDC9P@V*?F.#@=31I_B;2-3FNH+6Y9KFU7=/;/
M#)',@[$QLH?].:Y;XK,R0>$&1#(R^)[(A 0"QR_'/%6;3P]J>H?% >++NV6P
MM;;3_L4,)D5Y9R6+%GVY4*,\#)/% '2Z%KECXCTB/5-.=WM96=49T*$E'*'@
M\CE3UK2KS#P=>7MC\+-.DL[BVME;4YTN+B=@/*A-U)N* \,_0*#G)/0]*F_X
M2[6ET3QQY-RKSZ$/-M9[NT*.Z&'S,.GRX/4 X';B@#TFBN M==\06NO^$A?7
MUO<6FNPNLENEN$\EUA\P,K9R<X(.<#T KOZ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHJIJ6IVFD6$E[?3"*!, M@L22<  #DDD@ #DDT 5]
M!TG^Q=&BLFF\^8,\DTVW;YDKL7=L9.,LQ.,FJ*:3XEBT>RMT\3127\,K-/=3
MZ<K+<(2<*45EVX! R#V]ZGMO%%A/J=OILD=Y;7MP&:**YMG3>JC)()&WCTSD
M9''-;(96+!6!*G# 'H<9Y_,4 9FF:/\ 8KR[U"XF%QJ%X$6:54V*%3.U%7)P
MHW,>23ECSTQJ44BLKC*L&&2,@YY'!H 6BBB@ K@?&2V]WXFT>:2^O;=]'G^T
M)'%H=S<K(S+C!D0;<8/;H:[ZB@#SB[NM,_X2R/Q'I5WJUC>/#Y%[&?#UY)%=
MJ/NEEV AEYPV<XXZ5G110Z?K-]-H_B'7[#2M0G:XNK$>';ER)&^^8I#'F/=]
M#BO6*3<H<)N&X@D#/) __6* /'[?Q39K\5M5ETVZN($_LNW@$4NC74S$JS]8
MU"NN,CD\'/Y7IK/P]_95A':W&N0:I8WK:A%J!T*[8M.Y)D+KY8RK9(*@CC'/
M%>GB"%9/,$48?KN"C/YU)0!YR][IUQ<ZCJ-W<:D^J7=E]@29/#MZL<,622%3
M:222Q));L/3F _V/-\-SX.N;K6'C%H+5;J/P_>*0J@;25V')&!GD9]J]-K O
M/%^GV=UY1ANYHENULIKF"+?'#,V,*V#G^)<D @$X)!H YO\ MIOW1?5;^X!M
MC!<Q7'A>[:*;GA@H4;<<C&3D$Y[8U/"^D&UT?0K?0]4NX-,T]I5N(+FP:-KK
M=DXQ( R ,Q(P.G':M;7/%&E^'9;2/46N$:\E$-OY5M)+YDAZ*-@//'2C3_%.
MD:G->6]K/*;JS4-/:R6\D<Z ]#Y;*&(/8@<T ;-<UXE\+W.OZMHM['J4=L-*
MN?M*1FV,GF-C&"=XXP3T%:>@:[9^)=$M]7T_S/LMQN\OS%VM\K%3D=N5-:5
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M ZT 6(=0UVQ^(::)=:I'=VU]ILEU&#;*@MY$=5PN#DJ0W1B3QUKF(?%'BI?
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M+.,O./*$BJXQM &<$@ GVQST\WA)GUO0=1BU%A_9"S!5ECWM.91AV=LCD]>
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M:+>19TJ*_E:R\GS-TI( S*<;1M/0$DD=,<[OA1M>.@QIXD2,:C&[(SQE?WB
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M^)Q73T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?JVGW%^MJU
MK?/9S6TXF5U0.'^5E*L#U4AO8\<$5H44 <;?_#^WO],U&U>^:*;4KV.]NYH8
M0-SIM*A5.0H^09SDGGGFKM[X174/$3:O<WSDOISZ;)"D856B<Y8YSD-GH>U=
M+10!Q%I\.VMET /XBU"4Z&Q%H?+B7$10IL.%Y.TXW')XXQUK3M/"KVE_K]XF
MHL9-:*F4&(8B*IL!7G^[ZYYKI** ,KPWH@\.>'K/1TN&N(K2,11R.H#%1TSC
MC-9NI>$#JUO=V%[J+3:7=7(N6MWA!="&#[4?/"DCT)Y.".U^S\1VU[XFU#05
MM[B.YL8HYI'D4!'5R0-N#D_=/4"MB@#CKKP)(/$=WJVD>(-0TE;\AKZWMU1D
MF8#&Y=X.QB.I'-7Y_"4)\1:=K%I?7%F]G:&R:*,*RRP[@P4E@2.5'(Y]ZZ*B
M@#/US3#K6B7NF?:# EW"\#R*H9@K @XSQG!K&N?!4-UH6D6#W\JW6CM&UA?1
MH!)&44*-PY# @88< ^U=36/K7B*VT.]TJUN+>X<ZE=+:Q21J"BN02-Q)&. >
M@/2@"LWA<S/J-W=7OFZG?6@LVN1$%6*'GY43)QRQ/).3CL *A/@NWE^'Y\(7
M-Y-):?91:K.%"R! !M/H2,#ZUT]% ',-X2GEUC0]4N-9GGN=)64*9(4 E\Q0
MK;@,8X QC&.^:MZ#X=.B7^K7?VUISJ=S]ID5HPH1]H7Y<=L =<UN5#=W M+.
M:X,<DHB0L4C +-CL,T 8^J>&5U'Q'IVMQ:A<6ES9Q20,(@I$L;D$J=P..5'(
MYK.'@;_B5>(]/.J2&/7I9);AO)7,9D4*P3GI@#&<UN^']:M_$6@V>L6J21V]
MW'YD:R@!@/?!(_6I[[4(;&TNIRKS&VC\V2*'!?;SV)'H?RH YC4/ +7$FE7M
MAKEWINKZ=;"T6]@C4^="/X71LJWK]>?3'2Z7IXTRQ6 W$US*27EN)R"\KGJQ
MP /;     ' IFAZO!K^A66K6R2)!>0K,BR !@",C."1FM"@#A]0^&\5];:_9
M#6[Z'3]9F-S+;*J$),=N6#$;L94?+D=*U8O"TL?BBWUYM5EEN(;$V.V2)<.I
M8.6.,?-N Z8&.,5T=% '&GP"K>&=;T-M5E,&KW,MS/)Y*[T,ARX7MC.,9!QS
M^%R7PD1J]EK-GJ#6VJV]K]CEE\H-'<Q9R Z9'(/(((_+BNFHH Y6]\"V-YX:
MO=)-U.DUY=?;9;T!?,-P'#!\8QP548QT&/>EM?!]Q!XE3Q!-KUU<:@+$V3%H
MHPC@ONSM X&<<#!XY)S74T4 <4GP\2/P=8>&EU:;[-97*W,<IB7S"5D\P ]L
M;CZ=*T9/"(;Q#J&KQZG<PG4+5+>Z@C5=DA0,%;)!88W'@'GBM>VU![C4[ZS-
MC=0K:^7MN)$ CGW#/R'/.WH>!S5V@#GK7PNW]K:;J6I7YOKG3(I(K:0PB-SO
M #,Y!^8X'; Y)QZ6/$GANV\26=O'+-+;W-I<)=6ES#C?#*O1AG@CJ"#P0:N6
MVH/<:I?61L;J%;7R]MQ(@$4^X9^0YYV]#P.:NT 8MGH+0ZK+K%W=BYU1K86J
M2^5L2*/.["ID]6P3D\X'3%,\+>'#X8L)K-;Y[J*2XDN,R1A6#.VYNG&,D]JW
M:* ///$<A?XO>'([?4(K:>.PN@2ZAQEBF%9<@\@$@ @\5J7_ (!MK_39XVU"
MXCU*:_CU)K]%7<)X\;,*>-J@ !3V[DY-=?10!R"Z-;^$]1U7Q;?ZS?SK+;1B
M\4PJP;R\@,%1<\!CP..YSUI?"FG6%UKNL>++2WDB34S&D)D1D+HJ@-($8 KN
M( Y'(13WKKJQ[GQ';6OBFQT"2WN/M%[#)-%+M'EX0#<,YSGD=N] $.B>&SHV
MIZQ>F]:X_M2<3RQM& $;:%^7';  P<UFV_@""VTB;0$U"8^'I93)]A*#<BEM
MQB$G7RR<\8S@D;J["L=/$5L_BY_#?V>X6Z6S^V^:RCRV3>$X.<YR?3M0!#)X
M;W>,8?$27C))%9FR6W$8V>66#'GKG('X=J=X;\._\(Z-2 O7N1?WLE\^^,+M
MDD.6 Q_#QP/UK<JGJNHQZ1I-UJ,T4LL5M$TKI" 6*J,G )';WH QM5\(F[\3
M0>(=-U.?3=16'[-,T<:R)/%G(5E;N#T/\ZS?^%:64F@W^EW&JW\INM0;4HKD
M;$DMIRVX.A51S]??&*ZO2=1BUC1K'4X$=(KRW2=%?&X*ZA@#COS5R@#E$\$K
M>Z'>Z=XBU>[UIKN'R&FF5(_+3.1L5  #D Y.22HSTJO%X$NVN-$FOO$]]=-H
M\I>W/DQ*Q!0IACM.XX.">_L>:[.B@#BKWX>BZ7Q!;1:W=V^G:VSRSVJ1H0LK
MJ%9@V-V#@';GJ/3(+[_P"9KG3-0T[7;[3]6L+86?VU4C<SP]=DB%=IP>1Q^=
M=E10!S.I>#8]0TS3;<:G=Q7=A>K?)>G8\CR@,"6!&TY#'C  X P!BID\,;?%
MJZ^]_)(XL/[/,+Q@AH]V[)/]XGOT]JT]2U!]/6V9+&ZN_/N$@(MD#&,,?OMD
MC"CN:@U37(M.NH+*.WFO+^XC>6*UA*AF1,;FRQ  RRCKU(]Z ,.V\ 06VCR>
M'UU"9O#SR^8+%D!95+;S$).OEY[8S@XW5HIX;>+Q;=>(8[XB:>T6T\DQ HJ*
M2RD<YSDFM+2-336-*M]02VN;99ESY-U$8Y4()!#*>AR*NT <GH_@RXT#3;"S
MT_6Y0+)YF4RP*PE$K;V5P",@-R,$'I5>Z\*7FF:7;V^@ZG=6MV^I-?3F&)1'
M,SMEPXZ+&,].N!CD\UVE% $5U;QW=I-;2Y\N9&C?!P<$8-<>GP_9-$T72VUR
MZDBT>ZBN;9GB3/[K(C0X ^4 \]SZUVM% '-2>#H+K7=5U&]N3<1:I9BRN+4Q
M@)Y8W8P<Y!^8\_RJ#PYX+N-">"*?Q'J.HV%IQ9VEP$ BXP-S ;GP.!DX'ID#
M'644 4=8TBQU[2;C3-2@6>TN%VR(>/<$'L0<$'L163+X:U"YTLZ3=>(+B33V
M3RG80JMS)'T*M*#CD<$A0??/-=)10!YQXX@M-.U;P+IUE/#IZ6U^?*"@8B01
M,HR#_#G"_CUS73CPI;W']KRZA.UQ=ZK;?9)YD78$AVL D8YVCYF/)))/T Z"
MB@#CY? KS>'=)TB76[F1=,N(;B*9HDW$PX\M<  ;1CGN?6KTOA9HO$=QKNEZ
M@;*\O(4AO%,0DCGV<*^TD$. 2 <XQU!KHJ* .3N/ EJVGZ/96MY+!'IE\-0#
M% [3SY8EG/'4NQ.,=>,8J_9>'39^+-0U_P"VL\E[#'#)#Y8"JJ9VX/7/S'/]
M*W:* .>\5>%_^$HCL(WOY+5+*[CO4\N,,6D3.W)/;GI^M;C+,;8H)568KCS-
MG /KC/Z9J6B@#F=(\(#1_!#>%X=0DD@\J2%)WC&]5<G/3@GYCC\.M4KOX>Q3
MZ)H5I!JUU::AH2!+#4847S$4*%*LIX8%0 1WQ]:[.B@#E;_P/;ZOX<DTW4]2
MO;F[>9;C^T<JDR3+]QT"@*N.P QR>Y)HB\-ZA::+?+=^)=2O-1E@,,5\(4#P
M+_TS1!C.<9)R3@<\5U5% &=H,-_;Z#90ZG,T]ZD0$LC8W,??'&<=<<9S6*?!
M(1O$*P:M<Q6^MEWE@V(5C=T".P.,DX' )P/0UU=% ')MX*)M?#<']IN%T!D:
MW/DC,FU-@W\_W3VQS5=/A^;76+VXTWQ!J-CIE_,9[O38@A1W;[Q5B-T>[OMP
M?0CC':44 0SP&2SD@A<0ED**P7.WC'2N23P L?AG1-#3591!I%U'<P2>2N]F
MC;<H;MC).< 9X_'LZ* .5NO!C3:]J6I6VL7-HFJ0)%?6\<:$2E%*JP8C*\'!
MQ^8ZU7M? (M+7PW!'J]PZZ"Q:W,D2$N2I3#8 XVD@=_<UV5% '.6_A>2UUK7
M=4CU%O-UA(TD4PC;'L4JI7GT)SG/-4+?P EGI6@6UMJLZ7.@LQLKAHE;(92I
M5UZ,,$CC!KLJ* .;F\%Z=J%CJ\&JL]Y-JZ*EW,0$.U1\BH!]T*>1U.3DDU'H
M7A2_TE5^V>);[5# A2S%U&F(,C&X[0"[8XRQZ$^M=110!B>%/#J^%?#UOHT=
MW)=06Y;RWD0!L,Q8@XX/)--UOPS'JFJZ?J]O=/9:I8;A#.JA@R,,,CJ?O*?J
M"#R"*W:* ,!/"Z)9ZN/M;&_U<8NKLQC.-FP!5Z *O0<]R<Y-6_#VCG0-!L])
M%RUQ%9Q+#$[(%;8HP,XX)_*M2B@#FM7\)OK,>K6=QJ3-IFJ,IFMGA#&,!%4B
M-L_+G8#R#@G(P:DM_##6GBB[UV"^(DN+5+00M$"B(A)7'.<Y)[\UT-% '#6O
MPX6QT_0X+36[N&XT6::2VN1$A)67/F*RD%3G)P<<43_#:*;1M<TK^V[[[/K%
MW]KFW(A9'RA)!P.247KP!P *[FB@#G?$OA./Q-I]FDU]/:ZC92B:VO[7"O%)
MC!..001U'>F0^%[U-/VR^(;R?4S+'*U^\: D(3A B@*$Y;(ZG<>:Z6B@#'TC
M0(],U+4M3>19;[4FC-PZ1^6F$7:H"Y/8GDDDY^@&Q110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %<A\1=1U/2M M;K2KXVL[:A;0M^[5U=7D5
M2#D9[]B#77UPGQ8*OX4MH/-:.1]2M2"GWU"RJ68#!Z#G.,"@"%9M>T/XA66B
MW>N7&HZ?K5I/)&TD4:R6TT6"2I50-I#  $'_ !S+?Q/KDOPN\+:VVIR?;[G4
M((;B01IB5'G*$$;<#Y?3%=W9Z'&=636KJ\:^NUMS! Y552.-B"Q4#NV%R?88
MP*YY?AE;+I$6D#7=4&G6UVMU:0+Y8^SD/O !V9;D_P 6<#M0!#_Q/]6^('B#
M1X?$ES9VEI#:7$(C@B8J6+DKRO*G;WYZ<X!!?IUUKGB[P_<:SI6L?8;L7\D=
MM"Z!H$BBE*%9%QDEE4DG/!88QBN@L/#*V/BB^UX:A<RS7L4<,L3JFS:F=N,*
M#GD]^]9<?P]MK;5[VXL]7U*UTZ_F,]WID3J(97/WCDC<H;N%(S].* ,LV-SJ
M7Q6\106VJ3Z?NTNTS-;*AD^])C!8$ >O&?<4S1/$6J:QX+\)WUWJBPR7CNEX
ML,?^D790.H6( '!)4,Q&, 'D"NJA\,BW\3W^O1:C<BXO($MVC*H414SMV_+G
M(W'J36/:_#>VL;#0[>SUG48)M%>8VMRHB+[)?OHP*%2#].* ,K3_ !#XDG\'
MZU+#%=WMUINMR6A1!']J-JCJ6 Q\K2!21QUQQSS3H_&T;>'I+K2=5GO&N]5@
ML(TND5)[$OM5D8,!\PPY!;(R1DD"MRR\"QZ:MY]CUK4XWN-0.H!BR-LD(PPY
M7D-T.<\=,<T^\\!:7JEEK$.I/)--JSQR7$\>(V5HP!&4Q]TKC.3G.3G(XH R
M+_5/$?A*/7-8N]UQHL.GF:&&ZF1IEN0<;04'^K((SGD'I5'Q':7JS> KVZU6
M>ZDFU>!ID8*(V=HG.Y0!\H'( ST/.3S73V'@N./3KJTUG5K_ %P7%NUJ6O67
MY(FZJ H')P,L<G@<U1C^'9%KI-K-XDU6:WTBZ2XLE80[DV*0JEMGS8!QD]J
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2*10R.AR&!Y!![BLJ3Q5HL-Y%:R7H5I9_LR2&-_*:;G]V),;-V01MSG((ZT
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MFT_^,4?\(WJ'_0WZ[_WS:?\ QB@#A)YK8>#OA<A:/=!>V32KWC"P,K%O3#$
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M8O\ 2=HY8*5)!'!-:WAN^MX?'OB^5[FZEBN;&TECNKF$J)%5) S9VA0,D <
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M2(EP%&28W90K\<\$\<]*HO\ $7PM'"TQU,^2EP;>206\I6)P0OSG;A!DXRV
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M[MDE4D[""VU5Z$]>>P&?6:* .&\?2?:5\)R6\,\R)KMM<.8X';9&H?+, /E
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M^2)B0-^W PV.3D?3IKY/^$G\8>%M4LH+N.WTK[1<7$LUL\17?&%$8# $L3U
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M*AG !!4[@1@Y_05J44 5[&R@TZQ@L[92L,*!%!.3]23R2>I/<U8HHH ****
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M L,YR3R.W?K6W7%:_P#\E8\'?]>NH?\ H,5=K0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 !Z5CZ/X<MM$O=0NK>XN9)-0E\^X$K*0TF -PP!C@
M 8''M6Q10!CWOARVOO$-CK<ES=+=6*ND 1E"*K@!QC;SG Z_ABMBBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
-BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>elicio2021employeestockp012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K,UVRU'4=/%KINI-ILKR+OND0.Z(.2%!XR
M< <]B:TZ* .'T&RUJR\=364_B>_U2SM;$2SI<1Q*!)(Q$8^50?NHY/U6MKQC
MK,VA>&;F[MX;F2<[8D-M 9FC+'!?:.H49;G@XQWJ+P>C3V%YK4JL)-6NGN5W
M#D0C"1#_ +]HIQZL:/\ A-]&71++6)3=Q65W,84>2TD!1@6'SC&5&5/)XZ4
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M.X7GZ 5E?$0ZWX=\$ZWKUMX@ODNXY5:"-!'Y4:-*JA0"F3\I[GK5_P"$Q(\
MVT+PSPO'<7.5EA9.&F=AC(&1@CI4/QDS+\,-5M8E:2XG\H10QJ6=\2H3@#DX
M )H Z&VL+C2;M[^YUVYFT];9C,EXR;8V!!#@A1@8#9R?2GP>*M'GOWL?M$D5
MTL)N!%<6\D+/&.K+O4;A],UF^.+>ZUOX=:BFC#[1<21))$D;8,NUU8J".Y"D
M?C65X=U7PSK^J6>J6EAJ9OK*-S--J!N!]A#*0REI#M))P,+GC)[4 :T/Q'\)
MSQB2/5@T9@DN-_D2;=B'#'.WJ/3KC!Q@BID\>^&GGM(?[2"&[B\ZWDDAD6.0
M;=Q <KM+ =5SD=,9KD?"Q6+X"7ENR-'.MG?(T+(5?>S2[1MQG)R,>N13+F2+
M^P_ABO>VGMFF&T_N0MNRL7_NX8@'..: .WMO%>B:K8:G)!?2QK8C;=;X9(98
M,C(.UU##(Y!QS52Q\3^'](\/:(9M<EGM[Q%CM;N\W-)<<9#,=HP2 3DXK#@G
MBB\=^/)';;'+86JHY!VNR1R!@#W(+ $#UK"@95\#?#*%U826NI6S3H4.80L<
M@8N/X0"1R?44 >CV/B_0M0M]1GAOMB:;S>?:(GA:$8W LK@'! R#C!I]IXHT
MF]NI+6&6?[2EL+OR9+65'>'IO564%AGCC//%<#K%Z]IXD^(-S;Z8FIEM,M1'
M:R1EX[@J'#C'\6T,"0.>U2Z/>12_%'2;Z*74+R"XT22%;J2T>-"_FQMM5=H"
MJ /IZDF@#8A\:Z7XA\":AJ=Y=7^C6A,T9N8XI(Y(E$C(K*VT@OA<D+G!XKII
M-7L-/MK)9;B65KA/W"K&TDLP"@EMJ@D\8).,#->7VLA3X&Z_H[V]RE_ +R)X
M6@<'>\SE57(^8D$'C-;9N'TKQUX?UZZ+?V+<:']@^T8.RVFWJ^7/\(8*%R>X
MP: .JE\:>'X-!FUJ7456P@D,4KF-]T;@X*,F-RMGL1FI;'Q5HNI:Q)I-K>%[
MQ(_."-$ZB1,X+(Q 5QD]5)KS+Q/I\S^'/B/J=O'(;/5YK9;&)4.9F14#NB]2
M&;//<+GIS75:E<0R_%+PI-"P:$6%TC2(,JI;R]@)Z G!P#0!VE]?6NFVCW=Y
M,L,"8RS>I.  .I))  '))Q5*T\1Z9>W5S:12RB[MHQ+);2V\D<NP]&",H9AV
MR >>.M8'Q(M[YM,T?4+2"6XBTS5[>]NH(5+.\*$[B%')(R&Q[>U0RB'7?B3H
MFMZ7,LECI]A<"[ND^XV_;LCW=R"&8CMCG&10!5T"^G\9WNHW U+5K"XL=7D2
M#RHY4A,$15?+=6&PEN20WS@GL!BN@USQ=;Z+XCT?1WMKJ1]0,K,\=M)(%1$+
M<;0=S9V\#.!DG'%97PUF1K?Q"G*N^NWDR*ZE2T;."K@'JI]>E+XQD-EX[\%Z
ME+#.UI!)>1R210M)M9X@$!"@GDC H I6'BR#0?%OC*/6]4NY+2UFMC"IC>8Q
M(80[D*BG:H)Y.,=,FNUFUS3X;6VN?/,J72[[<01M*TJXSE54$D8(.<8Y%<':
MS1#7OB5(_P JSQ0^46'^MQ;;"%_O8;Y>,\G%8EI<G1+#P1K&I0:B^CQZ)_9]
MT]H95>SF_=G+B,AL'9M(]A[4 >L:1K.GZ[8_;--N!/#O:-CM*LCJ<%65@"K#
MN" :X_49M2G^+<&AQ:S?6NGRZ.]X8X2G$HEVY!93Q@]*WO",.EBQNKO1[">U
MM;RX:?S)_,#W+$#,I$GS#)XYY.,]Q7+ZI#97WQOM!=Q"6U&B/ 793L$IFR$W
M= V,\9S^= &//XIUZZ\ ^.HI-3E-UH-S)!;ZG;A8VF4=C@8##N5QU'X^DR^(
M+#3H[2WNII7NY;;SA##"\TA10-SE4!.,D<GN<=:P/B!IMGIOPJUK3],LHK>-
M[9DAM[:(#<Q/0*HY)JI>ZQ$/%NE6SPS06T^DYCU"UM6DEN&WC-N'"DH!C<1P
M<D<C'(!TLWC/P[;V&G7TFJ0BUU)E6UEPVV0GISCY>AZXQ@^E3Z/XDTK7I;N'
M3[AWFLV59XI(7B=-PRI*N <$=#T->3Z5)M^'GP_M98+B.:SUZ-ITEA93&JM+
MECD?=&Y<MTYZUV.GWD-K\4O%-V^\P#3;8[D0MO,?F%PN/O, 1P.: .]HJIIF
MHP:MI=MJ%L)!!<QB1!*A1L$=P>15N@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !114%W>06-N9[B0(@(4<$EF)
MP  .22> !R: )Z*13N4-@C(S@]14#7UNE^ED[[)Y%+QJPP' Z[3T)'<=>] %
MBBBB@ HHHH ***YN[\>>';$2M<7=PD<4[6SR_8IS'YH8J5#A-I.X$<'K0!TE
M%<W=^.] LK*]NKB>[C2RC66=7L9T=58D*=K(#@D$9Z5T4;K+&DB_=8!A]#0
MZBBHKFXCM+:2>7?Y<8RVR-G./HH)- $M%<W#X\\.3Z:FI)?2C3W^[>/:3)#U
MQ_K"@4#/&2:Z*.1)HDEB=7C<!E93D,#T(/<4 .HHHH ***S-4U_3]'NM/MKQ
MY$EOYQ;V^V)F5G/0%@,#H3R>U &G1110 4444 %%%% !15+4]4M])@BFN5F9
M99T@7RHFD.YS@9 ' ]ZNT %%%4H]4MY=9GTM5F^T0PK,Q,3!-K$@8;&">.E
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M %%(2 0"0,\#WI: "BBLO7O$&G>&](EU34I)$M8B [1Q-)@DX&=H..2!DX%
M&I1110 45!>WD.GV<MU<%Q#$I9RD;.0!U.%!-8EEXZ\-WYL_)U':MZVVUDF@
MDA2<^B,Z@,?8&@#HJ*S+?7]/NM?NM$B>0WUK"LTJ-$R@*QP""1@]#TS6G0 4
M444 %%%)D9QD9'.* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:FV"_9Y05QB3J^X;R1VX]J *WCC6=2T.RTNXT^2!1/J=M:SB2(L2DCA3M.0
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M7I!\*:Q>ZC;7FFZQ-;VEQ9I;!#"TR_*ZOG+<]>@] .P!Z2D:1($C140<!5&
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M@X7OM H Z"BN6\':_;^(#>7%EKAU*T41J(YHECGMY/FWK(H5<?PXX['ZUU-
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M#:9<J"QQDF)@!]2:S/#NAOK/A[PO<7^I0W=G80PW-O%##MW2K'A"[;CNVY/
M"\\]L5J>(?&6C^'I##?)=SLB>;*+6T><0IS\\A4$*.#U]*V--OK+4]-M[[3Y
MHYK2=!)%)'T8&@#'T#PP^CRZT;B\CNX=5NWNY8_(V!6=0I ^8Y7"CBLVV\ F
M#0!X:EU0S^'EE#+;/!^^\L/O$1EW8*9&/NYQQFNTHH PO$_A:S\4V]E%=,\?
MV2Z2X5DZD#(=#_LLI93]:3Q3X=D\26EE;I>BU%K>17>?)\S<T;;E'WA@9Z_T
MK>HH Y27PA=0>*[C7](UC[#+?1I'J$#6PE2<H,*ZY8;& XSR/8UEQ_#'R?"V
MG:7#KUU%?Z9<O=6.HI$H:%G9F8;>C*=QR">?TKOZQ]7\2V&C2:8MP)I!J5U'
M:V[PQ[D+O]W+= .I_"@#'O? TFM>';BPUO6[B\OY7CD2_CB6$P/&<H41>!@D
MYSDG)YZ8=;^$=4;Q'I>N:GXA^TW-A!)!MBLEB657VY)Y;!^7G'X8[]=10!@>
M$H-8MM-N8]9U&34'^TL;>XEMQ [1$+]Y!T^;?COC%(/#EPGC2X\1I?Q[I;);
M(0-;DA55BX.=W)RQ_#TZU:U#Q%9:;KNEZ1.EP;G4F=8&6,E 44L<MT' Z<FM
M:@#AK?X<K!X<L--&JL+O3;U[ZQO4@ :-V=G8,NXAE.X@C(XQ]:W]/T%H=<EU
MO4+F.ZU)[=;57BA,4<<08L0JEF.2QR22>@Z8K:KG[SQ?8VET8Q;7MQ#'=K93
MW-O$'CAF;&%;!W?Q+D@$ G!.: *A\!:6P\3*Y=H]>SYB'I#N0!BON6&\GUQZ
M5/>>#+"_\#KX7N)9C L2*+A6Q+YBD,)<_P![<-Q]R:Z2B@#GO#V@:MISB76O
M$4VL21IL@W6Z0J@/4D+G<W &XGU]3F2P\+6>G^+-3\01._G7\:*T7\*,!AF'
MNP6//^Y[UNT4 <9+X'OK;Q%>ZEH?B6YTJVU&02WMHMNDH>3&"Z%ON,0.3@_R
MK0B\+/!XPM]=AOE6.#3_ .SEM3"6_=[@V=Y;.[('..GYUT=% &!IT&LQ^+=4
MEGU&2XTF1$\F"2W$8@<<%4;JXQDDGCD =#2^(_#;ZY=:3>6]^UE=Z9<F>*01
M"0$,I1E(/J#U[5O4V21(HVDD8(B LS,<  =2: .;M?"UU::]KFJIJ:,^JPQ1
M,CVV?+\M653D.,G#'/3)]*R[+X>7&FP>'!9Z\\5QHD4MNDAM0PEBDQD%2W#<
M###\JV['Q=8WVH6MLMM>Q1WD'VBTNI8@(;A,C&U@3@G<N P4G(XK?H X7_A7
M&?#.KZ*VMW#K?7YOHI6A3,$GFB7D#&[YAST&.@%=I:130VL<=Q<&XF ^>4J%
MW'Z#H/;^=344 81\*V1\8R^(R6,TEHMN\)^XQ!;$A'=MK%?H3ZT>&/#$'A30
M3I>GREAYDDBR2@MC)^4$9Y"J%7J.%'2MVB@#AXOAXT/@FQ\.KJ["2PO%O+6[
M%N,JZRF0;EW889)'4=JU(O#%W'XO3Q"VJ+),NG_8#&]M]X;]^XD,.=WH,8X]
MZZ+>N_9N&_&=N><>M5-,U)=4@EE6UN[81S/#MNHC&S;3C<!W4]0>XH Y./X<
MH- &G2:HWVF'4FU.SO(X K03ERW0L0RY)&/0_C6Y:>'G.LMK&J7,5W??93:1
MF*$Q1QQD[FPI9CECC)ST  QSG=HH \^A^&UW'HNEZ0WB64V>E7L=U9 6B!E"
M,657.?F(SC/ QV/;H+7PS)9>,+_78=2D$=_'"MS:F)3O:-2JMNZ@8/( Z]^U
M;=W<I9VDMS(LC)$I9A&A=B!Z <FJNAZQ:^(-$M-6LA(+:ZC\R/S%PV/<4 9W
MB+PU-K6HZ/J5GJ36%[I<KO$WDB5'#KM8%21VZ'/%<+X[\.CPQ\./%KR:U).N
MIWD=T%F1$*R-)%NY'WC\N>  /2O6Z:R*_P!Y0WU&: ,"+1C=:K8ZWJFHP7?V
M")_LIAB\J-2XPTA.YLG:,#H ">.>.*\ Z2_B7X?7&G-JL)TNXOKD7$,469=A
MG8E X; ##_9)PQP>A'I5_?6VG6%S<3!FBMHS)(D2%V"_[HY[&F:+J-KK&C6>
MJ62,EO>0K-&'4*VUAD9 [\T 9L/AF2'QJWB%+V-4-BM@+008 C5RX(;=UR3V
MQCMWJO%X2N=.U35KG1M5%G;ZL_G7,#V_F[)B,-)&=PVDC&<AAD9QVKJ::[;$
M9MK-@9PO4_2@#"N/"&F3>!W\)QH8]/-K]F3NR<</[L#AOK4.K^#XM3\&1^'8
M[V:W\H1-'=8#MYD;!P[ _>RPR<]<FDM/'>CWUM=7%M%J4D%I*\,[I82MY;I]
MX$!2>.^!6YINIV6L:?#?Z=<QW-I,NZ.6,Y##_/&* .?L?"=]:^*9/$$NNO/<
MRV2VLL9M55&*LQ4@ Y"@M]W.?]KM5WPCX=?PKX>AT@W@NTA>1DD\K8?G<N<\
MGNQK=HH YN7PO-;^*+K7]'U!+.XOHDBO89K<S1S%.$? 92& XSD@CMWJGJ/@
M**Z\'?\ ".VE^UO&]P+F>X>$222R^:)2QY &7'Y<#%=A63XB\167AC3/[0OT
MN&A\Q(_W,9<@LP49[ 9(ZF@#3B$@B42NKR8^9D7:#]!DX_.N.E\!2G3O$NG1
M:TZ6>N2S3-$UNK>2TN-Y!R">G'3&3G-=I37=8QEV"@D#)..2< ?F: .8D\)7
M,NI>&KUM3CW:&CJJBV.)MT?EG/S\?+Z=_P JHV7@"[TN^NH=/\275OH%U,TT
MFEB!&VECEU24\HI.> ,\G!!YKH;?Q%97/B:ZT!$N!>6T"W#EXRJ%&) P3UY!
MZ#''6M:@!DL4<\+PRHKQ.I5T89# \$$>E<MH_A34_#4)L-$UR-=)#$PVM[:&
M=K<$Y*HXD4[<DX# X]:ZRL/5_%FFZ)JEEIMXEV;J^W"V2&V>3S2HRV-H/0'-
M %?6?"$6KV=G_IT\6I65T+RWOB S+*.#E> 5(X*\#&/2G#PU-+>WNIW=[%+J
MEQ9_8DF2W*1PQ9)(5"Y)))R26[#IBI+;QAHUY8ZC=6\\LATW/VNW\AUGB(&<
M&,@-V/;%:.CZI;ZWHUGJEJ'%O=PK-&)!AMK#(R/6@#E_^$#F'AGP_HJZL@31
M;J&YBE-KDR&(Y0,-_3UQU]JGU30FL]7U?Q/<:E$$DTHV;PF':JJNY@=Q;KEC
MVKKJ0J&&& (]#0!YMX%T-_$'PW\,PWNHPSZ9#'#.;>.'#,R894=]Q!"L <!0
M3@9/7-W4?AQ+?6?B+3T\03PZ?K4YNFA^SJS1RG;GYR<E?E'R\=.OKWBJJ#"J
M /0"EH YJ+PQ=Q^+(-??5A+-'IYL2CVP^8%PY;(8<[@.W3CWJA:'2_ASI,L.
MMZLCPZC?RR1DVK?-)*2[)A=V1UQ^7-=I2$ XR <<T <UX#\/1>'/#$=O'#)"
MT\CW#12MEHPQ^2,_[B!%_P" ULZM97&H:<]O:WC6<Y='2=4W[2KANF1D'&"/
M0U=HH PM*\."QU^_URXEADO[R&.&0P0>4FU"2"068ECNZD] !VYW:** "BFE
MU#A"PWD$A<\D#&3^H_.LOQ!XBLO#5E%=WR7#1R3)"/)C+89V"C)Z 9(ZF@#6
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG?&>J:AI&BQ7EA;W4R+<(+L
MVD8DFC@YW,BD$$CCL>"3715GZM87-\MJUI?M9S6TXF#>6'5_E92K+D94[O4'
M@8Q0!YOXGU8ZU\-;G4--\3S7MLVIVZ1RQ*B.(VDB4Q2C8,$$L<8&<C.1Q74M
MJ=[=>-/^$5AU*XB6UTX7D]V$B,TK,^U5Y3:  "3A><CISE+SP!:7VBZQ9R7;
M176JW27DUQ!$$"2H4*E4.1CY!G))))YYXM7'A.1M8L=<M=4DCUBW@:VEN)(0
MZ7,1.[:Z KP&Y&",>] '-0^.-5MTNM$NY(WU2+78=(CO?+ #)*-ZRE1QOV \
M#C=CC'%;.M6>N6>B^*1>:DE[I3Z7*;;S559XW\MMX.Q54KT([U+?_#_3M2T&
M]T^XN)_M5W=B_>^C(65;@8VNO8!0  /3WYJ6/PI?R:-?6FI^(;C4+N[MFM?M
M4MNB"*-AA@B+@9/4DYR0.PQ0!A_#W5I?$&DZ7;V6HR6EOI%A;075OY:^9-(8
M4(8AE)6/&<$?>YZ <XZOK%K!\1]2TK538O87\MRH6!)/-9+=&VMN!^4@8X /
MOVKJK3P&=/OM%OK+5&@NM-LQ8NZP#%W"H 591GG&.",')_"I%\$R"Q\2VIU3
M*Z^[O.?L_,1= AV?-_= QG/- %>V\2W>N^(M*T6"=K'SM%75KB6%5+G>RJJ+
MO! &2Q)P3TZ<U@:WK>H7G@GXAZ%JD@GNM'A9%N@@4S121[T+ <;@.#@ >PKJ
M?^$*\F;1;ZSU$P:KI5K]B6X,.Y)X,#Y)$R,] >".>?:GW?@J&[T#6M.:\87.
MM,6O;ORP6;*A<*,X4!0 !S@>IYH J1:Q<W.OZ-X7M+EK0?V0-0N9T52Y7*QJ
MB[@0,DDDX/ &,9S7,:-J]WX<3Q4HF:ZO;GQ/'91S%$#$R+$-Q'RKN"Y] 3CH
M*ZZ^\%27%YI&J6>K266KZ=!]E%TD(99X>Z.A/(XSP1@\^F*I^&UK<Z=KEG?Z
MK>7(U:Y%VSA4C:"8!=KH5'!&T>WM0 C3>+[*XUAFDF_LL:<TUO<7RVYFAN%S
ME=L1PR$<Y/(-9MCJ/C#_ (0*T\3?VC+J4ES8VLCV-M9Q^8@+*99(S_$^PMA2
M,9Z#'%=#9>%-2CTZZAU+Q)<ZG<RV[6T4\T"((8V^]A5QN8X'S,3T'OF>S\,W
M%AX3L-#MM6DC>P\H070B&[;&1A67.#D#!Z9!H B\&ZY;Z_!>75GK;:E;"155
M)HUCFMFQ\R.H5><\@D?RS3-6U>\'CK3M!^TO865Q8S7 N45=TTJLH$8+@@84
MECQD\=LYT='\/IIFJZGJLDB2W^I&+SVBB\M,1@A<+DG/)R23G/L*XSQQ=V\G
MC"&"[U^;0$@L_P!U-<V:3VURSMDA=ZE0R[%R<Y.X8Z'(!5G\3^*8_A'K/B$Z
MF@O+>61;:<6J8DC278' Z'<.<XQQQQ73>(-4U/1?%_AZ9[]QH>H2FSGB\M,)
M.5S$=VW=AB"#SUQ5&+1-2\6^$=3T34-<^UZ?<[%AU!; 0.Z=655SM(!"X;&#
MDCMFNDU_P[%XD\,S:/?3L#(JXN(EVLCJ0RNO/!! /6@#"U+Q#J%C9"[CGEF7
M5=62QL$V1_NHSD%ES@,6V.5W$CE.O.8;JZ\8:=;^(IGDE73X=.>YLKF]6!IH
MYD!)0K$=K*<9!(XY%;^O>$]/U[PTFB2&6VAA\LVTL#;7MWC^XRGU&*I0^$M0
M?1KZTU3Q'<ZC=75L]HMS+ B"&)AAMJ+@%CQ\Q)Z#Z4 8-GK?B*VE\#7]WJXN
M8-<5(KFU^SHB@M 9 ZL!NW9'/.#G@"NQ\4IJS>&K]M#N3;ZG'$TEN1&KAW R
M%(8$8/2LIO!<C6OAJ#^U,#0&1H#]GYEVH8QO^;^Z>V.:ZV@#S0>-;B75?!=Y
M#J4S:3JT2I>1^5&?*E=2(MS;<C<ZNI QRO&*L^*-;US3O .J^(+'5&5C=*UH
M'@C8+ 95C&..=P)8$YX(K2;X<Z2?#.JZ&DDR0ZA=-="13\T#%]ZA/0*>@]SZ
MFM'Q+X7B\0^%G\/QW!LK5A&N8XPQ54964+DX'*CUXH P;V*[E^--C&NJ7D<(
MT6640KY91?WT8( *GAL#)Z\<$"N9CN-:TSPYX]UC2M5^QG3]<NYQ$($<3%0A
M*N6!^4CCY<'W[5Z%>^&'N_$NGZ\FI2V]W;6S6LPBC7;-&S!B/FR5Y7J#G'YU
MG?\ "!L=!\0Z2VJDQ:Y<RW$[_9QNC,@ 8+\W3 &,YQ[T %WKFICQSX7M(KE4
ML-3L[B:2#R@?F1$*G=U_C[8Z5S%QK_BO_A$_%FL+KRI+H>IW,4,:VD>V9(BO
MROD'@@GI@Y)Y/ '9MX4F?6]"U1M2!DTB"2"-!!\L@=0K%OFZX48QW_*J1\!,
MWA[7]';528M;NI;F>3[.-T9DQN"_-C' QG..>M '76TWVBUAFQCS$5\>F1FN
M/G_Y+;9?]B]-_P"E$===90/:V,%O)()6B0(7"[=V!C.,FLB3PY))XTA\1B^
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M<\9NC$0WRYS@\%2 ,#C/-=A;:E>>(_%6OZ=!J$]C;:1Y4"^0J;GE=-Y=MP/
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M %7R\ AL?-O_ !/-:7@+4M0OK/6;34;MKR73-6GL4N'55>2-0I4MM &?FQD
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M)O\ 42?[I_E7B_A?P]J_C#X%Z-X?A6RMK"Y),UV\K-(J+.S';'LQNR,<MC%
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MS'J^MZ7JRW]U9W6GB5%,&W]XD@ 93N!Q]T<CD5H6%_)>S7L<EA<VHMIS$KS
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MB>QUY]2E-Q:6K6HC\M0CJQ!8GOG*CH:HCP(@T/7]*.JW!AUN>6>X?RTW(T@
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MKKZ-(H].X /O3;KPI%_PD":YI=VVGWOV<6LH2-7BFB!RH9#W7L01Z<BNAHH
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MJXBG6)I=2&1NW)F-HVXX)DR1TX1JZ32]%ATRXO+OS9+B]O65KBXDP&?:,*H
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M>"#UQ6O9>'XH-1DU*\N9;Z_> 6WG2JJA(LY*JJ@ 9/)[G [ "@#AX?$6LR>
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M '10!U'AOQ%%XDM;R>*UFMOLMY+9O',5W;XSAONDCK[FMJN*^&W_ !Y^)/\
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M%(C%3%(DDQ1@RX^;@]<\8XQ74VL]_H_Q&O=(;6;FXLYM%-_NOV5A#*LNS<,
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M !V"]B0!S^6* ,'7I+SPO?>%KZPU"\NHK[4(M/O(IYVE6=95.) "2$8$9^7
MP<8Q6K\2+B[L_A[K5W8WD]I<P6[2)+ P# CMG''X<U:T_P )6=@; 27=[>1:
M=_QY173JRP':5!&%!8A20"Q8@&KNO:+;^(M%N=)O))DMKE=DODL S+W&2#B@
M#D%>_P!(\>^%D&K7]S%J]I<_:H9Y=T>Z.-'5D7HIR2..HZYZUFP:IJ6N?"B]
M\:PZG=VVJQK<WD2I,PBC6)WQ$8L[6&U,'(R2<YZ5VLGA6VFU32-1DO;UKC2D
M=+8[DQAP%;<-O.0 /PXP:KCP-I:+>V\4UW%IM]*9KG3D=?(D8\M_#N4-W56
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6&\TCXHVGB%[:XN-*N=+.GRM;Q-*UO()/,5BJ@G:W3('!'.*Y'Q?I<]MX/\
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M5K<O%;QEY"B2J6*J.20.PH S+W5S8?%BVG<:DT4^@R2"Q7?(QD\Y -L8) ;
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M."YCMX-I/']U1DG\,UY?H<FLZ1\._"%FVD:DB1W3QZB8K%VN;9<N044KD9R
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M+/)'(LA4KGY5^7 SU)[ 9-U-2U#QKH5]IXT/4-&,]E+!+-J$6PI(Z%0L?.6
M)SNQC '<\=E10!Y9-IVI>(/AA8>#9],O+758OLUK.[PL(HEA=-TJRXVL"J9
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MEHQ9ULXD5?*!)(!"\;L<G'&2>3UK2HHH **** "BBB@ HHHH **** "BBB@
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MNW(![]QTSR*S?#FG7VBPOX8O_!*WUU%-(+75C!$]O)&S%E>5B=P(!Y4 DXH
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MY2001R"#6P3M4GDX&>!7'0:O+I?A^]UJS\&7%JA,82Q2*.*YD .&=PI( &>
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M%/RJ2"V RDX]>,T =517.7WBZ.T\2_V!%I5_=7K69O(O*";)%#!<!BP Y/\
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MBT;*65D.[!X5N#@\4 =)17(6/Q MKR70B^DZC;V>M*HM;N54"&1DWA" VX<
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M@GM;AD!A?:"')#$,N&!X)ST]Z .Z) QD]>E+7':CJUA)>>%AK.BW?VRXNO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M![FYLI8HD) W,5( R>G-;=% 'G!T_6DU+PGXE32+D"PM7L;VQ9D,RQLJCS%
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M2/QJ]!XU)\2Q:'?:)?:?->1O)I\EPR;+K8,LN5)V-CG!YQUQTJ7X@Z->^(/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH YI/ ND0WDT]K-J=G'/(TLMM:ZA-%"SL<L=BL ,GKC
M%;L-A:6_D^5;QIY">7%A?N+Z#TJQ10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !115!]4C_M==,@7S;D1B6;!P(8R
M2 6/J2#@=\'IB@"_162NIZ@MO?S7&C2QK;3LD2),KM<0@ ^8H'0GGY3SQ5^S
MO+?4+*&\M)EFMYT$D<BGAE(R#0!/1110 4444 %%%% !16#H7B9=9N];@DLW
ML_[*NOL[F613N^0-NXX P?4UM6\\5U;17$+AXI4#HP_B4C(/Y4 24452U*ZO
M;5;8V6GM>F2X2.4"58_*C/WI.>NWT')H NT444 %%%1374$$D$<LJH\[^7$I
MZNVTM@?@K'\* ):*PM'\1_VKXBUS1VL9+=]*:$%W<-YOF*6! '08 []^U;M
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M"3;,YV[E!QGOUH MT52L+J\N9;U;O3VM$AG,<#&57\^/ (DP/NY)(P>>*NT
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MUPUS)$[@^9,P )S@!0<#V&*D\+:"/#NAI9M();F21[BZE P))I&+.1[9.![
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M;/9B&Z>66"&294,;R, SK][&?<=JT_%%A=>'(]"-IKNL2_:_$EJ)1/=%LH[
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M*H"KGOM )[YKCO#&AR:AJ_C%;LZO9V]]J+-L,30I<0F-5R"RY&3N&5(./PH
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MKA-/BFTCXL2Z;;WMY+:W>BF[DCNKEY1YRS!=XW$[<AL$+@=.*YVS76]7\/Z
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M8I*DE[,T\J&9V0.Q!8JI.%)(!.!6M10!DZMX;TW6KZPO;Q)?M%B7\F2*9XR
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M^'K;3#*\@A+[=\AD**7+*FX\G:"!GV[=*V*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*P6IDEB B*R PDJ75L@9!&.N>@/5^![O3Y+_ %8K;ZI!JM]+]LN1J%DUL7&
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M>176GQWMIFXAEB$L7ED?O%(R,9('(QUQ7!0^,+?6_AQJVJ>(]'ODTW=<1RI
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M'4DD #WKAY+^27XQZ8TMCJ%HPTBX=HIF#AQN3!4([+GJ"!@_F#0!Z+17%?\
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M,MRN?XC@'(QDYQ:2QO\ ^ROB-%_9UX'U.29K)?(;]\&@$8QQQ\P[X]:],HH
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M=2K#L!A3UQC'N*Z;4HKFY^(?A34(K&[-I;6MTD\I@8"-I%3:#QZJ?IWKMZ*
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MDNYAN)8$,"Q!&/I7I6@I/'X?TZ.YMWMYX[:-)(G*DJP4 C*DCMV- &C1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/DW 7:V1_=8!3GL0<]10!S%EJ.K-X0^(,C:O=M<Z=?7BVMP=N^-8X595'RX
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M)S?36BR1M+!(J3[5&\I(1M<C/.":M7GC#1K#SGGGD%M!-Y$]TL+M#%)G&UG
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MWV60)NCSN!8KA3QT.#T]1E/$OBR/P]J6C61M;B9]1N?*WQP.ZHH4L?NCEN.
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MT#I'<<9PC$8)QR!W'(S7-W^J?\)!X]O_  W--JUM:0V">6UHLT++,\C R%E
MX 5<$_+UZT >@45ESWUMX<T6V.I7TDNSRK832+NDN)#A5^51RS'L!58>+]'%
MGJ=S+--$-+.+V-[=_,@^7<"5 )(*\Y&1B@#=HKG;'QOH6H:C8V4%Q-YE_$9;
M5WMI%CFPNXJKD;68#J >.G6K6E^)]+UA-0:RDF?^SY&BN0]O(A1P,E<,H)./
M2@#8HJMIU_;ZIIUO?VI<V]P@DC9XV0E3T.U@",^XJS0 4444 %%%% !1110
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MDO\ 3HC:R7%M*6G_ -'9.I'4L0 O!]@!QZ]10!Y?*6\GX98M[G-J4-QBW?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH P;SPX]WXNL-?^W%&LH9($@\H%65\;LG.<_*,>GO6]
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115:]OH-/
M@$MPY 9@B*!EG<]%4=R: +-%(I+*"5*DC.#U%5I-0@AU"&RF+1RS@F$L/ED(
MY*@_W@.<=<9(S@X +5%%% !1110 445BV?BG3[[Q#=Z%"MS]OM%5YT:%@J*P
MRIW=#GV- &U16=-K5O!K5OI+Q7!NKB-I8]L1*%%*ACNZ#!=>OJ*T: "BBB@
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MK187RU#  '.>C-GUSVJM9^"/(TRQT>[U.2\T>PE26WMY(@'(0YC21\_,JD#
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M#[=\SIF0A(4VMN<D#C!XS7567A&XL_$5UKG]N7,UW=6B6\HDA38S+NVM@ 8
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MXB:;I=G:RO>:W>0>;<3E$CWHJDD!22 #GCKTXKU*TMY;73H;8S*\D4802;,
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MD^[D*#R,8/)R37):%=ZOHGPOT76[/5I8XHM4,360B3RI8WO'1@Q(+;OF.""
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV[:%P,$C &.G.<FJR?#Z"/POI&@)JMT+;2[F.Y@DV)O9D;<H;C! )]!7944
M<I)X)$>O7^J:=K%Y8?VDH%];Q(C),P& XW [&QU(Z_K5%OAE:+H.C6-MK&HV
M][HV?L6HQE!+&&^\A 7#*?0_G7<T4 <G?>!+75- 6POM2OI[Y;A+M-3+*)TG
M3[KK@;5 '&T#&">YS4MAX1EMO$\7B"[UR]O+Y+/[&P:.)$=-^[D*O'.#P<^^
M.*Z>B@#!\0>&5UR]TN_BU"YL+W397D@G@"-PZ[74JP(((]JH6?@4:>-0-IKF
MHH]Y?"_W-L;9+\N[^'D-M (/&.!BNMHH R-)T&+3=2U'4WE\Z_U$Q_:) @12
M(UVJ H] 3R23S] (]2T&>^O;J:+4Y(8;NU%K-;M$LB%06^9<]&PY'<<#(-;=
M% '+#P/9V=UI5YI%S+87>FV@L8Y !();<8PD@/WL$9!!!S3KKP+I=[H5WIUR
M\[2W=U]MDO%8+,+@$%9%(& 5P !C&!CGFNGHH P[;P\XU&+4[^_>\U""W:WM
MY6B5%B#8W,%'\3;5R?;  YSCCX=P+X-A\,#5KO[)%<_:%DV)YF[S?-QG&,;^
M>GM7:44 4]2TV+5M&N],O&9H;NW>"5D^4E64J2/0\US5IX!\B[T&[F\0:E<3
M:,KQ0%A$H:)E"[" OHH^;[Q]>F.QHH YF+P@&.EI?:C->P:7<?:+59(U#AP"
M%#..J@-P, \#)-9GQ>93\,]4AWXDE,*HH^\Q$R$X'? !/X5W-% &#;Z&+O4+
M35[G4OMTUM"Z64@10B;P TF!]YB !G@8S@#)JE9^!+2W\':AX8FOKFXLKTRE
MG8*KH9&+-@@8^\<C(KJZ* .2M/ YAUC2M5N=>U&ZNM/@>WRXC598VV_*0%X^
MZ,D<GN:BT?X?1:)<F*TUK41H@F,\>DDIY2,3NQNQNV9YVYQZYYSV5% '/V_A
M86?B+5=8M=2NHCJ6QI;?"&,2*FP/TST'3.,\^E97_"MK#_A#]/\ #_\ :%XI
MTV;S[&^0JL\#Y)!R!@_>(Z=/SKM:* .2N_ JZEX?GT_4M:U"ZO9GBD.H-L61
M&C;<FU0H4 '/&.<GFI+;P6D6OSZQ<:Q?W4]S9"SN5D\M5E +8.%4;<;CP,#N
M<FNIHH Y73_!$5IIVGZ7<ZC<7FEZ<Z/;6TB(O*'*"1E WA3@CIR!G-64\)V_
M]OZQJD]S).FK6Z6US:NJ^7Y:A@ ,#/1CGGG-=#10!R/A[P*= DAA_M_4[S3+
M4YM+"X92D/IE@-S!>P)P,#C(%:GB?PY%XFTV&U>ZGM);>YCNK>X@QNCE0Y4X
M((/T-;5% ',Z=X0;3=>O]936;Z6[OH(XIO-$95F0$*^ HQ@,>!@>QJK#\/K2
M/P#+X/DU&ZDLF_U<Q"B5#YGF9R!@_-[5V%% '(ZOX%_M.?3]0BUW4+36K)&C
M&HQ;-\J,<E73;M*YY Q@5+>^"DO;32X7U:]\RPO4U W#!&DGG7(!?(QC!Q@
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MH5L 90@9& JXSGD9KJ:* .=L_"I2737U'4Y]1&F9-H)D5<-M*AW('SN%) /
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M>U+3-3$ M[BX@V-]J0=-ZLNW=UP0./3I77T4 <U/X.BDU+0[V/4+J-]',C1
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M:NJHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,UVUU6]T\6VD:
M@NG7#R+NNS$)3&@Y.U6X). .>@)/:M.B@#A]!A\26OCB73[[Q1-JUG;V(FG1
M[*&$+([D1C*#/1)#U]/6MKQ=XFB\*Z)]M:+S[F:5+:T@W;?-F<X5<]AU)/8
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MC-)O5?,A_B4X ;N.#G[N* /1-0\1Z5I4DJ7=T5,*"2;9$\@A4]&<J#L'!Y;
MX/I3;SQ1H>GR6<=UJMK&UXI>WS(#YBA2VX$=L G/2N1T#4+?0?$GC"P\1RI
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M8H;:61T# D'"J21@$DC@<9QF@ _X1W5/^ARUO_OS9_\ R/1_PCNJ?]#EK?\
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MDCE2<#:%4[N_ ST/I4T/B?1KC08-;AO5?3[C BD56)=B=H4+C<6SQMQG/&*
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M< C!!P00>00>"#S5;4/$NE:9+<Q7$[E[6(3W(BA>3R(SG#/M!VC@GGL">@H
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MD4;9& _ARN">U=Q10!P%E"K>+_%7B6)MNE3V$-NLN#MN)%#99?[P *J".I)
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M.Z%M ,0E490N9U8+NZ9VY./2NYHH Y'QU:6%]'ID5Y>WFFSK.TEKJ5L<?99
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M###87,<DRP.8T9RA4%@, G:>] %ZVUK3?"^ER6-SJ6HZBFFY%U>RQM.T(/S
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M "BBB@ HHHH ***Y[QM>Z78>%+R769[VWL2%$DMEO$B_,,89.5R<#)P.<=Z
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MN+B==5C>2S,-M(_FA5+$# ^]QC;UR1Q4X\7V$E@EU!;7\Q:W%R\"6Q\V*,Y
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MN]\LQU5XWDB$.T(8TV+M.X]ASGOZ5OT4 %%%% !1110 4444 %%%% !1110
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M:73Q=2>(?A].VF:E''::7/#<-)9R 1,T<:J&./ER5;KZ5Z=10!P7A/35O_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]LJW&F-Y<:&:&3Y(PH"@%A*=A)&,D<5V^GPW-OI]O%>7)NKE(P)9BH7>W<X
M '/M0!D3>,=,B6ZF6*]FLK1VCN+R"V:2*-E^\,CEMO()4$#!R>#6Q;7L%W:6
MUU&X\NY17BW<%@5W#CUQS^%>92Q^)OAO]KN],@3Q#X0EDDNFMT8"XM%<EG*'
MHZ9)/?\ #DU/J-Q%JWB+X=3:+JEY;:9=)<&".()A MN=IPRM\V"5.<XYQ@\T
M >G45Q5AJ6J>*Y_$8T_5)-._LR]?3[94BC8-(B*6>3<IR"S8P,<#UY&=X=\<
M7OBY/#=HK?V?/?V4]U=R1*"P,4@BVQ[@0,MD\@X QWR #L->\16?AR"UEO4N
M&6YN8[9/)CW8=V"C)Z 9-:-S.MK;23NKLL:EBL:%F/T ZUYMXTCUBP\'0+KE
MW'>O%X@M6@EAC_>-!YRE Z@ &3J#M&#Q73>&]2F\1V$VOQZDS:?<JWV>R54Q
M" ,$.=N[?D$D9P.G/6@#7T'6[7Q'H=IJ]D)!;72;XQ*H#8R1R,GTK1KQKPO?
MZSH?P_\  NH6^J'[)<7D%C+8^0FQHY'92=Q&[>#SD$#MCU[*RU+4O%6H>(XK
M'5)--32[HV-N(XHVW2*@9G?>IR-S8 &. >YX -W6?$5GH=SIL%VEPS:C=):0
MF./*AVSC<>@Z'WXK1N;A;6UEN'61EC4L5C0LQQZ =:\LNO$,WBGPIX U:ZA6
M&YD\1P1S(GW=Z><C$>Q*Y_&NE@U._P#$VI^)(+349+"WTJ3['$(HT8R2[ S.
M^Y3\N6  &.A.>1@ Z+0=:M?$6AVFKV0D%M=)OC$J@-C)'(R?2M&O)_!FMW5O
MX-\$:'9K.)+VQFG=[?R_,"QD#"^8=N27&3SP#QSD6M<U;QMH7@S4[JYN!#/;
MZA"EG/*D323022(F) F5##<>0.>* /3J*X+7K_7?"<5O<:EJ=]?Z7+=2/=W=
ME91B2SCV#8NT!LINW$MC(X'UZ;PQ>KJ/A^WNTU2/5$E+LEX@ \Q-[;<@  ,%
MP",#D&@#7K%UKQ5I?AZZLX=5DEMDNY1#%<-$3%O/12XX7\<5M5ROC?2++7H]
M%TO481-:7.H,DB'T^S3X(]"#@@]B* -S5]6M]%T][ZZ29H$(#F*,N1DX' YZ
MD5<C?S(U<HR9&=K=1]:\D.L7WA[3KWP-XCG:6XC16TF_?_E]@#K\I/\ ST4<
M$=Q^9[$ZM=ZUXWU30+:]EL8-,M89))(50R222[B.75@%55';DGT&" =96;J6
MNV.EW%O:S,\EY<Y\BU@0O+(!U( Z =V. /6LCP-KU]K-CJ=MJ>Q[[2M0EL)9
MD7:L^S!#X[$AAD>M87AEWN/C;XT:[R9K>UM(K4-_#"5W-M]BV"?>@#L+'Q#9
M7FI-IKK-::@$\T6MRFQV3IN4\JP]=I..^*UJ\Y^*!D@UGP-=6F1?+KL4*%>I
MB<$2#Z$ 9J"&Y\9:U'XK6S\1I:RZ3J$D5J%LHR) L:,$;(.%YZCGGKQB@#TM
MG1656907.%!/4XS@?@"?PJI;:D+G5+VQ^R7<9M!&3/+%MBEW@G]VW\6,8/H:
M\TMM6OO%'B/X>ZH=0NK/^T+"[FD@AV;$D1$!*AE/7<PYSQTQSG8D\6ZAH^K>
M/9+Z;[7::+;6\]K"(PF-\;L5R.3D@#)H ] HKS[5=;UOP]H^@>()-2:]ANY[
M>*_M6B0)MFP-T150P*L1@$G(Z\\U6FU'Q/>7OCB"+Q ;9=&*/:F.TC)Y@\S:
M=P/RY//<^H[@'I5%97AG4I=9\*:1JDZJLUY90SR!1P&9 QQ[9-<&^J^*+G1/
M&UTGB%H)-#O)_LWEVD7S+'$KA&W _+R>G//7M0!ZC17GBZWKMOJG@Z_FU,2V
MNND1SV(@18XMT)D4HV-^01SEB#Z"JVO^)=;TH7%XFJ">6'68[<V]M$KVT=NT
MBH$D<J#YN&R0K$@D=!0!Z917&S:Q?Z)\15L]5U)FT;4;1Y;+?'&JQ2Q\R(6"
M@GY/F&3V/6MOPT]]/HD5WJ$\LLMTS3HLB*IBC8DHA"@<A=N<\YS0 NE>(K/5
M]5U33K>.X6?3'2.?S8]@)==PVYY(Q[#K6M7F-KIVLZCX\\=QZ/K?]E2+-:$2
M+;)*6;[., [L@+ZX&3ZCN[0_'.J^(;'P]:F&:*^O+:YFNVL_*W9AD$6$\T[0
M&)+'J0!@>H /3**Y_P )GQ"+2\A\0KEX[EA:3,8_,E@_A,@C^4..0<<&L[4-
M8O)?&]WHDFH-I5I%I@NH)U5,RN6(9LN",( O ]<GC% '8T5Y4GB3Q:_@GPEJ
MLM^D%]JNJV\$R/:*!Y4C$#CK@A0W8X;K70W US3+NPL+WQ*]Q'*L[EH+9!>3
M-D;%5 C+L4$Y; YVYP#0!VE%>51^+?$=U\/_  MJL=]'%?7>LQV%RS6ZD2K]
MH:/D=!D*,[<=3@BM>*\UJ#Q-XA\/76MSW$8TM+ZWN1%%'+ S,ZE5PN"/E!&0
M2/7O0!WB.DB[D967IE3D4ZO*_#&L7^F^!/!=G%=7=Q<ZR H;$1>%5C:1MFX
M$G 'SD]2>>E7[_Q#XH\+:5K=SJ,9F@,T$6D2W9B\S?*0A$HB.TJK'(/!(X-
M'7W?B*SLO$>G:'+'<?:]061H6$?[O$:[FRQ]L=,]:UJ\[U2RN[/XJ>"3<:I/
M>JT5\,3)&I5A$N2-BC@\<'IBNA\9:]-H>G6*6I5;O4M0@T^"1QE8VD/+D=\*
M&('KB@"ZWB*S7Q5'X=,=Q]M>U:Z#&/$>Q6"GYCU.6'3-:U>=M8W5O\9;&.35
M+FX#Z%/L>1(P\9\V/.-J@'L>0>_;@48_%FO/\)M*U\ZB?[1>_6"5Q#'B5#=F
M+!&W ^7TQ0!ZE5*UU(76IWUD+2[B-H4!FEBVQ3;ES^[;^+'0^AKCKJ?Q+J?C
M_6-"LO$ L+:&RM[F%ULXY&0L[ CYNH(7G/X8I8]:ULZKX]M#J*G^RH89+)O(
M7$6Z%I#Q_%SQSGI0!WM%>8V6N^(X++P)J]UK'VF/6F@M[JT^SQJA\R$OO! W
M!LKD\XYX J;6/$^K"+QI(FHG3KK1,&RMO+0B9?+#*S!@2WF-E1@C& !S0!Z1
M16?H;7KZ'92:BQ:\DA5YLH$*L1DK@>F<?A7!ZIXEUO3I[:X&J"XD;7H[.:&V
MB5K5('DV!"Y4'S ""<,2&SGCB@#TRBN"^T^(M4\<>)=%AUYK.UM;:VFMVBM8
MV>,N'XRP((^49R#TXQ67_P )7K\OPZ\->,#?-' K1G6(HH8SOA+;&D&5)!!P
M2!QC/3% 'J-%8FG7=SJ'B+4)8KQFTRV2.!(PJ%7F(WNP;&2 K1CKC.[TK&\4
MZAKD/C;PWI.FZDEI;ZDET)<VZN5,: AAGO\ -QVR!G/0@':45Y:GC#7O#S^(
M]&U2Z74KRPN;..SO3$D9=+E@HWJ,+E.?0'':M^'_ (2Z'6+H&2X_LF2R9EFO
MA;F6"X'3:(N&4CL>A]N* .MO+C['93W)BEF$,;2>7"NYWP,X4=R>@'K265R+
MVQM[H0S0B:-9/*G3;(F1G##L1W%>=:+J'BJ\^'#>*Y_$0,KZ-),MM]BCVK*N
M6$F?7"X(QCGVJ_9^)K^_?P;HXNFBNM5TL7UW=*B[R%C4X4$%069LGC@ XZY
M!WM9-_XBL].U_2]&FCN#<ZD9! RQ_NQL0L<M]!T&37$ZEXZU+PJWBJPOG6_F
MTV.WFL+B10I<3ML59 H ^5SU &1[U/K5C>VGQ'\"&YU6>]#27882QQJ _P!G
M;E=JC /H<]![Y /1:*YWQKX@E\.: MQ;!/M5S<PVD+.,JC2.%W$=P!DX[XK.
MO=3U3P]XTT+3IK^:_P!.UD2PGSHXQ)!,B[@RE%4%2,@@CC&?:@#3U7Q=9:7+
M<K]EO;M+-XTO'M(A(+<O@C<,[CP03M#8!!-=!7GW@*SN(_%7C!WU.[F$>J!6
M1UBQ*?)C^9L(#D?[) XZ5Z#0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 9VAZ2NBZ/#8+*9F3<\DQ&#)([%G<CMEF)_&DTK3KS3M$2RN-5FOKI0
M_P#IDZ*&)))&0,#C('X5I44 4=%TN+1=%L]-A9G2VB6/>W5R!RQ]R<D^YJ]1
M10 4444 %<YXBU=1!=Z6MKJN^6,QF>WTZ2= &7G:1P3S^!KHZJZE>'3M-N;Q
M;6XNS#&7$%LFZ23'91D9- ''^&+^V\-^'+71/L.O75O;)Y<;/I$JL5YX; P>
MOM6)HFFQ:'.+:WNO%K:"DOFQ:2^E.40YW;?,V[]@/\.1GOGG/J4,GFPQR%'C
MWJ&V.,,N1T/O3Z //]%NTT;5-9OEM]=F;5)A.Z-HTH$;A0HQCG& .#^8K(?2
M[:3P7?\ AAAXA-M>W#SR3?V+)Y@+2>8P';[WMTS7J]% 'GUS=+=^)]*UR6#7
M/.TZ*2)8ET64+(),;R>X/RC&.GO4GA[7;[3IM3344\1W\,ER9+5YM*D#(I&2
MO"_=!X&?0^U=[7/7/BZVANFC@L+^\@BO%LI[FUC5TAE..&&[<0-P!(! S[&@
M#)GU<3^)+75C;:[Y5M"\26IT:4K\^W<V<9W?* #V!(QR:H^)G@\1:AI%\D/B
M&RGTN<SP/%H\C,6(P021]TC@CO7H;2(C(KNJM(VU 3C<<$X'KP"?P-9.E>([
M75]8U;3(8+B*?2WC28S* &+KN4K@G(QCKCK0!YK8>)S)\4/$,]F]_'+-9VL1
MC&EO*69 ^X[ 0RD9&,DCDY!JMXFU'3-'C\(:98QZM:-:ZK]J:6ZL6$DA*R;G
M((&XL[<@8Z\8KVNB@#SJ9[>[&K7%S;:X^HZE:_8WN%T:4+##@_+&ASCEF.23
MR?0 4R:#3+SP1;>&+VR\12Q6L<:6]U'I4J2QF/'EN."-PP.>_I73W_C"ST_Q
M FAO97\M_) ;B-(80X>,'!8$'U['FH9/'NBCPQ?Z];FXN;?3V9+J&.(K-"R_
M>5D;!4CWH R;2^C.K6NJ:K;:Y?7EG"\-LRZ-+$J!\;VV\Y<[0"<XQT R:=Y^
MD_\ "8_\)+_9&OB[^R_9BG]F2[3@DAR,?> ++GT)KMK:=;FUBG0$+*@< ]0"
M,U+0!Y?J-C:WVHZ]/&WBFVMM<@$5Y;)I+$%A'Y88,4) V]0.OK3Q#&#X;;_B
MHG?0@?*:31G/FDIL.[ &!MX 'XDUZ;10!R.LZU8:YHM[I5UI7B%8+R%X)#'I
MLH8*PP<$KUYK)LY8@^EG5(=>OTTOYK1/[%DC <*5#O@'<P4D#&!R3C.,>B44
M >83Z]H7BKQ;I&LVNEZS<)I/GK)-'ITO^L.T+&PQS@Y;V*CUKKO^$NM_^@1K
MO_@LE_PKH:HZKJMMI%M'-<EB99D@AC3&Z21SA5&<#)/J0!R3P* .$AFN[32Y
M-,M;OQ&+27?DS:&[RQAB21&V  .3C<&Q27-II?D^'H],M/$FG'0BPM6BTIW)
M1DV,#N4@DCOZUVFCZZFK2W,$EE=V%U;R-&T%V@4L!@[D()#+\R\@]^:UJ /.
M$,5CK.HZAHZ>(;$:GM-W$=&DD!D QYB9 VN1USD'J1534-*TF2RT5-'M?$ND
M7FBJ4LKN'2Y'8*PPZNK+APW4Y[_4UZE39)$AB>65U2- 69F. H'4DT >::C#
M%J6CV]C.WB629;R.]FNY-'<O-*A!7@*%51M P!T'KDF6R*:7K.JW^GQZ[;QZ
MGAY[3^Q93")=N#*HZACU/.#W!ZUZ110!Y2FFV\7A;1=!0>(!!I-U'=0RG19-
M[&-MRANV,DYP!GCIWT Z6>N:AJFDQZ_9/J2K]LB.BR2(SJ,"1 <;7Q]0>,@U
MZ-10!YG=VFFOI>@Z=8V6OVEMHMTEW"/[(E<R2+N^^2!G.YB<8))ZBAXHX/$=
M]J^EMXET\:DJ_;K=-'=TD8# ==R_(V.O4'TKO[O4&M+^QM18W<XNW93-"@,<
M&%)S(<\ XP.O-7: /(AH%C%X;T73K:3Q7!?Z,S-8ZBFE.'CW?>7;MP4/H<_6
MKVHVR:KX;ETJ]F\33W%Q+'+<7KZ,^]S&P9%50H5%!'0#N>Y)KT^FR2)$H:1U
M12P4%CCDG 'XD@?C0!Q=[KD]Q=65W;QZY!/;HZ.IT65XI@VW.Y>",%<C!K/L
M3!I5A96FFQ^)+18K]KVY\K2'Q<EV9FC(V_*A+< = !]:[E]09-:BT[[#=LKP
M--]J"#R5P0-A;/WCG(&.@J[0 U&WHK@$;@#AA@CZBLS5M*N-1N].GBO1;BQG
M^T*OD[][;'3!Y'&'/3G/>M6B@#$\3>%M.\56,-O?I\]O.EQ!,H^:)U(.1['&
M".XJ*]\,%_$R^(=-O39:@T'V:?=%YD4\8.1N7(.X'H01Z<BN@JGJNJ6NC:;-
M?WK[((@,D#))) 4 =R20![F@"'1-%M]#LY((&>22>=[FXF?&Z65SEF../; Z
M  55U+PU%=ZW!KEE<-9:M#$8//50RS1$YV2*?O+GD8((/>I]*ULZE?7ME+IE
M_8SVA3=]IC7;(K D%'4E6Z'/.1WHUW7[30-%OM4G26>&R4M,EN SK@9/!(QP
M0>3WH K0^'/-UN#6M7N_MU[:HR6JK'Y<-ON^\R)DG<1P26/'3'-<?X3@EU?5
MO'%O9ZRD$-SJKJZQHKOL,:#?&V>">1DAAP..N?2+6X6[LX+E 0DT:R*&Z@$9
MYJ:@#F+OP5:O<>'Y=.NY]._L2-X(!"JMF)U564[@><*.>O6G1^#X3K'B"]O+
MC[3!KD*0W-LT>%"(I0!3G/1CGWZ8KH9Y3! \JQ22E1G9'C<?ID@5R5K\3/#]
MSI=KJK_;;;2[J3RXKV>V98=VXK@L,[>01DX'O0!-9>"S#9:9IM[JDM]INF2I
M+:PR1!7)3_5B1P?G"\8P%Y SFG1^$)([CQ',-3);70!-F ?NL)Y8V\_W?7//
M/L=$>([4^+O^$<\BX%V;,WHE*CRS&'5.#G).6].U;% &;H&E?V%H%CI(G,Z6
M<*01R%=I*J !GWP*Q(_!3QZ=XCL_[4)77I)))V\@9C,B!&V<]-H&,Y_&NMHH
M Y27P;)+%X<0ZF1_83*T)$ _>D(4&_G^Z>V.>?:LZ?X:"73+[34U^^CL9[[[
M?#$(XSY,GF"0\D98;AP">_>N\K$U/Q/;:9=7,#V6H3_9H1/-)!!N1%.>K9'.
M%)Q0!SOB$:/XPO;?PD?M-W>:?>0S7<CPN@B11EB7VA3O4E,#KO/&!7>US.G^
M-['4XK":WL-3\B_!-M,UMA'PA?&<\9"G&<5H>&_$%KXHT.'5K.*:*"9I%5)U
M"N-CLAR 3W4T 46\+3P:]JFJ:;J\EJ=5$?VI&A63!1-BM&3C:<>NX9[53U/X
M>V-QI^CQ:1>7.D7>CY%E=V^&90WWPX;APW4YZGZG/84A. 3C/L* ,[1M+DTN
MT9;F_GU"[E;=-=3!59SC PJ@!5 Z #]22?/_ !3=P3>.;M;GQ)<>'W@@BB@%
MS8QSPW Y<O&9%(!RP4X.25YZ"NF/Q!TI9-35K/4]NEOLO76U+B XSD[221CG
M(SQ5RY\9:7 -$DA,MU;ZS.L%K<0 &/<P)&XDC' /OQ0!B0Z#JOB?2;(:EK32
M"PU-+VTN_L(A>X" %2R$\#<7' &0 >.^SJ?A:2^\36>O6VK7%C=PVS6DOE1H
MRRQ%@V,,#M.X9SS7144 <-#\.!;:%8:1%K5R;>QU(:C"9(E8AA(9%7MD;F).
M>3ZCI6POA@GQ7=:[+>[VN;(64D BPOE@E@0<YSEC70T4 <-_PK6!O"=GH;ZS
M?E].E673KQ B26I7.W&!SP2#GK[<5<F\#)JGAV^TOQ!JUWJLUXJJ]VRI$T>T
MY3RU487!YSR2>N1@5JQ>([67Q9-X=$%PMW%:"[,CJ!&R%M@P<Y/(/;M6Q0!R
M$/@N^?6-$U34?$MW=W&DB58R+>-/,#J%.[@\X')[]L=]7Q1X:M/%6C'3[J66
M!DD2>"XA.'AE4Y5U]Q_4U;UK5H=#T:[U2XBFE@M8FED6%0S;5&20"1V'K6;+
MXOLH6\/AK:[QKA46[!!M0LF\!SG@X';- %:S\(7:>);+7K_Q!<W=W:VK6I"V
M\<:2*S G( ..@Z'\0.*RW^&>[0Y-$'B"]33%NQ=6T"Q1Y@/F^:1NQEN<XSP,
M]#@8Z_6M5AT/1KO5+B*:6"UB:6185#-M49) )'8>M3:=>QZEIEI?Q*RQW,*3
M(K]0& (!]^: ,BS\-26OBZY\0'46E>XMDM7A:( ;4)*G(_BR3GMST%5QX0D7
M4/$EXNIG?KL:1RKY Q$%3RP5YZ[2>N>>?:NHHH Y ^!W.E>'-/&J,(]!ECEM
MV\@9D,:E%#\]-I.<8KD)[R.X\4ZM.?%USH5\;QE2QN]-CG<! $5HRZ9*MMW
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M!'/(Q75LP52S$  9)/:L#3_%MOJ5]8PP:=J!M+^-I;6^\H&"0+SR024R.1N
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MW&,'JW3CKC.,'FNBK/U;39=16U,%]-9S6TXG1XU5MQVLI5@1RI#'/0^A% '
M7_BJ5_!+ZUH/B.:Z4:M!"IDB021([QHT,BE.",MSC/(Y-=!-JFJ1_$^328+H
MR6CZ&]W';2*NT3"54!W ;L8/3-27G@.PO]'U>SGN)A<:I<)=3W40"%94V["J
M] !L7@YSSD\TD?@C.M_VQ=ZYJ%S>M8/82,RQJKHS9/RA<#G&-N.G).: ,?PG
MXCGU;4XM,OM3U'3]<CM'%[IM["BEI/E_>PG;AE&&P 2,$''%<ZNN>,$^%EIX
MY_X2%I;BU)DFLFMXQ%<1B8JP8@9#8Z$$   8SR?0XO#D5M?:?JFJZF]W)I4,
MB6\TZHA4. K,[#[QP,=AR>,\UR'PXT$:W\,M,L;Z_D>P$KO/8E%#9$S,$8]=
MA(#8QDYZX.* -2YU;6O$5_K]II$EW;/I[)!;F%H5 E,2R;I ^21EL8Z84]^D
M,U[XI?Q3X8TJ[U064E]IUPU]';1QNJRQA 60LIY^8]<@>AK7U3P*MUXDEUW3
M-;U'1[NY18[P6A0K<*HPI(92 P' :K;>$H!KVE:K%>7$;:9 \$,/RLK*^-Q8
MD;BQV@YSUH Y:QUSQ(OA774B>ZU6ZTG6VLS)$B?:9+52C,5& IDVL1TY^M+<
M^*'NOASXEUG0?$-Q++:*TD7GPJ)K0J@S$ZLO]X,<D$\]3BN@M?!9L5O3;:U>
M1RW>HG4C($CRLI&" -OW"!@@]N]%WX(MK[3]=@GO)5N-<"K>W$2*I*JNT*JG
M(''<Y/)YZ8 *@UR[U'Q7I/AM;J2W5]'_ +2N9HP-\IW*BJ"0<#)8DCGITYKF
M];\4^(=.\/>.+!=3D%_X?>%[>^\I-TL4P#*KC;MW $@D =C]>TNO"$4UQI-]
M!?SP:II<1@BNU13YD9&"DBXPP. >,8/(Q46H^!;/4]!U;39KVX$NKR+)?7:A
M?,D(   XPH 50!CH/4DT 4EN]7TKXC:387&KRWMIJME<220R1(JPR1["#'M
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MS5=4"%_)<[E  VCJ,>F._-=#;>"HI-)O+#7=5O=;^U0&W:2[*J4C/90H&#D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0,8&._7C !['17"R:UJ&N>(5TB R1(FE0WKB"X$+L\I89#8)PNT=.[<YK?\
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MA>68/OW.64Y);)/3\N*==^#89?$?]O66J7^G7TL*PW36WEE;E5Z;U=2-P[$
M$"K5WXCCM/%NG>'WLY_,OH99H[C*^7B,#<.N<_,.PZUMT <3_P *QTG_ (1F
MWT7[=J0^RW+7=I=K,%FMI2Q8E& Z98\'/7Z5:NO =M?^&;S1;_5]4N3>[1<W
MDDB&9U4Y"C*[54'L .I[DUUE% &5=Z-+<_8'35;R&XLR2)D$>9<C!#C;@CZ
M<@4_1=$MM#M[B.W9WDNKA[JXE? ,DK]3@  = , =JTJ* ,G5_#NGZW>Z7=7D
M9:73;G[3 0<?-M(P?;)!^JBEL/#UAINN:IK%O&5NM3,9G/;Y%VC'IGOZUJT4
M <[;^#[.&YU^:2[NYUUQ=MW'(4"@;-GR[5!'R\=350> ;?\ LW1;%]9U61-'
MN([BV9FB)W(NU ?W>,!21P!GJ<GFNICGBEEEC216>(A9%!Y4D @'\"#^-24
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M[4)C/=NCI)*1@OLD9 3[D**ZFN9T_P %6NEZ-INE6FJ:K';:?=BZCVSJK/\
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M@\U-\0-.O=,^&?BR"YU9[Z!VBEM8Y<M);QF1/E9B27&0<$\^];G_  K/1/\
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M1P$8/MW;AC/\(Z$<<'(XH PY_$AO7\07\EZ]EH>AEX'DBP'GG1<N<D'"J2%
M'WFSGCBL+0=3O-#\/^&M&W2#6-<674[^X2 RO$K'S'8( <L2ZH,C ZG.,'H;
MGX<Z1=6NLVCW>HBTU:62>6!9ALBD?[[H-O4_[60,G %7=0\&V=[<Z9=Q7U_9
M7VG*Z0W5M(N]E?[RL'5E8$C.,<=L4 8LVL:[HXE5MYGU>^CM-'MKPAWA&S,D
MLA7^'AGVYXP!QG ;!;M?_%:VM3J$][%H5@;B8R[?EN9LHO0#!\L.<#@9&.IK
M>U/P?9:I'8%[R_ANK&X^TQ7<4P\W>5VMDL",$'&,8QTQ2Z?X2T_2=3U+4;66
M\\Z^51(IER%*IMW+QG<>3EB>23QDT =!16'X2TFZT30ELKJ\O+HK*[1M>S"6
M94)X#N.">_' S@9QFMR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HYY#%!)(
M I*J3AFVC\3VJ2N3^).I2:=X#U$6^XW=XJV-NJ#+%YB$&T>H#$_A0!J^&-;/
MB3PW9:Q]D:U6[0R)$[;B%R=ISCN,'\:UZ\YLKNZT'Q3);R7TPTG1O#_GW=HF
MTQ0\XC1<#)8)&Y))Y]AP(-5US6X/ALGBN6[DCUB\>"6QLHF_=J)'79#M_C)4
M_,3SDG&,# !Z;17&7.K7VE_$.>Q^TRW,-YIBS6MK(1A9Q+M(7 SMPP)ZX"D]
MJI:%KE[J/A72-1O=1E2XLY+FYU)H@ K11-*A##T) P./ND_PT >@45Y[IU[X
MA\5:3IVHVC7=I->3177F']W!:VVX-L"GF9F3C.",L2"H J:'4[ZW\1>,-&N-
M0NY0(;>33RI7S4:9'7:AQC(=,C(P.IX!H [RBN!M=;U*\U2ZT;-Y>#1H(8+A
MK5=C7MTR!FS(<"-1P>H)+>@P8)IO$=GJ?A#0'U1YM4=)KB_9.8_+0<;N 2 S
MH,\;MG8F@#T6HKFYAL[66YN)%B@A0R2.QP%4#))_"J>BZ?=:;9/!>:I/J4K3
M/()YU56"LV0N%P.!@?T'2N7^,$*R_"_6&9I%,:QL-DC+D^8HYP>1ST/% &[?
M^(Q8^+-(T%K*5CJ23.ESO4(OEJ&(QU)Y'IUK<KSWQ-IP_P"%@^"+*&ZNHD,>
MH R^<SRX,:$X=LGVSU';'%4;'4+RV\/^*].F\0W4"V&LBUMKR8M//Y;>4WE*
M?O,QW,JGJ-P]* /4*BMKF&\MH[BWD62&10R.IR&!Z$5YO%/>3:MXTT>=]0AL
M5TJ*YA@GO&>2)F60'#AB1G:. Q'YFNB^&MLEO\.M 9&E8RV$#MYDK. =@Z D
M[1[# H ZNBO-/$NLW6CZ_?G73J=MI,\L0L=7L9W,-K\J@QS1J1C+[OF(.0^.
M,#&MI<]Q/\0/%VFR7ETUG':6DD4?GM^Z9Q)N*'.5S@=/2@#M:P_%OB,>%/#\
MVK/92W<<3HK+&ZKC<P4$D]LL.@-<-X9\1W^HZ/X!TR^O[@G5X;F6YN/-*RS&
M(9"!QR,YR2,'"X[FI_'VF7.E?#7Q);3:Q+?1O=6\UM'/EGMHVGCPA8L6<9#8
M)^G:@#TZJ.KZO8Z%I<^I:E.L%K",NY&?8  <DDX  ZFN4M_MFD?%6WT\:G?7
M5K?Z7+/+%<S;U65)$ 9!T3AB,+@>U4?BYO6#PG-)G^SXO$%JUWZ!,G!;V_Q%
M '1W7BJ?3M/.J:AH5[;::J[Y92R/)"G]]XU)( ZG&2.XZUT$$\5U;QW$$B2P
MRJ'CD0Y5E(R"#W&*J:XT"Z!J37.T6XM93+NZ;=ISG\*\?\)+K4?A_P"&>GMJ
MM]9)?+>+*D3 ;H@CO&>1UVD8SG'!QQ0![:[K&C.[!44$LQ. !ZU1N]1N$AL)
MM/L6OXKJ9%=DD5/*B8$F4[NH'' YYKRK6H]0L=-^(/AJZU2_O["UTM;ZTFN+
MAC+%N5\QLX(++E>AXP.<UO:N;G2-$\"FQU"]B2XU2SAG3[0S"1'0DJ223CY1
MQG'M0!Z/17#Z=/+XM\0^*;2XO;RUCTV=+2V2UN'A,?R!C*=I&XECQNR,*..N
M>7L=>U[6M/\ !$MQJMU;W%QJ5Q87;V^%6X$8D&_&,9.P>V>U 'L%%>:VCZ[!
M<^.]"TK4;BYFLS;/IYO;@LZM+'N9!(W(R1A<]":U?!.MVNI:KJ5N1JMCJ$44
M0N-*U*1Y&@(+_O$9B=RMD#(/\(]: .UK#U/Q&--\4:+HK64K_P!JF4)<!U"(
M8T+D8ZD\>@'/6L?QK?:GINH65XMC?W^B1PR"\ATV=DN(F)7;+M4@NH 88![Y
M[5@7<L&L:M\-7L-6N+F";[6%ONDK@6Y!)R.&X(/<'- 'J=-D9DB9EC:1@"0B
MD9;V&<"O,K:_O+#3/&VER>(KJVBT^^BCM;ZY+7$L2R)&Q0?Q,26*KWRPK4\.
M7M[%\1]4TMOML5B=,@NH[:\N3,Z.7=2<EFVY '&3TS0!*WQ$C7X>#Q<-(N#"
M96C:W\U=R8F,0+'ZXZ ]?QKMJ\4;_DVRX_Z^6_\ 2^O:74O&RABI((W+U'N*
M '45XLUWK$/PRNO$A\0:H]_I^J.D.ZX.QD%WY95U'#@J<<\#C&*[6WO)/$?C
MWQ'HUS<W4%KI,%LL,=M</"7:56=I"R$$X^50,X&#QS0!U]Q<PVL:O/(L:LZQ
M@L>K,P51]22!^-%U,UO:RS)"\S(I81H0"WL,D#]:\:NKJ]UK1="AU:YN)KG3
M?&2Z7]I25HS.B.0'(4@;N@W=00<8R:]D,:PV1B4L52/:"[%F.!W)Y)]S0!G>
M&-=3Q-X:L=:C@:!+N/S%C9MQ49(Y/X5KUX9I\&IZ)\&-$\6:;K>HK=6,<3"R
M\S_1I8S*$,9C Y)W=>3GOTQU\TNL>+;[Q1:65R;:>PN?LEJR:A+;F B)6$C(
MB$/EF/WC@@8P.20#T2BJ.DF\71+0ZA-#<7JPJ)Y;?[DC@?,5]B<UY[I+^)/%
M'AK2?$UAJ,%I</*+F:23493"8@QWQ-#LV  #;GJ-N<YR: /4**\P\57-]X>\
M8I"-9NETC6HU@E=[B0G2Y"X D4]%#\J,\!AZ BMO6;VZ_P"$NTOPQ;,Q@?3Y
M;EO,OI('F9610/-4,YP"Q(XSQSQ@@':45Y7KD/B?0_#%O!<^('\\:_!% ]O.
M9'6WDD7;'*S*"Y )Y/4=:UV233O&.F>%'U?4YK2[BN;]Y;BY/FR,"@6%77#!
M!EFP#G@<XR* .PU:[N['3I+BQT]]0N%*A;9)%C+ L 3N;@8!)_"KM>;>,(-5
M\-_#O5FB\27D\\%]&\$@;$D4,DT:B)W)+-@,WS$@G(]*G\:ZI?:1K$]S?PZH
M_AYK14%YI<[!["7+;I)(U(+ @H<G(&WIR<@'H58>J^(QI?B/1-(:RED_M622
M-;@.H6,HA<@CJ3QZ8YZUS6K79O[IUL]8O+U1HJRQ06,K0^46R1<R2!AG< ,*
M<G@G!YK$:XO/$%K\+;BZO9H[N[$K2W,6 ^3:MDC(P">><=Z /3]7U#^R='O-
M0^SR7 MH6E,49 9@HR<9(':FZ'J:ZUH&G:JL1B6]MH[@1DY*!U#8SWQFO/T.
MH:1?^,_#<VI7FHZ?'HYO;>2\D\R6$NLBLA<\D';D9Z4:5J=W_9'@#0+<A8[W
M1A.X-TUN93'%%A Z*6'WBQ Q]T<XR" >GT5SGA.PUG3$O[35K^*Z3[09+1?/
M::2&%NB.[ %L$'!//OQ6#>VU_JWQ0U'16UW5+;3SI$5SY=K,(RKF5U^5@/E^
MZ/?WQD$ ]!JE>W=W;W5C';:>]U'/+LGE615%NNTG>0>6Y &!ZUY,-6\0_P#"
M,6UI-K=X+K3_ !:FD?:U(#7,(D4 OQ\QP<'UQSFNDU>TO/#NN>$K6WUW5KB"
MZU619ENKC?O4QNVTG )4$# - 'H5%<%I,MSXRD\5&34+VSFL=1ET^S%M.T8@
M$:KB0J" Y9B3\V1C Z5SUAKNM>)X_AW<3ZG>63:J+N*\2V8(LGEQ.-V,<$[<
MCTR".@H ]>J*"YAND9X)%D57:,E3T9258?@01^%5K#318Z/%IKWEY="./RS<
M7$Q,SCU+C!S[C!KR?0=0E\.?"BQGLY[B.?4-8:P:=YFD$"/=R*S@,2 =N><=
M2"<T >S5%<7,-I TUQ(L<:D LQXR3@?J0*XR]FN_#GQ"\.V=G=74^G:PEQ#<
M6]Q.\WEO&F]9%+DD=P1G'MFF?%:V2?PWIY9YEVZM9@>7*R YF4'.",^V>AY'
M- &^WB,+XVC\-M92JTEB]XMR77:0KJNT <]6[XZ=ZW*\\U+3!/\ %K3;%+N[
MAC_L"<-)',WFLOG)QYARP^N<^]96G>(]5M] L]+>]EG>3Q+<:0+JYG*R-$AD
M*@R $ACM"[L9YXP>: /6*BEN88988I)%62=BD2D\L0I8@?@"?PKG/#NF:WIF
MN:B+V^B?3;A%DM;1[R2YEA8</AW4$J<@XYP?K61XJL(KGXJ>#B\EROF0WP;R
M[F1,;40C&UACJ<XZ]\XH [*WN[N75;RVET]X;6%8S#=&12)RP.X!1RNW '/7
M-7:\_AN=0?Q7X^LSJEYY5O9VLEM\X_<%HY&.P8P.0.V:P(YM6C\)> =;37]4
M^VZA=6EI<%I]T;QRJ0V4/REAU#$$YH ]?HKS*XU:_P#".N^,(8+V\OK>TT1=
M2@CO9FF*2_O <$\A3M!(Z>F*TM.T_7VO]"UFWU.);)T'VT2ZC+.MVKJ-I5&0
M*C9.1MP.<=* .[HKF?'MKJ,_@^^FTBYN(-0M4^T0^1*R&39R4.#R& (^I%<J
M?%T,?C31];2]NO\ A&[^R$,A>X8PPW31^<F5S][RQ@CIEAWS0!VFO^(QH5]H
M]L]E+,NIWJV:RJZA8V8$\]SPI[?C6Y7F/B:SNETWP5Y]Q=1W5UXBBF8R2&1X
M-\<I"#=D?("%';C/-17.N:CX2F\?0P7UU>1:;:6UU:?;)3,8GE5@W)Y*@@-C
MV- 'J=%<5:Z1KT>O:=?0:HD6FRPO'=QOJ4ER;@LN4>,.@5&!YXX([<5Q:7>L
M0_"]/$[:_JDE_9:H40-<'8Z?;/**NO1P5/?I@8Q0![37/>(?%D&AZ3;ZC%;/
M?037:6N^)U"H6D\O))Y(SZ ]*V;Z!+FPN(':14>-E)CD9& QV92"/J#7C,-J
M(_@'X?DCEF\R>[LB2\K.%/V@?=5B0/H,4 >W45YS-?WOA?QOK5O'?7M]:KX>
M?5/)NYC)B9)"/E_N@CL,"GZ5:^(K^'PWK]MJD,<<HBDOFEU&66.ZCD R!$4"
M(V2-NW&#QS0!V>N:JNAZ)>:H]O+<16D332I$5W;%!)(W$ \#UKGX/B'8^7HT
M^H:;J&G6FL[!9W4XC:-F==R*Q1V*D@\9 _0UH^.?^2?^(_\ L%W/_HIJY'2_
M"E[XL\%>"H=0N[>'2K*WL[PQ0QL99V2(;%+$X4<\X!S[4 =CI?B,:EXGUK1#
M92P/I:P,97=2)1*&(( S@?+WYYZ"MRO/;:;[/X^^(4PO([(QZ=9,+F1<K"1'
M+\Y'<#KCVJKI-]?V_C+PQ:QW>I-::CILYFDNYF;[2Z*A$RQL6\O)8G''7! Q
M0!Z917B]S<ZQ'\//$NN_\)#JIO=)U:X6U/VC"[4F"@.!]\$<8/'H!SGV7F2'
M[Q4LO4=10!5TR[N[R"5[S3WL769XUC>17+H#A7RO0,.<=15VO+])O?$5UX#O
MWLIKC4KV#6YXVCDN?+EG@CF.Z-'XVMM'&,=\5TO@;6++5[;4FM9M162.ZQ-8
MZD7\ZS;8H\L[B3@D%AR1\QH ZNBN%\4333:SJ4$&HWLKP:7O2SLI6@^RN2Q\
MZ20,,YP %Y/RGC&:PXM2UG5_^%;%M:O;<ZM:2_;/(*KYA%ONW=/O9S]#R!D4
M >K45XYJMWKGA^R\>:+%KNHS0Z=917]C=RR[YXMX;,9<C)&5X[X%:]]'J_A[
M7?">IPZ[J-Y'JUREE>VMQ)NC.^,L'1<83;M/3KQG/.0#TRBO+M#;4/L7B;7;
MK6]6N3H6JW_D6HGQ',D:<(XQ\P]!Q@CCJ<LU+4M2T_X7Z5XWM=3NYM3"6MU<
MQM,QAN!*RAXO+SM4#?@8 (VCGK0!ZI17!7NI2>%OB)(^H7EV^D:I822VR23,
MRPSQ?-(BKG'S)R/<$"FW5QJ=CJ'AKPZ\TC3ZE'<W5SYM])&6= I\I90&8*-Y
MX&"0@YY.0#OZPV\1A?&T?AMK*56>Q>\6Y+KM8*ZKM '/5N^.G>N.O[OQ#X5T
M^+3+S5$8:KK=O:6LJW#336=O*3N!=U!8_(P5CD\^U7(M.CT_XUV8BGN9$?09
MCMGG>7:1-'G!<D\\<9QQ[F@#T&BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/U+1K35;
MC3YKL.QL+@74*AL+Y@4J"1WQN)'O6A6#XJ\1MX9LK2Z%BUTL]W%:MB0((_,<
M*&/7/7H!^5 $B^%M,_M;5M1D26:35$6.YCD?,954V8"]LKG\STR:9:>%+"V.
MGB62XNTTT 64=RX98,#:"  -S <!FR1Z\FMVB@"@^CV4FN1:R\6Z]A@:WC<_
MPHQ!./<X'-0Z=X<TO2].NK"WMA]GNI)9)U<[O,,C$L#[?,1CTK5KF]=\71:3
M8:5>VMM]NMM0OH;194E"JGF/M#="2.O3KZT 2Z%X2L] MX;:"\U"XMK?BW@N
M;C>D([!1@9 [;LX[5=30M/3Q#-KGDYOY8$@,C'(5%+$8'8_,>:TJ* .?;P?8
MC7KO5[>ZO[66]"_:X;>X*1SE1@,1C(..,J15Z#0[&WUIM6C1A<FU2S7GY4B5
MBP"CMR>?H/2M*H;NZ@L;.:[NI5BMX4,DDC=%4#)- &-JFAS7OBK2-4AN;R'[
M&'$BK/B&1"#\IC_B;.WGH /4"K^MZ-9^(=%NM)U!&>UN4V2!6VGKD$'L00#6
MA10!S_\ PB-H=2TK4'O=0DN=,618'DF#D[QARV1\V0 /;'&*J7'P^TBZM=2@
MGGOF&H72WLKB4*R3KC;(A &TC:/;CI70:I>MIVE75ZD#3M;Q-)Y2L%+8&<9/
M2H/#VK?V]X<TW5Q#Y O;9)_*W;MFX XS@9Z^E &=:>"M+M=7GU,RWT]S<6PM
MIS/<LPE49Y8=SAB/0=@*O>'] M/#>EQZ=92W,D$0"Q_:)C(54=%&>@'856T#
MQ&VMZEK5D]BUJ^EW(MSND#&3*!L\=.".,FMZ@# O?"5G?M?I<7=ZUGJ$BR75
MGO4Q2$!1CE=R@A1D*1FB\\(:?>:^VL>?>V\\D*P7$=O.4CN$4DJ' ZXR>A'!
MQTJUXDUEO#WAR_U=;1KH6<+3-$KA,JHR>3[#WJYI]U]OTVUO-FSSX4EV9SMW
M '&>_6@#F6^&V@MX9L=#!O4BL)/-M+E+EA/ _P#>1^WT Q[59N? ^FWGAR;1
M+BYU"6"XD62XFDN-\T[*05+.03P57@8'&.E6?#_B-M<U#6K1[%K5M,NA;'=(
M&,F4#;N.G##C)K=H QF\-V\GB*UUR2ZNGO;: VZ$LH4HQ!8$!>Y /\L5?U'3
MK/5M/GL+^WCN+2==DD4@R&%6J* .>D\(V]S9K87NI:E>::N!]CGE4HP'168*
M'<>S,<]\UA^,K.2X\:>#%MX;^."TFN&DN+.W9A #$53)"E0"<#!XQU&*[VB@
M#%'A;3GL=5MKD2W)U5"E[-*P\R5=NT#*@  +P   .3U)JI)X(L)=.TNR>]U%
MDTRX2Y@=IPS^8@PA)(.<#C'3VKI:* ,*X\*VDFM3ZO:W5Y87MS$L5R]JZ@7"
MK]W<&4C(' 88('>HYO!NEN-'6$SVL>COOLXX6 "M@@DY!+$@G.?4GK70T4 <
MY)X,L);S5[HW=\)M5,1N&24*08L>65P/E(QV_'-7['0X+/4I=2DGGN[^6%8#
M<3[=PC4DA0%50!EB>F3^ J>QU)+ZXO85MKJ$VDWDLT\119#@'<A/WEYQGU!J
MAJ^ORZ9KVBZ7'9K<-J<KQ[O.VF)44NS8VG(  [CDB@"S>Z*+O4H]0BO[RTN$
MB,.8&7:RDYY5E8$Y[XR/Q-9Z>"=+@FT62V>Y@_L??]D2-Q@%P0Y;(.XMDYSZ
M\8KHZ9,YCA=U"$JI(WMM'XG!P/PH YBZ\ :1?1:Q'<S7L@U:5)K@^:%*R)C8
MZ$ ;2-H]N.:L6?@RPLM;_MF.[U%]0-K]E::6Y+[P"2&8'@D9..,>U6O"NN/X
ME\-6>L/9_9!=*72+S-_R;B%.<#J #T[UKNZHC.[!549))P * .6_X0#2O^$1
M;PQ]HOO[,:3S"GFKNSO\S&[;G&_G_P"MQ73+&RP",RNS!<>8<;L^O3&?PK(T
MK7;G6&M+FVTUCI5TCR1W9F 8*,;"4(SAP21@G@#.,XK;H Y0^ -*;PS<>'VN
M;XZ?<3F>1?-7<6+[S\VW.-W/_P!:KUSX6M9]7CU>&[N[34U@^SR7-NR!IH\Y
M =2I4X/(.,CM6[6!X@\2_P!D:=I]Y9V\=^M]=0VT*B?9O,API4[2",9/T% "
M7?@S2+O0[;20L\$-M<K=PRPRD2K,&+>9NYRQ)))/7)K<B@2&W2!=S(JA<NQ8
MD>Y/)/O4E% '-:?X(TS3K6VL4GO)=,M)1+;6$T@:*)@<KVW, >0&8@'!["H]
M5\ Z5J>O-K2W.I6%[*BQW+:?=M +E1T$FWKQQD8/O74U#+=003V\,LJK+<,4
MB4]7(4L<?@": '0016MO';P1K'#$H1$48"J!@ 5RUG\.M%T_5Y;VUFU"*WEF
M^T/IR7;"T,F<[O+Z=><=.!QQ5_0O$;:SK&N:<]BUL^E3I"2T@;S-R!P< <<$
M=S6]0!A7GA.PU#3M7L;R6XGBU5LW!=E+ 8  4[>  !CTZC!YJIJG@/2]7TW3
MK6YNM0$^FG_1+^.XV7,7&.) .<@ '.<XKHKFZ@LXA+<2K&A=(PS=V9@JC\20
M/QJ:@#FKGP1IMUH]OILES?F.&Y6[,S3[I99E(*N[L"21@>W &, "I_$7A'3O
M$T5G]LDNHKNR??;7MK+Y4\3$8)# =^XQBK,6K3P:/>ZCK-E_9R6IF=E\X2YA
M3)$F1ZJ,XZCI572-=U+4KRV$VB-#I]W:"Z@O$N X&<$)(N!M;!!X+#KSQ0!'
M>>"M-OO#;Z%//>M;2R++/(T^Z:=U(8,[L"2<JOIT Z#%3W?AF.[GN93J6H1_
M:H%M[E$=-LJ@$<@J=I(8\K@\^PK<HH YE_ >C'45O(/M=J/L:64D%M<-''+"
M@PBL!R<#CJ..N:9#X!TFVTG2[&WGOXFTIS)97(N,RQ$KM.,@J1MXP1C':NIK
M!\5^(V\,Z?;78L6NEFNHK9L2! GF.%#'KGKT H D'AFS^PZE;M+</-J2[;NZ
M9AYLHV[<9Q@ +D   #)Q@G-4+[P!H^H:!IND327BKIFW[#=13;)[?:,#:X'H
M .<]!Z5U-% &=HVC6^B61MX9;F=F;?+<74QEEE;&,LQZ\ #T %<A)8W%W\8K
MJYC;4[.'^QX[=;J&W(C9Q*[,FYT*'@@_R/6O0** .;NO!.E7.E6>G![J&"TN
MA>J8I!O><,6\QV()8[B3[DU<U7PY;:Q>:9=W-S<K+ITOG0&-E WX(W$;>>"1
MCIS6Q10!@3>$K)M5O=0M;J\L9;]0MXMK(%6? P"00=K8XW+M/O1/X0TV2[T:
M>%I[4:,"ME% RJD8*[3P0<Y7CFM^B@ KF(O .A1Z/J&D/'<3:?>R-(UO+.Q6
M(LV\^7_=^;YLCG/>NGIDK,D3LB&1P"0@(&X^F30!E6/AZ"TO8;VXN[N_NH(C
M#!-=LK-$AQN VJ!DX&6.2<=:EU_0;/Q'I3Z=?>:(BZ2*\+['1U8,K*>Q! JO
MX1\0_P#"5>&;761:FU\]I!Y)?>5V2,G7 _NY_&F6?B-KKQG?^'FL6B-I:QW(
MG,@/F!V*C"CI]T]_PH 5/"MI'KMOK"W=[]K@MC:HS2A@8R0S9R#DE@#D_P N
M*HO\/=$GT.^TBY^TW%K>737KF20!XYV.3(C  J<\^GYFNKHH Q] \.6WA^*0
M1W=_>SR ![F_N3-*5'1<GH!D\ #K1K/AJQUN^TZ]N'N8KFP9S#);S&,X<8=2
M1V( ]^.M;%% &"/"=FNI:O?K=WBSZK$L-SAUQM4%5"C;Q@$C\?6JY\#:<='T
MC2Q=7PM=)FCGM )%RKI]S)V\XYX/XYKIJ* ,0>%K$Z]=ZQ+)/-/=VPM)XY"I
MC>(9PI7;[G\ZHZ!X!TGPY=))9W.I201$FVM+B[:2"V)SDHAX!P2,G.,GUKH[
M6Z@O8//MI5EB+,H=>A*L5/Z@BL>U\1M<>-+[PZUBT1MK1+H3F0'S S%1A1T^
MZ>_X4 ;U<ZO@?0%\.PZ"+,?V?#<K=)'GHXD\SKZ9X_W>*Z*B@#(UOP[;:[-I
M\MS/<QM87"W4 A90!* 0&.0<\$C'3FH1X2TYM5U6_G::X;585M[N*4J8Y(U!
M"K@#C 8_GS6[10!R^@>!--\..#:7NJ2I$I6UBNKMI8[4$8_=J>!P<9.3C([G
M+#\/]*/AA_#IN;[^SGG\]D\U=V[?YGWMN<;_ )O_ *U=70>E #53$01F+X&"
MS8RWN<<5R:?#K1X] CT2.YU%;&*=9HXS<;MA5MR*,@X4-SC\\UH^&?$;>(AJ
MP>R:T;3M0DL65I Y<HJG=P.,[NG/2M>6Z@AN(+>255FG+")#U; R<?04 9?_
M  C-HWB/^W9)[B6[-I]B97*[&BSN*E=O][G/].*SM$^'NCZ!>B:RGU(VT;F2
M"PENV:V@8]UCZ9Y.,YQU'-=75(W-\-;6U&GYL#;F0WOG#B3=@1[.O3G=T[4
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q'Q44OX5M%5RC-JMD
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MGCKETBS777UG8QO7MUM=Y8X$88M@#H.3S^'I45YH5K=ZHFIK)-;WJP&W,T#
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MRT61D!CP&([@9S^%<YKK7/AU/"FK:7?WEPUW?V]G=I-</*EU',.6VL2 P/S
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M,S%FW=^!T&*P_#'BC4O$Q\%Z9K$KJMY:75Q<LK%/M;1.40$C'! +D#@\=N*
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MF<%.2H7'&!CF@#URBO.8M._MKXE:]I][>:D+)M-M9C;)>R(JNQ?."K CIT!
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M='7/Z)XAN-4\2^(-(N+..#^RG@5724OYHD3>"<@8XQQ]>: )8?"FE6VH7]]
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MJR0$YSM<-N .3QFD?X>^''M-3M3:3"#4V#W4:W4@$A '^UQG:"<=<<YKJ**
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M,VFL3:-)>2N8P1MV#+?<QQMZ>W6NIHH Q(?"6BPW6ISK:%O[3+&[B>5VBD+
M!CY9.T$@#) R<5!X>\$:'X8F,FFPS@A2D8FN9)1"IZJ@8D*/IUKHJ* ,K7/#
MFF^(H[9;^.7?:S">"6&9XI(G QE64@C@UFM\/_#K0ZG#]EF$>J8^UJ+J4"3
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M"",$*R$$*1P1T]JANO"6B7NB2Z/<6C/8S2>;-'Y\@,KYSN=@VYCD \D]!Z4
M<IJ6C06WQ0TBSBN;Y;?5+"Z-\GVN3]^8RA4GGC[Q^[CCCIQ6)%JUQH/AK7K*
M&\DAL;?Q4NGK++*S?9K9S&6&[.X+\Q&<Y ;@@UZ7)X;TR;5K359(YVO;1#'!
M*;J7Y5.,C&[!S@9SG.*AC\'Z#'::G:FQ,EOJ;F2\CFFDD65SC+$,QP>!R,=!
MZ4 9VB^'KC1_%LMVNIVZ6EW:8.F01L$,BL/WRY8X.&"G YR,\U1\<0--XO\
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M)<V*E()3,^[:<95OF^<' X;-5QX,T(6.I67V6;[/J<C27B&[F/G,W#$_-W
M..M '.VNH/KWCVST?5/WEFN@1WR0-PDTKN SD=&VC  /3)-<OJUS?VGA7Q78
M_:;AH-'UNVBL+DRMOCCDDB+1;\Y(4/CD]#BO3Y_"FD7":?N@E233UV6L\=Q(
MLL2D8*[PVX@CL214DWAG1[C0KC19K)7L+G)FC9F)D8G<6+9W%L\[LYR.M '/
M72A_C%!:%W^SW&@3--$'(5SYR*"1GK@D9ZXJ'X/V5O;?#ZSEAC"/)-<JQ!/1
M;B4#CMQ6_8^#-#T_4K?48;65KVWB,*7$MS)(Y4G)W%F.[H.N<8&.E6M'\.Z5
MH'VC^S+7R!/(TCKYC, 223M#$A022<+@4 <?JVD6NM_&(V=Z9S;MX=RZ13-%
MO_T@\$J0<>V:YZTU34=(L?[!DU&1M,3Q2VF1W=T[,?(\LNL3,""1OPN<],CI
MQ7J&H>'--U+4HM2FCFCOHHS$MQ;SO"_EDY*$H1E<\X/?FFW7A?1+W0'T*YTZ
M&337^] <\G.=V<YW9YW9SGG- ')7GAZZT33?%;?VQLM[G3I)X;"T\R(6SHA_
M>(=Y*@G&0, D?6LR2.2ZL_A8&O+R/[3"D<_E7+IY@^R%N<'KG^+KSP17<6'@
MO0M-T:ZTJVM)%M;M=EQNN)&DD7&-I<MNQ@D8SCD^M._X0_1 NE*+:8#2ABR'
MVN7]SQCCYN>..<\<4 <99QW^F_\ "R-(T.Z>'[&D<MCY\Y(@>2WW,0SG@9&>
M3@&I].TN;4?$/A6[T^WU.SLHK)WU42--;B1]J^4'Y'FOOW9/((SG.16UXB\+
M1QZ/K\^BZ;]JU/58UCN8YKI\7"<*1\Q*A@FX+P #CM6)HOA>W^WVD^E:%XBT
M26"9'DDO-2+1; P+)L\Y]^X KT YSGB@#H/B%JTVC>%UGBG^SI+>6\$]QDCR
M8GE57;(((X)&001G@@U6L/"SVGB269]2MUT^_LS%)I=NCJDCJ0?.4ESM(! )
M&,Y'>NJO["TU2PGL;ZWCN+6="DD4@R&%8ND^!?#^B65S:6%G+%'<1^5(QNI6
M<)_=5RVY1[*10!QO@P"#Q6/#^I7D]Q;V9FN=$N)&;_3HR_SEF)^<QD8'8@[N
M1M-31V=WXX/B>+^TH;2]L]2EMH9B'\ZR5,>6R8<8! W?[63G...UN_"FC7HT
MSS[:0G2\?8V6XD0Q< <%6!/  YS534O /AG5]:_M>\TT/>L LCI*Z"8#H)%4
M@./]X'TH Y272$USXC1:;?ZG>W-K/X92:4P7,D22R><!YB@-\H. <#CIG-6-
M)LX/&-OXIMKZ]N(+VQU*2SMYDE(DLHHPOENA)X)P6+?Q9.3@<=I_PCNF?V^-
M<$,@U%8?LXE$\@'EYSLV[MN,\XQUJAJ'@3PWJFMG6+O3@UXX"RLLKHLP'02*
MI"O_ ,"!H QI79?BKX=\J]N)H9](N&;=*Q20@QX?9]T$@]@*RM(NY])\3:5:
M^(K&3S;B[D:QUVTEWPWV]7VI*.JG:W .1\HQ@"N^F\/Z;<:Y;ZU)#(;^WC,<
M4@GD 53U&T-MP<#/':H+/PII%B]L889BEJYDMXI;B21(G((+*K,0#ACCTR<8
MH X#2[2^\8>$TU]=;M].U*&[DFEO-CM+;%)#F)AO V;1C;C&"#@DY.G8M%XK
MF\;MJ99I;"ZDLK:+>5^SQK&"KIC[K,Q8[NO '05T/_" >&1X@?6QIBK>R2"5
M]LKB-Y <AVC!VEL\Y(Z\]:FO?!FA7^KS:I+:R)=SQB*X>"XDB$Z@8 D56 ?C
M^\#0!3^&G_),_#G_ %XQ_P JZNL&V\&Z#9PZ3#!9,D>DN9+-?.<^6Q7:>IYX
M/?-;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN0&++D D9 _ \54G^)%C#:ZM<IH^L31:3.T-Z4A0>4%4,7Y<9&#T&3QG&.:
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MDLM+U.*TN+;[1'=SPA8C\VTID,?F]NG!YXKI: "BBB@ HHHH **** "BBB@
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M..A-9'@J.ZT^[\527FGWD"W6K2WEN6A)\R(HB@C'?*G@X-:G_"$Z#_S[W/\
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M3H/_ #[W/_@=/_\ %T <9<^"-3TCX>K'' ;[5I=9BUB^CML?,WFJSJF<9PH
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MJ>G4 CFMO_A"=!_Y][G_ ,#I_P#XNC_A"=!_Y][G_P #I_\ XN@!_C*VEN/
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M;=MX"Y/S<XP:V-"M-0T_XA^*'FTZ?[)J,EO-#=@KY>%A"$'G.[<,8Q[UV5%
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M75^L=N&5K:&Y:.&=6QE95'WQQT^H.10!!X+BO7\/1:EJB*FIZGB[N548"$J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %4-7U>VT:UCFG#N\TR000Q@%Y9&.%5<D#/7J0  2>!5^
MN2\?Z3JM_I^F7^B0K<7^DZA'?);,X43JH960$\ D,<$T 65\96D#:PFJVUQI
MS:3$L]PTH#(T; D,C+][H1CKGBG#Q9'!JFG6.I:==6!U+(M))2A5G SY;;2=
MKXZ \'GG/%8VOV6M>/\ P1JVGOILNC&>%1;QW;J9'E5P^6V$A5RH'J<DX&!E
MU_9ZEXP?PRMWI5QISZ=?QZA>-,5PKQJP"(03NRS#D<8!SSQ0!)-\1HDT_6+V
M+0-5EBT>Y>"]P(@8PBJS/R^&&&Z*2>,G&1F[%XVMY-9TRR?3;Z*UU56^PWL@
M01S,$WXV[MZY7.-P&:YV'2-8'AGX@VC:1<B?5KJZDLD+1_O5DA5%/WN.1WQQ
M4]SIFK2'P 5TJY/]ELK7O*?N?W!C_O<\GMGB@"U<?$N&*UU2YA\.ZS<1:5<O
M;WQC2/\ <A "S??^8<]%R<#)P,9VG\6V4T=G_9JF^DN[47D2K(L8\HXPQ+$8
MR3@#KD'T)''^';JY$?CZRMM,N+J6?6;I(2FWRV=HT&UB3\H'!)/8\9/%0CPM
MJW@V]T.[M=&7Q#9PZ3'IMY!'L\Q'1BPE0/@$$LPQ0!T*_$O2Y=*TK4(;&_DC
MU"]_L_:B*6AGYRC@-G/RG[N0:M6_CJTV:[_:5A>:;-HL2SW,,^QF,3*65E*,
M0<[2,9X-9.O:?J]_;>&9(=!,!M];BOIK: Q_Z/"JNOS'(#/\P)VY].<9*S6&
MJ)XO\67XT&2\M+S3X(((Y3'LN2@?>A!;@$-C)P* .B/B46T-W/?V%Q;6]M9F
M],P995>,9)"[2<L .1[C!-067BY;K58--FTRZM[FZL3?6JLR'S$! *D@_*XW
M#@\<]:Y2R\/:]H2ZT/!ZWMKI\FFL;2QU!PPAO-W BW$X&W.<G;DCDCI)I6EZ
MJ/&_A_6!X=O8(1836]W-=7$;S"1BAW2'<21P<=3[** )K/Q=_;/PXUG5?$6A
MW$M@K7*3PPO&0T2R,I4?,#P!R>,]173+KUI:Q:386-K)+<WEMYMO:(P'EQ*J
MY9B3@*-RCN23P#S7'6NBZ[!\,/$?AQ]%N/M;F\2W821[9_-=V0K\W PW.[&/
M?M?_ +)U;3?$?ASQ)%I\\\4>E?V9?VJE3+",A@ZC.&^88.#G&",T :%Y\1=/
MLO#^KZG+87OG:1+Y-]9 )YL+'&#][!4Y!# G(/L:OVGBV.?Q/'HEQIE[9R7$
M#W%I-.$VW"J0&P Q92-P.& ..PKC?$OA35M1T7QS?VNG3->:_P#9H;:SW('"
M0J '<DX!/S'&<@ =^*Z'4+34+OXB>&M3CTVY^QVMK<QSRL4'EM($V@C=D_=.
M<9H Z/6-8M=$LEN;K>WF2I!#%& 7ED<[510<<DGO@=S@"L^#Q2AUN31;NPN+
M;4OLYN8(2R,+F,'!V-G&X'J#CKGIS5/Q]HFH:OIFFW.E();W2M2AU".W9@HG
MV9!3)X!(8X)[BH9+"YUOQII'B%K"ZM;;2;2<*DP4232RA1M"@]%"GD\$D8SR
M: +/AGQLOBD6DUGHNIQ65RDK"[F5!&C(Y78<,3DXSQQVSP</\37VE6^L^'8-
M2TV:YEFO@ME.N-D,VUN3\P/W=W8BJ_PTT^_TGP-9:=J=E+:7<#S;XY&5LAI7
M<$%21T84GC2QO[W5_"TME837,=EJ:W-PZ%0$0(ZYY(SRPX&: "Y\>"*^UNRM
MM U2ZN-'"-<(GE %64ON!+X(V@<?>.>G!K0C\665U::1+81RW4VK0?:+6!<*
MWEA02S$G"@;E!]R ,UA6EAJ</B;QU=OI=SY&HQ0"S8%/WQ2$H0!NXY/?%86G
MZ-XE\.V7@[6;?1IKJ?3=.;3=1T]9$$NP[3O0YVG#*.,\\>^ #M;;QG9SZ8]S
M):75O<)?-I_V250KM..JJ2=I7&6W9Q@'TJE)\0[&WAUP7-A=K=Z+$)[FWC:-
MRT1&1(C;L$8'/((]*H^*;'Q%KNBZ=J]OI$8O=/U!;R+2KB1"TL.QD9&;E0Y#
M,1R0..])J,6J:YX(UZ.W\*-IDMU8R6T%LWE":61E(R=IVJH]SD\\# R :UGX
MWBN=8TRPFTF_MDU2%I;*XE";9BJ!V7 ;<IP>-P&<5G:3XLN=7T;Q3/J^BW!L
M[*YN;=X8GC;]W&JJR?>!+?>8]N< ]*CN-.U235_ ,ZZ5<^7IB2?;#E/W):#R
MQGYN?F],\4S2]-UFPTOQKITND3L;R\O+FUF62,K,)@-BK\V0>N<X ]: -"U\
M5Z;I&@^%!:Z3=Q:;JR006>TIM@+IE$<EL]._/2MJ]\1VNGW&H+=12I;V,"32
MW/RE/F)"H #N+<=,=QZBN=3PO=:K\'[+P_<PO::G;Z?"D>XC,5Q$J[6!!(^\
MHY!Z4:AX;U?7/AG>6D_E0Z_J 2\E#?<6=61EC/L B)^&: -:T\86\WB6'0;N
MTEM+NY@:>V+2(ZRJOWERC'##J1Z=":G\2>*+;PPM@UU:7<R7MVEHC6Z!MKMG
M&1G/8] >E9OABZU/4+B%KSP>FAO"I^T2R&)M[8QMBV'.,G.XXX&.<Y%3XG2/
M#;^%Y(X7F9/$5H1&A 9OO\#) S]30!HZ1XLM=>UB^\.WVE7NG7\4(F-M>!/W
MT!.-ZE&((SP>>_UKG_A[K46B_"OPR'AFGFO)WM8(X^K.99#R3P  I))].YK:
MBTZXOO'Q\3-9SPVUIIILX4D4+).[/O8A<\   #.,DGL,GF=(T_Q5H_P^\-:<
M-*O1]GNW&J6MO-&L[0EG8;&W@8R5SA@<<>M '43>/;2VT+6]2FTZ]#Z+,T-Y
M;IL+*0 VX'< 5(8'/7VJ>S\917'B"QTJ?2[ZT_M"!YK*XG";)]@!88#%E(!!
M^8"N*F\.ZXN@>/M.M_#LL(U5]]DD<L6UMT2+M^]P1@Y[9Z$UT-Y8ZG/XL\$7
MJ:7<_9]/AN%NW)3]T7B5%!&[)Y!Z9H VM.\4IJDEG):V$\EC>3R017:LA4%
MY)9<Y4'80/J,XH\;7FG6'@[4KC5]/FO].6$_:((<;F3OU8<?0YKE--\.WL'B
M73=6T?3KW1;J>X+:U:%Q]CF3:V7"[B-Y;;C;R,G('-=-\0+&\U3P'K&GZ?:O
M<W=U;M%%$A49)]V( % #;SQ=;Z5J>E:/%I-]-+?6S2VHA"%2$4$KDL,'D<G
M]ZN^&O$<7B2SNI5M9[2XL[I[2YMY]I:.1<9&5)!&"""#WK N+'4YO&GA"_72
M[D6ME97$5S(2G[II%0*"-V3RISC-6O!-C?V-_P")WO;&:V2]U:2ZMVD*D/&4
M10>"<'*G@T :VI^(8[*]>PMK9KR]2$3O$LB1[4)(7)8@98JV!['.*X[Q5XS7
M6? >F:EHD-R]IJ5];P2G*(RCSE5XF!;J<%>,C&><&K.O6.JZ/X[EURV\/?V]
MINH6L<$\,9C\ZWDC+;64.0"I#$'G_P"N_P 5Z=J]_P"%M+AM]$Q<C4[>[DM;
M5HP((TD#$$D@%L#G'?...: ,K6;2'2?&'A^VL?#T\%MK%W)->V2R1>7.\<#[
M1LW[!@X8] 2 >2*W$U;2/!FG:G!I.ESR6FGNUQ>113)B!F42,B*S<D*0VU>!
MGCGBI/$EMJ%WXR\(W]KIES-:V$MQ)<NI0>6'A*+P6!)R>V:RFLM8\/>+M9(\
M*_V[INK7 N[>>)H@\$A159'WD87Y001T]^P!U*>++2]-I'I$,FHS75HMZB1L
M$"PM]UF+$8R<@#KD'T)K!U#Q]<36GABYTK2[HPZO?>1()PL<D>W=NCVL?O$H
M1G.,=#S4-W:>(?#?C*'7K71CJEI>Z=':7EM8,JM!*C%E9 Y *?,1V]35KQ-9
MZ[?P^&=3_LIIKBRU5;J>RMY$+QQ%'4 %B%9AN7/.,YQP,T =H\LBVIE6W=Y
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M$AT**6:7[5%]IC@<),]ON_>"-B0 Q'?(/7'.* &#QG#&NO)<:==I=:)&DUS
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M,GN<T ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M!Y'7'O110!CZ)X=MM!FU"2VN+F0W]PUU.)F4@RL "PPHQP!QTXK8HHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?7?#MMX@-
MB;JXN8Q97*7<(A91B5,[6.0<XR>.GM6Q10 @&  23[GO2T44 %%%% !1110
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M>E8^C^'+;1;W4+JWN;J234)?/N!*RD-)@#<,*,< # X]JV** .,;X;Z>TL\@
MUSQ(AN)#)*(]5D0,QZG P*Z^W@CM;:*WA7;%$@1%'8 8 J2B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>elicio2021employeestockp013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.$[,P# 8]2*Q_#NO:%J$_@Z+4]:2*?1XQ'!&;*>(S2M&(U#.ZA5P#T!(8XY
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M$[#[DMG9JCX^5V3S-P!Z$C(SZ4 =7?:K::?+#%.TAFF#&.**)Y78+C<=J@G
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M/YUFH>>.6"2)E4YPP#J"RG!Y&17F4>$^$W@2W=&$UOJ=DTT10[HPDF7++U
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MELT4:J&R.,E6 SUQQ5[PI86FL_\ "=Z9=INM;_59OE(QYD;1(N]?49!P1W%
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MGTGPQ;0R0:_";.V:V9"LEJ\3H'D8?PJ%5B&Z'( R3B@#N;GQYX:M-0GL9M2
MN8)HX)8UAD8J\APN<+T/KT&1D\BMG4=2L](L9+V_G6&WCP&<@GDD   <DDD
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M170>WD0QNHR5PR@DX]*5_$FGBUMIXQ=3&YA\^*&*V=I3'Q\Q3&0.1U ZXZT
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M>6EN\\J+>2^3;7#0N(9I.?E63&TDX..<''&: -VBL@^)=.%R(09V#7/V03)
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M61!$JDJ2,$ @CBK/Q/#R_#G6[:&*6:>>W,<444;.SL2.  ":ZZB@#A;6_P!
ML]&TNYCTF:34[6)/(CBTZ19#*8]F"VSC.X@D\#J:-)E\CXI>*+F:.9(7LK15
ME,+;'9 ^\*V,$C(Z5W5% 'BT$4\?P/T&R:SNQ=Q:A"SV_P!F?S$"W6\DKC(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6,C+YF>",J<D83 //"@<UT7@.Q6?X8:5I>H6<T>+$6US;W,+1M]W#*0P![T
M;LNMVL/]F[EF)U%]D 6,GG:7YQT&T$Y/I6E7 _#_ $[4X9Y[75&\V+0"^F6,
MV[)F0D-O/N$\I/8A_4UTV@>([;Q"EX8+2]M7M+AH)(KR Q.2.C =U/8T 37V
MN6ME>+9!)[F\,1F^SVZ;W$8.-Q[ 9X&3SSC.#6;/X[\/6^AVNL->.;*YG%ND
MBPN=LA;;M?CY"#UW8Z5DD7/A_P"*.HZG>07$FEZM8PQQ7$4+2B&2(M^[8*"5
MR&)!Z$\=:Y?4=%OK/PS?3_8+UCJ?BI-3BMH[9W>. 2H2S*H)4D*6P>>0.O%
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M2^6QGMWC#< AEW ;E(/45YCXET6^D\,>/-0M[&\<:W=VYL[1+9VD=8_+#/L
MRNXACR!P >]>O0RK/"DJ!@KC(#H5/X@X(_&@#!U+QIH^EO?>>\[1:>R+>SQ1
M%DMB^"NX]>A!. < \XJW?^(;.PGFA*7%P]O +B<6\>\Q1G=AB.^=K8 R>#Q7
MF_C-M3U;3O&VFR:1J8N0/]"AL[5Q%<1A%_>M(H D;@C:2<  !20:O^(;7[?<
M_P!J:<^MZ+KT&GQFWN([61H[M?F(ADCVD$@_PG##>/3  .WN?$ME;DJL=S<,
MELMW*L$6\Q1-G:Q'7G:V ,G@\4L/B73Y]8BTI#-]KFL_ML2F,@/%D#(/3.6
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MIF4C&TD@X^HZ?EBQH>M67B+1K;5=/=GM;A25++M8$$@@CL000?I65'J.C_\
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MLT27849;RF;&[CGG''/2K%AXPT[4=$U'5H8[E+;3GD2X$L81U:,9<;2>H]Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*)!Y/+;7/RODC"[2>N3C% &K<_$73(%U8QZ=JUQ_9,FV\$5K_JU"[B_S$?*
M<^I[ XJY>>-M+M+W2K18KRXDU6!I[0P0%A(H4-P?7!'TSS@<US45I>B+XC Z
M=>@ZB7-F/L[_ +_-N(QMX_O#O]>E,L+.^75?AN[Z=>JFFZ=+!>,;=P(':&-
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M82X#L>,XZ=_?C@&L^P\>Z??7>I61L-3MK^PA^TO9W4 CDDB_OH"V"/Q!K/\
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MT'YB,*& R?3->FT4 >>76AWMP?'.MI9SAM7L%L[.VVXDDVQ,H9E_ARS8&<$
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MXF*%P-T<A<C:H(X//!K5.GZG8?$C2]1&EF6U?1/L#O:;1%!*)5<Y!((3 .,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<U\0-4O-'\":S>V"2&XCM)-LD;*#"=I^?DCI[9/M72USGCVS
MO-2\"ZQI^GVLEU=W5L\,4:%1EF&.2Q  H Y273_#6GMX8U;4?"]PE[=7-K9P
MR(Z!1+D&.60*^"0=Q!()Z@]:Z&\\<^1KNH:/;:!JMY=V*PO(L*QX9)"1O!+]
M!CIU]L D4/$EAJE_HOA)+;2;EY;+4[2YN8]T8,21CYSRV#U[$YJYI-EJ$7Q-
MU[49=/GCL;NTMHH;ABFUFCW[N VX?>&.* (9OB+&FGZQ>Q>']5EBT>YD@O<>
M4#&$569^7PW#= 2>,G&1F]#XVMY-:TNR?3;Z&UU4-]AO9 @CF8)OQMW;URO3
M<!FN=ATC61X9^(-H=(N1/JUU=262%H_WJR0K&I^]QR.^.*GN=,U:0^ "NDW)
M_LME:]^:/]U^X,?][GD]L\4 =MJ^JVFAZ5<:E?2%+:!=S$#)/.  .Y)( 'J:
MRQXJ2#6[/2M2T^YL;B^1WLR[(RRE1EH\J3AP.<'@]B:B\?Z!=^)?!UWI^GR*
MEZ&CG@WG"L\;API]CC%9][9WWBO5_#=W/I=SI\>ESM>7 G*Y\S85$:8)W<G)
M/3 ]30!:T;QP-<U VUIH.J"*.]FLKBX=8]D$D8YW88]2,<9[>M;&L:W'I,UA
M;BWEN+J_F,%O''@ D*6)9CPH 4_T!K$\ V.H:?#KR:A836AN=9NKR'S&0[XY
M'RI^5C@^QJ7QA_;7VO1OL%G<WFE_:'_M*"TE6.9UV_)@LR_+NY8 C(]LT .@
M\<6$FD7=[+;S0RVNH?V9+;R%01<;E4 -G;M.]3NST_*K%QXI2PMKB34+">VD
MBN8K5$9T(F>0J%*MG&W+8).,8/'KQ^DZ#?6FD^)=-U'PC]HT^^UEKC[*LD95
MH'"#Y,,,,FW/;D#&3TEL?#E[9:/J^EW&G7NL^&IKB%;6POI T\<6/WI4LP("
MMM*@D'Y3CJ"0#K9O$\5A87]UJEG/9BSD2+:=KF=G"[1'@_-DL%&<<YSBDA\4
M1IX@@T34;*:PN[J)IK4R,K),%^^H92<,HY(].A-<--X)UZ7PYJECIUQ=R6EI
M?6U[HEOJ4N9,Q_,\98\A">%W=,>G)Z'4-*NO%_B#0;V:PNM/MM-2XDE^T;0Y
MDDCV!%P3G&22>G QG)P 7QXVMV73KJ/3KR33-0NA:V][&H8%B2%<J#N$9(X;
M'IQ@YJ&RUK1;?Q'XNG&FW%I>:?#!+J-PP#>>@1V0J%8YPJGT//2LOP4WBK1M
M*L_"MYH+!K$B$:J)D-N\ /# 9W;MO 7'7DD4XV'B.W\1^.[_ $RP>*>^M+==
M,GE9-CRQQNIXSQRPQN&* -NP\7I=ZI9Z?-IMU;37]DU[:;V0^8@QE3@_*_S+
MP>.>M8%GXN?5_!'B/4-?T.XDL()+J*:"%XVS$A*L@^8$D $D\=\=JJZ9I>L'
MQAX8UC_A'+R%8[.>"^FNKB-YO,8)\[G<25X;'?\ V5&*6VT;7+?P)XPT%M&G
M,]S+?FUD66/;/YQ8IM^;(X;G=C'OS@ ZR'7[*UL]%LK"TD>>^M1):6:,!LB5
M%)+$G 4949Y))& :I7'Q!L;71-9OYK"]%QHK[+ZR 3S8LC*M][!0CD$'IVK)
M71]7TW6/"OB*+3YYEM=+_LW4+-2OFQ A2'49PV&7D YQC&:JZ]X8U34--\<Z
ME;Z?,;O78(;6TM"R!]L:;=[Y.!DD\9R !W.  =3:>,8[CQ#9Z3<:7?6?V^!Y
MK*><)MG" %A@,64@,#\P%=+7#WMCJ=QXP\%WR:7<_9K""Y6Z<E/W1DC55!&[
M)Y4YQFNHTF^O+Z.Z:\TR6P:*Y>*-9)%?S8UZ2#'0'T//% &A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 445F:[K*Z'IWVK[%=WLC.L<=M9Q
MAY9&/902!P 2<GH#0!IT5RNC>-CJVO)I$WAW6M-G>![@->Q1JNQ2 ?NN3U8#
MI6SJ^LV^CQ6YE1Y9[J9;>W@CQOED.3@9( P 223@ &@#1HK'TOQ!#J&J7FE3
M026FI6BK))!(0=T;?=="#AER"/4$8(K8H **** "BBLK6_$%GH2VR3B6:ZNY
M/*M;2!0TL[XR0H) P!R22 !U- &K16!/XCN+![4:AHMW MU<1VZ21NDB(SL%
M&\@Y7KUP1VSDBM^@ HHJ.XGBM;:6XG<)#$A=W/15 R3^5 $E%<]I/B2ZU2ZL
MB-%N(].O[7[5;7H<,H4@$+(O&QB""!S]>#70T %%%% !14%[--;V-Q/;VS7,
MT<;/' K!3*P&0H)X&3QDU'!? VUBUW']DN;H "W=@6$FPN4R."0%;IZ&@"W1
M110 45%'<0RS311R*TD)"R*#RI(! /X$'\:EH **J:IJ=IHVE76I7TOE6MM&
M997QG"@>G<^U8Y\47$#61O= U"VBO9HX8I"T;A"YP/,"ME?U';.<4 ='1110
M 4444 %%4]5N[JQTN>YLK![^YC7*6L<BHTAST!;@>OX5,US$DL,,CJDTP)2,
MGDX&3^5 $U%4K2[NY]0OH)]/DMX(&007#2*PN 5R2 .5P>.:NT %%%8OBKQ)
M!X2T"XUFZM+BXM;?!E%OMW*"P4'#,,\D4 ;5%06=P]U:1SO;R6[.H;RY"I9<
M^NTD?K4] !1110 4444 %%%<WI_C2PO/%MUX8G@N+'5((Q*D=QLQ.A[H58YQ
MW!P?;@X .DHK+EU@Q>(;?2/L-PS3PO.LX*>6%0HK9^;=G,B]JU* "BHC<0K=
M);&11.Z-(J9Y*@@$_3+#\ZEH ***S;'5)9-'BOM5LVTN1FVO!-(KE"7VK\R\
M'=QCZ@4 :5%88\1K_P )L/#1LI5<V+7HN69=K*'5,  YZGOCI6Y0 45%<7$-
MI T]Q(L<2_>9CP.U2T %%%% !16'J_B-=)U[1=+>RED_M29XEG#*$C*H6Y&<
MDX'ICWJ_9W=W<7M]#/I\EM#!(JP3-(K"X4J"6 '(P>.?2@"[1110 4444 %%
M%% !1110 45%<7$-I;2W-Q(L<,2%Y'8X"J!DD_A61?>(UL?%FDZ"UE*QU))G
M2YW+L7RU#$8SG/([#K0!N4444 %%%% !1110 4444 %%4K6[NY]1OK>;3Y(+
M> H(+EI%(N 5RQ '*[3QSUJXQ(4D*6(' '>@!:*IZ5=75]I=O<WM@]A<R+F2
MV=U=HSGH2O!JY0 4444 %%%<[JGB>6VO+^STO3)-3NM.ACFNH8Y C!7W;53(
M.Y\*3CCC'.3B@#HJ*KF\ACM(KB<F!9"B@2\$,Y 53[Y('UK+C\1K)XUE\--9
M2I(EB+T7#,NUU+[,  D]<]<=.E &Y1110 45SOB#Q8GA_5-,T]]+O;N74I&B
MMS;F/!8#)!WNN.*98^-+.^N-4L197D.JZ;'YDVGS!%D*D9#*0Q1@?4-0!TM%
M97AK6T\2>'+#68X6@2\B$JQLV2H/8FM6@ HHHH **A>ZB2?[.&#7!C,JQ C<
MR@@9Y]R!S67X6\1)XGTF2_2TDM=ES+;F*1@S QL5.<<=1[T ;5%%% !1110
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M1@ R[?-Z$*![8XQ4$6EW<-GK5JOASQ)Y>LR/)=DW=CEF==K;?WGRY4 <>G%
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M([JVTYMUE;W-Y9,EN0"H((E#-@$@;BV.U '8:_8Z?JF@WFGZH<65U'Y,ISC
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M*YW<D')P#G-:NK6$=Q\7_#[O+= OI=PQ"7,BC*M'C !P.O..O?.*6\L+J_\
M""^&+CPOXA;3Q$D)(N[(2-&N,*6\WV'/7CK3[VTN[_4=,U"?PMXB%WIZ-&DL
M=]:(9$;&Y7VS#(.T=,4 9EYXDU/0F^(US]MFN/[-:V^R"<[EA\R)22 !C +9
MZ=JW+72_$%IXALK^'48(]-D@DCNH+C49;KSGVYC=-R *0020I ([<53BT^9+
MO6IYO"&NW2ZTH6]AGNK(HX"[!@"48PO'!_7FJVA:%-H *0^&_%5U$B-';Q7F
MJ6LJ6RD8(C4S8''&>3CC/)H 7PGK4_\ PD%AI&O_ -JZ?KZPR>9%<3-+;:B0
M!F2(YVC&"VT 8!(QQQ?^,7_))]?_ .N4?_HU*BL;6^L[C3YI?#/B*];349+/
M[5=V+>3N7:3D2 L=O&6)XJ;Q*E[XIT:;2;_PIKR6<V/-2&ZLE+@$$ DRDCD#
MIB@#L8I$BL4DD8(B1!F9C@  <DUYCXUU6_L]*\4ZGI^JWMQ=:?<1F*2WD,4%
MEC9F)EW;96.23\I^\,XXK2:QU26.&&XTCQ=/;QLC&%]0L@KA2"%;$@)4XY&>
M:IWWAA+]=8CD\*^)DMM6<RW-M'J5JL7FG&9 OG?>.!UR..G H U]=NY=#\>:
M7=WE_<IHFJ6TMK*C7#+%!<*N]7'/&Y5<<=QGK6+X6U2_OK"Y\-7MWJ":NNI)
M^\EN'\X6C#SE8D'C]V#'QQNQFMK489M6TBVTR_\ !>M7$%O+%,IEO+1F+(P8
M$DS<YY!]B14R/<)XCDUY?!&K#4)+5;1I/M-I_JPQ;'^NZY/Z"@#&UK6;G1_$
M=Q'KS:G::?->1?V?JUK.[6T:#8##,@.%)8,"S YW=1@5Z77GUU87EZ+N&X\-
M>(Y+*\G$\]DUW8F)V!!Q_K-P&5&0& /XG/7V.EK#JEWJQFO1->QQ![::;='#
MM'\*C@'GG!.30!I5Y[X@\)KXHUC6FMI_L>L6+V\^GWJ_>AD"'@^JG&"/\*]"
MK-L]'2SU6\U!;RZDDN]OF)(5V?*,+@!01@>_UH XKPOXM?7_ !/;1ZA:M:ZW
MIFG7D.HV8'*OYEN0R^JL 2/Z]:H#5=3U'X1OXY@U.YBU=4DO559F\@*DA_<F
M+.TKM&W.-V><YKT4:'IZ^(CKJP!=0-L;5Y%XWQ[@P!]2"O!]S63'X%TJ&&YL
MXI;M-*N9C/+IH=?(+$[C@;=P4GDJ&"GTP2* .=L+>/4_BZMW(UY$;CPY#=&-
M;J1=C-*?EX88' XZ9YQFLF_O-9M] \2^'X=2U&7Q%I^H;[%Q<OOG@9?-0$YY
M'EI(I]U]37HUSX9L;KQ+;Z\9+F*\A@^SD12E4DC#;PK@=0&Y_GD5/_86G_\
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MF*2.2-B<IT+ @'<>?>NW\?:]<>&/ NK:Q:(&N;>$>5D9 9F"AB.X&[/X5&?
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MT =+/=7L>K6EM%IYELY4D,]WYRKY!&-HV'EMV3TZ8J[7&:S/=0?%3PQ!'>7
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M_M5P9@I@ 7*X7'S9/'&,5=H YZ3P;IKW6H2QRWD,6I-OO;:*<B.=L $D=5R
M =I&1UK)EMY-=\5^'VM=+O+"UT*YN/-%Q;^4A7RC&GED<,ISD8Z <XXKMZ*
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M\.WHGL6OO*C9G@M);MW@MV.<E(R< \GGD\UN/<7ZZS#;I8JVGM"SR7?G %)
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MY:2.:-XR2P0_*I7;D;0 *BN=<O\ 0;/XCW4-Y<2-97<*P--*TGD*\<>2N[.
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MLIQ<V_ES,FR09PW!Y(R>OK0!SMKYK_%G6K%[N[-J^D02B+[0^(V:1P2G/R\
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MFN9)B9609PH;^$<G@8Y)/4YJ.'PGI$/A9_#7D.^DM$8?)DE9B$/8,3D>W/%
M'*>(M-B'C'P#91S7,<3->Y99W,F#!D@.26&>F0<CMBM#P$9+75?%6D"XN)K2
MPU%5MA<3-*T:O$C%=S$DC)/4]ZUU\':2MSI=S_IC3Z9N^RR/=R,REAAB23\Q
M(XYSQQ5K3/#UAI%_?WMH)A/?N)+DO,SAV P#@G X&.* ,#Q))/#\2_!:Q75P
MD5PUXLT*S,(Y-L!*DIG!()/.*Y2>QEN]'^(LTNJZMOTNYGDLMM_*ODLENKJ<
MALD ]CD#L*]*O_#UAJ6L:?JMP)C=Z>6-LR3,H0L,-P#@Y''-5%\&:0MOJ\ %
MUY>KLS7H^TO^]+#:>_&1QQCB@"_X?NI;[PWI=W.VZ:>TBED;U9D!)_,UYI-?
M7$:^&]4T^_O+M+GQ$L$FIR3%!=1N\@,:Q9(,8 V@G'W 0.<UZGIUA!I>G6]A
M;;_(MXQ'&'<L0H& ,GDX%<VOPV\-);1VRV]TL$-T+N",7LH6WD#%OW8W?)R3
MTQUH YMM-;4_$?Q!M;G4M4^SVB6[VT:7TJ")C;E\@@YP&R=N=OMTQ'<W>HCP
M'X0\;O=WLKV,,$NIQ).X6X@90'=D!PS*3O\ P-=Q%X2TJ&YU2XB%RDNJ(J79
M%P_SA5VK@9^7"\<8XK+O[>;1-*M_">B:%=W5I<6KP1W$D@>"V!&W$A9MQ4 Y
MQSG&![ &AX>9=3U'4M<CGDDM9Y!;VH$K&,QQ\,X7.,L^[D#D*I[U1U\)>^+[
M73Q<7%U+]@D?^S$D,4:@N )Y) <C&"H #')) X)KI=-T^WTG2[73K1-EO:Q+
M#&OHJC _E6?J/A72M4UJWU>XCG6]AB,'F0W#Q>9$3G8X4C<N><&@#S2UO]4U
M#P#\/KB75[^.ZNM76TGFCN&#21YE'S=F/R+R0>E7KNUO/#OBCQ#HMEJFI/IM
MQX?DU)!+=R/);3JQ4%')W 'KUY(]JN>)O!]IIEAX9TG1;"_-G;ZW'=S>0TLA
MAC DRP;)*@%@0!ZDXZUTVK:+!9Z!KD]O'<W6H7MF\32,#)+)\C!$  X +'@
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M16L_*DPH\L?+@J 2#UW'/;':7?A32KV\TJ[E29;C2E*VDD<[(8P0 1P1D$
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MH[@-\Q)R0 #CK6?J]C:W'@GP1K1FDGOKG5-.FGNC(29F=@6#=B 3P/X<8&*
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MEK)'=S6QB23>!Y;E<[L#/3TK?KPR2T%K\+=9U^"XNH]0L-:GDMG2X=5C/VL
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M8PJC/3)[FN,EB:Q^"_BC[-<W43VNMW"QR)<.'(^TJIW$'+9!.<YSF@#V^BN
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MK9=1CT\RK]JDA:=8^^Q2JD_FPKQ:[MI(_AEXHUH7^HG4-+U>Y-E,UY(3%LG
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M1ZOX@>RM;P:)8O#-Y3,L6H.TBHQ&2%,(!(!SC(Z5T5 '.W7@;P[>^'(- N+
MR:=;$&"-IG+0D="CEMRX]C6CHVAZ?H%C]CTZ$QQ%M[%W9W=NF69B2QP .3T
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MM8;ZRGL[A-\$\;12+G&588(_(UC+X-T81PP-'<R6D#*T=I+=RO I4Y7Y"Q!
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M^A]*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,CEN+R+R;DEV"RJ!@;E!VD@< XR.QI;?P=H5K<:?/!9-'+IR&.U*SR#RE/4
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M</<QK,ZQ3L.[QAMC'CG(.>] '!1V;>*/&/AU-:-T/[1\,-->6Z7#QJ7)BR,
M_+R>V.G->A:OI]J/"5YI[1>9;)9M&$D)?*JG&2>3T'6GRZ!ILVN1:T\#G4(8
M_*CF$SC:G==H.,'N,<UI,JNA1U#*PP01D$4 >-?8K>/X1^!!"@A:XU'3&D>/
MABQ8#=GUK3O'D\)^*?&$>B"157PZ-02%I&D'V@&0;_F)Y( SZXKL4\">&XM/
M@L(].*6MO,+B*-9Y!LD!RI!W9X[=AVQ5^/P_ID>LR:NL#F_DA\AY6F=MT?\
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MDV2S><Z;FYR3CWYZGFN=0SR_#WPY$;V\3R/%*V4;K<,&$0N64*>?FP ,9SC
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MNR*;S71POH64@L.O!)ZGUJ[)X>TF2[TNY-E&)=*#+9;"5$(9=I 4'&, #D4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 445POQ6B#^&+-O,EC9=4M%#1R%< RJ#['
MCUH [JBO*]3TL^#OB!#+X8CD7[=I%[->6WF-(KR1*#'(0Q/S%F"Y[_B:?X?T
MBVUG1_"WB:'6[2"='A:6YM[8B>Z=L*\,K^8=Q+$@Y'!&1B@#U&BO,O!?AC2M
M3U7Q+<7D,LTECXBG^S$W$@\K]U&.,-W!P<^@]*Y6/2[5/@G8ZVHD&J6FHC[/
M=^8QDBS?%#M.> 03GUZF@#W>L8ZK<:1HMYJ'B-K.W2"20J;=F(,6[$>=V/G(
MP,#N>*Y>'2[/1OB_;V^GQF"*_P!&F>Z57;]\ZRH [$G);#'YNO/6N/OK2WD^
M"OB(2Q)+]GUV7RFE&\IB[5<@GG.TD9]": /9;C4[2VU&ST^24"ZN]YBC'4A1
MEC]!Q^)%7*\YUO1-&C^*7A.)=+L%A^QWVY!;H%^7RR,C&."6(],GUK,M=/3Q
MKI6O27NJV=EJ-GJ<ZR736Y-S8B.0^7MD\P;5V =  <MU))H ]6E,@B8Q*K28
M^4.V 3VR<''Y5A>"-?N?$_A*TU>[@B@GG>56CB)*KLE=!@GGHHKG=&:W\2>/
M/$NGZVD=Y_9\%K':PW$? C>/<\@0]"S'D]1@"K?PB54^&6EHI)59+D#)R>+B
M2@#4T/Q!>:EXK\1Z1=6\$2:6UN(FB8L7$B%\L3CVXQZ]:Z.O,X/#.D^)OB'X
MZMM7MVN(%^PX3S64*3 ?FP"/F'8]NW4UBVUE?3_"[0_%$BO?:CH%P\Z/)R]W
M9I*P*GU_=C<I]0".M 'LU%<SX9:TUJ_OO%,"HT5V%M[27;@M!'G+?\"<O]0J
M52\01V.H^-['3FB%]>II\LWV.Z(^RQQ%U4RL""6?(V@#L6Y'6@#LZ*\/M%:^
M^&OP^,]U<%SKZ6QD2=E/E^=,H'7T50#U&!@UKW6A0>'_ !KKFF:0)8-*O?#L
MMW<VR3/M2=7VJX.<@D9^N#0!ZS7.:3X@O+[QIK^B7%O!'#IT5O)"\;%F<2!S
M\V<8^Z.!^9KS5M"AL?A]X*\3Z8TRZ^K6"+,)F+3K)M5HB,XVX/3';ZUVNC1)
M-\5/&<3Y*/9V"L 2#C;+W% '5Z2VIMIL1UA+5+_+>8MHS-&/F.W!;G[N,^^:
MNUXOH>I?8OAWX%MKN8IIE[JTT%[([<./,F*(Y_NLX7.>H&#P373^(M,\/>'M
M*\0[;Z^M(M0^S&6SL751&Q8(HC7 ">81ALGD9/&* .WU&XFM=,N;BVCCDFBC
M9T21BJD@9Y(!_E5#PEK,WB'PEI>KW$<<4UY;K,R1YVJ3V&:XO38WL/'_ (DL
MA;VME%)H<4[6EH?W:OND7/0 M@#G XQ]:YI- MK+X3^%_$VF":/Q%#]C%M,L
MK%I=\BH8L9P5()^7&./K0!Z?I_B"\NO'6K:#/;P);V=K#<12(Q9GWEA\V< ?
M=Z#\ZZ.O.+RZN;+Q]XTN[)=UU!X?ADA7&<NOG%1CZ@5#H.CVNIV/A?Q/;:U9
MP2*8R\UM;$2WA< /%,YD)<DYSD9!!/% '9>,-9NO#WA/4M7LX(9YK.%I=DSE
M5( R>@Y^G'UK3L9VN=/MKAP TL2N0.@) -<]\2?^2:^(_P#KPE_]!K(GBL=2
MU[1].:(7UXFB^8UI=D?98HF*KYI&"3)D%1CMG)'< ] HKQBSMIKOX):!X@ -
MU?Z')]L7<=S20Q3,'C)/4; >/515M-7BTSQM=:O96D,FG^)[9H--;9D27,>
M,_W5D+-]0@/>@#URJFJ:E::/I=SJ-]*(K6VC,DCGL!_7L!ZU%I5C9Z)IUEI,
M#(HBB"HI(#28'S-CN2>3]:Y?XOV\,_PNULS0QR&*)7C+J#L;<!D9Z'!//O0!
MJ:IXAO+#QIX>T=+>!K35!<%Y2Q\Q3''NP!TYR.<GO725YUXCTK3SXZ\"Z?%;
MQPV9^WAH8!Y:G,()&%QP>_KGWKGI+QO#.@^,;2P<VFFVNOV\1V[BMM;R>5YN
MT @A<%N 1]XXQUH ]FKF/&_B:\\*:5;WUM9078ENHK8I)*8\%S@'(4\9JIHW
MAV#3/%L>J6NIV<:7EF4-A86OE0SA2")L!V&1D#=Z$#O5+XO@GPA9@-M)U6T
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MVNIV<:7MF4-A86OE0S!2")L!V&1D#=Z$"@#L:*XCQI?%/%/AC2IYK:*POFN
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M3K<H?WMV\K*LB2-U?<6.0>X]J /6J*** "BBB@ HHHH **** "BBB@ HHHH
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M-O+>[M=+B%S;(8X9G9I'1?0%B3_A26G@CPS8ZZ^MVNC6L6HNQ8S*IX8]6 Z
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MBH8%AU&>17FG@_5I=#^ $6JQ_--::?<3)NYRX9R,_CBJ>H(/#7@+PGXBM_\
MD)K<6CWEQ_RTN1/@3*[=6!+9YZ%5]* /6**** "BBO//B'X<N=1UG1+S09(K
M+7XGED@N0H'F%$SY;GNIZ<],_6@#T.BO.7U[3_&_A&VFN[&./4;/5;*"]LIT
M!>VE^U1*Z\_PD9Y[CCU%=1-KSG4[S2=&L$O+C3XD>X5IA"B;@2D:G!RQ SC
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M95<$JZ\?=X.3V/&* .AHKEW\91QVVG"6"WM[Z_@:YC@N;H1(D0QR[D<$[EP
M">?8D6O"?BFU\6:;/=6\;0RVUR]K<1%P^R1.N&'#*0001US0!O4R*6.9-\4B
M2+DC<IR,@X(_.N1M];U._P#B+JN@SV$#:9;V<+8,N=P<OEB"O.=N-OMUYKE?
M OB=O#/P^T;?H\SZ6;Z6VENUD51$7N752$ZLH) )XQVS0!ZW17*ZYXWMM*GU
M""WCMKB73HP]S'+>+"QRN[8@(.YMN#@X'(YSTV]%U>UU[1;/5;(L;:[B66/<
M,$ ]B/4=* +KR)&NZ1U5?5C@4H(/0@]Z\Y^'WD^-X=0\4ZQ#'=M->RPV,,ZA
MTM8$. %4\!CR6;J:Z":TTCP3_;'B'_CVLGMXA);Q#Y0R,^-B] 6,@&!@$_4T
M =/17-MXIEL=:T[3=7TTV9U(,+25)A(ID49,;\#:^.G4'!YK(E^(TRZ1K&IQ
M>&[Q[?1[R6WO-T\:LJQXW,.3N/).!Q@=>U '=T5RL?C)CX@TS3Y](N(+754D
M:QNFD4^843>0R=4RO(R?J!65/\2KA=/U2_MO"NHSVVDW<MO?,)HP8Q'C<P&?
MF(R3@= .M '?T5S4OBWSV@&D6#7J2Z<-2$TCF&(Q'[JAMI^<]=IQ@#DBJ4GQ
M"MSI?AS4+;2KRXAUUUCAVE 48J6VD$]?E/M[B@#LJ*Y&V\9W4\>OPMH,R:GH
MP226S$ZL98W4LI1@,$D \>HQFK=MXJ%[H6AZG:6BS'5W18HA-]S<I8Y./X54
MEAVP>M '1T5B^*_$*^%?#=YK,EG-=QVJ[FCB90<9QG+$<?3)]JRH_',D?B6R
MTG4="O+&/45<Z?<R2(PG91DJ5!^0D= WXXH Z^BN,TKQY+JDDTHT"Z@TZTN;
MBWO;R6:,+;&$$DD9RPX_AR!QR><32>.!:V>EZI>Z;);Z-J4D<<-UYH+Q^9_J
MVE3'RJW'()QD9Q0!UM%<C+XTNWU;7=,L/#US<W6DK$S!IXT60.K,"#DXX7@=
M3GD#%5H?B*D]GH>IKHUTND:M-%;I=O(@,<DG"@IG)7=\I;CU (P2 =O17&W7
MCB]_M;6M+TWPQ?7UWI7E-(HFC0.KJ6R#D]@,#J<]!BLZZ\?W.IP>$;S0+57L
M]9NC')YTFQU**Y,9&#CE3D^WOF@#T.BJM[>/9:7/>&V>9H8C(88F7<<#) )(
M%<E9?$-KJ'P]>2Z'<V^FZU(D$5RTR'9*ZDJI0<[3@C=Q],8) .WHKF[CQ3*[
M:JVE::VH1:4YCNF$P1FD"AF2,8.Y@",Y*C)QGK6->>-KN^UKPA_8,$5QINL+
M/-O>78S[(F.PC!VX)!/NN* .Z6:)IGA61#*@!9 PRH/0D=LX/Y4^N2MM=TF#
MQ;XE\[3!8W&G6D,UY?OMS-%AR#\N3@!3UY]JLVWB>[EU#2HIM$N8[35$9X+A
M&\PQ87<!,H&(\CI@MSQQ0!TE%<->_$W3+.."]*P2:7+<BV,R72F9<MM$ABZ[
M,]\YQSBNYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** ,/PK87-CI#RWT7EW][<27=RF
MX':SMPF1P=J!%X_NU9TN^U.YT-+K4M(:SOSNW64<Z2D88@8?A3D8/;K6G5:7
M4;&"\BM)KRWCN9?]7"\JAW^BDY- '(^$/#-TGPLC\+:Y:M;2M;36TP#HXPY;
ME2I/9N^.:J_\(UJ^JZ#X<\.ZE:^5#I4\#W=WYBE+A(!A @!W?.0I.X# SUXK
MT&B@ HHHH *PM5BO7\2:--!82S6UN93-,KQ@+N3 X+ GGVK=K"U3PWX5OKY;
MG5M(TF>[N&""2Z@C9Y"!@ %ADG Z>U &%XH\#2WOBG3/$.C2>1<"[MAJ<(.%
MNH(Y4<$_[2%00>I QZ"IK;2]5\.^.M;U2VL)=1TW64AD8021K);S1KLP0[*"
MK#!R#P1T[U>3P7X(EGE@C\.Z$\T./-C6TB+)D9&X8XR/6I?^$"\'_P#0KZ-_
MX!1_X4 <I-X*U:P\-Z4;6V2ZU"'Q"-:NK:.55&&9RR(S8'RAE'.,X-;,NE:I
M=?$BVU6;3F6P.C/92RI,A"R/(K\#(8@ $9QU[5I?\(%X/_Z%?1O_  "C_P *
M/^$"\'_]"OHW_@%'_A0!S_@ZU\8:!IUOX6N-*@:ULV\N+6!<KM:#=D?NOO;\
M<8/&><^I86WB[POKFK65CHL&JZ7J%[)>VUV;M8?LS2G+K(I!)4-DC:"?Z=!_
MP@7@_P#Z%?1O_ */_"HI?!?@B"2*.7P[H4;S-MB5[2(%VQG &.3@$\4 ;5U8
MF^T:;3[F4L9[=H99%&W.Y=I(';K7GZ>&M>O?ANG@6^L"C(([1M165#"T"."'
M4;M^[8N-I7KWQ75_\(%X/_Z%?1O_  "C_P *BM_!?@B[@6>V\.Z%-"V=LD=I
M$RG!P<$#U% %6YTS4A\3=.U2'397TVWTV2S:82Q\,SJP.TMG "^G>MWQ'%<7
M'AS4K:TMWN+B>VDBCC5E7+,I R6( &35'_A O!__ $*^C?\ @%'_ (4?\(%X
M/_Z%?1O_  "C_P * ,?PX/$VB^!M-T:#P^PU.UM5@\VYN8A;A@,;B49G([XV
MY/M67J/@&^TWX4WGA[3E;4M6OKE+JYFW+&))3*CNWS$8&$P/H*ZS_A O!_\
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M<O)'CS8]^>-Q(SNX)'7K70?\(%X/_P"A7T;_ , H_P#"C_A O!__ $*^C?\
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M- 'D]W:ZCHFB_#.RN;!_MUE?)#);K(A+%8'!VMNV^I&2/PK:U?0?$.H7^O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "LO7=<@T*T@ED1I9KFXCM;:%3@RRN<*N3T'4D]@#6I7+
M^./#][KFGZ?/IC1C4=+OXK^W25MJ2E,@H3VR">?7% $L'B>=?$C>']0L([;4
M)+8W-F4N#)#<*#AANV JP.,C:>#GFN;\%VDGB,^(!KNFVEQ%'X@GD$AG9WCE
MB*! HV#A0H ;(],<UN+I5YJ_C#3O$-[8R62:9:310V[R(TDDDNW<?E8J% 7
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MS%9_[[OM&!Z*.V<GD8S=/\-ZKX=\7I?Z4IN-.U"'.KI/, QN,\3(.FXY(8#
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M;!E=3T((ZB@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,US4;S3K6!K'3WO9Y[B.
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M>,QQA 67:.Z@\'VK1T2#QM-:+:ZW)IUJUO$R"YM)&D:Y?:55RK* H&=Q'))
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M:'H^B6EW+#91WL,LEZ461'<KS\G!X.!R/<5I^.=?D\,>!]5UB)1Y]O!^Z!Y
MD8A5^HW,*JV.@ZC:?$.XU=8;9=+?38K&,"8F12C,P.W;C'S8Z]JL^/M!E\3^
M!=7TBWQ]HGAS""<9D4AU'XE0* .:\=:>ND^ =%MU1IYH-3L2S$C?+(95+-D_
MQ,<DD]S6UIWBO5%\8)X=U[28+*6Z@>XL9[:Y,R2A2-R'*J0P!!Z8_JS7+*Y\
M:^"=/ETTQ)<K/;W@CN"4&^)PS1L0"5.05/!P15R'1KS4_%5EK^IPQ6WV"VDA
MM;9)/,.Z3;O=FP!T4  9ZDGTH I^%[YK3QCXC\,?\NUH8;NS7^Y'*N60>P<$
M@=@V.@%7]8\176D^*-$TU[.$V.J.\(NVE(,<JJ6"%=N#N ..>QJAX;L'NO'/
MB;Q'C_1IC#8VK?WQ$I\QA[;R5'^X:T?&>@S^(?#KVUE(D.HP2QW5E,_2.:-@
MRGZ'!!]B: ,RP\;7-U#XG66RM4O-$G\A8([@OYY(RG.T8W'Y0.>015E]:N$\
M=V&D7.DV8N9M-EN%NUEW,I5D#1C* A<D<]\#BJB>!3;^+=+U.WN?]%CM?+U!
M&ZW4J/OBD/\ M;V=B?4"KMYHNI3?$?3M<CCMS86UC+:OF4B0EV5LA=N,#;Z]
MZ .*O-4U?6_A9XYFU=;5Q%+>PJ8W8[3&=H 4CA0!USGVYKJ=+\2ZE::UH.C7
M^F016NIV;M:2QW!>0-$BL1(NT 9![$]*S'\'^(5\*>+- C33VCU.YNIK68SL
M#B9MWSC9\NWGIG/MCG4N- UF?Q%X0U 06BQ:1%,ER/M!R3)&$^3Y><8SSB@"
MHOC.>S\.>+M6BT*TCGT>^ECEACGP)]B(3(6"<DY[CMUJ_:^+=3'B71M.U'2H
M(+768))+62.X+R*T:!R)%V@#(/&">E9$OA#7I/#?C73O*L1-KMW+-;G[0VU%
M=%3Y_DZC;GC/6M.YT#69_$'@^_$%H(M'CF6Y!N#DEXA'\GR\XQGG% &[XBUV
M'P]I7VR2,RR231V\$(;!EED8*BY[<GD]@#6:WB:]T_Q/9Z%JEG;K+J,,DEC/
M#*VQY(QEHFRN5..0W.1V'2IO&WAN7Q/H M;6X6WOK>XCN[25P2JRQME=V.QY
M'XYJL^CZEK/B'1]9U.T@M3I,<S101S^89)I%"DYVC"@9QW)/08Y ,.+XC:LW
MABW\1RZ%;1Z:+TVMT/MA,BCS_)W(-F& .,Y()YXQS6WK'C"2VO=2LM-BM9;C
M3HU:5;B1E\QV7>(UVJ>=I')_O#@\XYX^"O$)^%\GAGR[#[:U\;@/]I;R]OVG
MSNNS.>W2M.YT;Q7I'BZ^UGP_'IUU:ZLD1N[2\F:,PS(H0.C*IR-H&1CM0!U.
MAZK_ &YH-GJ:VLUJUQ$',$ZE7C;NI'L:P=-\97,UIXE.HV,%I>:'(RO L[/Y
MB[-Z/G:#AQTX)XKI[&.XBLHDNYEFN,9D=5VJ6/)P.P[#VQUKC-4T6VU;XD:9
M>V-XI0VI.IQ1$,LR12*T.XCH1)GZA6'8T :%UXKN8KI-,\FR@U1+1+FY6:9C
M%$7)"H"JY8DJV3@8 SSG%1:?XQU#5M(TFZ@T2:TDO&E6Z:[RL5EY8.2YP,AB
M %Z9SGC&*BUS1?$=CXP'B3PU]BN?M-LMK>V-Y(T8<(Q*.K '!&XCD=*35M%\
M3W5]H%\QT^_^S22O>V,LK10EF \ME.UL^7@XR,G.>"> "K+\1[A/ UUXAATN
M&=[2_-A/''<Y0D2B/?&VWY@=P(!QUZUUVCW&KW"7)U>P@LV68B 0W'FAX\ @
MDX&#G(Q[5P%QX(\32>#]>T7&F/+?:R;^&3SW5=IG64Y&TX^[C'/7KQSZ?&7:
M-3(@1R/F4'(!^O>@#BO$GCB\\/6NI:A/IL45C8W*0*EQ*8Y;Q3MW/$,8(&_C
MKG:>E0>*KC55^)?A""VCM6B(O)(EDF90S")02V%.,!FQC/4]*SM=\%^*-4L/
M%E@!ILQU2?S;6^FF?S%B!4K!MV_*J[3R#CG.,DUOZGH^NWWC#PUK'V>R\K38
M[@7"BX;):5 ,)\G(&.IQGT% &7X?U2YTGQ5XRAGM["TT;2A',Z6Y*B-6C>9G
M"[<,Q+?,>.@ZXJ]#XXNWU+2(SIL<MIJ9V@V[N[VK$97S?EQ@]"0>#Z]:)/">
MH3^)/%?G?9CH_B&VCBDD$C":+;"8B NW!SG.<\>A[+X8L_&]C!:Z5J[:6UG9
M!4%]!(QEN47[J[",*3@;CD]\#G( '^'?%>N^(+Z4+H=M#96NH7%C=R_;"S(8
M^ R#:-P)^G7\:7QWJVL:9<^'(=,^SB.]U6*WF\QV5FX9PN0#A3LY//ICK5GP
M5HNIZ)#J\>HQVR_:]3N+V(P2E\+(V=IRHP12^,]$U'6(M%GTL6[W&FZG%>^5
M<2&-9%574KN"M@_/GH>E '/F35(/BQJ_]F6-I+?/HEL6$TQCB5O,DSE@I8^@
MX^N*T['X@0W_ (;T/4!;I!=ZNTB)#+(=D1CW"0E@,D K@8')(Z<D3V>C:S!X
M^OM>FAM&MY].BM0$G8-O1F8G!7A26QU)XKF[/P-XFTWPKX?^Q36$>O:%<W$L
M:M(S07$<S,70G:".&'..H_$ '7>%_$EQKEQJ=I=V)@GL)53SH]QAN$895T9@
M/0@CG![UG:AJ^N)\4['2;<6IL#IDMQL:1E+'S(U+-A3R.0![G)[#>T/^VY(9
M+C7$M8)Y,!+6U<R)$!GDN0"6.>>,# ]R<O5-$U4^/=-U_3UM)(8[*6RG2>1D
M9 SJX=0%.[[N,9'UH IZ-XNU[6;R\$7A^ 6MAJ,]E=.MYN?$:@@QC:-Q)[''
M4>Y#K+QK>'7M!TW4-/@MY=9ADD6W$Q\^T*IO"RJ1W7//&",<]:?X=\/ZWING
M^)X)GMK:?4[ZYO+2>&4R>495 7<"HY4C/>L73O"7BB&X\(W$MKI,4FC/*+DI
M<NYN#)$4:8G8,L3\V#DD_P 0[ %B;Q_K@T?Q#J<.@6ABT*]E@N0UZ?G2-5)*
M?)RV&)YP!QUYQLWGC!?[<MM(LOLBW5Q8K>P+>2F,7&XD"-" ?FXR>N,C@\XQ
M?^$2UX^%O&FF&*R$VN7EQ/;M]H;:BRHJX?Y.HVYXSUJSJ_A>\UK2H=+U71=/
MO[1-/CBB/VC;);W(W!F5MN=I&SD<\'Y3F@"OXOO=8DUGP.%MK>,3WHD:&29E
M_>B!SM;"G@9Z\\CI5FZ\21Z0^M1:)ING_:;-_.O(@S(;FY:-794VH<MM*C<>
MI.,=Z+OPQKN/!B++!>MHCJ]W<3S,KS'RC&=HVG)Y)R31+HWBS0_%>I:AX?73
M;O3M79)I[>\F:,V\P4(64JIW*0HR.O':@!9_'.J3ZAH]EIF@J\FJZ?)=PB[N
M#$T;(%RDB[3MP6QD9S[=:ZE]2-AX?;4]61+4P6OGW2(^\1$+N< _Q8YY[US\
M^@ZT_C?0M79K:X@L;2:"YE:0H[M)M)94VD  KT)Z'VKHM:TN'7-#O]*N&98;
MR!X'9>JAE(R/<9H YJX\:7FG:=I&LZCIT46D:E)$A9)BTMKYO^K9QC!'(#8/
MRD_Q52>34[CXS3VLD%G);#1 /+>5B/*:<ACC;C<0HRO3@<TY?"VMZIX5TOPQ
MK*6@MK*6#S[R*4G[1%"P*A4QE6;:H.3@<XS6FFC:JOQ,FU\PVW]GOIJV(Q.?
M,R)2^[;MQCG&,]J +>N:I8^"O#<,D5O!;V<4D5M&/N0P!F"AF('"C.?\YK-U
MOQ=J6A^%=1UN2PL[F*UEC$30W)V7,3[!O4[3CER,<_=Z\UOZ[!>W%@L5E;6E
MUND GM[HXCEBY#+]T\^G'4<\5P\GPXN3X3\4Z3IWE:?;ZH\<MC8M*7CMV3:Q
MY_AWLO(&0!CZ  ZNZ\1R6?C6TT*6VC^SW-G+="Y\T@IY94$%<8_BZYJE:^*=
M5O[/2M6L=%^TZ5J%PL8"2'SHX6)"SL,8V\ E<Y (Y[53.B>(]4\8Z5K>HV>G
M6]O%8SVMQ;QW3.RB0KR&V#<?EZ8&/4U'X4T3QAX?M(/#DLNG2:/:/MAU$2-Y
M[0;LA/+Q@-CY=V< >IH R;34M4T77_B%>:3IMM<BUN8KB43SF(%5ME8A<*V6
M.#UP/>O1])U&/5]&L=3A4K%>6\=PBMU =0P!_.N1C\-ZVDGC9C#9_P#$\'^B
MXN#\O[D1?/\ )QTSQFNC\+6%UI/A32=-O5C%Q9VD5N_E.64E$"Y!('7&>E &
M5I'BV;7+QUL(;26*&^DM+J#SB+BV",R[V7'<J..,!LY."*Y+3-:U/PY;>/-1
MT[2[:YMK+6I[BX$MP8B4$<98( IRV 3S@=.O;:G\(7VI:_I>KSV-I9:M97OF
M2ZG:S8-Q;@G]VRA1DLNT'/ YP>U,'A/73X=\;:>8K(2Z[<3RVQ^T-A!)&J?/
M\G4;<\9ZT ;M_P"([Q9(38V<26CV'VTWUZYCA!) 6+(_B.<^P]:R#\0[J?0_
M"NIV6C+*NO3+ (WN=IA<JQQ]WD?(>>/H>E$7A[Q)#KNDW?EZ=<6T&EI9F*:=
ML6DX/S3(-GSY&!_">,9 K,T[P7XEL_#O@_3I(M.:30[\7$I6Y8!T <<?)]X[
M\^G'7G@ WO\ A+=1CECTR\M;"TUE;<W$Z/<,\,:EV6,!E7)+;2>@Q[]*K6_Q
M$6?3=%DN;1=*N=2FE@87[%8XGC[;L#=NXV],@^HP9M>T7Q%:>+XO$OAK[%</
M+:BSO;&\D:-756+(ZL <,"Q'(Z59U'2M6U&QM;;5[#3=6MIA(;^T8X5&.WR_
M*+#G;AADE2<YXX% &_I=Q>7-@LM_;);7.]U:-'WK@.0""0,@@ ]!UK$;Q)?Z
MA-K"Z#8V]TNDRF"3SIBAGF"AFC3 .,!@-Q[G&.,U/X+T&?PWX;CTR>8N$ED:
M)/,,GD1,Y*1ACRVU2!FLW3M"UGPUKNNRZ9#;7EAJUP;U%EG,;6]PP ?=\IW(
M< Y'(Z8/6@#"\5>)9?$7A#PMJNCI']BU#5[(,LTA5MPF'[M@ 1@,N"?;H:[Z
M&W@TZ"[U%K*WAO)D\V[:W&?,*KQEL M@<#(KC;KP+?V/@_PUH6DFVG.EZA!>
MSRSR&,2%',C[0%;JQ./2O05R\8\Q "1\RYR/I0!P7PEW:MX5_P"$JOL2ZKK$
MTLLTQY*(LC(L:GL@"\#W-:^I'2_!$6HZS!; 2:C-"@MHL*)KACL7'H6RN3_L
MD\UG^'M USP1]HTO2[:VU+0GF>:U1[@Q36NXY,9RI#+DD@Y!Y/!JWXH\,ZEX
MI\.RP2W,-KJ"3Q75F$)>*&2,Y7<< MGG)P,9&!QD@$K^)KW3O$]CH>JV=NKZ
ME%(UE/!*Q1I$&6C;(R#CD-W]!6!)\1M83PG<^)#H-L+*QO)(+N/[83)M67RR
M8_DPV.O.WZ=ZW'T?4M:U_1M7U6T@M?[)25XX(Y_,\V9UVYSM&% SCN21P,<\
M]+X*\02_#/6O#ACL1>7]Y+-&_P!H;RU5Y?,Y.S.1TZ4 =%'XFU2'Q?:Z+J.E
MV\,>H6TL]E)'<EVS'MRL@V@ X8'Y20.G/6L.7XB:RGA?4/$ T&U^RZ9>2V]W
M&;T[RJ2;"8_DP3WYVULZCH^KWGC;P_K26]JMOI]O<1S(;@[BTH4?+\N"!M[D
M=:PI/!FOR_#OQ'H!CL1=ZG>SSQ-]H8HJRR;_ )CLSD=.G- '01^*-1A\7Z?I
M&I:9!!;:G!-+9RQ7!=U,84LLB[0 2&!X)';)ZU2G\=77_"+2>++33H[C0XG8
MD"4B=X5<HTJC&WL2%)Y'.0>*L:CH>K7_ (N\,:I]GM5MM-AN([E3.=Q,J*OR
MC;R!M[XSFLFQ\':Y8>";[P0GV:33I1+!;7[2G=';R,20R8Y=0S 8.#QR* -6
M;Q=J5QXJ&AZ3IEK<";2UU&WNI;HHC*SA1N 0D=^F<Y'3G&GX0\0/XF\/1ZA+
M:BUN!+)!-"'WA9(W*-@X&1D9_&LRU\-W^G^/(=4MH+?^R[?15TR)3.?,RK[@
M<;<8P,=:L^!=%U'0-$N+/4DMQ(][/<*8)2XVR.7 .5'(SB@#G?$E]JG@SQQ=
M^);C2)=5T&\M8H)9;==\UALW9^7NC;LG]>@S!J^LV>F?"G5-9\#7-J;.XN/,
M#*"GD&1E5PJ@<-ELX.,9]A78O_PD-GK5_-%;6U[ILQ1H8S<%)8V" -P5*E21
MZC'/7-<K-\/+V3P/XFT^ V=M?ZU>?;5MT8^1 0R$)G&3G9R<#D],"@#IYM?O
M%UJUT"*WM3JTML]W-^]8Q0Q!@H.=H+$D@ 8'1N>.<V'Q_&MIJ,-[8^5K%A?1
M:>UFDN5EEE($15R!\C YR1D '@XY+K0M<7Q7IOBV"&T-Z+-K&_L1.=K1%]ZF
M.0KRRMZ@ ^U4-5^'][JMGK>H+<PVFO7]];W]NP)>.!K=0L2DXR> <G'5N,XY
M -B^O]6FBUO2]4TE%MAISS17L+%HG)!!C((!##K[CTK*^'^L7-QX1\-V&E00
M7*0:?"+Z=Y2JV[;%*H, [G(.=O&!@G&1G6@B\6:CI%Z-6MM-MIWM7@BMK:=F
M1W88WLY7Y0.P /4Y)XQSWAKP7K_A.;1KG3$L0WV1+76;8W#".<HH"31G9P_7
M.0,CCWH ]+HH'3G@T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<?\2M3U32O"HGTN6*)
MWNX(9'?.[8\BJ0N.F<]?3/?H =-J.FVFK6$MC?1>=;2C;)'N(#CT.",CVI]I
M9P65E':6ZLD$2[$7>3M7L 2<UA2:[?2Z^GAZU6T_M&.S^UW4SAFBC4MM10H(
M))(/<8 [Y J3PKXD;Q!%J$%S;"UU'3;IK2[A5MR[AR&4X&58$$9&: -#3-#T
M[1FN6L+<PFYE,TW[QF\R0]6.2?F/<]36A7(ZMXMG@\17NAV+62:C!:K<6]O>
M,5:]9MWRQG(QC:!GYN3T&,U<37[MO'4_AQH80HTP7\<XSD$R%-K+^&<@T =%
M574-2LM)LWO-0NX+6V3[TLSA%'XFN3TSQW-?Z'I\S6<2ZE?ZC-I\$(D.S=&S
MAG)QG:%0MCZ#OFJGC&\U>?P+XTLM6T^.-+:R8V]Y$<1W*LA)PI)*E2,')/;%
M '?QR)-$DL;!D=0RL.X/0U%>7UII\!GO;J"VA!P9)I B_F>*X_2_$>JV6M>'
M='O["U2SU6S?[*\4Q:5&BC5B)!C'*GL3@]SUK2^(8!^''B3(S_Q+9_\ T T
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M+JI^+'AN& VOE"TO'B60MZ1ABV._ICUJ:S\266A:EXOMYM(L]/LM#ABN6>S
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MD9E?!//*@BLGQ?X3O?%,6H6=S9:;-$^#IMZ\K)/9/L +<)V8%@ W/0^W;T4
M<:_A[7;'QHNL:;+97,-QIT5C<M=NRNC(Q(D 4'?G<<KE>>]8-I\/_$5CX5T%
M;6]T]-=T.[FGMF)<PS)*S%XW.,C(;&0.WOD>H44 <1X@T#Q/XE\#ZKIMY)IL
M>H7Z+$L4<C^1 H.2=Q4LS'OP!T';)MW>AZQ=^,_#VLE+%+?3K>>*=/M#EB90
MHROR8.-O<C.>U=95&VUC3KS4KK3K:]AFO+0*;B)&R8MV<;O0\'B@"EXL\,VW
MBWP_-I=S(\)9EDAG3[T,JG*N/H?S&:J3Q^+;K2&T\IIEO=21^4^H),[!<C!=
M8M@^;N%+8![GOTU% 'F/B#1(_##?#[2-%B1DM-298UF<J'/DR%BS '!)).<=
M3TK>N/"=UJUYK^HWS0P7>I:8=+MTC8NL,6&.6.!DEGS@#@ =:NZ[<>$?[2M?
M[=OM-CO;<[[<7-TL;QG^\H)&#[BM,ZYI(TI]5_M.S.GH"6NEF4Q@#_:!Q0!R
M%UX5\27G@_P[I4G]E"ZTN[M)7*SR!&2#&,'9DEL>@ SWZUHQ:!JVC>,=4UO2
MEM+BVU>.(W5M/.T9BFC7:'1@C94CJ, ]_:NHM+J"^LX+NVD$EO/&LL3CHRL,
M@_D:FH \]E\!ZC;Z7HEM926<L]MK?]L7LDLC1B1R7+*@"MQ\^!GLH]:UK?1-
M:MO&FNZY&MAY=[9106ZM,Y*O'NVEQL'!+<X/&*ZRB@"IIAOSI=L=5%N+_P L
M?:!;9\O?CG;GG'UJW13)IH[>%YII$CBC4L[N<*H')))Z"@#D]/\ #^L6WQ(U
M3Q#,MC]AO+6*V5$G<R+L.<D% .<GC-3W.B:H_P 1;77XELS90Z=)9E6F82$L
MZONQL(P-N.O>M?3M>TO5KFXMK*[22XML>="05= >02I .#V/0UHT >:_\(#K
MK:#=QI=V5KJL>NR:UI\T;M)&&9B=D@*@XPQ!QGK^%=?H*>(Y-UQXB;3XI=NQ
M+>P+L@]69F )/3 QP,\G/&W10!RWBOPM<:MJ&EZYI-S%:ZWI3L8'F4F.5&&'
MC?'.".XY%:%L_B"\")>VMEIZ @R/;W33LV.H7,:@9]3S[9Y&S10!QNG>'M;\
M.:GKO]D"RN+#5;EKV,7$S1M;3N 'R IWJ2 1R#V]ZJ6W@6[TBY\&0Z8UK)9:
M LWG-/*R22M(A5BH"D=26Y/M[UWM% '%VWAS6H-2\873)8%=:"?9U%P^4*Q"
M/Y_W?'KQGT]ZYR33=4T'5?ACI;):2WUDEU 0LS"-PMO@D,5R"1GMU_.O5ZP@
MGAS7]==E:VO-3TD@%D<EK4N#P"#\I(4YQZ<T <]K'@O5]5M/$=[%=6]IJ^JK
M!%$@=C&D,1SY;, "=^6W$#H0.<9,UEX=\10>,#KK1Z/%"^DK8FTADDQ&RNS
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MX?UW1?&NJZMHQL+G3]8\M[F"ZE>-H)47;O0JK;@1U!QSW%8UMX%\0P?#_0]
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MB0:>'\H=RQ+\DGCL,#US5/PQX1'AW5=8N1<>9;7-PTEG!VMD?#2*/3=)DX]
MM &>GCC^SU\8W6K6D$,.A2H/]'8LTVZ,,N20.3E1TXK.\1'66\6^!)-3%D%D
MOW8QP*P:%_(?Y"23O'7G"].G/%NY\!76K1^,K749K>.VU]HWB:%V9H61%5<@
MJ >5!Z^WO22>'/&&I7/AN;4[G1Q+H]SYLDL1D8W \LINP0-IYZ9(]^U !?\
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MB&-F94E+!B,':#C:.&Z\4^7Q/XEN==\3:7I]CI:-I"0R1R3R.P<.C/@@ <G
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M<91223O4D$;L+ZXK6\4ZW_PCGARZU7RC((-F[Y2P16=5+D#DA02Q [ UD?\
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M0YR<@8^Z.,>O)H Z2BBB@ HHK UF]U^VGO);&&P%C;6HEWW&\M(_S%E !
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M)T+I*C*#@D,",^E #Z*;O3 .Y<'H<U6U34[31M+N=2OYEAM;:,R2.QZ ?U[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"VMY[M_,N)(H@K2MZL1U[_G4=YH&CZAJ4&HWFF6EQ>P#;%/+"K.@SG )]^:
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M7@3XB_V7&8HX_$#B5;<;2D!$/F8 Z?*6_#-=7XCM8$\6>"+S0TA5YIG@?R
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M:.)@-7M%9G4'Y29,CGMTKISI^F:I\8IXI[:VNK5?#L!CC=0\>//DP=O0\=*
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M+@Y>1 ,*Q.!G(QS7!>&])_MKQ3\0;1M2O+6"34$CE2U9%+J8@"-Q4L.XX(H
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M]W]Y>@(/;CIQ5_7(;2PMM>\1^'==:[U>31)!LL_+\O8IRLI"#[XR=I/8'T-
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M2^#=/DU77WMM6L[WS9XHUB6Z2\$AR!D;B6/&.X.*]DH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***CGN(;6!I[B:.&).6DD8*H^I- $0T^S6VBMA:PB")E>.,(-J,IR"!V
M(/-,OM*T[4S$;^PM;LPMOC\^%7V-ZC(X-.34["6T>[CO;9[9/OS+*I1?JV<#
MJ*KS^(-(MM(GU9]2M380 F2X24,@QU&1W]NM $LNCZ9/?+?3:=:27:QF$3O"
MI<(>J[B,XY/'O5?_ (1G0/L2V7]B:;]E5]X@^RIL#>NW&,^]5#K']L:+I>H:
M5JMG:)/- TAFVR;E;!,(^88<Y ^O:M6YU33[.98;J^MH)6&526958CU )H B
M70M'2YDN5TJQ%Q*FR246Z;G7I@G&2/:F_P#".Z)_93Z7_9%@-/<Y:U%N@B)]
M=N,9K$USQ0B>*;/PW;:E;V4TUM+/+<L48Q%2H1 K'&26SSV''7(U=*U)X+>U
MT_6]3TQM;QB2.WD"[SS@JC'=R,''UH G3P_HT>DC2ETFQ&G#I:_9U\KU^[C%
M)>>'M%U"QALKS2;&>U@(,4,D"LD9_P!D8P/PJQ>:E8Z<$-]>VUL'.$,\JIN/
MMD\U0O\ Q3I&G:W9:1<7L*7EVK.J-(!M11]XYZ9. /7GTH NV.D:;IAD-A86
MMJ93F0P1*FX]LX'-$VD:;<7\=_/I]I+>1#$=P\*F1![,1D5#9/='6=3674;6
M>W'E>3:QH!);_*=V\YYW$9' Z=ZL0:G87-U):P7UM+<1_?BCE5G7Z@'(H JC
MPWH0MY[<:+IP@N&WS1_94VR-ZL,8)]S6A!!#:P)!;Q)%#&-J1QJ%51Z #I5>
M?5]-M0YN-1M(1&XC?S)E7:QZ*<G@GTJYUH S8?#^C6^K2:M#I5E'J,F=]TD"
MB1L]<MC/-+=Z#I%]>"[N],LY[D*%\V2%68@<@$D<C/:IY=3L(+Q+.:^MH[J3
M&R%Y5#M]%)R:P?%'BF'2-3TC24N[>WN-1G:-Y9'7]Q&L;.6P>,G:%&>.>^,4
M ;EQI.FW5[#>W&GVLUU!_JIY(59X_P#=8C(_"JS>&=!=)T;1--*7#!IE-JF)
M2.[<<GZT[0TU6*P9=8N[6[E$K>5/;H4#Q?PEAT#8ZXXJ6/6M*E61H]3LG6,9
M<K.I"C..>>.H_.@!/["TC[3;W/\ 9=EY]L-L$OV=-T0]%.,K^%,'A[15U@ZN
M-)L1J1ZW8@7S>F/O8STXJS_:-D# #>6_^D?ZG]ZO[S_=YY_"DN=3L+*:.&[O
MK:"64XC2655+_0$\T 5[OP_HU_J4.HWFE65Q>P8\JXE@5G3'3#$9XJ>XTO3[
MN]M[RYL;::ZML^1-)$K/%GKM8C(_"N=F\0WEG\27TF[NK6/2!H[7VYDV%&$J
MI\SDXQC/IUKJ8)X;J!)[>6.:%QN22-@RL/4$=: *UKH^EV)G-GIUI;_:"3-Y
M4"IYA/7=@<_C3+#0M)TLL;#3;2U++M/DPJOR]<<#I[=*GO-1L=.56OKVWM5<
MX4SRJ@8^V37/^+-;U#2;_P -?8IH!:ZAJ<=I.&CW,596;*MG ^[Z=^M &J/#
M6A"UFMAHNG"WG??+%]E3;(WJPQ@GW-:$,$5M"D,$211(-J(BA54>@ Z5574(
M=0L9Y-*OK29T!42(PE17'8A6'Y9%<QX=US5=>^'6BZO)J5E8WUTR/-++$/+8
M>804 R,$@8'- '8BWA6Y>Y$2"=T5&D"C<RJ20"?0%F_,U&+&T6R^Q"UA^RE2
MOD[!LP>HV],4EWJ%E8!3>7EO;AL[3-($S],FG37UI;VQN)KJ".!>#*\@"C\3
MQ0!4/A[16TO^S#I%@=/W;OLOV9/*SG.=F,9S[4\:'I*WC78TNR%RR>69A;KO
M*8QMW8SC':JNK^*=(T;PY/KL]] ]C$A99(Y PD/95(ZDGC%.N;Q[J;2YM/U>
MRCMI)R)5;#FX7:?D0YX(//&>E %VPTRPTJ P:=96UI$3N,=O$L:D^N !3)M(
MTRXOQ?3Z=:27@C,0G>%3)L/5=Q&<<GCWI]UJ=A8RQQ7=];6\DG^K2654+_0$
M\U)+=6]O)''-<11O)G8KN 6P,G /7 !/X4 4/^$9T#[$MG_8FF_95?>L'V5-
M@;U"XQGWIVH>'-$U:2WDU'2+&[>WXA:>W5S&/09' ]JM0:C8W5FUY;WEO-:K
MG,T<JL@QU^8''%+::A97ZLUG=V]RJ_>,,@<#ZX/M0!.0"NT@8QC%4;/1-)TZ
MXEN++3+*VGE.9)(8%1G^I R:PM3U^]T_XA:;IDMS;1Z3<6-Q<2%DVLK1E>2Y
M.,?-Z#\:Z#^U]-^R1W?]HVGV:4XCF\Y=C_1LX- !>Z3INI/"]]I]K=/"VZ)I
MX5<H?5<C@_2J\WAO0KFYN;F?1M/EGND\NXE>V0M*OHQ(R1P.OI5UKZT1H%:Z
M@!G_ -2#(/WG^[Z_A3Y[B&U@:>XFCAB09:21@JK]2: *::#H\=TMRFE6*W"1
MB)95MT#! ,;0<9QCMTK.U3P9HFH:/)I2:5IT%K-)OD"VJ<'!!=0  'P2 W;-
M;5I>6M_!Y]G<PW$1)'F0R!UR.V17-ZGK][IWQ!TS39;FVCTFYL;BXD+)M96C
MV\ER<8^;T'XT =765_PB_A_[,UL=#TWR&E,QC^R)M,A_BQC&[WZU;74[!K#[
M>M];&SQG[0)5\O'KNSBE&HV+)<.MY;E;9BL["5<1$=0W/RGZT 1IHVEI?K?I
MIUHMXJ>6MP(%$@7TW8SCVJ*U\.Z+8ZG+J5II-C!?39\RXB@59&SURP&>>_K3
M;S4UGT"]O='O+29XHG:.4$2QAE&<':PS^=4/"WB%;_P=H>HZK>6T5W?6D<K;
MF6,.Q )V@_6@#HZR!X4\/"\:\&B:>+AVWM(+=<LW]X\<GWZU=N-3T^TN8K:Y
MOK:&>7B.*2559_H"<FBYU.PLBPNKZV@*)O82RJNU<@9.3TR0,^] !?Z98ZK
M(-0LX+J)6#JLT88*PZ$9Z'WJ-]$TJ33O[.?3;-[+.?L[0*8R<YSM(QG/-7=R
M[=V1MQG.>,56L]3L-0+BROK:Y,>-XAE5]N?7!XH A.@Z.TUM,=*L3+:C%NYM
MTS$/13CY?PK \8^$XK[PEK5CH6E646H:G%Y;RHB1;B3G+L!D_K720ZII]Q<M
M;07UM+.I(:))E9ACKD YHAU33[FY:V@OK:6=,AHDF5F&.N0#F@"MHVCV6GV\
M4L6F6]G=&((_EHN0.ZY';/.*8/"WAX"4#0M- EF$\@^RI\\@Y#GCEAD\^].T
MRYEBL[R;4=5L[E8[B0B6(!$ACSPC<GE1U/%0:OXNT31]!N=8FU"VDMH>,Q2J
MV]^R#!^\?2@"Y_8.C^;<R_V38^9=#%PWV=,S#T<X^;\:R-4TS5X5@TCP[9Z7
M8Z1-$\=Q*N8WM\\9C11M)QG&>_7WVY-6TV&R%[+J%JEHQP)VF4(3_O9QV-3&
M\MA:?:S<0BVV[_.+C9M]=W3'O0 MO;Q6EM%;0((X84$<:+T50, #\*AO]+L-
M5A2+4+."Z1&#HLT8;:PZ$9Z'W%<YH/B2YU7QWK>FB\L[K3;:V@FMGME'5RX8
M%MQW'Y>V/I73W=[:6$0EO+J&WC)VAYI @)],F@"O+H>DSZ<-.ETRSDLE.1;O
M K1@YSG:1CK5N&&*VA2&")(HD&%1%"JH] !TJ&74["&S6[EOK:.V8X$S2J$)
M_P![.*Y[QWX@N])\ 7^NZ'=6K20QJ\<C+YJ,I8#C! []>1QTH V9_#NB75Y/
M>7&D6$MS<1F*:9[=&>1",%6)&2,<8I4T#1H[B&X32;%9H$$<,@MT#1H.BJ<9
M ]A5BZU"ST^V6>^NX+:(X&^>0(N?J:GCD2:-9(G5XW 964Y!'J#0!@W^GW>C
MVF[PCH^D)<S7 :X64>0K*0<ME%)+9QU]ZT=&TXZ7ID=N\@EG9FEGE"X$DKL6
M=L=@6)P.PP*ENM3L+&2..[OK:WDDX19I50M] 3S6+XO\41>';:QC$T"7-]>P
MVJ&5A^[5VPTA&>0 #[9Q0!LZAI>GZM"(=1L+6\B!R$N(5D4'Z,#4\%O#:P)!
M;Q1PQ(,+'&H55'L!TK+T9M2@@O)=4U*SO+/?YEI=1J$/DXS^\Q\N0<\C@CFN
M8\1^/1+\/;_Q#X8OK1WMI=GSKYF5\[RMP (QGD@D'([4 =0OA;P\HD"Z%IH$
MDPG<"U3YI!T<\<L,GGW-6K?1],L[V:]MM.M(;J;_ %L\<*J[_P"\P&3^-2PW
M]G<7,UM!=P2SP8$L22!FC_W@.1^--74]/>_-@M];&\ R;<2KY@'^[G- %<^'
M=%.L#5SI-B=2'_+WY"^;TQ][&>G%._L'1_.N9O[*L?-NABX?[.FZ8>CG'S?C
M5V6:.")I9I$CC099W8 */4DU735-/DN6MH[ZU:=8Q*8EF4L$_O8SG'O0! WA
MW1'L(K%M'T]K.%Q)';FV3RT<?Q!<8!]ZTJH_;[>_TR>?3=0M7&QE2X5Q)&C@
M=3@X.#U&:;I]V(M+T_[=J5K/<31J//C(1+A]N24&>AZX&>* $L]!TC3[EKFS
MTRSMYB22\4*J<GKT'&>_K4EII&F6%S-<V>G6EO//_K98851I/]X@9/XT"_M[
M_3KB;3=0M7VJRB='$B1N!_%@]N,C-1Z?=B+2M/\ MVI6EQ<31HOVB,A$N'QU
M09[]<"@"?4--L-6M&M-1LK>\MF()BN(PZDCH<'BJQ\.:&?.SHVGGSXUBE_T9
M/G1>%4\<@=A4G]N:2;.2\&J67V6-]CS?:$V*WH6S@'VJ<W]F)(8S=P"28;HE
M,@S(/51W_"@"J?#^BG[-G2+ _9.+?_1D_<_[G'R_A6;I5EKM[JXU#Q!#80BS
M\Q+.*T=GSN./,8L!@[1@ ?WF]<#<2_LY/.V7<#>1_KML@/E_[WIT/7TID>JZ
M=-<1V\5_:O/)&)4C692S(1D,!G)&._2@"W61)X5\/ROODT33V;()S;K\V.F>
M.?QJ_9W]GJ$;265W!<HC%&:&0. PZ@D'K3Y;JW@DC2:>*-Y"0BNX!; R<9ZX
M )_"@"OJ6C:9K-LEMJ>GVMY C!UCN(E=58=" 1UI(M%TJ W)BTVT3[2,3[85
M'FC&,-QR, #!I4UC3)+/[8FHVC6N[9YPG4IN]-V<9J;[;:_:4MOM,/GNNY(O
M,&YAZ@=2* (-/T72])W?V=IUK:;@%/DQ*G Z#CM[4RTT'2+"<3V>F6=O*I)5
MHH54J3U(P.">_K4DFL:9#CS=1M$S+Y(W3J,R<?)U^]R..O-2+?V<EY)8Q7EN
MUY&NYH!("ZCU*YSB@"*VT;2[,W!M=-LX#<Y\\Q0*OFYZ[L#YOQJI:>$O#E@\
M;VF@Z; T;F1&CM44JQ[CC@UD>$O%,EY#JB:[?V,=Q#K%Q86^,0B18R  JEB2
M>?4]:ZB\O[/3H?.OKN"UB)QOGD"+GTR30!67P_HR)=(NDV"K> BY MT F!_O
M\?-^-,A\-Z%;&$P:-I\9AC:&+9;(-B-]Y1QP#W'>KKWUI&D3O=0*DV/*8R !
M^,_+Z\>E.MKJWO;=+BUGBG@?[LD3AE;MP1P: ,RYT^31="N(_"VEZ;%=##16
MY40PL<C.=@],_CBG:%I]U:0W%UJ)A.HWLOG7'D9*)A0JHI/) 51SQDY.!G%7
M'U.PCO5LI+ZV6[?[L#2J)#]%SFL#Q)XIATW7=(T-+ZWM9M0>7S9W9<VZ)&6S
M@\9)V@9XZ]: .AO;"SU*V:VO[2"ZMV.3%/&'4_@>*KG0='::VF.E6)EM1BW<
MVZ;HAZ*<?+^%-T5=4@TL+K=S:W%RC-^_MU**\>?E8@]#C&<<9Z52UK7HQX9U
M:]T34+&:ZL[62=2&$R@JI(R%8=<>OYT 7#X=T0I=)_8^G[;P8N1]F3]]W^?C
MYOQJ*31+/3K9[G1-'TV/4H+9H;0F%8PHY(3<HRJ;CR!ZFH_#6N1:GHFD&YO+
M=M3N=/AN985=0_S(I+;.H&36B^J:?'?+8O?VJW;=(#,HD/?[N<T 9WA^QU)7
MGU36UMDU2Z1(VCMF+1Q1IG:@8@$_,SL3C^+';-:]S:V][;/;74$4\$@P\4J!
ME8>A!X-0W&J:?9LZW-];0,@!82S*I4$X&<GC)XI9]3T^VNHK6XOK:*YE_P!7
M#)*JN_T!.30 0:986U@;""QMHK,J5-O'$JQD'J-H&,5#I>A:3HD,D.E:9:64
M4AW.EO"J!C[X'-2W6J:?8R+'=WUM;R,,JLLRH2/4 FK= '#:_P"#8H[K1'\.
M:)8VZVVK1:A=F%4AWJJN,<#EOGXSQ[UTUQX>T6\OVO[G2;*6\:(PM/) K.4(
MP5W8SC!(^AK3HH S3X>T4BV!TBP(M?\ CW_T9/W/^YQ\OX5+:Z/IEC=S7=II
MUI;W,_\ K9HH55Y/]X@9/XU=HH S1X>T5=8.KC2;$:D>MV(%\WT^]C/3BM*B
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KF?&MG+?6&GPVFJ1Z?J(ODDLI)DWQR3*KL$<=
MP0&]\@8YKIJKWEA9ZC"(;ZT@N8@VX)-&'4'UP>_)H \OEUZ%M,>WU_1H;75H
M_$=O#((;@K:/=;%=)BW]S:JDJ<DG&>3D5OM$4K_%F!KRUNI7L5D'D *K-]D;
M<57)Z$ 'D\BO4WT;2Y-/.GOIMFUD3N-NT"F,G.<[<8SGFI(M,L()9)8;&VCD
MDC$;ND2@L@& I('( Z"@#S+63I]QX'^'\\)MI'BU72UWIM)1B%)&1T.,9_"I
M_%CW^D7OB/6+,VFL:,3&-8TN;Y)H"L28:)_]TJV#WZ<UZ =!T8VL-J=)L#;P
MDM%$;9-D9/4J,8'X4LFB:3+=_:Y-+LGN<J?.:!2^5Z<XSQ@8],4 <E=B"7XR
MZ.QC3+Z)</M=1G/FQXR/7K7'>(-3T^X\-W]Q836]I OB9':*:3?<23K<('DR
M3^['7"X/RXY'2O89-(TV6]%[)I]H]V.D[0J7'_ L9J-]!T>5KEI-)L7:Z(-P
M6MT)F(.1OX^;! /- '#6FL:/+XY\7Z=XAN[:..[MX/LK7$H1)K-HOF",3TW%
MR<'J?:HYUTC3_''@80;8=-33+Q(&N6ZHJQ;<EN3\HR,\XKO[W1M+U*2"2^TV
MSNG@.86G@5S&?]G(X_"IKBPL[R2&2YM()W@??"TL88QMZJ3T/N* /+;Q;JTU
M+XL#0X_+O1;6KQK ,,&-N22 /XNI]<U:UI;:\\)^ [[P_L%TM]:"R:+J(RO[
MU3C^':&W#_9YKT:#3+"UNI+JWL;:*XE_UDL<2J[_ %(&34=KHVEV-R]S::;9
MV\\F2\L4"HS9ZY(&>: /,DT?2YG^*7F6-JXB+;,Q@B/-J"2O]TYYR.X]J[_P
M5(TO@3P]([%V;3;8LQ.23Y:U=&AZ0//QI5C_ *1_KO\ 1T_>=_FXY_&K5M:V
M]E L%K!%!"OW8XD"J/H!Q0!Y3IC6^I?"+Q9%K(7^U(9KUK[?]]+@,S1'UR!Y
M>WZ "KMY'<G5/A=_;"J=182"Z\P#<9/LAW9]]WZUZ!+HVESWXOY=-LY+P8Q<
M- ID&.GS8SQ3KK2=-O9TGN]/M+B:/[DDL*NR_0D9% $'B*.VD\,:K%=W#6MJ
MUG*LLZ=8D*$%A]!S^%</ILVL6NJSZ#KUI9WET=&F-EJMD-HN( 5!61.S9*D8
MXY..M>D2PQ30/#+&DD3J59'4%64\$$=Q5>RTK3M-W?8;"UM=P ;R(53('0'
MH \ABU*P/P\^&"?:[<R1ZI8EAY@R@57#9],'BMG3-0T"_G\<:+XLN;>*:74'
M\Q+F7RVDM-J^24.0< #C'0G/>N^C\/:)#GRM'L$W3"<[;9!F09 ?I][D\]>3
M4MSHVEWE]#?7.FVD]W!_JIY8%:2/_=8C(_"@#B/L5C>?%[3X9K4/"GAG<D-R
MNXK^_4#<#GD#U[U=^%86/PK=V\8"PP:K>QQ(O1%$S8 ]!S75OI.FR7AO'T^U
M:Z(VF=H5+D=,;L9I]GIUCIR.EC9V]JKG<P@B5 Q]3@<T <;HLPF^*/BZRU55
M:1K:U^QI*,A[78=^W/4;R=WN:XJ"TSX4\)VE]B73/^$N:*S$IRK6O[X(.>JG
MG'8@CM7LE]I&FZFT;:AI]I=F+.PSPJ^W/7&1Q4ES86=Y9FSNK2">U( ,,L89
M,#H-IXH X;3M)MM,^+6J-H]O';6#:,OV^.!0L8N/,/EY X#; Q^ASWKDXHH'
M^!?@V9TC9X[^TV.0,KFXP<'MQ7L<.F6%M9-9P6-M%:MG="D2A#GKE0,5 = T
M8VJ6ITBP-NC;UB^S)L5O4#&,T <9JM];:7\3-0DNI[6ZCNM'CB-M-<QQ-#\[
MX'[P@%7YSC)&T9'(K-L-.TWPIH'@?1I&LI]1>Z>2&\23;;"81MN=R,>80IVJ
M#@D@<BMS5O#.J3^(;NZ?1/#NN6$RQI;QZ@3&]HJKC:/W;@KDENQY]A6QI'A#
M3+/2Y+2ZTO36CFN?M1M8[<&WA?:J_(I''"YS@9))P,XH \MNYX)OAI\2H5NK
M>XD&JRRKY6,$'R<NJY. 23S^M=EXI-A-XF\!W5K]F<_VD\8EBVGCR7)&1VSV
M]:[<:9IZBY"V-L!=?\? $*_ON,?/Q\W''-1MH>DLMNK:79%;88@!MTQ$/]GC
MY?PH XGPV;749_']AX@$9G_M"43K-C_CR,:B$\_P[0Q'ODUS>C6$EV?A2-=M
MUFNY(KQ9#.N6>(0L8PV>3\NW@UZW=Z-I=_<I<WFFV=Q/&,)+- KLHSG )&1S
M3[C3-/N[F*YN;&VFGB_U<LD*LR?0D9% 'F4.GVLC_$#2HKY-)A.K6A@E1 4B
MF982I*],,X4$=\FNE\':AJ4NOZSIVNZ=:PZQ;QP--=V3$PW49WA&P>5;A@0?
M;L*Z,Z#HY6=3I-B1<?ZX?9D_><Y^;CGGGFK%G86>GQM'96D%LC'<RPQA 3TR
M<4 <3XCL[*^^+/AF"^@AGB;3[PB.90RLP,9'!X/K^&>U9>D^#[+5U\?:%!$L
M6@W-TBV00?)#<",&1HQVVR;>G&5([5Z/?:98:I&L>H6-M=HC;E6>)7"GU&1P
M:IZM%JUII,4/ABVTQ9T=5$5WN2)8^^-@X/3'&* .:\%:E>>*9K>\U2W:*YT2
M-[*X5EP#>YVR,/HBJ01VE([5?\=WMA:Q:%'>1!Y9M5A%H9)3'$DP#%6D(ZJ,
M$[>YQTZC=T;3FTS3A#+(LMS([37$JK@/(Y+,0.PR< =@ .U6+VPL]2MC;W]I
M!=0$@F*>,.I(Z'!&* .%\ 743>,?&L'VZVN)&O89?W&%5CY*;F5<GC/!Y//4
MU)XEM+.^^+'A>"^@AGA:PO"(YE#*S QD<'@^OX9[5VT%A9VL\D]O:0132A5D
MDCC"LX484$@<@#@>E-OM,L-4C6/4+&VNT1MRK/$KA3ZC(X- 'BOB32+6S\(_
M$I+.WC71$N[=K)0H\N.?Y/.\OTPQQQT(([5UWBNSL- U[PF]O96]KH]QJF;]
MXXPJO+Y96 R$=?FYR>X!ZUW4NDZ;/9)93:?:R6B8V0/"I1<=,*1@4^33[*6Q
M-C):6[V978;=HP8ROIMQC% '!:A;R6_Q*\0267RV<OATR7X7[IGW,(R?]K8&
M_ 5C_#;43:'P]9^((XS]ITR(Z%<_\LP @$D6#TESSGN.!CH?48M(TR"R>RBT
MZTCM'^_ L*A&^JXP>@J-M T9H8H6TBP,4)+1(;9-J$]2HQQT'2@#S2*31=9_
MX3'0_%&O/I\YU*8S02-"C/!D&%T+H6.$"XP>,>]7HM"TB^^+"6EY9)=1/X8C
M9TO(U9Y#YQ7=(,8+XX)Q7H%QHNE7=[#>W.F6<UW!CRIY(%9X\=-K$9'X4_\
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M33[6"UMTW%(84"("22< =,DDU'<:/IET(1<:=9S"  1>9 K>6!T"Y''X5=H
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M*)8?'>DVZ:G9G0;K3[BY=UV[08RHW&3.,?,>F.E,^++!/AY=NQ 1+FT9F/0
M7$>2:JZJUAJGQ8\+L&@NH3I]XR'(=20T?(['D'\J .VM]2L;NP%_;7MM-9E2
MPN(Y5:/ ZG<#C Q26.J:?JBR-I]_:W:QMM<V\RR!3Z'!X->.R77]F>&==EB:
M2+3;/QJ[7GV= WE6X922%((P&*G&".*[OPY'X?O/%ESK.E:Y)JU[/9+'<212
MQ-$J!@4W^6H ?KC/. U '57&H65G)''<W=O \@8HLL@4L%!9L GG !)] *@A
MUS2+C3GU&#5+*6Q0D-<I<(T2XZY8' KCO&UK83?$7P)]MA@9))[M&\U1AOW)
MVJ<]?FQQZUROB/2+6T3XGM901)I9L(2R*H$:W81BVT= V"I..["@#UV+6-,F
M%R8M1LY!:X-P5G4^3D9&_GY>.>:?9:E8:DCO87MM=+&VUS!*KA3Z'!X->=>)
M[:ST;1?"=_;6EO#IC:C9-J<T48&Z,*?+:1A]Y0Y4Y/?%.\66^H-XYOKGPX6^
MUMX:N1<F$]7_ .7?./X]V[;WP#VH ] AUC3+B^:QAU&TDNUSN@2=3(,=<J#G
MBB36=+BU!-/DU*S2]<X6W:=1(QQG 7.>E<3X6U3P?KVD>$V@>";4[&-5MK:*
M3$UN_E[9-R @@ 9R6X/'4D9YO1I]#USPF^C>(]>NH-6MK]VN-.5H4N#<B8LI
MCRF]BQ(P03UQG% 'K5[K.EZ;+''?ZE9VLDF-BSSJA;)P, GGFGWVHV>G0B2\
MO;:U5N$>XD"*3C/<C->8F]TB?6_&>@^*M=;3&N;DMY4S0QK/:M$JH49T))&#
MPIX/(YS5O1[VUTGXDVUEJ$\L-J- ACTE[]MK,H/[P$G \PX3(ZX44 ;O@KQ+
M-J6BZK?:OJ%JT=KJMQ:I<C;'&8T8*I!SCGZGKUKJ+.^L]0B,ME=07,:MM+PR
M!P&],COR*\CT"*SU'P]J%GINMP:==Q^+;E]/E0*\8DRYC5ESRC*& _#%=QX'
MU*]O5UFWU73[:UU.TOO+NY+1BT-P_EH0ZYY'R[<CM]: -V\UO2=/>1+W4[*V
M:- [B:X5"JD@ G)X&2!GWI;G6M*LKB*WNM3LX)IL>7'+.JL^>F 3SFN*N-,T
MN_\ C9<07EE:W"OX>5FBEC5@Q\]@25/!..,^AK#AN-#O3XN\.^*==?3I&U&4
MO:.88_.@)'DM&60LWR!0 IR,#':@#U*ZUC3+)Y4N]1M('BC\V199U4HF0-QR
M>!D@9]ZB/B#156T8ZO8 7O%J3<I^_P#]SGYOPKBK&PL?^%P6\;0;F7PQ&V+E
M09,B;&Y_]O'!/UKDY[.QC^!WBN6."!7BU*X$;A1E MU\H![8SQ]?>@#UZYG=
M/$5JO]LVT, MY&DL'5?,E/&) Q.0%YSQCFL=/B1X8?2-4U0:I;&VL)'1L2J6
MDVXY5>I!8X'K5'4!"/C)X=D41B272KK<PQEN8\9]>]<LMS WPM^(=DLR&Z2^
MU-VA#?.J^8>2.H'(H ]1M]?TN?2(M4.H6B6C@9E,Z[%8C[N[.,U:BU*QGT_^
MT(KVWDLMI?[0DJF/:.IW9QBO-M2\06=KXC\)W=SK'V31Y-.EMX[V$QM%'<D1
MG#,RLJY0$ _49ZU0U<:/H=CIMSIM]-=^'I_$J7&IW3NK0%R,Y!4!?+$FTG P
M&&* .OT[Q--J'Q,N-)MM2M+O2ETH72BW"MMD\W806!.3@>W7I76W%Q!:0//<
MS1PPH,O)(P55'N3P*X*UO=-E^.<K6UU:N\WA]03'(IWL)R<<=3MQ^&*G\?7X
MT[Q+X,FOG$>B?;Y/M4C\(LOED0%CT #$GGC(![4 6-%\33ZEXYU^P74[.XTN
MUM()H'@"[8RQ<-N8$Y(VC/(^@K:TK4(K;0[!M2UZRO9IB(UO5*1)<.6P H!(
MSVP#UKDM,GTJX^+/BJ-9K247&F6I=0RL)"N_=GUP-N?PKE;:"TG^$OPX^T)$
MZG6;2,E\?=,CAAGT]: /8!KVCG3_ +>-5L39;BGV@7">7N'4;LXSP>*F74K%
M]/&H+>VS617<+D2J8ROKNSC%<!K\]AX9^(6D)/<KH>D7%E.L%Q#'$D2W32*S
M[BRE5+*!SP>.O)K)NGT7PS+X?O;*]FN?#!UZ::\NI&5H1,\1".I4!?+60GIP
M&!]* /0M5\8:%I/ARZUR34K6:SMPPW0S*^^0#_5C!Y8],5E:YXEN5U3PH^DW
M]K)I^I7_ -GG\L"3<-C-@/G P5QP,^]87C7^P+GP%XWOM",4\ES CWES;R^9
M%(X   ()7<% )QZC-7O%-]:7FI> IK:YBFB;5P \;AE/[EQP1UY.* .VM]5T
MZ\FFAM;^UGEA_P!:D4RLT?\ O 'C\:EM;RUOH!/:7,-Q"21YD+AUR.HR*X#Q
M&UYX0\:_VIIEL9(_$<0LG15R$OE!\AV_V2"0?]W-=UI>GQ:3I5K80$F.WC6,
M,>K8')/N3R?<T 9NB^+M&U_4-0L]/OH)I;.8PD+*"7PJEF4=2H+8STR#6A:Z
MQI=]<O;6FI6=Q.@RT44ZNRC.,D YZUY3>7-ROASXH66F38U9]1EDC@1OWIC\
MJ+<P'7[N[!]:V_$#6NJV_@"]\/-'YW]HP-;&'&5M?+/G+QT4* "/4 =: .VU
M[7;#PWHUSJNI3K#;0(6))Y8]E'J3T KF]2\63-KWA)M.U"T;2M2EF2Z";7^[
M"SXWYP,$#/ Z=:N?$L%OAIXC !)^P2'CZ5SNM3Z?JNM?#D++;W5NUQ*#A@ZL
M1;'CT/.* /0K'4]/U2U-UI]];7=N"5,MO*LB CJ,@XS3++6-,U.26.PU&TNG
MBQYBP3JY3/3(!XKR?66ELX_B>FG1MY<-U8RRPVZC/EE(S-@=.5#YR.>:ZO1'
M\,ZUXIT_6]-\03:KJ"VCQJ(GBPD!Y_>JB*0-V,!N<]NM &SXN\3CPSI]L8;<
M76H7UREG96Y;:))7/&X]E'4G_&H[^#Q9:Z+<W-GJ5E=:DL+,MN]IMB9L<*N&
MW#GIDFL'XHVL]O<>&?$BQ/+::+J(FO%C4L4A; :3 Z[<?K79C7-,;3TOH[Z"
M6VD \MXG#^83T"X^\3V YH ?=:OI^GP12ZA>VUFLBY'VB58^W/WB.E22ZC90
M1P22WEO''<,J0L\J@2,WW0ISR3D8QUKC='NV7XL^);;5!L>XL;5]/67',"JW
MFJO;AVY _I7$_8$B\'Z3'.B-I_\ PFBKIF\ C[(9B%"Y_A.&(]1CM0!Z\/$>
MAM;W-PNLZ<8;5MMQ(+I-L)]'.<*?K5C^U-/^S6]S]OM?(N658)?.7;*6^Z%.
M<,3VQUKBH-/T_P#X79>1BTM\?V##)L\L8W"9UW8]=O&?3BN*CBL7^&_AD7"0
MFWA\6B++8PD9N9,C/9<?I0![38:OINJ>;_9^H6EWY+;)?L\RR;&]&P3@_6FV
MFLZ7?SM!9ZE9W,R+N:.&=78#.,D ],\5YWK=CIVC>/\ 4[^TLMNGQ>&IVU:"
MS&P.,_NQ\N,.0'P>N!5*PU&P?QEX!87^G_9FTVYACMH'#+"ACCV1,Q)+MVYQ
MG'04 >FMXAT16B5M8T\--*88@;E,O(.JKSRW(X'-3KJFGO?M8+?6IO5&3;B9
M?, Z_=SFO%[JRL%^#GC>X2WMQ)'J]ULD"C*[;@;0#VQGCZ^]=MXU/_".ZKI7
MCFWB:1+8?8]26)=S26LA&&]RC[3^)H [:WO;6[>5+:YAF:%MDHCD#%&]&QT/
ML:KW>N:3I_G?;=4LK;R0IE\ZX1/+#?=W9/&<<9ZU#X=L9K+1T-TH6]N6:YN@
M.TKG<5SW"Y"CV45QUIIND77QB\217MI:2EM,MI!'+&I!R7#M@]>H!/O[T =V
M=5TX&V!O[4&ZP;<><O[[/39S\WX4+JFGL]RBWUJ6M?\ CX43+F+_ 'N?EZ'K
M7C=E -*\(^%9)'\O2H?&!>SDD;"I:DS",Y/13G(/N*VI;W3;[QA\0%6XMIXY
M-&@*C<&#[$EW$>N#C)'2@#T6/7M'F\SRM6L7\N)9WVW"';&W*N>>%/8]#2?\
M)!HWV=KC^U[#R$;8TGVE-JMZ$YP#[5P&F:)I4WPE\/217$&E7T]K8B+4DB5F
M$P9'0.3]Y?, X)ZFLSQ)>ZK=^ ?'>G:SI]JFK64=NUQ=663%=*=I5\'E6"KR
M/IVQ0!ZW]OL_MHLOM<'VLKO$'F#>5]=O7%0QZSI<M_\ 8(]2LWO,D?9UG4R9
M'4;<YX[UQ&HZUI=S\5?"DMO?VTR?8+Q=T<@8%F$9501U)';K^=<HNLZ5-I7@
M>[L[JTLK!==#QV?F[I8$;SMS2NQSDD\C@#=CYL9H ]?N?$&BV0E-UJ]A (7$
M<IEN478QZ*<G@G!X-4]7\7Z+HNJZ;IU[?V\<]^6V!Y54(@1FWL3T!*A1ZD\=
MZXBVT_39M=^)Y:UMG"Q1 90':#:Y./3)'/TJM8WL-O%\([R[N(XH5LY0\TKA
M5!^R #)/'7B@#U'4]5L=&TR?4=0N8[>T@3>\KG  _J3V'>JNE>(],U70(-9C
MO+=+62-'D9IEQ"64':QS@$;@,5%XO_>>!M>V G=IMQ@ =?W35P*:M"(?A?<&
MXBDT:)1#=NK!DCN3;*(0YZ @ENO0D4 >HV5_9ZC 9[&[@NH@Q4O!('7(ZC([
MTEYJ%EIT2R7UW;VT;':&GD" GK@$GK7(Z9;21_&'6Y[+BP?2X/MNW[INM[;<
M_P"UY8Y]B/44_P 4:G86OC;0+>5K>VOS;W,D-]=R$10IA0X"Y =SQU/ !//0
M@'7VUS;WMM'<VL\4\$@RDL3AE8>H(X-2UP7PDN8)/"EU;Q7"2M#J5V" 1E09
MG(R!TSUKO: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;FUM[V!H+JW
MBGA;K'*@93^!J:JU]J-CID2RWUY!;1LP16FD"!F/0#/4^U #X[2VAE>6*WB2
M1U"LZH 6 Z GN!VIEGIUCIXD%E9V]MYC;G\F)4W'U.!R:I#Q3X?;[;C6]//V
M'_CZ_P!)3]SSCYN>.>.>]3Q:WI4VE#58]1M'T]AD70F4QGG'WLXZ\?6@# \8
M^$Y-7TP0Z+::=!=27L%S<2R?NC)Y<@?DJA+$XQSZUTKV-K<3P7=S9V[W<0^2
M0H&://4*Q&0/RJ"+7M(FLY[Q-3M#;6[%9I?.4+$?1CGY3]:9;>(M%O+]+"VU
M:RFO'B$RP1SJ7*$9#;<YQ@@_2@"=M)TUX(H&T^T:&$8BC,*E4^@Q@?A3H]-L
M(KG[3'96R7'_ #U6)0WYXS6!XW\20Z+X;U9K75K6TU2WM'FB5RK-N"DJ-I_O
M$8&>O;-7;'7[.W\/:5=:MJ$$,US:1RL9752YV LP'H,Y..!0!I2:;82WL=[)
M96SW<8PD[1*9%'LV,BEN=.L;R:&:ZL[>>6$[HGEB5FC/JI(X_"LC6O&6C:)#
MIDD][ RZE/'%;L)1M96/+[NFT#)STZ#O6C=ZYI5A%'+=ZE:PQRIYB,\J@,G]
MX<_=Y'/3F@"W;V\%I"L-O#'#$OW4C4*H^@%12Z=8SW274UG;R7"*465XE+JI
MZ@$C('/2HI]9TNV2V>?4;2-;H@0%YE ESTV\_-^%5[/Q3X?U":&&SUS3;B6?
M/E1Q72,TF"0=H!R>A_*@"TVDZ:PB#:?:$0C;$#"OR#T7CC\*?%IUE!,\T-G;
MQRN"'=(E#-GKD@<TL5_9SW<UI#=027,&/-A20%X\]-PZC/O6%=>([FW\576E
M#3KV3R[ W-N8X"8YV&<@R=CP ![G/44 ;%MHVEV;*UKIMG RL64Q0*I!/4C
MZFGMIM@U^M^UE;&\4;1<&)?, ]-V,UCZ%XIM+[PW9ZE?2R6C3EE*WL7D,7!.
MX!#S@8..O Y[UJG6--&GIJ'V^V^QOPDXE!1^<<'H>G:@"2/3K*&Y:YBL[=+A
MLEI5B4,<]<G&:G>-)8VCD171@596&00>Q%<=XY\2RV_PWU+7O#>J6Y>! T=Q
M$%F4_,%([C//X5/K.K:E9^/_  KI\-T!8:@MUY\/EC+&.,,IW=1R>V.E '0?
MV3II,1_L^TS" L1\E?D Z <<?A3X-.LK:1Y+>SMXGD&':.)5+?4@<U---';P
MO--(L<4:EG=C@*!U)-8GA[Q=I'B31Y-3L[N$01M)OW2 %$5V4.P_A#!=PSC@
MT :MGIUCIR.EC9V]JKMN<01*@8^IP.32W6GV5[M^UVD%QM^[YL8?'TR*BL=8
MTW4WE2QOK>X>+'F+%(&*YZ$@= >WK5V@!B0Q1PB%(D6(#:$50% ],56&D:8M
MO+;KIUH(9<>9&(%VOCID8P:9::YI6H736MGJ5K/.J[S''*K-MSC=@'D9XS2'
M7=)%^MB=2M!=L_EB$S+N+_W<9^][=: )FTRP8,&L;8AD6-@8EY0=%/'0=A3#
MHVEE44Z;9E8_N#R%POTXXI8M7TV?49-.BU"TDOHAF2V693(@]2N<BD&L:8;6
M6Y&HVA@A?RY)!,I5'SC:3G@YXQUH BL=&MK'5+[442(7%YM$ACC" JI8C..K
M?,<L>OMBM"2-)4*2(KH>JL,@UFCQ)H9TQ]2_M>Q%E&Q1YS.H16'52<\'VZUD
M:QK-[>7ED/#&JV$YMK]8-1M@OFL5)&Y25/[LJNYB3Z8]B =28T,JRE%,BJ5#
MXY .,C/H<#\A4)T^R-W]K-I;FY_Y[>6-_I][&:R-#DUTZ[K<6I3P7&GK(K6+
MQPF,H"6W1G/WMH"?,.[$=L"_>Z]I&G2R17NJ6=M)%$9I$EG52J9 W$$\#) S
M[B@"5]+T^42"2PM7$K^9(&A4[V_O'CD^] TK3EECE%A:B2+'EN(5RF.F#CBH
M!XAT4Z;%J0U:R^PS';'<>>NQSG& <X)SQBEB\0:-/:SW46JV3V\$ODRRK.I5
M)./D)SPW(X]Z +TT,5Q"\,\:2Q.,,CJ&5AZ$'K5<Z7IYE24V%J9(P C^2N5
MZ ''&*6QU*QU.!I[&[@N8E8HS1.&"L.H..A'I55/$FAR2K$FKV)D<91?M"Y<
M9QE>>1GCB@"U#IMC;+(L%E;1+*,2!(E4./? YIUG86>G0F&QM(+6(G<4@C"+
MGUP!5(>)M":YCMEUFP,\DQMTC%PA9I0 2@&>6P1Q[BI(->TBZO190:G:2W+;
MML23*6;;][ SSCOCIWH Q/$OAR^UKQ3X>OT@L)K#36G,\5S(V9!)'LP%V$<=
M>3S71?V98?8UL_L-M]E4Y$/E+L!_W<8JC<>+/#MI&\EQKNFQ(DODLSW2 "3
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M-]H39*V<85LX)SQ@=ZI0>+](N?%5UX>CNX?MEM&C.#(!EV+?(H[D!<G'3(H
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M)8*J#/5CDG YX]Z -ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'>N$L89-_P!C5HI %D=B6+D\<XR<X!QFO:HK6W@8M#!%&Q&"40 G\J:MG:H
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M,4:=I0%5AU4YZ-_L]:Y75=0>Q^)V@:MJ2M;:1<:=/:0R3_*L-PSJPWGHI9%
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M?127*()3%R&*'@. ?O+_ +0R*\MM99-1^&GCF+2'%U=?VW=S"&%\M)%YZLP
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MNW<A<G'TR: +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4A4,,, 0>QI:AN[RW
ML+5[FZF2&%,;G<X R< ?4G  [DT 2X ).!DTBQQIC:BKC.,#&,]:S['7]+U!
MKM8+L"2SQ]ICE5HGA!&065P" 1R"1@TRT\2:3?7D=I!=@SRQF6%'C9/.0=6C
MW ;Q[KD4 :FT<\#GK1M'H/RK-L/$.EZG'>265UYRV;F.XVQMF-QR5(QG</3K
M22>(=+BLK>[-PS17$9EA$<+N[H,98(H+;>1SC'(]: -(QHSJY12Z]&(Y%+@9
MS@9K%D\8>'8[2RNGUFS$%]_Q[/Y@(DZYQ],'/ICFKVDZO8:[IT>H:9<I<VDA
M8)(H(!()!Z\]0: +F!G.!1M7T'Y5DKXHT5[V*T%\OF2S-;QML;RWE7.8UDQM
M+#!^4'/!]*KW?C?PU8O>)<:Q;A[(J+A5)<QD@D9"@]@2?3OB@#=,:%PY12R]
M&(Y%#1HS*S(I9>02.15*;6M.@L+>]:[1K>YV_9VCRYFW#*A N2Q(YP >*YCP
M;K=QJOB_Q= =1GN[.TFMEMA*@0Q;H\NNW:I!#9'(SQS0!VU)M7T'Y51U#6;#
M3)8HKJ8B:56:.&.-I)&5?O$*H)P,C)Q@9%-37M+DTF'5([Z*2RGQY,J'<)"3
M@!0.22>,#G/% &A@9S@4@C179PBAFZL!R:X3QYXG$GPYUO4O#VK207=@51S&
MFV2-MR@HZNNY3@^@/2NOEUBP@U$Z?)<;;I8O.9-C?+'R-Q., <'DGM0!>IGD
MQ>;YOEIYF,;]HS^=8"^//"S_ &;9K5JPN9?)B922I?<5P3C R00"< XXK2U#
M6]/TR01W4["4H9/+BC:5P@ZL50$A?<\4 7W19%*NH93U!&0: JA0H P.@Q65
M+XGT6*#3YVU")H=18):2)EUF8]%4@$$GT^M2V^NZ;=:G=Z;!<%[RT -Q"(VW
M1@],\=^WKVS0!H;1Z"L'QEH5QXD\)W^C6LL,#WD?EF60$A!G).!U/'M6/KNN
MS2ZYX.GTK4IO[/O[]X98U0!)E$;G/*[NJ^N*Z'4O$VCZ1(RWUZL(C*B5RC%(
MBWW?,< JF<C&XB@"]8PM!:1K*D2S;0)#%T)'>I]B\_*.3D\=ZH:AK%C8[(9K
MEEFF1FC2"-I9-HZN%4$X&1SC'(KE_ /B/[1X*GU75]5^T1K?W$:W4I'SJ)2J
M ;0 <\  #G/ H [?:/05A:]I.L:I<0P6>K16>ER1M'>Q"WW2R _W'S\IQD9Q
MQG-6;3Q+HU[J+Z=#?Q"_3[UI)F.8<9SL8!L8YSCI20>)M&N=1AL(KU3<3JS0
M!D95G"]3&Q&U\?[)- %^6V#69MH6\A=H12B@[![ C'3VHL[2&PLH+.V39!!&
ML<:YSA0,#GO5./Q#I<M[%:)<DRS2/%$?*?9(Z@EE5\;21M;(!['TJMXN\2VW
MA+PY=:M<I)((AA$1"=SGA0<=!G&2: -L #H!36BC=-CHK+_=(R*X?6_$;6?C
MGPQ(-4EAT>[@O&GAD0(A,:KM/*ALY8\'KQ@5TEMXIT.\T676(-2A:PB<I),<
MKL8'&T@\ALD#&,\CUH U^E-:.-V#,BL0" 2,\&LC_A*=(-KJ$XN)#_9RAKJ$
MP.)8P1D9C(#<CIQS2^&/$$'B;0+35(4>,3Q+(492-NX9QDCGZCB@#69$="C*
MK*>"I&10R(R;&52N,8(XK$O/&?ARPGO(+G5K=9K,+]HC4EV3.<# !.?E)P.1
MCFKIUS3!IEOJ0O(VM+D+Y$B?-YN[[H0#EB?0#- %\(H4*% 4<  <"N7U#0]?
M7Q#<:GI6IV#0W,4<3VNH6K2+$$SS&RLI&<DD'/-;>FZQ8:NLQLK@2- _ES1E
M2KQ-Z,K ,I^HIU[JEII[QI<2/YDH8I''$TCL!C)VJ"<#(R<8&1ZT 5]'T@::
MMQ+,T,EW=.))WAA$2$@!0%7)P,#N2??TT\#.<"N%\0>(S%XD\'7EIK!31KZ2
M?SQ\HBD1868,21NZCUQTXKH[/Q5H=]I5UJ=OJ4!L[1F2XE<E/*8=0P;!!Y'7
MUH UPBC&% QTP.E+@ DXY/6LJW\2:1<&[47BQ/:()+A+A&A:-#T8JX!P<'GI
M5:Q\:>&]2G,-GK%M*XMC=GYL 1 X+DG@#^ASTH W$C2,'8BKDY.!C)I!%&&+
M"-=Q.2<<D^M9MGXCTF^O);.&["W,47G-%,C1-Y?]\!P,K_M#(]Z?9:]INH72
MVUM.S3/$9T5HG3?&"!O4L &7+#D9'- &E35C1&9E15+'+$#&?K5+4-:T[2KB
MT@O;D0RW<GE6ZE6/F/\ W1@=?:FVVNZ;>:A>:?;W!DN[( W$0C;='GD9X[CD
M>O;- &@ !T I/+3S/,V+OQC=CG'UKG;C6M*O]2T%H/$#V[7$CO!;1X'VU=C<
M$$9VC!.>!Q]*HZ+=ZC=>/O&&F3:G<-;V\5F;883,'F)(6V_+@\@=0>@SF@#L
M<#.<"C:N",#!ZC%<I\--2O=7^'NE7^HW+W-W,LADE?&6(D<=O8"LI?%T.@^/
M/%$.O:V4TZ"&T>V28#]V7$A8*%7)Z#GDX')H []41$"*JJHZ # %.QCI6>-<
MTQM,@U&.\CEM+C'D219?S2>@0+DL>#P!G@T[2]8T_6K>2;3[E9DCD,4@P5:-
MQU5E(!4CT(!H NE5))*C)&,X[4;1Z"L2>\LSXQL[4:XZ7:VTC'3$*D2*2/WC
M#&1CMR.M68_$.ES7L5HER3+-(\41\I]DCJ"657QM8C:V<'L: -+:/04B11Q@
M!$50!@;1CBLU?$6EO=QVJW+-)+(\49$+E)'0$LJMC:Q 5L@$]#43>*]#329]
M5;4$%C;RM#--M;$3@X(;C*X/'/>@#9(!&",BDP,YP*H:AK>GZ6JM=3L"4,@6
M.)I&V#JVU02%&1DXP*0Z]I0TRWU%;V*2TN2HMY(CO\XGH$"Y+'@\ $\'TH T
M,#&,#FD6-$0(B*JCHH&!7%^#=;N-5\8>+H#J$]W9VDMLMNLJ!##NC)==NU2"
M&R.1GCFNVH 3:OH/RI:XOX@>)X=-\):W]AU26VU"T@8B6"+>(Y-N51F*E5)R
M."0>1CJ*VXM;M;'1M/EOYW,TMLLA5(VED8!06;:H)P,C)Q@9% &QL4?PCKGI
MW]:Y&/P_XDLK^]^S:KI=S97=R]Q_I]BTDL6[^'*NH8   9 P !VJMXMUZ22P
M\+ZEH>K$VE[K5I [6Y5DGB=\,"<9[8X([@UM?;['_A+[B-=;DDN(;#,NEQX=
M4 ?/FD ;MW(7&>G:@#0TS2K?3-,6Q15>/<[OE  S.Q=CM' RS$X[5=VC &!@
M=*RK;Q-H]YHLNL6]ZLNG1;M]PJ,5&.">G0=SVP:74/$FE:5&7O;EHU6,2R8B
M=O*0]&? .P<'EL#@^E &I@9S@4AC1E*LBE3U!'!K&O\ QAX=TQD6[UBTC:2
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MJ*&9H)&CSA7&,C]1^=4'\;>&8[X6;:S:FX-RMH$5L_O6Z+QWY'TR* -X #H
M*18T3.Q%7<<G QDUER>)]&AOXK.2^5)99C!&S(PC>4?\LQ)C87X(VYSGC%8V
M@7]])\1/%MA<WTL]I:Q63V\<@4"'>LA8# 'H.3D\=: .M"(KLX50S=2!R:7
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M5-LL$@7.&1U^4^S"LWP?KV?ASH>JZQ>EIKBVC+RORTDC=  .2Q/0 9- '5D
MC!&12/&DF-Z*V#D;AG!KA-$\1FZ\;^+8I]8E_LRSMK9T%P@B^REO,W#!4$=!
M]X9Z=:V--\1:)IGA_2#=>(UNTN@([>\N6 >Y)/7@#\\8]: .EHK+TGQ'I&N&
MZ&FWT=PUJP6=1D%,C(R"!P1T/0U7/C'P\CP"358(A< FW>;,:3@=3&S *_;[
MI/6@#<HJIJEQ!:Z7=37-X+*%8FW7)8+Y7'WLGC(K/T[5K"T\/Z4[:G-J"W$"
M^1<>6SRW(VYW[47)XY/'% &W15:PO[74[-+NSE$L#DA7 (S@D'K[@BK- !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7$_$J6YLM.T75HX);BSTW58;J]CB4LWD@,"V!UVDAO
MPSVKMJ* /,O%4]EXR\$^)+GP?;"ZN[BT19+V*$H;@*P)B!(!<[-XQVR!WXGU
MJ]L_&%WX,FT"9)+FWU*.[E$9^:V@5&\Q9!_!GY4P<9/':O1NE&* /.M3T^]T
MWQ_<V-E#(=.\50#SW3I!+%@2M[;HC@'^\!47B74;+PU\18[S7FN[71;O38[:
MWN[>25(X94D<E&\L\9# C/I7I5'6@#R75X=!T^S\&)IEN;73F\1+=(MP[DLA
M23,I$AW*I8@C/J#QFO65557"  =>*6B@#PV?7+.^T?P[<*&L1:^)HGGTJ"W(
M2Q'FODR';G><YZ@'<<+Q74Z==V)\<?$.:26%5>UM &<@9 @8,.?0X!'8\&O2
M:* /%-"U-='M/AQJ^H.5T:WT^:TFG(REK<,JA3)_=R 5R>F376>"[^TO/B+X
MWDM7\R*9[)XY%0[7 @ )!Q@_7OG-=_UHH X;Q'K%M9_$#3;.X L&FL)"FI+#
MOED.]?\ 1X^" 3@,>"3P!@G-<'H.IG1_"?@G5YHKE],TC4+V/4@(6)@,C2JD
MC#'\.XYQTW>]>ZT4 >5>.]1T35/AIXHO]&@CV7JP@W:1%#>2!EX7(!?:H'/(
MZ^AK5\*:XFD^(-1T#6KN&6[G8WMKJ>X8O86)VACT#IC;MX& ,#%>@44 >&RS
MVO\ PHO6422+S6U9W"@C<?\ 3 P..I^49^@KL;'4X=%^*'B"?5[J*"RU6UM9
M--NY7"Q.D:L'C#GC.YBV,]#FO0:,9H \IL?"U[=?#/6TMD>*8ZK<:KHJ%2&B
M"R;X<#MNVG\'J.2?7)-9TGQ;96\T1\30'3G@P,VJE-T$I]<8D8Y[-BO6J* /
M/_& L],U[P':(Z10VU^0JEON1B%U!/MD@9K"2^T*SUCQ-X<\8C4(YKV_EFMX
MD>XV7T$F-@01G#,!\N/8>G'KM% 'F6G:C;>$_B/=QZT#IUE>Z7:0Z7)<.61!
M$&#P^8<_-N;/7G\17.V\]H/AD]TTTMLUAXG-U$S6[^6K"Y)7S !D)@\XY''&
M>*]OK$\1Z+>ZLMC+IVJ?8+JRG\^,O")8I#M*X=,C(PQQ@C!YH X:UOM-\4WG
MBN\T;7+&;6]0T@VEO9VLK90*KX8EE4L=SCG P,4OA;4?"GB)="MC;:C)K^FM
M&6LII;@&RD48=FR=H48.,]>!C)Q7<6&DZB]Y!>ZY>VEU<6^[R%M+4PHA(P2=
MSNQ."1U Y/'0C;H \HT6XETO7-(70=4CU71;V^</I-P USIK,'+NK#D(I+ [
MN,,,$[LUTGQ7BDF^&.MK%&SL$C8JHR<+(A)Q[ $_A79]\T4 >=ZOJFG:C\2_
M ]U!<1R0F&^*N>!\R(%//K@X/?M7/MK%I8:7XUF:VM[R$^)(W/F*9(X5/E#S
MV5>6564GCJ1C->R44 >5:5<Q7/CGQ9'!=W-\][HT!@F>$CSL"4$KA0-O( /0
MYZDUT_PQO8+OX>:)%"Y9[:SBAF!4C9(JX9>1U!'-==10!P&EW5E'\6O%<DTT
M"@6%HN]V 'R[]XR?3Y<_A7'^&;B33_#WPUU>=C_9-@UU!?-VMI) 5C=_[H'(
MR>@;WKV^B@#B-$@%[\4=8US3I%DTN338+>2:,YCGN S'((X;:F 3VW8]:;XV
MAADUS3I;7Q#_ &%K<-O*UK<R[3!,A*[XI W!R0I]>"1G%=S1UH \F_M5]0OO
MAM=:K;6UE<FYNI)84X1?W;JK@'HK'!7/]X56U+5;6RN?B1.;.#4(?M5DWDNI
M>/&R-6D*KRRHW)QW7&17L5% 'ENE:K9#XH7]R^IR7<%QH$92[DBV1OB5R2I"
MA=H'?\,DU1TNVGNOV=K2/2K<SWEO"CR00\2,$G#R)QR"5!XZG/O7L%% 'F=I
MJ/@GQ)YNKV,6H:A/;:?.MR\DMP6MXF0[XSO.W<>@7D]2.F:?X/GO;#Q-9:3;
MZQ!XAT1K&1K:[*C[18J"F(Y&7@AN,9 )*G^[7I-% ',>/])GU;PE<FR'_$QL
M66^LB!R)HCN4#ZX*_P# JXV1]:;7]-\2V4$\0\5P&PDBP,V@V[H)3ZD*)&.>
MF<5ZS10!P'BW[)I_BWP%;(T<,5O=RJJ9QL3R&1?H,X%/T"]M8_BGXV9[B)5\
MBQ^9G 'R(^_GVR,^F:[RB@#B/A%(C?#'2$##?&)5=>ZGS7.".W!!_&JMM>V&
MD?%;Q-+JTT-HEU8V@MWN2$$P4/O"$_>QE<@5Z#10!XE!:3^$M*\-:IJ=M?6^
M@QW]_)+' 9$>RBG/[EF"88  '([;\=>*]$\')H$[ZCJGA^*=X+UT:6\EDE87
M+@$97S#D@# R.#T[5U-% '"ZM/"OQD\/*94##3;I",]"S(5'U.#CZ5A:%<2Z
M9K>C)H6J1ZKHE[>/NTNX :YTQF5RSJPY"#)!W=F&"=V:]7HH \HT6XETO7-(
M70=4CU71;V^</I-P USIK,'+NK#D("6!W<888)W9K%U34;:V^'OQ"T.5V&J'
M5+R46H0E_+>4,KXQ]T@]>G;K7N/?-&* /+-0UO3M$\=27VOS7UMI.J:=;K97
ML;S1QJ\9?=&VS!!._<,C^=02G3?">M>#M1@LY[#PG$+N-6FWD6\DN-DC[LLH
M?G&>@8YQDBO6NM'6@#S/0O$FDV'C'Q_K$MP?L"K9SF>.)F5E$."1@<]1TZY!
MZ5Z'I]_:ZKIUO?V4HEMKB,21. 1N4C(X/(^AJ6:-I871)6B9AC>@&1],@C]*
M;:6D-C9PVMNFR&% B+G/ ]SU^M 'C UFWL_A=XO\-ZO)Y7B&,WKRP2*?,N-[
M,RRJ/XEP1R.@'.!6E+K-CHGB;3M1UZ2^MM&O]%MX+:]B::-(I8RQ9'V8(R&!
M&?2O6\"CK0!Y1KT.C:9X9\+)I-N]GI[>);6XB6=WW,GF$M+ASN53UY[$'C-;
MB7,#?'%]LT9)\/+&,,.6\\MM^N#G'IS7=T4 ><Z=IMWI_C74_"ZP/_8UW<)K
M,<@'RHI/[R+\950X_NLU4+[4](T;QQXDL/%LE];6VJ-'+93)).(KB/REC:+$
M9^\"IXQDYKU6B@#S#RM,T_Q]X%M+>W%G;V]A=I%;SN6>$,$V*VXDAB,\$YZB
MH;W4='T/QQXBT_Q6][:VFIF*2QECDF6*>/R5C:+$9QD%3QCG/TKU6B@#RN*X
MLO!_CO1+B[MY-,\.R:(;*Q:Y9BMM+YN_:[-G860+U/;':M?X;74%Q?>,/)W%
M7UR693Y94,I2, @D=R#7>]:* ."EO!H7Q<NKO6)5@T_4-,BBL[J9ML2O&[%H
MBQX#'=NYZUQVL6BVG@S7IY=JZ?J/B>.YLXG'#Q>;'O=0?X3M8^F.>AKV[K10
M R(QL@DB*%'^8,F,-GOGO7">#Y+6?Q[XZ\MX6EDN[=D(P2P6%1D>H#9'L:[Z
MB@#QGPQ<>'KW0;+PKXAM]2D\1V,P1]->:X&^56)65<':%/WMW0<GZZ=VDVH^
M)_B;8Z=*IOKK2[:*W56 +N(I00/<%@#Z9%>I]Z* /,?#.I^$_$T^B^5;ZC-K
MNGD,;2:6XS8.%PY;<=H'&!Z\#Z<V^N6=[I'A6Y3=9+;>)(VFTN"V(2Q&Z7(<
M[<[R3GDC.XX6O<J* /)]3N9=+UJ]U'P[JB7/FZFBWWAR\4,TDF]5\R'^)3P'
M[C@D_=Q40O\ 0K+6_$WA[QC_ &A'+?WTLUO&CW'EWL$@ 54$9PS #;CKP/3C
MUVB@#S'2]0M?"?Q%O(M94Z=97NEV<6EO<.61%B4AX/,.?FW-G&<G\16G\)YH
MY/"MTD:NNS4[LX:,K@&9B.H';\J[NB@#SY=3M-$^+VL?VA(83J&FVOV0;"3.
M4:0,J #YF&1P.>:XW2;JU;X=?#>*5E4Q:ZC2+(,;5!F^8Y[?,O/3D5[G10!Y
ME*\=QXV^($%NRR2SZ/ B(AR9'$<H('J1D#\167?ZI97/P;\))'."T$^F1R9!
M&UHRGF#GKMP<XZ5[#10!PD]U;GXV6&)HSG094!W#EC,C ?4@$X]*Z'Q;H8\2
M>%=1TG.V2>(^2_\ <E'S(WX, :VJ* /'VO\ Q#-_PC_CZ.QE%Y(JZ3-8E<;E
M<;0[>@^T?^.X/<UN>.8+?2-'\'V1F4_9]=LF9W."P5B7D/YDD^]>B44 <%87
MUOIWQ<\1+=R>5]LL+-X"RG#J@DWL#TP,C)[5Q4%Q:I\#-+021+,NKHY7(# B
M\+9(Z_<Y^GM7N5% ' :9>V/_  M[Q#.UQ;[/[+ME$A<8X+E@#[ J3^%<;X8N
M'T_0/AQJ\Y/]DV$EY!?-VMGDW+&[_P!T#)&3T#>]>XT4 >=HL4_C?Q/X@LYX
MSI#:-';RW"L/+FN 7.0W1MJ8!/\ M8KF=/O_ .R_#GPQUBY+'1M/62._=06%
MO*T6R-G Z;26!)Z9KVJB@#S72-7TVX^(GC"[AN4>UFTVU9;A0?+<*LF2'Z$<
MCG-<[:W%K_PK/X:Q2R19BUBU,J,1\@7S-Q8=@,C.>F17ME% 'FY:SN_B)XSM
MGG/E7&BPQN8/F<X$H;:!U8!AQUY%8/AK7] U4>"[.\\1:=#+HRKY**726=_+
M\M%8,H"'!Y +9/ KU?6]-.LZ)>Z:+J:U-S"T7GPXWID=16-!H.O75N+'7-7T
M^ZL!@,EMIQADE [,3(R@''.U1[$4 :GB22.+POJKRNJI]DE!+' Y4BO.+2.S
MNO!7@81Z^VB:O!IQ^R7GRF(,J1K)%(K<'.1P<'Y:];HZ]: .<\#ZA?:EX6AN
M-1MH(+KS9E<VX(BFQ(P\U,\[7^\/7.>]='110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56
MOK^VTZ!9;J0JK.(T"J69V/0*H!)/L!5FN6\=VVGW>E64&H7ES8;KU#;WUNVU
MK64*Y5R>FW@J<\?-VZT :7_"3:0+&6\>Z9(HK@6S"2%U?S3C"!"-Q8[EP .<
MU6N?&6D6^C:KJ2//,NE@_:H%MW$T9"[L%" 1D<Y(QCG..:X677-5M/#Q.L0V
MFI)!KL$*ZY':;D,>T'[5L&063 3<. ?7&"R -<W7Q/M;=;^YDO=.C:W>:W<-
M/_HK+D?*!RW &![#% '6R^(].U70M O+O5+O29;RYMC&D:/&9Y3@^5\RY:,E
ML$C@^M;=]XCTO3I9H[F>0&#;YS1P22+%NZ!F52%)R#@GH1ZUY[JNHVUWX!\#
M-$7Q!J>F^9NC92HCV^8<$?=7N>@I_BMGLM:UO5?#NJ&/5%,:W>C72>9#J@\M
M-OEKUW%2%RN?NX..M &YK_B$3>.;'PTTFH0VKV<TT[VL,RNS@HJ;71<[1N8D
MCC. 3V-OPD]K9R:O;R>*[O6;BS,8NVNR%2VPIQC  &5&2<G.,\9K/O+N(?&/
M2'E81XT>:-\G(21I$(0GID@'BL'4K6ZU:\^*-II?[RZN8[4P*#CSMD(#JI[]
M"IQW.* /1+/Q-I-]J2Z=#<NMV\7G1QS021&5.[(74!Q_NYKD_B+XKB@\,2-I
M&J74-TE[# );>)O+=O-573S=NW(&[@,#D$=B*ATG4?#_ (MN+6YTJSU,Z[:P
MR@->M<9TYWC*G)D.W).%P,D]>U<M<:Q;GX)Q>'Y8+B+6M/EM8;FR,#F166Y0
MEN!R".0>^<=: /<JR]4TZ^O[RU-OJUS86T:R>:ML$W2L=NWEU;  W=,=13H-
M=LKG6GTF,S?:TMENB'A=5V,<#DC&<CIUK0=TC1GD9411EF8X 'J: /-_!_\
MPD'B+2]9G;Q/?K=66K7%K "D.QDC8;0X\O//0D8J72O%]OH>N^+DU_6)WM[6
M^18?,1I#%&8E8_*B_*H+<G 'J:D^$\R-I_B!,X=]<NYE5A@M&S JP!ZJ?6LR
M*>W*_%(EU_?[O+_Z:C[,$^7^]\V1QWXH ]%NM9L+2&"5YFD%PN^%8(VF>1<
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M+?;CSW4R,8N1][! (ZC/2@#K++Q9HE_=V]M;WA,EU&TML7A=%G1?O-&S *X
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MPT5TAA2-HML1^\-F,$<Y^E7$BLK'XC>$+>&T^Q06^E7$20.2QMRQ38C$YPQ
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M[M8ER[K%M,B;>Y!&<>U 'H=GK^FZC?2Z?!<21WJ1B4P30O#)L/&\*Z@D9XR
M1FN CU75_P#A6WCBZ_M>\^V:=J%^EO<[EWJL1^5>F ..P'X5K7CV_B3X@>%=
M5T:X2>WTZ&ZDO+B(_*J.@58V/]XMSM/(VDX%<[#-&WPR^(D:MF2?4=1,28^:
M02'Y"H[ANQ'6@#U+1Y'FT2PED8O(]M&S,QR22HR35VLWP_(DOAS37C8,OV6,
M9'J% (_.M*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M, %0<9. >.^.]/O_ !=HNFZLVE7-U)]O$!N!;QP22.R9 ^4*IW')Z#)Z^AH
MW*AO(II[*>*WN#;SO&RQS! WEL1PV#P<'G!JMHVM6'B#3(]1TV?SK:0LH8J5
M((.""I ((((P14.J>(]-T?S1=/,QAC\Z806[S&).?F;8#M'!Z^A]#0 S0-&N
M=*ADDU'4GU/4IPHGNWB6+<%&%547A0,DX]6)[UL5CR^*-(1;3RKEKEKR W%N
MEK&TS21#&7 4'Y>1SZG'6G1>)=(GT6UU>&\66RNR%MW1&9I6.0%50-Q;@\8S
MP?0T :U%>?>._$T-]\.O$=QHFI75K?:: LHC#0S0OD<$$ @$'J.O8UTNG>*]
M(U#51I$%RYO1#YRJ\+HLJ# +([ *X!(Y4F@#</(.#@^M8.@:#?Z=))=:QK4F
MKW[)Y23M;I"(X\YVA5XR3C)[X'I6M?7UMIMH]U>3"*%2 6.3DDX  ')))  '
M))P*S(O%NBR?VB'NS;OIL8ENTN8VB:)",AB& )!'<?SH VZ*R+#Q+IFHW[6$
M,LL=TL N?*G@>)FB)P'&X#(SQ[=\4MEXDTW4+FW@MWG)N8S+;NUO(J2H,996
M(P1R._(.>E &M16&/%VBF^M+4W+J;QS%;3/ ZPS./X4D(VD\''//;-:E]?6^
MG6<EW=R>7"F,M@DY)   ')))  '))H L45AW'B[2+.TOKJZDN8(K%5:Y\RTE
M!C5LX)&W)'!Y&15B;7M-74;'3&N72[U&-WM1Y3XD"KN8AL;<@<X)H U**\Q\
M*>/-,T;2[Z'Q#K%R\B:O=0">9))1&@E*H'< J@XXSBNNN;[3&\9Z9;-JMVE^
M;:5HK*-F\B9#C+MQM)7C'/>@#<G65H'6%T20C"LZE@#[@$9_,5C>#O#TOA7P
MO9Z+)>)=BU#*DRP^7D%B>1N;GFEN_%VBV,ZQW-RZ1M/]F^T>0YA$N<;#)C:#
MGCKP>.M2:IXHTG1S<?:YY,6J"2Y,4#RB!3T+E0=O'//;GI0!L45R\_C6T3Q=
MI^APPW$R75FUW]IBMW="N4";2H.0=V2W0<<\U;\8^)$\)>%;[67MY9S!&=D<
M:%@7/W=Q'W5SU)_G@4 ;M%9;^(+"*WMI)#<+)<DK# ;:02R%>3B,KNP/7&.G
MK4NDZU8:W;R36$_F"*0PRHR%'B<=596 *GV(H OT5EZCXAT[2[H6D\DKW)A:
MX\F"%Y7$2G!<A0<#)Q[GIFJEQXU\.VUIIUU+J<8M]2&;60(Q$@P3U XX!ZXH
M WZ*YNS\>^&[ZQU&\BU!ECTWF\66"2.2$8SDHRAL8!.<4EGX_P##5_JEIIT&
MHDW%XF^VWPNJ2\9VJY4*6 ZC.0>.O% '2T5PVBZA-!XO\=PW^HW3V5F;4Q[W
M+>0KP[FV #CD]AZ5L:-J^DV?A+2[F+5+J]M)E5+:XN=TD]R3G'&-S,<$].@S
MVH Z&J.M6$FJ:)?:?%.L#W4#P^:T>\*&!!.,C/7UJA'XPT-]/O+TWOEQV4P@
MN4DB=9(Y"0 I0C=DDC&!SGC-5-6U^UU/P_XB@T^\N;;4-/M'>5?+:*6$E"R'
M##H<<$>AH UO#VER:)X>T_2I;A;@V5O';B58]FY44*#C)YP/6M*N%\(>.]&F
MT?PWI=YJ<C:I=6$ $DT<A6:7RU++YI&UGSU&<YXZU-H%[<I\1/&=O=7\\EG;
M164D232?)"&21FP.@''/T]J .THK%MO%6D76IV^G+/+'<W4;26PF@DC%PHY)
MC9@ V!SQVYZ5D_%&YN[+X<:Q>6-[<6ES!&'26W?8P^8#&>O?M0!V!SCCK7/>
M&/#MSH$^L237\5TNI7SWQ5+<Q^6S!05SO;(PHJW?>(=.TR9+6XDE>Z-N;@PP
M0O*XC'!<A0<#/'N>F:B/B_0]NDLMXSIJV!8ND,C+*2,XR%P#CL<=#Z4 ;=8N
MO:3JFJO:K8:]+IENN\7216Z.TZL ,!FY0CG!'K[5)9^)-,O[[4;*WEF:YT['
MVJ,VTBF/(R.JC.1R,9S5W3[^WU/3X+ZT9VMYT#QL\;(64]#A@"/Q% $MO;Q6
MEM%;0((X8D$<:+T50, #\*DK"C\8Z')=6\*W3E;FX:T@F\E_)DF7(*+)C:3E
M6'7D@@57N_'WARSEU"*2\F:73R!=1Q6LLC1@C.2%4G:!R6Z#(YYH Z6BLV;7
M]-ALK*[^T^;'?;?LHA0R-/E=PVJH)/R\^PY.*YCP-JLVI>*/&"&]O+BVM[N%
M($NMRF+,0+*%(&WYL]J .YHHKSI=1?Q?XJ\1:/\ ;]8TX67V>.RFM8YH?*8Q
MF1F?@+R2!B3@@<=<D ]%HK!A\6Z+OLXC>R%;I_(M[IX'6&>3T63:$).#C!Y[
M9J&\\>>'+'4+FPGOG%U:O%'-&MO(Q0R'"]%Z>_09'/(H Z2BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *XGXE1WJ:?HNI6MM-=6^F:M!>7<$"EG:%=P)"C[VTD'
M'MGM7;44 >7W=VOB+XB22Z4+HQ7?AF>UAN_LLJHLK2 KEBO'?D\<8ZU%X2NM
M)U.TT71]0T'5?[?TQX?,M[H3F*W>/ ,P8DQ@8!*XY.0!UKU6B@#QE+V73?AU
MXP\+:G:W@UH?;G4"V=Q=+(699%8 @CGUXQS6P;Q=+\4^#M7O+>\CLFT:2S+_
M &20LDQ\LA64+N!.TXR.<5Z=10!XJ$U/^P-5O[72[Z1]/\8OJDMJ8&#S0!N=
MG&&(ZX!/*UVL^J67BS0-<N-%TV=VFTR6 W4MHT+R.5.V)=RAFQDY[ D8SDX[
M6B@#R74+M;KX7>#XH[>Z\RVN]-65'MG5E\HIYAP1G"X.6Z>];EA<MX?^)/B.
M?52R6.KQ6TUC=E28SY:%&C+#@-DY [Y-=]10!XT=*N-*\/: )X)HUG\7C48[
M<QMNM[8NY!88^4 $$YZ;N>:Z:"_BL?B?XFU"1)FMDTF!M\<3-YAC,C,JX'S,
M 1P.:[^FR*7C90[(2" RXRON,\4 4M$UBUU_2+?4[+S/(G!P)4*.I!*D,#T(
M((_"O/M$U:/0KK7_  QX@TB\NKBZU*>YM46S::.^BE;<OS8*@CH=Q &.O!QZ
M5:6D-C;);VZ;8UR>2222<DDGDDDDDGJ34U 'E7BB\GN;GQAI4VG7-K,VE!;9
M+&T8_;R86Y>55Y5&.T+D=\YS@(\%O?Z7X>N(-4U#P]K-KI$0M[YH66*08 :*
M1'&&&Y00#@G.1G%>K44 >7PW=_=^(OAO=:K8_9;N.VNS=1QQ,$@+1*J9X^3=
MC@'Z5L^!6_XJ+QE\KJLNJ>;$60@2)Y2+N4GJ,@C(KMZ* . UB]M;#XRZ1+=R
M".,Z+<*)&'RJ?-3DG^$=LGU [U@S)<:/!K>MPZ:6T_5/$,$D;M:&5K:( ![M
M8\$YW E3CN&P1U[V?PY/-XWMO$8OXU$%H]H+;R"<HS!B=V[KE1VKH* /.O!P
M1O'WB^-X-0DM[Z*S>.6\@<"9!$RL26  Y.-O'L,#A?!>EZA::U/H-VI;3/#<
M[FPE+9\P2KF('WC1I%/^\OI7;ZO:7=_I5Q:V.H2:?<R*!'=1QJ[1G(.=K<'T
M_&F:-I7]DV1B>YEN[F5S+<74H ::0@ L0H '    X  H \]MI%_LKXFJ4DS<
MS3M #&W[X&W5 4X^;+ CC--N)!_8WPQ4))NMI[<S@1MF$"W9&W\?+AB <UZI
M10!Y%92Z?87>M^&O%&D:O<W-QJ$\ULD2SR0WT4LA=<;3L!&<'=@#')ZUO:<8
M[7XLWCO'Y,$>@P0;@"8U=)'+('(P2 0?7%=_10!XK8)+!\./"4KVMT!I_B47
M%T@MW+Q1&:8AB@&<8=3T[UZMK-O/J_A74+>R9H;B[LI$A9P4*,Z$+D=002/I
M6I10!Y+<K)XB^$^E^%H+::WU^+[);/;O$5>U>%TWR'CA=J,0W0Y &2:Z'P\Z
M_P#"U?%[E'"S0V:Q2%"%<HCAPK8P<$C.*[FB@#GO&UOI]WX:DM]32Z^RR31*
M9;3<)8&W@K*I4$C:V&SZ"O/M8;6G^'_C+3+N[.M0)#%%I^HQP8ENMW)C.W[Y
M3CYAZGWQ[%10!Y_J4Z2_$3P3/"&>*.SO%D=4.U"Z1A QQ@$E2 #Z5R;:A)?Z
M9X6NY-.U"VGM/$$;W6GV]A(D-BN9/E"JOS$Y!+?,<D],XKVRB@#AO"DBM\1O
M&LFQU%P]H8G9"!(%AVMM/0X/!Q7+>'/[/72%\(>(M$U6ZUNVF9!;OY[6]SAR
MR3!@?+5>023C&#C)KV*B@!LL:31/%(H>-U*LI&00>HKQQ] U]/"UU:)',)?!
MMTTNE,2?]+VL)%^H$)V8[ESZ5[+10!P/B:WG_P"%2ZY)/!(-0U.VEF>$*6?S
M)!\L>!U*KM3_ (#5:_G-OXJ\!ZF8+F2T6QN8&>&!WVR,D>U2 ,@DJ1SZ&O1Z
M* /*4<'2?BBNR3==//\ 9QY;9F!M@@V<?-E@1QFI;*4-XC^&K%9,6^E3QSL8
MVQ$[11*%8X^4DJPP>XKU&B@#QB[L]0O-'\6/IUM/.\'B>/4A;*A!NH$\HG8#
M][)4GCKM^E=9>F+Q/XY\*:II3,]OIJW,UU/L*A%>,*L9R!\Q/.WJ ISCBN[H
MH \7GM=0N_!?BHV%K//+%XH?4#:B,AKFW65&^4'[P.W(QUQ707&N6FN?$?P?
MJ&GQ7DMJMM>K)+]CE C++'@,2O'(P>P[UZ110!XW=;I/A[\2($AF::ZU6Y>W
MC$3;IE8(%*#'S [3R/2NCU">.7Q[X#FB#-%%;7:R.J';'OC0*&./ER00 >XK
MT&@C((H \2EO=#33-;\+:C?W=EI<VL23-YFFSO(JK,'90ZJ4P74D-G(!Y&>G
MJ,7BS2I]?M='B>5YKNU%U!,L1,,B') #]"< G'H*SM*\)ZQI$"6%OXKN3IL>
M0B26D;3JI.<>:>O7J5)K?M])M+9[4QHVVTA$-NA.5B7 ''O@ 9.3^9R <Q\6
M TGPZU""*.26:22WV1QH79L3(QP!SP 3^%137$3?&.RN@2;?^PI(_.VG8',J
M,%W=,E03CTKNJ* .)^&9QI>M(R.A.M7DJJZ%24>0E6 /8CH:Q=1N[;0?'VNK
MXBL]5;3M6\F2SN;03O&V(A&T3+$>N5R,CO7J%% 'F[3PZ5X@T73$T:XTC36T
MUS#+:VK2S$F3(MMZAC'QAR >N,,,<\QHDE_H_A'P7J[:9J$EOH=]=IJ%N+=_
M,193(HD"D9;:&R2,]?KCV^B@#S/QK?VFN_#7Q+=:3ILP6\B1(YC:-'+>29'1
M"H=@   2/7' J]J4\<WQ+\'3P[FA2RNU>14.U"ZQ[ QQ@$[3@'TKOJ* .,^)
M$=^FDZ5J=C:2W@TO5(+VXMH1N>2)=P;:.Y&X''M5/5_$=KJOA76]7T/PZ=2(
ML]C&[L&3[0<_ZO:RAI%4%B1T[ Y)QW]% 'E=A=1O\1[34$35+^UN- EA\^>T
MDC61_-5BH7: @VCT ]R:CT*SOK6\L]+\/:G<7FAWMG./LU]&3-H[>7\@WD;@
M,D+M;GCC.":]8HH \F\)3Z5?:=HV@:IH.JG7],:%7MKD3F&%XL#SPQ)C"@ D
M8]< <UW?C."PN?"MU!J<5S)9R-$DGV7=YD>9% D7:"<J<-P/X:WJ* /)I[77
M[OPCXST8WAUZV33P+#41$!+,2')A8CB1EXY'=O4X%G^V(=6\7?#^[L[:^DMH
M(KI)9?L<@",T*K@Y7/!X)Z#UKU"B@#R>QVQ^"/%_AV>SF?5;R^OQ!9-"P:7S
M6;RW&1C;R#OZ #.>*TUL)-+\=^ =/FD$DMKH]U [C^(JD*D_F*]%KG],\-W$
M&J0ZGJVJ-J=[;12P6\I@6+8DC!FR%X+?*HR .!TYH \]T,Z?'ILW@_Q)HFJW
M>KQ7$BI WGM;W@,A=) 0?+5>023C!!/6M>RU>/PQXH\3Z1K^G7L\.K7GVNSE
MBLWN$ND>-4,7R@\C;C#8'/I7I=% ' 79DT_XE>'+R;3YH()-'EM52WA,B12E
MXR(\J,# !Y.!Q6E\3[2XOOAIKUM:0R3SO;96.-2S-A@3@#KP#76T4 >=WM^T
M7CW0?%)BN3H4VGRV+3/ Z_9Y&97#LI&55MH7<1CCT(K2\*6$A\9>+-=C5ET_
M49+9+?*E1*8X\/( >Q)P#WVD],5V5% '"Z]J#)X]2QGM+F""73?W=W:6K/+=
M/O.8/-5244?>QD<G.0.O%:;<+9^#/AF+R"XA-IJOES+- ZE2$ER<$9(&>HXX
M/I7M]<_XA\.3ZYJ.C7<=_';#3+K[4J- 9/,;:5P3N&!AC0!QNOV8O]6\9^(;
M(?\ $O\ ^$9DLFF PMQ-AV)4_P 05=HSTYQV--:*'Q+X3\!:?IH+WEI<6-U(
M0A!M8XDR[-_=ST /WB1C(YKT/7M-DUG0;[3$N%M_MD#P-*8]^U64J2!D<X/K
M3M$T^32=#LM.DG6<VL"0"18]FX*H4$C)YP/6@#C=)G2+QK\09I ZQ2K;&-V0
M@2;8-K;3CYL-QQWKFM-DO=%\)?#S7&L;J:TTA98=1@CA8RP^8FP.4QGY><\=
M&]Z]FHH \]\0:];S^&;G5]*T'S;2:\MO,NIM/)<C<-UQY3*&?RP%VDCJ/0<Y
M5FDD_B;QHEO#JEP-1T6(6TUQ;N#.0DH)Y4!>2 !@>PQ7J]% 'E*VZ^(? /@_
M0;.*0ZE9R6+7 :)D:R\D+YC/D#:>"H'4D\9&33M1L+K5]>^)=A9!Q<7^G6T-
MJQ4JLKK%(&56/!Y(!],UZI10!YSX9U'1/$5YI;?V'JHUJR.Z5;X3[;%MN'(9
MSMYZ #DY&0 #C4^*RO+\,]:@BC>6::)4CCC0LSMO!P .3T/Y5V5% ' :KJRR
M>,X+5[:YBM9]+!AO+.U9I;IBYS!YBJ2BC[V,KR<Y '.'I.EW>H_ G35MK:>+
M5]'5;NV6:%D83PN6P 0,Y&5]/FKUNB@#RR;3-;;Q'9:M%!,B^*[<VFHQ9Q]C
M4?/&?9A#YB_[WUKU%$6-%1%"JHP% P /2G44 >)S:A)J&E>';F73K^UN+/Q'
M%)=:=;V$B0V2"1\X"K\['()/S$ECC&<5T=E,@\2?$:9TD2.XAM_*+1D>9MM]
MI"\?-AN.,\UZ310!XWHUQ<:$/ &LWUO<G2[?27T^Y*PLQLYF"?,Z@9 .W;G%
M;6AZ];Z9XA\>ZS-::@;,S6TR,EE)F51"BG;D#)R>GISTKTJHYXO/@>+S)(]P
MP6C.& ]CV^M $6GWUOJFG6U_:L6M[F)98R5()5AD9!Z'VKS^QBEU+Q)\1[6T
M=X9M0CACLYF4JKL+782K$<X;KBO1;>WBM+:*W@C6.&) D:+T50, #\*DH \C
MN4D\0_"/3?"D-M-;Z_$+2U:W>,J]L\3INE/'"[48ANAR .371Z ZCXK^+7*N
M%FM[-8I"A"N45]X5L8)&1G%=S10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
M*_$/5;_1?",M]8K/A)HA=26ZAI8K<N/,= ?X@N>>W7M755E:_JDVD6MM<16<
M]VC7"QS1V\1D<1D'+!1R<<'Z T 8>@_8]5N=-U?PUXAN;W2<N+J"2[:<$E#M
M)\PEU8''RY YSCBM._\ &.CZ:Q:ZEF6U6<6TEV(6,$<F=NUGQ@<\$] >"0:X
MQ-!TY/B1H^K>#;>>T+M)_; BA>*W:+:<;@P W[L8 Y[D<9JEH\=M9VUYX3\0
M^%]0OM06ZF,#>2[VUXCR%T<O]Q0,C.>F/7B@#T75?%&F:0;KSVFD^QQ":[,$
M+2"WC()W/@<< G'7'.,5FW'C>V7Q3I&DVL$]Q!?VCW8NHH6=&3Y=NW'7[V2>
M@X]>,&TU*;PGXO\ $=CJVD:A=6>K3I<V<]K:-.DN8U1HFP#@C:  >,>@JWJ(
MN;+X@>%M0ETNX2W.G7%L4M8#*L,C&,JA*C"C (R<+QU H V](U/1WUCQ'+!J
M-XTEN\9ODNV=8K8A.-@< *"HW$C@]:GM_%FE3WMG:EIX6OE+6;SP-&EP ,_*
M2.N.<'!(Y KA-0T?4-<E^)UA907$4VH+;_9'DA:-)]D*JP5B #D@KU[^E:&I
MM)XRTSPI;6MI=6][:ZC;7=TDMN\9M!$"7#$@#.?E '7.1QDT ;EQ\1?#ULE^
MYEO'&GRF*[\NQF8P8 )9QMRJ@'J>.N,XKJ(9H[B".>%P\4BAT=3D,",@BO,(
MTF.E?$U/L5[NO))C;*;63,X-N$&SY?FRP(XKN/"@?_A"]'C99894L(8V62,J
MR,$ (*L,@@CO0!S'C[7M2C^QQZ3<O;VT&J6D-Y.AP9&>5?W2GT"G+?4#^]CH
M==\/7NO3D?V]J.FVR1@1+ITHC<OSEG;!)'0!>G7.<\<)XK\%>([/P]I]K;>)
M;^_B34K9A"NGPDJ3*"9257)()+$GKSFND\1>(I=+6VT*>'6[MF@'VS4+/3I'
M+#&"%,:[0[<\C[HZ<XH =X.EUGQ!X"A74M2DCN?.EA:^@4+)/$DC*'7LI8 <
MXZ9(Y((/ INDU?Q%:IK<NKZ1;3QI:2SSB:5)-F94+#D@$J!GW'8U<M/%&F6_
MAV.Y.D:I9Z:DJV<43Z?)N"A>&,8!94[9([?2J?A[0[:+QWJ6O:3:-9:;<V4<
M,B>285N)P[$R!" >%P-V.<G'>@"?QWXDN]&CTG3-,9$U/6;U+."9UW"!3]^3
M'<@=!ZG\*3Q%I-YHWAR\U31]4U#^TK&!K@&YNGFCN-@W,CQL=H# $?*%P3QB
MHOB%H%]J2Z)K.EPFXOM$OENQ; @&>/\ C1<\;L 8^E2^(?$"ZIX9O+#1;:[N
M=3O;=X(H&MGC,3."NZ4L $"YR<XZ8&30!CZQX[^W>&/"E[9QW<4>MWELD_DQ
MN2L9W%T5U'WLH5XYQDBJ]Y<KH_BO2-"CN=>FTO4FN;N6&03,Z 1+MC1@-^T%
MBQ&3@X!QTI=8T-O#GA[P%HD$5S='3=5MI)Y(+=Y JJLF^0[0<#<W?UK5U^1F
M^)WA.X2WNGMX+>\$TR6TC)&9$39N8# SM- %V'6=+\':5):W6H:G?6]BY%Q>
M3(TYMPQW*LC@=@R^I P3UJ?4O'F@:5>R6<\]Q)<):_:]D%K))OBR!N7"X8<]
M1D  YQBN-A-OI&N^(-&\1^'=3OUO[Z6YLY;>!YHKF*7GRS@[05Z'=@8Z\5L6
M4#6OQ8LR-/E@MH_#JV@:.!S#'()0WEA\8X4?I0!KV6LZ,_B75YH;W4GNH+2%
M[FV>.7RXT^8JR1E>6/.=N>E):?$/P[?'3#!<7!AU*016UP;601-(<[4+D;0Q
MP<#.:S;1V@^*'B6ZDMKH6[Z;;HDOV:0H[(7+!3C#$;AP*Y:UM[N+X4>![1]/
MOQ=6FJVDD\/V23?$J2EF9EVY  YS0!Z7J'BC3=.FO(I&FD:QB$]YY$1?[/&<
MD,V/8$X&3@9QBFP^*]+N[>TELVN+G[6C20)';N'D1=NYP& ^4;EYZ'<,9S7"
M:WJ$&E>,?%,:'4+>+5;6".>5=+ENT+^65WH4^[A" 5;J1GIUFN;+P]J6C^'(
M-)U#5;$6-K)%8:Q;QN# 4V(T<RE<?-C)5@,[3B@#T;3K^#5+"*]MBYAE!*[T
M*-P<<J<$=.AJIXDUM/#GAV^U>2WFN%M(6E,<2Y+8&?P'J>U<_HOBJ[TS0_#\
M/B6RN1J.I3/ 9K>T(C4^9M1Y1_RSW[D.".K'@8.-CQK:3WW@77[2UB:6XFT^
M=(XT&2[%"  /4T <GKOB"26;P-JQN;RTCN+P+=1 21I(# S8V?Q#=C'7/;-=
M;IOBW2-3MM1G2:6W&G-MNTNX6A>'C<"RL 0".0>]<9>7+WL/P]EBL-1"6MTA
MGWV4JF,"!D)8;<@;CC)QGJ..:IZWI>IZKJ7Q%ATZTN#-<KI\MH9(G1+@P@%U
M5B #]W;P>] 'H5GXGTZ[UC^R3]HM[YH?/CBN8&B,L><%ER.<=QU'<5?O]0MM
M.A22X9LR.(XT12SR.>BJHY)P"?8 D\ UQ_AB]T?7M4M+VT\-:A:WMLC"6?4+
M=XS;9&"BL_WF)[+QC).. 7?$2&[ADT'6H=/N-1M--NW>\M;;)D,;QLA=0.25
MSG ]?3- &[:>+-'N[?493<FV.FMMO8[E#&\'&1N![$<@C(/:FQ^+=-?5K;2W
MCO8;RZ1Y+>.:U=/-11EB"1CCC@X/(XYKA]=M(]8\*ZAJOAGP[=(PN+2XE\Z%
MHY[]89 Q0*WS$* ,9ZG('2KDNNV_B#XD^"KJUMKV*+R+_FZMFA.?+CR & )Q
MW(X]">: .G?QOH4?AZ?76N)AIUO,T$TGV>3,;JVT@KC/#<9Q5C4_%.FZ5<W%
MM,9Y9K:W^U7"01&0PQ<_.V/H>.O!XKRS4Q=Q?#?QAX;&EZE)JAU*>58X[20J
M\;W =75\;6!!X )/M72:_?W-_KNM6+Z9J44$^E+]B:TLG5KURKY660 %=A(
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M2>=-=BW:Z:"WB+LL(."Y [9X'<\X!Q52X\;Z!;6NE73WK&#5<?8Y%A<K)D9
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M+D?:H3<6[R0,J2QC;\P)X_B7@X//2G:[XCTSPW#;S:I,\,=Q,L$;B)F7>QP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!UM%8C^*M.37-/TD>>T^HQ&:U=8_W<J 9)#=.!@XZ\TM[<1:W;ZSI$#ZA!+
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MC86TES;R/%&V](T^5CE,D-U)QP/7C-;]OK6GV>DZ1';_ &FX:[MU-G!]^:5
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M<A,48\WYC@<#YU_.O9J* /*?$&BZGK>L?$"TLK6ZC?4-,MHK69X'2.9XP^Y
MY '.0.O>I-1U>YUW_A"I8M!UB*:RU*-[V%["1?(Q$ZGD@ C)ZC(QUQD"O4J*
M /)]/B32;_5] UWP;=ZK)<7\\]G<QV8FAN8Y7+@.Y^5""V#NX%;VDP30?%6_
MD:QN(K9M(M[=)EMG6#>C.656(Q@ C'-=U10!@^-K*XU'P+KUG:1-+<SV$T<4
M:]78H< >YKD;B6XO;KX?3II6J(EG*3<>992 Q#[.4RPQ\OS''..F>G->F44
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M:W&F>.+/7I?#LNN:1+8?89H;>W6>6W=7+JX0]0=Q!QZ?3,&NVDDFF^')-/\
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MEK=B(6:&-%#$9 R5/T[XJK<V5_)X<^)%NFF7YEU*XE:S7[+(#,&A5 5X]0:
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MU0%E8'OC!S6CXVL-4\7>"-3M-,MGAD(BEM5N 8VG9'#D%3RH.W W8.>H &2
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M1W! S@8)921R P&>U5+7XA:7>W+PVMCJ\PBNI;6:2.Q=EBDC&2'QR,]!QGU
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M8%Y!&" Q)!QR<$=P: -Y?B#IAN;&UET[6(+N]$QAMYK%E=O+.&&._;IG@@G
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M9\XA0I/)VD@< E<$CL2: -JBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1QD KD#/).,UT5I'>6_Q*U[5/[.NWM9--ACA<1$"62,N649[_,,9P#ZUVU%
M%32[R74=+MKR:SFLI9HP[6T^-\9/8X[U;HHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB8#]Y'L.[=@DYSPPQBM#3]3O?$?BW4]'N;I[6/2K.U:5;*4KYL\REBP?J54
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MJ$&KI:?9+EH&2/[1%O+*L@ (#<\E",$G!Z5<U7Q?'I?B2ST'^R-1NKR\C>6
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MUE/]+MHI56-GV[?,'RY!P!QG:>X(XJX/!UO_ &CH=\=3U!IM&C>.#<T9#AP
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MO]3M++5M[7=E;S*(6=QAG *DJ3WP<'N".*Z?3K&+3-.M[&%I&B@C$:&5RS$
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MK;YDP590K;ALYRH _#UJQH_AVWT6^U*[@N;J6349O/G$Q4C?@#(PHQP /PH
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M@$<@C/6L5/ FF10WEG%<7D>E7DQFGTU77R&8G+ ?+O52>2H8#KQ@FNG "@
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M?>7YB2S%HTV+M&Q>BY[XZFM"BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG.?ZUK7KKHOCG6I=8\.:AJ>FZQY,]I<VMHTVQA$L;1.HY7[H(SZT =5=^/M
MM7L$$]Q<-J%NUS:?9[:23SD5<G;@<GD<#D=\5NV-]#J&FV]_$)$AGB$JB9"C
M!2,_,#R#7!RVC6OC?P28-%GL[2UMKQ7CM[9FBM?,"[%9E!4'@YP<9SVKMM=L
M9=3\/ZE802>7-=6LL*.?X69" ?S- &='XRTB2\T^#=.D>I,4LKEXB(KA@,X5
MO<<@D -V)I;WQCI5@ES/*;AK.TE\FZNXXBT4#\ AB.>,C) ('<C!K \&:[=W
M&DZ3H5YX;U"WU33TC@N&N+8K!%L&TR+(>#D#@+D\^F367I$-[I'@?Q#X2U#3
M[R;4"]XEL4MW=+Q9BQ1@X&T<O@Y(VXYH [2\\8:19:O'I3-<RWDML;J)(+9W
M\Q 0/D(&&Z]LXYSBLX_$KP^-*;4L7YMX9&CNMMG(3:,K;6\T8^3!_'O6+I&E
M7>B^-?"UK-#=3)8>'FLIKI+=VB\W,>!OQC^$]ZSOLUXWP_\ B':C3=0^T7NH
MWKVL1LY0TRR !"HV\@X- '>WWB_2=/U>'2I&N9+R>!KB*.&V=_,08^Z0,,>1
MP,X[XK-/Q)T :5+J.W4##;R-'=JME(6M"IPWFC'R8_ST-94 G;QYX3N?L5\(
M(=&EAEE:TD"QNWEX5B5X/RGK6:D%V?!7Q(M_[.U#SKZ]O7M8S9RAIEDB54*C
M;R"0: /0?^$BT_\ MRWTC=(;JYMVN8,(2DD8QDANG<5FS^/="M='O-4GDN4M
MK.\-C.3;OF.8$ J>, 98#)XYZUS;O-IGB#P7K$^GZ@]FFDRV<IBLY'>&4B/
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M76W!&<OCV(8@9(!!(P17F]K9WT7PH\%V3Z9J(N[35;62>#[%+OB5)BS,1MR
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MP\SZ?I\I;)E1MK[C[K'Y:?\ ?0K2^)MA=ZG\.]6MK&WDN+C$<BQ1C+.$E1R
M.YPIXH V9O$%C;Z\NC2^<+Q[=KE%$3,'C4@,01G)!(XZUBQ_$GP]+:V]VCWI
MLYKC[,;DVD@CB??L D8CY,MZ\\C(&:RO[1?4_B;HNK6^F:H-/&EW$1GELI$
M8NAP01D?=/4#/;-<[)9WS?!2^TX:7J7VY]3:1;?[%+YA4W@D!QMSC9SF@#T_
M4=:M(+E].$=U<W7D^;)#:*2\<9R-Q((QG!P =QP< XKEOAQKB)\-],N[VZN;
MJ:YNKF.$N6DFG;SY, 9Y)VKGGH 2< 4RSN[CP]\2=>NKZQU"73];BMI+.YM[
M224*T:;3$X4$H<G(R .M<KI]CJEEX-\-:E)H%_=1Z3J-XU[IY@(E:*9Y,.BG
M[VT,#QZ_6@#T2;Q_H5KI>IWUR]U#_9;B.]@:W8RPL1E=R@'@CHV=I]:U-(U^
MSUN2[2TCNE%LRJ7FMVC60,,AD+#YE([C^HKS_P 206VJ_#OQ+/H?AB\M9+^"
M.),V++<73@]T +;5& "??MC/IME*LUE!(JNJL@(61"C#CNI (_&@#.O_ !)9
MV-Q<VZQ7-U+:1B6Y6UB,AA4Y(+>Y )VC+8YQ56[\<Z!:6VEW)NY)8-4.+22"
M!Y%D."<9 Z\'Y?O9XQ6)H[W'ACQIXG74[:[>UU.=+RSNH;=YE?Y K1G8#AAM
M& >HZ5SMIH-_H6C^![6>QNV>'69+V>.&W>46L;^:0&*@@8WJ#[YH ]1TC58-
M:TN&_MXKB**7< EQ"T4BD,5.5;D<@U>HHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YW
MQQ>Z38>$;V76_M@T\A1*;/>)!\PQAEP5YQR2!VH Z*BL#4?%VFZ7KD>BR17L
MM]);M/''#;,^]00,*>YY^@YR15O0-?LO$FFF]LA,BK*\,L4Z;)(I$.&1AV(-
M &I161J7B&VT^XEMDM[F\N8(/M$T-JJEHX^<,VX@<X.!G)P< XJ&+Q;I5U8:
M9=6+R7AU-"]G#"OSR@#+'#$!0.Y8@ X'4B@#=HKF9?'>C0:+J>IS?:HQICF.
M]MS 3- V,X91D8(Y#9VGUJ2T\::9=ZS;Z8(;Z&6Z@:>UDFMRL=PJ@%MAZD@$
M'IR.1F@#HJQ[_P .P:A=O<OJ&JPLV/DM[^6)!@8X52 *Q9/B9H4=E<7OD:DU
MI:W36MU,+1@MNRL%)?/09/U]JWM0UR&RG:WBM;F^N4B\]X+159DCR0&.X@<D
M' SDX. <&@"E_P (A:_]!77?_!K-_P#%4?\ "(6O_05UW_P:S?\ Q5/MO&&D
MW^F:=?:?))>#4MWV2&%?WDFW[W#$!=N#DL0 >.I%8NL?$6"#P^;_ $RRN9YU
MU)=,GB=0K6TN]58/S@G!XP2"2.<9- &O_P (A:_]!77?_!K-_P#%4?\ "(6O
M_05UW_P:S?\ Q50W&I:5-XRT2"YBU"'5GMYWMHVW+&%P-^_!V,1QZXS4M[XS
MTVQANKIHKJ73[.4PW5[%&&BA8'#9YW$*3R54@<Y/!P +_P (A:_]!77?_!K-
M_P#%4?\ "(6O_05UW_P:S?\ Q5)>>--+L]9CTD)>7-Y+:F[B6WMV<2ID#Y3T
M;.>W YR15[0->LO$FEB_L?-5/,>)XYDV21NIPRLO8@B@"E_PB%K_ -!77?\
MP:S?_%5MVELMI:QVZR2R+&,!YI"[GZL>2:RQXEMF\07>B+:W9OK:V%T4V*!)
M&3@%"6YR<C\.<5!9>,+#4?#L&N6MO=R6MQ.((EV*)&8OY?W2W'S<<\CKTYH
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MXE*[@Q'/!&2,>E.M_%5G+KD&CW%O=V5Y<Q--:K<QA1.B_>VD$X(!!*MAAZ4
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MF/+;Z*FCPSRF5+80K$^" -TBKP&./KC&><BN3TR34/#7B[Q1:WNEZA<V^K7
MO+*[M;=I4;,84QN1]PC: -V!CN*]$HH \4TO3=5TGPWX*U6[\,7E_;Z?:SV5
M_I[6X>=!(RLLB1GK@J,]#BMS7M,FOO#]KK&B>$%@2TU.*]?3)+9(IKV-49'+
M(.-V'.T'GY?<"O3Z* /.KDVVK>$?$5SI7@^YTR2XTN:V4RZ<(KF>1D(5 JY;
M:#U)XR1CH345U!=M;?#H#3[\FQDC:Z M),P@0%#N^7CYCC]>E>E44 >5ZQH6
MIZUJOQ#MK2UN(WU"VLQ92S0,D<SQ*2RAB,=<#WSZ5HZ.T/B.,1P^"9=$U%()
M$EN[NQ2(6[,A7]R_5B21R.-N<]@?0Z* /&)SJS_":U\+R>'=6&KZ=-:Q21QV
MK-&ZQSH=Z2?=8$#/!SUXP,U[!,&N+"150J\D1 5NH)'0U/10!X_9:9K:^ O!
MTL>CWXN?#EY%)=V<D6UY5 9',8)^8@-D=CGC)KKH;*36OB/9^(8(+B&RLM.D
MMS)/ \+2R2."%"N V% ))QC)&.^.RHH XSX@0W%Q+X7^SVEU<?9]<M[F8P0/
M)Y<2APS':#TW#WK(U$:Q;^+/&=_I>E3W$TVDPQV?G6S>5-(@?<N2,-]X<=^E
M>E44 >7Z5'>2>/O#NJKI.N-"^FS03W%[$5*RDQGYE) C P> %!_A!K4@\/:A
M9_$&^MX8?^*>U!X]5E;LMRG!0>[,(I/^ 'UKO** /,]2B?0O'VL7.I^%;G6]
M,U<0R6\]K9K<M Z1A&C<'H#M!!Z<_7'>Z+;K:Z1;Q)I\.GJ%)6TA556$$DA<
M+QGGG'&<XJ_10!YII\5[8:1XST:;2;Z2]U'4;V6T06[&*9)N$/FXV >N2"/2
MJ)T6Y\%:SI<E]H$_B#2SH]MI\DEK:BXDMYH=W(0\[&W'D5ZS10!Y?KFFSV4G
MA[7[3P>)-,M6N5N='M[9#*D<VS$GECY2X* D#GYL>IH\3VHU+X?:D='\*7%@
MUY<VK1VZ6.RXFV3(S.Z(.  #C=SP?45ZA10!Q4ZSR_%K3;]+.\-F-(E@:<VS
MA%=I$95)(X.%/T[TOQ"L]2)T#6-/LYKY=)U%;FXM(!F1XRK*61?XF&[('O7:
M44 >>VKW6K?$^XU"'2]1BL+C0%MDN+FV:)1)YKM@AL$<'H1GVP03S=K'JI\"
M^#M(_P"$>U<7>CZM:F\#6Q 41LV2I/WACG(X]2.,^S44 <7ID5P/BQK-V]G=
MI;3:=;PQSO PC9T9RPW8QP&'?Z51TG0KNR\?W^DIL.@)*NM1J#RDTFY?*Q_=
MWJT@]"!7=WML;RQN+83S6YFC:,30MM>/(QN4]B.H-4="T.+0K-H1=W=[/(0T
MUW>2;Y92  ,G X    'ZDF@";7$@ET#48[F(RV[6LJRQAPN]2IR-QX&1W->7
MZ#J5LL?A==>LO$$,6CHJVSSZ0\<2.4\M3+*"00H. <*.YKU+6-*MM<TBZTR\
M#FVN8S')Y;E6P?0CI659>%YX2J7_ (BU74[9""MO=>2%..1N*1JS_0G![@T
M9WAV&XC^)/C"YEM+J.WNELQ!-) ZI)Y<;*^&(QP2/KVS5;PIX>U#2?$5_IDT
M.W0M/NGO-,;L3./N#VC)E'_;0>E=Y10!Y7:P'1-<UO2=9\%7&LK?7\MW97D-
MDDT<J2G=Y<C-PA4DCYN,?KLVEO/:_%-;EM/FBLXO#R6GF06S^0LJREBB$#&
MO3\NO%=W10!QOPSM[FT\+2V]W:7-M,+ZYDV3PM&2KRLRD9 SD$5'XKT?5?\
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M,Y0J"P&/X3]*P([2]/@[XC6W]FWXGU&]O)+2,VD@,RR0JB%?E[D'Z=Z]3HH
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M(B^3,Y&5'#;AN XW*,TFI>.--TRWN+R2"[ETZUN!;7%]$BF**3<%((W;B Q
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MW<82PM6.Z9P 6P2S8X ))+8'KT%26_C?2);'5+BX\^SETN40W=M.@\U';&P
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MUM/T^YL[VS.I*S64UPBA)\#<0,,2K8YPP4_CQ7+ZUH=]KOBWQ1##;W$,&HZ
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M9!*PLYHDBEV1LJE_F<#:2RXP><^QQ8_X2BT-OIK1V]T]UJ*E[>S"J)B%&6+
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M'=* 7'57&#T(KG+E-2\/?$Z[UAM-O+_2]5LHH/,M(_,:WEC)P&4<A2&)SZT
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MA95D5@YSP1N' SG]: -EO&VG1W&F":VO(;/5)1#97SHODS.PR@X;<-P'RDJ
M:R/'GB""Z\&>)H;.VOYUL[>6*6[M6"I%,$SC.X,VTD;L @=^AQF>#X;B&UT[
M0]1\!B'5; QQR:B]M$;8JF!YJR=2Q R !G<>PSBG%:ZUI'@[Q=X3GT34;JXG
M^VR65U;Q;X[A)@Q!+9X8$G*GGTS0!Z-X='F>$])#$_-8PY()!^X.]>>>%/&5
MIX6T#4S?6FK7%I#K-VDUY%"TL=NGFD*7<G)XQTW$=^HKT3PTD\?AC2XKFWDM
MYX[6)'BDQN4A0#G!([5PMC8ZG;>$O%'AM])NSJ&H7=[]GW1'R&2=FVN91\H
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M[<L0[9X8>ORG@9/'&:YZPTO6= GT'P_=6%[?:1;Z0L1>QP%>Z#?,LC9!"8Z
MG!R<Y[9&EZ9J\'@CP+83Z+J$5QIFL)-<KY.[9&IER_RYX^<>Y[#% '=0>.+.
M:+6<Z9J<5SI"K)<VDD2^:8V!(=0&PP(![YXZ9JY'XIM)]#TO5H+:ZEAU-HUM
MXT";SO&5)&['3D\\#.>AK)TBWN5^*'B*\DL[E+2YM+6*&=X6".T>_<,D?[0^
MO:J/@[0;O3O$NHZ:[(VBZ-<.^F@')1IU#E#Z>6&8#VEH [74[N2QTVXNH;:2
MYDB0L(HRH)_[Z('OUKSOPE/8MX;T'Q=JT%]#JK(J"=9%SJ,DV0%VJQW\D8#
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M-UY\T"AEMX\HH)+,"V/1<D <XXKO[[7TM[EK6SLY]0ND@%P\5NR#:C$A22[
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M4;.-(9+)-H?E\$@DX( .>M=W110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (3@
M$^GI6-H'B2#Q!<:I##:W%NVG71M9!.H!9@H;( )X^85M5Q7@;_D8?&W_ &&?
M_:,= %G5/' TC4+=;O1-132IKE;5=3^3RQ(QV@E-V\)GC<1@]L@@GK*X3XFM
MK%EH\.M69L[FPTN=+NYT^:$[IPK<$/NX*G# 8Z@'G&*[H'*@X(SV- "T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 !Z5CZ/X<MM$O=0NK>XN9)-0E
M\^X$K*0TF -PP!C@ 8''M6Q10!@0>$[:-F6XU'4[ZV,WGBVO+GS(U;=N';<0
M#T4DC@<5OT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>elicio2021employeestockp014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 elicio2021employeestockp014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L>_P!#
MFO;MYTUW5;16Q^YMWC"+@8XW(3^M;%% '/?\(Q<_]#1KO_?R'_XU1_PC%S_T
M-&N_]_(?_C5=#10!SW_",7/_ $-&N_\ ?R'_ .-4?\(Q<_\ 0T:[_P!_(?\
MXU70T4 <]_PC%S_T-&N_]_(?_C5'_",7/_0T:[_W\A_^-5T-% '/?\(Q<_\
M0T:[_P!_(?\ XU1_PC%S_P!#1KO_ '\A_P#C5=#10!SW_",7/_0T:[_W\A_^
M-4?\(Q<_]#1KO_?R'_XU70T4 <]_PC%S_P!#1KO_ '\A_P#C5'_",7/_ $-&
MN_\ ?R'_ .-5T-% '/?\(Q<_]#1KO_?R'_XU1_PC%S_T-&N_]_(?_C5=#10!
MSW_",7/_ $-&N_\ ?R'_ .-4?\(Q<_\ 0T:[_P!_(?\ XU70T4 <]_PC%S_T
M-&N_]_(?_C5'_",7/_0T:[_W\A_^-5T-% '/?\(Q<_\ 0T:[_P!_(?\ XU1_
MPC%S_P!#1KO_ '\A_P#C5=#10!SW_",7/_0T:[_W\A_^-4?\(Q<_]#1KO_?R
M'_XU70T4 <]_PC%S_P!#1KO_ '\A_P#C5'_",7/_ $-&N_\ ?R'_ .-5T-%
M'/?\(Q<_]#1KO_?R'_XU1_PC%S_T-&N_]_(?_C5=#10!SW_",7/_ $-&N_\
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M+>769]+59OM$$*3.3$P3:Q(&&Q@G@\4 7:*** "BD!# $$$'N*6@ HI"0.I
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M$1MA(Z$1&,%'+?=(/(QZX(SFHM>T"XN_!5EX)^U_:KB<00W%PL801VZ,I=R
M3C(3:!DY)]C@ [:WF6XMHIE!"R(' /H1FI*155$5% "J, #L*6@ HHHH *\S
M\3>&K[4O%NI:[H,OD^(=*CMWM23\DZ%7WPO[-C\#Z5Z9618Z5>6NO:AJ,M[#
M)#=K&HA6W*E-@('S;SGKZ"@#F_#WBJS\5:[I&HPJT$T>G7T=W;2??MI5DMMR
M,/;]155O%FMW?P^E\<V$L/DQ^9<)ISQC:]LCD$%_O"0JI;(X!XP>M='!X/T^
MT\<3^*;8>5<W-FUM<Q@?+*2R$/['"8/KQZ<Y=MX!FL]!O?#4&JJOAZY=\0&
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M&6!!SQ@=: .=\5ZO>:A\.I;_ $[Q%%=6LFI6\<5S;(N9(6DC78^.A!+9&!G
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M".V&"C_>1XRQ# CKSVKKM%TZ]L;=VU/4CJ%]*09)A$(D '150$X Y[DDD\]
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M:$K.D3 8.6RH(SZG/>NOA\-WUU?:7=ZWJ,%[+IFYK?RK8Q!I2NWS'!=LG!.
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M&L.W^&VHP:-I&ECQ*#!I&H+>VA^PC<0"YQ(=WS-\Y^88]P>P!=T7_DKGBO\
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MFQU/Q!X:FO?W\>COJ=AJ"1*'" E65Q]W<&'! '!Z5N?#Y;@> =">YN3.TEA
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M;C&5XYYS1XF\67&F>(KO3+O4I-%66%/[*NY(%:UN)"#N$CE3M(.!C*\<\YH
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M1R[02Z[1D;CSG('%+-J_BJ[OO&MM!K-O;+HQ1[=DLU8G,/F;3N)X[$\GTQW
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M:,-.6]%HOG1S&3RO,.4<.H'([@5O5%<W,%G;2W-S,D,$2EY))&"JJCJ23T%
M'/>*/"4GB$:;=V^J2:;K.FN7MKZ",,%+ !U*,<%6P.">W7UJZCX&EUC0!:ZC
MKES-JR7$=U#J:1*AAEC^X4C' 49/'?<>>:T5\7V#61U#[-J TT+O^V&T?85Z
M[L8W[<<[MN,<YQ6S9W45]907<!+0SQK+&2,95AD?H: /.[%9['XQZ?;ZGK*7
M]Z="E5G\M(1GSD( 0'C(!/4GKVX%G_A6ER/#XT%?$<J:;!>+=6D:VJ[HL2^;
MM9L_/SG!XZ\@\5W_ ):%MVQ=WKCFG4 <Z/#=ROC)O$:ZDAD.GBP$+V^1M#[P
MQ(8<[CZ 8XXZU6TGP1!9^"[KPOJ%U]NLKCSLL(O+8"1BQ[GD,Q(/;BNKHH Y
M/0/".IZ<L<&K^);C6+*W0I;P2VZ1X!4K^\8<R$*2.<#G."<8R&^&=Y_PB\OA
MB+Q+*NC"9)+:-K16EA"RB0(7+?,N1QP"..2!@^AT4 ,1"(51W+D+@L0 6]^*
MXBW^&\<?A&VT"76+B06%PMQIMRL2J]JZ,60_[1^8@YZCL.M=U1TH P[/0)?[
M<CUK5+N*[OH;<VT!A@,4<:L07(4LQW-@<YZ# '7*>*_#K^)M-@LUO1:K%<Q7
M);R?,),;!E'WA@9'-5I?'6CPV#ZDR7ITQ<@7R6KM"V#C@@9QG@-C:?6ND+J'
M5"P#-G )Y..M ',ZUX5N];MM5L;G4X7T[4E42026F]H3L528VW_*3MR,@X//
MU;JGA"?4K'4=+;4HSI-]$L1MYK7S'A 0)F-RPP?ER"0<'GUSU5% '+7'@^9/
M$EKK&E:L]B4L5T^:,P++YD2MN4J2?E89/)##VK*3X9(GA2TTA-<NH[NPO'O+
M&_CC4-!(S,QX_B!W$$$\UU&J^(K+1]2TRQN4G,VI3^1 4C)4-@GYFZ#@'W]J
MUJ ,C0M)O].CDDU75Y-4OI %:<PK"JJ,X"HO ZDDY)/T  JZIX8:Y\2VOB+3
M;T66IPP-:R%X?-CGA)W;'7<IX;D$$?C70T4 <;J?@)=1\.:GIG]H^7<:I=+=
MWMWY&XLZLK*%7=\JC8H )/ [DYKKXA((E$K*\@'S,J[03[#)Q^=/HH X]O!-
MS:ZUJUYI&MM96FKY>\M&MA*/,*[3)&Q(VDCKD,#^6*1^&TD.B:#!8^(+FUU;
M1$,=KJ"P*<HP 9&CZ,IP."?QKO:* .1U7P9=:SX3N-&O=<DEN;N2.2XO7MUR
M=C*RJB @*ORCCGOW.:NW?ARXO/%>D:Z^H1J^G0RQ>2MN<2>8!N.=W'W1CKCW
MKH:* ,*^\+6=_P"+=-\0N[K<64,D.Q?NRAB"N[UVG)'N<]JH:]X.NK_Q%#K^
MB:Y+H^IB'[/.ZP+-'/$#D!D8@9!)P:ZIW6-"[L%4#)9C@"G4 <K>^#Y[J?0Y
MUU=C+I=PUT9)H [7$C ABV&4 88X ''&.!BNI90Z,IS@C'!Q2*ZN6"L&VG!P
M<X/I3J //[;X:W5OI6CZ</$LYAT>]6ZL\6D>0HW?*W]YL.1NZ?[)K6B\(7,5
MUXEG&J(6UU5#@VW^IQ'Y8(^?GY?U_*NH=UC1G=@J*,LS'  ]367/XBLK?Q-:
M: Z7'VRZA>:-O+/E[4QGYCU/(Z9H Y35AI&C>#H? %]<_;[^?3OLUG;K RM.
M -B'(R%((!)SQC/05V6B:7'HNBV>FQNT@MX@AD8Y:1OXF/N3DGW-7L#.<#([
MTM '*^(?!\^IZ]::_I&L2:1JT$)MFF$"S)-"3NV.A(S@\@Y_IB/6? QU73K#
MR]9N[?6K&<W,&JA59_,88;<G"E2,#;P, #IUZZB@#C=3\$WVL^%KO2=1\027
M%W>-&9[PVJKA8V#*J1J0%&1WR3D^V-+Q'X;E\0V.FH=0^S7FGWD5[%.D.Y3(
M@(P4)Z$,>,UT%% '.Q^&KA/&4?B%M2$CKI_V Q/!]Y=V_>6##YMWH,8[=Z9H
MGAF\T636Y%U.*9M4NGNSFU($4C*%X^?E<*..OO72T4 <&/AJ$\)Z-I,.LRP7
M^BRF33]1BA :,G.0R$D,"#@CC/'XW-0\%7>K:";:^\03RZI]HAN5OA;JJHT3
M;D B'&T')P222>O3'1V6I+>W5] +6[A-I*(B\\119<J#NC/\2\XSZBKM ')V
MG@V>+7]1U6[UJ:Y.HV:6MS$($0,5# $$=!AS@=?4FJ+?#EY/">FZ0VO7*WFE
M2(^G7\4*HUOL&U1M_B&#@Y//M7=44 <S#X<UA=,D6Y\22W&JO)$PO3:JB*L;
MA@@B4@8/(/.3GKP,6M&\.)IFLZIK$LL4E]J(B68P0^4F(P0#MW,2WS'))]/2
MMRN?E\7V,=]' EM>SP/>?83=PQ!XHY\XV-@[ASP6V[0>": $U7PPUUXDL_$.
MG7HLM3@A:V=GB\V.>$G=L==RGAN001@^M9VJ> 5U+P_J>G?VCY=SJETEW>7?
MD9+,C*5"KN^51L4 $GC/<YKLJ* &QB01*)65I /F95V@GV&3C\ZYRV\+W-KK
MGB#5$U*,OK"1J4:V.(O+0HI'S\\'GW].E=+5/4]5L=&LFO-0N%@A#!02"2S$
MX"J!RS$]  2: .5'@&9?"NA:$NKJ$T>ZAN8IC:Y,AB;<@(W^O7U]JBU'X<S7
MUOXCLUU^:&QUR0SRPBV5BDI502&)R5^4?+QTZ]<] /%%C'<V\%[#=V!NG$=N
M]W"421ST7=R%8]@V">PK;H Y&?P2U]K4%_J&H1WD::<^G2P2VHQ,CD%B2&&#
MD#&!P/4\U4/P\EG\(6^@W>O7$KV$R3Z=?)%MFM73.SG<=P )'/;O7;NZQH7=
M@J@9+,< 54N-26WU6RL#:W<ANED83QQ%HHM@!P[?PDYX]<&@"EH.CZCIX>;6
M-;DU:\90@E,"P(B]<*B\9)ZDDYP.F*K:GX7N+OQ9:^(+'5Y+*>.T:SF00K()
M(BP?Y=WW6R.N#VXKHZ* .#M_AQ-:^']*TB/77:'3=3&HPM):@G(D:0(<,.,L
M<GOQC%:=QIL>A>(M2\8ZAJ:):_85AGC%L<)'&2P;(8DG+'M74UDQ>(;*?Q//
MX>5)Q>0VHNG+Q80H6VC!/7G/3C@T 87A6PTS4?%&K>+].#FVOHXX8)"&592
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M+&"OF A>1QG9G'?/-6KKPE%)K^E:K97LUBUA;-9^5$JLLD)*G9\P.WE1R.:
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M ')^;(^Z,>GO5OQ+H,'B?PY?:+<RR117<>PR1XW*<@@C/N!0!R/B:UO%\?\
M@>VBU&1K@IJ(^U31HS@&-.=JA5R!P.,=,@]X+;Q?J^F:1K=K>7/V^]L]<CTN
MVN6B1&993'M9E&U=RASZ X&<5TDGA6ZGUO0]5N-9>>XTI90"\"CSC* KYVD
M< 8QT[YJG+\/;6\LO$%GJ%[)-#K5P+IS&GEM!* H5D.3C&U>N>E %C1SXGB\
M42QW:W$VAR6VY9+TVXFBG!Z#RN"A7GD9!]JR?B^7'A33S&JL_P#:]IM#' )W
M\9.#C\JW_#_AW4-+<2ZKXAN]9FC3RX6FB2,1KQGA1\S' ^9B3],G*>+O"[>*
M[&VLVOVM(H+F.Y!2(,Q=#E>IQC/M^- '&_$*ZU%-4\,7'B2UM[/0+75(IVN+
M&8SN)QGRP^Y4VIR<D!C]*Z2VU._\2^(O$.GV>I2Z=#I+1V\;0QQLSRLFXLV]
M3\HR  ,=#SR,3:GX-;Q!-9C7M5FO+2TF6X6SCB6*.21?NE^I8#TR!4\GA:2W
M\27FN:1J'V*>_C1+R)X?-CE*#"N!D%7 XSD@]Q0!SNE>+=5UOP_H]S<7<&GR
M?;9[/4?(3?-,\88 6Z%6SE@">,@9],UFW?B_Q$GPU\0ZE%>[-0TK5GLDEF@3
M>\8E11O &T-A^2!VKIY? %O"-"?2M2N;&XTAIF2;8LAF\[_6EP1@LQYSVSTJ
MI/\ #82Z#K>D?V[=FWU:]-Y(SQ(61BRN<$ <ED'7C'0#K0 ^^OM;TG6]*T*;
M6Q<W.N7<K1SBU1/LD$4>]T0<AB3@ L#C=SG%0^&;>>V^+'BJ.>\DNS]ALBDD
MBJ&"_O.#M !P<\XZ8^M;?B/PI_PD,.G3&_DL]5TV7SK6^@C'R-C# H<@JPZC
M--TCPK/IWB:\UZYUB>[N;RWCAEC\E$C.S." !D?>/?ZYH Z6BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBN9\9Z]/HT&DVUJXBN-5U*&P68J#Y0?)9@#P3A2!GC)'7I0!TU%
M<5)J&J:1X^L] ?4)KFQU>SFD@EE1#);2Q8+8(4 J01P0<'VXJ#X;S:_KF@Z7
MX@U37I)UFBF22T%O&J,PE8*^0,@@#H.,8XX.0#NFD1&17=59SM0$XW'!.!Z\
M G\*R=*\16NKZQJVF0PW$<^EO&DYF0*&+KN7;SDC'KCK7->+X+B;XD>"HXM2
MN[=)6O/EB*;598#\P#*03AB.<\=,5E&WU&7Q;\1I+#5IM.>!;657AC1F9UML
M@'>"-O'( !/J.X!ZE17GEAXLU+6HO#%D@F6XU#1_[1NGM3&KL1Y:[5W\ 9=B
M<<\#'>ND\)KX@CL;J#Q"RR2QW+BUE)0R/!_!Y@3Y=XY!QP<4 6]4U^QTFXM[
M64R37MUGR+2!-\LF.I [ =V) 'K447B2W.J6NF7-I>V=[=;C#%/$"&"KDG>I
M9./3.>1Q7)>'':X^.'C%KO\ UUO9VD5H&[0E=S;?;=@GWKO+X6\<(O+B/?\
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M6JLTFF$H]@\[QF=>/G1MG!&>AZ^M %VY\16MKXHL= DAN/M5Y%)+%($'EX0
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M+35?#Z:?>ZC?R7J7"W::F'"SK.HP'& %&!Q@#&/?FM/0=#FTF-WO=6N]5O)
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M0,B[4>"<X.Z,@<8VC&<_K7944 <M:>"U?2[NRUW5KW6_M,#6Q>ZVKLB/4*%
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MM4N8Y=1L/L#B-5 C0;L,IQD,"Q.3GZ5LZ+JD6N:'8:K CQQ7ENDZ(^-RAE!
M.._-7J .=_X1*WN]0:^UB?\ M"8V+Z?S$(PT+D%]P'4G ] .< 9-4_#O@=M
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ML*>!\N&;WYZ],=O65JFN1Z==V]C%;R7>H7$<DD5M$R@LB8W,2Q  RRCZD>^
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M86?A]C%=R!NX![G&*76? UGJ6IV6IV%_>Z/?VD'V9)[!E7=#VC96!! [<<4
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MBKAUD+*C\;MH(#;3[<D<5V2^&HD\63^(EOKH7,UJ+0Q?)Y80$L,#;G())ZT
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M/'V;'E_-A-GS_)S\O'&*K)\/;*#6+V[M-4U.UL;^4SW>FPR@03.?O'IN ;N
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M0!K1N9_C.'&Z,R>&01ZKFX_G618^+-6M_"S?:-0>6\N?$SZ0EY*BYB0S%=V
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M43>LB''?D$'CT%<G)K'B.+X=ZCXE;Q%=O=Z9J<D<<?EQB.9%N1'B0!><J>V
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M_$%E_:=^8M=>1[HGRLJ74(VSY./E '.: .?D-QJOQ&\(W<E[=1&ZT6:=HXG
M16_=$X!!ZYY[].>*@UK7M6L,7T&JS7<JZ]';.]NH%HD#2A/((;&YP#RRY(;/
M(Z5U;>"K8W&B7":E?QSZ3 UM'*C(#-$P4%7^7_9'*X/O6=)\,K%]/GT]=9U:
M.R:]%]! DD>VWE\SS"5RF2,YX;<!GUYH <O_ "7"3_L6U_\ 2EJ[6L*+PQ#%
MXK'B$7]XUR+(6/E.4*&,-NY^7=G=SG-;M !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%<_XNN9+?3;7R]2^PB2]AC?8A:6="W,4>.0[
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M,R@[L@'N/2@#KJ*\Y@\2'4!X9TS2=3;4+;5%NYC<R3M!)*L3#$98*65AOYP
M?D[4VZOO$OABSBL-2U&%EU+6H+2SG$QEFMH)<DAF91EOD*JQ!Z\YQ0!Z117%
M:[I^I:+I'B:[@UVY-J--DN+.W>1FEMYHT8EA(225)V_*<C-4I=6U$-\.IA>S
MAM1VI>#=\LP-L7Y'3.X9R* /0JSK/5'EL;J[O[.73H[>613]H9>8T/\ K,@G
M"D#-<9X;MM7UGQ!KXN/$NIK%I>L[(8X_+ =/+0['^7!7YN@ [GD].;UNYO\
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M9S@$Y.3WZ#\JW#P#QGVH Y>V\%PVVM1ZU/K&K7FH1V;6?F2RH-T9.[HB*,Y
M_+G-7/"6DW>BZ&+.[O;R[*RNT;WLPEF5"> [C@GO[9QSC-7])N[J^TN"YO=/
MDT^Y<$O:R2*[1\D<LO!XP?QJIXIU\>&/#=YK+6<MVEJF]HXF53CUR3T_,^U
M#5\-P+XKE\1"\N_M<EJ+0QY3RQ&&+  ;<Y#$G.?THT#PU!X>DOVM[V\G%]=/
M=S+.4(\U\;B-JC'0<=*UH)?/MXY0,;T#8],C-)<7$-I;2W-Q(L<,2EW=C@*!
MR30!CZOX5M=6UNQUC[9?6=[:1O")+24+YD;$$HV0>,C/&"/6N)\7>%+7P_X:
ML--TV74Y4FUZ"Z8;FF>!?-WNRX7@#).3D^I-=O=^(UM/%^F^'VLI2U]#+,ES
MN78/+ )&,YS\PZX_&MR@# ;2+:S-WK5Q=7%[=FT,"S3*N4CZ[55% Y.">,G
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M#_2T\+VOAU;N_&GVLPFB7S$W!@^\?-MR0&Y_^M6@_AF!_$:Z]]NO!?K:&S#
MIM\LD,1C;C.X Y_IQ0!YC#>:TOPGTGQ/_P )!J;:G%?*F6FS'(K79C*NG1Q@
M]^F !@5U#W5YX:^(5Q;#4+^^LY=#FOY(+F;?^]CD493C"Y!(P ![5JCX?Z6/
M"L7AL7=^-.BF$RKYB[MP?S!\VW.-_/\ ];BM)O#5N_B2#7I+NZ>\AMC:@$IL
M,9(+ @+W(!_E@<4 <'>:KJD?PFM?'5OJ=RVK)''>R(9F,$@9P&A,6=H4 X!
MW9 .<YSII#?:U\1=;TR;6M5M['^S;:=88)O+,;.7!"D#*]!TY..3CBMVU\"Z
M7:6WV"*6[_LD3_:%TQG4P*^[?@?+NV[OFV[MN>U7$\-01>(;S7([R[2\NX5@
MDP4*A%SM !7C!)/X\YH S_AMJ=YK'P^TB]U"=I[IT=))6ZOLD9 3[X45U597
MAW0+7PQHT6E6,L[VL)8QB9@Q7<2Q&0!GDD\^M:M !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=7;&,GW.*Y6(:[XST[6+C3[X65_;ZG/;P7 U"5!:^5)@*T*KL;*C)W$YW?0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M89X4DVYSC< <?K5B@#F=(\"Z/I%I-:A[Z\AE@:V"WMV\PCA88,: G"J>.G/
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MW@@C(Y 888>M-N/"&E3+I"1K+;QZ0X>SC@?:L;8(R>NXX)ZYZFMTDA20,G'
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MFU$Q^4+JYGDF=4_NJ7)VCV&*@;P7HQFO"L4R6]])YUU:),P@F?NS)G'.!D#
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MH,<C(P&.S Y!]\UX]:V\J_#CP/KJ:A?KJDM_:0/<_:G),<DA5EVD[<$'T^M
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MXZ5G:5X \-:)JK:CI^G>3,7,BH)7,4;'JRQD[5/N!]*Z6FN7$;&-59\':&.
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M8'6=T=& QG>I#="0>>>]);^&]+M=:EU>&!UO98A [^<Y4QCHNPG;@=N*U:*
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M))_M+P"9_),N<[_*W;-V0#G'4 ]:;>^#/#VHZE=:A=Z9'+<W40AN&+L%E4#
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MM]USNRUP&A=MSG^,DC.3TR<=:2#3YO'%KXC\W5K6RO[/5)X5N&MV:XL5C?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME=EK_97V?(;<WG>=NZ8QMV;>_7-7:\]=/L'Q<NVL(MQ7PQYD4*D[2PFPH Z
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M!G' !;GODUUNG^';"36-$UZQU>RA@GA>$1Z?;-&-01T) =O,8DK@MNZ@YR:
M.^HKP@Z7:I\$SK*B0:G9:DYM;KS&,D/^G%?E)/&03GU[UV4MA!X?^*UG_9,!
MC:\T>Y>X0.Q^T.CH59\GYFY/S'GF@#T6BO)O#VFQ>)?"N@>)#K=I;7\$T<UQ
M>0VI^TO-G#PR-YF6#,=NW']W Q@55FT'3[W3_B:UU$\QLYY9+;S)6;RG%LK!
MUR?O ]Z /5[C4[2UU"SL)90+J\+B&/NP52S'Z#U]2*N5Y2UI::IXJ^&]WJ-K
M;W,UUI$[SR31*QD(AB8%B1S@EB,],FG7S3:)XA:[UC38-2T>ZUA7M]9M2//L
MY/-"K%*#R4##9D'&..M 'JE%-61'=T5U+(<, <E>_/I3J "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAW%DR>O!)ZY.?6J.C^"?#?A^YN+C2=(@LYIU*O)%D$ ]0IS\H_W<=!Z5OT4
M87_"&Z!_8[:1_9Z_V<TGF-;>:^PMG=G&?7GZ\]:M'0--;5+?4V@9KVW3RXIV
MF<LJ]QR>A[^O>M.B@# M_!'AFTUYM<@T:UCU)F+F=5/WCU8#H&Y/(&>34P\*
MZ*L>H(+,[=1R;P><_P"_R,'=\W.1Q]..E;-% &-+X4T*>WT^";38I8]._P"/
M02$MY(QC R?NX &.F .*>GAG2$N6G6T.YK@W3(97,9FSN\S9G;NSSG&<X]*U
MJ* *-GH^GV%_?7UK:I%<W[*]S(N<R%1A2?H*O444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEHE8-P&W8RW&1V[5BZ!8^)O#AN/#O_"-P7UL+B5[+5C-&$6-W+?O5/S$J6/
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M:>!WRQ'8<Y) !QVBWFEZ1\%+N35-)?4=,COKE9;:/;C'VI@N<D<!MO3)]J]
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MFECQ<1%BH.Y20IW#!!Z5PZ>&?$<7@N?2!H!65?$(O8UAN(MIA$_F97+# VC
MS@^PKKUL-2;XK#6#ITRZ<=&^Q^>7CXE\W?C:&W8QWQUH G^'VOWWB;PC9ZM?
MVWE/<AI%(8%6!=L  <@ 8'-1#Q'J;_$R30!8?Z%%IZW&\2+EMTFW>1Z#:0 .
M>2:;\-=/U31?!=EHVJZ>UK-8JT6XRHXE^9CN7:3A<$=<'KQQRVYTS4XOB@=4
MBL&GTZ[TE;)YTE1?)=968E@3DC:W& >?3K0!)<^/+:WT=M>6PGET%)C&]ZC
MD*'V&4)U,8;OUQSC'-=0\Q-J9K=1/E-T:JP&_C(P>G/K7FMAX>UZT^&]YX#D
MTYY)=DMI;Z@'3R&A=B1(WS;@5#'*XSD#&<YKT>PLTT_3K6RC):.WA2)2>I"@
M ?RH \CU_6KOQ5\#;O5]4L5CE^U*\3@A@,7NW"XY^51MSW_&O0;/Q:LWB:71
M+W3+G3Y/LIO()9W0K+$K!6/RD[2"1P><>E<.WASQ(/@_<^%?[#E:^BN?W;"X
MBVS+]J\[<,MP-OK@Y[=ZZ/5M'U'5?'UI=_V?<)IS:/<64L^^/]V\I4CC=DX
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M7#(!@X("Y51C<36O>>-=1TV2U.H^&I[.WN=06QCFEND(&_&QVVYV@YQ[$8H
M[&BLZ/4WE\0S:6EL"D%NDTD_F?=+E@JXQU^4GKTQZUFZ_P"*SH>M:5I:Z3=W
MDVI>:(6A9 -R(6V\GZ<G  .<\4 ='17#)\1PFE^();W0[NVU+0E$EW8>:C'R
MRI975\@%2 >G/L:N1^-94M1<WNAW5K'<R6\6G;I4)O'E!P  <IC&3NQQS[4
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M=BR!@2%;:W4\9'XUTTFDWVI^+/\ A))M.GMQ::;):6]K(\?FRR.V6)VL5
M RW))Z8&>QHH \MA\,Z_#\/O!^DG29#>:5J-M<7*">+ 2)RQ(._!R#P/SQ7H
MFL"]?0K\:<,7YMI/LP) Q+M.WGIUQ5E[F".>.!YHUFESY<;, SX&3@=\"I:
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MCIS7J=1?:8#<_9O.C^T;-_E;ANVYQG'7&>] #;.6>:TCDN;?[/,PRT.\.4]
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M\4)*TJECOP"8P,=P<Y'3M'J<?BKQ'X-UJVO-&AL+BZLI+6"S2[64EW4C>[X
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M@\PY*N)MO,9 .#MSGC%3>*]+UXZQHWB7P];Q3WMBDD,^GW$HC\^&3:2 _(#
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M-1W'5+>=%CGM!(?ED4'+$Q@#!7KCG%=1XRM-8OO"E];:#,(M2=5\L^9Y9(W
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MG01W-H)#\LB@Y9FCP,%>O?%=/XTT^[U;P9J^FV,/FW5Y:O!&I8* 6!&23V%
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M5O46XNY",$L54*".V$50?<&@"YJFNBRU6QTBU@6XU&\5Y(XVDV(D:8W.S8)
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M:0%2R[<#<.H#'''7L >IT5QNM>/$L/[5^P165R=+;;-#->"*69@H9EB7:=Q
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M)):3+<[W#(@=E=-H"Y!XPQZ?D ==17+:)XLFU^:&6QM+:6R:ZEMIRMR3-:[
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M5I^'IO&SK%#K]EI\*VJGS)[:X\QKU@"!A2H$8)Y))[8P,\=;10!RWP_T?4=
M\+KINIPQQSQW$T@,<F]6$DK./3D;L4GC+2-1U:X\//80)(NGZI%>S%Y OR*K
M A?4_-[#CK7544 >7^(?"/BC5[7Q;9FWL;EM2.;&^FN"&BAPN( FWY<%3SD
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M6'H#>([C=<>((K&T8+L2VLY&D!/=V8@>G '3G).>-R@ HHHH **** "BBB@
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M]_>'S<=/NUC+\0]<_P"$5'B631[%+""^-M=H+EFDV^?Y68_EP<$CKC// ZD
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M&.]=C:ZAKA\9S6%S'I[:5]C$J/ SF:.0%01)G@!LMM[X0UT%(  20 ,\GWH
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MTL)H6ENH96+7*0D%!L*C:3A=WS'H<9SQW5% '+Z#H>J:=XP\2:K="S^RZK)
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M*ID!*C+$KG!QU^\<UZ("",CD44 <)<Z58:W\2K'4M.OTEA2TWZC' P>.4QR
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M<N5ANXL [MF6(/."I/XUDVWP]UVP\,^'DLK^QBUW0)YI+>5M[03)*S%T<8!
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MSNQC/XT 9.H^-M4:UU"]T33FO4L;I[?[(ME/(]UY;;9-DJC:IR&P"&SMYQG
MFOO&EPVMW6D6;6=IJ"6D=Q:VFHHRO>%U)VJ=P (/RD<G.>F*BM/#/BO0M9U&
M/0M2TS^Q=1NGNBMY&[36CN<OY8'RL,Y(#$8_/,OB?PC>^([*_P!,NH-.NK21
M%%C=7$C"XLWV!2XPIW'<-WWAGH>#P (U_KC_ !;FTY+JV-E%I"W$<#1L/O2[
M3D@_>.P<XP!VZY3PQXD\5>(X_M:Z=I,5G%<W5M,&GDWEHV*H5^4C&0 <\]<
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H) !).
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M26<7PK^(*1K EP+W4UVJ &"A^GK@9'YB@#UG3M0BN[:!6GB:Z,"2R1JPW+N
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M$,UW!'*5+!'D 8@=3@GI7G6A6WAW6%\*ZS9:]NN;90MK;VPB61MR8>-P!N(
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M:<T.I?!/Q(FK@?VO!)>M>[O]8MV'9HSZY_U87Z "O4-%TN/1='MM.A*[(5(
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MP=T3_P"XV<$=0<<UZ/$\=[9H[1GRYHP3'(O.".A'X]*JOH.CR3K.^E6+3*%
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M(=WE964;@1LW&)B"#@CUJ[XBT_0SX>\;:GI>L2ZI=7>DLUT4>)X5*H0C'RU
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MM(FDZ;%>F]CT^U2[(QYZPJ'Q_O8S0!YY%##!XC^*<<$<<8-C;,50 #)MI,G
M]:RGT/3S\/O -YI-K!'KK2V#03P*!*YVKYNYAR5"ABV>!BO68=+T^WNI;J"Q
MMHKB7_63)"JN_P!2!DTRST72M.G>>RTVSMIGSODA@5&;/7) H \X-U:6DOQ4
M@N9H8G<Y$;L 6W6H P.^3^=06EQ8BY^$]Q-+;B!=.F5Y'8;01:)P2>.N:].G
MT72KJ\-Y<:99RW31F(SR0*SE",%=Q&<$$\>].?2=.D@MX'T^U:*W8/!&T*E8
MF'0J,<$>U 'G$ZW-MXE^)S:)&$OSIEK)"(1AC(8I3D8_B[_7%1ZH+>^^&O@N
M\T+8+^.YLA8M']X.<"53^&_</8YZ5Z;%IEA!>27D-C;1W4GWYDB4.WU8#)J.
MWT;2[.\>[MM-LX;F0DO-' JNQ/7) SS0!YS!H^E7'B3XF++8VLBI'#M#1@A-
MUKEB!V)/)-=A\/I&E^'7AQW8LQTZ#))S_ *U?[$TG=.W]EV6ZX&)C]G3,@_V
MN.?QJS:VEM8P+!:6\5O"O2.) BC\!Q0!YGHIMM2\&^.[77@GVQ+V\^W"7[RK
MMS$PS_"%"[3_ +/%4K'3/MOB'X=)XAM(I[V;1KD72W" M*0D>T2 _>(!Z'OF
MO4;C1M+N[U+VXTVSFND "SR0*SC'(PQ&>*?-I>G7%XEY-86LEU']R9X5+K]&
M(R* *FK6\MAX1O[?1(5AF@L9$LXH5P%8(=@4#WQBN!\.#PQX@TWPE>Q^(;A[
MZQ>,V]G$T"RI)MQ(CJ$#[?O%N>0,Y[UZI5&WT72K2^FOK;3+.&[GR)9XX%5Y
M,]=S 9/XT >9ZK'9:'XSDUM8B?"-Y>QQZE@CR5O5)"S8Q]P/M#'IO /\-:NI
M:G:P?%&\L]9U8Z=!<Z9$+!W\H12+N?S5S(K#))7(&,@#.<"NW.BZ4;'["=,L
MC:;M_D&!?+W>NW&,^]-N]"TB_M8;6\TJRN+>'F**:W1TC_W01@?A0!YC=:!H
M-F_P_L;&1[_3UU.:**>Z*N9(]DAVA@ &CW=!T(]0:V(KK2?#?Q2;3+U;33M/
M;25&EJP6*!29&,RKT4,25)'< 5W-QI&F7;0M<Z=:3-" (C) K&,#IMR./PI=
M0TG3=7B2+4M/M;V-&W*MS"L@4^H# X- 'G'B#3]"LO#_ (+CT2)?L$'B2V2U
MD9B_RF1RVQB22I.<=B ,<8IWBJ2_T6]\1:Q:?9-9T1I8O[7TR7Y)[=ECCPT3
M=_EV-M/?IS7HUSI6G7J1)=V%K.L/^J$L*L$^F1Q^%1OHFDR7GVQ],LFNLJ?.
M:!2^1T.[&>,#'I0!YVUWI=_XH\8Z+XDUIM-:Y*;(YC"BRVAA4#:TB'HV\D \
M$D]<UW_AZWAM/#>GV]G-<36\5NJ0R71_>.@&%+<#MCL*FOM&TO4YH9K_ $VS
MNY83F)YX%=D/^R2.*O4 >.V31:E\!M9_M'_D,P-=/=9_UJ7PD9D]]V?+ ]B
M*V]0CE;QK\-UU-(VOGMKO[3N RT@MTW?KFNY;1M+?4/[0;3;-KW@_:# IDXZ
M?-C/%.N-(TV[N5N;G3[2:X3[LLD*LR_0D9H SO&EU96/@G69]1BFELEM)!-'
M VUV4C& >W7KVKB=.N;8_%#14FN]->.;0)(!#;L&15+Q[(RQ/SG!XX&?05ZA
M+%'-$\4J+)&ZE61QD,#U!'<53AT+2+=85ATJQC$"LL02W0>6&^\%P. >^.M
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M!=UR@W2#&4'/+<CCKR*X_P 2?9M4U?P'?:"T3RM>;D:'&#9&(^;G'\. @^I
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M"!U/W7!+G X.3CI0!UMQJ%E:31PW-Y;PRRAC&DD@5G"@DX!/. "3["J9\3:
M-/&H'7--^Q&3RA<?:X_++_W=V<9]JY?QA:VDWQ)\"^?#"Y>6\!WJ#N @) ]^
M<5EV.GZ<VN_$Y6M;9D0)@% 0NZU!;'IDC)]2/:@#T>[U*PL(4FO+VVMXG.$>
M:545N,\$GGBHI-<TB&V@N9=4LD@N/]3*UP@67_=.<'\*\TT/5[&&Q^'\,TMO
M;ZA_8C/%?WDI$42;(PZA=P#.<#J> ">>E)X5T>#Q5\)[_2+:ZC-[;W]S+:R
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M:&A2X2\0X;Y=@<@G<22>A))X- 'L-%%% !1110 4444 %%%% !1110 4444
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MULX/X5 /%&@,UZHUK3RUB,W0^TI^Y&<?-SQSQSWH T(;.VMW9X+>&)F 5F1
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M"HNEZ>LT<RV%J)8P CB%=RXZ8..*5--L([Y[Y+*V6\<8:X6)1(P]"V,FK5%
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M\S04AF#V6X+,LJDHH#$D-N&WTY% '6W6LZ=9:A::?<WD,=Y>$BW@+?/)@$G
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MWLHAMXSDF1ST  _GTH Q?#7A,:)KVK:JEO:V*:@D0-E9N6B#KNS)RJ_,=P&
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M,B6ABC*EHE8KN;+'.2"01CC![U@>+/%&L:&NLW$:V%O!8VHGM%N%,KWQ"EI
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M_AQWJEI7C/4[ZQ\2PNU@=5TR^%G;)'"X20L0L3-E\X8DC@\8/6K^H^$;O5/
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MA^T^7)M8QG=^[XY&=W/IWZ/Q#K^JV$\QMOL5I9K8^?!/=*96N9^3Y2HKJW
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM16(.>?E]:Z^_P#^0;=9_P">+_R- &59>-/#>H26Z6VL6K&Y.V#<VT2GT0G
M8^PK>KP[3-'U7Q;\#= \/:=I<BO*R/\ VA+)&L=NJRDEQAMY/48"]S7:^*_$
MVM:!#K,Z26<4>GVR3644B&:2] 7,C,%;**#\N< 9YSCB@#O*IV>E:=ITDKV-
MA:VKRG=(T$*H7/J<#FN2U3Q)X@D\1Z)IFD_V?%'JVGRW*O<1NYB=54C.&&X?
M/TX^M5M'F\1R?$Z]M+_4[1S!I-L[QQVS>6&9FW!/GR,LN<G/&!@8H [73-6L
M]7BGDLI6D2"=[>0F-EQ(APPY SSW'%7&8(I9N@&37 6/CG4#X=N;B\BM7U%M
M=?1K81JRQ%O,\M68$DX RQYYQCBN@A?Q/!J-_!<?89K(6PDM;S84(EYW(Z!B
M2.A!!'IS0!J:5JEIK6EV^HV$ADM;A=T;LC(2,XZ, 1T[U<KS6/QSK\W@SP?K
M$,.GM<ZU>QVL\;JZJ-Y?&TY.!\F.<]:NVGB7Q18^)M4\.ZG;V%_?#36U'39+
M53 DV#M\I]S':=Q'.>E '>T5PND^*]2F\666C37-E=K=Z=)<&6"%@L4Z%0RJ
MVXJZ_-V.1CK6,?&_BI/!<_B>0Z5Y-CJ#V\]LL#YG03^4=K%_D(!ST;./PH ]
M1DC26-HY$5T<%65AD,#U!%1VEI;6%LEM9V\-O @PD4*!%7Z <"N,$^KO\99;
M/^T(OL4>CI.D+0$[0TQ5@#N'S'8/F.?I6]XFUQ]$M;%8$1KO4+V*RM_,SL5W
MS\S8Y("AC@8SC&1G- &W17(ZAKFN>&;76[[5X;:[TVU@26TGB_=O)(3M,;+D
MX^8CYO0]Z9;:OXF_X2.UM#;"YT^ZAD\RY:Q> 6DJC*Y#-\Z-TP.0>] '8UE:
MC/HVBW":I=PPQ7-S)':"Y2WW2.6.%4LH)QGUX%<+8^(?&>M_#^Y\1"[TJSB6
MRO&(BMW:021LX5ERV!PI&#G'7G.!9CUS6]!^'WA"Y2>SN#=RV%M(7@8,(I0@
MX.\Y8<\GKGH* .YU'5K/2U0W+OODW>7%%$TLC[1DX102<#KQZ53T#Q7HOB@3
MMHU[]J6 (9&$;J!N!(Y8#)X.0.A&#@US&K)J3_&/1UBO;=$_LNY:,/;LVU=\
M08'YQDG YXQZ&I?^$SN-(N?&W]HPV[6?A](9($MD*&021E\')/)) SQZT =?
M+I.FSW\=_-I]I)>1_<N'A4R+]&(R*??:=8ZG!Y&H65O=PYSY=Q$LBY^A!K&M
M9/%,>K:<;A;&YT^XA<W9B4QM;2  KMRQWJ3D=/?VK A\8:S;ZQX?MM0-D9=2
MNI+:\LX$+_9&VLRCS58J6 49!Y.<@"@#OHHHX8EBB18XT&%1!@ >PI]>9Z=X
M@U+1[WQ[J^IWL=W;:7.,0K 48@0JR*IW$*,MCD'DDYK;M-9\2+XCTZ"2S-WI
MMTCBZE6R>#[(X&5(+,=ZGD=,CK[4 =C17#>$O&%QXENK=1>V:7*%QJ.E20F.
MXM" < 9;+ ' )QSD'CI6[XGUXZ':V0B3=<WUVEI#E"X5B&8L57EL*K' QDX&
M1UH W**XJWU7Q?--K-G%:1,8;<3:=>W%H\22OCF)T+ YSC# @8/3BI=#\3WN
MOZ#X;NK22V%WJ&6NU,#8C5 1* N[(P^U.2>6'% '1V>K6=]?7UE;RLT]BZQW
M"F-E"EE##!(P>#VS4=]KNG:;J-C87=QY=U?.8[:/8QWL 2>0,#@'K7*GQS<Z
M6/&MQJZ0/!H#QB%;=2ID#QA@"23R2P&?TJCXC361XF\"2ZE<6L@DU$L\<,)7
MRY/)?A26.5QD<\\9[X !Z317G]WXOUZ]T^ZU+P_9FZ^SW;PQ61LW;[2D<AC<
M^;D!2=K$<8& #GM9;6_$M_XSU+0;*33K2.*PANHI9[=W>,N6&UE#@,?E]1CT
M- ';U5U/4;72-,N-1O9#':VZ&25PA8A1UX )/X5Q>B>.;W6M&\+HL5O!JFM>
M>'8J6CB$&1(P7.3D@ #/&[)SC!L:UK7BK0?"'B+4+F+3S<:>6DLYBI*W$( .
M60-E6'(ZXXZ4 =G%(DT*2QG*.H93C&0:?7%:GXAUZ/Q+X;TNR-@(]7M)I6>:
M)R8WC1#GAAD?/TXZ=16>/'>J:;X.\2WVH0VUSJ&BZ@;'?$C)%)DQA9&7)*@"
M3)&?X3S0!Z+17(1ZSKD/Q!M_#SRV=Q:26!OFG\AE=<.$*\-@ D@@GW'/6KOC
M+Q"_AK2(+[!6W:Y2*YN1$91;1$',A4<D @#VW9YQ@@&CK&NZ;H%M'<:G<>1%
M)(L2'8S99C@#@'N16C7F/C74)]2^&TUW]ML=0B;5+0VEQ:G"21^=%C/+8;=N
M!^G0=*WK+7-<M_'-UH&HFRNE?33J%L;>-HBA$FPQL69MW4?-QWXH ["BN L/
M%^KKXC\.:;?/92R:JLZ7<,$9(LY8XR^P2!BK$8*D=>_'2C2/$?B;4+K6;B>7
M2HM/T;5)K>YQ#)OEA2-6^7YN&&<\YSGMCD [^BN"M/%/B.\_L+4;33VN;+4'
MC^TVRV;H;:&09$@E)PVW(SQSVQ4FF>,+C5/$4^EK>VEK?VU\\4VEW,)25K=6
M($D;%AN)4!L@$8)&.Y .YK..@:,=0_M Z38&]SN^TFV3S,^N[&:J^+?$">%_
M#=UJK1><\>U(HB<!Y'8*H)[#)&3Z9K+OM>U;P]XCT2SU22VN['5I#;>;#"8F
M@GV[EX+'<C8(]1CJ: -;5_%6CZ%YG]H731K$$,S)"\BPACA3(5!" D=3BM2:
MY@M[9[F::..W1=[2NP"JOJ2> *X+PA#J$OCWQHMW=6LT0NK=)T^S$>9_HZXQ
MESM [@@YYZ9IGQ(F:Z\3^"=!E_Y!U_J+27*'[LGE!61&]02>G? H ZEO&&@I
M;_:9;[R;;&5N)X9(XG_W790K9[8)SVK<JKJ.GVVJZ;<:?>1B2VN(S'(I[@C^
M=8":UJ&L^(=:TG29[>U&DK$CS30F7S)G7=C 884#&>Y)/3'(!U-%>;#X@:O>
M:'H-[:VMG#=7.M#2+^"7<0D@+!BC \#Y>X/WO:K]MJWBR?Q3J_AHWFDB:"WB
MNX;X6CX5'+#88O,Y.5Z[NG8]@#NJ*\V3QWKEQX.\+:Q#!8+<:EJD>GW4;JVW
M)D9"R'/RYV'J#U]JOP:MXKD\6ZGX9:\TKS4M([V"]%H^$1F92AC\SYCE>#N'
MT/2@#NJ*\^TOQ[>W_ASPZ7AMDUC5[R6RR 3$AB9Q))C.2,)PN>K#FKC^)=7T
M_P 2:AX=NC:RW/\ 9S:A877E,JLJG:R2*&Z@\Y!&0: .UI&944LS!549))P
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M[:QSL@.0I902!^= &G1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MER?E)/(+GOVJE/X+UBY\(Z)HLNJV;2Z9<6THE%LP5E@QL7&[.3CDY^@KNJ*
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M:E- ]NMJW^D)'*$(R7^3C)_B.>]=5>:WJ>F_$#3+"[FA_L75()%MF$6'6Y4
M^6S9Q@KDCC)(Q6=)\/KR7P9K?AYM9@QJMW+=-.+,_N_,?>RA?,YY'!S1XR?2
M_$%K%X1.HJWB%)[>5!:Y22W8,&,PZ[0$W'KWQG)% '2^'KR[U&TN+VXE1[>6
MX?[&%3:?)#$*Q.>=V-P/H17)>')7U#XV>+Y+SE].M;6WLU;^")UWOCZM@UZ!
M;6\5I:Q6T"".&%!'&@Z*H& /RK"U#PP7\21^(M*N5M-3$/V>?S(]\5S%G(5U
M!!R#T8'([Y'% '.?$V22PU[P1J=GE;T:U':97JT,H(D4^W J--;\;ZI%XG_L
MZ[TF*71KZ2*)6M&/V@+&K!#\_P O4\Y.2>V.>G7PW-?Z_9ZQK=S%<2V(;[%;
M01E(H6889SDDN^. > .PSS7+>%[?4;_5/'=O8:A;01S:O)&S-$7>,F) 67#
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M'\?S?+].: -OP[J;:WX:TO57C$;WMI%<,B]%+H&('YUG^.M6O]!\%ZIJNF-
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MWFL5D_=@M(CG#MG& 5'/''YU#HWB;4+GQD-#%]#>P3Z2;U+K[,5595=4(4C
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M*"1\L>0">!CDYST% '(>$=9E_M;Q%X?TNXAAU6?Q!>7):=-RI '0,0,C>QZ
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M4W0@/L:%L9?HA)W'(W< 5CZ3XAOO#/AGQMK]Y?27[6FL7$$<4JJH=]T<<9)
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M[B2"UE@M?LL1B6/S0 [\LQ+$  <X SUSFN@DABEQYD:/CIN4'%.50JA5  '
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+J%+%AD\@ $YZ<5Y[XHU?36U[Q98)+!87?\ 9"+)+(=TM\I20JD2D[=JY()
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M/56&0:4HK(4*@J1@J1QB@#R_QM/HFK_#CQCJ'A^&.<7,$;7%[ I*W#*1T/\
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MZ\730'0+NGU$^0Q4@'(\M0=IVC/4DKBO3].TZ'38I5C)9YI#+*Y &]B ,X'
MP H'L!5HHA;<54MC&<<X]* /+9=3L9M2^%DBW<14K)\Q<#/^BE>_^UQ]:V?#
M%U;R?%;QQ&D\;.5L,*&!)Q$P/Y9&:[G8G'RKQP..E*%4'(4 ^N* /.OC%<6:
M:%HL-U-"BMK5HS+(X&4#'<?H!U-:UO/X.T_7[2XTJYLI-1N5-G'!:3J[2*S*
MQ)4$\*$))],^U=>55NJ@_44@10<A0#["@#S/2;ZS-S\32;F#:)V8Y<8Q]G5<
M_3((^M99OK*R^'?PXU634((39208\YB(6/DLKJ[ '80,X.#SQCG(]@V)S\J\
M^U8'B'1=5O;W3[[2+^V@DL_,!M;N R03;P!D[2"& !P>?O'UH YK0;K1;E/&
M6M0:WI=S)J"B66"UN ZVZ)%L!).#EL9)P!T'.,USUM+:'P'\+[BX>$V<%[")
MY)"#'&?*<?,3P/FP.>]>E:3H<\-]_:6IFP:]$+0*+*V,2*C%6;)))8DHO/ &
M.G4G;,:,A0HI0\%2.#0!YV8;9O'OB/7;!XETP:(+>[N$($<MSN8CGH2J8!/;
M<!7-66J1:9X-^'&K74\R:+;0O#>W%L2?L\CQA49L9P =RGTW>]>TK&B1B-45
M4 P% P!08T9"A12IX*D<&@#E_!\>@2W&JZGH$LUS'>R(T]XTC,DT@!'RYXX&
M,D<<XZ@XYSQ]/I3?$_P+#J5Q:B!#?&=9I H3,(V[LGC)QC/6O3$18T"(H50,
M  8 I"BDY*@GW% '*:7>>%-/UBY@T>[M'ENXO.N4MYU=(DC!'F,<D+G<J^_X
M&O-[>73A\!O"ZN]K_P A*W+*Q7J+CYL_\!Z^U>YA%'11S[4;$QC8OY4 >?SW
M-H?C0T:30$OX99=H8?,?/! _+)^E<=:VUAJ_P#T/3M.-N^M22P"T6+'FI<"8
M9;CD83<2?[M>V743M:RBW2,S%2$WG S[D UB^"_#TOAGPO8:5=&WEN+2/R?/
MB!&]<Y&<C(Z].: .8NYGG^*7B2UT^YC74'\.)'!AP")=\F/Q&5-8=Q-!K7P0
MTS1;%E3Q!";6VBM<XGANXY%#$KU4C#,3Z9->Q[5SG:,^N*:(8Q*91&@D88+A
M1DCZT <%XP%]X9\3V/B?2K4W+7T?]EWD"C[[MG[.Y^C_ "D^C53\4B+PA>>#
MY[V>Y31;43P7EY%G,<TBKME? /WCYF3_ +9]:ZQ-'U>Y\1-=:GJ<$VF03>=9
M6D5OL96V[09&R=V,L0,=2#V K?=%D0HZAE(P01D&@#R/7/[(MM!F\0>'?MMW
MIW]L6UYJEU"[/YRIG>Z9Z[3L)(&,C_9.+\S>"-;M-:U:WU&[NXIM.^S7VHQ3
M,1#&6&T<\;QDMT) !SU /IJHJ($50J@8  P *:D4<2;(XT1.NU5 % '#>#KW
M5X_%%UI&IWEGK,<=BDT&L6RA79"Y"QR@$KNZL".HR:7Q3<OIGQ(\+:C?-LT?
MRKBV\YN$AN' VECT&X J#[GUKN(XHX5*Q1H@)R0J@9/K2NB2(4=0RG@JPR#0
M!Y]IRQQ>+O&^LPSQIHTMM C3;AY3SK&V\@]. 5!/KQU%:7PKGBF^&6@"*5'*
M6BJX5@=I&<@^AKKPB*@144(!@*!P*4*%Z #Z4 <&+ZUT_P"--ZMY.D)N=%@6
M .<>85EDW;?7 .3Z#D\5P[7-@OP(OG2:W$IU@OD,NXM]N!!^NSGZ>U>Z%5)R
M0"<8SBD\M/[B_E0!Y=>ZUI.F>/O$-KXEU&:QL]3A@DL9_,*PSPB(*Z;@,9#;
MCC_:]Z[WPQ9V6G^&[&UTZ">"RCCQ!'.6+A,DKG=R..<'D9QVK3>&.3;OC1MI
MRNY0<'U%/H \Q^']U;>"I]7\*:Y/'93B_ENK*6X8(EU ^""C'@L,'(ZBM;X@
M7,^O?#S7[?P\6NY1;C]Y =RR ,"\:D?>.P,"!ZXZFNTE@BN$V31)(N<[74$?
MK3PH50J@ #@ =J /.M=N[+Q1>^![KP]/%+<1ZBESF%@6AM1&WFAL?='W5(/?
M K$AN-.;P;\5CYUL6>]O<'<N6S NWZ_-G'OFO7DABC9FCC12YRQ50,GWI=B?
MW%_*@#RRYNK"*3X6&.>V3#<%748!MB#^;<?6HM*?0CIGQ)MM1-J7DU2Z#QOC
MS'4QKL '4G=G&._3FO6"BXX1<CIQ7->%O#EUHUWK,U[]DF^WZC)?QF/),1<*
M-O(_V>O'TH XW1KM=$OO#FB:M(FF:JGAZ-7OI1NFE&X#[-$#E2P(!/#$\ #O
M6%I=[ITWPX^&T$L\#&+78EE20CY<>=D'/IE<_45[J45F5BH++T)'2D\M,8V+
M@=L4 <%H[V5U\6/&%HSP2+/8V:R1;@=^!(&!'?@@'ZBJWA"TU"+5O^$2O(Y&
MLO#<[30W#\B>)A_HR^Y4-)GT,:5W>J07LNF7":5/#;7[)^YFEBWJK>XXS4&A
MZ9<:=;2O?72W>H7+^;<SI'L5FVA0%7)PH"@ 9/<]2: .<^+\$UQ\*]<6!2S*
MD<C =T65&;_QT&F?$6>6+3O#NJ1AGTJTU:WN;XH,A81G#D?W5)5OP![5V\T,
M=Q#)#,BR12*4=&&0P(P01Z53TG3CI5@E@)C+;0C9!O\ O+&.BL?XL#@'KC&<
MGD@'(SM;WOQ5L-7TZZ@>SMM)F34;B.0&/:S Q*S#C.=S?09I/@ZED_PST66!
M8&F1)%=D W*3(V03U'0?D*[N.&**/RXXT1/[JJ /RIP4+T 'TH X77;IM*^+
M&AWVHN(])FTZ:TAFD.(XKEG5N3T4LJ@#/7&*S;=$M[CXDZK'-&FBW4:^1)N
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M.YU.0W;H_P!Y%8 1H?=8P@/N#ZU@?"B)U\*WEP<^3=:K=SV__7,RD#'MD$T
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MO9:C//!;2L9H K2Q21/&Z!L[258 \[3CZ5#J7B31=(N4MM0U2UMIW1I!')(
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M0O&L[>Z!NEC$ODR(T;E#QO"L 2ON.*LWU_::9:FYO9TAA!"[F[L3@ #J220
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M/B6%E@+S:M>E &&7R5V$>N><?I0!Z]>ZK9:?)%%<38EE#&.)$9W<+]XA5!)
MR,G'&1ZTS2M<TK7(6ETK4;6]1,;S!*'VYZ XZ'@\&O/-8U_3- \7^']=DU*W
M03Z*]NWVIG6%TWHP*R*K8?=U&.G<<9Z3X<+I<?A<II>KVVIJ;F6::2W;Y$DD
M<N4 Z@#=QGKU[T ;>H>(-+TII5O+KR_*022D1LPB4YP7*@A0<'&<9P:YF[\1
M/H_Q/N;?4=69-(&BK<K#(%VI(9BOR[1N8X7IR>M8_C*1K'6M;U/1-:@AU*&W
M1;[1KY0\.HQA,J$'W@Q#%?EZG XSS=M;^WE^,B7%R8K>;_A&DWQR.,Q/YQ9D
M)]0#S[<T =@OB/1Y-(MM5COXI+*Z(6"5,MYK$X"J!R6R#P!G@^E9FO:['>>!
M]>U#1-2:.XLK:<^9&@WQ2QH6VLKKP>F00#@UYWHNN6&G>#=#$PMEC_X2"Y47
MTR[DL,R2E7QT!8'"D\?-GG&*LV5];)H7Q2@:ZE=W\Z17GCV,X:V4*3\H&6/0
M8&>PH Z"^U?58M-^'MS'J,R_VA<VT5XF%Q,&A9R2<9SE>Q'6NO\ $<EQ#X:U
M.:UN7MKB*UDDCE0*2K*I(X8$=O2O/-2OK0>'_A@3=0X6]M&8[Q\H%NRDGTP2
M ?<UW_BF6.'PEK$DLBHGV*8;F.!RA H QO!WB_3K[1?#]C>:M%+K5WI\,K(Q
M^:1_+#-STW<Y(Z^U;,WB?18+S[++?HLGGBV+;6V+*>D9?&T.<CY2<\UYLMW9
M1>%?A4%G@1HKJVW@, 4_<,'SZ?,0#[FL[Q+K=E>>'==1"+"2UUY&FTZ&$Y&+
MA,SS-@GYNH((7D#DT >PPZYIL^L3:1%=*VH0IOD@VG<J]F/'0^O>D&NZ:;62
MX^T_NXYC ?D;)D!P4 QEFSQ@ FN2\8M<Z3KFA^,=)M9+EV']G7,*J5,L4W^J
M)STQ+M_[[-5/&$8\+_\ "*7UZ;J32+&69=1N+8N&225,>>VSG&XOG_?/KB@#
MN],UC3]9@DFT^Y298I#%( "&C<=593@J?8@4:CK-AI0!O)RA*E]B(TC;1U;:
MH)VC(R<8&:P_!R^'KBXU/5?#RSRQ7K1F>]DDE9;AU!'R[SSM& 2.#G'4''/:
M_JUCX=^)5S<>(Y[NTTS4+"&.SO(I9$C5XVD+1L4/4[\C- '=G7=+_LR#4EOH
M7L[C'DRQMO$I/0(!DL3Z#FJB>+M!>VO9QJ"".Q -WN1@;?.<>8",K]T]0*X"
M6;2/"&K>$=0AM;BQ\)HMY'')-YC+#+*04D?=EE#C=C/0,>F3399%UJ7XL/IR
MO.+G3X!#M0@R?Z*P& 1DY[>O&* /3#KFFK>6-HUV@FOU+VJD']\ NX[3T.!S
M]*@;Q/HJ7JVC7Z"5I_LH;:VPS?\ //?C;O\ ]G.?:O/$\0Z7J.L?#22RNA<1
MP>:DKQJ6".;4KM)Q][) (ZCOU%8^K:Y8WFAK(C"P-IXEB>?3(H3_ */BYYDF
M;!.YOO9R!S@ D4 >B6]_?K\6KK2WO99+#^QDNDMV"A8W,Q4D8 )X7N3U-;^I
MZWI>C"W_ +2OX+7[1*L,(E< NY.  ._7\*Y&VO;:7XW3;)DR_A^-0I.#N\]F
MVX/(."#CK2_%.:UCTO04N7B"'7+-V60C!19,L2#V ZT :4GB70]9N-)>P\4)
M%NO3&D,#*3=LH(,9!&<<YR/;GI6O?^(=*TR25+N\6,PH))OE+"%#T9R 0@.#
MRV!P?2N5\>7%I#K?@H^;"@.LK*3N ^4QN-WTR1S[US^NZSI>B^*_&>FW&KV5
MK_;%O"C_ -H>8GEN82F4PI$B;2#C*\@CWH Z+7_$Z)XE\)76GZ[$VC7<]PES
MY4D;0N$A9@2X&>"/7''2M>Y\<Z##X9O]>@O!=6ECN640JQ8.HSL*XR#TZ\8.
M>E<A>RZ/!J/PQMK/4[>]LK9W2.X,BL'5;<HK'T^8 ?7CK534'2['Q<M[1UF>
M2!&CCC.XMBU 8@#KR,'WH ]%M/$VGSZ99W;R,&N4W+$D3NY( +84#<0,C)QC
MD>M:-E>VVHV<5W9S+-;RC*2+T85YQ?76GZO9^&;O2O$PTC58K%_L=VX!MYE
MB\R)PV PSMZ<@J>X-=?X)U"[U3PC8WE]9Q6ES)OWQP@B-B'8;USSM;&X>S4
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M%O(RCYT50"!@CYFR>@P,F@!-=\/WFJ^)-!U2"YMXX]*EDD,<B$F7>A0C(/&
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MQ7!;&%R00,XSVS0!TE%%<)J7B34I?B%X:L[*41Z-/<W,$I R;EXX78X/]U6
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M)QTK1HH \Q\!W5O\/X+[PKX@E6Q$-Y)+8W<_RPW,+G(PY^7<#G*DYZ=:U/B
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M,UK="0"$^'G57D&W#&=6 YZ$J"<=<<UR%U+&WP8\2P*<R-K4ICB RS*;M7!
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M63ZO)I2/*UY$BO(JP.50-G&7QM&<'C-1:QX@TK0%MFU2\2V6YF6"(N"0SL<
M<#CZGBN6\&:E-I&JWOAC5&,\PD-U:ZF$^6]CD.1O8<>:.A'< 8XIWQ2ECATS
MP_+,"8T\063. I8D!SG@<GZ4 ;.G>./#VJM?I9WKR2V*[[B(VTJR*O\ >"%0
MS#W -3_\)9HALM+O!>$VVJR)%9RB&3;*[_=&=ORD_P"UBN;FLEUWXD?VOI96
M2VM]&EM9KF/[DLCL"D8;HV,$G'3(]:Y"UU%7\!>!=.6TOVN],UBS6]B%G)F
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M;%UC\P0O( Q.!G:#C)P.>YK1K,\1:-#XA\.ZAI%QQ'=P-%N_NDCAOJ#@_A0
MB^(=-;7QH8FE&HF'[0(3;R#]WG&[<5VXSQUZ\=:RM9U[1+JRM3-K%]8(=22W
M1X(Y(FEF63:8CE>5+?*>W7FN(/\ PE$FGZ#XS>QF;6+"1=,ELF./.C;]U(Y^
MLQ#?[J@UO>.K)=-\)Z!8H7F>'5;-W95)9]L@:20@?BQ/O0!N+XL@NO&=YX92
M"\C>"V1VG%L^-SD@8.T@* /O'@GZ5SO@?QM96GAJUBUW5;B6[FU"XMQ/,CR
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M:UDGDN2/^/+R&6=6_NLA *\\9. /7'- %C^VH--MK.VU!I7U!K82/!!$\\G
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MSWD-_>1VB%8'_=DR!'WC&01R O4G&!75K<H]G]I"3!-F_:8F#X]-N,Y]L9H
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MI#+MR,$@9QUH Z6BL^;6;2"\M[207'G3PO.BK;NWR+C=G X(W*,'G) KD/\
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M)YQ?83C&[;SC\.O%<A;:?JEMX3TO4!H=]=#2]=NKFYT]K=TED@E,J[T5@-Q
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MI;!P>1WXKJ6\S_A<,5]]DO/LG]@M ;C[+)Y?F&97"[MN,[03_P#7H T&\?\
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M,53U20Z?I?P_U 6>IK?V,)3]U8O,T2^0%D5X1ASD@#(QC&?8@&EXM\466L^
MO$XTNXU"WO=.MY1*5CE@:&5!]TN %)Y' )R#GI6QHGB_39Y].TAC=K=S68EA
MDEMW6.XVJ-_EN1AR,YX^HS7&3S:??>!O&EOIR:G<:UJ227$UO+ITL,C,Z[%"
M1D$[1M SD\]3S6Q=K/+XK^'UPEE?&*UAN!</]DDQ#N@"J'.WY<L,<T :>A^.
MX-2M=9O+RTN;.WL+U[93)$<G:40*<9RY=CA1Z@5T%AJT=_=7-K]GN;>XMU1I
M(YTQPV=I!!((^4]":\^L+9(]#\8Z1K.A:G<03ZU-.ZQ6TGSPRRIMDC91\Q )
M?"Y(V<XXSM^"(-7L=3U.QFO[O4]%BCB-E>7T12<$[MT18@&0+P=V/XL>N #H
MM1U^TT_4(=/V3W-]-$\Z6UNFY_+4@,QR0 ,D#KDD\9K.E\>>'XM)TK5#=2FS
MU258;:18'(+DD88X^4@@\'G@]:H>(+V[C\<6-K+87YTN2Q?%U86[-))-O'[E
MI%&8TP V<J">IP*XO3+74(?A]X+L9='U2.XL/$$<MPALY"419I6+' /R@,O/
M0YXSS0!Z;I/BO3-7N=0MH_M%M/8!6N([R!H&5&!*OA@/E(!Y]N<5R7BOQ$E]
MJ'@V73VU*&&ZUF )+\\<-S"0Q/&>1G:1N R.1D9JMX@TK4=9\3>,[:QMKJ-K
M_0H[:WG>!TCDD!D)3>1CHP'7O4%_JT^L:-X*BCT/5XKK3]7M6O8&L)1Y&R-U
M8YVX8=\C/'7% 'K%% Y%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M :A,Z,5N=X<O'O.S<PZL%V@^X-:E]KD%G?II\<$]W?/$9_LUN%W",'&XEB%
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MY..<<BM'3M0M=5TZWU"QF6:UN(Q)%(O1E(R#0!9HHHH **** "BBB@ HHHH
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MH H&?;)XR3@5I444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6I:UK/Q M;6UN(FU&QM8[.:6%EBE>(-N7<1CJ0/QKU*B@#@O#5[:ZI=6D[^
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M; KM#* 2006Z ]/2N"MO!#S7'C&#PU;W&FZ'JFEF"."XC>%'NSNRR(X#*FW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A.
M3Z>E8V@>)(/$%QJD,-K<6[:==&UD$Z@%F"AL@ GCYA6U7$^"#MU[QNV"<:P3
M@#G_ %,= &QXF\5V/A>*R-TDDLMY<QV\44?7YF"ECZ*-PR?4@=ZWJ\2\6^(S
M=Z1'>7NA:]#?SZI9N?.TZ14BB28%8E)ZGJ?]IF/; 'L]G<B\LH;D131"5 XC
MF0HZY&<,IY!]10!-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 'I6
M/H_ARVT2]U"ZM[BYDDU"7S[@2LI#28 W# &. !@<>U;%% &=K.BV>O6D5K>A
MS''/'<+L;:=Z,&7\,BM&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>eltx-powerofattorney2025001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 eltx-powerofattorney2025001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;2?PYY'4<ZOA_0?$MKXB\4:K?K>-8W2[=-L);[S&CR#GY=Y1<\=ZD\8> ?\
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M]HVX0_;K6YBC2>)MO!PJK@;N#P0>,' .>YKSFW\"1'XC:5XETS1FT,6Z3&^
M>,+<EEVJH1&(ZDDDX[=3T]&H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>?6(R49D^=G)C(R#P'//?'05O^)]$D\1>%;_ $@7"PRW,.P2E,@-P0<9Z9%
M$4OB&?[9/86NG&YO[6W6XN85F "!BP10V.7;:V!P..2,C-W1]9M=>T*VU;3M
MTD%S%YD8;Y3G^Z?0@@@^XK(CT#5;/Q%-KEK<V;W-[:I!>PNK+&70G9(AR3P&
M(*GKQR*U?#NBP^'= L])@<R);I@NPP78DLS8[98DX]Z . G\0:EK.B>%-8N;
M9XYI-?,8AMI^)$!G 0C@'&Q1EO3/%=3;^-K9K*Y>\M6L[NWU#^SFMY95P9=H
M<?/TV[#NSZ \$\'.MO!6J6NG:18"^M)(=,U9K^,^6RLZ%I#M/)Y_>GGMMZ'/
M"W?@C4;C^TYX-1AMKV75DU6RE5"ZQ2+&L>QP<;E*@@XQ][VH Z#P_P"(8]=%
MZ@@:&:SF\F3#!XWX!#(XX92#[$$$$5G?\)IC4]4MVTBZ2TTJ4I?7;R1A84\G
MS=^-V6&".!SS6SI$.JQVS/K%S;37;D96UC9(D [ ,22>I))_E61%X5DFE\51
MW\L;6FO'E8LAXU\E8B,G@\+G/8T 1)X]L([B5;V+R+=+)[X7$<JS*$7[ROM^
MZ^"#MY!YP35D^)[F+5[73;C2'AFO+66Z@S.I^6/;N5\#Y6^=>F1[UGIX4U[4
MO#5WH'B'6;:>U>U:UBFM;=DD?(P)),L02/08!-9R#4X?B%X9M=>O[">[_LZ]
MCS;(8]W,/)#$\M@G XX.* -^P\90:@OAMTLY5CUZ)Y(26&8RL9DPP^@[=ZS;
M3Q=9:;I9GM=&O\7.N2V#Q&9783F0JQ)9C@%@< ' ]A4>C^"M9T]O#"3:E8O!
MH!DCC"0-NFC:,H-V6X;![<#'?/#QX,U,620BZM-RZ^VLYPV,&0R>7^N-WZ4
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M^[PF<<]<=LU-H.@^)-*T]-,N]7L[NRM(3#:,L#)+(NW:GFMDC@?W1DD YZY
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MEB4LUM+;G*,0<!@2!D<>GO70:)!K<<3R:[=V<UP0%5+.)DC4#O\ ,223GZ#
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M6T-[#\6[<7EU'<$Z#*0R1;,'SX\CJ>/3OZDT =L  , 8I:** "BBB@ HHHH
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M#*62+()7( SD@<G)XZ]:UZ* ,B]\/6]WK']JQW5W:7AM_LLCV[J/,B#%@I#
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M]O=ZE9W%A;"TCN+6Z*220CI&Y_B'\NV*ZJB@#(M?#EG9:V-5@DG646B68C+
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M;FS^U--<6JAKA+:"28P@]-^Q3M/L<5?L-0L]5L8KVPN8KFUE&8Y8F#*P^HH
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M)R>!0!T-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^AS0LB.<*ZL?8YH =135='SM96QZ'-.H **** "BBB@ HHHH **** "BBB@
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M2O\ P,C_ ,:/^$K\.?\ 0?TK_P #(_\ &@#7HK(_X2OPY_T']*_\#(_\:/\
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MPA/A3_H6-&_\ (O_ (FMVB@#"_X0GPI_T+&C?^ $7_Q-'_"$^%/^A8T;_P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3'P%NDCL[-K7^S[[]XUTROC=+D[?+(SUXW?B*]$\)?\ (F:'_P!@^W_]%K0
MB^+?#C[L:]IOROY;?Z4G#=-IYX/M6P"&4,I!!&01WKB?A]!#<Z3XD@GB26&3
M7K]7C=058&0Y!!ZBF?">20^%+N .TEC:ZG=6^GNQSNME?"8/<#D#Z4 =U52V
MU33[R\N+2VO;>:YML>?#'("\6>FX=1G'>K=>8ZR3X=\<W'B]/EMDOX].U/T^
MSR00;'/^Y)@_1C0!Z'<ZI86=W;VES>V\-S<Y\B&20!Y<==HZG&>U&H:I8:3;
MB?4;VWM(20OF3R!%R>@R:\]F)OOBIX4UICE;L7\=M_UP2)0A_P"!$N^?1E]*
MV/BQN_X5Y>%0"WVFTP"< G[3%WH ZBTUC3;^=X+/4+6>9%W-'%*K,H]2 <@5
M=KSK6I[R+XG^$[G6;:&S@'VB"TELY3-YLSIC9(2J%5P,C ;)ZXKM]8U$:5I%
MS>^697C7$<2]9)"<(@]RQ _&@"S#<0W'F>3*DGEN8WVMG:PZ@^]2UYMX2D_X
M1SQS<:.[71MM;@%[')<PO'OO$ $^ P_B&U_;!KTF@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0OA]KVD7&EWNN2_9;A=DJQV\ZEE[C.S(_"IX/B?X'M[!+1/$,N$0(LAM9BX
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M*?*..@KT"B@#B_\ A;7@C_H-_P#DI/\ _$4?\+:\$?\ 0;_\E)__ (BNTHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(_**"/=NQAHSSGG-26GABRL8-1^SS72WNHJ1<:@9,W#';A2&Q@;0?E   ]*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#))RI/!Z]96#H'ABUT&[O;FVBMK?[6$#6]G#Y4*E=WS!,D;CNY/&0%XXYWJ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD_P\YSU/([<9) -?4?B?;:=?ZC8MH>IR7.GV"ZA.H\L!8B 3DE^HSR/4<9H
M[NBN5D\>Z<T.D&S@GNKC5;1KV" ;598E3<2Q)P/0#N?;)%:V^).E7>J>'[2&
MUNS#KT326=TP41Y4'<C?-D,",8QU(H [.BJ>EWYU*R%S]GD@4NZJKD$L%8C<
M,$C!QD>Q%7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB3P4MO(D<IU1]K.A<#]Q)U (S^= '0VWB33[N6\@A,YN[-0\UHT#+,%/0A2
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M8RBWECS\C!@?FP<D#D<U%X4O=3UN#P]X@&LQ(ERK+>VWG/()G*DF-8R,1LC
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MNI7O[81V@+7#>:O[H#^]SQ^-0VNO:7=:5;:FM[!':W**\;RR*O49 .3UP>E
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MHZVS6RZ;;B%YA.R!,!I!C#GU(VK@^P]*NS6L%Q&D<T*2+&ZN@<9VLIRI'N"
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MFC4\RCU#JL7XJ:P]!B-K:_#6XN+2;9!8S6\Q^SLQCD,:!58 94Y5NOI7J]%
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M@CCM7;]T;B)PX(&"",].>M3:MI%E?#QY:76F&75;V</I@:W/F.3;QK&T;$<
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M= ]H_EJC*ZD'>OR @*?4>] '9W^I6VFPQR7#D>;(L42*"S2.>BJ!U/7\ 2>
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ML@B>/:0?=@<^F>_%3ZCI.K&Q\)7=M8^=<Z1,K3VIF525,#Q-M8G:<%@>O(H
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MR-P/S=,_A6YJGB"QTF<03^;).8)+GRH8R["),;G(]!N'N<\ URFC>'M9L_\
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MPC3_ ",I.Y=B@CXSE54Y(., ENF:W)O&NB6]B]U//-&L5VME,A@??%,Q "N
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MPVXU&!8;Z4BV <2A8UVDD9RJDDYYP,D"NP\,Z?IY@;7()K>\NM2 FDO(1\K
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MVXU'7K/5+?4C;&&WEMGB:$2!DD*DLF2-C_+UP>.,5OT4 <?HW@FYTB7P^_\
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MLA4L=ZE21C(J_<>%[^]72)+S6A-<V-^+YY#;861@C(%50WR+ACW)SSFNGHH
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M<CLV]PLN<A"V25QW//-8?AG1I->TC6+*YND&FR:]<SO (2))$%P9%&_=C:V
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MN[_>SN^]@]J6'P)<0B ?VUYBPZT^KKOM1DLV_*'##^^W/TX'.>THH XZ_P#
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M;O3G@@\9K85@Z*ZG*L,@T 5KZPAU/2[G3[Q?,@N86AF'3<K#!^G!K#T[PI+
M=&74-1%['HP/V/\ <;&)V&-6D.XAB$)' ')S7344 <9;>!;BULM*LEUA6@TS
M4FOH UKR03)\A(?G_6MS[#@<Y+KP')<Q:BRZPT%W<:HNJVMQ%!@VTRH$'!8A
MUVC!!QG)KLZ* .5NO"VIZA:Z?]MUU9KNUOH[UI?LFU&,>=J*@?Y1R<G))SUZ
M =5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM)QB2-9&CW#TRI!_6JLGA?29;NZNGBG,]U;"TF?[7+EXAG"_>X^\>1SR>>:
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ML+2ZWW$C"2( @+@M@?>;D<\FDC\+:3%<V%PL5P9[")X;>1KR8E5?&[.6^8G
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MT\A62+!&TINVX^9N@[FJUIX)T&RFBECM)9'CM6LP9[F67,)ZHP=B&7T!Z=J
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MI*@8/&9%X[1@@\UE>(#H[>#?$NI:+X@CG@FMH6:/3V\NWA<. #PQVNP)RO?
MR.E 'L%%<#XCT:R\+Q67BC2X9&CT^Y-Q>H)'E\V"0;9'Y)R5X<?1O4UU/AZT
M>VTOSIHO+N;R1KJ9#U1G.=G_  $$+^&: -6BO(M,UFQ?Q1X9N[*]1%N;^_AF
M$\P:YDRLI59R,8^=5"(0< +@UI^#;O1=<MM(EO+QCXGB,T>H6JR 2NY#+(LR
M=3&.HSP,*!V% 'HEK=V]]!Y]M*LL6YD#KT)5BI_4$5-7$_"I;&/P/;16H@6:
M.25;A8\95A*X 8#H<=CVKF+?6-/?Q+H%Y:WR1";6KR"X\^?-RP*S#;*1C:NY
M5"(02 $YSQ0!Z[61XDUT>'='.HM:O<(LT43*C!<;W5 >>V6%>9Z>+:WTG1-3
MCNG^UKXKEM5F:Y9CY37$JE.3T*X^O!J/6]1T^^\):Y+J\\*:]:ZXBLDT@62*
M-;I/+"@\^7Y6#QP>3UR: /8;N[M["TEN[J58H(E+.[= !6=%KHD\6W&@FU=&
MALTNQ.6&'5G9< =>JGK6)\4([>Y^'&I/(D<L:"*4,0"!B1?F_+/-8>IVFBZG
MXUU*$-"]DGAE&C6&7:G$TI!&TX.."/P- 'HLT]RE_;0QV9DMY YEG\P#R2 -
MHVGELY/3IBK->8:1>F\O?AM-<7KO+=Z--YY,Y_>-Y,?)&?O9+<]>M9F@?9[?
M1_ VJ173F\GUF>UDE:X9B\1^T90Y.,9"'ZX/4T >Q45Y)YUIJ>K/IT^MV*ZC
M#XB>22Y-^L4KVX8_N-NX2=,1[<;>-P)XKJ?B643PO;LUP\&-2LP'28QG!G0-
MR"/X2: .RHKS#6H]'TCQ&?#^HWEMIFBSZ<9+)[UF:/SFDD,Q5W<!9 #&1SD#
MIBG6U]IZ:U-H_B+4#/;QZ1;G2WU [#<YWB20 ]9<B/\ VAVQDT >FU6NI[F&
M6U6WLS<))+LF82!?)3!._!^]R ,#GGVKR_PO?P6LO@:YU*Z2*&\\.S)+)<28
M69P82 Q/WFP6Z\]:BT6]CD\.> )1>,9/[;FA<&8\KBX^5AGV3KTXH ]>JA;Z
MDPMK5M2@%A<W,K1);M*')8;B ".#E5+>WX5P^D320>+;>&X6VU"UOKF\^S:G
M:R%)XR-Y>*X7N%Y4,#QM48&:P-/_ +.E\/> ;S47@EA35[N)Y[A@P (N< LW
MJ0O7J0* /9J*\KL;NSU;6)8=1UE;+Q#9:U)L@1,74D8D/EHN6RT31%<X&,9)
M[FNI\:WMC;-HD%])L6XOMJ^=*([8D1N<3$CE>X7C+!>10!U=%>-:?<PWFE>&
MK634"_E^*+JT98KAD BS<;4P&R!@)@$\#&*F744TF&[L?/,>A1>+?LUU^\)6
M"W,*L%)S\L9E(![<D'@F@#TC3-<&I:UK&F_97A?3)(T9V8'S-Z;P0!T&"*UZ
MX7P4VF)XU\8PZ;+;F$S6KJD+@J!Y(S@#MG/3C-<_XDMK2>[^),DL\ADLM/AN
M+<?:7'DRB&1@RC/!W 8].W6@#UJBO*M3U*RU+5KO3O$6L6^GQ7&F6\FGW$XQ
MG*G>\+[@!('QTY^[U J62]TJYUC6='\5:E-;S+;VITV:9_*G:/RUR\/_ $U,
MN[.T9S@<X H ]0HKRO4[NSU'7-=TO6]8&E:A%<0R:<63%SY6Q"AMVW<L7#@A
M0<DD'/%7FGFL_&D4\BVVIV=SJGDK-$^R[L9MA7RW7H\6 3QC .<'&: /1J*\
MBMM3_LBQNS?YN[>31;J>WUK2)-L\T0*;C*ISMF&5P^2,YZ<U7N;^TC3Q?;6U
M_:)!)X92YACL;@[!*HF&X,"-S<)E@!GC(H ]EHKS>_T&VTWPKIWBC28I)KRQ
M\G4)QYS2?:HQ&!*,$D9V988_B45U_AN(264NJ-&4DU.4W.",%4( C!'8[ I(
M_O%O6@#3@N[>YDN(X95=[>3RI0O\#[5;!]\,I_&IJ\>EG@T>S\7FR6."9/$*
M&]\GY9H[)O(,K<<A2"W/NQ[5U^D(+?XB7<6D,G]C2:7'+/'"08DN#(0A4#@%
MDSG'7"DT ;=OKHG\57NA&U='M;6*Y\XL"'5V=1@#I@H>M:]>=:SIVC:C\1]7
MAUR41VQT2W<9N&BZ2S988(R5R.>V:P[34)A!HVF>-=0BLX;G1%,,VI+A6EWL
M&RQ8!91'Y1R>1SCDG(![#61>:Z+/Q-IFBM:NQOXII%GW#:OEA<C'7/S"LV[D
MO]-^&5Q)I5S<W]];Z:YMIYES+*P0[7([D\'U-<<;W2#X@\)WOAVXM9KR;2KW
M81*&>67RXRGF<Y+ELYSR3GTH ]:HKRW395N=-\#7^E3L=6N)EBU3#GS)4\IO
MM'G#KE7 Y/W6P!C-9VE"VM]%\,ZG'=/]L/B::U\YKEF)B:><%.3T(QQ]#0![
M'5:]GN8$B-K9FZ9ID1U$@38A.&?GK@<XZFO-=*N[/5M61-0UI;/Q'9:S)NMD
M3%U(OFMMCY;+0F,KT& !GJ,UTGQ!D6&ST*0S-$1KEB.)"H(,RY!&<$8]: .O
MHKQSQ&ENME\0[T7,OVG3KR"6T?[2W[A_*B.5YX.[/ZBN^\>7UU8^";^\L3*2
M@C:1H,[Q#YB^:5(YSY>XY'3K0!TM%>8ZW?Z/;Z-?:IX6OS-9336?]I?89=T,
M%N) )&4+]URA.['.!DXX-0^)U6UD\6+I,XCT<^&WN)%MI=L<=UEO+*[3A2R@
MY ZX4GK0!ZI17EOEVEEKXB@N7CCO?"LL\Y^TMF1U:/:Y.>H#-SZ>PJOH>+&7
MP)<Z?,QOM0T&83;YRWGLL$3(&!/9LX].: /6J0D*"20 .237DNA7L.I:;9ZI
MI.LA_$L&G3K/80QXFEG\HY%RI))VR 8) Y( X.*T-)?PUKV@1W-A=FYU"31Y
M(KRU23>6)4%C<)UWAP0"W/)QD= #O!J+W*:=/I]O]KL[O#-<+(%$<90LKX/+
M G P/7-7Z\GT6:P33?A@UC<1+N81S+#+A6?[&VX, <%MVWKSFFBYN;OP<;Y)
M"GC*WUGRB-V)=YN<>41U,?DGI]W:,]LT >M5#=W=O86<]Y=2K%;P(9))&Z*H
M&237D.N);1Z9X[OQ=2?:M/U>%[60W+$PML@.5YXY+#\Q7:_%"&.Y^&.O[HUE
M"VC2+D9P1R"/IUH V%UT-XN?0#:NK+9"\$Y8;6!?9@#KU]:UZ\UNK30M5\>/
M;HUO)I__  CK,B02[8R//;GY3R.I^O-9&G:Y#<Z9X5@\1ZE;0Z;>:"NRXOQN
MB>X! <,Q8 /MP02<_>QR: /8:*\MM=(T^^\7:)I%YJ5YJ-H^@3?//<.C7 6>
M+8Q"D=N0>IP#3=,N;+5]5$6HZREGXBLM8D#6J)BZD3S&VQC+9:$Q%<X&,#/4
M$T >J56OI[FW@1[6S-U(945D$@3:I8!FR?[HR<=\8KRG5;2^T[^UM*L[5I9=
M$OAKEN[ D26C?,8<]R6$B 'L@]!6OXC,1\+6FM;GMY-1UJRN%^<QGRS-&J C
M/_/, D'H2U '7Z[XBM]%TC5KU(S=R:9;^?/!&P#!<%N2>!P"?7\ZU;>7S[:*
M8#;YB!L>F1FO)M=33;5OBHNVVBNWL@\8X#LK6HW$=\%NI]:VM*DL-%\=Q&.Z
M$-K-X=-W=%YR59DD7$C9/4*6Y]/I0!Z'16>^J6=QH$FJ6UP9[,V[3++;'<67
M:3E?4^GO7ENC:I8+JD(M]8BM+2Z\+3.989O,E5U*$22,,!YPI=CP".>W- 'L
M58NJZ])9W_\ 9UA9&^U#[*]WY'FB/,:L%P&((W$G@' X.2*PO!$UQ#JNH:=>
MV5FEU':V\GVO3GS;7,9,@5]O\#GYLCG/!SBF366F3_&,I-!;22MHGF%64$EO
M. SCUQQ0!V\+M+!'(T;1LRABCXRI(Z''&17*3>.5AT/4M3;2YL6.IC3I(_-7
M.2Z)OSZ9<<#-<;H&KVO]G_#N-]00WD=[-!= S9=?W4PV/SD?,!@'N*=J%Q#_
M ,(-XP/G1X'BA<G</^?F#_ T >O45P&NQ7&A^+))+&%I(?$L'V-2%W+!=#.'
MQV4H79O7R_>NYL[6*QLX;2!2L4*!$!.3@#')[F@":BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@!KHLB,CJ&5A@JPR"*8;:W(P8(R.
M!@H.W3\JAU34(M)TNYOY@QCMXS(0H))P.G%<YX>UZXN;"RUB_P!3B>UO[6-E
MM!;,)$G*[V6/'+J%)XP3QG.* .J6WA1]Z0QJV,9"@'%)#:V]O_J8(H^OW$ Z
M\GI6;)XIT&&SMKN35K18+IBD+F0?.PSD#W&#D=L<U;M]6L+K25U6&[B:P:+S
MA<%L)LQDL2>@QZT 66BC=U=XT9ESM8J"1GKBFFV@/EYAC/E?ZOY1\G;CTK%O
M_$4$VA:O-I-W&;VRM6GVRQ-E/D+*2AP<'!P>AK,LO$&IS:KX.ADEB,&JZ;)<
M7"B+#&18XVR#G@9<\8H Z[R(@J+Y2;8_N#:,+QCCTIOV.VQC[/#CKC8*HZS?
M):2:=&=4@L7GNTC594#FX'>-1D8)]><5 _C#P['.8&U>U\Q;@6K /G;*<?*3
MT'W@.>YQUH US;P&X%P88S,!M$FT;@/3/6@6\*EB(8P7&&(4<_6LBW\4:=<:
M[J>E!V233D1YY)%*H-P8GDC&  #G..?:GOXKT**&[EFU*&%+-!)/YV8RBG[K
M88 D'!P1P>U &H+>%5"B&,*&W !1@'U^M9FE:3=VEW/>:EJ9U"Y;*0MY"Q"&
M(MG: .IZ9/?:O Q3?^$LT-H[]H]0CE-A%YUPL0+,J<\@ 98<$<9Y&*99>*],
MN]%LM2>1H4NK<7 C:-BR+M!8D ?=7<,MTY'- &VR*Z%'4,K#!!&014<EM!,8
MS+!&YC.4W(#M/J/2D:Z@2S-V\R);K'YIE8X4)C.XD]!CFL[_ (2G1!;75P^H
MQ116D:RSF;,91&R58A@#@X.#T..* ->HH[6WB<O'!$CDEBRH 23U/XU1L/$.
MD:G>36EE?PSSPH)'13R%/ ;W&>,CH>*Q)O%7G^-M!TW3[N*6QO8;AY1Y1R^Q
M059'/#+DGE<].M '5);P1S/,D,:RO]]PH#-]3WITD4<H D17 (8;AG!'0U0U
M+7M*T>2&/4=0M[:28,8TD< N%&3@?05#:^*=#O;:SN;;4H)8;R7R('4G#R<_
M)[-P>#SQ0!I?9H"03!'D$D'8.I.2:3[);^6\?V>+RW&&78,-]1WK/F\3Z);P
MSRSZE;Q)!<"UE,C;=LIQA"#W^8?G5,^._"PB:3^W;,A49R ^6 5MI..O7B@#
M?CABA!$4:(#C(50.@P/T %8>E^&_L/B#5]5N)X+EK^=)D7[-M: K&L?#%CG(
M4=AS5[^WM+-C;7D=Y'-!=+NMVAS(91C/RA<DX'7 XI5UW3'LK>\BNTF@N<^2
MT(,ADQUP%!)Q@Y],<T 7)((97C>2*-WC.49E!*GV]*!!"'9Q$@9NK;1DU0G\
M0Z5;6,-[)>)]GFA\]'52V8L [\ $A<$98\#-.FU[2X C/>(4=$D#H"ZA'.$8
ME00 QZ$]>U %Q;>!%95AC56&& 4 $>](MK;I (%MXEB7I&$ 4?A27EY;:?:O
M=7<R0P1XW.YP!DX'XDD #N356+7M,FMIITN@5@E$$JE6#I(<80H1NW'<,#&3
MD>M %PVT!*DPQDJ,*=HX'M2?8[;&/L\..N-@IMG?6^H0&:UDWH&9"=I!#*<$
M$'D$'C%<MX=\8PS37EEK6HVJWPU:>RMU5=@8*V$&,G!.#C)Y/2@#L&170HRA
ME(P5(R"*C%K;B%81!$(EQM38-HQTP*IW&O:7:7B6EQ>)'*\BPC<#M\QAE4+8
MP&(QA2<G(J;4=4L-(MUN-0NXK:)G6-6E; +,< #W)H G:W@>)XGAC:-SEU*@
MAOJ.]!MX#LS#&=@PN5'R_3TK%?QKX;CBN)'UBV"VS!9N3E,C.2,9VXYW=,=Z
ML-J,,GB*TM8M6MOGM7E^Q! SRC*XD#9X49QTYW>U &G'#%#GRXT3/7:H&:3[
M/#N+>3'N9@Q.T9)'0_6LT>)M&>XAMEU*W6:X)6WWG F(.#L)P'P>/E)K$\)^
M,8+^SAMM6U"V_M6:]NK>.-5V!_+E=5 '.#M3."<G'>@#J_L=MC'V>''7&P4/
M:6TDGF/;Q,^W;N9 3C.<9],UFZ)XDL=>N=1AM/,S8W+6[%XV7<5522,CU;'X
M9Z&I[_7=,TQV2\O$B**'D)!(B4G 9R!A 2#RV!P: -&HX8(;>/RX(DB3.=J*
M%&?H*R[_ ,5:#IET;6]U6UAG"HQC9_F 8X4X]S6C=WEO8P^=<RB-"P49Y+,>
M@ '))[ <T 3!5484 #K@"HEL[9(O*2WA6/.[8$ &?7%4X]?TJ:R%Y'>1O"93
M!P"6\T'!CVXW;Q@_+C/'2FKXBTAX()EOXO+GN/LJ-S_KLX\L\?*V>,'!H CU
M+1[K4+RW4:CY.E(N)[%(%/G$$$?/U5>,$ <C-;%<KXN\2M8^$O$%WHUW#_:&
ME0EI%DC+>6V-P!4XZCD'IWYK1US7(-+TV<FZCBNQ;-,@:-I H ^^P7HN>Y('
MO0!JBWA5MPAC!W;\A1][IGZ^]"P0I,\RQ(LKXWN% +8Z9/>LSPKJ%QJWA#1=
M1NBIN+NQAGE*C +,@8X';DUD:CXK_P"*L\-Z?IUW#);7UQ/'./*)WA(7;*/T
M(#* <9^M '6(B)G8JKDDG QD^M,^SP9)\F/);>3M'+8QGZXJFNO:6]\EFM['
MYTCM'&#D+(ZYW*K=&88.0#D8/I3/$%\FGZ0\S:I!IA+HJW,Z!U!+#Y=N1DD9
M ^N: +WV.VQC[/#CKC8*5K6W>4RO!$TA !<H"< Y'/UYK*O?%WA_3IKF&[U:
MVBDM=OGH7R8]V<;L=.A^G>M2XN[:TM'N[B>.*VC3>\KL JKZD^E $K*KJ590
MRD8((R"*C-K;DY,$1.,9V#I69I_BO0=5OQ8V&JVT]TT0F6)'Y9#W'KU&<=.]
M2+XCT=KDV_\ :$*R"-I1O)571?O,K'A@.Y!.* +WV2VX_P!'BXX'R#BC[);#
M'^CQ<'(^0<5E6OC#P_?9%GJD%PP5&"PY=F#YVX &3G:>!Z&K?]N:;]DAN1<A
MHYF9(@B,SNRDA@$ W$C:<C'&#0!@1>"[@QRV=]J5K>Z?(SEO.T]?M)#$D@R[
ML=^NP'W!YKK)(HY@!)&C@= R@UF/XHT*.VM+A]6M%AO"1;N9!B0@$D#Z8.?3
M%6M,U:PUFT^U:=<I<0AVC++_  L#@J0>01Z&@"Q+;P3*JRPQR*A!4,H(4CH1
M4=W:K<Q$!8A,%(BDDCW["1C.,C^8K%\<:K?:'X1O-2T^2*.X@,>#(F\8+JIX
MR.<'KS]*T+/Q#I%^;S[+J-O)]BP;@[L",$$AB3_"0#STX- $'AW0%T/PWIFD
M3RQWAT^)8XYC#MSM& <$G!Q[UJ?9H-J+Y$>$^Z-@^7Z5ER>*]"AM[R>?4H8$
MLPK7'G9C:,-]TE6 .#V..>U/C\3Z--#++!?QS+%,T#"$%VWJ Q 502< @\#I
MS0!H+:6R2/(EO$KR##L$ +#T)[TX6\"J%$,84-NP%&,^OUKD+_QI;VGB727_
M +4LSH%[I]Q<>:HSN9&C PP)S]\\ 9XK=@\3:+<G3Q;ZC#+_ &B";,QDL)L?
M>VD=<8.?3O0!I>1"9Q/Y4?G!=HDVC=CTSUQ3I(HY5"R(K@$$!AGD=#4-O>V]
MU+<10R;WMW\N48(V-@''Y$'Z$>M9O_"7>'OMK6?]L6GVA7>-D\P?*R)O8$]!
MA>3]#Z4 :IMH&.3!&>2W*#J>IH^RV^QT\B+:XPZ[!AA[^M9,WBW1H=.OKW[4
M7CLH!<3(L;;Q&02K!2,D'!P1P<'FHK;7[?4;K1'AU.*V-Y$\IL9(LR3C9G@G
M!4*<G.,&@#=BABA!$421@XX10.@P/T%--K;L6)@B);[Q*#GZUQ$?C07=W?7I
MU6+3]/T[4?LLJ3VS%)8MJ9); *N7; YQT!!S75:AJUG:Q3127T=I-]F:<23(
M=L:CC><X& 2."1^M %UK6W?R]T$3>4<QY0'8?4>E*\$,DB2/$C/'RC,H)7Z'
MM6+'XHTBSL[)+[6K66YELUN ZC:9DPN9%09(!)! ]^]75UW2Y+&TO(KR.6"\
M&;9HLN9N"?E R3P"3@<8- %UX(9)4E>*-I(\['*@E?H>U(+:W$_GB"(38QY@
M0;L>F>M0:;JVG:Q;&XTV]@NX0=I>%PP!]#CH?:H1X@THWZV(O8_/:5H5'.UI
M%&60-C:6 R2N<\'B@"Y':V\)<Q6\2&3[Y5 -WU]:7[+;A0H@BVA0H&P8QZ?2
MLF+Q?X>GN8;>+5[5Y9IC;QA7R&D!(VYZ9R"!ZX.*S/'7BO\ L+P_?2Z?=Q+J
M%NT8(>(R*I9A\I(X5B#D GTX.: -;5]&NM2-O;P:C]CT[#I=VT<"DW"-CY0Q
MY3N#@<ACT.#6P  , 8 IDTT5O"\TTB1Q1J6=W.%4#DDD]!5"'Q!I,ZW16^C7
M[(H>X$N8S&I&0Q#8(4@'!Z'% &@(T#,P1=S_ 'CCD_6FPP0VT?EP11Q)G.U%
M"C\A6<?$NC+;WD\E_%"EDH:Y\[,;1*1D%E8 @'L<<]J+3Q+HU_//!::A#-+!
M%YTB)DD)_> [CMQGGCK0!HRV\$[(TL,<C1G<A=02I]1Z4300W"A9HHY IW .
MH.#Z\UP-GXIO-8L+;68_$%II=I)>/ ]O<VF_($Y2-4)*DNP7!ZXW< 8KJ+CQ
M=X>M+YK*?6+2.Y201-&T@RKD$@'T.!0!M5%':V\+;HH(D;).50 Y/7\\#\JQ
MXO&?AN9H5CUFU8S1&6([^'4<G!Z$XYQUIEUXBTZ[TBWO+#7;6VCENXX%F=-^
M]O, :+:2"&/*^HSG% &VMM DDDB0QJ\GWV" %OJ>])]DML ?9XL#G&P5E77C
M#P]93SPW.KVL<D$BQ3*7SY;'H&QTZCD],C-6[_7--TMF6]NTB*1^;)G)\N/.
M-[8^ZN<\G X/I0!<\B'S_/\ *C\[;M\S:-V/3/7%+)#%, )8T<#IN4'%1V][
M:W5FMW;W$4MLREEF1P4('?/3%4;?7;#4UEATV]B:Y$ F3<C<H<[9 #C<A(Z@
MX/K0!?-I;'.;>+GD_(.:E"JJA5 "@8  X%<%I'BK5[VP\!7,LL&-:W"\418+
M'R'D&TYX&5';\:Z?7_$-GX=@M);L2'[5=16L81"WS.P&3@'  )/OC'4T :<4
M$,$7E0Q1QQ\_*B@#GKP*:EI;1P^3';Q+%G.Q4 7/TKDK?QG!9>)->MM:U&V@
ML[9[86I9"A"R)N.[J>I&2< <=*Z&]U_2M.G,-W>QQ.H0OD$B,.<*7(&$!((!
M;&<4 7/LEL>MO%TQ]P4HM;=2I$$0*_=(0<?2LRU\26-WXFOM"C\S[39QQO(Q
MC8*2^_@'&. G7ISCJ#5J_P!8L-+S]LN!'MC,K85FV(.K-@':ON>* +200QRO
M*D4:R2??95 +?4]Z(X(86=HHD1I#N<JH!8^I]:HW&OZ5:7GV2>]C2;>D1!!P
MKO\ <5FQA2W& 2"<CUJ*VU. ZOJZ-K%K+%9I&TEN%"FTX8DN^><XSSC&WWH
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M 8!ZC\:Y_P 4>(UTB]TC3ED:*34;DQ-,L9<Q((W<L!@@G* 8YZYQQ4^F:W#
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M_2]8NAXE>/1]4<:EX;6TA:X\O<9AYPVE5;"??7@  <GBO5Z* /.-6T35-3U
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M4BE+^:K]RR\8^]ECD8R:Z7X@6=UJ'@R[M+*VDN;B22 I'&,D[948_HIKIZ*
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M4GS.,%U*.%<]0P.X'''S>G5BW7A72;O4Y-1:.YANIMOG/;7DT EP,#>$8!L
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MDC:S,H;:.<Y *DY]17+1:DVE>-O&%Q+]MN;>VT^RG6VB+2MD^?D1H3P3@<#
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M\O>P(&SY2WR@MR>O'-K7-&O+O7-%U:Q:!I=.:;,$[%!(LB!3\P!P1C/0Y]J
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M-OM,/F.7>->=I4L3@GD9/7BHH_!MW<>&_$.DWEU%"VIWLMY#-;DL869@ZY!
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MBB@ I%15+%5 +')P.II:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "D9%8J64$J<C(Z&EHH **** "BBB@ HHHH *0(H<N% 8C!
M..32T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[=I#<6#(MPKQLH4L,C&1SQW'%:% !116?J>LV>CM9K>-(IO+E+6';&S R,<
M$@8'U.* -"BBB@ HHHH ***K6E]'>-<K''.AMYC"WFQ,FX@ Y7(^9>>HXZT
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MZCZU<F\,Z//)%(UF%>.$P!XW9"T9Y*,5(W+GG#9')K4CCCBB6*-%2-%"JBC
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MTQY%2,EH%,VT<KU C7!_,&M*YDU.SU^_T5]:O9X(_#IG61]BR"4.RE]RJ.2
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MVDYPHD8*O_?./PQ7"V\>F0>$M/LO+A@GC\5A;I OEL%%W(0&(QP$(/L".QH
M]G#!AD$$>U"LKJ&5@P/<'->17KQ:2_BRWTR+R]*MM8LIKFWLHP=EN8X_.*H
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MZ/NK;@V2.<@@]*T?$5_I\UQXZM-<,!GEL-VD^< 1+!Y&1Y)[D2;B=O.<>@H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@#M:*XK/Q0_N^$/^^KG_  HS\4/[OA#_ +ZN?\* .UHKBL_%#^[X0_[ZN?\
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M5S_A0!VM%<5GXH?W?"'_ 'U<_P"%&?BA_=\(?]]7/^% ':T5Q6?BA_=\(?\
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M_A1GXH?W?"'_ 'U<_P"% ':T5Q6?BA_=\(?]]7/^%&?BA_=\(?\ ?5S_ (4
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M:.UI>SRLL]S//$8HHS+O)^1F9CCC&.YKM,_%#^[X0_[ZN?\ "C/Q0_N^$/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCY>5;[V.E;E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4456O]1M-+M3<WLZ0Q;@H+?Q,3@*!U))X ')H LT5DCQ)IGG+"\D\<
MSHSI%+:RH[JHRQ564$X'H.X]:MZ7J5KK&EVVI6,ADM;F,21.5*[E/0X/(H M
MT56LK^'4(Y9(!*%CE>%O,B9#N4X. P&1D<$<&G7EY;Z?:O<W4HCA3 +'GDD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY%V09Y,^<#D,&W9!!Z<X%177@[0+W64U>XTY7OE"J9?,<>8%^[O4'#X_V@:
M,BSU'4M>;5+JVUA; Z;JS6S0M&K1^5&5W!\C.7!)!R,97'?.7=>(=9@\-Z[=
M+J4GGV/B&.SB<Q1_ZDRPJ4(VX/$C<]?>NMD\):%+KQUMM/3^T&*L\@=@KLOW
M69 =K,.Q()&!45WX*\/7T]W-<Z?O:[D2:9?.D"-(I4A]H;:&^5?F !(&#D4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-7C8X R3P?PZ^W( .JHKE?\ A.;&?3["XLUC:6]L1?I#<3K#B,XP"3GYB<@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8# !B2PYZ ]>N;.E^$]2L9_";S7=K*-#LI+1]B,OFAE101UQ@1CZY/2NQHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%NF@8F.59%+*0#RK<'*DGMR<UI:YJ3:3HUS>10F>=%VP0CK+*QVHGXL0/QH
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MN[1H;FV5GVM$[$#?M3<P;'!&#U%>BDI!#PI"(O"HI. /0"L?_A$M%_Y]I?\
MP)E_^*H_X1+1?^?:7_P)E_\ BJ .9^'7ARV/A73WU;3;E;ZSNKB9(KQ9 (F:
M:1E=4;Y0=K Y SSZU630[R]T#QW!:Z>\6H75]<26C30-%YJM$BC:S <-AUX/
M?WKK_P#A$M%_Y]I?_ F7_P"*H_X1+1?^?:7_ ,"9?_BJ .*O;(^(M$U*_P!)
M\/:Q:ZQ]A6!_[1DEC+JLBN;==[88'##<.!GKR:36+"+Q#X3\17NE>'M:AU*X
MTS[.YU#S5ED(.X1JCL=V/FY'J "<G';?\(EHO_/M+_X$R_\ Q5'_  B6B_\
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M./%-Q/I\B+)+:M!/+;MM?9"%)5V'.#D9KL:** "BBB@ HHHH **** "BBB@
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M=6FLZ78RV%F-,>&[5[<P>8Y=3&NT@9*@/D]L@9YKLZ* "BBB@ HHHH ****
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MCJUK=WY$-MK<]E:FZN"S8R"D89SECEB ,DU%X=D1/B7XY9W5546!))Q@>2U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,L_[/TRVM2^]XT =_P"^_5F/N3D_C0 EKJVG7UQ-;VE_:W$\)Q+'%,KM'_O
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MQW9#G/ Y%7O'W_(1\&?]C!%_Z*EH ZJRU.PU(.;&^MKH(<,8)5?:??!XJU7
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MWUF+*: .1#+$-V R=#@.P_'Z4VP\+6>GBUV7-W-]BB:&R\]U?[,K#!V\<G
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M@S.7)4@ @[SN'H:Z&B@#FG\%6,VB3:9<WVI7*S-&TL\]QOE81MN1=Q' !&<
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MN4@^SQS7#!F2/(.T8 ZD#)/)P,DX%:=% !1110 4444 %%%% !1110 4444
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M!VME>#E1\RX-2Z5X)ATF71I(M4O)6TFR>R@$HCP8VV_>PHY&Q<?3G.30!?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"7[<LMLZ;$,.SR1D?/E]I 7(PF?3(!V-EK6EZE,T-CJ5I=2*@D9()U<A3T;
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MJD@QXW850>2,'.!FMK1X7C^(VO3K:7$5K/86:QR-;LD;LAEW $@#(#+_ )%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!&]O%)-%*Z!GBR4)_A)&"0/7&1GT)]:DHHH **** "BBB@
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M3(YI9H].M%EEW>8ZP*&?=][)QSGOZTB:+I48A$>F62"!MT.V!1Y9]5XX/TH
MX'PK>R:X=&U:3Q*D.I+<21WNGJ'+R/\ ,'A9#)@!2,@A!@+GIFO3*J1:5IT&
MH2ZA%86L=[*,27"0J)''H6QDU;H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/ "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>eltx-powerofattorney2025002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 eltx-powerofattorney2025002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX^_Y"'@S_L8(?_14M '3V.L:;J<DD=C?VUS)%CS$BE#,G^\!R/QJ2SU"UO\
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MX;=QDDY'>@#L:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<"M&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K$\4WAM])^R1W2VMQ
M?N+2*8L!Y>X$LXSW5 S#W '>MNLF;29;KQ"E_<RV\MG%;M%%;M"259B"S[B<
M'.T#IP,\\F@#(^'^K/K/A$6E]*LM]ISOIUXRMG>\?R[L]]R[6S[UR6B@GPI\
M-I2[ESJA0DN>08[@G/KR!^5=I8^&;G3/%^IZS97EM%::A#&DMD+<_P"L0$+)
MN#=<'!&.0!5"R\$7EGHWAK3_ .TX'_L6\-SO^S$>=\KKMQO^7B0\\]!0!9/C
M='O+46UA)<V4]ZUEYL+%I$8,4WE-N!'N4C=NX!!Q5>#Q[-+]GFDT22*SDU9M
M*DE-RI9)?,,:D*!RI8<\C&>]6-(\+ZOHM]-;VNMQ_P!A/<O=):M;?OHRS%S&
MLF[&PL2>5)P2,]ZJCP1?#2TL_P"U+?<NM_VOO^S-C/G>;Y>-_KQGT[4 :?CF
MP&H>%;F(32V\VZ,17$+E7B8NHW*01Z_C7-QZW<WNES>'/$05/$&GW-KYC+\H
MNH3.BB>/'9@2& Z$D'KBNVUNPN-3TMK2WGC@D9T;?)&7 VL&Z CT]:SO$?A*
MT\1RZ7=S.8;_ $ZYCGBN(Q@D*RL\9]58#IZX/:@"C=:_I^CZ_P"(9GTN1)M.
MTR&>6=7SYT69-JA1PH!5N??VJ>X\916>DC4;E+,6LD\4,%U'>;[=P_\ $9-O
MR@'(/'7'K4D_AW4#XBU75[74H(7O+.&VC5K<MY9C9F#'YAN!WD$<<=ZJ6?@M
M]/.H/9&P@2_G22XL1;EK5U",K#9G@OD$G_9'!P<@%V;Q0T"6<,EK"E_=^<\<
M37!\LQQL!OWA2<'<A'R_Q>QJA!XZN+I]'AAT"Y6YU,7 $<\@C\IXNH)(Y4\$
M,!T.<$\55C^']UIEOI\VA:I'8W]C/</$KPF2W$4S M!LW A!M4C!ZCMGC7?P
MYJ,VM:'J<^J12S:<)S*#;D"5I5 .WYOD4 # Y]R3S0!4@\>P3:?ILLMO%:7-
M[<SVACNKG9''+"Q5E\P*<DE?EXY_2M >(KF:[BTZUTY6U/["E[<6\T^Q80QP
M$+!3EBP8=,?*3D<9S+;P9=P:5)IUS<:??V<US=3SV]S:'9)YTF\?Q'!4DX/<
M'L>:=IG@JXT&[T^\TS4@\\&GKI]P+J,LLR*Q9&&&RI4D@<G@X[9H 2W\?#46
MT5-,TF:=M5BN"@EF6/RI(2 Z/UZ'C(S[9K<\-ZV/$.B1:A]G:V<R2120LP;8
M\;LC#(ZC*G!]*QK+P4VFW^A3VM['Y>F+=&17A):>2<AG;(;Y?FY P>N*33]$
MUSP]9V%E97]O.K:E+/<C[(PWQ2R%V&[<=A7<2#WP!B@"Q\0-.?5/"DEI!<R6
MMS+<6\4-S$Q5XB\R+D$<]#6=IWB:[UOP-;Q[C!KLTC:;<A?O03ID3/[856<?
M51WKI]:T^YU*TB@MYXH2ES#.S21E\B.17Q@$8SMQGWK-@\(P67B+5M<M9MMS
MJ$2KY;J3'')@!W !'+!8\_[G7F@"I\+F:7X:Z'/*[2336^^21V+,[$GDD\FL
MSPOI%IJ>M^,(KGSRL.J>5#LN)$,2^5&V$*L-O))XQ6WX<\.ZGX<\.Z+H\.IV
M\D=@VV=S;$&>+#?*!N.TY(YYZ5%IGAK6M*OM;N;;5K'.J77VD[[)F\H[%3 _
M>C/"B@"'P!JE]<'7=&U"YDO)-'U!K:*ZDY>6(@,F\]V .">_%=E7.:9X9ET'
M2OLVE7W^ESW@N[V[NHO,:Y9F!DR 0 2!@8X&!71T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ[NK6"99)K4JLRJ<["PR ??&#^(JP&4@D,"!U.:\EU+99WWCYM/M"-0::UN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>T2RU:TWBWNXEE0.,, 1T/N.E,U>_O;**-=.TQM0NI"=L?FB)% ZEG(..H&
M"3GIC)%#2M>\.6EGHFFV-RD4-W&T6FQE&'FK$,'&1Z8Z]>V:F\2^*-/\,VD3
MWEQ%'-<-L@60D GN3CHHZD_@.2!0!G6OCF"XT)+R2PF@OVO_ .S/L$C#<+K=
M@IN'!4?>W#^$$X[5<C\2O(-2M4TYY-6L)4B>SBD!#%U#(P<@#81G)(&-K#!P
M,\C<C3;G3= U/1[HWMGINN"YU&Z"%0S2*XDD.1T#2J3CA5_W:O6VJV>D>)/%
MOBN[G"Z5(+2UMY5.1.\:-NV?WN7VYZ95N>#0!NZ)XJ-_+JUKJM@=*O-*"/<H
M\PDC$;J6619!@$85L\#&*T-'U636;=;V*T:&PE7=!)*V))5[-LQ\JD<C)SCJ
M!7G^L3V?B?P3XI71+H:AJ]Y$DUV+56($:D 0J2!GY%< =22QP,XK;TB.+_A.
M;:;P_=O+H\NF,;Q!,TD:R!E\H\DX<@OGOA>>U '<4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M20%E +L=I!V [5P#PHQ6;K<<$&@3R:5K5MJ,,NMZ=)#%$?\ 1K>3SDRB,&;
M. Q4'C.0.:]42UMX[<VZ01+"008P@"D'KQTJ(:98"W2W%C;"",Y2,1+M7Z#&
M!0!Y[_;>GMX,OI[^2ZM=6-]#;:I&LP1XIVE0;"QR$@;CY@.4)/+$UA:K/;7'
MAWQ?:2W-M+#9ZU8RPQPRYC@1FM]VSGA<L_H,DG KV!M-L6\S=96Y\T8DS$OS
MCT/'-.^Q6NR1/LT.V4!9%\L8< 8 /KQQ0!YKJE[I]_KNM:/>Z];:5%%# ^ES
M,Q#"(H#YD#;P"PDW X!)P <CBM'1]-AU/Q_KR7MW>S&SCL)XD-U)'MD*/D[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"Z@X+ 'ZTM>;^-18V_P 1
M]!N[O2OM\::;?/+%' LCN%\L_=;[V.<#KSQ0!Z12,RHI9F"J!DDG  KSGPKJ
M!\+?#J^UV9EFL+J[:ZTVTBEW""*9U6*'=T'S'G&0N3Z5>\2ZQ.L.K>'=7MK>
M0W6C7%U;31 [&V+AT96SR-RD'//H,4 =NCK(BNC!D8 JRG((]13J\\T3Q3J&
MB6GANUU>QMDTR]TT&WN()F=T:*#S")%*@<HK$8S@C'/6M&V\6:O<-;3Q:.9;
M.[LWN5DV21"W8*&5'=EPP8<;E'!'0@YH [*D) &20![UYQ/XI\4WGAWP_JJ0
M:=90:I=:>$V2/(^V5@75N  .G0G@D=>:ZCQK$)?A_KRW"1N1IEP2,9&X1-R,
M^] &^"&Z$'Z4M>1^&8(K[Q+X4BTFS&E7&F:9'<:B[*L9O(9(@%"A3^\&[DL?
MNGW->N4 )O7.-PSZ9I:\N\5R:7IWQ/FO]1T;^T;:+PW)+-'';I*V!.,MAL9P
M,C/H?2KFB76I>#?AA;7LLD%[FY1HHA,9%C@FF5419.^U7'/3C'3F@#T6J_V^
MSS./M<&;?_7?O!^[_P![GC\:Y^ZUZ_?4?$FEP) DFG645Q#,<\^8)."/4>7^
MM<3!:72Z'\.;Y8['[5<M:PM,4;?(GV=Y0KG/S#>N[_> - 'K<4T5Q$LL,B21
MN,JZ,""/8B@2QF8Q"1?,"[BF>0/7'I7#CQ"-'T+6[_1=,M%TO1;J5+BW3*M*
M5(:=T[+@LV 0<[3R,U7NM:L-&\<:[X@9,VJ>&[:[?8N&D_>S8_$@ <^U 'H=
M%<TGB&^L_$.DZ7JEO !JT,C6\EN3^[D10S1MGK\N2&&,X/ KI: $W*3@,,^F
M:6O./,72OB)XUU.VLX)+BVTBVG56^3<0)2?F )&=H[=A76>&=1U75M-BO]1M
M;2WBN88IK=8)6=L,@)#Y  .3V)_Q -ND#*3@,#]#2UXO)H7]I0>.[32]$\W5
MFUDBRNH@D9MG\N(AO,R"H!)/'7)ZYH ]E66-I7B613(@!9 >5!Z9';.#^5/)
M &2<"O+_ +7JGAWQ#XQOK2WL[FXM-,LKF[:5C&)2D<I8C:/O-@\GIQ7HT4L.
MIZ5',T0:&YA#[' (PPS@C\: +(96Z$'Z&EKR[P-X6T?5O@_I9EM(8+IK5V6]
MB4)-$X9L.'&"".._:NI^'6LWGB#X?:-J>H$F[F@Q(Q&-Y5BN[\<9_&@#J***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4Y'/2O6!R : "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%#,\;+F/S%5E8J3NV8<<X]?0D0Q>+[>35;&R>QNXA?S7$%L\@52[P[BV5)R
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+D!_,<\=,\4Z^U&;5!HL][?VAN;+4EO94BM[A8U549-B$H23\Y.3CTQ7H]%
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MZ7XSU75%G!TZY87,%J/^6=PX"S/^(1<?[[4 3IXOTNWN+&S9KEHKJ1K:VNV
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MBUG9S?:M5N'F"W!++%+*SAD&WDKORV<<*?6NAUZUN[RS@BLXHW9;N"9O,DV
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
' **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Mar. 10, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Entity Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Elicio Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-3430072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">451 D Street, 5th Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">209-0050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,396,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the registrant&#8217;s definitive proxy statement relating to the 2026 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;) is filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, then portions of the Proxy Statement will be incorporated by reference into Part III of this Annual Report on Form 10-K. If the Proxy Statement is not filed within such 120-day period, then the registrant will file an amendment to this Annual Report (the &#8220;Form 10-K/A&#8221;) within such 120-day period that will contain the information required to be included or incorporated by reference into Part III of this Annual Report.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Baker Tilly US, LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tewksbury, Massachusetts<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 18,563<span></span>
</td>
<td class="nump">$ 17,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash, current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">748<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">19,311<span></span>
</td>
<td class="nump">20,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">4,782<span></span>
</td>
<td class="nump">5,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, noncurrent</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other long-term prepaid assets</a></td>
<td class="nump">770<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">25,862<span></span>
</td>
<td class="nump">28,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">6,427<span></span>
</td>
<td class="nump">8,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred research obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,110<span></span>
</td>
<td class="nump">11,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantLiability', window );">Warrant liabilities</a></td>
<td class="nump">2,615<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">4,094<span></span>
</td>
<td class="nump">5,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">9,407<span></span>
</td>
<td class="nump">20,034<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">24,226<span></span>
</td>
<td class="nump">39,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies&#8212;Note 9</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value; 10,000,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value; 300,000,000 shares authorized; 17,814,762 and 11,043,837 shares issued at December 31, 2025 and 2024, respectively; 17,800,307 and 11,029,382 shares outstanding as of December 31, 2025 and 2024, respectively</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 14,455 shares outstanding</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">235,407<span></span>
</td>
<td class="nump">183,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(127)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(233,672)<span></span>
</td>
<td class="num">(194,101)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">1,636<span></span>
</td>
<td class="num">(11,312)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock, and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 25,862<span></span>
</td>
<td class="nump">$ 28,178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">17,814,762<span></span>
</td>
<td class="nump">11,043,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">17,800,307<span></span>
</td>
<td class="nump">11,029,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares outstanding (in shares)</a></td>
<td class="nump">14,455<span></span>
</td>
<td class="nump">14,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 24,903<span></span>
</td>
<td class="nump">$ 33,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">12,811<span></span>
</td>
<td class="nump">11,330<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">37,714<span></span>
</td>
<td class="nump">44,986<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(37,714)<span></span>
</td>
<td class="num">(44,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other (expense) income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(1,915)<span></span>
</td>
<td class="num">(3,886)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of pre-funded warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale of equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange transaction gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GrantRevenueNonoperating', window );">Grant income</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperatingAndNonoperating', window );">Interest income</a></td>
<td class="nump">776<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(1,133)<span></span>
</td>
<td class="num">(455)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(1,857)<span></span>
</td>
<td class="num">(6,912)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(39,571)<span></span>
</td>
<td class="num">(51,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract', window );"><strong>Other comprehensive gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (39,523)<span></span>
</td>
<td class="num">$ (51,876)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="num">$ (2.58)<span></span>
</td>
<td class="num">$ (4.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="num">$ (2.58)<span></span>
</td>
<td class="num">$ (4.25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">15,312,751<span></span>
</td>
<td class="nump">12,202,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">15,312,751<span></span>
</td>
<td class="nump">12,202,996<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain Loss On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GrantRevenueNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of grant revenue, non operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GrantRevenueNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperatingAndNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income classified as operating and nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperatingAndNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Conversion of Convertible Debt</div></th>
<th class="th"><div>At-the-Market Offering</div></th>
<th class="th"><div>January Offering</div></th>
<th class="th"><div>July Public Offering</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Conversion of Convertible Debt</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>At-the-Market Offering</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>January Offering</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>July Public Offering</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Conversion of Convertible Debt</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>At-the-Market Offering</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>January Offering</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>July Public Offering</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,618,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2023</a></td>
<td class="nump">$ 11,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="nump">$ 153,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (197)<span></span>
</td>
<td class="num">$ (142,203)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">703,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants', window );">Issuance of common stock from the exercise of July 2024 Common Warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of common stock from the exercise of July 2024 Common Warrants</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(51,898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,898)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock units</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants', window );">Reclassification of liability-classified warrants to equity classified warrants</a></td>
<td class="nump">$ 19,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2024</a></td>
<td class="nump">11,029,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,043,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2024</a></td>
<td class="num">$ (11,312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="nump">183,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(194,101)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Dec. 31, 2024</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">32,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,717,507<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,244<span></span>
</td>
<td class="nump">$ 9,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,227<span></span>
</td>
<td class="nump">$ 9,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants', window );">Issuance of common stock from the exercise of July 2024 Common Warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of common stock from the exercise of July 2024 Common Warrants</a></td>
<td class="nump">3,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of Convertible note into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of Convertible Note into common stock, net of issuance costs of $0.3 million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of common warrants associated with June 2025 Promissory Note</a></td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (39,571)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,571)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2025</a></td>
<td class="nump">17,800,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,814,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2025</a></td>
<td class="nump">$ 1,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="nump">$ 235,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (127)<span></span>
</td>
<td class="num">$ (233,672)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Dec. 31, 2025</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclass Liability-Classified Warrants to Equity Classified Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock and Warrants Issued During Period, Share, Preferred Stock and Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Net of debt issuance costs</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketOfferingMember', window );">At-the-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryOfferingMember', window );">January Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (39,571)<span></span>
</td>
<td class="num">$ (51,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets, operating leases</a></td>
<td class="nump">924<span></span>
</td>
<td class="nump">857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_InterestExpenseNoncash', window );">Non-cash interest expense</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CostsExpensedUponTheIssuanceOfWarrants', window );">Costs expensed upon the issuance of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">1,915<span></span>
</td>
<td class="nump">3,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">2,697<span></span>
</td>
<td class="nump">1,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,149<span></span>
</td>
<td class="nump">835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term prepaid assets</a></td>
<td class="num">(170)<span></span>
</td>
<td class="nump">2,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(366)<span></span>
</td>
<td class="num">(3,331)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(1,988)<span></span>
</td>
<td class="nump">4,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred research obligation</a></td>
<td class="num">(1,169)<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(901)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(36,952)<span></span>
</td>
<td class="num">(37,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from the exercise of common stock warrants</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from June 2025 Promissory Note, net of issuance costs</a></td>
<td class="nump">9,866<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common stock warrants from March 2024 Offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering', window );">Proceeds from issuance of common stock warrants from July 2024 Public Offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.</a></td>
<td class="nump">16,244<span></span>
</td>
<td class="nump">4,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering', window );">Proceeds from issuance of common stock from July 2024 Public Offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_PaymentOfWarrantIssuanceCosts', window );">Payment of warrant issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of Convertible Note, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="nump">9,143<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">36,695<span></span>
</td>
<td class="nump">42,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency on cash</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(225)<span></span>
</td>
<td class="nump">5,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the year</a></td>
<td class="nump">19,492<span></span>
</td>
<td class="nump">14,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the year</a></td>
<td class="nump">19,267<span></span>
</td>
<td class="nump">19,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Components of cash, cash equivalents and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">18,563<span></span>
</td>
<td class="nump">17,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">19,267<span></span>
</td>
<td class="nump">19,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfPreFundedWarrants', window );">Fair value of pre-funded warrants at issuance date</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfCommonStockWarrants', window );">Fair value of common warrants at issuance date</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfCommonStockWarrantsUponSettlement', window );">Fair value of common warrants upon settlement</a></td>
<td class="nump">2,126<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccretionOfPromissoryNoteToFaceValue', window );">Accretion of promissory note to face value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantIssuedStockIssuance', window );">Fair value of common warrants issued with January 2025 Offering</a></td>
<td class="nump">9,719<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantIssuedDebtIssuance', window );">Fair value of common warrants issued with June 2025 Promissory Note</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_VestingOfRestrictedCommonStockNoncash', window );">Non-cash vesting of restricted common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of related-party senior note and interest into common stock</a></td>
<td class="nump">$ 20,176<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccretionOfPromissoryNoteToFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion Of Promissory Note To Face Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccretionOfPromissoryNoteToFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CostsExpensedUponTheIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs Expensed Upon The Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CostsExpensedUponTheIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_FairValueOfCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Common Stock Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_FairValueOfCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_FairValueOfCommonStockWarrantsUponSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Common Stock Warrants Upon Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_FairValueOfCommonStockWarrantsUponSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_FairValueOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Pre Funded Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_FairValueOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain Loss On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_InterestExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_InterestExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_PaymentOfWarrantIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Of Warrant Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_PaymentOfWarrantIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance of Common Stock From July Public Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance of Common Stock Warrants From July Public Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_VestingOfRestrictedCommonStockNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Of Restricted Common Stock, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_VestingOfRestrictedCommonStockNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantIssuedDebtIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Issued, Debt Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantIssuedDebtIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantIssuedStockIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Common Warrants Issued With January 2025 Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantIssuedStockIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business and Financial Condition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of the Business and Financial Condition</a></td>
<td class="text">Description of the Business and Financial Condition<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic, colorectal cancer, lung cancer and other mKRAS positive cancers. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#8220;ESC&#8221;), an investment company, Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;) and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#8220;Elicio&#8221; throughout these consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Liquidity and Going Concern</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has experienced net losses and negative cash flows from operating activities since inception. As of December&#160;31, 2025, the Company had an accumulated deficit of $233.7&#160;million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. Our sources of liquidity for the years ended December&#160;31, 2025 and 2024 are described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a registration statement on Form S-3 (the &#8220;Prior Shelf Registration St</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">atement&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;) that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $100 million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $21 million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#8220;2022 ATM Program"). During the year ended December&#160;31, 2024, the Company issued and sold a total of 650,179 shares of common stock under the 2022 ATM Program for aggregate net proceeds of $5.4 million after deducting sales commissions. In May 2024, the Company terminated the 2022 ATM Program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, the Company filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, the Company entered into the Capital on Demand</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services, LLC, as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221; and, collectively with the 2022 ATM Program, the &#8220;ATM Programs&#8221;). During the year ended December&#160;31, 2025, the Company issued and sold 1,717,507 shares of common stock for net proceeds of $16.2 million</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">under the 2024 ATM Program. During the year ended December&#160;31, 2024, the Company issued and sold 53,795 shares of common stock for net proceeds of $0.3 million under the 2024 ATM Program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Private Placement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, LLC (&#8220;GKCC&#8221;), an entity controlled by a member of Elicio&#8217;s board of directors, providing for the issuance and sale by Elicio to GKCC of pre-funded warrants (the &#8220;March 2024 Pre-Funded Warrants&#8221;) to purchase up to 1,032,702 shares of common stock, at a purchase price per March 2024 Pre-Funded Warrant of $5.81 (the &#8220;March 2024 Offering&#8221;). Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds from the March 2024 Offering were $6.0&#160;million. Refer to Note 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Public Offerings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed an underwritten public offering (the &#8220;July 2024 Public Offering&#8221;), consisting of (i) 500,000 shares of common stock (the &#8220;July 2024 Shares&#8221;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#8220;July 2024 Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock, (the &#8220;July 2024 Common Warrants&#8221;). Each July 2024 Pre-Funded Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable and will expire five years from the issuance date. The net proceeds from the July 2024 Public Offering were $10.9&#160;million after deducting commissions and other transaction costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The July 2024 Public Offering consisted of the July 2024 Shares or in lieu thereof, the July 2024 Pre-Funded Warrants, and accompanying July 2024 Common Warrants. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $5.00 per July Share and accompanying July 2024 Common Warrant. Each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $4.99 per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant, which represented the combined purchase price per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant less the $0.01 per share exercise price for each such July 2024 Pre-Funded Warrant. The July 2024 Common Warrants have an exercise price of $5.00 per share, are immediately exercisable and will expire five years from the issuance date. Refer to Notes 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by Elicio directly to the Investors (the &#8220;January 2025 Offering&#8221;): (i) an aggregate of 1,261,830 shares of common stock (the &#8220;January 2025 Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#8220;January 2025 Common Warrants&#8221;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The January 2025 Offering resulted in net proceeds of $9.2&#160;million after deducting the placement agent&#8217;s fees and related offering expenses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC pursuant to which the Company issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $20.0&#160;million (the &#8220;Convertible Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7&#160;million from the Convertible Note Financing, after deducting debt issuance costs. In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#8217;s common stock. In March 2025, the Company issued 3,500,573 shares of common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into a note purchase agreement (the &#8220;June 2025 Promissory Note Financing&#8221;) with GKCC pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#8220;June 2025 Promissory Note&#8221;) in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of 103,225 shares of common stock (the &#8220;June 2025 Warrant&#8221;). The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. The Company received net proceeds of approximately $9.9&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, the Company had $18.6&#160;million in cash and cash equivalents. The Company&#8217;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the consolidated financial statements, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of its common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it may need to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Segments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The Chief Executive Officer serves as the CODM. The Company operates as a single operating and reportable segment, reflecting the integrated nature of the Company&#8217;s business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. Significant estimates reflected in these consolidated financial statements include but are not limited to, the accrual of research and development expenses, the valuation of stock-based awards, the valuation of warrants, the valuation of embedded derivatives and convertible debt, and the operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liability. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Foreign Currency Translation and Transactions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Australian Dollar (&#8220;AUD&#8221;) is the functional currency for Elicio Pty. Accordingly, nonmonetary assets and liabilities originally acquired or assumed in other currencies are recorded in AUD at the date they were acquired or assumed. As part of the consolidation process, the Elicio Pty results are translated from AUD into the reporting currency of US Dollars using average rates for profit and loss transactions and applicable spot rates for period-end balances. The effect of translating the Company&#8217;s functional currency into the Company&#8217;s reporting currency is reported separately in Accumulated Other Comprehensive Loss.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Concentrations of Credit Risk and Off-Balance Sheet Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and restricted cash. At times, cash balances deposited at major financial institutions exceed the federally insured limit. The Company regularly monitors the financial condition of the institutions in which it has depository accounts and believes the risk of loss is minimal. The Company has not experienced any losses in such accounts. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents are comprised of deposits at major financial banking institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. As of December&#160;31, 2025 and 2024, the Company&#8217;s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Restricted Cash</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Restricted cash consists of cash securing a collateral letter of credit issued in connection with the Company&#8217;s facility operating lease and unused funds received from the Company&#8217;s research grant. See Note 10 for further discussion. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Fair Value Measurement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company follows the guidance prescribed by ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, which establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The standard provides a consistent definition of fair value that focuses on an exit price which is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a three-level hierarchy for fair value measurements based on the nature of inputs used in the valuation of an asset or liability as of the measurement date.</span></div><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 1:&#160;&#160;&#160;&#160;Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at measurement. </span></div><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 2:&#160;&#160;&#160;&#160;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. </span></div><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 3:&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The carrying amounts of financial instruments reflected in the consolidated balance sheets for cash and cash equivalents, non-current restricted cash, accounts payable, and accrued expenses approximate their respective fair values because of the short-term maturity of those financial assets and liabilities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of the asset. Upon sale or retirement, the cost and accumulated depreciation are eliminated from their respective accounts, and the resulting gain or loss is recorded in the consolidated statement of operations and comprehensive loss. Repair and maintenance expenditures are expensed as incurred. Construction in process is not depreciated until the asset is placed into service.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:67.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Asset Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Estimated Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shorter of useful life or lease term</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Impairment of Long-Lived Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company evaluates its long-lived assets, which consist primarily of property and equipment, and ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. During the years ended December&#160;31, 2025 and 2024, no impairments have occurred.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Debt Issuance Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These deferred costs will be amortized and recognized as additional interest expense over the term of the Company&#8217;s Convertible Note (as defined below) using the effective interest method. The Company will present debt issuance costs as a direct deduction from the Convertible Note (as defined below) liability on its financial statements. See Note 11 for further discussion of the Company&#8217;s accounting for its outstanding debt and related issuance costs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for income taxes in accordance with ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. Deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates and laws in effect in the years in which the differences are expected to reverse. A valuation allowance is provided if, based upon the weighted available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company is required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, the position will be sustained upon examination. As of December&#160;31, 2025, there were no accruals for interest or penalties related to uncertain tax provisions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Research and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development costs are charged to expense as incurred and consist of expenses incurred in performing research and development activities, including salaries and benefits, materials and supplies, preclinical expenses, stock-based compensation expense, depreciation of equipment, contract services, and other outside expenses. The Company accrues for costs incurred by external service providers, based on estimates of services performed and costs. The Company expenses all </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by the Company&#8217;s vendors and service providers. Based on the timing of payments to service providers, the Company may also record prepaid expenses for those service providers that will be recognized as expenses in future periods as the related services are rendered. Research and development costs may be offset by research grants and research and development refundable tax rebates received by Elicio Pty.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 842&#8221;) requires a lessee to recognize a ROU asset and corresponding lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the consolidated statements of operations and comprehensive loss as well as the reduction of the ROU asset. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on specific facts and circumstances, the existence of an identified asset(s), if any, and the Company&#8217;s control over the use of the identified asset(s), if applicable. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected lease term. When the interest rate implicit in lease contracts is not readily determinable, the Company will utilize its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has elected to combine lease and non-lease components as a single component. Operating leases are recognized on the consolidated balance sheet as ROU lease assets, current lease liabilities and non-current lease liabilities. Fixed rents are included in the calculation of the lease balances, while variable costs paid for certain operating and pass-through costs are excluded. Lease expense is recognized over the expected term on a straight-line basis.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Grant Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Not-for-Profit Entities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, and that the grants are not within the scope of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company issues stock-based awards to employees and non-employees, generally in the form of stock options. The Company accounts for stock-based awards in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, which requires all stock-based payments to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period. The Company has elected to account for option forfeitures as they occur. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses the Black-Scholes option-pricing model (&#8220;Black-Scholes&#8221;) to determine the fair value of options granted, which uses as inputs the fair value of the Company&#8217;s common stock, assumptions the Company makes for the volatility of its common stock, the expected term of its stock options, the risk-free interest rate for a period that approximates the expected term of its stock options and its expected dividend yield. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Compensation cost of awards that contain a performance condition is recognized when success is considered probable during the performance period. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the Merger, there was no public market for Former Elicio&#8217;s common stock. The estimated fair value of the Company&#8217;s common stock underlying Former Elicio&#8217;s stock-based awards was determined by Former Elicio&#8217;s board of directors as of the grant date of each option grant. To determine the fair value of Former Elicio&#8217;s common stock underlying option grants, Former Elicio&#8217;s board of directors considered, among other things, input from management and valuations of Former Elicio's common stock prepared by third-party valuation firms and performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants' Accounting and Valuation Guide, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Valuation of Privately-Held-Company Equity Securities Issued as Compensation</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. Following the Merger, the fair value of the Company&#8217;s common stock is based on the closing stock price on the date of grant as reported on the Nasdaq Capital Market.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Warrants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s common stock warrants are evaluated pursuant to ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 480&#8221;), and ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 815&#8221;). The Company classifies its freestanding warrants as (i) </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">liabilities, if the warrant terms allow settlement of the warrant exercise in cash, or (ii) equity, if the warrant terms only allow settlement in shares of common stock. Please refer to Note 8 below for the application to the Company&#8217;s pre-funded and common warrants.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Net Loss Per Share</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic net loss per share of the Company&#8217;s common stock is computed by dividing net loss attributable to the Company&#8217;s common stockholders by the weighted average number of shares of the Company&#8217;s common stock and pre-funded warrants outstanding for the period. Pre-funded warrants are considered outstanding for the purposes of computing basic and diluted net loss per share because shares may be issued for little or no additional consideration and are fully vested and exercisable after the original issuance date of the pre-funded warrants. Diluted net loss per share excludes the potential impact of the Company&#8217;s common stock options, warrants and unvested shares of restricted stock because their effect would be anti-dilutive due to the Company's net loss. Since the Company had net losses for the years ended December&#160;31, 2025 and 2024, basic and diluted net loss per common share are the same.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other Comprehensive Gain (Loss)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other comprehensive gain (loss) is defined as a change in equity during a period from foreign exchange transactions and other events and circumstances from non-owner sources. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Adopted Accounting Standards During the Period</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2023-09&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the new guidance, public business entities (&#8220;PBEs&#8221;) are required to disclose an annual tabular effective tax rate reconciliation using both reporting currency amounts and percentages, disaggregated into specified categories as well as the amount of income taxes paid, disaggregated by federal, state and foreign jurisdictions. ASU No. 2023-09 is effective for annual periods beginning after December 15, 2024 and may be applied prospectively or retrospectively. The Company adopted ASU No. 2023-09 on a prospective basis for the year ended December 31, 2025. The Company&#8217;s adoption of ASU No. 2023-09 did not have a material impact on its consolidated financial statements. The additional required disclosures have been included in Note 12.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB finalized ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2023-07&#8221;). ASU 2023-07 requires enhanced disclosures about reportable segments and the CODM. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-07 on January 1, 2024. There was no impact on the Company's reportable segments identified and additional required disclosures have been included in Note 16.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2024-04&#8221;). ASU 2024-04 clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact the adoption of ASU 2024-04 will have on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">___________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash equivalents at December&#160;31, 2025 and 2024 were held in U.S. Treasury securities.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There were no transfers made among the three levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the warrants assumed in the Merger with Angion (the &#8220;Angion Warrants&#8221;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liabilities (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk free interest rate, and the expected term.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrant liabilities was estimated using the following assumptions:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">76.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">76.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Contractual term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Volatility (annual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">67.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into the March Subscription Agreement with GKCC. The March 2024 Offering provided for the issuance and sale of the March 2024 Pre-Funded Warrants. The Company identified these warrants as liabilities and measured them at fair value on March 19, 2024, and subsequently remeasured the fair value of these warrant liabilities on a quarterly basis. The Company was able to calculate the fair value measurement based on directly observable inputs for the asset from active markets, therefore these warrants were classified as Level 2. At the Company&#8217;s annual </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">stockholder&#8217;s meeting in November 2024, the Company obtained stockholder approval (the &#8220;Stockholder Approval&#8221;) for GKCC, together with its affiliates, to exceed the 19.99% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;). As a result of the receipt of Stockholder Approval, the March 2024 Pre-Funded Warrants were classified as equity at December 31, 2024 and no longer needed quarterly fair value remeasurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed the July 2024 Public Offering, consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable and will expire five years from the issuance date. Upon issuance, the Company identified the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Refer to Note 6 and 8 for further discussion. As a result of obtaining the Stockholder Approval in November 2024, the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants held by GKCC, together with its affiliates, met the equity classification requirements under ASC 815. As such, the Company remeasured the July 2024 Common Warrants held by that shareholder at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. The remaining liability classified July 2024 Pre-Funded Warrants were exercised in the fourth quarter of 2024, leaving no remaining liability classified July 2024 Pre-Funded Warrants outstanding as of December 31, 2024. The remaining July 2024 Common Warrants not held by GKCC and its affiliates remain liability classified as of December 31, 2024 and the fair value is remeasured in each reporting period. During the year ended December 31, 2025, there were no changes to the equity classification. The Company will re-assess the liability classification for the remaining July 2024 Common Warrants at each period end. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the consolidated statements of operations and comprehensive loss.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prepaid and Other Current Assets</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense for the years ended December&#160;31, 2025 and 2024 was $0.2 million and $0.3 million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other long-term prepaid assets</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $0.8 million and $0.6 million as of December&#160;31, 2025 and December&#160;31, 2024, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Expenses</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued professional fees</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued research and development</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,427&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">8,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Grant<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research Grant</a></td>
<td class="text">Research Grant<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $2.8 million award, $2.3&#160;million was received in September 2022 and the remaining $0.5&#160;million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $0.5&#160;million payment was applied as a credit to the second grant agreement described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $3.1 million, with such amount received net of the $0.5&#160;million credit, described above. During the year ended December&#160;31, 2024, the Company incurred $2.2 million in research and development expenses related to this project and completed the development efforts defined in the second grant agreement in the third quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $1.5 million. During the years ended December&#160;31, 2025 and 2024, the Company incurred $0.8&#160;million and $0.3&#160;million, respectively, in research and development expenses related to this project, all of which were reimbursed from available grant funds. The third grant agreement activities were completed in the second quarter of 2025. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The award money for the three agreements was recorded as contra-expense to offset the research and development costs incurred. Following completion of the third grant agreement with GI Research Foundation, during 2025, the remaining $0.4&#160;million of the grant funds were recognized as grant income, as there were no further conditions to be met.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock and Stockholders' Equity</a></td>
<td class="text">Common Stock and Stockholders' Equity<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes 300,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2024, the Company issued and sold a total of 650,179 shares of common stock under the 2022 ATM Program for aggregate net proceeds of $5.4 million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2025, the Company issued and sold 1,717,507 shares of common stock for net proceeds of $16.2 million under the 2024 ATM Program. During the year ended December&#160;31, 2024, the Company issued and sold 53,795 shares of common stock for net proceeds of $0.3 million under the 2024 ATM Program.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company closed the March 2024 Offering, which resulted in net proceeds of $6.0&#160;million. The March 2024 Offering providing for the issuance and sale by the Company to GKCC of the March 2024 Pre-Funded Warrants to purchase up to 1,032,702 shares of common stock, at a purchase price of $5.81. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds to the Company from the March 2024 Offering were $6.0&#160;million. Refer to Note 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offerings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed the July 2024 Public Offering, which resulted in gross proceeds of $11.5 million, with net proceeds of $10.9&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The July 2024 Public Offering consisted of (i) 500,000 July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants exercisable for 1,800,000 shares of common stock, and (iii) the July 2024 Common Warrants to purchase up to 2,300,000 shares of common stock. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $5.00. Each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $4.99, which represented the combined purchase price less the $0.01 per share exercise price for each such July 2024 Pre-Funded Warrant. The July 2024 Common Warrants have an exercise price of $5.00 per share, are immediately exercisable, and will expire five years from the issuance date. Refer to Notes 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell 1,261,830 January 2025 Shares and the January 2025 Common Warrants to purchase up to an aggregate of 1,261,830 shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire 5 years from the issuance date. The January 2025 Offering resulted in gross proceeds of $10.0&#160;million, with net proceeds of $9.2&#160;million to the Company after deducting the placement agent&#8217;s fees and related offering expenses. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. Refer to Note 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC pursuant to which the Company issued the 3% Convertible Note in the principal amount of $20.0 million. Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#8217;s common stock. In March 2025, the Company issued 3,500,573 shares of common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. Refer to Note 11 for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2012 Plan and 2022 Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As a result of the Merger, the Company assumed the Former Elicio 2012 Equity Incentive Plan and the Former Elicio 2022 Equity Incentive Plan (collectively, the &#8220;Former Elicio Plans&#8221;) and all stock options issued and outstanding under the Former Elicio Plans. Each outstanding and unexercised option to purchase Former Elicio&#8217;s common stock was adjusted with such Company stock options henceforth representing the right to purchase a number of shares of the Company&#8217;s common stock based on the exchange ratio established for the Merger. Any restriction on the exercise of any Former Elicio stock options assumed by the Company continued in full force and effect and the term, exercisability, vesting schedule, accelerated vesting provisions, and any other provisions of such Former Elicio stock options otherwise remained unchanged. As of December&#160;31, 2025, 177,671 shares remain available for future grants under the Former Elicio 2022 Equity Incentive Plan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2015 Plan </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2019, Angion&#8217;s board of directors approved an Amended and Restated 2015 Equity Incentive Plan (the &#8220;2015 Plan&#8221;) permitting the granting of incentive stock options, non-statutory stock options, restricted stock and other stock-based awards. Following the effectiveness of the 2021 Incentive Award Plan (&#8220;2021 Plan&#8221;), Angion ceased making grants under the 2015 Plan. However, the 2015 Plan continues to govern the terms and conditions of the outstanding awards granted under it. Shares of common stock subject to awards granted under the 2015 Plan that cease to be subject to such awards by forfeiture or otherwise after the termination of the 2015 Plan will be available for issuance under the 2021 Plan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2021 Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, Angion&#8217;s board of directors approved the 2021 Plan which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards to employees, directors, officers and consultants. The 2021 Plan provides that the number of shares reserved and available for issuance will automatically increase each January 1st by the lesser of 5% of the Company&#8217;s common stock outstanding on the immediately preceding December 31st, or such lesser number of shares as determined by the Company&#8217;s board of directors. The Company has a policy of issuing shares out of respective plan pools (to the extent available) to satisfy share option exercises and restricted stock vesting. As of December&#160;31, 2025, 460,025 shares remain available for future grants under the 2021 Plan. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2024 Inducement Incentive Award Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In February 2024, the Company&#8217;s board of directors approved the Company&#8217;s 2024 Inducement Incentive Award Plan (the &#8220;2024 Inducement Plan&#8221;) which permits the granting of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock-based awards to employees as an inducement pursuant to Listing Rule 5635(c)(4) of the corporate governance rules of Nasdaq. The 2024 Inducement Plan originally provided for an overall share limit of 500,000 shares of the Company&#8217;s common stock. As of December&#160;31, 2025, 10,940 shares remain available for future grants under the 2024 Inducement Plan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Options</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,890,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">15.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">821,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(32,515)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(58,406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,621,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">13.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Options vested and exercisable</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">1,416,162&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">19.19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3,127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. The weighted average grant date fair value per share for the stock option grants during the year ended December&#160;31, 2025 was $7.63. As of December&#160;31, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $5.3 million, which the Company expects to recognize over a weighted-average period of approximately 2.8 years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-based Compensation Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the consolidated statements of operations and comprehensive loss (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,697&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,452&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#8217;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.7% - 4.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.4% - 4.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">100.0% - 110.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">79.5% - 107.8%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.0 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.0  - 6.1</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the consolidated financial statements for the year ended December&#160;31, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Stock Purchase Plan</span></div>In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#8217;s initial public offering. The offering period and purchase period was determined by Angion&#8217;s board of directors. No offering periods or purchasing periods were active as of December&#160;31, 2025. As of December&#160;31, 2025, 275,309 shares remained available for purchase under the ESPP, and no offerings w<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingAbstract', window );"><strong>Warrants and Rights Outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with ASC Topic 815, certain of the Company&#8217;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the March 2024 Pre-Funded Warrants were liability classified, with a fair value of $6.6&#160;million, as determined by the Black-Scholes option pricing model as of the grant date. The Company recorded the $0.6&#160;million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024. The Company subsequently remeasured the fair value of these warrant liabilities on a quarterly basis. As a result of the receipt of Stockholder Approval in November 2024, as discussed in Note 3, the March 2024 Pre-Funded Warrants were classified as equity at December 31, 2025 and 2024. During the year ended December 31, 2024, the Company recognized a gain of $1.3 million in fair value remeasurement of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 3 and 6, in July 2024, the Company closed its July 2024 Public Offering consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the July 2024 Pre-Funded Warrants and July 2024 Common Warrants were liability classified, with a fair value of $6.8&#160;million and $6.5&#160;million, respectively, measured using the Black-Scholes option pricing model as of the grant date. The Company recorded the $2.9&#160;million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As a result of the receipt of Stockholder Approval in November 2024, certain July 2024 Pre-Funded Warrants and July 2024 Common Warrants held by GKCC and its affiliates were classified as equity. The remaining liability classified July 2024 Pre-Funded Warrants were exercised in the fourth quarter of 2024, leaving no remaining liability classified July 2024 Pre-Funded Warrants outstanding as of December 31, 2024. The remaining July 2024 Common Warrants not held by GKCC and its affiliates remain liability classified as of December 31, 2024 and the fair value is remeasured in each reporting period. During the year ended December 31, 2025, there were no changes to the equity classification. For the years ended December&#160;31, 2025 and 2024, the Company recognized a loss of $0 and $2.4 million in fair value remeasurement of the July 2024 Pre-Funded Warrants, respectively. For the years ended December&#160;31, 2025 and 2024, the Company recognized a loss of $1.9 million and $2.8 million in fair value remeasurement of the July 2024 Common Warrants, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell 1,261,830 January 2025 Shares and the January 2025 Common Warrants to purchase up to an aggregate of 1,261,830 shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $9.7&#160;million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $0.6&#160;million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables summarize information regarding the warrants outstanding and warrant activity at December&#160;31, 2025:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Number of Warrants Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">144,814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">53.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Angion Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3,950</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">76.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">2.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,032,702</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,600,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">441,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,600,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">January 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,261,830</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">June 2025 Common Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">103,225</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total Warrants Outstanding at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,188,021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3.7</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of December 31, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> During the fourth quarter of 2024, the Company reclassified the March 2024 Pre-Funded Warrants, the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants held by GKCC and its affiliates from liability to equity classification. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5,081,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Issued</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,365,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(258,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding at December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,188,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.7</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Legal Proceedings </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company may be exposed to litigation in connection with its products under development and operations. The Company&#8217;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In January 2016, Former Elicio entered into a license agreement to license certain intellectual property rights from MIT, which agreement has been amended from time to time to add additional intellectual property rights to the Company&#8217;s license and to adjust fees and milestones and diligence requirements. The Company is required to pay certain license maintenance fees and certain milestone payments upon the occurrence of specific development and commercialization achievements during the term of the agreement, including those related to the making of certain regulatory filings, the initiation of certain clinical trials and the achievement of certain product sales thresholds, and royalty payments based on net sales on certain products over the term of the agreement, with royalty payments commencing in the calendar year of commercialization of such products. Royalty rates range from 0.25% - 2.00%, depending on whether commercial sales relate to a product that is covered by patents under which Elicio licenses rights from MIT or a product that could not have been identified, selected, or determined to have biological activity but for the use or modification of a product covered by the patents, and also on the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions in the agreement. During the year ended December&#160;31, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $0.4&#160;million. No such expenses were recorded during the year ended December&#160;31, 2025. No commercialization royalties have been achieved to date. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company would be required to pay a total of up to $26.2&#160;million if all remaining possible clinical development and commercial sales milestones are achieved. The clinical development milestone payments will be recorded when each milestone is achieved, and the commercial sales milestone payments and royalties will be recorded when the sales occur.</span></div>For the years ended December&#160;31, 2025 and 2024, the Company recorded an annual license maintenance fee payment of $0.1&#160;million. Future annual license maintenance fee payments will continue to be $0.1&#160;million and are due until the termination of the agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#8220;Boston Lease&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $11.1&#160;million in the aggregate. As a result, at the commencement of the Boston Lease, the Company recognized a ROU lease asset of $8.0&#160;million with a corresponding lease liability of $8.0&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $0.7&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the consolidated balance sheets as of December&#160;31, 2025 and 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately 6,157 square feet for approximately $0.2&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Lease expense for all leases for the years ended December&#160;31, 2025 and 2024 was $1.4&#160;million and $1.5&#160;million, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,040&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less present value discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(935)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC pursuant to which the Company issued the 3% Convertible Note in the principal amount of $20.0 million. Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815, and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the years ended December&#160;31, 2025 and 2024, the Company recorded an immaterial amount and $0.1 million of other expense related to the accretion of the discount of Convertible Note debt issuance costs, respectively. During the years ended December&#160;31, 2025 and 2024, the Company recorded accrued interest expense of $0.1 million and $0.2 million related to the interest due on the Convertible Note but not yet payable, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. In March 2025, the Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million to GKCC. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus 5.00%, provided that the maximum interest rate shall not exceed 12.5% per annum, with an initial interest payment date of July 1, 2026. As of December&#160;31, 2025, the interest rate was 12.5% per annum. The first 24 months of the June 2025 Promissory Note is an interest only period, with payments towards the principal commencing on July 1, 2027 as shown in the below future principal payments table. The Company may prepay the June 2025 Promissory Note in full at any time, but the payment must include the principal, all accrued unpaid interest, and a prepayment fee in one aggregate payment. If the prepayment occurs during the first, second, or third year of the June 2025 Promissory Note, the prepayment fee will be equal to the outstanding principal balance prepaid multiplied by 3%, 2%, or 1%, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">respectively. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default. As of December&#160;31, 2025, the Company was in compliance with all covenants.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of 49.99% of the number of shares of the Company&#8217;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrants, as determined by the Black-Scholes option pricing model, was $0.6&#160;million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of $9.9&#160;million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of December&#160;31, 2025, the net carrying value of the June 2025 Promissory Note was $9.4 million, which is net of the debt discount of $0.6 million. During the year ended December&#160;31, 2025, the Company recognized $0.2 million in accretion of the debt discount and $0.7 million in accrued interest.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, the future principal payments for the June 2025 Promissory Note were as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2026</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Total principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">10,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Income (loss) before taxes related to the Company&#8217;s United States and foreign operations for the years ended December&#160;31, 2025 and 2024 consists of the following (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(39,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(51,728)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(39,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(51,898)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company had no income tax expense or benefit due to operating losses incurred for the years ended December&#160;31, 2025 and 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Beginning with the year ended December 31, 2025, the Company adopted ASU 2023-09 on a prospective basis. See Note 2</span><span style="color:#000000;font-family:'MS Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">for additional details. A reconciliation between the federal statutory income tax amount and rate to the Company's actual effective amount and rate pursuant to the disclosure requirements of ASU 2023-09 for the year ended December&#160;31, 2025 is as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended Year Ended December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">US federal statutory income tax rate</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(8,310)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Domestic state and local taxes, net of federal effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign tax effects</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Tax credits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Nontaxable or nondeductible items:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Nondeductible stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Other nontaxable and nondeductible items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">8,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(21.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes and effective income tax rate</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A reconciliation between the federal statutory income tax rate and the Company's effective income tax rate prior to the adoption of ASU 2023-09 for the year ended December 31, 2024 is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">State tax, net of federal benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Federal research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">State research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(19.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of the Company's net deferred tax assets at December&#160;31, 2025 and 2024 is as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">77,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">64,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">16,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">15,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Capitalized research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">13,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">17,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">110,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">100,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: Deferred tax asset valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(110,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(100,117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Net operating losses (&#8220;NOLs&#8221;) generated in tax years ended December 31, 2017 and prior can be carried forward 20 years under the Internal Revenue Code (&#8220;IRC&#8221;). Use of NOLs arising in tax years ended after December 31, 2017 are limited to 80% of taxable income in any one tax year, and are carried forward indefinitely. At December&#160;31, 2025, Elicio has federal NOLs of $311.4 million, of which $19.1 million will start to expire in 2032 and $292.3 million can be carried forward indefinitely, and state NOLs of $179.5 million that will start to expire in 2032. At December&#160;31, 2025, Elicio has $14.1 million and $2.9 million of federal and state research and development credit carryforwards, respectively, that start to expire in 2027. At December&#160;31, 2025, Elicio has $1.4 million and $0.2 million of Australian NOLs and research and development credit carryforwards, respectively, that can be carried forward indefinitely.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As the Company has not yet achieved profitable operations, management believes the tax benefits as of December&#160;31, 2025 did not satisfy the realization criteria set forth in ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, and, therefore, has recorded a full valuation allowance for the entire deferred tax asset. The valuation allowance increased in 2025 by $10.2 million primarily due to current year operating losses and research and development credits generated.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ownership changes, as defined in the IRC, may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income pursuant to IRC Section 382 or similar provisions. Subsequent ownership changes could further affect the limitation in future years. The Company has not completed a study to assess whether a change in control has occurred or whether there have been multiple changes in control since the Company&#8217;s formation due to the significant complexity and cost associated with such study and because there could be additional changes in control in the future. As a result, the Company is not able to estimate the effect of the change in control, if any, on the Company&#8217;s ability to utilize NOL and research and development credit carryforwards in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company files tax returns in the United States, Australia, California, Connecticut, Florida, Massachusetts, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New York, North Carolina, Pennsylvania, Tennessee, and Utah. The federal and state tax returns for the periods ended December 31, 2022, 2023, and 2024 remain open to examination by the major taxing jurisdictions to which the Company is subject, as carryforward attributes generated in years past may still be adjusted upon examination by the Internal Revenue Service (&#8220;IRS&#8221;) or other authorities if they have or will be used in a future period. To its knowledge, the Company is not currently under examination by the IRS or any other jurisdictions for any tax years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A reconciliation of the unrecognized tax benefits for the years ended December&#160;31, 2025 and 2024 is as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Gross unrecognized tax benefit, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Increase (decrease) recognized in the income statement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Gross unrecognized tax benefit, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, the Company had $4.1 million of unrecognized tax benefits related to prior research tax credits that may not be substantiated upon audit. If recognized, the Company anticipates that its effective tax rate would not be affected for the years ended December&#160;31, 2025 and 2024. The Company has elected to recognize interest and penalties related to income tax matters as a component of income tax expense, of which no interest or penalties were recorded for the years ended December&#160;31, 2025 and 2024.</span></div>On July 4, 2025, H.R. 1 (the &#8220;Act&#8221;), commonly referred to as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act has multiple effective dates, with certain provisions effective in 2025 and others to be implemented through 2027. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The provisions impacting the Company have been reflected in the financial statements for the year ended December&#160;31, 2025, and did not have a material impact as the Company has a valuation allowance against its net deferred tax assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text">Employee Benefit Plan<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Benefit Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company provides a retirement savings plan through the Elicio Therapeutics, Inc. 401(k) Plan (the &#8220;Elicio Retirement Plan&#8221;), subject to certain limitations. As allowed under Section 401(k) of the IRC, the Elicio Retirement Plan allows tax deferred salary deductions for eligible employees. An employee&#8217;s interest in his or her salary deferral contributions is 100% vested when contributed.</span></div>Pursuant to the Merger Agreement, the Company assumed the retirement savings plan sponsored by Angion (the &#8220;Angion Retirement Plan&#8221;). The Angion Retirement Plan is intended to qualify for favorable tax treatment under Section 401(a) of the IRC, and contains a cash or deferred feature that is intended to meet the requirements of Section 401(k) of the IRC. Currently, no employees are contributing under the Angion Retirement Plan.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715-70/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the years ended December&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Numerator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(39,571)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(51,898)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares used in computing net loss per share, basic and diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">15,312,751</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,202,996</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(2.58)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(4.25)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">2,621,203</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,890,932</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of common warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3,555,319</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,448,764</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,176,522</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4,339,696</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement and Subscription Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the March 2024 Offering were approximately $6.0&#160;million. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">July 2024 Public Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As part of the July 2024 Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#8217;s board of directors, and Jay Venkatesan, a member of the Company&#8217;s board of directors, and trusts affiliated with Jay Venkatesan, purchased 1,600,000 July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants and 200,000 July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants, respectively, with such July 2024 Pre-Funded Warrants and July 2024 Common Warrants subject to the terms and conditions of the July 2024 Pre-Funded Warrants and July 2024 Common Warrants.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the July 2024 Public Offering were approximately $10.9&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. The Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million. The Company received net proceeds of approximately $9.9&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has one reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#8217;s CODM, its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the consolidated statements of cash flows. Other segment items include interest income, interest expense, grant income, and change in the fair value of warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the consolidated statements of cash flows. The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Clinical trial expenses </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">9,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">15,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">8,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">8,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">1,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">7,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">7,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Other segment items </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">39,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">51,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">25,862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">28,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has completed an evaluation of all subsequent events after the consolidated balance sheet date as of December&#160;31, 2025 through the date these consolidated financial statements were issued to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements as of December&#160;31, 2025, and events which occurred subsequently but were not recognized in the consolidated financial statements. Non-recognizable subsequent events are summarized below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2024 ATM Program</span></div>After the year ended December&#160;31, 2025 through March&#160;11, 2026, the Company issued and sold 668,504 shares of common stock for net proceeds of $6.3&#160;million under the 2024 ATM Program.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We recognize the critical importance of protecting the confidentiality, integrity and availability of our business operations and systems. With this in mind, we have implemented and maintain ongoing cybersecurity risk management practices, in accordance with our risk profile and business size, under the oversight of our Audit Committee that are designed to identify, assess, and mitigate cybersecurity risk. Our cybersecurity program is informed by the National Institute of Standards and Technology Cybersecurity Framework, and other applicable industry standards. We engage third-party service providers and vendors to assist us in managing our cybersecurity programs and information technology systems.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Cybersecurity Risk Management and Strategy; Effect of Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To identify and assess material risks from cybersecurity threats, we maintain a cybersecurity program to develop and implement effective systems and prepare for information security risks. We consider risks from cybersecurity threats alongside other company risks as part of our overall risk assessment process. We employ a range of tools and services supported by our third-party service providers, including regular network and endpoint monitoring to inform our risk identification and assessment, as well as undertaking the following activities: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">monitor emerging data protection laws and implement changes to our processes that are designed to comply with such laws;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">through our policies, practices and contracts (as applicable), require employees, as well as third parties that provide services on our behalf, to treat confidential information and data with care;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">employ technical safeguards that are designed to protect our information systems from cybersecurity threats, including firewalls, device encryption, multi-factor authentication, advanced threat protection for emails, anti-virus and anti-malware functionality and access controls, which are evaluated and improved from time to time;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">employ multiple backup systems for our data stored on our servers or other information systems with backup data stored in secure, offsite locations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">perform annual phishing tests with employees in an effort to deter and detect cyber threats; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">hold and maintain third-party cyber-liability insurance coverage, covering security and privacy matters, commensurate with industry standards for a company of our size and stage.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We face risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. During the reporting period, we have not identified any risks from cybersecurity threats, including as a result of previous cyber security incidents, that we believe have materially affected, or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition. For more information, see the section in our Risk Factors in this Annual Report on Form 10-K under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Our internal information technology systems, or those of our vendors, collaborators or other contractors or consultants, may fail or suffer cybersecurity incidents, loss of data, and other disruptions, which could result in a material disruption of our product development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; which disclosures are incorporated by reference herein.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">We recognize the critical importance of protecting the confidentiality, integrity and availability of our business operations and systems. With this in mind, we have implemented and maintain ongoing cybersecurity risk management practices, in accordance with our risk profile and business size, under the oversight of our Audit Committee that are designed to identify, assess, and mitigate cybersecurity risk. Our cybersecurity program is informed by the National Institute of Standards and Technology Cybersecurity Framework, and other applicable industry standards. We engage third-party service providers and vendors to assist us in managing our cybersecurity programs and information technology systems.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our board of directors considers cybersecurity risks as part of its risk oversight function and has delegated the oversight of cybersecurity and other information technology risks to our Audit Committee.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our General Counsel who manages our contracted third-party managed security service provider. Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above. Our legal, finance, and operations teams oversee and review any reports of cybersecurity risks or breaches provided by our third-party managed security service provider. Additionally, our legal, finance, and operations teams review and assess potential </span></div>improvements to our cybersecurity policies and procedures with input from third-party vendors and professional services firms, as appropriate. As discussed above, the General Counsel reports to the Audit Committee of our board of directors about cybersecurity related matters, periodically.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our board of directors considers cybersecurity risks as part of its risk oversight function and has delegated the oversight of cybersecurity and other information technology risks to our Audit Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our General Counsel who manages our contracted third-party managed security service provider. Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above. Our legal, finance, and operations teams oversee and review any reports of cybersecurity risks or breaches provided by our third-party managed security service provider. Additionally, our legal, finance, and operations teams review and assess potential </span></div>improvements to our cybersecurity policies and procedures with input from third-party vendors and professional services firms, as appropriate. As discussed above, the General Counsel reports to the Audit Committee of our board of directors about cybersecurity related matters, periodically.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our General Counsel who manages our contracted third-party managed security service provider.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our board of directors considers cybersecurity risks as part of its risk oversight function and has delegated the oversight of cybersecurity and other information technology risks to our Audit Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our General Counsel who manages our contracted third-party managed security service provider. Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above. Our legal, finance, and operations teams oversee and review any reports of cybersecurity risks or breaches provided by our third-party managed security service provider. Additionally, our legal, finance, and operations teams review and assess potential </span></div>improvements to our cybersecurity policies and procedures with input from third-party vendors and professional services firms, as appropriate. As discussed above, the General Counsel reports to the Audit Committee of our board of directors about cybersecurity related matters, periodically.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Segments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The Chief Executive Officer serves as the CODM. The Company operates as a single operating and reportable segment, reflecting the integrated nature of the Company&#8217;s business.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div>The Company&#8217;s management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. Significant estimates reflected in these consolidated financial statements include but are not limited to, the accrual of research and development expenses, the valuation of stock-based awards, the valuation of warrants, the valuation of embedded derivatives and convertible debt, and the operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liability.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation and Transactions</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Foreign Currency Translation and Transactions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Australian Dollar (&#8220;AUD&#8221;) is the functional currency for Elicio Pty. Accordingly, nonmonetary assets and liabilities originally acquired or assumed in other currencies are recorded in AUD at the date they were acquired or assumed. As part of the consolidation process, the Elicio Pty results are translated from AUD into the reporting currency of US Dollars using average rates for profit and loss transactions and applicable spot rates for period-end balances. The effect of translating the Company&#8217;s functional currency into the Company&#8217;s reporting currency is reported separately in Accumulated Other Comprehensive Loss.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Off-Balance Sheet Risk</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Concentrations of Credit Risk and Off-Balance Sheet Risk</span></div>Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and restricted cash. At times, cash balances deposited at major financial institutions exceed the federally insured limit. The Company regularly monitors the financial condition of the institutions in which it has depository accounts and believes the risk of loss is minimal. The Company has not experienced any losses in such accounts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents are comprised of deposits at major financial banking institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. As of December&#160;31, 2025 and 2024, the Company&#8217;s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Restricted Cash</span></div>Restricted cash consists of cash securing a collateral letter of credit issued in connection with the Company&#8217;s facility operating lease and unused funds received from the Company&#8217;s research grant.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Fair Value Measurement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company follows the guidance prescribed by ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, which establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The standard provides a consistent definition of fair value that focuses on an exit price which is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a three-level hierarchy for fair value measurements based on the nature of inputs used in the valuation of an asset or liability as of the measurement date.</span></div><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 1:&#160;&#160;&#160;&#160;Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at measurement. </span></div><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 2:&#160;&#160;&#160;&#160;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. </span></div><div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Level 3:&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The carrying amounts of financial instruments reflected in the consolidated balance sheets for cash and cash equivalents, non-current restricted cash, accounts payable, and accrued expenses approximate their respective fair values because of the short-term maturity of those financial assets and liabilities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of the asset. Upon sale or retirement, the cost and accumulated depreciation are eliminated from their respective accounts, and the resulting gain or loss is recorded in the consolidated statement of operations and comprehensive loss. Repair and maintenance expenditures are expensed as incurred. Construction in process is not depreciated until the asset is placed into service.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:67.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Asset Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Estimated Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shorter of useful life or lease term</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Impairment of Long-Lived Assets</span></div>The Company evaluates its long-lived assets, which consist primarily of property and equipment, and ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Issuance Costs</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Debt Issuance Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">These deferred costs will be amortized and recognized as additional interest expense over the term of the Company&#8217;s Convertible Note (as defined below) using the effective interest method. The Company will present debt issuance costs as a direct deduction from the Convertible Note (as defined below) liability on its financial statements. See Note 11 for further discussion of the Company&#8217;s accounting for its outstanding debt and related issuance costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for income taxes in accordance with ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. Deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates and laws in effect in the years in which the differences are expected to reverse. A valuation allowance is provided if, based upon the weighted available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company is required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, the position will be sustained upon examination. As of December&#160;31, 2025, there were no accruals for interest or penalties related to uncertain tax provisions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development and Grant Income</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Research and Development</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Research and development costs are charged to expense as incurred and consist of expenses incurred in performing research and development activities, including salaries and benefits, materials and supplies, preclinical expenses, stock-based compensation expense, depreciation of equipment, contract services, and other outside expenses. The Company accrues for costs incurred by external service providers, based on estimates of services performed and costs. The Company expenses all </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by the Company&#8217;s vendors and service providers. Based on the timing of payments to service providers, the Company may also record prepaid expenses for those service providers that will be recognized as expenses in future periods as the related services are rendered. Research and development costs may be offset by research grants and research and development refundable tax rebates received by Elicio Pty.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Grant Income</span></div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Not-for-Profit Entities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, and that the grants are not within the scope of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue from Contracts with Customers</span>, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 842&#8221;) requires a lessee to recognize a ROU asset and corresponding lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the consolidated statements of operations and comprehensive loss as well as the reduction of the ROU asset. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on specific facts and circumstances, the existence of an identified asset(s), if any, and the Company&#8217;s control over the use of the identified asset(s), if applicable. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected lease term. When the interest rate implicit in lease contracts is not readily determinable, the Company will utilize its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company has elected to combine lease and non-lease components as a single component. Operating leases are recognized on the consolidated balance sheet as ROU lease assets, current lease liabilities and non-current lease liabilities. Fixed rents are included in the calculation of the lease balances, while variable costs paid for certain operating and pass-through costs are excluded. Lease expense is recognized over the expected term on a straight-line basis.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company issues stock-based awards to employees and non-employees, generally in the form of stock options. The Company accounts for stock-based awards in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, which requires all stock-based payments to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period. The Company has elected to account for option forfeitures as they occur. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses the Black-Scholes option-pricing model (&#8220;Black-Scholes&#8221;) to determine the fair value of options granted, which uses as inputs the fair value of the Company&#8217;s common stock, assumptions the Company makes for the volatility of its common stock, the expected term of its stock options, the risk-free interest rate for a period that approximates the expected term of its stock options and its expected dividend yield. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Compensation cost of awards that contain a performance condition is recognized when success is considered probable during the performance period. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the Merger, there was no public market for Former Elicio&#8217;s common stock. The estimated fair value of the Company&#8217;s common stock underlying Former Elicio&#8217;s stock-based awards was determined by Former Elicio&#8217;s board of directors as of the grant date of each option grant. To determine the fair value of Former Elicio&#8217;s common stock underlying option grants, Former Elicio&#8217;s board of directors considered, among other things, input from management and valuations of Former Elicio's common stock prepared by third-party valuation firms and performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants' Accounting and Valuation Guide, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Valuation of Privately-Held-Company Equity Securities Issued as Compensation</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">. Following the Merger, the fair value of the Company&#8217;s common stock is based on the closing stock price on the date of grant as reported on the Nasdaq Capital Market.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Warrants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s common stock warrants are evaluated pursuant to ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 480&#8221;), and ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 815&#8221;). The Company classifies its freestanding warrants as (i) </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">liabilities, if the warrant terms allow settlement of the warrant exercise in cash, or (ii) equity, if the warrant terms only allow settlement in shares of common stock. Please refer to Note 8 below for the application to the Company&#8217;s pre-funded and common warrants.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Net Loss Per Share</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic net loss per share of the Company&#8217;s common stock is computed by dividing net loss attributable to the Company&#8217;s common stockholders by the weighted average number of shares of the Company&#8217;s common stock and pre-funded warrants outstanding for the period. Pre-funded warrants are considered outstanding for the purposes of computing basic and diluted net loss per share because shares may be issued for little or no additional consideration and are fully vested and exercisable after the original issuance date of the pre-funded warrants. Diluted net loss per share excludes the potential impact of the Company&#8217;s common stock options, warrants and unvested shares of restricted stock because their effect would be anti-dilutive due to the Company's net loss. Since the Company had net losses for the years ended December&#160;31, 2025 and 2024, basic and diluted net loss per common share are the same.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Other Comprehensive Gain (Loss)</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other Comprehensive Gain (Loss)</span></div>Other comprehensive gain (loss) is defined as a change in equity during a period from foreign exchange transactions and other events and circumstances from non-owner sources.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards During the Period and Recently Issued Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Adopted Accounting Standards During the Period</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2023-09&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the new guidance, public business entities (&#8220;PBEs&#8221;) are required to disclose an annual tabular effective tax rate reconciliation using both reporting currency amounts and percentages, disaggregated into specified categories as well as the amount of income taxes paid, disaggregated by federal, state and foreign jurisdictions. ASU No. 2023-09 is effective for annual periods beginning after December 15, 2024 and may be applied prospectively or retrospectively. The Company adopted ASU No. 2023-09 on a prospective basis for the year ended December 31, 2025. The Company&#8217;s adoption of ASU No. 2023-09 did not have a material impact on its consolidated financial statements. The additional required disclosures have been included in Note 12.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB finalized ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2023-07&#8221;). ASU 2023-07 requires enhanced disclosures about reportable segments and the CODM. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-07 on January 1, 2024. There was no impact on the Company's reportable segments identified and additional required disclosures have been included in Note 16.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2024-04&#8221;). ASU 2024-04 clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact the adoption of ASU 2024-04 will have on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479693/815-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4F<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:67.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Asset Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Estimated Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shorter of useful life or lease term</span></td></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Money market funds </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Warrant liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">___________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liabilities (in thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrant liabilities was estimated using the following assumptions:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">76.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">76.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Contractual term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Volatility (annual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">67.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text">Prepaid and other current assets consisted of the following (in thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid insurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:67.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Asset Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Estimated Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shorter of useful life or lease term</span></td></tr></table></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">295&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued professional fees</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued research and development</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,427&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">8,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,890,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">15.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">821,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(32,515)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(58,406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,621,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">13.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Options vested and exercisable</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">1,416,162&#160;</span></td><td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">19.19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3,127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Components of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the consolidated statements of operations and comprehensive loss (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,697&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,452&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.7% - 4.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.4% - 4.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">100.0% - 110.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">79.5% - 107.8%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.0 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.0  - 6.1</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingAbstract', window );"><strong>Warrants and Rights Outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Outstanding Warrants</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following tables summarize information regarding the warrants outstanding and warrant activity at December&#160;31, 2025:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Number of Warrants Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">144,814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">53.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Angion Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3,950</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">76.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">2.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,032,702</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,600,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">441,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">July 2024 Common Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,600,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">January 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,261,830</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">June 2025 Common Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">103,225</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total Warrants Outstanding at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,188,021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3.7</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of December 31, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"> During the fourth quarter of 2024, the Company reclassified the March 2024 Pre-Funded Warrants, the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants held by GKCC and its affiliates from liability to equity classification. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5,081,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Issued</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,365,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(258,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Outstanding at December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,188,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.7</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock', window );">Schedule Of Quantitative Information On Operating Leases</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,040&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less present value discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(935)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">5,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,011)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Quantitative Information On Operating Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Principal Payments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As of December&#160;31, 2025, the future principal payments for the June 2025 Promissory Note were as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2026</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Total principal amount</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">10,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Income (loss) before taxes related to the Company&#8217;s United States and foreign operations for the years ended December&#160;31, 2025 and 2024 consists of the following (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(39,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(51,728)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(39,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(51,898)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">A reconciliation between the federal statutory income tax amount and rate to the Company's actual effective amount and rate pursuant to the disclosure requirements of ASU 2023-09 for the year ended December&#160;31, 2025 is as follows (in thousands):<div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended Year Ended December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">US federal statutory income tax rate</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(8,310)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Domestic state and local taxes, net of federal effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Foreign tax effects</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Tax credits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Nontaxable or nondeductible items:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Nondeductible stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Other nontaxable and nondeductible items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">8,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(21.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes and effective income tax rate</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A reconciliation between the federal statutory income tax rate and the Company's effective income tax rate prior to the adoption of ASU 2023-09 for the year ended December 31, 2024 is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">State tax, net of federal benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Federal research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">State research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(19.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">0.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of the Company's net deferred tax assets at December&#160;31, 2025 and 2024 is as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">77,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">64,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Research and development tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">16,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">15,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Capitalized research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">13,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">17,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(1,470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">110,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">100,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Less: Deferred tax asset valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(110,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(100,117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">A reconciliation of the unrecognized tax benefits for the years ended December&#160;31, 2025 and 2024 is as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Gross unrecognized tax benefit, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Increase (decrease) recognized in the income statement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Gross unrecognized tax benefit, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Net Loss Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the years ended December&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Numerator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(39,571)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">(51,898)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares used in computing net loss per share, basic and diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">15,312,751</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">12,202,996</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(2.58)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(4.25)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share</a></td>
<td class="text">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">2,621,203</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">1,890,932</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of common warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">3,555,319</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">2,448,764</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">6,176,522</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%">4,339,696</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Clinical trial expenses </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">9,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">15,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">8,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">8,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">1,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">4,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">5,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">3,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">7,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">7,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Other segment items </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">39,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">51,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">25,862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">28,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business and Financial Condition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 233,672,000<span></span>
</td>
<td class="nump">$ 233,672,000<span></span>
</td>
<td class="nump">$ 194,101,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,244,000<span></span>
</td>
<td class="nump">$ 4,555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,143,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,563,000<span></span>
</td>
<td class="nump">$ 18,563,000<span></span>
</td>
<td class="nump">$ 17,618,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember', window );">January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember', window );">Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember', window );">At-The-Market Equity Offering Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member', window );">At-The-Market Equity Offering Sales Agreement 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member', window );">At-The-Market Equity Offering Sales Agreement 2022 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember', window );">2024 Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member', window );">At-The-Market Equity Offering Sales Agreement 2024 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,717,507<span></span>
</td>
<td class="nump">53,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Pre-Funded Warrant | March 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,032,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember', window );">March Subscription Agreement | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Share And July Common Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants and July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants and July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember', window );">January Public Offering | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SaleOfStockAggregateInitialOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Initial Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SaleOfStockAggregateInitialOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_March2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_March2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_July2024PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_July2024PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">$ 6,245<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">6,245<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">2,615<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">2,615<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">6,245<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">6,245<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">2,614<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">2,614<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Warrant Liability - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, beginning of the period</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, end of the period</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=angn_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=angn_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Weighted average strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">76.00<span></span>
</td>
<td class="nump">76.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Volatility (annual)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.676<span></span>
</td>
<td class="nump">0.749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.038<span></span>
</td>
<td class="nump">0.044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Dividend yield (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.000<span></span>
</td>
<td class="nump">0.000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=angn_MeasurementInputStrikePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=angn_MeasurementInputStrikePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockBeneficialOwnershipLimitationPercentage', window );">Sale of stock, beneficial ownership limitation, percentage</a></td>
<td class="nump">0.1999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | March Subscription Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember', window );">July Pre-Funded Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SaleOfStockBeneficialOwnershipLimitationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Beneficial Ownership Limitation, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SaleOfStockBeneficialOwnershipLimitationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_PrepaidResearchAndDevelopmentExpenses', window );">Prepaid research and development contract services</a></td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 1,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AdvancedProfessionalFees', window );">Advanced professional fees</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_OtherPrepaidExpensesAndOtherAssetsCurrent', window );">Other prepaid expenses and other current assets</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">$ 1,897<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AdvancedProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advanced Professional Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AdvancedProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_OtherPrepaidExpensesAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Prepaid Expenses And Other Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_OtherPrepaidExpensesAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_PrepaidResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Research And Development Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_PrepaidResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 2,051<span></span>
</td>
<td class="nump">$ 2,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(1,756)<span></span>
</td>
<td class="num">(1,552)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 204<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other long-term prepaid assets</a></td>
<td class="nump">$ 770<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">$ 818<span></span>
</td>
<td class="nump">$ 1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">2,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedResearchAndDevelopmentCurrent', window );">Accrued research and development</a></td>
<td class="nump">2,298<span></span>
</td>
<td class="nump">4,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedInterest', window );">Accrued interest</a></td>
<td class="nump">741<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedOtherOperatingLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 6,427<span></span>
</td>
<td class="nump">$ 8,415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedOtherOperatingLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Other Operating Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedOtherOperatingLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Grant (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 24,903<span></span>
</td>
<td class="nump">$ 33,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_NumberOfResearchGrantAgreements', window );">Number of research grant agreements | agreement</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GrantRevenueNonoperating', window );">Grant income</a></td>
<td class="nump">$ 415<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member', window );">Research Grant Agreement with GIRF Sept. 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrantReceived', window );">Grant award received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member', window );">Research Grant Agreement with GIRF July 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementCredit', window );">Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member', window );">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member', window );">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GrantRevenueNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of grant revenue, non operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GrantRevenueNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_NumberOfResearchGrantAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Research Grant Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_NumberOfResearchGrantAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementGrantReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Grant Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementGrantReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Stockholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of Convertible Note, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 19,727,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,244,000<span></span>
</td>
<td class="nump">4,555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,143,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember', window );">January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember', window );">March Subscription Agreement | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Share And July Common Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants and July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Pre-Funded Warrant | March 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,032,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants and July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember', window );">January Public Offering | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of Convertible Note, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Equity Offering Sales Agreement 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Equity Offering Sales Agreement 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,717,507<span></span>
</td>
<td class="nump">53,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_March2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_March2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation related to unvested stock option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_A2021PlanMember', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding', window );">Percentage of outstanding stock</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_A2022PlanMember', window );">2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_A2024PlanMember', window );">2024 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit', window );">Share Based Compensation Arrangement By Share Based Payment Award, Share Limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved for Future Issuance, Increase, Percentage Of Common Stock Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Share Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_A2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_A2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_A2022PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_A2022PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_A2024PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_A2024PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Share Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">1,890,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">821,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(32,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (unvested) (in shares)</a></td>
<td class="num">(58,406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">2,621,203<span></span>
</td>
<td class="nump">1,890,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options vested and exercisable (in shares)</a></td>
<td class="nump">1,416,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 15.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="nump">7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">4.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (unvested) (in dollars per share)</a></td>
<td class="nump">6.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share)</a></td>
<td class="nump">13.50<span></span>
</td>
<td class="nump">$ 15.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 19.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Option Activity, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, weighted average remaining contractual life (in years)</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and exercisable, weighted average remaining contractual life (in years)</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, total intrinsic value</a></td>
<td class="nump">$ 5,057<span></span>
</td>
<td class="nump">$ 920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options vested and exercisable, total intrinsic value</a></td>
<td class="nump">$ 3,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,697<span></span>
</td>
<td class="nump">$ 1,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,604<span></span>
</td>
<td class="nump">$ 870<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">110.40%<span></span>
</td>
<td class="nump">107.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Loss on fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,915)<span></span>
</td>
<td class="num">(3,886)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | March Subscription Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Loss on fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantExercisedFairValue', window );">Fair value of common warrants at issuance date</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Loss on fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantExercisedFairValue', window );">Fair value of common warrants at issuance date</a></td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Loss on fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,900)<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember', window );">July Pre-Funded Warrants and July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember', window );">January 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember', window );">June 2025 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants | March Subscription Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantExercisedFairValue', window );">Fair value of common warrants at issuance date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain Loss On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantExercisedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Exercised, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantExercisedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Outstanding Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">6,188,021<span></span>
</td>
<td class="nump">5,081,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_ElicioWarrantsMember', window );">Elicio Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">144,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_ElicioWarrantsMember', window );">Elicio Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 53.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_AngionWarrantsMember', window );">Angion Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">3,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_AngionWarrantsMember', window );">Angion Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 76.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,032,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July 2024 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">441,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July 2024 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantOneMember', window );">July 2024 Common Warrants One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantOneMember', window );">July 2024 Common Warrants One | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember', window );">January 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember', window );">January 2025 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025CommonWarrantsMember', window );">June 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025CommonWarrantsMember', window );">June 2025 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Weighted Average Remaining Contractual Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_ElicioWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_ElicioWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_AngionWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_AngionWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_June2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Warrants Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightRollForward', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding beginning balance (in shares) | shares</a></td>
<td class="nump">5,081,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares) | shares</a></td>
<td class="nump">1,365,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightExercisedInPeriod', window );">Exercised (in shares) | shares</a></td>
<td class="num">(258,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding ending balance (in shares) | shares</a></td>
<td class="nump">6,188,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Outstanding beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod', window );">Issued (in dollars per share) | $ / shares</a></td>
<td class="nump">7.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Outstanding ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward', window );"><strong>Weighted Average Life (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLife', window );">Outstanding beginning balance (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLife', window );">Outstanding ending balance (in years)</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightExercisedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercised In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightExercisedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant Or Right, Weighted Average Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Weighted Average Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentAndContingenciesDisclosureLineItems', window );"><strong>Commitment and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 24,903<span></span>
</td>
<td class="nump">$ 33,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentAndContingenciesDisclosureLineItems', window );"><strong>Commitment and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_RoyaltyRatePercent', window );">Royalty rates (as a percent)</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentAndContingenciesDisclosureLineItems', window );"><strong>Commitment and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_RoyaltyRatePercent', window );">Royalty rates (as a percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentAndContingenciesDisclosureLineItems', window );"><strong>Commitment and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty Expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentAndContingenciesDisclosureLineItems', window );"><strong>Commitment and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct', window );">Aggregate sales milestone payments per product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CollaborativeArrangementFutureMinimumMaintenancePayments', window );">Future minimum annual maintenance payments</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CollaborativeArrangementFutureMinimumMaintenancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Future Minimum Maintenance Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CollaborativeArrangementFutureMinimumMaintenancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CommitmentAndContingenciesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitment and Contingencies Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CommitmentAndContingenciesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_RoyaltyRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_RoyaltyRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_UniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_UniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 01, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,782<span></span>
</td>
<td class="nump">5,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,011<span></span>
</td>
<td class="nump">$ 901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSecuredLinesOfCredit', window );">Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=angn_BostonMassachusettsMember', window );">Boston, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember', window );">Newton, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in sqft) | ft&#178;</a></td>
<td class="nump">6,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_LesseeOperatingLeaseAnnualRentExpense', window );">Operating lease, payment per year</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_LesseeOperatingLeaseAnnualRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Annual Rent Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_LesseeOperatingLeaseAnnualRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSecuredLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSecuredLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=angn_BostonMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=angn_BostonMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Quantitative Information about Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="nump">$ 1,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term&#8212;operating leases (in years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate&#8212;operating leases</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2026</a></td>
<td class="nump">$ 1,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2027</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2028</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2029</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2030</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">6,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less present value discount</a></td>
<td class="num">(935)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">5,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: operating lease liability, current portion</a></td>
<td class="num">(1,011)<span></span>
</td>
<td class="num">$ (901)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent portion</a></td>
<td class="nump">$ 4,094<span></span>
</td>
<td class="nump">$ 5,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="nump">$ 9,143,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Net carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,407,000<span></span>
</td>
<td class="nump">$ 20,034,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">First year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, prepayment fee prepaid (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember', window );">Second year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, prepayment fee prepaid (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember', window );">Three Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, prepayment fee prepaid (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | GKCC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightOwnershipPercentMaximum', window );">Ownership maximum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember', window );">June 2025 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Net carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightOwnershipPercentMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Ownership Percent Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightOwnershipPercentMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 470<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=angn_GKCCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=angn_GKCCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Future Principal Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2026</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2027</a></td>
<td class="nump">5,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2028</a></td>
<td class="nump">4,215<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total principal amount</a></td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (39,476)<span></span>
</td>
<td class="num">$ (51,728)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (39,571)<span></span>
</td>
<td class="num">$ (51,898)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Amount</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">US federal statutory income tax rate</a></td>
<td class="num">$ (8,310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">Domestic state and local taxes, net of federal effect</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax effects</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="num">(1,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Nondeductible stock based compensation</a></td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount', window );">Change in fair value of warrants</a></td>
<td class="nump">402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other nontaxable and nondeductible items</a></td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="nump">8,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes and effective income tax rate</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Percent</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax effects</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Nondeductible stock based compensation</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent', window );">Change in fair value of warrants</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Other nontaxable and nondeductible items</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(21.40%)<span></span>
</td>
<td class="num">(19.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">Domestic state and local taxes, net of federal effect</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other nontaxable and nondeductible items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent', window );">Permanent differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent', window );">State research and development credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.006<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Credit, State Research And Development, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax assets (liabilities):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 77,260<span></span>
</td>
<td class="nump">$ 64,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Research and development tax credits</a></td>
<td class="nump">16,534<span></span>
</td>
<td class="nump">15,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Capitalized research and development</a></td>
<td class="nump">13,412<span></span>
</td>
<td class="nump">17,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_DeferredTaxAssetsOperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">1,301<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">3,023<span></span>
</td>
<td class="nump">2,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">ROU asset</a></td>
<td class="num">(1,218)<span></span>
</td>
<td class="num">(1,470)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_DeferredTaxAssetsNetBeforeValuationAllowance', window );">Total deferred tax assets</a></td>
<td class="nump">110,304<span></span>
</td>
<td class="nump">100,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Deferred tax asset valuation allowance</a></td>
<td class="num">(110,304)<span></span>
</td>
<td class="num">(100,117)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_DeferredTaxAssetsNetBeforeValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Net, Before Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_DeferredTaxAssetsNetBeforeValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefit, beginning of period</a></td>
<td class="nump">$ 4,141<span></span>
</td>
<td class="nump">$ 4,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Increase (decrease) recognized in the income statement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefit, end of period</a></td>
<td class="nump">$ 4,141<span></span>
</td>
<td class="nump">$ 4,141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expenses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">292,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance increase</a></td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax positions</a></td>
<td class="nump">$ 4,141,000<span></span>
</td>
<td class="nump">$ 4,141,000<span></span>
</td>
<td class="nump">$ 4,141,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, income tax penalties and interest accrued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">311,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction | Tax Year 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">19,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">179,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=angn_EmployeeBenefitPlanMember', window );">Employee Benefit Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage', window );">Employers matching contribution annual vesting (in percentage)</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employer's matching contributions to a defined contribution plan that vests in a given year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=angn_EmployeeBenefitPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=angn_EmployeeBenefitPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (39,571)<span></span>
</td>
<td class="num">$ (51,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net loss per share, basic (in shares)</a></td>
<td class="nump">15,312,751<span></span>
</td>
<td class="nump">12,202,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net loss per share, diluted (in shares)</a></td>
<td class="nump">15,312,751<span></span>
</td>
<td class="nump">12,202,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (2.58)<span></span>
</td>
<td class="num">$ (4.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (2.58)<span></span>
</td>
<td class="num">$ (4.25)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">6,176,522<span></span>
</td>
<td class="nump">4,339,696<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">2,621,203<span></span>
</td>
<td class="nump">1,890,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Shares issuable upon the exercise of common warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">3,555,319<span></span>
</td>
<td class="nump">2,448,764<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.68<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common stock warrants from March 2024 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,985,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,365,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,143,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares of common stock to purchase (up to) (in shares)</a></td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember', window );">March Subscription Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common stock warrants from March 2024 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember', window );">March Subscription Agreement | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July 2024 Public Offering | Yekaterina Chudnovsky And Jay Venkatesan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common stock warrants from March 2024 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember', window );">July 2024 Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember', window );">Purchase Of Warrants | July 2024 Public Offering | July Pre-Funded Warrants and July Common Warrants | Yekaterina Chudnovsky</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember', window );">Purchase Of Warrants | July 2024 Public Offering | July Pre-Funded Warrants and July Common Warrants | Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_July2024PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyAndJayVenkatesanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyAndJayVenkatesanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>entity</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | entity</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 24,903<span></span>
</td>
<td class="nump">$ 33,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Employee related general and administrative expenses</a></td>
<td class="nump">12,811<span></span>
</td>
<td class="nump">11,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(39,571)<span></span>
</td>
<td class="num">(51,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total segment assets</a></td>
<td class="nump">25,862<span></span>
</td>
<td class="nump">28,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecoveryOfDirectCosts', window );">Contract and grant reimbursements</a></td>
<td class="num">(754)<span></span>
</td>
<td class="num">(1,027)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Employee related general and administrative expenses</a></td>
<td class="nump">5,506<span></span>
</td>
<td class="nump">3,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Professional fees and other general and administrative expenses</a></td>
<td class="nump">7,300<span></span>
</td>
<td class="nump">7,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">1,858<span></span>
</td>
<td class="nump">6,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">39,571<span></span>
</td>
<td class="nump">51,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total segment assets</a></td>
<td class="nump">25,862<span></span>
</td>
<td class="nump">28,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_ClinicalTrailMember', window );">Clinical trial expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">9,602<span></span>
</td>
<td class="nump">15,892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember', window );">Employee related research and development expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">8,915<span></span>
</td>
<td class="nump">8,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember', window );">Chemistry, manufacturing and controls expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,896<span></span>
</td>
<td class="nump">4,260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_OtherMember', window );">Other research and development expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 5,248<span></span>
</td>
<td class="nump">$ 5,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecoveryOfDirectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecoveryOfDirectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_ClinicalTrailMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_ClinicalTrailMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event - 2024 ATM Program - Common Stock<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 11, 2026 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued of common stock | shares</a></td>
<td class="nump">668,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds | $</a></td>
<td class="nump">$ 6.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_A2024ATMProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_A2024ATMProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>217</ContextCount>
  <ElementCount>371</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>87</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of the Business and Financial Condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition</Role>
      <ShortName>Description of the Business and Financial Condition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Research Grant</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ResearchGrant</Role>
      <ShortName>Research Grant</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Common Stock and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommonStockandStockholdersEquity</Role>
      <ShortName>Common Stock and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/EmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.angn.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/FairValueMeasurements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/BalanceSheetComponents</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/StockBasedCompensation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/Warrants</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/Debt</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/NetLossPerShare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/SegmentReporting</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Description of the Business and Financial Condition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails</Role>
      <ShortName>Description of the Business and Financial Condition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Balance Sheet Components - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Balance Sheet Components - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Research Grant (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ResearchGrantDetails</Role>
      <ShortName>Research Grant (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/ResearchGrant</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Common Stock and Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommonStockandStockholdersEquityDetails</Role>
      <ShortName>Common Stock and Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/CommonStockandStockholdersEquity</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Share Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Warrants - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsNarrativeDetails</Role>
      <ShortName>Warrants - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails</Role>
      <ShortName>Warrants - Schedule of Outstanding Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Warrants - Schedule of Warrants Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails</Role>
      <ShortName>Warrants - Schedule of Warrants Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/CommitmentsandContingencies</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Quantitative Information about Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Debt - Schedule of Future Principal Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails</Role>
      <ShortName>Debt - Schedule of Future Principal Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Income Taxes - Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails</Role>
      <ShortName>Income Taxes - Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Employee Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/EmployeeBenefitPlanDetails</Role>
      <ShortName>Employee Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/EmployeeBenefitPlan</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/RelatedPartyTransactions</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/SegmentReportingTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="angn-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/SubsequentEvents</ParentRole>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="angn-20251231.htm">angn-20251231.htm</File>
    <File>angn-20251231.xsd</File>
    <File>angn-20251231_cal.xml</File>
    <File>angn-20251231_def.xml</File>
    <File>angn-20251231_lab.xml</File>
    <File>angn-20251231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>angn-20251231_g1.jpg</File>
    <File>angn-20251231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="727">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="42">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="6">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>138
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "angn-20251231.htm": {
   "nsprefix": "angn",
   "nsuri": "http://www.angn.com/20251231",
   "dts": {
    "inline": {
     "local": [
      "angn-20251231.htm"
     ]
    },
    "schema": {
     "local": [
      "angn-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "angn-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "angn-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "angn-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "angn-20251231_pre.xml"
     ]
    }
   },
   "keyStandard": 318,
   "keyCustom": 53,
   "axisStandard": 30,
   "axisCustom": 0,
   "memberStandard": 34,
   "memberCustom": 50,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "contextCount": 217,
   "entityCount": 1,
   "segmentCount": 87,
   "elementCount": 710,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 727,
    "http://xbrl.sec.gov/dei/2025": 42,
    "http://xbrl.sec.gov/cyd/2025": 15,
    "http://xbrl.sec.gov/ecd/2025": 6
   },
   "report": {
    "R1": {
     "role": "http://www.angn.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.angn.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.angn.com/role/ConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RestrictedCashCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
     "longName": "9952153 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
     "longName": "9952154 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-30",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-30",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
     "longName": "9952155 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition",
     "longName": "9952157 - Disclosure - Description of the Business and Financial Condition",
     "shortName": "Description of the Business and Financial Condition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952158 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.angn.com/role/FairValueMeasurements",
     "longName": "9952159 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.angn.com/role/BalanceSheetComponents",
     "longName": "9952160 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.angn.com/role/ResearchGrant",
     "longName": "9952161 - Disclosure - Research Grant",
     "shortName": "Research Grant",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.angn.com/role/CommonStockandStockholdersEquity",
     "longName": "9952162 - Disclosure - Common Stock and Stockholders' Equity",
     "shortName": "Common Stock and Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.angn.com/role/StockBasedCompensation",
     "longName": "9952163 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.angn.com/role/Warrants",
     "longName": "9952164 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "angn:WarrantsAndRightsOutstandingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:WarrantsAndRightsOutstandingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.angn.com/role/CommitmentsandContingencies",
     "longName": "9952165 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.angn.com/role/Leases",
     "longName": "9952166 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.angn.com/role/Debt",
     "longName": "9952167 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.angn.com/role/IncomeTaxes",
     "longName": "9952168 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.angn.com/role/EmployeeBenefitPlan",
     "longName": "9952169 - Disclosure - Employee Benefit Plan",
     "shortName": "Employee Benefit Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.angn.com/role/NetLossPerShare",
     "longName": "9952170 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.angn.com/role/RelatedPartyTransactions",
     "longName": "9952171 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.angn.com/role/SegmentReporting",
     "longName": "9952172 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.angn.com/role/SubsequentEvents",
     "longName": "9952173 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-217",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-217",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R31": {
     "role": "http://www.angn.com/role/FairValueMeasurementsTables",
     "longName": "9955513 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsTables",
     "longName": "9955514 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.angn.com/role/StockBasedCompensationTables",
     "longName": "9955515 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.angn.com/role/WarrantsTables",
     "longName": "9955516 - Disclosure - Warrants (Tables)",
     "shortName": "Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.angn.com/role/LeasesTables",
     "longName": "9955517 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.angn.com/role/DebtTables",
     "longName": "9955518 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.angn.com/role/IncomeTaxesTables",
     "longName": "9955519 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.angn.com/role/NetLossPerShareTables",
     "longName": "9955520 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.angn.com/role/SegmentReportingTables",
     "longName": "9955521 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
     "longName": "9955522 - Disclosure - Description of the Business and Financial Condition (Details)",
     "shortName": "Description of the Business and Financial Condition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-46",
      "name": "angn:SaleOfStockAggregateInitialOfferingPrice",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails",
     "longName": "9955523 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9955524 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "longName": "9955525 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails",
     "longName": "9955526 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-81",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails",
     "longName": "9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-77",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-77",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955528 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "angn:SaleOfStockBeneficialOwnershipLimitationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "angn:SaleOfStockBeneficialOwnershipLimitationPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails",
     "longName": "9955529 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "shortName": "Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "angn:PrepaidResearchAndDevelopmentExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "angn:PrepaidResearchAndDevelopmentExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
     "longName": "9955530 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "shortName": "Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
     "longName": "9955531 - Disclosure - Balance Sheet Components - Narrative (Details)",
     "shortName": "Balance Sheet Components - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R50": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails",
     "longName": "9955532 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.angn.com/role/ResearchGrantDetails",
     "longName": "9955533 - Disclosure - Research Grant (Details)",
     "shortName": "Research Grant (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "angn:NumberOfResearchGrantAgreements",
      "unitRef": "agreement",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
     "longName": "9955534 - Disclosure - Common Stock and Stockholders' Equity (Details)",
     "shortName": "Common Stock and Stockholders' Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955535 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails",
     "longName": "9955536 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Share Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails",
     "longName": "9955537 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
     "longName": "9955538 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.angn.com/role/WarrantsNarrativeDetails",
     "longName": "9955539 - Disclosure - Warrants - Narrative (Details)",
     "shortName": "Warrants - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-131",
      "name": "angn:GainLossOnIssuanceOfWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails",
     "longName": "9955540 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)",
     "shortName": "Warrants - Schedule of Outstanding Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails",
     "longName": "9955541 - Disclosure - Warrants - Schedule of Warrants Activity (Details)",
     "shortName": "Warrants - Schedule of Warrants Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:ClassOfWarrantOrRightExercisedInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.angn.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955542 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-167",
      "name": "angn:RoyaltyRatePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.angn.com/role/LeasesNarrativeDetails",
     "longName": "9955543 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails",
     "longName": "9955544 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)",
     "shortName": "Leases - Schedule of Quantitative Information about Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails",
     "longName": "9955545 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.angn.com/role/DebtNarrativeDetails",
     "longName": "9955546 - Disclosure - Debt - Narrative (Details)",
     "shortName": "Debt - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-112",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-183",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails",
     "longName": "9955547 - Disclosure - Debt - Schedule of Future Principal Payments (Details)",
     "shortName": "Debt - Schedule of Future Principal Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails",
     "longName": "9955548 - Disclosure - Income Taxes - Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations (Details)",
     "shortName": "Income Taxes - Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "longName": "9955549 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "shortName": "Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955550 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.angn.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails",
     "longName": "9955551 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Schedule of Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.angn.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9955552 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.angn.com/role/EmployeeBenefitPlanDetails",
     "longName": "9955553 - Disclosure - Employee Benefit Plan (Details)",
     "shortName": "Employee Benefit Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-195",
      "name": "us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-195",
      "name": "us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails",
     "longName": "9955554 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)",
     "shortName": "Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R73": {
     "role": "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails",
     "longName": "9955555 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.angn.com/role/RelatedPartyTransactionsDetails",
     "longName": "9955556 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-200",
      "name": "us-gaap:ProceedsFromIssuanceOfWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.angn.com/role/SegmentReportingDetails",
     "longName": "9955557 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "entity",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "entity",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.angn.com/role/SubsequentEventsDetails",
     "longName": "9955558 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-216",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-216",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20251231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "angn_A2021PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "A2021PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Plan",
        "label": "2021 Plan [Member]",
        "documentation": "2021 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_A2022PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "A2022PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Plan",
        "label": "2022 Plan [Member]",
        "documentation": "2022 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_A2024ATMProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "A2024ATMProgramMember",
     "presentation": [
      "http://www.angn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 ATM Program",
        "label": "2024 ATM Program [Member]",
        "documentation": "2024 ATM Program"
       }
      }
     },
     "auth_ref": []
    },
    "angn_A2024PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "A2024PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Plan",
        "label": "2024 Plan [Member]",
        "documentation": "2024 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_A2024RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "A2024RegistrationStatementMember",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Registration Statement",
        "label": "2024 Registration Statement [Member]",
        "documentation": "2024 Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "country_AU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "AU",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AUSTRALIA",
        "label": "AUSTRALIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r949"
     ]
    },
    "angn_AccretionOfPromissoryNoteToFaceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AccretionOfPromissoryNoteToFaceValue",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accretion of promissory note to face value",
        "label": "Accretion Of Promissory Note To Face Value",
        "documentation": "Accretion Of Promissory Note To Face Value"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AccruedInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Accrued Interest",
        "documentation": "Accrued Interest"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AccruedInterestPremiumForConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AccruedInterestPremiumForConvertiblePreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Accrued Interest Premium For Convertible Preferred Stock",
        "documentation": "Accrued Interest Premium For Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails",
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "angn_AccruedOtherOperatingLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AccruedOtherOperatingLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "label": "Accrued Other Operating Liabilities, Current",
        "documentation": "Accrued Other Operating Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "angn_AccruedResearchAndDevelopmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued research and development",
        "label": "Accrued Research And Development, Current",
        "documentation": "Accrued Research And Development, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r126",
      "r709"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r62",
      "r132",
      "r705",
      "r744",
      "r745",
      "r1239"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r9",
      "r16",
      "r560",
      "r563",
      "r633",
      "r740",
      "r741",
      "r1108",
      "r1109",
      "r1110",
      "r1167",
      "r1168",
      "r1169",
      "r1170"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r949",
      "r1300"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1240",
      "r1304"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r86"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common warrants associated with June 2025 Promissory Note",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r33",
      "r86"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AdvancedProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AdvancedProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advanced professional fees",
        "label": "Advanced Professional Fees",
        "documentation": "Advanced Professional Fees"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1010",
      "r1020",
      "r1053"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1013",
      "r1023",
      "r1056"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1048",
      "r1057",
      "r1061",
      "r1069"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r483",
      "r492"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt discount",
        "label": "Amortization of Debt Discount (Premium)",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r69",
      "r314",
      "r1251"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net of debt issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r314",
      "r1155",
      "r1251"
     ]
    },
    "angn_AngionWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AngionWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Angion Warrants",
        "label": "Angion Warrants [Member]",
        "documentation": "Angion Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of office space (in sqft)",
        "label": "Area of Real Estate Property",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Total segment assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r105",
      "r127",
      "r153",
      "r156",
      "r157",
      "r197",
      "r210",
      "r235",
      "r239",
      "r249",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r542",
      "r544",
      "r600",
      "r692",
      "r693",
      "r700",
      "r799",
      "r897",
      "r898",
      "r911",
      "r949",
      "r964",
      "r965",
      "r977",
      "r1190",
      "r1191",
      "r1256"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r133",
      "r153",
      "r156",
      "r157",
      "r249",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r542",
      "r544",
      "r600",
      "r949",
      "r1190",
      "r1191",
      "r1256"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r574",
      "r575",
      "r939"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets, Fair Value Disclosure [Abstract]",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreement2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AtTheMarketEquityOfferingSalesAgreement2022Member",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement 2022",
        "label": "At-The-Market Equity Offering Sales Agreement 2022 [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement 2022"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreement2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AtTheMarketEquityOfferingSalesAgreement2024Member",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement 2024",
        "label": "At-The-Market Equity Offering Sales Agreement 2024 [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement 2024"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AtTheMarketEquityOfferingSalesAgreementMember",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement",
        "label": "At-The-Market Equity Offering Sales Agreement [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-the-Market Offering",
        "label": "At-the-Market Offering [Member]",
        "documentation": "At-the-Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.angn.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r1006"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.angn.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r1006"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://www.angn.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r1006"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1157"
     ]
    },
    "angn_BostonMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "BostonMassachusettsMember",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Boston, Massachusetts",
        "label": "Boston, Massachusetts [Member]",
        "documentation": "Boston, Massachusetts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Project [Axis]",
        "label": "Project [Axis]",
        "documentation": "Information by project."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r688",
      "r1265"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets",
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r124",
      "r874"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r596",
      "r597",
      "r1241",
      "r1242"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r92"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the year",
        "totalLabel": "Total cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r73",
      "r150"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of cash, cash equivalents and restricted cash:",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r73"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r129",
      "r130",
      "r131",
      "r153",
      "r157",
      "r186",
      "r187",
      "r189",
      "r191",
      "r199",
      "r200",
      "r249",
      "r283",
      "r285",
      "r286",
      "r287",
      "r290",
      "r291",
      "r323",
      "r324",
      "r326",
      "r327",
      "r329",
      "r332",
      "r335",
      "r336",
      "r339",
      "r342",
      "r349",
      "r600",
      "r752",
      "r753",
      "r754",
      "r755",
      "r761",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r787",
      "r807",
      "r830",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r1092",
      "r1160",
      "r1162",
      "r1171"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r199",
      "r326",
      "r335",
      "r336",
      "r337",
      "r339",
      "r342",
      "r347",
      "r349",
      "r556",
      "r752",
      "r753",
      "r754",
      "r755",
      "r912",
      "r1092",
      "r1158",
      "r1160"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails",
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in dollars per share)",
        "verboseLabel": "Exercise price of equity-classified broker warrants (in dollars per share)",
        "netLabel": "Weighted average exercise price (in dollars per share)",
        "periodStartLabel": "Outstanding beginning balance (in dollars per share)",
        "periodEndLabel": "Outstanding ending balance (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r160",
      "r350"
     ]
    },
    "angn_ClassOfWarrantOrRightExercisedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightExercisedInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Class Of Warrant Or Right, Exercised In Period",
        "documentation": "Class Of Warrant Or Right, Exercised In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightIssuedInPeriod",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in shares)",
        "label": "Class Of Warrant Or Right, Issued In Period",
        "documentation": "Class Of Warrant Or Right, Issued In Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares of common stock to purchase (up to) (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails",
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of warrants outstanding (in shares)",
        "periodStartLabel": "Outstanding beginning balance (in shares)",
        "periodEndLabel": "Outstanding ending balance (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightOwnershipPercentMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightOwnershipPercentMaximum",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership maximum (as a percent)",
        "label": "Class of Warrant or Right, Ownership Percent Maximum",
        "documentation": "Class of Warrant or Right, Ownership Percent Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Class of Warrant or Right [Roll Forward]",
        "documentation": "Class of Warrant or Right"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Table]",
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period",
        "documentation": "Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in dollars per share)",
        "label": "Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period",
        "documentation": "Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Class of Warrant or Right, Weighted Average Exercise Price [Roll Forward]",
        "documentation": "Class of Warrant or Right, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightWeightedAverageLife",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding beginning balance (in years)",
        "periodEndLabel": "Outstanding ending balance (in years)",
        "label": "Class of Warrant Or Right, Weighted Average Life",
        "documentation": "Class of Warrant Or Right, Weighted Average Life"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightWeightedAverageLifeRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Life (years)",
        "label": "Class of Warrant or Right, Weighted Average Life [Roll Forward]",
        "documentation": "Class of Warrant or Right, Weighted Average Life"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Life (years)",
        "label": "Class of Warrant or Right, Weighted Average Remaining Contractual Terms",
        "documentation": "Class of Warrant or Right, Weighted Average Remaining Contractual Terms"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClinicalTrailMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ClinicalTrailMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical trial expenses",
        "label": "Clinical Trail [Member]",
        "documentation": "Clinical Trail"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "angn_CollaborativeArrangementFutureMinimumMaintenancePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "CollaborativeArrangementFutureMinimumMaintenancePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future minimum annual maintenance payments",
        "label": "Collaborative Arrangement, Future Minimum Maintenance Payments",
        "documentation": "Collaborative Arrangement, Future Minimum Maintenance Payments"
       }
      }
     },
     "auth_ref": []
    },
    "angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate sales milestone payments per product",
        "label": "Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "angn_CommitmentAndContingenciesDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "CommitmentAndContingenciesDisclosureLineItems",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment and Contingencies Disclosure [Line Items]",
        "label": "Commitment and Contingencies Disclosure [Line Items]",
        "documentation": "Commitment and Contingencies Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_CommitmentAndContingenciesDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "CommitmentAndContingenciesDisclosureTable",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment and Contingencies Disclosure [Table]",
        "label": "Commitment and Contingencies Disclosure [Table]",
        "documentation": "Commitment and Contingencies Disclosure [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies\u2014Note 9",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r97",
      "r701",
      "r786"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r275",
      "r276",
      "r857",
      "r1182",
      "r1187"
     ]
    },
    "angn_CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of outstanding stock",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance, Increase, Percentage Of Common Stock Outstanding",
        "documentation": "Common Stock, Capital Shares Reserved for Future Issuance, Increase, Percentage Of Common Stock Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/SubsequentEventsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r967",
      "r968",
      "r969",
      "r971",
      "r972",
      "r973",
      "r974",
      "r1167",
      "r1168",
      "r1170",
      "r1240",
      "r1299",
      "r1304"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r787"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "periodEndLabel": "Balance at end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r787",
      "r805",
      "r1304",
      "r1305"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.01 par value; 300,000,000 shares authorized; 17,814,762 and 11,043,837 shares issued at December 31, 2025 and 2024, respectively; 17,800,307 and 11,029,382 shares outstanding as of December 31, 2025 and 2024, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r324",
      "r331",
      "r704",
      "r949"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets (liabilities):",
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r135",
      "r137",
      "r142",
      "r690",
      "r714",
      "r715"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Gain (Loss)",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of Credit Risk and Off-Balance Sheet Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r599"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r886"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred research obligation",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355"
     ]
    },
    "angn_ConversionOfConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ConversionOfConvertibleDebtMember",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Convertible Debt",
        "label": "Conversion Of Convertible Debt [Member]",
        "documentation": "Conversion Of Convertible Debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of related-party senior note and interest into common stock",
        "label": "Conversion of Stock, Amount Issued",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23"
     ]
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion Description [Axis]",
        "label": "Stock Conversion Description [Axis]",
        "documentation": "Information by description of stock conversions."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23"
     ]
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockNameDomain",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Stock, Name [Domain]",
        "label": "Conversion of Stock, Name [Domain]",
        "documentation": "The unique name of a noncash or part noncash stock conversion."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Debt",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r293",
      "r294",
      "r304",
      "r305",
      "r306",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "angn_CostsExpensedUponTheIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "CostsExpensedUponTheIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs expensed upon the issuance of warrants",
        "label": "Costs Expensed Upon The Issuance Of Warrants",
        "documentation": "Costs Expensed Upon The Issuance Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r153",
      "r163",
      "r164",
      "r296",
      "r337",
      "r639",
      "r649",
      "r699",
      "r876",
      "r877",
      "r878",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1235",
      "r1236",
      "r1237",
      "r1238"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1080"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1080"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r993",
      "r1082"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r993",
      "r1082"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r995",
      "r1084"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r993",
      "r1082"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r986",
      "r1075"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r987",
      "r1076"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r987",
      "r1076"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r985",
      "r1074"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r985",
      "r1074"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r985",
      "r1074"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r988",
      "r1077"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1079"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1079"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1080"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r994",
      "r1083"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r992",
      "r1081"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r989",
      "r1078"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r153",
      "r155",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r281",
      "r282",
      "r292",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r308",
      "r315",
      "r316",
      "r318",
      "r556",
      "r617"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r47",
      "r48",
      "r94",
      "r96",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r947",
      "r1158",
      "r1159",
      "r1161",
      "r1166",
      "r1183",
      "r1184",
      "r1185",
      "r1250",
      "r1252",
      "r1266"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate (as a percent)",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r617",
      "r618",
      "r907",
      "r908",
      "r947"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated interest rate (as a percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r294"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r317",
      "r556",
      "r696",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r947",
      "r1158",
      "r1159",
      "r1161",
      "r1166",
      "r1250",
      "r1252"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r947",
      "r1158",
      "r1159",
      "r1161",
      "r1166",
      "r1183",
      "r1184",
      "r1185",
      "r1250",
      "r1252",
      "r1266"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "documentation": "Information by period of debt redemption feature under terms of debt agreement."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First year",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Three Year",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second year",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, prepayment fee prepaid (as a percent)",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r36",
      "r39",
      "r45",
      "r84",
      "r85",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r317",
      "r556",
      "r696",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r947",
      "r1158",
      "r1159",
      "r1161",
      "r1166",
      "r1250",
      "r1252"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt discount",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "documentation": "Amount, after accumulated amortization, of debt discount (premium)."
       }
      }
     },
     "auth_ref": [
      "r1193",
      "r1249",
      "r1250",
      "r1252"
     ]
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Issuance Costs",
        "label": "Debt, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid and Other Current Assets",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "angn_DeferredTaxAssetsNetBeforeValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "DeferredTaxAssetsNetBeforeValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net, Before Valuation Allowance",
        "documentation": "Deferred Tax Assets, Net, Before Valuation Allowance"
       }
      }
     },
     "auth_ref": []
    },
    "angn_DeferredTaxAssetsOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "angn_DeferredTaxAssetsNetBeforeValuationAllowance",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "documentation": "Deferred Tax Assets, Operating Lease, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "angn_DeferredTaxAssetsNetBeforeValuationAllowance",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "angn_DeferredTaxAssetsNetBeforeValuationAllowance",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "angn_DeferredTaxAssetsNetBeforeValuationAllowance",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development tax credits",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "angn_DeferredTaxAssetsNetBeforeValuationAllowance",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized research and development",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Deferred tax asset valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "angn_DeferredTaxAssetsNetBeforeValuationAllowance",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "ROU asset",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "angn_DeferredTaxAssetsNetBeforeValuationAllowance",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Property and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1231"
     ]
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "presentation": [
      "http://www.angn.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plan Disclosure [Line Items]",
        "label": "Defined Contribution Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage",
     "presentation": [
      "http://www.angn.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employers matching contribution annual vesting (in percentage)",
        "label": "Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage",
        "documentation": "Percentage of employer's matching contributions to a defined contribution plan that vests in a given year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedContributionPlanTable",
     "presentation": [
      "http://www.angn.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plan [Table]",
        "label": "Defined Contribution Plan [Table]",
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "us-gaap_DefinedContributionPlanTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedContributionPlanTextBlock",
     "presentation": [
      "http://www.angn.com/role/EmployeeBenefitPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefit Plan",
        "label": "Defined Contribution Plan [Text Block]",
        "documentation": "The entire disclosure for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r438"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r30",
      "r147",
      "r879",
      "r880",
      "r882",
      "r884"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r165",
      "r182",
      "r546",
      "r550",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r558"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r447",
      "r478",
      "r479",
      "r481",
      "r929"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sale of equipment",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r263",
      "r1155",
      "r1181"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r1006"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r1006",
      "r1049"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1027"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Tax Jurisdiction",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share, basic (in dollars per share)",
        "verboseLabel": "Net loss per share, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r143",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r184",
      "r186",
      "r189",
      "r190",
      "r191",
      "r196",
      "r322",
      "r482",
      "r535",
      "r540",
      "r571",
      "r572",
      "r691",
      "r716",
      "r887"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share, diluted (in dollars per share)",
        "verboseLabel": "Net loss per share, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r143",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r186",
      "r189",
      "r190",
      "r191",
      "r196",
      "r322",
      "r482",
      "r535",
      "r540",
      "r571",
      "r572",
      "r691",
      "r716",
      "r887"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r193"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r192",
      "r194",
      "r195"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of foreign currency on cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails",
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective income tax rate",
        "terseLabel": "Effective tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r932"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent",
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory federal income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r159",
      "r503",
      "r526",
      "r932"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r932",
      "r1158",
      "r1165",
      "r1224"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign tax effects",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r507",
      "r932",
      "r1158",
      "r1165",
      "r1224"
     ]
    },
    "angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrants",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "angn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrants",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Change In Fair Value Of Warrants, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other nontaxable and nondeductible items",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1158",
      "r1165",
      "r1224",
      "r1226"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nondeductible stock based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1158",
      "r1165",
      "r1224",
      "r1226"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other nontaxable and nondeductible items",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1158",
      "r1165",
      "r1224",
      "r1225"
     ]
    },
    "angn_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Permanent differences",
        "label": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic state and local taxes, net of federal effect",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r932",
      "r1158",
      "r1165",
      "r1224"
     ]
    },
    "angn_EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State research and development credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, State Research And Development, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Credit, State Research And Development, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research and development credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1158",
      "r1165",
      "r1224",
      "r1226"
     ]
    },
    "angn_ElicioWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ElicioWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elicio Warrants",
        "label": "Elicio Warrants [Member]",
        "documentation": "Elicio Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_EmployeeBenefitPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "EmployeeBenefitPlanMember",
     "presentation": [
      "http://www.angn.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefit Plan",
        "label": "Employee Benefit Plan [Member]",
        "documentation": "Employee Benefit Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "angn_EmployeeRelatedReasearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "EmployeeRelatedReasearchAndDevelopmentMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee related research and development expenses",
        "label": "Employee Related Reasearch and Development [Member]",
        "documentation": "Employee Related Reasearch and Development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation related to unvested stock option awards, period for recognition (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation related to unvested stock option awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1222"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option",
        "verboseLabel": "Shares issuable upon exercise of stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment",
        "verboseLabel": "Equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/SubsequentEventsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r114",
      "r115",
      "r116",
      "r139",
      "r140",
      "r141",
      "r167",
      "r168",
      "r169",
      "r171",
      "r178",
      "r180",
      "r182",
      "r198",
      "r250",
      "r251",
      "r262",
      "r321",
      "r351",
      "r482",
      "r524",
      "r525",
      "r532",
      "r533",
      "r534",
      "r536",
      "r539",
      "r540",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r570",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r619",
      "r621",
      "r633",
      "r713",
      "r740",
      "r741",
      "r742",
      "r761",
      "r830"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1010",
      "r1020",
      "r1053"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1007",
      "r1017",
      "r1050"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in fair value of warrant liabilities",
        "terseLabel": "Change in fair value of warrant liabilities",
        "negatedLabel": "Loss on fair value of warrants",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r577",
      "r578",
      "r933",
      "r935",
      "r942"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r577",
      "r578",
      "r933",
      "r935",
      "r942"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Measurement Inputs and Valuation Techniques",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r577",
      "r942"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r596",
      "r597",
      "r871",
      "r946",
      "r1247"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r597",
      "r871",
      "r946",
      "r1246",
      "r1247"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r409",
      "r410",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r587",
      "r588",
      "r590",
      "r595",
      "r644",
      "r645",
      "r646",
      "r871",
      "r907",
      "r908",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r939",
      "r942",
      "r946"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r589"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r583",
      "r585",
      "r586",
      "r587",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r689",
      "r939",
      "r943"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r380",
      "r385",
      "r409",
      "r575",
      "r588",
      "r595",
      "r644",
      "r871",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r939",
      "r946"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r380",
      "r385",
      "r409",
      "r411",
      "r575",
      "r576",
      "r588",
      "r595",
      "r645",
      "r871",
      "r907",
      "r908",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r939",
      "r946"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r409",
      "r410",
      "r575",
      "r576",
      "r577",
      "r578",
      "r588",
      "r595",
      "r646",
      "r871",
      "r907",
      "r908",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r939",
      "r942",
      "r946"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r589"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r589"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r584",
      "r589"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r580",
      "r589"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of the period",
        "periodEndLabel": "Balance, end of the period",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r589"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r409",
      "r410",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r587",
      "r588",
      "r590",
      "r595",
      "r644",
      "r645",
      "r646",
      "r871",
      "r907",
      "r908",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r939",
      "r942",
      "r946"
     ]
    },
    "angn_FairValueOfCommonStockWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "FairValueOfCommonStockWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants at issuance date",
        "label": "Fair Value Of Common Stock Warrants",
        "documentation": "Fair Value Of Common Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_FairValueOfCommonStockWarrantsUponSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "FairValueOfCommonStockWarrantsUponSettlement",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants upon settlement",
        "label": "Fair Value Of Common Stock Warrants Upon Settlement",
        "documentation": "Fair Value Of Common Stock Warrants Upon Settlement"
       }
      }
     },
     "auth_ref": []
    },
    "angn_FairValueOfPreFundedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "FairValueOfPreFundedWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of pre-funded warrants at issuance date",
        "label": "Fair Value Of Pre Funded Warrants",
        "documentation": "Fair Value Of Pre Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange transaction gain",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r605",
      "r606",
      "r607",
      "r608",
      "r827"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation and Transactions",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1057"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1057"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1057"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1057"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1057"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "verboseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "angn_GKCCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "GKCCMember",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GKCC",
        "label": "GKCC [Member]",
        "documentation": "GKCC"
       }
      }
     },
     "auth_ref": []
    },
    "angn_GainLossOnIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "GainLossOnIssuanceOfWarrants",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on issuance of pre-funded warrants",
        "negatedLabel": "Loss on issuance of warrants",
        "negatedTerseLabel": "Loss on issuance of pre-funded warrants",
        "label": "Gain Loss On Issuance Of Warrants",
        "documentation": "Gain Loss On Issuance Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on disposal of property and equipment",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "verboseLabel": "Employee related general and administrative expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r809"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "angn_GrantRevenueNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "GrantRevenueNonoperating",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant income",
        "label": "Grant Revenue, Nonoperating",
        "documentation": "The amount of grant revenue, non operating."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983",
      "r1006"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long lived assets",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r29",
      "r78",
      "r144",
      "r880",
      "r940"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r79"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r158",
      "r502"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r99",
      "r104",
      "r692",
      "r694",
      "r711",
      "r881",
      "r883",
      "r885",
      "r891",
      "r897",
      "r1173",
      "r1175",
      "r1176",
      "r1177",
      "r1178"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofIncomeLossBeforeTaxesRelatedtoourUnitedStatesandForeignOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r158",
      "r502"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r271",
      "r272",
      "r547",
      "r548",
      "r549",
      "r551",
      "r580",
      "r584",
      "r589",
      "r601",
      "r602",
      "r603",
      "r737",
      "r739",
      "r814",
      "r870",
      "r871",
      "r933",
      "r934",
      "r937",
      "r938",
      "r941",
      "r946",
      "r1232",
      "r1233",
      "r1270"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r547",
      "r548",
      "r549",
      "r551",
      "r580",
      "r584",
      "r589",
      "r601",
      "r602",
      "r603",
      "r737",
      "r739",
      "r814",
      "r870",
      "r871",
      "r933",
      "r934",
      "r937",
      "r938",
      "r941",
      "r946",
      "r1232",
      "r1233",
      "r1270"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r503",
      "r504",
      "r513",
      "r521",
      "r932",
      "r1230"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r503",
      "r504",
      "r513",
      "r521",
      "r932",
      "r1230"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r159",
      "r497",
      "r503",
      "r509",
      "r510",
      "r511",
      "r515",
      "r520",
      "r527",
      "r529",
      "r530",
      "r531",
      "r698",
      "r747",
      "r757",
      "r932"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails",
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Provision for income taxes and effective income tax rate",
        "verboseLabel": "Income tax expenses",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r112",
      "r153",
      "r181",
      "r182",
      "r197",
      "r218",
      "r239",
      "r501",
      "r503",
      "r528",
      "r717",
      "r881",
      "r883",
      "r885",
      "r932"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount",
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r499",
      "r500",
      "r515",
      "r516",
      "r519",
      "r523",
      "r751"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r932",
      "r1224"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign tax effects",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r507",
      "r932",
      "r1224"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US federal statutory income tax rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r932"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other nontaxable and nondeductible items",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1224",
      "r1226"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nondeductible stock based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1224",
      "r1226"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic state and local taxes, net of federal effect",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r932",
      "r1224"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research and development credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1224",
      "r1226"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred research obligation",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r651",
      "r1154"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1094",
      "r1154"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other long-term prepaid assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1048",
      "r1057",
      "r1061",
      "r1069"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r1073"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r1073"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r984",
      "r1073"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r312",
      "r320",
      "r909",
      "r910",
      "r1302"
     ]
    },
    "angn_InterestExpenseNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "InterestExpenseNoncash",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Interest Expense, Noncash",
        "documentation": "Interest Expense, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r881",
      "r885",
      "r1111"
     ]
    },
    "us-gaap_InterestIncomeOperatingAndNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeOperatingAndNonoperating",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Operating and Nonoperating",
        "documentation": "Amount of interest income classified as operating and nonoperating."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r897"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Interest Payable",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r1267"
     ]
    },
    "angn_January2025CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "January2025CommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2025 Common Warrants",
        "label": "January 2025 Common Warrants [Member]",
        "documentation": "January 2025 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JanuaryCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JanuaryCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Common Warrants",
        "label": "January Common Warrants [Member]",
        "documentation": "January Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JanuaryOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JanuaryOfferingMember",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Offering",
        "label": "January Offering [Member]",
        "documentation": "January Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JanuaryPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JanuaryPublicOfferingMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Public Offering",
        "label": "January Public Offering [Member]",
        "documentation": "January Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan",
        "label": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member]",
        "documentation": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_July2024PublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "July2024PublicOfferingMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Public Offering",
        "verboseLabel": "July Public Offering 2024",
        "netLabel": "July 2024 Public Offering",
        "label": "July 2024 Public Offering [Member]",
        "documentation": "Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyCommonWarrantOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JulyCommonWarrantOneMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July 2024 Common Warrants One",
        "label": "July Common Warrant One [Member]",
        "documentation": "July Common Warrant One"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JulyCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Common Warrants",
        "verboseLabel": "July 2024 Common Warrants",
        "label": "July Common Warrants [Member]",
        "documentation": "July Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JulyPreFundedWarrantsAndJulyCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Pre-Funded Warrants and July Common Warrants",
        "label": "July Pre-Funded Warrants and July Common Warrants [Member]",
        "documentation": "July Pre-Funded Warrants and July Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JulyPreFundedWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Pre-Funded Warrants",
        "label": "July Pre-Funded Warrants [Member]",
        "documentation": "July Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JulyPublicOfferingMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Public Offering",
        "label": "July Public Offering [Member]",
        "documentation": "Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulySharesAndJulyCommonWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "JulySharesAndJulyCommonWarrantMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Share And July Common Warrant",
        "label": "July Shares And July Common Warrant [Member]",
        "documentation": "July Shares And July Common Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "angn_June2025CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "June2025CommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "June 2025 Common Warrants",
        "label": "June 2025 Common Warrants [Member]",
        "documentation": "June 2025 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_June2025WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "June2025WarrantsMember",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "June 2025 Warrants",
        "label": "June 2025 Warrants [Member]",
        "documentation": "June 2025 Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r631"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r632"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r632"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "angn_LesseeOperatingLeaseAnnualRentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "LesseeOperatingLeaseAnnualRentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, payment per year",
        "label": "Lessee, Operating Lease, Annual Rent Expense",
        "documentation": "Lessee, Operating Lease, Annual Rent Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1254"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r630",
      "r1159",
      "r1166",
      "r1266"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r630",
      "r1159",
      "r1166",
      "r1266"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r630",
      "r1159",
      "r1166",
      "r1266"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r630",
      "r1159",
      "r1166",
      "r1266"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r630",
      "r1159",
      "r1166",
      "r1266"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r630",
      "r1159",
      "r1166",
      "r1266"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less present value discount",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.angn.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r47",
      "r48",
      "r49",
      "r51",
      "r52",
      "r53",
      "r54",
      "r153",
      "r156",
      "r157",
      "r249",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r543",
      "r544",
      "r545",
      "r600",
      "r785",
      "r890",
      "r911",
      "r977",
      "r1190",
      "r1256",
      "r1257"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, convertible preferred stock, and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r98",
      "r707",
      "r949",
      "r964",
      "r965",
      "r1158",
      "r1163",
      "r1179",
      "r1248"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, convertible preferred stock, and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r123",
      "r153",
      "r156",
      "r157",
      "r249",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r543",
      "r544",
      "r545",
      "r600",
      "r949",
      "r1190",
      "r1256",
      "r1257"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r1241"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, Fair Value Disclosure [Abstract]",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total principal amount",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r96",
      "r154",
      "r166",
      "r305",
      "r319",
      "r696",
      "r907",
      "r908",
      "r947",
      "r1268"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r154",
      "r166",
      "r310",
      "r696"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r154",
      "r166",
      "r310",
      "r696"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/DebtScheduleofFuturePrincipalPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r154",
      "r166",
      "r310",
      "r696"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets",
      "http://www.angn.com/role/DebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Long-term debt, net",
        "terseLabel": "Net carrying value",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r1183",
      "r1184",
      "r1185"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r32",
      "r1183",
      "r1184",
      "r1185"
     ]
    },
    "angn_March2024PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "March2024PreFundedWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March 2024 Pre-Funded Warrants",
        "label": "March 2024 Pre-Funded Warrants [Member]",
        "documentation": "March 2024 Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_MarchSubscriptionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "MarchSubscriptionAgreementMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March Subscription Agreement",
        "label": "March Subscription Agreement [Member]",
        "documentation": "March Subscription Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r205",
      "r277",
      "r278",
      "r279",
      "r280",
      "r441",
      "r473",
      "r474",
      "r475",
      "r493",
      "r578",
      "r650",
      "r736",
      "r738",
      "r746",
      "r777",
      "r778",
      "r837",
      "r839",
      "r841",
      "r842",
      "r844",
      "r852",
      "r853",
      "r855",
      "r856",
      "r867",
      "r868",
      "r903",
      "r912",
      "r928",
      "r933",
      "r935",
      "r936",
      "r942",
      "r943",
      "r944",
      "r945",
      "r959",
      "r1192",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield (per share)",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r1243",
      "r1244",
      "r1245"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility (annual)",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r942",
      "r1243",
      "r1244",
      "r1245"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r475",
      "r1243",
      "r1244",
      "r1245"
     ]
    },
    "angn_MeasurementInputStrikePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "MeasurementInputStrikePriceMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average strike price",
        "label": "Measurement Input, Strike Price [Member]",
        "documentation": "Measurement Input, Strike Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r576",
      "r577",
      "r578",
      "r933",
      "r935",
      "r936",
      "r942"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r577",
      "r578",
      "r933",
      "r935",
      "r936",
      "r942"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r205",
      "r277",
      "r278",
      "r279",
      "r280",
      "r441",
      "r473",
      "r474",
      "r475",
      "r493",
      "r578",
      "r650",
      "r736",
      "r738",
      "r746",
      "r777",
      "r778",
      "r837",
      "r839",
      "r841",
      "r842",
      "r844",
      "r852",
      "r853",
      "r855",
      "r856",
      "r867",
      "r868",
      "r903",
      "r912",
      "r928",
      "r933",
      "r935",
      "r936",
      "r942",
      "r943",
      "r944",
      "r959",
      "r1192",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r75"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r75",
      "r100",
      "r116",
      "r121",
      "r134",
      "r136",
      "r141",
      "r153",
      "r156",
      "r157",
      "r162",
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r188",
      "r249",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r322",
      "r325",
      "r328",
      "r333",
      "r482",
      "r535",
      "r540",
      "r572",
      "r600",
      "r712",
      "r806",
      "r828",
      "r829",
      "r881",
      "r883",
      "r885",
      "r975",
      "r1190"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Standards During the Period and Recently Issued Accounting Standards Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "angn_NewtonMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "NewtonMassachusettsMember",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Newton, Massachusetts",
        "label": "Newton, Massachusetts [Member]",
        "documentation": "Newton, Massachusetts"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1014",
      "r1024",
      "r1048",
      "r1057"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other expense, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r892",
      "r902",
      "r1174"
     ]
    },
    "angn_NumberOfResearchGrantAgreements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "NumberOfResearchGrantAgreements",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of research grant agreements",
        "label": "Number Of Research Grant Agreements",
        "documentation": "Number Of Research Grant Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingCostsAndExpensesAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r881",
      "r885",
      "r891",
      "r1173",
      "r1175",
      "r1176",
      "r1177",
      "r1178"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1253"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesNarrativeDetails",
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, current",
        "negatedLabel": "Less: operating lease liability, current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, noncurrent",
        "verboseLabel": "Operating lease liability, noncurrent portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash outflows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r624",
      "r627"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets, operating leases",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1155"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate\u2014operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r629",
      "r948"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term\u2014operating leases (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r628",
      "r948"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business and Financial Condition",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r117",
      "r118",
      "r119",
      "r748",
      "r749"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r91"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive gain:",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees and other general and administrative expenses",
        "label": "Other General and Administrative Expense",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r1303"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncomeAndExpensesAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (expense) income",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "OtherMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other research and development expenses",
        "label": "Other [Member]",
        "documentation": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "angn_OtherPrepaidExpensesAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "OtherPrepaidExpensesAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other prepaid expenses and other current assets",
        "label": "Other Prepaid Expenses And Other Assets, Current",
        "documentation": "Other Prepaid Expenses And Other Assets, Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1012",
      "r1022",
      "r1055"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1015",
      "r1025",
      "r1058"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1015",
      "r1025",
      "r1058"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "angn_PaymentOfWarrantIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "PaymentOfWarrantIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of warrant issuance costs",
        "label": "Payment Of Warrant Issuance Costs",
        "documentation": "Payment Of Warrant Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "angn_PreFundedWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "PreFundedWarrantMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrant",
        "verboseLabel": "July 2024 Pre-Funded Warrants",
        "label": "Pre-Funded Warrant [Member]",
        "documentation": "Pre-Funded Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r335"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r787"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r335"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r787",
      "r805",
      "r1304",
      "r1305"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.01 par value; 10,000,000 shares authorized; no shares issued and outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r324",
      "r330",
      "r703",
      "r949"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails",
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1098"
     ]
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseOtherNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term prepaid assets",
        "label": "Prepaid Expense Other, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1097"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r875",
      "r904",
      "r1180"
     ]
    },
    "angn_PrepaidResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "PrepaidResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid research and development contract services",
        "label": "Prepaid Research And Development Expenses",
        "documentation": "Prepaid Research And Development Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock and common warrants from January 2025 Offering",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs.",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "angn_ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock from July 2024 Public Offering",
        "label": "Proceeds From Issuance of Common Stock From July Public Offering",
        "documentation": "Proceeds From Issuance of Common Stock From July Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock warrants from July 2024 Public Offering",
        "label": "Proceeds From Issuance of Common Stock Warrants From July Public Offering",
        "documentation": "Proceeds From Issuance of Common Stock Warrants From July Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from issuance of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r752"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of Convertible Note, net of issuance costs",
        "label": "Proceeds from Issuance of Senior Long-Term Debt",
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer)."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock warrants from March 2024 Offering",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from June 2025 Promissory Note, net of issuance costs",
        "label": "Proceeds from Notes Payable",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of property and equipment",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_ProceedsFromSecuredLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSecuredLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of credit",
        "label": "Proceeds from Secured Lines of Credit",
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r13"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the exercise of common stock warrants",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r1153"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r243",
      "r652",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r872",
      "r880",
      "r883",
      "r885",
      "r913",
      "r914",
      "r958",
      "r959",
      "r960",
      "r963",
      "r966",
      "r1093",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1188",
      "r1189",
      "r1269",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r243",
      "r652",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r872",
      "r880",
      "r883",
      "r885",
      "r913",
      "r914",
      "r958",
      "r959",
      "r960",
      "r963",
      "r966",
      "r1093",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1188",
      "r1189",
      "r1269",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298"
     ]
    },
    "us-gaap_ProjectMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProjectMember",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Project [Domain]",
        "label": "Project [Domain]",
        "documentation": "Planned program of work."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r688",
      "r1265"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r631"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r125",
      "r710"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r631",
      "r697",
      "r710",
      "r949"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r110",
      "r111",
      "r708"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "verboseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r631"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, useful life (in years)",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "angn_PurchaseOfWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "PurchaseOfWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase Of Warrants",
        "label": "Purchase Of Warrants [Member]",
        "documentation": "Purchase Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r205",
      "r277",
      "r278",
      "r279",
      "r280",
      "r378",
      "r441",
      "r473",
      "r474",
      "r475",
      "r481",
      "r493",
      "r578",
      "r647",
      "r648",
      "r650",
      "r736",
      "r738",
      "r746",
      "r777",
      "r778",
      "r837",
      "r839",
      "r841",
      "r842",
      "r844",
      "r852",
      "r853",
      "r855",
      "r856",
      "r867",
      "r868",
      "r903",
      "r912",
      "r928",
      "r933",
      "r935",
      "r936",
      "r942",
      "r943",
      "r944",
      "r945",
      "r959",
      "r969",
      "r1186",
      "r1192",
      "r1244",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r205",
      "r277",
      "r278",
      "r279",
      "r280",
      "r378",
      "r441",
      "r473",
      "r474",
      "r475",
      "r481",
      "r493",
      "r578",
      "r647",
      "r648",
      "r650",
      "r736",
      "r738",
      "r746",
      "r777",
      "r778",
      "r837",
      "r839",
      "r841",
      "r842",
      "r844",
      "r852",
      "r853",
      "r855",
      "r856",
      "r867",
      "r868",
      "r903",
      "r912",
      "r928",
      "r933",
      "r935",
      "r936",
      "r942",
      "r943",
      "r944",
      "r945",
      "r959",
      "r969",
      "r1186",
      "r1192",
      "r1244",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263"
     ]
    },
    "angn_ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of liability-classified warrants to equity classified warrants",
        "label": "Reclass Liability-Classified Warrants to Equity Classified Warrants",
        "documentation": "Reclass Liability-Classified Warrants to Equity Classified Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RecoveryOfDirectCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RecoveryOfDirectCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract and grant reimbursements",
        "label": "Recovery of Direct Costs",
        "documentation": "Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1007",
      "r1017",
      "r1050"
     ]
    },
    "angn_RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "RegistrationStatementMember",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registration Statement",
        "label": "Registration Statement [Member]",
        "documentation": "Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r161",
      "r162",
      "r637",
      "r638",
      "r1255"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r161",
      "r162",
      "r1255"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r161",
      "r162",
      "r248",
      "r637",
      "r638",
      "r639",
      "r810",
      "r811",
      "r814"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r635",
      "r636",
      "r638",
      "r640",
      "r758",
      "r759",
      "r760",
      "r812",
      "r813",
      "r814",
      "r834",
      "r836"
     ]
    },
    "angn_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r153",
      "r163",
      "r164",
      "r296",
      "r337",
      "r639",
      "r649",
      "r699",
      "r876",
      "r877",
      "r878",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1235",
      "r1236",
      "r1237",
      "r1238"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1223"
     ]
    },
    "angn_ResearchAndDevelopmentArrangementCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ResearchAndDevelopmentArrangementCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit",
        "label": "Research And Development Arrangement, Credit",
        "documentation": "Research And Development Arrangement, Credit"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchAndDevelopmentArrangementGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ResearchAndDevelopmentArrangementGrant",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant award",
        "label": "Research And Development Arrangement, Grant",
        "documentation": "Research And Development Arrangement, Grant"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchAndDevelopmentArrangementGrantReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ResearchAndDevelopmentArrangementGrantReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant award received",
        "label": "Research And Development Arrangement, Grant Received",
        "documentation": "Research And Development Arrangement, Grant Received"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/ResearchGrantDetails",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r870",
      "r881",
      "r882",
      "r897",
      "r1264"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development and Grant Income",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/ResearchGrant"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r869"
     ]
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF July 2023",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) July 2023 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) July 2023"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Sept. 2022",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2022 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2022"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchMember",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Tax Credit Carryforward",
        "label": "Research Tax Credit Carryforward [Member]",
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes."
       }
      }
     },
     "auth_ref": [
      "r1230"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1008",
      "r1018",
      "r1051"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r998",
      "r1009",
      "r1019",
      "r1052"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1016",
      "r1026",
      "r1059"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r92",
      "r124",
      "r150",
      "r702"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, current",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1096",
      "r1156"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, noncurrent",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r1097",
      "r1156"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedTerseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r86",
      "r706",
      "r743",
      "r745",
      "r756",
      "r788",
      "r949"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r167",
      "r168",
      "r169",
      "r171",
      "r178",
      "r180",
      "r182",
      "r250",
      "r251",
      "r262",
      "r321",
      "r482",
      "r524",
      "r525",
      "r532",
      "r533",
      "r534",
      "r536",
      "r539",
      "r540",
      "r559",
      "r561",
      "r562",
      "r564",
      "r570",
      "r619",
      "r621",
      "r740",
      "r742",
      "r761",
      "r1304"
     ]
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetirementPlanTypeAxis",
     "presentation": [
      "http://www.angn.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Axis]",
        "label": "Retirement Plan Type [Axis]",
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927"
     ]
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetirementPlanTypeDomain",
     "presentation": [
      "http://www.angn.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Domain]",
        "label": "Retirement Plan Type [Domain]",
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927"
     ]
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty Expense",
        "label": "Royalty Expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "angn_RoyaltyRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "RoyaltyRatePercent",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty rates (as a percent)",
        "label": "Royalty Rate, Percent",
        "documentation": "Royalty Rate, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "angn_SaleOfStockAggregateInitialOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "SaleOfStockAggregateInitialOfferingPrice",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, aggregate offering price",
        "label": "Sale of Stock, Aggregate Initial Offering Price",
        "documentation": "Sale of Stock, Aggregate Initial Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "angn_SaleOfStockBeneficialOwnershipLimitationPercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "SaleOfStockBeneficialOwnershipLimitationPercentage",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, beneficial ownership limitation, percentage",
        "label": "Sale Of Stock, Beneficial Ownership Limitation, Percentage",
        "documentation": "Sale Of Stock, Beneficial Ownership Limitation, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/SubsequentEventsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares sold in offering (in shares)",
        "verboseLabel": "Shares issued of common stock",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Loss Per Share, Basic and Diluted",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r932",
      "r1224"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1241",
      "r1242"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income (Loss) Before Taxes Related to our United States and Foreign Operations",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1158",
      "r1164"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Principal Payments",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r631"
     ]
    },
    "angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Quantitative Information On Operating Leases",
        "label": "Schedule Of Quantitative Information On Operating Leases [Table Text Block]",
        "documentation": "Schedule Of Quantitative Information On Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r161",
      "r162",
      "r637",
      "r638",
      "r639",
      "r810",
      "r811",
      "r814"
     ]
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development, Contract to Perform for Others [Table]",
        "label": "Research and Development, Contract to Perform for Others [Table]",
        "documentation": "Disclosure of information about research and development arrangement accounted for as contract to perform research and development for others. Includes, but is not limited to, royalty arrangement, purchase provision, license agreement, and commitment to provide additional funding."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1223"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r446",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r481"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r87"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock, Class of Stock [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r84",
      "r85",
      "r86",
      "r129",
      "r130",
      "r131",
      "r199",
      "r335",
      "r336",
      "r337",
      "r339",
      "r342",
      "r347",
      "r349",
      "r556",
      "r752",
      "r753",
      "r754",
      "r755",
      "r912",
      "r1092",
      "r1158",
      "r1160"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.angn.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Outstanding Warrants",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r1194"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r931"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r197",
      "r207",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r224",
      "r225",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r247",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r273",
      "r274",
      "r537",
      "r538",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r894",
      "r897",
      "r898",
      "r905",
      "r962",
      "r1269",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails",
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r202",
      "r245",
      "r246",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r692",
      "r693",
      "r694",
      "r695",
      "r774",
      "r775",
      "r776",
      "r838",
      "r840",
      "r843",
      "r845",
      "r852",
      "r854",
      "r855",
      "r856",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r873",
      "r888",
      "r913",
      "r915",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r961",
      "r969",
      "r1269",
      "r1271",
      "r1272",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r197",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r222",
      "r224",
      "r225",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r247",
      "r892",
      "r895",
      "r896",
      "r897",
      "r899",
      "r901",
      "r902"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r224",
      "r225",
      "r239",
      "r897"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r242",
      "r245",
      "r893",
      "r894",
      "r900"
     ]
    },
    "angn_SeniorSecuredConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "SeniorSecuredConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Convertible Promissory Note",
        "label": "Senior Secured Convertible Promissory Note [Member]",
        "documentation": "Senior Secured Convertible Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r474"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r475"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r475"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r446",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r481"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for future grants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option Activity, Additional Disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r454"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r454"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (unvested) (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, total intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r453"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r453"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award, Share Limit",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Share Limit",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Share Limit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (unvested) (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r451",
      "r470",
      "r471",
      "r472",
      "r473",
      "r476",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term in years",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, total intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share of shares issued (in dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r120",
      "r197",
      "r207",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r224",
      "r225",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r247",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r265",
      "r273",
      "r274",
      "r537",
      "r538",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r894",
      "r897",
      "r898",
      "r905",
      "r962",
      "r1269",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r129",
      "r130",
      "r131",
      "r153",
      "r157",
      "r186",
      "r187",
      "r189",
      "r191",
      "r199",
      "r200",
      "r249",
      "r283",
      "r285",
      "r286",
      "r287",
      "r290",
      "r291",
      "r323",
      "r324",
      "r326",
      "r327",
      "r329",
      "r332",
      "r335",
      "r336",
      "r339",
      "r342",
      "r349",
      "r600",
      "r752",
      "r753",
      "r754",
      "r755",
      "r761",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r787",
      "r807",
      "r830",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r1092",
      "r1160",
      "r1162",
      "r1171"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/SubsequentEventsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r59",
      "r60",
      "r114",
      "r115",
      "r116",
      "r139",
      "r140",
      "r141",
      "r167",
      "r168",
      "r169",
      "r171",
      "r178",
      "r180",
      "r182",
      "r198",
      "r250",
      "r251",
      "r262",
      "r321",
      "r351",
      "r482",
      "r524",
      "r525",
      "r532",
      "r533",
      "r534",
      "r536",
      "r539",
      "r540",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r570",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r619",
      "r621",
      "r633",
      "r713",
      "r740",
      "r741",
      "r742",
      "r761",
      "r830"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails",
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r202",
      "r245",
      "r246",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r692",
      "r693",
      "r694",
      "r695",
      "r774",
      "r775",
      "r776",
      "r838",
      "r840",
      "r843",
      "r845",
      "r852",
      "r854",
      "r855",
      "r856",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r873",
      "r888",
      "r913",
      "r915",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r961",
      "r969",
      "r1269",
      "r1271",
      "r1272",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r198",
      "r323",
      "r324",
      "r326",
      "r329",
      "r621",
      "r652",
      "r750",
      "r762",
      "r773",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r787",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r808",
      "r809",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r830",
      "r883",
      "r885",
      "r970",
      "r1301"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity (deficit):",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r198",
      "r248",
      "r323",
      "r324",
      "r326",
      "r329",
      "r621",
      "r652",
      "r750",
      "r762",
      "r773",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r787",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r808",
      "r809",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r830",
      "r883",
      "r885",
      "r970",
      "r1301"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1011",
      "r1021",
      "r1054"
     ]
    },
    "angn_StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from the exercise of July 2024 Common Warrants (in shares)",
        "label": "Stock and Warrants Issued During Period, Share, Preferred Stock and Warrants",
        "documentation": "Stock and Warrants Issued During Period, Share, Preferred Stock and Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from the exercise of July 2024 Common Warrants",
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Convertible note into common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r36",
      "r56",
      "r59",
      "r86",
      "r309"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r86",
      "r752",
      "r830",
      "r847"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock upon settlement of restricted stock units (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r86"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options (in shares)",
        "negatedTerseLabel": "Options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r86",
      "r457"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Convertible Note into common stock, net of issuance costs of $0.3 million",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r59",
      "r60",
      "r86"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r86",
      "r761",
      "r830",
      "r847",
      "r976"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon settlement of restricted stock units",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r86"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r59",
      "r60",
      "r86"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity (deficit)",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r59",
      "r60",
      "r76",
      "r789",
      "r805",
      "r831",
      "r832",
      "r949",
      "r977",
      "r1158",
      "r1162",
      "r1163",
      "r1179",
      "r1248",
      "r1304"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock and Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r334",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r351",
      "r556",
      "r569",
      "r833",
      "r835",
      "r851"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.angn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r642"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r642"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.angn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r642"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r642"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r642"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.angn.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r643"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/SubsequentEventsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward [Axis]",
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward, Name [Domain]",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_TaxPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxPeriodAxis",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Period [Axis]",
        "label": "Tax Period [Axis]",
        "documentation": "Information by period subject to enacted tax law."
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    },
    "us-gaap_TaxPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxPeriodDomain",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Period [Domain]",
        "label": "Tax Period [Domain]",
        "documentation": "Identified tax period."
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    },
    "us-gaap_TaxYear2017Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxYear2017Member",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Year 2017",
        "label": "Tax Year 2017 [Member]",
        "documentation": "Identified as tax year 2017."
       }
      }
     },
     "auth_ref": [
      "r1227"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "angn_TranslationalMedicineAndCMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "TranslationalMedicineAndCMCMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chemistry, manufacturing and controls expenses",
        "label": "Translational Medicine and CMC [Member]",
        "documentation": "Translational Medicine and CMC"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.angn.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares outstanding (in shares)",
        "negatedPeriodStartLabel": "Treasury stock, beginning balance (in shares)",
        "negatedPeriodEndLabel": "Treasury stock, ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 14,455 shares outstanding",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r59"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "angn_UniversityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "UniversityMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "University",
        "label": "University [Member]",
        "documentation": "University"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails",
      "http://www.angn.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Gross unrecognized tax benefit, beginning of period",
        "periodEndLabel": "Gross unrecognized tax benefit, end of period",
        "verboseLabel": "Uncertain tax positions",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r514",
      "r931"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r931"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) recognized in the income statement",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns."
       }
      }
     },
     "auth_ref": [
      "r1228"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r201",
      "r203",
      "r204",
      "r205",
      "r692",
      "r694",
      "r889"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance increase",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "angn_VestingOfRestrictedCommonStockNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "VestingOfRestrictedCommonStockNoncash",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash vesting of restricted common stock",
        "label": "Vesting Of Restricted Common Stock, Noncash",
        "documentation": "Vesting Of Restricted Common Stock, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "angn_WarrantExercisedFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "WarrantExercisedFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants at issuance date",
        "label": "Warrant Exercised, Fair Value",
        "documentation": "Warrant Exercised, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantIssuedDebtIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "WarrantIssuedDebtIssuance",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants issued with June 2025 Promissory Note",
        "label": "Warrant Issued, Debt Issuance",
        "documentation": "Warrant Issued, Debt Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantIssuedStockIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "WarrantIssuedStockIssuance",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants issued with January 2025 Offering",
        "label": "Warrant Issued, Stock Issuance",
        "documentation": "Fair Value Of Common Warrants Issued With January 2025 Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrant Liability",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liability",
        "label": "Warrant Liability [Member]",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issuable upon the exercise of common warrants",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r967",
      "r968",
      "r971",
      "r972",
      "r973",
      "r974"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and rights outstanding",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1243",
      "r1244",
      "r1245"
     ]
    },
    "angn_WarrantsAndRightsOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "WarrantsAndRightsOutstandingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding [Abstract]",
        "documentation": "Warrants and Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, measurement input",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r1243",
      "r1244",
      "r1245"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtNarrativeDetails",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, contractual term (in years)",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1243",
      "r1244",
      "r1245"
     ]
    },
    "angn_WarrantsAndRightsOutstandingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "WarrantsAndRightsOutstandingTextBlock",
     "presentation": [
      "http://www.angn.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrants And Rights Outstanding [Text Block]",
        "documentation": "Warrants And Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "WarrantsFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrants, Fair Value Disclosure",
        "documentation": "Warrants, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average",
        "label": "Weighted Average [Member]"
       }
      }
     },
     "auth_ref": [
      "r473",
      "r474",
      "r578",
      "r648",
      "r867",
      "r868",
      "r942",
      "r1258",
      "r1260",
      "r1263"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding, diluted (in shares)",
        "verboseLabel": "Weighted-average shares used in computing net loss per share, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r191"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.angn.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding, basic (in shares)",
        "verboseLabel": "Weighted-average shares used in computing net loss per share, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r191"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_YekaterinaChudnovskyAndJayVenkatesanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "YekaterinaChudnovskyAndJayVenkatesanMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Yekaterina Chudnovsky And Jay Venkatesan",
        "label": "Yekaterina Chudnovsky And Jay Venkatesan [Member]",
        "documentation": "Yekaterina Chudnovsky And Jay Venkatesan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_YekaterinaChudnovskyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20251231",
     "localname": "YekaterinaChudnovskyMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Yekaterina Chudnovsky",
        "label": "Yekaterina Chudnovsky [Member]",
        "documentation": "Yekaterina Chudnovsky"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-7"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715-70/tableOfContent"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480606/715-80-35-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-9"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8C"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479693/815-10-S50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii)(B)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479664/932-10-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477385/932-360-S50-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-18"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-1B"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>139
<FILENAME>0001601485-26-000027-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001601485-26-000027-xbrl.zip
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M/D(^X"$H01[-(6LD]Z.(I"8<B1'Y'\5 S+_L1>YXXB';T&>C$$^<H>#:0^0
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MJCEX+;Q]L\@8>3T(6Y4?""1J5-:3'<KMY5J4EY0K&R_9*0SAG<VW;-\NV2F
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M@(@)5N!BP&,;'L$"X:[2PW=84!$\3%.S&LTKB]086%'X:R1P)B8>LB^<TU?
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MU5FE/OH12E+=,(TZZB.QQB"JL#.]YN!2[7=!5^Y$S89FO^(4;XR[E*&6G2>
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MPL_3MQ(RQWP(E@"Z#H).XI$>".=Q(Q6GS1RW,GL+&>=1PP0HOZ>Z*6KL,LD
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M7'KEDP755"B@.OW&(%K%KA,2S%(;XK?,M_!0 K4@7)/\6"H?T4RC]Y:_FSS
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MOT#KEWK'N3/3TRKDUQRDR8"6BA)C*(T*"VGL ^9A1(S$Q:"@4::8ED[ 4[W
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MX>3C;RJD@]$S%<^AX*"J2A?N="[$4S'#.PI!HG+8'9/4%@\#5%6QZ(6"('Z
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MO6Y:WXR75*D<5)<:F17P<H(<;<,6.1Q]#OF<JN.&(C-J'ITBTR)\K5^ESW&
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M8XQ!UC/PF8F>JK85/950%-P0WUERJQ$%)W 9 L@5,L2]?@(F3(F=5,\-//X
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MZ?UMI2!%0ZZP.NJEYHPNB%_NN7>&E8#(AD5E:])SI+7+0M$10\HI,^1@]>Y
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M>%H:AI^V(U$C:(YDJ2OC9#FY$Y/EF/BAG&N;'KH_(&QC:&->.(WI:_"P'L0
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MPSIZ)!-2"G%=&61G.?['XN6O7[V:PPVN&9'58(1;0?;!6H&ZNI+;QN0Z'Q?
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M#"OE? Y2AVREMA[\F1U5@^2AF)>OYLBP/U0$S6U)=\%-O6?X!>@@K4U092N
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MI_TD_AN4"2V'@_%[;:KI/2#'EET4E3BAE;.C1%A;<5DUTZB?.NM%.7F=_LA
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M=P:YH=MB8LCPZHN;^G\\:/H08$.)=_#W= /.[:U1H^-N?X*9;/OR?GI /A$
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MB'^CGMC*P5:5Y#Y39K-PP&(+L9:%EJS'N0J@DY*2/=35AP?.-09(G^VJ"]H
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MX7L88E#N=1_Y6!<MYD=OVT3K4?+%#SC8J50Z[]9A/'QSY]'T>*@?-S1RJ(A
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M^&8!67Q@O,OVHLZ+-2]2&7[R#Z#WUS.9-K'M[TG[5TPIGX;<F<VO41L^8-8
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M=36M@)3DGG\XBO#P?@>\Z:Y:^V?T0&=0!U<,F<<G?;KYR9+\I#T]GM+FV/N
MV(LO0^KE^FI"/9SNMM=/S;IR6+PK\H18N5;22$4LX1(H'CT_2!8+F>PK%L6#
MX^L^Y6F^ZFN)%%RQ]B6Q&HO-Y=/T F-9\<"E!5:$#I@]"I;;HSB=8"/?5N01
MRE:%;^]<6(6'O[N4#1:.!_= 53IXCSQ+:0M^:S@X?8[HVR+5+,\QA$%TMB!R
MNP1WD3'D2*L5)4J/"<I$3YMV,12R75]Q87D$%>F?S1%<]\+MKVFR7!W,OX,(
MYE%:$]-*CK!'F-CAMFQV)J/C+=*^8GJ\:=RK8[FW ^TPM1?3'VK3)36 CMS=
MM*V$O5B?8<VU-)AP!]) #;ES9'-$@Y';.%0Q)X=;Q3EJ_G4#)0]QR+=/L#A0
M9L=CH\P_K#+/C++!]^,P9Z]%82O3L:G5C-0U]YY.5],A%<KF#7A N7?L0IE5
M*XI3CB1O"$)GS038I-1[I:&94Y#2%L+*2)JX'+B\N6%TK*"T^'0WC164;KGE
M:3\(9/@H=>U KS-XJV;HR?.//OIC@>GH!C!PI61T\4*$R*MDS<XV4$R - HI
M.M>+[R7*S0[NEH$@W"-1U<*@5GLLX9?%4M"' *_2=D8 L,>+2LZ<I\!,J*Y&
MY&RW2J+@4J;HUPV]ZKTX78ON).<O %,75IYQ(;N;#Y$J2XEZ)=[X^!$4H)0<
MX_Y"Q7$8:XW(_YYKFB9ESXR(0X!(>\C]Z2,Z2B=KP DWP4*IX4TY(W[X  60
M_-PTDF6-6LYH$DC>W=6.@I%-L7IO3%EM0B/KN[Z:P%LG*+V''17A0'TJCOU!
MUF:85SS'%N=,/KX;[:))@]P)BL5OV\PP%[:H<Q\G"U83RF\U/I_,4L,1!ZLM
MC%U-2)& _J5U)>-D5.I&L73%]-1RQF)LN?I&#N&LY-O[%M @81<$[T[)M+/U
M^"T<"[FK;&R"J",5R0_)E;3,2B)IMP_E0(A6>4CR+_2C2KETJ^[-?9GC>PU.
MZYX55ZLZ*+A!][<=S\ ;+"<R@IE'5&W=#_$0?/A(T[_B9IP73U[[92/@]\A9
M'&Y1#,9_*%:U]ZJ=9IVD2$-%L<<!RL&ID3N UQ8$\V_A/-K2*NK@1:M\6*M7
MC/!418R8D[21LS]=21'?L[_\Y4_N.7_YXM55\IT15['>N.Y[N]4@)THUK$FI
M"03;H._GLK'5]T@968+S2#M[,'(5^:Q"DZ_-;255=ML*NZ>=(;HUFR@%*UZ.
M*TH <$'_(DK9PE>9NB1*EUJK(^.QUKDWR:7I6WCK(%EQP<Y8FJWF?HV CP<=
MS[KUJ- S7ZB=U2A6+.LXSC =/J^*Q<40X%I(2IE)I\1P<,J%;=744L63H@Q\
M5Q9&\-!>D&?XSW\VJEXX#-UXF.H=LPGI=;(T^W&CJM /2U:U+OHJ/I"3\EQ!
M@\K],\/C?:5[A[.2@@R%Y]SYC>,!-E@+OG3N;]B#M6U3H2&<QCW8@187[JUE
M^>TS?4V5PB7#N]=\5TS6O3BS\ @&%I-H8"(3BC_:EZCD(4'O10#-*40\]YKG
M7([],II:K7=G)YW?6SG"N/*KH?NI8[Z..'@P\%N\(^#[R.5SZHMBXM.9H%:O
MS(UY/3(TII4D@"'4ZKWR!.=TX\.4&R( 38?0,MM.(]LBSA+U(" #^+?;NMGV
M5>LIG+E.49W]0=;].V7Z/U223;3X;ML10&TIL**-OG[Y.CB8[L>E )H1?@R.
MR)"X)LA1C?#.@X [3^QP6<:AMFHI>/K++$>'0,1EHR^W=R48#)D_.=$-+V*4
MM!B"XPL\A=MN.#"B-J^G31PF0IS!HD^3672I =^^K1JXBVD\AAYD8C"K$5G)
M>;Q<71LQCBT9J!,G'9DD=H.@J3NXR!KNU]8=J08:[Q(;P7LTZ()J7#(RNXCV
MB2QCC_TR.NL*UPK/S.OS*,2<['_=J0*8QZX= #HXH%5NXYERY$L1OC&Y9\%&
MOWAI0]Y4F]N6;[J$N+R,G%]Z;4=!?X=L"#_'[;HWGU]_&<O*WREHU%.8X%1:
MOW+.CQ!5F,0-L89%*!I70J-V(#/+BBA3$+!QELL:8DHO7E9XZDSZ"D:B <R_
M=MXM2O/G?R-F^TXIR[?#[6%(0S\1J3(@LIO:X4F?.EPPX'G837(T[C!TFUJ@
MEUI0)H4[20E'3NC"9\;A2,6/J?,?=^7D(WY""3%*Z#^?4$)/**&?4]/<=_U;
M!&L*L:K%AQ;"<\Y60;X(8[ V.13A>'Q8ON7II.FEUR8,.ZTWA\$D$,W$G@K]
M J$F4<<D%YUN%0U(JU:=BX5L08HI12"FA?8MHC15$\6RU!,#R1-F\H<;]@<4
MOT\"IR='W+NPHIU&5ER[JQL?IZ;S4.FF*2)@A[T(/]:O*Y8IA=8RM2Y^D5<@
M#%7UUD?C\G5760U/A_)<FYG2(2*S!1\Z RYX;N\?E6<F9KN)S9ROV?_/WKLV
MMW$EV:)_!3$Q]X8=463KZ>D>Q[T1-"79:EMM'<D^CO.Q !3(L@I5Z"H4*<RO
M/SM7/G;N>E!4MT6+-N9#CPP"]=B/W/E8N9:/VAR)JE&4Q",'_6ANQL$2U'>%
M%O?FEYDZITG/D7HP2 _T8^\S;=/D.V)D" 500TZ2B^M*T&\=>%#HZO8,:@N/
MPK]-"25D=:$(3UY)\FCWW3%-"D,W-%A-M\-$*!M_"XXL'61A:!,"0&[E\1TQ
M\=)3O3&X'7NW FFL*OY3QN(J5#)C\0CC7-;?!OO$"^M$^RMCD,?.#9)"SG5+
MY*'/"5\=MEJ9&[\HXM/X\;D^L'8D)B1*YZ_/AOQ)^Z9YYS1J_QZB:,J0/\R$
MT$G8@_D_W(VN&K2$>7:G^$>]^1N:S6[D=I^_?C-Z#N'JBB*LS-&5/L]C*=DE
M]5Z$"!RQT0LJ*0;2^4.!(#\5*8%I+#&L&V[H$A,37CZ^63;LQC,P!2?VR H/
M*>LE/S4Q/ [\>(9OWO<=^XJ2AA+E<3*,3L]\W>R0*K?6V9Q:9WDC=>'X)&@_
MC25M387T+HE?2#<D;]$H#,4(DYPL/E7B5\V.<Z36<S*%+Q3\PMI2H<,>4&\S
MG!)("<HK2CJ>)WH-;';H!=6-4*G*3@Y"A1[%SI63)**C)3FXJEV1B;@L$(NT
M1_'!I@BA^=!-M2-PL$TWV]B)'1GVW:^A-549TPSF)49L@R_J<VS[ZD)=JAN
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M(KKR!=@MW.F)*'15J%W[DEE[=OO421L7H!,N#>XL4KUH#<W46=HVZZ+J%&E
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M)6.0<^%$YY!#3&*!JESX=/ .'?HFR;U8@Z^]TV4Q6G)NAT H2H!4=CMA)67
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MD@M*;_E32]$G^8LE\DVQOZP+3H$P#*LDO5#J2*R94('0!V%FS2F6IK)>:][
MAY1;H083#X#V@S3>= YS]@2_5>%P=2Q8*K-@I>FE]/RARLM<W0[P=T,Z[ 88
M8T+/,Q;83$BL2:_G0@*X/7GO> H: "_::'P4=7"QFO:=RB\9XLBW$0)_^:)8
MMOK67V6+UV%Y0D9%G*I!6L>L#-W8O1(GU>#G*05(%#Y:]NL+RE(RX"^IAO?,
MR0P#PP=$@@XCOY]V+[,G$H".E)*IEL9!P-+00H V),)J28N,DE!][?M_ +O
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M=O!7BT1Z];HE=PE CJ9E*59S[\OHJC?LW,K-Y-1FSF3"4(<I@QOUSYY EYC
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MI+^@X/+1@X</L6$B&O)<O0G*1 ,@1Z!&XC"BYO26 &Y.RY&=BK/Z@O[]3=D
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MY:X4-",(7^EEU:CXUK=@04<"-E:TV.J:6L+X2.O&3]K9[9=%Q"<JG9F]H5_
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M?,^J!)0Q.BA9VRZLK#W@Z&[[)-'4,H460ZG&$&"CZQX/\SO#!KH.$:"2.*0
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M),)RA7]P0SPUC_*_VH(GN;1&>1"V;8I6F.8GRE<6CG]0)6U^XO],0-TG#XY
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M3":*?DPMN#8*% 5_#I/6Q&<J[=[@B!QV71,=Y:*@U&'D(B 18T9#S'=W_:D
M]P^/@/LCX/Z3)[AOM'M,#GE!CMH7L($/OG[S_-5;_//AUU]FDJ8F[DBU .NV
MO^ *"!3'*8&W\;!Q6(P%]?#8^11QOX8N%<TZV!>MK!U/E;MV'.+$@$9"7 >E
M9;DL=UTV *PY=-PT..XXB7> :)L ]-\B8WR<FCNAW"CV9=1^-]F9Z#B1\*)Q
M.(4]1/_-;1(H5?%TY:O+PN61P]YJ+XZ=$G>3U3!(P(9 G24@OV&>'$.;]F-Q
M*5?"+^MTIMW8>BFDM,=Y$(4=+>:='WM5H3,UJ+42;,)I/QB"@I+X98<)]O +
MG^\_)O9__WEUY5R'!Z#&3)%1,/R>M$IJ2R0!?OI1Z?C(0G*W,Z@X)?8P(X?8
M(O;/#JOF;'H]GX"BOD$K )C_C0A^ F(U+2F+#(NX1X3W'>>YU()6ADM@J/U]
MARB=@>DUO#BA- 8X6LJM38$.6<:^(_EZ2N ).*,E$9'UHM]11JU+$G51TBXB
M,GX;F-=G@KH#CIC[J1AO96>PSWKS[DX;DV-#G@ X%CC'(PZE+8!%JB\@!QDI
MY1(PJ16*&;5>K'I%+[%DTBUO ?PY,SX2[J:N"^9/9&C(\#*=A^:L"VI:@WXU
MIU_L#3T&D!?7 AAG5HE?;,LNZM0K(HN$JYH*GLIZ4M#>X,8C_3 &<S(&:A.\
MX'I5Q*LRR X\R=#*Y>?AA<]04FUI^ /IJ/Z2M@=DS,TOA\K; D63Q9,'3RS)
MYC[37)L"X=[F[3(/!]#)C^^K(KBDJSVK^CQXQ".Z946M+^B[>K713V("#UI"
M;0V^"EF&U%01WC;GC,V"LO]C#!'/F"VQVI5Y/V(_G=.N.1@MEQ\*&2RLD?*B
M:9N>VYJ#^:<%);2GGM[/.*-H^PCT6A2'0+<Z@?M.=NWHN6.!(K,6#<;7'J*K
M2-3?ZS(7+K*X>3=Y=QD^T_80PH:S#RJF")$DGGAU^.B1PU2C7Y14S]9YN^;N
MBFVS1M-3QFXK)I!)8'5=<,\!#1 !SLIM,0>)#RX6L.S:6Y+7:+Q@-!I5;,+_
MLE@O<,;V1: Q_P7C.D5Z[M?#_/)77A+4@6A&>@5<.L9S^_WS<YT2H=_5IM\#
MU V[[C=8V-F<#93'+%T*(56:XDMTVM8R%G-46\Z5.\&:FRF7[\OC*S\JBUJ3
ML,2]QW.GFIH,.*7AI0=,&N-L2*Z+_%T-N1H]A#YB&I6+>; W:*&T^RC6-CZ7
MH4^L:^AT\8+DGM_G9&PR?0S"+],?MHN'#TZ^S]R;D!/W6SR_[0@)7<RNU5=E
MVX!#[W3QBD:K&RI">F?"-C8[FFK!"%5MDFKD1U;8OWW-SF5P'E80MC2Y( '4
MR0BY9V,K_)Y)VW+!)SOO@'FZJSPL8O)C\:*%<,W;#0&H3S1RD+BAI_OY].VI
MM%]14,B)\2+Y=?AF&+Q=Y0I=^-6W9V>O[01&Z@<) .K="$/<%5JH(BU(68:9
MGAO)(VJ_)5Y4Z,U/PJ&VIU8:_^*LP$<(WIDY*&N7.IR:=8944:^-#?; GG-C
M9[&.'9C7Z+%;K5HPO^PEP"!U3NEG(PV]"_ 9Z(&'QR*O=&:IJL;G0.)SH>J>
MV+[L4DQ=@7:0VP\IF7/3:G<=R/?]:7Z(:R"1Y@@KQQ\GDWXVVJAH&!.?5^,Q
MP[GKX])/Q7<>V.7H9>M!T%'W4\G2]@.G>.*698T=%;$1X3BHBGS-R'37@064
MG3/OBQ>Q!\T/Q^U.4GYX"[E)0+9?_DHG"8ON=;DJ 3;:LV4$%M*)&\Y7=@U?
MV,N\K-?A!&D/BS<1<W1F\B0?:-M-")RM-T\E3>E=XFF:AX]*E8VL(IS$U"Z=
M="2IHMS_J)>:Z\*"<+TRIAT**T#_H$T0#%)A/,O7I*&82ET.Y)XYU6:) K$2
ML'78VNL"2!JU;0F8:-)KT19AO\+#..Y[7COT&K#AY-$2,KZ#OWQZZP3K9^JM
M?#XSQ-J;R[S"T7E95&I1NR+.(BJ)[U<%6_;%BW"RD43),[G62SI!\/OSIMU)
MQ=\"$+ME:5]CS%AXY?]\]/1!%D89GG<^O0KH>8PS!Z,V6 UL=#HS262/'"V!
MNK[6-10% **.:QAY:H%2/0_NJ+9UZZZ<1_/2<  @?:O)5.()^QIO3/8;S]JT
MHVLQP(X#'!4XN.7E3A=G(=KDAVC-!^+KN)XAW)E?).X^:B*6SLXNV-/]"?D3
M85;"<EMK0MV71W2MC=?5;R. ^SD8S?-+@J)T?#2'\=@17PA/0.OEW6B4S0.<
MSG---N?.#\^?"KOXZ(A=_/-@%S_?TS?L[ATJ [?*:'/OEU;T;??C[ 0AA,6(
M8".)%GY@2924QNYQ%@/-MY:O^Z:A4U.CS1=G;[]Q6=GP\[-M>&U*N[V40Y)G
MB>).1$2O^V"45WKMG+G%V .'9:?^54J:CKWK-'!>-M2(0\P.*]C&L6GL(*LF
ML)341F9R +FQH4>6O)0_G].4E,4\&EQIE$, =&]@8UA+88M/$,3F;I'<RNT%
MZ')U>+\5M4&_C'V7%*2%RT^P]>3K9K<'U"I-*?!<<6BX+4)4LN[D_-4O(:XG
MP6L:-O YHK$73Y(&A9'2P57X4B*!0;NR1.',7$3_XE%B%@>DN1(J!U179+6/
MPU=P/92$\N?BX3T_R-^ZM47)ICT+R8%=+]&(\T2GGKYM5;:K?ML!(=E-]'$G
MRE1I,HHD7X4&2I;98A]VVV8#/.SM$[-3O>[-S/*X[YE;YWBE743,AXA\X<&/
M.>6L%!U)J]:  )(#NN6(JQ-<)^B-;&KLE4!N:O01/Q$8I"O5/00PDQ_"$P?A
M%>W)[0OUXJ(AZ\& $JW$-$IQ9E7;].\P,RTE++C+_[I0.RRXI;:3IRQ&J:?+
M,/JTSL'7QITZ:R/*(O2V)<9TT(3Z)SQ!C3]1)DZ;C$9,0,.<]EFP+I5D]L:]
M8A@ZLM5MDZ_]J/#["AG65=D2"H=V%H@<Y.4SU<H.)T$P=CF!(>CM9J]S?AEF
M5[E,\#!TF+_M=Y0-#)Y.WX81ZCHD.ZE>A#UN1)"H1'.(I%&9WBB\YXMBV?:$
M!@RO^A6_ZD]MOR6T7W!52[1,*&F%LP^CY9-C 057#ODI)/3X+@NX<F*EJN*"
M%K.FRS*M=K4XYK0$1_? $03R2EK1M23\.!G*U]6</,[$L$YV1!""(%*W4D>D
M57'-84\9<W'!Y(I5R7;5C3TGV&EYX\2KA*\BQ.HD^!5N$"EV\XNV$'<KV.@<
MP!?\_D17B%SW=/$=&$.T**&WPS-5BO'@+;<6(P+^&ST+%GOJ0Q >^DQI>GC"
MFGX/?BY)A>KC<2*SV%\7Q5R_(Z\.]JSB0(6I4 *:557D[>GB]<1CI(>(LWNE
M<2 &=Z1?%?*WJQ#G;0LM)G*'>\KG7;P7ER<>:R$BJ)LMX<0CQXR^TC;_M;'Z
MD0!3Y?L%6O;HV0R%<L/A=5$UR_C;E4^ZZ"!U>U?DE.]'FROY%\YNK.+1<--)
M+CR\XWOZ4P-+,1W:S_),_I0'\+3#]*;LWG6+-['L1K/T;$P*]5IP=N>&5/[,
MWO(C'<4936+0@A%X8%'@/&%>,$\5,=0^<2")!&0JWV.<1<IM=-^=MI?N6'^<
MI:Q@CFM#S*BR>#UZH#QAY'4H4=BCUV3#+Y@ Z_NR[8)A7(2-M.CR-EPUI\.?
M<K3UJJ%:[>*RV9*=LPCY^S=GUGB(:NYBV^^UZXSCK-$T)U1(G3S*$P[G^KJD
M_4_A^:O7)XJ<69SOO@V6X=?^*J?J>!B 'U?[1OC&;C\$1F3V<)K(S ],^"Y+
M )1[+JO>XK+S_&A_SVOU3I[@^<>$:?\>$YL^-M^1G]R3O0F+L'=\C/"U+9BO
M99TD2EX^>W6><I)./PAQAG ]DUC+>,96+G@&_5P>_N< 2DZMH[/=KQ?/P7\9
M'NF,L^>O!4*F#3=N/A1=QM5R\[/"<555:B?YN)VQ+,":%K.F)!%$[_HE1:$2
MV["@N)9YD( /IU (>+ILD<B@&_VN0SHE= X<[0_T[3%<86RT1JX,A6#M"U,B
M@S"+"G-R/F%'$?,#D^,3X-5W50B]"P:0G HZ=5%/9H&I,<'N,%'C>/WBSD#?
MU#(\L4F8UP=_+7:31="3TCKAS]*7Y6K*]]TJ4R@*")_/8"G)AY%Y*+DP<6,K
ME57.ZA9*VN'IL<,J[VLA",27EF&/[0\[]K_1R]TQ_QV!.KRZSY"&:8)O24)/
MEH<'/KT.GBTPG<:MYR+_RW134&]5B#S$!DWC!#A =WZ]$7IW>@A0T(2LC45+
MIXL?V:95=# Y(E9J8I<ZJMMQX*G.%]T6Q$1A1X5/R6F89M1F!,K4MF3]2:1A
MVV+H,> ]G+<Y09J4L0M?(GT0UNH)@D>VCO)+\97AV=R>VMMM>*6*O+(@R3T3
MN9#M"7M,@ZM'! KE@1OBBF0WZ\!+=LTLIE@SR2]U7$[- 4WI9W!/]M*ZJ15&
MSZX@V^ZR0<\L3%0+#LZQ@%7X6["Q,#/2@'M!VDDXLIA_:HZOBNW1B,_]=/$/
M]X.)\==KH)I(:Y+H5L+G?1V%9\8N3(B.2.,@S'>P0*MDHPP(T2F'']<P8^TM
MC"?06-&F#)HA/M\O\]4[H;V_RG%BCR34PY*@0Q?I<!FJ+2-M=$V4[$67! ^7
ML0C6'-D$RJD@Q9I)VH+6!;G0[C$HH-9H$=Q$?%4-6RG)C;T[M929/WT[-7)"
MY7F#J9E&MNO]5@)DB\MS3><PC1J9T'"H<$O)O@E&?^)W9*8/.]M TBP<O*&=
MHI(S'_O"(*PO^0H:H(TWB=X->S+GJM"Z;7;D$_';#'^#M%FYRRT!7EPUU552
MX>"$A KXX>RHB^OJD/)ZW/N3,^FU*J9Y^N4@-0!A1T9"L@*<EB:T!4RH=^O$
M911("4/+\PZ8RT/31ZSPE-RPL/_>.JH<LLT[W>38X8JDQ:I@MWN&[*N]B63X
M9E7/8;892!MY)/F5\=UB9:=(FLV((5Z[.?\P7/ W)![">&D2,9YHHR!A&GQ^
M&R9H0&L'C(L)TZ(>1>N&%3EP!;\"?6'V+Q(@#:VO_/B(>"'$R^,CXN7/C'CY
M' S.N@C'/U-VB5LT]GIG#?K7XJUZ0 9_@G$VYV^*Z],59V=#"/'?V<!PWG_J
M5#$)HQGV4&Z&98RL>*RLMSB=:TEQ.F'6J!@33T3!A "CP6XI54M%1H/BE1-"
M#?5;R[.HGB/U?Y3PT_HZ:D&ME3*5,:!1<TD/8M>5X"2#;FO5[[OW-1'8\01U
MU)!3RE@IMI^;UL6CT.A=8TG+UNLH)8%ZFDI $,I.=4/%52NX-Y0$=C+'5A"Z
M4DX?[]3 SXH;S':47Z@:_)Q/+<:R$SQM>252/V'T*:_BTRJN*9577$E/(FF-
MLIM)8]PF9["CQL.PDBDY/(@0?O^DP8ROI-=6X3;T@IBZ&?W5Y1:EOA>CQ6 G
MZ@BO4" (>47Z'RKJ15<:_7Q;4'!6=EM&?'%.D2Y)G7J< DBLHYBFVHG[$ JC
M#[,K0ZNOXQX:T95 /\A> Q%BC8/W?,/3LIQU09,=&P,7F-HP.>_R"_RSRI<$
MC@C_(C1 ?H&2,$5Q)^^*8L>&F?;MOF1)7DI.-&S8@P,91D4#GK!U2\(32(><
M;]8%= 0"6?C_+J%,:4N"=)!&1SGLA(\5]NR&_7&+,\C+&-(MEP>?K1TGL&E=
M:0[7*NF_Q(:X'?4-[J7,&WDW>6CF8X8IS .A'"MN^^,C;#K!##S+-S^<L6@?
MRR8GE-!DP\!,+(;A W?I@J6J\G:0T<<MJ<#37""?,TYC)Z=T33Q>\9*$XYF(
MA".+\;PJTCW?AV\E)SXS\;!\2&Y#OHH*2]QQF:<G2;&W37$MR"KJ,M58,@I@
MN>6NT-B$0=ZU94)TC^!.0K5%Q:&),WU8Y-)L+>])X4*8>#7]'BL5)66WX0GW
M113U<<^_I0L#:NLW;GP![VQ\>_XZ9M2^S%)N"F."2TS=G-\"_4!NB8M#^>VK
MUPFEP6W>FU-Y;A:]JRPS&EY"(-2:<DBD$:G>EA;L% "N'4CZ&?UDKCQCZK4W
MP#$DUYCQ; D'@AL!%"L5DEY[-G*B/=(6<Y=?Q=;F>?67Y)>18LLAYN/3NPE,
M.$*;FHT9C<SDFVAQ)REU#KJN\[;FH763VKPGN5S["X#&N:-IB@IN>2\?^!JL
MIF*!Z<.YZ+L7HG98TW+A0VM]/JTS0>T.;M_A4">;E'O759UU?R)'BN=$Z?KV
MJ@A+)X=DMFOJG=XJ4N*C]FF#0Q*S-+8<']0^A&6GR")89---->RE2G[2.$VE
M/*W7V"<_,WGLC]98FTG+#>5=[7SL)K68-6/:D&YGP3,EK%)-*WXI1\E^<45%
MCJARFV1TI=";2#'?F,#].-@T2SZ,$7+W_8#\B1>4BM5,E)(&1]&-(L,^T"//
MD(!.H_JY!H!7M&-=M9M.84!:42;7&E*FW!':MUD'2U#M1[N!LN=-=56L#8?I
M[!?R)K"#G(/>,S,#V7 J_7 8*05$W"/?2S;_]LH]3LS0$AV;IITL0<#F0F:O
M$W  EFOMWRC. 5>\@C?.HKG.,MN+34Q<V0E.1?M\UJVN8U>@Y^,T'F("'8F
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MCV@MW:9Y-#K_89,U.-\0$EW9ORAKBE46";G D@*1R7=JX53ZK4@%QX@+UA&
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MK"O*+(<QUGL4G95](ND[L:-=(9P1!$$LQHD0BJ3%_=2PF+!;1C<;@O>BM]\
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M<[/IS#\TJ1%RM!*Y 9\0C[$NKY!6'5GZ]*)KO<=Q'T]^\3J$7ITN2Q@T_3
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MC9[BSN\>D$KNE5[KZ,:SZ/KIG#@1 _D\0U=01SIR"E2LL#C/5# O3LL]AR%
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MTV?8!L$V_GJ&;9QA&P]Y?5@9@0S\D9*'+B?;=UM+ESJV1_$?HK7B(L/E$-P
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MF;0P&/2GR3ZA>2'VE1AKK=!'P'G]\&D.+M4)X0SR&-R,/IL?#X6 65T*/!)
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M=WMU,"9(UPOLJ6E*CL!YL1X  >SF'\V30Z;X'3SZ;M 3&1DN"XKU,UQB(BV
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MA]5;T,L,9TC0@VR)D1BJZZ$&_91JP6@R;G+[$+9 $HJ0Q"4^1.Y<F+#TNJK
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M#LLLIN94#YBF0]#_#\G6CZV36^B;E4,<<"HBISPAIXK[UU(5TKY&NB1L&&)
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MBO4"/%E\WV#6R(EJPU]RV'2 GQG/ZC]&NEC$PH1WO.I5/-5 &*(/(]6_2GI
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M<?BQ;RKP#=X6PMADYOD6$$F!M3*Q)A3+6;.O9!V8##F9;UF)FY+8:S&H8RN
M @<J@L(9A=0)?3C&DWM?0,8(&%._;@:Z$U/B8D:@75*ZF+Y:=_MM;15<]Z7D
M87Z_=J:?SOU>MG_QD#EBVW!H+(]MEDU)H:.I@XZJXZA&@IK.IN!C;L,F&=>1
M4]OR!OJ(M>*<5L(:YFUF^H9/%I\3ID_D,BYK;ML<A!_.;0:O..Y5K\3\PIG
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M8SBYJ065E/[0AIV!R2'8=@?[MZ4]IJ_)WW=_\?^S]^X]<AO7]NA7:5S<"]@
M1\=RXKP$7$"6[40Y5BQ8S@GN_8_=S9YAQ";[D,T9=S[]K_;:C]I5)'M&L25K
MX@:"6#/3S4<]=NW'VFNYY$E3UGMD_%QO&/&&MK0U4Y)[R)PU7(E6O*5.KMO.
MNYJR93,D>$JCHZ9GKFXK.RQL>G+9F96?A[S<W-05TP)KH/2_=#+%_ IDD$6\
M1XS45=CC6Q\=L]8YD04D/>BL#\+A5LPO* .OXX'H8P25:+EISXC50P_2Y!$-
MUZD.\8N2K0.I^](KK?+I/Z.R2G],9]^2FOM*V]W".^OK(TB7N=R<EHF-#MP,
MZ79 K$=OK;,_SVLU94M8QYE0:9<="+A!H12RRT:5^9ZKN5!K!AL6H\&P-W\2
M)?M'86.?#W-#HFI#*C+N%=\5*T%Q0#8)QXXUC6(.Q,B8>=5EAZ "3.D/G; /
MWX9H'[6!%"^= ,GXZ(P@BW1U,MFA)!"\(BXM;C7[?'ZTW']/OV@ZH5^[8VQS
MJ:$/4DG!8=S7_S+S;G2?</#@=<!C' ];9$<-U\!V^JZ+$L&?*$+L\]>?%LSY
M0_ 9<B_%G*5?'IA8>O+UW]/7G;:37]R)A)P)$&(Q%Q/9*G[FB*+SF%K:/-):
MQ7&!N?W8- ?<V>%5=RS!Q(<HBP$*9INW#6-FEIU"WRY&G6PB6\BMA4*Q1?8M
M]@0Y'SM?C>2)CQM/A.'LL',<MJN1>P5D*=@<"_N?OH(U,QNU.V;NY=^^4D6/
MN@&<-(Z'27R2L0\&T.PV&Q:0Q[#S^2^3A:YUL/BL$VD)61L3>(L^"_=HX86!
M1NOK+5@@9^PD#QO3I,H!ZNA@)W<0#$[^%VTXYZ?T+/=+Z-WPPO^LN@,)O?VK
MRMOY8!O(TV;%P9C'/!K:_ GQ&%OC(R.8: 2] F2D'.2A*.UDY3N1\9(.?.U!
M&#(@W04+0EB0+RY8D%\S%N3#.R)JXS>N$VS"VS!3Q&'K_&3UE87?S/\:V\/9
M?JKN<*DVH!,?-@K?JJ]!1L6;8,:K<JDBC^UG_1I/SWV\F?4LEPTE'Y[R*!0!
M7'=,Z1K[61P#M?4WP&+VW=WQ1D)8.;58L"8YM]1(AO?HJ.A'.A/BSG!%(LV[
M<$M8^LKNJED /#W]\EY:53*4)!HY,+ZOC,<\]_F6A^N1.^!)"4)77TRG+J2I
M_)DGA.CCFI;& -BTB4U3/"[_G'3J'[OK"O<P]RC\Y=AMB-%XN.GNE(_8N5@N
M-J7)95V<EJ5*%.S .CAUOQGW?%+31IA[C]/LR2U54N.C 6R?N%'#Z=QP)Q>+
M<:KC1/:" 1+<:/:F@1Z+2WN(.5E(E>0H+G8NZ6<+:(_R*(-6,MF;*+(2QMBZ
MP#OK&+=!CY#5^:R)%^J1O,F3U;?G/Y!XU[P<Q'F<>G^6@H$F3=Z^MJZ43P,,
M<'$ASF<8?\4%$T7,+&2+;IA.G4V?,B*BY&Q)Y:WC(BELL4DS-8]6MF1#C-BU
M;>7I+IB.?"9'8^M[OCLQS5:[+!%E##7_+EW9"MW@8V@1#>.V>%*]?.03_<,T
MS7RF?Y.S&5;*D($8DH(4ED!P.ZK4^$P.O')[RXSWZ<RBWE+_KQ[Z2GRC;/0<
M)EG_S#5)0[#='"B)L(FT]4GF>2:;OM@SY/ 2RAP)[BBF\)<U%8L9<VU^_;Q5
MCIBT0M7EY_^,>A[%I5B&*.T095K\>\;YO6FZ*#7",B^T@T0SC;PM\H* ("+-
MJOHZ F'VU?:D\74"*+$<1P(>X9WF=!S-:J8</8"GSG= #L$P;T<A'TX\T<S[
M-.8MEXV::5'A@R'$_-(T1,V/P*YXTG]0%\DY;)I;=?AEE:(/9Q:*YHZT@_<H
M<K9S['9TJXYZ8+-,$Y9@N/4,JRP[F_&+9>QC4N<F/NQC-S<ZENC<%U#$1K9Z
M2KK%$'AAC2(B-[+8AR:9G1XNFO20\I*U(TKVZ>RQH7DBMZ%@[DU9P)#3.(/>
M"GJ=LC)A]Q3JC:%^,]S4A\5V7]..X&?"2L7;U$=NM!2]V%@JH6>E7X!0L17Z
M0"4@20\Y<"%TW.\S#KX>HCV(4E7P,4<3#&:_9+= 8A9;Y69 6[E-?_[J];<O
MO_G_KG[_FC_@[ 8_6F^)OLQNS&]YLE.QB_IA'MFR>9 4)SU)%9]%'4IQ<-["
MJ2Q9U9Z<8>24:0U$R5[F&[0D&@5U+0A#XFB@RMKG_"Z1_X4K5^66BI\1W4KY
MOOHXSF T8BP<*7=<].D>=,YD3HNI$1D]NR5X?#RD.@*FC;(P,_,B/^-*F[9:
M#%JB6//<5[\S_FM)9JJ*9T.EXRZF.%MA'Q=6!<<W\:!$>Z$\<7-9"DBFY#F.
MGV)C/Q;0R@PD5HE&@--6U^I(A89Q8-46)CFA^-;*@826CN+   14J 0-C$5E
M!\0?:F.+>U?;!"#\R$\MN!&$:X[C&N$,8=%==T!EDY /P<MQTD\H-RR,>K:Z
M45I,5SQF3);6WF/=6='#S*<T,[%6%#"=%@.C"X? %#-=.'CU&<1Z$8_CB&E@
M#!-UQW?Q6XBDR0RX*]FS%E)_Y)"J78W[=3A!FU+HMN"FS=30[36,'=;QE1U]
MV?SLL.% .KM"3S,)IP-(4B)H4V#BJ5#V;*OUIAQN(@'&\MGTN*V,:8QZS*&=
MK/FXJ!?LTB6:VBT4"I\?ZX,F"4ZQ2)>R*6NOQ&,W+VF'GR;6NTC1:MN-RJ^W
M]8!_J8^J/] :*[%$7WS_G7'711_&@%"S/$'DE :7Y'@3-M);FI5=TT&9^29L
M,]HXD.4^'6XZ/&(8-0H=@]TI!>$39VU7 QZ%CDI*M?9'[BT[@%0AXJ?,.C(Y
MX>#^I&HPU:&&P^2Y)D,@.BJ[51CU*Q!IAP"=.B3Z!#>=+$UNI S/CS<!-5C?
M!9<$J50-0<CXC7AL>:3W-!4XC6_'ALRRBE]J"UYXR9T!G;1'B5S8@MC+PN*M
M8%+'UE+$2A%!X4G?AU\->QK^/GE-O G]W!%E4)3WL#%_X C30!I]+6)5[9-A
MLNK2ZUZD34HXXG#<"!%DSS^*LGIWY$H+&TNEO;%O.S_19K@3P7JYU4U5;L/Z
M[?DQN:V VJ.39C4'\W#^]%"%\X2. K@\OD1!)[I$9<"4<9VME>Z:$HJ,TF<:
MYI?>L.(^@ID\ "!!@*@@9Y':SCHA!^Y:@Q\DO7!SWGXQAYQ(*E**D<F0;@[6
M%[F=_>?%<$?8@A/;<Q_C?#"U=DLB-4Q(G#GIE1@4T%<G>H])2[!?AI$0U^Z4
M9?]\!)SA-T(L4 J;^J2O9 JE.9<]G@L<E)D6!9.$$GSFJ!+5^%NV3GVEV3$$
MY.$Q'_OQ]6W]MKI#OO>N4FYR)_!CW=XYW'T92*/!WY3N!N,='K_L>?\-3"Y%
M!CIN0RM*U:PA5(9-<KC)TWQU/SF!@L$,/F"L [MPV*4,WJU[(MBA3DHC++YM
M.H[6U8,TDMH? IP@"<5&)*[*4I<ZTDX7' _A>'YWP?%<<#P?%,<#+RUL3$[?
MXI2A )3KA')JH_R#LR*8( I+J7S42.<NJDL[)OCB-A_^7'4LD6 @2&@9F]D=
M8T$:@K-3T>.DO!^RLPQ<M)@ IQZK>96-H2=4L>(G8<$_AH#U95BX^[9FFA*E
MZ@YFU1#9UWTE_9N^)8/37!&%8@F!.!NL9!2<5W*V1RZ7(K="LTE^4<6=IU@L
MDG0SD"R[.IRA?NR.  58;AAG6&<DF$=2JN8)4<RPGQ86\;5J#*[)U4O^"HH9
M>Q$>0NZ:^6QY]6*W /6>5M*X&8?^=?]LQ8*,2V,F'@0JM*YSWRHU)5^V6S=4
M9I7V3[1@U7$)JLR1]F/^!.2)P\8Y_$G"3L$-48X1B(688XDA+F9,&I&T2(B$
M:,>]B^4LP[)KFIEV<KL49]Z(T6<\*IS"+8?[;Y4TJR8^EJ'K>$+"9ZD()^M-
M>6#D+IR BQ^3=2GMO)I95-$O*^S0E"B7P<_0<?@^-^.\O?L><>SW(B 0AI=V
MYTN_\%_+PO_(WNK?*'<H\:&0LD>IR_F-+L4/.W1]BZ^P@5EU*K:+:;F$N4!F
MKON?8+YG1A)T(MQ#RF#6SLO@<DX@(J@.Y5$R$W+,L;."/L&!Z/*3OVD+W$(<
MR%&:ZW+B7X\YNW#6_[BK6BU0#Y4\410B\:70*&:1M0N&M5>U Z2@A [4^7.L
MQT41FZ!HK%(Q??OE-YQH/FEKT*0@J2^RJ'<WD\YUJS@KJR@P (6>8XUT)$ZP
M??D621P6IA/B/IWC</5&$7*<_]'2D'3U["*!!F\('J6CMC+-;\6>UM\$@3/_
MLN_"7?!N,(%'OG&U/V^@\_XXLP@7U9N0@&P%-<7*S'I<"+HC]I6;E3SEQ-Y[
MHF>^VO; XC%[->6G"6DR8(;^.=Z64.<<R4L@;8GP#O]U# %DU]+;X%'#0X;U
M1ZFS+[]__DUZ.=YE_.T?7G_QFZO@EO?2B"Z?B,@''0X IK:V_R$Q,@1+%#R4
M8O7B)MRK6'T]TDHL5G^A^N1_=[3F7PY]24WX?RW#+!:K5R4E ^DKK\I-.8;_
M!*=A$^(_FK?_OPI_)1/YM_J:EF.Q^GX<\.$WY;BM5\^I-8M^"@]:'H @>M.-
M1*P?_AU^__>WE#"M8B]%QL6.K&'2Z#:S+]8C[S"=][!Y=UU3=R3+: R,L3H,
M4R[,B<&!I7Y8L9<^BN5RLUS2_<$@5"2P,L-0&M/G48['CM4C*@0DI[BN9O0$
MH_E5/\PHOZ.%EP;^HZ#8%TZ/]2D[H^*I(.M!ZP,+#VQA"O>I- TZ!O[T4$MQ
MH-)">WW55+OCGW[S -MQ]?0/OX3IH%K]Y[][IJ_U0>^>#M+3W[+Q/"33E*Q)
M.\U<4I0P0++!UQ4P MCUSRX3]=XG2H:=.1]$ (9-KB*[U+N"#WD;QA3]X^$<
MZ+8A[J=_!5^D>TO_X)8:<DSHIQTKA77L@5>4%-M4++J<D,+DQ(7KLN_![ 1T
MVI%9'9E0E)V=FF/)<(Z4U]5ED;SW16)"$KM8 P$ #8#T!**?L+0M-->%Y5*'
MYR18M(=CLOU7OH5#-S"_+%;F&HJ_<Y_7@RCQM;<LM*6.D%@AX+=^/-0]+\"^
MVC.\BA,(E0+" *,K&?.@X'L[.^8((B E(OD'Y2GEUS[%96I*3'B6RZ)][XN6
M4WD6':%J[K37V-=.5$BOB=*\<JR73($T#A.'9MM9[U-^2< L/%*-FS7VZKW&
MT"M-6" ;5U5O"R8R.IDXNP\*2A9=92U!T5PN5HD-%\*G/6'3$1A01A79LB+E
MO,[B5@;(LZ:G1(J93)F&BI>U^_[7+IV-@R"@:3&I[":OPB.CM)$(=XTZ_GA,
M%U?D' /7^" +=@?AF8B^0;/Y)H125FF2E65Y]'/Q_V5=?,AU8>)"#)  PX[.
MTKJ,<ZRP&!1CQI9GE,NX<2TE_CF*+^KG^65PF>#W/L$<6RO&S9TBJJZIK(%_
M?_+FB1,$=57()!OD/A)^6'?*BN7X''6_3Q-.D(NK6U@'YAAC2S'-0L'S8VFT
M* PB!Q(Z^GWHCX+>OCP>1=9K7#?0&A/1YNL2#-B$*6RV=W0_E3?M*+1O+\OP
M_2]#]#AP-P3C!Y@*<DYS#;Z(K!W0WJ(#:U?>=@:*Y;]6ZD\QT&L\@*I\?<JN
M&6[='UD3C1UN)1CTF>XR; ]>/R;/R@Q-\."*V#84P8XS.>]GXD]=UM/[7D^Q
M$B=:.ULN1]T-8WT<DKH<L3,C49 [(#%X,K94J^],""*<E@7%J%> <^\U%AW;
M:(XNNFK X/W^@L'[-6/P/HH*&&H5TRK&RA26M;.?2T@S!28I'S'#Q9553EYT
M?4OQ[-^YF@58R_1WX2@;1%V&8FV)B4D>G@%-OD_8?DG^6/2<4$W6*B5;)R[&
MMER%%]*,T>H6\3IB'[=5.'?%70.]3=*KW<U2$EJ%N3P_-'3H/?8JJ:.BBJX%
MXYF$/TQ ZPZK,$RP(F_;[N[JIKM+ 5:L6!SFO%5>[!0O,KVFQE-AF>DE_7S!
MF'/+(S=#&V(4^,]S(#MM-W(@4X<JE;(O)=H93Y%=RKHVDD8F;M>Q?J<IJ(_1
M8-)J+>I"\9Y,75PQ)@=_!;DRP=X%S.\_[99\$YM#IPJJFL;@TF&1M@ME?5CZ
M[!RBQBWE.K=67F199"&.J%'6 YJDT1D"[_!,X9%[G/JNO68T"F.!":-PY/*K
M8('9)HV:5]EF2\0"\@5PL.1<!!U3V8OWZO#4QKW=U#^1I^AC0'G9(EC!P]MR
M)"I$-BCVB.?72Z5W&:8E.:="4Z+W@E-RE_&Q&\*??RP-6Y5 :->G-(M><DGO
MC%V4JR2MC2.QW@7;'2STML.1*%OTT)3BZB^@_(XF]B:585^"Y+0677]27D2&
M@Z'$;=GWW1W'')SN$!7+:"G:,'AAMU>]QUAI0SHP4 RWRHB%%&8EA:"8/2\;
M:1*(&=F(M/J& ?_T40,^I<5PF4BQNF5K5D3%N:P>YE- S#FHA.,(U]^\_N&[
MP@WT'$C$CW';M5=4_B6?P3VH%1)$9T0> [V-P<MPF!+]/9U,QZ;2!D?WAQ]Q
MY- ;4P>@,%(5J_<7K2X:J?F-53-)'CWC\(N$T/_7_RL54FJV'HXDS] >[5=(
MQ!V,F<"-+3)M5(>G/9L>[M1/W7,):7V**T/KZIIBT6QP0GZYKN1HZR(40,PM
M*V 0'KL 3$G^B2.==QJV(C:LB$YD0?U,_CGX9-;02]H(6?%Y2N< +0:A=CO%
M:C1J;6TKN4RX1?,F)FZV0K!--5H.C 0$;"KR[(E'EKN5F;>4VD5'7KD/7]K7
M0B+EVHJV0IY'OM7QQ&G9^'292*; L/2JDD8EGC2"0.TU3Y*QH]Y49<\;<=_%
M1B>7.0XSY]=46M(7^U_OM-.1.9'*YB3R55SL)#\LC"U+5C 25!^!T2!M=8TL
M"HK]"2(TF=X)*%0:0C=N.J#*$&ZY>:L\48GM]._"-TIKODFG;V<M\=*0PL %
MZ_.-A>'RM@P>KXDLSFH9V.YRW==%;+TNF,92*&3AU+L.Z7]DG#*.GBFB8FWF
M$E9D[;L=SH]&/-W"P"4K/.99%9EL>BB#A :5=$5WN_MN \)^GL$PX5!3";;T
M3@&$?F\';U=+\/$=W9A3+K=#>00#ZOKHJ^W"WC88)72./3)PAJ:[;L-;Q/A*
M!"C,4]<D=_*J^<G\;@#G-)(/PUY%RDE:)CBT6?D8FF5'AP#UF=0(H/M)KH-+
M]JOZTB2U\?A#$$R-N+SD$=+:GU\]L/[X^+JJ6L\?JJ(S:>W"C2BIC#"/=22_
M/-Z,RHAHX>^NVH+4R0L%J@>'//YGS_;$&A'"#?SX])E%/JK8W5>"]$\H;47;
MCCQ7==S(5*%NJ"*X_P$QT,\ZF5E-]7',X2H7_\:M<U'NV"4(06.@]_0A]%6X
M/1:ED^!D2)]SM+]YI]^Y9W:\A][$"1\GKD2A!MXDH0*-9]&]$7U8GQS-6Q8F
MSJ[JLL3)/48Q[;EYUM)0R3HU/1M)GZ>2F9J9[(S/!*":!SQ_]O#<+DO?>O7R
MA]6W_,?5<\WL\:#1G^;>DEM\YEZ,_.G805O,@@<H\6TKD1\.?;IS#U_M@2(P
M"N4I,8N!C3)=U-67Y>GFZJLN^!+/60'HZ1__\)EFPO-GBGM:G\SE.^.QSZ,6
MOW>5;UKM "BQX&SQ%_@Q+,=VV#%]4_!%>P(R,U%X1!_(-/$L5?XIE+XRP5B$
MEZ9>\ZFS/COJ2;DAY:[CL,\],(*YJ$G.OZ3TAG\O?5QF&C61CO3!H>CEVVMK
M7J[NX;85<P8(->&?5I_4GT:&/DZ/8R%R7QK1=R-Q/JE)Q$@QW/I9N$RXCO<\
MI+=I"#$!5631R=DQ6:B$- +_H#PSB_,29?;PC'X1KO;PRR7JSJ""Y>M#D #+
M:,Z0?R)EA;!*>MZK4ZLNBU6,^Z?<=3-!Z##K3#;G-&HKI$IBUYR;*5:&I*Z\
M0FO@CLU>DYGXP "E-DU,I^.N.S ^CK"*\:V5O0]LWDGI#:ORN@8IV[)!4WIS
M5GVD42)<.,Z X0$; 6C7C4AL+ ]%*ST (UH"PH]<\R_G^IMJYEZ&VMGYQWOD
M+M!?:@JWJ:F,<B4VNG].S4S5EBB@UA!83Q:MXS'MJ+?N.KS<Z@_%ZO///O_"
M7?"KBBR%LOZ_X"U.R8T6XK2,Q@G3]I>RORV#77%E55I;K"N')\AQ__H\O&OD
M2L-1#N_@LX6OW)6#16=T4%O_6D:&G[1YT4%<78>KI.?.;=W)WOZ3DXB=",9/
MS058K4\9#8POPA&995-%F29:RL\6[V%/)4RK0^[F78 I!$SYPP68\FL&IGQX
MBYI$5\^$02YN81S8EL^*0 &67B;OEWR0#>O*VGF$/!G'$M%B&*G<.A@P3;\1
MCB <6M?A4&9G7\1::M4(+4'-YVR3Q!JIE8L":! 6J4JDQ"/O9;2:R(X+3]W:
MDF"/7S4XI4DQ7\7%3/#Y[@OZ:R'1GPD%EP+@7'\HZL9%#_^<.U?$,#S)AULH
M_@"?RD1]C*G0PC)$<"?5?I@LRRC -1\]SW]IG=1%IUGV^)#@F7 #I@U\=V5]
MRVN4/HIRTODPFKY'&G KT7<OAXYI7JB5WD,\C>@S1L[HTK(@RV(F*B4(EH7"
M'T8 F:<B'S.V=MU>HBZ8,6/.CT"2+Q0]F<+%_IDHW;;;TS;=)%<6YS;&643[
M'UZ?VB5E?.<R1ID"=9(4<ED:BW?3Q2E.MJ(I6'S:HLYUN+NF,'1[)*_R4VS=
MW"Z;M7J/W60Q>0T\+8:,24:E[/M2\!B#Y/UI/*8I+,=[]#8)GC(2-9P"]IU[
M@2%*ZZ4Y4\6+I3S,^8*)3'"S<Y4QJDJN8CZEM$#U-OQ;>;Y"RHAG'X_Q<&P+
M&G &-\*%5OU(FR[<02KI[@:$^)#%3Z$!4>+P &8$<0DL1+SQXM^GC?LY] H_
MDMI,.3&<#CC;&G( ;SW3NI91#JHIDUE H2\8FEC$YM*EI&%3"]>4F[<A&KUF
MGFAI3:@I=%4RO))Y5_B>_E(1CBEM4WV\B4*MJ)RGL"0< [4EA&E=1\+.8N7D
M.+E:FG07[P]EW;/JT@0=O,Q%Y9;I?Z9D[7=>N(59;F87%8-9(RG29.WHHGFR
M>IVELV?3](4!B?WY6$SSR87+-&@R<$!"DO^J,W3?DC>0.SU.QOPD:<KG^\--
M'?['J08J/WVB?WGU6I.6?A ^<5^FRR8[P[Z@BHS6\"= '()3D.M"4-UMU4>,
M9I27('?H9@SS*YCDMMX3A;MJ0FWK\KKMX/<D[TI_P]?PR=L*Z&I*\0)>^(/,
M2;J/F;*])KD$E+?+PZS>5%;-" &3BP'8A^XK@2#&ZL/L$.C,"19_2JLU) ,L
M8GHZ-7+33XUGZ\NK[Y]_$WX@MJW54/9A(Y>KVYKRU%V[Z>@$7-UT>YJYU9=/
M;6JI!4"G*KM]841<6"OCGCU^D'<=OOB-78(XNNP2$ZXN@Z@_:'R/Q%<%+\Y,
MCP(3Z+YNC/&L_> 64\(2:)/"):\7AS_#N6F-H(R9?.EY1 1!\>BT_OXYM@X/
M1G$P'CPLM;W) X01/6(U<1'P'1C^!LJCGM--]\T!,N_%.>LDD"=_#-%$5H,Y
M+=,%;T?-?07%.8P+SX)^Y(FYY8F94BE#=J,H,2SHN5W=F!/JNV$2ZI,,>]IN
M$Y4HW^6W:(OO>[5D]NY,/70=SSTAF$V8)1<,K)*7&5DD41_)XPI%HV"/&8I#
M<5;+8CH#:&6.T=(C^ ',KAHB)CV*#(0 @%X(Y9QD6.!>6+,+,R97@_//N:GV
M/+*RB-,XV#%ERT4<>H:[;1.ND*WY,;8&EC>!<^0MY6";VR</NO,.V!F9HX3>
M]2<38T*W89D7DR9DOG:G^P#X>@XY6"01'2WE,%0<MTHISJ%@_2I7#=#Y40 O
M(;V1E )I$ _D'![EG$>171#M\B!^S8NZ(R/V+&Z@9X!/\X_%S4&OC:5/C=@;
M%'TC!#&"0G!TU(06EF)OW2M;CNP*/1;=$K8L@C:YN!%DM6+/;9+P]?+&.3MF
M3U9?I^,%Y6"I=%MED6TJUXN'!(K?C4<T*2VP>AMHD42 L!1TR8VRTL2H2L>>
M>?5G(VS?BR"*T#Q;56XB?.:OG'2OS:W/;")F1BX2@L_ST+(2[3_#P;5A9U/&
M31JC] >V7I'SEVJUX4)B;;ONK78A@+)$Z->I7@/MUD$ZM/6Q=3&XQW_L4<D/
MBX=QU&07MTK=_T3F "D6^XZE8(8-J::KX*)*+&.[A&D[>BY0VKF-G<I<4!=4
M5OIY2(79K8P>$$&O; T.8%-6J3M9R.OP*RJ'<%$A(1JQ<V30.&7!]K$* ,.S
MYZ^;D@0;'-?3S]_C*@3C6O-W=@F'P+O) _V$E,WJA2)Z%=+/)DO3#(/4SY/Y
MP&+(YI<H,>X Q GO^D+4W.B[;,E3[!Z"%F2XG1\Y]:,>=SXIX0(W[C9.,4GP
M)JUN< /:^R%[&*RD2]?Z%]8,B6]$UR4AG1 <9QL68R1&T6-&<"TYC/[?68:/
MW3QZ[GJX7!P)#9RE\6&8,BWKSV++Q+JH0EPBUAB=5B^@5VE'1L9Z-Z-(7=-9
M>YQ9,KX%:&&A/%G]3;F5D9663 >ZKC*&:];96Z3/5:H36L:6^\D6)?@L];S8
MU56S'2)>2IPBUP2MOFYAG4ZQ8NDYN%5ZI;?G\\W;E =HRD,,=M3/CU1/%T0+
M(5K^>$&T7! M']*L+M?W%F4MGJR^E"AG+B5"E7?@8,!_>JI*-J\P$^K%*'NT
M]2O-M1XGY"9,"]924;A5[I-HB!JE9I4VZ<QJFEK[C.7.U-D\-:9H67&_.XZ9
M)ZLW6O7+7B6[8S!/U6T9ZRYS-]ZE-A>!Z%WXUV,_J#/XR81'9 2(/7.P."8T
MXOXL2$^U 2+1O\NH &[IM=CHE%E('>CRBRX9I:\9K9HQ@J$'DV-8A-<H2M]*
ML%SZ!^/&YNPQ(N%!$D5;'_*QN^@-?  :^U,"E1(=[@M5Y'L?^2$,H212+7_H
M#2Q*354P[MO+;'R@V8CXQ 7%<<'#7>;CO<^'EDG JQ*/0L_'K9OC0D;Z@>9$
M^,VZ%KDA, H8 %2X 'SD_MA=M9VY(KXN5#*;]*D;K?:@A4ZMI,DX^1H= S\W
ME&[F3U$*$?5(JN\UC>KOS>78(CR&4UM5BU:N*A4>A7ZQY;H3-1$/@7U'?61&
M[GFBE[L;44;N9OAF?7VJ4_HL=?/0522!D Z=ON)VY74)K<D[31#FE+3*4GPR
M3Y1>M13ODF5IF9^%N:8HY"B'MX]^93X?I.JQ[UJN"\FLK^O.R]21[TY5N/")
MD3LKM#L#JXDY\^AW]6V]'0E'='?3<4L#5>9(%YIZ9IE:;TLK55CRD]M0D)C>
M98,<>IVB-G*&E,XK9+@_Y/!6BT^-VQ";Q)-X$.:#LL.#R_ 9&ETK_ I<./$+
M)B0@1PFQ<C)!'Y8L,"]RH<T>C;-^">-AHM@$0BBFKU$:1$K&2K_=NY,@,AXY
MYT T:C_>9 ]ZJ'__.9ZLOHW9=QFMI(DXLP,NVBPRK07-47C#!KZ< O;51YS2
M-:"[':2B3; /3#MW?_J?@L[J89&T>^#';CKN(\2A[GZ1R;F3C@_2J23C;JT%
M2[K"K@9#[.2/O ;VPSO8TUIW/O4>A9_:3=K(XX<FZDVDW$>0:!#*V_.LG3-Y
M(^T]$W!&PE9%>YJS2&P-V'JJ1QV\@WJ(XKY*KQ6-@W3]6AKJ_..A TGJ<UEA
M&%IV&F'IP2T(D(+=E_3.J0A3XJ!$UKJ%".VQ[]/OA**-W32K[;U+68\/7%_(
MB]S:#RCK.34K 5RZI4O*N!ZYBD+=N^X86HB;\%?JL&>RT_7)2>2Y/1.U37RM
M[WYA)0]_+;?!9<3QH:2BMD7(UU:&1G<3[[UX'D_/W5E\-.R;JX^-?G,UI=],
MF$N3*1!NM:,GV(QDG7Z^X5SVVBAE%ZA;*PO_<^SK85MO!+SSCSD73NV/EGJY
M[BTDVPIXDU;3Y/@KQ)4H^SHSM*#.=2B$!QGT";Z$=FVB.\T B%EHN#BGMHOG
MEVO*(CLE1KVLX+D5S.?*'$7O=*W"4$J\\9 U:1QG?H6[J[(J=WCOUQQ4?T?P
MT<JZ"[Y^_5TDS'GDY]SSX9T"5SHV@H_%>T)(+>U(Z+72J'#MX:W!X%R=<[*[
M9G86;:MK9GIC JOY0EJ&SW>$Z62J" (='K #10QKLR*!!#P"4PLP#0O'Y.S0
M;>I#F9T]L9RKK\JM([?!!A$NA@AO%8[&9W&J6\A^FV1+646#$WCQT ?5&4P1
M"M-Q+JY($6_K@"Y)8=?G;.;*W=RC'0(LG1<K+H8XL!^%&QDO0V:]:[5!^8'S
M).T*HOHY=///E !OG!!24F&.T=#8HM),#CV^H$D*Z)R6(@$HZ\$$ZL'FGBA'
MXH5D<Q=^]!-?J\LGYK$[KE^FI-,-=2^MVG&_%LTZQ>XS)&"I=83IIZ2UC'%8
M<^5RSE=P5L?+J<E&I$1I<!:X]VJIKRB=M3@?X /([X?.A"22XJ2+J]+/X25.
MAH%39O\8"])U02 FSY[8EP@<,\DO7S27;EQY%*\:[DHFAI&<V1D+=?<5586E
M$DP-E>50S2>-&?<9@0KVPM:Z*+GP,FU%BL_#SI;'JVA;BA%%PYMRC V.L$*0
MN)9%?^2;Y[MS&D4+4)E9?@P<D.N^*ZT[::8W@5>.E#5B[@M]=$C8+2S%R93>
M.T$@PU/0SXQ]ED9M.@>6RA .]&)(=G>E!:(3:2B2% )MP/"4]=$XX)E I>VX
MJ@/B&>ZX8C5%82K9U6TT1I1HIC?^WY'X1:1[(ZW4:,-2L3)M#<QI<<%QTN/\
M_K,+CO."X_R@.$[KM2,J$MG;IC)#ULW'9]I!T#5;W^XZ9[C(LF"W^VY6C!G]
M'%F38IES?7+^/-](BQ0"M\LM]7GE.LW-":.N999GH)P)ND@IO(6+A3V;K QK
MB,.7Q&VUY:)O<E"DNB:^47/.ZS"^1B#YS=\Q]EC,"UP2MKO6SQ<>%8D9$'H/
MX_Z@_H?>$?$+J$#68WC0EH5(;L(2 %J!71N.I:35=> SC6(P:><.WOX&VG.W
M)%.RJ2 %U,WTH#[XU;3&=51ME.6#9GDQ\E X77%TI%HX^M"'\0"#!4>1'%+O
ME-EE[J](R(43[C"4T/:(]+1^((1JOB=;B[G81"0&E^I1W3FA%N^@/LRMU%[.
MNAU]WX;/=SL8@<B+S/1A^XVD#=U^-SU9_46I8.=[J_5Q6R>S\V#OR8%$G!>$
M*O8<XJ2,1"F^QRHC\<::7"/+,5>=C_G6-.HJ-\H>BT85DC%,08N#:G2ZI]A%
M9UXQ'2EC-TBWTGJ9*(!RVK@[E0WLT6DO!FD7EUP^QJ[V[!C(R[EDQ7U#[\.C
M>*.I6YZD*KHE^\MEY$D8I1Q[4^UZ>.)->0( R1T8Y/*/?9M]=-)OS?(GE!:Q
M1<!L"SZY!)4Z6" R\ 6S-);#O=O%OX>VZ@M\H#G-QX3S(Y,U9OL-SW:JJ4TN
MR/,W!<O"4;;%J:XC(BSM\!7Y"Y^JP5/NV^HTB%4+APZ^,S6*7/RNFX:/N'AT
M1_N8F5E=35$U1DC,SAC.)ZL7B7XGWS:IQ0HH8U'*="*4E??.90)1DJ%^#YVY
MD;CDI[*I?11A^ ]I=X0W'$L-%6D1G0:*Y-N4,)L_?[8]]@@O$3B,80DZP-KL
MBN%3DH\4!<CDX7S+#!ZC*"5F<>=ZG+)1,%@N,1Z0$YGFW.Y3M9)F_!E5I0<)
M6L5<7DKMH_I62U2N=+2./U&G*A.0_#?UJ/JR%A)0J(BD4"CS1IQJFM!!\.TB
M_.']-=+GVU6RZ/P FD=_I+)X" )^-F&\1V[(/B#:ZZ*9-I?/A4NJ;JQR4EDU
MPE[W*-H'"N]AOS2APM9B'\9V&T+(ACB.-R-&-"SQ<  -3"565>HH%\Z-3RB
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MJ/,H.%0T<(GL1QCID_GE4?[/!W]13\8_GJ0@3\5R)_-CW\\_, <(8N(P]-7
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M!W^L>%?[!XP%]D+?>,?&8\^QG/0#\9B@NR(<RV,CY,C[\BW.\0L)%F!#O[_
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MX;Y5DDZ=3:%R&,I1LE^GDVJ2KE2]KJL]\5WRC$'A,.J' ^]J8.CX9+?\=YZ
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M]]FLR/",I!+Q=]Y47(^. 8I_9UV'RO0B4'^6[=*OS@]PLA5)M1)U?>Y.3VF
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M.)N()XQ5PX#P"Z,BB^GYAC-L898^6WWR^LFW3U9/G_[NZH^__=3E[BGS,=)
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M%(9&KIA=;,T..HN),1N+<U+/V-4SOG=2^I)(E3.?&X<HXA@QR8]! (*>@@;
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M8M"87F.QA'9.8PW%C+'3],YFS($0@#:%L7'PP]:*^HR3*43NW)-V<Z4<NN:
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MSUIQ$W\K)S6M.<P#'^''_>;LM],P;MZ1V.E@9>9FPV?GK 2)>H ?R0/Q#_I
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MHT64+]&05+P:33#Y+#:3.R-N0=X0$3PNDT)&2\^8!XR.DQMQ:*"^KD':,!S
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M>DF"<%C?;*_GEL7NR:9J/Y15]..$LIYND5/T:#_Y?UXYRO7-_M]-%N[A^X2
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M-]/QZH>RG^X?K3<_J,++5W91PLF''^=.ZB0UA>.738OUMT!;W3($]-H55-6
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MTO!7BU)\+$H($#^*#@YPB47!JX4<)FJG'6XRZN<G;4O4J**5CA?30ASWKYX
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MJ5L/N8ZJOH>P3))YNWIQW<;V>:6P')1Q>8 3J97D85Q<M[I;RT!E6&8Q+.E
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MH;5/;C NKC$]K5E4QD19#ZE+JN_^8#;#D">J.W,PL6S+\UT*3YY-)F>!BD)
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M#;W=JAT^_"C,ITW"CT70TH$"] =CDQ+)V-\.@>_,>"Z-S$BS4YL9.EN-G#'
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M,MPZII8;51V@H'(,CI>FTK13EO9Z&Y3AUKM ,8I62D\K*NU!(48A9F?2M7Z
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M@8UN24AE5U9G207K"'#'\+AO:%JN]H;3:R5AJHTMLV>-5V<WG;-EL<99_PI
MI8G T1'L,HFZ_L"\C1W@]*ZQM7^FK--2T= :/[Y8&L+3)[W3:96$AL[+C,4T
M&0VH09FM!9BM?YB6C0!]L+<S5EO*6#U-XEF7Q9:3BC((US8*UV9UZQB!,F4W
M( TJQK[LF1@@P)I<\$,H]JWLUOQV*W5<_(R@O)4@F9L?\-A);W55./6TB&>-
MP5H0\6#C(;W15 '70Y #JD6T5+%6U?',,5JJ4Q>SH?RY9MH#C?U[9DW1%U%V
M:W[Q&AD=ST#U#\-' =G',9@==P%D<QBQG:HR8H^'DK:KQ=B,E)(D8X"Q>KJ5
M%^44JSS<ZBV45U"N*4E5*=RJ2BUV4&IAM ^0S/'HLJEI#8+C2XYI!P>!:WV:
M]^T+$E!U&%L79=[;?>P?S[XP_M][6T#_"QLR@/5 '%#=V ,:Q4Y9I+D=_4X-
M;5.C-&=62MGN)V*T+94E":E^<=VIJX2[PPMIPI,V=NS72Y^Y$W!VN-#>6C(?
M8S!@NWKY=;Q"H,8\*Z[\EC,'GG>V"Y@6H.)&QRY>EY!,3JW=Q'!DK9[T>DXW
MHH2RM"24<M.GY'-/FYIS;'EV-H&CG70?2?)( -]'#MXT!FB!R]]*'OT?8\<1
M12W;2=0$M>24I7346:^7H'W-.5NM@$5WQJ+0@K)3=R19$<K?HN!<;G;I4.I>
M9YM6-\J8+;<QNP<JZEY<-_16,TE%IV7 'H/D#2(]FLL\9KK]D>;T8+7QC)/S
MB./N20IC8VY\PS\M?W0[\V"GS V8*??<A6Z5(KBM9 17&<,E(JV="N0U!)6D
M&0/$KZJ.+H'P?8AWY0F/3>?*_MV%Y(VW8%G)(K6+ZVX1LZ>4E5L2JMDB9IN=
M:NI -48)J.8 !NTAFEBO;?.YO0%[=,/M]]LX&KO)/[K.FS5@@\_S'X *B5]N
M0CSDMFH;&.#5NRE)L[G-VL//]RO(X#U'4LS1P'E7I(B%AFV]VBJ@N_..1]?M
MUX@^]. *RWYC7CYY7^R0"#6^HHPNU>/,[8^PPVF&3'\5ULJ;!/-HSJG]^HMS
MTP=PNBR6IGUC#U9E:G=;%]>&.K4]'6)9$ZG:CEBPUVFRX.YD3F5+FMP"*(+U
M#X2.]4P^2[+ BJEC##04*4 %?+\">%,*7>),D;ELJMLIK&Q*Q:U*14[K1&P>
M<DJ233>M=.ILSF /'K+:P(51<8)=A*SN T3(<8)%=JGCV.LB[%<5D3IB2MLR
M(I61T@PP?I/S(4I$:6<8<!I:MFGW5<!)!9Q6>$S8S)?]8F[?\LASZCN3B8.K
M<?H_DRW2SB, M2/W272WNA/0SAO9KU>I^+76W=H"5F&I4I%0#I=I-0FM<KGK
MU7K9.I6<<R)57 C_8V8SK5:M-37X?F)YGN/.M>^.SW2:#@IB.6Q<V<=FSV>6
M;;4C>8P WK ,IUYM7%QW]4Y*39<*7QTS^>20Q<O)9[4<;I8M]'EFY;!QT2MW
M!$ZU??EE?U*E 8CHAO8P',)[[=>S*:/=D?C=IGEPO:J:!Y\H!>60P%LW#JY7
MVQ?73;W;.?7:@E,2Q?^8C>=<$C_.>F.KOYU /G6#9E4C]W1>NB704U/G@*WP
M @0[!W@ [SSB6IWWGBA]K1I,5"A]91#FV+C8T!LI!Q'*L"Z/-*=?3?_2'['+
MB>G^I  'Q[BW)-Y14;9V4;:VQ'UY^<N@XV2]UMB:OY3)72I"VLCDWH:0L)Y7
M;S:5U5UZ.:V,[;T9VUL;V49QTS^5D5TJNMK*R"[&N#;J>/A<[22[@BK;>A\R
MFY<FR!-"EQP)*@LYHSSF$ UCAP'OT#3=/%*WH2+1QT,]190+92&?))DTTV<M
MJ_J@0QF[MXY-2^R-6:9<"V7H;AEZ>&:VY;C?'/OUA;F3+ZR7HV*H;A1WX*>,
MVU+1TD;1AW6TE,&@;8-!V]7;M;(,23PWBS9;% (+.,47"\> ICTSW3E/FU,Y
M&<4(:TDG;L13'<R*,QHJ0_FT*"B'B%Y)0:LU?+=LCM19F\IR40@7Q<X4<:$,
MXFVKZ!&8#QR602+_((4?:GC<MOVD,V7MEHI0\M3'9R44'"A:%CHYI[+XJ:B5
MU7KS38HMSZ=@N4!)NJ1,^6L _HT;Y]5K->KAV.H6=2RMRN:/EPK7B.D=4F']
MXKI1TT&HEYX*]UV_MU]JN1L.69_BP8! ^,$6,X/[<PUH!^7_-H;P&;+4&L'.
MX?TPO/O5IUG=3Z;/'FSD,OP_=@5Z U:Q?>^)>;YK]7TVP!]N[$'\"^G*-/9J
M 'L5-<;E\ *^(&O[#*EQC8#?$S7B8,QDR^BR4>.9V/0?!J*%_N^:)9KJ8],K
M%/4Z-_A9A$T*3+LAKN,*X3S:9.RDX=56+/8(^W &R8D(_?$,P2HS,V?P-)YL
M(4\F?0#5];5$I%>@I-\WP>5T!ZA T>@6Y0T<F\U_ %5PFUG>:Z9/_9-Z[-6R
M;8S]@+> 7\R9Z6[?H^,,K;+F#GDU-^MU*$&@T2V_@:;<A5T39KU4E(F%C@V]
MGC+OJVR4N6_785<4M+SC8CY5P>"G-"51:# OE?-*!+;?=K3MPPN:]/WF$32-
M$LF9>I4T8*V53)$+,+A?B5VV"'@!+IKB^'/G^#)9%G5CJ<VK.%ZR9X(5!&NM
M40O)P_4[KL-6!LX,2QG*UHIY[=).W$1T)E/')K,04YLS&XQ72T\7MXT%'N+^
MTSXJIL;KE*B^@-AMDJ_*H]+3-YU=I:=M[O"*>_N80 93'73S@D:^\6]-UYT#
M(/[;',]R]YVM8P_PCMYLE64,3@&*17'%*7%%!G.V>*[ Y@1MO644E=FAPEZK
MR.%IR;'WJ1]X%Z@<$B[<^F21>N/BNEU5O;=.BT[6B,OU=))34C:QC4NG718R
M.A7'(-WY>W%\<[Q) E&AYS;EL9FV#0[FV_;AQ<.)'0>TCOLXX!B.X17'GSO'
ME^HXH'W<QP'[2F_8[CB@H*#K+HX##K T NE''Z?J!,ESTN"NB>F^6C8]J187
M;WT@<.;N@K7I65<6F')6?S6-UJIH](V89O;[S@36@1$-S<9!09KIPM<X0MEG
MKRY8A5/3]44JB(>MIFPB2Q--05%+"A=Y/GR!?<:D%M@;@N3Z;SWWX_72IX@M
M-)KPB*GC6<CD5RX;F[[UQCZ]6P-_=&54<7_R79P3KJK1+68/]C'SE]^R2Y09
MU752A#!D&-6%[$SIWU'(S5/SE5WV7&;^O#2'L- K<_QNSCTD4AG\ /L >-4*
M@F]QYTOW-QP6OC^0DIP"0*@[KDDH 7YD+EX%RS'+L QMY**N^XO5&=9[@W:[
MW1S6:HUVJ]EMULQFW^@.S5;5Z+?[_XM=1U]0%(B&;3X_53&OT_!W&#&1 $;"
M!"":N_MV?WO_H+W\_>[IYO'NQ\O][;.NW7^_K6A+6;($J[Z5Q=)S*(P(&^C/
M?J5IPQ_0@K'L&1O\7N;-?+!LD+;.S //V\N_TC4"-.TVTF*1K"0E"!L=FU./
M704?/@TL;SHVYU>636NFFSX)"A8"MIEL$D/OXS\+B=/M5CK-.@H=$5 1+Q;R
MJ (P^)C\OEVK-!O-U)^J%2/U^V6/,HQ*/>>CEG_?J36*6E2[TUKYJ),J:DCW
M0)YGT^F8F!>L"B"X_MCQ9BZ)5;#J*39E!9/>*3*5UL_B:D'J;C ]_-")*2>;
M?9+N+WTU+5=[PR,UQ/3499=#5,.#J)>>*3621C&_30"X/&&';0]GTS9W^.#"
M;AMB(ZW0Z>O#\-%E7XE.-IC,6"]NU%=YCJH4%YP2%ZSJZYV="S*$S[!.IZ[7
M.UM7D*G3MMS*;K%I[,:*3F4AE617.U!T*;,(<ZBZ1O4$>Y(K/C@E/LBHZM;R
MP7IEUS NKEMZLWJNC2C+I.MF4^R?SGR?N_S*ISME:W9S5?<#R.0YI)+<#%^[
MN*[I1JU5$N-6N7F*,0K2?:L88[5%6"];\..T7;Z;?M]E1 @4WG0FX.(Y[IR.
MW#7?T88F>'ND)I6[=\IF[BH=&-((1G0""L&!7R_.5R"/E(*3U2Q>W+P_Y?0I
M;MBWXLO&#4FJQTZE6UMZRK7;VK7#&":>WUG^*-L(+&73GA)KKU)TTB12-B![
M-IB7E]NU:^$<K[:Q=2Q'N7:*#?:MX;*RP6HKKZT<N9(JO9G-N,:+[!>:WZL\
MO%.V:3,K/IPZ&#%\DK$[%]>M1E&-,Y7KILC\,(HM3N;9]5IQ0S:5,Y<!]]\=
M^Y*R:X/<6M!N<M&W-.I8.6ZG;+&NTE__S6GC82@5;D:'$M]Y?G8.)F\6EY>B
M'#C%#OO6<QG9(4GVQL5URN 6Y:X5CVH^Y=L3!V]4)@KB"$M:YYK';,MQ^1$<
M5I)@Q2NJ//S@;*;QE"E;DET5..\O(J&'(3'VS02@(JQ;(V_$LHG)*%7=:)?E
MC$)Y=HH=LFB\3=AAM?%77 I*D1[>MAT=UE3?JKX09][1P5C>T0&7BLR1H=U
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M3G^$Y>C82"N$7AJLHU\EJ+_#@T,E&(H&^"_P(B,K>3CSL;>/Z<4 &]Q"]MR
M ;\[4UK#U'50.J#X'1 7@P1^F('T<&9NGPN;<<@"P?MP>J6'XRP!/^EHI:W
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MDPCEHS0,]PL>@$8FR,V/+_*T8YZJ;?>#P[< /FCF1+9[A1PS%^T1+' &2IN
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MPA@P.FY$8P0S%?X%/#Z,[4,TH/""@6 DG=E Q _A"DJM)B-I,?7Q%7@12\%
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M R*+$J9!@(V#9,W5OYE954#A2(($25#"1NRT)9% 55:>*_/)_F14Z1M%BS+
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M[AU_MP"]ISVAXM,>+>:9WNSQ19L#$<1W5K B=^YK*V!/[,2?5R,,URW_"OW
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MXP!&P8-&:4;.A(]FW"W.K; O<9:2RU]4GBD_,?+OI(&(K/O"11:2CALR#.<
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M*H>6+6."VGR?H[@XMY[UA";KUC9G+-M4>G*JF2P3YJZR(H<9!G$]$W]$NUF
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M1@<PWYQUAE6WG;B]/>]GMLVUVA;['.?O,VL^N!&R8->QCHEX%_@4F^]>159
M"B:/0^Y9QI$RX1\(BP0"%J[PE]7$;&SDLS!/)&,GWSVUHSZQ2X]L,G(POTL
MKKZYMT6<Y7\U?UK+<'DI0Z*O4GW<"C\!#-PM5[)YTCD!$S?J9H=G)\03HS8(
MP120 0B@?0OCRT@9%3M^PA:J_JL7.5ASKNMS'Y/C?C[#@OAI"'$#T^MH#!ZF
M?!J#5?'T3N30%:\G?GKLPR&'Y[\+GR4\.?2 4^F1?77$'Y#[2S+(QMG%9V&'
MJ6^J5+D1-7/Q$#@U85.FXW"4BMQ81)Y+=1LV[F\A7)\I\?<5^!#$Z6N\%"E'
M>=(S1=M6=!$>V3;^Y UW*_A.9NI1LP /-G+_XUYO@_U'$"=SV(UPTH1WA(Z:
M FH2.V!9.<JQ*9M>/@V;>_FD][:Z??K"?)^Q&YYZ=!Z^, @S_<QMT[B7O?&!
MWV5OF_CWM[E6$H_+>4GCKY4BZFER^Z_&9\&,%;S<C79HXPXIA.(7!"220@E@
MG@36.J/KGU]<M(@=[:OI^V!"(>(+$#8!A1,9U>A]Y)_@-*-?Z1_?1S:PMCT;
MFV$W'0DS"FFMTD%F8OAEW6=V[\G)(T8R&H00G#*3$#J *YGZ<+_'7:'$D_$H
M/;2!D75 T;7YL7*#8K_(G"5W2"N:BD%Y*)54,H5AWK@' J_K:VU!.H%/%Q.F
MN"SK8,U@Y*L!/:7U#U)DR7H4#PZ<'T;/WV]^%^R.ERW;^ [#*@3A!76+WWUV
MB:_+(TS_[&+2+2I_E70A-C%A+1Z08N7RS!+?1PS3M.>]1-.#KRBQF[N9P2:;
MB;*>/,$#P3@<XY-IATP>YI)[&<3:F" 7S-W5KITHBYX\9'**EN8?BI]$^BS2
M<5$XSM,A\%3P[BGY9OYD_,D2:K^??+3/P(\GYK%9('"\9O +*TY]523[J)SL
MHI;!QT* ._[R+W@+=;.XHM?F$9ZR*.,UA)\SPK:2I$^*#-<1SZ:\],,=X[_]
M *P]_C0S_<>.!D_GB?T@3M<IN#KWH'S08_4?&:-;:A7LKB  >$U7R)3'!-4"
M3A+G&&E9HPB6\U]T!Q'95EA'UK9BM<!RY5D^Z?/5RG,AF@="VR_%J2'_ST60
MY;E$\KV79KE+D(B;Q7<0BT\D%;?B2JIB ?"X-Z("X&&6$S4?8? HE.%RD]Q-
M10F:E 0P>=[O)9G"[V69R'%O3+<+:V0('DO!;4?DBTV4B/,9,KW-\;U2;A7E
MWKE%)Z5'6J;?X\GA/ 2]POS V\*U&Z8HT^+:M;AV+:Y=XW'M>'"?%_)7Q;-K
MA&WG89:\+2.[!8XF:78_<O\J)#O)P:IF[&H*P":@5-?=L]$R*ZUNC2N[\>JF
MN+HB' &QN@YZHUC!!>;.?NEF$E ;(GG?S1[9/+39S>+_#['L,B#[>>UP3P?>
M<^.D4V>HX++Y,[V7SI2='G__()ABVW:?Z5:2XT>&2U@\/,1'Z.*(0N"D1B32
MS'LW#-0PZ:]^VO,!O3/'7+(G;M#=T,>JX_<?-C$-?2+&2>!9CO6N,9K4@]*H
M=T?ZM&G0D?VN890O:A?HR.G)006J=UPIK8^=K%5@>S;MDCHA7*5\FFTZ^&?M
M1M\"I0956*@N'! @V9IH:%]-X9'9P P3UH0OP!R)4K:T3<G' SDP B G55/[
M;VN&_SO&9K?WCS-%3TE7+KZLWB2OU8]=/9W0KH9UP534W;:.AW228)JM*#5(
ME$8'$26\">P,C*++BH:(TAJK*V,.6#\KEKQ]?NI 2#''X%G9$Y\SO4CDU)FW
M%)4QV: 3@LT<U.Y=J-07S+,),,P197P-!D&^&!>-,*,_XO R?2T<P1B3P.NF
MM!\3/N*DSV]-3JV6\QL@!E?Y^1TT"CFRN@%52STHU/-4H&=VP<'?#G*J4=Y#
M?E-5HEAHC?^08MQ?!<W+>Z[&^K"LPN0P:'''.(B_[&UJ\EOFU^'^^774\FLA
M%I%J:W8N<([*T[Z:0>C!?XMN;<;9VTE]G*UZ+KB8F$K./][%#5W_7I945G40
MU@!I8'&TAV2AH"5[TDQ?7/UPI[GPAF:'L8Z%[2*<Y&67R/U3N?^9#+NC<7U#
MR*I]H^0F:3@8U7%ITQ18PDRVG$[J?_$.YE/F#D;;P%SN:X#5?M5M_J7!Y1)M
MD?]6/'90<J.Z':(V\?EV$Y^#\L1GJ;LA\Z"_ANP;//'',[.?V%=X_&/UU.B$
M;ADF_9-.C9YRYA$4RWAO::N]C11Y(^*%MO['LUM9JJ;\PN&X4VJVE9V3,LJ3
M-DO19-EY]!BK*CU&CZ1G5-=U76MY"J5GVEJ>!DO/9S?T*@L/E8T,]:*FHM;T
MU"4\_5YK>IHL/-83RY,/ V=)U17NM*8E_\Q_8-__,6U+W<-WWHC@5+8V?6R^
M[0WJ&J#8E/3!Z=@A/-D4HH&L)6C-TV[S#VL6L]\=>3!L_NGG##[*4^AY8C4X
MNYCVL]F# PT[?/WVZ2;5,:]<5+96JS%6JT"0*ANIX=G%L*/WZLK&M49J&R/U
M(0-3$<$(=32)[X(H,' PK>4ZM.5:A[M44>)&F(3HZ5GLK=:"[=F"O23PDG:1
MIQVF3.YM,&I3J%]Y-&4M%&FD%MJ_$OH6\7-E/30^NQAT>M,B#(IF#X95E5A4
MR;C!/,4#EP7N@(,[68>#>SP87'TK&-Q?V7U0,FUQ;$RRE:#&)%L)BL_9"OV6
M/RSG%:7HMPT=(77'',OU- %(B*A#)"$H<'1( GG(>3AQ-+]K1[L,'W"T4A:<
M/#%6"O] U. EM;>A-WLTU1E;'+7SM_^YNM)6H><CE KB-0DPUL0<)C]D'(:^
M8@'[*-&R:>1)P+7C QOC>JYI]3Z5K!,ZU%P4KIL/<7)>J5TWIF<7V=S\7[)'
M;TDH3PL88(48AY1+J0Q(.EJ#)I3<SF=SQE))FQA0J-_#6Z&<PGLM@EW_W;$Q
M7<=,S[9H. _MBH/TKIW7DJ9!)_>W8CP$56/C@)88SU<?4JGV"(%'^:E(.,W,
M,V M7DB ^'-"CUJ9+U06C7B*\%7[A483$G1"P3FP/Q%8'EBO2=S5U_.Y"P$6
M$;EX*>9:F8X8S<6GIA&I)/(_8I[AB:B8BL/DC#./S9B%TT=PQ):81DBGN O^
MI%XPG2,/P54Y3R18'J]B1_0T![U5\JH8*9?'')'6[6@$@ C+PE$>&(K,X6VD
M6HB-:6KH*QF]DE$_. (.CG@9VH&ULIF091IENF D?*G)=PR3\P289_)A"NF/
MQP]%)K3R15-B@%[>76D3E&@:O*=,SGH4@-5SMC#YM%?!P.(UVI)%'R FER.S
MX*G6$Z%N=6C&%GZ&WR>@!I@+A&3+SXRBVGGF1C4<UC7#H$ ] [GX;*";A?3'
M4"?=>FQIA<O-AQ"-^_VS"VLIYW5F947HNLH(=OIDS;2H#3:1%>E!_N2+2*+A
ME/D870DMF!KFA4J?J<,OHIY4CK.9E( <44^!Y=7,)\(D1?R\]3BQ=1PDK8J
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MY%6E;J-:RE602:1T3,M+SK+.?-"GM2BON^?YDE]L<_;'^=WLT;61'A0MDCK
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MV)O@3RF$FTQK".&.)?@;7"6?W V>V@_X:,XUQU4\EAB\VA,]UAQ^.7#5(7G
M7KQ5$'M<YMM<VIUZ[^HO#!;I(#&B_KJ<[BHMO['*G+LK3#]?WOV.?^V?]Z:(
M0H(X;:Z$5]'N$6>QJ]TQ@=YL5.QI_'JG_>8&C]8,]F@Z_OFV+8U':J5$GC(C
M# ]LJC0M&V<V;'ES_XDZX8&PD>9#",/O"&(W(VP!>$_!M3WB+J3+",:];,7"
M)77,Q8\# 0J>&>,]M L&*@HVX@=F$ ;80*0(G0+73S".R1OTO_J:R5%FF-Q$
MYALJ-HU$R.<5&!)6=2D!8U2N4R6W7' 1;;&DSZFL/J/%9HNPV=(EY"TV6XO-
MUF*S-1^;C:K&\FK)^F>%WR$3T989O<TRH^URY=.=[I4:54V"+0O:)_(HE']F
M'./="DXVH>D&WS_]VIU,9J7>[;]=PO[E374Q_WY7'J=@J+%=E_/;3F"^B11E
MM;L)#, 3T7+T:S%$[!>>?;H,/G..O),,F0C@JR8EQ^"233I]?9?;T4IG>Z3K
MABHMF#O(9F/JG:HB/JZ!5=TD6[26,[-8D&/C[,+0"Z?P')L#CW%P.QK8TZFV
MDI5P9%DYZBM"M-F\3J C$<>D_>6IOC=3F[63H=G(OE#JX-*9?T&B*]=?%5 W
MQOW:4#?>4J'6J=F##$=M8@VV9B_5/ R:P5\G: =.I_5$U.WQRU9BK$R16(N?
ML;66%]1-".JO%I 9L1BM_)  YR#5Y9*=F.M_.@J].!3=3*,7!*.;J/:->4I5
MY:/\(=P';%XX,0U^.IX\L( V\]C<"OP/N^1==\VNUO[]-U2O_9WYC&:-<\3N
M)V:[*QH5) [V_[7WK=V)(TF;?T7'O>][JLYBC,2]:E[OH5RN;O=4E;UV]<S.
MISY"2HRFA$3K8IOY]1L1F1("21AA 0*R/U1CT"4S,C*>B,BXG PDO\W%MQ8F
MPQ=7G*H1U0M[[3"CH4:M[?8C3R5 ;]OB>@,^9_%7!B)C9_K<-@X2EK< RWLX
MP?H.5^@O/';'4V"=18<-ZLB-L<T?LL^O)&X76-2%\)HYKN^<M;\O+"]OBS34
M?692:SOF^"0>9(W*DO%\@>SBM(X:L'U"VE\E2'_E^D$6G/?/+K..X*3)72GD
MV*/)O2&+)>"^UT #?*_5 RJ-]%$$(="&Y>^";5ZU+56D@M;FU5AW'C$Q>*DE
MWK/H-R>/^=8')VK*N*D,X0MQXWR!9?@'KL*\Q>> ,BHRT*JGGEVV&NG.0_+$
MKU+2KV2TVA:;B8:AF9"EG5UF!8?LJ&Y#Y2'K6/R/F-YV2PUNG;FUBG[(#'/U
M9/R0^S%;:!FR9'[S[%)KI3L%2@NE4N*C8A;*(C<E)7M.ET9IC)3K=MR3[.)P
MCPGQ"N^O2VV?,5,6F_E*Y;XT$1[I59_9B&'E ;A@X/LL\/\1D7T04;WH$5.O
MC8'AK4Y9G0^DGG]\,K\0^V6@0(>BO]-:A53PRSVHV)/\N_/<)XMW4W>]A2IP
MI-W/BS?D9515L4;<0=3CE8V!BF#J8H)5@?CW7K?LKI-[Z0^TG_2J\K=K]9FT
MO&#[K$IFF1C;0TNKY 2K';)G!?!YL=S9P57FVKP*DQ?E92W67LK%;>SSA_63
M>,4E*NJ%[UN_Q%)4!:&U6%WI%/H45;%M_-%W>%E1B.-D.K_$R;JQ+'A%&]\
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M5/]PR!%*4A6$0&Q4UI0K^!\0QJ'/KN/@?C1"6-4O,'(0RS7E&_ 3V$S ,D$
M]WZSP'YZU!W\!(P6>E8-9O&DXZ4XF]_TR12V*"KI^.?OL&'9C'_^E^O]A$]D
M\(!M#&+?@9ONF./X,_M)IS'\@+]@SS'&O6!_!/J8;]BT:R,YSTC/!WW6<LT<
MI[6FT;_-VKPLM<<F.M (]&"'NSA@=1S1=IP;;A/]W_AL_06UY'_#='W3(IE%
M\,7=I4L[P ^'_P8ZDK!-<IZB!X%G#4.$O@5G.W=H3W78O"B(@;ELF^])Y#2X
M)IS"@#(&E_*G/S#OR3*2+O6'V+\/TW"Y' N#,2PNGO3@GH/O9EQ2H?P2KPZ%
MX:-'LI-3%M;"5= &^.FXSS8S'UGF_A=&!@ "]_UG#?W^ =]'_G<:U2)M1^*W
MV-^_M$\WK/+^AX-6(\C/_Y"5]4G8\_>N;7_ABY1=Z+VG'4&A]P&9S/-6(Y$H
M#A-$671S1-LJZR1(5GJ7E=ZS'_5*P-6:!=T/I1#VO]"1<IW"FR*UL=<MTGP,
M1</7*LC^YG+8QT"I0N75(ZD'H,CRZ;+-JXX[S/)7#PM\YR%E#3X OCBH(P*H
M<EUI.YD'%0[8(K#<-&#K $.RN')07DA6CG):-/A:ZYU=MFIJJZP"5\<0(RDW
MU=%NJN:.=E7_4';5+O+,^AD6U![:P]V(,UKE'2P<?7JO)!!:>+^$[]F/SA3>
MTA)H!9$JLH$*!PJK&^V?.])QH@7X+,A?(&RXV<@/&RYCA39MS72$*]S9TPJK
M:ZZPM&TJ;=LPQWRS57.L22IO4L^.+DFEL/+V2F)92;I;4]N*[B9SRN1V/:WM
MNAM3J]D\CNUZC.ED@Q6!S[6EF.MR,W%RF2L5%=ML ?^LRN2 &>2?>5),*L\:
MX^EM<7!)HHD5#X/"PWH\[AXR//,'^]()>-P-G=?K(5Q95VY&"9-TD41X/7;=
MIE@X?" ^F44-YGF  T8Z/%.0CG@3#W+B4?M%#V?3L4_,Y@^#V<:C!(,Y8##K
M@.?X,4>W*58@01EA4N,(86/#U73HJ\^[AR.-$Q>Q%WB,SQ(I9AMSQLWW+VNR
M!H]<AR_NHBD,'/-&S&U@&%[(S%?-F<:<K=IO$);[&W7G[-)Q,^ROY<T1+SJP
MU7S-GS%(+(ZTWX3E"L2('X8(7!$["H+GUE%^#^V9THIDXF_U^[JB*N^0;B(J
M9V $451.#;?,Q'7@#B].3L#(0Z+SK<.43]:C\HGI(<P_M.$OVU8&&%ST#-=@
M*"#YN> 66W_."?>R,+[.# T\G8IB^^"&/^H/]3BL"C?I/.I2"!F\81CZ%D5D
MB<!)>#<)CCB@<2ZO3/XZ"CHT !0QLBKQS/F%44(%\@@%_]!X0+99&,V(+CJD
MPABP_'$LDLVB5X-,L4,3)C!Q30J"C$.Q**@PZH 5Q[?D1@8*B<13'L3M)IL"
MJ\^#8VACB8(J? B)Z<!8=4ZB1=2+(CYA.85LC>(-X^AF?Q[=G-Q1*S<4#UJ+
M4HOH-3K*7DPDLL5@(K9)"G@],[E%?X3%\3G@.-D59.KIO:JDPW>0]]<(M&]C
M_/1KT?3["4-7U&;DI"H45/:9AU%C=#H%]0&!L+IH.G2LV4U%E,-W^,#%@+)K
M8'YWQF#'<R10\'$IC7$Y"BY#$HFG9[Q3*QBVMI45R<T_2T="H+C-(<O1!.V2
M2$&)AA'5F*5&XLG7GT"T^,H4)AN+0MS;(K46GN ![P#;&2!R06>H*ZV&^N[G
M>R+/ MJ(.^[G#\=+Y@ DPE4I.4Q([7GTO,^#O5%PH%Y+T9Q1T+YXH8@BI#R"
MQ B7WL>?P:.38VGCZ[;NS>!O0*=YW">#];+0/F-BZ7$03OQ7'! >:RPPXK'E
MH^*"@:3Q0_$E&,Z>V*$^AB?F*G%@F@ZQD\5RTN]KFER.*!"<Z_G?], 8PW(F
M+QA0RL0_,$+>>;QC'D8?Z8\LUN!@K\;;N4?5U%(JVW\I3XS"@Y_'S)E/LUA>
MWF%LF!62#F3:72*K!#GP&_,>@1$&CQXC!ERRNGP?A*DITG*S=YP_Q;PD9-'A
M#'CO$5^YH,'QKW+VE%!7,J]!!D3&):B'\?X58@3^C!A_I#^Y'L^=@%T2>$P/
MZ+[TMM,7MQW/_7!P[Y(5IOMCW WQ/AO!DR@;AXS,Q0%,& L$+?X*Q4C)R,_=
MYG7E*HKOKH$V,M^FO&Y*S.2@&LU+OV13HUPEHUMA):.UD9)QK7L85(9G<0]C
MH&Z&=M'/0/I^6KO .D!8E$"Y0U;"9VVF6O0S58M^8=6B$F)EV1OBL:GKH405
MZ= \,PO_F091P0B\#MT<*&B5H>[#(J(&C7?@$9GB(VWC5(\H$XI;>3 U6+NQ
M:YMH\X!H 8I9Z&.</V+-&W%+\:F!Z0_&@ ?8H7#\PIU*@Z!=G+Q?U&QBYZ.0
M=O^SCNU%<+>' 7JO:"2+J33<G(/?<<U]RQ1U$NBJJ8L)LQ8E_IF6'9)MYS,C
MY+DEB\XF03*?7PDOSR!::KA4W.G1>B++=>']:".#)9P]A,S)UX3M2#&:T]AL
MG(9@'6((R<*;DP0Q83["RN,T ;D*XYI0$F7H1[^AN/9#;W8^)[4U.H=1HW\8
MKIPPH"/6XV OR$X(VMYR8MQ\A#QI+Z:E< &B^P^F>QY-M0Y*<9S-E\W)$9G3
MW$RH"+?&-,SCFKE-N_!RGDU(&X";IGQ=E];T.9JE#X*-I_7@NHD\K2G:YTY:
M9=DPO6=97'["T0T<\S,?6TYN3ZN1EFBM1EJ$'IY\^Y1:G0U%U3.ELME&R#W
MF^0%Y24%Q1M"C(9<SM'83#W0E[.&4K ERTY$92?ZLNR$+#NQ&ZU6EITHK^Q$
MI#_G_$I8](I-(W,C96YD];+82LB-W*Q+SQKW'T6.X%K9E)M3X*1I6RC_<N.L
MBKSIKE*QMC1GTJCU -ZR!%T;1.%O@;=*BN\O,++C#OO^+DS!MS2#K7"HYV;M
M ZH>LEF\^T\JO0>#1N#3LA<%V(&''J&7N&C(9@L4U&:_UNZFH^X.L7&UW )'
MM052^4];V0)@P;756J]?@=[MNU96=JNG?&:.2^6DDIJ*U%%VHZ-L52_-WNO_
M7#[G$N<448TR?K2T<(H6>Y!KZ1.*-RBWK].N2C(R5T1R^JU4%!K+LC%:A %?
M@^]TU'@[$B<K=-KBW\Y/S=:3GO,PY59S-^--#92.2 J/%CL+M&M-5:MUVVF5
MIYQ\YI+\',?)K)T]+OZJ/( 21UO:UL(B\5I-:VBU?K]3D%F/19/(SGW[7@@O
MUNQ7*E,HMT64"LHNHL9*8R2*15@)7UJN3;(<TB"D0M8^[Z[.3RIY($)VIH?1
MPSY%[;05]/9.P%7/NUZA_4NA(85&"4*C4[K0Z&\F-#8<2)[0:#<P95=+]Y@[
M7*&1D_V]3B#^/,9C?_%C%"^A;!J(-X!)1G&"#W$4X_4+)>^97SQW<D5&.Y$A
M';>7CM%K9T0=M]5TC-X/ZM2%RSMDMOL\SZYY)5B5LNI$<F&<L1=%O"5J9:^(
MHXL;*[C 8<!).3&;'S:*NZ:YRA@0&0-R<#$@LBBV+(HMBV(?KW>>^Z<4R_=#
MPA_1JX1YAL5;>(N,"IYR\7;G^T9L7"7%OZB;N[_:>_A&52OJ+5G,I]C68#?6
M .AJ6B/=[7J?[NY#9H^-3FWZW0JR1_/L$H_"&[5^,]V<]'CCZ@I(2$K\2DA)
MD743I>2]/0+O6-F]5T%V;YU=-FOM-IX(IANTRV+&Y3-!OX),T$9(;+5ZM6XG
MW7->JJT5$\H_W$"W2]-&W^I=/):-6<%MV3F[[-34;J?6UEY11?:CJ4K662-$
M8C^LT\4ZM,UFO];)C)M8ENBO.?O7=?\W5WG_LW(+"]1(Z30J7".EO5&-E'M>
MEO1.]X+9#U">?;Y _F?+-VS7#S./$WH9QPF]]'&">+9"#U>23]_,B]];X<7O
M;(GP]+#UZZW=>=83%IV]LW6#%^K!6!CLPFUX%B^#$A=6.O R;#>.\HV*0Z)C
M<;%(%+D]H]*:5%.*+LPF R]Y^>O?KZ@4$]Z+?:I%7VN;%Y'2E0F+JK-D=;<>
MNM@A&'XT+8\9@8N-RJ]U>.5\A,J=Q\Z_\-(M_^1V(AF5U(#=1(B(3ZX2-]V.
M1HP*F%A^9'"2%:H'--;(!)UZV#>883DJ/,%:6;DY-Y)$ZR\="R_NU"M;]_W;
MD1C[K7>/:W$M1G"' XA_],6OOIHEF/MGEXUZ(Z/"<R*.*Z.L'>^GS/.[D6*)
M,G=8GD*<%9J)JE58Y\6/EFSE2L!R'?ANP*-3/-8$,H""8L9%5>/NXH"RN<Q%
M95[T*=S[0AW?[5FQXM]:H[&Z_/>=&!5B_0UZ4IPDMV14 4>DZ]335?-X?1)1
M"OPMBU8%84VEACE'@NH(6!DMR('SX@#;H7M!M/-RIPDL@_)XR,_L28OHU)1_
ML9]4&-?1E:MQ:#KND_]S5MM !//*>K_K,^4?S,%G^MCX?M/G@$KA!U1;F3IP
M8P$NQ(WEQT<5J<S\0I79*K36R+:_= =6-U/VWA!ZW#B\U5-1_;BCHI>WTVC4
M&AG5*9.+EI:61!#=,#CI<"7GEU]Q5^C"I85)H>V6%'@>LFU"U+":]937T,;2
MB\0]5"CL]3?D4S>!DW/$$P4E38N#8WH;%GU-?EF8PQ!(:X-COJAZ.T0VRX9(
M/*9IU-,NZT6,/&R(?& .=O$@KP&PZQ4OR$?UA0DO1/6?@X=,,&8&X2,,:!UK
M9NY# 385!1 SS9EIHK0N;]R1?*ZP/OA72W05E@C8%0[V.+$5G9PP*$L*L7VG
MLYKK/[-A<./X *XX]B]@M$;>GC2_MU!*9^B$2JP.)DM6 G@S$+7FXL:'\;]A
M$\-:K;^)$S3%66;-J T[N%_OYO>ZB053/N/71*%-48:;M*HA-RVI68#A^H<O
MP).V_E*GHL@&-JD= OE0$R9@BF[4*H=*)=,>X243Z1K>YB&TD[R>]8AD*5*L
MAJGSKBZ$H*$SU2TSKFU>XWMV7IDS2^%,5FQ<9&&Q08OZ8GNO%#S/U*#B++M8
MMESIZ/WX-%NVZ0MK5QTZ7P7]JMU-1YLDB(/KMU"Z%$A':V2AIX/W/ID7N(TE
MTU"WB='W*9JZ.:)I 8J5J1WZ!<?8SQXC:<*BG5#470BTNHD53KZX7H)C[Z*^
M- \!>5#30^^A-R:]+HLC1_>+8/,D;RN^'EC^2$P$_J;MD[-OCDL3 4D_@?WI
M>K.C4T1^#QV6)6B7U9#XNGQB;*2,Y#^W+*VDVWBU)\3Z>[]/:OBKKJIMZR;=
M JK)W+[XZCJ//\!HS-%0@%"7_==,C*3Y]"I'G(2Z,C"Y[8WY*C5>Y,)Q1$,&
MVA%K$RMKBPA47'Q&=*20+(J.?5L>P2YXQ!,AX*Z"BL2KNV3'BD07/5:-9DW+
MR#0KHF,5Z*]R4@6HFXW\ M1%#JF;\2&U+%LMRU;+LM7[+EM=O5"1SD:A(@_L
M$<ET3\TQ !U7A8B@-K0<(M+5TB$BXIE*_-"-(D/HR0>HIRQWT,E5$'A0Q,J
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MS]Q$@G)-X;Z_J)RAVJ6SJV8-CZBHA-G$=1Z5@?.(YU>?+!=KTQ@ZQ:G6:\K
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M)PDF:D.BR8&CB?7R?TS7^)],5)E''B2#$%HX [6-00C..4H/!!J)*1)31&R
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MRU94'DJC23BMRN0K(<8DG+X&I]H1P&FE7-G=7^2QX9&C7C)W7-,N#-<9629
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M>:^OVQ%< 9+U+O3\$$\D08;>AS:,7FWJYVKKG?Z>3B?5MBG^FL?9/,!#/"M
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M:I22J%_=A*ZK'G4/>C(D5M9A$>?-=$CHUM2A-+JK0#%1ZM_<4HWRVF+IA(1
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MHV,&IQ9;>8N%_U0[]&>#N#=!4_CYA_\'4$L#!!0    ( !:#;%RF\?ETGB
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M0HD"BF<'7A?ZS@J9(XM1Q=;^6*-D"3]6DJXE<=:566L1M8D^;Z"B85[LQ=P
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M5*@G\8=T8+WI$,+L:G99W/!WTR\X+@L?XY=R4G[#U\/LK^,-4*F-H<&#H*A
M6$'!6&J!)$F(U(H97OM0Z SN+&C21!,/*</[4N8#3O-:,?[BQL/!\/-DB8K&
M@ E)]K<00T;E [AH.6B1J&7&$VE$97YL1G(.9*@@XX>:%[V#"3,_&<2!R\>:
MN\1WBV#=W"A&R13:; \3QS,OD_1@1%EU_K%FWAI&;.U PC8PYQ!$J"+H!L?%
M"IRW[BI_^6GLAA,7BGR7M.^"L%$T83^Z$X46ZJASG21M=-' YNR U"B><4H-
MRM&,+S(.+N^?^>61*"W-=I$W9\*6?=&'4Y'E$!54)$G)"UV\F'[Z@K^Z\3]Q
M^BXE'.<S;WGD.>*YCSXOFI8CCP0'UB4!@;HD60I&,[(ON[7[$<>W%VHK8U1=
MDA5C#W-4_^6&L\SH-42$VD "VNSL9']84T\@6S$2G'*"")LP,M=)MQL__KST
MVE^"M=_9_YI=7F=5B/<S?SD(:\"B4LH8XT%ZK8NCXL'Z$C2-G@03E&.FHVIW
M/.7,-%Q+G@WLOI>CX;(6;+GZGZ[_-AS\:X8_XR2,!U_G4I]'QPLAC::0S=M,
M2,,M^,Q0< 0#$2P##[4=@:[8SL O:**&!B&"!SC+RW*3]^H K9%_L /6:1R#
M-OK<1YJ>RFB2@CH 8M[Y9-1@*(T8@LOO4NU4Y-%YLL<E>'HTV:&#VF;&*J[%
MU]-!WD=_1C]=-8+NT%F"8*S/!["USF2'R209.MD:>Q]U?(.CFE9&S43:($_Y
M>AA*_BPC6OS[]?!A7>"'T>7EJ]'X-S>.%XDS1C&E;&D1"B(D!<YZ 5HE'I1D
MPHO:=4P'0CR!J5JW%JZE2AHP:"7U_O&+&^/DW6Q:2NW+_84+I;0,1/.R.5H0
M,N4=TAD#4E!IDG8!L6%]PP,\Q^=&4V5N+X+HIXD6@<D'J[[(MKCB/I5L&L_O
MB,[;GPU:@E)<!T.\R-M@]9+(=13GS8B>4F_@WFZHUEAP]8)G3BIM%7B#O&R9
M"3P1$2P/AO%DF>&T?5W, LQYLZ*.#AHXLW- KR>3&<:?9R4D\Q['@U%<@)O_
M\MW< I_\\CN.PV""\4):RI,6!'A2JJ1^#1A!!/#L]Q.'FHE4/1UZ,,KSIE-C
MK;7(KF]&_'=W.</-@&F@(O!B]@MABGPX.!:RD'P2/A$E$VUR5AT"\KMD626=
M/229;+J9O<7?YK_*6VX@T7NC0(4807A%P"N>S31E2%(8"1>UBWFZ(?LNZ=1'
M.P\YI%IN5'<@152!&J? $EHR%@KS@:T)4.0^6&TILB.=@?>!?9<,ZJ&;AP32
MO>)YBWJ&8?R'&X_=<#K90O?WF1(X'I?;H??__L*CI38Z!H&XO(,*$<H.BD!D
MI-HH*0A=(]:6<%]?).?)I.,KZ2'#3)4M:B?^^1NQ'7_@(6F6&+!YH2V:!/FM
ML! "CU+++#VSX4YX_]VK!^;SI.-)-/J0D;:IX;4E(/\10_[3Z0 ?9'9*%9CC
M!B'Z(&E4CD3ACFF0[47\';#Q.-K<$/;L'1W?925T1B\R7!5 "\8@VQ(,;*(L
MOT@D>'\DYZ ;X.^2B@UTN8&)%:ZC_=_99#IO_O%IM.6FU'(+7ZQQB5A)X-QY
MT%**$BH.("-)UOK(C*Q_1>U D.?-N+8ZV\"R_K?<.B">[]VE!58L%WEP.)EW
MUOJ 6723P32_,^-O@X"+E^L#AM'GA4KG[]F%$RY14J*&1F!VJ'A^@VBV-1)J
MGG02B=-3D++/FO[@\-$8L8'RO;,6V^X09N'AX//PY2P;R<-PO5*_FHWE^7>7
M\V7>">AMJ23_Y'Y_/QK/?S&=C@=^-BW%C)]&[[.(AM,+[H(7TEE@*CMYPH9R
MBY5D[R]*B4XJ;FQM\_2H"SSOE^'I<F7#F]$[SY(Q+I;W9C297"C!+1JM 'V2
M($BIH$\D^X96TTB-L9K7=O3O 3AO9CU>UALTWS;Y\0$GF:QA>A,Z*&N?TSG+
M(>%@.BNIZ&"$#TJ7NJE4FK](!289!S8F9T@P3*$ZIAO>!?1Y,^RX.MW RJ;I
ME$X+B)PKSK2'$(C+XF,&C$X<$L48#9-HQ3$S+7]P\J@:W4#)?@F:;,I>NLGD
MS<#YP67I:U"^&Z0!WL92/XV6'0\>_.9">Q<<YQ:X-/EP]\*!X3;EL]Y9(W34
MU/).R9D^*,Z37<=5S@9:]<[*["P%M4YH08.!*%G)&&D-EE@)FE&EDH_.<E)Y
M%^M>E%NEM-2&2$7R/'N#E&7#UUAPDB#P;/Q$S$:Q<M7ON.\I+:U9*HD\1:6#
M!^5B=GMC2?G10,%*2;5V&9JL[0/N*97\]Q_7-H W^=NC]&!>N#I?<#H(KD/_
M\PH-F>\_\=C=F7>LMUVK9B)0$A8B)!7S2R4U >-T]B:U4TY%E;)76?U]:MRJ
M6="$&DD YF7*+I+ O$?H!-138U7VC_(>V6I-IV[5?(@^][1J/D2,3Z95\];&
M'UXZ9B-5H CFU1@=P>?3$@SCT3G)A?2UC\:GWEWI( 5W[JYTB*!/TR>G"\(_
MNBL]1IV'-\QYC"Y.U%W)IM(A*(%/Y>*?L@)\R;\)I0EZYQ0EU3/VSZV[4F.R
M'**"XW576O:/R=Y(\;QTR5)YGYT31B+E@2F2HMAGJC['[DJ'**-;=Z5#)'G4
M[DH(&94#G1><N4PE&".S%VI-LNKLNBL]5J_])7C4[DI4,&NC$1 5EC:P*EO*
M5F2(7%OM Z74=FN*]ORZ*SU:P[7DV:()<Y=BA+N8<OEG&1KW<C293BYB=%ID
M_""%*TFUD, Q)2$9[664VIM0>V!1'[Q/HA%"'T_S:,IJT!7AQ57)R__W/&G_
M+KT:##.R_!8LL"V+M#P8'Q-H)@P8BAR(3I$G&AWJVKG-77B>/U%J"7OKT5(M
MOKG21VB4IE_PI]DDBV R<<.XQ.TN7XZ&"Z[_7'I37TX>$]5\U'-ZQC+[KZU6
M!'.3Z[%"M<R(J$M#=Y80=,JGD1%6@A*:,2)YC-5+J'8CJA?/>C=>!(M_Q>F7
M4=XEO^%DBKCRS)^N'_[QS9\MXCUKTL&\A7IA(X3D3;;%A%:A=H%E3?Q'BZK6
MX]CVJ-F1U?GTX[-KJQ'E8J4E.B^)\2S:R+,C>/;QV9/1HW-T]Q UG29.UP7A
M']'=QZCS\(#=8W3Q)%A#,/O$EHN2A[<!27!\O?_ALV7+HZ.[QR7+3A74CA1]
MP,^#R70\]S-N79B5"-8*+FX8>)9Q>1*\"H%+J>4^HWW?0YYDG.@@A8P:2+-V
MC'<E\KPX,6]"6$48DQ>?Q[@#J<@^IN&4 C5"21:#)^O#NO;']?<_]KR8T$[B
M#?,[NY!F[;+-:%62X)BUX*P*SB;-41P\5:/;H[]+CCQ2\A5#S0NT)0!^P :G
M X)%94 F0UU(RF#'E-&^)YT9"VK*M6('PP,I*C:C=:5.U842I,;D+4&K-*N\
M.8BSI$53R3?H0/A^//B6B?O^TH4=[*7Y5/,H74F\41]D<%[QRO[%9B1G0X^*
M J_8(W!.VLS7\*7X4;>#!78;.O-6O4@YI)!W-,>CX<EWVAWV/>ELM%U?KA6;
M^MTFQS<FQM>M6F8@[T$>O'9.,AJHIZJ3LK<]X;R47$6.M1ON[:Q\6 ,6E0;C
M @<63*($8XB6=E;PLZHDZ:7D*O*LV/=NM8AI-RX;J ;M.043>#9#:9D&Z/*)
MHCI6#&U_R)FIN9(TF_226[H7:X.G)YM"G<@D&"T-!*VD9P2=:="[=P>@/S)2
MU=35H/9L\^SR+J :):(V CI1[JF>XD:MI-X@Y=0)G%$1\CX7@40M*=4R[W^U
M+R$=D0K[$DNG9<).83>9QW=[,7J+ 5M*H8ES$*,493B+$[3VO<0'((YO7U10
MSO9I2(^0;(M!6:5-P+NT[!'P;OQA\/G+=!.K20A@O64@J12,HLWX:I=<;07S
MW=L0==348M3K)F!;;.]-T%J->MT.ZT2C7NLHL LM>DB_Q5G2':+D!#PM#<&2
M0T>-H(G'YTZ,?;-=3\V+G4*OG:F>1T'GP9,QOIJ5HNJ;YC2;3T-//+C($E"N
MK#=4&[/>2'57='G'DTXPRK663AZ$E6L)M';-RCJF+2EPH<!KE8DMA$_6\&Q"
M=8M%;?[\,]%L!>&UN)/8D6>Q3+@*TD/PGAI**9>D^Y7$\WYG:XFQ=GE(P;7P
M3W:#HN4*+'I9+BL9EJ)%3-VJ"+<]X8P4VUN M>L_-K+MQ3#N![L(;@>7P4;J
M@6J=0G(IK_^ G-\!3SXC%C03>,6JC]4L1Q=<0O(L 8S =4C:)R1)=GSMMS_D
M7'1>28RUJSGVYRJ-TQ""CMDT3!*L5 YD_D<)0:&QIO.+_G1RO\U>ZBJ";#*/
M<1F<7JY\ZZT'2;.QZ%F P(5PG$A5OR7C5C#??0BOCIH:E/VMXMGRGFQ"U#9R
MMX+FQ,F_?NK:')CI*^MV<;H=R!@58!TSH-!RSPPFIAME )IKOVN^[\C*WRGB
MDP?CG"N3.APP(:F3UB#R;MW!GFPP[M&JZ!6#VR7'ZKW!LN&RZ(F\R0794GMJ
M:3:+= (2$S%1152D6]2UR].>M[*KR[/!5OXS^NGKX60ZGI4M[/ZVM7!"(H_@
MC1607!242"*4JMVBX"&*[]X$[*F8BM[A9D2EB'+]!=F!JY$%N W3:>S OCK;
M28&> F^^=VS'IS/O#:,&A&1&DL"-(OI9$V&/27@B'NR4<VV+\",.!Z/Q?#QL
M&7IX.S#V?9;&8#(9C:_?CJ:X)6S)-3AG'*"CC"24W*_7!VTQ&@YYZO&-ASJ*
M&AU#R@W*P]Z,AI^G.+XJ4OB4_YM-O$<7P7A-@;* *FAG]?IE@MY;P28<W[TY
MT5LY#8*1ZY@VORP;434R)S8C.HTQT5]C>RC00]P-C(ENZ&1^[2SC"9SF/""U
M'&/MN-(Q2;#'D#@1!W9*N4D-^>W!5H!M/LY,M& M<Q "Y00-R>NL[8=N!')\
M.Z*&EAX4D_<5<0.+X4-IH3K$^(L;#P?#SY,7(<RN9I=EE-1R6-2#\(C+9YYC
M><W">AY*9^_UN&)O$NQ'=8+;B^V:=5960NV@Y&IWML^?Q_@Y WM=Q.TN;U*K
M[\>#\- ZHJGD:QD$3ZV)R3%/NZ6HNS[Q+%C03L:-&QS.BJCR-_/XZK)_^G#E
M3N^#[ N)V1M*^9CD4OG F/0A5=XY#L%W%NQIKI@&MUA7L);9A8/\J?-&3!\P
MX. ;QG<[P;IRYF:PQ*&*PB;%L'HSZ4, GBN-*JOF6+>9;ME?(C99$3AYZ2XO
M,?YT?9/G6_[A T$9BN!38$!=8CRX_/UZOY0V%UJZ0SXKKAU3?0T*<5;D,3^:
MW^-XON,^,.FSF>9-4F46A>,Q*62T^H3W+5C.BB]5!-X@*[>1Q[_\CN,PF. <
MZ>TO;\E+']P=*!.TO5#@I$&1&8QNO>EKF\UG']"SHE![536I&+V=3_3S;.X)
M9']@%!?FW5O\;?ZKA]NA#>"U9$!0RD L"1*;#"S?B^RL&-1 &15;B-VB7#']
MM^R5RZ:5V77,QEHFM(HQ22ULK'\X;0-S7L2H(O**7<9N@*U<:EEL:.]FT\G4
M#6,F[R<<7ZT?G\XD,(IPX-XX(E2PP=:FQ#Y,9\6,J@IHT*#L_7@4$./D51;*
MS0"\=VFE]\G##FH!K/8,5#:SF1-)!EW[:-D+ZJPH4E<%&^)^O1,%]PLK7@^G
MF'>[Z0<WQ7GU=<R[7<B_<)\?F.-,>G!.,>#HD0K*C)>U.Q!W1W=6M&FDE W\
MJ5RI]LH%?'$UF@VGZ\"4=]EODP%0\,04DT;QVN&];5C.F!N/%/@&)O2._J[N
M=6LYT75LA)JR8(0H$J%*E+.PY4&S!N>L^%!+[!LHT7/D00CC>89BL7N]'^/5
M8';U:C2^5VR'"<=CC!L/PTBRP61$]JZ(9R3ZD$_#C@-S#G[V67#B&'+?P),*
M(P\VF4FE5N/3LE9C'2)-%IR(99_+.QM:K1*M7:VP']59D*:1$C;PI']$UDV^
M9&^K_*M4<7[+(BC^U_1E]L2NL]?U=W<Y>V 2$4? 4*V!4Z>L4%&AQLI4Z03L
MK-A27Q4;"*,J3]C^.+NZRL(8I8^#S\-!&H3LON?MLIA/)>(WNAR$ 4X^AB\8
M9Y<X2OF5^)IWS.OLTY=%?BT65X_!VS4?WW,>=S-)5!K3??.\]Y<%V,I#[]BK
MC,QV##= /3$@(A/@@G!@#1-!BZ#X>F.4&B?"'E2] [Q+B;]+6Y^UJ%CGT2J-
MAD#,[Q((RDOPT41 XV+0FGMAJO>7[XCM6&.V*W/D0>"WA2HVE6Z=8HSVUB7]
M='U;#1V]EXB*0U+:YC,BYM/>6 O*!<*%01[7NT"V>\'N8)WLODD3.CRTP:JJ
MI4&EX/;5WY53=X'8Z)Y)!WBGN7127;5=J=-3+R>BD+/>J^QA !6>@G!$@I<^
M(Q<^*.*C4Z+V%86346?/596GP)Q#U-%H&,;7E3%ML4SOY#;#D2A A%(4)&B
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MB!0^D6PJ6U_JZ348EQ($#"9+-G+/V;$H=Q_:]TRY'DIZHKO<GU>6(YW2.O
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MZ&7>.+F+P-"::$.28GTBY7,CQ+Z>UZ?DPTYQM^?!2G.>.2B1STS092ZG0^Z
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MY_1,'^W'5BEY='^ _ H3J+5*4@<1>595R#:?DR[[^RJHI%+2%&M;55N@]#T
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MQ/<$P(5Y_>7&'6QCZ;Q>KBH68^8RLZP@N%BF[64*SE&TB7=2*.=5<K5K ZH
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MG!K%9'75FU/PG3WG5.D2JY5+VH;/NRFNI?BIR^OZ+RFDT?<4/ST!&VC*1IH
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M2]W_RO0P2R&RS+^LL5WU!JY</I0HN)G.<0$(2R'.3PL[#4D>;\JYDDDSRKQ
MD+VYJW1HVUT8]#. ;B.D223+:OLLXFLQU!ZX.^<Y%CHKJ*^E6F3@.C02['2N
MO_!@W T9Q ]-N@"8C,*:&SX^89EAN4<ALRF],%XX&EY%;\&=L1NY'"=MR3E6
M92N"N9U;HLZBYC;49!0<[,0W5[_20Y;-C&A#)5SZ. 9HMI&EVJAC!-,"6!XE
MA-$H8E.*,\*1N\4,F6B2+FR*C16G^T(>F<]/A[,8/KWS?S2N^2CC^(8M6OC;
ME7\I1(1)G+.B <+_!"(B+L(D7/,M0FJ0'A^J%N>Y%\C'H2(22V"CJ58$F<=>
MVL2F4"<B3A$1&B0*4T5'(.S !7W+U#GL,6+? Z'/:!5(1__L7*[RZRU.2$J8
M[\B+6HS*6VTO=X:I_=*9WG3QLSM[N]!BW*NI;8>ZGL4=O+98-B9@_)Y]4ZWN
MZS[/8>$X8Z5:=XXNI?46+Q@Y6S9E:!7'L5>CL16'^L_CC\_GSB8B84+G;XD\
M,,F)S/$O[H0'A3,HO+\L!==-E:@'K?RC$\, NY ?.7/]OV?NY,=_,I'-NA1G
MH2KL'WDZ?R/+_2=__FLE__\,!JGS+%6Q.0(KSLYK.5",PT<LJJQTCQ 3<4,K
MX7X89BOE2.7V%K)J1S>)Q-(YZ6%VS7V%<_!/-; !8">8.8C.9M,66,V>\BEY
MO*)$/910*%K)G7%?;-S;W'9"JSSTP3O^$,;(S*LD12/)O[^ZVV1%B^I<%<YZ
M\Z\"4U/+TD)G[\!UF"EF/RS_>^C\0GO"PP_6&AU-,Z/ S[P4*L6C8IU$%H+*
MA+(\IGTY. JR9\HC:9E$4?%90?!^ <E*K:S.N-^M^>WNJB%UUEOD+(;W_P'\
MO*-5/W/,[>XJD:E?=[1[ ]C6_L9 5Q/9JG9-S:7PSPIQ$,*.T_G]<)5V>A?V
MX>/Y_N>)!DD=C,'4!6"I=" "9H"AZ4QNB(O/5WM7?4/&:&ODW<L#YIM2'PCF
M[N#I[37PYA/U2SE=_4=^.=_(LU(;/GG=IU%G>4KR_RU\(NDE:.#BL@BBZ*:&
M"T"48"!<[IY=>+J,N)\2N:UJ7H.255A3;02TW^[#HT*5UNNLAQM[B]3G7X_I
MZ8.K2@*#1WR0?NA]PAOOUIG=H0R"M\E!V;.?J!J9@JSHT-!_X?(GD^V%>BV;
M1BYGL$'?MB<Q-VZG<-V<[_KY)C="@R%@6P^VAA9"3-NMV$J_54$J7 #R7I:)
M;I7+P7G469[1_C.%)A:)FRMPY02U@5AG7>0JYEWY#1*?AU+]CM_MK271M,UK
MC$9G3/<NLU4O+C! S9Z@Q_"3.V?8:O(T04G4$ 6%38NZK(=9 O/DZ/D' H/D
MFR 2'$B_OCKA%U9+K[.#Z8:&YDLHW]$*MUGYL]>:JVU1-CFBF;JUIC^VX=LZ
M7U2=7EM>+E&M%__WN8G[L?R&PBU;]MWR/KL+\2JZIABY;4SV?<1M?MV)>^F9
M6=<% &VX$&]["VWLK$H_"'$<7AS=F_^SO3T7W;/-Y1S+V]X,HWNQ@F1TP=9B
M!W=20FI&^<!6!0+U?A9VKQRT7@:,F6/1]?;E+&.FNXC,)I]+9Y<!EX&$%EGU
M75F?># T_ @;R!IVSX$2(84P"EQAQ2[L?L0_Z<8_ALJM@V>@N\J/<BLZ@VF=
M3MS>^_:@WBQBIEM$? PB4&)#[N)\C>@_N2P-H6)3R"GKF/#G5%+O5=VS<W4+
MY&."..9<@WCJ4O#M)T91Q#G[^*%[*YX1W?QOAXMZL& '7,#@TUS[@=FU#U9_
MWB_HP(/N$7^K5;%'J[(2#(=\MVN3IV]G^O%4'\<>5!5M_F9_/6OP6_I#]'ET
M_ ,!UY5L@/J#0_,F@>\)ANXGEW/]*1X@Q-+Y2?J%N7R9V/(^3KB[&W(-2J,W
M".-?VJGWGI+U3@#WUFE;*%?S48UB^_6#$M%.(2@I:/O2PKM2GSD@J"7^#R5M
MKVQ[3P+M04G)ZP=;)G93[6N5'4;8PLGS;A8S>?1,YP(Z'4K93KQY0%>+S?UD
MIL'D5>D9J@Y%[I%@P-TH7MS0(O(*[O:)[LB,3;4++UQG\C=K^WM%[I"0QR]7
M=Q&<MNL;0Z/5AY V@VE)FUH,,A;&A;EWU*M[ :"?.?^^C;70$HBR\WVP%5NF
ME#;Q#4>*3<3!,=*VG+?#RZB/A1X)/.UC?NQH.)JW*.^WI=>FFRFJG9ZM#JTI
MQ+^ B0ZM.O]1?H)RU1_?Y[R_]N'3XJI=2/IQ",;N,DX\:0]F@^KJUX+A!CIC
M*U:IS0]X,!#W=K&;@!Q5N/3#L(S[ZUIGO*'@#IF,J&%P"U"F9[?)Q97(C4*?
MCMX<Y)P;-S5B38*O/J?E#=M(628J!TW8,@/I"59VBP-LXK82E3'G;%J#;_HK
MA%]P,48H#.BXTC7R>6I;GR5$'\R!5[K#49PXS79V58EQ\F9LK@-M,=.-! OS
MKMQ4U]@5H5*#"P#==32>>.W1"@-.ZSDG1_(N\84IDW_+X8"CO#NV6R?=;!+6
M<]0@%H\#8^PNF53-I%XVL:U>91L^E8:\R[:'.9'=*>O*>?&?K%/)V#,<#PRF
MPVSU-<]VW0;<JT57 $C]261Z"X2"'^O7TLIW 7 QCZ=76VN8:(3Z$=7/I8G-
MV1> 074SR48/D!6GC*&Z5MN_TGGX%F8%SP()/Q:\ "2E2C5BNH\+=S8D0_S5
MJKJ[FA*"@\'QP5N?BPP;7B7MPKDNU>6G?\_;&MF;!F66SKC\>E)1M#(Z8N@Y
MQ"PB7-PSE)=$\U,!>1=#V06F4_+LY'/DC:C3W8_C3,^]$?^+6N#E:S)GJU.S
M5W=\!,J.E(OJOUYU_SEW"GPHNRHV]B,OV-GJ C"@3MC96$U=IB_I[AVY_9(G
M-D,X5Y4+%SV;:@K$#IJV/ N==V['ZWCB7*0W&>$T\"D2Y#5,)$(&R10T;,N)
MIIN(V)/-^&XI5Y3R*1:V0]W@H/F$=2:ESXU_62(E2<Y( 3CW6L]_/2Y_&\6*
M^UH$7<>VF^C9;DN69U2W1@UI2%=RO[_/ Q==>1O3&#MTMX_;;4 /^0%KGHND
M&R0JBL>R;2""$C>GV3LDE"RN,CG0!CK6N[YP'1G+1L6KAKNQ5"O^$E5P9W*8
MC>4PWHD]DI^T%,X*"6<QNG31*_[ ]'(M=I(:9*;#FRQ+AV6^6S2]T;XI.7\#
M7FD-BD%)XX(-,&%!9-_');KC((L?2OGL[PIXDI_"^EK\A,;K@D,S*N.P;Y>U
M8?X89B->0<QN_Q,C^\_BQA5=*J\-5(]A11/V"S8,P<B/:FX,,U?QBS:=^1'*
M$K1,N)1M1@^)OE_[NN8_3[5 RW9OQU%5R) +P&(FL-(O6MENN5B2%^JDEVJ!
MV 6[P,'N\KH<#W7J;%?(UG-YXRED\FU$&X'\!"W<U'(&(B4O 2716%W7%-(4
M ZX.TW@FA2^-SY;]LW#ULK\TE.PX0<]./OJ/^-$ ??=-7;&9)[<2H%WTH]U/
MSE(.0"$+%1> ^" ):*U!3<RCIA%OZ!^SO93$50D6#[Y[KYP2YL?PS+E;&!=%
MM])/?*>F&''MNM4E#7*E]'4ECN];1NW5+R7D'Y</'^'%Q *=Q^?[92/('<BR
M"@" H%"4UGEYR\O4A5A;/@-VG)SYC0E;*=;CK^V[NF]4=R)V?WCL=\(1ZOP;
MPA.%#X.&&8PQ[)WI=!C*W4,,TZ\)$S:W91Z9SH#WQ=0K[PX_,4RF*YJ-M%0.
M$%B$.KV@A_I#*#YM,#QKFZFTKCF:D7FZD9M"8;M^)SW1#HL[3X89%L#N9W03
M.4:<QKUW-EE 5M.%_A*K#T)Q?W("O#MAN7DP5DS?1H2L&K-0I"R-&[N.@>+R
M&?3)B_M'E.FB1TX3(D^[G^H7FZG9-FGB'\/DT?%-,C9V70$F2;GO2\F2284-
M^.1/@CD/!J9WL/6(1:=(F3IE.0D?T+4=QB]N-JFPI^W3QHCFCR.;X(/X]67=
MK9RZ=,UT%_V3!(U>*96?2"-T<!N$F_ *3?<G-\O2!@Q>\DPJIA1?%Q*?X1^P
MR1= 8 O-UXB_LM6[?&YE:BXO= ^P$3S!%!CX7/-LTJVF=UFUYK]?1,W>58RG
M9-T#40<OI@=)8WR1N;8[$Z:FO&R?-5^?R!V^LT_ACYA^XRW@MV=[#SV =<-<
M #HEF=1S7(B\+94&,NH^<#]23=9:A9<=Q]TJ8MA'/XCLM6B#,&_XE=&DVI%2
MNQH-@03?6.:!PCXZ!$^,N;.HN6],.G"PI$DJ<W*+T_OF?-LOUE"J2'5UCBLH
M[?/")EG_Y9;I["7WKTZ%"\X) W8WZ72Z5 9(#KG>:W4%56-E-8;XM;BSDFWC
M0C[@AJ@]&S/X;_75'P"[&:;*@  8*>93 VU#\CME]4)E8]>4N!G_9'DI?OLW
ME "OP0!3^7:E8#*8.BX$O;X5Q+_#F=Z<_0W/EM+PT*H$^@!UC^>I1WBW4#6\
MW,2M:L;J'J^YQ(L(S7N^\7=R$?4\KN?9U5^XHT_4E(B\,"VTYELB+\%RF/ H
M^Z=<93'(]E9:C*,#.U":7/TU_=5RBBID5>-"&)'Z/%T6PF[1QY.>$2@S\6I\
M72-42"E!_JEB^![(%L:' ^83A$:.4V4:W&QDZ73TM"VW67\_64VC5W(J#9#M
M+#$S_+P1<2];Q4B=5HW?;,\H@.:CGD&\LK9 NO1Y46X#>OL7_RB!Q'N<F>J+
M9G_,=SMN)@8=S&F3SY+P!<!N!DFBN[13"/.W$ZON8:.UO&[J[GX=\^/J0[,M
MG5;.M!+7'+IOX8"5X6PVMEZ!!!IH6()=X.YU2.&^MHFN+FD(^J0#)-VFQMET
M?9DNV!*%GH_T6@*#P72FTZWN'<QA-MN_%L-[5#Q2HB%D!-&,)52A+U%M?)IF
MX%KI*&>["\K2"D3U<R"I.#3<JU\*Y#5KT>Y'\TA9JH_9)_XQ;<N''#?5J3UB
M__C@9RF$<-?5E2W=Z<@;AQ> W4 ,5\>\\K"R)D7]ZK9I@,/&5$GUIIOJ[]I-
M"GFW'T+;X,V4:"K^VCC^:-EH68ZK;P"4P[DEN;>=O%U8'9Y?1F8:_YGGFYX9
M3*I<FRVL36*2D<>X=#<Y;;LO2?+"?OP4MD'?S+1=W)-\T3/=Q#(!JNQ)VJL'
M#-,CR_2UZ.[%N?G&)7RF2V%W(/CJKZ=RK&LF+][N@L=E+.9WM,O3C1NTGVO:
MQ><4"!8-)"T/KVT+9_U+'9PKLIXH+APX"PKJ1-W W J[*UA8=E=VI2JLF)6#
M@Z>X2'DB%B:">U<&35Z)[+@ ,+BRZ\HE9_5>L7A\C93#GFSU9+U0R.F%',+Y
M[^)G)1\;]2VP?'@E7E_O4>'V^RW???'?K,^<4M 97# -U$0UP^[<+5M_>WCT
MAP.#-1OO.P<E!(0::VS$=3]X?&/7 GMI52*T=%+F;3S=:U]%@QCBK>]) F!=
M064#N6>,>SLVM6]0U*VN9D88:O:)T@@KWS7^L[.48^B2N:$ABZCP#Q,.@-FS
MXI',/T-F\ %%#AU<[< [7YL/ZR@>'%WF5E&"*_FQ;OKZHS#@ QOBU\Q)%ZG=
MRLK0*0_$'!\PH]0VMXQZ_*O!N_1.<5E.T<&XL)EH2^$2_0]23Q)8/[S^Q>'-
M%R^J(\SZ<79-=B""EWMB]#Q;[YW G@#_"V"B?W(4BF*[@:MZ(A(2UT8/>Q?/
M#6<(.(E^*%:4+EBJDAY)_HKNZDS70(.J+_H"T#%GULX9.2D;91^JKB#"QS=1
M!85TL04<-RA[%MI-)W<&40XWO7!].2HQM@ 4Z&W/'YR( *=S3P0QN^HJ>\J.
M?[):JS/\@87H[-GVLI16(23/\V_[05* T:H?>4?-2!>!4>/$&[7/_#KJ5CGW
MD+(T<-4N<.^7!!KSIS\%*KA%"ZX+I!RZ&B>*>/:<.(^'0T5:/_[EW^W;2GG@
M'VZB[N"^J+5GT';[%\URV,?CK4>TG&4FIA^NE8=Z;08KKE<!$9;YW9!W=-]P
MTH_9+V.8)6VWXSC/M13).XE\5!Q^E(=8I#G."OVV'4AY)#],D'U>4ZZUKIT'
M2;'XG%XRMV6A">]SG^^61QMCO2Y%T5I=WQ*O[=/"O, &[O/$KZ>8VB6PX[.:
MG;YE)676G B+<+BS5!F12.G^V['A</T%X'A,Q4J[>L)[IEF1.'>[Y$^6LV/$
M@T3O%Z%49R;;PCR[,(GE =RM]<1": JXF;*+V853!M%DWN>RH0P[8#VA5USA
MCSZK7-QHS6 @,*!?J7*A=V_7%*U;.'U^*S#,6]8]$;WOG.^5ER=:;5Z@;Z;E
M/KLB4U5E=._A?WH24$3X"E=O78G;O'^:)B=MDNMB-4/T\KWH:4O*6(\&C58U
M':=.-[T3JZD;;1_JB]?AD!5L1MZV8@EG4$CQSKBE[FE ^'G8\\Y7[0GWULH7
M6 \5"#[.8]X%WK/%0"/G%I;2/^OFD.=XJ9< AWO .#\1O@^/1,@-^"X=27OT
M?M0KF$66Q?;TJWEXW.Q+\QR>UW#PC"KG#EV!BP19K*6N)X5!YA:AJ&(6KC/B
M[?J'OSPK6FR+[-\O?_CMW4#G/\4-H5$;[9P.>V49?A)SS3_2T5*Q5*OTFK^H
M?UYIYM*M!O/(#4_U.$6PQ"9N:@$<ZUKB0&P20=2XJ\$LMELCKN_5/>CJ:VM\
M- 4UJ>BMXJ5M2L,'496U]2:B@G'V5P/M2:-+W58E;EO^[U7]VBD 2Q'JY29$
M%ZBJ.YS N*S;S'1&]]"JT8C--'2VPCX6#4YE?)<=CE!Q$49*ZWAOF%I7C4WM
M5)F]F0N:M.4RZ2O[6&B=H6&".!W*(TX&<=6]I]D3,BPWNC][I1?WM7JU!"_N
MN68RUG^29&?4F$-<62@H"VR=5QY2#LP[KWW4$H^]]GH)ZJT:VZP."?5(D+*=
M%=7(>?;MSY?U7[=O__9A72:*GN=[2U(1[M>AC\=R)MB2?DAT9;YJ#3-*+S N
M[+[>K7/,0 =%ZF""4FK/U F*X<7<_N]K[O,7J$;4%]J]/MX0]5Y/RVZ03>3\
MM)PK7)7>57_FV%2Y--!FH]G:PH;B@U9L8\<#U1BU:69FVKA^1]U\X[=J=X T
M=EU49L4$C'1E,"J_6%+PWHD!(^B5721&XW.%YNNY[J_:S3>.[>X^WQL]NOJ7
MS3)!(IGZYU:]WF252+L9@7M4):$KNW=2%8"W9U\8R YI?"R69?%\64[#H->7
M-M'!P&6+2S;1X]<U37'A>IGEU:@VW"RTA&Q7 E%,E1P*9Y@D>HGO2M>>)V)+
M$&]!#/$(I_/J@F^*B8.ST0$=D=\N+8"XF?[-"E!#?H7R+AOKSW-'5$6@/V!?
M5YUU@W?Q?[QY8&*U)[=@5)DPO7TKG9H=S!\;*CIV2V9ZC#KWEB-L#D/:YJ=&
M[2,X+G,!4+1A6>L?M,C>KXV?3PQ!(Y;E$4$J4*+$PWLO!H.X+;)_8.4-J05&
M6[FTGL,/CY"%LFZ"$Y8C&Y6-4;J0NXD^KJ=#I1!59MS@E!+P>R,D9.)-C\$A
MZ^Y((;>)/+4D'"AMF59Q]JM$+>+$!O&M278)+M2F^,32,2;?:BL ]OA3;<W]
MHKN>!N/58,GVLR;+ZC!C?B?/L_%2Z('^[=]G6MKZHH:3PEG1"?];D@D)7V2*
MR23YOQ9E"TQ\@*9VFS7DCG1#Q*QF1&X\=B+#?[16*'%0%O#/HRR#%S&VIMP)
MGF?)>/66&*AY 8!?/3W0S3-QX7T(N.YH]X,W9X(G&^:(CHR"Z7I]<YD7J*P?
M*^WGG+/G3E_DO0"$^S/V?TH<DU,"6L++&$[W@.='PGAKX.&T&G[3; #E=6*G
MF8;#KV?C/8$];*JA?Z\RQ-:I;50%GPPB,Y0WN/_(]N#:5RC#""3!+@[(G?$S
MG[$1\G@1KO6->I[(\:)[PZE5+M_+CQ$S?!> ]*$+P,)#1'7K!4 E^P* "H?M
M.Q7<.J[R8SLL[6"B^RG^ZKHY\*$HY![F)$YRKZ>4^TKW( C\=VJJ$Y0$+()X
MQGJXGW:*[RK8L>6K1/])E27FPWGB/HE]$?P:6D#8C/>[[OR-3?7]/XXV"<:,
MD6Y?8)00J$?_J:3(9[$OCII9!Q5LB^4<IN*[TBKK.J>?3=, '_R',.R!A_-J
M^-V_A'$!@(ZRIX29LE58SUGG-C>Y6JPEAA8A/%U-_=FSWIB?">TE70#^]K8A
MMC?X=!]XCA5;O0!0P"S0^1TB9=_0Q$9PH8%[IT"\$%=D'4]WLT\C KFE;S$<
M4U7XO?P(."-Q =AH"CZ9S-ZK^;>.S 92$04RJ:D\K]42#;"KP>_%X=1_[UL8
M[]9".$$0\:P'C]6N*W-Y+*^C?T&C?U8G<LBU&4Z,J$COV:2OS.0^JRP#1:?>
MOVPX\S\V/%P_\._).>2:?'8!<.\^!9PQ_SL%(WC- C&P\U+JT:<&72TL31+H
MO>>J-\=+C[J_AG9SEQ[*!:Z4J>QDCASKPHVZN!KO#6^/.S!PE]]Q>!X8*CKO
MXQ#LV&VW.5#S5[H)>@'8+]><<?LW>LAT0IMBQG#<!C<O6&UO\@+ 5_+/6!T:
M1#49Y$%U-3.>C4MFC>P^MQF0Z0"HH*K-VE05AF#P',W"3<5/BHD?/=8?_EB9
MC!\+GK'=EZ_TI0$^A5=<CKW[K[&K3D$N5]K*Y4KKA)W6G0U#5%MR_R9(ALS_
MK@KXJO9R:5Y&U LO4="Z.EUG6PN;E^_8 Y72R"\WD-B26DPZ$V8\US]_,V"O
M+#/0=<8^0HZK[H^*YG#1O8F[;L8O[': _\%4"_*WB01=,LV0YZ3A1/R-H_FN
MJI#61S"58>+$<Z!('\SXO+Z4( 5DK)(@V[*L>7]B9#WKRLYN:S%"VW3GB\?A
M\W0ID/'M1Y*C9C\6F)2=LIT5\_?(<T +FI!"UX^:/%\;?3Y%D"TWG?FHUEMZ
MZ7J6P./0P>UWH)I+J+=Y5K821X8S$>S"JA8TL Z$.Q3IAS-6?MH=C'K\Y%/7
M.NEXD]J2%!VZNVV5^VU^>\\%X+69V==\%3K/%Q@UDP[%!#/&(Z/OSZ^F(0QU
M;6]DXMJ?#FX\>3+<.B]XCP.+M!\^YJBV$BY[<4_3^EQL%PW=AG:<>CNK-PAG
M-=_XZ^B/EP'O"@TTP6C^"-RAXVV#ZYQ6T\BS87OK?Y7\,E^9-*O<E))1O)V6
M(&)F!6T7\R$37OZ&D8^N0I!O21;N!(0I.J;'EU=W;%!=CV<)$EBN6DJ\S1^O
M-0-S)Q6C#^.-*/YR,&DZOEKU3_.V?QVAYPQP>UEP=L=4@1@2&I**G>R7_/R]
M](MPQS1I*>_T[YA]_#X,>?S*R$PVBZ"%[H[B<L\HF[)&>53V7^W>I*<N.0>M
MR(=ZZU;7-&#D,K ?TQZ0M3FMG'_Z61#GZF46^U%LJA];/C%K^P#\>Z3[V@7
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M],9!;M>L?1D46:Y*3U",7-H/]<9?EW ;,199M]5C<:71FGVOQ;VB,%#]^@+
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M;L!];BRY5M9@N;8KCG3I=DII@=9$0,ZEXY2>Z'8XH)3^1GA39><3+AFO? $
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M#:V.K<,[S"7NC!D93-I.R$UOK+O1!=O?-0\*NMRV*!\Y66:K[]WM+82CK"A
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MZJ< Y)FO;\7WIT;\.]Z(?^;=\T]SP!BV0?0?0$JMTL:U2-J7$'_ /6PYFS*
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MU>"5^V!LB/46A$VL_?"^EJ!15&Z4T,$5/L(FY+TI[O1^B]2^95+F#MG@$3,
M,4XI9#YVE*N-;JU8LTE(IQL_;"=+=.ZX]4'35HV;X^O.8_W9J;51IJ26=<^"
MXM$;DXWLRK=. 3<8)8^N]NG MLG,79:B=4HG<]U3SD_HP'04NS/9:3E;FAH+
M=(57TZ18*W>_'06FQT1*V3N&BNGI+QDD5=S7%*+93Q_<+[TFX"9"$<N55R2C
M+O4M]7I)7D)QWH,#<L+(V1'&$[$A&#1#KP3EU'6-=C83?JT]9WE<NT/0E2['
M.7WR'%EZ7]: 009*7_JFMQ!E9GFG[4D<(V@J9T>^%TJP;QO-5?^>L]'KX4+^
MTX\F\<0VV"',]+R)P6XY/C:P.ECEI:V6)\,G24D>18^E,AF)P@+7(6W']N*<
M:NEJH?;74N0SZ>E"J:F5E<$C['P#? ]0>D[OP4SP=U=HA M?VS^^WW[W/8N"
MQLA>+H1R1<(CAMAE]]J664VTNY^&(EJGEAO;S=O&RE(\*JK:OG== "_;+L!^
M7" L?R+/Y@>P[?\/1JO_V=#4''A.G@A'$"#<K:@ >E;ZD.<F#Q:J?.8W*!-^
M;/\"AGIB:Z;%1]?%Z<HS*@X?\'G6O7T0/T<"PPT0/DA*>]GG\6^'F<Y.G:2?
MYF/ K[>?+4U*%1RH54M,>.5WF/A;Q:K5?P4,VSK<L7XW_&>H^T\U.#['VUU+
MA@N&7(*KX]M"H!I&&?A;D9(55TJ;BAZV>HZFQ^]  423Z%8$C:P3AFM0(8=@
M_S32OO;GX?'0K?ERGICU=6ZS@>74X,B_*G0JB.7I7=7I$SK(MOJF!G6*&R:>
M^[X:[/:C:J_E[43%CTGEL5)NRPS/Z[3#%&KZ;WJ8OIPM^,\0) >!.VN\A-GH
MJ]F!XMUOT1A$8-IM@91WB(T45.I;N?OB@@=*"R9LIDCM</!ZC@DS5&2IC*!:
MT"-T,'H1\GR J>XECG/R$O914[T[RFU"CGQ!@3L\>_!1K)[2ADFR2QJ1;? -
MHT&?%&MJC1I8OF10^W**#ME$:5:!P4BV%M;22Y:?!WKA"8#2EZ940Y_E7YX@
M&GC?2[9UN+Y:/!DQVV;+R\UXZ)/H:/AYI&$NM$]D#GVE5,2J\&F+*684/L8@
M,QG;OM$#RV<.\=J,3*\AHQ!"I8"XO7N/' +M.-"XZ5)I]=IBQG<?T_6DCMOG
MWHJ<K#L&'S:9]I?-7ER]0H?.F%IY)T(;CGU9S>@X^L8W?+[@'L@__"XM;;E9
MAE_IL QC>8G79B61QS;!OZ)\YYR%_8-HS<DI)035!4'(5[57/_-OA89%E^*N
M<[DR/YB2_L'Y.>N9><R&243CUCD;Z U9A0P;C8DN\H"\ EVL:L>HS11M#QUX
MB^)@I<6=E& ?UX[OW6D)JS=BI5026S\%E"R%ELD(4LEC1-XYE#K9;!LUKDJ,
M7VCKO/PK99IH(+7U;+Y%1>/[(22U;20VTMH*Y&SK-7*DM_A1.N[C:]QH2_ZE
MG4:W^%- Z-;>FM_ 8FF1-85Y.?U!VN9.,N]N757O(.T"^KSWC6DB)Y0N)'=Y
M"UU>%N3"\2";F;;Z_D%^=F^,B)1"1]I2%M$.C\ LIN'0&-=(A*5=WJHTY0JZ
M--4 'N161:&_K?*-S.%9\%H*P0_OV8JFYB(XI<!\50=<@$#K-8&B@HX7Q?D_
M?^%R&1DTVE>V3..P6SYNR1PGWVJY\5?E%"7S=FW%RZ/Z/\>]4YT[RR[/G_ F
MX _.9,>.D7A-"<>8V> 7?2YR*F.&LT8S1D%F;\&!GC@@1J^;OK+*4-82"VQQ
M8",JG"")+NDV;B.NTJ> CV5W+ O4+CSD7^=@J7EPP"S)S1K3!R6:X]L:H.])
MEP(T1IR/\Z'-[UH<7F9UV5\P=$'%4JZ0XPM9RY8]@.O?G6=]O05P9?MHSE-
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M[4!F(T!U^"7;RJ'ZJVMJ>%1SO=R@6&7IX9X@,.SNT*',Q,QSS,>/K)?G,U[
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MG!:6ZJ./%WQ. 1L>>MDY&T=:LNOJ[),R2B^'-!3(+_^?/A7]3\:Y'?0&YA3
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M0;6,S_#'^IPBD5N>_?(A?./GB1E1G7P\U(%GJ%O,U9/45W%U]"4%ET*G49Q
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MC%9D3L=8=$F./*G:(&I:<]=&#.8^1<L[!%F&,K>3F)"'1FZ=AO%%)\9FUO;
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MS"$A+E-J"4T&+)>#V::NFU6JQ/_(A*\1W3I#\8C#G;0?%3%V [ZN6^+;VMK
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M<67<S,.=\;Y.JX]OQ@80KZ#*<Q]AP=/B]DC(',3"N8,,,(9D@CK/MU68:]Q
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MA9CK(2%MT1C!B@J";DJ0M5Y*63+I_MAU1#/M!WXO'7@*)?2-I/R<@6!!#-D
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M11+%IO2/9P#SY]6Y:DN>G7:)SFES>&A%A@/GMQ=#:%-X8]79AV2W(;IKCG5
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MO[(3/\,,?=$O#(&#J."E7MU^&W")ITKV\L:AKWTDUSII!BH<DV1EKJC3:/#
MLC_2,M-%WBY>=Z=;8%YHE0(\GBS<7XB6\@Y\4J/=5:&!3&KG1N"6/AFI1BW.
MFK8!F<MP3]<>O!N]$\:<&',@T<'CA_7YZJS1,>7&&6 [UPAEZ'WI#) 6V8LY
MR=I8'H-:JQY%3/7K<Z %!"Y@+^U6,VP ^[$![/P,W1,</P/,.)XFGN!69*/;
MME8*KV,H8GW!*\:EV,"N8.4N?I-;(_4O-5KE\?^!H/HGJN-S5%+EH"5Y#J0J
M7.03]L[K"91"L"TX)W.\8F!?ZO%FA+YQE-NSD=$? E,#N7@'+ ZP4^&E$&V[
MF'>3J7Z@:8$^C-,:"%%[7I&084LY/53$FM/[S1RG<>JH1;5$ >..9/J$A"3N
MVLJ9XQ6',\!5X/4UF%&00*W5O'*;DP"%$<>[O,N>"9S@Y40W]$VK49[7/R#&
M^M'P''$8UH_YW!ZZD4N1$N8>!)*WF5B*K46&:S];/V76VF40A,0%R@&SP\HY
MQI_M$B2KVYB.Z9FWT[\^UB+[P<?@QAV$P"F!,_APR@QK_\K!T!D@CNZ=LPC2
M38_QK63J/=.'A#[[^*NHAS"O8AV-C7[2N$J%>NVF%'4)S*V6?W#'8+D%?HCC
M5U<*+,D;N*2O'OO=&]44&>4C.JZ()[-/V5JP0ST*,;:A;BZ!L?UZ!LB[ZO.B
MUZ ^Q=\.BJBM/7<=W3]<=X[RILXY2H_;!Q056>BV3>J6R:# "*I=Z C:[S#1
M>&E_?B2MI#]?N&I:@H?&2B%E._/7W,O'/K<+Y3$4*=_ZPBH8[N9*@0F0 )UL
M0<R 3;_;&*4]L1GDW4T^]N 9#6Z;EWPV7/[ *V?W#-#_[/0,<#PS!9D&UZVC
M1FE^0/*=O^A[O/PF-# F3L?>$<:9+?UCXWKC<JUV>JXQ-U1S (]L5W2M\[N%
MQ9WRU4MM+%A\9<@Q2$:G0HWO.NDJ".Z&^A-8PV;.&>"F>'L9G<C<:B';8 %;
ME1-L4/*J06":6#O9D_'/ \+)][R-^5N>^;%YX6W=EM2B^N]BB<7V6]UY /3,
ML %PF[)X:FTYN4O '9A<=XEXI8(X)#Q&I(W?+9&7^V+V,.H(2KT _<Y'WW6Q
MC/&A#7I8["Y+?GG_"UYK0QBL$38-4X42/,S-\+I#*7R2Q-YQ,,SWDG=SN5S?
M.D A.MPXNT..)_R'/@OZP?]8,\$W)?2LM%_,::?Z,P9=)A<;XO;=P%6*KU+]
M7O/W5_.!PP;H9S>, 7#C[A\]T S8>+ 'C:-;9 (EV?K-Q_K&^1@1ZPI* 5Z,
M\!TV=YX!R Q$$F8-J.?5JYZI[2N/Q=.(@6"=QEWKGPW+AKGJ7W<2/^"1MP-R
M&:C.]9*YNC1H4D:P5JO(:+[ 6=23<^$$^F?B05Z,YG'"4J]%MZ"E4*[U^)4U
MU36U48]'G? DUS?E;.I8G!]CUJ[Y:)G=@PT(CE^B[-3I=295DS5Q_-N7E=_V
M*E4Q5[\;\+!I4F,E\R+(Q _CVGJ^BQNPG0B]HWJR\&A(?=' )W#C([B7$NO)
M"/EQQC- LB VVLSOT\,>CUWQ[L1%(R&8(U*O&**C>8;3'6Y+3BQ'R,9'[#22
M]'QS.H[Q)W]A:?\IRY]*E ^TP<O!X!GFK+^TC_Q?M:_O)$(CL=C5_]H^_ \C
M_H+H&X?:_Q?%/X;AT460L0^XD_7<VXIE_   D:43Z48XGK(LZ>>_5IG#%$@>
M,PWK@\N$'D.+-SS&/X,W?\.. 9]D94(-5UQ,01L>#$>[?IC3(I3:*<3X# "T
M!<^48QM4R]+W2 5VG;P[ Q1O@)=[B$X.0(V0/UL_[N \L-N@[:U6/:%OQ7C.
MG@&@5AA2L#$V >]-9#C<!#<6JLFS>N *;6E@6HO/ "EBH&W8^=J'8P>@W67<
MTQ,&N!9GQGCK1P?@XD]!%&/([(-OLXS=3K%/.9""H(\:S@#>HV@NT)]P"OOE
M2R%/EKPZP-^$&B$ROH.#%2"5^#] ,$+DO5-KIV_XEZPT1G/^($T_/4SAX)K9
M9-9WR$FA/ZC8F/_1BM:?^=HO[I#K#/"=__Z  ?D93"AV]/C3*]R+I!YBYRBR
M?Q#\O:]^&@V.[S ]AOTO(OK/_/U[P/+=#3)5JOG2Y/8?7<CGWJ3,5E.1E3?A
MJ:Q2DR63_N'1A9(NYP4NZ_DXI;809K#3.^)'9P XW4![^V !=D NY,&09<A*
ME+@].Y1S0;/4&)WB%("W.[ZNH!FV:K1W#6LC]&L;H-GD;>.Q[C/ :QNE\QTA
MBTZ/C!#8Q/:UP_FI]=?3 FK.):_F3OH6K*AXK5,<ZS]$61CM$?XABK:WZLAX
MK.='W@P,<3</QK<">K@(;BPSSX@[O*9]( 2%TPY 5^BLL.[3.E]0\+7+G\J_
M:FN*D0K=1LD[%AWCZF*OW>BO:R#2#9SOG?D[$X]<\.T4VT6(L02&>$H XSOR
M54$4AKB.Y]M)V8<?M-'\J>VOMOU#FW#1\678']J^X_E>V9_60'[DZ$\/^^K+
M?\$!_Z:01+^7'_M]?+XJHV#UH%J'GPK2V*\>I)Y(0^&: V1OG=.Y/ZR0/LM*
MCYZ8],QY\3HK,ROS;V68_QS_.?Z/CU_.QO\+4$L#!!0    ( !:#;%P/PE F
M*MH! $WX 0 4    86YG;BTR,#(U,3(S,5]G,BYJ<&?LO =84^VR+[X0:=*1
MWI6J-$5ZBZ!T!2D"TJ+T(B!-.J%($2D" @H"TJ03D=X2>A60(I$.H8- 0@T0
MDLOWG;W/WN?;^YR[]_WO>^_SO\]9R3S/RBHS\YN9->_,6N\*_B=^ :#14M-4
M P@("("W%Q\ /PW< P@O7?KM>[%<OO@2D1(17;Y,=(6$A)B4X@H%!?D5<G)*
M*CH:2BI:*G)R&D8:VJOT# P,%-1,S(STS'3T#/2_,2$@O#CG,A$9$1$9/24Y
M)?T_O>!; 5I2@I;+'P@)K@.7: D(:0GPG0 7 ! 0$?R^ ']:""Y=Z$A,0DIV
MA?SB@!H:X!(!(>&ERX2_:7VQ-^AB/W"9EHCNVFUEXJMZSTBNN].+AR;FD/*H
M5+8QZ(^@>.]8>82176%D8F9AY>,7$+QQ4T)22EI&5N[>?54U=0U-+0/#QT;&
M)D],K6UL[>P=')T\O;Q?^OCZ^8>_BHB,BGX=DY3\+B4U[?V']-R\_(+/A47%
M)5^KJFMJZ^H;&ML[.KNZ>WK[^D?'QG],('Y.3BTBEY975M?6-S;1>_L'AT?'
MF)/3WW 1 (0$?U[^+B[:"UR7+E\FO$SR&RZ"2SZ_'4![F>C:;6(Z93V29^Y7
MKXN'DM*K).94MI'QW-%',5AYC%QAY)58Y$/_!NUW9/\8L+#_)63_#NPON*8
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M=^=7+Y*UK\ 4$;W>W?\31)DDF:+5&&DPSCJ4?.]UAN"O\+%RQY&[+*"?0GA
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MV6]38&-N.LKRS5Q#Y=GCF(X[J$\%<71XH&T%B@?8\_YF2YG;'\\&+6IA%?!
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M[&(PU$T<BVX ECRR/YBVB/_EK<C_CW2]\=6,Z2"-2\3W(K<'L7:P%S,O4UB
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M>M%&;\Y;<H>?P[>BAAEUB-%C^\O!DE!5(!"+DO"0D_LJ1U=6=DN9Y#+MEF5
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M;JEO9%8X/]MU:.@,MM PHN#Y*<-0"1>RK%.)60)"X1B^3\VZC"&$@+Q9K<+
MW$/D7JU)Z)<8]O(*KKLQ3S\P&YO1R^W,+"T6K)687@.6A8)H'0D5")KS\\$\
ME[F)]&M C-?YS P;37?\?2CD%(C-2B[$<U&+(/EZ6.9]? 8K+8:]7 0COJW5
MBQT,<+ZX!A@R:_\Q3.ROY,7G7ZJ;P6ROTL$.--06VZUL.*F1<*^=)[DXQL^I
M;WZUAOG=)DOC29+TR%/M2/OSUN.G=<M&UU(U*I[@E[=EDAT1Q&L,!&Z:=/E/
MAQ<YS@+"=29FK*%9\W,U0SR_^Y)D/<;WM^I<1;V:S;&6O4N,07?Q$QU9(%Q%
M& K$&:P0X!Q/LTD[U_&VI./KE]1MU2^_24N+F#"Q+L+VOA/C8W7S!T07(W<G
M\9"X2!-B\_ UP+_NW&(=B#PX5ZKDN ;\C<ZY!FRI+/B-[+DXY^T $?;(6(6N
M( H<69<2$][T]==-"Z!<VA C ]J.WR["2IE;H2W"W5(-"E_&CP9).R_=:T,T
M'Y4X&,B+G/K.U)Y;VB<9'L&&-A2:YUUFQ>J*1]A&NML^60C@PKLKJ6'*6+>X
M,MC#,H<+_>F$L6T6DBFN]">K<<\^"%O-*D?XG^25@_D4".=[YY7/91=4G4M?
M$>A$SL&OXW%JW:7@&0AZZ2-BT/+6/-0>314OR+*0O^L!*L[I%Q.Z&9-K3,JM
MJ2D[>._=,QJGZ"Y@C5JWDDS[-8#"+0>;&D(627SHG&1LZB@?,Z&:'EB6H"W5
M]');0[R$2_*3&EB\B.QVX\&#H&'_MNX(PD-[G%9W+4AT3-*^OK%M;/?XN8U+
MJ=DO =?#XOID<@H)*[EYO+4JH)(=_QLKT\-!.7H-L#^XN=DJT=S2.$:P?3Q.
M>'9AE*HM/_9^7[O9]X[YYY+H6J[5@K7V<XCD6=!IW1<7(B-/^LGNI3?D6:W%
M@?H L5@ZNQ"NX-BD]  )9@-QF>QD/X#18#:PVMDQS2*%L\X,)OL[T4(,S@K!
M*W\RS5>A?^QDR#:0[@.'SNEXPTL+)R(/3J8+3&/F3"3#[6QR,,)IC9VSJ(SS
M:GBU2DU?QDNVB=H^8[9,<?TX'8>X9-VQO-<L@>. LT(74:]P(S%ID/A++9WQ
ME](,]V8T>>L^"649.G*+U-<[@ERZW&-0:KG$(>*329@5QI(!VMO3Z$*L+,=K
M0LBCE1B?2Z?ZZ$JD&7-3*S2]K:9E;N +_D%B//@]92X W)9R2#@8R,Y<V-TU
M\W.M1* 6H$>P\B$WX339:\ MXCB0?HE(AXIL-LV#ZM#<)JC5UTVL_!IO'9\-
M_3PQIS@Z,-YT[EJ^EM%SCX[J]BEG^B:1G ##679#HA:YQRI/+,DV?SE<9.[%
M]@87UM9#[CV_^7*0>BRQ8(9+(Q2>RIYC9M5?$0>9^07^%$0)=2/2<H'1IDM;
M9YT;NY:']RZ%JCOJW+Y=EL^=V8O$V)"5V]',G/58/,+WHL%,4%3W!4.Y/9KU
M^_?,QUL60&F3&.)[-Z:H]>7A;1M]S\.>*+:/.O(&AVNG275(/UXBJ^K(-&&.
MR,(D[&97B3.V1"TV'N.]"2>*O>CX7J'7ZOC_2$/X79C #T>.)[C""*E2!5;G
MPOI Z1X!Y^_A#0T);N+_"(0/&;.C+/]M@;PIL&,;$"8W%B2^N2@^H:@4L *Y
M@?=3U+#RR^M5- G*=^;J8_324Q]A%4P4_W5TU^,.5TW>5;P; ;P,)#7&._>4
M%O[#!O^>G-(MD[6>M'73/A'>;P6UZ4M#@ZK]PIT&3ST^A<GK?X/;LMMT9S'B
MB_EB%>W=BO%+F-L)C3P7%=GY3(+'@V_4[G??:GKYIUTR;K7FFW6 ]2_8?%+M
M*?Q")_7\[(BX-=H0F.OF? W8VS_[1ZGAK'XQV+2>I2@6WVZW<!.9N.,12K4?
MA*?5C=]UPI]?*C>-KX?=RE!3K!+30*JJST=\M9KW"$JJ%)DFWHFUZ<DF)RA?
M55E= SY3"W\QO4KSG6O>478[JXL785H8JYZ(0VS3-Y^[3DHWU>4?RVT=&7NZ
MV<(M_C,#SN[3_[2+FL%C%5^=NGI=JLY)SP]R9;U6HO-G\SSF1L5U-KMN'UWJ
M;9L.=:?ZB NO9-SP(!NE>$E1I>@SVES5V$WG9+PP3/^&*@EB%77$;FH"9W4X
M2U_,\0.%8P]G)3A%4^-V]'4)QD#Q9[VA^LC^Q+Z;I'4K1=^[%[G&"4P_HYGS
MY,,JZV*GBSKT'NP)9@#U8WO]!\>;M7,(;W&8K48E DO8)[1>FHPSS7PJMEKP
MR<27&.Y6M5NU-ONC/J_#^3?J"+>(;CG)6#CR,#X2]'#2U6O0G&EVR\=GNM&\
MC)*I*DHM%?)D1FWXTN"1S=_?I)^21E@D3.8(>A39N+WB+9.O%R6S&=> 58KL
MY;8N:+,-+AI3FYY*:_R=M8].<N2H/E8QY-#FT]=H>W"/ .E**J)X$\2*;PLH
M<'0I:I+.?H?OO__DDU;?T]4]6I%U&F5(\=2@+H:.IVQ)9&7 /[YS<Z@46J?M
M"NJN7*"W5/ENVW=E+S7OI[^^=$>D$B%R'Q^WH1LJ5.E-2<WWICY,RI9<L#:?
M#3#_D4JV8R/.,1W5-:@%F>5&!E'%7:#SLS4;DP)D$V.LG^EB[)5(9MB:3^?!
M+5K%_?P>F:II*KYGYNG9+"G9Z(IR>^:K]5RKB:<GER_ZR:]XI)!F#.FHUZRR
MK?@0%R!'0K\KR36@W_W<T!?G9YNTU)DZ>LN1#W>KF&)Y^6NJ1H_[B)'RRGBS
M#9HO6JJ-&:8X@7!Q4Y?W[L3C>#Q*^BILT]8?FB;0K\V,%%8XEL=N]E@,9GK!
MLY:BE$A7>L,+VQJQ^E=??#R6.DH056I%3ZLZ^ =OA@]^4&ZWCQ.K]VCHVXHJ
M1\]4P,!YPDUH+>=O-8\75J84^<06I+.YV#2%&M!?-L0"IYF>Q,3T7D)@ZO'H
MO;9@/2URD594Q=Q@Q+L;*D;FYL$5(.OVO6WYZ;9X1;6?!'9<?EH$0F"S9H^F
MB_J4_?F?88:U>S42RU2')6._CP_[T0Z;LCT>A;><%T^/:J\!6/!RYG1RR0P^
M1 LQ67/YN:FJ,4:+:NS8%KR1LVIP%@H2W$IWBWI/X"NRX#<W*[Y\DORIGNH\
M()Z9DXWBR/RV;#,WCO)2?F$2#^\JYKU*>/XE:N^I8Z(80?SAT=,38QI_'' 6
M@S%G?&6NNL1E:F^<YLB=.*([_AG!%<9L4+H[L> 0F+_L#9+$46_$K+.6U2+B
M(F)'3<.N5E<6#71#KKH@K\U/[*$^ <Z5-%O)QEV_C/N='R!IJ?@?/M5_>DQ*
MGZ>\$?J_-3'___OZ_RS5Q!4JQ7>5,V#FU=B'8G,A;K*1+R/6U3;<F;G7V#CD
M+](O+%0/5^Q6]YB7:>'\Y\ZGJ2Y$,$()CC$'@D_'-?'#0L7R?C9?V+,E?4#(
M4*[\;[R\<!^U28,JYO+<Q-8C3AM\5.KO9AF,"]#B([)@NU8^9KJO5-&GCES@
MA?M8<'(-UG]Z*#"I47.C=T&CCCTXZG$!V49E;)E;FT/\[, EDJ6B9#;P"TMH
M3_;M@W.;6ZV$,B?H_"7Y16V =>LN%OSIV"T<Q%P]ZB6@4C.Q%TXYE1F_Z.N&
ML?;/WOID^2CH+_@&_)=W 3X>/:0C!#K%>#GNPG!T(^X)-VL)P7]TR'6'/50]
MGNXHTN,N,:#P959MK6X+8%4Z.XCKK'I>9\S"K!,<HUJB;R;R:@D:%SW=LMN)
MD/_J+TQ/&Y>XYCKR_00,'I@=Q/TM6N%<4)UOV)U=W:R9<YO(!>47512(=AJK
M;FSF34[6Q#1]@YS!,Z%\FX^[PCMK48R6[R=3W"J:R%57(6_E#99)G@+>_F<F
M%A)FB 5&!'%N%FJ/-OL5X^_)"@A-)SK?3*Y7"ADHK][^ZN:_[_!#;8.A^!IP
MTWE\'^$H96H9?;%J\GW857MM.#WYI:U0TQ]A7CU37X7JC"/+'T&4XR>!-)W^
M.IF5SI08=NOIF8>-4WJHW25G;R;QKW6B>G_[27XGN7]JG\W]*.!D\EE>)]L[
MX,.<RQ[&\:?5S!M:N+*E6- (2#IN!7,6XVW^6H4A&9^Y5R$)S?F[L;MHTL"J
MW,<CKS[TD34YN8;DA'JAS'>ZVG1 1H6?SFI7E1IVA$6I8#?:@;$LBYFE%DQ6
MD[LN$\];)R/>&'UIO7R3@$OP26#;?WM;G!% .E[>K(VQY, O&8W7-'WUT@9J
MNM.E/1(1]\OFDR4+9;-)/!AZ"^V<>X.'KRS0TE +IEVDMK 1O122>.UBGS-#
M;/HWXLX/C$$"N#,"?]O]?ZQM0J2&^K5J&Y?&^SE==5<#R!M9-PDEGQ5%-G\V
MR(WM)0:0P#\9Z>*.+N=#?IA#\M8F%NXP>D1^^ /K3=3U*//A[-B4^>!Q![#K
M I,I)LAALV.)G- !]0.8AK?]-ZZJUUQS2);,7[VCOP4U>+S[VD\&\;YH=D\,
M7YQ0L\:*U2G3<=+2WT;JZM2X43JDEL1;LB]A<[T#TKC%.N]8QEXBJ,:<LMO$
M-3D7'Z1JT)R$>A7P33C%"/CX2>RS8B*7QO"=CMLM LCJP-3Q0^<Q]J)+97W[
MMR"=&QM*CTG3\:4K[[#$/+0+N8O%H8OKE<MGS0_2=XV2-^D>X#T_#?F**]5F
MWOQP9_JQ;(RPZ$>.X)*=A#F3+N_G;T4J]@S%'K^R!$5FD6Q4LOM/["%(BDP0
M\S>U7/,_J;[.*.8DYGY4#._.8A\E/H >J4Z^_Y-@#"W8W?)PW'ID$^81SS](
M 6PZ8_UPDXK][W)Z)SZE])]R;AY7Y$6[&$R?&4^O)TEEJ6LXRTIG##VB40&%
M9/B?Y%]JP?188D#W$%AQX3J,1*F@.BYX;%8P<9!A2XG<]6/\,A_")YL41-&/
M14+J)Z6&M)M55MA?V%T##!(_^'&>NU]PMJ_$[)G%Q(R2!K$'C31:AJQ/()3L
M]:<4C3$"RBUN".>Z%*XO^X/=S JOT#,>M]7!::7_.4H;X)JT_Q79YTEM86G>
M.$VZ!B1[XPNO =85I=> GTFC9#\(0O] T09-<TDZ<PW8_%*1VP /;3M\"7MX
M#7@; +ZB39G\_\R)N>GY[85]_YV1S=5/%P9TQ,=:"CL![-;=NZDX0H2]-4]=
MRL@+H9GXM^WV^5Y2*9AXZEE\TS^25LEBA*[7C7SK4O6B/<SP^4S*Q[>!*@!W
M^#U%"?!G&+@(G]8)=*B9DOP[>[R5>BA6V_KB/(N;?"!X@.G&CWOJ%=^1X/O-
M8BNL"JRQ0(N)@]!= 4DQI%<L]Q/FRQ\;H#R$'RH>)H1[C6RE04FYD&)X>\J+
MMZ8ES(VW/#:E*T]G;&*_/;3^(6WVL<$,F/[K&'*'0':5JTCI6V;BT,J0>IYS
MY$VYQ[7(&FBHWCB7^NB%KE)+UWL:/N?@&I(=HCPNOR[X.*T^,;'"#/A(6I;-
MV^Y8=[%5#PL.D:*9$^B*KW0N?XR7L_?05)TQP-EVN<0%"NJF,6V)F05V'/G5
MQA=!*U?L>X!4,"I\8I'%U9=>;T]XQ36@&/1HO%Q?\2NW-U@PB?$:H*Z_>F>U
MX\93YUU(+)!>D'@++Z,^WBR7ARS"Y[VQ^HDW13+\>)$\4-SS[!I06A<*\ -^
MC*C??L/@I7$IU5>W0U337K&,YB#!:[%_YA#$^883.-.8XL:%#%^%_5$G8U+Q
M82:-RZ#8<=GG:JZ+@O)J+*<\[Q5\SVRNWO=6[>;]Q=8/>$^LB YVU_>B-YJ%
MA@5Z9&H^NQ0AQ>KMDY$8<E.S/:+\"ZR8=AD@U\_S'5BU-P%3P-G'MMX=XOZG
M3C==&!#HT,1HEW'A:)KJ8CD%EWWN=+'D3LEGB9^.S6$ME[)UF8XXX=7 &2(G
M/MSQA#R0QW)8PO(5:A!>]3TP#ZTRM75YMLB'HY\ FL\.K=.LW@+$6^5&/7Y<
M662!+#0>\G07_("DW7?D_5 "^GE<>:MQL@W--\G8Y3L=3=\]+C*SEU+%_30O
M*2 ;9I^@0!7 %R^XVHIU_7W3E=NWUNUKS[N>VQH4<GRD,;[=T%O=9VG.^<V"
MI<#D-?K7*<:,K&DG5P+S VB&-9E&T&NE8EU5.E3GD$+E/3.3[(4(161,O. Q
M>^.4 /B!MEM)=#0-PFBH54[X(:+!8:BSU)7S_EQ<_7+&"DK>N$[Z3.Y1=3K.
M:DIH5?#'$["8(N!-&-\<<Z6'3_I::N_ >(O<$Z1JW,2I$RXT/DJJD@Z:9]X8
M!^& 5NR:+?#7OZM!/#48[Y&8L8XY2I!1Z%O8:<1GXIH@>-M2DQD+Y>;AG)#J
M/;;L',(0S!@=Z$N\M\3JV,ICX%"V/LEW,X>71_^M,BE'?N/=I[=;'IQ&X\O1
M\&@.IMH 4V]MDW&OPY\\!TA1/3+2WT[88O3F9/QT<<= ^CK$/,,48ID:/CK5
MBRG6N@2U&"'O\Y&1N45):)0K[-@?(49^$^0PE! ZQWM.TI!69C5,8;U4H:5\
MT"#P7LT"N%U>)[9XX=P$,<A@]/WR)SHH$U"9NS/2_0KJ7Q6NDQ7>EFICH$!)
M46<V;:B5IQB-#OJ'.E0;."O8+0]893A(HBEU TE;=W_+),].XWA))<XMRT&-
MR4V*3)]^@#C1"DSK@M>0A1*HBYP,9_\=M4RN(Z-_I,07$6BR_H1+M4;B(=5]
MO=?<7/>,1$< J"*" QX*>@*3F": V0HF=%,?@K[[ASO/6K[HU'*</'W"SQUT
MT[?"OFO6_&S/\5( JM S2]MKA6/4"1;RU+1C?2%?0S%F;MP&%U9],%=__/Y$
MURR\DMQ#J^\T.^147CA\64E!==1K3IL#J0VISD_Y\DQV@FWU,?%,+R#)N;;R
M&X@,9AK>]:]H*.H7AH?U&M3&&;O87HYM'/0LQL4V0!K3+UR_Z>?T[==:J=#I
MB?Y7P'B5H%_B5^=HRWQNH_#S&A#PBT!V5 Z_[YRXZ7/[98@"X3=?\<D%Q;++
M.\=\X5WCF2JCDT>-11.7[X_<]9.NQI>*D3")?V@^@ _YA^:JX=> _/240&9+
M.<+_Y:O1"$;A,>%.)\XBGB.G8/#RER4;F^&(!<_86KI<>1VB^=/4N';#[$#'
MEY4V3L-)P9POP>+4GOYUG\J\Y2B_4/0T_L*':LN.V/G5[[*5(O2^5ZL-[Z;/
M3_B%&QH-!N+152IJS&2.9')F1\'^R<<5*^BECS.I,\]<ZD*?,K.[+^U8A+A@
MQWN8G]]/W#+7C\N^FWTGCI>"+-]14$56I80?)5H87&G@9/3-G,O4B&'V9JSJ
MC9C7(N73ZPMC8:K\W=+*#4P!AM]$_!2RE8$^TXK<O8OLB$GKANH&1^YHA:Z$
M!K5G=Y4-V$*.*Q6Q2\@=,+VC[S1%\L"[^D34^]7WZL% F8"0C+J;)$=OL]PM
M6E9B'QD+/S+[0N7!NNEI87_3ORYTY??M14K\^V>"05HMS7_R.&-BPA5#XM-2
M@.'#:'L**5N6N(7$8Z-&\6ZKE4$.UZOA/#7$A*0ES>Q5([0GFE745I"RE_,\
MN$FTG<?7S(8ORZDP!!UW#>BV>)@U>T>HW*XI_MZ<)D^,;*0O/7>,A[R_06!W
M5B6F@TXFM+PF6\[6V9C1<[ N5"25DU8^!O@258 '=EHO).9%J-Q3^'5;/"!]
M[KZ);%B1WA03^M<!&9E!0;HQ]ZA7-$]-=0S_,J9R0M?G,4=*#_X:@)D.QTYC
M9J2*$"1T8Y)+#HBJ)&B" #\Z*B18*P9^48KR"&6RT.GG,)?7=]?W>Z(R ,F=
MWYUY[LU<1!W:)+U"N['URL'_]#O&19A=2Z.U;K+LT4B:IS-GDDP')SJ<[9[:
MI/[%C.;V5L9A2+1[>O4+QYON5Y.DV.(G!2H69;<HMA?N.M27R?_'^T;Q?[O3
M, /^GSD#WRQ.(O]67@,R"J_#CS(@=N&H4]"RZFNLUX %19E-[0 7V"6&!E/Y
M%A]8=@UPA6IV>LSEQRI^4_(58;M2I5DQ-RH*^)W==W@XN]2<R;A#A.>,C:G0
MKP-?_*]'GRRL+M6A=6I8M\[ 9SLFDX3G!:;S\Z;&SV"/T%):D6O?&!0"?,#>
M/ZT?R)G=YO,X(6^B%JB>V*P,4918<6.%"KO-<B.'%Z6P"P5IRU*HXU(@(_23
M5, E95C<ULO?9C^/Z W$BO^^XS76 -@U BD[,/'A08)7&3#-:\"]9D.,0B6'
MW407@TE/[H31,,^$Q1J+@-O)ARIY  5 ?1C3E>0$.BO(#O#0PD4_LM@C5! U
M5"'8)"("5(3/P7&KXI\OF[_N7N1TG%"?T&?QJ8O_DTS-]:-S(_M;M_>=SA<&
M[$SO#-<KN_: )OCB2T9H+X98AZ/LVBG?9BD;?!0F]8C8%[6H],JT]YW@R/YD
M26[F,KF,9WVP\N41QKZ+%1@*IE147J%6OP;D;#:^3ZMH6!MXI$_6)$T7D/AJ
M-4][V!S<#]XAE"T<-KQYLS*%.%. 6V(W?4-;A:#/>Q:%<2*AQTK^*#T4089+
MI=2H4^=2]8-F6%_'IO^#8-$/SA65PS3!Q,?PSY:T("I\FBZV+;I&&](5[9T#
M1;U!23[9W1,6D2*/G;S[Z -]U'RU:@.1;"4_( TY0KV=70/L@D3YG]:M7 .8
MH('-8IA^+W8^+>QIU:E!;8*IV@.W) #%R_$TNT?Z5C4? ?0ET6-*X[Y[>1IS
M;=T,S=F)WY.FRC/+-R><KEJ9 WO':XFB8R(\TWFU4R["ZV.F@Y,YM5^T>//.
MK;63N-92:N]UJ/??U(/*]+! NF@H';.X1BLLCM0F<Q@9JOMO)E3W^-,F\3=>
M,9'^D]$C;7<?()>8VQSVK)>ZB(_35S2F?51N#?\63'AI^3+R[,]GC)K>7P.P
M%_^G\:I69H(=#OB1('<I3WB&\XWRIERZ@R]$TFY>[&PS"N+4@KAE#%#:R<3?
M79ZJIL4#4</B9B5Z$^I@'8=^POZXUM#)UL_<_4GOZJ23-<<@[;:TI3-JNQTB
MSSA,X&W=['2AX\^9FK&Y\N[='2H[#38>QX8(UF]?'[-K<!KVF%A&(\"T,!$L
M.<[V&M 5Z-8#O_>??MI6$#W6ITIR1B4Y!9J7A,X/[P]FHN*[H3^H'F2PM[XH
M+/]O,7SFT2&0;B>(O[8%V]O-5/.8NWE:<;"[CB6ED<?WM>J?ZOY[GK7:0V&O
MVM.+>G2<J)V]\0-B<,DUUUDE#9?'1WP%;<')EH_R=HHO'@2NM#S0P16DH16B
M&QY83);;-2-J&<:KFG7I:<42A+L[O-%?'V21E%^<IW6;3%=CLU=ZD4M46[/[
M#64.TT0JU,%Z[>3!:D/2A8/%0I[CMP9?UF_*BA__TJ\\L,#7/;U*A?%>/G^.
MD^CV3XMSVY?<T]QXF6R0>!R0W]@4)_/+%'BB65*5<NN-[+MAA_@6Y_<+K><#
M I!+[R4B=;!A+,KR,.;=-> X_^K1R"B+P$KE/:AGER4#2"QHM%;FG\BP^N%H
M01_6:<Z!1%Y4S_ V'SIVOG[X#BE*U7#8_U=+C#-)[ !<+1-S HG(KEY"5M+N
MO XL-)R2%-#ZWG#Z:5US3'BC??G=*FY'D^/8K*WS&H#EV3L'(U>U%AQ]V]!N
M1Y:16U_^^QSPE5=%LTUO^%="20$4IY3?6D?<!-OFGRTE#/E)NH<"2-J7]6P4
M+Y$RI].-&UWP!Q;]T0$*H=7"?C.W$%7J2WA"M;M9X6XI6A8&_(DOZ=WM'#YT
M><:ZY7+^1T/IIWB9C2*:LM%S05OIXV0KTZ))Z3V8(:9AEVA!'GJPP',-Z+NO
MY"]<CL[4TL;%5D8<TX6]=F?SD<^/J5R+S#'@Y57MN9FX'T1#5::J3*DR?*Z5
M*AYZ-G$-(*DC/!B0G-MS[H C:HL:]TY:XL,)D+>E^3U57.638W=2WE3(,-\V
M\QG>/]ENH]\MF&J6N!WM<G-"NW1ISD0LDOQ^[[K GWWXYSMY01#8W9_Z<"",
M9C2("]^$!/&V95V,Z(\^HIW3LA6-AU*Q<:]RB"N\/?2K?*%_7.QF(Y]B):Q1
M/HY:JT,[9RDMCT2P2#=<OH!N//N=:GS@4E/*M&X;<^Z '01_S6]1F^7FP+MI
MKA*T@[*QLUDT-1RLL8_,65:(?+2NMU_I#AN2DME-Z\ W<K8.4;K8@=X7S5<Y
M0?S;T@9B:H%N#-E.*/5\V%#?^NM-'7QG\@Z[!L9%<QL\"T&2\'1G,'!UK[2O
M+O#._]RHO-T)O-R<\CYGUTJ58D_[2\  66#P/"BDUY+R>$A[/5BKQ:5  Y9K
MW5Z;#J"\2[3M,O-_EV&HO6PJ5P._AQ_4RB)/E9YLJRDO> <R2X2P)",:WVDF
M!<O'?SG[1X7'4EEX"_*Q$Q:3NS;U]54XI69RR8]U*701>P^Y"\A2XY-D9])/
M]1!*]P=UN_5"4[>(@33?@X0MG$'"5[D$$O3(7:=[9LC</BDEN^Z?SX2F3,39
M4:QU=.YUV2OL<E)301,<-+6XLT_'(]0O-4=*G!E^F3:>J Y*U*%9^IQ_C@:1
M;8* ^.)RPM.X@,MRWS?1_>[>H@XY9H^YQ#ZJW<E+^G#[EFD-=KBP#+J V'.Q
M"D-I'[T=V[4*Q%,?MOP))]VP9=576]";3^J]>VDT-1UC+J--H-P(O : V]$'
MB!?->+7ED?O/[_W^KM8R,9-C<9.J6BC_#US%\!N<XFAICELK59NW\/#[8*)H
M>1QY+Z3<UX*G6II(A4?^*/"T/MR>'E!32;WOWGX-J.B7\F^NG;;@G+!RCG9P
MW;-[\\TF2W3G;W$'NXJ>SV2)=VNEGI1+H.5"GA*D4_0JN]-?T-1GM^J3SX6U
M%%.Y_S!V-UC[[J ;B?4=\%UPOL.HWW\>#/F?;ZJ2;HC\/2"JJZ1=A7M? ZX4
M%U$(PRCB?V\N?WSL/-ME 1P]8=?SL@_KF=5*>W/9K:MU3PDKL 9G@R(4S=)=
MFS!_WP8;"RUJ:7.K1JYE&?UNNWL-\#LE37K#5<R3'&*I =.Y!B2Y8$8N;RY<
M S;3*C,DX7CB1-NNQA3X6+_%P]KA.=V654EIC\N26U5%N=?_0]M[AC7U;>^B
M450$*8+T%J4J7>DU@M(%!*0W%:F1#M(" 9%>(B @("!-!(1("1$(39J 2"<4
M(83>2:@!0G+8]YYS[SZ__[[WG"_GP_HRGZR9-=<:<XSW'<\[YMB&VY[QF DQ
MQW:8KA3(L:1.(9KJZUV;%>UF=]X KVX?+!-@A;.N]9*3:K[8IE*+A223)2G+
M!V4WUG^0G"=:WL'S5*]<>(!9K.$9LP?HP#$IE%[SXH',WGH<K9 !(TNN$817
M(QNM!Q^CF(QLG0LA#7BP,>DW_KA3)70^^>CL<4VXQ7F1Z!W[6BIJ^/$C*4;O
MQ)6&?&[7QKS( J+!B+^^[6&6N^B'.%0!H_C9TV6C2TK/6'9T%E/!X$4H,:I%
MD@Q )X).'R. W7 "B=!,!MA)0M>IS6EUO3YL/$M%?2@K/BTY:V[R.%(5;PH[
M;=TGJ:+#R !J#-@EU%F#R=S[*.)_.M7%\^PA1*6&$(,;-:EOJ'Y[M-.K.N.X
M^AA>XT)ZD=2V*-_>8Y1BEZ+=QZW[G:;X>>30$&4W1PP,=0GT%L*\D$^WIBB/
MQK8@TT7]SEQ0.-WM%-DJ]DRNYUP'\XO,:]/VV^R@9)0.720V(02L'W@OY6 V
M3(%7A_FA4Z#SPT>XS93$Q,3%@L-0$%;B+42NRC8POK_#RK^J4G!= )5\E5'.
M1^?PUR Z&X^)-I_.[-KEV+13R1@N'O$;#G HMJI@LJE@]M'BS(I/[^V^%LSR
MXB$C40M!@'W;M&./M$$?_$ IE<^)9X86KWOK)NW'G$PL>D&B>,*=V1<5,&.%
M>*$(:5!U8,T$IHO$A.#DM(A"54S>WMK7##,7(3YY]XHFBG+Y*T3?\3.A:'X/
M YX>JV?UU0=.O8IH >MU^@S'+@*#QN#J=.J?\-D;F=WZV.8;3Q#XL$(04ISO
MNKO?V3VAU'D(1B%.[?EUD[2V/UHE +\\3KQI59JC<^F<K4PGZU7-_#?EEDY)
MU=4^2OO;=J'%&W:*./VDW1@3O0>S=G\-LD-^]>&TFD39N*>F+X'N<</8-L5S
M%S95K#7KZH<JH=]9^O0GCI 3]![K")AVSE5S9;]=N\BB0#JGB3HR@ %\O/IT
MHK+09;3WFH@?I?*[WE7**A>*GL.*2LYVI!TK;AAY1E?[9</*5X?K%XNMGJ^T
MN["L[VV:^;3-B'!O6('(+ZB+OEY'\.J[I7&'KHE*+%JN,72,X=I]FXAWIB]+
M=].^1UW)G>1"EZ\C&6W7ZVO["@12!0*,AA@O\8:+#FLP <S_#RGL+RY(]9D'
M@;6]T3#BD![8W8N5X''UT@GP7 B]QRC2P>5B6923:/-XTO2^-AOWW^?[]@9N
MTR7U":4V]K:]R]8_FW);/Q^KB"P.UMB2T$">/UE>.2W 0-6=&[/^U8TB39V\
MUOJ2;YZ7OMZ_<%D9;MXH;(X);"9$XO?I+>QN[*TV4.U.Q *02Z8U9KEFZ,[8
M(?H]4_*$YVT=W_:E%_V)_O/4>]!WBG85^!M='#'=$BQ3_0X5X*<W[.G7COGH
M"]?.D%J<$JZK\MEV\Q\,4D9;!-WL<</VK#EM.+E<W&J[G)$-(0[]$>%NZ<W/
M$;0UW+XW<'>)]?X=H CUX;1F,/(-\[*J!)2@20:X[KZ=WM+J)4TH(J/%E[CY
MD_4>!3'*C>@QP(YAE<&((-;MFV3 \S2L'?P86AMVV^6;_5F%<O< ;)3U<9CT
MI<-_O<+;R*PS%8('](20_[2!#&C-/*8G VK-QP[WD%ON@UOMN&W87*BD$A1E
M&W>N\UG[R.UNX=MW,@NM0&D1"9HU)$DL'5LW7)E2A7 0C5)/!XC&?GY5O?0<
M^#%]/M5WVW\?N<VP>,/6>D$H"@)4C#M0H2E-(&IP F<;U5>W6 9G&&WXGJAM
MU+\+J$I4+M<L/+*NC>'D>% @%#LB8GTDO\OLND\0X.41R+!E6$X8C.=L@DB)
M2_7.AH<X5(684RR(/7J*1MSPI%\K>(=,$47*B<LI>]_J <R_BHQ(^^3CJBI/
M-,8#>Q+.53?/*)]FZB-\UFXC_&\EWBR65:3]K<;9T/-%I(9 /Q^2!-1I;&I
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M8:R&$NKUP%W@0&^E5<'GJ@&>(6AU_F!VZY.]M__>]>%3ZS\/3?WW=L@[K61
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M\(_J\Y7(K51ZV]1@,U@/,.84EJPLY!Z [2VJP<-CX'P3*)4@B>N9*<X,#61
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M"CT>!EZ*XZT,I $2$_[UG'##^)<Q3PG(0[QTIH]NGOOGQ&66OUL_[Q[3YIW
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M#")^II-GG$<O/U(NT>+59GE'#1!O=*%8DR"JZ+YTK87>I7;II75GTFD42AU
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M5[PYA^J\ K LP@*[>LVG"RM=3XTLPZ NM@+NY.*+/"_4WZ9W<0PE3=6<AK+
M_:;6H0<> 2(^>U4'AT&?*H^ ]./QZ>5'UD/>(,=UWYHC49/4_?UZC7%E"OS4
M<EYL(/ST\\K!?8MM<(.KM?,4A[+!&S,=?JJO*0.I3QB T8@G,+9>3IX0,@W<
M+=FYK(-N%_IPX*O!W0]E&AV;ZW8] 3%)RIRNC6CV?"B;5M;X@ >IY=9@R+UF
M'=@&E]IST=NCZF"2)[U""LO[\'++8(E&O"V1'"65?']NZZRAUA5L8FU<1"NA
MU: BL&WYG9UJ,U4HPU2;*JU"M[' KV5BM370-3WCO96_$GE B8Q<[,I.64U
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MR> B,D[/[;2'&1XYMK7\&T>P&R,\+WR);UR^>$+UQZW2XT0IIVWT580,@3$
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MT#W*#W&W7DM?+#Z3*TE0M[M0A$ HBIL,]6Y!I2(7,OBJ @=EJ]X J:AG3ZX
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M0?B[P;YJ.P8KK8*YLDJ_AJ/+).?B>\G\T90AK:@?X-BXPC8XV%*'LKS)KE
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M1R(SOB)(:Z6L?G:^J,4R&=KX)]XO%&(-6JW!\R%R/-L)LABA';JIUY-[X\M
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M,6 MSX>J?DU)WY?1*.@>:'PO2CTHS!/SM"BX.TEI:^Z"5>_CMWYYU[/&D\N
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M\\CH^M8:AJ>5?-C+Z>S5V($DC9E]NPS]H8>>>%1JB"\P0,M? XK1O +47NN
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M9RCU%+M^0,'"$HNBRJIZ[ZV6Q>V<3LU^QC?IB210VS<F33M7@"@<'GE:@$(
MMY9HH"0=W[N*Y[=?S&Y%H_3S-.L3:VZQI=_R"BDXW98;B- ;?*+"[!XZ6U;4
M$LU"^^31\Q3B=AU ?Q3\9+%@ 9<7+K\6=JTS'?43:F<$9[<XJ:<)1I>?/>Z0
M9S1@V^KNC%(QO'C_E@P 4  _O *0HU]@Q78WL7T]1)HH#&ZS:X1JSG)>X^[\
M9;'[]^>H:=KD5;,I-H[IIPF/U9ZB4C6N +<V\5V5W7Z#J^_1]#K,IZU3HE ,
M,+Z6Z'L\E?C%C]' O%N<7KQ2$S1+0O+7X,XA.DGYP82OKNHR7R_';4_OXD57
M3Q<1>2SOQ GL6:_^^+IPDH*W=9VU0 'Q]_<MUN@46Z+$]#X1^"?P!THJF53>
MHJJX&/5IO.^SB;A4BAIW71^=\M3#P*B;[=7AN;+EP4(H!.T.V%H$+X4UM=05
M:)H*IO85NYZQ/)>G":_>ZZ3-O60S#=\0NJEYFA>)9)422SB_-[61D6GN7EZJ
M>ZIK\6P2<UA3/_C%OD<J ,.=_D:[:5V+@2& KZ>&;$>9!4=:T^,!,/_<YE*H
MMN[*^E+#%O]>E\PGPRMLPI@%9GF)8KZHGKR1>1$6]M-H91X8;2V%1;_W/2#O
M+-[9U)W,4\NQ,XD_!(D*/ )K:!CG/+"JKD2V\[%T,BHJX50QZ @IMGLV+T;K
MD>^)+$U1CA9#PO<D39X&1B>X1YA8JUP!#)K968_1G"[FU'L.%Q+;#7,B,TWC
MP38%+/7S#0.?2@1Y&E-BC&$;+Q\%1C^CUEX#O4+'3@0_PY.5] <B3(J=N#N]
M[UX!,KQN"PD2Z82[L"50!B;=!KA-"GP9.:^ZXA1_0*<W">_#BK9ID6GB$FQF
MTQC9[R=M#F039S5/]OS\&\X3*_UETGI\/1XLI#U;&8LIXXXT#17 >ZS8L N*
MQ2HJE$ >FBJ+00TM4T;9DS1^+*.R%HD]>:1.+:FKJ Z_0/9:CJ$KP)W+H=Z/
MDMNDE2GA>')UJD5J:+5'-Y*VC7NYHZ^;4W#,YP$RZ$+G130::+4K]#ML)8Y(
MU=_3%UUS0GK F;_*H;=%_</,G9EF5\TGE.TR,Y0:IECA? 6@:..V$SS.D;+P
M%L,\?-9W]%4#Y'WA1.#-6-6Q(K%IP4UMYQ3,=V89+]6;GI,U)(Z&"I.J7?\+
MLRH6!UI[@:=9U7B'%258E<_^^1'B1Y85'&)+-M>.F)MC4X M-_X_M+UG5%-1
MUS4:14$%045Z57H7Z0B)BC01D-Y!I1,ATD,-14!Z[R72.P'IO?<F-=(A])Y0
M X3P\=QQWW'?][OC^W%_W)]G[#/&V>>,?=:<<^^UY@IF#A2L9@E_7Q3YENAC
M@H\4#_[IX2Q3#]/1$XRKGS?];(8G@FS;$2QF.C=:;Y5-M-0GLN#Y"FL)0U]=
MJ7AI]!JS8X;QF>LTEIA[?]U^Q"WALZA?1HC[+CH&],_6<]QM;/A_T*6CZ54K
M)I7IB>JUPNPM^O0OJ#1/-XG=(L"1N\E3T)["7]!)K2;"X??=D$^^R)#5%OX=
M_8C$9085+SZCLIJ (9B;9IH@4X"1^)4B)W^>2%&1\+I:\8SAE@@/ X]QF(%Q
M-]C=9TV>']E^J1/H/<YX!PT+\*9;W/D!M6NW>Q+;_(WA;@)HH(42\BN#=QQG
MY,9?BN(SZ*Q]/:2<LZCKH>!NJ_@DO(T\NC&C_F2T> =>9==8!N6'W<=>/V-Q
M"-K3'Q?=!8<5&C/5+JXQPM\+;:WLR)!%Z.HI]RCN72^:+_*?@3%2),[<2?,9
M>@&2:H4/Y5'^&FLN6(N2-/W=W$3'&*P0^DB T9-O6GB;%#EUP&B5H^%/%_B&
MVNN1?]\ELL5[L+5*'2MBLM(:*;/M/I+D69?QV660>H1!%<-%4-M:Q_CP2A0[
M)CRS@5X[NE]7Q8;ZT1;XJX(;NMW/<HFLQ7U"6P8".;?'Y NM]Y#60Z[V8HG"
M'"W3],=XBHM]^H$\O?!NM1Z>?-&UAL6#$2#,7WY7O*0HT-ZG'3FX;J=OOQ9?
M5N^FOAZSGU\$G@+E'."!4-(^[ZLNT0%8XPB83O.Z ,_P[]^PL#%S37T\E4-'
MV?-:E+M.SS2H4B[:8HYY0OU"\XNAL:"KG63&_#7G),C"X[':2BVM>6[5FQ;3
M[[YFP!GZB&N>_&NSCL*9KQM(;.(%_>[/"H>@YO"?YGC"&\#9#>#OS'238C%^
MVIBGKK'1C1G-%O:3K2$FZSKN>NER[<'F56^D?A]V'_/04R1S%NOQ/H"O;,.D
MLJO"O@(6//+FS@5\I#E(&3U5ZUNE(-QH-0ZH>#!.'4A!/G&"2 8*8^V.R$*F
M71/%^+[F+G95Y&7&7@62**KUW)%R[%6UP>2&YR>9KDAU'XT;Y([Q:>JDSE0N
M92=J#SK,QOVQ*D2"%QS&CUQ4'&X I-LNVO)_\(-(;P"6V/H:@;JV6^S42W[?
M">&B^\N$8D$B4%[%>P( SV_HQ*ZM&=R;DG<%MJQ?Z6(CZDX1PSSAQGP"AC R
M+%5G#5('XWN6KG(F4#TR]'95>O2]!YD*>+;5G,G?Y(D3+)08)6T\8 L<_T+K
M\%+WVW>G#@1-NYTJ2,0[6J[:<TK*L.!*DL^CM/][395KK0QF=O)5FM2T 8EJ
M35<A/[1 <9?#34+5;.JP[#KZO/D_GKIE_[]EX>>!?#QY;@ /$[N\R#\Y+=DA
M[^KUB!_%;G[QSKQE8?/5Q[U[C2MP(;7IIG<O[6E#.0WF5Y9.'EZD7#(VI8W7
M5I7\K@D!I@:B6WH?[#1O'![I"R /'W&6F:)4F@4"<52%QG,U@SY^XDG.VA;$
M\$Y6/,5Q4LFG5U#WI!0X"3EDC =N+A=7/!7."6%/7+2$5J+. E8,\JM<8BXQ
MI(QTGQ_(; TI *Y(4C*S<$Y_JWFZ:YI"5C]&1Q#, TQ'ZXDBN[XU);9-;+GK
MMU04B<V=LJ;)6^=%_=!=OBAS_V*97U"6C5IKH*PH C]\0>O2F/_\P3\VR.>B
M-'HG>WB?MTEX&><P^&MN4D>U>,Y4H;1=2NRTZ[BR[(R127\5? %FNKP]I:OW
MWFY7[V*KRJA:_P80:]E8_/#Y_VUE)=G4NRSPBWU*2LC>]$TR;<?;Z(H=EB\*
M)FV!.$'C=).2=;V?0H84O+8BYB(>+AXB1ZY  9K !+*GDL]<[6'H=EG/?K%]
MMM6^DR4J: P3J96.-Q5ZL90]W9%IUCP"$V_(O][',Y9XBJKA;[5N?$R$RH]'
MV$1M&S^N0^^WY']GJ[5(&N92)^HC)J_* .RG7$;N[<G+PI3=C6>=*X'R5["[
M+5PBI=7:!G6+ATKL*9#,$P:*G@7<-[1MI)]MDY%HZ_<,QOH77YLZF03_R$V]
M%4OH _&_?@5%98WC1; \^NB,3)2!LCN-L*U$S>*G,87P.ZP QM>9O1Q7U;VG
M[M.0Z*W]RJ7:PIUK#V)G)C!=M7/1%,1Y?;-B;LR0(Z!% DK5T\*>V'G)\6N_
M^K&^B,41B_R=MK4]ATP3@JN<J3>CLSPKPT&_YF3@W93]!:Q+%K"%CU_UA,(#
MO[3H2IS:<;<4FZ0FSC3.7DDW7CZ]SO;[?)8Q*U5;?1&/F#U?ZCMQY^FUN,YK
M$K/$),#N&C;]Z*4'T^[0I1TT61*?P7@Y6ESMNET$/8W1GHMDC1AU<%3ZW7&-
M>^>I] _62*BLC1HK$^A-FR6^@MOE5$C'JUL\O%#YR5]V!GX$:$%%,QH-8(W%
M__:L_I/$N\^ 7NTX'B;,1X5Z@'^9Z>;X]\>O:9N3 +7>V_M)]!#:3U<W*6-"
MVUO(_IXLF&@BOP1VJG^>5GW4-/SC 1%G=+$@-4N:?8:UEWY+QBK2EK$E &;U
M94FD6'YA:5'?"6DD\G=OZS\U'+VRF,4@THK?-D]M])UR E)X(^2UF'TT(]_?
M*4WI4(NC"XM/D=R>#- MG+#.K]3/NXT!BK__>]<!;<O@.4C@J6KC<$D(@1-K
M(8"IIVHW%1LD%KM"MY26+2A++<ZQJ2Z_]AC@]K+9W;63VM2(<<.^:N#XNX5Q
MW:,'1/A+#@R"6P?Q :M5(.35,)P6=7<@-"(]Z0:P!8I_F6R DO*!AKP($YOY
MO-FZY+YF45'5T%S=E+(HP5_JZD;^&C=V0/V=<89Z=+PA,CC9A/S#0G@6&<Y;
M%8,0QH#"F&3KJR:<=MFGJN?:AN^G]*\79:TZ_6DA[>MY._*0U>>.<$,\=?T;
MEG(]Z=THC&M$257QK1*^!HY(0[J*,K[I%]ZQC<6[CW)1!PHB.6)QS,ATJ,Y*
M;U?Q$@5X-C($YRJ=%^_,PRMI$;8DD!BE8]JPP0P\'!!C; P0F&L"E;470RT[
M.6M:*":^7=FU%O3&( >/\>MF(.'&(3M&==5'FL]427O5LZD'41M*-4O(O.L>
M[T'@G;KQ;QBJ<)''LB(>\*?SE7-&?A>O>"./'50(:H>(#.^/2))Y'/_'O,#2
M2'T#$HB>6>RJ.9_6><;Z]_=LX4;T#Q_23K,!HO%F624I!_%U4VZZ.1?[&\#O
M%+9Z\<*/6CGKU_QP7Q2L.M_'KDEO.1UD,'$8D>JQ,@>OJ1ZH)%0@O1?6Z%%&
M<>DD$RFS!7R*V4A'\72"G:T:0,&4KX[T/FE6!=\ I%]$V0M;5@J@[J#JEV9Y
MC/&]6,72^V'#;/^4M +<&RH)F&\ K=]DL#H@'BRL\[R&D1@CKG>BF+AOS#!5
M^[JZQ"/^ [MYYX<^(PKZI_5Z.A+TS6-5$/6?IOSA<ZUR-P $EJ-..%YI3S2X
M4+& K^G;I4("8=W<<=)D#!70IT+\'$%]J[E@P>!"JUKO9YCKKIIIQ[)KD.:L
M[^I"PA*WP"&A>">7N+0B0@[=&GH#J%T\&#@:/FFVZ2IHJ(CNW'^<_H<ELI7N
MRTJYY).WS"':$KE*"=QJ,5[[$Y.'.)K;F?]$J-R[JZ08(>F]O5N'.7DZO)*:
MZ-689>9DL3?GAX>R>HNT85D$4/M"UPE1-X U#J;IAAM \*R__E;Y7/&^V#-<
M)X.6G +N#*_)DG;,[G[:&E0*?Z@7F<@];B;0% :3>GJ!C*C4*?#D2AWZ:_>Y
MWL(@QB7V_)U6[TH43)]P9#J$,T_A_US6,%O<#?O?V\N]O2_K#'Y\6E6#?-5K
M#^&.B^'2?"T9[?= ZHF\34((@1?-VF=\_Q(Q\V1N$R-%0,I[@W[K'$$N#A#W
M0=NE$\41LN/-&UA0:XU9BFP"+Z\V?F- /+GBZ'7-Y"8:\9<;#8]<^G.0B-&;
M,Q[+5R;J>>JCC7%X6=_6$6S?)P6@=R#ZW :03F,47'3"D+O$5"_6' -5A0?&
MP[FQM&H:^6P\K-E##<47&8,(J%]OI[O18F:!2KG!;,=$GR+-;#8' 1IQ;QID
M8T C$-.K/2;0!,HSX1253-^0JG^(IWFE,G1*L^?6P[-)1N4]VOK$Z<V[(FRM
M8<0'@U^93Z6/1UESYYD)RD<\HB\PQJ$H^'/>1:XZ=.EBH',ZY1OJM8:C.*FH
M0E;(W*2OCX/DEPS!E.6NN?O::=8"8(]:6][XFJW%5NDPMB14A7V<(0-E*?@*
MV7Q>4Z@GW:R2N'(8<B*!YS8!ECJ*IC,6@QEJ(IT=R64?3T8WTFB+L8"?N#A)
M+5\^.INI@@4KV3I"\G=F-?0D-VCR2"PW:^S#/$X1L?PGNB=>0LK54^:3.%-T
M$9<G=K_J*B91W]2.A.'!^IC]^</5N1COO]6W@CFRA8GO!N /R9JT90WW'N5]
MO;]XARY;>JPBZET[44').N>T\6QJD\GRE<C8!2A^U%&@6R.-@K#>DJ(2-['3
MA!P9E4E&M[;3*5/.\I2:Z#=-Z8DI2=F6L]1+2#";^2@21!\:CI1+<:%:@_\N
M+EE_'K5=H7YTV!#D]-EPV(_BW7)#UMIJWLIX?60@(Q<VG[30,0_,2$9U/&HO
M5**FWUST[^NO.QM1%PY^ .9,OHCLZ(P;@ P6@B%3"M)O#%GM?*7J)K20ER[\
M;/Y%<L7@<-RNSZLGJY.K::J&1WSOZ<+%5GLJBQ=TE:S-44;2E#W+US.?>!U>
MR;WC%C/]2^**4$1#<$&Q.Z!<Z&'OX2_WZI%F]+BT<;>3LDNOUJLEW<%Z#3(:
M=8P@M9,40V<Y2YFL!YG_FN[I&N\/8LMCA,ECGK\Q0!,F1D,SML7>6GE\J7?<
MCMDG6A&6Z! O-Z+)^_^Q\517!NBT-"F)Z_U;O=LTVK7XPJ/&X8ZGI0TI?JH8
MM>\QY!IL\*@9/."I=P,@5U;O56ALP0].E+U(.?[<T,9;4\&_*<L:1KE,_L^;
MYF)/5N];4='S,V#H8SEQ?=6GFI .!KK.#&%T2W,QM*ACMZLAYUR,<O1>N5#W
M,YX_#[ZU <+X'6/39U;##+#?\"QH@:Y02-!?&PUHL7)E%=4T,H;><!M3Y>L]
MZN#^M+Q"W1L29S__':K"QRY^,I<.ZU):>2RHXY*Z8B2Y8IL50AX3R26K8\E3
M5<Y:M'G/M51PE4^LXXE-"JP30KRP>YGW>_]%\SU9*\NO/F;)+1:;L=4&K1_/
M,RGNFT7>=8Q;$K)T+KH5%*5E]<#8L\'4T&+M.4>1\)S*3IM>)MZ8K#B9O@O%
M48VPN_+1T.*N6?/-7F6;$9XDW.#^L^F-?P)*<??/%?(SVYSN1=0#3FA.(_V-
M[]5C79=3;25O  ,)9S(;"U)*Y[FF#?*FN \5'"*K)G1 HMU%NMK('F.*298I
M\G?Q=IE_#UD4IM\XR\L%<FD2U)*65E?&/@.\+;%_OJ"O0NSX741+KL3BDC%]
M.=4GUBQ#=",'FXS11[;IO^QGG M7WQ:RMEN\ ?3@0T :O86,!,N@T!9NC$HB
MN'1;DJ&T)IF;?]!+:Y;+C'J-A"#LZLI;0K(FMQ":VMNI@>E)ML^R=ASP\VBD
MO/JD)@?X3/0FCMZ=WBS#G2FE:Y1&YA$:RYINL6]G[NQ= ]%N=*K?_HJI5_9T
M* PMF&)-Q9I;VB56EUR=5LQX,J*!" QQ#S&J5,7->Q#L5"MP*^?<4>8O_ 3*
MVT:_B#,NJ6DI<ZA6CCL-@I6!G"M_ NYV15__;47N+I8B<V/7[0?0^!'<1,(?
MKW^5WP?TTKT]''HD95W>R3[7J8-F_J?PY.Y296TW,Z$J[N5_5:.X7<G!^IMQ
MJK=2RT3S/]4HUL%;9=]Q(MC$E3>@(""%'^S9]N=ARGB;2+J%'AK=]SY^0NV$
M#:I8?6_2&T!FOL(-H.W?[7=K!9W +N[IW@"0]VY5LJP!HA3?G8_;P_5>VW;!
M1G.Q</<;0,<$VO7ZL:0\GK 7+PS[[U<B:*WGL&\3>!>F73L6O)= UQ423PGW
M;]VR'@>A14&8[/]QA? KR+ZBA!^7WP ,[)F.M[TY&KTG,SC'<$J.*YTY.PDI
M40'\]P*GS6,M/D%'R&C:<<4=5EG-)=(403F%'!Y,;!'=@PR_$EY^'-'&442J
M8^4Q$VI85V$7L1:+[-]"GM,7@^T9I32@2S*9/3>$,A8#R<&IHPW59PSEO7)M
MSL1H/6,$Q$GKN#L+Q%WZ1([O&U5@M+-7DHSVV?@(3]ULD])C3%FB=_W<$$)T
M"3VMAUS; D.7WT-_62:."%< 3T'=L+:CJXCC+D9V>!>\'-2Q](N*M29_N3B<
M7+-98G34W"$A\4*ZU?6L!#FNM0SZP^NNVJ4:!*("4H!%]R[I&^+7*O0K 2KP
MPFREEXA,O<5]Q[DUZ>XWG28T[%BR; .HV.KKI:W+A(A02UO4=$6*K8"A+U"W
MC!(ZE<"5_/XPY'T)?7JC+V&+Z(]X"7%EO>Q322WKZ9#"CSJA,QD7FJ=>WSH[
M+\U'<HN,Y[8;O(IH+!L;X[^%L#+HI?]Z)-V/X Y:3:C'T*K^\61'LY>B\NQ(
M6\O:^4.S#3;K$Z!=E:;^-0_@P.Q2M]%@IUU"3,-V"V<,9)8#U1W+.[C"("T+
M#Y 2>[%NO/:LKT2B4\4BN?R17'V!2/V_)9PN1J [G/WHJLV5,H,0Z_H]X+"%
M$YOW@J$V#GAL?79$<=R<G_C=R'[#"0'\V\*T?0-X+IRZS[&2X/\2ZZ'I;&N)
M.HSX(N9>4Z?3'*?NHR=I&]WQONG"7DS_](V)7VW+ZTG;6Q63:.#?HQ^0^G#O
MA X:QL@XKNOT:DX0Z(@ M:15PIPX/FX+ ,6A*CV*S%3=:^\ZBGYXQS=S.UL<
M*KXIZZ5DKZ&-<[-_K0B\5HWP5$2?JZ%+4N(D:><-=_ ,Z=HB+@*\9W8Y7WPD
M>)BC,#/E1!__8G4*H<4K$;G%-MJ,="U)AJ_,DFNNAQSC78A<Q<_;$;)H$B3H
M"9 -W,*[2)A2<.:K06=Y\:=7&@UE.H#K'YX:4._-4-"Q)7*D7(2YN(4,8D2X
MOL[&D=L,&QG-]-M5J:LL"6T['-"V621)BH<9FM/^47,-59SE_OAXZ_2'#3YZ
MS^$2MN_&%I(D4DJ+FMWR7R]).!"+WM+X ?)%<&"#,0ACC'R$<+.ZD"C<DH[7
M8E8!5\G<26E.M-'A [0C-&B%*&.T(ZVF(QV6Y;: RMEA*9@WOM8KUU2H[AZ$
MW3GP1>W?TX=5%SG?5#9J' G;_YD5(7.C-K6$>)7\\ZG%^2W!M3PB6<HS)F67
MW]WH-3I/_I0\M^&>*"A2BG84+VBONMX6H>M'5/YI+O,XJ\^Y 5C VB7Q]%N=
M04@[*2$FY'Y*=<XH-CZZ5?)2I44*T]H3:NO50HOC+?]%1T:ZR\A@NY4F495
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M9.<D2;>8?*R](MU-!*\PD6/E+I4GL*X:9EJ@MAC*@6NQWA<W %_:["NQE1N
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M<0#,R6JJ/3/'6.2OJOJU,$Z)A.8W3U(K/4]\1M^4RF9^/]+11^+0.-?8UEV
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MNPP#2H^:U'D":8S=D1%;WG2W3+ESB0(K9CC=6A4S*CAG5$D&Y&Q[UC9.G]9
MQKM9;S@IR=2Y8-+3 (PLNWW#WIR!L1Q,:4,B<X2.*S.3?<1F2MNN)%-$!GDK
MALEWHZ'":NGSA,Q\+SDNZ_/SC5=N[5)?+GV--<J@[*OZ:)74U1M D"BA7%.X
MV603L-<JD4;OX]T?;-KWG@#/R!Q''0M!7=*NRE/?2Q%.X2I@Z3$E$H_L8SJ:
M!RKBXLS+]J/Z^<N@8%JJSEO>X'*F-F?R6%XYZI]J3JBK1TVC!60AZT["O(-6
M$)W;B$1AG*EXG;(1,%#$6JZHJD6UZ$3*LN-R/1?O+[E-*:.-OIZAHLJ@:C0E
M;]N$2TY%ONKO!RU\3UN.L<FH)DPNV3K_N_.TOPS++4')-KGY.='=Z2>)O /<
MC49QKC5S.>(!Q9;)DR8:)E\\P0(TOTO^BJ5+>[S?NY8RVBU&WPU)HV3[.U)0
M#IVJ2"/]@$-D#:V:"T7MC.RJ5=6,-VG8.#Y/"?\M.-3V1-W*Y!\\[DC,7*%/
M9%"\P9H[,8ZRR,2.T74!(5*TDP+T>!KHU#S#DY\?>U2SQ)%]Q<][X$F  ?7"
M246:J>2;ZN$]0(K4<TJJ@2S%5:*#G"Z' 5#KY)UM'^FK-B!S[<375MKU]>KJ
MZ_6)^?@^3:WO7X7^QA.D'$ES=!9G01^+\%%25X4[=E$]M:YQ>35B^:<B08Y[
M0DY<O(VO5LIK40)A @EHH9LX,8">I@9FP.*-+U$KT3FQ #//?S1[DCJ.<6NM
MT FO\6K<[.SU?N;.,N=(.+^>8O68]/=&HUT[Y-1W!V-^#"*HA0([?MB=*-04
M9>,RE/7&BE''GEI])//=*ML[#@)6QV$W9.#IU2$EM%$34SKT;!N]@Z":X<U]
MQ"BN]59]19%N5&.4GK0+;H*1;V],C9\XK JWDZ^?R$X1WZ]^KE=Z\#5:M$G5
MAYK MT_Z[8XXD&K9H"<0ZI2G1[DT>/Q"3V7#WS1IW3<5&^9 :'C>6P:N?#@X
M>DB]X8GOG3\L/!7U=SYK%J6Z =S*5DKE]>T]:1M5D@N72RF0&!T8U$V;6U53
M2KFLWY3V/>ZKB ?C&>'K6/_JT31O@9VS_3*H_(>&F3-;)=T BV/@BNXQE\:_
M@Q[!>?)#_<L@O]@N1I%)',URL\.<TI@=[UJBW@3_"ZJ$X!</*%B"F'NZ#25F
M!Z/])"3H&%^C+8)7#;0JIO=9&JH7-G![FCUOF<6_#D1G9$\WM791TH(ZEYY;
MB\&)J\=<43^; P2J=([YPX<LG2#U?US"8RPYUH? 2RG'?V8KG*Y3]#/R+#]^
MS"I8#-M'+N=W[=/)-"B;]E1ZOON[\K-?(-"%6,^.A2@I 9)4U^.M+N?H]T.B
M<14>0BO0%4XZT;E(456C!-4QWU]+V"G]]NO'UW8F%K\'+',9XA:+GLH85__J
MU"4BZU'S4JI0T=G1),_A_\7;>T<U%77[HE%4%"F"]*J" H8B73J(2!,1I'?I
M$'H--2H"TCLH+4H+2(F4T"%TI/=>0^\DU  AN7SGGGO&O=]WWGCGOO'N_6..
ML;-&UII[[37WG+_?6GO-)4IUQ_*'\I,WQLRB^^"_+Q^=5X 8==H<#!41;8V9
MWPW@+.ZVX\Y6WO>IQ'1Y>J:E/\D:GEAS<S_WQ(O!D_1\+OC@?[%]-D]5)-[/
MPL\AZ9L-TS^6>?T_(&J&=X\IR!5_V]T)C%?R\C:_#/AYV'Z;YR^YBA11Y9>V
M@F/H7:RL 08645KRN%9OLC29S6@"%4MI/V1YC_2Y'[-K^&RJBY\I#7J@8IF"
M2L'6\4_O<GT!C4'K/F*8IPMP8[3Z_OB4MV97^56J 9IW/7H)>7M3J-=>P/Z$
MUWVO"C=]OF:[$A#E3]YN"2!9^\JNP]6%54/.!BYZ07#WSCEBC&58)E*MJ@F
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M@&7"![K(HKD+\%-MWA ?W ,"0,?M:N4,>2CS,KNIBP (M42+X2X6($L?- D
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M++N0VTNP+$3%3VT](I/=+6\0-"0 :K85/&+<WVEPI@DO?F&]/]+ 5( U)&.
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M$5?7#85&86ROF,[:X8-*!,!:2$#@"C2R;F]R;QIU98^G 7?.',I6K+Q.VB(
M' /DVM8ZAF.S<OA>ENZ*Z-V'_^@U9)ZPG866'[29J*'$6M2)VBY:.G]GJZ5_
M3PZ^:ZK$O_;EY;D\8"5J@V9Q$2RK,,YGN'R@4E&3V72<\"HO=FPR@0#XI[[%
M8NT&:2'#R !5W#$$KZ_'*56;D3B>+N&:I&U5&NN(J/C221.Z0+\4#K['&$*$
MIA$!N^"$;2-E-Q>;G@;YR1( /%S_TB=YD#KEOK9>Z/^;LO="<P5PLG^ISH8>
MSN(A '*"L,GGFP0 [L]/"O?L!C$\HU ']-AED0HIS48 I%#_RRA)]S3131(
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MT^/<\8]T@#4=D$[I[$/1ZN$)?T?]O_W_C/K_/XY3"]N<\#8KO"#9H/G:2K-
M+3JT_VGDLMXHPD1VH/;(ZTYEKJ;)E+#H,KGK0=A(*;EXPI#\'D*,Z+RQ1/)X
MD6OM&G@K?KHORG6I_:>5O=GS4PLRRANZ7HCBFV6PO)R^9N.M"8)M_8%0"FX)
MKK (X^I_LIP. ;;W4[2=T_)1PHK8_+RY()=-X1_USLT8?Q'L_9,M:A#)'4#@
M,O]Z/Y+ZZ._L*U9(30\=4+/I+L^O/<ZO?V3C;#X[?4;OH+C"Z5Y\SQDM1R-_
M9/5"J H_/]["_Z=)ZCT)6)/D)Z)NNW+CO7G+QGM.2%<:_UCRT,:59RZ0$[O/
M9YX)W1I^F,.LQ_Q-(' LZ,%&&@;4G88[,J5\?.QA6%".B) Y#%'4#)PH>U%1
M1V#Y"$>2?7?;P'.P<6QX3:&A0$8 ;(E5]4&2Y=E$;L<ISU.RW J8%4W6J,Y,
M:8+TVWDI2*-5@<P[=]&$^?$=$TAPVY)(K,[UMXD7ICC%A$^--TVT_UV8)S(7
M),CZ>W(;4SKA!GX=W/72LN*56 FG<.(:&%IPZJV9!,I]&H<?//0*$?3NRDS>
M,=A:I&Z2,V5FK_:7T %_K"T:?J2M>0\CYW:=/+?ZPAV>)?:J/65&Z'<0E-[X
M].-.^(,[TVA53D 2\-T,OVB_896_>I9"L>-B?*[G=LW3X*R["WC,BKXDCUX_
MHA%-<3Q*U[[YPS>.RKJC^7BLVIBL$W*&JM)4F_&R9D(,LT@4S2NQ'5Q\%#[]
M)P1SHW8Q:N!F 3<WEI5#':OQ&<ZRI$ND \(61K@Z@"[5F'331 I_"^IPPQIR
M:-9[Y_V">'>?+L>^7'9/:6Q64OB%[STWLBF7*E"<2S-"[JK:WR'4>O/*LH&%
MS0;TXJ%EG_Q&=H-D2"!U*S@#Z1\IR&E'YD=FC:@KS%U$LJC7*MK=1*>IB=2Q
M<< J2Z0/+K^[:9-1JO_65C-LEMQH-;]]<D7@QOAD9YHG66?>15H**L(Y,2#]
MTG+A)3?/[;+6EYYW-< KO9LOZN/ZTVXNQ:E,W@CG"^)-9#2X 58Z"OT?[>VU
M *.$\*$ST&P+$):A^XW04-[NJ*TW$3VC&U<?CT+M;@^RQ;M'+[Z9WOGJL%@Q
M@ZK9K@9;A^<5/+.;R2OK[N@I7=B1=OC8&%YM.!QN>J%H^8VN]=%+9Z$?CT5B
M'"YH =98SJV$U(@(3,R8@H^63(]OL2 :&$'0IWN_;D<WIOPZ@1\1Y7W5\0OY
M):9+U=O>("C5_&RH@7SR0^8P+V$WZNS)B_^<:Q5M,B9Y84JY6H[VC@PWHWIA
MA5/Z4FY0WD5OPMV=S3_IISF>\3V';=T!*.#\\2V^S<H1CW:AR.J&Z3LK=G]P
M+ENAEH[G>C\)Z^J<L0WG>;B4TAIRJIH (GT=GIE9JX\M>BT-]>&_]VM0[=W3
M9^^>:I]X"N"X.Y]R)TGEODT-M$UR#]J_U#4_BA>II -4X(A]AP"_%M:/ IP$
M9#N4E6QL/K8IC^2P[/&>;.*<ORMS:?A3Z ,0+"RQP?_T/W^&K'?I $!4DWT7
MR<\:\9'*T+1M@FSZTG/US:D^+MEL/R@WW]5BV+2J;UY$<?_=,=*>Y&S8@N@S
M5KZ4;9CCJR&WJOOG!447L:B[C(>F5KMWY\/$*2 X5J&$UKPMLUIN[)=P!&^G
M Q#[F"7$:7&&&4EI48</K,X;+_J #(>UG<2]A!LXD])AV^1:.N!Q=J3$A;_^
M6[V$%%X;;LSJ[X(5=M*\.?*TXK&1YNA7<T1W*PQ,T.U"_.XC3I>G*+:ZWY[S
MI5(\<.YK6PJ7I/O-8V]NE\XVQHJ;^H_/BWP2_N G]$:7.?<DZV/7WA-O3SL(
M9&<<_P0ITO925B[J1X;HP0;1H[M%/HQF\IO3R"R8*_2>C/N^LC/E+*OSS[:X
MV\!IK2*1>S]G/+X>(&4):OYK%"W4N/N6C+2\U)-VE)PKFRMOHX6+A^1] 17(
MO)F A<A;L\/7[4)""IMI7&TX)G^09;K9B+I,KDO:Y\FP:6LK7;X(OYFK;WJ&
M@GVV]7*"I0A^$3X72XYEVK :[Q='U+T,H8Z\<B6P?6&6F"EOC74]/0,$I1_)
M(/-!\&(%^_Q<#SJ%.$E%\P^)D*_2 4(I873 QE>&LSA2; XKI0BRKEH[_!IT
MRK?"&ERJ_-,I_,^-.W<+)*]\4KX;>',VT/R]:HU&3OTNU0&W9JCL*1D8<ME@
MC]'8%0K_/U]*+G^\\)!'>?Y[L!X><K6U-A1O.UI6O2 DR1>3*G@\QH>:O>2!
MX NYHTL8,C PN):X/O'AT<VI4G',P M<9E@=TTBSRK@/(X1>=I4#K5EXSLSH
M>^X^FOQ((@FTOP5=RO104*^$LMY7WU<EV37A4N9AY0;M/G(W@P*'DA%&VYC*
M72IKJ0P= &8]:_W(]"K,?!^^G*NXPB@O[@<PS\496-W]=K_NBKCTEG<1WRRL
M^5()PM>T!:;'081Q$(CX6WUR2\%EOBCJ5018^G+_UP"+.[!M.N!D]TIIX+?Z
MZMBMGP^A$(>K"<Y\JM_W3[_6UCTN$SO@VD=^U.2A6HZ'\*Q]%,DM\\AO6,(;
MQZ/]KFWI'M@<9ZW(Q7?"HG+6S05N_7+;'Q2G]DOF3IU8B_E5Q/]!A6G*8E5%
M.DA7.4S/<]0&.>8'BC^<\4@8[W-(/_A&@N?L4@=!FR[HY;205XD4:WRU!^U5
MT3#(V'[IL#$*A)VPS8G8E<>4S/C&L@X6-WEIWB)_S/&_L_9SY! I+5,^MA#>
M;U21MN/[H.O@SY6*"W?N/.R^9M+O]V(W@/_%V#9%%W)8<WOM*,5Y$ZY8G :C
MJN:];UJL>(7Z$>,877]'UIR'QQP0%MMQ4E)SM]/<7%,"$PR\EK)Y0,),WS?3
M&8QGOY28R;K-Q1<XW+/MGK7)@71PRP"9;W(@EO;:2]8ULBOH@.;,#&U=L71)
M+-SGLF)%.2G*B&IM3,CGM^_0R,8 MXN ;5GI-A6H<:GJ(FE[0YTE<;'P*43J
M\(6(%QL7D<L614% 18L:VIH$(T-3]@AZNPC>]@7;':FFE1LB)4,V6Q,/ F[+
M4J!;,C^&5+NCU+1RX#@O^/O;ZP(RFRP,E08;I'$4:!M7T'8I?0RE.07R^.P3
MQ^,;<9]1LR6&+8N$7B;W=<EYB&;DXK0%!TBDA#Y1GRVVUUT;WDQE$!/3%<U$
M.)QZ,ODZR-J#@IY-"V1I<IPWE+Y*.=^X'J#QO:\]M%0UG"F45?\74GGT%C18
MH=B@?,4D8%#T$BVYX*)O#AGS_3-+!+E>H*L!PF17251,8<DJ&%RVZ=T,-^?C
M>#%Z6_V?0!/]$D^2F7P")6T+;8;9@IAE?X:52;VD[5& P_N4D>'B"8L[-KM5
MGD>1568^!A1;&:.ZQJ:DY]6HF+QDW97BLWKE'Q4X?#=BG?.G$^K87*,NE:98
MR'#DE>I;+:>&%K\=33 ^V=C0@:OA"ML3S[PHYU.FWPBMCCY7M5KW86CTI.3R
M=A2">U_F8V!.Y]5>IV]MOU$5YBUNW@&R8^A[O_S$?I;L!&.BBX-TC64,DF %
M9<=<4%#+L;'4'&]P9+Y&LQ/)/'D?=LQ:R'!J;ORR^2?A++;=7+ZQ<[;H&TR[
M2&T"J)OU/'GK >K[J&9OR/)%IY#FI]$PKH12V%O19NX\<XF6L%"5TQ;QX7CF
MKL_;UAC;,F@=DBQ6\F'N5G,I1)\ VX:WT@$M0&VQ43$4I.Q*G%;B( -T,G]!
M=_H805,T+#-F?4?54\ET.3MY==5&>A"K)%:TIW'DU1GTKJ+ZSATE$U"Y8UT,
M,X:E@EVP> WQ*L3LRZRD8\WTA?[A/7 =F&(-/5Q"E(F1JNF W9_ @3%5R=&*
M):\ 3H:B+5?3%5QR =:4HY>_ E.+JTV_,]*-D %89;B<H6K3@?,F':!8>#,G
M92!XYD&WQ:C:7SPI44"FF_S(I3%^]KK@[J&%"'Z0V;^0P)2L'6=74F<B6XA.
M<?*"IZ2_8K>RT_Q'W1/Z)@/E A)0VH?W6N@ YUF6!9.>R4JWD&$1W_AZ'QBX
MVAQX@,$8_46/,:/?,NS+A?8)=8\"?[A-[<C6NZZE^;ZE8V;G"X>OW7")F6CE
MEJ,Q.H!EO7;F)H&67FKU\4S><:/?XX\Z5^T+7\1GLEP2&,0>^-(!$72 J,"8
MW53)$>HP>WA<@3;L@CX81<P9JG9_:-#.HP-PIO#W5MD%?^B @*1->'UDA"51
MQKD:25D#$?(S[#OYLT: ?_&8^'3\^3"VQRB%Q7V+$PNL:MF9^WWE(H3)E>#9
M#?!3"$RII.T*UM+6*)%,ED0+9V_XOP4PNHL_JEI5YOA B6P>P]X4=X"8 4*/
M.P]X&+>!.WL;4[:@A%S5[N@@K2Q&51B@=C5YL@%OINTT5QSW''<9D[ICU+2^
M_<<E,<8)?#F<07ZP(1H'4EOFQ?$A;&X_;DMW2U9T(AC*#+E6^:M</V9&W_!.
M%9Y\3PB >-+I3>,F:B B]X;]G*UX++LU&G/<OC_4W%$E">VO*1?[#(%Y-39C
M\X[1WR"&5D]OD7[Z=L*Y:4Q[+Z@RDUGSE9]='Q_,3Z6838S!4^S2MG,=C2]O
MZ=ULCH&LT %#!;:*>_J2@FVTFU7$5VG2FQ>%)+F7:[] DF?N'>3X;.BNCWK8
M</PYWY7[='8KM5M9_^M7T=+A2QUQ%[;,IM2.QORA>3\@19PPXQ<6)4MH+"O^
M'8DK19.=,+7TN\L7![K_&S8]?U_5GAQG-_5\>6"@2D+%ELFN:L_69B/0RAUD
M(U=>:&*'S+8=>D(LZ#8^[\]I@6H:U9P,B;CD5(!,6PL*5[E0\/L3K&1([/A[
M=>>7#\$J?L)6<[D_S* ]IZCKB_-Z*NII^M2XRUT\258S,=\:&%8WB@YX$U(6
MP0#E9XCY+FP;V@IOU>PA#&W>F]T,= C=+*_62W\S$1_&"5,J4C[Z="802DK4
M@_(/-FCY@&^$ZV5#^EKVKL6.'8[9)1+"\(HYA$E3@X 9@R'6@=^9@['!C9EV
M0!W22A!)Z$\?N2^GL.C5>:OCO+PF"ZA6S\ /G0LL^2<:D)7[Z!PZ0&XC;M,E
MZ$9(-0*+@0\I,Q+,@ON#2L!!_2KF09*?K[1+\(6;WCE'%4\ZJJ].P@"E_:*J
MM-&;X-CA[L,TXTUP^7#[85J)MMK%])Y*GZ"??\]<QK8;=*&'-?>TI4&RNP%7
M,D"/-_E12Z,,P,)RJJG85*MZF0][VY<5O]7#NK$L"%^2$E!()N4.P$KEE#*S
M"@_??D[RL>Z0^P>,:G,95A(XN%I@,1ZD;<_HC1I2C"#P^[C@P(1G7.'G,$.8
M'6#H@/?RZ[P,H%?C*&O&A*(205.B67+*O.'5!U\,2--63F#/X@LAJUJ:^$SE
M%Y%V/X]$NS<A))/@=8$;FYPIC$+U:.R84O^4:FN+XWT&!]9+P! 'J7:3E)(M
M<?[_AN47GS@.4H0.(V PH'SA5RF4T[^XOS4-2$K^)J)("U:D ^H>#]9;F2O@
MA6)^RFWJ5D!R<[LW1R;B81UTP*2 ]"9+U+_\R8[;C.,F16C])V..9A?\9J0?
MXX^Z#X0.>,0LB0AG;YE_P4K[340ZRPM2MN"$LD )6,0!;@98"O<$>GP(]BCS
M#YP7;]1U>EG_(,(A)2VH!_?*?CC77/#UWBU5O_F&G@6KR[;<JK=['%5.!T8N
M"\>(QN3$FPV_-3?G.2WP+7+)3>%\"/?4N7RG]+8KBAP_K:J[Q++VWV72 :U[
MJXF?OY?O^D6$5.SO4)L4QW24\YPEC2NQ=IDAMC"_O7KQBI[*&_6WO5]\ZO,\
MM\^^MJV^D]2YE[P9'@USO;KIB=/#+*!'RZ]A2G-X7,KY).(&1C6EB9R(.1G6
M&3!O.J2FQG!Y+$[;9$VO1=":'#&OV[$)FC>O//#;J39W[MX8O]G=_SXD8W*L
M'O'B+4@JTVFTTO_F9%IN+:ADASI4T.NI7U<]A>PW=*<#M)</!77(8:120F:*
M7&?!) [,TGA>Z!Z[[HKEWTV"P#>Z22TCPE\N#K'.M'+YACO$HX50AQ/]3RV6
MY.8WQI\LF>KY+II3&06Q[7UYG6_%O?.CEC*-(U1261NI5XG@=CO@XS3%/)ZF
M+L.D'MG![9U,M%E/>:BAOK\-^$'QS"%RZ&+01[<MH<SS=N=SGO<*NYE]CGUW
M^=<$@RM.T&25.BX^F3MVUU9=; SZ5J=^]3._%^WW]IK*!GBS4O.FU7OM\$X1
MGJ:T/X<!P 'RU'JXW<GTCCF0/.?J5B-U8B%PFU2-^\N>(W P@Z+4\=3!IXXW
M.Q^V\O'J'Y_L;MT-X$37E ?I<BVYL"#]_M*G66$>0X2R9=A1JAE4E/[$"%GH
M&SNQZQH9J1+</;@0D0%ZLLE?\"\&I[.KJ#/?U5_@8ZZV^/JBK =VM?C'VK M
MM:3$9[W">5:AQ0^B.^8L]S8-"2EQWC)\NMY8A0.L0XT'?V?C]][3!%F>$_/Q
M9A-"^7<'!09K?%Z3/JK)Q^#_2Y^F^<3X55O#C_?%R&:L[/[A$VUV_*/[)7/7
MJS";,TLOKFS!/N3%GM4Q.B.:,B]I:TT*LKRRZ!#.7? J87KD3N5)"W!\31S?
M>S&^5RE54)L*RM/F/ND,^P[^; S\K[I-\XF[3(HR^$_:KM(VKJ+M2F+I !_V
MGQ7S[K]6@0>CZ+^,&QFDE?.7<?].22I6[4+9?[.6&L_QXL]K,. [J<=Z9KKM
MQK'!;<$8&4>82JH=%N<(:V>IF)_YM8(^F,+]+2"*HI7]K_9U&6;09".-2($S
M1'$?@T ;M++^O:!$L>]"[+;?8]1EF5&7"0:0X?\;Q]Q^ M)$H\B2@"*7>MA2
M!@\=\-!684$NV\_'G-O-1ZA<+G*S>E-GTKPBE-3G75>3<:K[EI-$7U!D9[GM
M^/K<\1XV,_7BU(I770(=\.B#8[98*2'.;B,,:3+T+&\H/'BP3@OIL[S4<+Q4
ML= I_?2S$Z9J9P?6C!]9*<:ZYX%++5N#'%6?88W>XM/DDAPU.JW*%T:3QKM/
M&4D/>38-MO^'^'50&KR3?+Z"*V'C]1E#+WESTDZ_6NEKG;SIJ3FSN[W")(!%
M-Y"G617DO[8#D7F8;"#(HJ-_[M<FN!3.1@=4K: _+A>\3U]FOQ-H-U)>&21-
M!RPT#GF)]X%?C06(KW(T,*0<4\\1:P>NFBLT6$:N5;3H..<U(E!#0WTCR)U2
M1P6GHH[+&H6$6X4Q^Q\>(_9CF!^P%EYYU:R;C98JZ;**7O:_V>E;P]"#(:G&
M[^Z0=3">B=M!(;HX 39RR5P<'S5-L>ST!&AW7?%E"L&\%6@2;U/E:MHV:<TL
M>%"R6\N3BTH5B=2)?/J\9^6AHU#6:6^%/8;LA<=>\:]\2)6=UVL<?!A&4B-U
MO6JAQ-'&507(RYEHJP3B,X\Q3D$NCK_(;,9N#"7_5+:SY(5>?A\\;%-0;[LW
M+8 [KA"C$D&4=3J@3.^X0LGY"8T"G#,3CLF*CP\_ES^QXJMYEJ8]M/F1<D_P
MF 1G]->2S'$B'-=.XS"/--\5O+-AJ3JV#':&;Z_2 ?,N!=8,*H72 ?!T.N!C
MH7-.TH'@'=I3]?7 .+ :E$+#40WEU].08$ECZCDH[49"B<M11F:9NU-%0^@.
M8/MRPHQVO%8)AV./AM;)<QOWV.M OD!G=%((<,G(9]"^)B:5#D E,VXC7H8$
MPZHI@M0+<-J-W.P4(9H3&?[I.)MF1J8#4D],U-"PO@@ZX"VC(EVK,4AR5&UZ
M/DTI 4ZLKV$ ##Y ![#N2&*[#[GP-$>A>58VWY$]-/52(AT0\\3X@_J32?T1
M-$'5F*9@L9*WD4?=)M !URG.#-E6\[?XK\%:\\U8HWA&^3MT +'8A<@5U>#"
M"Z0QB] !>(6_;C*%2H5''')LXND 3?S?/)^#M?$"6$T&88;QP,F#M@1<C$CS
MF.##<8C0R#XL_Z&IRJ-/4UVJ7Z;>)J@5 6*;)#I?K1]=0GUP>\>6$FGYV^#,
M@-A?[;F>XRNTOP)6>5+"&OAU$IQ3@Y@K*/(HT0G9?"B,, M"-JVO^%9;\,\)
M<CWKA1V'(=VB;&(,M%1C*D!=P,7LP-LTX<U1#]L8J'XI6#<-2'BR\3.P.D_G
M625#O$UXLYMHN[W\=T[_'V'+X8P>,Y.$[F_L:YW$JH?-S!,#5KLZB-=/H+8S
M-B^KBH!.YXTKY0L$ @K]G-HR@42'&65B>%'I@ V7'-N5"DI\[&7XF5/[Y8&1
MDH>^97KC11*)?I#IHZJCEQG*P^]<6JU$''<4@Y5FIZ%=;/TL,?E#A>H&]<;B
M(4\%-OP%,^PS65BM2? _B1V\D>01#6[;GGJK\/E9;%%;=3I@"N9_"JE/3 6.
M*XU.A BQZF?RQKA"4)I@7'TM#DZ5;=>Z;)HO47,^S[FP!JH)H6V3/6KV6#?2
MY[L-+<P('5N&-:,@\!NVMIX?S$QC#X&$"X='33(D#Q>F+@VF5Z^U6X(# Z[X
M4#ULK2X%S.VJ7HFP$MD)! XL#MWL:K:QDUOEI('-#@6?Q5=_"AQYFB)(),I0
MN@]'?8YYX1KO P2[7(*!!>MI(<4S*K4$I:A2MT5%/R[W3+,!YI9&8[XO5XH<
M^<296<XAGQ4NH2+QT/0K!M5;MFLLK(4'^=5^]T8&"/QL\^DV9*3N1..+.V2W
M=0%6O2OCKQQB#>+5.!]^WG&0Z+G/W,S- H['Y!..]Y&M >J0D%\NIF3?W:&T
MG<6YCU,US6.I.YJF\,:[M]A]6I E#N$J5A>SZ[3J# "^")-5@UMZ\A"^#Y5"
MS!PO/L$O3&*%MU+VM^$[H+<I0FL4^"::&C<?7/(-MWK V7RQAAB>(PQB<?@Q
MKMGJ463;^-BHY#;G?:N+S'&2 ^(_=M].1*[E$U$15,'Y00?IRO%Z_H-W9>B*
MT[L]2RLE4^+_;(ODPM,TSUJ&-I7@<E&1SM0Z(3TA&OZF4.Q7TVK9GIZ!R($(
MB8Z3%JNK3\1WI2V6R3B+Y?)%'?5R&D+J2>4.QGZI2<GPUU6&UCR]#[_<SR?E
M,^>HW=!8[_P.I9]<=F7KU@E/ ^)8TSI0FRB5GT?T:JM/3N1$Y-K:@@]\_9+C
M7=F&BN1=$\,IUK+82"N.)%;C%)?YYMP$[J7))1UD#4IZ]F^S9[V(5?)[:N:W
M^(69\^AH/'/RZ2:.Z,> @U:!]]@!:K:,<??#]'95=5]5P;?4IXDSBDU>^/.W
M'!L2UG2DW":4+G_Q3<:R 8)_K/_=G@5>XSISI[I^M%'OVZJF5$2'9U2A._25
MK;GSNPW-@>M2U1W#]LZGW&^W?TT[RLZAR-O!$8MB&3'-KX8;!%*+8FR\:=48
MC''W=I%6^M$^'0!LWSHT5]M4Q!O'$EQ-!:,1A,0 0S )1;$$U3[O>C'=B?Y3
M1VF0_>EE':),'&N.F-N.M.88_SY.NY[2(=OK:+^$PC(S2WU1O;G<WQ+\_5!7
M16$/_6=^-WK&.N#WY!+D:L4J0A\D"E0;_-WLKKC=/1CWZ,B$-U*QGM8TW=B$
MZS"-4-B@ Y!!5#K@5)NZ7*%+&K [*LJQ 1-L$E1B9YO46-/H5>ABP[84.L\7
MOQ#38/:C57(GP<MNWZ2L44^NKR*[;_;LZQR/[D=I"56>]9$;I=;FD(,+2S67
M-"GMJKGUI#"NKR//UWBMOTIAX_!&;8]5!>=7@GA7G<NM1^VM%0,5JM80/L?@
MJE^K.=9/'7V*@\IC?.'CZ66&,JSDT.X.[%/5<(12!D2LEL?RM5F$V7/_:WM(
M[N,R=2O1U#E;):WWM1E&Y@EN@H=. A@4\=43AH8MC\E-UR/'.PJ&=V?X!;?N
MI_/-GPD[?3$<V"KZFLF//_!5(Y+4; 6<N_7KRW*?XB,NC.:+H5V.'1[2G5S/
M-")%K["VUL^5=.@\H5N0?C00QV1DE7<>EOPU(6@E [D[IED"$FHI[D(43*U-
M_++ZTW*@].1'K+(]SRO[7R?,UF82^3>P&:6!T*_0F;O?+WH^>-_;,AGK!8K
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M:YB8=Q&SY^1JC>H.[ZIT!B2A?T^6L;YOLDA?%]1<1Y;3D@1)U85#\P:Z"_5
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MH%?:?)EA*R706@_Z!PD<WMM3<QXUM6LKKPCR,^[?MX49'44NA?"M'=76S=F
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MBL.E#YO?,+-B."Z)O^Q([)5/.OXG0;^'>J)V^K>)-GL'PZC>FXB-D'G?4M>
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M[[9L^_ "HQ3:* )S3_%Z?4_+U8)PJ8@IHAY&H>DJP@5B4BJ]J>.\2..(ADI
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MUU5I_M7>:W9%JH?2J]N,5]>&U&ZS9K=USC@7,&5Q9!H.\M6O@H&_/<2[U+3
M:]M(SWAY[S3MQLT+]9>^"+K37:4O&W:V>B(#1X->I8CA2%O_!1;Z'$ E8AF-
M9!JJ+(M!(;D7\#*Q3MW3CI,7 =D ;*<"9X(-IOXN*^(Q\/>B53N>@_1R53DV
MG'SO53>>0^:AJL;!D)?:D&_N'Y;K)RD_R^IKR>7G.UK)7V@MQ5[KEV7[2;45
M;4W!V]M5^5]2=.'+K]9U4V_M%)ZH/%:F:$!DHD9H(E$AXQ!IG<A8Q%7((I 6
MG(S3&>U.P^!ZU>;9#[&XJ.5\OT7VFV_F9\M#X?0S";4X7W!^@+:HX:R?@#[,
M8?\&IY\(T95UI ]E0Y>&S:$N]TPFZ42 >C=6??/Y0F;L1'"?-G"G(N@01+";
MW?:NKA]-%^X;94IIKE>MOC)_^,OC\NGC(UN6_$8IS<#J=A&&65:8H,"0%!+A
M!*>(RI"B/ LS/1EQS%*KI-=+F)A8D>\G<Y8]7T:1\Y:SH#:L=7\US)D\=1QT
M+ 8#CX#K=->I&%?7<P$,T\0;; WAX-T.MAU3W5[9_;7%=GY8 >$*,\#K%K<P
M&<RP&(8+\1D-9G =>[ZHA@NEWPMON'0LK[V$NV8]S8+Q1&99F*.\T#L #C.&
MBI01I,)$I3+,(B$C4"^V47(3:_U3G86?KOI^:M"^:>/8A8G(,YKD"&=,(&QJ
M%^:BH"C#21;2/*$\S1<K>6M\U+.A5W3H[9*UQL_$%O\Y6)]%,7CH^C9Y1=/N
MY.+O^X)M>F.A]:_.?%N^NC@_$W+:9LX#L>^AI_,SP2U;.S]_RTU_OJ5E]3>Z
M?-R,6\JZOQ84-RMMW&LJFK0^ I3U7U=K5NMS@3EGMM?AQO9?<?U6N_5O3^DB
MDF'(M:Z-1!0B+'B*\H1@%&>2IIG(>2I!63I3,#FCJ\6P'[3\;]>5:<<PB!!H
M:V<C1-!*<17LRM''?^Q+ M-.D\RSG4Y[Z=F#:<)I)FM2[\R4 'O2PI.P.*ON
MGA+DYQI_4EJ.\<1+6M=][O_[<B7;XMF+)$_"F,82Q3),M'G-$T1IQ)"@2O^?
MC$B2Q1!%?Y3*Q)JZI;GQ@0>_&[I!2Q@887@<(CL=>;'@,"7G(C,\.'A,)E]A
MP4=IS!L0/";F02CPZ,/P:O.O>]_+V[+F=-EY8-_JW]4+P0J2J=#T'B\BA&G.
M$#7U__(HRAGFPI2>MRTZ?Y+*Q$MSH!MTA(=J4BUI^QKTIS$:7YO>)(>M32>A
M097ISPKE5*#^]*BSU:D_*]ANN?KS#U^042R;N[78&LK0E.+]UR=>9?M)MBUI
MAU3B9Q*/+RU/PL(6UA$YM5GNTR"W$.NR5.)G8\Z?2WQ<J*/)Q"<>=;@(-$[C
MSH_\=VJNQ)NZ+U^=D%#$(5=Z4Z,QPLJ4MZ5QCJ),6Z)<4*DW0>N;OE-4)EY]
M[=U&?^4Q$ 9<(9W$INV@2HE"&1<$D:Q(M6G.&4JR2!52)8HD?/%55FP]&SJ[
MU&#XM->7$X!D<3_I0W"8GCKV1;B4BS\I->#ZT(?T;O>#H'4!N_,[)]3HI=[)
ME^>[M3O'_]ZUW-F''?W&C]6J;$P5J)5X6WXS/VT^+ZQBD24A$A(+A#,E49[J
M@PB)1"B*(I=Y!NKT?IK4Q*IY0[B-N5(]::#?]31.BE$>$Y$@1F.]>T4IU1I:
MZ/\(E88,,R;RW$Y#^T7*24U/C)6EI]F+_$!_\9[@ ]4).MV?%\Z7K_8TH7D]
MKF<%/O";GG_#3=MU1NV0,:Q2%1/352&26"*<9MJTXDHAE;&<YTK)F%*(@ML;
M?9[#GFL6]3X0=JO263RGX]T4.=)')?"TVO;'GG6!'17K^9HZ_I##*>Y$*.DV
MQOF7I^TC?0AT2[S][7M];#>UPB.:1#Q!&<-8FQ8RUYMG))#$C(<%RV,"".WT
MP-#4E\B&4' D*G^W1_@OIGOE]KE-\+CA]*K_4\LLX.C@8ZXLSE8SSP!,G_RW
M!A]PQ)MY$MQ.@S--!NP<Z1&YT2.G#SKSG4X]HK)WD/4YKL/V=<UY]2C%37,G
MJVU$UO9^?HCSDS+ED>(Q8H28!K4I0Y30 C$N:)H40N;,JIT%A.C$VU!+/J =
M+X'L$I$@_C=;["RVC D0 9J9/0P=*#MQDUL>SH=,ND,$4.P30.6FO+U !E/-
M0-E'U:_M6/.I6*!T>VH4^JYC9??UZM8T=39=AOJ^8#%%H4@S1 BGJ$CT/Q.L
MJ R3+ QC#*DWN#LX2/7!"PQ^,:\$#U6YXN6#_HD"NB8<Q<+NR.PJ(4R5[;?>
M]E@K_0CWOLJ@[PX];X7S(T(=%"\_]@P\J.>]O*7+-ZO&=-8Q;I9,Q5$:J@*E
MTB1BI)RAHB 2"4E(5E#*$F453GUD[(DMAY9:T)$#^9N.P3"^="X4#KAR '*!
M0G-.2. 4D/-\K-G"<$X(L1M\<^H11_=L7<NF7J1"BM#<H,3,](M/XP(5*LX1
MYTP5-"=,$ G99[IA9]EA:$L*Z(OMI&:*DC1.,!)Q7B L:89H+F,DHA#++*5Q
M+$"E/AVDABN&3NI:WK8G] NDMW1!@V4"'@K&!8 [G/?X]>5I[@:=U\6\)\B!
M;WG_KXYE8X[Z!6[:9I;7*_%.\ZGUS%=I6N+6']?+DC\M$B&3),<891F.NC63
MIVF,$E$449C%21B#TD(=>)C:=7RBH NPD(L#MG8K<F+$'%R]IXNO!+]W#$Q4
M6\4="5]54QPXF+<>BCM$!Y5.+A@*;LE_J:C0Q^O/3_=LO5P0%6%*LQ0IAA.$
MB:2(%FF"2%RH*(RX$':!,0<C3[U9=[2"CIB] ;\O_7GSW5DFV&JW% =DMQ]E
MW<EJWQ]I-IO]J "[%OOQ!QR]0X F7V_U-"[2C$6DR"7*N#(A982CG++(U".(
M]>+),Q*!;%PH Q,O,/T!%--U_6L1M/0[38@+](3MT///L/0R+?]VP7B!CG\M
M^>^VX=\N.)?T^]L;QS&-E=:F_X[Y'].Z^BM=FO$_R;JI2M/:]/C?>\N6IERE
M29HBEA"]?^NS@U9 /$<JC/6^SH0J,E 9R4N8F5@CM4VLNTJ#^H<=ZNTOMRRV
M?P>FR5XR!79J;"Y@82KM)*97SP$]\51_"IGT-.(#.E^YO9>P,F\*L ?0#C*%
M?8P)4Y)UU2P^=RZY7^7ZMJ(/=R6GR]?K>UJN%C(4(6>R0'G(0H1S'"(FM?9+
M"IF$(9%"V15U&:4RL5K;)1C\WI&TO)$8!V=<+WD3&:9P8-):JPHK:<9T@!Y@
M9_WK?VW7_OC8LRQJ*_&&U6KW\*6E[=9U_8I6U9-:5R:@J6YKR2S2! O,"HGT
M$:A F(8",4P+%&>I8*9"&XU Q3?.T)LZR&AKZ&ORP1[]OGH.,%;]''YVMH1'
M5&"K]R) +JC)-BJF]Z)LQZF]4%6V4=%/EV4;?\UM\;]12O)FTR_P"_WVB39R
MO[;/JSOCH7ZW>BV5K"HI]$/=C8JI';0IU/R'*<2YX'DJ"BYS%$5YAG!*<D1S
M%:$BBU66I"RGU*K%\D3\37V<:3D)RE7P=2 =T($V3*OXGA@[+?2"<,.TUH;1
MG78A@>'U64&TJV [)P/#[;,=R\&&YV##])4IA<*]5J*<"%9/6M(W=[-JU8F@
M?:Z%IR)S2:LF/7YW#MOI;\=I+D/"$"Z2!.$XRE 1A]S\1$BAHI2%#GV8#@E-
MK$=W6P"Y]%@Z@HR=_O,A+TR1[;: F\/Q<DY"KZV-CI!Y@;Y%IX4]WI1HY'GX
MU6P??":$_@;J5_K'F^K+^H_5(I>12F(1(R)3?:K2V@7E84H1U\<I+'(2:85C
M>TE[@L;$B[0/2^S)ZHW6_&M=!8:T_>7M*7S.7^-ZD!IH<[@(#+K>/2.2TT7O
MJ3%GN_(](]3NY>^Y1QTO8S8MJ&[4P=Y\O1([60G7K&XJRIL%$U&1*YJC@L4*
M8;UY(I:*%&4ISXLT"RD6H,@M!QXF7KX;:[C1UG 7&1G\N-RR\=.?@?<M#BA;
M7K-,BQWP=F6OG]FQ(X6Y5-FMZ/S[P)3/ZQ-W2'S=FCAP,.]EB3M$!W<D%PSE
MIK(^R,;<N'RLUE]+(<4O3W^MI7BWVOB"KLU99'\M%2K&>18*)".3O<%5AO(X
M(4C$<11'BB0TL2I2Y\["''?%2A^@^G94VP8;=,,*3&4YH&RGL:;%SN$Z>. D
M8$_!CX:9H%S]M!/TTC/T=&7<*<O'-F[M=5GSKBVGR:D<VG).HL[<\?*DS1P8
MF%69N0/T7)==,-)T'F;]RU=:IY;MQ;/4).[Z9$ZMOS"G!!%ADFPX9BC-BTAQ
MTUV/Q4-7H"]^_<F'W%BMSOV605_@"FZ@UEH00GZ5R_5#&Q?..V[\.Y"/X.[/
M3^P(X\3N8/.'CJTV'*;EZX4\OJ<!FM&Q>X2)[\Y_>QHH%S?MR&@.]3IL*'Y8
MK[2J?=2/L:7L&^P.SN)-#XX;-13.[!KMMAJ0Y4*@@H@0D=S4MY02HR**"_TK
M&D:Y?=7AR=B<[49-F88YYEJM[77T![PZ[W0S-:XSOQ_\I]*I>XP/':0W-V_O
M5CN=J8(;M2FS.[24_B[F$%#PY+N82[<2*2\_I[#Z*I-#/5J193KJ\]5PF1S!
MO:HOTU-S3-[M8N<^R;;EYNJV+4MCFN+TJU\*F9K[&!1B8>Y-"XF*(HT1H[3(
M$I'*!-:_]0R]J6/<V@)(0]9[:7K_ /-QS\!E=TCP" )LY^H)!QO*5WU-J.$/
MA@E_F@HHKZ]LVC/4YLV<M1/]($O6\K5+/ \WZLTWWJH7HXIN5L;[<2[:??\7
M.T]J11$KFH<4T4P66E$H@DP!=13F(2]RK!)&"#R^S2N/4U_[MAP;&URM*UG>
MKOIVQOS)M*SDX#R=*68)XL1X,>Q=K'$#^\!N9[=IS T/5\_S> Z2?:Z.I53M
MO?"J\_8:W^_&W>O;(S()VE[=)7XY? %?RB00'W>T3$,*W@]-FY0?Y?J#7%]_
MO367==>\>:3+Y9/)V;V^;VS[HIT99F+%JJFCCV]N@@_Z_Z^_ZO6GE_A^#>*>
MG385&71VML%H7&=ZA@>F^_PB VJS9BFS4[NU<V//UG;-4LC=]FNVKSAX5#_(
M/YKUZC=:UY3?/=:RV324HKC@448BE'$9(<QSBEC$4L1%P2(>IB*T:P,\3F;J
M9=[2O0KV* -<8*?AL7!#>A$:N'B/R>O29^RTX #?G1< W'QOL(F'^<G.BC7J
MYSK]]GQ^JK,2[/F9SC]]26#]9SVS;46N]P9U/<=]]FU"190428S2L(@1+HC2
M^B<C*$Q3EG-.&*96J<E6U"960QNJYDC1.X,'!JZ"7^C2I"D <Y?M4+0[G'G#
M!N@Z\@.+8UC^&7&]QN:?HO4" ?IGQ#X>I7_N)?@IXKD=\[>Z]4?])FG]6$EP
MEV7+X::^0#UM)W^M_]3[17N>[ \3ME"=/U1,@!)LQ4, FJ"/,U!^IX.&+8W9
M#AQ H7</'M!7+ZGTO+F-,J&0R[4AL D$S4F:A8I21!C79Y&B*! +&451EN,X
M2442,8=RR",4)]83'?VKW6O=+0\V09^..-I9 U[1@>F'BX%QK,IL(:S7@LUC
M]%Z@EK.%^,?+/-N\Z-B72;8U7-5'S7)9U^OJZ<.ZD5_6;RF7+<4%8RI5ILLN
M4<PX*%*&&)$Y"HN$LH22O.#V?0-M*$ZM% 86C#7\L&$B6&DN3%E$I?GH8K*
M+8C.(FGAR_"-#U M;*"Y4<&6?F 8"+ZL \-"IRY\0P-LS>03(O>^3!="!>_*
M9"OVV99,9P>:MQ^3K5P'S9BL7W10CKWU93Z-=ZN'Q^9S4Y7_D!^KDLO>12>E
MC&B*&9)*F)C^G*.<YS&2(L[#/&<R2K&U9CQ+;F*U^'=9WMZ9*U3:7T;4+0.F
M?Y-MF1=+V"S4H%<P8#IPAW30TKX*.NI!2][%R7L>$H#Z\PJ-F^X[ Y$GA6<M
MZ*BV.S_*?*K.6J(]/6?_EFLAAS?WLKHM5[>_5NL_FCMS&*6KIT4:4JIBB5%"
M3*=V4\>!TD@A+DF>LCCFC%MU:C]#9^K(GJZ^P4 ZZ&@'/7%H28?C2(TK-(_R
MPS29H^@.Q1U&!;N@P,/Q<6<N\C JW&&AA_''+^\(^1MM'JLVE_&3?.AK?!L+
MJ.^R^&YEJGU_T:#+/MV0*I05A"-2<(DH)A(5."(YC1*99CFH\K\3&Q,O</W9
MY.X])0%HVCEUIL<(I@3V^U2:B]J6IZ>^ZG]+?9KNE7#I)^AS"6#BQ3IBPH$:
MZYWI,)J;4NIS&7H+5J4A86$DD4SB'.$LS9#6-R&*(D',42BA!.0ZWAM]ZFMC
MT]>H#O0)\M%4'PT>'_2QOKF3@?PF*U[6;7(>7]_?ZU_#<O2.8V6G29P1@"F(
MGLSY<PU8&1P5P-,:WQ][UJ5[5*SG*_+X0X[Q&]J$*"NSD&^46>GORZ]2='[A
M_R.7XNVZ^FLM%ZI(8ZIPAF(18X0Y,_5I!4,\#,,BRU(59J!L'RNJ$R_,+0]F
M!2XU%\'2L.'4]-(.1KNUZ1T<V)K=DK\*V@V^I=_5:KH*# =(K2ND>? 8S $1
MV5=0AQ7->8,[(# <!'F 7G8]SK]J=ZJVB66WL]T\-G5#5Z8 SH)+540QHRBD
MIH2J4J'>ITF&9!KS*$T5I](J =^.W#R'^XZ#H&7A*NAW\QTNH*?\40!M#_N^
M8'$Z\SLCXG#XMQ'T A_ Z/ SNP)L1#WT"%B]Y;-_[T[[U5^>MH_T'<&N39W]
MKFGG+B<?'EO;E$N9J2(G*,JH"0&1%+$"1XBHE-*81(HJNGB05;D6GQM:-7;&
MA'<^(2OH.;?6BVF':D";@,G;<K4R_S 7Q^V@P8_E*JC;2?W)1W?@2V8NHSC%
M),<HE4:S$Y8@J@U"1%DHL50IQVG:S]R;E?AO,V\#KZZS)E?B^YPO.TOS16<
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MA(KR&+$P,@M+*<22-$&A)'',9*XB;E4%$$IXZD77L]'>Y[]Q<W!:8VBY+"=
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M#H9T)[83S33BHC>-^*42+^2UZ1DAA6C_6G"'(YS/(SQL.R;$#68_C@8X[WA
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M$WK"EI?S-!9A$ +-A@G9R2W')K#=7,,K T(J]%TST%@*OEPLE*W0(0M4:W;
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M>/$P$4&2JN_AZV%I,HUP1M(8)T)0I;221#+?X'4_UZ]M'[3[G_Y'9^"6NM)
MV(:AJ:(&C-MR-RGK5F[36YW]C,R]4U=(V/FG]HC ?%43*0>]U<$%YO-73>38
M\UB-7K"+X6[G3.I1S[6.$K?%?;O),"R/F>=SCOV )C@27H!SD:F_JDU4INI?
M96[4@=V8XL2;YVZ":E?'6 ,S;\<A,POU.@4"9L-V&#2TVYN<COHDJ;+&LCH*
M"(_3FS4X;"S^8:#8_$7+_/RU/O?J)*Z79;72Z5C?Q*/> >H'RKP\]^(8,\F5
MLQQD>O >C[ (P]13& @_,2J)&B<U]?FV(:S=E6I+&M4=;6#2_7FXS'3>#0C
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MQ8&NO(]\SG$>$HZI] 1+ BIX9-2(?XS0U+:B39CNT4::^&@7*AA8PV;")01
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M_=+=U#K3\-C80A/KRXX^4@S\\OT?:,<#('XV"H=!2,TE$L HVP (Z$^G\_E
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M;%&> 6'ZL9ZAQVQW?:6DNB#VT_-+M?S>^A[=#RO2T_%$&&-"_1!' 4MQ'I$
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M-UF^(TN5/_SEJQ";/:5Z_^$R*3!C68H8YCG"F&)$& T1+2+&0BQ\G D06@&
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M7O>/=-FH#037_8MZL-ZWXSP'>)\E$8G#)$:Q\'V$&6$H+^(<%7',_8A&F<A
M9UZGW#K>HYJ^9U[+B'>K4HQ*!9D]Z"8[X GF5KN=1#TG_(>9&MBNU_"$&J:.
MPF^#%EKTU1L^UR>^-^S?=%-:7YI*)T&"6;1MZ5C@EM=9#Q&SJ/WXR#$/43B>
MKH)N;>C_(M9/%7GYJD!<&V190K%?J*9$'%.&<$8IHKC@2.1^$&<L2@H?Z^+K
M7J3BV%P/R8%!=B^K9MR86A,89@0ALH*0=R=EN0*)]_+8LR'S3HHW1.J=?MCP
MRD'4M1"?A%S]/XN:566SZC_M,$IRPM.(D!AE<:[@)T.*2) RQ ,I;EP4*<]
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M1<1('*9:=<AOP/M,,90GQ="/$D$!S.Q,X1,W\_6&L9-6H'_-P E\,GZ4J F
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M*/("U#9J.+KCT(?"^)7^'3#T>2A_F.1!E.<"-85N.&,<T2R+4<A8QGF!4UZ
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MO2OFBY3FOF&>$OG,!?/D*U?V3!C4FT649%F8!B@,BQSA(,\0]0E!A0@H3XO
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MZ^,P8QFF*@IQGA8)YBRF41&$F4BL^HMWD_"L&O8$K^F2<LX76W&_!BU4MD%
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M.-8*!60248:5%Z[&H9CP?(V*:\-R]B8>:Y1["G8Z$=8"EGH!8#ZT-AJ V$=
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ML CS^J[.A<S:2,G0+>-E%"#DXJ5EP+-7<RH8!W,_KJR^C].,<W.6Q.*SA-W
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M'(7G5U@KIO$HO^O==YC?*&(V/'/"UT798#/!'>A(C"(IHU#:MO9HZ;XTC]X
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MWYOH;NC\\]_%55?PR8C&,#7,SY#VZ,1Q$D(+;@*)D9919+S,"LJ"9 8I6:[
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M.^.9&ZOS=XRB<6U&#^WO&H6*@F_1"*S'")Q@ N['#_2K-]]=O58F!S]XS^F
MEMI;R2P163$B-0O$QL")#!%=72ME,K7[0^^GI'?FY<&G;J4C64[:.4Y2L(E(
MD))X+P'/)&4-SU1S43L[?("4D3,E_?7_* -20>0M6H"W,_P2/OL_3O,%MG^]
MMSTX2$LELW#W^?NPH:ESENNBPE(URB,)JKRZEA"I=R"=K9V,/$).7P.QYZ.W
M#BV>6=#1DVP MT$NMR)16Z+ .>I4R)G*X5EMQ%34PL2NO:BF@1:-QB]H&N;?
M 5["#/)D]6'J3[HSVO<QO8W(D[352WK<I<'77=-6DTTM]!X@038\T/*RD?-,
MI)2"!(91JC;1@8LN*EZ]JVAW\OI[(WDR@W7$O)B$Z[)BD?K6DR$C,!)7F0@3
M(FXF:\IP84/P@#0</\_E5-\M.4[3Z$F-0;#SV&FIJ)D6#=&OL'HW7Y:A!^O;
MIU.,T.Y']#9 1VFJ50#C%S,,1^\6N7\JF)-#3Y22Z*- R,22E0)'J)5*>QFL
MJQX!'**E]X2@G<^]1RW-S$;F!0%JD,ED2_T%_C6!8)!L3K;Z./F#Q(Q<]%(#
M!X\F]501?(OFXN:Z^H-?K+Y_7GBTP'$]U>VT0N #GU6A)K@+E=7*@_<O=M__
M(1F.H:P@T3(,<+7F) "4]R\.E(3$/:UM49ZBJ7^)\/[/W^>J4R^S\\H2'Q'H
M,L9(/.6><"NSL=8I6SVU^@SRQBX#KHB=QX7 PRBI1;OT";X4[^\C?)TO2IKY
MI *\W<_H7WIWE*I*]F=WD:T"SNQ$$IHP#9)@J$V)#>#1-05AJ!=9TMJ'_"%:
M>I?W[GSNWNIUZSQR6]HJK"&<+0E>1 *:>QZL%-;6OJ+J0-;(/85K8.-1<6]E
M931I3Z[#$O[S&C_FEV^GOO%\]!D5^E8<HZJ6/=E9Y XS3JM,K=<D1L>(1/@0
MRX&3[*S1C$8-/M3>8 =HZ?_Z\N'GW@-7::,D^O:$"1:(5!3W!#!'N#128XR?
M\VZC\>I,MF([:N#@\5/)&H)OTV)TZ2DS?'><<W?)&:M;CLA6!2XR\9+)<@-0
MQB=DQ(N-(%5 $-':CP6&ZY;STB\GR_=Y9X'OF__>[Q$=<] E"0%>%Y[10;?"
M12(MSU$9[DRH;8&[4=9LMYSGH&375@V@E#9Z?-X_D=_EQ4H; _Z/I)!-Z9R-
M86!PZ,6YP!DR2C74/OV.T3/NB(6!8%5- 0V :3<4V+]#7'9&@0G$FR*M\I55
MI;ITW6G&!)-U]29?70@;=^K"0/"JKY(&</;;$M[G7Y:KR95?P?+"&BYUL)J8
ME#&Z9 R(S\(0H7EBG'&;>.V*[X<4C#ME82#D]!!R Q!Y,U\ ^JFOKG'M67R8
M39VE]5^G:PTM=_=",)8;0S7AB:+,M$-&G?(D6&.#,)R:ZB_"3R9VW($- P'O
M/*IK *-X]$<4\V+S\G.R_.<KI&&R*E]=T!"4#+Q,7E49SWNAB8V)DZ1L% #<
M^=UI'S5<KT/DC#OV83C/JXKX6T#2WM&I3XU6W6R?"V59E-+*\L:GE.912D+I
MRI>BTL+)($0<8N;HJ?2..TEB*"R>2X$-@'5?O]/];FD*D@KN M' 6'D2QHGC
M'&6KE.629>9D[2NKSL2-.VQBJ*-W$-4T@+D/B_E76*R^EVJ]TO^J;**O]]QM
MI6\H92QZ2G26&&>G:$F0WA&+1T"D6GO':AO#KK2-.[QV(,0-HI@& /?VZBON
MI?6PW\7KR?+K?.FG[_.[^>S+N\DW2"^62U@]\E^CM"D%D 2B11X5,\2#Y@3-
M>'2"41#5 ]E3Z.R6WJ4_&!('UU@#J"R/KG99X,K'8-%GB+3(C&%T[Q.U1"L:
ME XTI=T)IU7>N)V$J1_MSJ"OO!N S-V[FT<Y0\>9- H(=8D2:3'L#DEF I1'
M[RE$YFJ?E(=HZ0:>'^UFH(KD&T#0_N:FO_Q17FS 30@#UCF?>6DL*!21%,]Y
M6P[[S/'4MZ!-R+6O,CN0U0U7/]J50&U]- "Q35>!33.!W=UBM'24JDBTS $=
M1Q^)SYD3)BFS@86@?.U'ZD?(Z0:I'^VNH);\&X#2?=>][4=E[[_>/"U[N\X9
MHD-8 I;;!$QB0C&)7J"QI=]7-(X$CE^I$*DRU@<J:C>Z/H',;M#[T6X+AM97
M Y!\#8O)-U^8>+2YREABZVPB8$4DAKO2G\D7QE2VD*+B4+O;_&%JN@'L1[LF
MJ"3]!G"T^P[M<3#+\:#G@0#'HUYJ .)$4 3W!-@4@H4P]#/ DQ#UHR7[:^JA
M 5@5N[N 2S2]N$<V0<O^G+'%("5DD0C/Z]8N-I(0N"LW%EQ'",Z; 3KS=:*M
M&]!^M'3^()II '&_PN];$EO,9_AEW$SP.5#?%'60T4KB3&+(E4/^=,2_9J<4
M53;$ZEG]Y]+8#8$_6GI_4$W]N'7_GWV8#EGU?_/Y9ZKYW\?-\!7_B5L?F?4$
M73"T64Q[X@&=>.%U$A"H"U#[-!FNXO_@-=A6',VUR52A=RD4QM&&*^(=!\(E
MX]:FB-ND=C'VTU0U6^G_''1TOI,\31DMFJF],V=/MTK'/FZ8^;@#VIRCTU S
M'D\\ 2.,.51\UJ7WJ;#XGYR\96!S]8![R"FYG^(EI.LIO,]WJVPN.A'V[R8^
M3*:3%6ZK&\FG][./$*\7"]QQZ^<P:RULQ<,&70):1H1QF<JHV$3*?$,2<F(Q
M@XAJ=Z!!_SQ8308:GL+['-P]2I&-IN0&8H4[ECMP^MML'I:P^%88?CO[>KW"
M;\]G$7]K#8*MZB<A,202B@2I(Y$)!6$=?N6]-,)%1B.K?:<P!!_C/J@:#.^C
MJ[PEV'?<Z?@#O\YGBP>R*;]_(X5X.9O\YS7LV@+P(C#/ G$REG;= ,2FG G+
M)FG/HXJYML$_"V/C/@4;?F,T XH6?>/]0]-/=XZ/?MY (]X'=(_K#-B6+'/I
MC234FU+#XA/Q47FBJ0E::Z=D]:JS*H17Z.VZ!OEZPMLK_W6R\M/)?T$AX*N?
M)"3E_>H2%IL-NJ^5CK",RIB :,EP=R5EB#.&D:R &>:,B*'V77-?FO\, ^&?
M@]<]76//I_,&?(\.^1/'RY2/]>0 F_$42Q@_) ]$24HAQ>R#J-T%L%(R:S!W
M>'R<5M;;R4C\!HLPKU7.<Q?[OHAQ<0W;'L^NWV)L8!8]?%^&&Z]?_SGC-9'&
M9L_!JQR'RUX\1=VX'NGXV!Q(CRWZG_LG-/>X,CKV>0/-DQ[0_^PYM==[I:.3
M@0 KDW-IP8F1&)TP864L@R)4[6F)XTZ5OM\Y^TOEU@K<U,LM7\35Y-MD]7TW
MY2>U"\9%8D69=&R-)X'[3,!Z\"8Z"E"]=6AOJG_HV=+/0>EA4WD6A3?@<-YS
M?#NLY!,LODU*5+Q/ "^FZX]<GU<EW?=EMO;&83&9;Q2S]>I0>RHE'B-J\[XK
M,!1$*%-VHQ?,1\FK7S(/QLRX[FT3&V),>#2U3Q[-EG_QNU^D;<MPE^?#L/3Z
M:O-O.U8B@ T@?231E#K%%%QYR4:)4%(I2,DX5;OG8ET.QG6JF]@19P="BQ[W
M[<3UTWWLG4_H[54?HZBG']U]@KTSB4N=,\EE(JMDWI#@4B).NFBHI);MIAH?
M"Z;S:A5M6P'OY7R*NW=94ABK[[_.5W!+P_O%AH2MFST+G)7FYRYXAO%BML1:
MJXFPW N164@P7-S_3&+'<6J'@<P1HS2@!ENT/S=3D$^V/@]^O](8\0$C^)UQ
MTLD;2LN987FI+RZOL7P(&'OPP!G3E(.O[6/7&2:^WA;WJ/V_KQ&=D]7ZJ=#;
M69XOKC9.Y&QWVO7#P].G'&.0CM#L5.FXF4N_NDRD=RI&_+M4MI.5[4M)4S/&
MGP.*6T-R?GTTX-/O&ZA^FQO]_G>_NEX\#N\C,)JD441CG$*D@U+,E1C1/FBJ
M(C.T^G.($\@<-UZM@,=SJ:C%(ZUT/CG]0-OZ[=['V2%*:J6C]X]&+T]#D^64
M*"COC!7&10$BFA(6O$W9N\1J7W#NIZ2>7WV#U DL-VV1/L/BZDZX#Q_%;G'.
M;,DB:DLR3YY*+Y00PV4%NM$X<FJX/V(.N\X#**E%\[(UV?YT*_/X0WH;FR?H
MJF1SCLU83TE!<E$2RC0G$G0@#I0GI4V9!:J<RK4?*!PAIY[UV2SR$M"/@_L%
M\8_E:A(Q)KWI&KT'YPXDQH/11&)\UNC,"4>B5A$<HX[3X?+W)Y$\KFVJA:S#
M!FIX/3;@E&_=..0,<77W_!IY_>A7L%-DOE._X!)W*%(B0&, $@(E/KI(HN \
MZZ"<A>KS,7K0.ZZ;/CQ@!]9@4VB]K51$)O>5B.^RR;3-'D/C=<]]*2DG%D+I
M%,8B!:5-RM5';)Y&ZK@7/<-C=#B]-07/W\I;A)O[6&3U)<P@3U;+C_/I%(^-
M<G&UU\T5E&B@B9A4WDDXKDBT@4D0BFJH/47A=&K'G2(S/$@'U5Z+0<JOL'HW
M7]ZU^3D]4-G_0;V#E0[T50I8=CL>W2'+T.2-I@&AE!.1Z,R14+[B5 N;O'=2
MR,H;]! M%7V^G17*NZGBVKZ>3*]7L(OR%$Q@@C/BUE6QS#/B.0^$@^,<+ 7N
MASM%GT7JN*%)%0P=<?,&4UI31^B+V6J2"DOHT'XJ#_O6#L(O?\3I-6[S-RCU
M4HIR?5O.O2N5[5E+D-#+I41H&8F,0F!$5AI\<BH-J.R$'[!:OA(7X\8N R-Z
M%%6W> [OSD#L44J__Y/Z%]%WH+#6//>=I>Y IVW(T617YGA[!)WW) 0KB9*:
MTLRYD;QV3X-#M%2L!=I98>L>^.7WFV]N=?6)N+U0"L0&B7&[U8E8#VC?'3>4
M25Z&@@U7"?0<4D>>!5\#0T?*?P936HO6Z34LXV*RKJN<Y]4EO+Q>3F:P7/I9
MNGM,]6H^2Y/R$Z]AY2?3$^]43UBGPNUK7^Z:>K;.F%8F!3P ?2J#<F-I $(]
M.G]2)DM#]+SVZZ$FGJU_N@Y+=";\XOO[Q:8B[^^PNIRGM[-OL%P!?/)W=7NX
M11_]\.V/K<^U35QO0*,#D8$8X(X$Z1*)&6U%#M+H6'O80TWZ_PS/V9^#XT>&
M>BPLM!!(W;&SQ>6+/R;+74:DU\0Y:I ;CFZS22*PZF'\(6)&]@Y&P\=!H/91
M5@NHNR?_5W^%7V[-1'X]O_*3V2Y'%"0)3DBB?7(1:/1"U:XW>IJJ5G#82_V[
MH*JKBQ'1M2Z7_0A?)LN;&<AWY\3?X2K 8I</83D)'/D(M/0WC4(IHY[R.I]:
M9&2(5%;F? #)CHV0%ZO/E_!WO_@GK#8&^GU&(C L*\);OOBR@".<R92)%8P1
M9J56/,7'HW .8.99RXZ;QQL21<-)_P?!%2*#[^=.9X7^JG/$.QV]RT: I#6Q
M=;_TN/4##>#K1"V,CC&D6S[#$)L(Q(&V1&7+?,S:@O;=(/7$2N->[@^*H)HR
M'ATPG;>#W,^=M[@3?%0D6\C!47#:\,I&23X#4H.-<VO#*)VBA08"N@_KD6)E
M)ET\LE,8GMRAU-F$:%B(*OJ@:U_![*>D$[0&&^0V$+0J"G]L,X5[(UZ6^/8V
MM_Z$(VA*I0(P07)$R^M%LF)WGNX!J_342IV0,MB MB&-4%49CPV8_WD]_?[A
M.DPG\=:4'H@8N"5H*P,)QGO%662!Z4Y .;1")X ,-EAM2(!4D6D+P"CG:!=&
MDC;$^B@(CS:STN\S.=89'(=6Z020P>:>#0V0*K(='21^=NT73X#=16:("8(1
M&P6Z^(PRB!Y/S=V9+X<P<GB1;DE"^D-BI))H&W!J[^*^C<]^WXQ^7\X=N"+6
M*$NBT2IP"M[*ZK4UQP@:.678S!U9-:4U@, ='O;OS5(@A%LG$9J,8LPHW%*U
M*U7W$C+R54<]1>^.,^XM]0:@@^1?W;1&/>#%&4XL]>71BY+2H2\G6>V'U(^(
M&+GBOK]B'P\D[B'E%F R]<OE^WS3BNRF$]F^'41C)"XX3A13DC-PR$_MHJ:#
MQ(Q\7='*V59'6:VB;O]V5(*2P&@F+GOPS$J61?6AZH?)&==@55)X%QB=(/VQ
MH[AU0FL=CR[@S74IJ;WMJ+C?%@<:B$\\$R:T"Y89:]DSDH9'5FH0):?H\U&V
ML)9PQT;*+@\';GZE)L%HW$12ANRLP,._6ZB___/'C<@&044%08Z-A766LQNF
MDPC$115(#(%9QIA0M&/NY_ BX_HR@Z"BEDA;@,;&HS_.!&.J-)A0A)IL>4X.
M('<K'#RTPKC5%(.!HK<P6T#$(V2_F*6GF=ND.*-'YA(+A!F38_89Y?6,ZZ=G
MK#QN\<3YS$HMX8^.K$V>O L?4@F4&"0B3,PF9*!9=30WAQ<9MR)B&+Q4$NGH
MT'CRFLUZ0V(T"=WNK(A3VA.%_RF))K"N6W?MWE>8@Q5!#&9,J@BU@?3)7>K[
M1E(''X(HAHYXX*51FY1>4*55]6%P!XD9N4*TE:1='64U@+IM^O?OQM))W'EN
MB08G K>0N1DH1[Q%12/74/W4NS]%=ZJLQS[!GIT\\AYC .H)EXKYTDX2=MMD
M_<B9N9/5V"LA=TRF8P.DG,;KICQ[_?D#]8B.X5EO,J$I4YMT DV[I6^[K-9$
MLJX*4*K+MH&SIW1\?SM;KA;7ZY%N#\SKQJ-/(I%@G239)\FHHE+KVN_3'U,Q
M\I.%5GR<GNII#F"E*FYW&V[X,'P],:7,QN16T2BLIK6G/QRB9?PI#WUT?!0R
M)PI\[&/L$\PF\\6Z%UV9;XG[:;&:X&;Z@-*;+)?SQ7K.VX'LE##$>^L)QJV<
M9E B[!94')J+]8Q56\+,J4J>GT/B#=B@,MYD=3O>!']GWQX#GX@-AA'&(^AH
MO#.[Y<C]1UOMH6/D!U2M''2]5=0@S/9O216 ."XR\4:(",P)2+5C^?V4C#RV
MK[>&GX#,">)N #1;IK8PLM_ VN2(<]R3&)F@8"G*I;8/OI>0MB!SBH8?U97V
M%7<#F-G;K^C=9 9O5W#U*#^6K216.D6T-)Q3)5)RU7/51RD:^>EG*V=<1;4U
M ,*/I07G#-)M-^@7,5Y?7:\'TK^&/(F3U:-<B$=A>8X;5;H@8LC)5^_9_S15
M#;8:.Q$#\T$5\GR(N0W$9O"EK/FY4B2XU9'MRY?%^K/?SB:KB9_>WC5^6$SB
MXYW)RD!$RDD,S)6IB#RPCM.1.Z[8RKNP:D :3MX-F*OMIYG7Y=#'OZQSN6^7
MRVO PV#KJ>:C&R::,+[-Z)8*I4/D7(68:Y^@SZ"OE5<;U4W88$IJ"X"E&^\D
MP:8)TD>(,/D&Z?U1YGSQ<9$YZD$GZ;+F4+WS\7,(;*4&84@(5E93 QC<6P!T
MM]/N)G^\\M,II)??;^]!;W[PD6 M Q)RY(3YS$7T^/?='B##/"'J3G(K]TC5
M<7I.53: W"WYK=V/V]DSCT)W]&:#S9I8;[Q(60-GU6>@'J"EE53ND#;Q=.$W
M **]>^:7/V 1)TM8<W;WS;N-PAX]M#"&N" U\<J"Q-T"?K=1[3!&[RE"6\FR
MG,?4555; ]A<RVOCYKZ^7D=9&&O-T\;]_15^7W_KL=EVD02C.*&@5*2.1@6V
MMKGK1-G(W;L&-'[U%=,"W+;"J@,V_:9!)H;TZ,SBYM$I966D2_4/U$/$C-SQ
M:T!051%_ SC:>CVT,;SOKU?+E9^E,IL.%E>[+H*WF5A-!1'!>BIU=-'5AM-3
M-(W=)&PX6%751@/H^K"81X"T+",HRV;QLW+6;_6&>=SY+!)G B=:E,%$,JMH
M:I^'3Q+5#5\_XA5#77TT +"'=51O9_C)L%Q]]"M8/S](:)9C4=Z71[$.5X%X
MKSD1$(!)QFU0M5LN=Z>N&^1^I,N(@374'/;>^ @OKN;7L]4N'SIX#*A5)"!%
MYIHKJT7MW.\A6KKAZD>\:J@B_090M&V2=XI;=EFAS!;Y $DR4Z9E.>^'/!QW
MR.F&I1_QSJ"6#L:NNGX1XV)]S;8QLA\6<#6YOGHS7SRH![XA;.]YGR@ZE%9B
MV$L#IRE$// [3G%Z]MK=\/0CY?;/H83&3-:]%UF*_3[?%/OM<L2R(UZF8H[1
M (,S.K/:E4-/4]4-<#]B@K^R1D[&&.([S&LE^_WR$N/@\D<IY/N&,BN1\>H5
MQLC?,1[^#S^]?N0S4D^)9<80P;QV4B<-!BH#K1-AW;#V0V;SJ^NEQ5GMGZZO
MKE!Z\_QI\F4VR9/H9RNT[,7#+"GD^702)["\G60_S[@#OZ)Q_^YGJ4CE:W%*
M>XQPK[E\[\GN@\FBTL#WQ[1L3;]V+GHE"1CAB02!)ZM4AC"74E(4H1AKGT.'
MJ>F=\[^1\/L["7^8%E5LB7E3Y"R2TP8L)0FW&Y%,E!RT302L3]$8$:2MWH&_
M(VWC5N]60LJCVX A%-.&H[>?FY??[UX I1 4@!8D:^/P/$GH5UCGB/:1"FE!
MI-U6LC4\O:?(&KE(?! \//;YJBJG9;QM/1[R+@2-[BMA,C B/54DJ( <RA U
M#<EK6?ME50>RQL5;=2ATA=J)>FD :G<LW+P@2V5:J7!(O@))9"Q%4))%@BY9
M%,"XL[&V&=LAH5$(G:KB/:-#3I5W W!Y<[V835;7"T#1O)G\4;ZZ[2X4N;?>
M.0QM% -T'((EP9F 4I$<DA-,R=KW2H>I&?=-R] @JJ2%!O!T4%+W,;JV*LDL
M+&&!6B(3E\1'Z8FS7$8CHQ:[O4Z'.^C>/>LEZ'#7E*/Z5:>IIF6P_;:$?#U]
M-\F ]E@[ZJ(@,L= 9- 6N?&XDR1C*#66DJ[],J #68V>B2<BH2O03E3+CYM&
M^[64/:TFWV#PC-FCE<Z4'#O.X?!Y,*X3Y49I@J<KGKJ"6?3^(Y 01!#,>$B^
M=II\N#S8VZNO?K(H.V5SQ_&NO.MZL5S":OD_8)K>S!>X@RYR8!C7)$X$%08=
MC:B09971UY1.!_0[#-3VRSH1UFP&[#D8V;5E]572HC5[@SRNKS?^#GZ)SF?A
M=ROO???M#>-^EMY-?)A,UP^Y;GXEK5\B7B]*(?I+OYPL>YB\(<GI;1?/)JM*
MQO..H->399S.R_KW6\-(*[B3M%QDH3\IO24VJ$0$RRG2C'M#U1Z]=HR>WM'L
M[6>__/[23\ME\:=+@-7?%O/KKZ72>-,I10OJ#$\D4.Z*_T&)-SX0QX2S5DH9
M4^TCHPM=XYK/:BAY%-K65DD#<<<63W=?_H\)+)"HR^_OX!M,UYE)/%Y\%$H2
M!4QAL.8$P?-&DW(:**&SCK)VE5LWRAJ!6C5$'(9<+?6T!+KM<^<Q?S?9*. I
M22H22HTB<U%XXKGA)&)8IUW6+,?:8>^S"&P&@M40<@B$U=75$A;?SKY>KY9K
MB;';!+C*2>20B.0\XF$1RF25*$FB0H-3S)CJTUR/D-,(SNJ#X!#<>FJD47#Q
M&U8D$P*IE00#KI*6HJ5HN;Q$U!:#.Z^<9-7O) Z3,V[2>%QPG:*11L$E;EA1
MR4'0%)V,'#2*".-YGZ0CAB5/0W!)0NU^"D?(&;>7UKC@.D4C+8%KGU_[9C+#
M?YOXZ?W\(/^UJ'-YGW4/7#/IC"[/] .1-*+#D0Q#2\UL",IDNSM+LF+$<!K-
MC=C X6.),ZBT 0AOLE9[L@'W]81)1,45(SFX6'*=R)"CCKA47G5HL,K7;N+[
M)%&->'EGP<A\2(4U@,#]9?A[&+Q0I:PB*$NT*V+CWI*0,3P#%@+ZM8%17[N0
MH#-Q(U^&U 5%IX<2?374 /0.BNT"!$O&Z4!2*2V42F9BO?3$: "E%6?4U78-
M#Q(S[HD[++3J:.!T*,U7?EIGY,;]I<]163DCI+22\!Q15EQC],0S)9&I3!T(
M6O\P[499*V[=""?J *H;^_WT;?N=?1LK&N&BP8VE$VY2*5!*P7%!(@99V@H9
MX^Y#PP,/I8\L,O*TC@$4.A] N@V<@,=%=<&\ NZ9(<)YC/.I<"3PR(BP+,0
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M=IGABAJY#)!]2B&-OJ=XG0WAB0@%5**#+C01X+13P),+DF4;@Z\)MKMUAS6
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MGZ5GR@H!IG3$%)%3<"9[X#)E&XCS+'=ZE7&TBWY0C<:Y;E /T?;SGOA1@F[
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MF3'<$"I[<%(K,(%)+EV6UM;..3XB8%B\].GT'"_GED"RWC\N:"XX1T&$B(+
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M+N]+O1*+[AYS"E [I.(&98=E7A\30.RMM%@\\=6NKWTF;:(^@M$0VB/S>I@
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MAM%3^G4C ^61!#))\)"$;:";+/)X@]U\+-BQS$\Z7\=%7LEN 5E68'D$G9)
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MSI.JCB3->%VI@F,K"QH=K*,U(R@GU]&QN"8%ZUF$;_1D7UQ%42%#\:!RT +
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M0>@ 4@9)UE=!071IO+7MFKJ(OY7__;$)M/6#OL?&7VNC[\W]%U!+ P04
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MA?U0(/."'U""81^#6;ERSU5'F.5CQ)E/.H](FP]K0NM_Y**=$%Y<Z/X82GM
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MP:/D_0]!E-3?5Y="8GZN/9I7=HX(.%]CXMC8Q%O@:V086G($ CL\EQ"+"#I
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M18!D$0OBKC 3Z,/QA_7$[+S8-40#>*"@HV:,,[B7UV95$=165;$P.\09\!!
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M3WURK78Z87;3+5P$.646KB>.5AW_B2;9WSZG2?:WH4GVMR]GDD6:=S94Z\2
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ME=Z?MV?'_\3?GZX^O/_A_P-02P,$%     @ %H-L7$VT.7[A,@  )L   !P
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M_@9VC8K<*@_+0"V<B0;3".T%N,ZBFE$FJA?_0#OR^Q?_0)OR;R_>??_BY_?
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M7;LC%JG([V!A[R;ULX#4UB6Y,%SD7P5';=\@NKMIP9W9*_;1ZRQ!3[9KT&1
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M]X-B;R^_'38L-+6Y2[!T8"FT=)=+)MF1G$!AJXK2[#\5$CDW&_ODWH&B!"<
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MXM[6IKS<J%#<[LP0T]2YF480O!BI;/5U*8<^J8T<?Z8%+\!&.[]!4#V>J*
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M"7S(%9K8U[L8)6(2))LN%B**>1YFFQ1(,PL>@Y%ND>:%1U[*S,8H"+;LJ[E
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M2P$"% ,4    "  6@VQ<E&'N4A</! #6BR  $0              @ $
M86YG;BTR,#(U,3(S,2YH=&U02P$"% ,4    "  6@VQ<M[00I\84  #7]
M$0              @ %&#P0 86YG;BTR,#(U,3(S,2YX<V102P$"% ,4
M"  6@VQ<IO'Y=)X@  "A5@$ %0              @ $[) 0 86YG;BTR,#(U
M,3(S,5]C86PN>&UL4$L! A0#%     @ %H-L7/913=/D90  ?K,$ !4
M         ( !#$4$ &%N9VXM,C R-3$R,S%?9&5F+GAM;%!+ 0(4 Q0    (
M !:#;%S.\?7$>^4  '(2 0 4              "  2.K! !A;F=N+3(P,C4Q
M,C,Q7V<Q+FIP9U!+ 0(4 Q0    ( !:#;%P/PE F*MH! $WX 0 4
M      "  ="0!0!A;F=N+3(P,C4Q,C,Q7V<R+FIP9U!+ 0(4 Q0    ( !:#
M;%R9:HOW02\! $#S"P 5              "  2QK!P!A;F=N+3(P,C4Q,C,Q
M7VQA8BYX;6Q02P$"% ,4    "  6@VQ<&]$RT8C   ![)PD %0
M    @ &@F@@ 86YG;BTR,#(U,3(S,5]P<F4N>&UL4$L! A0#%     @ %H-L
M7.\GWI00#   /B<  !P              ( !6UL) &5L:6-I;RUA<FYO;GAE
M;7!L;WEE961I<BYH=&U02P$"% ,4    "  6@VQ<135="R@#  "$!0  '
M            @ &E9PD 96QI8VEO+6)T8V]N<V5N=#(P,C4Q,'AK+FAT;5!+
M 0(4 Q0    ( !:#;%ROV%) I 8  ,H0   <              "  0=K"0!E
M;&EC:6\M97AH:6)I=#,Q,3(P,C4Q,'@N:'1M4$L! A0#%     @ %H-L7*K#
MK'BQ!@  #1$  !P              ( !Y7$) &5L:6-I;RUE>&AI8FET,S$R
M,C R-3$P>"YH=&U02P$"% ,4    "  6@VQ<ME!T#5@#  #6!0  '
M        @ '0> D 96QI8VEO+65X:&EB:70S,C$R,#(U,3!X+FAT;5!+ 0(4
M Q0    ( !:#;%RDK"3$;0,  !$&   <              "  6)\"0!E;&EC
M:6\M97AH:6)I=#,R,C(P,C4Q,'@N:'1M4$L! A0#%     @ %H-L7+2@OZ'^
M)P  Z(@  !P              ( !"8 ) &5L:6-I;RUI;G-I9&5R=')A9&EN
M9V-O;2YH=&U02P$"% ,4    "  6@VQ<3;0Y?N$R   FP   '
M    @ %!J D 96QI8VEO,C R,65M<&QO>65E<W1O8VMP+FAT;5!+ 0(4 Q0
M   ( !:#;%R,1J$N8 4  "T.   <              "  5S;"0!E;'1X+7!O
K=V5R;V9A='1O<FYE>3(P,C4N:'1M4$L%!@     1 !$ J 0  /;@"0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>angn-20251231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:angn="http://www.angn.com/20251231"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="angn-20251231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2026-03-10</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:A2024RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:JulySharesAndJulyCommonWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFJuly2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2024PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:A2024PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-01-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-01</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">angn:GKCCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">angn:EmployeeBenefitPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyAndJayVenkatesanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:July2024PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:A2024ATMProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-11</startDate>
            <endDate>2026-03-11</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="agreement">
        <measure>angn:agreement</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="entity">
        <measure>angn:entity</measure>
    </unit>
    <dei:SecurityExchangeName contextRef="c-1" id="f-36">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-37">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-38">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-39">0001601485</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-40">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-39990</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">Elicio Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">11-3430072</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">451 D Street, 5th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">02210</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">209-0050</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, par value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">ELTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-26">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-27">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-28">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-29">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-5" id="f-30" unitRef="usd">81800000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-31" unitRef="shares">18396074</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-32">&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the registrant&#x2019;s definitive proxy statement relating to the 2026 Annual Meeting of Stockholders (the &#x201c;Proxy Statement&#x201d;) is filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, then portions of the Proxy Statement will be incorporated by reference into Part III of this Annual Report on Form 10-K. If the Proxy Statement is not filed within such 120-day period, then the registrant will file an amendment to this Annual Report (the &#x201c;Form 10-K/A&#x201d;) within such 120-day period that will contain the information required to be included or incorporated by reference into Part III of this Annual Report.&lt;/span&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName contextRef="c-1" id="f-33">Baker Tilly US, LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-34">Tewksbury, Massachusetts</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="c-1" id="f-35">23</dei:AuditorFirmId>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-41">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We recognize the critical importance of protecting the confidentiality, integrity and availability of our business operations and systems. With this in mind, we have implemented and maintain ongoing cybersecurity risk management practices, in accordance with our risk profile and business size, under the oversight of our Audit Committee that are designed to identify, assess, and mitigate cybersecurity risk. Our cybersecurity program is informed by the National Institute of Standards and Technology Cybersecurity Framework, and other applicable industry standards. We engage third-party service providers and vendors to assist us in managing our cybersecurity programs and information technology systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Cybersecurity Risk Management and Strategy; Effect of Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;To identify and assess material risks from cybersecurity threats, we maintain a cybersecurity program to develop and implement effective systems and prepare for information security risks. We consider risks from cybersecurity threats alongside other company risks as part of our overall risk assessment process. We employ a range of tools and services supported by our third-party service providers, including regular network and endpoint monitoring to inform our risk identification and assessment, as well as undertaking the following activities: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;monitor emerging data protection laws and implement changes to our processes that are designed to comply with such laws;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;through our policies, practices and contracts (as applicable), require employees, as well as third parties that provide services on our behalf, to treat confidential information and data with care;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;employ technical safeguards that are designed to protect our information systems from cybersecurity threats, including firewalls, device encryption, multi-factor authentication, advanced threat protection for emails, anti-virus and anti-malware functionality and access controls, which are evaluated and improved from time to time;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;employ multiple backup systems for our data stored on our servers or other information systems with backup data stored in secure, offsite locations;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;perform annual phishing tests with employees in an effort to deter and detect cyber threats; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;hold and maintain third-party cyber-liability insurance coverage, covering security and privacy matters, commensurate with industry standards for a company of our size and stage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We face risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. During the reporting period, we have not identified any risks from cybersecurity threats, including as a result of previous cyber security incidents, that we believe have materially affected, or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition. For more information, see the section in our Risk Factors in this Annual Report on Form 10-K under the heading &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Our internal information technology systems, or those of our vendors, collaborators or other contractors or consultants, may fail or suffer cybersecurity incidents, loss of data, and other disruptions, which could result in a material disruption of our product development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x201d; which disclosures are incorporated by reference herein.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-42">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We recognize the critical importance of protecting the confidentiality, integrity and availability of our business operations and systems. With this in mind, we have implemented and maintain ongoing cybersecurity risk management practices, in accordance with our risk profile and business size, under the oversight of our Audit Committee that are designed to identify, assess, and mitigate cybersecurity risk. Our cybersecurity program is informed by the National Institute of Standards and Technology Cybersecurity Framework, and other applicable industry standards. We engage third-party service providers and vendors to assist us in managing our cybersecurity programs and information technology systems.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-43">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-44">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-45">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-46">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-48">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our board of directors considers cybersecurity risks as part of its risk oversight function and has delegated the oversight of cybersecurity and other information technology risks to our Audit Committee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our General Counsel who manages our contracted third-party managed security service provider. Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above. Our legal, finance, and operations teams oversee and review any reports of cybersecurity risks or breaches provided by our third-party managed security service provider. Additionally, our legal, finance, and operations teams review and assess potential &lt;/span&gt;&lt;/div&gt;improvements to our cybersecurity policies and procedures with input from third-party vendors and professional services firms, as appropriate. As discussed above, the General Counsel reports to the Audit Committee of our board of directors about cybersecurity related matters, periodically.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-47">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our board of directors considers cybersecurity risks as part of its risk oversight function and has delegated the oversight of cybersecurity and other information technology risks to our Audit Committee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our General Counsel who manages our contracted third-party managed security service provider. Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above. Our legal, finance, and operations teams oversee and review any reports of cybersecurity risks or breaches provided by our third-party managed security service provider. Additionally, our legal, finance, and operations teams review and assess potential &lt;/span&gt;&lt;/div&gt;improvements to our cybersecurity policies and procedures with input from third-party vendors and professional services firms, as appropriate. As discussed above, the General Counsel reports to the Audit Committee of our board of directors about cybersecurity related matters, periodically.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-49">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our board of directors considers cybersecurity risks as part of its risk oversight function and has delegated the oversight of cybersecurity and other information technology risks to our Audit Committee.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-50">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-51">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our General Counsel who manages our contracted third-party managed security service provider. Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above. Our legal, finance, and operations teams oversee and review any reports of cybersecurity risks or breaches provided by our third-party managed security service provider. Additionally, our legal, finance, and operations teams review and assess potential &lt;/span&gt;&lt;/div&gt;improvements to our cybersecurity policies and procedures with input from third-party vendors and professional services firms, as appropriate. As discussed above, the General Counsel reports to the Audit Committee of our board of directors about cybersecurity related matters, periodically.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-52">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Audit Committee receives periodic updates from our General Counsel regarding our cybersecurity program and risks, including, as necessary, any material cybersecurity threat risks or incidents, as well as the steps management has taken to respond to such risks. Members of our Audit Committee are also encouraged to engage in conversations with management on cybersecurity-related news events, including any updates to applicable regulatory requirements and industry standards, and discuss our ongoing or any proposed updates to our cybersecurity risk management and strategy programs. The Audit Committee reports to the full board of directors regarding its activities and risk management functions, including those related to cybersecurity.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-53">Our cybersecurity program, which is discussed in greater detail above, is overseen by certain members of our management team, including our General Counsel who manages our contracted third-party managed security service provider.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-54">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-55">Our third-party managed security service provider has over 25 years of experience in cybersecurity and is informed about and monitors our cybersecurity risk through participation in the cybersecurity risk management and strategy processes described above.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <dei:AuditorName contextRef="c-1" id="f-56">Baker Tilly US, LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-57">Tewksbury, Massachusetts</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">18563000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-59" unitRef="usd">17618000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-5" decimals="-3" id="f-61" unitRef="usd">1178000</us-gaap:RestrictedCashCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">748000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-63" unitRef="usd">1897000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">19311000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-65" unitRef="usd">20693000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">295000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-67" unitRef="usd">483000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-68" unitRef="usd">4782000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-69" unitRef="usd">5706000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-70" unitRef="usd">704000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-71" unitRef="usd">696000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">770000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-5" decimals="-3" id="f-73" unitRef="usd">600000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">25862000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-75" unitRef="usd">28178000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">672000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-77" unitRef="usd">1038000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">6427000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-79" unitRef="usd">8415000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-81" unitRef="usd">1169000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">1011000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-83" unitRef="usd">901000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">8110000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-85" unitRef="usd">11523000</us-gaap:LiabilitiesCurrent>
    <angn:WarrantLiability contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">2615000</angn:WarrantLiability>
    <angn:WarrantLiability contextRef="c-5" decimals="-3" id="f-87" unitRef="usd">2828000</angn:WarrantLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">4094000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-89" unitRef="usd">5105000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-90" unitRef="usd">9407000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-91" unitRef="usd">20034000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-92" unitRef="usd">24226000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-93" unitRef="usd">39490000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-94" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-95" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-96"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-97"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-98" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-99" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-100" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-101" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-102" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-103" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-104" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="-3" id="f-105" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-106"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-107"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-108" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-109" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-110" unitRef="shares">17814762</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-111" unitRef="shares">11043837</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-112" unitRef="shares">17800307</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-113" unitRef="shares">11029382</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-114" unitRef="usd">178000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-115" unitRef="usd">110000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="INF" id="f-116" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-117" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-3" id="f-118" unitRef="usd">150000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-5" decimals="-3" id="f-119" unitRef="usd">150000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-120" unitRef="usd">235407000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">183004000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-122" unitRef="usd">-127000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-123" unitRef="usd">-175000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-124" unitRef="usd">-233672000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-125" unitRef="usd">-194101000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-126" unitRef="usd">1636000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-127" unitRef="usd">-11312000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-128" unitRef="usd">25862000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-129" unitRef="usd">28178000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-130" unitRef="usd">24903000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-131" unitRef="usd">33656000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">12811000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-133" unitRef="usd">11330000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-134" unitRef="usd">37714000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-6" decimals="-3" id="f-135" unitRef="usd">44986000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-136" unitRef="usd">-37714000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-137" unitRef="usd">-44986000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">1915000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-6" decimals="-3" id="f-139" unitRef="usd">3886000</us-gaap:FairValueAdjustmentOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-140" unitRef="usd">0</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-6" decimals="-3" id="f-141" unitRef="usd">-3502000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-1" decimals="-3" id="f-142" unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-6" decimals="-3" id="f-143" unitRef="usd">3000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-6" decimals="-3" id="f-145" unitRef="usd">151000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <angn:GrantRevenueNonoperating contextRef="c-1" decimals="-3" id="f-146" unitRef="usd">415000</angn:GrantRevenueNonoperating>
    <angn:GrantRevenueNonoperating contextRef="c-6" decimals="-3" id="f-147" unitRef="usd">0</angn:GrantRevenueNonoperating>
    <us-gaap:InterestIncomeOperatingAndNonoperating contextRef="c-1" decimals="-3" id="f-148" unitRef="usd">776000</us-gaap:InterestIncomeOperatingAndNonoperating>
    <us-gaap:InterestIncomeOperatingAndNonoperating contextRef="c-6" decimals="-3" id="f-149" unitRef="usd">777000</us-gaap:InterestIncomeOperatingAndNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-150" unitRef="usd">1133000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-6" decimals="-3" id="f-151" unitRef="usd">455000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-152" unitRef="usd">-1857000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-153" unitRef="usd">-6912000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-154" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-155" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">-39571000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-157" unitRef="usd">-51898000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-158" unitRef="usd">48000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-159" unitRef="usd">22000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">-39523000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-161" unitRef="usd">-51876000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-162"
      unitRef="usdPerShare">-2.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-163"
      unitRef="usdPerShare">-2.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-164"
      unitRef="usdPerShare">-4.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-165"
      unitRef="usdPerShare">-4.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-166" unitRef="shares">15312751</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-167" unitRef="shares">15312751</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-168" unitRef="shares">12202996</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-169" unitRef="shares">12202996</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-170" unitRef="shares">11043837</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-171" unitRef="usd">110000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-8" decimals="INF" id="f-172" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-173" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-174" unitRef="usd">183004000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-175" unitRef="usd">-175000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-176" unitRef="usd">-194101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-177" unitRef="usd">-11312000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-12"
      decimals="INF"
      id="f-178"
      unitRef="shares">32515</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-13" decimals="-3" id="f-179" unitRef="usd">149000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-180" unitRef="usd">149000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-14" decimals="-5" id="f-181" unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-15"
      decimals="INF"
      id="f-182"
      unitRef="shares">1717507</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-15" decimals="-3" id="f-183" unitRef="usd">17000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-16" decimals="-3" id="f-184" unitRef="usd">16227000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-14" decimals="-3" id="f-185" unitRef="usd">16244000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-17" decimals="-5" id="f-186" unitRef="usd">800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-18"
      decimals="INF"
      id="f-187"
      unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-18" decimals="-3" id="f-188" unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-19" decimals="-3" id="f-189" unitRef="usd">9130000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-17" decimals="-3" id="f-190" unitRef="usd">9143000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <angn:StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants
      contextRef="c-12"
      decimals="INF"
      id="f-191"
      unitRef="shares">258500</angn:StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-12" decimals="-3" id="f-192" unitRef="usd">3000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-13" decimals="-3" id="f-193" unitRef="usd">3418000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-1" decimals="-3" id="f-194" unitRef="usd">3421000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-5" id="f-195" unitRef="usd">300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-20"
      decimals="INF"
      id="f-196"
      unitRef="shares">3500573</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-20" decimals="-3" id="f-197" unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-21" decimals="-3" id="f-198" unitRef="usd">20141000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-22" decimals="-3" id="f-199" unitRef="usd">20176000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-13" decimals="-3" id="f-200" unitRef="usd">641000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-1" decimals="-3" id="f-201" unitRef="usd">641000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-3" id="f-202" unitRef="usd">2697000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-203" unitRef="usd">2697000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-23" decimals="-3" id="f-204" unitRef="usd">48000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-205" unitRef="usd">48000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-24" decimals="-3" id="f-206" unitRef="usd">-39571000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-207" unitRef="usd">-39571000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-25"
      decimals="INF"
      id="f-208"
      unitRef="shares">17814762</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-209" unitRef="usd">178000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-26"
      decimals="INF"
      id="f-210"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-211" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-212" unitRef="usd">235407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-213" unitRef="usd">-127000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-214" unitRef="usd">-233672000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-215" unitRef="usd">1636000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-30"
      decimals="INF"
      id="f-216"
      unitRef="shares">9618178</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-217" unitRef="usd">96000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-31"
      decimals="INF"
      id="f-218"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-219" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-220" unitRef="usd">153827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-221" unitRef="usd">-197000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-222" unitRef="usd">-142203000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-223" unitRef="usd">11373000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-36" decimals="-3" id="f-224" unitRef="usd">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-37"
      decimals="INF"
      id="f-225"
      unitRef="shares">703974</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-37" decimals="-3" id="f-226" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-38" decimals="-3" id="f-227" unitRef="usd">5628000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-36" decimals="-3" id="f-228" unitRef="usd">5635000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-39"
      decimals="INF"
      id="f-229"
      unitRef="shares">9757</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-39" decimals="-3" id="f-230" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-40" decimals="-3" id="f-231" unitRef="usd">39000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-6" decimals="-3" id="f-232" unitRef="usd">39000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-39"
      decimals="INF"
      id="f-233"
      unitRef="shares">1928</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-39" decimals="-3" id="f-234" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-40" decimals="-3" id="f-235" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-6" decimals="-3" id="f-236" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-41" decimals="-3" id="f-237" unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-42"
      decimals="INF"
      id="f-238"
      unitRef="shares">510000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-42" decimals="-3" id="f-239" unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-43" decimals="-3" id="f-240" unitRef="usd">1075000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-41" decimals="-3" id="f-241" unitRef="usd">1080000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <angn:StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants
      contextRef="c-39"
      decimals="INF"
      id="f-242"
      unitRef="shares">200000</angn:StockAndWarrantsIssuedDuringPeriodSharePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-39" decimals="-3" id="f-243" unitRef="usd">2000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-40" decimals="-3" id="f-244" unitRef="usd">1014000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-6" decimals="-3" id="f-245" unitRef="usd">1016000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <angn:ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants contextRef="c-40" decimals="-3" id="f-246" unitRef="usd">19944000</angn:ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants>
    <angn:ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants contextRef="c-6" decimals="-3" id="f-247" unitRef="usd">19944000</angn:ReclassLiabilityClassifiedWarrantsToEquityClassifiedWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-40" decimals="-3" id="f-248" unitRef="usd">1452000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-249" unitRef="usd">1452000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-44" decimals="-3" id="f-250" unitRef="usd">22000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-251" unitRef="usd">22000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-45" decimals="-3" id="f-252" unitRef="usd">-51898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-253" unitRef="usd">-51898000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-254" unitRef="shares">11043837</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-255" unitRef="usd">110000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-8" decimals="INF" id="f-256" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-257" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-258" unitRef="usd">183004000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-259" unitRef="usd">-175000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-260" unitRef="usd">-194101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-261" unitRef="usd">-11312000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-262" unitRef="usd">-39571000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-263" unitRef="usd">-51898000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-264" unitRef="usd">204000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-3" id="f-265" unitRef="usd">321000</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-266" unitRef="usd">924000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-6" decimals="-3" id="f-267" unitRef="usd">857000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-1" decimals="-3" id="f-268" unitRef="usd">217000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-6" decimals="-3" id="f-269" unitRef="usd">75000</us-gaap:AmortizationOfDebtDiscountPremium>
    <angn:InterestExpenseNoncash contextRef="c-1" decimals="-3" id="f-270" unitRef="usd">107000</angn:InterestExpenseNoncash>
    <angn:InterestExpenseNoncash contextRef="c-6" decimals="-3" id="f-271" unitRef="usd">232000</angn:InterestExpenseNoncash>
    <angn:CostsExpensedUponTheIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-272" unitRef="usd">0</angn:CostsExpensedUponTheIssuanceOfWarrants>
    <angn:CostsExpensedUponTheIssuanceOfWarrants contextRef="c-6" decimals="-3" id="f-273" unitRef="usd">549000</angn:CostsExpensedUponTheIssuanceOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-274" unitRef="usd">1915000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-6" decimals="-3" id="f-275" unitRef="usd">3886000</us-gaap:FairValueAdjustmentOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-276" unitRef="usd">0</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-6" decimals="-3" id="f-277" unitRef="usd">-3502000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-278" unitRef="usd">2697000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-3" id="f-279" unitRef="usd">1452000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-280" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-6" decimals="-3" id="f-281" unitRef="usd">3000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-282" unitRef="usd">-1149000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-6" decimals="-3" id="f-283" unitRef="usd">-835000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-284" unitRef="usd">170000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-6" decimals="-3" id="f-285" unitRef="usd">-2233000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-286" unitRef="usd">-366000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-6" decimals="-3" id="f-287" unitRef="usd">-3331000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-3" id="f-288" unitRef="usd">-1988000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-6" decimals="-3" id="f-289" unitRef="usd">4658000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-290" unitRef="usd">-1169000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-6" decimals="-3" id="f-291" unitRef="usd">475000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-292" unitRef="usd">-901000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-293" unitRef="usd">-911000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-294" unitRef="usd">-36952000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-6" decimals="-3" id="f-295" unitRef="usd">-37068000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-296" unitRef="usd">16000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-297" unitRef="usd">87000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-298" unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-299" unitRef="usd">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">-16000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-6" decimals="-3" id="f-301" unitRef="usd">-84000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-302" unitRef="usd">1293000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-6" decimals="-3" id="f-303" unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-1" decimals="-3" id="f-304" unitRef="usd">9866000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-6" decimals="-3" id="f-305" unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-306" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-6" decimals="-3" id="f-307" unitRef="usd">5985000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <angn:ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering contextRef="c-1" decimals="-3" id="f-308" unitRef="usd">0</angn:ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering>
    <angn:ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering contextRef="c-6" decimals="-3" id="f-309" unitRef="usd">11484000</angn:ProceedsFromIssuanceOfCommonStockWarrantsFromJulyPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-310" unitRef="usd">16244000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-6" decimals="-3" id="f-311" unitRef="usd">4555000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <angn:ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering contextRef="c-1" decimals="-3" id="f-312" unitRef="usd">0</angn:ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering>
    <angn:ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering contextRef="c-6" decimals="-3" id="f-313" unitRef="usd">1080000</angn:ProceedsFromIssuanceOfCommonStockFromJulyPublicOffering>
    <angn:PaymentOfWarrantIssuanceCosts contextRef="c-1" decimals="-3" id="f-314" unitRef="usd">0</angn:PaymentOfWarrantIssuanceCosts>
    <angn:PaymentOfWarrantIssuanceCosts contextRef="c-6" decimals="-3" id="f-315" unitRef="usd">549000</angn:PaymentOfWarrantIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c-1" decimals="-3" id="f-316" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c-6" decimals="-3" id="f-317" unitRef="usd">19727000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-1" decimals="-3" id="f-318" unitRef="usd">9143000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-6" decimals="-3" id="f-319" unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-320" unitRef="usd">149000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-6" decimals="-3" id="f-321" unitRef="usd">39000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-322" unitRef="usd">36695000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-6" decimals="-3" id="f-323" unitRef="usd">42321000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-324" unitRef="usd">48000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-325" unitRef="usd">22000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-326" unitRef="usd">-225000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-6" decimals="-3" id="f-327" unitRef="usd">5191000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-328" unitRef="usd">19492000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-35" decimals="-3" id="f-329" unitRef="usd">14301000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-330" unitRef="usd">19267000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-331" unitRef="usd">19492000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-332" unitRef="usd">18563000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-333" unitRef="usd">17618000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-4" decimals="-3" id="f-334" unitRef="usd">704000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-5" decimals="-3" id="f-335" unitRef="usd">1874000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-336" unitRef="usd">19267000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-337" unitRef="usd">19492000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <angn:FairValueOfPreFundedWarrants contextRef="c-1" decimals="-3" id="f-338" unitRef="usd">0</angn:FairValueOfPreFundedWarrants>
    <angn:FairValueOfPreFundedWarrants contextRef="c-6" decimals="-3" id="f-339" unitRef="usd">13382000</angn:FairValueOfPreFundedWarrants>
    <angn:FairValueOfCommonStockWarrants contextRef="c-1" decimals="-3" id="f-340" unitRef="usd">0</angn:FairValueOfCommonStockWarrants>
    <angn:FairValueOfCommonStockWarrants contextRef="c-6" decimals="-3" id="f-341" unitRef="usd">6509000</angn:FairValueOfCommonStockWarrants>
    <angn:FairValueOfCommonStockWarrantsUponSettlement contextRef="c-1" decimals="-3" id="f-342" unitRef="usd">2126000</angn:FairValueOfCommonStockWarrantsUponSettlement>
    <angn:FairValueOfCommonStockWarrantsUponSettlement contextRef="c-6" decimals="-3" id="f-343" unitRef="usd">0</angn:FairValueOfCommonStockWarrantsUponSettlement>
    <angn:AccretionOfPromissoryNoteToFaceValue contextRef="c-1" decimals="-3" id="f-344" unitRef="usd">0</angn:AccretionOfPromissoryNoteToFaceValue>
    <angn:AccretionOfPromissoryNoteToFaceValue contextRef="c-6" decimals="-3" id="f-345" unitRef="usd">26000</angn:AccretionOfPromissoryNoteToFaceValue>
    <angn:WarrantIssuedStockIssuance contextRef="c-1" decimals="-3" id="f-346" unitRef="usd">9719000</angn:WarrantIssuedStockIssuance>
    <angn:WarrantIssuedStockIssuance contextRef="c-6" decimals="-3" id="f-347" unitRef="usd">0</angn:WarrantIssuedStockIssuance>
    <angn:WarrantIssuedDebtIssuance contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">641000</angn:WarrantIssuedDebtIssuance>
    <angn:WarrantIssuedDebtIssuance contextRef="c-6" decimals="-3" id="f-349" unitRef="usd">0</angn:WarrantIssuedDebtIssuance>
    <angn:VestingOfRestrictedCommonStockNoncash contextRef="c-1" decimals="-3" id="f-350" unitRef="usd">0</angn:VestingOfRestrictedCommonStockNoncash>
    <angn:VestingOfRestrictedCommonStockNoncash contextRef="c-6" decimals="-3" id="f-351" unitRef="usd">25000</angn:VestingOfRestrictedCommonStockNoncash>
    <us-gaap:ConversionOfStockAmountIssued1 contextRef="c-1" decimals="-3" id="f-352" unitRef="usd">20176000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1 contextRef="c-6" decimals="-3" id="f-353" unitRef="usd">0</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-354">Description of the Business and Financial Condition&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Elicio Therapeutics, Inc. (&#x201c;Elicio&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic, colorectal cancer, lung cancer and other mKRAS positive cancers. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#x201c;ESC&#x201d;), an investment company, Elicio Operating Company, Inc. (&#x201c;Former Elicio&#x201d;) and Elicio Australia Pty Ltd. (&#x201c;Elicio Pty&#x201d;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#x201c;Elicio&#x201d; throughout these consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Liquidity and Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has experienced net losses and negative cash flows from operating activities since inception. As of December&#160;31, 2025, the Company had an accumulated deficit of $233.7&#160;million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. Our sources of liquidity for the years ended December&#160;31, 2025 and 2024 are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;At-The-Market Equity Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In May 2022, the Company filed a registration statement on Form S-3 (the &#x201c;Prior Shelf Registration St&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;atement&#x201d;) with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $100 million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp;amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $21 million of shares of common stock from time to time in &#x201c;at-the-market&#x201d; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#x201c;2022 ATM Program"). During the year ended December&#160;31, 2024, the Company issued and sold a total of 650,179 shares of common stock under the 2022 ATM Program for aggregate net proceeds of $5.4 million after deducting sales commissions. In May 2024, the Company terminated the 2022 ATM Program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2024, the Company filed a registration statement on Form S-3 (the &#x201c;2024 Registration Statement&#x201d;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, the Company entered into the Capital on Demand&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; Sales Agreement with JonesTrading Institutional Services, LLC, as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#x201c;at-the-market&#x201d; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#x201c;2024 ATM Program&#x201d; and, collectively with the 2022 ATM Program, the &#x201c;ATM Programs&#x201d;). During the year ended December&#160;31, 2025, the Company issued and sold 1,717,507 shares of common stock for net proceeds of $16.2 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;under the 2024 ATM Program. During the year ended December&#160;31, 2024, the Company issued and sold 53,795 shares of common stock for net proceeds of $0.3 million under the 2024 ATM Program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2024, the Company entered into a subscription agreement (the &#x201c;March Subscription Agreement&#x201d;) with GKCC, LLC (&#x201c;GKCC&#x201d;), an entity controlled by a member of Elicio&#x2019;s board of directors, providing for the issuance and sale by Elicio to GKCC of pre-funded warrants (the &#x201c;March 2024 Pre-Funded Warrants&#x201d;) to purchase up to 1,032,702 shares of common stock, at a purchase price per March 2024 Pre-Funded Warrant of $5.81 (the &#x201c;March 2024 Offering&#x201d;). Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds from the March 2024 Offering were $6.0&#160;million. Refer to Note 8 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Public Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2024, the Company closed an underwritten public offering (the &#x201c;July 2024 Public Offering&#x201d;), consisting of (i) 500,000 shares of common stock (the &#x201c;July 2024 Shares&#x201d;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#x201c;July 2024 Pre-Funded Warrants&#x201d;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock, (the &#x201c;July 2024 Common Warrants&#x201d;). Each July 2024 Pre-Funded Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable and will expire five years from the issuance date. The net proceeds from the July 2024 Public Offering were $10.9&#160;million after deducting commissions and other transaction costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The July 2024 Public Offering consisted of the July 2024 Shares or in lieu thereof, the July 2024 Pre-Funded Warrants, and accompanying July 2024 Common Warrants. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $5.00 per July Share and accompanying July 2024 Common Warrant. Each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $4.99 per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant, which represented the combined purchase price per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant less the $0.01 per share exercise price for each such July 2024 Pre-Funded Warrant. The July 2024 Common Warrants have an exercise price of $5.00 per share, are immediately exercisable and will expire five years from the issuance date. Refer to Notes 3 and 8 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#x201c;Investor&#x201d; and, collectively, the &#x201c;Investors&#x201d;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by Elicio directly to the Investors (the &#x201c;January 2025 Offering&#x201d;): (i) an aggregate of 1,261,830 shares of common stock (the &#x201c;January 2025 Shares&#x201d;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#x201c;January 2025 Common Warrants&#x201d;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The January 2025 Offering resulted in net proceeds of $9.2&#160;million after deducting the placement agent&#x2019;s fees and related offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with GKCC pursuant to which the Company issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#x201c;Convertible Note&#x201d;) in the principal amount of $20.0&#160;million (the &#x201c;Convertible Note Financing&#x201d;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7&#160;million from the Convertible Note Financing, after deducting debt issuance costs. In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#x2019;s common stock. In March 2025, the Company issued 3,500,573 shares of common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company entered into a note purchase agreement (the &#x201c;June 2025 Promissory Note Financing&#x201d;) with GKCC pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#x201c;June 2025 Promissory Note&#x201d;) in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of 103,225 shares of common stock (the &#x201c;June 2025 Warrant&#x201d;). The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. The Company received net proceeds of approximately $9.9&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs. Refer to Note 11 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of December&#160;31, 2025, the Company had $18.6&#160;million in cash and cash equivalents. The Company&#x2019;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the consolidated financial statements, raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of its common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it may need to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-355" unitRef="usd">-233700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-46" decimals="-6" id="f-356" unitRef="usd">100000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-47" decimals="-6" id="f-357" unitRef="usd">21000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-48" decimals="0" id="f-358" unitRef="shares">650179</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-48" decimals="-5" id="f-359" unitRef="usd">5400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-49" decimals="-6" id="f-360" unitRef="usd">200000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-50" decimals="-6" id="f-361" unitRef="usd">40000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-51" decimals="0" id="f-362" unitRef="shares">1717507</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-51" decimals="-5" id="f-363" unitRef="usd">16200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-52" decimals="0" id="f-364" unitRef="shares">53795</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-52" decimals="-5" id="f-365" unitRef="usd">300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-53" decimals="0" id="f-366" unitRef="shares">1032702</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-53"
      decimals="2"
      id="f-367"
      unitRef="usdPerShare">5.81</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-53"
      decimals="2"
      id="f-368"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-54" decimals="-5" id="f-369" unitRef="usd">6000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-55" decimals="0" id="f-370" unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-56" decimals="0" id="f-371" unitRef="shares">1800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-57" decimals="0" id="f-372" unitRef="shares">2300000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-58"
      decimals="2"
      id="f-373"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-59"
      decimals="2"
      id="f-374"
      unitRef="usdPerShare">5.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-60" id="f-375">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-55" decimals="-5" id="f-376" unitRef="usd">10900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-59"
      decimals="2"
      id="f-377"
      unitRef="usdPerShare">5.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-61"
      decimals="2"
      id="f-378"
      unitRef="usdPerShare">4.99</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-56"
      decimals="2"
      id="f-379"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-57"
      decimals="INF"
      id="f-380"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-57" id="f-381">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-62" decimals="0" id="f-382" unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-63"
      decimals="INF"
      id="f-383"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-64"
      decimals="3"
      id="f-384"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-64"
      decimals="1"
      id="f-385"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-63" id="f-386">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-65" decimals="-5" id="f-387" unitRef="usd">9200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-66" decimals="2" id="f-388" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-66" decimals="-5" id="f-389" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-66" decimals="2" id="f-390" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-67" decimals="-5" id="f-391" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-68"
      decimals="INF"
      id="f-392"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-66" decimals="-5" id="f-393" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <angn:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-69" decimals="-5" id="f-394" unitRef="usd">300000</angn:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-70" decimals="-5" id="f-395" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-71"
      decimals="INF"
      id="f-396"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-70"
      decimals="2"
      id="f-397"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-70" id="f-398">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-72" decimals="-5" id="f-399" unitRef="usd">9900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-400" unitRef="usd">18600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-401">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), or decision-making group, in deciding how to allocate resources and in assessing performance. The Chief Executive Officer serves as the CODM. The Company operates as a single operating and reportable segment, reflecting the integrated nature of the Company&#x2019;s business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. Significant estimates reflected in these consolidated financial statements include but are not limited to, the accrual of research and development expenses, the valuation of stock-based awards, the valuation of warrants, the valuation of embedded derivatives and convertible debt, and the operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Australian Dollar (&#x201c;AUD&#x201d;) is the functional currency for Elicio Pty. Accordingly, nonmonetary assets and liabilities originally acquired or assumed in other currencies are recorded in AUD at the date they were acquired or assumed. As part of the consolidation process, the Elicio Pty results are translated from AUD into the reporting currency of US Dollars using average rates for profit and loss transactions and applicable spot rates for period-end balances. The effect of translating the Company&#x2019;s functional currency into the Company&#x2019;s reporting currency is reported separately in Accumulated Other Comprehensive Loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Concentrations of Credit Risk and Off-Balance Sheet Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and restricted cash. At times, cash balances deposited at major financial institutions exceed the federally insured limit. The Company regularly monitors the financial condition of the institutions in which it has depository accounts and believes the risk of loss is minimal. The Company has not experienced any losses in such accounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash and cash equivalents are comprised of deposits at major financial banking institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. As of December&#160;31, 2025 and 2024, the Company&#x2019;s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Restricted cash consists of cash securing a collateral letter of credit issued in connection with the Company&#x2019;s facility operating lease and unused funds received from the Company&#x2019;s research grant. See Note 10 for further discussion. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company follows the guidance prescribed by ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The standard provides a consistent definition of fair value that focuses on an exit price which is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a three-level hierarchy for fair value measurements based on the nature of inputs used in the valuation of an asset or liability as of the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 1:&#160;&#160;&#160;&#160;Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 2:&#160;&#160;&#160;&#160;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 3:&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The carrying amounts of financial instruments reflected in the consolidated balance sheets for cash and cash equivalents, non-current restricted cash, accounts payable, and accrued expenses approximate their respective fair values because of the short-term maturity of those financial assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of the asset. Upon sale or retirement, the cost and accumulated depreciation are eliminated from their respective accounts, and the resulting gain or loss is recorded in the consolidated statement of operations and comprehensive loss. Repair and maintenance expenditures are expensed as incurred. Construction in process is not depreciated until the asset is placed into service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.668%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Class&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Shorter of useful life or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company evaluates its long-lived assets, which consist primarily of property and equipment, and ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. During the years ended December&#160;31, 2025 and 2024, no impairments have occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;These deferred costs will be amortized and recognized as additional interest expense over the term of the Company&#x2019;s Convertible Note (as defined below) using the effective interest method. The Company will present debt issuance costs as a direct deduction from the Convertible Note (as defined below) liability on its financial statements. See Note 11 for further discussion of the Company&#x2019;s accounting for its outstanding debt and related issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company accounts for income taxes in accordance with ASC Topic 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. Deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates and laws in effect in the years in which the differences are expected to reverse. A valuation allowance is provided if, based upon the weighted available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, the position will be sustained upon examination. As of December&#160;31, 2025, there were no accruals for interest or penalties related to uncertain tax provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Research and development costs are charged to expense as incurred and consist of expenses incurred in performing research and development activities, including salaries and benefits, materials and supplies, preclinical expenses, stock-based compensation expense, depreciation of equipment, contract services, and other outside expenses. The Company accrues for costs incurred by external service providers, based on estimates of services performed and costs. The Company expenses all &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by the Company&#x2019;s vendors and service providers. Based on the timing of payments to service providers, the Company may also record prepaid expenses for those service providers that will be recognized as expenses in future periods as the related services are rendered. Research and development costs may be offset by research grants and research and development refundable tax rebates received by Elicio Pty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Leases,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASC 842&#x201d;) requires a lessee to recognize a ROU asset and corresponding lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the consolidated statements of operations and comprehensive loss as well as the reduction of the ROU asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on specific facts and circumstances, the existence of an identified asset(s), if any, and the Company&#x2019;s control over the use of the identified asset(s), if applicable. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected lease term. When the interest rate implicit in lease contracts is not readily determinable, the Company will utilize its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has elected to combine lease and non-lease components as a single component. Operating leases are recognized on the consolidated balance sheet as ROU lease assets, current lease liabilities and non-current lease liabilities. Fixed rents are included in the calculation of the lease balances, while variable costs paid for certain operating and pass-through costs are excluded. Lease expense is recognized over the expected term on a straight-line basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Grant Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Not-for-Profit Entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and that the grants are not within the scope of ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company issues stock-based awards to employees and non-employees, generally in the form of stock options. The Company accounts for stock-based awards in accordance with ASC 718,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt; Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which requires all stock-based payments to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period. The Company has elected to account for option forfeitures as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company uses the Black-Scholes option-pricing model (&#x201c;Black-Scholes&#x201d;) to determine the fair value of options granted, which uses as inputs the fair value of the Company&#x2019;s common stock, assumptions the Company makes for the volatility of its common stock, the expected term of its stock options, the risk-free interest rate for a period that approximates the expected term of its stock options and its expected dividend yield. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Compensation cost of awards that contain a performance condition is recognized when success is considered probable during the performance period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Prior to the Merger, there was no public market for Former Elicio&#x2019;s common stock. The estimated fair value of the Company&#x2019;s common stock underlying Former Elicio&#x2019;s stock-based awards was determined by Former Elicio&#x2019;s board of directors as of the grant date of each option grant. To determine the fair value of Former Elicio&#x2019;s common stock underlying option grants, Former Elicio&#x2019;s board of directors considered, among other things, input from management and valuations of Former Elicio's common stock prepared by third-party valuation firms and performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants' Accounting and Valuation Guide, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Valuation of Privately-Held-Company Equity Securities Issued as Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. Following the Merger, the fair value of the Company&#x2019;s common stock is based on the closing stock price on the date of grant as reported on the Nasdaq Capital Market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s common stock warrants are evaluated pursuant to ASC 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASC 480&#x201d;), and ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASC 815&#x201d;). The Company classifies its freestanding warrants as (i) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;liabilities, if the warrant terms allow settlement of the warrant exercise in cash, or (ii) equity, if the warrant terms only allow settlement in shares of common stock. Please refer to Note 8 below for the application to the Company&#x2019;s pre-funded and common warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic net loss per share of the Company&#x2019;s common stock is computed by dividing net loss attributable to the Company&#x2019;s common stockholders by the weighted average number of shares of the Company&#x2019;s common stock and pre-funded warrants outstanding for the period. Pre-funded warrants are considered outstanding for the purposes of computing basic and diluted net loss per share because shares may be issued for little or no additional consideration and are fully vested and exercisable after the original issuance date of the pre-funded warrants. Diluted net loss per share excludes the potential impact of the Company&#x2019;s common stock options, warrants and unvested shares of restricted stock because their effect would be anti-dilutive due to the Company's net loss. Since the Company had net losses for the years ended December&#160;31, 2025 and 2024, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Other Comprehensive Gain (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other comprehensive gain (loss) is defined as a change in equity during a period from foreign exchange transactions and other events and circumstances from non-owner sources. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Adopted Accounting Standards During the Period&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(&#x201c;ASU 2023-09&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Under the new guidance, public business entities (&#x201c;PBEs&#x201d;) are required to disclose an annual tabular effective tax rate reconciliation using both reporting currency amounts and percentages, disaggregated into specified categories as well as the amount of income taxes paid, disaggregated by federal, state and foreign jurisdictions. ASU No. 2023-09 is effective for annual periods beginning after December 15, 2024 and may be applied prospectively or retrospectively. The Company adopted ASU No. 2023-09 on a prospective basis for the year ended December 31, 2025. The Company&#x2019;s adoption of ASU No. 2023-09 did not have a material impact on its consolidated financial statements. The additional required disclosures have been included in Note 12.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, the FASB finalized ASU No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2023-07&#x201d;). ASU 2023-07 requires enhanced disclosures about reportable segments and the CODM. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-07 on January 1, 2024. There was no impact on the Company's reportable segments identified and additional required disclosures have been included in Note 16.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2024-03&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#x2019;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(&#x201c;ASU 2024-04&#x201d;). ASU 2024-04 clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact the adoption of ASU 2024-04 will have on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-402">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-403">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio. All significant intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-404">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), or decision-making group, in deciding how to allocate resources and in assessing performance. The Chief Executive Officer serves as the CODM. The Company operates as a single operating and reportable segment, reflecting the integrated nature of the Company&#x2019;s business.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-405">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. Significant estimates reflected in these consolidated financial statements include but are not limited to, the accrual of research and development expenses, the valuation of stock-based awards, the valuation of warrants, the valuation of embedded derivatives and convertible debt, and the operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liability.</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-406">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Australian Dollar (&#x201c;AUD&#x201d;) is the functional currency for Elicio Pty. Accordingly, nonmonetary assets and liabilities originally acquired or assumed in other currencies are recorded in AUD at the date they were acquired or assumed. As part of the consolidation process, the Elicio Pty results are translated from AUD into the reporting currency of US Dollars using average rates for profit and loss transactions and applicable spot rates for period-end balances. The effect of translating the Company&#x2019;s functional currency into the Company&#x2019;s reporting currency is reported separately in Accumulated Other Comprehensive Loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-407">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Concentrations of Credit Risk and Off-Balance Sheet Risk&lt;/span&gt;&lt;/div&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and restricted cash. At times, cash balances deposited at major financial institutions exceed the federally insured limit. The Company regularly monitors the financial condition of the institutions in which it has depository accounts and believes the risk of loss is minimal. The Company has not experienced any losses in such accounts.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-408">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash and cash equivalents are comprised of deposits at major financial banking institutions and highly liquid investments with an original maturity of three months or less at the date of purchase. As of December&#160;31, 2025 and 2024, the Company&#x2019;s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;Restricted cash consists of cash securing a collateral letter of credit issued in connection with the Company&#x2019;s facility operating lease and unused funds received from the Company&#x2019;s research grant.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-409">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Fair Value Measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company follows the guidance prescribed by ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which establishes a framework for measuring fair value, and expands disclosures about fair value measurements. The standard provides a consistent definition of fair value that focuses on an exit price which is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a three-level hierarchy for fair value measurements based on the nature of inputs used in the valuation of an asset or liability as of the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 1:&#160;&#160;&#160;&#160;Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 2:&#160;&#160;&#160;&#160;Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:76.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Level 3:&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The carrying amounts of financial instruments reflected in the consolidated balance sheets for cash and cash equivalents, non-current restricted cash, accounts payable, and accrued expenses approximate their respective fair values because of the short-term maturity of those financial assets and liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-410">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of the asset. Upon sale or retirement, the cost and accumulated depreciation are eliminated from their respective accounts, and the resulting gain or loss is recorded in the consolidated statement of operations and comprehensive loss. Repair and maintenance expenditures are expensed as incurred. Construction in process is not depreciated until the asset is placed into service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.668%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Class&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Shorter of useful life or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-411">&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.668%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Class&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Shorter of useful life or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-73" id="f-412">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-74" id="f-413">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-414">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;The Company evaluates its long-lived assets, which consist primarily of property and equipment, and ROU assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-6" decimals="INF" id="f-415" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="INF" id="f-416" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:DebtPolicyTextBlock contextRef="c-1" id="f-417">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;These deferred costs will be amortized and recognized as additional interest expense over the term of the Company&#x2019;s Convertible Note (as defined below) using the effective interest method. The Company will present debt issuance costs as a direct deduction from the Convertible Note (as defined below) liability on its financial statements. See Note 11 for further discussion of the Company&#x2019;s accounting for its outstanding debt and related issuance costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-418">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company accounts for income taxes in accordance with ASC Topic 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. Deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates and laws in effect in the years in which the differences are expected to reverse. A valuation allowance is provided if, based upon the weighted available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, the position will be sustained upon examination. As of December&#160;31, 2025, there were no accruals for interest or penalties related to uncertain tax provisions.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-419">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Research and development costs are charged to expense as incurred and consist of expenses incurred in performing research and development activities, including salaries and benefits, materials and supplies, preclinical expenses, stock-based compensation expense, depreciation of equipment, contract services, and other outside expenses. The Company accrues for costs incurred by external service providers, based on estimates of services performed and costs. The Company expenses all &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by the Company&#x2019;s vendors and service providers. Based on the timing of payments to service providers, the Company may also record prepaid expenses for those service providers that will be recognized as expenses in future periods as the related services are rendered. Research and development costs may be offset by research grants and research and development refundable tax rebates received by Elicio Pty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Grant Income&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Not-for-Profit Entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and that the grants are not within the scope of ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Revenue from Contracts with Customers&lt;/span&gt;, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-420">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Leases,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASC 842&#x201d;) requires a lessee to recognize a ROU asset and corresponding lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the consolidated statements of operations and comprehensive loss as well as the reduction of the ROU asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on specific facts and circumstances, the existence of an identified asset(s), if any, and the Company&#x2019;s control over the use of the identified asset(s), if applicable. Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected lease term. When the interest rate implicit in lease contracts is not readily determinable, the Company will utilize its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has elected to combine lease and non-lease components as a single component. Operating leases are recognized on the consolidated balance sheet as ROU lease assets, current lease liabilities and non-current lease liabilities. Fixed rents are included in the calculation of the lease balances, while variable costs paid for certain operating and pass-through costs are excluded. Lease expense is recognized over the expected term on a straight-line basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-421">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company issues stock-based awards to employees and non-employees, generally in the form of stock options. The Company accounts for stock-based awards in accordance with ASC 718,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt; Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which requires all stock-based payments to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period. The Company has elected to account for option forfeitures as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company uses the Black-Scholes option-pricing model (&#x201c;Black-Scholes&#x201d;) to determine the fair value of options granted, which uses as inputs the fair value of the Company&#x2019;s common stock, assumptions the Company makes for the volatility of its common stock, the expected term of its stock options, the risk-free interest rate for a period that approximates the expected term of its stock options and its expected dividend yield. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Compensation cost of awards that contain a performance condition is recognized when success is considered probable during the performance period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Prior to the Merger, there was no public market for Former Elicio&#x2019;s common stock. The estimated fair value of the Company&#x2019;s common stock underlying Former Elicio&#x2019;s stock-based awards was determined by Former Elicio&#x2019;s board of directors as of the grant date of each option grant. To determine the fair value of Former Elicio&#x2019;s common stock underlying option grants, Former Elicio&#x2019;s board of directors considered, among other things, input from management and valuations of Former Elicio's common stock prepared by third-party valuation firms and performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants' Accounting and Valuation Guide, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Valuation of Privately-Held-Company Equity Securities Issued as Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. Following the Merger, the fair value of the Company&#x2019;s common stock is based on the closing stock price on the date of grant as reported on the Nasdaq Capital Market.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-422">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s common stock warrants are evaluated pursuant to ASC 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASC 480&#x201d;), and ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASC 815&#x201d;). The Company classifies its freestanding warrants as (i) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;liabilities, if the warrant terms allow settlement of the warrant exercise in cash, or (ii) equity, if the warrant terms only allow settlement in shares of common stock. Please refer to Note 8 below for the application to the Company&#x2019;s pre-funded and common warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-423">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic net loss per share of the Company&#x2019;s common stock is computed by dividing net loss attributable to the Company&#x2019;s common stockholders by the weighted average number of shares of the Company&#x2019;s common stock and pre-funded warrants outstanding for the period. Pre-funded warrants are considered outstanding for the purposes of computing basic and diluted net loss per share because shares may be issued for little or no additional consideration and are fully vested and exercisable after the original issuance date of the pre-funded warrants. Diluted net loss per share excludes the potential impact of the Company&#x2019;s common stock options, warrants and unvested shares of restricted stock because their effect would be anti-dilutive due to the Company's net loss. Since the Company had net losses for the years ended December&#160;31, 2025 and 2024, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-424">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Other Comprehensive Gain (Loss)&lt;/span&gt;&lt;/div&gt;Other comprehensive gain (loss) is defined as a change in equity during a period from foreign exchange transactions and other events and circumstances from non-owner sources.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-425">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Adopted Accounting Standards During the Period&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(&#x201c;ASU 2023-09&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Under the new guidance, public business entities (&#x201c;PBEs&#x201d;) are required to disclose an annual tabular effective tax rate reconciliation using both reporting currency amounts and percentages, disaggregated into specified categories as well as the amount of income taxes paid, disaggregated by federal, state and foreign jurisdictions. ASU No. 2023-09 is effective for annual periods beginning after December 15, 2024 and may be applied prospectively or retrospectively. The Company adopted ASU No. 2023-09 on a prospective basis for the year ended December 31, 2025. The Company&#x2019;s adoption of ASU No. 2023-09 did not have a material impact on its consolidated financial statements. The additional required disclosures have been included in Note 12.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, the FASB finalized ASU No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2023-07&#x201d;). ASU 2023-07 requires enhanced disclosures about reportable segments and the CODM. The new guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-07 on January 1, 2024. There was no impact on the Company's reportable segments identified and additional required disclosures have been included in Note 16.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2024-03&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ASU 2024-03 requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#x2019;s definition of selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(&#x201c;ASU 2024-04&#x201d;). ASU 2024-04 clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025. The Company is evaluating the potential impact the adoption of ASU 2024-04 will have on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-426">Fair Value Measurements&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Money market funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Money market funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"&gt;___________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in cash, cash equivalents, and restricted cash on the consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash equivalents at December&#160;31, 2025 and 2024 were held in U.S. Treasury securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There were no transfers made among the three levels in the fair value hierarchy during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the warrants assumed in the Merger with Angion (the &#x201c;Angion Warrants&#x201d;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. The following table presents a summary of changes in Level 3 in the fair value of the Company&#x2019;s common stock warrant liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Balance, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Balance, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk free interest rate, and the expected term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the Angion Warrant liabilities was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.422%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Weighted average strike price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Volatility (annual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;67.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Dividend yield (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2024, the Company entered into the March Subscription Agreement with GKCC. The March 2024 Offering provided for the issuance and sale of the March 2024 Pre-Funded Warrants. The Company identified these warrants as liabilities and measured them at fair value on March 19, 2024, and subsequently remeasured the fair value of these warrant liabilities on a quarterly basis. The Company was able to calculate the fair value measurement based on directly observable inputs for the asset from active markets, therefore these warrants were classified as Level 2. At the Company&#x2019;s annual &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;stockholder&#x2019;s meeting in November 2024, the Company obtained stockholder approval (the &#x201c;Stockholder Approval&#x201d;) for GKCC, together with its affiliates, to exceed the 19.99% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;). As a result of the receipt of Stockholder Approval, the March 2024 Pre-Funded Warrants were classified as equity at December 31, 2024 and no longer needed quarterly fair value remeasurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2024, the Company closed the July 2024 Public Offering, consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants, are immediately exercisable and will expire five years from the issuance date. Upon issuance, the Company identified the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Refer to Note 6 and 8 for further discussion. As a result of obtaining the Stockholder Approval in November 2024, the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants held by GKCC, together with its affiliates, met the equity classification requirements under ASC 815. As such, the Company remeasured the July 2024 Common Warrants held by that shareholder at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. The remaining liability classified July 2024 Pre-Funded Warrants were exercised in the fourth quarter of 2024, leaving no remaining liability classified July 2024 Pre-Funded Warrants outstanding as of December 31, 2024. The remaining July 2024 Common Warrants not held by GKCC and its affiliates remain liability classified as of December 31, 2024 and the fair value is remeasured in each reporting period. During the year ended December 31, 2025, there were no changes to the equity classification. The Company will re-assess the liability classification for the remaining July 2024 Common Warrants at each period end. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-427">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Money market funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Money market funds &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"&gt;___________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in cash, cash equivalents, and restricted cash on the consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-75" decimals="-3" id="f-428" unitRef="usd">6245000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-76" decimals="-3" id="f-429" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-77" decimals="-3" id="f-430" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-431" unitRef="usd">6245000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-75" decimals="-3" id="f-432" unitRef="usd">6245000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-76" decimals="-3" id="f-433" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-77" decimals="-3" id="f-434" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-435" unitRef="usd">6245000</us-gaap:AssetsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-75" decimals="-3" id="f-436" unitRef="usd">0</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-76" decimals="-3" id="f-437" unitRef="usd">2614000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-77" decimals="-3" id="f-438" unitRef="usd">1000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-439" unitRef="usd">2615000</angn:WarrantsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-75" decimals="-3" id="f-440" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-76" decimals="-3" id="f-441" unitRef="usd">2614000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-77" decimals="-3" id="f-442" unitRef="usd">1000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-4" decimals="-3" id="f-443" unitRef="usd">2615000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-78" decimals="-3" id="f-444" unitRef="usd">12100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-79" decimals="-3" id="f-445" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-80" decimals="-3" id="f-446" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-447" unitRef="usd">12100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-78" decimals="-3" id="f-448" unitRef="usd">12100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-79" decimals="-3" id="f-449" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-80" decimals="-3" id="f-450" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-451" unitRef="usd">12100000</us-gaap:AssetsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-78" decimals="-3" id="f-452" unitRef="usd">0</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-79" decimals="-3" id="f-453" unitRef="usd">2827000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-80" decimals="-3" id="f-454" unitRef="usd">1000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-455" unitRef="usd">2828000</angn:WarrantsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-78" decimals="-3" id="f-456" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-79" decimals="-3" id="f-457" unitRef="usd">2827000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-80" decimals="-3" id="f-458" unitRef="usd">1000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-5" decimals="-3" id="f-459" unitRef="usd">2828000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-460">The following table presents a summary of changes in Level 3 in the fair value of the Company&#x2019;s common stock warrant liabilities (in thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Balance, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Balance, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-81" decimals="-3" id="f-461" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-82" decimals="-3" id="f-462" unitRef="usd">11000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-83" decimals="-3" id="f-463" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-84" decimals="-3" id="f-464" unitRef="usd">-10000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-85" decimals="-3" id="f-465" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-81" decimals="-3" id="f-466" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-467">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the Angion Warrant liabilities was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.422%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Weighted average strike price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Volatility (annual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;67.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Dividend yield (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-86"
      decimals="2"
      id="f-468"
      unitRef="usdPerShare">76.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-87"
      decimals="2"
      id="f-469"
      unitRef="usdPerShare">76.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-77" id="f-470">P2Y8M12D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-80" id="f-471">P3Y8M12D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-88" decimals="3" id="f-472" unitRef="number">0.676</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-89" decimals="3" id="f-473" unitRef="number">0.749</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-90" decimals="3" id="f-474" unitRef="number">0.038</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-91" decimals="3" id="f-475" unitRef="number">0.044</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-92" decimals="3" id="f-476" unitRef="number">0.000</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-93" decimals="3" id="f-477" unitRef="number">0.000</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <angn:SaleOfStockBeneficialOwnershipLimitationPercentage contextRef="c-4" decimals="INF" id="f-478" unitRef="number">0.1999</angn:SaleOfStockBeneficialOwnershipLimitationPercentage>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-94"
      decimals="2"
      id="f-479"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-95"
      decimals="2"
      id="f-480"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-95" id="f-481">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-482">Balance Sheet Components&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; Prepaid and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Prepaid research and development contract services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Advanced professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Depreciation expense for the years ended December&#160;31, 2025 and 2024 was $0.2 million and $0.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Other long-term prepaid assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $0.8 million and $0.6 million as of December&#160;31, 2025 and December&#160;31, 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Accrued Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accrued professional fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accrued research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="c-1" id="f-483">Prepaid and other current assets consisted of the following (in thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Prepaid research and development contract services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Advanced professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <angn:PrepaidResearchAndDevelopmentExpenses contextRef="c-4" decimals="-3" id="f-484" unitRef="usd">115000</angn:PrepaidResearchAndDevelopmentExpenses>
    <angn:PrepaidResearchAndDevelopmentExpenses contextRef="c-5" decimals="-3" id="f-485" unitRef="usd">1206000</angn:PrepaidResearchAndDevelopmentExpenses>
    <angn:AdvancedProfessionalFees contextRef="c-4" decimals="-3" id="f-486" unitRef="usd">193000</angn:AdvancedProfessionalFees>
    <angn:AdvancedProfessionalFees contextRef="c-5" decimals="-3" id="f-487" unitRef="usd">243000</angn:AdvancedProfessionalFees>
    <us-gaap:PrepaidInsurance contextRef="c-4" decimals="-3" id="f-488" unitRef="usd">367000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-5" decimals="-3" id="f-489" unitRef="usd">347000</us-gaap:PrepaidInsurance>
    <angn:OtherPrepaidExpensesAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-490" unitRef="usd">73000</angn:OtherPrepaidExpensesAndOtherAssetsCurrent>
    <angn:OtherPrepaidExpensesAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-491" unitRef="usd">101000</angn:OtherPrepaidExpensesAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-492" unitRef="usd">748000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-493" unitRef="usd">1897000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-73" decimals="-3" id="f-494" unitRef="usd">1661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-96" decimals="-3" id="f-495" unitRef="usd">1661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-74" decimals="-3" id="f-496" unitRef="usd">258000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-97" decimals="-3" id="f-497" unitRef="usd">242000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-98" decimals="-3" id="f-498" unitRef="usd">132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-99" decimals="-3" id="f-499" unitRef="usd">132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-500" unitRef="usd">2051000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-5" decimals="-3" id="f-501" unitRef="usd">2035000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-502" unitRef="usd">1756000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-503" unitRef="usd">1552000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-504" unitRef="usd">295000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-505" unitRef="usd">483000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-506" unitRef="usd">200000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-5" id="f-507" unitRef="usd">300000</us-gaap:Depreciation>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-4" decimals="-5" id="f-508" unitRef="usd">800000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-5" decimals="-5" id="f-509" unitRef="usd">600000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-510">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accrued professional fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accrued research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-511" unitRef="usd">818000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-5" decimals="-3" id="f-512" unitRef="usd">1167000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-513" unitRef="usd">2528000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-514" unitRef="usd">2312000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <angn:AccruedResearchAndDevelopmentCurrent contextRef="c-4" decimals="-3" id="f-515" unitRef="usd">2298000</angn:AccruedResearchAndDevelopmentCurrent>
    <angn:AccruedResearchAndDevelopmentCurrent contextRef="c-5" decimals="-3" id="f-516" unitRef="usd">4910000</angn:AccruedResearchAndDevelopmentCurrent>
    <angn:AccruedInterest contextRef="c-4" decimals="-3" id="f-517" unitRef="usd">741000</angn:AccruedInterest>
    <angn:AccruedInterest contextRef="c-5" decimals="-3" id="f-518" unitRef="usd">0</angn:AccruedInterest>
    <angn:AccruedOtherOperatingLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-519" unitRef="usd">42000</angn:AccruedOtherOperatingLiabilitiesCurrent>
    <angn:AccruedOtherOperatingLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-520" unitRef="usd">26000</angn:AccruedOtherOperatingLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-521" unitRef="usd">6427000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-522" unitRef="usd">8415000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="c-1" id="f-523">Research Grant&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#x201c;GI&#x201d;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $2.8 million award, $2.3&#160;million was received in September 2022 and the remaining $0.5&#160;million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $0.5&#160;million payment was applied as a credit to the second grant agreement described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $3.1 million, with such amount received net of the $0.5&#160;million credit, described above. During the year ended December&#160;31, 2024, the Company incurred $2.2 million in research and development expenses related to this project and completed the development efforts defined in the second grant agreement in the third quarter of 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $1.5 million. During the years ended December&#160;31, 2025 and 2024, the Company incurred $0.8&#160;million and $0.3&#160;million, respectively, in research and development expenses related to this project, all of which were reimbursed from available grant funds. The third grant agreement activities were completed in the second quarter of 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The award money for the three agreements was recorded as contra-expense to offset the research and development costs incurred. Following completion of the third grant agreement with GI Research Foundation, during 2025, the remaining $0.4&#160;million of the grant funds were recognized as grant income, as there were no further conditions to be met.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-100" decimals="-5" id="f-524" unitRef="usd">2800000</angn:ResearchAndDevelopmentArrangementGrant>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-100" decimals="-5" id="f-525" unitRef="usd">2300000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-101" decimals="-5" id="f-526" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-101" decimals="-5" id="f-527" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-102" decimals="-5" id="f-528" unitRef="usd">3100000</angn:ResearchAndDevelopmentArrangementGrant>
    <angn:ResearchAndDevelopmentArrangementCredit contextRef="c-102" decimals="-5" id="f-529" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementCredit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-103" decimals="-5" id="f-530" unitRef="usd">2200000</us-gaap:ResearchAndDevelopmentExpense>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-104" decimals="-5" id="f-531" unitRef="usd">1500000</angn:ResearchAndDevelopmentArrangementGrant>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-105" decimals="-5" id="f-532" unitRef="usd">800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-106" decimals="-5" id="f-533" unitRef="usd">300000</us-gaap:ResearchAndDevelopmentExpense>
    <angn:NumberOfResearchGrantAgreements
      contextRef="c-4"
      decimals="INF"
      id="f-534"
      unitRef="agreement">3</angn:NumberOfResearchGrantAgreements>
    <angn:GrantRevenueNonoperating contextRef="c-1" decimals="-5" id="f-535" unitRef="usd">400000</angn:GrantRevenueNonoperating>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-536">Common Stock and Stockholders' Equity&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Authorized Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes 300,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;At-The-Market Equity Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the year ended December&#160;31, 2024, the Company issued and sold a total of 650,179 shares of common stock under the 2022 ATM Program for aggregate net proceeds of $5.4 million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the year ended December&#160;31, 2025, the Company issued and sold 1,717,507 shares of common stock for net proceeds of $16.2 million under the 2024 ATM Program. During the year ended December&#160;31, 2024, the Company issued and sold 53,795 shares of common stock for net proceeds of $0.3 million under the 2024 ATM Program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2024, the Company closed the March 2024 Offering, which resulted in net proceeds of $6.0&#160;million. The March 2024 Offering providing for the issuance and sale by the Company to GKCC of the March 2024 Pre-Funded Warrants to purchase up to 1,032,702 shares of common stock, at a purchase price of $5.81. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds to the Company from the March 2024 Offering were $6.0&#160;million. Refer to Note 8 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Public Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2024, the Company closed the July 2024 Public Offering, which resulted in gross proceeds of $11.5 million, with net proceeds of $10.9&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The July 2024 Public Offering consisted of (i) 500,000 July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants exercisable for 1,800,000 shares of common stock, and (iii) the July 2024 Common Warrants to purchase up to 2,300,000 shares of common stock. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $5.00. Each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $4.99, which represented the combined purchase price less the $0.01 per share exercise price for each such July 2024 Pre-Funded Warrant. The July 2024 Common Warrants have an exercise price of $5.00 per share, are immediately exercisable, and will expire five years from the issuance date. Refer to Notes 3 and 8 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell 1,261,830 January 2025 Shares and the January 2025 Common Warrants to purchase up to an aggregate of 1,261,830 shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire 5 years from the issuance date. The January 2025 Offering resulted in gross proceeds of $10.0&#160;million, with net proceeds of $9.2&#160;million to the Company after deducting the placement agent&#x2019;s fees and related offering expenses. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. Refer to Note 8 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into the Securities Purchase Agreement with GKCC pursuant to which the Company issued the 3% Convertible Note in the principal amount of $20.0 million. Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. In March 2025, Elicio exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of Elicio&#x2019;s common stock. In March 2025, the Company issued 3,500,573 shares of common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. Refer to Note 11 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. Refer to Note 11 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-537" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-538"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-539" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-540"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-48" decimals="0" id="f-541" unitRef="shares">650179</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-48" decimals="-5" id="f-542" unitRef="usd">5400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-51" decimals="0" id="f-543" unitRef="shares">1717507</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-51" decimals="-5" id="f-544" unitRef="usd">16200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-52" decimals="0" id="f-545" unitRef="shares">53795</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-52" decimals="-5" id="f-546" unitRef="usd">300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-54" decimals="-5" id="f-547" unitRef="usd">6000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-53" decimals="0" id="f-548" unitRef="shares">1032702</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-53"
      decimals="2"
      id="f-549"
      unitRef="usdPerShare">5.81</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-53"
      decimals="2"
      id="f-550"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-54" decimals="-5" id="f-551" unitRef="usd">6000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c-107" decimals="-5" id="f-552" unitRef="usd">11500000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-55" decimals="-5" id="f-553" unitRef="usd">10900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-55" decimals="0" id="f-554" unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-56" decimals="0" id="f-555" unitRef="shares">1800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-57" decimals="0" id="f-556" unitRef="shares">2300000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-59"
      decimals="2"
      id="f-557"
      unitRef="usdPerShare">5.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-108"
      decimals="2"
      id="f-558"
      unitRef="usdPerShare">4.99</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-109"
      decimals="2"
      id="f-559"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-95"
      decimals="INF"
      id="f-560"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-95" id="f-561">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-62" decimals="0" id="f-562" unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-62" decimals="0" id="f-563" unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-64"
      decimals="3"
      id="f-564"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-64"
      decimals="1"
      id="f-565"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-110" id="f-566">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c-111" decimals="-5" id="f-567" unitRef="usd">10000000.0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-65" decimals="-5" id="f-568" unitRef="usd">9200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-66" decimals="2" id="f-569" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-66" decimals="-5" id="f-570" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-66" decimals="2" id="f-571" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-112" decimals="-5" id="f-572" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-68"
      decimals="INF"
      id="f-573"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-66" decimals="-5" id="f-574" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <angn:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-69" decimals="-5" id="f-575" unitRef="usd">300000</angn:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-70" decimals="INF" id="f-576" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-70"
      decimals="INF"
      id="f-577"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-70"
      decimals="2"
      id="f-578"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-70" id="f-579">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-580">Stock-Based Compensation&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;2012 Plan and 2022 Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As a result of the Merger, the Company assumed the Former Elicio 2012 Equity Incentive Plan and the Former Elicio 2022 Equity Incentive Plan (collectively, the &#x201c;Former Elicio Plans&#x201d;) and all stock options issued and outstanding under the Former Elicio Plans. Each outstanding and unexercised option to purchase Former Elicio&#x2019;s common stock was adjusted with such Company stock options henceforth representing the right to purchase a number of shares of the Company&#x2019;s common stock based on the exchange ratio established for the Merger. Any restriction on the exercise of any Former Elicio stock options assumed by the Company continued in full force and effect and the term, exercisability, vesting schedule, accelerated vesting provisions, and any other provisions of such Former Elicio stock options otherwise remained unchanged. As of December&#160;31, 2025, 177,671 shares remain available for future grants under the Former Elicio 2022 Equity Incentive Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;2015 Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2019, Angion&#x2019;s board of directors approved an Amended and Restated 2015 Equity Incentive Plan (the &#x201c;2015 Plan&#x201d;) permitting the granting of incentive stock options, non-statutory stock options, restricted stock and other stock-based awards. Following the effectiveness of the 2021 Incentive Award Plan (&#x201c;2021 Plan&#x201d;), Angion ceased making grants under the 2015 Plan. However, the 2015 Plan continues to govern the terms and conditions of the outstanding awards granted under it. Shares of common stock subject to awards granted under the 2015 Plan that cease to be subject to such awards by forfeiture or otherwise after the termination of the 2015 Plan will be available for issuance under the 2021 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;2021 Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2021, Angion&#x2019;s board of directors approved the 2021 Plan which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards to employees, directors, officers and consultants. The 2021 Plan provides that the number of shares reserved and available for issuance will automatically increase each January 1st by the lesser of 5% of the Company&#x2019;s common stock outstanding on the immediately preceding December 31st, or such lesser number of shares as determined by the Company&#x2019;s board of directors. The Company has a policy of issuing shares out of respective plan pools (to the extent available) to satisfy share option exercises and restricted stock vesting. As of December&#160;31, 2025, 460,025 shares remain available for future grants under the 2021 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;2024 Inducement Incentive Award Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In February 2024, the Company&#x2019;s board of directors approved the Company&#x2019;s 2024 Inducement Incentive Award Plan (the &#x201c;2024 Inducement Plan&#x201d;) which permits the granting of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock-based awards to employees as an inducement pursuant to Listing Rule 5635(c)(4) of the corporate governance rules of Nasdaq. The 2024 Inducement Plan originally provided for an overall share limit of 500,000 shares of the Company&#x2019;s common stock. As of December&#160;31, 2025, 10,940 shares remain available for future grants under the 2024 Inducement Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information and activity related to the Company&#x2019;s stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Remaining Contractual Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Total &lt;br/&gt;Intrinsic Value &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,890,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;15.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;821,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(32,515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Forfeited (unvested)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(58,406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,621,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;13.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,416,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. The weighted average grant date fair value per share for the stock option grants during the year ended December&#160;31, 2025 was $7.63. As of December&#160;31, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $5.3 million, which the Company expects to recognize over a weighted-average period of approximately 2.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes total stock-based compensation expense recorded in the consolidated statements of operations and comprehensive loss (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#x2019;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.422%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.7% - 4.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.4% - 4.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;100.0% - 110.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;79.5% - 107.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.0 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.0  - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the consolidated financial statements for the year ended December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#x2019;s initial public offering. The offering period and purchase period was determined by Angion&#x2019;s board of directors. No offering periods or purchasing periods were active as of December&#160;31, 2025. As of December&#160;31, 2025, 275,309 shares remained available for purchase under the ESPP, and no offerings w</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-113"
      decimals="INF"
      id="f-581"
      unitRef="shares">177671</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <angn:CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding contextRef="c-114" decimals="2" id="f-582" unitRef="number">0.05</angn:CommonStockCapitalSharesReservedForFutureIssuanceIncreasePercentageOfCommonStockOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-115"
      decimals="INF"
      id="f-583"
      unitRef="shares">460025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <angn:ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit
      contextRef="c-116"
      decimals="INF"
      id="f-584"
      unitRef="shares">500000</angn:ShareBasedCompensationArrangementByShareBasedPaymentAwardShareLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-117"
      decimals="INF"
      id="f-585"
      unitRef="shares">10940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-586">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information and activity related to the Company&#x2019;s stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Remaining Contractual Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Total &lt;br/&gt;Intrinsic Value &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,890,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;15.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;821,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(32,515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Forfeited (unvested)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(58,406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,621,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;13.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,416,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-5" decimals="INF" id="f-587" unitRef="shares">1890932</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-588"
      unitRef="usdPerShare">15.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-6" id="f-589">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-3" id="f-590" unitRef="usd">920000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-591" unitRef="shares">821192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-592"
      unitRef="usdPerShare">7.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-593" unitRef="shares">32515</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-594"
      unitRef="usdPerShare">4.59</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-595" unitRef="shares">58406</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-596"
      unitRef="usdPerShare">6.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="INF" id="f-597" unitRef="shares">2621203</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-598"
      unitRef="usdPerShare">13.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-599">P6Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-600" unitRef="usd">5057000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-4" decimals="INF" id="f-601" unitRef="shares">1416162</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-602"
      unitRef="usdPerShare">19.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-603">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-3" id="f-604" unitRef="usd">3127000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-605"
      unitRef="usdPerShare">7.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-4" decimals="-5" id="f-606" unitRef="usd">5300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-607">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-608">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes total stock-based compensation expense recorded in the consolidated statements of operations and comprehensive loss (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-118" decimals="-3" id="f-609" unitRef="usd">1093000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-119" decimals="-3" id="f-610" unitRef="usd">582000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-120" decimals="-3" id="f-611" unitRef="usd">1604000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-121" decimals="-3" id="f-612" unitRef="usd">870000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-613" unitRef="usd">2697000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-614" unitRef="usd">1452000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-615">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.422%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.7% - 4.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.4% - 4.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;100.0% - 110.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;79.5% - 107.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.0 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.0  - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-122" decimals="4" id="f-616" unitRef="number">0.037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-122" decimals="4" id="f-617" unitRef="number">0.044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-123" decimals="3" id="f-618" unitRef="number">0.034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-123" decimals="3" id="f-619" unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-122" decimals="3" id="f-620" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-123" decimals="3" id="f-621" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-122" decimals="4" id="f-622" unitRef="number">1.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-122" decimals="4" id="f-623" unitRef="number">1.104</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-6" decimals="4" id="f-624" unitRef="number">0.795</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-123" decimals="4" id="f-625" unitRef="number">1.078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-124" id="f-626">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-125" id="f-627">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-126" id="f-628">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-127" id="f-629">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-128"
      decimals="INF"
      id="f-630"
      unitRef="shares">275309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-128"
      decimals="INF"
      id="f-631"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <angn:WarrantsAndRightsOutstandingTextBlock contextRef="c-1" id="f-632">Warrants&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In accordance with ASC Topic 815, certain of the Company&#x2019;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon issuance, the March 2024 Pre-Funded Warrants were liability classified, with a fair value of $6.6&#160;million, as determined by the Black-Scholes option pricing model as of the grant date. The Company recorded the $0.6&#160;million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024. The Company subsequently remeasured the fair value of these warrant liabilities on a quarterly basis. As a result of the receipt of Stockholder Approval in November 2024, as discussed in Note 3, the March 2024 Pre-Funded Warrants were classified as equity at December 31, 2025 and 2024. During the year ended December 31, 2024, the Company recognized a gain of $1.3 million in fair value remeasurement of the March 2024 Pre-Funded Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Notes 3 and 6, in July 2024, the Company closed its July 2024 Public Offering consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Warrant issued and sold in the July 2024 Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon issuance, the July 2024 Pre-Funded Warrants and July 2024 Common Warrants were liability classified, with a fair value of $6.8&#160;million and $6.5&#160;million, respectively, measured using the Black-Scholes option pricing model as of the grant date. The Company recorded the $2.9&#160;million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As a result of the receipt of Stockholder Approval in November 2024, certain July 2024 Pre-Funded Warrants and July 2024 Common Warrants held by GKCC and its affiliates were classified as equity. The remaining liability classified July 2024 Pre-Funded Warrants were exercised in the fourth quarter of 2024, leaving no remaining liability classified July 2024 Pre-Funded Warrants outstanding as of December 31, 2024. The remaining July 2024 Common Warrants not held by GKCC and its affiliates remain liability classified as of December 31, 2024 and the fair value is remeasured in each reporting period. During the year ended December 31, 2025, there were no changes to the equity classification. For the years ended December&#160;31, 2025 and 2024, the Company recognized a loss of $0 and $2.4 million in fair value remeasurement of the July 2024 Pre-Funded Warrants, respectively. For the years ended December&#160;31, 2025 and 2024, the Company recognized a loss of $1.9 million and $2.8 million in fair value remeasurement of the July 2024 Common Warrants, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Note 6, in January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell 1,261,830 January 2025 Shares and the January 2025 Common Warrants to purchase up to an aggregate of 1,261,830 shares of common stock. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the issuance date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $9.7&#160;million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $0.6&#160;million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables summarize information regarding the warrants outstanding and warrant activity at December&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Number of Warrants Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average Remaining Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Elicio Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;144,814&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;53.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Angion Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,950&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;March 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,032,702&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;July 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;441,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;January 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,261,830&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;June 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;103,225&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total Warrants Outstanding at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,188,021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of December 31, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt; During the fourth quarter of 2024, the Company reclassified the March 2024 Pre-Funded Warrants, the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants held by GKCC and its affiliates from liability to equity classification. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.131%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,081,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Issued&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,365,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(258,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,188,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</angn:WarrantsAndRightsOutstandingTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-129"
      decimals="2"
      id="f-633"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:WarrantExercisedFairValue contextRef="c-130" decimals="-5" id="f-634" unitRef="usd">6600000</angn:WarrantExercisedFairValue>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-131" decimals="-5" id="f-635" unitRef="usd">-600000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-132" decimals="-5" id="f-636" unitRef="usd">-1300000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-94"
      decimals="2"
      id="f-637"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-95"
      decimals="2"
      id="f-638"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:WarrantExercisedFairValue contextRef="c-133" decimals="-5" id="f-639" unitRef="usd">6800000</angn:WarrantExercisedFairValue>
    <angn:WarrantExercisedFairValue contextRef="c-134" decimals="-5" id="f-640" unitRef="usd">6500000</angn:WarrantExercisedFairValue>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-135" decimals="-5" id="f-641" unitRef="usd">-2900000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-136" decimals="-5" id="f-642" unitRef="usd">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-137" decimals="-5" id="f-643" unitRef="usd">-2400000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-138" decimals="-5" id="f-644" unitRef="usd">1900000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-139" decimals="-5" id="f-645" unitRef="usd">-2800000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-62" decimals="0" id="f-646" unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-62" decimals="0" id="f-647" unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-140"
      decimals="3"
      id="f-648"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-140"
      decimals="1"
      id="f-649"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-141" id="f-650">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-142" decimals="-5" id="f-651" unitRef="usd">9700000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-70"
      decimals="INF"
      id="f-652"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-70"
      decimals="2"
      id="f-653"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-70" id="f-654">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-143" decimals="-5" id="f-655" unitRef="usd">600000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c-1" id="f-656">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables summarize information regarding the warrants outstanding and warrant activity at December&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Number of Warrants Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average Remaining Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Elicio Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;144,814&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;53.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Angion Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,950&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;March 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,032,702&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;July 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;441,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;January 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,261,830&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;June 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;103,225&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total Warrants Outstanding at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,188,021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of December 31, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt; During the fourth quarter of 2024, the Company reclassified the March 2024 Pre-Funded Warrants, the July 2024 Pre-Funded Warrants and the July 2024 Common Warrants held by GKCC and its affiliates from liability to equity classification. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.131%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Weighted Average Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,081,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Issued&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,365,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(258,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,188,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-144"
      decimals="INF"
      id="f-657"
      unitRef="shares">144814</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-145"
      decimals="2"
      id="f-658"
      unitRef="usdPerShare">53.59</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-146" id="f-659">P3Y6M</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-147"
      decimals="INF"
      id="f-660"
      unitRef="shares">3950</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-148"
      decimals="2"
      id="f-661"
      unitRef="usdPerShare">76.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-149" id="f-662">P2Y8M12D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-150"
      decimals="INF"
      id="f-663"
      unitRef="shares">1032702</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-151"
      decimals="2"
      id="f-664"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-152"
      decimals="INF"
      id="f-665"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-153"
      decimals="2"
      id="f-666"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-154"
      decimals="INF"
      id="f-667"
      unitRef="shares">441500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-155"
      decimals="2"
      id="f-668"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-156" id="f-669">P3Y6M</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-157"
      decimals="INF"
      id="f-670"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-158"
      decimals="2"
      id="f-671"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-159" id="f-672">P3Y6M</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-160"
      decimals="INF"
      id="f-673"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-161"
      decimals="2"
      id="f-674"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-162" id="f-675">P4Y1M6D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-163"
      decimals="INF"
      id="f-676"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-164"
      decimals="2"
      id="f-677"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-165" id="f-678">P4Y4M24D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-4" decimals="INF" id="f-679" unitRef="shares">6188021</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-166"
      decimals="2"
      id="f-680"
      unitRef="usdPerShare">4.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-1" id="f-681">P3Y8M12D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-5" decimals="INF" id="f-682" unitRef="shares">5081466</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-5"
      decimals="INF"
      id="f-683"
      unitRef="usdPerShare">3.85</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageLife contextRef="c-5" id="f-684">P4Y6M</angn:ClassOfWarrantOrRightWeightedAverageLife>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-1" decimals="INF" id="f-685" unitRef="shares">1365055</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-686"
      unitRef="usdPerShare">7.80</angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod>
    <angn:ClassOfWarrantOrRightExercisedInPeriod contextRef="c-1" decimals="INF" id="f-687" unitRef="shares">258500</angn:ClassOfWarrantOrRightExercisedInPeriod>
    <angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-688"
      unitRef="usdPerShare">5.00</angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-4" decimals="INF" id="f-689" unitRef="shares">6188021</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-4"
      decimals="INF"
      id="f-690"
      unitRef="usdPerShare">4.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageLife contextRef="c-4" id="f-691">P3Y8M12D</angn:ClassOfWarrantOrRightWeightedAverageLife>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-692">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Legal Proceedings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company may be exposed to litigation in connection with its products under development and operations. The Company&#x2019;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2016, Former Elicio entered into a license agreement to license certain intellectual property rights from MIT, which agreement has been amended from time to time to add additional intellectual property rights to the Company&#x2019;s license and to adjust fees and milestones and diligence requirements. The Company is required to pay certain license maintenance fees and certain milestone payments upon the occurrence of specific development and commercialization achievements during the term of the agreement, including those related to the making of certain regulatory filings, the initiation of certain clinical trials and the achievement of certain product sales thresholds, and royalty payments based on net sales on certain products over the term of the agreement, with royalty payments commencing in the calendar year of commercialization of such products. Royalty rates range from 0.25% - 2.00%, depending on whether commercial sales relate to a product that is covered by patents under which Elicio licenses rights from MIT or a product that could not have been identified, selected, or determined to have biological activity but for the use or modification of a product covered by the patents, and also on the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions in the agreement. During the year ended December&#160;31, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $0.4&#160;million. No such expenses were recorded during the year ended December&#160;31, 2025. No commercialization royalties have been achieved to date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company would be required to pay a total of up to $26.2&#160;million if all remaining possible clinical development and commercial sales milestones are achieved. The clinical development milestone payments will be recorded when each milestone is achieved, and the commercial sales milestone payments and royalties will be recorded when the sales occur.&lt;/span&gt;&lt;/div&gt;For the years ended December&#160;31, 2025 and 2024, the Company recorded an annual license maintenance fee payment of $0.1&#160;million. Future annual license maintenance fee payments will continue to be $0.1&#160;million and are due until the termination of the agreement.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <angn:RoyaltyRatePercent contextRef="c-167" decimals="4" id="f-693" unitRef="number">0.0025</angn:RoyaltyRatePercent>
    <angn:RoyaltyRatePercent contextRef="c-168" decimals="4" id="f-694" unitRef="number">0.0200</angn:RoyaltyRatePercent>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-169" decimals="-5" id="f-695" unitRef="usd">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-170" decimals="-5" id="f-696" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RoyaltyExpense contextRef="c-171" decimals="-3" id="f-697" unitRef="usd">0</us-gaap:RoyaltyExpense>
    <angn:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct contextRef="c-172" decimals="-5" id="f-698" unitRef="usd">26200000</angn:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct>
    <angn:CollaborativeArrangementFutureMinimumMaintenancePayments contextRef="c-173" decimals="-5" id="f-699" unitRef="usd">100000</angn:CollaborativeArrangementFutureMinimumMaintenancePayments>
    <angn:CollaborativeArrangementFutureMinimumMaintenancePayments contextRef="c-173" decimals="-5" id="f-700" unitRef="usd">100000</angn:CollaborativeArrangementFutureMinimumMaintenancePayments>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-701">Leases&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#x201c;Boston Lease&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $11.1&#160;million in the aggregate. As a result, at the commencement of the Boston Lease, the Company recognized a ROU lease asset of $8.0&#160;million with a corresponding lease liability of $8.0&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $0.7&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the consolidated balance sheets as of December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately 6,157 square feet for approximately $0.2&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Lease expense for all leases for the years ended December&#160;31, 2025 and 2024 was $1.4&#160;million and $1.5&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.229%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Weighted-average remaining lease term&#x2014;operating leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Less present value discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Less: operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating lease liability, noncurrent portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseExpense contextRef="c-174" decimals="-5" id="f-702" unitRef="usd">11100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-175" decimals="-5" id="f-703" unitRef="usd">8000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-175" decimals="-5" id="f-704" unitRef="usd">8000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ProceedsFromSecuredLinesOfCredit contextRef="c-176" decimals="-5" id="f-705" unitRef="usd">700000</us-gaap:ProceedsFromSecuredLinesOfCredit>
    <us-gaap:AreaOfRealEstateProperty contextRef="c-177" decimals="0" id="f-706" unitRef="sqft">6157</us-gaap:AreaOfRealEstateProperty>
    <angn:LesseeOperatingLeaseAnnualRentExpense contextRef="c-178" decimals="-5" id="f-707" unitRef="usd">200000</angn:LesseeOperatingLeaseAnnualRentExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-5" id="f-708" unitRef="usd">1400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-6" decimals="-5" id="f-709" unitRef="usd">1500000</us-gaap:OperatingLeaseExpense>
    <angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock contextRef="c-1" id="f-710">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.229%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Weighted-average remaining lease term&#x2014;operating leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-711" unitRef="usd">1350000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-6" decimals="-3" id="f-712" unitRef="usd">1427000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-713">P4Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-714">P5Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="3" id="f-715" unitRef="number">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="3" id="f-716" unitRef="number">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-717">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2025, maturities of lease liabilities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Less present value discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Less: operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating lease liability, noncurrent portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-718" unitRef="usd">1383000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-719" unitRef="usd">1425000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-720" unitRef="usd">1467000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-721" unitRef="usd">1512000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-722" unitRef="usd">253000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-723" unitRef="usd">6040000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-724" unitRef="usd">935000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-725" unitRef="usd">5105000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-726" unitRef="usd">1011000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-727" unitRef="usd">4094000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-728">Debt&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into the Securities Purchase Agreement with GKCC pursuant to which the Company issued the 3% Convertible Note in the principal amount of $20.0 million. Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815, and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the years ended December&#160;31, 2025 and 2024, the Company recorded an immaterial amount and $0.1 million of other expense related to the accretion of the discount of Convertible Note debt issuance costs, respectively. During the years ended December&#160;31, 2025 and 2024, the Company recorded accrued interest expense of $0.1 million and $0.2 million related to the interest due on the Convertible Note but not yet payable, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#x2019;s common stock. In March 2025, the Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million to GKCC. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus 5.00%, provided that the maximum interest rate shall not exceed 12.5% per annum, with an initial interest payment date of July 1, 2026. As of December&#160;31, 2025, the interest rate was 12.5% per annum. The first 24 months of the June 2025 Promissory Note is an interest only period, with payments towards the principal commencing on July 1, 2027 as shown in the below future principal payments table. The Company may prepay the June 2025 Promissory Note in full at any time, but the payment must include the principal, all accrued unpaid interest, and a prepayment fee in one aggregate payment. If the prepayment occurs during the first, second, or third year of the June 2025 Promissory Note, the prepayment fee will be equal to the outstanding principal balance prepaid multiplied by 3%, 2%, or 1%, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;respectively. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default. As of December&#160;31, 2025, the Company was in compliance with all covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of 49.99% of the number of shares of the Company&#x2019;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrants, as determined by the Black-Scholes option pricing model, was $0.6&#160;million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company received net proceeds of $9.9&#160;million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of December&#160;31, 2025, the net carrying value of the June 2025 Promissory Note was $9.4 million, which is net of the debt discount of $0.6 million. During the year ended December&#160;31, 2025, the Company recognized $0.2 million in accretion of the debt discount and $0.7 million in accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of December&#160;31, 2025, the future principal payments for the June 2025 Promissory Note were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Total principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-66" decimals="2" id="f-729" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-66" decimals="-5" id="f-730" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-66" decimals="2" id="f-731" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-112" decimals="-5" id="f-732" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-179" decimals="-5" id="f-733" unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-180" decimals="-5" id="f-734" unitRef="usd">100000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt contextRef="c-179" decimals="-5" id="f-735" unitRef="usd">100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-180" decimals="-5" id="f-736" unitRef="usd">200000</us-gaap:InterestExpenseDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-68"
      decimals="INF"
      id="f-737"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-66" decimals="-5" id="f-738" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <angn:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-69" decimals="-5" id="f-739" unitRef="usd">300000</angn:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-70" decimals="-5" id="f-740" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-72" decimals="4" id="f-741" unitRef="number">0.0500</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-181" decimals="3" id="f-742" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-182" decimals="3" id="f-743" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-183" decimals="2" id="f-744" unitRef="number">0.03</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-184" decimals="2" id="f-745" unitRef="number">0.02</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-185" decimals="2" id="f-746" unitRef="number">0.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-70"
      decimals="INF"
      id="f-747"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-70"
      decimals="2"
      id="f-748"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-70" id="f-749">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <angn:ClassOfWarrantOrRightOwnershipPercentMaximum contextRef="c-186" decimals="4" id="f-750" unitRef="number">0.4999</angn:ClassOfWarrantOrRightOwnershipPercentMaximum>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-143" decimals="-5" id="f-751" unitRef="usd">600000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-72" decimals="-5" id="f-752" unitRef="usd">9900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-182" decimals="-5" id="f-753" unitRef="usd">9400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="c-182" decimals="-5" id="f-754" unitRef="usd">600000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-187" decimals="-5" id="f-755" unitRef="usd">200000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="c-182" decimals="-5" id="f-756" unitRef="usd">700000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-757">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of December&#160;31, 2025, the future principal payments for the June 2025 Promissory Note were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Total principal amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-4" decimals="-3" id="f-758" unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-4" decimals="-3" id="f-759" unitRef="usd">5785000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-4" decimals="-3" id="f-760" unitRef="usd">4215000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="-3" id="f-761" unitRef="usd">10000000</us-gaap:LongTermDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-762">Income Taxes&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Income (loss) before taxes related to the Company&#x2019;s United States and foreign operations for the years ended December&#160;31, 2025 and 2024 consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(39,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(51,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company had no income tax expense or benefit due to operating losses incurred for the years ended December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Beginning with the year ended December 31, 2025, the Company adopted ASU 2023-09 on a prospective basis. See Note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'MS Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;for additional details. A reconciliation between the federal statutory income tax amount and rate to the Company's actual effective amount and rate pursuant to the disclosure requirements of ASU 2023-09 for the year ended December&#160;31, 2025 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Year Ended Year Ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;US federal statutory income tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Domestic state and local taxes, net of federal effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Foreign tax effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Tax credits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Nontaxable or nondeductible items:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Nondeductible stock based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Change in fair value of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other nontaxable and nondeductible items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for income taxes and effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;A reconciliation between the federal statutory income tax rate and the Company's effective income tax rate prior to the adoption of ASU 2023-09 for the year ended December 31, 2024 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;State tax, net of federal benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Federal research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;State research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(19.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The principal components of the Company's net deferred tax assets at December&#160;31, 2025 and 2024 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;77,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;64,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Research and development tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;16,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;15,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Capitalized research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;13,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;17,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;110,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;100,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Less: Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(110,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(100,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Net operating losses (&#x201c;NOLs&#x201d;) generated in tax years ended December 31, 2017 and prior can be carried forward 20 years under the Internal Revenue Code (&#x201c;IRC&#x201d;). Use of NOLs arising in tax years ended after December 31, 2017 are limited to 80% of taxable income in any one tax year, and are carried forward indefinitely. At December&#160;31, 2025, Elicio has federal NOLs of $311.4 million, of which $19.1 million will start to expire in 2032 and $292.3 million can be carried forward indefinitely, and state NOLs of $179.5 million that will start to expire in 2032. At December&#160;31, 2025, Elicio has $14.1 million and $2.9 million of federal and state research and development credit carryforwards, respectively, that start to expire in 2027. At December&#160;31, 2025, Elicio has $1.4 million and $0.2 million of Australian NOLs and research and development credit carryforwards, respectively, that can be carried forward indefinitely.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As the Company has not yet achieved profitable operations, management believes the tax benefits as of December&#160;31, 2025 did not satisfy the realization criteria set forth in ASC Topic 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and, therefore, has recorded a full valuation allowance for the entire deferred tax asset. The valuation allowance increased in 2025 by $10.2 million primarily due to current year operating losses and research and development credits generated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Ownership changes, as defined in the IRC, may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income pursuant to IRC Section 382 or similar provisions. Subsequent ownership changes could further affect the limitation in future years. The Company has not completed a study to assess whether a change in control has occurred or whether there have been multiple changes in control since the Company&#x2019;s formation due to the significant complexity and cost associated with such study and because there could be additional changes in control in the future. As a result, the Company is not able to estimate the effect of the change in control, if any, on the Company&#x2019;s ability to utilize NOL and research and development credit carryforwards in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company files tax returns in the United States, Australia, California, Connecticut, Florida, Massachusetts, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New York, North Carolina, Pennsylvania, Tennessee, and Utah. The federal and state tax returns for the periods ended December 31, 2022, 2023, and 2024 remain open to examination by the major taxing jurisdictions to which the Company is subject, as carryforward attributes generated in years past may still be adjusted upon examination by the Internal Revenue Service (&#x201c;IRS&#x201d;) or other authorities if they have or will be used in a future period. To its knowledge, the Company is not currently under examination by the IRS or any other jurisdictions for any tax years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;A reconciliation of the unrecognized tax benefits for the years ended December&#160;31, 2025 and 2024 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Gross unrecognized tax benefit, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Increase (decrease) recognized in the income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Gross unrecognized tax benefit, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of December&#160;31, 2025, the Company had $4.1 million of unrecognized tax benefits related to prior research tax credits that may not be substantiated upon audit. If recognized, the Company anticipates that its effective tax rate would not be affected for the years ended December&#160;31, 2025 and 2024. The Company has elected to recognize interest and penalties related to income tax matters as a component of income tax expense, of which no interest or penalties were recorded for the years ended December&#160;31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;On July 4, 2025, H.R. 1 (the &#x201c;Act&#x201d;), commonly referred to as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act has multiple effective dates, with certain provisions effective in 2025 and others to be implemented through 2027. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The provisions impacting the Company have been reflected in the financial statements for the year ended December&#160;31, 2025, and did not have a material impact as the Company has a valuation allowance against its net deferred tax assets.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-763">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Income (loss) before taxes related to the Company&#x2019;s United States and foreign operations for the years ended December&#160;31, 2025 and 2024 consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(39,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(51,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-3" id="f-764" unitRef="usd">-39476000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-6" decimals="-3" id="f-765" unitRef="usd">-51728000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-3" id="f-766" unitRef="usd">-95000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-6" decimals="-3" id="f-767" unitRef="usd">-170000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-768" unitRef="usd">-39571000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-769" unitRef="usd">-51898000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-770">A reconciliation between the federal statutory income tax amount and rate to the Company's actual effective amount and rate pursuant to the disclosure requirements of ASU 2023-09 for the year ended December&#160;31, 2025 is as follows (in thousands):&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Year Ended Year Ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;US federal statutory income tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Domestic state and local taxes, net of federal effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Foreign tax effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Tax credits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Nontaxable or nondeductible items:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Nondeductible stock based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Change in fair value of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other nontaxable and nondeductible items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for income taxes and effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;A reconciliation between the federal statutory income tax rate and the Company's effective income tax rate prior to the adoption of ASU 2023-09 for the year ended December 31, 2024 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;State tax, net of federal benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Federal research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;State research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(19.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-771" unitRef="usd">-8310000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="INF" id="f-772" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="-3" id="f-773" unitRef="usd">0</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-774" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-3" id="f-775" unitRef="usd">20000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="3" id="f-776" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-1" decimals="-3" id="f-777" unitRef="usd">1126000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-1" decimals="3" id="f-778" unitRef="number">-0.029</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-3" id="f-779" unitRef="usd">310000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="3" id="f-780" unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <angn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount contextRef="c-1" decimals="-3" id="f-781" unitRef="usd">402000</angn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsAmount>
    <angn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent contextRef="c-1" decimals="3" id="f-782" unitRef="number">-0.010</angn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfWarrantsPercent>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-1" decimals="-3" id="f-783" unitRef="usd">244000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="c-1" decimals="3" id="f-784" unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-785" unitRef="usd">8460000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="3" id="f-786" unitRef="number">-0.214</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-787" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-788" unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-6" decimals="INF" id="f-789" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-6" decimals="3" id="f-790" unitRef="number">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <angn:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent contextRef="c-6" decimals="3" id="f-791" unitRef="number">-0.035</angn:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-6" decimals="3" id="f-792" unitRef="number">-0.036</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <angn:EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent contextRef="c-6" decimals="3" id="f-793" unitRef="number">0.006</angn:EffectiveIncomeTaxRateReconciliationTaxCreditStateResearchAndDevelopmentPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-6" decimals="3" id="f-794" unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="3" id="f-795" unitRef="number">-0.194</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-6" decimals="3" id="f-796" unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-797">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The principal components of the Company's net deferred tax assets at December&#160;31, 2025 and 2024 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;77,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;64,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Research and development tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;16,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;15,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Capitalized research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;13,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;17,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;110,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;100,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Less: Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(110,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(100,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="-3" id="f-798" unitRef="usd">77260000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-3" id="f-799" unitRef="usd">64646000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-4" decimals="-3" id="f-800" unitRef="usd">16534000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="-3" id="f-801" unitRef="usd">15117000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-4" decimals="-3" id="f-802" unitRef="usd">13412000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-5" decimals="-3" id="f-803" unitRef="usd">17585000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <angn:DeferredTaxAssetsOperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-804" unitRef="usd">1301000</angn:DeferredTaxAssetsOperatingLeaseLiability>
    <angn:DeferredTaxAssetsOperatingLeaseLiability contextRef="c-5" decimals="-3" id="f-805" unitRef="usd">1548000</angn:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-4" decimals="-3" id="f-806" unitRef="usd">3023000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-5" decimals="-3" id="f-807" unitRef="usd">2704000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-4" decimals="-3" id="f-808" unitRef="usd">1218000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-5" decimals="-3" id="f-809" unitRef="usd">1470000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-810" unitRef="usd">8000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-811" unitRef="usd">13000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <angn:DeferredTaxAssetsNetBeforeValuationAllowance contextRef="c-4" decimals="-3" id="f-812" unitRef="usd">110304000</angn:DeferredTaxAssetsNetBeforeValuationAllowance>
    <angn:DeferredTaxAssetsNetBeforeValuationAllowance contextRef="c-5" decimals="-3" id="f-813" unitRef="usd">100117000</angn:DeferredTaxAssetsNetBeforeValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-814" unitRef="usd">110304000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-815" unitRef="usd">100117000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-4" decimals="-3" id="f-816" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-5" decimals="-3" id="f-817" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards contextRef="c-188" decimals="-5" id="f-818" unitRef="usd">311400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-189" decimals="-5" id="f-819" unitRef="usd">19100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-4" decimals="-5" id="f-820" unitRef="usd">292300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-190" decimals="-5" id="f-821" unitRef="usd">179500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-191" decimals="-5" id="f-822" unitRef="usd">14100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-192" decimals="-5" id="f-823" unitRef="usd">2900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-193" decimals="-5" id="f-824" unitRef="usd">1400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-194" decimals="-5" id="f-825" unitRef="usd">200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-826" unitRef="usd">10200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-827">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;A reconciliation of the unrecognized tax benefits for the years ended December&#160;31, 2025 and 2024 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Gross unrecognized tax benefit, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Increase (decrease) recognized in the income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Gross unrecognized tax benefit, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-3" id="f-828" unitRef="usd">4141000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-35" decimals="-3" id="f-829" unitRef="usd">4141000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease contextRef="c-1" decimals="-3" id="f-830" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease contextRef="c-6" decimals="-3" id="f-831" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-3" id="f-832" unitRef="usd">4141000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-3" id="f-833" unitRef="usd">4141000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-5" id="f-834" unitRef="usd">4100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-4" decimals="INF" id="f-835" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-5" decimals="INF" id="f-836" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DefinedContributionPlanTextBlock contextRef="c-1" id="f-837">Employee Benefit Plan&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Employee Benefit Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company provides a retirement savings plan through the Elicio Therapeutics, Inc. 401(k) Plan (the &#x201c;Elicio Retirement Plan&#x201d;), subject to certain limitations. As allowed under Section 401(k) of the IRC, the Elicio Retirement Plan allows tax deferred salary deductions for eligible employees. An employee&#x2019;s interest in his or her salary deferral contributions is 100% vested when contributed.&lt;/span&gt;&lt;/div&gt;Pursuant to the Merger Agreement, the Company assumed the retirement savings plan sponsored by Angion (the &#x201c;Angion Retirement Plan&#x201d;). The Angion Retirement Plan is intended to qualify for favorable tax treatment under Section 401(a) of the IRC, and contains a cash or deferred feature that is intended to meet the requirements of Section 401(k) of the IRC. Currently, no employees are contributing under the Angion Retirement Plan.</us-gaap:DefinedContributionPlanTextBlock>
    <us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
      contextRef="c-195"
      decimals="INF"
      id="f-838"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-839">Net Loss Per Share&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated for the years ended December&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(39,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(51,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Weighted-average shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;15,312,751&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,202,996&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,621,203&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,890,932&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Shares issuable upon the exercise of common warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,555,319&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,448,764&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,176,522&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4,339,696&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-840">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated for the years ended December&#160;31, 2025 and 2024 as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(39,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(51,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Weighted-average shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;15,312,751&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,202,996&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-841" unitRef="usd">-39571000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-842" unitRef="usd">-51898000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-843" unitRef="shares">15312751</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-844" unitRef="shares">15312751</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-845" unitRef="shares">12202996</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-846" unitRef="shares">12202996</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-847"
      unitRef="usdPerShare">-2.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-848"
      unitRef="usdPerShare">-2.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-849"
      unitRef="usdPerShare">-4.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-850"
      unitRef="usdPerShare">-4.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-851">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,621,203&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,890,932&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Shares issuable upon the exercise of common warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,555,319&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,448,764&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6,176,522&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%"&gt;4,339,696&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-196" decimals="0" id="f-852" unitRef="shares">2621203</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-197" decimals="0" id="f-853" unitRef="shares">1890932</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-198" decimals="0" id="f-854" unitRef="shares">3555319</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-199" decimals="0" id="f-855" unitRef="shares">2448764</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-856" unitRef="shares">6176522</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-6" decimals="0" id="f-857" unitRef="shares">4339696</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-858">Related Party Transactions&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Private Placement and Subscription Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The net proceeds to the Company from the March 2024 Offering were approximately $6.0&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;July 2024 Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the July 2024 Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#x2019;s board of directors, and Jay Venkatesan, a member of the Company&#x2019;s board of directors, and trusts affiliated with Jay Venkatesan, purchased 1,600,000 July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants and 200,000 July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants, respectively, with such July 2024 Pre-Funded Warrants and July 2024 Common Warrants subject to the terms and conditions of the July 2024 Pre-Funded Warrants and July 2024 Common Warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The net proceeds to the Company from the July 2024 Public Offering were approximately $10.9&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#x2019;s common stock. The Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0&#160;million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million. The Company received net proceeds of approximately $9.9&#160;million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-129"
      decimals="2"
      id="f-859"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-200" decimals="-5" id="f-860" unitRef="usd">6000000.0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-201" decimals="0" id="f-861" unitRef="shares">1600000</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-202" decimals="0" id="f-862" unitRef="shares">200000</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-203" decimals="-5" id="f-863" unitRef="usd">10900000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-66" decimals="-5" id="f-864" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-112" decimals="-5" id="f-865" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-68"
      decimals="INF"
      id="f-866"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-66" decimals="-5" id="f-867" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <angn:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-69" decimals="-5" id="f-868" unitRef="usd">300000</angn:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-70" decimals="INF" id="f-869" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-72" decimals="-5" id="f-870" unitRef="usd">9900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-70"
      decimals="INF"
      id="f-871"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-872">Segment Reporting&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has one reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#x2019;s CODM, its Chief Executive Officer, manages the Company&#x2019;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the consolidated statements of cash flows. Other segment items include interest income, interest expense, grant income, and change in the fair value of warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the consolidated statements of cash flows. The following table presents certain financial data for the Company&#x2019;s reportable segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clinical trial expenses &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employee related research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Chemistry, manufacturing and controls expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract and grant reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employee related general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees and other general and administrative expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other segment items &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments contextRef="c-1" decimals="INF" id="f-873" unitRef="entity">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-874">The following table presents certain financial data for the Company&#x2019;s reportable segment (in thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clinical trial expenses &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employee related research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Chemistry, manufacturing and controls expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract and grant reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employee related general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees and other general and administrative expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other segment items &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-204" decimals="-3" id="f-875" unitRef="usd">9602000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-205" decimals="-3" id="f-876" unitRef="usd">15892000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-206" decimals="-3" id="f-877" unitRef="usd">8915000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-207" decimals="-3" id="f-878" unitRef="usd">8560000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-208" decimals="-3" id="f-879" unitRef="usd">1896000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-209" decimals="-3" id="f-880" unitRef="usd">4260000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-210" decimals="-3" id="f-881" unitRef="usd">5248000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-211" decimals="-3" id="f-882" unitRef="usd">5971000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-212" decimals="-3" id="f-883" unitRef="usd">-754000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-213" decimals="-3" id="f-884" unitRef="usd">-1027000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-212" decimals="-3" id="f-885" unitRef="usd">5506000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-213" decimals="-3" id="f-886" unitRef="usd">3682000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-212" decimals="-3" id="f-887" unitRef="usd">7300000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-213" decimals="-3" id="f-888" unitRef="usd">7648000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-212" decimals="-3" id="f-889" unitRef="usd">1858000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-213" decimals="-3" id="f-890" unitRef="usd">6912000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:NetIncomeLoss contextRef="c-212" decimals="-3" id="f-891" unitRef="usd">39571000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-213" decimals="-3" id="f-892" unitRef="usd">51898000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets contextRef="c-214" decimals="-3" id="f-893" unitRef="usd">25862000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-215" decimals="-3" id="f-894" unitRef="usd">28178000</us-gaap:Assets>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-895">Subsequent Events&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has completed an evaluation of all subsequent events after the consolidated balance sheet date as of December&#160;31, 2025 through the date these consolidated financial statements were issued to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements as of December&#160;31, 2025, and events which occurred subsequently but were not recognized in the consolidated financial statements. Non-recognizable subsequent events are summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;2024 ATM Program&lt;/span&gt;&lt;/div&gt;After the year ended December&#160;31, 2025 through March&#160;11, 2026, the Company issued and sold 668,504 shares of common stock for net proceeds of $6.3&#160;million under the 2024 ATM Program.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-216"
      decimals="INF"
      id="f-896"
      unitRef="shares">668504</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-216" decimals="-5" id="f-897" unitRef="usd">6300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-217" id="f-898">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-217" id="f-899">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-217" id="f-900">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-217" id="f-901">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-902">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-903">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
